id|nct_id|result_group_id|ctgov_group_code|period|reason|count
650353|NCT03231371|2069870|P1|Overall Study|chose or were ineligible to have MRI|12
650354|NCT03231371|2069870|P1|Overall Study|Withdrawal by Subject|1
887807|NCT02755805|2820844|P2|Overall Study|Withdrawal by Subject|2
887808|NCT02755805|2820845|P1|Overall Study|Withdrawal by Subject|0
650357|NCT03072719|2070038|P2|Overall Study|Adverse Event|1
650358|NCT03072719|2070039|P1|Overall Study|Adverse Event|1
650359|NCT03065933|2070185|P1|Overall Study|study terminated|5
650360|NCT03055221|2070200|P1|Overall Study|Study terminated by Sponsor|3
650361|NCT03055221|2070200|P1|Overall Study|Physician Decision|1
650362|NCT03055221|2070200|P1|Overall Study|Death|6
650363|NCT03055221|2070200|P1|Overall Study|Withdrawal by Subject|4
650364|NCT03055221|2070200|P1|Overall Study|Adverse Event|2
650365|NCT03023137|2070379|P2|Overall Study|Lost the baby in a car accident|0
650366|NCT03023137|2070380|P1|Overall Study|Lost the baby in a car accident|1
650367|NCT03023137|2070379|P2|Overall Study|Protocol Violation|4
650368|NCT03023137|2070380|P1|Overall Study|Protocol Violation|0
650369|NCT03023137|2070379|P2|Overall Study|Lost to Follow-up|1
650370|NCT03023137|2070380|P1|Overall Study|Lost to Follow-up|1
650371|NCT03023137|2070379|P2|Overall Study|Multiple pregnancy|4
650372|NCT03023137|2070380|P1|Overall Study|Multiple pregnancy|2
650373|NCT03022422|2070438|P6|Overall Study|3 subjects consented but not vaccinated|0
650374|NCT03022422|2070439|P5|Overall Study|3 subjects consented but not vaccinated|0
650375|NCT03022422|2070440|P4|Overall Study|3 subjects consented but not vaccinated|0
650376|NCT03022422|2070441|P3|Overall Study|3 subjects consented but not vaccinated|3
650377|NCT03022422|2070442|P2|Overall Study|3 subjects consented but not vaccinated|0
650378|NCT03022422|2070443|P1|Overall Study|3 subjects consented but not vaccinated|0
650379|NCT02990910|2070589|P2|Overall Study|Lack of Efficacy|10
650380|NCT02990910|2070590|P1|Overall Study|Lack of Efficacy|6
650381|NCT02988219|2070600|P2|Overall Study|Withdrawal by Subject|2
650382|NCT02988219|2070601|P1|Overall Study|Withdrawal by Subject|0
650383|NCT02988219|2070600|P2|Overall Study|Lack of Efficacy|1
650384|NCT02988219|2070601|P1|Overall Study|Lack of Efficacy|1
650385|NCT02977572|2070621|P2|Overall Study|Exclusion criterion|2
650386|NCT02977572|2070622|P1|Overall Study|Exclusion criterion|2
650387|NCT02974543|2070646|P2|Overall Study|Withdrawal by Subject|0
650388|NCT02974543|2070647|P1|Overall Study|Withdrawal by Subject|1
650389|NCT02971670|2070671|P4|Overall Study|Withdrawal by Subject|2
650390|NCT02971670|2070672|P3|Overall Study|Withdrawal by Subject|1
650391|NCT02971670|2070673|P2|Overall Study|Withdrawal by Subject|1
650392|NCT02971670|2070674|P1|Overall Study|Withdrawal by Subject|4
650403|NCT02951767|2070797|P1|Overall Study|Lost to Follow-up|1
650404|NCT02951767|2070797|P1|Overall Study|Death|59
650405|NCT02951767|2070797|P1|Overall Study|Withdrawal by Subject|5
650406|NCT02951767|2070797|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
650407|NCT02912650|2070929|P4|Overall Study|Adverse Event|0
650408|NCT02912650|2070930|P3|Overall Study|Adverse Event|1
650409|NCT02912650|2070931|P2|Overall Study|Adverse Event|0
650410|NCT02912650|2070932|P1|Overall Study|Adverse Event|0
650411|NCT02912650|2070929|P4|Overall Study|Withdrawal by Subject|5
650412|NCT02912650|2070930|P3|Overall Study|Withdrawal by Subject|1
650413|NCT02912650|2070931|P2|Overall Study|Withdrawal by Subject|0
650414|NCT02912650|2070932|P1|Overall Study|Withdrawal by Subject|1
650415|NCT02903238|2071023|P1|Overall Study|Lost to Follow-up|4
650416|NCT02895347|2071034|P2|Overall Study|Withdrawal by Subject|1
650417|NCT02895347|2071035|P1|Overall Study|Withdrawal by Subject|3
650418|NCT02886338|2071058|P1|Overall Study|Withdrawal by Subject|1
650419|NCT02882152|2071083|P2|Overall Study|Lost to Follow-up|0
650420|NCT02882152|2071084|P1|Overall Study|Lost to Follow-up|1
650421|NCT02873429|2071131|P2|16 Weeks|Lost to Follow-up|0
650422|NCT02873429|2071132|P1|16 Weeks|Lost to Follow-up|3
650423|NCT02873429|2071131|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
650424|NCT02873429|2071132|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
650425|NCT02873429|2071131|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
650426|NCT02873429|2071132|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
650427|NCT02862600|2071165|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
650428|NCT02862600|2071165|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
650429|NCT02862600|2071165|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
650430|NCT02862600|2071165|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
650431|NCT02862106|2071178|P2|Overall Study|Subjects moved to other city|0
650432|NCT02862106|2071179|P1|Overall Study|Subjects moved to other city|1
650433|NCT02862106|2071178|P2|Overall Study|Withdrawal by Subject|0
650434|NCT02862106|2071179|P1|Overall Study|Withdrawal by Subject|2
650435|NCT02862106|2071178|P2|Overall Study|Lost to Follow-up|5
650436|NCT02862106|2071179|P1|Overall Study|Lost to Follow-up|15
650437|NCT02862106|2071178|P2|Overall Study|Protocol Violation|1
650438|NCT02862106|2071179|P1|Overall Study|Protocol Violation|16
650439|NCT02862106|2071178|P2|Overall Study|Adverse Event|0
650440|NCT02862106|2071179|P1|Overall Study|Adverse Event|4
650441|NCT02856880|2071237|P1|Overall Study|Withdrawal of consent|1
650442|NCT02855411|2071261|P1|Overall Study|Does not meet entrance criteria|14
650443|NCT02855411|2071261|P1|Overall Study|Study terminated by sponsor|21
887809|NCT02755805|2820844|P2|Overall Study|Refused assessments|0
887810|NCT02755805|2820845|P1|Overall Study|Refused assessments|1
887811|NCT02755805|2820844|P2|Overall Study|Lost to Follow-up|2
887812|NCT02755805|2820845|P1|Overall Study|Lost to Follow-up|1
650448|NCT02832375|2071430|P2|Overall Study|Withdrawal of Consent|0
650449|NCT02832375|2071431|P1|Overall Study|Withdrawal of Consent|1
650450|NCT02832375|2071430|P2|Overall Study|Lost to Follow-up|0
650451|NCT02832375|2071431|P1|Overall Study|Lost to Follow-up|1
650452|NCT02829775|2071441|P1|Overall Study|Disease remission|1
650453|NCT02829775|2071441|P1|Overall Study|Withdrawal by Subject|3
650454|NCT02829775|2071441|P1|Overall Study|Death|1
650455|NCT02826421|2071472|P4|Overall Study|Reason not given|0
650456|NCT02826421|2071473|P3|Overall Study|Reason not given|1
650457|NCT02826421|2071474|P2|Overall Study|Reason not given|0
650458|NCT02826421|2071475|P1|Overall Study|Reason not given|1
650459|NCT02826421|2071472|P4|Overall Study|Withdrawal by Subject|1
650460|NCT02826421|2071473|P3|Overall Study|Withdrawal by Subject|1
650461|NCT02826421|2071474|P2|Overall Study|Withdrawal by Subject|3
650462|NCT02826421|2071475|P1|Overall Study|Withdrawal by Subject|1
650463|NCT02826421|2071472|P4|Overall Study|Adverse Event|1
650464|NCT02826421|2071473|P3|Overall Study|Adverse Event|0
650465|NCT02826421|2071474|P2|Overall Study|Adverse Event|0
650466|NCT02826421|2071475|P1|Overall Study|Adverse Event|1
650467|NCT02815735|2071575|P2|Second Intervention (4 Weeks)|Protocol Violation|0
650468|NCT02815735|2071576|P1|Second Intervention (4 Weeks)|Protocol Violation|1
650469|NCT02815735|2071575|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
650470|NCT02815735|2071576|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
650471|NCT02815735|2071575|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
650472|NCT02815735|2071576|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
650473|NCT02815735|2071575|P2|First Intervention (4 Weeks)|Discomfort|0
650474|NCT02815735|2071576|P1|First Intervention (4 Weeks)|Discomfort|1
650475|NCT02809833|2071634|P1|Overall Study|Missing Information|52
650476|NCT02809833|2071634|P1|Overall Study|Not Specified|5
650477|NCT02809833|2071634|P1|Overall Study|Adverse Event (AE)|24
650478|NCT02809833|2071634|P1|Overall Study|Lost to Follow-up|35
650479|NCT02809833|2071634|P1|Overall Study|Withdrawal by Subject|34
650480|NCT02809833|2071634|P1|Overall Study|Noncompliance|1
650481|NCT02809833|2071634|P1|Overall Study|Remission/Treatment No Longer Needed|3
650482|NCT02809833|2071634|P1|Overall Study|Lack of Efficacy|89
650483|NCT02809833|2071634|P1|Overall Study|Intolerance|54
650484|NCT02809833|2071634|P1|Overall Study|Death|3
650485|NCT02806505|2071756|P2|Overall Study|Insufficient therapeutic response|4
650486|NCT02806505|2071757|P1|Overall Study|Insufficient therapeutic response|2
650487|NCT02806505|2071756|P2|Overall Study|Failure to return|1
650488|NCT02806505|2071757|P1|Overall Study|Failure to return|0
650489|NCT02806505|2071756|P2|Overall Study|Did not cooperate/refused treatment|3
650490|NCT02806505|2071757|P1|Overall Study|Did not cooperate/refused treatment|3
650491|NCT02806505|2071756|P2|Overall Study|Death|0
650492|NCT02806505|2071757|P1|Overall Study|Death|4
650493|NCT02806505|2071756|P2|Overall Study|Adverse event/intercurrent illness|3
650494|NCT02806505|2071757|P1|Overall Study|Adverse event/intercurrent illness|1
650495|NCT02805907|2071769|P2|Overall Study|Lost to Follow-up|3
650496|NCT02805907|2071770|P1|Overall Study|Lost to Follow-up|3
650497|NCT02802592|2071782|P1|Overall Study|Study terminated due to loss of funding|4
650498|NCT02801396|2071791|P6|Period 1|Withdrawal by Subject|0
650499|NCT02801396|2071792|P5|Period 1|Withdrawal by Subject|1
650500|NCT02801396|2071793|P4|Period 1|Withdrawal by Subject|0
650501|NCT02801396|2071794|P3|Period 1|Withdrawal by Subject|0
650502|NCT02801396|2071795|P2|Period 1|Withdrawal by Subject|0
650503|NCT02801396|2071796|P1|Period 1|Withdrawal by Subject|0
650504|NCT02799082|2071824|P2|Overall Study|Protocol Violation|1
650505|NCT02799082|2071825|P1|Overall Study|Protocol Violation|0
650506|NCT02799082|2071824|P2|Overall Study|Refused second PDT or withdraw consent|3
650507|NCT02799082|2071825|P1|Overall Study|Refused second PDT or withdraw consent|4
650508|NCT02799069|2071862|P3|Overall Study|Protocol Violation|2
650509|NCT02799069|2071863|P2|Overall Study|Protocol Violation|0
650510|NCT02799069|2071864|P1|Overall Study|Protocol Violation|1
650511|NCT02799069|2071862|P3|Overall Study|Withdrawal by Subject|3
650512|NCT02799069|2071863|P2|Overall Study|Withdrawal by Subject|4
650513|NCT02799069|2071864|P1|Overall Study|Withdrawal by Subject|4
650514|NCT02799069|2071862|P3|Overall Study|Lost to Follow-up|0
650515|NCT02799069|2071863|P2|Overall Study|Lost to Follow-up|1
650516|NCT02799069|2071864|P1|Overall Study|Lost to Follow-up|1
650517|NCT02799069|2071862|P3|Overall Study|Lack of Efficacy|0
650518|NCT02799069|2071863|P2|Overall Study|Lack of Efficacy|0
650519|NCT02799069|2071864|P1|Overall Study|Lack of Efficacy|2
650520|NCT02799069|2071862|P3|Overall Study|Adverse Event|2
650521|NCT02799069|2071863|P2|Overall Study|Adverse Event|2
650522|NCT02799069|2071864|P1|Overall Study|Adverse Event|0
650523|NCT02791659|2072028|P2|Overall Study|Protocol Violation|1
650524|NCT02791659|2072029|P1|Overall Study|Protocol Violation|0
650525|NCT02791269|2072037|P2|Overall Study|Lost to Follow-up|1
650526|NCT02791269|2072038|P1|Overall Study|Lost to Follow-up|0
650527|NCT02788357|2072060|P2|Overall Study|Lost to Follow-up|0
650528|NCT02788357|2072061|P1|Overall Study|Lost to Follow-up|3
887813|NCT02732561|2820859|P2|Overall Study|Withdrawal by Subject|0
887814|NCT02732561|2820860|P1|Overall Study|Withdrawal by Subject|1
650531|NCT02777125|2072169|P2|Overall Study|Protocol Violation|12
650532|NCT02777125|2072170|P1|Overall Study|Protocol Violation|8
650533|NCT02777125|2072169|P2|Overall Study|Assent form violation|23
650534|NCT02777125|2072170|P1|Overall Study|Assent form violation|21
650535|NCT02777125|2072169|P2|Overall Study|Consent form violation|12
650536|NCT02777125|2072170|P1|Overall Study|Consent form violation|14
650537|NCT02774278|2072184|P1|Overall Study|Protocol Violation|2
650538|NCT02774278|2072184|P1|Overall Study|Withdrawal by Subject|3
650539|NCT02774278|2072184|P1|Overall Study|Administrative reasons|6
650540|NCT02774278|2072184|P1|Overall Study|Refused treatment/did not cooperate|9
650541|NCT02774278|2072184|P1|Overall Study|Adverse event/intercurrent illness|16
650542|NCT02774278|2072184|P1|Overall Study|Death|29
650543|NCT02774278|2072184|P1|Overall Study|Lack of Efficacy|199
650544|NCT02767765|2072229|P1|Overall Study|Withdrawal by Subject|1
650545|NCT02767765|2072229|P1|Overall Study|Non-Compliance|1
650546|NCT02767765|2072229|P1|Overall Study|Investigator decision|1
650547|NCT02767765|2072229|P1|Overall Study|Lost to Follow-up|2
650548|NCT02767765|2072229|P1|Overall Study|Insufficient response|1
650549|NCT02767765|2072229|P1|Overall Study|Death|1
650550|NCT02767765|2072229|P1|Overall Study|Adverse Event|4
650557|NCT02761733|2072286|P4|Overall Study|Cognitive Impairment|0
650558|NCT02761733|2072287|P3|Overall Study|Cognitive Impairment|1
650559|NCT02761733|2072288|P2|Overall Study|Cognitive Impairment|0
650560|NCT02761733|2072289|P1|Overall Study|Cognitive Impairment|5
650561|NCT02761733|2072286|P4|Overall Study|Discharged from Study Site|11
650562|NCT02761733|2072287|P3|Overall Study|Discharged from Study Site|25
650563|NCT02761733|2072288|P2|Overall Study|Discharged from Study Site|9
650564|NCT02761733|2072289|P1|Overall Study|Discharged from Study Site|10
650565|NCT02761733|2072286|P4|Overall Study|Withdrawal by Subject|0
650566|NCT02761733|2072287|P3|Overall Study|Withdrawal by Subject|0
650567|NCT02761733|2072288|P2|Overall Study|Withdrawal by Subject|0
650568|NCT02761733|2072289|P1|Overall Study|Withdrawal by Subject|2
650569|NCT02761733|2072286|P4|Overall Study|Physician Decision|0
650570|NCT02761733|2072287|P3|Overall Study|Physician Decision|0
650571|NCT02761733|2072288|P2|Overall Study|Physician Decision|0
650572|NCT02761733|2072289|P1|Overall Study|Physician Decision|4
650573|NCT02761733|2072286|P4|Overall Study|Lost to Follow-up|3
650574|NCT02761733|2072287|P3|Overall Study|Lost to Follow-up|0
650575|NCT02761733|2072288|P2|Overall Study|Lost to Follow-up|7
650576|NCT02761733|2072289|P1|Overall Study|Lost to Follow-up|6
650577|NCT02761733|2072286|P4|Overall Study|Death|1
650578|NCT02761733|2072287|P3|Overall Study|Death|1
650579|NCT02761733|2072288|P2|Overall Study|Death|5
650580|NCT02761733|2072289|P1|Overall Study|Death|3
650581|NCT02761629|2072321|P2|Overall Study|Randomized But Not Treated|4
650582|NCT02761629|2072322|P1|Overall Study|Randomized But Not Treated|8
650583|NCT02761629|2072321|P2|Overall Study|Lost to Follow-up|1
650584|NCT02761629|2072322|P1|Overall Study|Lost to Follow-up|4
650585|NCT02761629|2072321|P2|Overall Study|Unspecified|2
650586|NCT02761629|2072322|P1|Overall Study|Unspecified|0
650587|NCT02761629|2072321|P2|Overall Study|Withdrawal by Subject|3
650588|NCT02761629|2072322|P1|Overall Study|Withdrawal by Subject|0
650589|NCT02761629|2072321|P2|Overall Study|Protocol Violation|2
650590|NCT02761629|2072322|P1|Overall Study|Protocol Violation|2
650591|NCT02761629|2072321|P2|Overall Study|Did not Cooperate/Refused Treatment|4
650592|NCT02761629|2072322|P1|Overall Study|Did not Cooperate/Refused Treatment|2
650593|NCT02761629|2072321|P2|Overall Study|Failure to Return|4
650594|NCT02761629|2072322|P1|Overall Study|Failure to Return|2
650595|NCT02761629|2072321|P2|Overall Study|Insufficient Therapeutic Response|7
650596|NCT02761629|2072322|P1|Overall Study|Insufficient Therapeutic Response|2
650597|NCT02761629|2072321|P2|Overall Study|Adverse Event/Intercurrent Illness|5
650598|NCT02761629|2072322|P1|Overall Study|Adverse Event/Intercurrent Illness|7
650599|NCT02760810|2072342|P1|Overall Study|Protocol Violation|1
650604|NCT02759692|2072375|P2|Period 2|Test article no longer available|1
650605|NCT02759692|2072376|P1|Period 2|Test article no longer available|0
650606|NCT02759692|2072375|P2|Period 2|Lost to Follow-up|0
650607|NCT02759692|2072376|P1|Period 2|Lost to Follow-up|1
650608|NCT02759692|2072375|P2|Period 1|Miss-Randomized|1
650609|NCT02759692|2072376|P1|Period 1|Miss-Randomized|1
650610|NCT02759692|2072375|P2|Period 1|No longer meets eligibility criteria.|0
650611|NCT02759692|2072376|P1|Period 1|No longer meets eligibility criteria.|1
650612|NCT02759692|2072375|P2|Period 1|Test article no longer available|1
650613|NCT02759692|2072376|P1|Period 1|Test article no longer available|1
650614|NCT02759471|2072392|P1|Overall Study|discomfort|2
650615|NCT02756637|2072413|P2|Overall Study|Did not complete curative therapy|0
650616|NCT02756637|2072414|P1|Overall Study|Did not complete curative therapy|33
650617|NCT02756637|2072413|P2|Overall Study|No available NLR value|44
650618|NCT02756637|2072414|P1|Overall Study|No available NLR value|44
650619|NCT02756637|2072413|P2|Overall Study|Not eligible for initial SWOG study|10
650620|NCT02756637|2072414|P1|Overall Study|Not eligible for initial SWOG study|10
887815|NCT02732561|2820859|P2|Overall Study|Lost to Follow-up|1
887816|NCT02732561|2820860|P1|Overall Study|Lost to Follow-up|1
887817|NCT02724644|2820870|P2|Overall Study|Administrative|0
887818|NCT02724644|2820871|P1|Overall Study|Administrative|1
887819|NCT02724644|2820870|P2|Overall Study|Withdrawal by Subject|1
887820|NCT02724644|2820871|P1|Overall Study|Withdrawal by Subject|7
650627|NCT02755090|2072463|P2|Overall Study|equipment malfunction|0
650628|NCT02755090|2072464|P1|Overall Study|equipment malfunction|1
650629|NCT02753075|2072529|P3|Overall Study|Physician Decision|0
650630|NCT02753075|2072530|P2|Overall Study|Physician Decision|1
650631|NCT02753075|2072531|P1|Overall Study|Physician Decision|3
650632|NCT02753075|2072529|P3|Overall Study|Withdrawal of Consent|3
650633|NCT02753075|2072530|P2|Overall Study|Withdrawal of Consent|1
650634|NCT02753075|2072531|P1|Overall Study|Withdrawal of Consent|1
650635|NCT02753075|2072529|P3|Overall Study|Lost to Follow-up|0
650636|NCT02753075|2072530|P2|Overall Study|Lost to Follow-up|0
650637|NCT02753075|2072531|P1|Overall Study|Lost to Follow-up|2
650638|NCT02753075|2072529|P3|Overall Study|Adverse Event|0
650639|NCT02753075|2072530|P2|Overall Study|Adverse Event|1
650640|NCT02753075|2072531|P1|Overall Study|Adverse Event|2
650641|NCT02752802|2072558|P2|Overall Study|Contrast Volume Not Collected|0
650642|NCT02752802|2072559|P1|Overall Study|Contrast Volume Not Collected|1
650643|NCT02751450|2072570|P2|Overall Study|Adverse Event|0
650644|NCT02751450|2072571|P1|Overall Study|Adverse Event|1
887821|NCT02724644|2820870|P2|Overall Study|Lost to Follow-up|2
887822|NCT02724644|2820871|P1|Overall Study|Lost to Follow-up|6
887823|NCT02724644|2820870|P2|Overall Study|Adverse Event|1
887824|NCT02724644|2820871|P1|Overall Study|Adverse Event|7
650649|NCT02750813|2072600|P2|Period 1, First 14 Days of Wear|Reason not given|1
650650|NCT02750813|2072601|P1|Period 1, First 14 Days of Wear|Reason not given|0
650651|NCT02750813|2072600|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
650652|NCT02750813|2072601|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
650653|NCT02750709|2072610|P6|Treatment Period 1|Adverse Event|1
650654|NCT02750709|2072611|P5|Treatment Period 1|Adverse Event|0
650655|NCT02750709|2072612|P4|Treatment Period 1|Adverse Event|0
650656|NCT02750709|2072613|P3|Treatment Period 1|Adverse Event|0
650657|NCT02750709|2072614|P2|Treatment Period 1|Adverse Event|0
650658|NCT02750709|2072615|P1|Treatment Period 1|Adverse Event|0
650659|NCT02750345|2072641|P6|Intervention 1|Adverse Event|0
650660|NCT02750345|2072642|P5|Intervention 1|Adverse Event|1
650661|NCT02750345|2072643|P4|Intervention 1|Adverse Event|0
650662|NCT02750345|2072644|P3|Intervention 1|Adverse Event|0
650663|NCT02750345|2072645|P2|Intervention 1|Adverse Event|0
650664|NCT02750345|2072646|P1|Intervention 1|Adverse Event|0
650665|NCT02750332|2072672|P2|Treatment Period 1|Withdrawal by Subject|1
650666|NCT02750332|2072673|P1|Treatment Period 1|Withdrawal by Subject|0
650667|NCT02748213|2072734|P2|Overall Study|Not Specified|29
650668|NCT02748213|2072735|P1|Overall Study|Not Specified|30
650669|NCT02748213|2072734|P2|Overall Study|Failure to Return|0
650670|NCT02748213|2072735|P1|Overall Study|Failure to Return|1
650671|NCT02748213|2072734|P2|Overall Study|Refused Treatment*|6
650672|NCT02748213|2072735|P1|Overall Study|Refused Treatment*|6
650673|NCT02748213|2072734|P2|Overall Study|Protocol Violation|4
650674|NCT02748213|2072735|P1|Overall Study|Protocol Violation|6
650675|NCT02748213|2072734|P2|Overall Study|Violation of Selection Criteria|0
650676|NCT02748213|2072735|P1|Overall Study|Violation of Selection Criteria|2
650677|NCT02748213|2072734|P2|Overall Study|Insufficient Therapeutic Response|57
650678|NCT02748213|2072735|P1|Overall Study|Insufficient Therapeutic Response|56
650679|NCT02748213|2072734|P2|Overall Study|Death|3
650680|NCT02748213|2072735|P1|Overall Study|Death|5
650681|NCT02748213|2072734|P2|Overall Study|Adverse Event or Intercurrent Illness|11
650682|NCT02748213|2072735|P1|Overall Study|Adverse Event or Intercurrent Illness|5
650683|NCT02748213|2072734|P2|Overall Study|Abnormal Laboratory Test|0
650684|NCT02748213|2072735|P1|Overall Study|Abnormal Laboratory Test|1
650685|NCT02748213|2072734|P2|Overall Study|Withdrawal Prior to Treatment|2
650686|NCT02748213|2072735|P1|Overall Study|Withdrawal Prior to Treatment|1
650687|NCT02746679|2072753|P2|Overall Study|Lost to Follow-up|6
650688|NCT02746679|2072754|P1|Overall Study|Lost to Follow-up|4
650689|NCT02743780|2072850|P5|Part 3 (7 Days)|Adverse Event|0
650690|NCT02743780|2072851|P4|Part 3 (7 Days)|Adverse Event|0
650691|NCT02743780|2072852|P3|Part 3 (7 Days)|Adverse Event|1
650692|NCT02743780|2072853|P2|Part 3 (7 Days)|Adverse Event|0
650693|NCT02743780|2072854|P1|Part 3 (7 Days)|Adverse Event|0
650694|NCT02743117|2072910|P2|Overall Study|Unspecified|0
650695|NCT02743117|2072911|P1|Overall Study|Unspecified|1
650696|NCT02743117|2072910|P2|Overall Study|Lost to Follow-up|1
650697|NCT02743117|2072911|P1|Overall Study|Lost to Follow-up|0
650698|NCT02739594|2072945|P2|Overall Study|Not Specified|2
650699|NCT02739594|2072946|P1|Overall Study|Not Specified|6
650700|NCT02739594|2072945|P2|Overall Study|Elevated Serum Creatinine|1
650701|NCT02739594|2072946|P1|Overall Study|Elevated Serum Creatinine|0
650702|NCT02739594|2072945|P2|Overall Study|Lost to Follow-up|1
650703|NCT02739594|2072946|P1|Overall Study|Lost to Follow-up|0
650704|NCT02739594|2072945|P2|Overall Study|Withdrawal by Subject|1
650705|NCT02739594|2072946|P1|Overall Study|Withdrawal by Subject|1
650706|NCT02739594|2072945|P2|Overall Study|Administrative Reasons|3
650707|NCT02739594|2072946|P1|Overall Study|Administrative Reasons|1
650708|NCT02739594|2072945|P2|Overall Study|Renal Insufficiency|6
650709|NCT02739594|2072946|P1|Overall Study|Renal Insufficiency|4
650710|NCT02739594|2072945|P2|Overall Study|Death|2
650711|NCT02739594|2072946|P1|Overall Study|Death|4
650712|NCT02739594|2072945|P2|Overall Study|Protocol Violation|6
650713|NCT02739594|2072946|P1|Overall Study|Protocol Violation|5
650714|NCT02739594|2072945|P2|Overall Study|Violation of Eligibility Criteria|2
650715|NCT02739594|2072946|P1|Overall Study|Violation of Eligibility Criteria|1
650716|NCT02739594|2072945|P2|Overall Study|Undesired Event|4
650717|NCT02739594|2072946|P1|Overall Study|Undesired Event|3
650718|NCT02737852|2072976|P1|Overall Study|Withdrawal by Subject|2
650719|NCT02737618|2072986|P1|Overall Study|Withdrawal by Subject|9
650720|NCT02737592|2072991|P1|Overall Study|Withdrawal by Subject|1
650721|NCT02736721|2072996|P1|Overall Study|Unspecified|5
650722|NCT02736721|2072996|P1|Overall Study|Lost to Follow-up|3
650723|NCT02736721|2072996|P1|Overall Study|Adverse Event|8
650724|NCT02735200|2073007|P2|Overall Study|Withdrawal by Subject|0
650725|NCT02735200|2073008|P1|Overall Study|Withdrawal by Subject|8
650726|NCT02735200|2073007|P2|Overall Study|Lost to Follow-up|5
650727|NCT02735200|2073008|P1|Overall Study|Lost to Follow-up|0
650728|NCT02734212|2073049|P2|Overall Study|Lost to Follow-up|10
650729|NCT02734212|2073050|P1|Overall Study|Lost to Follow-up|5
650730|NCT02732639|2073069|P1|Overall Study|Lost to Follow-up|1
887825|NCT02696226|2820956|P4|Overall Study|Study terminated - lack of enrollment|0
887826|NCT02696226|2820957|P3|Overall Study|Study terminated - lack of enrollment|2
887827|NCT02696226|2820958|P2|Overall Study|Study terminated - lack of enrollment|0
887828|NCT02696226|2820959|P1|Overall Study|Study terminated - lack of enrollment|1
650735|NCT02732327|2073093|P2|Overall Study|Protocol Violation|1
650736|NCT02732327|2073094|P1|Overall Study|Protocol Violation|0
650737|NCT02732210|2073102|P2|Overall Study|Missing|8
650738|NCT02732210|2073103|P1|Overall Study|Missing|0
650739|NCT02732210|2073102|P2|Overall Study|Other|103
650740|NCT02732210|2073103|P1|Overall Study|Other|35
650741|NCT02732210|2073102|P2|Overall Study|Death|15
650742|NCT02732210|2073103|P1|Overall Study|Death|4
650743|NCT02732210|2073102|P2|Overall Study|Lost to Follow-up|57
650744|NCT02732210|2073103|P1|Overall Study|Lost to Follow-up|5
650745|NCT02732210|2073102|P2|Overall Study|Withdrawal by Subject|87
650746|NCT02732210|2073103|P1|Overall Study|Withdrawal by Subject|28
650747|NCT02732210|2073102|P2|Overall Study|Study Ended|13
650748|NCT02732210|2073103|P1|Overall Study|Study Ended|13
650749|NCT02732210|2073102|P2|Overall Study|Site Closed|11
650750|NCT02732210|2073103|P1|Overall Study|Site Closed|0
650751|NCT02731131|2073155|P2|Overall Study|Refused Therapy|1
650752|NCT02731131|2073156|P1|Overall Study|Refused Therapy|0
650753|NCT02731131|2073155|P2|Overall Study|Psychiatric Disorder|1
650754|NCT02731131|2073156|P1|Overall Study|Psychiatric Disorder|0
650756|NCT02726022|2073209|P1|Overall Study|Treatment Failure and Poor Compliance|1
650757|NCT02726022|2073209|P1|Overall Study|Poor Compliance|13
650758|NCT02726022|2073209|P1|Overall Study|Treatment Failure|8
650759|NCT02726022|2073209|P1|Overall Study|Adverse Event|14
650760|NCT02725788|2073220|P2|Overall Study|Protocol Violation|1
650761|NCT02725788|2073221|P1|Overall Study|Protocol Violation|0
650762|NCT02725788|2073220|P2|Overall Study|Lost to Follow-up|1
650763|NCT02725788|2073221|P1|Overall Study|Lost to Follow-up|1
650764|NCT02723188|2073234|P3|Overall Study|Withdrawal by Subject|0
650765|NCT02723188|2073235|P2|Overall Study|Withdrawal by Subject|0
650766|NCT02723188|2073236|P1|Overall Study|Withdrawal by Subject|1
650767|NCT02717754|2073301|P6|Overall Study|Incorrect Infusion Duration|20
650768|NCT02717754|2073302|P5|Overall Study|Incorrect Infusion Duration|20
650769|NCT02717754|2073303|P4|Overall Study|Incorrect Infusion Duration|10
650770|NCT02717754|2073304|P3|Overall Study|Incorrect Infusion Duration|0
650771|NCT02717754|2073305|P2|Overall Study|Incorrect Infusion Duration|0
650772|NCT02717754|2073306|P1|Overall Study|Incorrect Infusion Duration|0
650773|NCT02716779|2073337|P3|Combination Therapy|Adverse Event|1
650774|NCT02716779|2073338|P2|Combination Therapy|Adverse Event|2
650775|NCT02716779|2073339|P1|Combination Therapy|Adverse Event|0
650776|NCT02716779|2073337|P3|Monotherapy|Adverse Event|1
650777|NCT02716779|2073338|P2|Monotherapy|Adverse Event|1
650778|NCT02716779|2073339|P1|Monotherapy|Adverse Event|0
650779|NCT02716298|2073383|P2|First Intervention (1 Month)|Lens discomfort|1
650780|NCT02716298|2073384|P1|First Intervention (1 Month)|Lens discomfort|1
650781|NCT02713594|2073401|P2|Overall Study|Lost to Follow-up|374
650782|NCT02713594|2073402|P1|Overall Study|Lost to Follow-up|358
650783|NCT02713594|2073401|P2|Overall Study|Withdrawal by Subject|22
650784|NCT02713594|2073402|P1|Overall Study|Withdrawal by Subject|32
650785|NCT02712333|2073414|P2|First Period|Withdrawal by Subject|2
650786|NCT02712333|2073415|P1|First Period|Withdrawal by Subject|3
650787|NCT02710292|2073505|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
650875|NCT02699593|2073824|P1|Period 1|Adverse Event|1
650788|NCT02710292|2073506|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
650789|NCT02710292|2073505|P2|Period 1, First 10 Days of Wear|Adverse Event|1
650790|NCT02710292|2073506|P1|Period 1, First 10 Days of Wear|Adverse Event|0
650791|NCT02709577|2073515|P4|Overall Study|Withdrawal by Subject|0
650792|NCT02709577|2073516|P3|Overall Study|Withdrawal by Subject|2
650793|NCT02709577|2073517|P2|Overall Study|Withdrawal by Subject|3
650794|NCT02709577|2073518|P1|Overall Study|Withdrawal by Subject|2
650795|NCT02709577|2073515|P4|Overall Study|procedural complication|0
650796|NCT02709577|2073516|P3|Overall Study|procedural complication|0
650797|NCT02709577|2073517|P2|Overall Study|procedural complication|1
650798|NCT02709577|2073518|P1|Overall Study|procedural complication|0
650799|NCT02709577|2073515|P4|Overall Study|non-accommodating anatomy|0
650800|NCT02709577|2073516|P3|Overall Study|non-accommodating anatomy|0
650801|NCT02709577|2073517|P2|Overall Study|non-accommodating anatomy|1
650802|NCT02709577|2073518|P1|Overall Study|non-accommodating anatomy|0
650803|NCT02709096|2073532|P2|Overall Study|non-compliance|1
650804|NCT02709096|2073533|P1|Overall Study|non-compliance|1
650805|NCT02708524|2073543|P4|Overall Study|Subject lost study lens|0
650806|NCT02708524|2073544|P3|Overall Study|Subject lost study lens|0
650807|NCT02708524|2073545|P2|Overall Study|Subject lost study lens|0
650808|NCT02708524|2073546|P1|Overall Study|Subject lost study lens|1
650809|NCT02708524|2073543|P4|Overall Study|Did not wear lens at final visit|0
650810|NCT02708524|2073544|P3|Overall Study|Did not wear lens at final visit|0
650811|NCT02708524|2073545|P2|Overall Study|Did not wear lens at final visit|1
650812|NCT02708524|2073546|P1|Overall Study|Did not wear lens at final visit|0
650813|NCT02708524|2073543|P4|Overall Study|Dispensed incorrect study lens|0
650814|NCT02708524|2073544|P3|Overall Study|Dispensed incorrect study lens|1
650815|NCT02708524|2073545|P2|Overall Study|Dispensed incorrect study lens|1
650816|NCT02708524|2073546|P1|Overall Study|Dispensed incorrect study lens|0
650817|NCT02708524|2073543|P4|Overall Study|Withdrawal by Subject|0
650818|NCT02708524|2073544|P3|Overall Study|Withdrawal by Subject|0
650819|NCT02708524|2073545|P2|Overall Study|Withdrawal by Subject|1
650820|NCT02708524|2073546|P1|Overall Study|Withdrawal by Subject|1
650821|NCT02708524|2073543|P4|Overall Study|Protocol Violation|0
650822|NCT02708524|2073544|P3|Overall Study|Protocol Violation|0
650823|NCT02708524|2073545|P2|Overall Study|Protocol Violation|1
650824|NCT02708524|2073546|P1|Overall Study|Protocol Violation|0
650825|NCT02708524|2073543|P4|Overall Study|Lost to Follow-up|0
650826|NCT02708524|2073544|P3|Overall Study|Lost to Follow-up|1
650827|NCT02708524|2073545|P2|Overall Study|Lost to Follow-up|1
650828|NCT02708524|2073546|P1|Overall Study|Lost to Follow-up|1
650829|NCT02708524|2073543|P4|Overall Study|Lens Discomfort|0
650830|NCT02708524|2073544|P3|Overall Study|Lens Discomfort|1
650831|NCT02708524|2073545|P2|Overall Study|Lens Discomfort|0
650832|NCT02708524|2073546|P1|Overall Study|Lens Discomfort|1
650833|NCT02708524|2073543|P4|Overall Study|Adverse Event|0
650834|NCT02708524|2073544|P3|Overall Study|Adverse Event|0
650835|NCT02708524|2073545|P2|Overall Study|Adverse Event|1
650836|NCT02708524|2073546|P1|Overall Study|Adverse Event|0
650837|NCT02708355|2073595|P3|Overall Study|Adverse Event|0
650838|NCT02708355|2073596|P2|Overall Study|Adverse Event|0
650839|NCT02708355|2073597|P1|Overall Study|Adverse Event|1
650840|NCT02708277|2073610|P2|Overall Study|Lost to Follow-up|4
650841|NCT02708277|2073611|P1|Overall Study|Lost to Follow-up|7
650842|NCT02707640|2073654|P2|Overall Study|Sponsor Discretion|0
650843|NCT02707640|2073655|P1|Overall Study|Sponsor Discretion|1
650844|NCT02707640|2073654|P2|Overall Study|Participant's Personal Decision|2
650845|NCT02707640|2073655|P1|Overall Study|Participant's Personal Decision|1
650846|NCT02707640|2073654|P2|Overall Study|Withdrawal by Subject|1
650847|NCT02707640|2073655|P1|Overall Study|Withdrawal by Subject|0
650848|NCT02707640|2073654|P2|Overall Study|Physician Decision|0
650849|NCT02707640|2073655|P1|Overall Study|Physician Decision|2
650850|NCT02707640|2073654|P2|Overall Study|Death|2
650851|NCT02707640|2073655|P1|Overall Study|Death|1
650852|NCT02707640|2073654|P2|Overall Study|Adverse Event|2
650853|NCT02707640|2073655|P1|Overall Study|Adverse Event|4
887829|NCT02668822|2820971|P2|Overall Study|Study Terminated by Sponsor|9
887830|NCT02668822|2820972|P1|Overall Study|Study Terminated by Sponsor|7
887831|NCT02668822|2820971|P2|Overall Study|Protocol Violation|0
650857|NCT02705716|2073735|P2|Overall Study|Withdrawal of Consent|1
650858|NCT02705716|2073736|P1|Overall Study|Withdrawal of Consent|1
650859|NCT02705716|2073735|P2|Overall Study|Protocol Violation|0
650860|NCT02705716|2073736|P1|Overall Study|Protocol Violation|3
650861|NCT02705716|2073735|P2|Overall Study|Adverse Event|1
650862|NCT02705716|2073736|P1|Overall Study|Adverse Event|0
650863|NCT02701296|2073773|P2|Overall Study|Incomplete Data|2
650864|NCT02701296|2073774|P1|Overall Study|Incomplete Data|0
650865|NCT02699892|2073807|P1|Overall Study|Unspecified|36
650866|NCT02699684|2073812|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
650867|NCT02699684|2073813|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
650868|NCT02699593|2073823|P2|Period 2|Torn Contact Lens|0
650869|NCT02699593|2073824|P1|Period 2|Torn Contact Lens|1
650870|NCT02699593|2073823|P2|Period 2|Lost Contact Lens|1
650871|NCT02699593|2073824|P1|Period 2|Lost Contact Lens|0
650872|NCT02699593|2073823|P2|Period 2|Adverse Event|1
650873|NCT02699593|2073824|P1|Period 2|Adverse Event|1
650874|NCT02699593|2073823|P2|Period 1|Adverse Event|1
650876|NCT02699593|2073823|P2|Period 1|Withdrawal by Subject|1
650877|NCT02699593|2073824|P1|Period 1|Withdrawal by Subject|0
650878|NCT02699593|2073823|P2|Period 1|Protocol Violation|1
650879|NCT02699593|2073824|P1|Period 1|Protocol Violation|0
650880|NCT02699593|2073823|P2|Period 1|Torn Contact Len|3
650881|NCT02699593|2073824|P1|Period 1|Torn Contact Len|4
650882|NCT02699593|2073823|P2|Period 1|Unsatisfactory Visual Response|1
650883|NCT02699593|2073824|P1|Period 1|Unsatisfactory Visual Response|0
887832|NCT02668822|2820972|P1|Overall Study|Protocol Violation|2
887833|NCT02639247|2820994|P2|Overall Study|Protocol Violation|0
887834|NCT02639247|2820995|P1|Overall Study|Protocol Violation|1
887835|NCT02639247|2820994|P2|Overall Study|Withdrew Consent|1
650890|NCT02694718|2073889|P1|Overall Study|Withdrawal by Subject|1
650891|NCT02694718|2073889|P1|Overall Study|Death|1
650892|NCT02694536|2073899|P1|Overall Study|Not Specified|22
650893|NCT02694536|2073899|P1|Overall Study|Death|8
650894|NCT02694536|2073899|P1|Overall Study|Withdrawal by Subject|8
650895|NCT02694536|2073899|P1|Overall Study|Study Drug-Related Adverse Event|1
650896|NCT02694536|2073899|P1|Overall Study|Lost to Follow-up|1
650897|NCT02694536|2073899|P1|Overall Study|Progressive Disease|40
650898|NCT02691507|2073954|P2|Overall Study|Missed Visit 3|1
650899|NCT02691507|2073955|P1|Overall Study|Missed Visit 3|0
650900|NCT02689804|2074130|P2|Overall Study|Withdrawal by Subject|0
650901|NCT02689804|2074131|P1|Overall Study|Withdrawal by Subject|2
650902|NCT02678923|2074342|P2|Overall Study|Did Not Return for Study Visits|0
650903|NCT02678923|2074343|P1|Overall Study|Did Not Return for Study Visits|1
650904|NCT02678923|2074342|P2|Overall Study|Lost to Follow-up|0
650905|NCT02678923|2074343|P1|Overall Study|Lost to Follow-up|1
650906|NCT02678923|2074342|P2|Overall Study|Withdrawal by Subject|2
650907|NCT02678923|2074343|P1|Overall Study|Withdrawal by Subject|3
650908|NCT02678923|2074342|P2|Overall Study|Protocol Deviation (Not Dosed)|3
650909|NCT02678923|2074343|P1|Overall Study|Protocol Deviation (Not Dosed)|1
650910|NCT02678676|2074359|P2|Overall Study|Unconfirmed for lost to follow-up|67
650911|NCT02678676|2074360|P1|Overall Study|Unconfirmed for lost to follow-up|85
650912|NCT02678676|2074359|P2|Overall Study|Lost to Follow-up|151
650913|NCT02678676|2074360|P1|Overall Study|Lost to Follow-up|171
650914|NCT02678676|2074359|P2|Overall Study|Withdrawal by Subject|5
650915|NCT02678676|2074360|P1|Overall Study|Withdrawal by Subject|13
650916|NCT02678676|2074359|P2|Overall Study|Death|649
650917|NCT02678676|2074360|P1|Overall Study|Death|619
887836|NCT02639247|2820995|P1|Overall Study|Withdrew Consent|0
887837|NCT02639247|2820994|P2|Overall Study|Death|0
887838|NCT02639247|2820995|P1|Overall Study|Death|2
887839|NCT02639247|2820994|P2|Overall Study|Lost to Follow-up|1
887840|NCT02639247|2820995|P1|Overall Study|Lost to Follow-up|2
887841|NCT02636907|2821011|P1|Overall Study|Withdrawal by Subject|2
887842|NCT02636907|2821011|P1|Overall Study|Adverse Event|2
887843|NCT02607800|2821020|P2|Overall Study|Randomized/Enrolled but Not Treated|1
887844|NCT02607800|2821021|P1|Overall Study|Randomized/Enrolled but Not Treated|1
887845|NCT02607800|2821020|P2|Overall Study|Withdrew Consent|0
887846|NCT02607800|2821021|P1|Overall Study|Withdrew Consent|2
887847|NCT02607800|2821020|P2|Overall Study|Lost to Follow-up|10
887848|NCT02607800|2821021|P1|Overall Study|Lost to Follow-up|7
887849|NCT02600845|2821037|P1|Overall Study|Consent Withdrawal|5
887850|NCT02600845|2821037|P1|Overall Study|Non-compliance with Study Procedures|10
887851|NCT02600845|2821037|P1|Overall Study|Reason Not Specified|3
887852|NCT02596854|2821052|P1|Overall Study|Withdrawn|8
887853|NCT02591290|2821056|P1|Overall Study|Withdrawal by Subject|2
887858|NCT02577718|2821073|P1|Overall Study|Withdrawal by Subject|2
887859|NCT02577718|2821073|P1|Overall Study|Death|6
650952|NCT02674334|2074475|P2|Overall Study|NIRS not recording|0
650953|NCT02674334|2074476|P1|Overall Study|NIRS not recording|1
650954|NCT02674334|2074475|P2|Overall Study|participant difficulty breathing|0
650955|NCT02674334|2074476|P1|Overall Study|participant difficulty breathing|1
650956|NCT02674334|2074475|P2|Overall Study|Lost to Follow-up|3
650957|NCT02674334|2074476|P1|Overall Study|Lost to Follow-up|5
650958|NCT02670473|2074517|P1|Overall Study|Withdrawal by Subject|1
650959|NCT02669095|2074572|P2|Overall Study|Visit 5 assessments not completed|1
650960|NCT02669095|2074573|P1|Overall Study|Visit 5 assessments not completed|0
650961|NCT02669095|2074572|P2|Overall Study|Torn Lens|1
650962|NCT02669095|2074573|P1|Overall Study|Torn Lens|0
650963|NCT02669095|2074572|P2|Overall Study|Unsatisfactory Lens Fitting|1
650964|NCT02669095|2074573|P1|Overall Study|Unsatisfactory Lens Fitting|0
650965|NCT02669095|2074572|P2|Overall Study|Adverse Event|0
650966|NCT02669095|2074573|P1|Overall Study|Adverse Event|1
650967|NCT02669043|2074581|P1|Overall Study|Didn't meet I/E criteria|4
650968|NCT02666222|2074619|P1|Overall Study|Death|2
650969|NCT02663453|2074698|P2|Overall Study|Withdrawal by Subject|0
650970|NCT02663453|2074699|P1|Overall Study|Withdrawal by Subject|1
650971|NCT02663453|2074698|P2|Overall Study|Death|4
650972|NCT02663453|2074699|P1|Overall Study|Death|4
650973|NCT02662556|2074746|P1|Overall Study|Lack of Efficacy|4
650974|NCT02662556|2074746|P1|Overall Study|Adverse Event|4
650975|NCT02653495|2074854|P2|Overall Study|Screening Failure|0
650976|NCT02653495|2074855|P1|Overall Study|Screening Failure|10
650977|NCT02653495|2074854|P2|Overall Study|Lost to Follow-up|0
650978|NCT02653495|2074855|P1|Overall Study|Lost to Follow-up|2
650979|NCT02651922|2074889|P1|Overall Study|due to exclusion criteria|2
650980|NCT02651467|2074909|P3|Overall Study|Other (Not specified)|2
650981|NCT02651467|2074910|P2|Overall Study|Other (Not specified)|0
650982|NCT02651467|2074911|P1|Overall Study|Other (Not specified)|1
650983|NCT02651467|2074909|P3|Overall Study|Withdrawal by Subject|2
650984|NCT02651467|2074910|P2|Overall Study|Withdrawal by Subject|0
650985|NCT02651467|2074911|P1|Overall Study|Withdrawal by Subject|0
650986|NCT02649634|2074964|P2|Overall Study|Lost to Follow-up|1
650987|NCT02649634|2074965|P1|Overall Study|Lost to Follow-up|0
650988|NCT02649634|2074964|P2|Overall Study|Withdrawal by Subject|5
650989|NCT02649634|2074965|P1|Overall Study|Withdrawal by Subject|3
650990|NCT02648438|2075024|P3|Overall Study|Withdrawal by Subject|0
650991|NCT02648438|2075025|P2|Overall Study|Withdrawal by Subject|1
650992|NCT02648438|2075026|P1|Overall Study|Withdrawal by Subject|1
650993|NCT02648438|2075024|P3|Overall Study|Protocol Violation|0
650994|NCT02648438|2075025|P2|Overall Study|Protocol Violation|0
650995|NCT02648438|2075026|P1|Overall Study|Protocol Violation|2
650996|NCT02648438|2075024|P3|Overall Study|Eligibility criteria not fulfilled|0
650997|NCT02648438|2075025|P2|Overall Study|Eligibility criteria not fulfilled|2
650998|NCT02648438|2075026|P1|Overall Study|Eligibility criteria not fulfilled|0
650999|NCT02644356|2075105|P1|Overall Study|Withdrawal by Subject|2
651000|NCT02643251|2075117|P2|Overall Study|PI Decision to terminate patient|0
651001|NCT02643251|2075118|P1|Overall Study|PI Decision to terminate patient|1
651002|NCT02643251|2075117|P2|Overall Study|Protocol Violation|0
651003|NCT02643251|2075118|P1|Overall Study|Protocol Violation|1
651004|NCT02643251|2075117|P2|Overall Study|Lost to Follow-up|1
651005|NCT02643251|2075118|P1|Overall Study|Lost to Follow-up|4
651006|NCT02643251|2075117|P2|Overall Study|Withdrawal by Subject|0
651007|NCT02643251|2075118|P1|Overall Study|Withdrawal by Subject|2
651008|NCT02643251|2075117|P2|Overall Study|Adverse Event|1
651009|NCT02643251|2075118|P1|Overall Study|Adverse Event|3
651010|NCT02644109|2075150|P2|Overall Study|Adverse Event|4
651011|NCT02644109|2075151|P1|Overall Study|Adverse Event|0
651012|NCT02644096|2075159|P2|Overall Study|Withdrawal by Subject|25
651013|NCT02644096|2075160|P1|Overall Study|Withdrawal by Subject|28
651018|NCT02641379|2075365|P11|Overall Study|PCR positive|0
651019|NCT02641379|2075366|P10|Overall Study|PCR positive|0
651020|NCT02641379|2075367|P9|Overall Study|PCR positive|0
651021|NCT02641379|2075368|P8|Overall Study|PCR positive|0
651022|NCT02641379|2075369|P7|Overall Study|PCR positive|1
651023|NCT02641379|2075370|P6|Overall Study|PCR positive|0
651024|NCT02641379|2075371|P5|Overall Study|PCR positive|0
651025|NCT02641379|2075372|P4|Overall Study|PCR positive|0
651026|NCT02641379|2075373|P3|Overall Study|PCR positive|0
651027|NCT02641379|2075374|P2|Overall Study|PCR positive|0
651028|NCT02641379|2075375|P1|Overall Study|PCR positive|0
651029|NCT02641379|2075365|P11|Overall Study|Missing PCR result at Week 8|0
651030|NCT02641379|2075366|P10|Overall Study|Missing PCR result at Week 8|1
651031|NCT02641379|2075367|P9|Overall Study|Missing PCR result at Week 8|0
651032|NCT02641379|2075368|P8|Overall Study|Missing PCR result at Week 8|0
651033|NCT02641379|2075369|P7|Overall Study|Missing PCR result at Week 8|0
651034|NCT02641379|2075370|P6|Overall Study|Missing PCR result at Week 8|0
651035|NCT02641379|2075371|P5|Overall Study|Missing PCR result at Week 8|0
651036|NCT02641379|2075372|P4|Overall Study|Missing PCR result at Week 8|0
651037|NCT02641379|2075373|P3|Overall Study|Missing PCR result at Week 8|0
651038|NCT02641379|2075374|P2|Overall Study|Missing PCR result at Week 8|0
651039|NCT02641379|2075375|P1|Overall Study|Missing PCR result at Week 8|0
651040|NCT02641379|2075365|P11|Overall Study|Participant treated after Week 24|0
651041|NCT02641379|2075366|P10|Overall Study|Participant treated after Week 24|0
651042|NCT02641379|2075367|P9|Overall Study|Participant treated after Week 24|1
651043|NCT02641379|2075368|P8|Overall Study|Participant treated after Week 24|0
651044|NCT02641379|2075369|P7|Overall Study|Participant treated after Week 24|0
651045|NCT02641379|2075370|P6|Overall Study|Participant treated after Week 24|0
651046|NCT02641379|2075371|P5|Overall Study|Participant treated after Week 24|0
651047|NCT02641379|2075372|P4|Overall Study|Participant treated after Week 24|0
651048|NCT02641379|2075373|P3|Overall Study|Participant treated after Week 24|0
651049|NCT02641379|2075374|P2|Overall Study|Participant treated after Week 24|0
651050|NCT02641379|2075375|P1|Overall Study|Participant treated after Week 24|0
651051|NCT02641379|2075365|P11|Overall Study|Participant’s PCR high|0
651052|NCT02641379|2075366|P10|Overall Study|Participant’s PCR high|0
651053|NCT02641379|2075367|P9|Overall Study|Participant’s PCR high|0
651054|NCT02641379|2075368|P8|Overall Study|Participant’s PCR high|1
651055|NCT02641379|2075369|P7|Overall Study|Participant’s PCR high|0
651056|NCT02641379|2075370|P6|Overall Study|Participant’s PCR high|0
651057|NCT02641379|2075371|P5|Overall Study|Participant’s PCR high|0
651058|NCT02641379|2075372|P4|Overall Study|Participant’s PCR high|0
651059|NCT02641379|2075373|P3|Overall Study|Participant’s PCR high|0
651060|NCT02641379|2075374|P2|Overall Study|Participant’s PCR high|0
651061|NCT02641379|2075375|P1|Overall Study|Participant’s PCR high|0
651062|NCT02641379|2075365|P11|Overall Study|Negative PCR result|0
651063|NCT02641379|2075366|P10|Overall Study|Negative PCR result|1
651064|NCT02641379|2075367|P9|Overall Study|Negative PCR result|0
651065|NCT02641379|2075368|P8|Overall Study|Negative PCR result|0
651066|NCT02641379|2075369|P7|Overall Study|Negative PCR result|0
651067|NCT02641379|2075370|P6|Overall Study|Negative PCR result|0
651068|NCT02641379|2075371|P5|Overall Study|Negative PCR result|0
651069|NCT02641379|2075372|P4|Overall Study|Negative PCR result|0
651070|NCT02641379|2075373|P3|Overall Study|Negative PCR result|0
651071|NCT02641379|2075374|P2|Overall Study|Negative PCR result|0
651072|NCT02641379|2075375|P1|Overall Study|Negative PCR result|0
651073|NCT02641379|2075365|P11|Overall Study|No 2 Log drop at Week 12|1
651074|NCT02641379|2075366|P10|Overall Study|No 2 Log drop at Week 12|0
651075|NCT02641379|2075367|P9|Overall Study|No 2 Log drop at Week 12|0
651076|NCT02641379|2075368|P8|Overall Study|No 2 Log drop at Week 12|0
651077|NCT02641379|2075369|P7|Overall Study|No 2 Log drop at Week 12|0
651078|NCT02641379|2075370|P6|Overall Study|No 2 Log drop at Week 12|0
651079|NCT02641379|2075371|P5|Overall Study|No 2 Log drop at Week 12|0
651080|NCT02641379|2075372|P4|Overall Study|No 2 Log drop at Week 12|0
651081|NCT02641379|2075373|P3|Overall Study|No 2 Log drop at Week 12|0
651082|NCT02641379|2075374|P2|Overall Study|No 2 Log drop at Week 12|0
651083|NCT02641379|2075375|P1|Overall Study|No 2 Log drop at Week 12|0
651084|NCT02641379|2075365|P11|Overall Study|Non-response Week 12|0
651085|NCT02641379|2075366|P10|Overall Study|Non-response Week 12|0
651086|NCT02641379|2075367|P9|Overall Study|Non-response Week 12|0
651087|NCT02641379|2075368|P8|Overall Study|Non-response Week 12|1
651088|NCT02641379|2075369|P7|Overall Study|Non-response Week 12|0
651089|NCT02641379|2075370|P6|Overall Study|Non-response Week 12|0
651090|NCT02641379|2075371|P5|Overall Study|Non-response Week 12|0
651091|NCT02641379|2075372|P4|Overall Study|Non-response Week 12|0
651092|NCT02641379|2075373|P3|Overall Study|Non-response Week 12|0
651093|NCT02641379|2075374|P2|Overall Study|Non-response Week 12|0
651094|NCT02641379|2075375|P1|Overall Study|Non-response Week 12|0
651095|NCT02641379|2075365|P11|Overall Study|Participant showed weight reduction|0
651096|NCT02641379|2075366|P10|Overall Study|Participant showed weight reduction|0
651097|NCT02641379|2075367|P9|Overall Study|Participant showed weight reduction|0
651098|NCT02641379|2075368|P8|Overall Study|Participant showed weight reduction|1
651099|NCT02641379|2075369|P7|Overall Study|Participant showed weight reduction|0
651100|NCT02641379|2075370|P6|Overall Study|Participant showed weight reduction|0
651101|NCT02641379|2075371|P5|Overall Study|Participant showed weight reduction|0
651102|NCT02641379|2075372|P4|Overall Study|Participant showed weight reduction|0
651103|NCT02641379|2075373|P3|Overall Study|Participant showed weight reduction|0
651104|NCT02641379|2075374|P2|Overall Study|Participant showed weight reduction|0
651105|NCT02641379|2075375|P1|Overall Study|Participant showed weight reduction|0
651106|NCT02641379|2075365|P11|Overall Study|Source data not found|0
651107|NCT02641379|2075366|P10|Overall Study|Source data not found|0
651108|NCT02641379|2075367|P9|Overall Study|Source data not found|0
651109|NCT02641379|2075368|P8|Overall Study|Source data not found|0
651110|NCT02641379|2075369|P7|Overall Study|Source data not found|0
651111|NCT02641379|2075370|P6|Overall Study|Source data not found|1
651112|NCT02641379|2075371|P5|Overall Study|Source data not found|0
651113|NCT02641379|2075372|P4|Overall Study|Source data not found|0
651114|NCT02641379|2075373|P3|Overall Study|Source data not found|0
651115|NCT02641379|2075374|P2|Overall Study|Source data not found|0
651116|NCT02641379|2075375|P1|Overall Study|Source data not found|0
651117|NCT02641379|2075365|P11|Overall Study|Lost to Follow-up|0
651118|NCT02641379|2075366|P10|Overall Study|Lost to Follow-up|0
651119|NCT02641379|2075367|P9|Overall Study|Lost to Follow-up|1
651120|NCT02641379|2075368|P8|Overall Study|Lost to Follow-up|0
651121|NCT02641379|2075369|P7|Overall Study|Lost to Follow-up|0
651122|NCT02641379|2075370|P6|Overall Study|Lost to Follow-up|0
651123|NCT02641379|2075371|P5|Overall Study|Lost to Follow-up|0
651124|NCT02641379|2075372|P4|Overall Study|Lost to Follow-up|0
651125|NCT02641379|2075373|P3|Overall Study|Lost to Follow-up|0
651126|NCT02641379|2075374|P2|Overall Study|Lost to Follow-up|0
651127|NCT02641379|2075375|P1|Overall Study|Lost to Follow-up|0
651128|NCT02641379|2075365|P11|Overall Study|Participation in sili rescue study|0
651129|NCT02641379|2075366|P10|Overall Study|Participation in sili rescue study|0
651130|NCT02641379|2075367|P9|Overall Study|Participation in sili rescue study|0
651131|NCT02641379|2075368|P8|Overall Study|Participation in sili rescue study|0
651132|NCT02641379|2075369|P7|Overall Study|Participation in sili rescue study|0
651133|NCT02641379|2075370|P6|Overall Study|Participation in sili rescue study|1
651134|NCT02641379|2075371|P5|Overall Study|Participation in sili rescue study|0
651135|NCT02641379|2075372|P4|Overall Study|Participation in sili rescue study|0
651136|NCT02641379|2075373|P3|Overall Study|Participation in sili rescue study|0
651137|NCT02641379|2075374|P2|Overall Study|Participation in sili rescue study|0
651138|NCT02641379|2075375|P1|Overall Study|Participation in sili rescue study|0
651139|NCT02641379|2075365|P11|Overall Study|Protocol Violation|0
651140|NCT02641379|2075366|P10|Overall Study|Protocol Violation|0
651141|NCT02641379|2075367|P9|Overall Study|Protocol Violation|1
651142|NCT02641379|2075368|P8|Overall Study|Protocol Violation|0
651143|NCT02641379|2075369|P7|Overall Study|Protocol Violation|0
651144|NCT02641379|2075370|P6|Overall Study|Protocol Violation|0
651145|NCT02641379|2075371|P5|Overall Study|Protocol Violation|2
651146|NCT02641379|2075372|P4|Overall Study|Protocol Violation|0
651147|NCT02641379|2075373|P3|Overall Study|Protocol Violation|0
651148|NCT02641379|2075374|P2|Overall Study|Protocol Violation|0
651149|NCT02641379|2075375|P1|Overall Study|Protocol Violation|0
651150|NCT02641379|2075365|P11|Overall Study|Blood could not be drawn|0
651151|NCT02641379|2075366|P10|Overall Study|Blood could not be drawn|0
651152|NCT02641379|2075367|P9|Overall Study|Blood could not be drawn|0
651153|NCT02641379|2075368|P8|Overall Study|Blood could not be drawn|0
651154|NCT02641379|2075369|P7|Overall Study|Blood could not be drawn|0
651155|NCT02641379|2075370|P6|Overall Study|Blood could not be drawn|0
651156|NCT02641379|2075371|P5|Overall Study|Blood could not be drawn|1
651157|NCT02641379|2075372|P4|Overall Study|Blood could not be drawn|0
651158|NCT02641379|2075373|P3|Overall Study|Blood could not be drawn|0
651159|NCT02641379|2075374|P2|Overall Study|Blood could not be drawn|0
651160|NCT02641379|2075375|P1|Overall Study|Blood could not be drawn|0
651161|NCT02641379|2075365|P11|Overall Study|Baseline viral load unavailable|0
651162|NCT02641379|2075366|P10|Overall Study|Baseline viral load unavailable|0
651163|NCT02641379|2075367|P9|Overall Study|Baseline viral load unavailable|0
651164|NCT02641379|2075368|P8|Overall Study|Baseline viral load unavailable|0
651165|NCT02641379|2075369|P7|Overall Study|Baseline viral load unavailable|0
651166|NCT02641379|2075370|P6|Overall Study|Baseline viral load unavailable|0
651167|NCT02641379|2075371|P5|Overall Study|Baseline viral load unavailable|0
651168|NCT02641379|2075372|P4|Overall Study|Baseline viral load unavailable|1
651169|NCT02641379|2075373|P3|Overall Study|Baseline viral load unavailable|0
651170|NCT02641379|2075374|P2|Overall Study|Baseline viral load unavailable|0
651171|NCT02641379|2075375|P1|Overall Study|Baseline viral load unavailable|0
651172|NCT02641379|2075365|P11|Overall Study|Inclusion criteria not fulfilled|0
651173|NCT02641379|2075366|P10|Overall Study|Inclusion criteria not fulfilled|0
651174|NCT02641379|2075367|P9|Overall Study|Inclusion criteria not fulfilled|0
651175|NCT02641379|2075368|P8|Overall Study|Inclusion criteria not fulfilled|0
651176|NCT02641379|2075369|P7|Overall Study|Inclusion criteria not fulfilled|0
651177|NCT02641379|2075370|P6|Overall Study|Inclusion criteria not fulfilled|0
651178|NCT02641379|2075371|P5|Overall Study|Inclusion criteria not fulfilled|0
651179|NCT02641379|2075372|P4|Overall Study|Inclusion criteria not fulfilled|1
651180|NCT02641379|2075373|P3|Overall Study|Inclusion criteria not fulfilled|0
651181|NCT02641379|2075374|P2|Overall Study|Inclusion criteria not fulfilled|0
651182|NCT02641379|2075375|P1|Overall Study|Inclusion criteria not fulfilled|0
651183|NCT02641379|2075365|P11|Overall Study|PCR sample for Week 4 not drawn|0
651184|NCT02641379|2075366|P10|Overall Study|PCR sample for Week 4 not drawn|0
651185|NCT02641379|2075367|P9|Overall Study|PCR sample for Week 4 not drawn|0
651186|NCT02641379|2075368|P8|Overall Study|PCR sample for Week 4 not drawn|0
651187|NCT02641379|2075369|P7|Overall Study|PCR sample for Week 4 not drawn|0
651188|NCT02641379|2075370|P6|Overall Study|PCR sample for Week 4 not drawn|0
651189|NCT02641379|2075371|P5|Overall Study|PCR sample for Week 4 not drawn|0
651190|NCT02641379|2075372|P4|Overall Study|PCR sample for Week 4 not drawn|1
651191|NCT02641379|2075373|P3|Overall Study|PCR sample for Week 4 not drawn|0
651192|NCT02641379|2075374|P2|Overall Study|PCR sample for Week 4 not drawn|0
651193|NCT02641379|2075375|P1|Overall Study|PCR sample for Week 4 not drawn|0
651194|NCT02641379|2075365|P11|Overall Study|PCR positive at Week 28|0
651195|NCT02641379|2075366|P10|Overall Study|PCR positive at Week 28|0
651196|NCT02641379|2075367|P9|Overall Study|PCR positive at Week 28|0
651197|NCT02641379|2075368|P8|Overall Study|PCR positive at Week 28|0
651198|NCT02641379|2075369|P7|Overall Study|PCR positive at Week 28|0
651199|NCT02641379|2075370|P6|Overall Study|PCR positive at Week 28|0
651200|NCT02641379|2075371|P5|Overall Study|PCR positive at Week 28|0
651201|NCT02641379|2075372|P4|Overall Study|PCR positive at Week 28|0
651202|NCT02641379|2075373|P3|Overall Study|PCR positive at Week 28|1
651203|NCT02641379|2075374|P2|Overall Study|PCR positive at Week 28|0
651204|NCT02641379|2075375|P1|Overall Study|PCR positive at Week 28|0
651205|NCT02641379|2075365|P11|Overall Study|No PCR at baseline|0
651206|NCT02641379|2075366|P10|Overall Study|No PCR at baseline|0
651207|NCT02641379|2075367|P9|Overall Study|No PCR at baseline|0
651208|NCT02641379|2075368|P8|Overall Study|No PCR at baseline|0
651209|NCT02641379|2075369|P7|Overall Study|No PCR at baseline|0
651210|NCT02641379|2075370|P6|Overall Study|No PCR at baseline|0
651211|NCT02641379|2075371|P5|Overall Study|No PCR at baseline|0
651212|NCT02641379|2075372|P4|Overall Study|No PCR at baseline|0
651213|NCT02641379|2075373|P3|Overall Study|No PCR at baseline|1
651214|NCT02641379|2075374|P2|Overall Study|No PCR at baseline|0
651215|NCT02641379|2075375|P1|Overall Study|No PCR at baseline|0
651216|NCT02641379|2075365|P11|Overall Study|PCR not performed at Week 12|0
651217|NCT02641379|2075366|P10|Overall Study|PCR not performed at Week 12|0
651218|NCT02641379|2075367|P9|Overall Study|PCR not performed at Week 12|0
651219|NCT02641379|2075368|P8|Overall Study|PCR not performed at Week 12|0
651220|NCT02641379|2075369|P7|Overall Study|PCR not performed at Week 12|0
651221|NCT02641379|2075370|P6|Overall Study|PCR not performed at Week 12|0
651222|NCT02641379|2075371|P5|Overall Study|PCR not performed at Week 12|0
651223|NCT02641379|2075372|P4|Overall Study|PCR not performed at Week 12|0
651224|NCT02641379|2075373|P3|Overall Study|PCR not performed at Week 12|1
651225|NCT02641379|2075374|P2|Overall Study|PCR not performed at Week 12|0
651226|NCT02641379|2075375|P1|Overall Study|PCR not performed at Week 12|0
651227|NCT02641379|2075365|P11|Overall Study|PCR positive at Week 48|0
651228|NCT02641379|2075366|P10|Overall Study|PCR positive at Week 48|0
651229|NCT02641379|2075367|P9|Overall Study|PCR positive at Week 48|0
651230|NCT02641379|2075368|P8|Overall Study|PCR positive at Week 48|0
651231|NCT02641379|2075369|P7|Overall Study|PCR positive at Week 48|0
651232|NCT02641379|2075370|P6|Overall Study|PCR positive at Week 48|0
651233|NCT02641379|2075371|P5|Overall Study|PCR positive at Week 48|0
651234|NCT02641379|2075372|P4|Overall Study|PCR positive at Week 48|0
651235|NCT02641379|2075373|P3|Overall Study|PCR positive at Week 48|0
651236|NCT02641379|2075374|P2|Overall Study|PCR positive at Week 48|1
651237|NCT02641379|2075375|P1|Overall Study|PCR positive at Week 48|0
651238|NCT02641379|2075365|P11|Overall Study|PCR positive at Week 68|0
651239|NCT02641379|2075366|P10|Overall Study|PCR positive at Week 68|0
651240|NCT02641379|2075367|P9|Overall Study|PCR positive at Week 68|0
651241|NCT02641379|2075368|P8|Overall Study|PCR positive at Week 68|0
651242|NCT02641379|2075369|P7|Overall Study|PCR positive at Week 68|0
651243|NCT02641379|2075370|P6|Overall Study|PCR positive at Week 68|0
651244|NCT02641379|2075371|P5|Overall Study|PCR positive at Week 68|0
651245|NCT02641379|2075372|P4|Overall Study|PCR positive at Week 68|0
651246|NCT02641379|2075373|P3|Overall Study|PCR positive at Week 68|0
651247|NCT02641379|2075374|P2|Overall Study|PCR positive at Week 68|1
651248|NCT02641379|2075375|P1|Overall Study|PCR positive at Week 68|0
651249|NCT02641379|2075365|P11|Overall Study|Financial problems|0
651250|NCT02641379|2075366|P10|Overall Study|Financial problems|0
651251|NCT02641379|2075367|P9|Overall Study|Financial problems|0
651252|NCT02641379|2075368|P8|Overall Study|Financial problems|0
651253|NCT02641379|2075369|P7|Overall Study|Financial problems|0
651254|NCT02641379|2075370|P6|Overall Study|Financial problems|0
651255|NCT02641379|2075371|P5|Overall Study|Financial problems|0
651256|NCT02641379|2075372|P4|Overall Study|Financial problems|0
651257|NCT02641379|2075373|P3|Overall Study|Financial problems|0
651258|NCT02641379|2075374|P2|Overall Study|Financial problems|1
651259|NCT02641379|2075375|P1|Overall Study|Financial problems|0
651260|NCT02641379|2075365|P11|Overall Study|Therapy stopped due to misunderstanding|0
651261|NCT02641379|2075366|P10|Overall Study|Therapy stopped due to misunderstanding|0
651262|NCT02641379|2075367|P9|Overall Study|Therapy stopped due to misunderstanding|0
651263|NCT02641379|2075368|P8|Overall Study|Therapy stopped due to misunderstanding|0
651264|NCT02641379|2075369|P7|Overall Study|Therapy stopped due to misunderstanding|0
651265|NCT02641379|2075370|P6|Overall Study|Therapy stopped due to misunderstanding|0
651266|NCT02641379|2075371|P5|Overall Study|Therapy stopped due to misunderstanding|0
651267|NCT02641379|2075372|P4|Overall Study|Therapy stopped due to misunderstanding|0
651268|NCT02641379|2075373|P3|Overall Study|Therapy stopped due to misunderstanding|0
651269|NCT02641379|2075374|P2|Overall Study|Therapy stopped due to misunderstanding|0
651270|NCT02641379|2075375|P1|Overall Study|Therapy stopped due to misunderstanding|1
651271|NCT02641379|2075365|P11|Overall Study|Participant stopped study/treatment|0
651272|NCT02641379|2075366|P10|Overall Study|Participant stopped study/treatment|0
651273|NCT02641379|2075367|P9|Overall Study|Participant stopped study/treatment|1
651274|NCT02641379|2075368|P8|Overall Study|Participant stopped study/treatment|0
651275|NCT02641379|2075369|P7|Overall Study|Participant stopped study/treatment|2
651276|NCT02641379|2075370|P6|Overall Study|Participant stopped study/treatment|1
651277|NCT02641379|2075371|P5|Overall Study|Participant stopped study/treatment|0
651278|NCT02641379|2075372|P4|Overall Study|Participant stopped study/treatment|0
651279|NCT02641379|2075373|P3|Overall Study|Participant stopped study/treatment|1
651280|NCT02641379|2075374|P2|Overall Study|Participant stopped study/treatment|3
651281|NCT02641379|2075375|P1|Overall Study|Participant stopped study/treatment|1
651282|NCT02641379|2075365|P11|Overall Study|Participant showed relapse|0
651283|NCT02641379|2075366|P10|Overall Study|Participant showed relapse|0
651284|NCT02641379|2075367|P9|Overall Study|Participant showed relapse|0
651285|NCT02641379|2075368|P8|Overall Study|Participant showed relapse|0
651286|NCT02641379|2075369|P7|Overall Study|Participant showed relapse|1
651287|NCT02641379|2075370|P6|Overall Study|Participant showed relapse|0
651288|NCT02641379|2075371|P5|Overall Study|Participant showed relapse|0
651289|NCT02641379|2075372|P4|Overall Study|Participant showed relapse|0
651290|NCT02641379|2075373|P3|Overall Study|Participant showed relapse|0
651291|NCT02641379|2075374|P2|Overall Study|Participant showed relapse|0
651292|NCT02641379|2075375|P1|Overall Study|Participant showed relapse|1
651293|NCT02641379|2075365|P11|Overall Study|PCR positive at follow up 2|0
651294|NCT02641379|2075366|P10|Overall Study|PCR positive at follow up 2|0
651295|NCT02641379|2075367|P9|Overall Study|PCR positive at follow up 2|0
651296|NCT02641379|2075368|P8|Overall Study|PCR positive at follow up 2|0
651297|NCT02641379|2075369|P7|Overall Study|PCR positive at follow up 2|0
651298|NCT02641379|2075370|P6|Overall Study|PCR positive at follow up 2|0
651299|NCT02641379|2075371|P5|Overall Study|PCR positive at follow up 2|0
651300|NCT02641379|2075372|P4|Overall Study|PCR positive at follow up 2|0
651301|NCT02641379|2075373|P3|Overall Study|PCR positive at follow up 2|0
651302|NCT02641379|2075374|P2|Overall Study|PCR positive at follow up 2|0
651303|NCT02641379|2075375|P1|Overall Study|PCR positive at follow up 2|1
651304|NCT02641379|2075365|P11|Overall Study|PCR positive at Week 24|0
651305|NCT02641379|2075366|P10|Overall Study|PCR positive at Week 24|1
651306|NCT02641379|2075367|P9|Overall Study|PCR positive at Week 24|0
651307|NCT02641379|2075368|P8|Overall Study|PCR positive at Week 24|8
651308|NCT02641379|2075369|P7|Overall Study|PCR positive at Week 24|3
651309|NCT02641379|2075370|P6|Overall Study|PCR positive at Week 24|6
651310|NCT02641379|2075371|P5|Overall Study|PCR positive at Week 24|0
651311|NCT02641379|2075372|P4|Overall Study|PCR positive at Week 24|0
651312|NCT02641379|2075373|P3|Overall Study|PCR positive at Week 24|62
651313|NCT02641379|2075374|P2|Overall Study|PCR positive at Week 24|21
651314|NCT02641379|2075375|P1|Overall Study|PCR positive at Week 24|15
651315|NCT02641379|2075365|P11|Overall Study|Participant cannot be reached|1
651316|NCT02641379|2075366|P10|Overall Study|Participant cannot be reached|2
651317|NCT02641379|2075367|P9|Overall Study|Participant cannot be reached|0
651318|NCT02641379|2075368|P8|Overall Study|Participant cannot be reached|1
651319|NCT02641379|2075369|P7|Overall Study|Participant cannot be reached|0
651320|NCT02641379|2075370|P6|Overall Study|Participant cannot be reached|1
651321|NCT02641379|2075371|P5|Overall Study|Participant cannot be reached|2
651322|NCT02641379|2075372|P4|Overall Study|Participant cannot be reached|8
651323|NCT02641379|2075373|P3|Overall Study|Participant cannot be reached|0
651324|NCT02641379|2075374|P2|Overall Study|Participant cannot be reached|4
651325|NCT02641379|2075375|P1|Overall Study|Participant cannot be reached|4
651326|NCT02641379|2075365|P11|Overall Study|Participant’s compliance|1
651327|NCT02641379|2075366|P10|Overall Study|Participant’s compliance|1
651328|NCT02641379|2075367|P9|Overall Study|Participant’s compliance|1
651329|NCT02641379|2075368|P8|Overall Study|Participant’s compliance|0
651330|NCT02641379|2075369|P7|Overall Study|Participant’s compliance|0
651331|NCT02641379|2075370|P6|Overall Study|Participant’s compliance|2
651332|NCT02641379|2075371|P5|Overall Study|Participant’s compliance|0
651333|NCT02641379|2075372|P4|Overall Study|Participant’s compliance|1
651334|NCT02641379|2075373|P3|Overall Study|Participant’s compliance|0
651335|NCT02641379|2075374|P2|Overall Study|Participant’s compliance|1
651336|NCT02641379|2075375|P1|Overall Study|Participant’s compliance|0
651337|NCT02641379|2075365|P11|Overall Study|Participant unable to attend study visit|0
651338|NCT02641379|2075366|P10|Overall Study|Participant unable to attend study visit|2
651339|NCT02641379|2075367|P9|Overall Study|Participant unable to attend study visit|0
651340|NCT02641379|2075368|P8|Overall Study|Participant unable to attend study visit|1
651341|NCT02641379|2075369|P7|Overall Study|Participant unable to attend study visit|1
651342|NCT02641379|2075370|P6|Overall Study|Participant unable to attend study visit|1
651343|NCT02641379|2075371|P5|Overall Study|Participant unable to attend study visit|5
651344|NCT02641379|2075372|P4|Overall Study|Participant unable to attend study visit|2
651345|NCT02641379|2075373|P3|Overall Study|Participant unable to attend study visit|1
651346|NCT02641379|2075374|P2|Overall Study|Participant unable to attend study visit|10
651347|NCT02641379|2075375|P1|Overall Study|Participant unable to attend study visit|4
651348|NCT02641379|2075365|P11|Overall Study|Lack of Efficacy|0
651349|NCT02641379|2075366|P10|Overall Study|Lack of Efficacy|0
651350|NCT02641379|2075367|P9|Overall Study|Lack of Efficacy|0
651351|NCT02641379|2075368|P8|Overall Study|Lack of Efficacy|5
651352|NCT02641379|2075369|P7|Overall Study|Lack of Efficacy|0
651353|NCT02641379|2075370|P6|Overall Study|Lack of Efficacy|2
651354|NCT02641379|2075371|P5|Overall Study|Lack of Efficacy|0
651355|NCT02641379|2075372|P4|Overall Study|Lack of Efficacy|0
651356|NCT02641379|2075373|P3|Overall Study|Lack of Efficacy|2
651357|NCT02641379|2075374|P2|Overall Study|Lack of Efficacy|0
651358|NCT02641379|2075375|P1|Overall Study|Lack of Efficacy|0
651359|NCT02641379|2075365|P11|Overall Study|Adverse Event|5
651360|NCT02641379|2075366|P10|Overall Study|Adverse Event|1
651361|NCT02641379|2075367|P9|Overall Study|Adverse Event|1
651362|NCT02641379|2075368|P8|Overall Study|Adverse Event|0
651363|NCT02641379|2075369|P7|Overall Study|Adverse Event|5
651364|NCT02641379|2075370|P6|Overall Study|Adverse Event|1
651365|NCT02641379|2075371|P5|Overall Study|Adverse Event|5
651366|NCT02641379|2075372|P4|Overall Study|Adverse Event|2
651367|NCT02641379|2075373|P3|Overall Study|Adverse Event|2
651368|NCT02641379|2075374|P2|Overall Study|Adverse Event|8
651369|NCT02641379|2075375|P1|Overall Study|Adverse Event|7
651370|NCT02641379|2075365|P11|Overall Study|Withdrawal of informed consent|0
651371|NCT02641379|2075366|P10|Overall Study|Withdrawal of informed consent|0
651372|NCT02641379|2075367|P9|Overall Study|Withdrawal of informed consent|0
651373|NCT02641379|2075368|P8|Overall Study|Withdrawal of informed consent|1
651374|NCT02641379|2075369|P7|Overall Study|Withdrawal of informed consent|0
651375|NCT02641379|2075370|P6|Overall Study|Withdrawal of informed consent|0
651376|NCT02641379|2075371|P5|Overall Study|Withdrawal of informed consent|0
651377|NCT02641379|2075372|P4|Overall Study|Withdrawal of informed consent|0
651378|NCT02641379|2075373|P3|Overall Study|Withdrawal of informed consent|0
651379|NCT02641379|2075374|P2|Overall Study|Withdrawal of informed consent|1
651380|NCT02641379|2075375|P1|Overall Study|Withdrawal of informed consent|0
651381|NCT02641379|2075365|P11|Overall Study|Exclusion criterion during screening|0
651382|NCT02641379|2075366|P10|Overall Study|Exclusion criterion during screening|0
651383|NCT02641379|2075367|P9|Overall Study|Exclusion criterion during screening|0
651384|NCT02641379|2075368|P8|Overall Study|Exclusion criterion during screening|0
651385|NCT02641379|2075369|P7|Overall Study|Exclusion criterion during screening|0
651386|NCT02641379|2075370|P6|Overall Study|Exclusion criterion during screening|0
651387|NCT02641379|2075371|P5|Overall Study|Exclusion criterion during screening|2
651388|NCT02641379|2075372|P4|Overall Study|Exclusion criterion during screening|1
651389|NCT02641379|2075373|P3|Overall Study|Exclusion criterion during screening|0
651390|NCT02641379|2075374|P2|Overall Study|Exclusion criterion during screening|0
651391|NCT02641379|2075375|P1|Overall Study|Exclusion criterion during screening|1
651394|NCT02640157|2075465|P3|Overall Study|Randomized in error; did not receive Tx|0
651395|NCT02640157|2075466|P2|Overall Study|Randomized in error; did not receive Tx|1
651396|NCT02640157|2075467|P1|Overall Study|Randomized in error; did not receive Tx|0
651397|NCT02640157|2075465|P3|Overall Study|Lost to Follow-up|7
651398|NCT02640157|2075466|P2|Overall Study|Lost to Follow-up|2
651399|NCT02640157|2075467|P1|Overall Study|Lost to Follow-up|9
651400|NCT02640157|2075465|P3|Overall Study|Withdrew consent|2
651401|NCT02640157|2075466|P2|Overall Study|Withdrew consent|0
651402|NCT02640157|2075467|P1|Overall Study|Withdrew consent|2
651403|NCT02640157|2075465|P3|Overall Study|Adverse Event|1
651404|NCT02640157|2075466|P2|Overall Study|Adverse Event|2
651405|NCT02640157|2075467|P1|Overall Study|Adverse Event|2
651406|NCT02639052|2075484|P1|Overall Study|Lost to Follow-up|1
651407|NCT02638493|2075501|P3|Overall Study|Inability to provide semen samples|0
651408|NCT02638493|2075502|P2|Overall Study|Inability to provide semen samples|0
651409|NCT02638493|2075503|P1|Overall Study|Inability to provide semen samples|2
651410|NCT02638129|2075534|P2|Overall Study|Study terminated|30
651411|NCT02638129|2075535|P1|Overall Study|Study terminated|28
651412|NCT02637063|2075563|P3|Overall Study|Withdrawal by Subject|3
651413|NCT02637063|2075564|P2|Overall Study|Withdrawal by Subject|2
651414|NCT02637063|2075565|P1|Overall Study|Withdrawal by Subject|2
651415|NCT02637063|2075563|P3|Overall Study|Lost to Follow-up|3
651416|NCT02637063|2075564|P2|Overall Study|Lost to Follow-up|2
651417|NCT02637063|2075565|P1|Overall Study|Lost to Follow-up|3
651420|NCT02636595|2075598|P1|Overall Study|Not specified|1
651421|NCT02636595|2075598|P1|Overall Study|Lost to Follow-up|1
651422|NCT02634788|2075622|P4|Overall Study|Withdrawal by Subject|0
651423|NCT02634788|2075623|P3|Overall Study|Withdrawal by Subject|1
651424|NCT02634788|2075624|P2|Overall Study|Withdrawal by Subject|1
651425|NCT02634788|2075625|P1|Overall Study|Withdrawal by Subject|0
651426|NCT02634788|2075622|P4|Overall Study|Lost to Follow-up|0
651427|NCT02634788|2075623|P3|Overall Study|Lost to Follow-up|0
651428|NCT02634788|2075624|P2|Overall Study|Lost to Follow-up|1
651429|NCT02634788|2075625|P1|Overall Study|Lost to Follow-up|0
651430|NCT02634788|2075622|P4|Overall Study|Lack of Efficacy|4
651431|NCT02634788|2075623|P3|Overall Study|Lack of Efficacy|1
651432|NCT02634788|2075624|P2|Overall Study|Lack of Efficacy|0
651433|NCT02634788|2075625|P1|Overall Study|Lack of Efficacy|4
651434|NCT02634788|2075622|P4|Overall Study|Adverse Event|1
651435|NCT02634788|2075623|P3|Overall Study|Adverse Event|3
651436|NCT02634788|2075624|P2|Overall Study|Adverse Event|8
651437|NCT02634788|2075625|P1|Overall Study|Adverse Event|0
651438|NCT02633787|2075780|P1|Overall Study|Withdrawal by Subject|1
651439|NCT02633215|2075788|P2|Overall Study|Lost to Follow-up|3
651440|NCT02633215|2075789|P1|Overall Study|Lost to Follow-up|2
651441|NCT02630563|2075820|P1|Overall Study|Administrative|1
651442|NCT02628938|2075857|P3|Overall Study|Failure to comply with the instructions|3
651443|NCT02628938|2075858|P2|Overall Study|Failure to comply with the instructions|0
651444|NCT02628938|2075859|P1|Overall Study|Failure to comply with the instructions|3
651445|NCT02628938|2075857|P3|Overall Study|Did not attend the follow up recall|1
651446|NCT02628938|2075858|P2|Overall Study|Did not attend the follow up recall|2
651447|NCT02628938|2075859|P1|Overall Study|Did not attend the follow up recall|2
651448|NCT02628418|2075875|P2|Overall Study|Lost to Follow-up|2
651449|NCT02628418|2075876|P1|Overall Study|Lost to Follow-up|1
651450|NCT02627144|2075938|P1|Overall Study|Unspecified|17
651451|NCT02627144|2075938|P1|Overall Study|Enrolled, not treated|6
651452|NCT02627144|2075938|P1|Overall Study|Lost to Follow-up|8
651453|NCT02627144|2075938|P1|Overall Study|Administrative reasons|65
651454|NCT02627144|2075938|P1|Overall Study|Refusal of treatment / poor cooperation|38
651455|NCT02627144|2075938|P1|Overall Study|Death from other cause|8
651456|NCT02627144|2075938|P1|Overall Study|Death from cancer|20
651457|NCT02627144|2075938|P1|Overall Study|Cancer progression|171
651458|NCT02627144|2075938|P1|Overall Study|Serious adverse event|32
651459|NCT02625233|2075972|P2|Overall Study|Adverse Event|0
651460|NCT02625233|2075973|P1|Overall Study|Adverse Event|2
651461|NCT02625220|2075981|P1|Overall Study|Study discontinued at site|2
651462|NCT02625220|2075981|P1|Overall Study|Protocol Violation|1
651463|NCT02625220|2075981|P1|Overall Study|Lost to Follow-up|2
651464|NCT02625220|2075981|P1|Overall Study|Adverse Event|2
651465|NCT02624791|2076081|P6|Overall Study|Withdrawal by Subject|0
651466|NCT02624791|2076082|P5|Overall Study|Withdrawal by Subject|0
651467|NCT02624791|2076083|P4|Overall Study|Withdrawal by Subject|0
651468|NCT02624791|2076084|P3|Overall Study|Withdrawal by Subject|0
651469|NCT02624791|2076085|P2|Overall Study|Withdrawal by Subject|0
651470|NCT02624791|2076086|P1|Overall Study|Withdrawal by Subject|2
651471|NCT02622568|2076093|P2|Overall Study|Lost to Follow-up|5
651472|NCT02622568|2076094|P1|Overall Study|Lost to Follow-up|5
651473|NCT02621034|2076103|P3|Overall Study|Lost to Follow-up|5
651474|NCT02621034|2076104|P2|Overall Study|Lost to Follow-up|2
651475|NCT02621034|2076105|P1|Overall Study|Lost to Follow-up|3
651476|NCT02619812|2076122|P4|Overall Study|Withdrawal by Subject|2
651477|NCT02619812|2076123|P3|Overall Study|Withdrawal by Subject|1
651478|NCT02619812|2076124|P2|Overall Study|Withdrawal by Subject|0
651479|NCT02619812|2076125|P1|Overall Study|Withdrawal by Subject|0
651480|NCT02613910|2076368|P1|Overall Study|Termination of study|1
651481|NCT02612077|2076417|P1|Overall Study|Unknown reason|2
651482|NCT02612077|2076417|P1|Overall Study|Disease Progression|3
651483|NCT02612077|2076417|P1|Overall Study|Enrollment in a Clinical Trial|1
651484|NCT02612077|2076417|P1|Overall Study|Moved or Changed Medical Team|23
651485|NCT02612077|2076417|P1|Overall Study|Death|377
651486|NCT02612077|2076417|P1|Overall Study|Lost to Follow-up|20
651487|NCT02612077|2076417|P1|Overall Study|Protocol Violation|28
651488|NCT02612077|2076417|P1|Overall Study|Withdrawal by Subject|9
651489|NCT02612077|2076417|P1|Overall Study|Adverse Event|3
651490|NCT02612064|2076429|P2|Overall Study|Not Specified|2
651491|NCT02612064|2076430|P1|Overall Study|Not Specified|0
651492|NCT02612064|2076429|P2|Overall Study|Withdrawal by Subject|1
651493|NCT02612064|2076430|P1|Overall Study|Withdrawal by Subject|1
651496|NCT02609178|2076522|P6|First Crown|Withdrawal by Subject|0
651497|NCT02609178|2076523|P5|First Crown|Withdrawal by Subject|0
651498|NCT02609178|2076524|P4|First Crown|Withdrawal by Subject|1
651499|NCT02609178|2076525|P3|First Crown|Withdrawal by Subject|1
651500|NCT02609178|2076526|P2|First Crown|Withdrawal by Subject|0
651501|NCT02609178|2076527|P1|First Crown|Withdrawal by Subject|0
651502|NCT02605928|2076577|P1|Overall Study|Lack of Efficacy|5
651503|NCT02605928|2076577|P1|Overall Study|Model tuning phase|28
651504|NCT02604589|2076584|P3|Overall Study|catheter dislodgement|1
651505|NCT02604589|2076585|P2|Overall Study|catheter dislodgement|0
651506|NCT02604589|2076586|P1|Overall Study|catheter dislodgement|0
651507|NCT02604550|2076614|P2|Overall Study|Incomplete data using paper journal|19
651508|NCT02604550|2076615|P1|Overall Study|Incomplete data using paper journal|18
651509|NCT02604550|2076614|P2|Overall Study|Withdrawal by Subject|1
651510|NCT02604550|2076615|P1|Overall Study|Withdrawal by Subject|0
651511|NCT02604550|2076614|P2|Overall Study|Lost to Follow-up|6
651512|NCT02604550|2076615|P1|Overall Study|Lost to Follow-up|7
651513|NCT02604407|2076642|P3|Overall Study|Unspecified|4
651514|NCT02604407|2076643|P2|Overall Study|Unspecified|1
651515|NCT02604407|2076644|P1|Overall Study|Unspecified|3
651516|NCT02604407|2076642|P3|Overall Study|Lack of Efficacy|0
651517|NCT02604407|2076643|P2|Overall Study|Lack of Efficacy|0
651518|NCT02604407|2076644|P1|Overall Study|Lack of Efficacy|1
651519|NCT02604407|2076642|P3|Overall Study|Lost to Follow-up|2
651520|NCT02604407|2076643|P2|Overall Study|Lost to Follow-up|1
651521|NCT02604407|2076644|P1|Overall Study|Lost to Follow-up|2
651522|NCT02604407|2076642|P3|Overall Study|Withdrawal by Subject|5
651523|NCT02604407|2076643|P2|Overall Study|Withdrawal by Subject|3
651524|NCT02604407|2076644|P1|Overall Study|Withdrawal by Subject|3
651525|NCT02604407|2076642|P3|Overall Study|Protocol Violation|0
651526|NCT02604407|2076643|P2|Overall Study|Protocol Violation|0
651527|NCT02604407|2076644|P1|Overall Study|Protocol Violation|2
651528|NCT02604407|2076642|P3|Overall Study|Adverse Event|5
651529|NCT02604407|2076643|P2|Overall Study|Adverse Event|7
651530|NCT02604407|2076644|P1|Overall Study|Adverse Event|0
651531|NCT02604264|2076657|P2|Overall Study|Had central venous catheter <21 days|242
651532|NCT02604264|2076658|P1|Overall Study|Had central venous catheter <21 days|200
651533|NCT02604017|2076666|P2|Overall Study|Not Specified|0
651534|NCT02604017|2076667|P1|Overall Study|Not Specified|1
651535|NCT02604017|2076666|P2|Overall Study|Lost to Follow-up|6
651536|NCT02604017|2076667|P1|Overall Study|Lost to Follow-up|5
651537|NCT02604017|2076666|P2|Overall Study|Withdrew Consent|2
651538|NCT02604017|2076667|P1|Overall Study|Withdrew Consent|0
651539|NCT02598934|2076718|P2|Overall Study|Protocol Violation|2
651540|NCT02598934|2076719|P1|Overall Study|Protocol Violation|1
651541|NCT02598934|2076718|P2|Overall Study|Administrative|1
651542|NCT02598934|2076719|P1|Overall Study|Administrative|2
651543|NCT02598934|2076718|P2|Overall Study|Withdrawal by Subject|3
651544|NCT02598934|2076719|P1|Overall Study|Withdrawal by Subject|2
651545|NCT02598934|2076718|P2|Overall Study|Failure to Return|3
651546|NCT02598934|2076719|P1|Overall Study|Failure to Return|3
651547|NCT02598934|2076718|P2|Overall Study|Adverse Event|13
651548|NCT02598934|2076719|P1|Overall Study|Adverse Event|11
651549|NCT02598622|2076731|P2|Overall Study|Physician Decision|0
651550|NCT02598622|2076732|P1|Overall Study|Physician Decision|3
651551|NCT02598622|2076731|P2|Overall Study|Withdrawal by Subject|0
651552|NCT02598622|2076732|P1|Overall Study|Withdrawal by Subject|3
651553|NCT02598128|2076738|P4|Period A: Days -7 to -1|Adverse Event|0
651554|NCT02598128|2076739|P3|Period A: Days -7 to -1|Adverse Event|0
651555|NCT02598128|2076740|P2|Period A: Days -7 to -1|Adverse Event|0
651556|NCT02598128|2076741|P1|Period A: Days -7 to -1|Adverse Event|1
651557|NCT02597855|2076764|P2|Overall Study|Lost to Follow-up|1
651558|NCT02597855|2076765|P1|Overall Study|Lost to Follow-up|2
651559|NCT02596958|2076811|P1|Overall Study|Excluded Due to Second Line Treatment|9
651560|NCT02596958|2076811|P1|Overall Study|Missing|32
651561|NCT02596958|2076811|P1|Overall Study|Lost to Follow-up|33
651562|NCT02596958|2076811|P1|Overall Study|Administrative Reasons/Other|231
651563|NCT02596958|2076811|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
651564|NCT02596958|2076811|P1|Overall Study|Death From Other Cause|33
651565|NCT02596958|2076811|P1|Overall Study|Death From Cancer|112
651566|NCT02596958|2076811|P1|Overall Study|Cancer Progression|441
651567|NCT02596958|2076811|P1|Overall Study|Serious Adverse Drug Reactions|44
651568|NCT02596945|2076823|P1|Overall Study|Missing|1
651569|NCT02596945|2076823|P1|Overall Study|Withdrawal by Subject|1
651570|NCT02596945|2076823|P1|Overall Study|Other Erythropoietin stimulating agent|4
651571|NCT02596945|2076823|P1|Overall Study|Change to hemodialysis|15
651572|NCT02596945|2076823|P1|Overall Study|Unspecified|32
651573|NCT02596945|2076823|P1|Overall Study|No documentation of study drug dosing|3
651574|NCT02596620|2076831|P2|Overall Study|Lost to Follow-up|1
651575|NCT02596620|2076832|P1|Overall Study|Lost to Follow-up|1
651576|NCT02595502|2076850|P2|Period 3|Received Incorrect Treatment at period 3|1
651577|NCT02595502|2076851|P1|Period 3|Received Incorrect Treatment at period 3|0
651578|NCT02595502|2076850|P2|Period 3|Lost to Follow-up|0
651579|NCT02595502|2076851|P1|Period 3|Lost to Follow-up|1
651580|NCT02595502|2076850|P2|Period 3|Protocol Violation|1
651581|NCT02595502|2076851|P1|Period 3|Protocol Violation|0
651582|NCT02595502|2076850|P2|Period 2|Received incorrect lens at Period 1|1
651583|NCT02595502|2076851|P1|Period 2|Received incorrect lens at Period 1|0
651584|NCT02595502|2076850|P2|Period 2|Adverse Event|1
651585|NCT02595502|2076851|P1|Period 2|Adverse Event|1
651586|NCT02595502|2076850|P2|Period 1|Lost to Follow-up|1
651587|NCT02595502|2076851|P1|Period 1|Lost to Follow-up|0
651588|NCT02595502|2076850|P2|Period 1|Withdrawal by Subject|0
651589|NCT02595502|2076851|P1|Period 1|Withdrawal by Subject|1
651590|NCT02595502|2076850|P2|Period 1|Adverse Event|1
651591|NCT02595502|2076851|P1|Period 1|Adverse Event|0
651592|NCT02595450|2076857|P1|Overall Study|Enrolled, but not treated|8
651593|NCT02595450|2076857|P1|Overall Study|Unspecified (only completed 1 cycle)|73
651594|NCT02591238|2076916|P4|Overall Study|personal circumstances|0
651595|NCT02591238|2076917|P3|Overall Study|personal circumstances|0
651596|NCT02591238|2076918|P2|Overall Study|personal circumstances|1
651597|NCT02591238|2076919|P1|Overall Study|personal circumstances|0
651598|NCT02591238|2076916|P4|Overall Study|personal circumstances|1
651599|NCT02591238|2076917|P3|Overall Study|personal circumstances|0
651600|NCT02591238|2076918|P2|Overall Study|personal circumstances|0
651601|NCT02591238|2076919|P1|Overall Study|personal circumstances|0
651602|NCT02591238|2076916|P4|Overall Study|influenza|1
651603|NCT02591238|2076917|P3|Overall Study|influenza|0
651604|NCT02591238|2076918|P2|Overall Study|influenza|0
651605|NCT02591238|2076919|P1|Overall Study|influenza|0
651606|NCT02591238|2076916|P4|Overall Study|Withdrawal by Subject|1
651607|NCT02591238|2076917|P3|Overall Study|Withdrawal by Subject|0
651608|NCT02591238|2076918|P2|Overall Study|Withdrawal by Subject|0
651609|NCT02591238|2076919|P1|Overall Study|Withdrawal by Subject|0
651610|NCT02591238|2076916|P4|Overall Study|Pregnancy|0
651611|NCT02591238|2076917|P3|Overall Study|Pregnancy|0
651612|NCT02591238|2076918|P2|Overall Study|Pregnancy|0
651613|NCT02591238|2076919|P1|Overall Study|Pregnancy|1
651614|NCT02590588|2076953|P1|Overall Study|Adverse Event|1
651615|NCT02590562|2076961|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
651616|NCT02587819|2077040|P1|Overall Study|Lost to Follow-up|1
651617|NCT02587819|2077040|P1|Overall Study|Adverse Event|1
651618|NCT02587234|2077049|P2|Overall Study|Lost to Follow-up|2
651619|NCT02587234|2077050|P1|Overall Study|Lost to Follow-up|0
651620|NCT02587234|2077049|P2|Overall Study|Withdrawal by Subject|1
651621|NCT02587234|2077050|P1|Overall Study|Withdrawal by Subject|1
651629|NCT02585999|2077083|P1|Overall Study|Protocol Violation|1
651630|NCT02585999|2077083|P1|Overall Study|Lost to Follow-up|1
651631|NCT02582983|2077150|P1|Overall Study|Adverse Event|1
651632|NCT02582983|2077150|P1|Overall Study|Withdrawal by Subject|2
651633|NCT02582983|2077150|P1|Overall Study|Death|3
651640|NCT02580357|2077228|P3|Overall Study|Protocol Violation|0
651641|NCT02580357|2077229|P2|Overall Study|Protocol Violation|0
651642|NCT02580357|2077230|P1|Overall Study|Protocol Violation|1
651643|NCT02580357|2077228|P3|Overall Study|Lost to Follow-up|0
651644|NCT02580357|2077229|P2|Overall Study|Lost to Follow-up|0
651645|NCT02580357|2077230|P1|Overall Study|Lost to Follow-up|2
651646|NCT02580240|2077247|P2|Overall Study|Physician Decision|0
651647|NCT02580240|2077248|P1|Overall Study|Physician Decision|2
651648|NCT02578992|2077258|P2|Overall Study|equipment not available or malfunction|3
651649|NCT02578992|2077259|P1|Overall Study|equipment not available or malfunction|3
651650|NCT02578316|2077271|P1|Extension Phase|Progression of disease|6
651651|NCT02578186|2077300|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
651652|NCT02578186|2077301|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
651653|NCT02578186|2077300|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
651654|NCT02578186|2077301|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
651655|NCT02577315|2077336|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
651656|NCT02577315|2077337|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
651657|NCT02576639|2077358|P5|Overall Study|Physician Decision|1
651658|NCT02576639|2077359|P4|Overall Study|Physician Decision|0
651659|NCT02576639|2077360|P3|Overall Study|Physician Decision|0
651660|NCT02576639|2077361|P2|Overall Study|Physician Decision|0
651661|NCT02576639|2077362|P1|Overall Study|Physician Decision|0
651662|NCT02576639|2077358|P5|Overall Study|Adverse Event|2
651663|NCT02576639|2077359|P4|Overall Study|Adverse Event|1
651664|NCT02576639|2077360|P3|Overall Study|Adverse Event|1
651665|NCT02576639|2077361|P2|Overall Study|Adverse Event|0
651666|NCT02576639|2077362|P1|Overall Study|Adverse Event|1
651667|NCT02576639|2077358|P5|Overall Study|Withdrawal by Subject|1
651668|NCT02576639|2077359|P4|Overall Study|Withdrawal by Subject|0
651669|NCT02576639|2077360|P3|Overall Study|Withdrawal by Subject|1
651670|NCT02576639|2077361|P2|Overall Study|Withdrawal by Subject|2
651671|NCT02576639|2077362|P1|Overall Study|Withdrawal by Subject|1
651672|NCT02576535|2077419|P1|Overall Study|Withdrawal by Subject|2
651673|NCT02576145|2077443|P2|Overall Study|Tetanus Titers Decreased|1
651674|NCT02576145|2077444|P1|Overall Study|Tetanus Titers Decreased|0
651675|NCT02576145|2077443|P2|Overall Study|Acute rejection|0
651676|NCT02576145|2077444|P1|Overall Study|Acute rejection|1
651677|NCT02576145|2077443|P2|Overall Study|Withdrawal by Subject|0
651678|NCT02576145|2077444|P1|Overall Study|Withdrawal by Subject|1
651679|NCT02576145|2077443|P2|Overall Study|Adverse Event|0
651680|NCT02576145|2077444|P1|Overall Study|Adverse Event|1
651681|NCT02575911|2077486|P1|Overall Study|Lost to Follow-up|1
651682|NCT02574845|2077510|P6|Overall Study|Adverse Event|1
651683|NCT02574845|2077511|P5|Overall Study|Adverse Event|0
651684|NCT02574845|2077512|P4|Overall Study|Adverse Event|0
651685|NCT02574845|2077513|P3|Overall Study|Adverse Event|0
651686|NCT02574845|2077514|P2|Overall Study|Adverse Event|1
651687|NCT02574845|2077515|P1|Overall Study|Adverse Event|0
651688|NCT02574845|2077510|P6|Overall Study|Consent withdrawn further participation|0
651689|NCT02574845|2077511|P5|Overall Study|Consent withdrawn further participation|1
651690|NCT02574845|2077512|P4|Overall Study|Consent withdrawn further participation|0
651691|NCT02574845|2077513|P3|Overall Study|Consent withdrawn further participation|0
651692|NCT02574845|2077514|P2|Overall Study|Consent withdrawn further participation|0
651693|NCT02574845|2077515|P1|Overall Study|Consent withdrawn further participation|0
651694|NCT02574260|2077541|P1|Overall Study|Disease Progression|1
651695|NCT02573870|2077549|P2|Overall Study|Other: Fail to Meet Visit|2
651696|NCT02573870|2077550|P1|Overall Study|Other: Fail to Meet Visit|0
651697|NCT02573870|2077549|P2|Overall Study|Lost to Follow-up|1
651698|NCT02573870|2077550|P1|Overall Study|Lost to Follow-up|0
651699|NCT02573870|2077549|P2|Overall Study|Other: Reached defined stopping criteria|1
651700|NCT02573870|2077550|P1|Overall Study|Other: Reached defined stopping criteria|0
651701|NCT02573870|2077549|P2|Overall Study|Lack of Efficacy|1
651702|NCT02573870|2077550|P1|Overall Study|Lack of Efficacy|0
651703|NCT02573870|2077549|P2|Overall Study|Adverse Event|2
651704|NCT02573870|2077550|P1|Overall Study|Adverse Event|0
651761|NCT02569996|2077757|P1|Overall Study|Unknown reason|1
651762|NCT02569996|2077757|P1|Overall Study|Complete remission|7
651763|NCT02569996|2077757|P1|Overall Study|Lost to Follow-up|5
651764|NCT02569996|2077757|P1|Overall Study|Withdrawal by Subject|5
651765|NCT02569996|2077757|P1|Overall Study|Non-compliance|9
651766|NCT02569996|2077757|P1|Overall Study|New anti-lymphoma treatment|1
651767|NCT02569996|2077757|P1|Overall Study|Progression of the disease|18
651768|NCT02569996|2077757|P1|Overall Study|Physician Decision|3
651769|NCT02569996|2077757|P1|Overall Study|Adverse Event|6
651770|NCT02568384|2077825|P1|Overall Study|Mobile devices incompatible with App|2
651771|NCT02568254|2077839|P6|Period 3|Unstatisfactory Lens fitting|0
651772|NCT02568254|2077840|P5|Period 3|Unstatisfactory Lens fitting|1
651773|NCT02568254|2077841|P4|Period 3|Unstatisfactory Lens fitting|0
651774|NCT02568254|2077842|P3|Period 3|Unstatisfactory Lens fitting|0
651775|NCT02568254|2077843|P2|Period 3|Unstatisfactory Lens fitting|0
651776|NCT02568254|2077844|P1|Period 3|Unstatisfactory Lens fitting|0
651777|NCT02568254|2077839|P6|Period 2|Adverse Event|0
651778|NCT02568254|2077840|P5|Period 2|Adverse Event|0
651779|NCT02568254|2077841|P4|Period 2|Adverse Event|0
651780|NCT02568254|2077842|P3|Period 2|Adverse Event|1
651781|NCT02568254|2077843|P2|Period 2|Adverse Event|0
651782|NCT02568254|2077844|P1|Period 2|Adverse Event|0
651783|NCT02567188|2077852|P1|Overall Study|Protocol Violation|5
651784|NCT02567188|2077852|P1|Overall Study|Started Hemodialysis|2
651785|NCT02567188|2077852|P1|Overall Study|Moved and Changed Clinic|1
651786|NCT02567188|2077852|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
651787|NCT02567188|2077852|P1|Overall Study|Withdrawal by Subject|1
651788|NCT02567188|2077852|P1|Overall Study|Adverse Event|1
651789|NCT02567188|2077852|P1|Overall Study|Lost to Follow-up|5
651790|NCT02567188|2077852|P1|Overall Study|Terminated Mircera Treatment|9
651791|NCT02567188|2077852|P1|Overall Study|Death|10
651792|NCT02565381|2077915|P3|Overall Study|Lost to Follow-up|1
651793|NCT02565381|2077916|P2|Overall Study|Lost to Follow-up|0
651794|NCT02565381|2077917|P1|Overall Study|Lost to Follow-up|1
651795|NCT02561572|2078009|P2|Overall Study|Protocol Violation|1
651796|NCT02561572|2078010|P1|Overall Study|Protocol Violation|0
651797|NCT02561572|2078009|P2|Overall Study|Inadequate time before surgery|1
651798|NCT02561572|2078010|P1|Overall Study|Inadequate time before surgery|2
651799|NCT02559622|2078030|P4|Overall Study|Patient/guardian decision|1
651800|NCT02559622|2078031|P3|Overall Study|Patient/guardian decision|0
651801|NCT02559622|2078032|P2|Overall Study|Patient/guardian decision|2
651802|NCT02559622|2078033|P1|Overall Study|Patient/guardian decision|1
651803|NCT02559622|2078030|P4|Overall Study|Adverse Event|2
651804|NCT02559622|2078031|P3|Overall Study|Adverse Event|2
651805|NCT02559622|2078032|P2|Overall Study|Adverse Event|2
651806|NCT02559622|2078033|P1|Overall Study|Adverse Event|0
651807|NCT02559622|2078030|P4|Overall Study|Progressive disease|0
651808|NCT02559622|2078031|P3|Overall Study|Progressive disease|0
651809|NCT02559622|2078032|P2|Overall Study|Progressive disease|1
651810|NCT02559622|2078033|P1|Overall Study|Progressive disease|0
651811|NCT02559414|2078115|P3|Overall Study|Other|1
651812|NCT02559414|2078116|P2|Overall Study|Other|1
651813|NCT02559414|2078117|P1|Overall Study|Other|0
651814|NCT02559414|2078115|P3|Overall Study|Withdrawal by Subject|1
651815|NCT02559414|2078116|P2|Overall Study|Withdrawal by Subject|0
651816|NCT02559414|2078117|P1|Overall Study|Withdrawal by Subject|1
651817|NCT02559414|2078115|P3|Overall Study|Lost to Follow-up|0
651818|NCT02559414|2078116|P2|Overall Study|Lost to Follow-up|1
651819|NCT02559414|2078117|P1|Overall Study|Lost to Follow-up|0
651820|NCT02557646|2078204|P1|Overall Study|Unspecified|14
651821|NCT02557646|2078204|P1|Overall Study|Lost to Follow-up|17
651822|NCT02557646|2078204|P1|Overall Study|Withdrawal by Subject|18
651823|NCT02557646|2078204|P1|Overall Study|Lack of Efficacy|186
651824|NCT02557646|2078204|P1|Overall Study|Death|1
651825|NCT02557646|2078204|P1|Overall Study|Adverse Event|40
651826|NCT02556307|2078227|P1|Overall Study|Enrolled but not treated|2
651827|NCT02556307|2078227|P1|Overall Study|Change to triple therapy|4
651828|NCT02556307|2078227|P1|Overall Study|Lost to Follow-up|36
651829|NCT02556307|2078227|P1|Overall Study|Premature treatment interruption|11
651830|NCT02555722|2078239|P2|Month 2|Adverse Event|0
651831|NCT02555722|2078240|P1|Month 2|Adverse Event|3
651832|NCT02555722|2078239|P2|Month 1|Withdrawal by Subject|0
651833|NCT02555722|2078240|P1|Month 1|Withdrawal by Subject|2
651834|NCT02555722|2078239|P2|Week 2|Lens Discomfort|1
651835|NCT02555722|2078240|P1|Week 2|Lens Discomfort|0
651836|NCT02555722|2078239|P2|Week 1|Withdrawal by Subject|0
651837|NCT02555722|2078240|P1|Week 1|Withdrawal by Subject|1
651838|NCT02555618|2078400|P2|Overall Study|Sponsor's Circumstances|0
651839|NCT02555618|2078401|P1|Overall Study|Sponsor's Circumstances|1
651840|NCT02554981|2078458|P1|Overall Study|Other Miscellaneous Reasons|3
651841|NCT02554981|2078458|P1|Overall Study|Administrative Reasons|1
651842|NCT02554981|2078458|P1|Overall Study|Adverse Event|1
651843|NCT02554877|2078486|P4|Overall Study|No longer willing to participate|0
651844|NCT02554877|2078487|P3|Overall Study|No longer willing to participate|2
651845|NCT02554877|2078488|P2|Overall Study|No longer willing to participate|2
651846|NCT02554877|2078489|P1|Overall Study|No longer willing to participate|0
651847|NCT02554877|2078486|P4|Overall Study|Insufficient clinical response|0
651848|NCT02554877|2078487|P3|Overall Study|Insufficient clinical response|0
651849|NCT02554877|2078488|P2|Overall Study|Insufficient clinical response|0
651850|NCT02554877|2078489|P1|Overall Study|Insufficient clinical response|4
651851|NCT02554877|2078486|P4|Overall Study|Unspecified|3
651852|NCT02554877|2078487|P3|Overall Study|Unspecified|0
651853|NCT02554877|2078488|P2|Overall Study|Unspecified|3
651854|NCT02554877|2078489|P1|Overall Study|Unspecified|1
651855|NCT02554877|2078486|P4|Overall Study|Protocol Violation|0
651856|NCT02554877|2078487|P3|Overall Study|Protocol Violation|1
651857|NCT02554877|2078488|P2|Overall Study|Protocol Violation|1
651858|NCT02554877|2078489|P1|Overall Study|Protocol Violation|3
651859|NCT02554877|2078486|P4|Overall Study|No longer met eligibility criteria|1
651860|NCT02554877|2078487|P3|Overall Study|No longer met eligibility criteria|1
651861|NCT02554877|2078488|P2|Overall Study|No longer met eligibility criteria|0
651862|NCT02554877|2078489|P1|Overall Study|No longer met eligibility criteria|1
651863|NCT02554877|2078486|P4|Overall Study|Did not meet entrance criteria|0
651864|NCT02554877|2078487|P3|Overall Study|Did not meet entrance criteria|1
651865|NCT02554877|2078488|P2|Overall Study|Did not meet entrance criteria|0
651866|NCT02554877|2078489|P1|Overall Study|Did not meet entrance criteria|0
651867|NCT02554877|2078486|P4|Overall Study|Lost to Follow-up|2
651868|NCT02554877|2078487|P3|Overall Study|Lost to Follow-up|1
651869|NCT02554877|2078488|P2|Overall Study|Lost to Follow-up|1
651870|NCT02554877|2078489|P1|Overall Study|Lost to Follow-up|1
651871|NCT02554877|2078486|P4|Overall Study|Adverse Event|1
651872|NCT02554877|2078487|P3|Overall Study|Adverse Event|0
651873|NCT02554877|2078488|P2|Overall Study|Adverse Event|0
651874|NCT02554877|2078489|P1|Overall Study|Adverse Event|2
651875|NCT02553629|2078553|P2|Overall Study|Logistic reasons|6
651876|NCT02553629|2078554|P1|Overall Study|Logistic reasons|3
651877|NCT02553421|2078578|P2|Overall Study|Improper Device Placement|0
651878|NCT02553421|2078579|P1|Overall Study|Improper Device Placement|3
651879|NCT02553421|2078578|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
651880|NCT02553421|2078579|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
651881|NCT02553421|2078578|P2|Overall Study|Lost to Follow-up|1
651882|NCT02553421|2078579|P1|Overall Study|Lost to Follow-up|21
651883|NCT02552303|2078610|P4|Follow-Up|ineligible|0
651884|NCT02552303|2078611|P3|Follow-Up|ineligible|0
651885|NCT02552303|2078612|P2|Follow-Up|ineligible|2
651886|NCT02552303|2078613|P1|Follow-Up|ineligible|0
651887|NCT02552303|2078610|P4|Follow-Up|Lost to Follow-up|0
651888|NCT02552303|2078611|P3|Follow-Up|Lost to Follow-up|1
651889|NCT02552303|2078612|P2|Follow-Up|Lost to Follow-up|0
651890|NCT02552303|2078613|P1|Follow-Up|Lost to Follow-up|0
651891|NCT02552303|2078610|P4|Allocation|ineligible|0
651892|NCT02552303|2078611|P3|Allocation|ineligible|0
651893|NCT02552303|2078612|P2|Allocation|ineligible|1
651894|NCT02552303|2078613|P1|Allocation|ineligible|1
651895|NCT02552303|2078610|P4|Allocation|Withdrawal by Subject|1
651896|NCT02552303|2078611|P3|Allocation|Withdrawal by Subject|1
651897|NCT02552303|2078612|P2|Allocation|Withdrawal by Subject|1
651898|NCT02552303|2078613|P1|Allocation|Withdrawal by Subject|2
651924|NCT02549027|2078810|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
651925|NCT02549027|2078811|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
651926|NCT02549027|2078812|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
651927|NCT02549027|2078813|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
651928|NCT02549027|2078814|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
651929|NCT02549027|2078815|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
651930|NCT02549027|2078810|P6|Washout After Period 4|Withdrawal by Subject|0
651931|NCT02549027|2078811|P5|Washout After Period 4|Withdrawal by Subject|0
651932|NCT02549027|2078812|P4|Washout After Period 4|Withdrawal by Subject|1
651933|NCT02549027|2078813|P3|Washout After Period 4|Withdrawal by Subject|1
651934|NCT02549027|2078814|P2|Washout After Period 4|Withdrawal by Subject|1
651935|NCT02549027|2078815|P1|Washout After Period 4|Withdrawal by Subject|0
651936|NCT02548156|2078943|P6|Washout Period 1|Lost to Follow-up|0
651937|NCT02548156|2078944|P5|Washout Period 1|Lost to Follow-up|1
651938|NCT02548156|2078945|P4|Washout Period 1|Lost to Follow-up|0
651939|NCT02548156|2078946|P3|Washout Period 1|Lost to Follow-up|0
651940|NCT02548156|2078947|P2|Washout Period 1|Lost to Follow-up|0
651941|NCT02548156|2078948|P1|Washout Period 1|Lost to Follow-up|0
651942|NCT02547454|2078975|P1|Overall Study|No data|11
651943|NCT02547454|2078975|P1|Overall Study|Unspecified|39
651944|NCT02547454|2078975|P1|Overall Study|Lost to Follow-up|26
651945|NCT02547454|2078975|P1|Overall Study|Death|38
651946|NCT02547454|2078975|P1|Overall Study|Due to no further need to treat|4
651947|NCT02547454|2078975|P1|Overall Study|Due to transplantation|1
651948|NCT02547454|2078975|P1|Overall Study|Due to hemodialysis|53
651949|NCT02545543|2079034|P2|Overall Study|Enrolment of subject at >1 study site|1
651950|NCT02545543|2079035|P1|Overall Study|Enrolment of subject at >1 study site|1
651951|NCT02545543|2079034|P2|Overall Study|Noncomplaince|0
651952|NCT02545543|2079035|P1|Overall Study|Noncomplaince|1
651953|NCT02545543|2079034|P2|Overall Study|Withdrawal by Subject|8
651954|NCT02545543|2079035|P1|Overall Study|Withdrawal by Subject|9
651955|NCT02545543|2079034|P2|Overall Study|Physician Decision|0
651956|NCT02545543|2079035|P1|Overall Study|Physician Decision|3
651957|NCT02545543|2079034|P2|Overall Study|Lost to Follow-up|25
651958|NCT02545543|2079035|P1|Overall Study|Lost to Follow-up|67
651959|NCT02545322|2079059|P1|Overall Study|Withdrawal by Subject|3
651960|NCT02543918|2079066|P2|Overall Study|Adverse Event|1
651961|NCT02543918|2079067|P1|Overall Study|Adverse Event|1
651962|NCT02543918|2079066|P2|Overall Study|Withdrawal by Subject|1
651963|NCT02543918|2079067|P1|Overall Study|Withdrawal by Subject|1
651964|NCT02543918|2079066|P2|Overall Study|Lost to Follow-up|1
651965|NCT02543918|2079067|P1|Overall Study|Lost to Follow-up|1
651966|NCT02543918|2079066|P2|Overall Study|Never treated|1
651967|NCT02543918|2079067|P1|Overall Study|Never treated|0
651968|NCT02542943|2079081|P3|Overall Study|Withdrawal by Subject|0
651969|NCT02542943|2079082|P2|Overall Study|Withdrawal by Subject|1
651970|NCT02542943|2079083|P1|Overall Study|Withdrawal by Subject|0
651971|NCT02542943|2079081|P3|Overall Study|Lost to Follow-up|0
651972|NCT02542943|2079082|P2|Overall Study|Lost to Follow-up|0
651973|NCT02542943|2079083|P1|Overall Study|Lost to Follow-up|1
651986|NCT02540850|2079249|P3|Overall Study|Lost to Follow-up|34
651987|NCT02540850|2079250|P2|Overall Study|Lost to Follow-up|66
651988|NCT02540850|2079251|P1|Overall Study|Lost to Follow-up|69
651991|NCT02540265|2079357|P3|Overall Study|Lost to Follow-up|1
651992|NCT02540265|2079358|P2|Overall Study|Lost to Follow-up|0
651993|NCT02540265|2079359|P1|Overall Study|Lost to Follow-up|0
651994|NCT02540213|2079379|P1|Overall Study|Enrolled but not treated|2
651995|NCT02540213|2079379|P1|Overall Study|Consent withdrawn|7
651996|NCT02540213|2079379|P1|Overall Study|Lack of Efficacy|6
651997|NCT02540213|2079379|P1|Overall Study|Kidney transplant|3
651998|NCT02540213|2079379|P1|Overall Study|Administrative reasons|3
651999|NCT02540213|2079379|P1|Overall Study|Death/adverse event|18
652000|NCT02539134|2079437|P6|Overall Study|Lost to Follow-up|0
652001|NCT02539134|2079438|P5|Overall Study|Lost to Follow-up|0
652002|NCT02539134|2079439|P4|Overall Study|Lost to Follow-up|0
652003|NCT02539134|2079440|P3|Overall Study|Lost to Follow-up|0
652004|NCT02539134|2079441|P2|Overall Study|Lost to Follow-up|0
652005|NCT02539134|2079442|P1|Overall Study|Lost to Follow-up|1
652006|NCT02537522|2079511|P4|Phase II - Period 1 Bilateral|Adverse Event|1
652007|NCT02537522|2079512|P3|Phase II - Period 1 Bilateral|Adverse Event|0
652008|NCT02537522|2079513|P2|Phase II - Period 1 Bilateral|Adverse Event|0
652009|NCT02537522|2079514|P1|Phase II - Period 1 Bilateral|Adverse Event|0
652010|NCT02537522|2079511|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
652011|NCT02537522|2079512|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
652012|NCT02537522|2079513|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
652013|NCT02537522|2079514|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
652014|NCT02537522|2079511|P4|Phase I - Contralateral|incorrect randomization|0
652015|NCT02537522|2079512|P3|Phase I - Contralateral|incorrect randomization|0
652016|NCT02537522|2079513|P2|Phase I - Contralateral|incorrect randomization|1
652017|NCT02537522|2079514|P1|Phase I - Contralateral|incorrect randomization|0
652018|NCT02537522|2079511|P4|Phase I - Contralateral|Withdrawal by Subject|0
652019|NCT02537522|2079512|P3|Phase I - Contralateral|Withdrawal by Subject|0
652020|NCT02537522|2079513|P2|Phase I - Contralateral|Withdrawal by Subject|1
652021|NCT02537522|2079514|P1|Phase I - Contralateral|Withdrawal by Subject|0
652022|NCT02537522|2079511|P4|Phase I - Contralateral|Subject no longer eligible|0
652023|NCT02537522|2079512|P3|Phase I - Contralateral|Subject no longer eligible|0
652024|NCT02537522|2079513|P2|Phase I - Contralateral|Subject no longer eligible|7
652025|NCT02537522|2079514|P1|Phase I - Contralateral|Subject no longer eligible|15
652026|NCT02538107|2079522|P1|Overall Study|Not recorded|7
652027|NCT02538107|2079522|P1|Overall Study|Unspecified|7
652028|NCT02538107|2079522|P1|Overall Study|Surgery|1
652029|NCT02538107|2079522|P1|Overall Study|Adverse Event|4
652030|NCT02538107|2079522|P1|Overall Study|Administrative reason|5
652031|NCT02538107|2079522|P1|Overall Study|Death|4
652032|NCT02538107|2079522|P1|Overall Study|Withdrawal by Subject|17
652033|NCT02538107|2079522|P1|Overall Study|No further treatment necessary|18
652034|NCT02538107|2079522|P1|Overall Study|Administration of other ESA|11
652035|NCT02538107|2079522|P1|Overall Study|Necessity of dialysis|20
652036|NCT02538107|2079522|P1|Overall Study|Missing|5
652037|NCT02538107|2079522|P1|Overall Study|Did not receive any Mircera dose|11
652038|NCT02536781|2079557|P2|Overall Study|Lost to Follow-up|0
652039|NCT02536781|2079558|P1|Overall Study|Lost to Follow-up|2
652040|NCT02536664|2079568|P2|Overall Study|Missing|20
652041|NCT02536664|2079569|P1|Overall Study|Missing|53
652042|NCT02536664|2079568|P2|Overall Study|Unspecified|24
652043|NCT02536664|2079569|P1|Overall Study|Unspecified|18
652044|NCT02536664|2079568|P2|Overall Study|Withdrawal by Subject|5
652045|NCT02536664|2079569|P1|Overall Study|Withdrawal by Subject|8
652046|NCT02536664|2079568|P2|Overall Study|Intolerability|6
652047|NCT02536664|2079569|P1|Overall Study|Intolerability|8
652048|NCT02536664|2079568|P2|Overall Study|Death due to other reason|2
652049|NCT02536664|2079569|P1|Overall Study|Death due to other reason|3
652050|NCT02536664|2079568|P2|Overall Study|Death due to lymphoma|1
652051|NCT02536664|2079569|P1|Overall Study|Death due to lymphoma|2
652052|NCT02536664|2079568|P2|Overall Study|Progression|18
652053|NCT02536664|2079569|P1|Overall Study|Progression|13
652054|NCT02536664|2079568|P2|Overall Study|Inadequate completion of documentation|4
652055|NCT02536664|2079569|P1|Overall Study|Inadequate completion of documentation|2
652056|NCT02536313|2079589|P2|Overall Study|Lack of Efficacy|1
652057|NCT02536313|2079590|P1|Overall Study|Lack of Efficacy|0
652058|NCT02535741|2079606|P1|Overall Study|Missing data|6
652059|NCT02535741|2079606|P1|Overall Study|Exclusion criteria: Bilateral implant|4
652060|NCT02535741|2079606|P1|Overall Study|Lost to Follow-up|10
652061|NCT02535741|2079606|P1|Overall Study|Withdrawal by Subject|9
652062|NCT02535741|2079606|P1|Overall Study|Adverse Event|3
652063|NCT02534324|2079664|P2|Overall Study|Adverse Event|0
652064|NCT02534324|2079665|P1|Overall Study|Adverse Event|1
652065|NCT02534324|2079664|P2|Overall Study|Lost to Follow-up|7
652066|NCT02534324|2079665|P1|Overall Study|Lost to Follow-up|20
652067|NCT02534324|2079664|P2|Overall Study|Protocol Violation|1
652068|NCT02534324|2079665|P1|Overall Study|Protocol Violation|4
652069|NCT02533401|2079709|P1|Overall Study|Violation of Selection Criteria|1
652070|NCT02533401|2079709|P1|Overall Study|Lost to Follow-up|1
652071|NCT02533401|2079709|P1|Overall Study|Insufficient Response/Progressed Disease|1
652072|NCT02533401|2079709|P1|Overall Study|Death|5
652073|NCT02533401|2079709|P1|Overall Study|Adverse Event/Intercurrent Disease|3
652074|NCT02533258|2079717|P1|Overall Study|Lack of Efficacy|2
652075|NCT02533258|2079717|P1|Overall Study|Progression of pleural effusion|1
652076|NCT02533258|2079717|P1|Overall Study|Economic factor|1
652077|NCT02533258|2079717|P1|Overall Study|Unspecified|1
652078|NCT02533258|2079717|P1|Overall Study|Death|2
652079|NCT02533258|2079717|P1|Overall Study|Adverse Event|1
652080|NCT02532374|2079811|P1|Overall Study|Physician Decision|1
652081|NCT02532374|2079811|P1|Overall Study|Withdrawal by Subject|1
652082|NCT02531646|2079842|P3|Overall Study|equip. image processing issue|0
652083|NCT02531646|2079843|P2|Overall Study|equip. image processing issue|1
652084|NCT02531646|2079844|P1|Overall Study|equip. image processing issue|5
652085|NCT02530671|2079864|P2|Overall Study|Withdrawal by Subject|0
652086|NCT02530671|2079865|P1|Overall Study|Withdrawal by Subject|1
652087|NCT02530671|2079864|P2|Overall Study|Lost to Follow-up|0
652088|NCT02530671|2079865|P1|Overall Study|Lost to Follow-up|2
652089|NCT02529995|2079892|P2|Part A|Discontinued Study|0
652090|NCT02529995|2079893|P1|Part A|Discontinued Study|1
652091|NCT02529995|2079892|P2|Part A|Ongoing Study at Data Cut-off|16
652092|NCT02529995|2079893|P1|Part A|Ongoing Study at Data Cut-off|14
652093|NCT02528331|2079940|P1|Overall Study|Withdrawal by Subject|2
652094|NCT02527161|2079958|P1|Overall Study|Consent violation|4
652095|NCT02527161|2079958|P1|Overall Study|MRI contraindication|2
652096|NCT02527161|2079958|P1|Overall Study|Delay in or unfit for surgery|5
652097|NCT02527161|2079958|P1|Overall Study|Exclusion RA diagnosis|1
652098|NCT02527161|2079958|P1|Overall Study|Exclusion for excessive deformity|1
652099|NCT02527161|2079958|P1|Overall Study|Exclusion for BMI|2
652100|NCT02527161|2079958|P1|Overall Study|Shape Match not used in surgery|2
652101|NCT02527161|2079958|P1|Overall Study|Withdrawal by Subject|6
652102|NCT02527161|2079958|P1|Overall Study|Failed MRI|39
652103|NCT02527148|2079977|P2|Overall Study|Did not receive study intervention|0
652104|NCT02527148|2079978|P1|Overall Study|Did not receive study intervention|1
652105|NCT02526550|2079996|P1|Overall Study|Lost to Follow-up|1
652106|NCT02524665|2080078|P1|Overall Study|Lost to Follow-up|1
652107|NCT02524288|2080129|P1|Overall Study|Physician Decision|2
652108|NCT02524288|2080129|P1|Overall Study|Pregnancy|22
652109|NCT02524288|2080129|P1|Overall Study|Withdrawal by Subject|76
652110|NCT02524288|2080129|P1|Overall Study|Subject Moved|32
652111|NCT02524288|2080129|P1|Overall Study|Study Terminated By Sponsor|1417
652112|NCT02524288|2080129|P1|Overall Study|Site Discontinued Study Participation|1
652113|NCT02524288|2080129|P1|Overall Study|Screen Failure|2
652114|NCT02524288|2080129|P1|Overall Study|Protocol Violation|6
652115|NCT02524288|2080129|P1|Overall Study|Pregnancy Wish|6
652116|NCT02524288|2080129|P1|Overall Study|Non-Compliance With Study Drug|14
652117|NCT02524288|2080129|P1|Overall Study|Non-Compliance With Protocol|32
652118|NCT02524288|2080129|P1|Overall Study|Lost to Follow-up|216
652119|NCT02524288|2080129|P1|Overall Study|Adverse Event|115
652128|NCT02522624|2080154|P2|Overall Study|Technical failure|0
652129|NCT02522624|2080155|P1|Overall Study|Technical failure|1
652134|NCT02519595|2080197|P3|Overall Study|Protocol Violation|16
652135|NCT02519595|2080198|P2|Overall Study|Protocol Violation|22
652136|NCT02519595|2080199|P1|Overall Study|Protocol Violation|8
652137|NCT02518048|2080230|P1|Overall Study|Withdrawal by Subject|1
652140|NCT02516163|2080250|P1|Overall Study|MRI contraindication exclusion|6
652141|NCT02516163|2080250|P1|Overall Study|Data not recorded|2
652142|NCT02516163|2080250|P1|Overall Study|Use of incorrect measurement technique|5
652143|NCT02516163|2080250|P1|Overall Study|Unfit/delay in surgery|3
652144|NCT02516163|2080250|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
652145|NCT02516163|2080250|P1|Overall Study|Withdrawal by Subject|1
652146|NCT02516098|2080264|P2|Period 2|Withdrawal by Subject|1
652147|NCT02516098|2080265|P1|Period 2|Withdrawal by Subject|0
652148|NCT02516098|2080264|P2|Washout After Period 1|Adverse Event|1
652149|NCT02516098|2080265|P1|Washout After Period 1|Adverse Event|0
652150|NCT02516098|2080264|P2|Period 1|Protocol Violation|0
652151|NCT02516098|2080265|P1|Period 1|Protocol Violation|1
652152|NCT02515994|2080279|P2|Overall Study|Withdrawal by Subject|0
652153|NCT02515994|2080280|P1|Overall Study|Withdrawal by Subject|2
652154|NCT02515994|2080279|P2|Overall Study|Adverse Event|1
652155|NCT02515994|2080280|P1|Overall Study|Adverse Event|3
652156|NCT02515994|2080279|P2|Overall Study|No Longer Meets Eligibility Criteria|1
652157|NCT02515994|2080280|P1|Overall Study|No Longer Meets Eligibility Criteria|2
652158|NCT02515994|2080279|P2|Overall Study|Protocol Violation|5
652159|NCT02515994|2080280|P1|Overall Study|Protocol Violation|3
652160|NCT02515279|2080292|P1|Overall Study|Unspecified|22
652161|NCT02515279|2080292|P1|Overall Study|End-of-treatment visit not attended|17
652162|NCT02515279|2080292|P1|Overall Study|Withdrawal by Subject|18
652163|NCT02515279|2080292|P1|Overall Study|Lost to Follow-up|9
652164|NCT02515279|2080292|P1|Overall Study|Lack of Efficacy|31
652165|NCT02515279|2080292|P1|Overall Study|Adverse Event|7
652166|NCT02515045|2080300|P3|Overall Study|Lost to Follow-up|1
652167|NCT02515045|2080301|P2|Overall Study|Lost to Follow-up|1
652168|NCT02515045|2080302|P1|Overall Study|Lost to Follow-up|0
652169|NCT02515045|2080300|P3|Overall Study|Adverse Event|3
652170|NCT02515045|2080301|P2|Overall Study|Adverse Event|3
652171|NCT02515045|2080302|P1|Overall Study|Adverse Event|0
887916|NCT02556632|2821118|P3|Overall Study|Treatment or Change Delay|1
887917|NCT02556632|2821119|P2|Overall Study|Treatment or Change Delay|0
887918|NCT02556632|2821120|P1|Overall Study|Treatment or Change Delay|0
887919|NCT02556632|2821118|P3|Overall Study|Disliked Study Procedures|1
887920|NCT02556632|2821119|P2|Overall Study|Disliked Study Procedures|0
887921|NCT02556632|2821120|P1|Overall Study|Disliked Study Procedures|0
887922|NCT02556632|2821118|P3|Overall Study|Ineligible|0
887923|NCT02556632|2821119|P2|Overall Study|Ineligible|1
887924|NCT02556632|2821120|P1|Overall Study|Ineligible|0
887925|NCT02556632|2821118|P3|Overall Study|Did Not Start RT|0
887926|NCT02556632|2821119|P2|Overall Study|Did Not Start RT|1
887927|NCT02556632|2821120|P1|Overall Study|Did Not Start RT|0
887928|NCT02556632|2821118|P3|Overall Study|Possibly Related Adverse Event|1
887929|NCT02556632|2821119|P2|Overall Study|Possibly Related Adverse Event|0
887930|NCT02556632|2821120|P1|Overall Study|Possibly Related Adverse Event|0
887931|NCT02556632|2821118|P3|Overall Study|Related Adverse Event|0
887932|NCT02556632|2821119|P2|Overall Study|Related Adverse Event|1
887933|NCT02556632|2821120|P1|Overall Study|Related Adverse Event|0
887934|NCT02556632|2821118|P3|Overall Study|Unrelated Adverse Event|3
887935|NCT02556632|2821119|P2|Overall Study|Unrelated Adverse Event|0
887936|NCT02556632|2821120|P1|Overall Study|Unrelated Adverse Event|1
887937|NCT02556632|2821118|P3|Overall Study|Withdrew (Unrelated Medical)|0
887938|NCT02556632|2821119|P2|Overall Study|Withdrew (Unrelated Medical)|0
887939|NCT02556632|2821120|P1|Overall Study|Withdrew (Unrelated Medical)|1
887940|NCT02556632|2821118|P3|Overall Study|Changed Mind|0
887941|NCT02556632|2821119|P2|Overall Study|Changed Mind|1
887942|NCT02556632|2821120|P1|Overall Study|Changed Mind|0
887943|NCT02556632|2821118|P3|Overall Study|Personal Issues|1
652220|NCT02513095|2080360|P2|Overall Study|Stampede resulted in transfers out of ER|16
652221|NCT02513095|2080361|P1|Overall Study|Stampede resulted in transfers out of ER|14
652222|NCT02511782|2080526|P3|Overall Study|Withdrawal by Subject|0
652223|NCT02511782|2080527|P2|Overall Study|Withdrawal by Subject|0
652224|NCT02511782|2080528|P1|Overall Study|Withdrawal by Subject|1
652225|NCT02510820|2080538|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
652226|NCT02510820|2080539|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
887944|NCT02556632|2821119|P2|Overall Study|Personal Issues|1
887945|NCT02556632|2821120|P1|Overall Study|Personal Issues|0
887946|NCT02556632|2821118|P3|Overall Study|No Reason|1
887947|NCT02556632|2821119|P2|Overall Study|No Reason|0
887948|NCT02556632|2821120|P1|Overall Study|No Reason|1
887949|NCT02556632|2821118|P3|Overall Study|Disliked Intervention|1
887950|NCT02556632|2821119|P2|Overall Study|Disliked Intervention|1
887951|NCT02556632|2821120|P1|Overall Study|Disliked Intervention|1
887952|NCT02556632|2821118|P3|Overall Study|Lost to Follow-up|0
887953|NCT02556632|2821119|P2|Overall Study|Lost to Follow-up|0
887954|NCT02556632|2821120|P1|Overall Study|Lost to Follow-up|1
887955|NCT02544074|2821155|P21|Overall Study|Tablet error|0
652227|NCT02510820|2080538|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
652228|NCT02510820|2080539|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
652229|NCT02507752|2080588|P1|Overall Study|Participant didn't perform visit Week 24|1
652230|NCT02507752|2080588|P1|Overall Study|Participant didn't perform visit Week 12|1
652231|NCT02507752|2080588|P1|Overall Study|Infusion reaction at first infusion|1
652232|NCT02507752|2080588|P1|Overall Study|Lost to Follow-up|7
652233|NCT02507752|2080588|P1|Overall Study|Protocol Violation|6
652234|NCT02507752|2080588|P1|Overall Study|Adverse Event|1
652235|NCT02507375|2080632|P2|Overall Study|Adverse Event|1
652236|NCT02507375|2080633|P1|Overall Study|Adverse Event|0
652237|NCT02507375|2080632|P2|Overall Study|Refused treatment|1
652238|NCT02507375|2080633|P1|Overall Study|Refused treatment|0
652239|NCT02507375|2080632|P2|Overall Study|Death|1
652240|NCT02507375|2080633|P1|Overall Study|Death|0
652241|NCT02507375|2080632|P2|Overall Study|Progressive Disease|5
652242|NCT02507375|2080633|P1|Overall Study|Progressive Disease|4
652243|NCT02506881|2080654|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
652244|NCT02506881|2080655|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
652245|NCT02506881|2080656|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
652246|NCT02506881|2080657|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
652247|NCT02506881|2080654|P4|First Intervention (Day 1)|Withdrawal by Subject|0
652248|NCT02506881|2080655|P3|First Intervention (Day 1)|Withdrawal by Subject|0
652249|NCT02506881|2080656|P2|First Intervention (Day 1)|Withdrawal by Subject|0
652250|NCT02506881|2080657|P1|First Intervention (Day 1)|Withdrawal by Subject|1
652251|NCT02506881|2080654|P4|First Intervention (Day 1)|Protocol Violation|0
652252|NCT02506881|2080655|P3|First Intervention (Day 1)|Protocol Violation|1
652253|NCT02506881|2080656|P2|First Intervention (Day 1)|Protocol Violation|0
652254|NCT02506881|2080657|P1|First Intervention (Day 1)|Protocol Violation|0
652255|NCT02506257|2080710|P4|Overall Study|Protocol Violation|0
652256|NCT02506257|2080711|P3|Overall Study|Protocol Violation|1
652257|NCT02506257|2080712|P2|Overall Study|Protocol Violation|0
652258|NCT02506257|2080713|P1|Overall Study|Protocol Violation|0
652259|NCT02506257|2080710|P4|Overall Study|Adverse Event|0
652260|NCT02506257|2080711|P3|Overall Study|Adverse Event|3
652261|NCT02506257|2080712|P2|Overall Study|Adverse Event|2
652262|NCT02506257|2080713|P1|Overall Study|Adverse Event|0
652263|NCT02504502|2080773|P2|Crossover to Enhanced Report|Lost to Follow-up|0
652264|NCT02504502|2080774|P1|Crossover to Enhanced Report|Lost to Follow-up|5
652265|NCT02504502|2080773|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
652266|NCT02504502|2080774|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
652267|NCT02504320|2080784|P4|Treatment Period 3|Adverse Event|0
652268|NCT02504320|2080785|P3|Treatment Period 3|Adverse Event|1
652269|NCT02504320|2080786|P2|Treatment Period 3|Adverse Event|0
652270|NCT02504320|2080787|P1|Treatment Period 3|Adverse Event|0
652271|NCT02504320|2080784|P4|Treatment Period 3|Positive Drug Screen|1
652272|NCT02504320|2080785|P3|Treatment Period 3|Positive Drug Screen|0
652273|NCT02504320|2080786|P2|Treatment Period 3|Positive Drug Screen|0
652274|NCT02504320|2080787|P1|Treatment Period 3|Positive Drug Screen|0
652275|NCT02504320|2080784|P4|Treatment Period 2|Positive Drug Screen|0
652276|NCT02504320|2080785|P3|Treatment Period 2|Positive Drug Screen|0
652277|NCT02504320|2080786|P2|Treatment Period 2|Positive Drug Screen|1
652278|NCT02504320|2080787|P1|Treatment Period 2|Positive Drug Screen|0
652279|NCT02504320|2080784|P4|Treatment Period 1|Positive Drug Screen|0
652280|NCT02504320|2080785|P3|Treatment Period 1|Positive Drug Screen|1
652281|NCT02504320|2080786|P2|Treatment Period 1|Positive Drug Screen|0
652282|NCT02504320|2080787|P1|Treatment Period 1|Positive Drug Screen|0
652283|NCT02503865|2080818|P3|Overall Study|Refused treatment|2
652284|NCT02503865|2080819|P2|Overall Study|Refused treatment|39
652285|NCT02503865|2080820|P1|Overall Study|Refused treatment|4
652286|NCT02503865|2080818|P3|Overall Study|Moved out of area|0
652287|NCT02503865|2080819|P2|Overall Study|Moved out of area|8
652288|NCT02503865|2080820|P1|Overall Study|Moved out of area|1
652289|NCT02503787|2080840|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
652290|NCT02503787|2080840|P1|Implant to 3 Month Endpoint|Adverse Event|2
652291|NCT02503787|2080840|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
652292|NCT02503787|2080840|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
652293|NCT02503787|2080840|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
652294|NCT02503787|2080840|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
652295|NCT02503787|2080840|P1|Enrollment|Unable to be programmed|1
652296|NCT02503787|2080840|P1|Enrollment|Inability to implant system|1
652297|NCT02503787|2080840|P1|Enrollment|Protocol Violation|1
652298|NCT02503787|2080840|P1|Enrollment|Adverse Event|1
652299|NCT02503787|2080840|P1|Enrollment|Study closure|1
652300|NCT02503787|2080840|P1|Enrollment|Lost to Follow-up|1
652301|NCT02503787|2080840|P1|Enrollment|Insurance issue|2
652302|NCT02503787|2080840|P1|Enrollment|Physician Decision|2
652303|NCT02503787|2080840|P1|Enrollment|Inclusion/exclusion criteria not met|4
652304|NCT02503787|2080840|P1|Enrollment|Withdrawal by Subject|6
652305|NCT02503215|2080863|P1|Overall Study|Unable to use positive airway pressure|2
652306|NCT02503215|2080863|P1|Overall Study|Unable to wear compression stockings|1
652311|NCT02500758|2080976|P2|Second Intervention (2 Minutes)|Protocol Violation|1
652312|NCT02500758|2080977|P1|Second Intervention (2 Minutes)|Protocol Violation|1
652313|NCT02500758|2080976|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
652314|NCT02500758|2080977|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
652315|NCT02500758|2080976|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
652316|NCT02500758|2080977|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
652317|NCT02500758|2080976|P2|Washout (1 Week)|Lost to Follow-up|2
652318|NCT02500758|2080977|P1|Washout (1 Week)|Lost to Follow-up|2
652319|NCT02500758|2080976|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
652320|NCT02500758|2080977|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
652321|NCT02500537|2080987|P2|Overall Study|Withdrawal by Subject|0
652322|NCT02500537|2080988|P1|Overall Study|Withdrawal by Subject|1
652323|NCT02500537|2080987|P2|Overall Study|Lost to Follow-up|1
652324|NCT02500537|2080988|P1|Overall Study|Lost to Follow-up|0
652325|NCT02500537|2080987|P2|Overall Study|Death|0
652326|NCT02500537|2080988|P1|Overall Study|Death|2
652327|NCT02500056|2081057|P2|Overall Study|Death|1
652328|NCT02500056|2081058|P1|Overall Study|Death|3
652329|NCT02500056|2081057|P2|Overall Study|Recurrence|0
652330|NCT02500056|2081058|P1|Overall Study|Recurrence|1
652331|NCT02500056|2081057|P2|Overall Study|Lost to Follow-up|7
652332|NCT02500056|2081058|P1|Overall Study|Lost to Follow-up|3
652333|NCT02499575|2081079|P2|Overall Study|Protocol Violation|1
652334|NCT02499575|2081080|P1|Overall Study|Protocol Violation|0
652335|NCT02498821|2081092|P2|Overall Study|Screen failure|5
652336|NCT02498821|2081093|P1|Overall Study|Screen failure|3
652337|NCT02498678|2081122|P2|Overall Study|interference from the surgical team|2
652338|NCT02498678|2081123|P1|Overall Study|interference from the surgical team|0
652339|NCT02496533|2081187|P2|Overall Study|Late for radiologic testing|2
652340|NCT02496533|2081188|P1|Overall Study|Late for radiologic testing|0
652341|NCT02496533|2081187|P2|Overall Study|Patient did not complete all measures|4
652342|NCT02496533|2081188|P1|Overall Study|Patient did not complete all measures|0
652343|NCT02496533|2081187|P2|Overall Study|Lack of data on outcome|0
652344|NCT02496533|2081188|P1|Overall Study|Lack of data on outcome|3
652345|NCT02496221|2081200|P2|Treatment Period 2 - 4 Days|Physician Decision|0
652346|NCT02496221|2081201|P1|Treatment Period 2 - 4 Days|Physician Decision|1
652347|NCT02496221|2081200|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
652348|NCT02496221|2081201|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
652349|NCT02496221|2081200|P2|Treatment Period 2 - 4 Days|Adverse Event|1
652350|NCT02496221|2081201|P1|Treatment Period 2 - 4 Days|Adverse Event|0
652351|NCT02496039|2081235|P1|Overall Study|Protocol Violation|1
652352|NCT02496039|2081235|P1|Overall Study|Adverse Event|3
652353|NCT02496000|2081250|P3|Overall Study|undetermined|0
652354|NCT02496000|2081251|P2|Overall Study|undetermined|1
652355|NCT02496000|2081252|P1|Overall Study|undetermined|0
652356|NCT02496000|2081250|P3|Overall Study|Non-compliance or lack of cooperation|0
652357|NCT02496000|2081251|P2|Overall Study|Non-compliance or lack of cooperation|2
652358|NCT02496000|2081252|P1|Overall Study|Non-compliance or lack of cooperation|0
652359|NCT02496000|2081250|P3|Overall Study|Protocol Violation|1
652360|NCT02496000|2081251|P2|Overall Study|Protocol Violation|0
652361|NCT02496000|2081252|P1|Overall Study|Protocol Violation|0
652362|NCT02496000|2081250|P3|Overall Study|Lost to Follow-up|1
652363|NCT02496000|2081251|P2|Overall Study|Lost to Follow-up|0
652364|NCT02496000|2081252|P1|Overall Study|Lost to Follow-up|1
652365|NCT02496000|2081250|P3|Overall Study|Withdrawal by Subject|0
652366|NCT02496000|2081251|P2|Overall Study|Withdrawal by Subject|2
652367|NCT02496000|2081252|P1|Overall Study|Withdrawal by Subject|1
652368|NCT02495948|2081261|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
652369|NCT02495948|2081262|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
652370|NCT02495948|2081261|P2|Period 1, First 30 Days of Wear|Adverse Event|1
652371|NCT02495948|2081262|P1|Period 1, First 30 Days of Wear|Adverse Event|0
652372|NCT02494596|2081297|P3|Overall Study|Refused Treatment|0
652373|NCT02494596|2081298|P2|Overall Study|Refused Treatment|1
652374|NCT02494596|2081299|P1|Overall Study|Refused Treatment|0
652375|NCT02494596|2081297|P3|Overall Study|Adverse Event|0
652376|NCT02494596|2081298|P2|Overall Study|Adverse Event|1
652377|NCT02494596|2081299|P1|Overall Study|Adverse Event|0
652378|NCT02494596|2081297|P3|Overall Study|Insufficient Therapeutic Response|1
652379|NCT02494596|2081298|P2|Overall Study|Insufficient Therapeutic Response|3
652380|NCT02494596|2081299|P1|Overall Study|Insufficient Therapeutic Response|3
887956|NCT02544074|2821156|P20|Overall Study|Tablet error|0
887957|NCT02544074|2821157|P19|Overall Study|Tablet error|0
887958|NCT02544074|2821158|P18|Overall Study|Tablet error|0
887959|NCT02544074|2821159|P17|Overall Study|Tablet error|0
887960|NCT02544074|2821160|P16|Overall Study|Tablet error|0
887961|NCT02544074|2821161|P15|Overall Study|Tablet error|0
887962|NCT02544074|2821162|P14|Overall Study|Tablet error|0
887963|NCT02544074|2821163|P13|Overall Study|Tablet error|0
887964|NCT02544074|2821164|P12|Overall Study|Tablet error|0
652390|NCT02493127|2081350|P2|Overall Study|Lost to Follow-up|1
652391|NCT02493127|2081351|P1|Overall Study|Lost to Follow-up|1
652392|NCT02492984|2081384|P2|Overall Study|Withdrawal by Subject|0
652393|NCT02492984|2081385|P1|Overall Study|Withdrawal by Subject|1
652394|NCT02492984|2081384|P2|Overall Study|Protocol Violation|0
652395|NCT02492984|2081385|P1|Overall Study|Protocol Violation|1
652396|NCT02492984|2081384|P2|Overall Study|Adverse Event|0
652397|NCT02492984|2081385|P1|Overall Study|Adverse Event|1
652398|NCT02492841|2081408|P3|Overall Study|Lost to Follow-up|35
652399|NCT02492841|2081409|P2|Overall Study|Lost to Follow-up|31
652400|NCT02492841|2081410|P1|Overall Study|Lost to Follow-up|34
652401|NCT02492165|2081438|P4|Overall Study|Withdrawal by Subject|0
652402|NCT02492165|2081439|P3|Overall Study|Withdrawal by Subject|0
652403|NCT02492165|2081440|P2|Overall Study|Withdrawal by Subject|1
652404|NCT02492165|2081441|P1|Overall Study|Withdrawal by Subject|0
652405|NCT02491892|2081485|P2|Overall Study|Lost to Follow-up|0
652406|NCT02491892|2081486|P1|Overall Study|Lost to Follow-up|1
652407|NCT02491892|2081485|P2|Overall Study|Refused Treatment|0
652408|NCT02491892|2081486|P1|Overall Study|Refused Treatment|1
652409|NCT02491892|2081485|P2|Overall Study|Lack of Efficacy|36
652410|NCT02491892|2081486|P1|Overall Study|Lack of Efficacy|37
652411|NCT02491892|2081485|P2|Overall Study|Death|1
652412|NCT02491892|2081486|P1|Overall Study|Death|1
652413|NCT02491892|2081485|P2|Overall Study|Adverse Event|1
652414|NCT02491892|2081486|P1|Overall Study|Adverse Event|1
652415|NCT02490475|2081545|P4|Period 2: Extension Phase|Adverse Event|0
652416|NCT02490475|2081546|P3|Period 2: Extension Phase|Adverse Event|1
652417|NCT02490475|2081547|P2|Period 2: Extension Phase|Adverse Event|0
652418|NCT02490475|2081548|P1|Period 2: Extension Phase|Adverse Event|0
652419|NCT02490475|2081545|P4|Period 2: Extension Phase|Refused Treatment|1
652420|NCT02490475|2081546|P3|Period 2: Extension Phase|Refused Treatment|0
652421|NCT02490475|2081547|P2|Period 2: Extension Phase|Refused Treatment|0
652422|NCT02490475|2081548|P1|Period 2: Extension Phase|Refused Treatment|0
652423|NCT02490475|2081545|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
652424|NCT02490475|2081546|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
652425|NCT02490475|2081547|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
652426|NCT02490475|2081548|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
652427|NCT02490475|2081545|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
652428|NCT02490475|2081546|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
652429|NCT02490475|2081547|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
652430|NCT02490475|2081548|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
652431|NCT02490475|2081545|P4|Period 1: First 6 Cycles|Refused Treatment|0
652432|NCT02490475|2081546|P3|Period 1: First 6 Cycles|Refused Treatment|0
652433|NCT02490475|2081547|P2|Period 1: First 6 Cycles|Refused Treatment|0
652434|NCT02490475|2081548|P1|Period 1: First 6 Cycles|Refused Treatment|1
652435|NCT02490475|2081545|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
652436|NCT02490475|2081546|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
652437|NCT02490475|2081547|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
652438|NCT02490475|2081548|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
652439|NCT02490475|2081545|P4|Period 1: First 6 Cycles|Adverse Event|1
652440|NCT02490475|2081546|P3|Period 1: First 6 Cycles|Adverse Event|0
652441|NCT02490475|2081547|P2|Period 1: First 6 Cycles|Adverse Event|1
652442|NCT02490475|2081548|P1|Period 1: First 6 Cycles|Adverse Event|2
652443|NCT02489799|2081637|P2|Overall Study|Death|1
652444|NCT02489799|2081638|P1|Overall Study|Death|0
652445|NCT02489799|2081637|P2|Overall Study|Withdrawal by Subject|1
652446|NCT02489799|2081638|P1|Overall Study|Withdrawal by Subject|1
652447|NCT02489799|2081637|P2|Overall Study|Failure to Maintain Eligibility|6
652448|NCT02489799|2081638|P1|Overall Study|Failure to Maintain Eligibility|4
652449|NCT02489799|2081637|P2|Overall Study|Lost to Follow-up|1
652450|NCT02489799|2081638|P1|Overall Study|Lost to Follow-up|4
652451|NCT02488980|2081665|P3|Overall Study|Protocol Violation|2
652452|NCT02488980|2081666|P2|Overall Study|Protocol Violation|2
652453|NCT02488980|2081667|P1|Overall Study|Protocol Violation|2
887965|NCT02544074|2821165|P11|Overall Study|Tablet error|0
887966|NCT02544074|2821166|P10|Overall Study|Tablet error|1
887967|NCT02544074|2821167|P9|Overall Study|Tablet error|0
887968|NCT02544074|2821168|P8|Overall Study|Tablet error|0
887969|NCT02544074|2821169|P7|Overall Study|Tablet error|0
887970|NCT02544074|2821170|P6|Overall Study|Tablet error|1
652460|NCT02486952|2081744|P1|Overall Study|Unspecified|2
652461|NCT02486952|2081744|P1|Overall Study|Lost to Follow-up|26
652462|NCT02486952|2081744|P1|Overall Study|Lack of Efficacy|3
652463|NCT02486952|2081744|P1|Overall Study|Death|15
652464|NCT02486952|2081744|P1|Overall Study|Adverse Event|1
652465|NCT02486952|2081744|P1|Overall Study|Not Started Induction Therapy|3
652466|NCT02485483|2081751|P2|Overall Study|Discontinued after baseline|0
652467|NCT02485483|2081752|P1|Overall Study|Discontinued after baseline|39
652468|NCT02485483|2081751|P2|Overall Study|Depression at baseline|0
652469|NCT02485483|2081752|P1|Overall Study|Depression at baseline|15
652470|NCT02485353|2081767|P1|Overall Study|Disease Progression|1
652471|NCT02485353|2081767|P1|Overall Study|Death|1
652472|NCT02485158|2081772|P1|Overall Study|expected drug side effect|1
652473|NCT02485158|2081772|P1|Overall Study|Withdrawal by Subject|3
652474|NCT02484911|2081861|P2|Overall Study|Protocol Violation|1
652475|NCT02484911|2081862|P1|Overall Study|Protocol Violation|2
652476|NCT02484911|2081861|P2|Overall Study|Withdrawal by Subject|1
652477|NCT02484911|2081862|P1|Overall Study|Withdrawal by Subject|2
652478|NCT02484729|2081904|P10|Overall Study|Failure of IntelliCap Error|1
652479|NCT02484729|2081905|P9|Overall Study|Failure of IntelliCap Error|0
652480|NCT02484729|2081906|P8|Overall Study|Failure of IntelliCap Error|0
652481|NCT02484729|2081907|P7|Overall Study|Failure of IntelliCap Error|0
652482|NCT02484729|2081908|P6|Overall Study|Failure of IntelliCap Error|0
652483|NCT02484729|2081909|P5|Overall Study|Failure of IntelliCap Error|0
652484|NCT02484729|2081910|P4|Overall Study|Failure of IntelliCap Error|0
652485|NCT02484729|2081911|P3|Overall Study|Failure of IntelliCap Error|0
652486|NCT02484729|2081912|P2|Overall Study|Failure of IntelliCap Error|0
652487|NCT02484729|2081913|P1|Overall Study|Failure of IntelliCap Error|0
652488|NCT02483975|2082111|P2|Overall Study|Physician Decision|0
652489|NCT02483975|2082112|P1|Overall Study|Physician Decision|2
652490|NCT02483975|2082111|P2|Overall Study|Lost to Follow-up|1
652491|NCT02483975|2082112|P1|Overall Study|Lost to Follow-up|0
652492|NCT02483975|2082111|P2|Overall Study|Adverse Event|1
652493|NCT02483975|2082112|P1|Overall Study|Adverse Event|0
652494|NCT02483611|2082129|P3|Overall Study|Protocol Violation|1
652495|NCT02483611|2082130|P2|Overall Study|Protocol Violation|0
652496|NCT02483611|2082131|P1|Overall Study|Protocol Violation|0
652497|NCT02482428|2082231|P5|Overall Study|subject/guardian decision|2
652498|NCT02482428|2082232|P4|Overall Study|subject/guardian decision|0
652499|NCT02482428|2082233|P3|Overall Study|subject/guardian decision|0
652500|NCT02482428|2082234|P2|Overall Study|subject/guardian decision|2
652501|NCT02482428|2082235|P1|Overall Study|subject/guardian decision|4
652502|NCT02482428|2082231|P5|Overall Study|protocol deviation|0
652503|NCT02482428|2082232|P4|Overall Study|protocol deviation|0
652504|NCT02482428|2082233|P3|Overall Study|protocol deviation|0
652505|NCT02482428|2082234|P2|Overall Study|protocol deviation|1
652506|NCT02482428|2082235|P1|Overall Study|protocol deviation|1
652507|NCT02482428|2082231|P5|Overall Study|Physician Decision|1
652508|NCT02482428|2082232|P4|Overall Study|Physician Decision|0
652509|NCT02482428|2082233|P3|Overall Study|Physician Decision|0
652510|NCT02482428|2082234|P2|Overall Study|Physician Decision|0
652511|NCT02482428|2082235|P1|Overall Study|Physician Decision|0
652512|NCT02482428|2082231|P5|Overall Study|Lost to Follow-up|4
652513|NCT02482428|2082232|P4|Overall Study|Lost to Follow-up|2
652514|NCT02482428|2082233|P3|Overall Study|Lost to Follow-up|1
652515|NCT02482428|2082234|P2|Overall Study|Lost to Follow-up|9
652516|NCT02482428|2082235|P1|Overall Study|Lost to Follow-up|4
652517|NCT02482129|2082257|P2|Overall Study|Criteria not met|0
652518|NCT02482129|2082258|P1|Overall Study|Criteria not met|1
652519|NCT02482129|2082257|P2|Overall Study|Withdrawal by Subject|0
652520|NCT02482129|2082258|P1|Overall Study|Withdrawal by Subject|2
652521|NCT02482129|2082257|P2|Overall Study|Adverse Event|0
652522|NCT02482129|2082258|P1|Overall Study|Adverse Event|1
652523|NCT02482129|2082257|P2|Overall Study|Criteria not met-prior to treatment|0
652524|NCT02482129|2082258|P1|Overall Study|Criteria not met-prior to treatment|1
652525|NCT02482129|2082257|P2|Overall Study|Unable to draw blood-prior to treatment|0
652526|NCT02482129|2082258|P1|Overall Study|Unable to draw blood-prior to treatment|1
652527|NCT02482129|2082257|P2|Overall Study|Withdrawal by subject-prior to treatment|1
652528|NCT02482129|2082258|P1|Overall Study|Withdrawal by subject-prior to treatment|0
652529|NCT02482129|2082257|P2|Overall Study|Adverse Event-prior to treatment|1
652530|NCT02482129|2082258|P1|Overall Study|Adverse Event-prior to treatment|0
652531|NCT02481934|2082285|P1|Overall Study|Death|2
652532|NCT02480712|2082309|P1|Overall Study|Lack of Efficacy|1
652533|NCT02480712|2082309|P1|Overall Study|Death|1
652534|NCT02480712|2082309|P1|Overall Study|Withdrew Consent|3
652535|NCT02480712|2082309|P1|Overall Study|Lost to Follow-up|5
652536|NCT02480712|2082309|P1|Overall Study|Enrolled but Never Treated|1
887971|NCT02544074|2821171|P5|Overall Study|Tablet error|0
887972|NCT02544074|2821172|P4|Overall Study|Tablet error|0
887973|NCT02544074|2821173|P3|Overall Study|Tablet error|0
887974|NCT02544074|2821174|P2|Overall Study|Tablet error|0
887975|NCT02544074|2821175|P1|Overall Study|Tablet error|0
887976|NCT02544074|2821155|P21|Overall Study|Withdrawal by Subject|0
652543|NCT02480010|2082406|P2|Overall Study|Refused Treatment|3
652544|NCT02480010|2082407|P1|Overall Study|Refused Treatment|0
652545|NCT02480010|2082406|P2|Overall Study|Insufficient therapeutic response|29
652546|NCT02480010|2082407|P1|Overall Study|Insufficient therapeutic response|31
652547|NCT02480010|2082406|P2|Overall Study|Death|0
652548|NCT02480010|2082407|P1|Overall Study|Death|1
652549|NCT02480010|2082406|P2|Overall Study|Adverse Event|1
652550|NCT02480010|2082407|P1|Overall Study|Adverse Event|3
652551|NCT02479412|2082469|P9|Overall Study|Randomization to wrong PK sampling group|0
652552|NCT02479412|2082470|P8|Overall Study|Randomization to wrong PK sampling group|0
652553|NCT02479412|2082471|P7|Overall Study|Randomization to wrong PK sampling group|0
652554|NCT02479412|2082472|P6|Overall Study|Randomization to wrong PK sampling group|0
652555|NCT02479412|2082473|P5|Overall Study|Randomization to wrong PK sampling group|1
652556|NCT02479412|2082474|P4|Overall Study|Randomization to wrong PK sampling group|0
652557|NCT02479412|2082475|P3|Overall Study|Randomization to wrong PK sampling group|0
652558|NCT02479412|2082476|P2|Overall Study|Randomization to wrong PK sampling group|0
652559|NCT02479412|2082477|P1|Overall Study|Randomization to wrong PK sampling group|0
652560|NCT02479412|2082469|P9|Overall Study|Study-specific withdrawal criteria|1
652561|NCT02479412|2082470|P8|Overall Study|Study-specific withdrawal criteria|1
887977|NCT02544074|2821156|P20|Overall Study|Withdrawal by Subject|0
652562|NCT02479412|2082471|P7|Overall Study|Study-specific withdrawal criteria|0
652563|NCT02479412|2082472|P6|Overall Study|Study-specific withdrawal criteria|0
652564|NCT02479412|2082473|P5|Overall Study|Study-specific withdrawal criteria|0
652565|NCT02479412|2082474|P4|Overall Study|Study-specific withdrawal criteria|1
652566|NCT02479412|2082475|P3|Overall Study|Study-specific withdrawal criteria|1
652567|NCT02479412|2082476|P2|Overall Study|Study-specific withdrawal criteria|0
652568|NCT02479412|2082477|P1|Overall Study|Study-specific withdrawal criteria|0
652569|NCT02479412|2082469|P9|Overall Study|Adverse Event|0
652570|NCT02479412|2082470|P8|Overall Study|Adverse Event|0
652571|NCT02479412|2082471|P7|Overall Study|Adverse Event|0
652572|NCT02479412|2082472|P6|Overall Study|Adverse Event|0
652573|NCT02479412|2082473|P5|Overall Study|Adverse Event|0
652574|NCT02479412|2082474|P4|Overall Study|Adverse Event|0
652575|NCT02479412|2082475|P3|Overall Study|Adverse Event|1
652576|NCT02479412|2082476|P2|Overall Study|Adverse Event|0
652577|NCT02479412|2082477|P1|Overall Study|Adverse Event|0
652578|NCT02479139|2082554|P6|Overall Study|Other Miscellaneous Reasons|0
652579|NCT02479139|2082555|P5|Overall Study|Other Miscellaneous Reasons|1
652580|NCT02479139|2082556|P4|Overall Study|Other Miscellaneous Reasons|1
652581|NCT02479139|2082557|P3|Overall Study|Other Miscellaneous Reasons|1
652582|NCT02479139|2082558|P2|Overall Study|Other Miscellaneous Reasons|0
652583|NCT02479139|2082559|P1|Overall Study|Other Miscellaneous Reasons|1
652584|NCT02479139|2082554|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
652585|NCT02479139|2082555|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
652586|NCT02479139|2082556|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
652587|NCT02479139|2082557|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
652588|NCT02479139|2082558|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
652589|NCT02479139|2082559|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
652590|NCT02479139|2082554|P6|Overall Study|Withdrew Consent|1
652591|NCT02479139|2082555|P5|Overall Study|Withdrew Consent|1
652592|NCT02479139|2082556|P4|Overall Study|Withdrew Consent|4
652593|NCT02479139|2082557|P3|Overall Study|Withdrew Consent|1
652594|NCT02479139|2082558|P2|Overall Study|Withdrew Consent|6
652595|NCT02479139|2082559|P1|Overall Study|Withdrew Consent|5
652596|NCT02479139|2082554|P6|Overall Study|Lost to Follow-up|5
652597|NCT02479139|2082555|P5|Overall Study|Lost to Follow-up|3
652598|NCT02479139|2082556|P4|Overall Study|Lost to Follow-up|2
652599|NCT02479139|2082557|P3|Overall Study|Lost to Follow-up|4
652600|NCT02479139|2082558|P2|Overall Study|Lost to Follow-up|4
652601|NCT02479139|2082559|P1|Overall Study|Lost to Follow-up|2
652602|NCT02478372|2082601|P2|Overall Study|Death|2
652603|NCT02478372|2082602|P1|Overall Study|Death|0
652604|NCT02478372|2082601|P2|Overall Study|Lost to Follow-up|4
652605|NCT02478372|2082602|P1|Overall Study|Lost to Follow-up|1
652606|NCT02478372|2082601|P2|Overall Study|Protocol Violation|8
652607|NCT02478372|2082602|P1|Overall Study|Protocol Violation|12
652608|NCT02477605|2082630|P2|Overall Study|Administered gas during surgery|1
652609|NCT02477605|2082631|P1|Overall Study|Administered gas during surgery|0
652610|NCT02477605|2082630|P2|Overall Study|Withdrawal by Subject|1
652611|NCT02477605|2082631|P1|Overall Study|Withdrawal by Subject|0
652612|NCT02477605|2082630|P2|Overall Study|Lost to Follow-up|2
652613|NCT02477605|2082631|P1|Overall Study|Lost to Follow-up|0
652614|NCT02477605|2082630|P2|Overall Study|Discontinued prior to treatment|0
652615|NCT02477605|2082631|P1|Overall Study|Discontinued prior to treatment|1
652616|NCT02477527|2082645|P1|Overall Study|Screen Failure|3
652617|NCT02477527|2082645|P1|Overall Study|Withdrawal by Subject|1
652618|NCT02477527|2082645|P1|Overall Study|Lost to Follow-up|2
652619|NCT02477020|2082655|P2|Overall Study|Lack of Efficacy|5
652620|NCT02477020|2082656|P1|Overall Study|Lack of Efficacy|14
652621|NCT02477020|2082655|P2|Overall Study|Reason not Specified|1
652622|NCT02477020|2082656|P1|Overall Study|Reason not Specified|3
652623|NCT02477020|2082655|P2|Overall Study|Voluntary Withdrawal|16
652624|NCT02477020|2082656|P1|Overall Study|Voluntary Withdrawal|7
652625|NCT02477020|2082655|P2|Overall Study|Pretreatment Event/Adverse Event|6
652626|NCT02477020|2082656|P1|Overall Study|Pretreatment Event/Adverse Event|6
652627|NCT02476617|2082684|P1|Overall Study|Lost to Follow-up|1
652628|NCT02476617|2082684|P1|Overall Study|Adverse Event|1
652629|NCT02476422|2082690|P2|Overall Study|Subject/guardian decision|1
652630|NCT02476422|2082691|P1|Overall Study|Subject/guardian decision|0
652631|NCT02475980|2082721|P1|Overall Study|Withdrawal by Subject|1
652632|NCT02475980|2082721|P1|Overall Study|Lost to Follow-up|4
652633|NCT02475564|2082732|P2|Overall Study|Intense Menstrual bleeding|0
652634|NCT02475564|2082733|P1|Overall Study|Intense Menstrual bleeding|1
652635|NCT02475564|2082732|P2|Overall Study|Lost to Follow-up|1
652636|NCT02475564|2082733|P1|Overall Study|Lost to Follow-up|2
652637|NCT02475564|2082732|P2|Overall Study|Withdrawal by Subject|0
652638|NCT02475564|2082733|P1|Overall Study|Withdrawal by Subject|1
887978|NCT02544074|2821157|P19|Overall Study|Withdrawal by Subject|0
887979|NCT02544074|2821158|P18|Overall Study|Withdrawal by Subject|0
652641|NCT02475278|2082756|P1|Overall Study|Reason Not Specified|1
652642|NCT02475278|2082756|P1|Overall Study|Lost to Follow-up|1
652643|NCT02473523|2082812|P1|Overall Study|Lost to Follow-up|1
652644|NCT02473523|2082812|P1|Overall Study|Death|1
652645|NCT02473510|2082833|P2|Overall Study|Lost to Follow-up|2
652646|NCT02473510|2082834|P1|Overall Study|Lost to Follow-up|1
652647|NCT02473367|2082848|P1|Period 4|Lost to Follow-up|1
652648|NCT02473367|2082848|P1|Wait 1|Withdrawal by Subject|1
652649|NCT02472886|2082869|P3|Overall Study|Lack of Efficacy|1
652650|NCT02472886|2082870|P2|Overall Study|Lack of Efficacy|2
652651|NCT02472886|2082871|P1|Overall Study|Lack of Efficacy|0
652652|NCT02472847|2082899|P2|Overall Study|Withdrawal by Subject|5
652653|NCT02472847|2082900|P1|Overall Study|Withdrawal by Subject|1
652654|NCT02472756|2082906|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
652655|NCT02472756|2082906|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
652656|NCT02472756|2082906|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
652657|NCT02472756|2082906|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
652658|NCT02472756|2082906|P1|Induction (Approximately 6 Months)|Adverse Event|1
652661|NCT02472366|2082964|P2|Overall Study|Lost to Follow-up|0
652662|NCT02472366|2082965|P1|Overall Study|Lost to Follow-up|1
652663|NCT02471755|2082981|P2|Overall Study|Lost to Follow-up|1
652664|NCT02471755|2082982|P1|Overall Study|Lost to Follow-up|0
652665|NCT02471755|2082981|P2|Overall Study|Withdrawal by Subject|0
652666|NCT02471755|2082982|P1|Overall Study|Withdrawal by Subject|1
652667|NCT02471612|2082998|P1|Overall Study|Lost to Follow-up|2
652668|NCT02470429|2083036|P2|Overall Study|Withdrawal by Subject|0
652669|NCT02470429|2083037|P1|Overall Study|Withdrawal by Subject|1
652670|NCT02470429|2083036|P2|Overall Study|Adverse Event|0
652671|NCT02470429|2083037|P1|Overall Study|Adverse Event|1
652672|NCT02470403|2083055|P5|Overall Study|Subject/guardian decision|0
652673|NCT02470403|2083056|P4|Overall Study|Subject/guardian decision|4
652674|NCT02470403|2083057|P3|Overall Study|Subject/guardian decision|0
652675|NCT02470403|2083058|P2|Overall Study|Subject/guardian decision|0
652676|NCT02470403|2083059|P1|Overall Study|Subject/guardian decision|1
652677|NCT02470403|2083055|P5|Overall Study|Lost to Follow-up|0
652678|NCT02470403|2083056|P4|Overall Study|Lost to Follow-up|0
652679|NCT02470403|2083057|P3|Overall Study|Lost to Follow-up|0
652680|NCT02470403|2083058|P2|Overall Study|Lost to Follow-up|1
652681|NCT02470403|2083059|P1|Overall Study|Lost to Follow-up|0
652682|NCT02470403|2083055|P5|Overall Study|Adverse Event|0
652683|NCT02470403|2083056|P4|Overall Study|Adverse Event|0
652684|NCT02470403|2083057|P3|Overall Study|Adverse Event|0
652685|NCT02470403|2083058|P2|Overall Study|Adverse Event|0
652686|NCT02470403|2083059|P1|Overall Study|Adverse Event|1
652687|NCT02469961|2083099|P2|Overall Study|Physician Decision|1
652688|NCT02469961|2083100|P1|Overall Study|Physician Decision|4
652689|NCT02469298|2083135|P4|Overall Study|Withdrawal by Subject|1
652690|NCT02469298|2083136|P3|Overall Study|Withdrawal by Subject|0
652691|NCT02469298|2083137|P2|Overall Study|Withdrawal by Subject|0
652692|NCT02469298|2083138|P1|Overall Study|Withdrawal by Subject|0
652693|NCT02469298|2083135|P4|Overall Study|Physician Decision|1
652694|NCT02469298|2083136|P3|Overall Study|Physician Decision|0
652695|NCT02469298|2083137|P2|Overall Study|Physician Decision|0
652696|NCT02469298|2083138|P1|Overall Study|Physician Decision|0
652697|NCT02469298|2083135|P4|Overall Study|Lost to Follow-up|0
652698|NCT02469298|2083136|P3|Overall Study|Lost to Follow-up|1
652699|NCT02469298|2083137|P2|Overall Study|Lost to Follow-up|0
652700|NCT02469298|2083138|P1|Overall Study|Lost to Follow-up|1
652701|NCT02469298|2083135|P4|Overall Study|Protocol Violation|0
652702|NCT02469298|2083136|P3|Overall Study|Protocol Violation|1
652703|NCT02469298|2083137|P2|Overall Study|Protocol Violation|1
652704|NCT02469298|2083138|P1|Overall Study|Protocol Violation|0
652705|NCT02468414|2083288|P2|Overall Study|Screen Failure|0
652706|NCT02468414|2083289|P1|Overall Study|Screen Failure|1
652707|NCT02468414|2083288|P2|Overall Study|Poor in-vitro secreting TARGTs|0
652708|NCT02468414|2083289|P1|Overall Study|Poor in-vitro secreting TARGTs|1
652709|NCT02468414|2083288|P2|Overall Study|Early Study Termination by Sponsor|0
652710|NCT02468414|2083289|P1|Overall Study|Early Study Termination by Sponsor|1
652711|NCT02466425|2083349|P2|Overall Study|Withdrawal by Parent/Guardian|0
652712|NCT02466425|2083350|P1|Overall Study|Withdrawal by Parent/Guardian|2
652713|NCT02466425|2083349|P2|Overall Study|Unspecified|3
652714|NCT02466425|2083350|P1|Overall Study|Unspecified|1
652715|NCT02466425|2083349|P2|Overall Study|Withdrawal by Subject|1
652716|NCT02466425|2083350|P1|Overall Study|Withdrawal by Subject|0
652717|NCT02466425|2083349|P2|Overall Study|Protocol Violation|0
652718|NCT02466425|2083350|P1|Overall Study|Protocol Violation|1
652719|NCT02466425|2083349|P2|Overall Study|Lost to Follow-up|0
652720|NCT02466425|2083350|P1|Overall Study|Lost to Follow-up|3
652721|NCT02466425|2083349|P2|Overall Study|Lack of Efficacy|1
652722|NCT02466425|2083350|P1|Overall Study|Lack of Efficacy|4
652723|NCT02466425|2083349|P2|Overall Study|Adverse Event|11
652724|NCT02466425|2083350|P1|Overall Study|Adverse Event|3
652725|NCT02465866|2083370|P4|Period 3|Withdrawal by Subject|0
652726|NCT02465866|2083371|P3|Period 3|Withdrawal by Subject|0
652727|NCT02465866|2083372|P2|Period 3|Withdrawal by Subject|1
652728|NCT02465866|2083373|P1|Period 3|Withdrawal by Subject|0
652729|NCT02465489|2083459|P1|Overall Study|Adverse Event|5
652730|NCT02463409|2083499|P1|Overall Study|Screen failure|1
652731|NCT02463409|2083499|P1|Overall Study|Withdrawal by Subject|1
652732|NCT02463331|2083507|P2|Overall Study|Physician Decision|0
652733|NCT02463331|2083508|P1|Overall Study|Physician Decision|3
652734|NCT02463331|2083507|P2|Overall Study|Lack of Efficacy|0
652735|NCT02463331|2083508|P1|Overall Study|Lack of Efficacy|6
652736|NCT02463331|2083507|P2|Overall Study|Pregnancy|3
652737|NCT02463331|2083508|P1|Overall Study|Pregnancy|2
652738|NCT02463331|2083507|P2|Overall Study|Lost to Follow-up|1
652739|NCT02463331|2083508|P1|Overall Study|Lost to Follow-up|1
652740|NCT02463331|2083507|P2|Overall Study|Adverse Event|2
652741|NCT02463331|2083508|P1|Overall Study|Adverse Event|4
652742|NCT02463097|2083524|P1|Overall Study|Withdrawal by Subject|1
652743|NCT02462473|2083530|P1|Overall Study|Unspecified|3
652744|NCT02462473|2083530|P1|Overall Study|Death|1
652745|NCT02461290|2083614|P1|Overall Study|Lost to Follow-up|3
652746|NCT02461290|2083614|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
652747|NCT02460822|2083621|P1|Overall Study|Withdrawal by Subject|1
652748|NCT02457611|2083672|P1|Overall Study|Lost to Follow-up|3
652749|NCT02457247|2083688|P4|Period 2|Voluntary Withdrawal|0
652750|NCT02457247|2083689|P3|Period 2|Voluntary Withdrawal|0
652751|NCT02457247|2083690|P2|Period 2|Voluntary Withdrawal|1
652752|NCT02457247|2083691|P1|Period 2|Voluntary Withdrawal|1
652753|NCT02457247|2083688|P4|Period 2|Lost to Follow-up|0
652754|NCT02457247|2083689|P3|Period 2|Lost to Follow-up|0
652755|NCT02457247|2083690|P2|Period 2|Lost to Follow-up|1
652756|NCT02457247|2083691|P1|Period 2|Lost to Follow-up|0
652757|NCT02457247|2083688|P4|Period 2|Significant Protocol Deviation|0
652758|NCT02457247|2083689|P3|Period 2|Significant Protocol Deviation|0
652759|NCT02457247|2083690|P2|Period 2|Significant Protocol Deviation|0
652760|NCT02457247|2083691|P1|Period 2|Significant Protocol Deviation|1
652761|NCT02457247|2083688|P4|Period 2|Pretreatment Event/Adverse Event|0
652762|NCT02457247|2083689|P3|Period 2|Pretreatment Event/Adverse Event|0
652763|NCT02457247|2083690|P2|Period 2|Pretreatment Event/Adverse Event|1
652764|NCT02457247|2083691|P1|Period 2|Pretreatment Event/Adverse Event|0
652765|NCT02457247|2083688|P4|Period 1|Voluntary Withdrawal|0
652766|NCT02457247|2083689|P3|Period 1|Voluntary Withdrawal|0
652767|NCT02457247|2083690|P2|Period 1|Voluntary Withdrawal|0
652768|NCT02457247|2083691|P1|Period 1|Voluntary Withdrawal|1
652769|NCT02457247|2083688|P4|Period 1|Significant Protocol Deviation|0
652770|NCT02457247|2083689|P3|Period 1|Significant Protocol Deviation|0
652771|NCT02457247|2083690|P2|Period 1|Significant Protocol Deviation|1
652772|NCT02457247|2083691|P1|Period 1|Significant Protocol Deviation|1
652773|NCT02457247|2083688|P4|Period 1|Pretreatment Event/Adverse Event|0
652774|NCT02457247|2083689|P3|Period 1|Pretreatment Event/Adverse Event|0
652775|NCT02457247|2083690|P2|Period 1|Pretreatment Event/Adverse Event|1
652776|NCT02457247|2083691|P1|Period 1|Pretreatment Event/Adverse Event|0
652777|NCT02455050|2083715|P4|Treatment Period 2|Lost to Follow-up|1
652778|NCT02455050|2083716|P3|Treatment Period 2|Lost to Follow-up|2
652779|NCT02455050|2083717|P2|Treatment Period 2|Lost to Follow-up|0
652780|NCT02455050|2083718|P1|Treatment Period 2|Lost to Follow-up|1
652781|NCT02455050|2083715|P4|Treatment Period 1|Lost to Follow-up|2
652782|NCT02455050|2083716|P3|Treatment Period 1|Lost to Follow-up|1
652783|NCT02455050|2083717|P2|Treatment Period 1|Lost to Follow-up|1
652784|NCT02455050|2083718|P1|Treatment Period 1|Lost to Follow-up|1
652785|NCT02454959|2083782|P1|Overall Study|Adverse Event|2
652786|NCT02454959|2083782|P1|Overall Study|Withdrawal by Subject|3
652787|NCT02454959|2083782|P1|Overall Study|Physician Decision|1
652788|NCT02454959|2083782|P1|Overall Study|Protocol-Specified Criteria|3
887980|NCT02544074|2821159|P17|Overall Study|Withdrawal by Subject|0
887981|NCT02544074|2821160|P16|Overall Study|Withdrawal by Subject|0
652791|NCT02454101|2083892|P2|Overall Study|Lost to Follow-up|4
652792|NCT02454101|2083893|P1|Overall Study|Lost to Follow-up|3
652793|NCT02454101|2083892|P2|Overall Study|Adverse Event|3
652794|NCT02454101|2083893|P1|Overall Study|Adverse Event|2
652795|NCT02449902|2084043|P2|Overall Study|Withdrawal by Subject|1
652796|NCT02449902|2084044|P1|Overall Study|Withdrawal by Subject|0
652797|NCT02449902|2084043|P2|Overall Study|Adverse Event|1
652798|NCT02449902|2084044|P1|Overall Study|Adverse Event|0
652799|NCT02449044|2084099|P1|Overall Study|Sponsor Discontinued Trial|3
652800|NCT02449044|2084099|P1|Overall Study|Physician Decision|9
652801|NCT02449044|2084099|P1|Overall Study|Met Withdrawal Criteria|7
652802|NCT02449044|2084099|P1|Overall Study|Adverse Event|30
652803|NCT02449044|2084099|P1|Overall Study|Withdrawal by Subject|13
652804|NCT02449044|2084099|P1|Overall Study|Lost to Follow-up|2
652805|NCT02448563|2084156|P2|Overall Study|Withdrawal by Subject|1
652806|NCT02448563|2084157|P1|Overall Study|Withdrawal by Subject|0
652807|NCT02448563|2084156|P2|Overall Study|Lost to Follow-up|10
652808|NCT02448563|2084157|P1|Overall Study|Lost to Follow-up|16
652809|NCT02447458|2084182|P6|Overall Study|Other|0
652810|NCT02447458|2084183|P5|Overall Study|Other|0
652811|NCT02447458|2084184|P4|Overall Study|Other|0
652812|NCT02447458|2084185|P3|Overall Study|Other|1
652813|NCT02447458|2084186|P2|Overall Study|Other|0
652814|NCT02447458|2084187|P1|Overall Study|Other|0
652815|NCT02447432|2084285|P2|Epoch 001|Lost to Follow-up|3
652816|NCT02447432|2084286|P1|Epoch 001|Lost to Follow-up|1
652817|NCT02447432|2084285|P2|Epoch 001|Migrated/moved from study area|5
652818|NCT02447432|2084286|P1|Epoch 001|Migrated/moved from study area|3
652819|NCT02447432|2084285|P2|Epoch 001|Withdrawal by Subject|4
652820|NCT02447432|2084286|P1|Epoch 001|Withdrawal by Subject|0
652821|NCT02447432|2084285|P2|Epoch 001|Adverse Event|1
652822|NCT02447432|2084286|P1|Epoch 001|Adverse Event|1
652823|NCT02447029|2084326|P2|Overall Study|Withdrawal by Subject|2
652824|NCT02447029|2084327|P1|Overall Study|Withdrawal by Subject|3
652833|NCT02446717|2084385|P5|Overall Study|Withdrew consent|0
652834|NCT02446717|2084386|P4|Overall Study|Withdrew consent|1
652835|NCT02446717|2084387|P3|Overall Study|Withdrew consent|0
652836|NCT02446717|2084388|P2|Overall Study|Withdrew consent|0
652837|NCT02446717|2084389|P1|Overall Study|Withdrew consent|0
652838|NCT02446717|2084385|P5|Overall Study|Lost to Follow-up|1
652839|NCT02446717|2084386|P4|Overall Study|Lost to Follow-up|0
652840|NCT02446717|2084387|P3|Overall Study|Lost to Follow-up|1
652841|NCT02446717|2084388|P2|Overall Study|Lost to Follow-up|1
652842|NCT02446717|2084389|P1|Overall Study|Lost to Follow-up|0
652843|NCT02446717|2084385|P5|Overall Study|Adverse Event|0
652844|NCT02446717|2084386|P4|Overall Study|Adverse Event|0
652845|NCT02446717|2084387|P3|Overall Study|Adverse Event|1
652846|NCT02446717|2084388|P2|Overall Study|Adverse Event|0
652847|NCT02446717|2084389|P1|Overall Study|Adverse Event|0
652848|NCT02446171|2084470|P4|Overall Study|Withdrawal by Subject|0
652849|NCT02446171|2084471|P3|Overall Study|Withdrawal by Subject|2
652850|NCT02446171|2084472|P2|Overall Study|Withdrawal by Subject|0
652851|NCT02446171|2084473|P1|Overall Study|Withdrawal by Subject|0
652852|NCT02446015|2084544|P2|Overall Study|Withdrawal by Subject|0
652853|NCT02446015|2084545|P1|Overall Study|Withdrawal by Subject|1
652854|NCT02446015|2084544|P2|Overall Study|Adverse Event|1
652855|NCT02446015|2084545|P1|Overall Study|Adverse Event|0
652856|NCT02445755|2084556|P1|Overall Study|Screen Failure|5
652857|NCT02445755|2084556|P1|Overall Study|Protocol Violation|6
652858|NCT02445755|2084556|P1|Overall Study|Withdrawal by Subject|2
652859|NCT02445573|2084565|P2|Overall Study|Lost to Follow-up|1
652860|NCT02445573|2084566|P1|Overall Study|Lost to Follow-up|0
652861|NCT02445573|2084565|P2|Overall Study|Withdrawal by Subject|1
652862|NCT02445573|2084566|P1|Overall Study|Withdrawal by Subject|1
652863|NCT02444533|2084646|P2|Overall Study|Only gave post-procedure complications|2
652864|NCT02444533|2084647|P1|Overall Study|Only gave post-procedure complications|2
652865|NCT02444533|2084646|P2|Overall Study|Not able to complete forms|2
652866|NCT02444533|2084647|P1|Overall Study|Not able to complete forms|0
652867|NCT02444182|2084663|P2|Overall Study|Lost to Follow-up|4
652868|NCT02444182|2084664|P1|Overall Study|Lost to Follow-up|0
652869|NCT02444182|2084663|P2|Overall Study|non-compliance|1
652870|NCT02444182|2084664|P1|Overall Study|non-compliance|2
652871|NCT02442804|2084691|P2|Overall Study|Adverse Event|0
652872|NCT02442804|2084692|P1|Overall Study|Adverse Event|1
652873|NCT02442804|2084691|P2|Overall Study|Withdrawal by Subject|1
652874|NCT02442804|2084692|P1|Overall Study|Withdrawal by Subject|0
652875|NCT02442349|2084731|P1|Overall Study|On-going Study at Data Cut-off|149
652876|NCT02442349|2084731|P1|Overall Study|Withdrawal by Subject|8
652877|NCT02442349|2084731|P1|Overall Study|Death|14
652878|NCT02442310|2084736|P1|Overall Study|Withdrawal by Subject|1
652879|NCT02442310|2084736|P1|Overall Study|Adverse Event|2
887982|NCT02544074|2821161|P15|Overall Study|Withdrawal by Subject|0
887983|NCT02544074|2821162|P14|Overall Study|Withdrawal by Subject|0
887984|NCT02544074|2821163|P13|Overall Study|Withdrawal by Subject|0
887985|NCT02544074|2821164|P12|Overall Study|Withdrawal by Subject|0
652884|NCT02442271|2084765|P1|Overall Study|Not Specified|1
652885|NCT02442271|2084765|P1|Overall Study|Lost to Follow-up|1
652886|NCT02442271|2084765|P1|Overall Study|Withdrew Consent|1
652887|NCT02442271|2084765|P1|Overall Study|Adverse Event|1
652894|NCT02441179|2084818|P2|Overall Study|Withdrawal by Subject|1
652895|NCT02441179|2084819|P1|Overall Study|Withdrawal by Subject|1
652896|NCT02441114|2084837|P1|Washout2|Withdrawal by Subject|4
652897|NCT02439138|2084891|P1|Overall Study|PI decision to terminate the study|2
652898|NCT02439138|2084891|P1|Overall Study|Adverse Event|1
652899|NCT02438137|2084947|P2|Overall Study|Physician Decision|1
652900|NCT02438137|2084948|P1|Overall Study|Physician Decision|0
652901|NCT02438137|2084947|P2|Overall Study|Withdrawal by Subject|3
652902|NCT02438137|2084948|P1|Overall Study|Withdrawal by Subject|4
652903|NCT02438137|2084947|P2|Overall Study|Adverse Event|0
652904|NCT02438137|2084948|P1|Overall Study|Adverse Event|1
652905|NCT02438137|2084947|P2|Overall Study|Lost to Follow-up|2
652906|NCT02438137|2084948|P1|Overall Study|Lost to Follow-up|3
652907|NCT02437903|2084956|P1|Overall Study|Lost to Follow-up|3
652908|NCT02437903|2084956|P1|Overall Study|Withdrawal by Subject|1
652909|NCT02437903|2084956|P1|Overall Study|Adverse Event|1
652910|NCT02437513|2084964|P1|Overall Study|Withdrawal by Subject|2
652911|NCT02437409|2084972|P1|Overall Study|Screening failure|12
652912|NCT02437409|2084972|P1|Overall Study|Withdrawal by Subject|3
652913|NCT02437305|2084987|P2|Overall Study|Lost to Follow-up|12
652914|NCT02437305|2084988|P1|Overall Study|Lost to Follow-up|18
652915|NCT02436811|2085016|P3|Overall Study|Lost to Follow-up|7
652916|NCT02436811|2085017|P2|Overall Study|Lost to Follow-up|9
652917|NCT02436811|2085018|P1|Overall Study|Lost to Follow-up|2
652918|NCT02436577|2085032|P6|Overall Study|Protocol Deviation|0
652919|NCT02436577|2085033|P5|Overall Study|Protocol Deviation|0
652920|NCT02436577|2085034|P4|Overall Study|Protocol Deviation|0
652921|NCT02436577|2085035|P3|Overall Study|Protocol Deviation|0
652922|NCT02436577|2085036|P2|Overall Study|Protocol Deviation|1
652923|NCT02436577|2085037|P1|Overall Study|Protocol Deviation|0
652924|NCT02436330|2085092|P2|Cohort 6|Withdrawal by Subject|1
652925|NCT02436330|2085093|P1|Cohort 6|Withdrawal by Subject|1
652926|NCT02436330|2085092|P2|Cohort 6|Lost to Follow-up|0
652927|NCT02436330|2085093|P1|Cohort 6|Lost to Follow-up|2
652928|NCT02436330|2085092|P2|Cohort 5|Withdrawal by Subject|2
652929|NCT02436330|2085093|P1|Cohort 5|Withdrawal by Subject|3
652930|NCT02436330|2085092|P2|Cohort 5|Lost to Follow-up|2
652931|NCT02436330|2085093|P1|Cohort 5|Lost to Follow-up|3
652932|NCT02436330|2085092|P2|Cohort 4|Withdrawal by Subject|0
652933|NCT02436330|2085093|P1|Cohort 4|Withdrawal by Subject|1
652934|NCT02436330|2085092|P2|Cohort 4|Lost to Follow-up|0
652935|NCT02436330|2085093|P1|Cohort 4|Lost to Follow-up|1
652936|NCT02436330|2085092|P2|Cohort 3|Withdrawal by Subject|0
652937|NCT02436330|2085093|P1|Cohort 3|Withdrawal by Subject|4
652938|NCT02436330|2085092|P2|Cohort 3|Lost to Follow-up|0
652939|NCT02436330|2085093|P1|Cohort 3|Lost to Follow-up|1
652940|NCT02436330|2085092|P2|Cohort 2|Withdrawal by Subject|3
652941|NCT02436330|2085093|P1|Cohort 2|Withdrawal by Subject|2
652942|NCT02436330|2085092|P2|Cohort 2|Lost to Follow-up|0
652943|NCT02436330|2085093|P1|Cohort 2|Lost to Follow-up|2
652944|NCT02436330|2085092|P2|Cohort 1|Withdrawal by Subject|1
652945|NCT02436330|2085093|P1|Cohort 1|Withdrawal by Subject|0
652946|NCT02436330|2085092|P2|Cohort 1|Lost to Follow-up|2
652947|NCT02436330|2085093|P1|Cohort 1|Lost to Follow-up|5
652948|NCT02436304|2085138|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
652949|NCT02436304|2085139|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
652950|NCT02436304|2085140|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
652951|NCT02436304|2085138|P3|Overall Study|Withdrawal by Subject|0
652952|NCT02436304|2085139|P2|Overall Study|Withdrawal by Subject|1
652953|NCT02436304|2085140|P1|Overall Study|Withdrawal by Subject|0
652954|NCT02436304|2085138|P3|Overall Study|Lost to Follow-up|0
652955|NCT02436304|2085139|P2|Overall Study|Lost to Follow-up|1
652956|NCT02436304|2085140|P1|Overall Study|Lost to Follow-up|0
652957|NCT02435966|2085169|P3|Overall Study|Withdrawal by Subject|0
652958|NCT02435966|2085170|P2|Overall Study|Withdrawal by Subject|1
652959|NCT02435966|2085171|P1|Overall Study|Withdrawal by Subject|0
652960|NCT02435836|2085179|P1|Overall Study|AE of Worsening Schizophrenia|96
652961|NCT02435836|2085179|P1|Overall Study|Met Withdrawal Criteria|7
652962|NCT02435836|2085179|P1|Overall Study|Protocol Violation|6
652963|NCT02435836|2085179|P1|Overall Study|Noncompliance|27
652964|NCT02435836|2085179|P1|Overall Study|Sponsor discontinued trial|167
652965|NCT02435836|2085179|P1|Overall Study|Adverse Event|44
652966|NCT02435836|2085179|P1|Overall Study|Insufficient Clinical Response|26
652967|NCT02435836|2085179|P1|Overall Study|Withdrawal by Subject|236
652968|NCT02435836|2085179|P1|Overall Study|Lack of Efficacy|1
652969|NCT02435836|2085179|P1|Overall Study|Lost to Follow-up|21
652970|NCT02434939|2085197|P2|Overall Study|Adverse Event|1
652971|NCT02434939|2085198|P1|Overall Study|Adverse Event|0
652972|NCT02434939|2085197|P2|Overall Study|Withdrawal by Subject|0
652973|NCT02434939|2085198|P1|Overall Study|Withdrawal by Subject|3
652974|NCT02434939|2085197|P2|Overall Study|Lack of Efficacy|48
652975|NCT02434939|2085198|P1|Overall Study|Lack of Efficacy|34
652976|NCT02433834|2085237|P1|Overall Study|Physician Decision|1
652977|NCT02433834|2085237|P1|Overall Study|Adverse Event|6
652978|NCT02433834|2085237|P1|Overall Study|Withdrawal by Subject|14
652979|NCT02433834|2085237|P1|Overall Study|Lost to Follow-up|6
652980|NCT02433834|2085237|P1|Overall Study|Protocol Violation|3
652981|NCT02433834|2085237|P1|Overall Study|Protocol-specified criteria|7
652982|NCT02433340|2085310|P4|Overall Study|Not Specified|0
652983|NCT02433340|2085311|P3|Overall Study|Not Specified|0
652984|NCT02433340|2085312|P2|Overall Study|Not Specified|1
652985|NCT02433340|2085313|P1|Overall Study|Not Specified|0
652986|NCT02433340|2085310|P4|Overall Study|Required Alternative/Prohibited Therapy|0
652987|NCT02433340|2085311|P3|Overall Study|Required Alternative/Prohibited Therapy|0
652988|NCT02433340|2085312|P2|Overall Study|Required Alternative/Prohibited Therapy|0
652989|NCT02433340|2085313|P1|Overall Study|Required Alternative/Prohibited Therapy|1
652990|NCT02433340|2085310|P4|Overall Study|Lost to Follow-up|0
652991|NCT02433340|2085311|P3|Overall Study|Lost to Follow-up|0
652992|NCT02433340|2085312|P2|Overall Study|Lost to Follow-up|1
652993|NCT02433340|2085313|P1|Overall Study|Lost to Follow-up|0
652994|NCT02433340|2085310|P4|Overall Study|Withdrawal by Subject|2
652995|NCT02433340|2085311|P3|Overall Study|Withdrawal by Subject|1
652996|NCT02433340|2085312|P2|Overall Study|Withdrawal by Subject|0
652997|NCT02433340|2085313|P1|Overall Study|Withdrawal by Subject|1
652998|NCT02433340|2085310|P4|Overall Study|Adverse Event|0
652999|NCT02433340|2085311|P3|Overall Study|Adverse Event|1
653000|NCT02433340|2085312|P2|Overall Study|Adverse Event|0
653001|NCT02433340|2085313|P1|Overall Study|Adverse Event|0
653002|NCT02432105|2086208|P3|Overall Study|Randomized in error|2
653003|NCT02432105|2086209|P2|Overall Study|Randomized in error|0
653004|NCT02432105|2086210|P1|Overall Study|Randomized in error|0
653005|NCT02432105|2086208|P3|Overall Study|Culture positive for yeast|0
653006|NCT02432105|2086209|P2|Overall Study|Culture positive for yeast|1
653007|NCT02432105|2086210|P1|Overall Study|Culture positive for yeast|0
653008|NCT02432105|2086208|P3|Overall Study|Withdrawal by Subject|1
653009|NCT02432105|2086209|P2|Overall Study|Withdrawal by Subject|0
653010|NCT02432105|2086210|P1|Overall Study|Withdrawal by Subject|1
653011|NCT02432105|2086208|P3|Overall Study|Lost to Follow-up|0
653012|NCT02432105|2086209|P2|Overall Study|Lost to Follow-up|1
653013|NCT02432105|2086210|P1|Overall Study|Lost to Follow-up|1
653014|NCT02432040|2086227|P2|Overall Study|Physician Decision|1
653015|NCT02432040|2086228|P1|Overall Study|Physician Decision|1
653016|NCT02432040|2086227|P2|Overall Study|Lost to Follow-up|5
653017|NCT02432040|2086228|P1|Overall Study|Lost to Follow-up|4
653018|NCT02432040|2086227|P2|Overall Study|Lack of Efficacy|0
653019|NCT02432040|2086228|P1|Overall Study|Lack of Efficacy|3
653020|NCT02430870|2086341|P8|Part 2|Other Reason Not Specified|1
653021|NCT02430870|2086342|P7|Part 2|Other Reason Not Specified|0
653022|NCT02430870|2086343|P6|Part 2|Other Reason Not Specified|0
653023|NCT02430870|2086344|P5|Part 2|Other Reason Not Specified|0
653024|NCT02430870|2086345|P4|Part 2|Other Reason Not Specified|0
653025|NCT02430870|2086346|P3|Part 2|Other Reason Not Specified|0
653026|NCT02430870|2086347|P2|Part 2|Other Reason Not Specified|0
653027|NCT02430870|2086348|P1|Part 2|Other Reason Not Specified|0
653028|NCT02430870|2086341|P8|Part 2|Voluntary Withdrawal|0
653029|NCT02430870|2086342|P7|Part 2|Voluntary Withdrawal|1
653030|NCT02430870|2086343|P6|Part 2|Voluntary Withdrawal|0
653031|NCT02430870|2086344|P5|Part 2|Voluntary Withdrawal|0
653032|NCT02430870|2086345|P4|Part 2|Voluntary Withdrawal|0
653033|NCT02430870|2086346|P3|Part 2|Voluntary Withdrawal|0
653034|NCT02430870|2086347|P2|Part 2|Voluntary Withdrawal|0
653035|NCT02430870|2086348|P1|Part 2|Voluntary Withdrawal|0
653036|NCT02430532|2086422|P2|Overall Study|Adverse Event|1
653037|NCT02430532|2086423|P1|Overall Study|Adverse Event|0
653038|NCT02430532|2086422|P2|Overall Study|Consent Withdrawn|2
653039|NCT02430532|2086423|P1|Overall Study|Consent Withdrawn|0
653040|NCT02430532|2086422|P2|Overall Study|Sponsor Decision to Stop Study Early|25
653041|NCT02430532|2086423|P1|Overall Study|Sponsor Decision to Stop Study Early|30
653042|NCT02429258|2086463|P2|Overall Study|Protocol Violation|1
653043|NCT02429258|2086464|P1|Overall Study|Protocol Violation|0
653044|NCT02429258|2086463|P2|Overall Study|Withdrawal by Subject|0
653045|NCT02429258|2086464|P1|Overall Study|Withdrawal by Subject|2
653046|NCT02428413|2086501|P2|Overall Study|Nurse Refusal|0
653047|NCT02428413|2086502|P1|Overall Study|Nurse Refusal|1
653048|NCT02428413|2086501|P2|Overall Study|Missed Cases|2
653049|NCT02428413|2086502|P1|Overall Study|Missed Cases|1
653050|NCT02428413|2086501|P2|Overall Study|Case Cancelled|0
653051|NCT02428413|2086502|P1|Overall Study|Case Cancelled|2
653052|NCT02428413|2086501|P2|Overall Study|Protocol Violation|2
653053|NCT02428413|2086502|P1|Overall Study|Protocol Violation|1
653054|NCT02428413|2086501|P2|Overall Study|Device to measure WAG malfunctioned|5
653055|NCT02428413|2086502|P1|Overall Study|Device to measure WAG malfunctioned|3
653056|NCT02428231|2086516|P2|Overall Study|Adverse Event|0
653057|NCT02428231|2086517|P1|Overall Study|Adverse Event|3
653058|NCT02428231|2086516|P2|Overall Study|Required Symptomatic Therapy|1
653059|NCT02428231|2086517|P1|Overall Study|Required Symptomatic Therapy|0
653060|NCT02428231|2086516|P2|Overall Study|Not Specified|16
653061|NCT02428231|2086517|P1|Overall Study|Not Specified|10
653062|NCT02427984|2086534|P3|Overall Study|Lost to Follow-up|18
653063|NCT02427984|2086535|P2|Overall Study|Lost to Follow-up|5
653064|NCT02427984|2086536|P1|Overall Study|Lost to Follow-up|13
653065|NCT02427477|2086578|P2|Period 1|Adverse Event|0
653066|NCT02427477|2086579|P1|Period 1|Adverse Event|1
653067|NCT02427399|2086592|P5|Overall Study|Protocol Violation|15
653068|NCT02427399|2086593|P4|Overall Study|Protocol Violation|18
653069|NCT02427399|2086594|P3|Overall Study|Protocol Violation|12
653070|NCT02427399|2086595|P2|Overall Study|Protocol Violation|16
653071|NCT02427399|2086596|P1|Overall Study|Protocol Violation|14
653082|NCT02424591|2086655|P2|Overall Study|Protocol Violation|3
653083|NCT02424591|2086656|P1|Overall Study|Protocol Violation|2
653084|NCT02424578|2086668|P2|Overall Study|Withdrawal by Subject|1
653085|NCT02424578|2086669|P1|Overall Study|Withdrawal by Subject|0
653086|NCT02424565|2086675|P2|Period 1 (D0)|Protocol Violation|1
653087|NCT02424565|2086676|P1|Period 1 (D0)|Protocol Violation|0
653088|NCT02424149|2086684|P2|Overall Study|Withdrawal by Subject|1
653089|NCT02424149|2086685|P1|Overall Study|Withdrawal by Subject|0
653090|NCT02424149|2086684|P2|Overall Study|surgery cancelled|0
653091|NCT02424149|2086685|P1|Overall Study|surgery cancelled|2
887986|NCT02544074|2821165|P11|Overall Study|Withdrawal by Subject|0
653093|NCT02423291|2086812|P1|Overall Study|Adverse Event|1
653094|NCT02423291|2086812|P1|Overall Study|Lack of Efficacy|14
653095|NCT02421120|2086863|P1|Overall Study|Adverse Event|1
653096|NCT02420093|2086886|P2|Overall Study|Withdrawal by Subject|1
653097|NCT02420093|2086887|P1|Overall Study|Withdrawal by Subject|1
653098|NCT02419313|2086940|P2|Second Intervention|Lost to Follow-up|0
653099|NCT02419313|2086941|P1|Second Intervention|Lost to Follow-up|1
653100|NCT02419313|2086940|P2|First Intervention|Lost to Follow-up|0
653101|NCT02419313|2086941|P1|First Intervention|Lost to Follow-up|2
653102|NCT02419001|2086953|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
653103|NCT02419001|2086954|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
653104|NCT02418468|2086982|P2|Overall Study|Withdrawal of informed consent|1
653105|NCT02418468|2086983|P1|Overall Study|Withdrawal of informed consent|1
653106|NCT02418468|2086982|P2|Overall Study|Adverse Event|0
653107|NCT02418468|2086983|P1|Overall Study|Adverse Event|1
653108|NCT02417961|2087033|P1|Overall Study|Withdrawal by Subject|2
653109|NCT02417961|2087033|P1|Overall Study|Lost to Follow-up|1
653110|NCT02417961|2087033|P1|Overall Study|Adverse Event|1
653111|NCT02417753|2087043|P1|Overall Study|Death|1
653112|NCT02417532|2087053|P1|Overall Study|unable to complete exercises|4
653113|NCT02416180|2087135|P1|Overall Study|Withdrawal by Subject|1
653114|NCT02415959|2087147|P5|Overall Study|Protocol Violation|0
653115|NCT02415959|2087148|P4|Overall Study|Protocol Violation|1
653116|NCT02415959|2087149|P3|Overall Study|Protocol Violation|0
653117|NCT02415959|2087150|P2|Overall Study|Protocol Violation|0
653118|NCT02415959|2087151|P1|Overall Study|Protocol Violation|0
653119|NCT02415959|2087147|P5|Overall Study|Adverse Event|0
653120|NCT02415959|2087148|P4|Overall Study|Adverse Event|0
653121|NCT02415959|2087149|P3|Overall Study|Adverse Event|0
653122|NCT02415959|2087150|P2|Overall Study|Adverse Event|1
653123|NCT02415959|2087151|P1|Overall Study|Adverse Event|0
653124|NCT02414828|2087266|P4|Overall Study|Lost to Follow-up|2
653125|NCT02414828|2087267|P3|Overall Study|Lost to Follow-up|1
653126|NCT02414828|2087268|P2|Overall Study|Lost to Follow-up|1
653127|NCT02414828|2087269|P1|Overall Study|Lost to Follow-up|0
653128|NCT02414152|2087307|P1|Overall Study|Lack of Efficacy|1
653129|NCT02414152|2087307|P1|Overall Study|Withdrawal by Subject|1
653130|NCT02413593|2087317|P1|Overall Study|Adverse Event|1
653131|NCT02413593|2087317|P1|Overall Study|Lost to Follow-up|3
653132|NCT02413333|2087330|P2|Period 2|Protocol Deviation|0
653133|NCT02413333|2087331|P1|Period 2|Protocol Deviation|1
653134|NCT02413333|2087330|P2|Period 1|Reason Not Specified|1
653135|NCT02413333|2087331|P1|Period 1|Reason Not Specified|0
653136|NCT02413333|2087330|P2|Period 1|Adverse Event|0
653137|NCT02413333|2087331|P1|Period 1|Adverse Event|1
653138|NCT02413294|2087339|P1|Overall Study|Withdrawal by Subject|1
653139|NCT02412657|2087394|P3|Overall Study|Protocol Violation|3
653140|NCT02412657|2087395|P2|Overall Study|Protocol Violation|2
653141|NCT02412657|2087396|P1|Overall Study|Protocol Violation|0
653142|NCT02412657|2087394|P3|Overall Study|Lost to Follow-up|0
653143|NCT02412657|2087395|P2|Overall Study|Lost to Follow-up|0
653144|NCT02412657|2087396|P1|Overall Study|Lost to Follow-up|1
653145|NCT02411747|2087436|P2|Overall Study|Protocol Violation|4
653146|NCT02411747|2087437|P1|Overall Study|Protocol Violation|2
653147|NCT02411747|2087436|P2|Overall Study|Withdrawal by Subject|0
653148|NCT02411747|2087437|P1|Overall Study|Withdrawal by Subject|1
653149|NCT02411539|2087445|P2|Overall Study|Confounding medical condition|1
653150|NCT02411539|2087446|P1|Overall Study|Confounding medical condition|0
653151|NCT02411539|2087445|P2|Overall Study|Lost to Follow-up|0
653152|NCT02411539|2087446|P1|Overall Study|Lost to Follow-up|2
653153|NCT02411292|2087515|P1|Overall Study|Lost to Follow-up|3
653154|NCT02411292|2087515|P1|Overall Study|Death|2
653155|NCT02411292|2087515|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
653156|NCT02411201|2087521|P1|Overall Study|Age group completed|2
653157|NCT02411201|2087521|P1|Overall Study|Withdrawal by Subject|2
653158|NCT02411201|2087521|P1|Overall Study|Adverse Event|2
653159|NCT02410824|2087532|P2|First Intervention (One Week)|Headache|1
653160|NCT02410824|2087533|P1|First Intervention (One Week)|Headache|0
887987|NCT02544074|2821166|P10|Overall Study|Withdrawal by Subject|0
653162|NCT02406586|2087665|P3|Overall Study|Withdrawal by Subject|0
653163|NCT02406586|2087666|P2|Overall Study|Withdrawal by Subject|0
653164|NCT02406586|2087667|P1|Overall Study|Withdrawal by Subject|1
653165|NCT02406586|2087665|P3|Overall Study|Lost to Follow-up|2
653166|NCT02406586|2087666|P2|Overall Study|Lost to Follow-up|4
653167|NCT02406586|2087667|P1|Overall Study|Lost to Follow-up|0
653168|NCT02404649|2087780|P2|Overall Study|Adverse Event|2
653169|NCT02404649|2087781|P1|Overall Study|Adverse Event|1
653170|NCT02404545|2087789|P2|Overall Study|Sponsor Termination|6
653171|NCT02404545|2087790|P1|Overall Study|Sponsor Termination|6
653172|NCT02404493|2087799|P2|Overall Study|Adverse Event|1
653173|NCT02404493|2087800|P1|Overall Study|Adverse Event|1
653174|NCT02403206|2088053|P2|Overall Study|Reason not given|4
653175|NCT02403206|2088054|P1|Overall Study|Reason not given|2
653176|NCT02403206|2088053|P2|Overall Study|Withdrawal by Subject|3
653177|NCT02403206|2088054|P1|Overall Study|Withdrawal by Subject|3
653178|NCT02403206|2088053|P2|Overall Study|Physician Decision|0
653179|NCT02403206|2088054|P1|Overall Study|Physician Decision|2
653180|NCT02403206|2088053|P2|Overall Study|Lost to Follow-up|3
653181|NCT02403206|2088054|P1|Overall Study|Lost to Follow-up|4
653182|NCT02403180|2088065|P2|Period 2 (5 Days)|Withdrawal by Subject|1
653183|NCT02403180|2088066|P1|Period 2 (5 Days)|Withdrawal by Subject|0
653184|NCT02403180|2088065|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
653185|NCT02403180|2088066|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
653186|NCT02402933|2088074|P1|Overall Study|Sponsor Decision|10
653187|NCT02402933|2088074|P1|Overall Study|Withdrawal by Subject|4
653188|NCT02402322|2088092|P3|Follow-up|Withdrawal by Subject|24
653189|NCT02402322|2088093|P2|Follow-up|Withdrawal by Subject|3
653190|NCT02402322|2088094|P1|Follow-up|Withdrawal by Subject|6
653191|NCT02402322|2088092|P3|Pretreatment|Withdrawal by Subject|1
653192|NCT02402322|2088093|P2|Pretreatment|Withdrawal by Subject|1
653193|NCT02402322|2088094|P1|Pretreatment|Withdrawal by Subject|3
653194|NCT02401867|2088163|P1|Analysis|Cervical assay could not be conducted|9
653195|NCT02401867|2088163|P1|Specimen Collection|Didn't receive 1 or more tests|10
653196|NCT02401529|2088183|P2|Overall Study|Protocol Violation|0
653197|NCT02401529|2088184|P1|Overall Study|Protocol Violation|5
653198|NCT02401529|2088183|P2|Overall Study|Physician Decision|6
653199|NCT02401529|2088184|P1|Overall Study|Physician Decision|2
653200|NCT02401529|2088183|P2|Overall Study|Lost to Follow-up|1
653201|NCT02401529|2088184|P1|Overall Study|Lost to Follow-up|2
653202|NCT02400346|2088264|P1|Overall Study|Lost to Follow-up|1
653203|NCT02400346|2088264|P1|Overall Study|Administrative or other reason(s)|2
653204|NCT02400346|2088264|P1|Overall Study|Withdrawal by Subject|7
653205|NCT02400346|2088264|P1|Overall Study|Non-compliance with IMP|1
653206|NCT02400346|2088264|P1|Overall Study|Lack of Efficacy|9
653207|NCT02400346|2088264|P1|Overall Study|Adverse Event|24
653208|NCT02400333|2088272|P4|Overall Study|Protocol Violation|1
653209|NCT02400333|2088273|P3|Overall Study|Protocol Violation|2
653210|NCT02400333|2088274|P2|Overall Study|Protocol Violation|0
653211|NCT02400333|2088275|P1|Overall Study|Protocol Violation|1
653212|NCT02400333|2088272|P4|Overall Study|Withdrawal by Subject|1
653213|NCT02400333|2088273|P3|Overall Study|Withdrawal by Subject|0
653214|NCT02400333|2088274|P2|Overall Study|Withdrawal by Subject|1
653215|NCT02400333|2088275|P1|Overall Study|Withdrawal by Subject|0
653216|NCT02399163|2088339|P1|Overall Study|Withdrawal by Participant|5
653217|NCT02399163|2088339|P1|Overall Study|Protocol Deviation|2
653218|NCT02399163|2088339|P1|Overall Study|Adverse Event|2
653219|NCT02397915|2088384|P4|Period 1|Physician Decision|0
653220|NCT02397915|2088385|P3|Period 1|Physician Decision|0
653221|NCT02397915|2088386|P2|Period 1|Physician Decision|0
653222|NCT02397915|2088387|P1|Period 1|Physician Decision|1
653223|NCT02397915|2088384|P4|Period 1|Protocol Violation|0
653224|NCT02397915|2088385|P3|Period 1|Protocol Violation|0
653225|NCT02397915|2088386|P2|Period 1|Protocol Violation|1
653226|NCT02397915|2088387|P1|Period 1|Protocol Violation|0
653227|NCT02397655|2088437|P1|Overall Study|data not completed|1301
653228|NCT02396537|2088448|P2|Overall Study|Protocol Violation|1
653229|NCT02396537|2088449|P1|Overall Study|Protocol Violation|0
653230|NCT02396316|2088457|P2|Overall Study|Treatment unblinded|1
653231|NCT02396316|2088458|P1|Overall Study|Treatment unblinded|0
653232|NCT02396316|2088457|P2|Overall Study|Protocol Violation|1
653233|NCT02396316|2088458|P1|Overall Study|Protocol Violation|0
653234|NCT02396316|2088457|P2|Overall Study|Progressive disease|3
653235|NCT02396316|2088458|P1|Overall Study|Progressive disease|6
653236|NCT02396316|2088457|P2|Overall Study|Physician Decision|0
653237|NCT02396316|2088458|P1|Overall Study|Physician Decision|1
887988|NCT02544074|2821167|P9|Overall Study|Withdrawal by Subject|0
887989|NCT02544074|2821168|P8|Overall Study|Withdrawal by Subject|0
887990|NCT02544074|2821169|P7|Overall Study|Withdrawal by Subject|0
887991|NCT02544074|2821170|P6|Overall Study|Withdrawal by Subject|0
887992|NCT02544074|2821171|P5|Overall Study|Withdrawal by Subject|0
887993|NCT02544074|2821172|P4|Overall Study|Withdrawal by Subject|0
887994|NCT02544074|2821173|P3|Overall Study|Withdrawal by Subject|0
653245|NCT02395536|2088565|P2|Overall Study|Insurance issue|1
653246|NCT02395536|2088566|P1|Overall Study|Insurance issue|0
653247|NCT02395536|2088565|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
653248|NCT02395536|2088566|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
653249|NCT02395536|2088565|P2|Overall Study|Withdrawal by Subject|17
653250|NCT02395536|2088566|P1|Overall Study|Withdrawal by Subject|9
653251|NCT02395536|2088565|P2|Overall Study|Physician Decision|6
653252|NCT02395536|2088566|P1|Overall Study|Physician Decision|4
653253|NCT02395536|2088565|P2|Overall Study|Death|0
653254|NCT02395536|2088566|P1|Overall Study|Death|2
653255|NCT02395536|2088565|P2|Overall Study|Lost to Follow-up|4
653256|NCT02395536|2088566|P1|Overall Study|Lost to Follow-up|4
653257|NCT02395302|2088572|P1|Overall Study|Physician Decision|2
653258|NCT02395302|2088572|P1|Overall Study|Withdrawal by Subject|2
653259|NCT02395302|2088572|P1|Overall Study|Run In Failure|7
653260|NCT02395302|2088572|P1|Overall Study|Screen Failure|3
653261|NCT02395055|2088578|P2|Overall Study|Withdrawal by Subject|3
653262|NCT02395055|2088579|P1|Overall Study|Withdrawal by Subject|7
653263|NCT02394925|2088589|P1|Overall Study|Unsatisfactory Visual Response|5
653264|NCT02394925|2088589|P1|Overall Study|No longer meet eligibility criteria|1
653265|NCT02394925|2088589|P1|Overall Study|Protocol Violation|5
653266|NCT02394925|2088589|P1|Overall Study|Lost to Follow-up|9
653267|NCT02394925|2088589|P1|Overall Study|Lens handling difficulities|5
653268|NCT02394925|2088589|P1|Overall Study|Lens Discomfort|3
653269|NCT02394925|2088589|P1|Overall Study|Adverse Event|1
653270|NCT02394808|2088593|P2|Period 2|Lost to Follow-up|0
653271|NCT02394808|2088594|P1|Period 2|Lost to Follow-up|1
653272|NCT02394808|2088593|P2|Period 1|Unsatisfactory lens fitting|1
653273|NCT02394808|2088594|P1|Period 1|Unsatisfactory lens fitting|0
653274|NCT02394756|2088602|P6|Period 2|Unsatisfactory Visual Response|0
653275|NCT02394756|2088603|P5|Period 2|Unsatisfactory Visual Response|1
653276|NCT02394756|2088604|P4|Period 2|Unsatisfactory Visual Response|0
653277|NCT02394756|2088605|P3|Period 2|Unsatisfactory Visual Response|0
653278|NCT02394756|2088606|P2|Period 2|Unsatisfactory Visual Response|0
653279|NCT02394756|2088607|P1|Period 2|Unsatisfactory Visual Response|0
653280|NCT02394756|2088602|P6|Period 1|Withdrawal by Subject|0
653281|NCT02394756|2088603|P5|Period 1|Withdrawal by Subject|0
653282|NCT02394756|2088604|P4|Period 1|Withdrawal by Subject|1
653283|NCT02394756|2088605|P3|Period 1|Withdrawal by Subject|1
653284|NCT02394756|2088606|P2|Period 1|Withdrawal by Subject|1
653285|NCT02394756|2088607|P1|Period 1|Withdrawal by Subject|0
653286|NCT02394756|2088602|P6|Period 1|Lens Discomfort|1
653287|NCT02394756|2088603|P5|Period 1|Lens Discomfort|0
653288|NCT02394756|2088604|P4|Period 1|Lens Discomfort|0
653289|NCT02394756|2088605|P3|Period 1|Lens Discomfort|0
653290|NCT02394756|2088606|P2|Period 1|Lens Discomfort|0
653291|NCT02394756|2088607|P1|Period 1|Lens Discomfort|0
653292|NCT02394665|2088621|P3|Overall Study|Physician Decision|0
653293|NCT02394665|2088622|P2|Overall Study|Physician Decision|0
653294|NCT02394665|2088623|P1|Overall Study|Physician Decision|1
653295|NCT02393950|2088664|P2|Overall Study|Withdrawal by Subject|1
653296|NCT02393950|2088665|P1|Overall Study|Withdrawal by Subject|0
653297|NCT02393950|2088664|P2|Overall Study|Adverse Event|0
653298|NCT02393950|2088665|P1|Overall Study|Adverse Event|1
653299|NCT02393547|2088739|P1|Overall Study|Lost to Follow-up|1
653300|NCT02393547|2088739|P1|Overall Study|Withdrawal by Subject|3
653301|NCT02393547|2088739|P1|Overall Study|Adverse Event|2
653302|NCT02392247|2088765|P1|Overall Study|Surgery cancelled; no data|1
653303|NCT02392247|2088765|P1|Overall Study|Withdrawal by Subject|1
653304|NCT02391311|2088795|P2|Overall Study|deemed ineligible after baseline|1
653305|NCT02391311|2088796|P1|Overall Study|deemed ineligible after baseline|1
653306|NCT02391311|2088795|P2|Overall Study|Lost to Follow-up|1
653307|NCT02391311|2088796|P1|Overall Study|Lost to Follow-up|2
653308|NCT02391038|2088804|P3|Overall Study|Progressive disease|6
653309|NCT02391038|2088805|P2|Overall Study|Progressive disease|3
653310|NCT02391038|2088806|P1|Overall Study|Progressive disease|3
653311|NCT02390167|2088920|P1|Overall Study|Lost to Follow-up|1
653312|NCT02389452|2089001|P1|Overall Study|Enrolled but Not Eligible for Study|6
653313|NCT02389452|2089001|P1|Overall Study|Withdrawal by Subject|5
653314|NCT02389452|2089001|P1|Overall Study|Adverse Event|1
653315|NCT02389452|2089001|P1|Overall Study|Lost to Follow-up|13
653316|NCT02388763|2089111|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
653317|NCT02388763|2089112|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
653318|NCT02388763|2089111|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
653319|NCT02388763|2089112|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
653320|NCT02388347|2089133|P5|Overall Study|Withdrawal by Subject|0
653321|NCT02388347|2089134|P4|Overall Study|Withdrawal by Subject|0
653322|NCT02388347|2089135|P3|Overall Study|Withdrawal by Subject|1
653323|NCT02388347|2089136|P2|Overall Study|Withdrawal by Subject|0
653324|NCT02388347|2089137|P1|Overall Study|Withdrawal by Subject|0
653325|NCT02388295|2089205|P3|Treatment Weeks 3 to 12|Adverse Event|0
653326|NCT02388295|2089206|P2|Treatment Weeks 3 to 12|Adverse Event|1
653327|NCT02388295|2089207|P1|Treatment Weeks 3 to 12|Adverse Event|1
653328|NCT02388295|2089205|P3|Dose Escalation Week 2|Determined not eligible|1
653329|NCT02388295|2089206|P2|Dose Escalation Week 2|Determined not eligible|1
653330|NCT02388295|2089207|P1|Dose Escalation Week 2|Determined not eligible|1
653331|NCT02388295|2089205|P3|Dose Escalation Week 2|Protocol Violation|0
653332|NCT02388295|2089206|P2|Dose Escalation Week 2|Protocol Violation|1
653333|NCT02388295|2089207|P1|Dose Escalation Week 2|Protocol Violation|0
653334|NCT02388295|2089205|P3|Dose Escalation Week 1|Determined not eligible|1
653335|NCT02388295|2089206|P2|Dose Escalation Week 1|Determined not eligible|1
653336|NCT02388295|2089207|P1|Dose Escalation Week 1|Determined not eligible|1
653337|NCT02388295|2089205|P3|Dose Escalation Week 1|Adverse Event|1
653338|NCT02388295|2089206|P2|Dose Escalation Week 1|Adverse Event|2
653339|NCT02388295|2089207|P1|Dose Escalation Week 1|Adverse Event|1
653340|NCT02388191|2089223|P2|Overall Study|Patient did not receive IUD|0
653341|NCT02388191|2089224|P1|Overall Study|Patient did not receive IUD|1
653342|NCT02388074|2089238|P1|Overall Study|Sample Not Returned|1
653343|NCT02388074|2089238|P1|Overall Study|Lost in Transit|2
887995|NCT02544074|2821174|P2|Overall Study|Withdrawal by Subject|1
887996|NCT02544074|2821175|P1|Overall Study|Withdrawal by Subject|0
887997|NCT02516306|2821201|P2|Period 2: Day 8 - 91|Protocol Violation|2
887998|NCT02516306|2821202|P1|Period 2: Day 8 - 91|Protocol Violation|1
653351|NCT02387983|2089253|P1|Overall Study|Withdrawal by Subject|2
653352|NCT02387983|2089253|P1|Overall Study|Protocol Violation|1
653353|NCT02387983|2089253|P1|Overall Study|Adverse Event|4
653354|NCT02387580|2089303|P6|Overall Study|Withdrawal by Subject|0
653355|NCT02387580|2089304|P5|Overall Study|Withdrawal by Subject|0
653356|NCT02387580|2089305|P4|Overall Study|Withdrawal by Subject|1
653357|NCT02387580|2089306|P3|Overall Study|Withdrawal by Subject|0
653358|NCT02387580|2089307|P2|Overall Study|Withdrawal by Subject|0
653359|NCT02387580|2089308|P1|Overall Study|Withdrawal by Subject|0
653360|NCT02384538|2089372|P2|Overall Study|Not Specified|3
653361|NCT02384538|2089373|P1|Overall Study|Not Specified|1
653362|NCT02384538|2089372|P2|Overall Study|Withdrew Consent|4
653363|NCT02384538|2089373|P1|Overall Study|Withdrew Consent|0
653364|NCT02384538|2089372|P2|Overall Study|Lack of Efficacy|4
653365|NCT02384538|2089373|P1|Overall Study|Lack of Efficacy|4
653366|NCT02384538|2089372|P2|Overall Study|Adverse Event|4
653367|NCT02384538|2089373|P1|Overall Study|Adverse Event|1
653368|NCT02383862|2089412|P2|3 Month Follow up|Lost to Follow-up|21
653369|NCT02383862|2089413|P1|3 Month Follow up|Lost to Follow-up|23
653370|NCT02382640|2089520|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
653371|NCT02382640|2089521|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
653372|NCT02382640|2089522|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
653373|NCT02382640|2089523|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
653374|NCT02382133|2089561|P1|Overall Study|pressure injury both sites|1
653375|NCT02382133|2089561|P1|Overall Study|arterial catheter loss|4
653376|NCT02382133|2089561|P1|Overall Study|Physician Decision|2
653377|NCT02382133|2089561|P1|Overall Study|transfer out of ICU|4
653378|NCT02382133|2089561|P1|Overall Study|Death|22
653379|NCT02380742|2089616|P2|Overall Study|Withdrawal by Subject|0
653380|NCT02380742|2089617|P1|Overall Study|Withdrawal by Subject|1
653381|NCT02380287|2089637|P8|Overall Study|Adverse Event|0
653382|NCT02380287|2089638|P7|Overall Study|Adverse Event|0
653383|NCT02380287|2089639|P6|Overall Study|Adverse Event|0
653384|NCT02380287|2089640|P5|Overall Study|Adverse Event|0
653385|NCT02380287|2089641|P4|Overall Study|Adverse Event|0
653386|NCT02380287|2089642|P3|Overall Study|Adverse Event|1
653387|NCT02380287|2089643|P2|Overall Study|Adverse Event|0
653388|NCT02380287|2089644|P1|Overall Study|Adverse Event|0
653389|NCT02380248|2089660|P1|Overall Study|Withdrawal by Subject|3
653390|NCT02380248|2089660|P1|Overall Study|Lost to Follow-up|11
653391|NCT02379637|2089667|P2|Overall Study|Withdrawal by Subject|0
653392|NCT02379637|2089668|P1|Overall Study|Withdrawal by Subject|1
653393|NCT02379637|2089667|P2|Overall Study|Adverse Event|0
653394|NCT02379637|2089668|P1|Overall Study|Adverse Event|1
653395|NCT02379637|2089667|P2|Overall Study|Protocol Violation|1
653396|NCT02379637|2089668|P1|Overall Study|Protocol Violation|0
653397|NCT02378961|2089680|P4|Overall Study|Death|0
653398|NCT02378961|2089681|P3|Overall Study|Death|1
653399|NCT02378961|2089682|P2|Overall Study|Death|0
653400|NCT02378961|2089683|P1|Overall Study|Death|0
653401|NCT02378961|2089680|P4|Overall Study|Lack of Efficacy|1
653402|NCT02378961|2089681|P3|Overall Study|Lack of Efficacy|0
653403|NCT02378961|2089682|P2|Overall Study|Lack of Efficacy|2
653404|NCT02378961|2089683|P1|Overall Study|Lack of Efficacy|4
653405|NCT02378506|2089713|P1|Overall Study|Randomized But Not Treated|1
653406|NCT02378506|2089713|P1|Overall Study|Adverse Event|14
653407|NCT02378506|2089713|P1|Overall Study|Death|1
653408|NCT02378506|2089713|P1|Overall Study|Protocol Violation|2
653409|NCT02378506|2089713|P1|Overall Study|Withdrawal by Subject|4
653410|NCT02378506|2089713|P1|Overall Study|Lack of Efficacy|3
653411|NCT02375724|2089753|P2|Overall Study|Adverse Event|4
653412|NCT02375724|2089754|P1|Overall Study|Adverse Event|2
653413|NCT02375724|2089753|P2|Overall Study|Protocol Violation|0
653414|NCT02375724|2089754|P1|Overall Study|Protocol Violation|1
653415|NCT02375724|2089753|P2|Overall Study|Lost to Follow-up|0
653416|NCT02375724|2089754|P1|Overall Study|Lost to Follow-up|1
653417|NCT02375724|2089753|P2|Overall Study|Withdrawal by Subject|1
653418|NCT02375724|2089754|P1|Overall Study|Withdrawal by Subject|1
653419|NCT02375724|2089753|P2|Overall Study|Lack of Efficacy|1
653420|NCT02375724|2089754|P1|Overall Study|Lack of Efficacy|1
653421|NCT02375373|2089764|P1|Overall Study|Withdrawal by Subject|11
653422|NCT02375347|2089768|P1|Overall Study|Protocol Violation|1
888003|NCT02451917|2821236|P2|First Intervention (24 Weeks)|Adverse Event|2
653425|NCT02374346|2089818|P1|Overall Study|operated or discharged during weekend|48
653426|NCT02372071|2089891|P1|Overall Study|Protocol Violation|18
653427|NCT02372058|2089896|P1|Overall Study|Withdrawal by Subject|3
653428|NCT02371759|2089925|P8|Overall Study|Withdrawal by Subject|1
653429|NCT02371759|2089926|P7|Overall Study|Withdrawal by Subject|0
653430|NCT02371759|2089927|P6|Overall Study|Withdrawal by Subject|0
653431|NCT02371759|2089928|P5|Overall Study|Withdrawal by Subject|0
653432|NCT02371759|2089929|P4|Overall Study|Withdrawal by Subject|0
653433|NCT02371759|2089930|P3|Overall Study|Withdrawal by Subject|0
653434|NCT02371759|2089931|P2|Overall Study|Withdrawal by Subject|0
653435|NCT02371759|2089932|P1|Overall Study|Withdrawal by Subject|0
653436|NCT02371759|2089925|P8|Overall Study|Protocol Violation|3
653437|NCT02371759|2089926|P7|Overall Study|Protocol Violation|0
653438|NCT02371759|2089927|P6|Overall Study|Protocol Violation|1
653439|NCT02371759|2089928|P5|Overall Study|Protocol Violation|3
653440|NCT02371759|2089929|P4|Overall Study|Protocol Violation|0
653441|NCT02371759|2089930|P3|Overall Study|Protocol Violation|1
653442|NCT02371759|2089931|P2|Overall Study|Protocol Violation|1
653443|NCT02371759|2089932|P1|Overall Study|Protocol Violation|3
653444|NCT02370914|2090142|P1|Overall Study|Protocol Violation|2
653445|NCT02370667|2090149|P3|Overall Study|Lost to Follow-up|0
653446|NCT02370667|2090150|P2|Overall Study|Lost to Follow-up|1
653447|NCT02370667|2090151|P1|Overall Study|Lost to Follow-up|0
653448|NCT02370615|2090215|P2|Overall Study|Adverse Event|0
653449|NCT02370615|2090216|P1|Overall Study|Adverse Event|1
653450|NCT02370602|2090259|P6|Overall Study|Pretreatment Event/Adverse Event|0
653451|NCT02370602|2090260|P5|Overall Study|Pretreatment Event/Adverse Event|0
653452|NCT02370602|2090261|P4|Overall Study|Pretreatment Event/Adverse Event|0
653453|NCT02370602|2090262|P3|Overall Study|Pretreatment Event/Adverse Event|0
653454|NCT02370602|2090263|P2|Overall Study|Pretreatment Event/Adverse Event|0
653455|NCT02370602|2090264|P1|Overall Study|Pretreatment Event/Adverse Event|1
653456|NCT02370537|2090358|P3|Part B|Withdrawal by Subject|0
653457|NCT02370537|2090359|P2|Part B|Withdrawal by Subject|1
653458|NCT02370537|2090360|P1|Part B|Withdrawal by Subject|0
653459|NCT02370537|2090358|P3|Part B|Not randomised to receive treatment|259
653460|NCT02370537|2090359|P2|Part B|Not randomised to receive treatment|2
653461|NCT02370537|2090360|P1|Part B|Not randomised to receive treatment|1
653462|NCT02370537|2090358|P3|Part A (Open-label Recruitment)|Adverse Event|1
653463|NCT02370537|2090359|P2|Part A (Open-label Recruitment)|Adverse Event|0
653464|NCT02370537|2090360|P1|Part A (Open-label Recruitment)|Adverse Event|0
653465|NCT02370537|2090358|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
653466|NCT02370537|2090359|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
653467|NCT02370537|2090360|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
653468|NCT02370121|2090434|P2|Overall Study|Lost to Follow-up|1
653469|NCT02370121|2090435|P1|Overall Study|Lost to Follow-up|1
653470|NCT02369510|2090524|P3|Overall Study|Epidural Activation|5
653471|NCT02369510|2090525|P2|Overall Study|Epidural Activation|1
653472|NCT02369510|2090526|P1|Overall Study|Epidural Activation|1
653473|NCT02369510|2090524|P3|Overall Study|Spilled Medication|1
653474|NCT02369510|2090525|P2|Overall Study|Spilled Medication|2
653475|NCT02369510|2090526|P1|Overall Study|Spilled Medication|1
888004|NCT02451917|2821237|P1|First Intervention (24 Weeks)|Adverse Event|0
888005|NCT02451917|2821236|P2|First Intervention (24 Weeks)|Death|1
653478|NCT02368314|2090625|P2|Overall Study|Adverse Event|2
653479|NCT02368314|2090626|P1|Overall Study|Adverse Event|1
653480|NCT02368314|2090625|P2|Overall Study|Withdrawal by Subject|1
653481|NCT02368314|2090626|P1|Overall Study|Withdrawal by Subject|2
653482|NCT02367885|2090648|P3|Overall Study|Withdrawal by Subject|0
653483|NCT02367885|2090649|P2|Overall Study|Withdrawal by Subject|0
653484|NCT02367885|2090650|P1|Overall Study|Withdrawal by Subject|1
653485|NCT02367885|2090648|P3|Overall Study|Lost to Follow-up|0
653486|NCT02367885|2090649|P2|Overall Study|Lost to Follow-up|0
653487|NCT02367885|2090650|P1|Overall Study|Lost to Follow-up|1
653488|NCT02366936|2090978|P1|Overall Study|Physician Decision|2
653489|NCT02366936|2090978|P1|Overall Study|Lost to Follow-up|4
653490|NCT02366936|2090978|P1|Overall Study|Withdrawal by Subject|2
653491|NCT02366923|2090983|P1|Overall Study|High Astigmatism|3
653492|NCT02366923|2090983|P1|Overall Study|Positive Slit Lamp Findings|2
653493|NCT02366923|2090983|P1|Overall Study|Withdrawal by Subject|1
653494|NCT02366910|2090996|P1|Overall Study|Screen Failure|3
653495|NCT02366910|2090996|P1|Overall Study|Withdrawal by Subject|2
653496|NCT02366767|2091010|P2|Overall Study|left for home after 1 day at camp|0
653497|NCT02366767|2091011|P1|Overall Study|left for home after 1 day at camp|1
653498|NCT02366689|2091024|P3|Overall Study|Pregnancy|1
653499|NCT02366689|2091025|P2|Overall Study|Pregnancy|1
653500|NCT02366689|2091026|P1|Overall Study|Pregnancy|0
653501|NCT02366689|2091024|P3|Overall Study|Lost to Follow-up|0
653502|NCT02366689|2091025|P2|Overall Study|Lost to Follow-up|2
653503|NCT02366689|2091026|P1|Overall Study|Lost to Follow-up|3
653504|NCT02366689|2091024|P3|Overall Study|Withdrawal by Subject|1
653505|NCT02366689|2091025|P2|Overall Study|Withdrawal by Subject|0
653506|NCT02366689|2091026|P1|Overall Study|Withdrawal by Subject|1
653507|NCT02366637|2091049|P2|Second Intervention Period|Study Terminated by Sponsor|1
653508|NCT02366637|2091050|P1|Second Intervention Period|Study Terminated by Sponsor|1
653509|NCT02366637|2091049|P2|First Intervention Period|Study Terminated by Sponsor|4
653510|NCT02366637|2091050|P1|First Intervention Period|Study Terminated by Sponsor|6
653511|NCT02366637|2091049|P2|First Intervention Period|Adverse Event|1
653512|NCT02366637|2091050|P1|First Intervention Period|Adverse Event|0
653513|NCT02365298|2091091|P2|Period 2|Protocol Violation|1
653514|NCT02365298|2091092|P1|Period 2|Protocol Violation|0
653515|NCT02365298|2091091|P2|Period 2|Test Article longer available|1
653516|NCT02365298|2091092|P1|Period 2|Test Article longer available|0
653517|NCT02365298|2091091|P2|Period 2|Discontinued at request of Sponsor|0
653518|NCT02365298|2091092|P1|Period 2|Discontinued at request of Sponsor|1
653519|NCT02365298|2091091|P2|Period 2|incorrect Rx dispensed|0
653520|NCT02365298|2091092|P1|Period 2|incorrect Rx dispensed|1
653521|NCT02364180|2091131|P1|Overall Study|Screen Fail|1
653522|NCT02363478|2091139|P1|Overall Study|Adverse Event|4
653523|NCT02363478|2091139|P1|Overall Study|Lost to Follow-up|4
653524|NCT02362412|2091155|P2|Treatment Period III|Lost to Follow-up|1
653525|NCT02362412|2091156|P1|Treatment Period III|Lost to Follow-up|0
653526|NCT02362360|2091190|P2|Period 1|Withdrawal by Subject|1
653527|NCT02362360|2091191|P1|Period 1|Withdrawal by Subject|2
653528|NCT02362360|2091190|P2|Period 1|Lack of Efficacy|0
653529|NCT02362360|2091191|P1|Period 1|Lack of Efficacy|1
653530|NCT02361580|2091229|P2|Overall Study|Lost to Follow-up|3
653531|NCT02361580|2091230|P1|Overall Study|Lost to Follow-up|6
653532|NCT02360995|2091243|P3|Overall Study|Withdrawal by Subject|0
653533|NCT02360995|2091244|P2|Overall Study|Withdrawal by Subject|1
653534|NCT02360995|2091245|P1|Overall Study|Withdrawal by Subject|0
653535|NCT02360995|2091243|P3|Overall Study|Lost to Follow-up|2
653536|NCT02360995|2091244|P2|Overall Study|Lost to Follow-up|0
653537|NCT02360995|2091245|P1|Overall Study|Lost to Follow-up|2
653538|NCT02360475|2091272|P4|Overall Study|Migrated/moved from study area|1
653539|NCT02360475|2091273|P3|Overall Study|Migrated/moved from study area|0
653540|NCT02360475|2091274|P2|Overall Study|Migrated/moved from study area|0
653541|NCT02360475|2091275|P1|Overall Study|Migrated/moved from study area|0
653542|NCT02360475|2091272|P4|Overall Study|Withdrawal by Subject|0
653543|NCT02360475|2091273|P3|Overall Study|Withdrawal by Subject|2
653544|NCT02360475|2091274|P2|Overall Study|Withdrawal by Subject|1
653545|NCT02360475|2091275|P1|Overall Study|Withdrawal by Subject|0
653546|NCT02360475|2091272|P4|Overall Study|Lost to Follow-up|4
653547|NCT02360475|2091273|P3|Overall Study|Lost to Follow-up|6
653548|NCT02360475|2091274|P2|Overall Study|Lost to Follow-up|12
653549|NCT02360475|2091275|P1|Overall Study|Lost to Follow-up|4
653550|NCT02359903|2091379|P2|Overall Study|Adverse Event|2
653551|NCT02359903|2091380|P1|Overall Study|Adverse Event|0
653552|NCT02359877|2091392|P4|Overall Study|Adverse Event|1
653553|NCT02359877|2091393|P3|Overall Study|Adverse Event|0
653554|NCT02359877|2091394|P2|Overall Study|Adverse Event|0
653555|NCT02359877|2091395|P1|Overall Study|Adverse Event|0
653556|NCT02359877|2091392|P4|Overall Study|Withdrawal by Subject|2
653557|NCT02359877|2091393|P3|Overall Study|Withdrawal by Subject|0
653558|NCT02359877|2091394|P2|Overall Study|Withdrawal by Subject|0
653559|NCT02359877|2091395|P1|Overall Study|Withdrawal by Subject|1
653560|NCT02359435|2091447|P2|Overall Study|Lost to Follow-up|4
653561|NCT02359435|2091448|P1|Overall Study|Lost to Follow-up|4
653562|NCT02359045|2091456|P2|Overall Study|Adverse Event|1
653563|NCT02359045|2091457|P1|Overall Study|Adverse Event|0
653564|NCT02359045|2091456|P2|Overall Study|Lost to Follow-up|1
653565|NCT02359045|2091457|P1|Overall Study|Lost to Follow-up|1
653566|NCT02359045|2091456|P2|Overall Study|Eligibility criteria not fulfilled|1
653567|NCT02359045|2091457|P1|Overall Study|Eligibility criteria not fulfilled|3
653568|NCT02358668|2091697|P3|Overall Study|Withdrawal by Subject|0
653569|NCT02358668|2091698|P2|Overall Study|Withdrawal by Subject|1
653570|NCT02358668|2091699|P1|Overall Study|Withdrawal by Subject|0
653571|NCT02358668|2091697|P3|Overall Study|Adverse Event|0
653572|NCT02358668|2091698|P2|Overall Study|Adverse Event|0
653573|NCT02358668|2091699|P1|Overall Study|Adverse Event|2
653574|NCT02358044|2091841|P2|Overall Study|Withdrawal by Subject|4
653575|NCT02358044|2091842|P1|Overall Study|Withdrawal by Subject|0
653576|NCT02358044|2091841|P2|Overall Study|Physician Decision|1
653577|NCT02358044|2091842|P1|Overall Study|Physician Decision|0
653578|NCT02358044|2091841|P2|Overall Study|Lost to Follow-up|1
653579|NCT02358044|2091842|P1|Overall Study|Lost to Follow-up|2
653580|NCT02358044|2091841|P2|Overall Study|Adverse Event|1
653581|NCT02358044|2091842|P1|Overall Study|Adverse Event|0
653582|NCT02357940|2091860|P2|Overall Study|Investigator's judgement|1
653583|NCT02357940|2091861|P1|Overall Study|Investigator's judgement|0
653584|NCT02357940|2091860|P2|Overall Study|Adverse Event|1
653585|NCT02357940|2091861|P1|Overall Study|Adverse Event|0
653586|NCT02357342|2091995|P2|First 6 Months|Death|0
653587|NCT02357342|2091996|P1|First 6 Months|Death|2
653588|NCT02356588|2092038|P2|Overall Study|Protocol Violation|1
653589|NCT02356588|2092039|P1|Overall Study|Protocol Violation|0
653590|NCT02356588|2092038|P2|Overall Study|Withdrawal by Subject|0
653591|NCT02356588|2092039|P1|Overall Study|Withdrawal by Subject|1
653592|NCT02356588|2092038|P2|Overall Study|Adverse Event|2
653593|NCT02356588|2092039|P1|Overall Study|Adverse Event|0
653594|NCT02356588|2092038|P2|Overall Study|Lack of Efficacy|10
653595|NCT02356588|2092039|P1|Overall Study|Lack of Efficacy|4
653596|NCT02354599|2092133|P6|Overall Study|Withdrawal by Subject|0
653597|NCT02354599|2092134|P5|Overall Study|Withdrawal by Subject|0
653598|NCT02354599|2092135|P4|Overall Study|Withdrawal by Subject|0
653599|NCT02354599|2092136|P3|Overall Study|Withdrawal by Subject|0
653600|NCT02354599|2092137|P2|Overall Study|Withdrawal by Subject|1
653601|NCT02354599|2092138|P1|Overall Study|Withdrawal by Subject|1
653602|NCT02354599|2092133|P6|Overall Study|Pretreatment Event/Adverse Event|1
653603|NCT02354599|2092134|P5|Overall Study|Pretreatment Event/Adverse Event|0
653604|NCT02354599|2092135|P4|Overall Study|Pretreatment Event/Adverse Event|0
653605|NCT02354599|2092136|P3|Overall Study|Pretreatment Event/Adverse Event|0
653606|NCT02354599|2092137|P2|Overall Study|Pretreatment Event/Adverse Event|0
653607|NCT02354599|2092138|P1|Overall Study|Pretreatment Event/Adverse Event|0
653614|NCT02353572|2092244|P1|Overall Study|Study terminated|2
653615|NCT02353572|2092244|P1|Overall Study|Withdrawal by Subject|1
653616|NCT02353468|2092248|P1|Overall Study|Study terminated|3
653617|NCT02353442|2092254|P2|Overall Study|Withdrawal by Subject|4
653618|NCT02353442|2092255|P1|Overall Study|Withdrawal by Subject|3
653619|NCT02352779|2092272|P3|Overall Study|No Reason|1
653620|NCT02352779|2092273|P2|Overall Study|No Reason|0
653621|NCT02352779|2092274|P1|Overall Study|No Reason|0
653622|NCT02352779|2092272|P3|Overall Study|Other Medical Reason|1
653623|NCT02352779|2092273|P2|Overall Study|Other Medical Reason|0
653624|NCT02352779|2092274|P1|Overall Study|Other Medical Reason|0
653625|NCT02352779|2092272|P3|Overall Study|Absence of Symptoms|0
653626|NCT02352779|2092273|P2|Overall Study|Absence of Symptoms|0
653627|NCT02352779|2092274|P1|Overall Study|Absence of Symptoms|1
653628|NCT02352779|2092272|P3|Overall Study|Study Related Symptoms|0
653629|NCT02352779|2092273|P2|Overall Study|Study Related Symptoms|0
653630|NCT02352779|2092274|P1|Overall Study|Study Related Symptoms|1
653631|NCT02352779|2092272|P3|Overall Study|Changed Mind|0
653632|NCT02352779|2092273|P2|Overall Study|Changed Mind|0
653633|NCT02352779|2092274|P1|Overall Study|Changed Mind|1
653634|NCT02352779|2092272|P3|Overall Study|Disliked Intervention|0
653635|NCT02352779|2092273|P2|Overall Study|Disliked Intervention|0
653636|NCT02352779|2092274|P1|Overall Study|Disliked Intervention|1
653637|NCT02352779|2092272|P3|Overall Study|Feeling Overwhelmed|0
653638|NCT02352779|2092273|P2|Overall Study|Feeling Overwhelmed|0
653639|NCT02352779|2092274|P1|Overall Study|Feeling Overwhelmed|1
653640|NCT02352779|2092272|P3|Overall Study|Too Many Forms|0
653641|NCT02352779|2092273|P2|Overall Study|Too Many Forms|0
653642|NCT02352779|2092274|P1|Overall Study|Too Many Forms|2
653643|NCT02352779|2092272|P3|Overall Study|Personal Issues|0
653644|NCT02352779|2092273|P2|Overall Study|Personal Issues|1
653645|NCT02352779|2092274|P1|Overall Study|Personal Issues|1
653646|NCT02351960|2092289|P2|Overall Study|Significant Protocol Deviation|5
653647|NCT02351960|2092290|P1|Overall Study|Significant Protocol Deviation|0
653648|NCT02351960|2092289|P2|Overall Study|Voluntary Withdrawal|4
653649|NCT02351960|2092290|P1|Overall Study|Voluntary Withdrawal|5
653650|NCT02351960|2092289|P2|Overall Study|Pretreatment Event/Adverse Event|3
653651|NCT02351960|2092290|P1|Overall Study|Pretreatment Event/Adverse Event|6
653652|NCT02351934|2092311|P2|Follow-Up|ERAS Noncompliant|10
653653|NCT02351934|2092312|P1|Follow-Up|ERAS Noncompliant|0
653654|NCT02351934|2092311|P2|Follow-Up|Acute Kidney Injury|0
653655|NCT02351934|2092312|P1|Follow-Up|Acute Kidney Injury|7
653656|NCT02351934|2092311|P2|Allocation|Hypotension preventing administration|0
653657|NCT02351934|2092312|P1|Allocation|Hypotension preventing administration|3
653658|NCT02351934|2092311|P2|Allocation|No medication due to complications|0
653659|NCT02351934|2092312|P1|Allocation|No medication due to complications|8
653660|NCT02351817|2092328|P2|Period 2|Protocol Violation|0
653661|NCT02351817|2092329|P1|Period 2|Protocol Violation|1
653662|NCT02351817|2092328|P2|Period 2|Adverse Event|2
653663|NCT02351817|2092329|P1|Period 2|Adverse Event|0
653664|NCT02351817|2092328|P2|Period 1|Lack of Efficacy|1
653665|NCT02351817|2092329|P1|Period 1|Lack of Efficacy|0
653666|NCT02351817|2092328|P2|Period 1|Adverse Event|2
653667|NCT02351817|2092329|P1|Period 1|Adverse Event|1
653668|NCT02349711|2092387|P2|Overall Study|Lost to Follow-up|1
653669|NCT02349711|2092388|P1|Overall Study|Lost to Follow-up|1
653670|NCT02349711|2092387|P2|Overall Study|Withdrawal by Subject|1
653671|NCT02349711|2092388|P1|Overall Study|Withdrawal by Subject|2
653672|NCT02349542|2092416|P1|Overall Study|Withdrawal by Subject|5
653673|NCT02349451|2092425|P4|Overall Study|Withdrawal by Subject|1
653674|NCT02349451|2092426|P3|Overall Study|Withdrawal by Subject|2
653675|NCT02349451|2092427|P2|Overall Study|Withdrawal by Subject|1
653676|NCT02349451|2092428|P1|Overall Study|Withdrawal by Subject|0
653677|NCT02349048|2092477|P2|Overall Study|Lost to Follow-up|0
653678|NCT02349048|2092478|P1|Overall Study|Lost to Follow-up|1
653679|NCT02349048|2092477|P2|Overall Study|Withdrawal by Subject|0
653680|NCT02349048|2092478|P1|Overall Study|Withdrawal by Subject|4
653681|NCT02347176|2092547|P4|Overall Study|Unspecified|0
653682|NCT02347176|2092548|P3|Overall Study|Unspecified|2
653683|NCT02347176|2092549|P2|Overall Study|Unspecified|2
653684|NCT02347176|2092550|P1|Overall Study|Unspecified|1
653685|NCT02347176|2092547|P4|Overall Study|Withdrawal by Subject|3
653686|NCT02347176|2092548|P3|Overall Study|Withdrawal by Subject|5
653687|NCT02347176|2092549|P2|Overall Study|Withdrawal by Subject|5
653688|NCT02347176|2092550|P1|Overall Study|Withdrawal by Subject|9
653689|NCT02347176|2092547|P4|Overall Study|Lost to Follow-up|1
653690|NCT02347176|2092548|P3|Overall Study|Lost to Follow-up|1
653691|NCT02347176|2092549|P2|Overall Study|Lost to Follow-up|3
653692|NCT02347176|2092550|P1|Overall Study|Lost to Follow-up|2
653693|NCT02347085|2092596|P1|Overall Study|Protocol Criteria|2
653694|NCT02347085|2092596|P1|Overall Study|Lost to Follow-up|1
653695|NCT02347085|2092596|P1|Overall Study|Withdrawal by Subject|4
653696|NCT02347085|2092596|P1|Overall Study|Lack of Efficacy|1
653697|NCT02347085|2092596|P1|Overall Study|Adverse Event|2
653698|NCT02347072|2092618|P1|Overall Study|Disc due to Protocol-specified Criteria|6
653699|NCT02347072|2092618|P1|Overall Study|Protocol Violation|1
653700|NCT02347072|2092618|P1|Overall Study|Lost to Follow-up|2
653701|NCT02347072|2092618|P1|Overall Study|Physician Decision|1
653702|NCT02347072|2092618|P1|Overall Study|Withdrawal by Subject|6
653703|NCT02347072|2092618|P1|Overall Study|Adverse Event|2
653704|NCT02346877|2092652|P2|Overall Study|Missing|0
653705|NCT02346877|2092653|P1|Overall Study|Missing|5
653706|NCT02346877|2092652|P2|Overall Study|Sponsor Decision|0
653707|NCT02346877|2092653|P1|Overall Study|Sponsor Decision|12
653708|NCT02346877|2092652|P2|Overall Study|Administrative Decision|0
653709|NCT02346877|2092653|P1|Overall Study|Administrative Decision|1
653710|NCT02346877|2092652|P2|Overall Study|Adverse Event|0
653711|NCT02346877|2092653|P1|Overall Study|Adverse Event|1
653712|NCT02346721|2092663|P1|Overall Study|Lack of Efficacy|1
653713|NCT02346721|2092663|P1|Overall Study|Withdrew Consent|3
653714|NCT02344745|2092695|P2|Overall Study|Data collection sheets were lost|0
653715|NCT02344745|2092696|P1|Overall Study|Data collection sheets were lost|2
653716|NCT02344342|2092728|P4|Overall Study|Industry partner dropped out|10
653717|NCT02344342|2092729|P3|Overall Study|Industry partner dropped out|14
653718|NCT02344342|2092730|P2|Overall Study|Industry partner dropped out|9
653719|NCT02344342|2092731|P1|Overall Study|Industry partner dropped out|11
653720|NCT02343159|2092769|P3|Overall Study|Enrollment Error|0
653721|NCT02343159|2092770|P2|Overall Study|Enrollment Error|0
653722|NCT02343159|2092771|P1|Overall Study|Enrollment Error|1
653723|NCT02343159|2092769|P3|Overall Study|Sponsor Decision|0
653724|NCT02343159|2092770|P2|Overall Study|Sponsor Decision|1
653725|NCT02343159|2092771|P1|Overall Study|Sponsor Decision|0
653726|NCT02343159|2092769|P3|Overall Study|Adverse Event|2
653727|NCT02343159|2092770|P2|Overall Study|Adverse Event|4
653728|NCT02343159|2092771|P1|Overall Study|Adverse Event|4
653729|NCT02343159|2092769|P3|Overall Study|Lost to Follow-up|2
653730|NCT02343159|2092770|P2|Overall Study|Lost to Follow-up|2
653731|NCT02343159|2092771|P1|Overall Study|Lost to Follow-up|0
653732|NCT02343159|2092769|P3|Overall Study|Withdrawal by Subject|2
653733|NCT02343159|2092770|P2|Overall Study|Withdrawal by Subject|0
653734|NCT02343159|2092771|P1|Overall Study|Withdrawal by Subject|3
653735|NCT02343159|2092769|P3|Overall Study|Physician Decision|1
653736|NCT02343159|2092770|P2|Overall Study|Physician Decision|0
653737|NCT02343159|2092771|P1|Overall Study|Physician Decision|2
653738|NCT02343159|2092769|P3|Overall Study|Early Study Termination|23
653739|NCT02343159|2092770|P2|Overall Study|Early Study Termination|19
653740|NCT02343159|2092771|P1|Overall Study|Early Study Termination|16
888006|NCT02451917|2821237|P1|First Intervention (24 Weeks)|Death|0
888007|NCT02451917|2821236|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
888008|NCT02451917|2821237|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
888009|NCT02423798|2821255|P1|Overall Study|Withdrawal by Subject|3
888010|NCT02422797|2821263|P2|Overall Study|Withdrawal by Subject|7
888011|NCT02422797|2821264|P1|Overall Study|Withdrawal by Subject|2
888012|NCT02422797|2821263|P2|Overall Study|Other; Reached stopping criteria|1
888013|NCT02422797|2821264|P1|Overall Study|Other; Reached stopping criteria|1
888014|NCT02422797|2821263|P2|Overall Study|Protocol Violation|3
888015|NCT02422797|2821264|P1|Overall Study|Protocol Violation|0
888016|NCT02422797|2821263|P2|Overall Study|Lost to Follow-up|1
653753|NCT02342704|2092834|P2|Overall Study|Adverse Event|3
653754|NCT02342704|2092835|P1|Overall Study|Adverse Event|1
653755|NCT02342704|2092834|P2|Overall Study|Lost to Follow-up|1
653756|NCT02342704|2092835|P1|Overall Study|Lost to Follow-up|2
653757|NCT02342704|2092834|P2|Overall Study|Withdrawal by Subject|0
653758|NCT02342704|2092835|P1|Overall Study|Withdrawal by Subject|1
653759|NCT02342704|2092834|P2|Overall Study|Not Specified|1
653760|NCT02342704|2092835|P1|Overall Study|Not Specified|0
653761|NCT02342704|2092834|P2|Overall Study|Sponsor Termination|43
653762|NCT02342704|2092835|P1|Overall Study|Sponsor Termination|49
653763|NCT02342704|2092834|P2|Overall Study|Physician Decision|3
653764|NCT02342704|2092835|P1|Overall Study|Physician Decision|0
653765|NCT02342418|2092875|P2|Overall Study|Adverse Event|1
653766|NCT02342418|2092876|P1|Overall Study|Adverse Event|0
653767|NCT02342288|2092886|P2|Overall Study|coordinator not available|2
653768|NCT02342288|2092887|P1|Overall Study|coordinator not available|0
653769|NCT02342288|2092886|P2|Overall Study|subject cannot tolerate numbing drops|1
653770|NCT02342288|2092887|P1|Overall Study|subject cannot tolerate numbing drops|0
653771|NCT02342288|2092886|P2|Overall Study|coordinator contaminated with blood|1
653772|NCT02342288|2092887|P1|Overall Study|coordinator contaminated with blood|0
653773|NCT02342288|2092886|P2|Overall Study|Withdrawal by Subject|0
653774|NCT02342288|2092887|P1|Overall Study|Withdrawal by Subject|1
653775|NCT02342288|2092886|P2|Overall Study|anesthesia leak in system|0
653776|NCT02342288|2092887|P1|Overall Study|anesthesia leak in system|1
653777|NCT02342288|2092886|P2|Overall Study|no protocol anesthesiologist available|2
653778|NCT02342288|2092887|P1|Overall Study|no protocol anesthesiologist available|3
653779|NCT02342223|2092893|P1|Overall Study|Lost to Follow-up|1
653780|NCT02341482|2093065|P1|Overall Study|Adverse Event|1
653781|NCT02340000|2093151|P2|Time Period 2|Lost to Follow-up|8
653782|NCT02340000|2093152|P1|Time Period 2|Lost to Follow-up|10
653783|NCT02340000|2093151|P2|Time Period 2|Withdrawal by Subject|7
653784|NCT02340000|2093152|P1|Time Period 2|Withdrawal by Subject|9
653785|NCT02340000|2093151|P2|Time Period 1|Lost to Follow-up|7
653786|NCT02340000|2093152|P1|Time Period 1|Lost to Follow-up|6
653787|NCT02340000|2093151|P2|Time Period 1|Withdrawal by Subject|8
653788|NCT02340000|2093152|P1|Time Period 1|Withdrawal by Subject|6
653789|NCT02339584|2093206|P2|Overall Study|Withdrawal by Subject|4
653790|NCT02339584|2093207|P1|Overall Study|Withdrawal by Subject|2
653791|NCT02339584|2093206|P2|Overall Study|Protocol Violation|1
653792|NCT02339584|2093207|P1|Overall Study|Protocol Violation|1
653793|NCT02339584|2093206|P2|Overall Study|Physician Decision|2
653794|NCT02339584|2093207|P1|Overall Study|Physician Decision|1
653795|NCT02339584|2093206|P2|Overall Study|Lack of Efficacy|1
653796|NCT02339584|2093207|P1|Overall Study|Lack of Efficacy|0
653797|NCT02339584|2093206|P2|Overall Study|Adverse Event|7
653798|NCT02339584|2093207|P1|Overall Study|Adverse Event|11
653799|NCT02336607|2093332|P4|Overall Study|Withdrawal by Subject|20
653800|NCT02336607|2093333|P3|Overall Study|Withdrawal by Subject|0
653801|NCT02336607|2093334|P2|Overall Study|Withdrawal by Subject|2
653802|NCT02336607|2093335|P1|Overall Study|Withdrawal by Subject|0
653803|NCT02336607|2093332|P4|Overall Study|Adverse Event|26
653804|NCT02336607|2093333|P3|Overall Study|Adverse Event|2
653805|NCT02336607|2093334|P2|Overall Study|Adverse Event|2
653806|NCT02336607|2093335|P1|Overall Study|Adverse Event|0
653807|NCT02336607|2093332|P4|Overall Study|Protocol Violation|3
653808|NCT02336607|2093333|P3|Overall Study|Protocol Violation|1
653809|NCT02336607|2093334|P2|Overall Study|Protocol Violation|1
653810|NCT02336607|2093335|P1|Overall Study|Protocol Violation|0
653811|NCT02336607|2093332|P4|Overall Study|Lost to Follow-up|21
653812|NCT02336607|2093333|P3|Overall Study|Lost to Follow-up|0
653813|NCT02336607|2093334|P2|Overall Study|Lost to Follow-up|1
653814|NCT02336607|2093335|P1|Overall Study|Lost to Follow-up|2
653815|NCT02336607|2093332|P4|Overall Study|Lack of Efficacy|2
653816|NCT02336607|2093333|P3|Overall Study|Lack of Efficacy|0
653817|NCT02336607|2093334|P2|Overall Study|Lack of Efficacy|0
653818|NCT02336607|2093335|P1|Overall Study|Lack of Efficacy|1
653819|NCT02336607|2093332|P4|Overall Study|Physician Decision|15
653820|NCT02336607|2093333|P3|Overall Study|Physician Decision|3
653821|NCT02336607|2093334|P2|Overall Study|Physician Decision|4
653822|NCT02336607|2093335|P1|Overall Study|Physician Decision|1
653823|NCT02336425|2093402|P4|Overall Study|Study terminated.|3
653824|NCT02336425|2093403|P3|Overall Study|Study terminated.|3
653825|NCT02336425|2093404|P2|Overall Study|Study terminated.|2
653826|NCT02336425|2093405|P1|Overall Study|Study terminated.|2
653827|NCT02336178|2093455|P1|Overall Study|Unspecified|1
653828|NCT02336178|2093455|P1|Overall Study|Withdrawal by Subject|1
653829|NCT02336178|2093455|P1|Overall Study|Protocol Violation|1
653830|NCT02336178|2093455|P1|Overall Study|Lost to Follow-up|1
653831|NCT02335489|2093569|P1|Overall Study|Lack of Efficacy|1
653832|NCT02335489|2093569|P1|Overall Study|Physician Decision|2
653833|NCT02335489|2093569|P1|Overall Study|Withdrawal by Subject|2
653834|NCT02335489|2093569|P1|Overall Study|Lost to Follow-up|1
653835|NCT02335489|2093569|P1|Overall Study|Sponsor terminated study|4
653836|NCT02332798|2093751|P3|Overall Study|Abnormal laboratory findings|0
653837|NCT02332798|2093752|P2|Overall Study|Abnormal laboratory findings|0
653838|NCT02332798|2093753|P1|Overall Study|Abnormal laboratory findings|1
653839|NCT02332798|2093751|P3|Overall Study|Positive urine drug test|0
653840|NCT02332798|2093752|P2|Overall Study|Positive urine drug test|1
653841|NCT02332798|2093753|P1|Overall Study|Positive urine drug test|0
653842|NCT02332798|2093751|P3|Overall Study|Unwilling to participate in study|1
653843|NCT02332798|2093752|P2|Overall Study|Unwilling to participate in study|1
653844|NCT02332798|2093753|P1|Overall Study|Unwilling to participate in study|0
653855|NCT02331446|2093902|P4|Overall Study|Lost before baseline analysis|0
653856|NCT02331446|2093903|P3|Overall Study|Lost before baseline analysis|1
653857|NCT02331446|2093904|P2|Overall Study|Lost before baseline analysis|1
653858|NCT02331446|2093905|P1|Overall Study|Lost before baseline analysis|0
653859|NCT02331446|2093902|P4|Overall Study|Physician Decision|1
653860|NCT02331446|2093903|P3|Overall Study|Physician Decision|0
653861|NCT02331446|2093904|P2|Overall Study|Physician Decision|1
653862|NCT02331446|2093905|P1|Overall Study|Physician Decision|0
653863|NCT02331446|2093902|P4|Overall Study|Disease|1
653864|NCT02331446|2093903|P3|Overall Study|Disease|2
653865|NCT02331446|2093904|P2|Overall Study|Disease|2
653866|NCT02331446|2093905|P1|Overall Study|Disease|0
653867|NCT02331446|2093902|P4|Overall Study|Personal Problem|0
653868|NCT02331446|2093903|P3|Overall Study|Personal Problem|0
653869|NCT02331446|2093904|P2|Overall Study|Personal Problem|0
653870|NCT02331446|2093905|P1|Overall Study|Personal Problem|2
653871|NCT02331446|2093902|P4|Overall Study|Lost to Follow-up|1
653872|NCT02331446|2093903|P3|Overall Study|Lost to Follow-up|0
653873|NCT02331446|2093904|P2|Overall Study|Lost to Follow-up|1
653874|NCT02331446|2093905|P1|Overall Study|Lost to Follow-up|2
653875|NCT02329730|2094120|P12|Overall Study|Withdrawal by Subject|0
653876|NCT02329730|2094121|P11|Overall Study|Withdrawal by Subject|0
653877|NCT02329730|2094122|P10|Overall Study|Withdrawal by Subject|1
653878|NCT02329730|2094123|P9|Overall Study|Withdrawal by Subject|1
653879|NCT02329730|2094124|P8|Overall Study|Withdrawal by Subject|1
653880|NCT02329730|2094125|P7|Overall Study|Withdrawal by Subject|1
653881|NCT02329730|2094126|P6|Overall Study|Withdrawal by Subject|0
653882|NCT02329730|2094127|P5|Overall Study|Withdrawal by Subject|1
653883|NCT02329730|2094128|P4|Overall Study|Withdrawal by Subject|0
653884|NCT02329730|2094129|P3|Overall Study|Withdrawal by Subject|0
653885|NCT02329730|2094130|P2|Overall Study|Withdrawal by Subject|0
653886|NCT02329730|2094131|P1|Overall Study|Withdrawal by Subject|0
653887|NCT02329730|2094120|P12|Overall Study|Protocol Violation|0
653888|NCT02329730|2094121|P11|Overall Study|Protocol Violation|0
653889|NCT02329730|2094122|P10|Overall Study|Protocol Violation|0
653890|NCT02329730|2094123|P9|Overall Study|Protocol Violation|0
653891|NCT02329730|2094124|P8|Overall Study|Protocol Violation|0
653892|NCT02329730|2094125|P7|Overall Study|Protocol Violation|0
653893|NCT02329730|2094126|P6|Overall Study|Protocol Violation|2
653894|NCT02329730|2094127|P5|Overall Study|Protocol Violation|2
653895|NCT02329730|2094128|P4|Overall Study|Protocol Violation|0
653896|NCT02329730|2094129|P3|Overall Study|Protocol Violation|0
653897|NCT02329730|2094130|P2|Overall Study|Protocol Violation|0
653898|NCT02329730|2094131|P1|Overall Study|Protocol Violation|0
653899|NCT02329431|2094223|P2|Overall Study|Lost to Follow-up|13
653900|NCT02329431|2094224|P1|Overall Study|Lost to Follow-up|20
653901|NCT02329223|2094243|P3|Overall Study|Adverse Event|0
653902|NCT02329223|2094244|P2|Overall Study|Adverse Event|1
653903|NCT02329223|2094245|P1|Overall Study|Adverse Event|0
653904|NCT02329223|2094243|P3|Overall Study|Physician Decision|1
653905|NCT02329223|2094244|P2|Overall Study|Physician Decision|0
653906|NCT02329223|2094245|P1|Overall Study|Physician Decision|0
653907|NCT02329223|2094243|P3|Overall Study|Withdrawal by Subject|5
653908|NCT02329223|2094244|P2|Overall Study|Withdrawal by Subject|2
653909|NCT02329223|2094245|P1|Overall Study|Withdrawal by Subject|1
653910|NCT02328937|2094295|P6|Period 2|Adverse Event|0
653911|NCT02328937|2094296|P5|Period 2|Adverse Event|0
653912|NCT02328937|2094297|P4|Period 2|Adverse Event|0
653913|NCT02328937|2094298|P3|Period 2|Adverse Event|1
653914|NCT02328937|2094299|P2|Period 2|Adverse Event|0
653915|NCT02328937|2094300|P1|Period 2|Adverse Event|0
653916|NCT02328937|2094295|P6|Period 1|Lost to Follow-up|0
653917|NCT02328937|2094296|P5|Period 1|Lost to Follow-up|0
653918|NCT02328937|2094297|P4|Period 1|Lost to Follow-up|1
653919|NCT02328937|2094298|P3|Period 1|Lost to Follow-up|0
653920|NCT02328937|2094299|P2|Period 1|Lost to Follow-up|0
653921|NCT02328937|2094300|P1|Period 1|Lost to Follow-up|0
653922|NCT02325713|2094415|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653923|NCT02325713|2094416|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653924|NCT02325713|2094417|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653925|NCT02325713|2094418|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653926|NCT02325713|2094419|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653927|NCT02325713|2094420|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653928|NCT02325713|2094421|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
653929|NCT02325713|2094422|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653930|NCT02325713|2094423|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653931|NCT02325713|2094424|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653932|NCT02325713|2094425|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653933|NCT02325713|2094426|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653934|NCT02325713|2094427|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653935|NCT02325713|2094428|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653936|NCT02325713|2094429|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653937|NCT02325713|2094430|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
653938|NCT02325713|2094415|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653939|NCT02325713|2094416|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653940|NCT02325713|2094417|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653941|NCT02325713|2094418|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653942|NCT02325713|2094419|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653943|NCT02325713|2094420|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653944|NCT02325713|2094421|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653945|NCT02325713|2094422|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653946|NCT02325713|2094423|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653947|NCT02325713|2094424|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653948|NCT02325713|2094425|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653949|NCT02325713|2094426|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653950|NCT02325713|2094427|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653951|NCT02325713|2094428|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653952|NCT02325713|2094429|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
653953|NCT02325713|2094430|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
653954|NCT02325713|2094415|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653955|NCT02325713|2094416|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653956|NCT02325713|2094417|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653957|NCT02325713|2094418|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653958|NCT02325713|2094419|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
654045|NCT02319148|2095011|P3|Second Intervention Period|Unspecified|0
653959|NCT02325713|2094420|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
653960|NCT02325713|2094421|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653961|NCT02325713|2094422|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653962|NCT02325713|2094423|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653963|NCT02325713|2094424|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653964|NCT02325713|2094425|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653965|NCT02325713|2094426|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653966|NCT02325713|2094427|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653967|NCT02325713|2094428|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653968|NCT02325713|2094429|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653969|NCT02325713|2094430|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
653970|NCT02325518|2094525|P2|Overall Study|Withdrawal by Subject|1
653971|NCT02325518|2094526|P1|Overall Study|Withdrawal by Subject|0
653972|NCT02325518|2094525|P2|Overall Study|Physician Decision|1
653973|NCT02325518|2094526|P1|Overall Study|Physician Decision|0
653974|NCT02325518|2094525|P2|Overall Study|Adverse Event|1
653975|NCT02325518|2094526|P1|Overall Study|Adverse Event|4
653976|NCT02322892|2094648|P2|Overall Study|Protocol Violation|0
653977|NCT02322892|2094649|P1|Overall Study|Protocol Violation|1
653978|NCT02322892|2094648|P2|Overall Study|Met exclusion criteria|1
653979|NCT02322892|2094649|P1|Overall Study|Met exclusion criteria|0
653980|NCT02322892|2094648|P2|Overall Study|Surgery cancelled|2
653981|NCT02322892|2094649|P1|Overall Study|Surgery cancelled|1
653982|NCT02322879|2094665|P2|First Intervention|Physician Decision|0
653983|NCT02322879|2094666|P1|First Intervention|Physician Decision|1
653984|NCT02322775|2094687|P2|Overall Study|Not willing to perform all FU visits|1
653985|NCT02322775|2094688|P1|Overall Study|Not willing to perform all FU visits|0
653986|NCT02322775|2094687|P2|Overall Study|Withdrawal by Subject|4
653987|NCT02322775|2094688|P1|Overall Study|Withdrawal by Subject|3
653988|NCT02322775|2094687|P2|Overall Study|Protocol Violation|0
653989|NCT02322775|2094688|P1|Overall Study|Protocol Violation|1
653990|NCT02322775|2094687|P2|Overall Study|Lost to Follow-up|1
653991|NCT02322775|2094688|P1|Overall Study|Lost to Follow-up|0
653992|NCT02322775|2094687|P2|Overall Study|Adverse Event|0
653993|NCT02322775|2094688|P1|Overall Study|Adverse Event|1
653994|NCT02322749|2094714|P6|Period 3|Withdrawal by Subject|0
653995|NCT02322749|2094715|P5|Period 3|Withdrawal by Subject|0
653996|NCT02322749|2094716|P4|Period 3|Withdrawal by Subject|0
653997|NCT02322749|2094717|P3|Period 3|Withdrawal by Subject|1
653998|NCT02322749|2094718|P2|Period 3|Withdrawal by Subject|0
653999|NCT02322749|2094719|P1|Period 3|Withdrawal by Subject|0
654000|NCT02322749|2094714|P6|Period 2|Withdrawal by Subject|0
654001|NCT02322749|2094715|P5|Period 2|Withdrawal by Subject|0
654002|NCT02322749|2094716|P4|Period 2|Withdrawal by Subject|1
654003|NCT02322749|2094717|P3|Period 2|Withdrawal by Subject|0
654004|NCT02322749|2094718|P2|Period 2|Withdrawal by Subject|0
654005|NCT02322749|2094719|P1|Period 2|Withdrawal by Subject|0
654006|NCT02322749|2094714|P6|Period 2|Adverse Event|0
654007|NCT02322749|2094715|P5|Period 2|Adverse Event|0
654008|NCT02322749|2094716|P4|Period 2|Adverse Event|1
654009|NCT02322749|2094717|P3|Period 2|Adverse Event|0
654010|NCT02322749|2094718|P2|Period 2|Adverse Event|0
654011|NCT02322749|2094719|P1|Period 2|Adverse Event|0
654016|NCT02321436|2094763|P2|Overall Study|Lost to Follow-up|1
654017|NCT02321436|2094764|P1|Overall Study|Lost to Follow-up|0
654018|NCT02321436|2094763|P2|Overall Study|Withdrawal by Subject|0
654019|NCT02321436|2094764|P1|Overall Study|Withdrawal by Subject|1
654020|NCT02320721|2094851|P2|Overall Study|Other than specified above|20
654021|NCT02320721|2094852|P1|Overall Study|Other than specified above|15
654022|NCT02320721|2094851|P2|Overall Study|Hypoglycemia|0
654023|NCT02320721|2094852|P1|Overall Study|Hypoglycemia|1
654024|NCT02320721|2094851|P2|Overall Study|Randomized but not treated|1
654025|NCT02320721|2094852|P1|Overall Study|Randomized but not treated|0
654026|NCT02320721|2094851|P2|Overall Study|Poor compliance to protocol|7
654027|NCT02320721|2094852|P1|Overall Study|Poor compliance to protocol|3
654028|NCT02320721|2094851|P2|Overall Study|Lack of Efficacy|0
654029|NCT02320721|2094852|P1|Overall Study|Lack of Efficacy|2
654030|NCT02320721|2094851|P2|Overall Study|Adverse Event|6
654031|NCT02320721|2094852|P1|Overall Study|Adverse Event|6
654032|NCT02320396|2094909|P2|Overall Study|Withdrawal by Subject|0
654033|NCT02320396|2094910|P1|Overall Study|Withdrawal by Subject|2
654034|NCT02320396|2094909|P2|Overall Study|Protocol Violation|1
654035|NCT02320396|2094910|P1|Overall Study|Protocol Violation|0
654036|NCT02320396|2094909|P2|Overall Study|Pregnancy|1
654037|NCT02320396|2094910|P1|Overall Study|Pregnancy|0
654038|NCT02320396|2094909|P2|Overall Study|Adverse Event|2
654039|NCT02320396|2094910|P1|Overall Study|Adverse Event|2
654040|NCT02319668|2094958|P2|Overall Study|Other (Not specified)|2
654041|NCT02319668|2094959|P1|Overall Study|Other (Not specified)|0
654042|NCT02319525|2094973|P2|Overall Study|Withdrawal by Subject|1
654043|NCT02319525|2094974|P1|Overall Study|Withdrawal by Subject|2
654044|NCT02319148|2095010|P4|Second Intervention Period|Unspecified|1
654046|NCT02319148|2095012|P2|Second Intervention Period|Unspecified|0
654047|NCT02319148|2095013|P1|Second Intervention Period|Unspecified|0
654048|NCT02319148|2095010|P4|Second Intervention Period|No longer willing to participate|0
654049|NCT02319148|2095011|P3|Second Intervention Period|No longer willing to participate|0
654050|NCT02319148|2095012|P2|Second Intervention Period|No longer willing to participate|1
654051|NCT02319148|2095013|P1|Second Intervention Period|No longer willing to participate|0
654052|NCT02319148|2095010|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
654053|NCT02319148|2095011|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
654054|NCT02319148|2095012|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
654055|NCT02319148|2095013|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
654056|NCT02319031|2095075|P2|Treatment Period|Death|0
654057|NCT02319031|2095076|P1|Treatment Period|Death|1
654058|NCT02318940|2095088|P2|Overall Study|lost the record|0
654059|NCT02318940|2095089|P1|Overall Study|lost the record|1
654060|NCT02318693|2095103|P2|Overall Study|Protocol Violation|1
654061|NCT02318693|2095104|P1|Overall Study|Protocol Violation|0
654062|NCT02317809|2095147|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
654063|NCT02317809|2095148|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
654064|NCT02317809|2095147|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
654065|NCT02317809|2095148|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
654066|NCT02317510|2095192|P2|Overall Study|Adverse Event|1
654067|NCT02317510|2095193|P1|Overall Study|Adverse Event|0
888017|NCT02422797|2821264|P1|Overall Study|Lost to Follow-up|1
888018|NCT02422797|2821263|P2|Overall Study|Lack of Efficacy|2
888019|NCT02422797|2821264|P1|Overall Study|Lack of Efficacy|1
888020|NCT02422797|2821263|P2|Overall Study|Physician Decision|1
888021|NCT02422797|2821264|P1|Overall Study|Physician Decision|0
888022|NCT02422797|2821263|P2|Overall Study|Adverse Event|1
888023|NCT02422797|2821264|P1|Overall Study|Adverse Event|11
654075|NCT02316769|2095249|P2|Overall Study|Withdrawal by Subject|0
654076|NCT02316769|2095250|P1|Overall Study|Withdrawal by Subject|1
654077|NCT02316769|2095249|P2|Overall Study|Physician Decision|0
654078|NCT02316769|2095250|P1|Overall Study|Physician Decision|1
654079|NCT02316613|2095267|P1|Overall Study|Did not met selection criteria|14
654080|NCT02316613|2095267|P1|Overall Study|No data and duplicate cases|5
654081|NCT02316613|2095267|P1|Overall Study|Participant moved/changed medical team|11
654082|NCT02316613|2095267|P1|Overall Study|Lymphoma transformation|2
654083|NCT02316613|2095267|P1|Overall Study|Lost to Follow-up|9
654084|NCT02316613|2095267|P1|Overall Study|Death|63
654085|NCT02314637|2095468|P2|Overall Study|Other Reason|0
654086|NCT02314637|2095469|P1|Overall Study|Other Reason|1
654087|NCT02314637|2095468|P2|Overall Study|Withdrawal by Subject|4
654088|NCT02314637|2095469|P1|Overall Study|Withdrawal by Subject|5
654089|NCT02314637|2095468|P2|Overall Study|Physician Decision|2
654090|NCT02314637|2095469|P1|Overall Study|Physician Decision|5
654091|NCT02314637|2095468|P2|Overall Study|Lack of Efficacy|0
654092|NCT02314637|2095469|P1|Overall Study|Lack of Efficacy|1
654093|NCT02314637|2095468|P2|Overall Study|Adverse Event|8
654094|NCT02314637|2095469|P1|Overall Study|Adverse Event|4
654095|NCT02313766|2095560|P3|Overall Study|Adverse Event|0
654096|NCT02313766|2095561|P2|Overall Study|Adverse Event|1
654097|NCT02313766|2095562|P1|Overall Study|Adverse Event|0
654098|NCT02313766|2095560|P3|Overall Study|Lost to Follow-up|0
654099|NCT02313766|2095561|P2|Overall Study|Lost to Follow-up|2
654100|NCT02313766|2095562|P1|Overall Study|Lost to Follow-up|0
654101|NCT02313766|2095560|P3|Overall Study|surgery cancelled|0
654102|NCT02313766|2095561|P2|Overall Study|surgery cancelled|0
654103|NCT02313766|2095562|P1|Overall Study|surgery cancelled|1
654104|NCT02313558|2095578|P2|Overall Study|Lost to Follow-up|4
654105|NCT02313558|2095579|P1|Overall Study|Lost to Follow-up|4
654106|NCT02313558|2095578|P2|Overall Study|Withdrawal by Subject|0
654107|NCT02313558|2095579|P1|Overall Study|Withdrawal by Subject|2
654108|NCT02313233|2095593|P2|Overall Study|Administrative reason|1
654109|NCT02313233|2095594|P1|Overall Study|Administrative reason|1
654110|NCT02313233|2095593|P2|Overall Study|Withdrawal by Subject|2
654111|NCT02313233|2095594|P1|Overall Study|Withdrawal by Subject|1
654112|NCT02313155|2095616|P2|Overall Study|Lost to Follow-up|1
654113|NCT02313155|2095617|P1|Overall Study|Lost to Follow-up|0
654114|NCT02311881|2095759|P3|Overall Study|Serious Adverse Event|0
654115|NCT02311881|2095760|P2|Overall Study|Serious Adverse Event|1
654116|NCT02311881|2095761|P1|Overall Study|Serious Adverse Event|0
654117|NCT02311881|2095759|P3|Overall Study|Participant taking another medication|1
654118|NCT02311881|2095760|P2|Overall Study|Participant taking another medication|0
654119|NCT02311881|2095761|P1|Overall Study|Participant taking another medication|0
654120|NCT02311881|2095759|P3|Overall Study|Medical Monitor Discretion|1
654121|NCT02311881|2095760|P2|Overall Study|Medical Monitor Discretion|0
654122|NCT02311881|2095761|P1|Overall Study|Medical Monitor Discretion|0
654123|NCT02311881|2095759|P3|Overall Study|Physician Decision|1
654124|NCT02311881|2095760|P2|Overall Study|Physician Decision|0
654125|NCT02311881|2095761|P1|Overall Study|Physician Decision|0
654126|NCT02311881|2095759|P3|Overall Study|Non-Compliance|2
654127|NCT02311881|2095760|P2|Overall Study|Non-Compliance|0
654128|NCT02311881|2095761|P1|Overall Study|Non-Compliance|1
888024|NCT02335346|2821350|P1|Overall Study|Withdrawal by Subject|1
888025|NCT02335346|2821350|P1|Overall Study|Adverse Event|11
654129|NCT02311881|2095759|P3|Overall Study|Protocol Deviation|0
654130|NCT02311881|2095760|P2|Overall Study|Protocol Deviation|0
654131|NCT02311881|2095761|P1|Overall Study|Protocol Deviation|1
654132|NCT02311881|2095759|P3|Overall Study|Sponsor Decision|1
654133|NCT02311881|2095760|P2|Overall Study|Sponsor Decision|1
654134|NCT02311881|2095761|P1|Overall Study|Sponsor Decision|1
654135|NCT02311881|2095759|P3|Overall Study|Withdrawal by Subject|4
654136|NCT02311881|2095760|P2|Overall Study|Withdrawal by Subject|1
654137|NCT02311881|2095761|P1|Overall Study|Withdrawal by Subject|3
654138|NCT02311881|2095759|P3|Overall Study|Subject has border line pregnancy test|0
654139|NCT02311881|2095760|P2|Overall Study|Subject has border line pregnancy test|0
654140|NCT02311881|2095761|P1|Overall Study|Subject has border line pregnancy test|1
654141|NCT02311881|2095759|P3|Overall Study|Lack of Efficacy|0
654142|NCT02311881|2095760|P2|Overall Study|Lack of Efficacy|2
654143|NCT02311881|2095761|P1|Overall Study|Lack of Efficacy|1
654144|NCT02311881|2095759|P3|Overall Study|Not Specified|1
654145|NCT02311881|2095760|P2|Overall Study|Not Specified|0
654146|NCT02311881|2095761|P1|Overall Study|Not Specified|0
654147|NCT02311881|2095759|P3|Overall Study|Withdrawal of consent|17
654148|NCT02311881|2095760|P2|Overall Study|Withdrawal of consent|16
654149|NCT02311881|2095761|P1|Overall Study|Withdrawal of consent|14
654150|NCT02311881|2095759|P3|Overall Study|Protocol Violation|3
654151|NCT02311881|2095760|P2|Overall Study|Protocol Violation|2
654152|NCT02311881|2095761|P1|Overall Study|Protocol Violation|1
654153|NCT02311881|2095759|P3|Overall Study|Lost to Follow-up|2
654154|NCT02311881|2095760|P2|Overall Study|Lost to Follow-up|3
654155|NCT02311881|2095761|P1|Overall Study|Lost to Follow-up|3
654156|NCT02311881|2095759|P3|Overall Study|Adverse Event|8
654157|NCT02311881|2095760|P2|Overall Study|Adverse Event|15
654158|NCT02311881|2095761|P1|Overall Study|Adverse Event|7
654159|NCT02311881|2095759|P3|Overall Study|Did not meet the study criteria|0
654160|NCT02311881|2095760|P2|Overall Study|Did not meet the study criteria|2
654161|NCT02311881|2095761|P1|Overall Study|Did not meet the study criteria|2
654162|NCT02310750|2095827|P16|HP Washout 2|Lost to Follow-up|0
654163|NCT02310750|2095828|P15|HP Washout 2|Lost to Follow-up|0
654164|NCT02310750|2095829|P14|HP Washout 2|Lost to Follow-up|0
654165|NCT02310750|2095830|P13|HP Washout 2|Lost to Follow-up|0
654166|NCT02310750|2095831|P12|HP Washout 2|Lost to Follow-up|0
654167|NCT02310750|2095832|P11|HP Washout 2|Lost to Follow-up|0
654168|NCT02310750|2095833|P10|HP Washout 2|Lost to Follow-up|0
654169|NCT02310750|2095834|P9|HP Washout 2|Lost to Follow-up|0
654170|NCT02310750|2095835|P8|HP Washout 2|Lost to Follow-up|0
654171|NCT02310750|2095836|P7|HP Washout 2|Lost to Follow-up|7
654172|NCT02310750|2095837|P6|HP Washout 2|Lost to Follow-up|0
654173|NCT02310750|2095838|P5|HP Washout 2|Lost to Follow-up|1
654174|NCT02310750|2095839|P4|HP Washout 2|Lost to Follow-up|0
654175|NCT02310750|2095840|P3|HP Washout 2|Lost to Follow-up|0
654176|NCT02310750|2095841|P2|HP Washout 2|Lost to Follow-up|0
654177|NCT02310750|2095842|P1|HP Washout 2|Lost to Follow-up|0
654178|NCT02310750|2095827|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654179|NCT02310750|2095828|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654180|NCT02310750|2095829|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654181|NCT02310750|2095830|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654182|NCT02310750|2095831|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654183|NCT02310750|2095832|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654184|NCT02310750|2095833|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654185|NCT02310750|2095834|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
654186|NCT02310750|2095835|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
654187|NCT02310750|2095836|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654188|NCT02310750|2095837|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654189|NCT02310750|2095838|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654190|NCT02310750|2095839|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654191|NCT02310750|2095840|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654192|NCT02310750|2095841|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654193|NCT02310750|2095842|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
654194|NCT02310750|2095827|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654195|NCT02310750|2095828|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654196|NCT02310750|2095829|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654197|NCT02310750|2095830|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654198|NCT02310750|2095831|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654199|NCT02310750|2095832|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654200|NCT02310750|2095833|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
654201|NCT02310750|2095834|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
654202|NCT02310750|2095835|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
654203|NCT02310750|2095836|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654204|NCT02310750|2095837|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654205|NCT02310750|2095838|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654206|NCT02310750|2095839|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654207|NCT02310750|2095840|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654208|NCT02310750|2095841|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654209|NCT02310750|2095842|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
654210|NCT02310750|2095827|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654211|NCT02310750|2095828|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654212|NCT02310750|2095829|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654213|NCT02310750|2095830|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654214|NCT02310750|2095831|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654215|NCT02310750|2095832|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654216|NCT02310750|2095833|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
654217|NCT02310750|2095834|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654218|NCT02310750|2095835|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654219|NCT02310750|2095836|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654220|NCT02310750|2095837|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654221|NCT02310750|2095838|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654222|NCT02310750|2095839|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654223|NCT02310750|2095840|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654224|NCT02310750|2095841|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654225|NCT02310750|2095842|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
654226|NCT02310750|2095827|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654227|NCT02310750|2095828|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654228|NCT02310750|2095829|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654229|NCT02310750|2095830|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654230|NCT02310750|2095831|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654231|NCT02310750|2095832|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654232|NCT02310750|2095833|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
654233|NCT02310750|2095834|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
654234|NCT02310750|2095835|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654235|NCT02310750|2095836|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654236|NCT02310750|2095837|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
654237|NCT02310750|2095838|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654238|NCT02310750|2095839|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
654239|NCT02310750|2095840|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654240|NCT02310750|2095841|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654241|NCT02310750|2095842|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
654242|NCT02310750|2095827|P16|HP Washout 1|Lost to Follow-up|0
654243|NCT02310750|2095828|P15|HP Washout 1|Lost to Follow-up|0
654244|NCT02310750|2095829|P14|HP Washout 1|Lost to Follow-up|0
654245|NCT02310750|2095830|P13|HP Washout 1|Lost to Follow-up|0
654246|NCT02310750|2095831|P12|HP Washout 1|Lost to Follow-up|0
654247|NCT02310750|2095832|P11|HP Washout 1|Lost to Follow-up|0
654248|NCT02310750|2095833|P10|HP Washout 1|Lost to Follow-up|0
654249|NCT02310750|2095834|P9|HP Washout 1|Lost to Follow-up|0
654250|NCT02310750|2095835|P8|HP Washout 1|Lost to Follow-up|0
654251|NCT02310750|2095836|P7|HP Washout 1|Lost to Follow-up|3
654252|NCT02310750|2095837|P6|HP Washout 1|Lost to Follow-up|2
654253|NCT02310750|2095838|P5|HP Washout 1|Lost to Follow-up|2
654254|NCT02310750|2095839|P4|HP Washout 1|Lost to Follow-up|1
654255|NCT02310750|2095840|P3|HP Washout 1|Lost to Follow-up|1
654256|NCT02310750|2095841|P2|HP Washout 1|Lost to Follow-up|0
654257|NCT02310750|2095842|P1|HP Washout 1|Lost to Follow-up|0
654258|NCT02310750|2095827|P16|HP Period 1|Withdrawal by Subject|0
654259|NCT02310750|2095828|P15|HP Period 1|Withdrawal by Subject|0
654260|NCT02310750|2095829|P14|HP Period 1|Withdrawal by Subject|0
654261|NCT02310750|2095830|P13|HP Period 1|Withdrawal by Subject|0
654262|NCT02310750|2095831|P12|HP Period 1|Withdrawal by Subject|0
654263|NCT02310750|2095832|P11|HP Period 1|Withdrawal by Subject|0
654264|NCT02310750|2095833|P10|HP Period 1|Withdrawal by Subject|0
654265|NCT02310750|2095834|P9|HP Period 1|Withdrawal by Subject|0
654266|NCT02310750|2095835|P8|HP Period 1|Withdrawal by Subject|0
654267|NCT02310750|2095836|P7|HP Period 1|Withdrawal by Subject|0
654268|NCT02310750|2095837|P6|HP Period 1|Withdrawal by Subject|0
654269|NCT02310750|2095838|P5|HP Period 1|Withdrawal by Subject|0
654270|NCT02310750|2095839|P4|HP Period 1|Withdrawal by Subject|1
654271|NCT02310750|2095840|P3|HP Period 1|Withdrawal by Subject|0
654272|NCT02310750|2095841|P2|HP Period 1|Withdrawal by Subject|0
654273|NCT02310750|2095842|P1|HP Period 1|Withdrawal by Subject|1
654274|NCT02310750|2095827|P16|HP Period 1|Lost to Follow-up|0
654275|NCT02310750|2095828|P15|HP Period 1|Lost to Follow-up|0
654276|NCT02310750|2095829|P14|HP Period 1|Lost to Follow-up|0
654277|NCT02310750|2095830|P13|HP Period 1|Lost to Follow-up|0
654278|NCT02310750|2095831|P12|HP Period 1|Lost to Follow-up|0
654279|NCT02310750|2095832|P11|HP Period 1|Lost to Follow-up|0
654280|NCT02310750|2095833|P10|HP Period 1|Lost to Follow-up|0
654281|NCT02310750|2095834|P9|HP Period 1|Lost to Follow-up|0
654282|NCT02310750|2095835|P8|HP Period 1|Lost to Follow-up|0
654283|NCT02310750|2095836|P7|HP Period 1|Lost to Follow-up|1
654284|NCT02310750|2095837|P6|HP Period 1|Lost to Follow-up|0
654285|NCT02310750|2095838|P5|HP Period 1|Lost to Follow-up|0
654286|NCT02310750|2095839|P4|HP Period 1|Lost to Follow-up|0
654287|NCT02310750|2095840|P3|HP Period 1|Lost to Follow-up|0
654288|NCT02310750|2095841|P2|HP Period 1|Lost to Follow-up|0
654289|NCT02310750|2095842|P1|HP Period 1|Lost to Follow-up|0
654290|NCT02310646|2096283|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
654291|NCT02310646|2096284|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
654292|NCT02310646|2096283|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
654293|NCT02310646|2096284|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
654294|NCT02310581|2096312|P4|Overall Study|Withdrawal by Subject|1
654295|NCT02310581|2096313|P3|Overall Study|Withdrawal by Subject|0
654296|NCT02310581|2096314|P2|Overall Study|Withdrawal by Subject|1
654297|NCT02310581|2096315|P1|Overall Study|Withdrawal by Subject|2
654298|NCT02310581|2096312|P4|Overall Study|Adverse Event|0
654299|NCT02310581|2096313|P3|Overall Study|Adverse Event|1
654300|NCT02310581|2096314|P2|Overall Study|Adverse Event|1
654301|NCT02310581|2096315|P1|Overall Study|Adverse Event|1
654302|NCT02310568|2096354|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
654303|NCT02310568|2096355|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
654304|NCT02310568|2096356|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
654305|NCT02310568|2096357|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
654306|NCT02310568|2096358|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
654307|NCT02310568|2096354|P5|Stage 2 (4 Weeks)|Protocol Violation|0
654308|NCT02310568|2096355|P4|Stage 2 (4 Weeks)|Protocol Violation|1
654309|NCT02310568|2096356|P3|Stage 2 (4 Weeks)|Protocol Violation|0
654310|NCT02310568|2096357|P2|Stage 2 (4 Weeks)|Protocol Violation|0
654311|NCT02310568|2096358|P1|Stage 2 (4 Weeks)|Protocol Violation|0
654312|NCT02310568|2096354|P5|Stage 2 (4 Weeks)|Adverse Event|1
654313|NCT02310568|2096355|P4|Stage 2 (4 Weeks)|Adverse Event|1
654314|NCT02310568|2096356|P3|Stage 2 (4 Weeks)|Adverse Event|0
654315|NCT02310568|2096357|P2|Stage 2 (4 Weeks)|Adverse Event|0
654316|NCT02310568|2096358|P1|Stage 2 (4 Weeks)|Adverse Event|0
654317|NCT02310568|2096354|P5|Stage 2 (4 Weeks)|Unspecified|0
654318|NCT02310568|2096355|P4|Stage 2 (4 Weeks)|Unspecified|0
654319|NCT02310568|2096356|P3|Stage 2 (4 Weeks)|Unspecified|1
654320|NCT02310568|2096357|P2|Stage 2 (4 Weeks)|Unspecified|1
654321|NCT02310568|2096358|P1|Stage 2 (4 Weeks)|Unspecified|0
654322|NCT02310568|2096354|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
654323|NCT02310568|2096355|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
654324|NCT02310568|2096356|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
654325|NCT02310568|2096357|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
654326|NCT02310568|2096358|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
654327|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
654328|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
654329|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
654330|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
654331|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
654332|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
654333|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
654334|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
654335|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
654336|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
654337|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
654338|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
654339|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
654340|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
654341|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
654342|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|Unspecified|0
654343|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|Unspecified|0
654344|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|Unspecified|0
654345|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|Unspecified|1
654346|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|Unspecified|1
654347|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
654348|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
654349|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
654350|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
654351|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
654352|NCT02310568|2096354|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
654353|NCT02310568|2096355|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
654354|NCT02310568|2096356|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
654355|NCT02310568|2096357|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
654356|NCT02310568|2096358|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
654357|NCT02310126|2096438|P2|Period 1 (15 Minutes)|Protocol Violation|1
654358|NCT02310126|2096439|P1|Period 1 (15 Minutes)|Protocol Violation|0
654359|NCT02310126|2096438|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
654360|NCT02310126|2096439|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
654361|NCT02309723|2096448|P3|Overall Study|Withdrawal by Subject|24
654362|NCT02309723|2096449|P2|Overall Study|Withdrawal by Subject|23
654363|NCT02309723|2096450|P1|Overall Study|Withdrawal by Subject|24
654364|NCT02309294|2096464|P1|Overall Study|Withdrawal by Subject|2
654365|NCT02309112|2096471|P3|Overall Study|Lost to Follow-up|0
654366|NCT02309112|2096472|P2|Overall Study|Lost to Follow-up|1
654367|NCT02309112|2096473|P1|Overall Study|Lost to Follow-up|0
654368|NCT02309112|2096471|P3|Overall Study|Withdrawal by Subject|1
654369|NCT02309112|2096472|P2|Overall Study|Withdrawal by Subject|0
654370|NCT02309112|2096473|P1|Overall Study|Withdrawal by Subject|1
654371|NCT02308748|2096509|P10|Period 5|Adverse Event|0
654372|NCT02308748|2096510|P9|Period 5|Adverse Event|1
654373|NCT02308748|2096511|P8|Period 5|Adverse Event|0
654374|NCT02308748|2096512|P7|Period 5|Adverse Event|0
654375|NCT02308748|2096513|P6|Period 5|Adverse Event|0
654376|NCT02308748|2096514|P5|Period 5|Adverse Event|0
654377|NCT02308748|2096515|P4|Period 5|Adverse Event|0
654378|NCT02308748|2096516|P3|Period 5|Adverse Event|0
654379|NCT02308748|2096517|P2|Period 5|Adverse Event|0
654380|NCT02308748|2096518|P1|Period 5|Adverse Event|1
654381|NCT02308748|2096509|P10|Period 3|Protocol Violation|1
654382|NCT02308748|2096510|P9|Period 3|Protocol Violation|0
654383|NCT02308748|2096511|P8|Period 3|Protocol Violation|0
654384|NCT02308748|2096512|P7|Period 3|Protocol Violation|0
654385|NCT02308748|2096513|P6|Period 3|Protocol Violation|0
654386|NCT02308748|2096514|P5|Period 3|Protocol Violation|0
654387|NCT02308748|2096515|P4|Period 3|Protocol Violation|0
654388|NCT02308748|2096516|P3|Period 3|Protocol Violation|0
654389|NCT02308748|2096517|P2|Period 3|Protocol Violation|0
654390|NCT02308748|2096518|P1|Period 3|Protocol Violation|0
654391|NCT02308748|2096509|P10|Period 2|Adverse Event|0
654392|NCT02308748|2096510|P9|Period 2|Adverse Event|0
654393|NCT02308748|2096511|P8|Period 2|Adverse Event|1
654394|NCT02308748|2096512|P7|Period 2|Adverse Event|0
654395|NCT02308748|2096513|P6|Period 2|Adverse Event|0
654396|NCT02308748|2096514|P5|Period 2|Adverse Event|0
654397|NCT02308748|2096515|P4|Period 2|Adverse Event|0
654398|NCT02308748|2096516|P3|Period 2|Adverse Event|0
654399|NCT02308748|2096517|P2|Period 2|Adverse Event|0
654400|NCT02308748|2096518|P1|Period 2|Adverse Event|0
654401|NCT02308748|2096509|P10|Period 1|Withdrawal by Subject|0
654402|NCT02308748|2096510|P9|Period 1|Withdrawal by Subject|0
654403|NCT02308748|2096511|P8|Period 1|Withdrawal by Subject|0
654404|NCT02308748|2096512|P7|Period 1|Withdrawal by Subject|0
654405|NCT02308748|2096513|P6|Period 1|Withdrawal by Subject|0
654406|NCT02308748|2096514|P5|Period 1|Withdrawal by Subject|0
654407|NCT02308748|2096515|P4|Period 1|Withdrawal by Subject|0
654408|NCT02308748|2096516|P3|Period 1|Withdrawal by Subject|1
654409|NCT02308748|2096517|P2|Period 1|Withdrawal by Subject|0
654410|NCT02308748|2096518|P1|Period 1|Withdrawal by Subject|0
654411|NCT02308124|2096550|P3|Overall Study|Adverse Event|2
654412|NCT02308124|2096551|P2|Overall Study|Adverse Event|2
654413|NCT02308124|2096552|P1|Overall Study|Adverse Event|0
654414|NCT02308124|2096550|P3|Overall Study|Lost to Follow-up|6
654415|NCT02308124|2096551|P2|Overall Study|Lost to Follow-up|6
654416|NCT02308124|2096552|P1|Overall Study|Lost to Follow-up|6
654417|NCT02307266|2096644|P3|Overall Study|Lost to Follow-up|0
654418|NCT02307266|2096645|P2|Overall Study|Lost to Follow-up|0
654419|NCT02307266|2096646|P1|Overall Study|Lost to Follow-up|3
654420|NCT02307266|2096644|P3|Overall Study|Withdrawal by Subject|1
654421|NCT02307266|2096645|P2|Overall Study|Withdrawal by Subject|0
654422|NCT02307266|2096646|P1|Overall Study|Withdrawal by Subject|2
654423|NCT02307266|2096644|P3|Overall Study|Adverse Event|5
654424|NCT02307266|2096645|P2|Overall Study|Adverse Event|1
654425|NCT02307266|2096646|P1|Overall Study|Adverse Event|3
654426|NCT02305446|2096688|P1|Overall Study|Adverse Event|1
654427|NCT02304926|2096791|P2|Overall Study|Lost to Follow-up|1
654428|NCT02304926|2096792|P1|Overall Study|Lost to Follow-up|2
654429|NCT02303704|2096884|P2|Overall Study|Protocol Violation|9
654430|NCT02303704|2096885|P1|Overall Study|Protocol Violation|5
888026|NCT02296931|2821377|P2|Overall Study|Protocol Violation|2
888027|NCT02296931|2821378|P1|Overall Study|Protocol Violation|0
888028|NCT02295644|2821388|P4|Overall Study|Did not meet inclusion criterion|2
888029|NCT02295644|2821389|P3|Overall Study|Did not meet inclusion criterion|1
888030|NCT02295644|2821390|P2|Overall Study|Did not meet inclusion criterion|0
888031|NCT02295644|2821391|P1|Overall Study|Did not meet inclusion criterion|0
888032|NCT02288091|2821409|P1|Overall Study|Screen fail|7
888033|NCT02288091|2821409|P1|Overall Study|Lost to Follow-up|1
888034|NCT02252939|2821448|P1|Overall Study|Lost to Follow-up|3
888035|NCT02229214|2821465|P2|Overall Study|Withdrawal by Subject|0
888036|NCT02229214|2821466|P1|Overall Study|Withdrawal by Subject|4
888037|NCT02229214|2821465|P2|Overall Study|Adverse Event|0
888038|NCT02229214|2821466|P1|Overall Study|Adverse Event|2
888039|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
888040|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
888041|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
888042|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
654449|NCT02301936|2096950|P2|Overall Study|Lost to Follow-up|0
654450|NCT02301936|2096951|P1|Overall Study|Lost to Follow-up|1
654451|NCT02301429|2096973|P1|Overall Study|not acceptable vascular anatomy|3
654454|NCT02300311|2097009|P2|Overall Study|Refused to continue taking medication|0
654455|NCT02300311|2097010|P1|Overall Study|Refused to continue taking medication|18
654456|NCT02300311|2097009|P2|Overall Study|Other than the reason specified|0
654457|NCT02300311|2097010|P1|Overall Study|Other than the reason specified|1
654458|NCT02300129|2097022|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
654459|NCT02300129|2097023|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
654460|NCT02300129|2097024|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
654461|NCT02300129|2097025|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
654462|NCT02300129|2097022|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
654463|NCT02300129|2097023|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
654464|NCT02300129|2097024|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
654465|NCT02300129|2097025|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
654466|NCT02300129|2097022|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
654467|NCT02300129|2097023|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
654468|NCT02300129|2097024|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
654469|NCT02300129|2097025|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
654470|NCT02300103|2097035|P1|Overall Study|Withdrew Consent|2
654471|NCT02300103|2097035|P1|Overall Study|Protocol Violation|1
654472|NCT02300103|2097035|P1|Overall Study|Lack of Efficacy|3
654473|NCT02299635|2097132|P1|Overall Study|Unspecified|3
654474|NCT02299635|2097132|P1|Overall Study|Withdrawal by Subject|2
654475|NCT02299635|2097132|P1|Overall Study|Objective progression or relapse|10
654476|NCT02299635|2097132|P1|Overall Study|Global deterioration of health status|1
654477|NCT02299635|2097132|P1|Overall Study|Death|1
654478|NCT02299635|2097132|P1|Overall Study|Adverse Event|2
654479|NCT02299427|2097153|P2|Overall Study|not adherent to dog website use|0
654480|NCT02299427|2097154|P1|Overall Study|not adherent to dog website use|21
654481|NCT02299427|2097153|P2|Overall Study|Lost to Follow-up|3
654482|NCT02299427|2097154|P1|Overall Study|Lost to Follow-up|1
654483|NCT02299427|2097153|P2|Overall Study|Withdrawal by Subject|0
654484|NCT02299427|2097154|P1|Overall Study|Withdrawal by Subject|1
654485|NCT02299076|2097186|P2|Overall Study|Fraudulent Entries|14
654486|NCT02299076|2097187|P1|Overall Study|Fraudulent Entries|20
654487|NCT02298868|2097195|P1|Overall Study|Patient underwent transplant|1
654488|NCT02298868|2097195|P1|Overall Study|Death|1
654489|NCT02298868|2097195|P1|Overall Study|Adverse Event|1
654490|NCT02298192|2097255|P2|Overall Study|Adverse Event|2
654491|NCT02298192|2097256|P1|Overall Study|Adverse Event|6
654492|NCT02298192|2097255|P2|Overall Study|Lost to Follow-up|1
654493|NCT02298192|2097256|P1|Overall Study|Lost to Follow-up|2
654494|NCT02298192|2097255|P2|Overall Study|Withdrawal by Subject|1
654495|NCT02298192|2097256|P1|Overall Study|Withdrawal by Subject|6
654496|NCT02298192|2097255|P2|Overall Study|Withdrawal criteria|0
654497|NCT02298192|2097256|P1|Overall Study|Withdrawal criteria|2
654498|NCT02298192|2097255|P2|Overall Study|Unclassified|2
654499|NCT02298192|2097256|P1|Overall Study|Unclassified|3
654500|NCT02297841|2097268|P1|Overall Study|Protocol Violation|7
654501|NCT02297841|2097268|P1|Overall Study|Withdrawal by Subject|1
888043|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
888044|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
654504|NCT02295774|2097286|P1|Overall Study|Withdrawal by Subject|2
654505|NCT02295774|2097286|P1|Overall Study|Lost to Follow-up|1
654506|NCT02295020|2097317|P2|Overall Study|Withdrawal by Subject|2
654507|NCT02295020|2097318|P1|Overall Study|Withdrawal by Subject|3
654508|NCT02295020|2097317|P2|Overall Study|Adverse Event|1
654509|NCT02295020|2097318|P1|Overall Study|Adverse Event|0
654510|NCT02294773|2097350|P2|Overall Study|Withdrawal by Subject|2
654511|NCT02294773|2097351|P1|Overall Study|Withdrawal by Subject|0
654512|NCT02294734|2097367|P2|Overall Study|Withdrawal by Subject|2
654513|NCT02294734|2097368|P1|Overall Study|Withdrawal by Subject|4
654514|NCT02294734|2097367|P2|Overall Study|Physician Decision|1
654515|NCT02294734|2097368|P1|Overall Study|Physician Decision|2
654516|NCT02294734|2097367|P2|Overall Study|Lost to Follow-up|0
654517|NCT02294734|2097368|P1|Overall Study|Lost to Follow-up|2
654518|NCT02294734|2097367|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
654519|NCT02294734|2097368|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
654520|NCT02294734|2097367|P2|Overall Study|Adverse Event|5
654521|NCT02294734|2097368|P1|Overall Study|Adverse Event|5
654522|NCT02294682|2097420|P2|Overall Study|Could not swallow pills|0
654523|NCT02294682|2097421|P1|Overall Study|Could not swallow pills|1
654524|NCT02294604|2097464|P3|Overall Study|Culture contamination|0
654525|NCT02294604|2097465|P2|Overall Study|Culture contamination|2
654526|NCT02294604|2097466|P1|Overall Study|Culture contamination|1
654527|NCT02294604|2097464|P3|Overall Study|Did not provide samples for culture|0
654528|NCT02294604|2097465|P2|Overall Study|Did not provide samples for culture|1
654529|NCT02294604|2097466|P1|Overall Study|Did not provide samples for culture|0
888045|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
888046|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
888047|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
888048|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888049|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888050|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
888051|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888052|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888053|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
654542|NCT02294019|2097538|P1|Overall Study|Withdrawal by Subject|1
654543|NCT02294019|2097538|P1|Overall Study|Unspecified|1
654544|NCT02294019|2097538|P1|Overall Study|Lost to Follow-up|31
654545|NCT02294019|2097538|P1|Overall Study|Protocol Violation|68
654546|NCT02294019|2097538|P1|Overall Study|Adverse Event|2
654547|NCT02293538|2097545|P2|Overall Study|Withdrawal by Subject|1
654548|NCT02293538|2097546|P1|Overall Study|Withdrawal by Subject|0
654549|NCT02293538|2097545|P2|Overall Study|Lost to Follow-up|0
654550|NCT02293538|2097546|P1|Overall Study|Lost to Follow-up|1
654551|NCT02293538|2097545|P2|Overall Study|Adverse Event|1
654552|NCT02293538|2097546|P1|Overall Study|Adverse Event|0
654553|NCT02292849|2097562|P3|Overall Study|Physician Decision|0
654554|NCT02292849|2097563|P2|Overall Study|Physician Decision|0
654555|NCT02292849|2097564|P1|Overall Study|Physician Decision|4
654556|NCT02292849|2097562|P3|Overall Study|Lost to Follow-up|2
654557|NCT02292849|2097563|P2|Overall Study|Lost to Follow-up|2
654558|NCT02292849|2097564|P1|Overall Study|Lost to Follow-up|0
654559|NCT02292212|2097648|P1|ViE Phase|Protocol Violation|2
654560|NCT02292212|2097648|P1|ViE Phase|Withdrawal by Subject|1
654561|NCT02291679|2097705|P3|Overall Study|Not Specified|2
654562|NCT02291679|2097706|P2|Overall Study|Not Specified|4
654563|NCT02291679|2097707|P1|Overall Study|Not Specified|2
654564|NCT02291679|2097705|P3|Overall Study|Insufficient Therapeutic Response|7
654565|NCT02291679|2097706|P2|Overall Study|Insufficient Therapeutic Response|5
654566|NCT02291679|2097707|P1|Overall Study|Insufficient Therapeutic Response|5
654567|NCT02291679|2097705|P3|Overall Study|Lost to Follow-up|9
654568|NCT02291679|2097706|P2|Overall Study|Lost to Follow-up|10
654569|NCT02291679|2097707|P1|Overall Study|Lost to Follow-up|12
654570|NCT02291679|2097705|P3|Overall Study|Withdrew Consent|15
654571|NCT02291679|2097706|P2|Overall Study|Withdrew Consent|10
654572|NCT02291679|2097707|P1|Overall Study|Withdrew Consent|18
654573|NCT02291679|2097705|P3|Overall Study|Protocol Violation|7
654574|NCT02291679|2097706|P2|Overall Study|Protocol Violation|1
654575|NCT02291679|2097707|P1|Overall Study|Protocol Violation|5
654576|NCT02291679|2097705|P3|Overall Study|Adverse Event|19
654577|NCT02291679|2097706|P2|Overall Study|Adverse Event|12
654578|NCT02291679|2097707|P1|Overall Study|Adverse Event|2
654579|NCT02291510|2097740|P4|Overall Study|Adverse Event|1
654580|NCT02291510|2097741|P3|Overall Study|Adverse Event|0
654581|NCT02291510|2097742|P2|Overall Study|Adverse Event|0
654582|NCT02291510|2097743|P1|Overall Study|Adverse Event|0
654583|NCT02291419|2097759|P2|Overall Study|Early study termination|5
654584|NCT02291419|2097760|P1|Overall Study|Early study termination|1
654585|NCT02290821|2097778|P2|Overall Study|Lost to Follow-up|2
654586|NCT02290821|2097779|P1|Overall Study|Lost to Follow-up|3
654587|NCT02290821|2097778|P2|Overall Study|Unable or unwilling to cooperate with|0
654588|NCT02290821|2097779|P1|Overall Study|Unable or unwilling to cooperate with|2
654589|NCT02290821|2097778|P2|Overall Study|Withdrawal by Subject|1
654590|NCT02290821|2097779|P1|Overall Study|Withdrawal by Subject|1
654591|NCT02289963|2097821|P2|Overall Study|Other than specified above|2
654592|NCT02289963|2097822|P1|Overall Study|Other than specified above|0
654593|NCT02289963|2097821|P2|Overall Study|End treatment visit outside visit window|4
654594|NCT02289963|2097822|P1|Overall Study|End treatment visit outside visit window|0
654595|NCT02289963|2097821|P2|Overall Study|Last injection missed|2
654596|NCT02289963|2097822|P1|Overall Study|Last injection missed|2
654597|NCT02289963|2097821|P2|Overall Study|Withdrawal by Subject|0
654598|NCT02289963|2097822|P1|Overall Study|Withdrawal by Subject|1
654599|NCT02289963|2097821|P2|Overall Study|Poor compliance to protocol|0
654600|NCT02289963|2097822|P1|Overall Study|Poor compliance to protocol|1
654601|NCT02289963|2097821|P2|Overall Study|Adverse Event|2
654602|NCT02289963|2097822|P1|Overall Study|Adverse Event|1
654603|NCT02289742|2097877|P4|Third Wear Period|Reason not given|1
654604|NCT02289742|2097878|P3|Third Wear Period|Reason not given|0
654605|NCT02289742|2097879|P2|Third Wear Period|Reason not given|0
654606|NCT02289742|2097880|P1|Third Wear Period|Reason not given|0
654607|NCT02289742|2097877|P4|Third Wear Period|Adverse Event|0
654608|NCT02289742|2097878|P3|Third Wear Period|Adverse Event|0
654609|NCT02289742|2097879|P2|Third Wear Period|Adverse Event|1
654610|NCT02289742|2097880|P1|Third Wear Period|Adverse Event|0
654611|NCT02289742|2097877|P4|First Wear Period|Other prior to treatment|1
654612|NCT02289742|2097878|P3|First Wear Period|Other prior to treatment|0
654613|NCT02289742|2097879|P2|First Wear Period|Other prior to treatment|0
654614|NCT02289742|2097880|P1|First Wear Period|Other prior to treatment|0
654615|NCT02289742|2097877|P4|First Wear Period|Adverse Event|0
654616|NCT02289742|2097878|P3|First Wear Period|Adverse Event|1
654617|NCT02289742|2097879|P2|First Wear Period|Adverse Event|0
654618|NCT02289742|2097880|P1|First Wear Period|Adverse Event|0
654619|NCT02289742|2097877|P4|First Wear Period|Adverse event prior to treatment|0
654620|NCT02289742|2097878|P3|First Wear Period|Adverse event prior to treatment|0
654621|NCT02289742|2097879|P2|First Wear Period|Adverse event prior to treatment|1
654622|NCT02289742|2097880|P1|First Wear Period|Adverse event prior to treatment|0
654623|NCT02289469|2097899|P2|Overall Study|Unable to match a control|0
654624|NCT02289469|2097900|P1|Overall Study|Unable to match a control|6
654625|NCT02289079|2097923|P2|Overall Study|Lost to Follow-up|1
654626|NCT02289079|2097924|P1|Overall Study|Lost to Follow-up|0
654627|NCT02289079|2097923|P2|Overall Study|Physician Decision|0
654628|NCT02289079|2097924|P1|Overall Study|Physician Decision|2
654629|NCT02288312|2097966|P3|Overall Study|Pregnancy|0
654630|NCT02288312|2097967|P2|Overall Study|Pregnancy|0
654631|NCT02288312|2097968|P1|Overall Study|Pregnancy|1
888054|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888055|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
654634|NCT02287623|2098169|P2|Overall Study|Protocol Violation|1
654635|NCT02287623|2098170|P1|Overall Study|Protocol Violation|0
654636|NCT02287610|2098186|P1|Overall Study|Excluded-investigator non-responsiveness|5
654637|NCT02287610|2098186|P1|Overall Study|Withdrawal by Subject|8
654638|NCT02287610|2098186|P1|Overall Study|Lost to Follow-up|3
654639|NCT02287402|2098225|P1|Follow-up|Voluntary Withdrawal|2
654640|NCT02287402|2098225|P1|Follow-up|Lost to Follow-up|1
654641|NCT02287402|2098225|P1|Treatment Period|Voluntary Withdrawal|10
654642|NCT02287402|2098225|P1|Treatment Period|Adverse Event|17
654646|NCT02286102|2098502|P2|Overall Study|Screen Failure|1
654647|NCT02286102|2098503|P1|Overall Study|Screen Failure|1
888056|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
888057|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888058|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888059|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
888060|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888061|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888062|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888063|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
654658|NCT02285270|2098540|P1|Overall Study|Determined to be ineligible|1
654659|NCT02285270|2098540|P1|Overall Study|Physician Decision|3
654660|NCT02285270|2098540|P1|Overall Study|Lost to Follow-up|1
654661|NCT02284347|2098633|P1|Overall Study|Withdrawn prior to treatment|1
654662|NCT02284347|2098633|P1|Overall Study|Lost to Follow-up|2
654663|NCT02284243|2098641|P2|Overall Study|Adverse Event|0
654664|NCT02284243|2098642|P1|Overall Study|Adverse Event|1
654665|NCT02284243|2098641|P2|Overall Study|Lack of Efficacy|3
654666|NCT02284243|2098642|P1|Overall Study|Lack of Efficacy|3
654667|NCT02283788|2098738|P4|Overall Study|Withdrawal by Subject|1
654668|NCT02283788|2098739|P3|Overall Study|Withdrawal by Subject|0
654669|NCT02283788|2098740|P2|Overall Study|Withdrawal by Subject|1
654670|NCT02283788|2098741|P1|Overall Study|Withdrawal by Subject|0
654671|NCT02283788|2098738|P4|Overall Study|Adverse Event|1
654672|NCT02283788|2098739|P3|Overall Study|Adverse Event|5
654673|NCT02283788|2098740|P2|Overall Study|Adverse Event|3
654674|NCT02283788|2098741|P1|Overall Study|Adverse Event|1
654676|NCT02282982|2098812|P1|Overall Study|Other, not specified|18
654677|NCT02282982|2098812|P1|Overall Study|Palivizumab is ended|11
654678|NCT02282982|2098812|P1|Overall Study|Lack of product|156
654679|NCT02282982|2098812|P1|Overall Study|Death|4
654680|NCT02282982|2098812|P1|Overall Study|Withdrew consent|2
654681|NCT02282982|2098812|P1|Overall Study|Lost to Follow-up|15
654682|NCT02282813|2098830|P3|Overall Study|Administrative reasons|0
654683|NCT02282813|2098831|P2|Overall Study|Administrative reasons|1
654684|NCT02282813|2098832|P1|Overall Study|Administrative reasons|0
654685|NCT02282813|2098830|P3|Overall Study|Lack of Efficacy|0
654686|NCT02282813|2098831|P2|Overall Study|Lack of Efficacy|0
654687|NCT02282813|2098832|P1|Overall Study|Lack of Efficacy|1
654688|NCT02282813|2098830|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
654689|NCT02282813|2098831|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
654690|NCT02282813|2098832|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
654691|NCT02282813|2098830|P3|Overall Study|Lost to Follow-up|1
654692|NCT02282813|2098831|P2|Overall Study|Lost to Follow-up|0
654693|NCT02282813|2098832|P1|Overall Study|Lost to Follow-up|2
654694|NCT02282813|2098830|P3|Overall Study|Physician Decision|1
654695|NCT02282813|2098831|P2|Overall Study|Physician Decision|3
654696|NCT02282813|2098832|P1|Overall Study|Physician Decision|0
654697|NCT02282813|2098830|P3|Overall Study|Subject non-compliance|0
654698|NCT02282813|2098831|P2|Overall Study|Subject non-compliance|4
654699|NCT02282813|2098832|P1|Overall Study|Subject non-compliance|1
654700|NCT02282813|2098830|P3|Overall Study|Adverse Event|1
654701|NCT02282813|2098831|P2|Overall Study|Adverse Event|10
654702|NCT02282813|2098832|P1|Overall Study|Adverse Event|3
654703|NCT02282813|2098830|P3|Overall Study|Withdrawal by Subject|0
654704|NCT02282813|2098831|P2|Overall Study|Withdrawal by Subject|5
654705|NCT02282813|2098832|P1|Overall Study|Withdrawal by Subject|4
654706|NCT02282631|2098851|P2|Overall Study|Lost to Follow-up|0
654707|NCT02282631|2098852|P1|Overall Study|Lost to Follow-up|2
654708|NCT02282605|2098893|P3|Overall Study|negative SA result on Day -1|0
654709|NCT02282605|2098894|P2|Overall Study|negative SA result on Day -1|0
654710|NCT02282605|2098895|P1|Overall Study|negative SA result on Day -1|3
654711|NCT02282527|2098917|P2|Overall Study|Lack of home health aid|0
654712|NCT02282527|2098918|P1|Overall Study|Lack of home health aid|1
654713|NCT02282527|2098917|P2|Overall Study|Lost to Follow-up|1
654714|NCT02282527|2098918|P1|Overall Study|Lost to Follow-up|0
654725|NCT02280499|2099116|P1|Overall Study|Adverse Event|5
654726|NCT02280499|2099116|P1|Overall Study|Lost to Follow-up|42
654727|NCT02280499|2099116|P1|Overall Study|Death|14
654728|NCT02280473|2099124|P2|Overall Study|Lost to Follow-up|1
654729|NCT02280473|2099125|P1|Overall Study|Lost to Follow-up|0
654730|NCT02280473|2099124|P2|Overall Study|Lack of Efficacy|1
654731|NCT02280473|2099125|P1|Overall Study|Lack of Efficacy|0
654732|NCT02280473|2099124|P2|Overall Study|Adverse Event|1
654733|NCT02280473|2099125|P1|Overall Study|Adverse Event|1
654734|NCT02280187|2099139|P1|Overall Study|Lost to Follow-up|218
654735|NCT02279420|2099188|P1|Overall Study|Lost to Follow-up|23
654736|NCT02279407|2099196|P4|Overall Study|Adverse Event|0
654737|NCT02279407|2099197|P3|Overall Study|Adverse Event|2
654738|NCT02279407|2099198|P2|Overall Study|Adverse Event|1
654739|NCT02279407|2099199|P1|Overall Study|Adverse Event|1
654740|NCT02279407|2099196|P4|Overall Study|Withdrawal by Subject|1
654741|NCT02279407|2099197|P3|Overall Study|Withdrawal by Subject|1
654742|NCT02279407|2099198|P2|Overall Study|Withdrawal by Subject|0
654743|NCT02279407|2099199|P1|Overall Study|Withdrawal by Subject|1
654744|NCT02279407|2099196|P4|Overall Study|Couldn't swallow IP; noncompliance|0
654745|NCT02279407|2099197|P3|Overall Study|Couldn't swallow IP; noncompliance|2
654746|NCT02279407|2099198|P2|Overall Study|Couldn't swallow IP; noncompliance|0
654747|NCT02279407|2099199|P1|Overall Study|Couldn't swallow IP; noncompliance|0
654748|NCT02278614|2099230|P2|Overall Study|left eye was not eligible|0
654749|NCT02278614|2099231|P1|Overall Study|left eye was not eligible|1
654750|NCT02278614|2099230|P2|Overall Study|Adverse Event|0
654751|NCT02278614|2099231|P1|Overall Study|Adverse Event|1
654752|NCT02278614|2099230|P2|Overall Study|Withdrawal by Subject|5
654753|NCT02278614|2099231|P1|Overall Study|Withdrawal by Subject|3
654754|NCT02277691|2099257|P1|Overall Study|Used Other Antihypertensive Drug|1
654755|NCT02277691|2099257|P1|Overall Study|Lack of Efficacy|5
654756|NCT02277691|2099257|P1|Overall Study|Voluntary Withdrawal|7
654757|NCT02277691|2099257|P1|Overall Study|Pretreatment Event/Adverse Event|33
654758|NCT02277119|2099294|P3|Overall Study|Protocol Violation|7
654759|NCT02277119|2099295|P2|Overall Study|Protocol Violation|3
654760|NCT02277119|2099296|P1|Overall Study|Protocol Violation|2
654761|NCT02277119|2099294|P3|Overall Study|Lack of Efficacy|1
654762|NCT02277119|2099295|P2|Overall Study|Lack of Efficacy|1
654763|NCT02277119|2099296|P1|Overall Study|Lack of Efficacy|1
654764|NCT02276560|2099324|P3|Overall Study|Adverse Event|0
654765|NCT02276560|2099325|P2|Overall Study|Adverse Event|0
654766|NCT02276560|2099326|P1|Overall Study|Adverse Event|1
654767|NCT02275611|2099465|P4|Inpatient Withdrawal|Withdrawal by Subject|0
654768|NCT02275611|2099466|P3|Inpatient Withdrawal|Withdrawal by Subject|0
654769|NCT02275611|2099467|P2|Inpatient Withdrawal|Withdrawal by Subject|0
654770|NCT02275611|2099468|P1|Inpatient Withdrawal|Withdrawal by Subject|1
654771|NCT02275546|2099480|P2|Treatment Period 2|Protocol Violation|1
654772|NCT02275546|2099481|P1|Treatment Period 2|Protocol Violation|0
654773|NCT02275546|2099480|P2|Treatment Period 2|Withdrawal by Subject|1
654774|NCT02275546|2099481|P1|Treatment Period 2|Withdrawal by Subject|2
654775|NCT02275481|2099491|P2|Overall Study|Physician Decision|1
654776|NCT02275481|2099492|P1|Overall Study|Physician Decision|0
654777|NCT02275481|2099491|P2|Overall Study|all other reasons combined|1
654778|NCT02275481|2099492|P1|Overall Study|all other reasons combined|2
654779|NCT02275481|2099491|P2|Overall Study|Withdrawal by Subject|0
654780|NCT02275481|2099492|P1|Overall Study|Withdrawal by Subject|3
654781|NCT02275481|2099491|P2|Overall Study|Lost to Follow-up|0
654782|NCT02275481|2099492|P1|Overall Study|Lost to Follow-up|2
654783|NCT02275481|2099491|P2|Overall Study|Death|1
654784|NCT02275481|2099492|P1|Overall Study|Death|2
654785|NCT02275364|2099498|P2|Period 1|Other reason|0
654786|NCT02275364|2099499|P1|Period 1|Other reason|1
654787|NCT02275364|2099498|P2|Period 1|Withdrawal by Subject|0
654788|NCT02275364|2099499|P1|Period 1|Withdrawal by Subject|1
888064|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888065|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
888066|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
888067|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
888068|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
888069|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888070|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888071|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888072|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888073|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888074|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
888075|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
888076|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
888077|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
888078|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
888079|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
888080|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
888081|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
888082|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
888083|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
654893|NCT02273141|2099751|P2|Overall Study|Adverse Event|1
888084|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
888085|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
888086|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888087|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888088|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888089|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888090|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888091|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888092|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
888093|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888094|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
888095|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888096|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888097|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888098|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888099|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888100|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888101|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
888102|NCT02207244|2821515|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
888103|NCT02207244|2821516|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
888104|NCT02207244|2821517|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
888105|NCT02207244|2821518|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
888106|NCT02207244|2821519|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
654833|NCT02274948|2099577|P2|Overall Study|Left the area|3
654834|NCT02274948|2099578|P1|Overall Study|Left the area|4
654835|NCT02274948|2099577|P2|Overall Study|Stopped on family Practitioner advice|5
654836|NCT02274948|2099578|P1|Overall Study|Stopped on family Practitioner advice|2
654837|NCT02274948|2099577|P2|Overall Study|Withdrawal by Subject|58
654838|NCT02274948|2099578|P1|Overall Study|Withdrawal by Subject|64
654839|NCT02274948|2099577|P2|Overall Study|Lost to Follow-up|25
654840|NCT02274948|2099578|P1|Overall Study|Lost to Follow-up|28
654841|NCT02274792|2099592|P1|Overall Study|Sponsor Decision|2
654842|NCT02274792|2099592|P1|Overall Study|Protocol Specified Criteria|2
654843|NCT02274792|2099592|P1|Overall Study|Lost to Follow-up|8
654844|NCT02274792|2099592|P1|Overall Study|Withdrawal by Subject|13
654845|NCT02274558|2099638|P3|Overall Study|Physician Decision|1
654846|NCT02274558|2099639|P2|Overall Study|Physician Decision|2
654847|NCT02274558|2099640|P1|Overall Study|Physician Decision|0
654848|NCT02274558|2099638|P3|Overall Study|Lost to Follow-up|1
654849|NCT02274558|2099639|P2|Overall Study|Lost to Follow-up|1
654850|NCT02274558|2099640|P1|Overall Study|Lost to Follow-up|2
654851|NCT02274558|2099638|P3|Overall Study|Death|1
654852|NCT02274558|2099639|P2|Overall Study|Death|0
654853|NCT02274558|2099640|P1|Overall Study|Death|0
654854|NCT02274558|2099638|P3|Overall Study|Withdrawal by Subject|4
654855|NCT02274558|2099639|P2|Overall Study|Withdrawal by Subject|5
654856|NCT02274558|2099640|P1|Overall Study|Withdrawal by Subject|1
654857|NCT02274558|2099638|P3|Overall Study|Non-compliance|0
654858|NCT02274558|2099639|P2|Overall Study|Non-compliance|1
654859|NCT02274558|2099640|P1|Overall Study|Non-compliance|2
654860|NCT02274558|2099638|P3|Overall Study|Adverse Event|2
654861|NCT02274558|2099639|P2|Overall Study|Adverse Event|4
654862|NCT02274558|2099640|P1|Overall Study|Adverse Event|2
654863|NCT02273908|2099656|P2|Overall Study|Withdrawal by Subject|2
654864|NCT02273908|2099657|P1|Overall Study|Withdrawal by Subject|4
654865|NCT02273908|2099656|P2|Overall Study|Did not meet entrance criteria|2
654866|NCT02273908|2099657|P1|Overall Study|Did not meet entrance criteria|3
654867|NCT02273908|2099656|P2|Overall Study|Lost to Follow-up|1
654868|NCT02273908|2099657|P1|Overall Study|Lost to Follow-up|10
654869|NCT02273908|2099656|P2|Overall Study|Adverse Event|0
654870|NCT02273908|2099657|P1|Overall Study|Adverse Event|16
654871|NCT02273752|2099679|P1|Overall Study|Trial was terminated early|2
654872|NCT02273167|2099724|P3|Overall Study|Various|8
654873|NCT02273167|2099725|P2|Overall Study|Various|9
654874|NCT02273167|2099726|P1|Overall Study|Various|10
654875|NCT02273167|2099724|P3|Overall Study|Withdrawal by Subject|11
654876|NCT02273167|2099725|P2|Overall Study|Withdrawal by Subject|12
654877|NCT02273167|2099726|P1|Overall Study|Withdrawal by Subject|10
654878|NCT02273167|2099724|P3|Overall Study|Lost to Follow-up|1
654879|NCT02273167|2099725|P2|Overall Study|Lost to Follow-up|1
654880|NCT02273167|2099726|P1|Overall Study|Lost to Follow-up|0
654881|NCT02273167|2099724|P3|Overall Study|Protocol Violation|1
654882|NCT02273167|2099725|P2|Overall Study|Protocol Violation|1
654883|NCT02273167|2099726|P1|Overall Study|Protocol Violation|3
654884|NCT02273167|2099724|P3|Overall Study|Adverse Event|0
654885|NCT02273167|2099725|P2|Overall Study|Adverse Event|0
654886|NCT02273167|2099726|P1|Overall Study|Adverse Event|1
654887|NCT02273141|2099751|P2|Overall Study|Various|6
654888|NCT02273141|2099752|P1|Overall Study|Various|6
654889|NCT02273141|2099751|P2|Overall Study|Withdrawal by Subject|15
654890|NCT02273141|2099752|P1|Overall Study|Withdrawal by Subject|10
654891|NCT02273141|2099751|P2|Overall Study|Lost to Follow-up|3
654892|NCT02273141|2099752|P1|Overall Study|Lost to Follow-up|1
888107|NCT02207244|2821520|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
654894|NCT02273141|2099752|P1|Overall Study|Adverse Event|0
654895|NCT02272725|2099819|P2|Overall Study|equipment malfunction|0
654896|NCT02272725|2099820|P1|Overall Study|equipment malfunction|2
654897|NCT02271854|2099830|P1|Overall Study|Lost to Follow-up|1
654898|NCT02271854|2099830|P1|Overall Study|Unable or unwilling to cooperate with st|1
654899|NCT02271854|2099830|P1|Overall Study|Withdrawal by Subject|2
654900|NCT02271529|2099858|P1|Overall Study|Withdrawal by Subject|1
654901|NCT02270944|2099879|P2|Overall Study|Withdrawal by Subject|1
654902|NCT02270944|2099880|P1|Overall Study|Withdrawal by Subject|2
654903|NCT02270944|2099879|P2|Overall Study|Lost to Follow-up|4
654904|NCT02270944|2099880|P1|Overall Study|Lost to Follow-up|9
654905|NCT02270684|2099896|P2|Overall Study|Study terminated|0
654906|NCT02270684|2099897|P1|Overall Study|Study terminated|1
654907|NCT02270684|2099896|P2|Overall Study|Lost to Follow-up|3
654908|NCT02270684|2099897|P1|Overall Study|Lost to Follow-up|0
654909|NCT02270515|2099903|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
654910|NCT02270515|2099903|P1|Intervention Period 3: 12-18 Months|Death|3
654911|NCT02270515|2099903|P1|Intervention Period 3: 12-18 Months|Received transplant|2
654912|NCT02270515|2099903|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
654913|NCT02270515|2099903|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
654914|NCT02270515|2099903|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
654915|NCT02270515|2099903|P1|Intervention Period 2: 6-12 Months|Death|5
654916|NCT02270515|2099903|P1|Intervention Period 2: 6-12 Months|Received transplant|1
654917|NCT02270515|2099903|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
654918|NCT02270515|2099903|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
654919|NCT02270515|2099903|P1|Intervention Period 1: 0-6 Months|Death|7
654920|NCT02270515|2099903|P1|Intervention Period 1: 0-6 Months|Received transplant|3
654921|NCT02270515|2099903|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
654922|NCT02270515|2099903|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
654923|NCT02269709|2099918|P1|Six Month Follow-up|Lost to Follow-up|12
654924|NCT02269709|2099918|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
654925|NCT02269709|2099918|P1|Time of Enrollment|Withdrawal by Subject|3
654926|NCT02269657|2099923|P1|Overall Study|Protocol Violation|3
654927|NCT02269475|2099943|P2|Overall Study|Withdrawal by Subject|1
654928|NCT02269475|2099944|P1|Overall Study|Withdrawal by Subject|0
654929|NCT02269475|2099943|P2|Overall Study|Meet Exclusion Criteria No. 17|0
654930|NCT02269475|2099944|P1|Overall Study|Meet Exclusion Criteria No. 17|3
654931|NCT02269098|2099957|P2|Overall Study|Lost to Follow-up|9
654932|NCT02269098|2099958|P1|Overall Study|Lost to Follow-up|14
654933|NCT02268864|2099986|P3|Overall Study|Death|0
654934|NCT02268864|2099987|P2|Overall Study|Death|1
654935|NCT02268864|2099988|P1|Overall Study|Death|0
654936|NCT02268864|2099986|P3|Overall Study|Withdrawal by Subject|0
654937|NCT02268864|2099987|P2|Overall Study|Withdrawal by Subject|0
654938|NCT02268864|2099988|P1|Overall Study|Withdrawal by Subject|2
654939|NCT02268396|2100010|P1|Overall Study|2 Subjects no Day 29 Assessment|2
654940|NCT02268396|2100010|P1|Overall Study|Protocol-Specified Criteria|2
654941|NCT02268396|2100010|P1|Overall Study|Lost to Follow-up|2
654942|NCT02268396|2100010|P1|Overall Study|Withdrawal by Subject|1
654943|NCT02268396|2100010|P1|Overall Study|Administrative|2
654944|NCT02268396|2100010|P1|Overall Study|Adverse Event|3
654945|NCT02268058|2100023|P4|Overall Study|Protocol Violation|0
654946|NCT02268058|2100024|P3|Overall Study|Protocol Violation|0
654947|NCT02268058|2100025|P2|Overall Study|Protocol Violation|0
654948|NCT02268058|2100026|P1|Overall Study|Protocol Violation|1
654949|NCT02267824|2100059|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
654950|NCT02267824|2100060|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
654951|NCT02267824|2100059|P2|Overall Study|Protocol Violation|0
654952|NCT02267824|2100060|P1|Overall Study|Protocol Violation|3
654953|NCT02267824|2100059|P2|Overall Study|Lost to Follow-up|0
654954|NCT02267824|2100060|P1|Overall Study|Lost to Follow-up|4
654955|NCT02267824|2100059|P2|Overall Study|Pregnancy|1
654956|NCT02267824|2100060|P1|Overall Study|Pregnancy|1
654957|NCT02266381|2100150|P3|Overall Study|Physician Decision|4
654958|NCT02266381|2100151|P2|Overall Study|Physician Decision|5
654959|NCT02266381|2100152|P1|Overall Study|Physician Decision|3
654960|NCT02265237|2100225|P4|As Treated (Overall Study)|Other|1
654961|NCT02265237|2100226|P3|As Treated (Overall Study)|Other|3
654962|NCT02265237|2100227|P2|As Treated (Overall Study)|Other|0
654963|NCT02265237|2100228|P1|As Treated (Overall Study)|Other|2
654964|NCT02265237|2100225|P4|As Treated (Overall Study)|Lost to Follow-up|0
654965|NCT02265237|2100226|P3|As Treated (Overall Study)|Lost to Follow-up|6
654966|NCT02265237|2100227|P2|As Treated (Overall Study)|Lost to Follow-up|2
654967|NCT02265237|2100228|P1|As Treated (Overall Study)|Lost to Follow-up|1
654968|NCT02265237|2100225|P4|As Treated (Overall Study)|Withdrawal by Subject|0
654969|NCT02265237|2100226|P3|As Treated (Overall Study)|Withdrawal by Subject|1
654970|NCT02265237|2100227|P2|As Treated (Overall Study)|Withdrawal by Subject|0
654971|NCT02265237|2100228|P1|As Treated (Overall Study)|Withdrawal by Subject|1
654972|NCT02265237|2100225|P4|As Treated (Overall Study)|Adverse Event|0
654973|NCT02265237|2100226|P3|As Treated (Overall Study)|Adverse Event|0
654974|NCT02265237|2100227|P2|As Treated (Overall Study)|Adverse Event|1
654975|NCT02265237|2100228|P1|As Treated (Overall Study)|Adverse Event|1
654976|NCT02264821|2100258|P3|Overall Study|Protocol Violation|6
654977|NCT02264821|2100259|P2|Overall Study|Protocol Violation|3
654978|NCT02264821|2100260|P1|Overall Study|Protocol Violation|1
654979|NCT02262754|2100363|P3|Overall Study|Unspecified|2
654980|NCT02262754|2100364|P2|Overall Study|Unspecified|0
654981|NCT02262754|2100365|P1|Overall Study|Unspecified|4
654982|NCT02262754|2100363|P3|Overall Study|Withdrawal by Subject|1
654983|NCT02262754|2100364|P2|Overall Study|Withdrawal by Subject|0
654984|NCT02262754|2100365|P1|Overall Study|Withdrawal by Subject|1
654985|NCT02262754|2100363|P3|Overall Study|Protocol Violation|0
654986|NCT02262754|2100364|P2|Overall Study|Protocol Violation|0
654987|NCT02262754|2100365|P1|Overall Study|Protocol Violation|1
654988|NCT02262754|2100363|P3|Overall Study|Study terminated by sponsor|4
654989|NCT02262754|2100364|P2|Overall Study|Study terminated by sponsor|4
654990|NCT02262754|2100365|P1|Overall Study|Study terminated by sponsor|5
654991|NCT02262754|2100363|P3|Overall Study|No longer meets eligibility criteria|0
654992|NCT02262754|2100364|P2|Overall Study|No longer meets eligibility criteria|1
654993|NCT02262754|2100365|P1|Overall Study|No longer meets eligibility criteria|0
654994|NCT02262754|2100363|P3|Overall Study|Lost to Follow-up|1
654995|NCT02262754|2100364|P2|Overall Study|Lost to Follow-up|0
654996|NCT02262754|2100365|P1|Overall Study|Lost to Follow-up|0
654997|NCT02262754|2100363|P3|Overall Study|Lack of Efficacy|1
654998|NCT02262754|2100364|P2|Overall Study|Lack of Efficacy|0
654999|NCT02262754|2100365|P1|Overall Study|Lack of Efficacy|2
655000|NCT02262754|2100363|P3|Overall Study|Adverse Event|0
655001|NCT02262754|2100364|P2|Overall Study|Adverse Event|4
655002|NCT02262754|2100365|P1|Overall Study|Adverse Event|3
655003|NCT02261493|2100519|P3|Overall Study|Adverse Event|0
655004|NCT02261493|2100520|P2|Overall Study|Adverse Event|1
655005|NCT02261493|2100521|P1|Overall Study|Adverse Event|0
655006|NCT02261493|2100519|P3|Overall Study|Lack of Efficacy|0
655007|NCT02261493|2100520|P2|Overall Study|Lack of Efficacy|1
655008|NCT02261493|2100521|P1|Overall Study|Lack of Efficacy|0
655009|NCT02261493|2100519|P3|Overall Study|Pregnancy|0
655010|NCT02261493|2100520|P2|Overall Study|Pregnancy|2
655011|NCT02261493|2100521|P1|Overall Study|Pregnancy|1
655012|NCT02261493|2100519|P3|Overall Study|Lost to Follow-up|8
655013|NCT02261493|2100520|P2|Overall Study|Lost to Follow-up|27
655014|NCT02261493|2100521|P1|Overall Study|Lost to Follow-up|14
655015|NCT02261493|2100519|P3|Overall Study|Personal Reasons|16
655016|NCT02261493|2100520|P2|Overall Study|Personal Reasons|14
655017|NCT02261493|2100521|P1|Overall Study|Personal Reasons|14
655018|NCT02261493|2100519|P3|Overall Study|Protocol Violation|0
655019|NCT02261493|2100520|P2|Overall Study|Protocol Violation|0
655020|NCT02261493|2100521|P1|Overall Study|Protocol Violation|1
655021|NCT02261493|2100519|P3|Overall Study|Undisclosed alcohol abuse|0
655022|NCT02261493|2100520|P2|Overall Study|Undisclosed alcohol abuse|1
655023|NCT02261493|2100521|P1|Overall Study|Undisclosed alcohol abuse|0
655024|NCT02261493|2100519|P3|Overall Study|Physician Decision|0
655025|NCT02261493|2100520|P2|Overall Study|Physician Decision|1
655026|NCT02261493|2100521|P1|Overall Study|Physician Decision|0
655027|NCT02261493|2100519|P3|Overall Study|Noncompliance|2
655028|NCT02261493|2100520|P2|Overall Study|Noncompliance|0
655029|NCT02261493|2100521|P1|Overall Study|Noncompliance|0
655030|NCT02261467|2100549|P2|Overall Study|Adverse Event|1
655031|NCT02261467|2100550|P1|Overall Study|Adverse Event|1
655032|NCT02261467|2100549|P2|Overall Study|Lost to Follow-up|13
655033|NCT02261467|2100550|P1|Overall Study|Lost to Follow-up|2
655034|NCT02261467|2100549|P2|Overall Study|Personal Reasons|22
655035|NCT02261467|2100550|P1|Overall Study|Personal Reasons|17
655036|NCT02261467|2100549|P2|Overall Study|Protocol Violation|1
655037|NCT02261467|2100550|P1|Overall Study|Protocol Violation|0
655038|NCT02261467|2100549|P2|Overall Study|Enrolled in Error|0
655039|NCT02261467|2100550|P1|Overall Study|Enrolled in Error|1
655040|NCT02260882|2100591|P2|Overall Study|Protocol Violation|1
655041|NCT02260882|2100592|P1|Overall Study|Protocol Violation|0
888108|NCT02207244|2821521|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
888109|NCT02207244|2821522|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
888110|NCT02207244|2821523|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
888111|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
888112|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
888113|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
888114|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
888115|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
888116|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
888117|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
888118|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
655056|NCT02260492|2100656|P3|Overall Study|Withdrawal by Subject|2
655057|NCT02260492|2100657|P2|Overall Study|Withdrawal by Subject|2
655058|NCT02260492|2100658|P1|Overall Study|Withdrawal by Subject|3
655059|NCT02260492|2100656|P3|Overall Study|Physician Decision|1
655060|NCT02260492|2100657|P2|Overall Study|Physician Decision|0
655061|NCT02260492|2100658|P1|Overall Study|Physician Decision|2
655062|NCT02260492|2100656|P3|Overall Study|Lost to Follow-up|0
655063|NCT02260492|2100657|P2|Overall Study|Lost to Follow-up|9
655064|NCT02260492|2100658|P1|Overall Study|Lost to Follow-up|12
655065|NCT02260492|2100656|P3|Overall Study|Death|0
655066|NCT02260492|2100657|P2|Overall Study|Death|1
655067|NCT02260492|2100658|P1|Overall Study|Death|0
655068|NCT02260492|2100656|P3|Overall Study|Adverse Event|2
655069|NCT02260492|2100657|P2|Overall Study|Adverse Event|1
655070|NCT02260492|2100658|P1|Overall Study|Adverse Event|6
655071|NCT02259400|2100694|P2|Overall Study|Death|2
655072|NCT02259400|2100695|P1|Overall Study|Death|0
655073|NCT02259348|2100727|P1|Overall Study|Death|4
655074|NCT02259348|2100727|P1|Overall Study|Donors|6
655075|NCT02258529|2100739|P1|Overall Study|Adverse Event|1
655076|NCT02258529|2100739|P1|Overall Study|Study Terminated by Sponsor|9
655077|NCT02258334|2100785|P4|Overall Study|Adverse Event|0
655078|NCT02258334|2100786|P3|Overall Study|Adverse Event|0
655079|NCT02258334|2100787|P2|Overall Study|Adverse Event|0
655080|NCT02258334|2100788|P1|Overall Study|Adverse Event|1
655081|NCT02257918|2100817|P3|Overall Study|Pregnancy|1
655082|NCT02257918|2100818|P2|Overall Study|Pregnancy|0
655083|NCT02257918|2100819|P1|Overall Study|Pregnancy|0
655084|NCT02257918|2100817|P3|Overall Study|Withdrawal by Subject|1
655085|NCT02257918|2100818|P2|Overall Study|Withdrawal by Subject|0
655086|NCT02257918|2100819|P1|Overall Study|Withdrawal by Subject|0
655087|NCT02257918|2100817|P3|Overall Study|Lost to Follow-up|0
655088|NCT02257918|2100818|P2|Overall Study|Lost to Follow-up|1
655089|NCT02257918|2100819|P1|Overall Study|Lost to Follow-up|4
655090|NCT02257684|2100869|P1|Overall Study|Sponsor's Decision|1
655091|NCT02257684|2100869|P1|Overall Study|Lack of Efficacy|1
655092|NCT02257684|2100869|P1|Overall Study|Adverse Event|2
655093|NCT02257385|2100879|P2|Overall Study|Withdrawal by Subject|4
655094|NCT02257385|2100880|P1|Overall Study|Withdrawal by Subject|4
655095|NCT02257385|2100879|P2|Overall Study|Lost to Follow-up|1
655096|NCT02257385|2100880|P1|Overall Study|Lost to Follow-up|0
655097|NCT02257385|2100879|P2|Overall Study|Protocol Violation|7
655098|NCT02257385|2100880|P1|Overall Study|Protocol Violation|5
655099|NCT02257385|2100879|P2|Overall Study|Lack of Efficacy|2
655100|NCT02257385|2100880|P1|Overall Study|Lack of Efficacy|1
655101|NCT02257385|2100879|P2|Overall Study|Adverse Event|8
655102|NCT02257385|2100880|P1|Overall Study|Adverse Event|12
655103|NCT02257372|2100890|P2|Overall Study|Withdrew consent|0
655104|NCT02257372|2100891|P1|Overall Study|Withdrew consent|1
655105|NCT02257372|2100890|P2|Overall Study|Lost to Follow-up|1
655106|NCT02257372|2100891|P1|Overall Study|Lost to Follow-up|0
655107|NCT02257372|2100890|P2|Overall Study|Protocol Violation|1
655108|NCT02257372|2100891|P1|Overall Study|Protocol Violation|1
655109|NCT02257372|2100890|P2|Overall Study|Lack of Efficacy|1
655110|NCT02257372|2100891|P1|Overall Study|Lack of Efficacy|2
655111|NCT02257372|2100890|P2|Overall Study|Adverse Event|7
655112|NCT02257372|2100891|P1|Overall Study|Adverse Event|3
655113|NCT02256982|2100901|P2|Overall Study|Disease Progression|1
655114|NCT02256982|2100902|P1|Overall Study|Disease Progression|0
655115|NCT02256969|2100911|P3|Overall Study|Screenfailed or withdrew|1
655116|NCT02256969|2100912|P2|Overall Study|Screenfailed or withdrew|1
655117|NCT02256969|2100913|P1|Overall Study|Screenfailed or withdrew|2
655118|NCT02256891|2100932|P2|Overall Study|Equipment Malfunction|1
655119|NCT02256891|2100933|P1|Overall Study|Equipment Malfunction|0
655120|NCT02256891|2100932|P2|Overall Study|Screen Fail|4
655121|NCT02256891|2100933|P1|Overall Study|Screen Fail|5
655122|NCT02256891|2100932|P2|Overall Study|Physician Decision|3
655123|NCT02256891|2100933|P1|Overall Study|Physician Decision|7
655124|NCT02256891|2100932|P2|Overall Study|Lost to Follow-up|3
655125|NCT02256891|2100933|P1|Overall Study|Lost to Follow-up|0
655126|NCT02256891|2100932|P2|Overall Study|Death|2
655127|NCT02256891|2100933|P1|Overall Study|Death|0
655128|NCT02256553|2100957|P1|Period III|Adverse Event|3
655129|NCT02256553|2100957|P1|Period II|Subject Moved|1
655130|NCT02256553|2100957|P1|Period II|Adverse Event|1
655131|NCT02256553|2100957|P1|Period I|Protocol Violation|1
655132|NCT02256553|2100957|P1|Period I|Adverse Event|5
655133|NCT02256488|2100970|P4|Overall Study|Withdrawal by Subject|2
655134|NCT02256488|2100971|P3|Overall Study|Withdrawal by Subject|0
655135|NCT02256488|2100972|P2|Overall Study|Withdrawal by Subject|0
655136|NCT02256488|2100973|P1|Overall Study|Withdrawal by Subject|1
655137|NCT02256488|2100970|P4|Overall Study|OTHER|1
655138|NCT02256488|2100971|P3|Overall Study|OTHER|1
655139|NCT02256488|2100972|P2|Overall Study|OTHER|0
655140|NCT02256488|2100973|P1|Overall Study|OTHER|1
655141|NCT02256488|2100970|P4|Overall Study|Lost to Follow-up|3
655142|NCT02256488|2100971|P3|Overall Study|Lost to Follow-up|9
655143|NCT02256488|2100972|P2|Overall Study|Lost to Follow-up|6
655144|NCT02256488|2100973|P1|Overall Study|Lost to Follow-up|6
888119|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
888120|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888121|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888122|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888123|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
888124|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888125|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
888126|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888127|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888128|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
888129|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
655159|NCT02255565|2101070|P3|Overall Study|Withdrawal by Subject|0
655160|NCT02255565|2101071|P2|Overall Study|Withdrawal by Subject|1
655161|NCT02255565|2101072|P1|Overall Study|Withdrawal by Subject|0
655162|NCT02255279|2101133|P2|Overall Study|Withdrawal by Subject|6
655163|NCT02255279|2101134|P1|Overall Study|Withdrawal by Subject|3
655164|NCT02255279|2101133|P2|Overall Study|Protocol Violation|1
655165|NCT02255279|2101134|P1|Overall Study|Protocol Violation|0
655166|NCT02255279|2101133|P2|Overall Study|Lost to Follow-up|2
655167|NCT02255279|2101134|P1|Overall Study|Lost to Follow-up|2
655168|NCT02255149|2101160|P1|Overall Study|Implant Failure|1
655169|NCT02255149|2101160|P1|Overall Study|Withdrawal by PI|1
655170|NCT02255149|2101160|P1|Overall Study|Withdrawal by Subject|1
655171|NCT02255149|2101160|P1|Overall Study|Lost to Follow-up|2
888130|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
888131|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
888132|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
888133|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
888134|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
888135|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
888136|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
888137|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
655183|NCT02254772|2101185|P1|Overall Study|Withdrawal by Subject|1
655184|NCT02254772|2101185|P1|Overall Study|Ineligible|1
655185|NCT02254551|2101191|P1|Dose Escalation|Dose-limiting toxicity|2
655186|NCT02254551|2101191|P1|Dose Escalation|Physician Decision|1
655187|NCT02254486|2101201|P2|Overall Study|Various|12
655188|NCT02254486|2101202|P1|Overall Study|Various|12
655189|NCT02254486|2101201|P2|Overall Study|GFR<60mL/min|21
655190|NCT02254486|2101202|P1|Overall Study|GFR<60mL/min|16
655191|NCT02254486|2101201|P2|Overall Study|Withdrawal by Subject|15
655192|NCT02254486|2101202|P1|Overall Study|Withdrawal by Subject|17
655193|NCT02254486|2101201|P2|Overall Study|Protocol Violation|2
655194|NCT02254486|2101202|P1|Overall Study|Protocol Violation|1
655195|NCT02254486|2101201|P2|Overall Study|Lost to Follow-up|4
655196|NCT02254486|2101202|P1|Overall Study|Lost to Follow-up|2
655197|NCT02254486|2101201|P2|Overall Study|Lack of Efficacy|0
655198|NCT02254486|2101202|P1|Overall Study|Lack of Efficacy|1
655199|NCT02254486|2101201|P2|Overall Study|Adverse Event|1
655200|NCT02254486|2101202|P1|Overall Study|Adverse Event|1
655201|NCT02254460|2101218|P2|Overall Study|Adverse Event|0
655202|NCT02254460|2101219|P1|Overall Study|Adverse Event|1
655203|NCT02253654|2101240|P2|Overall Study|Did Not Receive Study Treatment|1
655204|NCT02253654|2101241|P1|Overall Study|Did Not Receive Study Treatment|4
655205|NCT02253654|2101240|P2|Overall Study|Death|7
655206|NCT02253654|2101241|P1|Overall Study|Death|4
655207|NCT02253654|2101240|P2|Overall Study|Lost to Follow-up|5
655208|NCT02253654|2101241|P1|Overall Study|Lost to Follow-up|2
655209|NCT02253654|2101240|P2|Overall Study|Decision by Sponsor|1
655210|NCT02253654|2101241|P1|Overall Study|Decision by Sponsor|1
655211|NCT02253654|2101240|P2|Overall Study|Withdrawal by Subject|4
655212|NCT02253654|2101241|P1|Overall Study|Withdrawal by Subject|12
655213|NCT02252016|2101505|P2|Overall Study|Withdrawal by Subject|2
655214|NCT02252016|2101506|P1|Overall Study|Withdrawal by Subject|0
655215|NCT02252016|2101505|P2|Overall Study|Physician Decision|0
655216|NCT02252016|2101506|P1|Overall Study|Physician Decision|1
655217|NCT02252016|2101505|P2|Overall Study|Lost to Follow-up|1
655218|NCT02252016|2101506|P1|Overall Study|Lost to Follow-up|2
655219|NCT02252965|2101520|P2|Overall Study|Unspecified|5
655220|NCT02252965|2101521|P1|Overall Study|Unspecified|4
655221|NCT02252965|2101520|P2|Overall Study|Withdrawal by Subject|9
655222|NCT02252965|2101521|P1|Overall Study|Withdrawal by Subject|7
655223|NCT02252965|2101520|P2|Overall Study|Lack of Efficacy|2
655224|NCT02252965|2101521|P1|Overall Study|Lack of Efficacy|0
655225|NCT02252965|2101520|P2|Overall Study|Protocol Violation|5
655226|NCT02252965|2101521|P1|Overall Study|Protocol Violation|4
655227|NCT02252965|2101520|P2|Overall Study|Lost to Follow-up|8
655228|NCT02252965|2101521|P1|Overall Study|Lost to Follow-up|16
655229|NCT02252965|2101520|P2|Overall Study|Adverse Event|14
655230|NCT02252965|2101521|P1|Overall Study|Adverse Event|9
655231|NCT02251912|2101640|P2|Overall Study|Adverse Event|2
655232|NCT02251912|2101641|P1|Overall Study|Adverse Event|0
655233|NCT02251912|2101640|P2|Overall Study|Withdrawal by Subject|3
655234|NCT02251912|2101641|P1|Overall Study|Withdrawal by Subject|2
655235|NCT02251652|2101668|P1|Overall Study|Withdrawal by Subject|1
655236|NCT02250274|2101721|P2|Overall Study|Insufficient blood draw amount|6
655237|NCT02250274|2101722|P1|Overall Study|Insufficient blood draw amount|7
655238|NCT02248818|2101775|P9|Randomised Study|Administrative - randomization error|0
655239|NCT02248818|2101776|P8|Randomised Study|Administrative - randomization error|0
655240|NCT02248818|2101777|P7|Randomised Study|Administrative - randomization error|0
655241|NCT02248818|2101778|P6|Randomised Study|Administrative - randomization error|8
655242|NCT02248818|2101779|P5|Randomised Study|Administrative - randomization error|0
655243|NCT02248818|2101780|P4|Randomised Study|Administrative - randomization error|0
655244|NCT02248818|2101781|P3|Randomised Study|Administrative - randomization error|0
655245|NCT02248818|2101782|P2|Randomised Study|Administrative - randomization error|0
655246|NCT02248818|2101783|P1|Randomised Study|Administrative - randomization error|0
655247|NCT02248818|2101775|P9|Screening|Lost to Follow-up|7
655248|NCT02248818|2101776|P8|Screening|Lost to Follow-up|0
655249|NCT02248818|2101777|P7|Screening|Lost to Follow-up|0
655250|NCT02248818|2101778|P6|Screening|Lost to Follow-up|0
655251|NCT02248818|2101779|P5|Screening|Lost to Follow-up|0
655252|NCT02248818|2101780|P4|Screening|Lost to Follow-up|0
655253|NCT02248818|2101781|P3|Screening|Lost to Follow-up|0
655254|NCT02248818|2101782|P2|Screening|Lost to Follow-up|0
655255|NCT02248818|2101783|P1|Screening|Lost to Follow-up|0
655256|NCT02248818|2101775|P9|Screening|Withdrawal by Subject|6
655257|NCT02248818|2101776|P8|Screening|Withdrawal by Subject|0
655258|NCT02248818|2101777|P7|Screening|Withdrawal by Subject|0
655259|NCT02248818|2101778|P6|Screening|Withdrawal by Subject|0
655260|NCT02248818|2101779|P5|Screening|Withdrawal by Subject|0
655261|NCT02248818|2101780|P4|Screening|Withdrawal by Subject|0
655262|NCT02248818|2101781|P3|Screening|Withdrawal by Subject|0
655263|NCT02248818|2101782|P2|Screening|Withdrawal by Subject|0
655264|NCT02248818|2101783|P1|Screening|Withdrawal by Subject|0
655265|NCT02248818|2101775|P9|Screening|Physician Decision|73
655266|NCT02248818|2101776|P8|Screening|Physician Decision|0
655267|NCT02248818|2101777|P7|Screening|Physician Decision|0
655268|NCT02248818|2101778|P6|Screening|Physician Decision|0
655269|NCT02248818|2101779|P5|Screening|Physician Decision|0
655270|NCT02248818|2101780|P4|Screening|Physician Decision|0
655271|NCT02248818|2101781|P3|Screening|Physician Decision|0
655272|NCT02248818|2101782|P2|Screening|Physician Decision|0
655273|NCT02248818|2101783|P1|Screening|Physician Decision|0
655274|NCT02248818|2101775|P9|Screening|Study fully enrolled|14
655275|NCT02248818|2101776|P8|Screening|Study fully enrolled|0
655276|NCT02248818|2101777|P7|Screening|Study fully enrolled|0
655277|NCT02248818|2101778|P6|Screening|Study fully enrolled|0
655278|NCT02248818|2101779|P5|Screening|Study fully enrolled|0
655279|NCT02248818|2101780|P4|Screening|Study fully enrolled|0
655280|NCT02248818|2101781|P3|Screening|Study fully enrolled|0
655281|NCT02248818|2101782|P2|Screening|Study fully enrolled|0
655282|NCT02248818|2101783|P1|Screening|Study fully enrolled|0
655283|NCT02248818|2101775|P9|Screening|Protocol Violation|7
655284|NCT02248818|2101776|P8|Screening|Protocol Violation|0
655285|NCT02248818|2101777|P7|Screening|Protocol Violation|0
655286|NCT02248818|2101778|P6|Screening|Protocol Violation|0
655287|NCT02248818|2101779|P5|Screening|Protocol Violation|0
655288|NCT02248818|2101780|P4|Screening|Protocol Violation|0
655289|NCT02248818|2101781|P3|Screening|Protocol Violation|0
655290|NCT02248818|2101782|P2|Screening|Protocol Violation|0
655291|NCT02248818|2101783|P1|Screening|Protocol Violation|0
655292|NCT02248675|2101946|P2|Overall Study|Lost to Follow-up|1
655293|NCT02248675|2101947|P1|Overall Study|Lost to Follow-up|3
655294|NCT02248480|2101974|P2|Overall Study|Other:Physician Decision|1
655295|NCT02248480|2101975|P1|Overall Study|Other:Physician Decision|0
655296|NCT02248480|2101974|P2|Overall Study|Entry Criteria Not Met|1
655297|NCT02248480|2101975|P1|Overall Study|Entry Criteria Not Met|0
655298|NCT02248480|2101974|P2|Overall Study|Withdrawal by Subject|4
655299|NCT02248480|2101975|P1|Overall Study|Withdrawal by Subject|2
655300|NCT02248480|2101974|P2|Overall Study|Adverse Event|2
655301|NCT02248480|2101975|P1|Overall Study|Adverse Event|11
655302|NCT02248480|2101974|P2|Overall Study|Lack of Efficacy|6
655303|NCT02248480|2101975|P1|Overall Study|Lack of Efficacy|4
655304|NCT02247960|2102033|P2|Catheter Removed|Lost to Follow-up|10
655305|NCT02247960|2102034|P1|Catheter Removed|Lost to Follow-up|7
655306|NCT02247960|2102033|P2|Patient Consent and Randomization|Withdrawal by Subject|4
655307|NCT02247960|2102034|P1|Patient Consent and Randomization|Withdrawal by Subject|0
655308|NCT02247960|2102033|P2|Patient Consent and Randomization|Physician Decision|2
655309|NCT02247960|2102034|P1|Patient Consent and Randomization|Physician Decision|2
655310|NCT02247401|2102052|P3|Overall Study|Lost to Follow-up|1
655311|NCT02247401|2102053|P2|Overall Study|Lost to Follow-up|1
655312|NCT02247401|2102054|P1|Overall Study|Lost to Follow-up|1
655313|NCT02247401|2102052|P3|Overall Study|Withdrawal by Subject|1
655314|NCT02247401|2102053|P2|Overall Study|Withdrawal by Subject|1
655315|NCT02247401|2102054|P1|Overall Study|Withdrawal by Subject|4
655316|NCT02247401|2102052|P3|Overall Study|Adverse Event|0
655317|NCT02247401|2102053|P2|Overall Study|Adverse Event|0
655318|NCT02247401|2102054|P1|Overall Study|Adverse Event|1
655319|NCT02247011|2102073|P1|Overall Study|Poor quality of radiological results|125
655320|NCT02246673|2102095|P5|Overall Study|Protocol Violation|0
655321|NCT02246673|2102096|P4|Overall Study|Protocol Violation|1
655322|NCT02246673|2102097|P3|Overall Study|Protocol Violation|0
655323|NCT02246673|2102098|P2|Overall Study|Protocol Violation|0
655324|NCT02246673|2102099|P1|Overall Study|Protocol Violation|0
655325|NCT02246673|2102095|P5|Overall Study|Lost to Follow-up|0
655326|NCT02246673|2102096|P4|Overall Study|Lost to Follow-up|1
655327|NCT02246673|2102097|P3|Overall Study|Lost to Follow-up|0
655328|NCT02246673|2102098|P2|Overall Study|Lost to Follow-up|0
655329|NCT02246673|2102099|P1|Overall Study|Lost to Follow-up|0
655330|NCT02246673|2102095|P5|Overall Study|Withdrawal by Subject|1
655331|NCT02246673|2102096|P4|Overall Study|Withdrawal by Subject|0
655332|NCT02246673|2102097|P3|Overall Study|Withdrawal by Subject|0
655333|NCT02246673|2102098|P2|Overall Study|Withdrawal by Subject|0
655334|NCT02246673|2102099|P1|Overall Study|Withdrawal by Subject|0
655335|NCT02246673|2102095|P5|Overall Study|Sponsor Decision|0
655336|NCT02246673|2102096|P4|Overall Study|Sponsor Decision|0
655337|NCT02246673|2102097|P3|Overall Study|Sponsor Decision|0
655338|NCT02246673|2102098|P2|Overall Study|Sponsor Decision|0
655339|NCT02246673|2102099|P1|Overall Study|Sponsor Decision|1
655340|NCT02246582|2102204|P2|Overall Study|Withdrawal by Subject|4
655341|NCT02246582|2102205|P1|Overall Study|Withdrawal by Subject|3
655342|NCT02246166|2102213|P2|Overall Study|Protocol Violation|0
655343|NCT02246166|2102214|P1|Overall Study|Protocol Violation|1
655344|NCT02246114|2102250|P2|Overall Study|miscarriage|0
655345|NCT02246114|2102251|P1|Overall Study|miscarriage|1
655346|NCT02245412|2102285|P3|Overall Study|Other|0
655347|NCT02245412|2102286|P2|Overall Study|Other|0
655348|NCT02245412|2102287|P1|Overall Study|Other|1
655349|NCT02245412|2102285|P3|Overall Study|Biopsy did not confirm GI GVHD|0
655350|NCT02245412|2102286|P2|Overall Study|Biopsy did not confirm GI GVHD|0
655351|NCT02245412|2102287|P1|Overall Study|Biopsy did not confirm GI GVHD|1
655352|NCT02245412|2102285|P3|Overall Study|Withdrawal by Subject|0
655353|NCT02245412|2102286|P2|Overall Study|Withdrawal by Subject|1
655354|NCT02245412|2102287|P1|Overall Study|Withdrawal by Subject|1
655355|NCT02245412|2102285|P3|Overall Study|Physician Decision|0
655356|NCT02245412|2102286|P2|Overall Study|Physician Decision|1
655357|NCT02245412|2102287|P1|Overall Study|Physician Decision|1
655358|NCT02245412|2102285|P3|Overall Study|Death|0
655359|NCT02245412|2102286|P2|Overall Study|Death|1
655360|NCT02245412|2102287|P1|Overall Study|Death|1
655361|NCT02244619|2102312|P2|Overall Study|Did not receive study intervention|21
655362|NCT02244619|2102313|P1|Overall Study|Did not receive study intervention|8
655363|NCT02244580|2102331|P1|Overall Study|No cancer tissues available|241
655364|NCT02243293|2102369|P22|Overall Study|Randomized but did'nt receive study drug|0
655365|NCT02243293|2102370|P21|Overall Study|Randomized but did'nt receive study drug|0
655366|NCT02243293|2102371|P20|Overall Study|Randomized but did'nt receive study drug|1
655367|NCT02243293|2102372|P19|Overall Study|Randomized but did'nt receive study drug|0
655368|NCT02243293|2102373|P18|Overall Study|Randomized but did'nt receive study drug|0
655369|NCT02243293|2102374|P17|Overall Study|Randomized but did'nt receive study drug|0
655370|NCT02243293|2102375|P16|Overall Study|Randomized but did'nt receive study drug|0
655371|NCT02243293|2102376|P15|Overall Study|Randomized but did'nt receive study drug|0
655372|NCT02243293|2102377|P14|Overall Study|Randomized but did'nt receive study drug|0
655373|NCT02243293|2102378|P13|Overall Study|Randomized but did'nt receive study drug|0
655374|NCT02243293|2102379|P12|Overall Study|Randomized but did'nt receive study drug|0
655375|NCT02243293|2102380|P11|Overall Study|Randomized but did'nt receive study drug|0
655376|NCT02243293|2102381|P10|Overall Study|Randomized but did'nt receive study drug|1
655377|NCT02243293|2102382|P9|Overall Study|Randomized but did'nt receive study drug|0
655378|NCT02243293|2102383|P8|Overall Study|Randomized but did'nt receive study drug|0
655379|NCT02243293|2102384|P7|Overall Study|Randomized but did'nt receive study drug|0
655380|NCT02243293|2102385|P6|Overall Study|Randomized but did'nt receive study drug|0
655381|NCT02243293|2102386|P5|Overall Study|Randomized but did'nt receive study drug|1
655382|NCT02243293|2102387|P4|Overall Study|Randomized but did'nt receive study drug|0
655383|NCT02243293|2102388|P3|Overall Study|Randomized but did'nt receive study drug|0
655384|NCT02243293|2102389|P2|Overall Study|Randomized but did'nt receive study drug|0
655385|NCT02243293|2102390|P1|Overall Study|Randomized but did'nt receive study drug|0
655386|NCT02243293|2102369|P22|Overall Study|Enrolled into a Re-treatment Study|0
655387|NCT02243293|2102370|P21|Overall Study|Enrolled into a Re-treatment Study|0
655388|NCT02243293|2102371|P20|Overall Study|Enrolled into a Re-treatment Study|0
655389|NCT02243293|2102372|P19|Overall Study|Enrolled into a Re-treatment Study|0
655390|NCT02243293|2102373|P18|Overall Study|Enrolled into a Re-treatment Study|0
655391|NCT02243293|2102374|P17|Overall Study|Enrolled into a Re-treatment Study|0
655392|NCT02243293|2102375|P16|Overall Study|Enrolled into a Re-treatment Study|0
655393|NCT02243293|2102376|P15|Overall Study|Enrolled into a Re-treatment Study|1
655394|NCT02243293|2102377|P14|Overall Study|Enrolled into a Re-treatment Study|0
655395|NCT02243293|2102378|P13|Overall Study|Enrolled into a Re-treatment Study|0
655396|NCT02243293|2102379|P12|Overall Study|Enrolled into a Re-treatment Study|0
655397|NCT02243293|2102380|P11|Overall Study|Enrolled into a Re-treatment Study|0
655398|NCT02243293|2102381|P10|Overall Study|Enrolled into a Re-treatment Study|0
655399|NCT02243293|2102382|P9|Overall Study|Enrolled into a Re-treatment Study|0
655400|NCT02243293|2102383|P8|Overall Study|Enrolled into a Re-treatment Study|0
655401|NCT02243293|2102384|P7|Overall Study|Enrolled into a Re-treatment Study|0
655402|NCT02243293|2102385|P6|Overall Study|Enrolled into a Re-treatment Study|0
655403|NCT02243293|2102386|P5|Overall Study|Enrolled into a Re-treatment Study|0
655404|NCT02243293|2102387|P4|Overall Study|Enrolled into a Re-treatment Study|0
655405|NCT02243293|2102388|P3|Overall Study|Enrolled into a Re-treatment Study|0
655406|NCT02243293|2102389|P2|Overall Study|Enrolled into a Re-treatment Study|0
655407|NCT02243293|2102390|P1|Overall Study|Enrolled into a Re-treatment Study|0
655408|NCT02243293|2102369|P22|Overall Study|Lost to Follow-up|2
655409|NCT02243293|2102370|P21|Overall Study|Lost to Follow-up|1
655410|NCT02243293|2102371|P20|Overall Study|Lost to Follow-up|0
655411|NCT02243293|2102372|P19|Overall Study|Lost to Follow-up|0
655412|NCT02243293|2102373|P18|Overall Study|Lost to Follow-up|1
655413|NCT02243293|2102374|P17|Overall Study|Lost to Follow-up|3
655414|NCT02243293|2102375|P16|Overall Study|Lost to Follow-up|0
655415|NCT02243293|2102376|P15|Overall Study|Lost to Follow-up|0
655416|NCT02243293|2102377|P14|Overall Study|Lost to Follow-up|0
655417|NCT02243293|2102378|P13|Overall Study|Lost to Follow-up|0
655418|NCT02243293|2102379|P12|Overall Study|Lost to Follow-up|2
655419|NCT02243293|2102380|P11|Overall Study|Lost to Follow-up|0
655420|NCT02243293|2102381|P10|Overall Study|Lost to Follow-up|0
655421|NCT02243293|2102382|P9|Overall Study|Lost to Follow-up|0
655422|NCT02243293|2102383|P8|Overall Study|Lost to Follow-up|0
655423|NCT02243293|2102384|P7|Overall Study|Lost to Follow-up|3
655424|NCT02243293|2102385|P6|Overall Study|Lost to Follow-up|0
655425|NCT02243293|2102386|P5|Overall Study|Lost to Follow-up|0
655426|NCT02243293|2102387|P4|Overall Study|Lost to Follow-up|1
655427|NCT02243293|2102388|P3|Overall Study|Lost to Follow-up|1
655428|NCT02243293|2102389|P2|Overall Study|Lost to Follow-up|1
655429|NCT02243293|2102390|P1|Overall Study|Lost to Follow-up|0
655430|NCT02243293|2102369|P22|Overall Study|Withdrawal by Subject|1
655431|NCT02243293|2102370|P21|Overall Study|Withdrawal by Subject|0
655432|NCT02243293|2102371|P20|Overall Study|Withdrawal by Subject|0
655433|NCT02243293|2102372|P19|Overall Study|Withdrawal by Subject|0
655434|NCT02243293|2102373|P18|Overall Study|Withdrawal by Subject|0
655435|NCT02243293|2102374|P17|Overall Study|Withdrawal by Subject|0
655436|NCT02243293|2102375|P16|Overall Study|Withdrawal by Subject|0
655437|NCT02243293|2102376|P15|Overall Study|Withdrawal by Subject|0
655438|NCT02243293|2102377|P14|Overall Study|Withdrawal by Subject|0
655439|NCT02243293|2102378|P13|Overall Study|Withdrawal by Subject|0
655440|NCT02243293|2102379|P12|Overall Study|Withdrawal by Subject|1
655441|NCT02243293|2102380|P11|Overall Study|Withdrawal by Subject|0
655442|NCT02243293|2102381|P10|Overall Study|Withdrawal by Subject|1
655443|NCT02243293|2102382|P9|Overall Study|Withdrawal by Subject|0
655444|NCT02243293|2102383|P8|Overall Study|Withdrawal by Subject|0
655445|NCT02243293|2102384|P7|Overall Study|Withdrawal by Subject|0
655446|NCT02243293|2102385|P6|Overall Study|Withdrawal by Subject|0
655447|NCT02243293|2102386|P5|Overall Study|Withdrawal by Subject|0
655448|NCT02243293|2102387|P4|Overall Study|Withdrawal by Subject|0
655449|NCT02243293|2102388|P3|Overall Study|Withdrawal by Subject|0
655450|NCT02243293|2102389|P2|Overall Study|Withdrawal by Subject|0
655451|NCT02243293|2102390|P1|Overall Study|Withdrawal by Subject|1
655452|NCT02243293|2102369|P22|Overall Study|Adverse Event|0
655453|NCT02243293|2102370|P21|Overall Study|Adverse Event|1
655454|NCT02243293|2102371|P20|Overall Study|Adverse Event|0
655455|NCT02243293|2102372|P19|Overall Study|Adverse Event|0
655456|NCT02243293|2102373|P18|Overall Study|Adverse Event|0
655457|NCT02243293|2102374|P17|Overall Study|Adverse Event|0
655458|NCT02243293|2102375|P16|Overall Study|Adverse Event|1
655459|NCT02243293|2102376|P15|Overall Study|Adverse Event|0
655460|NCT02243293|2102377|P14|Overall Study|Adverse Event|0
655461|NCT02243293|2102378|P13|Overall Study|Adverse Event|0
655462|NCT02243293|2102379|P12|Overall Study|Adverse Event|0
655463|NCT02243293|2102380|P11|Overall Study|Adverse Event|0
655464|NCT02243293|2102381|P10|Overall Study|Adverse Event|0
655465|NCT02243293|2102382|P9|Overall Study|Adverse Event|0
655466|NCT02243293|2102383|P8|Overall Study|Adverse Event|0
655467|NCT02243293|2102384|P7|Overall Study|Adverse Event|0
655468|NCT02243293|2102385|P6|Overall Study|Adverse Event|0
655469|NCT02243293|2102386|P5|Overall Study|Adverse Event|0
655470|NCT02243293|2102387|P4|Overall Study|Adverse Event|0
655471|NCT02243293|2102388|P3|Overall Study|Adverse Event|0
655472|NCT02243293|2102389|P2|Overall Study|Adverse Event|0
655473|NCT02243293|2102390|P1|Overall Study|Adverse Event|1
655474|NCT02243280|2102489|P11|Treated|Lost to Follow-up|2
655475|NCT02243280|2102490|P10|Treated|Lost to Follow-up|0
655476|NCT02243280|2102491|P9|Treated|Lost to Follow-up|1
655477|NCT02243280|2102492|P8|Treated|Lost to Follow-up|0
655478|NCT02243280|2102493|P7|Treated|Lost to Follow-up|0
655479|NCT02243280|2102494|P6|Treated|Lost to Follow-up|0
655480|NCT02243280|2102495|P5|Treated|Lost to Follow-up|0
655481|NCT02243280|2102496|P4|Treated|Lost to Follow-up|0
655482|NCT02243280|2102497|P3|Treated|Lost to Follow-up|0
655483|NCT02243280|2102498|P2|Treated|Lost to Follow-up|0
655484|NCT02243280|2102499|P1|Treated|Lost to Follow-up|0
655485|NCT02243280|2102489|P11|Treated|Adverse Event|1
655486|NCT02243280|2102490|P10|Treated|Adverse Event|0
655487|NCT02243280|2102491|P9|Treated|Adverse Event|0
655488|NCT02243280|2102492|P8|Treated|Adverse Event|0
655489|NCT02243280|2102493|P7|Treated|Adverse Event|0
655490|NCT02243280|2102494|P6|Treated|Adverse Event|0
655491|NCT02243280|2102495|P5|Treated|Adverse Event|0
655492|NCT02243280|2102496|P4|Treated|Adverse Event|0
655493|NCT02243280|2102497|P3|Treated|Adverse Event|0
655494|NCT02243280|2102498|P2|Treated|Adverse Event|0
655495|NCT02243280|2102499|P1|Treated|Adverse Event|1
655496|NCT02243202|2102554|P4|Overall Study|Randomized but not received treatment|1
655497|NCT02243202|2102555|P3|Overall Study|Randomized but not received treatment|0
655498|NCT02243202|2102556|P2|Overall Study|Randomized but not received treatment|0
655499|NCT02243202|2102557|P1|Overall Study|Randomized but not received treatment|0
655500|NCT02243202|2102554|P4|Overall Study|Unspecified|2
655501|NCT02243202|2102555|P3|Overall Study|Unspecified|1
655502|NCT02243202|2102556|P2|Overall Study|Unspecified|3
655503|NCT02243202|2102557|P1|Overall Study|Unspecified|1
655504|NCT02243202|2102554|P4|Overall Study|Withdrawal by Subject|4
655505|NCT02243202|2102555|P3|Overall Study|Withdrawal by Subject|4
655506|NCT02243202|2102556|P2|Overall Study|Withdrawal by Subject|6
655507|NCT02243202|2102557|P1|Overall Study|Withdrawal by Subject|7
655508|NCT02243202|2102554|P4|Overall Study|Protocol Violation|1
655509|NCT02243202|2102555|P3|Overall Study|Protocol Violation|2
655510|NCT02243202|2102556|P2|Overall Study|Protocol Violation|1
655511|NCT02243202|2102557|P1|Overall Study|Protocol Violation|3
655512|NCT02243202|2102554|P4|Overall Study|Lost to Follow-up|11
655513|NCT02243202|2102555|P3|Overall Study|Lost to Follow-up|14
655514|NCT02243202|2102556|P2|Overall Study|Lost to Follow-up|9
655515|NCT02243202|2102557|P1|Overall Study|Lost to Follow-up|9
655516|NCT02243202|2102554|P4|Overall Study|Adverse Event|4
655517|NCT02243202|2102555|P3|Overall Study|Adverse Event|10
655518|NCT02243202|2102556|P2|Overall Study|Adverse Event|6
655519|NCT02243202|2102557|P1|Overall Study|Adverse Event|5
655520|NCT02243176|2102593|P2|Overall Study|Adverse Event|2
655521|NCT02243176|2102594|P1|Overall Study|Adverse Event|2
655522|NCT02243176|2102593|P2|Overall Study|Withdrawal by Subject|7
655523|NCT02243176|2102594|P1|Overall Study|Withdrawal by Subject|8
655524|NCT02243176|2102593|P2|Overall Study|Protocol Violation|1
655525|NCT02243176|2102594|P1|Overall Study|Protocol Violation|2
655526|NCT02243176|2102593|P2|Overall Study|protocol specified withdrawal critera|3
655527|NCT02243176|2102594|P1|Overall Study|protocol specified withdrawal critera|1
655528|NCT02243176|2102593|P2|Overall Study|Other reason|2
655529|NCT02243176|2102594|P1|Overall Study|Other reason|1
655530|NCT02243046|2102619|P3|Overall Study|Lost to Follow-up|4
655531|NCT02243046|2102620|P2|Overall Study|Lost to Follow-up|1
655532|NCT02243046|2102621|P1|Overall Study|Lost to Follow-up|1
655553|NCT02242305|2102732|P2|Overall Study|Lost to Follow-up|0
655554|NCT02242305|2102733|P1|Overall Study|Lost to Follow-up|2
655555|NCT02242305|2102732|P2|Overall Study|Subject withdraws inform consent|4
655556|NCT02242305|2102733|P1|Overall Study|Subject withdraws inform consent|0
655557|NCT02242305|2102732|P2|Overall Study|Non-compliance dosing regimen or visit|2
655558|NCT02242305|2102733|P1|Overall Study|Non-compliance dosing regimen or visit|2
655559|NCT02242305|2102732|P2|Overall Study|Adverse Event|0
655560|NCT02242305|2102733|P1|Overall Study|Adverse Event|1
655561|NCT02242305|2102732|P2|Overall Study|Without spasm-like pain during 3 weeks|4
655562|NCT02242305|2102733|P1|Overall Study|Without spasm-like pain during 3 weeks|1
655563|NCT02241889|2102757|P6|Overall Study|Withdrawal by Subject|1
655564|NCT02241889|2102758|P5|Overall Study|Withdrawal by Subject|0
655565|NCT02241889|2102759|P4|Overall Study|Withdrawal by Subject|0
655566|NCT02241889|2102760|P3|Overall Study|Withdrawal by Subject|0
655567|NCT02241889|2102761|P2|Overall Study|Withdrawal by Subject|0
655568|NCT02241889|2102762|P1|Overall Study|Withdrawal by Subject|0
655569|NCT02241889|2102757|P6|Overall Study|device issues|0
655570|NCT02241889|2102758|P5|Overall Study|device issues|0
655571|NCT02241889|2102759|P4|Overall Study|device issues|0
655572|NCT02241889|2102760|P3|Overall Study|device issues|1
655573|NCT02241889|2102761|P2|Overall Study|device issues|0
655574|NCT02241889|2102762|P1|Overall Study|device issues|0
655575|NCT02241785|2102797|P1|Overall Study|Adverse Event|1
655576|NCT02241785|2102797|P1|Overall Study|Lost to Follow-up|2
655577|NCT02241785|2102797|P1|Overall Study|Withdrawal by Subject|1
655578|NCT02241785|2102797|P1|Overall Study|Sponsor Termination|43
655579|NCT02241187|2102809|P1|Overall Study|Protocol closed due to lack of accrual.|2
655580|NCT02240628|2102816|P2|Overall Study|Physician Decision|5
655581|NCT02240628|2102817|P1|Overall Study|Physician Decision|6
655582|NCT02240368|2102851|P3|Overall Study|Entropy failed to detect more than 50%|1
655583|NCT02240368|2102852|P2|Overall Study|Entropy failed to detect more than 50%|0
655584|NCT02240368|2102853|P1|Overall Study|Entropy failed to detect more than 50%|0
655585|NCT02240368|2102851|P3|Overall Study|Surgery lasted less then 20 minutes|0
655586|NCT02240368|2102852|P2|Overall Study|Surgery lasted less then 20 minutes|0
655587|NCT02240368|2102853|P1|Overall Study|Surgery lasted less then 20 minutes|1
655588|NCT02239978|2102877|P2|Overall Study|Withdrawal by Subject|0
655589|NCT02239978|2102878|P1|Overall Study|Withdrawal by Subject|2
655590|NCT02239926|2102895|P2|Overall Study|Withdrawal by Subject|1
655591|NCT02239926|2102896|P1|Overall Study|Withdrawal by Subject|0
655592|NCT02239692|2102921|P2|Overall Study|Other reason|0
655593|NCT02239692|2102922|P1|Overall Study|Other reason|1
655594|NCT02239692|2102921|P2|Overall Study|Withdrawal by Subject|5
655595|NCT02239692|2102922|P1|Overall Study|Withdrawal by Subject|3
655596|NCT02239692|2102921|P2|Overall Study|Lost to Follow-up|4
655597|NCT02239692|2102922|P1|Overall Study|Lost to Follow-up|1
655598|NCT02239692|2102921|P2|Overall Study|Physician Decision|1
655599|NCT02239692|2102922|P1|Overall Study|Physician Decision|0
655600|NCT02239692|2102921|P2|Overall Study|Adverse Event|1
655601|NCT02239692|2102922|P1|Overall Study|Adverse Event|0
655602|NCT02239692|2102921|P2|Overall Study|Incomplete colonoscopy|2
655603|NCT02239692|2102922|P1|Overall Study|Incomplete colonoscopy|1
655604|NCT02239679|2102941|P3|Overall Study|Withdrawal by Subject|1
655605|NCT02239679|2102942|P2|Overall Study|Withdrawal by Subject|3
655606|NCT02239679|2102943|P1|Overall Study|Withdrawal by Subject|2
655607|NCT02239679|2102941|P3|Overall Study|Lost to Follow-up|0
655608|NCT02239679|2102942|P2|Overall Study|Lost to Follow-up|0
655609|NCT02239679|2102943|P1|Overall Study|Lost to Follow-up|1
655610|NCT02238379|2103180|P2|Overall Study|Lost to Follow-up|0
655611|NCT02238379|2103181|P1|Overall Study|Lost to Follow-up|1
655612|NCT02238080|2103207|P1|Overall Study|Unspecified|4
655613|NCT02238080|2103207|P1|Overall Study|Withdrawal by Subject|2
655614|NCT02238080|2103207|P1|Overall Study|Treatment interrupted|6
655615|NCT02238080|2103207|P1|Overall Study|Death|13
655616|NCT02238067|2103221|P1|Overall Study|Not completed survey at Month 6|45
655617|NCT02237118|2103266|P2|Overall Study|consent withdrawn|0
655618|NCT02237118|2103267|P1|Overall Study|consent withdrawn|1
655619|NCT02237118|2103266|P2|Overall Study|Protocol Violation|1
655620|NCT02237118|2103267|P1|Overall Study|Protocol Violation|0
888138|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
888139|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
888140|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
888141|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
888142|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
888143|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
888144|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
888145|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
655631|NCT02236598|2103313|P2|Overall Study|Withdrawal by Subject|1
655632|NCT02236598|2103314|P1|Overall Study|Withdrawal by Subject|0
655633|NCT02236598|2103313|P2|Overall Study|Adverse Event|1
655634|NCT02236598|2103314|P1|Overall Study|Adverse Event|0
655635|NCT02236130|2103335|P2|Overall Study|Lost to Follow-up|12
655636|NCT02236130|2103336|P1|Overall Study|Lost to Follow-up|7
655637|NCT02235454|2103361|P1|Overall Study|Withdrawal by Subject|2
655638|NCT02235311|2103367|P2|Overall Study|Protocol Violation|1
655639|NCT02235311|2103368|P1|Overall Study|Protocol Violation|0
655640|NCT02235311|2103367|P2|Overall Study|Lost to Follow-up|1
655641|NCT02235311|2103368|P1|Overall Study|Lost to Follow-up|0
655642|NCT02235077|2103386|P2|Overall Study|Physician Decision|1
655643|NCT02235077|2103387|P1|Overall Study|Physician Decision|0
655644|NCT02235077|2103386|P2|Overall Study|Withdrawal by Subject|5
655645|NCT02235077|2103387|P1|Overall Study|Withdrawal by Subject|8
655646|NCT02235077|2103386|P2|Overall Study|Lost to Follow-up|6
655647|NCT02235077|2103387|P1|Overall Study|Lost to Follow-up|5
655648|NCT02235077|2103386|P2|Overall Study|Death|7
655649|NCT02235077|2103387|P1|Overall Study|Death|5
655650|NCT02234479|2103444|P2|Overall Study|Withdrawal by Subject|3
655651|NCT02234479|2103445|P1|Overall Study|Withdrawal by Subject|1
655652|NCT02234362|2103455|P1|Overall Study|Withdrawal by Subject|3
655653|NCT02234362|2103455|P1|Overall Study|Lost to Follow-up|6
655654|NCT02234362|2103455|P1|Overall Study|Not eligible after first screening visit|17
655655|NCT02233803|2103531|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
655656|NCT02233803|2103532|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
655657|NCT02233803|2103531|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
655658|NCT02233803|2103532|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
655659|NCT02233803|2103531|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
655660|NCT02233803|2103532|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
655661|NCT02233803|2103531|P2|Washout Period (4-Wks)|Physician Decision|0
655662|NCT02233803|2103532|P1|Washout Period (4-Wks)|Physician Decision|1
655663|NCT02233803|2103531|P2|Washout Period (4-Wks)|Lost to Follow-up|1
655664|NCT02233803|2103532|P1|Washout Period (4-Wks)|Lost to Follow-up|0
655665|NCT02233803|2103531|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
655666|NCT02233803|2103532|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
655667|NCT02233803|2103531|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
655668|NCT02233803|2103532|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
655669|NCT02233803|2103531|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
655670|NCT02233803|2103532|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
655671|NCT02233803|2103531|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
655672|NCT02233803|2103532|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
655673|NCT02233647|2103542|P1|Overall Study|Adverse Event|1
655674|NCT02233309|2103571|P1|Overall Study|Physician Decision|5
655675|NCT02232880|2103605|P1|Overall Study|study stopped prior to randomization|1
655676|NCT02232698|2103614|P2|Overall Study|Withdrawal by Subject|11
655677|NCT02232698|2103615|P1|Overall Study|Withdrawal by Subject|0
655678|NCT02232698|2103614|P2|Overall Study|Allocated to control group|3
655679|NCT02232698|2103615|P1|Overall Study|Allocated to control group|0
655680|NCT02232698|2103614|P2|Overall Study|Non-compliance with study device|4
655681|NCT02232698|2103615|P1|Overall Study|Non-compliance with study device|1
655682|NCT02232698|2103614|P2|Overall Study|Had device-associated symptoms|0
655683|NCT02232698|2103615|P1|Overall Study|Had device-associated symptoms|7
655684|NCT02232698|2103614|P2|Overall Study|Met exclusion criteria|1
655685|NCT02232698|2103615|P1|Overall Study|Met exclusion criteria|1
655686|NCT02232698|2103614|P2|Overall Study|Pregnancy|1
655687|NCT02232698|2103615|P1|Overall Study|Pregnancy|1
655688|NCT02231918|2103650|P3|Overall Study|Adverse Event|1
655689|NCT02231918|2103651|P2|Overall Study|Adverse Event|0
655690|NCT02231918|2103652|P1|Overall Study|Adverse Event|0
655691|NCT02231918|2103650|P3|Overall Study|Withdrawal by Subject|0
655692|NCT02231918|2103651|P2|Overall Study|Withdrawal by Subject|1
655693|NCT02231918|2103652|P1|Overall Study|Withdrawal by Subject|0
655694|NCT02231164|2103775|P2|Overall Study|Withdrawal by Subject|2
655695|NCT02231164|2103776|P1|Overall Study|Withdrawal by Subject|1
655696|NCT02231164|2103775|P2|Overall Study|Lack of Efficacy|3
655697|NCT02231164|2103776|P1|Overall Study|Lack of Efficacy|4
655698|NCT02231164|2103775|P2|Overall Study|Adverse Event|1
655699|NCT02231164|2103776|P1|Overall Study|Adverse Event|1
655700|NCT02230956|2103804|P3|Overall Study|Other Miscellaneous Reason|2
655701|NCT02230956|2103805|P2|Overall Study|Other Miscellaneous Reason|1
655702|NCT02230956|2103806|P1|Overall Study|Other Miscellaneous Reason|0
655703|NCT02230956|2103804|P3|Overall Study|Protocol Violation|1
655704|NCT02230956|2103805|P2|Overall Study|Protocol Violation|1
655705|NCT02230956|2103806|P1|Overall Study|Protocol Violation|0
655706|NCT02230956|2103804|P3|Overall Study|Personal Reasons|1
655707|NCT02230956|2103805|P2|Overall Study|Personal Reasons|1
655708|NCT02230956|2103806|P1|Overall Study|Personal Reasons|2
655709|NCT02230956|2103804|P3|Overall Study|Lost to Follow-up|2
655710|NCT02230956|2103805|P2|Overall Study|Lost to Follow-up|1
655711|NCT02230956|2103806|P1|Overall Study|Lost to Follow-up|1
655712|NCT02230956|2103804|P3|Overall Study|Lack of Efficacy|1
655713|NCT02230956|2103805|P2|Overall Study|Lack of Efficacy|1
655714|NCT02230956|2103806|P1|Overall Study|Lack of Efficacy|1
655715|NCT02230956|2103804|P3|Overall Study|Adverse Event|0
655716|NCT02230956|2103805|P2|Overall Study|Adverse Event|1
655717|NCT02230956|2103806|P1|Overall Study|Adverse Event|1
655718|NCT02230904|2103828|P2|Overall Study|Safety follow up could not take place|1
655719|NCT02230904|2103829|P1|Overall Study|Safety follow up could not take place|0
655720|NCT02230683|2103862|P1|Overall Study|Adverse Event|1
655721|NCT02230670|2103879|P2|Overall Study|Progression to Child-Pugh C|2
655722|NCT02230670|2103880|P1|Overall Study|Progression to Child-Pugh C|1
655723|NCT02230670|2103879|P2|Overall Study|Protocol Violation|1
655724|NCT02230670|2103880|P1|Overall Study|Protocol Violation|0
655725|NCT02230670|2103879|P2|Overall Study|Physician Decision|1
655726|NCT02230670|2103880|P1|Overall Study|Physician Decision|0
655727|NCT02230670|2103879|P2|Overall Study|Withdrawal by Subject|2
655728|NCT02230670|2103880|P1|Overall Study|Withdrawal by Subject|2
655729|NCT02230670|2103879|P2|Overall Study|Adverse Event|2
655730|NCT02230670|2103880|P1|Overall Study|Adverse Event|1
655731|NCT02230085|2103895|P1|Overall Study|Withdrawal by Subject|3
655732|NCT02230085|2103895|P1|Overall Study|Physician Decision|1
655733|NCT02229864|2103899|P1|2 - Year Visit|Missed Visits|1
655734|NCT02229539|2103948|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
655735|NCT02229539|2103949|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
655736|NCT02229539|2103950|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
655737|NCT02229539|2103948|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
655738|NCT02229539|2103949|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
655739|NCT02229539|2103950|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
655740|NCT02229539|2103948|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
655741|NCT02229539|2103949|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
655742|NCT02229539|2103950|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
655743|NCT02229539|2103948|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
655744|NCT02229539|2103949|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
655745|NCT02229539|2103950|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
655746|NCT02229539|2103948|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
655747|NCT02229539|2103949|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
655748|NCT02229539|2103950|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
655749|NCT02229539|2103948|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
655750|NCT02229539|2103949|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
655751|NCT02229539|2103950|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
655752|NCT02229539|2103948|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
655753|NCT02229539|2103949|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
655754|NCT02229539|2103950|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
655755|NCT02229539|2103948|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
655756|NCT02229539|2103949|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
655757|NCT02229539|2103950|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
655758|NCT02229539|2103948|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
655759|NCT02229539|2103949|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
655760|NCT02229539|2103950|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
888146|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
888147|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888148|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888149|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888150|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
888151|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888152|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888153|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888154|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888155|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
888156|NCT02207244|2821515|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888157|NCT02207244|2821516|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888158|NCT02207244|2821517|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888159|NCT02207244|2821518|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
888160|NCT02207244|2821519|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
888161|NCT02207244|2821520|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888162|NCT02207244|2821521|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888163|NCT02207244|2821522|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888164|NCT02207244|2821523|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
888165|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Other|0
888166|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Other|0
888167|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Other|0
888168|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Other|0
888169|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Other|0
888170|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Other|0
888171|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Other|0
888172|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Other|1
888173|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Other|0
888174|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888175|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888176|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888177|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888178|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888179|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888180|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
655803|NCT02228980|2104136|P4|Overall Study|Withdrawal by Subject|3
655804|NCT02228980|2104137|P3|Overall Study|Withdrawal by Subject|2
655805|NCT02228980|2104138|P2|Overall Study|Withdrawal by Subject|3
655806|NCT02228980|2104139|P1|Overall Study|Withdrawal by Subject|3
655807|NCT02228980|2104136|P4|Overall Study|Protocol Violation|0
655808|NCT02228980|2104137|P3|Overall Study|Protocol Violation|0
655809|NCT02228980|2104138|P2|Overall Study|Protocol Violation|0
655810|NCT02228980|2104139|P1|Overall Study|Protocol Violation|7
655811|NCT02228980|2104136|P4|Overall Study|Adverse Event|0
655812|NCT02228980|2104137|P3|Overall Study|Adverse Event|0
655813|NCT02228980|2104138|P2|Overall Study|Adverse Event|0
655814|NCT02228980|2104139|P1|Overall Study|Adverse Event|14
655815|NCT02228720|2104161|P1|Open Label - Day 30|Lost to Follow-up|1
655816|NCT02228395|2104169|P3|First Intervention Period|Unable to comply with study dates|1
655817|NCT02228395|2104170|P2|First Intervention Period|Unable to comply with study dates|1
655818|NCT02228395|2104171|P1|First Intervention Period|Unable to comply with study dates|0
655819|NCT02228395|2104169|P3|First Intervention Period|No longer willing to participate|0
655820|NCT02228395|2104170|P2|First Intervention Period|No longer willing to participate|0
655821|NCT02228395|2104171|P1|First Intervention Period|No longer willing to participate|1
655822|NCT02227368|2104271|P2|Overall Study|Adverse Event|0
655823|NCT02227368|2104272|P1|Overall Study|Adverse Event|1
655824|NCT02227368|2104271|P2|Overall Study|Lost to Follow-up|0
655825|NCT02227368|2104272|P1|Overall Study|Lost to Follow-up|1
655826|NCT02227368|2104271|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
655827|NCT02227368|2104272|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
655828|NCT02227108|2104284|P1|Overall Study|Adverse Event|6
655829|NCT02227108|2104284|P1|Overall Study|Investigator discretion|1
655830|NCT02227108|2104284|P1|Overall Study|Initiation of alternative therapy|2
655831|NCT02227108|2104284|P1|Overall Study|Progressive disease|17
655832|NCT02227108|2104284|P1|Overall Study|Unspecified|3
655833|NCT02227108|2104284|P1|Overall Study|Did not receive treatment|2
655834|NCT02226562|2104313|P2|Overall Study|Lost to Follow-up|1
655835|NCT02226562|2104314|P1|Overall Study|Lost to Follow-up|0
655836|NCT02226549|2104332|P2|Overall Study|Lost to Follow-up|1
655837|NCT02226549|2104333|P1|Overall Study|Lost to Follow-up|0
655838|NCT02226549|2104332|P2|Overall Study|Randomized but Never Treated|0
655839|NCT02226549|2104333|P1|Overall Study|Randomized but Never Treated|1
655840|NCT02226198|2104343|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
655841|NCT02226198|2104344|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
655842|NCT02226198|2104345|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
655843|NCT02226198|2104343|P3|Lead-in Phase|Protocol Violation|0
655844|NCT02226198|2104344|P2|Lead-in Phase|Protocol Violation|0
655845|NCT02226198|2104345|P1|Lead-in Phase|Protocol Violation|1
655846|NCT02226003|2104421|P3|Overall Study|Withdrawal by Subject|3
655847|NCT02226003|2104422|P2|Overall Study|Withdrawal by Subject|0
655848|NCT02226003|2104423|P1|Overall Study|Withdrawal by Subject|0
655849|NCT02226003|2104421|P3|Overall Study|Lost to Follow-up|3
655850|NCT02226003|2104422|P2|Overall Study|Lost to Follow-up|1
655851|NCT02226003|2104423|P1|Overall Study|Lost to Follow-up|2
655852|NCT02224664|2104476|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
655853|NCT02224664|2104477|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
655854|NCT02224664|2104478|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
655855|NCT02224664|2104479|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
655856|NCT02224664|2104480|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
655857|NCT02224664|2104476|P5|Dose Escalation Period (21 Days)|Adverse Event|7
655858|NCT02224664|2104477|P4|Dose Escalation Period (21 Days)|Adverse Event|2
655859|NCT02224664|2104478|P3|Dose Escalation Period (21 Days)|Adverse Event|2
655860|NCT02224664|2104479|P2|Dose Escalation Period (21 Days)|Adverse Event|0
655861|NCT02224664|2104480|P1|Dose Escalation Period (21 Days)|Adverse Event|0
655862|NCT02224664|2104476|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
655863|NCT02224664|2104477|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
655864|NCT02224664|2104478|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
655865|NCT02224664|2104479|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
655866|NCT02224664|2104480|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
655867|NCT02224625|2104560|P1|Sensitization|Adverse Event|55
655868|NCT02224625|2104560|P1|Irritation|Adverse Event|6
655869|NCT02224053|2104590|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
655870|NCT02224053|2104590|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
655871|NCT02224053|2104590|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
655872|NCT02224053|2104590|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
655873|NCT02224053|2104590|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
655874|NCT02223754|2104636|P2|Period 2|Test Article No Longer Available|1
655875|NCT02223754|2104637|P1|Period 2|Test Article No Longer Available|0
655876|NCT02223754|2104636|P2|Period 2|Lost to Follow-up|0
655877|NCT02223754|2104637|P1|Period 2|Lost to Follow-up|1
655878|NCT02223754|2104636|P2|Period 2|Lens Discomfort|1
655879|NCT02223754|2104637|P1|Period 2|Lens Discomfort|1
655880|NCT02223754|2104636|P2|Period 2|Protocol Violation|0
655881|NCT02223754|2104637|P1|Period 2|Protocol Violation|1
655882|NCT02223754|2104636|P2|Period 2|Adverse Event|1
655883|NCT02223754|2104637|P1|Period 2|Adverse Event|0
655884|NCT02223754|2104636|P2|Period 1|Unsatisfactory Visual Response|1
655885|NCT02223754|2104637|P1|Period 1|Unsatisfactory Visual Response|0
655886|NCT02223754|2104636|P2|Period 1|Test Article No Longer Available|5
655887|NCT02223754|2104637|P1|Period 1|Test Article No Longer Available|1
655888|NCT02223754|2104636|P2|Period 1|Withdrawal by Subject|4
655889|NCT02223754|2104637|P1|Period 1|Withdrawal by Subject|0
655890|NCT02223754|2104636|P2|Period 1|Protocol Violation|4
655891|NCT02223754|2104637|P1|Period 1|Protocol Violation|2
655892|NCT02223754|2104636|P2|Period 1|Lost to Follow-up|1
655893|NCT02223754|2104637|P1|Period 1|Lost to Follow-up|0
655894|NCT02223754|2104636|P2|Period 1|Adverse Event|0
655895|NCT02223754|2104637|P1|Period 1|Adverse Event|1
655896|NCT02223715|2104657|P1|Overall Study|Lost to Follow-up|73
655897|NCT02223715|2104657|P1|Overall Study|Death|31
655898|NCT02223364|2104735|P3|Overall Study|Physician Decision|0
655899|NCT02223364|2104736|P2|Overall Study|Physician Decision|0
655900|NCT02223364|2104737|P1|Overall Study|Physician Decision|1
655901|NCT02223364|2104735|P3|Overall Study|subject expired before surgery|0
655902|NCT02223364|2104736|P2|Overall Study|subject expired before surgery|0
655903|NCT02223364|2104737|P1|Overall Study|subject expired before surgery|1
655904|NCT02223364|2104735|P3|Overall Study|Protocol Violation|3
655905|NCT02223364|2104736|P2|Overall Study|Protocol Violation|0
655906|NCT02223364|2104737|P1|Overall Study|Protocol Violation|3
655907|NCT02222818|2104841|P2|Period 1|Eligibility criteria not met|3
655908|NCT02222818|2104842|P1|Period 1|Eligibility criteria not met|0
655909|NCT02222558|2104849|P6|Period 3|Withdrawal by Subject|1
655910|NCT02222558|2104850|P5|Period 3|Withdrawal by Subject|0
655911|NCT02222558|2104851|P4|Period 3|Withdrawal by Subject|0
655912|NCT02222558|2104852|P3|Period 3|Withdrawal by Subject|0
655913|NCT02222558|2104853|P2|Period 3|Withdrawal by Subject|0
655914|NCT02222558|2104854|P1|Period 3|Withdrawal by Subject|0
655915|NCT02222558|2104849|P6|Period 1: Single Dose|Withdrawal by Subject|0
655916|NCT02222558|2104850|P5|Period 1: Single Dose|Withdrawal by Subject|0
655917|NCT02222558|2104851|P4|Period 1: Single Dose|Withdrawal by Subject|0
655918|NCT02222558|2104852|P3|Period 1: Single Dose|Withdrawal by Subject|0
655919|NCT02222558|2104853|P2|Period 1: Single Dose|Withdrawal by Subject|0
655920|NCT02222558|2104854|P1|Period 1: Single Dose|Withdrawal by Subject|4
655921|NCT02222493|2104870|P2|Overall Study|Randomized but not treated|0
655922|NCT02222493|2104871|P1|Overall Study|Randomized but not treated|1
655923|NCT02222493|2104870|P2|Overall Study|Unspecified|0
655924|NCT02222493|2104871|P1|Overall Study|Unspecified|4
655925|NCT02222493|2104870|P2|Overall Study|Adverse Event|20
655926|NCT02222493|2104871|P1|Overall Study|Adverse Event|18
655927|NCT02222493|2104870|P2|Overall Study|Pregnancy|0
655928|NCT02222493|2104871|P1|Overall Study|Pregnancy|2
655929|NCT02222493|2104870|P2|Overall Study|Non-compliance with study treatment|0
655930|NCT02222493|2104871|P1|Overall Study|Non-compliance with study treatment|1
655931|NCT02222493|2104870|P2|Overall Study|Insufficient clinical response|7
655932|NCT02222493|2104871|P1|Overall Study|Insufficient clinical response|0
655933|NCT02222493|2104870|P2|Overall Study|Protocol Violation|1
655934|NCT02222493|2104871|P1|Overall Study|Protocol Violation|5
655935|NCT02222493|2104870|P2|Overall Study|Withdrawal by Subject|9
655936|NCT02222493|2104871|P1|Overall Study|Withdrawal by Subject|11
655937|NCT02222493|2104870|P2|Overall Study|Lost to Follow-up|1
655938|NCT02222493|2104871|P1|Overall Study|Lost to Follow-up|0
655939|NCT02222493|2104870|P2|Overall Study|Death|2
655940|NCT02222493|2104871|P1|Overall Study|Death|2
655941|NCT02222246|2104879|P2|Overall Study|Physician Decision|1
655942|NCT02222246|2104880|P1|Overall Study|Physician Decision|0
655943|NCT02222246|2104879|P2|Overall Study|No Emergency Department Visits|26
655944|NCT02222246|2104880|P1|Overall Study|No Emergency Department Visits|27
655945|NCT02222207|2104908|P1|Overall Study|Adverse Event|1
655946|NCT02222207|2104908|P1|Overall Study|Other reasons|2
655947|NCT02222207|2104908|P1|Overall Study|Death|1
655948|NCT02221648|2104945|P2|Overall Study|Withdrawal by Subject|3
655949|NCT02221648|2104946|P1|Overall Study|Withdrawal by Subject|3
655950|NCT02220998|2104962|P2|Overall Study|Lost to Follow-up|4
655951|NCT02220998|2104963|P1|Overall Study|Lost to Follow-up|4
655952|NCT02220998|2104962|P2|Overall Study|Lack of Efficacy|5
655953|NCT02220998|2104963|P1|Overall Study|Lack of Efficacy|0
655954|NCT02220998|2104962|P2|Overall Study|Death|0
655955|NCT02220998|2104963|P1|Overall Study|Death|2
655956|NCT02220998|2104962|P2|Overall Study|Randomized but Never Treated|2
655957|NCT02220998|2104963|P1|Overall Study|Randomized but Never Treated|1
655958|NCT02220920|2104981|P2|Overall Study|Conflict with the stopping criteria|2
655959|NCT02220920|2104982|P1|Overall Study|Conflict with the stopping criteria|1
655960|NCT02220920|2104981|P2|Overall Study|Withdrawal by Subject|0
655961|NCT02220920|2104982|P1|Overall Study|Withdrawal by Subject|1
655962|NCT02220920|2104981|P2|Overall Study|Lack of Efficacy|1
655963|NCT02220920|2104982|P1|Overall Study|Lack of Efficacy|0
655964|NCT02220920|2104981|P2|Overall Study|Adverse Event|0
655965|NCT02220920|2104982|P1|Overall Study|Adverse Event|1
655966|NCT02220764|2104998|P2|Overall Study|Death|0
655967|NCT02220764|2104999|P1|Overall Study|Death|1
655968|NCT02220764|2104998|P2|Overall Study|Lost to Follow-up|1
655969|NCT02220764|2104999|P1|Overall Study|Lost to Follow-up|3
655970|NCT02220205|2105011|P2|Overall Study|Withdrawal by Subject|0
655971|NCT02220205|2105012|P1|Overall Study|Withdrawal by Subject|1
655972|NCT02219932|2105037|P2|Overall Study|Adverse Event|21
655973|NCT02219932|2105038|P1|Overall Study|Adverse Event|23
655974|NCT02219932|2105037|P2|Overall Study|Lost to Follow-up|2
655975|NCT02219932|2105038|P1|Overall Study|Lost to Follow-up|4
655976|NCT02219932|2105037|P2|Overall Study|Pregnancy|0
655977|NCT02219932|2105038|P1|Overall Study|Pregnancy|1
655978|NCT02219932|2105037|P2|Overall Study|Protocol Violation|6
655979|NCT02219932|2105038|P1|Overall Study|Protocol Violation|10
655980|NCT02219932|2105037|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
655981|NCT02219932|2105038|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
655982|NCT02219932|2105037|P2|Overall Study|Consent Withdrawn|7
655983|NCT02219932|2105038|P1|Overall Study|Consent Withdrawn|11
655984|NCT02219932|2105037|P2|Overall Study|Investigator Decision|1
655985|NCT02219932|2105038|P1|Overall Study|Investigator Decision|0
655986|NCT02219932|2105037|P2|Overall Study|Death|1
655987|NCT02219932|2105038|P1|Overall Study|Death|1
655988|NCT02219932|2105037|P2|Overall Study|Not Specified|11
655989|NCT02219932|2105038|P1|Overall Study|Not Specified|5
655990|NCT02219685|2105054|P2|Blinded Treatment Phase|Withdrew Consent|0
655991|NCT02219685|2105055|P1|Blinded Treatment Phase|Withdrew Consent|1
655992|NCT02219685|2105054|P2|Blinded Treatment Phase|Lost to Follow-up|0
655993|NCT02219685|2105055|P1|Blinded Treatment Phase|Lost to Follow-up|1
655994|NCT02219477|2105161|P3|Overall Study|Withdrawal by Subject|0
655995|NCT02219477|2105162|P2|Overall Study|Withdrawal by Subject|1
655996|NCT02219477|2105163|P1|Overall Study|Withdrawal by Subject|0
655997|NCT02219477|2105161|P3|Overall Study|Adverse Event|1
655998|NCT02219477|2105162|P2|Overall Study|Adverse Event|1
655999|NCT02219477|2105163|P1|Overall Study|Adverse Event|0
656000|NCT02219464|2105191|P2|Overall Study|catheter malfunction|0
656001|NCT02219464|2105192|P1|Overall Study|catheter malfunction|1
656002|NCT02219464|2105191|P2|Overall Study|case cancelled|0
656003|NCT02219464|2105192|P1|Overall Study|case cancelled|1
656004|NCT02219464|2105191|P2|Overall Study|Withdrawal by Subject|0
656005|NCT02219464|2105192|P1|Overall Study|Withdrawal by Subject|1
888181|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
888182|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
888183|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
888184|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
888185|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
656012|NCT02217280|2105391|P1|Overall Study|Post-consent sceen fail|2
656013|NCT02217280|2105391|P1|Overall Study|Withdrawal by Subject|2
656014|NCT02218268|2105407|P2|24 Hour Washout|Physician Decision|9
656015|NCT02218268|2105408|P1|24 Hour Washout|Physician Decision|11
656016|NCT02218216|2105416|P3|Overall Study|Study terminated before completed|0
656017|NCT02218216|2105417|P2|Overall Study|Study terminated before completed|0
656018|NCT02218216|2105418|P1|Overall Study|Study terminated before completed|6
656019|NCT02217982|2105428|P2|Overall Study|Adverse Event|1
656020|NCT02217982|2105429|P1|Overall Study|Adverse Event|0
656021|NCT02217982|2105428|P2|Overall Study|Trial discontinued|0
656022|NCT02217982|2105429|P1|Overall Study|Trial discontinued|1
656023|NCT02217878|2105439|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
656024|NCT02217878|2105440|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
656025|NCT02217878|2105439|P2|Overall Study|required morphine due to chest pain|2
656026|NCT02217878|2105440|P1|Overall Study|required morphine due to chest pain|1
656027|NCT02216591|2105531|P2|Overall Study|Lost to Follow-up|1
656028|NCT02216591|2105532|P1|Overall Study|Lost to Follow-up|0
656029|NCT02216357|2105550|P2|Overall Study|Inclusion or exclusion criteria not met|1
656030|NCT02216357|2105551|P1|Overall Study|Inclusion or exclusion criteria not met|2
656031|NCT02215954|2105603|P3|Overall Study|Not exposed|3
656032|NCT02215954|2105604|P2|Overall Study|Not exposed|1
656033|NCT02215954|2105605|P1|Overall Study|Not exposed|1
656034|NCT02215954|2105603|P3|Overall Study|Withdrawal by Subject|2
656035|NCT02215954|2105604|P2|Overall Study|Withdrawal by Subject|0
656036|NCT02215954|2105605|P1|Overall Study|Withdrawal by Subject|0
656037|NCT02215954|2105603|P3|Overall Study|Adverse Event|1
656038|NCT02215954|2105604|P2|Overall Study|Adverse Event|0
656039|NCT02215954|2105605|P1|Overall Study|Adverse Event|0
656040|NCT02215252|2105628|P3|Overall Study|Unspecified|1
656041|NCT02215252|2105629|P2|Overall Study|Unspecified|1
656042|NCT02215252|2105630|P1|Overall Study|Unspecified|0
656043|NCT02215252|2105628|P3|Overall Study|Withdrawal by Subject|0
656044|NCT02215252|2105629|P2|Overall Study|Withdrawal by Subject|0
656045|NCT02215252|2105630|P1|Overall Study|Withdrawal by Subject|1
656046|NCT02215252|2105628|P3|Overall Study|Protocol Violation|0
656047|NCT02215252|2105629|P2|Overall Study|Protocol Violation|1
656048|NCT02215252|2105630|P1|Overall Study|Protocol Violation|0
656049|NCT02215252|2105628|P3|Overall Study|Does not Meet Entrance Criteria|0
656050|NCT02215252|2105629|P2|Overall Study|Does not Meet Entrance Criteria|1
656051|NCT02215252|2105630|P1|Overall Study|Does not Meet Entrance Criteria|0
656052|NCT02215252|2105628|P3|Overall Study|Lost to Follow-up|1
656053|NCT02215252|2105629|P2|Overall Study|Lost to Follow-up|0
656054|NCT02215252|2105630|P1|Overall Study|Lost to Follow-up|0
656055|NCT02215252|2105628|P3|Overall Study|Adverse Event|2
656056|NCT02215252|2105629|P2|Overall Study|Adverse Event|5
656057|NCT02215252|2105630|P1|Overall Study|Adverse Event|1
656058|NCT02214225|2105714|P3|Overall Study|randomized in error, not vaccinated|1
656059|NCT02214225|2105715|P2|Overall Study|randomized in error, not vaccinated|1
656060|NCT02214225|2105716|P1|Overall Study|randomized in error, not vaccinated|2
656061|NCT02214225|2105714|P3|Overall Study|Death|1
656062|NCT02214225|2105715|P2|Overall Study|Death|0
656063|NCT02214225|2105716|P1|Overall Study|Death|5
656064|NCT02214225|2105714|P3|Overall Study|Withdrawal by Subject|2
656065|NCT02214225|2105715|P2|Overall Study|Withdrawal by Subject|0
656066|NCT02214225|2105716|P1|Overall Study|Withdrawal by Subject|2
656067|NCT02214225|2105714|P3|Overall Study|Lost to Follow-up|18
656068|NCT02214225|2105715|P2|Overall Study|Lost to Follow-up|18
656069|NCT02214225|2105716|P1|Overall Study|Lost to Follow-up|46
656070|NCT02214186|2105775|P2|Overall Study|Protocol Violation|1
656071|NCT02214186|2105776|P1|Overall Study|Protocol Violation|1
656072|NCT02214186|2105775|P2|Overall Study|Lost to Follow-up|1
656073|NCT02214186|2105776|P1|Overall Study|Lost to Follow-up|1
656074|NCT02213666|2105813|P1|Overall Study|Withdrawal by Subject|1
656075|NCT02213510|2105819|P2|Overall Study|Lost to Follow-up|0
656076|NCT02213510|2105820|P1|Overall Study|Lost to Follow-up|1
656077|NCT02213510|2105819|P2|Overall Study|Death|1
656078|NCT02213510|2105820|P1|Overall Study|Death|0
656079|NCT02213198|2105878|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
656080|NCT02213198|2105879|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
656081|NCT02213198|2105878|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
656082|NCT02213198|2105879|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
656083|NCT02213198|2105878|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
656084|NCT02213198|2105879|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
656085|NCT02213198|2105878|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
656086|NCT02213198|2105879|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
656087|NCT02213198|2105878|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
656088|NCT02213198|2105879|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
656089|NCT02213198|2105878|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
656090|NCT02213198|2105879|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
656091|NCT02213198|2105878|P2|Baseline|incarcerated,violent|1
656092|NCT02213198|2105879|P1|Baseline|incarcerated,violent|0
656093|NCT02213198|2105878|P2|Baseline|Lost to Follow-up|21
656094|NCT02213198|2105879|P1|Baseline|Lost to Follow-up|40
656095|NCT02213198|2105878|P2|Baseline|transferred out of clinic|9
656096|NCT02213198|2105879|P1|Baseline|transferred out of clinic|7
656097|NCT02213198|2105878|P2|Baseline|Withdrawal by Subject|11
656098|NCT02213198|2105879|P1|Baseline|Withdrawal by Subject|34
656099|NCT02213198|2105878|P2|Baseline|No show for intake|9
656100|NCT02213198|2105879|P1|Baseline|No show for intake|7
656101|NCT02213055|2105889|P2|Overall Study|Did not Return to School|0
656102|NCT02213055|2105890|P1|Overall Study|Did not Return to School|5
656103|NCT02213055|2105889|P2|Overall Study|Did not meet Inclusion Criteria|0
656104|NCT02213055|2105890|P1|Overall Study|Did not meet Inclusion Criteria|6
656105|NCT02213055|2105889|P2|Overall Study|Had another Treatment during the Study|0
656106|NCT02213055|2105890|P1|Overall Study|Had another Treatment during the Study|3
656107|NCT02213055|2105889|P2|Overall Study|Did not have Live Lice|0
656108|NCT02213055|2105890|P1|Overall Study|Did not have Live Lice|8
656109|NCT02213055|2105889|P2|Overall Study|Documentation Issue during Study|0
656110|NCT02213055|2105890|P1|Overall Study|Documentation Issue during Study|10
656111|NCT02213055|2105889|P2|Overall Study|Documentation Issue at Enrollment|0
656112|NCT02213055|2105890|P1|Overall Study|Documentation Issue at Enrollment|1
656113|NCT02213055|2105889|P2|Overall Study|Protocol was not Followed during Study|0
656114|NCT02213055|2105890|P1|Overall Study|Protocol was not Followed during Study|1
656115|NCT02213055|2105889|P2|Overall Study|Protocol was not Followed at Enrollment|0
656116|NCT02213055|2105890|P1|Overall Study|Protocol was not Followed at Enrollment|5
656117|NCT02212457|2105928|P6|Overall Study|Unspecified|1
656118|NCT02212457|2105929|P5|Overall Study|Unspecified|0
656119|NCT02212457|2105930|P4|Overall Study|Unspecified|1
656120|NCT02212457|2105931|P3|Overall Study|Unspecified|2
656121|NCT02212457|2105932|P2|Overall Study|Unspecified|1
656122|NCT02212457|2105933|P1|Overall Study|Unspecified|2
656123|NCT02212457|2105928|P6|Overall Study|Protocol Violation|3
656124|NCT02212457|2105929|P5|Overall Study|Protocol Violation|2
656125|NCT02212457|2105930|P4|Overall Study|Protocol Violation|1
656126|NCT02212457|2105931|P3|Overall Study|Protocol Violation|0
656127|NCT02212457|2105932|P2|Overall Study|Protocol Violation|1
656128|NCT02212457|2105933|P1|Overall Study|Protocol Violation|2
656129|NCT02212457|2105928|P6|Overall Study|Lost to Follow-up|4
656130|NCT02212457|2105929|P5|Overall Study|Lost to Follow-up|8
656131|NCT02212457|2105930|P4|Overall Study|Lost to Follow-up|1
656132|NCT02212457|2105931|P3|Overall Study|Lost to Follow-up|4
656133|NCT02212457|2105932|P2|Overall Study|Lost to Follow-up|7
656134|NCT02212457|2105933|P1|Overall Study|Lost to Follow-up|6
656135|NCT02212457|2105928|P6|Overall Study|Withdrawal by Subject|4
656136|NCT02212457|2105929|P5|Overall Study|Withdrawal by Subject|5
656137|NCT02212457|2105930|P4|Overall Study|Withdrawal by Subject|6
656138|NCT02212457|2105931|P3|Overall Study|Withdrawal by Subject|8
656139|NCT02212457|2105932|P2|Overall Study|Withdrawal by Subject|10
656140|NCT02212457|2105933|P1|Overall Study|Withdrawal by Subject|8
656141|NCT02212457|2105928|P6|Overall Study|Adverse Event|1
656142|NCT02212457|2105929|P5|Overall Study|Adverse Event|0
656143|NCT02212457|2105930|P4|Overall Study|Adverse Event|2
656144|NCT02212457|2105931|P3|Overall Study|Adverse Event|2
656145|NCT02212457|2105932|P2|Overall Study|Adverse Event|2
656146|NCT02212457|2105933|P1|Overall Study|Adverse Event|1
656147|NCT02212301|2105971|P2|Period 1|Lost to Follow-up|1
656148|NCT02212301|2105972|P1|Period 1|Lost to Follow-up|0
656149|NCT02212197|2105983|P3|Overall Study|Need for radiotherapy|0
656150|NCT02212197|2105984|P2|Overall Study|Need for radiotherapy|0
656151|NCT02212197|2105985|P1|Overall Study|Need for radiotherapy|1
888186|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
888187|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
888188|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
656156|NCT02209766|2106136|P5|Overall Study|Withdrawal by Subject|0
656157|NCT02209766|2106137|P4|Overall Study|Withdrawal by Subject|1
656158|NCT02209766|2106138|P3|Overall Study|Withdrawal by Subject|0
656159|NCT02209766|2106139|P2|Overall Study|Withdrawal by Subject|0
656160|NCT02209766|2106140|P1|Overall Study|Withdrawal by Subject|0
656161|NCT02209506|2106191|P5|Overall Study|Withdrawal by Subject|1
656162|NCT02209506|2106192|P4|Overall Study|Withdrawal by Subject|0
656163|NCT02209506|2106193|P3|Overall Study|Withdrawal by Subject|0
656164|NCT02209506|2106194|P2|Overall Study|Withdrawal by Subject|0
656165|NCT02209506|2106195|P1|Overall Study|Withdrawal by Subject|0
656166|NCT02209454|2106270|P2|Second Period|Adverse Event|0
656167|NCT02209454|2106271|P1|Second Period|Adverse Event|1
656168|NCT02209181|2106289|P4|Overall Study|Withdrawal by Subject|0
656169|NCT02209181|2106290|P3|Overall Study|Withdrawal by Subject|0
656170|NCT02209181|2106291|P2|Overall Study|Withdrawal by Subject|1
656171|NCT02209181|2106292|P1|Overall Study|Withdrawal by Subject|0
656172|NCT02209181|2106289|P4|Overall Study|Adverse Event|0
656173|NCT02209181|2106290|P3|Overall Study|Adverse Event|1
656174|NCT02209181|2106291|P2|Overall Study|Adverse Event|0
656175|NCT02209181|2106292|P1|Overall Study|Adverse Event|1
656176|NCT02207907|2106496|P2|Overall Study|Pregnancy|1
656177|NCT02207907|2106497|P1|Overall Study|Pregnancy|0
656178|NCT02207907|2106496|P2|Overall Study|Did not meet study criteria|0
656179|NCT02207907|2106497|P1|Overall Study|Did not meet study criteria|3
656180|NCT02207907|2106496|P2|Overall Study|Withdrawal by Subject|6
656181|NCT02207907|2106497|P1|Overall Study|Withdrawal by Subject|5
656182|NCT02207907|2106496|P2|Overall Study|Lost to Follow-up|1
656183|NCT02207907|2106497|P1|Overall Study|Lost to Follow-up|3
656184|NCT02207829|2106515|P2|Overall Study|Withdrew consent|14
656185|NCT02207829|2106516|P1|Overall Study|Withdrew consent|18
656186|NCT02207829|2106515|P2|Overall Study|Protocol deviation|4
656187|NCT02207829|2106516|P1|Overall Study|Protocol deviation|5
656188|NCT02207829|2106515|P2|Overall Study|Lost to Follow-up|2
656189|NCT02207829|2106516|P1|Overall Study|Lost to Follow-up|2
656190|NCT02207829|2106515|P2|Overall Study|Lack of Efficacy|5
656191|NCT02207829|2106516|P1|Overall Study|Lack of Efficacy|7
656192|NCT02207829|2106515|P2|Overall Study|Adverse Event|9
656193|NCT02207829|2106516|P1|Overall Study|Adverse Event|10
656194|NCT02207608|2106524|P2|Overall Study|Adverse Event|0
656195|NCT02207608|2106525|P1|Overall Study|Adverse Event|1
656196|NCT02207413|2106548|P6|Overall Study|Migrated/moved from study area|0
656197|NCT02207413|2106549|P5|Overall Study|Migrated/moved from study area|1
656198|NCT02207413|2106550|P4|Overall Study|Migrated/moved from study area|0
656199|NCT02207413|2106551|P3|Overall Study|Migrated/moved from study area|0
656200|NCT02207413|2106552|P2|Overall Study|Migrated/moved from study area|0
656201|NCT02207413|2106553|P1|Overall Study|Migrated/moved from study area|0
656202|NCT02207413|2106548|P6|Overall Study|Adverse Event|1
656203|NCT02207413|2106549|P5|Overall Study|Adverse Event|2
656204|NCT02207413|2106550|P4|Overall Study|Adverse Event|0
656205|NCT02207413|2106551|P3|Overall Study|Adverse Event|0
656206|NCT02207413|2106552|P2|Overall Study|Adverse Event|0
656207|NCT02207413|2106553|P1|Overall Study|Adverse Event|0
656208|NCT02207413|2106548|P6|Overall Study|Lost to Follow-up|5
656209|NCT02207413|2106549|P5|Overall Study|Lost to Follow-up|1
656210|NCT02207413|2106550|P4|Overall Study|Lost to Follow-up|1
656211|NCT02207413|2106551|P3|Overall Study|Lost to Follow-up|0
656212|NCT02207413|2106552|P2|Overall Study|Lost to Follow-up|0
656213|NCT02207413|2106553|P1|Overall Study|Lost to Follow-up|0
656214|NCT02207413|2106548|P6|Overall Study|Withdrawal by Subject|7
656215|NCT02207413|2106549|P5|Overall Study|Withdrawal by Subject|3
656216|NCT02207413|2106550|P4|Overall Study|Withdrawal by Subject|0
656217|NCT02207413|2106551|P3|Overall Study|Withdrawal by Subject|0
656218|NCT02207413|2106552|P2|Overall Study|Withdrawal by Subject|0
656219|NCT02207413|2106553|P1|Overall Study|Withdrawal by Subject|1
656220|NCT02207400|2106649|P2|Overall Study|Positive Urine Pregnancy Test|1
656221|NCT02207400|2106650|P1|Overall Study|Positive Urine Pregnancy Test|0
656222|NCT02207400|2106649|P2|Overall Study|Withdrawal by Subject|4
656223|NCT02207400|2106650|P1|Overall Study|Withdrawal by Subject|8
656224|NCT02207400|2106649|P2|Overall Study|Protocol Violation|1
656225|NCT02207400|2106650|P1|Overall Study|Protocol Violation|1
656226|NCT02207400|2106649|P2|Overall Study|Lost to Follow-up|7
656227|NCT02207400|2106650|P1|Overall Study|Lost to Follow-up|6
656228|NCT02207400|2106649|P2|Overall Study|Adverse Event|1
656229|NCT02207400|2106650|P1|Overall Study|Adverse Event|1
656230|NCT02206607|2106677|P5|Second Intervention Period|Insufficient Clinical Response|0
656231|NCT02206607|2106678|P4|Second Intervention Period|Insufficient Clinical Response|1
656232|NCT02206607|2106679|P3|Second Intervention Period|Insufficient Clinical Response|0
656233|NCT02206607|2106680|P2|Second Intervention Period|Insufficient Clinical Response|0
656234|NCT02206607|2106681|P1|Second Intervention Period|Insufficient Clinical Response|0
656235|NCT02206607|2106677|P5|Open-Label Run-In|Withdrawal by Subject|0
656236|NCT02206607|2106678|P4|Open-Label Run-In|Withdrawal by Subject|0
656237|NCT02206607|2106679|P3|Open-Label Run-In|Withdrawal by Subject|0
656238|NCT02206607|2106680|P2|Open-Label Run-In|Withdrawal by Subject|0
656239|NCT02206607|2106681|P1|Open-Label Run-In|Withdrawal by Subject|3
656240|NCT02205814|2106737|P4|Overall Study|not compliant with study procedures|0
656241|NCT02205814|2106738|P3|Overall Study|not compliant with study procedures|1
656242|NCT02205814|2106739|P2|Overall Study|not compliant with study procedures|0
656243|NCT02205814|2106740|P1|Overall Study|not compliant with study procedures|0
656244|NCT02205814|2106737|P4|Overall Study|Withdrawal by Subject|1
656245|NCT02205814|2106738|P3|Overall Study|Withdrawal by Subject|2
656246|NCT02205814|2106739|P2|Overall Study|Withdrawal by Subject|1
656247|NCT02205814|2106740|P1|Overall Study|Withdrawal by Subject|0
656248|NCT02205814|2106737|P4|Overall Study|Protocol Violation|1
656249|NCT02205814|2106738|P3|Overall Study|Protocol Violation|0
656250|NCT02205814|2106739|P2|Overall Study|Protocol Violation|0
656251|NCT02205814|2106740|P1|Overall Study|Protocol Violation|1
656252|NCT02205814|2106737|P4|Overall Study|Physician Decision|0
656253|NCT02205814|2106738|P3|Overall Study|Physician Decision|1
656254|NCT02205814|2106739|P2|Overall Study|Physician Decision|0
656255|NCT02205814|2106740|P1|Overall Study|Physician Decision|0
656256|NCT02205814|2106737|P4|Overall Study|Lack of Efficacy|1
656257|NCT02205814|2106738|P3|Overall Study|Lack of Efficacy|1
656258|NCT02205814|2106739|P2|Overall Study|Lack of Efficacy|0
656259|NCT02205814|2106740|P1|Overall Study|Lack of Efficacy|1
656260|NCT02205814|2106737|P4|Overall Study|Lost to Follow-up|1
656261|NCT02205814|2106738|P3|Overall Study|Lost to Follow-up|0
656262|NCT02205814|2106739|P2|Overall Study|Lost to Follow-up|0
656263|NCT02205814|2106740|P1|Overall Study|Lost to Follow-up|0
656264|NCT02205476|2106764|P2|Overall Study|Study termination by Sponsor|3
656265|NCT02205476|2106765|P1|Overall Study|Study termination by Sponsor|7
656266|NCT02205333|2106804|P9|Overall Study|Withdrawal by Subject|0
656267|NCT02205333|2106805|P8|Overall Study|Withdrawal by Subject|0
656268|NCT02205333|2106806|P7|Overall Study|Withdrawal by Subject|2
656269|NCT02205333|2106807|P6|Overall Study|Withdrawal by Subject|0
656270|NCT02205333|2106808|P5|Overall Study|Withdrawal by Subject|0
656271|NCT02205333|2106809|P4|Overall Study|Withdrawal by Subject|1
656272|NCT02205333|2106810|P3|Overall Study|Withdrawal by Subject|0
656273|NCT02205333|2106811|P2|Overall Study|Withdrawal by Subject|0
656274|NCT02205333|2106812|P1|Overall Study|Withdrawal by Subject|1
656275|NCT02205333|2106804|P9|Overall Study|Death|0
656276|NCT02205333|2106805|P8|Overall Study|Death|2
656277|NCT02205333|2106806|P7|Overall Study|Death|3
656278|NCT02205333|2106807|P6|Overall Study|Death|3
656279|NCT02205333|2106808|P5|Overall Study|Death|5
656280|NCT02205333|2106809|P4|Overall Study|Death|6
656281|NCT02205333|2106810|P3|Overall Study|Death|2
656282|NCT02205333|2106811|P2|Overall Study|Death|6
656283|NCT02205333|2106812|P1|Overall Study|Death|5
656284|NCT02204579|2107008|P1|Overall Study|Screen failures|2
656285|NCT02204449|2107062|P2|Overall Study|Withdrawal by Subject|1
656286|NCT02204449|2107063|P1|Overall Study|Withdrawal by Subject|0
656287|NCT02204449|2107062|P2|Overall Study|Death|1
656288|NCT02204449|2107063|P1|Overall Study|Death|0
656289|NCT02204449|2107062|P2|Overall Study|Lost to Follow-up|9
656290|NCT02204449|2107063|P1|Overall Study|Lost to Follow-up|7
656291|NCT02204410|2107073|P1|Overall Study|Withdrawal by Subject|3
656292|NCT02204410|2107073|P1|Overall Study|Protocol Violation|1
656293|NCT02204410|2107073|P1|Overall Study|Physician Decision|2
656294|NCT02204410|2107073|P1|Overall Study|Lost to Follow-up|5
656295|NCT02204371|2107078|P1|Overall Study|Adverse Event|1
656296|NCT02204319|2107101|P1|Overall Study|Withdrawal by Subject|2
656297|NCT02204319|2107101|P1|Overall Study|Pregnancy|1
656298|NCT02204007|2107109|P2|Overall Study|Surgery Canceled|1
656299|NCT02204007|2107110|P1|Overall Study|Surgery Canceled|1
656300|NCT02203916|2107121|P3|Overall Study|Reason Not Specified|1
656301|NCT02203916|2107122|P2|Overall Study|Reason Not Specified|2
656302|NCT02203916|2107123|P1|Overall Study|Reason Not Specified|0
656303|NCT02203916|2107121|P3|Overall Study|Lack of Efficacy|0
656304|NCT02203916|2107122|P2|Overall Study|Lack of Efficacy|0
656305|NCT02203916|2107123|P1|Overall Study|Lack of Efficacy|3
656306|NCT02203916|2107121|P3|Overall Study|Voluntary Withdrawal|8
656307|NCT02203916|2107122|P2|Overall Study|Voluntary Withdrawal|3
656308|NCT02203916|2107123|P1|Overall Study|Voluntary Withdrawal|3
656309|NCT02203916|2107121|P3|Overall Study|Lost to Follow-up|0
656310|NCT02203916|2107122|P2|Overall Study|Lost to Follow-up|1
656311|NCT02203916|2107123|P1|Overall Study|Lost to Follow-up|0
656312|NCT02203916|2107121|P3|Overall Study|Major Protocol Deviation|0
656313|NCT02203916|2107122|P2|Overall Study|Major Protocol Deviation|1
656314|NCT02203916|2107123|P1|Overall Study|Major Protocol Deviation|1
656315|NCT02203916|2107121|P3|Overall Study|Pretreatment Event/Adverse Event|2
656316|NCT02203916|2107122|P2|Overall Study|Pretreatment Event/Adverse Event|3
656317|NCT02203916|2107123|P1|Overall Study|Pretreatment Event/Adverse Event|1
656318|NCT02203721|2107193|P2|Overall Study|Illness|1
656319|NCT02203721|2107194|P1|Overall Study|Illness|0
656320|NCT02203721|2107193|P2|Overall Study|Death|2
656321|NCT02203721|2107194|P1|Overall Study|Death|0
656322|NCT02203721|2107193|P2|Overall Study|Lost to Follow-up|0
656323|NCT02203721|2107194|P1|Overall Study|Lost to Follow-up|1
656324|NCT02203149|2107227|P5|Part 2|Adverse Event|1
656325|NCT02203149|2107228|P4|Part 2|Adverse Event|1
656326|NCT02203149|2107229|P3|Part 2|Adverse Event|0
656327|NCT02203149|2107230|P2|Part 2|Adverse Event|0
656328|NCT02203149|2107231|P1|Part 2|Adverse Event|0
656329|NCT02203149|2107227|P5|Part 2|Withdrawal by Subject|0
656330|NCT02203149|2107228|P4|Part 2|Withdrawal by Subject|1
656331|NCT02203149|2107229|P3|Part 2|Withdrawal by Subject|0
656332|NCT02203149|2107230|P2|Part 2|Withdrawal by Subject|0
656333|NCT02203149|2107231|P1|Part 2|Withdrawal by Subject|0
656334|NCT02203149|2107227|P5|Part 2|Death|0
656335|NCT02203149|2107228|P4|Part 2|Death|1
656336|NCT02203149|2107229|P3|Part 2|Death|1
656337|NCT02203149|2107230|P2|Part 2|Death|0
656338|NCT02203149|2107231|P1|Part 2|Death|0
656339|NCT02203149|2107227|P5|Part 1|Adverse Event|0
656340|NCT02203149|2107228|P4|Part 1|Adverse Event|0
656341|NCT02203149|2107229|P3|Part 1|Adverse Event|0
656342|NCT02203149|2107230|P2|Part 1|Adverse Event|1
656343|NCT02203149|2107231|P1|Part 1|Adverse Event|0
656344|NCT02203032|2107264|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
656345|NCT02203032|2107265|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
656346|NCT02203032|2107266|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
656347|NCT02203032|2107267|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
656348|NCT02203032|2107264|P4|Blinded Phase (Week 16 to Week 44)|Death|1
656349|NCT02203032|2107265|P3|Blinded Phase (Week 16 to Week 44)|Death|0
656350|NCT02203032|2107266|P2|Blinded Phase (Week 16 to Week 44)|Death|0
656351|NCT02203032|2107267|P1|Blinded Phase (Week 16 to Week 44)|Death|0
656352|NCT02203032|2107264|P4|Blinded Phase (Week 16 to Week 44)|Unspecified|15
656353|NCT02203032|2107265|P3|Blinded Phase (Week 16 to Week 44)|Unspecified|1
656354|NCT02203032|2107266|P2|Blinded Phase (Week 16 to Week 44)|Unspecified|4
656355|NCT02203032|2107267|P1|Blinded Phase (Week 16 to Week 44)|Unspecified|0
656356|NCT02203032|2107264|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
656357|NCT02203032|2107265|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
656358|NCT02203032|2107266|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
656359|NCT02203032|2107267|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
656360|NCT02203032|2107264|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
656361|NCT02203032|2107265|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
656362|NCT02203032|2107266|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
656363|NCT02203032|2107267|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
656364|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
656365|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
656366|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
656367|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
656368|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
656369|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
656370|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
656371|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Unspecified|2
656372|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
656373|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
656374|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
656375|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
656376|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
656377|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
656378|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
656379|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
656380|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
656381|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
656382|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
656383|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
656384|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
656385|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
656386|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
656387|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
656388|NCT02203032|2107264|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
656389|NCT02203032|2107265|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
656390|NCT02203032|2107266|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
656391|NCT02203032|2107267|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
656392|NCT02202785|2107284|P3|Overall Study|Reason not Specified|13
656393|NCT02202785|2107285|P2|Overall Study|Reason not Specified|7
656394|NCT02202785|2107286|P1|Overall Study|Reason not Specified|10
656395|NCT02202785|2107284|P3|Overall Study|Lost to Follow-up|0
656396|NCT02202785|2107285|P2|Overall Study|Lost to Follow-up|1
656397|NCT02202785|2107286|P1|Overall Study|Lost to Follow-up|0
656398|NCT02202785|2107284|P3|Overall Study|Withdrawal by Subject|0
656399|NCT02202785|2107285|P2|Overall Study|Withdrawal by Subject|1
656400|NCT02202785|2107286|P1|Overall Study|Withdrawal by Subject|0
656401|NCT02202785|2107284|P3|Overall Study|Study Terminated by Sponsor|4
656402|NCT02202785|2107285|P2|Overall Study|Study Terminated by Sponsor|6
656403|NCT02202785|2107286|P1|Overall Study|Study Terminated by Sponsor|1
656404|NCT02202759|2107323|P3|Overall Study|Reason not Specified|10
656405|NCT02202759|2107324|P2|Overall Study|Reason not Specified|11
656406|NCT02202759|2107325|P1|Overall Study|Reason not Specified|4
656407|NCT02202759|2107323|P3|Overall Study|Withdrawal by Subject|1
656408|NCT02202759|2107324|P2|Overall Study|Withdrawal by Subject|1
656409|NCT02202759|2107325|P1|Overall Study|Withdrawal by Subject|2
656410|NCT02202759|2107323|P3|Overall Study|Study Terminated by Sponsor|3
656411|NCT02202759|2107324|P2|Overall Study|Study Terminated by Sponsor|3
656412|NCT02202759|2107325|P1|Overall Study|Study Terminated by Sponsor|3
656413|NCT02202538|2107359|P1|Overall Study|Investigator Decision|1
656414|NCT02202538|2107359|P1|Overall Study|Did not meet all inclusion criteria|2
656415|NCT02202538|2107359|P1|Overall Study|Withdrawal by Subject|5
656416|NCT02201953|2107389|P2|Overall Study|Death|3
656417|NCT02201953|2107390|P1|Overall Study|Death|0
656418|NCT02201953|2107389|P2|Overall Study|Adverse Event|5
656419|NCT02201953|2107390|P1|Overall Study|Adverse Event|0
656420|NCT02201953|2107389|P2|Overall Study|Withdrew Consent|5
656421|NCT02201953|2107390|P1|Overall Study|Withdrew Consent|2
656422|NCT02201953|2107389|P2|Overall Study|Lost to Follow-up|8
656423|NCT02201953|2107390|P1|Overall Study|Lost to Follow-up|8
656424|NCT02201953|2107389|P2|Overall Study|Lack of Efficacy|30
656425|NCT02201953|2107390|P1|Overall Study|Lack of Efficacy|9
656426|NCT02201953|2107389|P2|Overall Study|Randomized but Never Treated|5
656427|NCT02201953|2107390|P1|Overall Study|Randomized but Never Treated|1
656428|NCT02201940|2107408|P2|Overall Study|Adverse Event|1
656429|NCT02201940|2107409|P1|Overall Study|Adverse Event|0
656430|NCT02201940|2107408|P2|Overall Study|Death|0
656431|NCT02201940|2107409|P1|Overall Study|Death|1
656432|NCT02201940|2107408|P2|Overall Study|Investigator's Discretion|1
656433|NCT02201940|2107409|P1|Overall Study|Investigator's Discretion|1
656434|NCT02201940|2107408|P2|Overall Study|Withdrew Consent|1
656435|NCT02201940|2107409|P1|Overall Study|Withdrew Consent|2
656436|NCT02201940|2107408|P2|Overall Study|Lost to Follow-up|0
656437|NCT02201940|2107409|P1|Overall Study|Lost to Follow-up|5
656438|NCT02201940|2107408|P2|Overall Study|Lack of Efficacy|113
656439|NCT02201940|2107409|P1|Overall Study|Lack of Efficacy|2
656440|NCT02201940|2107408|P2|Overall Study|Randomized/Enrolled but Never Treated|0
656441|NCT02201940|2107409|P1|Overall Study|Randomized/Enrolled but Never Treated|1
656442|NCT02201901|2107428|P3|Overall Study|Adverse Event|0
656443|NCT02201901|2107429|P2|Overall Study|Adverse Event|1
656444|NCT02201901|2107430|P1|Overall Study|Adverse Event|1
656445|NCT02201901|2107428|P3|Overall Study|Withdrew Consent|2
656446|NCT02201901|2107429|P2|Overall Study|Withdrew Consent|0
656447|NCT02201901|2107430|P1|Overall Study|Withdrew Consent|2
656448|NCT02201901|2107428|P3|Overall Study|Lost to Follow-up|2
656449|NCT02201901|2107429|P2|Overall Study|Lost to Follow-up|3
656450|NCT02201901|2107430|P1|Overall Study|Lost to Follow-up|2
656451|NCT02201901|2107428|P3|Overall Study|Death|3
656452|NCT02201901|2107429|P2|Overall Study|Death|3
656453|NCT02201901|2107430|P1|Overall Study|Death|3
656454|NCT02201901|2107428|P3|Overall Study|Lack of Efficacy|6
656455|NCT02201901|2107429|P2|Overall Study|Lack of Efficacy|1
656456|NCT02201901|2107430|P1|Overall Study|Lack of Efficacy|7
656457|NCT02201901|2107428|P3|Overall Study|Randomized but never treated|0
656458|NCT02201901|2107429|P2|Overall Study|Randomized but never treated|1
656459|NCT02201901|2107430|P1|Overall Study|Randomized but never treated|0
656460|NCT02201784|2107461|P2|Overall Study|Failure to achieve adequate block|0
656461|NCT02201784|2107462|P1|Overall Study|Failure to achieve adequate block|2
656462|NCT02201524|2107480|P4|Overall Study|Unspecified|0
656463|NCT02201524|2107481|P3|Overall Study|Unspecified|0
656464|NCT02201524|2107482|P2|Overall Study|Unspecified|1
656465|NCT02201524|2107483|P1|Overall Study|Unspecified|1
656466|NCT02201524|2107480|P4|Overall Study|Withdrawal by Subject|1
656467|NCT02201524|2107481|P3|Overall Study|Withdrawal by Subject|1
656468|NCT02201524|2107482|P2|Overall Study|Withdrawal by Subject|0
656469|NCT02201524|2107483|P1|Overall Study|Withdrawal by Subject|0
656470|NCT02201524|2107480|P4|Overall Study|Protocol Violation|1
656471|NCT02201524|2107481|P3|Overall Study|Protocol Violation|0
656472|NCT02201524|2107482|P2|Overall Study|Protocol Violation|0
656473|NCT02201524|2107483|P1|Overall Study|Protocol Violation|0
656474|NCT02201524|2107480|P4|Overall Study|No longer meets eligibility criteria|2
656475|NCT02201524|2107481|P3|Overall Study|No longer meets eligibility criteria|0
656476|NCT02201524|2107482|P2|Overall Study|No longer meets eligibility criteria|0
656477|NCT02201524|2107483|P1|Overall Study|No longer meets eligibility criteria|0
656478|NCT02201524|2107480|P4|Overall Study|Lost to Follow-up|0
656479|NCT02201524|2107481|P3|Overall Study|Lost to Follow-up|2
656480|NCT02201524|2107482|P2|Overall Study|Lost to Follow-up|0
656481|NCT02201524|2107483|P1|Overall Study|Lost to Follow-up|0
656482|NCT02201524|2107480|P4|Overall Study|Insufficient clinical response|0
656483|NCT02201524|2107481|P3|Overall Study|Insufficient clinical response|0
656484|NCT02201524|2107482|P2|Overall Study|Insufficient clinical response|0
656485|NCT02201524|2107483|P1|Overall Study|Insufficient clinical response|1
656486|NCT02201524|2107480|P4|Overall Study|Adverse Event|0
656487|NCT02201524|2107481|P3|Overall Study|Adverse Event|1
656488|NCT02201524|2107482|P2|Overall Study|Adverse Event|2
656489|NCT02201524|2107483|P1|Overall Study|Adverse Event|0
656490|NCT02199509|2107716|P2|Overall Study|Misunderstood titration schedule|0
656491|NCT02199509|2107717|P1|Overall Study|Misunderstood titration schedule|1
656492|NCT02199509|2107716|P2|Overall Study|Suicidal Ideation|1
656493|NCT02199509|2107717|P1|Overall Study|Suicidal Ideation|0
656494|NCT02198963|2107729|P1|Overall Study|Withdrawal by Subject|6
656495|NCT02198963|2107729|P1|Overall Study|Adverse Event|1
656496|NCT02198235|2107771|P3|Overall Study|Lost to Follow-up|2
656497|NCT02198235|2107772|P2|Overall Study|Lost to Follow-up|2
656498|NCT02198235|2107773|P1|Overall Study|Lost to Follow-up|3
656499|NCT02198040|2107793|P3|Overall Study|Withdrawal by Subject|1
656500|NCT02198040|2107794|P2|Overall Study|Withdrawal by Subject|0
656501|NCT02198040|2107795|P1|Overall Study|Withdrawal by Subject|0
656502|NCT02198040|2107793|P3|Overall Study|Work reasons|0
656503|NCT02198040|2107794|P2|Overall Study|Work reasons|1
656504|NCT02198040|2107795|P1|Overall Study|Work reasons|0
656505|NCT02197806|2107825|P4|Overall Study|Adverse Event|1
656506|NCT02197806|2107826|P3|Overall Study|Adverse Event|0
656507|NCT02197806|2107827|P2|Overall Study|Adverse Event|1
656508|NCT02197806|2107828|P1|Overall Study|Adverse Event|0
888189|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
888190|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
888191|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
656512|NCT02197234|2107899|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
656513|NCT02197234|2107899|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
656514|NCT02197234|2107899|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
656515|NCT02197234|2107899|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
656516|NCT02197234|2107899|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
656517|NCT02197234|2107899|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
656518|NCT02197234|2107899|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
656519|NCT02196714|2107947|P4|Overall Study|Protocol Violation|0
656520|NCT02196714|2107948|P3|Overall Study|Protocol Violation|1
656521|NCT02196714|2107949|P2|Overall Study|Protocol Violation|0
656522|NCT02196714|2107950|P1|Overall Study|Protocol Violation|0
656523|NCT02196675|2108073|P3|Overall Study|Death|1
656524|NCT02196675|2108074|P2|Overall Study|Death|0
656525|NCT02196675|2108075|P1|Overall Study|Death|0
656526|NCT02196675|2108073|P3|Overall Study|Protocol Violation|0
656527|NCT02196675|2108074|P2|Overall Study|Protocol Violation|1
656528|NCT02196675|2108075|P1|Overall Study|Protocol Violation|0
656529|NCT02196675|2108073|P3|Overall Study|Intra-operative surgical exclusion|0
656530|NCT02196675|2108074|P2|Overall Study|Intra-operative surgical exclusion|1
656531|NCT02196675|2108075|P1|Overall Study|Intra-operative surgical exclusion|1
656532|NCT02196675|2108073|P3|Overall Study|Withdrawal by Subject|0
656533|NCT02196675|2108074|P2|Overall Study|Withdrawal by Subject|0
656534|NCT02196675|2108075|P1|Overall Study|Withdrawal by Subject|1
656535|NCT02196259|2108098|P3|Overall Study|Partial data analysis|0
656536|NCT02196259|2108099|P2|Overall Study|Partial data analysis|3
656537|NCT02196259|2108100|P1|Overall Study|Partial data analysis|0
656538|NCT02196259|2108098|P3|Overall Study|Researcher choice|1
656539|NCT02196259|2108099|P2|Overall Study|Researcher choice|0
656540|NCT02196259|2108100|P1|Overall Study|Researcher choice|0
656541|NCT02196077|2108128|P1|Overall Study|Protocol Violation|24
656542|NCT02196077|2108128|P1|Overall Study|Lost to Follow-up|3
656543|NCT02196077|2108128|P1|Overall Study|Physician Decision|1
656544|NCT02196077|2108128|P1|Overall Study|Withdrawal by Subject|14
656545|NCT02196077|2108128|P1|Overall Study|Lack of Efficacy|1
656546|NCT02196077|2108128|P1|Overall Study|Adverse Event|4
656562|NCT02195687|2108206|P2|Overall Study|Lost to Follow-up|1
656563|NCT02195687|2108207|P1|Overall Study|Lost to Follow-up|4
656564|NCT02195687|2108206|P2|Overall Study|Personal Reasons|1
656565|NCT02195687|2108207|P1|Overall Study|Personal Reasons|1
656566|NCT02195583|2108223|P1|Overall Study|Other Reason|2
656567|NCT02195583|2108223|P1|Overall Study|Adverse Event|2
656568|NCT02195583|2108223|P1|Overall Study|Withdrawal by Subject|4
656569|NCT02195583|2108223|P1|Overall Study|Lost to Follow-up|1
656570|NCT02194621|2108265|P3|Overall Study|Withdrawal by Subject|7
656571|NCT02194621|2108266|P2|Overall Study|Withdrawal by Subject|4
656572|NCT02194621|2108267|P1|Overall Study|Withdrawal by Subject|4
656573|NCT02194621|2108265|P3|Overall Study|6 withdrew prior to randomization|2
656574|NCT02194621|2108266|P2|Overall Study|6 withdrew prior to randomization|2
656575|NCT02194621|2108267|P1|Overall Study|6 withdrew prior to randomization|2
656576|NCT02194062|2108300|P3|Overall Study|Lost to Follow-up|5
656577|NCT02194062|2108301|P2|Overall Study|Lost to Follow-up|2
656578|NCT02194062|2108302|P1|Overall Study|Lost to Follow-up|2
656579|NCT02193828|2108317|P4|Overall Study|Withdrawal by Subject|1
656580|NCT02193828|2108318|P3|Overall Study|Withdrawal by Subject|1
656581|NCT02193828|2108319|P2|Overall Study|Withdrawal by Subject|0
656582|NCT02193828|2108320|P1|Overall Study|Withdrawal by Subject|0
656583|NCT02193178|2108393|P1|Overall Study|Dry eyes|1
656584|NCT02193178|2108393|P1|Overall Study|Lost to Follow-up|1
656585|NCT02193165|2108443|P3|6 Week Product Use|Lost to Follow-up|0
656586|NCT02193165|2108444|P2|6 Week Product Use|Lost to Follow-up|1
656587|NCT02193165|2108445|P1|6 Week Product Use|Lost to Follow-up|0
656588|NCT02193165|2108443|P3|4 Week Product Use|Lost to Follow-up|1
656589|NCT02193165|2108444|P2|4 Week Product Use|Lost to Follow-up|1
656590|NCT02193165|2108445|P1|4 Week Product Use|Lost to Follow-up|1
656591|NCT02193087|2108472|P4|Overall Study|Did Not Receive Any Vaccination|1
656592|NCT02193087|2108473|P3|Overall Study|Did Not Receive Any Vaccination|0
656593|NCT02193087|2108474|P2|Overall Study|Did Not Receive Any Vaccination|3
656594|NCT02193087|2108475|P1|Overall Study|Did Not Receive Any Vaccination|2
656595|NCT02193087|2108472|P4|Overall Study|Other Reason Not Specified|9
656596|NCT02193087|2108473|P3|Overall Study|Other Reason Not Specified|1
656597|NCT02193087|2108474|P2|Overall Study|Other Reason Not Specified|2
656598|NCT02193087|2108475|P1|Overall Study|Other Reason Not Specified|7
656599|NCT02193087|2108472|P4|Overall Study|Withdrawal by Subject|19
656600|NCT02193087|2108473|P3|Overall Study|Withdrawal by Subject|1
656601|NCT02193087|2108474|P2|Overall Study|Withdrawal by Subject|3
656602|NCT02193087|2108475|P1|Overall Study|Withdrawal by Subject|10
656603|NCT02193087|2108472|P4|Overall Study|Protocol Violation|2
656604|NCT02193087|2108473|P3|Overall Study|Protocol Violation|1
656605|NCT02193087|2108474|P2|Overall Study|Protocol Violation|0
656606|NCT02193087|2108475|P1|Overall Study|Protocol Violation|2
656607|NCT02193087|2108472|P4|Overall Study|Lost to Follow-up|37
656608|NCT02193087|2108473|P3|Overall Study|Lost to Follow-up|4
656609|NCT02193087|2108474|P2|Overall Study|Lost to Follow-up|6
656610|NCT02193087|2108475|P1|Overall Study|Lost to Follow-up|14
656611|NCT02193087|2108472|P4|Overall Study|Adverse Event|11
656612|NCT02193087|2108473|P3|Overall Study|Adverse Event|0
656613|NCT02193087|2108474|P2|Overall Study|Adverse Event|0
656614|NCT02193087|2108475|P1|Overall Study|Adverse Event|2
656615|NCT02193074|2108520|P2|Overall Study|Adverse Event|13
656616|NCT02193074|2108521|P1|Overall Study|Adverse Event|16
656617|NCT02193074|2108520|P2|Overall Study|Withdrawal by Subject|2
656618|NCT02193074|2108521|P1|Overall Study|Withdrawal by Subject|1
656619|NCT02192606|2108606|P2|Overall Study|3D equipment rep unable to join|1
656620|NCT02192606|2108607|P1|Overall Study|3D equipment rep unable to join|0
656621|NCT02192606|2108606|P2|Overall Study|Physician Decision|2
656622|NCT02192606|2108607|P1|Overall Study|Physician Decision|1
656623|NCT02192606|2108606|P2|Overall Study|surgery type was changed|1
656624|NCT02192606|2108607|P1|Overall Study|surgery type was changed|1
656625|NCT02192164|2108615|P1|Overall Study|Did not meet the exclusion criteria|1
656626|NCT02192164|2108615|P1|Overall Study|Physician Decision|4
656627|NCT02192164|2108615|P1|Overall Study|Withdrawal by Subject|1
656628|NCT02192164|2108615|P1|Overall Study|Unspecified|8
656629|NCT02191046|2108658|P2|Overall Study|low compliance|1
656630|NCT02191046|2108659|P1|Overall Study|low compliance|5
656631|NCT02190604|2108697|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656632|NCT02190604|2108698|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656633|NCT02190604|2108699|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656634|NCT02190604|2108700|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656635|NCT02190604|2108701|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656636|NCT02190604|2108702|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
656637|NCT02190604|2108703|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656638|NCT02190604|2108704|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656639|NCT02190604|2108705|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656640|NCT02190604|2108706|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656641|NCT02190604|2108707|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656642|NCT02190604|2108708|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656643|NCT02190604|2108709|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656644|NCT02190604|2108710|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656645|NCT02190604|2108711|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656646|NCT02190604|2108712|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656647|NCT02190604|2108713|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656648|NCT02190604|2108714|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656649|NCT02190604|2108715|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
656650|NCT02190604|2108697|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656651|NCT02190604|2108698|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656652|NCT02190604|2108699|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656653|NCT02190604|2108700|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656654|NCT02190604|2108701|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
656655|NCT02190604|2108702|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656656|NCT02190604|2108703|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656657|NCT02190604|2108704|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656658|NCT02190604|2108705|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656659|NCT02190604|2108706|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656660|NCT02190604|2108707|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656661|NCT02190604|2108708|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656662|NCT02190604|2108709|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656663|NCT02190604|2108710|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656664|NCT02190604|2108711|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656665|NCT02190604|2108712|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656666|NCT02190604|2108713|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656667|NCT02190604|2108714|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656668|NCT02190604|2108715|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
656669|NCT02190591|2108906|P2|Overall Study|face presentation so she was ineligible|1
656670|NCT02190591|2108907|P1|Overall Study|face presentation so she was ineligible|0
656671|NCT02190591|2108906|P2|Overall Study|did not use peanut ball as instructed|2
656672|NCT02190591|2108907|P1|Overall Study|did not use peanut ball as instructed|0
656673|NCT02190591|2108906|P2|Overall Study|Protocol Violation|0
656674|NCT02190591|2108907|P1|Overall Study|Protocol Violation|1
656675|NCT02190591|2108906|P2|Overall Study|Withdrawal by Subject|8
656676|NCT02190591|2108907|P1|Overall Study|Withdrawal by Subject|1
656677|NCT02190435|2108919|P2|Overall Study|3 consented screen fails|0
656678|NCT02190435|2108920|P1|Overall Study|3 consented screen fails|3
656679|NCT02190435|2108919|P2|Overall Study|First 12 patients were lead-ins|0
656680|NCT02190435|2108920|P1|Overall Study|First 12 patients were lead-ins|12
656681|NCT02189941|2108939|P3|Overall Study|Non-compliance|1
656682|NCT02189941|2108940|P2|Overall Study|Non-compliance|0
656683|NCT02189941|2108941|P1|Overall Study|Non-compliance|0
656684|NCT02189863|2108969|P2|First 2 Weeks|Motion Sickness|2
656685|NCT02189863|2108970|P1|First 2 Weeks|Motion Sickness|4
888192|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888193|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888194|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888195|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888196|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888197|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
656694|NCT02189759|2109018|P4|Overall Study|Lost to Follow-up|5
656695|NCT02189759|2109019|P3|Overall Study|Lost to Follow-up|2
656696|NCT02189759|2109020|P2|Overall Study|Lost to Follow-up|0
656697|NCT02189759|2109021|P1|Overall Study|Lost to Follow-up|0
656698|NCT02189252|2109056|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
656699|NCT02189252|2109057|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
656700|NCT02189252|2109058|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
656701|NCT02189252|2109059|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
656702|NCT02189252|2109056|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
656703|NCT02189252|2109057|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
656704|NCT02189252|2109058|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
656705|NCT02189252|2109059|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
656706|NCT02188849|2109118|P2|Overall Study|Lost to Follow-up|8
656707|NCT02188849|2109119|P1|Overall Study|Lost to Follow-up|3
656708|NCT02188784|2109133|P2|Overall Study|Physician Decision|3
656709|NCT02188784|2109134|P1|Overall Study|Physician Decision|2
656710|NCT02188784|2109133|P2|Overall Study|Withdrawal by Subject|9
656711|NCT02188784|2109134|P1|Overall Study|Withdrawal by Subject|3
656712|NCT02188784|2109133|P2|Overall Study|Lost to Follow-up|0
656713|NCT02188784|2109134|P1|Overall Study|Lost to Follow-up|1
656714|NCT02188784|2109133|P2|Overall Study|Death|1
656715|NCT02188784|2109134|P1|Overall Study|Death|3
656716|NCT02187809|2109155|P1|Overall Study|The study was terminated|3
656717|NCT02187744|2109167|P2|Treatment|Participant refused continued treatment|1
656718|NCT02187744|2109168|P1|Treatment|Participant refused continued treatment|1
656719|NCT02187744|2109167|P2|Treatment|Not specified|0
656720|NCT02187744|2109168|P1|Treatment|Not specified|2
656721|NCT02187744|2109167|P2|Treatment|Lost to Follow-up|1
656722|NCT02187744|2109168|P1|Treatment|Lost to Follow-up|0
656723|NCT02187744|2109167|P2|Treatment|Related adverse event, not serious|2
656724|NCT02187744|2109168|P1|Treatment|Related adverse event, not serious|0
656725|NCT02187744|2109167|P2|Treatment|Related adverse event, serious non-fatal|1
656726|NCT02187744|2109168|P1|Treatment|Related adverse event, serious non-fatal|0
656727|NCT02187744|2109167|P2|Treatment|Death|0
656728|NCT02187744|2109168|P1|Treatment|Death|1
656729|NCT02187744|2109167|P2|Study|Related adverse event, serious non-fatal|1
656730|NCT02187744|2109168|P1|Study|Related adverse event, serious non-fatal|0
656731|NCT02187744|2109167|P2|Study|Death|0
656732|NCT02187744|2109168|P1|Study|Death|1
656733|NCT02187744|2109167|P2|Study|Related adverse event, not serious|2
656734|NCT02187744|2109168|P1|Study|Related adverse event, not serious|0
656735|NCT02187744|2109167|P2|Study|Lost to Follow-up|2
656736|NCT02187744|2109168|P1|Study|Lost to Follow-up|0
656737|NCT02187744|2109167|P2|Study|Not specified|1
656738|NCT02187744|2109168|P1|Study|Not specified|2
656739|NCT02187744|2109167|P2|Study|Participant refused further follow-up|0
656740|NCT02187744|2109168|P1|Study|Participant refused further follow-up|1
656741|NCT02187029|2109188|P4|Overall Study|Withdrawal by Subject|0
656742|NCT02187029|2109189|P3|Overall Study|Withdrawal by Subject|0
656743|NCT02187029|2109190|P2|Overall Study|Withdrawal by Subject|0
656744|NCT02187029|2109191|P1|Overall Study|Withdrawal by Subject|1
656745|NCT02187029|2109188|P4|Overall Study|Study Terminated by Sponsor|3
656746|NCT02187029|2109189|P3|Overall Study|Study Terminated by Sponsor|10
656747|NCT02187029|2109190|P2|Overall Study|Study Terminated by Sponsor|0
656748|NCT02187029|2109191|P1|Overall Study|Study Terminated by Sponsor|0
656749|NCT02187029|2109188|P4|Overall Study|Adverse Event|0
656750|NCT02187029|2109189|P3|Overall Study|Adverse Event|1
656751|NCT02187029|2109190|P2|Overall Study|Adverse Event|1
656752|NCT02187029|2109191|P1|Overall Study|Adverse Event|0
656753|NCT02186223|2109322|P1|Overall Study|Device in place less than 48 hours|9
656754|NCT02186223|2109322|P1|Overall Study|Death|3
656755|NCT02186223|2109322|P1|Overall Study|Unable to obtain femoral access|3
656756|NCT02186223|2109322|P1|Overall Study|Not eligible for device placement|6
656757|NCT02185534|2109352|P6|First Washout Period|Protocol Violation|1
656758|NCT02185534|2109353|P5|First Washout Period|Protocol Violation|0
656759|NCT02185534|2109354|P4|First Washout Period|Protocol Violation|0
656760|NCT02185534|2109355|P3|First Washout Period|Protocol Violation|0
656761|NCT02185534|2109356|P2|First Washout Period|Protocol Violation|0
656762|NCT02185534|2109357|P1|First Washout Period|Protocol Violation|0
656763|NCT02185534|2109352|P6|First Washout Period|Withdrawal by Subject|0
656764|NCT02185534|2109353|P5|First Washout Period|Withdrawal by Subject|1
656765|NCT02185534|2109354|P4|First Washout Period|Withdrawal by Subject|0
656766|NCT02185534|2109355|P3|First Washout Period|Withdrawal by Subject|0
656767|NCT02185534|2109356|P2|First Washout Period|Withdrawal by Subject|0
656768|NCT02185534|2109357|P1|First Washout Period|Withdrawal by Subject|1
656769|NCT02185534|2109352|P6|First Period|Withdrawal by Subject|0
656770|NCT02185534|2109353|P5|First Period|Withdrawal by Subject|0
656771|NCT02185534|2109354|P4|First Period|Withdrawal by Subject|1
656772|NCT02185534|2109355|P3|First Period|Withdrawal by Subject|0
656773|NCT02185534|2109356|P2|First Period|Withdrawal by Subject|0
656774|NCT02185534|2109357|P1|First Period|Withdrawal by Subject|0
656775|NCT02183675|2109537|P6|Treatment Period 2 (10 Days)|Adverse Event|2
656776|NCT02183675|2109538|P5|Treatment Period 2 (10 Days)|Adverse Event|0
656777|NCT02183675|2109539|P4|Treatment Period 2 (10 Days)|Adverse Event|0
656778|NCT02183675|2109540|P3|Treatment Period 2 (10 Days)|Adverse Event|0
656779|NCT02183675|2109541|P2|Treatment Period 2 (10 Days)|Adverse Event|0
656780|NCT02183675|2109542|P1|Treatment Period 2 (10 Days)|Adverse Event|0
656781|NCT02183519|2109566|P2|Overall Study|Did not respond to cough inducter|3
656782|NCT02183519|2109567|P1|Overall Study|Did not respond to cough inducter|0
656783|NCT02183519|2109566|P2|Overall Study|computer error|0
656784|NCT02183519|2109567|P1|Overall Study|computer error|3
656785|NCT02182895|2109575|P2|Overall Study|Discharged from hospital within 24 hours|4
656786|NCT02182895|2109576|P1|Overall Study|Discharged from hospital within 24 hours|2
656787|NCT02181790|2109598|P2|Overall Study|study terminated|0
656788|NCT02181790|2109599|P1|Overall Study|study terminated|2
656789|NCT02181504|2109645|P3|Overall Study|Adverse Event|1
656790|NCT02181504|2109646|P2|Overall Study|Adverse Event|1
656791|NCT02181504|2109647|P1|Overall Study|Adverse Event|1
656792|NCT02180061|2109747|P2|Overall Study|Continuing in Study|2
656793|NCT02180061|2109748|P1|Overall Study|Continuing in Study|19
656794|NCT02180061|2109747|P2|Overall Study|Progressive Disease|4
656795|NCT02180061|2109748|P1|Overall Study|Progressive Disease|9
656796|NCT02180061|2109747|P2|Overall Study|Clinical Progression|0
656797|NCT02180061|2109748|P1|Overall Study|Clinical Progression|3
656798|NCT02180061|2109747|P2|Overall Study|Adverse Event|2
656799|NCT02180061|2109748|P1|Overall Study|Adverse Event|3
656800|NCT02179398|2109801|P2|Overall Study|Lost to Follow-up|1
656801|NCT02179398|2109802|P1|Overall Study|Lost to Follow-up|0
656802|NCT02179398|2109801|P2|Overall Study|Lack of obligatory data|3
656803|NCT02179398|2109802|P1|Overall Study|Lack of obligatory data|3
656804|NCT02178995|2109822|P9|Open Label|Adverse Event|0
656805|NCT02178995|2109823|P8|Open Label|Adverse Event|0
656806|NCT02178995|2109824|P7|Open Label|Adverse Event|0
656807|NCT02178995|2109825|P6|Open Label|Adverse Event|0
656808|NCT02178995|2109826|P5|Open Label|Adverse Event|0
656809|NCT02178995|2109827|P4|Open Label|Adverse Event|0
656810|NCT02178995|2109828|P3|Open Label|Adverse Event|0
656811|NCT02178995|2109829|P2|Open Label|Adverse Event|0
656812|NCT02178995|2109830|P1|Open Label|Adverse Event|2
656813|NCT02178995|2109822|P9|Double Blind|Lost to Follow-up|0
656814|NCT02178995|2109823|P8|Double Blind|Lost to Follow-up|1
656815|NCT02178995|2109824|P7|Double Blind|Lost to Follow-up|0
656816|NCT02178995|2109825|P6|Double Blind|Lost to Follow-up|0
656817|NCT02178995|2109826|P5|Double Blind|Lost to Follow-up|0
656818|NCT02178995|2109827|P4|Double Blind|Lost to Follow-up|0
656819|NCT02178995|2109828|P3|Double Blind|Lost to Follow-up|0
656820|NCT02178995|2109829|P2|Double Blind|Lost to Follow-up|1
656821|NCT02178995|2109830|P1|Double Blind|Lost to Follow-up|0
656822|NCT02178995|2109822|P9|Double Blind|Adverse Event|1
656823|NCT02178995|2109823|P8|Double Blind|Adverse Event|1
656824|NCT02178995|2109824|P7|Double Blind|Adverse Event|0
656825|NCT02178995|2109825|P6|Double Blind|Adverse Event|1
656826|NCT02178995|2109826|P5|Double Blind|Adverse Event|0
656827|NCT02178995|2109827|P4|Double Blind|Adverse Event|0
656828|NCT02178995|2109828|P3|Double Blind|Adverse Event|0
656829|NCT02178995|2109829|P2|Double Blind|Adverse Event|0
656830|NCT02178995|2109830|P1|Double Blind|Adverse Event|0
656831|NCT02178787|2109903|P2|Overall Study|Physician Decision|0
656832|NCT02178787|2109904|P1|Overall Study|Physician Decision|1
656833|NCT02178787|2109903|P2|Overall Study|No TCD window|7
656834|NCT02178787|2109904|P1|Overall Study|No TCD window|3
656835|NCT02178787|2109903|P2|Overall Study|Withdrawal by Subject|2
656836|NCT02178787|2109904|P1|Overall Study|Withdrawal by Subject|0
656837|NCT02178787|2109903|P2|Overall Study|Lost to Follow-up|0
656838|NCT02178787|2109904|P1|Overall Study|Lost to Follow-up|1
656839|NCT02178059|2109919|P2|Washout|Physician Decision|0
656840|NCT02178059|2109920|P1|Washout|Physician Decision|1
656841|NCT02177266|2109938|P2|Overall Study|Withdrawal by Subject|0
656842|NCT02177266|2109939|P1|Overall Study|Withdrawal by Subject|1
656843|NCT02177266|2109938|P2|Overall Study|Adverse Event|1
656844|NCT02177266|2109939|P1|Overall Study|Adverse Event|0
656845|NCT02177032|2109962|P4|Overall Study|Withdrawal by Subject|0
656846|NCT02177032|2109963|P3|Overall Study|Withdrawal by Subject|1
656847|NCT02177032|2109964|P2|Overall Study|Withdrawal by Subject|0
656848|NCT02177032|2109965|P1|Overall Study|Withdrawal by Subject|1
656849|NCT02177032|2109962|P4|Overall Study|OTHER|0
656850|NCT02177032|2109963|P3|Overall Study|OTHER|1
656851|NCT02177032|2109964|P2|Overall Study|OTHER|0
656852|NCT02177032|2109965|P1|Overall Study|OTHER|2
656853|NCT02177032|2109962|P4|Overall Study|Lost to Follow-up|0
656854|NCT02177032|2109963|P3|Overall Study|Lost to Follow-up|0
656855|NCT02177032|2109964|P2|Overall Study|Lost to Follow-up|2
656856|NCT02177032|2109965|P1|Overall Study|Lost to Follow-up|0
656857|NCT02177032|2109962|P4|Overall Study|ADMINISTRATIVE REASON|0
656858|NCT02177032|2109963|P3|Overall Study|ADMINISTRATIVE REASON|1
656859|NCT02177032|2109964|P2|Overall Study|ADMINISTRATIVE REASON|0
656860|NCT02177032|2109965|P1|Overall Study|ADMINISTRATIVE REASON|2
656861|NCT02176655|2109999|P1|Overall Study|Subjects did not treat|6
656862|NCT02176525|2110028|P8|Overall Study|not treated|0
656863|NCT02176525|2110029|P7|Overall Study|not treated|0
656864|NCT02176525|2110030|P6|Overall Study|not treated|1
656865|NCT02176525|2110031|P5|Overall Study|not treated|0
656866|NCT02176525|2110032|P4|Overall Study|not treated|0
656867|NCT02176525|2110033|P3|Overall Study|not treated|0
656868|NCT02176525|2110034|P2|Overall Study|not treated|0
656869|NCT02176525|2110035|P1|Overall Study|not treated|1
656870|NCT02176525|2110028|P8|Overall Study|Adverse Event|0
656871|NCT02176525|2110029|P7|Overall Study|Adverse Event|1
656872|NCT02176525|2110030|P6|Overall Study|Adverse Event|0
656873|NCT02176525|2110031|P5|Overall Study|Adverse Event|1
656874|NCT02176525|2110032|P4|Overall Study|Adverse Event|1
656875|NCT02176525|2110033|P3|Overall Study|Adverse Event|0
656876|NCT02176525|2110034|P2|Overall Study|Adverse Event|0
656877|NCT02176525|2110035|P1|Overall Study|Adverse Event|0
656878|NCT02176421|2110212|P1|Overall Study|Adverse Event|1
656879|NCT02176421|2110212|P1|Overall Study|Lost to Follow-up|4
656880|NCT02176356|2110221|P1|Overall Study|Other Miscellaneous Reasons|2
656881|NCT02176356|2110221|P1|Overall Study|Personal Reasons|3
656882|NCT02176356|2110221|P1|Overall Study|Lost to Follow-up|4
656883|NCT02176356|2110221|P1|Overall Study|Screen Failure|14
656884|NCT02175771|2110257|P9|Treatment Period|Not specified|0
656885|NCT02175771|2110258|P8|Treatment Period|Not specified|2
656886|NCT02175771|2110259|P7|Treatment Period|Not specified|0
656887|NCT02175771|2110260|P6|Treatment Period|Not specified|0
656888|NCT02175771|2110261|P5|Treatment Period|Not specified|1
656889|NCT02175771|2110262|P4|Treatment Period|Not specified|3
656890|NCT02175771|2110263|P3|Treatment Period|Not specified|0
656891|NCT02175771|2110264|P2|Treatment Period|Not specified|1
656892|NCT02175771|2110265|P1|Treatment Period|Not specified|0
656893|NCT02175771|2110257|P9|Treatment Period|Lack of Efficacy|0
656894|NCT02175771|2110258|P8|Treatment Period|Lack of Efficacy|1
656895|NCT02175771|2110259|P7|Treatment Period|Lack of Efficacy|0
656896|NCT02175771|2110260|P6|Treatment Period|Lack of Efficacy|1
656897|NCT02175771|2110261|P5|Treatment Period|Lack of Efficacy|0
656898|NCT02175771|2110262|P4|Treatment Period|Lack of Efficacy|0
656899|NCT02175771|2110263|P3|Treatment Period|Lack of Efficacy|0
656900|NCT02175771|2110264|P2|Treatment Period|Lack of Efficacy|0
656901|NCT02175771|2110265|P1|Treatment Period|Lack of Efficacy|0
656902|NCT02175771|2110257|P9|Treatment Period|Lost to Follow-up|2
656903|NCT02175771|2110258|P8|Treatment Period|Lost to Follow-up|2
656904|NCT02175771|2110259|P7|Treatment Period|Lost to Follow-up|1
656905|NCT02175771|2110260|P6|Treatment Period|Lost to Follow-up|2
656906|NCT02175771|2110261|P5|Treatment Period|Lost to Follow-up|1
656907|NCT02175771|2110262|P4|Treatment Period|Lost to Follow-up|3
656908|NCT02175771|2110263|P3|Treatment Period|Lost to Follow-up|1
656909|NCT02175771|2110264|P2|Treatment Period|Lost to Follow-up|3
656910|NCT02175771|2110265|P1|Treatment Period|Lost to Follow-up|0
656911|NCT02175771|2110257|P9|Treatment Period|Disease progression|0
656912|NCT02175771|2110258|P8|Treatment Period|Disease progression|2
656913|NCT02175771|2110259|P7|Treatment Period|Disease progression|0
656914|NCT02175771|2110260|P6|Treatment Period|Disease progression|0
656915|NCT02175771|2110261|P5|Treatment Period|Disease progression|0
656916|NCT02175771|2110262|P4|Treatment Period|Disease progression|0
656917|NCT02175771|2110263|P3|Treatment Period|Disease progression|0
656918|NCT02175771|2110264|P2|Treatment Period|Disease progression|0
656919|NCT02175771|2110265|P1|Treatment Period|Disease progression|0
656920|NCT02175771|2110257|P9|Treatment Period|Protocol Violation|0
656921|NCT02175771|2110258|P8|Treatment Period|Protocol Violation|1
656922|NCT02175771|2110259|P7|Treatment Period|Protocol Violation|0
656923|NCT02175771|2110260|P6|Treatment Period|Protocol Violation|0
656924|NCT02175771|2110261|P5|Treatment Period|Protocol Violation|0
656925|NCT02175771|2110262|P4|Treatment Period|Protocol Violation|0
656926|NCT02175771|2110263|P3|Treatment Period|Protocol Violation|0
656927|NCT02175771|2110264|P2|Treatment Period|Protocol Violation|0
656928|NCT02175771|2110265|P1|Treatment Period|Protocol Violation|0
656929|NCT02175771|2110257|P9|Treatment Period|Noncompliance|1
656930|NCT02175771|2110258|P8|Treatment Period|Noncompliance|0
656931|NCT02175771|2110259|P7|Treatment Period|Noncompliance|0
656932|NCT02175771|2110260|P6|Treatment Period|Noncompliance|0
656933|NCT02175771|2110261|P5|Treatment Period|Noncompliance|0
656934|NCT02175771|2110262|P4|Treatment Period|Noncompliance|0
656935|NCT02175771|2110263|P3|Treatment Period|Noncompliance|2
656936|NCT02175771|2110264|P2|Treatment Period|Noncompliance|1
656937|NCT02175771|2110265|P1|Treatment Period|Noncompliance|0
656938|NCT02175771|2110257|P9|Treatment Period|Withdrawal by Subject|2
656939|NCT02175771|2110258|P8|Treatment Period|Withdrawal by Subject|9
656940|NCT02175771|2110259|P7|Treatment Period|Withdrawal by Subject|2
656941|NCT02175771|2110260|P6|Treatment Period|Withdrawal by Subject|4
656942|NCT02175771|2110261|P5|Treatment Period|Withdrawal by Subject|2
656943|NCT02175771|2110262|P4|Treatment Period|Withdrawal by Subject|6
656944|NCT02175771|2110263|P3|Treatment Period|Withdrawal by Subject|3
656945|NCT02175771|2110264|P2|Treatment Period|Withdrawal by Subject|9
656946|NCT02175771|2110265|P1|Treatment Period|Withdrawal by Subject|0
656947|NCT02175771|2110257|P9|Treatment Period|Adverse Event|1
656948|NCT02175771|2110258|P8|Treatment Period|Adverse Event|0
656949|NCT02175771|2110259|P7|Treatment Period|Adverse Event|2
656950|NCT02175771|2110260|P6|Treatment Period|Adverse Event|3
656951|NCT02175771|2110261|P5|Treatment Period|Adverse Event|1
656952|NCT02175771|2110262|P4|Treatment Period|Adverse Event|1
656953|NCT02175771|2110263|P3|Treatment Period|Adverse Event|1
656954|NCT02175771|2110264|P2|Treatment Period|Adverse Event|2
656955|NCT02175771|2110265|P1|Treatment Period|Adverse Event|0
656956|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Not specified|0
656957|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Not specified|0
656958|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Not specified|0
656959|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Not specified|0
656960|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Not specified|0
656961|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Not specified|0
656962|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Not specified|0
656963|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Not specified|0
656964|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Not specified|8
656965|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656966|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656967|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656968|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656969|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656970|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656971|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656972|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
656973|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
656974|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656975|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656976|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656977|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656978|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656979|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656980|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656981|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
656982|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
656983|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Adverse Event|0
656984|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Adverse Event|0
656985|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Adverse Event|0
656986|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Adverse Event|0
656987|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Adverse Event|0
656988|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Adverse Event|0
656989|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Adverse Event|0
656990|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Adverse Event|0
656991|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Adverse Event|9
656992|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656993|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656994|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656995|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656996|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656997|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656998|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
656999|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657000|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
657001|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657002|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657003|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657004|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657005|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657006|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657007|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657008|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657009|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
657010|NCT02175771|2110257|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657011|NCT02175771|2110258|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657012|NCT02175771|2110259|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657013|NCT02175771|2110260|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657014|NCT02175771|2110261|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657015|NCT02175771|2110262|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657016|NCT02175771|2110263|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657017|NCT02175771|2110264|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657018|NCT02175771|2110265|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
657019|NCT02175745|2110323|P1|Overall Study|Not Eligible|1
657020|NCT02175199|2110347|P2|Overall Study|Sponsor Decision|0
657021|NCT02175199|2110348|P1|Overall Study|Sponsor Decision|1
657022|NCT02175199|2110347|P2|Overall Study|Randomized in Error|0
657023|NCT02175199|2110348|P1|Overall Study|Randomized in Error|1
657024|NCT02175199|2110347|P2|Overall Study|Withdrawal by Subject|5
657025|NCT02175199|2110348|P1|Overall Study|Withdrawal by Subject|1
657026|NCT02175121|2110362|P5|Overall Study|Time issues|0
657027|NCT02175121|2110363|P4|Overall Study|Time issues|0
657028|NCT02175121|2110364|P3|Overall Study|Time issues|1
657029|NCT02175121|2110365|P2|Overall Study|Time issues|0
657030|NCT02175121|2110366|P1|Overall Study|Time issues|0
657031|NCT02175121|2110362|P5|Overall Study|Schedule conflict|0
657032|NCT02175121|2110363|P4|Overall Study|Schedule conflict|0
657033|NCT02175121|2110364|P3|Overall Study|Schedule conflict|1
657034|NCT02175121|2110365|P2|Overall Study|Schedule conflict|0
657035|NCT02175121|2110366|P1|Overall Study|Schedule conflict|0
657036|NCT02175121|2110362|P5|Overall Study|Personal emergency|1
657037|NCT02175121|2110363|P4|Overall Study|Personal emergency|0
657038|NCT02175121|2110364|P3|Overall Study|Personal emergency|0
657039|NCT02175121|2110365|P2|Overall Study|Personal emergency|0
657040|NCT02175121|2110366|P1|Overall Study|Personal emergency|0
657041|NCT02175121|2110362|P5|Overall Study|Lost to Follow-up|0
657042|NCT02175121|2110363|P4|Overall Study|Lost to Follow-up|1
657043|NCT02175121|2110364|P3|Overall Study|Lost to Follow-up|0
657044|NCT02175121|2110365|P2|Overall Study|Lost to Follow-up|1
657045|NCT02175121|2110366|P1|Overall Study|Lost to Follow-up|0
657046|NCT02175121|2110362|P5|Overall Study|Lack of Efficacy|0
657047|NCT02175121|2110363|P4|Overall Study|Lack of Efficacy|0
657048|NCT02175121|2110364|P3|Overall Study|Lack of Efficacy|0
657049|NCT02175121|2110365|P2|Overall Study|Lack of Efficacy|0
657050|NCT02175121|2110366|P1|Overall Study|Lack of Efficacy|1
657051|NCT02173769|2110493|P1|Overall Study|Protocol Violation|4
657052|NCT02173054|2110596|P3|Overall Study|Withdrawal by Subject|1
657053|NCT02173054|2110597|P2|Overall Study|Withdrawal by Subject|0
657054|NCT02173054|2110598|P1|Overall Study|Withdrawal by Subject|0
657055|NCT02173054|2110596|P3|Overall Study|lack of compliance|0
657056|NCT02173054|2110597|P2|Overall Study|lack of compliance|0
657057|NCT02173054|2110598|P1|Overall Study|lack of compliance|1
657058|NCT02172625|2110643|P2|Overall Study|car accident|1
657059|NCT02172625|2110644|P1|Overall Study|car accident|0
657060|NCT02172625|2110643|P2|Overall Study|Pregnancy|1
657061|NCT02172625|2110644|P1|Overall Study|Pregnancy|0
657062|NCT02172625|2110643|P2|Overall Study|Adverse Event|1
657063|NCT02172625|2110644|P1|Overall Study|Adverse Event|0
657064|NCT02172040|2110666|P4|Overall Study|Family emergency abroad|1
657065|NCT02172040|2110667|P3|Overall Study|Family emergency abroad|0
657066|NCT02172040|2110668|P2|Overall Study|Family emergency abroad|0
657067|NCT02172040|2110669|P1|Overall Study|Family emergency abroad|0
657068|NCT02172040|2110666|P4|Overall Study|Not available for Day 13 & 14 visits|0
657069|NCT02172040|2110667|P3|Overall Study|Not available for Day 13 & 14 visits|1
657070|NCT02172040|2110668|P2|Overall Study|Not available for Day 13 & 14 visits|0
657071|NCT02172040|2110669|P1|Overall Study|Not available for Day 13 & 14 visits|0
657072|NCT02172040|2110666|P4|Overall Study|Withdrawal by Subject|0
657073|NCT02172040|2110667|P3|Overall Study|Withdrawal by Subject|1
657074|NCT02172040|2110668|P2|Overall Study|Withdrawal by Subject|0
657075|NCT02172040|2110669|P1|Overall Study|Withdrawal by Subject|0
657076|NCT02172040|2110666|P4|Overall Study|Protocol Violation|0
657077|NCT02172040|2110667|P3|Overall Study|Protocol Violation|0
657078|NCT02172040|2110668|P2|Overall Study|Protocol Violation|1
657079|NCT02172040|2110669|P1|Overall Study|Protocol Violation|0
657080|NCT02172040|2110666|P4|Overall Study|Adverse Event|0
657081|NCT02172040|2110667|P3|Overall Study|Adverse Event|0
657082|NCT02172040|2110668|P2|Overall Study|Adverse Event|2
657083|NCT02172040|2110669|P1|Overall Study|Adverse Event|0
657084|NCT02170779|2110871|P2|Overall Study|Lost to Follow-up|1
657085|NCT02170779|2110872|P1|Overall Study|Lost to Follow-up|0
657086|NCT02170779|2110871|P2|Overall Study|Withdrawal by Subject|0
657087|NCT02170779|2110872|P1|Overall Study|Withdrawal by Subject|1
657088|NCT02170688|2110899|P5|Overall Study|Physician Decision|0
657089|NCT02170688|2110900|P4|Overall Study|Physician Decision|0
657090|NCT02170688|2110901|P3|Overall Study|Physician Decision|1
657091|NCT02170688|2110902|P2|Overall Study|Physician Decision|0
657092|NCT02170688|2110903|P1|Overall Study|Physician Decision|0
657093|NCT02170688|2110899|P5|Overall Study|Full dose not received|0
657094|NCT02170688|2110900|P4|Overall Study|Full dose not received|0
657095|NCT02170688|2110901|P3|Overall Study|Full dose not received|0
657096|NCT02170688|2110902|P2|Overall Study|Full dose not received|1
657097|NCT02170688|2110903|P1|Overall Study|Full dose not received|0
657098|NCT02170688|2110899|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
657099|NCT02170688|2110900|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
657100|NCT02170688|2110901|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
657101|NCT02170688|2110902|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
657102|NCT02170688|2110903|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
657103|NCT02170207|2111064|P1|Overall Study|Case report forms unavailable|5
657104|NCT02170077|2111075|P3|Overall Study|Exacerbation of seizures|1
657105|NCT02170077|2111076|P2|Overall Study|Exacerbation of seizures|2
657106|NCT02170077|2111077|P1|Overall Study|Exacerbation of seizures|0
657107|NCT02170077|2111075|P3|Overall Study|Exclusion criteria|5
657108|NCT02170077|2111076|P2|Overall Study|Exclusion criteria|2
657109|NCT02170077|2111077|P1|Overall Study|Exclusion criteria|2
657110|NCT02170077|2111075|P3|Overall Study|Lost to Follow-up|0
657111|NCT02170077|2111076|P2|Overall Study|Lost to Follow-up|1
657112|NCT02170077|2111077|P1|Overall Study|Lost to Follow-up|0
657113|NCT02170077|2111075|P3|Overall Study|Adverse Event|4
657114|NCT02170077|2111076|P2|Overall Study|Adverse Event|4
657115|NCT02170077|2111077|P1|Overall Study|Adverse Event|4
657116|NCT02170077|2111075|P3|Overall Study|Withdrawal by Subject|2
657117|NCT02170077|2111076|P2|Overall Study|Withdrawal by Subject|4
657118|NCT02170077|2111077|P1|Overall Study|Withdrawal by Subject|3
657119|NCT02170064|2111088|P3|Overall Study|Physician Decision|0
657120|NCT02170064|2111089|P2|Overall Study|Physician Decision|1
657121|NCT02170064|2111090|P1|Overall Study|Physician Decision|1
657122|NCT02170064|2111088|P3|Overall Study|Withdrawal by Subject|1
657123|NCT02170064|2111089|P2|Overall Study|Withdrawal by Subject|1
657124|NCT02170064|2111090|P1|Overall Study|Withdrawal by Subject|5
657125|NCT02169414|2111246|P4|Overall Study|Adverse Event|0
657126|NCT02169414|2111247|P3|Overall Study|Adverse Event|0
657127|NCT02169414|2111248|P2|Overall Study|Adverse Event|1
657128|NCT02169414|2111249|P1|Overall Study|Adverse Event|0
657129|NCT02169414|2111246|P4|Overall Study|Withdrawal by Subject|0
657130|NCT02169414|2111247|P3|Overall Study|Withdrawal by Subject|0
657131|NCT02169414|2111248|P2|Overall Study|Withdrawal by Subject|0
657132|NCT02169414|2111249|P1|Overall Study|Withdrawal by Subject|1
657133|NCT02169336|2111290|P3|Overall Study|Subject declined to continue dosing|1
657134|NCT02169336|2111291|P2|Overall Study|Subject declined to continue dosing|0
657135|NCT02169336|2111292|P1|Overall Study|Subject declined to continue dosing|0
657136|NCT02169336|2111290|P3|Overall Study|Physician Decision|1
657137|NCT02169336|2111291|P2|Overall Study|Physician Decision|0
657138|NCT02169336|2111292|P1|Overall Study|Physician Decision|0
657139|NCT02169336|2111290|P3|Overall Study|Withdrawal by Subject|0
657140|NCT02169336|2111291|P2|Overall Study|Withdrawal by Subject|0
657141|NCT02169336|2111292|P1|Overall Study|Withdrawal by Subject|1
657142|NCT02169336|2111290|P3|Overall Study|Adverse Event|1
657143|NCT02169336|2111291|P2|Overall Study|Adverse Event|3
657144|NCT02169336|2111292|P1|Overall Study|Adverse Event|2
657145|NCT02169336|2111290|P3|Overall Study|Lack of Efficacy|0
657146|NCT02169336|2111291|P2|Overall Study|Lack of Efficacy|1
657147|NCT02169336|2111292|P1|Overall Study|Lack of Efficacy|1
657148|NCT02168491|2111313|P1|Overall Study|Withdrawal by Subject|1
657149|NCT02168478|2111319|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
657150|NCT02168478|2111319|P1|Overall Study|Did Not Consent to Participation|2
657151|NCT02168478|2111319|P1|Overall Study|Withdrawal by Subject|1
657152|NCT02168439|2111325|P2|Overall Study|Protocol Violation|2
657153|NCT02168439|2111326|P1|Overall Study|Protocol Violation|0
657154|NCT02168387|2111344|P2|Overall Study|Death|0
657155|NCT02168387|2111345|P1|Overall Study|Death|1
657156|NCT02168387|2111344|P2|Overall Study|Planned exubation|3
657157|NCT02168387|2111345|P1|Overall Study|Planned exubation|6
657158|NCT02167893|2111366|P1|Overall Study|Case report forms not collected|68
657159|NCT02167893|2111366|P1|Overall Study|Investigator health reasons|10
657160|NCT02167893|2111366|P1|Overall Study|Investigator transferred|85
657161|NCT02167139|2111400|P4|Transition-extension|Lost to Follow-up|0
657162|NCT02167139|2111401|P3|Transition-extension|Lost to Follow-up|0
657163|NCT02167139|2111402|P2|Transition-extension|Lost to Follow-up|0
657164|NCT02167139|2111403|P1|Transition-extension|Lost to Follow-up|1
657165|NCT02167139|2111400|P4|Transition-extension|Other|0
657166|NCT02167139|2111401|P3|Transition-extension|Other|1
657167|NCT02167139|2111402|P2|Transition-extension|Other|0
657168|NCT02167139|2111403|P1|Transition-extension|Other|1
657169|NCT02167139|2111400|P4|Transition-extension|Lack of Efficacy|1
657170|NCT02167139|2111401|P3|Transition-extension|Lack of Efficacy|1
657171|NCT02167139|2111402|P2|Transition-extension|Lack of Efficacy|0
657172|NCT02167139|2111403|P1|Transition-extension|Lack of Efficacy|0
657173|NCT02167139|2111400|P4|Transition-extension|Withdrawal by Subject|1
657174|NCT02167139|2111401|P3|Transition-extension|Withdrawal by Subject|4
657175|NCT02167139|2111402|P2|Transition-extension|Withdrawal by Subject|0
657176|NCT02167139|2111403|P1|Transition-extension|Withdrawal by Subject|2
657177|NCT02167139|2111400|P4|Transition-extension|Adverse Event|3
657178|NCT02167139|2111401|P3|Transition-extension|Adverse Event|2
657179|NCT02167139|2111402|P2|Transition-extension|Adverse Event|0
657180|NCT02167139|2111403|P1|Transition-extension|Adverse Event|2
657181|NCT02167139|2111400|P4|Randomised, Double-blind|Other|0
657182|NCT02167139|2111401|P3|Randomised, Double-blind|Other|0
657183|NCT02167139|2111402|P2|Randomised, Double-blind|Other|0
657184|NCT02167139|2111403|P1|Randomised, Double-blind|Other|3
657185|NCT02167139|2111400|P4|Randomised, Double-blind|Lack of Efficacy|0
657186|NCT02167139|2111401|P3|Randomised, Double-blind|Lack of Efficacy|0
657187|NCT02167139|2111402|P2|Randomised, Double-blind|Lack of Efficacy|2
657188|NCT02167139|2111403|P1|Randomised, Double-blind|Lack of Efficacy|1
657189|NCT02167139|2111400|P4|Randomised, Double-blind|Adverse Event|0
657190|NCT02167139|2111401|P3|Randomised, Double-blind|Adverse Event|0
657191|NCT02167139|2111402|P2|Randomised, Double-blind|Adverse Event|9
657192|NCT02167139|2111403|P1|Randomised, Double-blind|Adverse Event|2
657193|NCT02167139|2111400|P4|Randomised, Double-blind|Withdrawal by Subject|0
657194|NCT02167139|2111401|P3|Randomised, Double-blind|Withdrawal by Subject|0
657195|NCT02167139|2111402|P2|Randomised, Double-blind|Withdrawal by Subject|8
657196|NCT02167139|2111403|P1|Randomised, Double-blind|Withdrawal by Subject|11
657197|NCT02166697|2111417|P1|Overall Study|Protocol Violation|347
657198|NCT02165826|2111429|P3|Down-Titration Period|Reason Not Specified|2
657199|NCT02165826|2111430|P2|Down-Titration Period|Reason Not Specified|0
657200|NCT02165826|2111431|P1|Down-Titration Period|Reason Not Specified|1
657201|NCT02165826|2111429|P3|Down-Titration Period|Voluntary Withdrawal|2
657202|NCT02165826|2111430|P2|Down-Titration Period|Voluntary Withdrawal|1
657203|NCT02165826|2111431|P1|Down-Titration Period|Voluntary Withdrawal|2
657204|NCT02165826|2111429|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
657205|NCT02165826|2111430|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
657206|NCT02165826|2111431|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
657207|NCT02165826|2111429|P3|Main Treatment Period|Did Not Receive Study Drug|0
657208|NCT02165826|2111430|P2|Main Treatment Period|Did Not Receive Study Drug|2
657209|NCT02165826|2111431|P1|Main Treatment Period|Did Not Receive Study Drug|0
657210|NCT02165826|2111429|P3|Main Treatment Period|Reason Not Specified|16
657211|NCT02165826|2111430|P2|Main Treatment Period|Reason Not Specified|5
657212|NCT02165826|2111431|P1|Main Treatment Period|Reason Not Specified|8
657213|NCT02165826|2111429|P3|Main Treatment Period|Lack of Efficacy|0
657214|NCT02165826|2111430|P2|Main Treatment Period|Lack of Efficacy|0
657215|NCT02165826|2111431|P1|Main Treatment Period|Lack of Efficacy|2
657216|NCT02165826|2111429|P3|Main Treatment Period|Voluntary Withdrawal|21
657217|NCT02165826|2111430|P2|Main Treatment Period|Voluntary Withdrawal|23
657218|NCT02165826|2111431|P1|Main Treatment Period|Voluntary Withdrawal|23
657219|NCT02165826|2111429|P3|Main Treatment Period|Lost to Follow-up|1
657220|NCT02165826|2111430|P2|Main Treatment Period|Lost to Follow-up|2
657221|NCT02165826|2111431|P1|Main Treatment Period|Lost to Follow-up|4
657222|NCT02165826|2111429|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
657223|NCT02165826|2111430|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
657224|NCT02165826|2111431|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
657225|NCT02165826|2111429|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
657226|NCT02165826|2111430|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
657227|NCT02165826|2111431|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
888198|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
888199|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
888200|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
888201|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888202|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888203|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888204|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888205|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888206|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
888207|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
888208|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
888209|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
888210|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888211|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888212|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888213|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888214|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888215|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888216|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
888217|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
888218|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
888219|NCT02207244|2821515|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888220|NCT02207244|2821516|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888221|NCT02207244|2821517|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888222|NCT02207244|2821518|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888223|NCT02207244|2821519|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888224|NCT02207244|2821520|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
888225|NCT02207244|2821521|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
888226|NCT02207244|2821522|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
888227|NCT02207244|2821523|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
888229|NCT02202161|2821575|P8|Overall Study|Withdrawal by Subject|0
888230|NCT02202161|2821576|P7|Overall Study|Withdrawal by Subject|0
888231|NCT02202161|2821577|P6|Overall Study|Withdrawal by Subject|0
888232|NCT02202161|2821578|P5|Overall Study|Withdrawal by Subject|1
888233|NCT02202161|2821579|P4|Overall Study|Withdrawal by Subject|0
888234|NCT02202161|2821580|P3|Overall Study|Withdrawal by Subject|0
888235|NCT02202161|2821581|P2|Overall Study|Withdrawal by Subject|0
888236|NCT02202161|2821582|P1|Overall Study|Withdrawal by Subject|0
888237|NCT02202161|2821575|P8|Overall Study|Physician Decision|3
888238|NCT02202161|2821576|P7|Overall Study|Physician Decision|0
888239|NCT02202161|2821577|P6|Overall Study|Physician Decision|0
888240|NCT02202161|2821578|P5|Overall Study|Physician Decision|0
888241|NCT02202161|2821579|P4|Overall Study|Physician Decision|0
888242|NCT02202161|2821580|P3|Overall Study|Physician Decision|0
888243|NCT02202161|2821581|P2|Overall Study|Physician Decision|0
888244|NCT02202161|2821582|P1|Overall Study|Physician Decision|0
888245|NCT02202161|2821575|P8|Overall Study|Did not meet continuation criteria|3
888246|NCT02202161|2821576|P7|Overall Study|Did not meet continuation criteria|0
888247|NCT02202161|2821577|P6|Overall Study|Did not meet continuation criteria|0
888248|NCT02202161|2821578|P5|Overall Study|Did not meet continuation criteria|0
888249|NCT02202161|2821579|P4|Overall Study|Did not meet continuation criteria|0
657282|NCT02163915|2111678|P5|Overall Study|Physician Decision|0
657283|NCT02163915|2111679|P4|Overall Study|Physician Decision|1
657284|NCT02163915|2111680|P3|Overall Study|Physician Decision|0
657285|NCT02163915|2111681|P2|Overall Study|Physician Decision|0
657286|NCT02163915|2111682|P1|Overall Study|Physician Decision|0
657287|NCT02163915|2111678|P5|Overall Study|Study termination|2
657288|NCT02163915|2111679|P4|Overall Study|Study termination|0
657289|NCT02163915|2111680|P3|Overall Study|Study termination|0
657290|NCT02163915|2111681|P2|Overall Study|Study termination|0
657291|NCT02163915|2111682|P1|Overall Study|Study termination|1
657292|NCT02163915|2111678|P5|Overall Study|Withdrawal by Subject|2
657293|NCT02163915|2111679|P4|Overall Study|Withdrawal by Subject|2
657294|NCT02163915|2111680|P3|Overall Study|Withdrawal by Subject|2
657295|NCT02163915|2111681|P2|Overall Study|Withdrawal by Subject|0
657296|NCT02163915|2111682|P1|Overall Study|Withdrawal by Subject|2
657297|NCT02163733|2111737|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
657298|NCT02163733|2111738|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
657299|NCT02163733|2111739|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
657300|NCT02163733|2111737|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
657301|NCT02163733|2111738|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
657302|NCT02163733|2111739|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
657303|NCT02163395|2111788|P1|Overall Study|Adverse Event|1
657304|NCT02163395|2111788|P1|Overall Study|Lost to Follow-up|3
657305|NCT02163395|2111788|P1|Overall Study|Withdrawal by Subject|1
657306|NCT02162862|2111807|P3|Overall Study|Subject did not feel the med was needed|4
657307|NCT02162862|2111808|P2|Overall Study|Subject did not feel the med was needed|0
657308|NCT02162862|2111809|P1|Overall Study|Subject did not feel the med was needed|0
657309|NCT02162862|2111807|P3|Overall Study|Lost to Follow-up|0
657310|NCT02162862|2111808|P2|Overall Study|Lost to Follow-up|11
657311|NCT02162862|2111809|P1|Overall Study|Lost to Follow-up|0
657312|NCT02162758|2111822|P2|Overall Study|Study termination|1
657313|NCT02162758|2111823|P1|Overall Study|Study termination|0
657314|NCT02161549|2111850|P2|Overall Study|Physician Decision|2
657315|NCT02161549|2111851|P1|Overall Study|Physician Decision|6
657316|NCT02161146|2111862|P5|Overall Study|Other Miscellaneous Reasons|0
657317|NCT02161146|2111863|P4|Overall Study|Other Miscellaneous Reasons|0
657318|NCT02161146|2111864|P3|Overall Study|Other Miscellaneous Reasons|0
657319|NCT02161146|2111865|P2|Overall Study|Other Miscellaneous Reasons|1
657320|NCT02161146|2111866|P1|Overall Study|Other Miscellaneous Reasons|0
657321|NCT02161146|2111862|P5|Overall Study|Personal Reasons|1
657322|NCT02161146|2111863|P4|Overall Study|Personal Reasons|2
657323|NCT02161146|2111864|P3|Overall Study|Personal Reasons|0
657324|NCT02161146|2111865|P2|Overall Study|Personal Reasons|1
657325|NCT02161146|2111866|P1|Overall Study|Personal Reasons|0
657326|NCT02161146|2111862|P5|Overall Study|Lost to Follow-up|0
657327|NCT02161146|2111863|P4|Overall Study|Lost to Follow-up|0
657328|NCT02161146|2111864|P3|Overall Study|Lost to Follow-up|0
657329|NCT02161146|2111865|P2|Overall Study|Lost to Follow-up|1
657330|NCT02161146|2111866|P1|Overall Study|Lost to Follow-up|0
657331|NCT02161146|2111862|P5|Overall Study|Adverse Event|0
657332|NCT02161146|2111863|P4|Overall Study|Adverse Event|1
657333|NCT02161146|2111864|P3|Overall Study|Adverse Event|0
657334|NCT02161146|2111865|P2|Overall Study|Adverse Event|1
657335|NCT02161146|2111866|P1|Overall Study|Adverse Event|1
657336|NCT02161016|2111879|P1|Overall Study|withdrawn by IRB|1
657337|NCT02160977|2111910|P2|Six Months After Surgery|Lost to Follow-up|1
657338|NCT02160977|2111911|P1|Six Months After Surgery|Lost to Follow-up|2
657339|NCT02160977|2111910|P2|Three Months After Surgery|Lost to Follow-up|2
657340|NCT02160977|2111911|P1|Three Months After Surgery|Lost to Follow-up|0
657341|NCT02160977|2111910|P2|Six Weeks After Surgery|Lost to Follow-up|0
657342|NCT02160977|2111911|P1|Six Weeks After Surgery|Lost to Follow-up|1
657343|NCT02160314|2111938|P2|Overall Study|Lost to Follow-up|1
657344|NCT02160314|2111939|P1|Overall Study|Lost to Follow-up|0
657345|NCT02160314|2111938|P2|Overall Study|Withdrawal by Subject|2
657346|NCT02160314|2111939|P1|Overall Study|Withdrawal by Subject|1
657347|NCT02160314|2111938|P2|Overall Study|Protocol Violation|4
657348|NCT02160314|2111939|P1|Overall Study|Protocol Violation|0
657349|NCT02160314|2111938|P2|Overall Study|Adverse Event|6
657350|NCT02160314|2111939|P1|Overall Study|Adverse Event|0
657351|NCT02159950|2111947|P2|Overall Study|Progression|1
657352|NCT02159950|2111948|P1|Overall Study|Progression|0
657353|NCT02159950|2111947|P2|Overall Study|Adverse Event|1
657354|NCT02159950|2111948|P1|Overall Study|Adverse Event|0
657355|NCT02159482|2112009|P1|Overall Study|Physician Decision|3
657356|NCT02159482|2112009|P1|Overall Study|Withdrawal by Subject|2
657364|NCT02159352|2112020|P2|Overall Study|Withdrawal by Subject|1
657365|NCT02159352|2112021|P1|Overall Study|Withdrawal by Subject|0
657366|NCT02159352|2112020|P2|Overall Study|Adverse Event|1
657367|NCT02159352|2112021|P1|Overall Study|Adverse Event|3
657368|NCT02159040|2112096|P1|Overall Study|Death|1
657369|NCT02158728|2112109|P1|Overall Study|no qualified dataset|24
657370|NCT02158728|2112109|P1|Overall Study|no procedure according to CIP done|3
657371|NCT02158442|2112126|P2|Overall Study|Perfusion staff not available|0
657372|NCT02158442|2112127|P1|Overall Study|Perfusion staff not available|1
657373|NCT02158442|2112126|P2|Overall Study|Withdrawal by Subject|0
657374|NCT02158442|2112127|P1|Overall Study|Withdrawal by Subject|1
657375|NCT02158247|2112146|P1|Overall Study|Invisible vocal cords|5
657376|NCT02158039|2112162|P1|Overall Study|Screen Failure|9
657377|NCT02158039|2112162|P1|Overall Study|Withdrawal by Subject|1
657378|NCT02157948|2112169|P2|Overall Study|Decision by Sponsor|1
657379|NCT02157948|2112170|P1|Overall Study|Decision by Sponsor|0
657380|NCT02157948|2112169|P2|Overall Study|Protocol Specified Criteria|1
657381|NCT02157948|2112170|P1|Overall Study|Protocol Specified Criteria|2
657382|NCT02157948|2112169|P2|Overall Study|Lost to Follow-up|2
657383|NCT02157948|2112170|P1|Overall Study|Lost to Follow-up|3
657384|NCT02157948|2112169|P2|Overall Study|Withdrawal by Subject|5
657385|NCT02157948|2112170|P1|Overall Study|Withdrawal by Subject|4
888250|NCT02202161|2821580|P3|Overall Study|Did not meet continuation criteria|0
888251|NCT02202161|2821581|P2|Overall Study|Did not meet continuation criteria|0
888252|NCT02202161|2821582|P1|Overall Study|Did not meet continuation criteria|0
888253|NCT02202161|2821575|P8|Overall Study|Adverse Event|0
888254|NCT02202161|2821576|P7|Overall Study|Adverse Event|0
888255|NCT02202161|2821577|P6|Overall Study|Adverse Event|1
888256|NCT02202161|2821578|P5|Overall Study|Adverse Event|0
888257|NCT02202161|2821579|P4|Overall Study|Adverse Event|0
888258|NCT02202161|2821580|P3|Overall Study|Adverse Event|0
888259|NCT02202161|2821581|P2|Overall Study|Adverse Event|1
888260|NCT02202161|2821582|P1|Overall Study|Adverse Event|1
888261|NCT02199795|2821738|P2|Overall Study|withdrew due to shoulder pain|0
888262|NCT02199795|2821739|P1|Overall Study|withdrew due to shoulder pain|1
888263|NCT02199795|2821738|P2|Overall Study|no longer met inclusion criteria|0
888264|NCT02199795|2821739|P1|Overall Study|no longer met inclusion criteria|1
657407|NCT02157623|2112240|P2|Overall Study|Physician Decision|3
657408|NCT02157623|2112241|P1|Overall Study|Physician Decision|4
657409|NCT02157376|2112249|P2|Overall Study|Investigator's misjudgement|2
657410|NCT02157376|2112250|P1|Overall Study|Investigator's misjudgement|1
657411|NCT02157376|2112249|P2|Overall Study|Not treated|3
657412|NCT02157376|2112250|P1|Overall Study|Not treated|8
657413|NCT02157376|2112249|P2|Overall Study|Withdrawal by Subject|8
657414|NCT02157376|2112250|P1|Overall Study|Withdrawal by Subject|3
657415|NCT02157376|2112249|P2|Overall Study|Eligibility criteria not fulfilled|1
657416|NCT02157376|2112250|P1|Overall Study|Eligibility criteria not fulfilled|0
657417|NCT02157376|2112249|P2|Overall Study|Death|4
657418|NCT02157376|2112250|P1|Overall Study|Death|10
657419|NCT02157298|2112260|P2|Overall Study|Withdrawal by Subject|0
657420|NCT02157298|2112261|P1|Overall Study|Withdrawal by Subject|1
657421|NCT02157298|2112260|P2|Overall Study|Poor/Non-compliance|0
657422|NCT02157298|2112261|P1|Overall Study|Poor/Non-compliance|1
657423|NCT02157298|2112260|P2|Overall Study|Subject no longer meets study criteria|2
657424|NCT02157298|2112261|P1|Overall Study|Subject no longer meets study criteria|1
657425|NCT02157298|2112260|P2|Overall Study|Adverse Event|0
657426|NCT02157298|2112261|P1|Overall Study|Adverse Event|1
657427|NCT02157116|2112275|P1|Overall Study|Failed Screening|2
657428|NCT02157116|2112275|P1|Overall Study|Physician Decision|3
657429|NCT02157116|2112275|P1|Overall Study|Withdrawal by Subject|4
657430|NCT02156466|2112289|P5|Overall Study|Quantiferon Positivity|0
657431|NCT02156466|2112290|P4|Overall Study|Quantiferon Positivity|1
657432|NCT02156466|2112291|P3|Overall Study|Quantiferon Positivity|0
657433|NCT02156466|2112292|P2|Overall Study|Quantiferon Positivity|0
657434|NCT02156466|2112293|P1|Overall Study|Quantiferon Positivity|0
657435|NCT02156466|2112289|P5|Overall Study|Adverse Event|0
657436|NCT02156466|2112290|P4|Overall Study|Adverse Event|1
657437|NCT02156466|2112291|P3|Overall Study|Adverse Event|1
657438|NCT02156466|2112292|P2|Overall Study|Adverse Event|0
657439|NCT02156466|2112293|P1|Overall Study|Adverse Event|0
657440|NCT02156271|2112474|P2|Overall Study|Physician Decision|3
657441|NCT02156271|2112475|P1|Overall Study|Physician Decision|4
657442|NCT02155985|2112514|P3|Overall Study|Lost to Follow-up|0
657443|NCT02155985|2112515|P2|Overall Study|Lost to Follow-up|0
657444|NCT02155985|2112516|P1|Overall Study|Lost to Follow-up|1
657445|NCT02155985|2112514|P3|Overall Study|Withdrawal by Subject|1
657446|NCT02155985|2112515|P2|Overall Study|Withdrawal by Subject|0
657447|NCT02155985|2112516|P1|Overall Study|Withdrawal by Subject|0
657448|NCT02155881|2112583|P2|Overall Study|Inappropriately randomized|2
657449|NCT02155881|2112584|P1|Overall Study|Inappropriately randomized|2
657450|NCT02155881|2112583|P2|Overall Study|Withdrawal by Subject|2
657451|NCT02155881|2112584|P1|Overall Study|Withdrawal by Subject|0
657452|NCT02155322|2112636|P1|Overall Study|Withdrawal by Subject|4
657453|NCT02155322|2112636|P1|Overall Study|Relapse/Recurrence|8
657454|NCT02155322|2112636|P1|Overall Study|Physician Decision|1
657455|NCT02155322|2112636|P1|Overall Study|Adverse Event|1
657456|NCT02155283|2112641|P1|Overall Study|Protocol Violation|3
657457|NCT02155283|2112641|P1|Overall Study|Withdrawal by Subject|1
657458|NCT02155283|2112641|P1|Overall Study|Lost to Follow-up|3
657459|NCT02154425|2112668|P1|Screening Period|Adverse Event|1
657460|NCT02154139|2112727|P1|Overall Study|Investigator transferred|3
657461|NCT02154139|2112727|P1|Overall Study|Other|2
657462|NCT02154139|2112727|P1|Overall Study|Injection not administered|2
657463|NCT02154087|2112735|P1|Overall Study|Study Termination|1
657464|NCT02153827|2112754|P2|Overall Study|Lost to Follow-up|9
657465|NCT02153827|2112755|P1|Overall Study|Lost to Follow-up|3
657466|NCT02153788|2112771|P2|Overall Study|Physician Decision|1
657467|NCT02153788|2112772|P1|Overall Study|Physician Decision|2
657468|NCT02153736|2112792|P2|Overall Study|Withdrawal by Subject|1
657469|NCT02153736|2112793|P1|Overall Study|Withdrawal by Subject|0
657470|NCT02153736|2112792|P2|Overall Study|Death|1
657471|NCT02153736|2112793|P1|Overall Study|Death|0
657472|NCT02153736|2112792|P2|Overall Study|Medical status change made ineligible|0
657473|NCT02153736|2112793|P1|Overall Study|Medical status change made ineligible|1
657474|NCT02153736|2112792|P2|Overall Study|Lost to Follow-up|0
657475|NCT02153736|2112793|P1|Overall Study|Lost to Follow-up|1
657476|NCT02153398|2112853|P5|Overall Study|Adverse Event|0
657477|NCT02153398|2112854|P4|Overall Study|Adverse Event|1
657478|NCT02153398|2112855|P3|Overall Study|Adverse Event|1
657479|NCT02153398|2112856|P2|Overall Study|Adverse Event|0
657480|NCT02153398|2112857|P1|Overall Study|Adverse Event|0
657481|NCT02153398|2112853|P5|Overall Study|Withdrawal by Subject|0
657482|NCT02153398|2112854|P4|Overall Study|Withdrawal by Subject|0
657483|NCT02153398|2112855|P3|Overall Study|Withdrawal by Subject|0
657484|NCT02153398|2112856|P2|Overall Study|Withdrawal by Subject|0
657485|NCT02153398|2112857|P1|Overall Study|Withdrawal by Subject|1
657486|NCT02153346|2112979|P1|Overall Study|Lost to Follow-up|11
657487|NCT02153086|2113053|P1|Overall Study|Other|2
657488|NCT02153086|2113053|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
657499|NCT02152566|2113080|P1|Overall Study|Withdrawal by Subject|2
657500|NCT02152566|2113080|P1|Overall Study|Lost to Follow-up|1
657501|NCT02152371|2113086|P2|Overall Study|Reason Not Given|1
657502|NCT02152371|2113087|P1|Overall Study|Reason Not Given|0
657503|NCT02152371|2113086|P2|Overall Study|Physician Decision|2
657504|NCT02152371|2113087|P1|Overall Study|Physician Decision|0
657505|NCT02152371|2113086|P2|Overall Study|Lack of Efficacy|1
657506|NCT02152371|2113087|P1|Overall Study|Lack of Efficacy|0
657507|NCT02152371|2113086|P2|Overall Study|Lost to Follow-up|0
657508|NCT02152371|2113087|P1|Overall Study|Lost to Follow-up|1
657509|NCT02152371|2113086|P2|Overall Study|Protocol Violation|3
657510|NCT02152371|2113087|P1|Overall Study|Protocol Violation|2
657511|NCT02152371|2113086|P2|Overall Study|Withdrawal by Subject|7
657512|NCT02152371|2113087|P1|Overall Study|Withdrawal by Subject|3
657513|NCT02152371|2113086|P2|Overall Study|Adverse Event|2
657514|NCT02152371|2113087|P1|Overall Study|Adverse Event|6
657515|NCT02152007|2113123|P1|Overall Study|Withdrawal by Subject|1
657526|NCT02151786|2113201|P1|Overall Study|Unavailability of Information|8
657527|NCT02151786|2113201|P1|Overall Study|Randomized, not Treated|1
657528|NCT02151786|2113201|P1|Overall Study|Outside the Contract Period|1
657529|NCT02151786|2113201|P1|Overall Study|Unavailability of Case Report Form|26
657530|NCT02151773|2113212|P1|Overall Study|Protocol Deviation|64
657531|NCT02151058|2113235|P3|Overall Study|Lost to Follow-up|2
657532|NCT02151058|2113236|P2|Overall Study|Lost to Follow-up|0
657533|NCT02151058|2113237|P1|Overall Study|Lost to Follow-up|1
657534|NCT02151058|2113235|P3|Overall Study|Withdrawal by Subject|3
657535|NCT02151058|2113236|P2|Overall Study|Withdrawal by Subject|1
657536|NCT02151058|2113237|P1|Overall Study|Withdrawal by Subject|1
657537|NCT02150954|2113271|P2|Overall Study|Protocol Violation|0
657538|NCT02150954|2113272|P1|Overall Study|Protocol Violation|1
657539|NCT02150213|2113344|P1|Overall Study|Withdrawal by Subject|1
657540|NCT02150213|2113344|P1|Overall Study|Lost to Follow-up|1
657541|NCT02149875|2113370|P3|Overall Study|Physician Decision|2
657542|NCT02149875|2113371|P2|Overall Study|Physician Decision|2
657543|NCT02149875|2113372|P1|Overall Study|Physician Decision|1
657544|NCT02149875|2113370|P3|Overall Study|Withdrawal by Subject|2
657545|NCT02149875|2113371|P2|Overall Study|Withdrawal by Subject|2
657546|NCT02149875|2113372|P1|Overall Study|Withdrawal by Subject|3
657547|NCT02149875|2113370|P3|Overall Study|Lost to Follow-up|5
657548|NCT02149875|2113371|P2|Overall Study|Lost to Follow-up|4
657549|NCT02149875|2113372|P1|Overall Study|Lost to Follow-up|3
888265|NCT02189837|2821755|P4|Overall Study|Sponsor Decision|1
888266|NCT02189837|2821756|P3|Overall Study|Sponsor Decision|0
888267|NCT02189837|2821757|P2|Overall Study|Sponsor Decision|0
657554|NCT02149108|2113416|P2|Overall Study|Lost to Follow-up|0
657555|NCT02149108|2113417|P1|Overall Study|Lost to Follow-up|1
657556|NCT02149108|2113416|P2|Overall Study|Refusal to continue trial medication|11
657557|NCT02149108|2113417|P1|Overall Study|Refusal to continue trial medication|15
657558|NCT02149108|2113416|P2|Overall Study|Other not defined above|2
657559|NCT02149108|2113417|P1|Overall Study|Other not defined above|0
657560|NCT02149108|2113416|P2|Overall Study|Other Adverse Event (AE)|18
657561|NCT02149108|2113417|P1|Overall Study|Other Adverse Event (AE)|8
657562|NCT02149108|2113416|P2|Overall Study|Worsening/adverse event cancer disease|32
657563|NCT02149108|2113417|P1|Overall Study|Worsening/adverse event cancer disease|31
657564|NCT02149108|2113416|P2|Overall Study|Progressive Disease (PD)|318
657565|NCT02149108|2113417|P1|Overall Study|Progressive Disease (PD)|324
657566|NCT02149108|2113416|P2|Overall Study|Not treated|2
657567|NCT02149108|2113417|P1|Overall Study|Not treated|1
657568|NCT02148445|2113456|P2|Overall Study|Death|3
657569|NCT02148445|2113457|P1|Overall Study|Death|1
657570|NCT02147691|2113516|P2|Overall Study|Lost to Follow-up|1
657571|NCT02147691|2113517|P1|Overall Study|Lost to Follow-up|0
657572|NCT02147691|2113516|P2|Overall Study|Adverse Event|0
657573|NCT02147691|2113517|P1|Overall Study|Adverse Event|2
657574|NCT02147691|2113516|P2|Overall Study|Withdrawal by Subject|0
657575|NCT02147691|2113517|P1|Overall Study|Withdrawal by Subject|2
657576|NCT02147561|2113561|P1|Overall Study|Subjects who didn’t receive BOTOX|1
657577|NCT02147561|2113561|P1|Overall Study|Lost to Follow-up|3
657578|NCT02147288|2113582|P10|Overall Study|complications from concurrent hernia rep|0
657579|NCT02147288|2113583|P9|Overall Study|complications from concurrent hernia rep|0
657580|NCT02147288|2113584|P8|Overall Study|complications from concurrent hernia rep|0
657581|NCT02147288|2113585|P7|Overall Study|complications from concurrent hernia rep|0
657582|NCT02147288|2113586|P6|Overall Study|complications from concurrent hernia rep|0
657583|NCT02147288|2113587|P5|Overall Study|complications from concurrent hernia rep|0
657584|NCT02147288|2113588|P4|Overall Study|complications from concurrent hernia rep|0
657585|NCT02147288|2113589|P3|Overall Study|complications from concurrent hernia rep|0
657586|NCT02147288|2113590|P2|Overall Study|complications from concurrent hernia rep|1
657587|NCT02147288|2113591|P1|Overall Study|complications from concurrent hernia rep|0
657588|NCT02147288|2113582|P10|Overall Study|post-operative hematoma|0
657589|NCT02147288|2113583|P9|Overall Study|post-operative hematoma|0
657590|NCT02147288|2113584|P8|Overall Study|post-operative hematoma|0
657591|NCT02147288|2113585|P7|Overall Study|post-operative hematoma|0
657592|NCT02147288|2113586|P6|Overall Study|post-operative hematoma|0
657593|NCT02147288|2113587|P5|Overall Study|post-operative hematoma|0
657594|NCT02147288|2113588|P4|Overall Study|post-operative hematoma|0
657595|NCT02147288|2113589|P3|Overall Study|post-operative hematoma|0
657596|NCT02147288|2113590|P2|Overall Study|post-operative hematoma|1
657597|NCT02147288|2113591|P1|Overall Study|post-operative hematoma|1
657598|NCT02147093|2113599|P2|Period 2|Protocol Violation|0
657599|NCT02147093|2113600|P1|Period 2|Protocol Violation|2
657600|NCT02147093|2113599|P2|Period 1|Lost to Follow-up|1
657601|NCT02147093|2113600|P1|Period 1|Lost to Follow-up|0
657602|NCT02146599|2113608|P1|Overall Study|Failed to meet inclusion criteria|5
657603|NCT02146352|2113621|P1|Overall Study|Patient entered hospice care|1
657604|NCT02146352|2113621|P1|Overall Study|Death|1
657605|NCT02146326|2113639|P4|Overall Study|Unable to complete interview|6
657606|NCT02146326|2113640|P3|Overall Study|Unable to complete interview|10
657607|NCT02146326|2113641|P2|Overall Study|Unable to complete interview|0
657608|NCT02146326|2113642|P1|Overall Study|Unable to complete interview|0
657609|NCT02146326|2113639|P4|Overall Study|Death|4
657610|NCT02146326|2113640|P3|Overall Study|Death|4
657611|NCT02146326|2113641|P2|Overall Study|Death|0
657612|NCT02146326|2113642|P1|Overall Study|Death|0
657613|NCT02146326|2113639|P4|Overall Study|Incarcerated|8
657614|NCT02146326|2113640|P3|Overall Study|Incarcerated|3
657615|NCT02146326|2113641|P2|Overall Study|Incarcerated|0
657616|NCT02146326|2113642|P1|Overall Study|Incarcerated|0
657617|NCT02146326|2113639|P4|Overall Study|Separated from mental health center|0
657618|NCT02146326|2113640|P3|Overall Study|Separated from mental health center|0
657619|NCT02146326|2113641|P2|Overall Study|Separated from mental health center|33
657620|NCT02146326|2113642|P1|Overall Study|Separated from mental health center|23
657621|NCT02146326|2113639|P4|Overall Study|Withdrawal by Subject|11
657622|NCT02146326|2113640|P3|Overall Study|Withdrawal by Subject|15
657623|NCT02146326|2113641|P2|Overall Study|Withdrawal by Subject|1
657624|NCT02146326|2113642|P1|Overall Study|Withdrawal by Subject|2
657625|NCT02146326|2113639|P4|Overall Study|Lost to Follow-up|19
657626|NCT02146326|2113640|P3|Overall Study|Lost to Follow-up|11
657627|NCT02146326|2113641|P2|Overall Study|Lost to Follow-up|3
657628|NCT02146326|2113642|P1|Overall Study|Lost to Follow-up|3
657629|NCT02146248|2113804|P1|Overall Study|Withdrawal by Subject|2
657630|NCT02146105|2113812|P1|Overall Study|Withdrawal by Subject|5
657631|NCT02146105|2113812|P1|Overall Study|Adverse Event|1
657632|NCT02145468|2113863|P2|Overall Study|Withdrawal by Subject|8
657633|NCT02145468|2113864|P1|Overall Study|Withdrawal by Subject|5
657634|NCT02145156|2113952|P3|Overall Study|No match to vaccination records|41
657635|NCT02145156|2113953|P2|Overall Study|No match to vaccination records|52
657636|NCT02145156|2113954|P1|Overall Study|No match to vaccination records|60
657637|NCT02144337|2113997|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
657638|NCT02144337|2113998|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
657639|NCT02144337|2113997|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
657640|NCT02144337|2113998|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
657641|NCT02144337|2113997|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
657642|NCT02144337|2113998|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
657643|NCT02144337|2113997|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
657644|NCT02144337|2113998|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
657645|NCT02144337|2113997|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
657646|NCT02144337|2113998|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
657647|NCT02144220|2114027|P1|Overall Study|Protocol Violation|1
657648|NCT02144220|2114027|P1|Overall Study|Withdrawal by Subject|2
657649|NCT02144220|2114027|P1|Overall Study|Physician Decision|3
657650|NCT02144220|2114027|P1|Overall Study|Lack of Efficacy|4
657651|NCT02144220|2114027|P1|Overall Study|technology incompatibility|9
657652|NCT02144012|2114037|P2|Overall Study|Other|0
657653|NCT02144012|2114038|P1|Overall Study|Other|3
657654|NCT02144012|2114037|P2|Overall Study|Study Terminated by Sponsor|12
657655|NCT02144012|2114038|P1|Overall Study|Study Terminated by Sponsor|18
657656|NCT02144012|2114037|P2|Overall Study|Withdrawal by Subject|3
657657|NCT02144012|2114038|P1|Overall Study|Withdrawal by Subject|11
657658|NCT02144012|2114037|P2|Overall Study|Death|0
657659|NCT02144012|2114038|P1|Overall Study|Death|1
657660|NCT02144012|2114037|P2|Overall Study|Adverse Event|0
657661|NCT02144012|2114038|P1|Overall Study|Adverse Event|1
657662|NCT02143947|2114075|P2|Overall Study|Lost to Follow-up|2
657663|NCT02143947|2114076|P1|Overall Study|Lost to Follow-up|4
657664|NCT02143583|2114091|P3|Overall Study|husband illness|1
657665|NCT02143583|2114092|P2|Overall Study|husband illness|0
657666|NCT02143583|2114093|P1|Overall Study|husband illness|0
657667|NCT02143583|2114091|P3|Overall Study|Withdrawal by Subject|1
657668|NCT02143583|2114092|P2|Overall Study|Withdrawal by Subject|0
657669|NCT02143583|2114093|P1|Overall Study|Withdrawal by Subject|1
888268|NCT02189837|2821758|P1|Overall Study|Sponsor Decision|0
888269|NCT02189837|2821755|P4|Overall Study|Withdrawal by Subject|1
657682|NCT02142712|2114133|P4|Overall Study|Lost to Follow-up|0
657683|NCT02142712|2114134|P3|Overall Study|Lost to Follow-up|1
657684|NCT02142712|2114135|P2|Overall Study|Lost to Follow-up|1
657685|NCT02142712|2114136|P1|Overall Study|Lost to Follow-up|1
657686|NCT02142504|2114159|P3|Overall Study|Reason Not Specified|4
657687|NCT02142504|2114160|P2|Overall Study|Reason Not Specified|5
657688|NCT02142504|2114161|P1|Overall Study|Reason Not Specified|4
657689|NCT02142504|2114159|P3|Overall Study|Physician Decision|3
657690|NCT02142504|2114160|P2|Overall Study|Physician Decision|1
657691|NCT02142504|2114161|P1|Overall Study|Physician Decision|0
657692|NCT02142504|2114159|P3|Overall Study|Pregnancy|2
657693|NCT02142504|2114160|P2|Overall Study|Pregnancy|4
657694|NCT02142504|2114161|P1|Overall Study|Pregnancy|4
657695|NCT02142504|2114159|P3|Overall Study|Withdrawal by Subject|11
657696|NCT02142504|2114160|P2|Overall Study|Withdrawal by Subject|9
657697|NCT02142504|2114161|P1|Overall Study|Withdrawal by Subject|7
657698|NCT02142504|2114159|P3|Overall Study|Lost to Follow-up|17
657699|NCT02142504|2114160|P2|Overall Study|Lost to Follow-up|19
657700|NCT02142504|2114161|P1|Overall Study|Lost to Follow-up|12
657701|NCT02142504|2114159|P3|Overall Study|Adverse Event|4
657702|NCT02142504|2114160|P2|Overall Study|Adverse Event|3
657703|NCT02142504|2114161|P1|Overall Study|Adverse Event|2
657704|NCT02142504|2114159|P3|Overall Study|Protocol Violation|2
657705|NCT02142504|2114160|P2|Overall Study|Protocol Violation|1
657706|NCT02142504|2114161|P1|Overall Study|Protocol Violation|2
657707|NCT02141997|2114403|P4|Overall Study|Not specified|0
657708|NCT02141997|2114404|P3|Overall Study|Not specified|0
657709|NCT02141997|2114405|P2|Overall Study|Not specified|4
657710|NCT02141997|2114406|P1|Overall Study|Not specified|1
657711|NCT02141997|2114403|P4|Overall Study|Withdrew consent|0
657712|NCT02141997|2114404|P3|Overall Study|Withdrew consent|3
657713|NCT02141997|2114405|P2|Overall Study|Withdrew consent|0
657714|NCT02141997|2114406|P1|Overall Study|Withdrew consent|1
657715|NCT02141997|2114403|P4|Overall Study|Participant noncompliance|0
657716|NCT02141997|2114404|P3|Overall Study|Participant noncompliance|0
657717|NCT02141997|2114405|P2|Overall Study|Participant noncompliance|0
657718|NCT02141997|2114406|P1|Overall Study|Participant noncompliance|1
657719|NCT02141997|2114403|P4|Overall Study|Adverse Event|1
657720|NCT02141997|2114404|P3|Overall Study|Adverse Event|0
657721|NCT02141997|2114405|P2|Overall Study|Adverse Event|2
657722|NCT02141997|2114406|P1|Overall Study|Adverse Event|0
657723|NCT02141984|2114444|P1|Overall Study|Lack of Efficacy|2
657724|NCT02141854|2114463|P6|Treatment Period|Lost to Follow-up|1
657725|NCT02141854|2114464|P5|Treatment Period|Lost to Follow-up|0
657726|NCT02141854|2114465|P4|Treatment Period|Lost to Follow-up|1
888270|NCT02189837|2821756|P3|Overall Study|Withdrawal by Subject|3
657727|NCT02141854|2114466|P3|Treatment Period|Lost to Follow-up|1
657728|NCT02141854|2114467|P2|Treatment Period|Lost to Follow-up|1
657729|NCT02141854|2114468|P1|Treatment Period|Lost to Follow-up|0
657730|NCT02141854|2114463|P6|Treatment Period|Disease progression|18
657731|NCT02141854|2114464|P5|Treatment Period|Disease progression|0
657732|NCT02141854|2114465|P4|Treatment Period|Disease progression|3
657733|NCT02141854|2114466|P3|Treatment Period|Disease progression|1
657734|NCT02141854|2114467|P2|Treatment Period|Disease progression|2
657735|NCT02141854|2114468|P1|Treatment Period|Disease progression|0
657736|NCT02141854|2114463|P6|Treatment Period|Withdrawal by Subject|7
657737|NCT02141854|2114464|P5|Treatment Period|Withdrawal by Subject|4
657738|NCT02141854|2114465|P4|Treatment Period|Withdrawal by Subject|3
657739|NCT02141854|2114466|P3|Treatment Period|Withdrawal by Subject|3
657740|NCT02141854|2114467|P2|Treatment Period|Withdrawal by Subject|2
657741|NCT02141854|2114468|P1|Treatment Period|Withdrawal by Subject|0
657742|NCT02141854|2114463|P6|Treatment Period|Adverse Event|2
657743|NCT02141854|2114464|P5|Treatment Period|Adverse Event|2
657744|NCT02141854|2114465|P4|Treatment Period|Adverse Event|0
657745|NCT02141854|2114466|P3|Treatment Period|Adverse Event|2
657746|NCT02141854|2114467|P2|Treatment Period|Adverse Event|2
657747|NCT02141854|2114468|P1|Treatment Period|Adverse Event|0
657748|NCT02141854|2114463|P6|Treatment Period|Not specified|2
657749|NCT02141854|2114464|P5|Treatment Period|Not specified|1
657750|NCT02141854|2114465|P4|Treatment Period|Not specified|0
657751|NCT02141854|2114466|P3|Treatment Period|Not specified|2
657752|NCT02141854|2114467|P2|Treatment Period|Not specified|1
657753|NCT02141854|2114468|P1|Treatment Period|Not specified|0
657754|NCT02141854|2114463|P6|Treatment Period|Pregnancy|0
657755|NCT02141854|2114464|P5|Treatment Period|Pregnancy|0
657756|NCT02141854|2114465|P4|Treatment Period|Pregnancy|0
657757|NCT02141854|2114466|P3|Treatment Period|Pregnancy|0
657758|NCT02141854|2114467|P2|Treatment Period|Pregnancy|1
657759|NCT02141854|2114468|P1|Treatment Period|Pregnancy|0
657760|NCT02141854|2114463|P6|Treatment Period|Lack of Efficacy|7
657761|NCT02141854|2114464|P5|Treatment Period|Lack of Efficacy|1
657762|NCT02141854|2114465|P4|Treatment Period|Lack of Efficacy|1
657763|NCT02141854|2114466|P3|Treatment Period|Lack of Efficacy|0
657764|NCT02141854|2114467|P2|Treatment Period|Lack of Efficacy|0
657765|NCT02141854|2114468|P1|Treatment Period|Lack of Efficacy|0
657766|NCT02141854|2114463|P6|Treatment Period|Noncompliance|0
657767|NCT02141854|2114464|P5|Treatment Period|Noncompliance|0
657768|NCT02141854|2114465|P4|Treatment Period|Noncompliance|1
657769|NCT02141854|2114466|P3|Treatment Period|Noncompliance|0
657770|NCT02141854|2114467|P2|Treatment Period|Noncompliance|0
657771|NCT02141854|2114468|P1|Treatment Period|Noncompliance|0
657772|NCT02141854|2114463|P6|Treatment Period|Protocol Violation|1
657773|NCT02141854|2114464|P5|Treatment Period|Protocol Violation|2
657774|NCT02141854|2114465|P4|Treatment Period|Protocol Violation|2
657775|NCT02141854|2114466|P3|Treatment Period|Protocol Violation|0
657776|NCT02141854|2114467|P2|Treatment Period|Protocol Violation|1
657777|NCT02141854|2114468|P1|Treatment Period|Protocol Violation|0
657778|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657779|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657780|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657781|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657782|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657783|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
657784|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657785|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657786|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657787|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657788|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657789|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
657790|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Adverse Event|0
657791|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Adverse Event|0
657792|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Adverse Event|0
657793|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Adverse Event|0
657794|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Adverse Event|0
657795|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Adverse Event|10
657796|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Not specified|0
657797|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Not specified|0
657798|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Not specified|0
657799|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Not specified|0
657800|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Not specified|0
657801|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Not specified|14
657802|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657803|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657804|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657805|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657806|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657807|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
657808|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657809|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657810|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657811|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657812|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657813|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
657814|NCT02141854|2114463|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657815|NCT02141854|2114464|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657816|NCT02141854|2114465|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657817|NCT02141854|2114466|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657818|NCT02141854|2114467|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657819|NCT02141854|2114468|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
657820|NCT02141633|2114522|P2|Overall Study|Physician Decision|0
657821|NCT02141633|2114523|P1|Overall Study|Physician Decision|1
657822|NCT02141620|2114531|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
657823|NCT02141620|2114532|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
657824|NCT02141516|2114609|P3|Overall Study|Other|0
657825|NCT02141516|2114610|P2|Overall Study|Other|3
657826|NCT02141516|2114611|P1|Overall Study|Other|0
657827|NCT02141516|2114609|P3|Overall Study|Lost to Follow-up|0
657828|NCT02141516|2114610|P2|Overall Study|Lost to Follow-up|1
657829|NCT02141516|2114611|P1|Overall Study|Lost to Follow-up|0
657830|NCT02141516|2114609|P3|Overall Study|Adverse Event|0
657831|NCT02141516|2114610|P2|Overall Study|Adverse Event|1
657832|NCT02141516|2114611|P1|Overall Study|Adverse Event|0
657833|NCT02141360|2114661|P3|Overall Study|Study Terminated before Visit|0
657834|NCT02141360|2114662|P2|Overall Study|Study Terminated before Visit|0
657835|NCT02141360|2114663|P1|Overall Study|Study Terminated before Visit|1
657836|NCT02141360|2114661|P3|Overall Study|Withdrawal by Subject|0
657837|NCT02141360|2114662|P2|Overall Study|Withdrawal by Subject|0
657838|NCT02141360|2114663|P1|Overall Study|Withdrawal by Subject|6
657839|NCT02141217|2114673|P2|Overall Study|Surgical Intervention|1
657840|NCT02141217|2114674|P1|Overall Study|Surgical Intervention|1
657841|NCT02141217|2114673|P2|Overall Study|Physician Decision|0
657842|NCT02141217|2114674|P1|Overall Study|Physician Decision|1
657843|NCT02141217|2114673|P2|Overall Study|Lost to Follow-up|1
657844|NCT02141217|2114674|P1|Overall Study|Lost to Follow-up|1
657845|NCT02141217|2114673|P2|Overall Study|Withdrawal by Subject|0
657846|NCT02141217|2114674|P1|Overall Study|Withdrawal by Subject|6
657847|NCT02141217|2114673|P2|Overall Study|Protocol Violation|4
657848|NCT02141217|2114674|P1|Overall Study|Protocol Violation|1
657849|NCT02141217|2114673|P2|Overall Study|Adverse Event|2
657850|NCT02141217|2114674|P1|Overall Study|Adverse Event|1
657851|NCT02140645|2114740|P6|Overall Study|Not linked|70896
657852|NCT02140645|2114741|P5|Overall Study|Not linked|3286
657853|NCT02140645|2114742|P4|Overall Study|Not linked|13833
657854|NCT02140645|2114743|P3|Overall Study|Not linked|4236
657855|NCT02140645|2114744|P2|Overall Study|Not linked|61654
657856|NCT02140645|2114745|P1|Overall Study|Not linked|5489
657858|NCT02140060|2114871|P6|Overall Study|Lack of Efficacy|0
657859|NCT02140060|2114872|P5|Overall Study|Lack of Efficacy|0
657860|NCT02140060|2114873|P4|Overall Study|Lack of Efficacy|1
657861|NCT02140060|2114874|P3|Overall Study|Lack of Efficacy|0
657862|NCT02140060|2114875|P2|Overall Study|Lack of Efficacy|0
657863|NCT02140060|2114876|P1|Overall Study|Lack of Efficacy|0
657864|NCT02140060|2114871|P6|Overall Study|Adverse Event|1
657865|NCT02140060|2114872|P5|Overall Study|Adverse Event|1
657866|NCT02140060|2114873|P4|Overall Study|Adverse Event|1
657867|NCT02140060|2114874|P3|Overall Study|Adverse Event|0
657868|NCT02140060|2114875|P2|Overall Study|Adverse Event|0
657869|NCT02140060|2114876|P1|Overall Study|Adverse Event|0
657870|NCT02139982|2114901|P10|Overall Study|Lack of Efficacy|0
657871|NCT02139982|2114902|P9|Overall Study|Lack of Efficacy|0
657872|NCT02139982|2114903|P8|Overall Study|Lack of Efficacy|0
657873|NCT02139982|2114904|P7|Overall Study|Lack of Efficacy|0
657874|NCT02139982|2114905|P6|Overall Study|Lack of Efficacy|0
657875|NCT02139982|2114906|P5|Overall Study|Lack of Efficacy|0
657876|NCT02139982|2114907|P4|Overall Study|Lack of Efficacy|1
657877|NCT02139982|2114908|P3|Overall Study|Lack of Efficacy|0
657878|NCT02139982|2114909|P2|Overall Study|Lack of Efficacy|1
657879|NCT02139982|2114910|P1|Overall Study|Lack of Efficacy|0
657880|NCT02139943|2114955|P3|Overall Study|eGFR Withdrawal Criteria|1
657881|NCT02139943|2114956|P2|Overall Study|eGFR Withdrawal Criteria|0
657882|NCT02139943|2114957|P1|Overall Study|eGFR Withdrawal Criteria|0
657883|NCT02139943|2114955|P3|Overall Study|Participant in Poor Compliance|1
657884|NCT02139943|2114956|P2|Overall Study|Participant in Poor Compliance|0
657885|NCT02139943|2114957|P1|Overall Study|Participant in Poor Compliance|1
657886|NCT02139943|2114955|P3|Overall Study|Participant wishes to discontinue|0
657887|NCT02139943|2114956|P2|Overall Study|Participant wishes to discontinue|0
657888|NCT02139943|2114957|P1|Overall Study|Participant wishes to discontinue|2
657889|NCT02139943|2114955|P3|Overall Study|Unspecified|1
657890|NCT02139943|2114956|P2|Overall Study|Unspecified|0
657891|NCT02139943|2114957|P1|Overall Study|Unspecified|0
657892|NCT02139943|2114955|P3|Overall Study|Withdrawal by Subject|0
657893|NCT02139943|2114956|P2|Overall Study|Withdrawal by Subject|3
657894|NCT02139943|2114957|P1|Overall Study|Withdrawal by Subject|4
657895|NCT02139943|2114955|P3|Overall Study|Lost to Follow-up|2
657896|NCT02139943|2114956|P2|Overall Study|Lost to Follow-up|2
657897|NCT02139943|2114957|P1|Overall Study|Lost to Follow-up|3
657898|NCT02139943|2114955|P3|Overall Study|Adverse Event|2
657899|NCT02139943|2114956|P2|Overall Study|Adverse Event|1
657900|NCT02139943|2114957|P1|Overall Study|Adverse Event|0
657901|NCT02139644|2114982|P6|Treatment Period|Not specified|1
657902|NCT02139644|2114983|P5|Treatment Period|Not specified|0
657903|NCT02139644|2114984|P4|Treatment Period|Not specified|1
657904|NCT02139644|2114985|P3|Treatment Period|Not specified|1
657905|NCT02139644|2114986|P2|Treatment Period|Not specified|3
657906|NCT02139644|2114987|P1|Treatment Period|Not specified|0
657907|NCT02139644|2114982|P6|Treatment Period|Lack of Efficacy|4
657908|NCT02139644|2114983|P5|Treatment Period|Lack of Efficacy|1
657909|NCT02139644|2114984|P4|Treatment Period|Lack of Efficacy|0
657910|NCT02139644|2114985|P3|Treatment Period|Lack of Efficacy|1
657911|NCT02139644|2114986|P2|Treatment Period|Lack of Efficacy|0
657912|NCT02139644|2114987|P1|Treatment Period|Lack of Efficacy|0
657913|NCT02139644|2114982|P6|Treatment Period|Lost to Follow-up|1
657914|NCT02139644|2114983|P5|Treatment Period|Lost to Follow-up|1
657915|NCT02139644|2114984|P4|Treatment Period|Lost to Follow-up|1
657916|NCT02139644|2114985|P3|Treatment Period|Lost to Follow-up|1
657917|NCT02139644|2114986|P2|Treatment Period|Lost to Follow-up|0
657918|NCT02139644|2114987|P1|Treatment Period|Lost to Follow-up|0
657919|NCT02139644|2114982|P6|Treatment Period|Disease progression|2
657920|NCT02139644|2114983|P5|Treatment Period|Disease progression|1
657921|NCT02139644|2114984|P4|Treatment Period|Disease progression|1
657922|NCT02139644|2114985|P3|Treatment Period|Disease progression|0
657923|NCT02139644|2114986|P2|Treatment Period|Disease progression|0
657924|NCT02139644|2114987|P1|Treatment Period|Disease progression|0
657925|NCT02139644|2114982|P6|Treatment Period|Protocol Violation|1
657926|NCT02139644|2114983|P5|Treatment Period|Protocol Violation|1
657927|NCT02139644|2114984|P4|Treatment Period|Protocol Violation|1
657928|NCT02139644|2114985|P3|Treatment Period|Protocol Violation|0
657929|NCT02139644|2114986|P2|Treatment Period|Protocol Violation|0
657930|NCT02139644|2114987|P1|Treatment Period|Protocol Violation|0
657931|NCT02139644|2114982|P6|Treatment Period|Non-compliance|0
657932|NCT02139644|2114983|P5|Treatment Period|Non-compliance|0
657933|NCT02139644|2114984|P4|Treatment Period|Non-compliance|1
657934|NCT02139644|2114985|P3|Treatment Period|Non-compliance|0
657935|NCT02139644|2114986|P2|Treatment Period|Non-compliance|0
657936|NCT02139644|2114987|P1|Treatment Period|Non-compliance|0
657937|NCT02139644|2114982|P6|Treatment Period|Withdrawal by Subject|2
657938|NCT02139644|2114983|P5|Treatment Period|Withdrawal by Subject|3
657939|NCT02139644|2114984|P4|Treatment Period|Withdrawal by Subject|2
657940|NCT02139644|2114985|P3|Treatment Period|Withdrawal by Subject|2
657941|NCT02139644|2114986|P2|Treatment Period|Withdrawal by Subject|0
657942|NCT02139644|2114987|P1|Treatment Period|Withdrawal by Subject|0
657943|NCT02139644|2114982|P6|Treatment Period|Adverse Event|6
657944|NCT02139644|2114983|P5|Treatment Period|Adverse Event|1
657945|NCT02139644|2114984|P4|Treatment Period|Adverse Event|2
657946|NCT02139644|2114985|P3|Treatment Period|Adverse Event|3
657947|NCT02139644|2114986|P2|Treatment Period|Adverse Event|0
657948|NCT02139644|2114987|P1|Treatment Period|Adverse Event|0
657949|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Not specified|0
657950|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Not specified|0
657951|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Not specified|0
657952|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Not specified|0
657953|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Not specified|0
657954|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Not specified|6
657955|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Adverse Event|0
657956|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Adverse Event|0
657957|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Adverse Event|0
657958|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Adverse Event|0
657959|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Adverse Event|0
657960|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Adverse Event|3
657961|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657962|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657963|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657964|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657965|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
657966|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
657967|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657968|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657969|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657970|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657971|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
657972|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
657973|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657974|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657975|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657976|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657977|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
657978|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
657979|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657980|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657981|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657982|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657983|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
657984|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
657985|NCT02139644|2114982|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657986|NCT02139644|2114983|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657987|NCT02139644|2114984|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657988|NCT02139644|2114985|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657989|NCT02139644|2114986|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
657990|NCT02139644|2114987|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
657991|NCT02139046|2115085|P5|Overall Study|Other Miscellaneous Reasons|12
657992|NCT02139046|2115086|P4|Overall Study|Other Miscellaneous Reasons|9
657993|NCT02139046|2115087|P3|Overall Study|Other Miscellaneous Reasons|4
657994|NCT02139046|2115088|P2|Overall Study|Other Miscellaneous Reasons|9
657995|NCT02139046|2115089|P1|Overall Study|Other Miscellaneous Reasons|10
657996|NCT02139046|2115085|P5|Overall Study|Withdrawal due to a Gout Flare|1
657997|NCT02139046|2115086|P4|Overall Study|Withdrawal due to a Gout Flare|0
657998|NCT02139046|2115087|P3|Overall Study|Withdrawal due to a Gout Flare|1
657999|NCT02139046|2115088|P2|Overall Study|Withdrawal due to a Gout Flare|1
658000|NCT02139046|2115089|P1|Overall Study|Withdrawal due to a Gout Flare|1
658001|NCT02139046|2115085|P5|Overall Study|Lack of Efficacy|2
658002|NCT02139046|2115086|P4|Overall Study|Lack of Efficacy|1
658003|NCT02139046|2115087|P3|Overall Study|Lack of Efficacy|2
658004|NCT02139046|2115088|P2|Overall Study|Lack of Efficacy|1
658005|NCT02139046|2115089|P1|Overall Study|Lack of Efficacy|0
658006|NCT02139046|2115085|P5|Overall Study|Voluntary Withdrawal|16
658007|NCT02139046|2115086|P4|Overall Study|Voluntary Withdrawal|15
658008|NCT02139046|2115087|P3|Overall Study|Voluntary Withdrawal|10
658009|NCT02139046|2115088|P2|Overall Study|Voluntary Withdrawal|8
658010|NCT02139046|2115089|P1|Overall Study|Voluntary Withdrawal|20
658011|NCT02139046|2115085|P5|Overall Study|Lost to Follow-up|13
658012|NCT02139046|2115086|P4|Overall Study|Lost to Follow-up|18
658013|NCT02139046|2115087|P3|Overall Study|Lost to Follow-up|16
658014|NCT02139046|2115088|P2|Overall Study|Lost to Follow-up|16
658015|NCT02139046|2115089|P1|Overall Study|Lost to Follow-up|13
658016|NCT02139046|2115085|P5|Overall Study|Major Protocol Deviation|6
658017|NCT02139046|2115086|P4|Overall Study|Major Protocol Deviation|12
658018|NCT02139046|2115087|P3|Overall Study|Major Protocol Deviation|16
658019|NCT02139046|2115088|P2|Overall Study|Major Protocol Deviation|10
658020|NCT02139046|2115089|P1|Overall Study|Major Protocol Deviation|9
658021|NCT02139046|2115085|P5|Overall Study|Pretreatment Event/Adverse Event|7
658022|NCT02139046|2115086|P4|Overall Study|Pretreatment Event/Adverse Event|13
658023|NCT02139046|2115087|P3|Overall Study|Pretreatment Event/Adverse Event|10
658024|NCT02139046|2115088|P2|Overall Study|Pretreatment Event/Adverse Event|9
658025|NCT02139046|2115089|P1|Overall Study|Pretreatment Event/Adverse Event|9
658026|NCT02138838|2115129|P2|Overall Study|Withdrawal by Subject|5
658027|NCT02138838|2115130|P1|Overall Study|Withdrawal by Subject|1
658028|NCT02138838|2115129|P2|Overall Study|Study Closure|6
658029|NCT02138838|2115130|P1|Overall Study|Study Closure|7
658044|NCT02138747|2115161|P4|Treatment Period 2|Other - Miscellaneous|0
658045|NCT02138747|2115162|P3|Treatment Period 2|Other - Miscellaneous|0
658046|NCT02138747|2115163|P2|Treatment Period 2|Other - Miscellaneous|0
658047|NCT02138747|2115164|P1|Treatment Period 2|Other - Miscellaneous|3
658048|NCT02138747|2115161|P4|Treatment Period 2|Withdrawal by Subject|2
658049|NCT02138747|2115162|P3|Treatment Period 2|Withdrawal by Subject|1
658050|NCT02138747|2115163|P2|Treatment Period 2|Withdrawal by Subject|4
658051|NCT02138747|2115164|P1|Treatment Period 2|Withdrawal by Subject|5
658052|NCT02138747|2115161|P4|Treatment Period 2|Protocol Violation|0
658053|NCT02138747|2115162|P3|Treatment Period 2|Protocol Violation|0
658054|NCT02138747|2115163|P2|Treatment Period 2|Protocol Violation|0
658055|NCT02138747|2115164|P1|Treatment Period 2|Protocol Violation|1
658056|NCT02138747|2115161|P4|Treatment Period 2|Lost to Follow-up|0
658057|NCT02138747|2115162|P3|Treatment Period 2|Lost to Follow-up|0
658058|NCT02138747|2115163|P2|Treatment Period 2|Lost to Follow-up|0
658059|NCT02138747|2115164|P1|Treatment Period 2|Lost to Follow-up|2
658060|NCT02138747|2115161|P4|Treatment Period 2|Adverse Event|1
658061|NCT02138747|2115162|P3|Treatment Period 2|Adverse Event|1
658062|NCT02138747|2115163|P2|Treatment Period 2|Adverse Event|3
658063|NCT02138747|2115164|P1|Treatment Period 2|Adverse Event|6
658064|NCT02138747|2115161|P4|Treatment Period 1|Other - Miscellaneous|0
658065|NCT02138747|2115162|P3|Treatment Period 1|Other - Miscellaneous|0
658066|NCT02138747|2115163|P2|Treatment Period 1|Other - Miscellaneous|4
658067|NCT02138747|2115164|P1|Treatment Period 1|Other - Miscellaneous|2
658068|NCT02138747|2115161|P4|Treatment Period 1|Withdrawal by Subject|3
658069|NCT02138747|2115162|P3|Treatment Period 1|Withdrawal by Subject|1
658070|NCT02138747|2115163|P2|Treatment Period 1|Withdrawal by Subject|4
658071|NCT02138747|2115164|P1|Treatment Period 1|Withdrawal by Subject|8
658072|NCT02138747|2115161|P4|Treatment Period 1|Protocol Violation|0
658073|NCT02138747|2115162|P3|Treatment Period 1|Protocol Violation|0
658074|NCT02138747|2115163|P2|Treatment Period 1|Protocol Violation|2
658075|NCT02138747|2115164|P1|Treatment Period 1|Protocol Violation|0
658076|NCT02138747|2115161|P4|Treatment Period 1|Lost to Follow-up|0
658077|NCT02138747|2115162|P3|Treatment Period 1|Lost to Follow-up|1
658078|NCT02138747|2115163|P2|Treatment Period 1|Lost to Follow-up|1
658079|NCT02138747|2115164|P1|Treatment Period 1|Lost to Follow-up|0
658080|NCT02138747|2115161|P4|Treatment Period 1|Adverse Event|1
658081|NCT02138747|2115162|P3|Treatment Period 1|Adverse Event|2
658082|NCT02138747|2115163|P2|Treatment Period 1|Adverse Event|14
658083|NCT02138747|2115164|P1|Treatment Period 1|Adverse Event|10
658084|NCT02137785|2115427|P2|Overall Study|subject moved out of state|0
658085|NCT02137785|2115428|P1|Overall Study|subject moved out of state|1
658086|NCT02137785|2115427|P2|Overall Study|Withdrawal by Subject|4
658087|NCT02137785|2115428|P1|Overall Study|Withdrawal by Subject|1
658088|NCT02137785|2115427|P2|Overall Study|Lost to Follow-up|0
658089|NCT02137785|2115428|P1|Overall Study|Lost to Follow-up|1
658100|NCT02135445|2115652|P2|Overall Study|Withdrawal by Subject|0
658101|NCT02135445|2115653|P1|Overall Study|Withdrawal by Subject|1
658102|NCT02135445|2115652|P2|Overall Study|Lost to Follow-up|0
658103|NCT02135445|2115653|P1|Overall Study|Lost to Follow-up|1
658104|NCT02134977|2115742|P1|Overall Study|Protocol Deviation|102
658105|NCT02134587|2115767|P1|Overall Study|Did not completed all meetings|30
658106|NCT02133664|2115851|P2|Overall Study|Adverse Event|6
658107|NCT02133664|2115852|P1|Overall Study|Adverse Event|3
658108|NCT02133664|2115851|P2|Overall Study|Lost to Follow-up|1
658109|NCT02133664|2115852|P1|Overall Study|Lost to Follow-up|2
658110|NCT02133352|2115868|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
658111|NCT02133131|2115899|P7|Overall Study|Protocol Violation|1
658112|NCT02133131|2115900|P6|Overall Study|Protocol Violation|0
658113|NCT02133131|2115901|P5|Overall Study|Protocol Violation|0
658114|NCT02133131|2115902|P4|Overall Study|Protocol Violation|0
658115|NCT02133131|2115903|P3|Overall Study|Protocol Violation|0
658116|NCT02133131|2115904|P2|Overall Study|Protocol Violation|0
658117|NCT02133131|2115905|P1|Overall Study|Protocol Violation|0
658118|NCT02133131|2115899|P7|Overall Study|Ongoing in study|11
658119|NCT02133131|2115900|P6|Overall Study|Ongoing in study|14
658120|NCT02133131|2115901|P5|Overall Study|Ongoing in study|15
658121|NCT02133131|2115902|P4|Overall Study|Ongoing in study|0
658122|NCT02133131|2115903|P3|Overall Study|Ongoing in study|0
658123|NCT02133131|2115904|P2|Overall Study|Ongoing in study|0
658124|NCT02133131|2115905|P1|Overall Study|Ongoing in study|0
658125|NCT02133131|2115899|P7|Overall Study|Status not recorded|0
658126|NCT02133131|2115900|P6|Overall Study|Status not recorded|0
658127|NCT02133131|2115901|P5|Overall Study|Status not recorded|0
658128|NCT02133131|2115902|P4|Overall Study|Status not recorded|4
658129|NCT02133131|2115903|P3|Overall Study|Status not recorded|1
658130|NCT02133131|2115904|P2|Overall Study|Status not recorded|5
658131|NCT02133131|2115905|P1|Overall Study|Status not recorded|4
658132|NCT02133131|2115899|P7|Overall Study|Lost to Follow-up|0
658133|NCT02133131|2115900|P6|Overall Study|Lost to Follow-up|0
658134|NCT02133131|2115901|P5|Overall Study|Lost to Follow-up|0
658135|NCT02133131|2115902|P4|Overall Study|Lost to Follow-up|1
658136|NCT02133131|2115903|P3|Overall Study|Lost to Follow-up|0
658137|NCT02133131|2115904|P2|Overall Study|Lost to Follow-up|0
658138|NCT02133131|2115905|P1|Overall Study|Lost to Follow-up|1
658139|NCT02133131|2115899|P7|Overall Study|Adverse Event|0
658140|NCT02133131|2115900|P6|Overall Study|Adverse Event|0
658141|NCT02133131|2115901|P5|Overall Study|Adverse Event|0
658142|NCT02133131|2115902|P4|Overall Study|Adverse Event|1
658143|NCT02133131|2115903|P3|Overall Study|Adverse Event|0
658144|NCT02133131|2115904|P2|Overall Study|Adverse Event|0
658145|NCT02133131|2115905|P1|Overall Study|Adverse Event|0
658178|NCT02132767|2116044|P2|Overall Study|Lost to Follow-up|4
658179|NCT02132767|2116045|P1|Overall Study|Lost to Follow-up|4
658180|NCT02132767|2116044|P2|Overall Study|Withdrawal by Subject|9
658181|NCT02132767|2116045|P1|Overall Study|Withdrawal by Subject|10
658182|NCT02132767|2116044|P2|Overall Study|Death|2
658183|NCT02132767|2116045|P1|Overall Study|Death|3
658184|NCT02132611|2116065|P1|Overall Study|Death|2
658185|NCT02132117|2116091|P2|Overall Study|Other Miscellaneous Reasons|0
658186|NCT02132117|2116092|P1|Overall Study|Other Miscellaneous Reasons|2
658187|NCT02132117|2116091|P2|Overall Study|Personal Reasons|2
658188|NCT02132117|2116092|P1|Overall Study|Personal Reasons|1
658189|NCT02132117|2116091|P2|Overall Study|Lost to Follow-up|2
658190|NCT02132117|2116092|P1|Overall Study|Lost to Follow-up|2
658191|NCT02132117|2116091|P2|Overall Study|Adverse Event|1
658192|NCT02132117|2116092|P1|Overall Study|Adverse Event|6
658193|NCT02131636|2116110|P2|Overall Study|Adverse Event|1
658194|NCT02131636|2116111|P1|Overall Study|Adverse Event|4
658195|NCT02131636|2116110|P2|Overall Study|Lost to Follow-up|0
658196|NCT02131636|2116111|P1|Overall Study|Lost to Follow-up|4
658197|NCT02131636|2116110|P2|Overall Study|Personal Reasons|4
658198|NCT02131636|2116111|P1|Overall Study|Personal Reasons|4
658199|NCT02131532|2116127|P1|Overall Study|Other health conditions|2
658200|NCT02131532|2116127|P1|Overall Study|Physician Decision|1
658201|NCT02131532|2116127|P1|Overall Study|Withdrawal by Subject|1
658202|NCT02131311|2116217|P1|Overall Study|Lost to Follow-up|1
658203|NCT02131311|2116217|P1|Overall Study|Protocol Violation|1
658204|NCT02131311|2116217|P1|Overall Study|Adverse Event|2
658205|NCT02131272|2116229|P2|Overall Study|Withdrawal Criteria|0
658206|NCT02131272|2116230|P1|Overall Study|Withdrawal Criteria|1
658207|NCT02131272|2116229|P2|Overall Study|Withdrawal by Subject|1
658208|NCT02131272|2116230|P1|Overall Study|Withdrawal by Subject|0
658209|NCT02131272|2116229|P2|Overall Study|Withdrawal by parent|1
658210|NCT02131272|2116230|P1|Overall Study|Withdrawal by parent|0
658239|NCT02130284|2116520|P1|Overall Study|Screen Failure|1
658240|NCT02130284|2116520|P1|Overall Study|Subject was screened as backup for study|3
658241|NCT02130284|2116520|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
658242|NCT02130284|2116520|P1|Overall Study|Subject Withdrew Consent|1
658243|NCT02130284|2116520|P1|Overall Study|Withdrawal by Subject|3
658244|NCT02130193|2116533|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
658245|NCT02130193|2116534|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
658246|NCT02130193|2116535|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
658247|NCT02130193|2116533|P3|Part B: 52-week Double-blind Period|Physician Decision|1
658248|NCT02130193|2116534|P2|Part B: 52-week Double-blind Period|Physician Decision|0
658249|NCT02130193|2116535|P1|Part B: 52-week Double-blind Period|Physician Decision|0
658250|NCT02130193|2116533|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
658251|NCT02130193|2116534|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
658252|NCT02130193|2116535|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
658253|NCT02130193|2116533|P3|Part B: 52-week Double-blind Period|Adverse Event|3
658254|NCT02130193|2116534|P2|Part B: 52-week Double-blind Period|Adverse Event|5
658255|NCT02130193|2116535|P1|Part B: 52-week Double-blind Period|Adverse Event|0
658256|NCT02129777|2116604|P7|Open-Label Period|Study Termination|39
658257|NCT02129777|2116605|P6|Open-Label Period|Study Termination|10
658258|NCT02129777|2116606|P5|Open-Label Period|Study Termination|0
658259|NCT02129777|2116607|P4|Open-Label Period|Study Termination|0
658260|NCT02129777|2116608|P3|Open-Label Period|Study Termination|0
658261|NCT02129777|2116609|P2|Open-Label Period|Study Termination|0
658262|NCT02129777|2116610|P1|Open-Label Period|Study Termination|0
658263|NCT02129777|2116604|P7|Open-Label Period|Withdrawal by Subject|3
658264|NCT02129777|2116605|P6|Open-Label Period|Withdrawal by Subject|1
658265|NCT02129777|2116606|P5|Open-Label Period|Withdrawal by Subject|0
658266|NCT02129777|2116607|P4|Open-Label Period|Withdrawal by Subject|0
658267|NCT02129777|2116608|P3|Open-Label Period|Withdrawal by Subject|0
658268|NCT02129777|2116609|P2|Open-Label Period|Withdrawal by Subject|0
658269|NCT02129777|2116610|P1|Open-Label Period|Withdrawal by Subject|0
658270|NCT02129777|2116604|P7|Open-Label Period|Lost to Follow-up|1
658271|NCT02129777|2116605|P6|Open-Label Period|Lost to Follow-up|1
658272|NCT02129777|2116606|P5|Open-Label Period|Lost to Follow-up|0
658273|NCT02129777|2116607|P4|Open-Label Period|Lost to Follow-up|0
658274|NCT02129777|2116608|P3|Open-Label Period|Lost to Follow-up|0
658275|NCT02129777|2116609|P2|Open-Label Period|Lost to Follow-up|0
658276|NCT02129777|2116610|P1|Open-Label Period|Lost to Follow-up|0
658277|NCT02129777|2116604|P7|Open-Label Period|Lack of Efficacy|5
658278|NCT02129777|2116605|P6|Open-Label Period|Lack of Efficacy|0
658279|NCT02129777|2116606|P5|Open-Label Period|Lack of Efficacy|0
658280|NCT02129777|2116607|P4|Open-Label Period|Lack of Efficacy|0
658281|NCT02129777|2116608|P3|Open-Label Period|Lack of Efficacy|0
658282|NCT02129777|2116609|P2|Open-Label Period|Lack of Efficacy|0
658283|NCT02129777|2116610|P1|Open-Label Period|Lack of Efficacy|0
658284|NCT02129777|2116604|P7|Double-Blind Period|Other|0
658285|NCT02129777|2116605|P6|Double-Blind Period|Other|0
658286|NCT02129777|2116606|P5|Double-Blind Period|Other|0
658287|NCT02129777|2116607|P4|Double-Blind Period|Other|0
658288|NCT02129777|2116608|P3|Double-Blind Period|Other|0
658289|NCT02129777|2116609|P2|Double-Blind Period|Other|2
658290|NCT02129777|2116610|P1|Double-Blind Period|Other|1
658291|NCT02129777|2116604|P7|Double-Blind Period|Lack of Efficacy|0
658292|NCT02129777|2116605|P6|Double-Blind Period|Lack of Efficacy|0
658293|NCT02129777|2116606|P5|Double-Blind Period|Lack of Efficacy|2
658294|NCT02129777|2116607|P4|Double-Blind Period|Lack of Efficacy|3
658295|NCT02129777|2116608|P3|Double-Blind Period|Lack of Efficacy|0
658296|NCT02129777|2116609|P2|Double-Blind Period|Lack of Efficacy|1
658297|NCT02129777|2116610|P1|Double-Blind Period|Lack of Efficacy|3
658298|NCT02129777|2116604|P7|Double-Blind Period|Pregnancy|0
658299|NCT02129777|2116605|P6|Double-Blind Period|Pregnancy|0
658300|NCT02129777|2116606|P5|Double-Blind Period|Pregnancy|1
658301|NCT02129777|2116607|P4|Double-Blind Period|Pregnancy|0
658302|NCT02129777|2116608|P3|Double-Blind Period|Pregnancy|0
658303|NCT02129777|2116609|P2|Double-Blind Period|Pregnancy|0
658304|NCT02129777|2116610|P1|Double-Blind Period|Pregnancy|0
658305|NCT02129777|2116604|P7|Double-Blind Period|Withdrawal by Subject|0
658306|NCT02129777|2116605|P6|Double-Blind Period|Withdrawal by Subject|0
658307|NCT02129777|2116606|P5|Double-Blind Period|Withdrawal by Subject|3
658308|NCT02129777|2116607|P4|Double-Blind Period|Withdrawal by Subject|2
658309|NCT02129777|2116608|P3|Double-Blind Period|Withdrawal by Subject|3
658310|NCT02129777|2116609|P2|Double-Blind Period|Withdrawal by Subject|4
658311|NCT02129777|2116610|P1|Double-Blind Period|Withdrawal by Subject|2
658312|NCT02129777|2116604|P7|Double-Blind Period|Lost to Follow-up|0
658313|NCT02129777|2116605|P6|Double-Blind Period|Lost to Follow-up|0
658314|NCT02129777|2116606|P5|Double-Blind Period|Lost to Follow-up|0
658315|NCT02129777|2116607|P4|Double-Blind Period|Lost to Follow-up|2
658316|NCT02129777|2116608|P3|Double-Blind Period|Lost to Follow-up|1
658317|NCT02129777|2116609|P2|Double-Blind Period|Lost to Follow-up|1
658318|NCT02129777|2116610|P1|Double-Blind Period|Lost to Follow-up|1
658319|NCT02129777|2116604|P7|Double-Blind Period|Adverse Event|0
658320|NCT02129777|2116605|P6|Double-Blind Period|Adverse Event|0
658321|NCT02129777|2116606|P5|Double-Blind Period|Adverse Event|1
658322|NCT02129777|2116607|P4|Double-Blind Period|Adverse Event|0
658323|NCT02129777|2116608|P3|Double-Blind Period|Adverse Event|0
658324|NCT02129777|2116609|P2|Double-Blind Period|Adverse Event|0
658325|NCT02129777|2116610|P1|Double-Blind Period|Adverse Event|0
658326|NCT02129608|2116726|P3|Overall Study|Withdrawal by Subject|2
658327|NCT02129608|2116727|P2|Overall Study|Withdrawal by Subject|0
658328|NCT02129608|2116728|P1|Overall Study|Withdrawal by Subject|0
658329|NCT02129608|2116726|P3|Overall Study|Lost to Follow-up|1
658330|NCT02129608|2116727|P2|Overall Study|Lost to Follow-up|1
658331|NCT02129608|2116728|P1|Overall Study|Lost to Follow-up|0
658332|NCT02129192|2116741|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
658333|NCT02129192|2116742|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
658334|NCT02129062|2116759|P1|Overall Study|Disease Progression|2
658335|NCT02129062|2116759|P1|Overall Study|Death|1
658336|NCT02128542|2116792|P2|Overall Study|Withdrew Consent|0
658337|NCT02128542|2116793|P1|Overall Study|Withdrew Consent|1
658338|NCT02128542|2116792|P2|Overall Study|Lost to Follow-up|0
658339|NCT02128542|2116793|P1|Overall Study|Lost to Follow-up|3
658340|NCT02128490|2116811|P5|Overall Study|Other Miscellaneous Reasons|1
658341|NCT02128490|2116812|P4|Overall Study|Other Miscellaneous Reasons|1
658342|NCT02128490|2116813|P3|Overall Study|Other Miscellaneous Reasons|2
658343|NCT02128490|2116814|P2|Overall Study|Other Miscellaneous Reasons|0
658344|NCT02128490|2116815|P1|Overall Study|Other Miscellaneous Reasons|0
658345|NCT02128490|2116811|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
658346|NCT02128490|2116812|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
658347|NCT02128490|2116813|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
658348|NCT02128490|2116814|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
658349|NCT02128490|2116815|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
658350|NCT02128490|2116811|P5|Overall Study|Lack of Efficacy|0
658351|NCT02128490|2116812|P4|Overall Study|Lack of Efficacy|0
658352|NCT02128490|2116813|P3|Overall Study|Lack of Efficacy|0
658353|NCT02128490|2116814|P2|Overall Study|Lack of Efficacy|1
658354|NCT02128490|2116815|P1|Overall Study|Lack of Efficacy|0
658355|NCT02128490|2116811|P5|Overall Study|Voluntary Withdrawal|2
658356|NCT02128490|2116812|P4|Overall Study|Voluntary Withdrawal|1
658357|NCT02128490|2116813|P3|Overall Study|Voluntary Withdrawal|1
658358|NCT02128490|2116814|P2|Overall Study|Voluntary Withdrawal|3
658359|NCT02128490|2116815|P1|Overall Study|Voluntary Withdrawal|3
658360|NCT02128490|2116811|P5|Overall Study|Lost to Follow-up|1
658361|NCT02128490|2116812|P4|Overall Study|Lost to Follow-up|1
658362|NCT02128490|2116813|P3|Overall Study|Lost to Follow-up|1
658363|NCT02128490|2116814|P2|Overall Study|Lost to Follow-up|0
658364|NCT02128490|2116815|P1|Overall Study|Lost to Follow-up|0
658365|NCT02128490|2116811|P5|Overall Study|Major Protocol Deviation|2
658366|NCT02128490|2116812|P4|Overall Study|Major Protocol Deviation|2
658367|NCT02128490|2116813|P3|Overall Study|Major Protocol Deviation|0
658368|NCT02128490|2116814|P2|Overall Study|Major Protocol Deviation|2
658369|NCT02128490|2116815|P1|Overall Study|Major Protocol Deviation|1
658370|NCT02128490|2116811|P5|Overall Study|Pretreatment Event/Adverse Event|0
658371|NCT02128490|2116812|P4|Overall Study|Pretreatment Event/Adverse Event|1
658372|NCT02128490|2116813|P3|Overall Study|Pretreatment Event/Adverse Event|1
658373|NCT02128490|2116814|P2|Overall Study|Pretreatment Event/Adverse Event|0
658374|NCT02128490|2116815|P1|Overall Study|Pretreatment Event/Adverse Event|1
658375|NCT02128269|2116837|P1|Treatment Period|Physician Decision|1
658376|NCT02128269|2116837|P1|Treatment Period|Adverse Event|1
658377|NCT02127372|2116896|P2|Overall Study|Withdrawal by Subject|0
658378|NCT02127372|2116897|P1|Overall Study|Withdrawal by Subject|1
658379|NCT02127307|2116907|P1|Overall Study|Other than specified above|169
658380|NCT02127307|2116907|P1|Overall Study|Death|101
658381|NCT02127307|2116907|P1|Overall Study|Lost to Follow-up|2
658382|NCT02127307|2116907|P1|Overall Study|Protocol Violation|36
658383|NCT02126839|2116913|P2|Overall Study|Not specified|5
658384|NCT02126839|2116914|P1|Overall Study|Not specified|5
658385|NCT02126839|2116913|P2|Overall Study|Lost to Follow-up|4
658386|NCT02126839|2116914|P1|Overall Study|Lost to Follow-up|1
658387|NCT02126839|2116913|P2|Overall Study|Sponsor request|1
658388|NCT02126839|2116914|P1|Overall Study|Sponsor request|0
658389|NCT02126839|2116913|P2|Overall Study|Protocol Violation|3
658390|NCT02126839|2116914|P1|Overall Study|Protocol Violation|2
658391|NCT02126839|2116913|P2|Overall Study|Withdrawal by parent/guardian|0
658392|NCT02126839|2116914|P1|Overall Study|Withdrawal by parent/guardian|1
658393|NCT02126839|2116913|P2|Overall Study|Withdrawal by Subject|0
658394|NCT02126839|2116914|P1|Overall Study|Withdrawal by Subject|1
658395|NCT02126839|2116913|P2|Overall Study|Adverse Event|1
658396|NCT02126839|2116914|P1|Overall Study|Adverse Event|0
658397|NCT02126670|2116941|P4|Overall Study|Withdrawal by Subject|1
658398|NCT02126670|2116942|P3|Overall Study|Withdrawal by Subject|0
658399|NCT02126670|2116943|P2|Overall Study|Withdrawal by Subject|0
658400|NCT02126670|2116944|P1|Overall Study|Withdrawal by Subject|1
658401|NCT02125877|2116996|P2|Overall Study|Adverse Event|4
658402|NCT02125877|2116997|P1|Overall Study|Adverse Event|6
658403|NCT02125877|2116996|P2|Overall Study|Protocol deviation|1
658404|NCT02125877|2116997|P1|Overall Study|Protocol deviation|4
658405|NCT02125877|2116996|P2|Overall Study|Withdrawal by Subject|1
658406|NCT02125877|2116997|P1|Overall Study|Withdrawal by Subject|2
658407|NCT02125877|2116996|P2|Overall Study|Participant/guardian decision|2
658408|NCT02125877|2116997|P1|Overall Study|Participant/guardian decision|0
658409|NCT02125877|2116996|P2|Overall Study|Administrative problems|1
658410|NCT02125877|2116997|P1|Overall Study|Administrative problems|0
658411|NCT02125877|2116996|P2|Overall Study|Death|1
658412|NCT02125877|2116997|P1|Overall Study|Death|0
658413|NCT02125877|2116996|P2|Overall Study|Physician Decision|0
658414|NCT02125877|2116997|P1|Overall Study|Physician Decision|1
658415|NCT02125838|2117027|P2|Overall Study|Lost to Follow-up|4
658416|NCT02125838|2117028|P1|Overall Study|Lost to Follow-up|4
658417|NCT02125734|2117046|P2|Period 2|Adverse Event|1
658418|NCT02125734|2117047|P1|Period 2|Adverse Event|0
658419|NCT02125604|2117057|P1|Overall Study|Adverse Event|20
658420|NCT02125604|2117057|P1|Overall Study|Consent Withdrawn|4
658421|NCT02125604|2117057|P1|Overall Study|Lost to Follow-up|2
658422|NCT02125604|2117057|P1|Overall Study|Investigator Decision|1
658423|NCT02125604|2117057|P1|Overall Study|Not Specified|4
658424|NCT02124798|2117103|P1|Overall Study|Lost to Follow-up|1
658425|NCT02124798|2117103|P1|Overall Study|Adverse Event|3
658426|NCT02124161|2117161|P2|Overall Study|Lost to Follow-up|4
658427|NCT02124161|2117162|P1|Overall Study|Lost to Follow-up|3
658428|NCT02124161|2117161|P2|Overall Study|No longer meets eligibility criteria|4
658429|NCT02124161|2117162|P1|Overall Study|No longer meets eligibility criteria|5
658430|NCT02124161|2117161|P2|Overall Study|Does not meet entrance criteria|3
658431|NCT02124161|2117162|P1|Overall Study|Does not meet entrance criteria|2
658432|NCT02124161|2117161|P2|Overall Study|Adverse Event|0
658433|NCT02124161|2117162|P1|Overall Study|Adverse Event|2
658434|NCT02124161|2117161|P2|Overall Study|Withdrawal by Subject|2
658435|NCT02124161|2117162|P1|Overall Study|Withdrawal by Subject|1
658436|NCT02124161|2117161|P2|Overall Study|Protocol Violation|1
658437|NCT02124161|2117162|P1|Overall Study|Protocol Violation|2
658438|NCT02124161|2117161|P2|Overall Study|Death|0
658439|NCT02124161|2117162|P1|Overall Study|Death|1
658440|NCT02124161|2117161|P2|Overall Study|Other unspecified|1
658441|NCT02124161|2117162|P1|Overall Study|Other unspecified|0
658442|NCT02123472|2117220|P2|Period 2 (7 Days)|Withdrawal by Subject|1
658443|NCT02123472|2117221|P1|Period 2 (7 Days)|Withdrawal by Subject|0
658444|NCT02123459|2117231|P2|Washout Period (1 Day)|Adverse Event|0
658445|NCT02123459|2117232|P1|Washout Period (1 Day)|Adverse Event|1
658446|NCT02123446|2117242|P2|Washout Period (1 Day)|Physician Decision|0
658447|NCT02123446|2117243|P1|Washout Period (1 Day)|Physician Decision|1
658448|NCT02121847|2117314|P1|Overall Study|Adverse Event|2
658449|NCT02121847|2117314|P1|Overall Study|Administrative Reasons|1
658450|NCT02121795|2117335|P2|Overall Study|Still in Study up to the Data Cut Date|316
658451|NCT02121795|2117336|P1|Overall Study|Still in Study up to the Data Cut Date|315
658452|NCT02121795|2117335|P2|Overall Study|Lost to Follow-up|1
658453|NCT02121795|2117336|P1|Overall Study|Lost to Follow-up|2
658454|NCT02121795|2117335|P2|Overall Study|Withdrew Consent|10
658455|NCT02121795|2117336|P1|Overall Study|Withdrew Consent|10
658456|NCT02121795|2117335|P2|Overall Study|Protocol Violation|2
658457|NCT02121795|2117336|P1|Overall Study|Protocol Violation|0
658458|NCT02121795|2117335|P2|Overall Study|Non-Compliance with Study Drug|1
658459|NCT02121795|2117336|P1|Overall Study|Non-Compliance with Study Drug|1
658460|NCT02121795|2117335|P2|Overall Study|Investigator's Discretion|0
658461|NCT02121795|2117336|P1|Overall Study|Investigator's Discretion|1
658462|NCT02121795|2117335|P2|Overall Study|Adverse Event|0
658463|NCT02121795|2117336|P1|Overall Study|Adverse Event|4
658464|NCT02121795|2117335|P2|Overall Study|Randomized but Never Treated|4
658465|NCT02121795|2117336|P1|Overall Study|Randomized but Never Treated|1
658466|NCT02121535|2117352|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
658467|NCT02121535|2117353|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
658468|NCT02121535|2117352|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
658469|NCT02121535|2117353|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
658470|NCT02121522|2117376|P1|Overall Study|Adverse Event|1
658471|NCT02121509|2117383|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
658472|NCT02121509|2117384|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
658473|NCT02121509|2117385|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
658474|NCT02121509|2117386|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
658475|NCT02121509|2117383|P4|Washout Period (35 Days)|Withdrawal by Subject|0
658476|NCT02121509|2117384|P3|Washout Period (35 Days)|Withdrawal by Subject|0
658477|NCT02121509|2117385|P2|Washout Period (35 Days)|Withdrawal by Subject|3
658478|NCT02121509|2117386|P1|Washout Period (35 Days)|Withdrawal by Subject|0
658479|NCT02121509|2117383|P4|Washout Period (35 Days)|Adverse Event|0
658480|NCT02121509|2117384|P3|Washout Period (35 Days)|Adverse Event|0
658481|NCT02121509|2117385|P2|Washout Period (35 Days)|Adverse Event|1
658482|NCT02121509|2117386|P1|Washout Period (35 Days)|Adverse Event|1
658483|NCT02121210|2117452|P2|Overall Study|Other than specified above|2
658484|NCT02121210|2117453|P1|Overall Study|Other than specified above|0
658485|NCT02121210|2117452|P2|Overall Study|Lack of Efficacy|0
658486|NCT02121210|2117453|P1|Overall Study|Lack of Efficacy|2
658487|NCT02121210|2117452|P2|Overall Study|Adverse Event|7
658488|NCT02121210|2117453|P1|Overall Study|Adverse Event|5
658489|NCT02120833|2117478|P2|Overall Study|Lost to Follow-up|1
658490|NCT02120833|2117479|P1|Overall Study|Lost to Follow-up|1
658491|NCT02120833|2117478|P2|Overall Study|Withdrawal by Subject|0
658492|NCT02120833|2117479|P1|Overall Study|Withdrawal by Subject|2
658493|NCT02120833|2117478|P2|Overall Study|Adverse Event|0
658494|NCT02120833|2117479|P1|Overall Study|Adverse Event|1
658495|NCT02120664|2117638|P5|Overall Study|Withdrawal by Subject|0
658496|NCT02120664|2117639|P4|Overall Study|Withdrawal by Subject|1
658497|NCT02120664|2117640|P3|Overall Study|Withdrawal by Subject|0
658498|NCT02120664|2117641|P2|Overall Study|Withdrawal by Subject|0
658499|NCT02120664|2117642|P1|Overall Study|Withdrawal by Subject|0
658500|NCT02120625|2117660|P1|Overall Study|Physician Decision|2
658501|NCT02120417|2117675|P2|Overall Study|Other unspecified|4
658502|NCT02120417|2117676|P1|Overall Study|Other unspecified|5
658503|NCT02120417|2117675|P2|Overall Study|Physician Decision|3
658504|NCT02120417|2117676|P1|Overall Study|Physician Decision|2
658505|NCT02120417|2117675|P2|Overall Study|Noncompliance with study treatment|2
658506|NCT02120417|2117676|P1|Overall Study|Noncompliance with study treatment|0
658507|NCT02120417|2117675|P2|Overall Study|Disease progression|45
658508|NCT02120417|2117676|P1|Overall Study|Disease progression|41
658509|NCT02120417|2117675|P2|Overall Study|Participant decision|4
658510|NCT02120417|2117676|P1|Overall Study|Participant decision|4
658511|NCT02120417|2117675|P2|Overall Study|Adverse Event|9
658512|NCT02120417|2117676|P1|Overall Study|Adverse Event|3
658513|NCT02120417|2117675|P2|Overall Study|Death|1
658514|NCT02120417|2117676|P1|Overall Study|Death|5
658515|NCT02120300|2117698|P4|Overall Study|Lost to Follow-up|0
658516|NCT02120300|2117699|P3|Overall Study|Lost to Follow-up|0
658517|NCT02120300|2117700|P2|Overall Study|Lost to Follow-up|0
658518|NCT02120300|2117701|P1|Overall Study|Lost to Follow-up|1
658519|NCT02120300|2117698|P4|Overall Study|Lack of Efficacy|1
658520|NCT02120300|2117699|P3|Overall Study|Lack of Efficacy|0
658521|NCT02120300|2117700|P2|Overall Study|Lack of Efficacy|0
658522|NCT02120300|2117701|P1|Overall Study|Lack of Efficacy|0
658523|NCT02120300|2117698|P4|Overall Study|Enrolled but Never Treated|0
658524|NCT02120300|2117699|P3|Overall Study|Enrolled but Never Treated|0
658525|NCT02120300|2117700|P2|Overall Study|Enrolled but Never Treated|0
658526|NCT02120300|2117701|P1|Overall Study|Enrolled but Never Treated|2
658527|NCT02120027|2117739|P2|Overall Study|Withdrawal by Subject|25
658528|NCT02120027|2117740|P1|Overall Study|Withdrawal by Subject|33
658529|NCT02120027|2117739|P2|Overall Study|Study terminated by Sponsor|47
658530|NCT02120027|2117740|P1|Overall Study|Study terminated by Sponsor|45
658531|NCT02120027|2117739|P2|Overall Study|Protocol Violation|21
658532|NCT02120027|2117740|P1|Overall Study|Protocol Violation|18
658533|NCT02120027|2117739|P2|Overall Study|Physician Decision|3
658534|NCT02120027|2117740|P1|Overall Study|Physician Decision|4
658535|NCT02120027|2117739|P2|Overall Study|Other|0
658536|NCT02120027|2117740|P1|Overall Study|Other|4
658537|NCT02120027|2117739|P2|Overall Study|Lost to Follow-up|13
658538|NCT02120027|2117740|P1|Overall Study|Lost to Follow-up|5
658539|NCT02120027|2117739|P2|Overall Study|Lack of Efficacy|5
658540|NCT02120027|2117740|P1|Overall Study|Lack of Efficacy|3
658541|NCT02120027|2117739|P2|Overall Study|Adverse Event|5
658542|NCT02120027|2117740|P1|Overall Study|Adverse Event|4
658543|NCT02119676|2117769|P4|Overall Study|Did not receive study med|5
658544|NCT02119676|2117770|P3|Overall Study|Did not receive study med|4
658545|NCT02119676|2117771|P2|Overall Study|Did not receive study med|2
658546|NCT02119676|2117772|P1|Overall Study|Did not receive study med|2
658547|NCT02119676|2117769|P4|Overall Study|Other, unspecified|4
658548|NCT02119676|2117770|P3|Overall Study|Other, unspecified|3
658549|NCT02119676|2117771|P2|Overall Study|Other, unspecified|1
658550|NCT02119676|2117772|P1|Overall Study|Other, unspecified|2
658551|NCT02119676|2117769|P4|Overall Study|Protocol deviation|0
658552|NCT02119676|2117770|P3|Overall Study|Protocol deviation|1
658553|NCT02119676|2117771|P2|Overall Study|Protocol deviation|0
658554|NCT02119676|2117772|P1|Overall Study|Protocol deviation|0
658555|NCT02119676|2117769|P4|Overall Study|Lost to Follow-up|0
658556|NCT02119676|2117770|P3|Overall Study|Lost to Follow-up|1
658557|NCT02119676|2117771|P2|Overall Study|Lost to Follow-up|0
658558|NCT02119676|2117772|P1|Overall Study|Lost to Follow-up|0
658559|NCT02119676|2117769|P4|Overall Study|Noncompliance|0
658560|NCT02119676|2117770|P3|Overall Study|Noncompliance|0
658561|NCT02119676|2117771|P2|Overall Study|Noncompliance|1
658562|NCT02119676|2117772|P1|Overall Study|Noncompliance|0
658563|NCT02119676|2117769|P4|Overall Study|Death|1
658564|NCT02119676|2117770|P3|Overall Study|Death|2
658565|NCT02119676|2117771|P2|Overall Study|Death|3
658566|NCT02119676|2117772|P1|Overall Study|Death|9
658567|NCT02119676|2117769|P4|Overall Study|Physician Decision|2
658568|NCT02119676|2117770|P3|Overall Study|Physician Decision|3
658569|NCT02119676|2117771|P2|Overall Study|Physician Decision|2
658570|NCT02119676|2117772|P1|Overall Study|Physician Decision|4
658571|NCT02119676|2117769|P4|Overall Study|Patient decision, inc. consent withdrawn|6
658572|NCT02119676|2117770|P3|Overall Study|Patient decision, inc. consent withdrawn|5
658573|NCT02119676|2117771|P2|Overall Study|Patient decision, inc. consent withdrawn|5
658574|NCT02119676|2117772|P1|Overall Study|Patient decision, inc. consent withdrawn|4
658575|NCT02119676|2117769|P4|Overall Study|Disease progression|73
658576|NCT02119676|2117770|P3|Overall Study|Disease progression|68
658577|NCT02119676|2117771|P2|Overall Study|Disease progression|55
658578|NCT02119676|2117772|P1|Overall Study|Disease progression|53
658579|NCT02119676|2117769|P4|Overall Study|Adverse Event|10
658580|NCT02119676|2117770|P3|Overall Study|Adverse Event|10
658581|NCT02119676|2117771|P2|Overall Study|Adverse Event|17
658582|NCT02119676|2117772|P1|Overall Study|Adverse Event|9
658583|NCT02119663|2117804|P2|Overall Study|Study Terminated by the Sponsor|4
658584|NCT02119663|2117805|P1|Overall Study|Study Terminated by the Sponsor|3
658585|NCT02119663|2117804|P2|Overall Study|Subject decision|1
658586|NCT02119663|2117805|P1|Overall Study|Subject decision|0
658587|NCT02119663|2117804|P2|Overall Study|Other unspecified|0
658588|NCT02119663|2117805|P1|Overall Study|Other unspecified|2
658589|NCT02119663|2117804|P2|Overall Study|Physician Decision|2
658590|NCT02119663|2117805|P1|Overall Study|Physician Decision|1
658591|NCT02119663|2117804|P2|Overall Study|Death|2
658592|NCT02119663|2117805|P1|Overall Study|Death|3
658593|NCT02119663|2117804|P2|Overall Study|Adverse Event|5
658594|NCT02119663|2117805|P1|Overall Study|Adverse Event|5
658595|NCT02119663|2117804|P2|Overall Study|Disease progression|27
658596|NCT02119663|2117805|P1|Overall Study|Disease progression|26
888271|NCT02189837|2821757|P2|Overall Study|Withdrawal by Subject|1
888272|NCT02189837|2821758|P1|Overall Study|Withdrawal by Subject|2
888273|NCT02157935|2821795|P2|Overall Study|Adverse Event|5
888274|NCT02157935|2821796|P1|Overall Study|Adverse Event|3
888275|NCT02157935|2821795|P2|Overall Study|Death|4
888276|NCT02157935|2821796|P1|Overall Study|Death|4
888277|NCT02157935|2821795|P2|Overall Study|Lack of Efficacy|1
888278|NCT02157935|2821796|P1|Overall Study|Lack of Efficacy|0
888279|NCT02157935|2821795|P2|Overall Study|Other|12
888280|NCT02157935|2821796|P1|Overall Study|Other|5
888281|NCT02157935|2821795|P2|Overall Study|Progressive disease|2
888282|NCT02157935|2821796|P1|Overall Study|Progressive disease|0
888283|NCT02157935|2821795|P2|Overall Study|Protocol Violation|0
888284|NCT02157935|2821796|P1|Overall Study|Protocol Violation|1
888285|NCT02157935|2821795|P2|Overall Study|Screen failure|2
888286|NCT02157935|2821796|P1|Overall Study|Screen failure|1
658613|NCT02119325|2117838|P2|Washout Period 1|Adverse Event|1
658614|NCT02119325|2117839|P1|Washout Period 1|Adverse Event|0
658615|NCT02119299|2117883|P1|Overall Study|Pregnancy|1
658616|NCT02119299|2117883|P1|Overall Study|Lack of Efficacy|1
658617|NCT02119299|2117883|P1|Overall Study|Withdrawal by Subject|7
658618|NCT02119286|2117897|P3|Overall Study|Withdrawal by Subject|0
658619|NCT02119286|2117898|P2|Overall Study|Withdrawal by Subject|1
658620|NCT02119286|2117899|P1|Overall Study|Withdrawal by Subject|4
658621|NCT02119286|2117897|P3|Overall Study|Lost to Follow-up|1
658622|NCT02119286|2117898|P2|Overall Study|Lost to Follow-up|0
658623|NCT02119286|2117899|P1|Overall Study|Lost to Follow-up|2
658624|NCT02119286|2117897|P3|Overall Study|Lack of Efficacy|4
658625|NCT02119286|2117898|P2|Overall Study|Lack of Efficacy|3
658626|NCT02119286|2117899|P1|Overall Study|Lack of Efficacy|11
658627|NCT02119286|2117897|P3|Overall Study|Adverse Event|2
658628|NCT02119286|2117898|P2|Overall Study|Adverse Event|7
658629|NCT02119286|2117899|P1|Overall Study|Adverse Event|9
658630|NCT02119104|2117910|P1|Overall Study|Protocol Violation|16
658631|NCT02118961|2117916|P2|Overall Study|Withdrawal by Subject|0
658632|NCT02118961|2117917|P1|Overall Study|Withdrawal by Subject|1
658633|NCT02118896|2117945|P10|Overall Study|Miscellaneous|0
658634|NCT02118896|2117946|P9|Overall Study|Miscellaneous|0
658635|NCT02118896|2117947|P8|Overall Study|Miscellaneous|0
658636|NCT02118896|2117948|P7|Overall Study|Miscellaneous|0
658637|NCT02118896|2117949|P6|Overall Study|Miscellaneous|4
658638|NCT02118896|2117950|P5|Overall Study|Miscellaneous|0
658639|NCT02118896|2117951|P4|Overall Study|Miscellaneous|2
658640|NCT02118896|2117952|P3|Overall Study|Miscellaneous|0
658641|NCT02118896|2117953|P2|Overall Study|Miscellaneous|2
658642|NCT02118896|2117954|P1|Overall Study|Miscellaneous|1
658643|NCT02118896|2117945|P10|Overall Study|Prohibited medication|0
658644|NCT02118896|2117946|P9|Overall Study|Prohibited medication|0
658645|NCT02118896|2117947|P8|Overall Study|Prohibited medication|0
658646|NCT02118896|2117948|P7|Overall Study|Prohibited medication|0
658647|NCT02118896|2117949|P6|Overall Study|Prohibited medication|3
658648|NCT02118896|2117950|P5|Overall Study|Prohibited medication|1
658649|NCT02118896|2117951|P4|Overall Study|Prohibited medication|0
658650|NCT02118896|2117952|P3|Overall Study|Prohibited medication|0
658651|NCT02118896|2117953|P2|Overall Study|Prohibited medication|0
658652|NCT02118896|2117954|P1|Overall Study|Prohibited medication|0
658653|NCT02118896|2117945|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
658654|NCT02118896|2117946|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
658655|NCT02118896|2117947|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
658656|NCT02118896|2117948|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
658657|NCT02118896|2117949|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
658658|NCT02118896|2117950|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
658659|NCT02118896|2117951|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
658660|NCT02118896|2117952|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
658661|NCT02118896|2117953|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
658662|NCT02118896|2117954|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
658663|NCT02118896|2117945|P10|Overall Study|Lost to Follow-up|0
888287|NCT02157935|2821795|P2|Overall Study|Withdrawal by Subject|39
658664|NCT02118896|2117946|P9|Overall Study|Lost to Follow-up|0
658665|NCT02118896|2117947|P8|Overall Study|Lost to Follow-up|0
658666|NCT02118896|2117948|P7|Overall Study|Lost to Follow-up|0
658667|NCT02118896|2117949|P6|Overall Study|Lost to Follow-up|1
658668|NCT02118896|2117950|P5|Overall Study|Lost to Follow-up|2
658669|NCT02118896|2117951|P4|Overall Study|Lost to Follow-up|0
658670|NCT02118896|2117952|P3|Overall Study|Lost to Follow-up|1
658671|NCT02118896|2117953|P2|Overall Study|Lost to Follow-up|2
658672|NCT02118896|2117954|P1|Overall Study|Lost to Follow-up|1
658673|NCT02118896|2117945|P10|Overall Study|Pregnancy|0
658674|NCT02118896|2117946|P9|Overall Study|Pregnancy|0
658675|NCT02118896|2117947|P8|Overall Study|Pregnancy|0
658676|NCT02118896|2117948|P7|Overall Study|Pregnancy|1
658677|NCT02118896|2117949|P6|Overall Study|Pregnancy|3
658678|NCT02118896|2117950|P5|Overall Study|Pregnancy|1
658679|NCT02118896|2117951|P4|Overall Study|Pregnancy|0
658680|NCT02118896|2117952|P3|Overall Study|Pregnancy|0
658681|NCT02118896|2117953|P2|Overall Study|Pregnancy|1
658682|NCT02118896|2117954|P1|Overall Study|Pregnancy|1
658683|NCT02118896|2117945|P10|Overall Study|Non-compliance|0
658684|NCT02118896|2117946|P9|Overall Study|Non-compliance|0
658685|NCT02118896|2117947|P8|Overall Study|Non-compliance|1
658686|NCT02118896|2117948|P7|Overall Study|Non-compliance|0
658687|NCT02118896|2117949|P6|Overall Study|Non-compliance|1
658688|NCT02118896|2117950|P5|Overall Study|Non-compliance|0
658689|NCT02118896|2117951|P4|Overall Study|Non-compliance|5
658690|NCT02118896|2117952|P3|Overall Study|Non-compliance|1
658691|NCT02118896|2117953|P2|Overall Study|Non-compliance|1
658692|NCT02118896|2117954|P1|Overall Study|Non-compliance|2
658693|NCT02118896|2117945|P10|Overall Study|Consent withdrawn|0
658694|NCT02118896|2117946|P9|Overall Study|Consent withdrawn|0
658695|NCT02118896|2117947|P8|Overall Study|Consent withdrawn|0
658696|NCT02118896|2117948|P7|Overall Study|Consent withdrawn|0
658697|NCT02118896|2117949|P6|Overall Study|Consent withdrawn|4
658698|NCT02118896|2117950|P5|Overall Study|Consent withdrawn|1
658699|NCT02118896|2117951|P4|Overall Study|Consent withdrawn|4
658700|NCT02118896|2117952|P3|Overall Study|Consent withdrawn|3
658701|NCT02118896|2117953|P2|Overall Study|Consent withdrawn|0
658702|NCT02118896|2117954|P1|Overall Study|Consent withdrawn|2
658703|NCT02118896|2117945|P10|Overall Study|Adverse Event|0
658704|NCT02118896|2117946|P9|Overall Study|Adverse Event|4
658705|NCT02118896|2117947|P8|Overall Study|Adverse Event|1
658706|NCT02118896|2117948|P7|Overall Study|Adverse Event|1
658707|NCT02118896|2117949|P6|Overall Study|Adverse Event|9
658708|NCT02118896|2117950|P5|Overall Study|Adverse Event|5
658709|NCT02118896|2117951|P4|Overall Study|Adverse Event|5
658710|NCT02118896|2117952|P3|Overall Study|Adverse Event|4
658711|NCT02118896|2117953|P2|Overall Study|Adverse Event|4
658712|NCT02118896|2117954|P1|Overall Study|Adverse Event|5
658713|NCT02118896|2117945|P10|Overall Study|Death|0
658714|NCT02118896|2117946|P9|Overall Study|Death|0
658715|NCT02118896|2117947|P8|Overall Study|Death|0
658716|NCT02118896|2117948|P7|Overall Study|Death|0
658717|NCT02118896|2117949|P6|Overall Study|Death|1
658718|NCT02118896|2117950|P5|Overall Study|Death|3
658719|NCT02118896|2117951|P4|Overall Study|Death|6
658720|NCT02118896|2117952|P3|Overall Study|Death|4
658721|NCT02118896|2117953|P2|Overall Study|Death|0
658722|NCT02118896|2117954|P1|Overall Study|Death|4
658723|NCT02118792|2118044|P2|Overall Study|Randomised but not treated|0
658724|NCT02118792|2118045|P1|Overall Study|Randomised but not treated|1
658725|NCT02118792|2118044|P2|Overall Study|Unspecified|6
658726|NCT02118792|2118045|P1|Overall Study|Unspecified|1
658727|NCT02118792|2118044|P2|Overall Study|Withdrawal by parent/guardian|20
658728|NCT02118792|2118045|P1|Overall Study|Withdrawal by parent/guardian|14
658729|NCT02118792|2118044|P2|Overall Study|Adverse Event|4
658730|NCT02118792|2118045|P1|Overall Study|Adverse Event|5
658731|NCT02118792|2118044|P2|Overall Study|Lost to Follow-up|4
658732|NCT02118792|2118045|P1|Overall Study|Lost to Follow-up|4
658733|NCT02118792|2118044|P2|Overall Study|Withdrawal by Subject|3
658734|NCT02118792|2118045|P1|Overall Study|Withdrawal by Subject|6
658735|NCT02118766|2118087|P2|Overall Study|Unspecified|1
658736|NCT02118766|2118088|P1|Overall Study|Unspecified|3
658737|NCT02118766|2118087|P2|Overall Study|Withdrawal by parent/guardian|18
658738|NCT02118766|2118088|P1|Overall Study|Withdrawal by parent/guardian|12
658739|NCT02118766|2118087|P2|Overall Study|Lost to Follow-up|4
658740|NCT02118766|2118088|P1|Overall Study|Lost to Follow-up|5
658741|NCT02118766|2118087|P2|Overall Study|Withdrawal by Subject|6
658742|NCT02118766|2118088|P1|Overall Study|Withdrawal by Subject|3
658743|NCT02118766|2118087|P2|Overall Study|Adverse Event|2
658744|NCT02118766|2118088|P1|Overall Study|Adverse Event|7
658745|NCT02118597|2118110|P1|Overall Study|Investigator's decision|1
658746|NCT02118597|2118110|P1|Overall Study|Serious Adverse Event|1
658747|NCT02118597|2118110|P1|Overall Study|Sponsor terminated the study|14
658748|NCT02117687|2118141|P2|Overall Study|Other Reasons|1
658749|NCT02117687|2118142|P1|Overall Study|Other Reasons|1
658750|NCT02117687|2118141|P2|Overall Study|Adverse Event|2
658751|NCT02117687|2118142|P1|Overall Study|Adverse Event|0
658752|NCT02117687|2118141|P2|Overall Study|Lost to Follow-up|1
658753|NCT02117687|2118142|P1|Overall Study|Lost to Follow-up|0
658754|NCT02117570|2118177|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
658755|NCT02117570|2118178|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
658756|NCT02117570|2118179|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
658757|NCT02117570|2118177|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
658758|NCT02117570|2118178|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
658759|NCT02117570|2118179|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
658760|NCT02117570|2118177|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
658761|NCT02117570|2118178|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
658762|NCT02117570|2118179|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
658763|NCT02117570|2118177|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
658764|NCT02117570|2118178|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
658765|NCT02117570|2118179|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
658766|NCT02117570|2118177|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
658767|NCT02117570|2118178|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
658768|NCT02117570|2118179|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
658769|NCT02117570|2118177|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
658770|NCT02117570|2118178|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
658771|NCT02117570|2118179|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
658772|NCT02117570|2118177|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
658773|NCT02117570|2118178|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
658774|NCT02117570|2118179|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
658775|NCT02117544|2118229|P2|Period 1|Lost to follow-up (prior to treatment)|0
658776|NCT02117544|2118230|P1|Period 1|Lost to follow-up (prior to treatment)|2
658777|NCT02117479|2118245|P2|Overall Study|Other unspecified|7
658778|NCT02117479|2118246|P1|Overall Study|Other unspecified|11
658779|NCT02117479|2118245|P2|Overall Study|Physician Decision|2
658780|NCT02117479|2118246|P1|Overall Study|Physician Decision|7
658781|NCT02117479|2118245|P2|Overall Study|Study terminated by the sponsor|6
658782|NCT02117479|2118246|P1|Overall Study|Study terminated by the sponsor|4
658783|NCT02117479|2118245|P2|Overall Study|Noncompliance with study treatment|0
658784|NCT02117479|2118246|P1|Overall Study|Noncompliance with study treatment|1
658785|NCT02117479|2118245|P2|Overall Study|Disease progression|108
658786|NCT02117479|2118246|P1|Overall Study|Disease progression|104
658787|NCT02117479|2118245|P2|Overall Study|Subject decision|9
658788|NCT02117479|2118246|P1|Overall Study|Subject decision|8
658789|NCT02117479|2118245|P2|Overall Study|Adverse Event|16
658790|NCT02117479|2118246|P1|Overall Study|Adverse Event|8
658791|NCT02117479|2118245|P2|Overall Study|Death|8
658792|NCT02117479|2118246|P1|Overall Study|Death|13
658793|NCT02117414|2118264|P2|Overall Study|Withdrawal by Subject|4
658794|NCT02117414|2118265|P1|Overall Study|Withdrawal by Subject|10
658795|NCT02117414|2118264|P2|Overall Study|Death|2
658796|NCT02117414|2118265|P1|Overall Study|Death|5
658797|NCT02117050|2118309|P1|Overall Study|Subject Enrolled but not Dosed|1
658805|NCT02116530|2118331|P2|Overall Study|Other Medical Problems|2
658806|NCT02116530|2118332|P1|Overall Study|Other Medical Problems|2
658807|NCT02116530|2118331|P2|Overall Study|Lost to Follow-up|0
658808|NCT02116530|2118332|P1|Overall Study|Lost to Follow-up|1
658809|NCT02116530|2118331|P2|Overall Study|Physician Decision|0
658810|NCT02116530|2118332|P1|Overall Study|Physician Decision|1
658811|NCT02116530|2118331|P2|Overall Study|Adverse Event|0
658812|NCT02116530|2118332|P1|Overall Study|Adverse Event|4
658813|NCT02116530|2118331|P2|Overall Study|Withdrawal by Subject|2
658814|NCT02116530|2118332|P1|Overall Study|Withdrawal by Subject|1
658815|NCT02115815|2118367|P7|Overall Study|Missed appointment, randomized in error|0
658816|NCT02115815|2118368|P6|Overall Study|Missed appointment, randomized in error|1
658817|NCT02115815|2118369|P5|Overall Study|Missed appointment, randomized in error|0
658818|NCT02115815|2118370|P4|Overall Study|Missed appointment, randomized in error|0
658819|NCT02115815|2118371|P3|Overall Study|Missed appointment, randomized in error|0
658820|NCT02115815|2118372|P2|Overall Study|Missed appointment, randomized in error|0
658821|NCT02115815|2118373|P1|Overall Study|Missed appointment, randomized in error|0
658822|NCT02115815|2118367|P7|Overall Study|Not enough drug to dose participant|0
658823|NCT02115815|2118368|P6|Overall Study|Not enough drug to dose participant|1
658824|NCT02115815|2118369|P5|Overall Study|Not enough drug to dose participant|0
658825|NCT02115815|2118370|P4|Overall Study|Not enough drug to dose participant|0
658826|NCT02115815|2118371|P3|Overall Study|Not enough drug to dose participant|0
658827|NCT02115815|2118372|P2|Overall Study|Not enough drug to dose participant|0
658828|NCT02115815|2118373|P1|Overall Study|Not enough drug to dose participant|0
658829|NCT02115815|2118367|P7|Overall Study|Withdrawal by Subject|0
658830|NCT02115815|2118368|P6|Overall Study|Withdrawal by Subject|0
658831|NCT02115815|2118369|P5|Overall Study|Withdrawal by Subject|0
658832|NCT02115815|2118370|P4|Overall Study|Withdrawal by Subject|0
658833|NCT02115815|2118371|P3|Overall Study|Withdrawal by Subject|0
658834|NCT02115815|2118372|P2|Overall Study|Withdrawal by Subject|0
658835|NCT02115815|2118373|P1|Overall Study|Withdrawal by Subject|2
658836|NCT02115321|2118481|P2|Overall Study|Death|0
658837|NCT02115321|2118482|P1|Overall Study|Death|1
658838|NCT02115269|2118502|P1|Overall Study|Didn't take study drug|2
658839|NCT02115269|2118502|P1|Overall Study|Withdrawal by Subject|2
658840|NCT02115269|2118502|P1|Overall Study|Moved to another city|7
658841|NCT02115269|2118502|P1|Overall Study|Did not complete patient diary|3
658842|NCT02115269|2118502|P1|Overall Study|Lost to Follow-up|43
658843|NCT02115256|2118522|P2|Overall Study|Withdrawal by Subject|1
658844|NCT02115256|2118523|P1|Overall Study|Withdrawal by Subject|0
658845|NCT02114931|2118537|P2|Overall Study|Other|1
658846|NCT02114931|2118538|P1|Overall Study|Other|2
658847|NCT02114931|2118537|P2|Overall Study|Physician Decision|2
658848|NCT02114931|2118538|P1|Overall Study|Physician Decision|1
658849|NCT02114931|2118537|P2|Overall Study|Lost to Follow-up|3
658850|NCT02114931|2118538|P1|Overall Study|Lost to Follow-up|3
658851|NCT02114931|2118537|P2|Overall Study|Adverse Event|6
658852|NCT02114931|2118538|P1|Overall Study|Adverse Event|4
658853|NCT02114931|2118537|P2|Overall Study|Withdrawal by Subject|18
658854|NCT02114931|2118538|P1|Overall Study|Withdrawal by Subject|15
658855|NCT02114892|2118554|P2|Overall Study|Lost to Follow-up|2
658856|NCT02114892|2118555|P1|Overall Study|Lost to Follow-up|1
658857|NCT02114268|2118595|P6|Overall Study|Withdrawn by site due to noncompliance|0
658858|NCT02114268|2118596|P5|Overall Study|Withdrawn by site due to noncompliance|0
658859|NCT02114268|2118597|P4|Overall Study|Withdrawn by site due to noncompliance|0
658860|NCT02114268|2118598|P3|Overall Study|Withdrawn by site due to noncompliance|0
658861|NCT02114268|2118599|P2|Overall Study|Withdrawn by site due to noncompliance|0
658862|NCT02114268|2118600|P1|Overall Study|Withdrawn by site due to noncompliance|1
658863|NCT02114268|2118595|P6|Overall Study|Withdrawal by Subject|1
658864|NCT02114268|2118596|P5|Overall Study|Withdrawal by Subject|0
658865|NCT02114268|2118597|P4|Overall Study|Withdrawal by Subject|0
658866|NCT02114268|2118598|P3|Overall Study|Withdrawal by Subject|0
658867|NCT02114268|2118599|P2|Overall Study|Withdrawal by Subject|0
658868|NCT02114268|2118600|P1|Overall Study|Withdrawal by Subject|1
658869|NCT02114268|2118595|P6|Overall Study|Lost to Follow-up|2
658870|NCT02114268|2118596|P5|Overall Study|Lost to Follow-up|0
658871|NCT02114268|2118597|P4|Overall Study|Lost to Follow-up|0
658872|NCT02114268|2118598|P3|Overall Study|Lost to Follow-up|1
658873|NCT02114268|2118599|P2|Overall Study|Lost to Follow-up|1
658874|NCT02114268|2118600|P1|Overall Study|Lost to Follow-up|4
658875|NCT02114177|2118668|P2|Overall Study|Unspecified|1
658876|NCT02114177|2118669|P1|Overall Study|Unspecified|2
658877|NCT02114177|2118668|P2|Overall Study|Withdrawal by Subject|1
658878|NCT02114177|2118669|P1|Overall Study|Withdrawal by Subject|6
658879|NCT02114177|2118668|P2|Overall Study|Lost to Follow-up|2
658880|NCT02114177|2118669|P1|Overall Study|Lost to Follow-up|1
658881|NCT02114151|2118693|P1|Overall Study|Withdrawal by Subject|5
658882|NCT02114151|2118693|P1|Overall Study|Lost to Follow-up|1
658883|NCT02114151|2118693|P1|Overall Study|Death|1
658884|NCT02113579|2118710|P2|Overall Study|Lost to Follow-up|2
658885|NCT02113579|2118711|P1|Overall Study|Lost to Follow-up|6
658886|NCT02113579|2118710|P2|Overall Study|Withdrawal by Subject|2
658887|NCT02113579|2118711|P1|Overall Study|Withdrawal by Subject|3
658888|NCT02113579|2118710|P2|Overall Study|Adverse Event|0
658889|NCT02113579|2118711|P1|Overall Study|Adverse Event|1
658890|NCT02113449|2118735|P1|Overall Study|Adverse Event|4
658891|NCT02113436|2118751|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
658892|NCT02113436|2118752|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
658893|NCT02113436|2118753|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
658894|NCT02113436|2118754|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
658895|NCT02113436|2118751|P4|Period 2: 16 Weeks|Physician Decision|0
658896|NCT02113436|2118752|P3|Period 2: 16 Weeks|Physician Decision|2
658897|NCT02113436|2118753|P2|Period 2: 16 Weeks|Physician Decision|0
658898|NCT02113436|2118754|P1|Period 2: 16 Weeks|Physician Decision|0
658899|NCT02113436|2118751|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
658900|NCT02113436|2118752|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
658901|NCT02113436|2118753|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
658902|NCT02113436|2118754|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
658903|NCT02113436|2118751|P4|Period 2: 16 Weeks|Adverse Event|5
658904|NCT02113436|2118752|P3|Period 2: 16 Weeks|Adverse Event|4
658905|NCT02113436|2118753|P2|Period 2: 16 Weeks|Adverse Event|0
658906|NCT02113436|2118754|P1|Period 2: 16 Weeks|Adverse Event|0
658907|NCT02113436|2118751|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
658908|NCT02113436|2118752|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
658909|NCT02113436|2118753|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
658910|NCT02113436|2118754|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
658911|NCT02113436|2118751|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
658912|NCT02113436|2118752|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
658913|NCT02113436|2118753|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
658914|NCT02113436|2118754|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
658915|NCT02113436|2118751|P4|Period 1: 8 Weeks|Protocol Violation|0
658916|NCT02113436|2118752|P3|Period 1: 8 Weeks|Protocol Violation|0
658917|NCT02113436|2118753|P2|Period 1: 8 Weeks|Protocol Violation|0
658918|NCT02113436|2118754|P1|Period 1: 8 Weeks|Protocol Violation|1
658919|NCT02113436|2118751|P4|Period 1: 8 Weeks|Adverse Event|0
658920|NCT02113436|2118752|P3|Period 1: 8 Weeks|Adverse Event|0
658921|NCT02113436|2118753|P2|Period 1: 8 Weeks|Adverse Event|0
658922|NCT02113436|2118754|P1|Period 1: 8 Weeks|Adverse Event|1
658923|NCT02113124|2118777|P2|Overall Study|Unable to retrieve blood sample|1
658924|NCT02113124|2118778|P1|Overall Study|Unable to retrieve blood sample|1
658925|NCT02113007|2118784|P1|Overall Study|Progressive disease|2
658926|NCT02112448|2118792|P2|Overall Study|required heparin so could not use ketoro|0
658927|NCT02112448|2118793|P1|Overall Study|required heparin so could not use ketoro|1
658928|NCT02112448|2118792|P2|Overall Study|Physician Decision|6
658929|NCT02112448|2118793|P1|Overall Study|Physician Decision|4
658930|NCT02112448|2118792|P2|Overall Study|Protocol Violation|2
658931|NCT02112448|2118793|P1|Overall Study|Protocol Violation|1
658932|NCT02112448|2118792|P2|Overall Study|lab values precluding use of ketorolac|2
658933|NCT02112448|2118793|P1|Overall Study|lab values precluding use of ketorolac|2
658934|NCT02111603|2118830|P1|Overall Study|Withdrawal by Subject|1
658935|NCT02111369|2118839|P1|Overall Study|Withdrawal by Subject|1
658936|NCT02111369|2118839|P1|Overall Study|Lost to Follow-up|2
658937|NCT02111083|2118863|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
658938|NCT02111083|2118864|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
658939|NCT02110238|2118898|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
658940|NCT02110238|2118899|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
658941|NCT02110238|2118898|P2|14 Week Blinded Extension Phase|Protocol Violation|3
658942|NCT02110238|2118899|P1|14 Week Blinded Extension Phase|Protocol Violation|2
658943|NCT02110238|2118898|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
658944|NCT02110238|2118899|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
658945|NCT02110238|2118898|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
658946|NCT02110238|2118899|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
658947|NCT02110238|2118898|P2|14 Week Blinded Extension Phase|Adverse Event|1
658948|NCT02110238|2118899|P1|14 Week Blinded Extension Phase|Adverse Event|1
658949|NCT02110238|2118898|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
658950|NCT02110238|2118899|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
658951|NCT02110238|2118898|P2|12 Week Pivotal Phase|Protocol Violation|1
658952|NCT02110238|2118899|P1|12 Week Pivotal Phase|Protocol Violation|0
658953|NCT02110238|2118898|P2|12 Week Pivotal Phase|Physician Decision|2
658954|NCT02110238|2118899|P1|12 Week Pivotal Phase|Physician Decision|0
658955|NCT02110238|2118898|P2|12 Week Pivotal Phase|Lost to Follow-up|0
658956|NCT02110238|2118899|P1|12 Week Pivotal Phase|Lost to Follow-up|2
658957|NCT02110238|2118898|P2|12 Week Pivotal Phase|Lack of Efficacy|3
658958|NCT02110238|2118899|P1|12 Week Pivotal Phase|Lack of Efficacy|2
658959|NCT02110238|2118898|P2|12 Week Pivotal Phase|Adverse Event|0
658960|NCT02110238|2118899|P1|12 Week Pivotal Phase|Adverse Event|3
658961|NCT02109445|2118940|P1|Overall Study|Adverse Event|1
658962|NCT02109445|2118940|P1|Overall Study|Symptomatic deterioration|2
658963|NCT02109172|2118973|P6|Overall Study|Death|0
658964|NCT02109172|2118974|P5|Overall Study|Death|1
658965|NCT02109172|2118975|P4|Overall Study|Death|0
658966|NCT02109172|2118976|P3|Overall Study|Death|0
658967|NCT02109172|2118977|P2|Overall Study|Death|0
658968|NCT02109172|2118978|P1|Overall Study|Death|0
658969|NCT02109172|2118973|P6|Overall Study|Adverse Event|1
658970|NCT02109172|2118974|P5|Overall Study|Adverse Event|0
658971|NCT02109172|2118975|P4|Overall Study|Adverse Event|0
658972|NCT02109172|2118976|P3|Overall Study|Adverse Event|1
658973|NCT02109172|2118977|P2|Overall Study|Adverse Event|0
658974|NCT02109172|2118978|P1|Overall Study|Adverse Event|0
658975|NCT02109172|2118973|P6|Overall Study|Withdrawal by Subject|0
658976|NCT02109172|2118974|P5|Overall Study|Withdrawal by Subject|0
658977|NCT02109172|2118975|P4|Overall Study|Withdrawal by Subject|1
658978|NCT02109172|2118976|P3|Overall Study|Withdrawal by Subject|0
658979|NCT02109172|2118977|P2|Overall Study|Withdrawal by Subject|0
658980|NCT02109172|2118978|P1|Overall Study|Withdrawal by Subject|1
658981|NCT02109133|2118999|P2|Overall Study|Lost to Follow-up|0
658982|NCT02109133|2119000|P1|Overall Study|Lost to Follow-up|1
658983|NCT02109107|2119012|P1|Overall Study|Lost to Follow-up|2
658984|NCT02108652|2119055|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
658985|NCT02108652|2119055|P1|Overall Study|Withdrawal by Subject|8
658986|NCT02108652|2119055|P1|Overall Study|Lost to Follow-up|2
658987|NCT02108652|2119055|P1|Overall Study|Death|226
658988|NCT02107898|2119224|P2|Overall Study|Randomized but not treated|1
658989|NCT02107898|2119225|P1|Overall Study|Randomized but not treated|0
658990|NCT02107898|2119224|P2|Overall Study|Consent withdrawn by participant|1
658991|NCT02107898|2119225|P1|Overall Study|Consent withdrawn by participant|2
658992|NCT02107898|2119224|P2|Overall Study|Participant moved|2
658993|NCT02107898|2119225|P1|Overall Study|Participant moved|0
658994|NCT02107898|2119224|P2|Overall Study|Poor compliance to protocol|1
658995|NCT02107898|2119225|P1|Overall Study|Poor compliance to protocol|0
658996|NCT02107898|2119224|P2|Overall Study|Adverse Event|7
658997|NCT02107898|2119225|P1|Overall Study|Adverse Event|4
658998|NCT02107482|2119284|P1|Overall Study|Lack of Efficacy|1
658999|NCT02107482|2119284|P1|Overall Study|Lost to Follow-up|1
659000|NCT02107482|2119284|P1|Overall Study|inconveinence|2
659001|NCT02107313|2119321|P2|Overall Study|One participant did not do the FED cohor|1
659002|NCT02107313|2119322|P1|Overall Study|One participant did not do the FED cohor|0
659003|NCT02107274|2119332|P2|Control Phase|Adverse Event|1
659004|NCT02107274|2119333|P1|Control Phase|Adverse Event|0
659005|NCT02107274|2119332|P2|Control Phase|Death|0
659006|NCT02107274|2119333|P1|Control Phase|Death|2
659007|NCT02107274|2119332|P2|Control Phase|Lost to Follow-up|1
659008|NCT02107274|2119333|P1|Control Phase|Lost to Follow-up|1
659009|NCT02107274|2119332|P2|Treatment vs. Placebo|Lost to Follow-up|2
659010|NCT02107274|2119333|P1|Treatment vs. Placebo|Lost to Follow-up|0
659011|NCT02107274|2119332|P2|Treatment vs. Placebo|Adverse Event|0
659012|NCT02107274|2119333|P1|Treatment vs. Placebo|Adverse Event|3
659013|NCT02107196|2119347|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
659014|NCT02107196|2119348|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
659015|NCT02107196|2119347|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
659016|NCT02107196|2119348|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
659017|NCT02107196|2119347|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
659018|NCT02107196|2119348|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
659019|NCT02107196|2119347|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
659020|NCT02107196|2119348|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
659021|NCT02107196|2119347|P2|12-week Treatment Period|Reason Missing|8
659022|NCT02107196|2119348|P1|12-week Treatment Period|Reason Missing|11
659023|NCT02107196|2119347|P2|12-week Treatment Period|Protocol Violation|8
659024|NCT02107196|2119348|P1|12-week Treatment Period|Protocol Violation|7
659025|NCT02107196|2119347|P2|12-week Treatment Period|Withdrawal by Subject|12
659026|NCT02107196|2119348|P1|12-week Treatment Period|Withdrawal by Subject|15
659027|NCT02107196|2119347|P2|12-week Treatment Period|Physician Decision|1
659028|NCT02107196|2119348|P1|12-week Treatment Period|Physician Decision|0
659029|NCT02107196|2119347|P2|12-week Treatment Period|Lost to Follow-up|6
659030|NCT02107196|2119348|P1|12-week Treatment Period|Lost to Follow-up|3
659031|NCT02107196|2119347|P2|12-week Treatment Period|Lack of Efficacy|1
659032|NCT02107196|2119348|P1|12-week Treatment Period|Lack of Efficacy|2
659033|NCT02107196|2119347|P2|12-week Treatment Period|Adverse Event|3
659034|NCT02107196|2119348|P1|12-week Treatment Period|Adverse Event|6
659035|NCT02107014|2119361|P1|Overall Study|Withdrew before drug: moving interstate|1
659036|NCT02106923|2119443|P6|Overall Study|Protocol Violation|1
659037|NCT02106923|2119444|P5|Overall Study|Protocol Violation|0
659038|NCT02106923|2119445|P4|Overall Study|Protocol Violation|0
659039|NCT02106923|2119446|P3|Overall Study|Protocol Violation|0
659040|NCT02106923|2119447|P2|Overall Study|Protocol Violation|0
659041|NCT02106923|2119448|P1|Overall Study|Protocol Violation|0
659042|NCT02106832|2119496|P4|Overall Study|Technical problems|0
659043|NCT02106832|2119497|P3|Overall Study|Technical problems|0
659044|NCT02106832|2119498|P2|Overall Study|Technical problems|1
659045|NCT02106832|2119499|P1|Overall Study|Technical problems|0
659046|NCT02106832|2119496|P4|Overall Study|Withdrawal by Subject|7
659047|NCT02106832|2119497|P3|Overall Study|Withdrawal by Subject|10
659048|NCT02106832|2119498|P2|Overall Study|Withdrawal by Subject|17
659049|NCT02106832|2119499|P1|Overall Study|Withdrawal by Subject|17
659050|NCT02106832|2119496|P4|Overall Study|Protocol Violation|1
659051|NCT02106832|2119497|P3|Overall Study|Protocol Violation|0
659052|NCT02106832|2119498|P2|Overall Study|Protocol Violation|0
659053|NCT02106832|2119499|P1|Overall Study|Protocol Violation|0
659054|NCT02106832|2119496|P4|Overall Study|Physician Decision|0
659055|NCT02106832|2119497|P3|Overall Study|Physician Decision|0
659056|NCT02106832|2119498|P2|Overall Study|Physician Decision|0
659057|NCT02106832|2119499|P1|Overall Study|Physician Decision|1
659058|NCT02106832|2119496|P4|Overall Study|Lost to Follow-up|3
659059|NCT02106832|2119497|P3|Overall Study|Lost to Follow-up|1
659060|NCT02106832|2119498|P2|Overall Study|Lost to Follow-up|1
659061|NCT02106832|2119499|P1|Overall Study|Lost to Follow-up|0
659062|NCT02106832|2119496|P4|Overall Study|Deterioration of general conditions|0
659063|NCT02106832|2119497|P3|Overall Study|Deterioration of general conditions|1
659064|NCT02106832|2119498|P2|Overall Study|Deterioration of general conditions|0
659065|NCT02106832|2119499|P1|Overall Study|Deterioration of general conditions|0
659066|NCT02106832|2119496|P4|Overall Study|Death|4
659067|NCT02106832|2119497|P3|Overall Study|Death|1
659068|NCT02106832|2119498|P2|Overall Study|Death|4
659069|NCT02106832|2119499|P1|Overall Study|Death|4
659070|NCT02106832|2119496|P4|Overall Study|Adverse Event|0
659071|NCT02106832|2119497|P3|Overall Study|Adverse Event|3
659072|NCT02106832|2119498|P2|Overall Study|Adverse Event|2
659073|NCT02106832|2119499|P1|Overall Study|Adverse Event|1
659074|NCT02106403|2119566|P6|Follow-Up Visit 3|Other Reason|1
659075|NCT02106403|2119567|P5|Follow-Up Visit 3|Other Reason|0
659076|NCT02106403|2119568|P4|Follow-Up Visit 3|Other Reason|0
659077|NCT02106403|2119569|P3|Follow-Up Visit 3|Other Reason|0
659078|NCT02106403|2119570|P2|Follow-Up Visit 3|Other Reason|0
659079|NCT02106403|2119571|P1|Follow-Up Visit 3|Other Reason|0
659080|NCT02106156|2119594|P3|Overall Study|Relocation/Change of Physician|0
659081|NCT02106156|2119595|P2|Overall Study|Relocation/Change of Physician|1
659082|NCT02106156|2119596|P1|Overall Study|Relocation/Change of Physician|40
659083|NCT02106156|2119594|P3|Overall Study|Hospitalization/Surgical Intervention|0
659084|NCT02106156|2119595|P2|Overall Study|Hospitalization/Surgical Intervention|0
659085|NCT02106156|2119596|P1|Overall Study|Hospitalization/Surgical Intervention|6
659086|NCT02106156|2119594|P3|Overall Study|Change of Laboratory Parameter|0
659087|NCT02106156|2119595|P2|Overall Study|Change of Laboratory Parameter|0
659088|NCT02106156|2119596|P1|Overall Study|Change of Laboratory Parameter|10
659089|NCT02106156|2119594|P3|Overall Study|Unplanned Event|0
659090|NCT02106156|2119595|P2|Overall Study|Unplanned Event|2
659091|NCT02106156|2119596|P1|Overall Study|Unplanned Event|82
659092|NCT02106156|2119594|P3|Overall Study|Lost to Follow-up|0
659093|NCT02106156|2119595|P2|Overall Study|Lost to Follow-up|8
659094|NCT02106156|2119596|P1|Overall Study|Lost to Follow-up|451
659095|NCT02106156|2119594|P3|Overall Study|Patients Request|0
659096|NCT02106156|2119595|P2|Overall Study|Patients Request|9
659097|NCT02106156|2119596|P1|Overall Study|Patients Request|307
659098|NCT02106156|2119594|P3|Overall Study|Lack of Compliance|0
659099|NCT02106156|2119595|P2|Overall Study|Lack of Compliance|7
659100|NCT02106156|2119596|P1|Overall Study|Lack of Compliance|211
659101|NCT02106156|2119594|P3|Overall Study|Concomitant Disease|0
659102|NCT02106156|2119595|P2|Overall Study|Concomitant Disease|2
659103|NCT02106156|2119596|P1|Overall Study|Concomitant Disease|74
659104|NCT02106156|2119594|P3|Overall Study|Lack of Virological Response|0
659105|NCT02106156|2119595|P2|Overall Study|Lack of Virological Response|8
659106|NCT02106156|2119596|P1|Overall Study|Lack of Virological Response|1044
659107|NCT02106156|2119594|P3|Overall Study|Lack of Tolerability|0
659108|NCT02106156|2119595|P2|Overall Study|Lack of Tolerability|3
659109|NCT02106156|2119596|P1|Overall Study|Lack of Tolerability|305
659110|NCT02106156|2119594|P3|Overall Study|Patient Died|0
659111|NCT02106156|2119595|P2|Overall Study|Patient Died|0
659112|NCT02106156|2119596|P1|Overall Study|Patient Died|19
659113|NCT02105987|2119620|P6|Continuation Phase|Protocol Violation|0
659114|NCT02105987|2119621|P5|Continuation Phase|Protocol Violation|1
659115|NCT02105987|2119622|P4|Continuation Phase|Protocol Violation|0
659116|NCT02105987|2119623|P3|Continuation Phase|Protocol Violation|0
659117|NCT02105987|2119624|P2|Continuation Phase|Protocol Violation|0
659118|NCT02105987|2119625|P1|Continuation Phase|Protocol Violation|0
659119|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
659120|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
659121|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
659122|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
659123|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
659124|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
659125|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
659126|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
659127|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
659128|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
659129|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
659130|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
659131|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
659132|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
659133|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
659134|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
659135|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
659136|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
659137|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
659138|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
659139|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
659140|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
659141|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
659142|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
659143|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
659144|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
659145|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
659146|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
659147|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
659148|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
659149|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
659150|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
659151|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
659152|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
659153|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
659154|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
659155|NCT02105987|2119620|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
659156|NCT02105987|2119621|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
659157|NCT02105987|2119622|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
659158|NCT02105987|2119623|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
659159|NCT02105987|2119624|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
659160|NCT02105987|2119625|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
659161|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
659162|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
659163|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
659164|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
659165|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
659166|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
659167|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
659168|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
659169|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
659170|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
659171|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
659172|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
659173|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
659174|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
659175|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
659176|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
659177|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
659178|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
659179|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
659180|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
659181|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
659182|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
659183|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
659184|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
659185|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
659186|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
659187|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
659188|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
659189|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
659190|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
659191|NCT02105987|2119620|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
659192|NCT02105987|2119621|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
659193|NCT02105987|2119622|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
659194|NCT02105987|2119623|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
659195|NCT02105987|2119624|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
659196|NCT02105987|2119625|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
659239|NCT02105701|2119706|P4|Overall Study|Death|0
659240|NCT02105701|2119707|P3|Overall Study|Death|0
659241|NCT02105701|2119708|P2|Overall Study|Death|0
659242|NCT02105701|2119709|P1|Overall Study|Death|1
659243|NCT02105701|2119706|P4|Overall Study|Withdrawal by Subject|1
659244|NCT02105701|2119707|P3|Overall Study|Withdrawal by Subject|0
659245|NCT02105701|2119708|P2|Overall Study|Withdrawal by Subject|1
659246|NCT02105701|2119709|P1|Overall Study|Withdrawal by Subject|2
659247|NCT02105701|2119706|P4|Overall Study|Protocol Violation|0
659248|NCT02105701|2119707|P3|Overall Study|Protocol Violation|1
659249|NCT02105701|2119708|P2|Overall Study|Protocol Violation|0
659250|NCT02105701|2119709|P1|Overall Study|Protocol Violation|0
659251|NCT02105701|2119706|P4|Overall Study|Lost to Follow-up|1
659252|NCT02105701|2119707|P3|Overall Study|Lost to Follow-up|2
659253|NCT02105701|2119708|P2|Overall Study|Lost to Follow-up|0
659254|NCT02105701|2119709|P1|Overall Study|Lost to Follow-up|1
888288|NCT02157935|2821796|P1|Overall Study|Withdrawal by Subject|25
888299|NCT02143141|2821836|P2|Overall Study|pain scores at 24 hours not collected|0
659267|NCT02105662|2119744|P1|Overall Study|Withdrawal by Subject|1
659268|NCT02105662|2119744|P1|Overall Study|Lost to Follow-up|5
888300|NCT02143141|2821837|P1|Overall Study|pain scores at 24 hours not collected|1
888301|NCT02105636|2821931|P2|Overall Study|Not Reported|0
888302|NCT02105636|2821932|P1|Overall Study|Not Reported|3
888303|NCT02105636|2821931|P2|Overall Study|Reason Not Specified|2
888304|NCT02105636|2821932|P1|Overall Study|Reason Not Specified|0
888305|NCT02105636|2821931|P2|Overall Study|Poor/Non-compliance|1
888306|NCT02105636|2821932|P1|Overall Study|Poor/Non-compliance|0
888307|NCT02105636|2821931|P2|Overall Study|Maximum Clinical Benefit|1
888308|NCT02105636|2821932|P1|Overall Study|Maximum Clinical Benefit|1
888309|NCT02105636|2821931|P2|Overall Study|Subject Withdrew Consent|1
888310|NCT02105636|2821932|P1|Overall Study|Subject Withdrew Consent|4
888311|NCT02105636|2821931|P2|Overall Study|Subject Request to Discontinue Treatment|6
888312|NCT02105636|2821932|P1|Overall Study|Subject Request to Discontinue Treatment|4
888313|NCT02105636|2821931|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
888314|NCT02105636|2821932|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
888315|NCT02105636|2821931|P2|Overall Study|Study Drug Toxicity|11
888316|NCT02105636|2821932|P1|Overall Study|Study Drug Toxicity|9
888317|NCT02105636|2821931|P2|Overall Study|Disease Progression|83
659287|NCT02105467|2119766|P2|Period 3|Lost to Follow-up|1
659288|NCT02105467|2119767|P1|Period 3|Lost to Follow-up|0
659289|NCT02105467|2119766|P2|Period 2|Withdrawal by Subject|2
659290|NCT02105467|2119767|P1|Period 2|Withdrawal by Subject|0
659291|NCT02105467|2119766|P2|Period 2|Death|0
659292|NCT02105467|2119767|P1|Period 2|Death|1
659293|NCT02105467|2119766|P2|Period 2|Lost to Follow-up|0
659294|NCT02105467|2119767|P1|Period 2|Lost to Follow-up|1
659295|NCT02105467|2119766|P2|Period 1|Death|0
659296|NCT02105467|2119767|P1|Period 1|Death|1
659297|NCT02105467|2119766|P2|Period 1|Lost to Follow-up|0
659298|NCT02105467|2119767|P1|Period 1|Lost to Follow-up|1
659299|NCT02105454|2119779|P1|Overall Study|Withdrawal by Subject|1
659300|NCT02105285|2119789|P3|Overall Study|Withdrawal by Subject|0
659301|NCT02105285|2119790|P2|Overall Study|Withdrawal by Subject|0
659302|NCT02105285|2119791|P1|Overall Study|Withdrawal by Subject|1
659303|NCT02105285|2119789|P3|Overall Study|Protocol Violation|0
659304|NCT02105285|2119790|P2|Overall Study|Protocol Violation|1
659305|NCT02105285|2119791|P1|Overall Study|Protocol Violation|0
659306|NCT02105285|2119789|P3|Overall Study|Adverse Event|0
659307|NCT02105285|2119790|P2|Overall Study|Adverse Event|1
659308|NCT02105285|2119791|P1|Overall Study|Adverse Event|1
659309|NCT02105272|2119810|P2|Overall Study|Withdrawal by Subject|0
659310|NCT02105272|2119811|P1|Overall Study|Withdrawal by Subject|2
659311|NCT02105272|2119810|P2|Overall Study|Protocol Violation|0
659312|NCT02105272|2119811|P1|Overall Study|Protocol Violation|2
659313|NCT02105272|2119810|P2|Overall Study|Physician Decision|1
659314|NCT02105272|2119811|P1|Overall Study|Physician Decision|0
659315|NCT02105272|2119810|P2|Overall Study|Adverse Event|2
659316|NCT02105272|2119811|P1|Overall Study|Adverse Event|1
659317|NCT02105012|2119827|P1|Overall Study|Lack of Efficacy|1
659318|NCT02105012|2119827|P1|Overall Study|Adverse Event|1
659319|NCT02105012|2119827|P1|Overall Study|Physician Decision|3
659320|NCT02105012|2119827|P1|Overall Study|Protocol Violation|4
659321|NCT02105012|2119827|P1|Overall Study|Lost to Follow-up|4
659322|NCT02105012|2119827|P1|Overall Study|Protocol Specified Criteria|9
659323|NCT02105012|2119827|P1|Overall Study|Withdrawal by Subject|11
659324|NCT02104947|2119861|P2|Overall Study|Other than stated above|3
659325|NCT02104947|2119862|P1|Overall Study|Other than stated above|2
659326|NCT02104947|2119861|P2|Overall Study|Adverse Event|38
659327|NCT02104947|2119862|P1|Overall Study|Adverse Event|57
659328|NCT02104947|2119861|P2|Overall Study|Protocol Violation|8
659329|NCT02104947|2119862|P1|Overall Study|Protocol Violation|6
659330|NCT02104947|2119861|P2|Overall Study|Lost to Follow-up|4
659331|NCT02104947|2119862|P1|Overall Study|Lost to Follow-up|4
659332|NCT02104947|2119861|P2|Overall Study|Withdrawal by Subject|3
659333|NCT02104947|2119862|P1|Overall Study|Withdrawal by Subject|10
659334|NCT02104895|2119880|P2|Overall Study|Withdrawal by Subject|14
659335|NCT02104895|2119881|P1|Overall Study|Withdrawal by Subject|0
659336|NCT02104804|2119921|P2|Overall Study|Withdrawal by Subject|12
659337|NCT02104804|2119922|P1|Overall Study|Withdrawal by Subject|4
659338|NCT02104804|2119921|P2|Overall Study|Adverse Event|3
659339|NCT02104804|2119922|P1|Overall Study|Adverse Event|4
659340|NCT02104804|2119921|P2|Overall Study|Protocol Violation|1
659341|NCT02104804|2119922|P1|Overall Study|Protocol Violation|0
659342|NCT02104804|2119921|P2|Overall Study|Other listed|1
659343|NCT02104804|2119922|P1|Overall Study|Other listed|2
659344|NCT02104804|2119921|P2|Overall Study|Study specific discontinuation criteria|1
659345|NCT02104804|2119922|P1|Overall Study|Study specific discontinuation criteria|6
659346|NCT02104804|2119921|P2|Overall Study|Did not take study medication|1
659347|NCT02104804|2119922|P1|Overall Study|Did not take study medication|0
659348|NCT02103439|2119955|P2|Overall Study|Withdrawal by Subject|1
659349|NCT02103439|2119956|P1|Overall Study|Withdrawal by Subject|3
659350|NCT02103439|2119955|P2|Overall Study|Adverse Event|2
659351|NCT02103439|2119956|P1|Overall Study|Adverse Event|0
659352|NCT02103062|2120048|P2|Overall Study|Death|1
659353|NCT02103062|2120049|P1|Overall Study|Death|0
659354|NCT02103062|2120048|P2|Overall Study|Progressive Disease|20
659355|NCT02103062|2120049|P1|Overall Study|Progressive Disease|17
659356|NCT02103062|2120048|P2|Overall Study|Adverse Event|2
659357|NCT02103062|2120049|P1|Overall Study|Adverse Event|1
888318|NCT02105636|2821932|P1|Overall Study|Disease Progression|162
659361|NCT02102399|2120157|P2|Overall Study|Withdrawal by Subject|4
659362|NCT02102399|2120158|P1|Overall Study|Withdrawal by Subject|6
659363|NCT02101359|2120208|P2|Overall Study|Protocol Violation|2
659364|NCT02101359|2120209|P1|Overall Study|Protocol Violation|0
659365|NCT02101359|2120208|P2|Overall Study|Lost to Follow-up|0
659366|NCT02101359|2120209|P1|Overall Study|Lost to Follow-up|1
659367|NCT02101359|2120208|P2|Overall Study|Withdrawal by Subject|4
659368|NCT02101359|2120209|P1|Overall Study|Withdrawal by Subject|5
659369|NCT02101359|2120208|P2|Overall Study|Not included|13
659370|NCT02101359|2120209|P1|Overall Study|Not included|23
659371|NCT02101294|2120215|P1|Overall Study|Lost to Follow-up|6
659372|NCT02101294|2120215|P1|Overall Study|Withdrawal by Subject|5
659373|NCT02101112|2120235|P6|Overall Study|Withdrawal by Subject|0
659374|NCT02101112|2120236|P5|Overall Study|Withdrawal by Subject|1
659375|NCT02101112|2120237|P4|Overall Study|Withdrawal by Subject|0
659376|NCT02101112|2120238|P3|Overall Study|Withdrawal by Subject|0
659377|NCT02101112|2120239|P2|Overall Study|Withdrawal by Subject|0
659378|NCT02101112|2120240|P1|Overall Study|Withdrawal by Subject|0
659379|NCT02101112|2120235|P6|Overall Study|Adverse Event|0
659380|NCT02101112|2120236|P5|Overall Study|Adverse Event|0
659381|NCT02101112|2120237|P4|Overall Study|Adverse Event|0
659382|NCT02101112|2120238|P3|Overall Study|Adverse Event|1
659383|NCT02101112|2120239|P2|Overall Study|Adverse Event|0
659384|NCT02101112|2120240|P1|Overall Study|Adverse Event|0
659385|NCT02100839|2120272|P2|Multiple Ascending Dose|Withdrawal by Subject|0
659386|NCT02100839|2120273|P1|Multiple Ascending Dose|Withdrawal by Subject|2
659387|NCT02100839|2120272|P2|Multiple Ascending Dose|Adverse Event|0
659388|NCT02100839|2120273|P1|Multiple Ascending Dose|Adverse Event|2
659412|NCT02100475|2120384|P2|Overall Study|Withdrawal criteria|0
659413|NCT02100475|2120385|P1|Overall Study|Withdrawal criteria|1
659414|NCT02100475|2120384|P2|Overall Study|Unclassified|2
659415|NCT02100475|2120385|P1|Overall Study|Unclassified|1
659416|NCT02099838|2120436|P2|Overall Study|Withdrawal by Subject|1
659417|NCT02099838|2120437|P1|Overall Study|Withdrawal by Subject|0
659418|NCT02099838|2120436|P2|Overall Study|Lost to Follow-up|1
659419|NCT02099838|2120437|P1|Overall Study|Lost to Follow-up|3
659420|NCT02099838|2120436|P2|Overall Study|Death|0
659421|NCT02099838|2120437|P1|Overall Study|Death|1
659422|NCT02099708|2120467|P1|Overall Study|Other|29
659423|NCT02099708|2120467|P1|Overall Study|Lost to Follow-up|141
659424|NCT02099708|2120467|P1|Overall Study|Data Not Available|30
659425|NCT02099682|2120478|P1|Overall Study|Other|29
659426|NCT02099682|2120478|P1|Overall Study|Lost to Follow-up|31
659427|NCT02099682|2120478|P1|Overall Study|Data Not Available|51
659428|NCT02099344|2120504|P2|Overall Study|Physician Decision|0
659429|NCT02099344|2120505|P1|Overall Study|Physician Decision|1
659430|NCT02098746|2120562|P1|Overall Study|Data Not Available After Treatment|1
659431|NCT02098746|2120562|P1|Overall Study|Enrolled 15 Days After the First Dose|1
659432|NCT02098746|2120562|P1|Overall Study|Other Miscellaneous Reasons|1
659433|NCT02098746|2120562|P1|Overall Study|Changes of Investigator|2
659434|NCT02098733|2120570|P1|Overall Study|Lost to Follow-up|5
659435|NCT02098733|2120570|P1|Overall Study|Data Not Available|5
659436|NCT02098395|2120584|P4|Overall Study|Unclassified|2
659437|NCT02098395|2120585|P3|Overall Study|Unclassified|3
659438|NCT02098395|2120586|P2|Overall Study|Unclassified|0
659439|NCT02098395|2120587|P1|Overall Study|Unclassified|0
659440|NCT02098395|2120584|P4|Overall Study|Lost to Follow-up|3
659441|NCT02098395|2120585|P3|Overall Study|Lost to Follow-up|0
659442|NCT02098395|2120586|P2|Overall Study|Lost to Follow-up|1
659443|NCT02098395|2120587|P1|Overall Study|Lost to Follow-up|2
659444|NCT02098395|2120584|P4|Overall Study|Adverse Event|2
659445|NCT02098395|2120585|P3|Overall Study|Adverse Event|34
659446|NCT02098395|2120586|P2|Overall Study|Adverse Event|19
659447|NCT02098395|2120587|P1|Overall Study|Adverse Event|12
659448|NCT02098395|2120584|P4|Overall Study|Withdrawal by Subject|13
659449|NCT02098395|2120585|P3|Overall Study|Withdrawal by Subject|5
659450|NCT02098395|2120586|P2|Overall Study|Withdrawal by Subject|10
659451|NCT02098395|2120587|P1|Overall Study|Withdrawal by Subject|10
659452|NCT02098395|2120584|P4|Overall Study|Protocol Violation|7
659453|NCT02098395|2120585|P3|Overall Study|Protocol Violation|0
659454|NCT02098395|2120586|P2|Overall Study|Protocol Violation|2
659455|NCT02098395|2120587|P1|Overall Study|Protocol Violation|2
659456|NCT02098109|2120614|P2|Overall Study|Protocol Violation|0
659457|NCT02098109|2120615|P1|Overall Study|Protocol Violation|3
659458|NCT02097823|2120691|P2|Overall Study|Withdrawal by Subject|1
659459|NCT02097823|2120692|P1|Overall Study|Withdrawal by Subject|1
659460|NCT02097745|2120707|P1|Overall Study|Reason Not Specified|96
659461|NCT02097745|2120707|P1|Overall Study|Administrative/Other|27
659462|NCT02097745|2120707|P1|Overall Study|Failure to Return|14
659463|NCT02097745|2120707|P1|Overall Study|Death|16
659464|NCT02097745|2120707|P1|Overall Study|Adverse Event|25
659465|NCT02097719|2120731|P2|Overall Study|Adverse Event|0
659466|NCT02097719|2120732|P1|Overall Study|Adverse Event|2
659467|NCT02097719|2120731|P2|Overall Study|Lost to Follow-up|1
659468|NCT02097719|2120732|P1|Overall Study|Lost to Follow-up|0
659469|NCT02097719|2120731|P2|Overall Study|Subject Withdrew Consent|0
659470|NCT02097719|2120732|P1|Overall Study|Subject Withdrew Consent|1
659471|NCT02097290|2120744|P1|Overall Study|Attempt|8
659472|NCT02097290|2120744|P1|Overall Study|Total Withdrawals|3
659473|NCT02097290|2120744|P1|Overall Study|Death|6
659474|NCT02097238|2120754|P1|Overall Study|Progressive Disease|17
659475|NCT02097238|2120754|P1|Overall Study|Physician Decision|1
659476|NCT02097238|2120754|P1|Overall Study|Death|1
659477|NCT02097108|2120760|P1|Overall Study|patient was abroad for 6 months|1
659478|NCT02097108|2120760|P1|Overall Study|Adverse Event|1
659479|NCT02097056|2120767|P1|Overall Study|Not specified|2
659480|NCT02097056|2120767|P1|Overall Study|Adverse Event|37
659481|NCT02097056|2120767|P1|Overall Study|Lost to Follow-up|2
659482|NCT02097056|2120767|P1|Overall Study|Withdrawal by Subject|15
659483|NCT02097056|2120767|P1|Overall Study|Protocol Violation|2
659484|NCT02097030|2120775|P2|First Intervention (3 Days)|Visual Acuity|1
659485|NCT02097030|2120776|P1|First Intervention (3 Days)|Visual Acuity|0
659486|NCT02097030|2120775|P2|First Intervention (3 Days)|Lost to Follow-up|0
659487|NCT02097030|2120776|P1|First Intervention (3 Days)|Lost to Follow-up|1
659488|NCT02096900|2120839|P2|Overall Study|Surgery cancelled- medication received|1
659489|NCT02096900|2120840|P1|Overall Study|Surgery cancelled- medication received|1
659490|NCT02096900|2120839|P2|Overall Study|Did not receive medication|1
659491|NCT02096900|2120840|P1|Overall Study|Did not receive medication|3
659492|NCT02096835|2120857|P3|Overall Study|Lost to Follow-up|1
659493|NCT02096835|2120858|P2|Overall Study|Lost to Follow-up|0
659494|NCT02096835|2120859|P1|Overall Study|Lost to Follow-up|1
659495|NCT02096835|2120857|P3|Overall Study|converted to open procedures|0
659496|NCT02096835|2120858|P2|Overall Study|converted to open procedures|0
659497|NCT02096835|2120859|P1|Overall Study|converted to open procedures|1
659498|NCT02096835|2120857|P3|Overall Study|Withdrawal by Subject|0
659499|NCT02096835|2120858|P2|Overall Study|Withdrawal by Subject|0
659500|NCT02096835|2120859|P1|Overall Study|Withdrawal by Subject|1
659501|NCT02096744|2120876|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
659502|NCT02096744|2120877|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
659503|NCT02096744|2120876|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
659504|NCT02096744|2120877|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
659505|NCT02096744|2120876|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
659506|NCT02096744|2120877|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
659507|NCT02096705|2120931|P2|Follow-up|Subjects not reporting status|2
659508|NCT02096705|2120932|P1|Follow-up|Subjects not reporting status|1
659509|NCT02096705|2120931|P2|Follow-up|Adverse Event|2
659510|NCT02096705|2120932|P1|Follow-up|Adverse Event|2
659511|NCT02096705|2120931|P2|Follow-up|Withdrawal by Subject|0
659512|NCT02096705|2120932|P1|Follow-up|Withdrawal by Subject|1
659513|NCT02096705|2120931|P2|Treatment|Unspecified|1
659514|NCT02096705|2120932|P1|Treatment|Unspecified|1
659515|NCT02096705|2120931|P2|Treatment|Withdrawal by Subject|0
659516|NCT02096705|2120932|P1|Treatment|Withdrawal by Subject|1
659517|NCT02096705|2120931|P2|Treatment|Subject request to discontinue treatment|1
659518|NCT02096705|2120932|P1|Treatment|Subject request to discontinue treatment|1
659519|NCT02096705|2120931|P2|Treatment|Adverse Event|3
659520|NCT02096705|2120932|P1|Treatment|Adverse Event|6
659521|NCT02096042|2121030|P3|Overall Study|Disease Progression|0
659522|NCT02096042|2121031|P2|Overall Study|Disease Progression|0
659523|NCT02096042|2121032|P1|Overall Study|Disease Progression|1
659524|NCT02095873|2121041|P2|Second Intervention (8 Weeks)|Protocol Violation|0
659525|NCT02095873|2121042|P1|Second Intervention (8 Weeks)|Protocol Violation|1
659526|NCT02095873|2121041|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
659527|NCT02095873|2121042|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
659528|NCT02095873|2121041|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
659529|NCT02095873|2121042|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
659530|NCT02095691|2121054|P1|Overall Study|Physician Decision|1
659531|NCT02095535|2121086|P1|Recruitment|Protocol Violation|2
659532|NCT02095223|2121092|P2|Overall Study|Withdrawal by Subject|0
659533|NCT02095223|2121093|P1|Overall Study|Withdrawal by Subject|1
659534|NCT02095197|2121103|P2|Overall Study|Lost to Follow-up|3
659535|NCT02095197|2121104|P1|Overall Study|Lost to Follow-up|0
659536|NCT02095158|2121116|P1|Overall Study|Other Miscellaneous Reasons|1
659537|NCT02095158|2121116|P1|Overall Study|Protocol Violation|1
659538|NCT02095158|2121116|P1|Overall Study|Personal Reasons|35
659539|NCT02095158|2121116|P1|Overall Study|Lost to Follow-up|20
659540|NCT02095158|2121116|P1|Overall Study|Pregnancy|1
659541|NCT02095158|2121116|P1|Overall Study|Lack of Efficacy|3
659542|NCT02095158|2121116|P1|Overall Study|Adverse Event|14
659543|NCT02094937|2121121|P4|12 Weeks in Period 2|Randomized incorrectly|0
659544|NCT02094937|2121122|P3|12 Weeks in Period 2|Randomized incorrectly|0
659545|NCT02094937|2121123|P2|12 Weeks in Period 2|Randomized incorrectly|1
659546|NCT02094937|2121124|P1|12 Weeks in Period 2|Randomized incorrectly|0
659547|NCT02094937|2121121|P4|12 Weeks in Period 2|Withdrawal by Subject|0
659548|NCT02094937|2121122|P3|12 Weeks in Period 2|Withdrawal by Subject|2
659549|NCT02094937|2121123|P2|12 Weeks in Period 2|Withdrawal by Subject|2
659550|NCT02094937|2121124|P1|12 Weeks in Period 2|Withdrawal by Subject|0
659551|NCT02094937|2121121|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
659552|NCT02094937|2121122|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
659553|NCT02094937|2121123|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
659554|NCT02094937|2121124|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
659555|NCT02094937|2121121|P4|12 Weeks in Period 2|Lack of Efficacy|0
659556|NCT02094937|2121122|P3|12 Weeks in Period 2|Lack of Efficacy|0
659557|NCT02094937|2121123|P2|12 Weeks in Period 2|Lack of Efficacy|1
659558|NCT02094937|2121124|P1|12 Weeks in Period 2|Lack of Efficacy|0
659559|NCT02094937|2121121|P4|12 Weeks in Period 2|Adverse Event|1
659560|NCT02094937|2121122|P3|12 Weeks in Period 2|Adverse Event|4
659561|NCT02094937|2121123|P2|12 Weeks in Period 2|Adverse Event|2
659562|NCT02094937|2121124|P1|12 Weeks in Period 2|Adverse Event|0
659563|NCT02094937|2121121|P4|8 Weeks in Period 1|Withdrawal by Subject|0
659564|NCT02094937|2121122|P3|8 Weeks in Period 1|Withdrawal by Subject|0
659565|NCT02094937|2121123|P2|8 Weeks in Period 1|Withdrawal by Subject|0
659566|NCT02094937|2121124|P1|8 Weeks in Period 1|Withdrawal by Subject|4
659567|NCT02094937|2121121|P4|8 Weeks in Period 1|Physician Decision|0
659568|NCT02094937|2121122|P3|8 Weeks in Period 1|Physician Decision|0
659569|NCT02094937|2121123|P2|8 Weeks in Period 1|Physician Decision|0
659570|NCT02094937|2121124|P1|8 Weeks in Period 1|Physician Decision|1
659571|NCT02094937|2121121|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
659572|NCT02094937|2121122|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
659573|NCT02094937|2121123|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
659574|NCT02094937|2121124|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
659575|NCT02094937|2121121|P4|8 Weeks in Period 1|Protocol Violation|0
659576|NCT02094937|2121122|P3|8 Weeks in Period 1|Protocol Violation|0
659577|NCT02094937|2121123|P2|8 Weeks in Period 1|Protocol Violation|0
659578|NCT02094937|2121124|P1|8 Weeks in Period 1|Protocol Violation|2
659579|NCT02094937|2121121|P4|8 Weeks in Period 1|Lack of Efficacy|0
659580|NCT02094937|2121122|P3|8 Weeks in Period 1|Lack of Efficacy|0
659581|NCT02094937|2121123|P2|8 Weeks in Period 1|Lack of Efficacy|0
659582|NCT02094937|2121124|P1|8 Weeks in Period 1|Lack of Efficacy|3
659583|NCT02094937|2121121|P4|8 Weeks in Period 1|Adverse Event|0
659584|NCT02094937|2121122|P3|8 Weeks in Period 1|Adverse Event|0
659585|NCT02094937|2121123|P2|8 Weeks in Period 1|Adverse Event|0
659586|NCT02094937|2121124|P1|8 Weeks in Period 1|Adverse Event|9
659587|NCT02094898|2121154|P1|Overall Study|Lack of Efficacy|1
659588|NCT02094898|2121154|P1|Overall Study|Adverse Event|2
659589|NCT02094898|2121154|P1|Overall Study|Clinical Worsening|2
659590|NCT02094885|2121201|P2|Overall Study|Withdrawn due to age|0
659591|NCT02094885|2121202|P1|Overall Study|Withdrawn due to age|1
659592|NCT02094885|2121201|P2|Overall Study|Death|5
659593|NCT02094885|2121202|P1|Overall Study|Death|1
659594|NCT02094677|2121216|P2|Overall Study|Screening|1
659595|NCT02094677|2121217|P1|Overall Study|Screening|3
659596|NCT02094612|2121281|P2|Overall Study|Never started ADHD medication|23
659597|NCT02094612|2121282|P1|Overall Study|Never started ADHD medication|32
659598|NCT02094612|2121281|P2|Overall Study|Lost to Follow-up|47
659599|NCT02094612|2121282|P1|Overall Study|Lost to Follow-up|47
659600|NCT02094573|2121302|P2|Overall Study|Ongoing|76
659601|NCT02094573|2121303|P1|Overall Study|Ongoing|64
659602|NCT02094573|2121302|P2|Overall Study|Randomized but not treated|0
659603|NCT02094573|2121303|P1|Overall Study|Randomized but not treated|3
659604|NCT02094573|2121302|P2|Overall Study|Withdrawal by Subject|4
659605|NCT02094573|2121303|P1|Overall Study|Withdrawal by Subject|2
659606|NCT02094573|2121302|P2|Overall Study|Non-compliance with study drug|1
659607|NCT02094573|2121303|P1|Overall Study|Non-compliance with study drug|0
659608|NCT02094573|2121302|P2|Overall Study|Death|1
659609|NCT02094573|2121303|P1|Overall Study|Death|7
659610|NCT02094573|2121302|P2|Overall Study|Adverse Event|9
659611|NCT02094573|2121303|P1|Overall Study|Adverse Event|3
659612|NCT02094573|2121302|P2|Overall Study|Clinical Progressive Disease|3
659613|NCT02094573|2121303|P1|Overall Study|Clinical Progressive Disease|4
659614|NCT02094573|2121302|P2|Overall Study|Documented Progressive Disease|16
659615|NCT02094573|2121303|P1|Overall Study|Documented Progressive Disease|29
659616|NCT02094300|2121385|P1|Overall Study|Still be eligible for follow-up|3
659617|NCT02094300|2121385|P1|Overall Study|Lost to Follow-up|10
659618|NCT02094300|2121385|P1|Overall Study|Death|7
659623|NCT02093923|2121431|P5|Overall Study|Screen failure after randomization|0
659624|NCT02093923|2121432|P4|Overall Study|Screen failure after randomization|1
659625|NCT02093923|2121433|P3|Overall Study|Screen failure after randomization|0
659626|NCT02093923|2121434|P2|Overall Study|Screen failure after randomization|0
659627|NCT02093923|2121435|P1|Overall Study|Screen failure after randomization|0
659628|NCT02093923|2121431|P5|Overall Study|Lost to Follow-up|0
659629|NCT02093923|2121432|P4|Overall Study|Lost to Follow-up|1
659630|NCT02093923|2121433|P3|Overall Study|Lost to Follow-up|0
659631|NCT02093923|2121434|P2|Overall Study|Lost to Follow-up|0
659632|NCT02093923|2121435|P1|Overall Study|Lost to Follow-up|0
659633|NCT02093897|2121490|P1|Overall Study|Adverse event, non-fatal|1
659634|NCT02093897|2121490|P1|Overall Study|Planned age group closure - no's reached|17
659635|NCT02093897|2121490|P1|Overall Study|Physician Decision|1
659638|NCT02093390|2121605|P2|Overall Study|Withdrawal by Subject|1
659639|NCT02093390|2121606|P1|Overall Study|Withdrawal by Subject|0
659649|NCT02093026|2121698|P1|Overall Study|Unspecified|157
659650|NCT02093026|2121698|P1|Overall Study|Death|10
659651|NCT02093026|2121698|P1|Overall Study|Adverse Event|26
659652|NCT02092961|2121720|P3|Overall Study|Adverse Event|0
659653|NCT02092961|2121721|P2|Overall Study|Adverse Event|4
659654|NCT02092961|2121722|P1|Overall Study|Adverse Event|2
659655|NCT02092961|2121720|P3|Overall Study|Dev. of study specific discont. criteria|0
659656|NCT02092961|2121721|P2|Overall Study|Dev. of study specific discont. criteria|0
659657|NCT02092961|2121722|P1|Overall Study|Dev. of study specific discont. criteria|3
659658|NCT02092961|2121720|P3|Overall Study|Lack of therapeutic response|3
659659|NCT02092961|2121721|P2|Overall Study|Lack of therapeutic response|1
659660|NCT02092961|2121722|P1|Overall Study|Lack of therapeutic response|2
659661|NCT02092961|2121720|P3|Overall Study|Study stopped|12
659662|NCT02092961|2121721|P2|Overall Study|Study stopped|9
659663|NCT02092961|2121722|P1|Overall Study|Study stopped|13
659664|NCT02092961|2121720|P3|Overall Study|Not reported|1
659665|NCT02092961|2121721|P2|Overall Study|Not reported|0
659666|NCT02092961|2121722|P1|Overall Study|Not reported|1
659667|NCT02092662|2121758|P2|Overall Study|Lost to Follow-up|0
659668|NCT02092662|2121759|P1|Overall Study|Lost to Follow-up|13
659669|NCT02092389|2121818|P1|Overall Study|Not specified|5
659670|NCT02092389|2121818|P1|Overall Study|Adverse Event|1
659671|NCT02092350|2121830|P2|Overall Study|Withdrawal by Subject|2
659672|NCT02092350|2121831|P1|Overall Study|Withdrawal by Subject|2
659673|NCT02092350|2121830|P2|Overall Study|Screen Failure|0
659674|NCT02092350|2121831|P1|Overall Study|Screen Failure|1
659675|NCT02092350|2121830|P2|Overall Study|Physician Decision|1
659676|NCT02092350|2121831|P1|Overall Study|Physician Decision|1
659677|NCT02092350|2121830|P2|Overall Study|Protocol Violation|0
659678|NCT02092350|2121831|P1|Overall Study|Protocol Violation|1
659679|NCT02092350|2121830|P2|Overall Study|Lost to Follow-up|1
659680|NCT02092350|2121831|P1|Overall Study|Lost to Follow-up|3
659681|NCT02092350|2121830|P2|Overall Study|Death|5
659682|NCT02092350|2121831|P1|Overall Study|Death|2
659683|NCT02092350|2121830|P2|Overall Study|Adverse Event|3
659684|NCT02092350|2121831|P1|Overall Study|Adverse Event|0
659685|NCT02092116|2121874|P2|Overall Study|Adverse Event|1
659686|NCT02092116|2121875|P1|Overall Study|Adverse Event|0
659687|NCT02092116|2121874|P2|Overall Study|Withdrawal by Subject|3
659688|NCT02092116|2121875|P1|Overall Study|Withdrawal by Subject|0
659689|NCT02091986|2121887|P3|Overall Study|Adverse Event|2
659690|NCT02091986|2121888|P2|Overall Study|Adverse Event|0
659691|NCT02091986|2121889|P1|Overall Study|Adverse Event|0
659692|NCT02091986|2121887|P3|Overall Study|Withdrawal by Subject|3
659693|NCT02091986|2121888|P2|Overall Study|Withdrawal by Subject|8
659694|NCT02091986|2121889|P1|Overall Study|Withdrawal by Subject|4
659695|NCT02091986|2121887|P3|Overall Study|Lost to Follow-up|0
659696|NCT02091986|2121888|P2|Overall Study|Lost to Follow-up|0
659697|NCT02091986|2121889|P1|Overall Study|Lost to Follow-up|1
659698|NCT02091986|2121887|P3|Overall Study|7 rand in error 1 patient decision|3
659699|NCT02091986|2121888|P2|Overall Study|7 rand in error 1 patient decision|3
659700|NCT02091986|2121889|P1|Overall Study|7 rand in error 1 patient decision|2
659703|NCT02091752|2121980|P1|Overall Study|Adverse Event|1
659704|NCT02091752|2121980|P1|Overall Study|Study terminated by Sponsor|2
659705|NCT02091726|2121991|P1|Overall Study|Lost to Follow-up|6
659706|NCT02091414|2122008|P1|Overall Study|Death|2
659707|NCT02091414|2122008|P1|Overall Study|Withdrawal by Subject|2
659708|NCT02090855|2122020|P1|Overall Study|no evaluable Standard of Truth results|2
659709|NCT02090764|2122033|P2|Overall Study|Lost to Follow-up|2
659710|NCT02090764|2122034|P1|Overall Study|Lost to Follow-up|2
659711|NCT02090764|2122033|P2|Overall Study|Intercurrent illness and other|1
659712|NCT02090764|2122034|P1|Overall Study|Intercurrent illness and other|1
659713|NCT02090764|2122033|P2|Overall Study|Withdrawal by Subject|1
659714|NCT02090764|2122034|P1|Overall Study|Withdrawal by Subject|2
659715|NCT02090764|2122033|P2|Overall Study|Lack of Efficacy|13
659716|NCT02090764|2122034|P1|Overall Study|Lack of Efficacy|0
659717|NCT02090764|2122033|P2|Overall Study|Adverse Event|3
659718|NCT02090764|2122034|P1|Overall Study|Adverse Event|1
659719|NCT02090413|2122043|P3|Overall Study|Lost to Follow-up|0
659720|NCT02090413|2122044|P2|Overall Study|Lost to Follow-up|1
659721|NCT02090413|2122045|P1|Overall Study|Lost to Follow-up|1
659722|NCT02090413|2122043|P3|Overall Study|Not Specified|0
659723|NCT02090413|2122044|P2|Overall Study|Not Specified|1
659724|NCT02090413|2122045|P1|Overall Study|Not Specified|2
659725|NCT02090413|2122043|P3|Overall Study|Investigator Decision|0
659726|NCT02090413|2122044|P2|Overall Study|Investigator Decision|1
659727|NCT02090413|2122045|P1|Overall Study|Investigator Decision|1
659728|NCT02090413|2122043|P3|Overall Study|Withdrawal by Subject|2
659729|NCT02090413|2122044|P2|Overall Study|Withdrawal by Subject|2
659730|NCT02090413|2122045|P1|Overall Study|Withdrawal by Subject|2
659731|NCT02090413|2122043|P3|Overall Study|Flushing event|1
659732|NCT02090413|2122044|P2|Overall Study|Flushing event|0
659733|NCT02090413|2122045|P1|Overall Study|Flushing event|2
659734|NCT02090413|2122043|P3|Overall Study|Adverse Event|20
659735|NCT02090413|2122044|P2|Overall Study|Adverse Event|15
659736|NCT02090413|2122045|P1|Overall Study|Adverse Event|11
659737|NCT02089737|2122131|P1|Overall Study|Not treated|1
659738|NCT02089737|2122131|P1|Overall Study|Survey form not completed|5
659739|NCT02089347|2122140|P2|Overall Study|Protocol Violation|0
659740|NCT02089347|2122141|P1|Overall Study|Protocol Violation|1
659741|NCT02088957|2122181|P2|Overall Study|Lack of Efficacy|0
659742|NCT02088957|2122182|P1|Overall Study|Lack of Efficacy|1
659743|NCT02088177|2122198|P1|Overall Study|Lost to Follow-up|3
659744|NCT02087943|2122210|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
659745|NCT02087943|2122211|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
659746|NCT02087943|2122212|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
659747|NCT02087943|2122213|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
659748|NCT02087943|2122214|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
659749|NCT02087943|2122210|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
659750|NCT02087943|2122211|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
659751|NCT02087943|2122212|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
659752|NCT02087943|2122213|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
659753|NCT02087943|2122214|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
659754|NCT02087943|2122210|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
659755|NCT02087943|2122211|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
659756|NCT02087943|2122212|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
659757|NCT02087943|2122213|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
659758|NCT02087943|2122214|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
659759|NCT02087943|2122210|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
659760|NCT02087943|2122211|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
659761|NCT02087943|2122212|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
659762|NCT02087943|2122213|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
659763|NCT02087943|2122214|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
659764|NCT02087943|2122210|P5|Active Treatment Phase Week 12-24|Adverse Event|1
659765|NCT02087943|2122211|P4|Active Treatment Phase Week 12-24|Adverse Event|0
659766|NCT02087943|2122212|P3|Active Treatment Phase Week 12-24|Adverse Event|2
659767|NCT02087943|2122213|P2|Active Treatment Phase Week 12-24|Adverse Event|1
659768|NCT02087943|2122214|P1|Active Treatment Phase Week 12-24|Adverse Event|0
659769|NCT02087943|2122210|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
659770|NCT02087943|2122211|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
659771|NCT02087943|2122212|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
659772|NCT02087943|2122213|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
659773|NCT02087943|2122214|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
659774|NCT02087943|2122210|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
659775|NCT02087943|2122211|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
659776|NCT02087943|2122212|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
659777|NCT02087943|2122213|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
659778|NCT02087943|2122214|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
659779|NCT02087943|2122210|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
659780|NCT02087943|2122211|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
659781|NCT02087943|2122212|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
659782|NCT02087943|2122213|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
659783|NCT02087943|2122214|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
659784|NCT02087943|2122210|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
659785|NCT02087943|2122211|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
659786|NCT02087943|2122212|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
659787|NCT02087943|2122213|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
659788|NCT02087943|2122214|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
659789|NCT02087943|2122210|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
659790|NCT02087943|2122211|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
659791|NCT02087943|2122212|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
659792|NCT02087943|2122213|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
659793|NCT02087943|2122214|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
659794|NCT02087774|2122240|P2|Overall Study|Were absent day of data collection|20
659795|NCT02087774|2122241|P1|Overall Study|Were absent day of data collection|8
659796|NCT02087670|2122261|P2|Overall Study|Withdrawal by Subject|2
659797|NCT02087670|2122262|P1|Overall Study|Withdrawal by Subject|3
659798|NCT02087241|2122274|P4|Overall Study|Study Terminated by Sponsor|4
659799|NCT02087241|2122275|P3|Overall Study|Study Terminated by Sponsor|0
659800|NCT02087241|2122276|P2|Overall Study|Study Terminated by Sponsor|2
659801|NCT02087241|2122277|P1|Overall Study|Study Terminated by Sponsor|0
659802|NCT02087241|2122274|P4|Overall Study|Progressive Disease|1
659803|NCT02087241|2122275|P3|Overall Study|Progressive Disease|0
659804|NCT02087241|2122276|P2|Overall Study|Progressive Disease|0
659805|NCT02087241|2122277|P1|Overall Study|Progressive Disease|0
659806|NCT02087241|2122274|P4|Overall Study|Withdrawal by Subject|1
659807|NCT02087241|2122275|P3|Overall Study|Withdrawal by Subject|0
659808|NCT02087241|2122276|P2|Overall Study|Withdrawal by Subject|0
659809|NCT02087241|2122277|P1|Overall Study|Withdrawal by Subject|1
659810|NCT02087241|2122274|P4|Overall Study|Death|1
659811|NCT02087241|2122275|P3|Overall Study|Death|1
659812|NCT02087241|2122276|P2|Overall Study|Death|1
659813|NCT02087241|2122277|P1|Overall Study|Death|2
659814|NCT02087176|2122303|P1|Overall Study|Study Terminated by Sponsor|2
659815|NCT02087176|2122303|P1|Overall Study|Censored|19
659816|NCT02087176|2122303|P1|Overall Study|Death|10
659817|NCT02087176|2122303|P1|Overall Study|Withdrawal by Subject|1
659818|NCT02087059|2122308|P1|Overall Study|Lost to Follow-up|1
659819|NCT02087059|2122308|P1|Overall Study|Adverse Event|5
659820|NCT02087059|2122308|P1|Overall Study|Disease Progression|1
659821|NCT02086591|2122355|P1|Overall Study|protocol terminated|3
659822|NCT02086591|2122355|P1|Overall Study|Withdrawal by Subject|1
659823|NCT02086591|2122355|P1|Overall Study|Adverse Event|1
659824|NCT02085785|2122363|P2|Overall Study|Lost to Follow-up|1
659825|NCT02085785|2122364|P1|Overall Study|Lost to Follow-up|0
659826|NCT02085785|2122363|P2|Overall Study|Withdrawal by Subject|1
659827|NCT02085785|2122364|P1|Overall Study|Withdrawal by Subject|2
659828|NCT02085161|2122388|P4|Overall Study|Other Reason|1
659829|NCT02085161|2122389|P3|Overall Study|Other Reason|1
659830|NCT02085161|2122390|P2|Overall Study|Other Reason|0
659831|NCT02085161|2122391|P1|Overall Study|Other Reason|1
659832|NCT02085161|2122388|P4|Overall Study|Withdrawal by Subject|3
659833|NCT02085161|2122389|P3|Overall Study|Withdrawal by Subject|0
659834|NCT02085161|2122390|P2|Overall Study|Withdrawal by Subject|4
659835|NCT02085161|2122391|P1|Overall Study|Withdrawal by Subject|2
659836|NCT02085161|2122388|P4|Overall Study|Protocol Violation|1
659837|NCT02085161|2122389|P3|Overall Study|Protocol Violation|0
659838|NCT02085161|2122390|P2|Overall Study|Protocol Violation|1
659839|NCT02085161|2122391|P1|Overall Study|Protocol Violation|0
659840|NCT02085161|2122388|P4|Overall Study|Adverse Event|5
659841|NCT02085161|2122389|P3|Overall Study|Adverse Event|4
659842|NCT02085161|2122390|P2|Overall Study|Adverse Event|5
659843|NCT02085161|2122391|P1|Overall Study|Adverse Event|8
659844|NCT02085161|2122388|P4|Overall Study|Not Treated|0
659845|NCT02085161|2122389|P3|Overall Study|Not Treated|0
659846|NCT02085161|2122390|P2|Overall Study|Not Treated|0
659847|NCT02085161|2122391|P1|Overall Study|Not Treated|1
659848|NCT02084238|2122459|P1|Overall Study|Lost to Follow-up|2
659849|NCT02084082|2122472|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
659850|NCT02084082|2122473|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659851|NCT02084082|2122474|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659852|NCT02084082|2122475|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659853|NCT02084082|2122472|P4|Washout Period 1 (35 Days)|Adverse Event|1
659854|NCT02084082|2122473|P3|Washout Period 1 (35 Days)|Adverse Event|1
659855|NCT02084082|2122474|P2|Washout Period 1 (35 Days)|Adverse Event|0
659856|NCT02084082|2122475|P1|Washout Period 1 (35 Days)|Adverse Event|0
659857|NCT02084056|2122516|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659858|NCT02084056|2122517|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659859|NCT02084056|2122518|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
659860|NCT02084056|2122519|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
659861|NCT02084056|2122516|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
659862|NCT02084056|2122517|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
659863|NCT02084056|2122518|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
659864|NCT02084056|2122519|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
659865|NCT02083965|2122551|P2|Treatment Period|Not Specified|0
659866|NCT02083965|2122552|P1|Treatment Period|Not Specified|1
659867|NCT02083380|2122654|P3|Overall Study|Other|6
659868|NCT02083380|2122655|P2|Overall Study|Other|4
659869|NCT02083380|2122656|P1|Overall Study|Other|8
659870|NCT02083380|2122654|P3|Overall Study|Lost to Follow-up|3
659871|NCT02083380|2122655|P2|Overall Study|Lost to Follow-up|3
659872|NCT02083380|2122656|P1|Overall Study|Lost to Follow-up|5
659873|NCT02083380|2122654|P3|Overall Study|Adverse Event|1
659874|NCT02083380|2122655|P2|Overall Study|Adverse Event|0
659875|NCT02083380|2122656|P1|Overall Study|Adverse Event|0
659876|NCT02083380|2122654|P3|Overall Study|Physician Decision|3
659877|NCT02083380|2122655|P2|Overall Study|Physician Decision|6
659878|NCT02083380|2122656|P1|Overall Study|Physician Decision|1
659879|NCT02083380|2122654|P3|Overall Study|Withdrawal by Subject|7
659880|NCT02083380|2122655|P2|Overall Study|Withdrawal by Subject|3
659881|NCT02083380|2122656|P1|Overall Study|Withdrawal by Subject|9
659882|NCT02083380|2122654|P3|Overall Study|Lack of Efficacy|64
659883|NCT02083380|2122655|P2|Overall Study|Lack of Efficacy|79
659884|NCT02083380|2122656|P1|Overall Study|Lack of Efficacy|68
659885|NCT02082912|2122800|P2|Overall Study|Physician Decision|1
659886|NCT02082912|2122801|P1|Overall Study|Physician Decision|0
659887|NCT02082262|2122865|P1|Overall Study|Adverse Event|48
659888|NCT02082262|2122865|P1|Overall Study|Withdrawal by Subject|3
659889|NCT02082184|2122871|P2|Overall Study|Subject non-compliance|1
659890|NCT02082184|2122872|P1|Overall Study|Subject non-compliance|0
659891|NCT02082184|2122871|P2|Overall Study|Lost to Follow-up|2
659892|NCT02082184|2122872|P1|Overall Study|Lost to Follow-up|0
659893|NCT02082184|2122871|P2|Overall Study|Protocol Violation|6
659894|NCT02082184|2122872|P1|Overall Study|Protocol Violation|0
659895|NCT02082184|2122871|P2|Overall Study|Withdrawal by Subject|2
659896|NCT02082184|2122872|P1|Overall Study|Withdrawal by Subject|3
659897|NCT02082184|2122871|P2|Overall Study|Device associated symptoms|0
659898|NCT02082184|2122872|P1|Overall Study|Device associated symptoms|5
659899|NCT02082184|2122871|P2|Overall Study|Medical diagnosis|2
659900|NCT02082184|2122872|P1|Overall Study|Medical diagnosis|1
659901|NCT02082184|2122871|P2|Overall Study|Adverse Event|0
659902|NCT02082184|2122872|P1|Overall Study|Adverse Event|1
659903|NCT02082158|2122897|P6|Overall Study|Failed Fit-testing|7
659904|NCT02082158|2122898|P5|Overall Study|Failed Fit-testing|3
659905|NCT02082158|2122899|P4|Overall Study|Failed Fit-testing|4
659906|NCT02082158|2122900|P3|Overall Study|Failed Fit-testing|14
659907|NCT02082158|2122901|P2|Overall Study|Failed Fit-testing|8
659908|NCT02082158|2122902|P1|Overall Study|Failed Fit-testing|8
659909|NCT02082158|2122897|P6|Overall Study|Withdrawal by Subject|0
659910|NCT02082158|2122898|P5|Overall Study|Withdrawal by Subject|1
659911|NCT02082158|2122899|P4|Overall Study|Withdrawal by Subject|0
659912|NCT02082158|2122900|P3|Overall Study|Withdrawal by Subject|0
659913|NCT02082158|2122901|P2|Overall Study|Withdrawal by Subject|0
659914|NCT02082158|2122902|P1|Overall Study|Withdrawal by Subject|0
659915|NCT02081859|2122924|P2|Overall Study|Other reasons|0
659916|NCT02081859|2122925|P1|Overall Study|Other reasons|2
659917|NCT02081859|2122924|P2|Overall Study|< 4 embryos|23
659918|NCT02081859|2122925|P1|Overall Study|< 4 embryos|27
659919|NCT02081859|2122924|P2|Overall Study|Unanticipated freeze all cycle|6
659920|NCT02081859|2122925|P1|Overall Study|Unanticipated freeze all cycle|2
659921|NCT02081859|2122924|P2|Overall Study|No sperm|0
659922|NCT02081859|2122925|P1|Overall Study|No sperm|1
659923|NCT02081859|2122924|P2|Overall Study|No fertilization|2
659924|NCT02081859|2122925|P1|Overall Study|No fertilization|2
659925|NCT02081677|2122937|P4|Overall Study|Unsatisfactory Lens Fitting|0
659926|NCT02081677|2122938|P3|Overall Study|Unsatisfactory Lens Fitting|0
659927|NCT02081677|2122939|P2|Overall Study|Unsatisfactory Lens Fitting|1
659928|NCT02081677|2122940|P1|Overall Study|Unsatisfactory Lens Fitting|0
659929|NCT02081677|2122937|P4|Overall Study|Not comfortable with lens care system|0
659930|NCT02081677|2122938|P3|Overall Study|Not comfortable with lens care system|0
659931|NCT02081677|2122939|P2|Overall Study|Not comfortable with lens care system|0
659932|NCT02081677|2122940|P1|Overall Study|Not comfortable with lens care system|1
659933|NCT02081677|2122937|P4|Overall Study|No Longer Meets Eligibility Criteria|0
659934|NCT02081677|2122938|P3|Overall Study|No Longer Meets Eligibility Criteria|1
659935|NCT02081677|2122939|P2|Overall Study|No Longer Meets Eligibility Criteria|0
659936|NCT02081677|2122940|P1|Overall Study|No Longer Meets Eligibility Criteria|0
659937|NCT02081677|2122937|P4|Overall Study|Adverse Event|0
659938|NCT02081677|2122938|P3|Overall Study|Adverse Event|1
659939|NCT02081677|2122939|P2|Overall Study|Adverse Event|0
659940|NCT02081677|2122940|P1|Overall Study|Adverse Event|0
659941|NCT02081599|2123032|P2|Period 2：Open-label Period|Withdrawal by Subject|0
659942|NCT02081599|2123033|P1|Period 2：Open-label Period|Withdrawal by Subject|2
659943|NCT02081599|2123032|P2|Period 2：Open-label Period|Physician Decision|0
659944|NCT02081599|2123033|P1|Period 2：Open-label Period|Physician Decision|1
659945|NCT02081599|2123032|P2|Period 2：Open-label Period|Lack of Efficacy|4
659946|NCT02081599|2123033|P1|Period 2：Open-label Period|Lack of Efficacy|2
659947|NCT02081599|2123032|P2|Period 2：Open-label Period|Adverse Event|0
659948|NCT02081599|2123033|P1|Period 2：Open-label Period|Adverse Event|1
659949|NCT02081599|2123032|P2|Period 1：Double-blind Period|stopping criteria|0
659950|NCT02081599|2123033|P1|Period 1：Double-blind Period|stopping criteria|1
659951|NCT02081599|2123032|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
659952|NCT02081599|2123033|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
659953|NCT02081599|2123032|P2|Period 1：Double-blind Period|Protocol Violation|1
659954|NCT02081599|2123033|P1|Period 1：Double-blind Period|Protocol Violation|0
659955|NCT02081599|2123032|P2|Period 1：Double-blind Period|Physician Decision|0
659956|NCT02081599|2123033|P1|Period 1：Double-blind Period|Physician Decision|1
659957|NCT02081599|2123032|P2|Period 1：Double-blind Period|Lack of Efficacy|1
659958|NCT02081599|2123033|P1|Period 1：Double-blind Period|Lack of Efficacy|2
659959|NCT02081599|2123032|P2|Period 1：Double-blind Period|Adverse Event|0
659960|NCT02081599|2123033|P1|Period 1：Double-blind Period|Adverse Event|3
659961|NCT02081586|2123051|P4|Overall Study|Head injury not related to study|0
659962|NCT02081586|2123052|P3|Overall Study|Head injury not related to study|1
659963|NCT02081586|2123053|P2|Overall Study|Head injury not related to study|0
659964|NCT02081586|2123054|P1|Overall Study|Head injury not related to study|0
659965|NCT02081586|2123051|P4|Overall Study|Lost to Follow-up|1
659966|NCT02081586|2123052|P3|Overall Study|Lost to Follow-up|0
659967|NCT02081586|2123053|P2|Overall Study|Lost to Follow-up|1
659968|NCT02081586|2123054|P1|Overall Study|Lost to Follow-up|0
659969|NCT02081183|2123111|P2|Overall Study|Not specified|3
659970|NCT02081183|2123112|P1|Overall Study|Not specified|3
659971|NCT02081183|2123111|P2|Overall Study|Protocol Violation|0
659972|NCT02081183|2123112|P1|Overall Study|Protocol Violation|1
659973|NCT02081183|2123111|P2|Overall Study|Lost to Follow-up|1
659974|NCT02081183|2123112|P1|Overall Study|Lost to Follow-up|0
659975|NCT02081079|2123128|P2|Overall Study|Lost to Follow-up|0
659976|NCT02081079|2123129|P1|Overall Study|Lost to Follow-up|1
659977|NCT02081079|2123128|P2|Overall Study|Lack of Efficacy|2
659978|NCT02081079|2123129|P1|Overall Study|Lack of Efficacy|3
659979|NCT02081001|2123202|P12|Overall Study|Adverse Event|0
659980|NCT02081001|2123203|P11|Overall Study|Adverse Event|0
659981|NCT02081001|2123204|P10|Overall Study|Adverse Event|0
659982|NCT02081001|2123205|P9|Overall Study|Adverse Event|0
659983|NCT02081001|2123206|P8|Overall Study|Adverse Event|0
659984|NCT02081001|2123207|P7|Overall Study|Adverse Event|0
659985|NCT02081001|2123208|P6|Overall Study|Adverse Event|0
659986|NCT02081001|2123209|P5|Overall Study|Adverse Event|1
659987|NCT02081001|2123210|P4|Overall Study|Adverse Event|0
659988|NCT02081001|2123211|P3|Overall Study|Adverse Event|0
659989|NCT02081001|2123212|P2|Overall Study|Adverse Event|0
659990|NCT02081001|2123213|P1|Overall Study|Adverse Event|0
659991|NCT02080481|2123308|P2|Overall Study|Never received a block.|0
659992|NCT02080481|2123309|P1|Overall Study|Never received a block.|1
659993|NCT02080091|2123327|P1|Overall Study|Other|1
659994|NCT02080091|2123327|P1|Overall Study|Withdrawal by Subject|1
659995|NCT02080091|2123327|P1|Overall Study|Death|1
659996|NCT02080091|2123327|P1|Overall Study|Study Terminated|22
659997|NCT02079844|2123336|P3|Treatment Period 2|Voluntary Withdrawal|0
659998|NCT02079844|2123337|P2|Treatment Period 2|Voluntary Withdrawal|1
659999|NCT02079844|2123338|P1|Treatment Period 2|Voluntary Withdrawal|0
660000|NCT02079844|2123336|P3|Treatment Period 1|Voluntary Withdrawal|2
660001|NCT02079844|2123337|P2|Treatment Period 1|Voluntary Withdrawal|0
660002|NCT02079844|2123338|P1|Treatment Period 1|Voluntary Withdrawal|0
660003|NCT02079805|2123396|P2|Overall Study|Voluntary Withdrawal|1
660004|NCT02079805|2123397|P1|Overall Study|Voluntary Withdrawal|0
660005|NCT02079805|2123396|P2|Overall Study|Pretreatment Event/Adverse Event|1
660006|NCT02079805|2123397|P1|Overall Study|Pretreatment Event/Adverse Event|0
660007|NCT02079649|2123419|P4|Overall Study|Randomization error (prior to treatment)|0
660008|NCT02079649|2123420|P3|Overall Study|Randomization error (prior to treatment)|1
660009|NCT02079649|2123421|P2|Overall Study|Randomization error (prior to treatment)|0
660010|NCT02079649|2123422|P1|Overall Study|Randomization error (prior to treatment)|1
660011|NCT02079649|2123419|P4|Overall Study|Withdrawal by Subject|1
660012|NCT02079649|2123420|P3|Overall Study|Withdrawal by Subject|0
660013|NCT02079649|2123421|P2|Overall Study|Withdrawal by Subject|0
660014|NCT02079649|2123422|P1|Overall Study|Withdrawal by Subject|0
660015|NCT02079649|2123419|P4|Overall Study|Lost to Follow-up|1
660016|NCT02079649|2123420|P3|Overall Study|Lost to Follow-up|0
660017|NCT02079649|2123421|P2|Overall Study|Lost to Follow-up|0
660018|NCT02079649|2123422|P1|Overall Study|Lost to Follow-up|0
660019|NCT02079610|2123439|P2|Overall Study|Withdrawal by Subject|1
660020|NCT02079610|2123440|P1|Overall Study|Withdrawal by Subject|1
660021|NCT02079532|2123450|P1|Overall Study|Not specified|3
660022|NCT02079532|2123450|P1|Overall Study|Inclusion into ReFIRST|3
660023|NCT02079532|2123450|P1|Overall Study|Administrative problems|1
660024|NCT02079532|2123450|P1|Overall Study|Withdrawal by Subject|1
660025|NCT02079532|2123450|P1|Overall Study|Protocol Violation|3
660026|NCT02079532|2123450|P1|Overall Study|Lack of Efficacy|9
660027|NCT02079532|2123450|P1|Overall Study|Additional or changed therapy|2
660028|NCT02079532|2123450|P1|Overall Study|Adverse Event|7
660029|NCT02079519|2123472|P1|Overall Study|Adverse Event|1
660030|NCT02079519|2123472|P1|Overall Study|Disease Progression|9
660031|NCT02077374|2123530|P2|Overall Study|Protocol Violation|1
660032|NCT02077374|2123531|P1|Overall Study|Protocol Violation|0
660033|NCT02077374|2123530|P2|Overall Study|Withdrawal by Subject|1
660034|NCT02077374|2123531|P1|Overall Study|Withdrawal by Subject|0
660035|NCT02076334|2123664|P4|Overall Study|muscle soreness|1
660036|NCT02076334|2123665|P3|Overall Study|muscle soreness|0
660037|NCT02076334|2123666|P2|Overall Study|muscle soreness|0
660038|NCT02076334|2123667|P1|Overall Study|muscle soreness|0
660039|NCT02076334|2123664|P4|Overall Study|Lost to Follow-up|0
660040|NCT02076334|2123665|P3|Overall Study|Lost to Follow-up|1
660041|NCT02076334|2123666|P2|Overall Study|Lost to Follow-up|1
660042|NCT02076334|2123667|P1|Overall Study|Lost to Follow-up|0
660043|NCT02076334|2123664|P4|Overall Study|Protocol Violation|0
660044|NCT02076334|2123665|P3|Overall Study|Protocol Violation|0
660045|NCT02076334|2123666|P2|Overall Study|Protocol Violation|0
660046|NCT02076334|2123667|P1|Overall Study|Protocol Violation|1
660047|NCT02076009|2123683|P2|Overall Study|Subjects randomized but not treated|3
660048|NCT02076009|2123684|P1|Overall Study|Subjects randomized but not treated|2
660049|NCT02076009|2123683|P2|Overall Study|Ongoing|249
660050|NCT02076009|2123684|P1|Overall Study|Ongoing|226
660051|NCT02076009|2123683|P2|Overall Study|Progressive disease|0
660052|NCT02076009|2123684|P1|Overall Study|Progressive disease|1
660053|NCT02076009|2123683|P2|Overall Study|Lost to Follow-up|1
660054|NCT02076009|2123684|P1|Overall Study|Lost to Follow-up|1
660055|NCT02076009|2123683|P2|Overall Study|Withdrawal by Subject|3
660056|NCT02076009|2123684|P1|Overall Study|Withdrawal by Subject|9
660057|NCT02076009|2123683|P2|Overall Study|Death|30
660058|NCT02076009|2123684|P1|Overall Study|Death|44
660059|NCT02075632|2123706|P2|Overall Study|Withdrawal by Subject|1
660060|NCT02075632|2123707|P1|Overall Study|Withdrawal by Subject|0
660061|NCT02075632|2123706|P2|Overall Study|Lost to Follow-up|3
660062|NCT02075632|2123707|P1|Overall Study|Lost to Follow-up|0
660063|NCT02075632|2123706|P2|Overall Study|Adverse Event|1
660064|NCT02075632|2123707|P1|Overall Study|Adverse Event|1
660065|NCT02075515|2123720|P3|Overall Study|Lost to Follow-up|6
660066|NCT02075515|2123721|P2|Overall Study|Lost to Follow-up|3
660067|NCT02075515|2123722|P1|Overall Study|Lost to Follow-up|1
660068|NCT02075515|2123720|P3|Overall Study|Withdrawal by Subject|1
660069|NCT02075515|2123721|P2|Overall Study|Withdrawal by Subject|0
660070|NCT02075515|2123722|P1|Overall Study|Withdrawal by Subject|2
660071|NCT02075515|2123720|P3|Overall Study|Non-Serious Adverse Event|0
660072|NCT02075515|2123721|P2|Overall Study|Non-Serious Adverse Event|1
660073|NCT02075515|2123722|P1|Overall Study|Non-Serious Adverse Event|0
660074|NCT02075515|2123720|P3|Overall Study|Serious Adverse Event|1
660075|NCT02075515|2123721|P2|Overall Study|Serious Adverse Event|1
660076|NCT02075515|2123722|P1|Overall Study|Serious Adverse Event|1
660077|NCT02075463|2123757|P1|Overall Study|Withdrawal by Subject|1
660078|NCT02075463|2123757|P1|Overall Study|Par. reached stopping criteria|4
660079|NCT02075463|2123757|P1|Overall Study|Adverse Event|3
660080|NCT02075073|2123831|P3|Overall Study|Withdrawal by Subject|0
660081|NCT02075073|2123832|P2|Overall Study|Withdrawal by Subject|1
660082|NCT02075073|2123833|P1|Overall Study|Withdrawal by Subject|0
660083|NCT02075008|2123855|P1|Overall Study|Study terminated by Sponsor|159
660084|NCT02075008|2123855|P1|Overall Study|Withdrawal by Subject|6
660085|NCT02075008|2123855|P1|Overall Study|Adverse Event|5
660086|NCT02075008|2123855|P1|Overall Study|Death|1
660087|NCT02075008|2123855|P1|Overall Study|Lack of Efficacy|1
660088|NCT02075008|2123855|P1|Overall Study|Lost to Follow-up|1
660089|NCT02075008|2123855|P1|Overall Study|Physician Decision|1
660090|NCT02075008|2123855|P1|Overall Study|Pregnancy|1
660091|NCT02075008|2123855|P1|Overall Study|Technical problems|1
660092|NCT02074982|2123878|P2|Overall Study|Death|2
660093|NCT02074982|2123879|P1|Overall Study|Death|0
660094|NCT02074982|2123878|P2|Overall Study|Subject/guardian decision|24
660095|NCT02074982|2123879|P1|Overall Study|Subject/guardian decision|15
660096|NCT02074982|2123878|P2|Overall Study|Technical problems|2
660097|NCT02074982|2123879|P1|Overall Study|Technical problems|0
660098|NCT02074982|2123878|P2|Overall Study|Protocol deviation|3
660099|NCT02074982|2123879|P1|Overall Study|Protocol deviation|4
660100|NCT02074982|2123878|P2|Overall Study|Pregnancy|2
660101|NCT02074982|2123879|P1|Overall Study|Pregnancy|1
660102|NCT02074982|2123878|P2|Overall Study|Physician Decision|1
660103|NCT02074982|2123879|P1|Overall Study|Physician Decision|1
660104|NCT02074982|2123878|P2|Overall Study|Non-compliance with study treatment|2
660105|NCT02074982|2123879|P1|Overall Study|Non-compliance with study treatment|0
660106|NCT02074982|2123878|P2|Overall Study|Lost to Follow-up|10
660107|NCT02074982|2123879|P1|Overall Study|Lost to Follow-up|9
660108|NCT02074982|2123878|P2|Overall Study|Lack of Efficacy|1
660109|NCT02074982|2123879|P1|Overall Study|Lack of Efficacy|6
660110|NCT02074982|2123878|P2|Overall Study|Adverse Event|7
660111|NCT02074982|2123879|P1|Overall Study|Adverse Event|15
660112|NCT02074553|2123900|P8|Washout Period 3|Physician Decision|1
660113|NCT02074553|2123901|P7|Washout Period 3|Physician Decision|0
660114|NCT02074553|2123902|P6|Washout Period 3|Physician Decision|0
660115|NCT02074553|2123903|P5|Washout Period 3|Physician Decision|0
660116|NCT02074553|2123904|P4|Washout Period 3|Physician Decision|0
660117|NCT02074553|2123905|P3|Washout Period 3|Physician Decision|0
660118|NCT02074553|2123906|P2|Washout Period 3|Physician Decision|0
660119|NCT02074553|2123907|P1|Washout Period 3|Physician Decision|0
660120|NCT02074553|2123900|P8|Washout Period 2|Lost to Follow-up|0
660121|NCT02074553|2123901|P7|Washout Period 2|Lost to Follow-up|0
660122|NCT02074553|2123902|P6|Washout Period 2|Lost to Follow-up|0
660123|NCT02074553|2123903|P5|Washout Period 2|Lost to Follow-up|0
660124|NCT02074553|2123904|P4|Washout Period 2|Lost to Follow-up|0
660125|NCT02074553|2123905|P3|Washout Period 2|Lost to Follow-up|1
660126|NCT02074553|2123906|P2|Washout Period 2|Lost to Follow-up|0
660127|NCT02074553|2123907|P1|Washout Period 2|Lost to Follow-up|0
660128|NCT02074553|2123900|P8|Washout Period 2|Physician Decision|0
660129|NCT02074553|2123901|P7|Washout Period 2|Physician Decision|0
660130|NCT02074553|2123902|P6|Washout Period 2|Physician Decision|1
660131|NCT02074553|2123903|P5|Washout Period 2|Physician Decision|0
660132|NCT02074553|2123904|P4|Washout Period 2|Physician Decision|0
660133|NCT02074553|2123905|P3|Washout Period 2|Physician Decision|0
660134|NCT02074553|2123906|P2|Washout Period 2|Physician Decision|0
660135|NCT02074553|2123907|P1|Washout Period 2|Physician Decision|0
660136|NCT02074553|2123900|P8|Washout Period 2|Adverse Event|0
660137|NCT02074553|2123901|P7|Washout Period 2|Adverse Event|1
660138|NCT02074553|2123902|P6|Washout Period 2|Adverse Event|0
660139|NCT02074553|2123903|P5|Washout Period 2|Adverse Event|0
660140|NCT02074553|2123904|P4|Washout Period 2|Adverse Event|0
660141|NCT02074553|2123905|P3|Washout Period 2|Adverse Event|0
660142|NCT02074553|2123906|P2|Washout Period 2|Adverse Event|0
660143|NCT02074553|2123907|P1|Washout Period 2|Adverse Event|0
660144|NCT02074553|2123900|P8|Washout Period 1|Unspecified|0
660145|NCT02074553|2123901|P7|Washout Period 1|Unspecified|0
660146|NCT02074553|2123902|P6|Washout Period 1|Unspecified|1
660147|NCT02074553|2123903|P5|Washout Period 1|Unspecified|0
660148|NCT02074553|2123904|P4|Washout Period 1|Unspecified|0
660149|NCT02074553|2123905|P3|Washout Period 1|Unspecified|0
660150|NCT02074553|2123906|P2|Washout Period 1|Unspecified|0
660151|NCT02074553|2123907|P1|Washout Period 1|Unspecified|0
660152|NCT02074553|2123900|P8|Washout Period 1|Physician Decision|0
660153|NCT02074553|2123901|P7|Washout Period 1|Physician Decision|0
660154|NCT02074553|2123902|P6|Washout Period 1|Physician Decision|0
660155|NCT02074553|2123903|P5|Washout Period 1|Physician Decision|0
660156|NCT02074553|2123904|P4|Washout Period 1|Physician Decision|1
660157|NCT02074553|2123905|P3|Washout Period 1|Physician Decision|0
660158|NCT02074553|2123906|P2|Washout Period 1|Physician Decision|0
660159|NCT02074553|2123907|P1|Washout Period 1|Physician Decision|0
660160|NCT02074553|2123900|P8|Washout Period 1|Adverse Event|0
660161|NCT02074553|2123901|P7|Washout Period 1|Adverse Event|0
660162|NCT02074553|2123902|P6|Washout Period 1|Adverse Event|0
660163|NCT02074553|2123903|P5|Washout Period 1|Adverse Event|0
660164|NCT02074553|2123904|P4|Washout Period 1|Adverse Event|0
660165|NCT02074553|2123905|P3|Washout Period 1|Adverse Event|0
660166|NCT02074553|2123906|P2|Washout Period 1|Adverse Event|0
660167|NCT02074553|2123907|P1|Washout Period 1|Adverse Event|1
660168|NCT02074553|2123900|P8|Intervention Period 1|Family Emergency|0
660169|NCT02074553|2123901|P7|Intervention Period 1|Family Emergency|0
660170|NCT02074553|2123902|P6|Intervention Period 1|Family Emergency|0
660171|NCT02074553|2123903|P5|Intervention Period 1|Family Emergency|0
660172|NCT02074553|2123904|P4|Intervention Period 1|Family Emergency|1
660173|NCT02074553|2123905|P3|Intervention Period 1|Family Emergency|0
660174|NCT02074553|2123906|P2|Intervention Period 1|Family Emergency|0
660175|NCT02074553|2123907|P1|Intervention Period 1|Family Emergency|0
660176|NCT02074514|2124089|P2|Overall Study|Withdrew Consent|1
660177|NCT02074514|2124090|P1|Overall Study|Withdrew Consent|0
660178|NCT02074514|2124089|P2|Overall Study|Lost to Follow-up|1
660179|NCT02074514|2124090|P1|Overall Study|Lost to Follow-up|0
660180|NCT02074514|2124089|P2|Overall Study|Lack of Efficacy|2
660181|NCT02074514|2124090|P1|Overall Study|Lack of Efficacy|3
660182|NCT02074059|2124231|P6|Overall Study|Death|1
660183|NCT02074059|2124232|P5|Overall Study|Death|1
660184|NCT02074059|2124233|P4|Overall Study|Death|0
660185|NCT02074059|2124234|P3|Overall Study|Death|0
660186|NCT02074059|2124235|P2|Overall Study|Death|0
660187|NCT02074059|2124236|P1|Overall Study|Death|0
660188|NCT02073656|2124283|P1|Primary Study|Withdrew Consent|1
660189|NCT02073656|2124283|P1|Primary Study|Death|1
660190|NCT02073656|2124283|P1|Primary Study|Lost to Follow-up|6
660191|NCT02072980|2124361|P2|Period 2, Second Wear|Adverse Event|1
660192|NCT02072980|2124362|P1|Period 2, Second Wear|Adverse Event|0
660193|NCT02072096|2124384|P2|Overall Study|Lost to Follow-up|0
660194|NCT02072096|2124385|P1|Overall Study|Lost to Follow-up|1
660195|NCT02072096|2124384|P2|Overall Study|Study Terminated by Sponsor|30
660196|NCT02072096|2124385|P1|Overall Study|Study Terminated by Sponsor|43
660197|NCT02072096|2124384|P2|Overall Study|Physician Decision|1
660198|NCT02072096|2124385|P1|Overall Study|Physician Decision|0
660199|NCT02072096|2124384|P2|Overall Study|Death|0
660200|NCT02072096|2124385|P1|Overall Study|Death|2
660201|NCT02072096|2124384|P2|Overall Study|No Reason Provided|2
660202|NCT02072096|2124385|P1|Overall Study|No Reason Provided|4
660203|NCT02072096|2124384|P2|Overall Study|Adverse Event|2
660204|NCT02072096|2124385|P1|Overall Study|Adverse Event|5
660205|NCT02072096|2124384|P2|Overall Study|Withdrawal by Subject|7
660206|NCT02072096|2124385|P1|Overall Study|Withdrawal by Subject|5
660207|NCT02072096|2124384|P2|Overall Study|Protocol Violation|7
660208|NCT02072096|2124385|P1|Overall Study|Protocol Violation|7
660209|NCT02072096|2124384|P2|Overall Study|Lack of Efficacy|29
660210|NCT02072096|2124385|P1|Overall Study|Lack of Efficacy|18
660211|NCT02071849|2124407|P1|2-year Extended Follow-up|Adverse Event|1
660212|NCT02071849|2124407|P1|6-month Primary Endpoint|Adverse Event|1
660213|NCT02071849|2124407|P1|6-month Primary Endpoint|Did not receive device|4
660214|NCT02071771|2124473|P2|Period 1: First 10 Days|Unavailable lens power|0
660215|NCT02071771|2124474|P1|Period 1: First 10 Days|Unavailable lens power|1
660216|NCT02071771|2124473|P2|Period 1: First 10 Days|Unacceptable lens fit|0
660217|NCT02071771|2124474|P1|Period 1: First 10 Days|Unacceptable lens fit|1
660230|NCT02070965|2124535|P3|Overall Study|Subject moved|0
660231|NCT02070965|2124536|P2|Overall Study|Subject moved|0
660232|NCT02070965|2124537|P1|Overall Study|Subject moved|1
660233|NCT02070965|2124535|P3|Overall Study|Withdrawal by Subject|1
660234|NCT02070965|2124536|P2|Overall Study|Withdrawal by Subject|1
660235|NCT02070965|2124537|P1|Overall Study|Withdrawal by Subject|1
660236|NCT02070965|2124535|P3|Overall Study|Lost to Follow-up|0
660237|NCT02070965|2124536|P2|Overall Study|Lost to Follow-up|1
660238|NCT02070965|2124537|P1|Overall Study|Lost to Follow-up|0
660239|NCT02070588|2124578|P3|Overall Study|Adverse Event|0
660240|NCT02070588|2124579|P2|Overall Study|Adverse Event|0
660241|NCT02070588|2124580|P1|Overall Study|Adverse Event|1
660242|NCT02070588|2124578|P3|Overall Study|Writhdrawal due to early termination|0
660243|NCT02070588|2124579|P2|Overall Study|Writhdrawal due to early termination|0
660244|NCT02070588|2124580|P1|Overall Study|Writhdrawal due to early termination|9
660245|NCT02070588|2124578|P3|Overall Study|Withdrawal by Subject|0
660246|NCT02070588|2124579|P2|Overall Study|Withdrawal by Subject|1
660247|NCT02070588|2124580|P1|Overall Study|Withdrawal by Subject|29
660248|NCT02070380|2124598|P4|Second Injection|Protocol Violation|5
660249|NCT02070380|2124599|P3|Second Injection|Protocol Violation|1
660250|NCT02070380|2124600|P2|Second Injection|Protocol Violation|1
660251|NCT02070380|2124601|P1|Second Injection|Protocol Violation|0
660252|NCT02070380|2124598|P4|Second Injection|Image sets missing or technically inadeq|0
660253|NCT02070380|2124599|P3|Second Injection|Image sets missing or technically inadeq|0
660254|NCT02070380|2124600|P2|Second Injection|Image sets missing or technically inadeq|1
660255|NCT02070380|2124601|P1|Second Injection|Image sets missing or technically inadeq|0
660256|NCT02070380|2124598|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
660257|NCT02070380|2124599|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
660258|NCT02070380|2124600|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
660259|NCT02070380|2124601|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
660260|NCT02069093|2124679|P1|Overall Study|Adverse Event|10
660261|NCT02069093|2124679|P1|Overall Study|Abnormal laboratory values|1
660262|NCT02069093|2124679|P1|Overall Study|Withdrawal by Subject|2
660263|NCT02069093|2124679|P1|Overall Study|Administrative problems|1
660264|NCT02069093|2124679|P1|Overall Study|Death|1
660265|NCT02069093|2124679|P1|Overall Study|New cancer therapy|1
660266|NCT02069093|2124679|P1|Overall Study|Disease progression|14
660267|NCT02068443|2124691|P3|Overall Study|Other Reason Not Specified|0
660268|NCT02068443|2124692|P2|Overall Study|Other Reason Not Specified|0
660269|NCT02068443|2124693|P1|Overall Study|Other Reason Not Specified|1
660270|NCT02068443|2124691|P3|Overall Study|Lack of Efficacy|0
660271|NCT02068443|2124692|P2|Overall Study|Lack of Efficacy|1
660272|NCT02068443|2124693|P1|Overall Study|Lack of Efficacy|2
660273|NCT02068443|2124691|P3|Overall Study|Voluntary Withdrawal|1
660274|NCT02068443|2124692|P2|Overall Study|Voluntary Withdrawal|0
660275|NCT02068443|2124693|P1|Overall Study|Voluntary Withdrawal|4
660276|NCT02068443|2124691|P3|Overall Study|Pretreatment Event/Adverse Event|2
660277|NCT02068443|2124692|P2|Overall Study|Pretreatment Event/Adverse Event|5
660278|NCT02068443|2124693|P1|Overall Study|Pretreatment Event/Adverse Event|0
660279|NCT02068222|2124728|P1|Overall Study|Lost to Follow-up|1
660280|NCT02067728|2124753|P2|6 Month Measurements|Unable to attend|97
660281|NCT02067728|2124754|P1|6 Month Measurements|Unable to attend|114
660282|NCT02067728|2124753|P2|6 Month Follow up Survey|Lost to Follow-up|60
660283|NCT02067728|2124754|P1|6 Month Follow up Survey|Lost to Follow-up|48
660284|NCT02067728|2124753|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
660285|NCT02067728|2124754|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
660286|NCT02067533|2124824|P2|Overall Study|Lost to Follow-up|2
660287|NCT02067533|2124825|P1|Overall Study|Lost to Follow-up|4
660288|NCT02066922|2124840|P1|Overall Study|Adverse Event|1
660289|NCT02066402|2124894|P2|Overall Study|Protocol driven decision point|1
660290|NCT02066402|2124895|P1|Overall Study|Protocol driven decision point|0
660291|NCT02066402|2124894|P2|Overall Study|Progressive disease-clinical progression|1
660292|NCT02066402|2124895|P1|Overall Study|Progressive disease-clinical progression|0
660293|NCT02066402|2124894|P2|Overall Study|Withdrawal by Subject|11
660294|NCT02066402|2124895|P1|Overall Study|Withdrawal by Subject|14
660295|NCT02066402|2124894|P2|Overall Study|Lost to Follow-up|8
660296|NCT02066402|2124895|P1|Overall Study|Lost to Follow-up|11
660297|NCT02066402|2124894|P2|Overall Study|Adverse Event|2
660298|NCT02066402|2124895|P1|Overall Study|Adverse Event|1
660299|NCT02066233|2124923|P2|EG Scan II (Day 1)|difficulty intubating subject|6
660300|NCT02066233|2124924|P1|EG Scan II (Day 1)|difficulty intubating subject|6
660301|NCT02066051|2124932|P1|Overall Study|Subject developed active GVHD|1
660302|NCT02064920|2125113|P2|Overall Study|Withdrawal by Subject|3
660303|NCT02064920|2125114|P1|Overall Study|Withdrawal by Subject|1
660304|NCT02064920|2125113|P2|Overall Study|Technical Problems|1
660305|NCT02064920|2125114|P1|Overall Study|Technical Problems|0
660306|NCT02064920|2125113|P2|Overall Study|Physician Decision|1
660307|NCT02064920|2125114|P1|Overall Study|Physician Decision|0
660308|NCT02064920|2125113|P2|Overall Study|Adverse Event|4
660309|NCT02064920|2125114|P1|Overall Study|Adverse Event|0
660310|NCT02064894|2125144|P3|Overall Study|Withdrawal by Subject|115
660311|NCT02064894|2125145|P2|Overall Study|Withdrawal by Subject|102
660312|NCT02064894|2125146|P1|Overall Study|Withdrawal by Subject|43
660313|NCT02064231|2125157|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
660314|NCT02064231|2125158|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
660315|NCT02064231|2125159|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
660316|NCT02064231|2125160|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
660317|NCT02064231|2125157|P4|First Test Period (Test A or Test C)|Adverse Event|0
660318|NCT02064231|2125158|P3|First Test Period (Test A or Test C)|Adverse Event|1
660319|NCT02064231|2125159|P2|First Test Period (Test A or Test C)|Adverse Event|0
660320|NCT02064231|2125160|P1|First Test Period (Test A or Test C)|Adverse Event|1
660321|NCT02064231|2125157|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
660322|NCT02064231|2125158|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
660323|NCT02064231|2125159|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
660324|NCT02064231|2125160|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
660325|NCT02064231|2125157|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
660326|NCT02064231|2125158|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
660327|NCT02064231|2125159|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
660328|NCT02064231|2125160|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
660329|NCT02064205|2125172|P1|Overall Study|Withdrawal by Subject|1
660330|NCT02063880|2125190|P2|Overall Study|Ineligible|2
660331|NCT02063880|2125191|P1|Overall Study|Ineligible|0
660332|NCT02063880|2125190|P2|Overall Study|Lost to Follow-up|7
660333|NCT02063880|2125191|P1|Overall Study|Lost to Follow-up|7
660334|NCT02063880|2125190|P2|Overall Study|Death|18
660335|NCT02063880|2125191|P1|Overall Study|Death|21
660336|NCT02063854|2125208|P7|Overall Study|Did Not Receive Study Drug|0
660337|NCT02063854|2125209|P6|Overall Study|Did Not Receive Study Drug|1
660338|NCT02063854|2125210|P5|Overall Study|Did Not Receive Study Drug|0
660339|NCT02063854|2125211|P4|Overall Study|Did Not Receive Study Drug|0
660340|NCT02063854|2125212|P3|Overall Study|Did Not Receive Study Drug|0
660341|NCT02063854|2125213|P2|Overall Study|Did Not Receive Study Drug|0
660342|NCT02063854|2125214|P1|Overall Study|Did Not Receive Study Drug|0
660343|NCT02063854|2125208|P7|Overall Study|Reason Not Specified|0
660344|NCT02063854|2125209|P6|Overall Study|Reason Not Specified|0
660345|NCT02063854|2125210|P5|Overall Study|Reason Not Specified|0
660346|NCT02063854|2125211|P4|Overall Study|Reason Not Specified|0
660347|NCT02063854|2125212|P3|Overall Study|Reason Not Specified|0
660348|NCT02063854|2125213|P2|Overall Study|Reason Not Specified|0
660349|NCT02063854|2125214|P1|Overall Study|Reason Not Specified|1
660350|NCT02063854|2125208|P7|Overall Study|Surgical Dental Work Performed/Planned|1
660351|NCT02063854|2125209|P6|Overall Study|Surgical Dental Work Performed/Planned|6
660352|NCT02063854|2125210|P5|Overall Study|Surgical Dental Work Performed/Planned|1
660353|NCT02063854|2125211|P4|Overall Study|Surgical Dental Work Performed/Planned|1
660354|NCT02063854|2125212|P3|Overall Study|Surgical Dental Work Performed/Planned|6
660355|NCT02063854|2125213|P2|Overall Study|Surgical Dental Work Performed/Planned|2
660356|NCT02063854|2125214|P1|Overall Study|Surgical Dental Work Performed/Planned|5
660357|NCT02063854|2125208|P7|Overall Study|Voluntary Withdrawal|1
660358|NCT02063854|2125209|P6|Overall Study|Voluntary Withdrawal|6
660359|NCT02063854|2125210|P5|Overall Study|Voluntary Withdrawal|3
660360|NCT02063854|2125211|P4|Overall Study|Voluntary Withdrawal|1
660361|NCT02063854|2125212|P3|Overall Study|Voluntary Withdrawal|8
660362|NCT02063854|2125213|P2|Overall Study|Voluntary Withdrawal|0
660363|NCT02063854|2125214|P1|Overall Study|Voluntary Withdrawal|2
660364|NCT02063854|2125208|P7|Overall Study|Major Protocol Deviation|0
660365|NCT02063854|2125209|P6|Overall Study|Major Protocol Deviation|0
660366|NCT02063854|2125210|P5|Overall Study|Major Protocol Deviation|0
660367|NCT02063854|2125211|P4|Overall Study|Major Protocol Deviation|0
660368|NCT02063854|2125212|P3|Overall Study|Major Protocol Deviation|3
660369|NCT02063854|2125213|P2|Overall Study|Major Protocol Deviation|0
660370|NCT02063854|2125214|P1|Overall Study|Major Protocol Deviation|0
660371|NCT02063854|2125208|P7|Overall Study|Pretreatment Event/Adverse Event|4
660372|NCT02063854|2125209|P6|Overall Study|Pretreatment Event/Adverse Event|18
660373|NCT02063854|2125210|P5|Overall Study|Pretreatment Event/Adverse Event|7
660374|NCT02063854|2125211|P4|Overall Study|Pretreatment Event/Adverse Event|8
660375|NCT02063854|2125212|P3|Overall Study|Pretreatment Event/Adverse Event|13
660376|NCT02063854|2125213|P2|Overall Study|Pretreatment Event/Adverse Event|10
660377|NCT02063854|2125214|P1|Overall Study|Pretreatment Event/Adverse Event|13
660378|NCT02063737|2125298|P2|Overall Study|Lost to Follow-up|4
660379|NCT02063737|2125299|P1|Overall Study|Lost to Follow-up|11
660380|NCT02063659|2125334|P3|Overall Study|Withdrawal by Subject|3
660381|NCT02063659|2125335|P2|Overall Study|Withdrawal by Subject|1
660382|NCT02063659|2125336|P1|Overall Study|Withdrawal by Subject|0
660383|NCT02063659|2125334|P3|Overall Study|Physician Decision|0
660384|NCT02063659|2125335|P2|Overall Study|Physician Decision|0
660385|NCT02063659|2125336|P1|Overall Study|Physician Decision|1
660386|NCT02063659|2125334|P3|Overall Study|Adverse Event|0
660387|NCT02063659|2125335|P2|Overall Study|Adverse Event|2
660388|NCT02063659|2125336|P1|Overall Study|Adverse Event|1
660389|NCT02062879|2125440|P2|Overall Study|Withdrawal by Subject|1
660390|NCT02062879|2125441|P1|Overall Study|Withdrawal by Subject|4
660391|NCT02062658|2125477|P1|Overall Study|Lack of Efficacy|1
660392|NCT02062658|2125477|P1|Overall Study|Withdrawal by Subject|1
660393|NCT02062645|2125481|P1|Overall Study|Lost to Follow-up|5
660394|NCT02062645|2125481|P1|Overall Study|Protocol Violation|8
660395|NCT02062645|2125481|P1|Overall Study|Adverse Event|2
660396|NCT02062450|2125523|P1|Overall Study|No follow-up visit|124
660397|NCT02062437|2125537|P1|Overall Study|Pt. couldn't come due to med. condition|1
660398|NCT02062437|2125537|P1|Overall Study|Death|2
660399|NCT02062437|2125537|P1|Overall Study|Patient not available for the 2y visit|18
660400|NCT02062437|2125537|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
660429|NCT02061592|2125688|P2|Period 2|Lost to Follow-up|1
660430|NCT02061592|2125689|P1|Period 2|Lost to Follow-up|0
660431|NCT02061592|2125688|P2|Period 1|Protocol Violation|0
660432|NCT02061592|2125689|P1|Period 1|Protocol Violation|1
660433|NCT02061592|2125688|P2|Period 1|Withdrawal by Subject|0
660434|NCT02061592|2125689|P1|Period 1|Withdrawal by Subject|1
660435|NCT02061540|2125701|P1|Overall Study|Withdrawal by Subject|2
660436|NCT02061540|2125701|P1|Overall Study|Adverse Event|2
660437|NCT02059291|2126003|P6|Overall Study|Withdrawal by Subject|1
660438|NCT02059291|2126004|P5|Overall Study|Withdrawal by Subject|0
660439|NCT02059291|2126005|P4|Overall Study|Withdrawal by Subject|0
660440|NCT02059291|2126006|P3|Overall Study|Withdrawal by Subject|0
660441|NCT02059291|2126007|P2|Overall Study|Withdrawal by Subject|1
660442|NCT02059291|2126008|P1|Overall Study|Withdrawal by Subject|0
660443|NCT02059291|2126003|P6|Overall Study|Adverse Event|0
660444|NCT02059291|2126004|P5|Overall Study|Adverse Event|0
660445|NCT02059291|2126005|P4|Overall Study|Adverse Event|1
660446|NCT02059291|2126006|P3|Overall Study|Adverse Event|1
660447|NCT02059291|2126007|P2|Overall Study|Adverse Event|0
660448|NCT02059291|2126008|P1|Overall Study|Adverse Event|0
660449|NCT02059291|2126003|P6|Overall Study|Lack of Efficacy|1
660450|NCT02059291|2126004|P5|Overall Study|Lack of Efficacy|0
660451|NCT02059291|2126005|P4|Overall Study|Lack of Efficacy|1
660452|NCT02059291|2126006|P3|Overall Study|Lack of Efficacy|0
660453|NCT02059291|2126007|P2|Overall Study|Lack of Efficacy|0
660454|NCT02059291|2126008|P1|Overall Study|Lack of Efficacy|0
660455|NCT02059187|2126024|P2|Overall Study|Withdrawal by Subject|8
660456|NCT02059187|2126025|P1|Overall Study|Withdrawal by Subject|12
660457|NCT02059187|2126024|P2|Overall Study|Protocol Violation|0
660458|NCT02059187|2126025|P1|Overall Study|Protocol Violation|1
660459|NCT02059187|2126024|P2|Overall Study|Physician Decision|2
660460|NCT02059187|2126025|P1|Overall Study|Physician Decision|1
660461|NCT02059187|2126024|P2|Overall Study|Non-compliance with study drug|0
660462|NCT02059187|2126025|P1|Overall Study|Non-compliance with study drug|1
660463|NCT02059187|2126024|P2|Overall Study|Lost to Follow-up|8
660464|NCT02059187|2126025|P1|Overall Study|Lost to Follow-up|9
660465|NCT02059187|2126024|P2|Overall Study|Death|1
660466|NCT02059187|2126025|P1|Overall Study|Death|1
660467|NCT02059187|2126024|P2|Overall Study|Adverse Event|3
660468|NCT02059187|2126025|P1|Overall Study|Adverse Event|0
660477|NCT02059161|2126076|P2|Overall Study|Non-compliance with study drug|2
660478|NCT02059161|2126077|P1|Overall Study|Non-compliance with study drug|6
660479|NCT02059161|2126076|P2|Overall Study|Randomized in error, no study drug|1
660480|NCT02059161|2126077|P1|Overall Study|Randomized in error, no study drug|0
660481|NCT02059161|2126076|P2|Overall Study|Withdrawal by Subject|13
660482|NCT02059161|2126077|P1|Overall Study|Withdrawal by Subject|16
660483|NCT02059161|2126076|P2|Overall Study|Protocol Violation|1
660484|NCT02059161|2126077|P1|Overall Study|Protocol Violation|1
660485|NCT02059161|2126076|P2|Overall Study|Physician Decision|4
660486|NCT02059161|2126077|P1|Overall Study|Physician Decision|4
660487|NCT02059161|2126076|P2|Overall Study|Lost to Follow-up|12
660488|NCT02059161|2126077|P1|Overall Study|Lost to Follow-up|20
660489|NCT02059161|2126076|P2|Overall Study|Adverse Event|6
660490|NCT02059161|2126077|P1|Overall Study|Adverse Event|2
660491|NCT02059161|2126076|P2|Overall Study|Pregnancy|2
660492|NCT02059161|2126077|P1|Overall Study|Pregnancy|0
660493|NCT02059135|2126139|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
660494|NCT02059135|2126140|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
660495|NCT02059135|2126139|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
660496|NCT02059135|2126140|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
660497|NCT02059135|2126139|P2|Neonatal Follow-up (Safety Population)|Death|2
660498|NCT02059135|2126140|P1|Neonatal Follow-up (Safety Population)|Death|3
660499|NCT02059135|2126139|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
660500|NCT02059135|2126140|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
660501|NCT02059135|2126139|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
660502|NCT02059135|2126140|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
660503|NCT02059135|2126139|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
660504|NCT02059135|2126140|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
660505|NCT02059135|2126139|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
660506|NCT02059135|2126140|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
660507|NCT02059135|2126139|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
660508|NCT02059135|2126140|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
660509|NCT02058992|2126167|P1|Overall Study|CRF Uncollected|20
660510|NCT02058992|2126167|P1|Overall Study|Protocol Violation|92
660511|NCT02058992|2126167|P1|Overall Study|Lost to Follow-up|4
660512|NCT02058628|2126178|P2|Overall Study|Non compliance|0
660513|NCT02058628|2126179|P1|Overall Study|Non compliance|1
660514|NCT02058628|2126178|P2|Overall Study|A lot of time for study for participant|0
660515|NCT02058628|2126179|P1|Overall Study|A lot of time for study for participant|1
660516|NCT02058628|2126178|P2|Overall Study|The visit date was not in timeline|1
660517|NCT02058628|2126179|P1|Overall Study|The visit date was not in timeline|0
660518|NCT02058628|2126178|P2|Overall Study|Not in time schedule|1
660519|NCT02058628|2126179|P1|Overall Study|Not in time schedule|0
660520|NCT02058628|2126178|P2|Overall Study|Lost to Follow-up|4
660521|NCT02058628|2126179|P1|Overall Study|Lost to Follow-up|2
660522|NCT02058628|2126178|P2|Overall Study|Withdrawal by Subject|2
660523|NCT02058628|2126179|P1|Overall Study|Withdrawal by Subject|2
660524|NCT02058628|2126178|P2|Overall Study|Adverse Event|0
660525|NCT02058628|2126179|P1|Overall Study|Adverse Event|1
660526|NCT02058563|2126211|P2|Overall Study|Other (patient incarcerated)|1
660527|NCT02058563|2126212|P1|Overall Study|Other (patient incarcerated)|0
660528|NCT02058563|2126211|P2|Overall Study|Consent Withdrawal|1
660529|NCT02058563|2126212|P1|Overall Study|Consent Withdrawal|1
660530|NCT02058563|2126211|P2|Overall Study|Other (vaccinated later as new subject)|0
660531|NCT02058563|2126212|P1|Overall Study|Other (vaccinated later as new subject)|1
660532|NCT02058563|2126211|P2|Overall Study|Lost to Follow-up|22
660533|NCT02058563|2126212|P1|Overall Study|Lost to Follow-up|26
660534|NCT02058537|2126248|P1|Overall Study|Withdrawal by Subject|1
660535|NCT02058498|2126254|P1|Overall Study|Withdrawal by Subject|4
660536|NCT02058290|2126262|P2|Overall Study|Withdrawal by Subject|1
660537|NCT02058290|2126263|P1|Overall Study|Withdrawal by Subject|0
660538|NCT02058290|2126262|P2|Overall Study|Didn't meet intraoperative criteria|7
660539|NCT02058290|2126263|P1|Overall Study|Didn't meet intraoperative criteria|8
660540|NCT02058290|2126262|P2|Overall Study|Physician Decision|0
660541|NCT02058290|2126263|P1|Overall Study|Physician Decision|1
660542|NCT02058290|2126262|P2|Overall Study|Protocol Violation|1
660543|NCT02058290|2126263|P1|Overall Study|Protocol Violation|2
660544|NCT02058160|2126279|P2|Overall Study|Other than specified above|6
660545|NCT02058160|2126280|P1|Overall Study|Other than specified above|12
660546|NCT02058160|2126279|P2|Overall Study|Lost to Follow-up|0
660547|NCT02058160|2126280|P1|Overall Study|Lost to Follow-up|1
660548|NCT02058160|2126279|P2|Overall Study|Adverse Event|3
660549|NCT02058160|2126280|P1|Overall Study|Adverse Event|12
660550|NCT02058160|2126279|P2|Overall Study|Poor compliance to protocol|1
660551|NCT02058160|2126280|P1|Overall Study|Poor compliance to protocol|4
660552|NCT02058160|2126279|P2|Overall Study|Randomized but not treated|4
660553|NCT02058160|2126280|P1|Overall Study|Randomized but not treated|2
660554|NCT02058147|2126317|P3|Overall Study|Other than specified|0
660555|NCT02058147|2126318|P2|Overall Study|Other than specified|9
660556|NCT02058147|2126319|P1|Overall Study|Other than specified|8
660557|NCT02058147|2126317|P3|Overall Study|Poor compliance to protocol|4
660558|NCT02058147|2126318|P2|Overall Study|Poor compliance to protocol|9
660559|NCT02058147|2126319|P1|Overall Study|Poor compliance to protocol|8
660560|NCT02058147|2126317|P3|Overall Study|Lack of Efficacy|3
660561|NCT02058147|2126318|P2|Overall Study|Lack of Efficacy|0
660562|NCT02058147|2126319|P1|Overall Study|Lack of Efficacy|1
660563|NCT02058147|2126317|P3|Overall Study|Adverse Event|21
660564|NCT02058147|2126318|P2|Overall Study|Adverse Event|9
660565|NCT02058147|2126319|P1|Overall Study|Adverse Event|12
660566|NCT02058147|2126317|P3|Overall Study|Randomized but not treated|1
660567|NCT02058147|2126318|P2|Overall Study|Randomized but not treated|0
660568|NCT02058147|2126319|P1|Overall Study|Randomized but not treated|0
660569|NCT02058069|2126368|P1|Overall Study|Withdrawal by Subject|6
660570|NCT02058069|2126368|P1|Overall Study|Exclusion due to implant size|5
660571|NCT02057835|2126387|P10|Overall Study|Withdrawal by Subject|0
660572|NCT02057835|2126388|P9|Overall Study|Withdrawal by Subject|0
660573|NCT02057835|2126389|P8|Overall Study|Withdrawal by Subject|0
660574|NCT02057835|2126390|P7|Overall Study|Withdrawal by Subject|0
660575|NCT02057835|2126391|P6|Overall Study|Withdrawal by Subject|0
660576|NCT02057835|2126392|P5|Overall Study|Withdrawal by Subject|0
660577|NCT02057835|2126393|P4|Overall Study|Withdrawal by Subject|0
660578|NCT02057835|2126394|P3|Overall Study|Withdrawal by Subject|0
660579|NCT02057835|2126395|P2|Overall Study|Withdrawal by Subject|2
660580|NCT02057835|2126396|P1|Overall Study|Withdrawal by Subject|0
660581|NCT02057549|2126475|P2|Overall Study|Withdrawal by Subject|0
660582|NCT02057549|2126476|P1|Overall Study|Withdrawal by Subject|1
660583|NCT02057549|2126475|P2|Overall Study|Physician Decision|0
660584|NCT02057549|2126476|P1|Overall Study|Physician Decision|1
660585|NCT02057549|2126475|P2|Overall Study|Lost to Follow-up|0
660586|NCT02057549|2126476|P1|Overall Study|Lost to Follow-up|1
660587|NCT02057406|2126499|P3|Overall Study|Patient transportation issues|1
660588|NCT02057406|2126500|P2|Overall Study|Patient transportation issues|0
660589|NCT02057406|2126501|P1|Overall Study|Patient transportation issues|0
660590|NCT02057406|2126499|P3|Overall Study|Protocol Violation|0
660591|NCT02057406|2126500|P2|Overall Study|Protocol Violation|1
660592|NCT02057406|2126501|P1|Overall Study|Protocol Violation|0
660593|NCT02057406|2126499|P3|Overall Study|Death|0
660594|NCT02057406|2126500|P2|Overall Study|Death|0
660595|NCT02057406|2126501|P1|Overall Study|Death|1
660596|NCT02057406|2126499|P3|Overall Study|Lost to Follow-up|1
660597|NCT02057406|2126500|P2|Overall Study|Lost to Follow-up|0
660598|NCT02057406|2126501|P1|Overall Study|Lost to Follow-up|0
660599|NCT02057406|2126499|P3|Overall Study|Withdrawal by Subject|0
660600|NCT02057406|2126500|P2|Overall Study|Withdrawal by Subject|2
660601|NCT02057406|2126501|P1|Overall Study|Withdrawal by Subject|0
660602|NCT02057406|2126499|P3|Overall Study|Physician Decision|2
660603|NCT02057406|2126500|P2|Overall Study|Physician Decision|0
660604|NCT02057406|2126501|P1|Overall Study|Physician Decision|0
660605|NCT02057393|2126512|P1|Overall Study|Patient did not meet criteria|1
660606|NCT02057393|2126512|P1|Overall Study|Withdrawal by Subject|1
660607|NCT02057250|2126533|P5|Extension Phase|Other than specified above|7
660608|NCT02057250|2126534|P4|Extension Phase|Other than specified above|0
660609|NCT02057250|2126535|P3|Extension Phase|Other than specified above|0
660610|NCT02057250|2126536|P2|Extension Phase|Other than specified above|0
660611|NCT02057250|2126537|P1|Extension Phase|Other than specified above|0
660612|NCT02057250|2126533|P5|Extension Phase|Entered in this period but not treated|4
660613|NCT02057250|2126534|P4|Extension Phase|Entered in this period but not treated|0
660614|NCT02057250|2126535|P3|Extension Phase|Entered in this period but not treated|0
660615|NCT02057250|2126536|P2|Extension Phase|Entered in this period but not treated|0
660616|NCT02057250|2126537|P1|Extension Phase|Entered in this period but not treated|0
660617|NCT02057250|2126533|P5|Extension Phase|Lack of Efficacy|10
660618|NCT02057250|2126534|P4|Extension Phase|Lack of Efficacy|0
660619|NCT02057250|2126535|P3|Extension Phase|Lack of Efficacy|0
660620|NCT02057250|2126536|P2|Extension Phase|Lack of Efficacy|0
660621|NCT02057250|2126537|P1|Extension Phase|Lack of Efficacy|0
660622|NCT02057250|2126533|P5|Extension Phase|Adverse Event|15
660623|NCT02057250|2126534|P4|Extension Phase|Adverse Event|0
660624|NCT02057250|2126535|P3|Extension Phase|Adverse Event|0
660625|NCT02057250|2126536|P2|Extension Phase|Adverse Event|0
660626|NCT02057250|2126537|P1|Extension Phase|Adverse Event|0
660627|NCT02057250|2126533|P5|AID Assessment Phase|Other than specified above|0
660628|NCT02057250|2126534|P4|AID Assessment Phase|Other than specified above|1
660629|NCT02057250|2126535|P3|AID Assessment Phase|Other than specified above|1
660630|NCT02057250|2126536|P2|AID Assessment Phase|Other than specified above|1
660631|NCT02057250|2126537|P1|AID Assessment Phase|Other than specified above|1
660632|NCT02057250|2126533|P5|AID Assessment Phase|Adverse Event|0
660633|NCT02057250|2126534|P4|AID Assessment Phase|Adverse Event|1
660634|NCT02057250|2126535|P3|AID Assessment Phase|Adverse Event|6
660635|NCT02057250|2126536|P2|AID Assessment Phase|Adverse Event|2
660636|NCT02057250|2126537|P1|AID Assessment Phase|Adverse Event|3
660637|NCT02056834|2126555|P1|Overall Study|Lost to Follow-up|7
660638|NCT02056392|2126580|P6|Overall Study|Withdrawal by Subject|0
660639|NCT02056392|2126581|P5|Overall Study|Withdrawal by Subject|1
660640|NCT02056392|2126582|P4|Overall Study|Withdrawal by Subject|0
660641|NCT02056392|2126583|P3|Overall Study|Withdrawal by Subject|0
660642|NCT02056392|2126584|P2|Overall Study|Withdrawal by Subject|0
660643|NCT02056392|2126585|P1|Overall Study|Withdrawal by Subject|1
660644|NCT02056392|2126580|P6|Overall Study|Protocol Violation|0
660645|NCT02056392|2126581|P5|Overall Study|Protocol Violation|0
660646|NCT02056392|2126582|P4|Overall Study|Protocol Violation|0
660647|NCT02056392|2126583|P3|Overall Study|Protocol Violation|1
660648|NCT02056392|2126584|P2|Overall Study|Protocol Violation|0
660649|NCT02056392|2126585|P1|Overall Study|Protocol Violation|1
660650|NCT02056392|2126580|P6|Overall Study|Lost to Follow-up|0
660651|NCT02056392|2126581|P5|Overall Study|Lost to Follow-up|0
660652|NCT02056392|2126582|P4|Overall Study|Lost to Follow-up|0
660653|NCT02056392|2126583|P3|Overall Study|Lost to Follow-up|2
660654|NCT02056392|2126584|P2|Overall Study|Lost to Follow-up|1
660655|NCT02056392|2126585|P1|Overall Study|Lost to Follow-up|0
660656|NCT02055352|2126644|P2|Overall Study|Reason unknown|5
660657|NCT02055352|2126645|P1|Overall Study|Reason unknown|1
660658|NCT02055352|2126644|P2|Overall Study|Withdrawal of informed consent|0
660659|NCT02055352|2126645|P1|Overall Study|Withdrawal of informed consent|1
660660|NCT02055352|2126644|P2|Overall Study|AE, study drug would be detrimental|3
660661|NCT02055352|2126645|P1|Overall Study|AE, study drug would be detrimental|1
660662|NCT02055352|2126644|P2|Overall Study|Use of prohibited treatment|3
660663|NCT02055352|2126645|P1|Overall Study|Use of prohibited treatment|0
660664|NCT02055352|2126644|P2|Overall Study|Patient decision|1
660665|NCT02055352|2126645|P1|Overall Study|Patient decision|1
660666|NCT02055352|2126644|P2|Overall Study|Death|2
660667|NCT02055352|2126645|P1|Overall Study|Death|1
660668|NCT02055352|2126644|P2|Overall Study|Poor compliance|1
660669|NCT02055352|2126645|P1|Overall Study|Poor compliance|1
660670|NCT02055352|2126644|P2|Overall Study|Non-eligible|1
660671|NCT02055352|2126645|P1|Overall Study|Non-eligible|0
660672|NCT02055352|2126644|P2|Overall Study|Adverse Event|1
660673|NCT02055352|2126645|P1|Overall Study|Adverse Event|0
660674|NCT02054910|2126661|P2|Overall Study|Lost to Follow-up|1
660675|NCT02054910|2126662|P1|Overall Study|Lost to Follow-up|4
660676|NCT02054715|2126702|P2|Follow-up 2|Treatment Change or Delay|0
660677|NCT02054715|2126703|P1|Follow-up 2|Treatment Change or Delay|1
660678|NCT02054715|2126702|P2|Follow-up 2|No Reason|0
660679|NCT02054715|2126703|P1|Follow-up 2|No Reason|2
660680|NCT02054715|2126702|P2|Follow-up 2|Changed Mind|1
660681|NCT02054715|2126703|P1|Follow-up 2|Changed Mind|0
660682|NCT02054715|2126702|P2|Follow-up 2|Changed MD/Facility|1
660683|NCT02054715|2126703|P1|Follow-up 2|Changed MD/Facility|0
660684|NCT02054715|2126702|P2|Follow-up 2|Hospitalization|2
660685|NCT02054715|2126703|P1|Follow-up 2|Hospitalization|0
660686|NCT02054715|2126702|P2|Follow-up 2|Death|3
660687|NCT02054715|2126703|P1|Follow-up 2|Death|3
660688|NCT02054715|2126702|P2|Follow-up 2|Ineligible|5
660689|NCT02054715|2126703|P1|Follow-up 2|Ineligible|4
660690|NCT02054715|2126702|P2|Follow-up 2|Followup Not Completed|4
660691|NCT02054715|2126703|P1|Follow-up 2|Followup Not Completed|3
660692|NCT02054715|2126702|P2|Follow-up 2|Refused|2
660693|NCT02054715|2126703|P1|Follow-up 2|Refused|3
660694|NCT02054715|2126702|P2|Follow-up 2|Lost to Followup|1
660695|NCT02054715|2126703|P1|Follow-up 2|Lost to Followup|3
660696|NCT02054715|2126702|P2|Baseline/Follow-up 1|Changed Mind|0
660697|NCT02054715|2126703|P1|Baseline/Follow-up 1|Changed Mind|1
660698|NCT02054715|2126702|P2|Baseline/Follow-up 1|Hospitalization|0
660699|NCT02054715|2126703|P1|Baseline/Follow-up 1|Hospitalization|1
660700|NCT02054715|2126702|P2|Baseline/Follow-up 1|Ineligible|0
660701|NCT02054715|2126703|P1|Baseline/Follow-up 1|Ineligible|3
660702|NCT02054715|2126702|P2|Baseline/Follow-up 1|Overwhelmed|0
660703|NCT02054715|2126703|P1|Baseline/Follow-up 1|Overwhelmed|2
660704|NCT02054715|2126702|P2|Baseline/Follow-up 1|No Reason|1
660705|NCT02054715|2126703|P1|Baseline/Follow-up 1|No Reason|0
660706|NCT02054715|2126702|P2|Baseline/Follow-up 1|Disliked Procedure|1
660707|NCT02054715|2126703|P1|Baseline/Follow-up 1|Disliked Procedure|0
660708|NCT02054715|2126702|P2|Baseline/Follow-up 1|Changed MD/Facility|1
660709|NCT02054715|2126703|P1|Baseline/Follow-up 1|Changed MD/Facility|0
660710|NCT02054715|2126702|P2|Baseline/Follow-up 1|Medical|1
660711|NCT02054715|2126703|P1|Baseline/Follow-up 1|Medical|0
660712|NCT02054715|2126702|P2|Baseline/Follow-up 1|Refused|3
660713|NCT02054715|2126703|P1|Baseline/Follow-up 1|Refused|1
660714|NCT02054702|2126717|P2|Overall Study|Withdrawal by Subject|4
660715|NCT02054702|2126718|P1|Overall Study|Withdrawal by Subject|14
660716|NCT02054702|2126717|P2|Overall Study|Physician Decision|1
660717|NCT02054702|2126718|P1|Overall Study|Physician Decision|0
660718|NCT02054702|2126717|P2|Overall Study|Met Withdrawal Criteria|1
660719|NCT02054702|2126718|P1|Overall Study|Met Withdrawal Criteria|4
660720|NCT02054702|2126717|P2|Overall Study|Adverse Event|1
660721|NCT02054702|2126718|P1|Overall Study|Adverse Event|3
660722|NCT02054702|2126717|P2|Overall Study|Lost to Follow-up|5
660723|NCT02054702|2126718|P1|Overall Study|Lost to Follow-up|3
660724|NCT02054481|2126773|P4|Overall Study|Other reason|0
660725|NCT02054481|2126774|P3|Overall Study|Other reason|2
660726|NCT02054481|2126775|P2|Overall Study|Other reason|1
660727|NCT02054481|2126776|P1|Overall Study|Other reason|2
660728|NCT02054481|2126773|P4|Overall Study|Lost to Follow-up|0
660729|NCT02054481|2126774|P3|Overall Study|Lost to Follow-up|0
660730|NCT02054481|2126775|P2|Overall Study|Lost to Follow-up|0
660731|NCT02054481|2126776|P1|Overall Study|Lost to Follow-up|1
660732|NCT02054481|2126773|P4|Overall Study|Adverse Event|1
660733|NCT02054481|2126774|P3|Overall Study|Adverse Event|0
660734|NCT02054481|2126775|P2|Overall Study|Adverse Event|1
660735|NCT02054481|2126776|P1|Overall Study|Adverse Event|1
660736|NCT02054325|2126824|P2|Overall Study|Lost to Follow-up|5
660737|NCT02054325|2126825|P1|Overall Study|Lost to Follow-up|8
660754|NCT02053493|2126868|P2|Overall Study|Withdrawal by Subject|1
660755|NCT02053493|2126869|P1|Overall Study|Withdrawal by Subject|1
660756|NCT02052466|2126975|P1|Overall Study|Acromial fracture|1
660757|NCT02052466|2126975|P1|Overall Study|Withdrawal by Subject|1
660758|NCT02052414|2126990|P1|Overall Study|Withdrawal by Subject|3
660759|NCT02052414|2126990|P1|Overall Study|Lack of Efficacy|2
660760|NCT02052414|2126990|P1|Overall Study|Adverse Event|12
660761|NCT02052011|2127000|P2|Overall Study|Withdrawal by Subject|2
660762|NCT02052011|2127001|P1|Overall Study|Withdrawal by Subject|1
660763|NCT02052011|2127000|P2|Overall Study|Lost to Follow-up|0
660764|NCT02052011|2127001|P1|Overall Study|Lost to Follow-up|3
660765|NCT02050048|2127147|P2|Overall Study|Ineligible after ERCP|1
660766|NCT02050048|2127148|P1|Overall Study|Ineligible after ERCP|4
660767|NCT02050048|2127147|P2|Overall Study|Death|0
660768|NCT02050048|2127148|P1|Overall Study|Death|1
660769|NCT02050048|2127147|P2|Overall Study|Lost to Follow-up|1
660770|NCT02050048|2127148|P1|Overall Study|Lost to Follow-up|0
660771|NCT02049450|2127167|P1|Overall Study|Patients/guardian decision|1
660772|NCT02049450|2127167|P1|Overall Study|Withdrawal by Subject|1
660773|NCT02049450|2127167|P1|Overall Study|Adverse Event|2
660774|NCT02048904|2127198|P1|Overall Study|Physician Decision|70
660775|NCT02048904|2127198|P1|Overall Study|Withdrawal by Subject|7
660776|NCT02048072|2127211|P1|Overall Study|Lost to Follow-up|1
660777|NCT02048072|2127211|P1|Overall Study|Adverse Event|3
660778|NCT02047227|2127222|P2|Overall Study|Unspecified|9
660779|NCT02047227|2127223|P1|Overall Study|Unspecified|10
660780|NCT02047227|2127222|P2|Overall Study|All embryos discarded|11
660781|NCT02047227|2127223|P1|Overall Study|All embryos discarded|12
660782|NCT02047227|2127222|P2|Overall Study|Intention to freeze all embryos|0
660783|NCT02047227|2127223|P1|Overall Study|Intention to freeze all embryos|1
660784|NCT02047227|2127222|P2|Overall Study|No fertilization|51
660785|NCT02047227|2127223|P1|Overall Study|No fertilization|61
660786|NCT02047227|2127222|P2|Overall Study|No oocytes retrieved|20
660787|NCT02047227|2127223|P1|Overall Study|No oocytes retrieved|21
660788|NCT02047227|2127222|P2|Overall Study|Lack of ovarian response to stimulation|32
660789|NCT02047227|2127223|P1|Overall Study|Lack of ovarian response to stimulation|35
660790|NCT02047227|2127222|P2|Overall Study|Spontaneous pregnancy|0
660791|NCT02047227|2127223|P1|Overall Study|Spontaneous pregnancy|1
660792|NCT02047227|2127222|P2|Overall Study|Protocol Violation|0
660793|NCT02047227|2127223|P1|Overall Study|Protocol Violation|1
660794|NCT02047227|2127222|P2|Overall Study|Lost to Follow-up|3
660795|NCT02047227|2127223|P1|Overall Study|Lost to Follow-up|0
660796|NCT02047227|2127222|P2|Overall Study|Adverse Event|4
660797|NCT02047227|2127223|P1|Overall Study|Adverse Event|2
660798|NCT02046993|2127241|P2|Overall Study|Lost to Follow-up|1
660799|NCT02046993|2127242|P1|Overall Study|Lost to Follow-up|1
660800|NCT02046993|2127241|P2|Overall Study|Withdrawal by Subject|10
660801|NCT02046993|2127242|P1|Overall Study|Withdrawal by Subject|2
660802|NCT02046226|2127309|P1|Overall Study|Lost to Follow-up|7
660807|NCT02045836|2127404|P2|Overall Study|Migrated from study area|2
660808|NCT02045836|2127405|P1|Overall Study|Migrated from study area|0
660809|NCT02045836|2127404|P2|Overall Study|Lost to Follow-up|7
660810|NCT02045836|2127405|P1|Overall Study|Lost to Follow-up|4
660811|NCT02045836|2127404|P2|Overall Study|Withdrawal by Subject|1
660812|NCT02045836|2127405|P1|Overall Study|Withdrawal by Subject|1
660813|NCT02045836|2127404|P2|Overall Study|Adverse Event|4
660814|NCT02045836|2127405|P1|Overall Study|Adverse Event|4
660830|NCT02045732|2127582|P2|Overall Study|At the discretion of the investigator|1
660831|NCT02045732|2127583|P1|Overall Study|At the discretion of the investigator|1
660832|NCT02044848|2127661|P2|Overall Study|Administrative Problems|3
660833|NCT02044848|2127662|P1|Overall Study|Administrative Problems|2
660834|NCT02044822|2127668|P1|Overall Study|Lost to Follow-up|1
660835|NCT02044822|2127668|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
660836|NCT02044822|2127668|P1|Overall Study|Withdrew Consent|3
660837|NCT02044822|2127668|P1|Overall Study|Investigator's Discretion|10
660838|NCT02044822|2127668|P1|Overall Study|Study Terminated by Sponsor|77
660839|NCT02044458|2127680|P2|Overall Study|Protocol Violation|8
660840|NCT02044458|2127681|P1|Overall Study|Protocol Violation|3
660841|NCT02044302|2127739|P2|Overall Study|study terminated|0
660842|NCT02044302|2127740|P1|Overall Study|study terminated|2
660843|NCT02043782|2127787|P6|Period 1|Adverse Event|0
660844|NCT02043782|2127788|P5|Period 1|Adverse Event|0
660845|NCT02043782|2127789|P4|Period 1|Adverse Event|0
660846|NCT02043782|2127790|P3|Period 1|Adverse Event|1
660847|NCT02043782|2127791|P2|Period 1|Adverse Event|0
660848|NCT02043782|2127792|P1|Period 1|Adverse Event|0
660849|NCT02043366|2127865|P6|Overall Study|Lost to Follow-up|2
660850|NCT02043366|2127866|P5|Overall Study|Lost to Follow-up|2
660851|NCT02043366|2127867|P4|Overall Study|Lost to Follow-up|2
660852|NCT02043366|2127868|P3|Overall Study|Lost to Follow-up|2
660853|NCT02043366|2127869|P2|Overall Study|Lost to Follow-up|2
660854|NCT02043366|2127870|P1|Overall Study|Lost to Follow-up|2
660855|NCT02043132|2127908|P2|Overall Study|screen failures|8
660856|NCT02043132|2127909|P1|Overall Study|screen failures|4
660857|NCT02043132|2127908|P2|Overall Study|Lost to Follow-up|1
660858|NCT02043132|2127909|P1|Overall Study|Lost to Follow-up|1
660860|NCT02042443|2127977|P2|Overall Study|Not eligible/not analyzable|6
660861|NCT02042443|2127978|P1|Overall Study|Not eligible/not analyzable|3
660862|NCT02042443|2127977|P2|Overall Study|not protocol specified|1
660863|NCT02042443|2127978|P1|Overall Study|not protocol specified|1
660864|NCT02042443|2127977|P2|Overall Study|Progression|17
660865|NCT02042443|2127978|P1|Overall Study|Progression|21
660866|NCT02042443|2127977|P2|Overall Study|Withdrawal by Subject|1
660867|NCT02042443|2127978|P1|Overall Study|Withdrawal by Subject|0
660868|NCT02042443|2127977|P2|Overall Study|Adverse Event|1
660869|NCT02042443|2127978|P1|Overall Study|Adverse Event|2
660870|NCT02042404|2127990|P2|Overall Study|Inability to meet time requirements|0
660871|NCT02042404|2127991|P1|Overall Study|Inability to meet time requirements|1
660872|NCT02042404|2127990|P2|Overall Study|Unrelated Adverse Event|0
660873|NCT02042404|2127991|P1|Overall Study|Unrelated Adverse Event|3
660874|NCT02042404|2127990|P2|Overall Study|Death|0
660875|NCT02042404|2127991|P1|Overall Study|Death|1
660876|NCT02041533|2128031|P2|Overall Study|Randomized, not treated|7
660877|NCT02041533|2128032|P1|Overall Study|Randomized, not treated|4
660878|NCT02041533|2128031|P2|Overall Study|Completed max number of chemo cycles|29
660879|NCT02041533|2128032|P1|Overall Study|Completed max number of chemo cycles|0
660880|NCT02041533|2128031|P2|Overall Study|Other reasons|1
660881|NCT02041533|2128032|P1|Overall Study|Other reasons|0
660882|NCT02041533|2128031|P2|Overall Study|Poor/non-compliance|0
660883|NCT02041533|2128032|P1|Overall Study|Poor/non-compliance|1
660884|NCT02041533|2128031|P2|Overall Study|Maximum clinical benefit|18
660885|NCT02041533|2128032|P1|Overall Study|Maximum clinical benefit|0
660886|NCT02041533|2128031|P2|Overall Study|Withdrawal by Subject|1
660887|NCT02041533|2128032|P1|Overall Study|Withdrawal by Subject|2
660888|NCT02041533|2128031|P2|Overall Study|Subject request to discontinue treatment|9
660889|NCT02041533|2128032|P1|Overall Study|Subject request to discontinue treatment|5
660890|NCT02041533|2128031|P2|Overall Study|Adverse Event unrelated to study drug|21
660891|NCT02041533|2128032|P1|Overall Study|Adverse Event unrelated to study drug|20
660892|NCT02041533|2128031|P2|Overall Study|Death|0
660893|NCT02041533|2128032|P1|Overall Study|Death|1
660894|NCT02041533|2128031|P2|Overall Study|Study drug toxicity|30
660895|NCT02041533|2128032|P1|Overall Study|Study drug toxicity|27
660896|NCT02041533|2128031|P2|Overall Study|Disease Progression|142
660897|NCT02041533|2128032|P1|Overall Study|Disease Progression|168
660898|NCT02041520|2128054|P2|Overall Study|Hypothiroidism identified during follow-|1
660899|NCT02041520|2128055|P1|Overall Study|Hypothiroidism identified during follow-|0
660900|NCT02041520|2128054|P2|Overall Study|Lost to Follow-up|1
660901|NCT02041520|2128055|P1|Overall Study|Lost to Follow-up|0
660902|NCT02041520|2128054|P2|Overall Study|Protocol Violation|0
660903|NCT02041520|2128055|P1|Overall Study|Protocol Violation|1
660904|NCT02041520|2128054|P2|Overall Study|Withdrawal by Subject|4
660905|NCT02041520|2128055|P1|Overall Study|Withdrawal by Subject|3
660906|NCT02041520|2128054|P2|Overall Study|Adverse Event|1
660907|NCT02041520|2128055|P1|Overall Study|Adverse Event|2
660908|NCT02041286|2128098|P1|Overall Study|Adverse Event|1
660909|NCT02040532|2128165|P1|Overall Study|Withdrawal by Subject|3
660910|NCT02040532|2128165|P1|Overall Study|Adverse Event|4
660911|NCT02040532|2128165|P1|Overall Study|Physician Decision|4
660912|NCT02040532|2128165|P1|Overall Study|Lost to Follow-up|1
660913|NCT02040428|2128178|P2|Overall Study|Withdrawal by Subject|1
660914|NCT02040428|2128179|P1|Overall Study|Withdrawal by Subject|1
660915|NCT02040428|2128178|P2|Overall Study|Death|3
660916|NCT02040428|2128179|P1|Overall Study|Death|4
660917|NCT02039778|2128227|P1|Overall Study|Never started the protocol treatment|1
660918|NCT02039778|2128227|P1|Overall Study|Withdrawal by Subject|1
660919|NCT02039778|2128227|P1|Overall Study|Death|2
660920|NCT02039687|2128239|P4|Overall Study|treatment assignment could not be confir|0
660921|NCT02039687|2128240|P3|Overall Study|treatment assignment could not be confir|2
660922|NCT02039687|2128241|P2|Overall Study|treatment assignment could not be confir|0
660923|NCT02039687|2128242|P1|Overall Study|treatment assignment could not be confir|0
660924|NCT02039687|2128239|P4|Overall Study|Withdrawal by Subject|0
660925|NCT02039687|2128240|P3|Overall Study|Withdrawal by Subject|0
660926|NCT02039687|2128241|P2|Overall Study|Withdrawal by Subject|1
660927|NCT02039687|2128242|P1|Overall Study|Withdrawal by Subject|0
660928|NCT02039687|2128239|P4|Overall Study|Adverse Event|0
660929|NCT02039687|2128240|P3|Overall Study|Adverse Event|1
660930|NCT02039687|2128241|P2|Overall Study|Adverse Event|0
660931|NCT02039687|2128242|P1|Overall Study|Adverse Event|0
660932|NCT02039427|2128272|P4|Overall Study|Steroid Use|0
660933|NCT02039427|2128273|P3|Overall Study|Steroid Use|0
660934|NCT02039427|2128274|P2|Overall Study|Steroid Use|0
660935|NCT02039427|2128275|P1|Overall Study|Steroid Use|1
660936|NCT02039427|2128272|P4|Overall Study|Loss of follow - up|4
660937|NCT02039427|2128273|P3|Overall Study|Loss of follow - up|2
660938|NCT02039427|2128274|P2|Overall Study|Loss of follow - up|0
660939|NCT02039427|2128275|P1|Overall Study|Loss of follow - up|1
660940|NCT02039427|2128272|P4|Overall Study|Cancellation of surgery|0
660941|NCT02039427|2128273|P3|Overall Study|Cancellation of surgery|1
660942|NCT02039427|2128274|P2|Overall Study|Cancellation of surgery|0
660943|NCT02039427|2128275|P1|Overall Study|Cancellation of surgery|0
660944|NCT02039427|2128272|P4|Overall Study|Withdrawal on concent|1
660945|NCT02039427|2128273|P3|Overall Study|Withdrawal on concent|0
660946|NCT02039427|2128274|P2|Overall Study|Withdrawal on concent|0
660947|NCT02039427|2128275|P1|Overall Study|Withdrawal on concent|0
660948|NCT02039427|2128272|P4|Overall Study|Duration of surgery > 3h|0
660949|NCT02039427|2128273|P3|Overall Study|Duration of surgery > 3h|0
660950|NCT02039427|2128274|P2|Overall Study|Duration of surgery > 3h|1
660951|NCT02039427|2128275|P1|Overall Study|Duration of surgery > 3h|1
660952|NCT02039414|2128295|P2|Overall Study|Protocol Violation|1
660953|NCT02039414|2128296|P1|Overall Study|Protocol Violation|3
660954|NCT02039414|2128295|P2|Overall Study|Lost to Follow-up|0
660955|NCT02039414|2128296|P1|Overall Study|Lost to Follow-up|2
660956|NCT02039414|2128295|P2|Overall Study|Delivered|1
660957|NCT02039414|2128296|P1|Overall Study|Delivered|1
660958|NCT02038959|2128319|P2|Overall Study|Withdrawal by Subject|8
660959|NCT02038959|2128320|P1|Overall Study|Withdrawal by Subject|6
660960|NCT02038933|2128348|P1|Follow-up|Disease Progression|2
660961|NCT02038933|2128348|P1|Follow-up|Withdrawal by Subject|1
660962|NCT02038933|2128348|P1|Follow-up|Lost to Follow-up|1
660963|NCT02038933|2128348|P1|Follow-up|Adverse event unrelated to study drug|4
660964|NCT02038933|2128348|P1|Follow-up|Death|11
660965|NCT02038933|2128348|P1|Treatment|Withdrawal by Subject|1
660966|NCT02038933|2128348|P1|Treatment|Disease Progression|101
660967|NCT02038933|2128348|P1|Treatment|Study Drug Toxicity|4
660968|NCT02038933|2128348|P1|Treatment|Adverse Event Unrelated to Study Drug|6
660969|NCT02038933|2128348|P1|Treatment|Lost to Follow-up|1
660970|NCT02038933|2128348|P1|Treatment|No longer meets study criteria|1
660971|NCT02038907|2128381|P14|Overall Study|Withdrawal by Subject|0
660972|NCT02038907|2128382|P13|Overall Study|Withdrawal by Subject|0
660973|NCT02038907|2128383|P12|Overall Study|Withdrawal by Subject|0
660974|NCT02038907|2128384|P11|Overall Study|Withdrawal by Subject|1
660975|NCT02038907|2128385|P10|Overall Study|Withdrawal by Subject|0
660976|NCT02038907|2128386|P9|Overall Study|Withdrawal by Subject|0
660977|NCT02038907|2128387|P8|Overall Study|Withdrawal by Subject|0
660978|NCT02038907|2128388|P7|Overall Study|Withdrawal by Subject|0
660979|NCT02038907|2128389|P6|Overall Study|Withdrawal by Subject|0
660980|NCT02038907|2128390|P5|Overall Study|Withdrawal by Subject|0
660981|NCT02038907|2128391|P4|Overall Study|Withdrawal by Subject|0
660982|NCT02038907|2128392|P3|Overall Study|Withdrawal by Subject|0
660983|NCT02038907|2128393|P2|Overall Study|Withdrawal by Subject|0
660984|NCT02038907|2128394|P1|Overall Study|Withdrawal by Subject|0
660985|NCT02038907|2128381|P14|Overall Study|Protocol Violation|0
660986|NCT02038907|2128382|P13|Overall Study|Protocol Violation|0
660987|NCT02038907|2128383|P12|Overall Study|Protocol Violation|0
660988|NCT02038907|2128384|P11|Overall Study|Protocol Violation|1
660989|NCT02038907|2128385|P10|Overall Study|Protocol Violation|0
660990|NCT02038907|2128386|P9|Overall Study|Protocol Violation|0
660991|NCT02038907|2128387|P8|Overall Study|Protocol Violation|0
660992|NCT02038907|2128388|P7|Overall Study|Protocol Violation|0
660993|NCT02038907|2128389|P6|Overall Study|Protocol Violation|0
660994|NCT02038907|2128390|P5|Overall Study|Protocol Violation|0
660995|NCT02038907|2128391|P4|Overall Study|Protocol Violation|0
660996|NCT02038907|2128392|P3|Overall Study|Protocol Violation|0
660997|NCT02038907|2128393|P2|Overall Study|Protocol Violation|0
660998|NCT02038907|2128394|P1|Overall Study|Protocol Violation|0
660999|NCT02038790|2128922|P2|Day 0 - First Treatment|Withdrawal by Subject|1
661000|NCT02038790|2128923|P1|Day 0 - First Treatment|Withdrawal by Subject|1
661001|NCT02038543|2128958|P4|Overall Study|Withdrawal by Subject|1
661002|NCT02038543|2128959|P3|Overall Study|Withdrawal by Subject|0
661003|NCT02038543|2128960|P2|Overall Study|Withdrawal by Subject|0
661004|NCT02038543|2128961|P1|Overall Study|Withdrawal by Subject|0
661005|NCT02038543|2128958|P4|Overall Study|Screen Failure|1
661006|NCT02038543|2128959|P3|Overall Study|Screen Failure|0
661007|NCT02038543|2128960|P2|Overall Study|Screen Failure|0
661008|NCT02038543|2128961|P1|Overall Study|Screen Failure|0
661009|NCT02038075|2128977|P2|Overall Study|Withdrawal by Subject|0
661010|NCT02038075|2128978|P1|Overall Study|Withdrawal by Subject|3
661011|NCT02037477|2129011|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
661012|NCT02037477|2129012|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
661013|NCT02037477|2129013|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
661014|NCT02037477|2129014|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
661015|NCT02036775|2129092|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
661016|NCT02036775|2129093|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
661017|NCT02036775|2129094|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
661018|NCT02036775|2129095|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
661019|NCT02036775|2129096|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
661020|NCT02036775|2129097|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
661021|NCT02036580|2129138|P3|Overall Study|Adverse Event|0
661022|NCT02036580|2129139|P2|Overall Study|Adverse Event|0
661023|NCT02036580|2129140|P1|Overall Study|Adverse Event|1
661024|NCT02036580|2129138|P3|Overall Study|Withdrawal by Subject|0
661025|NCT02036580|2129139|P2|Overall Study|Withdrawal by Subject|1
661026|NCT02036580|2129140|P1|Overall Study|Withdrawal by Subject|0
661045|NCT02035748|2129262|P1|Overall Study|Progressive Disease|1
661046|NCT02035748|2129262|P1|Overall Study|Withdrawal by Subject|6
661047|NCT02035748|2129262|P1|Overall Study|Physician Decision|3
661048|NCT02035748|2129262|P1|Overall Study|Lost to Follow-up|2
661049|NCT02035748|2129262|P1|Overall Study|Death|3
661050|NCT02035748|2129262|P1|Overall Study|Adverse Event|5
661059|NCT02035475|2129321|P1|Overall Study|Equipment Error|1
661060|NCT02035475|2129321|P1|Overall Study|Physician Decision|1
661061|NCT02035475|2129321|P1|Overall Study|Withdrawal by Subject|4
661062|NCT02035332|2129332|P1|Overall Study|Procedure Aborted due to Uterine Width|1
661063|NCT02034877|2129340|P2|Overall Study|No Longer Willing to Participate|3
661064|NCT02034877|2129341|P1|Overall Study|No Longer Willing to Participate|0
661065|NCT02034877|2129340|P2|Overall Study|Lost to Follow-up|3
661066|NCT02034877|2129341|P1|Overall Study|Lost to Follow-up|0
661067|NCT02034708|2129359|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
661068|NCT02034708|2129360|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
661069|NCT02034708|2129359|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
661070|NCT02034708|2129360|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
661071|NCT02034708|2129359|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
661072|NCT02034708|2129360|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
661073|NCT02034708|2129359|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
661074|NCT02034708|2129360|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
661075|NCT02034591|2129371|P6|Overall Study|Withdrawal by Subject|0
661076|NCT02034591|2129372|P5|Overall Study|Withdrawal by Subject|1
661077|NCT02034591|2129373|P4|Overall Study|Withdrawal by Subject|0
661078|NCT02034591|2129374|P3|Overall Study|Withdrawal by Subject|0
661079|NCT02034591|2129375|P2|Overall Study|Withdrawal by Subject|0
661080|NCT02034591|2129376|P1|Overall Study|Withdrawal by Subject|0
661081|NCT02034565|2129431|P2|Overall Study|Adverse Event|0
661082|NCT02034565|2129432|P1|Overall Study|Adverse Event|1
661101|NCT02034513|2129476|P2|Overall Study|Unclassified|1
661102|NCT02034513|2129477|P1|Overall Study|Unclassified|0
661103|NCT02034513|2129476|P2|Overall Study|Withdrawal by Subject|25
661104|NCT02034513|2129477|P1|Overall Study|Withdrawal by Subject|25
661105|NCT02034513|2129476|P2|Overall Study|Protocol Violation|10
661106|NCT02034513|2129477|P1|Overall Study|Protocol Violation|7
661107|NCT02034513|2129476|P2|Overall Study|Pregnancy|3
661108|NCT02034513|2129477|P1|Overall Study|Pregnancy|0
661109|NCT02034513|2129476|P2|Overall Study|Lost to Follow-up|7
661110|NCT02034513|2129477|P1|Overall Study|Lost to Follow-up|6
661111|NCT02034513|2129476|P2|Overall Study|Lack of Efficacy|1
661112|NCT02034513|2129477|P1|Overall Study|Lack of Efficacy|0
661113|NCT02034513|2129476|P2|Overall Study|Adverse Event|10
661114|NCT02034513|2129477|P1|Overall Study|Adverse Event|11
661115|NCT02034162|2129495|P3|Double-blind|Withdrawal by Subject|0
661116|NCT02034162|2129496|P2|Double-blind|Withdrawal by Subject|7
661117|NCT02034162|2129497|P1|Double-blind|Withdrawal by Subject|5
661118|NCT02034162|2129495|P3|Double-blind|Protocol Violation|0
661119|NCT02034162|2129496|P2|Double-blind|Protocol Violation|1
661120|NCT02034162|2129497|P1|Double-blind|Protocol Violation|0
661121|NCT02034162|2129495|P3|Double-blind|Physician Decision|0
661122|NCT02034162|2129496|P2|Double-blind|Physician Decision|0
661123|NCT02034162|2129497|P1|Double-blind|Physician Decision|1
661124|NCT02034162|2129495|P3|Double-blind|Lost to Follow-up|0
661125|NCT02034162|2129496|P2|Double-blind|Lost to Follow-up|0
661126|NCT02034162|2129497|P1|Double-blind|Lost to Follow-up|3
661127|NCT02032901|2129581|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
661128|NCT02032901|2129582|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
661129|NCT02032901|2129581|P2|Treatment Period (12 Weeks)|Pregnancy|0
661130|NCT02032901|2129582|P1|Treatment Period (12 Weeks)|Pregnancy|1
661131|NCT02032888|2129606|P3|Follow-up Period|Not specified|0
661132|NCT02032888|2129607|P2|Follow-up Period|Not specified|0
661133|NCT02032888|2129608|P1|Follow-up Period|Not specified|1
661134|NCT02032888|2129606|P3|Follow-up Period|Death|0
661135|NCT02032888|2129607|P2|Follow-up Period|Death|1
661136|NCT02032888|2129608|P1|Follow-up Period|Death|1
661137|NCT02032888|2129606|P3|Follow-up Period|Lost to Follow-up|0
661138|NCT02032888|2129607|P2|Follow-up Period|Lost to Follow-up|1
661139|NCT02032888|2129608|P1|Follow-up Period|Lost to Follow-up|1
661140|NCT02032888|2129606|P3|Treatment Period|Not specified|0
661141|NCT02032888|2129607|P2|Treatment Period|Not specified|1
661142|NCT02032888|2129608|P1|Treatment Period|Not specified|1
661143|NCT02032888|2129606|P3|Treatment Period|Poor compliance/noncompliance|0
661144|NCT02032888|2129607|P2|Treatment Period|Poor compliance/noncompliance|1
661145|NCT02032888|2129608|P1|Treatment Period|Poor compliance/noncompliance|1
661146|NCT02032875|2129639|P2|Follow-up Period|Virologic Relapse|10
661147|NCT02032875|2129640|P1|Follow-up Period|Virologic Relapse|3
661148|NCT02032875|2129639|P2|Follow-up Period|Death|1
661149|NCT02032875|2129640|P1|Follow-up Period|Death|0
661150|NCT02032875|2129639|P2|Treatment Period|Liver transplant, Treatment extension|3
661151|NCT02032875|2129640|P1|Treatment Period|Liver transplant, Treatment extension|0
661152|NCT02032875|2129639|P2|Treatment Period|Liver transplant, No extension needed|1
661153|NCT02032875|2129640|P1|Treatment Period|Liver transplant, No extension needed|0
661154|NCT02032875|2129639|P2|Treatment Period|Adverse Event|0
661155|NCT02032875|2129640|P1|Treatment Period|Adverse Event|1
661156|NCT02032706|2129669|P1|Overall Study|Protocol Violation|1
661157|NCT02032706|2129669|P1|Overall Study|Did not qualify|5
661158|NCT02032407|2129707|P1|Overall Study|Other Miscellaneous Reasons|2
661159|NCT02032407|2129707|P1|Overall Study|Pregnancy|1
661160|NCT02032407|2129707|P1|Overall Study|Lost to Follow-up|2
661161|NCT02032238|2129720|P2|Overall Study|Lost to Follow-up|0
661162|NCT02032238|2129721|P1|Overall Study|Lost to Follow-up|2
661163|NCT02031679|2129762|P2|Overall Study|Lack of Efficacy|1
661164|NCT02031679|2129763|P1|Overall Study|Lack of Efficacy|0
661165|NCT02031679|2129762|P2|Overall Study|Protocol Violation|1
661166|NCT02031679|2129763|P1|Overall Study|Protocol Violation|0
661167|NCT02031471|2129773|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
661168|NCT02031471|2129773|P1|Long Term Extension (LTE) Period|Adverse Event|1
661169|NCT02031471|2129773|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
661170|NCT02031471|2129773|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
661171|NCT02031471|2129773|P1|24 Week Treatment Period|Protocol Violation|1
661172|NCT02031471|2129773|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
661173|NCT02031471|2129773|P1|24 Week Treatment Period|Adverse Event|6
661174|NCT02031458|2129806|P3|Overall Study|Lost to Follow-up|2
661175|NCT02031458|2129807|P2|Overall Study|Lost to Follow-up|1
661176|NCT02031458|2129808|P1|Overall Study|Lost to Follow-up|1
661177|NCT02031458|2129806|P3|Overall Study|On Treatment|73
661178|NCT02031458|2129807|P2|Overall Study|On Treatment|81
661179|NCT02031458|2129808|P1|Overall Study|On Treatment|43
661180|NCT02031458|2129806|P3|Overall Study|On Survival Follow-Up|73
661181|NCT02031458|2129807|P2|Overall Study|On Survival Follow-Up|83
661182|NCT02031458|2129808|P1|Overall Study|On Survival Follow-Up|46
661183|NCT02031458|2129806|P3|Overall Study|Withdrawal by Subject|3
661184|NCT02031458|2129807|P2|Overall Study|Withdrawal by Subject|9
661185|NCT02031458|2129808|P1|Overall Study|Withdrawal by Subject|6
661186|NCT02031458|2129806|P3|Overall Study|Unknown Reason|2
661187|NCT02031458|2129807|P2|Overall Study|Unknown Reason|1
661188|NCT02031458|2129808|P1|Overall Study|Unknown Reason|0
661189|NCT02031458|2129806|P3|Overall Study|Physician Decision|0
661190|NCT02031458|2129807|P2|Overall Study|Physician Decision|1
661191|NCT02031458|2129808|P1|Overall Study|Physician Decision|0
661192|NCT02031458|2129806|P3|Overall Study|Protocol Violation|0
661193|NCT02031458|2129807|P2|Overall Study|Protocol Violation|4
661194|NCT02031458|2129808|P1|Overall Study|Protocol Violation|7
661195|NCT02031458|2129806|P3|Overall Study|Death|100
661196|NCT02031458|2129807|P2|Overall Study|Death|87
661197|NCT02031458|2129808|P1|Overall Study|Death|36
661198|NCT02030600|2129904|P2|Treatment Period 2|Unclassified|0
661199|NCT02030600|2129905|P1|Treatment Period 2|Unclassified|1
661200|NCT02030600|2129904|P2|Treatment Period 2|Withdrawal by Subject|9
661201|NCT02030600|2129905|P1|Treatment Period 2|Withdrawal by Subject|13
661202|NCT02030600|2129904|P2|Treatment Period 2|Protocol Violation|2
661203|NCT02030600|2129905|P1|Treatment Period 2|Protocol Violation|1
661204|NCT02030600|2129904|P2|Treatment Period 2|Lost to Follow-up|2
661205|NCT02030600|2129905|P1|Treatment Period 2|Lost to Follow-up|4
661206|NCT02030600|2129904|P2|Treatment Period 2|Lack of Efficacy|1
661207|NCT02030600|2129905|P1|Treatment Period 2|Lack of Efficacy|2
661208|NCT02030600|2129904|P2|Treatment Period 2|Adverse Event|4
661209|NCT02030600|2129905|P1|Treatment Period 2|Adverse Event|4
661210|NCT02030600|2129904|P2|Treatment Period 1|Unclassified|0
661211|NCT02030600|2129905|P1|Treatment Period 1|Unclassified|1
661212|NCT02030600|2129904|P2|Treatment Period 1|Casebook Unsigned|0
661213|NCT02030600|2129905|P1|Treatment Period 1|Casebook Unsigned|1
661214|NCT02030600|2129904|P2|Treatment Period 1|Withdrawal by Subject|17
661215|NCT02030600|2129905|P1|Treatment Period 1|Withdrawal by Subject|13
661216|NCT02030600|2129904|P2|Treatment Period 1|Protocol Violation|17
661217|NCT02030600|2129905|P1|Treatment Period 1|Protocol Violation|22
661218|NCT02030600|2129904|P2|Treatment Period 1|Lost to Follow-up|3
661219|NCT02030600|2129905|P1|Treatment Period 1|Lost to Follow-up|11
661220|NCT02030600|2129904|P2|Treatment Period 1|Lack of Efficacy|1
661221|NCT02030600|2129905|P1|Treatment Period 1|Lack of Efficacy|0
661222|NCT02030600|2129904|P2|Treatment Period 1|Adverse Event|7
661223|NCT02030600|2129905|P1|Treatment Period 1|Adverse Event|5
661224|NCT02030535|2129926|P1|Washout Period 1 (21 Days)|Adverse Event|1
661225|NCT02030405|2129994|P1|Overall Study|Lost to Follow-up|1
661226|NCT02030405|2129994|P1|Overall Study|Withdrawal by Subject|1
661227|NCT02030041|2130002|P3|Overall Study|Withdrawal by Subject|1
661228|NCT02030041|2130003|P2|Overall Study|Withdrawal by Subject|2
661229|NCT02030041|2130004|P1|Overall Study|Withdrawal by Subject|2
661244|NCT02029521|2130070|P2|Overall Study|Withdrawal by Subject|1
661245|NCT02029521|2130071|P1|Overall Study|Withdrawal by Subject|1
661246|NCT02029521|2130070|P2|Overall Study|Protocol Violation|0
661247|NCT02029521|2130071|P1|Overall Study|Protocol Violation|1
661248|NCT02029417|2130169|P1|Overall Study|Adverse Event|1
661249|NCT02029417|2130169|P1|Overall Study|Death|1
661250|NCT02028767|2130273|P2|Treatment Period 2|Reason other than those specified above|0
661251|NCT02028767|2130274|P1|Treatment Period 2|Reason other than those specified above|1
661252|NCT02028767|2130273|P2|Treatment Period 2|Non compliant with protocol|0
661253|NCT02028767|2130274|P1|Treatment Period 2|Non compliant with protocol|1
661254|NCT02028169|2130499|P1|Overall Study|Concomitant Medication Usage|1
661255|NCT02028169|2130499|P1|Overall Study|Cessation of Drug|1
661256|NCT02028169|2130499|P1|Overall Study|Adverse Event|1
661257|NCT02028169|2130499|P1|Overall Study|Withdrawal by Subject|2
661258|NCT02028169|2130499|P1|Overall Study|Lack of Efficacy|2
661259|NCT02028169|2130499|P1|Overall Study|Lost to Follow-up|21
661260|NCT02028065|2130525|P3|Treatment Through Study Completion|Adverse Event|5
661261|NCT02028065|2130526|P2|Treatment Through Study Completion|Adverse Event|3
661262|NCT02028065|2130527|P1|Treatment Through Study Completion|Adverse Event|3
661263|NCT02028065|2130525|P3|Treatment Through Study Completion|Withdrawal by Subject|3
661264|NCT02028065|2130526|P2|Treatment Through Study Completion|Withdrawal by Subject|4
661265|NCT02028065|2130527|P1|Treatment Through Study Completion|Withdrawal by Subject|5
661266|NCT02028065|2130525|P3|Treatment Through Study Completion|Protocol Violation|0
661267|NCT02028065|2130526|P2|Treatment Through Study Completion|Protocol Violation|4
661268|NCT02028065|2130527|P1|Treatment Through Study Completion|Protocol Violation|1
661269|NCT02028065|2130525|P3|Treatment Through Study Completion|Physician Decision|0
661270|NCT02028065|2130526|P2|Treatment Through Study Completion|Physician Decision|0
661271|NCT02028065|2130527|P1|Treatment Through Study Completion|Physician Decision|1
661272|NCT02028065|2130525|P3|Treatment Through Study Completion|Lost to Follow-up|6
661273|NCT02028065|2130526|P2|Treatment Through Study Completion|Lost to Follow-up|4
661274|NCT02028065|2130527|P1|Treatment Through Study Completion|Lost to Follow-up|2
661275|NCT02028065|2130525|P3|Randomization Through Start Treatment|Not treated|3
661276|NCT02028065|2130526|P2|Randomization Through Start Treatment|Not treated|3
661277|NCT02028065|2130527|P1|Randomization Through Start Treatment|Not treated|1
661278|NCT02027844|2130554|P3|Overall Study|Incomlete data|0
661279|NCT02027844|2130555|P2|Overall Study|Incomlete data|0
661280|NCT02027844|2130556|P1|Overall Study|Incomlete data|2
661281|NCT02027844|2130554|P3|Overall Study|Protocol Violation|0
661282|NCT02027844|2130555|P2|Overall Study|Protocol Violation|2
661283|NCT02027844|2130556|P1|Overall Study|Protocol Violation|0
661284|NCT02027844|2130554|P3|Overall Study|Lost to Follow-up|1
661285|NCT02027844|2130555|P2|Overall Study|Lost to Follow-up|2
661286|NCT02027844|2130556|P1|Overall Study|Lost to Follow-up|0
661287|NCT02027844|2130554|P3|Overall Study|Withdrawal by Subject|1
661288|NCT02027844|2130555|P2|Overall Study|Withdrawal by Subject|2
661289|NCT02027844|2130556|P1|Overall Study|Withdrawal by Subject|3
661290|NCT02027402|2130575|P2|Overall Study|Withdrawal by Subject|1
661291|NCT02027402|2130576|P1|Overall Study|Withdrawal by Subject|4
661292|NCT02027311|2130590|P2|Overall Study|Protocol Violation|2
661293|NCT02027311|2130591|P1|Overall Study|Protocol Violation|3
661294|NCT02026258|2130626|P2|Recieved Allocated Intervention|Lost to Follow-up|1
661295|NCT02026258|2130627|P1|Recieved Allocated Intervention|Lost to Follow-up|0
661296|NCT02026258|2130626|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
661297|NCT02026258|2130627|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
661298|NCT02026258|2130626|P2|Randomized|Presence of periodontal disease|1
661299|NCT02026258|2130627|P1|Randomized|Presence of periodontal disease|1
661300|NCT02026258|2130626|P2|Randomized|Change in treatment plan|0
661301|NCT02026258|2130627|P1|Randomized|Change in treatment plan|1
661302|NCT02026258|2130626|P2|Randomized|Did not start treatment|1
661303|NCT02026258|2130627|P1|Randomized|Did not start treatment|2
661304|NCT02026141|2130661|P2|Overall Study|Protocol Violation|1
661305|NCT02026141|2130662|P1|Overall Study|Protocol Violation|0
661306|NCT02025907|2130670|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
661307|NCT02025907|2130671|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
661308|NCT02025907|2130670|P2|Overall Study|Adverse Event|1
661309|NCT02025907|2130671|P1|Overall Study|Adverse Event|3
661310|NCT02025907|2130670|P2|Overall Study|Lost to Follow-up|2
661311|NCT02025907|2130671|P1|Overall Study|Lost to Follow-up|2
661312|NCT02025907|2130670|P2|Overall Study|Physician Decision|0
661313|NCT02025907|2130671|P1|Overall Study|Physician Decision|2
661314|NCT02025907|2130670|P2|Overall Study|Protocol Violation|0
661315|NCT02025907|2130671|P1|Overall Study|Protocol Violation|2
661316|NCT02025907|2130670|P2|Overall Study|Withdrawal by Subject|8
661317|NCT02025907|2130671|P1|Overall Study|Withdrawal by Subject|15
661318|NCT02025907|2130670|P2|Overall Study|Lack of Efficacy|0
661319|NCT02025907|2130671|P1|Overall Study|Lack of Efficacy|1
661320|NCT02024971|2130753|P1|Overall Study|Lost to Follow-up|6
661321|NCT02024971|2130753|P1|Overall Study|Data Not Available|30
661322|NCT02024932|2130766|P6|Overall Study|Abnormal laboratory value|0
661323|NCT02024932|2130767|P5|Overall Study|Abnormal laboratory value|0
661324|NCT02024932|2130768|P4|Overall Study|Abnormal laboratory value|2
661325|NCT02024932|2130769|P3|Overall Study|Abnormal laboratory value|0
661326|NCT02024932|2130770|P2|Overall Study|Abnormal laboratory value|0
661327|NCT02024932|2130771|P1|Overall Study|Abnormal laboratory value|0
661328|NCT02024932|2130766|P6|Overall Study|Adverse Event|0
661329|NCT02024932|2130767|P5|Overall Study|Adverse Event|2
661330|NCT02024932|2130768|P4|Overall Study|Adverse Event|0
661331|NCT02024932|2130769|P3|Overall Study|Adverse Event|0
661332|NCT02024932|2130770|P2|Overall Study|Adverse Event|3
661333|NCT02024932|2130771|P1|Overall Study|Adverse Event|2
661334|NCT02024867|2130830|P2|Overall Study|Lost to Follow-up|4
661335|NCT02024867|2130831|P1|Overall Study|Lost to Follow-up|6
661336|NCT02024867|2130830|P2|Overall Study|Protocol Violation|3
661337|NCT02024867|2130831|P1|Overall Study|Protocol Violation|3
661338|NCT02024698|2130856|P2|First Intervention (7 Days)|Withdrawal by Subject|1
661339|NCT02024698|2130857|P1|First Intervention (7 Days)|Withdrawal by Subject|0
661340|NCT02023879|2130935|P3|Overall Study|Other than specified above|1
661341|NCT02023879|2130936|P2|Overall Study|Other than specified above|3
661342|NCT02023879|2130937|P1|Overall Study|Other than specified above|1
661343|NCT02023879|2130935|P3|Overall Study|Randomized but not treated|1
661344|NCT02023879|2130936|P2|Overall Study|Randomized but not treated|1
661345|NCT02023879|2130937|P1|Overall Study|Randomized but not treated|0
661346|NCT02023879|2130935|P3|Overall Study|Consent withdrawn by participant|1
661347|NCT02023879|2130936|P2|Overall Study|Consent withdrawn by participant|0
661348|NCT02023879|2130937|P1|Overall Study|Consent withdrawn by participant|1
661349|NCT02023879|2130935|P3|Overall Study|Physician Decision|0
661350|NCT02023879|2130936|P2|Overall Study|Physician Decision|1
661351|NCT02023879|2130937|P1|Overall Study|Physician Decision|0
661352|NCT02023879|2130935|P3|Overall Study|Poor compliance to protocol|1
661353|NCT02023879|2130936|P2|Overall Study|Poor compliance to protocol|2
661354|NCT02023879|2130937|P1|Overall Study|Poor compliance to protocol|0
661355|NCT02023879|2130935|P3|Overall Study|Adverse Event|5
661356|NCT02023879|2130936|P2|Overall Study|Adverse Event|2
661357|NCT02023879|2130937|P1|Overall Study|Adverse Event|2
661358|NCT02023268|2131039|P2|Overall Study|Withdrawal by Subject|1
661359|NCT02023268|2131040|P1|Overall Study|Withdrawal by Subject|0
661360|NCT02023268|2131039|P2|Overall Study|Adverse Event|2
661361|NCT02023268|2131040|P1|Overall Study|Adverse Event|0
661362|NCT02023268|2131039|P2|Overall Study|Lack of Efficacy|1
661363|NCT02023268|2131040|P1|Overall Study|Lack of Efficacy|0
661364|NCT02023112|2131111|P2|Overall Study|Withdrawal by Subject|1
661365|NCT02023112|2131112|P1|Overall Study|Withdrawal by Subject|2
661366|NCT02023099|2131133|P3|Overall Study|Non-treatment-emergent Fatal AE|1
661367|NCT02023099|2131134|P2|Overall Study|Non-treatment-emergent Fatal AE|0
661368|NCT02023099|2131135|P1|Overall Study|Non-treatment-emergent Fatal AE|0
661369|NCT02023099|2131133|P3|Overall Study|Withdrawn Consent|1
661370|NCT02023099|2131134|P2|Overall Study|Withdrawn Consent|0
661371|NCT02023099|2131135|P1|Overall Study|Withdrawn Consent|3
661372|NCT02023099|2131133|P3|Overall Study|Non-fatal Adverse Event (AE)|1
661373|NCT02023099|2131134|P2|Overall Study|Non-fatal Adverse Event (AE)|0
661374|NCT02023099|2131135|P1|Overall Study|Non-fatal Adverse Event (AE)|0
661375|NCT02022748|2131153|P3|Overall Study|Withdrawal by Subject|0
661376|NCT02022748|2131154|P2|Overall Study|Withdrawal by Subject|1
661377|NCT02022748|2131155|P1|Overall Study|Withdrawal by Subject|0
661378|NCT02022748|2131153|P3|Overall Study|Adverse Event|0
661379|NCT02022748|2131154|P2|Overall Study|Adverse Event|1
661380|NCT02022748|2131155|P1|Overall Study|Adverse Event|1
661381|NCT02022670|2131181|P3|Overall Study|Adverse Event|1
661382|NCT02022670|2131182|P2|Overall Study|Adverse Event|0
661383|NCT02022670|2131183|P1|Overall Study|Adverse Event|1
661384|NCT02022007|2131227|P3|Overall Study|Noncompliant|1
661385|NCT02022007|2131228|P2|Overall Study|Noncompliant|0
661386|NCT02022007|2131229|P1|Overall Study|Noncompliant|0
661387|NCT02022007|2131227|P3|Overall Study|Withdrawal by Subject|1
661388|NCT02022007|2131228|P2|Overall Study|Withdrawal by Subject|1
661389|NCT02022007|2131229|P1|Overall Study|Withdrawal by Subject|1
661390|NCT02021331|2131286|P2|Overall Study|Adverse Event|2
661391|NCT02021331|2131287|P1|Overall Study|Adverse Event|0
661392|NCT02020941|2131307|P1|Overall Study|Disease Progression|4
661393|NCT02020941|2131307|P1|Overall Study|Withdrawal by Subject|1
661394|NCT02020941|2131307|P1|Overall Study|Physician Decision|2
661395|NCT02020941|2131307|P1|Overall Study|Adverse Event|1
661396|NCT02020863|2131316|P1|Overall Study|Team chose not to place an a line|1
661397|NCT02020863|2131316|P1|Overall Study|Discovery of Metastatic disease|4
661398|NCT02020577|2131322|P2|Overall Study|Other than stated above|1
661399|NCT02020577|2131323|P1|Overall Study|Other than stated above|0
661400|NCT02020577|2131322|P2|Overall Study|Withdrawal by Subject|1
661401|NCT02020577|2131323|P1|Overall Study|Withdrawal by Subject|0
661402|NCT02020577|2131322|P2|Overall Study|Other AE or clinical progression|15
661575|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Adverse Event|0
661403|NCT02020577|2131323|P1|Overall Study|Other AE or clinical progression|0
661404|NCT02020577|2131322|P2|Overall Study|Progressive disease|38
661405|NCT02020577|2131323|P1|Overall Study|Progressive disease|3
661406|NCT02020512|2131350|P1|Overall Study|Protocol Violation|4
661407|NCT02020512|2131350|P1|Overall Study|Lost to Follow-up|3
661408|NCT02020512|2131350|P1|Overall Study|Adverse Event|1
661409|NCT02020031|2131402|P2|Overall Study|Physician Decision|1
661410|NCT02020031|2131403|P1|Overall Study|Physician Decision|1
661411|NCT02019550|2131430|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
661412|NCT02019550|2131431|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
888361|NCT02104505|2821958|P2|Second Intervention (14 Days)|Adverse Event|0
888362|NCT02104505|2821959|P1|Second Intervention (14 Days)|Adverse Event|2
888363|NCT02104505|2821958|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
888364|NCT02104505|2821959|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
888365|NCT02104505|2821958|P2|First Intervention (14 Days)|exclusionary condition|1
888366|NCT02104505|2821959|P1|First Intervention (14 Days)|exclusionary condition|0
888367|NCT02104505|2821958|P2|First Intervention (14 Days)|Lost to Follow-up|1
888368|NCT02104505|2821959|P1|First Intervention (14 Days)|Lost to Follow-up|0
888369|NCT02104505|2821958|P2|First Intervention (14 Days)|Withdrawal by Subject|1
661437|NCT02017015|2131538|P1|Overall Study|Physician Decision|2
661438|NCT02017015|2131538|P1|Overall Study|Non-compliance with study drug|2
661439|NCT02017015|2131538|P1|Overall Study|Progressive Disease|31
661440|NCT02017015|2131538|P1|Overall Study|Death|4
661441|NCT02017015|2131538|P1|Overall Study|Withdrawal by Subject|21
661442|NCT02017015|2131538|P1|Overall Study|Adverse Event|9
661443|NCT02016690|2131561|P1|Overall Study|Hospitalized for RSV at study start|3
661444|NCT02016690|2131561|P1|Overall Study|Did not meet inclusion criteria|13
661445|NCT02016690|2131561|P1|Overall Study|Excluded from SAS: Ineligible for study|2
661446|NCT02016690|2131561|P1|Overall Study|Excluded from SAS: Early treatment|2
661447|NCT02016690|2131561|P1|Overall Study|Excluded from SAS: Duplication|2
661448|NCT02016690|2131561|P1|Overall Study|Excluded from SAS: Enrollment violation|2
661449|NCT02016625|2131574|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
661450|NCT02016625|2131575|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
661451|NCT02016625|2131574|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
661452|NCT02016625|2131575|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
661453|NCT02016625|2131574|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
661454|NCT02016625|2131575|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
661455|NCT02016482|2131609|P2|Period B|Required Alternative/Prohibited Therapy|2
661456|NCT02016482|2131610|P1|Period B|Required Alternative/Prohibited Therapy|0
661457|NCT02016482|2131609|P2|Period B|Not Specified|0
661458|NCT02016482|2131610|P1|Period B|Not Specified|4
661459|NCT02016482|2131609|P2|Period B|Lack of Efficacy|4
661460|NCT02016482|2131610|P1|Period B|Lack of Efficacy|6
661461|NCT02016482|2131609|P2|Period B|Lost to Follow-up|0
661462|NCT02016482|2131610|P1|Period B|Lost to Follow-up|2
661463|NCT02016482|2131609|P2|Period B|Withdrawal by Subject|1
661464|NCT02016482|2131610|P1|Period B|Withdrawal by Subject|1
661465|NCT02016482|2131609|P2|Period A|Required Alternative/Prohibited Therapy|1
661466|NCT02016482|2131610|P1|Period A|Required Alternative/Prohibited Therapy|0
661467|NCT02016482|2131609|P2|Period A|Protocol Violation|1
661468|NCT02016482|2131610|P1|Period A|Protocol Violation|0
661469|NCT02016482|2131609|P2|Period A|Not Specified|0
661470|NCT02016482|2131610|P1|Period A|Not Specified|3
661471|NCT02016482|2131609|P2|Period A|Lack of Efficacy|1
661472|NCT02016482|2131610|P1|Period A|Lack of Efficacy|2
661473|NCT02016482|2131609|P2|Period A|Lost to Follow-up|3
661474|NCT02016482|2131610|P1|Period A|Lost to Follow-up|3
661475|NCT02016482|2131609|P2|Period A|Withdrawal by Subject|4
661476|NCT02016482|2131610|P1|Period A|Withdrawal by Subject|3
661477|NCT02016482|2131609|P2|Period A|Adverse Event|5
661478|NCT02016482|2131610|P1|Period A|Adverse Event|3
661479|NCT02016170|2131701|P3|Overall Study|Protocol Violation|0
661480|NCT02016170|2131702|P2|Overall Study|Protocol Violation|0
661481|NCT02016170|2131703|P1|Overall Study|Protocol Violation|1
661482|NCT02016170|2131701|P3|Overall Study|Adverse Event|0
661483|NCT02016170|2131702|P2|Overall Study|Adverse Event|1
661484|NCT02016170|2131703|P1|Overall Study|Adverse Event|1
661485|NCT02016105|2131714|P6|EXTENSION PERIOD|Lost to Follow-up|2
661486|NCT02016105|2131715|P5|EXTENSION PERIOD|Lost to Follow-up|0
661487|NCT02016105|2131716|P4|EXTENSION PERIOD|Lost to Follow-up|0
661488|NCT02016105|2131717|P3|EXTENSION PERIOD|Lost to Follow-up|0
661489|NCT02016105|2131718|P2|EXTENSION PERIOD|Lost to Follow-up|0
661490|NCT02016105|2131719|P1|EXTENSION PERIOD|Lost to Follow-up|0
661491|NCT02016105|2131714|P6|EXTENSION PERIOD|Non-compliance with study indication|0
661492|NCT02016105|2131715|P5|EXTENSION PERIOD|Non-compliance with study indication|1
661493|NCT02016105|2131716|P4|EXTENSION PERIOD|Non-compliance with study indication|0
661494|NCT02016105|2131717|P3|EXTENSION PERIOD|Non-compliance with study indication|0
661495|NCT02016105|2131718|P2|EXTENSION PERIOD|Non-compliance with study indication|0
661496|NCT02016105|2131719|P1|EXTENSION PERIOD|Non-compliance with study indication|0
661497|NCT02016105|2131714|P6|EXTENSION PERIOD|Withdrawal by Subject|2
661498|NCT02016105|2131715|P5|EXTENSION PERIOD|Withdrawal by Subject|2
661499|NCT02016105|2131716|P4|EXTENSION PERIOD|Withdrawal by Subject|2
661500|NCT02016105|2131717|P3|EXTENSION PERIOD|Withdrawal by Subject|2
661501|NCT02016105|2131718|P2|EXTENSION PERIOD|Withdrawal by Subject|0
661502|NCT02016105|2131719|P1|EXTENSION PERIOD|Withdrawal by Subject|0
661503|NCT02016105|2131714|P6|EXTENSION PERIOD|Adverse Event|0
661504|NCT02016105|2131715|P5|EXTENSION PERIOD|Adverse Event|1
661505|NCT02016105|2131716|P4|EXTENSION PERIOD|Adverse Event|0
661506|NCT02016105|2131717|P3|EXTENSION PERIOD|Adverse Event|2
661507|NCT02016105|2131718|P2|EXTENSION PERIOD|Adverse Event|0
661508|NCT02016105|2131719|P1|EXTENSION PERIOD|Adverse Event|0
661509|NCT02016105|2131714|P6|EXTENSION PERIOD|Lack of Efficacy|1
661510|NCT02016105|2131715|P5|EXTENSION PERIOD|Lack of Efficacy|1
661511|NCT02016105|2131716|P4|EXTENSION PERIOD|Lack of Efficacy|3
661512|NCT02016105|2131717|P3|EXTENSION PERIOD|Lack of Efficacy|1
661513|NCT02016105|2131718|P2|EXTENSION PERIOD|Lack of Efficacy|0
661514|NCT02016105|2131719|P1|EXTENSION PERIOD|Lack of Efficacy|0
661515|NCT02016105|2131714|P6|EXTENSION PERIOD|New therapy for study indication|1
661516|NCT02016105|2131715|P5|EXTENSION PERIOD|New therapy for study indication|1
661517|NCT02016105|2131716|P4|EXTENSION PERIOD|New therapy for study indication|0
661518|NCT02016105|2131717|P3|EXTENSION PERIOD|New therapy for study indication|0
661519|NCT02016105|2131718|P2|EXTENSION PERIOD|New therapy for study indication|0
661520|NCT02016105|2131719|P1|EXTENSION PERIOD|New therapy for study indication|0
661521|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
661522|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
661523|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
661524|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
661525|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
661526|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
661527|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
661528|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
661529|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
661530|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
661531|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
661532|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
661533|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Adverse Event|1
661534|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Adverse Event|0
661535|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Adverse Event|4
661536|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Adverse Event|0
661537|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Adverse Event|0
661538|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Adverse Event|0
661539|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Death|1
661540|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Death|0
661541|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Death|0
661542|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Death|0
661543|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Death|0
661544|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Death|0
661545|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Pregnancy|1
661546|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Pregnancy|0
661547|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Pregnancy|0
661548|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Pregnancy|0
661549|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Pregnancy|0
661550|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Pregnancy|0
661551|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
661552|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
661553|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
661554|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
661555|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
661556|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
661557|NCT02016105|2131714|P6|TREATMENT PERIOD 2|Non compliance study medication|1
661558|NCT02016105|2131715|P5|TREATMENT PERIOD 2|Non compliance study medication|0
661559|NCT02016105|2131716|P4|TREATMENT PERIOD 2|Non compliance study medication|0
661560|NCT02016105|2131717|P3|TREATMENT PERIOD 2|Non compliance study medication|0
661561|NCT02016105|2131718|P2|TREATMENT PERIOD 2|Non compliance study medication|0
661562|NCT02016105|2131719|P1|TREATMENT PERIOD 2|Non compliance study medication|0
661563|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
661564|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
661565|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
661566|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
661567|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
661568|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
661569|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
661570|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
661571|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
661572|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
661573|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
661574|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
661576|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Adverse Event|0
661577|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Adverse Event|0
661578|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Adverse Event|0
661579|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Adverse Event|5
661580|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Adverse Event|3
661581|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Pregnancy|0
661582|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Pregnancy|0
661583|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Pregnancy|0
661584|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Pregnancy|0
661585|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Pregnancy|1
661586|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Pregnancy|0
661587|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
661588|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
661589|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
661590|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
661591|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
661592|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
661593|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Physician Decision|0
661594|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Physician Decision|0
661595|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Physician Decision|0
661596|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Physician Decision|0
661597|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Physician Decision|2
661598|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Physician Decision|0
661599|NCT02016105|2131714|P6|TREATMENT PERIOD 1|Protocol Violation|0
661600|NCT02016105|2131715|P5|TREATMENT PERIOD 1|Protocol Violation|0
661601|NCT02016105|2131716|P4|TREATMENT PERIOD 1|Protocol Violation|0
661602|NCT02016105|2131717|P3|TREATMENT PERIOD 1|Protocol Violation|0
661603|NCT02016105|2131718|P2|TREATMENT PERIOD 1|Protocol Violation|8
661604|NCT02016105|2131719|P1|TREATMENT PERIOD 1|Protocol Violation|2
661605|NCT02015793|2131778|P2|Overall Study|Withdrawal by Subject|1
661606|NCT02015793|2131779|P1|Overall Study|Withdrawal by Subject|1
661607|NCT02015793|2131778|P2|Overall Study|Adverse Event|3
661608|NCT02015793|2131779|P1|Overall Study|Adverse Event|3
661609|NCT02015676|2131812|P3|Overall Study|Disease progression|1
661610|NCT02015676|2131813|P2|Overall Study|Disease progression|1
661611|NCT02015676|2131814|P1|Overall Study|Disease progression|3
661612|NCT02015676|2131812|P3|Overall Study|Death|0
661613|NCT02015676|2131813|P2|Overall Study|Death|1
661614|NCT02015676|2131814|P1|Overall Study|Death|0
661615|NCT02015676|2131812|P3|Overall Study|Administrative reasons|1
661616|NCT02015676|2131813|P2|Overall Study|Administrative reasons|3
661617|NCT02015676|2131814|P1|Overall Study|Administrative reasons|0
661618|NCT02015676|2131812|P3|Overall Study|Withdrawal by Subject|1
661619|NCT02015676|2131813|P2|Overall Study|Withdrawal by Subject|7
661620|NCT02015676|2131814|P1|Overall Study|Withdrawal by Subject|1
661621|NCT02015676|2131812|P3|Overall Study|Protocol Violation|0
661622|NCT02015676|2131813|P2|Overall Study|Protocol Violation|0
661623|NCT02015676|2131814|P1|Overall Study|Protocol Violation|1
661624|NCT02015676|2131812|P3|Overall Study|Lack of Efficacy|0
661625|NCT02015676|2131813|P2|Overall Study|Lack of Efficacy|4
661626|NCT02015676|2131814|P1|Overall Study|Lack of Efficacy|2
661627|NCT02015676|2131812|P3|Overall Study|Adverse Event|0
661628|NCT02015676|2131813|P2|Overall Study|Adverse Event|18
661629|NCT02015676|2131814|P1|Overall Study|Adverse Event|2
661630|NCT02015663|2131830|P2|Overall Study|Administrative problems|11
661631|NCT02015663|2131831|P1|Overall Study|Administrative problems|10
661632|NCT02015663|2131830|P2|Overall Study|Adverse Event|0
661633|NCT02015663|2131831|P1|Overall Study|Adverse Event|3
661634|NCT02015663|2131830|P2|Overall Study|Protocol Violation|1
661635|NCT02015663|2131831|P1|Overall Study|Protocol Violation|0
661636|NCT02015663|2131830|P2|Overall Study|Withdrawal by Subject|0
661637|NCT02015663|2131831|P1|Overall Study|Withdrawal by Subject|1
661638|NCT02015663|2131830|P2|Overall Study|unsatisfactory therapeutic effect|0
661639|NCT02015663|2131831|P1|Overall Study|unsatisfactory therapeutic effect|1
661640|NCT02015546|2131863|P3|Overall Study|Screem Failure|3
661641|NCT02015546|2131864|P2|Overall Study|Screem Failure|1
661642|NCT02015546|2131865|P1|Overall Study|Screem Failure|2
661643|NCT02015546|2131863|P3|Overall Study|Withdrawal by Subject|1
661644|NCT02015546|2131864|P2|Overall Study|Withdrawal by Subject|1
661645|NCT02015546|2131865|P1|Overall Study|Withdrawal by Subject|1
661647|NCT02015221|2131921|P2|Overall Study|Lost to Follow-up|0
661648|NCT02015221|2131922|P1|Overall Study|Lost to Follow-up|1
661649|NCT02015221|2131921|P2|Overall Study|Withdrawal by Subject|6
661650|NCT02015221|2131922|P1|Overall Study|Withdrawal by Subject|8
661651|NCT02015195|2131935|P7|Overall Study|Adverse Event|0
661652|NCT02015195|2131936|P6|Overall Study|Adverse Event|0
661653|NCT02015195|2131937|P5|Overall Study|Adverse Event|0
661654|NCT02015195|2131938|P4|Overall Study|Adverse Event|1
661655|NCT02015195|2131939|P3|Overall Study|Adverse Event|0
661656|NCT02015195|2131940|P2|Overall Study|Adverse Event|0
661657|NCT02015195|2131941|P1|Overall Study|Adverse Event|0
661658|NCT02014584|2131964|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
661659|NCT02014584|2131965|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
661660|NCT02014584|2131966|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
661661|NCT02014584|2131967|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
661662|NCT02014584|2131968|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
661740|NCT02014402|2132267|P4|Overall Study|Lost to Follow-up|2
661663|NCT02014584|2131969|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
661664|NCT02014584|2131964|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
661665|NCT02014584|2131965|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
661666|NCT02014584|2131966|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
661667|NCT02014584|2131967|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
661668|NCT02014584|2131968|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
661669|NCT02014584|2131969|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
661670|NCT02014584|2131964|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
661671|NCT02014584|2131965|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
661672|NCT02014584|2131966|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
661673|NCT02014584|2131967|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
661674|NCT02014584|2131968|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
661675|NCT02014584|2131969|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
661676|NCT02014584|2131964|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
661677|NCT02014584|2131965|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
661678|NCT02014584|2131966|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
661679|NCT02014584|2131967|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
661680|NCT02014584|2131968|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
661681|NCT02014584|2131969|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
661682|NCT02014584|2131964|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
661683|NCT02014584|2131965|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
661684|NCT02014584|2131966|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
661685|NCT02014584|2131967|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
661686|NCT02014584|2131968|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
661687|NCT02014584|2131969|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
661688|NCT02014480|2132086|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
661689|NCT02014480|2132087|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
661690|NCT02014480|2132088|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
661691|NCT02014480|2132089|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
661692|NCT02014480|2132090|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
661693|NCT02014480|2132091|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
661694|NCT02014480|2132086|P6|Treatment Period 3 (14 Days)|Adverse Event|1
661695|NCT02014480|2132087|P5|Treatment Period 3 (14 Days)|Adverse Event|0
661696|NCT02014480|2132088|P4|Treatment Period 3 (14 Days)|Adverse Event|0
661697|NCT02014480|2132089|P3|Treatment Period 3 (14 Days)|Adverse Event|1
661698|NCT02014480|2132090|P2|Treatment Period 3 (14 Days)|Adverse Event|0
661699|NCT02014480|2132091|P1|Treatment Period 3 (14 Days)|Adverse Event|0
661700|NCT02014480|2132086|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
661701|NCT02014480|2132087|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
661702|NCT02014480|2132088|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
661703|NCT02014480|2132089|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
661704|NCT02014480|2132090|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
661705|NCT02014480|2132091|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
661706|NCT02014480|2132086|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
661707|NCT02014480|2132087|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
661708|NCT02014480|2132088|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
661709|NCT02014480|2132089|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
661710|NCT02014480|2132090|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
661711|NCT02014480|2132091|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
661712|NCT02014480|2132086|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
661713|NCT02014480|2132087|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
661714|NCT02014480|2132088|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
661715|NCT02014480|2132089|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
661716|NCT02014480|2132090|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
661717|NCT02014480|2132091|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
661718|NCT02014480|2132086|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
661719|NCT02014480|2132087|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
661720|NCT02014480|2132088|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
661721|NCT02014480|2132089|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
661722|NCT02014480|2132090|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
661723|NCT02014480|2132091|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
661724|NCT02014480|2132086|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
661725|NCT02014480|2132087|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
661726|NCT02014480|2132088|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
661727|NCT02014480|2132089|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
661728|NCT02014480|2132090|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
661729|NCT02014480|2132091|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
661730|NCT02014467|2132110|P2|Overall Study|Withdrawal by Subject|4
661731|NCT02014467|2132111|P1|Overall Study|Withdrawal by Subject|16
661732|NCT02014467|2132110|P2|Overall Study|Physician Decision|3
661733|NCT02014467|2132111|P1|Overall Study|Physician Decision|2
661734|NCT02014467|2132110|P2|Overall Study|Protocol Violation|0
661735|NCT02014467|2132111|P1|Overall Study|Protocol Violation|3
661736|NCT02014467|2132110|P2|Overall Study|Adverse Event|0
661737|NCT02014467|2132111|P1|Overall Study|Adverse Event|4
661738|NCT02014441|2132171|P1|Overall Study|Continuing in Study|21
661739|NCT02014441|2132171|P1|Overall Study|Withdrawal by Subject|9
661741|NCT02014402|2132268|P3|Overall Study|Lost to Follow-up|1
661742|NCT02014402|2132269|P2|Overall Study|Lost to Follow-up|0
661743|NCT02014402|2132270|P1|Overall Study|Lost to Follow-up|0
661744|NCT02014402|2132267|P4|Overall Study|Subject did not have transportation|0
661745|NCT02014402|2132268|P3|Overall Study|Subject did not have transportation|0
661746|NCT02014402|2132269|P2|Overall Study|Subject did not have transportation|1
661747|NCT02014402|2132270|P1|Overall Study|Subject did not have transportation|0
661748|NCT02014402|2132267|P4|Overall Study|Withdrawal by Subject|1
661749|NCT02014402|2132268|P3|Overall Study|Withdrawal by Subject|2
661750|NCT02014402|2132269|P2|Overall Study|Withdrawal by Subject|2
661751|NCT02014402|2132270|P1|Overall Study|Withdrawal by Subject|1
661752|NCT02014402|2132267|P4|Overall Study|Adverse Event|0
661753|NCT02014402|2132268|P3|Overall Study|Adverse Event|0
661754|NCT02014402|2132269|P2|Overall Study|Adverse Event|0
661755|NCT02014402|2132270|P1|Overall Study|Adverse Event|1
661756|NCT02014272|2132310|P2|Intervention Period 1|Adverse Event|1
661757|NCT02014272|2132311|P1|Intervention Period 1|Adverse Event|0
661758|NCT02014272|2132310|P2|Intervention Period 1|Withdrawal by Subject|0
661759|NCT02014272|2132311|P1|Intervention Period 1|Withdrawal by Subject|1
661760|NCT02013830|2132343|P1|Overall Study|Refused treatment|1
661761|NCT02013830|2132343|P1|Overall Study|Insufficient therapeutic response|25
661762|NCT02013830|2132343|P1|Overall Study|Death|1
661763|NCT02013830|2132343|P1|Overall Study|Adverse Event|3
661764|NCT02013817|2132354|P1|Overall Study|Not specified|9
661765|NCT02013817|2132354|P1|Overall Study|Death|2
661766|NCT02013817|2132354|P1|Overall Study|Withdrawal by Subject|4
661767|NCT02013817|2132354|P1|Overall Study|Adverse Event|12
661768|NCT02013765|2132363|P1|Overall Study|Trial was terminated by sponsor|1
661769|NCT02013687|2132377|P4|Overall Study|Missed visits due to patient travel|0
661770|NCT02013687|2132378|P3|Overall Study|Missed visits due to patient travel|1
661771|NCT02013687|2132379|P2|Overall Study|Missed visits due to patient travel|0
661772|NCT02013687|2132380|P1|Overall Study|Missed visits due to patient travel|0
661773|NCT02013687|2132377|P4|Overall Study|Withdrawal by Subject|1
661774|NCT02013687|2132378|P3|Overall Study|Withdrawal by Subject|0
661775|NCT02013687|2132379|P2|Overall Study|Withdrawal by Subject|0
661776|NCT02013687|2132380|P1|Overall Study|Withdrawal by Subject|0
661777|NCT02013687|2132377|P4|Overall Study|Protocol Violation|1
661778|NCT02013687|2132378|P3|Overall Study|Protocol Violation|0
661779|NCT02013687|2132379|P2|Overall Study|Protocol Violation|0
661780|NCT02013687|2132380|P1|Overall Study|Protocol Violation|0
661781|NCT02013687|2132377|P4|Overall Study|Lost to Follow-up|0
661782|NCT02013687|2132378|P3|Overall Study|Lost to Follow-up|1
661783|NCT02013687|2132379|P2|Overall Study|Lost to Follow-up|0
661784|NCT02013687|2132380|P1|Overall Study|Lost to Follow-up|0
661785|NCT02013622|2132410|P1|Overall Study|Lack of Efficacy|1
661786|NCT02013622|2132410|P1|Overall Study|Protocol Deviation|1
661787|NCT02013622|2132410|P1|Overall Study|Withdrawal by Subject|6
661788|NCT02013622|2132410|P1|Overall Study|Met Withdrawal Criteria|3
661789|NCT02013622|2132410|P1|Overall Study|Adverse Event|3
661790|NCT02013622|2132410|P1|Overall Study|Lost to Follow-up|10
661791|NCT02013609|2132430|P1|Overall Study|Met Withdrawal Criteria|3
661792|NCT02013609|2132430|P1|Overall Study|Adverse Event|3
661793|NCT02013609|2132430|P1|Overall Study|Lost to Follow-up|3
661794|NCT02013609|2132430|P1|Overall Study|Withdrawal by Subject|9
661795|NCT02013544|2132455|P2|Overall Study|Entry criteria not met/non-compliance|3
661796|NCT02013544|2132456|P1|Overall Study|Entry criteria not met/non-compliance|2
661797|NCT02013544|2132455|P2|Overall Study|Physician Decision|1
661798|NCT02013544|2132456|P1|Overall Study|Physician Decision|0
661799|NCT02013544|2132455|P2|Overall Study|Withdrawal by Subject|8
661800|NCT02013544|2132456|P1|Overall Study|Withdrawal by Subject|2
661801|NCT02013544|2132455|P2|Overall Study|Lost to Follow-up|3
661802|NCT02013544|2132456|P1|Overall Study|Lost to Follow-up|2
661803|NCT02013544|2132455|P2|Overall Study|Adverse Event|5
661804|NCT02013544|2132456|P1|Overall Study|Adverse Event|5
661805|NCT02013531|2132478|P1|Overall Study|Withdrawal by Subject|1
661806|NCT02013531|2132478|P1|Overall Study|Met Withdrawal Criteria|1
661807|NCT02013531|2132478|P1|Overall Study|Lost to Follow-up|3
661808|NCT02013388|2132508|P8|Overall Study|work emergency|0
661809|NCT02013388|2132509|P7|Overall Study|work emergency|0
661810|NCT02013388|2132510|P6|Overall Study|work emergency|0
661811|NCT02013388|2132511|P5|Overall Study|work emergency|1
661812|NCT02013388|2132512|P4|Overall Study|work emergency|0
661813|NCT02013388|2132513|P3|Overall Study|work emergency|0
661814|NCT02013388|2132514|P2|Overall Study|work emergency|0
661815|NCT02013388|2132515|P1|Overall Study|work emergency|1
661816|NCT02013206|2132572|P2|Overall Study|Other reasons off treatment|2
661817|NCT02013206|2132573|P1|Overall Study|Other reasons off treatment|5
661818|NCT02013206|2132572|P2|Overall Study|Death|2
661819|NCT02013206|2132573|P1|Overall Study|Death|1
661820|NCT02013206|2132572|P2|Overall Study|Patient non-compliance|0
661821|NCT02013206|2132573|P1|Overall Study|Patient non-compliance|1
661822|NCT02013206|2132572|P2|Overall Study|Patient refusal|0
661823|NCT02013206|2132573|P1|Overall Study|Patient refusal|2
661824|NCT02013206|2132572|P2|Overall Study|Adverse Event|0
661825|NCT02013206|2132573|P1|Overall Study|Adverse Event|1
661826|NCT02013206|2132572|P2|Overall Study|Symptomatic deterioration|1
661827|NCT02013206|2132573|P1|Overall Study|Symptomatic deterioration|3
661828|NCT02013206|2132572|P2|Overall Study|Progressive disease (PD)|17
661829|NCT02013206|2132573|P1|Overall Study|Progressive disease (PD)|14
661838|NCT02012686|2132674|P2|Overall Study|electrocardiography monitoring noise|1
661839|NCT02012686|2132675|P1|Overall Study|electrocardiography monitoring noise|0
661840|NCT02012686|2132674|P2|Overall Study|muscle contraction|1
661841|NCT02012686|2132675|P1|Overall Study|muscle contraction|0
661842|NCT02012452|2132722|P2|Overall Study|Withdrawal by Subject|0
661843|NCT02012452|2132723|P1|Overall Study|Withdrawal by Subject|4
661844|NCT02012452|2132722|P2|Overall Study|Lost to Follow-up|1
661845|NCT02012452|2132723|P1|Overall Study|Lost to Follow-up|2
661846|NCT02012218|2132736|P5|Overall Study|Protocol Deviation|0
661847|NCT02012218|2132737|P4|Overall Study|Protocol Deviation|0
661848|NCT02012218|2132738|P3|Overall Study|Protocol Deviation|0
661849|NCT02012218|2132739|P2|Overall Study|Protocol Deviation|0
661850|NCT02012218|2132740|P1|Overall Study|Protocol Deviation|1
661851|NCT02012218|2132736|P5|Overall Study|Protocol Specified|0
661852|NCT02012218|2132737|P4|Overall Study|Protocol Specified|0
661853|NCT02012218|2132738|P3|Overall Study|Protocol Specified|0
661854|NCT02012218|2132739|P2|Overall Study|Protocol Specified|0
661855|NCT02012218|2132740|P1|Overall Study|Protocol Specified|1
661856|NCT02012218|2132736|P5|Overall Study|Lost to Follow-up|0
661857|NCT02012218|2132737|P4|Overall Study|Lost to Follow-up|0
661858|NCT02012218|2132738|P3|Overall Study|Lost to Follow-up|1
661859|NCT02012218|2132739|P2|Overall Study|Lost to Follow-up|1
661860|NCT02012218|2132740|P1|Overall Study|Lost to Follow-up|0
661861|NCT02012218|2132736|P5|Overall Study|Adverse Event|0
661862|NCT02012218|2132737|P4|Overall Study|Adverse Event|1
661863|NCT02012218|2132738|P3|Overall Study|Adverse Event|0
661864|NCT02012218|2132739|P2|Overall Study|Adverse Event|0
661865|NCT02012218|2132740|P1|Overall Study|Adverse Event|1
661866|NCT02012218|2132736|P5|Overall Study|Withdrawal by Subject|1
661867|NCT02012218|2132737|P4|Overall Study|Withdrawal by Subject|1
661868|NCT02012218|2132738|P3|Overall Study|Withdrawal by Subject|1
661869|NCT02012218|2132739|P2|Overall Study|Withdrawal by Subject|0
661870|NCT02012218|2132740|P1|Overall Study|Withdrawal by Subject|1
661871|NCT02011893|2132752|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
661872|NCT02011893|2132753|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
661873|NCT02011893|2132754|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
661874|NCT02011893|2132752|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
661875|NCT02011893|2132753|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
661876|NCT02011893|2132754|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
661877|NCT02011893|2132752|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
661878|NCT02011893|2132753|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
661879|NCT02011893|2132754|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
661880|NCT02011893|2132752|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
661881|NCT02011893|2132753|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
661882|NCT02011893|2132754|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
661883|NCT02011893|2132752|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
661884|NCT02011893|2132753|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
661885|NCT02011893|2132754|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
661886|NCT02011893|2132752|P3|Enrollment to Randomization|Screening Failure|0
661887|NCT02011893|2132753|P2|Enrollment to Randomization|Screening Failure|0
661888|NCT02011893|2132754|P1|Enrollment to Randomization|Screening Failure|29
661889|NCT02011893|2132752|P3|Enrollment to Randomization|Withdrawal by Subject|0
661890|NCT02011893|2132753|P2|Enrollment to Randomization|Withdrawal by Subject|0
661891|NCT02011893|2132754|P1|Enrollment to Randomization|Withdrawal by Subject|21
661892|NCT02011893|2132752|P3|Enrollment to Randomization|Physician Decision|0
661893|NCT02011893|2132753|P2|Enrollment to Randomization|Physician Decision|0
661894|NCT02011893|2132754|P1|Enrollment to Randomization|Physician Decision|10
661895|NCT02011893|2132752|P3|Enrollment to Randomization|Adverse Event|0
661896|NCT02011893|2132753|P2|Enrollment to Randomization|Adverse Event|0
661897|NCT02011893|2132754|P1|Enrollment to Randomization|Adverse Event|2
661898|NCT02011113|2132891|P1|Overall Study|Study terminated by sponsor|11
661899|NCT02011113|2132891|P1|Overall Study|Investigator's judgement- DP|3
661900|NCT02011113|2132891|P1|Overall Study|Insufficient effect of Pomalidomide|1
661901|NCT02011113|2132891|P1|Overall Study|Death|1
661902|NCT02011113|2132891|P1|Overall Study|Disease Progression (DP)|16
661903|NCT02011113|2132891|P1|Overall Study|Adverse Event|4
661904|NCT02010684|2132920|P2|Overall Study|Withdrawal by Subject|5
661905|NCT02010684|2132921|P1|Overall Study|Withdrawal by Subject|4
661906|NCT02010684|2132920|P2|Overall Study|Lost to Follow-up|18
661907|NCT02010684|2132921|P1|Overall Study|Lost to Follow-up|8
661908|NCT02010632|2132939|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
661909|NCT02010632|2132940|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
661910|NCT02010255|2132960|P14|Overall Study|Randomized but Not Treated|1
661911|NCT02010255|2132961|P13|Overall Study|Randomized but Not Treated|0
661912|NCT02010255|2132962|P12|Overall Study|Randomized but Not Treated|0
661913|NCT02010255|2132963|P11|Overall Study|Randomized but Not Treated|0
661914|NCT02010255|2132964|P10|Overall Study|Randomized but Not Treated|0
661915|NCT02010255|2132965|P9|Overall Study|Randomized but Not Treated|0
661916|NCT02010255|2132966|P8|Overall Study|Randomized but Not Treated|0
661917|NCT02010255|2132967|P7|Overall Study|Randomized but Not Treated|0
661918|NCT02010255|2132968|P6|Overall Study|Randomized but Not Treated|0
661919|NCT02010255|2132969|P5|Overall Study|Randomized but Not Treated|0
661920|NCT02010255|2132970|P4|Overall Study|Randomized but Not Treated|0
661921|NCT02010255|2132971|P3|Overall Study|Randomized but Not Treated|0
661922|NCT02010255|2132972|P2|Overall Study|Randomized but Not Treated|0
661923|NCT02010255|2132973|P1|Overall Study|Randomized but Not Treated|0
661924|NCT02010255|2132960|P14|Overall Study|Lost to Follow-up|0
661925|NCT02010255|2132961|P13|Overall Study|Lost to Follow-up|0
661926|NCT02010255|2132962|P12|Overall Study|Lost to Follow-up|0
661927|NCT02010255|2132963|P11|Overall Study|Lost to Follow-up|0
661928|NCT02010255|2132964|P10|Overall Study|Lost to Follow-up|0
661929|NCT02010255|2132965|P9|Overall Study|Lost to Follow-up|0
661930|NCT02010255|2132966|P8|Overall Study|Lost to Follow-up|0
661931|NCT02010255|2132967|P7|Overall Study|Lost to Follow-up|0
661932|NCT02010255|2132968|P6|Overall Study|Lost to Follow-up|0
661933|NCT02010255|2132969|P5|Overall Study|Lost to Follow-up|1
661934|NCT02010255|2132970|P4|Overall Study|Lost to Follow-up|0
661935|NCT02010255|2132971|P3|Overall Study|Lost to Follow-up|1
661936|NCT02010255|2132972|P2|Overall Study|Lost to Follow-up|0
661937|NCT02010255|2132973|P1|Overall Study|Lost to Follow-up|0
661938|NCT02010255|2132960|P14|Overall Study|Adverse Event|0
661939|NCT02010255|2132961|P13|Overall Study|Adverse Event|0
661940|NCT02010255|2132962|P12|Overall Study|Adverse Event|0
661941|NCT02010255|2132963|P11|Overall Study|Adverse Event|0
661942|NCT02010255|2132964|P10|Overall Study|Adverse Event|0
661943|NCT02010255|2132965|P9|Overall Study|Adverse Event|0
661944|NCT02010255|2132966|P8|Overall Study|Adverse Event|0
661945|NCT02010255|2132967|P7|Overall Study|Adverse Event|0
661946|NCT02010255|2132968|P6|Overall Study|Adverse Event|0
661947|NCT02010255|2132969|P5|Overall Study|Adverse Event|0
661948|NCT02010255|2132970|P4|Overall Study|Adverse Event|0
661949|NCT02010255|2132971|P3|Overall Study|Adverse Event|0
661950|NCT02010255|2132972|P2|Overall Study|Adverse Event|0
661951|NCT02010255|2132973|P1|Overall Study|Adverse Event|1
661952|NCT02010255|2132960|P14|Overall Study|Withdrew Consent|0
661953|NCT02010255|2132961|P13|Overall Study|Withdrew Consent|0
661954|NCT02010255|2132962|P12|Overall Study|Withdrew Consent|0
661955|NCT02010255|2132963|P11|Overall Study|Withdrew Consent|0
661956|NCT02010255|2132964|P10|Overall Study|Withdrew Consent|0
661957|NCT02010255|2132965|P9|Overall Study|Withdrew Consent|0
661958|NCT02010255|2132966|P8|Overall Study|Withdrew Consent|0
661959|NCT02010255|2132967|P7|Overall Study|Withdrew Consent|0
661960|NCT02010255|2132968|P6|Overall Study|Withdrew Consent|0
661961|NCT02010255|2132969|P5|Overall Study|Withdrew Consent|0
661962|NCT02010255|2132970|P4|Overall Study|Withdrew Consent|1
661963|NCT02010255|2132971|P3|Overall Study|Withdrew Consent|0
661964|NCT02010255|2132972|P2|Overall Study|Withdrew Consent|0
661965|NCT02010255|2132973|P1|Overall Study|Withdrew Consent|1
661966|NCT02010255|2132960|P14|Overall Study|Lack of Efficacy|0
661967|NCT02010255|2132961|P13|Overall Study|Lack of Efficacy|0
661968|NCT02010255|2132962|P12|Overall Study|Lack of Efficacy|0
661969|NCT02010255|2132963|P11|Overall Study|Lack of Efficacy|1
661970|NCT02010255|2132964|P10|Overall Study|Lack of Efficacy|0
661971|NCT02010255|2132965|P9|Overall Study|Lack of Efficacy|0
661972|NCT02010255|2132966|P8|Overall Study|Lack of Efficacy|0
661973|NCT02010255|2132967|P7|Overall Study|Lack of Efficacy|0
661974|NCT02010255|2132968|P6|Overall Study|Lack of Efficacy|0
661975|NCT02010255|2132969|P5|Overall Study|Lack of Efficacy|1
661976|NCT02010255|2132970|P4|Overall Study|Lack of Efficacy|1
661977|NCT02010255|2132971|P3|Overall Study|Lack of Efficacy|2
661978|NCT02010255|2132972|P2|Overall Study|Lack of Efficacy|1
661979|NCT02010255|2132973|P1|Overall Study|Lack of Efficacy|4
661980|NCT02010255|2132960|P14|Overall Study|Death|0
661981|NCT02010255|2132961|P13|Overall Study|Death|0
661982|NCT02010255|2132962|P12|Overall Study|Death|1
661983|NCT02010255|2132963|P11|Overall Study|Death|1
661984|NCT02010255|2132964|P10|Overall Study|Death|0
661985|NCT02010255|2132965|P9|Overall Study|Death|1
661986|NCT02010255|2132966|P8|Overall Study|Death|1
661987|NCT02010255|2132967|P7|Overall Study|Death|1
661988|NCT02010255|2132968|P6|Overall Study|Death|0
661989|NCT02010255|2132969|P5|Overall Study|Death|2
661990|NCT02010255|2132970|P4|Overall Study|Death|4
661991|NCT02010255|2132971|P3|Overall Study|Death|4
661992|NCT02010255|2132972|P2|Overall Study|Death|1
661993|NCT02010255|2132973|P1|Overall Study|Death|0
661994|NCT02009878|2133317|P3|Overall Study|Participant Met Withdrawal Criteria|0
661995|NCT02009878|2133318|P2|Overall Study|Participant Met Withdrawal Criteria|1
661996|NCT02009878|2133319|P1|Overall Study|Participant Met Withdrawal Criteria|0
661997|NCT02009865|2133353|P2|Overall Study|Withdrawal by Subject|1
661998|NCT02009865|2133354|P1|Overall Study|Withdrawal by Subject|1
661999|NCT02009865|2133353|P2|Overall Study|Protocol Violation|2
662000|NCT02009865|2133354|P1|Overall Study|Protocol Violation|0
662001|NCT02009865|2133353|P2|Overall Study|Adverse Event|2
662002|NCT02009865|2133354|P1|Overall Study|Adverse Event|0
662003|NCT02009722|2133370|P2|Overall Study|Did not receive intervention|1
662004|NCT02009722|2133371|P1|Overall Study|Did not receive intervention|0
662005|NCT02009722|2133370|P2|Overall Study|Protocol Violation|2
662006|NCT02009722|2133371|P1|Overall Study|Protocol Violation|1
662007|NCT02009696|2133395|P1|Overall Study|Withdrawal by Subject|2
662008|NCT02009163|2133403|P3|Randomized-withdrawal Period|Not specified|5
662009|NCT02009163|2133404|P2|Randomized-withdrawal Period|Not specified|9
662010|NCT02009163|2133405|P1|Randomized-withdrawal Period|Not specified|0
662011|NCT02009163|2133403|P3|Randomized-withdrawal Period|Pregnancy|2
662012|NCT02009163|2133404|P2|Randomized-withdrawal Period|Pregnancy|0
662013|NCT02009163|2133405|P1|Randomized-withdrawal Period|Pregnancy|0
662014|NCT02009163|2133403|P3|Randomized-withdrawal Period|Protocol Violation|2
662015|NCT02009163|2133404|P2|Randomized-withdrawal Period|Protocol Violation|1
662016|NCT02009163|2133405|P1|Randomized-withdrawal Period|Protocol Violation|0
662017|NCT02009163|2133403|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
662018|NCT02009163|2133404|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
662019|NCT02009163|2133405|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
662020|NCT02009163|2133403|P3|Randomized-withdrawal Period|Adverse Event|6
662021|NCT02009163|2133404|P2|Randomized-withdrawal Period|Adverse Event|0
662022|NCT02009163|2133405|P1|Randomized-withdrawal Period|Adverse Event|0
662023|NCT02009163|2133403|P3|Randomized-withdrawal Period|Lost to Follow-up|6
662024|NCT02009163|2133404|P2|Randomized-withdrawal Period|Lost to Follow-up|13
662025|NCT02009163|2133405|P1|Randomized-withdrawal Period|Lost to Follow-up|0
662026|NCT02009163|2133403|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
662027|NCT02009163|2133404|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
662028|NCT02009163|2133405|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
662029|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Not specified|0
662030|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Not specified|0
662031|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Not specified|13
662032|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Pregnancy|0
662033|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Pregnancy|0
662034|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Pregnancy|1
662035|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Protocol Violation|0
662036|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Protocol Violation|0
662037|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Protocol Violation|10
662038|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
662039|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
662040|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
662041|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Adverse Event|0
662042|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Adverse Event|0
662043|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Adverse Event|22
662044|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
662045|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
662046|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
662047|NCT02009163|2133403|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
662048|NCT02009163|2133404|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
662049|NCT02009163|2133405|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
662050|NCT02008526|2133482|P3|Overall Study|Lost to Follow-up|6
662051|NCT02008526|2133483|P2|Overall Study|Lost to Follow-up|9
662052|NCT02008526|2133484|P1|Overall Study|Lost to Follow-up|5
662053|NCT02008526|2133482|P3|Overall Study|Withdrawal by Subject|2
662054|NCT02008526|2133483|P2|Overall Study|Withdrawal by Subject|3
662055|NCT02008526|2133484|P1|Overall Study|Withdrawal by Subject|3
662056|NCT02008526|2133482|P3|Overall Study|Death|1
662057|NCT02008526|2133483|P2|Overall Study|Death|2
662058|NCT02008526|2133484|P1|Overall Study|Death|0
662059|NCT02008227|2133497|P2|Overall Study|Ongoing Survival Follow-up|106
662060|NCT02008227|2133498|P1|Overall Study|Ongoing Survival Follow-up|135
662061|NCT02008227|2133497|P2|Overall Study|Ongoing on Study Treatment|85
662062|NCT02008227|2133498|P1|Overall Study|Ongoing on Study Treatment|4
662063|NCT02008227|2133497|P2|Overall Study|Withdrawal by Subject|34
662064|NCT02008227|2133498|P1|Overall Study|Withdrawal by Subject|63
662065|NCT02008227|2133497|P2|Overall Study|Death|383
662066|NCT02008227|2133498|P1|Overall Study|Death|407
662067|NCT02008227|2133497|P2|Overall Study|Lost to Follow-up|5
662068|NCT02008227|2133498|P1|Overall Study|Lost to Follow-up|3
662069|NCT02007954|2133559|P1|Overall Study|Death|1
662070|NCT02007954|2133559|P1|Overall Study|Disease progression and unrelated AE|1
662071|NCT02007954|2133559|P1|Overall Study|Switch in treatment modality|2
662072|NCT02007954|2133559|P1|Overall Study|Received liver transplant|3
662073|NCT02007577|2133578|P2|Overall Study|Withdrawal by Subject|1
662074|NCT02007577|2133579|P1|Overall Study|Withdrawal by Subject|0
662075|NCT02007577|2133578|P2|Overall Study|Adverse Event|0
662076|NCT02007577|2133579|P1|Overall Study|Adverse Event|1
662077|NCT02007434|2133595|P8|Overall Study|Non-compliance|0
662078|NCT02007434|2133596|P7|Overall Study|Non-compliance|0
662079|NCT02007434|2133597|P6|Overall Study|Non-compliance|0
662080|NCT02007434|2133598|P5|Overall Study|Non-compliance|0
662081|NCT02007434|2133599|P4|Overall Study|Non-compliance|0
662082|NCT02007434|2133600|P3|Overall Study|Non-compliance|1
662083|NCT02007434|2133601|P2|Overall Study|Non-compliance|0
662084|NCT02007434|2133602|P1|Overall Study|Non-compliance|1
662085|NCT02007434|2133595|P8|Overall Study|Lost to Follow-up|0
662086|NCT02007434|2133596|P7|Overall Study|Lost to Follow-up|0
662087|NCT02007434|2133597|P6|Overall Study|Lost to Follow-up|0
662088|NCT02007434|2133598|P5|Overall Study|Lost to Follow-up|0
662089|NCT02007434|2133599|P4|Overall Study|Lost to Follow-up|0
662090|NCT02007434|2133600|P3|Overall Study|Lost to Follow-up|0
662091|NCT02007434|2133601|P2|Overall Study|Lost to Follow-up|1
662092|NCT02007434|2133602|P1|Overall Study|Lost to Follow-up|0
662093|NCT02007278|2133724|P2|Overall Study|Mis-randomization|1
662094|NCT02007278|2133725|P1|Overall Study|Mis-randomization|1
662095|NCT02007278|2133724|P2|Overall Study|Incorrect medication administration|0
662096|NCT02007278|2133725|P1|Overall Study|Incorrect medication administration|1
662097|NCT02007278|2133724|P2|Overall Study|Ingestion of drugs not allowed in study|1
662098|NCT02007278|2133725|P1|Overall Study|Ingestion of drugs not allowed in study|0
662099|NCT02007278|2133724|P2|Overall Study|Failure to comply with an eligibility|1
662100|NCT02007278|2133725|P1|Overall Study|Failure to comply with an eligibility|0
662101|NCT02007252|2133747|P2|Overall Study|Adverse Event|4
662102|NCT02007252|2133748|P1|Overall Study|Adverse Event|7
662103|NCT02007252|2133747|P2|Overall Study|Abnormal laboratory value(s)|0
662104|NCT02007252|2133748|P1|Overall Study|Abnormal laboratory value(s)|1
662105|NCT02007252|2133747|P2|Overall Study|Administrative problems|7
662106|NCT02007252|2133748|P1|Overall Study|Administrative problems|3
662107|NCT02007070|2133761|P1|Overall Study|Continuing|9
662108|NCT02007070|2133761|P1|Overall Study|Progressive Disease|18
662109|NCT02007070|2133761|P1|Overall Study|Physician Decision|1
662110|NCT02007070|2133761|P1|Overall Study|Protocol Violation|2
662111|NCT02007070|2133761|P1|Overall Study|Death|1
662112|NCT02007070|2133761|P1|Overall Study|Clinical Progression|4
662113|NCT02007070|2133761|P1|Overall Study|Adverse Event|3
662114|NCT02006732|2133795|P4|Overall Study|Withdrawal by Subject|1
662115|NCT02006732|2133796|P3|Overall Study|Withdrawal by Subject|4
662116|NCT02006732|2133797|P2|Overall Study|Withdrawal by Subject|0
662117|NCT02006732|2133798|P1|Overall Study|Withdrawal by Subject|3
662118|NCT02006732|2133795|P4|Overall Study|Lost to Follow-up|0
662119|NCT02006732|2133796|P3|Overall Study|Lost to Follow-up|0
662120|NCT02006732|2133797|P2|Overall Study|Lost to Follow-up|1
662121|NCT02006732|2133798|P1|Overall Study|Lost to Follow-up|0
662122|NCT02006732|2133795|P4|Overall Study|Protocol Violation|0
662123|NCT02006732|2133796|P3|Overall Study|Protocol Violation|0
662124|NCT02006732|2133797|P2|Overall Study|Protocol Violation|1
662125|NCT02006732|2133798|P1|Overall Study|Protocol Violation|1
662126|NCT02006732|2133795|P4|Overall Study|Lack of Efficacy|1
662127|NCT02006732|2133796|P3|Overall Study|Lack of Efficacy|1
662128|NCT02006732|2133797|P2|Overall Study|Lack of Efficacy|3
662129|NCT02006732|2133798|P1|Overall Study|Lack of Efficacy|6
662130|NCT02006732|2133795|P4|Overall Study|Adverse Event|2
662131|NCT02006732|2133796|P3|Overall Study|Adverse Event|4
662132|NCT02006732|2133797|P2|Overall Study|Adverse Event|7
662133|NCT02006732|2133798|P1|Overall Study|Adverse Event|10
662134|NCT02006719|2133838|P2|Overall Study|Other/Unknown|1
662135|NCT02006719|2133839|P1|Overall Study|Other/Unknown|0
662136|NCT02006719|2133838|P2|Overall Study|Adverse Event|1
662137|NCT02006719|2133839|P1|Overall Study|Adverse Event|1
662138|NCT02006719|2133838|P2|Overall Study|Protocol Violation|0
662139|NCT02006719|2133839|P1|Overall Study|Protocol Violation|2
662140|NCT02006719|2133838|P2|Overall Study|Lost to Follow-up|1
662141|NCT02006719|2133839|P1|Overall Study|Lost to Follow-up|5
662142|NCT02006719|2133838|P2|Overall Study|Withdrawal by Subject|2
662143|NCT02006719|2133839|P1|Overall Study|Withdrawal by Subject|10
662144|NCT02006706|2133869|P1|Overall Study|Lost to Follow-up|1
662145|NCT02006667|2133874|P1|Overall Study|Withdrawal by Subject|1
662146|NCT02006667|2133874|P1|Overall Study|Death|2
662147|NCT02006667|2133874|P1|Overall Study|Adverse Event|3
662148|NCT02005692|2133912|P1|Overall Study|Discharged earlier than anticipated|5
662149|NCT02005692|2133912|P1|Overall Study|Withdrawal by Subject|1
662150|NCT02005692|2133912|P1|Overall Study|Protocol Violation|1
662151|NCT02005562|2133932|P2|Overall Study|Physician Decision|1
662152|NCT02005562|2133933|P1|Overall Study|Physician Decision|0
662153|NCT02005562|2133932|P2|Overall Study|No transplant|4
662154|NCT02005562|2133933|P1|Overall Study|No transplant|1
662155|NCT02005562|2133932|P2|Overall Study|Withdrawal by Subject|2
662156|NCT02005562|2133933|P1|Overall Study|Withdrawal by Subject|2
662157|NCT02005562|2133932|P2|Overall Study|Graft loss|6
662158|NCT02005562|2133933|P1|Overall Study|Graft loss|7
662159|NCT02005562|2133932|P2|Overall Study|Death|2
662160|NCT02005562|2133933|P1|Overall Study|Death|2
662161|NCT02005484|2133975|P1|Overall Study|Sponsor decision|1
662162|NCT02005484|2133975|P1|Overall Study|Changed to a Different Study|1
662163|NCT02005484|2133975|P1|Overall Study|Disease progression|1
662164|NCT02005484|2133975|P1|Overall Study|Death|1
662165|NCT02005211|2133996|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662166|NCT02005211|2133997|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662167|NCT02005211|2133998|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
662168|NCT02005211|2133999|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662169|NCT02005211|2134000|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662170|NCT02005211|2134001|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662171|NCT02005211|2134002|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
662172|NCT02005029|2134037|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
662173|NCT02005029|2134038|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
662174|NCT02004886|2134073|P4|Overall Study|Unable to attend future visits|0
662175|NCT02004886|2134074|P3|Overall Study|Unable to attend future visits|0
662176|NCT02004886|2134075|P2|Overall Study|Unable to attend future visits|0
662177|NCT02004886|2134076|P1|Overall Study|Unable to attend future visits|1
662178|NCT02004886|2134073|P4|Overall Study|Adverse Event|0
662179|NCT02004886|2134074|P3|Overall Study|Adverse Event|0
662180|NCT02004886|2134075|P2|Overall Study|Adverse Event|1
662181|NCT02004886|2134076|P1|Overall Study|Adverse Event|0
662182|NCT02004873|2134126|P1|Overall Study|Withdrawal by Subject|1
662183|NCT02004873|2134126|P1|Overall Study|Death|23
662184|NCT02004873|2134126|P1|Overall Study|Missed 6-month visit|4
662185|NCT02004873|2134126|P1|Overall Study|Awaiting 6-month visit|390
662186|NCT02004873|2134126|P1|Overall Study|Implant unsuccessful|6
662187|NCT02004847|2134135|P2|Overall Study|Protocol Violation|1
662188|NCT02004847|2134136|P1|Overall Study|Protocol Violation|1
888370|NCT02104505|2821959|P1|First Intervention (14 Days)|Withdrawal by Subject|0
888371|NCT02104505|2821958|P2|First Intervention (14 Days)|Adverse Event|0
662192|NCT02004093|2134245|P2|Overall Study|Not specified|1
662193|NCT02004093|2134246|P1|Overall Study|Not specified|3
662194|NCT02004093|2134245|P2|Overall Study|Withdrawal by Subject|7
662195|NCT02004093|2134246|P1|Overall Study|Withdrawal by Subject|3
662196|NCT02004093|2134245|P2|Overall Study|Lost to Follow-up|1
662197|NCT02004093|2134246|P1|Overall Study|Lost to Follow-up|0
662198|NCT02004093|2134245|P2|Overall Study|Protocol Violation|1
662199|NCT02004093|2134246|P1|Overall Study|Protocol Violation|0
662200|NCT02004093|2134245|P2|Overall Study|Lack of Efficacy|62
662201|NCT02004093|2134246|P1|Overall Study|Lack of Efficacy|66
662202|NCT02004093|2134245|P2|Overall Study|Death|1
662203|NCT02004093|2134246|P1|Overall Study|Death|2
662204|NCT02003963|2134278|P2|Overall Study|Lost to Follow-up|1
662205|NCT02003963|2134279|P1|Overall Study|Lost to Follow-up|2
662206|NCT02003638|2134297|P2|Overall Study|Withdrawal by Subject|0
662207|NCT02003638|2134298|P1|Overall Study|Withdrawal by Subject|1
662208|NCT02003534|2134304|P1|Overall Study|Lost to Follow-up|47
662209|NCT02003391|2134316|P2|Overall Study|Adverse Event|0
662210|NCT02003391|2134317|P1|Overall Study|Adverse Event|1
662211|NCT02003391|2134316|P2|Overall Study|Protocol Violation|1
662212|NCT02003391|2134317|P1|Overall Study|Protocol Violation|0
662213|NCT02003391|2134316|P2|Overall Study|Withdrawal by Subject|1
662214|NCT02003391|2134317|P1|Overall Study|Withdrawal by Subject|2
662215|NCT02003014|2134331|P1|Overall Study|Investigator's transfer|4
662216|NCT02003014|2134331|P1|Overall Study|Patient did not visit the study site|5
662217|NCT02003014|2134331|P1|Overall Study|Treatment started after contract period|1
662218|NCT02003014|2134331|P1|Overall Study|Case report forms uncollected|9
662219|NCT02002689|2134413|P1|Overall Study|Adverse Event|3
662220|NCT02002689|2134413|P1|Overall Study|Disease Progression|7
662221|NCT02002221|2134432|P2|Overall Study|Patient withdrew consent|1
662222|NCT02002221|2134433|P1|Overall Study|Patient withdrew consent|0
662223|NCT02002221|2134432|P2|Overall Study|Unsatisfactory therapeutic effect|1
662224|NCT02002221|2134433|P1|Overall Study|Unsatisfactory therapeutic effect|0
662225|NCT02002221|2134432|P2|Overall Study|Adverse Event|1
662226|NCT02002221|2134433|P1|Overall Study|Adverse Event|2
662227|NCT02001181|2134460|P2|Overall Study|Withdrawal by Subject|1
662228|NCT02001181|2134461|P1|Overall Study|Withdrawal by Subject|0
662229|NCT02001181|2134460|P2|Overall Study|Lost to Follow-up|0
662230|NCT02001181|2134461|P1|Overall Study|Lost to Follow-up|1
662231|NCT02001181|2134460|P2|Overall Study|Adverse Event|2
662232|NCT02001181|2134461|P1|Overall Study|Adverse Event|0
662233|NCT02000921|2134507|P3|Overall Study|Physician Decision|0
662234|NCT02000921|2134508|P2|Overall Study|Physician Decision|2
662235|NCT02000921|2134509|P1|Overall Study|Physician Decision|0
662236|NCT02000921|2134507|P3|Overall Study|Lost to Follow-up|5
662237|NCT02000921|2134508|P2|Overall Study|Lost to Follow-up|4
662238|NCT02000921|2134509|P1|Overall Study|Lost to Follow-up|2
662239|NCT02000921|2134507|P3|Overall Study|Withdrawal by Subject|5
662240|NCT02000921|2134508|P2|Overall Study|Withdrawal by Subject|10
662241|NCT02000921|2134509|P1|Overall Study|Withdrawal by Subject|3
662242|NCT02000752|2134528|P2|Overall Study|Shift Changes|5
662243|NCT02000752|2134529|P1|Overall Study|Shift Changes|12
662244|NCT02000752|2134528|P2|Overall Study|Dystocic delivery|8
662245|NCT02000752|2134529|P1|Overall Study|Dystocic delivery|19
662246|NCT02000531|2134543|P2|Overall Study|Discontinued due to data cut-off|8
662247|NCT02000531|2134544|P1|Overall Study|Discontinued due to data cut-off|3
662248|NCT02000531|2134543|P2|Overall Study|Lost to Follow-up|0
662249|NCT02000531|2134544|P1|Overall Study|Lost to Follow-up|1
662250|NCT02000440|2134552|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
662251|NCT02000440|2134552|P1|Overall Study|Adverse Event|3
662252|NCT02000427|2134572|P1|Overall Study|Death|22
662253|NCT01999894|2134595|P1|Overall Study|Inclusion/exclusion criteria not met|1
662254|NCT01999894|2134595|P1|Overall Study|Other Reason|3
662255|NCT01999894|2134595|P1|Overall Study|Lost to Follow-up|10
662256|NCT01999894|2134595|P1|Overall Study|Withdrawal by Subject|7
662257|NCT01999894|2134595|P1|Overall Study|Protocol Violation|1
662258|NCT01999894|2134595|P1|Overall Study|Lack of Efficacy|5
662259|NCT01999894|2134595|P1|Overall Study|Adverse Event|9
662260|NCT01998919|2134691|P2|Overall Study|Not specified|2
662261|NCT01998919|2134692|P1|Overall Study|Not specified|5
662262|NCT01998919|2134691|P2|Overall Study|Lost to Follow-up|0
662263|NCT01998919|2134692|P1|Overall Study|Lost to Follow-up|2
662264|NCT01998919|2134691|P2|Overall Study|Withdrawal by Subject|4
662265|NCT01998919|2134692|P1|Overall Study|Withdrawal by Subject|2
662266|NCT01998919|2134691|P2|Overall Study|Disease progression|22
662267|NCT01998919|2134692|P1|Overall Study|Disease progression|31
662268|NCT01998919|2134691|P2|Overall Study|Adverse Event|5
662269|NCT01998919|2134692|P1|Overall Study|Adverse Event|0
662270|NCT01998919|2134691|P2|Overall Study|Death|2
662271|NCT01998919|2134692|P1|Overall Study|Death|2
662272|NCT01998906|2134713|P3|Overall Study|Not specified|4
662273|NCT01998906|2134714|P2|Overall Study|Not specified|8
662274|NCT01998906|2134715|P1|Overall Study|Not specified|3
662275|NCT01998906|2134713|P3|Overall Study|Administrative/Other|3
662276|NCT01998906|2134714|P2|Overall Study|Administrative/Other|1
662277|NCT01998906|2134715|P1|Overall Study|Administrative/Other|2
662278|NCT01998906|2134713|P3|Overall Study|Withdrawal by Subject|3
662279|NCT01998906|2134714|P2|Overall Study|Withdrawal by Subject|4
662280|NCT01998906|2134715|P1|Overall Study|Withdrawal by Subject|1
662281|NCT01998906|2134713|P3|Overall Study|Violation of Selection Criteria|1
662282|NCT01998906|2134714|P2|Overall Study|Violation of Selection Criteria|0
662283|NCT01998906|2134715|P1|Overall Study|Violation of Selection Criteria|0
662284|NCT01998906|2134713|P3|Overall Study|Failure to return|4
662285|NCT01998906|2134714|P2|Overall Study|Failure to return|2
662286|NCT01998906|2134715|P1|Overall Study|Failure to return|0
662287|NCT01998906|2134713|P3|Overall Study|Lack of Efficacy|8
662288|NCT01998906|2134714|P2|Overall Study|Lack of Efficacy|9
662289|NCT01998906|2134715|P1|Overall Study|Lack of Efficacy|10
662290|NCT01998906|2134713|P3|Overall Study|Death|17
662291|NCT01998906|2134714|P2|Overall Study|Death|30
662292|NCT01998906|2134715|P1|Overall Study|Death|21
662293|NCT01998906|2134713|P3|Overall Study|Participants ongoing in follow−up|58
662294|NCT01998906|2134714|P2|Overall Study|Participants ongoing in follow−up|60
662295|NCT01998906|2134715|P1|Overall Study|Participants ongoing in follow−up|77
662296|NCT01998893|2134759|P1|Overall Study|Transformation to high-grade lymphoma|1
662297|NCT01998893|2134759|P1|Overall Study|Withdrawal by Subject|1
662298|NCT01998893|2134759|P1|Overall Study|Protocol Violation|2
662299|NCT01998893|2134759|P1|Overall Study|Physician Decision|2
662300|NCT01998893|2134759|P1|Overall Study|Lost to Follow-up|8
662301|NCT01998893|2134759|P1|Overall Study|Death|1
662302|NCT01998893|2134759|P1|Overall Study|Adverse Event|2
662321|NCT01998737|2134790|P2|Overall Study|Corrupted database|0
662322|NCT01998737|2134791|P1|Overall Study|Corrupted database|23
662323|NCT01998581|2134803|P2|Overall Study|Randomized but withdrew before treatment|0
662324|NCT01998581|2134804|P1|Overall Study|Randomized but withdrew before treatment|1
662325|NCT01998581|2134803|P2|Overall Study|Other reasons|2
662326|NCT01998581|2134804|P1|Overall Study|Other reasons|3
662327|NCT01998581|2134803|P2|Overall Study|Adverse Event|1
662328|NCT01998581|2134804|P1|Overall Study|Adverse Event|1
662329|NCT01998581|2134803|P2|Overall Study|Lost to Follow-up|4
662330|NCT01998581|2134804|P1|Overall Study|Lost to Follow-up|12
662331|NCT01998581|2134803|P2|Overall Study|Withdrawal by Subject|1
662332|NCT01998581|2134804|P1|Overall Study|Withdrawal by Subject|8
662333|NCT01998581|2134803|P2|Overall Study|Protocol Violation|0
662334|NCT01998581|2134804|P1|Overall Study|Protocol Violation|1
662335|NCT01998581|2134803|P2|Overall Study|Refused repeat treatment|4
662336|NCT01998581|2134804|P1|Overall Study|Refused repeat treatment|20
662337|NCT01998477|2134816|P2|Overall Study|Withdrawal by Subject|0
662338|NCT01998477|2134817|P1|Overall Study|Withdrawal by Subject|6
662339|NCT01998477|2134816|P2|Overall Study|Lost to Follow-up|5
662340|NCT01998477|2134817|P1|Overall Study|Lost to Follow-up|4
662349|NCT01997892|2134900|P1|Overall Study|Study completion data not recorded|35
662350|NCT01997892|2134900|P1|Overall Study|Other|3
662351|NCT01997892|2134900|P1|Overall Study|Renal transplant|8
662352|NCT01997892|2134900|P1|Overall Study|Death|14
662353|NCT01997892|2134900|P1|Overall Study|Lost to Follow-up|6
662354|NCT01997892|2134900|P1|Overall Study|Physician Decision|2
662355|NCT01996904|2135058|P2|Overall Study|Lost to Follow-up|27
662356|NCT01996904|2135059|P1|Overall Study|Lost to Follow-up|38
662357|NCT01996748|2135072|P2|Overall Study|Lost to Follow-up|1
662358|NCT01996748|2135073|P1|Overall Study|Lost to Follow-up|4
662359|NCT01996748|2135072|P2|Overall Study|Withdrawal by Subject|1
662360|NCT01996748|2135073|P1|Overall Study|Withdrawal by Subject|0
662361|NCT01996748|2135072|P2|Overall Study|Adverse Event|4
662362|NCT01996748|2135073|P1|Overall Study|Adverse Event|1
662363|NCT01996748|2135072|P2|Overall Study|Physician Decision|0
662364|NCT01996748|2135073|P1|Overall Study|Physician Decision|2
662365|NCT01996748|2135072|P2|Overall Study|Personal reason|0
662366|NCT01996748|2135073|P1|Overall Study|Personal reason|1
662367|NCT01996709|2135087|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
662368|NCT01996709|2135088|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
662369|NCT01996709|2135087|P2|Overall Study|Subject Non-Compliant|0
662370|NCT01996709|2135088|P1|Overall Study|Subject Non-Compliant|1
662371|NCT01996709|2135087|P2|Overall Study|Lost to Follow-up|0
662372|NCT01996709|2135088|P1|Overall Study|Lost to Follow-up|3
662373|NCT01996709|2135087|P2|Overall Study|Withdrawal by Subject|0
662374|NCT01996709|2135088|P1|Overall Study|Withdrawal by Subject|1
662375|NCT01996332|2135148|P1|Overall Study|Lost to Follow-up|34
662376|NCT01996332|2135148|P1|Overall Study|Physician Decision|17
662377|NCT01996332|2135148|P1|Overall Study|Clinical Deterioration|28
662378|NCT01996332|2135148|P1|Overall Study|Other|20
662379|NCT01996332|2135148|P1|Overall Study|Withdrawal by Subject|71
662380|NCT01996332|2135148|P1|Overall Study|Protocol Violation|9
662381|NCT01996332|2135148|P1|Overall Study|Death|264
662382|NCT01996332|2135148|P1|Overall Study|Lack of Efficacy|1245
662383|NCT01996332|2135148|P1|Overall Study|Adverse Event|117
662384|NCT01996319|2135156|P2|Overall Study|Adverse Event|2
662385|NCT01996319|2135157|P1|Overall Study|Adverse Event|2
662386|NCT01996319|2135156|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
662387|NCT01996319|2135157|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
662388|NCT01996319|2135156|P2|Overall Study|Protocol Violation|0
662389|NCT01996319|2135157|P1|Overall Study|Protocol Violation|1
662390|NCT01995461|2135177|P1|Overall Study|Withdrawal by Subject|2
662391|NCT01995461|2135177|P1|Overall Study|Lost to Follow-up|2
662392|NCT01995461|2135177|P1|Overall Study|Death|1
662393|NCT01995357|2135183|P6|Period 5|Adverse Event|0
662394|NCT01995357|2135184|P5|Period 5|Adverse Event|0
662395|NCT01995357|2135185|P4|Period 5|Adverse Event|0
662396|NCT01995357|2135186|P3|Period 5|Adverse Event|1
662397|NCT01995357|2135187|P2|Period 5|Adverse Event|0
662398|NCT01995357|2135188|P1|Period 5|Adverse Event|1
662399|NCT01995357|2135183|P6|Period 5|Lack of Efficacy|0
662400|NCT01995357|2135184|P5|Period 5|Lack of Efficacy|0
662401|NCT01995357|2135185|P4|Period 5|Lack of Efficacy|0
662402|NCT01995357|2135186|P3|Period 5|Lack of Efficacy|0
662403|NCT01995357|2135187|P2|Period 5|Lack of Efficacy|0
662404|NCT01995357|2135188|P1|Period 5|Lack of Efficacy|1
662405|NCT01995136|2135204|P1|Overall Study|Change in residence|1
662406|NCT01994902|2135223|P2|Test Period 2|not known|3
662407|NCT01994902|2135224|P1|Test Period 2|not known|0
662408|NCT01994902|2135223|P2|Test Period 2|Lack of Efficacy|1
662409|NCT01994902|2135224|P1|Test Period 2|Lack of Efficacy|0
662410|NCT01994902|2135223|P2|Test Period 2|Withdrawal by Subject|2
662411|NCT01994902|2135224|P1|Test Period 2|Withdrawal by Subject|0
662412|NCT01994902|2135223|P2|Test Period 1|bag too small|0
662413|NCT01994902|2135224|P1|Test Period 1|bag too small|1
662414|NCT01994902|2135223|P2|Test Period 1|Lack of Efficacy|1
662415|NCT01994902|2135224|P1|Test Period 1|Lack of Efficacy|0
662416|NCT01994902|2135223|P2|Test Period 1|Adverse Event|1
662417|NCT01994902|2135224|P1|Test Period 1|Adverse Event|2
662418|NCT01994902|2135223|P2|Test Period 1|device deficiency with adverse event|1
662419|NCT01994902|2135224|P1|Test Period 1|device deficiency with adverse event|0
662420|NCT01994902|2135223|P2|Test Period 1|Withdrawal by Subject|0
662421|NCT01994902|2135224|P1|Test Period 1|Withdrawal by Subject|3
662422|NCT01994876|2135230|P2|Test Period 2|Protocol Violation|1
662423|NCT01994876|2135231|P1|Test Period 2|Protocol Violation|0
662424|NCT01994876|2135230|P2|Test Period 2|Adverse Event|0
662425|NCT01994876|2135231|P1|Test Period 2|Adverse Event|1
662426|NCT01994876|2135230|P2|Test Period 1|Adverse Event|1
662427|NCT01994876|2135231|P1|Test Period 1|Adverse Event|0
662428|NCT01994876|2135230|P2|Test Period 1|Withdrawal by Subject|1
662429|NCT01994876|2135231|P1|Test Period 1|Withdrawal by Subject|0
662430|NCT01994863|2135239|P2|Period 2|Withdrawal by Subject|1
662431|NCT01994863|2135240|P1|Period 2|Withdrawal by Subject|1
662432|NCT01994863|2135239|P2|Period 2|Lack of Efficacy|2
662433|NCT01994863|2135240|P1|Period 2|Lack of Efficacy|0
662434|NCT01994863|2135239|P2|Period 2|Adverse Event|1
662435|NCT01994863|2135240|P1|Period 2|Adverse Event|0
662436|NCT01994863|2135239|P2|Period 1|Lack of Efficacy|0
662437|NCT01994863|2135240|P1|Period 1|Lack of Efficacy|1
662438|NCT01994863|2135239|P2|Period 1|Trial stopped by sponsor|3
662439|NCT01994863|2135240|P1|Period 1|Trial stopped by sponsor|1
662440|NCT01994863|2135239|P2|Period 1|Withdrawal by Subject|0
662441|NCT01994863|2135240|P1|Period 1|Withdrawal by Subject|1
662442|NCT01994863|2135239|P2|Period 1|Adverse Event|0
662443|NCT01994863|2135240|P1|Period 1|Adverse Event|4
662444|NCT01994720|2135272|P2|Overall Study|Withdrawal by Subject|56
662445|NCT01994720|2135273|P1|Overall Study|Withdrawal by Subject|46
888372|NCT02104505|2821959|P1|First Intervention (14 Days)|Adverse Event|2
888373|NCT02094261|2821971|P1|Overall Study|Ongoing Study at Data Cut-off|181
888374|NCT02094261|2821971|P1|Overall Study|Withdrawal by Subject|4
888375|NCT02094261|2821971|P1|Overall Study|Lost to Follow-up|1
662450|NCT01994291|2135352|P3|Overall Study|Unspecified|0
662451|NCT01994291|2135353|P2|Overall Study|Unspecified|2
662452|NCT01994291|2135354|P1|Overall Study|Unspecified|1
662453|NCT01994291|2135352|P3|Overall Study|Withdrawal by Subject|5
662454|NCT01994291|2135353|P2|Overall Study|Withdrawal by Subject|3
662455|NCT01994291|2135354|P1|Overall Study|Withdrawal by Subject|6
662456|NCT01994291|2135352|P3|Overall Study|Protocol Violation|0
662457|NCT01994291|2135353|P2|Overall Study|Protocol Violation|0
662458|NCT01994291|2135354|P1|Overall Study|Protocol Violation|1
662459|NCT01994291|2135352|P3|Overall Study|Medication error without associated AE|1
662460|NCT01994291|2135353|P2|Overall Study|Medication error without associated AE|0
662461|NCT01994291|2135354|P1|Overall Study|Medication error without associated AE|1
662462|NCT01994291|2135352|P3|Overall Study|Does not meet entrance criteria|0
662463|NCT01994291|2135353|P2|Overall Study|Does not meet entrance criteria|0
662464|NCT01994291|2135354|P1|Overall Study|Does not meet entrance criteria|1
662465|NCT01994291|2135352|P3|Overall Study|Lost to Follow-up|0
662466|NCT01994291|2135353|P2|Overall Study|Lost to Follow-up|1
662467|NCT01994291|2135354|P1|Overall Study|Lost to Follow-up|1
662468|NCT01994291|2135352|P3|Overall Study|Adverse Event|3
662469|NCT01994291|2135353|P2|Overall Study|Adverse Event|1
662470|NCT01994291|2135354|P1|Overall Study|Adverse Event|4
662471|NCT01993940|2135410|P2|Overall Study|Other - Miscellaneous|1
662472|NCT01993940|2135411|P1|Overall Study|Other - Miscellaneous|1
662473|NCT01993940|2135410|P2|Overall Study|Death|0
662474|NCT01993940|2135411|P1|Overall Study|Death|1
662475|NCT01993940|2135410|P2|Overall Study|Protocol Violation|8
662476|NCT01993940|2135411|P1|Overall Study|Protocol Violation|5
662477|NCT01993940|2135410|P2|Overall Study|Lost to Follow-up|5
662478|NCT01993940|2135411|P1|Overall Study|Lost to Follow-up|2
662479|NCT01993940|2135410|P2|Overall Study|Withdrawal by Subject|19
662480|NCT01993940|2135411|P1|Overall Study|Withdrawal by Subject|15
662481|NCT01993940|2135410|P2|Overall Study|Adverse Event|11
662482|NCT01993940|2135411|P1|Overall Study|Adverse Event|16
662483|NCT01993888|2135427|P2|Overall Study|Withdrawal by Subject|1
662484|NCT01993888|2135428|P1|Overall Study|Withdrawal by Subject|0
662485|NCT01993888|2135427|P2|Overall Study|Lost to Follow-up|1
662486|NCT01993888|2135428|P1|Overall Study|Lost to Follow-up|1
662487|NCT01993888|2135427|P2|Overall Study|Death|1
662488|NCT01993888|2135428|P1|Overall Study|Death|1
662489|NCT01993823|2135446|P2|Overall Study|Lost to Follow-up|4
662490|NCT01993823|2135447|P1|Overall Study|Lost to Follow-up|1
662491|NCT01993823|2135446|P2|Overall Study|Protocol Violation|1
662492|NCT01993823|2135447|P1|Overall Study|Protocol Violation|0
662493|NCT01993823|2135446|P2|Overall Study|Requested by the patient|11
662494|NCT01993823|2135447|P1|Overall Study|Requested by the patient|6
662495|NCT01993030|2135462|P2|Overall Study|Adverse Event|4
662496|NCT01993030|2135463|P1|Overall Study|Adverse Event|0
662497|NCT01992536|2135517|P10|Overall Study|Withdrawal by Subject|0
662498|NCT01992536|2135518|P9|Overall Study|Withdrawal by Subject|0
662499|NCT01992536|2135519|P8|Overall Study|Withdrawal by Subject|0
662500|NCT01992536|2135520|P7|Overall Study|Withdrawal by Subject|0
662501|NCT01992536|2135521|P6|Overall Study|Withdrawal by Subject|0
662502|NCT01992536|2135522|P5|Overall Study|Withdrawal by Subject|0
662503|NCT01992536|2135523|P4|Overall Study|Withdrawal by Subject|2
662504|NCT01992536|2135524|P3|Overall Study|Withdrawal by Subject|0
662505|NCT01992536|2135525|P2|Overall Study|Withdrawal by Subject|1
662506|NCT01992536|2135526|P1|Overall Study|Withdrawal by Subject|0
662507|NCT01992536|2135517|P10|Overall Study|Lost to Follow-up|1
662508|NCT01992536|2135518|P9|Overall Study|Lost to Follow-up|1
662509|NCT01992536|2135519|P8|Overall Study|Lost to Follow-up|0
662510|NCT01992536|2135520|P7|Overall Study|Lost to Follow-up|0
662511|NCT01992536|2135521|P6|Overall Study|Lost to Follow-up|1
662512|NCT01992536|2135522|P5|Overall Study|Lost to Follow-up|0
662513|NCT01992536|2135523|P4|Overall Study|Lost to Follow-up|0
662514|NCT01992536|2135524|P3|Overall Study|Lost to Follow-up|1
662515|NCT01992536|2135525|P2|Overall Study|Lost to Follow-up|2
662516|NCT01992536|2135526|P1|Overall Study|Lost to Follow-up|4
662517|NCT01992536|2135517|P10|Overall Study|Administrative Reason|0
662518|NCT01992536|2135518|P9|Overall Study|Administrative Reason|0
662519|NCT01992536|2135519|P8|Overall Study|Administrative Reason|0
662520|NCT01992536|2135520|P7|Overall Study|Administrative Reason|7
662521|NCT01992536|2135521|P6|Overall Study|Administrative Reason|0
662522|NCT01992536|2135522|P5|Overall Study|Administrative Reason|0
662523|NCT01992536|2135523|P4|Overall Study|Administrative Reason|0
662524|NCT01992536|2135524|P3|Overall Study|Administrative Reason|0
662525|NCT01992536|2135525|P2|Overall Study|Administrative Reason|0
662526|NCT01992536|2135526|P1|Overall Study|Administrative Reason|0
662527|NCT01992107|2135777|P3|Overall Study|Withdrawal by Subject|8
662528|NCT01992107|2135778|P2|Overall Study|Withdrawal by Subject|7
662529|NCT01992107|2135779|P1|Overall Study|Withdrawal by Subject|13
662530|NCT01992107|2135777|P3|Overall Study|noncompliance and were unavailable|2
662531|NCT01992107|2135778|P2|Overall Study|noncompliance and were unavailable|3
662532|NCT01992107|2135779|P1|Overall Study|noncompliance and were unavailable|7
662533|NCT01992107|2135777|P3|Overall Study|Lost to Follow-up|26
662534|NCT01992107|2135778|P2|Overall Study|Lost to Follow-up|22
662535|NCT01992107|2135779|P1|Overall Study|Lost to Follow-up|46
662536|NCT01992107|2135777|P3|Overall Study|Adverse Event|0
662537|NCT01992107|2135778|P2|Overall Study|Adverse Event|1
662538|NCT01992107|2135779|P1|Overall Study|Adverse Event|0
662539|NCT01992107|2135777|P3|Overall Study|Administrative reasons|0
662540|NCT01992107|2135778|P2|Overall Study|Administrative reasons|0
662541|NCT01992107|2135779|P1|Overall Study|Administrative reasons|2
662542|NCT01992094|2135835|P3|Overall Study|Withdrawal by Subject|4
662543|NCT01992094|2135836|P2|Overall Study|Withdrawal by Subject|3
662544|NCT01992094|2135837|P1|Overall Study|Withdrawal by Subject|7
662545|NCT01992094|2135835|P3|Overall Study|Protocol Violation|1
662546|NCT01992094|2135836|P2|Overall Study|Protocol Violation|0
662547|NCT01992094|2135837|P1|Overall Study|Protocol Violation|1
662548|NCT01992094|2135835|P3|Overall Study|OTHER|0
662549|NCT01992094|2135836|P2|Overall Study|OTHER|0
662550|NCT01992094|2135837|P1|Overall Study|OTHER|4
662551|NCT01992094|2135835|P3|Overall Study|Lost to Follow-up|13
662552|NCT01992094|2135836|P2|Overall Study|Lost to Follow-up|9
662553|NCT01992094|2135837|P1|Overall Study|Lost to Follow-up|26
662554|NCT01992094|2135835|P3|Overall Study|Death|2
662555|NCT01992094|2135836|P2|Overall Study|Death|5
662556|NCT01992094|2135837|P1|Overall Study|Death|5
662557|NCT01992094|2135835|P3|Overall Study|Adverse Event|0
662558|NCT01992094|2135836|P2|Overall Study|Adverse Event|0
662559|NCT01992094|2135837|P1|Overall Study|Adverse Event|1
662560|NCT01992094|2135835|P3|Overall Study|ADMINISTRATIVE REASON|1
662561|NCT01992094|2135836|P2|Overall Study|ADMINISTRATIVE REASON|7
662562|NCT01992094|2135837|P1|Overall Study|ADMINISTRATIVE REASON|6
662563|NCT01991314|2135942|P2|Overall Study|Lost to Follow-up|10
662564|NCT01991314|2135943|P1|Overall Study|Lost to Follow-up|6
662565|NCT01991314|2135942|P2|Overall Study|Adverse Event|1
662566|NCT01991314|2135943|P1|Overall Study|Adverse Event|5
662567|NCT01990859|2135965|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
662568|NCT01990859|2135965|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
662569|NCT01990664|2136114|P2|Overall Study|Unsatisfactory Visual Response|1
662570|NCT01990664|2136115|P1|Overall Study|Unsatisfactory Visual Response|0
662571|NCT01990664|2136114|P2|Overall Study|Lens Handling Difficulties|0
662572|NCT01990664|2136115|P1|Overall Study|Lens Handling Difficulties|1
662573|NCT01990664|2136114|P2|Overall Study|Lens Discomfort|1
662574|NCT01990664|2136115|P1|Overall Study|Lens Discomfort|1
662575|NCT01990664|2136114|P2|Overall Study|Protocol Violation|0
662576|NCT01990664|2136115|P1|Overall Study|Protocol Violation|1
662577|NCT01990664|2136114|P2|Overall Study|Withdrawal by Subject|3
662578|NCT01990664|2136115|P1|Overall Study|Withdrawal by Subject|2
662579|NCT01990664|2136114|P2|Overall Study|Lost to Follow-up|6
662580|NCT01990664|2136115|P1|Overall Study|Lost to Follow-up|2
662581|NCT01990534|2136121|P1|Overall Study|Overall Survival Follow-up|25
662582|NCT01990534|2136121|P1|Overall Study|Progression Free Survival Follow-up|11
662583|NCT01990534|2136121|P1|Overall Study|Reason Not Specified|2
662584|NCT01990534|2136121|P1|Overall Study|Withdrawal by Subject|3
662585|NCT01990534|2136121|P1|Overall Study|Symptomatic Deterioration|1
662586|NCT01990534|2136121|P1|Overall Study|Withdrawal of Informed Consent|2
662587|NCT01990534|2136121|P1|Overall Study|Protocol Violation|1
662588|NCT01990534|2136121|P1|Overall Study|Progressive disease|3
662589|NCT01990534|2136121|P1|Overall Study|Death|12
662590|NCT01990339|2136137|P1|Overall Study|Lost to Follow-up|861
662591|NCT01990339|2136137|P1|Overall Study|Voluntary Withdrawal|1402
662592|NCT01990339|2136137|P1|Overall Study|Data Not Available|49
662593|NCT01990261|2136142|P1|Overall Study|Lost to Follow-up|2
662594|NCT01990261|2136142|P1|Overall Study|Dossier not Approved|1
662595|NCT01990261|2136142|P1|Overall Study|PD Before Treatment Start|1
662596|NCT01990261|2136142|P1|Overall Study|Disease Progression (PD)|8
662597|NCT01990261|2136142|P1|Overall Study|Death From other Causes|1
662598|NCT01990261|2136142|P1|Overall Study|Death due to Disease Progression (PD)|10
662599|NCT01990261|2136142|P1|Overall Study|Death Before Treatment Start|2
662600|NCT01989689|2136154|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
662601|NCT01989689|2136155|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
662602|NCT01989689|2136154|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
662603|NCT01989689|2136155|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
662604|NCT01989572|2136171|P6|Overall Study|alternative therapy|3
662605|NCT01989572|2136172|P5|Overall Study|alternative therapy|1
662606|NCT01989572|2136173|P4|Overall Study|alternative therapy|0
662607|NCT01989572|2136174|P3|Overall Study|alternative therapy|0
662608|NCT01989572|2136175|P2|Overall Study|alternative therapy|0
662609|NCT01989572|2136176|P1|Overall Study|alternative therapy|3
662610|NCT01989572|2136171|P6|Overall Study|not start protocol therapy|18
662611|NCT01989572|2136172|P5|Overall Study|not start protocol therapy|4
662612|NCT01989572|2136173|P4|Overall Study|not start protocol therapy|3
662613|NCT01989572|2136174|P3|Overall Study|not start protocol therapy|2
662614|NCT01989572|2136175|P2|Overall Study|not start protocol therapy|1
662615|NCT01989572|2136176|P1|Overall Study|not start protocol therapy|5
662616|NCT01989572|2136171|P6|Overall Study|unknown/not specify|5
662617|NCT01989572|2136172|P5|Overall Study|unknown/not specify|3
662618|NCT01989572|2136173|P4|Overall Study|unknown/not specify|3
662619|NCT01989572|2136174|P3|Overall Study|unknown/not specify|1
662620|NCT01989572|2136175|P2|Overall Study|unknown/not specify|4
662621|NCT01989572|2136176|P1|Overall Study|unknown/not specify|3
662622|NCT01989572|2136171|P6|Overall Study|maximum dose reached|0
662623|NCT01989572|2136172|P5|Overall Study|maximum dose reached|1
662624|NCT01989572|2136173|P4|Overall Study|maximum dose reached|0
662625|NCT01989572|2136174|P3|Overall Study|maximum dose reached|0
662626|NCT01989572|2136175|P2|Overall Study|maximum dose reached|1
662627|NCT01989572|2136176|P1|Overall Study|maximum dose reached|0
662628|NCT01989572|2136171|P6|Overall Study|error|1
662629|NCT01989572|2136172|P5|Overall Study|error|1
662630|NCT01989572|2136173|P4|Overall Study|error|1
662631|NCT01989572|2136174|P3|Overall Study|error|1
662632|NCT01989572|2136175|P2|Overall Study|error|1
662633|NCT01989572|2136176|P1|Overall Study|error|2
662634|NCT01989572|2136171|P6|Overall Study|complicating disease|0
662635|NCT01989572|2136172|P5|Overall Study|complicating disease|1
662636|NCT01989572|2136173|P4|Overall Study|complicating disease|0
662637|NCT01989572|2136174|P3|Overall Study|complicating disease|2
662638|NCT01989572|2136175|P2|Overall Study|complicating disease|1
662639|NCT01989572|2136176|P1|Overall Study|complicating disease|1
662640|NCT01989572|2136171|P6|Overall Study|Withdrawal by Subject|4
662641|NCT01989572|2136172|P5|Overall Study|Withdrawal by Subject|12
662642|NCT01989572|2136173|P4|Overall Study|Withdrawal by Subject|1
662643|NCT01989572|2136174|P3|Overall Study|Withdrawal by Subject|5
662644|NCT01989572|2136175|P2|Overall Study|Withdrawal by Subject|1
662645|NCT01989572|2136176|P1|Overall Study|Withdrawal by Subject|4
662646|NCT01989572|2136171|P6|Overall Study|Death|0
662647|NCT01989572|2136172|P5|Overall Study|Death|1
662648|NCT01989572|2136173|P4|Overall Study|Death|0
662649|NCT01989572|2136174|P3|Overall Study|Death|0
662650|NCT01989572|2136175|P2|Overall Study|Death|0
662651|NCT01989572|2136176|P1|Overall Study|Death|0
662652|NCT01989572|2136171|P6|Overall Study|Adverse Event|0
662653|NCT01989572|2136172|P5|Overall Study|Adverse Event|3
662654|NCT01989572|2136173|P4|Overall Study|Adverse Event|0
662655|NCT01989572|2136174|P3|Overall Study|Adverse Event|3
662656|NCT01989572|2136175|P2|Overall Study|Adverse Event|1
662657|NCT01989572|2136176|P1|Overall Study|Adverse Event|2
662658|NCT01989572|2136171|P6|Overall Study|Lack of Efficacy|79
662659|NCT01989572|2136172|P5|Overall Study|Lack of Efficacy|71
662660|NCT01989572|2136173|P4|Overall Study|Lack of Efficacy|43
662661|NCT01989572|2136174|P3|Overall Study|Lack of Efficacy|48
662662|NCT01989572|2136175|P2|Overall Study|Lack of Efficacy|48
662663|NCT01989572|2136176|P1|Overall Study|Lack of Efficacy|35
662664|NCT01989455|2136209|P5|Overall Study|Technical problems with infusion|1
662665|NCT01989455|2136210|P4|Overall Study|Technical problems with infusion|0
662666|NCT01989455|2136211|P3|Overall Study|Technical problems with infusion|1
662667|NCT01989455|2136212|P2|Overall Study|Technical problems with infusion|0
662668|NCT01989455|2136213|P1|Overall Study|Technical problems with infusion|0
662669|NCT01989455|2136209|P5|Overall Study|Withdrawal by Subject|0
662670|NCT01989455|2136210|P4|Overall Study|Withdrawal by Subject|0
662671|NCT01989455|2136211|P3|Overall Study|Withdrawal by Subject|0
662672|NCT01989455|2136212|P2|Overall Study|Withdrawal by Subject|1
662673|NCT01989455|2136213|P1|Overall Study|Withdrawal by Subject|0
662674|NCT01989455|2136209|P5|Overall Study|Adverse Event|0
662675|NCT01989455|2136210|P4|Overall Study|Adverse Event|0
662676|NCT01989455|2136211|P3|Overall Study|Adverse Event|0
662677|NCT01989455|2136212|P2|Overall Study|Adverse Event|1
662678|NCT01989455|2136213|P1|Overall Study|Adverse Event|0
662679|NCT01989169|2136257|P2|Period 2|Adverse Event|1
662680|NCT01989169|2136258|P1|Period 2|Adverse Event|0
888376|NCT02094261|2821971|P1|Overall Study|Death|24
888379|NCT02034916|2822018|P2|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|20
888380|NCT02034916|2822019|P1|Overall Study|Ongoing as of data cutoff (01 Sep 2016)|15
888381|NCT02034916|2822018|P2|Overall Study|Lost to Follow-up|1
888382|NCT02034916|2822019|P1|Overall Study|Lost to Follow-up|1
888383|NCT02034916|2822018|P2|Overall Study|Withdrawal by Subject|1
888384|NCT02034916|2822019|P1|Overall Study|Withdrawal by Subject|1
888385|NCT02034916|2822018|P2|Overall Study|Death|13
888386|NCT02034916|2822019|P1|Overall Study|Death|32
888387|NCT02034552|2822055|P3|Overall Study|Non-compliance with study drug|1
888388|NCT02034552|2822056|P2|Overall Study|Non-compliance with study drug|0
888389|NCT02034552|2822057|P1|Overall Study|Non-compliance with study drug|0
888390|NCT02034552|2822055|P3|Overall Study|Withdrawal by Subject|1
888391|NCT02034552|2822056|P2|Overall Study|Withdrawal by Subject|0
888392|NCT02034552|2822057|P1|Overall Study|Withdrawal by Subject|2
888393|NCT02034552|2822055|P3|Overall Study|AE associated with disease progression|0
888394|NCT02034552|2822056|P2|Overall Study|AE associated with disease progression|1
888395|NCT02034552|2822057|P1|Overall Study|AE associated with disease progression|0
888396|NCT02034552|2822055|P3|Overall Study|AE not assoc. with disease progression|2
888397|NCT02034552|2822056|P2|Overall Study|AE not assoc. with disease progression|3
888398|NCT02034552|2822057|P1|Overall Study|AE not assoc. with disease progression|1
888399|NCT02034552|2822055|P3|Overall Study|Ongoing with treatment|11
888400|NCT02034552|2822056|P2|Overall Study|Ongoing with treatment|11
888401|NCT02034552|2822057|P1|Overall Study|Ongoing with treatment|0
888402|NCT02034552|2822055|P3|Overall Study|Never treated|0
662705|NCT01988662|2136317|P2|Overall Study|Adverse Event|1
662706|NCT01988662|2136318|P1|Overall Study|Adverse Event|3
662707|NCT01988662|2136317|P2|Overall Study|Subject/guardian decision|1
662708|NCT01988662|2136318|P1|Overall Study|Subject/guardian decision|1
662709|NCT01988402|2136345|P2|Overall Study|Withdrawal by Subject|0
662710|NCT01988402|2136346|P1|Overall Study|Withdrawal by Subject|1
662711|NCT01988402|2136345|P2|Overall Study|Adverse Event|2
662712|NCT01988402|2136346|P1|Overall Study|Adverse Event|1
662713|NCT01988012|2136384|P1|Overall Study|Protocol Violation|1
662714|NCT01988012|2136384|P1|Overall Study|Physician Decision|1
662715|NCT01988012|2136384|P1|Overall Study|Lost to Follow-up|1
662716|NCT01988012|2136384|P1|Overall Study|Patient Withdrawal of Consent|4
662717|NCT01988012|2136384|P1|Overall Study|Insufficient Therapeutic Response|3
662718|NCT01988012|2136384|P1|Overall Study|Adverse Event|5
662719|NCT01987986|2136410|P4|Overall Study|Adverse Event|0
662720|NCT01987986|2136411|P3|Overall Study|Adverse Event|2
662721|NCT01987986|2136412|P2|Overall Study|Adverse Event|0
662722|NCT01987986|2136413|P1|Overall Study|Adverse Event|1
662723|NCT01987986|2136410|P4|Overall Study|Lost to Follow-up|0
662724|NCT01987986|2136411|P3|Overall Study|Lost to Follow-up|0
662725|NCT01987986|2136412|P2|Overall Study|Lost to Follow-up|0
662726|NCT01987986|2136413|P1|Overall Study|Lost to Follow-up|1
662727|NCT01987960|2136453|P4|Period 3|Administrative or other reason|43
662728|NCT01987960|2136454|P3|Period 3|Administrative or other reason|0
662729|NCT01987960|2136455|P2|Period 3|Administrative or other reason|0
662730|NCT01987960|2136456|P1|Period 3|Administrative or other reason|0
662731|NCT01987960|2136453|P4|Period 3|Lost to Follow-up|5
662732|NCT01987960|2136454|P3|Period 3|Lost to Follow-up|0
662733|NCT01987960|2136455|P2|Period 3|Lost to Follow-up|0
662734|NCT01987960|2136456|P1|Period 3|Lost to Follow-up|0
662735|NCT01987960|2136453|P4|Period 3|Withdrawal by Subject|9
662736|NCT01987960|2136454|P3|Period 3|Withdrawal by Subject|0
662737|NCT01987960|2136455|P2|Period 3|Withdrawal by Subject|0
662738|NCT01987960|2136456|P1|Period 3|Withdrawal by Subject|0
662739|NCT01987960|2136453|P4|Period 3|Protocol Violation|6
662740|NCT01987960|2136454|P3|Period 3|Protocol Violation|0
662741|NCT01987960|2136455|P2|Period 3|Protocol Violation|0
662742|NCT01987960|2136456|P1|Period 3|Protocol Violation|0
662743|NCT01987960|2136453|P4|Period 3|Non-compliance with IMP|1
662744|NCT01987960|2136454|P3|Period 3|Non-compliance with IMP|0
662745|NCT01987960|2136455|P2|Period 3|Non-compliance with IMP|0
662746|NCT01987960|2136456|P1|Period 3|Non-compliance with IMP|0
662747|NCT01987960|2136453|P4|Period 3|Adverse Event|7
662748|NCT01987960|2136454|P3|Period 3|Adverse Event|0
662749|NCT01987960|2136455|P2|Period 3|Adverse Event|0
662750|NCT01987960|2136456|P1|Period 3|Adverse Event|0
662751|NCT01987960|2136453|P4|Period 2|Administrative or other reason|0
662752|NCT01987960|2136454|P3|Period 2|Administrative or other reason|7
662753|NCT01987960|2136455|P2|Period 2|Administrative or other reason|5
662754|NCT01987960|2136456|P1|Period 2|Administrative or other reason|0
662755|NCT01987960|2136453|P4|Period 2|Withdrawal by Subject|0
662756|NCT01987960|2136454|P3|Period 2|Withdrawal by Subject|1
662757|NCT01987960|2136455|P2|Period 2|Withdrawal by Subject|0
662758|NCT01987960|2136456|P1|Period 2|Withdrawal by Subject|0
662759|NCT01987960|2136453|P4|Period 2|Adverse Event|0
662760|NCT01987960|2136454|P3|Period 2|Adverse Event|1
662761|NCT01987960|2136455|P2|Period 2|Adverse Event|0
662762|NCT01987960|2136456|P1|Period 2|Adverse Event|0
662763|NCT01987960|2136453|P4|Period 1|Withdrawal of consent before treatment|0
662764|NCT01987960|2136454|P3|Period 1|Withdrawal of consent before treatment|0
662765|NCT01987960|2136455|P2|Period 1|Withdrawal of consent before treatment|0
662766|NCT01987960|2136456|P1|Period 1|Withdrawal of consent before treatment|4
662767|NCT01987960|2136453|P4|Period 1|administrative or other reason|0
662768|NCT01987960|2136454|P3|Period 1|administrative or other reason|0
662769|NCT01987960|2136455|P2|Period 1|administrative or other reason|0
662770|NCT01987960|2136456|P1|Period 1|administrative or other reason|75
662771|NCT01987960|2136453|P4|Period 1|Lost to Follow-up|0
662772|NCT01987960|2136454|P3|Period 1|Lost to Follow-up|0
662773|NCT01987960|2136455|P2|Period 1|Lost to Follow-up|0
662774|NCT01987960|2136456|P1|Period 1|Lost to Follow-up|40
662775|NCT01987960|2136453|P4|Period 1|Withdrawal by Subject|0
662776|NCT01987960|2136454|P3|Period 1|Withdrawal by Subject|0
662777|NCT01987960|2136455|P2|Period 1|Withdrawal by Subject|0
662778|NCT01987960|2136456|P1|Period 1|Withdrawal by Subject|21
662779|NCT01987960|2136453|P4|Period 1|Protocol Violation|0
662780|NCT01987960|2136454|P3|Period 1|Protocol Violation|0
662781|NCT01987960|2136455|P2|Period 1|Protocol Violation|0
662782|NCT01987960|2136456|P1|Period 1|Protocol Violation|12
662783|NCT01987960|2136453|P4|Period 1|Non-compliance with IMP|0
888403|NCT02034552|2822056|P2|Overall Study|Never treated|2
888404|NCT02034552|2822057|P1|Overall Study|Never treated|3
662784|NCT01987960|2136454|P3|Period 1|Non-compliance with IMP|0
662785|NCT01987960|2136455|P2|Period 1|Non-compliance with IMP|0
662786|NCT01987960|2136456|P1|Period 1|Non-compliance with IMP|6
662787|NCT01987960|2136453|P4|Period 1|Lack of Efficacy|0
662788|NCT01987960|2136454|P3|Period 1|Lack of Efficacy|0
662789|NCT01987960|2136455|P2|Period 1|Lack of Efficacy|0
662790|NCT01987960|2136456|P1|Period 1|Lack of Efficacy|4
662791|NCT01987960|2136453|P4|Period 1|Adverse Event|0
662792|NCT01987960|2136454|P3|Period 1|Adverse Event|0
662793|NCT01987960|2136455|P2|Period 1|Adverse Event|0
662794|NCT01987960|2136456|P1|Period 1|Adverse Event|24
888423|NCT01945489|2822098|P2|Cycle 2|Lost to Follow-up|1
888424|NCT01945489|2822099|P1|Cycle 2|Lost to Follow-up|0
888425|NCT01945489|2822098|P2|Cycle 2|Adverse Event|0
662816|NCT01987765|2136551|P1|Overall Study|Lost to Follow-up|37
662817|NCT01987765|2136551|P1|Overall Study|Protocol Violation|65
662818|NCT01987557|2136575|P3|Overall Study|Adverse Event|0
662819|NCT01987557|2136576|P2|Overall Study|Adverse Event|2
662820|NCT01987557|2136577|P1|Overall Study|Adverse Event|0
662821|NCT01987557|2136575|P3|Overall Study|Withdrawal by Subject|2
662822|NCT01987557|2136576|P2|Overall Study|Withdrawal by Subject|1
662823|NCT01987557|2136577|P1|Overall Study|Withdrawal by Subject|2
662824|NCT01987557|2136575|P3|Overall Study|Protocol Violation|1
662825|NCT01987557|2136576|P2|Overall Study|Protocol Violation|0
662826|NCT01987557|2136577|P1|Overall Study|Protocol Violation|1
662827|NCT01987479|2136585|P1|Overall Study|Adverse Event|7
662828|NCT01987479|2136585|P1|Overall Study|Lost to Follow-up|1
662829|NCT01987479|2136585|P1|Overall Study|Unspecified|5
662830|NCT01987479|2136585|P1|Overall Study|Participant/legal guardian decision|1
662831|NCT01987479|2136585|P1|Overall Study|Physician Decision|2
662832|NCT01987479|2136585|P1|Overall Study|Protocol Violation|1
662833|NCT01987453|2136613|P3|Overall Study|Lack of Efficacy|0
662834|NCT01987453|2136614|P2|Overall Study|Lack of Efficacy|12
662835|NCT01987453|2136615|P1|Overall Study|Lack of Efficacy|1
662836|NCT01987453|2136613|P3|Overall Study|Death|1
662837|NCT01987453|2136614|P2|Overall Study|Death|0
662838|NCT01987453|2136615|P1|Overall Study|Death|0
662839|NCT01987232|2136684|P5|Overall Study|Ongoing in Study|0
662840|NCT01987232|2136685|P4|Overall Study|Ongoing in Study|1
662841|NCT01987232|2136686|P3|Overall Study|Ongoing in Study|0
662842|NCT01987232|2136687|P2|Overall Study|Ongoing in Study|0
662843|NCT01987232|2136688|P1|Overall Study|Ongoing in Study|0
662844|NCT01986985|2136775|P1|Overall Study|Scan not completed due to malfunction|3
662845|NCT01986985|2136775|P1|Overall Study|Withdrawal by Subject|4
662846|NCT01986855|2136815|P3|Overall Study|Withdrawal by Subject|5
662847|NCT01986855|2136816|P2|Overall Study|Withdrawal by Subject|8
662848|NCT01986855|2136817|P1|Overall Study|Withdrawal by Subject|7
662849|NCT01986855|2136815|P3|Overall Study|Participant Moved|2
662850|NCT01986855|2136816|P2|Overall Study|Participant Moved|0
662851|NCT01986855|2136817|P1|Overall Study|Participant Moved|0
662852|NCT01986855|2136815|P3|Overall Study|Screen Failure|0
662853|NCT01986855|2136816|P2|Overall Study|Screen Failure|1
662854|NCT01986855|2136817|P1|Overall Study|Screen Failure|0
662855|NCT01986855|2136815|P3|Overall Study|Lost to Follow-up|0
662856|NCT01986855|2136816|P2|Overall Study|Lost to Follow-up|1
662857|NCT01986855|2136817|P1|Overall Study|Lost to Follow-up|2
662858|NCT01986855|2136815|P3|Overall Study|Death|4
662859|NCT01986855|2136816|P2|Overall Study|Death|4
662860|NCT01986855|2136817|P1|Overall Study|Death|3
662861|NCT01986855|2136815|P3|Overall Study|Adverse Event|0
662862|NCT01986855|2136816|P2|Overall Study|Adverse Event|0
662863|NCT01986855|2136817|P1|Overall Study|Adverse Event|1
662864|NCT01986751|2136867|P2|Overall Study|improperly consented|2
662865|NCT01986751|2136868|P1|Overall Study|improperly consented|10
662866|NCT01986231|2136913|P1|Overall Study|Adverse Event|1
662867|NCT01986062|2136920|P2|Overall Study|Lost to Follow-up|1
662868|NCT01986062|2136921|P1|Overall Study|Lost to Follow-up|1
662869|NCT01985321|2136994|P2|Overall Study|Subject treated wrong type of sore|0
662870|NCT01985321|2136995|P1|Overall Study|Subject treated wrong type of sore|1
888426|NCT01945489|2822099|P1|Cycle 2|Adverse Event|1
888427|NCT01945489|2822098|P2|Cycle 1|Other Miscellaneous Reasons|1
888428|NCT01945489|2822099|P1|Cycle 1|Other Miscellaneous Reasons|3
888429|NCT01945489|2822098|P2|Cycle 1|Protocol Violation|1
662871|NCT01985321|2136994|P2|Overall Study|Lost to Follow-up|2
662872|NCT01985321|2136995|P1|Overall Study|Lost to Follow-up|5
662873|NCT01985321|2136994|P2|Overall Study|Withdrawal by Subject|0
662874|NCT01985321|2136995|P1|Overall Study|Withdrawal by Subject|1
662875|NCT01985321|2136994|P2|Overall Study|Protocol Violation|3
662876|NCT01985321|2136995|P1|Overall Study|Protocol Violation|4
662877|NCT01985126|2137005|P2|Overall Study|Ongoing|67
662878|NCT01985126|2137006|P1|Overall Study|Ongoing|9
662879|NCT01985126|2137005|P2|Overall Study|Lost to Follow-up|3
662880|NCT01985126|2137006|P1|Overall Study|Lost to Follow-up|0
662881|NCT01985126|2137005|P2|Overall Study|Withdrawal by Subject|5
662882|NCT01985126|2137006|P1|Overall Study|Withdrawal by Subject|2
662883|NCT01985126|2137005|P2|Overall Study|Death|31
662884|NCT01985126|2137006|P1|Overall Study|Death|7
662885|NCT01984697|2137029|P5|Overall Study|Follow-up continues|308
662886|NCT01984697|2137030|P4|Overall Study|Follow-up continues|290
662887|NCT01984697|2137031|P3|Overall Study|Follow-up continues|292
662888|NCT01984697|2137032|P2|Overall Study|Follow-up continues|294
662889|NCT01984697|2137033|P1|Overall Study|Follow-up continues|290
662890|NCT01984697|2137029|P5|Overall Study|Withdrawal by Subject|2
662891|NCT01984697|2137030|P4|Overall Study|Withdrawal by Subject|7
662892|NCT01984697|2137031|P3|Overall Study|Withdrawal by Subject|4
662893|NCT01984697|2137032|P2|Overall Study|Withdrawal by Subject|5
662894|NCT01984697|2137033|P1|Overall Study|Withdrawal by Subject|3
662895|NCT01984697|2137029|P5|Overall Study|Protocol Violation|0
662896|NCT01984697|2137030|P4|Overall Study|Protocol Violation|1
662897|NCT01984697|2137031|P3|Overall Study|Protocol Violation|0
662898|NCT01984697|2137032|P2|Overall Study|Protocol Violation|0
662899|NCT01984697|2137033|P1|Overall Study|Protocol Violation|0
662900|NCT01984697|2137029|P5|Overall Study|Physician Decision|0
662901|NCT01984697|2137030|P4|Overall Study|Physician Decision|0
662902|NCT01984697|2137031|P3|Overall Study|Physician Decision|0
662903|NCT01984697|2137032|P2|Overall Study|Physician Decision|0
662904|NCT01984697|2137033|P1|Overall Study|Physician Decision|1
662905|NCT01984697|2137029|P5|Overall Study|Lost to Follow-up|4
662906|NCT01984697|2137030|P4|Overall Study|Lost to Follow-up|3
662907|NCT01984697|2137031|P3|Overall Study|Lost to Follow-up|4
662908|NCT01984697|2137032|P2|Overall Study|Lost to Follow-up|2
662909|NCT01984697|2137033|P1|Overall Study|Lost to Follow-up|7
662910|NCT01984697|2137029|P5|Overall Study|Adverse Event|0
662911|NCT01984697|2137030|P4|Overall Study|Adverse Event|0
662912|NCT01984697|2137031|P3|Overall Study|Adverse Event|1
662913|NCT01984697|2137032|P2|Overall Study|Adverse Event|0
662914|NCT01984697|2137033|P1|Overall Study|Adverse Event|0
662937|NCT01984294|2137152|P3|Overall Study|Adverse Event|0
662938|NCT01984294|2137153|P2|Overall Study|Adverse Event|1
662939|NCT01984294|2137154|P1|Overall Study|Adverse Event|0
662940|NCT01984294|2137152|P3|Overall Study|Lack of Efficacy|6
662941|NCT01984294|2137153|P2|Overall Study|Lack of Efficacy|2
662942|NCT01984294|2137154|P1|Overall Study|Lack of Efficacy|4
662943|NCT01984294|2137152|P3|Overall Study|Randomized but Never Treated|1
662944|NCT01984294|2137153|P2|Overall Study|Randomized but Never Treated|0
662945|NCT01984294|2137154|P1|Overall Study|Randomized but Never Treated|0
662946|NCT01984229|2137176|P2|Safety Follow-up Period|Lost to Follow-up|0
662947|NCT01984229|2137177|P1|Safety Follow-up Period|Lost to Follow-up|1
662948|NCT01984229|2137176|P2|Safety Follow-up Period|Adverse Event|1
662949|NCT01984229|2137177|P1|Safety Follow-up Period|Adverse Event|1
662950|NCT01983254|2137294|P2|Overall Study|too ill|8
662951|NCT01983254|2137295|P1|Overall Study|too ill|11
662952|NCT01983254|2137294|P2|Overall Study|Lost to Follow-up|16
662953|NCT01983254|2137295|P1|Overall Study|Lost to Follow-up|17
662954|NCT01983254|2137294|P2|Overall Study|Death|6
662955|NCT01983254|2137295|P1|Overall Study|Death|6
662956|NCT01983111|2137307|P2|Overall Study|Protocol Violation|1
662957|NCT01983111|2137308|P1|Overall Study|Protocol Violation|0
662958|NCT01983111|2137307|P2|Overall Study|Adverse Event|0
662959|NCT01983111|2137308|P1|Overall Study|Adverse Event|4
662960|NCT01983111|2137307|P2|Overall Study|Withdrawal by Subject|6
662961|NCT01983111|2137308|P1|Overall Study|Withdrawal by Subject|8
662962|NCT01982812|2137343|P2|Overall Study|Adverse Event|5
662963|NCT01982812|2137344|P1|Overall Study|Adverse Event|0
662964|NCT01982812|2137343|P2|Overall Study|Death|5
662965|NCT01982812|2137344|P1|Overall Study|Death|1
662966|NCT01982435|2137371|P2|Overall Study|Adverse Event|0
662967|NCT01982435|2137372|P1|Overall Study|Adverse Event|1
662968|NCT01982292|2137402|P2|Overall Study|Technical Problems|0
662969|NCT01982292|2137403|P1|Overall Study|Technical Problems|2
662970|NCT01982292|2137402|P2|Overall Study|Patient/Guardian Decision|1
662971|NCT01982292|2137403|P1|Overall Study|Patient/Guardian Decision|3
662972|NCT01982292|2137402|P2|Overall Study|Protocol Deviation|0
662973|NCT01982292|2137403|P1|Overall Study|Protocol Deviation|1
662974|NCT01982292|2137402|P2|Overall Study|Non-Compliance With Study Treatment|0
662975|NCT01982292|2137403|P1|Overall Study|Non-Compliance With Study Treatment|1
662976|NCT01982292|2137402|P2|Overall Study|Lost to Follow-up|0
662977|NCT01982292|2137403|P1|Overall Study|Lost to Follow-up|2
662978|NCT01982292|2137402|P2|Overall Study|Death|0
662979|NCT01982292|2137403|P1|Overall Study|Death|1
662980|NCT01982292|2137402|P2|Overall Study|Adverse Event|0
662981|NCT01982292|2137403|P1|Overall Study|Adverse Event|2
662982|NCT01982253|2137424|P3|Overall Study|Study terminated by sponsor|4
662983|NCT01982253|2137425|P2|Overall Study|Study terminated by sponsor|4
662984|NCT01982253|2137426|P1|Overall Study|Study terminated by sponsor|1
662985|NCT01982253|2137424|P3|Overall Study|Withdrawal by Subject|0
662986|NCT01982253|2137425|P2|Overall Study|Withdrawal by Subject|0
662987|NCT01982253|2137426|P1|Overall Study|Withdrawal by Subject|1
662988|NCT01981616|2137465|P2|Overall Study|Protocol Violation|0
662989|NCT01981616|2137466|P1|Overall Study|Protocol Violation|1
662990|NCT01981616|2137465|P2|Overall Study|Adverse Event|1
662991|NCT01981616|2137466|P1|Overall Study|Adverse Event|0
662992|NCT01981473|2137481|P3|Overall Study|Received treatment for >24 months|6
662993|NCT01981473|2137482|P2|Overall Study|Received treatment for >24 months|0
662994|NCT01981473|2137483|P1|Overall Study|Received treatment for >24 months|2
662995|NCT01981473|2137481|P3|Overall Study|Received treatment for < 6 months|1
662996|NCT01981473|2137482|P2|Overall Study|Received treatment for < 6 months|0
662997|NCT01981473|2137483|P1|Overall Study|Received treatment for < 6 months|0
662998|NCT01981473|2137481|P3|Overall Study|Incorrect diagnosis of RA|1
662999|NCT01981473|2137482|P2|Overall Study|Incorrect diagnosis of RA|0
663000|NCT01981473|2137483|P1|Overall Study|Incorrect diagnosis of RA|0
663001|NCT01981356|2137524|P2|Overall Study|Protocol Violation|0
663002|NCT01981356|2137525|P1|Overall Study|Protocol Violation|2
663003|NCT01981356|2137524|P2|Overall Study|Withdrawal by Subject|1
663004|NCT01981356|2137525|P1|Overall Study|Withdrawal by Subject|1
663005|NCT01981356|2137524|P2|Overall Study|Lost to Follow-up|1
663006|NCT01981356|2137525|P1|Overall Study|Lost to Follow-up|4
663007|NCT01980992|2137561|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
663008|NCT01980992|2137562|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
663009|NCT01980992|2137561|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
663010|NCT01980992|2137562|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
663011|NCT01980992|2137561|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
663012|NCT01980992|2137562|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
663013|NCT01980992|2137561|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
663014|NCT01980992|2137562|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
663015|NCT01980992|2137561|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
663016|NCT01980992|2137562|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
663017|NCT01980992|2137561|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
663018|NCT01980992|2137562|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
663019|NCT01980940|2137576|P8|Overall Study|Protocol Violation|0
663020|NCT01980940|2137577|P7|Overall Study|Protocol Violation|0
663021|NCT01980940|2137578|P6|Overall Study|Protocol Violation|2
663022|NCT01980940|2137579|P5|Overall Study|Protocol Violation|0
663023|NCT01980940|2137580|P4|Overall Study|Protocol Violation|0
663024|NCT01980940|2137581|P3|Overall Study|Protocol Violation|0
663025|NCT01980940|2137582|P2|Overall Study|Protocol Violation|0
663026|NCT01980940|2137583|P1|Overall Study|Protocol Violation|0
663027|NCT01980875|2137638|P3|Overall Study|Lost to Follow-up|1
663028|NCT01980875|2137639|P2|Overall Study|Lost to Follow-up|0
663029|NCT01980875|2137640|P1|Overall Study|Lost to Follow-up|0
663030|NCT01980875|2137638|P3|Overall Study|Study Terminated by Sponsor|22
663031|NCT01980875|2137639|P2|Overall Study|Study Terminated by Sponsor|24
663032|NCT01980875|2137640|P1|Overall Study|Study Terminated by Sponsor|7
663033|NCT01980875|2137638|P3|Overall Study|Withdrew Consent|1
663034|NCT01980875|2137639|P2|Overall Study|Withdrew Consent|1
663035|NCT01980875|2137640|P1|Overall Study|Withdrew Consent|1
663036|NCT01980095|2137703|P2|Overall Study|Study drug discontinued|0
663037|NCT01980095|2137704|P1|Overall Study|Study drug discontinued|1
663038|NCT01980095|2137703|P2|Overall Study|Safety issue|1
663039|NCT01980095|2137704|P1|Overall Study|Safety issue|0
663040|NCT01980095|2137703|P2|Overall Study|Poor compliance|0
663041|NCT01980095|2137704|P1|Overall Study|Poor compliance|5
663042|NCT01980095|2137703|P2|Overall Study|Withdrawal by Subject|3
663043|NCT01980095|2137704|P1|Overall Study|Withdrawal by Subject|2
663044|NCT01980095|2137703|P2|Overall Study|Lost to Follow-up|7
663045|NCT01980095|2137704|P1|Overall Study|Lost to Follow-up|6
663046|NCT01979185|2137714|P2|Period 2|Not specified|1
663047|NCT01979185|2137715|P1|Period 2|Not specified|0
663048|NCT01978145|2137780|P2|Treatment Period 2|Par. reached defined stopping criteria|5
663049|NCT01978145|2137781|P1|Treatment Period 2|Par. reached defined stopping criteria|8
663050|NCT01978145|2137780|P2|Treatment Period 2|Withdrawal by Subject|4
663051|NCT01978145|2137781|P1|Treatment Period 2|Withdrawal by Subject|7
663052|NCT01978145|2137780|P2|Treatment Period 2|Lost to Follow-up|1
663053|NCT01978145|2137781|P1|Treatment Period 2|Lost to Follow-up|1
663054|NCT01978145|2137780|P2|Treatment Period 2|Protocol Violation|1
663055|NCT01978145|2137781|P1|Treatment Period 2|Protocol Violation|0
663056|NCT01978145|2137780|P2|Treatment Period 2|Adverse Event|3
663057|NCT01978145|2137781|P1|Treatment Period 2|Adverse Event|3
663058|NCT01978145|2137780|P2|Washout Period 1|Par. reached defined stopping criteria|1
663059|NCT01978145|2137781|P1|Washout Period 1|Par. reached defined stopping criteria|0
663060|NCT01978145|2137780|P2|Washout Period 1|Withdrawal by Subject|1
663061|NCT01978145|2137781|P1|Washout Period 1|Withdrawal by Subject|1
663062|NCT01978145|2137780|P2|Washout Period 1|Adverse Event|1
663063|NCT01978145|2137781|P1|Washout Period 1|Adverse Event|0
663064|NCT01978145|2137780|P2|Treatment Period 1|Par. reached defined stopping criteria|3
663065|NCT01978145|2137781|P1|Treatment Period 1|Par. reached defined stopping criteria|2
663066|NCT01978145|2137780|P2|Treatment Period 1|Withdrawal by Subject|4
663067|NCT01978145|2137781|P1|Treatment Period 1|Withdrawal by Subject|5
663068|NCT01978145|2137780|P2|Treatment Period 1|Physician Decision|0
663069|NCT01978145|2137781|P1|Treatment Period 1|Physician Decision|1
663070|NCT01978145|2137780|P2|Treatment Period 1|Adverse Event|9
663071|NCT01978145|2137781|P1|Treatment Period 1|Adverse Event|1
663072|NCT01978119|2137797|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
663073|NCT01978119|2137798|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
663074|NCT01978119|2137797|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
663075|NCT01978119|2137798|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
663076|NCT01978119|2137797|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
663077|NCT01978119|2137798|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
663078|NCT01977820|2137824|P2|Overall Study|Sponsor terminated the study|1
663079|NCT01977820|2137825|P1|Overall Study|Sponsor terminated the study|1
663080|NCT01977794|2137833|P2|Overall Study|Unspecified|1
663081|NCT01977794|2137834|P1|Overall Study|Unspecified|0
663082|NCT01977794|2137833|P2|Overall Study|Withdrew consent|1
663083|NCT01977794|2137834|P1|Overall Study|Withdrew consent|2
663084|NCT01977794|2137833|P2|Overall Study|Death|1
663085|NCT01977794|2137834|P1|Overall Study|Death|1
663086|NCT01977794|2137833|P2|Overall Study|Protocol Violation|0
663087|NCT01977794|2137834|P1|Overall Study|Protocol Violation|1
663088|NCT01977794|2137833|P2|Overall Study|Lost to Follow-up|1
663089|NCT01977794|2137834|P1|Overall Study|Lost to Follow-up|2
663090|NCT01977794|2137833|P2|Overall Study|Adverse Event|2
663091|NCT01977794|2137834|P1|Overall Study|Adverse Event|2
663092|NCT01977729|2137869|P1|Overall Study|Study terminated|1
663093|NCT01977690|2137881|P2|Overall Study|Withdrawal by Subject|4
663094|NCT01977690|2137882|P1|Overall Study|Withdrawal by Subject|0
663095|NCT01977625|2137888|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
663096|NCT01977625|2137889|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
663097|NCT01977625|2137888|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
663098|NCT01977625|2137889|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
663099|NCT01977612|2137899|P2|Overall Study|Lost to Follow-up|1
663100|NCT01977612|2137900|P1|Overall Study|Lost to Follow-up|1
663101|NCT01977573|2137922|P4|Overall Study|Withdrawal by Subject|1
663102|NCT01977573|2137923|P3|Overall Study|Withdrawal by Subject|1
663103|NCT01977573|2137924|P2|Overall Study|Withdrawal by Subject|1
663104|NCT01977573|2137925|P1|Overall Study|Withdrawal by Subject|6
663105|NCT01977573|2137922|P4|Overall Study|Reached Defined Stopping Criteria|0
663106|NCT01977573|2137923|P3|Overall Study|Reached Defined Stopping Criteria|1
663107|NCT01977573|2137924|P2|Overall Study|Reached Defined Stopping Criteria|1
663108|NCT01977573|2137925|P1|Overall Study|Reached Defined Stopping Criteria|2
663109|NCT01977573|2137922|P4|Overall Study|Protocol Violation|0
663110|NCT01977573|2137923|P3|Overall Study|Protocol Violation|0
663111|NCT01977573|2137924|P2|Overall Study|Protocol Violation|1
663112|NCT01977573|2137925|P1|Overall Study|Protocol Violation|3
663113|NCT01977573|2137922|P4|Overall Study|Physician Decision|0
663114|NCT01977573|2137923|P3|Overall Study|Physician Decision|0
663115|NCT01977573|2137924|P2|Overall Study|Physician Decision|0
663116|NCT01977573|2137925|P1|Overall Study|Physician Decision|1
663117|NCT01977573|2137922|P4|Overall Study|Lost to Follow-up|1
663118|NCT01977573|2137923|P3|Overall Study|Lost to Follow-up|0
663119|NCT01977573|2137924|P2|Overall Study|Lost to Follow-up|0
663120|NCT01977573|2137925|P1|Overall Study|Lost to Follow-up|1
663121|NCT01977573|2137922|P4|Overall Study|Adverse Event|1
663122|NCT01977573|2137923|P3|Overall Study|Adverse Event|2
663123|NCT01977573|2137924|P2|Overall Study|Adverse Event|0
663124|NCT01977573|2137925|P1|Overall Study|Adverse Event|7
663125|NCT01977482|2138039|P6|Overall Study|Withdrawal by Subject|5
663126|NCT01977482|2138040|P5|Overall Study|Withdrawal by Subject|1
663127|NCT01977482|2138041|P4|Overall Study|Withdrawal by Subject|3
663128|NCT01977482|2138042|P3|Overall Study|Withdrawal by Subject|1
663129|NCT01977482|2138043|P2|Overall Study|Withdrawal by Subject|4
663130|NCT01977482|2138044|P1|Overall Study|Withdrawal by Subject|2
663131|NCT01977482|2138039|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
663132|NCT01977482|2138040|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
663133|NCT01977482|2138041|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
663134|NCT01977482|2138042|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
663135|NCT01977482|2138043|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
663136|NCT01977482|2138044|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
663137|NCT01977482|2138039|P6|Overall Study|Protocol Violation|0
663138|NCT01977482|2138040|P5|Overall Study|Protocol Violation|0
663139|NCT01977482|2138041|P4|Overall Study|Protocol Violation|0
663140|NCT01977482|2138042|P3|Overall Study|Protocol Violation|1
663141|NCT01977482|2138043|P2|Overall Study|Protocol Violation|0
663142|NCT01977482|2138044|P1|Overall Study|Protocol Violation|0
663143|NCT01977482|2138039|P6|Overall Study|Physician Decision|0
663144|NCT01977482|2138040|P5|Overall Study|Physician Decision|0
663145|NCT01977482|2138041|P4|Overall Study|Physician Decision|0
663146|NCT01977482|2138042|P3|Overall Study|Physician Decision|0
663147|NCT01977482|2138043|P2|Overall Study|Physician Decision|1
663148|NCT01977482|2138044|P1|Overall Study|Physician Decision|0
663149|NCT01977482|2138039|P6|Overall Study|Lost to Follow-up|0
663150|NCT01977482|2138040|P5|Overall Study|Lost to Follow-up|0
663151|NCT01977482|2138041|P4|Overall Study|Lost to Follow-up|0
663152|NCT01977482|2138042|P3|Overall Study|Lost to Follow-up|0
663153|NCT01977482|2138043|P2|Overall Study|Lost to Follow-up|0
663154|NCT01977482|2138044|P1|Overall Study|Lost to Follow-up|1
663155|NCT01977482|2138039|P6|Overall Study|Adverse Event|0
663156|NCT01977482|2138040|P5|Overall Study|Adverse Event|2
663157|NCT01977482|2138041|P4|Overall Study|Adverse Event|0
663158|NCT01977482|2138042|P3|Overall Study|Adverse Event|1
663159|NCT01977482|2138043|P2|Overall Study|Adverse Event|1
663160|NCT01977482|2138044|P1|Overall Study|Adverse Event|0
663161|NCT01977456|2138159|P1|Overall Study|Death|5
663162|NCT01976845|2138197|P3|Overall Study|Physician Decision|3
663163|NCT01976845|2138198|P2|Overall Study|Physician Decision|8
663164|NCT01976845|2138199|P1|Overall Study|Physician Decision|8
663171|NCT01976663|2138231|P1|Overall Study|Lost to Follow-up|3
663172|NCT01976663|2138231|P1|Overall Study|Adverse Event|2
663173|NCT01976663|2138231|P1|Overall Study|Screen Failure|3
663174|NCT01976663|2138231|P1|Overall Study|Withdrawal by Subject|4
663175|NCT01976663|2138231|P1|Overall Study|Personal Reasons|6
663176|NCT01976663|2138231|P1|Overall Study|Completed 18 mos but no repeat treatment|24
663177|NCT01976624|2138250|P1|Overall Study|Participants age less than 19 years|12
663178|NCT01976624|2138250|P1|Overall Study|Participants contraindicated|2
663179|NCT01976507|2138278|P1|Overall Study|ablation not done, drug not given|1
663180|NCT01976507|2138278|P1|Overall Study|Adverse Event|6
663181|NCT01976338|2138302|P2|Overall Study|Adverse Event|1
663182|NCT01976338|2138303|P1|Overall Study|Adverse Event|5
663183|NCT01976338|2138302|P2|Overall Study|Withdrawal by Subject|2
663184|NCT01976338|2138303|P1|Overall Study|Withdrawal by Subject|5
663185|NCT01976338|2138302|P2|Overall Study|Lost to Follow-up|0
663186|NCT01976338|2138303|P1|Overall Study|Lost to Follow-up|3
663187|NCT01976338|2138302|P2|Overall Study|Physician Decision|1
663188|NCT01976338|2138303|P1|Overall Study|Physician Decision|0
663189|NCT01976312|2138330|P2|Overall Study|Protocol Violation|0
663190|NCT01976312|2138331|P1|Overall Study|Protocol Violation|2
663191|NCT01976312|2138330|P2|Overall Study|Adverse Event|6
663192|NCT01976312|2138331|P1|Overall Study|Adverse Event|6
663193|NCT01976312|2138330|P2|Overall Study|Withdrawal by Subject|2
663194|NCT01976312|2138331|P1|Overall Study|Withdrawal by Subject|7
663195|NCT01976312|2138330|P2|Overall Study|Lost to Follow-up|0
663196|NCT01976312|2138331|P1|Overall Study|Lost to Follow-up|2
663197|NCT01976312|2138330|P2|Overall Study|Pregnancy|1
663198|NCT01976312|2138331|P1|Overall Study|Pregnancy|0
663199|NCT01976299|2138352|P2|Overall Study|See clarification above in comments|2
663200|NCT01976299|2138353|P1|Overall Study|See clarification above in comments|9
663201|NCT01976299|2138352|P2|Overall Study|Lost to Follow-up|1
663202|NCT01976299|2138353|P1|Overall Study|Lost to Follow-up|7
663203|NCT01976299|2138352|P2|Overall Study|Death|2
663204|NCT01976299|2138353|P1|Overall Study|Death|4
663205|NCT01976299|2138352|P2|Overall Study|Withdrawal by Subject|1
663206|NCT01976299|2138353|P1|Overall Study|Withdrawal by Subject|3
663207|NCT01975948|2138384|P4|Overall Study|Withdrawal by Subject|6
663208|NCT01975948|2138385|P3|Overall Study|Withdrawal by Subject|7
663209|NCT01975948|2138386|P2|Overall Study|Withdrawal by Subject|21
663210|NCT01975948|2138387|P1|Overall Study|Withdrawal by Subject|17
663211|NCT01975675|2138447|P4|Overall Study|Death|0
663212|NCT01975675|2138448|P3|Overall Study|Death|0
663213|NCT01975675|2138449|P2|Overall Study|Death|1
663214|NCT01975675|2138450|P1|Overall Study|Death|0
663215|NCT01975285|2138483|P2|Overall Study|Failed Block and follow up|2
663216|NCT01975285|2138484|P1|Overall Study|Failed Block and follow up|2
663217|NCT01975246|2138500|P2|Overall Study|Other than stated|1
663218|NCT01975246|2138501|P1|Overall Study|Other than stated|0
663219|NCT01975246|2138500|P2|Overall Study|Protocol Violation|0
663220|NCT01975246|2138501|P1|Overall Study|Protocol Violation|1
663221|NCT01975246|2138500|P2|Overall Study|Lack of Efficacy|0
663222|NCT01975246|2138501|P1|Overall Study|Lack of Efficacy|1
663223|NCT01975246|2138500|P2|Overall Study|Adverse Event|1
663224|NCT01975246|2138501|P1|Overall Study|Adverse Event|2
663225|NCT01975220|2138514|P6|Test Period 1|Not treated|0
663226|NCT01975220|2138515|P5|Test Period 1|Not treated|0
663227|NCT01975220|2138516|P4|Test Period 1|Not treated|0
663228|NCT01975220|2138517|P3|Test Period 1|Not treated|0
663229|NCT01975220|2138518|P2|Test Period 1|Not treated|1
663230|NCT01975220|2138519|P1|Test Period 1|Not treated|0
663231|NCT01974895|2138565|P2|Overall Study|Other (Reason unknown)|8
663232|NCT01974895|2138566|P1|Overall Study|Other (Reason unknown)|9
663233|NCT01974895|2138565|P2|Overall Study|Other (Missed Visit)|0
663234|NCT01974895|2138566|P1|Overall Study|Other (Missed Visit)|1
663235|NCT01974895|2138565|P2|Overall Study|Withdrawal by Subject|1
663236|NCT01974895|2138566|P1|Overall Study|Withdrawal by Subject|0
663237|NCT01974895|2138565|P2|Overall Study|Lost to Follow-up|6
663238|NCT01974895|2138566|P1|Overall Study|Lost to Follow-up|4
663239|NCT01974895|2138565|P2|Overall Study|Protocol Violation|0
663240|NCT01974895|2138566|P1|Overall Study|Protocol Violation|1
663241|NCT01974817|2138596|P1|Overall Study|Protocol Violation|2
663242|NCT01974817|2138596|P1|Overall Study|Lost to Follow-up|2
663243|NCT01974817|2138596|P1|Overall Study|Death|4
663244|NCT01974752|2138602|P2|Overall Study|Other Eligibility Criteria|1
663245|NCT01974752|2138603|P1|Overall Study|Other Eligibility Criteria|0
663246|NCT01974752|2138602|P2|Overall Study|Withdrawal by Subject|3
663247|NCT01974752|2138603|P1|Overall Study|Withdrawal by Subject|2
663248|NCT01974752|2138602|P2|Overall Study|Lost to Follow-up|0
663249|NCT01974752|2138603|P1|Overall Study|Lost to Follow-up|2
663250|NCT01974752|2138602|P2|Overall Study|Death|11
663251|NCT01974752|2138603|P1|Overall Study|Death|33
663252|NCT01974323|2138630|P2|Overall Study|Adverse Event|2
663253|NCT01974323|2138631|P1|Overall Study|Adverse Event|2
663254|NCT01974323|2138630|P2|Overall Study|Lack of Efficacy|1
663255|NCT01974323|2138631|P1|Overall Study|Lack of Efficacy|1
663256|NCT01974323|2138630|P2|Overall Study|Pregnancy|1
663257|NCT01974323|2138631|P1|Overall Study|Pregnancy|2
663258|NCT01974323|2138630|P2|Overall Study|Lost to Follow-up|40
663259|NCT01974323|2138631|P1|Overall Study|Lost to Follow-up|45
663260|NCT01974323|2138630|P2|Overall Study|Personal Reasons|19
663261|NCT01974323|2138631|P1|Overall Study|Personal Reasons|15
663262|NCT01974323|2138630|P2|Overall Study|Protocol Violation|2
663263|NCT01974323|2138631|P1|Overall Study|Protocol Violation|2
663264|NCT01974323|2138630|P2|Overall Study|Other Reasons|28
663265|NCT01974323|2138631|P1|Overall Study|Other Reasons|25
663266|NCT01974141|2138664|P2|Overall Study|Adverse Event|5
663267|NCT01974141|2138665|P1|Overall Study|Adverse Event|4
663268|NCT01974141|2138664|P2|Overall Study|Lack of Efficacy|1
663269|NCT01974141|2138665|P1|Overall Study|Lack of Efficacy|0
663270|NCT01974141|2138664|P2|Overall Study|Pregnancy|3
663271|NCT01974141|2138665|P1|Overall Study|Pregnancy|3
663272|NCT01974141|2138664|P2|Overall Study|Lost to Follow-up|29
663273|NCT01974141|2138665|P1|Overall Study|Lost to Follow-up|38
663274|NCT01974141|2138664|P2|Overall Study|Personal Reasons|20
663275|NCT01974141|2138665|P1|Overall Study|Personal Reasons|21
663276|NCT01974141|2138664|P2|Overall Study|Protocol Violation|6
663277|NCT01974141|2138665|P1|Overall Study|Protocol Violation|2
663278|NCT01974141|2138664|P2|Overall Study|Other Reasons|18
663279|NCT01974141|2138665|P1|Overall Study|Other Reasons|28
663280|NCT01973595|2138722|P4|Washout|Withdrawal by Subject|0
663281|NCT01973595|2138723|P3|Washout|Withdrawal by Subject|1
663282|NCT01973595|2138724|P2|Washout|Withdrawal by Subject|0
663283|NCT01973595|2138725|P1|Washout|Withdrawal by Subject|1
663284|NCT01973491|2138739|P1|Treatment Period (16 Weeks)|Adverse Event|1
663285|NCT01973491|2138739|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
663286|NCT01973491|2138739|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
663287|NCT01973439|2138755|P1|Overall Study|PK curve incomplete|2
663288|NCT01973439|2138755|P1|Overall Study|Vomiting after commencing once daily|1
663289|NCT01973439|2138755|P1|Overall Study|Lost samples from one PK Day|2
663290|NCT01973387|2138777|P2|Overall Study|Did not receive study drug|2
663291|NCT01973387|2138778|P1|Overall Study|Did not receive study drug|2
663292|NCT01973387|2138777|P2|Overall Study|Ongoing|0
663293|NCT01973387|2138778|P1|Overall Study|Ongoing|72
663294|NCT01973387|2138777|P2|Overall Study|Adverse Event|4
663295|NCT01973387|2138778|P1|Overall Study|Adverse Event|13
663296|NCT01973387|2138777|P2|Overall Study|Progressive disease or relapse|5
663297|NCT01973387|2138778|P1|Overall Study|Progressive disease or relapse|10
663298|NCT01973387|2138777|P2|Overall Study|Death|3
663299|NCT01973387|2138778|P1|Overall Study|Death|3
663300|NCT01973387|2138777|P2|Overall Study|Withdrawal by Subject|4
663301|NCT01973387|2138778|P1|Overall Study|Withdrawal by Subject|6
663302|NCT01973231|2138815|P2|Overall Study|Withdrawal by Subject|9
663303|NCT01973231|2138816|P1|Overall Study|Withdrawal by Subject|7
663304|NCT01973231|2138815|P2|Overall Study|unclassified|1
663305|NCT01973231|2138816|P1|Overall Study|unclassified|2
663306|NCT01973231|2138815|P2|Overall Study|Lost to Follow-up|1
663307|NCT01973231|2138816|P1|Overall Study|Lost to Follow-up|1
663308|NCT01973231|2138815|P2|Overall Study|Protocol Violation|1
663309|NCT01973231|2138816|P1|Overall Study|Protocol Violation|1
663310|NCT01973218|2138836|P2|Overall Study|Withdrawal by Subject|0
663311|NCT01973218|2138837|P1|Overall Study|Withdrawal by Subject|1
663312|NCT01973218|2138836|P2|Overall Study|Adverse Event|0
663313|NCT01973218|2138837|P1|Overall Study|Adverse Event|1
663314|NCT01972776|2138879|P6|Part 2|Administrative problems|7
663315|NCT01972776|2138880|P5|Part 2|Administrative problems|10
663316|NCT01972776|2138881|P4|Part 2|Administrative problems|0
663317|NCT01972776|2138882|P3|Part 2|Administrative problems|0
663318|NCT01972776|2138883|P2|Part 2|Administrative problems|0
663319|NCT01972776|2138884|P1|Part 2|Administrative problems|0
663320|NCT01972776|2138879|P6|Part 2|Adverse Event|0
663321|NCT01972776|2138880|P5|Part 2|Adverse Event|3
663322|NCT01972776|2138881|P4|Part 2|Adverse Event|0
663323|NCT01972776|2138882|P3|Part 2|Adverse Event|0
663324|NCT01972776|2138883|P2|Part 2|Adverse Event|0
663325|NCT01972776|2138884|P1|Part 2|Adverse Event|0
663326|NCT01972776|2138879|P6|Part 1|Adverse Event|0
663327|NCT01972776|2138880|P5|Part 1|Adverse Event|0
663328|NCT01972776|2138881|P4|Part 1|Adverse Event|1
663329|NCT01972776|2138882|P3|Part 1|Adverse Event|1
663330|NCT01972776|2138883|P2|Part 1|Adverse Event|0
663331|NCT01972776|2138884|P1|Part 1|Adverse Event|0
663332|NCT01972776|2138879|P6|Part 1|Withdrawal by Subject|0
663333|NCT01972776|2138880|P5|Part 1|Withdrawal by Subject|0
663334|NCT01972776|2138881|P4|Part 1|Withdrawal by Subject|0
663335|NCT01972776|2138882|P3|Part 1|Withdrawal by Subject|1
663336|NCT01972776|2138883|P2|Part 1|Withdrawal by Subject|0
663337|NCT01972776|2138884|P1|Part 1|Withdrawal by Subject|0
663338|NCT01972659|2138954|P2|Overall Study|problems realted to acceleromyograph|1
663339|NCT01972659|2138955|P1|Overall Study|problems realted to acceleromyograph|2
663340|NCT01972659|2138954|P2|Overall Study|Protocol Violation|2
663341|NCT01972659|2138955|P1|Overall Study|Protocol Violation|2
663342|NCT01972438|2138980|P2|Post Month 12 Study Period|Early Study Closure|4
663343|NCT01972438|2138981|P1|Post Month 12 Study Period|Early Study Closure|3
663344|NCT01972438|2138980|P2|Months 6-12 Study Period|Early Study Closure|2
663345|NCT01972438|2138981|P1|Months 6-12 Study Period|Early Study Closure|2
663346|NCT01972438|2138980|P2|Months 6-12 Study Period|Death|0
663347|NCT01972438|2138981|P1|Months 6-12 Study Period|Death|1
663348|NCT01972438|2138980|P2|Months 3-6 Crossover Period|Early Study Closure|1
663349|NCT01972438|2138981|P1|Months 3-6 Crossover Period|Early Study Closure|0
663350|NCT01972438|2138980|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
663351|NCT01972438|2138981|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
663352|NCT01972438|2138980|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
663353|NCT01972438|2138981|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
663354|NCT01972438|2138980|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
663355|NCT01972438|2138981|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
663356|NCT01972438|2138980|P2|Baseline-Month 3 Crossover Period|Death|0
663357|NCT01972438|2138981|P1|Baseline-Month 3 Crossover Period|Death|1
663358|NCT01972152|2139033|P6|Second Treatment Visit|Protocol Violation|0
663359|NCT01972152|2139034|P5|Second Treatment Visit|Protocol Violation|0
663360|NCT01972152|2139035|P4|Second Treatment Visit|Protocol Violation|0
663361|NCT01972152|2139036|P3|Second Treatment Visit|Protocol Violation|0
663362|NCT01972152|2139037|P2|Second Treatment Visit|Protocol Violation|1
663363|NCT01972152|2139038|P1|Second Treatment Visit|Protocol Violation|0
663364|NCT01972152|2139033|P6|First Treatment Visit|Lost to Follow-up|0
663365|NCT01972152|2139034|P5|First Treatment Visit|Lost to Follow-up|0
663366|NCT01972152|2139035|P4|First Treatment Visit|Lost to Follow-up|0
663367|NCT01972152|2139036|P3|First Treatment Visit|Lost to Follow-up|0
663368|NCT01972152|2139037|P2|First Treatment Visit|Lost to Follow-up|1
663369|NCT01972152|2139038|P1|First Treatment Visit|Lost to Follow-up|0
663370|NCT01971723|2139075|P2|Overall Study|Protocol Violation|2
663371|NCT01971723|2139076|P1|Overall Study|Protocol Violation|1
663372|NCT01971723|2139075|P2|Overall Study|Withdrawal by Subject|1
663373|NCT01971723|2139076|P1|Overall Study|Withdrawal by Subject|1
663374|NCT01971554|2139110|P4|Overall Study|Lost to Follow-up|0
663375|NCT01971554|2139111|P3|Overall Study|Lost to Follow-up|0
663376|NCT01971554|2139112|P2|Overall Study|Lost to Follow-up|0
663377|NCT01971554|2139113|P1|Overall Study|Lost to Follow-up|1
663378|NCT01970995|2139193|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
663379|NCT01970995|2139194|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
663380|NCT01970995|2139195|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
663381|NCT01970995|2139193|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
663382|NCT01970995|2139194|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
663383|NCT01970995|2139195|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
663384|NCT01970982|2139218|P3|Overall Study|Withdrawal by Subject|2
663385|NCT01970982|2139219|P2|Overall Study|Withdrawal by Subject|0
663386|NCT01970982|2139220|P1|Overall Study|Withdrawal by Subject|0
663387|NCT01970878|2139242|P4|Overall Study|No Completion Status|0
663388|NCT01970878|2139243|P3|Overall Study|No Completion Status|0
663389|NCT01970878|2139244|P2|Overall Study|No Completion Status|1
663390|NCT01970878|2139245|P1|Overall Study|No Completion Status|0
663391|NCT01970878|2139242|P4|Overall Study|Physician Decision|0
663392|NCT01970878|2139243|P3|Overall Study|Physician Decision|1
663393|NCT01970878|2139244|P2|Overall Study|Physician Decision|1
663394|NCT01970878|2139245|P1|Overall Study|Physician Decision|0
663395|NCT01970878|2139242|P4|Overall Study|Protocol Specified Criteria|6
663396|NCT01970878|2139243|P3|Overall Study|Protocol Specified Criteria|3
663397|NCT01970878|2139244|P2|Overall Study|Protocol Specified Criteria|4
663398|NCT01970878|2139245|P1|Overall Study|Protocol Specified Criteria|10
663399|NCT01970878|2139242|P4|Overall Study|Adverse Event|3
663400|NCT01970878|2139243|P3|Overall Study|Adverse Event|4
663401|NCT01970878|2139244|P2|Overall Study|Adverse Event|7
663402|NCT01970878|2139245|P1|Overall Study|Adverse Event|12
663403|NCT01970878|2139242|P4|Overall Study|Lack of Efficacy|0
663404|NCT01970878|2139243|P3|Overall Study|Lack of Efficacy|2
663405|NCT01970878|2139244|P2|Overall Study|Lack of Efficacy|1
663406|NCT01970878|2139245|P1|Overall Study|Lack of Efficacy|2
663407|NCT01970878|2139242|P4|Overall Study|Administrative Reasons|4
663408|NCT01970878|2139243|P3|Overall Study|Administrative Reasons|0
663409|NCT01970878|2139244|P2|Overall Study|Administrative Reasons|0
663410|NCT01970878|2139245|P1|Overall Study|Administrative Reasons|1
663411|NCT01970878|2139242|P4|Overall Study|Lost to Follow-up|4
663412|NCT01970878|2139243|P3|Overall Study|Lost to Follow-up|2
663413|NCT01970878|2139244|P2|Overall Study|Lost to Follow-up|3
663414|NCT01970878|2139245|P1|Overall Study|Lost to Follow-up|1
663415|NCT01970878|2139242|P4|Overall Study|Withdrawal by Subject|7
663416|NCT01970878|2139243|P3|Overall Study|Withdrawal by Subject|14
663417|NCT01970878|2139244|P2|Overall Study|Withdrawal by Subject|10
663418|NCT01970878|2139245|P1|Overall Study|Withdrawal by Subject|11
663419|NCT01970488|2139281|P5|Part 2: Post Week 16|Lost to Follow-up|2
663420|NCT01970488|2139282|P4|Part 2: Post Week 16|Lost to Follow-up|1
663421|NCT01970488|2139283|P3|Part 2: Post Week 16|Lost to Follow-up|1
663422|NCT01970488|2139284|P2|Part 2: Post Week 16|Lost to Follow-up|0
663423|NCT01970488|2139285|P1|Part 2: Post Week 16|Lost to Follow-up|0
663424|NCT01970488|2139281|P5|Part 2: Post Week 16|Withdrawal by Subject|3
663425|NCT01970488|2139282|P4|Part 2: Post Week 16|Withdrawal by Subject|3
663426|NCT01970488|2139283|P3|Part 2: Post Week 16|Withdrawal by Subject|8
663427|NCT01970488|2139284|P2|Part 2: Post Week 16|Withdrawal by Subject|0
663428|NCT01970488|2139285|P1|Part 2: Post Week 16|Withdrawal by Subject|0
663429|NCT01970488|2139281|P5|Part 2: Post Week 16|Adverse Event|1
663430|NCT01970488|2139282|P4|Part 2: Post Week 16|Adverse Event|1
663431|NCT01970488|2139283|P3|Part 2: Post Week 16|Adverse Event|5
663432|NCT01970488|2139284|P2|Part 2: Post Week 16|Adverse Event|0
663433|NCT01970488|2139285|P1|Part 2: Post Week 16|Adverse Event|0
663434|NCT01970488|2139281|P5|Part 2: Post Week 16|Lack of Efficacy|1
663435|NCT01970488|2139282|P4|Part 2: Post Week 16|Lack of Efficacy|3
663436|NCT01970488|2139283|P3|Part 2: Post Week 16|Lack of Efficacy|2
663437|NCT01970488|2139284|P2|Part 2: Post Week 16|Lack of Efficacy|0
663438|NCT01970488|2139285|P1|Part 2: Post Week 16|Lack of Efficacy|0
663439|NCT01970488|2139281|P5|Part 2: Post Week 16|Non-compliance|0
663440|NCT01970488|2139282|P4|Part 2: Post Week 16|Non-compliance|0
663441|NCT01970488|2139283|P3|Part 2: Post Week 16|Non-compliance|1
663442|NCT01970488|2139284|P2|Part 2: Post Week 16|Non-compliance|0
663443|NCT01970488|2139285|P1|Part 2: Post Week 16|Non-compliance|0
663444|NCT01970488|2139281|P5|Part 2: Post Week 16|Physician Decision|1
663445|NCT01970488|2139282|P4|Part 2: Post Week 16|Physician Decision|0
663446|NCT01970488|2139283|P3|Part 2: Post Week 16|Physician Decision|0
663447|NCT01970488|2139284|P2|Part 2: Post Week 16|Physician Decision|0
663448|NCT01970488|2139285|P1|Part 2: Post Week 16|Physician Decision|0
663449|NCT01970488|2139281|P5|Part 1: Through Week 16|Lost to Follow-up|0
663450|NCT01970488|2139282|P4|Part 1: Through Week 16|Lost to Follow-up|0
663451|NCT01970488|2139283|P3|Part 1: Through Week 16|Lost to Follow-up|0
663452|NCT01970488|2139284|P2|Part 1: Through Week 16|Lost to Follow-up|2
663453|NCT01970488|2139285|P1|Part 1: Through Week 16|Lost to Follow-up|0
663454|NCT01970488|2139281|P5|Part 1: Through Week 16|Withdrawal by Subject|0
663455|NCT01970488|2139282|P4|Part 1: Through Week 16|Withdrawal by Subject|0
663456|NCT01970488|2139283|P3|Part 1: Through Week 16|Withdrawal by Subject|0
663457|NCT01970488|2139284|P2|Part 1: Through Week 16|Withdrawal by Subject|2
663458|NCT01970488|2139285|P1|Part 1: Through Week 16|Withdrawal by Subject|3
663459|NCT01970488|2139281|P5|Part 1: Through Week 16|Adverse Event|0
663460|NCT01970488|2139282|P4|Part 1: Through Week 16|Adverse Event|0
663461|NCT01970488|2139283|P3|Part 1: Through Week 16|Adverse Event|0
663462|NCT01970488|2139284|P2|Part 1: Through Week 16|Adverse Event|5
663463|NCT01970488|2139285|P1|Part 1: Through Week 16|Adverse Event|6
663464|NCT01970488|2139281|P5|Part 1: Through Week 16|Protocol Violation|0
663465|NCT01970488|2139282|P4|Part 1: Through Week 16|Protocol Violation|0
663466|NCT01970488|2139283|P3|Part 1: Through Week 16|Protocol Violation|0
663467|NCT01970488|2139284|P2|Part 1: Through Week 16|Protocol Violation|2
663468|NCT01970488|2139285|P1|Part 1: Through Week 16|Protocol Violation|1
663469|NCT01970488|2139281|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
663470|NCT01970488|2139282|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
663471|NCT01970488|2139283|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
663472|NCT01970488|2139284|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
663473|NCT01970488|2139285|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
663474|NCT01970475|2139352|P2|Overall Study|Protocol Violation|0
663475|NCT01970475|2139353|P1|Overall Study|Protocol Violation|1
663476|NCT01970475|2139352|P2|Overall Study|Lost to Follow-up|2
663477|NCT01970475|2139353|P1|Overall Study|Lost to Follow-up|2
663478|NCT01970475|2139352|P2|Overall Study|Adverse Event|3
663479|NCT01970475|2139353|P1|Overall Study|Adverse Event|7
663480|NCT01970475|2139352|P2|Overall Study|Withdrawal by Subject|6
663481|NCT01970475|2139353|P1|Overall Study|Withdrawal by Subject|11
663482|NCT01970397|2139373|P2|Overall Study|Protocol Violation|1
663483|NCT01970397|2139374|P1|Overall Study|Protocol Violation|1
663484|NCT01970397|2139373|P2|Overall Study|Personal Reasons|2
663485|NCT01970397|2139374|P1|Overall Study|Personal Reasons|1
663486|NCT01970397|2139373|P2|Overall Study|Lost to Follow-up|1
663487|NCT01970397|2139374|P1|Overall Study|Lost to Follow-up|0
663488|NCT01970397|2139373|P2|Overall Study|Adverse Event|1
663489|NCT01970397|2139374|P1|Overall Study|Adverse Event|0
663490|NCT01969799|2139386|P2|Overall Study|Physician Decision|0
663491|NCT01969799|2139387|P1|Overall Study|Physician Decision|1
663492|NCT01969799|2139386|P2|Overall Study|Lost to Follow-up|2
663493|NCT01969799|2139387|P1|Overall Study|Lost to Follow-up|0
663494|NCT01969799|2139386|P2|Overall Study|Death|11
663495|NCT01969799|2139387|P1|Overall Study|Death|16
663496|NCT01969799|2139386|P2|Overall Study|Adverse Event|1
663497|NCT01969799|2139387|P1|Overall Study|Adverse Event|0
663498|NCT01969721|2139424|P4|Overall Study|Discontinued during washout periods.|2
663499|NCT01969721|2139425|P3|Overall Study|Discontinued during washout periods.|1
663500|NCT01969721|2139426|P2|Overall Study|Discontinued during washout periods.|1
663501|NCT01969721|2139427|P1|Overall Study|Discontinued during washout periods.|0
663502|NCT01969721|2139424|P4|Overall Study|Other not defined above|0
663503|NCT01969721|2139425|P3|Overall Study|Other not defined above|0
663504|NCT01969721|2139426|P2|Overall Study|Other not defined above|2
663505|NCT01969721|2139427|P1|Overall Study|Other not defined above|0
663506|NCT01969721|2139424|P4|Overall Study|Non compliant with protocol|2
663507|NCT01969721|2139425|P3|Overall Study|Non compliant with protocol|0
663508|NCT01969721|2139426|P2|Overall Study|Non compliant with protocol|1
663509|NCT01969721|2139427|P1|Overall Study|Non compliant with protocol|1
663510|NCT01969721|2139424|P4|Overall Study|Lack of Efficacy|0
663511|NCT01969721|2139425|P3|Overall Study|Lack of Efficacy|1
663512|NCT01969721|2139426|P2|Overall Study|Lack of Efficacy|0
663513|NCT01969721|2139427|P1|Overall Study|Lack of Efficacy|0
663514|NCT01969721|2139424|P4|Overall Study|Adverse Event|2
663515|NCT01969721|2139425|P3|Overall Study|Adverse Event|3
663516|NCT01969721|2139426|P2|Overall Study|Adverse Event|8
663517|NCT01969721|2139427|P1|Overall Study|Adverse Event|3
663519|NCT01969084|2139482|P2|Overall Study|Adverse Event|1
663520|NCT01969084|2139483|P1|Overall Study|Adverse Event|0
663525|NCT01968980|2139532|P2|Overall Study|Other unspecified|2
663526|NCT01968980|2139533|P1|Overall Study|Other unspecified|1
663527|NCT01968980|2139532|P2|Overall Study|Withdrawal by Subject|5
663528|NCT01968980|2139533|P1|Overall Study|Withdrawal by Subject|13
663529|NCT01968980|2139532|P2|Overall Study|Does not meet entry criteria|3
663530|NCT01968980|2139533|P1|Overall Study|Does not meet entry criteria|1
663531|NCT01968980|2139532|P2|Overall Study|Adverse Event|3
663532|NCT01968980|2139533|P1|Overall Study|Adverse Event|1
663533|NCT01968980|2139532|P2|Overall Study|Death|1
663534|NCT01968980|2139533|P1|Overall Study|Death|0
663535|NCT01968967|2139595|P2|Overall Study|Randomized Not Treated|5
663536|NCT01968967|2139596|P1|Overall Study|Randomized Not Treated|6
663537|NCT01968967|2139595|P2|Overall Study|Death|2
663538|NCT01968967|2139596|P1|Overall Study|Death|9
663539|NCT01968967|2139595|P2|Overall Study|Adverse Event|8
663540|NCT01968967|2139596|P1|Overall Study|Adverse Event|9
663541|NCT01968967|2139595|P2|Overall Study|Protocol Violation|2
663542|NCT01968967|2139596|P1|Overall Study|Protocol Violation|1
663543|NCT01968967|2139595|P2|Overall Study|Lost to Follow-up|31
663544|NCT01968967|2139596|P1|Overall Study|Lost to Follow-up|26
663545|NCT01968967|2139595|P2|Overall Study|Did Not Meet Entrance Criteria|3
663546|NCT01968967|2139596|P1|Overall Study|Did Not Meet Entrance Criteria|2
663547|NCT01968967|2139595|P2|Overall Study|Withdrawal by Subject|61
663548|NCT01968967|2139596|P1|Overall Study|Withdrawal by Subject|71
663549|NCT01968967|2139595|P2|Overall Study|Unspecified|22
663550|NCT01968967|2139596|P1|Overall Study|Unspecified|22
663551|NCT01968954|2139657|P2|Overall Study|Did not met inclusion criteria|2
663552|NCT01968954|2139658|P1|Overall Study|Did not met inclusion criteria|0
663553|NCT01968954|2139657|P2|Overall Study|Protocol Violation|1
663554|NCT01968954|2139658|P1|Overall Study|Protocol Violation|0
663555|NCT01968954|2139657|P2|Overall Study|Unspecified|8
663556|NCT01968954|2139658|P1|Overall Study|Unspecified|7
663557|NCT01968954|2139657|P2|Overall Study|Withdrawal by Subject|23
663558|NCT01968954|2139658|P1|Overall Study|Withdrawal by Subject|20
663559|NCT01968954|2139657|P2|Overall Study|Lost to Follow-up|4
663560|NCT01968954|2139658|P1|Overall Study|Lost to Follow-up|6
663561|NCT01968954|2139657|P2|Overall Study|Death|2
663562|NCT01968954|2139658|P1|Overall Study|Death|1
663563|NCT01968954|2139657|P2|Overall Study|Adverse Event|3
663564|NCT01968954|2139658|P1|Overall Study|Adverse Event|6
663565|NCT01968811|2139722|P1|Overall Study|post op.ref. of subject to other hospita|1
663566|NCT01968811|2139722|P1|Overall Study|Protocol Violation|4
663567|NCT01968694|2139729|P2|Washout (1 Month)|Lost to Follow-up|1
663568|NCT01968694|2139730|P1|Washout (1 Month)|Lost to Follow-up|0
663569|NCT01968551|2139747|P3|Extension Phase|Lost to Follow-up|1
663570|NCT01968551|2139748|P2|Extension Phase|Lost to Follow-up|0
663571|NCT01968551|2139749|P1|Extension Phase|Lost to Follow-up|1
663572|NCT01968551|2139747|P3|Extension Phase|Withdrew Consent|1
663573|NCT01968551|2139748|P2|Extension Phase|Withdrew Consent|0
663574|NCT01968551|2139749|P1|Extension Phase|Withdrew Consent|0
663575|NCT01968551|2139747|P3|Extension Phase|Death|0
663576|NCT01968551|2139748|P2|Extension Phase|Death|1
663577|NCT01968551|2139749|P1|Extension Phase|Death|0
663578|NCT01968551|2139747|P3|Extension Phase|Adverse Event|2
663579|NCT01968551|2139748|P2|Extension Phase|Adverse Event|0
663580|NCT01968551|2139749|P1|Extension Phase|Adverse Event|0
663581|NCT01968551|2139747|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
663582|NCT01968551|2139748|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
663583|NCT01968551|2139749|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
663584|NCT01968551|2139747|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
663585|NCT01968551|2139748|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
663586|NCT01968551|2139749|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
663587|NCT01968551|2139747|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
663588|NCT01968551|2139748|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
663589|NCT01968551|2139749|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
663590|NCT01968551|2139747|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
663591|NCT01968551|2139748|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
663592|NCT01968551|2139749|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
663593|NCT01968434|2139765|P2|Overall Study|Lost to Follow-up|6
663594|NCT01968434|2139766|P1|Overall Study|Lost to Follow-up|3
663595|NCT01968226|2139776|P1|Overall Study|[F-18] RDG-K5 was not available|2
663596|NCT01967940|2139808|P3|Part 2|Still on Study|14
663597|NCT01967940|2139809|P2|Part 2|Still on Study|16
663598|NCT01967940|2139810|P1|Part 2|Still on Study|8
663599|NCT01967732|2139837|P4|First Intervention (Day 1)|Poor venous access|0
663600|NCT01967732|2139838|P3|First Intervention (Day 1)|Poor venous access|0
663601|NCT01967732|2139839|P2|First Intervention (Day 1)|Poor venous access|1
663602|NCT01967732|2139840|P1|First Intervention (Day 1)|Poor venous access|0
663603|NCT01967732|2139837|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
663604|NCT01967732|2139838|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
663605|NCT01967732|2139839|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
663606|NCT01967732|2139840|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
663607|NCT01967719|2139854|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
663608|NCT01967719|2139855|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
663609|NCT01967719|2139856|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
663610|NCT01967719|2139857|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
663611|NCT01967719|2139854|P4|First Intervention (Day 1)|Withdrawal by Subject|1
663612|NCT01967719|2139855|P3|First Intervention (Day 1)|Withdrawal by Subject|0
663613|NCT01967719|2139856|P2|First Intervention (Day 1)|Withdrawal by Subject|1
663614|NCT01967719|2139857|P1|First Intervention (Day 1)|Withdrawal by Subject|0
663615|NCT01967706|2139872|P4|First Intervention (Day 1)|Withdrawal by Subject|0
663616|NCT01967706|2139873|P3|First Intervention (Day 1)|Withdrawal by Subject|0
663617|NCT01967706|2139874|P2|First Intervention (Day 1)|Withdrawal by Subject|0
663618|NCT01967706|2139875|P1|First Intervention (Day 1)|Withdrawal by Subject|1
663619|NCT01967550|2139890|P2|Overall Study|Non Compliance|1
663620|NCT01967550|2139891|P1|Overall Study|Non Compliance|0
663621|NCT01967550|2139890|P2|Overall Study|Protocol Violation|1
663622|NCT01967550|2139891|P1|Overall Study|Protocol Violation|2
663623|NCT01967550|2139890|P2|Overall Study|Adverse Event|0
663624|NCT01967550|2139891|P1|Overall Study|Adverse Event|2
663625|NCT01967550|2139890|P2|Overall Study|Withdrawal by Subject|0
663626|NCT01967550|2139891|P1|Overall Study|Withdrawal by Subject|1
663627|NCT01967277|2139921|P2|Overall Study|Unrelated illness|1
663628|NCT01967277|2139922|P1|Overall Study|Unrelated illness|0
663629|NCT01967277|2139921|P2|Overall Study|Lost to Follow-up|2
663630|NCT01967277|2139922|P1|Overall Study|Lost to Follow-up|1
663631|NCT01967147|2139932|P2|Overall Study|Other|5
663632|NCT01967147|2139933|P1|Overall Study|Other|4
663633|NCT01967147|2139932|P2|Overall Study|Non-compliance with Study Drug|3
663634|NCT01967147|2139933|P1|Overall Study|Non-compliance with Study Drug|0
663635|NCT01967147|2139932|P2|Overall Study|Withdrawal by Subject|4
663636|NCT01967147|2139933|P1|Overall Study|Withdrawal by Subject|2
663637|NCT01967147|2139932|P2|Overall Study|Lost to Follow-up|2
663638|NCT01967147|2139933|P1|Overall Study|Lost to Follow-up|1
663639|NCT01967147|2139932|P2|Overall Study|Lack of Efficacy|4
663640|NCT01967147|2139933|P1|Overall Study|Lack of Efficacy|1
663641|NCT01967147|2139932|P2|Overall Study|Adverse Event|2
663642|NCT01967147|2139933|P1|Overall Study|Adverse Event|5
663643|NCT01967069|2139963|P2|Overall Study|Lack of Efficacy|1
663644|NCT01967069|2139964|P1|Overall Study|Lack of Efficacy|0
663645|NCT01967069|2139963|P2|Overall Study|Withdrawal by Subject|3
663646|NCT01967069|2139964|P1|Overall Study|Withdrawal by Subject|1
663647|NCT01967069|2139963|P2|Overall Study|Lost to Follow-up|2
663648|NCT01967069|2139964|P1|Overall Study|Lost to Follow-up|5
663649|NCT01967069|2139963|P2|Overall Study|Adverse Event|2
663650|NCT01967069|2139964|P1|Overall Study|Adverse Event|2
663651|NCT01966432|2140109|P3|Overall Study|SBIRT program ended|20
663652|NCT01966432|2140110|P2|Overall Study|SBIRT program ended|8
663653|NCT01966432|2140111|P1|Overall Study|SBIRT program ended|1
663654|NCT01966432|2140109|P3|Overall Study|Subject Incarcerated|1
663655|NCT01966432|2140110|P2|Overall Study|Subject Incarcerated|0
663656|NCT01966432|2140111|P1|Overall Study|Subject Incarcerated|0
663657|NCT01966432|2140109|P3|Overall Study|Withdrawal by Subject|0
663658|NCT01966432|2140110|P2|Overall Study|Withdrawal by Subject|3
663659|NCT01966432|2140111|P1|Overall Study|Withdrawal by Subject|1
663660|NCT01966432|2140109|P3|Overall Study|Lost to Follow-up|5
663661|NCT01966432|2140110|P2|Overall Study|Lost to Follow-up|2
663662|NCT01966432|2140111|P1|Overall Study|Lost to Follow-up|3
663663|NCT01966120|2140181|P2|Overall Study|Lost to Follow-up|1
663664|NCT01966120|2140182|P1|Overall Study|Lost to Follow-up|1
663665|NCT01966120|2140181|P2|Overall Study|Withdrawal by Subject|5
663666|NCT01966120|2140182|P1|Overall Study|Withdrawal by Subject|0
663667|NCT01966068|2140206|P1|Overall Study|Lost to Follow-up|81
663668|NCT01966068|2140206|P1|Overall Study|Withdrawal by Subject|57
663669|NCT01966042|2140211|P1|Overall Study|Death|2
663670|NCT01965938|2140220|P2|Overall Study|Withdrawal by Subject|0
663671|NCT01965938|2140221|P1|Overall Study|Withdrawal by Subject|1
663672|NCT01965834|2140252|P1|Overall Study|Lack of Efficacy|4
663673|NCT01965652|2140283|P2|Overall Study|Pregnancy|1
663674|NCT01965652|2140284|P1|Overall Study|Pregnancy|0
663675|NCT01965652|2140283|P2|Overall Study|Other - Miscellaneous|21
663676|NCT01965652|2140284|P1|Overall Study|Other - Miscellaneous|18
663677|NCT01965652|2140283|P2|Overall Study|Death|4
663678|NCT01965652|2140284|P1|Overall Study|Death|3
663679|NCT01965652|2140283|P2|Overall Study|Protocol Violation|38
663680|NCT01965652|2140284|P1|Overall Study|Protocol Violation|34
663681|NCT01965652|2140283|P2|Overall Study|Lost to Follow-up|40
663682|NCT01965652|2140284|P1|Overall Study|Lost to Follow-up|53
663683|NCT01965652|2140283|P2|Overall Study|Withdrawal by Subject|69
663684|NCT01965652|2140284|P1|Overall Study|Withdrawal by Subject|62
663685|NCT01965652|2140283|P2|Overall Study|Adverse Event|37
663686|NCT01965652|2140284|P1|Overall Study|Adverse Event|40
663687|NCT01965600|2140314|P4|Second Intervention|Study terminated by Sponsor|2
663688|NCT01965600|2140315|P3|Second Intervention|Study terminated by Sponsor|2
663689|NCT01965600|2140316|P2|Second Intervention|Study terminated by Sponsor|0
663690|NCT01965600|2140317|P1|Second Intervention|Study terminated by Sponsor|0
663691|NCT01965600|2140314|P4|Washout Period of Approximately 15 Days|Adverse Event|1
663692|NCT01965600|2140315|P3|Washout Period of Approximately 15 Days|Adverse Event|0
663693|NCT01965600|2140316|P2|Washout Period of Approximately 15 Days|Adverse Event|0
663694|NCT01965600|2140317|P1|Washout Period of Approximately 15 Days|Adverse Event|0
663695|NCT01965600|2140314|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
663696|NCT01965600|2140315|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
663697|NCT01965600|2140316|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
663698|NCT01965600|2140317|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
663699|NCT01965600|2140314|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
663700|NCT01965600|2140315|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
663701|NCT01965600|2140316|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
663702|NCT01965600|2140317|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
663703|NCT01965600|2140314|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
663704|NCT01965600|2140315|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
663705|NCT01965600|2140316|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
663706|NCT01965600|2140317|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
663707|NCT01965535|2140374|P2|Overall Study|Lack of Efficacy|1
663708|NCT01965535|2140375|P1|Overall Study|Lack of Efficacy|2
663709|NCT01965431|2140389|P6|Overall Study|Other than stated above|6
663710|NCT01965431|2140390|P5|Overall Study|Other than stated above|6
663711|NCT01965431|2140391|P4|Overall Study|Other than stated above|6
663712|NCT01965431|2140392|P3|Overall Study|Other than stated above|6
663713|NCT01965431|2140393|P2|Overall Study|Other than stated above|5
663714|NCT01965431|2140394|P1|Overall Study|Other than stated above|6
663715|NCT01965431|2140389|P6|Overall Study|Adverse Event|0
663716|NCT01965431|2140390|P5|Overall Study|Adverse Event|0
663717|NCT01965431|2140391|P4|Overall Study|Adverse Event|0
663718|NCT01965431|2140392|P3|Overall Study|Adverse Event|0
663719|NCT01965431|2140393|P2|Overall Study|Adverse Event|1
663720|NCT01965431|2140394|P1|Overall Study|Adverse Event|0
663721|NCT01965327|2140407|P1|Overall Study|Physician Decision|2
663722|NCT01965262|2140621|P2|Second Intervention (7 Days)|Poor visual acuity|0
663723|NCT01965262|2140622|P1|Second Intervention (7 Days)|Poor visual acuity|1
663724|NCT01965262|2140621|P2|Second Intervention (7 Days)|Poor lens fit|9
663725|NCT01965262|2140622|P1|Second Intervention (7 Days)|Poor lens fit|0
663726|NCT01965262|2140621|P2|Second Intervention (7 Days)|Discontinued|1
663727|NCT01965262|2140622|P1|Second Intervention (7 Days)|Discontinued|0
663728|NCT01965158|2140686|P2|Overall Study|Other - Miscellaneous|0
663729|NCT01965158|2140687|P1|Overall Study|Other - Miscellaneous|3
663730|NCT01965158|2140686|P2|Overall Study|Protocol Violation|1
663731|NCT01965158|2140687|P1|Overall Study|Protocol Violation|1
663732|NCT01965158|2140686|P2|Overall Study|Lost to Follow-up|5
663733|NCT01965158|2140687|P1|Overall Study|Lost to Follow-up|7
663734|NCT01965158|2140686|P2|Overall Study|Withdrawal by Subject|24
663735|NCT01965158|2140687|P1|Overall Study|Withdrawal by Subject|16
663736|NCT01965158|2140686|P2|Overall Study|Adverse Event|5
663737|NCT01965158|2140687|P1|Overall Study|Adverse Event|14
663738|NCT01964976|2140722|P1|Overall Study|Protocol Violation|31
663739|NCT01964950|2140736|P1|Overall Study|Protocol Violation|25
663740|NCT01964898|2140750|P2|Overall Study|Withdrawal by Subject|0
663741|NCT01964898|2140751|P1|Overall Study|Withdrawal by Subject|1
663742|NCT01964898|2140750|P2|Overall Study|Lost to Follow-up|5
663743|NCT01964898|2140751|P1|Overall Study|Lost to Follow-up|3
663744|NCT01964898|2140750|P2|Overall Study|did not receive the allocated interventi|1
663745|NCT01964898|2140751|P1|Overall Study|did not receive the allocated interventi|2
663746|NCT01964898|2140750|P2|Overall Study|ineligible post-randomization|1
663747|NCT01964898|2140751|P1|Overall Study|ineligible post-randomization|1
663748|NCT01964716|2140773|P2|Overall Study|Death|0
663749|NCT01964716|2140774|P1|Overall Study|Death|1
663750|NCT01964716|2140773|P2|Overall Study|No longer met eligibility criteria|1
663751|NCT01964716|2140774|P1|Overall Study|No longer met eligibility criteria|1
663752|NCT01964716|2140773|P2|Overall Study|Lost to Follow-up|2
663753|NCT01964716|2140774|P1|Overall Study|Lost to Follow-up|1
663754|NCT01964716|2140773|P2|Overall Study|Withdrawal by Subject|3
663755|NCT01964716|2140774|P1|Overall Study|Withdrawal by Subject|2
663756|NCT01964547|2140812|P2|Overall Study|Withdrawal by Investigator|1
663757|NCT01964547|2140813|P1|Overall Study|Withdrawal by Investigator|0
663758|NCT01964547|2140812|P2|Overall Study|Lost to Follow-up|1
663759|NCT01964547|2140813|P1|Overall Study|Lost to Follow-up|0
663760|NCT01964547|2140812|P2|Overall Study|Withdrawal by Subject|7
663761|NCT01964547|2140813|P1|Overall Study|Withdrawal by Subject|4
663762|NCT01964547|2140812|P2|Overall Study|Adverse Event|2
663763|NCT01964547|2140813|P1|Overall Study|Adverse Event|8
663764|NCT01964352|2140841|P4|Overall Study|Other than stated above|2
663765|NCT01964352|2140842|P3|Overall Study|Other than stated above|1
663766|NCT01964352|2140843|P2|Overall Study|Other than stated above|2
663767|NCT01964352|2140844|P1|Overall Study|Other than stated above|0
663768|NCT01964352|2140841|P4|Overall Study|Withdrawal by Subject|0
663769|NCT01964352|2140842|P3|Overall Study|Withdrawal by Subject|1
663770|NCT01964352|2140843|P2|Overall Study|Withdrawal by Subject|2
663771|NCT01964352|2140844|P1|Overall Study|Withdrawal by Subject|4
663772|NCT01964352|2140841|P4|Overall Study|Lost to Follow-up|1
663773|NCT01964352|2140842|P3|Overall Study|Lost to Follow-up|0
663774|NCT01964352|2140843|P2|Overall Study|Lost to Follow-up|0
663775|NCT01964352|2140844|P1|Overall Study|Lost to Follow-up|1
663776|NCT01964352|2140841|P4|Overall Study|Protocol Violation|2
663777|NCT01964352|2140842|P3|Overall Study|Protocol Violation|0
663778|NCT01964352|2140843|P2|Overall Study|Protocol Violation|4
663779|NCT01964352|2140844|P1|Overall Study|Protocol Violation|2
663780|NCT01964352|2140841|P4|Overall Study|Lack of Efficacy|0
663781|NCT01964352|2140842|P3|Overall Study|Lack of Efficacy|0
663782|NCT01964352|2140843|P2|Overall Study|Lack of Efficacy|0
663783|NCT01964352|2140844|P1|Overall Study|Lack of Efficacy|6
663784|NCT01964352|2140841|P4|Overall Study|Adverse Event|3
663785|NCT01964352|2140842|P3|Overall Study|Adverse Event|4
663786|NCT01964352|2140843|P2|Overall Study|Adverse Event|3
663787|NCT01964352|2140844|P1|Overall Study|Adverse Event|13
663788|NCT01964326|2140874|P1|Overall Study|Did not meet eligibility criteria|1
663789|NCT01964326|2140874|P1|Overall Study|Unspecified|9
663790|NCT01964326|2140874|P1|Overall Study|Investigator Discretion|1
663791|NCT01964326|2140874|P1|Overall Study|Physician Decision|55
663792|NCT01964326|2140874|P1|Overall Study|No Longer Meets Eligibility Criteria|1
663793|NCT01964326|2140874|P1|Overall Study|Pregnancy|1
663794|NCT01964326|2140874|P1|Overall Study|Withdrawal by Subject|87
663795|NCT01964326|2140874|P1|Overall Study|Lost to Follow-up|88
663796|NCT01964326|2140874|P1|Overall Study|Protocol Violation|4
663797|NCT01964326|2140874|P1|Overall Study|Death|2
663798|NCT01964326|2140874|P1|Overall Study|Adverse Event|48
663799|NCT01964222|2140883|P2|Overall Study|Screening Failure|0
663800|NCT01964222|2140884|P1|Overall Study|Screening Failure|2
663801|NCT01964222|2140883|P2|Overall Study|Withdrawal by Subject|6
663802|NCT01964222|2140884|P1|Overall Study|Withdrawal by Subject|6
663803|NCT01964222|2140883|P2|Overall Study|Lost to Follow-up|5
663804|NCT01964222|2140884|P1|Overall Study|Lost to Follow-up|7
663805|NCT01963767|2140917|P2|Overall Study|Adverse Event|0
663806|NCT01963767|2140918|P1|Overall Study|Adverse Event|2
663807|NCT01963767|2140917|P2|Overall Study|Withdrawal by Subject|2
663808|NCT01963767|2140918|P1|Overall Study|Withdrawal by Subject|4
663809|NCT01963676|2140928|P2|Overall Study|Withdrawal by Subject|0
663810|NCT01963676|2140929|P1|Overall Study|Withdrawal by Subject|1
663811|NCT01963611|2140942|P5|Overall Study|Unspecified|45
663812|NCT01963611|2140943|P4|Overall Study|Unspecified|45
663813|NCT01963611|2140944|P3|Overall Study|Unspecified|48
663814|NCT01963611|2140945|P2|Overall Study|Unspecified|46
663815|NCT01963611|2140946|P1|Overall Study|Unspecified|47
663816|NCT01963611|2140942|P5|Overall Study|Withdrawal by Subject|3
663817|NCT01963611|2140943|P4|Overall Study|Withdrawal by Subject|1
663818|NCT01963611|2140944|P3|Overall Study|Withdrawal by Subject|1
663819|NCT01963611|2140945|P2|Overall Study|Withdrawal by Subject|2
663820|NCT01963611|2140946|P1|Overall Study|Withdrawal by Subject|3
663821|NCT01963611|2140942|P5|Overall Study|Lack of Efficacy|0
663822|NCT01963611|2140943|P4|Overall Study|Lack of Efficacy|1
663823|NCT01963611|2140944|P3|Overall Study|Lack of Efficacy|0
663824|NCT01963611|2140945|P2|Overall Study|Lack of Efficacy|0
663825|NCT01963611|2140946|P1|Overall Study|Lack of Efficacy|0
663826|NCT01963611|2140942|P5|Overall Study|Protocol Violation|0
663827|NCT01963611|2140943|P4|Overall Study|Protocol Violation|1
663828|NCT01963611|2140944|P3|Overall Study|Protocol Violation|0
663829|NCT01963611|2140945|P2|Overall Study|Protocol Violation|0
663830|NCT01963611|2140946|P1|Overall Study|Protocol Violation|0
663831|NCT01963611|2140942|P5|Overall Study|Adverse Event|3
663832|NCT01963611|2140943|P4|Overall Study|Adverse Event|4
663833|NCT01963611|2140944|P3|Overall Study|Adverse Event|3
663834|NCT01963611|2140945|P2|Overall Study|Adverse Event|1
663835|NCT01963611|2140946|P1|Overall Study|Adverse Event|1
663836|NCT01963403|2141005|P2|Overall Study|Implant removal|1
663837|NCT01963403|2141006|P1|Overall Study|Implant removal|0
663838|NCT01963403|2141005|P2|Overall Study|Lost to Follow-up|3
663839|NCT01963403|2141006|P1|Overall Study|Lost to Follow-up|2
663840|NCT01963260|2141028|P10|Overall Study|Withdrawal by Subject|0
663841|NCT01963260|2141029|P9|Overall Study|Withdrawal by Subject|0
663842|NCT01963260|2141030|P8|Overall Study|Withdrawal by Subject|0
663843|NCT01963260|2141031|P7|Overall Study|Withdrawal by Subject|0
663844|NCT01963260|2141032|P6|Overall Study|Withdrawal by Subject|0
663845|NCT01963260|2141033|P5|Overall Study|Withdrawal by Subject|2
663846|NCT01963260|2141034|P4|Overall Study|Withdrawal by Subject|1
663847|NCT01963260|2141035|P3|Overall Study|Withdrawal by Subject|0
663848|NCT01963260|2141036|P2|Overall Study|Withdrawal by Subject|0
663849|NCT01963260|2141037|P1|Overall Study|Withdrawal by Subject|2
663850|NCT01962974|2141117|P1|Overall Study|Study termination|7
663851|NCT01962922|2141144|P2|Extendion Portion (up to Month 6)|Physician Decision|0
663852|NCT01962922|2141145|P1|Extendion Portion (up to Month 6)|Physician Decision|1
663853|NCT01962922|2141144|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
663854|NCT01962922|2141145|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
663855|NCT01962922|2141144|P2|PK Portion Day 7|non-compliance|0
663856|NCT01962922|2141145|P1|PK Portion Day 7|non-compliance|1
663857|NCT01962922|2141144|P2|PK Portion Day 7|Withdrawal by Subject|0
663858|NCT01962922|2141145|P1|PK Portion Day 7|Withdrawal by Subject|3
663859|NCT01962493|2141184|P2|Overall Study|Withdrawal by Subject|2
663860|NCT01962493|2141185|P1|Overall Study|Withdrawal by Subject|4
663861|NCT01962493|2141184|P2|Overall Study|Protocol Violation|1
663862|NCT01962493|2141185|P1|Overall Study|Protocol Violation|0
663863|NCT01962493|2141184|P2|Overall Study|Adverse Event|2
663864|NCT01962493|2141185|P1|Overall Study|Adverse Event|1
663865|NCT01962441|2141208|P3|Retreatment Substudy|Lost to Follow-up|0
663866|NCT01962441|2141209|P2|Retreatment Substudy|Lost to Follow-up|0
663867|NCT01962441|2141210|P1|Retreatment Substudy|Lost to Follow-up|1
663868|NCT01962441|2141208|P3|Retreatment Substudy|Lack of Efficacy|0
663869|NCT01962441|2141209|P2|Retreatment Substudy|Lack of Efficacy|0
663870|NCT01962441|2141210|P1|Retreatment Substudy|Lack of Efficacy|1
663871|NCT01962441|2141208|P3|Randomized Period|Protocol Violation|0
663872|NCT01962441|2141209|P2|Randomized Period|Protocol Violation|1
663873|NCT01962441|2141210|P1|Randomized Period|Protocol Violation|0
663874|NCT01962441|2141208|P3|Randomized Period|Death|2
663875|NCT01962441|2141209|P2|Randomized Period|Death|0
663876|NCT01962441|2141210|P1|Randomized Period|Death|0
663877|NCT01962441|2141208|P3|Randomized Period|Adverse Event|0
663878|NCT01962441|2141209|P2|Randomized Period|Adverse Event|1
663879|NCT01962441|2141210|P1|Randomized Period|Adverse Event|1
663880|NCT01962441|2141208|P3|Randomized Period|Withdrew Consent|2
663881|NCT01962441|2141209|P2|Randomized Period|Withdrew Consent|3
663882|NCT01962441|2141210|P1|Randomized Period|Withdrew Consent|3
663883|NCT01962441|2141208|P3|Randomized Period|Lost to Follow-up|4
663884|NCT01962441|2141209|P2|Randomized Period|Lost to Follow-up|4
663885|NCT01962441|2141210|P1|Randomized Period|Lost to Follow-up|2
663886|NCT01962441|2141208|P3|Randomized Period|Randomized but Never Treated|3
663887|NCT01962441|2141209|P2|Randomized Period|Randomized but Never Treated|2
663888|NCT01962441|2141210|P1|Randomized Period|Randomized but Never Treated|4
663889|NCT01961544|2141249|P1|Overall Study|Aggravation of Steral Pain|1
663890|NCT01961544|2141249|P1|Overall Study|Poor Tolerance|1
663891|NCT01961544|2141249|P1|Overall Study|Physician Decision|2
663892|NCT01961544|2141249|P1|Overall Study|Adverse Event|1
663893|NCT01961544|2141249|P1|Overall Study|Withdrawal by Subject|7
663894|NCT01961544|2141249|P1|Overall Study|Protocol Violation|1
663895|NCT01961349|2141257|P3|Overall Study|registration error, personal reason etc|1
663896|NCT01961349|2141258|P2|Overall Study|registration error, personal reason etc|2
663897|NCT01961349|2141259|P1|Overall Study|registration error, personal reason etc|2
663898|NCT01961349|2141257|P3|Overall Study|Adverse Event|1
663899|NCT01961349|2141258|P2|Overall Study|Adverse Event|0
663900|NCT01961349|2141259|P1|Overall Study|Adverse Event|0
663901|NCT01961349|2141257|P3|Overall Study|Withdrawal by Subject|0
663902|NCT01961349|2141258|P2|Overall Study|Withdrawal by Subject|4
663903|NCT01961349|2141259|P1|Overall Study|Withdrawal by Subject|1
663904|NCT01960907|2141281|P2|Overall Study|Withdrawal by Subject|42
663905|NCT01960907|2141282|P1|Overall Study|Withdrawal by Subject|32
663906|NCT01960907|2141281|P2|Overall Study|Death|3
663907|NCT01960907|2141282|P1|Overall Study|Death|4
663908|NCT01960842|2141292|P1|Overall Study|Withdrawal by Subject|2
663909|NCT01960842|2141292|P1|Overall Study|Adverse Event|1
663910|NCT01960816|2141315|P1|Overall Study|Lost to Follow-up|1
663911|NCT01960725|2141323|P2|Overall Study|unable to obtain blood sample|2
663912|NCT01960725|2141324|P1|Overall Study|unable to obtain blood sample|1
663913|NCT01960725|2141323|P2|Overall Study|Withdrawal by Subject|0
663914|NCT01960725|2141324|P1|Overall Study|Withdrawal by Subject|1
663915|NCT01960725|2141323|P2|Overall Study|Lost to Follow-up|3
663916|NCT01960725|2141324|P1|Overall Study|Lost to Follow-up|4
663917|NCT01960296|2141403|P2|Overall Study|Received different procedure|3
663918|NCT01960296|2141404|P1|Overall Study|Received different procedure|1
663919|NCT01960296|2141403|P2|Overall Study|Postponed surgery|0
663920|NCT01960296|2141404|P1|Overall Study|Postponed surgery|1
663921|NCT01960140|2141424|P1|Period 2 (Days 3-18)|Adverse Event|2
663922|NCT01960114|2141435|P2|Overall Study|Could not swallow study medication|1
663923|NCT01960114|2141436|P1|Overall Study|Could not swallow study medication|0
663924|NCT01960114|2141435|P2|Overall Study|Adverse Event|0
663925|NCT01960114|2141436|P1|Overall Study|Adverse Event|1
663926|NCT01959932|2141482|P3|Overall Study|Withdrawal by Subject|0
663927|NCT01959932|2141483|P2|Overall Study|Withdrawal by Subject|0
663928|NCT01959932|2141484|P1|Overall Study|Withdrawal by Subject|1
663929|NCT01959880|2141506|P4|Overall Study|Study completed early-FDA approved|152
663930|NCT01959880|2141507|P3|Overall Study|Study completed early-FDA approved|179
663931|NCT01959880|2141508|P2|Overall Study|Study completed early-FDA approved|311
663932|NCT01959880|2141509|P1|Overall Study|Study completed early-FDA approved|1003
663933|NCT01959880|2141506|P4|Overall Study|Explantation w/o study device reimplant.|12
663934|NCT01959880|2141507|P3|Overall Study|Explantation w/o study device reimplant.|5
663935|NCT01959880|2141508|P2|Overall Study|Explantation w/o study device reimplant.|17
663936|NCT01959880|2141509|P1|Overall Study|Explantation w/o study device reimplant.|22
663937|NCT01959880|2141506|P4|Overall Study|Lost to Follow-up|8
663938|NCT01959880|2141507|P3|Overall Study|Lost to Follow-up|15
663939|NCT01959880|2141508|P2|Overall Study|Lost to Follow-up|18
663940|NCT01959880|2141509|P1|Overall Study|Lost to Follow-up|95
663941|NCT01959880|2141506|P4|Overall Study|Death|2
663942|NCT01959880|2141507|P3|Overall Study|Death|1
663943|NCT01959880|2141508|P2|Overall Study|Death|10
663944|NCT01959880|2141509|P1|Overall Study|Death|1
663945|NCT01959880|2141506|P4|Overall Study|Withdrawal by Subject|7
663946|NCT01959880|2141507|P3|Overall Study|Withdrawal by Subject|8
663947|NCT01959880|2141508|P2|Overall Study|Withdrawal by Subject|13
663948|NCT01959880|2141509|P1|Overall Study|Withdrawal by Subject|11
663949|NCT01959607|2141538|P4|First Intervention (Day 1)|Withdrawal by Subject|0
663950|NCT01959607|2141539|P3|First Intervention (Day 1)|Withdrawal by Subject|0
663951|NCT01959607|2141540|P2|First Intervention (Day 1)|Withdrawal by Subject|1
663952|NCT01959607|2141541|P1|First Intervention (Day 1)|Withdrawal by Subject|1
663953|NCT01959581|2141554|P1|Overall Study|Lost to Follow-up|5
663954|NCT01959516|2141558|P2|Epoch 2|Moderate or severe COPD exacerbation|1
663955|NCT01959516|2141559|P1|Epoch 2|Moderate or severe COPD exacerbation|0
663956|NCT01959516|2141558|P2|Epoch 2|Subject withdrew consent|0
663957|NCT01959516|2141559|P1|Epoch 2|Subject withdrew consent|1
663958|NCT01959516|2141558|P2|Epoch 2|unsatisfactory therapeutic effect|0
663959|NCT01959516|2141559|P1|Epoch 2|unsatisfactory therapeutic effect|1
663960|NCT01959516|2141558|P2|Epoch 1|Protocol deviation|1
663961|NCT01959516|2141559|P1|Epoch 1|Protocol deviation|0
663962|NCT01959516|2141558|P2|Epoch 1|Moderate or severe COPD exacerbation|1
663963|NCT01959516|2141559|P1|Epoch 1|Moderate or severe COPD exacerbation|0
663964|NCT01959516|2141558|P2|Epoch 1|Use of prohibited treatment|0
663965|NCT01959516|2141559|P1|Epoch 1|Use of prohibited treatment|1
663966|NCT01959516|2141558|P2|Epoch 1|Administrative problems|0
663967|NCT01959516|2141559|P1|Epoch 1|Administrative problems|1
663968|NCT01959516|2141558|P2|Epoch 1|Subject withdrew consent|2
663969|NCT01959516|2141559|P1|Epoch 1|Subject withdrew consent|3
663970|NCT01959516|2141558|P2|Epoch 1|unsatisfactory therapeutic effect|0
663971|NCT01959516|2141559|P1|Epoch 1|unsatisfactory therapeutic effect|1
663972|NCT01959516|2141558|P2|Epoch 1|Adverse Event|1
663973|NCT01959516|2141559|P1|Epoch 1|Adverse Event|4
663974|NCT01959503|2141569|P2|Overall Study|Randomized but not treated|1
663975|NCT01959503|2141570|P1|Overall Study|Randomized but not treated|1
663976|NCT01959503|2141569|P2|Overall Study|Death|1
663977|NCT01959503|2141570|P1|Overall Study|Death|2
663978|NCT01959412|2141590|P6|Overall Study|Adverse Event|0
663979|NCT01959412|2141591|P5|Overall Study|Adverse Event|0
663980|NCT01959412|2141592|P4|Overall Study|Adverse Event|1
663981|NCT01959412|2141593|P3|Overall Study|Adverse Event|0
663982|NCT01959412|2141594|P2|Overall Study|Adverse Event|0
663983|NCT01959412|2141595|P1|Overall Study|Adverse Event|0
663984|NCT01959412|2141590|P6|Overall Study|Protocol deviation|0
663985|NCT01959412|2141591|P5|Overall Study|Protocol deviation|3
663986|NCT01959412|2141592|P4|Overall Study|Protocol deviation|1
663987|NCT01959412|2141593|P3|Overall Study|Protocol deviation|0
663988|NCT01959412|2141594|P2|Overall Study|Protocol deviation|1
663989|NCT01959412|2141595|P1|Overall Study|Protocol deviation|1
663990|NCT01959035|2141633|P1|Overall Study|Other (no primary reason given)|1
663991|NCT01959035|2141633|P1|Overall Study|Lost to Follow-up|1
663992|NCT01959035|2141633|P1|Overall Study|Withdrawal by Subject|4
663993|NCT01959035|2141633|P1|Overall Study|Adverse Event|5
663994|NCT01958827|2141659|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
663995|NCT01958827|2141659|P1|Overall Study|Lack of Efficacy|6
663996|NCT01958827|2141659|P1|Overall Study|Adverse Event|3
663997|NCT01958671|2141690|P3|Overall Study|Withdrawal by Subject|13
663998|NCT01958671|2141691|P2|Overall Study|Withdrawal by Subject|10
663999|NCT01958671|2141692|P1|Overall Study|Withdrawal by Subject|8
664000|NCT01958671|2141690|P3|Overall Study|Participant moved|1
664001|NCT01958671|2141691|P2|Overall Study|Participant moved|0
664002|NCT01958671|2141692|P1|Overall Study|Participant moved|0
664003|NCT01958671|2141690|P3|Overall Study|Study site terminated by sponsor|1
664004|NCT01958671|2141691|P2|Overall Study|Study site terminated by sponsor|0
664005|NCT01958671|2141692|P1|Overall Study|Study site terminated by sponsor|1
664006|NCT01958671|2141690|P3|Overall Study|Protocol Violation|0
664007|NCT01958671|2141691|P2|Overall Study|Protocol Violation|1
664008|NCT01958671|2141692|P1|Overall Study|Protocol Violation|0
664009|NCT01958671|2141690|P3|Overall Study|Pregnancy|1
664010|NCT01958671|2141691|P2|Overall Study|Pregnancy|0
664011|NCT01958671|2141692|P1|Overall Study|Pregnancy|0
664012|NCT01958671|2141690|P3|Overall Study|Non-compliance with study drug|1
664013|NCT01958671|2141691|P2|Overall Study|Non-compliance with study drug|1
664014|NCT01958671|2141692|P1|Overall Study|Non-compliance with study drug|1
664015|NCT01958671|2141690|P3|Overall Study|Lost to Follow-up|7
664016|NCT01958671|2141691|P2|Overall Study|Lost to Follow-up|11
664017|NCT01958671|2141692|P1|Overall Study|Lost to Follow-up|7
664018|NCT01958671|2141690|P3|Overall Study|Hyperglycemia|2
664019|NCT01958671|2141691|P2|Overall Study|Hyperglycemia|0
664020|NCT01958671|2141692|P1|Overall Study|Hyperglycemia|0
664021|NCT01958671|2141690|P3|Overall Study|Excluded medication|1
664022|NCT01958671|2141691|P2|Overall Study|Excluded medication|0
664023|NCT01958671|2141692|P1|Overall Study|Excluded medication|0
664024|NCT01958671|2141690|P3|Overall Study|Death|0
664025|NCT01958671|2141691|P2|Overall Study|Death|0
664026|NCT01958671|2141692|P1|Overall Study|Death|1
664027|NCT01958671|2141690|P3|Overall Study|Adverse Event|5
664028|NCT01958671|2141691|P2|Overall Study|Adverse Event|1
664029|NCT01958671|2141692|P1|Overall Study|Adverse Event|1
664030|NCT01958619|2141766|P4|Overall Study|Protocol Violation|0
664031|NCT01958619|2141767|P3|Overall Study|Protocol Violation|1
664032|NCT01958619|2141768|P2|Overall Study|Protocol Violation|0
664033|NCT01958619|2141769|P1|Overall Study|Protocol Violation|2
664034|NCT01958164|2141843|P2|Overall Study|Lost to Follow-up|3
664035|NCT01958164|2141844|P1|Overall Study|Lost to Follow-up|2
664036|NCT01958164|2141843|P2|Overall Study|Adverse Event|2
664037|NCT01958164|2141844|P1|Overall Study|Adverse Event|0
664038|NCT01958060|2141863|P6|Overall Study|Not treated|0
664039|NCT01958060|2141864|P5|Overall Study|Not treated|1
664040|NCT01958060|2141865|P4|Overall Study|Not treated|0
664041|NCT01958060|2141866|P3|Overall Study|Not treated|0
664042|NCT01958060|2141867|P2|Overall Study|Not treated|0
664043|NCT01958060|2141868|P1|Overall Study|Not treated|2
664044|NCT01958021|2141893|P2|Overall Study|Death|0
664045|NCT01958021|2141894|P1|Overall Study|Death|2
664046|NCT01958021|2141893|P2|Overall Study|Protocol Violation|1
664047|NCT01958021|2141894|P1|Overall Study|Protocol Violation|3
664048|NCT01958021|2141893|P2|Overall Study|Physician Decision|13
664049|NCT01958021|2141894|P1|Overall Study|Physician Decision|10
664050|NCT01958021|2141893|P2|Overall Study|Subject/guardian decision|13
664051|NCT01958021|2141894|P1|Overall Study|Subject/guardian decision|12
664052|NCT01958021|2141893|P2|Overall Study|Adverse Event|7
664053|NCT01958021|2141894|P1|Overall Study|Adverse Event|25
664054|NCT01958021|2141893|P2|Overall Study|Progressive disease|146
664055|NCT01958021|2141894|P1|Overall Study|Progressive disease|87
664056|NCT01958008|2141906|P4|Overall Study|Other adverse event|0
664057|NCT01958008|2141907|P3|Overall Study|Other adverse event|0
664058|NCT01958008|2141908|P2|Overall Study|Other adverse event|0
664059|NCT01958008|2141909|P1|Overall Study|Other adverse event|1
664060|NCT01958008|2141906|P4|Overall Study|Worsening of disease under study|0
664061|NCT01958008|2141907|P3|Overall Study|Worsening of disease under study|1
664062|NCT01958008|2141908|P2|Overall Study|Worsening of disease under study|0
664063|NCT01958008|2141909|P1|Overall Study|Worsening of disease under study|0
664064|NCT01957865|2141949|P3|Overall Study|Lost to Follow-up|2
664065|NCT01957865|2141950|P2|Overall Study|Lost to Follow-up|2
664066|NCT01957865|2141951|P1|Overall Study|Lost to Follow-up|0
664067|NCT01957865|2141949|P3|Overall Study|Found HIV negative|1
664068|NCT01957865|2141950|P2|Overall Study|Found HIV negative|0
664069|NCT01957865|2141951|P1|Overall Study|Found HIV negative|0
664070|NCT01957579|2141984|P4|Overall Study|Death|0
664071|NCT01957579|2141985|P3|Overall Study|Death|2
664072|NCT01957579|2141986|P2|Overall Study|Death|0
664073|NCT01957579|2141987|P1|Overall Study|Death|0
664074|NCT01957579|2141984|P4|Overall Study|Withdrawal of concent|0
664075|NCT01957579|2141985|P3|Overall Study|Withdrawal of concent|0
664076|NCT01957579|2141986|P2|Overall Study|Withdrawal of concent|1
664077|NCT01957579|2141987|P1|Overall Study|Withdrawal of concent|0
664078|NCT01957553|2142054|P2|Test Period 2 (21 +- 1 Days)|Other|0
664079|NCT01957553|2142055|P1|Test Period 2 (21 +- 1 Days)|Other|1
664080|NCT01957553|2142054|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
664166|NCT01957488|2142065|P2|Test Period 1|Protocol Violation|2
664081|NCT01957553|2142055|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
664082|NCT01957553|2142054|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
664083|NCT01957553|2142055|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
664084|NCT01957553|2142054|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
664085|NCT01957553|2142055|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
664086|NCT01957553|2142054|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
664087|NCT01957553|2142055|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
664088|NCT01957553|2142054|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
664089|NCT01957553|2142055|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
664090|NCT01957553|2142054|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
664091|NCT01957553|2142055|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
664092|NCT01957553|2142054|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
664093|NCT01957553|2142055|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
664094|NCT01957553|2142054|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
664095|NCT01957553|2142055|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
664096|NCT01957488|2142061|P6|Test Period 3|Lack of Efficacy|0
664097|NCT01957488|2142062|P5|Test Period 3|Lack of Efficacy|0
664098|NCT01957488|2142063|P4|Test Period 3|Lack of Efficacy|0
664099|NCT01957488|2142064|P3|Test Period 3|Lack of Efficacy|0
664100|NCT01957488|2142065|P2|Test Period 3|Lack of Efficacy|1
664101|NCT01957488|2142066|P1|Test Period 3|Lack of Efficacy|0
664102|NCT01957488|2142061|P6|Test Period 3|Withdrawal by Subject|0
664103|NCT01957488|2142062|P5|Test Period 3|Withdrawal by Subject|0
664104|NCT01957488|2142063|P4|Test Period 3|Withdrawal by Subject|0
664105|NCT01957488|2142064|P3|Test Period 3|Withdrawal by Subject|0
664106|NCT01957488|2142065|P2|Test Period 3|Withdrawal by Subject|0
664107|NCT01957488|2142066|P1|Test Period 3|Withdrawal by Subject|1
664108|NCT01957488|2142061|P6|Test Period 2|Discontinue due to personal problems|1
664109|NCT01957488|2142062|P5|Test Period 2|Discontinue due to personal problems|0
664110|NCT01957488|2142063|P4|Test Period 2|Discontinue due to personal problems|0
664111|NCT01957488|2142064|P3|Test Period 2|Discontinue due to personal problems|0
664112|NCT01957488|2142065|P2|Test Period 2|Discontinue due to personal problems|0
664113|NCT01957488|2142066|P1|Test Period 2|Discontinue due to personal problems|0
664114|NCT01957488|2142061|P6|Test Period 2|Adverse Event|0
664115|NCT01957488|2142062|P5|Test Period 2|Adverse Event|2
664116|NCT01957488|2142063|P4|Test Period 2|Adverse Event|0
664117|NCT01957488|2142064|P3|Test Period 2|Adverse Event|0
664118|NCT01957488|2142065|P2|Test Period 2|Adverse Event|0
664119|NCT01957488|2142066|P1|Test Period 2|Adverse Event|0
664120|NCT01957488|2142061|P6|Test Period 2|Withdrawal by Subject|0
664121|NCT01957488|2142062|P5|Test Period 2|Withdrawal by Subject|0
664122|NCT01957488|2142063|P4|Test Period 2|Withdrawal by Subject|0
664123|NCT01957488|2142064|P3|Test Period 2|Withdrawal by Subject|0
664124|NCT01957488|2142065|P2|Test Period 2|Withdrawal by Subject|1
664125|NCT01957488|2142066|P1|Test Period 2|Withdrawal by Subject|0
664126|NCT01957488|2142061|P6|Test Period 2|not known|0
664127|NCT01957488|2142062|P5|Test Period 2|not known|0
664128|NCT01957488|2142063|P4|Test Period 2|not known|0
664129|NCT01957488|2142064|P3|Test Period 2|not known|0
664130|NCT01957488|2142065|P2|Test Period 2|not known|0
664131|NCT01957488|2142066|P1|Test Period 2|not known|1
664132|NCT01957488|2142061|P6|Test Period 2|Protocol Violation|0
664133|NCT01957488|2142062|P5|Test Period 2|Protocol Violation|0
664134|NCT01957488|2142063|P4|Test Period 2|Protocol Violation|1
664135|NCT01957488|2142064|P3|Test Period 2|Protocol Violation|1
664136|NCT01957488|2142065|P2|Test Period 2|Protocol Violation|0
664137|NCT01957488|2142066|P1|Test Period 2|Protocol Violation|2
664138|NCT01957488|2142061|P6|Test Period 1|screen failure|1
664139|NCT01957488|2142062|P5|Test Period 1|screen failure|0
664140|NCT01957488|2142063|P4|Test Period 1|screen failure|0
664141|NCT01957488|2142064|P3|Test Period 1|screen failure|0
664142|NCT01957488|2142065|P2|Test Period 1|screen failure|0
664143|NCT01957488|2142066|P1|Test Period 1|screen failure|0
664144|NCT01957488|2142061|P6|Test Period 1|subject did not want to wait for cut bag|0
664145|NCT01957488|2142062|P5|Test Period 1|subject did not want to wait for cut bag|1
664146|NCT01957488|2142063|P4|Test Period 1|subject did not want to wait for cut bag|0
664147|NCT01957488|2142064|P3|Test Period 1|subject did not want to wait for cut bag|0
664148|NCT01957488|2142065|P2|Test Period 1|subject did not want to wait for cut bag|0
664149|NCT01957488|2142066|P1|Test Period 1|subject did not want to wait for cut bag|0
664150|NCT01957488|2142061|P6|Test Period 1|Withdrawal by Subject|2
664151|NCT01957488|2142062|P5|Test Period 1|Withdrawal by Subject|1
664152|NCT01957488|2142063|P4|Test Period 1|Withdrawal by Subject|1
664153|NCT01957488|2142064|P3|Test Period 1|Withdrawal by Subject|0
664154|NCT01957488|2142065|P2|Test Period 1|Withdrawal by Subject|0
664155|NCT01957488|2142066|P1|Test Period 1|Withdrawal by Subject|0
664156|NCT01957488|2142061|P6|Test Period 1|Adverse Event|0
664157|NCT01957488|2142062|P5|Test Period 1|Adverse Event|1
664158|NCT01957488|2142063|P4|Test Period 1|Adverse Event|0
664159|NCT01957488|2142064|P3|Test Period 1|Adverse Event|1
664160|NCT01957488|2142065|P2|Test Period 1|Adverse Event|1
664161|NCT01957488|2142066|P1|Test Period 1|Adverse Event|0
664162|NCT01957488|2142061|P6|Test Period 1|Protocol Violation|3
664163|NCT01957488|2142062|P5|Test Period 1|Protocol Violation|0
664164|NCT01957488|2142063|P4|Test Period 1|Protocol Violation|1
664165|NCT01957488|2142064|P3|Test Period 1|Protocol Violation|2
664167|NCT01957488|2142066|P1|Test Period 1|Protocol Violation|1
664168|NCT01957488|2142061|P6|Test Period 1|Lost to Follow-up|0
664169|NCT01957488|2142062|P5|Test Period 1|Lost to Follow-up|0
664170|NCT01957488|2142063|P4|Test Period 1|Lost to Follow-up|1
664171|NCT01957488|2142064|P3|Test Period 1|Lost to Follow-up|1
664172|NCT01957488|2142065|P2|Test Period 1|Lost to Follow-up|0
664173|NCT01957488|2142066|P1|Test Period 1|Lost to Follow-up|2
664174|NCT01957475|2142074|P2|Test Period 2|Adverse Event|0
664175|NCT01957475|2142075|P1|Test Period 2|Adverse Event|1
664176|NCT01957475|2142074|P2|Test Period 1|Lack of Efficacy|1
664177|NCT01957475|2142075|P1|Test Period 1|Lack of Efficacy|0
664178|NCT01957475|2142074|P2|Test Period 1|Other|0
664179|NCT01957475|2142075|P1|Test Period 1|Other|1
664180|NCT01957475|2142074|P2|Test Period 1|Withdrawal by Subject|0
664181|NCT01957475|2142075|P1|Test Period 1|Withdrawal by Subject|1
664182|NCT01957462|2142081|P2|Test Period 1|Adverse Event|0
664183|NCT01957462|2142082|P1|Test Period 1|Adverse Event|1
664184|NCT01957462|2142081|P2|Test Period 1|Withdrawal by Subject|0
664185|NCT01957462|2142082|P1|Test Period 1|Withdrawal by Subject|1
664186|NCT01957397|2142093|P2|Test Period 3|the adhesive did not work|0
664187|NCT01957397|2142094|P1|Test Period 3|the adhesive did not work|1
664188|NCT01957397|2142093|P2|Test Period 3|Adverse Event|2
664189|NCT01957397|2142094|P1|Test Period 3|Adverse Event|1
664190|NCT01957397|2142093|P2|Test Period 2|Adverse Event|1
664191|NCT01957397|2142094|P1|Test Period 2|Adverse Event|0
664192|NCT01957397|2142093|P2|Test Period 1|Withdrawal by Subject|0
664193|NCT01957397|2142094|P1|Test Period 1|Withdrawal by Subject|1
664194|NCT01957397|2142093|P2|Test Period 1|sudden leakage/small bag|1
664195|NCT01957397|2142094|P1|Test Period 1|sudden leakage/small bag|1
664196|NCT01957215|2142119|P2|Overall Study|Withdrawal by Subject|5
664197|NCT01957215|2142120|P1|Overall Study|Withdrawal by Subject|7
664198|NCT01957215|2142119|P2|Overall Study|Protocol Violation|2
664199|NCT01957215|2142120|P1|Overall Study|Protocol Violation|1
664200|NCT01957215|2142119|P2|Overall Study|Lost to Follow-up|3
664201|NCT01957215|2142120|P1|Overall Study|Lost to Follow-up|3
664202|NCT01957215|2142119|P2|Overall Study|Adverse Event|2
664203|NCT01957215|2142120|P1|Overall Study|Adverse Event|2
664204|NCT01957202|2142148|P18|Treatment Period 3 (8 Days)|Adverse Event|0
664205|NCT01957202|2142149|P17|Treatment Period 3 (8 Days)|Adverse Event|1
664206|NCT01957202|2142150|P16|Treatment Period 3 (8 Days)|Adverse Event|0
664207|NCT01957202|2142151|P15|Treatment Period 3 (8 Days)|Adverse Event|0
664208|NCT01957202|2142152|P14|Treatment Period 3 (8 Days)|Adverse Event|0
664209|NCT01957202|2142153|P13|Treatment Period 3 (8 Days)|Adverse Event|0
664210|NCT01957202|2142154|P12|Treatment Period 3 (8 Days)|Adverse Event|0
664211|NCT01957202|2142155|P11|Treatment Period 3 (8 Days)|Adverse Event|0
664212|NCT01957202|2142156|P10|Treatment Period 3 (8 Days)|Adverse Event|0
664213|NCT01957202|2142157|P9|Treatment Period 3 (8 Days)|Adverse Event|0
664214|NCT01957202|2142158|P8|Treatment Period 3 (8 Days)|Adverse Event|0
664215|NCT01957202|2142159|P7|Treatment Period 3 (8 Days)|Adverse Event|0
664216|NCT01957202|2142160|P6|Treatment Period 3 (8 Days)|Adverse Event|0
664217|NCT01957202|2142161|P5|Treatment Period 3 (8 Days)|Adverse Event|0
664218|NCT01957202|2142162|P4|Treatment Period 3 (8 Days)|Adverse Event|0
664219|NCT01957202|2142163|P3|Treatment Period 3 (8 Days)|Adverse Event|0
664220|NCT01957202|2142164|P2|Treatment Period 3 (8 Days)|Adverse Event|0
664221|NCT01957202|2142165|P1|Treatment Period 3 (8 Days)|Adverse Event|0
664222|NCT01957202|2142148|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664223|NCT01957202|2142149|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
664224|NCT01957202|2142150|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664225|NCT01957202|2142151|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664226|NCT01957202|2142152|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664227|NCT01957202|2142153|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664228|NCT01957202|2142154|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664229|NCT01957202|2142155|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664230|NCT01957202|2142156|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664231|NCT01957202|2142157|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664232|NCT01957202|2142158|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664233|NCT01957202|2142159|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664234|NCT01957202|2142160|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664235|NCT01957202|2142161|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664236|NCT01957202|2142162|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664237|NCT01957202|2142163|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664238|NCT01957202|2142164|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
664239|NCT01957202|2142165|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
664260|NCT01957111|2142233|P2|Overall Study|Withdrawal by Subject|1
664261|NCT01957111|2142234|P1|Overall Study|Withdrawal by Subject|1
664262|NCT01956240|2142244|P2|Overall Study|Adverse Event|4
664263|NCT01956240|2142245|P1|Overall Study|Adverse Event|17
664264|NCT01956240|2142244|P2|Overall Study|Lost to Follow-up|20
664265|NCT01956240|2142245|P1|Overall Study|Lost to Follow-up|6
664266|NCT01955707|2142395|P2|Overall Study|Not Specified|2
664267|NCT01955707|2142396|P1|Overall Study|Not Specified|4
664268|NCT01955707|2142395|P2|Overall Study|Death|14
664269|NCT01955707|2142396|P1|Overall Study|Death|13
664270|NCT01955707|2142395|P2|Overall Study|Withdrawal by Subject|3
664271|NCT01955707|2142396|P1|Overall Study|Withdrawal by Subject|0
664272|NCT01955707|2142395|P2|Overall Study|Lost to Follow-up|1
664273|NCT01955707|2142396|P1|Overall Study|Lost to Follow-up|2
664274|NCT01955707|2142395|P2|Overall Study|Adverse Event|2
664275|NCT01955707|2142396|P1|Overall Study|Adverse Event|1
664276|NCT01955161|2142645|P3|Overall Study|Other reason: patient's will|1
664277|NCT01955161|2142646|P2|Overall Study|Other reason: patient's will|0
664278|NCT01955161|2142647|P1|Overall Study|Other reason: patient's will|0
664279|NCT01955161|2142645|P3|Overall Study|Other reason: primary biliary cirrhosis|0
664280|NCT01955161|2142646|P2|Overall Study|Other reason: primary biliary cirrhosis|0
664281|NCT01955161|2142647|P1|Overall Study|Other reason: primary biliary cirrhosis|1
664282|NCT01955161|2142645|P3|Overall Study|Other reason: insufficient compliance|1
664283|NCT01955161|2142646|P2|Overall Study|Other reason: insufficient compliance|0
664284|NCT01955161|2142647|P1|Overall Study|Other reason: insufficient compliance|0
664285|NCT01955161|2142645|P3|Overall Study|Other reason: moved to nursing home|0
664286|NCT01955161|2142646|P2|Overall Study|Other reason: moved to nursing home|1
664287|NCT01955161|2142647|P1|Overall Study|Other reason: moved to nursing home|0
664288|NCT01955161|2142645|P3|Overall Study|Other reason: caregiver unavailable|0
664289|NCT01955161|2142646|P2|Overall Study|Other reason: caregiver unavailable|0
664290|NCT01955161|2142647|P1|Overall Study|Other reason: caregiver unavailable|1
664291|NCT01955161|2142645|P3|Overall Study|Other reason: disallowed medication|1
664292|NCT01955161|2142646|P2|Overall Study|Other reason: disallowed medication|0
664293|NCT01955161|2142647|P1|Overall Study|Other reason: disallowed medication|1
664294|NCT01955161|2142645|P3|Overall Study|Other reason: physician decision|1
664295|NCT01955161|2142646|P2|Overall Study|Other reason: physician decision|1
664296|NCT01955161|2142647|P1|Overall Study|Other reason: physician decision|0
664297|NCT01955161|2142645|P3|Overall Study|Protocol Violation|0
664298|NCT01955161|2142646|P2|Overall Study|Protocol Violation|0
664299|NCT01955161|2142647|P1|Overall Study|Protocol Violation|2
664300|NCT01955161|2142645|P3|Overall Study|Withdrawal by Subject|12
664301|NCT01955161|2142646|P2|Overall Study|Withdrawal by Subject|8
664302|NCT01955161|2142647|P1|Overall Study|Withdrawal by Subject|9
664303|NCT01955161|2142645|P3|Overall Study|Death|3
664304|NCT01955161|2142646|P2|Overall Study|Death|1
664305|NCT01955161|2142647|P1|Overall Study|Death|1
664306|NCT01955161|2142645|P3|Overall Study|Adverse Event|15
664307|NCT01955161|2142646|P2|Overall Study|Adverse Event|14
664308|NCT01955161|2142647|P1|Overall Study|Adverse Event|10
664309|NCT01955161|2142645|P3|Overall Study|Withdrawal before treatment|1
664310|NCT01955161|2142646|P2|Overall Study|Withdrawal before treatment|0
664311|NCT01955161|2142647|P1|Overall Study|Withdrawal before treatment|2
664312|NCT01955122|2142687|P2|Overall Study|Physician Decision|5
664313|NCT01955122|2142688|P1|Overall Study|Physician Decision|5
664314|NCT01955083|2142708|P2|Overall Study|Lost to Follow-up|1
664315|NCT01955083|2142709|P1|Overall Study|Lost to Follow-up|1
664316|NCT01955044|2142742|P3|Overall Study|Death|0
664317|NCT01955044|2142743|P2|Overall Study|Death|1
664318|NCT01955044|2142744|P1|Overall Study|Death|1
664319|NCT01955005|2142757|P2|Overall Study|Withdrawal by Subject|5
664320|NCT01955005|2142758|P1|Overall Study|Withdrawal by Subject|3
664321|NCT01954771|2142771|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
664322|NCT01954771|2142772|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
664323|NCT01954771|2142773|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
664324|NCT01954771|2142771|P3|Overall Study|Missing CGMS of end-point|0
664325|NCT01954771|2142772|P2|Overall Study|Missing CGMS of end-point|1
664326|NCT01954771|2142773|P1|Overall Study|Missing CGMS of end-point|1
664327|NCT01954771|2142771|P3|Overall Study|Missing HbA1c of end-point|0
664328|NCT01954771|2142772|P2|Overall Study|Missing HbA1c of end-point|1
664329|NCT01954771|2142773|P1|Overall Study|Missing HbA1c of end-point|1
664330|NCT01954745|2142790|P1|Overall Study|Death|1
664331|NCT01954745|2142790|P1|Overall Study|Adverse Event|2
664332|NCT01954745|2142790|P1|Overall Study|Clinical Progression|5
664333|NCT01954745|2142790|P1|Overall Study|Radiological Progression|11
888430|NCT01945489|2822099|P1|Cycle 1|Protocol Violation|0
888431|NCT01945489|2822098|P2|Cycle 1|Personal Reasons|2
888432|NCT01945489|2822099|P1|Cycle 1|Personal Reasons|4
888433|NCT01945489|2822098|P2|Cycle 1|Lost to Follow-up|0
888434|NCT01945489|2822099|P1|Cycle 1|Lost to Follow-up|4
888435|NCT01945489|2822098|P2|Cycle 1|Adverse Event|0
664340|NCT01954121|2142919|P2|Overall Study|Subject did not follow instructions|2
664341|NCT01954121|2142920|P1|Overall Study|Subject did not follow instructions|0
664342|NCT01954121|2142919|P2|Overall Study|Non-compliant patient|1
664343|NCT01954121|2142920|P1|Overall Study|Non-compliant patient|1
664344|NCT01954121|2142919|P2|Overall Study|Non-compliant with study procedures|0
664345|NCT01954121|2142920|P1|Overall Study|Non-compliant with study procedures|1
664346|NCT01954121|2142919|P2|Overall Study|SAE, non-fatal|4
664347|NCT01954121|2142920|P1|Overall Study|SAE, non-fatal|1
664348|NCT01954121|2142919|P2|Overall Study|AE, non-serious non-fatal|22
664349|NCT01954121|2142920|P1|Overall Study|AE, non-serious non-fatal|5
664350|NCT01954121|2142919|P2|Overall Study|AE, serious fatal|0
664351|NCT01954121|2142920|P1|Overall Study|AE, serious fatal|1
664352|NCT01954121|2142919|P2|Overall Study|Pregnancy|1
664353|NCT01954121|2142920|P1|Overall Study|Pregnancy|1
664354|NCT01954121|2142919|P2|Overall Study|Withdrawal by Subject|12
664355|NCT01954121|2142920|P1|Overall Study|Withdrawal by Subject|18
664356|NCT01954121|2142919|P2|Overall Study|Lost to Follow-up|6
664357|NCT01954121|2142920|P1|Overall Study|Lost to Follow-up|5
664358|NCT01954121|2142919|P2|Overall Study|Protocol Violation|2
664359|NCT01954121|2142920|P1|Overall Study|Protocol Violation|0
664360|NCT01954121|2142919|P2|Overall Study|Lack of Efficacy|41
664361|NCT01954121|2142920|P1|Overall Study|Lack of Efficacy|94
664362|NCT01953354|2142936|P2|Overall Study|Disease Exacerbation|0
664363|NCT01953354|2142937|P1|Overall Study|Disease Exacerbation|1
664364|NCT01953354|2142936|P2|Overall Study|Decision of Sponsor|1
664365|NCT01953354|2142937|P1|Overall Study|Decision of Sponsor|0
664366|NCT01953354|2142936|P2|Overall Study|Withdrawal by Subject|1
664367|NCT01953354|2142937|P1|Overall Study|Withdrawal by Subject|0
664368|NCT01953328|2142965|P8|Overall Study|Lost to Follow-up|0
664369|NCT01953328|2142966|P7|Overall Study|Lost to Follow-up|0
664370|NCT01953328|2142967|P6|Overall Study|Lost to Follow-up|0
664371|NCT01953328|2142968|P5|Overall Study|Lost to Follow-up|1
664372|NCT01953328|2142969|P4|Overall Study|Lost to Follow-up|0
664373|NCT01953328|2142970|P3|Overall Study|Lost to Follow-up|0
664374|NCT01953328|2142971|P2|Overall Study|Lost to Follow-up|0
664375|NCT01953328|2142972|P1|Overall Study|Lost to Follow-up|0
664376|NCT01953328|2142965|P8|Overall Study|Withdrawal by Subject|0
664377|NCT01953328|2142966|P7|Overall Study|Withdrawal by Subject|0
664378|NCT01953328|2142967|P6|Overall Study|Withdrawal by Subject|0
664379|NCT01953328|2142968|P5|Overall Study|Withdrawal by Subject|1
664380|NCT01953328|2142969|P4|Overall Study|Withdrawal by Subject|0
664381|NCT01953328|2142970|P3|Overall Study|Withdrawal by Subject|0
664382|NCT01953328|2142971|P2|Overall Study|Withdrawal by Subject|0
664383|NCT01953328|2142972|P1|Overall Study|Withdrawal by Subject|0
664384|NCT01952834|2143202|P1|Overall Study|Adverse Event|1
664385|NCT01952691|2143209|P1|Overall Study|Lost to Follow-up|2
664386|NCT01952665|2143217|P2|Overall Study|Protocol Violation|1
664387|NCT01952665|2143218|P1|Overall Study|Protocol Violation|0
664388|NCT01952665|2143217|P2|Overall Study|Adverse Event|1
664389|NCT01952665|2143218|P1|Overall Study|Adverse Event|2
664390|NCT01952665|2143217|P2|Overall Study|Lost to Follow-up|2
664391|NCT01952665|2143218|P1|Overall Study|Lost to Follow-up|1
664392|NCT01952665|2143217|P2|Overall Study|Physician Decision|2
664393|NCT01952665|2143218|P1|Overall Study|Physician Decision|3
664394|NCT01952366|2143384|P1|Overall Study|Withdrawal by Subject|9
664395|NCT01952366|2143384|P1|Overall Study|Death|22
664396|NCT01952145|2143398|P2|Overall Study|Unclassified|1
664397|NCT01952145|2143399|P1|Overall Study|Unclassified|1
664398|NCT01952145|2143398|P2|Overall Study|Withdrawal Criteria|11
664399|NCT01952145|2143399|P1|Overall Study|Withdrawal Criteria|16
664400|NCT01952145|2143398|P2|Overall Study|Adverse Event|0
664401|NCT01952145|2143399|P1|Overall Study|Adverse Event|9
664402|NCT01952145|2143398|P2|Overall Study|Death|1
664403|NCT01952145|2143399|P1|Overall Study|Death|0
664404|NCT01952145|2143398|P2|Overall Study|Protocol Violation|1
664405|NCT01952145|2143399|P1|Overall Study|Protocol Violation|2
664406|NCT01952080|2143413|P4|Overall Study|Protocol Non-compliance|0
664407|NCT01952080|2143414|P3|Overall Study|Protocol Non-compliance|0
664408|NCT01952080|2143415|P2|Overall Study|Protocol Non-compliance|1
664409|NCT01952080|2143416|P1|Overall Study|Protocol Non-compliance|0
664410|NCT01952080|2143413|P4|Overall Study|Withdrawal by Subject|1
664411|NCT01952080|2143414|P3|Overall Study|Withdrawal by Subject|0
664412|NCT01952080|2143415|P2|Overall Study|Withdrawal by Subject|0
664413|NCT01952080|2143416|P1|Overall Study|Withdrawal by Subject|0
664414|NCT01951703|2143482|P2|Second Intervention|Unsatisfactory Lens fitting|1
664415|NCT01951703|2143483|P1|Second Intervention|Unsatisfactory Lens fitting|0
664416|NCT01951703|2143482|P2|Second Intervention|Protocol Violation|1
664417|NCT01951703|2143483|P1|Second Intervention|Protocol Violation|0
664418|NCT01951703|2143482|P2|First Intervention|Physician Decision|0
664419|NCT01951703|2143483|P1|First Intervention|Physician Decision|1
664420|NCT01951703|2143482|P2|First Intervention|Subject was not compliant|1
664421|NCT01951703|2143483|P1|First Intervention|Subject was not compliant|1
664422|NCT01951703|2143482|P2|First Intervention|Withdrawal by Subject|0
664423|NCT01951703|2143483|P1|First Intervention|Withdrawal by Subject|1
664424|NCT01951586|2143508|P2|Overall Study|Withdrawal by Subject|13
664425|NCT01951586|2143509|P1|Overall Study|Withdrawal by Subject|7
664426|NCT01951586|2143508|P2|Overall Study|Death|100
664427|NCT01951586|2143509|P1|Overall Study|Death|52
664428|NCT01951573|2143533|P2|Washout Period|Adverse Event|1
664429|NCT01951573|2143534|P1|Washout Period|Adverse Event|0
664430|NCT01951417|2143544|P1|Overall Study|Lost to Follow-up|6
664431|NCT01951417|2143544|P1|Overall Study|Protocol Violation|2
664432|NCT01951417|2143544|P1|Overall Study|Withdrawal by Subject|1
664433|NCT01951170|2143567|P1|Overall Study|Investigator decision|1
664434|NCT01951092|2143590|P1|Overall Study|Transfer of Care|1
664435|NCT01951092|2143590|P1|Overall Study|Incarceration|1
664436|NCT01951092|2143590|P1|Overall Study|Lost to Follow-up|10
664437|NCT01950741|2143601|P1|Overall Study|Withdrawal by Subject|1
664438|NCT01950741|2143601|P1|Overall Study|Death|1
664439|NCT01950741|2143601|P1|Overall Study|Lost to Follow-up|1
664440|NCT01950364|2143616|P2|Overall Study|Protocol Violation|1
664441|NCT01950364|2143617|P1|Overall Study|Protocol Violation|0
664442|NCT01950364|2143616|P2|Overall Study|Withdrawal by Subject|1
664443|NCT01950364|2143617|P1|Overall Study|Withdrawal by Subject|0
664444|NCT01950364|2143616|P2|Overall Study|Disease Progression|2
664445|NCT01950364|2143617|P1|Overall Study|Disease Progression|5
664446|NCT01950364|2143616|P2|Overall Study|Stem Cell Transplant|6
664447|NCT01950364|2143617|P1|Overall Study|Stem Cell Transplant|2
664448|NCT01950364|2143616|P2|Overall Study|Adverse Event|0
664449|NCT01950364|2143617|P1|Overall Study|Adverse Event|3
664450|NCT01949870|2143726|P1|Overall Study|Eligibility requirements not fulfilled|2
664451|NCT01949870|2143726|P1|Overall Study|Study termination|1
664452|NCT01949870|2143726|P1|Overall Study|Adverse Event|1
664453|NCT01949870|2143726|P1|Overall Study|Lack of Efficacy|2
664454|NCT01949532|2143885|P2|Overall Study|On-study at the Data Cut-off Date|3
664455|NCT01949532|2143886|P1|Overall Study|On-study at the Data Cut-off Date|3
664456|NCT01949155|2143961|P2|Overall Study|Protocol Violation|0
664457|NCT01949155|2143962|P1|Overall Study|Protocol Violation|1
664458|NCT01949155|2143961|P2|Overall Study|Lost to Follow-up|0
664459|NCT01949155|2143962|P1|Overall Study|Lost to Follow-up|1
664460|NCT01949142|2143974|P2|Overall Study|Parent changed their mind|0
664461|NCT01949142|2143975|P1|Overall Study|Parent changed their mind|1
664462|NCT01949142|2143974|P2|Overall Study|Lost to Follow-up|1
664463|NCT01949142|2143975|P1|Overall Study|Lost to Follow-up|1
664464|NCT01949142|2143974|P2|Overall Study|Withdrawal of consent|0
664465|NCT01949142|2143975|P1|Overall Study|Withdrawal of consent|1
664466|NCT01949051|2143985|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
664467|NCT01949051|2143986|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
664468|NCT01949051|2143987|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
664469|NCT01949051|2143988|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
664470|NCT01949051|2143989|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
664471|NCT01949051|2143990|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
664472|NCT01949051|2143985|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
664473|NCT01949051|2143986|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
664474|NCT01949051|2143987|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
664475|NCT01949051|2143988|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
664476|NCT01949051|2143989|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
664477|NCT01949051|2143990|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
664478|NCT01949051|2143985|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
664479|NCT01949051|2143986|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
664480|NCT01949051|2143987|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
664481|NCT01949051|2143988|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
664482|NCT01949051|2143989|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
664483|NCT01949051|2143990|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
664484|NCT01949051|2143985|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
664485|NCT01949051|2143986|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
664486|NCT01949051|2143987|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
664487|NCT01949051|2143988|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
664488|NCT01949051|2143989|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
664489|NCT01949051|2143990|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
664490|NCT01949051|2143985|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
664491|NCT01949051|2143986|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
664492|NCT01949051|2143987|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
664493|NCT01949051|2143988|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
664494|NCT01949051|2143989|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
664495|NCT01949051|2143990|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
664496|NCT01948908|2144004|P3|Overall Study|Protocol Violation|2
664497|NCT01948908|2144005|P2|Overall Study|Protocol Violation|0
664498|NCT01948908|2144006|P1|Overall Study|Protocol Violation|1
664499|NCT01948830|2144022|P2|Overall Study|Death|4
664500|NCT01948830|2144023|P1|Overall Study|Death|3
664501|NCT01948830|2144022|P2|Overall Study|Adverse Event|2
664502|NCT01948830|2144023|P1|Overall Study|Adverse Event|9
664503|NCT01948830|2144022|P2|Overall Study|Withdrawal by Subject|17
664504|NCT01948830|2144023|P1|Overall Study|Withdrawal by Subject|14
664505|NCT01948830|2144022|P2|Overall Study|Lost to Follow-up|4
664506|NCT01948830|2144023|P1|Overall Study|Lost to Follow-up|5
664507|NCT01948830|2144022|P2|Overall Study|Protocol deviation|2
664508|NCT01948830|2144023|P1|Overall Study|Protocol deviation|1
664509|NCT01948830|2144022|P2|Overall Study|Physician Decision|3
664510|NCT01948830|2144023|P1|Overall Study|Physician Decision|1
664511|NCT01948791|2144055|P1|Overall Study|Screening failure|35
664512|NCT01948791|2144055|P1|Overall Study|Others|7
664513|NCT01948791|2144055|P1|Overall Study|Management issues|1
664514|NCT01948791|2144055|P1|Overall Study|Lost to Follow-up|6
664515|NCT01948791|2144055|P1|Overall Study|Withdrawal by Subject|5
664516|NCT01948791|2144055|P1|Overall Study|Protocol Violation|2
664517|NCT01948791|2144055|P1|Overall Study|Lack of Efficacy|3
664518|NCT01948791|2144055|P1|Overall Study|Adverse Event|12
664519|NCT01948193|2144085|P1|Overall Study|Lost to Follow-up|7
664520|NCT01948193|2144085|P1|Overall Study|Serious event|2
664521|NCT01948076|2144107|P2|Overall Study|Withdrawal by Subject|1
664522|NCT01948076|2144108|P1|Overall Study|Withdrawal by Subject|0
664523|NCT01948063|2144118|P2|Overall Study|Blood samples were accidentally thawed|0
664524|NCT01948063|2144119|P1|Overall Study|Blood samples were accidentally thawed|1
664525|NCT01948063|2144118|P2|Overall Study|Discovered an enrollment in other study|1
664526|NCT01948063|2144119|P1|Overall Study|Discovered an enrollment in other study|0
664527|NCT01948063|2144118|P2|Overall Study|Boston MCI halted research protocol|1
664528|NCT01948063|2144119|P1|Overall Study|Boston MCI halted research protocol|0
664529|NCT01948050|2144127|P2|Overall Study|Withdrawal by Subject|1
664530|NCT01948050|2144128|P1|Overall Study|Withdrawal by Subject|0
664531|NCT01947855|2144196|P3|Overall Study|Withdrawal by Subject|0
664532|NCT01947855|2144197|P2|Overall Study|Withdrawal by Subject|0
664533|NCT01947855|2144198|P1|Overall Study|Withdrawal by Subject|1
664534|NCT01947582|2144206|P1|Overall Study|Withdrawal by Subject|1
664535|NCT01947517|2144215|P2|Overall Study|Withdrawal by Subject|1
664536|NCT01947517|2144216|P1|Overall Study|Withdrawal by Subject|1
664537|NCT01947491|2144234|P4|Overall Study|Adverse Event|2
664538|NCT01947491|2144235|P3|Overall Study|Adverse Event|0
664539|NCT01947491|2144236|P2|Overall Study|Adverse Event|1
664540|NCT01947491|2144237|P1|Overall Study|Adverse Event|0
664541|NCT01947491|2144234|P4|Overall Study|Worsening of condition|0
664542|NCT01947491|2144235|P3|Overall Study|Worsening of condition|0
664543|NCT01947491|2144236|P2|Overall Study|Worsening of condition|1
664544|NCT01947491|2144237|P1|Overall Study|Worsening of condition|0
664545|NCT01947491|2144234|P4|Overall Study|Withdrawal by Subject|0
664546|NCT01947491|2144235|P3|Overall Study|Withdrawal by Subject|1
664547|NCT01947491|2144236|P2|Overall Study|Withdrawal by Subject|1
664548|NCT01947491|2144237|P1|Overall Study|Withdrawal by Subject|1
664549|NCT01947491|2144234|P4|Overall Study|Protocol Violation|0
664550|NCT01947491|2144235|P3|Overall Study|Protocol Violation|0
664551|NCT01947491|2144236|P2|Overall Study|Protocol Violation|0
664552|NCT01947491|2144237|P1|Overall Study|Protocol Violation|1
664553|NCT01947491|2144234|P4|Overall Study|Lack of Efficacy|1
664554|NCT01947491|2144235|P3|Overall Study|Lack of Efficacy|0
664555|NCT01947491|2144236|P2|Overall Study|Lack of Efficacy|0
664556|NCT01947491|2144237|P1|Overall Study|Lack of Efficacy|1
664557|NCT01947491|2144234|P4|Overall Study|Lost to Follow-up|2
664558|NCT01947491|2144235|P3|Overall Study|Lost to Follow-up|1
664559|NCT01947491|2144236|P2|Overall Study|Lost to Follow-up|3
664560|NCT01947491|2144237|P1|Overall Study|Lost to Follow-up|5
664561|NCT01947127|2144281|P2|Overall Study|Data loss|4
664562|NCT01947127|2144282|P1|Overall Study|Data loss|4
664563|NCT01947127|2144281|P2|Overall Study|Withdrawal by Subject|1
664564|NCT01947127|2144282|P1|Overall Study|Withdrawal by Subject|1
664565|NCT01947127|2144281|P2|Overall Study|Protocol Violation|38
664566|NCT01947127|2144282|P1|Overall Study|Protocol Violation|18
888436|NCT01945489|2822099|P1|Cycle 1|Adverse Event|2
664573|NCT01946438|2144319|P4|Overall Study|Withdrawal by Subject|0
664574|NCT01946438|2144320|P3|Overall Study|Withdrawal by Subject|0
664575|NCT01946438|2144321|P2|Overall Study|Withdrawal by Subject|0
664576|NCT01946438|2144322|P1|Overall Study|Withdrawal by Subject|1
664577|NCT01946438|2144319|P4|Overall Study|Protocol Violation|0
664578|NCT01946438|2144320|P3|Overall Study|Protocol Violation|1
664579|NCT01946438|2144321|P2|Overall Study|Protocol Violation|0
664580|NCT01946438|2144322|P1|Overall Study|Protocol Violation|0
664581|NCT01946438|2144319|P4|Overall Study|Serious Adverse event|0
664582|NCT01946438|2144320|P3|Overall Study|Serious Adverse event|0
664583|NCT01946438|2144321|P2|Overall Study|Serious Adverse event|0
664584|NCT01946438|2144322|P1|Overall Study|Serious Adverse event|1
664585|NCT01946438|2144319|P4|Overall Study|Adverse Event|1
664586|NCT01946438|2144320|P3|Overall Study|Adverse Event|0
664587|NCT01946438|2144321|P2|Overall Study|Adverse Event|0
664588|NCT01946438|2144322|P1|Overall Study|Adverse Event|0
664589|NCT01946425|2144350|P2|Overall Study|Withdrawal by Subject|0
664590|NCT01946425|2144351|P1|Overall Study|Withdrawal by Subject|1
664591|NCT01946425|2144350|P2|Overall Study|Protocol Violation|0
664592|NCT01946425|2144351|P1|Overall Study|Protocol Violation|1
664593|NCT01946412|2144365|P1|Overall Study|Difficulty in swallowing|1
664594|NCT01946412|2144365|P1|Overall Study|Continued with commercial Kalydeco|2
664595|NCT01946412|2144365|P1|Overall Study|Non-Compliance|1
664596|NCT01946412|2144365|P1|Overall Study|Adverse Event|1
664597|NCT01946178|2144408|P1|Overall Study|Lost to Follow-up|1
664598|NCT01946178|2144408|P1|Overall Study|Pregnancy|1
664599|NCT01945944|2144477|P2|Overall Study|Withdrawal by Subject|1
664600|NCT01945944|2144478|P1|Overall Study|Withdrawal by Subject|0
664601|NCT01945944|2144477|P2|Overall Study|Physician Decision|0
664602|NCT01945944|2144478|P1|Overall Study|Physician Decision|1
664603|NCT01945944|2144477|P2|Overall Study|Adverse Event|2
664604|NCT01945944|2144478|P1|Overall Study|Adverse Event|0
664605|NCT01945242|2144537|P2|Overall Study|Physician Decision|3
664606|NCT01945242|2144538|P1|Overall Study|Physician Decision|3
664607|NCT01945086|2144596|P3|Overall Study|Adverse Event|1
664608|NCT01945086|2144597|P2|Overall Study|Adverse Event|0
664609|NCT01945086|2144598|P1|Overall Study|Adverse Event|0
664610|NCT01945086|2144596|P3|Overall Study|Withdrawal by Subject|1
664611|NCT01945086|2144597|P2|Overall Study|Withdrawal by Subject|0
664612|NCT01945086|2144598|P1|Overall Study|Withdrawal by Subject|1
664613|NCT01945034|2144642|P3|Overall Study|Protocol Violation|1
664614|NCT01945034|2144643|P2|Overall Study|Protocol Violation|0
664615|NCT01945034|2144644|P1|Overall Study|Protocol Violation|1
664616|NCT01945034|2144642|P3|Overall Study|Lost to Follow-up|2
664617|NCT01945034|2144643|P2|Overall Study|Lost to Follow-up|0
664618|NCT01945034|2144644|P1|Overall Study|Lost to Follow-up|0
664619|NCT01945034|2144642|P3|Overall Study|Unspecified|3
664620|NCT01945034|2144643|P2|Overall Study|Unspecified|1
664621|NCT01945034|2144644|P1|Overall Study|Unspecified|0
664622|NCT01945034|2144642|P3|Overall Study|Withdrawal by Subject|1
664623|NCT01945034|2144643|P2|Overall Study|Withdrawal by Subject|3
664624|NCT01945034|2144644|P1|Overall Study|Withdrawal by Subject|0
664625|NCT01945034|2144642|P3|Overall Study|Medication Error|0
664626|NCT01945034|2144643|P2|Overall Study|Medication Error|1
664627|NCT01945034|2144644|P1|Overall Study|Medication Error|0
664636|NCT01944969|2144708|P1|Overall Study|Administrative or other reasons|23
664637|NCT01944969|2144708|P1|Overall Study|Non-compliance with IMP|1
664638|NCT01944969|2144708|P1|Overall Study|Lack of Efficacy|1
664639|NCT01944969|2144708|P1|Overall Study|Adverse Event|1
664640|NCT01944774|2144733|P3|Overall Study|Lost to Follow-up|0
664641|NCT01944774|2144734|P2|Overall Study|Lost to Follow-up|1
664642|NCT01944774|2144735|P1|Overall Study|Lost to Follow-up|0
664643|NCT01944774|2144733|P3|Overall Study|Lack of Efficacy|2
664644|NCT01944774|2144734|P2|Overall Study|Lack of Efficacy|2
664645|NCT01944774|2144735|P1|Overall Study|Lack of Efficacy|1
664646|NCT01944774|2144733|P3|Overall Study|Adverse Event|3
664647|NCT01944774|2144734|P2|Overall Study|Adverse Event|2
664648|NCT01944774|2144735|P1|Overall Study|Adverse Event|3
664649|NCT01944774|2144733|P3|Overall Study|Withdrawal by Subject|3
664650|NCT01944774|2144734|P2|Overall Study|Withdrawal by Subject|3
664651|NCT01944774|2144735|P1|Overall Study|Withdrawal by Subject|2
664652|NCT01944670|2144776|P1|Overall Study|Lost to Follow-up|2
664653|NCT01944631|2144783|P2|Overall Study|Withdrawal by Subject|1
664654|NCT01944631|2144784|P1|Overall Study|Withdrawal by Subject|0
664655|NCT01944631|2144783|P2|Overall Study|Lost to Follow-up|1
664656|NCT01944631|2144784|P1|Overall Study|Lost to Follow-up|3
664657|NCT01944631|2144783|P2|Overall Study|Adverse Event|0
664658|NCT01944631|2144784|P1|Overall Study|Adverse Event|1
664659|NCT01944059|2144819|P1|Overall Study|Adverse Event|2
664660|NCT01944059|2144819|P1|Overall Study|Withdrawal by Subject|1
664661|NCT01944059|2144819|P1|Overall Study|Physician Decision|3
664662|NCT01944059|2144819|P1|Overall Study|Lost to Follow-up|1
664663|NCT01943552|2144892|P2|Overall Study|Other Reasons|17
664664|NCT01943552|2144893|P1|Overall Study|Other Reasons|16
664665|NCT01943552|2144892|P2|Overall Study|Withdrawal by Subject|6
664666|NCT01943552|2144893|P1|Overall Study|Withdrawal by Subject|6
664667|NCT01943552|2144892|P2|Overall Study|Adverse Event|2
664668|NCT01943552|2144893|P1|Overall Study|Adverse Event|3
664678|NCT01943292|2144959|P3|Overall Study|Withdrawal by Subject|0
664679|NCT01943292|2144960|P2|Overall Study|Withdrawal by Subject|0
664680|NCT01943292|2144961|P1|Overall Study|Withdrawal by Subject|1
664681|NCT01942785|2144988|P1|Overall Study|Protocol Violation|1
664682|NCT01942785|2144988|P1|Overall Study|Withdrawal by Subject|1
664683|NCT01942785|2144988|P1|Overall Study|Adverse Event|2
664684|NCT01942733|2145017|P1|Overall Study|Administrative|1
664685|NCT01942733|2145017|P1|Overall Study|Non-compliance with IMP|1
664686|NCT01942733|2145017|P1|Overall Study|Lost to Follow-up|1
664687|NCT01942161|2145070|P3|Overall Study|Withdrawal by Subject|1
664688|NCT01942161|2145071|P2|Overall Study|Withdrawal by Subject|3
664689|NCT01942161|2145072|P1|Overall Study|Withdrawal by Subject|3
664690|NCT01942161|2145070|P3|Overall Study|Protocol Violation|0
664691|NCT01942161|2145071|P2|Overall Study|Protocol Violation|0
664692|NCT01942161|2145072|P1|Overall Study|Protocol Violation|1
664693|NCT01942161|2145070|P3|Overall Study|Physician Decision|0
664694|NCT01942161|2145071|P2|Overall Study|Physician Decision|1
664695|NCT01942161|2145072|P1|Overall Study|Physician Decision|3
664696|NCT01942161|2145070|P3|Overall Study|Adverse Event|5
664697|NCT01942161|2145071|P2|Overall Study|Adverse Event|2
664698|NCT01942161|2145072|P1|Overall Study|Adverse Event|1
664699|NCT01942148|2145092|P1|Overall Study|Use of the prohibition medicine|1
664700|NCT01942148|2145092|P1|Overall Study|Withdrawal by Subject|8
664701|NCT01942148|2145092|P1|Overall Study|Protocol Violation|1
664702|NCT01942148|2145092|P1|Overall Study|Physician Decision|11
664703|NCT01942148|2145092|P1|Overall Study|Lack of Efficacy|2
664704|NCT01942148|2145092|P1|Overall Study|Adverse Event|4
664705|NCT01942135|2145100|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
664706|NCT01942135|2145101|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
664707|NCT01942135|2145100|P2|Overall Study|Withdrawal by Subject|2
664708|NCT01942135|2145101|P1|Overall Study|Withdrawal by Subject|4
664709|NCT01942135|2145100|P2|Overall Study|Participant Refused toContinue Treatment|1
664710|NCT01942135|2145101|P1|Overall Study|Participant Refused toContinue Treatment|1
664711|NCT01942135|2145100|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
664712|NCT01942135|2145101|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
664713|NCT01942135|2145100|P2|Overall Study|Death|1
664714|NCT01942135|2145101|P1|Overall Study|Death|0
664715|NCT01942135|2145100|P2|Overall Study|Randomized Not Treated|2
664716|NCT01942135|2145101|P1|Overall Study|Randomized Not Treated|2
664717|NCT01942135|2145100|P2|Overall Study|Global deterioration of health status|3
664718|NCT01942135|2145101|P1|Overall Study|Global deterioration of health status|8
664719|NCT01942135|2145100|P2|Overall Study|Adverse Event|3
664720|NCT01942135|2145101|P1|Overall Study|Adverse Event|9
664721|NCT01941940|2145138|P1|Overall Study|Other|1
664722|NCT01941940|2145138|P1|Overall Study|Unspecified|1
664723|NCT01941940|2145138|P1|Overall Study|Death|1
664724|NCT01941940|2145138|P1|Overall Study|Withdrawal by Subject|15
664725|NCT01941940|2145138|P1|Overall Study|Physician Decision|2
664726|NCT01941940|2145138|P1|Overall Study|Lost to Follow-up|2
664727|NCT01941940|2145138|P1|Overall Study|Adverse Event|11
664728|NCT01941498|2145187|P1|Overall Study|Relocated out of state|1
664729|NCT01941186|2145305|P2|Follow-up|Lost to Follow-up|0
664730|NCT01941186|2145306|P1|Follow-up|Lost to Follow-up|1
664731|NCT01940497|2145376|P2|Overall Study|Ongoing at data cut-off|117
664732|NCT01940497|2145377|P1|Overall Study|Ongoing at data cut-off|116
664733|NCT01940497|2145376|P2|Overall Study|Withdrawal by Subject|0
664734|NCT01940497|2145377|P1|Overall Study|Withdrawal by Subject|2
664735|NCT01940497|2145376|P2|Overall Study|Protocol Violation|0
664736|NCT01940497|2145377|P1|Overall Study|Protocol Violation|1
664737|NCT01940497|2145376|P2|Overall Study|Failure to return|1
664738|NCT01940497|2145377|P1|Overall Study|Failure to return|0
664739|NCT01940497|2145376|P2|Overall Study|Adverse event/Intercurrent illness|0
664740|NCT01940497|2145377|P1|Overall Study|Adverse event/Intercurrent illness|1
664741|NCT01940484|2145416|P1|Overall Study|Adverse Event|1
664742|NCT01940484|2145416|P1|Overall Study|Death|2
664743|NCT01940484|2145416|P1|Overall Study|Underwent transplantation|4
664744|NCT01940484|2145416|P1|Overall Study|Withdrawal by Subject|3
664745|NCT01940471|2145436|P2|Open-Label Extension|Still on Open-Label Treatment|8
664746|NCT01940471|2145437|P1|Open-Label Extension|Still on Open-Label Treatment|14
664747|NCT01940471|2145436|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
664748|NCT01940471|2145437|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
664749|NCT01940471|2145436|P2|Double-Blind Phase|HBsAg Seroconversion|0
664750|NCT01940471|2145437|P1|Double-Blind Phase|HBsAg Seroconversion|1
664751|NCT01940471|2145436|P2|Double-Blind Phase|Protocol Violation|1
664752|NCT01940471|2145437|P1|Double-Blind Phase|Protocol Violation|0
664753|NCT01940471|2145436|P2|Double-Blind Phase|Lack of Efficacy|0
664754|NCT01940471|2145437|P1|Double-Blind Phase|Lack of Efficacy|1
664755|NCT01940471|2145436|P2|Double-Blind Phase|Death|0
664756|NCT01940471|2145437|P1|Double-Blind Phase|Death|1
664757|NCT01940471|2145436|P2|Double-Blind Phase|Protocol-Specified Criteria|0
664758|NCT01940471|2145437|P1|Double-Blind Phase|Protocol-Specified Criteria|2
664759|NCT01940471|2145436|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
664760|NCT01940471|2145437|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
664761|NCT01940471|2145436|P2|Double-Blind Phase|Investigator's Discretion|1
664762|NCT01940471|2145437|P1|Double-Blind Phase|Investigator's Discretion|2
664763|NCT01940471|2145436|P2|Double-Blind Phase|Pregnancy|1
664764|NCT01940471|2145437|P1|Double-Blind Phase|Pregnancy|2
664765|NCT01940471|2145436|P2|Double-Blind Phase|Lost to Follow-up|2
664766|NCT01940471|2145437|P1|Double-Blind Phase|Lost to Follow-up|2
664767|NCT01940471|2145436|P2|Double-Blind Phase|Adverse Event|3
664768|NCT01940471|2145437|P1|Double-Blind Phase|Adverse Event|6
664769|NCT01940471|2145436|P2|Double-Blind Phase|Withdrew Consent|5
664770|NCT01940471|2145437|P1|Double-Blind Phase|Withdrew Consent|11
664771|NCT01940471|2145436|P2|Double-Blind Phase|Randomized but Never Treated|1
664772|NCT01940471|2145437|P1|Double-Blind Phase|Randomized but Never Treated|1
664773|NCT01940341|2145455|P2|Open-label Extension Phase|Still on Study|1
664774|NCT01940341|2145456|P1|Open-label Extension Phase|Still on Study|4
664775|NCT01940341|2145455|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
664776|NCT01940341|2145456|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
664777|NCT01940341|2145455|P2|Double-Blind Phase|Protocol Specified Criteria|0
664778|NCT01940341|2145456|P1|Double-Blind Phase|Protocol Specified Criteria|1
664779|NCT01940341|2145455|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
664780|NCT01940341|2145456|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
664781|NCT01940341|2145455|P2|Double-Blind Phase|Investigator's Discretion|0
664782|NCT01940341|2145456|P1|Double-Blind Phase|Investigator's Discretion|1
664783|NCT01940341|2145455|P2|Double-Blind Phase|Pregnancy|1
664784|NCT01940341|2145456|P1|Double-Blind Phase|Pregnancy|0
664785|NCT01940341|2145455|P2|Double-Blind Phase|Lost to Follow-up|1
664786|NCT01940341|2145456|P1|Double-Blind Phase|Lost to Follow-up|4
664787|NCT01940341|2145455|P2|Double-Blind Phase|Withdrew Consent|2
664788|NCT01940341|2145456|P1|Double-Blind Phase|Withdrew Consent|3
664789|NCT01940341|2145455|P2|Double-Blind Phase|Adverse Event|2
664790|NCT01940341|2145456|P1|Double-Blind Phase|Adverse Event|3
664791|NCT01940341|2145455|P2|Double-Blind Phase|Randomized but Never Treated|1
664792|NCT01940341|2145456|P1|Double-Blind Phase|Randomized but Never Treated|0
664793|NCT01940120|2145487|P1|Overall Study|Lost to Follow-up|4
664794|NCT01940120|2145487|P1|Overall Study|Withdrawal by Subject|7
664795|NCT01940120|2145487|P1|Overall Study|Death|33
664796|NCT01939548|2145617|P3|Overall Study|Did not complete follow-up|0
664797|NCT01939548|2145618|P2|Overall Study|Did not complete follow-up|1
664798|NCT01939548|2145619|P1|Overall Study|Did not complete follow-up|0
664799|NCT01939548|2145617|P3|Overall Study|Participant withdrew consent|0
664800|NCT01939548|2145618|P2|Overall Study|Participant withdrew consent|2
664801|NCT01939548|2145619|P1|Overall Study|Participant withdrew consent|0
664802|NCT01939548|2145617|P3|Overall Study|Participant unwilling to continue|0
664803|NCT01939548|2145618|P2|Overall Study|Participant unwilling to continue|1
664804|NCT01939548|2145619|P1|Overall Study|Participant unwilling to continue|0
664805|NCT01939548|2145617|P3|Overall Study|Participant dropped|1
664806|NCT01939548|2145618|P2|Overall Study|Participant dropped|0
664807|NCT01939548|2145619|P1|Overall Study|Participant dropped|0
664808|NCT01939548|2145617|P3|Overall Study|Death|1
664809|NCT01939548|2145618|P2|Overall Study|Death|0
664810|NCT01939548|2145619|P1|Overall Study|Death|0
664811|NCT01939548|2145617|P3|Overall Study|Adverse Event|7
664812|NCT01939548|2145618|P2|Overall Study|Adverse Event|9
664813|NCT01939548|2145619|P1|Overall Study|Adverse Event|2
664814|NCT01939548|2145617|P3|Overall Study|Lost to Follow-up|3
664815|NCT01939548|2145618|P2|Overall Study|Lost to Follow-up|5
664816|NCT01939548|2145619|P1|Overall Study|Lost to Follow-up|5
664817|NCT01939548|2145617|P3|Overall Study|Protocol Violation|5
664818|NCT01939548|2145618|P2|Overall Study|Protocol Violation|6
664819|NCT01939548|2145619|P1|Overall Study|Protocol Violation|7
664820|NCT01939548|2145617|P3|Overall Study|Withdrawal by Subject|1
664821|NCT01939548|2145618|P2|Overall Study|Withdrawal by Subject|4
664822|NCT01939548|2145619|P1|Overall Study|Withdrawal by Subject|4
664823|NCT01939548|2145617|P3|Overall Study|Did Not Meet Entrance Criteria|0
664824|NCT01939548|2145618|P2|Overall Study|Did Not Meet Entrance Criteria|0
664825|NCT01939548|2145619|P1|Overall Study|Did Not Meet Entrance Criteria|1
664826|NCT01939548|2145617|P3|Overall Study|Insufficient Clinical Response|0
664827|NCT01939548|2145618|P2|Overall Study|Insufficient Clinical Response|0
664828|NCT01939548|2145619|P1|Overall Study|Insufficient Clinical Response|1
664829|NCT01939548|2145617|P3|Overall Study|Study Terminated by Sponsor|12
664830|NCT01939548|2145618|P2|Overall Study|Study Terminated by Sponsor|19
664831|NCT01939548|2145619|P1|Overall Study|Study Terminated by Sponsor|17
664832|NCT01939548|2145617|P3|Overall Study|Non compliance|0
664833|NCT01939548|2145618|P2|Overall Study|Non compliance|2
664834|NCT01939548|2145619|P1|Overall Study|Non compliance|0
664835|NCT01939496|2145693|P3|Overall Study|Unspecified|1
664836|NCT01939496|2145694|P2|Overall Study|Unspecified|0
664837|NCT01939496|2145695|P1|Overall Study|Unspecified|2
664838|NCT01939496|2145693|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
664839|NCT01939496|2145694|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
664840|NCT01939496|2145695|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
664841|NCT01939496|2145693|P3|Overall Study|Withdrawal by Subject|1
664842|NCT01939496|2145694|P2|Overall Study|Withdrawal by Subject|1
664843|NCT01939496|2145695|P1|Overall Study|Withdrawal by Subject|0
664844|NCT01939496|2145693|P3|Overall Study|Protocol Violation|0
664845|NCT01939496|2145694|P2|Overall Study|Protocol Violation|0
664846|NCT01939496|2145695|P1|Overall Study|Protocol Violation|3
664847|NCT01939496|2145693|P3|Overall Study|Physician Decision|0
664848|NCT01939496|2145694|P2|Overall Study|Physician Decision|0
664849|NCT01939496|2145695|P1|Overall Study|Physician Decision|1
664850|NCT01939496|2145693|P3|Overall Study|Lost to Follow-up|0
664851|NCT01939496|2145694|P2|Overall Study|Lost to Follow-up|1
664852|NCT01939496|2145695|P1|Overall Study|Lost to Follow-up|1
664853|NCT01939496|2145693|P3|Overall Study|Adverse Event|0
664854|NCT01939496|2145694|P2|Overall Study|Adverse Event|0
664855|NCT01939496|2145695|P1|Overall Study|Adverse Event|2
664856|NCT01939314|2145762|P2|Overall Study|Lost to Follow-up|6
664857|NCT01939314|2145763|P1|Overall Study|Lost to Follow-up|5
664858|NCT01939314|2145762|P2|Overall Study|Pregnancy|1
664859|NCT01939314|2145763|P1|Overall Study|Pregnancy|0
664860|NCT01939314|2145762|P2|Overall Study|Protocol Violation|0
664861|NCT01939314|2145763|P1|Overall Study|Protocol Violation|1
664862|NCT01939314|2145762|P2|Overall Study|Withdrawal by Subject|1
664863|NCT01939314|2145763|P1|Overall Study|Withdrawal by Subject|3
664864|NCT01939002|2145786|P2|Overall Study|Not Specified|2
664865|NCT01939002|2145787|P1|Overall Study|Not Specified|1
664866|NCT01939002|2145786|P2|Overall Study|Withdrawal by Subject|3
664867|NCT01939002|2145787|P1|Overall Study|Withdrawal by Subject|5
664868|NCT01939002|2145786|P2|Overall Study|Adverse Event|13
664869|NCT01939002|2145787|P1|Overall Study|Adverse Event|13
664870|NCT01938430|2145882|P14|Overall Study|Withdrew Consent|0
664871|NCT01938430|2145883|P13|Overall Study|Withdrew Consent|0
664872|NCT01938430|2145884|P12|Overall Study|Withdrew Consent|0
664873|NCT01938430|2145885|P11|Overall Study|Withdrew Consent|0
664874|NCT01938430|2145886|P10|Overall Study|Withdrew Consent|0
664875|NCT01938430|2145887|P9|Overall Study|Withdrew Consent|1
664876|NCT01938430|2145888|P8|Overall Study|Withdrew Consent|0
664877|NCT01938430|2145889|P7|Overall Study|Withdrew Consent|0
664878|NCT01938430|2145890|P6|Overall Study|Withdrew Consent|0
664879|NCT01938430|2145891|P5|Overall Study|Withdrew Consent|0
664880|NCT01938430|2145892|P4|Overall Study|Withdrew Consent|0
664881|NCT01938430|2145893|P3|Overall Study|Withdrew Consent|0
664882|NCT01938430|2145894|P2|Overall Study|Withdrew Consent|0
664883|NCT01938430|2145895|P1|Overall Study|Withdrew Consent|0
664884|NCT01938430|2145882|P14|Overall Study|Lost to Follow-up|0
664885|NCT01938430|2145883|P13|Overall Study|Lost to Follow-up|0
664886|NCT01938430|2145884|P12|Overall Study|Lost to Follow-up|0
664887|NCT01938430|2145885|P11|Overall Study|Lost to Follow-up|0
664888|NCT01938430|2145886|P10|Overall Study|Lost to Follow-up|0
664889|NCT01938430|2145887|P9|Overall Study|Lost to Follow-up|0
664890|NCT01938430|2145888|P8|Overall Study|Lost to Follow-up|0
664891|NCT01938430|2145889|P7|Overall Study|Lost to Follow-up|0
664892|NCT01938430|2145890|P6|Overall Study|Lost to Follow-up|1
664893|NCT01938430|2145891|P5|Overall Study|Lost to Follow-up|0
664894|NCT01938430|2145892|P4|Overall Study|Lost to Follow-up|0
664895|NCT01938430|2145893|P3|Overall Study|Lost to Follow-up|1
664896|NCT01938430|2145894|P2|Overall Study|Lost to Follow-up|0
664897|NCT01938430|2145895|P1|Overall Study|Lost to Follow-up|0
664898|NCT01938430|2145882|P14|Overall Study|Lack of Efficacy|0
664899|NCT01938430|2145883|P13|Overall Study|Lack of Efficacy|0
664900|NCT01938430|2145884|P12|Overall Study|Lack of Efficacy|1
664901|NCT01938430|2145885|P11|Overall Study|Lack of Efficacy|2
664902|NCT01938430|2145886|P10|Overall Study|Lack of Efficacy|0
664903|NCT01938430|2145887|P9|Overall Study|Lack of Efficacy|1
664904|NCT01938430|2145888|P8|Overall Study|Lack of Efficacy|0
664905|NCT01938430|2145889|P7|Overall Study|Lack of Efficacy|0
664906|NCT01938430|2145890|P6|Overall Study|Lack of Efficacy|0
664907|NCT01938430|2145891|P5|Overall Study|Lack of Efficacy|0
664908|NCT01938430|2145892|P4|Overall Study|Lack of Efficacy|1
664909|NCT01938430|2145893|P3|Overall Study|Lack of Efficacy|1
664910|NCT01938430|2145894|P2|Overall Study|Lack of Efficacy|1
664911|NCT01938430|2145895|P1|Overall Study|Lack of Efficacy|3
664912|NCT01938430|2145882|P14|Overall Study|Investigator's Discretion|0
664913|NCT01938430|2145883|P13|Overall Study|Investigator's Discretion|0
664914|NCT01938430|2145884|P12|Overall Study|Investigator's Discretion|0
664915|NCT01938430|2145885|P11|Overall Study|Investigator's Discretion|0
664916|NCT01938430|2145886|P10|Overall Study|Investigator's Discretion|0
664917|NCT01938430|2145887|P9|Overall Study|Investigator's Discretion|0
664918|NCT01938430|2145888|P8|Overall Study|Investigator's Discretion|0
664919|NCT01938430|2145889|P7|Overall Study|Investigator's Discretion|0
664920|NCT01938430|2145890|P6|Overall Study|Investigator's Discretion|0
664921|NCT01938430|2145891|P5|Overall Study|Investigator's Discretion|0
664922|NCT01938430|2145892|P4|Overall Study|Investigator's Discretion|0
664923|NCT01938430|2145893|P3|Overall Study|Investigator's Discretion|1
664924|NCT01938430|2145894|P2|Overall Study|Investigator's Discretion|0
664925|NCT01938430|2145895|P1|Overall Study|Investigator's Discretion|0
664926|NCT01938430|2145882|P14|Overall Study|Death|0
664927|NCT01938430|2145883|P13|Overall Study|Death|0
664928|NCT01938430|2145884|P12|Overall Study|Death|0
664929|NCT01938430|2145885|P11|Overall Study|Death|0
664930|NCT01938430|2145886|P10|Overall Study|Death|3
664931|NCT01938430|2145887|P9|Overall Study|Death|2
664932|NCT01938430|2145888|P8|Overall Study|Death|1
664933|NCT01938430|2145889|P7|Overall Study|Death|1
664934|NCT01938430|2145890|P6|Overall Study|Death|0
664935|NCT01938430|2145891|P5|Overall Study|Death|0
664936|NCT01938430|2145892|P4|Overall Study|Death|1
664937|NCT01938430|2145893|P3|Overall Study|Death|2
664938|NCT01938430|2145894|P2|Overall Study|Death|2
664939|NCT01938430|2145895|P1|Overall Study|Death|1
664940|NCT01938430|2145882|P14|Overall Study|Adverse Event|0
664941|NCT01938430|2145883|P13|Overall Study|Adverse Event|0
664942|NCT01938430|2145884|P12|Overall Study|Adverse Event|0
664943|NCT01938430|2145885|P11|Overall Study|Adverse Event|0
664944|NCT01938430|2145886|P10|Overall Study|Adverse Event|0
664945|NCT01938430|2145887|P9|Overall Study|Adverse Event|0
664946|NCT01938430|2145888|P8|Overall Study|Adverse Event|0
664947|NCT01938430|2145889|P7|Overall Study|Adverse Event|1
664948|NCT01938430|2145890|P6|Overall Study|Adverse Event|0
664949|NCT01938430|2145891|P5|Overall Study|Adverse Event|0
664950|NCT01938430|2145892|P4|Overall Study|Adverse Event|0
664951|NCT01938430|2145893|P3|Overall Study|Adverse Event|0
664952|NCT01938430|2145894|P2|Overall Study|Adverse Event|0
664953|NCT01938430|2145895|P1|Overall Study|Adverse Event|0
664954|NCT01938430|2145882|P14|Overall Study|Randomized but Not Treated|1
664955|NCT01938430|2145883|P13|Overall Study|Randomized but Not Treated|0
664956|NCT01938430|2145884|P12|Overall Study|Randomized but Not Treated|0
664957|NCT01938430|2145885|P11|Overall Study|Randomized but Not Treated|1
664958|NCT01938430|2145886|P10|Overall Study|Randomized but Not Treated|0
664959|NCT01938430|2145887|P9|Overall Study|Randomized but Not Treated|0
664960|NCT01938430|2145888|P8|Overall Study|Randomized but Not Treated|0
664961|NCT01938430|2145889|P7|Overall Study|Randomized but Not Treated|0
664962|NCT01938430|2145890|P6|Overall Study|Randomized but Not Treated|0
664963|NCT01938430|2145891|P5|Overall Study|Randomized but Not Treated|0
664964|NCT01938430|2145892|P4|Overall Study|Randomized but Not Treated|0
664965|NCT01938430|2145893|P3|Overall Study|Randomized but Not Treated|0
664966|NCT01938430|2145894|P2|Overall Study|Randomized but Not Treated|0
664967|NCT01938430|2145895|P1|Overall Study|Randomized but Not Treated|0
664968|NCT01938391|2146220|P1|12 Month Follow up|Withdrawal by Subject|1
664969|NCT01938391|2146220|P1|12 Month Follow up|Physician Decision|1
664970|NCT01938391|2146220|P1|6 Month Follow up|Withdrawal by Subject|1
664971|NCT01937871|2146339|P3|Overall Study|Entry Criteria Not Met|1
664972|NCT01937871|2146340|P2|Overall Study|Entry Criteria Not Met|2
664973|NCT01937871|2146341|P1|Overall Study|Entry Criteria Not Met|1
664974|NCT01937871|2146339|P3|Overall Study|Physician Decision|0
664975|NCT01937871|2146340|P2|Overall Study|Physician Decision|1
664976|NCT01937871|2146341|P1|Overall Study|Physician Decision|0
664977|NCT01937871|2146339|P3|Overall Study|Withdrawal by Subject|4
664978|NCT01937871|2146340|P2|Overall Study|Withdrawal by Subject|6
664979|NCT01937871|2146341|P1|Overall Study|Withdrawal by Subject|9
664980|NCT01937871|2146339|P3|Overall Study|Lost to Follow-up|4
664981|NCT01937871|2146340|P2|Overall Study|Lost to Follow-up|2
664982|NCT01937871|2146341|P1|Overall Study|Lost to Follow-up|8
664983|NCT01937871|2146339|P3|Overall Study|Adverse Event|2
664984|NCT01937871|2146340|P2|Overall Study|Adverse Event|6
664985|NCT01937871|2146341|P1|Overall Study|Adverse Event|6
664986|NCT01937715|2146417|P5|Overall Study|Unspecified|0
664987|NCT01937715|2146418|P4|Overall Study|Unspecified|3
664988|NCT01937715|2146419|P3|Overall Study|Unspecified|0
664989|NCT01937715|2146420|P2|Overall Study|Unspecified|0
664990|NCT01937715|2146421|P1|Overall Study|Unspecified|0
664991|NCT01937715|2146417|P5|Overall Study|Withdrawal by Subject|2
664992|NCT01937715|2146418|P4|Overall Study|Withdrawal by Subject|0
664993|NCT01937715|2146419|P3|Overall Study|Withdrawal by Subject|0
664994|NCT01937715|2146420|P2|Overall Study|Withdrawal by Subject|1
664995|NCT01937715|2146421|P1|Overall Study|Withdrawal by Subject|0
664996|NCT01937715|2146417|P5|Overall Study|Death|0
664997|NCT01937715|2146418|P4|Overall Study|Death|1
664998|NCT01937715|2146419|P3|Overall Study|Death|0
664999|NCT01937715|2146420|P2|Overall Study|Death|0
665000|NCT01937715|2146421|P1|Overall Study|Death|0
665001|NCT01937364|2146607|P2|Overall Study|Adverse Event|1
665002|NCT01937364|2146608|P1|Overall Study|Adverse Event|2
665003|NCT01937351|2146620|P2|Overall Study|Not treated w device, per protocol fail|0
665004|NCT01937351|2146621|P1|Overall Study|Not treated w device, per protocol fail|4
665005|NCT01937351|2146620|P2|Overall Study|Death|0
665006|NCT01937351|2146621|P1|Overall Study|Death|1
665007|NCT01937351|2146620|P2|Overall Study|Withdrawal by Subject|2
665008|NCT01937351|2146621|P1|Overall Study|Withdrawal by Subject|4
665009|NCT01937312|2146629|P2|Overall Study|Withdrawal of subject prior to treatment|1
665010|NCT01937312|2146630|P1|Overall Study|Withdrawal of subject prior to treatment|1
665011|NCT01937312|2146629|P2|Overall Study|Lack of Efficacy|1
665012|NCT01937312|2146630|P1|Overall Study|Lack of Efficacy|0
665013|NCT01937312|2146629|P2|Overall Study|Adverse Event|1
665014|NCT01937312|2146630|P1|Overall Study|Adverse Event|10
665015|NCT01937299|2146645|P2|Overall Study|Withdrawal by Subject|0
665016|NCT01937299|2146646|P1|Overall Study|Withdrawal by Subject|1
665017|NCT01937299|2146645|P2|Overall Study|Lack of Efficacy|4
665018|NCT01937299|2146646|P1|Overall Study|Lack of Efficacy|0
665019|NCT01937299|2146645|P2|Overall Study|Adverse Event|0
665020|NCT01937299|2146646|P1|Overall Study|Adverse Event|13
665021|NCT01937130|2146681|P4|Overall Study|Patient lost to FU due to death|0
665022|NCT01937130|2146682|P3|Overall Study|Patient lost to FU due to death|0
665023|NCT01937130|2146683|P2|Overall Study|Patient lost to FU due to death|0
665024|NCT01937130|2146684|P1|Overall Study|Patient lost to FU due to death|2
665025|NCT01937130|2146681|P4|Overall Study|Patients unable to swallow|0
665026|NCT01937130|2146682|P3|Overall Study|Patients unable to swallow|0
665027|NCT01937130|2146683|P2|Overall Study|Patients unable to swallow|1
665028|NCT01937130|2146684|P1|Overall Study|Patients unable to swallow|0
665029|NCT01937130|2146681|P4|Overall Study|Physician Decision|0
665030|NCT01937130|2146682|P3|Overall Study|Physician Decision|0
665031|NCT01937130|2146683|P2|Overall Study|Physician Decision|1
665032|NCT01937130|2146684|P1|Overall Study|Physician Decision|0
665033|NCT01937130|2146681|P4|Overall Study|Lost to Follow-up|0
665034|NCT01937130|2146682|P3|Overall Study|Lost to Follow-up|2
665035|NCT01937130|2146683|P2|Overall Study|Lost to Follow-up|0
665036|NCT01937130|2146684|P1|Overall Study|Lost to Follow-up|2
665037|NCT01937130|2146681|P4|Overall Study|Death|0
665038|NCT01937130|2146682|P3|Overall Study|Death|1
665039|NCT01937130|2146683|P2|Overall Study|Death|1
665040|NCT01937130|2146684|P1|Overall Study|Death|1
665041|NCT01937130|2146681|P4|Overall Study|Adverse Event|1
665042|NCT01937130|2146682|P3|Overall Study|Adverse Event|0
665043|NCT01937130|2146683|P2|Overall Study|Adverse Event|1
665044|NCT01937130|2146684|P1|Overall Study|Adverse Event|0
665045|NCT01937130|2146681|P4|Overall Study|Withdrawal by Subject|1
665046|NCT01937130|2146682|P3|Overall Study|Withdrawal by Subject|0
665047|NCT01937130|2146683|P2|Overall Study|Withdrawal by Subject|0
665048|NCT01937130|2146684|P1|Overall Study|Withdrawal by Subject|0
665049|NCT01936870|2146725|P1|Overall Study|No Drug Administration|1
665050|NCT01936870|2146725|P1|Overall Study|Protocol Violation|12
665051|NCT01936870|2146725|P1|Overall Study|No Visit After Treatment|176
665052|NCT01936649|2146762|P1|Overall Study|Other than specified above|5
665053|NCT01936649|2146762|P1|Overall Study|Protocol Violation|2
665054|NCT01936649|2146762|P1|Overall Study|Physician Decision|2
665055|NCT01936649|2146762|P1|Overall Study|Withdrawal by Subject|4
665056|NCT01936623|2146769|P2|Overall Study|Lost to Follow-up|5
665057|NCT01936623|2146770|P1|Overall Study|Lost to Follow-up|0
665060|NCT01936181|2146841|P4|Transition-extension|Withdrawal by Subject|1
665061|NCT01936181|2146842|P3|Transition-extension|Withdrawal by Subject|2
665062|NCT01936181|2146843|P2|Transition-extension|Withdrawal by Subject|0
665063|NCT01936181|2146844|P1|Transition-extension|Withdrawal by Subject|7
665064|NCT01936181|2146841|P4|Transition-extension|Physician Decision|1
665065|NCT01936181|2146842|P3|Transition-extension|Physician Decision|0
665066|NCT01936181|2146843|P2|Transition-extension|Physician Decision|0
665067|NCT01936181|2146844|P1|Transition-extension|Physician Decision|2
665068|NCT01936181|2146841|P4|Transition-extension|Lost to Follow-up|2
665069|NCT01936181|2146842|P3|Transition-extension|Lost to Follow-up|1
665070|NCT01936181|2146843|P2|Transition-extension|Lost to Follow-up|0
665071|NCT01936181|2146844|P1|Transition-extension|Lost to Follow-up|3
665072|NCT01936181|2146841|P4|Transition-extension|Adverse Event|1
665073|NCT01936181|2146842|P3|Transition-extension|Adverse Event|3
665074|NCT01936181|2146843|P2|Transition-extension|Adverse Event|0
665075|NCT01936181|2146844|P1|Transition-extension|Adverse Event|3
665076|NCT01936181|2146841|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
665077|NCT01936181|2146842|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
665078|NCT01936181|2146843|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
665079|NCT01936181|2146844|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
665080|NCT01936181|2146841|P4|Randomised, Double-blind|Withdrawal by Subject|0
665081|NCT01936181|2146842|P3|Randomised, Double-blind|Withdrawal by Subject|0
665082|NCT01936181|2146843|P2|Randomised, Double-blind|Withdrawal by Subject|26
665083|NCT01936181|2146844|P1|Randomised, Double-blind|Withdrawal by Subject|23
665084|NCT01936181|2146841|P4|Randomised, Double-blind|Physician Decision|0
665085|NCT01936181|2146842|P3|Randomised, Double-blind|Physician Decision|0
665086|NCT01936181|2146843|P2|Randomised, Double-blind|Physician Decision|4
665087|NCT01936181|2146844|P1|Randomised, Double-blind|Physician Decision|4
665088|NCT01936181|2146841|P4|Randomised, Double-blind|Pregnancy|0
665089|NCT01936181|2146842|P3|Randomised, Double-blind|Pregnancy|0
665090|NCT01936181|2146843|P2|Randomised, Double-blind|Pregnancy|1
665091|NCT01936181|2146844|P1|Randomised, Double-blind|Pregnancy|0
665092|NCT01936181|2146841|P4|Randomised, Double-blind|Lost to Follow-up|0
665093|NCT01936181|2146842|P3|Randomised, Double-blind|Lost to Follow-up|0
665094|NCT01936181|2146843|P2|Randomised, Double-blind|Lost to Follow-up|1
665095|NCT01936181|2146844|P1|Randomised, Double-blind|Lost to Follow-up|0
665096|NCT01936181|2146841|P4|Randomised, Double-blind|Lack of Efficacy|0
665097|NCT01936181|2146842|P3|Randomised, Double-blind|Lack of Efficacy|0
665098|NCT01936181|2146843|P2|Randomised, Double-blind|Lack of Efficacy|6
665099|NCT01936181|2146844|P1|Randomised, Double-blind|Lack of Efficacy|5
665100|NCT01936181|2146841|P4|Randomised, Double-blind|Protocol Violation|0
665101|NCT01936181|2146842|P3|Randomised, Double-blind|Protocol Violation|0
665102|NCT01936181|2146843|P2|Randomised, Double-blind|Protocol Violation|5
665103|NCT01936181|2146844|P1|Randomised, Double-blind|Protocol Violation|1
665104|NCT01936181|2146841|P4|Randomised, Double-blind|Adverse Event|0
665105|NCT01936181|2146842|P3|Randomised, Double-blind|Adverse Event|0
665106|NCT01936181|2146843|P2|Randomised, Double-blind|Adverse Event|21
665107|NCT01936181|2146844|P1|Randomised, Double-blind|Adverse Event|27
665108|NCT01934894|2146891|P2|Overall Study|Progressive Disease|2
665109|NCT01934894|2146892|P1|Overall Study|Progressive Disease|3
665110|NCT01934894|2146891|P2|Overall Study|Withdrawal by Subject|1
665111|NCT01934894|2146892|P1|Overall Study|Withdrawal by Subject|0
665112|NCT01934894|2146891|P2|Overall Study|Death|0
665113|NCT01934894|2146892|P1|Overall Study|Death|2
665114|NCT01934894|2146891|P2|Overall Study|Adverse Event|2
665115|NCT01934894|2146892|P1|Overall Study|Adverse Event|1
665116|NCT01934790|2146907|P1|Overall Study|Study drug never administered|1
665117|NCT01934790|2146907|P1|Overall Study|Withdrawal by Subject|2
665118|NCT01934790|2146907|P1|Overall Study|Radiological progression|4
665119|NCT01934790|2146907|P1|Overall Study|Clinical progression|6
665120|NCT01934790|2146907|P1|Overall Study|Adverse Event|3
665121|NCT01934504|2146953|P4|Overall Study|Study Terminated by Sponsor|5
665122|NCT01934504|2146954|P3|Overall Study|Study Terminated by Sponsor|5
665123|NCT01934504|2146955|P2|Overall Study|Study Terminated by Sponsor|0
665124|NCT01934504|2146956|P1|Overall Study|Study Terminated by Sponsor|1
665125|NCT01934504|2146953|P4|Overall Study|Protocol Deviation|2
665126|NCT01934504|2146954|P3|Overall Study|Protocol Deviation|0
665127|NCT01934504|2146955|P2|Overall Study|Protocol Deviation|0
665128|NCT01934504|2146956|P1|Overall Study|Protocol Deviation|0
665129|NCT01934218|2146989|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
665130|NCT01934218|2146990|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
665131|NCT01934218|2146989|P2|Open-Label Phase|Noncompliance with Study Protocol|2
665132|NCT01934218|2146990|P1|Open-Label Phase|Noncompliance with Study Protocol|4
665133|NCT01934218|2146989|P2|Open-Label Phase|Withdrawal by Subject|11
665134|NCT01934218|2146990|P1|Open-Label Phase|Withdrawal by Subject|13
665135|NCT01934218|2146989|P2|Open-Label Phase|Protocol Violation|0
665136|NCT01934218|2146990|P1|Open-Label Phase|Protocol Violation|1
665137|NCT01934218|2146989|P2|Open-Label Phase|Physician Decision|0
665138|NCT01934218|2146990|P1|Open-Label Phase|Physician Decision|1
665139|NCT01934218|2146989|P2|Open-Label Phase|Lost to Follow-up|2
665140|NCT01934218|2146990|P1|Open-Label Phase|Lost to Follow-up|4
665141|NCT01934218|2146989|P2|Open-Label Phase|Lack of Efficacy|4
665142|NCT01934218|2146990|P1|Open-Label Phase|Lack of Efficacy|1
665143|NCT01934218|2146989|P2|Open-Label Phase|Adverse Event|4
665144|NCT01934218|2146990|P1|Open-Label Phase|Adverse Event|2
665145|NCT01934218|2146989|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
665146|NCT01934218|2146990|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
665147|NCT01934218|2146989|P2|Double-blind Phase|Noncompliance with Study Protocol|8
665148|NCT01934218|2146990|P1|Double-blind Phase|Noncompliance with Study Protocol|5
665149|NCT01934218|2146989|P2|Double-blind Phase|Withdrawal by Subject|13
665150|NCT01934218|2146990|P1|Double-blind Phase|Withdrawal by Subject|16
665151|NCT01934218|2146989|P2|Double-blind Phase|Protocol Violation|0
665152|NCT01934218|2146990|P1|Double-blind Phase|Protocol Violation|4
665153|NCT01934218|2146989|P2|Double-blind Phase|Physician Decision|2
665154|NCT01934218|2146990|P1|Double-blind Phase|Physician Decision|1
665155|NCT01934218|2146989|P2|Double-blind Phase|Lost to Follow-up|14
665156|NCT01934218|2146990|P1|Double-blind Phase|Lost to Follow-up|7
665157|NCT01934218|2146989|P2|Double-blind Phase|Lack of Efficacy|7
665158|NCT01934218|2146990|P1|Double-blind Phase|Lack of Efficacy|6
665159|NCT01934218|2146989|P2|Double-blind Phase|Adverse Event|8
665160|NCT01934218|2146990|P1|Double-blind Phase|Adverse Event|8
665161|NCT01933932|2146999|P2|Overall Study|Eligibility criteria not fulfilled|1
665162|NCT01933932|2147000|P1|Overall Study|Eligibility criteria not fulfilled|0
665163|NCT01933932|2146999|P2|Overall Study|Withdrawal by Subject|14
665164|NCT01933932|2147000|P1|Overall Study|Withdrawal by Subject|11
665165|NCT01933932|2146999|P2|Overall Study|Death|163
665166|NCT01933932|2147000|P1|Overall Study|Death|173
665167|NCT01933880|2147018|P2|Overall Study|Protocol Violation|0
665168|NCT01933880|2147019|P1|Overall Study|Protocol Violation|1
665169|NCT01933880|2147018|P2|Overall Study|Unspecified|0
665170|NCT01933880|2147019|P1|Overall Study|Unspecified|4
665171|NCT01933880|2147018|P2|Overall Study|Followup exceeded 4 days to visit window|0
665172|NCT01933880|2147019|P1|Overall Study|Followup exceeded 4 days to visit window|19
665173|NCT01933880|2147018|P2|Overall Study|Concomitant medication Interference|1
665174|NCT01933880|2147019|P1|Overall Study|Concomitant medication Interference|0
665175|NCT01933880|2147018|P2|Overall Study|Lack of Efficacy|0
665176|NCT01933880|2147019|P1|Overall Study|Lack of Efficacy|1
665177|NCT01933880|2147018|P2|Overall Study|Withdrawal by Subject|0
665178|NCT01933880|2147019|P1|Overall Study|Withdrawal by Subject|5
665179|NCT01933672|2147095|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665180|NCT01933672|2147096|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665181|NCT01933672|2147097|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665182|NCT01933672|2147098|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665183|NCT01933672|2147099|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665184|NCT01933672|2147100|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
665185|NCT01933672|2147101|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
665186|NCT01933672|2147095|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665187|NCT01933672|2147096|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665188|NCT01933672|2147097|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665189|NCT01933672|2147098|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
665190|NCT01933672|2147099|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665191|NCT01933672|2147100|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665192|NCT01933672|2147101|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
665193|NCT01933672|2147095|P7|Second Intervention Period (12-16 Days)|Unspecified|0
665194|NCT01933672|2147096|P6|Second Intervention Period (12-16 Days)|Unspecified|0
665195|NCT01933672|2147097|P5|Second Intervention Period (12-16 Days)|Unspecified|0
665196|NCT01933672|2147098|P4|Second Intervention Period (12-16 Days)|Unspecified|0
665197|NCT01933672|2147099|P3|Second Intervention Period (12-16 Days)|Unspecified|1
665198|NCT01933672|2147100|P2|Second Intervention Period (12-16 Days)|Unspecified|1
665199|NCT01933672|2147101|P1|Second Intervention Period (12-16 Days)|Unspecified|0
665200|NCT01933672|2147095|P7|First Intervention Period (12-16 Days)|Unspecified|0
665201|NCT01933672|2147096|P6|First Intervention Period (12-16 Days)|Unspecified|1
665202|NCT01933672|2147097|P5|First Intervention Period (12-16 Days)|Unspecified|0
665203|NCT01933672|2147098|P4|First Intervention Period (12-16 Days)|Unspecified|0
665204|NCT01933672|2147099|P3|First Intervention Period (12-16 Days)|Unspecified|1
665205|NCT01933672|2147100|P2|First Intervention Period (12-16 Days)|Unspecified|0
665206|NCT01933672|2147101|P1|First Intervention Period (12-16 Days)|Unspecified|0
665207|NCT01933672|2147095|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665208|NCT01933672|2147096|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665209|NCT01933672|2147097|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
665210|NCT01933672|2147098|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665211|NCT01933672|2147099|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665212|NCT01933672|2147100|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665213|NCT01933672|2147101|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
665214|NCT01933672|2147095|P7|Metformin Run-in Period|Unspecified|0
665215|NCT01933672|2147096|P6|Metformin Run-in Period|Unspecified|0
665216|NCT01933672|2147097|P5|Metformin Run-in Period|Unspecified|0
665217|NCT01933672|2147098|P4|Metformin Run-in Period|Unspecified|0
665218|NCT01933672|2147099|P3|Metformin Run-in Period|Unspecified|0
665219|NCT01933672|2147100|P2|Metformin Run-in Period|Unspecified|0
665220|NCT01933672|2147101|P1|Metformin Run-in Period|Unspecified|5
665221|NCT01933672|2147095|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
665222|NCT01933672|2147096|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
665223|NCT01933672|2147097|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
665224|NCT01933672|2147098|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
665225|NCT01933672|2147099|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
665226|NCT01933672|2147100|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
665227|NCT01933672|2147101|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
665228|NCT01933672|2147095|P7|Metformin Run-in Period|Adverse Event|0
665229|NCT01933672|2147096|P6|Metformin Run-in Period|Adverse Event|0
665230|NCT01933672|2147097|P5|Metformin Run-in Period|Adverse Event|0
665231|NCT01933672|2147098|P4|Metformin Run-in Period|Adverse Event|0
665232|NCT01933672|2147099|P3|Metformin Run-in Period|Adverse Event|0
665233|NCT01933672|2147100|P2|Metformin Run-in Period|Adverse Event|0
665234|NCT01933672|2147101|P1|Metformin Run-in Period|Adverse Event|1
665235|NCT01933334|2147176|P2|Overall Study|Withdrawal by Subject|1
665236|NCT01933334|2147177|P1|Overall Study|Withdrawal by Subject|0
665237|NCT01933334|2147176|P2|Overall Study|Adverse Event|1
665238|NCT01933334|2147177|P1|Overall Study|Adverse Event|5
665239|NCT01933048|2147193|P2|Overall Study|unknown reasons|1
665240|NCT01933048|2147194|P1|Overall Study|unknown reasons|1
665241|NCT01933048|2147193|P2|Overall Study|Physician Decision|0
665242|NCT01933048|2147194|P1|Overall Study|Physician Decision|1
665243|NCT01933048|2147193|P2|Overall Study|Protocol Violation|8
665244|NCT01933048|2147194|P1|Overall Study|Protocol Violation|7
665245|NCT01933048|2147193|P2|Overall Study|personal reasons|1
665246|NCT01933048|2147194|P1|Overall Study|personal reasons|1
665247|NCT01933048|2147193|P2|Overall Study|Lost to Follow-up|18
665248|NCT01933048|2147194|P1|Overall Study|Lost to Follow-up|15
665249|NCT01932970|2147207|P1|Overall Study|Protocol Specified Criteria|10
665250|NCT01932970|2147207|P1|Overall Study|Lost to Follow-up|2
665251|NCT01932970|2147207|P1|Overall Study|Death|1
665252|NCT01932970|2147207|P1|Overall Study|Withdrawal by Subject|5
665253|NCT01932762|2147219|P4|Overall Study|Physician Decision|0
665254|NCT01932762|2147220|P3|Overall Study|Physician Decision|0
665255|NCT01932762|2147221|P2|Overall Study|Physician Decision|0
665256|NCT01932762|2147222|P1|Overall Study|Physician Decision|1
665257|NCT01932762|2147219|P4|Overall Study|Lost to Follow-up|1
665258|NCT01932762|2147220|P3|Overall Study|Lost to Follow-up|0
665259|NCT01932762|2147221|P2|Overall Study|Lost to Follow-up|0
665260|NCT01932762|2147222|P1|Overall Study|Lost to Follow-up|4
665261|NCT01932762|2147219|P4|Overall Study|Withdrawal by Subject|0
665262|NCT01932762|2147220|P3|Overall Study|Withdrawal by Subject|0
665263|NCT01932762|2147221|P2|Overall Study|Withdrawal by Subject|2
665264|NCT01932762|2147222|P1|Overall Study|Withdrawal by Subject|1
665265|NCT01931956|2147331|P2|Overall Study|Withdrawal by Subject|0
665266|NCT01931956|2147332|P1|Overall Study|Withdrawal by Subject|2
665267|NCT01931956|2147331|P2|Overall Study|Lost to Follow-up|1
665268|NCT01931956|2147332|P1|Overall Study|Lost to Follow-up|3
665269|NCT01931956|2147331|P2|Overall Study|Death|5
665270|NCT01931956|2147332|P1|Overall Study|Death|18
665271|NCT01931865|2147389|P1|Overall Study|Withdrawal by Subject|2
665272|NCT01931865|2147389|P1|Overall Study|Lost to Follow-up|2
665273|NCT01931839|2147402|P7|Overall Study|Unspecified|0
665274|NCT01931839|2147403|P6|Overall Study|Unspecified|0
665275|NCT01931839|2147404|P5|Overall Study|Unspecified|0
665276|NCT01931839|2147405|P4|Overall Study|Unspecified|0
665277|NCT01931839|2147406|P3|Overall Study|Unspecified|6
665278|NCT01931839|2147407|P2|Overall Study|Unspecified|2
665279|NCT01931839|2147408|P1|Overall Study|Unspecified|4
665280|NCT01931839|2147402|P7|Overall Study|Lost to Follow-up|0
665281|NCT01931839|2147403|P6|Overall Study|Lost to Follow-up|0
665282|NCT01931839|2147404|P5|Overall Study|Lost to Follow-up|0
665283|NCT01931839|2147405|P4|Overall Study|Lost to Follow-up|5
665284|NCT01931839|2147406|P3|Overall Study|Lost to Follow-up|4
665285|NCT01931839|2147407|P2|Overall Study|Lost to Follow-up|2
665286|NCT01931839|2147408|P1|Overall Study|Lost to Follow-up|1
665287|NCT01931839|2147402|P7|Overall Study|Other non-compliance|0
665288|NCT01931839|2147403|P6|Overall Study|Other non-compliance|3
665289|NCT01931839|2147404|P5|Overall Study|Other non-compliance|0
665290|NCT01931839|2147405|P4|Overall Study|Other non-compliance|3
665291|NCT01931839|2147406|P3|Overall Study|Other non-compliance|12
665292|NCT01931839|2147407|P2|Overall Study|Other non-compliance|9
665293|NCT01931839|2147408|P1|Overall Study|Other non-compliance|15
665294|NCT01931839|2147402|P7|Overall Study|Withdrawal of consent (not due to AE)|2
665295|NCT01931839|2147403|P6|Overall Study|Withdrawal of consent (not due to AE)|2
665296|NCT01931839|2147404|P5|Overall Study|Withdrawal of consent (not due to AE)|0
665297|NCT01931839|2147405|P4|Overall Study|Withdrawal of consent (not due to AE)|3
665298|NCT01931839|2147406|P3|Overall Study|Withdrawal of consent (not due to AE)|13
665299|NCT01931839|2147407|P2|Overall Study|Withdrawal of consent (not due to AE)|8
665300|NCT01931839|2147408|P1|Overall Study|Withdrawal of consent (not due to AE)|11
665301|NCT01931839|2147402|P7|Overall Study|Adverse Event|1
665302|NCT01931839|2147403|P6|Overall Study|Adverse Event|0
665303|NCT01931839|2147404|P5|Overall Study|Adverse Event|0
665304|NCT01931839|2147405|P4|Overall Study|Adverse Event|3
665305|NCT01931839|2147406|P3|Overall Study|Adverse Event|1
665306|NCT01931839|2147407|P2|Overall Study|Adverse Event|4
665307|NCT01931839|2147408|P1|Overall Study|Adverse Event|9
665308|NCT01931839|2147402|P7|Overall Study|Withdrawal of consent|0
665309|NCT01931839|2147403|P6|Overall Study|Withdrawal of consent|0
665310|NCT01931839|2147404|P5|Overall Study|Withdrawal of consent|1
665311|NCT01931839|2147405|P4|Overall Study|Withdrawal of consent|0
665312|NCT01931839|2147406|P3|Overall Study|Withdrawal of consent|0
665313|NCT01931839|2147407|P2|Overall Study|Withdrawal of consent|0
665314|NCT01931839|2147408|P1|Overall Study|Withdrawal of consent|0
665315|NCT01931839|2147402|P7|Overall Study|Physician Decision|1
665316|NCT01931839|2147403|P6|Overall Study|Physician Decision|0
665317|NCT01931839|2147404|P5|Overall Study|Physician Decision|0
665318|NCT01931839|2147405|P4|Overall Study|Physician Decision|0
665319|NCT01931839|2147406|P3|Overall Study|Physician Decision|1
665320|NCT01931839|2147407|P2|Overall Study|Physician Decision|0
665321|NCT01931839|2147408|P1|Overall Study|Physician Decision|1
665322|NCT01931839|2147402|P7|Overall Study|Death|0
665323|NCT01931839|2147403|P6|Overall Study|Death|0
665324|NCT01931839|2147404|P5|Overall Study|Death|0
665325|NCT01931839|2147405|P4|Overall Study|Death|0
665326|NCT01931839|2147406|P3|Overall Study|Death|2
665327|NCT01931839|2147407|P2|Overall Study|Death|1
665328|NCT01931839|2147408|P1|Overall Study|Death|0
665329|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
665330|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
665331|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
665332|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
665333|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Physician Decision|1
665334|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Physician Decision|1
665335|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
665336|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
665337|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
665338|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
665339|NCT01931475|2147499|P2|Period 2: Extension Treatment Phase|Adverse Event|8
665340|NCT01931475|2147500|P1|Period 2: Extension Treatment Phase|Adverse Event|0
665341|NCT01931475|2147499|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
665342|NCT01931475|2147500|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
665343|NCT01931475|2147499|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
665344|NCT01931475|2147500|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
665345|NCT01931475|2147499|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
665346|NCT01931475|2147500|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
665347|NCT01931475|2147499|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
665348|NCT01931475|2147500|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
665349|NCT01931475|2147499|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
665350|NCT01931475|2147500|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
665351|NCT01931397|2147527|P1|Overall Study|moved out of state|1
665352|NCT01931397|2147527|P1|Overall Study|Withdrawal by Subject|8
665353|NCT01931397|2147527|P1|Overall Study|Physician Decision|2
665354|NCT01931150|2147538|P2|Overall Study|Withdrawal by Subject|2
665355|NCT01931150|2147539|P1|Overall Study|Withdrawal by Subject|1
665356|NCT01930890|2147549|P4|Overall Study|Adverse Event|0
665357|NCT01930890|2147550|P3|Overall Study|Adverse Event|0
665358|NCT01930890|2147551|P2|Overall Study|Adverse Event|1
665359|NCT01930890|2147552|P1|Overall Study|Adverse Event|0
665360|NCT01930890|2147549|P4|Overall Study|Consent Withdrawn|1
665361|NCT01930890|2147550|P3|Overall Study|Consent Withdrawn|0
665362|NCT01930890|2147551|P2|Overall Study|Consent Withdrawn|3
665363|NCT01930890|2147552|P1|Overall Study|Consent Withdrawn|0
665364|NCT01930890|2147549|P4|Overall Study|Investigator Decision|0
665365|NCT01930890|2147550|P3|Overall Study|Investigator Decision|0
665366|NCT01930890|2147551|P2|Overall Study|Investigator Decision|1
665367|NCT01930890|2147552|P1|Overall Study|Investigator Decision|0
665368|NCT01930890|2147549|P4|Overall Study|Death|1
665369|NCT01930890|2147550|P3|Overall Study|Death|0
665370|NCT01930890|2147551|P2|Overall Study|Death|0
665371|NCT01930890|2147552|P1|Overall Study|Death|0
665372|NCT01930890|2147549|P4|Overall Study|Study Termination|25
665373|NCT01930890|2147550|P3|Overall Study|Study Termination|13
665374|NCT01930890|2147551|P2|Overall Study|Study Termination|28
665375|NCT01930890|2147552|P1|Overall Study|Study Termination|14
665376|NCT01930799|2147566|P1|Overall Study|Lost to Follow-up|5
665377|NCT01930799|2147566|P1|Overall Study|Withdrawal by Subject|3
665378|NCT01930162|2147674|P1|Overall Study|Death|1
665379|NCT01930162|2147674|P1|Overall Study|Abnormal test procedure result(s)|4
665380|NCT01930045|2147710|P6|Pause (up to 37 Days)|Protocol Violation|1
665381|NCT01930045|2147711|P5|Pause (up to 37 Days)|Protocol Violation|0
665382|NCT01930045|2147712|P4|Pause (up to 37 Days)|Protocol Violation|0
665383|NCT01930045|2147713|P3|Pause (up to 37 Days)|Protocol Violation|0
665384|NCT01930045|2147714|P2|Pause (up to 37 Days)|Protocol Violation|0
665385|NCT01930045|2147715|P1|Pause (up to 37 Days)|Protocol Violation|0
665386|NCT01930045|2147710|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
665387|NCT01930045|2147711|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
665388|NCT01930045|2147712|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
665389|NCT01930045|2147713|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
665390|NCT01930045|2147714|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
665391|NCT01930045|2147715|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
665392|NCT01929993|2147742|P2|Overall Study|Absent CIN, invasion present or artifact|22
665393|NCT01929993|2147743|P1|Overall Study|Absent CIN, invasion present or artifact|26
665394|NCT01929993|2147742|P2|Overall Study|Protocol Violation|6
665395|NCT01929993|2147743|P1|Overall Study|Protocol Violation|4
665396|NCT01929980|2147749|P1|Overall Study|Physician Decision|1
665397|NCT01929876|2147757|P1|Period 2|Non-Compliance|1
665398|NCT01929863|2147770|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
665399|NCT01929863|2147771|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
665400|NCT01929863|2147770|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
665401|NCT01929863|2147771|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
665402|NCT01929863|2147770|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
665403|NCT01929863|2147771|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
665404|NCT01929681|2147828|P2|Overall Study|Physician Decision|1
665405|NCT01929681|2147829|P1|Overall Study|Physician Decision|1
665406|NCT01929681|2147828|P2|Overall Study|Withdrawal by Subject|0
665407|NCT01929681|2147829|P1|Overall Study|Withdrawal by Subject|1
665426|NCT01929135|2147944|P2|Overall Study|Lost to Follow-up|1
665427|NCT01929135|2147945|P1|Overall Study|Lost to Follow-up|1
665428|NCT01929083|2147959|P2|Intervention 2|Adverse Event|1
665429|NCT01929083|2147960|P1|Intervention 2|Adverse Event|0
665430|NCT01929083|2147959|P2|Intervention 1|Nonadherent to study medications|0
665431|NCT01929083|2147960|P1|Intervention 1|Nonadherent to study medications|1
665432|NCT01929083|2147959|P2|Intervention 1|Lost to Follow-up|0
665433|NCT01929083|2147960|P1|Intervention 1|Lost to Follow-up|2
665434|NCT01929044|2147986|P2|Overall Study|Not Treated|3
665435|NCT01929044|2147987|P1|Overall Study|Not Treated|1
665436|NCT01929044|2147986|P2|Overall Study|Protocol Violation|14
665437|NCT01929044|2147987|P1|Overall Study|Protocol Violation|9
665438|NCT01929044|2147986|P2|Overall Study|Adverse Event|0
665439|NCT01929044|2147987|P1|Overall Study|Adverse Event|1
665440|NCT01929031|2148009|P6|Overall Study|Reason other than specified above|0
665441|NCT01929031|2148010|P5|Overall Study|Reason other than specified above|1
665442|NCT01929031|2148011|P4|Overall Study|Reason other than specified above|0
665443|NCT01929031|2148012|P3|Overall Study|Reason other than specified above|0
665444|NCT01929031|2148013|P2|Overall Study|Reason other than specified above|1
665445|NCT01929031|2148014|P1|Overall Study|Reason other than specified above|0
665446|NCT01929031|2148009|P6|Overall Study|Protocol Violation|1
665447|NCT01929031|2148010|P5|Overall Study|Protocol Violation|0
665448|NCT01929031|2148011|P4|Overall Study|Protocol Violation|0
665449|NCT01929031|2148012|P3|Overall Study|Protocol Violation|0
665450|NCT01929031|2148013|P2|Overall Study|Protocol Violation|0
665451|NCT01929031|2148014|P1|Overall Study|Protocol Violation|1
665452|NCT01929031|2148009|P6|Overall Study|Adverse Event|0
665453|NCT01929031|2148010|P5|Overall Study|Adverse Event|0
665454|NCT01929031|2148011|P4|Overall Study|Adverse Event|0
665455|NCT01929031|2148012|P3|Overall Study|Adverse Event|1
665456|NCT01929031|2148013|P2|Overall Study|Adverse Event|1
665457|NCT01929031|2148014|P1|Overall Study|Adverse Event|3
665458|NCT01928940|2148038|P2|Overall Study|Adverse Event|1
665459|NCT01928940|2148039|P1|Overall Study|Adverse Event|0
665460|NCT01928927|2148082|P2|Overall Study|Withdrawal by Subject|1
665461|NCT01928927|2148083|P1|Overall Study|Withdrawal by Subject|1
665462|NCT01928927|2148082|P2|Overall Study|Lost to Follow-up|0
665463|NCT01928927|2148083|P1|Overall Study|Lost to Follow-up|1
665464|NCT01928771|2148221|P3|Overall Study|Severe Non-Compliance to Protocol|2
665465|NCT01928771|2148222|P2|Overall Study|Severe Non-Compliance to Protocol|2
665466|NCT01928771|2148223|P1|Overall Study|Severe Non-Compliance to Protocol|4
665467|NCT01928771|2148221|P3|Overall Study|Other Reasons|14
665468|NCT01928771|2148222|P2|Overall Study|Other Reasons|9
665469|NCT01928771|2148223|P1|Overall Study|Other Reasons|9
665470|NCT01928771|2148221|P3|Overall Study|Study-Specific Withdrawal Criteria|1
665471|NCT01928771|2148222|P2|Overall Study|Study-Specific Withdrawal Criteria|1
665472|NCT01928771|2148223|P1|Overall Study|Study-Specific Withdrawal Criteria|0
665473|NCT01928771|2148221|P3|Overall Study|Withdrawal by Subject|17
665474|NCT01928771|2148222|P2|Overall Study|Withdrawal by Subject|15
665475|NCT01928771|2148223|P1|Overall Study|Withdrawal by Subject|20
665476|NCT01928771|2148221|P3|Overall Study|Lost to Follow-up|3
665477|NCT01928771|2148222|P2|Overall Study|Lost to Follow-up|6
665478|NCT01928771|2148223|P1|Overall Study|Lost to Follow-up|5
665479|NCT01928771|2148221|P3|Overall Study|Death|2
665480|NCT01928771|2148222|P2|Overall Study|Death|2
665481|NCT01928771|2148223|P1|Overall Study|Death|2
665482|NCT01928771|2148221|P3|Overall Study|Adverse Event|1
665483|NCT01928771|2148222|P2|Overall Study|Adverse Event|5
665484|NCT01928771|2148223|P1|Overall Study|Adverse Event|6
665485|NCT01928615|2148335|P1|Overall Study|Study Terminated by Sponsor|2
665486|NCT01928472|2148354|P4|Overall Study|Unclassified|0
665487|NCT01928472|2148355|P3|Overall Study|Unclassified|1
665488|NCT01928472|2148356|P2|Overall Study|Unclassified|0
665489|NCT01928472|2148357|P1|Overall Study|Unclassified|0
665490|NCT01928472|2148354|P4|Overall Study|Administrative Reason|0
665491|NCT01928472|2148355|P3|Overall Study|Administrative Reason|0
665492|NCT01928472|2148356|P2|Overall Study|Administrative Reason|1
665493|NCT01928472|2148357|P1|Overall Study|Administrative Reason|2
665494|NCT01928472|2148354|P4|Overall Study|Lost to Follow-up|0
665495|NCT01928472|2148355|P3|Overall Study|Lost to Follow-up|4
665496|NCT01928472|2148356|P2|Overall Study|Lost to Follow-up|3
665497|NCT01928472|2148357|P1|Overall Study|Lost to Follow-up|2
665498|NCT01928472|2148354|P4|Overall Study|Withdrawal by Subject|2
665499|NCT01928472|2148355|P3|Overall Study|Withdrawal by Subject|1
665500|NCT01928472|2148356|P2|Overall Study|Withdrawal by Subject|4
665501|NCT01928472|2148357|P1|Overall Study|Withdrawal by Subject|4
665502|NCT01928472|2148354|P4|Overall Study|Death|0
665503|NCT01928472|2148355|P3|Overall Study|Death|1
665504|NCT01928472|2148356|P2|Overall Study|Death|0
665505|NCT01928472|2148357|P1|Overall Study|Death|0
665506|NCT01928433|2148427|P3|Overall Study|Other reasons|4
665507|NCT01928433|2148428|P2|Overall Study|Other reasons|3
665508|NCT01928433|2148429|P1|Overall Study|Other reasons|3
665509|NCT01928433|2148427|P3|Overall Study|Lost to Follow-up|3
665510|NCT01928433|2148428|P2|Overall Study|Lost to Follow-up|2
665511|NCT01928433|2148429|P1|Overall Study|Lost to Follow-up|0
665512|NCT01928433|2148427|P3|Overall Study|Negative screening urine culture|10
665513|NCT01928433|2148428|P2|Overall Study|Negative screening urine culture|6
665514|NCT01928433|2148429|P1|Overall Study|Negative screening urine culture|7
665515|NCT01928433|2148427|P3|Overall Study|Withdrawal by Subject|0
665516|NCT01928433|2148428|P2|Overall Study|Withdrawal by Subject|4
665517|NCT01928433|2148429|P1|Overall Study|Withdrawal by Subject|0
665518|NCT01928433|2148427|P3|Overall Study|Lack of Efficacy|4
665519|NCT01928433|2148428|P2|Overall Study|Lack of Efficacy|4
665520|NCT01928433|2148429|P1|Overall Study|Lack of Efficacy|5
665521|NCT01928433|2148427|P3|Overall Study|Protocol Violation|2
665522|NCT01928433|2148428|P2|Overall Study|Protocol Violation|0
665523|NCT01928433|2148429|P1|Overall Study|Protocol Violation|0
665524|NCT01928433|2148427|P3|Overall Study|Adverse Event|5
665525|NCT01928433|2148428|P2|Overall Study|Adverse Event|2
665526|NCT01928433|2148429|P1|Overall Study|Adverse Event|5
665527|NCT01928381|2148452|P7|Part 2 - Post Third Intervention|Protocol Violation|0
665528|NCT01928381|2148453|P6|Part 2 - Post Third Intervention|Protocol Violation|0
665529|NCT01928381|2148454|P5|Part 2 - Post Third Intervention|Protocol Violation|0
665530|NCT01928381|2148455|P4|Part 2 - Post Third Intervention|Protocol Violation|0
665531|NCT01928381|2148456|P3|Part 2 - Post Third Intervention|Protocol Violation|1
665532|NCT01928381|2148457|P2|Part 2 - Post Third Intervention|Protocol Violation|0
665533|NCT01928381|2148458|P1|Part 2 - Post Third Intervention|Protocol Violation|0
665534|NCT01928381|2148452|P7|Part 2 - Second Intervention|Lost to Follow-up|0
665535|NCT01928381|2148453|P6|Part 2 - Second Intervention|Lost to Follow-up|0
665536|NCT01928381|2148454|P5|Part 2 - Second Intervention|Lost to Follow-up|0
665537|NCT01928381|2148455|P4|Part 2 - Second Intervention|Lost to Follow-up|1
665538|NCT01928381|2148456|P3|Part 2 - Second Intervention|Lost to Follow-up|0
665539|NCT01928381|2148457|P2|Part 2 - Second Intervention|Lost to Follow-up|1
665540|NCT01928381|2148458|P1|Part 2 - Second Intervention|Lost to Follow-up|0
665541|NCT01928381|2148452|P7|Washout First Intervention|Protocol Violation|0
665542|NCT01928381|2148453|P6|Washout First Intervention|Protocol Violation|0
665543|NCT01928381|2148454|P5|Washout First Intervention|Protocol Violation|1
665544|NCT01928381|2148455|P4|Washout First Intervention|Protocol Violation|0
665545|NCT01928381|2148456|P3|Washout First Intervention|Protocol Violation|0
665546|NCT01928381|2148457|P2|Washout First Intervention|Protocol Violation|0
665547|NCT01928381|2148458|P1|Washout First Intervention|Protocol Violation|0
665548|NCT01928381|2148452|P7|Part 2 - First Intervention|Lost to Follow-up|0
665549|NCT01928381|2148453|P6|Part 2 - First Intervention|Lost to Follow-up|0
665550|NCT01928381|2148454|P5|Part 2 - First Intervention|Lost to Follow-up|0
665551|NCT01928381|2148455|P4|Part 2 - First Intervention|Lost to Follow-up|1
665552|NCT01928381|2148456|P3|Part 2 - First Intervention|Lost to Follow-up|0
665553|NCT01928381|2148457|P2|Part 2 - First Intervention|Lost to Follow-up|0
665554|NCT01928381|2148458|P1|Part 2 - First Intervention|Lost to Follow-up|0
665555|NCT01928381|2148452|P7|Part 2 - First Intervention|Eligibility criterion not met|1
665556|NCT01928381|2148453|P6|Part 2 - First Intervention|Eligibility criterion not met|1
665557|NCT01928381|2148454|P5|Part 2 - First Intervention|Eligibility criterion not met|0
665558|NCT01928381|2148455|P4|Part 2 - First Intervention|Eligibility criterion not met|0
665559|NCT01928381|2148456|P3|Part 2 - First Intervention|Eligibility criterion not met|0
665560|NCT01928381|2148457|P2|Part 2 - First Intervention|Eligibility criterion not met|0
665561|NCT01928381|2148458|P1|Part 2 - First Intervention|Eligibility criterion not met|0
665562|NCT01928381|2148452|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
665563|NCT01928381|2148453|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
665564|NCT01928381|2148454|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
665565|NCT01928381|2148455|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
665566|NCT01928381|2148456|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
665567|NCT01928381|2148457|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
665568|NCT01928381|2148458|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
665569|NCT01928381|2148452|P7|Part 2 - First Intervention|Withdrawal by Subject|0
665570|NCT01928381|2148453|P6|Part 2 - First Intervention|Withdrawal by Subject|0
665571|NCT01928381|2148454|P5|Part 2 - First Intervention|Withdrawal by Subject|0
665572|NCT01928381|2148455|P4|Part 2 - First Intervention|Withdrawal by Subject|0
665573|NCT01928381|2148456|P3|Part 2 - First Intervention|Withdrawal by Subject|1
665574|NCT01928381|2148457|P2|Part 2 - First Intervention|Withdrawal by Subject|0
665575|NCT01928381|2148458|P1|Part 2 - First Intervention|Withdrawal by Subject|0
665576|NCT01928381|2148452|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665577|NCT01928381|2148453|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665578|NCT01928381|2148454|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665579|NCT01928381|2148455|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665580|NCT01928381|2148456|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665581|NCT01928381|2148457|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
665582|NCT01928381|2148458|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
665583|NCT01928381|2148452|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665584|NCT01928381|2148453|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665585|NCT01928381|2148454|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665586|NCT01928381|2148455|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665587|NCT01928381|2148456|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665588|NCT01928381|2148457|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
665589|NCT01928381|2148458|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
665590|NCT01928381|2148452|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665591|NCT01928381|2148453|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665592|NCT01928381|2148454|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665593|NCT01928381|2148455|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665594|NCT01928381|2148456|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665595|NCT01928381|2148457|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
665596|NCT01928381|2148458|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
665597|NCT01928381|2148452|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665598|NCT01928381|2148453|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665599|NCT01928381|2148454|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665600|NCT01928381|2148455|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665601|NCT01928381|2148456|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665602|NCT01928381|2148457|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
665603|NCT01928381|2148458|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
665604|NCT01928381|2148452|P7|Part 1 - Pain Training|Protocol Violation|0
665605|NCT01928381|2148453|P6|Part 1 - Pain Training|Protocol Violation|0
665606|NCT01928381|2148454|P5|Part 1 - Pain Training|Protocol Violation|0
665607|NCT01928381|2148455|P4|Part 1 - Pain Training|Protocol Violation|0
665608|NCT01928381|2148456|P3|Part 1 - Pain Training|Protocol Violation|0
665609|NCT01928381|2148457|P2|Part 1 - Pain Training|Protocol Violation|0
665610|NCT01928381|2148458|P1|Part 1 - Pain Training|Protocol Violation|1
665611|NCT01928381|2148452|P7|Part 1 - Pain Training|Lost to Follow-up|0
665612|NCT01928381|2148453|P6|Part 1 - Pain Training|Lost to Follow-up|0
665613|NCT01928381|2148454|P5|Part 1 - Pain Training|Lost to Follow-up|0
665614|NCT01928381|2148455|P4|Part 1 - Pain Training|Lost to Follow-up|0
665615|NCT01928381|2148456|P3|Part 1 - Pain Training|Lost to Follow-up|0
665616|NCT01928381|2148457|P2|Part 1 - Pain Training|Lost to Follow-up|0
665617|NCT01928381|2148458|P1|Part 1 - Pain Training|Lost to Follow-up|4
665618|NCT01928381|2148452|P7|Part 1 - Pain Training|Withdrawal by Subject|0
665619|NCT01928381|2148453|P6|Part 1 - Pain Training|Withdrawal by Subject|0
665620|NCT01928381|2148454|P5|Part 1 - Pain Training|Withdrawal by Subject|0
665621|NCT01928381|2148455|P4|Part 1 - Pain Training|Withdrawal by Subject|0
665622|NCT01928381|2148456|P3|Part 1 - Pain Training|Withdrawal by Subject|0
665623|NCT01928381|2148457|P2|Part 1 - Pain Training|Withdrawal by Subject|0
665624|NCT01928381|2148458|P1|Part 1 - Pain Training|Withdrawal by Subject|1
665625|NCT01928381|2148452|P7|Part 1 - Pain Training|Pain training criteria not met|0
665626|NCT01928381|2148453|P6|Part 1 - Pain Training|Pain training criteria not met|0
665627|NCT01928381|2148454|P5|Part 1 - Pain Training|Pain training criteria not met|0
665628|NCT01928381|2148455|P4|Part 1 - Pain Training|Pain training criteria not met|0
665629|NCT01928381|2148456|P3|Part 1 - Pain Training|Pain training criteria not met|0
665630|NCT01928381|2148457|P2|Part 1 - Pain Training|Pain training criteria not met|0
665631|NCT01928381|2148458|P1|Part 1 - Pain Training|Pain training criteria not met|29
665632|NCT01928381|2148452|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665633|NCT01928381|2148453|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665634|NCT01928381|2148454|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665635|NCT01928381|2148455|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665636|NCT01928381|2148456|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665637|NCT01928381|2148457|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
665638|NCT01928381|2148458|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
665639|NCT01927757|2148499|P1|Overall Study|Ethical Reasons|4
665640|NCT01927757|2148499|P1|Overall Study|Other|1
665641|NCT01927757|2148499|P1|Overall Study|Decision by Sponsor|2
665642|NCT01927757|2148499|P1|Overall Study|Lost to Follow-up|2
665643|NCT01927757|2148499|P1|Overall Study|Withdrawal by Subject|14
888465|NCT01884571|2822334|P1|Overall Study|Disease progression|3
888466|NCT01884571|2822334|P1|Overall Study|Withdrawal by Subject|2
888467|NCT01884571|2822334|P1|Overall Study|Death|2
888468|NCT01884571|2822334|P1|Overall Study|Adverse Event|1
888469|NCT01879410|2822404|P2|Overall Study|Randomised in Error|2
888470|NCT01879410|2822405|P1|Overall Study|Randomised in Error|1
888471|NCT01879410|2822404|P2|Overall Study|Withdrawal by Subject|8
888472|NCT01879410|2822405|P1|Overall Study|Withdrawal by Subject|7
665658|NCT01927055|2148562|P3|Double-Blind|Extended Vacation|0
665659|NCT01927055|2148563|P2|Double-Blind|Extended Vacation|1
665660|NCT01927055|2148564|P1|Double-Blind|Extended Vacation|0
665661|NCT01927055|2148562|P3|Double-Blind|Supine Hypertension|1
665662|NCT01927055|2148563|P2|Double-Blind|Supine Hypertension|0
665663|NCT01927055|2148564|P1|Double-Blind|Supine Hypertension|0
665664|NCT01927055|2148562|P3|Double-Blind|Study Stopped|7
665665|NCT01927055|2148563|P2|Double-Blind|Study Stopped|7
665666|NCT01927055|2148564|P1|Double-Blind|Study Stopped|0
665667|NCT01927055|2148562|P3|Double-Blind|Withdrawal by Subject|3
665668|NCT01927055|2148563|P2|Double-Blind|Withdrawal by Subject|2
665669|NCT01927055|2148564|P1|Double-Blind|Withdrawal by Subject|0
665670|NCT01927055|2148562|P3|Double-Blind|Protocol Violation|1
665671|NCT01927055|2148563|P2|Double-Blind|Protocol Violation|0
665672|NCT01927055|2148564|P1|Double-Blind|Protocol Violation|0
665673|NCT01927055|2148562|P3|Double-Blind|Adverse Event|1
665674|NCT01927055|2148563|P2|Double-Blind|Adverse Event|1
665675|NCT01927055|2148564|P1|Double-Blind|Adverse Event|0
665676|NCT01927055|2148562|P3|Open-label|Difficulty attending study visits|0
665677|NCT01927055|2148563|P2|Open-label|Difficulty attending study visits|0
665678|NCT01927055|2148564|P1|Open-label|Difficulty attending study visits|1
665679|NCT01927055|2148562|P3|Open-label|Supine Hypertension|0
665680|NCT01927055|2148563|P2|Open-label|Supine Hypertension|0
665681|NCT01927055|2148564|P1|Open-label|Supine Hypertension|4
665682|NCT01927055|2148562|P3|Open-label|Study Stopped|0
665683|NCT01927055|2148563|P2|Open-label|Study Stopped|0
665684|NCT01927055|2148564|P1|Open-label|Study Stopped|4
665685|NCT01927055|2148562|P3|Open-label|Withdrawal by Subject|0
665686|NCT01927055|2148563|P2|Open-label|Withdrawal by Subject|0
665687|NCT01927055|2148564|P1|Open-label|Withdrawal by Subject|1
665688|NCT01927055|2148562|P3|Open-label|Adverse Event|0
665689|NCT01927055|2148563|P2|Open-label|Adverse Event|0
665690|NCT01927055|2148564|P1|Open-label|Adverse Event|6
665691|NCT01926782|2148588|P6|Overall Study|Related to study drug administration|2
665692|NCT01926782|2148589|P5|Overall Study|Related to study drug administration|0
665693|NCT01926782|2148590|P4|Overall Study|Related to study drug administration|0
665694|NCT01926782|2148591|P3|Overall Study|Related to study drug administration|0
888473|NCT01879410|2822404|P2|Overall Study|Lost to Follow-up|1
665695|NCT01926782|2148592|P2|Overall Study|Related to study drug administration|0
665696|NCT01926782|2148593|P1|Overall Study|Related to study drug administration|0
665697|NCT01926782|2148588|P6|Overall Study|Withdrawal by Subject|5
665698|NCT01926782|2148589|P5|Overall Study|Withdrawal by Subject|0
665699|NCT01926782|2148590|P4|Overall Study|Withdrawal by Subject|1
665700|NCT01926782|2148591|P3|Overall Study|Withdrawal by Subject|8
665701|NCT01926782|2148592|P2|Overall Study|Withdrawal by Subject|1
665702|NCT01926782|2148593|P1|Overall Study|Withdrawal by Subject|6
665703|NCT01926782|2148588|P6|Overall Study|Randomized and not treated|0
665704|NCT01926782|2148589|P5|Overall Study|Randomized and not treated|0
665705|NCT01926782|2148590|P4|Overall Study|Randomized and not treated|1
665706|NCT01926782|2148591|P3|Overall Study|Randomized and not treated|0
665707|NCT01926782|2148592|P2|Overall Study|Randomized and not treated|0
665708|NCT01926782|2148593|P1|Overall Study|Randomized and not treated|0
665709|NCT01926782|2148588|P6|Overall Study|Poor compliance to protocol|6
665710|NCT01926782|2148589|P5|Overall Study|Poor compliance to protocol|1
665711|NCT01926782|2148590|P4|Overall Study|Poor compliance to protocol|0
665712|NCT01926782|2148591|P3|Overall Study|Poor compliance to protocol|8
665713|NCT01926782|2148592|P2|Overall Study|Poor compliance to protocol|3
665714|NCT01926782|2148593|P1|Overall Study|Poor compliance to protocol|5
665715|NCT01926782|2148588|P6|Overall Study|Adverse Event|14
665716|NCT01926782|2148589|P5|Overall Study|Adverse Event|3
665717|NCT01926782|2148590|P4|Overall Study|Adverse Event|4
665718|NCT01926782|2148591|P3|Overall Study|Adverse Event|17
665719|NCT01926782|2148592|P2|Overall Study|Adverse Event|4
665720|NCT01926782|2148593|P1|Overall Study|Adverse Event|13
665721|NCT01926782|2148588|P6|Overall Study|Other than specified|11
665722|NCT01926782|2148589|P5|Overall Study|Other than specified|4
665723|NCT01926782|2148590|P4|Overall Study|Other than specified|12
665724|NCT01926782|2148591|P3|Overall Study|Other than specified|5
665725|NCT01926782|2148592|P2|Overall Study|Other than specified|3
665726|NCT01926782|2148593|P1|Overall Study|Other than specified|2
665727|NCT01926782|2148588|P6|Overall Study|Physician Decision|0
665728|NCT01926782|2148589|P5|Overall Study|Physician Decision|0
665729|NCT01926782|2148590|P4|Overall Study|Physician Decision|1
665730|NCT01926782|2148591|P3|Overall Study|Physician Decision|1
665731|NCT01926782|2148592|P2|Overall Study|Physician Decision|2
665732|NCT01926782|2148593|P1|Overall Study|Physician Decision|0
665733|NCT01926782|2148588|P6|Overall Study|Participant moved|3
665734|NCT01926782|2148589|P5|Overall Study|Participant moved|0
665735|NCT01926782|2148590|P4|Overall Study|Participant moved|1
665736|NCT01926782|2148591|P3|Overall Study|Participant moved|1
665737|NCT01926782|2148592|P2|Overall Study|Participant moved|0
665738|NCT01926782|2148593|P1|Overall Study|Participant moved|2
665739|NCT01926626|2148742|P1|Overall Study|Lost to Follow-up|7
665740|NCT01926626|2148742|P1|Overall Study|Withdrawal by Subject|15
665741|NCT01926119|2148752|P1|Overall Study|Withdrawal by Subject|1
665742|NCT01926015|2148764|P2|Overall Study|Randomized not treated|0
665743|NCT01926015|2148765|P1|Overall Study|Randomized not treated|2
665744|NCT01926015|2148764|P2|Overall Study|Withdrawal by parent/guardian|1
665745|NCT01926015|2148765|P1|Overall Study|Withdrawal by parent/guardian|0
665746|NCT01925768|2148808|P2|Overall Study|Non-compliance with study drug|1
665747|NCT01925768|2148809|P1|Overall Study|Non-compliance with study drug|0
665748|NCT01925768|2148808|P2|Overall Study|Withdrawal by Subject|4
665749|NCT01925768|2148809|P1|Overall Study|Withdrawal by Subject|1
665750|NCT01925768|2148808|P2|Overall Study|Lack of Efficacy|6
665751|NCT01925768|2148809|P1|Overall Study|Lack of Efficacy|3
665752|NCT01925768|2148808|P2|Overall Study|Adverse Event|10
665753|NCT01925768|2148809|P1|Overall Study|Adverse Event|5
665754|NCT01925768|2148808|P2|Overall Study|Protocol Violation|2
665755|NCT01925768|2148809|P1|Overall Study|Protocol Violation|1
665756|NCT01925768|2148808|P2|Overall Study|Lost to Follow-up|0
665757|NCT01925768|2148809|P1|Overall Study|Lost to Follow-up|1
665758|NCT01925703|2148817|P1|Overall Study|Discharge prior to full iron repletion|1
665759|NCT01925703|2148817|P1|Overall Study|Lost to Follow-up|2
665760|NCT01925703|2148817|P1|Overall Study|Physician Decision|1
665761|NCT01925417|2148836|P1|Overall Study|Death|1
665762|NCT01925417|2148836|P1|Overall Study|Withdrawal by Subject|2
665763|NCT01925274|2148846|P3|Overall Study|Protocol amendment|6
665764|NCT01925274|2148847|P2|Overall Study|Protocol amendment|3
665765|NCT01925274|2148848|P1|Overall Study|Protocol amendment|1
665766|NCT01925274|2148846|P3|Overall Study|Study terminated by sponsor|0
665767|NCT01925274|2148847|P2|Overall Study|Study terminated by sponsor|0
665768|NCT01925274|2148848|P1|Overall Study|Study terminated by sponsor|4
665769|NCT01925274|2148846|P3|Overall Study|Withdrawal by Subject|0
665770|NCT01925274|2148847|P2|Overall Study|Withdrawal by Subject|2
665771|NCT01925274|2148848|P1|Overall Study|Withdrawal by Subject|1
665772|NCT01925274|2148846|P3|Overall Study|Lost to Follow-up|0
665773|NCT01925274|2148847|P2|Overall Study|Lost to Follow-up|1
665774|NCT01925274|2148848|P1|Overall Study|Lost to Follow-up|0
665775|NCT01925274|2148846|P3|Overall Study|Death|0
665776|NCT01925274|2148847|P2|Overall Study|Death|0
665777|NCT01925274|2148848|P1|Overall Study|Death|1
665778|NCT01925209|2148929|P4|Follow-up|Withdrawal by Subject|2
665779|NCT01925209|2148930|P3|Follow-up|Withdrawal by Subject|0
665780|NCT01925209|2148931|P2|Follow-up|Withdrawal by Subject|2
665781|NCT01925209|2148932|P1|Follow-up|Withdrawal by Subject|0
665782|NCT01925209|2148929|P4|Follow-up|Non-compliance with study treatment|1
665783|NCT01925209|2148930|P3|Follow-up|Non-compliance with study treatment|0
665784|NCT01925209|2148931|P2|Follow-up|Non-compliance with study treatment|0
665785|NCT01925209|2148932|P1|Follow-up|Non-compliance with study treatment|0
665786|NCT01925209|2148929|P4|Follow-up|Physician Decision|0
665787|NCT01925209|2148930|P3|Follow-up|Physician Decision|1
665788|NCT01925209|2148931|P2|Follow-up|Physician Decision|0
665789|NCT01925209|2148932|P1|Follow-up|Physician Decision|0
665790|NCT01925209|2148929|P4|Follow-up|Adverse Event|1
665791|NCT01925209|2148930|P3|Follow-up|Adverse Event|0
665792|NCT01925209|2148931|P2|Follow-up|Adverse Event|4
665793|NCT01925209|2148932|P1|Follow-up|Adverse Event|1
665794|NCT01925209|2148929|P4|Maintenance Treatment Epoch|Adverse Event|0
665795|NCT01925209|2148930|P3|Maintenance Treatment Epoch|Adverse Event|1
665796|NCT01925209|2148931|P2|Maintenance Treatment Epoch|Adverse Event|0
665797|NCT01925209|2148932|P1|Maintenance Treatment Epoch|Adverse Event|0
665798|NCT01925209|2148929|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
665799|NCT01925209|2148930|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
665800|NCT01925209|2148931|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
665801|NCT01925209|2148932|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
665802|NCT01925209|2148929|P4|Treatment Epoch|Adverse Event|1
665803|NCT01925209|2148930|P3|Treatment Epoch|Adverse Event|3
665804|NCT01925209|2148931|P2|Treatment Epoch|Adverse Event|5
665805|NCT01925209|2148932|P1|Treatment Epoch|Adverse Event|3
665806|NCT01925209|2148929|P4|Treatment Epoch|Withdrawal by Subject|2
665807|NCT01925209|2148930|P3|Treatment Epoch|Withdrawal by Subject|3
665808|NCT01925209|2148931|P2|Treatment Epoch|Withdrawal by Subject|3
665809|NCT01925209|2148932|P1|Treatment Epoch|Withdrawal by Subject|4
665810|NCT01925209|2148929|P4|Treatment Epoch|Protocol deviation|1
665811|NCT01925209|2148930|P3|Treatment Epoch|Protocol deviation|1
665812|NCT01925209|2148931|P2|Treatment Epoch|Protocol deviation|0
665813|NCT01925209|2148932|P1|Treatment Epoch|Protocol deviation|0
665814|NCT01925209|2148929|P4|Treatment Epoch|Death|0
665815|NCT01925209|2148930|P3|Treatment Epoch|Death|0
665816|NCT01925209|2148931|P2|Treatment Epoch|Death|0
665817|NCT01925209|2148932|P1|Treatment Epoch|Death|1
665818|NCT01925209|2148929|P4|Treatment Epoch|Non-compliance with study treatment|1
665819|NCT01925209|2148930|P3|Treatment Epoch|Non-compliance with study treatment|0
665820|NCT01925209|2148931|P2|Treatment Epoch|Non-compliance with study treatment|0
665821|NCT01925209|2148932|P1|Treatment Epoch|Non-compliance with study treatment|0
665822|NCT01925209|2148929|P4|Treatment Epoch|Physician Decision|0
665823|NCT01925209|2148930|P3|Treatment Epoch|Physician Decision|0
665824|NCT01925209|2148931|P2|Treatment Epoch|Physician Decision|0
665825|NCT01925209|2148932|P1|Treatment Epoch|Physician Decision|1
665826|NCT01925183|2148964|P2|Overall Study|Adverse Event|0
665827|NCT01925183|2148965|P1|Overall Study|Adverse Event|1
665828|NCT01925170|2148973|P1|Overall Study|Unverified cancer status|53
665829|NCT01924767|2149034|P5|Overall Study|Adverse Event|0
665830|NCT01924767|2149035|P4|Overall Study|Adverse Event|0
665831|NCT01924767|2149036|P3|Overall Study|Adverse Event|1
665832|NCT01924767|2149037|P2|Overall Study|Adverse Event|0
665833|NCT01924767|2149038|P1|Overall Study|Adverse Event|1
665834|NCT01924299|2149167|P2|Period 2|Adverse Event|1
665835|NCT01924299|2149168|P1|Period 2|Adverse Event|0
665836|NCT01924299|2149167|P2|Period 2|Withdrawal by Subject|0
665837|NCT01924299|2149168|P1|Period 2|Withdrawal by Subject|1
665838|NCT01924182|2149190|P2|Overall Study|Withdrawal by Subject|0
665839|NCT01924182|2149191|P1|Overall Study|Withdrawal by Subject|1
665840|NCT01923896|2149199|P2|Overall Study|Adverse Event|0
665841|NCT01923896|2149200|P1|Overall Study|Adverse Event|1
665842|NCT01923467|2149384|P1|Overall Study|Subject non-interest|479
665843|NCT01923467|2149384|P1|Overall Study|Lost to Follow-up|62
665844|NCT01923389|2149390|P2|Overall Study|Protocol Violation|0
665845|NCT01923389|2149391|P1|Overall Study|Protocol Violation|1
665846|NCT01922934|2149428|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
665847|NCT01922934|2149429|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
665848|NCT01922934|2149428|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
665849|NCT01922934|2149429|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
665850|NCT01922934|2149428|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
665851|NCT01922934|2149429|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
665852|NCT01922934|2149428|P2|Eligible Patients|Did not meet inclusion criteria|81
665853|NCT01922934|2149429|P1|Eligible Patients|Did not meet inclusion criteria|36
665854|NCT01922934|2149428|P2|Eligible Patients|Physician Decision|0
665855|NCT01922934|2149429|P1|Eligible Patients|Physician Decision|17
665856|NCT01922934|2149428|P2|Eligible Patients|Death|7
665857|NCT01922934|2149429|P1|Eligible Patients|Death|0
665858|NCT01922739|2149441|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
665859|NCT01922739|2149441|P1|Open-label Treatment Period|Physician Decision|1
665860|NCT01922739|2149441|P1|Open-label Treatment Period|Lost to Follow-up|2
665861|NCT01922739|2149441|P1|Open-label Treatment Period|Noncompliance to study procedures|1
665862|NCT01922739|2149441|P1|Open-label Treatment Period|Pregnancy|1
665863|NCT01922739|2149441|P1|Open-label Treatment Period|Protocol Violation|5
665864|NCT01922739|2149441|P1|Open-label Treatment Period|Noncompliance to study medication|3
665865|NCT01922739|2149441|P1|Open-label Treatment Period|Withdrawal by Subject|14
665866|NCT01922739|2149441|P1|Open-label Treatment Period|Adverse Event|6
665867|NCT01922739|2149441|P1|Titration/Adjustment Period|Lack of Efficacy|3
665868|NCT01922739|2149441|P1|Titration/Adjustment Period|Lost to Follow-up|1
665869|NCT01922739|2149441|P1|Titration/Adjustment Period|Withdrawal by Subject|5
665870|NCT01922739|2149441|P1|Titration/Adjustment Period|Adverse Event|3
665871|NCT01922349|2149470|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
665872|NCT01922349|2149471|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
665873|NCT01922349|2149472|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
665874|NCT01922349|2149473|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
665875|NCT01922271|2149580|P2|WASHOUT Period|Withdrawal by Subject|0
665876|NCT01922271|2149581|P1|WASHOUT Period|Withdrawal by Subject|1
665877|NCT01922089|2149622|P2|Overall Study|Lost to Follow-up|1
665878|NCT01922089|2149623|P1|Overall Study|Lost to Follow-up|0
665879|NCT01922089|2149622|P2|Overall Study|Death|1
665880|NCT01922089|2149623|P1|Overall Study|Death|2
665881|NCT01922089|2149622|P2|Overall Study|Physician Decision|3
665882|NCT01922089|2149623|P1|Overall Study|Physician Decision|2
665883|NCT01922089|2149622|P2|Overall Study|administrative problems|1
665884|NCT01922089|2149623|P1|Overall Study|administrative problems|4
665885|NCT01922089|2149622|P2|Overall Study|Withdrawal by Subject|4
665886|NCT01922089|2149623|P1|Overall Study|Withdrawal by Subject|3
665887|NCT01922089|2149622|P2|Overall Study|Protocol Deviation|7
665888|NCT01922089|2149623|P1|Overall Study|Protocol Deviation|10
665889|NCT01922089|2149622|P2|Overall Study|Adverse Event|13
665890|NCT01922089|2149623|P1|Overall Study|Adverse Event|18
665891|NCT01922011|2149635|P2|Overall Study|Randomized in error|0
665892|NCT01922011|2149636|P1|Overall Study|Randomized in error|1
665893|NCT01922011|2149635|P2|Overall Study|Lack of willing home health agency|0
665894|NCT01922011|2149636|P1|Overall Study|Lack of willing home health agency|1
665895|NCT01922011|2149635|P2|Overall Study|Not Treated|0
665896|NCT01922011|2149636|P1|Overall Study|Not Treated|1
665897|NCT01922011|2149635|P2|Overall Study|Missed Test-of-Cure Visit|2
665898|NCT01922011|2149636|P1|Overall Study|Missed Test-of-Cure Visit|0
665899|NCT01922011|2149635|P2|Overall Study|Lost to Follow-up|1
665900|NCT01922011|2149636|P1|Overall Study|Lost to Follow-up|0
665901|NCT01922011|2149635|P2|Overall Study|Parent/Guardian Decision|0
665902|NCT01922011|2149636|P1|Overall Study|Parent/Guardian Decision|3
665903|NCT01922011|2149635|P2|Overall Study|Physician Decision|1
665904|NCT01922011|2149636|P1|Overall Study|Physician Decision|0
665905|NCT01922011|2149635|P2|Overall Study|Protocol Violation|1
665906|NCT01922011|2149636|P1|Overall Study|Protocol Violation|0
665907|NCT01921829|2149703|P2|Overall Study|Withdrawal by Subject|1
665908|NCT01921829|2149704|P1|Overall Study|Withdrawal by Subject|0
665909|NCT01921348|2149757|P2|Overall Study|Lost to Follow-up|2
665910|NCT01921348|2149758|P1|Overall Study|Lost to Follow-up|0
665911|NCT01921348|2149757|P2|Overall Study|Withdrawal by Subject|0
665912|NCT01921348|2149758|P1|Overall Study|Withdrawal by Subject|1
665913|NCT01921101|2149789|P2|Overall Study|Death|6
665914|NCT01921101|2149790|P1|Overall Study|Death|16
665915|NCT01920958|2149798|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
665916|NCT01920893|2149816|P2|Overall Study|Lack of Efficacy|0
665917|NCT01920893|2149817|P1|Overall Study|Lack of Efficacy|2
665918|NCT01920893|2149816|P2|Overall Study|Adverse Event|2
665919|NCT01920893|2149817|P1|Overall Study|Adverse Event|5
665920|NCT01920854|2149850|P7|Overall Study|Withdrawal by Subject|1
665921|NCT01920854|2149851|P6|Overall Study|Withdrawal by Subject|0
665922|NCT01920854|2149852|P5|Overall Study|Withdrawal by Subject|1
665923|NCT01920854|2149853|P4|Overall Study|Withdrawal by Subject|0
665924|NCT01920854|2149854|P3|Overall Study|Withdrawal by Subject|0
665925|NCT01920854|2149855|P2|Overall Study|Withdrawal by Subject|0
665926|NCT01920854|2149856|P1|Overall Study|Withdrawal by Subject|1
665927|NCT01920568|2150016|P2|Overall Study|Death due to disease progression|12
665928|NCT01920568|2150017|P1|Overall Study|Death due to disease progression|25
665929|NCT01920568|2150016|P2|Overall Study|Withdrawal by Subject|55
665930|NCT01920568|2150017|P1|Overall Study|Withdrawal by Subject|79
665931|NCT01920568|2150016|P2|Overall Study|Physician Decision|4
665932|NCT01920568|2150017|P1|Overall Study|Physician Decision|13
665933|NCT01920568|2150016|P2|Overall Study|Lost to Follow-up|2
665934|NCT01920568|2150017|P1|Overall Study|Lost to Follow-up|2
665935|NCT01920568|2150016|P2|Overall Study|Protocol Violation|3
665936|NCT01920568|2150017|P1|Overall Study|Protocol Violation|5
665937|NCT01920568|2150016|P2|Overall Study|Adverse Event|8
665938|NCT01920568|2150017|P1|Overall Study|Adverse Event|27
665939|NCT01920178|2150056|P2|Overall Study|Lost to Follow-up|1
665940|NCT01920178|2150057|P1|Overall Study|Lost to Follow-up|2
665941|NCT01919801|2150075|P2|Overall Study|Unspecified|1
665942|NCT01919801|2150076|P1|Overall Study|Unspecified|0
665943|NCT01919801|2150075|P2|Overall Study|Lost to Follow-up|1
665944|NCT01919801|2150076|P1|Overall Study|Lost to Follow-up|0
665945|NCT01919801|2150075|P2|Overall Study|Physician Decision|1
665946|NCT01919801|2150076|P1|Overall Study|Physician Decision|0
665947|NCT01919801|2150075|P2|Overall Study|Withdrawal by Subject|0
665948|NCT01919801|2150076|P1|Overall Study|Withdrawal by Subject|1
665949|NCT01919723|2150101|P2|Overall Study|Blood Samples Hemolyzed|2
665950|NCT01919723|2150102|P1|Overall Study|Blood Samples Hemolyzed|2
665951|NCT01919229|2150145|P3|Overall Study|Subject/guardian decision|1
665952|NCT01919229|2150146|P2|Overall Study|Subject/guardian decision|0
665953|NCT01919229|2150147|P1|Overall Study|Subject/guardian decision|0
665954|NCT01918371|2150199|P2|Overall Study|Missing Data|1
665955|NCT01918371|2150200|P1|Overall Study|Missing Data|1
665956|NCT01918332|2150278|P4|Overall Study|lipid result by central lab did not meet|0
665957|NCT01918332|2150279|P3|Overall Study|lipid result by central lab did not meet|1
665958|NCT01918332|2150280|P2|Overall Study|lipid result by central lab did not meet|0
665959|NCT01918332|2150281|P1|Overall Study|lipid result by central lab did not meet|0
665960|NCT01918332|2150278|P4|Overall Study|Protocol Violation|3
665961|NCT01918332|2150279|P3|Overall Study|Protocol Violation|6
665962|NCT01918332|2150280|P2|Overall Study|Protocol Violation|2
665963|NCT01918332|2150281|P1|Overall Study|Protocol Violation|6
665964|NCT01918332|2150278|P4|Overall Study|Withdrawal by Subject|3
665965|NCT01918332|2150279|P3|Overall Study|Withdrawal by Subject|2
665966|NCT01918332|2150280|P2|Overall Study|Withdrawal by Subject|3
665967|NCT01918332|2150281|P1|Overall Study|Withdrawal by Subject|2
665968|NCT01918332|2150278|P4|Overall Study|Adverse Event|1
665969|NCT01918332|2150279|P3|Overall Study|Adverse Event|0
665970|NCT01918332|2150280|P2|Overall Study|Adverse Event|0
665971|NCT01918332|2150281|P1|Overall Study|Adverse Event|0
665972|NCT01918306|2150293|P4|Overall Study|progress disease, crossover|0
665973|NCT01918306|2150294|P3|Overall Study|progress disease, crossover|1
665974|NCT01918306|2150295|P2|Overall Study|progress disease, crossover|0
665975|NCT01918306|2150296|P1|Overall Study|progress disease, crossover|0
665976|NCT01918306|2150293|P4|Overall Study|Lack of Efficacy|0
665977|NCT01918306|2150294|P3|Overall Study|Lack of Efficacy|0
665978|NCT01918306|2150295|P2|Overall Study|Lack of Efficacy|0
665979|NCT01918306|2150296|P1|Overall Study|Lack of Efficacy|1
665980|NCT01918306|2150293|P4|Overall Study|neutropenia|0
665981|NCT01918306|2150294|P3|Overall Study|neutropenia|0
665982|NCT01918306|2150295|P2|Overall Study|neutropenia|0
665983|NCT01918306|2150296|P1|Overall Study|neutropenia|1
665984|NCT01918306|2150293|P4|Overall Study|Withdrawal by Subject|2
665985|NCT01918306|2150294|P3|Overall Study|Withdrawal by Subject|0
665986|NCT01918306|2150295|P2|Overall Study|Withdrawal by Subject|0
665987|NCT01918306|2150296|P1|Overall Study|Withdrawal by Subject|0
665988|NCT01918306|2150293|P4|Overall Study|progresive disease|1
665989|NCT01918306|2150294|P3|Overall Study|progresive disease|1
665990|NCT01918306|2150295|P2|Overall Study|progresive disease|0
665991|NCT01918306|2150296|P1|Overall Study|progresive disease|4
665992|NCT01918085|2150318|P2|Test Period 1: Strata Strip|Adverse Event|1
665993|NCT01918085|2150319|P1|Test Period 1: Strata Strip|Adverse Event|0
665994|NCT01918033|2150330|P3|Overall Study|Withdrawal by Subject|0
665995|NCT01918033|2150331|P2|Overall Study|Withdrawal by Subject|1
665996|NCT01918033|2150332|P1|Overall Study|Withdrawal by Subject|2
665997|NCT01918033|2150330|P3|Overall Study|Protocol Violation|1
665998|NCT01918033|2150331|P2|Overall Study|Protocol Violation|0
665999|NCT01918033|2150332|P1|Overall Study|Protocol Violation|2
666000|NCT01918033|2150330|P3|Overall Study|Lost to Follow-up|0
666001|NCT01918033|2150331|P2|Overall Study|Lost to Follow-up|1
666002|NCT01918033|2150332|P1|Overall Study|Lost to Follow-up|0
666003|NCT01918033|2150330|P3|Overall Study|Adverse Event|2
666004|NCT01918033|2150331|P2|Overall Study|Adverse Event|0
666005|NCT01918033|2150332|P1|Overall Study|Adverse Event|1
666006|NCT01917656|2150403|P2|Overall Study|Lost to Follow-up|4
666007|NCT01917656|2150404|P1|Overall Study|Lost to Follow-up|3
666008|NCT01917656|2150403|P2|Overall Study|Withdrawal by Subject|3
666009|NCT01917656|2150404|P1|Overall Study|Withdrawal by Subject|4
666010|NCT01917656|2150403|P2|Overall Study|Unclassified|3
666011|NCT01917656|2150404|P1|Overall Study|Unclassified|0
666012|NCT01917656|2150403|P2|Overall Study|Withdrawal criteria|14
666013|NCT01917656|2150404|P1|Overall Study|Withdrawal criteria|8
666014|NCT01917656|2150403|P2|Overall Study|Adverse Event|0
666015|NCT01917656|2150404|P1|Overall Study|Adverse Event|11
666016|NCT01917526|2150430|P2|Overall Study|Protocol Violation|1
666017|NCT01917526|2150431|P1|Overall Study|Protocol Violation|1
666018|NCT01917344|2150439|P1|Overall Study|Withdrawal by Subject|1
888474|NCT01879410|2822405|P1|Overall Study|Lost to Follow-up|2
888475|NCT01879410|2822404|P2|Overall Study|Protocol Violation|7
888476|NCT01879410|2822405|P1|Overall Study|Protocol Violation|1
888477|NCT01879410|2822404|P2|Overall Study|Lack of Efficacy|6
888478|NCT01879410|2822405|P1|Overall Study|Lack of Efficacy|4
888479|NCT01879410|2822404|P2|Overall Study|Adverse Event|14
888480|NCT01879410|2822405|P1|Overall Study|Adverse Event|9
888481|NCT01844518|2822413|P1|Long-Term Extension|Still in On-Going Study|149
888482|NCT01844518|2822413|P1|Long-Term Extension|No Longer Met Study Criteria|1
888483|NCT01844518|2822413|P1|Long-Term Extension|Adverse Event|1
888484|NCT01844518|2822413|P1|Long-Term Extension|Lack of Efficacy|6
888485|NCT01844518|2822413|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
888486|NCT01844518|2822413|P1|Short-Term (ST) Period|Withdrawal of Consent|2
888487|NCT01844518|2822413|P1|Short-Term (ST) Period|Lack of Efficacy|3
888488|NCT01844518|2822413|P1|Short-Term (ST) Period|Adverse Event|3
888489|NCT01844505|2822430|P3|Overall Study|Not Reported|1
888490|NCT01844505|2822431|P2|Overall Study|Not Reported|0
888491|NCT01844505|2822432|P1|Overall Study|Not Reported|0
666037|NCT01916304|2150584|P1|Overall Study|Screening failure|17
666038|NCT01916226|2150596|P4|Overall Study|Physician Decision|1
666039|NCT01916226|2150597|P3|Overall Study|Physician Decision|0
666040|NCT01916226|2150598|P2|Overall Study|Physician Decision|0
666041|NCT01916226|2150599|P1|Overall Study|Physician Decision|0
666042|NCT01916226|2150596|P4|Overall Study|Protocol Violation|1
666043|NCT01916226|2150597|P3|Overall Study|Protocol Violation|0
666044|NCT01916226|2150598|P2|Overall Study|Protocol Violation|1
666045|NCT01916226|2150599|P1|Overall Study|Protocol Violation|0
666046|NCT01916226|2150596|P4|Overall Study|Lack of Efficacy|1
666047|NCT01916226|2150597|P3|Overall Study|Lack of Efficacy|2
666048|NCT01916226|2150598|P2|Overall Study|Lack of Efficacy|0
666049|NCT01916226|2150599|P1|Overall Study|Lack of Efficacy|0
666050|NCT01916226|2150596|P4|Overall Study|Adverse Event|1
666051|NCT01916226|2150597|P3|Overall Study|Adverse Event|1
666052|NCT01916226|2150598|P2|Overall Study|Adverse Event|0
666053|NCT01916226|2150599|P1|Overall Study|Adverse Event|1
666054|NCT01916109|2150633|P1|Overall Study|Withdrawal by Subject|1
666055|NCT01914926|2150639|P2|Overall Study|uncooperative, agitated and removed|1
666056|NCT01914926|2150640|P1|Overall Study|uncooperative, agitated and removed|0
666057|NCT01914926|2150639|P2|Overall Study|Adverse Event|0
666058|NCT01914926|2150640|P1|Overall Study|Adverse Event|1
666059|NCT01915914|2150646|P4|Follow-up Phase|Physician Decision|1
666060|NCT01915914|2150647|P3|Follow-up Phase|Physician Decision|0
666061|NCT01915914|2150648|P2|Follow-up Phase|Physician Decision|0
666062|NCT01915914|2150649|P1|Follow-up Phase|Physician Decision|0
666063|NCT01915914|2150646|P4|Follow-up Phase|Withdrawal by Subject|1
666064|NCT01915914|2150647|P3|Follow-up Phase|Withdrawal by Subject|0
666065|NCT01915914|2150648|P2|Follow-up Phase|Withdrawal by Subject|0
666066|NCT01915914|2150649|P1|Follow-up Phase|Withdrawal by Subject|0
666067|NCT01915914|2150646|P4|Maintenance Phase|Missing|0
666068|NCT01915914|2150647|P3|Maintenance Phase|Missing|0
666069|NCT01915914|2150648|P2|Maintenance Phase|Missing|1
666070|NCT01915914|2150649|P1|Maintenance Phase|Missing|0
666071|NCT01915914|2150646|P4|Maintenance Phase|Lost to Follow-up|0
666072|NCT01915914|2150647|P3|Maintenance Phase|Lost to Follow-up|1
666073|NCT01915914|2150648|P2|Maintenance Phase|Lost to Follow-up|4
666074|NCT01915914|2150649|P1|Maintenance Phase|Lost to Follow-up|0
666075|NCT01915914|2150646|P4|Maintenance Phase|Withdrawal by Subject|0
666076|NCT01915914|2150647|P3|Maintenance Phase|Withdrawal by Subject|1
666077|NCT01915914|2150648|P2|Maintenance Phase|Withdrawal by Subject|1
666078|NCT01915914|2150649|P1|Maintenance Phase|Withdrawal by Subject|0
666079|NCT01915914|2150646|P4|Acute Phase|Missing|0
666080|NCT01915914|2150647|P3|Acute Phase|Missing|0
666081|NCT01915914|2150648|P2|Acute Phase|Missing|0
666082|NCT01915914|2150649|P1|Acute Phase|Missing|1
666083|NCT01915914|2150646|P4|Acute Phase|"Not Achieved treatment success"|0
666084|NCT01915914|2150647|P3|Acute Phase|"Not Achieved treatment success"|0
666085|NCT01915914|2150648|P2|Acute Phase|"Not Achieved treatment success"|0
666086|NCT01915914|2150649|P1|Acute Phase|"Not Achieved treatment success"|1
666087|NCT01915914|2150646|P4|Acute Phase|Accepted Other Topic Therapies|0
666088|NCT01915914|2150647|P3|Acute Phase|Accepted Other Topic Therapies|0
666089|NCT01915914|2150648|P2|Acute Phase|Accepted Other Topic Therapies|0
666090|NCT01915914|2150649|P1|Acute Phase|Accepted Other Topic Therapies|1
666091|NCT01915914|2150646|P4|Acute Phase|Physician Decision|0
666092|NCT01915914|2150647|P3|Acute Phase|Physician Decision|0
666093|NCT01915914|2150648|P2|Acute Phase|Physician Decision|0
666094|NCT01915914|2150649|P1|Acute Phase|Physician Decision|1
666095|NCT01915914|2150646|P4|Acute Phase|Lost to Follow-up|0
666096|NCT01915914|2150647|P3|Acute Phase|Lost to Follow-up|0
666097|NCT01915914|2150648|P2|Acute Phase|Lost to Follow-up|0
666098|NCT01915914|2150649|P1|Acute Phase|Lost to Follow-up|4
666099|NCT01915914|2150646|P4|Acute Phase|Withdrawal by Subject|0
666100|NCT01915914|2150647|P3|Acute Phase|Withdrawal by Subject|0
666101|NCT01915914|2150648|P2|Acute Phase|Withdrawal by Subject|0
666102|NCT01915914|2150649|P1|Acute Phase|Withdrawal by Subject|4
666103|NCT01915849|2150681|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
666104|NCT01915849|2150682|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
666105|NCT01915849|2150683|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
666106|NCT01915849|2150684|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
666107|NCT01915849|2150681|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
666108|NCT01915849|2150682|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
666109|NCT01915849|2150683|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
666110|NCT01915849|2150684|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
666111|NCT01915732|2150709|P2|Overall Study|Poor Conscious Effect|1
666112|NCT01915732|2150710|P1|Overall Study|Poor Conscious Effect|0
666113|NCT01915732|2150709|P2|Overall Study|Improper Facial Procedure|1
666114|NCT01915732|2150710|P1|Overall Study|Improper Facial Procedure|0
666115|NCT01915732|2150709|P2|Overall Study|Job Transfer|1
666116|NCT01915732|2150710|P1|Overall Study|Job Transfer|0
666117|NCT01915732|2150709|P2|Overall Study|Par. Refused to Hospital Visits|1
666118|NCT01915732|2150710|P1|Overall Study|Par. Refused to Hospital Visits|0
666119|NCT01915732|2150709|P2|Overall Study|Par. not Willing to Continue Treatment|1
666120|NCT01915732|2150710|P1|Overall Study|Par. not Willing to Continue Treatment|0
666121|NCT01915732|2150709|P2|Overall Study|Got Well|1
666122|NCT01915732|2150710|P1|Overall Study|Got Well|0
666123|NCT01915732|2150709|P2|Overall Study|Par. Unable to Come to the Hospital|1
666124|NCT01915732|2150710|P1|Overall Study|Par. Unable to Come to the Hospital|0
666125|NCT01915732|2150709|P2|Overall Study|Poor Perceived Efficacy|0
666126|NCT01915732|2150710|P1|Overall Study|Poor Perceived Efficacy|1
666127|NCT01915732|2150709|P2|Overall Study|Pregnancy|0
666128|NCT01915732|2150710|P1|Overall Study|Pregnancy|1
666129|NCT01915732|2150709|P2|Overall Study|Recovered|0
666130|NCT01915732|2150710|P1|Overall Study|Recovered|1
666131|NCT01915732|2150709|P2|Overall Study|Drug Release Error|0
666132|NCT01915732|2150710|P1|Overall Study|Drug Release Error|1
666133|NCT01915732|2150709|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
666134|NCT01915732|2150710|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
666135|NCT01915732|2150709|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
666136|NCT01915732|2150710|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
666137|NCT01915732|2150709|P2|Overall Study|Lost to Follow-up|26
666138|NCT01915732|2150710|P1|Overall Study|Lost to Follow-up|22
666139|NCT01915732|2150709|P2|Overall Study|Lack of Efficacy|11
666140|NCT01915732|2150710|P1|Overall Study|Lack of Efficacy|6
666141|NCT01915732|2150709|P2|Overall Study|Protocol Violation|5
666142|NCT01915732|2150710|P1|Overall Study|Protocol Violation|5
666143|NCT01915732|2150709|P2|Overall Study|Adverse Event|4
666144|NCT01915732|2150710|P1|Overall Study|Adverse Event|12
666145|NCT01915732|2150709|P2|Overall Study|Failure to Meet Randomization Criteria|0
666146|NCT01915732|2150710|P1|Overall Study|Failure to Meet Randomization Criteria|1
666147|NCT01915732|2150709|P2|Overall Study|Withdrawal by Subject|18
666148|NCT01915732|2150710|P1|Overall Study|Withdrawal by Subject|18
666149|NCT01914757|2150779|P3|Overall Study|Other reasons|4
666150|NCT01914757|2150780|P2|Overall Study|Other reasons|9
666151|NCT01914757|2150781|P1|Overall Study|Other reasons|5
666152|NCT01914757|2150779|P3|Overall Study|Eligibility criteria not fulfilled|2
666153|NCT01914757|2150780|P2|Overall Study|Eligibility criteria not fulfilled|0
666154|NCT01914757|2150781|P1|Overall Study|Eligibility criteria not fulfilled|2
666155|NCT01914757|2150779|P3|Overall Study|Study specific withdrawal criteria|0
666156|NCT01914757|2150780|P2|Overall Study|Study specific withdrawal criteria|1
666157|NCT01914757|2150781|P1|Overall Study|Study specific withdrawal criteria|0
666158|NCT01914757|2150779|P3|Overall Study|Adverse Event|4
666159|NCT01914757|2150780|P2|Overall Study|Adverse Event|3
666160|NCT01914757|2150781|P1|Overall Study|Adverse Event|4
666161|NCT01914757|2150779|P3|Overall Study|Death|1
666162|NCT01914757|2150780|P2|Overall Study|Death|2
666163|NCT01914757|2150781|P1|Overall Study|Death|2
666164|NCT01914757|2150779|P3|Overall Study|Withdrawal by Subject|19
666165|NCT01914757|2150780|P2|Overall Study|Withdrawal by Subject|27
666166|NCT01914757|2150781|P1|Overall Study|Withdrawal by Subject|15
666167|NCT01914757|2150779|P3|Overall Study|Lost to Follow-up|6
666168|NCT01914757|2150780|P2|Overall Study|Lost to Follow-up|8
666169|NCT01914757|2150781|P1|Overall Study|Lost to Follow-up|5
666170|NCT01914757|2150779|P3|Overall Study|Severe non-compliance to protocol|2
666171|NCT01914757|2150780|P2|Overall Study|Severe non-compliance to protocol|1
666172|NCT01914757|2150781|P1|Overall Study|Severe non-compliance to protocol|3
666173|NCT01914679|2150855|P1|Overall Study|Sponsor terminated study|4
666174|NCT01914679|2150855|P1|Overall Study|Lack of Efficacy|1
666175|NCT01914666|2150862|P3|Treatment Period|Physician Decision|2
666176|NCT01914666|2150863|P2|Treatment Period|Physician Decision|0
666177|NCT01914666|2150864|P1|Treatment Period|Physician Decision|0
666178|NCT01914666|2150862|P3|Treatment Period|Withdrawal by Subject|2
666179|NCT01914666|2150863|P2|Treatment Period|Withdrawal by Subject|2
666180|NCT01914666|2150864|P1|Treatment Period|Withdrawal by Subject|3
666181|NCT01914666|2150862|P3|Treatment Period|Adverse Event|2
666182|NCT01914666|2150863|P2|Treatment Period|Adverse Event|4
666183|NCT01914666|2150864|P1|Treatment Period|Adverse Event|10
666184|NCT01914666|2150862|P3|Treatment Period|Lack of Efficacy|2
666185|NCT01914666|2150863|P2|Treatment Period|Lack of Efficacy|0
666186|NCT01914666|2150864|P1|Treatment Period|Lack of Efficacy|0
666187|NCT01913483|2150969|P2|Overall Study|Death|17
666188|NCT01913483|2150970|P1|Overall Study|Death|14
666189|NCT01913483|2150969|P2|Overall Study|Lost to Follow-up|3
666190|NCT01913483|2150970|P1|Overall Study|Lost to Follow-up|6
666191|NCT01913483|2150969|P2|Overall Study|Withdrawal by Subject|2
666192|NCT01913483|2150970|P1|Overall Study|Withdrawal by Subject|1
666193|NCT01913470|2150982|P2|Overall Study|Withdrawal by Subject|1
666194|NCT01913470|2150983|P1|Overall Study|Withdrawal by Subject|0
666195|NCT01913470|2150982|P2|Overall Study|Physician Decision|1
666196|NCT01913470|2150983|P1|Overall Study|Physician Decision|0
666197|NCT01913470|2150982|P2|Overall Study|Lost to Follow-up|1
666198|NCT01913470|2150983|P1|Overall Study|Lost to Follow-up|0
666199|NCT01913041|2151001|P1|Overall Study|Physician Decision|1
666200|NCT01913041|2151001|P1|Overall Study|Withdrawal by Subject|3
666201|NCT01913041|2151001|P1|Overall Study|Protocol Violation|35
666202|NCT01912781|2151007|P2|Overall Study|Withdrawal by Subject|0
666203|NCT01912781|2151008|P1|Overall Study|Withdrawal by Subject|2
666204|NCT01912768|2151039|P2|Overall Study|Randomized in error|0
666205|NCT01912768|2151040|P1|Overall Study|Randomized in error|1
666206|NCT01912768|2151039|P2|Overall Study|Withdrawal by Subject|3
666207|NCT01912768|2151040|P1|Overall Study|Withdrawal by Subject|5
666208|NCT01912768|2151039|P2|Overall Study|Lost to Follow-up|1
666209|NCT01912768|2151040|P1|Overall Study|Lost to Follow-up|2
666210|NCT01912768|2151039|P2|Overall Study|Adverse Event|0
666211|NCT01912768|2151040|P1|Overall Study|Adverse Event|2
666212|NCT01912599|2151071|P2|Overall Study|Withdrawal by Subject|1
666213|NCT01912599|2151072|P1|Overall Study|Withdrawal by Subject|0
666214|NCT01912404|2151097|P2|Overall Study|Due to personal reasons|0
666215|NCT01912404|2151098|P1|Overall Study|Due to personal reasons|1
666216|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
666217|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
666218|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
666219|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
666220|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
666221|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
666222|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
666223|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
666224|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
666225|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
666226|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
666227|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
666228|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
666229|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
666230|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
666231|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
666232|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
666233|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
666234|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
666235|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
666236|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
666237|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
666238|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
666239|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
666240|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
666241|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
666242|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
666243|NCT01912339|2151111|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
666244|NCT01912339|2151112|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
666245|NCT01912339|2151113|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
666246|NCT01912339|2151111|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
666247|NCT01912339|2151112|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
666248|NCT01912339|2151113|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
666249|NCT01912339|2151111|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
666250|NCT01912339|2151112|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
666251|NCT01912339|2151113|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
666252|NCT01912339|2151111|P3|Blinded (0 to 3 Months)|Declined to participate|0
666253|NCT01912339|2151112|P2|Blinded (0 to 3 Months)|Declined to participate|0
666254|NCT01912339|2151113|P1|Blinded (0 to 3 Months)|Declined to participate|1
666255|NCT01912222|2151130|P3|Part B: Treatment Period|Withdrawal by Subject|2
666256|NCT01912222|2151131|P2|Part B: Treatment Period|Withdrawal by Subject|1
666257|NCT01912222|2151132|P1|Part B: Treatment Period|Withdrawal by Subject|2
666258|NCT01912222|2151130|P3|Part B: Treatment Period|Adverse Event|3
666259|NCT01912222|2151131|P2|Part B: Treatment Period|Adverse Event|2
666260|NCT01912222|2151132|P1|Part B: Treatment Period|Adverse Event|1
666261|NCT01912222|2151130|P3|Part B: Treatment Period|Progressive disease|15
666262|NCT01912222|2151131|P2|Part B: Treatment Period|Progressive disease|12
666263|NCT01912222|2151132|P1|Part B: Treatment Period|Progressive disease|10
666264|NCT01912222|2151130|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
666265|NCT01912222|2151131|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
666266|NCT01912222|2151132|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
666267|NCT01911845|2151155|P1|Overall Study|Other (not specified)|3
666268|NCT01911845|2151155|P1|Overall Study|Lost to Follow-up|1
666269|NCT01911845|2151155|P1|Overall Study|Adverse Event|2
666270|NCT01911793|2151171|P2|Overall Study|Physician Decision|5
666271|NCT01911793|2151172|P1|Overall Study|Physician Decision|1
666272|NCT01911780|2151194|P2|Extension Period (52 Weeks)|Personal reason|1
666273|NCT01911780|2151195|P1|Extension Period (52 Weeks)|Personal reason|1
666274|NCT01911780|2151194|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
666275|NCT01911780|2151195|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
666276|NCT01911780|2151194|P2|Extension Period (52 Weeks)|Adverse Event|0
666277|NCT01911780|2151195|P1|Extension Period (52 Weeks)|Adverse Event|3
666278|NCT01911780|2151194|P2|Double-blind Period (8 Weeks)|Personal reason|0
666279|NCT01911780|2151195|P1|Double-blind Period (8 Weeks)|Personal reason|1
666280|NCT01911780|2151194|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
666281|NCT01911780|2151195|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
666282|NCT01911780|2151194|P2|Double-blind Period (8 Weeks)|Adverse Event|2
666283|NCT01911780|2151195|P1|Double-blind Period (8 Weeks)|Adverse Event|1
666284|NCT01911442|2151232|P3|Overall Study|Mother's Work Schedule|0
666285|NCT01911442|2151233|P2|Overall Study|Mother's Work Schedule|1
666286|NCT01911442|2151234|P1|Overall Study|Mother's Work Schedule|0
666287|NCT01911442|2151232|P3|Overall Study|Withdrawal by Subject|6
666288|NCT01911442|2151233|P2|Overall Study|Withdrawal by Subject|0
666289|NCT01911442|2151234|P1|Overall Study|Withdrawal by Subject|1
666290|NCT01911442|2151232|P3|Overall Study|Lost to Follow-up|1
666291|NCT01911442|2151233|P2|Overall Study|Lost to Follow-up|0
666292|NCT01911442|2151234|P1|Overall Study|Lost to Follow-up|2
666293|NCT01911442|2151232|P3|Overall Study|Lack of Efficacy|1
666294|NCT01911442|2151233|P2|Overall Study|Lack of Efficacy|1
666295|NCT01911442|2151234|P1|Overall Study|Lack of Efficacy|1
666296|NCT01911442|2151232|P3|Overall Study|Adverse Event|4
666297|NCT01911442|2151233|P2|Overall Study|Adverse Event|2
666298|NCT01911442|2151234|P1|Overall Study|Adverse Event|2
666299|NCT01911429|2151263|P3|Overall Study|subject left study|0
666300|NCT01911429|2151264|P2|Overall Study|subject left study|0
666301|NCT01911429|2151265|P1|Overall Study|subject left study|1
666302|NCT01911429|2151263|P3|Overall Study|Accidental randomization|1
666303|NCT01911429|2151264|P2|Overall Study|Accidental randomization|0
666304|NCT01911429|2151265|P1|Overall Study|Accidental randomization|0
666305|NCT01911429|2151263|P3|Overall Study|Withdrawal by Subject|4
666306|NCT01911429|2151264|P2|Overall Study|Withdrawal by Subject|5
666307|NCT01911429|2151265|P1|Overall Study|Withdrawal by Subject|5
666308|NCT01911429|2151263|P3|Overall Study|Protocol Violation|1
666309|NCT01911429|2151264|P2|Overall Study|Protocol Violation|0
666310|NCT01911429|2151265|P1|Overall Study|Protocol Violation|0
666311|NCT01911429|2151263|P3|Overall Study|Lost to Follow-up|1
666312|NCT01911429|2151264|P2|Overall Study|Lost to Follow-up|0
666313|NCT01911429|2151265|P1|Overall Study|Lost to Follow-up|0
666314|NCT01911429|2151263|P3|Overall Study|Lack of Efficacy|4
666315|NCT01911429|2151264|P2|Overall Study|Lack of Efficacy|2
666316|NCT01911429|2151265|P1|Overall Study|Lack of Efficacy|1
666317|NCT01911429|2151263|P3|Overall Study|Adverse Event|9
666318|NCT01911429|2151264|P2|Overall Study|Adverse Event|3
666319|NCT01911429|2151265|P1|Overall Study|Adverse Event|5
666320|NCT01911273|2151357|P2|Overall Study|Withdrawal by Subject|2
666321|NCT01911273|2151358|P1|Overall Study|Withdrawal by Subject|0
666322|NCT01911273|2151357|P2|Overall Study|Progression of Disease|0
666323|NCT01911273|2151358|P1|Overall Study|Progression of Disease|1
666324|NCT01911260|2151392|P4|Follow-up Period|transference or evasion of school|12
666325|NCT01911260|2151393|P3|Follow-up Period|transference or evasion of school|15
666326|NCT01911260|2151394|P2|Follow-up Period|transference or evasion of school|20
666327|NCT01911260|2151395|P1|Follow-up Period|transference or evasion of school|13
666328|NCT01911260|2151392|P4|Supplementation Period|less than 12 weeks supplementation|2
666329|NCT01911260|2151393|P3|Supplementation Period|less than 12 weeks supplementation|1
666330|NCT01911260|2151394|P2|Supplementation Period|less than 12 weeks supplementation|3
666331|NCT01911260|2151395|P1|Supplementation Period|less than 12 weeks supplementation|0
666332|NCT01911260|2151392|P4|Supplementation Period|refused to receive supplement|0
666333|NCT01911260|2151393|P3|Supplementation Period|refused to receive supplement|1
666334|NCT01911260|2151394|P2|Supplementation Period|refused to receive supplement|0
666335|NCT01911260|2151395|P1|Supplementation Period|refused to receive supplement|1
666336|NCT01911260|2151392|P4|Supplementation Period|Adverse Event|0
666337|NCT01911260|2151393|P3|Supplementation Period|Adverse Event|1
666338|NCT01911260|2151394|P2|Supplementation Period|Adverse Event|0
666339|NCT01911260|2151395|P1|Supplementation Period|Adverse Event|2
666340|NCT01911260|2151392|P4|Supplementation Period|transference or evasion of school|6
666341|NCT01911260|2151393|P3|Supplementation Period|transference or evasion of school|7
666342|NCT01911260|2151394|P2|Supplementation Period|transference or evasion of school|9
666343|NCT01911260|2151395|P1|Supplementation Period|transference or evasion of school|7
666344|NCT01910441|2151470|P2|Overall Study|Physician Decision|1
666345|NCT01910441|2151471|P1|Overall Study|Physician Decision|0
666346|NCT01910441|2151470|P2|Overall Study|Adverse Event|0
666347|NCT01910441|2151471|P1|Overall Study|Adverse Event|1
666348|NCT01910441|2151470|P2|Overall Study|Non-compliance|1
666349|NCT01910441|2151471|P1|Overall Study|Non-compliance|0
666350|NCT01910441|2151470|P2|Overall Study|Withdrawal by Subject|1
666351|NCT01910441|2151471|P1|Overall Study|Withdrawal by Subject|0
666352|NCT01910441|2151470|P2|Overall Study|Lost to Follow-up|5
666353|NCT01910441|2151471|P1|Overall Study|Lost to Follow-up|6
666354|NCT01910441|2151470|P2|Overall Study|Sponsor decision|2
666355|NCT01910441|2151471|P1|Overall Study|Sponsor decision|0
666376|NCT01910389|2151550|P2|Overall Study|Study Closed|8
666377|NCT01910389|2151551|P1|Overall Study|Study Closed|13
666378|NCT01910389|2151550|P2|Overall Study|Withdrawal by Subject|0
666379|NCT01910389|2151551|P1|Overall Study|Withdrawal by Subject|2
666383|NCT01910116|2151619|P2|Overall Study|incomplete data|1
666384|NCT01910116|2151620|P1|Overall Study|incomplete data|0
666385|NCT01910116|2151619|P2|Overall Study|uncertain allocation|3
666386|NCT01910116|2151620|P1|Overall Study|uncertain allocation|1
666387|NCT01910116|2151619|P2|Overall Study|Withdrawal by Subject|3
666388|NCT01910116|2151620|P1|Overall Study|Withdrawal by Subject|8
666389|NCT01910116|2151619|P2|Overall Study|Protocol Violation|2
666390|NCT01910116|2151620|P1|Overall Study|Protocol Violation|1
666391|NCT01910116|2151619|P2|Overall Study|Lost to Follow-up|0
666392|NCT01910116|2151620|P1|Overall Study|Lost to Follow-up|1
666393|NCT01910116|2151619|P2|Overall Study|Lack of Efficacy|4
666394|NCT01910116|2151620|P1|Overall Study|Lack of Efficacy|3
666395|NCT01910116|2151619|P2|Overall Study|Adverse Event|3
666396|NCT01910116|2151620|P1|Overall Study|Adverse Event|0
666397|NCT01909804|2151717|P12|Overall Study|Protocol Violation|1
666398|NCT01909804|2151718|P11|Overall Study|Protocol Violation|0
666399|NCT01909804|2151719|P10|Overall Study|Protocol Violation|0
666400|NCT01909804|2151720|P9|Overall Study|Protocol Violation|0
666401|NCT01909804|2151721|P8|Overall Study|Protocol Violation|0
666402|NCT01909804|2151722|P7|Overall Study|Protocol Violation|0
666403|NCT01909804|2151723|P6|Overall Study|Protocol Violation|0
666404|NCT01909804|2151724|P5|Overall Study|Protocol Violation|0
666405|NCT01909804|2151725|P4|Overall Study|Protocol Violation|0
666406|NCT01909804|2151726|P3|Overall Study|Protocol Violation|0
666407|NCT01909804|2151727|P2|Overall Study|Protocol Violation|0
666408|NCT01909804|2151728|P1|Overall Study|Protocol Violation|0
666409|NCT01909804|2151717|P12|Overall Study|Withdrew Consent|0
666410|NCT01909804|2151718|P11|Overall Study|Withdrew Consent|0
666411|NCT01909804|2151719|P10|Overall Study|Withdrew Consent|0
666412|NCT01909804|2151720|P9|Overall Study|Withdrew Consent|0
666413|NCT01909804|2151721|P8|Overall Study|Withdrew Consent|0
666414|NCT01909804|2151722|P7|Overall Study|Withdrew Consent|0
666415|NCT01909804|2151723|P6|Overall Study|Withdrew Consent|1
666416|NCT01909804|2151724|P5|Overall Study|Withdrew Consent|1
666417|NCT01909804|2151725|P4|Overall Study|Withdrew Consent|0
666418|NCT01909804|2151726|P3|Overall Study|Withdrew Consent|0
666419|NCT01909804|2151727|P2|Overall Study|Withdrew Consent|0
666420|NCT01909804|2151728|P1|Overall Study|Withdrew Consent|0
666421|NCT01909804|2151717|P12|Overall Study|Lack of Efficacy|1
666422|NCT01909804|2151718|P11|Overall Study|Lack of Efficacy|0
666423|NCT01909804|2151719|P10|Overall Study|Lack of Efficacy|1
666424|NCT01909804|2151720|P9|Overall Study|Lack of Efficacy|0
666425|NCT01909804|2151721|P8|Overall Study|Lack of Efficacy|1
666426|NCT01909804|2151722|P7|Overall Study|Lack of Efficacy|1
666427|NCT01909804|2151723|P6|Overall Study|Lack of Efficacy|3
666428|NCT01909804|2151724|P5|Overall Study|Lack of Efficacy|7
666429|NCT01909804|2151725|P4|Overall Study|Lack of Efficacy|0
666430|NCT01909804|2151726|P3|Overall Study|Lack of Efficacy|0
666431|NCT01909804|2151727|P2|Overall Study|Lack of Efficacy|1
666432|NCT01909804|2151728|P1|Overall Study|Lack of Efficacy|4
666433|NCT01909804|2151717|P12|Overall Study|Death|0
666434|NCT01909804|2151718|P11|Overall Study|Death|1
666435|NCT01909804|2151719|P10|Overall Study|Death|0
666436|NCT01909804|2151720|P9|Overall Study|Death|0
666437|NCT01909804|2151721|P8|Overall Study|Death|0
666438|NCT01909804|2151722|P7|Overall Study|Death|0
666439|NCT01909804|2151723|P6|Overall Study|Death|0
666440|NCT01909804|2151724|P5|Overall Study|Death|0
666441|NCT01909804|2151725|P4|Overall Study|Death|0
666442|NCT01909804|2151726|P3|Overall Study|Death|0
666443|NCT01909804|2151727|P2|Overall Study|Death|0
666444|NCT01909804|2151728|P1|Overall Study|Death|0
666445|NCT01909804|2151717|P12|Overall Study|Randomized but Never Treated|1
666446|NCT01909804|2151718|P11|Overall Study|Randomized but Never Treated|0
666447|NCT01909804|2151719|P10|Overall Study|Randomized but Never Treated|0
666448|NCT01909804|2151720|P9|Overall Study|Randomized but Never Treated|0
666449|NCT01909804|2151721|P8|Overall Study|Randomized but Never Treated|0
666450|NCT01909804|2151722|P7|Overall Study|Randomized but Never Treated|1
666451|NCT01909804|2151723|P6|Overall Study|Randomized but Never Treated|0
666452|NCT01909804|2151724|P5|Overall Study|Randomized but Never Treated|0
666453|NCT01909804|2151725|P4|Overall Study|Randomized but Never Treated|0
666454|NCT01909804|2151726|P3|Overall Study|Randomized but Never Treated|0
666455|NCT01909804|2151727|P2|Overall Study|Randomized but Never Treated|0
666456|NCT01909804|2151728|P1|Overall Study|Randomized but Never Treated|0
666457|NCT01909778|2151774|P1|Overall Study|failed screening|1
666458|NCT01909674|2151853|P2|Overall Study|Withdrawal by Subject|2
666459|NCT01909674|2151854|P1|Overall Study|Withdrawal by Subject|5
666460|NCT01909466|2151873|P2|Overall Study|Lack of Efficacy|0
666461|NCT01909466|2151874|P1|Overall Study|Lack of Efficacy|1
666462|NCT01909466|2151873|P2|Overall Study|Withdrawal by Subject|9
666463|NCT01909466|2151874|P1|Overall Study|Withdrawal by Subject|11
666464|NCT01909466|2151873|P2|Overall Study|Physician Decision|0
666465|NCT01909466|2151874|P1|Overall Study|Physician Decision|2
666466|NCT01909466|2151873|P2|Overall Study|Met Withdrawal Criteria|3
666467|NCT01909466|2151874|P1|Overall Study|Met Withdrawal Criteria|0
666468|NCT01909466|2151873|P2|Overall Study|Adverse Event|4
666469|NCT01909466|2151874|P1|Overall Study|Adverse Event|3
666470|NCT01909466|2151873|P2|Overall Study|Lost to Follow-up|7
666471|NCT01909466|2151874|P1|Overall Study|Lost to Follow-up|5
666472|NCT01909336|2151897|P3|Overall Study|Physician Decision|1
666473|NCT01909336|2151898|P2|Overall Study|Physician Decision|1
666474|NCT01909336|2151899|P1|Overall Study|Physician Decision|0
666475|NCT01909336|2151897|P3|Overall Study|Lost to Follow-up|2
666476|NCT01909336|2151898|P2|Overall Study|Lost to Follow-up|2
666477|NCT01909336|2151899|P1|Overall Study|Lost to Follow-up|4
888492|NCT01844505|2822430|P3|Overall Study|Other Reasons|2
888493|NCT01844505|2822431|P2|Overall Study|Other Reasons|2
888494|NCT01844505|2822432|P1|Overall Study|Other Reasons|4
888495|NCT01844505|2822430|P3|Overall Study|Subject no longer meets criteria|0
888496|NCT01844505|2822431|P2|Overall Study|Subject no longer meets criteria|1
888497|NCT01844505|2822432|P1|Overall Study|Subject no longer meets criteria|0
888498|NCT01844505|2822430|P3|Overall Study|Poor/non-compliance|1
888499|NCT01844505|2822431|P2|Overall Study|Poor/non-compliance|1
888500|NCT01844505|2822432|P1|Overall Study|Poor/non-compliance|1
888501|NCT01844505|2822430|P3|Overall Study|Maximum clinical benefit|2
888502|NCT01844505|2822431|P2|Overall Study|Maximum clinical benefit|11
888503|NCT01844505|2822432|P1|Overall Study|Maximum clinical benefit|8
888504|NCT01844505|2822430|P3|Overall Study|Lost to Follow-up|0
888505|NCT01844505|2822431|P2|Overall Study|Lost to Follow-up|0
888506|NCT01844505|2822432|P1|Overall Study|Lost to Follow-up|1
888507|NCT01844505|2822430|P3|Overall Study|Withdrawal by Subject|0
888508|NCT01844505|2822431|P2|Overall Study|Withdrawal by Subject|3
888509|NCT01844505|2822432|P1|Overall Study|Withdrawal by Subject|0
888510|NCT01844505|2822430|P3|Overall Study|Subject request discontinue treatment|8
888511|NCT01844505|2822431|P2|Overall Study|Subject request discontinue treatment|14
888512|NCT01844505|2822432|P1|Overall Study|Subject request discontinue treatment|17
888513|NCT01844505|2822430|P3|Overall Study|Adverse event unrelated to study drug|6
888514|NCT01844505|2822431|P2|Overall Study|Adverse event unrelated to study drug|15
666512|NCT01908140|2152104|P2|Overall Study|Adverse Event|23
666513|NCT01908140|2152105|P1|Overall Study|Adverse Event|22
666514|NCT01908140|2152104|P2|Overall Study|Protocol Violation|9
666515|NCT01908140|2152105|P1|Overall Study|Protocol Violation|8
666516|NCT01908140|2152104|P2|Overall Study|Lost to Follow-up|6
666517|NCT01908140|2152105|P1|Overall Study|Lost to Follow-up|1
666518|NCT01908140|2152104|P2|Overall Study|Withdrawal by Subject|24
666519|NCT01908140|2152105|P1|Overall Study|Withdrawal by Subject|23
666520|NCT01908140|2152104|P2|Overall Study|Lack of Efficacy|5
666521|NCT01908140|2152105|P1|Overall Study|Lack of Efficacy|7
666522|NCT01908140|2152104|P2|Overall Study|Other or Progressive Disease|12
666523|NCT01908140|2152105|P1|Overall Study|Other or Progressive Disease|5
666524|NCT01907906|2152126|P2|Overall Study|Physician Decision|1
666525|NCT01907906|2152127|P1|Overall Study|Physician Decision|3
666526|NCT01907906|2152126|P2|Overall Study|Withdrawal by Subject|0
666527|NCT01907906|2152127|P1|Overall Study|Withdrawal by Subject|1
666528|NCT01907854|2152207|P2|Overall Study|Unclassified|3
666529|NCT01907854|2152208|P1|Overall Study|Unclassified|4
666530|NCT01907854|2152207|P2|Overall Study|Lost to Follow-up|2
666531|NCT01907854|2152208|P1|Overall Study|Lost to Follow-up|2
666532|NCT01907854|2152207|P2|Overall Study|Withdrawal by Subject|7
666533|NCT01907854|2152208|P1|Overall Study|Withdrawal by Subject|9
666534|NCT01907854|2152207|P2|Overall Study|Protocol Violation|1
666535|NCT01907854|2152208|P1|Overall Study|Protocol Violation|1
666536|NCT01907516|2152228|P2|First Intervention (3 Weeks)|Developed DKA during study|0
666537|NCT01907516|2152229|P1|First Intervention (3 Weeks)|Developed DKA during study|1
666538|NCT01907516|2152228|P2|First Intervention (3 Weeks)|Delivered before second arm|4
666539|NCT01907516|2152229|P1|First Intervention (3 Weeks)|Delivered before second arm|3
666540|NCT01907516|2152228|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
666541|NCT01907516|2152229|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
666542|NCT01907516|2152228|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
666543|NCT01907516|2152229|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
666544|NCT01906372|2152387|P1|Overall Study|Withdrawal by Subject|2
666545|NCT01905657|2152420|P3|Overall Study|Excluded from Efficacy Analysis|0
666546|NCT01905657|2152421|P2|Overall Study|Excluded from Efficacy Analysis|0
666547|NCT01905657|2152422|P1|Overall Study|Excluded from Efficacy Analysis|1
666548|NCT01905657|2152420|P3|Overall Study|Continuing in Study|11
666549|NCT01905657|2152421|P2|Overall Study|Continuing in Study|74
666550|NCT01905657|2152422|P1|Overall Study|Continuing in Study|74
666551|NCT01905657|2152420|P3|Overall Study|Withdrawal by Subject|45
666552|NCT01905657|2152421|P2|Overall Study|Withdrawal by Subject|10
666553|NCT01905657|2152422|P1|Overall Study|Withdrawal by Subject|5
666554|NCT01905657|2152420|P3|Overall Study|Protocol Violation|1
666555|NCT01905657|2152421|P2|Overall Study|Protocol Violation|1
666556|NCT01905657|2152422|P1|Overall Study|Protocol Violation|2
666557|NCT01905657|2152420|P3|Overall Study|Progressive Disease|89
666558|NCT01905657|2152421|P2|Overall Study|Progressive Disease|126
666559|NCT01905657|2152422|P1|Overall Study|Progressive Disease|124
666560|NCT01905657|2152420|P3|Overall Study|Physician Decision|113
666561|NCT01905657|2152421|P2|Overall Study|Physician Decision|74
666562|NCT01905657|2152422|P1|Overall Study|Physician Decision|82
666563|NCT01905657|2152420|P3|Overall Study|Unspecified|1
666564|NCT01905657|2152421|P2|Overall Study|Unspecified|7
666565|NCT01905657|2152422|P1|Overall Study|Unspecified|3
666566|NCT01905657|2152420|P3|Overall Study|Death|21
666567|NCT01905657|2152421|P2|Overall Study|Death|21
666568|NCT01905657|2152422|P1|Overall Study|Death|21
666569|NCT01905657|2152420|P3|Overall Study|Adverse Event|47
666570|NCT01905657|2152421|P2|Overall Study|Adverse Event|32
666571|NCT01905657|2152422|P1|Overall Study|Adverse Event|33
666572|NCT01905657|2152420|P3|Overall Study|Not Treated|0
666573|NCT01905657|2152421|P2|Overall Study|Not Treated|1
666574|NCT01905657|2152422|P1|Overall Study|Not Treated|0
666575|NCT01905553|2152447|P2|Period 2|Adverse Event|0
666576|NCT01905553|2152448|P1|Period 2|Adverse Event|1
666577|NCT01905540|2152462|P4|Period 3|Not specified|1
666578|NCT01905540|2152463|P3|Period 3|Not specified|1
666579|NCT01905540|2152464|P2|Period 3|Not specified|0
666580|NCT01905540|2152465|P1|Period 3|Not specified|1
666581|NCT01904773|2152496|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666582|NCT01904773|2152497|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666583|NCT01904773|2152498|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666584|NCT01904773|2152499|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666585|NCT01904773|2152500|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666586|NCT01904773|2152501|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666587|NCT01904773|2152502|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666588|NCT01904773|2152503|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
666589|NCT01904773|2152504|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
666590|NCT01904773|2152496|P9|Fifth Intervention|Adverse Event|0
666591|NCT01904773|2152497|P8|Fifth Intervention|Adverse Event|1
666592|NCT01904773|2152498|P7|Fifth Intervention|Adverse Event|0
666593|NCT01904773|2152499|P6|Fifth Intervention|Adverse Event|0
666594|NCT01904773|2152500|P5|Fifth Intervention|Adverse Event|0
666595|NCT01904773|2152501|P4|Fifth Intervention|Adverse Event|0
666596|NCT01904773|2152502|P3|Fifth Intervention|Adverse Event|0
666597|NCT01904773|2152503|P2|Fifth Intervention|Adverse Event|0
666598|NCT01904773|2152504|P1|Fifth Intervention|Adverse Event|0
666599|NCT01904773|2152496|P9|Placebo Washout First Intervention|Condition worsened|0
666600|NCT01904773|2152497|P8|Placebo Washout First Intervention|Condition worsened|0
666601|NCT01904773|2152498|P7|Placebo Washout First Intervention|Condition worsened|0
666602|NCT01904773|2152499|P6|Placebo Washout First Intervention|Condition worsened|0
666603|NCT01904773|2152500|P5|Placebo Washout First Intervention|Condition worsened|0
666604|NCT01904773|2152501|P4|Placebo Washout First Intervention|Condition worsened|0
666605|NCT01904773|2152502|P3|Placebo Washout First Intervention|Condition worsened|0
666606|NCT01904773|2152503|P2|Placebo Washout First Intervention|Condition worsened|1
666607|NCT01904773|2152504|P1|Placebo Washout First Intervention|Condition worsened|0
666608|NCT01904773|2152496|P9|First Intervention|Adverse Event|0
666609|NCT01904773|2152497|P8|First Intervention|Adverse Event|0
666610|NCT01904773|2152498|P7|First Intervention|Adverse Event|1
666611|NCT01904773|2152499|P6|First Intervention|Adverse Event|0
666612|NCT01904773|2152500|P5|First Intervention|Adverse Event|0
666613|NCT01904773|2152501|P4|First Intervention|Adverse Event|0
666614|NCT01904773|2152502|P3|First Intervention|Adverse Event|0
666615|NCT01904773|2152503|P2|First Intervention|Adverse Event|0
666616|NCT01904773|2152504|P1|First Intervention|Adverse Event|0
666617|NCT01904773|2152496|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666618|NCT01904773|2152497|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666619|NCT01904773|2152498|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666620|NCT01904773|2152499|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666621|NCT01904773|2152500|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666622|NCT01904773|2152501|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666623|NCT01904773|2152502|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666624|NCT01904773|2152503|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
666625|NCT01904773|2152504|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
666626|NCT01904773|2152496|P9|Screen|Withdrawal by Subject|0
666627|NCT01904773|2152497|P8|Screen|Withdrawal by Subject|0
666628|NCT01904773|2152498|P7|Screen|Withdrawal by Subject|0
666629|NCT01904773|2152499|P6|Screen|Withdrawal by Subject|0
666630|NCT01904773|2152500|P5|Screen|Withdrawal by Subject|0
666631|NCT01904773|2152501|P4|Screen|Withdrawal by Subject|0
666632|NCT01904773|2152502|P3|Screen|Withdrawal by Subject|0
666633|NCT01904773|2152503|P2|Screen|Withdrawal by Subject|0
666634|NCT01904773|2152504|P1|Screen|Withdrawal by Subject|1
666635|NCT01904773|2152496|P9|Screen|Screen failure|0
666636|NCT01904773|2152497|P8|Screen|Screen failure|0
666637|NCT01904773|2152498|P7|Screen|Screen failure|0
666638|NCT01904773|2152499|P6|Screen|Screen failure|0
666639|NCT01904773|2152500|P5|Screen|Screen failure|0
666640|NCT01904773|2152501|P4|Screen|Screen failure|0
666641|NCT01904773|2152502|P3|Screen|Screen failure|0
666642|NCT01904773|2152503|P2|Screen|Screen failure|0
666643|NCT01904773|2152504|P1|Screen|Screen failure|3
666644|NCT01904760|2152521|P2|Overall Study|Protocol Violation|0
666645|NCT01904760|2152522|P1|Overall Study|Protocol Violation|1
666646|NCT01904721|2152537|P7|Overall Study|Adverse Event|0
666647|NCT01904721|2152538|P6|Overall Study|Adverse Event|1
666648|NCT01904721|2152539|P5|Overall Study|Adverse Event|3
666649|NCT01904721|2152540|P4|Overall Study|Adverse Event|0
666650|NCT01904721|2152541|P3|Overall Study|Adverse Event|0
666651|NCT01904721|2152542|P2|Overall Study|Adverse Event|0
666652|NCT01904721|2152543|P1|Overall Study|Adverse Event|0
666653|NCT01904721|2152537|P7|Overall Study|Lack of Efficacy|1
666654|NCT01904721|2152538|P6|Overall Study|Lack of Efficacy|0
666655|NCT01904721|2152539|P5|Overall Study|Lack of Efficacy|0
666656|NCT01904721|2152540|P4|Overall Study|Lack of Efficacy|0
666657|NCT01904721|2152541|P3|Overall Study|Lack of Efficacy|0
666658|NCT01904721|2152542|P2|Overall Study|Lack of Efficacy|0
666659|NCT01904721|2152543|P1|Overall Study|Lack of Efficacy|0
666660|NCT01904721|2152537|P7|Overall Study|Lost to Follow-up|1
666661|NCT01904721|2152538|P6|Overall Study|Lost to Follow-up|3
666662|NCT01904721|2152539|P5|Overall Study|Lost to Follow-up|1
666663|NCT01904721|2152540|P4|Overall Study|Lost to Follow-up|0
666664|NCT01904721|2152541|P3|Overall Study|Lost to Follow-up|0
666665|NCT01904721|2152542|P2|Overall Study|Lost to Follow-up|0
666666|NCT01904721|2152543|P1|Overall Study|Lost to Follow-up|0
666667|NCT01904721|2152537|P7|Overall Study|Personal Reasons|3
666668|NCT01904721|2152538|P6|Overall Study|Personal Reasons|3
666669|NCT01904721|2152539|P5|Overall Study|Personal Reasons|2
666670|NCT01904721|2152540|P4|Overall Study|Personal Reasons|0
666671|NCT01904721|2152541|P3|Overall Study|Personal Reasons|0
666672|NCT01904721|2152542|P2|Overall Study|Personal Reasons|0
666673|NCT01904721|2152543|P1|Overall Study|Personal Reasons|0
666674|NCT01904721|2152537|P7|Overall Study|Other Reasons|2
666675|NCT01904721|2152538|P6|Overall Study|Other Reasons|2
666676|NCT01904721|2152539|P5|Overall Study|Other Reasons|2
666677|NCT01904721|2152540|P4|Overall Study|Other Reasons|1
666678|NCT01904721|2152541|P3|Overall Study|Other Reasons|1
666679|NCT01904721|2152542|P2|Overall Study|Other Reasons|0
666680|NCT01904721|2152543|P1|Overall Study|Other Reasons|0
666681|NCT01904604|2152573|P3|Overall Study|Unrelated illness|0
666682|NCT01904604|2152574|P2|Overall Study|Unrelated illness|1
666683|NCT01904604|2152575|P1|Overall Study|Unrelated illness|0
666684|NCT01904604|2152573|P3|Overall Study|Increased syncope|0
666685|NCT01904604|2152574|P2|Overall Study|Increased syncope|1
666686|NCT01904604|2152575|P1|Overall Study|Increased syncope|0
666687|NCT01904604|2152573|P3|Overall Study|Patch site reactions|0
666688|NCT01904604|2152574|P2|Overall Study|Patch site reactions|1
666689|NCT01904604|2152575|P1|Overall Study|Patch site reactions|0
666690|NCT01904604|2152573|P3|Overall Study|Anxiety about OFC/Refused OFC|0
666691|NCT01904604|2152574|P2|Overall Study|Anxiety about OFC/Refused OFC|0
666692|NCT01904604|2152575|P1|Overall Study|Anxiety about OFC/Refused OFC|2
666693|NCT01904604|2152573|P3|Overall Study|Non-compliance|0
666694|NCT01904604|2152574|P2|Overall Study|Non-compliance|0
666695|NCT01904604|2152575|P1|Overall Study|Non-compliance|1
666696|NCT01904604|2152573|P3|Overall Study|Withdrew before receiving dosing|0
666697|NCT01904604|2152574|P2|Overall Study|Withdrew before receiving dosing|1
666698|NCT01904604|2152575|P1|Overall Study|Withdrew before receiving dosing|0
666699|NCT01904279|2152593|P2|Overall Study|Withdrawal by Subject|0
666700|NCT01904279|2152594|P1|Overall Study|Withdrawal by Subject|1
666701|NCT01904279|2152593|P2|Overall Study|Lack of Efficacy|3
666702|NCT01904279|2152594|P1|Overall Study|Lack of Efficacy|2
666703|NCT01904149|2152620|P6|Overall Study|non compliance with study drug|0
666704|NCT01904149|2152621|P5|Overall Study|non compliance with study drug|0
666705|NCT01904149|2152622|P4|Overall Study|non compliance with study drug|0
666706|NCT01904149|2152623|P3|Overall Study|non compliance with study drug|0
666707|NCT01904149|2152624|P2|Overall Study|non compliance with study drug|0
666708|NCT01904149|2152625|P1|Overall Study|non compliance with study drug|1
666709|NCT01904149|2152620|P6|Overall Study|Protocol Violation|0
666710|NCT01904149|2152621|P5|Overall Study|Protocol Violation|0
666711|NCT01904149|2152622|P4|Overall Study|Protocol Violation|0
666712|NCT01904149|2152623|P3|Overall Study|Protocol Violation|0
666713|NCT01904149|2152624|P2|Overall Study|Protocol Violation|1
666714|NCT01904149|2152625|P1|Overall Study|Protocol Violation|0
666715|NCT01904149|2152620|P6|Overall Study|Withdrawal by Subject|0
666716|NCT01904149|2152621|P5|Overall Study|Withdrawal by Subject|1
666717|NCT01904149|2152622|P4|Overall Study|Withdrawal by Subject|0
666718|NCT01904149|2152623|P3|Overall Study|Withdrawal by Subject|1
666719|NCT01904149|2152624|P2|Overall Study|Withdrawal by Subject|3
666720|NCT01904149|2152625|P1|Overall Study|Withdrawal by Subject|1
666721|NCT01904149|2152620|P6|Overall Study|Lack of Efficacy|1
666722|NCT01904149|2152621|P5|Overall Study|Lack of Efficacy|3
666723|NCT01904149|2152622|P4|Overall Study|Lack of Efficacy|3
666724|NCT01904149|2152623|P3|Overall Study|Lack of Efficacy|1
666725|NCT01904149|2152624|P2|Overall Study|Lack of Efficacy|3
666726|NCT01904149|2152625|P1|Overall Study|Lack of Efficacy|0
666727|NCT01904149|2152620|P6|Overall Study|Adverse Event|2
666728|NCT01904149|2152621|P5|Overall Study|Adverse Event|1
666729|NCT01904149|2152622|P4|Overall Study|Adverse Event|1
666730|NCT01904149|2152623|P3|Overall Study|Adverse Event|0
666731|NCT01904149|2152624|P2|Overall Study|Adverse Event|4
666732|NCT01904149|2152625|P1|Overall Study|Adverse Event|3
666733|NCT01904058|2152676|P4|Overall Study|Pregnancy|1
666734|NCT01904058|2152677|P3|Overall Study|Pregnancy|0
666735|NCT01904058|2152678|P2|Overall Study|Pregnancy|0
666736|NCT01904058|2152679|P1|Overall Study|Pregnancy|0
666737|NCT01904058|2152676|P4|Overall Study|Withdrawal by Subject|0
666738|NCT01904058|2152677|P3|Overall Study|Withdrawal by Subject|1
666739|NCT01904058|2152678|P2|Overall Study|Withdrawal by Subject|0
666740|NCT01904058|2152679|P1|Overall Study|Withdrawal by Subject|1
666741|NCT01904058|2152676|P4|Overall Study|Adverse Event|0
666742|NCT01904058|2152677|P3|Overall Study|Adverse Event|0
666743|NCT01904058|2152678|P2|Overall Study|Adverse Event|0
666744|NCT01904058|2152679|P1|Overall Study|Adverse Event|2
666745|NCT01903993|2152719|P2|Overall Study|Lost to Follow-up|1
666746|NCT01903993|2152720|P1|Overall Study|Lost to Follow-up|2
666747|NCT01903993|2152719|P2|Overall Study|Withdrawal by Subject|5
666748|NCT01903993|2152720|P1|Overall Study|Withdrawal by Subject|13
666749|NCT01903993|2152719|P2|Overall Study|Death|89
666750|NCT01903993|2152720|P1|Overall Study|Death|108
666751|NCT01903876|2152737|P2|Six-Month Follow-up Period|Lost to Follow-up|145
666752|NCT01903876|2152738|P1|Six-Month Follow-up Period|Lost to Follow-up|91
666753|NCT01903876|2152737|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
666754|NCT01903876|2152738|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
666755|NCT01903863|2152748|P2|Overall Study|Physician Decision|0
666756|NCT01903863|2152749|P1|Overall Study|Physician Decision|2
888515|NCT01844505|2822432|P1|Overall Study|Adverse event unrelated to study drug|7
888516|NCT01844505|2822430|P3|Overall Study|Death|1
888517|NCT01844505|2822431|P2|Overall Study|Death|3
888518|NCT01844505|2822432|P1|Overall Study|Death|1
888519|NCT01844505|2822430|P3|Overall Study|Study drug toxicity|50
666762|NCT01903460|2152788|P4|Overall Study|Adverse Event|1
666763|NCT01903460|2152789|P3|Overall Study|Adverse Event|0
666764|NCT01903460|2152790|P2|Overall Study|Adverse Event|0
666765|NCT01903460|2152791|P1|Overall Study|Adverse Event|0
666766|NCT01902888|2152874|P1|Overall Study|Study Terminated|3
666767|NCT01902303|2152890|P2|Overall Study|Did not develop a cold sore|19
666768|NCT01902303|2152891|P1|Overall Study|Did not develop a cold sore|21
666769|NCT01902303|2152890|P2|Overall Study|subject lost investigational product|1
666770|NCT01902303|2152891|P1|Overall Study|subject lost investigational product|0
666771|NCT01902303|2152890|P2|Overall Study|Protocol Violation|2
666772|NCT01902303|2152891|P1|Overall Study|Protocol Violation|2
666773|NCT01902303|2152890|P2|Overall Study|Lost to Follow-up|1
666774|NCT01902303|2152891|P1|Overall Study|Lost to Follow-up|0
666775|NCT01902303|2152890|P2|Overall Study|Adverse Event|1
666776|NCT01902303|2152891|P1|Overall Study|Adverse Event|0
666777|NCT01902134|2152905|P6|Overall Study|not specified|0
666778|NCT01902134|2152906|P5|Overall Study|not specified|1
666779|NCT01902134|2152907|P4|Overall Study|not specified|0
666780|NCT01902134|2152908|P3|Overall Study|not specified|2
666781|NCT01902134|2152909|P2|Overall Study|not specified|1
666782|NCT01902134|2152910|P1|Overall Study|not specified|0
666783|NCT01902134|2152905|P6|Overall Study|no compliance|0
666784|NCT01902134|2152906|P5|Overall Study|no compliance|0
666785|NCT01902134|2152907|P4|Overall Study|no compliance|0
666786|NCT01902134|2152908|P3|Overall Study|no compliance|0
666787|NCT01902134|2152909|P2|Overall Study|no compliance|0
666788|NCT01902134|2152910|P1|Overall Study|no compliance|1
666789|NCT01902134|2152905|P6|Overall Study|Withdrawal by Subject|4
666790|NCT01902134|2152906|P5|Overall Study|Withdrawal by Subject|5
666791|NCT01902134|2152907|P4|Overall Study|Withdrawal by Subject|1
666792|NCT01902134|2152908|P3|Overall Study|Withdrawal by Subject|9
666793|NCT01902134|2152909|P2|Overall Study|Withdrawal by Subject|8
666794|NCT01902134|2152910|P1|Overall Study|Withdrawal by Subject|4
666795|NCT01902134|2152905|P6|Overall Study|Protocol Violation|1
666796|NCT01902134|2152906|P5|Overall Study|Protocol Violation|0
666797|NCT01902134|2152907|P4|Overall Study|Protocol Violation|0
666798|NCT01902134|2152908|P3|Overall Study|Protocol Violation|0
666799|NCT01902134|2152909|P2|Overall Study|Protocol Violation|0
666800|NCT01902134|2152910|P1|Overall Study|Protocol Violation|0
666801|NCT01902134|2152905|P6|Overall Study|Physician Decision|0
666802|NCT01902134|2152906|P5|Overall Study|Physician Decision|0
666803|NCT01902134|2152907|P4|Overall Study|Physician Decision|0
666804|NCT01902134|2152908|P3|Overall Study|Physician Decision|0
666805|NCT01902134|2152909|P2|Overall Study|Physician Decision|1
666806|NCT01902134|2152910|P1|Overall Study|Physician Decision|0
666807|NCT01902134|2152905|P6|Overall Study|Lack of Efficacy|1
666808|NCT01902134|2152906|P5|Overall Study|Lack of Efficacy|0
666809|NCT01902134|2152907|P4|Overall Study|Lack of Efficacy|0
666810|NCT01902134|2152908|P3|Overall Study|Lack of Efficacy|2
666811|NCT01902134|2152909|P2|Overall Study|Lack of Efficacy|0
888520|NCT01844505|2822431|P2|Overall Study|Study drug toxicity|131
666812|NCT01902134|2152910|P1|Overall Study|Lack of Efficacy|0
666813|NCT01902134|2152905|P6|Overall Study|Adverse Event|3
666814|NCT01902134|2152906|P5|Overall Study|Adverse Event|1
666815|NCT01902134|2152907|P4|Overall Study|Adverse Event|1
666816|NCT01902134|2152908|P3|Overall Study|Adverse Event|2
666817|NCT01902134|2152909|P2|Overall Study|Adverse Event|1
666818|NCT01902134|2152910|P1|Overall Study|Adverse Event|3
666819|NCT01901393|2152957|P2|Overall Study|Adverse Event|0
666820|NCT01901393|2152958|P1|Overall Study|Adverse Event|1
666821|NCT01901341|2152976|P2|Overall Study|Withdrawal by Subject|1
666822|NCT01901341|2152977|P1|Overall Study|Withdrawal by Subject|1
666823|NCT01901341|2152976|P2|Overall Study|Study Terminated by Sponsor|15
666824|NCT01901341|2152977|P1|Overall Study|Study Terminated by Sponsor|13
666825|NCT01901341|2152976|P2|Overall Study|Protocol Violation|0
666826|NCT01901341|2152977|P1|Overall Study|Protocol Violation|2
666827|NCT01901341|2152976|P2|Overall Study|Lost to Follow-up|1
666828|NCT01901341|2152977|P1|Overall Study|Lost to Follow-up|0
666829|NCT01901341|2152976|P2|Overall Study|Lack of Efficacy|2
666830|NCT01901341|2152977|P1|Overall Study|Lack of Efficacy|0
666831|NCT01901341|2152976|P2|Overall Study|Adverse Event|2
666832|NCT01901341|2152977|P1|Overall Study|Adverse Event|4
666833|NCT01901328|2152991|P2|Overall Study|Lack of Efficacy|1
666834|NCT01901328|2152992|P1|Overall Study|Lack of Efficacy|0
666835|NCT01901328|2152991|P2|Overall Study|Withdrawal by Subject|2
666836|NCT01901328|2152992|P1|Overall Study|Withdrawal by Subject|1
666837|NCT01901328|2152991|P2|Overall Study|Study Terminated by Sponsor|16
666838|NCT01901328|2152992|P1|Overall Study|Study Terminated by Sponsor|19
666839|NCT01901328|2152991|P2|Overall Study|Protocol Violation|1
666840|NCT01901328|2152992|P1|Overall Study|Protocol Violation|1
666841|NCT01901328|2152991|P2|Overall Study|Physician Decision|1
666842|NCT01901328|2152992|P1|Overall Study|Physician Decision|0
666843|NCT01901328|2152991|P2|Overall Study|Lost to Follow-up|0
666844|NCT01901328|2152992|P1|Overall Study|Lost to Follow-up|1
666845|NCT01901302|2153006|P2|Overall Study|Withdrawal by Subject|0
666846|NCT01901302|2153007|P1|Overall Study|Withdrawal by Subject|2
666847|NCT01901302|2153006|P2|Overall Study|Study Terminated by Sponsor|20
666848|NCT01901302|2153007|P1|Overall Study|Study Terminated by Sponsor|23
666849|NCT01901302|2153006|P2|Overall Study|Lack of Efficacy|2
666850|NCT01901302|2153007|P1|Overall Study|Lack of Efficacy|0
666851|NCT01901302|2153006|P2|Overall Study|Adverse Event|1
666852|NCT01901302|2153007|P1|Overall Study|Adverse Event|2
666853|NCT01901185|2153037|P1|Overall Study|Withdrawal by Subject|2
666854|NCT01900431|2153046|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
666855|NCT01900431|2153047|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
666856|NCT01900431|2153048|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
666857|NCT01900431|2153046|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
666858|NCT01900431|2153047|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
666859|NCT01900431|2153048|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
666860|NCT01900431|2153046|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
666861|NCT01900431|2153047|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
666862|NCT01900431|2153048|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
666863|NCT01900431|2153046|P3|Extended Treatment Period (Part B)|Other than specified above|0
666864|NCT01900431|2153047|P2|Extended Treatment Period (Part B)|Other than specified above|1
666865|NCT01900431|2153048|P1|Extended Treatment Period (Part B)|Other than specified above|0
666866|NCT01900431|2153046|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
666867|NCT01900431|2153047|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
666868|NCT01900431|2153048|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
666869|NCT01900431|2153046|P3|Extended Treatment Period (Part B)|Adverse Event|0
666870|NCT01900431|2153047|P2|Extended Treatment Period (Part B)|Adverse Event|2
666871|NCT01900431|2153048|P1|Extended Treatment Period (Part B)|Adverse Event|0
666872|NCT01900431|2153046|P3|Principal Treatment Period (Part A)|Other than specified above|0
666873|NCT01900431|2153047|P2|Principal Treatment Period (Part A)|Other than specified above|1
666874|NCT01900431|2153048|P1|Principal Treatment Period (Part A)|Other than specified above|0
666875|NCT01900431|2153046|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
666876|NCT01900431|2153047|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
666877|NCT01900431|2153048|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
666878|NCT01900431|2153046|P3|Principal Treatment Period (Part A)|Adverse Event|0
666879|NCT01900431|2153047|P2|Principal Treatment Period (Part A)|Adverse Event|3
666880|NCT01900431|2153048|P1|Principal Treatment Period (Part A)|Adverse Event|1
666881|NCT01900314|2153074|P2|Overall Study|Withdrawal by Subject|3
666882|NCT01900314|2153075|P1|Overall Study|Withdrawal by Subject|3
666883|NCT01900314|2153074|P2|Overall Study|Protocol Violation|1
666884|NCT01900314|2153075|P1|Overall Study|Protocol Violation|0
666885|NCT01900314|2153074|P2|Overall Study|Lost to Follow-up|0
666886|NCT01900314|2153075|P1|Overall Study|Lost to Follow-up|1
666887|NCT01900054|2153105|P1|Overall Study|Withdrawal by Subject|1
666888|NCT01900054|2153105|P1|Overall Study|Physician Decision|1
666889|NCT01899768|2153114|P1|Part B|Withdrawal by Subject|1
666890|NCT01899768|2153114|P1|Part B|Adverse Event|1
666891|NCT01899768|2153114|P1|Part A|Withdrawal by Subject|1
666892|NCT01899768|2153114|P1|Part A|Adverse Event|2
666893|NCT01899742|2153188|P2|Overall Study|Withdrawal by Subject|5
666894|NCT01899742|2153189|P1|Overall Study|Withdrawal by Subject|9
666895|NCT01899742|2153188|P2|Overall Study|Protocol Violation|2
666896|NCT01899742|2153189|P1|Overall Study|Protocol Violation|2
666897|NCT01899742|2153188|P2|Overall Study|Lack of Efficacy|5
666898|NCT01899742|2153189|P1|Overall Study|Lack of Efficacy|1
666899|NCT01899742|2153188|P2|Overall Study|Adverse Event|4
666900|NCT01899742|2153189|P1|Overall Study|Adverse Event|5
666901|NCT01899144|2153228|P1|Treatment Period 5|Not specified|1
666902|NCT01899144|2153228|P1|Treatment Period 3|Not specified|2
666903|NCT01899144|2153228|P1|Treatment Period 2|Not specified|1
666904|NCT01898884|2153255|P9|Multiple Dose Period|Randomized Not Treated|1
666905|NCT01898884|2153256|P8|Multiple Dose Period|Randomized Not Treated|0
666906|NCT01898884|2153257|P7|Multiple Dose Period|Randomized Not Treated|0
666907|NCT01898884|2153258|P6|Multiple Dose Period|Randomized Not Treated|0
666908|NCT01898884|2153259|P5|Multiple Dose Period|Randomized Not Treated|0
666909|NCT01898884|2153260|P4|Multiple Dose Period|Randomized Not Treated|0
666910|NCT01898884|2153261|P3|Multiple Dose Period|Randomized Not Treated|0
666911|NCT01898884|2153262|P2|Multiple Dose Period|Randomized Not Treated|0
666912|NCT01898884|2153263|P1|Multiple Dose Period|Randomized Not Treated|0
666913|NCT01898884|2153255|P9|Multiple Dose Period|Adverse Event|0
666914|NCT01898884|2153256|P8|Multiple Dose Period|Adverse Event|0
666915|NCT01898884|2153257|P7|Multiple Dose Period|Adverse Event|1
666916|NCT01898884|2153258|P6|Multiple Dose Period|Adverse Event|0
666917|NCT01898884|2153259|P5|Multiple Dose Period|Adverse Event|0
666918|NCT01898884|2153260|P4|Multiple Dose Period|Adverse Event|0
666919|NCT01898884|2153261|P3|Multiple Dose Period|Adverse Event|0
666920|NCT01898884|2153262|P2|Multiple Dose Period|Adverse Event|0
666921|NCT01898884|2153263|P1|Multiple Dose Period|Adverse Event|0
666922|NCT01898598|2153415|P2|Overall Study|Unspecified|1
666923|NCT01898598|2153416|P1|Overall Study|Unspecified|0
666924|NCT01898598|2153415|P2|Overall Study|Lost to Follow-up|1
666925|NCT01898598|2153416|P1|Overall Study|Lost to Follow-up|0
666926|NCT01898598|2153415|P2|Overall Study|Withdrawal by Subject|0
666927|NCT01898598|2153416|P1|Overall Study|Withdrawal by Subject|3
666928|NCT01898598|2153415|P2|Overall Study|Adverse Event|0
666929|NCT01898598|2153416|P1|Overall Study|Adverse Event|1
666930|NCT01898442|2153435|P3|Overall Study|Patient vomited pills|1
666931|NCT01898442|2153436|P2|Overall Study|Patient vomited pills|0
666932|NCT01898442|2153437|P1|Overall Study|Patient vomited pills|0
666933|NCT01898442|2153435|P3|Overall Study|Hemolysis/technical problems|2
666934|NCT01898442|2153436|P2|Overall Study|Hemolysis/technical problems|2
666935|NCT01898442|2153437|P1|Overall Study|Hemolysis/technical problems|1
666936|NCT01898286|2153466|P1|Overall Study|Lost to Follow-up|1
666937|NCT01898286|2153466|P1|Overall Study|Protocol Violation|1
666938|NCT01898286|2153466|P1|Overall Study|Withdrawal by Subject|1
666939|NCT01898208|2153476|P3|Overall Study|Lost to Follow-up|1
666940|NCT01898208|2153477|P2|Overall Study|Lost to Follow-up|1
666941|NCT01898208|2153478|P1|Overall Study|Lost to Follow-up|3
666942|NCT01898208|2153476|P3|Overall Study|System/Technical Error|3
666943|NCT01898208|2153477|P2|Overall Study|System/Technical Error|2
666944|NCT01898208|2153478|P1|Overall Study|System/Technical Error|1
666945|NCT01898208|2153476|P3|Overall Study|Non-Blood Specimens in Bottles|4
666946|NCT01898208|2153477|P2|Overall Study|Non-Blood Specimens in Bottles|5
666947|NCT01898208|2153478|P1|Overall Study|Non-Blood Specimens in Bottles|3
666948|NCT01898208|2153476|P3|Overall Study|Negative Gram Stain|6
666949|NCT01898208|2153477|P2|Overall Study|Negative Gram Stain|9
666950|NCT01898208|2153478|P1|Overall Study|Negative Gram Stain|6
666951|NCT01898208|2153476|P3|Overall Study|Death/comfort care within 24 hours|8
666952|NCT01898208|2153477|P2|Overall Study|Death/comfort care within 24 hours|9
666953|NCT01898208|2153478|P1|Overall Study|Death/comfort care within 24 hours|10
666954|NCT01898208|2153476|P3|Overall Study|Positive blood culture|15
666955|NCT01898208|2153477|P2|Overall Study|Positive blood culture|23
666956|NCT01898208|2153478|P1|Overall Study|Positive blood culture|17
666957|NCT01898195|2153525|P3|Smoking Abstinence|Did not have good measurements|36
666958|NCT01898195|2153526|P2|Smoking Abstinence|Did not have good measurements|38
666959|NCT01898195|2153527|P1|Smoking Abstinence|Did not have good measurements|35
666960|NCT01898091|2153540|P2|Overall Study|Withdrawal by Subject|5
666961|NCT01898091|2153541|P1|Overall Study|Withdrawal by Subject|1
666962|NCT01898091|2153540|P2|Overall Study|Lost to Follow-up|1
666963|NCT01898091|2153541|P1|Overall Study|Lost to Follow-up|1
666964|NCT01897727|2153576|P2|Overall Study|Exclusion: central sleep apnea|1
666965|NCT01897727|2153577|P1|Overall Study|Exclusion: central sleep apnea|0
666966|NCT01897233|2153606|P1|Part B (24 Weeks)|Physician Decision|1
666967|NCT01897233|2153606|P1|Part B (24 Weeks)|Withdrawal by Subject|2
666968|NCT01897233|2153606|P1|Part B (24 Weeks)|Adverse Event|1
666969|NCT01896986|2153639|P2|Overall Study|samples lost|23
666970|NCT01896986|2153640|P1|Overall Study|samples lost|14
666971|NCT01896934|2153646|P1|Overall Study|Withdrawal by Subject|1
666972|NCT01896934|2153646|P1|Overall Study|Adverse Event|1
666973|NCT01896726|2153652|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
666974|NCT01896726|2153652|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
666981|NCT01896297|2153710|P1|Overall Study|Died in post treatment phase|1
666982|NCT01896232|2153717|P2|Overall Study|Lost to Follow-up|12
666983|NCT01896232|2153718|P1|Overall Study|Lost to Follow-up|9
666984|NCT01896232|2153717|P2|Overall Study|Sponsor Decision|0
666985|NCT01896232|2153718|P1|Overall Study|Sponsor Decision|2
666986|NCT01896232|2153717|P2|Overall Study|Withdrawal by Subject|31
666987|NCT01896232|2153718|P1|Overall Study|Withdrawal by Subject|32
666988|NCT01896232|2153717|P2|Overall Study|Death|10
666989|NCT01896232|2153718|P1|Overall Study|Death|6
666990|NCT01896193|2153746|P2|Overall Study|Withdrew Consent|0
666991|NCT01896193|2153747|P1|Overall Study|Withdrew Consent|1
666992|NCT01896193|2153746|P2|Overall Study|Protocol Violation|1
666993|NCT01896193|2153747|P1|Overall Study|Protocol Violation|0
666994|NCT01896193|2153746|P2|Overall Study|Lack of Efficacy|11
666995|NCT01896193|2153747|P1|Overall Study|Lack of Efficacy|20
666996|NCT01896050|2153796|P2|Overall Study|Death|0
666997|NCT01896050|2153797|P1|Overall Study|Death|1
666998|NCT01896050|2153796|P2|Overall Study|Adverse Event|2
666999|NCT01896050|2153797|P1|Overall Study|Adverse Event|37
667000|NCT01895608|2153840|P4|Overall Study|Withdrawal by Subject|0
667001|NCT01895608|2153841|P3|Overall Study|Withdrawal by Subject|2
667002|NCT01895608|2153842|P2|Overall Study|Withdrawal by Subject|0
667003|NCT01895608|2153843|P1|Overall Study|Withdrawal by Subject|0
667004|NCT01895608|2153840|P4|Overall Study|change in health status|0
667005|NCT01895608|2153841|P3|Overall Study|change in health status|1
667006|NCT01895608|2153842|P2|Overall Study|change in health status|1
667007|NCT01895608|2153843|P1|Overall Study|change in health status|0
667008|NCT01895543|2153873|P1|Overall Study|Other (Not fulfilling above criteria)|24
667009|NCT01895543|2153873|P1|Overall Study|Physician Decision|2
667010|NCT01895543|2153873|P1|Overall Study|Protocol Violation|1
667011|NCT01895543|2153873|P1|Overall Study|Subject's substantial non-compliance|6
667012|NCT01895543|2153873|P1|Overall Study|Adverse Event|28
667013|NCT01895543|2153873|P1|Overall Study|Lost to Follow-up|25
667014|NCT01895543|2153873|P1|Overall Study|Withdrawal by Subject|43
667015|NCT01895452|2153889|P2|Overall Study|Noncompliance with study drug|1
667016|NCT01895452|2153890|P1|Overall Study|Noncompliance with study drug|0
667017|NCT01895452|2153889|P2|Overall Study|Underlying disease|3
667018|NCT01895452|2153890|P1|Overall Study|Underlying disease|0
667019|NCT01895452|2153889|P2|Overall Study|Withdrawal by Subject|14
667020|NCT01895452|2153890|P1|Overall Study|Withdrawal by Subject|2
667021|NCT01895452|2153889|P2|Overall Study|Pregnancy|1
667022|NCT01895452|2153890|P1|Overall Study|Pregnancy|0
667023|NCT01895452|2153889|P2|Overall Study|Lost to Follow-up|5
667024|NCT01895452|2153890|P1|Overall Study|Lost to Follow-up|1
667025|NCT01895452|2153889|P2|Overall Study|Adverse Event|4
667026|NCT01895452|2153890|P1|Overall Study|Adverse Event|1
667027|NCT01895335|2153900|P1|Overall Study|Other than Specified Above|44
667028|NCT01895335|2153900|P1|Overall Study|Included But Not treated|1
667029|NCT01895335|2153900|P1|Overall Study|Poor Compliance to Protocol|11
667030|NCT01895335|2153900|P1|Overall Study|Lack of Efficacy|53
667031|NCT01895335|2153900|P1|Overall Study|Adverse Event|106
667032|NCT01895322|2153917|P1|Overall Study|Protocol Violation|10
667033|NCT01895322|2153917|P1|Overall Study|Withdrawal by Subject|2
667034|NCT01895322|2153917|P1|Overall Study|Adverse Event|1
667035|NCT01895309|2153926|P2|Overall Study|Withdrawal by Subject|18
667036|NCT01895309|2153927|P1|Overall Study|Withdrawal by Subject|9
667037|NCT01895309|2153926|P2|Overall Study|Physician Decision|10
667038|NCT01895309|2153927|P1|Overall Study|Physician Decision|15
667039|NCT01895309|2153926|P2|Overall Study|Lost to Follow-up|3
667040|NCT01895309|2153927|P1|Overall Study|Lost to Follow-up|1
667041|NCT01895309|2153926|P2|Overall Study|Lack of Efficacy|3
667042|NCT01895309|2153927|P1|Overall Study|Lack of Efficacy|1
667043|NCT01895309|2153926|P2|Overall Study|Protocol Violation|0
667044|NCT01895309|2153927|P1|Overall Study|Protocol Violation|1
667045|NCT01895309|2153926|P2|Overall Study|Adverse Event|17
667046|NCT01895309|2153927|P1|Overall Study|Adverse Event|13
667047|NCT01895270|2153941|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
667048|NCT01895270|2153942|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
667049|NCT01895270|2153941|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
667050|NCT01895270|2153942|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
667051|NCT01895270|2153941|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
667052|NCT01895270|2153942|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
667053|NCT01895270|2153941|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
667054|NCT01895270|2153942|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
667055|NCT01895270|2153941|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
667056|NCT01895270|2153942|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
667057|NCT01895270|2153941|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
667058|NCT01895270|2153942|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
667059|NCT01895270|2153941|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
667060|NCT01895270|2153942|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
667061|NCT01895101|2153961|P3|Overall Study|coagulation disorder|0
667062|NCT01895101|2153962|P2|Overall Study|coagulation disorder|1
667063|NCT01895101|2153963|P1|Overall Study|coagulation disorder|0
667064|NCT01895101|2153961|P3|Overall Study|Death|0
667065|NCT01895101|2153962|P2|Overall Study|Death|1
667066|NCT01895101|2153963|P1|Overall Study|Death|0
667067|NCT01895101|2153961|P3|Overall Study|another study, enrolled in other study|0
667068|NCT01895101|2153962|P2|Overall Study|another study, enrolled in other study|1
667069|NCT01895101|2153963|P1|Overall Study|another study, enrolled in other study|0
667070|NCT01895101|2153961|P3|Overall Study|Withdrawal by Subject|2
667071|NCT01895101|2153962|P2|Overall Study|Withdrawal by Subject|1
667072|NCT01895101|2153963|P1|Overall Study|Withdrawal by Subject|0
667073|NCT01895101|2153961|P3|Overall Study|OPCAB procedure|3
667074|NCT01895101|2153962|P2|Overall Study|OPCAB procedure|1
667075|NCT01895101|2153963|P1|Overall Study|OPCAB procedure|1
667076|NCT01894984|2153998|P2|Overall Study|Unspecified|175
667077|NCT01894984|2153999|P1|Overall Study|Unspecified|314
667078|NCT01894607|2154054|P1|Overall Study|Ineligible|1
667079|NCT01894581|2154061|P2|Overall Study|Screen Failure|4
667080|NCT01894581|2154062|P1|Overall Study|Screen Failure|3
667081|NCT01894581|2154061|P2|Overall Study|Withdrawal by Subject|3
667082|NCT01894581|2154062|P1|Overall Study|Withdrawal by Subject|2
667083|NCT01894256|2154075|P3|Part B|Lack of Efficacy|13
667084|NCT01894256|2154076|P2|Part B|Lack of Efficacy|12
667085|NCT01894256|2154077|P1|Part B|Lack of Efficacy|15
667086|NCT01894256|2154075|P3|Part B|Withdrawal by Subject|0
667087|NCT01894256|2154076|P2|Part B|Withdrawal by Subject|1
667088|NCT01894256|2154077|P1|Part B|Withdrawal by Subject|0
667089|NCT01894256|2154075|P3|Part B|Death|1
667090|NCT01894256|2154076|P2|Part B|Death|1
667091|NCT01894256|2154077|P1|Part B|Death|0
667092|NCT01894256|2154075|P3|Part A|Adverse Event|0
667093|NCT01894256|2154076|P2|Part A|Adverse Event|1
667094|NCT01894256|2154077|P1|Part A|Adverse Event|0
667095|NCT01894230|2154123|P2|Overall Study|Death|0
667096|NCT01894230|2154124|P1|Overall Study|Death|1
667097|NCT01894230|2154123|P2|Overall Study|Non-adherent|1
667098|NCT01894230|2154124|P1|Overall Study|Non-adherent|0
667099|NCT01894230|2154123|P2|Overall Study|Withdrawal by Subject|4
667100|NCT01894230|2154124|P1|Overall Study|Withdrawal by Subject|4
667101|NCT01894230|2154123|P2|Overall Study|Lost to Follow-up|2
667102|NCT01894230|2154124|P1|Overall Study|Lost to Follow-up|2
667103|NCT01894100|2154150|P2|Overall Study|Withdrawal by Subject|0
667104|NCT01894100|2154151|P1|Overall Study|Withdrawal by Subject|3
667105|NCT01894100|2154150|P2|Overall Study|Lost to Follow-up|1
667106|NCT01894100|2154151|P1|Overall Study|Lost to Follow-up|0
667107|NCT01894022|2154161|P2|Overall Study|Study Closed/terminated|10
667108|NCT01894022|2154162|P1|Overall Study|Study Closed/terminated|7
667109|NCT01894022|2154161|P2|Overall Study|Adverse Event, non-fatal|0
667110|NCT01894022|2154162|P1|Overall Study|Adverse Event, non-fatal|1
667111|NCT01894022|2154161|P2|Overall Study|Death|0
667112|NCT01894022|2154162|P1|Overall Study|Death|1
667113|NCT01893905|2154216|P2|Overall Study|Other reason|3
667114|NCT01893905|2154217|P1|Overall Study|Other reason|1
667115|NCT01893905|2154216|P2|Overall Study|Lack of adherence to treatment|0
667116|NCT01893905|2154217|P1|Overall Study|Lack of adherence to treatment|2
667117|NCT01893905|2154216|P2|Overall Study|Protocol Violation|1
667118|NCT01893905|2154217|P1|Overall Study|Protocol Violation|6
667119|NCT01893905|2154216|P2|Overall Study|Lost to Follow-up|0
667120|NCT01893905|2154217|P1|Overall Study|Lost to Follow-up|1
667121|NCT01893905|2154216|P2|Overall Study|Lack of Efficacy|7
667122|NCT01893905|2154217|P1|Overall Study|Lack of Efficacy|5
667123|NCT01893905|2154216|P2|Overall Study|Adverse Event|3
667124|NCT01893905|2154217|P1|Overall Study|Adverse Event|9
667125|NCT01893905|2154216|P2|Overall Study|Withdrawal by Subject|0
667126|NCT01893905|2154217|P1|Overall Study|Withdrawal by Subject|1
667127|NCT01893411|2154239|P3|Overall Study|Lost to Follow-up|1
667128|NCT01893411|2154240|P2|Overall Study|Lost to Follow-up|0
667129|NCT01893411|2154241|P1|Overall Study|Lost to Follow-up|2
667130|NCT01893411|2154239|P3|Overall Study|Withdrawal by Subject|3
667131|NCT01893411|2154240|P2|Overall Study|Withdrawal by Subject|4
667132|NCT01893411|2154241|P1|Overall Study|Withdrawal by Subject|7
667133|NCT01893411|2154239|P3|Overall Study|Adverse Event|0
667134|NCT01893411|2154240|P2|Overall Study|Adverse Event|0
667135|NCT01893411|2154241|P1|Overall Study|Adverse Event|1
667136|NCT01893411|2154239|P3|Overall Study|Not Specified|3
667137|NCT01893411|2154240|P2|Overall Study|Not Specified|1
667138|NCT01893411|2154241|P1|Overall Study|Not Specified|3
667139|NCT01893411|2154239|P3|Overall Study|Lack of Efficacy|0
667140|NCT01893411|2154240|P2|Overall Study|Lack of Efficacy|1
667141|NCT01893411|2154241|P1|Overall Study|Lack of Efficacy|2
667142|NCT01893411|2154239|P3|Overall Study|Physician Decision|2
667143|NCT01893411|2154240|P2|Overall Study|Physician Decision|1
667144|NCT01893411|2154241|P1|Overall Study|Physician Decision|1
667145|NCT01893411|2154239|P3|Overall Study|Protocol Violation|0
667146|NCT01893411|2154240|P2|Overall Study|Protocol Violation|0
667147|NCT01893411|2154241|P1|Overall Study|Protocol Violation|1
667148|NCT01893346|2154323|P4|Overall Study|Withdrawal by Subject|0
667149|NCT01893346|2154324|P3|Overall Study|Withdrawal by Subject|0
667150|NCT01893346|2154325|P2|Overall Study|Withdrawal by Subject|0
667151|NCT01893346|2154326|P1|Overall Study|Withdrawal by Subject|2
667152|NCT01893346|2154323|P4|Overall Study|Protocol Violation|0
667153|NCT01893346|2154324|P3|Overall Study|Protocol Violation|0
667154|NCT01893346|2154325|P2|Overall Study|Protocol Violation|0
667155|NCT01893346|2154326|P1|Overall Study|Protocol Violation|1
667156|NCT01893346|2154323|P4|Overall Study|Lost to Follow-up|0
667157|NCT01893346|2154324|P3|Overall Study|Lost to Follow-up|0
667158|NCT01893346|2154325|P2|Overall Study|Lost to Follow-up|1
667159|NCT01893346|2154326|P1|Overall Study|Lost to Follow-up|0
667160|NCT01893281|2154340|P1|Overall Study|Withdrawal by Subject|1
667161|NCT01893281|2154340|P1|Overall Study|Protocol Violation|1
667162|NCT01893281|2154340|P1|Overall Study|Adverse Event|1
667163|NCT01893203|2154347|P1|Overall Study|Withdrawal by Subject|1
667164|NCT01892657|2154354|P1|Overall Study|Protocol Violation|12
667165|NCT01892657|2154354|P1|Overall Study|Withdrawal by Subject|6
667166|NCT01892189|2154431|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667167|NCT01892189|2154432|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667168|NCT01892189|2154433|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667169|NCT01892189|2154434|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
667170|NCT01892189|2154435|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667171|NCT01892189|2154436|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667172|NCT01892189|2154437|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667173|NCT01892189|2154438|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667174|NCT01892189|2154439|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
667175|NCT01892189|2154431|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
667176|NCT01892189|2154432|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
667177|NCT01892189|2154433|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
667178|NCT01892189|2154434|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
667179|NCT01892189|2154435|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
667180|NCT01892189|2154436|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
667181|NCT01892189|2154437|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
667182|NCT01892189|2154438|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
667183|NCT01892189|2154439|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
667184|NCT01892189|2154431|P9|Washout Period 1 (7 Days)|Adverse Event|1
667185|NCT01892189|2154432|P8|Washout Period 1 (7 Days)|Adverse Event|0
667186|NCT01892189|2154433|P7|Washout Period 1 (7 Days)|Adverse Event|0
667187|NCT01892189|2154434|P6|Washout Period 1 (7 Days)|Adverse Event|0
667188|NCT01892189|2154435|P5|Washout Period 1 (7 Days)|Adverse Event|0
667189|NCT01892189|2154436|P4|Washout Period 1 (7 Days)|Adverse Event|0
667190|NCT01892189|2154437|P3|Washout Period 1 (7 Days)|Adverse Event|0
667191|NCT01892189|2154438|P2|Washout Period 1 (7 Days)|Adverse Event|0
667192|NCT01892189|2154439|P1|Washout Period 1 (7 Days)|Adverse Event|0
667193|NCT01892163|2154481|P2|Overall Study|Lost to Follow-up|0
667194|NCT01892163|2154482|P1|Overall Study|Lost to Follow-up|1
667195|NCT01892163|2154481|P2|Overall Study|Death|1
667196|NCT01892163|2154482|P1|Overall Study|Death|1
667197|NCT01892020|2154494|P2|Period 2|Protocol Violation|0
667198|NCT01892020|2154495|P1|Period 2|Protocol Violation|1
667199|NCT01892020|2154494|P2|Period 1|Unclassified|1
667200|NCT01892020|2154495|P1|Period 1|Unclassified|0
667201|NCT01892020|2154494|P2|Period 1|Protocol Violation|4
667202|NCT01892020|2154495|P1|Period 1|Protocol Violation|2
667203|NCT01892020|2154494|P2|Period 1|Adverse Event|1
667204|NCT01892020|2154495|P1|Period 1|Adverse Event|1
667205|NCT01891890|2154516|P3|Overall Study|Study ended before endpoint reached|6
667206|NCT01891890|2154517|P2|Overall Study|Study ended before endpoint reached|3
667207|NCT01891890|2154518|P1|Overall Study|Study ended before endpoint reached|7
667208|NCT01891890|2154516|P3|Overall Study|Lost to Follow-up|1
667209|NCT01891890|2154517|P2|Overall Study|Lost to Follow-up|0
667210|NCT01891890|2154518|P1|Overall Study|Lost to Follow-up|0
667211|NCT01891864|2154561|P6|Extension Period|Lost to Follow-up|0
667212|NCT01891864|2154562|P5|Extension Period|Lost to Follow-up|0
667213|NCT01891864|2154563|P4|Extension Period|Lost to Follow-up|0
667214|NCT01891864|2154564|P3|Extension Period|Lost to Follow-up|2
667215|NCT01891864|2154565|P2|Extension Period|Lost to Follow-up|0
667216|NCT01891864|2154566|P1|Extension Period|Lost to Follow-up|0
667217|NCT01891864|2154561|P6|Extension Period|Withdrawal by Subject|0
667218|NCT01891864|2154562|P5|Extension Period|Withdrawal by Subject|4
667219|NCT01891864|2154563|P4|Extension Period|Withdrawal by Subject|2
667220|NCT01891864|2154564|P3|Extension Period|Withdrawal by Subject|1
667221|NCT01891864|2154565|P2|Extension Period|Withdrawal by Subject|0
667222|NCT01891864|2154566|P1|Extension Period|Withdrawal by Subject|0
667223|NCT01891864|2154561|P6|Extension Period|Adverse Event|0
667224|NCT01891864|2154562|P5|Extension Period|Adverse Event|2
667225|NCT01891864|2154563|P4|Extension Period|Adverse Event|2
667226|NCT01891864|2154564|P3|Extension Period|Adverse Event|4
667227|NCT01891864|2154565|P2|Extension Period|Adverse Event|0
667228|NCT01891864|2154566|P1|Extension Period|Adverse Event|0
667229|NCT01891864|2154561|P6|Extension Period|Pregnancy|0
667230|NCT01891864|2154562|P5|Extension Period|Pregnancy|0
667231|NCT01891864|2154563|P4|Extension Period|Pregnancy|0
667232|NCT01891864|2154564|P3|Extension Period|Pregnancy|1
667233|NCT01891864|2154565|P2|Extension Period|Pregnancy|0
667234|NCT01891864|2154566|P1|Extension Period|Pregnancy|0
667235|NCT01891864|2154561|P6|Extension Period|Lack of Efficacy|0
667236|NCT01891864|2154562|P5|Extension Period|Lack of Efficacy|1
667237|NCT01891864|2154563|P4|Extension Period|Lack of Efficacy|1
667238|NCT01891864|2154564|P3|Extension Period|Lack of Efficacy|0
667239|NCT01891864|2154565|P2|Extension Period|Lack of Efficacy|0
667240|NCT01891864|2154566|P1|Extension Period|Lack of Efficacy|0
667241|NCT01891864|2154561|P6|Treatment Period 2|Withdrawal by Subject|1
667242|NCT01891864|2154562|P5|Treatment Period 2|Withdrawal by Subject|1
667243|NCT01891864|2154563|P4|Treatment Period 2|Withdrawal by Subject|4
667244|NCT01891864|2154564|P3|Treatment Period 2|Withdrawal by Subject|3
667245|NCT01891864|2154565|P2|Treatment Period 2|Withdrawal by Subject|0
667246|NCT01891864|2154566|P1|Treatment Period 2|Withdrawal by Subject|0
667247|NCT01891864|2154561|P6|Treatment Period 2|Termination of Site|0
667248|NCT01891864|2154562|P5|Treatment Period 2|Termination of Site|2
667249|NCT01891864|2154563|P4|Treatment Period 2|Termination of Site|0
667250|NCT01891864|2154564|P3|Treatment Period 2|Termination of Site|0
667251|NCT01891864|2154565|P2|Treatment Period 2|Termination of Site|0
667252|NCT01891864|2154566|P1|Treatment Period 2|Termination of Site|0
667253|NCT01891864|2154561|P6|Treatment Period 2|Adverse Event|4
667254|NCT01891864|2154562|P5|Treatment Period 2|Adverse Event|0
667255|NCT01891864|2154563|P4|Treatment Period 2|Adverse Event|2
667256|NCT01891864|2154564|P3|Treatment Period 2|Adverse Event|1
667257|NCT01891864|2154565|P2|Treatment Period 2|Adverse Event|0
667258|NCT01891864|2154566|P1|Treatment Period 2|Adverse Event|0
667259|NCT01891864|2154561|P6|Treatment Period 2|Lack of Efficacy|0
667260|NCT01891864|2154562|P5|Treatment Period 2|Lack of Efficacy|1
667261|NCT01891864|2154563|P4|Treatment Period 2|Lack of Efficacy|0
667262|NCT01891864|2154564|P3|Treatment Period 2|Lack of Efficacy|1
667263|NCT01891864|2154565|P2|Treatment Period 2|Lack of Efficacy|0
667264|NCT01891864|2154566|P1|Treatment Period 2|Lack of Efficacy|0
667265|NCT01891864|2154561|P6|Treatment Period 2|Site Termination|0
667266|NCT01891864|2154562|P5|Treatment Period 2|Site Termination|0
667267|NCT01891864|2154563|P4|Treatment Period 2|Site Termination|2
667268|NCT01891864|2154564|P3|Treatment Period 2|Site Termination|1
667269|NCT01891864|2154565|P2|Treatment Period 2|Site Termination|0
667270|NCT01891864|2154566|P1|Treatment Period 2|Site Termination|0
667271|NCT01891864|2154561|P6|Treatment Period 2|Physician Decision|0
667272|NCT01891864|2154562|P5|Treatment Period 2|Physician Decision|0
667273|NCT01891864|2154563|P4|Treatment Period 2|Physician Decision|0
667274|NCT01891864|2154564|P3|Treatment Period 2|Physician Decision|1
667275|NCT01891864|2154565|P2|Treatment Period 2|Physician Decision|0
667276|NCT01891864|2154566|P1|Treatment Period 2|Physician Decision|0
667277|NCT01891864|2154561|P6|Treatment Period 2|Protocol Violation|0
667278|NCT01891864|2154562|P5|Treatment Period 2|Protocol Violation|0
667279|NCT01891864|2154563|P4|Treatment Period 2|Protocol Violation|1
667280|NCT01891864|2154564|P3|Treatment Period 2|Protocol Violation|0
667281|NCT01891864|2154565|P2|Treatment Period 2|Protocol Violation|0
667282|NCT01891864|2154566|P1|Treatment Period 2|Protocol Violation|0
667283|NCT01891864|2154561|P6|Treatment Period 1|Lost to Follow-up|0
667284|NCT01891864|2154562|P5|Treatment Period 1|Lost to Follow-up|0
667285|NCT01891864|2154563|P4|Treatment Period 1|Lost to Follow-up|0
667286|NCT01891864|2154564|P3|Treatment Period 1|Lost to Follow-up|0
667287|NCT01891864|2154565|P2|Treatment Period 1|Lost to Follow-up|0
667288|NCT01891864|2154566|P1|Treatment Period 1|Lost to Follow-up|1
667289|NCT01891864|2154561|P6|Treatment Period 1|Withdrawal by Subject|0
667290|NCT01891864|2154562|P5|Treatment Period 1|Withdrawal by Subject|0
667291|NCT01891864|2154563|P4|Treatment Period 1|Withdrawal by Subject|0
667292|NCT01891864|2154564|P3|Treatment Period 1|Withdrawal by Subject|0
667293|NCT01891864|2154565|P2|Treatment Period 1|Withdrawal by Subject|5
667294|NCT01891864|2154566|P1|Treatment Period 1|Withdrawal by Subject|2
667295|NCT01891864|2154561|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
667296|NCT01891864|2154562|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
667297|NCT01891864|2154563|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
667298|NCT01891864|2154564|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
667299|NCT01891864|2154565|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
667300|NCT01891864|2154566|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
667301|NCT01891864|2154561|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
667302|NCT01891864|2154562|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
667303|NCT01891864|2154563|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
667304|NCT01891864|2154564|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
667305|NCT01891864|2154565|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
667306|NCT01891864|2154566|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
667307|NCT01891864|2154561|P6|Treatment Period 1|Physician Decision|0
667308|NCT01891864|2154562|P5|Treatment Period 1|Physician Decision|0
667309|NCT01891864|2154563|P4|Treatment Period 1|Physician Decision|0
667310|NCT01891864|2154564|P3|Treatment Period 1|Physician Decision|0
667311|NCT01891864|2154565|P2|Treatment Period 1|Physician Decision|1
667312|NCT01891864|2154566|P1|Treatment Period 1|Physician Decision|0
667313|NCT01891864|2154561|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
667314|NCT01891864|2154562|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
667315|NCT01891864|2154563|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
667316|NCT01891864|2154564|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
667317|NCT01891864|2154565|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
667318|NCT01891864|2154566|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
667319|NCT01891669|2154609|P10|Overall Study|Unspecified|0
667320|NCT01891669|2154610|P9|Overall Study|Unspecified|0
667321|NCT01891669|2154611|P8|Overall Study|Unspecified|1
667322|NCT01891669|2154612|P7|Overall Study|Unspecified|0
667323|NCT01891669|2154613|P6|Overall Study|Unspecified|0
667324|NCT01891669|2154614|P5|Overall Study|Unspecified|0
667325|NCT01891669|2154615|P4|Overall Study|Unspecified|0
667326|NCT01891669|2154616|P3|Overall Study|Unspecified|0
667327|NCT01891669|2154617|P2|Overall Study|Unspecified|0
667328|NCT01891669|2154618|P1|Overall Study|Unspecified|1
667329|NCT01891669|2154609|P10|Overall Study|Withdrawal by Subject|1
667330|NCT01891669|2154610|P9|Overall Study|Withdrawal by Subject|1
667331|NCT01891669|2154611|P8|Overall Study|Withdrawal by Subject|2
667332|NCT01891669|2154612|P7|Overall Study|Withdrawal by Subject|1
667333|NCT01891669|2154613|P6|Overall Study|Withdrawal by Subject|0
667334|NCT01891669|2154614|P5|Overall Study|Withdrawal by Subject|0
667335|NCT01891669|2154615|P4|Overall Study|Withdrawal by Subject|0
667336|NCT01891669|2154616|P3|Overall Study|Withdrawal by Subject|0
667337|NCT01891669|2154617|P2|Overall Study|Withdrawal by Subject|1
667338|NCT01891669|2154618|P1|Overall Study|Withdrawal by Subject|1
667339|NCT01891669|2154609|P10|Overall Study|Death|1
667340|NCT01891669|2154610|P9|Overall Study|Death|0
667341|NCT01891669|2154611|P8|Overall Study|Death|1
667342|NCT01891669|2154612|P7|Overall Study|Death|0
667343|NCT01891669|2154613|P6|Overall Study|Death|0
667344|NCT01891669|2154614|P5|Overall Study|Death|0
667345|NCT01891669|2154615|P4|Overall Study|Death|0
667346|NCT01891669|2154616|P3|Overall Study|Death|0
667347|NCT01891669|2154617|P2|Overall Study|Death|0
667348|NCT01891669|2154618|P1|Overall Study|Death|0
667349|NCT01890967|2154775|P6|Overall Study|Withdrawal by Subject|1
667350|NCT01890967|2154776|P5|Overall Study|Withdrawal by Subject|3
667351|NCT01890967|2154777|P4|Overall Study|Withdrawal by Subject|3
667352|NCT01890967|2154778|P3|Overall Study|Withdrawal by Subject|2
667353|NCT01890967|2154779|P2|Overall Study|Withdrawal by Subject|4
667354|NCT01890967|2154780|P1|Overall Study|Withdrawal by Subject|3
667355|NCT01890967|2154775|P6|Overall Study|Sponsor Decision|3
667356|NCT01890967|2154776|P5|Overall Study|Sponsor Decision|2
667357|NCT01890967|2154777|P4|Overall Study|Sponsor Decision|3
667358|NCT01890967|2154778|P3|Overall Study|Sponsor Decision|1
667359|NCT01890967|2154779|P2|Overall Study|Sponsor Decision|0
667360|NCT01890967|2154780|P1|Overall Study|Sponsor Decision|2
667361|NCT01890967|2154775|P6|Overall Study|Protocol Violation|1
667362|NCT01890967|2154776|P5|Overall Study|Protocol Violation|4
667363|NCT01890967|2154777|P4|Overall Study|Protocol Violation|2
667364|NCT01890967|2154778|P3|Overall Study|Protocol Violation|3
667365|NCT01890967|2154779|P2|Overall Study|Protocol Violation|3
667366|NCT01890967|2154780|P1|Overall Study|Protocol Violation|0
667367|NCT01890967|2154775|P6|Overall Study|Lost to Follow-up|1
667368|NCT01890967|2154776|P5|Overall Study|Lost to Follow-up|0
667369|NCT01890967|2154777|P4|Overall Study|Lost to Follow-up|1
667370|NCT01890967|2154778|P3|Overall Study|Lost to Follow-up|1
667371|NCT01890967|2154779|P2|Overall Study|Lost to Follow-up|1
667372|NCT01890967|2154780|P1|Overall Study|Lost to Follow-up|1
667373|NCT01890967|2154775|P6|Overall Study|Death|0
667374|NCT01890967|2154776|P5|Overall Study|Death|0
667375|NCT01890967|2154777|P4|Overall Study|Death|0
667376|NCT01890967|2154778|P3|Overall Study|Death|0
667377|NCT01890967|2154779|P2|Overall Study|Death|0
667378|NCT01890967|2154780|P1|Overall Study|Death|1
667379|NCT01890967|2154775|P6|Overall Study|Adverse Event|7
667380|NCT01890967|2154776|P5|Overall Study|Adverse Event|1
667381|NCT01890967|2154777|P4|Overall Study|Adverse Event|2
667382|NCT01890967|2154778|P3|Overall Study|Adverse Event|3
667383|NCT01890967|2154779|P2|Overall Study|Adverse Event|3
667384|NCT01890967|2154780|P1|Overall Study|Adverse Event|3
667385|NCT01890915|2154858|P2|Overall Study|Equipment Malfunction|1
667386|NCT01890915|2154859|P1|Overall Study|Equipment Malfunction|0
667387|NCT01890915|2154858|P2|Overall Study|Protocol Violation|0
667388|NCT01890915|2154859|P1|Overall Study|Protocol Violation|2
667389|NCT01890915|2154858|P2|Overall Study|Adverse Event|0
667390|NCT01890915|2154859|P1|Overall Study|Adverse Event|1
667391|NCT01890785|2154875|P6|Third Intervention|Withdrawal by Subject|0
667392|NCT01890785|2154876|P5|Third Intervention|Withdrawal by Subject|0
667393|NCT01890785|2154877|P4|Third Intervention|Withdrawal by Subject|0
667394|NCT01890785|2154878|P3|Third Intervention|Withdrawal by Subject|0
667395|NCT01890785|2154879|P2|Third Intervention|Withdrawal by Subject|1
667396|NCT01890785|2154880|P1|Third Intervention|Withdrawal by Subject|0
667397|NCT01890759|2154899|P2|Overall Study|Withdrawal by Subject|8
667398|NCT01890759|2154900|P1|Overall Study|Withdrawal by Subject|2
667399|NCT01890759|2154899|P2|Overall Study|Lost to Follow-up|2
667400|NCT01890759|2154900|P1|Overall Study|Lost to Follow-up|0
667401|NCT01890759|2154899|P2|Overall Study|Protocol Violation|2
667402|NCT01890759|2154900|P1|Overall Study|Protocol Violation|0
667403|NCT01890746|2154934|P2|Overall Study|Ongoing|50
667404|NCT01890746|2154935|P1|Overall Study|Ongoing|44
667405|NCT01890746|2154934|P2|Overall Study|Death|14
667406|NCT01890746|2154935|P1|Overall Study|Death|23
667407|NCT01890746|2154934|P2|Overall Study|Withdrawal by Subject|8
667408|NCT01890746|2154935|P1|Overall Study|Withdrawal by Subject|4
667409|NCT01890746|2154934|P2|Overall Study|Physician Decision|2
667410|NCT01890746|2154935|P1|Overall Study|Physician Decision|2
667411|NCT01890746|2154934|P2|Overall Study|Adverse Event|0
667412|NCT01890746|2154935|P1|Overall Study|Adverse Event|1
667413|NCT01890512|2155007|P1|Overall Study|Protocol Violation|1
667414|NCT01890512|2155007|P1|Overall Study|Withdrawal by Subject|1
667415|NCT01890512|2155007|P1|Overall Study|Physician Decision|1
667416|NCT01890473|2155013|P2|Overall Study|Poor/non-compliance|0
667417|NCT01890473|2155014|P1|Overall Study|Poor/non-compliance|1
667418|NCT01890473|2155013|P2|Overall Study|Lost to Follow-up|0
667419|NCT01890473|2155014|P1|Overall Study|Lost to Follow-up|1
667420|NCT01890148|2155056|P1|Overall Study|Adverse Event|1
667421|NCT01890122|2155076|P4|Overall Study|Randomized but not Treated|0
667422|NCT01890122|2155077|P3|Overall Study|Randomized but not Treated|0
667423|NCT01890122|2155078|P2|Overall Study|Randomized but not Treated|1
667424|NCT01890122|2155079|P1|Overall Study|Randomized but not Treated|1
667425|NCT01890122|2155076|P4|Overall Study|Reason not Specified|2
667426|NCT01890122|2155077|P3|Overall Study|Reason not Specified|1
667427|NCT01890122|2155078|P2|Overall Study|Reason not Specified|1
667428|NCT01890122|2155079|P1|Overall Study|Reason not Specified|0
667429|NCT01890122|2155076|P4|Overall Study|Lack of Efficacy|41
667430|NCT01890122|2155077|P3|Overall Study|Lack of Efficacy|7
667431|NCT01890122|2155078|P2|Overall Study|Lack of Efficacy|24
667432|NCT01890122|2155079|P1|Overall Study|Lack of Efficacy|14
667433|NCT01890122|2155076|P4|Overall Study|Voluntary Withdrawal|11
667434|NCT01890122|2155077|P3|Overall Study|Voluntary Withdrawal|2
667435|NCT01890122|2155078|P2|Overall Study|Voluntary Withdrawal|8
667436|NCT01890122|2155079|P1|Overall Study|Voluntary Withdrawal|8
667437|NCT01890122|2155076|P4|Overall Study|Lost to Follow-up|2
667438|NCT01890122|2155077|P3|Overall Study|Lost to Follow-up|2
667439|NCT01890122|2155078|P2|Overall Study|Lost to Follow-up|1
667440|NCT01890122|2155079|P1|Overall Study|Lost to Follow-up|0
667441|NCT01890122|2155076|P4|Overall Study|Major Protocol Deviation|1
667442|NCT01890122|2155077|P3|Overall Study|Major Protocol Deviation|0
667443|NCT01890122|2155078|P2|Overall Study|Major Protocol Deviation|1
667444|NCT01890122|2155079|P1|Overall Study|Major Protocol Deviation|3
667445|NCT01890122|2155076|P4|Overall Study|Adverse Event|2
667446|NCT01890122|2155077|P3|Overall Study|Adverse Event|1
667447|NCT01890122|2155078|P2|Overall Study|Adverse Event|1
667448|NCT01890122|2155079|P1|Overall Study|Adverse Event|1
667449|NCT01889251|2155226|P2|Overall Study|Adverse Event|0
667450|NCT01889251|2155227|P1|Overall Study|Adverse Event|1
667451|NCT01888965|2155233|P1|Overall Study|Lack of Efficacy|4
667452|NCT01888965|2155233|P1|Overall Study|Adverse Event|5
667453|NCT01888900|2155245|P2|Overall Study|failed treatment|2
667454|NCT01888900|2155246|P1|Overall Study|failed treatment|0
667455|NCT01888367|2155269|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
667456|NCT01888367|2155270|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
667457|NCT01888367|2155271|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
667458|NCT01888367|2155269|P3|Overall Study|Protocol Violation|1
667459|NCT01888367|2155270|P2|Overall Study|Protocol Violation|0
667460|NCT01888367|2155271|P1|Overall Study|Protocol Violation|0
667461|NCT01888367|2155269|P3|Overall Study|Lost to Follow-up|0
667462|NCT01888367|2155270|P2|Overall Study|Lost to Follow-up|1
667463|NCT01888367|2155271|P1|Overall Study|Lost to Follow-up|1
667464|NCT01888367|2155269|P3|Overall Study|Withdrawal by Subject|1
667465|NCT01888367|2155270|P2|Overall Study|Withdrawal by Subject|0
667466|NCT01888367|2155271|P1|Overall Study|Withdrawal by Subject|1
667467|NCT01888367|2155269|P3|Overall Study|Death|1
667468|NCT01888367|2155270|P2|Overall Study|Death|0
667469|NCT01888367|2155271|P1|Overall Study|Death|2
667470|NCT01888367|2155269|P3|Overall Study|Physician Decision|2
667471|NCT01888367|2155270|P2|Overall Study|Physician Decision|4
667472|NCT01888367|2155271|P1|Overall Study|Physician Decision|3
667473|NCT01888003|2155291|P3|Overall Study|Study Terminated|40
667474|NCT01888003|2155292|P2|Overall Study|Study Terminated|6
667475|NCT01888003|2155293|P1|Overall Study|Study Terminated|5
667476|NCT01887678|2155333|P2|Overall Study|Specified|2
667477|NCT01887678|2155334|P1|Overall Study|Specified|1
667478|NCT01887678|2155333|P2|Overall Study|Non-compliance|3
667479|NCT01887678|2155334|P1|Overall Study|Non-compliance|0
667480|NCT01887678|2155333|P2|Overall Study|Lack of Efficacy|2
667481|NCT01887678|2155334|P1|Overall Study|Lack of Efficacy|1
667482|NCT01887678|2155333|P2|Overall Study|Deterioration of clinical condition|4
667483|NCT01887678|2155334|P1|Overall Study|Deterioration of clinical condition|0
667484|NCT01887678|2155333|P2|Overall Study|Lost to Follow-up|2
667485|NCT01887678|2155334|P1|Overall Study|Lost to Follow-up|4
667486|NCT01887678|2155333|P2|Overall Study|Withdrawal of consent|4
667487|NCT01887678|2155334|P1|Overall Study|Withdrawal of consent|3
667488|NCT01887678|2155333|P2|Overall Study|Exceeded rescue medication dosage|5
667489|NCT01887678|2155334|P1|Overall Study|Exceeded rescue medication dosage|4
667490|NCT01887678|2155333|P2|Overall Study|Adverse Event|6
667491|NCT01887678|2155334|P1|Overall Study|Adverse Event|4
667492|NCT01887418|2155402|P3|Overall Study|Travelling difficulties|1
667493|NCT01887418|2155403|P2|Overall Study|Travelling difficulties|0
667494|NCT01887418|2155404|P1|Overall Study|Travelling difficulties|0
667495|NCT01887353|2155423|P2|Overall Study|Study stopped early|3
667496|NCT01887353|2155424|P1|Overall Study|Study stopped early|4
667497|NCT01886781|2155477|P2|Overall Study|Worsening of symptoms|1
667498|NCT01886781|2155478|P1|Overall Study|Worsening of symptoms|1
667499|NCT01886781|2155477|P2|Overall Study|Withdrawal by Subject|1
667500|NCT01886781|2155478|P1|Overall Study|Withdrawal by Subject|2
667501|NCT01886781|2155477|P2|Overall Study|Lost to Follow-up|0
667502|NCT01886781|2155478|P1|Overall Study|Lost to Follow-up|5
667503|NCT01886781|2155477|P2|Overall Study|Adverse Event|0
667504|NCT01886781|2155478|P1|Overall Study|Adverse Event|1
667505|NCT01886781|2155477|P2|Overall Study|Protocol Violation|0
667506|NCT01886781|2155478|P1|Overall Study|Protocol Violation|5
667507|NCT01886716|2155488|P4|Week 3|Lost to Follow-up|1
667508|NCT01886716|2155489|P3|Week 3|Lost to Follow-up|0
667509|NCT01886716|2155490|P2|Week 3|Lost to Follow-up|1
667510|NCT01886716|2155491|P1|Week 3|Lost to Follow-up|1
667511|NCT01886716|2155488|P4|Week 2|Lost to Follow-up|3
667512|NCT01886716|2155489|P3|Week 2|Lost to Follow-up|1
667513|NCT01886716|2155490|P2|Week 2|Lost to Follow-up|2
667514|NCT01886716|2155491|P1|Week 2|Lost to Follow-up|3
667515|NCT01886716|2155488|P4|Week 1|Lost to Follow-up|2
667516|NCT01886716|2155489|P3|Week 1|Lost to Follow-up|2
667517|NCT01886716|2155490|P2|Week 1|Lost to Follow-up|0
667518|NCT01886716|2155491|P1|Week 1|Lost to Follow-up|0
667519|NCT01886690|2155507|P2|Overall Study|Personal Reasons|1
667520|NCT01886690|2155508|P1|Overall Study|Personal Reasons|0
667521|NCT01886690|2155507|P2|Overall Study|Protocol Violation|1
667522|NCT01886690|2155508|P1|Overall Study|Protocol Violation|0
667523|NCT01886313|2155524|P2|Overall Study|Adverse Event|1
667524|NCT01886313|2155525|P1|Overall Study|Adverse Event|1
667525|NCT01886300|2155531|P1|Overall Study|Trial terminated by sponsor|16
667526|NCT01886287|2155542|P1|Overall Study|Clinical progression due to disease|1
667527|NCT01886287|2155542|P1|Overall Study|Radiographic disease progression|1
667528|NCT01885559|2155582|P2|Overall Study|Protocol Violation|1
667529|NCT01885559|2155583|P1|Overall Study|Protocol Violation|0
667530|NCT01885559|2155582|P2|Overall Study|Less than full participation|19
667531|NCT01885559|2155583|P1|Overall Study|Less than full participation|9
667532|NCT01885559|2155582|P2|Overall Study|Lost to Follow-up|16
667533|NCT01885559|2155583|P1|Overall Study|Lost to Follow-up|15
667534|NCT01885104|2155628|P2|Overall Study|Physician Decision|0
667535|NCT01885104|2155629|P1|Overall Study|Physician Decision|1
667536|NCT01885104|2155628|P2|Overall Study|Lost to Follow-up|1
667537|NCT01885104|2155629|P1|Overall Study|Lost to Follow-up|0
667538|NCT01885104|2155628|P2|Overall Study|Withdrawal of Consent|0
667539|NCT01885104|2155629|P1|Overall Study|Withdrawal of Consent|1
667540|NCT01885000|2155639|P2|Overall Study|Protocol Violation|1
667541|NCT01885000|2155640|P1|Overall Study|Protocol Violation|0
667542|NCT01885000|2155639|P2|Overall Study|Withdrawal by Subject|1
667543|NCT01885000|2155640|P1|Overall Study|Withdrawal by Subject|1
667544|NCT01885000|2155639|P2|Overall Study|Adverse Event|0
667545|NCT01885000|2155640|P1|Overall Study|Adverse Event|1
667546|NCT01884688|2155652|P1|Overall Study|Screen Failure|2
667547|NCT01884675|2155658|P2|Overall Study|Study closed/terminated|2
667548|NCT01884675|2155659|P1|Overall Study|Study closed/terminated|3
888521|NCT01844505|2822432|P1|Overall Study|Study drug toxicity|40
888522|NCT01844505|2822430|P3|Overall Study|Disease progression|224
888523|NCT01844505|2822431|P2|Overall Study|Disease progression|88
888524|NCT01844505|2822432|P1|Overall Study|Disease progression|170
888525|NCT01835470|2822482|P1|Long Term Treatment Period|Lack of Efficacy|1
888526|NCT01835470|2822482|P1|Long Term Treatment Period|Subject Request to Discontinue|1
888527|NCT01835132|2822492|P1|Initial Phase|Insufficient Therapeutic Response|2
888528|NCT01817764|2822538|P2|Overall Study|Withdrawal by Subject|12
888529|NCT01817764|2822539|P1|Overall Study|Withdrawal by Subject|10
888530|NCT01817764|2822538|P2|Overall Study|Lost to Follow-up|4
888531|NCT01817764|2822539|P1|Overall Study|Lost to Follow-up|1
667562|NCT01883895|2155823|P1|Overall Study|Lost to Follow-up|2
667563|NCT01883635|2155830|P2|Overall Study|Withdrawal by Subject|0
667564|NCT01883635|2155831|P1|Overall Study|Withdrawal by Subject|4
667565|NCT01883453|2155845|P2|Overall Study|No episode of common cold|23
667566|NCT01883453|2155846|P1|Overall Study|No episode of common cold|25
667567|NCT01882907|2155874|P2|Overall Study|Withdrawal by Subject|6
667568|NCT01882907|2155875|P1|Overall Study|Withdrawal by Subject|0
667569|NCT01882907|2155874|P2|Overall Study|Protocol Violation|14
667570|NCT01882907|2155875|P1|Overall Study|Protocol Violation|10
667571|NCT01882907|2155874|P2|Overall Study|Lost to Follow-up|4
667572|NCT01882907|2155875|P1|Overall Study|Lost to Follow-up|1
667573|NCT01882907|2155874|P2|Overall Study|Lack of Efficacy|3
667574|NCT01882907|2155875|P1|Overall Study|Lack of Efficacy|0
667575|NCT01882907|2155874|P2|Overall Study|Adverse Event|1
667576|NCT01882907|2155875|P1|Overall Study|Adverse Event|3
667577|NCT01882647|2155918|P2|Overall Study|Withdrawal by Subject|4
667578|NCT01882647|2155919|P1|Overall Study|Withdrawal by Subject|0
667579|NCT01882647|2155918|P2|Overall Study|Lost to Follow-up|2
667580|NCT01882647|2155919|P1|Overall Study|Lost to Follow-up|2
667581|NCT01882465|2155959|P7|Period 2|Protocol Violation|0
667582|NCT01882465|2155960|P6|Period 2|Protocol Violation|0
667583|NCT01882465|2155961|P5|Period 2|Protocol Violation|1
667584|NCT01882465|2155962|P4|Period 2|Protocol Violation|0
667585|NCT01882465|2155963|P3|Period 2|Protocol Violation|0
667586|NCT01882465|2155964|P2|Period 2|Protocol Violation|0
667587|NCT01882465|2155965|P1|Period 2|Protocol Violation|0
667588|NCT01882465|2155959|P7|Period 1|Withdrawal by Subject|1
667589|NCT01882465|2155960|P6|Period 1|Withdrawal by Subject|0
667590|NCT01882465|2155961|P5|Period 1|Withdrawal by Subject|0
667591|NCT01882465|2155962|P4|Period 1|Withdrawal by Subject|0
667592|NCT01882465|2155963|P3|Period 1|Withdrawal by Subject|0
667593|NCT01882465|2155964|P2|Period 1|Withdrawal by Subject|0
667594|NCT01882465|2155965|P1|Period 1|Withdrawal by Subject|0
667595|NCT01882465|2155959|P7|Period 1|Lens Discomfort|0
667596|NCT01882465|2155960|P6|Period 1|Lens Discomfort|0
667597|NCT01882465|2155961|P5|Period 1|Lens Discomfort|0
667598|NCT01882465|2155962|P4|Period 1|Lens Discomfort|1
667599|NCT01882465|2155963|P3|Period 1|Lens Discomfort|0
667600|NCT01882465|2155964|P2|Period 1|Lens Discomfort|0
667601|NCT01882465|2155965|P1|Period 1|Lens Discomfort|0
667602|NCT01882439|2155977|P4|Overall Study|Adverse event unrelated to study drug|1
667603|NCT01882439|2155978|P3|Overall Study|Adverse event unrelated to study drug|1
667604|NCT01882439|2155979|P2|Overall Study|Adverse event unrelated to study drug|2
667605|NCT01882439|2155980|P1|Overall Study|Adverse event unrelated to study drug|2
667606|NCT01882439|2155977|P4|Overall Study|Insufficient clinical response|2
667607|NCT01882439|2155978|P3|Overall Study|Insufficient clinical response|4
667608|NCT01882439|2155979|P2|Overall Study|Insufficient clinical response|4
667609|NCT01882439|2155980|P1|Overall Study|Insufficient clinical response|1
667610|NCT01882439|2155977|P4|Overall Study|Medication error with no associated AE|0
667611|NCT01882439|2155978|P3|Overall Study|Medication error with no associated AE|2
667612|NCT01882439|2155979|P2|Overall Study|Medication error with no associated AE|0
667613|NCT01882439|2155980|P1|Overall Study|Medication error with no associated AE|0
667614|NCT01882439|2155977|P4|Overall Study|No longer willing to participate|3
667615|NCT01882439|2155978|P3|Overall Study|No longer willing to participate|2
667616|NCT01882439|2155979|P2|Overall Study|No longer willing to participate|4
667617|NCT01882439|2155980|P1|Overall Study|No longer willing to participate|1
667618|NCT01882439|2155977|P4|Overall Study|Protocol Violation|1
667619|NCT01882439|2155978|P3|Overall Study|Protocol Violation|0
667620|NCT01882439|2155979|P2|Overall Study|Protocol Violation|2
667621|NCT01882439|2155980|P1|Overall Study|Protocol Violation|2
667622|NCT01882439|2155977|P4|Overall Study|Pregnancy|0
667623|NCT01882439|2155978|P3|Overall Study|Pregnancy|0
667624|NCT01882439|2155979|P2|Overall Study|Pregnancy|1
667625|NCT01882439|2155980|P1|Overall Study|Pregnancy|0
667626|NCT01882439|2155977|P4|Overall Study|Adverse event related to study drug|2
667627|NCT01882439|2155978|P3|Overall Study|Adverse event related to study drug|1
667628|NCT01882439|2155979|P2|Overall Study|Adverse event related to study drug|8
667629|NCT01882439|2155980|P1|Overall Study|Adverse event related to study drug|3
667630|NCT01882257|2156177|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
667631|NCT01882257|2156178|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
667632|NCT01882257|2156179|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
667633|NCT01882257|2156177|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
667634|NCT01882257|2156178|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
667635|NCT01882257|2156179|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
667636|NCT01881776|2156211|P3|Overall Study|Protocol Violation|1
667637|NCT01881776|2156212|P2|Overall Study|Protocol Violation|2
667638|NCT01881776|2156213|P1|Overall Study|Protocol Violation|0
667639|NCT01881776|2156211|P3|Overall Study|Lost to Follow-up|1
667640|NCT01881776|2156212|P2|Overall Study|Lost to Follow-up|2
667641|NCT01881776|2156213|P1|Overall Study|Lost to Follow-up|1
667642|NCT01881737|2156239|P1|Overall Study|Worsening of baseline behavior|1
667643|NCT01881737|2156239|P1|Overall Study|Withdrawal by Subject|1
667644|NCT01881737|2156239|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
667645|NCT01881126|2156250|P2|Overall Study|Adverse Event|1
667646|NCT01881126|2156251|P1|Overall Study|Adverse Event|0
667647|NCT01881126|2156250|P2|Overall Study|Non-compliance|1
667648|NCT01881126|2156251|P1|Overall Study|Non-compliance|1
667649|NCT01880736|2156286|P4|Overall Study|Withdrawal Criteria|5
667650|NCT01880736|2156287|P3|Overall Study|Withdrawal Criteria|1
667651|NCT01880736|2156288|P2|Overall Study|Withdrawal Criteria|2
667652|NCT01880736|2156289|P1|Overall Study|Withdrawal Criteria|1
667653|NCT01880736|2156286|P4|Overall Study|Adverse Event|1
667654|NCT01880736|2156287|P3|Overall Study|Adverse Event|0
667655|NCT01880736|2156288|P2|Overall Study|Adverse Event|0
667656|NCT01880736|2156289|P1|Overall Study|Adverse Event|0
667657|NCT01880515|2156373|P2|Overall Study|Disease Progression|7
667658|NCT01880515|2156374|P1|Overall Study|Disease Progression|5
667659|NCT01880515|2156373|P2|Overall Study|Lost to Follow-up|2
667660|NCT01880515|2156374|P1|Overall Study|Lost to Follow-up|3
667661|NCT01880437|2156385|P3|Overall Study|Study terminated by Sponsor|2
667662|NCT01880437|2156386|P2|Overall Study|Study terminated by Sponsor|0
667663|NCT01880437|2156387|P1|Overall Study|Study terminated by Sponsor|3
667664|NCT01880437|2156385|P3|Overall Study|Death|17
667665|NCT01880437|2156386|P2|Overall Study|Death|4
667666|NCT01880437|2156387|P1|Overall Study|Death|12
667667|NCT01880424|2156413|P2|Overall Study|Not specified|0
667668|NCT01880424|2156414|P1|Overall Study|Not specified|1
667669|NCT01880424|2156413|P2|Overall Study|Withdrawal by Subject|30
667670|NCT01880424|2156414|P1|Overall Study|Withdrawal by Subject|10
667671|NCT01880424|2156413|P2|Overall Study|Protocol Violation|13
667672|NCT01880424|2156414|P1|Overall Study|Protocol Violation|11
667673|NCT01880424|2156413|P2|Overall Study|Lost to Follow-up|2
667674|NCT01880424|2156414|P1|Overall Study|Lost to Follow-up|3
667675|NCT01880424|2156413|P2|Overall Study|Lack of Efficacy|4
667676|NCT01880424|2156414|P1|Overall Study|Lack of Efficacy|1
667677|NCT01880424|2156413|P2|Overall Study|Adverse Event|6
667678|NCT01880424|2156414|P1|Overall Study|Adverse Event|7
667679|NCT01880086|2156470|P2|Overall Study|Lost to Follow-up|1
667680|NCT01880086|2156471|P1|Overall Study|Lost to Follow-up|1
667681|NCT01879852|2156491|P2|Overall Study|Withdrawal by Subject|0
667682|NCT01879852|2156492|P1|Overall Study|Withdrawal by Subject|2
667683|NCT01879722|2156536|P10|Overall Study|Voluntary Withdrawal|0
667684|NCT01879722|2156537|P9|Overall Study|Voluntary Withdrawal|1
667685|NCT01879722|2156538|P8|Overall Study|Voluntary Withdrawal|0
667686|NCT01879722|2156539|P7|Overall Study|Voluntary Withdrawal|0
667687|NCT01879722|2156540|P6|Overall Study|Voluntary Withdrawal|0
667688|NCT01879722|2156541|P5|Overall Study|Voluntary Withdrawal|0
667689|NCT01879722|2156542|P4|Overall Study|Voluntary Withdrawal|0
667690|NCT01879722|2156543|P3|Overall Study|Voluntary Withdrawal|0
667691|NCT01879722|2156544|P2|Overall Study|Voluntary Withdrawal|0
667692|NCT01879722|2156545|P1|Overall Study|Voluntary Withdrawal|0
667693|NCT01879722|2156536|P10|Overall Study|Pretreatment Event/Adverse Event|0
667694|NCT01879722|2156537|P9|Overall Study|Pretreatment Event/Adverse Event|1
667695|NCT01879722|2156538|P8|Overall Study|Pretreatment Event/Adverse Event|1
667696|NCT01879722|2156539|P7|Overall Study|Pretreatment Event/Adverse Event|0
667697|NCT01879722|2156540|P6|Overall Study|Pretreatment Event/Adverse Event|0
667698|NCT01879722|2156541|P5|Overall Study|Pretreatment Event/Adverse Event|1
667699|NCT01879722|2156542|P4|Overall Study|Pretreatment Event/Adverse Event|1
667700|NCT01879722|2156543|P3|Overall Study|Pretreatment Event/Adverse Event|0
667701|NCT01879722|2156544|P2|Overall Study|Pretreatment Event/Adverse Event|1
667702|NCT01879722|2156545|P1|Overall Study|Pretreatment Event/Adverse Event|0
667703|NCT01879683|2156693|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
667704|NCT01879618|2156700|P1|Overall Study|Adverse Event|5
667705|NCT01879618|2156700|P1|Overall Study|Protocol Violation|6
667706|NCT01879618|2156700|P1|Overall Study|Surgery;changed schedule; not available|8
667707|NCT01879618|2156700|P1|Overall Study|Withdrawal by Subject|1
667708|NCT01879618|2156700|P1|Overall Study|Does not meet entrance criteria|1
667709|NCT01879579|2156707|P2|Overall Study|Discontinued insulin - possible allergy|1
667710|NCT01879579|2156708|P1|Overall Study|Discontinued insulin - possible allergy|0
667711|NCT01879579|2156707|P2|Overall Study|Phenotypic type 1 diabetes|1
667712|NCT01879579|2156708|P1|Overall Study|Phenotypic type 1 diabetes|0
667713|NCT01879579|2156707|P2|Overall Study|Did not initiate insulin treatment|0
667714|NCT01879579|2156708|P1|Overall Study|Did not initiate insulin treatment|1
667715|NCT01879579|2156707|P2|Overall Study|Did not enroll in texting platform|0
667716|NCT01879579|2156708|P1|Overall Study|Did not enroll in texting platform|1
667717|NCT01879579|2156707|P2|Overall Study|Phone incompatible with texting platform|0
667718|NCT01879579|2156708|P1|Overall Study|Phone incompatible with texting platform|3
667719|NCT01879553|2156738|P2|Overall Study|Withdrawal by Subject|0
667720|NCT01879553|2156739|P1|Overall Study|Withdrawal by Subject|1
888532|NCT01817764|2822538|P2|Overall Study|Protocol Violation|5
888533|NCT01817764|2822539|P1|Overall Study|Protocol Violation|7
888534|NCT01817764|2822538|P2|Overall Study|Lack of Efficacy|7
888535|NCT01817764|2822539|P1|Overall Study|Lack of Efficacy|9
888536|NCT01817764|2822538|P2|Overall Study|Adverse Event|10
888537|NCT01817764|2822539|P1|Overall Study|Adverse Event|7
667733|NCT01879319|2156841|P2|Overall Study|Lost to Follow-up|5
667734|NCT01879319|2156842|P1|Overall Study|Lost to Follow-up|1
667735|NCT01879319|2156841|P2|Overall Study|Withdrawal by Subject|0
667736|NCT01879319|2156842|P1|Overall Study|Withdrawal by Subject|1
667737|NCT01878214|2156980|P2|Overall Study|Lost to Follow-up|36
667738|NCT01878214|2156981|P1|Overall Study|Lost to Follow-up|35
667739|NCT01878214|2156980|P2|Overall Study|Death|1
667740|NCT01878214|2156981|P1|Overall Study|Death|0
667741|NCT01878214|2156980|P2|Overall Study|Withdrawal by Subject|7
667742|NCT01878214|2156981|P1|Overall Study|Withdrawal by Subject|18
667743|NCT01878175|2156995|P1|Overall Study|Developed contraindicated health problem|2
667744|NCT01878149|2157014|P2|Overall Study|Did Not Meet Eligibility Criteria|2
667745|NCT01878149|2157015|P1|Overall Study|Did Not Meet Eligibility Criteria|2
667746|NCT01878097|2157023|P2|Implementation Year 5|Surveys not fully completed|3007
667747|NCT01878097|2157024|P1|Implementation Year 5|Surveys not fully completed|3604
667748|NCT01878097|2157023|P2|Implementation Year 3|Surveys not fully completed|2980
667749|NCT01878097|2157024|P1|Implementation Year 3|Surveys not fully completed|3494
667750|NCT01878097|2157023|P2|Implementation Year 2|Surveys not fully completed|2841
667751|NCT01878097|2157024|P1|Implementation Year 2|Surveys not fully completed|3281
667752|NCT01878097|2157023|P2|Implementation Year 1|Surveys not fully completed|2549
667753|NCT01878097|2157024|P1|Implementation Year 1|Surveys not fully completed|3202
667754|NCT01878097|2157023|P2|Baseline|Surveys not fully completed|1800
667755|NCT01878097|2157024|P1|Baseline|Surveys not fully completed|2497
667756|NCT01877720|2157040|P2|Overall Study|Adverse Event|0
667757|NCT01877720|2157041|P1|Overall Study|Adverse Event|1
667758|NCT01877668|2157070|P5|Overall Study|Adverse event unrelated to study drug|1
667759|NCT01877668|2157071|P4|Overall Study|Adverse event unrelated to study drug|0
667760|NCT01877668|2157072|P3|Overall Study|Adverse event unrelated to study drug|2
667761|NCT01877668|2157073|P2|Overall Study|Adverse event unrelated to study drug|1
667762|NCT01877668|2157074|P1|Overall Study|Adverse event unrelated to study drug|4
667763|NCT01877668|2157070|P5|Overall Study|Adverse event related to study drug|1
667764|NCT01877668|2157071|P4|Overall Study|Adverse event related to study drug|2
667765|NCT01877668|2157072|P3|Overall Study|Adverse event related to study drug|2
667766|NCT01877668|2157073|P2|Overall Study|Adverse event related to study drug|2
667767|NCT01877668|2157074|P1|Overall Study|Adverse event related to study drug|2
667768|NCT01877668|2157070|P5|Overall Study|Protocol Violation|3
667769|NCT01877668|2157071|P4|Overall Study|Protocol Violation|0
667770|NCT01877668|2157072|P3|Overall Study|Protocol Violation|0
667771|NCT01877668|2157073|P2|Overall Study|Protocol Violation|1
667772|NCT01877668|2157074|P1|Overall Study|Protocol Violation|1
667773|NCT01877668|2157070|P5|Overall Study|Not specified|3
667774|NCT01877668|2157071|P4|Overall Study|Not specified|1
667775|NCT01877668|2157072|P3|Overall Study|Not specified|1
667776|NCT01877668|2157073|P2|Overall Study|Not specified|1
667777|NCT01877668|2157074|P1|Overall Study|Not specified|1
667778|NCT01877668|2157070|P5|Overall Study|Withdrawal by Subject|2
667779|NCT01877668|2157071|P4|Overall Study|Withdrawal by Subject|2
667780|NCT01877668|2157072|P3|Overall Study|Withdrawal by Subject|3
667781|NCT01877668|2157073|P2|Overall Study|Withdrawal by Subject|0
667782|NCT01877668|2157074|P1|Overall Study|Withdrawal by Subject|2
667783|NCT01877668|2157070|P5|Overall Study|Lost to Follow-up|0
667784|NCT01877668|2157071|P4|Overall Study|Lost to Follow-up|0
667785|NCT01877668|2157072|P3|Overall Study|Lost to Follow-up|1
667786|NCT01877668|2157073|P2|Overall Study|Lost to Follow-up|2
667787|NCT01877668|2157074|P1|Overall Study|Lost to Follow-up|0
667788|NCT01877668|2157070|P5|Overall Study|Insufficient clinical response|0
667789|NCT01877668|2157071|P4|Overall Study|Insufficient clinical response|2
667790|NCT01877668|2157072|P3|Overall Study|Insufficient clinical response|2
667791|NCT01877668|2157073|P2|Overall Study|Insufficient clinical response|1
667792|NCT01877668|2157074|P1|Overall Study|Insufficient clinical response|0
667793|NCT01877668|2157070|P5|Overall Study|No longer met study criteria|0
667794|NCT01877668|2157071|P4|Overall Study|No longer met study criteria|0
667795|NCT01877668|2157072|P3|Overall Study|No longer met study criteria|1
667796|NCT01877668|2157073|P2|Overall Study|No longer met study criteria|0
667797|NCT01877668|2157074|P1|Overall Study|No longer met study criteria|1
667798|NCT01877668|2157070|P5|Overall Study|Death|0
667799|NCT01877668|2157071|P4|Overall Study|Death|1
667800|NCT01877668|2157072|P3|Overall Study|Death|0
667801|NCT01877668|2157073|P2|Overall Study|Death|0
667802|NCT01877668|2157074|P1|Overall Study|Death|0
667857|NCT01877408|2157467|P2|Overall Study|Lost to Follow-up|2
667858|NCT01877408|2157468|P1|Overall Study|Lost to Follow-up|0
667859|NCT01877278|2157501|P2|Overall Study|Lost to Follow-up|3
667860|NCT01877278|2157502|P1|Overall Study|Lost to Follow-up|3
667861|NCT01876979|2157550|P2|Overall Study|Physician Decision|3
667862|NCT01876979|2157551|P1|Overall Study|Physician Decision|2
667863|NCT01876823|2157557|P1|Overall Study|Patients moved|2
667864|NCT01876823|2157557|P1|Overall Study|Physician Decision|2
667865|NCT01876823|2157557|P1|Overall Study|Withdrawal by Subject|5
667866|NCT01876810|2157570|P2|Overall Study|Physician Decision|1
667867|NCT01876810|2157571|P1|Overall Study|Physician Decision|0
667886|NCT01876732|2157590|P1|Overall Study|MMA was not over 800mg/dL|75
667889|NCT01876368|2157614|P2|Overall Study|Subject/guardian decision|1
667890|NCT01876368|2157615|P1|Overall Study|Subject/guardian decision|3
667891|NCT01876368|2157614|P2|Overall Study|Protocol deviation|3
667892|NCT01876368|2157615|P1|Overall Study|Protocol deviation|3
667893|NCT01876368|2157614|P2|Overall Study|Physician Decision|2
667894|NCT01876368|2157615|P1|Overall Study|Physician Decision|0
667895|NCT01876368|2157614|P2|Overall Study|Non-compliance with study treatment|1
667896|NCT01876368|2157615|P1|Overall Study|Non-compliance with study treatment|0
667897|NCT01876368|2157614|P2|Overall Study|Lost to Follow-up|1
667898|NCT01876368|2157615|P1|Overall Study|Lost to Follow-up|0
667899|NCT01876368|2157614|P2|Overall Study|Lack of Efficacy|0
667900|NCT01876368|2157615|P1|Overall Study|Lack of Efficacy|1
667901|NCT01876368|2157614|P2|Overall Study|Adverse Event|5
667902|NCT01876368|2157615|P1|Overall Study|Adverse Event|2
667903|NCT01875991|2157659|P2|Overall Study|Sponsor Decision|0
667904|NCT01875991|2157660|P1|Overall Study|Sponsor Decision|1
667905|NCT01875991|2157659|P2|Overall Study|Withdrawal by Subject|6
667906|NCT01875991|2157660|P1|Overall Study|Withdrawal by Subject|6
667907|NCT01875848|2157698|P2|Overall Study|Withdrawal by Subject|0
667908|NCT01875848|2157699|P1|Overall Study|Withdrawal by Subject|2
667909|NCT01875731|2157713|P2|Overall Study|Fail to obtain lab sample|0
667910|NCT01875731|2157714|P1|Overall Study|Fail to obtain lab sample|1
667911|NCT01875471|2157733|P2|Overall Study|Unsatisfactory Lens Fitting|0
667912|NCT01875471|2157734|P1|Overall Study|Unsatisfactory Lens Fitting|1
667913|NCT01875471|2157733|P2|Overall Study|Adverse Event|1
667914|NCT01875471|2157734|P1|Overall Study|Adverse Event|0
667915|NCT01875445|2157742|P2|Overall Study|Withdrawal by Subject|0
667916|NCT01875445|2157743|P1|Overall Study|Withdrawal by Subject|2
667917|NCT01875445|2157742|P2|Overall Study|Lost to Follow-up|0
667918|NCT01875445|2157743|P1|Overall Study|Lost to Follow-up|5
667919|NCT01874665|2157787|P2|Overall Study|Treatment Ongoing|2
667920|NCT01874665|2157788|P1|Overall Study|Treatment Ongoing|4
667921|NCT01874340|2157797|P4|Overall Study|Withdrawal by Subject|1
667922|NCT01874340|2157798|P3|Overall Study|Withdrawal by Subject|0
667923|NCT01874340|2157799|P2|Overall Study|Withdrawal by Subject|0
667924|NCT01874340|2157800|P1|Overall Study|Withdrawal by Subject|0
667925|NCT01874340|2157797|P4|Overall Study|Study terminated by Sponsor|4
667926|NCT01874340|2157798|P3|Overall Study|Study terminated by Sponsor|8
667927|NCT01874340|2157799|P2|Overall Study|Study terminated by Sponsor|8
667928|NCT01874340|2157800|P1|Overall Study|Study terminated by Sponsor|6
667929|NCT01874275|2157828|P2|Overall Study|Lost to Follow-up|0
667930|NCT01874275|2157829|P1|Overall Study|Lost to Follow-up|1
667931|NCT01874145|2157852|P2|Extension Period|Lost to Follow-up|1
667932|NCT01874145|2157853|P1|Extension Period|Lost to Follow-up|1
667933|NCT01874145|2157852|P2|Extension Period|Withdrawal by Subject|1
667934|NCT01874145|2157853|P1|Extension Period|Withdrawal by Subject|2
667935|NCT01874145|2157852|P2|Extension Period|Adverse Event|2
667936|NCT01874145|2157853|P1|Extension Period|Adverse Event|3
667937|NCT01874145|2157852|P2|Core Period|Withdrawal by Subject|4
667938|NCT01874145|2157853|P1|Core Period|Withdrawal by Subject|0
667939|NCT01874145|2157852|P2|Core Period|Adverse Event|1
667940|NCT01874145|2157853|P1|Core Period|Adverse Event|0
667941|NCT01874145|2157852|P2|Core Period|Physician Decision|1
667942|NCT01874145|2157853|P1|Core Period|Physician Decision|1
667943|NCT01874145|2157852|P2|Core Period|Protocol Violation|1
667944|NCT01874145|2157853|P1|Core Period|Protocol Violation|1
667945|NCT01874145|2157852|P2|Core Period|Non-compliance|0
667946|NCT01874145|2157853|P1|Core Period|Non-compliance|1
667959|NCT01873859|2157952|P2|Overall Study|Withdrawal by Subject|4
667960|NCT01873859|2157953|P1|Overall Study|Withdrawal by Subject|0
667961|NCT01873729|2157961|P1|Overall Study|Withdrawal by Subject|1
667962|NCT01873417|2157966|P1|Overall Study|Physician Decision|3
667963|NCT01873417|2157966|P1|Overall Study|Withdrawal by Subject|2
667964|NCT01873417|2157966|P1|Overall Study|Lost to Follow-up|2
667965|NCT01873417|2157966|P1|Overall Study|Adverse Event|24
667966|NCT01873417|2157966|P1|Overall Study|Did Not Receive Any Study Drug|4
667967|NCT01872715|2157981|P1|Overall Study|Withdrawal by Subject|2
667968|NCT01872715|2157981|P1|Overall Study|Protocol Violation|1
667969|NCT01872715|2157981|P1|Overall Study|Adverse Event|1
667970|NCT01872611|2157998|P2|Overall Study|Reason not provided|6
667971|NCT01872611|2157999|P1|Overall Study|Reason not provided|6
667972|NCT01872611|2157998|P2|Overall Study|Withdrawal by Subject|1
667973|NCT01872611|2157999|P1|Overall Study|Withdrawal by Subject|6
667974|NCT01872611|2157998|P2|Overall Study|Physician Decision|0
667975|NCT01872611|2157999|P1|Overall Study|Physician Decision|1
667976|NCT01872611|2157998|P2|Overall Study|Lost to Follow-up|1
667977|NCT01872611|2157999|P1|Overall Study|Lost to Follow-up|8
667978|NCT01872611|2157998|P2|Overall Study|Death, prior to treatment|1
667979|NCT01872611|2157999|P1|Overall Study|Death, prior to treatment|0
667980|NCT01872611|2157998|P2|Overall Study|Death|1
667981|NCT01872611|2157999|P1|Overall Study|Death|0
667982|NCT01872611|2157998|P2|Overall Study|Adverse Event, prior to treatment|1
667983|NCT01872611|2157999|P1|Overall Study|Adverse Event, prior to treatment|0
667984|NCT01872611|2157998|P2|Overall Study|Adverse Event|1
667985|NCT01872611|2157999|P1|Overall Study|Adverse Event|3
667986|NCT01872078|2158021|P4|Overall Study|Patient met exclusion criterion 16.|1
667987|NCT01872078|2158022|P3|Overall Study|Patient met exclusion criterion 16.|0
667988|NCT01872078|2158023|P2|Overall Study|Patient met exclusion criterion 16.|0
667989|NCT01872078|2158024|P1|Overall Study|Patient met exclusion criterion 16.|0
667990|NCT01872078|2158021|P4|Overall Study|Withdrawal by Subject|0
667991|NCT01872078|2158022|P3|Overall Study|Withdrawal by Subject|1
667992|NCT01872078|2158023|P2|Overall Study|Withdrawal by Subject|0
667993|NCT01872078|2158024|P1|Overall Study|Withdrawal by Subject|0
667994|NCT01872078|2158021|P4|Overall Study|Protocol Violation|0
667995|NCT01872078|2158022|P3|Overall Study|Protocol Violation|1
667996|NCT01872078|2158023|P2|Overall Study|Protocol Violation|0
667997|NCT01872078|2158024|P1|Overall Study|Protocol Violation|0
667998|NCT01872078|2158021|P4|Overall Study|Dose administration non-compliance|1
667999|NCT01872078|2158022|P3|Overall Study|Dose administration non-compliance|0
668000|NCT01872078|2158023|P2|Overall Study|Dose administration non-compliance|0
668001|NCT01872078|2158024|P1|Overall Study|Dose administration non-compliance|0
668002|NCT01872078|2158021|P4|Overall Study|Adverse Event|0
668003|NCT01872078|2158022|P3|Overall Study|Adverse Event|1
668004|NCT01872078|2158023|P2|Overall Study|Adverse Event|0
668005|NCT01872078|2158024|P1|Overall Study|Adverse Event|0
668006|NCT01871870|2158034|P1|Overall Study|hyperglycemia|2
668007|NCT01871870|2158034|P1|Overall Study|Hardware issues|7
888568|NCT01791517|2822614|P12|Phase II|Pre-Existing Ocular Issue|1
888569|NCT01791517|2822615|P11|Phase II|Pre-Existing Ocular Issue|0
888570|NCT01791517|2822616|P10|Phase II|Pre-Existing Ocular Issue|0
888571|NCT01791517|2822617|P9|Phase II|Pre-Existing Ocular Issue|0
888572|NCT01791517|2822618|P8|Phase II|Pre-Existing Ocular Issue|0
888573|NCT01791517|2822619|P7|Phase II|Pre-Existing Ocular Issue|0
888574|NCT01791517|2822620|P6|Phase II|Pre-Existing Ocular Issue|0
888575|NCT01791517|2822621|P5|Phase II|Pre-Existing Ocular Issue|0
888576|NCT01791517|2822622|P4|Phase II|Pre-Existing Ocular Issue|0
888577|NCT01791517|2822623|P3|Phase II|Pre-Existing Ocular Issue|0
888578|NCT01791517|2822624|P2|Phase II|Pre-Existing Ocular Issue|0
888579|NCT01791517|2822625|P1|Phase II|Pre-Existing Ocular Issue|0
888580|NCT01791517|2822614|P12|Phase II|Unsatisfactory Lens Fitting|0
888581|NCT01791517|2822615|P11|Phase II|Unsatisfactory Lens Fitting|0
888582|NCT01791517|2822616|P10|Phase II|Unsatisfactory Lens Fitting|1
888583|NCT01791517|2822617|P9|Phase II|Unsatisfactory Lens Fitting|0
888584|NCT01791517|2822618|P8|Phase II|Unsatisfactory Lens Fitting|0
888585|NCT01791517|2822619|P7|Phase II|Unsatisfactory Lens Fitting|0
888586|NCT01791517|2822620|P6|Phase II|Unsatisfactory Lens Fitting|0
888587|NCT01791517|2822621|P5|Phase II|Unsatisfactory Lens Fitting|0
668056|NCT01871558|2158118|P2|Overall Study|Withdrawal by Subject|0
668057|NCT01871558|2158119|P1|Overall Study|Withdrawal by Subject|2
668058|NCT01871558|2158118|P2|Overall Study|antidiabetic drug prematurely stopped|1
668059|NCT01871558|2158119|P1|Overall Study|antidiabetic drug prematurely stopped|1
668060|NCT01871558|2158118|P2|Overall Study|Other reason|1
668061|NCT01871558|2158119|P1|Overall Study|Other reason|0
668062|NCT01871532|2158139|P2|Overall Study|Withdrawal by Subject|2
668063|NCT01871532|2158140|P1|Overall Study|Withdrawal by Subject|1
668064|NCT01871519|2158174|P1|Overall Study|Withdrawal by Subject|49
668065|NCT01871519|2158174|P1|Overall Study|Lost to Follow-up|15
668066|NCT01871519|2158174|P1|Overall Study|Death|26
668067|NCT01871402|2158197|P2|Overall Study|Non-compliance|1
668068|NCT01871402|2158198|P1|Overall Study|Non-compliance|0
668069|NCT01871402|2158197|P2|Overall Study|Withdrawal by Subject|2
668070|NCT01871402|2158198|P1|Overall Study|Withdrawal by Subject|0
668071|NCT01871402|2158197|P2|Overall Study|Lost to Follow-up|0
668072|NCT01871402|2158198|P1|Overall Study|Lost to Follow-up|1
668073|NCT01871285|2158216|P4|First Intervention (1 Day)|Lost to Follow-up|0
668074|NCT01871285|2158217|P3|First Intervention (1 Day)|Lost to Follow-up|1
668075|NCT01871285|2158218|P2|First Intervention (1 Day)|Lost to Follow-up|1
668076|NCT01871285|2158219|P1|First Intervention (1 Day)|Lost to Follow-up|0
668077|NCT01871285|2158216|P4|First Intervention (1 Day)|Adverse Event|0
668078|NCT01871285|2158217|P3|First Intervention (1 Day)|Adverse Event|0
668079|NCT01871285|2158218|P2|First Intervention (1 Day)|Adverse Event|0
668080|NCT01871285|2158219|P1|First Intervention (1 Day)|Adverse Event|1
668081|NCT01871142|2158245|P1|Overall Study|Adverse Event|1
668082|NCT01871090|2158261|P2|Overall Study|Subject Non-Compliance|1
668083|NCT01871090|2158262|P1|Overall Study|Subject Non-Compliance|0
668084|NCT01871090|2158261|P2|Overall Study|Interrogation not completed correctly|0
668085|NCT01871090|2158262|P1|Overall Study|Interrogation not completed correctly|1
668086|NCT01871090|2158261|P2|Overall Study|Interrogation not done in Emergency Room|22
668087|NCT01871090|2158262|P1|Overall Study|Interrogation not done in Emergency Room|1
668088|NCT01870999|2158275|P3|Overall Study|Protocol Violation|1
668089|NCT01870999|2158276|P2|Overall Study|Protocol Violation|0
668090|NCT01870999|2158277|P1|Overall Study|Protocol Violation|0
668091|NCT01870999|2158275|P3|Overall Study|Withdrawal by Subject|5
668092|NCT01870999|2158276|P2|Overall Study|Withdrawal by Subject|2
668093|NCT01870999|2158277|P1|Overall Study|Withdrawal by Subject|0
668094|NCT01870999|2158275|P3|Overall Study|Subject withdrawn by Investigator|0
668095|NCT01870999|2158276|P2|Overall Study|Subject withdrawn by Investigator|0
668096|NCT01870999|2158277|P1|Overall Study|Subject withdrawn by Investigator|1
668097|NCT01870999|2158275|P3|Overall Study|Subject met withdrawal criteria|0
668098|NCT01870999|2158276|P2|Overall Study|Subject met withdrawal criteria|2
668099|NCT01870999|2158277|P1|Overall Study|Subject met withdrawal criteria|3
668100|NCT01870999|2158275|P3|Overall Study|Adverse Event|1
668101|NCT01870999|2158276|P2|Overall Study|Adverse Event|4
668102|NCT01870999|2158277|P1|Overall Study|Adverse Event|0
668103|NCT01870973|2158335|P2|Overall Study|Lost to Follow-up|3
668104|NCT01870973|2158336|P1|Overall Study|Lost to Follow-up|10
668105|NCT01870921|2158342|P1|Overall Study|Other|1
668106|NCT01870921|2158342|P1|Overall Study|Subject Lost to Follow up|2
668107|NCT01870921|2158342|P1|Overall Study|Severe non-compliance to protocol|7
668108|NCT01870921|2158342|P1|Overall Study|Subject decision|80
668109|NCT01870843|2158361|P1|Overall Study|Withdrawal by Subject|18
668110|NCT01870843|2158361|P1|Overall Study|Death|1
668111|NCT01870843|2158361|P1|Overall Study|Lost to Follow-up|24
668112|NCT01870843|2158361|P1|Overall Study|Adverse Event|10
668113|NCT01870739|2158376|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
668114|NCT01870739|2158377|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
668115|NCT01870739|2158376|P2|Add-on Period (40 Weeks)|Protocol deviation|1
668116|NCT01870739|2158377|P1|Add-on Period (40 Weeks)|Protocol deviation|1
668117|NCT01870739|2158376|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
668118|NCT01870739|2158377|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
668119|NCT01870739|2158376|P2|Add-on Period (40 Weeks)|Adverse Event|1
668120|NCT01870739|2158377|P1|Add-on Period (40 Weeks)|Adverse Event|0
668121|NCT01870739|2158376|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
668122|NCT01870739|2158377|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
668123|NCT01870739|2158376|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
668124|NCT01870739|2158377|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
668125|NCT01870739|2158376|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
668126|NCT01870739|2158377|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
668127|NCT01870583|2158421|P3|Overall Study|Lost to Follow-up|5
668128|NCT01870583|2158422|P2|Overall Study|Lost to Follow-up|13
668129|NCT01870583|2158423|P1|Overall Study|Lost to Follow-up|11
668130|NCT01870583|2158421|P3|Overall Study|Protocol Violation|3
668131|NCT01870583|2158422|P2|Overall Study|Protocol Violation|5
668132|NCT01870583|2158423|P1|Overall Study|Protocol Violation|0
668133|NCT01869959|2158446|P5|Treatment Period|Withdrawal by Subject|0
668134|NCT01869959|2158447|P4|Treatment Period|Withdrawal by Subject|0
668135|NCT01869959|2158448|P3|Treatment Period|Withdrawal by Subject|0
668136|NCT01869959|2158449|P2|Treatment Period|Withdrawal by Subject|1
668137|NCT01869959|2158450|P1|Treatment Period|Withdrawal by Subject|0
668138|NCT01869959|2158446|P5|Treatment Period|Sponsor decision|0
668139|NCT01869959|2158447|P4|Treatment Period|Sponsor decision|1
668140|NCT01869959|2158448|P3|Treatment Period|Sponsor decision|0
668141|NCT01869959|2158449|P2|Treatment Period|Sponsor decision|1
668142|NCT01869959|2158450|P1|Treatment Period|Sponsor decision|0
668143|NCT01869959|2158446|P5|Treatment Period|Adverse Event|0
668144|NCT01869959|2158447|P4|Treatment Period|Adverse Event|1
668145|NCT01869959|2158448|P3|Treatment Period|Adverse Event|3
668146|NCT01869959|2158449|P2|Treatment Period|Adverse Event|0
668147|NCT01869959|2158450|P1|Treatment Period|Adverse Event|1
668148|NCT01869959|2158446|P5|Randomization Period|Physician Decision|1
668149|NCT01869959|2158447|P4|Randomization Period|Physician Decision|0
668150|NCT01869959|2158448|P3|Randomization Period|Physician Decision|0
668151|NCT01869959|2158449|P2|Randomization Period|Physician Decision|0
668152|NCT01869959|2158450|P1|Randomization Period|Physician Decision|0
668153|NCT01869699|2158520|P2|Overall Study|Withdrawal by Subject|0
668154|NCT01869699|2158521|P1|Overall Study|Withdrawal by Subject|1
668155|NCT01869348|2158580|P2|Overall Study|Withdrawal by Subject|1
668156|NCT01869348|2158581|P1|Overall Study|Withdrawal by Subject|1
668157|NCT01868997|2158614|P2|Overall Study|Not Specified|1
668158|NCT01868997|2158615|P1|Overall Study|Not Specified|2
668159|NCT01868997|2158614|P2|Overall Study|Lack of Efficacy|0
668160|NCT01868997|2158615|P1|Overall Study|Lack of Efficacy|2
668161|NCT01868997|2158614|P2|Overall Study|Adverse Event|5
668162|NCT01868997|2158615|P1|Overall Study|Adverse Event|1
668163|NCT01868893|2158631|P1|Overall Study|Neutropenia|1
668164|NCT01868893|2158631|P1|Overall Study|Commercial availability of study drug|17
668165|NCT01868893|2158631|P1|Overall Study|Adverse Event|2
668166|NCT01868542|2158666|P2|Overall Study|Unclassified|1
668167|NCT01868542|2158667|P1|Overall Study|Unclassified|0
668168|NCT01868542|2158666|P2|Overall Study|Protocol Violation|1
668169|NCT01868542|2158667|P1|Overall Study|Protocol Violation|0
668170|NCT01868503|2158685|P1|Overall Study|Protocol Violation|1
668171|NCT01868503|2158685|P1|Overall Study|Withdrawal by Subject|1
668172|NCT01868243|2158732|P2|Overall Study|Death|1
668173|NCT01868243|2158733|P1|Overall Study|Death|0
668174|NCT01868074|2158743|P2|Overall Study|Withdrawal by Subject|2
668175|NCT01868074|2158744|P1|Overall Study|Withdrawal by Subject|4
668176|NCT01868074|2158743|P2|Overall Study|Lost to Follow-up|2
668177|NCT01868074|2158744|P1|Overall Study|Lost to Follow-up|3
668178|NCT01868035|2158754|P1|Overall Study|Non-compliance|1
668179|NCT01868035|2158754|P1|Overall Study|Progressive Disease|2
668180|NCT01868035|2158754|P1|Overall Study|Withdrawal by Subject|1
668181|NCT01868035|2158754|P1|Overall Study|Lost to Follow-up|3
668182|NCT01868009|2158770|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
668183|NCT01868009|2158771|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
668184|NCT01868009|2158770|P2|Period 2 (5-9 Days)|Adverse Event|0
668185|NCT01868009|2158771|P1|Period 2 (5-9 Days)|Adverse Event|1
668186|NCT01868009|2158770|P2|Period 1 (5-9 Days)|Adverse Event|2
668187|NCT01868009|2158771|P1|Period 1 (5-9 Days)|Adverse Event|0
888588|NCT01791517|2822622|P4|Phase II|Unsatisfactory Lens Fitting|0
888589|NCT01791517|2822623|P3|Phase II|Unsatisfactory Lens Fitting|0
888590|NCT01791517|2822624|P2|Phase II|Unsatisfactory Lens Fitting|0
888591|NCT01791517|2822625|P1|Phase II|Unsatisfactory Lens Fitting|0
888592|NCT01791517|2822614|P12|Phase II|Lens Handling Difficulties|0
888593|NCT01791517|2822615|P11|Phase II|Lens Handling Difficulties|0
888594|NCT01791517|2822616|P10|Phase II|Lens Handling Difficulties|0
888595|NCT01791517|2822617|P9|Phase II|Lens Handling Difficulties|1
888596|NCT01791517|2822618|P8|Phase II|Lens Handling Difficulties|0
888597|NCT01791517|2822619|P7|Phase II|Lens Handling Difficulties|0
888598|NCT01791517|2822620|P6|Phase II|Lens Handling Difficulties|0
888599|NCT01791517|2822621|P5|Phase II|Lens Handling Difficulties|0
888600|NCT01791517|2822622|P4|Phase II|Lens Handling Difficulties|0
888601|NCT01791517|2822623|P3|Phase II|Lens Handling Difficulties|0
888602|NCT01791517|2822624|P2|Phase II|Lens Handling Difficulties|0
888603|NCT01791517|2822625|P1|Phase II|Lens Handling Difficulties|0
888604|NCT01791517|2822614|P12|Phase II|Adverse Event|0
888605|NCT01791517|2822615|P11|Phase II|Adverse Event|0
888606|NCT01791517|2822616|P10|Phase II|Adverse Event|1
888607|NCT01791517|2822617|P9|Phase II|Adverse Event|0
888608|NCT01791517|2822618|P8|Phase II|Adverse Event|1
888609|NCT01791517|2822619|P7|Phase II|Adverse Event|2
888610|NCT01791517|2822620|P6|Phase II|Adverse Event|0
888611|NCT01791517|2822621|P5|Phase II|Adverse Event|0
888612|NCT01791517|2822622|P4|Phase II|Adverse Event|0
888613|NCT01791517|2822623|P3|Phase II|Adverse Event|0
888614|NCT01791517|2822624|P2|Phase II|Adverse Event|0
888615|NCT01791517|2822625|P1|Phase II|Adverse Event|0
888616|NCT01791517|2822614|P12|Phase II|Lack of Efficacy|0
888617|NCT01791517|2822615|P11|Phase II|Lack of Efficacy|0
888618|NCT01791517|2822616|P10|Phase II|Lack of Efficacy|0
888619|NCT01791517|2822617|P9|Phase II|Lack of Efficacy|0
888620|NCT01791517|2822618|P8|Phase II|Lack of Efficacy|0
888621|NCT01791517|2822619|P7|Phase II|Lack of Efficacy|0
888622|NCT01791517|2822620|P6|Phase II|Lack of Efficacy|0
888623|NCT01791517|2822621|P5|Phase II|Lack of Efficacy|1
888624|NCT01791517|2822622|P4|Phase II|Lack of Efficacy|0
888625|NCT01791517|2822623|P3|Phase II|Lack of Efficacy|0
888626|NCT01791517|2822624|P2|Phase II|Lack of Efficacy|0
888627|NCT01791517|2822625|P1|Phase II|Lack of Efficacy|0
888628|NCT01791517|2822614|P12|Phase II|Withdrawal by Subject|0
888629|NCT01791517|2822615|P11|Phase II|Withdrawal by Subject|1
888630|NCT01791517|2822616|P10|Phase II|Withdrawal by Subject|0
888631|NCT01791517|2822617|P9|Phase II|Withdrawal by Subject|0
668232|NCT01867658|2158802|P1|Overall Study|Subject could not be contacted|1
668233|NCT01867658|2158802|P1|Overall Study|Death|2
668234|NCT01867658|2158802|P1|Overall Study|Withdrawal by Subject|6
888632|NCT01791517|2822618|P8|Phase II|Withdrawal by Subject|1
888633|NCT01791517|2822619|P7|Phase II|Withdrawal by Subject|0
888634|NCT01791517|2822620|P6|Phase II|Withdrawal by Subject|2
888635|NCT01791517|2822621|P5|Phase II|Withdrawal by Subject|0
888636|NCT01791517|2822622|P4|Phase II|Withdrawal by Subject|0
888637|NCT01791517|2822623|P3|Phase II|Withdrawal by Subject|0
888638|NCT01791517|2822624|P2|Phase II|Withdrawal by Subject|0
888639|NCT01791517|2822625|P1|Phase II|Withdrawal by Subject|1
888640|NCT01791517|2822614|P12|Phase II|Lost to Follow-up|0
888641|NCT01791517|2822615|P11|Phase II|Lost to Follow-up|0
888642|NCT01791517|2822616|P10|Phase II|Lost to Follow-up|1
888643|NCT01791517|2822617|P9|Phase II|Lost to Follow-up|1
668247|NCT01867021|2158873|P2|Overall Study|Withdrawal by Subject|6
668248|NCT01867021|2158874|P1|Overall Study|Withdrawal by Subject|1
668249|NCT01867021|2158873|P2|Overall Study|Lost to Follow-up|2
668250|NCT01867021|2158874|P1|Overall Study|Lost to Follow-up|0
668251|NCT01867021|2158873|P2|Overall Study|Death|0
668252|NCT01867021|2158874|P1|Overall Study|Death|1
668253|NCT01867021|2158873|P2|Overall Study|Not Eligible|1
668254|NCT01867021|2158874|P1|Overall Study|Not Eligible|0
668255|NCT01867021|2158873|P2|Overall Study|Adverse Event|1
668256|NCT01867021|2158874|P1|Overall Study|Adverse Event|0
668257|NCT01866709|2158895|P2|Overall Study|Adverse Event|0
668258|NCT01866709|2158896|P1|Overall Study|Adverse Event|1
668259|NCT01866423|2158904|P1|Overall Study|Sponsor Decision|1
668260|NCT01866423|2158904|P1|Overall Study|Lack of Efficacy|3
668282|NCT01866293|2159018|P1|Overall Study|Adverse Event|2
668283|NCT01865812|2159060|P1|Overall Study|Adverse Event|2
668284|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Other|1
668285|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Other|0
668286|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
668287|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
668288|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
668289|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
668290|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Physician Decision|2
888644|NCT01791517|2822618|P8|Phase II|Lost to Follow-up|1
888645|NCT01791517|2822619|P7|Phase II|Lost to Follow-up|0
888646|NCT01791517|2822620|P6|Phase II|Lost to Follow-up|2
888647|NCT01791517|2822621|P5|Phase II|Lost to Follow-up|1
668291|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Physician Decision|4
668292|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
668293|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
668294|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
668295|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
668296|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
668297|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
668298|NCT01865747|2159068|P2|Primary Intent to Treat (PITT)|Adverse Event|20
668299|NCT01865747|2159069|P1|Primary Intent to Treat (PITT)|Adverse Event|21
668300|NCT01865747|2159068|P2|Overall Study (ITT)|Reason Not Provided|1
668301|NCT01865747|2159069|P1|Overall Study (ITT)|Reason Not Provided|0
668302|NCT01865747|2159068|P2|Overall Study (ITT)|Progressive Disease|158
668303|NCT01865747|2159069|P1|Overall Study (ITT)|Progressive Disease|122
668304|NCT01865747|2159068|P2|Overall Study (ITT)|Sponsor Decision|1
668305|NCT01865747|2159069|P1|Overall Study (ITT)|Sponsor Decision|0
668306|NCT01865747|2159068|P2|Overall Study (ITT)|Withdrawal by Subject|11
668307|NCT01865747|2159069|P1|Overall Study (ITT)|Withdrawal by Subject|6
668308|NCT01865747|2159068|P2|Overall Study (ITT)|Physician Decision|2
668309|NCT01865747|2159069|P1|Overall Study (ITT)|Physician Decision|5
668310|NCT01865747|2159068|P2|Overall Study (ITT)|Protocol Violation|1
668311|NCT01865747|2159069|P1|Overall Study (ITT)|Protocol Violation|1
668312|NCT01865747|2159068|P2|Overall Study (ITT)|Lack of Efficacy|0
668313|NCT01865747|2159069|P1|Overall Study (ITT)|Lack of Efficacy|3
668314|NCT01865747|2159068|P2|Overall Study (ITT)|Clinical Deterioration|50
668315|NCT01865747|2159069|P1|Overall Study (ITT)|Clinical Deterioration|29
668316|NCT01865747|2159068|P2|Overall Study (ITT)|Adverse Event|31
668317|NCT01865747|2159069|P1|Overall Study (ITT)|Adverse Event|32
668318|NCT01865084|2159082|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
668319|NCT01865084|2159083|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
668320|NCT01865084|2159084|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
668321|NCT01865084|2159082|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
668322|NCT01865084|2159083|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
668323|NCT01865084|2159084|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
668324|NCT01865084|2159082|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
668325|NCT01865084|2159083|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
668326|NCT01865084|2159084|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
668327|NCT01865084|2159082|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
668328|NCT01865084|2159083|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
668329|NCT01865084|2159084|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
668330|NCT01865084|2159082|P3|Open Label Extension (OLE) Period|Adverse Event|1
668331|NCT01865084|2159083|P2|Open Label Extension (OLE) Period|Adverse Event|0
668332|NCT01865084|2159084|P1|Open Label Extension (OLE) Period|Adverse Event|0
668333|NCT01865084|2159082|P3|Double Blind Period (DB)|Withdrawal by Subject|0
668334|NCT01865084|2159083|P2|Double Blind Period (DB)|Withdrawal by Subject|0
668335|NCT01865084|2159084|P1|Double Blind Period (DB)|Withdrawal by Subject|1
668336|NCT01865084|2159082|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
668337|NCT01865084|2159083|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
668338|NCT01865084|2159084|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
668339|NCT01865084|2159082|P3|Double Blind Period (DB)|Protocol Violation|1
668340|NCT01865084|2159083|P2|Double Blind Period (DB)|Protocol Violation|0
668341|NCT01865084|2159084|P1|Double Blind Period (DB)|Protocol Violation|0
668342|NCT01865084|2159082|P3|Double Blind Period (DB)|Adverse Event|1
668343|NCT01865084|2159083|P2|Double Blind Period (DB)|Adverse Event|2
668344|NCT01865084|2159084|P1|Double Blind Period (DB)|Adverse Event|2
668345|NCT01864174|2159129|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
668346|NCT01864174|2159130|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
668347|NCT01864174|2159129|P2|Off Treatment Follow-Up|Unspecified|0
668348|NCT01864174|2159130|P1|Off Treatment Follow-Up|Unspecified|2
668349|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Unspecified|10
668350|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Unspecified|6
668351|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
668352|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
668353|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
668354|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
668355|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Death|0
668356|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Death|1
668357|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
668358|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
668359|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
668360|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
668361|NCT01864174|2159129|P2|Double Blind - Compliant Randomized|Adverse Event|1
668362|NCT01864174|2159130|P1|Double Blind - Compliant Randomized|Adverse Event|6
668363|NCT01864174|2159129|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
668364|NCT01864174|2159130|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
668365|NCT01864148|2159149|P5|Overall Study|Not Dosed|0
668366|NCT01864148|2159150|P4|Overall Study|Not Dosed|1
668367|NCT01864148|2159151|P3|Overall Study|Not Dosed|0
668368|NCT01864148|2159152|P2|Overall Study|Not Dosed|0
668369|NCT01864148|2159153|P1|Overall Study|Not Dosed|0
668370|NCT01864148|2159149|P5|Overall Study|Adverse Event|7
668371|NCT01864148|2159150|P4|Overall Study|Adverse Event|7
668372|NCT01864148|2159151|P3|Overall Study|Adverse Event|4
668373|NCT01864148|2159152|P2|Overall Study|Adverse Event|2
668374|NCT01864148|2159153|P1|Overall Study|Adverse Event|4
668375|NCT01864148|2159149|P5|Overall Study|Lost to Follow-up|1
668376|NCT01864148|2159150|P4|Overall Study|Lost to Follow-up|2
668377|NCT01864148|2159151|P3|Overall Study|Lost to Follow-up|0
668378|NCT01864148|2159152|P2|Overall Study|Lost to Follow-up|0
668379|NCT01864148|2159153|P1|Overall Study|Lost to Follow-up|0
668380|NCT01864148|2159149|P5|Overall Study|Withdrawal by Subject|8
668381|NCT01864148|2159150|P4|Overall Study|Withdrawal by Subject|8
668382|NCT01864148|2159151|P3|Overall Study|Withdrawal by Subject|6
668383|NCT01864148|2159152|P2|Overall Study|Withdrawal by Subject|2
668384|NCT01864148|2159153|P1|Overall Study|Withdrawal by Subject|9
668385|NCT01864148|2159149|P5|Overall Study|Investigator Decision|6
668386|NCT01864148|2159150|P4|Overall Study|Investigator Decision|4
668387|NCT01864148|2159151|P3|Overall Study|Investigator Decision|0
668388|NCT01864148|2159152|P2|Overall Study|Investigator Decision|0
668389|NCT01864148|2159153|P1|Overall Study|Investigator Decision|5
668390|NCT01864148|2159149|P5|Overall Study|Death|0
668391|NCT01864148|2159150|P4|Overall Study|Death|1
668392|NCT01864148|2159151|P3|Overall Study|Death|0
668393|NCT01864148|2159152|P2|Overall Study|Death|0
668394|NCT01864148|2159153|P1|Overall Study|Death|0
668395|NCT01864148|2159149|P5|Overall Study|Not Specified|1
668396|NCT01864148|2159150|P4|Overall Study|Not Specified|3
668397|NCT01864148|2159151|P3|Overall Study|Not Specified|1
668398|NCT01864148|2159152|P2|Overall Study|Not Specified|1
668399|NCT01864148|2159153|P1|Overall Study|Not Specified|2
668400|NCT01864005|2159182|P2|Overall Study|Need GP IIb/IIIa|3
668401|NCT01864005|2159183|P1|Overall Study|Need GP IIb/IIIa|1
668402|NCT01864005|2159182|P2|Overall Study|Disease need|1
668403|NCT01864005|2159183|P1|Overall Study|Disease need|1
668404|NCT01864005|2159182|P2|Overall Study|Incorrect enrolment|0
668405|NCT01864005|2159183|P1|Overall Study|Incorrect enrolment|1
668406|NCT01864005|2159182|P2|Overall Study|Withdrawal by Subject|1
668407|NCT01864005|2159183|P1|Overall Study|Withdrawal by Subject|0
668408|NCT01864005|2159182|P2|Overall Study|Protocol Violation|1
668409|NCT01864005|2159183|P1|Overall Study|Protocol Violation|0
668410|NCT01863953|2159200|P3|Overall Study|Adverse Event|1
668411|NCT01863953|2159201|P2|Overall Study|Adverse Event|0
668412|NCT01863953|2159202|P1|Overall Study|Adverse Event|0
668413|NCT01863771|2159216|P4|Maintenance Phase|Withdrawal by Subject|3
668414|NCT01863771|2159217|P3|Maintenance Phase|Withdrawal by Subject|2
668415|NCT01863771|2159218|P2|Maintenance Phase|Withdrawal by Subject|1
668416|NCT01863771|2159219|P1|Maintenance Phase|Withdrawal by Subject|0
668417|NCT01863771|2159216|P4|Maintenance Phase|Pregnancy|0
668418|NCT01863771|2159217|P3|Maintenance Phase|Pregnancy|0
668419|NCT01863771|2159218|P2|Maintenance Phase|Pregnancy|1
668420|NCT01863771|2159219|P1|Maintenance Phase|Pregnancy|0
668421|NCT01863771|2159216|P4|Maintenance Phase|Physician Decision|1
668422|NCT01863771|2159217|P3|Maintenance Phase|Physician Decision|2
668423|NCT01863771|2159218|P2|Maintenance Phase|Physician Decision|0
668424|NCT01863771|2159219|P1|Maintenance Phase|Physician Decision|0
668425|NCT01863771|2159216|P4|Maintenance Phase|Lack of Efficacy|38
668426|NCT01863771|2159217|P3|Maintenance Phase|Lack of Efficacy|7
668427|NCT01863771|2159218|P2|Maintenance Phase|Lack of Efficacy|3
668428|NCT01863771|2159219|P1|Maintenance Phase|Lack of Efficacy|0
668429|NCT01863771|2159216|P4|Maintenance Phase|Adverse Event|1
668430|NCT01863771|2159217|P3|Maintenance Phase|Adverse Event|1
668431|NCT01863771|2159218|P2|Maintenance Phase|Adverse Event|0
668432|NCT01863771|2159219|P1|Maintenance Phase|Adverse Event|0
668433|NCT01863771|2159216|P4|Induction Phase|Withdrawal by Subject|0
668434|NCT01863771|2159217|P3|Induction Phase|Withdrawal by Subject|0
668435|NCT01863771|2159218|P2|Induction Phase|Withdrawal by Subject|0
668436|NCT01863771|2159219|P1|Induction Phase|Withdrawal by Subject|2
668437|NCT01863771|2159216|P4|Induction Phase|Lack of Efficacy|0
668438|NCT01863771|2159217|P3|Induction Phase|Lack of Efficacy|0
668439|NCT01863771|2159218|P2|Induction Phase|Lack of Efficacy|0
668440|NCT01863771|2159219|P1|Induction Phase|Lack of Efficacy|10
668441|NCT01863771|2159216|P4|Induction Phase|Adverse Event|0
668442|NCT01863771|2159217|P3|Induction Phase|Adverse Event|0
668443|NCT01863771|2159218|P2|Induction Phase|Adverse Event|0
668444|NCT01863771|2159219|P1|Induction Phase|Adverse Event|9
668445|NCT01863680|2159231|P1|Overall Study|Unspecified|6
668446|NCT01863680|2159231|P1|Overall Study|Did not undergo IVF/ET|14
668447|NCT01863680|2159231|P1|Overall Study|Withdrawal by Subject|1
668448|NCT01863680|2159231|P1|Overall Study|Spontaneous pregnancy|2
668449|NCT01863680|2159231|P1|Overall Study|Risk of OHSS|17
668450|NCT01863680|2159231|P1|Overall Study|Adverse Event|17
668451|NCT01863667|2159239|P2|Overall Study|Withdrawal by Subject|2
668452|NCT01863667|2159240|P1|Overall Study|Withdrawal by Subject|2
668453|NCT01863667|2159239|P2|Overall Study|Study terminated by Sponsor|30
668454|NCT01863667|2159240|P1|Overall Study|Study terminated by Sponsor|30
668455|NCT01863667|2159239|P2|Overall Study|Adverse Event|0
668456|NCT01863667|2159240|P1|Overall Study|Adverse Event|1
668457|NCT01863433|2159260|P1|Overall Study|Protocol Violation|1
668458|NCT01863368|2159270|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
668459|NCT01863368|2159271|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
668460|NCT01863368|2159270|P2|Phase II, Day 35 to Day 90|Adverse Event|0
668461|NCT01863368|2159271|P1|Phase II, Day 35 to Day 90|Adverse Event|1
668462|NCT01863368|2159270|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
668463|NCT01863368|2159271|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
668464|NCT01863368|2159270|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
668465|NCT01863368|2159271|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
668466|NCT01863368|2159270|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
668467|NCT01863368|2159271|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
668468|NCT01863368|2159270|P2|Phase I, Day 0 to Day 35|Adverse Event|4
668469|NCT01863368|2159271|P1|Phase I, Day 0 to Day 35|Adverse Event|2
668470|NCT01862991|2159296|P3|Overall Study|Protocol Violation|0
668471|NCT01862991|2159297|P2|Overall Study|Protocol Violation|0
668472|NCT01862991|2159298|P1|Overall Study|Protocol Violation|1
668473|NCT01862991|2159296|P3|Overall Study|Lost to Follow-up|1
668474|NCT01862991|2159297|P2|Overall Study|Lost to Follow-up|1
668475|NCT01862991|2159298|P1|Overall Study|Lost to Follow-up|2
668476|NCT01862484|2159311|P2|Overall Study|Withdrawal by Subject|3
668477|NCT01862484|2159312|P1|Overall Study|Withdrawal by Subject|0
668478|NCT01862484|2159311|P2|Overall Study|Protocol Violation|2
668479|NCT01862484|2159312|P1|Overall Study|Protocol Violation|0
668480|NCT01862484|2159311|P2|Overall Study|Lost to Follow-up|2
668481|NCT01862484|2159312|P1|Overall Study|Lost to Follow-up|1
668482|NCT01862484|2159311|P2|Overall Study|Lack of Efficacy|1
668483|NCT01862484|2159312|P1|Overall Study|Lack of Efficacy|1
668484|NCT01861522|2159391|P2|Overall Study|Withdrawal by Subject|0
668485|NCT01861522|2159392|P1|Overall Study|Withdrawal by Subject|2
668486|NCT01861522|2159391|P2|Overall Study|Adverse Event|0
668487|NCT01861522|2159392|P1|Overall Study|Adverse Event|1
668488|NCT01860989|2159416|P1|Overall Study|Unsatisfactory therapeutic|5
668489|NCT01860976|2159422|P2|Long Term Extension|Ongoing treatment at time of analysis|100
668490|NCT01860976|2159423|P1|Long Term Extension|Ongoing treatment at time of analysis|106
668491|NCT01860976|2159422|P2|Long Term Extension|Withdrawal by Subject|0
668492|NCT01860976|2159423|P1|Long Term Extension|Withdrawal by Subject|1
668493|NCT01860976|2159422|P2|Long Term Extension|Subject request to discontinue treatment|0
668494|NCT01860976|2159423|P1|Long Term Extension|Subject request to discontinue treatment|2
668495|NCT01860976|2159422|P2|Long Term Extension|Lack of Efficacy|7
668496|NCT01860976|2159423|P1|Long Term Extension|Lack of Efficacy|3
668497|NCT01860976|2159422|P2|Long Term Extension|Adverse Event|0
668498|NCT01860976|2159423|P1|Long Term Extension|Adverse Event|1
668499|NCT01860976|2159422|P2|Open-Label|Ongoing OL treatment at time of analysis|45
668500|NCT01860976|2159423|P1|Open-Label|Ongoing OL treatment at time of analysis|46
668501|NCT01860976|2159422|P2|Open-Label|Other Reasons|1
668502|NCT01860976|2159423|P1|Open-Label|Other Reasons|1
668503|NCT01860976|2159422|P2|Open-Label|Withdrawal by Subject|1
668504|NCT01860976|2159423|P1|Open-Label|Withdrawal by Subject|4
668505|NCT01860976|2159422|P2|Open-Label|Subject request discontinue treatment|3
668506|NCT01860976|2159423|P1|Open-Label|Subject request discontinue treatment|4
668507|NCT01860976|2159422|P2|Open-Label|Lost to Follow-up|2
668508|NCT01860976|2159423|P1|Open-Label|Lost to Follow-up|1
668509|NCT01860976|2159422|P2|Open-Label|Lack of Efficacy|8
668510|NCT01860976|2159423|P1|Open-Label|Lack of Efficacy|16
668511|NCT01860976|2159422|P2|Open-Label|Adverse Event|4
668512|NCT01860976|2159423|P1|Open-Label|Adverse Event|2
668513|NCT01860976|2159422|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
668514|NCT01860976|2159423|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
668515|NCT01860976|2159422|P2|Blinded Treatment|Entered Open-Label in error|1
668516|NCT01860976|2159423|P1|Blinded Treatment|Entered Open-Label in error|0
668517|NCT01860976|2159422|P2|Blinded Treatment|Subject no longer met criteria|0
668518|NCT01860976|2159423|P1|Blinded Treatment|Subject no longer met criteria|1
668519|NCT01860976|2159422|P2|Blinded Treatment|Withdrawal by Subject|5
668520|NCT01860976|2159423|P1|Blinded Treatment|Withdrawal by Subject|3
668521|NCT01860976|2159422|P2|Blinded Treatment|Subject request to discontinue treatment|3
668522|NCT01860976|2159423|P1|Blinded Treatment|Subject request to discontinue treatment|2
668523|NCT01860976|2159422|P2|Blinded Treatment|Lack of Efficacy|12
668524|NCT01860976|2159423|P1|Blinded Treatment|Lack of Efficacy|5
668525|NCT01860976|2159422|P2|Blinded Treatment|Adverse Event|3
668526|NCT01860976|2159423|P1|Blinded Treatment|Adverse Event|1
668527|NCT01860846|2159445|P1|Overall Study|Lost to Follow-up|33
668528|NCT01860703|2159456|P4|Overall Study|Personal reason|0
668529|NCT01860703|2159457|P3|Overall Study|Personal reason|1
668530|NCT01860703|2159458|P2|Overall Study|Personal reason|0
668531|NCT01860703|2159459|P1|Overall Study|Personal reason|1
668532|NCT01860703|2159456|P4|Overall Study|Withdrawal by Subject|0
668533|NCT01860703|2159457|P3|Overall Study|Withdrawal by Subject|0
668534|NCT01860703|2159458|P2|Overall Study|Withdrawal by Subject|1
668535|NCT01860703|2159459|P1|Overall Study|Withdrawal by Subject|0
668536|NCT01860703|2159456|P4|Overall Study|Adverse Event|2
668537|NCT01860703|2159457|P3|Overall Study|Adverse Event|0
668538|NCT01860703|2159458|P2|Overall Study|Adverse Event|4
668539|NCT01860703|2159459|P1|Overall Study|Adverse Event|1
668540|NCT01860677|2159491|P2|Second Intervention (1 Day)|Lost to Follow-up|0
668541|NCT01860677|2159492|P1|Second Intervention (1 Day)|Lost to Follow-up|7
668542|NCT01860534|2159530|P2|ROP #2|discharged prior to ROP #2|0
668543|NCT01860534|2159531|P1|ROP #2|discharged prior to ROP #2|1
668544|NCT01860534|2159530|P2|ROP #1|Needed treatment for ROP|1
668545|NCT01860534|2159531|P1|ROP #1|Needed treatment for ROP|0
668546|NCT01860079|2159579|P2|Overall Study|Physician Decision|22
668547|NCT01860079|2159580|P1|Overall Study|Physician Decision|14
668548|NCT01859988|2159592|P6|Overall Study|Other than specified above|3
668549|NCT01859988|2159593|P5|Overall Study|Other than specified above|5
668550|NCT01859988|2159594|P4|Overall Study|Other than specified above|3
668551|NCT01859988|2159595|P3|Overall Study|Other than specified above|11
668552|NCT01859988|2159596|P2|Overall Study|Other than specified above|2
668553|NCT01859988|2159597|P1|Overall Study|Other than specified above|0
668554|NCT01859988|2159592|P6|Overall Study|Protocol Violation|0
668555|NCT01859988|2159593|P5|Overall Study|Protocol Violation|0
668556|NCT01859988|2159594|P4|Overall Study|Protocol Violation|0
668557|NCT01859988|2159595|P3|Overall Study|Protocol Violation|1
668558|NCT01859988|2159596|P2|Overall Study|Protocol Violation|0
668559|NCT01859988|2159597|P1|Overall Study|Protocol Violation|0
668560|NCT01859988|2159592|P6|Overall Study|Lost to Follow-up|2
668561|NCT01859988|2159593|P5|Overall Study|Lost to Follow-up|3
668562|NCT01859988|2159594|P4|Overall Study|Lost to Follow-up|0
668563|NCT01859988|2159595|P3|Overall Study|Lost to Follow-up|3
668564|NCT01859988|2159596|P2|Overall Study|Lost to Follow-up|2
668565|NCT01859988|2159597|P1|Overall Study|Lost to Follow-up|1
668566|NCT01859988|2159592|P6|Overall Study|Adverse Event|2
668567|NCT01859988|2159593|P5|Overall Study|Adverse Event|2
668568|NCT01859988|2159594|P4|Overall Study|Adverse Event|1
668569|NCT01859988|2159595|P3|Overall Study|Adverse Event|3
668570|NCT01859988|2159596|P2|Overall Study|Adverse Event|1
668571|NCT01859988|2159597|P1|Overall Study|Adverse Event|2
668572|NCT01859988|2159592|P6|Overall Study|Physician Decision|1
668573|NCT01859988|2159593|P5|Overall Study|Physician Decision|4
668574|NCT01859988|2159594|P4|Overall Study|Physician Decision|3
668575|NCT01859988|2159595|P3|Overall Study|Physician Decision|1
668576|NCT01859988|2159596|P2|Overall Study|Physician Decision|3
668577|NCT01859988|2159597|P1|Overall Study|Physician Decision|1
668578|NCT01859988|2159592|P6|Overall Study|Lack of Efficacy|9
668579|NCT01859988|2159593|P5|Overall Study|Lack of Efficacy|7
668580|NCT01859988|2159594|P4|Overall Study|Lack of Efficacy|0
668581|NCT01859988|2159595|P3|Overall Study|Lack of Efficacy|5
668582|NCT01859988|2159596|P2|Overall Study|Lack of Efficacy|1
668583|NCT01859988|2159597|P1|Overall Study|Lack of Efficacy|1
668584|NCT01859988|2159592|P6|Overall Study|Withdrawal by Subject|2
668585|NCT01859988|2159593|P5|Overall Study|Withdrawal by Subject|2
668586|NCT01859988|2159594|P4|Overall Study|Withdrawal by Subject|3
668587|NCT01859988|2159595|P3|Overall Study|Withdrawal by Subject|4
668588|NCT01859988|2159596|P2|Overall Study|Withdrawal by Subject|3
668589|NCT01859988|2159597|P1|Overall Study|Withdrawal by Subject|6
668590|NCT01859949|2159691|P2|Overall Study|Adverse Event|1
668591|NCT01859949|2159692|P1|Overall Study|Adverse Event|0
668592|NCT01859949|2159691|P2|Overall Study|Protocol Violation|1
668593|NCT01859949|2159692|P1|Overall Study|Protocol Violation|1
668594|NCT01859949|2159691|P2|Overall Study|Withdrawal by Subject|10
668595|NCT01859949|2159692|P1|Overall Study|Withdrawal by Subject|11
668596|NCT01859949|2159691|P2|Overall Study|Physician Decision|4
668597|NCT01859949|2159692|P1|Overall Study|Physician Decision|2
668598|NCT01859949|2159691|P2|Overall Study|Family Matters|1
668599|NCT01859949|2159692|P1|Overall Study|Family Matters|0
668600|NCT01859793|2159710|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
668601|NCT01859793|2159711|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
668602|NCT01859793|2159710|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
668603|NCT01859793|2159711|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
668604|NCT01859793|2159710|P2|First Intervention (8 Weeks)|Adverse Event|0
668605|NCT01859793|2159711|P1|First Intervention (8 Weeks)|Adverse Event|1
668606|NCT01859793|2159710|P2|First Intervention (8 Weeks)|Protocol Violation|0
668607|NCT01859793|2159711|P1|First Intervention (8 Weeks)|Protocol Violation|2
668608|NCT01859715|2159724|P3|Overall Study|No 2nd VAS|23
668609|NCT01859715|2159725|P2|Overall Study|No 2nd VAS|8
668610|NCT01859715|2159726|P1|Overall Study|No 2nd VAS|16
668611|NCT01859702|2159737|P1|Overall Study|Adverse Event|2
668612|NCT01859702|2159737|P1|Overall Study|Protocol deviation|3
668613|NCT01859598|2159751|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
668614|NCT01859507|2159759|P1|Overall Study|left the country|4
668615|NCT01859494|2159764|P1|Overall Study|Adverse Event|1
668616|NCT01859390|2159775|P2|Overall Study|Shipment Error|1
668617|NCT01859390|2159776|P1|Overall Study|Shipment Error|0
668618|NCT01859390|2159775|P2|Overall Study|Tube Cracked|2
668619|NCT01859390|2159776|P1|Overall Study|Tube Cracked|0
668620|NCT01859390|2159775|P2|Overall Study|Sample Missing Collection Date|1
668621|NCT01859390|2159776|P1|Overall Study|Sample Missing Collection Date|0
668622|NCT01859390|2159775|P2|Overall Study|Insufficient Sputum Collected|3
668623|NCT01859390|2159776|P1|Overall Study|Insufficient Sputum Collected|1
668624|NCT01859143|2159840|P2|Overall Study|Lost to Follow-up|0
668625|NCT01859143|2159841|P1|Overall Study|Lost to Follow-up|2
668626|NCT01858766|2159897|P19|Overall Study|Withdrew Consent|0
668627|NCT01858766|2159898|P18|Overall Study|Withdrew Consent|0
668628|NCT01858766|2159899|P17|Overall Study|Withdrew Consent|0
668629|NCT01858766|2159900|P16|Overall Study|Withdrew Consent|0
668630|NCT01858766|2159901|P15|Overall Study|Withdrew Consent|0
668631|NCT01858766|2159902|P14|Overall Study|Withdrew Consent|0
668632|NCT01858766|2159903|P13|Overall Study|Withdrew Consent|0
668633|NCT01858766|2159904|P12|Overall Study|Withdrew Consent|1
668634|NCT01858766|2159905|P11|Overall Study|Withdrew Consent|0
668635|NCT01858766|2159906|P10|Overall Study|Withdrew Consent|0
668636|NCT01858766|2159907|P9|Overall Study|Withdrew Consent|0
668637|NCT01858766|2159908|P8|Overall Study|Withdrew Consent|0
668638|NCT01858766|2159909|P7|Overall Study|Withdrew Consent|0
668639|NCT01858766|2159910|P6|Overall Study|Withdrew Consent|0
668640|NCT01858766|2159911|P5|Overall Study|Withdrew Consent|0
668641|NCT01858766|2159912|P4|Overall Study|Withdrew Consent|0
668642|NCT01858766|2159913|P3|Overall Study|Withdrew Consent|0
668643|NCT01858766|2159914|P2|Overall Study|Withdrew Consent|0
668644|NCT01858766|2159915|P1|Overall Study|Withdrew Consent|0
668645|NCT01858766|2159897|P19|Overall Study|Lost to Follow-up|1
668646|NCT01858766|2159898|P18|Overall Study|Lost to Follow-up|0
668647|NCT01858766|2159899|P17|Overall Study|Lost to Follow-up|1
668648|NCT01858766|2159900|P16|Overall Study|Lost to Follow-up|1
668649|NCT01858766|2159901|P15|Overall Study|Lost to Follow-up|3
668650|NCT01858766|2159902|P14|Overall Study|Lost to Follow-up|0
668651|NCT01858766|2159903|P13|Overall Study|Lost to Follow-up|0
668652|NCT01858766|2159904|P12|Overall Study|Lost to Follow-up|1
668653|NCT01858766|2159905|P11|Overall Study|Lost to Follow-up|0
668654|NCT01858766|2159906|P10|Overall Study|Lost to Follow-up|0
668655|NCT01858766|2159907|P9|Overall Study|Lost to Follow-up|0
668656|NCT01858766|2159908|P8|Overall Study|Lost to Follow-up|2
668657|NCT01858766|2159909|P7|Overall Study|Lost to Follow-up|0
668658|NCT01858766|2159910|P6|Overall Study|Lost to Follow-up|1
668659|NCT01858766|2159911|P5|Overall Study|Lost to Follow-up|0
668660|NCT01858766|2159912|P4|Overall Study|Lost to Follow-up|0
668661|NCT01858766|2159913|P3|Overall Study|Lost to Follow-up|0
668662|NCT01858766|2159914|P2|Overall Study|Lost to Follow-up|0
668663|NCT01858766|2159915|P1|Overall Study|Lost to Follow-up|0
668664|NCT01858766|2159897|P19|Overall Study|Lack of Efficacy|3
668665|NCT01858766|2159898|P18|Overall Study|Lack of Efficacy|3
668666|NCT01858766|2159899|P17|Overall Study|Lack of Efficacy|2
668667|NCT01858766|2159900|P16|Overall Study|Lack of Efficacy|5
668668|NCT01858766|2159901|P15|Overall Study|Lack of Efficacy|5
668669|NCT01858766|2159902|P14|Overall Study|Lack of Efficacy|3
668670|NCT01858766|2159903|P13|Overall Study|Lack of Efficacy|5
668671|NCT01858766|2159904|P12|Overall Study|Lack of Efficacy|3
668672|NCT01858766|2159905|P11|Overall Study|Lack of Efficacy|0
668673|NCT01858766|2159906|P10|Overall Study|Lack of Efficacy|0
668674|NCT01858766|2159907|P9|Overall Study|Lack of Efficacy|0
668675|NCT01858766|2159908|P8|Overall Study|Lack of Efficacy|0
668676|NCT01858766|2159909|P7|Overall Study|Lack of Efficacy|0
668677|NCT01858766|2159910|P6|Overall Study|Lack of Efficacy|2
668678|NCT01858766|2159911|P5|Overall Study|Lack of Efficacy|1
668679|NCT01858766|2159912|P4|Overall Study|Lack of Efficacy|0
668680|NCT01858766|2159913|P3|Overall Study|Lack of Efficacy|0
668681|NCT01858766|2159914|P2|Overall Study|Lack of Efficacy|0
668682|NCT01858766|2159915|P1|Overall Study|Lack of Efficacy|1
668683|NCT01858766|2159897|P19|Overall Study|Death|0
668684|NCT01858766|2159898|P18|Overall Study|Death|0
668685|NCT01858766|2159899|P17|Overall Study|Death|0
668686|NCT01858766|2159900|P16|Overall Study|Death|0
668687|NCT01858766|2159901|P15|Overall Study|Death|0
668688|NCT01858766|2159902|P14|Overall Study|Death|0
668689|NCT01858766|2159903|P13|Overall Study|Death|0
668690|NCT01858766|2159904|P12|Overall Study|Death|0
668691|NCT01858766|2159905|P11|Overall Study|Death|0
668692|NCT01858766|2159906|P10|Overall Study|Death|0
668693|NCT01858766|2159907|P9|Overall Study|Death|0
668694|NCT01858766|2159908|P8|Overall Study|Death|0
668695|NCT01858766|2159909|P7|Overall Study|Death|0
668696|NCT01858766|2159910|P6|Overall Study|Death|0
668697|NCT01858766|2159911|P5|Overall Study|Death|0
668698|NCT01858766|2159912|P4|Overall Study|Death|0
668699|NCT01858766|2159913|P3|Overall Study|Death|1
668700|NCT01858766|2159914|P2|Overall Study|Death|0
668701|NCT01858766|2159915|P1|Overall Study|Death|0
668702|NCT01858766|2159897|P19|Overall Study|Randomized but Never Treated|0
668703|NCT01858766|2159898|P18|Overall Study|Randomized but Never Treated|1
668704|NCT01858766|2159899|P17|Overall Study|Randomized but Never Treated|0
668705|NCT01858766|2159900|P16|Overall Study|Randomized but Never Treated|0
668706|NCT01858766|2159901|P15|Overall Study|Randomized but Never Treated|0
668707|NCT01858766|2159902|P14|Overall Study|Randomized but Never Treated|0
668708|NCT01858766|2159903|P13|Overall Study|Randomized but Never Treated|0
668709|NCT01858766|2159904|P12|Overall Study|Randomized but Never Treated|0
668710|NCT01858766|2159905|P11|Overall Study|Randomized but Never Treated|0
668711|NCT01858766|2159906|P10|Overall Study|Randomized but Never Treated|0
668712|NCT01858766|2159907|P9|Overall Study|Randomized but Never Treated|0
668713|NCT01858766|2159908|P8|Overall Study|Randomized but Never Treated|0
668714|NCT01858766|2159909|P7|Overall Study|Randomized but Never Treated|0
668715|NCT01858766|2159910|P6|Overall Study|Randomized but Never Treated|1
668716|NCT01858766|2159911|P5|Overall Study|Randomized but Never Treated|0
668717|NCT01858766|2159912|P4|Overall Study|Randomized but Never Treated|0
668718|NCT01858766|2159913|P3|Overall Study|Randomized but Never Treated|0
668719|NCT01858766|2159914|P2|Overall Study|Randomized but Never Treated|0
668720|NCT01858766|2159915|P1|Overall Study|Randomized but Never Treated|0
668721|NCT01858701|2159986|P2|Period 2, Second 30 Days of Wear|Comfort|1
668722|NCT01858701|2159987|P1|Period 2, Second 30 Days of Wear|Comfort|0
668723|NCT01858701|2159986|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
668724|NCT01858701|2159987|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
668725|NCT01858701|2159986|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
668726|NCT01858701|2159987|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
668727|NCT01858701|2159986|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
668728|NCT01858701|2159987|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
668729|NCT01858636|2159993|P1|Overall Study|Withdrawal by Subject|1
668730|NCT01858636|2159993|P1|Overall Study|Lost to Follow-up|1
668731|NCT01858636|2159993|P1|Overall Study|Death|1
668732|NCT01858636|2159993|P1|Overall Study|Physician Decision|1
668733|NCT01858636|2159993|P1|Overall Study|No Device Deployment Attempted|24
668734|NCT01858389|2160000|P2|Overall Study|Did not receive treatment|3
668735|NCT01858389|2160001|P1|Overall Study|Did not receive treatment|0
668736|NCT01858389|2160000|P2|Overall Study|Adverse Event|1
668737|NCT01858389|2160001|P1|Overall Study|Adverse Event|3
668738|NCT01858389|2160000|P2|Overall Study|Not specified|4
668739|NCT01858389|2160001|P1|Overall Study|Not specified|2
668740|NCT01858389|2160000|P2|Overall Study|Progressive disease|11
668741|NCT01858389|2160001|P1|Overall Study|Progressive disease|10
668742|NCT01858389|2160000|P2|Overall Study|Withdrawal by Subject|1
668743|NCT01858389|2160001|P1|Overall Study|Withdrawal by Subject|0
668744|NCT01858389|2160000|P2|Overall Study|Study terminated by sponsor|2
668745|NCT01858389|2160001|P1|Overall Study|Study terminated by sponsor|0
668746|NCT01858389|2160000|P2|Overall Study|Death|3
668747|NCT01858389|2160001|P1|Overall Study|Death|1
668748|NCT01858376|2160016|P1|Overall Study|Dropped d/t lab work not fitting criter|4
668749|NCT01857622|2160054|P3|Overall Study|Withdrawal by Subject|0
668750|NCT01857622|2160055|P2|Overall Study|Withdrawal by Subject|0
668751|NCT01857622|2160056|P1|Overall Study|Withdrawal by Subject|1
668752|NCT01857622|2160054|P3|Overall Study|Protocol Violation|0
668753|NCT01857622|2160055|P2|Overall Study|Protocol Violation|1
668754|NCT01857622|2160056|P1|Overall Study|Protocol Violation|4
668755|NCT01857622|2160054|P3|Overall Study|Physician Decision|0
668756|NCT01857622|2160055|P2|Overall Study|Physician Decision|0
668757|NCT01857622|2160056|P1|Overall Study|Physician Decision|1
668758|NCT01857622|2160054|P3|Overall Study|Adverse Event|2
668759|NCT01857622|2160055|P2|Overall Study|Adverse Event|0
668760|NCT01857622|2160056|P1|Overall Study|Adverse Event|5
668761|NCT01857583|2160068|P4|Overall Study|Withdrawal by Subject|2
668762|NCT01857583|2160069|P3|Overall Study|Withdrawal by Subject|1
668763|NCT01857583|2160070|P2|Overall Study|Withdrawal by Subject|0
668764|NCT01857583|2160071|P1|Overall Study|Withdrawal by Subject|1
668765|NCT01857583|2160068|P4|Overall Study|Physician Decision|1
668766|NCT01857583|2160069|P3|Overall Study|Physician Decision|0
668767|NCT01857583|2160070|P2|Overall Study|Physician Decision|0
668768|NCT01857583|2160071|P1|Overall Study|Physician Decision|0
668769|NCT01857583|2160068|P4|Overall Study|Death|0
668770|NCT01857583|2160069|P3|Overall Study|Death|1
668771|NCT01857583|2160070|P2|Overall Study|Death|1
668772|NCT01857583|2160071|P1|Overall Study|Death|0
668773|NCT01857583|2160068|P4|Overall Study|Adverse Event|1
668774|NCT01857583|2160069|P3|Overall Study|Adverse Event|1
668775|NCT01857583|2160070|P2|Overall Study|Adverse Event|0
668776|NCT01857583|2160071|P1|Overall Study|Adverse Event|0
668777|NCT01857531|2160081|P1|Overall Study|Withdrawal by Subject|4
668778|NCT01857323|2160099|P1|Overall Study|Did not complete 180 doses|48
668779|NCT01857323|2160099|P1|Overall Study|Not specified|4
668780|NCT01857323|2160099|P1|Overall Study|Lost to Follow-up|1
668781|NCT01857323|2160099|P1|Overall Study|Protocol Violation|6
668782|NCT01857323|2160099|P1|Overall Study|Non-compliance|1
668783|NCT01857323|2160099|P1|Overall Study|Withdrawal by Subject|3
668784|NCT01857323|2160099|P1|Overall Study|Adverse Event|1
668785|NCT01857206|2160148|P2|Overall Study|Withdrawal by Subject|0
668786|NCT01857206|2160149|P1|Overall Study|Withdrawal by Subject|1
668787|NCT01857206|2160148|P2|Overall Study|Unclassified|3
668788|NCT01857206|2160149|P1|Overall Study|Unclassified|3
668789|NCT01857206|2160148|P2|Overall Study|Lost to Follow-up|6
668790|NCT01857206|2160149|P1|Overall Study|Lost to Follow-up|9
668791|NCT01857206|2160148|P2|Overall Study|ADMINISTRATIVE REASON|1
668792|NCT01857206|2160149|P1|Overall Study|ADMINISTRATIVE REASON|0
668793|NCT01857102|2160167|P2|Period 2|Unsatisfactory Lens Fit|0
668794|NCT01857102|2160168|P1|Period 2|Unsatisfactory Lens Fit|1
668795|NCT01857102|2160167|P2|Period 2|Lens Discomfort|0
668796|NCT01857102|2160168|P1|Period 2|Lens Discomfort|1
668797|NCT01857102|2160167|P2|Period 1|Physician Decision|0
668798|NCT01857102|2160168|P1|Period 1|Physician Decision|1
668799|NCT01857102|2160167|P2|Period 1|Unsatisfactory Visual Response|0
668800|NCT01857102|2160168|P1|Period 1|Unsatisfactory Visual Response|1
668801|NCT01857102|2160167|P2|Period 1|Unsatisfactory Lens Fit|0
668802|NCT01857102|2160168|P1|Period 1|Unsatisfactory Lens Fit|1
668803|NCT01857102|2160167|P2|Period 1|Lost to Follow-up|3
668804|NCT01857102|2160168|P1|Period 1|Lost to Follow-up|0
668805|NCT01857102|2160167|P2|Period 1|No longer meets Eligibility Criteria|2
668806|NCT01857102|2160168|P1|Period 1|No longer meets Eligibility Criteria|0
668807|NCT01857063|2160178|P2|Period 2 (7 Days)|Withdrawal by Subject|0
668808|NCT01857063|2160179|P1|Period 2 (7 Days)|Withdrawal by Subject|1
668809|NCT01857063|2160178|P2|Period 2 (7 Days)|Physician Decision|1
668810|NCT01857063|2160179|P1|Period 2 (7 Days)|Physician Decision|1
668811|NCT01857063|2160178|P2|Period 2 (7 Days)|Adverse Event|1
668812|NCT01857063|2160179|P1|Period 2 (7 Days)|Adverse Event|2
668813|NCT01857063|2160178|P2|Period 1 (7 Days)|Withdrawal by Subject|3
668814|NCT01857063|2160179|P1|Period 1 (7 Days)|Withdrawal by Subject|1
668815|NCT01857063|2160178|P2|Period 1 (7 Days)|Physician Decision|0
668816|NCT01857063|2160179|P1|Period 1 (7 Days)|Physician Decision|1
668817|NCT01857063|2160178|P2|Period 1 (7 Days)|Adverse Event|1
668818|NCT01857063|2160179|P1|Period 1 (7 Days)|Adverse Event|0
888648|NCT01791517|2822622|P4|Phase II|Lost to Follow-up|0
888649|NCT01791517|2822623|P3|Phase II|Lost to Follow-up|1
668821|NCT01856673|2160268|P3|Overall Study|Protocol Violation|1
668822|NCT01856673|2160269|P2|Overall Study|Protocol Violation|0
668823|NCT01856673|2160270|P1|Overall Study|Protocol Violation|1
668824|NCT01856673|2160268|P3|Overall Study|Death|0
668825|NCT01856673|2160269|P2|Overall Study|Death|1
668826|NCT01856673|2160270|P1|Overall Study|Death|2
668827|NCT01856673|2160268|P3|Overall Study|Paperwork errors|0
668828|NCT01856673|2160269|P2|Overall Study|Paperwork errors|0
668829|NCT01856673|2160270|P1|Overall Study|Paperwork errors|4
668830|NCT01856673|2160268|P3|Overall Study|Psychologist decision|0
668831|NCT01856673|2160269|P2|Overall Study|Psychologist decision|0
668832|NCT01856673|2160270|P1|Overall Study|Psychologist decision|3
668833|NCT01856673|2160268|P3|Overall Study|Unknown reasons|0
668834|NCT01856673|2160269|P2|Overall Study|Unknown reasons|0
668835|NCT01856673|2160270|P1|Overall Study|Unknown reasons|20
668836|NCT01856673|2160268|P3|Overall Study|Lost to Follow-up|0
668837|NCT01856673|2160269|P2|Overall Study|Lost to Follow-up|34
668838|NCT01856673|2160270|P1|Overall Study|Lost to Follow-up|22
668839|NCT01856673|2160268|P3|Overall Study|Withdrawal by Subject|33
668840|NCT01856673|2160269|P2|Overall Study|Withdrawal by Subject|50
668841|NCT01856673|2160270|P1|Overall Study|Withdrawal by Subject|46
668842|NCT01856569|2160281|P1|Overall Study|Did not met inclusion criteria|8
668843|NCT01856569|2160281|P1|Overall Study|Lost to Follow-up|3
668844|NCT01856569|2160281|P1|Overall Study|Changed Site/Structure|1
668845|NCT01856569|2160281|P1|Overall Study|Unspecified|1
668846|NCT01856322|2160329|P3|Overall Study|off study due to lack of accrual|3
668847|NCT01856322|2160330|P2|Overall Study|off study due to lack of accrual|0
668848|NCT01856322|2160331|P1|Overall Study|off study due to lack of accrual|0
668849|NCT01856257|2160341|P4|Overall Study|Donor complication|1
668850|NCT01856257|2160342|P3|Overall Study|Donor complication|0
668851|NCT01856257|2160343|P2|Overall Study|Donor complication|0
668852|NCT01856257|2160344|P1|Overall Study|Donor complication|0
668853|NCT01856257|2160341|P4|Overall Study|Withdrawal by Subject|0
668854|NCT01856257|2160342|P3|Overall Study|Withdrawal by Subject|0
668855|NCT01856257|2160343|P2|Overall Study|Withdrawal by Subject|1
668856|NCT01856257|2160344|P1|Overall Study|Withdrawal by Subject|1
668857|NCT01856257|2160341|P4|Overall Study|Physician Decision|1
668858|NCT01856257|2160342|P3|Overall Study|Physician Decision|0
668859|NCT01856257|2160343|P2|Overall Study|Physician Decision|0
668860|NCT01856257|2160344|P1|Overall Study|Physician Decision|0
668861|NCT01856257|2160341|P4|Overall Study|Death|0
668862|NCT01856257|2160342|P3|Overall Study|Death|0
668863|NCT01856257|2160343|P2|Overall Study|Death|0
668864|NCT01856257|2160344|P1|Overall Study|Death|2
668865|NCT01855958|2160498|P2|Overall Study|Withdrawal by Subject|0
668866|NCT01855958|2160499|P1|Overall Study|Withdrawal by Subject|1
668867|NCT01855945|2160529|P12|Overall Study|Withdrawal by Subject|1
668868|NCT01855945|2160530|P11|Overall Study|Withdrawal by Subject|4
668869|NCT01855945|2160531|P10|Overall Study|Withdrawal by Subject|2
668870|NCT01855945|2160532|P9|Overall Study|Withdrawal by Subject|0
668871|NCT01855945|2160533|P8|Overall Study|Withdrawal by Subject|0
668872|NCT01855945|2160534|P7|Overall Study|Withdrawal by Subject|1
668873|NCT01855945|2160535|P6|Overall Study|Withdrawal by Subject|0
668874|NCT01855945|2160536|P5|Overall Study|Withdrawal by Subject|1
668875|NCT01855945|2160537|P4|Overall Study|Withdrawal by Subject|1
668876|NCT01855945|2160538|P3|Overall Study|Withdrawal by Subject|4
668877|NCT01855945|2160539|P2|Overall Study|Withdrawal by Subject|0
668878|NCT01855945|2160540|P1|Overall Study|Withdrawal by Subject|4
668879|NCT01855945|2160529|P12|Overall Study|Other - Unclassified|0
668880|NCT01855945|2160530|P11|Overall Study|Other - Unclassified|1
668881|NCT01855945|2160531|P10|Overall Study|Other - Unclassified|0
668882|NCT01855945|2160532|P9|Overall Study|Other - Unclassified|0
668883|NCT01855945|2160533|P8|Overall Study|Other - Unclassified|1
668884|NCT01855945|2160534|P7|Overall Study|Other - Unclassified|2
668885|NCT01855945|2160535|P6|Overall Study|Other - Unclassified|0
668886|NCT01855945|2160536|P5|Overall Study|Other - Unclassified|0
668887|NCT01855945|2160537|P4|Overall Study|Other - Unclassified|0
668888|NCT01855945|2160538|P3|Overall Study|Other - Unclassified|1
668889|NCT01855945|2160539|P2|Overall Study|Other - Unclassified|1
668890|NCT01855945|2160540|P1|Overall Study|Other - Unclassified|1
668891|NCT01855945|2160529|P12|Overall Study|Lost to Follow-up|2
668892|NCT01855945|2160530|P11|Overall Study|Lost to Follow-up|0
668893|NCT01855945|2160531|P10|Overall Study|Lost to Follow-up|0
668894|NCT01855945|2160532|P9|Overall Study|Lost to Follow-up|2
668895|NCT01855945|2160533|P8|Overall Study|Lost to Follow-up|7
668896|NCT01855945|2160534|P7|Overall Study|Lost to Follow-up|4
668897|NCT01855945|2160535|P6|Overall Study|Lost to Follow-up|3
668898|NCT01855945|2160536|P5|Overall Study|Lost to Follow-up|0
668899|NCT01855945|2160537|P4|Overall Study|Lost to Follow-up|3
668900|NCT01855945|2160538|P3|Overall Study|Lost to Follow-up|7
668901|NCT01855945|2160539|P2|Overall Study|Lost to Follow-up|10
668902|NCT01855945|2160540|P1|Overall Study|Lost to Follow-up|11
668903|NCT01855945|2160529|P12|Overall Study|Death|0
668904|NCT01855945|2160530|P11|Overall Study|Death|0
668905|NCT01855945|2160531|P10|Overall Study|Death|0
668906|NCT01855945|2160532|P9|Overall Study|Death|0
668907|NCT01855945|2160533|P8|Overall Study|Death|0
668908|NCT01855945|2160534|P7|Overall Study|Death|2
668909|NCT01855945|2160535|P6|Overall Study|Death|0
668910|NCT01855945|2160536|P5|Overall Study|Death|0
668911|NCT01855945|2160537|P4|Overall Study|Death|0
668912|NCT01855945|2160538|P3|Overall Study|Death|0
668913|NCT01855945|2160539|P2|Overall Study|Death|0
668914|NCT01855945|2160540|P1|Overall Study|Death|0
668915|NCT01855945|2160529|P12|Overall Study|Adverse Event|0
668916|NCT01855945|2160530|P11|Overall Study|Adverse Event|0
668917|NCT01855945|2160531|P10|Overall Study|Adverse Event|0
668918|NCT01855945|2160532|P9|Overall Study|Adverse Event|0
668919|NCT01855945|2160533|P8|Overall Study|Adverse Event|0
668920|NCT01855945|2160534|P7|Overall Study|Adverse Event|1
668921|NCT01855945|2160535|P6|Overall Study|Adverse Event|0
668922|NCT01855945|2160536|P5|Overall Study|Adverse Event|0
668923|NCT01855945|2160537|P4|Overall Study|Adverse Event|0
668924|NCT01855945|2160538|P3|Overall Study|Adverse Event|0
668925|NCT01855945|2160539|P2|Overall Study|Adverse Event|0
668926|NCT01855945|2160540|P1|Overall Study|Adverse Event|0
668927|NCT01855919|2160676|P2|Overall Study|Protocol Violation|4
668928|NCT01855919|2160677|P1|Overall Study|Protocol Violation|1
668929|NCT01855919|2160676|P2|Overall Study|Entry Criteria Not Met|1
668930|NCT01855919|2160677|P1|Overall Study|Entry Criteria Not Met|1
668931|NCT01855919|2160676|P2|Overall Study|Withdrawal by Subject|10
668932|NCT01855919|2160677|P1|Overall Study|Withdrawal by Subject|4
668933|NCT01855919|2160676|P2|Overall Study|Lack of Efficacy|3
668934|NCT01855919|2160677|P1|Overall Study|Lack of Efficacy|1
668935|NCT01855919|2160676|P2|Overall Study|Adverse Event|8
668936|NCT01855919|2160677|P1|Overall Study|Adverse Event|16
668937|NCT01855074|2160709|P1|Overall Study|Started but not treated|1
668938|NCT01855074|2160709|P1|Overall Study|Withdrawal by Subject|8
668939|NCT01855074|2160709|P1|Overall Study|Lost to Follow-up|4
668940|NCT01855074|2160709|P1|Overall Study|Adverse Event|1
668941|NCT01854944|2160721|P3|Overall Study|Withdrawal by Subject|1
668942|NCT01854944|2160722|P2|Overall Study|Withdrawal by Subject|0
668943|NCT01854944|2160723|P1|Overall Study|Withdrawal by Subject|0
668944|NCT01854697|2160782|P5|Overall Study|Not Specified|0
668945|NCT01854697|2160783|P4|Overall Study|Not Specified|0
668946|NCT01854697|2160784|P3|Overall Study|Not Specified|1
668947|NCT01854697|2160785|P2|Overall Study|Not Specified|1
668948|NCT01854697|2160786|P1|Overall Study|Not Specified|0
668949|NCT01854697|2160782|P5|Overall Study|Withdrew Consent|0
668950|NCT01854697|2160783|P4|Overall Study|Withdrew Consent|1
668951|NCT01854697|2160784|P3|Overall Study|Withdrew Consent|0
668952|NCT01854697|2160785|P2|Overall Study|Withdrew Consent|1
668953|NCT01854697|2160786|P1|Overall Study|Withdrew Consent|0
668954|NCT01854697|2160782|P5|Overall Study|To enter another AbbVie study|1
668955|NCT01854697|2160783|P4|Overall Study|To enter another AbbVie study|0
668956|NCT01854697|2160784|P3|Overall Study|To enter another AbbVie study|0
668957|NCT01854697|2160785|P2|Overall Study|To enter another AbbVie study|0
668958|NCT01854697|2160786|P1|Overall Study|To enter another AbbVie study|1
668959|NCT01854697|2160782|P5|Overall Study|Lost to Follow-up|0
668960|NCT01854697|2160783|P4|Overall Study|Lost to Follow-up|2
668961|NCT01854697|2160784|P3|Overall Study|Lost to Follow-up|1
668962|NCT01854697|2160785|P2|Overall Study|Lost to Follow-up|1
668963|NCT01854697|2160786|P1|Overall Study|Lost to Follow-up|4
668964|NCT01854697|2160782|P5|Overall Study|Adverse Event|1
668965|NCT01854697|2160783|P4|Overall Study|Adverse Event|0
668966|NCT01854697|2160784|P3|Overall Study|Adverse Event|0
668967|NCT01854697|2160785|P2|Overall Study|Adverse Event|0
668968|NCT01854697|2160786|P1|Overall Study|Adverse Event|1
668969|NCT01854658|2160830|P4|Overall Study|Administrative reasons|2
668970|NCT01854658|2160831|P3|Overall Study|Administrative reasons|2
668971|NCT01854658|2160832|P2|Overall Study|Administrative reasons|1
668972|NCT01854658|2160833|P1|Overall Study|Administrative reasons|5
668973|NCT01854658|2160830|P4|Overall Study|Adverse Event|19
668974|NCT01854658|2160831|P3|Overall Study|Adverse Event|23
668975|NCT01854658|2160832|P2|Overall Study|Adverse Event|14
668976|NCT01854658|2160833|P1|Overall Study|Adverse Event|21
668977|NCT01854658|2160830|P4|Overall Study|Lack of Efficacy|7
668978|NCT01854658|2160831|P3|Overall Study|Lack of Efficacy|4
668979|NCT01854658|2160832|P2|Overall Study|Lack of Efficacy|8
668980|NCT01854658|2160833|P1|Overall Study|Lack of Efficacy|3
668981|NCT01854658|2160830|P4|Overall Study|Protocol-specified criteria|7
668982|NCT01854658|2160831|P3|Overall Study|Protocol-specified criteria|10
668983|NCT01854658|2160832|P2|Overall Study|Protocol-specified criteria|15
668984|NCT01854658|2160833|P1|Overall Study|Protocol-specified criteria|15
668985|NCT01854658|2160830|P4|Overall Study|Withdrawal by Subject|15
668986|NCT01854658|2160831|P3|Overall Study|Withdrawal by Subject|29
668987|NCT01854658|2160832|P2|Overall Study|Withdrawal by Subject|21
668988|NCT01854658|2160833|P1|Overall Study|Withdrawal by Subject|28
668989|NCT01854658|2160830|P4|Overall Study|Lost to Follow-up|4
668990|NCT01854658|2160831|P3|Overall Study|Lost to Follow-up|8
668991|NCT01854658|2160832|P2|Overall Study|Lost to Follow-up|9
668992|NCT01854658|2160833|P1|Overall Study|Lost to Follow-up|8
668993|NCT01854658|2160830|P4|Overall Study|Physician Decision|4
668994|NCT01854658|2160831|P3|Overall Study|Physician Decision|2
668995|NCT01854658|2160832|P2|Overall Study|Physician Decision|5
668996|NCT01854658|2160833|P1|Overall Study|Physician Decision|7
668997|NCT01854658|2160830|P4|Overall Study|Protocol Violation|1
668998|NCT01854658|2160831|P3|Overall Study|Protocol Violation|2
668999|NCT01854658|2160832|P2|Overall Study|Protocol Violation|2
669000|NCT01854658|2160833|P1|Overall Study|Protocol Violation|6
669001|NCT01854645|2160868|P5|Overall Study|Adverse Event|11
669002|NCT01854645|2160869|P4|Overall Study|Adverse Event|20
669003|NCT01854645|2160870|P3|Overall Study|Adverse Event|19
669004|NCT01854645|2160871|P2|Overall Study|Adverse Event|31
669005|NCT01854645|2160872|P1|Overall Study|Adverse Event|33
669006|NCT01854645|2160868|P5|Overall Study|Lack of Efficacy|9
669007|NCT01854645|2160869|P4|Overall Study|Lack of Efficacy|3
669008|NCT01854645|2160870|P3|Overall Study|Lack of Efficacy|9
669009|NCT01854645|2160871|P2|Overall Study|Lack of Efficacy|12
669010|NCT01854645|2160872|P1|Overall Study|Lack of Efficacy|7
669011|NCT01854645|2160868|P5|Overall Study|Withdrawal by Subject|24
669012|NCT01854645|2160869|P4|Overall Study|Withdrawal by Subject|21
669013|NCT01854645|2160870|P3|Overall Study|Withdrawal by Subject|30
669014|NCT01854645|2160871|P2|Overall Study|Withdrawal by Subject|41
669015|NCT01854645|2160872|P1|Overall Study|Withdrawal by Subject|31
669016|NCT01854645|2160868|P5|Overall Study|Physician Decision|7
669017|NCT01854645|2160869|P4|Overall Study|Physician Decision|3
669018|NCT01854645|2160870|P3|Overall Study|Physician Decision|3
669019|NCT01854645|2160871|P2|Overall Study|Physician Decision|5
669020|NCT01854645|2160872|P1|Overall Study|Physician Decision|1
669021|NCT01854645|2160868|P5|Overall Study|Lost to Follow-up|0
669022|NCT01854645|2160869|P4|Overall Study|Lost to Follow-up|5
669023|NCT01854645|2160870|P3|Overall Study|Lost to Follow-up|8
669024|NCT01854645|2160871|P2|Overall Study|Lost to Follow-up|7
669025|NCT01854645|2160872|P1|Overall Study|Lost to Follow-up|10
669026|NCT01854645|2160868|P5|Overall Study|Protocol Violation|1
669027|NCT01854645|2160869|P4|Overall Study|Protocol Violation|4
669028|NCT01854645|2160870|P3|Overall Study|Protocol Violation|5
669029|NCT01854645|2160871|P2|Overall Study|Protocol Violation|0
669030|NCT01854645|2160872|P1|Overall Study|Protocol Violation|3
669031|NCT01854645|2160868|P5|Overall Study|Administrative Reasons / Missing|1
669032|NCT01854645|2160869|P4|Overall Study|Administrative Reasons / Missing|1
669033|NCT01854645|2160870|P3|Overall Study|Administrative Reasons / Missing|0
669034|NCT01854645|2160871|P2|Overall Study|Administrative Reasons / Missing|0
669035|NCT01854645|2160872|P1|Overall Study|Administrative Reasons / Missing|0
669036|NCT01854645|2160868|P5|Overall Study|Protocol-Specified Criteria|7
669037|NCT01854645|2160869|P4|Overall Study|Protocol-Specified Criteria|5
669038|NCT01854645|2160870|P3|Overall Study|Protocol-Specified Criteria|8
669039|NCT01854645|2160871|P2|Overall Study|Protocol-Specified Criteria|10
669040|NCT01854645|2160872|P1|Overall Study|Protocol-Specified Criteria|13
669041|NCT01854528|2160953|P2|Overall Study|Virologic Failure|9
669042|NCT01854528|2160954|P1|Overall Study|Virologic Failure|0
669043|NCT01854528|2160953|P2|Overall Study|Withdrawal by Subject|2
669044|NCT01854528|2160954|P1|Overall Study|Withdrawal by Subject|0
669045|NCT01854528|2160953|P2|Overall Study|Adverse Event|4
669046|NCT01854528|2160954|P1|Overall Study|Adverse Event|0
669047|NCT01854047|2161002|P5|Overall Study|Other than specified above|8
669048|NCT01854047|2161003|P4|Overall Study|Other than specified above|5
669049|NCT01854047|2161004|P3|Overall Study|Other than specified above|3
669050|NCT01854047|2161005|P2|Overall Study|Other than specified above|3
669051|NCT01854047|2161006|P1|Overall Study|Other than specified above|3
669052|NCT01854047|2161002|P5|Overall Study|Randomized but not treated|4
669053|NCT01854047|2161003|P4|Overall Study|Randomized but not treated|0
669054|NCT01854047|2161004|P3|Overall Study|Randomized but not treated|2
669055|NCT01854047|2161005|P2|Overall Study|Randomized but not treated|1
669056|NCT01854047|2161006|P1|Overall Study|Randomized but not treated|0
669057|NCT01854047|2161002|P5|Overall Study|Adverse Event|7
669058|NCT01854047|2161003|P4|Overall Study|Adverse Event|10
669059|NCT01854047|2161004|P3|Overall Study|Adverse Event|6
669060|NCT01854047|2161005|P2|Overall Study|Adverse Event|4
669061|NCT01854047|2161006|P1|Overall Study|Adverse Event|5
669062|NCT01854047|2161002|P5|Overall Study|Poor compliance to protocol|0
669063|NCT01854047|2161003|P4|Overall Study|Poor compliance to protocol|0
669064|NCT01854047|2161004|P3|Overall Study|Poor compliance to protocol|2
669065|NCT01854047|2161005|P2|Overall Study|Poor compliance to protocol|0
669066|NCT01854047|2161006|P1|Overall Study|Poor compliance to protocol|3
669067|NCT01854047|2161002|P5|Overall Study|Lack of Efficacy|0
669068|NCT01854047|2161003|P4|Overall Study|Lack of Efficacy|0
669069|NCT01854047|2161004|P3|Overall Study|Lack of Efficacy|0
669070|NCT01854047|2161005|P2|Overall Study|Lack of Efficacy|0
669071|NCT01854047|2161006|P1|Overall Study|Lack of Efficacy|1
669072|NCT01853982|2161130|P2|Overall Study|Lost to Follow-up|1
669073|NCT01853982|2161131|P1|Overall Study|Lost to Follow-up|0
669074|NCT01853982|2161130|P2|Overall Study|Death|0
669075|NCT01853982|2161131|P1|Overall Study|Death|1
669076|NCT01853982|2161130|P2|Overall Study|Withdrawal by Subject|0
669077|NCT01853982|2161131|P1|Overall Study|Withdrawal by Subject|1
669078|NCT01853839|2161137|P1|Overall Study|Lost to follow-up or no valid BP measure|336
669079|NCT01853839|2161137|P1|Overall Study|End of treatment visit too early|33
669080|NCT01853839|2161137|P1|Overall Study|Not meet ITT population definition|58
669081|NCT01853839|2161137|P1|Overall Study|Violated inclusion criteria|2
669082|NCT01853696|2161159|P2|Overall Study|Lost to Follow-up|4
669083|NCT01853696|2161160|P1|Overall Study|Lost to Follow-up|5
669084|NCT01853696|2161159|P2|Overall Study|Withdrawal by Subject|1
669085|NCT01853696|2161160|P1|Overall Study|Withdrawal by Subject|1
669086|NCT01853475|2161196|P3|Overall Study|Withdrawal by Subject|0
669087|NCT01853475|2161197|P2|Overall Study|Withdrawal by Subject|1
669088|NCT01853475|2161198|P1|Overall Study|Withdrawal by Subject|0
669089|NCT01853397|2161219|P4|Overall Study|Subject Noncompliance|1
669090|NCT01853397|2161220|P3|Overall Study|Subject Noncompliance|0
669091|NCT01853397|2161221|P2|Overall Study|Subject Noncompliance|0
669092|NCT01853397|2161222|P1|Overall Study|Subject Noncompliance|0
669093|NCT01853397|2161219|P4|Overall Study|Withdrawal by Subject|1
669094|NCT01853397|2161220|P3|Overall Study|Withdrawal by Subject|0
669095|NCT01853397|2161221|P2|Overall Study|Withdrawal by Subject|0
669096|NCT01853397|2161222|P1|Overall Study|Withdrawal by Subject|0
669097|NCT01853384|2161250|P2|Completed Follow up Visit 2|Lost to Follow-up|1
669098|NCT01853384|2161251|P1|Completed Follow up Visit 2|Lost to Follow-up|0
669099|NCT01853384|2161250|P2|Completed Follow up Visit 2|Death|0
669100|NCT01853384|2161251|P1|Completed Follow up Visit 2|Death|1
669101|NCT01853384|2161250|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
669102|NCT01853384|2161251|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
669103|NCT01853384|2161250|P2|Completed Follow up Visit 2|Adverse Event|0
669104|NCT01853384|2161251|P1|Completed Follow up Visit 2|Adverse Event|1
669105|NCT01853384|2161250|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
669106|NCT01853384|2161251|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
669107|NCT01853384|2161250|P2|Completed Follow up Visit 1|Early Termination|9
669108|NCT01853384|2161251|P1|Completed Follow up Visit 1|Early Termination|13
669109|NCT01853384|2161250|P2|Randomized|Other|3
669110|NCT01853384|2161251|P1|Randomized|Other|3
669111|NCT01853384|2161250|P2|Randomized|Sponsor Decision|34
669112|NCT01853384|2161251|P1|Randomized|Sponsor Decision|47
669113|NCT01853384|2161250|P2|Randomized|Withdrawal by Subject|3
669114|NCT01853384|2161251|P1|Randomized|Withdrawal by Subject|5
669115|NCT01853384|2161250|P2|Randomized|Lost to Follow-up|1
669116|NCT01853384|2161251|P1|Randomized|Lost to Follow-up|1
669117|NCT01853384|2161250|P2|Randomized|Death|2
669118|NCT01853384|2161251|P1|Randomized|Death|1
669119|NCT01853384|2161250|P2|Randomized|Adverse Event|3
669120|NCT01853384|2161251|P1|Randomized|Adverse Event|5
669121|NCT01853254|2161289|P1|Overall Study|Administrative/Other|16
669122|NCT01853254|2161289|P1|Overall Study|Withdrawal of Consent|16
669123|NCT01853254|2161289|P1|Overall Study|Other Protocol Violation|1
669124|NCT01853254|2161289|P1|Overall Study|Refusal of Treatment|1
669125|NCT01853254|2161289|P1|Overall Study|Insufficient Therapeutic Response|22
669126|NCT01853254|2161289|P1|Overall Study|Failure to Return|43
669127|NCT01853254|2161289|P1|Overall Study|Death|1
669128|NCT01853254|2161289|P1|Overall Study|Adverse Event/Intercurrent Illness|3
669129|NCT01853254|2161289|P1|Overall Study|Abnormal Laboratory Test|1
669130|NCT01853176|2161306|P2|Overall Study|Study terminated|0
669131|NCT01853176|2161307|P1|Overall Study|Study terminated|4
669132|NCT01853072|2161326|P2|Overall Study|Reason not specified|6
669133|NCT01853072|2161327|P1|Overall Study|Reason not specified|9
669134|NCT01853072|2161326|P2|Overall Study|Withdrawal by Subject|2
669135|NCT01853072|2161327|P1|Overall Study|Withdrawal by Subject|1
669136|NCT01853072|2161326|P2|Overall Study|Physician Decision|1
669137|NCT01853072|2161327|P1|Overall Study|Physician Decision|1
669138|NCT01853072|2161326|P2|Overall Study|Non-compliance with study drug|1
669139|NCT01853072|2161327|P1|Overall Study|Non-compliance with study drug|0
669140|NCT01853072|2161326|P2|Overall Study|Lost to Follow-up|3
669141|NCT01853072|2161327|P1|Overall Study|Lost to Follow-up|0
669142|NCT01853072|2161326|P2|Overall Study|Death|4
669143|NCT01853072|2161327|P1|Overall Study|Death|1
669144|NCT01853072|2161326|P2|Overall Study|Adverse Event|3
669145|NCT01853072|2161327|P1|Overall Study|Adverse Event|0
669146|NCT01853072|2161326|P2|Overall Study|Adverse event prior to treatment|1
669147|NCT01853072|2161327|P1|Overall Study|Adverse event prior to treatment|0
669148|NCT01853046|2161347|P2|Overall Study|Disease progression|3
669149|NCT01853046|2161348|P1|Overall Study|Disease progression|13
669150|NCT01853046|2161347|P2|Overall Study|Adverse Event|2
669151|NCT01853046|2161348|P1|Overall Study|Adverse Event|4
669152|NCT01853046|2161347|P2|Overall Study|Withdrawal by Subject|1
669153|NCT01853046|2161348|P1|Overall Study|Withdrawal by Subject|1
669154|NCT01852825|2161416|P3|Overall Study|Withdrawal by Subject|0
669155|NCT01852825|2161417|P2|Overall Study|Withdrawal by Subject|0
669156|NCT01852825|2161418|P1|Overall Study|Withdrawal by Subject|2
669157|NCT01852812|2161444|P3|Overall Study|Non-compliance With Study Drug|0
669158|NCT01852812|2161445|P2|Overall Study|Non-compliance With Study Drug|1
669159|NCT01852812|2161446|P1|Overall Study|Non-compliance With Study Drug|0
669160|NCT01852812|2161444|P3|Overall Study|Adverse Event|1
669161|NCT01852812|2161445|P2|Overall Study|Adverse Event|0
669162|NCT01852812|2161446|P1|Overall Study|Adverse Event|0
669163|NCT01852591|2161475|P1|Overall Study|Not Evaluable at Time of Analysis|1
669164|NCT01852591|2161475|P1|Overall Study|Withdrawal by Subject|2
669165|NCT01852214|2161489|P2|Washout Period|Withdrawal by Subject|1
669166|NCT01852214|2161490|P1|Washout Period|Withdrawal by Subject|0
669167|NCT01852214|2161489|P2|Period 1|Withdrawal by Subject|1
669168|NCT01852214|2161490|P1|Period 1|Withdrawal by Subject|0
669169|NCT01852214|2161489|P2|Period 1|Adverse Event|2
669170|NCT01852214|2161490|P1|Period 1|Adverse Event|1
669171|NCT01852162|2161517|P2|Overall Study|Withdrawal by Subject|1
669172|NCT01852162|2161518|P1|Overall Study|Withdrawal by Subject|3
669173|NCT01852162|2161517|P2|Overall Study|Adverse Event|0
669174|NCT01852162|2161518|P1|Overall Study|Adverse Event|1
669175|NCT01851863|2161570|P4|Overall Study|Lost to Follow-up|3
669176|NCT01851863|2161571|P3|Overall Study|Lost to Follow-up|2
669177|NCT01851863|2161572|P2|Overall Study|Lost to Follow-up|4
669178|NCT01851863|2161573|P1|Overall Study|Lost to Follow-up|3
669179|NCT01851863|2161570|P4|Overall Study|Did not receive study medication|0
669180|NCT01851863|2161571|P3|Overall Study|Did not receive study medication|3
669181|NCT01851863|2161572|P2|Overall Study|Did not receive study medication|5
669182|NCT01851863|2161573|P1|Overall Study|Did not receive study medication|2
669183|NCT01851720|2161602|P2|Overall Study|Lost to Follow-up|1
669184|NCT01851720|2161603|P1|Overall Study|Lost to Follow-up|0
669185|NCT01851590|2161633|P3|Overall Study|Lack of Efficacy|0
669186|NCT01851590|2161634|P2|Overall Study|Lack of Efficacy|1
669187|NCT01851590|2161635|P1|Overall Study|Lack of Efficacy|0
669188|NCT01851590|2161633|P3|Overall Study|Adverse Event|2
669189|NCT01851590|2161634|P2|Overall Study|Adverse Event|0
669190|NCT01851590|2161635|P1|Overall Study|Adverse Event|0
669191|NCT01851590|2161633|P3|Overall Study|Withdrawal by Subject|1
669192|NCT01851590|2161634|P2|Overall Study|Withdrawal by Subject|0
669193|NCT01851590|2161635|P1|Overall Study|Withdrawal by Subject|0
669194|NCT01851330|2161658|P3|Overall Study|Investigator’s Discretion|1
669195|NCT01851330|2161659|P2|Overall Study|Investigator’s Discretion|0
669196|NCT01851330|2161660|P1|Overall Study|Investigator’s Discretion|0
669197|NCT01851330|2161658|P3|Overall Study|Withdrew Consent|0
669198|NCT01851330|2161659|P2|Overall Study|Withdrew Consent|1
669199|NCT01851330|2161660|P1|Overall Study|Withdrew Consent|2
669200|NCT01851330|2161658|P3|Overall Study|Lost to Follow-up|9
669201|NCT01851330|2161659|P2|Overall Study|Lost to Follow-up|6
669202|NCT01851330|2161660|P1|Overall Study|Lost to Follow-up|1
669203|NCT01851330|2161658|P3|Overall Study|Lack of Efficacy|2
669204|NCT01851330|2161659|P2|Overall Study|Lack of Efficacy|9
669205|NCT01851330|2161660|P1|Overall Study|Lack of Efficacy|10
669206|NCT01850589|2161697|P2|Overall Study|Withdrawal by Subject|0
669207|NCT01850589|2161698|P1|Overall Study|Withdrawal by Subject|8
669208|NCT01849848|2161761|P1|Overall Study|Progression of the primary disease|3
669209|NCT01849848|2161761|P1|Overall Study|Physician Decision|1
669210|NCT01849588|2161859|P1|Overall Study|Lack of Efficacy|3
669211|NCT01849562|2161869|P3|Overall Study|Non-compliance with Study Drug|0
669212|NCT01849562|2161870|P2|Overall Study|Non-compliance with Study Drug|0
669213|NCT01849562|2161871|P1|Overall Study|Non-compliance with Study Drug|1
669214|NCT01849562|2161869|P3|Overall Study|Lost to Follow-up|0
669215|NCT01849562|2161870|P2|Overall Study|Lost to Follow-up|0
669216|NCT01849562|2161871|P1|Overall Study|Lost to Follow-up|1
669217|NCT01849497|2161884|P2|Overall Study|Lost to Follow-up|1
669218|NCT01849497|2161885|P1|Overall Study|Lost to Follow-up|0
669219|NCT01849497|2161884|P2|Overall Study|Sponsor Decision|1
669220|NCT01849497|2161885|P1|Overall Study|Sponsor Decision|0
669221|NCT01849497|2161884|P2|Overall Study|Withdrawal by Subject|2
669222|NCT01849497|2161885|P1|Overall Study|Withdrawal by Subject|1
669223|NCT01849458|2161893|P1|Overall Study|Lost to Follow-up|4
669224|NCT01849289|2161932|P2|Overall Study|Unclassified|18
669225|NCT01849289|2161933|P1|Overall Study|Unclassified|25
669226|NCT01849289|2161932|P2|Overall Study|Withdrawal criteria|0
669227|NCT01849289|2161933|P1|Overall Study|Withdrawal criteria|1
669228|NCT01849289|2161932|P2|Overall Study|Protocol Violation|3
669229|NCT01849289|2161933|P1|Overall Study|Protocol Violation|3
669230|NCT01849289|2161932|P2|Overall Study|Adverse Event|3
669231|NCT01849289|2161933|P1|Overall Study|Adverse Event|3
669232|NCT01848990|2161967|P3|Overall Study|Death|0
669233|NCT01848990|2161968|P2|Overall Study|Death|0
669234|NCT01848990|2161969|P1|Overall Study|Death|1
669235|NCT01848990|2161967|P3|Overall Study|Non Compliance|0
669236|NCT01848990|2161968|P2|Overall Study|Non Compliance|0
669237|NCT01848990|2161969|P1|Overall Study|Non Compliance|1
669238|NCT01848990|2161967|P3|Overall Study|Physician Decision|0
669239|NCT01848990|2161968|P2|Overall Study|Physician Decision|0
669240|NCT01848990|2161969|P1|Overall Study|Physician Decision|1
669241|NCT01848990|2161967|P3|Overall Study|Withdrawal by Subject|9
669242|NCT01848990|2161968|P2|Overall Study|Withdrawal by Subject|6
669243|NCT01848990|2161969|P1|Overall Study|Withdrawal by Subject|20
669244|NCT01848990|2161967|P3|Overall Study|Protocol Violation|0
669245|NCT01848990|2161968|P2|Overall Study|Protocol Violation|1
669246|NCT01848990|2161969|P1|Overall Study|Protocol Violation|0
669247|NCT01848990|2161967|P3|Overall Study|Lost to Follow-up|2
669248|NCT01848990|2161968|P2|Overall Study|Lost to Follow-up|1
669249|NCT01848990|2161969|P1|Overall Study|Lost to Follow-up|6
669250|NCT01848990|2161967|P3|Overall Study|Adverse Event|0
669251|NCT01848990|2161968|P2|Overall Study|Adverse Event|1
669252|NCT01848990|2161969|P1|Overall Study|Adverse Event|4
669253|NCT01848938|2161995|P2|Overall Study|Lost to Follow-up|1
669254|NCT01848938|2161996|P1|Overall Study|Lost to Follow-up|1
669255|NCT01848834|2162045|P5|Overall Study|Not Treated|0
669256|NCT01848834|2162046|P4|Overall Study|Not Treated|0
669257|NCT01848834|2162047|P3|Overall Study|Not Treated|0
669258|NCT01848834|2162048|P2|Overall Study|Not Treated|1
669259|NCT01848834|2162049|P1|Overall Study|Not Treated|0
669260|NCT01848834|2162045|P5|Overall Study|Withdrawal by Subject|7
669261|NCT01848834|2162046|P4|Overall Study|Withdrawal by Subject|0
669262|NCT01848834|2162047|P3|Overall Study|Withdrawal by Subject|3
669263|NCT01848834|2162048|P2|Overall Study|Withdrawal by Subject|2
669264|NCT01848834|2162049|P1|Overall Study|Withdrawal by Subject|0
669265|NCT01848834|2162045|P5|Overall Study|Protocol Violation|2
669266|NCT01848834|2162046|P4|Overall Study|Protocol Violation|0
669267|NCT01848834|2162047|P3|Overall Study|Protocol Violation|1
669268|NCT01848834|2162048|P2|Overall Study|Protocol Violation|0
669269|NCT01848834|2162049|P1|Overall Study|Protocol Violation|0
669270|NCT01848834|2162045|P5|Overall Study|Progressive Disease|78
669271|NCT01848834|2162046|P4|Overall Study|Progressive Disease|36
669272|NCT01848834|2162047|P3|Overall Study|Progressive Disease|21
669273|NCT01848834|2162048|P2|Overall Study|Progressive Disease|41
669274|NCT01848834|2162049|P1|Overall Study|Progressive Disease|27
669275|NCT01848834|2162045|P5|Overall Study|Death|3
669276|NCT01848834|2162046|P4|Overall Study|Death|0
669277|NCT01848834|2162047|P3|Overall Study|Death|0
669278|NCT01848834|2162048|P2|Overall Study|Death|1
669279|NCT01848834|2162049|P1|Overall Study|Death|0
669280|NCT01848834|2162045|P5|Overall Study|Complete Response|0
669281|NCT01848834|2162046|P4|Overall Study|Complete Response|0
669282|NCT01848834|2162047|P3|Overall Study|Complete Response|0
669283|NCT01848834|2162048|P2|Overall Study|Complete Response|1
669284|NCT01848834|2162049|P1|Overall Study|Complete Response|0
669285|NCT01848834|2162045|P5|Overall Study|Adverse Event|15
669286|NCT01848834|2162046|P4|Overall Study|Adverse Event|1
669287|NCT01848834|2162047|P3|Overall Study|Adverse Event|6
669288|NCT01848834|2162048|P2|Overall Study|Adverse Event|8
669289|NCT01848834|2162049|P1|Overall Study|Adverse Event|3
669290|NCT01848834|2162045|P5|Overall Study|Physician Decision|1
669291|NCT01848834|2162046|P4|Overall Study|Physician Decision|0
669292|NCT01848834|2162047|P3|Overall Study|Physician Decision|0
669293|NCT01848834|2162048|P2|Overall Study|Physician Decision|0
669294|NCT01848834|2162049|P1|Overall Study|Physician Decision|0
669295|NCT01848834|2162045|P5|Overall Study|Ongoing in Study|26
669296|NCT01848834|2162046|P4|Overall Study|Ongoing in Study|0
669297|NCT01848834|2162047|P3|Overall Study|Ongoing in Study|1
669298|NCT01848834|2162048|P2|Overall Study|Ongoing in Study|6
669299|NCT01848834|2162049|P1|Overall Study|Ongoing in Study|0
669300|NCT01848756|2162084|P1|Overall Study|Enrolled in Error|1
669301|NCT01848756|2162084|P1|Overall Study|Withdrawal by Subject|1
669302|NCT01848756|2162084|P1|Overall Study|Adverse Event|1
669303|NCT01848288|2162098|P1|Overall Study|Withdrawal by Subject|1
669304|NCT01848288|2162098|P1|Overall Study|Protocol Violation|1
669305|NCT01848288|2162098|P1|Overall Study|Death|1
669306|NCT01848210|2162109|P2|Overall Study|Administrative|0
669307|NCT01848210|2162110|P1|Overall Study|Administrative|1
669308|NCT01848210|2162109|P2|Overall Study|Chronic Venous Insufficiency Course|2
669309|NCT01848210|2162110|P1|Overall Study|Chronic Venous Insufficiency Course|1
669310|NCT01848210|2162109|P2|Overall Study|Hepatic Function Alteration|0
669311|NCT01848210|2162110|P1|Overall Study|Hepatic Function Alteration|4
669312|NCT01848210|2162109|P2|Overall Study|Hypesensitivity|0
669313|NCT01848210|2162110|P1|Overall Study|Hypesensitivity|1
669314|NCT01848210|2162109|P2|Overall Study|Discontinuation Criterion|7
669315|NCT01848210|2162110|P1|Overall Study|Discontinuation Criterion|5
669316|NCT01848210|2162109|P2|Overall Study|Adverse Event|9
669317|NCT01848210|2162110|P1|Overall Study|Adverse Event|7
669318|NCT01848210|2162109|P2|Overall Study|Impedition Condition|9
669319|NCT01848210|2162110|P1|Overall Study|Impedition Condition|5
669320|NCT01848210|2162109|P2|Overall Study|Use of Forbidden Drugs|10
669321|NCT01848210|2162110|P1|Overall Study|Use of Forbidden Drugs|9
669322|NCT01848210|2162109|P2|Overall Study|Protocol Violation|5
669323|NCT01848210|2162110|P1|Overall Study|Protocol Violation|3
669324|NCT01848210|2162109|P2|Overall Study|Lost to Follow-up|12
669325|NCT01848210|2162110|P1|Overall Study|Lost to Follow-up|24
669326|NCT01848210|2162109|P2|Overall Study|Informed Consent Form Withdrawal|24
669327|NCT01848210|2162110|P1|Overall Study|Informed Consent Form Withdrawal|28
669328|NCT01848145|2162122|P1|Subsequent Infusions: Weeks 3-8|Death|1
669329|NCT01848145|2162122|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
669330|NCT01848145|2162122|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
669331|NCT01848145|2162122|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
669332|NCT01848145|2162122|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
669333|NCT01848145|2162122|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
669334|NCT01848145|2162122|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
669335|NCT01847443|2162199|P4|Washout Period Before Study Period 4|Positive alcohol test|0
669336|NCT01847443|2162200|P3|Washout Period Before Study Period 4|Positive alcohol test|0
669337|NCT01847443|2162201|P2|Washout Period Before Study Period 4|Positive alcohol test|0
669338|NCT01847443|2162202|P1|Washout Period Before Study Period 4|Positive alcohol test|1
669339|NCT01847443|2162199|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
669340|NCT01847443|2162200|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
669341|NCT01847443|2162201|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
669342|NCT01847443|2162202|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
669343|NCT01847443|2162199|P4|Washout Period Before Study Period 3|Other reason|0
669344|NCT01847443|2162200|P3|Washout Period Before Study Period 3|Other reason|0
669345|NCT01847443|2162201|P2|Washout Period Before Study Period 3|Other reason|0
669346|NCT01847443|2162202|P1|Washout Period Before Study Period 3|Other reason|1
669347|NCT01847443|2162199|P4|Washout Period Before Study Period 2|Other reason|0
669348|NCT01847443|2162200|P3|Washout Period Before Study Period 2|Other reason|0
669349|NCT01847443|2162201|P2|Washout Period Before Study Period 2|Other reason|0
669350|NCT01847443|2162202|P1|Washout Period Before Study Period 2|Other reason|1
669351|NCT01847443|2162199|P4|Washout Period Before Study Period 2|Adverse Event|0
669352|NCT01847443|2162200|P3|Washout Period Before Study Period 2|Adverse Event|0
669353|NCT01847443|2162201|P2|Washout Period Before Study Period 2|Adverse Event|1
669354|NCT01847443|2162202|P1|Washout Period Before Study Period 2|Adverse Event|1
669355|NCT01847443|2162199|P4|Study Period 1|Withdrawal by Subject|0
669356|NCT01847443|2162200|P3|Study Period 1|Withdrawal by Subject|0
669357|NCT01847443|2162201|P2|Study Period 1|Withdrawal by Subject|1
669358|NCT01847443|2162202|P1|Study Period 1|Withdrawal by Subject|0
669359|NCT01846741|2162259|P1|Baseline Visit|Subject did not meet entry criteria|2
669360|NCT01846442|2162385|P4|Overall Study|Left the city/Lost medication|1
669361|NCT01846442|2162386|P3|Overall Study|Left the city/Lost medication|1
669362|NCT01846442|2162387|P2|Overall Study|Left the city/Lost medication|0
669363|NCT01846442|2162388|P1|Overall Study|Left the city/Lost medication|1
669364|NCT01846442|2162385|P4|Overall Study|Withdrawal by Subject|1
669365|NCT01846442|2162386|P3|Overall Study|Withdrawal by Subject|0
669366|NCT01846442|2162387|P2|Overall Study|Withdrawal by Subject|2
669367|NCT01846442|2162388|P1|Overall Study|Withdrawal by Subject|3
669368|NCT01846442|2162385|P4|Overall Study|Lost to Follow-up|0
669369|NCT01846442|2162386|P3|Overall Study|Lost to Follow-up|1
669370|NCT01846442|2162387|P2|Overall Study|Lost to Follow-up|0
669371|NCT01846442|2162388|P1|Overall Study|Lost to Follow-up|0
669372|NCT01846442|2162385|P4|Overall Study|Adverse Event|1
669373|NCT01846442|2162386|P3|Overall Study|Adverse Event|2
669374|NCT01846442|2162387|P2|Overall Study|Adverse Event|4
669375|NCT01846442|2162388|P1|Overall Study|Adverse Event|2
669376|NCT01846416|2162429|P3|Overall Study|Lost to Follow-up|1
669377|NCT01846416|2162430|P2|Overall Study|Lost to Follow-up|2
669378|NCT01846416|2162431|P1|Overall Study|Lost to Follow-up|0
669379|NCT01846416|2162429|P3|Overall Study|Ongoing as of 7 January 2015|3
669380|NCT01846416|2162430|P2|Overall Study|Ongoing as of 7 January 2015|41
669381|NCT01846416|2162431|P1|Overall Study|Ongoing as of 7 January 2015|21
669382|NCT01846416|2162429|P3|Overall Study|Unspecified|0
669383|NCT01846416|2162430|P2|Overall Study|Unspecified|0
669384|NCT01846416|2162431|P1|Overall Study|Unspecified|1
669385|NCT01846416|2162429|P3|Overall Study|Withdrawal by Subject|0
669386|NCT01846416|2162430|P2|Overall Study|Withdrawal by Subject|7
669387|NCT01846416|2162431|P1|Overall Study|Withdrawal by Subject|1
669388|NCT01846416|2162429|P3|Overall Study|Death|9
669389|NCT01846416|2162430|P2|Overall Study|Death|43
669390|NCT01846416|2162431|P1|Overall Study|Death|8
669391|NCT01846299|2162476|P2|Overall Study|Adverse Event|0
669392|NCT01846299|2162477|P1|Overall Study|Adverse Event|2
669393|NCT01846299|2162476|P2|Overall Study|Withdrawal by Subject|6
669394|NCT01846299|2162477|P1|Overall Study|Withdrawal by Subject|1
669395|NCT01846299|2162476|P2|Overall Study|Lost to Follow-up|0
669396|NCT01846299|2162477|P1|Overall Study|Lost to Follow-up|3
669397|NCT01846299|2162476|P2|Overall Study|Death|2
669398|NCT01846299|2162477|P1|Overall Study|Death|1
669399|NCT01846299|2162476|P2|Overall Study|Protocol deviation|0
669400|NCT01846299|2162477|P1|Overall Study|Protocol deviation|1
669401|NCT01846299|2162476|P2|Overall Study|Physician Decision|2
669402|NCT01846299|2162477|P1|Overall Study|Physician Decision|4
669403|NCT01846104|2162513|P1|Overall Study|Withdrawal by Subject|1
669404|NCT01846039|2162519|P1|Overall Study|Subject Withdrew Consent|1
669405|NCT01846039|2162519|P1|Overall Study|Protocol Violation|1
669406|NCT01845831|2162531|P5|Inpatient Phase|Withdrawal by Subject|0
669407|NCT01845831|2162532|P4|Inpatient Phase|Withdrawal by Subject|0
669408|NCT01845831|2162533|P3|Inpatient Phase|Withdrawal by Subject|0
669409|NCT01845831|2162534|P2|Inpatient Phase|Withdrawal by Subject|1
669410|NCT01845831|2162535|P1|Inpatient Phase|Withdrawal by Subject|1
669411|NCT01845077|2162588|P6|Washout Period|Protocol Violation|0
669412|NCT01845077|2162589|P5|Washout Period|Protocol Violation|1
669413|NCT01845077|2162590|P4|Washout Period|Protocol Violation|1
669414|NCT01845077|2162591|P3|Washout Period|Protocol Violation|0
669415|NCT01845077|2162592|P2|Washout Period|Protocol Violation|0
669416|NCT01845077|2162593|P1|Washout Period|Protocol Violation|0
669417|NCT01845077|2162588|P6|Washout Period|elevated lab values (not clinic. sign.)|0
669418|NCT01845077|2162589|P5|Washout Period|elevated lab values (not clinic. sign.)|0
669419|NCT01845077|2162590|P4|Washout Period|elevated lab values (not clinic. sign.)|0
669420|NCT01845077|2162591|P3|Washout Period|elevated lab values (not clinic. sign.)|1
669421|NCT01845077|2162592|P2|Washout Period|elevated lab values (not clinic. sign.)|0
669422|NCT01845077|2162593|P1|Washout Period|elevated lab values (not clinic. sign.)|0
669423|NCT01845077|2162588|P6|Washout Period|Adverse Event|0
669424|NCT01845077|2162589|P5|Washout Period|Adverse Event|0
669425|NCT01845077|2162590|P4|Washout Period|Adverse Event|0
669426|NCT01845077|2162591|P3|Washout Period|Adverse Event|0
669427|NCT01845077|2162592|P2|Washout Period|Adverse Event|0
669428|NCT01845077|2162593|P1|Washout Period|Adverse Event|1
669429|NCT01845077|2162588|P6|Washout Period|Lost to Follow-up|1
669430|NCT01845077|2162589|P5|Washout Period|Lost to Follow-up|0
669431|NCT01845077|2162590|P4|Washout Period|Lost to Follow-up|1
669432|NCT01845077|2162591|P3|Washout Period|Lost to Follow-up|0
669433|NCT01845077|2162592|P2|Washout Period|Lost to Follow-up|1
669434|NCT01845077|2162593|P1|Washout Period|Lost to Follow-up|0
669435|NCT01845025|2162639|P2|Overall Study|Missing|1
669436|NCT01845025|2162640|P1|Overall Study|Missing|1
669437|NCT01845025|2162639|P2|Overall Study|Protocol deviation|6
669438|NCT01845025|2162640|P1|Overall Study|Protocol deviation|3
669439|NCT01845025|2162639|P2|Overall Study|Death|0
669440|NCT01845025|2162640|P1|Overall Study|Death|2
669441|NCT01845025|2162639|P2|Overall Study|Administrative problems|8
669442|NCT01845025|2162640|P1|Overall Study|Administrative problems|8
669443|NCT01845025|2162639|P2|Overall Study|Lost to Follow-up|13
669444|NCT01845025|2162640|P1|Overall Study|Lost to Follow-up|13
669445|NCT01845025|2162639|P2|Overall Study|Withdrawal by Subject|44
669446|NCT01845025|2162640|P1|Overall Study|Withdrawal by Subject|48
669447|NCT01845025|2162639|P2|Overall Study|Unsatisfactory therapeutic effect|2
669448|NCT01845025|2162640|P1|Overall Study|Unsatisfactory therapeutic effect|4
669449|NCT01845025|2162639|P2|Overall Study|Adverse Event|3
669450|NCT01845025|2162640|P1|Overall Study|Adverse Event|6
669451|NCT01844895|2162662|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
669452|NCT01844895|2162662|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
669453|NCT01844895|2162662|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
669454|NCT01844895|2162662|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
669455|NCT01844895|2162662|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
669456|NCT01844895|2162662|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
669457|NCT01844895|2162662|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
669458|NCT01844856|2162680|P2|Overall Study|Randomized but was a Screen Failure|1
669459|NCT01844856|2162681|P1|Overall Study|Randomized but was a Screen Failure|0
669460|NCT01844856|2162680|P2|Overall Study|Inadvertently Not Scheduled|0
669461|NCT01844856|2162681|P1|Overall Study|Inadvertently Not Scheduled|1
669462|NCT01844856|2162680|P2|Overall Study|Enterococcus Resistant|1
669463|NCT01844856|2162681|P1|Overall Study|Enterococcus Resistant|0
669464|NCT01844856|2162680|P2|Overall Study|Noncompliance|3
669465|NCT01844856|2162681|P1|Overall Study|Noncompliance|2
669466|NCT01844856|2162680|P2|Overall Study|Withdrawal by Subject|2
669467|NCT01844856|2162681|P1|Overall Study|Withdrawal by Subject|3
669468|NCT01844856|2162680|P2|Overall Study|Adverse Event|6
669469|NCT01844856|2162681|P1|Overall Study|Adverse Event|3
669470|NCT01844856|2162680|P2|Overall Study|Lost to Follow-up|3
669471|NCT01844856|2162681|P1|Overall Study|Lost to Follow-up|15
669472|NCT01844830|2162693|P2|Overall Study|Withdrawal by Subject|0
669473|NCT01844830|2162694|P1|Overall Study|Withdrawal by Subject|1
669474|NCT01844817|2162724|P2|Treatment|Other|3
669475|NCT01844817|2162725|P1|Treatment|Other|0
669476|NCT01844817|2162724|P2|Treatment|Lost to Follow-up|1
669477|NCT01844817|2162725|P1|Treatment|Lost to Follow-up|0
669478|NCT01844817|2162724|P2|Treatment|Death|8
669479|NCT01844817|2162725|P1|Treatment|Death|10
669480|NCT01844817|2162724|P2|Treatment|Withdrawal by Subject|6
669481|NCT01844817|2162725|P1|Treatment|Withdrawal by Subject|10
669482|NCT01844817|2162724|P2|Treatment|Adverse Event|9
669483|NCT01844817|2162725|P1|Treatment|Adverse Event|17
669484|NCT01844817|2162724|P2|Treatment|Progressive Disease|36
669485|NCT01844817|2162725|P1|Treatment|Progressive Disease|27
669486|NCT01844817|2162724|P2|Enrolled and Randomized|Withdrawal by Subject|3
669487|NCT01844817|2162725|P1|Enrolled and Randomized|Withdrawal by Subject|2
669488|NCT01844778|2162738|P3|Overall Study|Adverse Event|2
669489|NCT01844778|2162739|P2|Overall Study|Adverse Event|2
669490|NCT01844778|2162740|P1|Overall Study|Adverse Event|0
669491|NCT01844778|2162738|P3|Overall Study|Withdrawal by Subject|0
669492|NCT01844778|2162739|P2|Overall Study|Withdrawal by Subject|0
669493|NCT01844778|2162740|P1|Overall Study|Withdrawal by Subject|2
669494|NCT01844778|2162738|P3|Overall Study|Protocol deviation|2
669495|NCT01844778|2162739|P2|Overall Study|Protocol deviation|1
669496|NCT01844778|2162740|P1|Overall Study|Protocol deviation|0
669497|NCT01844700|2162766|P2|Overall Study|stopped taking meds|1
669498|NCT01844700|2162767|P1|Overall Study|stopped taking meds|0
669499|NCT01844700|2162766|P2|Overall Study|Withdrawal by Subject|0
669500|NCT01844700|2162767|P1|Overall Study|Withdrawal by Subject|1
669501|NCT01844700|2162766|P2|Overall Study|refused medication switch|0
669502|NCT01844700|2162767|P1|Overall Study|refused medication switch|1
669503|NCT01844700|2162766|P2|Overall Study|Lack of Efficacy|0
669504|NCT01844700|2162767|P1|Overall Study|Lack of Efficacy|1
669505|NCT01844687|2162779|P1|Visit 4|Withdrawal by Subject|2
669506|NCT01844687|2162779|P1|Visit 4|Lost to Follow-up|1
669507|NCT01844687|2162779|P1|Visit 4|Pregnancy|1
669508|NCT01844687|2162779|P1|Visit 3|child care problems|1
669509|NCT01844687|2162779|P1|Visit 3|Withdrawal by Subject|3
669510|NCT01844687|2162779|P1|Visit 3|Lost to Follow-up|1
669511|NCT01844687|2162779|P1|Visit 2|Protocol Violation|1
669512|NCT01844687|2162779|P1|Visit 2|Withdrawal by Subject|1
669513|NCT01844687|2162779|P1|Visit 1|Lost to Follow-up|5
669514|NCT01844687|2162779|P1|Visit 1|Protocol Violation|3
669515|NCT01844531|2162842|P4|Overall Study|Withdrawal by Subject|0
669516|NCT01844531|2162843|P3|Overall Study|Withdrawal by Subject|0
669517|NCT01844531|2162844|P2|Overall Study|Withdrawal by Subject|1
669518|NCT01844531|2162845|P1|Overall Study|Withdrawal by Subject|0
888650|NCT01791517|2822624|P2|Phase II|Lost to Follow-up|0
888651|NCT01791517|2822625|P1|Phase II|Lost to Follow-up|1
888652|NCT01791517|2822614|P12|Phase I: Period 3|Adverse Event|0
888653|NCT01791517|2822615|P11|Phase I: Period 3|Adverse Event|0
888654|NCT01791517|2822616|P10|Phase I: Period 3|Adverse Event|0
888655|NCT01791517|2822617|P9|Phase I: Period 3|Adverse Event|0
888656|NCT01791517|2822618|P8|Phase I: Period 3|Adverse Event|0
888657|NCT01791517|2822619|P7|Phase I: Period 3|Adverse Event|0
888658|NCT01791517|2822620|P6|Phase I: Period 3|Adverse Event|0
888659|NCT01791517|2822621|P5|Phase I: Period 3|Adverse Event|0
888660|NCT01791517|2822622|P4|Phase I: Period 3|Adverse Event|1
888661|NCT01791517|2822623|P3|Phase I: Period 3|Adverse Event|0
888662|NCT01791517|2822624|P2|Phase I: Period 3|Adverse Event|0
888663|NCT01791517|2822625|P1|Phase I: Period 3|Adverse Event|0
888664|NCT01791517|2822614|P12|Phase I: Period 3|Lost to Follow-up|0
888665|NCT01791517|2822615|P11|Phase I: Period 3|Lost to Follow-up|0
888666|NCT01791517|2822616|P10|Phase I: Period 3|Lost to Follow-up|0
888667|NCT01791517|2822617|P9|Phase I: Period 3|Lost to Follow-up|0
888668|NCT01791517|2822618|P8|Phase I: Period 3|Lost to Follow-up|0
888669|NCT01791517|2822619|P7|Phase I: Period 3|Lost to Follow-up|0
888670|NCT01791517|2822620|P6|Phase I: Period 3|Lost to Follow-up|0
888671|NCT01791517|2822621|P5|Phase I: Period 3|Lost to Follow-up|1
888672|NCT01791517|2822622|P4|Phase I: Period 3|Lost to Follow-up|0
888673|NCT01791517|2822623|P3|Phase I: Period 3|Lost to Follow-up|0
888674|NCT01791517|2822624|P2|Phase I: Period 3|Lost to Follow-up|1
888675|NCT01791517|2822625|P1|Phase I: Period 3|Lost to Follow-up|0
888676|NCT01791517|2822614|P12|Phase I: Period 3|Lens Discomfort|1
888677|NCT01791517|2822615|P11|Phase I: Period 3|Lens Discomfort|0
888678|NCT01791517|2822616|P10|Phase I: Period 3|Lens Discomfort|0
888679|NCT01791517|2822617|P9|Phase I: Period 3|Lens Discomfort|0
888680|NCT01791517|2822618|P8|Phase I: Period 3|Lens Discomfort|0
888681|NCT01791517|2822619|P7|Phase I: Period 3|Lens Discomfort|0
888682|NCT01791517|2822620|P6|Phase I: Period 3|Lens Discomfort|0
888683|NCT01791517|2822621|P5|Phase I: Period 3|Lens Discomfort|0
888684|NCT01791517|2822622|P4|Phase I: Period 3|Lens Discomfort|0
888685|NCT01791517|2822623|P3|Phase I: Period 3|Lens Discomfort|0
888686|NCT01791517|2822624|P2|Phase I: Period 3|Lens Discomfort|0
888687|NCT01791517|2822625|P1|Phase I: Period 3|Lens Discomfort|0
888688|NCT01791517|2822614|P12|Phase I: Period 2|Lost to Follow-up|0
888689|NCT01791517|2822615|P11|Phase I: Period 2|Lost to Follow-up|0
888690|NCT01791517|2822616|P10|Phase I: Period 2|Lost to Follow-up|0
888691|NCT01791517|2822617|P9|Phase I: Period 2|Lost to Follow-up|0
888692|NCT01791517|2822618|P8|Phase I: Period 2|Lost to Follow-up|0
888693|NCT01791517|2822619|P7|Phase I: Period 2|Lost to Follow-up|0
669563|NCT01843972|2163005|P10|Overall Study|Withdrawal by Subject|0
669564|NCT01843972|2163006|P9|Overall Study|Withdrawal by Subject|0
669565|NCT01843972|2163007|P8|Overall Study|Withdrawal by Subject|0
669566|NCT01843972|2163008|P7|Overall Study|Withdrawal by Subject|0
669567|NCT01843972|2163009|P6|Overall Study|Withdrawal by Subject|0
669568|NCT01843972|2163010|P5|Overall Study|Withdrawal by Subject|1
669569|NCT01843972|2163011|P4|Overall Study|Withdrawal by Subject|0
669570|NCT01843972|2163012|P3|Overall Study|Withdrawal by Subject|0
669571|NCT01843972|2163013|P2|Overall Study|Withdrawal by Subject|0
669572|NCT01843972|2163014|P1|Overall Study|Withdrawal by Subject|0
669573|NCT01843933|2163084|P2|Overall Study|Data lost|4
669574|NCT01843933|2163085|P1|Overall Study|Data lost|6
669575|NCT01843777|2163102|P2|Overall Study|Withdrawal by Subject|0
669576|NCT01843777|2163103|P1|Overall Study|Withdrawal by Subject|1
669577|NCT01843673|2163111|P1|Overall Study|Withdrawal by Subject|4
669578|NCT01843673|2163111|P1|Overall Study|Lack of Efficacy|2
669579|NCT01843660|2163123|P1|Overall Study|Unspecified|30
669584|NCT01843348|2163175|P3|Overall Study|Various reasons|6
669585|NCT01843348|2163176|P2|Overall Study|Various reasons|9
669586|NCT01843348|2163177|P1|Overall Study|Various reasons|4
669587|NCT01843348|2163175|P3|Overall Study|Graft loss/retransplantation|11
669588|NCT01843348|2163176|P2|Overall Study|Graft loss/retransplantation|8
669589|NCT01843348|2163177|P1|Overall Study|Graft loss/retransplantation|5
669590|NCT01843348|2163175|P3|Overall Study|Death|4
669591|NCT01843348|2163176|P2|Overall Study|Death|3
669592|NCT01843348|2163177|P1|Overall Study|Death|5
669593|NCT01843348|2163175|P3|Overall Study|Lost to Follow-up|2
669594|NCT01843348|2163176|P2|Overall Study|Lost to Follow-up|4
669595|NCT01843348|2163177|P1|Overall Study|Lost to Follow-up|5
669596|NCT01843348|2163175|P3|Overall Study|Withdrawal by Subject|18
669597|NCT01843348|2163176|P2|Overall Study|Withdrawal by Subject|16
669598|NCT01843348|2163177|P1|Overall Study|Withdrawal by Subject|4
669599|NCT01843192|2163220|P3|Overall Study|Intra-operative exclusions per protocol|2
888694|NCT01791517|2822620|P6|Phase I: Period 2|Lost to Follow-up|0
669600|NCT01843192|2163221|P2|Overall Study|Intra-operative exclusions per protocol|6
669601|NCT01843192|2163222|P1|Overall Study|Intra-operative exclusions per protocol|2
669602|NCT01842633|2163306|P3|Overall Study|Technical issues|0
669603|NCT01842633|2163307|P2|Overall Study|Technical issues|0
669604|NCT01842633|2163308|P1|Overall Study|Technical issues|1
669605|NCT01842633|2163306|P3|Overall Study|Withdrawal by Subject|0
669606|NCT01842633|2163307|P2|Overall Study|Withdrawal by Subject|1
669607|NCT01842633|2163308|P1|Overall Study|Withdrawal by Subject|0
669608|NCT01842633|2163306|P3|Overall Study|Adverse Event|0
669609|NCT01842633|2163307|P2|Overall Study|Adverse Event|1
669610|NCT01842633|2163308|P1|Overall Study|Adverse Event|1
669611|NCT01842633|2163306|P3|Overall Study|Screen Failure|0
669612|NCT01842633|2163307|P2|Overall Study|Screen Failure|0
669613|NCT01842633|2163308|P1|Overall Study|Screen Failure|1
669614|NCT01842607|2163355|P1|Overall Study|Withdrawal by Subject|14
669615|NCT01842607|2163355|P1|Overall Study|Physician Decision|9
669616|NCT01842607|2163355|P1|Overall Study|Lost to Follow-up|3
669617|NCT01842607|2163355|P1|Overall Study|Protocol defined stopping criteria|2
669618|NCT01842607|2163355|P1|Overall Study|Protocol Violation|8
669619|NCT01842607|2163355|P1|Overall Study|Lack of Efficacy|19
669620|NCT01842607|2163355|P1|Overall Study|Adverse Event|11
669621|NCT01842438|2163387|P2|T2: 6month Follow-up|Death|1
669622|NCT01842438|2163388|P1|T2: 6month Follow-up|Death|0
669623|NCT01842438|2163387|P2|T2: 6month Follow-up|Withdrawal by Subject|3
669624|NCT01842438|2163388|P1|T2: 6month Follow-up|Withdrawal by Subject|4
669625|NCT01842438|2163387|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
669626|NCT01842438|2163388|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
669627|NCT01841970|2163400|P1|Overall Study|Lost to Follow-up|8
669628|NCT01841970|2163400|P1|Overall Study|Physician Decision|2
669629|NCT01841970|2163400|P1|Overall Study|Withdrawal by Subject|1
669630|NCT01841697|2163418|P2|Overall Study|Withdrawal by Subject|16
669631|NCT01841697|2163419|P1|Overall Study|Withdrawal by Subject|16
669632|NCT01841697|2163418|P2|Overall Study|Lost to Follow-up|1
669633|NCT01841697|2163419|P1|Overall Study|Lost to Follow-up|4
669634|NCT01841697|2163418|P2|Overall Study|Death|1
669635|NCT01841697|2163419|P1|Overall Study|Death|0
669636|NCT01841593|2163445|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
669637|NCT01841593|2163446|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
669638|NCT01841593|2163445|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
669639|NCT01841593|2163446|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
669640|NCT01841567|2163462|P1|Overall Study|Adverse Event|3
669641|NCT01840943|2163490|P2|Overall Study|Lost to Follow-up|4
669642|NCT01840943|2163491|P1|Overall Study|Lost to Follow-up|4
669643|NCT01840943|2163490|P2|Overall Study|Physician Decision|2
669644|NCT01840943|2163491|P1|Overall Study|Physician Decision|4
669645|NCT01840943|2163490|P2|Overall Study|Withdrawal by Subject|6
669646|NCT01840943|2163491|P1|Overall Study|Withdrawal by Subject|5
669647|NCT01840605|2163527|P2|Overall Study|Physician Decision|1
669648|NCT01840605|2163528|P1|Overall Study|Physician Decision|2
669649|NCT01840605|2163527|P2|Overall Study|Adverse Event|1
669650|NCT01840605|2163528|P1|Overall Study|Adverse Event|0
669651|NCT01840410|2163536|P2|Overall Study|Adverse Event|1
669652|NCT01840410|2163537|P1|Overall Study|Adverse Event|1
669653|NCT01840410|2163536|P2|Overall Study|Withdrawal by Subject|1
669654|NCT01840410|2163537|P1|Overall Study|Withdrawal by Subject|2
669655|NCT01840410|2163536|P2|Overall Study|Lost to Follow-up|0
669656|NCT01840410|2163537|P1|Overall Study|Lost to Follow-up|1
669657|NCT01840410|2163536|P2|Overall Study|Protocol deviation|0
669658|NCT01840410|2163537|P1|Overall Study|Protocol deviation|1
669659|NCT01840410|2163536|P2|Overall Study|Pregnancy|0
669660|NCT01840410|2163537|P1|Overall Study|Pregnancy|1
669661|NCT01840410|2163536|P2|Overall Study|Physician Decision|2
669662|NCT01840410|2163537|P1|Overall Study|Physician Decision|1
669663|NCT01839279|2163662|P3|Overall Study|Classified as 'Other'|0
669664|NCT01839279|2163663|P2|Overall Study|Classified as 'Other'|0
669665|NCT01839279|2163664|P1|Overall Study|Classified as 'Other'|5
669666|NCT01839279|2163662|P3|Overall Study|Withdrawal by Subject|1
669667|NCT01839279|2163663|P2|Overall Study|Withdrawal by Subject|1
669668|NCT01839279|2163664|P1|Overall Study|Withdrawal by Subject|4
669669|NCT01839279|2163662|P3|Overall Study|Adverse Event|1
669670|NCT01839279|2163663|P2|Overall Study|Adverse Event|1
669671|NCT01839279|2163664|P1|Overall Study|Adverse Event|4
669672|NCT01838941|2163696|P1|Overall Study|Withdrawal by Subject|1
669673|NCT01838941|2163696|P1|Overall Study|Adverse Event|1
669674|NCT01838694|2163708|P2|Overall Study|Adverse Event|1
669675|NCT01838694|2163709|P1|Overall Study|Adverse Event|0
669676|NCT01838681|2163718|P4|Period B/A+|Administrative or other reasons|28
669677|NCT01838681|2163719|P3|Period B/A+|Administrative or other reasons|10
669678|NCT01838681|2163720|P2|Period B/A+|Administrative or other reasons|6
669679|NCT01838681|2163721|P1|Period B/A+|Administrative or other reasons|0
669680|NCT01838681|2163718|P4|Period B/A+|Withdrawal before treatment|0
669681|NCT01838681|2163719|P3|Period B/A+|Withdrawal before treatment|0
669682|NCT01838681|2163720|P2|Period B/A+|Withdrawal before treatment|1
669683|NCT01838681|2163721|P1|Period B/A+|Withdrawal before treatment|0
669684|NCT01838681|2163718|P4|Period B/A+|Lost to Follow-up|11
669685|NCT01838681|2163719|P3|Period B/A+|Lost to Follow-up|5
669686|NCT01838681|2163720|P2|Period B/A+|Lost to Follow-up|2
669687|NCT01838681|2163721|P1|Period B/A+|Lost to Follow-up|0
669688|NCT01838681|2163718|P4|Period B/A+|Non-compliance with IMP|3
669689|NCT01838681|2163719|P3|Period B/A+|Non-compliance with IMP|3
669690|NCT01838681|2163720|P2|Period B/A+|Non-compliance with IMP|2
669691|NCT01838681|2163721|P1|Period B/A+|Non-compliance with IMP|0
669692|NCT01838681|2163718|P4|Period B/A+|Protocol Violation|6
669693|NCT01838681|2163719|P3|Period B/A+|Protocol Violation|4
669694|NCT01838681|2163720|P2|Period B/A+|Protocol Violation|1
669695|NCT01838681|2163721|P1|Period B/A+|Protocol Violation|0
669696|NCT01838681|2163718|P4|Period B/A+|Withdrawal by Subject|47
669697|NCT01838681|2163719|P3|Period B/A+|Withdrawal by Subject|35
669698|NCT01838681|2163720|P2|Period B/A+|Withdrawal by Subject|28
669699|NCT01838681|2163721|P1|Period B/A+|Withdrawal by Subject|0
669700|NCT01838681|2163718|P4|Period B/A+|Lack of Efficacy|6
669701|NCT01838681|2163719|P3|Period B/A+|Lack of Efficacy|11
669702|NCT01838681|2163720|P2|Period B/A+|Lack of Efficacy|9
669703|NCT01838681|2163721|P1|Period B/A+|Lack of Efficacy|0
669704|NCT01838681|2163718|P4|Period B/A+|Adverse Event|16
669705|NCT01838681|2163719|P3|Period B/A+|Adverse Event|27
669706|NCT01838681|2163720|P2|Period B/A+|Adverse Event|13
669707|NCT01838681|2163721|P1|Period B/A+|Adverse Event|0
669708|NCT01838681|2163718|P4|Period A|Administrative or other reasons|0
669709|NCT01838681|2163719|P3|Period A|Administrative or other reasons|0
669710|NCT01838681|2163720|P2|Period A|Administrative or other reasons|0
669711|NCT01838681|2163721|P1|Period A|Administrative or other reasons|17
669712|NCT01838681|2163718|P4|Period A|Withdrawal before treatment|0
669713|NCT01838681|2163719|P3|Period A|Withdrawal before treatment|0
669714|NCT01838681|2163720|P2|Period A|Withdrawal before treatment|0
669715|NCT01838681|2163721|P1|Period A|Withdrawal before treatment|4
669716|NCT01838681|2163718|P4|Period A|Lost to Follow-up|0
669717|NCT01838681|2163719|P3|Period A|Lost to Follow-up|0
669718|NCT01838681|2163720|P2|Period A|Lost to Follow-up|0
669719|NCT01838681|2163721|P1|Period A|Lost to Follow-up|4
669720|NCT01838681|2163718|P4|Period A|Non-compliance with IMP|0
669721|NCT01838681|2163719|P3|Period A|Non-compliance with IMP|0
669722|NCT01838681|2163720|P2|Period A|Non-compliance with IMP|0
669723|NCT01838681|2163721|P1|Period A|Non-compliance with IMP|6
669724|NCT01838681|2163718|P4|Period A|Protocol Violation|0
669725|NCT01838681|2163719|P3|Period A|Protocol Violation|0
669726|NCT01838681|2163720|P2|Period A|Protocol Violation|0
669727|NCT01838681|2163721|P1|Period A|Protocol Violation|16
669728|NCT01838681|2163718|P4|Period A|Withdrawal by Subject|0
669729|NCT01838681|2163719|P3|Period A|Withdrawal by Subject|0
669730|NCT01838681|2163720|P2|Period A|Withdrawal by Subject|0
669731|NCT01838681|2163721|P1|Period A|Withdrawal by Subject|70
669732|NCT01838681|2163718|P4|Period A|Early response|0
669733|NCT01838681|2163719|P3|Period A|Early response|0
669734|NCT01838681|2163720|P2|Period A|Early response|0
669735|NCT01838681|2163721|P1|Period A|Early response|148
669736|NCT01838681|2163718|P4|Period A|Lack of Efficacy|0
669737|NCT01838681|2163719|P3|Period A|Lack of Efficacy|0
669738|NCT01838681|2163720|P2|Period A|Lack of Efficacy|0
669739|NCT01838681|2163721|P1|Period A|Lack of Efficacy|21
669740|NCT01838681|2163718|P4|Period A|Adverse Event|0
669741|NCT01838681|2163719|P3|Period A|Adverse Event|0
669742|NCT01838681|2163720|P2|Period A|Adverse Event|0
669743|NCT01838681|2163721|P1|Period A|Adverse Event|39
669744|NCT01838642|2163761|P1|Overall Study|Died on study|1
669745|NCT01838616|2163774|P2|Pick-up Arm|Technical problems|0
669746|NCT01838616|2163775|P1|Pick-up Arm|Technical problems|1
669747|NCT01838616|2163774|P2|Pick-up Arm|Withdrawal by Subject|0
669748|NCT01838616|2163775|P1|Pick-up Arm|Withdrawal by Subject|1
669749|NCT01838616|2163774|P2|Pick-up Arm|Adverse Event|0
669750|NCT01838616|2163775|P1|Pick-up Arm|Adverse Event|9
669751|NCT01838616|2163774|P2|Pick-up Arm|Lack of Efficacy|0
669752|NCT01838616|2163775|P1|Pick-up Arm|Lack of Efficacy|4
669753|NCT01838616|2163774|P2|Continuation Period|Technical problems|1
669754|NCT01838616|2163775|P1|Continuation Period|Technical problems|0
669755|NCT01838616|2163774|P2|Continuation Period|Withdrawal by Subject|4
669756|NCT01838616|2163775|P1|Continuation Period|Withdrawal by Subject|0
669757|NCT01838616|2163774|P2|Continuation Period|Lost to Follow-up|0
669758|NCT01838616|2163775|P1|Continuation Period|Lost to Follow-up|1
669759|NCT01838616|2163774|P2|Continuation Period|Protocol Violation|0
669760|NCT01838616|2163775|P1|Continuation Period|Protocol Violation|2
669761|NCT01838616|2163774|P2|Continuation Period|Adverse Event|4
669762|NCT01838616|2163775|P1|Continuation Period|Adverse Event|8
669763|NCT01838616|2163774|P2|Continuation Period|Lack of Efficacy|5
669764|NCT01838616|2163775|P1|Continuation Period|Lack of Efficacy|3
669765|NCT01838616|2163774|P2|Titration Period|Protocol Violation|1
669766|NCT01838616|2163775|P1|Titration Period|Protocol Violation|0
669767|NCT01838616|2163774|P2|Titration Period|Not specified|0
669768|NCT01838616|2163775|P1|Titration Period|Not specified|1
669769|NCT01838616|2163774|P2|Titration Period|Technical problems|0
669770|NCT01838616|2163775|P1|Titration Period|Technical problems|1
669771|NCT01838616|2163774|P2|Titration Period|Withdrawal by Subject|5
669772|NCT01838616|2163775|P1|Titration Period|Withdrawal by Subject|5
669773|NCT01838616|2163774|P2|Titration Period|Lack of Efficacy|12
669774|NCT01838616|2163775|P1|Titration Period|Lack of Efficacy|5
669775|NCT01838616|2163774|P2|Titration Period|Adverse Event|48
669776|NCT01838616|2163775|P1|Titration Period|Adverse Event|18
669777|NCT01838590|2163846|P2|Overall Study|Lost to Follow-up|1
669778|NCT01838590|2163847|P1|Overall Study|Lost to Follow-up|0
669779|NCT01838590|2163846|P2|Overall Study|Lack of Efficacy|4
669780|NCT01838590|2163847|P1|Overall Study|Lack of Efficacy|12
669781|NCT01838499|2163871|P2|Overall Study|Withdrawal by Subject|9
669782|NCT01838499|2163872|P1|Overall Study|Withdrawal by Subject|19
669783|NCT01838499|2163871|P2|Overall Study|Adverse Event|1
669784|NCT01838499|2163872|P1|Overall Study|Adverse Event|2
669785|NCT01838499|2163871|P2|Overall Study|Lack of Efficacy|2
669786|NCT01838499|2163872|P1|Overall Study|Lack of Efficacy|1
669787|NCT01838499|2163871|P2|Overall Study|Lost to Follow-up|4
669788|NCT01838499|2163872|P1|Overall Study|Lost to Follow-up|2
669789|NCT01838499|2163871|P2|Overall Study|Protocol Violation|1
669790|NCT01838499|2163872|P1|Overall Study|Protocol Violation|0
669791|NCT01838213|2163884|P2|Overall Study|Ineligible|191
669792|NCT01838213|2163885|P1|Overall Study|Ineligible|166
669793|NCT01838044|2163893|P2|Overall Study|Lost to Follow-up|2
669794|NCT01838044|2163894|P1|Overall Study|Lost to Follow-up|0
669795|NCT01838044|2163893|P2|Overall Study|Medication error without associated AE|1
669796|NCT01838044|2163894|P1|Overall Study|Medication error without associated AE|0
669797|NCT01838044|2163893|P2|Overall Study|Insufficient clinical response|2
669798|NCT01838044|2163894|P1|Overall Study|Insufficient clinical response|1
669799|NCT01838044|2163893|P2|Overall Study|Withdrawal by Subject|2
669800|NCT01838044|2163894|P1|Overall Study|Withdrawal by Subject|0
669801|NCT01838044|2163893|P2|Overall Study|Protocol Violation|3
669802|NCT01838044|2163894|P1|Overall Study|Protocol Violation|3
669803|NCT01838044|2163893|P2|Overall Study|Adverse Event|6
669804|NCT01838044|2163894|P1|Overall Study|Adverse Event|4
669805|NCT01837966|2163927|P2|Overall Study|Withdrawal by Subject|1
669806|NCT01837966|2163928|P1|Overall Study|Withdrawal by Subject|2
669807|NCT01837797|2163937|P5|Period 3|Other|2
669808|NCT01837797|2163938|P4|Period 3|Other|0
669809|NCT01837797|2163939|P3|Period 3|Other|0
669810|NCT01837797|2163940|P2|Period 3|Other|0
669811|NCT01837797|2163941|P1|Period 3|Other|0
669812|NCT01837797|2163937|P5|Period 3|Administrative reasons|20
669813|NCT01837797|2163938|P4|Period 3|Administrative reasons|0
669814|NCT01837797|2163939|P3|Period 3|Administrative reasons|0
669815|NCT01837797|2163940|P2|Period 3|Administrative reasons|0
669816|NCT01837797|2163941|P1|Period 3|Administrative reasons|0
669817|NCT01837797|2163937|P5|Period 3|Adverse Event|1
669818|NCT01837797|2163938|P4|Period 3|Adverse Event|0
669819|NCT01837797|2163939|P3|Period 3|Adverse Event|0
669820|NCT01837797|2163940|P2|Period 3|Adverse Event|0
669821|NCT01837797|2163941|P1|Period 3|Adverse Event|0
669822|NCT01837797|2163937|P5|Period 2|Adverse Event|0
669823|NCT01837797|2163938|P4|Period 2|Adverse Event|1
669824|NCT01837797|2163939|P3|Period 2|Adverse Event|0
669825|NCT01837797|2163940|P2|Period 2|Adverse Event|0
669826|NCT01837797|2163941|P1|Period 2|Adverse Event|0
669827|NCT01837797|2163937|P5|Period 2|Administrative or other reasons|0
669828|NCT01837797|2163938|P4|Period 2|Administrative or other reasons|4
669829|NCT01837797|2163939|P3|Period 2|Administrative or other reasons|2
669830|NCT01837797|2163940|P2|Period 2|Administrative or other reasons|5
669831|NCT01837797|2163941|P1|Period 2|Administrative or other reasons|0
669832|NCT01837797|2163937|P5|Period 1|Other|0
669833|NCT01837797|2163938|P4|Period 1|Other|0
669834|NCT01837797|2163939|P3|Period 1|Other|0
669835|NCT01837797|2163940|P2|Period 1|Other|0
669836|NCT01837797|2163941|P1|Period 1|Other|10
669837|NCT01837797|2163937|P5|Period 1|Withdrawal of consent before treatment|0
669838|NCT01837797|2163938|P4|Period 1|Withdrawal of consent before treatment|0
669839|NCT01837797|2163939|P3|Period 1|Withdrawal of consent before treatment|0
669840|NCT01837797|2163940|P2|Period 1|Withdrawal of consent before treatment|0
669841|NCT01837797|2163941|P1|Period 1|Withdrawal of consent before treatment|1
669842|NCT01837797|2163937|P5|Period 1|Administrative reasons|0
669843|NCT01837797|2163938|P4|Period 1|Administrative reasons|0
669844|NCT01837797|2163939|P3|Period 1|Administrative reasons|0
669845|NCT01837797|2163940|P2|Period 1|Administrative reasons|0
669846|NCT01837797|2163941|P1|Period 1|Administrative reasons|76
669847|NCT01837797|2163937|P5|Period 1|Withdrawal by Subject|0
669848|NCT01837797|2163938|P4|Period 1|Withdrawal by Subject|0
669849|NCT01837797|2163939|P3|Period 1|Withdrawal by Subject|0
669850|NCT01837797|2163940|P2|Period 1|Withdrawal by Subject|0
669851|NCT01837797|2163941|P1|Period 1|Withdrawal by Subject|6
669852|NCT01837797|2163937|P5|Period 1|Adverse Event|0
669853|NCT01837797|2163938|P4|Period 1|Adverse Event|0
669854|NCT01837797|2163939|P3|Period 1|Adverse Event|0
669855|NCT01837797|2163940|P2|Period 1|Adverse Event|0
669856|NCT01837797|2163941|P1|Period 1|Adverse Event|9
669857|NCT01837719|2163976|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
669858|NCT01837719|2163976|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
669859|NCT01837680|2164045|P2|Overall Study|switched to oral hypoglycemic or diet|4
669860|NCT01837680|2164046|P1|Overall Study|switched to oral hypoglycemic or diet|2
669861|NCT01837680|2164045|P2|Overall Study|allergic reaction|0
669862|NCT01837680|2164046|P1|Overall Study|allergic reaction|6
669863|NCT01837680|2164045|P2|Overall Study|lack of insurance|2
669864|NCT01837680|2164046|P1|Overall Study|lack of insurance|0
669865|NCT01837680|2164045|P2|Overall Study|Lost to Follow-up|2
669866|NCT01837680|2164046|P1|Overall Study|Lost to Follow-up|2
669867|NCT01836523|2164152|P4|Overall Study|Unclassified|29
669868|NCT01836523|2164153|P3|Overall Study|Unclassified|19
669869|NCT01836523|2164154|P2|Overall Study|Unclassified|28
669870|NCT01836523|2164155|P1|Overall Study|Unclassified|17
669871|NCT01836523|2164152|P4|Overall Study|Met Withdrawal Criteria|27
669872|NCT01836523|2164153|P3|Overall Study|Met Withdrawal Criteria|21
669873|NCT01836523|2164154|P2|Overall Study|Met Withdrawal Criteria|13
669874|NCT01836523|2164155|P1|Overall Study|Met Withdrawal Criteria|13
669875|NCT01836523|2164152|P4|Overall Study|Protocol Violation|4
669876|NCT01836523|2164153|P3|Overall Study|Protocol Violation|2
669877|NCT01836523|2164154|P2|Overall Study|Protocol Violation|3
669878|NCT01836523|2164155|P1|Overall Study|Protocol Violation|6
669879|NCT01836523|2164152|P4|Overall Study|Adverse Event|14
669880|NCT01836523|2164153|P3|Overall Study|Adverse Event|49
669881|NCT01836523|2164154|P2|Overall Study|Adverse Event|41
669882|NCT01836523|2164155|P1|Overall Study|Adverse Event|15
669883|NCT01836471|2164182|P5|Overall Study|Non compliance with tx|0
669884|NCT01836471|2164183|P4|Overall Study|Non compliance with tx|0
669885|NCT01836471|2164184|P3|Overall Study|Non compliance with tx|0
669886|NCT01836471|2164185|P2|Overall Study|Non compliance with tx|1
669887|NCT01836471|2164186|P1|Overall Study|Non compliance with tx|1
669888|NCT01836471|2164182|P5|Overall Study|Adverse Event|2
669889|NCT01836471|2164183|P4|Overall Study|Adverse Event|1
669890|NCT01836471|2164184|P3|Overall Study|Adverse Event|1
669891|NCT01836471|2164185|P2|Overall Study|Adverse Event|3
669892|NCT01836471|2164186|P1|Overall Study|Adverse Event|6
669893|NCT01836471|2164182|P5|Overall Study|Lost to Follow-up|1
669894|NCT01836471|2164183|P4|Overall Study|Lost to Follow-up|1
669895|NCT01836471|2164184|P3|Overall Study|Lost to Follow-up|0
669896|NCT01836471|2164185|P2|Overall Study|Lost to Follow-up|0
669897|NCT01836471|2164186|P1|Overall Study|Lost to Follow-up|0
669898|NCT01836471|2164182|P5|Overall Study|Physician Decision|0
669899|NCT01836471|2164183|P4|Overall Study|Physician Decision|0
669900|NCT01836471|2164184|P3|Overall Study|Physician Decision|0
669901|NCT01836471|2164185|P2|Overall Study|Physician Decision|1
669902|NCT01836471|2164186|P1|Overall Study|Physician Decision|0
669903|NCT01836471|2164182|P5|Overall Study|Withdrawal by Subject|2
669904|NCT01836471|2164183|P4|Overall Study|Withdrawal by Subject|0
669905|NCT01836471|2164184|P3|Overall Study|Withdrawal by Subject|1
669906|NCT01836471|2164185|P2|Overall Study|Withdrawal by Subject|4
669907|NCT01836471|2164186|P1|Overall Study|Withdrawal by Subject|3
669908|NCT01836471|2164182|P5|Overall Study|Pregnancy|0
669909|NCT01836471|2164183|P4|Overall Study|Pregnancy|0
669910|NCT01836471|2164184|P3|Overall Study|Pregnancy|0
669911|NCT01836471|2164185|P2|Overall Study|Pregnancy|0
669912|NCT01836471|2164186|P1|Overall Study|Pregnancy|1
669913|NCT01836458|2164215|P4|Overall Study|Unsatisfactory therapeutic effect|6
669914|NCT01836458|2164216|P3|Overall Study|Unsatisfactory therapeutic effect|5
669915|NCT01836458|2164217|P2|Overall Study|Unsatisfactory therapeutic effect|2
669916|NCT01836458|2164218|P1|Overall Study|Unsatisfactory therapeutic effect|3
669917|NCT01835899|2164280|P3|Overall Study|Other than stated above|0
669918|NCT01835899|2164281|P2|Overall Study|Other than stated above|1
669919|NCT01835899|2164282|P1|Overall Study|Other than stated above|0
669920|NCT01835899|2164280|P3|Overall Study|Adverse Event|1
669921|NCT01835899|2164281|P2|Overall Study|Adverse Event|0
669922|NCT01835899|2164282|P1|Overall Study|Adverse Event|0
888695|NCT01791517|2822621|P5|Phase I: Period 2|Lost to Follow-up|0
888696|NCT01791517|2822622|P4|Phase I: Period 2|Lost to Follow-up|0
669925|NCT01835431|2164345|P2|Overall Study|Protocol Violation|0
669926|NCT01835431|2164346|P1|Overall Study|Protocol Violation|1
669927|NCT01835431|2164345|P2|Overall Study|Withdrawal by Subject|10
669928|NCT01835431|2164346|P1|Overall Study|Withdrawal by Subject|6
669929|NCT01835431|2164345|P2|Overall Study|other|2
669930|NCT01835431|2164346|P1|Overall Study|other|0
669931|NCT01835431|2164345|P2|Overall Study|Adverse Event|0
669932|NCT01835431|2164346|P1|Overall Study|Adverse Event|1
888697|NCT01791517|2822623|P3|Phase I: Period 2|Lost to Follow-up|2
669934|NCT01835015|2164428|P5|Overall Study|Adverse Event|0
669935|NCT01835015|2164429|P4|Overall Study|Adverse Event|0
669936|NCT01835015|2164430|P3|Overall Study|Adverse Event|1
669937|NCT01835015|2164431|P2|Overall Study|Adverse Event|0
669938|NCT01835015|2164432|P1|Overall Study|Adverse Event|0
669939|NCT01834274|2164550|P2|Overall Study|Other|1
669940|NCT01834274|2164551|P1|Overall Study|Other|2
669941|NCT01834274|2164550|P2|Overall Study|Lost to Follow-up|1
669942|NCT01834274|2164551|P1|Overall Study|Lost to Follow-up|3
669943|NCT01834274|2164550|P2|Overall Study|Withdrawal by Subject|1
669944|NCT01834274|2164551|P1|Overall Study|Withdrawal by Subject|1
669945|NCT01834274|2164550|P2|Overall Study|Study Termination|38
669946|NCT01834274|2164551|P1|Overall Study|Study Termination|41
669947|NCT01834222|2164574|P1|Overall Study|Not meet inclusion/exclusion criteria|1
669948|NCT01833897|2164651|P1|Overall Study|Lack of Efficacy|1
669949|NCT01833533|2164678|P2|Overall Study|Not Specified|7
669950|NCT01833533|2164679|P1|Overall Study|Not Specified|2
669951|NCT01833533|2164678|P2|Overall Study|To Enter an Extension Study|4
669952|NCT01833533|2164679|P1|Overall Study|To Enter an Extension Study|0
669953|NCT01833533|2164678|P2|Overall Study|Lost to Follow-up|9
669954|NCT01833533|2164679|P1|Overall Study|Lost to Follow-up|4
669955|NCT01833533|2164678|P2|Overall Study|Adverse Event|1
669956|NCT01833533|2164679|P1|Overall Study|Adverse Event|0
669957|NCT01833065|2164781|P5|Overall Study|Others|4
669958|NCT01833065|2164782|P4|Overall Study|Others|1
669959|NCT01833065|2164783|P3|Overall Study|Others|1
669960|NCT01833065|2164784|P2|Overall Study|Others|1
669961|NCT01833065|2164785|P1|Overall Study|Others|2
669962|NCT01833065|2164781|P5|Overall Study|Trial terminated by sponsor|13
669963|NCT01833065|2164782|P4|Overall Study|Trial terminated by sponsor|3
669964|NCT01833065|2164783|P3|Overall Study|Trial terminated by sponsor|7
669965|NCT01833065|2164784|P2|Overall Study|Trial terminated by sponsor|8
669966|NCT01833065|2164785|P1|Overall Study|Trial terminated by sponsor|8
669967|NCT01833065|2164781|P5|Overall Study|Subject's substantial non-compliance|0
669968|NCT01833065|2164782|P4|Overall Study|Subject's substantial non-compliance|0
669969|NCT01833065|2164783|P3|Overall Study|Subject's substantial non-compliance|0
669970|NCT01833065|2164784|P2|Overall Study|Subject's substantial non-compliance|1
669971|NCT01833065|2164785|P1|Overall Study|Subject's substantial non-compliance|0
669972|NCT01833065|2164781|P5|Overall Study|Withdrawal by Subject|11
669973|NCT01833065|2164782|P4|Overall Study|Withdrawal by Subject|3
669974|NCT01833065|2164783|P3|Overall Study|Withdrawal by Subject|4
669975|NCT01833065|2164784|P2|Overall Study|Withdrawal by Subject|2
669976|NCT01833065|2164785|P1|Overall Study|Withdrawal by Subject|6
669977|NCT01833065|2164781|P5|Overall Study|Lost to Follow-up|3
669978|NCT01833065|2164782|P4|Overall Study|Lost to Follow-up|0
669979|NCT01833065|2164783|P3|Overall Study|Lost to Follow-up|0
669980|NCT01833065|2164784|P2|Overall Study|Lost to Follow-up|0
669981|NCT01833065|2164785|P1|Overall Study|Lost to Follow-up|1
669982|NCT01833065|2164781|P5|Overall Study|Protocol Violation|2
669983|NCT01833065|2164782|P4|Overall Study|Protocol Violation|0
669984|NCT01833065|2164783|P3|Overall Study|Protocol Violation|0
669985|NCT01833065|2164784|P2|Overall Study|Protocol Violation|0
669986|NCT01833065|2164785|P1|Overall Study|Protocol Violation|1
669987|NCT01833065|2164781|P5|Overall Study|Adverse Event|3
669988|NCT01833065|2164782|P4|Overall Study|Adverse Event|2
669989|NCT01833065|2164783|P3|Overall Study|Adverse Event|0
669990|NCT01833065|2164784|P2|Overall Study|Adverse Event|1
669991|NCT01833065|2164785|P1|Overall Study|Adverse Event|6
669992|NCT01832766|2164816|P2|Washout|Lost to Follow-up|1
669993|NCT01832766|2164817|P1|Washout|Lost to Follow-up|0
669994|NCT01832493|2164883|P1|Overall Study|Unable to place LV lead|2
669995|NCT01832493|2164883|P1|Overall Study|Protocol Violation|4
669996|NCT01832493|2164883|P1|Overall Study|Physician Decision|2
669997|NCT01832155|2164892|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
669998|NCT01832155|2164893|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
669999|NCT01832155|2164892|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
670000|NCT01832155|2164893|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
670001|NCT01831817|2164927|P4|Overall Study|Withdrawl of Consent|0
670002|NCT01831817|2164928|P3|Overall Study|Withdrawl of Consent|0
670003|NCT01831817|2164929|P2|Overall Study|Withdrawl of Consent|0
670004|NCT01831817|2164930|P1|Overall Study|Withdrawl of Consent|3
670005|NCT01831817|2164927|P4|Overall Study|Lost to Follow-up|0
670006|NCT01831817|2164928|P3|Overall Study|Lost to Follow-up|0
670007|NCT01831817|2164929|P2|Overall Study|Lost to Follow-up|0
670008|NCT01831817|2164930|P1|Overall Study|Lost to Follow-up|1
670010|NCT01831726|2164994|P1|Overall Study|Subject/guardian decision|7
670011|NCT01831726|2164994|P1|Overall Study|Physician Decision|1
670012|NCT01831726|2164994|P1|Overall Study|Disease Progression|49
670013|NCT01831726|2164994|P1|Overall Study|Death|7
670014|NCT01831726|2164994|P1|Overall Study|Adverse Event|16
670015|NCT01831466|2165013|P12|Overall Study|Adverse Event|2
670016|NCT01831466|2165014|P11|Overall Study|Adverse Event|0
670017|NCT01831466|2165015|P10|Overall Study|Adverse Event|1
670018|NCT01831466|2165016|P9|Overall Study|Adverse Event|1
670019|NCT01831466|2165017|P8|Overall Study|Adverse Event|1
670020|NCT01831466|2165018|P7|Overall Study|Adverse Event|0
670021|NCT01831466|2165019|P6|Overall Study|Adverse Event|7
670022|NCT01831466|2165020|P5|Overall Study|Adverse Event|3
670023|NCT01831466|2165021|P4|Overall Study|Adverse Event|6
670024|NCT01831466|2165022|P3|Overall Study|Adverse Event|4
670025|NCT01831466|2165023|P2|Overall Study|Adverse Event|0
670026|NCT01831466|2165024|P1|Overall Study|Adverse Event|0
670027|NCT01831466|2165013|P12|Overall Study|Lack of Efficacy|0
670028|NCT01831466|2165014|P11|Overall Study|Lack of Efficacy|2
670029|NCT01831466|2165015|P10|Overall Study|Lack of Efficacy|2
670030|NCT01831466|2165016|P9|Overall Study|Lack of Efficacy|2
670031|NCT01831466|2165017|P8|Overall Study|Lack of Efficacy|1
670032|NCT01831466|2165018|P7|Overall Study|Lack of Efficacy|1
670033|NCT01831466|2165019|P6|Overall Study|Lack of Efficacy|8
670034|NCT01831466|2165020|P5|Overall Study|Lack of Efficacy|9
670035|NCT01831466|2165021|P4|Overall Study|Lack of Efficacy|6
670036|NCT01831466|2165022|P3|Overall Study|Lack of Efficacy|7
670037|NCT01831466|2165023|P2|Overall Study|Lack of Efficacy|8
670038|NCT01831466|2165024|P1|Overall Study|Lack of Efficacy|5
670039|NCT01831466|2165013|P12|Overall Study|Lost to Follow-up|1
670040|NCT01831466|2165014|P11|Overall Study|Lost to Follow-up|0
670041|NCT01831466|2165015|P10|Overall Study|Lost to Follow-up|1
670042|NCT01831466|2165016|P9|Overall Study|Lost to Follow-up|0
670043|NCT01831466|2165017|P8|Overall Study|Lost to Follow-up|0
670044|NCT01831466|2165018|P7|Overall Study|Lost to Follow-up|0
670045|NCT01831466|2165019|P6|Overall Study|Lost to Follow-up|3
670046|NCT01831466|2165020|P5|Overall Study|Lost to Follow-up|0
670047|NCT01831466|2165021|P4|Overall Study|Lost to Follow-up|2
670048|NCT01831466|2165022|P3|Overall Study|Lost to Follow-up|4
670049|NCT01831466|2165023|P2|Overall Study|Lost to Follow-up|1
670050|NCT01831466|2165024|P1|Overall Study|Lost to Follow-up|0
670051|NCT01831466|2165013|P12|Overall Study|Withdrawal by Subject|1
670052|NCT01831466|2165014|P11|Overall Study|Withdrawal by Subject|0
670053|NCT01831466|2165015|P10|Overall Study|Withdrawal by Subject|1
670054|NCT01831466|2165016|P9|Overall Study|Withdrawal by Subject|0
670055|NCT01831466|2165017|P8|Overall Study|Withdrawal by Subject|0
670056|NCT01831466|2165018|P7|Overall Study|Withdrawal by Subject|0
670057|NCT01831466|2165019|P6|Overall Study|Withdrawal by Subject|5
670058|NCT01831466|2165020|P5|Overall Study|Withdrawal by Subject|3
670059|NCT01831466|2165021|P4|Overall Study|Withdrawal by Subject|3
670060|NCT01831466|2165022|P3|Overall Study|Withdrawal by Subject|3
670061|NCT01831466|2165023|P2|Overall Study|Withdrawal by Subject|3
670062|NCT01831466|2165024|P1|Overall Study|Withdrawal by Subject|6
670063|NCT01831466|2165013|P12|Overall Study|Death|0
670064|NCT01831466|2165014|P11|Overall Study|Death|0
670065|NCT01831466|2165015|P10|Overall Study|Death|0
670066|NCT01831466|2165016|P9|Overall Study|Death|0
670067|NCT01831466|2165017|P8|Overall Study|Death|0
670068|NCT01831466|2165018|P7|Overall Study|Death|0
670069|NCT01831466|2165019|P6|Overall Study|Death|0
670070|NCT01831466|2165020|P5|Overall Study|Death|0
670071|NCT01831466|2165021|P4|Overall Study|Death|0
670072|NCT01831466|2165022|P3|Overall Study|Death|0
670073|NCT01831466|2165023|P2|Overall Study|Death|1
670074|NCT01831466|2165024|P1|Overall Study|Death|0
670075|NCT01831466|2165013|P12|Overall Study|Non-compliance with study treatment|0
670076|NCT01831466|2165014|P11|Overall Study|Non-compliance with study treatment|0
670077|NCT01831466|2165015|P10|Overall Study|Non-compliance with study treatment|0
670078|NCT01831466|2165016|P9|Overall Study|Non-compliance with study treatment|0
670079|NCT01831466|2165017|P8|Overall Study|Non-compliance with study treatment|0
670080|NCT01831466|2165018|P7|Overall Study|Non-compliance with study treatment|0
670081|NCT01831466|2165019|P6|Overall Study|Non-compliance with study treatment|1
670082|NCT01831466|2165020|P5|Overall Study|Non-compliance with study treatment|0
670083|NCT01831466|2165021|P4|Overall Study|Non-compliance with study treatment|0
670084|NCT01831466|2165022|P3|Overall Study|Non-compliance with study treatment|1
670085|NCT01831466|2165023|P2|Overall Study|Non-compliance with study treatment|1
670086|NCT01831466|2165024|P1|Overall Study|Non-compliance with study treatment|2
670087|NCT01831466|2165013|P12|Overall Study|Not specified|0
670088|NCT01831466|2165014|P11|Overall Study|Not specified|0
670089|NCT01831466|2165015|P10|Overall Study|Not specified|0
670090|NCT01831466|2165016|P9|Overall Study|Not specified|0
670091|NCT01831466|2165017|P8|Overall Study|Not specified|0
670092|NCT01831466|2165018|P7|Overall Study|Not specified|0
670093|NCT01831466|2165019|P6|Overall Study|Not specified|1
670094|NCT01831466|2165020|P5|Overall Study|Not specified|2
670095|NCT01831466|2165021|P4|Overall Study|Not specified|2
670096|NCT01831466|2165022|P3|Overall Study|Not specified|2
670097|NCT01831466|2165023|P2|Overall Study|Not specified|3
670098|NCT01831466|2165024|P1|Overall Study|Not specified|2
670099|NCT01831466|2165013|P12|Overall Study|Protocol Violation|0
670100|NCT01831466|2165014|P11|Overall Study|Protocol Violation|0
670101|NCT01831466|2165015|P10|Overall Study|Protocol Violation|0
670102|NCT01831466|2165016|P9|Overall Study|Protocol Violation|0
670103|NCT01831466|2165017|P8|Overall Study|Protocol Violation|0
670104|NCT01831466|2165018|P7|Overall Study|Protocol Violation|0
670105|NCT01831466|2165019|P6|Overall Study|Protocol Violation|1
670106|NCT01831466|2165020|P5|Overall Study|Protocol Violation|0
670107|NCT01831466|2165021|P4|Overall Study|Protocol Violation|0
670108|NCT01831466|2165022|P3|Overall Study|Protocol Violation|2
670109|NCT01831466|2165023|P2|Overall Study|Protocol Violation|1
670110|NCT01831466|2165024|P1|Overall Study|Protocol Violation|1
670111|NCT01831258|2165146|P2|Overall Study|Lost to Follow-up|2
670112|NCT01831258|2165147|P1|Overall Study|Lost to Follow-up|3
670113|NCT01831258|2165146|P2|Overall Study|Withdrawal by Subject|1
670114|NCT01831258|2165147|P1|Overall Study|Withdrawal by Subject|2
670115|NCT01830920|2165242|P5|Overall Study|Not specified|3
670116|NCT01830920|2165243|P4|Overall Study|Not specified|5
670117|NCT01830920|2165244|P3|Overall Study|Not specified|1
670118|NCT01830920|2165245|P2|Overall Study|Not specified|1
670119|NCT01830920|2165246|P1|Overall Study|Not specified|15
670120|NCT01830920|2165242|P5|Overall Study|Death|4
670121|NCT01830920|2165243|P4|Overall Study|Death|4
670122|NCT01830920|2165244|P3|Overall Study|Death|5
670123|NCT01830920|2165245|P2|Overall Study|Death|3
670124|NCT01830920|2165246|P1|Overall Study|Death|3
670125|NCT01830920|2165242|P5|Overall Study|Withdrawal by Subject|1
670126|NCT01830920|2165243|P4|Overall Study|Withdrawal by Subject|7
670127|NCT01830920|2165244|P3|Overall Study|Withdrawal by Subject|1
670128|NCT01830920|2165245|P2|Overall Study|Withdrawal by Subject|2
670129|NCT01830920|2165246|P1|Overall Study|Withdrawal by Subject|2
670130|NCT01830920|2165242|P5|Overall Study|Adverse Event|0
670131|NCT01830920|2165243|P4|Overall Study|Adverse Event|0
670132|NCT01830920|2165244|P3|Overall Study|Adverse Event|1
670133|NCT01830920|2165245|P2|Overall Study|Adverse Event|0
670134|NCT01830920|2165246|P1|Overall Study|Adverse Event|1
670135|NCT01830881|2165285|P2|Overall Study|Changed decision to have an abortion|1
670136|NCT01830881|2165286|P1|Overall Study|Changed decision to have an abortion|0
670137|NCT01830855|2165330|P4|Overall Study|Lost to Follow-up|33
670138|NCT01830855|2165331|P3|Overall Study|Lost to Follow-up|23
670139|NCT01830855|2165332|P2|Overall Study|Lost to Follow-up|20
670140|NCT01830855|2165333|P1|Overall Study|Lost to Follow-up|47
670141|NCT01830855|2165330|P4|Overall Study|No longer willing to participate|17
670142|NCT01830855|2165331|P3|Overall Study|No longer willing to participate|12
670143|NCT01830855|2165332|P2|Overall Study|No longer willing to participate|13
670144|NCT01830855|2165333|P1|Overall Study|No longer willing to participate|32
670145|NCT01830855|2165330|P4|Overall Study|Withdrawal by Subject|12
670146|NCT01830855|2165331|P3|Overall Study|Withdrawal by Subject|10
670147|NCT01830855|2165332|P2|Overall Study|Withdrawal by Subject|14
670148|NCT01830855|2165333|P1|Overall Study|Withdrawal by Subject|33
670149|NCT01830855|2165330|P4|Overall Study|Protocol deviation|6
670150|NCT01830855|2165331|P3|Overall Study|Protocol deviation|6
670151|NCT01830855|2165332|P2|Overall Study|Protocol deviation|5
670152|NCT01830855|2165333|P1|Overall Study|Protocol deviation|10
670153|NCT01830855|2165330|P4|Overall Study|Adverse Event|3
670154|NCT01830855|2165331|P3|Overall Study|Adverse Event|6
670155|NCT01830855|2165332|P2|Overall Study|Adverse Event|5
670156|NCT01830855|2165333|P1|Overall Study|Adverse Event|11
670157|NCT01830855|2165330|P4|Overall Study|No longer meets eligibility criteria|5
670158|NCT01830855|2165331|P3|Overall Study|No longer meets eligibility criteria|3
670159|NCT01830855|2165332|P2|Overall Study|No longer meets eligibility criteria|2
670160|NCT01830855|2165333|P1|Overall Study|No longer meets eligibility criteria|11
670161|NCT01830855|2165330|P4|Overall Study|Pregnancy|1
670162|NCT01830855|2165331|P3|Overall Study|Pregnancy|2
670163|NCT01830855|2165332|P2|Overall Study|Pregnancy|1
670164|NCT01830855|2165333|P1|Overall Study|Pregnancy|3
670165|NCT01830855|2165330|P4|Overall Study|Medication error without associated AE|1
670166|NCT01830855|2165331|P3|Overall Study|Medication error without associated AE|0
670167|NCT01830855|2165332|P2|Overall Study|Medication error without associated AE|0
670168|NCT01830855|2165333|P1|Overall Study|Medication error without associated AE|1
670169|NCT01830855|2165330|P4|Overall Study|Unspecified|4
670170|NCT01830855|2165331|P3|Overall Study|Unspecified|4
670171|NCT01830855|2165332|P2|Overall Study|Unspecified|1
670172|NCT01830855|2165333|P1|Overall Study|Unspecified|7
670173|NCT01830543|2165464|P3|Overall Study|Unspecified|37
670174|NCT01830543|2165465|P2|Overall Study|Unspecified|17
670175|NCT01830543|2165466|P1|Overall Study|Unspecified|12
670176|NCT01830543|2165464|P3|Overall Study|Withdrawal by consent|3
670177|NCT01830543|2165465|P2|Overall Study|Withdrawal by consent|3
670178|NCT01830543|2165466|P1|Overall Study|Withdrawal by consent|3
670179|NCT01830543|2165464|P3|Overall Study|Physician Decision|12
670180|NCT01830543|2165465|P2|Overall Study|Physician Decision|5
670181|NCT01830543|2165466|P1|Overall Study|Physician Decision|11
670182|NCT01830543|2165464|P3|Overall Study|Protocol Violation|7
670183|NCT01830543|2165465|P2|Overall Study|Protocol Violation|7
670184|NCT01830543|2165466|P1|Overall Study|Protocol Violation|3
670185|NCT01830543|2165464|P3|Overall Study|Death|22
670186|NCT01830543|2165465|P2|Overall Study|Death|22
670187|NCT01830543|2165466|P1|Overall Study|Death|20
670188|NCT01830543|2165464|P3|Overall Study|Adverse Event|76
670189|NCT01830543|2165465|P2|Overall Study|Adverse Event|77
670190|NCT01830543|2165466|P1|Overall Study|Adverse Event|91
670191|NCT01830543|2165464|P3|Overall Study|Subject Decision|57
670192|NCT01830543|2165465|P2|Overall Study|Subject Decision|21
670193|NCT01830543|2165466|P1|Overall Study|Subject Decision|19
670194|NCT01830127|2165598|P2|Overall Study|Other reason not defined above|2
670195|NCT01830127|2165599|P1|Overall Study|Other reason not defined above|0
670196|NCT01830127|2165598|P2|Overall Study|Withdrawal by Subject|1
670197|NCT01830127|2165599|P1|Overall Study|Withdrawal by Subject|1
670198|NCT01830127|2165598|P2|Overall Study|Lack of Efficacy|0
670199|NCT01830127|2165599|P1|Overall Study|Lack of Efficacy|3
670200|NCT01830127|2165598|P2|Overall Study|Adverse Event|6
670201|NCT01830127|2165599|P1|Overall Study|Adverse Event|1
670202|NCT01829477|2165648|P2|Overall Study|Withdrawal by Subject|0
670203|NCT01829477|2165649|P1|Overall Study|Withdrawal by Subject|1
670204|NCT01829477|2165648|P2|Overall Study|Study Terminated by Sponsor|15
670205|NCT01829477|2165649|P1|Overall Study|Study Terminated by Sponsor|15
670206|NCT01829464|2165662|P3|Overall Study|Lack of Efficacy|0
670207|NCT01829464|2165663|P2|Overall Study|Lack of Efficacy|1
670208|NCT01829464|2165664|P1|Overall Study|Lack of Efficacy|0
670209|NCT01829464|2165662|P3|Overall Study|Study terminated by sponsor|25
670210|NCT01829464|2165663|P2|Overall Study|Study terminated by sponsor|28
670211|NCT01829464|2165664|P1|Overall Study|Study terminated by sponsor|25
670212|NCT01829464|2165662|P3|Overall Study|Withdrawal by Subject|0
670213|NCT01829464|2165663|P2|Overall Study|Withdrawal by Subject|0
670214|NCT01829464|2165664|P1|Overall Study|Withdrawal by Subject|2
670215|NCT01829464|2165662|P3|Overall Study|Lost to Follow-up|1
670216|NCT01829464|2165663|P2|Overall Study|Lost to Follow-up|0
670217|NCT01829464|2165664|P1|Overall Study|Lost to Follow-up|0
670218|NCT01829464|2165662|P3|Overall Study|Adverse Event|0
670219|NCT01829464|2165663|P2|Overall Study|Adverse Event|0
670220|NCT01829464|2165664|P1|Overall Study|Adverse Event|1
670221|NCT01829243|2165689|P2|First Intervention|Screen Failure|2
670222|NCT01829243|2165690|P1|First Intervention|Screen Failure|4
670223|NCT01829230|2165704|P2|Overall Study|Lost to Follow-up|1
670224|NCT01829230|2165705|P1|Overall Study|Lost to Follow-up|1
670225|NCT01829230|2165704|P2|Overall Study|Withdrawal by Subject|1
670226|NCT01829230|2165705|P1|Overall Study|Withdrawal by Subject|0
670227|NCT01829230|2165704|P2|Overall Study|Protocol Violation|2
670228|NCT01829230|2165705|P1|Overall Study|Protocol Violation|0
670229|NCT01829191|2165715|P2|Overall Study|Subject was fit for ortho - k|1
670230|NCT01829191|2165716|P1|Overall Study|Subject was fit for ortho - k|0
670231|NCT01829191|2165715|P2|Overall Study|Lost to Follow-up|1
670232|NCT01829191|2165716|P1|Overall Study|Lost to Follow-up|0
670233|NCT01829191|2165715|P2|Overall Study|Withdrawal by Subject|3
670234|NCT01829191|2165716|P1|Overall Study|Withdrawal by Subject|2
670235|NCT01829191|2165715|P2|Overall Study|Protocol Violation|1
670236|NCT01829191|2165716|P1|Overall Study|Protocol Violation|4
670237|NCT01829191|2165715|P2|Overall Study|Lens handling difficulty|4
670238|NCT01829191|2165716|P1|Overall Study|Lens handling difficulty|1
670239|NCT01829191|2165715|P2|Overall Study|Lens discomfort|3
670240|NCT01829191|2165716|P1|Overall Study|Lens discomfort|0
670241|NCT01829191|2165715|P2|Overall Study|Relocation|1
670242|NCT01829191|2165716|P1|Overall Study|Relocation|0
670243|NCT01828281|2165774|P2|Overall Study|Withdrawal by Subject|0
670244|NCT01828281|2165775|P1|Overall Study|Withdrawal by Subject|1
670245|NCT01828112|2165808|P2|Overall Study|Subject/guardian decision|8
670246|NCT01828112|2165809|P1|Overall Study|Subject/guardian decision|6
670247|NCT01828112|2165808|P2|Overall Study|Progressive disease|82
670248|NCT01828112|2165809|P1|Overall Study|Progressive disease|56
670249|NCT01828112|2165808|P2|Overall Study|Physician Decision|5
670250|NCT01828112|2165809|P1|Overall Study|Physician Decision|5
670251|NCT01828112|2165808|P2|Overall Study|Death|5
670252|NCT01828112|2165809|P1|Overall Study|Death|9
670253|NCT01828112|2165808|P2|Overall Study|Adverse Event|8
670254|NCT01828112|2165809|P1|Overall Study|Adverse Event|6
670255|NCT01828099|2165817|P2|Overall Study|Subject/guardian decision|23
670256|NCT01828099|2165818|P1|Overall Study|Subject/guardian decision|7
670257|NCT01828099|2165817|P2|Overall Study|Protocol Violation|0
670258|NCT01828099|2165818|P1|Overall Study|Protocol Violation|1
670259|NCT01828099|2165817|P2|Overall Study|Progressive disease|94
670260|NCT01828099|2165818|P1|Overall Study|Progressive disease|51
670261|NCT01828099|2165817|P2|Overall Study|Physician Decision|11
670262|NCT01828099|2165818|P1|Overall Study|Physician Decision|7
670263|NCT01828099|2165817|P2|Overall Study|Non-compliance with study treatment|0
670264|NCT01828099|2165818|P1|Overall Study|Non-compliance with study treatment|2
670265|NCT01828099|2165817|P2|Overall Study|Lost to Follow-up|0
670266|NCT01828099|2165818|P1|Overall Study|Lost to Follow-up|2
670267|NCT01828099|2165817|P2|Overall Study|Death|11
670268|NCT01828099|2165818|P1|Overall Study|Death|9
670269|NCT01828099|2165817|P2|Overall Study|Adverse Event|18
670270|NCT01828099|2165818|P1|Overall Study|Adverse Event|15
670273|NCT01827670|2165848|P2|Overall Study|Lost to Follow-up|1
670274|NCT01827670|2165849|P1|Overall Study|Lost to Follow-up|0
670275|NCT01827670|2165848|P2|Overall Study|Withdrawal of Consent|2
670276|NCT01827670|2165849|P1|Overall Study|Withdrawal of Consent|3
670277|NCT01827592|2165868|P3|Overall Study|Others|3
670278|NCT01827592|2165869|P2|Overall Study|Others|1
670279|NCT01827592|2165870|P1|Overall Study|Others|0
670280|NCT01827592|2165868|P3|Overall Study|Trial terminated by Sponsor|51
670281|NCT01827592|2165869|P2|Overall Study|Trial terminated by Sponsor|53
670282|NCT01827592|2165870|P1|Overall Study|Trial terminated by Sponsor|47
670283|NCT01827592|2165868|P3|Overall Study|Patient's substantial non-compliance|6
670284|NCT01827592|2165869|P2|Overall Study|Patient's substantial non-compliance|1
670285|NCT01827592|2165870|P1|Overall Study|Patient's substantial non-compliance|1
670286|NCT01827592|2165868|P3|Overall Study|Withdrawal by Subject|11
670287|NCT01827592|2165869|P2|Overall Study|Withdrawal by Subject|11
670288|NCT01827592|2165870|P1|Overall Study|Withdrawal by Subject|12
670289|NCT01827592|2165868|P3|Overall Study|Lost to Follow-up|2
670290|NCT01827592|2165869|P2|Overall Study|Lost to Follow-up|2
670291|NCT01827592|2165870|P1|Overall Study|Lost to Follow-up|1
670292|NCT01827592|2165868|P3|Overall Study|Protocol Violation|0
670293|NCT01827592|2165869|P2|Overall Study|Protocol Violation|1
670294|NCT01827592|2165870|P1|Overall Study|Protocol Violation|2
670295|NCT01827592|2165868|P3|Overall Study|Physician Decision|1
670296|NCT01827592|2165869|P2|Overall Study|Physician Decision|2
670297|NCT01827592|2165870|P1|Overall Study|Physician Decision|0
670298|NCT01827592|2165868|P3|Overall Study|Adverse Event|2
670299|NCT01827592|2165869|P2|Overall Study|Adverse Event|9
670300|NCT01827592|2165870|P1|Overall Study|Adverse Event|11
670301|NCT01826370|2165899|P1|Overall Study|Other reason not defined above|2
670302|NCT01826370|2165899|P1|Overall Study|Lost to Follow-up|12
670303|NCT01826370|2165899|P1|Overall Study|Protocol Violation|6
670304|NCT01827371|2165941|P4|Overall Study|Temporary study halt to vaccinations|13
670305|NCT01827371|2165942|P3|Overall Study|Temporary study halt to vaccinations|5
670306|NCT01827371|2165943|P2|Overall Study|Temporary study halt to vaccinations|2
670307|NCT01827371|2165944|P1|Overall Study|Temporary study halt to vaccinations|11
670308|NCT01827371|2165941|P4|Overall Study|Physician Decision|1
670309|NCT01827371|2165942|P3|Overall Study|Physician Decision|0
670310|NCT01827371|2165943|P2|Overall Study|Physician Decision|1
670311|NCT01827371|2165944|P1|Overall Study|Physician Decision|0
670312|NCT01827371|2165941|P4|Overall Study|Withdrawal by Subject|3
670313|NCT01827371|2165942|P3|Overall Study|Withdrawal by Subject|2
670314|NCT01827371|2165943|P2|Overall Study|Withdrawal by Subject|2
670315|NCT01827371|2165944|P1|Overall Study|Withdrawal by Subject|1
670316|NCT01827371|2165941|P4|Overall Study|Protocol Violation|0
670317|NCT01827371|2165942|P3|Overall Study|Protocol Violation|0
670318|NCT01827371|2165943|P2|Overall Study|Protocol Violation|0
670319|NCT01827371|2165944|P1|Overall Study|Protocol Violation|1
670320|NCT01827371|2165941|P4|Overall Study|Lost to Follow-up|4
670321|NCT01827371|2165942|P3|Overall Study|Lost to Follow-up|0
670322|NCT01827371|2165943|P2|Overall Study|Lost to Follow-up|2
670323|NCT01827371|2165944|P1|Overall Study|Lost to Follow-up|0
670324|NCT01827371|2165941|P4|Overall Study|Adverse Event|2
670325|NCT01827371|2165942|P3|Overall Study|Adverse Event|4
670326|NCT01827371|2165943|P2|Overall Study|Adverse Event|0
670327|NCT01827371|2165944|P1|Overall Study|Adverse Event|0
670328|NCT01827332|2166003|P2|Overall Study|Lost to Follow-up|1
670329|NCT01827332|2166004|P1|Overall Study|Lost to Follow-up|2
670330|NCT01827319|2166012|P1|Overall Study|Lost to Follow-up|3
670331|NCT01827267|2166035|P2|Overall Study|Still on study|2
670332|NCT01827267|2166036|P1|Overall Study|Still on study|0
670333|NCT01827267|2166035|P2|Overall Study|Sponsor Discontinued Study|8
670334|NCT01827267|2166036|P1|Overall Study|Sponsor Discontinued Study|2
670335|NCT01827267|2166035|P2|Overall Study|Disease Progression|1
670336|NCT01827267|2166036|P1|Overall Study|Disease Progression|1
670337|NCT01827267|2166035|P2|Overall Study|Physician Decision|0
670338|NCT01827267|2166036|P1|Overall Study|Physician Decision|1
670339|NCT01827267|2166035|P2|Overall Study|Did not receive study drug|1
670340|NCT01827267|2166036|P1|Overall Study|Did not receive study drug|1
670341|NCT01827254|2166051|P1|Overall Study|Intolerance to treatment|4
670342|NCT01827254|2166051|P1|Overall Study|Disease progression|36
670343|NCT01827254|2166051|P1|Overall Study|Did not complete re-challenge|1
670344|NCT01827254|2166051|P1|Overall Study|Discontinued prior initiation: sunitinib|1
670345|NCT01827254|2166051|P1|Overall Study|Invalidated centre|3
670346|NCT01827254|2166051|P1|Overall Study|Case report form not completed|4
670347|NCT01827254|2166051|P1|Overall Study|Death|10
670348|NCT01826981|2166076|P15|Overall Study|Enrolled/Randomized but Not Treated|0
670349|NCT01826981|2166077|P14|Overall Study|Enrolled/Randomized but Not Treated|0
670350|NCT01826981|2166078|P13|Overall Study|Enrolled/Randomized but Not Treated|0
670351|NCT01826981|2166079|P12|Overall Study|Enrolled/Randomized but Not Treated|0
670352|NCT01826981|2166080|P11|Overall Study|Enrolled/Randomized but Not Treated|0
670353|NCT01826981|2166081|P10|Overall Study|Enrolled/Randomized but Not Treated|0
670354|NCT01826981|2166082|P9|Overall Study|Enrolled/Randomized but Not Treated|0
670355|NCT01826981|2166083|P8|Overall Study|Enrolled/Randomized but Not Treated|1
670356|NCT01826981|2166084|P7|Overall Study|Enrolled/Randomized but Not Treated|0
670357|NCT01826981|2166085|P6|Overall Study|Enrolled/Randomized but Not Treated|0
670358|NCT01826981|2166086|P5|Overall Study|Enrolled/Randomized but Not Treated|0
670359|NCT01826981|2166087|P4|Overall Study|Enrolled/Randomized but Not Treated|0
670360|NCT01826981|2166088|P3|Overall Study|Enrolled/Randomized but Not Treated|0
670361|NCT01826981|2166089|P2|Overall Study|Enrolled/Randomized but Not Treated|0
670362|NCT01826981|2166090|P1|Overall Study|Enrolled/Randomized but Not Treated|0
670363|NCT01826981|2166076|P15|Overall Study|Upper G-I Haemorrhage|0
670364|NCT01826981|2166077|P14|Overall Study|Upper G-I Haemorrhage|1
670365|NCT01826981|2166078|P13|Overall Study|Upper G-I Haemorrhage|0
670366|NCT01826981|2166079|P12|Overall Study|Upper G-I Haemorrhage|0
670367|NCT01826981|2166080|P11|Overall Study|Upper G-I Haemorrhage|0
670368|NCT01826981|2166081|P10|Overall Study|Upper G-I Haemorrhage|0
670369|NCT01826981|2166082|P9|Overall Study|Upper G-I Haemorrhage|0
670370|NCT01826981|2166083|P8|Overall Study|Upper G-I Haemorrhage|0
670371|NCT01826981|2166084|P7|Overall Study|Upper G-I Haemorrhage|0
670372|NCT01826981|2166085|P6|Overall Study|Upper G-I Haemorrhage|0
670373|NCT01826981|2166086|P5|Overall Study|Upper G-I Haemorrhage|0
670374|NCT01826981|2166087|P4|Overall Study|Upper G-I Haemorrhage|0
670375|NCT01826981|2166088|P3|Overall Study|Upper G-I Haemorrhage|0
670376|NCT01826981|2166089|P2|Overall Study|Upper G-I Haemorrhage|0
670377|NCT01826981|2166090|P1|Overall Study|Upper G-I Haemorrhage|0
670378|NCT01826981|2166076|P15|Overall Study|Adverse Event|0
670379|NCT01826981|2166077|P14|Overall Study|Adverse Event|0
670380|NCT01826981|2166078|P13|Overall Study|Adverse Event|0
670381|NCT01826981|2166079|P12|Overall Study|Adverse Event|0
670382|NCT01826981|2166080|P11|Overall Study|Adverse Event|0
670383|NCT01826981|2166081|P10|Overall Study|Adverse Event|0
670384|NCT01826981|2166082|P9|Overall Study|Adverse Event|0
670385|NCT01826981|2166083|P8|Overall Study|Adverse Event|0
670386|NCT01826981|2166084|P7|Overall Study|Adverse Event|0
670387|NCT01826981|2166085|P6|Overall Study|Adverse Event|0
670388|NCT01826981|2166086|P5|Overall Study|Adverse Event|1
670389|NCT01826981|2166087|P4|Overall Study|Adverse Event|0
670390|NCT01826981|2166088|P3|Overall Study|Adverse Event|0
670391|NCT01826981|2166089|P2|Overall Study|Adverse Event|0
670392|NCT01826981|2166090|P1|Overall Study|Adverse Event|0
670393|NCT01826981|2166076|P15|Overall Study|Withdrew Consent|0
670394|NCT01826981|2166077|P14|Overall Study|Withdrew Consent|1
670395|NCT01826981|2166078|P13|Overall Study|Withdrew Consent|0
670396|NCT01826981|2166079|P12|Overall Study|Withdrew Consent|1
670397|NCT01826981|2166080|P11|Overall Study|Withdrew Consent|0
670398|NCT01826981|2166081|P10|Overall Study|Withdrew Consent|0
670399|NCT01826981|2166082|P9|Overall Study|Withdrew Consent|0
670400|NCT01826981|2166083|P8|Overall Study|Withdrew Consent|1
670401|NCT01826981|2166084|P7|Overall Study|Withdrew Consent|1
670402|NCT01826981|2166085|P6|Overall Study|Withdrew Consent|0
670403|NCT01826981|2166086|P5|Overall Study|Withdrew Consent|0
670404|NCT01826981|2166087|P4|Overall Study|Withdrew Consent|0
670405|NCT01826981|2166088|P3|Overall Study|Withdrew Consent|0
670406|NCT01826981|2166089|P2|Overall Study|Withdrew Consent|0
670407|NCT01826981|2166090|P1|Overall Study|Withdrew Consent|0
670408|NCT01826981|2166076|P15|Overall Study|Lost to Follow-up|0
670409|NCT01826981|2166077|P14|Overall Study|Lost to Follow-up|0
670410|NCT01826981|2166078|P13|Overall Study|Lost to Follow-up|1
670411|NCT01826981|2166079|P12|Overall Study|Lost to Follow-up|1
670412|NCT01826981|2166080|P11|Overall Study|Lost to Follow-up|1
670413|NCT01826981|2166081|P10|Overall Study|Lost to Follow-up|1
670414|NCT01826981|2166082|P9|Overall Study|Lost to Follow-up|0
670415|NCT01826981|2166083|P8|Overall Study|Lost to Follow-up|1
670416|NCT01826981|2166084|P7|Overall Study|Lost to Follow-up|0
670417|NCT01826981|2166085|P6|Overall Study|Lost to Follow-up|1
670418|NCT01826981|2166086|P5|Overall Study|Lost to Follow-up|1
670419|NCT01826981|2166087|P4|Overall Study|Lost to Follow-up|0
670420|NCT01826981|2166088|P3|Overall Study|Lost to Follow-up|0
670421|NCT01826981|2166089|P2|Overall Study|Lost to Follow-up|0
670422|NCT01826981|2166090|P1|Overall Study|Lost to Follow-up|0
670423|NCT01826981|2166076|P15|Overall Study|Lack of Efficacy|0
670424|NCT01826981|2166077|P14|Overall Study|Lack of Efficacy|3
670425|NCT01826981|2166078|P13|Overall Study|Lack of Efficacy|0
670426|NCT01826981|2166079|P12|Overall Study|Lack of Efficacy|0
670427|NCT01826981|2166080|P11|Overall Study|Lack of Efficacy|1
670428|NCT01826981|2166081|P10|Overall Study|Lack of Efficacy|0
670429|NCT01826981|2166082|P9|Overall Study|Lack of Efficacy|7
670430|NCT01826981|2166083|P8|Overall Study|Lack of Efficacy|8
670431|NCT01826981|2166084|P7|Overall Study|Lack of Efficacy|0
670432|NCT01826981|2166085|P6|Overall Study|Lack of Efficacy|0
670433|NCT01826981|2166086|P5|Overall Study|Lack of Efficacy|5
670434|NCT01826981|2166087|P4|Overall Study|Lack of Efficacy|0
670435|NCT01826981|2166088|P3|Overall Study|Lack of Efficacy|0
670436|NCT01826981|2166089|P2|Overall Study|Lack of Efficacy|1
670437|NCT01826981|2166090|P1|Overall Study|Lack of Efficacy|0
670438|NCT01826604|2166253|P2|Overall Study|Lost to Follow-up|9
670439|NCT01826604|2166254|P1|Overall Study|Lost to Follow-up|8
670440|NCT01826214|2166298|P2|Overall Study|Subject/guardian decision|3
670441|NCT01826214|2166299|P1|Overall Study|Subject/guardian decision|2
670442|NCT01826214|2166298|P2|Overall Study|Study terminated by Sponsor|1
670443|NCT01826214|2166299|P1|Overall Study|Study terminated by Sponsor|0
670444|NCT01826214|2166298|P2|Overall Study|Progressive disease|21
670445|NCT01826214|2166299|P1|Overall Study|Progressive disease|22
670446|NCT01826214|2166298|P2|Overall Study|Physician Decision|2
670447|NCT01826214|2166299|P1|Overall Study|Physician Decision|0
670448|NCT01826214|2166298|P2|Overall Study|Lost to Follow-up|0
670449|NCT01826214|2166299|P1|Overall Study|Lost to Follow-up|1
670450|NCT01826214|2166298|P2|Overall Study|Death|1
670451|NCT01826214|2166299|P1|Overall Study|Death|3
670452|NCT01826214|2166298|P2|Overall Study|Adverse Event|6
670453|NCT01826214|2166299|P1|Overall Study|Adverse Event|7
670454|NCT01826201|2166317|P1|Overall Study|Non compliance with protocol|4
670455|NCT01825837|2166327|P4|PART II|reason unspecified|0
670456|NCT01825837|2166328|P3|PART II|reason unspecified|2
670457|NCT01825837|2166329|P2|PART II|reason unspecified|2
670458|NCT01825837|2166330|P1|PART II|reason unspecified|2
670459|NCT01825837|2166327|P4|PART II|Treatment failure|0
670460|NCT01825837|2166328|P3|PART II|Treatment failure|5
670461|NCT01825837|2166329|P2|PART II|Treatment failure|4
670462|NCT01825837|2166330|P1|PART II|Treatment failure|6
670463|NCT01825837|2166327|P4|PART II|Adverse Event|0
670464|NCT01825837|2166328|P3|PART II|Adverse Event|1
670465|NCT01825837|2166329|P2|PART II|Adverse Event|3
670466|NCT01825837|2166330|P1|PART II|Adverse Event|3
670467|NCT01825837|2166327|P4|PART II|Patient non-compliance|0
670468|NCT01825837|2166328|P3|PART II|Patient non-compliance|4
670469|NCT01825837|2166329|P2|PART II|Patient non-compliance|2
670470|NCT01825837|2166330|P1|PART II|Patient non-compliance|5
670471|NCT01825837|2166327|P4|PART II|Withdrawal by Subject|0
670472|NCT01825837|2166328|P3|PART II|Withdrawal by Subject|7
670473|NCT01825837|2166329|P2|PART II|Withdrawal by Subject|3
670474|NCT01825837|2166330|P1|PART II|Withdrawal by Subject|3
670475|NCT01825837|2166327|P4|PART I|reason unspecified|3
670476|NCT01825837|2166328|P3|PART I|reason unspecified|0
670477|NCT01825837|2166329|P2|PART I|reason unspecified|0
670478|NCT01825837|2166330|P1|PART I|reason unspecified|0
670479|NCT01825837|2166327|P4|PART I|Treatment failure|7
670480|NCT01825837|2166328|P3|PART I|Treatment failure|0
670481|NCT01825837|2166329|P2|PART I|Treatment failure|0
670482|NCT01825837|2166330|P1|PART I|Treatment failure|0
670483|NCT01825837|2166327|P4|PART I|Patient non-compliance|1
670484|NCT01825837|2166328|P3|PART I|Patient non-compliance|0
670485|NCT01825837|2166329|P2|PART I|Patient non-compliance|0
670486|NCT01825837|2166330|P1|PART I|Patient non-compliance|0
670487|NCT01825837|2166327|P4|PART I|Withdrawal by Subject|6
670488|NCT01825837|2166328|P3|PART I|Withdrawal by Subject|0
670489|NCT01825837|2166329|P2|PART I|Withdrawal by Subject|0
670490|NCT01825837|2166330|P1|PART I|Withdrawal by Subject|0
670491|NCT01825577|2166338|P1|Overall Study|Lack of Efficacy|3
670492|NCT01825577|2166338|P1|Overall Study|Withdrawn by family members|2
670493|NCT01825577|2166338|P1|Overall Study|Withdrawal by Subject|1
670494|NCT01825577|2166338|P1|Overall Study|Physician Decision|2
670495|NCT01825200|2166362|P2|Overall Study|Withdrawal by Subject|1
670496|NCT01825200|2166363|P1|Overall Study|Withdrawal by Subject|0
670497|NCT01825200|2166362|P2|Overall Study|Lost to Follow-up|6
670498|NCT01825200|2166363|P1|Overall Study|Lost to Follow-up|5
670499|NCT01824823|2166393|P2|Overall Study|Off-treatment reason not submitted|0
670500|NCT01824823|2166394|P1|Overall Study|Off-treatment reason not submitted|1
670501|NCT01824823|2166393|P2|Overall Study|Lack of Efficacy|1
670502|NCT01824823|2166394|P1|Overall Study|Lack of Efficacy|1
670503|NCT01824602|2166404|P4|Overall Study|Treatment failure|1
670504|NCT01824602|2166405|P3|Overall Study|Treatment failure|0
670505|NCT01824602|2166406|P2|Overall Study|Treatment failure|0
670506|NCT01824602|2166407|P1|Overall Study|Treatment failure|0
670507|NCT01824602|2166404|P4|Overall Study|Adverse Event|2
670508|NCT01824602|2166405|P3|Overall Study|Adverse Event|2
670509|NCT01824602|2166406|P2|Overall Study|Adverse Event|0
670510|NCT01824602|2166407|P1|Overall Study|Adverse Event|1
670511|NCT01824602|2166404|P4|Overall Study|Patient non-compliance|0
670512|NCT01824602|2166405|P3|Overall Study|Patient non-compliance|1
670513|NCT01824602|2166406|P2|Overall Study|Patient non-compliance|0
670514|NCT01824602|2166407|P1|Overall Study|Patient non-compliance|0
670515|NCT01824602|2166404|P4|Overall Study|Withdrawal by Subject|2
670516|NCT01824602|2166405|P3|Overall Study|Withdrawal by Subject|1
670517|NCT01824602|2166406|P2|Overall Study|Withdrawal by Subject|0
670518|NCT01824602|2166407|P1|Overall Study|Withdrawal by Subject|0
670519|NCT01824576|2166446|P1|Overall Study|Device deficiency|2
670520|NCT01824498|2166464|P6|Washout (8 Weeks)|Withdrawal by Subject|0
670521|NCT01824498|2166465|P5|Washout (8 Weeks)|Withdrawal by Subject|1
670522|NCT01824498|2166466|P4|Washout (8 Weeks)|Withdrawal by Subject|1
670523|NCT01824498|2166467|P3|Washout (8 Weeks)|Withdrawal by Subject|2
670524|NCT01824498|2166468|P2|Washout (8 Weeks)|Withdrawal by Subject|0
670525|NCT01824498|2166469|P1|Washout (8 Weeks)|Withdrawal by Subject|2
670526|NCT01824355|2166500|P1|Overall Study|unevaluable reference method results per|1
670527|NCT01824355|2166500|P1|Overall Study|Adverse Event|2
670528|NCT01824342|2166511|P2|Overall Study|Death|0
670529|NCT01824342|2166512|P1|Overall Study|Death|2
670530|NCT01824342|2166511|P2|Overall Study|Physician Decision|0
670531|NCT01824342|2166512|P1|Overall Study|Physician Decision|5
670532|NCT01824342|2166511|P2|Overall Study|Disease Progression|1
670533|NCT01824342|2166512|P1|Overall Study|Disease Progression|1
670534|NCT01824342|2166511|P2|Overall Study|Adverse Event|1
670535|NCT01824342|2166512|P1|Overall Study|Adverse Event|1
670536|NCT01824342|2166511|P2|Overall Study|Withdrawal by Subject|3
670537|NCT01824342|2166512|P1|Overall Study|Withdrawal by Subject|0
670538|NCT01824303|2166526|P2|Randomized Study|Other Miscellaneous Reasons|0
670539|NCT01824303|2166527|P1|Randomized Study|Other Miscellaneous Reasons|1
670540|NCT01824303|2166526|P2|Randomized Study|Withdrawal by Subject|1
670541|NCT01824303|2166527|P1|Randomized Study|Withdrawal by Subject|1
670542|NCT01823679|2166555|P1|Overall Study|Death|1
670543|NCT01823536|2166608|P6|Overall Study|Subject moved out of the state|0
670544|NCT01823536|2166609|P5|Overall Study|Subject moved out of the state|1
670545|NCT01823536|2166610|P4|Overall Study|Subject moved out of the state|0
670546|NCT01823536|2166611|P3|Overall Study|Subject moved out of the state|0
670547|NCT01823536|2166612|P2|Overall Study|Subject moved out of the state|0
670548|NCT01823536|2166613|P1|Overall Study|Subject moved out of the state|0
670549|NCT01823536|2166608|P6|Overall Study|Met exclusion criterion No 6|0
670550|NCT01823536|2166609|P5|Overall Study|Met exclusion criterion No 6|0
670551|NCT01823536|2166610|P4|Overall Study|Met exclusion criterion No 6|1
670552|NCT01823536|2166611|P3|Overall Study|Met exclusion criterion No 6|0
670553|NCT01823536|2166612|P2|Overall Study|Met exclusion criterion No 6|0
670554|NCT01823536|2166613|P1|Overall Study|Met exclusion criterion No 6|0
670555|NCT01823536|2166608|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
670556|NCT01823536|2166609|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
670557|NCT01823536|2166610|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
670558|NCT01823536|2166611|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
670559|NCT01823536|2166612|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
670560|NCT01823536|2166613|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
670561|NCT01823536|2166608|P6|Overall Study|Withdrawal by Subject|0
670562|NCT01823536|2166609|P5|Overall Study|Withdrawal by Subject|0
670563|NCT01823536|2166610|P4|Overall Study|Withdrawal by Subject|0
670564|NCT01823536|2166611|P3|Overall Study|Withdrawal by Subject|0
670565|NCT01823536|2166612|P2|Overall Study|Withdrawal by Subject|1
670566|NCT01823536|2166613|P1|Overall Study|Withdrawal by Subject|1
670567|NCT01823536|2166608|P6|Overall Study|Protocol Violation|0
670568|NCT01823536|2166609|P5|Overall Study|Protocol Violation|0
670569|NCT01823536|2166610|P4|Overall Study|Protocol Violation|0
670570|NCT01823536|2166611|P3|Overall Study|Protocol Violation|0
670571|NCT01823536|2166612|P2|Overall Study|Protocol Violation|1
670572|NCT01823536|2166613|P1|Overall Study|Protocol Violation|0
670573|NCT01823536|2166608|P6|Overall Study|Lost to Follow-up|0
670574|NCT01823536|2166609|P5|Overall Study|Lost to Follow-up|1
670575|NCT01823536|2166610|P4|Overall Study|Lost to Follow-up|1
670576|NCT01823536|2166611|P3|Overall Study|Lost to Follow-up|0
670577|NCT01823536|2166612|P2|Overall Study|Lost to Follow-up|0
670578|NCT01823536|2166613|P1|Overall Study|Lost to Follow-up|1
670579|NCT01823341|2166664|P1|Overall Study|Adverse Event|1
670580|NCT01823341|2166664|P1|Overall Study|Withdrawal by Subject|7
670581|NCT01823341|2166664|P1|Overall Study|Failed run-in|7
670582|NCT01823289|2166707|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
670583|NCT01823289|2166707|P1|Overall Study|Drug affected efficacy and safety|1
670584|NCT01823289|2166707|P1|Overall Study|Transaminase increased more than 3 times|1
670585|NCT01823289|2166707|P1|Overall Study|Administered contraindicated medicine|1
670586|NCT01823289|2166707|P1|Overall Study|Physician Decision|9
670587|NCT01823289|2166707|P1|Overall Study|Lack of Efficacy|1
670588|NCT01823289|2166707|P1|Overall Study|Adverse Event|5
670589|NCT01823289|2166707|P1|Overall Study|Lost to Follow-up|5
670590|NCT01823224|2166715|P2|Overall Study|Withdrawal by Subject|1
670591|NCT01823224|2166716|P1|Overall Study|Withdrawal by Subject|0
670592|NCT01823224|2166715|P2|Overall Study|missed med dose|1
670593|NCT01823224|2166716|P1|Overall Study|missed med dose|0
670594|NCT01823224|2166715|P2|Overall Study|pharmacy error|1
670595|NCT01823224|2166716|P1|Overall Study|pharmacy error|0
670596|NCT01823224|2166715|P2|Overall Study|didn't qualify|2
670597|NCT01823224|2166716|P1|Overall Study|didn't qualify|1
670598|NCT01823224|2166715|P2|Overall Study|Lost to Follow-up|6
670599|NCT01823224|2166716|P1|Overall Study|Lost to Follow-up|5
670600|NCT01823146|2166726|P2|Overall Study|Lost to Follow-up|1
670601|NCT01823146|2166727|P1|Overall Study|Lost to Follow-up|2
670602|NCT01823146|2166726|P2|Overall Study|Withdrawal by Subject|1
670603|NCT01823146|2166727|P1|Overall Study|Withdrawal by Subject|0
670604|NCT01822899|2166739|P2|Overall Study|Withdrawal by Subject|7
670605|NCT01822899|2166740|P1|Overall Study|Withdrawal by Subject|5
670606|NCT01822899|2166739|P2|Overall Study|Lost to Follow-up|0
670607|NCT01822899|2166740|P1|Overall Study|Lost to Follow-up|1
670608|NCT01822899|2166739|P2|Overall Study|Protocol Violation|3
670609|NCT01822899|2166740|P1|Overall Study|Protocol Violation|6
670610|NCT01822899|2166739|P2|Overall Study|Lack of Efficacy|3
670611|NCT01822899|2166740|P1|Overall Study|Lack of Efficacy|6
670612|NCT01822899|2166739|P2|Overall Study|Adverse Event|5
670613|NCT01822899|2166740|P1|Overall Study|Adverse Event|6
670614|NCT01822821|2166750|P2|Overall Study|Other reasons|0
670615|NCT01822821|2166751|P1|Overall Study|Other reasons|1
670616|NCT01822821|2166750|P2|Overall Study|Eligible surgery cancelled|1
670617|NCT01822821|2166751|P1|Overall Study|Eligible surgery cancelled|1
670618|NCT01822756|2166780|P5|Overall Study|disease progression & patient preference|0
670619|NCT01822756|2166781|P4|Overall Study|disease progression & patient preference|0
670620|NCT01822756|2166782|P3|Overall Study|disease progression & patient preference|1
670621|NCT01822756|2166783|P2|Overall Study|disease progression & patient preference|0
670622|NCT01822756|2166784|P1|Overall Study|disease progression & patient preference|2
670623|NCT01822756|2166780|P5|Overall Study|Physician Decision|0
670624|NCT01822756|2166781|P4|Overall Study|Physician Decision|0
670625|NCT01822756|2166782|P3|Overall Study|Physician Decision|0
670626|NCT01822756|2166783|P2|Overall Study|Physician Decision|1
670627|NCT01822756|2166784|P1|Overall Study|Physician Decision|0
670628|NCT01822756|2166780|P5|Overall Study|Lost to Follow-up|1
670629|NCT01822756|2166781|P4|Overall Study|Lost to Follow-up|0
670630|NCT01822756|2166782|P3|Overall Study|Lost to Follow-up|1
670631|NCT01822756|2166783|P2|Overall Study|Lost to Follow-up|0
670632|NCT01822756|2166784|P1|Overall Study|Lost to Follow-up|1
670633|NCT01822756|2166780|P5|Overall Study|Death|0
670634|NCT01822756|2166781|P4|Overall Study|Death|0
670635|NCT01822756|2166782|P3|Overall Study|Death|1
670636|NCT01822756|2166783|P2|Overall Study|Death|2
670637|NCT01822756|2166784|P1|Overall Study|Death|2
670638|NCT01822756|2166780|P5|Overall Study|Disease progression|6
670639|NCT01822756|2166781|P4|Overall Study|Disease progression|2
670640|NCT01822756|2166782|P3|Overall Study|Disease progression|7
670641|NCT01822756|2166783|P2|Overall Study|Disease progression|1
670642|NCT01822756|2166784|P1|Overall Study|Disease progression|11
670643|NCT01822756|2166780|P5|Overall Study|Adverse Event|0
670644|NCT01822756|2166781|P4|Overall Study|Adverse Event|2
670645|NCT01822756|2166782|P3|Overall Study|Adverse Event|0
670646|NCT01822756|2166783|P2|Overall Study|Adverse Event|0
670647|NCT01822756|2166784|P1|Overall Study|Adverse Event|0
670648|NCT01822691|2166826|P1|Overall Study|Withdrawal by Subject|2
670649|NCT01822678|2166837|P3|Overall Study|Lost to Follow-up|1
670650|NCT01822678|2166838|P2|Overall Study|Lost to Follow-up|2
670651|NCT01822678|2166839|P1|Overall Study|Lost to Follow-up|0
670652|NCT01822678|2166837|P3|Overall Study|Lack of Efficacy|5
670653|NCT01822678|2166838|P2|Overall Study|Lack of Efficacy|6
670654|NCT01822678|2166839|P1|Overall Study|Lack of Efficacy|3
670655|NCT01822678|2166837|P3|Overall Study|Adverse Event|1
670656|NCT01822678|2166838|P2|Overall Study|Adverse Event|3
670657|NCT01822678|2166839|P1|Overall Study|Adverse Event|4
670658|NCT01822678|2166837|P3|Overall Study|Withdrawal by Subject|4
670659|NCT01822678|2166838|P2|Overall Study|Withdrawal by Subject|4
670660|NCT01822678|2166839|P1|Overall Study|Withdrawal by Subject|5
670661|NCT01822665|2166847|P1|Overall Study|Other Reason|5
670662|NCT01822665|2166847|P1|Overall Study|Adverse Event|3
670663|NCT01822535|2166903|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
670664|NCT01822535|2166904|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
670665|NCT01822535|2166903|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
670666|NCT01822535|2166904|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
670667|NCT01822535|2166903|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
670668|NCT01822535|2166904|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
670669|NCT01822223|2166928|P2|Overall Study|Death|1
670670|NCT01822223|2166929|P1|Overall Study|Death|0
670671|NCT01821963|2166974|P1|Overall Study|Adverse Event|1
670672|NCT01821937|2166980|P2|Overall Study|Adverse Event|3
670673|NCT01821937|2166981|P1|Overall Study|Adverse Event|0
670674|NCT01821807|2167005|P2|Overall Study|Lost to Follow-up|1
670675|NCT01821807|2167006|P1|Overall Study|Lost to Follow-up|3
670676|NCT01821118|2167094|P2|Overall Study|Death|1
670677|NCT01821118|2167095|P1|Overall Study|Death|0
670678|NCT01820585|2167138|P4|Overall Study|Pregnancy|0
670679|NCT01820585|2167139|P3|Overall Study|Pregnancy|0
670680|NCT01820585|2167140|P2|Overall Study|Pregnancy|1
670681|NCT01820585|2167141|P1|Overall Study|Pregnancy|0
670682|NCT01820585|2167138|P4|Overall Study|at sponsor request|0
670683|NCT01820585|2167139|P3|Overall Study|at sponsor request|1
670684|NCT01820585|2167140|P2|Overall Study|at sponsor request|0
670685|NCT01820585|2167141|P1|Overall Study|at sponsor request|0
670686|NCT01820585|2167138|P4|Overall Study|Subject non-compliance|2
670687|NCT01820585|2167139|P3|Overall Study|Subject non-compliance|1
670688|NCT01820585|2167140|P2|Overall Study|Subject non-compliance|0
670689|NCT01820585|2167141|P1|Overall Study|Subject non-compliance|0
670690|NCT01820585|2167138|P4|Overall Study|Protocol Violation|1
670691|NCT01820585|2167139|P3|Overall Study|Protocol Violation|1
670692|NCT01820585|2167140|P2|Overall Study|Protocol Violation|1
670693|NCT01820585|2167141|P1|Overall Study|Protocol Violation|3
670694|NCT01820585|2167138|P4|Overall Study|Lost to Follow-up|3
670695|NCT01820585|2167139|P3|Overall Study|Lost to Follow-up|0
670696|NCT01820585|2167140|P2|Overall Study|Lost to Follow-up|3
670697|NCT01820585|2167141|P1|Overall Study|Lost to Follow-up|3
670698|NCT01820585|2167138|P4|Overall Study|Withdrawal by Subject|8
670699|NCT01820585|2167139|P3|Overall Study|Withdrawal by Subject|3
670700|NCT01820585|2167140|P2|Overall Study|Withdrawal by Subject|7
670701|NCT01820585|2167141|P1|Overall Study|Withdrawal by Subject|3
670702|NCT01820585|2167138|P4|Overall Study|Lack of Efficacy|1
670703|NCT01820585|2167139|P3|Overall Study|Lack of Efficacy|5
670704|NCT01820585|2167140|P2|Overall Study|Lack of Efficacy|7
670705|NCT01820585|2167141|P1|Overall Study|Lack of Efficacy|9
670706|NCT01820585|2167138|P4|Overall Study|Adverse Event|34
670707|NCT01820585|2167139|P3|Overall Study|Adverse Event|23
670708|NCT01820585|2167140|P2|Overall Study|Adverse Event|13
670709|NCT01820585|2167141|P1|Overall Study|Adverse Event|9
670710|NCT01820559|2167154|P3|Overall Study|Lack of Efficacy|3
670711|NCT01820559|2167155|P2|Overall Study|Lack of Efficacy|2
670712|NCT01820559|2167156|P1|Overall Study|Lack of Efficacy|3
670713|NCT01820559|2167154|P3|Overall Study|At sponsor request|1
670714|NCT01820559|2167155|P2|Overall Study|At sponsor request|0
670715|NCT01820559|2167156|P1|Overall Study|At sponsor request|0
670716|NCT01820559|2167154|P3|Overall Study|Lost to Follow-up|2
670717|NCT01820559|2167155|P2|Overall Study|Lost to Follow-up|2
670718|NCT01820559|2167156|P1|Overall Study|Lost to Follow-up|3
670719|NCT01820559|2167154|P3|Overall Study|Subject's non-compliance|2
670720|NCT01820559|2167155|P2|Overall Study|Subject's non-compliance|0
670721|NCT01820559|2167156|P1|Overall Study|Subject's non-compliance|1
670722|NCT01820559|2167154|P3|Overall Study|Protocol Violation|3
670723|NCT01820559|2167155|P2|Overall Study|Protocol Violation|1
670724|NCT01820559|2167156|P1|Overall Study|Protocol Violation|2
670725|NCT01820559|2167154|P3|Overall Study|Withdrawal by Subject|5
670726|NCT01820559|2167155|P2|Overall Study|Withdrawal by Subject|2
670727|NCT01820559|2167156|P1|Overall Study|Withdrawal by Subject|1
670728|NCT01820559|2167154|P3|Overall Study|Adverse Event|13
670729|NCT01820559|2167155|P2|Overall Study|Adverse Event|6
670730|NCT01820559|2167156|P1|Overall Study|Adverse Event|4
670731|NCT01820364|2167177|P2|Part II: LGX818 + MEK162|Study Termination|1
670732|NCT01820364|2167178|P1|Part II: LGX818 + MEK162|Study Termination|0
670733|NCT01820364|2167177|P2|Part I: LGX818|Disease Progression|0
670734|NCT01820364|2167178|P1|Part I: LGX818|Disease Progression|4
670735|NCT01820364|2167177|P2|Part I: LGX818|Adverse Event|0
670736|NCT01820364|2167178|P1|Part I: LGX818|Adverse Event|6
670737|NCT01820364|2167177|P2|Part I: LGX818|Administrative Problems|0
670738|NCT01820364|2167178|P1|Part I: LGX818|Administrative Problems|3
670739|NCT01820364|2167177|P2|Part I: LGX818|Death|0
670740|NCT01820364|2167178|P1|Part I: LGX818|Death|1
670741|NCT01819272|2167353|P6|Overall Study|Loss of Glucose Control|0
670742|NCT01819272|2167354|P5|Overall Study|Loss of Glucose Control|2
670743|NCT01819272|2167355|P4|Overall Study|Loss of Glucose Control|1
670744|NCT01819272|2167356|P3|Overall Study|Loss of Glucose Control|0
670745|NCT01819272|2167357|P2|Overall Study|Loss of Glucose Control|1
670746|NCT01819272|2167358|P1|Overall Study|Loss of Glucose Control|2
670747|NCT01819272|2167353|P6|Overall Study|Withdrawal of Consent|1
670748|NCT01819272|2167354|P5|Overall Study|Withdrawal of Consent|0
670749|NCT01819272|2167355|P4|Overall Study|Withdrawal of Consent|1
670750|NCT01819272|2167356|P3|Overall Study|Withdrawal of Consent|2
670751|NCT01819272|2167357|P2|Overall Study|Withdrawal of Consent|1
670752|NCT01819272|2167358|P1|Overall Study|Withdrawal of Consent|0
670753|NCT01819272|2167353|P6|Overall Study|Physician Decision|0
670754|NCT01819272|2167354|P5|Overall Study|Physician Decision|0
670755|NCT01819272|2167355|P4|Overall Study|Physician Decision|0
670756|NCT01819272|2167356|P3|Overall Study|Physician Decision|0
670757|NCT01819272|2167357|P2|Overall Study|Physician Decision|1
670758|NCT01819272|2167358|P1|Overall Study|Physician Decision|0
670759|NCT01819272|2167353|P6|Overall Study|Protocol Violation|3
670760|NCT01819272|2167354|P5|Overall Study|Protocol Violation|2
670761|NCT01819272|2167355|P4|Overall Study|Protocol Violation|1
670762|NCT01819272|2167356|P3|Overall Study|Protocol Violation|0
670763|NCT01819272|2167357|P2|Overall Study|Protocol Violation|0
670764|NCT01819272|2167358|P1|Overall Study|Protocol Violation|0
670765|NCT01819272|2167353|P6|Overall Study|Lost to Follow-up|3
670766|NCT01819272|2167354|P5|Overall Study|Lost to Follow-up|0
670767|NCT01819272|2167355|P4|Overall Study|Lost to Follow-up|0
670768|NCT01819272|2167356|P3|Overall Study|Lost to Follow-up|1
670769|NCT01819272|2167357|P2|Overall Study|Lost to Follow-up|0
670770|NCT01819272|2167358|P1|Overall Study|Lost to Follow-up|3
670771|NCT01819272|2167353|P6|Overall Study|Adverse Event|0
670772|NCT01819272|2167354|P5|Overall Study|Adverse Event|0
670773|NCT01819272|2167355|P4|Overall Study|Adverse Event|2
670774|NCT01819272|2167356|P3|Overall Study|Adverse Event|0
670775|NCT01819272|2167357|P2|Overall Study|Adverse Event|0
670776|NCT01819272|2167358|P1|Overall Study|Adverse Event|1
670777|NCT01819194|2167384|P1|Overall Study|Loss of study articles|2
670778|NCT01818752|2167391|P2|Overall Study|Randomized but not Dosed|4
670779|NCT01818752|2167392|P1|Overall Study|Randomized but not Dosed|7
670780|NCT01818752|2167391|P2|Overall Study|Continuing Treatment|4
670781|NCT01818752|2167392|P1|Overall Study|Continuing Treatment|1
670782|NCT01818752|2167391|P2|Overall Study|Other|8
670783|NCT01818752|2167392|P1|Overall Study|Other|7
670784|NCT01818752|2167391|P2|Overall Study|Disease Progression|48
670785|NCT01818752|2167392|P1|Overall Study|Disease Progression|54
670786|NCT01818752|2167391|P2|Overall Study|Physician Decision|8
670787|NCT01818752|2167392|P1|Overall Study|Physician Decision|9
670788|NCT01818752|2167391|P2|Overall Study|Withdrawal by Subject|14
670789|NCT01818752|2167392|P1|Overall Study|Withdrawal by Subject|15
670790|NCT01818752|2167391|P2|Overall Study|Non-compliance|20
670791|NCT01818752|2167392|P1|Overall Study|Non-compliance|16
670792|NCT01818752|2167391|P2|Overall Study|Death|18
670793|NCT01818752|2167392|P1|Overall Study|Death|14
670794|NCT01818752|2167391|P2|Overall Study|Adverse Event|74
670795|NCT01818752|2167392|P1|Overall Study|Adverse Event|64
670796|NCT01818700|2167410|P1|Overall Study|Other|1
670797|NCT01818700|2167410|P1|Overall Study|Protocol Violation|2
670798|NCT01818700|2167410|P1|Overall Study|Withdrawal by Subject|27
670799|NCT01818700|2167410|P1|Overall Study|Lost to Follow-up|5
670800|NCT01818700|2167410|P1|Overall Study|Lack of Efficacy|2
670801|NCT01818700|2167410|P1|Overall Study|Adverse Event|67
670802|NCT01818596|2167421|P2|Overall Study|Still on Study|6
670803|NCT01818596|2167422|P1|Overall Study|Still on Study|232
670804|NCT01818596|2167421|P2|Overall Study|Lost to Follow-up|0
670805|NCT01818596|2167422|P1|Overall Study|Lost to Follow-up|2
670806|NCT01818596|2167421|P2|Overall Study|Protocol Violation|0
670807|NCT01818596|2167422|P1|Overall Study|Protocol Violation|1
670808|NCT01818596|2167421|P2|Overall Study|Withdrew Consent|0
670809|NCT01818596|2167422|P1|Overall Study|Withdrew Consent|3
670810|NCT01818596|2167421|P2|Overall Study|Adverse Event|0
670811|NCT01818596|2167422|P1|Overall Study|Adverse Event|4
670812|NCT01818596|2167421|P2|Overall Study|Enrolled but Not Treated|0
670813|NCT01818596|2167422|P1|Overall Study|Enrolled but Not Treated|4
670814|NCT01818336|2167470|P2|Overall Study|Lost to Follow-up|1
670815|NCT01818336|2167471|P1|Overall Study|Lost to Follow-up|0
670816|NCT01818336|2167470|P2|Overall Study|Declined retest visit|11
670817|NCT01818336|2167471|P1|Overall Study|Declined retest visit|0
670818|NCT01818297|2167479|P2|Open Label Phase (3-12 Months)|Early study closure|10
670819|NCT01818297|2167480|P1|Open Label Phase (3-12 Months)|Early study closure|17
670820|NCT01818297|2167479|P2|Open Label Phase (3-12 Months)|Physician Decision|0
670821|NCT01818297|2167480|P1|Open Label Phase (3-12 Months)|Physician Decision|1
670822|NCT01818297|2167479|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
670823|NCT01818297|2167480|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
670824|NCT01818141|2167498|P2|Overall Study|Lost to Follow-up|2
670825|NCT01818141|2167499|P1|Overall Study|Lost to Follow-up|0
670826|NCT01818141|2167498|P2|Overall Study|No baseline C.diff colonies|1
670827|NCT01818141|2167499|P1|Overall Study|No baseline C.diff colonies|1
670828|NCT01818141|2167498|P2|Overall Study|Withdrawal by Subject|0
670829|NCT01818141|2167499|P1|Overall Study|Withdrawal by Subject|2
670830|NCT01817790|2167555|P2|Overall Study|Other: Could not attend appointment|1
670831|NCT01817790|2167556|P1|Overall Study|Other: Could not attend appointment|1
670832|NCT01817790|2167555|P2|Overall Study|Withdrawal by Subject|3
670833|NCT01817790|2167556|P1|Overall Study|Withdrawal by Subject|1
670834|NCT01817790|2167555|P2|Overall Study|Protocol Violation|1
670835|NCT01817790|2167556|P1|Overall Study|Protocol Violation|2
670836|NCT01817790|2167555|P2|Overall Study|Lost to Follow-up|1
670837|NCT01817790|2167556|P1|Overall Study|Lost to Follow-up|0
670838|NCT01817790|2167555|P2|Overall Study|Adverse Event|2
670839|NCT01817790|2167556|P1|Overall Study|Adverse Event|0
670840|NCT01817777|2167600|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
670841|NCT01817777|2167601|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
670842|NCT01817777|2167602|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
670843|NCT01817777|2167600|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
670844|NCT01817777|2167601|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
670845|NCT01817777|2167602|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
670846|NCT01817777|2167600|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
670847|NCT01817777|2167601|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
670848|NCT01817777|2167602|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
670849|NCT01817777|2167600|P3|Observational Phase (8 Weeks)|Early Study Termination|0
670850|NCT01817777|2167601|P2|Observational Phase (8 Weeks)|Early Study Termination|0
670851|NCT01817777|2167602|P1|Observational Phase (8 Weeks)|Early Study Termination|2
670852|NCT01817777|2167600|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
670853|NCT01817777|2167601|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
670854|NCT01817777|2167602|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
888698|NCT01791517|2822624|P2|Phase I: Period 2|Lost to Follow-up|3
888699|NCT01791517|2822625|P1|Phase I: Period 2|Lost to Follow-up|0
888700|NCT01791517|2822614|P12|Phase I: Period 2|Lens Discomfort|0
888701|NCT01791517|2822615|P11|Phase I: Period 2|Lens Discomfort|0
888702|NCT01791517|2822616|P10|Phase I: Period 2|Lens Discomfort|0
888703|NCT01791517|2822617|P9|Phase I: Period 2|Lens Discomfort|0
888704|NCT01791517|2822618|P8|Phase I: Period 2|Lens Discomfort|0
888705|NCT01791517|2822619|P7|Phase I: Period 2|Lens Discomfort|0
888706|NCT01791517|2822620|P6|Phase I: Period 2|Lens Discomfort|1
888707|NCT01791517|2822621|P5|Phase I: Period 2|Lens Discomfort|0
670865|NCT01817725|2167635|P1|Overall Study|Withdrawal by Subject|1
670866|NCT01816685|2167665|P2|Overall Study|Surgery Cancelled|2
670867|NCT01816685|2167666|P1|Overall Study|Surgery Cancelled|3
670868|NCT01816685|2167665|P2|Overall Study|Lost to Follow-up|9
670869|NCT01816685|2167666|P1|Overall Study|Lost to Follow-up|7
670870|NCT01816477|2167676|P2|Overall Study|Unable to tolerate catheter placement|0
670871|NCT01816477|2167677|P1|Overall Study|Unable to tolerate catheter placement|3
670872|NCT01816477|2167676|P2|Overall Study|Withdrawal by Subject|1
670873|NCT01816477|2167677|P1|Overall Study|Withdrawal by Subject|13
670874|NCT01816295|2167731|P2|OLE Phase|Lack of Efficacy|7
670875|NCT01816295|2167732|P1|OLE Phase|Lack of Efficacy|3
670876|NCT01816295|2167731|P2|OLE Phase|Withdrawal by Subject|10
670877|NCT01816295|2167732|P1|OLE Phase|Withdrawal by Subject|10
670878|NCT01816295|2167731|P2|OLE Phase|Sponsor Decision|9
670879|NCT01816295|2167732|P1|OLE Phase|Sponsor Decision|7
670880|NCT01816295|2167731|P2|OLE Phase|Protocol Violation|4
670881|NCT01816295|2167732|P1|OLE Phase|Protocol Violation|4
670882|NCT01816295|2167731|P2|OLE Phase|Physician Decision|1
670883|NCT01816295|2167732|P1|OLE Phase|Physician Decision|3
670884|NCT01816295|2167731|P2|OLE Phase|Lost to Follow-up|5
670885|NCT01816295|2167732|P1|OLE Phase|Lost to Follow-up|5
670886|NCT01816295|2167731|P2|OLE Phase|Entry Criteria Not Met|5
670887|NCT01816295|2167732|P1|OLE Phase|Entry Criteria Not Met|3
670888|NCT01816295|2167731|P2|OLE Phase|Death|0
670889|NCT01816295|2167732|P1|OLE Phase|Death|1
670890|NCT01816295|2167731|P2|OLE Phase|Adverse Event|15
670891|NCT01816295|2167732|P1|OLE Phase|Adverse Event|17
670892|NCT01816295|2167731|P2|Double Blind Phase|Withdrawal by Subject|20
670893|NCT01816295|2167732|P1|Double Blind Phase|Withdrawal by Subject|22
670894|NCT01816295|2167731|P2|Double Blind Phase|Sponsor Decision|8
670895|NCT01816295|2167732|P1|Double Blind Phase|Sponsor Decision|8
670896|NCT01816295|2167731|P2|Double Blind Phase|Protocol Violation|11
670897|NCT01816295|2167732|P1|Double Blind Phase|Protocol Violation|17
670898|NCT01816295|2167731|P2|Double Blind Phase|Physician Decision|2
670899|NCT01816295|2167732|P1|Double Blind Phase|Physician Decision|2
670900|NCT01816295|2167731|P2|Double Blind Phase|Lost to Follow-up|5
670901|NCT01816295|2167732|P1|Double Blind Phase|Lost to Follow-up|3
670902|NCT01816295|2167731|P2|Double Blind Phase|Entry Criteria Not Met|2
670903|NCT01816295|2167732|P1|Double Blind Phase|Entry Criteria Not Met|0
670904|NCT01816295|2167731|P2|Double Blind Phase|Adverse Event|8
670905|NCT01816295|2167732|P1|Double Blind Phase|Adverse Event|11
670906|NCT01816243|2167747|P1|Overall Study|Amputation|3
670907|NCT01816243|2167747|P1|Overall Study|Not eligible for the study|1
670908|NCT01816243|2167747|P1|Overall Study|Lack of Efficacy|1
670909|NCT01816243|2167747|P1|Overall Study|Lost to Follow-up|1
670910|NCT01816243|2167747|P1|Overall Study|Adverse Event|6
888708|NCT01791517|2822622|P4|Phase I: Period 2|Lens Discomfort|0
888709|NCT01791517|2822623|P3|Phase I: Period 2|Lens Discomfort|0
888710|NCT01791517|2822624|P2|Phase I: Period 2|Lens Discomfort|0
670915|NCT01815918|2167769|P2|Overall Study|Lack of Efficacy|15
670916|NCT01815918|2167770|P1|Overall Study|Lack of Efficacy|15
670917|NCT01815918|2167769|P2|Overall Study|Patient samples not analyzable|4
670918|NCT01815918|2167770|P1|Overall Study|Patient samples not analyzable|3
670919|NCT01815840|2167786|P2|Overall Study|Sponsor Termination Treatment|0
670920|NCT01815840|2167787|P1|Overall Study|Sponsor Termination Treatment|1
670921|NCT01815840|2167786|P2|Overall Study|Refused Treatment|1
670922|NCT01815840|2167787|P1|Overall Study|Refused Treatment|5
670923|NCT01815840|2167786|P2|Overall Study|Lost to Follow-up|6
670924|NCT01815840|2167787|P1|Overall Study|Lost to Follow-up|3
670925|NCT01815840|2167786|P2|Overall Study|Investigators Decision|3
670926|NCT01815840|2167787|P1|Overall Study|Investigators Decision|2
670927|NCT01815840|2167786|P2|Overall Study|Disease progression|2
670928|NCT01815840|2167787|P1|Overall Study|Disease progression|3
670929|NCT01815840|2167786|P2|Overall Study|Death|2
670930|NCT01815840|2167787|P1|Overall Study|Death|2
670931|NCT01815840|2167786|P2|Overall Study|Adverse Event|16
670932|NCT01815840|2167787|P1|Overall Study|Adverse Event|10
670933|NCT01815840|2167786|P2|Overall Study|Administrative/Other|3
670934|NCT01815840|2167787|P1|Overall Study|Administrative/Other|1
670935|NCT01815840|2167786|P2|Overall Study|Withdrew Consent|30
670936|NCT01815840|2167787|P1|Overall Study|Withdrew Consent|31
670937|NCT01815840|2167786|P2|Overall Study|Missing|0
670938|NCT01815840|2167787|P1|Overall Study|Missing|1
670939|NCT01815736|2167817|P2|Overall Study|Still on Study|449
670940|NCT01815736|2167818|P1|Overall Study|Still on Study|929
670941|NCT01815736|2167817|P2|Overall Study|Lost to Follow-up|7
670942|NCT01815736|2167818|P1|Overall Study|Lost to Follow-up|6
670943|NCT01815736|2167817|P2|Overall Study|Withdrew Consent|15
670944|NCT01815736|2167818|P1|Overall Study|Withdrew Consent|7
670945|NCT01815736|2167817|P2|Overall Study|Investigator's Discretion|0
670946|NCT01815736|2167818|P1|Overall Study|Investigator's Discretion|4
670947|NCT01815736|2167817|P2|Overall Study|Death|0
670948|NCT01815736|2167818|P1|Overall Study|Death|4
670949|NCT01815736|2167817|P2|Overall Study|Adverse Event|4
670950|NCT01815736|2167818|P1|Overall Study|Adverse Event|7
670951|NCT01815736|2167817|P2|Overall Study|Randomized but Not Treated|3
670952|NCT01815736|2167818|P1|Overall Study|Randomized but Not Treated|4
670953|NCT01815138|2167866|P2|Overall Study|Physician Decision|5
670954|NCT01815138|2167867|P1|Overall Study|Physician Decision|8
670955|NCT01815138|2167866|P2|Overall Study|Withdrawal by Subject|1
670956|NCT01815138|2167867|P1|Overall Study|Withdrawal by Subject|0
670957|NCT01815099|2167879|P1|Overall Study|unable to attend study visits|1
670958|NCT01815099|2167879|P1|Overall Study|Lack of Efficacy|1
670959|NCT01814878|2167893|P2|Overall Study|Unspecified|0
670960|NCT01814878|2167894|P1|Overall Study|Unspecified|2
670961|NCT01814878|2167893|P2|Overall Study|Screening failure (drop-out)|3
670962|NCT01814878|2167894|P1|Overall Study|Screening failure (drop-out)|0
670963|NCT01814878|2167893|P2|Overall Study|Physician Decision|1
670964|NCT01814878|2167894|P1|Overall Study|Physician Decision|3
670965|NCT01814878|2167893|P2|Overall Study|Protocol Violation|5
670966|NCT01814878|2167894|P1|Overall Study|Protocol Violation|5
670967|NCT01814878|2167893|P2|Overall Study|Withdrawal by Subject|16
670968|NCT01814878|2167894|P1|Overall Study|Withdrawal by Subject|20
670969|NCT01814878|2167893|P2|Overall Study|Adverse Event|5
670970|NCT01814878|2167894|P1|Overall Study|Adverse Event|16
670971|NCT01814800|2167914|P1|Overall Study|Subject relocation|1
670972|NCT01814800|2167914|P1|Overall Study|Sponsor decision|1
670973|NCT01814800|2167914|P1|Overall Study|Pregnancy|1
670974|NCT01814800|2167914|P1|Overall Study|Adverse Event|2
670975|NCT01814761|2167974|P2|Overall Study|Lost to Follow-up|5
670976|NCT01814761|2167975|P1|Overall Study|Lost to Follow-up|1
670977|NCT01814761|2167974|P2|Overall Study|Ocular Adverse Event|15
670978|NCT01814761|2167975|P1|Overall Study|Ocular Adverse Event|6
670979|NCT01814761|2167974|P2|Overall Study|Other Reasons|10
670980|NCT01814761|2167975|P1|Overall Study|Other Reasons|1
670987|NCT01814696|2168034|P2|Overall Study|Randomized to wrong group|0
670988|NCT01814696|2168035|P1|Overall Study|Randomized to wrong group|1
670989|NCT01814696|2168034|P2|Overall Study|Withdrawal by Subject|0
670990|NCT01814696|2168035|P1|Overall Study|Withdrawal by Subject|1
670991|NCT01814670|2168053|P1|Overall Study|Protocol Violation|12
670992|NCT01814553|2168063|P2|Overall Study|Other than stated|8
670993|NCT01814553|2168064|P1|Overall Study|Other than stated|7
670994|NCT01814553|2168063|P2|Overall Study|Withdrawal by Subject|1
670995|NCT01814553|2168064|P1|Overall Study|Withdrawal by Subject|1
670996|NCT01814553|2168063|P2|Overall Study|Other Adverse Event|5
670997|NCT01814553|2168064|P1|Overall Study|Other Adverse Event|4
670998|NCT01814553|2168063|P2|Overall Study|PD per clinical progression|8
670999|NCT01814553|2168064|P1|Overall Study|PD per clinical progression|6
671000|NCT01814397|2168078|P1|Overall Study|Withdrawal by Subject|7
671001|NCT01814397|2168078|P1|Overall Study|Adverse Event|7
671002|NCT01814332|2168087|P2|Overall Study|Lost to Follow-up|1
671003|NCT01814332|2168088|P1|Overall Study|Lost to Follow-up|5
671004|NCT01814332|2168087|P2|Overall Study|Protocol Violation|4
671005|NCT01814332|2168088|P1|Overall Study|Protocol Violation|0
671006|NCT01814332|2168087|P2|Overall Study|Withdrawal by Subject|8
671007|NCT01814332|2168088|P1|Overall Study|Withdrawal by Subject|3
671008|NCT01814332|2168087|P2|Overall Study|Adverse Event|3
671009|NCT01814332|2168088|P1|Overall Study|Adverse Event|8
671010|NCT01814137|2168110|P2|Overall Study|Unclassified|1
671011|NCT01814137|2168111|P1|Overall Study|Unclassified|2
671012|NCT01814137|2168110|P2|Overall Study|Physician Decision|1
671013|NCT01814137|2168111|P1|Overall Study|Physician Decision|1
671014|NCT01814137|2168110|P2|Overall Study|Withdrawal by Subject|2
671015|NCT01814137|2168111|P1|Overall Study|Withdrawal by Subject|2
671016|NCT01814137|2168110|P2|Overall Study|Adverse Event|1
671017|NCT01814137|2168111|P1|Overall Study|Adverse Event|0
671018|NCT01814046|2168127|P3|Drug Administration|Death due to complications of RSV|0
671019|NCT01814046|2168128|P2|Drug Administration|Death due to complications of RSV|0
671020|NCT01814046|2168129|P1|Drug Administration|Death due to complications of RSV|1
671021|NCT01813890|2168143|P3|Overall Study|Lack of Efficacy|2
671022|NCT01813890|2168144|P2|Overall Study|Lack of Efficacy|1
671023|NCT01813890|2168145|P1|Overall Study|Lack of Efficacy|9
671024|NCT01813890|2168143|P3|Overall Study|Adverse Event|4
671025|NCT01813890|2168144|P2|Overall Study|Adverse Event|3
671026|NCT01813890|2168145|P1|Overall Study|Adverse Event|0
671027|NCT01813721|2168174|P1|Overall Study|Withdrawal by Subject|1
671028|NCT01813721|2168174|P1|Overall Study|Ineligibility determined|63
671029|NCT01813019|2168235|P2|Overall Study|Protocol Deviation|1
671030|NCT01813019|2168236|P1|Overall Study|Protocol Deviation|2
671031|NCT01813019|2168235|P2|Overall Study|administrative problems|0
671032|NCT01813019|2168236|P1|Overall Study|administrative problems|2
671033|NCT01813019|2168235|P2|Overall Study|Withdrawal by Subject|2
671034|NCT01813019|2168236|P1|Overall Study|Withdrawal by Subject|3
671035|NCT01813019|2168235|P2|Overall Study|Adverse Event|3
671036|NCT01813019|2168236|P1|Overall Study|Adverse Event|0
671037|NCT01812837|2168247|P3|Overall Study|Protocol Violation|0
671038|NCT01812837|2168248|P2|Overall Study|Protocol Violation|0
671039|NCT01812837|2168249|P1|Overall Study|Protocol Violation|1
671040|NCT01812837|2168247|P3|Overall Study|Lost to Follow-up|0
671041|NCT01812837|2168248|P2|Overall Study|Lost to Follow-up|1
671042|NCT01812837|2168249|P1|Overall Study|Lost to Follow-up|1
671043|NCT01812707|2168261|P4|Overall Study|Consent withdrawn by participant|0
671044|NCT01812707|2168262|P3|Overall Study|Consent withdrawn by participant|0
671045|NCT01812707|2168263|P2|Overall Study|Consent withdrawn by participant|0
671046|NCT01812707|2168264|P1|Overall Study|Consent withdrawn by participant|1
671047|NCT01812707|2168261|P4|Overall Study|Poor compliance to protocol|0
671048|NCT01812707|2168262|P3|Overall Study|Poor compliance to protocol|0
671049|NCT01812707|2168263|P2|Overall Study|Poor compliance to protocol|0
671050|NCT01812707|2168264|P1|Overall Study|Poor compliance to protocol|1
671051|NCT01812707|2168261|P4|Overall Study|Adverse Event|2
671052|NCT01812707|2168262|P3|Overall Study|Adverse Event|0
671053|NCT01812707|2168263|P2|Overall Study|Adverse Event|0
671054|NCT01812707|2168264|P1|Overall Study|Adverse Event|0
671055|NCT01812655|2168312|P3|Overall Study|Protocol Violation|0
671056|NCT01812655|2168313|P2|Overall Study|Protocol Violation|1
671057|NCT01812655|2168314|P1|Overall Study|Protocol Violation|1
671058|NCT01812057|2168339|P2|Overall Study|Physician Decision|0
671059|NCT01812057|2168340|P1|Overall Study|Physician Decision|1
671060|NCT01812057|2168339|P2|Overall Study|Protocol Violation|0
671061|NCT01812057|2168340|P1|Overall Study|Protocol Violation|1
671062|NCT01811953|2168418|P6|Overall Study|Protocol Violation|0
671063|NCT01811953|2168419|P5|Overall Study|Protocol Violation|1
671064|NCT01811953|2168420|P4|Overall Study|Protocol Violation|0
671065|NCT01811953|2168421|P3|Overall Study|Protocol Violation|0
671066|NCT01811953|2168422|P2|Overall Study|Protocol Violation|0
671067|NCT01811953|2168423|P1|Overall Study|Protocol Violation|0
671068|NCT01811953|2168418|P6|Overall Study|Adverse Event|1
671069|NCT01811953|2168419|P5|Overall Study|Adverse Event|0
671070|NCT01811953|2168420|P4|Overall Study|Adverse Event|1
671071|NCT01811953|2168421|P3|Overall Study|Adverse Event|0
671072|NCT01811953|2168422|P2|Overall Study|Adverse Event|0
671073|NCT01811953|2168423|P1|Overall Study|Adverse Event|0
671074|NCT01811732|2168469|P2|Overall Study|Correct study drug not available on site|0
671075|NCT01811732|2168470|P1|Overall Study|Correct study drug not available on site|1
671076|NCT01811732|2168469|P2|Overall Study|Admitted to another facility|0
671077|NCT01811732|2168470|P1|Overall Study|Admitted to another facility|1
671078|NCT01811732|2168469|P2|Overall Study|Subject incarcerated|2
671079|NCT01811732|2168470|P1|Overall Study|Subject incarcerated|1
671080|NCT01811732|2168469|P2|Overall Study|Protocol Violation|1
671081|NCT01811732|2168470|P1|Overall Study|Protocol Violation|0
671082|NCT01811732|2168469|P2|Overall Study|Insufficient venous access|1
671083|NCT01811732|2168470|P1|Overall Study|Insufficient venous access|0
671084|NCT01811732|2168469|P2|Overall Study|Death|1
671085|NCT01811732|2168470|P1|Overall Study|Death|1
671086|NCT01811732|2168469|P2|Overall Study|Physician Decision|0
671087|NCT01811732|2168470|P1|Overall Study|Physician Decision|2
671088|NCT01811732|2168469|P2|Overall Study|Non-compliance with study drug/procedure|3
671089|NCT01811732|2168470|P1|Overall Study|Non-compliance with study drug/procedure|3
671090|NCT01811732|2168469|P2|Overall Study|Lack of Efficacy|1
671091|NCT01811732|2168470|P1|Overall Study|Lack of Efficacy|3
671092|NCT01811732|2168469|P2|Overall Study|Adverse Event|9
671093|NCT01811732|2168470|P1|Overall Study|Adverse Event|3
671094|NCT01811732|2168469|P2|Overall Study|Withdrawal by Subject|10
671095|NCT01811732|2168470|P1|Overall Study|Withdrawal by Subject|16
671096|NCT01811732|2168469|P2|Overall Study|Lost to Follow-up|30
671097|NCT01811732|2168470|P1|Overall Study|Lost to Follow-up|24
671098|NCT01811706|2168480|P2|First Intervention ( 4 Weeks)|Adverse Event|0
671099|NCT01811706|2168481|P1|First Intervention ( 4 Weeks)|Adverse Event|1
671100|NCT01811563|2168498|P2|Overall Study|Incorrect Randomization procedure|1
671101|NCT01811563|2168499|P1|Overall Study|Incorrect Randomization procedure|0
671102|NCT01811563|2168498|P2|Overall Study|Lost to Follow-up|2
671103|NCT01811563|2168499|P1|Overall Study|Lost to Follow-up|5
671104|NCT01811485|2168528|P3|Overall Study|Protocol Deviation|0
671105|NCT01811485|2168529|P2|Overall Study|Protocol Deviation|1
671106|NCT01811485|2168530|P1|Overall Study|Protocol Deviation|0
671107|NCT01811485|2168528|P3|Overall Study|Administrative problems|0
671108|NCT01811485|2168529|P2|Overall Study|Administrative problems|0
671109|NCT01811485|2168530|P1|Overall Study|Administrative problems|1
671110|NCT01811485|2168528|P3|Overall Study|Unsatisfactory therapeutic effect|3
671111|NCT01811485|2168529|P2|Overall Study|Unsatisfactory therapeutic effect|0
671112|NCT01811485|2168530|P1|Overall Study|Unsatisfactory therapeutic effect|0
671113|NCT01811485|2168528|P3|Overall Study|Adverse Event|2
671114|NCT01811485|2168529|P2|Overall Study|Adverse Event|3
671115|NCT01811485|2168530|P1|Overall Study|Adverse Event|1
671116|NCT01811472|2168550|P3|Overall Study|Subject/guardian decision|0
671117|NCT01811472|2168551|P2|Overall Study|Subject/guardian decision|0
671118|NCT01811472|2168552|P1|Overall Study|Subject/guardian decision|1
671119|NCT01811472|2168550|P3|Overall Study|Lost to Follow-up|1
671120|NCT01811472|2168551|P2|Overall Study|Lost to Follow-up|0
671121|NCT01811472|2168552|P1|Overall Study|Lost to Follow-up|0
671122|NCT01811472|2168550|P3|Overall Study|Adverse Event|4
671123|NCT01811472|2168551|P2|Overall Study|Adverse Event|0
671124|NCT01811472|2168552|P1|Overall Study|Adverse Event|1
671125|NCT01811238|2168639|P1|Overall Study|subject refused study medication|6
671126|NCT01811238|2168639|P1|Overall Study|Lack of Efficacy|4
671127|NCT01811238|2168639|P1|Overall Study|Protocol Violation|4
671128|NCT01811238|2168639|P1|Overall Study|Adverse Event|25
671129|NCT01811238|2168639|P1|Overall Study|Withdrawal by Subject|42
671130|NCT01811186|2168650|P2|Overall Study|Lost to Follow-up|2
671131|NCT01811186|2168651|P1|Overall Study|Lost to Follow-up|4
671132|NCT01811186|2168650|P2|Overall Study|Lack of Efficacy|6
671133|NCT01811186|2168651|P1|Overall Study|Lack of Efficacy|3
671134|NCT01811186|2168650|P2|Overall Study|Withdrawal by Subject|10
671135|NCT01811186|2168651|P1|Overall Study|Withdrawal by Subject|5
671136|NCT01811186|2168650|P2|Overall Study|Protocol Violation|6
671137|NCT01811186|2168651|P1|Overall Study|Protocol Violation|5
671138|NCT01811186|2168650|P2|Overall Study|Adverse Event|38
671139|NCT01811186|2168651|P1|Overall Study|Adverse Event|54
671140|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
671141|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
671142|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
671143|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
671144|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
671145|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
671146|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
671147|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
671148|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
671149|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
671150|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
671151|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
671152|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
671153|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
671154|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
671155|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
671156|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
671157|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
671158|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Death|1
671159|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Death|0
671160|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Death|0
671161|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
671162|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
671163|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
671164|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
671165|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
671166|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
671167|NCT01810939|2168684|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
671168|NCT01810939|2168685|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
671169|NCT01810939|2168686|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
671170|NCT01810939|2168684|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
671171|NCT01810939|2168685|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
671172|NCT01810939|2168686|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
671173|NCT01810939|2168684|P3|Part A Treatment Period|Protocol-specified (High K+)|0
671174|NCT01810939|2168685|P2|Part A Treatment Period|Protocol-specified (High K+)|0
671175|NCT01810939|2168686|P1|Part A Treatment Period|Protocol-specified (High K+)|3
671176|NCT01810939|2168684|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
671177|NCT01810939|2168685|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
671178|NCT01810939|2168686|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
671179|NCT01810939|2168684|P3|Part A Treatment Period|Withdrawal by Subject|0
671180|NCT01810939|2168685|P2|Part A Treatment Period|Withdrawal by Subject|0
671181|NCT01810939|2168686|P1|Part A Treatment Period|Withdrawal by Subject|5
671182|NCT01810939|2168684|P3|Part A Treatment Period|Adverse Event|0
671183|NCT01810939|2168685|P2|Part A Treatment Period|Adverse Event|0
671184|NCT01810939|2168686|P1|Part A Treatment Period|Adverse Event|10
671185|NCT01810939|2168684|P3|Part A Treatment Period|Protocol Violation|0
671186|NCT01810939|2168685|P2|Part A Treatment Period|Protocol Violation|0
671187|NCT01810939|2168686|P1|Part A Treatment Period|Protocol Violation|2
671188|NCT01810939|2168684|P3|Part A Treatment Period|Non-compliance with Study Drug|0
671189|NCT01810939|2168685|P2|Part A Treatment Period|Non-compliance with Study Drug|0
671190|NCT01810939|2168686|P1|Part A Treatment Period|Non-compliance with Study Drug|1
671191|NCT01810783|2168699|P1|Overall Study|Enrolled, not treated|1
671192|NCT01810783|2168699|P1|Overall Study|Adminstrative or other reason(s)|23
671193|NCT01810783|2168699|P1|Overall Study|Non-compliance with IMP|4
671194|NCT01810783|2168699|P1|Overall Study|Protocol Violation|5
671195|NCT01810783|2168699|P1|Overall Study|Lost to Follow-up|10
671196|NCT01810783|2168699|P1|Overall Study|Lack of Efficacy|12
671197|NCT01810783|2168699|P1|Overall Study|Withdrawal by Subject|22
671198|NCT01810783|2168699|P1|Overall Study|Adverse Event|32
671199|NCT01810380|2168727|P3|Overall Study|Administrative or other reasons|9
671200|NCT01810380|2168728|P2|Overall Study|Administrative or other reasons|13
671201|NCT01810380|2168729|P1|Overall Study|Administrative or other reasons|11
671202|NCT01810380|2168727|P3|Overall Study|Withdrawal by Subject|6
671203|NCT01810380|2168728|P2|Overall Study|Withdrawal by Subject|0
671204|NCT01810380|2168729|P1|Overall Study|Withdrawal by Subject|6
671205|NCT01810380|2168727|P3|Overall Study|Protocol Violation|1
671206|NCT01810380|2168728|P2|Overall Study|Protocol Violation|0
671207|NCT01810380|2168729|P1|Overall Study|Protocol Violation|1
671208|NCT01810380|2168727|P3|Overall Study|Lack of Efficacy|11
671209|NCT01810380|2168728|P2|Overall Study|Lack of Efficacy|10
671210|NCT01810380|2168729|P1|Overall Study|Lack of Efficacy|24
671211|NCT01810380|2168727|P3|Overall Study|Adverse Event|4
671212|NCT01810380|2168728|P2|Overall Study|Adverse Event|14
671213|NCT01810380|2168729|P1|Overall Study|Adverse Event|11
671214|NCT01810380|2168727|P3|Overall Study|Randomised not treated|1
671215|NCT01810380|2168728|P2|Overall Study|Randomised not treated|1
671216|NCT01810380|2168729|P1|Overall Study|Randomised not treated|2
671217|NCT01810302|2168790|P2|Overall Study|Physician Decision|1
671218|NCT01810302|2168791|P1|Overall Study|Physician Decision|0
671219|NCT01810302|2168790|P2|Overall Study|Death|0
671220|NCT01810302|2168791|P1|Overall Study|Death|1
671221|NCT01810263|2168810|P2|Overall Study|Lost to Follow-up|7
671222|NCT01810263|2168811|P1|Overall Study|Lost to Follow-up|8
671223|NCT01810042|2168817|P1|Overall Study|Lost to Follow-up|10
671224|NCT01809327|2168872|P5|Overall Study|Unspecified|9
671225|NCT01809327|2168873|P4|Overall Study|Unspecified|4
671226|NCT01809327|2168874|P3|Overall Study|Unspecified|7
671227|NCT01809327|2168875|P2|Overall Study|Unspecified|15
671228|NCT01809327|2168876|P1|Overall Study|Unspecified|14
671229|NCT01809327|2168872|P5|Overall Study|Pregnancy|0
671230|NCT01809327|2168873|P4|Overall Study|Pregnancy|0
671231|NCT01809327|2168874|P3|Overall Study|Pregnancy|0
671232|NCT01809327|2168875|P2|Overall Study|Pregnancy|0
671233|NCT01809327|2168876|P1|Overall Study|Pregnancy|1
671234|NCT01809327|2168872|P5|Overall Study|Physician Decision|0
671235|NCT01809327|2168873|P4|Overall Study|Physician Decision|0
671236|NCT01809327|2168874|P3|Overall Study|Physician Decision|0
671237|NCT01809327|2168875|P2|Overall Study|Physician Decision|1
671238|NCT01809327|2168876|P1|Overall Study|Physician Decision|1
671239|NCT01809327|2168872|P5|Overall Study|Protocol Violation|0
671240|NCT01809327|2168873|P4|Overall Study|Protocol Violation|0
671241|NCT01809327|2168874|P3|Overall Study|Protocol Violation|0
671242|NCT01809327|2168875|P2|Overall Study|Protocol Violation|1
671243|NCT01809327|2168876|P1|Overall Study|Protocol Violation|0
671244|NCT01809327|2168872|P5|Overall Study|Death|0
671245|NCT01809327|2168873|P4|Overall Study|Death|0
671246|NCT01809327|2168874|P3|Overall Study|Death|0
671247|NCT01809327|2168875|P2|Overall Study|Death|0
671248|NCT01809327|2168876|P1|Overall Study|Death|1
671249|NCT01809327|2168872|P5|Overall Study|Adverse Event|8
671250|NCT01809327|2168873|P4|Overall Study|Adverse Event|4
671251|NCT01809327|2168874|P3|Overall Study|Adverse Event|7
671252|NCT01809327|2168875|P2|Overall Study|Adverse Event|3
671253|NCT01809327|2168876|P1|Overall Study|Adverse Event|4
671254|NCT01809327|2168872|P5|Overall Study|Withdrawal by Subject|5
671255|NCT01809327|2168873|P4|Overall Study|Withdrawal by Subject|2
671256|NCT01809327|2168874|P3|Overall Study|Withdrawal by Subject|4
671257|NCT01809327|2168875|P2|Overall Study|Withdrawal by Subject|4
671258|NCT01809327|2168876|P1|Overall Study|Withdrawal by Subject|6
671259|NCT01809327|2168872|P5|Overall Study|Lost to Follow-up|3
671260|NCT01809327|2168873|P4|Overall Study|Lost to Follow-up|2
671261|NCT01809327|2168874|P3|Overall Study|Lost to Follow-up|4
671262|NCT01809327|2168875|P2|Overall Study|Lost to Follow-up|2
671263|NCT01809327|2168876|P1|Overall Study|Lost to Follow-up|5
671264|NCT01809314|2168918|P1|Overall Study|Lost to Follow-up|724
671265|NCT01809314|2168918|P1|Overall Study|Insufficient Therapeutic Response|14
671266|NCT01809314|2168918|P1|Overall Study|Adverse Event|6
671267|NCT01809314|2168918|P1|Overall Study|Withdrawal Prior to Treatment|1
671268|NCT01809262|2168924|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
671269|NCT01809262|2168925|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
671270|NCT01809262|2168926|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
671271|NCT01809262|2168927|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
671272|NCT01809262|2168928|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
671273|NCT01809262|2168929|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
671274|NCT01809262|2168930|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
671275|NCT01809262|2168931|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
671276|NCT01809262|2168932|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
671277|NCT01809262|2168933|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
671278|NCT01809262|2168924|P10|Period 1 (First Dose + Washout)|Adverse Event|0
671279|NCT01809262|2168925|P9|Period 1 (First Dose + Washout)|Adverse Event|0
671280|NCT01809262|2168926|P8|Period 1 (First Dose + Washout)|Adverse Event|0
671281|NCT01809262|2168927|P7|Period 1 (First Dose + Washout)|Adverse Event|0
671282|NCT01809262|2168928|P6|Period 1 (First Dose + Washout)|Adverse Event|0
671283|NCT01809262|2168929|P5|Period 1 (First Dose + Washout)|Adverse Event|1
671284|NCT01809262|2168930|P4|Period 1 (First Dose + Washout)|Adverse Event|0
671285|NCT01809262|2168931|P3|Period 1 (First Dose + Washout)|Adverse Event|0
671286|NCT01809262|2168932|P2|Period 1 (First Dose + Washout)|Adverse Event|0
671287|NCT01809262|2168933|P1|Period 1 (First Dose + Washout)|Adverse Event|0
671288|NCT01809197|2169002|P2|Overall Study|Product not available|1
671289|NCT01809197|2169003|P1|Overall Study|Product not available|0
671290|NCT01809197|2169002|P2|Overall Study|Withdrawal by Subject|1
671291|NCT01809197|2169003|P1|Overall Study|Withdrawal by Subject|1
671292|NCT01809197|2169002|P2|Overall Study|Decision Unrelated to an Adverse Event|0
671293|NCT01809197|2169003|P1|Overall Study|Decision Unrelated to an Adverse Event|1
671294|NCT01809197|2169002|P2|Overall Study|Non-Compliance|1
671295|NCT01809197|2169003|P1|Overall Study|Non-Compliance|1
671296|NCT01809197|2169002|P2|Overall Study|Failed slit lamp exam|0
671297|NCT01809197|2169003|P1|Overall Study|Failed slit lamp exam|1
671298|NCT01809197|2169002|P2|Overall Study|Adverse Event|3
671299|NCT01809197|2169003|P1|Overall Study|Adverse Event|2
671300|NCT01809197|2169002|P2|Overall Study|Lost to Follow-up|2
671301|NCT01809197|2169003|P1|Overall Study|Lost to Follow-up|4
671302|NCT01808651|2169074|P3|Study Period 1|Participant Decision|3
671303|NCT01808651|2169075|P2|Study Period 1|Participant Decision|7
671304|NCT01808651|2169076|P1|Study Period 1|Participant Decision|9
671305|NCT01808651|2169074|P3|Study Period 1|Adverse Event|1
671306|NCT01808651|2169075|P2|Study Period 1|Adverse Event|4
671307|NCT01808651|2169076|P1|Study Period 1|Adverse Event|10
671308|NCT01808651|2169074|P3|Study Period 1|Lack of Efficacy|0
671309|NCT01808651|2169075|P2|Study Period 1|Lack of Efficacy|1
671310|NCT01808651|2169076|P1|Study Period 1|Lack of Efficacy|2
671311|NCT01808651|2169074|P3|Study Period 1|Physician Decision|0
671312|NCT01808651|2169075|P2|Study Period 1|Physician Decision|2
671313|NCT01808651|2169076|P1|Study Period 1|Physician Decision|3
671314|NCT01808651|2169074|P3|Study Period 1|Protocol Violation|1
671315|NCT01808651|2169075|P2|Study Period 1|Protocol Violation|0
671316|NCT01808651|2169076|P1|Study Period 1|Protocol Violation|1
671317|NCT01808651|2169074|P3|Study Period 1|Lost to Follow-up|0
671318|NCT01808651|2169075|P2|Study Period 1|Lost to Follow-up|3
671319|NCT01808651|2169076|P1|Study Period 1|Lost to Follow-up|1
671320|NCT01808612|2169111|P3|Discontinuation Period|Lost to Follow-up|0
671321|NCT01808612|2169112|P2|Discontinuation Period|Lost to Follow-up|1
671322|NCT01808612|2169113|P1|Discontinuation Period|Lost to Follow-up|0
671323|NCT01808612|2169111|P3|Discontinuation Period|Physician Decision|0
671324|NCT01808612|2169112|P2|Discontinuation Period|Physician Decision|0
671325|NCT01808612|2169113|P1|Discontinuation Period|Physician Decision|1
671326|NCT01808612|2169111|P3|Discontinuation Period|Adverse Event|0
671327|NCT01808612|2169112|P2|Discontinuation Period|Adverse Event|0
671328|NCT01808612|2169113|P1|Discontinuation Period|Adverse Event|1
671329|NCT01808612|2169111|P3|Treatment Period|Lack of Efficacy|2
671330|NCT01808612|2169112|P2|Treatment Period|Lack of Efficacy|1
671331|NCT01808612|2169113|P1|Treatment Period|Lack of Efficacy|1
671332|NCT01808612|2169111|P3|Treatment Period|Sponsor Decision|0
671333|NCT01808612|2169112|P2|Treatment Period|Sponsor Decision|0
671334|NCT01808612|2169113|P1|Treatment Period|Sponsor Decision|1
671335|NCT01808612|2169111|P3|Treatment Period|Physician Decision|4
671336|NCT01808612|2169112|P2|Treatment Period|Physician Decision|0
671337|NCT01808612|2169113|P1|Treatment Period|Physician Decision|1
671338|NCT01808612|2169111|P3|Treatment Period|Withdrawal by Subject|4
671339|NCT01808612|2169112|P2|Treatment Period|Withdrawal by Subject|0
671340|NCT01808612|2169113|P1|Treatment Period|Withdrawal by Subject|1
671341|NCT01808612|2169111|P3|Treatment Period|Protocol Violation|0
671342|NCT01808612|2169112|P2|Treatment Period|Protocol Violation|0
671343|NCT01808612|2169113|P1|Treatment Period|Protocol Violation|1
671344|NCT01808612|2169111|P3|Treatment Period|Lost to Follow-up|1
671345|NCT01808612|2169112|P2|Treatment Period|Lost to Follow-up|2
671346|NCT01808612|2169113|P1|Treatment Period|Lost to Follow-up|2
671347|NCT01808612|2169111|P3|Treatment Period|Adverse Event|3
671348|NCT01808612|2169112|P2|Treatment Period|Adverse Event|4
671349|NCT01808612|2169113|P1|Treatment Period|Adverse Event|8
671350|NCT01808534|2169151|P1|Overall Study|Physician Decision|1
671351|NCT01808534|2169151|P1|Overall Study|Disease progression|3
671352|NCT01808508|2169162|P3|Overall Study|Lost to Follow-up|0
671353|NCT01808508|2169163|P2|Overall Study|Lost to Follow-up|0
671354|NCT01808508|2169164|P1|Overall Study|Lost to Follow-up|1
671355|NCT01808339|2169181|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
671356|NCT01808339|2169182|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
671357|NCT01808339|2169183|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
671358|NCT01808339|2169184|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
671359|NCT01808339|2169185|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
671360|NCT01808339|2169186|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
671361|NCT01808339|2169181|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
671362|NCT01808339|2169182|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
671363|NCT01808339|2169183|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
671364|NCT01808339|2169184|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
671365|NCT01808339|2169185|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
671366|NCT01808339|2169186|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
671367|NCT01808339|2169181|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
671368|NCT01808339|2169182|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
671369|NCT01808339|2169183|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
671370|NCT01808339|2169184|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
671371|NCT01808339|2169185|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
671372|NCT01808339|2169186|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
671373|NCT01808313|2169230|P1|Overall Study|Physician Decision|1
671374|NCT01808313|2169230|P1|Overall Study|Lost to Follow-up|1
671375|NCT01808313|2169230|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
671376|NCT01808313|2169230|P1|Overall Study|Protocol Violation|2
671377|NCT01808313|2169230|P1|Overall Study|Adverse Event|5
671388|NCT01808248|2169317|P1|Overall Study|Lost to Follow-up|1
671389|NCT01808248|2169317|P1|Overall Study|Withdrawal by Subject|1
671390|NCT01808248|2169317|P1|Overall Study|Lack of Efficacy|3
671391|NCT01808209|2169331|P2|Overall Study|Lost to Follow-up|1
671392|NCT01808209|2169332|P1|Overall Study|Lost to Follow-up|0
671393|NCT01808092|2169376|P2|Overall Study|Other Eligibility criteria|5
671394|NCT01808092|2169377|P1|Overall Study|Other Eligibility criteria|3
671395|NCT01808092|2169376|P2|Overall Study|Withdrawal by Subject|4
671396|NCT01808092|2169377|P1|Overall Study|Withdrawal by Subject|9
671397|NCT01808092|2169376|P2|Overall Study|Lost to Follow-up|7
671398|NCT01808092|2169377|P1|Overall Study|Lost to Follow-up|3
671399|NCT01808092|2169376|P2|Overall Study|Death|29
671400|NCT01808092|2169377|P1|Overall Study|Death|39
671401|NCT01808066|2169479|P1|Overall Study|Withdrawal by Subject|15
671402|NCT01807949|2169486|P3|Overall Study|Randomized But Not Treated|2
671403|NCT01807949|2169487|P2|Overall Study|Randomized But Not Treated|2
671404|NCT01807949|2169488|P1|Overall Study|Randomized But Not Treated|0
671405|NCT01807949|2169486|P3|Overall Study|Undefined|2
671406|NCT01807949|2169487|P2|Overall Study|Undefined|1
671407|NCT01807949|2169488|P1|Overall Study|Undefined|0
671408|NCT01807949|2169486|P3|Overall Study|Non-Compliance|1
671409|NCT01807949|2169487|P2|Overall Study|Non-Compliance|0
671410|NCT01807949|2169488|P1|Overall Study|Non-Compliance|0
671411|NCT01807949|2169486|P3|Overall Study|Withdrawal by Subject|2
671412|NCT01807949|2169487|P2|Overall Study|Withdrawal by Subject|2
671413|NCT01807949|2169488|P1|Overall Study|Withdrawal by Subject|1
671414|NCT01807949|2169486|P3|Overall Study|Adverse Event|2
671415|NCT01807949|2169487|P2|Overall Study|Adverse Event|2
671416|NCT01807949|2169488|P1|Overall Study|Adverse Event|1
671417|NCT01807923|2169540|P3|Overall Study|Randomized But Not Treated|5
671418|NCT01807923|2169541|P2|Overall Study|Randomized But Not Treated|2
671419|NCT01807923|2169542|P1|Overall Study|Randomized But Not Treated|3
671420|NCT01807923|2169540|P3|Overall Study|Not Eligible (Genotype)|1
671421|NCT01807923|2169541|P2|Overall Study|Not Eligible (Genotype)|0
671422|NCT01807923|2169542|P1|Overall Study|Not Eligible (Genotype)|0
671423|NCT01807923|2169540|P3|Overall Study|Physician Decision|1
671424|NCT01807923|2169541|P2|Overall Study|Physician Decision|0
671425|NCT01807923|2169542|P1|Overall Study|Physician Decision|0
671426|NCT01807923|2169540|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
671427|NCT01807923|2169541|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
671428|NCT01807923|2169542|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
671429|NCT01807923|2169540|P3|Overall Study|Adverse Event|2
671430|NCT01807923|2169541|P2|Overall Study|Adverse Event|1
671431|NCT01807923|2169542|P1|Overall Study|Adverse Event|2
671432|NCT01807234|2169634|P6|Overall Study|Lack of Efficacy|1
671433|NCT01807234|2169635|P5|Overall Study|Lack of Efficacy|1
671434|NCT01807234|2169636|P4|Overall Study|Lack of Efficacy|0
671435|NCT01807234|2169637|P3|Overall Study|Lack of Efficacy|0
671436|NCT01807234|2169638|P2|Overall Study|Lack of Efficacy|0
671437|NCT01807234|2169639|P1|Overall Study|Lack of Efficacy|0
671438|NCT01807234|2169634|P6|Overall Study|Withdrawal by Subject|1
671439|NCT01807234|2169635|P5|Overall Study|Withdrawal by Subject|2
671440|NCT01807234|2169636|P4|Overall Study|Withdrawal by Subject|1
671441|NCT01807234|2169637|P3|Overall Study|Withdrawal by Subject|1
671442|NCT01807234|2169638|P2|Overall Study|Withdrawal by Subject|1
671443|NCT01807234|2169639|P1|Overall Study|Withdrawal by Subject|3
671444|NCT01807234|2169634|P6|Overall Study|Lost to Follow-up|2
671445|NCT01807234|2169635|P5|Overall Study|Lost to Follow-up|1
671446|NCT01807234|2169636|P4|Overall Study|Lost to Follow-up|1
671447|NCT01807234|2169637|P3|Overall Study|Lost to Follow-up|1
671448|NCT01807234|2169638|P2|Overall Study|Lost to Follow-up|5
671449|NCT01807234|2169639|P1|Overall Study|Lost to Follow-up|2
671450|NCT01807156|2169674|P1|Overall Study|Physician Decision|1
671451|NCT01806961|2169698|P1|Overall Study|sponsor decision|16
671452|NCT01806779|2169741|P3|Overall Study|Withdrawal by Subject|22
671453|NCT01806779|2169742|P2|Overall Study|Withdrawal by Subject|23
671454|NCT01806779|2169743|P1|Overall Study|Withdrawal by Subject|20
671455|NCT01806779|2169741|P3|Overall Study|Lost to Follow-up|0
671456|NCT01806779|2169742|P2|Overall Study|Lost to Follow-up|20
671457|NCT01806779|2169743|P1|Overall Study|Lost to Follow-up|19
671458|NCT01806779|2169741|P3|Overall Study|Lack of Efficacy|0
671459|NCT01806779|2169742|P2|Overall Study|Lack of Efficacy|1
671460|NCT01806779|2169743|P1|Overall Study|Lack of Efficacy|1
671461|NCT01806779|2169741|P3|Overall Study|Physician Decision|1
671462|NCT01806779|2169742|P2|Overall Study|Physician Decision|0
671463|NCT01806779|2169743|P1|Overall Study|Physician Decision|2
671464|NCT01806714|2169758|P2|Overall Study|No functioning phone number|170
671465|NCT01806714|2169759|P1|Overall Study|No functioning phone number|200
671466|NCT01806623|2169769|P1|Overall Study|Did not meet the inclusion criteria|56
671467|NCT01806623|2169769|P1|Overall Study|Adverse Event|1
671468|NCT01806623|2169769|P1|Overall Study|Withdrawal by Subject|1
671469|NCT01806584|2169788|P2|Overall Study|Other unspecified|0
671470|NCT01806584|2169789|P1|Overall Study|Other unspecified|1
671471|NCT01806584|2169788|P2|Overall Study|Withdrawal by Subject|1
671472|NCT01806584|2169789|P1|Overall Study|Withdrawal by Subject|1
671473|NCT01806584|2169788|P2|Overall Study|Study terminated by sponsor|14
671474|NCT01806584|2169789|P1|Overall Study|Study terminated by sponsor|9
671475|NCT01806584|2169788|P2|Overall Study|Lost to Follow-up|2
671476|NCT01806584|2169789|P1|Overall Study|Lost to Follow-up|0
671477|NCT01806584|2169788|P2|Overall Study|Death|0
671478|NCT01806584|2169789|P1|Overall Study|Death|1
671479|NCT01806584|2169788|P2|Overall Study|Adverse Event|1
671480|NCT01806584|2169789|P1|Overall Study|Adverse Event|2
671481|NCT01806545|2169803|P2|Overall Study|Withdrawal by Subject|2
671482|NCT01806545|2169804|P1|Overall Study|Withdrawal by Subject|3
671483|NCT01806545|2169803|P2|Overall Study|Lost to Follow-up|0
671484|NCT01806545|2169804|P1|Overall Study|Lost to Follow-up|1
671485|NCT01806545|2169803|P2|Overall Study|Adverse Event|3
671486|NCT01806545|2169804|P1|Overall Study|Adverse Event|2
671487|NCT01806389|2169826|P1|Overall Study|Withdrawal by Subject|4
671492|NCT01806051|2169850|P1|Overall Study|Withdrawal by Subject|6
671493|NCT01805180|2169919|P3|Lead-in Donor Phase|screen failure|0
671494|NCT01805180|2169920|P2|Lead-in Donor Phase|screen failure|0
671495|NCT01805180|2169921|P1|Lead-in Donor Phase|screen failure|1
671496|NCT01804946|2169959|P2|Overall Study|Do not meet inclusion criteria|2
671497|NCT01804946|2169960|P1|Overall Study|Do not meet inclusion criteria|1
671498|NCT01804946|2169959|P2|Overall Study|Insufficient data available|1
671499|NCT01804946|2169960|P1|Overall Study|Insufficient data available|0
671500|NCT01804946|2169959|P2|Overall Study|Adverse Event|1
671501|NCT01804946|2169960|P1|Overall Study|Adverse Event|0
671502|NCT01804946|2169959|P2|Overall Study|Protocol Violation|0
671503|NCT01804946|2169960|P1|Overall Study|Protocol Violation|1
888711|NCT01791517|2822625|P1|Phase I: Period 2|Lens Discomfort|0
888712|NCT01791517|2822614|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
888713|NCT01791517|2822615|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
888714|NCT01791517|2822616|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
888715|NCT01791517|2822617|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
888716|NCT01791517|2822618|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
888717|NCT01791517|2822619|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
888718|NCT01791517|2822620|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
888719|NCT01791517|2822621|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
888720|NCT01791517|2822622|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
671516|NCT01804673|2170017|P1|Overall Study|Unspecified|4
671517|NCT01804673|2170017|P1|Overall Study|Use of Prohibited Medication|1
671518|NCT01804673|2170017|P1|Overall Study|No Further Therapy Required|84
671519|NCT01804673|2170017|P1|Overall Study|Change to Oral Therapy|37
671520|NCT01804673|2170017|P1|Overall Study|Lack of Efficacy|9
671521|NCT01804673|2170017|P1|Overall Study|Withdrawal by Subject|1
671522|NCT01804673|2170017|P1|Overall Study|Adverse Event|4
671523|NCT01804140|2170037|P1|Overall Study|No sampling or biopsy procedures done|114
671524|NCT01803737|2170095|P2|Overall Study|Lost to Follow-up|2
671525|NCT01803737|2170096|P1|Overall Study|Lost to Follow-up|0
671526|NCT01803737|2170095|P2|Overall Study|Medical Reason|1
671527|NCT01803737|2170096|P1|Overall Study|Medical Reason|0
671528|NCT01803737|2170095|P2|Overall Study|Lack of Time|0
671529|NCT01803737|2170096|P1|Overall Study|Lack of Time|1
671530|NCT01803607|2170120|P2|Overall Study|Withdrawal by Subject|5
671531|NCT01803607|2170121|P1|Overall Study|Withdrawal by Subject|6
671532|NCT01803607|2170120|P2|Overall Study|Study terminated by sponsor|56
671533|NCT01803607|2170121|P1|Overall Study|Study terminated by sponsor|54
671534|NCT01803607|2170120|P2|Overall Study|Protocol Violation|2
671535|NCT01803607|2170121|P1|Overall Study|Protocol Violation|3
671536|NCT01803607|2170120|P2|Overall Study|Lack of Efficacy|1
671537|NCT01803607|2170121|P1|Overall Study|Lack of Efficacy|0
671538|NCT01803607|2170120|P2|Overall Study|Adverse Event|3
671539|NCT01803607|2170121|P1|Overall Study|Adverse Event|5
671570|NCT01802515|2170186|P3|Overall Study|Withdrawal by Subject|0
671571|NCT01802515|2170187|P2|Overall Study|Withdrawal by Subject|0
671572|NCT01802515|2170188|P1|Overall Study|Withdrawal by Subject|3
671573|NCT01802320|2170199|P1|Overall Study|Withdrawal by Subject|1
671574|NCT01802320|2170199|P1|Overall Study|Death|1
671575|NCT01801982|2170273|P1|Overall Study|Lost to Follow-up|1
671576|NCT01801735|2170283|P1|Overall Study|Other, including site closure|19
671577|NCT01801735|2170283|P1|Overall Study|Death|1
671578|NCT01801735|2170283|P1|Overall Study|Physician Decision|3
671579|NCT01801735|2170283|P1|Overall Study|Non-compliance with Trial Drug|13
671580|NCT01801735|2170283|P1|Overall Study|Lost to Follow-up|15
671581|NCT01801735|2170283|P1|Overall Study|Protocol Violation|25
671582|NCT01801735|2170283|P1|Overall Study|Withdrawal by Subject|27
671583|NCT01801735|2170283|P1|Overall Study|Lack of Efficacy|28
671584|NCT01801735|2170283|P1|Overall Study|Adverse Event|79
671585|NCT01801475|2170290|P5|Overall Study|Withdrawal by Subject|1
671586|NCT01801475|2170291|P4|Overall Study|Withdrawal by Subject|0
671587|NCT01801475|2170292|P3|Overall Study|Withdrawal by Subject|0
671588|NCT01801475|2170293|P2|Overall Study|Withdrawal by Subject|0
671589|NCT01801475|2170294|P1|Overall Study|Withdrawal by Subject|0
671590|NCT01801436|2170305|P1|Overall Study|Progressive disease|4
671591|NCT01801436|2170305|P1|Overall Study|Adverse Event|2
671592|NCT01801436|2170305|P1|Overall Study|Withdrawal by Subject|3
671593|NCT01801358|2170343|P6|Overall Study|Withdrawal by Subject|2
671594|NCT01801358|2170344|P5|Overall Study|Withdrawal by Subject|0
671595|NCT01801358|2170345|P4|Overall Study|Withdrawal by Subject|1
671596|NCT01801358|2170346|P3|Overall Study|Withdrawal by Subject|0
671597|NCT01801358|2170347|P2|Overall Study|Withdrawal by Subject|0
671598|NCT01801358|2170348|P1|Overall Study|Withdrawal by Subject|0
671599|NCT01801358|2170343|P6|Overall Study|Progressive Disease|5
671600|NCT01801358|2170344|P5|Overall Study|Progressive Disease|6
671601|NCT01801358|2170345|P4|Overall Study|Progressive Disease|5
671602|NCT01801358|2170346|P3|Overall Study|Progressive Disease|4
671603|NCT01801358|2170347|P2|Overall Study|Progressive Disease|4
671604|NCT01801358|2170348|P1|Overall Study|Progressive Disease|6
671605|NCT01801358|2170343|P6|Overall Study|Physician Decision|0
671606|NCT01801358|2170344|P5|Overall Study|Physician Decision|0
671607|NCT01801358|2170345|P4|Overall Study|Physician Decision|0
671608|NCT01801358|2170346|P3|Overall Study|Physician Decision|1
671609|NCT01801358|2170347|P2|Overall Study|Physician Decision|0
671610|NCT01801358|2170348|P1|Overall Study|Physician Decision|0
671611|NCT01801358|2170343|P6|Overall Study|Adverse Event|1
671612|NCT01801358|2170344|P5|Overall Study|Adverse Event|0
671613|NCT01801358|2170345|P4|Overall Study|Adverse Event|0
671614|NCT01801358|2170346|P3|Overall Study|Adverse Event|1
671615|NCT01801358|2170347|P2|Overall Study|Adverse Event|2
671616|NCT01801358|2170348|P1|Overall Study|Adverse Event|0
671617|NCT01801280|2170470|P4|Period 4|Protocol Violation|0
671618|NCT01801280|2170471|P3|Period 4|Protocol Violation|1
671619|NCT01801280|2170472|P2|Period 4|Protocol Violation|0
671620|NCT01801280|2170473|P1|Period 4|Protocol Violation|0
671621|NCT01801280|2170470|P4|Period 2|Withdrawal by Subject|0
671622|NCT01801280|2170471|P3|Period 2|Withdrawal by Subject|0
671623|NCT01801280|2170472|P2|Period 2|Withdrawal by Subject|0
671624|NCT01801280|2170473|P1|Period 2|Withdrawal by Subject|1
671625|NCT01801280|2170470|P4|Period 1|Withdrawal by Subject|0
671626|NCT01801280|2170471|P3|Period 1|Withdrawal by Subject|0
671627|NCT01801280|2170472|P2|Period 1|Withdrawal by Subject|1
671628|NCT01801280|2170473|P1|Period 1|Withdrawal by Subject|0
671629|NCT01801111|2170488|P1|Overall Study|On-going Survival Follow up|25
671630|NCT01801111|2170488|P1|Overall Study|Death|24
671631|NCT01801111|2170488|P1|Overall Study|Treatment On-going|89
671632|NCT01800968|2170513|P2|Overall Study|Physician Decision|0
671633|NCT01800968|2170514|P1|Overall Study|Physician Decision|1
671634|NCT01800968|2170513|P2|Overall Study|Withdrawal by Subject|9
671635|NCT01800968|2170514|P1|Overall Study|Withdrawal by Subject|7
671636|NCT01800968|2170513|P2|Overall Study|Lost to Follow-up|7
671637|NCT01800968|2170514|P1|Overall Study|Lost to Follow-up|5
671638|NCT01800968|2170513|P2|Overall Study|Death|16
671639|NCT01800968|2170514|P1|Overall Study|Death|23
671640|NCT01800916|2170556|P9|Test Period 1 (1 Week)|Adverse Event|0
671641|NCT01800916|2170557|P8|Test Period 1 (1 Week)|Adverse Event|0
671642|NCT01800916|2170558|P7|Test Period 1 (1 Week)|Adverse Event|0
671643|NCT01800916|2170559|P6|Test Period 1 (1 Week)|Adverse Event|0
671644|NCT01800916|2170560|P5|Test Period 1 (1 Week)|Adverse Event|1
671645|NCT01800916|2170561|P4|Test Period 1 (1 Week)|Adverse Event|0
671646|NCT01800916|2170562|P3|Test Period 1 (1 Week)|Adverse Event|0
671647|NCT01800916|2170563|P2|Test Period 1 (1 Week)|Adverse Event|0
671648|NCT01800916|2170564|P1|Test Period 1 (1 Week)|Adverse Event|0
671649|NCT01800916|2170556|P9|Test Period 1 (1 Week)|Convex product user|0
671650|NCT01800916|2170557|P8|Test Period 1 (1 Week)|Convex product user|0
671651|NCT01800916|2170558|P7|Test Period 1 (1 Week)|Convex product user|0
671652|NCT01800916|2170559|P6|Test Period 1 (1 Week)|Convex product user|0
671653|NCT01800916|2170560|P5|Test Period 1 (1 Week)|Convex product user|0
671654|NCT01800916|2170561|P4|Test Period 1 (1 Week)|Convex product user|1
671655|NCT01800916|2170562|P3|Test Period 1 (1 Week)|Convex product user|0
671656|NCT01800916|2170563|P2|Test Period 1 (1 Week)|Convex product user|0
671657|NCT01800916|2170564|P1|Test Period 1 (1 Week)|Convex product user|0
671658|NCT01800903|2170574|P6|Second Test Period|unable to catheterise|0
671659|NCT01800903|2170575|P5|Second Test Period|unable to catheterise|0
671660|NCT01800903|2170576|P4|Second Test Period|unable to catheterise|0
671661|NCT01800903|2170577|P3|Second Test Period|unable to catheterise|0
671662|NCT01800903|2170578|P2|Second Test Period|unable to catheterise|0
671663|NCT01800903|2170579|P1|Second Test Period|unable to catheterise|1
671664|NCT01799941|2170656|P1|Overall Study|Not Specified|15
671665|NCT01799941|2170656|P1|Overall Study|Lost to Follow-up|17
671666|NCT01799941|2170656|P1|Overall Study|Lack of Efficacy|3
671667|NCT01799941|2170656|P1|Overall Study|Investigator Decision|4
671668|NCT01799941|2170656|P1|Overall Study|Death|2
671669|NCT01799941|2170656|P1|Overall Study|Withdrawal by Subject|21
671670|NCT01799941|2170656|P1|Overall Study|Adverse Event|34
671671|NCT01799720|2170713|P3|Overall Study|Pregnancy|1
671672|NCT01799720|2170714|P2|Overall Study|Pregnancy|0
671673|NCT01799720|2170715|P1|Overall Study|Pregnancy|0
671674|NCT01799720|2170713|P3|Overall Study|Protocol Violation|0
671675|NCT01799720|2170714|P2|Overall Study|Protocol Violation|1
671676|NCT01799720|2170715|P1|Overall Study|Protocol Violation|0
671677|NCT01799720|2170713|P3|Overall Study|Withdrawal by Subject|0
671678|NCT01799720|2170714|P2|Overall Study|Withdrawal by Subject|0
671679|NCT01799720|2170715|P1|Overall Study|Withdrawal by Subject|3
671680|NCT01799590|2170753|P3|Overall Study|Unspecified|1
671681|NCT01799590|2170754|P2|Overall Study|Unspecified|0
671682|NCT01799590|2170755|P1|Overall Study|Unspecified|3
671683|NCT01799590|2170753|P3|Overall Study|Use of prohibited concomitant drugs|0
671684|NCT01799590|2170754|P2|Overall Study|Use of prohibited concomitant drugs|0
671685|NCT01799590|2170755|P1|Overall Study|Use of prohibited concomitant drugs|1
671686|NCT01799590|2170753|P3|Overall Study|Using drugs with restricted days of use|2
671687|NCT01799590|2170754|P2|Overall Study|Using drugs with restricted days of use|3
671688|NCT01799590|2170755|P1|Overall Study|Using drugs with restricted days of use|0
671689|NCT01799590|2170753|P3|Overall Study|Aggravation of complications|1
671690|NCT01799590|2170754|P2|Overall Study|Aggravation of complications|1
671691|NCT01799590|2170755|P1|Overall Study|Aggravation of complications|0
671692|NCT01799590|2170753|P3|Overall Study|Participants convenience|2
671693|NCT01799590|2170754|P2|Overall Study|Participants convenience|4
671694|NCT01799590|2170755|P1|Overall Study|Participants convenience|4
671695|NCT01799590|2170753|P3|Overall Study|Lack of Efficacy|3
671696|NCT01799590|2170754|P2|Overall Study|Lack of Efficacy|1
671697|NCT01799590|2170755|P1|Overall Study|Lack of Efficacy|3
671698|NCT01799590|2170753|P3|Overall Study|Pregnancy|0
671699|NCT01799590|2170754|P2|Overall Study|Pregnancy|0
671700|NCT01799590|2170755|P1|Overall Study|Pregnancy|2
671701|NCT01799590|2170753|P3|Overall Study|Adverse Event|5
671702|NCT01799590|2170754|P2|Overall Study|Adverse Event|7
671703|NCT01799590|2170755|P1|Overall Study|Adverse Event|13
671704|NCT01799239|2170790|P2|Period 2 (7 Days)|Protocol Violation|0
671705|NCT01799239|2170791|P1|Period 2 (7 Days)|Protocol Violation|1
671706|NCT01799239|2170790|P2|Period 2 (7 Days)|Withdrawal by Subject|1
671707|NCT01799239|2170791|P1|Period 2 (7 Days)|Withdrawal by Subject|1
671708|NCT01799239|2170790|P2|Period 1 (7 Days)|Protocol Violation|1
671709|NCT01799239|2170791|P1|Period 1 (7 Days)|Protocol Violation|0
671710|NCT01799239|2170790|P2|Period 1 (7 Days)|Withdrawal by Subject|0
671711|NCT01799239|2170791|P1|Period 1 (7 Days)|Withdrawal by Subject|2
671712|NCT01799239|2170790|P2|Period 1 (7 Days)|Lack of Efficacy|0
671713|NCT01799239|2170791|P1|Period 1 (7 Days)|Lack of Efficacy|1
671714|NCT01799226|2170799|P2|Overall Study|Disqualified at Day 14|0
671715|NCT01799226|2170800|P1|Overall Study|Disqualified at Day 14|1
671716|NCT01799226|2170799|P2|Overall Study|Withdrawal by Subject|0
671717|NCT01799226|2170800|P1|Overall Study|Withdrawal by Subject|1
671718|NCT01798992|2170812|P4|Overall Study|Insufficient biopsy tissue|0
671719|NCT01798992|2170813|P3|Overall Study|Insufficient biopsy tissue|1
671720|NCT01798992|2170814|P2|Overall Study|Insufficient biopsy tissue|0
671721|NCT01798992|2170815|P1|Overall Study|Insufficient biopsy tissue|0
671722|NCT01798992|2170812|P4|Overall Study|Lost to Follow-up|0
671723|NCT01798992|2170813|P3|Overall Study|Lost to Follow-up|1
671724|NCT01798992|2170814|P2|Overall Study|Lost to Follow-up|1
671725|NCT01798992|2170815|P1|Overall Study|Lost to Follow-up|0
671726|NCT01798992|2170812|P4|Overall Study|Administrative withdrawal|1
671727|NCT01798992|2170813|P3|Overall Study|Administrative withdrawal|0
671728|NCT01798992|2170814|P2|Overall Study|Administrative withdrawal|1
671729|NCT01798992|2170815|P1|Overall Study|Administrative withdrawal|0
671730|NCT01798927|2170835|P1|Overall Study|Withdrawal by Subject|1
671731|NCT01798706|2170843|P2|Overall Study|Other than specified above|9
671732|NCT01798706|2170844|P1|Overall Study|Other than specified above|5
671733|NCT01798706|2170843|P2|Overall Study|Poor compliance to protocol|0
671734|NCT01798706|2170844|P1|Overall Study|Poor compliance to protocol|1
671735|NCT01798706|2170843|P2|Overall Study|Lack of Efficacy|2
671736|NCT01798706|2170844|P1|Overall Study|Lack of Efficacy|0
671737|NCT01798706|2170843|P2|Overall Study|Adverse Event|10
671738|NCT01798706|2170844|P1|Overall Study|Adverse Event|15
671739|NCT01798485|2170872|P2|Overall Study|Clinical Progression|24
671740|NCT01798485|2170873|P1|Overall Study|Clinical Progression|35
671741|NCT01798485|2170872|P2|Overall Study|Sponsor Decision|54
671742|NCT01798485|2170873|P1|Overall Study|Sponsor Decision|61
671743|NCT01798485|2170872|P2|Overall Study|Death|22
671744|NCT01798485|2170873|P1|Overall Study|Death|25
671745|NCT01798485|2170872|P2|Overall Study|Objective Disease Progression|106
671746|NCT01798485|2170873|P1|Overall Study|Objective Disease Progression|152
671747|NCT01798485|2170872|P2|Overall Study|Physician Decision|10
671748|NCT01798485|2170873|P1|Overall Study|Physician Decision|14
671749|NCT01798485|2170872|P2|Overall Study|Lost to Follow-up|3
671750|NCT01798485|2170873|P1|Overall Study|Lost to Follow-up|0
671751|NCT01798485|2170872|P2|Overall Study|Withdrawal by Subject|31
671752|NCT01798485|2170873|P1|Overall Study|Withdrawal by Subject|27
671753|NCT01798485|2170872|P2|Overall Study|Adverse Event|40
671754|NCT01798485|2170873|P1|Overall Study|Adverse Event|32
671755|NCT01798134|2170999|P1|Overall Study|Liver transplant/surgery|4
671756|NCT01798134|2170999|P1|Overall Study|Physician Decision|3
671757|NCT01798134|2170999|P1|Overall Study|Adverse Event|3
671758|NCT01798134|2170999|P1|Overall Study|Death|2
671759|NCT01798134|2170999|P1|Overall Study|Withdrawal by Subject|3
671760|NCT01798134|2170999|P1|Overall Study|Lost to Follow-up|1
671761|NCT01798004|2171006|P1|Overall Study|Enrollment another COG therapeutic trial|32
671762|NCT01798004|2171006|P1|Overall Study|Initiation of other non-protocol therapy|5
671763|NCT01798004|2171006|P1|Overall Study|Patient/parent refusal|7
671764|NCT01798004|2171006|P1|Overall Study|Ineligible|4
671765|NCT01798004|2171006|P1|Overall Study|Withdrawal by Subject|4
671766|NCT01798004|2171006|P1|Overall Study|Physician Decision|25
671767|NCT01798004|2171006|P1|Overall Study|Lack of Efficacy|8
671768|NCT01798004|2171006|P1|Overall Study|Death|2
671769|NCT01797783|2171012|P2|Overall Study|Withdrawal by Subject|0
671770|NCT01797783|2171013|P1|Overall Study|Withdrawal by Subject|1
671771|NCT01797783|2171012|P2|Overall Study|Adverse Event|1
671772|NCT01797783|2171013|P1|Overall Study|Adverse Event|1
671773|NCT01797731|2171037|P2|Overall Study|Didn't have proper radiographs required|3
671774|NCT01797731|2171038|P1|Overall Study|Didn't have proper radiographs required|3
671775|NCT01797705|2171046|P1|Overall Study|Withdrawal by Subject|1
671776|NCT01797705|2171046|P1|Overall Study|Equipment anomalies during sleep studies|4
671777|NCT01797536|2171054|P4|Overall Study|Adverse Event|0
671778|NCT01797536|2171055|P3|Overall Study|Adverse Event|0
671779|NCT01797536|2171056|P2|Overall Study|Adverse Event|1
671780|NCT01797536|2171057|P1|Overall Study|Adverse Event|0
671781|NCT01797445|2171111|P2|Overall Study|Still on Study|383
671782|NCT01797445|2171112|P1|Overall Study|Still on Study|381
671783|NCT01797445|2171111|P2|Overall Study|Lost to Follow-up|15
671784|NCT01797445|2171112|P1|Overall Study|Lost to Follow-up|22
671785|NCT01797445|2171111|P2|Overall Study|Withdrew Consent|19
671786|NCT01797445|2171112|P1|Overall Study|Withdrew Consent|12
671787|NCT01797445|2171111|P2|Overall Study|Protocol Violation|1
671788|NCT01797445|2171112|P1|Overall Study|Protocol Violation|0
671789|NCT01797445|2171111|P2|Overall Study|Noncompliance with Study Drug|1
671790|NCT01797445|2171112|P1|Overall Study|Noncompliance with Study Drug|3
671791|NCT01797445|2171111|P2|Overall Study|Investigator's Discretion|12
671792|NCT01797445|2171112|P1|Overall Study|Investigator's Discretion|8
671793|NCT01797445|2171111|P2|Overall Study|Lack of Efficacy|2
671794|NCT01797445|2171112|P1|Overall Study|Lack of Efficacy|1
671795|NCT01797445|2171111|P2|Overall Study|Death|2
671796|NCT01797445|2171112|P1|Overall Study|Death|1
671797|NCT01797445|2171111|P2|Overall Study|Adverse Event|0
671798|NCT01797445|2171112|P1|Overall Study|Adverse Event|3
671799|NCT01797445|2171111|P2|Overall Study|Randomized but Not Treated|2
671800|NCT01797445|2171112|P1|Overall Study|Randomized but Not Treated|4
888721|NCT01791517|2822623|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
888722|NCT01791517|2822624|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
888723|NCT01791517|2822625|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
888724|NCT01791517|2822614|P12|Phase I: Period 2|Withdrawal by Subject|0
888725|NCT01791517|2822615|P11|Phase I: Period 2|Withdrawal by Subject|1
888726|NCT01791517|2822616|P10|Phase I: Period 2|Withdrawal by Subject|1
888727|NCT01791517|2822617|P9|Phase I: Period 2|Withdrawal by Subject|0
888728|NCT01791517|2822618|P8|Phase I: Period 2|Withdrawal by Subject|0
888729|NCT01791517|2822619|P7|Phase I: Period 2|Withdrawal by Subject|0
888730|NCT01791517|2822620|P6|Phase I: Period 2|Withdrawal by Subject|0
888731|NCT01791517|2822621|P5|Phase I: Period 2|Withdrawal by Subject|0
888732|NCT01791517|2822622|P4|Phase I: Period 2|Withdrawal by Subject|0
888733|NCT01791517|2822623|P3|Phase I: Period 2|Withdrawal by Subject|0
888734|NCT01791517|2822624|P2|Phase I: Period 2|Withdrawal by Subject|0
888735|NCT01791517|2822625|P1|Phase I: Period 2|Withdrawal by Subject|0
888736|NCT01791517|2822614|P12|Phase I: Period 2|Protocol Violation|0
888737|NCT01791517|2822615|P11|Phase I: Period 2|Protocol Violation|0
888738|NCT01791517|2822616|P10|Phase I: Period 2|Protocol Violation|0
888739|NCT01791517|2822617|P9|Phase I: Period 2|Protocol Violation|0
888740|NCT01791517|2822618|P8|Phase I: Period 2|Protocol Violation|0
888741|NCT01791517|2822619|P7|Phase I: Period 2|Protocol Violation|0
888742|NCT01791517|2822620|P6|Phase I: Period 2|Protocol Violation|0
671825|NCT01796964|2171237|P2|Overall Study|Withdrawal by Subject|1
671826|NCT01796964|2171238|P1|Overall Study|Withdrawal by Subject|1
671827|NCT01796964|2171237|P2|Overall Study|Protocol Violation|1
671828|NCT01796964|2171238|P1|Overall Study|Protocol Violation|0
671829|NCT01796964|2171237|P2|Overall Study|Death|0
671830|NCT01796964|2171238|P1|Overall Study|Death|1
671831|NCT01796964|2171237|P2|Overall Study|Adverse Event|1
671832|NCT01796964|2171238|P1|Overall Study|Adverse Event|1
671833|NCT01796860|2171260|P1|Overall Study|Withdrawal by Subject|3
671834|NCT01796548|2171266|P1|Overall Study|unspecified|2
671835|NCT01796548|2171266|P1|Overall Study|Lost to Follow-up|1
671836|NCT01795937|2171300|P3|Overall Study|Physician Decision|0
671837|NCT01795937|2171301|P2|Overall Study|Physician Decision|1
671838|NCT01795937|2171302|P1|Overall Study|Physician Decision|0
671839|NCT01795937|2171300|P3|Overall Study|Withdrawal by Subject|0
671840|NCT01795937|2171301|P2|Overall Study|Withdrawal by Subject|0
671841|NCT01795937|2171302|P1|Overall Study|Withdrawal by Subject|1
671842|NCT01795898|2171331|P1|Overall Study|Physician Decision|1
671843|NCT01795898|2171331|P1|Overall Study|Withdrew consent & had adverse events|3
671844|NCT01795898|2171331|P1|Overall Study|Death|1
671845|NCT01795898|2171331|P1|Overall Study|No pain|1
671846|NCT01795898|2171331|P1|Overall Study|Diagnosed with metastasis|1
671847|NCT01795898|2171331|P1|Overall Study|Withdrawal of consent|6
671848|NCT01795898|2171331|P1|Overall Study|Lost to Follow-up|20
671849|NCT01795898|2171331|P1|Overall Study|Adverse Event|27
671850|NCT01795547|2171367|P2|Overall Study|Not stated|1
671851|NCT01795547|2171368|P1|Overall Study|Not stated|0
671852|NCT01795547|2171367|P2|Overall Study|Others|1
671853|NCT01795547|2171368|P1|Overall Study|Others|4
671854|NCT01795547|2171367|P2|Overall Study|Non-compliance with IMP|1
671855|NCT01795547|2171368|P1|Overall Study|Non-compliance with IMP|1
671856|NCT01795547|2171367|P2|Overall Study|Not Treated|10
671857|NCT01795547|2171368|P1|Overall Study|Not Treated|4
671858|NCT01795547|2171367|P2|Overall Study|Withdrawal of consent|12
671859|NCT01795547|2171368|P1|Overall Study|Withdrawal of consent|7
671860|NCT01795547|2171367|P2|Overall Study|Lost to Follow-up|5
671861|NCT01795547|2171368|P1|Overall Study|Lost to Follow-up|2
671862|NCT01795547|2171367|P2|Overall Study|Protocol Violation|4
671863|NCT01795547|2171368|P1|Overall Study|Protocol Violation|6
671864|NCT01795547|2171367|P2|Overall Study|Lack of Efficacy|3
671865|NCT01795547|2171368|P1|Overall Study|Lack of Efficacy|8
671866|NCT01795547|2171367|P2|Overall Study|Adverse Event|27
671867|NCT01795547|2171368|P1|Overall Study|Adverse Event|16
671868|NCT01794949|2171399|P2|Overall Study|Lost to Follow-up|0
671869|NCT01794949|2171400|P1|Overall Study|Lost to Follow-up|1
671870|NCT01794845|2171411|P1|Overall Study|Withdrawal by Subject|1
671871|NCT01794000|2171461|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
671872|NCT01794000|2171462|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
671873|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
671874|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
671875|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
671876|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
671877|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Physician Decision|0
671878|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Physician Decision|2
671879|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
671880|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
671881|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
671882|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
671883|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Death|2
671884|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Death|1
671885|NCT01794000|2171461|P2|Double-Blind Phase (DBP)|Adverse Event|2
671886|NCT01794000|2171462|P1|Double-Blind Phase (DBP)|Adverse Event|5
671887|NCT01793883|2171496|P3|Overall Study|Respiratory distress during spirometry|1
671888|NCT01793883|2171497|P2|Overall Study|Respiratory distress during spirometry|0
671889|NCT01793883|2171498|P1|Overall Study|Respiratory distress during spirometry|0
671890|NCT01793883|2171496|P3|Overall Study|Dosing error|0
671891|NCT01793883|2171497|P2|Overall Study|Dosing error|1
671892|NCT01793883|2171498|P1|Overall Study|Dosing error|0
671893|NCT01793883|2171496|P3|Overall Study|Met exclusion criteria|0
671894|NCT01793883|2171497|P2|Overall Study|Met exclusion criteria|0
671895|NCT01793883|2171498|P1|Overall Study|Met exclusion criteria|1
671896|NCT01793883|2171496|P3|Overall Study|Unable to complete measurements|0
671897|NCT01793883|2171497|P2|Overall Study|Unable to complete measurements|0
671898|NCT01793883|2171498|P1|Overall Study|Unable to complete measurements|1
671899|NCT01793883|2171496|P3|Overall Study|Unable to complete spriometry|0
671900|NCT01793883|2171497|P2|Overall Study|Unable to complete spriometry|0
671901|NCT01793883|2171498|P1|Overall Study|Unable to complete spriometry|1
671902|NCT01793883|2171496|P3|Overall Study|Randomized in error|0
671903|NCT01793883|2171497|P2|Overall Study|Randomized in error|0
671904|NCT01793883|2171498|P1|Overall Study|Randomized in error|1
671905|NCT01793883|2171496|P3|Overall Study|Lost to Follow-up|3
671906|NCT01793883|2171497|P2|Overall Study|Lost to Follow-up|1
671907|NCT01793883|2171498|P1|Overall Study|Lost to Follow-up|5
671908|NCT01793883|2171496|P3|Overall Study|Subject noncompliance|1
671909|NCT01793883|2171497|P2|Overall Study|Subject noncompliance|1
671910|NCT01793883|2171498|P1|Overall Study|Subject noncompliance|0
671911|NCT01793883|2171496|P3|Overall Study|Withdrawal by Subject|3
671912|NCT01793883|2171497|P2|Overall Study|Withdrawal by Subject|7
671913|NCT01793883|2171498|P1|Overall Study|Withdrawal by Subject|3
671914|NCT01793688|2171506|P1|Overall Study|Protocol Violation|2
671915|NCT01792830|2171548|P7|Overall Study|Adverse Event|0
671916|NCT01792830|2171549|P6|Overall Study|Adverse Event|0
671917|NCT01792830|2171550|P5|Overall Study|Adverse Event|1
671918|NCT01792830|2171551|P4|Overall Study|Adverse Event|0
671919|NCT01792830|2171552|P3|Overall Study|Adverse Event|0
671920|NCT01792830|2171553|P2|Overall Study|Adverse Event|0
671921|NCT01792830|2171554|P1|Overall Study|Adverse Event|0
671922|NCT01792830|2171548|P7|Overall Study|Death|1
671923|NCT01792830|2171549|P6|Overall Study|Death|0
671924|NCT01792830|2171550|P5|Overall Study|Death|2
671925|NCT01792830|2171551|P4|Overall Study|Death|1
671926|NCT01792830|2171552|P3|Overall Study|Death|0
671927|NCT01792830|2171553|P2|Overall Study|Death|0
671928|NCT01792830|2171554|P1|Overall Study|Death|3
671929|NCT01792830|2171548|P7|Overall Study|Withdrawal by Subject|2
671930|NCT01792830|2171549|P6|Overall Study|Withdrawal by Subject|0
671931|NCT01792830|2171550|P5|Overall Study|Withdrawal by Subject|9
671932|NCT01792830|2171551|P4|Overall Study|Withdrawal by Subject|4
671933|NCT01792830|2171552|P3|Overall Study|Withdrawal by Subject|0
671934|NCT01792830|2171553|P2|Overall Study|Withdrawal by Subject|0
671935|NCT01792830|2171554|P1|Overall Study|Withdrawal by Subject|22
671936|NCT01792635|2171585|P3|Part B|Study terminated|3
671937|NCT01792635|2171586|P2|Part B|Study terminated|4
671938|NCT01792635|2171587|P1|Part B|Study terminated|0
671939|NCT01792635|2171585|P3|Part B|Adverse Event|1
671940|NCT01792635|2171586|P2|Part B|Adverse Event|0
671941|NCT01792635|2171587|P1|Part B|Adverse Event|0
671942|NCT01792518|2171615|P2|Overall Study|Other Reason|1
671943|NCT01792518|2171616|P1|Overall Study|Other Reason|0
671944|NCT01792518|2171615|P2|Overall Study|Withdrawal by Subject|0
671945|NCT01792518|2171616|P1|Overall Study|Withdrawal by Subject|2
671946|NCT01792518|2171615|P2|Overall Study|Lost to Follow-up|1
671947|NCT01792518|2171616|P1|Overall Study|Lost to Follow-up|3
671948|NCT01792518|2171615|P2|Overall Study|Protocol Violation|1
671949|NCT01792518|2171616|P1|Overall Study|Protocol Violation|0
671950|NCT01792518|2171615|P2|Overall Study|Adverse Event|4
671951|NCT01792518|2171616|P1|Overall Study|Adverse Event|3
671952|NCT01791894|2171639|P1|Overall Study|Adverse Event|1
671953|NCT01791803|2171650|P4|Overall Study|Death|2
671954|NCT01791803|2171651|P3|Overall Study|Death|2
671955|NCT01791803|2171652|P2|Overall Study|Death|0
671956|NCT01791803|2171653|P1|Overall Study|Death|0
671957|NCT01791803|2171650|P4|Overall Study|Physician Decision|1
671958|NCT01791803|2171651|P3|Overall Study|Physician Decision|0
671959|NCT01791803|2171652|P2|Overall Study|Physician Decision|2
671960|NCT01791803|2171653|P1|Overall Study|Physician Decision|0
671961|NCT01791803|2171650|P4|Overall Study|Withdrawal by Subject|2
671962|NCT01791803|2171651|P3|Overall Study|Withdrawal by Subject|0
671963|NCT01791803|2171652|P2|Overall Study|Withdrawal by Subject|0
671964|NCT01791803|2171653|P1|Overall Study|Withdrawal by Subject|0
671965|NCT01791725|2171671|P3|Overall Study|Withdrawal by Subject|0
671966|NCT01791725|2171672|P2|Overall Study|Withdrawal by Subject|1
671967|NCT01791725|2171673|P1|Overall Study|Withdrawal by Subject|0
671968|NCT01791413|2171731|P2|Overall Study|Lost to Follow-up|1
671969|NCT01791413|2171732|P1|Overall Study|Lost to Follow-up|5
671970|NCT01791244|2171741|P2|Overall Study|Laboratory Abnormality|1
671971|NCT01791244|2171742|P1|Overall Study|Laboratory Abnormality|0
671972|NCT01791244|2171741|P2|Overall Study|Insufficient clinical response|10
671973|NCT01791244|2171742|P1|Overall Study|Insufficient clinical response|10
671974|NCT01791244|2171741|P2|Overall Study|Adverse Event|7
671975|NCT01791244|2171742|P1|Overall Study|Adverse Event|5
671976|NCT01791205|2171778|P2|Phase II|Physician’s decision|0
671977|NCT01791205|2171779|P1|Phase II|Physician’s decision|1
671978|NCT01791205|2171778|P2|Phase II|Remission of disease|0
671979|NCT01791205|2171779|P1|Phase II|Remission of disease|1
671980|NCT01791205|2171778|P2|Phase II|Lost to Follow-up|0
671981|NCT01791205|2171779|P1|Phase II|Lost to Follow-up|1
671982|NCT01791205|2171778|P2|Phase II|Safety|0
671983|NCT01791205|2171779|P1|Phase II|Safety|1
671984|NCT01791205|2171778|P2|Phase II|Adverse Event|0
671985|NCT01791205|2171779|P1|Phase II|Adverse Event|2
671986|NCT01791205|2171778|P2|Phase II|Lack of Efficacy|0
671987|NCT01791205|2171779|P1|Phase II|Lack of Efficacy|6
671988|NCT01791153|2171863|P4|Overall Study|Withdrawal by Subject|1
671989|NCT01791153|2171864|P3|Overall Study|Withdrawal by Subject|2
671990|NCT01791153|2171865|P2|Overall Study|Withdrawal by Subject|2
671991|NCT01791153|2171866|P1|Overall Study|Withdrawal by Subject|6
671992|NCT01791153|2171863|P4|Overall Study|Protocol Violation|1
671993|NCT01791153|2171864|P3|Overall Study|Protocol Violation|0
671994|NCT01791153|2171865|P2|Overall Study|Protocol Violation|0
671995|NCT01791153|2171866|P1|Overall Study|Protocol Violation|0
671996|NCT01791153|2171863|P4|Overall Study|Physician Decision|1
671997|NCT01791153|2171864|P3|Overall Study|Physician Decision|0
671998|NCT01791153|2171865|P2|Overall Study|Physician Decision|0
671999|NCT01791153|2171866|P1|Overall Study|Physician Decision|0
672000|NCT01791153|2171863|P4|Overall Study|Non-Compliance|0
672001|NCT01791153|2171864|P3|Overall Study|Non-Compliance|0
672002|NCT01791153|2171865|P2|Overall Study|Non-Compliance|0
672003|NCT01791153|2171866|P1|Overall Study|Non-Compliance|1
672004|NCT01791153|2171863|P4|Overall Study|Lack of Efficacy|2
672005|NCT01791153|2171864|P3|Overall Study|Lack of Efficacy|2
672006|NCT01791153|2171865|P2|Overall Study|Lack of Efficacy|3
672007|NCT01791153|2171866|P1|Overall Study|Lack of Efficacy|1
672008|NCT01791153|2171863|P4|Overall Study|Adverse Event|0
672009|NCT01791153|2171864|P3|Overall Study|Adverse Event|2
672010|NCT01791153|2171865|P2|Overall Study|Adverse Event|3
672011|NCT01791153|2171866|P1|Overall Study|Adverse Event|7
672012|NCT01790828|2171931|P1|Overall Study|Not specified|34
672013|NCT01790633|2171991|P2|Overall Study|RT failure and no follow-up ELISA|3
672014|NCT01790633|2171992|P1|Overall Study|RT failure and no follow-up ELISA|0
672015|NCT01790633|2171991|P2|Overall Study|Did not have serology performed|0
672016|NCT01790633|2171992|P1|Overall Study|Did not have serology performed|47
672017|NCT01790633|2171991|P2|Overall Study|Protocol Violation|2
672018|NCT01790633|2171992|P1|Overall Study|Protocol Violation|1
672019|NCT01790516|2172016|P2|Overall Study|Physician Decision|0
672020|NCT01790516|2172017|P1|Overall Study|Physician Decision|1
672021|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
672022|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
672023|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
672024|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
672025|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
672026|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
672027|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
672028|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
672029|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
672030|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
672031|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
672032|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
672033|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
672034|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
672035|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
672036|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
672037|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
672038|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
672039|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
672040|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
672041|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
672042|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
672043|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
672044|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
672045|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
672046|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
672047|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
672048|NCT01789970|2172058|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
672049|NCT01789970|2172059|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
672050|NCT01789970|2172060|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
672051|NCT01789970|2172058|P3|Open-label Titration Period|Dropped out prior to dosing|0
672052|NCT01789970|2172059|P2|Open-label Titration Period|Dropped out prior to dosing|0
672053|NCT01789970|2172060|P1|Open-label Titration Period|Dropped out prior to dosing|2
672054|NCT01789970|2172058|P3|Open-label Titration Period|Not specified|0
672055|NCT01789970|2172059|P2|Open-label Titration Period|Not specified|0
672056|NCT01789970|2172060|P1|Open-label Titration Period|Not specified|76
672057|NCT01789970|2172058|P3|Open-label Titration Period|Pregnancy|0
672058|NCT01789970|2172059|P2|Open-label Titration Period|Pregnancy|0
672059|NCT01789970|2172060|P1|Open-label Titration Period|Pregnancy|2
672060|NCT01789970|2172058|P3|Open-label Titration Period|Noncompliance with study procedures|0
672061|NCT01789970|2172059|P2|Open-label Titration Period|Noncompliance with study procedures|0
672062|NCT01789970|2172060|P1|Open-label Titration Period|Noncompliance with study procedures|8
672063|NCT01789970|2172058|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
672064|NCT01789970|2172059|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
672065|NCT01789970|2172060|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
672066|NCT01789970|2172058|P3|Open-label Titration Period|Noncompliance to study drug admin|0
672067|NCT01789970|2172059|P2|Open-label Titration Period|Noncompliance to study drug admin|0
672068|NCT01789970|2172060|P1|Open-label Titration Period|Noncompliance to study drug admin|11
672069|NCT01789970|2172058|P3|Open-label Titration Period|Lost to Follow-up|0
672070|NCT01789970|2172059|P2|Open-label Titration Period|Lost to Follow-up|0
672071|NCT01789970|2172060|P1|Open-label Titration Period|Lost to Follow-up|5
672072|NCT01789970|2172058|P3|Open-label Titration Period|Protocol Violation|0
672073|NCT01789970|2172059|P2|Open-label Titration Period|Protocol Violation|0
672074|NCT01789970|2172060|P1|Open-label Titration Period|Protocol Violation|18
672075|NCT01789970|2172058|P3|Open-label Titration Period|Withdrawal by Subject|0
672076|NCT01789970|2172059|P2|Open-label Titration Period|Withdrawal by Subject|0
672077|NCT01789970|2172060|P1|Open-label Titration Period|Withdrawal by Subject|31
672078|NCT01789970|2172058|P3|Open-label Titration Period|Lack of Efficacy|0
672079|NCT01789970|2172059|P2|Open-label Titration Period|Lack of Efficacy|0
672080|NCT01789970|2172060|P1|Open-label Titration Period|Lack of Efficacy|31
672081|NCT01789970|2172058|P3|Open-label Titration Period|Adverse Event|0
672082|NCT01789970|2172059|P2|Open-label Titration Period|Adverse Event|0
672083|NCT01789970|2172060|P1|Open-label Titration Period|Adverse Event|68
672084|NCT01789606|2172103|P2|Overall Study|Ineligible or not Willing to Continue|348
672085|NCT01789606|2172104|P1|Overall Study|Ineligible or not Willing to Continue|0
672086|NCT01789606|2172103|P2|Overall Study|Lost to Follow-up|14
672087|NCT01789606|2172104|P1|Overall Study|Lost to Follow-up|0
672088|NCT01789606|2172103|P2|Overall Study|Adverse Event|3
672089|NCT01789606|2172104|P1|Overall Study|Adverse Event|0
672090|NCT01789606|2172103|P2|Overall Study|Protocol Violation|55
672091|NCT01789606|2172104|P1|Overall Study|Protocol Violation|0
672092|NCT01789606|2172103|P2|Overall Study|No Study Medication Taken|1
672093|NCT01789606|2172104|P1|Overall Study|No Study Medication Taken|0
672094|NCT01789606|2172103|P2|Overall Study|Administrative Reasons|6
672095|NCT01789606|2172104|P1|Overall Study|Administrative Reasons|17
672096|NCT01789606|2172103|P2|Overall Study|Ineligible|2
672097|NCT01789606|2172104|P1|Overall Study|Ineligible|6
672098|NCT01789606|2172103|P2|Overall Study|Withdrawal by Subject|1
672099|NCT01789606|2172104|P1|Overall Study|Withdrawal by Subject|0
672100|NCT01789606|2172103|P2|Overall Study|Participant not Purchased the Product|20
672101|NCT01789606|2172104|P1|Overall Study|Participant not Purchased the Product|0
672102|NCT01789476|2172124|P2|Overall Study|Unable to get IV access|0
672103|NCT01789476|2172125|P1|Overall Study|Unable to get IV access|1
672104|NCT01789476|2172124|P2|Overall Study|Adverse Event|0
672105|NCT01789476|2172125|P1|Overall Study|Adverse Event|1
672106|NCT01789476|2172124|P2|Overall Study|Lack of Efficacy|2
672107|NCT01789476|2172125|P1|Overall Study|Lack of Efficacy|6
672108|NCT01788566|2172151|P1|Overall Study|Clinical Progressive Disease|3
672109|NCT01788566|2172151|P1|Overall Study|Adverse Event|1
672110|NCT01788566|2172151|P1|Overall Study|Death|4
888743|NCT01791517|2822621|P5|Phase I: Period 2|Protocol Violation|0
888744|NCT01791517|2822622|P4|Phase I: Period 2|Protocol Violation|1
888745|NCT01791517|2822623|P3|Phase I: Period 2|Protocol Violation|0
888746|NCT01791517|2822624|P2|Phase I: Period 2|Protocol Violation|0
888747|NCT01791517|2822625|P1|Phase I: Period 2|Protocol Violation|0
888748|NCT01791517|2822614|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
672118|NCT01788228|2172175|P2|Overall Study|Migrated/moved from study area|0
672119|NCT01788228|2172176|P1|Overall Study|Migrated/moved from study area|1
672120|NCT01788215|2172195|P2|Overall Study|Lost to Follow-up|0
672121|NCT01788215|2172196|P1|Overall Study|Lost to Follow-up|2
672122|NCT01788215|2172195|P2|Overall Study|Withdrawal by Subject|1
672123|NCT01788215|2172196|P1|Overall Study|Withdrawal by Subject|0
672124|NCT01788163|2172225|P9|Overall Study|Withdrawal by Subject|1
672125|NCT01788163|2172226|P8|Overall Study|Withdrawal by Subject|0
672126|NCT01788163|2172227|P7|Overall Study|Withdrawal by Subject|0
672127|NCT01788163|2172228|P6|Overall Study|Withdrawal by Subject|0
672128|NCT01788163|2172229|P5|Overall Study|Withdrawal by Subject|0
672129|NCT01788163|2172230|P4|Overall Study|Withdrawal by Subject|0
672130|NCT01788163|2172231|P3|Overall Study|Withdrawal by Subject|0
672131|NCT01788163|2172232|P2|Overall Study|Withdrawal by Subject|0
672132|NCT01788163|2172233|P1|Overall Study|Withdrawal by Subject|2
672133|NCT01788163|2172225|P9|Overall Study|Other|15
672134|NCT01788163|2172226|P8|Overall Study|Other|48
672135|NCT01788163|2172227|P7|Overall Study|Other|1
672136|NCT01788163|2172228|P6|Overall Study|Other|7
672137|NCT01788163|2172229|P5|Overall Study|Other|0
672138|NCT01788163|2172230|P4|Overall Study|Other|0
672139|NCT01788163|2172231|P3|Overall Study|Other|0
672140|NCT01788163|2172232|P2|Overall Study|Other|0
672141|NCT01788163|2172233|P1|Overall Study|Other|53
672142|NCT01788046|2172396|P2|Overall Study|Protocol Specified Criteria|1
672143|NCT01788046|2172397|P1|Overall Study|Protocol Specified Criteria|25
672144|NCT01788046|2172396|P2|Overall Study|Death|5
672145|NCT01788046|2172397|P1|Overall Study|Death|7
672146|NCT01788046|2172396|P2|Overall Study|Lost to Follow-up|19
672147|NCT01788046|2172397|P1|Overall Study|Lost to Follow-up|12
672148|NCT01788046|2172396|P2|Overall Study|Withdrawal by Subject|12
672149|NCT01788046|2172397|P1|Overall Study|Withdrawal by Subject|12
672150|NCT01787838|2172413|P1|Overall Study|refused|1413
672151|NCT01787825|2172417|P2|Overall Study|Data Not Analyzable|1
672152|NCT01787825|2172418|P1|Overall Study|Data Not Analyzable|5
672153|NCT01787825|2172417|P2|Overall Study|Subject Did Not Ingest Capsules|0
672154|NCT01787825|2172418|P1|Overall Study|Subject Did Not Ingest Capsules|1
672155|NCT01787760|2172436|P3|Overall Study|Near vision blur|0
672156|NCT01787760|2172437|P2|Overall Study|Near vision blur|0
672157|NCT01787760|2172438|P1|Overall Study|Near vision blur|1
672158|NCT01787760|2172436|P3|Overall Study|Unsatisfactory visual response|0
672159|NCT01787760|2172437|P2|Overall Study|Unsatisfactory visual response|1
672160|NCT01787760|2172438|P1|Overall Study|Unsatisfactory visual response|1
672161|NCT01787760|2172436|P3|Overall Study|Unsatisfactory physiological response|0
672162|NCT01787760|2172437|P2|Overall Study|Unsatisfactory physiological response|4
672163|NCT01787760|2172438|P1|Overall Study|Unsatisfactory physiological response|2
672164|NCT01787760|2172436|P3|Overall Study|Unsatisfactory lens fitting performance|0
672165|NCT01787760|2172437|P2|Overall Study|Unsatisfactory lens fitting performance|6
672166|NCT01787760|2172438|P1|Overall Study|Unsatisfactory lens fitting performance|3
672167|NCT01787760|2172436|P3|Overall Study|Stroke|0
672168|NCT01787760|2172437|P2|Overall Study|Stroke|0
672169|NCT01787760|2172438|P1|Overall Study|Stroke|1
672170|NCT01787760|2172436|P3|Overall Study|Lost to Follow-up|1
672171|NCT01787760|2172437|P2|Overall Study|Lost to Follow-up|0
672172|NCT01787760|2172438|P1|Overall Study|Lost to Follow-up|1
672173|NCT01787760|2172436|P3|Overall Study|Withdrawal by Subject|2
672174|NCT01787760|2172437|P2|Overall Study|Withdrawal by Subject|1
672175|NCT01787760|2172438|P1|Overall Study|Withdrawal by Subject|5
672176|NCT01787760|2172436|P3|Overall Study|Protocol Violation|1
672177|NCT01787760|2172437|P2|Overall Study|Protocol Violation|0
672178|NCT01787760|2172438|P1|Overall Study|Protocol Violation|6
672179|NCT01787760|2172436|P3|Overall Study|Lens handling difficulty|0
672180|NCT01787760|2172437|P2|Overall Study|Lens handling difficulty|2
672181|NCT01787760|2172438|P1|Overall Study|Lens handling difficulty|1
672182|NCT01787760|2172436|P3|Overall Study|Lens discomfort|0
672183|NCT01787760|2172437|P2|Overall Study|Lens discomfort|0
672184|NCT01787760|2172438|P1|Overall Study|Lens discomfort|3
672185|NCT01787760|2172436|P3|Overall Study|Relocation|0
672186|NCT01787760|2172437|P2|Overall Study|Relocation|1
672187|NCT01787760|2172438|P1|Overall Study|Relocation|1
672188|NCT01787760|2172436|P3|Overall Study|Dryness|0
672189|NCT01787760|2172437|P2|Overall Study|Dryness|1
672190|NCT01787760|2172438|P1|Overall Study|Dryness|0
672191|NCT01787760|2172436|P3|Overall Study|Decompensated on left exotropia|1
672192|NCT01787760|2172437|P2|Overall Study|Decompensated on left exotropia|0
672193|NCT01787760|2172438|P1|Overall Study|Decompensated on left exotropia|0
672194|NCT01787760|2172436|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
672195|NCT01787760|2172437|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
672196|NCT01787760|2172438|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
672197|NCT01787591|2172452|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
672198|NCT01787591|2172453|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
672199|NCT01787591|2172454|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
672200|NCT01787591|2172455|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
672201|NCT01787461|2172483|P2|Overall Study|Protocol Violation|0
672202|NCT01787461|2172484|P1|Overall Study|Protocol Violation|3
672203|NCT01787461|2172483|P2|Overall Study|Withdrawal by Subject|4
672204|NCT01787461|2172484|P1|Overall Study|Withdrawal by Subject|3
672205|NCT01787461|2172483|P2|Overall Study|No longer met eligibility criteria|0
672206|NCT01787461|2172484|P1|Overall Study|No longer met eligibility criteria|1
672207|NCT01787461|2172483|P2|Overall Study|Lost to Follow-up|2
672208|NCT01787461|2172484|P1|Overall Study|Lost to Follow-up|3
672209|NCT01787461|2172483|P2|Overall Study|Adverse Event|3
672210|NCT01787461|2172484|P1|Overall Study|Adverse Event|4
672211|NCT01787279|2172533|P1|Overall Study|Lack of Efficacy|1
672212|NCT01787279|2172533|P1|Overall Study|Lost to Follow-up|2
672213|NCT01787188|2172559|P3|Overall Study|Other, including patient moved|0
672214|NCT01787188|2172560|P2|Overall Study|Other, including patient moved|3
672215|NCT01787188|2172561|P1|Overall Study|Other, including patient moved|0
672216|NCT01787188|2172559|P3|Overall Study|Lost to Follow-up|2
672217|NCT01787188|2172560|P2|Overall Study|Lost to Follow-up|2
672218|NCT01787188|2172561|P1|Overall Study|Lost to Follow-up|1
672219|NCT01787188|2172559|P3|Overall Study|Protocol Violation|3
672220|NCT01787188|2172560|P2|Overall Study|Protocol Violation|2
672221|NCT01787188|2172561|P1|Overall Study|Protocol Violation|3
672222|NCT01787188|2172559|P3|Overall Study|Withdrawal by Subject|2
672223|NCT01787188|2172560|P2|Overall Study|Withdrawal by Subject|3
672224|NCT01787188|2172561|P1|Overall Study|Withdrawal by Subject|4
672225|NCT01787188|2172559|P3|Overall Study|Non-compliance with Study Drug|0
672226|NCT01787188|2172560|P2|Overall Study|Non-compliance with Study Drug|1
672227|NCT01787188|2172561|P1|Overall Study|Non-compliance with Study Drug|0
672228|NCT01787188|2172559|P3|Overall Study|Lack of Efficacy|5
672229|NCT01787188|2172560|P2|Overall Study|Lack of Efficacy|3
672230|NCT01787188|2172561|P1|Overall Study|Lack of Efficacy|7
672231|NCT01787188|2172559|P3|Overall Study|Adverse Event|6
672232|NCT01787188|2172560|P2|Overall Study|Adverse Event|4
672233|NCT01787188|2172561|P1|Overall Study|Adverse Event|2
672234|NCT01787032|2172633|P6|Overall Study|Protocol Violation|1
672235|NCT01787032|2172634|P5|Overall Study|Protocol Violation|1
672236|NCT01787032|2172635|P4|Overall Study|Protocol Violation|0
672237|NCT01787032|2172636|P3|Overall Study|Protocol Violation|0
672238|NCT01787032|2172637|P2|Overall Study|Protocol Violation|0
672239|NCT01787032|2172638|P1|Overall Study|Protocol Violation|0
672240|NCT01786993|2172662|P2|Overall Study|Hospice Admission|0
672241|NCT01786993|2172663|P1|Overall Study|Hospice Admission|1
672242|NCT01786993|2172662|P2|Overall Study|System Explant|0
672243|NCT01786993|2172663|P1|Overall Study|System Explant|1
672244|NCT01786993|2172662|P2|Overall Study|Subject Non-Compliance|0
672245|NCT01786993|2172663|P1|Overall Study|Subject Non-Compliance|1
672246|NCT01786993|2172662|P2|Overall Study|Lost to Follow-up|1
672247|NCT01786993|2172663|P1|Overall Study|Lost to Follow-up|0
672248|NCT01786993|2172662|P2|Overall Study|Withdrawal by Subject|2
672249|NCT01786993|2172663|P1|Overall Study|Withdrawal by Subject|3
672250|NCT01786993|2172662|P2|Overall Study|Death|7
672251|NCT01786993|2172663|P1|Overall Study|Death|6
672252|NCT01786707|2172713|P2|Overall Study|Lost to Follow-up|1
672253|NCT01786707|2172714|P1|Overall Study|Lost to Follow-up|1
672254|NCT01786668|2172726|P4|Overall Study|Lost to Follow-up|0
672255|NCT01786668|2172727|P3|Overall Study|Lost to Follow-up|1
672256|NCT01786668|2172728|P2|Overall Study|Lost to Follow-up|0
672257|NCT01786668|2172729|P1|Overall Study|Lost to Follow-up|1
672258|NCT01786668|2172726|P4|Overall Study|Pregnancy|1
672259|NCT01786668|2172727|P3|Overall Study|Pregnancy|0
672260|NCT01786668|2172728|P2|Overall Study|Pregnancy|0
672261|NCT01786668|2172729|P1|Overall Study|Pregnancy|0
672262|NCT01786668|2172726|P4|Overall Study|Withdrawal by Subject|1
672263|NCT01786668|2172727|P3|Overall Study|Withdrawal by Subject|3
672264|NCT01786668|2172728|P2|Overall Study|Withdrawal by Subject|0
672265|NCT01786668|2172729|P1|Overall Study|Withdrawal by Subject|0
672266|NCT01786668|2172726|P4|Overall Study|Adverse Event|2
672267|NCT01786668|2172727|P3|Overall Study|Adverse Event|1
672268|NCT01786668|2172728|P2|Overall Study|Adverse Event|1
672269|NCT01786668|2172729|P1|Overall Study|Adverse Event|0
672270|NCT01786629|2172829|P2|Overall Study|Adverse Event|1
672271|NCT01786629|2172830|P1|Overall Study|Adverse Event|0
672272|NCT01786629|2172829|P2|Overall Study|Lack of Efficacy|4
672273|NCT01786629|2172830|P1|Overall Study|Lack of Efficacy|0
672274|NCT01786551|2172836|P1|Overall Study|Participant withdrew consent|2
672275|NCT01786330|2172844|P2|Overall Study|Protocol Violation|0
672276|NCT01786330|2172845|P1|Overall Study|Protocol Violation|1
672277|NCT01786330|2172844|P2|Overall Study|Excluded intraoperatively|1
672278|NCT01786330|2172845|P1|Overall Study|Excluded intraoperatively|0
672279|NCT01786330|2172844|P2|Overall Study|Lost to Follow-up|1
672280|NCT01786330|2172845|P1|Overall Study|Lost to Follow-up|0
672281|NCT01786330|2172844|P2|Overall Study|Withdrawal by Subject|1
672282|NCT01786330|2172845|P1|Overall Study|Withdrawal by Subject|0
672283|NCT01786174|2172883|P2|Overall Study|Discontinued Study Drug|0
672284|NCT01786174|2172884|P1|Overall Study|Discontinued Study Drug|2
672285|NCT01786109|2172914|P3|Overall Study|adverse effects colon preparation|1
672286|NCT01786109|2172915|P2|Overall Study|adverse effects colon preparation|0
672287|NCT01786109|2172916|P1|Overall Study|adverse effects colon preparation|0
672288|NCT01786109|2172914|P3|Overall Study|unrelated illness|1
672289|NCT01786109|2172915|P2|Overall Study|unrelated illness|0
672290|NCT01786109|2172916|P1|Overall Study|unrelated illness|0
672291|NCT01786109|2172914|P3|Overall Study|fail manometry barostat tube placement|0
672292|NCT01786109|2172915|P2|Overall Study|fail manometry barostat tube placement|0
672293|NCT01786109|2172916|P1|Overall Study|fail manometry barostat tube placement|1
672294|NCT01785875|2172945|P3|Overall Study|Missing|3
672295|NCT01785875|2172946|P2|Overall Study|Missing|1
672296|NCT01785875|2172947|P1|Overall Study|Missing|0
672297|NCT01785875|2172945|P3|Overall Study|Protocol Specified Criteria|55
672298|NCT01785875|2172946|P2|Overall Study|Protocol Specified Criteria|214
672299|NCT01785875|2172947|P1|Overall Study|Protocol Specified Criteria|207
672300|NCT01785875|2172945|P3|Overall Study|Sponsor Decision|0
672301|NCT01785875|2172946|P2|Overall Study|Sponsor Decision|2
672302|NCT01785875|2172947|P1|Overall Study|Sponsor Decision|0
672303|NCT01785875|2172945|P3|Overall Study|Death|7
672304|NCT01785875|2172946|P2|Overall Study|Death|16
672305|NCT01785875|2172947|P1|Overall Study|Death|27
672306|NCT01785875|2172945|P3|Overall Study|Lost to Follow-up|6
672307|NCT01785875|2172946|P2|Overall Study|Lost to Follow-up|22
672308|NCT01785875|2172947|P1|Overall Study|Lost to Follow-up|19
672309|NCT01785875|2172945|P3|Overall Study|Withdrawal by Subject|36
672310|NCT01785875|2172946|P2|Overall Study|Withdrawal by Subject|34
672311|NCT01785875|2172947|P1|Overall Study|Withdrawal by Subject|41
672312|NCT01785849|2173016|P2|Overall Study|Lost to Follow-up|11
672313|NCT01785849|2173017|P1|Overall Study|Lost to Follow-up|10
672314|NCT01785849|2173016|P2|Overall Study|Sponsor Decision|1
672315|NCT01785849|2173017|P1|Overall Study|Sponsor Decision|0
672316|NCT01785849|2173016|P2|Overall Study|Withdrawal by Subject|12
672317|NCT01785849|2173017|P1|Overall Study|Withdrawal by Subject|15
672318|NCT01785849|2173016|P2|Overall Study|Protocol Specified Criteria|1
672319|NCT01785849|2173017|P1|Overall Study|Protocol Specified Criteria|29
672320|NCT01785849|2173016|P2|Overall Study|Death|9
672321|NCT01785849|2173017|P1|Overall Study|Death|7
672322|NCT01785628|2173035|P2|Overall Study|Lost to Follow-up|3
672323|NCT01785628|2173036|P1|Overall Study|Lost to Follow-up|2
672324|NCT01785615|2173059|P4|Dietary Phase|Lost to Follow-up|24
672325|NCT01785615|2173060|P3|Dietary Phase|Lost to Follow-up|0
672326|NCT01785615|2173061|P2|Dietary Phase|Lost to Follow-up|0
672327|NCT01785615|2173062|P1|Dietary Phase|Lost to Follow-up|0
672328|NCT01785602|2173134|P2|Overall Study|Administrative problems|3
672329|NCT01785602|2173135|P1|Overall Study|Administrative problems|7
672330|NCT01785602|2173134|P2|Overall Study|Adverse Event|5
672331|NCT01785602|2173135|P1|Overall Study|Adverse Event|3
672332|NCT01785602|2173134|P2|Overall Study|Lost to Follow-up|1
672333|NCT01785602|2173135|P1|Overall Study|Lost to Follow-up|1
672334|NCT01785602|2173134|P2|Overall Study|Withdrawal by Subject|0
672335|NCT01785602|2173135|P1|Overall Study|Withdrawal by Subject|2
672336|NCT01785524|2173145|P2|Overall Study|Withdrawal by Subject|2
672337|NCT01785524|2173146|P1|Overall Study|Withdrawal by Subject|2
672338|NCT01785472|2173165|P3|Overall Study|Technical problems|1
672339|NCT01785472|2173166|P2|Overall Study|Technical problems|0
672340|NCT01785472|2173167|P1|Overall Study|Technical problems|0
672341|NCT01785472|2173165|P3|Overall Study|Subject/guardian decision|11
672342|NCT01785472|2173166|P2|Overall Study|Subject/guardian decision|10
672343|NCT01785472|2173167|P1|Overall Study|Subject/guardian decision|15
672344|NCT01785472|2173165|P3|Overall Study|Protocol deviation|2
672345|NCT01785472|2173166|P2|Overall Study|Protocol deviation|2
672346|NCT01785472|2173167|P1|Overall Study|Protocol deviation|0
672347|NCT01785472|2173165|P3|Overall Study|Physician Decision|1
672348|NCT01785472|2173166|P2|Overall Study|Physician Decision|1
672349|NCT01785472|2173167|P1|Overall Study|Physician Decision|1
672350|NCT01785472|2173165|P3|Overall Study|Lost to Follow-up|0
672351|NCT01785472|2173166|P2|Overall Study|Lost to Follow-up|2
672352|NCT01785472|2173167|P1|Overall Study|Lost to Follow-up|1
672353|NCT01785472|2173165|P3|Overall Study|Lack of Efficacy|1
672354|NCT01785472|2173166|P2|Overall Study|Lack of Efficacy|0
672355|NCT01785472|2173167|P1|Overall Study|Lack of Efficacy|2
672356|NCT01785472|2173165|P3|Overall Study|Adverse Event|6
672357|NCT01785472|2173166|P2|Overall Study|Adverse Event|4
672358|NCT01785472|2173167|P1|Overall Study|Adverse Event|5
672359|NCT01785160|2173240|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
672360|NCT01785160|2173240|P1|Treatment Period 1: Raltegravir|Not treated|1
672361|NCT01784965|2173275|P2|Overall Study|Adverse Event|8
672362|NCT01784965|2173276|P1|Overall Study|Adverse Event|0
672363|NCT01784965|2173275|P2|Overall Study|Withdrawal by Subject|3
672364|NCT01784965|2173276|P1|Overall Study|Withdrawal by Subject|6
672365|NCT01783938|2173342|P2|Overall Study|Not Specified|0
672366|NCT01783938|2173343|P1|Overall Study|Not Specified|1
672367|NCT01783938|2173342|P2|Overall Study|Withdrew Consent|0
672368|NCT01783938|2173343|P1|Overall Study|Withdrew Consent|3
672369|NCT01783938|2173342|P2|Overall Study|Request to Discontinue Study Treatment|2
672370|NCT01783938|2173343|P1|Overall Study|Request to Discontinue Study Treatment|1
672371|NCT01783938|2173342|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
672372|NCT01783938|2173343|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
672373|NCT01783938|2173342|P2|Overall Study|Study Drug Toxicity|10
672374|NCT01783938|2173343|P1|Overall Study|Study Drug Toxicity|22
672375|NCT01783938|2173342|P2|Overall Study|Disease Progression|39
672376|NCT01783938|2173343|P1|Overall Study|Disease Progression|18
672377|NCT01783886|2173371|P3|Overall Study|Adverse Event|4
672378|NCT01783886|2173372|P2|Overall Study|Adverse Event|5
672379|NCT01783886|2173373|P1|Overall Study|Adverse Event|4
672380|NCT01783886|2173371|P3|Overall Study|Withdrawal of consent by participant|4
672381|NCT01783886|2173372|P2|Overall Study|Withdrawal of consent by participant|3
672382|NCT01783886|2173373|P1|Overall Study|Withdrawal of consent by participant|1
672383|NCT01783886|2173371|P3|Overall Study|Protocol deviation|2
672384|NCT01783886|2173372|P2|Overall Study|Protocol deviation|0
672385|NCT01783886|2173373|P1|Overall Study|Protocol deviation|0
672386|NCT01783886|2173371|P3|Overall Study|Lost to Follow-up|0
672387|NCT01783886|2173372|P2|Overall Study|Lost to Follow-up|3
672388|NCT01783886|2173373|P1|Overall Study|Lost to Follow-up|0
672389|NCT01783821|2173420|P2|Overall Study|Screen Failure|1
672390|NCT01783821|2173421|P1|Overall Study|Screen Failure|1
672391|NCT01783730|2173437|P1|Overall Study|Failed to meet inclusion criteria|6
672392|NCT01783678|2173462|P6|Overall Study|Withdrew Consent|0
672393|NCT01783678|2173463|P5|Overall Study|Withdrew Consent|0
672394|NCT01783678|2173464|P4|Overall Study|Withdrew Consent|2
672395|NCT01783678|2173465|P3|Overall Study|Withdrew Consent|0
672396|NCT01783678|2173466|P2|Overall Study|Withdrew Consent|1
672397|NCT01783678|2173467|P1|Overall Study|Withdrew Consent|1
672398|NCT01783678|2173462|P6|Overall Study|Lost to Follow-up|0
672399|NCT01783678|2173463|P5|Overall Study|Lost to Follow-up|1
672400|NCT01783678|2173464|P4|Overall Study|Lost to Follow-up|2
672401|NCT01783678|2173465|P3|Overall Study|Lost to Follow-up|0
672402|NCT01783678|2173466|P2|Overall Study|Lost to Follow-up|4
672403|NCT01783678|2173467|P1|Overall Study|Lost to Follow-up|0
672404|NCT01783678|2173462|P6|Overall Study|Lack of Efficacy|5
672405|NCT01783678|2173463|P5|Overall Study|Lack of Efficacy|6
672406|NCT01783678|2173464|P4|Overall Study|Lack of Efficacy|3
672407|NCT01783678|2173465|P3|Overall Study|Lack of Efficacy|1
672408|NCT01783678|2173466|P2|Overall Study|Lack of Efficacy|13
672409|NCT01783678|2173467|P1|Overall Study|Lack of Efficacy|1
672410|NCT01783678|2173462|P6|Overall Study|Randomized but Not Treated|0
672411|NCT01783678|2173463|P5|Overall Study|Randomized but Not Treated|0
672412|NCT01783678|2173464|P4|Overall Study|Randomized but Not Treated|1
672413|NCT01783678|2173465|P3|Overall Study|Randomized but Not Treated|0
672414|NCT01783678|2173466|P2|Overall Study|Randomized but Not Treated|0
672415|NCT01783678|2173467|P1|Overall Study|Randomized but Not Treated|0
672416|NCT01783548|2173556|P2|Overall Study|Lack of Efficacy|1
672417|NCT01783548|2173557|P1|Overall Study|Lack of Efficacy|1
672418|NCT01783548|2173556|P2|Overall Study|Lost to Follow-up|3
672419|NCT01783548|2173557|P1|Overall Study|Lost to Follow-up|8
672420|NCT01783548|2173556|P2|Overall Study|Protocol Violation|2
672421|NCT01783548|2173557|P1|Overall Study|Protocol Violation|2
672422|NCT01783548|2173556|P2|Overall Study|Non-compliance|0
672423|NCT01783548|2173557|P1|Overall Study|Non-compliance|4
672424|NCT01783548|2173556|P2|Overall Study|Withdrawal by Subject|8
672425|NCT01783548|2173557|P1|Overall Study|Withdrawal by Subject|11
672426|NCT01783548|2173556|P2|Overall Study|Adverse Event|4
672427|NCT01783548|2173557|P1|Overall Study|Adverse Event|8
672428|NCT01783496|2173575|P6|Overall Study|Withdrawal by Subject|0
672429|NCT01783496|2173576|P5|Overall Study|Withdrawal by Subject|0
672430|NCT01783496|2173577|P4|Overall Study|Withdrawal by Subject|0
672431|NCT01783496|2173578|P3|Overall Study|Withdrawal by Subject|0
672432|NCT01783496|2173579|P2|Overall Study|Withdrawal by Subject|0
672433|NCT01783496|2173580|P1|Overall Study|Withdrawal by Subject|1
672434|NCT01783496|2173575|P6|Overall Study|Lost to Follow-up|1
672435|NCT01783496|2173576|P5|Overall Study|Lost to Follow-up|0
672436|NCT01783496|2173577|P4|Overall Study|Lost to Follow-up|2
672437|NCT01783496|2173578|P3|Overall Study|Lost to Follow-up|0
672438|NCT01783496|2173579|P2|Overall Study|Lost to Follow-up|0
672439|NCT01783496|2173580|P1|Overall Study|Lost to Follow-up|0
672440|NCT01783483|2173608|P2|Overall Study|Physician Decision|1
672441|NCT01783483|2173609|P1|Overall Study|Physician Decision|1
672442|NCT01783483|2173608|P2|Overall Study|Withdrawal by Subject|1
672443|NCT01783483|2173609|P1|Overall Study|Withdrawal by Subject|2
672444|NCT01783483|2173608|P2|Overall Study|Lost to Follow-up|10
672445|NCT01783483|2173609|P1|Overall Study|Lost to Follow-up|14
672446|NCT01783483|2173608|P2|Overall Study|Death|3
672447|NCT01783483|2173609|P1|Overall Study|Death|3
672448|NCT01783418|2173647|P2|Overall Study|Withdrawal by Subject|0
672449|NCT01783418|2173648|P1|Overall Study|Withdrawal by Subject|1
672450|NCT01783015|2173701|P3|Open Label Treatment|Study Terminated by Sponsor|6
672451|NCT01783015|2173702|P2|Open Label Treatment|Study Terminated by Sponsor|0
672452|NCT01783015|2173703|P1|Open Label Treatment|Study Terminated by Sponsor|0
672453|NCT01783015|2173701|P3|Blinded Treatment|Study Terminated by Sponsor|0
672454|NCT01783015|2173702|P2|Blinded Treatment|Study Terminated by Sponsor|0
672455|NCT01783015|2173703|P1|Blinded Treatment|Study Terminated by Sponsor|2
672456|NCT01783015|2173701|P3|Blinded Treatment|Withdrawal by Subject|0
672457|NCT01783015|2173702|P2|Blinded Treatment|Withdrawal by Subject|1
672458|NCT01783015|2173703|P1|Blinded Treatment|Withdrawal by Subject|0
672459|NCT01783015|2173701|P3|Blinded Treatment|Protocol Violation|0
672460|NCT01783015|2173702|P2|Blinded Treatment|Protocol Violation|1
672461|NCT01783015|2173703|P1|Blinded Treatment|Protocol Violation|0
672462|NCT01783015|2173701|P3|Blinded Treatment|Adverse Event|0
672463|NCT01783015|2173702|P2|Blinded Treatment|Adverse Event|1
672464|NCT01783015|2173703|P1|Blinded Treatment|Adverse Event|0
672465|NCT01782885|2173803|P2|Overall Study|Lost to Follow-up|6
672466|NCT01782885|2173804|P1|Overall Study|Lost to Follow-up|4
672467|NCT01782872|2173830|P4|Overall Study|Withdrawal by Subject|0
672468|NCT01782872|2173831|P3|Overall Study|Withdrawal by Subject|0
672469|NCT01782872|2173832|P2|Overall Study|Withdrawal by Subject|1
672470|NCT01782872|2173833|P1|Overall Study|Withdrawal by Subject|0
672471|NCT01782872|2173830|P4|Overall Study|Protocol Violation|1
672472|NCT01782872|2173831|P3|Overall Study|Protocol Violation|0
672473|NCT01782872|2173832|P2|Overall Study|Protocol Violation|0
672474|NCT01782872|2173833|P1|Overall Study|Protocol Violation|0
672475|NCT01782859|2173857|P2|Overall Study|Withdrawal by Subject|1
672476|NCT01782859|2173858|P1|Overall Study|Withdrawal by Subject|0
672477|NCT01782859|2173857|P2|Overall Study|Protocol Violation|6
672478|NCT01782859|2173858|P1|Overall Study|Protocol Violation|6
672479|NCT01782742|2173874|P2|Double-blind Treatment Phase|Adverse Event|0
672480|NCT01782742|2173875|P1|Double-blind Treatment Phase|Adverse Event|1
672481|NCT01782664|2173914|P6|Overall Study|Withdrawal by Subject|0
672482|NCT01782664|2173915|P5|Overall Study|Withdrawal by Subject|0
672483|NCT01782664|2173916|P4|Overall Study|Withdrawal by Subject|0
672484|NCT01782664|2173917|P3|Overall Study|Withdrawal by Subject|0
672485|NCT01782664|2173918|P2|Overall Study|Withdrawal by Subject|2
672486|NCT01782664|2173919|P1|Overall Study|Withdrawal by Subject|2
672487|NCT01782664|2173914|P6|Overall Study|Protocol Violation|0
672488|NCT01782664|2173915|P5|Overall Study|Protocol Violation|0
672489|NCT01782664|2173916|P4|Overall Study|Protocol Violation|1
672490|NCT01782664|2173917|P3|Overall Study|Protocol Violation|0
672491|NCT01782664|2173918|P2|Overall Study|Protocol Violation|1
672492|NCT01782664|2173919|P1|Overall Study|Protocol Violation|0
672493|NCT01782664|2173914|P6|Overall Study|Lack of Efficacy|0
672494|NCT01782664|2173915|P5|Overall Study|Lack of Efficacy|0
672495|NCT01782664|2173916|P4|Overall Study|Lack of Efficacy|2
672496|NCT01782664|2173917|P3|Overall Study|Lack of Efficacy|2
672497|NCT01782664|2173918|P2|Overall Study|Lack of Efficacy|0
672498|NCT01782664|2173919|P1|Overall Study|Lack of Efficacy|2
672499|NCT01782664|2173914|P6|Overall Study|Adverse Event|0
672500|NCT01782664|2173915|P5|Overall Study|Adverse Event|0
672501|NCT01782664|2173916|P4|Overall Study|Adverse Event|2
672502|NCT01782664|2173917|P3|Overall Study|Adverse Event|2
672503|NCT01782664|2173918|P2|Overall Study|Adverse Event|2
672504|NCT01782664|2173919|P1|Overall Study|Adverse Event|2
672505|NCT01782482|2174067|P2|Overall Study|Habitually wearing toric lens OS|1
672506|NCT01782482|2174068|P1|Overall Study|Habitually wearing toric lens OS|0
672507|NCT01782482|2174067|P2|Overall Study|Randomized in Error|2
672508|NCT01782482|2174068|P1|Overall Study|Randomized in Error|2
672509|NCT01782482|2174067|P2|Overall Study|Withdrawal by Subject|3
672510|NCT01782482|2174068|P1|Overall Study|Withdrawal by Subject|2
672511|NCT01782482|2174067|P2|Overall Study|Protocol Violation|0
672512|NCT01782482|2174068|P1|Overall Study|Protocol Violation|1
672513|NCT01782482|2174067|P2|Overall Study|Physician Decision|0
672514|NCT01782482|2174068|P1|Overall Study|Physician Decision|1
672515|NCT01782482|2174067|P2|Overall Study|Lost to Follow-up|3
672516|NCT01782482|2174068|P1|Overall Study|Lost to Follow-up|2
672517|NCT01782482|2174067|P2|Overall Study|Adverse Event|1
672518|NCT01782482|2174068|P1|Overall Study|Adverse Event|2
672519|NCT01782469|2174076|P1|Overall Study|Lost to Follow-up|1
672520|NCT01782326|2174086|P2|Double-blind Treatment|Technical problems|5
672521|NCT01782326|2174087|P1|Double-blind Treatment|Technical problems|0
672522|NCT01782326|2174086|P2|Double-blind Treatment|Protocol deviation|7
672523|NCT01782326|2174087|P1|Double-blind Treatment|Protocol deviation|8
672524|NCT01782326|2174086|P2|Double-blind Treatment|Physician Decision|16
672525|NCT01782326|2174087|P1|Double-blind Treatment|Physician Decision|13
672526|NCT01782326|2174086|P2|Double-blind Treatment|Lack of Efficacy|22
672527|NCT01782326|2174087|P1|Double-blind Treatment|Lack of Efficacy|17
672528|NCT01782326|2174086|P2|Double-blind Treatment|Subject/guardian decision|125
672529|NCT01782326|2174087|P1|Double-blind Treatment|Subject/guardian decision|111
672530|NCT01782326|2174086|P2|Double-blind Treatment|Adverse Event|145
672531|NCT01782326|2174087|P1|Double-blind Treatment|Adverse Event|129
672532|NCT01782326|2174086|P2|Planned Treatment Epoch|Technical problems|4
672533|NCT01782326|2174087|P1|Planned Treatment Epoch|Technical problems|0
672534|NCT01782326|2174086|P2|Planned Treatment Epoch|Lost to Follow-up|4
672535|NCT01782326|2174087|P1|Planned Treatment Epoch|Lost to Follow-up|4
672536|NCT01782326|2174086|P2|Planned Treatment Epoch|Protocol deviation|3
672537|NCT01782326|2174087|P1|Planned Treatment Epoch|Protocol deviation|2
672538|NCT01782326|2174086|P2|Planned Treatment Epoch|Physician Decision|16
672539|NCT01782326|2174087|P1|Planned Treatment Epoch|Physician Decision|18
672540|NCT01782326|2174086|P2|Planned Treatment Epoch|Death|30
672541|NCT01782326|2174087|P1|Planned Treatment Epoch|Death|29
672542|NCT01782326|2174086|P2|Planned Treatment Epoch|Subject/guardian decision|151
672543|NCT01782326|2174087|P1|Planned Treatment Epoch|Subject/guardian decision|149
672544|NCT01782222|2174150|P3|Overall Study|Moved to other state|0
672545|NCT01782222|2174151|P2|Overall Study|Moved to other state|1
672546|NCT01782222|2174152|P1|Overall Study|Moved to other state|0
672547|NCT01782222|2174150|P3|Overall Study|Withdrawal by Subject|1
672548|NCT01782222|2174151|P2|Overall Study|Withdrawal by Subject|4
672549|NCT01782222|2174152|P1|Overall Study|Withdrawal by Subject|1
672550|NCT01782222|2174150|P3|Overall Study|Protocol Violation|0
672551|NCT01782222|2174151|P2|Overall Study|Protocol Violation|0
672552|NCT01782222|2174152|P1|Overall Study|Protocol Violation|1
672553|NCT01782222|2174150|P3|Overall Study|Lack of Efficacy|0
672554|NCT01782222|2174151|P2|Overall Study|Lack of Efficacy|1
672555|NCT01782222|2174152|P1|Overall Study|Lack of Efficacy|2
672556|NCT01782222|2174150|P3|Overall Study|Adverse Event|3
672557|NCT01782222|2174151|P2|Overall Study|Adverse Event|5
672558|NCT01782222|2174152|P1|Overall Study|Adverse Event|4
672559|NCT01781962|2174184|P1|Overall Study|Other Miscellaneous Reasons|5
672560|NCT01781637|2174203|P2|Overall Study|Withdrawal by Subject|0
672561|NCT01781637|2174204|P1|Overall Study|Withdrawal by Subject|1
672562|NCT01781637|2174203|P2|Overall Study|Lack of Efficacy|6
672563|NCT01781637|2174204|P1|Overall Study|Lack of Efficacy|2
672564|NCT01781637|2174203|P2|Overall Study|Adverse Event|0
672565|NCT01781637|2174204|P1|Overall Study|Adverse Event|1
672566|NCT01781299|2174291|P2|Overall Study|Withdrawal by Subject|1
672567|NCT01781299|2174292|P1|Overall Study|Withdrawal by Subject|0
672568|NCT01781026|2174328|P1|Overall Study|Lack of Efficacy|2
672569|NCT01780987|2174334|P2|Overall Study|Not Receiving any Study Medication|1
672570|NCT01780987|2174335|P1|Overall Study|Not Receiving any Study Medication|0
672571|NCT01780987|2174334|P2|Overall Study|Changing Residence|0
672572|NCT01780987|2174335|P1|Overall Study|Changing Residence|1
672573|NCT01780987|2174334|P2|Overall Study|Request of Changing Hospital|1
672574|NCT01780987|2174335|P1|Overall Study|Request of Changing Hospital|0
672575|NCT01780987|2174334|P2|Overall Study|Withdrawal by Subject|0
672576|NCT01780987|2174335|P1|Overall Study|Withdrawal by Subject|2
672577|NCT01780987|2174334|P2|Overall Study|Adverse Event|4
672578|NCT01780987|2174335|P1|Overall Study|Adverse Event|0
672579|NCT01780974|2174353|P2|Overall Study|Adverse Event|3
672580|NCT01780974|2174354|P1|Overall Study|Adverse Event|1
672581|NCT01780974|2174353|P2|Overall Study|Death|0
672582|NCT01780974|2174354|P1|Overall Study|Death|1
672583|NCT01780935|2174364|P2|Overall Study|Patient withdrew consent|9
672584|NCT01780935|2174365|P1|Overall Study|Patient withdrew consent|8
672585|NCT01780935|2174364|P2|Overall Study|Protocol deviation|1
672586|NCT01780935|2174365|P1|Overall Study|Protocol deviation|0
672587|NCT01780935|2174364|P2|Overall Study|Physician Decision|1
672588|NCT01780935|2174365|P1|Overall Study|Physician Decision|1
672589|NCT01780935|2174364|P2|Overall Study|Lost to Follow-up|6
672590|NCT01780935|2174365|P1|Overall Study|Lost to Follow-up|2
672591|NCT01780935|2174364|P2|Overall Study|Death|6
672592|NCT01780935|2174365|P1|Overall Study|Death|1
672593|NCT01780935|2174364|P2|Overall Study|Adverse Event|4
672594|NCT01780935|2174365|P1|Overall Study|Adverse Event|2
672595|NCT01780935|2174364|P2|Overall Study|Admin problems due to early termination|309
672596|NCT01780935|2174365|P1|Overall Study|Admin problems due to early termination|321
672597|NCT01780584|2174469|P3|Overall Study|Protocol Violation|1
672598|NCT01780584|2174470|P2|Overall Study|Protocol Violation|0
672599|NCT01780584|2174471|P1|Overall Study|Protocol Violation|0
672600|NCT01780584|2174469|P3|Overall Study|Adverse Event|0
672601|NCT01780584|2174470|P2|Overall Study|Adverse Event|1
672602|NCT01780584|2174471|P1|Overall Study|Adverse Event|0
672603|NCT01780584|2174469|P3|Overall Study|Death|1
672604|NCT01780584|2174470|P2|Overall Study|Death|0
672605|NCT01780584|2174471|P1|Overall Study|Death|1
888749|NCT01791517|2822615|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
888750|NCT01791517|2822616|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
888751|NCT01791517|2822617|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
888752|NCT01791517|2822618|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
888753|NCT01791517|2822619|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
888754|NCT01791517|2822620|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
888755|NCT01791517|2822621|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
888756|NCT01791517|2822622|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
888757|NCT01791517|2822623|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
888758|NCT01791517|2822624|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
888759|NCT01791517|2822625|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
888760|NCT01791517|2822614|P12|Phase I: Period 1|Lens Handling DIfficulties|1
888761|NCT01791517|2822615|P11|Phase I: Period 1|Lens Handling DIfficulties|0
888762|NCT01791517|2822616|P10|Phase I: Period 1|Lens Handling DIfficulties|0
888763|NCT01791517|2822617|P9|Phase I: Period 1|Lens Handling DIfficulties|0
888764|NCT01791517|2822618|P8|Phase I: Period 1|Lens Handling DIfficulties|0
888765|NCT01791517|2822619|P7|Phase I: Period 1|Lens Handling DIfficulties|0
888766|NCT01791517|2822620|P6|Phase I: Period 1|Lens Handling DIfficulties|0
888767|NCT01791517|2822621|P5|Phase I: Period 1|Lens Handling DIfficulties|0
672628|NCT01780389|2174532|P1|Overall Study|Adverse Event|1
672629|NCT01779648|2174572|P2|Overall Study|Protocol Violation|0
672630|NCT01779648|2174573|P1|Overall Study|Protocol Violation|1
672631|NCT01778985|2174623|P2|Overall Study|Protocol Violation|1
672632|NCT01778985|2174624|P1|Overall Study|Protocol Violation|4
672633|NCT01778985|2174623|P2|Overall Study|Physician Decision|2
672634|NCT01778985|2174624|P1|Overall Study|Physician Decision|2
672635|NCT01778985|2174623|P2|Overall Study|Lost to Follow-up|0
672636|NCT01778985|2174624|P1|Overall Study|Lost to Follow-up|1
672637|NCT01778855|2174670|P2|Overall Study|Death|1
672638|NCT01778855|2174671|P1|Overall Study|Death|0
672639|NCT01778751|2174679|P2|Overall Study|Transfered care|0
672640|NCT01778751|2174680|P1|Overall Study|Transfered care|1
672641|NCT01778751|2174679|P2|Overall Study|Withdrawal by Subject|2
672642|NCT01778751|2174680|P1|Overall Study|Withdrawal by Subject|0
672643|NCT01778751|2174679|P2|Overall Study|Lost to Follow-up|0
672644|NCT01778751|2174680|P1|Overall Study|Lost to Follow-up|1
672645|NCT01778530|2174692|P1|Overall Study|Adverse event/side effect|1
672646|NCT01778530|2174692|P1|Overall Study|Progression on study|1
672647|NCT01778127|2174704|P3|Overall Study|Withdrawal by Subject|4
672648|NCT01778127|2174705|P2|Overall Study|Withdrawal by Subject|1
672649|NCT01778127|2174706|P1|Overall Study|Withdrawal by Subject|3
672650|NCT01778127|2174704|P3|Overall Study|Lost to Follow-up|2
672651|NCT01778127|2174705|P2|Overall Study|Lost to Follow-up|1
672652|NCT01778127|2174706|P1|Overall Study|Lost to Follow-up|5
672653|NCT01778062|2174749|P2|Overall Study|major protocol deviation|3
672654|NCT01778062|2174750|P1|Overall Study|major protocol deviation|4
672655|NCT01778062|2174749|P2|Overall Study|Consent Withdrawal|5
672656|NCT01778062|2174750|P1|Overall Study|Consent Withdrawal|1
672657|NCT01778062|2174749|P2|Overall Study|Adverse Event|3
672658|NCT01778062|2174750|P1|Overall Study|Adverse Event|1
672659|NCT01778049|2174764|P6|Double Blind Treatment Period|Other reason not defined above|1
672660|NCT01778049|2174765|P5|Double Blind Treatment Period|Other reason not defined above|2
672661|NCT01778049|2174766|P4|Double Blind Treatment Period|Other reason not defined above|2
672662|NCT01778049|2174767|P3|Double Blind Treatment Period|Other reason not defined above|4
672663|NCT01778049|2174768|P2|Double Blind Treatment Period|Other reason not defined above|0
672664|NCT01778049|2174769|P1|Double Blind Treatment Period|Other reason not defined above|0
672665|NCT01778049|2174764|P6|Double Blind Treatment Period|Not treated|0
672666|NCT01778049|2174765|P5|Double Blind Treatment Period|Not treated|2
672667|NCT01778049|2174766|P4|Double Blind Treatment Period|Not treated|2
672668|NCT01778049|2174767|P3|Double Blind Treatment Period|Not treated|0
672669|NCT01778049|2174768|P2|Double Blind Treatment Period|Not treated|0
672670|NCT01778049|2174769|P1|Double Blind Treatment Period|Not treated|0
672671|NCT01778049|2174764|P6|Double Blind Treatment Period|Withdrawal by Subject|1
672672|NCT01778049|2174765|P5|Double Blind Treatment Period|Withdrawal by Subject|0
672673|NCT01778049|2174766|P4|Double Blind Treatment Period|Withdrawal by Subject|2
672674|NCT01778049|2174767|P3|Double Blind Treatment Period|Withdrawal by Subject|1
672675|NCT01778049|2174768|P2|Double Blind Treatment Period|Withdrawal by Subject|0
672676|NCT01778049|2174769|P1|Double Blind Treatment Period|Withdrawal by Subject|0
672677|NCT01778049|2174764|P6|Double Blind Treatment Period|Lost to Follow-up|2
672678|NCT01778049|2174765|P5|Double Blind Treatment Period|Lost to Follow-up|5
672679|NCT01778049|2174766|P4|Double Blind Treatment Period|Lost to Follow-up|1
672680|NCT01778049|2174767|P3|Double Blind Treatment Period|Lost to Follow-up|4
672681|NCT01778049|2174768|P2|Double Blind Treatment Period|Lost to Follow-up|0
672682|NCT01778049|2174769|P1|Double Blind Treatment Period|Lost to Follow-up|0
672683|NCT01778049|2174764|P6|Double Blind Treatment Period|Protocol Violation|0
672684|NCT01778049|2174765|P5|Double Blind Treatment Period|Protocol Violation|0
672685|NCT01778049|2174766|P4|Double Blind Treatment Period|Protocol Violation|0
672686|NCT01778049|2174767|P3|Double Blind Treatment Period|Protocol Violation|2
672687|NCT01778049|2174768|P2|Double Blind Treatment Period|Protocol Violation|0
672688|NCT01778049|2174769|P1|Double Blind Treatment Period|Protocol Violation|0
672689|NCT01778049|2174764|P6|Double Blind Treatment Period|Lack of Efficacy|1
672690|NCT01778049|2174765|P5|Double Blind Treatment Period|Lack of Efficacy|0
672691|NCT01778049|2174766|P4|Double Blind Treatment Period|Lack of Efficacy|0
672692|NCT01778049|2174767|P3|Double Blind Treatment Period|Lack of Efficacy|0
672693|NCT01778049|2174768|P2|Double Blind Treatment Period|Lack of Efficacy|0
672694|NCT01778049|2174769|P1|Double Blind Treatment Period|Lack of Efficacy|0
672695|NCT01778049|2174764|P6|Double Blind Treatment Period|Adverse Event|2
672696|NCT01778049|2174765|P5|Double Blind Treatment Period|Adverse Event|3
672697|NCT01778049|2174766|P4|Double Blind Treatment Period|Adverse Event|5
672698|NCT01778049|2174767|P3|Double Blind Treatment Period|Adverse Event|4
672699|NCT01778049|2174768|P2|Double Blind Treatment Period|Adverse Event|0
672700|NCT01778049|2174769|P1|Double Blind Treatment Period|Adverse Event|0
672701|NCT01778049|2174764|P6|Open Label Treatment Period|Other reason not defined above|0
672702|NCT01778049|2174765|P5|Open Label Treatment Period|Other reason not defined above|0
672703|NCT01778049|2174766|P4|Open Label Treatment Period|Other reason not defined above|0
672704|NCT01778049|2174767|P3|Open Label Treatment Period|Other reason not defined above|0
672705|NCT01778049|2174768|P2|Open Label Treatment Period|Other reason not defined above|94
672706|NCT01778049|2174769|P1|Open Label Treatment Period|Other reason not defined above|77
672707|NCT01778049|2174764|P6|Open Label Treatment Period|Not treated|0
672708|NCT01778049|2174765|P5|Open Label Treatment Period|Not treated|0
672709|NCT01778049|2174766|P4|Open Label Treatment Period|Not treated|0
672710|NCT01778049|2174767|P3|Open Label Treatment Period|Not treated|0
672711|NCT01778049|2174768|P2|Open Label Treatment Period|Not treated|1
672712|NCT01778049|2174769|P1|Open Label Treatment Period|Not treated|2
672713|NCT01778049|2174764|P6|Open Label Treatment Period|Withdrawal by Subject|0
672714|NCT01778049|2174765|P5|Open Label Treatment Period|Withdrawal by Subject|0
672715|NCT01778049|2174766|P4|Open Label Treatment Period|Withdrawal by Subject|0
672716|NCT01778049|2174767|P3|Open Label Treatment Period|Withdrawal by Subject|0
672717|NCT01778049|2174768|P2|Open Label Treatment Period|Withdrawal by Subject|10
672718|NCT01778049|2174769|P1|Open Label Treatment Period|Withdrawal by Subject|4
672719|NCT01778049|2174764|P6|Open Label Treatment Period|Lost to Follow-up|0
672720|NCT01778049|2174765|P5|Open Label Treatment Period|Lost to Follow-up|0
672721|NCT01778049|2174766|P4|Open Label Treatment Period|Lost to Follow-up|0
672722|NCT01778049|2174767|P3|Open Label Treatment Period|Lost to Follow-up|0
672723|NCT01778049|2174768|P2|Open Label Treatment Period|Lost to Follow-up|3
672724|NCT01778049|2174769|P1|Open Label Treatment Period|Lost to Follow-up|4
672725|NCT01778049|2174764|P6|Open Label Treatment Period|Protocol Violation|0
672726|NCT01778049|2174765|P5|Open Label Treatment Period|Protocol Violation|0
672727|NCT01778049|2174766|P4|Open Label Treatment Period|Protocol Violation|0
672728|NCT01778049|2174767|P3|Open Label Treatment Period|Protocol Violation|0
672729|NCT01778049|2174768|P2|Open Label Treatment Period|Protocol Violation|5
672730|NCT01778049|2174769|P1|Open Label Treatment Period|Protocol Violation|5
672731|NCT01778049|2174764|P6|Open Label Treatment Period|Lack of Efficacy|0
672732|NCT01778049|2174765|P5|Open Label Treatment Period|Lack of Efficacy|0
672733|NCT01778049|2174766|P4|Open Label Treatment Period|Lack of Efficacy|0
672734|NCT01778049|2174767|P3|Open Label Treatment Period|Lack of Efficacy|0
672735|NCT01778049|2174768|P2|Open Label Treatment Period|Lack of Efficacy|1
672736|NCT01778049|2174769|P1|Open Label Treatment Period|Lack of Efficacy|1
672737|NCT01778049|2174764|P6|Open Label Treatment Period|Adverse Event|0
672738|NCT01778049|2174765|P5|Open Label Treatment Period|Adverse Event|0
672739|NCT01778049|2174766|P4|Open Label Treatment Period|Adverse Event|0
672740|NCT01778049|2174767|P3|Open Label Treatment Period|Adverse Event|0
672741|NCT01778049|2174768|P2|Open Label Treatment Period|Adverse Event|15
672742|NCT01778049|2174769|P1|Open Label Treatment Period|Adverse Event|5
672743|NCT01778023|2174787|P2|Overall Study|Withdrawal by Subject|3
672744|NCT01778023|2174788|P1|Overall Study|Withdrawal by Subject|0
672745|NCT01777932|2174815|P1|Overall Study|Patient refused further treatment|10
672746|NCT01777932|2174815|P1|Overall Study|Reimbursement limit|9
672747|NCT01777932|2174815|P1|Overall Study|Investigator decision|10
672748|NCT01777932|2174815|P1|Overall Study|Lost to Follow-up|3
672749|NCT01777932|2174815|P1|Overall Study|Adverse Event|34
672750|NCT01777932|2174815|P1|Overall Study|Death|3
672751|NCT01777932|2174815|P1|Overall Study|Disease progression|136
672752|NCT01777776|2174833|P4|Overall Study|Withdrawal by Subject|1
672753|NCT01777776|2174834|P3|Overall Study|Withdrawal by Subject|0
672754|NCT01777776|2174835|P2|Overall Study|Withdrawal by Subject|0
672755|NCT01777776|2174836|P1|Overall Study|Withdrawal by Subject|0
672756|NCT01777776|2174833|P4|Overall Study|Disease Progression|3
672757|NCT01777776|2174834|P3|Overall Study|Disease Progression|6
672758|NCT01777776|2174835|P2|Overall Study|Disease Progression|8
672759|NCT01777776|2174836|P1|Overall Study|Disease Progression|4
672760|NCT01777776|2174833|P4|Overall Study|Adverse Event|0
672761|NCT01777776|2174834|P3|Overall Study|Adverse Event|0
672762|NCT01777776|2174835|P2|Overall Study|Adverse Event|4
672763|NCT01777776|2174836|P1|Overall Study|Adverse Event|2
672764|NCT01777763|2174895|P2|Overall Study|Treatment Failure|6
672765|NCT01777763|2174896|P1|Overall Study|Treatment Failure|1
672766|NCT01777763|2174895|P2|Overall Study|Withdrawal by Subject|2
672767|NCT01777763|2174896|P1|Overall Study|Withdrawal by Subject|0
672768|NCT01777763|2174895|P2|Overall Study|Protocol Violation|7
672769|NCT01777763|2174896|P1|Overall Study|Protocol Violation|1
672770|NCT01777763|2174895|P2|Overall Study|Adverse Event|32
672771|NCT01777763|2174896|P1|Overall Study|Adverse Event|2
672772|NCT01777620|2174920|P2|Overall Study|Subject Withdrawal|0
672773|NCT01777620|2174921|P1|Overall Study|Subject Withdrawal|1
672774|NCT01777581|2174947|P2|Overall Study|Lack of Efficacy|1
672775|NCT01777581|2174948|P1|Overall Study|Lack of Efficacy|0
672776|NCT01777581|2174947|P2|Overall Study|Adverse Event|0
672777|NCT01777581|2174948|P1|Overall Study|Adverse Event|2
672778|NCT01777581|2174947|P2|Overall Study|Lost to Follow-up|1
672779|NCT01777581|2174948|P1|Overall Study|Lost to Follow-up|1
672790|NCT01777321|2175006|P2|Overall Study|Withdrawal by Subject|1
672791|NCT01777321|2175007|P1|Overall Study|Withdrawal by Subject|0
672792|NCT01777282|2175048|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
672793|NCT01777282|2175049|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
672794|NCT01777282|2175050|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
672795|NCT01777282|2175051|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
672796|NCT01777282|2175052|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
672797|NCT01777282|2175048|P5|Overall Study|Protocol Violation|2
672798|NCT01777282|2175049|P4|Overall Study|Protocol Violation|0
672799|NCT01777282|2175050|P3|Overall Study|Protocol Violation|1
672800|NCT01777282|2175051|P2|Overall Study|Protocol Violation|0
672801|NCT01777282|2175052|P1|Overall Study|Protocol Violation|2
672802|NCT01777282|2175048|P5|Overall Study|Withdrawal by Subject|2
672803|NCT01777282|2175049|P4|Overall Study|Withdrawal by Subject|1
672804|NCT01777282|2175050|P3|Overall Study|Withdrawal by Subject|0
672805|NCT01777282|2175051|P2|Overall Study|Withdrawal by Subject|0
672806|NCT01777282|2175052|P1|Overall Study|Withdrawal by Subject|4
672807|NCT01777282|2175048|P5|Overall Study|Adverse Event|3
672808|NCT01777282|2175049|P4|Overall Study|Adverse Event|1
672809|NCT01777282|2175050|P3|Overall Study|Adverse Event|2
672810|NCT01777282|2175051|P2|Overall Study|Adverse Event|4
672811|NCT01777282|2175052|P1|Overall Study|Adverse Event|4
672812|NCT01777282|2175048|P5|Overall Study|New Antidiabetic Medication|0
672813|NCT01777282|2175049|P4|Overall Study|New Antidiabetic Medication|0
672814|NCT01777282|2175050|P3|Overall Study|New Antidiabetic Medication|1
672815|NCT01777282|2175051|P2|Overall Study|New Antidiabetic Medication|0
672816|NCT01777282|2175052|P1|Overall Study|New Antidiabetic Medication|0
672817|NCT01777282|2175048|P5|Overall Study|Persistent Hyperglycemia|0
672818|NCT01777282|2175049|P4|Overall Study|Persistent Hyperglycemia|0
672819|NCT01777282|2175050|P3|Overall Study|Persistent Hyperglycemia|1
672820|NCT01777282|2175051|P2|Overall Study|Persistent Hyperglycemia|0
672821|NCT01777282|2175052|P1|Overall Study|Persistent Hyperglycemia|0
672822|NCT01777269|2175096|P2|Overall Study|Withdrawal by Subject|9
672823|NCT01777269|2175097|P1|Overall Study|Withdrawal by Subject|9
672824|NCT01777269|2175096|P2|Overall Study|Physician Decision|2
672825|NCT01777269|2175097|P1|Overall Study|Physician Decision|5
672826|NCT01777269|2175096|P2|Overall Study|Lost to Follow-up|0
672827|NCT01777269|2175097|P1|Overall Study|Lost to Follow-up|4
672828|NCT01777269|2175096|P2|Overall Study|Participants reached stopping criteria|1
672829|NCT01777269|2175097|P1|Overall Study|Participants reached stopping criteria|1
672830|NCT01777269|2175096|P2|Overall Study|Protocol Violation|4
672831|NCT01777269|2175097|P1|Overall Study|Protocol Violation|4
672832|NCT01777269|2175096|P2|Overall Study|Lack of Efficacy|10
672833|NCT01777269|2175097|P1|Overall Study|Lack of Efficacy|8
672834|NCT01777269|2175096|P2|Overall Study|Adverse Event|33
672835|NCT01777269|2175097|P1|Overall Study|Adverse Event|24
672836|NCT01777191|2175134|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
672837|NCT01777191|2175135|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
672838|NCT01777191|2175134|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
672839|NCT01777191|2175135|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
672840|NCT01777191|2175134|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
672841|NCT01777191|2175135|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
672842|NCT01777191|2175134|P2|Safety Extension Per (Week 12-Week 48)|Death|1
672843|NCT01777191|2175135|P1|Safety Extension Per (Week 12-Week 48)|Death|0
672844|NCT01777191|2175134|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
672845|NCT01777191|2175135|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
672846|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
672847|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
672848|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
672849|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
672850|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
672851|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
672852|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
672853|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
672854|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
672855|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
672856|NCT01777191|2175134|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
672857|NCT01777191|2175135|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
672858|NCT01776554|2175198|P2|Overall Study|Unclassified|1
672859|NCT01776554|2175199|P1|Overall Study|Unclassified|4
672860|NCT01776554|2175198|P2|Overall Study|Protocol Violation|0
672861|NCT01776554|2175199|P1|Overall Study|Protocol Violation|1
672862|NCT01776554|2175198|P2|Overall Study|Administrative Reason|5
672863|NCT01776554|2175199|P1|Overall Study|Administrative Reason|2
672864|NCT01776554|2175198|P2|Overall Study|Lost to Follow-up|9
672865|NCT01776554|2175199|P1|Overall Study|Lost to Follow-up|6
672866|NCT01776554|2175198|P2|Overall Study|Withdrawal by Subject|8
672867|NCT01776554|2175199|P1|Overall Study|Withdrawal by Subject|3
672868|NCT01776554|2175198|P2|Overall Study|Adverse Event|0
672869|NCT01776554|2175199|P1|Overall Study|Adverse Event|1
672870|NCT01776541|2175242|P2|Overall Study|Withdrawal by Subject|20
672871|NCT01776541|2175243|P1|Overall Study|Withdrawal by Subject|12
672872|NCT01776541|2175242|P2|Overall Study|Protocol Violation|1
672873|NCT01776541|2175243|P1|Overall Study|Protocol Violation|2
672874|NCT01776541|2175242|P2|Overall Study|Unclassified|4
672875|NCT01776541|2175243|P1|Overall Study|Unclassified|5
672876|NCT01776541|2175242|P2|Overall Study|Lost to Follow-up|48
672877|NCT01776541|2175243|P1|Overall Study|Lost to Follow-up|27
672878|NCT01776541|2175242|P2|Overall Study|Death|0
672879|NCT01776541|2175243|P1|Overall Study|Death|4
672880|NCT01776541|2175242|P2|Overall Study|Administrative Reason|2
672881|NCT01776541|2175243|P1|Overall Study|Administrative Reason|6
672882|NCT01775995|2175275|P2|Overall Study|Lost to Follow-up|1
672883|NCT01775995|2175276|P1|Overall Study|Lost to Follow-up|1
672884|NCT01775670|2175384|P2|Overall Study|Lost to Follow-up|1
672885|NCT01775670|2175385|P1|Overall Study|Lost to Follow-up|1
672886|NCT01775553|2175411|P1|Overall Study|Disease Progression|12
672887|NCT01775553|2175411|P1|Overall Study|Adverse Event|1
672888|NCT01775189|2175419|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
672889|NCT01775189|2175420|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
672890|NCT01775189|2175421|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
672891|NCT01775189|2175422|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
672892|NCT01775189|2175423|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
672893|NCT01775189|2175424|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
672894|NCT01775189|2175425|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
672895|NCT01775189|2175419|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
672896|NCT01775189|2175420|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
672897|NCT01775189|2175421|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
672898|NCT01775189|2175422|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
672899|NCT01775189|2175423|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
672900|NCT01775189|2175424|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
672901|NCT01775189|2175425|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
672902|NCT01775189|2175419|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
672903|NCT01775189|2175420|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
672904|NCT01775189|2175421|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
672905|NCT01775189|2175422|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
672906|NCT01775189|2175423|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
672907|NCT01775189|2175424|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
672908|NCT01775189|2175425|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
672909|NCT01775189|2175419|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
672910|NCT01775189|2175420|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
672911|NCT01775189|2175421|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
672912|NCT01775189|2175422|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
672913|NCT01775189|2175423|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
672914|NCT01775189|2175424|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
672915|NCT01775189|2175425|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
672916|NCT01775189|2175419|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
672917|NCT01775189|2175420|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
672918|NCT01775189|2175421|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
672919|NCT01775189|2175422|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
672920|NCT01775189|2175423|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
672921|NCT01775189|2175424|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
672922|NCT01775189|2175425|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
672923|NCT01775189|2175419|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
672924|NCT01775189|2175420|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
672925|NCT01775189|2175421|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
672926|NCT01775189|2175422|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
672927|NCT01775189|2175423|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
672928|NCT01775189|2175424|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
672929|NCT01775189|2175425|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
672930|NCT01775137|2175644|P1|Overall Study|Withdrawal by participants|5
672931|NCT01775137|2175644|P1|Overall Study|Adverse Event|1
672932|NCT01775137|2175644|P1|Overall Study|Unsatisfactory therapeutic effect|2
672933|NCT01775137|2175644|P1|Overall Study|Protocol deviation|2
672934|NCT01775137|2175644|P1|Overall Study|Death|1
672935|NCT01774981|2175677|P8|Overall Study|Death|0
672936|NCT01774981|2175678|P7|Overall Study|Death|0
672937|NCT01774981|2175679|P6|Overall Study|Death|0
672938|NCT01774981|2175680|P5|Overall Study|Death|1
672939|NCT01774981|2175681|P4|Overall Study|Death|0
672940|NCT01774981|2175682|P3|Overall Study|Death|0
672941|NCT01774981|2175683|P2|Overall Study|Death|0
672942|NCT01774981|2175684|P1|Overall Study|Death|0
672943|NCT01774981|2175677|P8|Overall Study|Withdrawal by Subject|1
672944|NCT01774981|2175678|P7|Overall Study|Withdrawal by Subject|0
672945|NCT01774981|2175679|P6|Overall Study|Withdrawal by Subject|0
672946|NCT01774981|2175680|P5|Overall Study|Withdrawal by Subject|0
672947|NCT01774981|2175681|P4|Overall Study|Withdrawal by Subject|0
672948|NCT01774981|2175682|P3|Overall Study|Withdrawal by Subject|0
672949|NCT01774981|2175683|P2|Overall Study|Withdrawal by Subject|0
672950|NCT01774981|2175684|P1|Overall Study|Withdrawal by Subject|0
672951|NCT01774981|2175677|P8|Overall Study|Adverse Event|0
672952|NCT01774981|2175678|P7|Overall Study|Adverse Event|0
672953|NCT01774981|2175679|P6|Overall Study|Adverse Event|1
672954|NCT01774981|2175680|P5|Overall Study|Adverse Event|0
672955|NCT01774981|2175681|P4|Overall Study|Adverse Event|0
672956|NCT01774981|2175682|P3|Overall Study|Adverse Event|0
672957|NCT01774981|2175683|P2|Overall Study|Adverse Event|0
672958|NCT01774981|2175684|P1|Overall Study|Adverse Event|0
672959|NCT01774968|2175716|P2|Overall Study|Withdrawal by Subject|11
672960|NCT01774968|2175717|P1|Overall Study|Withdrawal by Subject|6
672961|NCT01774968|2175716|P2|Overall Study|Sponsor Decision|2
672962|NCT01774968|2175717|P1|Overall Study|Sponsor Decision|0
672963|NCT01774968|2175716|P2|Overall Study|Protocol Violation|13
672964|NCT01774968|2175717|P1|Overall Study|Protocol Violation|14
672965|NCT01774968|2175716|P2|Overall Study|Physician Decision|1
672966|NCT01774968|2175717|P1|Overall Study|Physician Decision|5
672967|NCT01774968|2175716|P2|Overall Study|Lost to Follow-up|3
672968|NCT01774968|2175717|P1|Overall Study|Lost to Follow-up|1
672969|NCT01774968|2175716|P2|Overall Study|Death|1
672970|NCT01774968|2175717|P1|Overall Study|Death|0
672971|NCT01774968|2175716|P2|Overall Study|Adverse Event|4
672972|NCT01774968|2175717|P1|Overall Study|Adverse Event|4
672973|NCT01774929|2175751|P1|Overall Study|Adverse Event|3
672974|NCT01774903|2175757|P1|Overall Study|Ineligible to continue the trial|1
672975|NCT01774903|2175757|P1|Overall Study|Lack of Efficacy|1
672976|NCT01774903|2175757|P1|Overall Study|Withdrawal by Subject|2
672977|NCT01774903|2175757|P1|Overall Study|Adverse Event|7
672978|NCT01774344|2175796|P2|Overall Study|Non-compliance with study drug|2
672979|NCT01774344|2175797|P1|Overall Study|Non-compliance with study drug|0
672980|NCT01774344|2175796|P2|Overall Study|Physician Decision|1
672981|NCT01774344|2175797|P1|Overall Study|Physician Decision|0
672982|NCT01774344|2175796|P2|Overall Study|Adverse event (AE)|1
672983|NCT01774344|2175797|P1|Overall Study|Adverse event (AE)|0
672984|NCT01774344|2175796|P2|Overall Study|AE not related to disease progression|47
672985|NCT01774344|2175797|P1|Overall Study|AE not related to disease progression|12
672986|NCT01774344|2175796|P2|Overall Study|Ongoing with treatment|65
672987|NCT01774344|2175797|P1|Overall Study|Ongoing with treatment|10
672988|NCT01774344|2175796|P2|Overall Study|Unspecified|0
672989|NCT01774344|2175797|P1|Overall Study|Unspecified|1
672990|NCT01774344|2175796|P2|Overall Study|Study drug never administered|5
672991|NCT01774344|2175797|P1|Overall Study|Study drug never administered|1
672992|NCT01774344|2175796|P2|Overall Study|Withdrawal by Subject|26
672993|NCT01774344|2175797|P1|Overall Study|Withdrawal by Subject|5
672994|NCT01774344|2175796|P2|Overall Study|Protocol Violation|1
672995|NCT01774344|2175797|P1|Overall Study|Protocol Violation|3
672996|NCT01774305|2175813|P2|Overall Study|Physician Decision|0
672997|NCT01774305|2175814|P1|Overall Study|Physician Decision|1
672998|NCT01774253|2175822|P1|Overall Study|Death|1
672999|NCT01774253|2175822|P1|Overall Study|Withdrawal by Subject|2
673000|NCT01774253|2175822|P1|Overall Study|Physician Decision|2
673001|NCT01774253|2175822|P1|Overall Study|Lack of Efficacy|4
673002|NCT01774110|2175841|P1|Overall Study|Lost to Follow-up|7
673003|NCT01774097|2175849|P2|Overall Study|Adverse Event|1
673004|NCT01774097|2175850|P1|Overall Study|Adverse Event|1
673005|NCT01774097|2175849|P2|Overall Study|Withdrawal by Subject|1
673006|NCT01774097|2175850|P1|Overall Study|Withdrawal by Subject|1
673007|NCT01774084|2175880|P2|Overall Study|Personal reasons|0
673008|NCT01774084|2175881|P1|Overall Study|Personal reasons|1
673009|NCT01773889|2175906|P1|Overall Study|lack of funding|2
673010|NCT01773473|2175912|P2|Overall Study|Lost to Follow-up|0
673011|NCT01773473|2175913|P1|Overall Study|Lost to Follow-up|2
673012|NCT01773473|2175912|P2|Overall Study|Withdrawal by Subject|3
673013|NCT01773473|2175913|P1|Overall Study|Withdrawal by Subject|5
673014|NCT01773473|2175912|P2|Overall Study|Non-Compliance with study drug|4
673015|NCT01773473|2175913|P1|Overall Study|Non-Compliance with study drug|1
673016|NCT01773473|2175912|P2|Overall Study|Lack of Efficacy|1
673017|NCT01773473|2175913|P1|Overall Study|Lack of Efficacy|0
673018|NCT01773473|2175912|P2|Overall Study|Sponsor Decision|0
673019|NCT01773473|2175913|P1|Overall Study|Sponsor Decision|2
673020|NCT01773473|2175912|P2|Overall Study|Physician Decision|5
673021|NCT01773473|2175913|P1|Overall Study|Physician Decision|3
673022|NCT01773473|2175912|P2|Overall Study|Protocol Violation|4
673023|NCT01773473|2175913|P1|Overall Study|Protocol Violation|0
673024|NCT01773473|2175912|P2|Overall Study|Adverse Event|2
673025|NCT01773473|2175913|P1|Overall Study|Adverse Event|3
673026|NCT01773291|2175934|P3|Overall Study|Withdrawal by Subject|1
673027|NCT01773291|2175935|P2|Overall Study|Withdrawal by Subject|0
673028|NCT01773291|2175936|P1|Overall Study|Withdrawal by Subject|0
673029|NCT01773291|2175934|P3|Overall Study|Protocol Violation|0
673030|NCT01773291|2175935|P2|Overall Study|Protocol Violation|0
673031|NCT01773291|2175936|P1|Overall Study|Protocol Violation|1
673032|NCT01773226|2175947|P1|Overall Study|Withdrawal by Subject|1
673033|NCT01773122|2175966|P4|Overall Study|Due to amended age eligibility criteria|1
673034|NCT01773122|2175967|P3|Overall Study|Due to amended age eligibility criteria|0
673035|NCT01773122|2175968|P2|Overall Study|Due to amended age eligibility criteria|1
673036|NCT01773122|2175969|P1|Overall Study|Due to amended age eligibility criteria|3
673037|NCT01772576|2175992|P1|Overall Study|Withdrawal by Subject|6
673038|NCT01772576|2175992|P1|Overall Study|Adverse Event|6
673039|NCT01772576|2175992|P1|Overall Study|Study device not used|3
673040|NCT01772576|2175992|P1|Overall Study|Lost to Follow-up|3
673041|NCT01772576|2175992|P1|Overall Study|Protocol Violation|1
673042|NCT01772576|2175992|P1|Overall Study|Death|15
673043|NCT01772550|2176004|P3|Overall Study|Adverse Event|1
673044|NCT01772550|2176005|P2|Overall Study|Adverse Event|0
673045|NCT01772550|2176006|P1|Overall Study|Adverse Event|0
673046|NCT01772550|2176004|P3|Overall Study|Unable to insert IV in antecubital vein|5
673047|NCT01772550|2176005|P2|Overall Study|Unable to insert IV in antecubital vein|1
673048|NCT01772550|2176006|P1|Overall Study|Unable to insert IV in antecubital vein|1
673049|NCT01772537|2176047|P3|Overall Study|unsuccessful lumbar drain placement|0
673050|NCT01772537|2176048|P2|Overall Study|unsuccessful lumbar drain placement|0
673051|NCT01772537|2176049|P1|Overall Study|unsuccessful lumbar drain placement|1
673052|NCT01772368|2176063|P1|Overall Study|Not specified|1
673053|NCT01772368|2176063|P1|Overall Study|Protocol Violation|2
673054|NCT01772368|2176063|P1|Overall Study|Withdrawal by Subject|3
673055|NCT01772368|2176063|P1|Overall Study|Adverse Event|1
673056|NCT01772316|2176109|P1|Overall Study|Withdrawn by sponsor decision|5
673057|NCT01772316|2176109|P1|Overall Study|Inform consent withdrawn|1
673058|NCT01772316|2176109|P1|Overall Study|Serious adverse event|1
673059|NCT01772147|2176130|P3|Overall Study|Lack of Efficacy|6
673060|NCT01772147|2176131|P2|Overall Study|Lack of Efficacy|6
673061|NCT01772147|2176132|P1|Overall Study|Lack of Efficacy|8
673062|NCT01772147|2176130|P3|Overall Study|Protocol Deviation|1
673063|NCT01772147|2176131|P2|Overall Study|Protocol Deviation|1
673064|NCT01772147|2176132|P1|Overall Study|Protocol Deviation|2
673065|NCT01772147|2176130|P3|Overall Study|Lost to Follow-up|1
673066|NCT01772147|2176131|P2|Overall Study|Lost to Follow-up|0
673067|NCT01772147|2176132|P1|Overall Study|Lost to Follow-up|1
673068|NCT01772147|2176130|P3|Overall Study|Withdrew Consent|4
673069|NCT01772147|2176131|P2|Overall Study|Withdrew Consent|8
673070|NCT01772147|2176132|P1|Overall Study|Withdrew Consent|7
673071|NCT01772147|2176130|P3|Overall Study|Adverse Event|6
673072|NCT01772147|2176131|P2|Overall Study|Adverse Event|10
673073|NCT01772147|2176132|P1|Overall Study|Adverse Event|13
673095|NCT01771913|2176191|P2|Overall Study|Withdrawal by Subject|0
673096|NCT01771913|2176192|P1|Overall Study|Withdrawal by Subject|1
673097|NCT01770860|2176206|P1|Overall Study|Administrative decision made by the PI|1
673098|NCT01770860|2176206|P1|Overall Study|Lost to Follow-up|1
673099|NCT01770860|2176206|P1|Overall Study|Withdrawal by Subject|4
673100|NCT01770743|2176254|P5|Overall Study|Moving Out of State|0
673101|NCT01770743|2176255|P4|Overall Study|Moving Out of State|0
673102|NCT01770743|2176256|P3|Overall Study|Moving Out of State|0
673103|NCT01770743|2176257|P2|Overall Study|Moving Out of State|1
673104|NCT01770743|2176258|P1|Overall Study|Moving Out of State|0
673105|NCT01770743|2176254|P5|Overall Study|Sponsor Terminated Subject|0
673106|NCT01770743|2176255|P4|Overall Study|Sponsor Terminated Subject|1
673107|NCT01770743|2176256|P3|Overall Study|Sponsor Terminated Subject|0
673108|NCT01770743|2176257|P2|Overall Study|Sponsor Terminated Subject|0
673109|NCT01770743|2176258|P1|Overall Study|Sponsor Terminated Subject|1
673110|NCT01770743|2176254|P5|Overall Study|Lost to Follow-up|1
673111|NCT01770743|2176255|P4|Overall Study|Lost to Follow-up|0
673112|NCT01770743|2176256|P3|Overall Study|Lost to Follow-up|0
673113|NCT01770743|2176257|P2|Overall Study|Lost to Follow-up|2
673114|NCT01770743|2176258|P1|Overall Study|Lost to Follow-up|0
673115|NCT01770743|2176254|P5|Overall Study|Withdrawal by Subject|1
673116|NCT01770743|2176255|P4|Overall Study|Withdrawal by Subject|1
673117|NCT01770743|2176256|P3|Overall Study|Withdrawal by Subject|1
673118|NCT01770743|2176257|P2|Overall Study|Withdrawal by Subject|0
673119|NCT01770743|2176258|P1|Overall Study|Withdrawal by Subject|0
673120|NCT01770743|2176254|P5|Overall Study|Adverse Event|0
673121|NCT01770743|2176255|P4|Overall Study|Adverse Event|0
673122|NCT01770743|2176256|P3|Overall Study|Adverse Event|0
673123|NCT01770743|2176257|P2|Overall Study|Adverse Event|0
673124|NCT01770743|2176258|P1|Overall Study|Adverse Event|1
673125|NCT01770509|2176360|P2|Overall Study|Lost to Follow-up|2
673126|NCT01770509|2176361|P1|Overall Study|Lost to Follow-up|1
673127|NCT01770509|2176360|P2|Overall Study|Injury|1
673128|NCT01770509|2176361|P1|Overall Study|Injury|0
673129|NCT01770392|2176397|P1|Washout Period of at Least 14 Days|Adverse Event|1
673130|NCT01770379|2176412|P3|Overall Study|Adverse Event|2
673131|NCT01770379|2176413|P2|Overall Study|Adverse Event|3
673132|NCT01770379|2176414|P1|Overall Study|Adverse Event|1
673133|NCT01770379|2176412|P3|Overall Study|Lack of Efficacy|6
673134|NCT01770379|2176413|P2|Overall Study|Lack of Efficacy|6
673135|NCT01770379|2176414|P1|Overall Study|Lack of Efficacy|8
673136|NCT01770379|2176412|P3|Overall Study|Lost to Follow-up|2
673137|NCT01770379|2176413|P2|Overall Study|Lost to Follow-up|0
673138|NCT01770379|2176414|P1|Overall Study|Lost to Follow-up|0
673139|NCT01770379|2176412|P3|Overall Study|Physician Decision|2
673140|NCT01770379|2176413|P2|Overall Study|Physician Decision|1
673141|NCT01770379|2176414|P1|Overall Study|Physician Decision|0
673142|NCT01770379|2176412|P3|Overall Study|Protocol Violation|1
673143|NCT01770379|2176413|P2|Overall Study|Protocol Violation|1
673144|NCT01770379|2176414|P1|Overall Study|Protocol Violation|0
673145|NCT01770379|2176412|P3|Overall Study|study terminated by sponsor|22
673146|NCT01770379|2176413|P2|Overall Study|study terminated by sponsor|23
673147|NCT01770379|2176414|P1|Overall Study|study terminated by sponsor|22
673148|NCT01770379|2176412|P3|Overall Study|Withdrawal by Subject|7
673149|NCT01770379|2176413|P2|Overall Study|Withdrawal by Subject|10
673150|NCT01770379|2176414|P1|Overall Study|Withdrawal by Subject|7
673151|NCT01770379|2176412|P3|Overall Study|Technical issues|0
673152|NCT01770379|2176413|P2|Overall Study|Technical issues|0
673153|NCT01770379|2176414|P1|Overall Study|Technical issues|1
673160|NCT01769508|2176471|P1|Overall Study|Lost to Follow-up|1
673161|NCT01769508|2176471|P1|Overall Study|Adverse Event|1
673162|NCT01769508|2176471|P1|Overall Study|Withdrawal by Subject|1
673163|NCT01769508|2176471|P1|Overall Study|Death|3
673164|NCT01769443|2176482|P2|Overall Study|Study closure|0
673165|NCT01769443|2176483|P1|Overall Study|Study closure|1
673178|NCT01769378|2176547|P2|Overall Study|Lost to Follow-up|0
673179|NCT01769378|2176548|P1|Overall Study|Lost to Follow-up|2
673180|NCT01769378|2176547|P2|Overall Study|Sponsor Decision|0
673181|NCT01769378|2176548|P1|Overall Study|Sponsor Decision|1
673182|NCT01769378|2176547|P2|Overall Study|Withdrawal by Subject|3
673183|NCT01769378|2176548|P1|Overall Study|Withdrawal by Subject|10
673184|NCT01769378|2176547|P2|Overall Study|Protocol Violation|1
673185|NCT01769378|2176548|P1|Overall Study|Protocol Violation|1
673186|NCT01769378|2176547|P2|Overall Study|Entry criteria not met|0
673187|NCT01769378|2176548|P1|Overall Study|Entry criteria not met|1
673188|NCT01769378|2176547|P2|Overall Study|Adverse Event|0
673189|NCT01769378|2176548|P1|Overall Study|Adverse Event|10
673190|NCT01769339|2176628|P1|Overall Study|Adverse Event|1
673191|NCT01769339|2176628|P1|Overall Study|Lost to Follow-up|42
673192|NCT01769326|2176639|P4|Overall Study|Got sick and could not complete study|0
673193|NCT01769326|2176640|P3|Overall Study|Got sick and could not complete study|1
673194|NCT01769326|2176641|P2|Overall Study|Got sick and could not complete study|0
673195|NCT01769326|2176642|P1|Overall Study|Got sick and could not complete study|0
673196|NCT01769326|2176639|P4|Overall Study|got a job|0
673197|NCT01769326|2176640|P3|Overall Study|got a job|0
673198|NCT01769326|2176641|P2|Overall Study|got a job|1
673199|NCT01769326|2176642|P1|Overall Study|got a job|0
673200|NCT01769326|2176639|P4|Overall Study|unrelated injry|0
673201|NCT01769326|2176640|P3|Overall Study|unrelated injry|0
673202|NCT01769326|2176641|P2|Overall Study|unrelated injry|1
673203|NCT01769326|2176642|P1|Overall Study|unrelated injry|1
673204|NCT01769326|2176639|P4|Overall Study|Lost to Follow-up|0
673205|NCT01769326|2176640|P3|Overall Study|Lost to Follow-up|0
673206|NCT01769326|2176641|P2|Overall Study|Lost to Follow-up|2
673207|NCT01769326|2176642|P1|Overall Study|Lost to Follow-up|1
673208|NCT01769196|2176680|P2|Overall Study|Withdrew consent|40
673209|NCT01769196|2176681|P1|Overall Study|Withdrew consent|36
673210|NCT01769196|2176680|P2|Overall Study|Participant never dosed with study drug|0
673211|NCT01769196|2176681|P1|Overall Study|Participant never dosed with study drug|1
673212|NCT01769196|2176680|P2|Overall Study|Study terminated by sponsor|161
673213|NCT01769196|2176681|P1|Overall Study|Study terminated by sponsor|160
673214|NCT01769196|2176680|P2|Overall Study|Protocol Violation|3
673215|NCT01769196|2176681|P1|Overall Study|Protocol Violation|0
673216|NCT01769196|2176680|P2|Overall Study|Protocol defined criteria for withdrawal|11
673217|NCT01769196|2176681|P1|Overall Study|Protocol defined criteria for withdrawal|9
673218|NCT01769196|2176680|P2|Overall Study|Progressive disease|6
673219|NCT01769196|2176681|P1|Overall Study|Progressive disease|11
673220|NCT01769196|2176680|P2|Overall Study|Lack of Efficacy|2
673221|NCT01769196|2176681|P1|Overall Study|Lack of Efficacy|3
673222|NCT01769196|2176680|P2|Overall Study|Investigator Discretion|3
673223|NCT01769196|2176681|P1|Overall Study|Investigator Discretion|7
673224|NCT01769196|2176680|P2|Overall Study|Death|26
673225|NCT01769196|2176681|P1|Overall Study|Death|21
673226|NCT01769196|2176680|P2|Overall Study|Adverse Event|20
673227|NCT01769196|2176681|P1|Overall Study|Adverse Event|24
673228|NCT01769105|2176711|P2|Cross-over|Lost to Follow-up|0
673229|NCT01769105|2176712|P1|Cross-over|Lost to Follow-up|5
673230|NCT01769105|2176711|P2|First Intervention|Protocol Violation|2
673231|NCT01769105|2176712|P1|First Intervention|Protocol Violation|2
673232|NCT01768676|2176733|P2|Overall Study|Withdrawal by Subject|10
673233|NCT01768676|2176734|P1|Overall Study|Withdrawal by Subject|3
673234|NCT01768676|2176733|P2|Overall Study|Physician Decision|1
673235|NCT01768676|2176734|P1|Overall Study|Physician Decision|4
673236|NCT01768676|2176733|P2|Overall Study|Protocol Violation|1
673237|NCT01768676|2176734|P1|Overall Study|Protocol Violation|1
673238|NCT01768676|2176733|P2|Overall Study|Lost to Follow-up|16
673239|NCT01768676|2176734|P1|Overall Study|Lost to Follow-up|13
673240|NCT01768676|2176733|P2|Overall Study|Adverse Event|3
673241|NCT01768676|2176734|P1|Overall Study|Adverse Event|3
673242|NCT01768572|2176751|P3|Overall Study|Other, Not due to an adverse event|1
673243|NCT01768572|2176752|P2|Overall Study|Other, Not due to an adverse event|1
673244|NCT01768572|2176753|P1|Overall Study|Other, Not due to an adverse event|1
673245|NCT01768572|2176751|P3|Overall Study|Lack of Efficacy|1
673246|NCT01768572|2176752|P2|Overall Study|Lack of Efficacy|3
673247|NCT01768572|2176753|P1|Overall Study|Lack of Efficacy|1
673248|NCT01768572|2176751|P3|Overall Study|Adverse Event|4
673249|NCT01768572|2176752|P2|Overall Study|Adverse Event|8
673250|NCT01768572|2176753|P1|Overall Study|Adverse Event|7
673251|NCT01768559|2176764|P3|Overall Study|Other than specified|5
673252|NCT01768559|2176765|P2|Overall Study|Other than specified|8
673253|NCT01768559|2176766|P1|Overall Study|Other than specified|9
673254|NCT01768559|2176764|P3|Overall Study|Poor compliance to protocol|2
673255|NCT01768559|2176765|P2|Overall Study|Poor compliance to protocol|3
673256|NCT01768559|2176766|P1|Overall Study|Poor compliance to protocol|0
673257|NCT01768559|2176764|P3|Overall Study|Lack of Efficacy|0
673258|NCT01768559|2176765|P2|Overall Study|Lack of Efficacy|4
673259|NCT01768559|2176766|P1|Overall Study|Lack of Efficacy|6
673260|NCT01768559|2176764|P3|Overall Study|Adverse Event|5
673261|NCT01768559|2176765|P2|Overall Study|Adverse Event|2
673262|NCT01768559|2176766|P1|Overall Study|Adverse Event|15
673263|NCT01768559|2176764|P3|Overall Study|Randomized but not treated|1
673264|NCT01768559|2176765|P2|Overall Study|Randomized but not treated|0
673265|NCT01768559|2176766|P1|Overall Study|Randomized but not treated|0
673266|NCT01768286|2176831|P4|Overall Study|Withdrew Consent|0
673267|NCT01768286|2176832|P3|Overall Study|Withdrew Consent|1
673268|NCT01768286|2176833|P2|Overall Study|Withdrew Consent|0
673269|NCT01768286|2176834|P1|Overall Study|Withdrew Consent|0
673270|NCT01768286|2176831|P4|Overall Study|Lack of Efficacy|1
673271|NCT01768286|2176832|P3|Overall Study|Lack of Efficacy|0
673272|NCT01768286|2176833|P2|Overall Study|Lack of Efficacy|4
673273|NCT01768286|2176834|P1|Overall Study|Lack of Efficacy|7
673274|NCT01768286|2176831|P4|Overall Study|Randomized But Not Treated|0
673275|NCT01768286|2176832|P3|Overall Study|Randomized But Not Treated|1
673276|NCT01768286|2176833|P2|Overall Study|Randomized But Not Treated|0
673277|NCT01768286|2176834|P1|Overall Study|Randomized But Not Treated|0
673278|NCT01768117|2176896|P1|Overall Study|Protocol Violation|3
673279|NCT01768117|2176896|P1|Overall Study|Withdrawal by Subject|2
673280|NCT01768117|2176896|P1|Overall Study|Lost to Follow-up|1
673281|NCT01767987|2176960|P2|Overall Study|Physician Decision|1
673282|NCT01767987|2176961|P1|Overall Study|Physician Decision|4
673283|NCT01767597|2177019|P2|Overall Study|Withdrawal by Subject|0
673284|NCT01767597|2177020|P1|Overall Study|Withdrawal by Subject|1
673285|NCT01767597|2177019|P2|Overall Study|Incomplete intervention|1
673286|NCT01767597|2177020|P1|Overall Study|Incomplete intervention|3
673287|NCT01767519|2177029|P3|Overall Study|Adverse Event|1
673288|NCT01767519|2177030|P2|Overall Study|Adverse Event|5
673289|NCT01767519|2177031|P1|Overall Study|Adverse Event|5
673290|NCT01767519|2177029|P3|Overall Study|Lack of Efficacy|0
673291|NCT01767519|2177030|P2|Overall Study|Lack of Efficacy|0
673292|NCT01767519|2177031|P1|Overall Study|Lack of Efficacy|1
673293|NCT01767519|2177029|P3|Overall Study|Lost to Follow-up|2
673294|NCT01767519|2177030|P2|Overall Study|Lost to Follow-up|1
673295|NCT01767519|2177031|P1|Overall Study|Lost to Follow-up|3
673296|NCT01767519|2177029|P3|Overall Study|Personal Reasons|0
673297|NCT01767519|2177030|P2|Overall Study|Personal Reasons|0
673298|NCT01767519|2177031|P1|Overall Study|Personal Reasons|1
673299|NCT01767519|2177029|P3|Overall Study|Protocol Violation|0
673300|NCT01767519|2177030|P2|Overall Study|Protocol Violation|3
673301|NCT01767519|2177031|P1|Overall Study|Protocol Violation|0
673302|NCT01767519|2177029|P3|Overall Study|Other Reasons|2
673303|NCT01767519|2177030|P2|Overall Study|Other Reasons|4
673304|NCT01767519|2177031|P1|Overall Study|Other Reasons|4
673305|NCT01767467|2177072|P2|Overall Study|Subject unavailable|1
673306|NCT01767467|2177073|P1|Overall Study|Subject unavailable|0
673307|NCT01767467|2177072|P2|Overall Study|Physician Decision|0
673308|NCT01767467|2177073|P1|Overall Study|Physician Decision|1
673309|NCT01767467|2177072|P2|Overall Study|Suspected Herpes Zoster episode|1
673310|NCT01767467|2177073|P1|Overall Study|Suspected Herpes Zoster episode|0
673311|NCT01767467|2177072|P2|Overall Study|Withdrawal by Subject|10
673312|NCT01767467|2177073|P1|Overall Study|Withdrawal by Subject|7
673313|NCT01767467|2177072|P2|Overall Study|Protocol Violation|0
673314|NCT01767467|2177073|P1|Overall Study|Protocol Violation|1
673315|NCT01767467|2177072|P2|Overall Study|Adverse Event|8
673316|NCT01767467|2177073|P1|Overall Study|Adverse Event|8
673317|NCT01767376|2177104|P3|Overall Study|Withdrawal by Subject|0
673318|NCT01767376|2177105|P2|Overall Study|Withdrawal by Subject|1
673319|NCT01767376|2177106|P1|Overall Study|Withdrawal by Subject|1
673320|NCT01767376|2177104|P3|Overall Study|Lost to Follow-up|0
673321|NCT01767376|2177105|P2|Overall Study|Lost to Follow-up|2
673322|NCT01767376|2177106|P1|Overall Study|Lost to Follow-up|3
673323|NCT01767116|2177172|P2|Overall Study|Lost to Follow-up|2
673324|NCT01767116|2177173|P1|Overall Study|Lost to Follow-up|2
673325|NCT01766921|2177231|P2|Overall Study|Withdrawal by Subject|5
673326|NCT01766921|2177232|P1|Overall Study|Withdrawal by Subject|14
673327|NCT01766921|2177231|P2|Overall Study|Protocol Violation|1
673328|NCT01766921|2177232|P1|Overall Study|Protocol Violation|1
673329|NCT01766921|2177231|P2|Overall Study|Unclassified|2
673330|NCT01766921|2177232|P1|Overall Study|Unclassified|2
673331|NCT01766921|2177231|P2|Overall Study|Lost to Follow-up|3
673332|NCT01766921|2177232|P1|Overall Study|Lost to Follow-up|1
673333|NCT01766921|2177231|P2|Overall Study|Death|1
673334|NCT01766921|2177232|P1|Overall Study|Death|1
673335|NCT01766921|2177231|P2|Overall Study|Administrative Reason|5
673336|NCT01766921|2177232|P1|Overall Study|Administrative Reason|5
673337|NCT01766778|2177253|P2|Overall Study|Withdrawal by Subject|0
673338|NCT01766778|2177254|P1|Overall Study|Withdrawal by Subject|1
673339|NCT01766778|2177253|P2|Overall Study|Adverse Event|4
673340|NCT01766778|2177254|P1|Overall Study|Adverse Event|4
673341|NCT01766336|2177308|P2|Overall Study|Withdrawal by Subject|15
673342|NCT01766336|2177309|P1|Overall Study|Withdrawal by Subject|18
673343|NCT01766336|2177308|P2|Overall Study|Sponsor Decision|43
673344|NCT01766336|2177309|P1|Overall Study|Sponsor Decision|52
673345|NCT01766336|2177308|P2|Overall Study|Protocol Violation|1
673346|NCT01766336|2177309|P1|Overall Study|Protocol Violation|0
673347|NCT01766336|2177308|P2|Overall Study|Physician Decision|2
673348|NCT01766336|2177309|P1|Overall Study|Physician Decision|4
673349|NCT01766336|2177308|P2|Overall Study|Lost to Follow-up|3
673350|NCT01766336|2177309|P1|Overall Study|Lost to Follow-up|1
673351|NCT01766336|2177308|P2|Overall Study|Death|3
673352|NCT01766336|2177309|P1|Overall Study|Death|4
673353|NCT01766336|2177308|P2|Overall Study|Adverse Event|8
673354|NCT01766336|2177309|P1|Overall Study|Adverse Event|11
673355|NCT01766310|2177317|P2|Overall Study|Lost to Follow-up|3
673356|NCT01766310|2177318|P1|Overall Study|Lost to Follow-up|1
673357|NCT01766050|2177346|P1|Overall Study|Withdrawal by Subject|2
673358|NCT01766050|2177346|P1|Overall Study|Lost to Follow-up|1
673359|NCT01766050|2177346|P1|Overall Study|Adverse Event|1
673360|NCT01766037|2177481|P2|Overall Study|nausea / discomfort|0
673361|NCT01766037|2177482|P1|Overall Study|nausea / discomfort|3
673362|NCT01766037|2177481|P2|Overall Study|medical - unrelated|2
673363|NCT01766037|2177482|P1|Overall Study|medical - unrelated|1
673364|NCT01766037|2177481|P2|Overall Study|Moved from area|0
673365|NCT01766037|2177482|P1|Overall Study|Moved from area|5
673366|NCT01766037|2177481|P2|Overall Study|Withdrawal by Subject|16
673367|NCT01766037|2177482|P1|Overall Study|Withdrawal by Subject|18
673368|NCT01766037|2177481|P2|Overall Study|Physician Decision|1
673369|NCT01766037|2177482|P1|Overall Study|Physician Decision|0
673370|NCT01766037|2177481|P2|Overall Study|Lost to Follow-up|10
673371|NCT01766037|2177482|P1|Overall Study|Lost to Follow-up|0
673372|NCT01766037|2177481|P2|Overall Study|Lack of Efficacy|0
673373|NCT01766037|2177482|P1|Overall Study|Lack of Efficacy|1
673374|NCT01766037|2177481|P2|Overall Study|Adverse Event|0
673375|NCT01766037|2177482|P1|Overall Study|Adverse Event|1
673376|NCT01765764|2177551|P3|Treatment Period|Other Miscellaneous Reasons|2
673377|NCT01765764|2177552|P2|Treatment Period|Other Miscellaneous Reasons|2
673378|NCT01765764|2177553|P1|Treatment Period|Other Miscellaneous Reasons|1
673379|NCT01765764|2177551|P3|Treatment Period|Personal Reasons|1
673380|NCT01765764|2177552|P2|Treatment Period|Personal Reasons|2
673381|NCT01765764|2177553|P1|Treatment Period|Personal Reasons|1
673382|NCT01765764|2177551|P3|Treatment Period|Lost to Follow-up|2
673383|NCT01765764|2177552|P2|Treatment Period|Lost to Follow-up|3
673384|NCT01765764|2177553|P1|Treatment Period|Lost to Follow-up|0
673385|NCT01765764|2177551|P3|Treatment Period|Adverse Event|1
673386|NCT01765764|2177552|P2|Treatment Period|Adverse Event|2
673387|NCT01765764|2177553|P1|Treatment Period|Adverse Event|1
673388|NCT01765582|2177573|P3|Overall Study|Withdrawal of Consent|10
673389|NCT01765582|2177574|P2|Overall Study|Withdrawal of Consent|6
673390|NCT01765582|2177575|P1|Overall Study|Withdrawal of Consent|11
673391|NCT01765582|2177573|P3|Overall Study|Sponsor Decision|42
673392|NCT01765582|2177574|P2|Overall Study|Sponsor Decision|42
673393|NCT01765582|2177575|P1|Overall Study|Sponsor Decision|46
673394|NCT01765582|2177573|P3|Overall Study|Death|33
673395|NCT01765582|2177574|P2|Overall Study|Death|36
673396|NCT01765582|2177575|P1|Overall Study|Death|31
673397|NCT01765582|2177573|P3|Overall Study|Lost to Follow-up|1
673398|NCT01765582|2177574|P2|Overall Study|Lost to Follow-up|2
673399|NCT01765582|2177575|P1|Overall Study|Lost to Follow-up|2
673400|NCT01765582|2177573|P3|Overall Study|Other|9
673401|NCT01765582|2177574|P2|Overall Study|Other|6
673402|NCT01765582|2177575|P1|Overall Study|Other|3
673403|NCT01765569|2177608|P1|Period C|Death|1
673404|NCT01765569|2177608|P1|Period B|Withdrawal by Subject|1
673405|NCT01765543|2177629|P1|Overall Study|Withdrawal by Subject|2
673406|NCT01765543|2177629|P1|Overall Study|Death|1
673407|NCT01765426|2177681|P4|Overall Study|Lost to Follow-up|0
673408|NCT01765426|2177682|P3|Overall Study|Lost to Follow-up|0
673409|NCT01765426|2177683|P2|Overall Study|Lost to Follow-up|1
673410|NCT01765426|2177684|P1|Overall Study|Lost to Follow-up|0
673411|NCT01765270|2177740|P2|Overall Study|Withdrawal by Subject|1
673412|NCT01765270|2177741|P1|Overall Study|Withdrawal by Subject|0
673413|NCT01765270|2177740|P2|Overall Study|Physician Decision|0
673414|NCT01765270|2177741|P1|Overall Study|Physician Decision|1
673415|NCT01765192|2177763|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
673416|NCT01765192|2177764|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
673417|NCT01765192|2177763|P2|Treatment Period 2|Reason not specified|2
673418|NCT01765192|2177764|P1|Treatment Period 2|Reason not specified|0
673419|NCT01765192|2177763|P2|Washout Period|Reason not specified|0
673420|NCT01765192|2177764|P1|Washout Period|Reason not specified|1
673421|NCT01765192|2177763|P2|Washout Period|Voluntary Withdrawal|1
673422|NCT01765192|2177764|P1|Washout Period|Voluntary Withdrawal|1
673423|NCT01765192|2177763|P2|Treatment Period 1|Adverse Event|1
673424|NCT01765192|2177764|P1|Treatment Period 1|Adverse Event|0
673436|NCT01765153|2177789|P2|Rest Phase 2|Lost to Follow-up|1
673437|NCT01765153|2177790|P1|Rest Phase 2|Lost to Follow-up|2
673438|NCT01765153|2177789|P2|Training Phase 2|Withdrawal by Subject|1
673439|NCT01765153|2177790|P1|Training Phase 2|Withdrawal by Subject|0
673440|NCT01765153|2177789|P2|Rest Phase 1|Withdrawal by Subject|1
673441|NCT01765153|2177790|P1|Rest Phase 1|Withdrawal by Subject|0
673442|NCT01765153|2177789|P2|Training Phase 1|Poor participation in intervention|1
673443|NCT01765153|2177790|P1|Training Phase 1|Poor participation in intervention|0
673444|NCT01765153|2177789|P2|Training Phase 1|Format of intervention differed|0
673445|NCT01765153|2177790|P1|Training Phase 1|Format of intervention differed|1
673446|NCT01764997|2177897|P5|Study Drug Treatment Period|Other than specified above|10
673447|NCT01764997|2177898|P4|Study Drug Treatment Period|Other than specified above|0
673448|NCT01764997|2177899|P3|Study Drug Treatment Period|Other than specified above|0
673449|NCT01764997|2177900|P2|Study Drug Treatment Period|Other than specified above|0
673450|NCT01764997|2177901|P1|Study Drug Treatment Period|Other than specified above|0
673451|NCT01764997|2177897|P5|Study Drug Treatment Period|Lack of Efficacy|2
673452|NCT01764997|2177898|P4|Study Drug Treatment Period|Lack of Efficacy|0
673453|NCT01764997|2177899|P3|Study Drug Treatment Period|Lack of Efficacy|0
673454|NCT01764997|2177900|P2|Study Drug Treatment Period|Lack of Efficacy|0
673455|NCT01764997|2177901|P1|Study Drug Treatment Period|Lack of Efficacy|0
673456|NCT01764997|2177897|P5|Study Drug Treatment Period|Adverse Event|24
673457|NCT01764997|2177898|P4|Study Drug Treatment Period|Adverse Event|0
673458|NCT01764997|2177899|P3|Study Drug Treatment Period|Adverse Event|0
673459|NCT01764997|2177900|P2|Study Drug Treatment Period|Adverse Event|1
673460|NCT01764997|2177901|P1|Study Drug Treatment Period|Adverse Event|0
673461|NCT01764997|2177897|P5|Run-in Period|Other than specified above|0
673462|NCT01764997|2177898|P4|Run-in Period|Other than specified above|0
673463|NCT01764997|2177899|P3|Run-in Period|Other than specified above|0
673464|NCT01764997|2177900|P2|Run-in Period|Other than specified above|0
673465|NCT01764997|2177901|P1|Run-in Period|Other than specified above|17
673466|NCT01764997|2177897|P5|Run-in Period|Poor compliance to protocol|0
673467|NCT01764997|2177898|P4|Run-in Period|Poor compliance to protocol|0
673468|NCT01764997|2177899|P3|Run-in Period|Poor compliance to protocol|0
673469|NCT01764997|2177900|P2|Run-in Period|Poor compliance to protocol|0
673470|NCT01764997|2177901|P1|Run-in Period|Poor compliance to protocol|1
673471|NCT01764997|2177897|P5|Run-in Period|Lack of Efficacy|0
673472|NCT01764997|2177898|P4|Run-in Period|Lack of Efficacy|0
673473|NCT01764997|2177899|P3|Run-in Period|Lack of Efficacy|0
673474|NCT01764997|2177900|P2|Run-in Period|Lack of Efficacy|0
673475|NCT01764997|2177901|P1|Run-in Period|Lack of Efficacy|5
673476|NCT01764997|2177897|P5|Run-in Period|Adverse Event|0
673477|NCT01764997|2177898|P4|Run-in Period|Adverse Event|0
673478|NCT01764997|2177899|P3|Run-in Period|Adverse Event|0
673479|NCT01764997|2177900|P2|Run-in Period|Adverse Event|0
673480|NCT01764997|2177901|P1|Run-in Period|Adverse Event|15
673481|NCT01764945|2177928|P8|Overall Study|Adverse Event|0
673482|NCT01764945|2177929|P7|Overall Study|Adverse Event|1
673483|NCT01764945|2177930|P6|Overall Study|Adverse Event|0
673484|NCT01764945|2177931|P5|Overall Study|Adverse Event|0
673485|NCT01764945|2177932|P4|Overall Study|Adverse Event|0
673486|NCT01764945|2177933|P3|Overall Study|Adverse Event|0
673487|NCT01764945|2177934|P2|Overall Study|Adverse Event|1
673488|NCT01764945|2177935|P1|Overall Study|Adverse Event|0
673489|NCT01764841|2177981|P4|Overall Study|Lost to Follow-up|0
673490|NCT01764841|2177982|P3|Overall Study|Lost to Follow-up|1
673491|NCT01764841|2177983|P2|Overall Study|Lost to Follow-up|0
673492|NCT01764841|2177984|P1|Overall Study|Lost to Follow-up|3
673493|NCT01764841|2177981|P4|Overall Study|Withdrawal by Subject|15
673494|NCT01764841|2177982|P3|Overall Study|Withdrawal by Subject|11
673495|NCT01764841|2177983|P2|Overall Study|Withdrawal by Subject|24
673496|NCT01764841|2177984|P1|Overall Study|Withdrawal by Subject|16
673497|NCT01764841|2177981|P4|Overall Study|Protocol Violation|0
673498|NCT01764841|2177982|P3|Overall Study|Protocol Violation|0
673499|NCT01764841|2177983|P2|Overall Study|Protocol Violation|1
673500|NCT01764841|2177984|P1|Overall Study|Protocol Violation|0
673501|NCT01764841|2177981|P4|Overall Study|No Follow Up|0
673502|NCT01764841|2177982|P3|Overall Study|No Follow Up|1
673503|NCT01764841|2177983|P2|Overall Study|No Follow Up|0
673504|NCT01764841|2177984|P1|Overall Study|No Follow Up|1
673505|NCT01764841|2177981|P4|Overall Study|Death|4
673506|NCT01764841|2177982|P3|Overall Study|Death|1
673507|NCT01764841|2177983|P2|Overall Study|Death|0
673508|NCT01764841|2177984|P1|Overall Study|Death|3
673509|NCT01764841|2177981|P4|Overall Study|Logistical Difficulties|0
673510|NCT01764841|2177982|P3|Overall Study|Logistical Difficulties|0
673511|NCT01764841|2177983|P2|Overall Study|Logistical Difficulties|1
673512|NCT01764841|2177984|P1|Overall Study|Logistical Difficulties|0
673513|NCT01764386|2178032|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
673514|NCT01764386|2178033|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
673515|NCT01764386|2178032|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
673516|NCT01764386|2178033|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
673517|NCT01764386|2178032|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
673518|NCT01764386|2178033|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
673519|NCT01764386|2178032|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
673520|NCT01764386|2178033|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
673521|NCT01764386|2178032|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
673522|NCT01764386|2178033|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
673523|NCT01764386|2178032|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
673524|NCT01764386|2178033|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
673525|NCT01764386|2178032|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
673526|NCT01764386|2178033|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
673527|NCT01764386|2178032|P2|Controlled Treatment Period (CTP)|Adverse Event|0
673528|NCT01764386|2178033|P1|Controlled Treatment Period (CTP)|Adverse Event|35
673529|NCT01764022|2178076|P2|Overall Study|Protocol Violation|0
673530|NCT01764022|2178077|P1|Overall Study|Protocol Violation|1
673531|NCT01764022|2178076|P2|Overall Study|Physician Decision|2
673532|NCT01764022|2178077|P1|Overall Study|Physician Decision|2
673533|NCT01764022|2178076|P2|Overall Study|Lack of Efficacy|5
673534|NCT01764022|2178077|P1|Overall Study|Lack of Efficacy|10
673535|NCT01764022|2178076|P2|Overall Study|Withdrawal by Subject|4
673536|NCT01764022|2178077|P1|Overall Study|Withdrawal by Subject|5
673537|NCT01764022|2178076|P2|Overall Study|Death|1
673538|NCT01764022|2178077|P1|Overall Study|Death|3
673539|NCT01763996|2178105|P2|Treatment Period 2|Adverse Event|1
673540|NCT01763996|2178106|P1|Treatment Period 2|Adverse Event|0
673541|NCT01763918|2178136|P4|Overall Study|Sponsor Decision|0
673542|NCT01763918|2178137|P3|Overall Study|Sponsor Decision|9
673543|NCT01763918|2178138|P2|Overall Study|Sponsor Decision|0
673544|NCT01763918|2178139|P1|Overall Study|Sponsor Decision|4
673545|NCT01763918|2178136|P4|Overall Study|Withdrawal by Subject|2
673546|NCT01763918|2178137|P3|Overall Study|Withdrawal by Subject|1
673547|NCT01763918|2178138|P2|Overall Study|Withdrawal by Subject|1
673548|NCT01763918|2178139|P1|Overall Study|Withdrawal by Subject|2
673549|NCT01763905|2178237|P4|Overall Study|Lost to Follow-up|0
673550|NCT01763905|2178238|P3|Overall Study|Lost to Follow-up|1
673551|NCT01763905|2178239|P2|Overall Study|Lost to Follow-up|0
673552|NCT01763905|2178240|P1|Overall Study|Lost to Follow-up|0
673553|NCT01763905|2178237|P4|Overall Study|Decision by sponsor|0
673554|NCT01763905|2178238|P3|Overall Study|Decision by sponsor|8
673555|NCT01763905|2178239|P2|Overall Study|Decision by sponsor|0
673556|NCT01763905|2178240|P1|Overall Study|Decision by sponsor|5
673557|NCT01763905|2178237|P4|Overall Study|Withdrawal by Subject|1
673558|NCT01763905|2178238|P3|Overall Study|Withdrawal by Subject|0
673559|NCT01763905|2178239|P2|Overall Study|Withdrawal by Subject|1
673560|NCT01763905|2178240|P1|Overall Study|Withdrawal by Subject|1
673561|NCT01763866|2178358|P24|Overall Study|Death|0
673562|NCT01763866|2178359|P23|Overall Study|Death|0
673563|NCT01763866|2178360|P22|Overall Study|Death|0
673564|NCT01763866|2178361|P21|Overall Study|Death|0
673565|NCT01763866|2178362|P20|Overall Study|Death|0
673566|NCT01763866|2178363|P19|Overall Study|Death|0
673567|NCT01763866|2178364|P18|Overall Study|Death|0
673568|NCT01763866|2178365|P17|Overall Study|Death|1
673569|NCT01763866|2178366|P16|Overall Study|Death|0
673570|NCT01763866|2178367|P15|Overall Study|Death|0
673571|NCT01763866|2178368|P14|Overall Study|Death|0
673572|NCT01763866|2178369|P13|Overall Study|Death|0
673573|NCT01763866|2178370|P12|Overall Study|Death|0
673574|NCT01763866|2178371|P11|Overall Study|Death|0
673575|NCT01763866|2178372|P10|Overall Study|Death|0
673576|NCT01763866|2178373|P9|Overall Study|Death|0
673577|NCT01763866|2178374|P8|Overall Study|Death|0
673578|NCT01763866|2178375|P7|Overall Study|Death|0
673579|NCT01763866|2178376|P6|Overall Study|Death|0
673580|NCT01763866|2178377|P5|Overall Study|Death|0
673581|NCT01763866|2178378|P4|Overall Study|Death|0
673582|NCT01763866|2178379|P3|Overall Study|Death|0
673583|NCT01763866|2178380|P2|Overall Study|Death|0
673584|NCT01763866|2178381|P1|Overall Study|Death|0
673585|NCT01763866|2178358|P24|Overall Study|Lost to Follow-up|1
673586|NCT01763866|2178359|P23|Overall Study|Lost to Follow-up|0
673587|NCT01763866|2178360|P22|Overall Study|Lost to Follow-up|0
673588|NCT01763866|2178361|P21|Overall Study|Lost to Follow-up|0
673589|NCT01763866|2178362|P20|Overall Study|Lost to Follow-up|1
673590|NCT01763866|2178363|P19|Overall Study|Lost to Follow-up|1
673591|NCT01763866|2178364|P18|Overall Study|Lost to Follow-up|0
673592|NCT01763866|2178365|P17|Overall Study|Lost to Follow-up|0
673593|NCT01763866|2178366|P16|Overall Study|Lost to Follow-up|0
673594|NCT01763866|2178367|P15|Overall Study|Lost to Follow-up|1
673595|NCT01763866|2178368|P14|Overall Study|Lost to Follow-up|0
673596|NCT01763866|2178369|P13|Overall Study|Lost to Follow-up|1
673597|NCT01763866|2178370|P12|Overall Study|Lost to Follow-up|0
673598|NCT01763866|2178371|P11|Overall Study|Lost to Follow-up|0
673599|NCT01763866|2178372|P10|Overall Study|Lost to Follow-up|0
673600|NCT01763866|2178373|P9|Overall Study|Lost to Follow-up|0
673601|NCT01763866|2178374|P8|Overall Study|Lost to Follow-up|0
673602|NCT01763866|2178375|P7|Overall Study|Lost to Follow-up|1
673603|NCT01763866|2178376|P6|Overall Study|Lost to Follow-up|0
673604|NCT01763866|2178377|P5|Overall Study|Lost to Follow-up|0
673605|NCT01763866|2178378|P4|Overall Study|Lost to Follow-up|0
673606|NCT01763866|2178379|P3|Overall Study|Lost to Follow-up|0
673607|NCT01763866|2178380|P2|Overall Study|Lost to Follow-up|0
673608|NCT01763866|2178381|P1|Overall Study|Lost to Follow-up|0
673609|NCT01763866|2178358|P24|Overall Study|Decision by sponsor|0
673610|NCT01763866|2178359|P23|Overall Study|Decision by sponsor|1
673611|NCT01763866|2178360|P22|Overall Study|Decision by sponsor|0
673612|NCT01763866|2178361|P21|Overall Study|Decision by sponsor|2
673613|NCT01763866|2178362|P20|Overall Study|Decision by sponsor|0
673614|NCT01763866|2178363|P19|Overall Study|Decision by sponsor|4
673615|NCT01763866|2178364|P18|Overall Study|Decision by sponsor|0
673616|NCT01763866|2178365|P17|Overall Study|Decision by sponsor|0
673617|NCT01763866|2178366|P16|Overall Study|Decision by sponsor|0
673618|NCT01763866|2178367|P15|Overall Study|Decision by sponsor|5
673619|NCT01763866|2178368|P14|Overall Study|Decision by sponsor|0
673620|NCT01763866|2178369|P13|Overall Study|Decision by sponsor|1
673621|NCT01763866|2178370|P12|Overall Study|Decision by sponsor|0
673622|NCT01763866|2178371|P11|Overall Study|Decision by sponsor|6
673623|NCT01763866|2178372|P10|Overall Study|Decision by sponsor|0
673624|NCT01763866|2178373|P9|Overall Study|Decision by sponsor|2
673625|NCT01763866|2178374|P8|Overall Study|Decision by sponsor|0
673626|NCT01763866|2178375|P7|Overall Study|Decision by sponsor|2
673627|NCT01763866|2178376|P6|Overall Study|Decision by sponsor|0
673628|NCT01763866|2178377|P5|Overall Study|Decision by sponsor|2
673629|NCT01763866|2178378|P4|Overall Study|Decision by sponsor|0
673630|NCT01763866|2178379|P3|Overall Study|Decision by sponsor|1
673631|NCT01763866|2178380|P2|Overall Study|Decision by sponsor|0
673632|NCT01763866|2178381|P1|Overall Study|Decision by sponsor|0
673633|NCT01763866|2178358|P24|Overall Study|Withdrawal by Subject|1
673634|NCT01763866|2178359|P23|Overall Study|Withdrawal by Subject|2
673635|NCT01763866|2178360|P22|Overall Study|Withdrawal by Subject|1
673636|NCT01763866|2178361|P21|Overall Study|Withdrawal by Subject|2
673637|NCT01763866|2178362|P20|Overall Study|Withdrawal by Subject|1
673638|NCT01763866|2178363|P19|Overall Study|Withdrawal by Subject|1
673639|NCT01763866|2178364|P18|Overall Study|Withdrawal by Subject|1
673640|NCT01763866|2178365|P17|Overall Study|Withdrawal by Subject|0
673641|NCT01763866|2178366|P16|Overall Study|Withdrawal by Subject|3
673642|NCT01763866|2178367|P15|Overall Study|Withdrawal by Subject|6
673643|NCT01763866|2178368|P14|Overall Study|Withdrawal by Subject|0
673644|NCT01763866|2178369|P13|Overall Study|Withdrawal by Subject|2
673645|NCT01763866|2178370|P12|Overall Study|Withdrawal by Subject|2
673646|NCT01763866|2178371|P11|Overall Study|Withdrawal by Subject|2
673647|NCT01763866|2178372|P10|Overall Study|Withdrawal by Subject|1
673648|NCT01763866|2178373|P9|Overall Study|Withdrawal by Subject|1
673649|NCT01763866|2178374|P8|Overall Study|Withdrawal by Subject|0
673650|NCT01763866|2178375|P7|Overall Study|Withdrawal by Subject|4
673651|NCT01763866|2178376|P6|Overall Study|Withdrawal by Subject|3
673652|NCT01763866|2178377|P5|Overall Study|Withdrawal by Subject|0
673653|NCT01763866|2178378|P4|Overall Study|Withdrawal by Subject|0
673654|NCT01763866|2178379|P3|Overall Study|Withdrawal by Subject|4
673655|NCT01763866|2178380|P2|Overall Study|Withdrawal by Subject|1
673656|NCT01763866|2178381|P1|Overall Study|Withdrawal by Subject|2
673657|NCT01763827|2178941|P6|Overall Study|Lost to Follow-up|1
673658|NCT01763827|2178942|P5|Overall Study|Lost to Follow-up|2
673659|NCT01763827|2178943|P4|Overall Study|Lost to Follow-up|1
673660|NCT01763827|2178944|P3|Overall Study|Lost to Follow-up|1
673661|NCT01763827|2178945|P2|Overall Study|Lost to Follow-up|1
673662|NCT01763827|2178946|P1|Overall Study|Lost to Follow-up|0
673663|NCT01763827|2178941|P6|Overall Study|Decision by sponsor|1
673664|NCT01763827|2178942|P5|Overall Study|Decision by sponsor|2
673665|NCT01763827|2178943|P4|Overall Study|Decision by sponsor|0
673666|NCT01763827|2178944|P3|Overall Study|Decision by sponsor|3
673667|NCT01763827|2178945|P2|Overall Study|Decision by sponsor|0
673668|NCT01763827|2178946|P1|Overall Study|Decision by sponsor|2
673669|NCT01763827|2178941|P6|Overall Study|Withdrawal by Subject|0
673670|NCT01763827|2178942|P5|Overall Study|Withdrawal by Subject|2
673671|NCT01763827|2178943|P4|Overall Study|Withdrawal by Subject|0
673672|NCT01763827|2178944|P3|Overall Study|Withdrawal by Subject|0
673673|NCT01763827|2178945|P2|Overall Study|Withdrawal by Subject|0
673674|NCT01763827|2178946|P1|Overall Study|Withdrawal by Subject|1
673675|NCT01763047|2179117|P2|Period 2|Unsatisfactory lens Fitting|1
673676|NCT01763047|2179118|P1|Period 2|Unsatisfactory lens Fitting|0
673677|NCT01763047|2179117|P2|Period 2|Protocol Violation|2
673678|NCT01763047|2179118|P1|Period 2|Protocol Violation|0
673679|NCT01763047|2179117|P2|Period 2|Unsatisfactory Visual Response|1
673680|NCT01763047|2179118|P1|Period 2|Unsatisfactory Visual Response|1
673681|NCT01763047|2179117|P2|Period 2|Study Site office Closed|1
673682|NCT01763047|2179118|P1|Period 2|Study Site office Closed|1
673683|NCT01763047|2179117|P2|Period 2|No longer meets Eligibility Criteria|0
673684|NCT01763047|2179118|P1|Period 2|No longer meets Eligibility Criteria|1
673685|NCT01763047|2179117|P2|Period 2|Lens Discomfort|0
673686|NCT01763047|2179118|P1|Period 2|Lens Discomfort|1
673687|NCT01763047|2179117|P2|Period 1|Study Site office Closed|1
673688|NCT01763047|2179118|P1|Period 1|Study Site office Closed|0
673689|NCT01763047|2179117|P2|Period 1|Lens Power Not Available|1
673690|NCT01763047|2179118|P1|Period 1|Lens Power Not Available|0
673691|NCT01763047|2179117|P2|Period 1|Unsatisfactory Visual Response|3
673692|NCT01763047|2179118|P1|Period 1|Unsatisfactory Visual Response|0
673693|NCT01763047|2179117|P2|Period 1|Adverse Event|1
673694|NCT01763047|2179118|P1|Period 1|Adverse Event|0
673695|NCT01763047|2179117|P2|Period 1|No Longer Meets Eligibility criteria|0
673696|NCT01763047|2179118|P1|Period 1|No Longer Meets Eligibility criteria|1
673697|NCT01763047|2179117|P2|Period 1|Protocol Violation|4
673698|NCT01763047|2179118|P1|Period 1|Protocol Violation|4
673699|NCT01763047|2179117|P2|Period 1|Test Article Not Available|1
673700|NCT01763047|2179118|P1|Period 1|Test Article Not Available|4
673701|NCT01762800|2179164|P2|Overall Study|Withdrawal by Subject|4
673702|NCT01762800|2179165|P1|Overall Study|Withdrawal by Subject|7
673703|NCT01762800|2179164|P2|Overall Study|Physician Decision|1
673704|NCT01762800|2179165|P1|Overall Study|Physician Decision|1
673705|NCT01762800|2179164|P2|Overall Study|Study Closed/Terminated|1
673706|NCT01762800|2179165|P1|Overall Study|Study Closed/Terminated|0
673707|NCT01762800|2179164|P2|Overall Study|Lack of Efficacy|2
673708|NCT01762800|2179165|P1|Overall Study|Lack of Efficacy|3
673709|NCT01762800|2179164|P2|Overall Study|Adverse Event|13
673710|NCT01762800|2179165|P1|Overall Study|Adverse Event|8
673711|NCT01762761|2179239|P2|Overall Study|Physician Decision|1
673712|NCT01762761|2179240|P1|Overall Study|Physician Decision|0
673713|NCT01762761|2179239|P2|Overall Study|Protocol Violation|1
673714|NCT01762761|2179240|P1|Overall Study|Protocol Violation|0
673715|NCT01762761|2179239|P2|Overall Study|Lack of Efficacy|0
673716|NCT01762761|2179240|P1|Overall Study|Lack of Efficacy|1
673717|NCT01762761|2179239|P2|Overall Study|Adverse Event|2
673718|NCT01762761|2179240|P1|Overall Study|Adverse Event|1
673719|NCT01762345|2179318|P1|Overall Study|Protocol Violation|2
673720|NCT01762345|2179318|P1|Overall Study|Adverse Event|5
673721|NCT01761565|2179366|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
673722|NCT01761162|2179419|P1|Overall Study|Withdrawal by Subject|3
673723|NCT01760876|2179511|P1|Overall Study|Very poor baseline OCT quality|2
673724|NCT01760876|2179511|P1|Overall Study|Major depression|1
673725|NCT01760876|2179511|P1|Overall Study|Impaired renal function|1
673726|NCT01760876|2179511|P1|Overall Study|Carcinoma of prostate|1
673727|NCT01760876|2179511|P1|Overall Study|Non-cardiac death (head injury)|1
673728|NCT01759511|2179566|P1|Overall Study|Withdrawal by Subject|3
673729|NCT01759511|2179566|P1|Overall Study|Study Terminated by Sponsor|13
673730|NCT01759511|2179566|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
673731|NCT01759511|2179566|P1|Overall Study|Progressive Disease|5
673732|NCT01759511|2179566|P1|Overall Study|Physician Decision|1
673733|NCT01759511|2179566|P1|Overall Study|Lack of Efficacy|2
673734|NCT01759511|2179566|P1|Overall Study|Death|2
673735|NCT01759511|2179566|P1|Overall Study|Adverse Event|4
673736|NCT01759420|2179574|P1|Overall Study|Inaccurate EKG machine readings|1
673737|NCT01759420|2179574|P1|Overall Study|Screen failure|5
673738|NCT01759381|2179581|P2|Overall Study|Death|0
673739|NCT01759381|2179582|P1|Overall Study|Death|1
673740|NCT01759368|2179590|P2|Overall Study|Lost to Follow-up|0
673741|NCT01759368|2179591|P1|Overall Study|Lost to Follow-up|1
673742|NCT01759290|2179609|P1|Overall Study|Unknown reason|4
673743|NCT01759290|2179609|P1|Overall Study|Lost to Follow-up|53
673744|NCT01759290|2179609|P1|Overall Study|Death|17
673745|NCT01759290|2179609|P1|Overall Study|Physician Decision|2
673746|NCT01759290|2179609|P1|Overall Study|Subjects withdrawn consent|5
673747|NCT01759264|2179669|P1|Overall Study|Discontinued Humira Due to Business Trip|1
673748|NCT01759264|2179669|P1|Overall Study|Withdrawal by Subject|3
673749|NCT01759264|2179669|P1|Overall Study|Lost to Follow-up|2
673750|NCT01759264|2179669|P1|Overall Study|Not Specified|2
673751|NCT01759264|2179669|P1|Overall Study|Adverse Event|1
673752|NCT01759264|2179669|P1|Overall Study|Serious Adverse Events (SAEs)|1
673753|NCT01758900|2179697|P2|Overall Study|difficulty for further intubation|8
673754|NCT01758900|2179698|P1|Overall Study|difficulty for further intubation|7
673755|NCT01758289|2179716|P1|Overall Study|Adverse Event|9
673756|NCT01758289|2179716|P1|Overall Study|Premature Study Termination|44
673757|NCT01757847|2179742|P2|Overall Study|Withdrawal by Subject|4
673758|NCT01757847|2179743|P1|Overall Study|Withdrawal by Subject|3
673759|NCT01757704|2179753|P2|Overall Study|Protocol Violation|3
673760|NCT01757704|2179754|P1|Overall Study|Protocol Violation|1
673761|NCT01757691|2179772|P2|Overall Study|Administrative problems|0
673762|NCT01757691|2179773|P1|Overall Study|Administrative problems|2
888768|NCT01791517|2822622|P4|Phase I: Period 1|Lens Handling DIfficulties|0
888769|NCT01791517|2822623|P3|Phase I: Period 1|Lens Handling DIfficulties|0
888770|NCT01791517|2822624|P2|Phase I: Period 1|Lens Handling DIfficulties|0
888771|NCT01791517|2822625|P1|Phase I: Period 1|Lens Handling DIfficulties|0
673767|NCT01757275|2179828|P2|Overall Study|Not treated|4
673768|NCT01757275|2179829|P1|Overall Study|Not treated|3
673769|NCT01757275|2179828|P2|Overall Study|Withdrawal by Subject|4
673770|NCT01757275|2179829|P1|Overall Study|Withdrawal by Subject|2
673771|NCT01757275|2179828|P2|Overall Study|Adverse Event|3
673772|NCT01757275|2179829|P1|Overall Study|Adverse Event|3
673773|NCT01757275|2179828|P2|Overall Study|Lost to Follow-up|2
673774|NCT01757275|2179829|P1|Overall Study|Lost to Follow-up|1
673775|NCT01757197|2179851|P1|Overall Study|Death|2
673776|NCT01757184|2179858|P2|Double-Blind Period|Adverse Event|0
673777|NCT01757184|2179859|P1|Double-Blind Period|Adverse Event|1
673778|NCT01756300|2179903|P1|Overall Study|Withdrawal by Subject|1
673779|NCT01756300|2179903|P1|Overall Study|Death|1
673780|NCT01756274|2179925|P1|Overall Study|Laboratory error|1
673781|NCT01756274|2179925|P1|Overall Study|Protocol Violation|2
673782|NCT01756235|2179932|P1|Overall Study|Adalimumab Treatment was not Documented|2
673783|NCT01756157|2179953|P2|First Intervention Period|Lost to Follow-up|2
673784|NCT01756157|2179954|P1|First Intervention Period|Lost to Follow-up|0
673785|NCT01756157|2179953|P2|First Intervention Period|Withdrawal by Subject|0
673786|NCT01756157|2179954|P1|First Intervention Period|Withdrawal by Subject|1
673787|NCT01756079|2179968|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
673788|NCT01756079|2179968|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
673789|NCT01756079|2179968|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
673790|NCT01756079|2179968|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
673791|NCT01756079|2179968|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
673792|NCT01756053|2179974|P2|Period 2 (10 Days)|Protocol Violation|2
673793|NCT01756053|2179975|P1|Period 2 (10 Days)|Protocol Violation|0
673794|NCT01756053|2179974|P2|Period 1 (10 Days)|Protocol Violation|1
673795|NCT01756053|2179975|P1|Period 1 (10 Days)|Protocol Violation|1
673796|NCT01755702|2179995|P1|Washout Period II|Other Reason|5
673797|NCT01755702|2179995|P1|Wash Out Period I|Other Reason|3
673798|NCT01755637|2180037|P2|Period 1|Adverse Event|1
673799|NCT01755637|2180038|P1|Period 1|Adverse Event|0
673800|NCT01755234|2180071|P2|Overall Study|unblinded|0
673801|NCT01755234|2180072|P1|Overall Study|unblinded|1
673802|NCT01755234|2180071|P2|Overall Study|Withdrawal by Subject|1
673803|NCT01755234|2180072|P1|Overall Study|Withdrawal by Subject|0
673804|NCT01755234|2180071|P2|Overall Study|case cancelled|0
673805|NCT01755234|2180072|P1|Overall Study|case cancelled|1
673806|NCT01755234|2180071|P2|Overall Study|Change in surgical case|1
673807|NCT01755234|2180072|P1|Overall Study|Change in surgical case|2
673808|NCT01755234|2180071|P2|Overall Study|Lost to Follow-up|6
673809|NCT01755234|2180072|P1|Overall Study|Lost to Follow-up|11
673810|NCT01755156|2180103|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
673811|NCT01755156|2180104|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
673812|NCT01755156|2180103|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
673813|NCT01755156|2180104|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
673814|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
673815|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
673816|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
673817|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
673818|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
673819|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
673820|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Protocol Violation|1
673821|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Protocol Violation|1
673822|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Physician Decision|1
673823|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Physician Decision|0
673824|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
673825|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
673826|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
673827|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
673828|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
673829|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
673830|NCT01755156|2180103|P2|Phase A (Weeks 0-24)|Adverse Event|3
673831|NCT01755156|2180104|P1|Phase A (Weeks 0-24)|Adverse Event|2
673832|NCT01755026|2180167|P2|Overall Study|Withdrawal by Subject|1
673833|NCT01755026|2180168|P1|Overall Study|Withdrawal by Subject|1
673834|NCT01755026|2180167|P2|Overall Study|Adverse Event|0
673835|NCT01755026|2180168|P1|Overall Study|Adverse Event|1
673836|NCT01754922|2180176|P2|Overall Study|Adverse Event|1
673837|NCT01754922|2180177|P1|Overall Study|Adverse Event|0
673838|NCT01754766|2180190|P3|Overall Study|Personal reasons|0
673839|NCT01754766|2180191|P2|Overall Study|Personal reasons|1
673840|NCT01754766|2180192|P1|Overall Study|Personal reasons|1
673841|NCT01754727|2180206|P1|Overall Study|Adalimumab Treatment was not Documented|2
673842|NCT01754493|2180333|P1|Overall Study|Scheduling conflict|1
673843|NCT01754493|2180333|P1|Overall Study|Moved out of town|1
673844|NCT01754493|2180333|P1|Overall Study|Withdrawal by Subject|1
673845|NCT01754493|2180333|P1|Overall Study|Lost to Follow-up|3
673846|NCT01754493|2180333|P1|Overall Study|Adverse Event|1
673847|NCT01754467|2180358|P1|Overall Study|Lost to Follow-up|1
673848|NCT01754402|2180368|P3|Overall Study|Lack of Efficacy|1
673849|NCT01754402|2180369|P2|Overall Study|Lack of Efficacy|0
673850|NCT01754402|2180370|P1|Overall Study|Lack of Efficacy|0
673851|NCT01754402|2180368|P3|Overall Study|Withdrawal by Subject|1
673852|NCT01754402|2180369|P2|Overall Study|Withdrawal by Subject|0
673853|NCT01754402|2180370|P1|Overall Study|Withdrawal by Subject|0
673854|NCT01754402|2180368|P3|Overall Study|Adverse Event|1
673855|NCT01754402|2180369|P2|Overall Study|Adverse Event|2
673856|NCT01754402|2180370|P1|Overall Study|Adverse Event|2
673857|NCT01754402|2180368|P3|Overall Study|Death|1
673858|NCT01754402|2180369|P2|Overall Study|Death|0
673859|NCT01754402|2180370|P1|Overall Study|Death|0
673860|NCT01754376|2180404|P1|Overall Study|Lack of Efficacy|2
673861|NCT01754376|2180404|P1|Overall Study|Adverse Event|1
673862|NCT01754259|2180415|P2|Overall Study|Lost to Follow-up|1
673863|NCT01754259|2180416|P1|Overall Study|Lost to Follow-up|0
673864|NCT01754259|2180415|P2|Overall Study|Adverse Event|1
673865|NCT01754259|2180416|P1|Overall Study|Adverse Event|3
673866|NCT01754259|2180415|P2|Overall Study|Withdrawal by Subject|4
673867|NCT01754259|2180416|P1|Overall Study|Withdrawal by Subject|2
673868|NCT01754194|2180426|P2|Overall Study|Not Specified|8
673869|NCT01754194|2180427|P1|Overall Study|Not Specified|9
673870|NCT01754194|2180426|P2|Overall Study|Withdrawal by Subject|5
673871|NCT01754194|2180427|P1|Overall Study|Withdrawal by Subject|4
673872|NCT01754194|2180426|P2|Overall Study|Lost to Follow-up|14
673873|NCT01754194|2180427|P1|Overall Study|Lost to Follow-up|39
673874|NCT01753856|2180449|P2|Overall Study|Sponsor Decision|0
673875|NCT01753856|2180450|P1|Overall Study|Sponsor Decision|2
673876|NCT01753856|2180449|P2|Overall Study|Withdrawal by Subject|2
673877|NCT01753856|2180450|P1|Overall Study|Withdrawal by Subject|0
673878|NCT01753856|2180449|P2|Overall Study|Adverse Event|0
673879|NCT01753856|2180450|P1|Overall Study|Adverse Event|1
673880|NCT01753518|2180540|P2|Postpartum Follow-up|Lost to Follow-up|15
673881|NCT01753518|2180541|P1|Postpartum Follow-up|Lost to Follow-up|22
673882|NCT01753518|2180540|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
673883|NCT01753518|2180541|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
673884|NCT01753518|2180540|P2|Intention-to-Treat Analysis|Multifetal gestation|3
673885|NCT01753518|2180541|P1|Intention-to-Treat Analysis|Multifetal gestation|2
673886|NCT01753518|2180540|P2|Intention-to-Treat Analysis|Missing consent form|3
673887|NCT01753518|2180541|P1|Intention-to-Treat Analysis|Missing consent form|5
673888|NCT01753336|2180563|P1|Overall Study|Withdrawal by Subject|1
673889|NCT01753336|2180563|P1|Overall Study|Sponsor's decision|2
673890|NCT01753336|2180563|P1|Overall Study|Physician Decision|2
673891|NCT01753336|2180563|P1|Overall Study|Lost to Follow-up|3
673892|NCT01753336|2180563|P1|Overall Study|Patient decision|12
673893|NCT01753323|2180575|P3|Overall Study|Adverse Event|1
673894|NCT01753323|2180576|P2|Overall Study|Adverse Event|0
673895|NCT01753323|2180577|P1|Overall Study|Adverse Event|0
673896|NCT01753323|2180575|P3|Overall Study|Protocol deviation|0
673897|NCT01753323|2180576|P2|Overall Study|Protocol deviation|0
673898|NCT01753323|2180577|P1|Overall Study|Protocol deviation|1
673899|NCT01753323|2180575|P3|Overall Study|Lack of Efficacy|8
673900|NCT01753323|2180576|P2|Overall Study|Lack of Efficacy|0
673901|NCT01753323|2180577|P1|Overall Study|Lack of Efficacy|0
673902|NCT01753310|2180615|P2|Overall Study|Withdrawal by Subject|0
673903|NCT01753310|2180616|P1|Overall Study|Withdrawal by Subject|1
673904|NCT01753310|2180615|P2|Overall Study|Sponsor decision|0
673905|NCT01753310|2180616|P1|Overall Study|Sponsor decision|1
673906|NCT01753310|2180615|P2|Overall Study|Subject decision|2
673907|NCT01753310|2180616|P1|Overall Study|Subject decision|2
673908|NCT01753310|2180615|P2|Overall Study|Lost to Follow-up|0
673909|NCT01753310|2180616|P1|Overall Study|Lost to Follow-up|2
673910|NCT01753310|2180615|P2|Overall Study|Adverse Event|0
673911|NCT01753310|2180616|P1|Overall Study|Adverse Event|1
673912|NCT01753310|2180615|P2|Overall Study|Entered into open label extension study|22
673913|NCT01753310|2180616|P1|Overall Study|Entered into open label extension study|25
673914|NCT01753115|2180639|P3|Overall Study|Used excluded drug|0
673915|NCT01753115|2180640|P2|Overall Study|Used excluded drug|1
673916|NCT01753115|2180641|P1|Overall Study|Used excluded drug|0
673917|NCT01753115|2180639|P3|Overall Study|Subject non-compliant|0
673918|NCT01753115|2180640|P2|Overall Study|Subject non-compliant|3
673919|NCT01753115|2180641|P1|Overall Study|Subject non-compliant|3
673920|NCT01753115|2180639|P3|Overall Study|Withdrawal by Subject|6
673921|NCT01753115|2180640|P2|Overall Study|Withdrawal by Subject|5
673922|NCT01753115|2180641|P1|Overall Study|Withdrawal by Subject|6
673923|NCT01753115|2180639|P3|Overall Study|Lost to Follow-up|8
673924|NCT01753115|2180640|P2|Overall Study|Lost to Follow-up|6
673925|NCT01753115|2180641|P1|Overall Study|Lost to Follow-up|3
673926|NCT01753076|2180651|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
673927|NCT01753076|2180652|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
673928|NCT01753076|2180651|P2|Overall Study|Withdrawal by Subject|24
673929|NCT01753076|2180652|P1|Overall Study|Withdrawal by Subject|14
673930|NCT01753076|2180651|P2|Overall Study|Physician Decision|2
673931|NCT01753076|2180652|P1|Overall Study|Physician Decision|4
673932|NCT01753076|2180651|P2|Overall Study|Lost to Follow-up|1
673933|NCT01753076|2180652|P1|Overall Study|Lost to Follow-up|2
673934|NCT01753076|2180651|P2|Overall Study|Lack of Efficacy|1
673935|NCT01753076|2180652|P1|Overall Study|Lack of Efficacy|3
673936|NCT01753076|2180651|P2|Overall Study|Adverse Event|18
673937|NCT01753076|2180652|P1|Overall Study|Adverse Event|17
673938|NCT01752907|2180678|P2|Overall Study|Decision by Sponsor|9
673939|NCT01752907|2180679|P1|Overall Study|Decision by Sponsor|6
673940|NCT01752907|2180678|P2|Overall Study|Lost to Follow-up|1
673941|NCT01752907|2180679|P1|Overall Study|Lost to Follow-up|2
673942|NCT01752907|2180678|P2|Overall Study|Withdrawal by Subject|10
673943|NCT01752907|2180679|P1|Overall Study|Withdrawal by Subject|4
673944|NCT01752855|2180699|P2|Overall Study|Lack of Efficacy|2
673945|NCT01752855|2180700|P1|Overall Study|Lack of Efficacy|0
673946|NCT01752855|2180699|P2|Overall Study|Withdrew Consent|2
673947|NCT01752855|2180700|P1|Overall Study|Withdrew Consent|0
673948|NCT01752855|2180699|P2|Overall Study|Adverse Event|0
673949|NCT01752855|2180700|P1|Overall Study|Adverse Event|1
673950|NCT01752023|2180716|P2|Overall Study|Physician Decision|1
673951|NCT01752023|2180717|P1|Overall Study|Physician Decision|2
673952|NCT01751867|2180735|P2|Overall Study|Randomized but not treated.|1
673953|NCT01751867|2180736|P1|Overall Study|Randomized but not treated.|2
673954|NCT01751867|2180735|P2|Overall Study|Unspecified|37
673955|NCT01751867|2180736|P1|Overall Study|Unspecified|11
673956|NCT01751867|2180735|P2|Overall Study|Death|5
673957|NCT01751867|2180736|P1|Overall Study|Death|0
673958|NCT01751867|2180735|P2|Overall Study|Protocol Violation|2
673959|NCT01751867|2180736|P1|Overall Study|Protocol Violation|0
673960|NCT01751867|2180735|P2|Overall Study|Physician Decision|7
673961|NCT01751867|2180736|P1|Overall Study|Physician Decision|4
673962|NCT01751867|2180735|P2|Overall Study|Withdrawal by Subject|1
673963|NCT01751867|2180736|P1|Overall Study|Withdrawal by Subject|3
673964|NCT01751867|2180735|P2|Overall Study|Poor Compliance|5
673965|NCT01751867|2180736|P1|Overall Study|Poor Compliance|0
673966|NCT01751867|2180735|P2|Overall Study|Adverse Event|15
673967|NCT01751867|2180736|P1|Overall Study|Adverse Event|8
673968|NCT01751867|2180735|P2|Overall Study|Diease Progression|18
673969|NCT01751867|2180736|P1|Overall Study|Diease Progression|4
673970|NCT01751867|2180735|P2|Overall Study|Completed treatment,dropped in follow-up|8
673971|NCT01751867|2180736|P1|Overall Study|Completed treatment,dropped in follow-up|4
673972|NCT01751802|2180756|P2|Overall Study|Adverse Event|2
673973|NCT01751802|2180757|P1|Overall Study|Adverse Event|4
673974|NCT01751724|2180771|P2|Overall Study|withdrawn by parent|2
673975|NCT01751724|2180772|P1|Overall Study|withdrawn by parent|0
673976|NCT01751724|2180771|P2|Overall Study|extubated bef.start assigned treatment|0
673977|NCT01751724|2180772|P1|Overall Study|extubated bef.start assigned treatment|1
673978|NCT01751178|2180856|P3|Overall Study|Other Reason (unknown)|2
673979|NCT01751178|2180857|P2|Overall Study|Other Reason (unknown)|0
673980|NCT01751178|2180858|P1|Overall Study|Other Reason (unknown)|1
673981|NCT01751178|2180856|P3|Overall Study|Adverse Event|0
673982|NCT01751178|2180857|P2|Overall Study|Adverse Event|0
673983|NCT01751178|2180858|P1|Overall Study|Adverse Event|2
673984|NCT01751165|2180878|P3|Overall Study|Lost to Follow-up|1
673985|NCT01751165|2180879|P2|Overall Study|Lost to Follow-up|1
673986|NCT01751165|2180880|P1|Overall Study|Lost to Follow-up|1
673987|NCT01751165|2180878|P3|Overall Study|Serious adverse event|0
673988|NCT01751165|2180879|P2|Overall Study|Serious adverse event|2
673989|NCT01751165|2180880|P1|Overall Study|Serious adverse event|0
673990|NCT01751165|2180878|P3|Overall Study|Withdrawal by Subject|1
673991|NCT01751165|2180879|P2|Overall Study|Withdrawal by Subject|0
673992|NCT01751165|2180880|P1|Overall Study|Withdrawal by Subject|0
673993|NCT01751165|2180878|P3|Overall Study|Adverse event, serious fatal|1
673994|NCT01751165|2180879|P2|Overall Study|Adverse event, serious fatal|0
673995|NCT01751165|2180880|P1|Overall Study|Adverse event, serious fatal|1
673996|NCT01751113|2180920|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
673997|NCT01751113|2180921|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
673998|NCT01751113|2180922|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
673999|NCT01751113|2180923|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
674000|NCT01751113|2180924|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
674001|NCT01751113|2180925|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
674002|NCT01751113|2180920|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
674003|NCT01751113|2180921|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
674004|NCT01751113|2180922|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
674005|NCT01751113|2180923|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
674006|NCT01751113|2180924|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
674007|NCT01751113|2180925|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
674008|NCT01751087|2180966|P3|Overall Study|Physician Decision|1
674009|NCT01751087|2180967|P2|Overall Study|Physician Decision|0
674010|NCT01751087|2180968|P1|Overall Study|Physician Decision|0
674011|NCT01751087|2180966|P3|Overall Study|Withdrawal by Subject|0
674012|NCT01751087|2180967|P2|Overall Study|Withdrawal by Subject|0
674013|NCT01751087|2180968|P1|Overall Study|Withdrawal by Subject|1
674014|NCT01750840|2181056|P1|Overall Study|Lost to Follow-up|4
674015|NCT01750684|2181063|P2|Overall Study|Protocol Violation|0
674016|NCT01750684|2181064|P1|Overall Study|Protocol Violation|1
674017|NCT01750684|2181063|P2|Overall Study|Withdrawn by Sponsor|1
674018|NCT01750684|2181064|P1|Overall Study|Withdrawn by Sponsor|0
674019|NCT01750684|2181063|P2|Overall Study|Non-compliance with Study Drug|1
674020|NCT01750684|2181064|P1|Overall Study|Non-compliance with Study Drug|0
674021|NCT01750684|2181063|P2|Overall Study|Death|0
674022|NCT01750684|2181064|P1|Overall Study|Death|1
674023|NCT01750346|2181099|P3|Overall Study|Adverse Event|0
674024|NCT01750346|2181100|P2|Overall Study|Adverse Event|0
674025|NCT01750346|2181101|P1|Overall Study|Adverse Event|1
674026|NCT01750294|2181127|P1|Overall Study|Safety Endpoint|1
674027|NCT01750294|2181127|P1|Overall Study|Withdrawal by Subject|1
674028|NCT01750281|2181134|P3|Overall Study|Did not receive treatment|0
674029|NCT01750281|2181135|P2|Overall Study|Did not receive treatment|1
674030|NCT01750281|2181136|P1|Overall Study|Did not receive treatment|0
674031|NCT01750281|2181134|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
674032|NCT01750281|2181135|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
674033|NCT01750281|2181136|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
674119|NCT01744977|2182108|P2|Overall Study|Lost to Follow-up|0
674034|NCT01750281|2181134|P3|Overall Study|Discontinued Selumetinib/Placebo|75
674035|NCT01750281|2181135|P2|Overall Study|Discontinued Selumetinib/Placebo|77
674036|NCT01750281|2181136|P1|Overall Study|Discontinued Selumetinib/Placebo|37
674037|NCT01750242|2181166|P1|Overall Study|Unreadable Images|3
674038|NCT01749982|2181184|P4|Overall Study|Withdrawal by Subject|1
674039|NCT01749982|2181185|P3|Overall Study|Withdrawal by Subject|0
674040|NCT01749982|2181186|P2|Overall Study|Withdrawal by Subject|0
674041|NCT01749982|2181187|P1|Overall Study|Withdrawal by Subject|0
674042|NCT01749982|2181184|P4|Overall Study|Lost to Follow-up|1
674043|NCT01749982|2181185|P3|Overall Study|Lost to Follow-up|0
674044|NCT01749982|2181186|P2|Overall Study|Lost to Follow-up|0
674045|NCT01749982|2181187|P1|Overall Study|Lost to Follow-up|0
674046|NCT01749982|2181184|P4|Overall Study|Physician Decision|1
674047|NCT01749982|2181185|P3|Overall Study|Physician Decision|0
674048|NCT01749982|2181186|P2|Overall Study|Physician Decision|0
674049|NCT01749982|2181187|P1|Overall Study|Physician Decision|0
674050|NCT01749800|2181218|P3|Overall Study|Withdrawal by Subject|0
674051|NCT01749800|2181219|P2|Overall Study|Withdrawal by Subject|1
674052|NCT01749800|2181220|P1|Overall Study|Withdrawal by Subject|0
674053|NCT01749800|2181218|P3|Overall Study|not meeting inclusion criteria|0
674054|NCT01749800|2181219|P2|Overall Study|not meeting inclusion criteria|0
674055|NCT01749800|2181220|P1|Overall Study|not meeting inclusion criteria|3
674056|NCT01749735|2181230|P2|Overall Study|Withdrawal by Subject|0
674057|NCT01749735|2181231|P1|Overall Study|Withdrawal by Subject|1
888772|NCT01791517|2822614|P12|Phase I: Period 1|Lost to Follow-up|0
674059|NCT01748760|2181375|P2|Overall Study|Lost to Follow-up|1
674060|NCT01748760|2181376|P1|Overall Study|Lost to Follow-up|5
674061|NCT01748760|2181375|P2|Overall Study|Withdrawal by Subject|1
674062|NCT01748760|2181376|P1|Overall Study|Withdrawal by Subject|1
674063|NCT01748071|2181421|P3|Overall Study|Adverse Event|0
674064|NCT01748071|2181422|P2|Overall Study|Adverse Event|2
674065|NCT01748071|2181423|P1|Overall Study|Adverse Event|2
674066|NCT01747811|2181710|P2|Overall Study|Lack of Efficacy|4
674067|NCT01747811|2181711|P1|Overall Study|Lack of Efficacy|2
674068|NCT01747772|2181727|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
674069|NCT01747655|2181735|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
674070|NCT01747655|2181736|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
674071|NCT01747655|2181735|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
674072|NCT01747655|2181736|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
674073|NCT01747655|2181735|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
674074|NCT01747655|2181736|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
674075|NCT01747629|2181766|P2|Overall Study|Not specified|1
674076|NCT01747629|2181767|P1|Overall Study|Not specified|2
674077|NCT01747629|2181766|P2|Overall Study|Not treated|0
674078|NCT01747629|2181767|P1|Overall Study|Not treated|1
674079|NCT01747629|2181766|P2|Overall Study|Inclusion criteria not met|0
674080|NCT01747629|2181767|P1|Overall Study|Inclusion criteria not met|1
674081|NCT01747629|2181766|P2|Overall Study|Noncompliance|1
674082|NCT01747629|2181767|P1|Overall Study|Noncompliance|1
674083|NCT01747629|2181766|P2|Overall Study|Withdrawal by Subject|2
674084|NCT01747629|2181767|P1|Overall Study|Withdrawal by Subject|2
674085|NCT01747629|2181766|P2|Overall Study|Adverse Event|2
674086|NCT01747629|2181767|P1|Overall Study|Adverse Event|1
674087|NCT01746862|2181834|P2|Overall Study|Entered puberty during the study|0
674088|NCT01746862|2181835|P1|Overall Study|Entered puberty during the study|1
674089|NCT01746862|2181834|P2|Overall Study|Consent withdrawal by parent’s guardian|2
674090|NCT01746862|2181835|P1|Overall Study|Consent withdrawal by parent’s guardian|5
674091|NCT01746862|2181834|P2|Overall Study|Protocol Violation|0
674092|NCT01746862|2181835|P1|Overall Study|Protocol Violation|1
674093|NCT01746862|2181834|P2|Overall Study|Withdrawal by Subject|1
674094|NCT01746862|2181835|P1|Overall Study|Withdrawal by Subject|1
674095|NCT01746368|2181905|P2|Overall Study|Withdrawal by Subject|1
674096|NCT01746368|2181906|P1|Overall Study|Withdrawal by Subject|0
674097|NCT01746368|2181905|P2|Overall Study|Lost to Follow-up|0
674098|NCT01746368|2181906|P1|Overall Study|Lost to Follow-up|2
674099|NCT01746173|2181933|P1|Overall Study|Disease Progression|2
674100|NCT01746108|2181941|P3|Overall Study|Lost to Follow-up|0
674101|NCT01746108|2181942|P2|Overall Study|Lost to Follow-up|1
674102|NCT01746108|2181943|P1|Overall Study|Lost to Follow-up|0
674103|NCT01746108|2181941|P3|Overall Study|Withdrawal by Subject|0
674104|NCT01746108|2181942|P2|Overall Study|Withdrawal by Subject|1
674105|NCT01746108|2181943|P1|Overall Study|Withdrawal by Subject|0
674106|NCT01746108|2181941|P3|Overall Study|Adverse event, non-fatal|0
674107|NCT01746108|2181942|P2|Overall Study|Adverse event, non-fatal|1
674108|NCT01746108|2181943|P1|Overall Study|Adverse event, non-fatal|0
674109|NCT01746108|2181941|P3|Overall Study|Migrated /moved from study area|0
674110|NCT01746108|2181942|P2|Overall Study|Migrated /moved from study area|1
674111|NCT01746108|2181943|P1|Overall Study|Migrated /moved from study area|0
674112|NCT01745848|2182016|P1|Overall Study|Adverse Event|6
674113|NCT01745380|2182023|P2|Overall Study|Lack of Efficacy|1
674114|NCT01745380|2182024|P1|Overall Study|Lack of Efficacy|0
674115|NCT01745380|2182023|P2|Overall Study|Lost to Follow-up|0
674116|NCT01745380|2182024|P1|Overall Study|Lost to Follow-up|1
674117|NCT01744977|2182108|P2|Overall Study|No longer meets inclusion|0
674118|NCT01744977|2182109|P1|Overall Study|No longer meets inclusion|6
674120|NCT01744977|2182109|P1|Overall Study|Lost to Follow-up|2
674121|NCT01744977|2182108|P2|Overall Study|Death|3
674122|NCT01744977|2182109|P1|Overall Study|Death|2
674123|NCT01744977|2182108|P2|Overall Study|Withdrawal by Subject|2
674124|NCT01744977|2182109|P1|Overall Study|Withdrawal by Subject|1
674125|NCT01744691|2182232|P1|Overall Study|Physician Decision|4
674126|NCT01744691|2182232|P1|Overall Study|Withdrawal of consent for treatment|3
674127|NCT01744691|2182232|P1|Overall Study|Unacceptable toxicity, AE or death|18
674128|NCT01744691|2182232|P1|Overall Study|Progressive Disease|18
674129|NCT01744496|2182239|P2|Maintenance Period|Subject left town|0
674130|NCT01744496|2182240|P1|Maintenance Period|Subject left town|1
674131|NCT01744496|2182239|P2|Maintenance Period|Withdrawal by Subject|1
674132|NCT01744496|2182240|P1|Maintenance Period|Withdrawal by Subject|1
674133|NCT01744496|2182239|P2|Maintenance Period|Protocol Violation|0
674134|NCT01744496|2182240|P1|Maintenance Period|Protocol Violation|1
674135|NCT01744496|2182239|P2|Maintenance Period|Adverse Event|3
674136|NCT01744496|2182240|P1|Maintenance Period|Adverse Event|1
674137|NCT01744496|2182239|P2|Titration Period|Personal reasons|1
674138|NCT01744496|2182240|P1|Titration Period|Personal reasons|0
674139|NCT01744496|2182239|P2|Titration Period|Adverse Event|1
674140|NCT01744496|2182240|P1|Titration Period|Adverse Event|2
888773|NCT01791517|2822615|P11|Phase I: Period 1|Lost to Follow-up|0
888774|NCT01791517|2822616|P10|Phase I: Period 1|Lost to Follow-up|1
888775|NCT01791517|2822617|P9|Phase I: Period 1|Lost to Follow-up|1
888776|NCT01791517|2822618|P8|Phase I: Period 1|Lost to Follow-up|0
888777|NCT01791517|2822619|P7|Phase I: Period 1|Lost to Follow-up|1
888778|NCT01791517|2822620|P6|Phase I: Period 1|Lost to Follow-up|0
888779|NCT01791517|2822621|P5|Phase I: Period 1|Lost to Follow-up|0
888780|NCT01791517|2822622|P4|Phase I: Period 1|Lost to Follow-up|1
888781|NCT01791517|2822623|P3|Phase I: Period 1|Lost to Follow-up|0
888782|NCT01791517|2822624|P2|Phase I: Period 1|Lost to Follow-up|0
888783|NCT01791517|2822625|P1|Phase I: Period 1|Lost to Follow-up|0
888784|NCT01791517|2822614|P12|Phase I: Period 1|Protocol Violation|0
888785|NCT01791517|2822615|P11|Phase I: Period 1|Protocol Violation|0
888786|NCT01791517|2822616|P10|Phase I: Period 1|Protocol Violation|0
888787|NCT01791517|2822617|P9|Phase I: Period 1|Protocol Violation|0
888788|NCT01791517|2822618|P8|Phase I: Period 1|Protocol Violation|0
888789|NCT01791517|2822619|P7|Phase I: Period 1|Protocol Violation|0
888790|NCT01791517|2822620|P6|Phase I: Period 1|Protocol Violation|0
674159|NCT01744392|2182271|P1|Overall Study|Physician Decision|1
674160|NCT01744197|2182311|P2|Overall Study|No patch received|2
674161|NCT01744197|2182312|P1|Overall Study|No patch received|2
674162|NCT01744197|2182311|P2|Overall Study|Received 1 patch|1
674163|NCT01744197|2182312|P1|Overall Study|Received 1 patch|2
674164|NCT01743092|2182401|P2|Overall Study|Lost to Follow-up|15
674165|NCT01743092|2182402|P1|Overall Study|Lost to Follow-up|14
674166|NCT01743027|2182414|P4|Overall Study|Withdrawal by Subject|1
674167|NCT01743027|2182415|P3|Overall Study|Withdrawal by Subject|3
674168|NCT01743027|2182416|P2|Overall Study|Withdrawal by Subject|0
674169|NCT01743027|2182417|P1|Overall Study|Withdrawal by Subject|1
674170|NCT01743027|2182414|P4|Overall Study|Protocol Violation|0
674171|NCT01743027|2182415|P3|Overall Study|Protocol Violation|1
674172|NCT01743027|2182416|P2|Overall Study|Protocol Violation|1
674173|NCT01743027|2182417|P1|Overall Study|Protocol Violation|1
674174|NCT01743027|2182414|P4|Overall Study|Progressive Disease|0
674175|NCT01743027|2182415|P3|Overall Study|Progressive Disease|3
674176|NCT01743027|2182416|P2|Overall Study|Progressive Disease|4
674177|NCT01743027|2182417|P1|Overall Study|Progressive Disease|1
674178|NCT01743027|2182414|P4|Overall Study|Lost to Follow-up|0
674179|NCT01743027|2182415|P3|Overall Study|Lost to Follow-up|2
674180|NCT01743027|2182416|P2|Overall Study|Lost to Follow-up|0
674181|NCT01743027|2182417|P1|Overall Study|Lost to Follow-up|0
674182|NCT01743027|2182414|P4|Overall Study|Adverse Event|0
674183|NCT01743027|2182415|P3|Overall Study|Adverse Event|0
674184|NCT01743027|2182416|P2|Overall Study|Adverse Event|0
674185|NCT01743027|2182417|P1|Overall Study|Adverse Event|2
674186|NCT01742897|2182466|P1|Overall Study|Unspecified|1
674187|NCT01742897|2182466|P1|Overall Study|Withdrawal by Subject|1
674188|NCT01742897|2182466|P1|Overall Study|Adverse Event|3
674189|NCT01741792|2182515|P3|Overall Study|Death|12
674190|NCT01741792|2182516|P2|Overall Study|Death|1
674191|NCT01741792|2182517|P1|Overall Study|Death|6
674192|NCT01741701|2182584|P2|Overall Study|Withdrawal by Subject|1
674193|NCT01741701|2182585|P1|Overall Study|Withdrawal by Subject|0
674194|NCT01741701|2182584|P2|Overall Study|Adverse Event|1
674195|NCT01741701|2182585|P1|Overall Study|Adverse Event|5
674196|NCT01741688|2182601|P1|Overall Study|Withdrawal by Subject|1
674197|NCT01741688|2182601|P1|Overall Study|Lack of insurance coverage|2
674198|NCT01740440|2182821|P1|Overall Study|Lost to Follow-up|3
888791|NCT01791517|2822621|P5|Phase I: Period 1|Protocol Violation|0
888792|NCT01791517|2822622|P4|Phase I: Period 1|Protocol Violation|0
888793|NCT01791517|2822623|P3|Phase I: Period 1|Protocol Violation|0
888794|NCT01791517|2822624|P2|Phase I: Period 1|Protocol Violation|1
888795|NCT01791517|2822625|P1|Phase I: Period 1|Protocol Violation|0
888796|NCT01791517|2822614|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888797|NCT01791517|2822615|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888798|NCT01791517|2822616|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888799|NCT01791517|2822617|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888800|NCT01791517|2822618|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888801|NCT01791517|2822619|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888802|NCT01791517|2822620|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888803|NCT01791517|2822621|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888804|NCT01791517|2822622|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888805|NCT01791517|2822623|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888806|NCT01791517|2822624|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
888807|NCT01791517|2822625|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
888808|NCT01791517|2822614|P12|Phase I: Period 1|Adverse Event|0
674222|NCT01740388|2182891|P2|Overall Study|Subjects missing data, completed|36
674223|NCT01740388|2182892|P1|Overall Study|Subjects missing data, completed|41
674224|NCT01740388|2182891|P2|Overall Study|Physician Decision|6
674225|NCT01740388|2182892|P1|Overall Study|Physician Decision|2
674226|NCT01740388|2182891|P2|Overall Study|Lost to Follow-up|0
674227|NCT01740388|2182892|P1|Overall Study|Lost to Follow-up|2
674228|NCT01740388|2182891|P2|Overall Study|Withdrawal by Subject|2
674229|NCT01740388|2182892|P1|Overall Study|Withdrawal by Subject|1
888809|NCT01791517|2822615|P11|Phase I: Period 1|Adverse Event|0
888810|NCT01791517|2822616|P10|Phase I: Period 1|Adverse Event|0
888811|NCT01791517|2822617|P9|Phase I: Period 1|Adverse Event|0
888812|NCT01791517|2822618|P8|Phase I: Period 1|Adverse Event|0
888813|NCT01791517|2822619|P7|Phase I: Period 1|Adverse Event|0
888814|NCT01791517|2822620|P6|Phase I: Period 1|Adverse Event|0
888815|NCT01791517|2822621|P5|Phase I: Period 1|Adverse Event|0
888816|NCT01791517|2822622|P4|Phase I: Period 1|Adverse Event|1
888817|NCT01791517|2822623|P3|Phase I: Period 1|Adverse Event|1
888818|NCT01791517|2822624|P2|Phase I: Period 1|Adverse Event|0
888819|NCT01791517|2822625|P1|Phase I: Period 1|Adverse Event|0
674242|NCT01740089|2182998|P3|After 12 Weeks|Withdrawal by Subject|1
674243|NCT01740089|2182999|P2|After 12 Weeks|Withdrawal by Subject|1
674244|NCT01740089|2183000|P1|After 12 Weeks|Withdrawal by Subject|1
674245|NCT01740089|2182998|P3|After 12 Weeks|Protocol Violation|1
674246|NCT01740089|2182999|P2|After 12 Weeks|Protocol Violation|1
674247|NCT01740089|2183000|P1|After 12 Weeks|Protocol Violation|1
674248|NCT01740089|2182998|P3|After 12 Weeks|Adverse Event|5
674249|NCT01740089|2182999|P2|After 12 Weeks|Adverse Event|0
674250|NCT01740089|2183000|P1|After 12 Weeks|Adverse Event|2
674251|NCT01740089|2182998|P3|After 12 Weeks|Lack of Efficacy|4
674252|NCT01740089|2182999|P2|After 12 Weeks|Lack of Efficacy|1
674253|NCT01740089|2183000|P1|After 12 Weeks|Lack of Efficacy|3
674254|NCT01740089|2182998|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
674255|NCT01740089|2182999|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
674256|NCT01740089|2183000|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
674257|NCT01740089|2182998|P3|First 12 Weeks of Treatment|Adverse Event|2
674258|NCT01740089|2182999|P2|First 12 Weeks of Treatment|Adverse Event|1
674259|NCT01740089|2183000|P1|First 12 Weeks of Treatment|Adverse Event|0
674260|NCT01739803|2183018|P2|Overall Study|Lost to Follow-up|6
674261|NCT01739803|2183019|P1|Overall Study|Lost to Follow-up|9
674262|NCT01739790|2183031|P2|Overall Study|Early Trial Termination|4
674263|NCT01739790|2183032|P1|Overall Study|Early Trial Termination|2
674264|NCT01739595|2183041|P3|Overall Study|Drug discrepancy|0
674265|NCT01739595|2183042|P2|Overall Study|Drug discrepancy|0
674266|NCT01739595|2183043|P1|Overall Study|Drug discrepancy|1
674267|NCT01739595|2183041|P3|Overall Study|Lab assessment|0
674268|NCT01739595|2183042|P2|Overall Study|Lab assessment|0
674269|NCT01739595|2183043|P1|Overall Study|Lab assessment|1
674270|NCT01739595|2183041|P3|Overall Study|Protocol Violation|0
674271|NCT01739595|2183042|P2|Overall Study|Protocol Violation|0
674272|NCT01739595|2183043|P1|Overall Study|Protocol Violation|1
674273|NCT01739595|2183041|P3|Overall Study|Eligibility issue|0
674274|NCT01739595|2183042|P2|Overall Study|Eligibility issue|0
674275|NCT01739595|2183043|P1|Overall Study|Eligibility issue|3
674276|NCT01739595|2183041|P3|Overall Study|Withdrawal by Subject|2
674277|NCT01739595|2183042|P2|Overall Study|Withdrawal by Subject|1
674278|NCT01739595|2183043|P1|Overall Study|Withdrawal by Subject|2
674279|NCT01739595|2183041|P3|Overall Study|Lost to Follow-up|0
674280|NCT01739595|2183042|P2|Overall Study|Lost to Follow-up|0
674281|NCT01739595|2183043|P1|Overall Study|Lost to Follow-up|2
674282|NCT01739595|2183041|P3|Overall Study|Adverse Event|0
674283|NCT01739595|2183042|P2|Overall Study|Adverse Event|0
674284|NCT01739595|2183043|P1|Overall Study|Adverse Event|3
674285|NCT01738984|2183062|P2|Overall Study|Lost to Follow-up|39
674286|NCT01738984|2183063|P1|Overall Study|Lost to Follow-up|59
674287|NCT01738984|2183062|P2|Overall Study|Withdrawal by Subject|0
674288|NCT01738984|2183063|P1|Overall Study|Withdrawal by Subject|1
674289|NCT01738984|2183062|P2|Overall Study|Pregnancy|0
674290|NCT01738984|2183063|P1|Overall Study|Pregnancy|4
674291|NCT01738971|2183076|P3|Overall Study|Lost to Follow-up|17
674292|NCT01738971|2183077|P2|Overall Study|Lost to Follow-up|30
674293|NCT01738971|2183078|P1|Overall Study|Lost to Follow-up|19
674294|NCT01738919|2183094|P2|Overall Study|Not treated in accordance to guidelines|1
674295|NCT01738919|2183095|P1|Overall Study|Not treated in accordance to guidelines|0
674296|NCT01738919|2183094|P2|Overall Study|Withdrawal by Subject|1
674297|NCT01738919|2183095|P1|Overall Study|Withdrawal by Subject|0
674298|NCT01738919|2183094|P2|Overall Study|Immigrated|1
674299|NCT01738919|2183095|P1|Overall Study|Immigrated|0
674300|NCT01738919|2183094|P2|Overall Study|Lost to Follow-up|0
674301|NCT01738919|2183095|P1|Overall Study|Lost to Follow-up|1
674302|NCT01738646|2183236|P1|Overall Study|Still Receiving Treatment|2
674303|NCT01738581|2183246|P2|Overall Study|Lost to Follow-up|0
674304|NCT01738581|2183247|P1|Overall Study|Lost to Follow-up|1
674305|NCT01738438|2183265|P1|Overall Study|Adverse Event|3
674306|NCT01738438|2183265|P1|Overall Study|Disease Progression|32
674307|NCT01737996|2183283|P3|Overall Study|Withdrawal by Subject|1
674308|NCT01737996|2183284|P2|Overall Study|Withdrawal by Subject|0
674309|NCT01737996|2183285|P1|Overall Study|Withdrawal by Subject|0
674310|NCT01737996|2183283|P3|Overall Study|Adverse Event|1
674311|NCT01737996|2183284|P2|Overall Study|Adverse Event|1
674312|NCT01737996|2183285|P1|Overall Study|Adverse Event|0
674313|NCT01737931|2183347|P3|Overall Study|Physician Decision|0
674314|NCT01737931|2183348|P2|Overall Study|Physician Decision|1
674315|NCT01737931|2183349|P1|Overall Study|Physician Decision|0
674316|NCT01737931|2183347|P3|Overall Study|Withdrawal by Subject|1
674317|NCT01737931|2183348|P2|Overall Study|Withdrawal by Subject|1
674318|NCT01737931|2183349|P1|Overall Study|Withdrawal by Subject|0
674319|NCT01737879|2183364|P1|Overall Study|Sponsor decision|40
674320|NCT01737879|2183364|P1|Overall Study|Death|1
674321|NCT01737840|2183373|P2|Overall Study|Diagnosed with an other pathology|2
674322|NCT01737840|2183374|P1|Overall Study|Diagnosed with an other pathology|2
674323|NCT01737762|2183384|P2|Overall Study|Trial termination|9
674324|NCT01737762|2183385|P1|Overall Study|Trial termination|11
674325|NCT01737762|2183384|P2|Overall Study|Moved from area|1
674326|NCT01737762|2183385|P1|Overall Study|Moved from area|2
674327|NCT01737762|2183384|P2|Overall Study|Physician Decision|1
674328|NCT01737762|2183385|P1|Overall Study|Physician Decision|1
674329|NCT01737762|2183384|P2|Overall Study|Progressive disease|2
674330|NCT01737762|2183385|P1|Overall Study|Progressive disease|1
674331|NCT01737762|2183384|P2|Overall Study|Withdrawal by Subject|2
674332|NCT01737762|2183385|P1|Overall Study|Withdrawal by Subject|2
674333|NCT01737762|2183384|P2|Overall Study|Lost to Follow-up|0
674334|NCT01737762|2183385|P1|Overall Study|Lost to Follow-up|1
674335|NCT01737762|2183384|P2|Overall Study|Adverse Event|2
674336|NCT01737762|2183385|P1|Overall Study|Adverse Event|2
674337|NCT01737710|2183398|P5|Overall Study|Vaccinated in Error/Ineligible|0
674338|NCT01737710|2183399|P4|Overall Study|Vaccinated in Error/Ineligible|0
674339|NCT01737710|2183400|P3|Overall Study|Vaccinated in Error/Ineligible|0
674340|NCT01737710|2183401|P2|Overall Study|Vaccinated in Error/Ineligible|1
674341|NCT01737710|2183402|P1|Overall Study|Vaccinated in Error/Ineligible|1
674342|NCT01737710|2183398|P5|Overall Study|Withdrawal by Subject|0
674343|NCT01737710|2183399|P4|Overall Study|Withdrawal by Subject|0
674344|NCT01737710|2183400|P3|Overall Study|Withdrawal by Subject|1
674345|NCT01737710|2183401|P2|Overall Study|Withdrawal by Subject|1
674346|NCT01737710|2183402|P1|Overall Study|Withdrawal by Subject|1
674347|NCT01737710|2183398|P5|Overall Study|Lost to Follow-up|0
674348|NCT01737710|2183399|P4|Overall Study|Lost to Follow-up|0
674349|NCT01737710|2183400|P3|Overall Study|Lost to Follow-up|2
674350|NCT01737710|2183401|P2|Overall Study|Lost to Follow-up|2
674351|NCT01737710|2183402|P1|Overall Study|Lost to Follow-up|0
674352|NCT01737021|2183495|P2|Overall Study|Lost to Follow-up|3
674353|NCT01737021|2183496|P1|Overall Study|Lost to Follow-up|5
674354|NCT01736917|2183542|P1|Overall Study|Protocol Violation|10
674355|NCT01736917|2183542|P1|Overall Study|Adverse Event|1
674356|NCT01736696|2183556|P7|Overall Study|Withdrawal by Subject|0
674357|NCT01736696|2183557|P6|Overall Study|Withdrawal by Subject|0
674358|NCT01736696|2183558|P5|Overall Study|Withdrawal by Subject|0
674359|NCT01736696|2183559|P4|Overall Study|Withdrawal by Subject|0
674360|NCT01736696|2183560|P3|Overall Study|Withdrawal by Subject|1
674361|NCT01736696|2183561|P2|Overall Study|Withdrawal by Subject|0
674362|NCT01736696|2183562|P1|Overall Study|Withdrawal by Subject|0
674363|NCT01736657|2183879|P1|Overall Study|insufficient vascular access|1
888820|NCT01791517|2822614|P12|Phase I: Period 1|Withdrawal by Subject|0
888821|NCT01791517|2822615|P11|Phase I: Period 1|Withdrawal by Subject|0
674366|NCT01736540|2183923|P1|Overall Study|Unable to make MRI appointment|3
674367|NCT01736540|2183923|P1|Overall Study|No show for MRI appointment|1
674368|NCT01736540|2183923|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
674369|NCT01736540|2183923|P1|Overall Study|Protocol Violation|1
674370|NCT01736540|2183923|P1|Overall Study|Withdrawal by Subject|5
674371|NCT01736540|2183923|P1|Overall Study|Abnormal test procedure|1
674372|NCT01736540|2183923|P1|Overall Study|Death|1
674373|NCT01736540|2183923|P1|Overall Study|Did not complete scan within 45 days|2
888822|NCT01791517|2822616|P10|Phase I: Period 1|Withdrawal by Subject|0
674384|NCT01736215|2184043|P1|Overall Study|Insufficient data to perform analysis|8
674385|NCT01736215|2184043|P1|Overall Study|Progressive disease stop chemotherapy|1
674386|NCT01736215|2184043|P1|Overall Study|Adverse Event|4
674387|NCT01736215|2184043|P1|Overall Study|Early termination of erythropoietin use|1
674388|NCT01736176|2184055|P1|Overall Study|Unable to Complete PEG Placement|1
674389|NCT01736176|2184055|P1|Overall Study|Lack of Efficacy|3
674390|NCT01736176|2184055|P1|Overall Study|Withdrawal by Subject|4
674391|NCT01736176|2184055|P1|Overall Study|Adverse Event|3
888823|NCT01791517|2822617|P9|Phase I: Period 1|Withdrawal by Subject|0
888824|NCT01791517|2822618|P8|Phase I: Period 1|Withdrawal by Subject|0
888825|NCT01791517|2822619|P7|Phase I: Period 1|Withdrawal by Subject|0
888826|NCT01791517|2822620|P6|Phase I: Period 1|Withdrawal by Subject|1
888827|NCT01791517|2822621|P5|Phase I: Period 1|Withdrawal by Subject|1
888828|NCT01791517|2822622|P4|Phase I: Period 1|Withdrawal by Subject|0
888829|NCT01791517|2822623|P3|Phase I: Period 1|Withdrawal by Subject|1
888830|NCT01791517|2822624|P2|Phase I: Period 1|Withdrawal by Subject|1
888831|NCT01791517|2822625|P1|Phase I: Period 1|Withdrawal by Subject|0
674401|NCT01735630|2184142|P2|Overall Study|Withdrawal by Subject|9
674402|NCT01735630|2184143|P1|Overall Study|Withdrawal by Subject|7
674403|NCT01735630|2184142|P2|Overall Study|Sponsor Decision|1
674404|NCT01735630|2184143|P1|Overall Study|Sponsor Decision|2
674405|NCT01735630|2184142|P2|Overall Study|Physician Decision|1
674406|NCT01735630|2184143|P1|Overall Study|Physician Decision|0
674407|NCT01735630|2184142|P2|Overall Study|Lost to Follow-up|0
674408|NCT01735630|2184143|P1|Overall Study|Lost to Follow-up|1
674409|NCT01735630|2184142|P2|Overall Study|Adverse Event|7
674410|NCT01735630|2184143|P1|Overall Study|Adverse Event|8
674411|NCT01735396|2184170|P1|Overall Study|not evaluable|1
674412|NCT01735201|2184199|P8|Overall Study|Other Miscellaneous Reasons|1
674413|NCT01735201|2184200|P7|Overall Study|Other Miscellaneous Reasons|1
674414|NCT01735201|2184201|P6|Overall Study|Other Miscellaneous Reasons|2
674415|NCT01735201|2184202|P5|Overall Study|Other Miscellaneous Reasons|0
674416|NCT01735201|2184203|P4|Overall Study|Other Miscellaneous Reasons|1
674417|NCT01735201|2184204|P3|Overall Study|Other Miscellaneous Reasons|0
674418|NCT01735201|2184205|P2|Overall Study|Other Miscellaneous Reasons|0
674419|NCT01735201|2184206|P1|Overall Study|Other Miscellaneous Reasons|0
674420|NCT01735201|2184199|P8|Overall Study|Protocol Violation|0
674421|NCT01735201|2184200|P7|Overall Study|Protocol Violation|0
674422|NCT01735201|2184201|P6|Overall Study|Protocol Violation|0
674423|NCT01735201|2184202|P5|Overall Study|Protocol Violation|0
674424|NCT01735201|2184203|P4|Overall Study|Protocol Violation|0
674425|NCT01735201|2184204|P3|Overall Study|Protocol Violation|0
674426|NCT01735201|2184205|P2|Overall Study|Protocol Violation|0
674427|NCT01735201|2184206|P1|Overall Study|Protocol Violation|1
674428|NCT01735201|2184199|P8|Overall Study|Personal Reasons|0
674429|NCT01735201|2184200|P7|Overall Study|Personal Reasons|0
674430|NCT01735201|2184201|P6|Overall Study|Personal Reasons|0
674431|NCT01735201|2184202|P5|Overall Study|Personal Reasons|0
674432|NCT01735201|2184203|P4|Overall Study|Personal Reasons|0
674433|NCT01735201|2184204|P3|Overall Study|Personal Reasons|0
674434|NCT01735201|2184205|P2|Overall Study|Personal Reasons|0
674435|NCT01735201|2184206|P1|Overall Study|Personal Reasons|1
674436|NCT01735201|2184199|P8|Overall Study|Adverse Event|1
674437|NCT01735201|2184200|P7|Overall Study|Adverse Event|2
674438|NCT01735201|2184201|P6|Overall Study|Adverse Event|3
674439|NCT01735201|2184202|P5|Overall Study|Adverse Event|1
674440|NCT01735201|2184203|P4|Overall Study|Adverse Event|1
674441|NCT01735201|2184204|P3|Overall Study|Adverse Event|0
674442|NCT01735201|2184205|P2|Overall Study|Adverse Event|1
674443|NCT01735201|2184206|P1|Overall Study|Adverse Event|1
674444|NCT01735175|2184242|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
674445|NCT01735175|2184243|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
674446|NCT01735175|2184242|P2|Overall Study|Death|2
674447|NCT01735175|2184243|P1|Overall Study|Death|3
674448|NCT01735175|2184242|P2|Overall Study|Lost to Follow-up|2
674449|NCT01735175|2184243|P1|Overall Study|Lost to Follow-up|4
674450|NCT01735175|2184242|P2|Overall Study|Withdrawal by Subject|2
674451|NCT01735175|2184243|P1|Overall Study|Withdrawal by Subject|9
674452|NCT01734993|2184263|P1|Overall Study|Lack of Efficacy|1
674453|NCT01734993|2184263|P1|Overall Study|Adverse Event|1
674454|NCT01734785|2184300|P4|Double−Blind Period|Not treated|0
674455|NCT01734785|2184301|P3|Double−Blind Period|Not treated|0
674456|NCT01734785|2184302|P2|Double−Blind Period|Not treated|0
674457|NCT01734785|2184303|P1|Double−Blind Period|Not treated|1
674458|NCT01734785|2184300|P4|Double−Blind Period|Withdrawal by Subject|0
674459|NCT01734785|2184301|P3|Double−Blind Period|Withdrawal by Subject|0
674460|NCT01734785|2184302|P2|Double−Blind Period|Withdrawal by Subject|0
674461|NCT01734785|2184303|P1|Double−Blind Period|Withdrawal by Subject|2
674462|NCT01734785|2184300|P4|Double−Blind Period|Lost to Follow-up|0
674463|NCT01734785|2184301|P3|Double−Blind Period|Lost to Follow-up|2
674464|NCT01734785|2184302|P2|Double−Blind Period|Lost to Follow-up|4
674465|NCT01734785|2184303|P1|Double−Blind Period|Lost to Follow-up|2
674466|NCT01734785|2184300|P4|Double−Blind Period|Protocol Violation|0
674467|NCT01734785|2184301|P3|Double−Blind Period|Protocol Violation|1
674468|NCT01734785|2184302|P2|Double−Blind Period|Protocol Violation|1
674469|NCT01734785|2184303|P1|Double−Blind Period|Protocol Violation|0
674470|NCT01734785|2184300|P4|Double−Blind Period|Lack of Efficacy|0
674471|NCT01734785|2184301|P3|Double−Blind Period|Lack of Efficacy|0
674472|NCT01734785|2184302|P2|Double−Blind Period|Lack of Efficacy|1
674473|NCT01734785|2184303|P1|Double−Blind Period|Lack of Efficacy|0
674474|NCT01734785|2184300|P4|Double−Blind Period|Adverse Event|0
674475|NCT01734785|2184301|P3|Double−Blind Period|Adverse Event|2
674476|NCT01734785|2184302|P2|Double−Blind Period|Adverse Event|3
674477|NCT01734785|2184303|P1|Double−Blind Period|Adverse Event|0
674478|NCT01734785|2184300|P4|Open−Label Period|Other Reasons|224
674479|NCT01734785|2184301|P3|Open−Label Period|Other Reasons|0
674480|NCT01734785|2184302|P2|Open−Label Period|Other Reasons|0
674481|NCT01734785|2184303|P1|Open−Label Period|Other Reasons|0
674482|NCT01734785|2184300|P4|Open−Label Period|Withdrawal by Subject|12
674483|NCT01734785|2184301|P3|Open−Label Period|Withdrawal by Subject|0
674484|NCT01734785|2184302|P2|Open−Label Period|Withdrawal by Subject|0
674485|NCT01734785|2184303|P1|Open−Label Period|Withdrawal by Subject|0
674486|NCT01734785|2184300|P4|Open−Label Period|Lost to Follow-up|14
674487|NCT01734785|2184301|P3|Open−Label Period|Lost to Follow-up|0
674488|NCT01734785|2184302|P2|Open−Label Period|Lost to Follow-up|0
674489|NCT01734785|2184303|P1|Open−Label Period|Lost to Follow-up|0
674490|NCT01734785|2184300|P4|Open−Label Period|Protocol Violation|13
674491|NCT01734785|2184301|P3|Open−Label Period|Protocol Violation|0
674492|NCT01734785|2184302|P2|Open−Label Period|Protocol Violation|0
674493|NCT01734785|2184303|P1|Open−Label Period|Protocol Violation|0
674494|NCT01734785|2184300|P4|Open−Label Period|Lack of Efficacy|1
674495|NCT01734785|2184301|P3|Open−Label Period|Lack of Efficacy|0
674496|NCT01734785|2184302|P2|Open−Label Period|Lack of Efficacy|0
674497|NCT01734785|2184303|P1|Open−Label Period|Lack of Efficacy|0
674498|NCT01734785|2184300|P4|Open−Label Period|Adverse Event|9
674499|NCT01734785|2184301|P3|Open−Label Period|Adverse Event|0
674500|NCT01734785|2184302|P2|Open−Label Period|Adverse Event|0
674501|NCT01734785|2184303|P1|Open−Label Period|Adverse Event|0
674502|NCT01734772|2184320|P2|Overall Study|Withdrawal by Subject|1
674503|NCT01734772|2184321|P1|Overall Study|Withdrawal by Subject|0
674504|NCT01734772|2184320|P2|Overall Study|Adverse Event|2
674505|NCT01734772|2184321|P1|Overall Study|Adverse Event|1
674506|NCT01734395|2184362|P1|Overall Study|Missing the reasons for not completed|3
674507|NCT01734395|2184362|P1|Overall Study|Withdrawal by Subject|10
674508|NCT01734395|2184362|P1|Overall Study|Adverse Event|40
674509|NCT01734395|2184362|P1|Overall Study|Lack of Efficacy|5
674510|NCT01734395|2184362|P1|Overall Study|Lost to Follow-up|287
674511|NCT01734395|2184362|P1|Overall Study|Not specified|65
674512|NCT01733758|2184420|P4|Overall Study|Inv Decision, HbA1c not controlled|1
674513|NCT01733758|2184421|P3|Overall Study|Inv Decision, HbA1c not controlled|0
674514|NCT01733758|2184422|P2|Overall Study|Inv Decision, HbA1c not controlled|1
674515|NCT01733758|2184423|P1|Overall Study|Inv Decision, HbA1c not controlled|1
674516|NCT01733758|2184420|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
674517|NCT01733758|2184421|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
674518|NCT01733758|2184422|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
674519|NCT01733758|2184423|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
674520|NCT01733758|2184420|P4|Overall Study|Non-compliance|0
674521|NCT01733758|2184421|P3|Overall Study|Non-compliance|0
674522|NCT01733758|2184422|P2|Overall Study|Non-compliance|0
674523|NCT01733758|2184423|P1|Overall Study|Non-compliance|1
674524|NCT01733758|2184420|P4|Overall Study|Protocol Violation|2
674525|NCT01733758|2184421|P3|Overall Study|Protocol Violation|2
674526|NCT01733758|2184422|P2|Overall Study|Protocol Violation|1
674527|NCT01733758|2184423|P1|Overall Study|Protocol Violation|0
674528|NCT01733758|2184420|P4|Overall Study|Persistent Hyperglycemia|0
674529|NCT01733758|2184421|P3|Overall Study|Persistent Hyperglycemia|0
674530|NCT01733758|2184422|P2|Overall Study|Persistent Hyperglycemia|2
674531|NCT01733758|2184423|P1|Overall Study|Persistent Hyperglycemia|3
674532|NCT01733758|2184420|P4|Overall Study|Withdrawal by Subject|3
674533|NCT01733758|2184421|P3|Overall Study|Withdrawal by Subject|5
674534|NCT01733758|2184422|P2|Overall Study|Withdrawal by Subject|1
674535|NCT01733758|2184423|P1|Overall Study|Withdrawal by Subject|1
674536|NCT01733758|2184420|P4|Overall Study|Adverse Event|1
674537|NCT01733758|2184421|P3|Overall Study|Adverse Event|8
674538|NCT01733758|2184422|P2|Overall Study|Adverse Event|7
674539|NCT01733758|2184423|P1|Overall Study|Adverse Event|5
674540|NCT01733732|2184489|P2|Overall Study|Did not attend all study visits|0
674541|NCT01733732|2184490|P1|Overall Study|Did not attend all study visits|1
674542|NCT01733732|2184489|P2|Overall Study|Adverse Event|0
674543|NCT01733732|2184490|P1|Overall Study|Adverse Event|1
674544|NCT01733329|2184526|P2|Overall Study|Uterine artery injury|0
674545|NCT01733329|2184527|P1|Overall Study|Uterine artery injury|1
674546|NCT01733329|2184526|P2|Overall Study|Protocol Violation|1
674547|NCT01733329|2184527|P1|Overall Study|Protocol Violation|1
674548|NCT01733316|2184539|P1|Overall Study|Withdrawal by Subject|1
674549|NCT01733316|2184539|P1|Overall Study|Noncompliance|1
674550|NCT01733121|2184619|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
674551|NCT01733121|2184620|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
674552|NCT01733121|2184619|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
674553|NCT01733121|2184620|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
674554|NCT01733121|2184619|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
674555|NCT01733121|2184620|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
674556|NCT01733121|2184619|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
674557|NCT01733121|2184620|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
674558|NCT01732926|2184662|P2|Overall Study|Blind Broken by Subject or Study Site|1
674559|NCT01732926|2184663|P1|Overall Study|Blind Broken by Subject or Study Site|1
674560|NCT01732926|2184662|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
674561|NCT01732926|2184663|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
674562|NCT01732926|2184662|P2|Overall Study|Other Reason|4
674563|NCT01732926|2184663|P1|Overall Study|Other Reason|21
674564|NCT01732926|2184662|P2|Overall Study|Physician Decision|11
674565|NCT01732926|2184663|P1|Overall Study|Physician Decision|24
674566|NCT01732926|2184662|P2|Overall Study|Withdrawal by Subject|8
674567|NCT01732926|2184663|P1|Overall Study|Withdrawal by Subject|46
674568|NCT01732926|2184662|P2|Overall Study|Study Terminated by Sponsor|80
674569|NCT01732926|2184663|P1|Overall Study|Study Terminated by Sponsor|168
674570|NCT01732913|2184679|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
674571|NCT01732913|2184680|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
674572|NCT01732913|2184679|P2|Overall Study|Other|1
674573|NCT01732913|2184680|P1|Overall Study|Other|7
674574|NCT01732913|2184679|P2|Overall Study|Physician Decision|7
674575|NCT01732913|2184680|P1|Overall Study|Physician Decision|14
674576|NCT01732913|2184679|P2|Overall Study|Withdrawal by Subject|4
674577|NCT01732913|2184680|P1|Overall Study|Withdrawal by Subject|27
674578|NCT01732913|2184679|P2|Overall Study|Study Terminated by Sponsor|55
674579|NCT01732913|2184680|P1|Overall Study|Study Terminated by Sponsor|105
674580|NCT01732835|2184694|P1|2-year Extended Follow-up|Death|1
674581|NCT01732835|2184694|P1|2-year Extended Follow-up|Adverse Event|3
674582|NCT01732835|2184694|P1|2-year Extended Follow-up|Withdrawal by Subject|1
674583|NCT01732835|2184694|P1|6-month Primary Endpoint|Adverse Event|3
674584|NCT01732835|2184694|P1|6-month Primary Endpoint|Withdrawal by Subject|2
674585|NCT01732835|2184694|P1|6-month Primary Endpoint|Did not receive device|19
674586|NCT01732796|2184728|P3|Overall Study|Other reason not defined above|2
674587|NCT01732796|2184729|P2|Overall Study|Other reason not defined above|0
674588|NCT01732796|2184730|P1|Overall Study|Other reason not defined above|1
674589|NCT01732796|2184728|P3|Overall Study|Withdrawal by Subject|2
674590|NCT01732796|2184729|P2|Overall Study|Withdrawal by Subject|8
674591|NCT01732796|2184730|P1|Overall Study|Withdrawal by Subject|6
674592|NCT01732796|2184728|P3|Overall Study|Lost to Follow-up|0
674593|NCT01732796|2184729|P2|Overall Study|Lost to Follow-up|0
674594|NCT01732796|2184730|P1|Overall Study|Lost to Follow-up|2
674595|NCT01732796|2184728|P3|Overall Study|Lack of Efficacy|5
674596|NCT01732796|2184729|P2|Overall Study|Lack of Efficacy|18
674597|NCT01732796|2184730|P1|Overall Study|Lack of Efficacy|21
674598|NCT01732796|2184728|P3|Overall Study|Adverse Event|4
674599|NCT01732796|2184729|P2|Overall Study|Adverse Event|16
674600|NCT01732796|2184730|P1|Overall Study|Adverse Event|16
674601|NCT01732770|2184748|P2|Overall Study|Death|0
674602|NCT01732770|2184749|P1|Overall Study|Death|1
674603|NCT01732770|2184748|P2|Overall Study|Decision by Sponsor|2
674604|NCT01732770|2184749|P1|Overall Study|Decision by Sponsor|2
674605|NCT01732770|2184748|P2|Overall Study|Withdrawal by Subject|3
674606|NCT01732770|2184749|P1|Overall Study|Withdrawal by Subject|5
674607|NCT01732770|2184748|P2|Overall Study|Lost to Follow-up|3
674608|NCT01732770|2184749|P1|Overall Study|Lost to Follow-up|2
674609|NCT01732757|2184764|P3|Overall Study|Lost to Follow-up|0
674610|NCT01732757|2184765|P2|Overall Study|Lost to Follow-up|0
674611|NCT01732757|2184766|P1|Overall Study|Lost to Follow-up|1
674612|NCT01732692|2184806|P2|Overall Study|Adverse Event|1
674613|NCT01732692|2184807|P1|Overall Study|Adverse Event|0
674614|NCT01732588|2184824|P3|First Intervention (7 Days)|Adverse Event|0
674615|NCT01732588|2184825|P2|First Intervention (7 Days)|Adverse Event|1
674616|NCT01732588|2184826|P1|First Intervention (7 Days)|Adverse Event|0
674617|NCT01732549|2184842|P2|Overall Study|Not Specified|14
674618|NCT01732549|2184843|P1|Overall Study|Not Specified|8
674619|NCT01732549|2184842|P2|Overall Study|Disease progression|50
674620|NCT01732549|2184843|P1|Overall Study|Disease progression|37
674621|NCT01732549|2184842|P2|Overall Study|Consent withdrawn|6
674622|NCT01732549|2184843|P1|Overall Study|Consent withdrawn|13
674623|NCT01732549|2184842|P2|Overall Study|Adverse Event|3
674624|NCT01732549|2184843|P1|Overall Study|Adverse Event|13
674625|NCT01732510|2184870|P7|Overall Study|Study Terminated By Sponsor|6
674626|NCT01732510|2184871|P6|Overall Study|Study Terminated By Sponsor|12
674627|NCT01732510|2184872|P5|Overall Study|Study Terminated By Sponsor|0
674628|NCT01732510|2184873|P4|Overall Study|Study Terminated By Sponsor|1
674629|NCT01732510|2184874|P3|Overall Study|Study Terminated By Sponsor|0
674630|NCT01732510|2184875|P2|Overall Study|Study Terminated By Sponsor|0
674631|NCT01732510|2184876|P1|Overall Study|Study Terminated By Sponsor|0
674632|NCT01732510|2184870|P7|Overall Study|Pregnancy|0
674633|NCT01732510|2184871|P6|Overall Study|Pregnancy|0
674634|NCT01732510|2184872|P5|Overall Study|Pregnancy|0
674635|NCT01732510|2184873|P4|Overall Study|Pregnancy|1
674636|NCT01732510|2184874|P3|Overall Study|Pregnancy|0
674637|NCT01732510|2184875|P2|Overall Study|Pregnancy|0
674638|NCT01732510|2184876|P1|Overall Study|Pregnancy|0
674639|NCT01732510|2184870|P7|Overall Study|Physician Decision|0
674640|NCT01732510|2184871|P6|Overall Study|Physician Decision|0
674641|NCT01732510|2184872|P5|Overall Study|Physician Decision|0
674642|NCT01732510|2184873|P4|Overall Study|Physician Decision|0
674643|NCT01732510|2184874|P3|Overall Study|Physician Decision|0
674644|NCT01732510|2184875|P2|Overall Study|Physician Decision|1
674645|NCT01732510|2184876|P1|Overall Study|Physician Decision|0
674646|NCT01732510|2184870|P7|Overall Study|Lost to Follow-up|0
674647|NCT01732510|2184871|P6|Overall Study|Lost to Follow-up|1
674648|NCT01732510|2184872|P5|Overall Study|Lost to Follow-up|0
674649|NCT01732510|2184873|P4|Overall Study|Lost to Follow-up|1
674650|NCT01732510|2184874|P3|Overall Study|Lost to Follow-up|1
674651|NCT01732510|2184875|P2|Overall Study|Lost to Follow-up|0
674652|NCT01732510|2184876|P1|Overall Study|Lost to Follow-up|0
674653|NCT01732510|2184870|P7|Overall Study|Withdrawal by Subject|1
674654|NCT01732510|2184871|P6|Overall Study|Withdrawal by Subject|0
674655|NCT01732510|2184872|P5|Overall Study|Withdrawal by Subject|5
674656|NCT01732510|2184873|P4|Overall Study|Withdrawal by Subject|1
674657|NCT01732510|2184874|P3|Overall Study|Withdrawal by Subject|2
674658|NCT01732510|2184875|P2|Overall Study|Withdrawal by Subject|3
674659|NCT01732510|2184876|P1|Overall Study|Withdrawal by Subject|1
674660|NCT01732510|2184870|P7|Overall Study|Protocol Violation|0
674661|NCT01732510|2184871|P6|Overall Study|Protocol Violation|0
674662|NCT01732510|2184872|P5|Overall Study|Protocol Violation|0
674663|NCT01732510|2184873|P4|Overall Study|Protocol Violation|1
674664|NCT01732510|2184874|P3|Overall Study|Protocol Violation|0
674665|NCT01732510|2184875|P2|Overall Study|Protocol Violation|0
674666|NCT01732510|2184876|P1|Overall Study|Protocol Violation|0
674667|NCT01732510|2184870|P7|Overall Study|Adverse Event|1
674668|NCT01732510|2184871|P6|Overall Study|Adverse Event|0
674669|NCT01732510|2184872|P5|Overall Study|Adverse Event|0
674670|NCT01732510|2184873|P4|Overall Study|Adverse Event|0
674671|NCT01732510|2184874|P3|Overall Study|Adverse Event|1
674672|NCT01732510|2184875|P2|Overall Study|Adverse Event|1
674673|NCT01732510|2184876|P1|Overall Study|Adverse Event|0
674674|NCT01732484|2184955|P1|Overall Study|chronical illness|5
674675|NCT01732484|2184955|P1|Overall Study|Lost to Follow-up|14
674676|NCT01732484|2184955|P1|Overall Study|Death|7
674677|NCT01732471|2184963|P1|Overall Study|Withdrawal by Subject|1
888832|NCT01782495|2822662|P11|Overall Study|Withdrew Consent|0
888833|NCT01782495|2822663|P10|Overall Study|Withdrew Consent|0
888834|NCT01782495|2822664|P9|Overall Study|Withdrew Consent|0
888835|NCT01782495|2822665|P8|Overall Study|Withdrew Consent|1
888836|NCT01782495|2822666|P7|Overall Study|Withdrew Consent|0
888837|NCT01782495|2822667|P6|Overall Study|Withdrew Consent|0
888838|NCT01782495|2822668|P5|Overall Study|Withdrew Consent|0
888839|NCT01782495|2822669|P4|Overall Study|Withdrew Consent|0
888840|NCT01782495|2822670|P3|Overall Study|Withdrew Consent|0
888841|NCT01782495|2822671|P2|Overall Study|Withdrew Consent|1
888842|NCT01782495|2822672|P1|Overall Study|Withdrew Consent|0
888843|NCT01782495|2822662|P11|Overall Study|Adverse Event|0
888844|NCT01782495|2822663|P10|Overall Study|Adverse Event|0
888845|NCT01782495|2822664|P9|Overall Study|Adverse Event|0
888846|NCT01782495|2822665|P8|Overall Study|Adverse Event|2
888847|NCT01782495|2822666|P7|Overall Study|Adverse Event|0
888848|NCT01782495|2822667|P6|Overall Study|Adverse Event|0
888849|NCT01782495|2822668|P5|Overall Study|Adverse Event|0
888850|NCT01782495|2822669|P4|Overall Study|Adverse Event|0
888851|NCT01782495|2822670|P3|Overall Study|Adverse Event|0
674698|NCT01731990|2185041|P2|Overall Study|Death|0
674699|NCT01731990|2185042|P1|Overall Study|Death|1
674700|NCT01731990|2185041|P2|Overall Study|Protocol deviation|2
674701|NCT01731990|2185042|P1|Overall Study|Protocol deviation|1
674702|NCT01731990|2185041|P2|Overall Study|Withdrawal by Subject|1
674703|NCT01731990|2185042|P1|Overall Study|Withdrawal by Subject|1
674704|NCT01731990|2185041|P2|Overall Study|Adverse Event|5
674705|NCT01731990|2185042|P1|Overall Study|Adverse Event|1
674706|NCT01731938|2185058|P2|Primary Part II|Missed Week 6 visit|3
674707|NCT01731938|2185059|P1|Primary Part II|Missed Week 6 visit|2
674708|NCT01731938|2185058|P2|Primary Part II|Death|1
674709|NCT01731938|2185059|P1|Primary Part II|Death|2
674710|NCT01731938|2185058|P2|Primary Part II|Lost to Follow-up|5
674711|NCT01731938|2185059|P1|Primary Part II|Lost to Follow-up|4
674712|NCT01731938|2185058|P2|Primary Part II|Withdrawal by Subject|4
674713|NCT01731938|2185059|P1|Primary Part II|Withdrawal by Subject|5
674714|NCT01731938|2185058|P2|Preliminary Part I|Missed Week 6 visit|3
674715|NCT01731938|2185059|P1|Preliminary Part I|Missed Week 6 visit|0
674716|NCT01731938|2185058|P2|Preliminary Part I|Lost to Follow-up|3
674717|NCT01731938|2185059|P1|Preliminary Part I|Lost to Follow-up|0
674718|NCT01731938|2185058|P2|Preliminary Part I|Physician Decision|0
674719|NCT01731938|2185059|P1|Preliminary Part I|Physician Decision|1
674720|NCT01731938|2185058|P2|Preliminary Part I|Withdrawal by Subject|2
674721|NCT01731938|2185059|P1|Preliminary Part I|Withdrawal by Subject|2
674722|NCT01731470|2185071|P1|Overall Study|Did not meet study criteria|1
674723|NCT01731470|2185071|P1|Overall Study|Withdrawal by Subject|1
674724|NCT01730378|2185097|P2|Overall Study|Lost to Follow-up|0
674725|NCT01730378|2185098|P1|Overall Study|Lost to Follow-up|1
674726|NCT01730339|2185129|P2|Overall Study|Un-specified|0
674727|NCT01730339|2185130|P1|Overall Study|Un-specified|1
674728|NCT01730339|2185129|P2|Overall Study|Lost to Follow-up|1
674729|NCT01730339|2185130|P1|Overall Study|Lost to Follow-up|1
888852|NCT01782495|2822671|P2|Overall Study|Adverse Event|0
674730|NCT01730339|2185129|P2|Overall Study|Withdrawal by Subject|2
674731|NCT01730339|2185130|P1|Overall Study|Withdrawal by Subject|3
674732|NCT01730053|2185170|P6|Overall Study|Other than specified|9
674733|NCT01730053|2185171|P5|Overall Study|Other than specified|7
674734|NCT01730053|2185172|P4|Overall Study|Other than specified|4
674735|NCT01730053|2185173|P3|Overall Study|Other than specified|5
674736|NCT01730053|2185174|P2|Overall Study|Other than specified|6
674737|NCT01730053|2185175|P1|Overall Study|Other than specified|2
674738|NCT01730053|2185170|P6|Overall Study|Poor compliance to protocol|2
674739|NCT01730053|2185171|P5|Overall Study|Poor compliance to protocol|0
674740|NCT01730053|2185172|P4|Overall Study|Poor compliance to protocol|0
674741|NCT01730053|2185173|P3|Overall Study|Poor compliance to protocol|2
674742|NCT01730053|2185174|P2|Overall Study|Poor compliance to protocol|2
674743|NCT01730053|2185175|P1|Overall Study|Poor compliance to protocol|1
674744|NCT01730053|2185170|P6|Overall Study|Adverse Event|2
674745|NCT01730053|2185171|P5|Overall Study|Adverse Event|2
674746|NCT01730053|2185172|P4|Overall Study|Adverse Event|3
674747|NCT01730053|2185173|P3|Overall Study|Adverse Event|3
674748|NCT01730053|2185174|P2|Overall Study|Adverse Event|6
674749|NCT01730053|2185175|P1|Overall Study|Adverse Event|2
674750|NCT01730053|2185170|P6|Overall Study|Physician Decision|0
674751|NCT01730053|2185171|P5|Overall Study|Physician Decision|0
674752|NCT01730053|2185172|P4|Overall Study|Physician Decision|1
674753|NCT01730053|2185173|P3|Overall Study|Physician Decision|0
674754|NCT01730053|2185174|P2|Overall Study|Physician Decision|0
674755|NCT01730053|2185175|P1|Overall Study|Physician Decision|0
674756|NCT01730053|2185170|P6|Overall Study|Participant moved|0
674757|NCT01730053|2185171|P5|Overall Study|Participant moved|0
674758|NCT01730053|2185172|P4|Overall Study|Participant moved|0
674759|NCT01730053|2185173|P3|Overall Study|Participant moved|1
674760|NCT01730053|2185174|P2|Overall Study|Participant moved|0
674761|NCT01730053|2185175|P1|Overall Study|Participant moved|0
674762|NCT01730040|2185334|P7|Overall Study|Poor compliance to protocol|1
674763|NCT01730040|2185335|P6|Overall Study|Poor compliance to protocol|0
674764|NCT01730040|2185336|P5|Overall Study|Poor compliance to protocol|0
674765|NCT01730040|2185337|P4|Overall Study|Poor compliance to protocol|0
674766|NCT01730040|2185338|P3|Overall Study|Poor compliance to protocol|0
674767|NCT01730040|2185339|P2|Overall Study|Poor compliance to protocol|4
674768|NCT01730040|2185340|P1|Overall Study|Poor compliance to protocol|2
674769|NCT01730040|2185334|P7|Overall Study|Adverse Event|2
674770|NCT01730040|2185335|P6|Overall Study|Adverse Event|1
674771|NCT01730040|2185336|P5|Overall Study|Adverse Event|1
674772|NCT01730040|2185337|P4|Overall Study|Adverse Event|3
674773|NCT01730040|2185338|P3|Overall Study|Adverse Event|5
674774|NCT01730040|2185339|P2|Overall Study|Adverse Event|3
674775|NCT01730040|2185340|P1|Overall Study|Adverse Event|4
674776|NCT01730040|2185334|P7|Overall Study|Other than specified|4
674777|NCT01730040|2185335|P6|Overall Study|Other than specified|4
674778|NCT01730040|2185336|P5|Overall Study|Other than specified|5
674779|NCT01730040|2185337|P4|Overall Study|Other than specified|5
674780|NCT01730040|2185338|P3|Overall Study|Other than specified|5
674781|NCT01730040|2185339|P2|Overall Study|Other than specified|8
674782|NCT01730040|2185340|P1|Overall Study|Other than specified|7
674783|NCT01730040|2185334|P7|Overall Study|Physician Decision|1
674784|NCT01730040|2185335|P6|Overall Study|Physician Decision|1
674785|NCT01730040|2185336|P5|Overall Study|Physician Decision|0
674786|NCT01730040|2185337|P4|Overall Study|Physician Decision|0
674787|NCT01730040|2185338|P3|Overall Study|Physician Decision|0
674788|NCT01730040|2185339|P2|Overall Study|Physician Decision|0
674789|NCT01730040|2185340|P1|Overall Study|Physician Decision|0
674790|NCT01730040|2185334|P7|Overall Study|Subject moved|1
674791|NCT01730040|2185335|P6|Overall Study|Subject moved|0
674792|NCT01730040|2185336|P5|Overall Study|Subject moved|0
674793|NCT01730040|2185337|P4|Overall Study|Subject moved|0
674794|NCT01730040|2185338|P3|Overall Study|Subject moved|1
674795|NCT01730040|2185339|P2|Overall Study|Subject moved|0
674796|NCT01730040|2185340|P1|Overall Study|Subject moved|0
674797|NCT01730040|2185334|P7|Overall Study|Randomized but not treated|0
674798|NCT01730040|2185335|P6|Overall Study|Randomized but not treated|1
674799|NCT01730040|2185336|P5|Overall Study|Randomized but not treated|0
674800|NCT01730040|2185337|P4|Overall Study|Randomized but not treated|0
674801|NCT01730040|2185338|P3|Overall Study|Randomized but not treated|0
674802|NCT01730040|2185339|P2|Overall Study|Randomized but not treated|0
674803|NCT01730040|2185340|P1|Overall Study|Randomized but not treated|0
674804|NCT01729871|2185519|P2|Overall Study|Unspecified|9
674805|NCT01729871|2185520|P1|Overall Study|Unspecified|4
674806|NCT01729871|2185519|P2|Overall Study|Withdrawal by Subject|3
674807|NCT01729871|2185520|P1|Overall Study|Withdrawal by Subject|0
674808|NCT01729871|2185519|P2|Overall Study|Protocol Violation|0
674809|NCT01729871|2185520|P1|Overall Study|Protocol Violation|1
674810|NCT01729871|2185519|P2|Overall Study|Physician Decision|2
674811|NCT01729871|2185520|P1|Overall Study|Physician Decision|0
674812|NCT01729871|2185519|P2|Overall Study|Lack of Efficacy|1
674813|NCT01729871|2185520|P1|Overall Study|Lack of Efficacy|0
674814|NCT01729871|2185519|P2|Overall Study|Death|1
674815|NCT01729871|2185520|P1|Overall Study|Death|0
674816|NCT01729871|2185519|P2|Overall Study|Adverse Event|7
674817|NCT01729871|2185520|P1|Overall Study|Adverse Event|7
674818|NCT01729728|2185539|P3|Overall Study|Protocol Violation|1
674819|NCT01729728|2185540|P2|Overall Study|Protocol Violation|0
674820|NCT01729728|2185541|P1|Overall Study|Protocol Violation|1
674821|NCT01729728|2185539|P3|Overall Study|Adverse Event|0
674822|NCT01729728|2185540|P2|Overall Study|Adverse Event|6
674823|NCT01729728|2185541|P1|Overall Study|Adverse Event|0
674824|NCT01729559|2185674|P2|Overall Study|Protocol Violation|28
674825|NCT01729559|2185675|P1|Overall Study|Protocol Violation|31
674826|NCT01729026|2185718|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
674827|NCT01729026|2185719|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
674828|NCT01729026|2185718|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
674829|NCT01729026|2185719|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
674830|NCT01728792|2185730|P5|Overall Study|Lost to Follow-up|0
674831|NCT01728792|2185731|P4|Overall Study|Lost to Follow-up|2
674832|NCT01728792|2185732|P3|Overall Study|Lost to Follow-up|4
674833|NCT01728792|2185733|P2|Overall Study|Lost to Follow-up|1
674834|NCT01728792|2185734|P1|Overall Study|Lost to Follow-up|2
674835|NCT01728792|2185730|P5|Overall Study|Withdrawal of Consent|0
674836|NCT01728792|2185731|P4|Overall Study|Withdrawal of Consent|1
674837|NCT01728792|2185732|P3|Overall Study|Withdrawal of Consent|0
674838|NCT01728792|2185733|P2|Overall Study|Withdrawal of Consent|1
674839|NCT01728792|2185734|P1|Overall Study|Withdrawal of Consent|1
674840|NCT01728584|2185785|P4|Overall Study|Other reason (not specified)|1
674841|NCT01728584|2185786|P3|Overall Study|Other reason (not specified)|0
674842|NCT01728584|2185787|P2|Overall Study|Other reason (not specified)|0
674843|NCT01728584|2185788|P1|Overall Study|Other reason (not specified)|1
674844|NCT01728584|2185785|P4|Overall Study|Screen failure|0
674845|NCT01728584|2185786|P3|Overall Study|Screen failure|0
674846|NCT01728584|2185787|P2|Overall Study|Screen failure|0
674847|NCT01728584|2185788|P1|Overall Study|Screen failure|1
674848|NCT01728584|2185785|P4|Overall Study|Withdrawal by Subject|0
674849|NCT01728584|2185786|P3|Overall Study|Withdrawal by Subject|0
674850|NCT01728584|2185787|P2|Overall Study|Withdrawal by Subject|0
674851|NCT01728584|2185788|P1|Overall Study|Withdrawal by Subject|1
674852|NCT01728584|2185785|P4|Overall Study|Physician Decision|0
674853|NCT01728584|2185786|P3|Overall Study|Physician Decision|1
674854|NCT01728584|2185787|P2|Overall Study|Physician Decision|0
674855|NCT01728584|2185788|P1|Overall Study|Physician Decision|4
674856|NCT01728584|2185785|P4|Overall Study|Adverse Event|0
674857|NCT01728584|2185786|P3|Overall Study|Adverse Event|0
674858|NCT01728584|2185787|P2|Overall Study|Adverse Event|0
674859|NCT01728584|2185788|P1|Overall Study|Adverse Event|1
674860|NCT01728376|2185846|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
674861|NCT01728376|2185847|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
674862|NCT01728376|2185848|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
674863|NCT01728376|2185849|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
674864|NCT01728376|2185850|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
674865|NCT01728376|2185851|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
674866|NCT01728376|2185846|P6|Overall Study|Did not receive treatment|0
674867|NCT01728376|2185847|P5|Overall Study|Did not receive treatment|0
674868|NCT01728376|2185848|P4|Overall Study|Did not receive treatment|0
674869|NCT01728376|2185849|P3|Overall Study|Did not receive treatment|0
674870|NCT01728376|2185850|P2|Overall Study|Did not receive treatment|1
674871|NCT01728376|2185851|P1|Overall Study|Did not receive treatment|0
674872|NCT01728376|2185846|P6|Overall Study|No relevant bacteria|1
674873|NCT01728376|2185847|P5|Overall Study|No relevant bacteria|1
674874|NCT01728376|2185848|P4|Overall Study|No relevant bacteria|0
674875|NCT01728376|2185849|P3|Overall Study|No relevant bacteria|0
674876|NCT01728376|2185850|P2|Overall Study|No relevant bacteria|0
674877|NCT01728376|2185851|P1|Overall Study|No relevant bacteria|2
674878|NCT01728376|2185846|P6|Overall Study|Persistent Positive Blood Cultures|0
674879|NCT01728376|2185847|P5|Overall Study|Persistent Positive Blood Cultures|0
674880|NCT01728376|2185848|P4|Overall Study|Persistent Positive Blood Cultures|0
674881|NCT01728376|2185849|P3|Overall Study|Persistent Positive Blood Cultures|1
674882|NCT01728376|2185850|P2|Overall Study|Persistent Positive Blood Cultures|0
674883|NCT01728376|2185851|P1|Overall Study|Persistent Positive Blood Cultures|1
674884|NCT01728376|2185846|P6|Overall Study|Adverse Event|0
674885|NCT01728376|2185847|P5|Overall Study|Adverse Event|1
674886|NCT01728376|2185848|P4|Overall Study|Adverse Event|1
674887|NCT01728376|2185849|P3|Overall Study|Adverse Event|1
674888|NCT01728376|2185850|P2|Overall Study|Adverse Event|1
674889|NCT01728376|2185851|P1|Overall Study|Adverse Event|1
674890|NCT01728324|2185924|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
674891|NCT01728324|2185925|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
674892|NCT01728324|2185926|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
674893|NCT01728324|2185924|P3|Termination of RBV|Adverse Event (Placebo Period)|0
674894|NCT01728324|2185925|P2|Termination of RBV|Adverse Event (Placebo Period)|1
674895|NCT01728324|2185926|P1|Termination of RBV|Adverse Event (Placebo Period)|0
674896|NCT01728324|2185924|P3|Termination of RBV|Other than stated|1
674897|NCT01728324|2185925|P2|Termination of RBV|Other than stated|3
674898|NCT01728324|2185926|P1|Termination of RBV|Other than stated|1
674899|NCT01728324|2185924|P3|Termination of RBV|Withdrawal by Subject|2
674900|NCT01728324|2185925|P2|Termination of RBV|Withdrawal by Subject|5
674901|NCT01728324|2185926|P1|Termination of RBV|Withdrawal by Subject|9
674902|NCT01728324|2185924|P3|Termination of RBV|Lack of Efficacy|7
674903|NCT01728324|2185925|P2|Termination of RBV|Lack of Efficacy|11
674904|NCT01728324|2185926|P1|Termination of RBV|Lack of Efficacy|14
674905|NCT01728324|2185924|P3|Termination of RBV|Adverse Event|5
674906|NCT01728324|2185925|P2|Termination of RBV|Adverse Event|16
674907|NCT01728324|2185926|P1|Termination of RBV|Adverse Event|15
674908|NCT01728324|2185924|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
674909|NCT01728324|2185925|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
674910|NCT01728324|2185926|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
674911|NCT01728324|2185924|P3|Termination of FDV|Adverse Event (Placebo Period)|0
674912|NCT01728324|2185925|P2|Termination of FDV|Adverse Event (Placebo Period)|1
674913|NCT01728324|2185926|P1|Termination of FDV|Adverse Event (Placebo Period)|0
674914|NCT01728324|2185924|P3|Termination of FDV|Other than stated|0
674915|NCT01728324|2185925|P2|Termination of FDV|Other than stated|3
674916|NCT01728324|2185926|P1|Termination of FDV|Other than stated|1
674917|NCT01728324|2185924|P3|Termination of FDV|Withdrawal by Subject|2
674918|NCT01728324|2185925|P2|Termination of FDV|Withdrawal by Subject|6
674919|NCT01728324|2185926|P1|Termination of FDV|Withdrawal by Subject|9
674920|NCT01728324|2185924|P3|Termination of FDV|Lack of Efficacy|8
674921|NCT01728324|2185925|P2|Termination of FDV|Lack of Efficacy|12
674922|NCT01728324|2185926|P1|Termination of FDV|Lack of Efficacy|14
674923|NCT01728324|2185924|P3|Termination of FDV|Adverse Event|4
674924|NCT01728324|2185925|P2|Termination of FDV|Adverse Event|13
674925|NCT01728324|2185926|P1|Termination of FDV|Adverse Event|14
674926|NCT01728324|2185924|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
674927|NCT01728324|2185925|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
674928|NCT01728324|2185926|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
674929|NCT01728324|2185924|P3|Termination of DBV|Adverse Event (Placebo Period)|0
674930|NCT01728324|2185925|P2|Termination of DBV|Adverse Event (Placebo Period)|1
674931|NCT01728324|2185926|P1|Termination of DBV|Adverse Event (Placebo Period)|0
674932|NCT01728324|2185924|P3|Termination of DBV|Other than stated|0
674933|NCT01728324|2185925|P2|Termination of DBV|Other than stated|3
674934|NCT01728324|2185926|P1|Termination of DBV|Other than stated|1
674935|NCT01728324|2185924|P3|Termination of DBV|Withdrawal by Subject|2
674936|NCT01728324|2185925|P2|Termination of DBV|Withdrawal by Subject|6
674937|NCT01728324|2185926|P1|Termination of DBV|Withdrawal by Subject|9
674938|NCT01728324|2185924|P3|Termination of DBV|Lack of Efficacy|8
674939|NCT01728324|2185925|P2|Termination of DBV|Lack of Efficacy|12
674940|NCT01728324|2185926|P1|Termination of DBV|Lack of Efficacy|14
674941|NCT01728324|2185924|P3|Termination of DBV|Adverse Event|4
674942|NCT01728324|2185925|P2|Termination of DBV|Adverse Event|13
674943|NCT01728324|2185926|P1|Termination of DBV|Adverse Event|14
674944|NCT01728246|2185947|P2|Overall Study|Adverse Event|5
674945|NCT01728246|2185948|P1|Overall Study|Adverse Event|8
674946|NCT01728246|2185947|P2|Overall Study|Lack of Efficacy|1
674947|NCT01728246|2185948|P1|Overall Study|Lack of Efficacy|1
674948|NCT01728246|2185947|P2|Overall Study|Lost to Follow-up|22
674949|NCT01728246|2185948|P1|Overall Study|Lost to Follow-up|23
674950|NCT01728246|2185947|P2|Overall Study|Withdrawal by Subject|3
674951|NCT01728246|2185948|P1|Overall Study|Withdrawal by Subject|2
674952|NCT01728246|2185947|P2|Overall Study|Protocol Violation|0
674953|NCT01728246|2185948|P1|Overall Study|Protocol Violation|1
674954|NCT01728246|2185947|P2|Overall Study|Participant needed rescue medication|5
674955|NCT01728246|2185948|P1|Overall Study|Participant needed rescue medication|1
674956|NCT01728116|2185966|P2|Overall Study|various not noted previously|0
674957|NCT01728116|2185967|P1|Overall Study|various not noted previously|5
674958|NCT01728116|2185966|P2|Overall Study|Incorrectly enrolled in Study|1
674959|NCT01728116|2185967|P1|Overall Study|Incorrectly enrolled in Study|0
674960|NCT01728116|2185966|P2|Overall Study|Inter-current finding at procedure|0
674961|NCT01728116|2185967|P1|Overall Study|Inter-current finding at procedure|1
674962|NCT01728116|2185966|P2|Overall Study|Subject Non-Compliance|0
674963|NCT01728116|2185967|P1|Overall Study|Subject Non-Compliance|2
674964|NCT01728116|2185966|P2|Overall Study|Physician Decision|0
674965|NCT01728116|2185967|P1|Overall Study|Physician Decision|2
674966|NCT01728116|2185966|P2|Overall Study|Lost to Follow-up|2
674967|NCT01728116|2185967|P1|Overall Study|Lost to Follow-up|9
674968|NCT01728116|2185966|P2|Overall Study|Procedure/device failure|0
674969|NCT01728116|2185967|P1|Overall Study|Procedure/device failure|7
674970|NCT01728116|2185966|P2|Overall Study|Adverse Event|0
674971|NCT01728116|2185967|P1|Overall Study|Adverse Event|13
674972|NCT01728116|2185966|P2|Overall Study|Withdrawal by Subject|9
674973|NCT01728116|2185967|P1|Overall Study|Withdrawal by Subject|16
674974|NCT01728116|2185966|P2|Overall Study|Sponsor Terminated Study|35
674975|NCT01728116|2185967|P1|Overall Study|Sponsor Terminated Study|106
674976|NCT01728077|2185992|P2|Overall Study|Non compliance|0
674977|NCT01728077|2185993|P1|Overall Study|Non compliance|1
674978|NCT01728077|2185992|P2|Overall Study|Patient moving|0
674979|NCT01728077|2185993|P1|Overall Study|Patient moving|1
674980|NCT01728077|2185992|P2|Overall Study|Death|1
674981|NCT01728077|2185993|P1|Overall Study|Death|0
674982|NCT01728077|2185992|P2|Overall Study|Subject choice|3
674983|NCT01728077|2185993|P1|Overall Study|Subject choice|2
674984|NCT01728077|2185992|P2|Overall Study|Lost to Follow-up|0
674985|NCT01728077|2185993|P1|Overall Study|Lost to Follow-up|1
674986|NCT01728077|2185992|P2|Overall Study|Lack of Efficacy|1
674987|NCT01728077|2185993|P1|Overall Study|Lack of Efficacy|3
674988|NCT01727713|2186045|P1|Overall Study|Protocol Deviation|2
674989|NCT01727713|2186045|P1|Overall Study|Withdrawal by Subject|13
674990|NCT01727713|2186045|P1|Overall Study|Participant Met Withdrawal Criteria|5
674991|NCT01727713|2186045|P1|Overall Study|Adverse Event|10
674992|NCT01727713|2186045|P1|Overall Study|Lost to Follow-up|5
674993|NCT01727700|2186072|P3|Overall Study|Protocol Violation|0
674994|NCT01727700|2186073|P2|Overall Study|Protocol Violation|0
674995|NCT01727700|2186074|P1|Overall Study|Protocol Violation|2
674996|NCT01727700|2186072|P3|Overall Study|Particpant withdrew consent|1
674997|NCT01727700|2186073|P2|Overall Study|Particpant withdrew consent|3
674998|NCT01727700|2186074|P1|Overall Study|Particpant withdrew consent|0
674999|NCT01727700|2186072|P3|Overall Study|Adverse Event|1
675000|NCT01727700|2186073|P2|Overall Study|Adverse Event|7
675001|NCT01727700|2186074|P1|Overall Study|Adverse Event|0
675002|NCT01727505|2186097|P2|Second 24 Hours|Missing data|1
675003|NCT01727505|2186098|P1|Second 24 Hours|Missing data|0
675004|NCT01727505|2186097|P2|First 24 Hours|Adverse Event|1
675005|NCT01727505|2186098|P1|First 24 Hours|Adverse Event|0
675006|NCT01727258|2186126|P3|Overall Study|Lost to Follow-up|0
675007|NCT01727258|2186127|P2|Overall Study|Lost to Follow-up|0
675008|NCT01727258|2186128|P1|Overall Study|Lost to Follow-up|1
675009|NCT01727258|2186126|P3|Overall Study|Withdrawal by Subject|0
675010|NCT01727258|2186127|P2|Overall Study|Withdrawal by Subject|1
675011|NCT01727258|2186128|P1|Overall Study|Withdrawal by Subject|1
675012|NCT01727258|2186126|P3|Overall Study|Noncompliance with Study Drug|1
675013|NCT01727258|2186127|P2|Overall Study|Noncompliance with Study Drug|0
675014|NCT01727258|2186128|P1|Overall Study|Noncompliance with Study Drug|0
675015|NCT01727258|2186126|P3|Overall Study|Adverse Event|0
675016|NCT01727258|2186127|P2|Overall Study|Adverse Event|2
675017|NCT01727258|2186128|P1|Overall Study|Adverse Event|0
675018|NCT01727141|2186170|P4|Overall Study|Withdrawal by Subject|11
675019|NCT01727141|2186171|P3|Overall Study|Withdrawal by Subject|2
675020|NCT01727141|2186172|P2|Overall Study|Withdrawal by Subject|4
675021|NCT01727141|2186173|P1|Overall Study|Withdrawal by Subject|4
675022|NCT01727141|2186170|P4|Overall Study|Protocol deviation|1
675023|NCT01727141|2186171|P3|Overall Study|Protocol deviation|0
675024|NCT01727141|2186172|P2|Overall Study|Protocol deviation|1
675025|NCT01727141|2186173|P1|Overall Study|Protocol deviation|1
675026|NCT01727141|2186170|P4|Overall Study|Death|1
675027|NCT01727141|2186171|P3|Overall Study|Death|1
675028|NCT01727141|2186172|P2|Overall Study|Death|1
675029|NCT01727141|2186173|P1|Overall Study|Death|0
675030|NCT01727141|2186170|P4|Overall Study|Lost to Follow-up|0
675031|NCT01727141|2186171|P3|Overall Study|Lost to Follow-up|0
675032|NCT01727141|2186172|P2|Overall Study|Lost to Follow-up|2
675033|NCT01727141|2186173|P1|Overall Study|Lost to Follow-up|0
675034|NCT01727141|2186170|P4|Overall Study|Physician Decision|2
675035|NCT01727141|2186171|P3|Overall Study|Physician Decision|0
675036|NCT01727141|2186172|P2|Overall Study|Physician Decision|1
675037|NCT01727141|2186173|P1|Overall Study|Physician Decision|0
675038|NCT01727024|2186223|P2|Period 1|Withdrawal by Subject|3
675039|NCT01727024|2186224|P1|Period 1|Withdrawal by Subject|2
675040|NCT01727024|2186223|P2|Period 1|Lost to Follow-up|1
675041|NCT01727024|2186224|P1|Period 1|Lost to Follow-up|1
675042|NCT01726517|2186246|P5|Overall Study|Withdrawal by Subject|0
675043|NCT01726517|2186247|P4|Overall Study|Withdrawal by Subject|0
675044|NCT01726517|2186248|P3|Overall Study|Withdrawal by Subject|1
675045|NCT01726517|2186249|P2|Overall Study|Withdrawal by Subject|0
675046|NCT01726517|2186250|P1|Overall Study|Withdrawal by Subject|0
675047|NCT01726335|2186306|P1|Overall Study|Exacerbation of psychotic symptoms|1
675048|NCT01726335|2186306|P1|Overall Study|Lost to Follow-up|2
675049|NCT01726335|2186306|P1|Overall Study|Adverse Event|4
675050|NCT01726335|2186306|P1|Overall Study|Withdrawal by Subject|15
675051|NCT01726335|2186306|P1|Overall Study|Lost to Follow-up|2
675052|NCT01726049|2186324|P2|Overall Study|refused second HC|2
675053|NCT01726049|2186325|P1|Overall Study|refused second HC|0
675054|NCT01726049|2186324|P2|Overall Study|Adverse Event|1
675055|NCT01726049|2186325|P1|Overall Study|Adverse Event|4
675056|NCT01726049|2186324|P2|Overall Study|Death|1
675057|NCT01726049|2186325|P1|Overall Study|Death|1
675058|NCT01726023|2186339|P2|Overall Study|Withdrawal by Subject|8
675059|NCT01726023|2186340|P1|Overall Study|Withdrawal by Subject|16
675060|NCT01726023|2186339|P2|Overall Study|Other Eligibility criteria|7
675061|NCT01726023|2186340|P1|Overall Study|Other Eligibility criteria|7
675062|NCT01726023|2186339|P2|Overall Study|Lost to Follow-up|10
675063|NCT01726023|2186340|P1|Overall Study|Lost to Follow-up|5
675064|NCT01726023|2186339|P2|Overall Study|Death|1
675065|NCT01726023|2186340|P1|Overall Study|Death|1
675066|NCT01725529|2186460|P3|Overall Study|Withdrawal by Subject|8
675067|NCT01725529|2186461|P2|Overall Study|Withdrawal by Subject|14
675068|NCT01725529|2186462|P1|Overall Study|Withdrawal by Subject|12
675069|NCT01725529|2186460|P3|Overall Study|Protocol Violation|1
675070|NCT01725529|2186461|P2|Overall Study|Protocol Violation|1
675071|NCT01725529|2186462|P1|Overall Study|Protocol Violation|0
675072|NCT01725529|2186460|P3|Overall Study|Lost to Follow-up|1
675073|NCT01725529|2186461|P2|Overall Study|Lost to Follow-up|1
675074|NCT01725529|2186462|P1|Overall Study|Lost to Follow-up|2
675075|NCT01725529|2186460|P3|Overall Study|Adverse Event|0
675076|NCT01725529|2186461|P2|Overall Study|Adverse Event|0
675077|NCT01725529|2186462|P1|Overall Study|Adverse Event|1
675078|NCT01725451|2186488|P4|Period 4|Adverse Event|0
675079|NCT01725451|2186489|P3|Period 4|Adverse Event|1
675080|NCT01725451|2186490|P2|Period 4|Adverse Event|0
675081|NCT01725451|2186491|P1|Period 4|Adverse Event|0
675082|NCT01725451|2186488|P4|Washout From Period 3|Adverse Event|0
675083|NCT01725451|2186489|P3|Washout From Period 3|Adverse Event|0
675084|NCT01725451|2186490|P2|Washout From Period 3|Adverse Event|1
675085|NCT01725451|2186491|P1|Washout From Period 3|Adverse Event|0
675086|NCT01725451|2186488|P4|Washout From Period 3|Protocol Violation|0
675087|NCT01725451|2186489|P3|Washout From Period 3|Protocol Violation|1
675088|NCT01725451|2186490|P2|Washout From Period 3|Protocol Violation|0
675089|NCT01725451|2186491|P1|Washout From Period 3|Protocol Violation|0
675090|NCT01725451|2186488|P4|Period 1|Withdrawal by Subject|0
675091|NCT01725451|2186489|P3|Period 1|Withdrawal by Subject|0
675092|NCT01725451|2186490|P2|Period 1|Withdrawal by Subject|0
675093|NCT01725451|2186491|P1|Period 1|Withdrawal by Subject|1
675094|NCT01725386|2186513|P2|Overall Study|Withdrawal by Subject|0
675095|NCT01725386|2186514|P1|Overall Study|Withdrawal by Subject|10
675096|NCT01725386|2186513|P2|Overall Study|Lost to Follow-up|6
675097|NCT01725386|2186514|P1|Overall Study|Lost to Follow-up|81
675098|NCT01725386|2186513|P2|Overall Study|Death|40
675099|NCT01725386|2186514|P1|Overall Study|Death|84
675100|NCT01725308|2186533|P3|Overall Study|Miscellaneous|3
675101|NCT01725308|2186534|P2|Overall Study|Miscellaneous|0
675102|NCT01725308|2186535|P1|Overall Study|Miscellaneous|2
675103|NCT01725308|2186533|P3|Overall Study|Protocol Deviations|1
675104|NCT01725308|2186534|P2|Overall Study|Protocol Deviations|1
675105|NCT01725308|2186535|P1|Overall Study|Protocol Deviations|3
675106|NCT01725308|2186533|P3|Overall Study|Lost to Follow-up|2
675107|NCT01725308|2186534|P2|Overall Study|Lost to Follow-up|2
675108|NCT01725308|2186535|P1|Overall Study|Lost to Follow-up|3
675109|NCT01725308|2186533|P3|Overall Study|Subject Consent Withdrawal|5
675110|NCT01725308|2186534|P2|Overall Study|Subject Consent Withdrawal|7
675111|NCT01725308|2186535|P1|Overall Study|Subject Consent Withdrawal|12
675112|NCT01725308|2186533|P3|Overall Study|Episode Change|2
675113|NCT01725308|2186534|P2|Overall Study|Episode Change|0
675114|NCT01725308|2186535|P1|Overall Study|Episode Change|3
675115|NCT01725308|2186533|P3|Overall Study|Worsening of Underlying Disease|2
675116|NCT01725308|2186534|P2|Overall Study|Worsening of Underlying Disease|0
675117|NCT01725308|2186535|P1|Overall Study|Worsening of Underlying Disease|8
675118|NCT01725308|2186533|P3|Overall Study|Lack of Efficacy|5
675119|NCT01725308|2186534|P2|Overall Study|Lack of Efficacy|0
675120|NCT01725308|2186535|P1|Overall Study|Lack of Efficacy|7
675121|NCT01725308|2186533|P3|Overall Study|Adverse Event|21
675122|NCT01725308|2186534|P2|Overall Study|Adverse Event|4
675123|NCT01725308|2186535|P1|Overall Study|Adverse Event|5
675124|NCT01725308|2186533|P3|Overall Study|Did Not Receive Drug|0
675125|NCT01725308|2186534|P2|Overall Study|Did Not Receive Drug|0
675126|NCT01725308|2186535|P1|Overall Study|Did Not Receive Drug|1
675127|NCT01725282|2186589|P4|Overall Study|Lack of Efficacy|1
675128|NCT01725282|2186590|P3|Overall Study|Lack of Efficacy|0
675129|NCT01725282|2186591|P2|Overall Study|Lack of Efficacy|1
675130|NCT01725282|2186592|P1|Overall Study|Lack of Efficacy|0
675131|NCT01725282|2186589|P4|Overall Study|Withdrawal by Subject|1
675132|NCT01725282|2186590|P3|Overall Study|Withdrawal by Subject|1
675133|NCT01725282|2186591|P2|Overall Study|Withdrawal by Subject|0
675134|NCT01725282|2186592|P1|Overall Study|Withdrawal by Subject|0
675135|NCT01725282|2186589|P4|Overall Study|Study Site Withdrawal|0
675136|NCT01725282|2186590|P3|Overall Study|Study Site Withdrawal|0
675137|NCT01725282|2186591|P2|Overall Study|Study Site Withdrawal|1
675138|NCT01725282|2186592|P1|Overall Study|Study Site Withdrawal|0
675139|NCT01725282|2186589|P4|Overall Study|Met Exclusion Criteria|0
675140|NCT01725282|2186590|P3|Overall Study|Met Exclusion Criteria|1
675141|NCT01725282|2186591|P2|Overall Study|Met Exclusion Criteria|0
675142|NCT01725282|2186592|P1|Overall Study|Met Exclusion Criteria|0
675143|NCT01725282|2186589|P4|Overall Study|Exacerbation of Target Disease|1
675144|NCT01725282|2186590|P3|Overall Study|Exacerbation of Target Disease|0
675145|NCT01725282|2186591|P2|Overall Study|Exacerbation of Target Disease|0
675146|NCT01725282|2186592|P1|Overall Study|Exacerbation of Target Disease|1
675147|NCT01725282|2186589|P4|Overall Study|Adverse Event|4
675148|NCT01725282|2186590|P3|Overall Study|Adverse Event|6
675149|NCT01725282|2186591|P2|Overall Study|Adverse Event|3
675150|NCT01725282|2186592|P1|Overall Study|Adverse Event|1
675151|NCT01725217|2186625|P3|Overall Study|Withdrawal by Subject|0
675152|NCT01725217|2186626|P2|Overall Study|Withdrawal by Subject|0
675153|NCT01725217|2186627|P1|Overall Study|Withdrawal by Subject|1
675154|NCT01724528|2186657|P2|Overall Study|Patient refused to attend last visit|0
675155|NCT01724528|2186658|P1|Overall Study|Patient refused to attend last visit|1
675156|NCT01724528|2186657|P2|Overall Study|Protocol Violation|1
675157|NCT01724528|2186658|P1|Overall Study|Protocol Violation|0
675158|NCT01724528|2186657|P2|Overall Study|Withdrawal by Subject|2
675159|NCT01724528|2186658|P1|Overall Study|Withdrawal by Subject|0
675160|NCT01724528|2186657|P2|Overall Study|Death|0
675161|NCT01724528|2186658|P1|Overall Study|Death|3
675162|NCT01724359|2186672|P1|Overall Study|Not specified|20
675163|NCT01724359|2186672|P1|Overall Study|Death|1
675164|NCT01724359|2186672|P1|Overall Study|Adverse Event|10
675165|NCT01724216|2186685|P1|Overall Study|Scan was not completed|1
675166|NCT01724177|2186689|P1|Overall Study|Unspecified|2
675167|NCT01724177|2186689|P1|Overall Study|Progressive disease or Relapsed Disease|13
675168|NCT01724177|2186689|P1|Overall Study|Adverse Event|6
675169|NCT01724021|2186701|P2|Overall Study|Reason Not Specified|9
675170|NCT01724021|2186702|P1|Overall Study|Reason Not Specified|6
675171|NCT01724021|2186701|P2|Overall Study|Lack of Compliance|1
675172|NCT01724021|2186702|P1|Overall Study|Lack of Compliance|0
675173|NCT01724021|2186701|P2|Overall Study|Lost to Follow-up|7
675174|NCT01724021|2186702|P1|Overall Study|Lost to Follow-up|0
675175|NCT01724021|2186701|P2|Overall Study|Participant request/ Withdrew consent|10
675176|NCT01724021|2186702|P1|Overall Study|Participant request/ Withdrew consent|13
675177|NCT01724021|2186701|P2|Overall Study|Death|29
675178|NCT01724021|2186702|P1|Overall Study|Death|24
675179|NCT01724021|2186701|P2|Overall Study|Adverse Event|4
675180|NCT01724021|2186702|P1|Overall Study|Adverse Event|5
675181|NCT01723904|2186734|P1|Overall Study|Unable to follow protocol/ judged by inv|3
675182|NCT01723904|2186734|P1|Overall Study|Adverse Event|5
675183|NCT01723904|2186734|P1|Overall Study|Noncompliant|3
675184|NCT01723397|2186755|P2|Study Period 2|Protocol Violation|1
675185|NCT01723397|2186756|P1|Study Period 2|Protocol Violation|0
675186|NCT01723397|2186755|P2|Study Period 1|Protocol Violation|1
675187|NCT01723397|2186756|P1|Study Period 1|Protocol Violation|0
675188|NCT01723254|2186770|P8|Overall Study|Withdrawal by Subject|2
675189|NCT01723254|2186771|P7|Overall Study|Withdrawal by Subject|1
675190|NCT01723254|2186772|P6|Overall Study|Withdrawal by Subject|1
675191|NCT01723254|2186773|P5|Overall Study|Withdrawal by Subject|1
675192|NCT01723254|2186774|P4|Overall Study|Withdrawal by Subject|0
675193|NCT01723254|2186775|P3|Overall Study|Withdrawal by Subject|1
675194|NCT01723254|2186776|P2|Overall Study|Withdrawal by Subject|2
675195|NCT01723254|2186777|P1|Overall Study|Withdrawal by Subject|1
675196|NCT01723254|2186770|P8|Overall Study|Protocol Violation|0
675197|NCT01723254|2186771|P7|Overall Study|Protocol Violation|0
675198|NCT01723254|2186772|P6|Overall Study|Protocol Violation|0
675199|NCT01723254|2186773|P5|Overall Study|Protocol Violation|0
675200|NCT01723254|2186774|P4|Overall Study|Protocol Violation|0
675201|NCT01723254|2186775|P3|Overall Study|Protocol Violation|0
675202|NCT01723254|2186776|P2|Overall Study|Protocol Violation|1
675203|NCT01723254|2186777|P1|Overall Study|Protocol Violation|0
675204|NCT01723254|2186770|P8|Overall Study|Move/Left to another country/city|0
675205|NCT01723254|2186771|P7|Overall Study|Move/Left to another country/city|0
675206|NCT01723254|2186772|P6|Overall Study|Move/Left to another country/city|0
675207|NCT01723254|2186773|P5|Overall Study|Move/Left to another country/city|1
675208|NCT01723254|2186774|P4|Overall Study|Move/Left to another country/city|1
675209|NCT01723254|2186775|P3|Overall Study|Move/Left to another country/city|2
675210|NCT01723254|2186776|P2|Overall Study|Move/Left to another country/city|0
675211|NCT01723254|2186777|P1|Overall Study|Move/Left to another country/city|0
675212|NCT01723254|2186770|P8|Overall Study|No longer have time to participate|0
675213|NCT01723254|2186771|P7|Overall Study|No longer have time to participate|0
675214|NCT01723254|2186772|P6|Overall Study|No longer have time to participate|0
675215|NCT01723254|2186773|P5|Overall Study|No longer have time to participate|0
675216|NCT01723254|2186774|P4|Overall Study|No longer have time to participate|1
675217|NCT01723254|2186775|P3|Overall Study|No longer have time to participate|0
675218|NCT01723254|2186776|P2|Overall Study|No longer have time to participate|0
675219|NCT01723254|2186777|P1|Overall Study|No longer have time to participate|0
675220|NCT01723254|2186770|P8|Overall Study|Personal issues|0
675221|NCT01723254|2186771|P7|Overall Study|Personal issues|0
675222|NCT01723254|2186772|P6|Overall Study|Personal issues|1
675223|NCT01723254|2186773|P5|Overall Study|Personal issues|0
675224|NCT01723254|2186774|P4|Overall Study|Personal issues|0
675225|NCT01723254|2186775|P3|Overall Study|Personal issues|0
675226|NCT01723254|2186776|P2|Overall Study|Personal issues|0
675227|NCT01723254|2186777|P1|Overall Study|Personal issues|0
675228|NCT01723254|2186770|P8|Overall Study|Conflict with work schedule|1
675229|NCT01723254|2186771|P7|Overall Study|Conflict with work schedule|0
675230|NCT01723254|2186772|P6|Overall Study|Conflict with work schedule|0
675231|NCT01723254|2186773|P5|Overall Study|Conflict with work schedule|0
675232|NCT01723254|2186774|P4|Overall Study|Conflict with work schedule|0
675233|NCT01723254|2186775|P3|Overall Study|Conflict with work schedule|0
675234|NCT01723254|2186776|P2|Overall Study|Conflict with work schedule|0
675235|NCT01723254|2186777|P1|Overall Study|Conflict with work schedule|0
675236|NCT01723228|2186829|P2|Overall Study|Not Specified|1
675237|NCT01723228|2186830|P1|Overall Study|Not Specified|2
675238|NCT01723228|2186829|P2|Overall Study|Lost to Follow-up|1
675239|NCT01723228|2186830|P1|Overall Study|Lost to Follow-up|2
675240|NCT01723228|2186829|P2|Overall Study|Protocol Violation|2
675241|NCT01723228|2186830|P1|Overall Study|Protocol Violation|0
675242|NCT01723228|2186829|P2|Overall Study|Withdrawal by Subject|1
675243|NCT01723228|2186830|P1|Overall Study|Withdrawal by Subject|2
675244|NCT01723228|2186829|P2|Overall Study|Adverse Event|6
675245|NCT01723228|2186830|P1|Overall Study|Adverse Event|2
675246|NCT01722994|2186848|P2|Overall Study|Missing data|17
675247|NCT01722994|2186849|P1|Overall Study|Missing data|25
675248|NCT01722877|2186863|P1|Overall Study|Lost to Follow-up|1
675249|NCT01722877|2186863|P1|Overall Study|Death|1
675250|NCT01722266|2186924|P4|Overall Study|Dropped out due to Nausea|0
675251|NCT01722266|2186925|P3|Overall Study|Dropped out due to Nausea|2
675252|NCT01722266|2186926|P2|Overall Study|Dropped out due to Nausea|0
675253|NCT01722266|2186927|P1|Overall Study|Dropped out due to Nausea|0
675254|NCT01722266|2186924|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
675255|NCT01722266|2186925|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
675256|NCT01722266|2186926|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
675257|NCT01722266|2186927|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
675258|NCT01722266|2186924|P4|Overall Study|Withdrawal by Subject|0
675259|NCT01722266|2186925|P3|Overall Study|Withdrawal by Subject|0
675260|NCT01722266|2186926|P2|Overall Study|Withdrawal by Subject|2
675261|NCT01722266|2186927|P1|Overall Study|Withdrawal by Subject|1
675262|NCT01722162|2186955|P2|Overall Study|Noncompliance|1
675263|NCT01722162|2186956|P1|Overall Study|Noncompliance|0
675264|NCT01722162|2186955|P2|Overall Study|Insurance denial post enrollment|1
675265|NCT01722162|2186956|P1|Overall Study|Insurance denial post enrollment|0
675266|NCT01722162|2186955|P2|Overall Study|Adverse Event|1
675267|NCT01722162|2186956|P1|Overall Study|Adverse Event|1
675268|NCT01722162|2186955|P2|Overall Study|Unrelated to study adverse event|2
675269|NCT01722162|2186956|P1|Overall Study|Unrelated to study adverse event|2
675270|NCT01722162|2186955|P2|Overall Study|Found ineligible|0
675271|NCT01722162|2186956|P1|Overall Study|Found ineligible|1
675272|NCT01722162|2186955|P2|Overall Study|Withdrawal by Subject|1
675273|NCT01722162|2186956|P1|Overall Study|Withdrawal by Subject|1
675274|NCT01722097|2186966|P2|Overall Study|Patient sheets not returned|5
675275|NCT01722097|2186967|P1|Overall Study|Patient sheets not returned|6
675276|NCT01722071|2186975|P2|Overall Study|Protocol Violation|0
675277|NCT01722071|2186976|P1|Overall Study|Protocol Violation|1
675278|NCT01721772|2186997|P2|Overall Study|Not specified|1
675279|NCT01721772|2186998|P1|Overall Study|Not specified|0
675280|NCT01721772|2186997|P2|Overall Study|Maximum clinical benefit|1
675281|NCT01721772|2186998|P1|Overall Study|Maximum clinical benefit|1
675282|NCT01721772|2186997|P2|Overall Study|Withdrawal by Subject|5
675283|NCT01721772|2186998|P1|Overall Study|Withdrawal by Subject|7
675284|NCT01721772|2186997|P2|Overall Study|Unrelated adverse event|3
675285|NCT01721772|2186998|P1|Overall Study|Unrelated adverse event|2
675286|NCT01721772|2186997|P2|Overall Study|Study drug toxicity|7
675287|NCT01721772|2186998|P1|Overall Study|Study drug toxicity|5
675288|NCT01721772|2186997|P2|Overall Study|Disease progression|175
675289|NCT01721772|2186998|P1|Overall Study|Disease progression|96
888853|NCT01782495|2822672|P1|Overall Study|Adverse Event|0
888854|NCT01780506|2822731|P2|Overall Study|Still on Study|388
888855|NCT01780506|2822732|P1|Overall Study|Still on Study|401
888856|NCT01780506|2822731|P2|Overall Study|Lost to Follow-up|14
888857|NCT01780506|2822732|P1|Overall Study|Lost to Follow-up|10
888858|NCT01780506|2822731|P2|Overall Study|Withdrew Consent|15
888859|NCT01780506|2822732|P1|Overall Study|Withdrew Consent|13
888860|NCT01780506|2822731|P2|Overall Study|Protocol Violation|3
888861|NCT01780506|2822732|P1|Overall Study|Protocol Violation|3
888862|NCT01780506|2822731|P2|Overall Study|Non-Compliance with Study Drug|1
888863|NCT01780506|2822732|P1|Overall Study|Non-Compliance with Study Drug|1
888864|NCT01780506|2822731|P2|Overall Study|Investigator's Discretion|1
888865|NCT01780506|2822732|P1|Overall Study|Investigator's Discretion|2
888866|NCT01780506|2822731|P2|Overall Study|Lack of Efficacy|1
888867|NCT01780506|2822732|P1|Overall Study|Lack of Efficacy|1
888868|NCT01780506|2822731|P2|Overall Study|Pregnancy|0
888869|NCT01780506|2822732|P1|Overall Study|Pregnancy|1
888870|NCT01780506|2822731|P2|Overall Study|Death|1
888871|NCT01780506|2822732|P1|Overall Study|Death|0
888872|NCT01780506|2822731|P2|Overall Study|Adverse Event|8
888873|NCT01780506|2822732|P1|Overall Study|Adverse Event|3
888874|NCT01780506|2822731|P2|Overall Study|Randomized but not Treated|2
888875|NCT01780506|2822732|P1|Overall Study|Randomized but not Treated|3
675321|NCT01721486|2187051|P2|Overall Study|Physician Decision|1
675322|NCT01721486|2187052|P1|Overall Study|Physician Decision|0
675323|NCT01721486|2187051|P2|Overall Study|Protocol Violation|0
675324|NCT01721486|2187052|P1|Overall Study|Protocol Violation|1
675325|NCT01721330|2187066|P2|Overall Study|Withdrawal by Subject|1
675326|NCT01721330|2187067|P1|Overall Study|Withdrawal by Subject|0
675327|NCT01721317|2187075|P2|Overall Study|Withdrawal by Subject|1
675328|NCT01721317|2187076|P1|Overall Study|Withdrawal by Subject|0
675329|NCT01721317|2187075|P2|Overall Study|Physician Decision|1
675330|NCT01721317|2187076|P1|Overall Study|Physician Decision|0
675331|NCT01721317|2187075|P2|Overall Study|Study Closed / Terminated|2
675332|NCT01721317|2187076|P1|Overall Study|Study Closed / Terminated|2
675333|NCT01721161|2187155|P2|Overall Study|Not Specified|1
675334|NCT01721161|2187156|P1|Overall Study|Not Specified|0
675335|NCT01721161|2187155|P2|Overall Study|Withdrawal by Subject|1
675336|NCT01721161|2187156|P1|Overall Study|Withdrawal by Subject|1
675337|NCT01721161|2187155|P2|Overall Study|Lost to Follow-up|2
675338|NCT01721161|2187156|P1|Overall Study|Lost to Follow-up|1
675339|NCT01721161|2187155|P2|Overall Study|Adverse Event|3
675340|NCT01721161|2187156|P1|Overall Study|Adverse Event|2
675341|NCT01721109|2187179|P1|Extension Phase|Still on Study|35
675342|NCT01721109|2187179|P1|Extension Phase|Non-Compliance with Study Drug|2
675343|NCT01721109|2187179|P1|Main Phase|Non-Compliance with Study Drug|1
675344|NCT01721070|2187285|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
675401|NCT01720797|2187374|P2|Overall Study|Withdrawal by Subject|0
675402|NCT01720797|2187375|P1|Overall Study|Withdrawal by Subject|3
675403|NCT01720602|2187381|P1|Overall Study|Progressive disease on therapy|2
675404|NCT01720602|2187381|P1|Overall Study|Adverse Event|3
675405|NCT01720043|2187449|P1|Overall Study|Withdrawal by Subject|1
675406|NCT01719861|2187453|P1|Cycle 2|Death|1
675407|NCT01719861|2187453|P1|Cycle 1|Death|4
675408|NCT01719757|2187461|P1|Overall Study|well controlled pain|27
675409|NCT01719757|2187461|P1|Overall Study|Protocol Violation|1
675410|NCT01719757|2187461|P1|Overall Study|Lost to Follow-up|20
675411|NCT01719757|2187461|P1|Overall Study|Withdrawal by Subject|15
675412|NCT01719757|2187461|P1|Overall Study|Adverse Event|38
675413|NCT01719172|2187500|P1|Overall Study|Death|1
675414|NCT01719172|2187500|P1|Overall Study|Lost to Follow-up|1
675415|NCT01719003|2187514|P9|Overall Study|Lack of Efficacy|0
675416|NCT01719003|2187515|P8|Overall Study|Lack of Efficacy|0
675417|NCT01719003|2187516|P7|Overall Study|Lack of Efficacy|1
675418|NCT01719003|2187517|P6|Overall Study|Lack of Efficacy|0
675419|NCT01719003|2187518|P5|Overall Study|Lack of Efficacy|0
675420|NCT01719003|2187519|P4|Overall Study|Lack of Efficacy|0
675421|NCT01719003|2187520|P3|Overall Study|Lack of Efficacy|0
675422|NCT01719003|2187521|P2|Overall Study|Lack of Efficacy|0
675423|NCT01719003|2187522|P1|Overall Study|Lack of Efficacy|0
675424|NCT01719003|2187514|P9|Overall Study|Reason other than those specified|1
675425|NCT01719003|2187515|P8|Overall Study|Reason other than those specified|3
675426|NCT01719003|2187516|P7|Overall Study|Reason other than those specified|0
675427|NCT01719003|2187517|P6|Overall Study|Reason other than those specified|1
675428|NCT01719003|2187518|P5|Overall Study|Reason other than those specified|4
675429|NCT01719003|2187519|P4|Overall Study|Reason other than those specified|3
675430|NCT01719003|2187520|P3|Overall Study|Reason other than those specified|2
675431|NCT01719003|2187521|P2|Overall Study|Reason other than those specified|0
675432|NCT01719003|2187522|P1|Overall Study|Reason other than those specified|0
675433|NCT01719003|2187514|P9|Overall Study|Refusal to continue, not due to AE|1
675434|NCT01719003|2187515|P8|Overall Study|Refusal to continue, not due to AE|7
675435|NCT01719003|2187516|P7|Overall Study|Refusal to continue, not due to AE|8
675436|NCT01719003|2187517|P6|Overall Study|Refusal to continue, not due to AE|3
675437|NCT01719003|2187518|P5|Overall Study|Refusal to continue, not due to AE|4
675438|NCT01719003|2187519|P4|Overall Study|Refusal to continue, not due to AE|4
675439|NCT01719003|2187520|P3|Overall Study|Refusal to continue, not due to AE|4
675440|NCT01719003|2187521|P2|Overall Study|Refusal to continue, not due to AE|5
675441|NCT01719003|2187522|P1|Overall Study|Refusal to continue, not due to AE|2
675442|NCT01719003|2187514|P9|Overall Study|Lost to Follow-up|2
675443|NCT01719003|2187515|P8|Overall Study|Lost to Follow-up|2
675444|NCT01719003|2187516|P7|Overall Study|Lost to Follow-up|3
675445|NCT01719003|2187517|P6|Overall Study|Lost to Follow-up|4
675446|NCT01719003|2187518|P5|Overall Study|Lost to Follow-up|3
675447|NCT01719003|2187519|P4|Overall Study|Lost to Follow-up|2
675448|NCT01719003|2187520|P3|Overall Study|Lost to Follow-up|7
675449|NCT01719003|2187521|P2|Overall Study|Lost to Follow-up|6
675450|NCT01719003|2187522|P1|Overall Study|Lost to Follow-up|0
675451|NCT01719003|2187514|P9|Overall Study|Adverse Event|0
675452|NCT01719003|2187515|P8|Overall Study|Adverse Event|5
675453|NCT01719003|2187516|P7|Overall Study|Adverse Event|6
675454|NCT01719003|2187517|P6|Overall Study|Adverse Event|3
675455|NCT01719003|2187518|P5|Overall Study|Adverse Event|4
675456|NCT01719003|2187519|P4|Overall Study|Adverse Event|3
675457|NCT01719003|2187520|P3|Overall Study|Adverse Event|4
675458|NCT01719003|2187521|P2|Overall Study|Adverse Event|5
675459|NCT01719003|2187522|P1|Overall Study|Adverse Event|6
675460|NCT01719003|2187514|P9|Overall Study|Non compliant with protocol|0
675461|NCT01719003|2187515|P8|Overall Study|Non compliant with protocol|3
675462|NCT01719003|2187516|P7|Overall Study|Non compliant with protocol|2
675463|NCT01719003|2187517|P6|Overall Study|Non compliant with protocol|1
675464|NCT01719003|2187518|P5|Overall Study|Non compliant with protocol|2
675465|NCT01719003|2187519|P4|Overall Study|Non compliant with protocol|1
675466|NCT01719003|2187520|P3|Overall Study|Non compliant with protocol|0
675467|NCT01719003|2187521|P2|Overall Study|Non compliant with protocol|1
675468|NCT01719003|2187522|P1|Overall Study|Non compliant with protocol|1
675469|NCT01718535|2187603|P10|Overall Study|Bidirectional Sequencing not possible|0
675470|NCT01718535|2187604|P9|Overall Study|Bidirectional Sequencing not possible|0
675471|NCT01718535|2187605|P8|Overall Study|Bidirectional Sequencing not possible|0
675472|NCT01718535|2187606|P7|Overall Study|Bidirectional Sequencing not possible|0
675473|NCT01718535|2187607|P6|Overall Study|Bidirectional Sequencing not possible|0
675474|NCT01718535|2187608|P5|Overall Study|Bidirectional Sequencing not possible|0
675475|NCT01718535|2187609|P4|Overall Study|Bidirectional Sequencing not possible|1
675476|NCT01718535|2187610|P3|Overall Study|Bidirectional Sequencing not possible|0
675477|NCT01718535|2187611|P2|Overall Study|Bidirectional Sequencing not possible|0
675478|NCT01718535|2187612|P1|Overall Study|Bidirectional Sequencing not possible|1
675479|NCT01718509|2187636|P2|Overall Study|Lack of Efficacy|0
675480|NCT01718509|2187637|P1|Overall Study|Lack of Efficacy|1
675481|NCT01718509|2187636|P2|Overall Study|Protocol Violation|2
675482|NCT01718509|2187637|P1|Overall Study|Protocol Violation|4
675483|NCT01718509|2187636|P2|Overall Study|Not specified|11
675484|NCT01718509|2187637|P1|Overall Study|Not specified|13
675485|NCT01718509|2187636|P2|Overall Study|Adverse Event|7
675486|NCT01718509|2187637|P1|Overall Study|Adverse Event|5
675487|NCT01718509|2187636|P2|Overall Study|Withdrawal by Subject|13
675488|NCT01718509|2187637|P1|Overall Study|Withdrawal by Subject|7
675489|NCT01718509|2187636|P2|Overall Study|Lost to Follow-up|15
675490|NCT01718509|2187637|P1|Overall Study|Lost to Follow-up|18
675491|NCT01718483|2187683|P2|Overall Study|Lack of Efficacy|0
675492|NCT01718483|2187684|P1|Overall Study|Lack of Efficacy|1
675493|NCT01718483|2187683|P2|Overall Study|Pregnancy|1
675494|NCT01718483|2187684|P1|Overall Study|Pregnancy|1
675495|NCT01718483|2187683|P2|Overall Study|Not specified|4
675496|NCT01718483|2187684|P1|Overall Study|Not specified|1
675497|NCT01718483|2187683|P2|Overall Study|Protocol Violation|2
675498|NCT01718483|2187684|P1|Overall Study|Protocol Violation|4
675499|NCT01718483|2187683|P2|Overall Study|Lost to Follow-up|3
675500|NCT01718483|2187684|P1|Overall Study|Lost to Follow-up|8
675501|NCT01718483|2187683|P2|Overall Study|Adverse Event|12
675502|NCT01718483|2187684|P1|Overall Study|Adverse Event|5
675503|NCT01718483|2187683|P2|Overall Study|Withdrawal by Subject|12
675504|NCT01718483|2187684|P1|Overall Study|Withdrawal by Subject|14
675505|NCT01717989|2187743|P1|Overall Study|Other|40
675506|NCT01717989|2187743|P1|Overall Study|Protocol-specified criteria|551
675507|NCT01717989|2187743|P1|Overall Study|Death|439
675508|NCT01717989|2187743|P1|Overall Study|Lost to Follow-up|11
675509|NCT01717989|2187743|P1|Overall Study|Physician Decision|2
675510|NCT01717989|2187743|P1|Overall Study|Withdrawal by Subject|11
675511|NCT01717989|2187743|P1|Overall Study|Protocol deviation|6
675512|NCT01717989|2187743|P1|Overall Study|Ineligibility determined|6
675513|NCT01717976|2187811|P2|Overall Study|Protocol Violation|1
675514|NCT01717976|2187812|P1|Overall Study|Protocol Violation|0
675515|NCT01717768|2187849|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675516|NCT01717768|2187850|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675517|NCT01717768|2187851|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
675518|NCT01717768|2187852|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675519|NCT01717768|2187853|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675520|NCT01717768|2187854|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675521|NCT01717768|2187855|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675522|NCT01717768|2187856|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675523|NCT01717768|2187857|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675524|NCT01717768|2187858|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675525|NCT01717768|2187859|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675526|NCT01717768|2187860|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
675527|NCT01717768|2187849|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675528|NCT01717768|2187850|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675529|NCT01717768|2187851|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675530|NCT01717768|2187852|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675531|NCT01717768|2187853|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
675532|NCT01717768|2187854|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675533|NCT01717768|2187855|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675534|NCT01717768|2187856|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675535|NCT01717768|2187857|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675536|NCT01717768|2187858|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675537|NCT01717768|2187859|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675538|NCT01717768|2187860|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
675539|NCT01717768|2187849|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
675540|NCT01717768|2187850|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675541|NCT01717768|2187851|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675542|NCT01717768|2187852|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675543|NCT01717768|2187853|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675544|NCT01717768|2187854|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675545|NCT01717768|2187855|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675546|NCT01717768|2187856|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675547|NCT01717768|2187857|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675548|NCT01717768|2187858|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675549|NCT01717768|2187859|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675550|NCT01717768|2187860|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
675551|NCT01717768|2187849|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675552|NCT01717768|2187850|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675553|NCT01717768|2187851|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675554|NCT01717768|2187852|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675555|NCT01717768|2187853|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675556|NCT01717768|2187854|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675557|NCT01717768|2187855|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675558|NCT01717768|2187856|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675559|NCT01717768|2187857|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675560|NCT01717768|2187858|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675561|NCT01717768|2187859|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
675562|NCT01717768|2187860|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
675563|NCT01717638|2187911|P13|Overall Study|Withdrawal by Subject|18
675564|NCT01717638|2187912|P12|Overall Study|Withdrawal by Subject|0
675565|NCT01717638|2187913|P11|Overall Study|Withdrawal by Subject|0
675566|NCT01717638|2187914|P10|Overall Study|Withdrawal by Subject|1
675567|NCT01717638|2187915|P9|Overall Study|Withdrawal by Subject|2
675568|NCT01717638|2187916|P8|Overall Study|Withdrawal by Subject|1
675569|NCT01717638|2187917|P7|Overall Study|Withdrawal by Subject|2
675570|NCT01717638|2187918|P6|Overall Study|Withdrawal by Subject|0
675571|NCT01717638|2187919|P5|Overall Study|Withdrawal by Subject|1
675572|NCT01717638|2187920|P4|Overall Study|Withdrawal by Subject|0
675573|NCT01717638|2187921|P3|Overall Study|Withdrawal by Subject|1
675574|NCT01717638|2187922|P2|Overall Study|Withdrawal by Subject|1
675575|NCT01717638|2187923|P1|Overall Study|Withdrawal by Subject|0
675576|NCT01717638|2187911|P13|Overall Study|Father in hospital|1
675577|NCT01717638|2187912|P12|Overall Study|Father in hospital|0
675578|NCT01717638|2187913|P11|Overall Study|Father in hospital|0
675579|NCT01717638|2187914|P10|Overall Study|Father in hospital|0
675580|NCT01717638|2187915|P9|Overall Study|Father in hospital|0
675581|NCT01717638|2187916|P8|Overall Study|Father in hospital|0
675582|NCT01717638|2187917|P7|Overall Study|Father in hospital|0
675583|NCT01717638|2187918|P6|Overall Study|Father in hospital|0
675584|NCT01717638|2187919|P5|Overall Study|Father in hospital|0
675585|NCT01717638|2187920|P4|Overall Study|Father in hospital|0
675586|NCT01717638|2187921|P3|Overall Study|Father in hospital|0
675587|NCT01717638|2187922|P2|Overall Study|Father in hospital|0
675588|NCT01717638|2187923|P1|Overall Study|Father in hospital|0
675589|NCT01717638|2187911|P13|Overall Study|Lost to Follow-up|0
675590|NCT01717638|2187912|P12|Overall Study|Lost to Follow-up|0
675591|NCT01717638|2187913|P11|Overall Study|Lost to Follow-up|0
675592|NCT01717638|2187914|P10|Overall Study|Lost to Follow-up|0
675593|NCT01717638|2187915|P9|Overall Study|Lost to Follow-up|0
675594|NCT01717638|2187916|P8|Overall Study|Lost to Follow-up|0
675595|NCT01717638|2187917|P7|Overall Study|Lost to Follow-up|0
675596|NCT01717638|2187918|P6|Overall Study|Lost to Follow-up|1
675597|NCT01717638|2187919|P5|Overall Study|Lost to Follow-up|0
675598|NCT01717638|2187920|P4|Overall Study|Lost to Follow-up|0
675599|NCT01717638|2187921|P3|Overall Study|Lost to Follow-up|0
675600|NCT01717638|2187922|P2|Overall Study|Lost to Follow-up|0
675601|NCT01717638|2187923|P1|Overall Study|Lost to Follow-up|0
675602|NCT01717456|2188067|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
675603|NCT01717456|2188068|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
675604|NCT01717456|2188067|P2|End of Treatment|Lost to Follow-up|1
675605|NCT01717456|2188068|P1|End of Treatment|Lost to Follow-up|0
675606|NCT01717456|2188067|P2|End of Treatment|Physician Decision|1
675607|NCT01717456|2188068|P1|End of Treatment|Physician Decision|0
675608|NCT01717391|2188136|P1|Overall Study|FLT technical failure|3
675609|NCT01717391|2188136|P1|Overall Study|Physician Decision|1
675610|NCT01717391|2188136|P1|Overall Study|Withdrawal by Subject|5
675611|NCT01717326|2188165|P20|Overall Study|Withdrawal by Subject|3
675612|NCT01717326|2188166|P19|Overall Study|Withdrawal by Subject|2
675613|NCT01717326|2188167|P18|Overall Study|Withdrawal by Subject|0
675614|NCT01717326|2188168|P17|Overall Study|Withdrawal by Subject|0
675615|NCT01717326|2188169|P16|Overall Study|Withdrawal by Subject|1
675616|NCT01717326|2188170|P15|Overall Study|Withdrawal by Subject|0
675617|NCT01717326|2188171|P14|Overall Study|Withdrawal by Subject|0
675618|NCT01717326|2188172|P13|Overall Study|Withdrawal by Subject|1
675619|NCT01717326|2188173|P12|Overall Study|Withdrawal by Subject|0
675620|NCT01717326|2188174|P11|Overall Study|Withdrawal by Subject|0
675621|NCT01717326|2188175|P10|Overall Study|Withdrawal by Subject|1
675622|NCT01717326|2188176|P9|Overall Study|Withdrawal by Subject|0
675623|NCT01717326|2188177|P8|Overall Study|Withdrawal by Subject|0
675624|NCT01717326|2188178|P7|Overall Study|Withdrawal by Subject|0
675625|NCT01717326|2188179|P6|Overall Study|Withdrawal by Subject|0
675626|NCT01717326|2188180|P5|Overall Study|Withdrawal by Subject|0
675627|NCT01717326|2188181|P4|Overall Study|Withdrawal by Subject|0
675628|NCT01717326|2188182|P3|Overall Study|Withdrawal by Subject|0
675629|NCT01717326|2188183|P2|Overall Study|Withdrawal by Subject|1
675630|NCT01717326|2188184|P1|Overall Study|Withdrawal by Subject|0
675631|NCT01717326|2188165|P20|Overall Study|Protocol Violation|0
675632|NCT01717326|2188166|P19|Overall Study|Protocol Violation|0
675633|NCT01717326|2188167|P18|Overall Study|Protocol Violation|0
675634|NCT01717326|2188168|P17|Overall Study|Protocol Violation|0
675635|NCT01717326|2188169|P16|Overall Study|Protocol Violation|0
675636|NCT01717326|2188170|P15|Overall Study|Protocol Violation|0
675637|NCT01717326|2188171|P14|Overall Study|Protocol Violation|0
675638|NCT01717326|2188172|P13|Overall Study|Protocol Violation|0
675639|NCT01717326|2188173|P12|Overall Study|Protocol Violation|0
675640|NCT01717326|2188174|P11|Overall Study|Protocol Violation|0
675641|NCT01717326|2188175|P10|Overall Study|Protocol Violation|0
675642|NCT01717326|2188176|P9|Overall Study|Protocol Violation|0
675643|NCT01717326|2188177|P8|Overall Study|Protocol Violation|0
675644|NCT01717326|2188178|P7|Overall Study|Protocol Violation|0
675645|NCT01717326|2188179|P6|Overall Study|Protocol Violation|0
675646|NCT01717326|2188180|P5|Overall Study|Protocol Violation|1
675647|NCT01717326|2188181|P4|Overall Study|Protocol Violation|0
675648|NCT01717326|2188182|P3|Overall Study|Protocol Violation|0
675649|NCT01717326|2188183|P2|Overall Study|Protocol Violation|0
675650|NCT01717326|2188184|P1|Overall Study|Protocol Violation|0
675651|NCT01717326|2188165|P20|Overall Study|Physician Decision|0
675652|NCT01717326|2188166|P19|Overall Study|Physician Decision|0
675653|NCT01717326|2188167|P18|Overall Study|Physician Decision|0
675654|NCT01717326|2188168|P17|Overall Study|Physician Decision|0
675655|NCT01717326|2188169|P16|Overall Study|Physician Decision|0
675656|NCT01717326|2188170|P15|Overall Study|Physician Decision|0
675657|NCT01717326|2188171|P14|Overall Study|Physician Decision|0
675658|NCT01717326|2188172|P13|Overall Study|Physician Decision|0
675659|NCT01717326|2188173|P12|Overall Study|Physician Decision|0
675660|NCT01717326|2188174|P11|Overall Study|Physician Decision|0
675661|NCT01717326|2188175|P10|Overall Study|Physician Decision|1
675662|NCT01717326|2188176|P9|Overall Study|Physician Decision|0
675663|NCT01717326|2188177|P8|Overall Study|Physician Decision|0
675664|NCT01717326|2188178|P7|Overall Study|Physician Decision|0
675665|NCT01717326|2188179|P6|Overall Study|Physician Decision|0
675666|NCT01717326|2188180|P5|Overall Study|Physician Decision|0
675667|NCT01717326|2188181|P4|Overall Study|Physician Decision|0
675668|NCT01717326|2188182|P3|Overall Study|Physician Decision|0
675669|NCT01717326|2188183|P2|Overall Study|Physician Decision|0
675670|NCT01717326|2188184|P1|Overall Study|Physician Decision|0
675671|NCT01717326|2188165|P20|Overall Study|Lost to Follow-up|3
675672|NCT01717326|2188166|P19|Overall Study|Lost to Follow-up|2
675673|NCT01717326|2188167|P18|Overall Study|Lost to Follow-up|0
675674|NCT01717326|2188168|P17|Overall Study|Lost to Follow-up|1
675675|NCT01717326|2188169|P16|Overall Study|Lost to Follow-up|2
675676|NCT01717326|2188170|P15|Overall Study|Lost to Follow-up|0
675677|NCT01717326|2188171|P14|Overall Study|Lost to Follow-up|0
675678|NCT01717326|2188172|P13|Overall Study|Lost to Follow-up|0
675679|NCT01717326|2188173|P12|Overall Study|Lost to Follow-up|0
675680|NCT01717326|2188174|P11|Overall Study|Lost to Follow-up|1
675681|NCT01717326|2188175|P10|Overall Study|Lost to Follow-up|0
675682|NCT01717326|2188176|P9|Overall Study|Lost to Follow-up|0
675683|NCT01717326|2188177|P8|Overall Study|Lost to Follow-up|0
675684|NCT01717326|2188178|P7|Overall Study|Lost to Follow-up|1
675685|NCT01717326|2188179|P6|Overall Study|Lost to Follow-up|0
675686|NCT01717326|2188180|P5|Overall Study|Lost to Follow-up|1
675687|NCT01717326|2188181|P4|Overall Study|Lost to Follow-up|2
675688|NCT01717326|2188182|P3|Overall Study|Lost to Follow-up|0
675689|NCT01717326|2188183|P2|Overall Study|Lost to Follow-up|0
675690|NCT01717326|2188184|P1|Overall Study|Lost to Follow-up|3
675691|NCT01717326|2188165|P20|Overall Study|Death|0
675692|NCT01717326|2188166|P19|Overall Study|Death|0
675693|NCT01717326|2188167|P18|Overall Study|Death|0
675694|NCT01717326|2188168|P17|Overall Study|Death|0
675695|NCT01717326|2188169|P16|Overall Study|Death|0
675696|NCT01717326|2188170|P15|Overall Study|Death|0
675697|NCT01717326|2188171|P14|Overall Study|Death|0
675698|NCT01717326|2188172|P13|Overall Study|Death|0
675699|NCT01717326|2188173|P12|Overall Study|Death|0
675700|NCT01717326|2188174|P11|Overall Study|Death|1
675701|NCT01717326|2188175|P10|Overall Study|Death|0
675702|NCT01717326|2188176|P9|Overall Study|Death|0
675703|NCT01717326|2188177|P8|Overall Study|Death|0
675704|NCT01717326|2188178|P7|Overall Study|Death|0
675705|NCT01717326|2188179|P6|Overall Study|Death|0
675706|NCT01717326|2188180|P5|Overall Study|Death|0
675707|NCT01717326|2188181|P4|Overall Study|Death|0
675708|NCT01717326|2188182|P3|Overall Study|Death|0
675709|NCT01717326|2188183|P2|Overall Study|Death|0
675710|NCT01717326|2188184|P1|Overall Study|Death|0
675711|NCT01717313|2188448|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
675712|NCT01717313|2188449|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
675713|NCT01717313|2188448|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
675714|NCT01717313|2188449|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
675715|NCT01717313|2188448|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
675716|NCT01717313|2188449|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
675717|NCT01717313|2188448|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
675718|NCT01717313|2188449|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
675719|NCT01717313|2188448|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
675720|NCT01717313|2188449|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
675721|NCT01717313|2188448|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
675722|NCT01717313|2188449|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
675723|NCT01717313|2188448|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
675724|NCT01717313|2188449|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
675725|NCT01717313|2188448|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
675726|NCT01717313|2188449|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
675727|NCT01717313|2188448|P2|Phase A (Weeks 0 to 24)|Death|1
675728|NCT01717313|2188449|P1|Phase A (Weeks 0 to 24)|Death|0
675729|NCT01717287|2188487|P2|Overall Study|Protocol Violation|1
675730|NCT01717287|2188488|P1|Overall Study|Protocol Violation|0
675731|NCT01717287|2188487|P2|Overall Study|Lost to Follow-up|2
675732|NCT01717287|2188488|P1|Overall Study|Lost to Follow-up|0
675733|NCT01717040|2188521|P2|Overall Study|New Substance Use Disorder|0
675734|NCT01717040|2188522|P1|Overall Study|New Substance Use Disorder|1
675735|NCT01717040|2188521|P2|Overall Study|Required Medication Change|1
675736|NCT01717040|2188522|P1|Overall Study|Required Medication Change|0
675737|NCT01717040|2188521|P2|Overall Study|Adverse Event|0
675738|NCT01717040|2188522|P1|Overall Study|Adverse Event|1
675739|NCT01717040|2188521|P2|Overall Study|Lack of Efficacy|1
675740|NCT01717040|2188522|P1|Overall Study|Lack of Efficacy|1
675741|NCT01717040|2188521|P2|Overall Study|Lost to Follow-up|3
675742|NCT01717040|2188522|P1|Overall Study|Lost to Follow-up|2
675743|NCT01716754|2188540|P4|Overall Study|Withdrawal by Subject|3
675744|NCT01716754|2188541|P3|Overall Study|Withdrawal by Subject|4
675745|NCT01716754|2188542|P2|Overall Study|Withdrawal by Subject|0
675746|NCT01716754|2188543|P1|Overall Study|Withdrawal by Subject|5
675747|NCT01716754|2188540|P4|Overall Study|Adverse Event|1
675748|NCT01716754|2188541|P3|Overall Study|Adverse Event|2
675749|NCT01716754|2188542|P2|Overall Study|Adverse Event|2
675750|NCT01716754|2188543|P1|Overall Study|Adverse Event|4
675751|NCT01716754|2188540|P4|Overall Study|Lost to Follow-up|1
675752|NCT01716754|2188541|P3|Overall Study|Lost to Follow-up|0
675753|NCT01716754|2188542|P2|Overall Study|Lost to Follow-up|0
675754|NCT01716754|2188543|P1|Overall Study|Lost to Follow-up|1
675755|NCT01716754|2188540|P4|Overall Study|Physician Decision|0
675756|NCT01716754|2188541|P3|Overall Study|Physician Decision|0
675757|NCT01716754|2188542|P2|Overall Study|Physician Decision|0
675758|NCT01716754|2188543|P1|Overall Study|Physician Decision|1
675759|NCT01716754|2188540|P4|Overall Study|Non-compliance with study treatment|0
675760|NCT01716754|2188541|P3|Overall Study|Non-compliance with study treatment|1
675761|NCT01716754|2188542|P2|Overall Study|Non-compliance with study treatment|0
675762|NCT01716754|2188543|P1|Overall Study|Non-compliance with study treatment|0
675763|NCT01716754|2188540|P4|Overall Study|Protocol deviation|2
675764|NCT01716754|2188541|P3|Overall Study|Protocol deviation|7
675765|NCT01716754|2188542|P2|Overall Study|Protocol deviation|2
675766|NCT01716754|2188543|P1|Overall Study|Protocol deviation|0
675767|NCT01716754|2188540|P4|Overall Study|Death|1
675768|NCT01716754|2188541|P3|Overall Study|Death|0
675769|NCT01716754|2188542|P2|Overall Study|Death|0
675770|NCT01716754|2188543|P1|Overall Study|Death|0
675771|NCT01716663|2188564|P1|Overall Study|Treated with non-study catheter|2
675772|NCT01716663|2188564|P1|Overall Study|Withdrawn prior to procedure|4
675773|NCT01716585|2188574|P2|Open-label Treatment|Withdrawal by Subject|3
675774|NCT01716585|2188575|P1|Open-label Treatment|Withdrawal by Subject|0
675775|NCT01716585|2188574|P2|Open-label Treatment|Virologic Failure|2
675776|NCT01716585|2188575|P1|Open-label Treatment|Virologic Failure|0
675777|NCT01716585|2188574|P2|Open-label Treatment|Adverse Event|2
675778|NCT01716585|2188575|P1|Open-label Treatment|Adverse Event|0
675779|NCT01716585|2188574|P2|Double-blind Treatment|Not Specified|0
675780|NCT01716585|2188575|P1|Double-blind Treatment|Not Specified|1
675781|NCT01716585|2188574|P2|Double-blind Treatment|Subject Noncompliant|0
675782|NCT01716585|2188575|P1|Double-blind Treatment|Subject Noncompliant|1
675783|NCT01716585|2188574|P2|Double-blind Treatment|Lost to Follow-up|0
675784|NCT01716585|2188575|P1|Double-blind Treatment|Lost to Follow-up|2
675785|NCT01716585|2188574|P2|Double-blind Treatment|Withdrawal by Subject|0
675786|NCT01716585|2188575|P1|Double-blind Treatment|Withdrawal by Subject|3
675787|NCT01716585|2188574|P2|Double-blind Treatment|Adverse Event|1
675788|NCT01716585|2188575|P1|Double-blind Treatment|Adverse Event|2
675789|NCT01716585|2188574|P2|Double-blind Treatment|Did Not Receive Study Drug|1
675790|NCT01716585|2188575|P1|Double-blind Treatment|Did Not Receive Study Drug|4
675791|NCT01716559|2188587|P1|Overall Study|Other withdrawal reason|75
675792|NCT01716559|2188587|P1|Overall Study|Withdrawal by Subject|4
675793|NCT01716559|2188587|P1|Overall Study|Death|21
675794|NCT01716559|2188587|P1|Overall Study|Adverse Event|11
675795|NCT01716520|2188595|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
675796|NCT01716520|2188596|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
675797|NCT01716520|2188597|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
675798|NCT01716520|2188598|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
675799|NCT01716520|2188599|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
675800|NCT01716520|2188600|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
675801|NCT01716520|2188595|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
675802|NCT01716520|2188596|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
675803|NCT01716520|2188597|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
675804|NCT01716520|2188598|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
675805|NCT01716520|2188599|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
675806|NCT01716520|2188600|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
675807|NCT01716520|2188595|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
675808|NCT01716520|2188596|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
675809|NCT01716520|2188597|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
675810|NCT01716520|2188598|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
675811|NCT01716520|2188599|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
675812|NCT01716520|2188600|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
675813|NCT01716520|2188595|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
675814|NCT01716520|2188596|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
675815|NCT01716520|2188597|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
675816|NCT01716520|2188598|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
675817|NCT01716520|2188599|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
675818|NCT01716520|2188600|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
675819|NCT01716520|2188595|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
675820|NCT01716520|2188596|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
675821|NCT01716520|2188597|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
675822|NCT01716520|2188598|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
675823|NCT01716520|2188599|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
675824|NCT01716520|2188600|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
675825|NCT01716520|2188595|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
675826|NCT01716520|2188596|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
675827|NCT01716520|2188597|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
675828|NCT01716520|2188598|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
675829|NCT01716520|2188599|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
675830|NCT01716520|2188600|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
675831|NCT01716520|2188595|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
675832|NCT01716520|2188596|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
675833|NCT01716520|2188597|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
675834|NCT01716520|2188598|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
675835|NCT01716520|2188599|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
675836|NCT01716520|2188600|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
675837|NCT01716520|2188595|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
675838|NCT01716520|2188596|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
675839|NCT01716520|2188597|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
675840|NCT01716520|2188598|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
675841|NCT01716520|2188599|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
675842|NCT01716520|2188600|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
675843|NCT01716520|2188595|P6|Treatment Period 2 (14 Days)|Adverse Event|0
675844|NCT01716520|2188596|P5|Treatment Period 2 (14 Days)|Adverse Event|1
675845|NCT01716520|2188597|P4|Treatment Period 2 (14 Days)|Adverse Event|0
675846|NCT01716520|2188598|P3|Treatment Period 2 (14 Days)|Adverse Event|0
675847|NCT01716520|2188599|P2|Treatment Period 2 (14 Days)|Adverse Event|0
675848|NCT01716520|2188600|P1|Treatment Period 2 (14 Days)|Adverse Event|0
675849|NCT01716520|2188595|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
675850|NCT01716520|2188596|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
675851|NCT01716520|2188597|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
675852|NCT01716520|2188598|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
675853|NCT01716520|2188599|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
675854|NCT01716520|2188600|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
675855|NCT01716520|2188595|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
675856|NCT01716520|2188596|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
675857|NCT01716520|2188597|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
675858|NCT01716520|2188598|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
675859|NCT01716520|2188599|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
675860|NCT01716520|2188600|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
675861|NCT01716520|2188595|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
675862|NCT01716520|2188596|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
675863|NCT01716520|2188597|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
675864|NCT01716520|2188598|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
675865|NCT01716520|2188599|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
675866|NCT01716520|2188600|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
675867|NCT01716520|2188595|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
675868|NCT01716520|2188596|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
675869|NCT01716520|2188597|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
675870|NCT01716520|2188598|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
675871|NCT01716520|2188599|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
675872|NCT01716520|2188600|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
675873|NCT01716520|2188595|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
675874|NCT01716520|2188596|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
675875|NCT01716520|2188597|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
675876|NCT01716520|2188598|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
675877|NCT01716520|2188599|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
675878|NCT01716520|2188600|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
675879|NCT01716520|2188595|P6|Treatment Period 1 (14 Days)|Adverse Event|0
675880|NCT01716520|2188596|P5|Treatment Period 1 (14 Days)|Adverse Event|0
675881|NCT01716520|2188597|P4|Treatment Period 1 (14 Days)|Adverse Event|0
675882|NCT01716520|2188598|P3|Treatment Period 1 (14 Days)|Adverse Event|0
675883|NCT01716520|2188599|P2|Treatment Period 1 (14 Days)|Adverse Event|0
675884|NCT01716520|2188600|P1|Treatment Period 1 (14 Days)|Adverse Event|1
675885|NCT01716234|2188655|P7|Overall Study|Withdrawal by Subject|0
675886|NCT01716234|2188656|P6|Overall Study|Withdrawal by Subject|3
675887|NCT01716234|2188657|P5|Overall Study|Withdrawal by Subject|1
675888|NCT01716234|2188658|P4|Overall Study|Withdrawal by Subject|2
675889|NCT01716234|2188659|P3|Overall Study|Withdrawal by Subject|2
675890|NCT01716234|2188660|P2|Overall Study|Withdrawal by Subject|0
675891|NCT01716234|2188661|P1|Overall Study|Withdrawal by Subject|3
675892|NCT01716234|2188655|P7|Overall Study|Adverse Event|0
675893|NCT01716234|2188656|P6|Overall Study|Adverse Event|6
675894|NCT01716234|2188657|P5|Overall Study|Adverse Event|3
675895|NCT01716234|2188658|P4|Overall Study|Adverse Event|8
675896|NCT01716234|2188659|P3|Overall Study|Adverse Event|2
675897|NCT01716234|2188660|P2|Overall Study|Adverse Event|10
675898|NCT01716234|2188661|P1|Overall Study|Adverse Event|7
675899|NCT01716234|2188655|P7|Overall Study|Did not meet protocol eligibility|0
675900|NCT01716234|2188656|P6|Overall Study|Did not meet protocol eligibility|4
675901|NCT01716234|2188657|P5|Overall Study|Did not meet protocol eligibility|0
675902|NCT01716234|2188658|P4|Overall Study|Did not meet protocol eligibility|0
675903|NCT01716234|2188659|P3|Overall Study|Did not meet protocol eligibility|1
675904|NCT01716234|2188660|P2|Overall Study|Did not meet protocol eligibility|0
675905|NCT01716234|2188661|P1|Overall Study|Did not meet protocol eligibility|0
675906|NCT01716234|2188655|P7|Overall Study|Lack of Efficacy|0
675907|NCT01716234|2188656|P6|Overall Study|Lack of Efficacy|0
675908|NCT01716234|2188657|P5|Overall Study|Lack of Efficacy|0
675909|NCT01716234|2188658|P4|Overall Study|Lack of Efficacy|1
675910|NCT01716234|2188659|P3|Overall Study|Lack of Efficacy|0
675911|NCT01716234|2188660|P2|Overall Study|Lack of Efficacy|0
675912|NCT01716234|2188661|P1|Overall Study|Lack of Efficacy|0
675913|NCT01716234|2188655|P7|Overall Study|Protocol Violation|0
675914|NCT01716234|2188656|P6|Overall Study|Protocol Violation|1
675915|NCT01716234|2188657|P5|Overall Study|Protocol Violation|1
675916|NCT01716234|2188658|P4|Overall Study|Protocol Violation|1
675917|NCT01716234|2188659|P3|Overall Study|Protocol Violation|0
675918|NCT01716234|2188660|P2|Overall Study|Protocol Violation|0
675919|NCT01716234|2188661|P1|Overall Study|Protocol Violation|0
675920|NCT01716169|2188724|P1|Overall Study|inconsistent dressing application|1
675921|NCT01716169|2188724|P1|Overall Study|Withdrawal by Subject|1
675922|NCT01716169|2188724|P1|Overall Study|Lost to Follow-up|1
675923|NCT01716169|2188724|P1|Overall Study|Adverse Event|1
675924|NCT01716156|2188733|P3|Overall Study|Lost to Follow-up|0
675925|NCT01716156|2188734|P2|Overall Study|Lost to Follow-up|0
675926|NCT01716156|2188735|P1|Overall Study|Lost to Follow-up|1
675927|NCT01716156|2188733|P3|Overall Study|Withdrawal by Subject|2
675928|NCT01716156|2188734|P2|Overall Study|Withdrawal by Subject|1
675929|NCT01716156|2188735|P1|Overall Study|Withdrawal by Subject|0
675930|NCT01716156|2188733|P3|Overall Study|Protocol Violation|0
675931|NCT01716156|2188734|P2|Overall Study|Protocol Violation|0
675932|NCT01716156|2188735|P1|Overall Study|Protocol Violation|1
675933|NCT01716052|2188761|P2|Overall Study|Withdrawal of funding|1
675934|NCT01716052|2188762|P1|Overall Study|Withdrawal of funding|1
675935|NCT01715896|2188804|P2|Overall Study|Unspecified|5
675936|NCT01715896|2188805|P1|Overall Study|Unspecified|2
675937|NCT01715896|2188804|P2|Overall Study|Withdrawal by Subject|4
675938|NCT01715896|2188805|P1|Overall Study|Withdrawal by Subject|1
675939|NCT01715896|2188804|P2|Overall Study|Lost to Follow-up|2
675940|NCT01715896|2188805|P1|Overall Study|Lost to Follow-up|0
675941|NCT01715857|2188868|P1|Overall Study|Did Not Meet Eligibility Criteria|96
675942|NCT01715831|2188878|P1|Overall Study|Adverse Event|1
675943|NCT01715415|2188896|P2|Open-label Treatment|Subject Noncompliant|1
675944|NCT01715415|2188897|P1|Open-label Treatment|Subject Noncompliant|0
675945|NCT01715415|2188896|P2|Open-label Treatment|Adverse Event|1
675946|NCT01715415|2188897|P1|Open-label Treatment|Adverse Event|0
675947|NCT01715415|2188896|P2|Double-blind Treatment|Not Specified|0
675948|NCT01715415|2188897|P1|Double-blind Treatment|Not Specified|1
675949|NCT01715415|2188896|P2|Double-blind Treatment|Withdrawal by Subject|1
675950|NCT01715415|2188897|P1|Double-blind Treatment|Withdrawal by Subject|1
675951|NCT01715415|2188896|P2|Double-blind Treatment|Adverse Event|0
675952|NCT01715415|2188897|P1|Double-blind Treatment|Adverse Event|3
675953|NCT01715415|2188896|P2|Double-blind Treatment|Did Not Receive Study Drug|1
675954|NCT01715415|2188897|P1|Double-blind Treatment|Did Not Receive Study Drug|0
675955|NCT01715298|2188911|P2|Overall Study|Patient/guardian decision|9
675956|NCT01715298|2188912|P1|Overall Study|Patient/guardian decision|7
675957|NCT01715298|2188911|P2|Overall Study|Lost to Follow-up|2
675958|NCT01715298|2188912|P1|Overall Study|Lost to Follow-up|0
675959|NCT01715129|2188959|P1|Overall Study|Unspecified|1
675960|NCT01715129|2188959|P1|Overall Study|Lost to Follow-up|1
675961|NCT01715129|2188959|P1|Overall Study|Consent Withdrawn|2
675962|NCT01715129|2188959|P1|Overall Study|Protocol Violation|1
675963|NCT01715129|2188959|P1|Overall Study|Lack of Efficacy|3
675964|NCT01715129|2188959|P1|Overall Study|Adverse Event, fatal|1
675965|NCT01714635|2188988|P3|Overall Study|Missed 6-month exam|0
675966|NCT01714635|2188989|P2|Overall Study|Missed 6-month exam|0
675967|NCT01714635|2188990|P1|Overall Study|Missed 6-month exam|1
675968|NCT01714635|2188988|P3|Overall Study|Discontinued|2
675969|NCT01714635|2188989|P2|Overall Study|Discontinued|0
675970|NCT01714635|2188990|P1|Overall Study|Discontinued|1
675971|NCT01714609|2189006|P2|Overall Study|Protocol Violation|0
675972|NCT01714609|2189007|P1|Overall Study|Protocol Violation|1
675973|NCT01714544|2189013|P1|Overall Study|Withdrawal by Subject|1
675974|NCT01714544|2189013|P1|Overall Study|Physician Decision|1
675975|NCT01714544|2189013|P1|Overall Study|Lost to Follow-up|1
675987|NCT01713530|2189168|P2|Overall Study|Unclassified|2
675988|NCT01713530|2189169|P1|Overall Study|Unclassified|4
675989|NCT01713530|2189168|P2|Overall Study|Withdrawal criteria|12
675990|NCT01713530|2189169|P1|Overall Study|Withdrawal criteria|21
675991|NCT01713530|2189168|P2|Overall Study|Adverse Event|5
675992|NCT01713530|2189169|P1|Overall Study|Adverse Event|0
675993|NCT01713348|2189200|P4|Overall Study|Lost to Follow-up|0
675994|NCT01713348|2189201|P3|Overall Study|Lost to Follow-up|0
675995|NCT01713348|2189202|P2|Overall Study|Lost to Follow-up|0
675996|NCT01713348|2189203|P1|Overall Study|Lost to Follow-up|1
675997|NCT01713348|2189200|P4|Overall Study|Withdrawal by Subject|0
675998|NCT01713348|2189201|P3|Overall Study|Withdrawal by Subject|2
675999|NCT01713348|2189202|P2|Overall Study|Withdrawal by Subject|2
676000|NCT01713348|2189203|P1|Overall Study|Withdrawal by Subject|3
676001|NCT01713283|2189233|P2|Overall Study|Lost to Follow-up|1
676002|NCT01713283|2189234|P1|Overall Study|Lost to Follow-up|1
676003|NCT01713283|2189233|P2|Overall Study|Lack of Efficacy|2
676004|NCT01713283|2189234|P1|Overall Study|Lack of Efficacy|10
676005|NCT01713036|2189256|P1|Overall Study|Death|1
676006|NCT01712984|2189296|P3|Overall Study|Withdrawal by Subject|7
676007|NCT01712984|2189297|P2|Overall Study|Withdrawal by Subject|6
676008|NCT01712984|2189298|P1|Overall Study|Withdrawal by Subject|6
676009|NCT01712984|2189296|P3|Overall Study|Lost to Follow-up|1
676010|NCT01712984|2189297|P2|Overall Study|Lost to Follow-up|10
676011|NCT01712984|2189298|P1|Overall Study|Lost to Follow-up|8
676012|NCT01712984|2189296|P3|Overall Study|Protocol Violation|1
676013|NCT01712984|2189297|P2|Overall Study|Protocol Violation|0
676014|NCT01712984|2189298|P1|Overall Study|Protocol Violation|2
676015|NCT01712984|2189296|P3|Overall Study|Adverse Event|1
676016|NCT01712984|2189297|P2|Overall Study|Adverse Event|0
676017|NCT01712984|2189298|P1|Overall Study|Adverse Event|0
676018|NCT01712854|2189318|P1|Overall Study|Physician Decision|1
676019|NCT01712685|2189341|P1|Overall Study|pt declined to participate before trmt|1
676020|NCT01712516|2189357|P4|Overall Study|Withdrawal by Subject|9
676021|NCT01712516|2189358|P3|Overall Study|Withdrawal by Subject|3
676022|NCT01712516|2189359|P2|Overall Study|Withdrawal by Subject|9
676023|NCT01712516|2189360|P1|Overall Study|Withdrawal by Subject|3
676024|NCT01712516|2189357|P4|Overall Study|Physician Decision|1
676025|NCT01712516|2189358|P3|Overall Study|Physician Decision|0
676026|NCT01712516|2189359|P2|Overall Study|Physician Decision|0
676027|NCT01712516|2189360|P1|Overall Study|Physician Decision|2
676028|NCT01712516|2189357|P4|Overall Study|Protocol deviation|0
676029|NCT01712516|2189358|P3|Overall Study|Protocol deviation|1
676030|NCT01712516|2189359|P2|Overall Study|Protocol deviation|0
676031|NCT01712516|2189360|P1|Overall Study|Protocol deviation|1
676032|NCT01712516|2189357|P4|Overall Study|Death|0
676033|NCT01712516|2189358|P3|Overall Study|Death|0
676034|NCT01712516|2189359|P2|Overall Study|Death|1
676035|NCT01712516|2189360|P1|Overall Study|Death|0
676036|NCT01712516|2189357|P4|Overall Study|Lost to Follow-up|1
676037|NCT01712516|2189358|P3|Overall Study|Lost to Follow-up|2
676038|NCT01712516|2189359|P2|Overall Study|Lost to Follow-up|0
676039|NCT01712516|2189360|P1|Overall Study|Lost to Follow-up|0
676040|NCT01712516|2189357|P4|Overall Study|Technical problems|2
676041|NCT01712516|2189358|P3|Overall Study|Technical problems|0
676042|NCT01712516|2189359|P2|Overall Study|Technical problems|0
676043|NCT01712516|2189360|P1|Overall Study|Technical problems|0
676044|NCT01712399|2189410|P1|Overall Study|Study closure|345
676045|NCT01712399|2189410|P1|Overall Study|Adverse Event|11
676046|NCT01712399|2189410|P1|Overall Study|Death|1
676047|NCT01712399|2189410|P1|Overall Study|Withdrawal by Subject|39
676048|NCT01712399|2189410|P1|Overall Study|Lost to Follow-up|1
676049|NCT01712334|2189456|P2|Treatment Period 1|Randomized in Error|2
676050|NCT01712334|2189457|P1|Treatment Period 1|Randomized in Error|0
676051|NCT01712256|2189465|P1|Overall Study|Lost to Follow-up|1
676052|NCT01712204|2189476|P2|Overall Study|Protocol Violation|1
676053|NCT01712204|2189477|P1|Overall Study|Protocol Violation|1
676054|NCT01712204|2189476|P2|Overall Study|Lost to Follow-up|0
676055|NCT01712204|2189477|P1|Overall Study|Lost to Follow-up|1
676056|NCT01712204|2189476|P2|Overall Study|Withdrawal by Subject|3
676057|NCT01712204|2189477|P1|Overall Study|Withdrawal by Subject|3
676058|NCT01712204|2189476|P2|Overall Study|Adverse Event|1
676059|NCT01712204|2189477|P1|Overall Study|Adverse Event|3
676060|NCT01712178|2189485|P2|Overall Study|Lost to Follow-up|1
676061|NCT01712178|2189486|P1|Overall Study|Lost to Follow-up|0
676062|NCT01712178|2189485|P2|Overall Study|Serious adverse event/withdrew consent|1
676063|NCT01712178|2189486|P1|Overall Study|Serious adverse event/withdrew consent|0
676064|NCT01712178|2189485|P2|Overall Study|Withdrew consent due to an adverse event|1
676065|NCT01712178|2189486|P1|Overall Study|Withdrew consent due to an adverse event|1
676066|NCT01712074|2189511|P3|Double Blind Period|No longer met eligibility criteria|0
676067|NCT01712074|2189512|P2|Double Blind Period|No longer met eligibility criteria|3
676068|NCT01712074|2189513|P1|Double Blind Period|No longer met eligibility criteria|0
676069|NCT01712074|2189511|P3|Double Blind Period|Protocol Violation|1
676070|NCT01712074|2189512|P2|Double Blind Period|Protocol Violation|0
676071|NCT01712074|2189513|P1|Double Blind Period|Protocol Violation|0
676072|NCT01712074|2189511|P3|Double Blind Period|Unspecified|1
676073|NCT01712074|2189512|P2|Double Blind Period|Unspecified|4
676074|NCT01712074|2189513|P1|Double Blind Period|Unspecified|0
676075|NCT01712074|2189511|P3|Double Blind Period|Lost to Follow-up|1
676076|NCT01712074|2189512|P2|Double Blind Period|Lost to Follow-up|2
676077|NCT01712074|2189513|P1|Double Blind Period|Lost to Follow-up|0
676078|NCT01712074|2189511|P3|Double Blind Period|Death|0
676079|NCT01712074|2189512|P2|Double Blind Period|Death|1
676080|NCT01712074|2189513|P1|Double Blind Period|Death|0
676081|NCT01712074|2189511|P3|Double Blind Period|No longer willing to participate|4
676082|NCT01712074|2189512|P2|Double Blind Period|No longer willing to participate|2
676083|NCT01712074|2189513|P1|Double Blind Period|No longer willing to participate|0
676084|NCT01712074|2189511|P3|Double Blind Period|Adverse Event|1
676085|NCT01712074|2189512|P2|Double Blind Period|Adverse Event|2
676086|NCT01712074|2189513|P1|Double Blind Period|Adverse Event|0
676087|NCT01712074|2189511|P3|Placebo Run-in Period|No longer willing to participate|0
676088|NCT01712074|2189512|P2|Placebo Run-in Period|No longer willing to participate|0
676089|NCT01712074|2189513|P1|Placebo Run-in Period|No longer willing to participate|1
676090|NCT01712074|2189511|P3|Placebo Run-in Period|Unspecified|0
676091|NCT01712074|2189512|P2|Placebo Run-in Period|Unspecified|0
676092|NCT01712074|2189513|P1|Placebo Run-in Period|Unspecified|1
676093|NCT01712074|2189511|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
676094|NCT01712074|2189512|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
676095|NCT01712074|2189513|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
676096|NCT01712074|2189511|P3|Placebo Run-in Period|Lost to Follow-up|0
676097|NCT01712074|2189512|P2|Placebo Run-in Period|Lost to Follow-up|0
676098|NCT01712074|2189513|P1|Placebo Run-in Period|Lost to Follow-up|1
676099|NCT01712074|2189511|P3|Placebo Run-in Period|Adverse Event|0
676100|NCT01712074|2189512|P2|Placebo Run-in Period|Adverse Event|0
676101|NCT01712074|2189513|P1|Placebo Run-in Period|Adverse Event|2
676102|NCT01712061|2189569|P3|Overall Study|Unspecified|0
676103|NCT01712061|2189570|P2|Overall Study|Unspecified|3
676104|NCT01712061|2189571|P1|Overall Study|Unspecified|0
676105|NCT01712061|2189569|P3|Overall Study|Withdrawal by Subject|1
676106|NCT01712061|2189570|P2|Overall Study|Withdrawal by Subject|7
676107|NCT01712061|2189571|P1|Overall Study|Withdrawal by Subject|1
676108|NCT01712061|2189569|P3|Overall Study|Medication Error Without Associated AE|0
676109|NCT01712061|2189570|P2|Overall Study|Medication Error Without Associated AE|1
676110|NCT01712061|2189571|P1|Overall Study|Medication Error Without Associated AE|0
676111|NCT01712061|2189569|P3|Overall Study|Did Not Meet Entrance Criteria|3
676112|NCT01712061|2189570|P2|Overall Study|Did Not Meet Entrance Criteria|6
676113|NCT01712061|2189571|P1|Overall Study|Did Not Meet Entrance Criteria|4
676114|NCT01712061|2189569|P3|Overall Study|Lost to Follow-up|1
676115|NCT01712061|2189570|P2|Overall Study|Lost to Follow-up|0
676116|NCT01712061|2189571|P1|Overall Study|Lost to Follow-up|1
676117|NCT01712061|2189569|P3|Overall Study|Death|1
676118|NCT01712061|2189570|P2|Overall Study|Death|0
676119|NCT01712061|2189571|P1|Overall Study|Death|0
676120|NCT01712061|2189569|P3|Overall Study|Adverse Event|5
676121|NCT01712061|2189570|P2|Overall Study|Adverse Event|9
676122|NCT01712061|2189571|P1|Overall Study|Adverse Event|4
676123|NCT01712009|2189611|P3|Overall Study|Decision by Sponsor|12
676124|NCT01712009|2189612|P2|Overall Study|Decision by Sponsor|14
676125|NCT01712009|2189613|P1|Overall Study|Decision by Sponsor|12
676126|NCT01712009|2189611|P3|Overall Study|Lost to Follow-up|1
676127|NCT01712009|2189612|P2|Overall Study|Lost to Follow-up|0
676128|NCT01712009|2189613|P1|Overall Study|Lost to Follow-up|2
676129|NCT01712009|2189611|P3|Overall Study|Withdrawal by Subject|8
676130|NCT01712009|2189612|P2|Overall Study|Withdrawal by Subject|15
676131|NCT01712009|2189613|P1|Overall Study|Withdrawal by Subject|24
676132|NCT01711866|2189647|P1|Overall Study|Adverse Event|2
676133|NCT01711866|2189647|P1|Overall Study|Withdrawal by Subject|3
676134|NCT01711866|2189647|P1|Overall Study|Noncompliant|3
676135|NCT01711853|2189652|P1|Overall Study|Not treated|3
676136|NCT01711736|2189659|P2|Overall Study|Migrated/moved from study area|1
676137|NCT01711736|2189660|P1|Overall Study|Migrated/moved from study area|2
676138|NCT01711736|2189659|P2|Overall Study|Withdrawal by Subject|6
676139|NCT01711736|2189660|P1|Overall Study|Withdrawal by Subject|6
676140|NCT01711736|2189659|P2|Overall Study|Lost to Follow-up|1
676141|NCT01711736|2189660|P1|Overall Study|Lost to Follow-up|4
676142|NCT01711645|2189688|P1|Overall Study|Physician Decision|5
676143|NCT01711645|2189688|P1|Overall Study|Lost to Follow-up|6
676144|NCT01711645|2189688|P1|Overall Study|Withdrawal by Subject|8
676145|NCT01711359|2189733|P3|Treatment Period|Randomized, Not Treated|0
676146|NCT01711359|2189734|P2|Treatment Period|Randomized, Not Treated|1
676147|NCT01711359|2189735|P1|Treatment Period|Randomized, Not Treated|3
676148|NCT01711359|2189733|P3|Treatment Period|Lost to Follow-up|1
676149|NCT01711359|2189734|P2|Treatment Period|Lost to Follow-up|1
676150|NCT01711359|2189735|P1|Treatment Period|Lost to Follow-up|1
676151|NCT01711359|2189733|P3|Treatment Period|Sponsor Decision|0
676152|NCT01711359|2189734|P2|Treatment Period|Sponsor Decision|0
676153|NCT01711359|2189735|P1|Treatment Period|Sponsor Decision|1
676154|NCT01711359|2189733|P3|Treatment Period|Entry Criteria Not Met|0
676155|NCT01711359|2189734|P2|Treatment Period|Entry Criteria Not Met|0
676156|NCT01711359|2189735|P1|Treatment Period|Entry Criteria Not Met|1
676157|NCT01711359|2189733|P3|Treatment Period|Death|0
676158|NCT01711359|2189734|P2|Treatment Period|Death|0
676159|NCT01711359|2189735|P1|Treatment Period|Death|3
676160|NCT01711359|2189733|P3|Treatment Period|Physician Decision|2
676161|NCT01711359|2189734|P2|Treatment Period|Physician Decision|3
676162|NCT01711359|2189735|P1|Treatment Period|Physician Decision|4
676163|NCT01711359|2189733|P3|Treatment Period|Adverse Event|24
676164|NCT01711359|2189734|P2|Treatment Period|Adverse Event|10
676165|NCT01711359|2189735|P1|Treatment Period|Adverse Event|8
676166|NCT01711359|2189733|P3|Treatment Period|Lack of Efficacy|2
676167|NCT01711359|2189734|P2|Treatment Period|Lack of Efficacy|2
676168|NCT01711359|2189735|P1|Treatment Period|Lack of Efficacy|13
676169|NCT01711359|2189733|P3|Treatment Period|Withdrawal by Subject|13
676170|NCT01711359|2189734|P2|Treatment Period|Withdrawal by Subject|7
676171|NCT01711359|2189735|P1|Treatment Period|Withdrawal by Subject|18
676172|NCT01711216|2189806|P1|Overall Study|no reason specified|22
676173|NCT01711216|2189806|P1|Overall Study|variety of other minor reasons|83
676174|NCT01711216|2189806|P1|Overall Study|Lost to Follow-up|46
676175|NCT01711216|2189806|P1|Overall Study|Withdrawal by Subject|6
676176|NCT01711216|2189806|P1|Overall Study|Pregnancy|56
676177|NCT01711216|2189806|P1|Overall Study|Adverse Event|4
676178|NCT01710800|2189865|P1|Overall Study|Protocol Violation|1
676179|NCT01710800|2189865|P1|Overall Study|Withdrawal by Subject|21
676180|NCT01710657|2189932|P3|Overall Study|Lack of Efficacy|1
676181|NCT01710657|2189933|P2|Overall Study|Lack of Efficacy|1
676182|NCT01710657|2189934|P1|Overall Study|Lack of Efficacy|0
676183|NCT01710657|2189932|P3|Overall Study|Withdrawal by Subject|2
676184|NCT01710657|2189933|P2|Overall Study|Withdrawal by Subject|1
676185|NCT01710657|2189934|P1|Overall Study|Withdrawal by Subject|0
676186|NCT01710657|2189932|P3|Overall Study|Adverse Event|28
676187|NCT01710657|2189933|P2|Overall Study|Adverse Event|8
676188|NCT01710657|2189934|P1|Overall Study|Adverse Event|14
676189|NCT01710657|2189932|P3|Overall Study|Protocol Violation|0
676190|NCT01710657|2189933|P2|Overall Study|Protocol Violation|2
676191|NCT01710657|2189934|P1|Overall Study|Protocol Violation|2
676192|NCT01710657|2189932|P3|Overall Study|Lost to Follow-up|1
676193|NCT01710657|2189933|P2|Overall Study|Lost to Follow-up|0
676194|NCT01710657|2189934|P1|Overall Study|Lost to Follow-up|2
676195|NCT01710527|2189951|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
676196|NCT01710527|2189952|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
676197|NCT01710514|2189978|P2|Overall Study|Withdrawal by Subject|0
676198|NCT01710514|2189979|P1|Overall Study|Withdrawal by Subject|1
676199|NCT01710514|2189978|P2|Overall Study|Adverse Event|7
676200|NCT01710514|2189979|P1|Overall Study|Adverse Event|6
676201|NCT01710501|2190000|P3|Overall Study|Lost to Follow-up|0
676202|NCT01710501|2190001|P2|Overall Study|Lost to Follow-up|0
676203|NCT01710501|2190002|P1|Overall Study|Lost to Follow-up|2
676204|NCT01710358|2190034|P3|Rescue Period|Withdrawal by Subject|0
676205|NCT01710358|2190035|P2|Rescue Period|Withdrawal by Subject|8
676206|NCT01710358|2190036|P1|Rescue Period|Withdrawal by Subject|0
676207|NCT01710358|2190034|P3|Rescue Period|Lack of Efficacy|0
676208|NCT01710358|2190035|P2|Rescue Period|Lack of Efficacy|7
676209|NCT01710358|2190036|P1|Rescue Period|Lack of Efficacy|0
676210|NCT01710358|2190034|P3|Rescue Period|Death|0
676211|NCT01710358|2190035|P2|Rescue Period|Death|1
676212|NCT01710358|2190036|P1|Rescue Period|Death|0
676213|NCT01710358|2190034|P3|Rescue Period|Adverse Event|0
676214|NCT01710358|2190035|P2|Rescue Period|Adverse Event|15
676215|NCT01710358|2190036|P1|Rescue Period|Adverse Event|0
676216|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
676217|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
676218|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
676219|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
676220|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
676221|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
676222|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
676223|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
676224|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
676225|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
676226|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
676227|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
676228|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
676229|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
676230|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
676231|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
676232|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
676233|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
676234|NCT01710358|2190034|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
676235|NCT01710358|2190035|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
676236|NCT01710358|2190036|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
676237|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
676238|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
676239|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
676240|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
676241|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
676242|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
676243|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
676244|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
676245|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
676246|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
676247|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
676248|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
676249|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
676250|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
676251|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
676252|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
676253|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
676254|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
676255|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
676256|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
676343|NCT01709500|2190579|P1|Overall Study|Treatment ongoing|156
676257|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
676258|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
676259|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
676260|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
676261|NCT01710358|2190034|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
676262|NCT01710358|2190035|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
676263|NCT01710358|2190036|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
676264|NCT01710345|2190107|P3|Overall Study|Drug Dosing Error|0
676265|NCT01710345|2190108|P2|Overall Study|Drug Dosing Error|0
676266|NCT01710345|2190109|P1|Overall Study|Drug Dosing Error|1
676267|NCT01710345|2190107|P3|Overall Study|Lack of Efficacy|1
676268|NCT01710345|2190108|P2|Overall Study|Lack of Efficacy|3
676269|NCT01710345|2190109|P1|Overall Study|Lack of Efficacy|2
676270|NCT01710345|2190107|P3|Overall Study|Adverse Event|0
676271|NCT01710345|2190108|P2|Overall Study|Adverse Event|2
676272|NCT01710345|2190109|P1|Overall Study|Adverse Event|0
676275|NCT01710033|2190171|P5|Stage 2|Adverse Event|1
676276|NCT01710033|2190172|P4|Stage 2|Adverse Event|0
676277|NCT01710033|2190173|P3|Stage 2|Adverse Event|0
676278|NCT01710033|2190174|P2|Stage 2|Adverse Event|0
676279|NCT01710033|2190175|P1|Stage 2|Adverse Event|0
676280|NCT01710020|2190256|P1|Period 1|Protocol Violation|1
676281|NCT01709903|2190275|P2|Overall Study|Adverse Event|18
676282|NCT01709903|2190276|P1|Overall Study|Adverse Event|11
676283|NCT01709903|2190275|P2|Overall Study|Withdrawal by Subject|6
676284|NCT01709903|2190276|P1|Overall Study|Withdrawal by Subject|6
676285|NCT01709903|2190275|P2|Overall Study|Lack of Efficacy|3
676286|NCT01709903|2190276|P1|Overall Study|Lack of Efficacy|3
676287|NCT01709903|2190275|P2|Overall Study|Protocol Violation|2
676288|NCT01709903|2190276|P1|Overall Study|Protocol Violation|3
676289|NCT01709903|2190275|P2|Overall Study|Death|0
676290|NCT01709903|2190276|P1|Overall Study|Death|2
676291|NCT01709903|2190275|P2|Overall Study|Lost to Follow-up|2
676292|NCT01709903|2190276|P1|Overall Study|Lost to Follow-up|0
676293|NCT01709903|2190275|P2|Overall Study|no longer needed study drug|1
676294|NCT01709903|2190276|P1|Overall Study|no longer needed study drug|0
676295|NCT01709903|2190275|P2|Overall Study|In ability to use device|1
676296|NCT01709903|2190276|P1|Overall Study|In ability to use device|1
676297|NCT01709903|2190275|P2|Overall Study|Abnormal test procedure results|0
676298|NCT01709903|2190276|P1|Overall Study|Abnormal test procedure results|1
676299|NCT01709903|2190275|P2|Overall Study|administrative problems|6
676300|NCT01709903|2190276|P1|Overall Study|administrative problems|2
676301|NCT01709864|2190300|P2|Overall Study|Death|1
676302|NCT01709864|2190301|P1|Overall Study|Death|0
676303|NCT01709864|2190300|P2|Overall Study|Adverse Event|2
676304|NCT01709864|2190301|P1|Overall Study|Adverse Event|0
676305|NCT01709864|2190300|P2|Overall Study|non-compliance with study treatment|1
676306|NCT01709864|2190301|P1|Overall Study|non-compliance with study treatment|1
676307|NCT01709864|2190300|P2|Overall Study|Lost to Follow-up|0
676308|NCT01709864|2190301|P1|Overall Study|Lost to Follow-up|1
676309|NCT01709864|2190300|P2|Overall Study|subject/guardian decision|6
676310|NCT01709864|2190301|P1|Overall Study|subject/guardian decision|5
676311|NCT01709864|2190300|P2|Overall Study|Physician Decision|1
676312|NCT01709864|2190301|P1|Overall Study|Physician Decision|0
676315|NCT01709578|2190382|P3|Overall Study|Other, not related to safety or efficacy|5
676316|NCT01709578|2190383|P2|Overall Study|Other, not related to safety or efficacy|7
676317|NCT01709578|2190384|P1|Overall Study|Other, not related to safety or efficacy|2
676318|NCT01709578|2190382|P3|Overall Study|Poor compliance to protocol|1
676319|NCT01709578|2190383|P2|Overall Study|Poor compliance to protocol|2
676320|NCT01709578|2190384|P1|Overall Study|Poor compliance to protocol|1
676321|NCT01709578|2190382|P3|Overall Study|Lack of Efficacy|2
676322|NCT01709578|2190383|P2|Overall Study|Lack of Efficacy|4
676323|NCT01709578|2190384|P1|Overall Study|Lack of Efficacy|5
676324|NCT01709578|2190382|P3|Overall Study|Adverse Event|17
676325|NCT01709578|2190383|P2|Overall Study|Adverse Event|18
676326|NCT01709578|2190384|P1|Overall Study|Adverse Event|9
676327|NCT01709578|2190382|P3|Overall Study|Rescued and entered in long term safety|26
676328|NCT01709578|2190383|P2|Overall Study|Rescued and entered in long term safety|25
676329|NCT01709578|2190384|P1|Overall Study|Rescued and entered in long term safety|63
676330|NCT01709513|2190515|P3|Overall Study|Unspecified|7
676331|NCT01709513|2190516|P2|Overall Study|Unspecified|11
676332|NCT01709513|2190517|P1|Overall Study|Unspecified|3
676333|NCT01709513|2190515|P3|Overall Study|Poor compliance to protocol|0
676334|NCT01709513|2190516|P2|Overall Study|Poor compliance to protocol|0
676335|NCT01709513|2190517|P1|Overall Study|Poor compliance to protocol|2
676336|NCT01709513|2190515|P3|Overall Study|Adverse Event|23
676337|NCT01709513|2190516|P2|Overall Study|Adverse Event|31
676338|NCT01709513|2190517|P1|Overall Study|Adverse Event|16
676339|NCT01709513|2190515|P3|Overall Study|Randomized but not treated|0
676340|NCT01709513|2190516|P2|Overall Study|Randomized but not treated|1
676341|NCT01709513|2190517|P1|Overall Study|Randomized but not treated|0
676342|NCT01709500|2190578|P2|Overall Study|Treatment ongoing|78
676344|NCT01709500|2190578|P2|Overall Study|Related to IMP administration|0
676345|NCT01709500|2190579|P1|Overall Study|Related to IMP administration|1
676346|NCT01709500|2190578|P2|Overall Study|Unspecified|1
676347|NCT01709500|2190579|P1|Overall Study|Unspecified|3
676348|NCT01709500|2190578|P2|Overall Study|Poor compliance to protocol|1
676349|NCT01709500|2190579|P1|Overall Study|Poor compliance to protocol|2
676350|NCT01709500|2190578|P2|Overall Study|Adverse Event|1
676351|NCT01709500|2190579|P1|Overall Study|Adverse Event|5
676352|NCT01709500|2190578|P2|Overall Study|Randomized but not treated|1
676353|NCT01709500|2190579|P1|Overall Study|Randomized but not treated|0
676354|NCT01709383|2190657|P2|Overall Study|Lost to Follow-up|0
676355|NCT01709383|2190658|P1|Overall Study|Lost to Follow-up|1
676356|NCT01709331|2190676|P1|Overall Study|Adverse Event|1
676357|NCT01709305|2190682|P5|Phase 2|Withdrawal by Subject|12
676358|NCT01709305|2190683|P4|Phase 2|Withdrawal by Subject|15
676359|NCT01709305|2190684|P3|Phase 2|Withdrawal by Subject|6
676360|NCT01709305|2190685|P2|Phase 2|Withdrawal by Subject|8
676361|NCT01709305|2190686|P1|Phase 2|Withdrawal by Subject|0
676362|NCT01709305|2190682|P5|Phase 2|Protocol Violation|9
676363|NCT01709305|2190683|P4|Phase 2|Protocol Violation|13
676364|NCT01709305|2190684|P3|Phase 2|Protocol Violation|19
676365|NCT01709305|2190685|P2|Phase 2|Protocol Violation|19
676366|NCT01709305|2190686|P1|Phase 2|Protocol Violation|0
676367|NCT01709305|2190682|P5|Phase 2|Physician Decision|2
676368|NCT01709305|2190683|P4|Phase 2|Physician Decision|1
676369|NCT01709305|2190684|P3|Phase 2|Physician Decision|0
676370|NCT01709305|2190685|P2|Phase 2|Physician Decision|2
676371|NCT01709305|2190686|P1|Phase 2|Physician Decision|0
676372|NCT01709305|2190682|P5|Phase 2|Travel, moving, etc.|5
676373|NCT01709305|2190683|P4|Phase 2|Travel, moving, etc.|3
676374|NCT01709305|2190684|P3|Phase 2|Travel, moving, etc.|3
676375|NCT01709305|2190685|P2|Phase 2|Travel, moving, etc.|2
676376|NCT01709305|2190686|P1|Phase 2|Travel, moving, etc.|0
676377|NCT01709305|2190682|P5|Phase 2|Lost to Follow-up|5
676378|NCT01709305|2190683|P4|Phase 2|Lost to Follow-up|9
676379|NCT01709305|2190684|P3|Phase 2|Lost to Follow-up|6
676380|NCT01709305|2190685|P2|Phase 2|Lost to Follow-up|10
676381|NCT01709305|2190686|P1|Phase 2|Lost to Follow-up|0
676382|NCT01709305|2190682|P5|Phase 2|Laboratory Adverse Event|1
676383|NCT01709305|2190683|P4|Phase 2|Laboratory Adverse Event|1
676384|NCT01709305|2190684|P3|Phase 2|Laboratory Adverse Event|0
676385|NCT01709305|2190685|P2|Phase 2|Laboratory Adverse Event|1
676386|NCT01709305|2190686|P1|Phase 2|Laboratory Adverse Event|0
676387|NCT01709305|2190682|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
676388|NCT01709305|2190683|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
676389|NCT01709305|2190684|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
676390|NCT01709305|2190685|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
676391|NCT01709305|2190686|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
676392|NCT01709305|2190682|P5|Phase 2|Death|0
676393|NCT01709305|2190683|P4|Phase 2|Death|0
676394|NCT01709305|2190684|P3|Phase 2|Death|1
676395|NCT01709305|2190685|P2|Phase 2|Death|0
676396|NCT01709305|2190686|P1|Phase 2|Death|0
676397|NCT01709305|2190682|P5|Phase 2|Clinical Adverse Event|11
676398|NCT01709305|2190683|P4|Phase 2|Clinical Adverse Event|6
676399|NCT01709305|2190684|P3|Phase 2|Clinical Adverse Event|10
676400|NCT01709305|2190685|P2|Phase 2|Clinical Adverse Event|10
676401|NCT01709305|2190686|P1|Phase 2|Clinical Adverse Event|0
676402|NCT01709305|2190682|P5|Phase 1|Withdrawal by Subject|0
676403|NCT01709305|2190683|P4|Phase 1|Withdrawal by Subject|0
676404|NCT01709305|2190684|P3|Phase 1|Withdrawal by Subject|0
676405|NCT01709305|2190685|P2|Phase 1|Withdrawal by Subject|0
676406|NCT01709305|2190686|P1|Phase 1|Withdrawal by Subject|218
676407|NCT01709305|2190682|P5|Phase 1|Protocol Violation|0
676408|NCT01709305|2190683|P4|Phase 1|Protocol Violation|0
676409|NCT01709305|2190684|P3|Phase 1|Protocol Violation|0
676410|NCT01709305|2190685|P2|Phase 1|Protocol Violation|0
676411|NCT01709305|2190686|P1|Phase 1|Protocol Violation|118
676412|NCT01709305|2190682|P5|Phase 1|Physician Decision|0
676413|NCT01709305|2190683|P4|Phase 1|Physician Decision|0
676414|NCT01709305|2190684|P3|Phase 1|Physician Decision|0
676415|NCT01709305|2190685|P2|Phase 1|Physician Decision|0
676416|NCT01709305|2190686|P1|Phase 1|Physician Decision|13
676417|NCT01709305|2190682|P5|Phase 1|Travel, moving, etc.|0
676418|NCT01709305|2190683|P4|Phase 1|Travel, moving, etc.|0
676419|NCT01709305|2190684|P3|Phase 1|Travel, moving, etc.|0
676420|NCT01709305|2190685|P2|Phase 1|Travel, moving, etc.|0
676421|NCT01709305|2190686|P1|Phase 1|Travel, moving, etc.|30
676422|NCT01709305|2190682|P5|Phase 1|Lost to Follow-up|0
676423|NCT01709305|2190683|P4|Phase 1|Lost to Follow-up|0
676424|NCT01709305|2190684|P3|Phase 1|Lost to Follow-up|0
676425|NCT01709305|2190685|P2|Phase 1|Lost to Follow-up|0
676426|NCT01709305|2190686|P1|Phase 1|Lost to Follow-up|147
676427|NCT01709305|2190682|P5|Phase 1|Laboratory Adverse Event|0
676428|NCT01709305|2190683|P4|Phase 1|Laboratory Adverse Event|0
676429|NCT01709305|2190684|P3|Phase 1|Laboratory Adverse Event|0
676430|NCT01709305|2190685|P2|Phase 1|Laboratory Adverse Event|0
676431|NCT01709305|2190686|P1|Phase 1|Laboratory Adverse Event|16
676432|NCT01709305|2190682|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
676433|NCT01709305|2190683|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
676434|NCT01709305|2190684|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
676435|NCT01709305|2190685|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
676436|NCT01709305|2190686|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
676437|NCT01709305|2190682|P5|Phase 1|Death|0
676438|NCT01709305|2190683|P4|Phase 1|Death|0
676439|NCT01709305|2190684|P3|Phase 1|Death|0
676440|NCT01709305|2190685|P2|Phase 1|Death|0
676441|NCT01709305|2190686|P1|Phase 1|Death|2
676442|NCT01709305|2190682|P5|Phase 1|Clinical Adverse Event|0
676443|NCT01709305|2190683|P4|Phase 1|Clinical Adverse Event|0
676444|NCT01709305|2190684|P3|Phase 1|Clinical Adverse Event|0
676445|NCT01709305|2190685|P2|Phase 1|Clinical Adverse Event|0
676446|NCT01709305|2190686|P1|Phase 1|Clinical Adverse Event|80
676447|NCT01709227|2190723|P2|Overall Study|Pleural Peritoneal communication|9
676448|NCT01709227|2190724|P1|Overall Study|Pleural Peritoneal communication|0
676449|NCT01709227|2190723|P2|Overall Study|Physician Decision|0
676450|NCT01709227|2190724|P1|Overall Study|Physician Decision|1
676451|NCT01709162|2190750|P2|Overall Study|Withdrawal by Subject|1
676452|NCT01709162|2190751|P1|Overall Study|Withdrawal by Subject|0
676453|NCT01709162|2190750|P2|Overall Study|Not specified|0
676454|NCT01709162|2190751|P1|Overall Study|Not specified|1
676455|NCT01709162|2190750|P2|Overall Study|Administrative reason by sponsor|1
676456|NCT01709162|2190751|P1|Overall Study|Administrative reason by sponsor|0
676457|NCT01709162|2190750|P2|Overall Study|Study drug toxicity|0
676458|NCT01709162|2190751|P1|Overall Study|Study drug toxicity|2
676459|NCT01709162|2190750|P2|Overall Study|Disease progression|3
676460|NCT01709162|2190751|P1|Overall Study|Disease progression|3
676461|NCT01709084|2190772|P2|Overall Study|Not Treated|2
676462|NCT01709084|2190773|P1|Overall Study|Not Treated|0
676463|NCT01709084|2190772|P2|Overall Study|Participant Reached a Virologic Endpoint|1
676464|NCT01709084|2190773|P1|Overall Study|Participant Reached a Virologic Endpoint|0
676465|NCT01709084|2190772|P2|Overall Study|unspecified|3
676466|NCT01709084|2190773|P1|Overall Study|unspecified|5
676467|NCT01709084|2190772|P2|Overall Study|Adverse Event|0
676468|NCT01709084|2190773|P1|Overall Study|Adverse Event|5
676469|NCT01709084|2190772|P2|Overall Study|Withdrawal by Subject|2
676470|NCT01709084|2190773|P1|Overall Study|Withdrawal by Subject|2
676471|NCT01709084|2190772|P2|Overall Study|Lost to Follow-up|7
676472|NCT01709084|2190773|P1|Overall Study|Lost to Follow-up|4
676473|NCT01708954|2190801|P3|Step 2|Withdrawal by Subject|0
676474|NCT01708954|2190802|P2|Step 2|Withdrawal by Subject|1
676475|NCT01708954|2190803|P1|Step 2|Withdrawal by Subject|1
676476|NCT01708954|2190801|P3|Step 2|Adverse Event|0
676477|NCT01708954|2190802|P2|Step 2|Adverse Event|2
676478|NCT01708954|2190803|P1|Step 2|Adverse Event|3
676479|NCT01708954|2190801|P3|Step 2|Disease progression|0
676480|NCT01708954|2190802|P2|Step 2|Disease progression|4
676481|NCT01708954|2190803|P1|Step 2|Disease progression|9
676482|NCT01708954|2190801|P3|Step 1|Ineligible or never received treatment|8
676483|NCT01708954|2190802|P2|Step 1|Ineligible or never received treatment|2
676484|NCT01708954|2190803|P1|Step 1|Ineligible or never received treatment|4
676485|NCT01708954|2190801|P3|Step 1|Off-treatment reason not submitted|1
676486|NCT01708954|2190802|P2|Step 1|Off-treatment reason not submitted|1
676487|NCT01708954|2190803|P1|Step 1|Off-treatment reason not submitted|1
676488|NCT01708954|2190801|P3|Step 1|Symptomatic deterioration|1
676489|NCT01708954|2190802|P2|Step 1|Symptomatic deterioration|0
676490|NCT01708954|2190803|P1|Step 1|Symptomatic deterioration|1
676491|NCT01708954|2190801|P3|Step 1|Crossed over to Step 2|0
676492|NCT01708954|2190802|P2|Step 1|Crossed over to Step 2|0
676493|NCT01708954|2190803|P1|Step 1|Crossed over to Step 2|2
676494|NCT01708954|2190801|P3|Step 1|Other complicating disease|0
676495|NCT01708954|2190802|P2|Step 1|Other complicating disease|2
676496|NCT01708954|2190803|P1|Step 1|Other complicating disease|0
676497|NCT01708954|2190801|P3|Step 1|Withdrawal by Subject|3
676498|NCT01708954|2190802|P2|Step 1|Withdrawal by Subject|5
676499|NCT01708954|2190803|P1|Step 1|Withdrawal by Subject|2
676500|NCT01708954|2190801|P3|Step 1|Death|3
676501|NCT01708954|2190802|P2|Step 1|Death|2
676502|NCT01708954|2190803|P1|Step 1|Death|3
676503|NCT01708954|2190801|P3|Step 1|Adverse Event|13
676504|NCT01708954|2190802|P2|Step 1|Adverse Event|11
676505|NCT01708954|2190803|P1|Step 1|Adverse Event|3
676506|NCT01708954|2190801|P3|Step 1|Disease progression|14
676507|NCT01708954|2190802|P2|Step 1|Disease progression|17
676508|NCT01708954|2190803|P1|Step 1|Disease progression|26
676509|NCT01708915|2190828|P4|Overall Study|Other reasons than stated above|2
676510|NCT01708915|2190829|P3|Overall Study|Other reasons than stated above|0
676511|NCT01708915|2190830|P2|Overall Study|Other reasons than stated above|1
676512|NCT01708915|2190831|P1|Overall Study|Other reasons than stated above|1
676513|NCT01708915|2190828|P4|Overall Study|Withdrawal by Subject|2
676514|NCT01708915|2190829|P3|Overall Study|Withdrawal by Subject|2
676515|NCT01708915|2190830|P2|Overall Study|Withdrawal by Subject|1
676516|NCT01708915|2190831|P1|Overall Study|Withdrawal by Subject|0
676517|NCT01708915|2190828|P4|Overall Study|Protocol Violation|1
676518|NCT01708915|2190829|P3|Overall Study|Protocol Violation|0
676519|NCT01708915|2190830|P2|Overall Study|Protocol Violation|0
676520|NCT01708915|2190831|P1|Overall Study|Protocol Violation|0
676521|NCT01708915|2190828|P4|Overall Study|Lack of Efficacy|15
676522|NCT01708915|2190829|P3|Overall Study|Lack of Efficacy|35
676523|NCT01708915|2190830|P2|Overall Study|Lack of Efficacy|60
676524|NCT01708915|2190831|P1|Overall Study|Lack of Efficacy|84
676525|NCT01708915|2190828|P4|Overall Study|Adverse Event|13
676526|NCT01708915|2190829|P3|Overall Study|Adverse Event|9
676527|NCT01708915|2190830|P2|Overall Study|Adverse Event|0
676528|NCT01708915|2190831|P1|Overall Study|Adverse Event|1
676529|NCT01708902|2190860|P7|Overall Study|Other Reason|0
676530|NCT01708902|2190861|P6|Overall Study|Other Reason|2
676531|NCT01708902|2190862|P5|Overall Study|Other Reason|1
676532|NCT01708902|2190863|P4|Overall Study|Other Reason|1
676533|NCT01708902|2190864|P3|Overall Study|Other Reason|1
676534|NCT01708902|2190865|P2|Overall Study|Other Reason|0
676535|NCT01708902|2190866|P1|Overall Study|Other Reason|1
676536|NCT01708902|2190860|P7|Overall Study|Refused to continue trial medication|1
676537|NCT01708902|2190861|P6|Overall Study|Refused to continue trial medication|1
676538|NCT01708902|2190862|P5|Overall Study|Refused to continue trial medication|8
676539|NCT01708902|2190863|P4|Overall Study|Refused to continue trial medication|2
676540|NCT01708902|2190864|P3|Overall Study|Refused to continue trial medication|4
676541|NCT01708902|2190865|P2|Overall Study|Refused to continue trial medication|0
676542|NCT01708902|2190866|P1|Overall Study|Refused to continue trial medication|8
676543|NCT01708902|2190860|P7|Overall Study|Lost to Follow-up|1
676544|NCT01708902|2190861|P6|Overall Study|Lost to Follow-up|0
676545|NCT01708902|2190862|P5|Overall Study|Lost to Follow-up|0
676546|NCT01708902|2190863|P4|Overall Study|Lost to Follow-up|2
676547|NCT01708902|2190864|P3|Overall Study|Lost to Follow-up|2
676548|NCT01708902|2190865|P2|Overall Study|Lost to Follow-up|1
676549|NCT01708902|2190866|P1|Overall Study|Lost to Follow-up|2
676550|NCT01708902|2190860|P7|Overall Study|Non compliance with protocol|0
676551|NCT01708902|2190861|P6|Overall Study|Non compliance with protocol|0
676552|NCT01708902|2190862|P5|Overall Study|Non compliance with protocol|0
676553|NCT01708902|2190863|P4|Overall Study|Non compliance with protocol|3
676554|NCT01708902|2190864|P3|Overall Study|Non compliance with protocol|1
676555|NCT01708902|2190865|P2|Overall Study|Non compliance with protocol|2
676556|NCT01708902|2190866|P1|Overall Study|Non compliance with protocol|0
676557|NCT01708902|2190860|P7|Overall Study|Lack of Efficacy|0
676558|NCT01708902|2190861|P6|Overall Study|Lack of Efficacy|1
676559|NCT01708902|2190862|P5|Overall Study|Lack of Efficacy|0
676560|NCT01708902|2190863|P4|Overall Study|Lack of Efficacy|0
676561|NCT01708902|2190864|P3|Overall Study|Lack of Efficacy|0
676562|NCT01708902|2190865|P2|Overall Study|Lack of Efficacy|1
676563|NCT01708902|2190866|P1|Overall Study|Lack of Efficacy|3
676564|NCT01708902|2190860|P7|Overall Study|Adverse Event|5
676565|NCT01708902|2190861|P6|Overall Study|Adverse Event|3
676566|NCT01708902|2190862|P5|Overall Study|Adverse Event|7
676567|NCT01708902|2190863|P4|Overall Study|Adverse Event|2
676568|NCT01708902|2190864|P3|Overall Study|Adverse Event|9
676569|NCT01708902|2190865|P2|Overall Study|Adverse Event|4
676570|NCT01708902|2190866|P1|Overall Study|Adverse Event|3
676571|NCT01708291|2190939|P2|Overall Study|fighting|1
676572|NCT01708291|2190940|P1|Overall Study|fighting|2
676573|NCT01708187|2190979|P2|Overall Study|Lost to Follow-up|1
676574|NCT01708187|2190980|P1|Overall Study|Lost to Follow-up|0
676575|NCT01708174|2190989|P3|Treatment Period|Adverse Event|0
676576|NCT01708174|2190990|P2|Treatment Period|Adverse Event|1
676577|NCT01708174|2190991|P1|Treatment Period|Adverse Event|0
676578|NCT01708174|2190989|P3|Treatment Period|Death|1
676579|NCT01708174|2190990|P2|Treatment Period|Death|0
676580|NCT01708174|2190991|P1|Treatment Period|Death|0
676581|NCT01708174|2190989|P3|Treatment Period|Progressive disease|0
676582|NCT01708174|2190990|P2|Treatment Period|Progressive disease|1
676583|NCT01708174|2190991|P1|Treatment Period|Progressive disease|0
676584|NCT01708174|2190989|P3|Treatment Period|Withdrawal by Subject|0
676585|NCT01708174|2190990|P2|Treatment Period|Withdrawal by Subject|0
676586|NCT01708174|2190991|P1|Treatment Period|Withdrawal by Subject|1
676587|NCT01708057|2191028|P3|Overall Study|Withdrawal due to study termination.|1
676588|NCT01708057|2191029|P2|Overall Study|Withdrawal due to study termination.|1
676589|NCT01708057|2191030|P1|Overall Study|Withdrawal due to study termination.|1
676590|NCT01707667|2191088|P2|Period 1|expulsion of colonic sensor catheter|0
676591|NCT01707667|2191089|P1|Period 1|expulsion of colonic sensor catheter|1
676592|NCT01707290|2191113|P2|Overall Study|Other unspecified|0
676593|NCT01707290|2191114|P1|Overall Study|Other unspecified|17
676594|NCT01707290|2191113|P2|Overall Study|Commercial drug available|1
676595|NCT01707290|2191114|P1|Overall Study|Commercial drug available|60
676596|NCT01707290|2191113|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
676597|NCT01707290|2191114|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
676598|NCT01707290|2191113|P2|Overall Study|Lost to Follow-up|0
676599|NCT01707290|2191114|P1|Overall Study|Lost to Follow-up|3
676600|NCT01707290|2191113|P2|Overall Study|Physician Decision|0
676601|NCT01707290|2191114|P1|Overall Study|Physician Decision|1
676602|NCT01707290|2191113|P2|Overall Study|Adverse event (AE)|0
676603|NCT01707290|2191114|P1|Overall Study|Adverse event (AE)|1
676604|NCT01706926|2191208|P4|Overall Study|Unspecified|3
676605|NCT01706926|2191209|P3|Overall Study|Unspecified|4
676606|NCT01706926|2191210|P2|Overall Study|Unspecified|4
676607|NCT01706926|2191211|P1|Overall Study|Unspecified|4
676608|NCT01706926|2191208|P4|Overall Study|Withdrawal by Subject|2
676609|NCT01706926|2191209|P3|Overall Study|Withdrawal by Subject|1
676610|NCT01706926|2191210|P2|Overall Study|Withdrawal by Subject|0
676611|NCT01706926|2191211|P1|Overall Study|Withdrawal by Subject|2
676612|NCT01706926|2191208|P4|Overall Study|Lost to Follow-up|0
676613|NCT01706926|2191209|P3|Overall Study|Lost to Follow-up|1
676614|NCT01706926|2191210|P2|Overall Study|Lost to Follow-up|0
676615|NCT01706926|2191211|P1|Overall Study|Lost to Follow-up|0
676616|NCT01706770|2191330|P2|Overall Study|Physician Decision|0
676617|NCT01706770|2191331|P1|Overall Study|Physician Decision|1
676618|NCT01706770|2191330|P2|Overall Study|Lost to Follow-up|0
676619|NCT01706770|2191331|P1|Overall Study|Lost to Follow-up|1
676620|NCT01706575|2191379|P1|Overall Study|Started but not Treated|6
676621|NCT01706575|2191379|P1|Overall Study|Lost to Follow-up|2
676622|NCT01706575|2191379|P1|Overall Study|Participant Withdrew Consent|4
676659|NCT01706250|2191409|P1|Overall Study|Lost to Follow-up|2
676660|NCT01706159|2191440|P2|Overall Study|Unclassified|1
676661|NCT01706159|2191441|P1|Overall Study|Unclassified|6
676662|NCT01706159|2191440|P2|Overall Study|Withdrawal Criteria|1
676663|NCT01706159|2191441|P1|Overall Study|Withdrawal Criteria|2
676664|NCT01706146|2191455|P1|Overall Study|Developed AF and need for antiplatelets|2
676665|NCT01706146|2191455|P1|Overall Study|Adverse Event|3
676666|NCT01706146|2191455|P1|Overall Study|Withdrawal by Subject|1
676667|NCT01705717|2191462|P2|Overall Study|Not Specified|2
676668|NCT01705717|2191463|P1|Overall Study|Not Specified|0
676669|NCT01705717|2191462|P2|Overall Study|Lack of Efficacy|1
676670|NCT01705717|2191463|P1|Overall Study|Lack of Efficacy|0
676671|NCT01705717|2191462|P2|Overall Study|Adverse Event|2
676672|NCT01705717|2191463|P1|Overall Study|Adverse Event|2
676673|NCT01705652|2191480|P2|Overall Study|non-compliance|1
676674|NCT01705652|2191481|P1|Overall Study|non-compliance|1
676675|NCT01705652|2191480|P2|Overall Study|Withdrawal by Subject|2
676676|NCT01705652|2191481|P1|Overall Study|Withdrawal by Subject|1
676677|NCT01705652|2191480|P2|Overall Study|Adverse Event|0
676678|NCT01705652|2191481|P1|Overall Study|Adverse Event|1
676679|NCT01705574|2191489|P2|Overall Study|Still on Study|125
676680|NCT01705574|2191490|P1|Overall Study|Still on Study|135
676681|NCT01705574|2191489|P2|Overall Study|Lost to Follow-up|15
676682|NCT01705574|2191490|P1|Overall Study|Lost to Follow-up|11
676683|NCT01705574|2191489|P2|Overall Study|Withdrew Consent|5
676684|NCT01705574|2191490|P1|Overall Study|Withdrew Consent|8
676685|NCT01705574|2191489|P2|Overall Study|Protocol Violation|0
676686|NCT01705574|2191490|P1|Overall Study|Protocol Violation|1
676687|NCT01705574|2191489|P2|Overall Study|Non-Compliance with Study Drug|4
676688|NCT01705574|2191490|P1|Overall Study|Non-Compliance with Study Drug|4
676689|NCT01705574|2191489|P2|Overall Study|Pregnancy|1
676690|NCT01705574|2191490|P1|Overall Study|Pregnancy|1
676691|NCT01705574|2191489|P2|Overall Study|Adverse Event|9
676692|NCT01705574|2191490|P1|Overall Study|Adverse Event|3
676693|NCT01705574|2191489|P2|Overall Study|Randomized but Not Treated|4
676694|NCT01705574|2191490|P1|Overall Study|Randomized but Not Treated|4
676695|NCT01705145|2191508|P1|Part B|Adverse Event|1
676696|NCT01704846|2191555|P2|Treatment Period 2|Withdrawal by Subject|1
676697|NCT01704846|2191556|P1|Treatment Period 2|Withdrawal by Subject|0
676698|NCT01704755|2191611|P2|Overall Study|Withdrew consent and personal issues|0
676699|NCT01704755|2191612|P1|Overall Study|Withdrew consent and personal issues|1
676700|NCT01704755|2191611|P2|Overall Study|Other (not specified)|1
676701|NCT01704755|2191612|P1|Overall Study|Other (not specified)|3
676702|NCT01704755|2191611|P2|Overall Study|Withdrew consent|1
676703|NCT01704755|2191612|P1|Overall Study|Withdrew consent|1
676704|NCT01704755|2191611|P2|Overall Study|Lost to Follow-up|4
676705|NCT01704755|2191612|P1|Overall Study|Lost to Follow-up|3
676706|NCT01704755|2191611|P2|Overall Study|Adverse Event|1
676707|NCT01704755|2191612|P1|Overall Study|Adverse Event|4
676708|NCT01704651|2191626|P2|Overall Study|Post-op did not have laparotomy|1
676709|NCT01704651|2191627|P1|Overall Study|Post-op did not have laparotomy|2
676710|NCT01704651|2191626|P2|Overall Study|Nasogastric tube placement in surgery|1
676711|NCT01704651|2191627|P1|Overall Study|Nasogastric tube placement in surgery|1
676712|NCT01704651|2191626|P2|Overall Study|Pre-op change in treatment plan|4
676713|NCT01704651|2191627|P1|Overall Study|Pre-op change in treatment plan|1
676714|NCT01704651|2191626|P2|Overall Study|Pre-op withdrawal by subject|1
676715|NCT01704651|2191627|P1|Overall Study|Pre-op withdrawal by subject|1
676716|NCT01704599|2191635|P1|Overall Study|Adverse Event|1
676717|NCT01704495|2191675|P4|Optional Safety Extension|Withdrawal by Subject|2
676718|NCT01704495|2191676|P3|Optional Safety Extension|Withdrawal by Subject|1
676719|NCT01704495|2191677|P2|Optional Safety Extension|Withdrawal by Subject|0
676720|NCT01704495|2191678|P1|Optional Safety Extension|Withdrawal by Subject|2
676721|NCT01704495|2191675|P4|Optional Safety Extension|Other reason|28
676722|NCT01704495|2191676|P3|Optional Safety Extension|Other reason|30
676723|NCT01704495|2191677|P2|Optional Safety Extension|Other reason|29
676724|NCT01704495|2191678|P1|Optional Safety Extension|Other reason|27
676725|NCT01704495|2191675|P4|Optional Safety Extension|Adverse Event|1
676726|NCT01704495|2191676|P3|Optional Safety Extension|Adverse Event|0
676727|NCT01704495|2191677|P2|Optional Safety Extension|Adverse Event|4
676728|NCT01704495|2191678|P1|Optional Safety Extension|Adverse Event|0
676729|NCT01704495|2191675|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
676730|NCT01704495|2191676|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
676731|NCT01704495|2191677|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
676732|NCT01704495|2191678|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
676733|NCT01704495|2191675|P4|Subjects Randomized|Protocol Violation|0
676734|NCT01704495|2191676|P3|Subjects Randomized|Protocol Violation|2
676735|NCT01704495|2191677|P2|Subjects Randomized|Protocol Violation|1
676736|NCT01704495|2191678|P1|Subjects Randomized|Protocol Violation|1
676737|NCT01704495|2191675|P4|Subjects Randomized|Withdrawal by Subject|5
676738|NCT01704495|2191676|P3|Subjects Randomized|Withdrawal by Subject|5
676739|NCT01704495|2191677|P2|Subjects Randomized|Withdrawal by Subject|5
676740|NCT01704495|2191678|P1|Subjects Randomized|Withdrawal by Subject|5
676741|NCT01704495|2191675|P4|Subjects Randomized|Adverse Event|7
676742|NCT01704495|2191676|P3|Subjects Randomized|Adverse Event|0
676743|NCT01704495|2191677|P2|Subjects Randomized|Adverse Event|2
676744|NCT01704495|2191678|P1|Subjects Randomized|Adverse Event|8
676745|NCT01704495|2191675|P4|Subjects Randomized|Discontinuation criteria met|0
676746|NCT01704495|2191676|P3|Subjects Randomized|Discontinuation criteria met|2
676747|NCT01704495|2191677|P2|Subjects Randomized|Discontinuation criteria met|2
676748|NCT01704495|2191678|P1|Subjects Randomized|Discontinuation criteria met|4
676749|NCT01704495|2191675|P4|Subjects Randomized|Other Reason|2
676750|NCT01704495|2191676|P3|Subjects Randomized|Other Reason|3
676751|NCT01704495|2191677|P2|Subjects Randomized|Other Reason|2
676752|NCT01704495|2191678|P1|Subjects Randomized|Other Reason|3
676803|NCT01704261|2191933|P2|Overall Study|Lost to Follow-up|0
676804|NCT01704261|2191934|P1|Overall Study|Lost to Follow-up|1
676805|NCT01704261|2191933|P2|Overall Study|Withdrawal by Subject|15
676806|NCT01704261|2191934|P1|Overall Study|Withdrawal by Subject|12
676807|NCT01704079|2191961|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
676808|NCT01704079|2191962|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
676809|NCT01704079|2191961|P2|Overall Study|Subject noncompliance|3
676810|NCT01704079|2191962|P1|Overall Study|Subject noncompliance|2
676811|NCT01704079|2191961|P2|Overall Study|Protocol Violation|0
676812|NCT01704079|2191962|P1|Overall Study|Protocol Violation|1
676813|NCT01704079|2191961|P2|Overall Study|Adverse Event|7
676814|NCT01704079|2191962|P1|Overall Study|Adverse Event|4
676815|NCT01704079|2191961|P2|Overall Study|Lost to Follow-up|5
676816|NCT01704079|2191962|P1|Overall Study|Lost to Follow-up|2
676817|NCT01704079|2191961|P2|Overall Study|Withdrawal by Subject|7
676818|NCT01704079|2191962|P1|Overall Study|Withdrawal by Subject|5
676819|NCT01703988|2191978|P4|Overall Study|Investigator Judgment|1
676820|NCT01703988|2191979|P3|Overall Study|Investigator Judgment|0
676821|NCT01703988|2191980|P2|Overall Study|Investigator Judgment|0
676822|NCT01703988|2191981|P1|Overall Study|Investigator Judgment|0
676823|NCT01703858|2192011|P3|Overall Study|Withdrawal by Subject|0
676824|NCT01703858|2192012|P2|Overall Study|Withdrawal by Subject|1
676825|NCT01703858|2192013|P1|Overall Study|Withdrawal by Subject|0
676826|NCT01703845|2192038|P2|Overall Study|other than stated above|0
676827|NCT01703845|2192039|P1|Overall Study|other than stated above|1
676828|NCT01703845|2192038|P2|Overall Study|Protocol Violation|0
676829|NCT01703845|2192039|P1|Overall Study|Protocol Violation|1
676830|NCT01703845|2192038|P2|Overall Study|Adverse Event|0
676831|NCT01703845|2192039|P1|Overall Study|Adverse Event|1
676832|NCT01703832|2192076|P2|Overall Study|Withdrawal by Subject|0
676833|NCT01703832|2192077|P1|Overall Study|Withdrawal by Subject|1
676834|NCT01703819|2192109|P2|Overall Study|Withdrawal by Subject|1
676835|NCT01703819|2192110|P1|Overall Study|Withdrawal by Subject|0
676836|NCT01703819|2192109|P2|Overall Study|Adverse Event|1
676837|NCT01703819|2192110|P1|Overall Study|Adverse Event|0
676838|NCT01703741|2192140|P1|Overall Study|Subject started testosterone injections|1
676839|NCT01703741|2192140|P1|Overall Study|Subject cannot comply with study visits|1
676840|NCT01703741|2192140|P1|Overall Study|Subject did not want to continue|2
676841|NCT01703741|2192140|P1|Overall Study|Lost to Follow-up|3
676842|NCT01703741|2192140|P1|Overall Study|Protocol Violation|1
676843|NCT01703741|2192140|P1|Overall Study|Physician Decision|2
676844|NCT01703741|2192140|P1|Overall Study|Adverse Event|2
676845|NCT01703741|2192140|P1|Overall Study|Withdrawal by Subject|6
676846|NCT01703286|2192183|P6|Period 2 Including Washout|Adverse Event|0
676847|NCT01703286|2192184|P5|Period 2 Including Washout|Adverse Event|0
676848|NCT01703286|2192185|P4|Period 2 Including Washout|Adverse Event|1
676849|NCT01703286|2192186|P3|Period 2 Including Washout|Adverse Event|0
676850|NCT01703286|2192187|P2|Period 2 Including Washout|Adverse Event|0
676851|NCT01703286|2192188|P1|Period 2 Including Washout|Adverse Event|0
676852|NCT01703286|2192183|P6|Period 1 Including Washout|Withdrawal by Subject|1
676853|NCT01703286|2192184|P5|Period 1 Including Washout|Withdrawal by Subject|0
676854|NCT01703286|2192185|P4|Period 1 Including Washout|Withdrawal by Subject|1
676855|NCT01703286|2192186|P3|Period 1 Including Washout|Withdrawal by Subject|0
676856|NCT01703286|2192187|P2|Period 1 Including Washout|Withdrawal by Subject|0
676857|NCT01703286|2192188|P1|Period 1 Including Washout|Withdrawal by Subject|0
676858|NCT01703260|2192211|P3|Overall Study|Study Termination|0
676859|NCT01703260|2192212|P2|Overall Study|Study Termination|2
676860|NCT01703260|2192213|P1|Overall Study|Study Termination|1
676861|NCT01703260|2192211|P3|Overall Study|Withdrawal by Subject|1
676862|NCT01703260|2192212|P2|Overall Study|Withdrawal by Subject|0
676863|NCT01703260|2192213|P1|Overall Study|Withdrawal by Subject|0
676864|NCT01703260|2192211|P3|Overall Study|Lost to Follow-up|0
676865|NCT01703260|2192212|P2|Overall Study|Lost to Follow-up|0
676866|NCT01703260|2192213|P1|Overall Study|Lost to Follow-up|1
676867|NCT01703260|2192211|P3|Overall Study|Adverse Event|2
676868|NCT01703260|2192212|P2|Overall Study|Adverse Event|2
676869|NCT01703260|2192213|P1|Overall Study|Adverse Event|1
676870|NCT01703221|2192239|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
676871|NCT01703221|2192240|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
676872|NCT01703221|2192241|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
676873|NCT01703221|2192239|P3|Phase B - (Week 25 to 52)|Adverse Event|2
676874|NCT01703221|2192240|P2|Phase B - (Week 25 to 52)|Adverse Event|3
676875|NCT01703221|2192241|P1|Phase B - (Week 25 to 52)|Adverse Event|2
676876|NCT01703221|2192239|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
676877|NCT01703221|2192240|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
676878|NCT01703221|2192241|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
676879|NCT01703221|2192239|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
676880|NCT01703221|2192240|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
676881|NCT01703221|2192241|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
676882|NCT01703221|2192239|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
676883|NCT01703221|2192240|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
676884|NCT01703221|2192241|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
676885|NCT01703221|2192239|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
676886|NCT01703221|2192240|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
676887|NCT01703221|2192241|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
676888|NCT01703221|2192239|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
676889|NCT01703221|2192240|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
676890|NCT01703221|2192241|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
676891|NCT01703221|2192239|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
676892|NCT01703221|2192240|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
676893|NCT01703221|2192241|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
676894|NCT01703091|2192272|P2|Overall Study|Sponsor Decision|0
676895|NCT01703091|2192273|P1|Overall Study|Sponsor Decision|1
676896|NCT01703091|2192272|P2|Overall Study|Withdrawal by Subject|0
676897|NCT01703091|2192273|P1|Overall Study|Withdrawal by Subject|1
676898|NCT01703091|2192272|P2|Overall Study|Physician Decision|1
676899|NCT01703091|2192273|P1|Overall Study|Physician Decision|2
676900|NCT01703091|2192272|P2|Overall Study|Adverse Event|3
676901|NCT01703091|2192273|P1|Overall Study|Adverse Event|5
676902|NCT01703000|2192289|P1|Overall Study|Death|1
676903|NCT01702987|2192322|P2|Overall Study|Withdrawal by Subject|0
676904|NCT01702987|2192323|P1|Overall Study|Withdrawal by Subject|1
676905|NCT01702961|2192329|P1|Overall Study|Ongoing|11
676906|NCT01702961|2192329|P1|Overall Study|Lost to Follow-up|2
676907|NCT01702961|2192329|P1|Overall Study|Death|6
676908|NCT01702961|2192329|P1|Overall Study|Relapse|20
676909|NCT01702961|2192329|P1|Overall Study|Progressive disease|5
676910|NCT01702961|2192329|P1|Overall Study|Additional treatment|3
676911|NCT01702532|2192342|P2|Overall Study|Adverse Event|1
676912|NCT01702532|2192343|P1|Overall Study|Adverse Event|0
676913|NCT01702519|2192353|P2|Washout Period|Withdrawal by Subject|2
676914|NCT01702519|2192354|P1|Washout Period|Withdrawal by Subject|0
676915|NCT01702519|2192353|P2|Washout Period|Lost to Follow-up|0
676916|NCT01702519|2192354|P1|Washout Period|Lost to Follow-up|1
676917|NCT01702454|2192372|P2|Overall Study|Lost to Follow-up|6
676918|NCT01702454|2192373|P1|Overall Study|Lost to Follow-up|3
676919|NCT01702454|2192372|P2|Overall Study|Migrated/moved from study area|1
676920|NCT01702454|2192373|P1|Overall Study|Migrated/moved from study area|0
676921|NCT01702454|2192372|P2|Overall Study|Consent withdrawal|1
676922|NCT01702454|2192373|P1|Overall Study|Consent withdrawal|0
676923|NCT01702363|2192451|P1|Overall Study|Withdrawal by Subject|2
676924|NCT01702363|2192451|P1|Overall Study|Lack of Efficacy|4
676925|NCT01702363|2192451|P1|Overall Study|Adverse Event|14
676926|NCT01702311|2192468|P2|Overall Study|Physician Decision|4
676927|NCT01702311|2192469|P1|Overall Study|Physician Decision|3
676928|NCT01702311|2192468|P2|Overall Study|Discharge less than 24 hours|7
676929|NCT01702311|2192469|P1|Overall Study|Discharge less than 24 hours|10
676930|NCT01702311|2192468|P2|Overall Study|Withdrawal by Subject|2
676931|NCT01702311|2192469|P1|Overall Study|Withdrawal by Subject|3
676932|NCT01702298|2192475|P1|Overall Study|Withdrawal by Subject|1
676933|NCT01702246|2192503|P1|Overall Study|Physician Decision|1
676934|NCT01702246|2192503|P1|Overall Study|Withdrawal by Subject|2
676935|NCT01702246|2192503|P1|Overall Study|Lost to Follow-up|2
676936|NCT01702025|2192557|P4|Overall Study|Adverse Event|0
676937|NCT01702025|2192558|P3|Overall Study|Adverse Event|1
676938|NCT01702025|2192559|P2|Overall Study|Adverse Event|1
676939|NCT01702025|2192560|P1|Overall Study|Adverse Event|1
676940|NCT01702025|2192557|P4|Overall Study|Equipment failure|0
676941|NCT01702025|2192558|P3|Overall Study|Equipment failure|0
676942|NCT01702025|2192559|P2|Overall Study|Equipment failure|0
676943|NCT01702025|2192560|P1|Overall Study|Equipment failure|1
676944|NCT01701674|2192589|P1|Overall Study|Unable to safely complete treatment|1
676945|NCT01701401|2192673|P4|Overall Study|Protocol Violation|0
676946|NCT01701401|2192674|P3|Overall Study|Protocol Violation|1
676947|NCT01701401|2192675|P2|Overall Study|Protocol Violation|0
676948|NCT01701401|2192676|P1|Overall Study|Protocol Violation|0
676949|NCT01701401|2192673|P4|Overall Study|Adverse Event|0
676950|NCT01701401|2192674|P3|Overall Study|Adverse Event|0
676951|NCT01701401|2192675|P2|Overall Study|Adverse Event|0
676952|NCT01701401|2192676|P1|Overall Study|Adverse Event|1
676953|NCT01701401|2192673|P4|Overall Study|Lack of Efficacy|0
676954|NCT01701401|2192674|P3|Overall Study|Lack of Efficacy|2
676955|NCT01701401|2192675|P2|Overall Study|Lack of Efficacy|0
676956|NCT01701401|2192676|P1|Overall Study|Lack of Efficacy|1
676957|NCT01701401|2192673|P4|Overall Study|Withdrew Consent|2
676958|NCT01701401|2192674|P3|Overall Study|Withdrew Consent|1
676959|NCT01701401|2192675|P2|Overall Study|Withdrew Consent|3
676960|NCT01701401|2192676|P1|Overall Study|Withdrew Consent|0
676961|NCT01701401|2192673|P4|Overall Study|Lost to Follow-up|3
676962|NCT01701401|2192674|P3|Overall Study|Lost to Follow-up|1
676963|NCT01701401|2192675|P2|Overall Study|Lost to Follow-up|5
676964|NCT01701401|2192676|P1|Overall Study|Lost to Follow-up|5
676965|NCT01701401|2192673|P4|Overall Study|Randomized But Not Treated|1
676966|NCT01701401|2192674|P3|Overall Study|Randomized But Not Treated|0
676967|NCT01701401|2192675|P2|Overall Study|Randomized But Not Treated|1
676968|NCT01701401|2192676|P1|Overall Study|Randomized But Not Treated|3
676969|NCT01701362|2192728|P2|Overall Study|Reasons other than those mentioned above|5
676970|NCT01701362|2192729|P1|Overall Study|Reasons other than those mentioned above|3
676971|NCT01701362|2192728|P2|Overall Study|Randomized but not treated|2
676972|NCT01701362|2192729|P1|Overall Study|Randomized but not treated|1
676973|NCT01701362|2192728|P2|Overall Study|Death|1
676974|NCT01701362|2192729|P1|Overall Study|Death|0
676975|NCT01701362|2192728|P2|Overall Study|Insufficient clinical response|6
676976|NCT01701362|2192729|P1|Overall Study|Insufficient clinical response|6
676977|NCT01701362|2192728|P2|Overall Study|Lost to Follow-up|9
676978|NCT01701362|2192729|P1|Overall Study|Lost to Follow-up|6
676979|NCT01701362|2192728|P2|Overall Study|No longer willing to participate|14
676980|NCT01701362|2192729|P1|Overall Study|No longer willing to participate|8
676981|NCT01701362|2192728|P2|Overall Study|Protocol Violation|3
676982|NCT01701362|2192729|P1|Overall Study|Protocol Violation|5
676983|NCT01701362|2192728|P2|Overall Study|Adverse events related to study drug|10
676984|NCT01701362|2192729|P1|Overall Study|Adverse events related to study drug|12
676985|NCT01701362|2192728|P2|Overall Study|Adverse events not related to study drug|6
676986|NCT01701362|2192729|P1|Overall Study|Adverse events not related to study drug|1
676987|NCT01701245|2192765|P2|Overall Study|Did not complete the open label period|12
676988|NCT01701245|2192766|P1|Overall Study|Did not complete the open label period|11
676989|NCT01701245|2192765|P2|Overall Study|Protocol Violation|3
676990|NCT01701245|2192766|P1|Overall Study|Protocol Violation|1
676991|NCT01701063|2192813|P3|Overall Study|Unspecified|1
676992|NCT01701063|2192814|P2|Overall Study|Unspecified|0
676993|NCT01701063|2192815|P1|Overall Study|Unspecified|0
676994|NCT01701063|2192813|P3|Overall Study|Withdrawal by Subject|1
676995|NCT01701063|2192814|P2|Overall Study|Withdrawal by Subject|0
676996|NCT01701063|2192815|P1|Overall Study|Withdrawal by Subject|0
676997|NCT01701063|2192813|P3|Overall Study|Lost to Follow-up|0
676998|NCT01701063|2192814|P2|Overall Study|Lost to Follow-up|1
676999|NCT01701063|2192815|P1|Overall Study|Lost to Follow-up|0
677000|NCT01700530|2192946|P3|Overall Study|Withdrawal by Subject|1
677001|NCT01700530|2192947|P2|Overall Study|Withdrawal by Subject|3
677002|NCT01700530|2192948|P1|Overall Study|Withdrawal by Subject|0
677003|NCT01700387|2192974|P2|Overall Study|Lost to Follow-up|1
677004|NCT01700387|2192975|P1|Overall Study|Lost to Follow-up|2
677005|NCT01700387|2192974|P2|Overall Study|Adverse Event|1
677006|NCT01700387|2192975|P1|Overall Study|Adverse Event|1
677007|NCT01700387|2192974|P2|Overall Study|Withdrawal by Subject|2
677008|NCT01700387|2192975|P1|Overall Study|Withdrawal by Subject|1
677009|NCT01700348|2192985|P1|Overall Study|Lost to Follow-up|1
677010|NCT01700348|2192985|P1|Overall Study|Withdrawal by Subject|22
677011|NCT01700192|2193003|P2|Overall Study|Never received study drug|0
677012|NCT01700192|2193004|P1|Overall Study|Never received study drug|1
677013|NCT01700192|2193003|P2|Overall Study|Withdrawal by Subject|64
677014|NCT01700192|2193004|P1|Overall Study|Withdrawal by Subject|56
677015|NCT01700192|2193003|P2|Overall Study|Technical problems|1
677016|NCT01700192|2193004|P1|Overall Study|Technical problems|0
677017|NCT01700192|2193003|P2|Overall Study|Protocol Violation|4
677018|NCT01700192|2193004|P1|Overall Study|Protocol Violation|3
677019|NCT01700192|2193003|P2|Overall Study|Progressive disease|0
677020|NCT01700192|2193004|P1|Overall Study|Progressive disease|1
677021|NCT01700192|2193003|P2|Overall Study|Pregnancy|4
677022|NCT01700192|2193004|P1|Overall Study|Pregnancy|1
677023|NCT01700192|2193003|P2|Overall Study|Physician Decision|3
677024|NCT01700192|2193004|P1|Overall Study|Physician Decision|2
677025|NCT01700192|2193003|P2|Overall Study|Noncompliance with study drug|5
677026|NCT01700192|2193004|P1|Overall Study|Noncompliance with study drug|0
677027|NCT01700192|2193003|P2|Overall Study|Lost to Follow-up|29
677028|NCT01700192|2193004|P1|Overall Study|Lost to Follow-up|42
677029|NCT01700192|2193003|P2|Overall Study|Lack of Efficacy|0
677030|NCT01700192|2193004|P1|Overall Study|Lack of Efficacy|1
677031|NCT01700192|2193003|P2|Overall Study|Adverse Event|18
677032|NCT01700192|2193004|P1|Overall Study|Adverse Event|73
677033|NCT01700179|2193022|P1|Overall Study|Physician Decision|2
677034|NCT01700140|2193029|P3|Overall Study|Inclusion/exclusion criteria deviation|0
677035|NCT01700140|2193030|P2|Overall Study|Inclusion/exclusion criteria deviation|4
677036|NCT01700140|2193031|P1|Overall Study|Inclusion/exclusion criteria deviation|1
677037|NCT01700140|2193029|P3|Overall Study|Adverse Event|0
677038|NCT01700140|2193030|P2|Overall Study|Adverse Event|1
677039|NCT01700140|2193031|P1|Overall Study|Adverse Event|0
677040|NCT01700140|2193029|P3|Overall Study|Aggravation of symptoms|0
677041|NCT01700140|2193030|P2|Overall Study|Aggravation of symptoms|0
677042|NCT01700140|2193031|P1|Overall Study|Aggravation of symptoms|1
677043|NCT01700140|2193029|P3|Overall Study|Use of chemotherapy or surgical therapy|0
677044|NCT01700140|2193030|P2|Overall Study|Use of chemotherapy or surgical therapy|1
677045|NCT01700140|2193031|P1|Overall Study|Use of chemotherapy or surgical therapy|0
677046|NCT01700140|2193029|P3|Overall Study|Discontinuation of radiotherapy|0
677047|NCT01700140|2193030|P2|Overall Study|Discontinuation of radiotherapy|0
677048|NCT01700140|2193031|P1|Overall Study|Discontinuation of radiotherapy|1
677049|NCT01700140|2193029|P3|Overall Study|Use of rescue drugs|1
677050|NCT01700140|2193030|P2|Overall Study|Use of rescue drugs|3
677051|NCT01700140|2193031|P1|Overall Study|Use of rescue drugs|3
677052|NCT01699867|2193063|P1|Overall Study|Screening Failure|3
677053|NCT01699815|2193070|P2|Overall Study|Adverse Event|1
677054|NCT01699815|2193071|P1|Overall Study|Adverse Event|0
677055|NCT01699815|2193070|P2|Overall Study|record could not be located|0
677056|NCT01699815|2193071|P1|Overall Study|record could not be located|1
677057|NCT01699815|2193070|P2|Overall Study|Protocol Violation|7
677058|NCT01699815|2193071|P1|Overall Study|Protocol Violation|4
677059|NCT01699789|2193083|P2|Overall Study|Lost to Follow-up|101
677060|NCT01699789|2193084|P1|Overall Study|Lost to Follow-up|83
677061|NCT01699789|2193083|P2|Overall Study|Death|2
677062|NCT01699789|2193084|P1|Overall Study|Death|1
677063|NCT01699789|2193083|P2|Overall Study|Withdrawal by Subject|23
677064|NCT01699789|2193084|P1|Overall Study|Withdrawal by Subject|18
677065|NCT01699750|2193154|P2|Overall Study|Other|2
677066|NCT01699750|2193155|P1|Overall Study|Other|0
677067|NCT01699750|2193154|P2|Overall Study|Withdrew Consent|1
677068|NCT01699750|2193155|P1|Overall Study|Withdrew Consent|0
677069|NCT01699685|2193190|P2|Period 2|Lost to Follow-up|0
677070|NCT01699685|2193191|P1|Period 2|Lost to Follow-up|1
677071|NCT01699685|2193190|P2|Period 1|Patient request|1
677072|NCT01699685|2193191|P1|Period 1|Patient request|0
677073|NCT01699685|2193190|P2|Period 1|Other|1
677074|NCT01699685|2193191|P1|Period 1|Other|0
677075|NCT01699685|2193190|P2|Period 1|Medical or ethical, noncompliance|0
677076|NCT01699685|2193191|P1|Period 1|Medical or ethical, noncompliance|2
677077|NCT01699685|2193190|P2|Period 1|Adverse Event|1
677078|NCT01699685|2193191|P1|Period 1|Adverse Event|1
677079|NCT01699087|2193224|P1|Overall Study|Unable to make future visits|2
677080|NCT01699087|2193224|P1|Overall Study|Screen failure (prior to treatment)|15
677081|NCT01699087|2193224|P1|Overall Study|Lost to Follow-up|7
677082|NCT01699022|2193238|P1|Overall Study|Early discontinuation from the study|3
677083|NCT01698814|2193253|P2|Overall Study|Randomized in error|0
677084|NCT01698814|2193254|P1|Overall Study|Randomized in error|1
677085|NCT01698814|2193253|P2|Overall Study|Pregnancy|0
677086|NCT01698814|2193254|P1|Overall Study|Pregnancy|1
677087|NCT01698814|2193253|P2|Overall Study|Lost to Follow-up|1
677088|NCT01698814|2193254|P1|Overall Study|Lost to Follow-up|0
677089|NCT01698814|2193253|P2|Overall Study|Adverse Event|2
677090|NCT01698814|2193254|P1|Overall Study|Adverse Event|0
677091|NCT01698801|2193260|P1|Follow Up Phase|Death|4
677092|NCT01698801|2193260|P1|Follow Up Phase|Withdrawal by Subject|1
677093|NCT01698801|2193260|P1|Treatment Phase|Disease progression|1
677094|NCT01698801|2193260|P1|Treatment Phase|Withdrawal by Subject|1
677095|NCT01698801|2193260|P1|Treatment Phase|Not specified|4
677096|NCT01698801|2193260|P1|Treatment Phase|Protocol Violation|1
677097|NCT01698801|2193260|P1|Treatment Phase|Adverse Event|4
677098|NCT01698775|2193271|P2|Phase B|Withdrawal by Subject|2
677099|NCT01698775|2193272|P1|Phase B|Withdrawal by Subject|6
677100|NCT01698775|2193271|P2|Phase B|Protocol Violation|1
677101|NCT01698775|2193272|P1|Phase B|Protocol Violation|1
677102|NCT01698775|2193271|P2|Phase B|Physician Decision|1
677103|NCT01698775|2193272|P1|Phase B|Physician Decision|1
677104|NCT01698775|2193271|P2|Phase B|Lost to Follow-up|1
677105|NCT01698775|2193272|P1|Phase B|Lost to Follow-up|0
677106|NCT01698775|2193271|P2|Phase B|Lack of Efficacy|1
677107|NCT01698775|2193272|P1|Phase B|Lack of Efficacy|0
677108|NCT01698775|2193271|P2|Phase B|Death|1
677109|NCT01698775|2193272|P1|Phase B|Death|0
677110|NCT01698775|2193271|P2|Phase B|Adverse Event|3
677111|NCT01698775|2193272|P1|Phase B|Adverse Event|6
677112|NCT01698775|2193271|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
677113|NCT01698775|2193272|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
677114|NCT01698775|2193271|P2|Phase A|Kidney [transplant]|1
677115|NCT01698775|2193272|P1|Phase A|Kidney [transplant]|0
677116|NCT01698775|2193271|P2|Phase A|Withdrawal by Subject|4
677117|NCT01698775|2193272|P1|Phase A|Withdrawal by Subject|3
677118|NCT01698775|2193271|P2|Phase A|Protocol Violation|0
677119|NCT01698775|2193272|P1|Phase A|Protocol Violation|1
677120|NCT01698775|2193271|P2|Phase A|Lost to Follow-up|2
677121|NCT01698775|2193272|P1|Phase A|Lost to Follow-up|1
677122|NCT01698775|2193271|P2|Phase A|Lack of Efficacy|0
677123|NCT01698775|2193272|P1|Phase A|Lack of Efficacy|1
677124|NCT01698775|2193271|P2|Phase A|Death|1
677125|NCT01698775|2193272|P1|Phase A|Death|1
677126|NCT01698775|2193271|P2|Phase A|Adverse Event|1
677127|NCT01698775|2193272|P1|Phase A|Adverse Event|2
677128|NCT01698554|2193321|P4|Overall Study|Other Miscellaneous Reasons|0
677129|NCT01698554|2193322|P3|Overall Study|Other Miscellaneous Reasons|0
677130|NCT01698554|2193323|P2|Overall Study|Other Miscellaneous Reasons|0
677131|NCT01698554|2193324|P1|Overall Study|Other Miscellaneous Reasons|1
677132|NCT01698554|2193321|P4|Overall Study|Protocol Violation|0
677133|NCT01698554|2193322|P3|Overall Study|Protocol Violation|1
677134|NCT01698554|2193323|P2|Overall Study|Protocol Violation|0
677135|NCT01698554|2193324|P1|Overall Study|Protocol Violation|2
677136|NCT01698554|2193321|P4|Overall Study|Personal Reasons|1
677137|NCT01698554|2193322|P3|Overall Study|Personal Reasons|1
677138|NCT01698554|2193323|P2|Overall Study|Personal Reasons|5
677139|NCT01698554|2193324|P1|Overall Study|Personal Reasons|0
677140|NCT01698554|2193321|P4|Overall Study|Lost to Follow-up|0
677141|NCT01698554|2193322|P3|Overall Study|Lost to Follow-up|0
677142|NCT01698554|2193323|P2|Overall Study|Lost to Follow-up|0
677143|NCT01698554|2193324|P1|Overall Study|Lost to Follow-up|1
677144|NCT01698554|2193321|P4|Overall Study|Adverse Event|1
677145|NCT01698554|2193322|P3|Overall Study|Adverse Event|0
677146|NCT01698554|2193323|P2|Overall Study|Adverse Event|5
677147|NCT01698554|2193324|P1|Overall Study|Adverse Event|2
677148|NCT01698320|2193380|P3|40-Week Open-Label Period|Lost to Follow-up|0
677149|NCT01698320|2193381|P2|40-Week Open-Label Period|Lost to Follow-up|2
677150|NCT01698320|2193382|P1|40-Week Open-Label Period|Lost to Follow-up|0
677151|NCT01698320|2193380|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
677152|NCT01698320|2193381|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
677153|NCT01698320|2193382|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
677154|NCT01698320|2193380|P3|40-Week Open-Label Period|Pregnancy|1
677155|NCT01698320|2193381|P2|40-Week Open-Label Period|Pregnancy|2
677156|NCT01698320|2193382|P1|40-Week Open-Label Period|Pregnancy|0
677157|NCT01698320|2193380|P3|40-Week Open-Label Period|Withdrawal by Subject|7
677158|NCT01698320|2193381|P2|40-Week Open-Label Period|Withdrawal by Subject|11
677159|NCT01698320|2193382|P1|40-Week Open-Label Period|Withdrawal by Subject|0
677160|NCT01698320|2193380|P3|40-Week Open-Label Period|Adverse Event|2
677161|NCT01698320|2193381|P2|40-Week Open-Label Period|Adverse Event|3
677162|NCT01698320|2193382|P1|40-Week Open-Label Period|Adverse Event|0
677163|NCT01698320|2193380|P3|12-Week Double-Blind Period|Lost to Follow-up|4
677164|NCT01698320|2193381|P2|12-Week Double-Blind Period|Lost to Follow-up|0
677165|NCT01698320|2193382|P1|12-Week Double-Blind Period|Lost to Follow-up|0
677166|NCT01698320|2193380|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
677167|NCT01698320|2193381|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
677168|NCT01698320|2193382|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
677169|NCT01698320|2193380|P3|12-Week Double-Blind Period|Pregnancy|1
677170|NCT01698320|2193381|P2|12-Week Double-Blind Period|Pregnancy|1
677171|NCT01698320|2193382|P1|12-Week Double-Blind Period|Pregnancy|0
677172|NCT01698320|2193380|P3|12-Week Double-Blind Period|Protocol Violation|2
677173|NCT01698320|2193381|P2|12-Week Double-Blind Period|Protocol Violation|0
677174|NCT01698320|2193382|P1|12-Week Double-Blind Period|Protocol Violation|0
677175|NCT01698320|2193380|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
677176|NCT01698320|2193381|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
677177|NCT01698320|2193382|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
677178|NCT01698320|2193380|P3|12-Week Double-Blind Period|Adverse Event|1
677179|NCT01698320|2193381|P2|12-Week Double-Blind Period|Adverse Event|1
677180|NCT01698320|2193382|P1|12-Week Double-Blind Period|Adverse Event|0
677181|NCT01698320|2193380|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
677182|NCT01698320|2193381|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
677183|NCT01698320|2193382|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
677184|NCT01698320|2193380|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
677185|NCT01698320|2193381|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
677186|NCT01698320|2193382|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
677187|NCT01698320|2193380|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
677188|NCT01698320|2193381|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
677189|NCT01698320|2193382|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
677190|NCT01698320|2193380|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
677191|NCT01698320|2193381|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
677192|NCT01698320|2193382|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
677193|NCT01698268|2193402|P2|Overall Study|Physician Decision|1
677194|NCT01698268|2193403|P1|Overall Study|Physician Decision|2
677195|NCT01697969|2193409|P1|Overall Study|Did not meet inc/exc criteria|3
677196|NCT01697956|2193416|P2|Overall Study|Protocol Violation|1
677197|NCT01697956|2193417|P1|Overall Study|Protocol Violation|1
677198|NCT01697696|2193447|P2|Overall Study|Subject/guardian decision|35
677199|NCT01697696|2193448|P1|Overall Study|Subject/guardian decision|31
677200|NCT01697696|2193447|P2|Overall Study|Lost to Follow-up|7
677201|NCT01697696|2193448|P1|Overall Study|Lost to Follow-up|10
677202|NCT01697696|2193447|P2|Overall Study|Death|2
677203|NCT01697696|2193448|P1|Overall Study|Death|4
677204|NCT01697696|2193447|P2|Overall Study|Physician Decision|0
677205|NCT01697696|2193448|P1|Overall Study|Physician Decision|1
677206|NCT01697696|2193447|P2|Overall Study|Protocol deviation|0
677207|NCT01697696|2193448|P1|Overall Study|Protocol deviation|1
677208|NCT01697696|2193447|P2|Overall Study|Study terminated by sponsor|3
677209|NCT01697696|2193448|P1|Overall Study|Study terminated by sponsor|0
677210|NCT01697592|2193480|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
677211|NCT01697592|2193481|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
677212|NCT01697592|2193482|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
677213|NCT01697592|2193483|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
677214|NCT01697592|2193484|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
677215|NCT01697592|2193485|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
677216|NCT01697592|2193486|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
677217|NCT01697592|2193487|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
677218|NCT01697592|2193488|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
677219|NCT01697592|2193489|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
677220|NCT01697592|2193480|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677221|NCT01697592|2193481|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677222|NCT01697592|2193482|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
677223|NCT01697592|2193483|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677224|NCT01697592|2193484|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
677225|NCT01697592|2193485|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677226|NCT01697592|2193486|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677227|NCT01697592|2193487|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677228|NCT01697592|2193488|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
677229|NCT01697592|2193489|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
677230|NCT01697592|2193480|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
677231|NCT01697592|2193481|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
677232|NCT01697592|2193482|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
677233|NCT01697592|2193483|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
677234|NCT01697592|2193484|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
677235|NCT01697592|2193485|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
677236|NCT01697592|2193486|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
677237|NCT01697592|2193487|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
677238|NCT01697592|2193488|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
677239|NCT01697592|2193489|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
677240|NCT01697592|2193480|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
677241|NCT01697592|2193481|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
677242|NCT01697592|2193482|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
677243|NCT01697592|2193483|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
677244|NCT01697592|2193484|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
677245|NCT01697592|2193485|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
677246|NCT01697592|2193486|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
677247|NCT01697592|2193487|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
677248|NCT01697592|2193488|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
677249|NCT01697592|2193489|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
677250|NCT01697592|2193480|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
677251|NCT01697592|2193481|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677252|NCT01697592|2193482|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677253|NCT01697592|2193483|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
677254|NCT01697592|2193484|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677255|NCT01697592|2193485|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677256|NCT01697592|2193486|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677257|NCT01697592|2193487|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
677258|NCT01697592|2193488|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
677259|NCT01697592|2193489|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
677260|NCT01697592|2193480|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
677261|NCT01697592|2193481|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
677262|NCT01697592|2193482|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
677263|NCT01697592|2193483|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
677264|NCT01697592|2193484|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
677265|NCT01697592|2193485|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
677266|NCT01697592|2193486|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
677267|NCT01697592|2193487|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
677268|NCT01697592|2193488|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
677269|NCT01697592|2193489|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
677270|NCT01697592|2193480|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
677271|NCT01697592|2193481|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
677272|NCT01697592|2193482|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
677273|NCT01697592|2193483|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
677274|NCT01697592|2193484|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
677275|NCT01697592|2193485|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
677276|NCT01697592|2193486|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
677277|NCT01697592|2193487|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
677278|NCT01697592|2193488|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
677279|NCT01697592|2193489|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
677280|NCT01697592|2193480|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677281|NCT01697592|2193481|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677282|NCT01697592|2193482|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677283|NCT01697592|2193483|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677284|NCT01697592|2193484|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677285|NCT01697592|2193485|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677286|NCT01697592|2193486|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677287|NCT01697592|2193487|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677288|NCT01697592|2193488|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
677289|NCT01697592|2193489|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
677290|NCT01697501|2193553|P1|Overall Study|Protocol Violation|2
677291|NCT01697462|2193596|P1|Overall Study|Missing|5
677292|NCT01697462|2193596|P1|Overall Study|Unspecified|10
677293|NCT01697462|2193596|P1|Overall Study|Death|1
677294|NCT01697462|2193596|P1|Overall Study|Investigator Decision|21
677295|NCT01697462|2193596|P1|Overall Study|Withdrawal by Subject|12
677296|NCT01697462|2193596|P1|Overall Study|Lost to Follow-up|21
677297|NCT01697462|2193596|P1|Overall Study|Adverse Event|6
677298|NCT01697462|2193596|P1|Overall Study|Disease Progression|1
677299|NCT01697449|2193603|P1|Overall Study|Missing|25
677300|NCT01697449|2193603|P1|Overall Study|Unspecified|1
677301|NCT01697449|2193603|P1|Overall Study|Death|2
677302|NCT01697449|2193603|P1|Overall Study|Physician Decision|1
677303|NCT01697449|2193603|P1|Overall Study|Withdrawal by Subject|2
677304|NCT01697449|2193603|P1|Overall Study|Lost to Follow-up|5
677305|NCT01697449|2193603|P1|Overall Study|Adverse Event|7
677306|NCT01697449|2193603|P1|Overall Study|Disease progression|47
677307|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
677308|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
677309|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
677310|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
677311|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Death|1
677312|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Death|1
677313|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
677314|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
677315|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
677316|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
677317|NCT01697358|2193614|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
677318|NCT01697358|2193615|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
677319|NCT01697358|2193614|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
677320|NCT01697358|2193615|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
677321|NCT01697358|2193614|P2|Period I: Randomization to 6 Months|Adverse Event|1
677322|NCT01697358|2193615|P1|Period I: Randomization to 6 Months|Adverse Event|1
677323|NCT01697358|2193614|P2|Period I: Randomization to 6 Months|Physician Decision|0
677324|NCT01697358|2193615|P1|Period I: Randomization to 6 Months|Physician Decision|4
677325|NCT01697358|2193614|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
677326|NCT01697358|2193615|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
677327|NCT01697345|2193631|P1|Overall Study|Withdrawal by Subject|1
677328|NCT01697319|2193650|P1|Extension Phase|Terminated by Sponsor|15
677329|NCT01697319|2193650|P1|Primary Phase|Withdrawal by Subject|1
677330|NCT01696994|2193659|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
677331|NCT01696994|2193660|P1|Overall Study|Refused Screen (Ovarian Screening)|0
677332|NCT01696994|2193659|P2|Overall Study|Refused ASU (Control)|0
677333|NCT01696994|2193660|P1|Overall Study|Refused ASU (Control)|311
677334|NCT01696994|2193659|P2|Overall Study|No Ovaries at Baseline|4851
677335|NCT01696994|2193660|P1|Overall Study|No Ovaries at Baseline|4807
677336|NCT01696994|2193659|P2|Overall Study|Died Before ASU (Control)|0
677337|NCT01696994|2193660|P1|Overall Study|Died Before ASU (Control)|73
677338|NCT01696994|2193659|P2|Overall Study|Died Before Randomization|2
677339|NCT01696994|2193660|P1|Overall Study|Died Before Randomization|1
677340|NCT01696994|2193659|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
677341|NCT01696994|2193660|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
677342|NCT01696981|2193688|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
677343|NCT01696981|2193689|P1|Overall Study|Refused Screen (Colorectal Screening)|0
677344|NCT01696981|2193688|P2|Overall Study|Refused ASU (Control)|0
677345|NCT01696981|2193689|P1|Overall Study|Refused ASU (Control)|920
677346|NCT01696981|2193688|P2|Overall Study|Died Before ASU (Control)|0
677347|NCT01696981|2193689|P1|Overall Study|Died Before ASU (Control)|278
677348|NCT01696981|2193688|P2|Overall Study|Died Before Randomization|8
677349|NCT01696981|2193689|P1|Overall Study|Died Before Randomization|3
677350|NCT01696981|2193688|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
677351|NCT01696981|2193689|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
677352|NCT01696968|2193709|P2|Overall Study|Refused Screen (Lung Screening)|6796
677353|NCT01696968|2193710|P1|Overall Study|Refused Screen (Lung Screening)|0
677354|NCT01696968|2193709|P2|Overall Study|Refused ASU (Control)|0
677355|NCT01696968|2193710|P1|Overall Study|Refused ASU (Control)|920
677356|NCT01696968|2193709|P2|Overall Study|Died Before ASU (Control)|0
677357|NCT01696968|2193710|P1|Overall Study|Died Before ASU (Control)|278
677358|NCT01696968|2193709|P2|Overall Study|Died Before Randomization|8
677359|NCT01696968|2193710|P1|Overall Study|Died Before Randomization|3
677360|NCT01696968|2193709|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
677361|NCT01696968|2193710|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
677368|NCT01696929|2193741|P1|Overall Study|Physician Decision|1
677369|NCT01696773|2193748|P2|Days 15-27, Washout|Adverse Event|0
677370|NCT01696773|2193749|P1|Days 15-27, Washout|Adverse Event|1
677371|NCT01696695|2193776|P1|Overall Study|Major Protocol Violation|192
677372|NCT01696695|2193776|P1|Overall Study|Unspecified|74
677373|NCT01696695|2193776|P1|Overall Study|Lost to Follow-up|48
677374|NCT01696695|2193776|P1|Overall Study|Withdrawal by Subject|92
677375|NCT01696695|2193776|P1|Overall Study|Adverse Event|74
677376|NCT01696695|2193776|P1|Overall Study|Death|29
677377|NCT01696695|2193776|P1|Overall Study|Disease progression|373
677378|NCT01696643|2193788|P2|Overall Study|Participant Did Not Receive Study Drug|2
677379|NCT01696643|2193789|P1|Overall Study|Participant Did Not Receive Study Drug|2
677380|NCT01696643|2193788|P2|Overall Study|Medical Monitor Decision|2
677381|NCT01696643|2193789|P1|Overall Study|Medical Monitor Decision|0
677382|NCT01696643|2193788|P2|Overall Study|Participant Incarcerated|1
677383|NCT01696643|2193789|P1|Overall Study|Participant Incarcerated|0
677384|NCT01696643|2193788|P2|Overall Study|Site Error|1
677385|NCT01696643|2193789|P1|Overall Study|Site Error|2
677386|NCT01696643|2193788|P2|Overall Study|Participant on Restricted Bed Rest|0
677387|NCT01696643|2193789|P1|Overall Study|Participant on Restricted Bed Rest|1
677388|NCT01696643|2193788|P2|Overall Study|Withdrawal by Subject|149
677389|NCT01696643|2193789|P1|Overall Study|Withdrawal by Subject|142
677390|NCT01696643|2193788|P2|Overall Study|Study Terminated by Sponsor|294
677391|NCT01696643|2193789|P1|Overall Study|Study Terminated by Sponsor|286
677392|NCT01696643|2193788|P2|Overall Study|Protocol Violation|7
677393|NCT01696643|2193789|P1|Overall Study|Protocol Violation|7
677394|NCT01696643|2193788|P2|Overall Study|Pregnancy|1
677395|NCT01696643|2193789|P1|Overall Study|Pregnancy|0
677396|NCT01696643|2193788|P2|Overall Study|Physician Decision|2
677397|NCT01696643|2193789|P1|Overall Study|Physician Decision|3
677398|NCT01696643|2193788|P2|Overall Study|Lost to Follow-up|67
677399|NCT01696643|2193789|P1|Overall Study|Lost to Follow-up|67
677400|NCT01696643|2193788|P2|Overall Study|Lack of Efficacy|0
677401|NCT01696643|2193789|P1|Overall Study|Lack of Efficacy|3
677402|NCT01696643|2193788|P2|Overall Study|Death|2
677403|NCT01696643|2193789|P1|Overall Study|Death|1
677404|NCT01696643|2193788|P2|Overall Study|Adverse Event|7
677405|NCT01696643|2193789|P1|Overall Study|Adverse Event|15
677406|NCT01696214|2193817|P4|Overall Study|Lost to Follow-up|0
677407|NCT01696214|2193818|P3|Overall Study|Lost to Follow-up|0
677408|NCT01696214|2193819|P2|Overall Study|Lost to Follow-up|1
677409|NCT01696214|2193820|P1|Overall Study|Lost to Follow-up|0
677410|NCT01696188|2193832|P2|Overall Study|Protocol Violation|1
677411|NCT01696188|2193833|P1|Overall Study|Protocol Violation|1
677412|NCT01696071|2193864|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
677413|NCT01696071|2193865|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
677414|NCT01696058|2193893|P2|Overall Study|Other reason prematurely discontinued|3
677415|NCT01696058|2193894|P1|Overall Study|Other reason prematurely discontinued|5
677416|NCT01696058|2193893|P2|Overall Study|Withdrawal by Subject|6
677417|NCT01696058|2193894|P1|Overall Study|Withdrawal by Subject|4
677418|NCT01696058|2193893|P2|Overall Study|Lost to Follow-up|5
677419|NCT01696058|2193894|P1|Overall Study|Lost to Follow-up|2
677420|NCT01696058|2193893|P2|Overall Study|Protocol Violation|3
677421|NCT01696058|2193894|P1|Overall Study|Protocol Violation|9
677422|NCT01696058|2193893|P2|Overall Study|Lack of Efficacy|3
677423|NCT01696058|2193894|P1|Overall Study|Lack of Efficacy|2
677424|NCT01696058|2193893|P2|Overall Study|Adverse Event|11
677425|NCT01696058|2193894|P1|Overall Study|Adverse Event|21
677426|NCT01696045|2193922|P2|Overall Study|Disease progression|2
677427|NCT01696045|2193923|P1|Overall Study|Disease progression|2
677428|NCT01696045|2193922|P2|Overall Study|Study drug toxicity|5
677429|NCT01696045|2193923|P1|Overall Study|Study drug toxicity|1
677430|NCT01695772|2193939|P1|Overall Study|Unspecified Reason|1
677431|NCT01695772|2193939|P1|Overall Study|Protocol Violation|2
677432|NCT01695772|2193939|P1|Overall Study|Lost to Follow-up|4
677433|NCT01695772|2193939|P1|Overall Study|Investigator Decision|5
677434|NCT01695772|2193939|P1|Overall Study|Progressive Disease|8
677435|NCT01695772|2193939|P1|Overall Study|Withdrawal by Subject|18
677436|NCT01695746|2193951|P1|Overall Study|Participant not willing to participate|3
677437|NCT01695746|2193951|P1|Overall Study|Protocol Violation|5
677438|NCT01695746|2193951|P1|Overall Study|Non-compliance by the participant|3
677439|NCT01695746|2193951|P1|Overall Study|Adverse Event|1
888913|NCT01735916|2822819|P3|Overall Study|Withdrawal by Subject|0
888914|NCT01735916|2822820|P2|Overall Study|Withdrawal by Subject|0
888915|NCT01735916|2822821|P1|Overall Study|Withdrawal by Subject|3
888916|NCT01735916|2822819|P3|Overall Study|Early termination of study by sponsor|7
888917|NCT01735916|2822820|P2|Overall Study|Early termination of study by sponsor|19
888918|NCT01735916|2822821|P1|Overall Study|Early termination of study by sponsor|4
888919|NCT01735916|2822819|P3|Overall Study|Subject not eligible to be randomized|0
888920|NCT01735916|2822820|P2|Overall Study|Subject not eligible to be randomized|0
888921|NCT01735916|2822821|P1|Overall Study|Subject not eligible to be randomized|11
677472|NCT01694771|2194106|P2|Overall Study|Other reasons|6
677473|NCT01694771|2194107|P1|Overall Study|Other reasons|5
677474|NCT01694771|2194106|P2|Overall Study|Consent withdrawn|9
677475|NCT01694771|2194107|P1|Overall Study|Consent withdrawn|7
677476|NCT01694771|2194106|P2|Overall Study|Lost to Follow-up|3
677477|NCT01694771|2194107|P1|Overall Study|Lost to Follow-up|2
677478|NCT01694771|2194106|P2|Overall Study|Non compliance protocol|6
677479|NCT01694771|2194107|P1|Overall Study|Non compliance protocol|7
677480|NCT01694771|2194106|P2|Overall Study|Lack of Efficacy|0
677481|NCT01694771|2194107|P1|Overall Study|Lack of Efficacy|1
677482|NCT01694771|2194106|P2|Overall Study|Adverse Event|16
677483|NCT01694771|2194107|P1|Overall Study|Adverse Event|18
677484|NCT01694706|2194131|P3|Overall Study|other reason not defined above|0
677485|NCT01694706|2194132|P2|Overall Study|other reason not defined above|0
677486|NCT01694706|2194133|P1|Overall Study|other reason not defined above|1
677487|NCT01694706|2194131|P3|Overall Study|Adverse Event|0
677488|NCT01694706|2194132|P2|Overall Study|Adverse Event|1
677489|NCT01694706|2194133|P1|Overall Study|Adverse Event|0
677490|NCT01694420|2194176|P1|Overall Study|Lost to Follow-up|3
677491|NCT01693367|2194289|P2|Overall Study|Physician Decision|1
677492|NCT01693367|2194290|P1|Overall Study|Physician Decision|0
677493|NCT01693367|2194289|P2|Overall Study|Withdrawal by Subject|1
677494|NCT01693367|2194290|P1|Overall Study|Withdrawal by Subject|1
677495|NCT01693185|2194308|P2|Overall Study|diagnostic procedure after colonoscopy|6
677496|NCT01693185|2194309|P1|Overall Study|diagnostic procedure after colonoscopy|0
677497|NCT01693029|2194327|P2|Overall Study|Non-compliance|1
677498|NCT01693029|2194328|P1|Overall Study|Non-compliance|2
677499|NCT01693029|2194327|P2|Overall Study|Death|8
677500|NCT01693029|2194328|P1|Overall Study|Death|5
677501|NCT01693029|2194327|P2|Overall Study|Adverse Event|6
677502|NCT01693029|2194328|P1|Overall Study|Adverse Event|1
677503|NCT01693029|2194327|P2|Overall Study|Lost to Follow-up|1
677504|NCT01693029|2194328|P1|Overall Study|Lost to Follow-up|0
677505|NCT01693029|2194327|P2|Overall Study|Physician Decision|2
677506|NCT01693029|2194328|P1|Overall Study|Physician Decision|0
677507|NCT01693029|2194327|P2|Overall Study|Change in dialysis modality|1
677508|NCT01693029|2194328|P1|Overall Study|Change in dialysis modality|2
677509|NCT01693029|2194327|P2|Overall Study|Protocol Violation|7
677510|NCT01693029|2194328|P1|Overall Study|Protocol Violation|6
677511|NCT01693029|2194327|P2|Overall Study|Bindinging anti-EPO antibodies|2
677512|NCT01693029|2194328|P1|Overall Study|Bindinging anti-EPO antibodies|6
677513|NCT01693029|2194327|P2|Overall Study|Kidney transplantation|7
677514|NCT01693029|2194328|P1|Overall Study|Kidney transplantation|7
677515|NCT01693029|2194327|P2|Overall Study|Withdrawal by Subject|22
677516|NCT01693029|2194328|P1|Overall Study|Withdrawal by Subject|15
677517|NCT01692938|2194359|P2|Overall Study|Study completed prior to site completion|3
677518|NCT01692938|2194360|P1|Overall Study|Study completed prior to site completion|3
677519|NCT01692938|2194359|P2|Overall Study|Protocol Deviation|1
677520|NCT01692938|2194360|P1|Overall Study|Protocol Deviation|1
677521|NCT01692782|2194371|P3|Overall Study|Withdrawal by Subject|3
677522|NCT01692782|2194372|P2|Overall Study|Withdrawal by Subject|10
677523|NCT01692782|2194373|P1|Overall Study|Withdrawal by Subject|3
677524|NCT01692782|2194371|P3|Overall Study|SAE not related to study drug|0
677525|NCT01692782|2194372|P2|Overall Study|SAE not related to study drug|1
677526|NCT01692782|2194373|P1|Overall Study|SAE not related to study drug|0
677527|NCT01692782|2194371|P3|Overall Study|Non-compliant with study visits|1
677528|NCT01692782|2194372|P2|Overall Study|Non-compliant with study visits|0
677529|NCT01692782|2194373|P1|Overall Study|Non-compliant with study visits|0
677530|NCT01692782|2194371|P3|Overall Study|Non-complance with study drug|1
677531|NCT01692782|2194372|P2|Overall Study|Non-complance with study drug|4
677532|NCT01692782|2194373|P1|Overall Study|Non-complance with study drug|0
677533|NCT01692782|2194371|P3|Overall Study|Protocol Violation|2
677534|NCT01692782|2194372|P2|Overall Study|Protocol Violation|0
677535|NCT01692782|2194373|P1|Overall Study|Protocol Violation|1
677536|NCT01692782|2194371|P3|Overall Study|Pregnancy|0
677537|NCT01692782|2194372|P2|Overall Study|Pregnancy|0
677538|NCT01692782|2194373|P1|Overall Study|Pregnancy|1
677539|NCT01692782|2194371|P3|Overall Study|Lost to Follow-up|1
677540|NCT01692782|2194372|P2|Overall Study|Lost to Follow-up|7
677541|NCT01692782|2194373|P1|Overall Study|Lost to Follow-up|2
677542|NCT01692782|2194371|P3|Overall Study|Lack of Efficacy|0
677543|NCT01692782|2194372|P2|Overall Study|Lack of Efficacy|2
677544|NCT01692782|2194373|P1|Overall Study|Lack of Efficacy|1
677545|NCT01692782|2194371|P3|Overall Study|Adverse Event|2
677546|NCT01692782|2194372|P2|Overall Study|Adverse Event|32
677547|NCT01692782|2194373|P1|Overall Study|Adverse Event|12
677548|NCT01692626|2194401|P2|Overall Study|Withdrawal by Subject|0
677549|NCT01692626|2194402|P1|Overall Study|Withdrawal by Subject|1
677550|NCT01692626|2194401|P2|Overall Study|Protocol Violation|2
677551|NCT01692626|2194402|P1|Overall Study|Protocol Violation|1
677552|NCT01692626|2194401|P2|Overall Study|Adverse Event|3
677553|NCT01692626|2194402|P1|Overall Study|Adverse Event|2
677554|NCT01692626|2194401|P2|Overall Study|Death|1
677555|NCT01692626|2194402|P1|Overall Study|Death|0
677556|NCT01692301|2194431|P2|Overall Study|Lost to Follow-up|1
677557|NCT01692301|2194432|P1|Overall Study|Lost to Follow-up|1
677558|NCT01692301|2194431|P2|Overall Study|Physician Decision|2
677559|NCT01692301|2194432|P1|Overall Study|Physician Decision|2
677560|NCT01692301|2194431|P2|Overall Study|Technical problems|1
677561|NCT01692301|2194432|P1|Overall Study|Technical problems|0
677562|NCT01692301|2194431|P2|Overall Study|Patient/guardian decision|15
677563|NCT01692301|2194432|P1|Overall Study|Patient/guardian decision|16
677564|NCT01692301|2194431|P2|Overall Study|Protocol deviation|2
677565|NCT01692301|2194432|P1|Overall Study|Protocol deviation|9
677566|NCT01692301|2194431|P2|Overall Study|Non-compliance with study treatment|2
677567|NCT01692301|2194432|P1|Overall Study|Non-compliance with study treatment|1
677568|NCT01692301|2194431|P2|Overall Study|Lack of Efficacy|5
677569|NCT01692301|2194432|P1|Overall Study|Lack of Efficacy|0
677570|NCT01692301|2194431|P2|Overall Study|Death|2
677571|NCT01692301|2194432|P1|Overall Study|Death|1
677572|NCT01692301|2194431|P2|Overall Study|Adverse Event|12
677573|NCT01692301|2194432|P1|Overall Study|Adverse Event|15
677574|NCT01691885|2194458|P2|Washout Period (7-9 Days)|Adverse Event|1
677575|NCT01691885|2194459|P1|Washout Period (7-9 Days)|Adverse Event|0
677576|NCT01691885|2194458|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
677577|NCT01691885|2194459|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
677578|NCT01691794|2194468|P3|Overall Study|Poor compliance/noncompliance|1
677579|NCT01691794|2194469|P2|Overall Study|Poor compliance/noncompliance|0
677580|NCT01691794|2194470|P1|Overall Study|Poor compliance/noncompliance|0
677581|NCT01691794|2194468|P3|Overall Study|Lack of Efficacy|1
677582|NCT01691794|2194469|P2|Overall Study|Lack of Efficacy|1
677583|NCT01691794|2194470|P1|Overall Study|Lack of Efficacy|0
677584|NCT01691794|2194468|P3|Overall Study|No longer meets study criteria|0
677585|NCT01691794|2194469|P2|Overall Study|No longer meets study criteria|2
677586|NCT01691794|2194470|P1|Overall Study|No longer meets study criteria|0
677587|NCT01691794|2194468|P3|Overall Study|Adverse Event|1
677588|NCT01691794|2194469|P2|Overall Study|Adverse Event|0
677589|NCT01691794|2194470|P1|Overall Study|Adverse Event|0
677590|NCT01691781|2194486|P2|Overall Study|Adverse Event|1
677591|NCT01691781|2194487|P1|Overall Study|Adverse Event|0
677592|NCT01691781|2194486|P2|Overall Study|Protocol Violation|2
677593|NCT01691781|2194487|P1|Overall Study|Protocol Violation|2
677594|NCT01691781|2194486|P2|Overall Study|Physician Decision|1
677595|NCT01691781|2194487|P1|Overall Study|Physician Decision|1
677596|NCT01691781|2194486|P2|Overall Study|Withdrawal by Subject|3
677597|NCT01691781|2194487|P1|Overall Study|Withdrawal by Subject|4
677598|NCT01691612|2194510|P1|Overall Study|Adverse Event|1
677599|NCT01691612|2194510|P1|Overall Study|deemed ineligible after 1st visit|6
677600|NCT01691521|2194621|P3|Overall Study|Withdrawal by Subject|4
677601|NCT01691521|2194622|P2|Overall Study|Withdrawal by Subject|9
677602|NCT01691521|2194623|P1|Overall Study|Withdrawal by Subject|5
677603|NCT01691521|2194621|P3|Overall Study|Physician Decision|0
677604|NCT01691521|2194622|P2|Overall Study|Physician Decision|1
677605|NCT01691521|2194623|P1|Overall Study|Physician Decision|2
677606|NCT01691521|2194621|P3|Overall Study|Lost to Follow-up|2
677607|NCT01691521|2194622|P2|Overall Study|Lost to Follow-up|2
677608|NCT01691521|2194623|P1|Overall Study|Lost to Follow-up|0
677609|NCT01691521|2194621|P3|Overall Study|Protocol Violation|0
677610|NCT01691521|2194622|P2|Overall Study|Protocol Violation|3
677611|NCT01691521|2194623|P1|Overall Study|Protocol Violation|0
677612|NCT01691521|2194621|P3|Overall Study|Lack of Efficacy|2
677613|NCT01691521|2194622|P2|Overall Study|Lack of Efficacy|1
677614|NCT01691521|2194623|P1|Overall Study|Lack of Efficacy|1
677615|NCT01691521|2194621|P3|Overall Study|Adverse Event|1
677616|NCT01691521|2194622|P2|Overall Study|Adverse Event|0
677617|NCT01691521|2194623|P1|Overall Study|Adverse Event|4
677618|NCT01691508|2194645|P2|Overall Study|Withdrawal by Subject|0
677619|NCT01691508|2194646|P1|Overall Study|Withdrawal by Subject|1
677620|NCT01691508|2194645|P2|Overall Study|Adverse Event|3
677621|NCT01691508|2194646|P1|Overall Study|Adverse Event|3
677622|NCT01691482|2194660|P2|Treatment Period 2|Protocol Violation|1
677623|NCT01691482|2194661|P1|Treatment Period 2|Protocol Violation|1
677624|NCT01691482|2194660|P2|Treatment Period 2|Adverse Event|1
677625|NCT01691482|2194661|P1|Treatment Period 2|Adverse Event|0
677626|NCT01691248|2194750|P2|Overall Study|Not Treated|7
677627|NCT01691248|2194751|P1|Overall Study|Not Treated|4
677628|NCT01691248|2194750|P2|Overall Study|Reason not provided|4
677629|NCT01691248|2194751|P1|Overall Study|Reason not provided|4
677630|NCT01691248|2194750|P2|Overall Study|Lost to Follow-up|5
677631|NCT01691248|2194751|P1|Overall Study|Lost to Follow-up|2
677632|NCT01691248|2194750|P2|Overall Study|Confirmed CDAD|31
677633|NCT01691248|2194751|P1|Overall Study|Confirmed CDAD|14
677634|NCT01691248|2194750|P2|Overall Study|Withdrawal by Subject|18
677635|NCT01691248|2194751|P1|Overall Study|Withdrawal by Subject|20
677636|NCT01691248|2194750|P2|Overall Study|Adverse Event|22
677637|NCT01691248|2194751|P1|Overall Study|Adverse Event|24
677638|NCT01691248|2194750|P2|Overall Study|Protocol Violation|27
677639|NCT01691248|2194751|P1|Overall Study|Protocol Violation|43
677640|NCT01691092|2194761|P1|Overall Study|screen fail|19
677641|NCT01691092|2194761|P1|Overall Study|used for different study|2
677642|NCT01691092|2194761|P1|Overall Study|non-compliance|3
677643|NCT01691092|2194761|P1|Overall Study|Withdrawal by Subject|3
677644|NCT01691092|2194761|P1|Overall Study|Physician Decision|4
677645|NCT01691092|2194761|P1|Overall Study|Lost to Follow-up|10
677646|NCT01691014|2194769|P4|Overall Study|Lack of Efficacy|0
677647|NCT01691014|2194770|P3|Overall Study|Lack of Efficacy|7
677648|NCT01691014|2194771|P2|Overall Study|Lack of Efficacy|3
677649|NCT01691014|2194772|P1|Overall Study|Lack of Efficacy|2
677650|NCT01691014|2194769|P4|Overall Study|Adverse Event|1
677651|NCT01691014|2194770|P3|Overall Study|Adverse Event|1
677652|NCT01691014|2194771|P2|Overall Study|Adverse Event|5
677653|NCT01691014|2194772|P1|Overall Study|Adverse Event|0
677654|NCT01691014|2194769|P4|Overall Study|Withdrawal by Subject|1
677655|NCT01691014|2194770|P3|Overall Study|Withdrawal by Subject|1
677656|NCT01691014|2194771|P2|Overall Study|Withdrawal by Subject|1
677657|NCT01691014|2194772|P1|Overall Study|Withdrawal by Subject|0
677658|NCT01691014|2194769|P4|Overall Study|Unspecified|0
677659|NCT01691014|2194770|P3|Overall Study|Unspecified|2
677660|NCT01691014|2194771|P2|Overall Study|Unspecified|0
677661|NCT01691014|2194772|P1|Overall Study|Unspecified|0
677662|NCT01691014|2194769|P4|Overall Study|Premature Termination|3
677663|NCT01691014|2194770|P3|Overall Study|Premature Termination|0
677664|NCT01691014|2194771|P2|Overall Study|Premature Termination|6
677665|NCT01691014|2194772|P1|Overall Study|Premature Termination|1
677666|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
677667|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
677668|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
677669|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
677670|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
677671|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
677672|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
677673|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
677674|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
677675|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
677676|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
677677|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
677678|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
677679|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
677680|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
677681|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
677682|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
677683|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
677684|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
677685|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
677686|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
677687|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
677688|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
677689|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
677690|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
677691|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
677692|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
677693|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
677694|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
677695|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
677696|NCT01690299|2194857|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
677697|NCT01690299|2194858|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
677698|NCT01690299|2194859|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
677699|NCT01690299|2194860|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
677700|NCT01690299|2194861|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
677701|NCT01690299|2194862|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
677702|NCT01690299|2194857|P6|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
677703|NCT01690299|2194858|P5|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
677704|NCT01690299|2194859|P4|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
677705|NCT01690299|2194860|P3|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
677706|NCT01690299|2194861|P2|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
677707|NCT01690299|2194862|P1|Placebo-controlled Phase (Weeks 0-16)|Unspecified|2
677708|NCT01690299|2194857|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
677709|NCT01690299|2194858|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
677710|NCT01690299|2194859|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
677711|NCT01690299|2194860|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
677712|NCT01690299|2194861|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
677713|NCT01690299|2194862|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
677714|NCT01690299|2194857|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
677715|NCT01690299|2194858|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
677716|NCT01690299|2194859|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
677717|NCT01690299|2194860|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
677718|NCT01690299|2194861|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
677719|NCT01690299|2194862|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
677720|NCT01690299|2194857|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
677721|NCT01690299|2194858|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
677722|NCT01690299|2194859|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
677723|NCT01690299|2194860|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
677724|NCT01690299|2194861|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
677725|NCT01690299|2194862|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
677726|NCT01690052|2194998|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
677727|NCT01690052|2194999|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
677728|NCT01689857|2195016|P2|Overall Study|Lost to Follow-up|2
677729|NCT01689857|2195017|P1|Overall Study|Lost to Follow-up|5
677730|NCT01689649|2195042|P1|Overall Study|Lost to Follow-up|5
677731|NCT01689649|2195042|P1|Overall Study|Protocol Violation|3
677732|NCT01689649|2195042|P1|Overall Study|Non-compliance|11
677733|NCT01689649|2195042|P1|Overall Study|Lack of Efficacy|3
677734|NCT01689532|2195054|P2|Overall Study|Physician Decision|0
677735|NCT01689532|2195055|P1|Overall Study|Physician Decision|2
677736|NCT01689532|2195054|P2|Overall Study|Withdrawal by Subject|2
677737|NCT01689532|2195055|P1|Overall Study|Withdrawal by Subject|1
677738|NCT01689532|2195054|P2|Overall Study|Lack of Efficacy|2
677739|NCT01689532|2195055|P1|Overall Study|Lack of Efficacy|2
677740|NCT01689532|2195054|P2|Overall Study|Adverse Event|5
677741|NCT01689532|2195055|P1|Overall Study|Adverse Event|9
677742|NCT01689519|2195119|P2|Overall Study|Physician Decision|3
677743|NCT01689519|2195120|P1|Overall Study|Physician Decision|0
677744|NCT01689519|2195119|P2|Overall Study|Withdrawal by Subject|17
677745|NCT01689519|2195120|P1|Overall Study|Withdrawal by Subject|17
677746|NCT01689519|2195119|P2|Overall Study|Lost to Follow-up|2
677747|NCT01689519|2195120|P1|Overall Study|Lost to Follow-up|6
677748|NCT01689519|2195119|P2|Overall Study|Death|116
677749|NCT01689519|2195120|P1|Overall Study|Death|143
677750|NCT01689363|2195147|P8|Overall Study|Protocol Violation|0
677751|NCT01689363|2195148|P7|Overall Study|Protocol Violation|0
677752|NCT01689363|2195149|P6|Overall Study|Protocol Violation|0
677753|NCT01689363|2195150|P5|Overall Study|Protocol Violation|0
677754|NCT01689363|2195151|P4|Overall Study|Protocol Violation|0
677755|NCT01689363|2195152|P3|Overall Study|Protocol Violation|0
677756|NCT01689363|2195153|P2|Overall Study|Protocol Violation|1
677757|NCT01689363|2195154|P1|Overall Study|Protocol Violation|0
677758|NCT01689337|2195209|P1|Overall Study|Study Discontinuation|1
677759|NCT01689207|2195248|P11|Overall Study|Adverse Event|0
677760|NCT01689207|2195249|P10|Overall Study|Adverse Event|0
677761|NCT01689207|2195250|P9|Overall Study|Adverse Event|1
677762|NCT01689207|2195251|P8|Overall Study|Adverse Event|0
677763|NCT01689207|2195252|P7|Overall Study|Adverse Event|0
677764|NCT01689207|2195253|P6|Overall Study|Adverse Event|1
677765|NCT01689207|2195254|P5|Overall Study|Adverse Event|2
677766|NCT01689207|2195255|P4|Overall Study|Adverse Event|0
677767|NCT01689207|2195256|P3|Overall Study|Adverse Event|0
677768|NCT01689207|2195257|P2|Overall Study|Adverse Event|1
677769|NCT01689207|2195258|P1|Overall Study|Adverse Event|0
677778|NCT01688882|2195391|P2|Overall Study|Administrative problems|0
677779|NCT01688882|2195392|P1|Overall Study|Administrative problems|1
677780|NCT01688882|2195391|P2|Overall Study|Unsatisfactory therapeutic effect|1
677781|NCT01688882|2195392|P1|Overall Study|Unsatisfactory therapeutic effect|1
677782|NCT01688882|2195391|P2|Overall Study|Adverse Event|0
677783|NCT01688882|2195392|P1|Overall Study|Adverse Event|1
677784|NCT01688830|2195427|P21|Overall Study|Lost to Follow-up|0
677785|NCT01688830|2195428|P20|Overall Study|Lost to Follow-up|0
677786|NCT01688830|2195429|P19|Overall Study|Lost to Follow-up|0
677787|NCT01688830|2195430|P18|Overall Study|Lost to Follow-up|0
677788|NCT01688830|2195431|P17|Overall Study|Lost to Follow-up|0
677789|NCT01688830|2195432|P16|Overall Study|Lost to Follow-up|0
677790|NCT01688830|2195433|P15|Overall Study|Lost to Follow-up|0
677791|NCT01688830|2195434|P14|Overall Study|Lost to Follow-up|0
677792|NCT01688830|2195435|P13|Overall Study|Lost to Follow-up|0
677793|NCT01688830|2195436|P12|Overall Study|Lost to Follow-up|0
677794|NCT01688830|2195437|P11|Overall Study|Lost to Follow-up|1
677795|NCT01688830|2195438|P10|Overall Study|Lost to Follow-up|0
677796|NCT01688830|2195439|P9|Overall Study|Lost to Follow-up|0
677797|NCT01688830|2195440|P8|Overall Study|Lost to Follow-up|0
677798|NCT01688830|2195441|P7|Overall Study|Lost to Follow-up|0
677799|NCT01688830|2195442|P6|Overall Study|Lost to Follow-up|0
677800|NCT01688830|2195443|P5|Overall Study|Lost to Follow-up|0
677801|NCT01688830|2195444|P4|Overall Study|Lost to Follow-up|0
677802|NCT01688830|2195445|P3|Overall Study|Lost to Follow-up|0
677803|NCT01688830|2195446|P2|Overall Study|Lost to Follow-up|0
677804|NCT01688830|2195447|P1|Overall Study|Lost to Follow-up|0
677805|NCT01688726|2195593|P2|Overall Study|Relocated abroad|1
677806|NCT01688726|2195594|P1|Overall Study|Relocated abroad|0
677807|NCT01688726|2195593|P2|Overall Study|Adverse Event|0
677808|NCT01688726|2195594|P1|Overall Study|Adverse Event|1
677809|NCT01688635|2195606|P2|Washout 3|Withdrawal by Subject|0
677810|NCT01688635|2195607|P1|Washout 3|Withdrawal by Subject|1
677811|NCT01688635|2195606|P2|Washout 2|Sponsor Decision|2
677812|NCT01688635|2195607|P1|Washout 2|Sponsor Decision|1
677813|NCT01688635|2195606|P2|Washout 2|Withdrawal by Subject|0
677814|NCT01688635|2195607|P1|Washout 2|Withdrawal by Subject|1
677815|NCT01688635|2195606|P2|Washout 2|Physician Decision|0
677816|NCT01688635|2195607|P1|Washout 2|Physician Decision|1
677817|NCT01688635|2195606|P2|Washout 1|Physician Decision|1
677818|NCT01688635|2195607|P1|Washout 1|Physician Decision|0
677819|NCT01688635|2195606|P2|Washout 1|Adverse Event|1
677820|NCT01688635|2195607|P1|Washout 1|Adverse Event|0
677821|NCT01688635|2195606|P2|Washout 1|Withdrawal by Subject|0
677822|NCT01688635|2195607|P1|Washout 1|Withdrawal by Subject|1
677823|NCT01688050|2195689|P1|Overall Study|Still be eligible for follow-up|37
677824|NCT01688050|2195689|P1|Overall Study|Withdrawal by Subject|2
677825|NCT01688050|2195689|P1|Overall Study|Lost to Follow-up|5
677826|NCT01688050|2195689|P1|Overall Study|Conversion to open repair|1
677827|NCT01688050|2195689|P1|Overall Study|Death|5
677828|NCT01687478|2195702|P2|Overall Study|Entry Criteria Not Met|2
677829|NCT01687478|2195703|P1|Overall Study|Entry Criteria Not Met|6
677830|NCT01687478|2195702|P2|Overall Study|Physician Decision|3
677831|NCT01687478|2195703|P1|Overall Study|Physician Decision|1
677832|NCT01687478|2195702|P2|Overall Study|Withdrawal by Subject|19
677833|NCT01687478|2195703|P1|Overall Study|Withdrawal by Subject|21
677834|NCT01687478|2195702|P2|Overall Study|Protocol Violation|2
677835|NCT01687478|2195703|P1|Overall Study|Protocol Violation|0
677836|NCT01687478|2195702|P2|Overall Study|Lost to Follow-up|3
677837|NCT01687478|2195703|P1|Overall Study|Lost to Follow-up|1
677838|NCT01687478|2195702|P2|Overall Study|Adverse Event|10
677839|NCT01687478|2195703|P1|Overall Study|Adverse Event|3
677840|NCT01687283|2195727|P2|Overall Study|Withdrawal by Subject|8
677841|NCT01687283|2195728|P1|Overall Study|Withdrawal by Subject|9
677842|NCT01687283|2195727|P2|Overall Study|Investigator discretion|0
677843|NCT01687283|2195728|P1|Overall Study|Investigator discretion|2
677844|NCT01687283|2195727|P2|Overall Study|Lost to Follow-up|1
677845|NCT01687283|2195728|P1|Overall Study|Lost to Follow-up|1
677846|NCT01687283|2195727|P2|Overall Study|protocol defined stopping criteria|10
677847|NCT01687283|2195728|P1|Overall Study|protocol defined stopping criteria|8
677848|NCT01687283|2195727|P2|Overall Study|Protocol Violation|3
677849|NCT01687283|2195728|P1|Overall Study|Protocol Violation|1
677850|NCT01687283|2195727|P2|Overall Study|Lack of Efficacy|1
677851|NCT01687283|2195728|P1|Overall Study|Lack of Efficacy|3
677852|NCT01687283|2195727|P2|Overall Study|Adverse Event|4
677853|NCT01687283|2195728|P1|Overall Study|Adverse Event|11
677854|NCT01687270|2195751|P1|Overall Study|Lost to Follow-up|1
677855|NCT01687270|2195751|P1|Overall Study|Lack of Efficacy|11
677856|NCT01687257|2195762|P3|Overall Study|Investigator's Discretion|0
677857|NCT01687257|2195763|P2|Overall Study|Investigator's Discretion|3
677858|NCT01687257|2195764|P1|Overall Study|Investigator's Discretion|0
677859|NCT01687257|2195762|P3|Overall Study|Adverse Event|0
677860|NCT01687257|2195763|P2|Overall Study|Adverse Event|0
677861|NCT01687257|2195764|P1|Overall Study|Adverse Event|1
677862|NCT01687257|2195762|P3|Overall Study|Subject Withdrew Consent|1
677863|NCT01687257|2195763|P2|Overall Study|Subject Withdrew Consent|1
677864|NCT01687257|2195764|P1|Overall Study|Subject Withdrew Consent|1
677865|NCT01687257|2195762|P3|Overall Study|Efficacy Failure|5
677866|NCT01687257|2195763|P2|Overall Study|Efficacy Failure|0
677867|NCT01687257|2195764|P1|Overall Study|Efficacy Failure|6
677868|NCT01687218|2195829|P6|Overall Study|Relocated, no follow-up planned|0
677869|NCT01687218|2195830|P5|Overall Study|Relocated, no follow-up planned|0
677870|NCT01687218|2195831|P4|Overall Study|Relocated, no follow-up planned|1
677871|NCT01687218|2195832|P3|Overall Study|Relocated, no follow-up planned|1
677872|NCT01687218|2195833|P2|Overall Study|Relocated, no follow-up planned|0
677873|NCT01687218|2195834|P1|Overall Study|Relocated, no follow-up planned|1
677874|NCT01687218|2195829|P6|Overall Study|Withdrawal by Subject|0
677875|NCT01687218|2195830|P5|Overall Study|Withdrawal by Subject|1
677876|NCT01687218|2195831|P4|Overall Study|Withdrawal by Subject|1
677877|NCT01687218|2195832|P3|Overall Study|Withdrawal by Subject|0
677878|NCT01687218|2195833|P2|Overall Study|Withdrawal by Subject|3
677879|NCT01687218|2195834|P1|Overall Study|Withdrawal by Subject|2
677880|NCT01687101|2195858|P1|Overall Study|Lost to Follow-up|7
677881|NCT01686932|2195885|P2|Period 1|Adverse Event|1
677882|NCT01686932|2195886|P1|Period 1|Adverse Event|1
677916|NCT01686568|2196020|P2|Sub-Study|Not consented for sub-study|2
677917|NCT01686568|2196021|P1|Sub-Study|Not consented for sub-study|2
677918|NCT01686568|2196020|P2|Main Study|Liver enzymes above range of exclusion|0
677919|NCT01686568|2196021|P1|Main Study|Liver enzymes above range of exclusion|1
677920|NCT01686568|2196020|P2|Main Study|Noncompliance with protocol|1
677921|NCT01686568|2196021|P1|Main Study|Noncompliance with protocol|0
677922|NCT01686568|2196020|P2|Main Study|Withdrawal by Subject|3
677923|NCT01686568|2196021|P1|Main Study|Withdrawal by Subject|1
677924|NCT01685983|2196106|P1|Overall Study|Unspecified|7
677925|NCT01685983|2196106|P1|Overall Study|Noncompliance with Study Drug|1
677926|NCT01685983|2196106|P1|Overall Study|Physician Decision|13
677927|NCT01685983|2196106|P1|Overall Study|Progressive Disease|32
677928|NCT01685983|2196106|P1|Overall Study|Protocol Violation|2
677929|NCT01685983|2196106|P1|Overall Study|Withdrawal by Subject|19
677930|NCT01685983|2196106|P1|Overall Study|Death|1
677931|NCT01685983|2196106|P1|Overall Study|Adverse Event|7
677932|NCT01685801|2196120|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
677933|NCT01685801|2196121|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
677934|NCT01685801|2196122|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
677935|NCT01685801|2196123|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
677936|NCT01685801|2196120|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
677937|NCT01685801|2196121|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
677938|NCT01685801|2196122|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
677939|NCT01685801|2196123|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
677940|NCT01685606|2196171|P1|Overall Study|Withdrawal by Subject|1
677941|NCT01685437|2196184|P1|Overall Study|Unable to make visits due to work|1
677942|NCT01685437|2196184|P1|Overall Study|Protocol Violation|4
677943|NCT01685437|2196184|P1|Overall Study|Adverse Event|1
677944|NCT01685437|2196184|P1|Overall Study|Lost to Follow-up|3
677945|NCT01685437|2196184|P1|Overall Study|Withdrawal by Subject|22
677946|NCT01685216|2196264|P1|Overall Study|Did not receive study drug|1
677947|NCT01685203|2196281|P7|Overall Study|Patient's decision|0
677948|NCT01685203|2196282|P6|Overall Study|Patient's decision|1
677949|NCT01685203|2196283|P5|Overall Study|Patient's decision|0
677950|NCT01685203|2196284|P4|Overall Study|Patient's decision|0
677951|NCT01685203|2196285|P3|Overall Study|Patient's decision|0
677952|NCT01685203|2196286|P2|Overall Study|Patient's decision|0
677953|NCT01685203|2196287|P1|Overall Study|Patient's decision|0
677954|NCT01685203|2196281|P7|Overall Study|Adverse event and withdrew consent|0
677955|NCT01685203|2196282|P6|Overall Study|Adverse event and withdrew consent|0
677956|NCT01685203|2196283|P5|Overall Study|Adverse event and withdrew consent|0
677957|NCT01685203|2196284|P4|Overall Study|Adverse event and withdrew consent|0
677958|NCT01685203|2196285|P3|Overall Study|Adverse event and withdrew consent|0
677959|NCT01685203|2196286|P2|Overall Study|Adverse event and withdrew consent|0
677960|NCT01685203|2196287|P1|Overall Study|Adverse event and withdrew consent|1
677961|NCT01685203|2196281|P7|Overall Study|Adverse Event|0
677962|NCT01685203|2196282|P6|Overall Study|Adverse Event|2
677963|NCT01685203|2196283|P5|Overall Study|Adverse Event|0
677964|NCT01685203|2196284|P4|Overall Study|Adverse Event|0
677965|NCT01685203|2196285|P3|Overall Study|Adverse Event|0
677966|NCT01685203|2196286|P2|Overall Study|Adverse Event|0
677967|NCT01685203|2196287|P1|Overall Study|Adverse Event|0
677968|NCT01685203|2196281|P7|Overall Study|Lost to Follow-up|0
677969|NCT01685203|2196282|P6|Overall Study|Lost to Follow-up|0
677970|NCT01685203|2196283|P5|Overall Study|Lost to Follow-up|0
677971|NCT01685203|2196284|P4|Overall Study|Lost to Follow-up|1
677972|NCT01685203|2196285|P3|Overall Study|Lost to Follow-up|0
677973|NCT01685203|2196286|P2|Overall Study|Lost to Follow-up|3
677974|NCT01685203|2196287|P1|Overall Study|Lost to Follow-up|3
677975|NCT01685060|2196331|P1|Overall Study|Death|8
677976|NCT01685060|2196331|P1|Overall Study|Lost to Follow-up|1
677977|NCT01685060|2196331|P1|Overall Study|Subject/guardian decision|20
677978|NCT01685060|2196331|P1|Overall Study|Physician Decision|14
677979|NCT01685060|2196331|P1|Overall Study|Progressive disease|69
677980|NCT01685060|2196331|P1|Overall Study|Adverse Event|12
677981|NCT01685060|2196331|P1|Overall Study|Rollover patients|16
677982|NCT01684930|2196348|P2|Overall Study|Withdrawal by Subject|1
677983|NCT01684930|2196349|P1|Overall Study|Withdrawal by Subject|3
677984|NCT01684878|2196369|P4|Part 2: Randomized Phase|Participant noncompliance|1
677985|NCT01684878|2196370|P3|Part 2: Randomized Phase|Participant noncompliance|0
677986|NCT01684878|2196371|P2|Part 2: Randomized Phase|Participant noncompliance|0
677987|NCT01684878|2196372|P1|Part 2: Randomized Phase|Participant noncompliance|0
677988|NCT01684878|2196369|P4|Part 2: Randomized Phase|Alive at data-cut|7
677989|NCT01684878|2196370|P3|Part 2: Randomized Phase|Alive at data-cut|13
677990|NCT01684878|2196371|P2|Part 2: Randomized Phase|Alive at data-cut|0
677991|NCT01684878|2196372|P1|Part 2: Randomized Phase|Alive at data-cut|0
677992|NCT01684878|2196369|P4|Part 2: Randomized Phase|Death|68
677993|NCT01684878|2196370|P3|Part 2: Randomized Phase|Death|62
677994|NCT01684878|2196371|P2|Part 2: Randomized Phase|Death|0
677995|NCT01684878|2196372|P1|Part 2: Randomized Phase|Death|0
677996|NCT01684878|2196369|P4|Part 2: Randomized Phase|Lost to Follow-up|0
677997|NCT01684878|2196370|P3|Part 2: Randomized Phase|Lost to Follow-up|2
677998|NCT01684878|2196371|P2|Part 2: Randomized Phase|Lost to Follow-up|0
677999|NCT01684878|2196372|P1|Part 2: Randomized Phase|Lost to Follow-up|0
678000|NCT01684878|2196369|P4|Part 2: Randomized Phase|Participant withdrew consent|2
678001|NCT01684878|2196370|P3|Part 2: Randomized Phase|Participant withdrew consent|1
678002|NCT01684878|2196371|P2|Part 2: Randomized Phase|Participant withdrew consent|0
678003|NCT01684878|2196372|P1|Part 2: Randomized Phase|Participant withdrew consent|0
678004|NCT01684878|2196369|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
678005|NCT01684878|2196370|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
678006|NCT01684878|2196371|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
678007|NCT01684878|2196372|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
678008|NCT01684878|2196369|P4|Part 1: Safety Run in Phase|Death|0
678009|NCT01684878|2196370|P3|Part 1: Safety Run in Phase|Death|0
678010|NCT01684878|2196371|P2|Part 1: Safety Run in Phase|Death|20
678011|NCT01684878|2196372|P1|Part 1: Safety Run in Phase|Death|15
678012|NCT01684878|2196369|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
678013|NCT01684878|2196370|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
678014|NCT01684878|2196371|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
678015|NCT01684878|2196372|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
678016|NCT01684423|2196454|P5|Overall Study|Withdrawal by Subject|0
678017|NCT01684423|2196455|P4|Overall Study|Withdrawal by Subject|0
678018|NCT01684423|2196456|P3|Overall Study|Withdrawal by Subject|1
678019|NCT01684423|2196457|P2|Overall Study|Withdrawal by Subject|0
678020|NCT01684423|2196458|P1|Overall Study|Withdrawal by Subject|0
678041|NCT01684046|2196592|P2|Period 1, First 30 Days|Adverse Event|2
678042|NCT01684046|2196593|P1|Period 1, First 30 Days|Adverse Event|0
678043|NCT01684033|2196599|P2|Period 2, Second 30 Days|Adverse Event|0
678044|NCT01684033|2196600|P1|Period 2, Second 30 Days|Adverse Event|1
678045|NCT01684033|2196599|P2|Period 1, First 30 Days|Lost to Follow-up|0
678046|NCT01684033|2196600|P1|Period 1, First 30 Days|Lost to Follow-up|1
678047|NCT01684033|2196599|P2|Period 1, First 30 Days|Withdrawal by Subject|0
678048|NCT01684033|2196600|P1|Period 1, First 30 Days|Withdrawal by Subject|1
678049|NCT01684033|2196599|P2|Period 1, First 30 Days|Noncompliance|0
678050|NCT01684033|2196600|P1|Period 1, First 30 Days|Noncompliance|1
678051|NCT01684033|2196599|P2|Period 1, First 30 Days|Adverse Event|1
678052|NCT01684033|2196600|P1|Period 1, First 30 Days|Adverse Event|1
678053|NCT01683838|2196621|P2|Overall Study|not specified|3
678054|NCT01683838|2196622|P1|Overall Study|not specified|4
678055|NCT01683838|2196621|P2|Overall Study|Lost to Follow-up|1
678056|NCT01683838|2196622|P1|Overall Study|Lost to Follow-up|1
678057|NCT01683838|2196621|P2|Overall Study|Withdrawal by Subject|5
678058|NCT01683838|2196622|P1|Overall Study|Withdrawal by Subject|6
678059|NCT01683838|2196621|P2|Overall Study|Protocol Violation|1
678060|NCT01683838|2196622|P1|Overall Study|Protocol Violation|3
678061|NCT01683838|2196621|P2|Overall Study|Adverse Event|2
678062|NCT01683838|2196622|P1|Overall Study|Adverse Event|12
678063|NCT01683604|2196662|P1|Overall Study|Unspecified|2
678064|NCT01683604|2196662|P1|Overall Study|Lack of Efficacy|1
678065|NCT01683604|2196662|P1|Overall Study|Adverse Event|2
678066|NCT01683409|2196847|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
678067|NCT01683409|2196848|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
678068|NCT01683409|2196849|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
678069|NCT01683409|2196850|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
678070|NCT01683409|2196851|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
678071|NCT01683409|2196847|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
678072|NCT01683409|2196848|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
678073|NCT01683409|2196849|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
678074|NCT01683409|2196850|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
678075|NCT01683409|2196851|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
678076|NCT01683409|2196847|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
678077|NCT01683409|2196848|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
678078|NCT01683409|2196849|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
678079|NCT01683409|2196850|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
678080|NCT01683409|2196851|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
678081|NCT01683409|2196847|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
678082|NCT01683409|2196848|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
678083|NCT01683409|2196849|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
678084|NCT01683409|2196850|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
678085|NCT01683409|2196851|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
678086|NCT01683409|2196847|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
678087|NCT01683409|2196848|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
678088|NCT01683409|2196849|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
678089|NCT01683409|2196850|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
678090|NCT01683409|2196851|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
678091|NCT01683409|2196847|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
678092|NCT01683409|2196848|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
678093|NCT01683409|2196849|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
678094|NCT01683409|2196850|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
678095|NCT01683409|2196851|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
678096|NCT01683409|2196847|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
678097|NCT01683409|2196848|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
678098|NCT01683409|2196849|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
678099|NCT01683409|2196850|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
678100|NCT01683409|2196851|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
678101|NCT01683409|2196847|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
678102|NCT01683409|2196848|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
678103|NCT01683409|2196849|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
678104|NCT01683409|2196850|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
678105|NCT01683409|2196851|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
678106|NCT01683409|2196847|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
678107|NCT01683409|2196848|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
678108|NCT01683409|2196849|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
678109|NCT01683409|2196850|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
678110|NCT01683409|2196851|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
678111|NCT01683409|2196847|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
678112|NCT01683409|2196848|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
678113|NCT01683409|2196849|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
678114|NCT01683409|2196850|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
678115|NCT01683409|2196851|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
678116|NCT01683409|2196847|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
678117|NCT01683409|2196848|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
678118|NCT01683409|2196849|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
678119|NCT01683409|2196850|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
678120|NCT01683409|2196851|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
678121|NCT01683383|2196894|P2|Overall Study|Infant was not transported|0
678122|NCT01683383|2196895|P1|Overall Study|Infant was not transported|1
678123|NCT01683266|2196911|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
678124|NCT01683266|2196912|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
678125|NCT01683266|2196911|P2|Overall Study|Possibly Hypoglycemia|0
678126|NCT01683266|2196912|P1|Overall Study|Possibly Hypoglycemia|1
678127|NCT01683266|2196911|P2|Overall Study|Perceived Lack of Efficacy|1
678128|NCT01683266|2196912|P1|Overall Study|Perceived Lack of Efficacy|1
678129|NCT01683266|2196911|P2|Overall Study|Nonserious Hypoglycemia|3
678130|NCT01683266|2196912|P1|Overall Study|Nonserious Hypoglycemia|0
678131|NCT01683266|2196911|P2|Overall Study|Site Closure / Site Withdrawal|3
678132|NCT01683266|2196912|P1|Overall Study|Site Closure / Site Withdrawal|1
678133|NCT01683266|2196911|P2|Overall Study|Lost to Follow-up|0
678134|NCT01683266|2196912|P1|Overall Study|Lost to Follow-up|5
678135|NCT01683266|2196911|P2|Overall Study|Selection Criterion / Protocol Violation|5
678136|NCT01683266|2196912|P1|Overall Study|Selection Criterion / Protocol Violation|7
678137|NCT01683266|2196911|P2|Overall Study|Personal Reason|25
678138|NCT01683266|2196912|P1|Overall Study|Personal Reason|17
678139|NCT01683266|2196911|P2|Overall Study|Protocol Violation|6
678140|NCT01683266|2196912|P1|Overall Study|Protocol Violation|13
678141|NCT01683266|2196911|P2|Overall Study|Lack of Efficacy|2
678142|NCT01683266|2196912|P1|Overall Study|Lack of Efficacy|5
678143|NCT01683266|2196911|P2|Overall Study|Adverse Event|4
678144|NCT01683266|2196912|P1|Overall Study|Adverse Event|5
678145|NCT01683058|2196940|P1|Overall Study|Lack of Efficacy|2
678146|NCT01683058|2196940|P1|Overall Study|Withdrawal by Subject|7
678147|NCT01683058|2196940|P1|Overall Study|Subject Met Withdrawal Criteria|5
678148|NCT01683058|2196940|P1|Overall Study|Adverse Event|6
678149|NCT01683058|2196940|P1|Overall Study|Lost to Follow-up|9
678153|NCT01682876|2196996|P4|Overall Study|Other|1
678154|NCT01682876|2196997|P3|Overall Study|Other|1
678155|NCT01682876|2196998|P2|Overall Study|Other|0
678156|NCT01682876|2196999|P1|Overall Study|Other|1
678157|NCT01682876|2196996|P4|Overall Study|Withdrawal by Subject|2
678158|NCT01682876|2196997|P3|Overall Study|Withdrawal by Subject|0
678159|NCT01682876|2196998|P2|Overall Study|Withdrawal by Subject|0
678160|NCT01682876|2196999|P1|Overall Study|Withdrawal by Subject|4
678161|NCT01682876|2196996|P4|Overall Study|Protocol Violation|1
678162|NCT01682876|2196997|P3|Overall Study|Protocol Violation|1
678163|NCT01682876|2196998|P2|Overall Study|Protocol Violation|1
678164|NCT01682876|2196999|P1|Overall Study|Protocol Violation|1
678165|NCT01682876|2196996|P4|Overall Study|Lost to Follow-up|11
678166|NCT01682876|2196997|P3|Overall Study|Lost to Follow-up|9
678167|NCT01682876|2196998|P2|Overall Study|Lost to Follow-up|15
678168|NCT01682876|2196999|P1|Overall Study|Lost to Follow-up|11
678169|NCT01682876|2196996|P4|Overall Study|Adverse Event|1
678170|NCT01682876|2196997|P3|Overall Study|Adverse Event|0
678171|NCT01682876|2196998|P2|Overall Study|Adverse Event|0
678172|NCT01682876|2196999|P1|Overall Study|Adverse Event|0
678173|NCT01682876|2196996|P4|Overall Study|Administrative reason|3
678174|NCT01682876|2196997|P3|Overall Study|Administrative reason|0
678175|NCT01682876|2196998|P2|Overall Study|Administrative reason|4
678176|NCT01682876|2196999|P1|Overall Study|Administrative reason|4
678177|NCT01682863|2197045|P3|Overall Study|Physician Decision|1
678178|NCT01682863|2197046|P2|Overall Study|Physician Decision|0
678179|NCT01682863|2197047|P1|Overall Study|Physician Decision|0
678180|NCT01682863|2197045|P3|Overall Study|Adverse Event|2
678181|NCT01682863|2197046|P2|Overall Study|Adverse Event|1
678182|NCT01682863|2197047|P1|Overall Study|Adverse Event|0
678183|NCT01682863|2197045|P3|Overall Study|Technical problems|0
678184|NCT01682863|2197046|P2|Overall Study|Technical problems|0
678185|NCT01682863|2197047|P1|Overall Study|Technical problems|1
678186|NCT01682863|2197045|P3|Overall Study|Protocol deviation|1
678187|NCT01682863|2197046|P2|Overall Study|Protocol deviation|0
678188|NCT01682863|2197047|P1|Overall Study|Protocol deviation|1
678189|NCT01682863|2197045|P3|Overall Study|Death|4
678190|NCT01682863|2197046|P2|Overall Study|Death|3
678191|NCT01682863|2197047|P1|Overall Study|Death|1
678192|NCT01682863|2197045|P3|Overall Study|Lost to Follow-up|6
678193|NCT01682863|2197046|P2|Overall Study|Lost to Follow-up|1
678194|NCT01682863|2197047|P1|Overall Study|Lost to Follow-up|5
678195|NCT01682863|2197045|P3|Overall Study|Subject/guardian decision|10
678196|NCT01682863|2197046|P2|Overall Study|Subject/guardian decision|12
678197|NCT01682863|2197047|P1|Overall Study|Subject/guardian decision|19
678198|NCT01682837|2197076|P1|Baseline|Withdrawal by Subject|5
678199|NCT01682759|2197120|P2|Overall Study|Withdrawal by Subject|55
678200|NCT01682759|2197121|P1|Overall Study|Withdrawal by Subject|56
678201|NCT01682759|2197120|P2|Overall Study|Physician Decision|1
678202|NCT01682759|2197121|P1|Overall Study|Physician Decision|1
678203|NCT01682759|2197120|P2|Overall Study|Lost to Follow-up|13
678204|NCT01682759|2197121|P1|Overall Study|Lost to Follow-up|10
678205|NCT01682759|2197120|P2|Overall Study|Death|1
678206|NCT01682759|2197121|P1|Overall Study|Death|2
678207|NCT01682720|2197145|P4|Overall Study|Adverse Event|1
678208|NCT01682720|2197146|P3|Overall Study|Adverse Event|1
678209|NCT01682720|2197147|P2|Overall Study|Adverse Event|0
678210|NCT01682720|2197148|P1|Overall Study|Adverse Event|1
678211|NCT01682720|2197145|P4|Overall Study|Subject Withdrew Consent|2
678212|NCT01682720|2197146|P3|Overall Study|Subject Withdrew Consent|2
678213|NCT01682720|2197147|P2|Overall Study|Subject Withdrew Consent|0
678214|NCT01682720|2197148|P1|Overall Study|Subject Withdrew Consent|0
678215|NCT01682720|2197145|P4|Overall Study|Lost to Follow-up|6
678216|NCT01682720|2197146|P3|Overall Study|Lost to Follow-up|0
678217|NCT01682720|2197147|P2|Overall Study|Lost to Follow-up|1
678218|NCT01682720|2197148|P1|Overall Study|Lost to Follow-up|1
678219|NCT01682720|2197145|P4|Overall Study|Efficacy Failure|30
678220|NCT01682720|2197146|P3|Overall Study|Efficacy Failure|3
678221|NCT01682720|2197147|P2|Overall Study|Efficacy Failure|3
678222|NCT01682720|2197148|P1|Overall Study|Efficacy Failure|0
678223|NCT01682720|2197145|P4|Overall Study|Terminated by Sponsor|0
678224|NCT01682720|2197146|P3|Overall Study|Terminated by Sponsor|0
678225|NCT01682720|2197147|P2|Overall Study|Terminated by Sponsor|0
678226|NCT01682720|2197148|P1|Overall Study|Terminated by Sponsor|83
678227|NCT01682720|2197145|P4|Overall Study|Randomized but Not Treated|0
678228|NCT01682720|2197146|P3|Overall Study|Randomized but Not Treated|1
678229|NCT01682720|2197147|P2|Overall Study|Randomized but Not Treated|1
678230|NCT01682720|2197148|P1|Overall Study|Randomized but Not Treated|0
678231|NCT01682681|2197165|P1|Overall Study|Low compliance|13
678232|NCT01682681|2197165|P1|Overall Study|unspecified|21
678233|NCT01682681|2197165|P1|Overall Study|tapering of topiramate|5
678234|NCT01682681|2197165|P1|Overall Study|Adverse Event|46
678235|NCT01682681|2197165|P1|Overall Study|Lost to Follow-up|174
678236|NCT01682681|2197165|P1|Overall Study|Moved to other hospital|10
678237|NCT01682681|2197165|P1|Overall Study|Withdrawal by Subject|1
678238|NCT01682681|2197165|P1|Overall Study|Lack of Efficacy|62
678239|NCT01682603|2197194|P1|Overall Study|Lost to Follow-up|3
678240|NCT01682460|2197236|P1|Overall Study|Did not meet inclusion criteria|2
678241|NCT01682460|2197236|P1|Overall Study|Withdrawal by Subject|2
678244|NCT01682031|2197300|P2|Overall Study|Patient stopped selenium on his own|1
678245|NCT01682031|2197301|P1|Overall Study|Patient stopped selenium on his own|0
678246|NCT01682031|2197300|P2|Overall Study|Patient could not swallow tablets|0
678247|NCT01682031|2197301|P1|Overall Study|Patient could not swallow tablets|1
678248|NCT01682031|2197300|P2|Overall Study|MRI results indicate increased nodul|1
678249|NCT01682031|2197301|P1|Overall Study|MRI results indicate increased nodul|0
678250|NCT01682031|2197300|P2|Overall Study|Adverse Event|2
678251|NCT01682031|2197301|P1|Overall Study|Adverse Event|0
678252|NCT01682031|2197300|P2|Overall Study|Withdrawal by Subject|1
678253|NCT01682031|2197301|P1|Overall Study|Withdrawal by Subject|0
678254|NCT01681849|2197324|P3|Overall Study|Lost to Follow-up|6
678255|NCT01681849|2197325|P2|Overall Study|Lost to Follow-up|2
678256|NCT01681849|2197326|P1|Overall Study|Lost to Follow-up|3
678257|NCT01681849|2197324|P3|Overall Study|Withdrawal by Subject|33
678258|NCT01681849|2197325|P2|Overall Study|Withdrawal by Subject|5
678259|NCT01681849|2197326|P1|Overall Study|Withdrawal by Subject|3
678260|NCT01681849|2197324|P3|Overall Study|Protocol Violation|0
678261|NCT01681849|2197325|P2|Overall Study|Protocol Violation|0
678262|NCT01681849|2197326|P1|Overall Study|Protocol Violation|2
678263|NCT01681628|2197337|P2|19 Months Follow-up|Lost to Follow-up|43
678264|NCT01681628|2197338|P1|19 Months Follow-up|Lost to Follow-up|61
678265|NCT01681628|2197337|P2|19 Months Follow-up|Death|0
678266|NCT01681628|2197338|P1|19 Months Follow-up|Death|1
678267|NCT01681628|2197337|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
678268|NCT01681628|2197338|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
678269|NCT01681628|2197337|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
678270|NCT01681628|2197338|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
678271|NCT01681576|2197351|P2|Period 2|Non-compliance with study treatment|0
678272|NCT01681576|2197352|P1|Period 2|Non-compliance with study treatment|1
678273|NCT01681576|2197351|P2|Period 2|subject/guardian decision|1
678274|NCT01681576|2197352|P1|Period 2|subject/guardian decision|3
678275|NCT01681576|2197351|P2|Period 1|Protocol Deviation|0
678276|NCT01681576|2197352|P1|Period 1|Protocol Deviation|1
678277|NCT01681576|2197351|P2|Period 1|Adverse Event|0
678278|NCT01681576|2197352|P1|Period 1|Adverse Event|1
678279|NCT01681511|2197368|P2|Overall Study|No post-catheter sample collected|4
678280|NCT01681511|2197369|P1|Overall Study|No post-catheter sample collected|11
678281|NCT01681511|2197368|P2|Overall Study|No Daily Urine Sample Collected|1
678282|NCT01681511|2197369|P1|Overall Study|No Daily Urine Sample Collected|0
678283|NCT01681511|2197368|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
678284|NCT01681511|2197369|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
678285|NCT01681511|2197368|P2|Overall Study|Failed Inclusion/Exclusion|0
678286|NCT01681511|2197369|P1|Overall Study|Failed Inclusion/Exclusion|3
678287|NCT01681511|2197368|P2|Overall Study|No Treatment Received|3
678288|NCT01681511|2197369|P1|Overall Study|No Treatment Received|1
678289|NCT01681472|2197387|P4|Overall Study|Adverse Event|0
678290|NCT01681472|2197388|P3|Overall Study|Adverse Event|0
678291|NCT01681472|2197389|P2|Overall Study|Adverse Event|1
678292|NCT01681472|2197390|P1|Overall Study|Adverse Event|0
678293|NCT01681368|2197400|P1|Overall Study|Refused further follow up|1
678294|NCT01681368|2197400|P1|Overall Study|Refused further treatment|1
678295|NCT01681277|2197417|P5|Overall Study|Adverse Event|0
678296|NCT01681277|2197418|P4|Overall Study|Adverse Event|0
678297|NCT01681277|2197419|P3|Overall Study|Adverse Event|0
678298|NCT01681277|2197420|P2|Overall Study|Adverse Event|0
678299|NCT01681277|2197421|P1|Overall Study|Adverse Event|1
678300|NCT01681212|2197462|P1|Overall Study|Administrative reason by sponsor|1
678301|NCT01681212|2197462|P1|Overall Study|No longer met study criteria|5
678302|NCT01681069|2197520|P2|Overall Study|Adverse Event|1
678303|NCT01681069|2197521|P1|Overall Study|Adverse Event|0
678304|NCT01681069|2197520|P2|Overall Study|Protocol Violation|1
678305|NCT01681069|2197521|P1|Overall Study|Protocol Violation|1
678306|NCT01681069|2197520|P2|Overall Study|Withdrawal by Subject|5
678307|NCT01681069|2197521|P1|Overall Study|Withdrawal by Subject|4
678308|NCT01681004|2197533|P2|Study Completion|Death|1
678309|NCT01681004|2197534|P1|Study Completion|Death|1
678310|NCT01681004|2197533|P2|Study Completion|Site Termination|1
678311|NCT01681004|2197534|P1|Study Completion|Site Termination|2
678312|NCT01681004|2197533|P2|Study Completion|Physician Decision|3
678313|NCT01681004|2197534|P1|Study Completion|Physician Decision|1
678314|NCT01681004|2197533|P2|Study Completion|Lost to Follow-up|3
678315|NCT01681004|2197534|P1|Study Completion|Lost to Follow-up|8
678316|NCT01681004|2197533|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
678317|NCT01681004|2197534|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
678318|NCT01680991|2197591|P3|Overall Study|PD confirmed in other hospital|0
678319|NCT01680991|2197592|P2|Overall Study|PD confirmed in other hospital|0
678320|NCT01680991|2197593|P1|Overall Study|PD confirmed in other hospital|1
678321|NCT01680991|2197591|P3|Overall Study|Bad physical condition|1
678322|NCT01680991|2197592|P2|Overall Study|Bad physical condition|0
678323|NCT01680991|2197593|P1|Overall Study|Bad physical condition|0
678324|NCT01680991|2197591|P3|Overall Study|Physician Decision|2
678325|NCT01680991|2197592|P2|Overall Study|Physician Decision|7
678326|NCT01680991|2197593|P1|Overall Study|Physician Decision|0
678327|NCT01680991|2197591|P3|Overall Study|Progressive disease (PD)|0
678328|NCT01680991|2197592|P2|Overall Study|Progressive disease (PD)|10
678329|NCT01680991|2197593|P1|Overall Study|Progressive disease (PD)|0
678330|NCT01680991|2197591|P3|Overall Study|Withdrawal by Subject|0
678331|NCT01680991|2197592|P2|Overall Study|Withdrawal by Subject|1
678332|NCT01680991|2197593|P1|Overall Study|Withdrawal by Subject|5
678333|NCT01680991|2197591|P3|Overall Study|Protocol Violation|0
678334|NCT01680991|2197592|P2|Overall Study|Protocol Violation|1
678335|NCT01680991|2197593|P1|Overall Study|Protocol Violation|0
678336|NCT01680991|2197591|P3|Overall Study|Death|1
678337|NCT01680991|2197592|P2|Overall Study|Death|0
678338|NCT01680991|2197593|P1|Overall Study|Death|1
678339|NCT01680991|2197591|P3|Overall Study|Adverse Event|0
678340|NCT01680991|2197592|P2|Overall Study|Adverse Event|0
678341|NCT01680991|2197593|P1|Overall Study|Adverse Event|1
678342|NCT01680861|2197673|P2|Early Post-transplant Period|Protocol Violation|1
678343|NCT01680861|2197674|P1|Early Post-transplant Period|Protocol Violation|1
678344|NCT01680497|2197729|P1|Overall Study|Lost to Follow-up|2
678345|NCT01680458|2197739|P1|Overall Study|Protocol Violation|3
678346|NCT01680341|2197750|P2|Overall Study|Unclassified|15
678347|NCT01680341|2197751|P1|Overall Study|Unclassified|18
678348|NCT01680341|2197750|P2|Overall Study|Adverse Event|2
678349|NCT01680341|2197751|P1|Overall Study|Adverse Event|3
678350|NCT01680159|2197822|P1|Increased Dose Period|Withdrawal by Subject|2
678351|NCT01680159|2197822|P1|Increased Dose Period|Adverse Event|6
678352|NCT01680159|2197822|P1|Screening Period|Not meet criteria for dose-up period|7
678353|NCT01680016|2197849|P4|Overall Study|Withdrawal by Subject|1
678354|NCT01680016|2197850|P3|Overall Study|Withdrawal by Subject|1
678355|NCT01680016|2197851|P2|Overall Study|Withdrawal by Subject|7
678356|NCT01680016|2197852|P1|Overall Study|Withdrawal by Subject|5
678357|NCT01680016|2197849|P4|Overall Study|Protocol Violation|0
678358|NCT01680016|2197850|P3|Overall Study|Protocol Violation|0
678359|NCT01680016|2197851|P2|Overall Study|Protocol Violation|1
678360|NCT01680016|2197852|P1|Overall Study|Protocol Violation|0
678361|NCT01680016|2197849|P4|Overall Study|The Subject went out of The Trial|0
678362|NCT01680016|2197850|P3|Overall Study|The Subject went out of The Trial|3
678363|NCT01680016|2197851|P2|Overall Study|The Subject went out of The Trial|0
678364|NCT01680016|2197852|P1|Overall Study|The Subject went out of The Trial|1
678365|NCT01680016|2197849|P4|Overall Study|Adverse Event|4
678366|NCT01680016|2197850|P3|Overall Study|Adverse Event|1
678367|NCT01680016|2197851|P2|Overall Study|Adverse Event|0
678368|NCT01680016|2197852|P1|Overall Study|Adverse Event|0
678369|NCT01679613|2197914|P4|Overall Study|other than stated above|2
678370|NCT01679613|2197915|P3|Overall Study|other than stated above|2
678371|NCT01679613|2197916|P2|Overall Study|other than stated above|1
678372|NCT01679613|2197917|P1|Overall Study|other than stated above|0
678373|NCT01679236|2197960|P2|Overall Study|Lost to Follow-up|15
678374|NCT01679236|2197961|P1|Overall Study|Lost to Follow-up|15
678375|NCT01679002|2198008|P3|Overall Study|Adverse Event|0
678376|NCT01679002|2198009|P2|Overall Study|Adverse Event|1
678377|NCT01679002|2198010|P1|Overall Study|Adverse Event|1
678378|NCT01678911|2198037|P2|Second Intervention|Lost to Follow-up|0
678379|NCT01678911|2198038|P1|Second Intervention|Lost to Follow-up|2
678380|NCT01678820|2198084|P3|Overall Study|Not treated with double-blind study drug|2
678381|NCT01678820|2198085|P2|Overall Study|Not treated with double-blind study drug|2
678382|NCT01678820|2198086|P1|Overall Study|Not treated with double-blind study drug|0
678383|NCT01678820|2198084|P3|Overall Study|Protocol Violation|4
678384|NCT01678820|2198085|P2|Overall Study|Protocol Violation|5
678385|NCT01678820|2198086|P1|Overall Study|Protocol Violation|4
678386|NCT01678820|2198084|P3|Overall Study|Physician Decision|1
678387|NCT01678820|2198085|P2|Overall Study|Physician Decision|0
678388|NCT01678820|2198086|P1|Overall Study|Physician Decision|0
678389|NCT01678820|2198084|P3|Overall Study|Non-compliance with study drug|0
678390|NCT01678820|2198085|P2|Overall Study|Non-compliance with study drug|1
678391|NCT01678820|2198086|P1|Overall Study|Non-compliance with study drug|0
678392|NCT01678820|2198084|P3|Overall Study|Lost to Follow-up|2
678393|NCT01678820|2198085|P2|Overall Study|Lost to Follow-up|2
678394|NCT01678820|2198086|P1|Overall Study|Lost to Follow-up|7
678395|NCT01678820|2198084|P3|Overall Study|Adverse Event|2
678396|NCT01678820|2198085|P2|Overall Study|Adverse Event|2
678397|NCT01678820|2198086|P1|Overall Study|Adverse Event|2
678398|NCT01678820|2198084|P3|Overall Study|Protocol Specified Criteria|1
678399|NCT01678820|2198085|P2|Overall Study|Protocol Specified Criteria|3
678400|NCT01678820|2198086|P1|Overall Study|Protocol Specified Criteria|2
678401|NCT01678820|2198084|P3|Overall Study|Withdrawal by Subject|2
678402|NCT01678820|2198085|P2|Overall Study|Withdrawal by Subject|5
678403|NCT01678820|2198086|P1|Overall Study|Withdrawal by Subject|2
678404|NCT01678820|2198084|P3|Overall Study|Study Terminated by Sponsor|43
678405|NCT01678820|2198085|P2|Overall Study|Study Terminated by Sponsor|43
678406|NCT01678820|2198086|P1|Overall Study|Study Terminated by Sponsor|45
678407|NCT01678807|2198131|P3|Overall Study|Withdrawn by Parent/Guardian|0
678408|NCT01678807|2198132|P2|Overall Study|Withdrawn by Parent/Guardian|1
678409|NCT01678807|2198133|P1|Overall Study|Withdrawn by Parent/Guardian|0
678410|NCT01678807|2198131|P3|Overall Study|Adverse Event|0
678411|NCT01678807|2198132|P2|Overall Study|Adverse Event|4
678412|NCT01678807|2198133|P1|Overall Study|Adverse Event|4
678413|NCT01678313|2198146|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
678414|NCT01678313|2198147|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
678415|NCT01678313|2198146|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
678416|NCT01678313|2198147|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
678417|NCT01678313|2198146|P2|Completed the 3-month Therapy|Physician Decision|4
678418|NCT01678313|2198147|P1|Completed the 3-month Therapy|Physician Decision|3
678419|NCT01678313|2198146|P2|Completed the 3-month Therapy|Lost to Follow-up|8
678420|NCT01678313|2198147|P1|Completed the 3-month Therapy|Lost to Follow-up|3
678421|NCT01678131|2198181|P3|Overall Study|Withdrawal by Subject|2
678422|NCT01678131|2198182|P2|Overall Study|Withdrawal by Subject|0
678423|NCT01678131|2198183|P1|Overall Study|Withdrawal by Subject|0
678424|NCT01678131|2198181|P3|Overall Study|Adverse Event|0
678425|NCT01678131|2198182|P2|Overall Study|Adverse Event|1
678426|NCT01678131|2198183|P1|Overall Study|Adverse Event|0
678427|NCT01677988|2198191|P1|Overall Study|Lack of Efficacy|2
678428|NCT01677936|2198204|P2|Overall Study|Protocol Violation|4
678429|NCT01677936|2198205|P1|Overall Study|Protocol Violation|0
678430|NCT01677936|2198204|P2|Overall Study|Lost to Follow-up|0
678431|NCT01677936|2198205|P1|Overall Study|Lost to Follow-up|1
678432|NCT01677936|2198204|P2|Overall Study|Adverse Event|0
678433|NCT01677936|2198205|P1|Overall Study|Adverse Event|1
678434|NCT01677936|2198204|P2|Overall Study|Protocol Violation|0
678435|NCT01677936|2198205|P1|Overall Study|Protocol Violation|3
678436|NCT01677936|2198204|P2|Overall Study|Lost to Follow-up|1
678437|NCT01677936|2198205|P1|Overall Study|Lost to Follow-up|4
678438|NCT01677910|2198216|P3|Overall Study|Withdrawal by Subject|4
678439|NCT01677910|2198217|P2|Overall Study|Withdrawal by Subject|1
678440|NCT01677910|2198218|P1|Overall Study|Withdrawal by Subject|1
678441|NCT01677910|2198216|P3|Overall Study|Physician Decision|1
678442|NCT01677910|2198217|P2|Overall Study|Physician Decision|0
678443|NCT01677910|2198218|P1|Overall Study|Physician Decision|0
678444|NCT01677910|2198216|P3|Overall Study|Adverse Event|3
678445|NCT01677910|2198217|P2|Overall Study|Adverse Event|2
678446|NCT01677910|2198218|P1|Overall Study|Adverse Event|6
678447|NCT01677858|2198243|P5|Overall Study|Lost to Follow-up|1
678448|NCT01677858|2198244|P4|Overall Study|Lost to Follow-up|0
678449|NCT01677858|2198245|P3|Overall Study|Lost to Follow-up|0
678450|NCT01677858|2198246|P2|Overall Study|Lost to Follow-up|0
678451|NCT01677858|2198247|P1|Overall Study|Lost to Follow-up|0
678452|NCT01677858|2198243|P5|Overall Study|Withdrawal by Subject|15
678453|NCT01677858|2198244|P4|Overall Study|Withdrawal by Subject|0
678454|NCT01677858|2198245|P3|Overall Study|Withdrawal by Subject|1
678455|NCT01677858|2198246|P2|Overall Study|Withdrawal by Subject|1
678456|NCT01677858|2198247|P1|Overall Study|Withdrawal by Subject|0
678457|NCT01677858|2198243|P5|Overall Study|Progressive Disease|43
678458|NCT01677858|2198244|P4|Overall Study|Progressive Disease|3
678459|NCT01677858|2198245|P3|Overall Study|Progressive Disease|9
678460|NCT01677858|2198246|P2|Overall Study|Progressive Disease|1
678461|NCT01677858|2198247|P1|Overall Study|Progressive Disease|2
678462|NCT01677858|2198243|P5|Overall Study|Physician Decision|12
678463|NCT01677858|2198244|P4|Overall Study|Physician Decision|0
678464|NCT01677858|2198245|P3|Overall Study|Physician Decision|2
678465|NCT01677858|2198246|P2|Overall Study|Physician Decision|0
678466|NCT01677858|2198247|P1|Overall Study|Physician Decision|1
678467|NCT01677858|2198243|P5|Overall Study|Death|1
678468|NCT01677858|2198244|P4|Overall Study|Death|0
678469|NCT01677858|2198245|P3|Overall Study|Death|0
678470|NCT01677858|2198246|P2|Overall Study|Death|0
678471|NCT01677858|2198247|P1|Overall Study|Death|0
678472|NCT01677858|2198243|P5|Overall Study|Adverse Event|13
678473|NCT01677858|2198244|P4|Overall Study|Adverse Event|3
678474|NCT01677858|2198245|P3|Overall Study|Adverse Event|2
678475|NCT01677858|2198246|P2|Overall Study|Adverse Event|0
678476|NCT01677858|2198247|P1|Overall Study|Adverse Event|0
678477|NCT01677767|2198320|P1|Overall Study|Non-compliance by the participants|3
678478|NCT01677767|2198320|P1|Overall Study|Withdrawal by Subject|10
678479|NCT01677767|2198320|P1|Overall Study|Protocol Violation|4
678480|NCT01677767|2198320|P1|Overall Study|Death|4
678481|NCT01677767|2198320|P1|Overall Study|Adverse Event|1
678482|NCT01677624|2198334|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
678483|NCT01677507|2198339|P2|Second Assigment|Adverse Event|3
678484|NCT01677507|2198340|P1|Second Assigment|Adverse Event|1
678485|NCT01677507|2198339|P2|Second Assigment|Withdrawal by Subject|2
678486|NCT01677507|2198340|P1|Second Assigment|Withdrawal by Subject|2
678487|NCT01677507|2198339|P2|Initial Assignment|Protocol Violation|1
678488|NCT01677507|2198340|P1|Initial Assignment|Protocol Violation|0
678489|NCT01677507|2198339|P2|Initial Assignment|Adverse Event|1
678490|NCT01677507|2198340|P1|Initial Assignment|Adverse Event|0
678491|NCT01677299|2198354|P4|Overall Study|Withdrawal by Subject|1
678492|NCT01677299|2198355|P3|Overall Study|Withdrawal by Subject|0
678493|NCT01677299|2198356|P2|Overall Study|Withdrawal by Subject|1
678494|NCT01677299|2198357|P1|Overall Study|Withdrawal by Subject|0
678495|NCT01677299|2198354|P4|Overall Study|Adverse Event|0
678496|NCT01677299|2198355|P3|Overall Study|Adverse Event|1
678497|NCT01677299|2198356|P2|Overall Study|Adverse Event|2
678498|NCT01677299|2198357|P1|Overall Study|Adverse Event|0
678499|NCT01677195|2198389|P3|Overall Study|Protocol Violation|4
678500|NCT01677195|2198390|P2|Overall Study|Protocol Violation|3
678501|NCT01677195|2198391|P1|Overall Study|Protocol Violation|7
678502|NCT01677195|2198389|P3|Overall Study|Pregnancy|0
678503|NCT01677195|2198390|P2|Overall Study|Pregnancy|1
678504|NCT01677195|2198391|P1|Overall Study|Pregnancy|0
678505|NCT01677195|2198389|P3|Overall Study|Physician Decision|2
678506|NCT01677195|2198390|P2|Overall Study|Physician Decision|2
678507|NCT01677195|2198391|P1|Overall Study|Physician Decision|1
678508|NCT01677195|2198389|P3|Overall Study|Adverse Event|1
678509|NCT01677195|2198390|P2|Overall Study|Adverse Event|4
678510|NCT01677195|2198391|P1|Overall Study|Adverse Event|6
678511|NCT01677195|2198389|P3|Overall Study|Withdrawal by Subject|1
678512|NCT01677195|2198390|P2|Overall Study|Withdrawal by Subject|0
678513|NCT01677195|2198391|P1|Overall Study|Withdrawal by Subject|1
678514|NCT01677195|2198389|P3|Overall Study|Lost to Follow-up|22
678515|NCT01677195|2198390|P2|Overall Study|Lost to Follow-up|22
678516|NCT01677195|2198391|P1|Overall Study|Lost to Follow-up|14
678517|NCT01677182|2198402|P3|Overall Study|Other reasons|2
678518|NCT01677182|2198403|P2|Overall Study|Other reasons|5
678519|NCT01677182|2198404|P1|Overall Study|Other reasons|1
678520|NCT01677182|2198402|P3|Overall Study|Lack of Efficacy|1
678521|NCT01677182|2198403|P2|Overall Study|Lack of Efficacy|0
678522|NCT01677182|2198404|P1|Overall Study|Lack of Efficacy|3
678523|NCT01677182|2198402|P3|Overall Study|Study termination|11
678524|NCT01677182|2198403|P2|Overall Study|Study termination|9
678525|NCT01677182|2198404|P1|Overall Study|Study termination|12
678526|NCT01677182|2198402|P3|Overall Study|Withdrawal by Subject|10
678527|NCT01677182|2198403|P2|Overall Study|Withdrawal by Subject|12
678528|NCT01677182|2198404|P1|Overall Study|Withdrawal by Subject|7
678529|NCT01677182|2198402|P3|Overall Study|Lost to Follow-up|3
678530|NCT01677182|2198403|P2|Overall Study|Lost to Follow-up|0
678531|NCT01677182|2198404|P1|Overall Study|Lost to Follow-up|4
678532|NCT01677182|2198402|P3|Overall Study|Protocol Violation|4
678533|NCT01677182|2198403|P2|Overall Study|Protocol Violation|1
678534|NCT01677182|2198404|P1|Overall Study|Protocol Violation|5
678535|NCT01677182|2198402|P3|Overall Study|Adverse Event|8
678536|NCT01677182|2198403|P2|Overall Study|Adverse Event|1
678537|NCT01677182|2198404|P1|Overall Study|Adverse Event|2
678538|NCT01676961|2198436|P1|Overall Study|Withdrawal by Subject|1
678539|NCT01676961|2198436|P1|Overall Study|Lost to Follow-up|1
678540|NCT01676961|2198436|P1|Overall Study|Death|3
678541|NCT01676896|2198444|P3|Overall Study|Withdrawal by Subject|19
678542|NCT01676896|2198445|P2|Overall Study|Withdrawal by Subject|7
678543|NCT01676896|2198446|P1|Overall Study|Withdrawal by Subject|12
678544|NCT01676220|2198607|P2|Overall Study|No More Need of Insulin|0
678545|NCT01676220|2198608|P1|Overall Study|No More Need of Insulin|1
678546|NCT01676220|2198607|P2|Overall Study|Non Serious Hypoglycemia|0
678547|NCT01676220|2198608|P1|Overall Study|Non Serious Hypoglycemia|2
678548|NCT01676220|2198607|P2|Overall Study|Perceived Lack of Efficacy|1
678549|NCT01676220|2198608|P1|Overall Study|Perceived Lack of Efficacy|3
678550|NCT01676220|2198607|P2|Overall Study|Site Closure/Site Withdrawal|4
678551|NCT01676220|2198608|P1|Overall Study|Site Closure/Site Withdrawal|1
678552|NCT01676220|2198607|P2|Overall Study|Selection Criterion/Protocol Violation|9
678553|NCT01676220|2198608|P1|Overall Study|Selection Criterion/Protocol Violation|9
678554|NCT01676220|2198607|P2|Overall Study|Lost to Follow-up|18
678555|NCT01676220|2198608|P1|Overall Study|Lost to Follow-up|11
678556|NCT01676220|2198607|P2|Overall Study|Personal Reason|45
678557|NCT01676220|2198608|P1|Overall Study|Personal Reason|34
678558|NCT01676220|2198607|P2|Overall Study|Received Rescue Therapy|22
678559|NCT01676220|2198608|P1|Overall Study|Received Rescue Therapy|14
678560|NCT01676220|2198607|P2|Overall Study|Protocol Violation|12
678561|NCT01676220|2198608|P1|Overall Study|Protocol Violation|11
678562|NCT01676220|2198607|P2|Overall Study|Lack of Efficacy|5
678563|NCT01676220|2198608|P1|Overall Study|Lack of Efficacy|2
678564|NCT01676220|2198607|P2|Overall Study|Adverse Event|8
678565|NCT01676220|2198608|P1|Overall Study|Adverse Event|10
678566|NCT01676220|2198607|P2|Overall Study|Randomized But Not Treated|1
678567|NCT01676220|2198608|P1|Overall Study|Randomized But Not Treated|4
678568|NCT01676012|2198638|P1|Overall Study|incomplete set of videos|1
678569|NCT01676012|2198638|P1|Overall Study|Adverse Event|2
678570|NCT01675661|2198649|P2|Overall Study|Other reason|2
678571|NCT01675661|2198650|P1|Overall Study|Other reason|1
678572|NCT01675661|2198649|P2|Overall Study|Death|1
678573|NCT01675661|2198650|P1|Overall Study|Death|0
678574|NCT01675661|2198649|P2|Overall Study|Physician Decision|2
678575|NCT01675661|2198650|P1|Overall Study|Physician Decision|0
678576|NCT01675661|2198649|P2|Overall Study|Withdrawal by Subject|7
678577|NCT01675661|2198650|P1|Overall Study|Withdrawal by Subject|3
678578|NCT01675661|2198649|P2|Overall Study|Moved away|6
678579|NCT01675661|2198650|P1|Overall Study|Moved away|5
678580|NCT01675661|2198649|P2|Overall Study|Practical problems|5
678581|NCT01675661|2198650|P1|Overall Study|Practical problems|9
678582|NCT01675661|2198649|P2|Overall Study|Lost to Follow-up|23
678583|NCT01675661|2198650|P1|Overall Study|Lost to Follow-up|22
678584|NCT01675544|2198662|P1|Overall Study|Withdrawal by Subject|2
678585|NCT01675531|2198667|P1|Overall Study|Protocol Violation|8
678586|NCT01675531|2198667|P1|Overall Study|Lack of Efficacy|1
678587|NCT01675531|2198667|P1|Overall Study|Withdrawal by Subject|7
678588|NCT01675531|2198667|P1|Overall Study|Adverse Event|9
678589|NCT01675492|2198674|P1|Overall Study|study completed early - product approval|42
678590|NCT01675427|2198688|P1|Overall Study|Not Specified|2
678591|NCT01675427|2198688|P1|Overall Study|Lost to Follow-up|5
678592|NCT01675427|2198688|P1|Overall Study|Sample not Collected by Mistake|2
678593|NCT01675427|2198688|P1|Overall Study|Participant Refused Sample Collection|18
678594|NCT01675427|2198688|P1|Overall Study|Withdrawal by Subject|7
678595|NCT01675167|2198975|P3|Double-blind Treatment Phase|Not specified|5
678596|NCT01675167|2198976|P2|Double-blind Treatment Phase|Not specified|7
678597|NCT01675167|2198977|P1|Double-blind Treatment Phase|Not specified|0
678598|NCT01675167|2198975|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
678599|NCT01675167|2198976|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
678600|NCT01675167|2198977|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
678601|NCT01675167|2198975|P3|Double-blind Treatment Phase|Lost to Follow-up|5
678602|NCT01675167|2198976|P2|Double-blind Treatment Phase|Lost to Follow-up|1
678603|NCT01675167|2198977|P1|Double-blind Treatment Phase|Lost to Follow-up|0
678604|NCT01675167|2198975|P3|Double-blind Treatment Phase|Protocol Violation|11
678605|NCT01675167|2198976|P2|Double-blind Treatment Phase|Protocol Violation|4
678606|NCT01675167|2198977|P1|Double-blind Treatment Phase|Protocol Violation|0
678607|NCT01675167|2198975|P3|Double-blind Treatment Phase|Adverse Event|13
678608|NCT01675167|2198976|P2|Double-blind Treatment Phase|Adverse Event|5
678609|NCT01675167|2198977|P1|Double-blind Treatment Phase|Adverse Event|0
678610|NCT01675167|2198975|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
678611|NCT01675167|2198976|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
678612|NCT01675167|2198977|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
678613|NCT01675167|2198975|P3|Double-blind Treatment Phase|Lack of Efficacy|61
678614|NCT01675167|2198976|P2|Double-blind Treatment Phase|Lack of Efficacy|19
678615|NCT01675167|2198977|P1|Double-blind Treatment Phase|Lack of Efficacy|0
678616|NCT01675167|2198975|P3|Open-label Titration Phase|Not specified|0
678617|NCT01675167|2198976|P2|Open-label Titration Phase|Not specified|0
678618|NCT01675167|2198977|P1|Open-label Titration Phase|Not specified|55
678619|NCT01675167|2198975|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
678620|NCT01675167|2198976|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
678621|NCT01675167|2198977|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
678622|NCT01675167|2198975|P3|Open-label Titration Phase|Lost to Follow-up|0
678623|NCT01675167|2198976|P2|Open-label Titration Phase|Lost to Follow-up|0
678624|NCT01675167|2198977|P1|Open-label Titration Phase|Lost to Follow-up|15
678625|NCT01675167|2198975|P3|Open-label Titration Phase|Protocol Violation|0
678626|NCT01675167|2198976|P2|Open-label Titration Phase|Protocol Violation|0
678627|NCT01675167|2198977|P1|Open-label Titration Phase|Protocol Violation|43
678628|NCT01675167|2198975|P3|Open-label Titration Phase|Withdrawal by Subject|0
678629|NCT01675167|2198976|P2|Open-label Titration Phase|Withdrawal by Subject|0
678630|NCT01675167|2198977|P1|Open-label Titration Phase|Withdrawal by Subject|46
678631|NCT01675167|2198975|P3|Open-label Titration Phase|Lack of Efficacy|0
678632|NCT01675167|2198976|P2|Open-label Titration Phase|Lack of Efficacy|0
678633|NCT01675167|2198977|P1|Open-label Titration Phase|Lack of Efficacy|63
678634|NCT01675167|2198975|P3|Open-label Titration Phase|Adverse Event|0
678635|NCT01675167|2198976|P2|Open-label Titration Phase|Adverse Event|0
678636|NCT01675167|2198977|P1|Open-label Titration Phase|Adverse Event|81
678637|NCT01675141|2198999|P1|Overall Study|No treatment, per protocol|1
678638|NCT01675141|2198999|P1|Overall Study|Physician Decision|4
678639|NCT01675141|2198999|P1|Overall Study|Withdrawal by Subject|3
678640|NCT01675141|2198999|P1|Overall Study|Lenalidomide outside NIH|3
678641|NCT01675128|2199012|P3|Overall Study|Pulmonary complication; off study|0
678642|NCT01675128|2199013|P2|Overall Study|Pulmonary complication; off study|1
678643|NCT01675128|2199014|P1|Overall Study|Pulmonary complication; off study|0
678644|NCT01675128|2199012|P3|Overall Study|Refused further treatment|0
678645|NCT01675128|2199013|P2|Overall Study|Refused further treatment|0
678646|NCT01675128|2199014|P1|Overall Study|Refused further treatment|1
678647|NCT01675128|2199012|P3|Overall Study|Disease progression on study|1
678648|NCT01675128|2199013|P2|Overall Study|Disease progression on study|1
678649|NCT01675128|2199014|P1|Overall Study|Disease progression on study|1
678650|NCT01675050|2199042|P2|Period One Treatment|Withdrawal by Subject|0
678651|NCT01675050|2199043|P1|Period One Treatment|Withdrawal by Subject|1
678652|NCT01675011|2199053|P2|Overall Study|Trial terminated by Sponsor|1
678653|NCT01675011|2199054|P1|Overall Study|Trial terminated by Sponsor|3
678654|NCT01674725|2199062|P2|Overall Study|Lost to Follow-up|1
678655|NCT01674725|2199063|P1|Overall Study|Lost to Follow-up|0
678656|NCT01674725|2199062|P2|Overall Study|Withdrawal by Subject|0
678657|NCT01674725|2199063|P1|Overall Study|Withdrawal by Subject|1
678658|NCT01674725|2199062|P2|Overall Study|Did not receive study drug|0
678659|NCT01674725|2199063|P1|Overall Study|Did not receive study drug|1
678660|NCT01674725|2199062|P2|Overall Study|Adverse Event|0
678661|NCT01674725|2199063|P1|Overall Study|Adverse Event|1
678662|NCT01674712|2199082|P5|Overall Study|Lack of Efficacy|1
678663|NCT01674712|2199083|P4|Overall Study|Lack of Efficacy|0
678664|NCT01674712|2199084|P3|Overall Study|Lack of Efficacy|1
678665|NCT01674712|2199085|P2|Overall Study|Lack of Efficacy|0
678666|NCT01674712|2199086|P1|Overall Study|Lack of Efficacy|0
678667|NCT01674712|2199082|P5|Overall Study|Administrative|1
678668|NCT01674712|2199083|P4|Overall Study|Administrative|0
678669|NCT01674712|2199084|P3|Overall Study|Administrative|0
678670|NCT01674712|2199085|P2|Overall Study|Administrative|1
678671|NCT01674712|2199086|P1|Overall Study|Administrative|0
678672|NCT01674712|2199082|P5|Overall Study|Withdrawal by Subject|3
678673|NCT01674712|2199083|P4|Overall Study|Withdrawal by Subject|4
678674|NCT01674712|2199084|P3|Overall Study|Withdrawal by Subject|5
678675|NCT01674712|2199085|P2|Overall Study|Withdrawal by Subject|2
678676|NCT01674712|2199086|P1|Overall Study|Withdrawal by Subject|2
678677|NCT01674712|2199082|P5|Overall Study|Protocol Violation|0
678678|NCT01674712|2199083|P4|Overall Study|Protocol Violation|0
678679|NCT01674712|2199084|P3|Overall Study|Protocol Violation|0
678680|NCT01674712|2199085|P2|Overall Study|Protocol Violation|0
678681|NCT01674712|2199086|P1|Overall Study|Protocol Violation|2
678682|NCT01674712|2199082|P5|Overall Study|Lost to Follow-up|0
678683|NCT01674712|2199083|P4|Overall Study|Lost to Follow-up|0
678684|NCT01674712|2199084|P3|Overall Study|Lost to Follow-up|0
678685|NCT01674712|2199085|P2|Overall Study|Lost to Follow-up|0
678686|NCT01674712|2199086|P1|Overall Study|Lost to Follow-up|1
678687|NCT01674712|2199082|P5|Overall Study|Adverse Event|6
678688|NCT01674712|2199083|P4|Overall Study|Adverse Event|4
678689|NCT01674712|2199084|P3|Overall Study|Adverse Event|3
678690|NCT01674712|2199085|P2|Overall Study|Adverse Event|6
678691|NCT01674712|2199086|P1|Overall Study|Adverse Event|5
678692|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
678693|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
678694|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
678695|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
678696|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Logistical difficulties|3
678697|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Logistical difficulties|1
678698|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Protocol Violation|22
678699|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Protocol Violation|39
678700|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
678701|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
678702|NCT01674647|2199110|P2|30-day Safety Follow-up Period|Death|2
678703|NCT01674647|2199111|P1|30-day Safety Follow-up Period|Death|3
678704|NCT01674647|2199110|P2|Treatment Period|Protocol Violation|36
678705|NCT01674647|2199111|P1|Treatment Period|Protocol Violation|56
678706|NCT01674647|2199110|P2|Treatment Period|Treatment failure|14
678707|NCT01674647|2199111|P1|Treatment Period|Treatment failure|0
678708|NCT01674647|2199110|P2|Treatment Period|Logistical difficulties|8
678709|NCT01674647|2199111|P1|Treatment Period|Logistical difficulties|5
678710|NCT01674647|2199110|P2|Treatment Period|Switching to other therapy|2
678711|NCT01674647|2199111|P1|Treatment Period|Switching to other therapy|5
678712|NCT01674647|2199110|P2|Treatment Period|Withdrawal by Subject|16
678713|NCT01674647|2199111|P1|Treatment Period|Withdrawal by Subject|19
678714|NCT01674647|2199110|P2|Treatment Period|Lost to Follow-up|1
678715|NCT01674647|2199111|P1|Treatment Period|Lost to Follow-up|1
678716|NCT01674647|2199110|P2|Treatment Period|Non-compliance with study drug|0
678717|NCT01674647|2199111|P1|Treatment Period|Non-compliance with study drug|3
678718|NCT01674647|2199110|P2|Treatment Period|Adverse Event|22
678719|NCT01674647|2199111|P1|Treatment Period|Adverse Event|60
678720|NCT01674647|2199110|P2|Treatment Period|Physician Decision|1
678721|NCT01674647|2199111|P1|Treatment Period|Physician Decision|3
678722|NCT01674647|2199110|P2|Treatment Period|Efficacy outcome reached|1
678723|NCT01674647|2199111|P1|Treatment Period|Efficacy outcome reached|0
678724|NCT01674647|2199110|P2|Treatment Period|Death|1
678725|NCT01674647|2199111|P1|Treatment Period|Death|4
678726|NCT01674634|2199137|P1|Overall Study|Lost to Follow-up|3
678727|NCT01674634|2199137|P1|Overall Study|Withdrawal by Subject|3
678728|NCT01674062|2199185|P2|Overall Study|Programming Error|0
678729|NCT01674062|2199186|P1|Overall Study|Programming Error|1
678730|NCT01674062|2199185|P2|Overall Study|Death|1
678731|NCT01674062|2199186|P1|Overall Study|Death|0
678732|NCT01674062|2199185|P2|Overall Study|Adverse Event|1
678733|NCT01674062|2199186|P1|Overall Study|Adverse Event|1
678734|NCT01674062|2199185|P2|Overall Study|Not Specified|1
678735|NCT01674062|2199186|P1|Overall Study|Not Specified|8
678736|NCT01674062|2199185|P2|Overall Study|Insufficient Therapeutic Response|26
678737|NCT01674062|2199186|P1|Overall Study|Insufficient Therapeutic Response|56
678738|NCT01674010|2199201|P3|Randomization Phase 2|Withdrawal by Subject|7
678739|NCT01674010|2199202|P2|Randomization Phase 2|Withdrawal by Subject|8
678740|NCT01674010|2199203|P1|Randomization Phase 2|Withdrawal by Subject|0
678741|NCT01674010|2199201|P3|Randomization Phase 2|Sponsor Decision|45
678742|NCT01674010|2199202|P2|Randomization Phase 2|Sponsor Decision|42
678743|NCT01674010|2199203|P1|Randomization Phase 2|Sponsor Decision|0
678744|NCT01674010|2199201|P3|Randomization Phase 2|Protocol Violation|1
678745|NCT01674010|2199202|P2|Randomization Phase 2|Protocol Violation|1
678746|NCT01674010|2199203|P1|Randomization Phase 2|Protocol Violation|0
678747|NCT01674010|2199201|P3|Randomization Phase 2|Pregnancy|1
678748|NCT01674010|2199202|P2|Randomization Phase 2|Pregnancy|1
678749|NCT01674010|2199203|P1|Randomization Phase 2|Pregnancy|0
678750|NCT01674010|2199201|P3|Randomization Phase 2|Physician Decision|2
678751|NCT01674010|2199202|P2|Randomization Phase 2|Physician Decision|0
678752|NCT01674010|2199203|P1|Randomization Phase 2|Physician Decision|0
678753|NCT01674010|2199201|P3|Randomization Phase 2|Mood episode recurrence|2
678754|NCT01674010|2199202|P2|Randomization Phase 2|Mood episode recurrence|8
678755|NCT01674010|2199203|P1|Randomization Phase 2|Mood episode recurrence|0
678756|NCT01674010|2199201|P3|Randomization Phase 2|Lost to Follow-up|2
678757|NCT01674010|2199202|P2|Randomization Phase 2|Lost to Follow-up|1
678758|NCT01674010|2199203|P1|Randomization Phase 2|Lost to Follow-up|0
678759|NCT01674010|2199201|P3|Randomization Phase 2|Adverse Event|1
678760|NCT01674010|2199202|P2|Randomization Phase 2|Adverse Event|1
678761|NCT01674010|2199203|P1|Randomization Phase 2|Adverse Event|0
678762|NCT01674010|2199201|P3|Open Treatment Phase 1|Withdrawal by Subject|0
678763|NCT01674010|2199202|P2|Open Treatment Phase 1|Withdrawal by Subject|0
678764|NCT01674010|2199203|P1|Open Treatment Phase 1|Withdrawal by Subject|25
678765|NCT01674010|2199201|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
678766|NCT01674010|2199202|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
678767|NCT01674010|2199203|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
678768|NCT01674010|2199201|P3|Open Treatment Phase 1|Sponsor Decision|0
678769|NCT01674010|2199202|P2|Open Treatment Phase 1|Sponsor Decision|0
678770|NCT01674010|2199203|P1|Open Treatment Phase 1|Sponsor Decision|79
678771|NCT01674010|2199201|P3|Open Treatment Phase 1|Protocol Violation|0
678772|NCT01674010|2199202|P2|Open Treatment Phase 1|Protocol Violation|0
678773|NCT01674010|2199203|P1|Open Treatment Phase 1|Protocol Violation|7
678774|NCT01674010|2199201|P3|Open Treatment Phase 1|Physician Decision|0
678775|NCT01674010|2199202|P2|Open Treatment Phase 1|Physician Decision|0
678776|NCT01674010|2199203|P1|Open Treatment Phase 1|Physician Decision|9
678777|NCT01674010|2199201|P3|Open Treatment Phase 1|Lost to Follow-up|0
678778|NCT01674010|2199202|P2|Open Treatment Phase 1|Lost to Follow-up|0
678779|NCT01674010|2199203|P1|Open Treatment Phase 1|Lost to Follow-up|19
678780|NCT01674010|2199201|P3|Open Treatment Phase 1|Death|0
678781|NCT01674010|2199202|P2|Open Treatment Phase 1|Death|0
678782|NCT01674010|2199203|P1|Open Treatment Phase 1|Death|1
678783|NCT01674010|2199201|P3|Open Treatment Phase 1|Adverse Event|0
678784|NCT01674010|2199202|P2|Open Treatment Phase 1|Adverse Event|0
678785|NCT01674010|2199203|P1|Open Treatment Phase 1|Adverse Event|10
678786|NCT01673984|2199222|P2|Overall Study|Study termination|6
678787|NCT01673984|2199223|P1|Overall Study|Study termination|9
678788|NCT01673984|2199222|P2|Overall Study|Adverse Event|0
678789|NCT01673984|2199223|P1|Overall Study|Adverse Event|1
678790|NCT01673867|2199265|P2|Treatment|Physician Decision|1
678791|NCT01673867|2199266|P1|Treatment|Physician Decision|0
678792|NCT01673867|2199265|P2|Treatment|Symptomatic deterioration|1
678793|NCT01673867|2199266|P1|Treatment|Symptomatic deterioration|0
678794|NCT01673867|2199265|P2|Treatment|Required prolonged hospitalization|1
678795|NCT01673867|2199266|P1|Treatment|Required prolonged hospitalization|0
678796|NCT01673867|2199265|P2|Treatment|Health status not improved|0
678797|NCT01673867|2199266|P1|Treatment|Health status not improved|1
678798|NCT01673867|2199265|P2|Treatment|Required steroid therapy|0
678799|NCT01673867|2199266|P1|Treatment|Required steroid therapy|1
678800|NCT01673867|2199265|P2|Treatment|No longer meets criteria|0
678801|NCT01673867|2199266|P1|Treatment|No longer meets criteria|2
678802|NCT01673867|2199265|P2|Treatment|Maximum clinical benefit|10
678803|NCT01673867|2199266|P1|Treatment|Maximum clinical benefit|0
678804|NCT01673867|2199265|P2|Treatment|Withdrawal by Subject|6
678805|NCT01673867|2199266|P1|Treatment|Withdrawal by Subject|4
678806|NCT01673867|2199265|P2|Treatment|Requested treatment discontinuation|16
678807|NCT01673867|2199266|P1|Treatment|Requested treatment discontinuation|5
678808|NCT01673867|2199265|P2|Treatment|AE unrelated to study drug|11
678809|NCT01673867|2199266|P1|Treatment|AE unrelated to study drug|19
678810|NCT01673867|2199265|P2|Treatment|Death|1
678811|NCT01673867|2199266|P1|Treatment|Death|1
678812|NCT01673867|2199265|P2|Treatment|Study Drug Toxicity|42
678813|NCT01673867|2199266|P1|Treatment|Study Drug Toxicity|17
678814|NCT01673867|2199265|P2|Treatment|Disease Progression|179
678815|NCT01673867|2199266|P1|Treatment|Disease Progression|194
678816|NCT01673867|2199265|P2|Randomization|No longer meets criteria|5
678817|NCT01673867|2199266|P1|Randomization|No longer meets criteria|4
678818|NCT01673867|2199265|P2|Randomization|Lost to Follow-up|1
678819|NCT01673867|2199266|P1|Randomization|Lost to Follow-up|0
678820|NCT01673867|2199265|P2|Randomization|Withdrawal by Subject|12
678821|NCT01673867|2199266|P1|Randomization|Withdrawal by Subject|0
678822|NCT01673867|2199265|P2|Randomization|Requested treatment discontinuation|4
678823|NCT01673867|2199266|P1|Randomization|Requested treatment discontinuation|0
678824|NCT01673867|2199265|P2|Randomization|AE unrelated to study drug|0
678825|NCT01673867|2199266|P1|Randomization|AE unrelated to study drug|1
678826|NCT01673854|2199292|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
678827|NCT01673854|2199292|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
678828|NCT01673854|2199292|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
678829|NCT01673854|2199292|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
678830|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
678831|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
678832|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
678833|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
678834|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
678835|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
678836|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
678837|NCT01673854|2199292|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
678838|NCT01673698|2199315|P2|Overall Study|Lost to Follow-up|13
678839|NCT01673698|2199316|P1|Overall Study|Lost to Follow-up|51
678840|NCT01673620|2199326|P2|Overall Study|Adverse Event|0
678841|NCT01673620|2199327|P1|Overall Study|Adverse Event|1
678842|NCT01673594|2199337|P2|Overall Study|Withdrawal by Subject|1
678843|NCT01673594|2199338|P1|Overall Study|Withdrawal by Subject|0
678844|NCT01673594|2199337|P2|Overall Study|Physician Decision|4
678845|NCT01673594|2199338|P1|Overall Study|Physician Decision|2
678846|NCT01673594|2199337|P2|Overall Study|Lost to Follow-up|0
678847|NCT01673594|2199338|P1|Overall Study|Lost to Follow-up|1
678848|NCT01673594|2199337|P2|Overall Study|Adverse Event|1
678849|NCT01673594|2199338|P1|Overall Study|Adverse Event|3
678850|NCT01673490|2199357|P1|Overall Study|Withdrawal by Subject|3
678851|NCT01673490|2199357|P1|Overall Study|Adverse Event|3
678852|NCT01673490|2199357|P1|Overall Study|Lost to Follow-up|1
678853|NCT01673347|2199374|P1|Overall Study|failure of allograft|7
678854|NCT01673282|2199383|P2|Overall Study|unspecified|6
678855|NCT01673282|2199384|P1|Overall Study|unspecified|1
678856|NCT01673282|2199383|P2|Overall Study|Withdrawal by Subject|3
678857|NCT01673282|2199384|P1|Overall Study|Withdrawal by Subject|3
678858|NCT01673282|2199383|P2|Overall Study|Lost to Follow-up|10
678859|NCT01673282|2199384|P1|Overall Study|Lost to Follow-up|11
678860|NCT01673282|2199383|P2|Overall Study|Lack of Efficacy|2
678861|NCT01673282|2199384|P1|Overall Study|Lack of Efficacy|9
678862|NCT01673282|2199383|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
678863|NCT01673282|2199384|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
678864|NCT01673178|2199420|P5|Overall Study|Unspecified|0
678865|NCT01673178|2199421|P4|Overall Study|Unspecified|1
678866|NCT01673178|2199422|P3|Overall Study|Unspecified|2
678867|NCT01673178|2199423|P2|Overall Study|Unspecified|0
678868|NCT01673178|2199424|P1|Overall Study|Unspecified|1
678869|NCT01673178|2199420|P5|Overall Study|Adverse Event|0
678870|NCT01673178|2199421|P4|Overall Study|Adverse Event|2
678871|NCT01673178|2199422|P3|Overall Study|Adverse Event|0
678872|NCT01673178|2199423|P2|Overall Study|Adverse Event|0
678873|NCT01673178|2199424|P1|Overall Study|Adverse Event|1
678874|NCT01673178|2199420|P5|Overall Study|Protocol Violation|0
678875|NCT01673178|2199421|P4|Overall Study|Protocol Violation|1
678876|NCT01673178|2199422|P3|Overall Study|Protocol Violation|0
678877|NCT01673178|2199423|P2|Overall Study|Protocol Violation|1
678878|NCT01673178|2199424|P1|Overall Study|Protocol Violation|1
678879|NCT01673178|2199420|P5|Overall Study|Withdrawal by Subject|2
678880|NCT01673178|2199421|P4|Overall Study|Withdrawal by Subject|4
678881|NCT01673178|2199422|P3|Overall Study|Withdrawal by Subject|1
678882|NCT01673178|2199423|P2|Overall Study|Withdrawal by Subject|0
678883|NCT01673178|2199424|P1|Overall Study|Withdrawal by Subject|0
678884|NCT01673178|2199420|P5|Overall Study|Lost to Follow-up|0
678885|NCT01673178|2199421|P4|Overall Study|Lost to Follow-up|0
678886|NCT01673178|2199422|P3|Overall Study|Lost to Follow-up|0
678887|NCT01673178|2199423|P2|Overall Study|Lost to Follow-up|1
678888|NCT01673178|2199424|P1|Overall Study|Lost to Follow-up|0
678889|NCT01673126|2199663|P2|Overall Study|change of diagnosis|3
678890|NCT01673126|2199664|P1|Overall Study|change of diagnosis|4
678891|NCT01673009|2199680|P1|Overall Study|Withdrawal by Subject|8
678892|NCT01673009|2199680|P1|Overall Study|Physician Decision|5
678893|NCT01672970|2199765|P1|Overall Study|Enrolled but not treated|1
678894|NCT01672970|2199765|P1|Overall Study|Unspecified|9
678895|NCT01672970|2199765|P1|Overall Study|Lost to Follow-up|5
678896|NCT01672970|2199765|P1|Overall Study|Withdrawal by Subject|2
678897|NCT01672970|2199765|P1|Overall Study|Adverse Event|18
678898|NCT01672970|2199765|P1|Overall Study|Lack of Efficacy|12
678899|NCT01672957|2199801|P1|Overall Study|ICF Signed After Transplantation|5
678900|NCT01672957|2199801|P1|Overall Study|Death|2
678901|NCT01672957|2199801|P1|Overall Study|Protocol Violation|48
678902|NCT01672788|2199820|P4|Washout Period 2 (7 Days)|Adverse Event|1
678903|NCT01672788|2199821|P3|Washout Period 2 (7 Days)|Adverse Event|0
678904|NCT01672788|2199822|P2|Washout Period 2 (7 Days)|Adverse Event|0
678905|NCT01672788|2199823|P1|Washout Period 2 (7 Days)|Adverse Event|0
678906|NCT01672723|2199853|P2|First Intervention|Adverse Event|0
678907|NCT01672723|2199854|P1|First Intervention|Adverse Event|3
678908|NCT01672294|2199891|P4|Overall Study|Lost to Follow-up|9
678909|NCT01672294|2199892|P3|Overall Study|Lost to Follow-up|7
678910|NCT01672294|2199893|P2|Overall Study|Lost to Follow-up|16
678911|NCT01672294|2199894|P1|Overall Study|Lost to Follow-up|1
678912|NCT01672294|2199891|P4|Overall Study|Excluded by study|0
678913|NCT01672294|2199892|P3|Overall Study|Excluded by study|0
678914|NCT01672294|2199893|P2|Overall Study|Excluded by study|1
678915|NCT01672294|2199894|P1|Overall Study|Excluded by study|1
678916|NCT01672294|2199891|P4|Overall Study|Withdrawal by Subject|4
678917|NCT01672294|2199892|P3|Overall Study|Withdrawal by Subject|4
678918|NCT01672294|2199893|P2|Overall Study|Withdrawal by Subject|4
678919|NCT01672294|2199894|P1|Overall Study|Withdrawal by Subject|4
678920|NCT01671748|2199927|P2|4 Week run-in Phase|Not eligible|0
678921|NCT01671748|2199928|P1|4 Week run-in Phase|Not eligible|9
678922|NCT01671748|2199927|P2|4 Week run-in Phase|Adverse Event|0
678923|NCT01671748|2199928|P1|4 Week run-in Phase|Adverse Event|1
678924|NCT01671748|2199927|P2|4 Week run-in Phase|Withdrawal by Subject|0
678925|NCT01671748|2199928|P1|4 Week run-in Phase|Withdrawal by Subject|1
678926|NCT01671488|2199955|P1|Overall Study|Withdrawal by Subject|1
678927|NCT01671280|2199970|P1|Overall Study|Withdrawal by Subject|2
678928|NCT01671111|2199976|P1|Overall Study|Unspecified|24
678929|NCT01671111|2199976|P1|Overall Study|Physician Decision|1
678930|NCT01671111|2199976|P1|Overall Study|Withdrawal by Subject|2
678931|NCT01671111|2199976|P1|Overall Study|Lack of Efficacy|1
678932|NCT01671111|2199976|P1|Overall Study|Adverse Event|2
678933|NCT01671059|2199986|P1|Overall Study|Lack of Efficacy|1
678934|NCT01671059|2199986|P1|Overall Study|Adverse Event|4
678935|NCT01670721|2200078|P1|Overall Study|Other than specified above|38
678936|NCT01670721|2200078|P1|Overall Study|Participant's decision|15
678937|NCT01670656|2200090|P5|Overall Study|Subject moved|0
678938|NCT01670656|2200091|P4|Overall Study|Subject moved|1
678939|NCT01670656|2200092|P3|Overall Study|Subject moved|0
678940|NCT01670656|2200093|P2|Overall Study|Subject moved|0
678941|NCT01670656|2200094|P1|Overall Study|Subject moved|0
678942|NCT01670656|2200090|P5|Overall Study|Lost to Follow-up|3
678943|NCT01670656|2200091|P4|Overall Study|Lost to Follow-up|0
678944|NCT01670656|2200092|P3|Overall Study|Lost to Follow-up|0
678945|NCT01670656|2200093|P2|Overall Study|Lost to Follow-up|0
678946|NCT01670656|2200094|P1|Overall Study|Lost to Follow-up|0
678947|NCT01670656|2200090|P5|Overall Study|Subject withdrew consent|1
678948|NCT01670656|2200091|P4|Overall Study|Subject withdrew consent|1
678949|NCT01670656|2200092|P3|Overall Study|Subject withdrew consent|2
678950|NCT01670656|2200093|P2|Overall Study|Subject withdrew consent|1
678951|NCT01670656|2200094|P1|Overall Study|Subject withdrew consent|0
678952|NCT01670656|2200090|P5|Overall Study|Adverse Event|3
678953|NCT01670656|2200091|P4|Overall Study|Adverse Event|3
678954|NCT01670656|2200092|P3|Overall Study|Adverse Event|2
678955|NCT01670656|2200093|P2|Overall Study|Adverse Event|2
678956|NCT01670656|2200094|P1|Overall Study|Adverse Event|2
678957|NCT01670656|2200090|P5|Overall Study|Non-compliance with protocol|2
678958|NCT01670656|2200091|P4|Overall Study|Non-compliance with protocol|1
678959|NCT01670656|2200092|P3|Overall Study|Non-compliance with protocol|1
678960|NCT01670656|2200093|P2|Overall Study|Non-compliance with protocol|3
678961|NCT01670656|2200094|P1|Overall Study|Non-compliance with protocol|0
678962|NCT01670656|2200090|P5|Overall Study|Withdrawal by Subject|0
678963|NCT01670656|2200091|P4|Overall Study|Withdrawal by Subject|0
678964|NCT01670656|2200092|P3|Overall Study|Withdrawal by Subject|0
678965|NCT01670656|2200093|P2|Overall Study|Withdrawal by Subject|1
678966|NCT01670656|2200094|P1|Overall Study|Withdrawal by Subject|1
678967|NCT01670656|2200090|P5|Overall Study|Pregnancy|1
678968|NCT01670656|2200091|P4|Overall Study|Pregnancy|0
678969|NCT01670656|2200092|P3|Overall Study|Pregnancy|0
678970|NCT01670656|2200093|P2|Overall Study|Pregnancy|0
678971|NCT01670656|2200094|P1|Overall Study|Pregnancy|0
678972|NCT01670656|2200090|P5|Overall Study|Non-compliance with study drug|1
678973|NCT01670656|2200091|P4|Overall Study|Non-compliance with study drug|0
678974|NCT01670656|2200092|P3|Overall Study|Non-compliance with study drug|3
678975|NCT01670656|2200093|P2|Overall Study|Non-compliance with study drug|0
678976|NCT01670656|2200094|P1|Overall Study|Non-compliance with study drug|0
678977|NCT01670526|2200123|P2|Overall Study|Lost to Follow-up|5
678978|NCT01670526|2200124|P1|Overall Study|Lost to Follow-up|9
678979|NCT01670526|2200123|P2|Overall Study|Withdrawal by Subject|1
678980|NCT01670526|2200124|P1|Overall Study|Withdrawal by Subject|3
678981|NCT01670279|2200148|P4|Overall Study|Participant met withdrawal criteria|1
678982|NCT01670279|2200149|P3|Overall Study|Participant met withdrawal criteria|0
678983|NCT01670279|2200150|P2|Overall Study|Participant met withdrawal criteria|0
678984|NCT01670279|2200151|P1|Overall Study|Participant met withdrawal criteria|0
678985|NCT01670279|2200148|P4|Overall Study|Physician Decision|0
678986|NCT01670279|2200149|P3|Overall Study|Physician Decision|0
678987|NCT01670279|2200150|P2|Overall Study|Physician Decision|1
678988|NCT01670279|2200151|P1|Overall Study|Physician Decision|0
678989|NCT01670279|2200148|P4|Overall Study|Adverse Event|0
678990|NCT01670279|2200149|P3|Overall Study|Adverse Event|0
678991|NCT01670279|2200150|P2|Overall Study|Adverse Event|1
678992|NCT01670279|2200151|P1|Overall Study|Adverse Event|0
678993|NCT01670045|2200191|P1|Overall Study|Lost to Follow-up|11
678994|NCT01670045|2200191|P1|Overall Study|Death|1
678995|NCT01670045|2200191|P1|Overall Study|Adverse Event|1
678996|NCT01670045|2200191|P1|Overall Study|Withdrawal by Subject|3
678997|NCT01670019|2200209|P2|Overall Study|Withdrawal by Subject|0
678998|NCT01670019|2200210|P1|Overall Study|Withdrawal by Subject|6
678999|NCT01670019|2200209|P2|Overall Study|Adverse Event|0
679000|NCT01670019|2200210|P1|Overall Study|Adverse Event|3
679001|NCT01669902|2200224|P1|Overall Study|Unspecified|8
679002|NCT01669902|2200224|P1|Overall Study|Lack of Efficacy|10
679003|NCT01669902|2200224|P1|Overall Study|Adverse Event|11
679004|NCT01669811|2200259|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
679005|NCT01669811|2200260|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
679006|NCT01669811|2200259|P2|Overall Study|Adverse Event|6
679007|NCT01669811|2200260|P1|Overall Study|Adverse Event|2
679008|NCT01669811|2200259|P2|Overall Study|Withdrawal by Subject|2
679009|NCT01669811|2200260|P1|Overall Study|Withdrawal by Subject|1
679010|NCT01669811|2200259|P2|Overall Study|Investigator decision|1
679011|NCT01669811|2200260|P1|Overall Study|Investigator decision|0
679012|NCT01669629|2200327|P2|Period 1|protocol deviation|2
679013|NCT01669629|2200328|P1|Period 1|protocol deviation|1
679014|NCT01669577|2200351|P1|Overall Study|Physician Decision|34
679015|NCT01669577|2200351|P1|Overall Study|Lost to Follow-up|78
679016|NCT01669577|2200351|P1|Overall Study|Death|22
679017|NCT01669174|2200357|P2|Overall Study|Administrative problems|2
679018|NCT01669174|2200358|P1|Overall Study|Administrative problems|1
679019|NCT01669174|2200357|P2|Overall Study|Adverse Event|2
679020|NCT01669174|2200358|P1|Overall Study|Adverse Event|2
679021|NCT01669174|2200357|P2|Overall Study|Lost to Follow-up|0
679022|NCT01669174|2200358|P1|Overall Study|Lost to Follow-up|1
679023|NCT01669174|2200357|P2|Overall Study|Subject withdrew consent|2
679024|NCT01669174|2200358|P1|Overall Study|Subject withdrew consent|2
679025|NCT01669122|2200374|P1|Washout Period II|Protocol Violation|2
679026|NCT01669122|2200374|P1|Period I|Lost to Follow-up|1
679027|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
679028|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
679029|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
679030|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
679031|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
679032|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
679033|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
679034|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
679035|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
679036|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
679037|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
679038|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
679039|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
679040|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
679041|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
679042|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
679043|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
679044|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
679045|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
679046|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
679047|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
679048|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
679049|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
679050|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
679051|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
679052|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
679053|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
679054|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
679055|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
679056|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
679057|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
679058|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
679059|NCT01668797|2200467|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
679060|NCT01668797|2200468|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
679061|NCT01668797|2200469|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
679062|NCT01668797|2200470|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
679063|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
679064|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
679065|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
679066|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
679067|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
679068|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
679069|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
679070|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
679071|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
679072|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
679073|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
679074|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
679075|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Protocol Violation|0
679076|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Protocol Violation|0
679077|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Protocol Violation|3
679078|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Protocol Violation|0
679079|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
679080|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
679081|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
679082|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
679083|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Physician Decision|0
679084|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Physician Decision|0
679085|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Physician Decision|11
679086|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Physician Decision|0
679087|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
679088|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
679089|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
679090|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
679091|NCT01668797|2200467|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
679092|NCT01668797|2200468|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
679093|NCT01668797|2200469|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
679094|NCT01668797|2200470|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
679095|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
679096|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
679097|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
679098|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
679099|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
679100|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
679101|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
679102|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
679103|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
679104|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
679105|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
679106|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
679107|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Protocol Violation|0
679108|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Protocol Violation|0
679109|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Protocol Violation|0
679110|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Protocol Violation|2
679111|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
679112|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
679113|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
679114|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
679115|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Physician Decision|0
679116|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Physician Decision|0
679117|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Physician Decision|0
679118|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Physician Decision|2
679119|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
679120|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
679121|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
679122|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
679123|NCT01668797|2200467|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
679124|NCT01668797|2200468|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
679125|NCT01668797|2200469|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
679126|NCT01668797|2200470|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
888958|NCT01688037|2822900|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
888959|NCT01688037|2822901|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
888960|NCT01688037|2822902|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
888961|NCT01688037|2822900|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
888962|NCT01688037|2822901|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
888963|NCT01688037|2822902|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
888964|NCT01688037|2822900|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
888965|NCT01688037|2822901|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
888966|NCT01688037|2822902|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
888967|NCT01688037|2822900|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
888968|NCT01688037|2822901|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
888969|NCT01688037|2822902|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
888970|NCT01688037|2822900|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
888971|NCT01688037|2822901|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
888972|NCT01688037|2822902|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
888973|NCT01688037|2822900|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
888974|NCT01688037|2822901|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
888975|NCT01688037|2822902|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
679155|NCT01668667|2200564|P4|Overall Study|Withdrawal by Subject|5
679156|NCT01668667|2200565|P3|Overall Study|Withdrawal by Subject|5
679157|NCT01668667|2200566|P2|Overall Study|Withdrawal by Subject|4
679158|NCT01668667|2200567|P1|Overall Study|Withdrawal by Subject|7
679159|NCT01668667|2200564|P4|Overall Study|Physician Decision|0
679160|NCT01668667|2200565|P3|Overall Study|Physician Decision|1
679161|NCT01668667|2200566|P2|Overall Study|Physician Decision|0
679162|NCT01668667|2200567|P1|Overall Study|Physician Decision|3
679163|NCT01668667|2200564|P4|Overall Study|Lost to Follow-up|6
679164|NCT01668667|2200565|P3|Overall Study|Lost to Follow-up|7
679165|NCT01668667|2200566|P2|Overall Study|Lost to Follow-up|4
679166|NCT01668667|2200567|P1|Overall Study|Lost to Follow-up|9
679167|NCT01668667|2200564|P4|Overall Study|Protocol Violation|5
679168|NCT01668667|2200565|P3|Overall Study|Protocol Violation|12
679169|NCT01668667|2200566|P2|Overall Study|Protocol Violation|10
679170|NCT01668667|2200567|P1|Overall Study|Protocol Violation|6
679171|NCT01668667|2200564|P4|Overall Study|Lack of Efficacy|3
679172|NCT01668667|2200565|P3|Overall Study|Lack of Efficacy|2
679173|NCT01668667|2200566|P2|Overall Study|Lack of Efficacy|2
679174|NCT01668667|2200567|P1|Overall Study|Lack of Efficacy|3
679175|NCT01668667|2200564|P4|Overall Study|Adverse Event|4
679176|NCT01668667|2200565|P3|Overall Study|Adverse Event|4
679177|NCT01668667|2200566|P2|Overall Study|Adverse Event|6
679178|NCT01668667|2200567|P1|Overall Study|Adverse Event|3
679179|NCT01668654|2200589|P1|Overall Study|Withdrawal by Subject|1
679180|NCT01668654|2200589|P1|Overall Study|Study Closed/Terminated|3
679181|NCT01668589|2200650|P4|Overall Study|Other|15
679182|NCT01668589|2200651|P3|Overall Study|Other|7
679183|NCT01668589|2200652|P2|Overall Study|Other|10
679184|NCT01668589|2200653|P1|Overall Study|Other|44
679185|NCT01668589|2200650|P4|Overall Study|Death|11
679186|NCT01668589|2200651|P3|Overall Study|Death|2
679187|NCT01668589|2200652|P2|Overall Study|Death|3
679188|NCT01668589|2200653|P1|Overall Study|Death|12
679189|NCT01668589|2200650|P4|Overall Study|Full Consent/Agreement Withdrawn|4
679190|NCT01668589|2200651|P3|Overall Study|Full Consent/Agreement Withdrawn|11
679191|NCT01668589|2200652|P2|Overall Study|Full Consent/Agreement Withdrawn|8
679192|NCT01668589|2200653|P1|Overall Study|Full Consent/Agreement Withdrawn|54
679193|NCT01668589|2200650|P4|Overall Study|Lost to Follow-up|5
679194|NCT01668589|2200651|P3|Overall Study|Lost to Follow-up|15
679195|NCT01668589|2200652|P2|Overall Study|Lost to Follow-up|37
679196|NCT01668589|2200653|P1|Overall Study|Lost to Follow-up|29
679197|NCT01668173|2200691|P1|Overall Study|Trial suspension|4
679198|NCT01668173|2200691|P1|Overall Study|Adverse Event|3
679199|NCT01668004|2200817|P1|Overall Study|Non-compliance with treatment|2
679200|NCT01668004|2200817|P1|Overall Study|Lack of Efficacy|9
679201|NCT01668004|2200817|P1|Overall Study|Lost to Follow-up|5
679202|NCT01668004|2200817|P1|Overall Study|Withdrawal by Subject|2
679203|NCT01668004|2200817|P1|Overall Study|Adverse Event|7
679204|NCT01667926|2200839|P3|Overall Study|Side effects|0
679205|NCT01667926|2200840|P2|Overall Study|Side effects|0
679206|NCT01667926|2200841|P1|Overall Study|Side effects|3
679207|NCT01667926|2200839|P3|Overall Study|Lost to Follow-up|1
679208|NCT01667926|2200840|P2|Overall Study|Lost to Follow-up|2
679209|NCT01667926|2200841|P1|Overall Study|Lost to Follow-up|1
679210|NCT01667926|2200839|P3|Overall Study|Inclusion/Exclusion Criteria|5
679211|NCT01667926|2200840|P2|Overall Study|Inclusion/Exclusion Criteria|0
679212|NCT01667926|2200841|P1|Overall Study|Inclusion/Exclusion Criteria|0
679213|NCT01667926|2200839|P3|Overall Study|Time committment|2
679214|NCT01667926|2200840|P2|Overall Study|Time committment|0
679215|NCT01667926|2200841|P1|Overall Study|Time committment|0
679216|NCT01667926|2200839|P3|Overall Study|Physician Decision|1
679217|NCT01667926|2200840|P2|Overall Study|Physician Decision|0
679218|NCT01667926|2200841|P1|Overall Study|Physician Decision|0
679219|NCT01667926|2200839|P3|Overall Study|Withdrawal by Subject|2
679220|NCT01667926|2200840|P2|Overall Study|Withdrawal by Subject|2
679221|NCT01667926|2200841|P1|Overall Study|Withdrawal by Subject|1
679222|NCT01667900|2200854|P20|Part B|Death|0
679223|NCT01667900|2200855|P19|Part B|Death|0
679224|NCT01667900|2200856|P18|Part B|Death|0
679225|NCT01667900|2200857|P17|Part B|Death|1
679226|NCT01667900|2200858|P16|Part B|Death|0
679227|NCT01667900|2200859|P15|Part B|Death|0
679228|NCT01667900|2200860|P14|Part B|Death|0
679229|NCT01667900|2200861|P13|Part B|Death|0
679230|NCT01667900|2200862|P12|Part B|Death|0
679231|NCT01667900|2200863|P11|Part B|Death|0
679232|NCT01667900|2200864|P10|Part B|Death|0
679233|NCT01667900|2200865|P9|Part B|Death|0
679234|NCT01667900|2200866|P8|Part B|Death|0
679235|NCT01667900|2200867|P7|Part B|Death|0
679236|NCT01667900|2200868|P6|Part B|Death|0
679237|NCT01667900|2200869|P5|Part B|Death|0
679238|NCT01667900|2200870|P4|Part B|Death|0
679239|NCT01667900|2200871|P3|Part B|Death|0
679240|NCT01667900|2200872|P2|Part B|Death|0
679241|NCT01667900|2200873|P1|Part B|Death|0
679242|NCT01667731|2200936|P5|Overall Study|Death|0
679243|NCT01667731|2200937|P4|Overall Study|Death|0
679244|NCT01667731|2200938|P3|Overall Study|Death|0
679245|NCT01667731|2200939|P2|Overall Study|Death|1
679246|NCT01667731|2200940|P1|Overall Study|Death|0
679247|NCT01667731|2200936|P5|Overall Study|Subject Withdrew Consent|1
679248|NCT01667731|2200937|P4|Overall Study|Subject Withdrew Consent|0
679249|NCT01667731|2200938|P3|Overall Study|Subject Withdrew Consent|1
679250|NCT01667731|2200939|P2|Overall Study|Subject Withdrew Consent|0
679251|NCT01667731|2200940|P1|Overall Study|Subject Withdrew Consent|2
679252|NCT01667731|2200936|P5|Overall Study|Lost to Follow-up|2
679253|NCT01667731|2200937|P4|Overall Study|Lost to Follow-up|1
679254|NCT01667731|2200938|P3|Overall Study|Lost to Follow-up|1
679255|NCT01667731|2200939|P2|Overall Study|Lost to Follow-up|3
679256|NCT01667731|2200940|P1|Overall Study|Lost to Follow-up|2
679257|NCT01667731|2200936|P5|Overall Study|Efficacy Failure|24
679258|NCT01667731|2200937|P4|Overall Study|Efficacy Failure|1
679259|NCT01667731|2200938|P3|Overall Study|Efficacy Failure|0
679260|NCT01667731|2200939|P2|Overall Study|Efficacy Failure|12
679261|NCT01667731|2200940|P1|Overall Study|Efficacy Failure|1
679262|NCT01667731|2200936|P5|Overall Study|Enrolled but not treated|1
679263|NCT01667731|2200937|P4|Overall Study|Enrolled but not treated|0
679264|NCT01667731|2200938|P3|Overall Study|Enrolled but not treated|0
679265|NCT01667731|2200939|P2|Overall Study|Enrolled but not treated|0
679266|NCT01667731|2200940|P1|Overall Study|Enrolled but not treated|0
679267|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
679268|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
679269|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
679270|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
679271|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
679272|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
679273|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
679274|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
679275|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
679276|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
679277|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
679278|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
679279|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
679280|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
679281|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
679282|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
679283|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
679284|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
679285|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
679286|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
679287|NCT01667679|2200995|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
679288|NCT01667679|2200996|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
679289|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
679290|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
679291|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
679292|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
679293|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
679294|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
679295|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
679296|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
679297|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
679298|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
679299|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
679300|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
679301|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
679302|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
679303|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
679304|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
679305|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
679306|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
679307|NCT01667679|2200995|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
679308|NCT01667679|2200996|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
679309|NCT01667432|2201081|P1|Overall Study|Missing Information|4
679310|NCT01667432|2201081|P1|Overall Study|Reason Not Specified|2
679311|NCT01667432|2201081|P1|Overall Study|Principal Investigator Decision|1
679312|NCT01667432|2201081|P1|Overall Study|Protocol Deviation|2
679313|NCT01667432|2201081|P1|Overall Study|Adverse Event|1
679314|NCT01667432|2201081|P1|Overall Study|Insufficient Therapeutic Response|4
679315|NCT01667432|2201081|P1|Overall Study|Refused Treatment/Withdrew Consent|1
679316|NCT01667432|2201081|P1|Overall Study|Lost to Follow-up|3
679317|NCT01667432|2201081|P1|Overall Study|Moved to Another Center|3
679318|NCT01667432|2201081|P1|Overall Study|Failure to Return|10
679319|NCT01667432|2201081|P1|Overall Study|Premature Study Termination|26
679320|NCT01667224|2201088|P2|Overall Study|Protocol Violation|1
679321|NCT01667224|2201089|P1|Overall Study|Protocol Violation|1
679322|NCT01667224|2201088|P2|Overall Study|Withdrawal by Subject|1
679323|NCT01667224|2201089|P1|Overall Study|Withdrawal by Subject|3
679324|NCT01667107|2201103|P2|Overall Study|Lack of Efficacy|1
679325|NCT01667107|2201104|P1|Overall Study|Lack of Efficacy|0
679326|NCT01667107|2201103|P2|Overall Study|Protocol Violation|1
679327|NCT01667107|2201104|P1|Overall Study|Protocol Violation|0
679328|NCT01667107|2201103|P2|Overall Study|Tolerability issues|2
679329|NCT01667107|2201104|P1|Overall Study|Tolerability issues|0
679330|NCT01667107|2201103|P2|Overall Study|Adverse Event|3
679331|NCT01667107|2201104|P1|Overall Study|Adverse Event|4
679332|NCT01666951|2201122|P2|Overall Study|Not dosed|1
679333|NCT01666951|2201123|P1|Overall Study|Not dosed|1
679334|NCT01666782|2201174|P2|Overall Study|Enrolled both years; year 1 data used|0
679335|NCT01666782|2201175|P1|Overall Study|Enrolled both years; year 1 data used|4
679336|NCT01666782|2201174|P2|Overall Study|Received 2 doses of vaccine|1
679337|NCT01666782|2201175|P1|Overall Study|Received 2 doses of vaccine|0
679338|NCT01666119|2201213|P1|Overall Study|Subject experiencing withdrawal symptoms|5
679339|NCT01666119|2201213|P1|Overall Study|non compliance with study medication, pa|18
679340|NCT01666119|2201213|P1|Overall Study|Lost to Follow-up|7
679341|NCT01666119|2201213|P1|Overall Study|Withdrawal by Subject|16
679342|NCT01666119|2201213|P1|Overall Study|Adverse Event|6
679343|NCT01666002|2201220|P2|Overall Study|Lost to Follow-up|0
679344|NCT01666002|2201221|P1|Overall Study|Lost to Follow-up|5
679345|NCT01665911|2201242|P1|Overall Study|Adverse Event|1
679346|NCT01665911|2201242|P1|Overall Study|Withdrawal by Subject|1
679347|NCT01665911|2201242|P1|Overall Study|Protocol Violation|4
679348|NCT01665807|2201251|P3|Overall Study|Withdrawal by Subject|1
679349|NCT01665807|2201252|P2|Overall Study|Withdrawal by Subject|0
679350|NCT01665807|2201253|P1|Overall Study|Withdrawal by Subject|2
888976|NCT01688037|2822900|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
888977|NCT01688037|2822901|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
888978|NCT01688037|2822902|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
888979|NCT01688037|2822900|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
888980|NCT01688037|2822901|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
888981|NCT01688037|2822902|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
679358|NCT01664949|2201434|P2|Overall Study|Other Miscellaneous Reasons|1
679359|NCT01664949|2201435|P1|Overall Study|Other Miscellaneous Reasons|3
679360|NCT01664949|2201434|P2|Overall Study|Protocol Violation|5
679361|NCT01664949|2201435|P1|Overall Study|Protocol Violation|5
679362|NCT01664949|2201434|P2|Overall Study|Personal Reasons|4
679363|NCT01664949|2201435|P1|Overall Study|Personal Reasons|3
679364|NCT01664949|2201434|P2|Overall Study|Lost to Follow-up|2
679365|NCT01664949|2201435|P1|Overall Study|Lost to Follow-up|1
679366|NCT01664949|2201434|P2|Overall Study|Lack of Efficacy|1
679367|NCT01664949|2201435|P1|Overall Study|Lack of Efficacy|1
679368|NCT01664949|2201434|P2|Overall Study|Adverse Event|12
679369|NCT01664949|2201435|P1|Overall Study|Adverse Event|11
679384|NCT01664624|2201496|P4|Overall Study|Adverse Event|0
679385|NCT01664624|2201497|P3|Overall Study|Adverse Event|0
679386|NCT01664624|2201498|P2|Overall Study|Adverse Event|1
679387|NCT01664624|2201499|P1|Overall Study|Adverse Event|0
679388|NCT01664533|2201546|P1|Overall Study|Protocol Violation|3
679389|NCT01664533|2201546|P1|Overall Study|Study termination|9
679390|NCT01664533|2201546|P1|Overall Study|Lost to Follow-up|3
679391|NCT01664533|2201546|P1|Overall Study|Death|42
679392|NCT01664494|2201554|P1|Overall Study|Lost to Follow-up|99
679393|NCT01664494|2201554|P1|Overall Study|Not specified|49
679394|NCT01664494|2201554|P1|Overall Study|Death|18
679395|NCT01664494|2201554|P1|Overall Study|Withdrawal by Subject|27
679396|NCT01664247|2201561|P2|Overall Study|Unclassified|29
679397|NCT01664247|2201562|P1|Overall Study|Unclassified|5
679398|NCT01664247|2201561|P2|Overall Study|Withdrawal Criteria|4
679399|NCT01664247|2201562|P1|Overall Study|Withdrawal Criteria|1
679400|NCT01664247|2201561|P2|Overall Study|Protocol Violation|5
679401|NCT01664247|2201562|P1|Overall Study|Protocol Violation|3
679402|NCT01664247|2201561|P2|Overall Study|Adverse Event|3
679403|NCT01664247|2201562|P1|Overall Study|Adverse Event|5
679404|NCT01664104|2201639|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
679405|NCT01664104|2201639|P1|Overall Study|Other|1
679406|NCT01664104|2201639|P1|Overall Study|Lost to Follow-up|4
679407|NCT01664104|2201639|P1|Overall Study|Withdrawal by Subject|1
679408|NCT01664104|2201639|P1|Overall Study|Lack of Efficacy|2
679409|NCT01664104|2201639|P1|Overall Study|Adverse Event|6
679410|NCT01664052|2201708|P2|Phase 2|No device placement|4
679411|NCT01664052|2201709|P1|Phase 2|No device placement|0
679412|NCT01664052|2201708|P2|Phase 1|No HSG 1 hr post placement|0
679413|NCT01664052|2201709|P1|Phase 1|No HSG 1 hr post placement|1
679414|NCT01664052|2201708|P2|Phase 1|No device placement|0
679415|NCT01664052|2201709|P1|Phase 1|No device placement|6
679416|NCT01664039|2201727|P2|Overall Study|Noncompliance|1
679417|NCT01664039|2201728|P1|Overall Study|Noncompliance|1
679418|NCT01664039|2201727|P2|Overall Study|Withdrawal by Subject|3
679419|NCT01664039|2201728|P1|Overall Study|Withdrawal by Subject|1
679420|NCT01664039|2201727|P2|Overall Study|Lost to Follow-up|1
679421|NCT01664039|2201728|P1|Overall Study|Lost to Follow-up|1
679422|NCT01664039|2201727|P2|Overall Study|Adverse Event|4
679423|NCT01664039|2201728|P1|Overall Study|Adverse Event|3
679424|NCT01663987|2201750|P2|Overall Study|Other reason not defined above|0
679425|NCT01663987|2201751|P1|Overall Study|Other reason not defined above|3
679426|NCT01663987|2201750|P2|Overall Study|Withdrawal by Subject|3
679427|NCT01663987|2201751|P1|Overall Study|Withdrawal by Subject|2
679428|NCT01663987|2201750|P2|Overall Study|Lost to Follow-up|1
679429|NCT01663987|2201751|P1|Overall Study|Lost to Follow-up|1
679430|NCT01663987|2201750|P2|Overall Study|Adverse Event|2
679431|NCT01663987|2201751|P1|Overall Study|Adverse Event|7
679432|NCT01663727|2201794|P2|Overall Study|Lost to Follow-up|3
679433|NCT01663727|2201795|P1|Overall Study|Lost to Follow-up|8
679434|NCT01663727|2201794|P2|Overall Study|Alive in Follow-Up|132
679435|NCT01663727|2201795|P1|Overall Study|Alive in Follow-Up|143
679436|NCT01663727|2201794|P2|Overall Study|Alive on Treatment|39
679437|NCT01663727|2201795|P1|Overall Study|Alive on Treatment|31
679438|NCT01663727|2201794|P2|Overall Study|Death|65
679439|NCT01663727|2201795|P1|Overall Study|Death|60
679440|NCT01663714|2201823|P1|Long-Term Follow-Up|Non-compliance|1
679441|NCT01663714|2201823|P1|Long-Term Follow-Up|Death|4
679442|NCT01663714|2201823|P1|Long-Term Follow-Up|Lost to Follow-up|1
679443|NCT01663714|2201823|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
679444|NCT01663714|2201823|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
679445|NCT01663714|2201823|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
679446|NCT01663532|2201852|P2|Overall Study|Lack of Efficacy|60
679447|NCT01663532|2201853|P1|Overall Study|Lack of Efficacy|15
679448|NCT01663532|2201852|P2|Overall Study|Withdrawal by Subject|17
679449|NCT01663532|2201853|P1|Overall Study|Withdrawal by Subject|35
679450|NCT01663532|2201852|P2|Overall Study|Physician Decision|1
679451|NCT01663532|2201853|P1|Overall Study|Physician Decision|1
679452|NCT01663532|2201852|P2|Overall Study|Met Withdrawal Criteria|6
679453|NCT01663532|2201853|P1|Overall Study|Met Withdrawal Criteria|7
679454|NCT01663532|2201852|P2|Overall Study|Adverse Event|13
679455|NCT01663532|2201853|P1|Overall Study|Adverse Event|7
679456|NCT01663532|2201852|P2|Overall Study|Lost to Follow-up|10
679457|NCT01663532|2201853|P1|Overall Study|Lost to Follow-up|9
679458|NCT01663506|2201871|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
679459|NCT01663506|2201871|P1|Overall Study|Adverse Event|1
679460|NCT01663506|2201871|P1|Overall Study|Lost to Follow-up|1
679461|NCT01663506|2201871|P1|Overall Study|Consent Withdrawal by Subject|1
679462|NCT01663506|2201871|P1|Overall Study|Lack of Efficacy|3
679463|NCT01663233|2201913|P2|Overall Study|Lost to Follow-up|1
679464|NCT01663233|2201914|P1|Overall Study|Lost to Follow-up|0
679465|NCT01663233|2201913|P2|Overall Study|Protocol Deviation|4
679466|NCT01663233|2201914|P1|Overall Study|Protocol Deviation|1
679467|NCT01663233|2201913|P2|Overall Study|Withdrawal by Subject|2
679468|NCT01663233|2201914|P1|Overall Study|Withdrawal by Subject|3
679469|NCT01663103|2201938|P2|Overall Study|dog bite|0
679470|NCT01663103|2201939|P1|Overall Study|dog bite|1
679471|NCT01663103|2201938|P2|Overall Study|Adverse Event|0
679472|NCT01663103|2201939|P1|Overall Study|Adverse Event|1
679473|NCT01663103|2201938|P2|Overall Study|Withdrawal by Subject|2
679474|NCT01663103|2201939|P1|Overall Study|Withdrawal by Subject|1
679475|NCT01662999|2201967|P6|Period 3|Withdrawal by Subject|0
679476|NCT01662999|2201968|P5|Period 3|Withdrawal by Subject|0
679477|NCT01662999|2201969|P4|Period 3|Withdrawal by Subject|0
679478|NCT01662999|2201970|P3|Period 3|Withdrawal by Subject|0
679479|NCT01662999|2201971|P2|Period 3|Withdrawal by Subject|1
679480|NCT01662999|2201972|P1|Period 3|Withdrawal by Subject|0
679481|NCT01662986|2202043|P2|Overall Study|Other than stated above|0
679482|NCT01662986|2202044|P1|Overall Study|Other than stated above|3
679483|NCT01662986|2202043|P2|Overall Study|Not Treated|0
679484|NCT01662986|2202044|P1|Overall Study|Not Treated|1
679485|NCT01662986|2202043|P2|Overall Study|Withdrawal by Subject|2
679486|NCT01662986|2202044|P1|Overall Study|Withdrawal by Subject|2
679487|NCT01662986|2202043|P2|Overall Study|Lost to Follow-up|4
679488|NCT01662986|2202044|P1|Overall Study|Lost to Follow-up|5
679489|NCT01662986|2202043|P2|Overall Study|Protocol Violation|3
679490|NCT01662986|2202044|P1|Overall Study|Protocol Violation|2
679491|NCT01662986|2202043|P2|Overall Study|Adverse Event|4
679492|NCT01662986|2202044|P1|Overall Study|Adverse Event|5
679493|NCT01662648|2202164|P2|Overall Study|LOE and Participant non-compliant|1
679494|NCT01662648|2202165|P1|Overall Study|LOE and Participant non-compliant|0
679495|NCT01662648|2202164|P2|Overall Study|LOE and other reason unspecified|0
679496|NCT01662648|2202165|P1|Overall Study|LOE and other reason unspecified|1
679497|NCT01662648|2202164|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
679498|NCT01662648|2202165|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
679499|NCT01662648|2202164|P2|Overall Study|Unspecified|11
679500|NCT01662648|2202165|P1|Overall Study|Unspecified|8
679501|NCT01662648|2202164|P2|Overall Study|Participant non-compliant|20
679502|NCT01662648|2202165|P1|Overall Study|Participant non-compliant|16
679503|NCT01662648|2202164|P2|Overall Study|Withdrawal by Subject|53
679504|NCT01662648|2202165|P1|Overall Study|Withdrawal by Subject|36
679505|NCT01662648|2202164|P2|Overall Study|Lost to Follow-up|36
679506|NCT01662648|2202165|P1|Overall Study|Lost to Follow-up|24
679507|NCT01662648|2202164|P2|Overall Study|Participant ineligible to continue trial|1
679508|NCT01662648|2202165|P1|Overall Study|Participant ineligible to continue trial|1
679509|NCT01662648|2202164|P2|Overall Study|Lack of Efficacy|16
679510|NCT01662648|2202165|P1|Overall Study|Lack of Efficacy|17
679511|NCT01662648|2202164|P2|Overall Study|Adverse Event|37
679512|NCT01662648|2202165|P1|Overall Study|Adverse Event|40
679513|NCT01662648|2202164|P2|Overall Study|Death|3
679514|NCT01662648|2202165|P1|Overall Study|Death|1
679515|NCT01662635|2202187|P1|Overall Study|scarce samples for evaluation|30
679516|NCT01662492|2202238|P3|Overall Study|Lack of Efficacy|2
679517|NCT01662492|2202239|P2|Overall Study|Lack of Efficacy|1
679518|NCT01662492|2202240|P1|Overall Study|Lack of Efficacy|1
679519|NCT01662492|2202238|P3|Overall Study|Lost to Follow-up|2
679520|NCT01662492|2202239|P2|Overall Study|Lost to Follow-up|0
679521|NCT01662492|2202240|P1|Overall Study|Lost to Follow-up|0
679522|NCT01662492|2202238|P3|Overall Study|Protocol Violation|0
679523|NCT01662492|2202239|P2|Overall Study|Protocol Violation|0
679524|NCT01662492|2202240|P1|Overall Study|Protocol Violation|1
679525|NCT01662492|2202238|P3|Overall Study|Withdrawal by Subject|1
679526|NCT01662492|2202239|P2|Overall Study|Withdrawal by Subject|0
679527|NCT01662492|2202240|P1|Overall Study|Withdrawal by Subject|0
679528|NCT01662492|2202238|P3|Overall Study|Other miscellaneous reasons.|1
679529|NCT01662492|2202239|P2|Overall Study|Other miscellaneous reasons.|0
679530|NCT01662492|2202240|P1|Overall Study|Other miscellaneous reasons.|1
888982|NCT01688037|2822900|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
888983|NCT01688037|2822901|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
888984|NCT01688037|2822902|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
888985|NCT01688037|2822900|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
888986|NCT01688037|2822901|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
888987|NCT01688037|2822902|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
679555|NCT01662362|2202315|P1|Overall Study|Lost to Follow-up|38
679556|NCT01662310|2202320|P5|Open-Label Extension Phase|Withdrawal by Subject|7
679557|NCT01662310|2202321|P4|Open-Label Extension Phase|Withdrawal by Subject|2
679558|NCT01662310|2202322|P3|Open-Label Extension Phase|Withdrawal by Subject|0
679559|NCT01662310|2202323|P2|Open-Label Extension Phase|Withdrawal by Subject|0
679560|NCT01662310|2202324|P1|Open-Label Extension Phase|Withdrawal by Subject|0
679561|NCT01662310|2202320|P5|Open-Label Extension Phase|Pregnancy|0
679562|NCT01662310|2202321|P4|Open-Label Extension Phase|Pregnancy|1
679563|NCT01662310|2202322|P3|Open-Label Extension Phase|Pregnancy|0
679564|NCT01662310|2202323|P2|Open-Label Extension Phase|Pregnancy|0
679565|NCT01662310|2202324|P1|Open-Label Extension Phase|Pregnancy|0
679566|NCT01662310|2202320|P5|Open-Label Extension Phase|Lost to Follow-up|1
679567|NCT01662310|2202321|P4|Open-Label Extension Phase|Lost to Follow-up|2
679568|NCT01662310|2202322|P3|Open-Label Extension Phase|Lost to Follow-up|0
679569|NCT01662310|2202323|P2|Open-Label Extension Phase|Lost to Follow-up|0
679570|NCT01662310|2202324|P1|Open-Label Extension Phase|Lost to Follow-up|0
679571|NCT01662310|2202320|P5|Open-Label Extension Phase|Lack of Efficacy|2
679572|NCT01662310|2202321|P4|Open-Label Extension Phase|Lack of Efficacy|2
679573|NCT01662310|2202322|P3|Open-Label Extension Phase|Lack of Efficacy|0
679574|NCT01662310|2202323|P2|Open-Label Extension Phase|Lack of Efficacy|0
679575|NCT01662310|2202324|P1|Open-Label Extension Phase|Lack of Efficacy|0
679576|NCT01662310|2202320|P5|Open-Label Extension Phase|Death|0
679577|NCT01662310|2202321|P4|Open-Label Extension Phase|Death|1
679578|NCT01662310|2202322|P3|Open-Label Extension Phase|Death|0
679579|NCT01662310|2202323|P2|Open-Label Extension Phase|Death|0
679580|NCT01662310|2202324|P1|Open-Label Extension Phase|Death|0
679581|NCT01662310|2202320|P5|Open-Label Extension Phase|Adverse Event|0
679582|NCT01662310|2202321|P4|Open-Label Extension Phase|Adverse Event|3
679583|NCT01662310|2202322|P3|Open-Label Extension Phase|Adverse Event|0
679584|NCT01662310|2202323|P2|Open-Label Extension Phase|Adverse Event|0
679585|NCT01662310|2202324|P1|Open-Label Extension Phase|Adverse Event|0
679586|NCT01662310|2202320|P5|Double-Blind Phase|Randomized but not treated|0
679587|NCT01662310|2202321|P4|Double-Blind Phase|Randomized but not treated|0
679588|NCT01662310|2202322|P3|Double-Blind Phase|Randomized but not treated|0
679589|NCT01662310|2202323|P2|Double-Blind Phase|Randomized but not treated|1
679590|NCT01662310|2202324|P1|Double-Blind Phase|Randomized but not treated|0
679591|NCT01662310|2202320|P5|Double-Blind Phase|unspecified|0
679592|NCT01662310|2202321|P4|Double-Blind Phase|unspecified|0
679593|NCT01662310|2202322|P3|Double-Blind Phase|unspecified|1
679594|NCT01662310|2202323|P2|Double-Blind Phase|unspecified|0
679595|NCT01662310|2202324|P1|Double-Blind Phase|unspecified|0
679596|NCT01662310|2202320|P5|Double-Blind Phase|Withdrawal by Subject|0
679597|NCT01662310|2202321|P4|Double-Blind Phase|Withdrawal by Subject|0
679598|NCT01662310|2202322|P3|Double-Blind Phase|Withdrawal by Subject|3
679599|NCT01662310|2202323|P2|Double-Blind Phase|Withdrawal by Subject|9
679600|NCT01662310|2202324|P1|Double-Blind Phase|Withdrawal by Subject|0
679601|NCT01662310|2202320|P5|Double-Blind Phase|Pregnancy|0
679602|NCT01662310|2202321|P4|Double-Blind Phase|Pregnancy|0
679603|NCT01662310|2202322|P3|Double-Blind Phase|Pregnancy|0
679604|NCT01662310|2202323|P2|Double-Blind Phase|Pregnancy|2
679605|NCT01662310|2202324|P1|Double-Blind Phase|Pregnancy|0
679606|NCT01662310|2202320|P5|Double-Blind Phase|Lost to Follow-up|0
679607|NCT01662310|2202321|P4|Double-Blind Phase|Lost to Follow-up|0
679608|NCT01662310|2202322|P3|Double-Blind Phase|Lost to Follow-up|0
679609|NCT01662310|2202323|P2|Double-Blind Phase|Lost to Follow-up|3
679610|NCT01662310|2202324|P1|Double-Blind Phase|Lost to Follow-up|0
679611|NCT01662310|2202320|P5|Double-Blind Phase|Adverse Event|0
679612|NCT01662310|2202321|P4|Double-Blind Phase|Adverse Event|0
679613|NCT01662310|2202322|P3|Double-Blind Phase|Adverse Event|1
679614|NCT01662310|2202323|P2|Double-Blind Phase|Adverse Event|0
679615|NCT01662310|2202324|P1|Double-Blind Phase|Adverse Event|0
679616|NCT01662310|2202320|P5|Run-In or Stabilization Phase|unspecified|0
679617|NCT01662310|2202321|P4|Run-In or Stabilization Phase|unspecified|0
679618|NCT01662310|2202322|P3|Run-In or Stabilization Phase|unspecified|0
679619|NCT01662310|2202323|P2|Run-In or Stabilization Phase|unspecified|0
679620|NCT01662310|2202324|P1|Run-In or Stabilization Phase|unspecified|1
679621|NCT01662310|2202320|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
679622|NCT01662310|2202321|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
679623|NCT01662310|2202322|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
679624|NCT01662310|2202323|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
679625|NCT01662310|2202324|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
679626|NCT01662310|2202320|P5|Run-In or Stabilization Phase|Protocol Violation|0
679627|NCT01662310|2202321|P4|Run-In or Stabilization Phase|Protocol Violation|0
679628|NCT01662310|2202322|P3|Run-In or Stabilization Phase|Protocol Violation|0
679629|NCT01662310|2202323|P2|Run-In or Stabilization Phase|Protocol Violation|0
679630|NCT01662310|2202324|P1|Run-In or Stabilization Phase|Protocol Violation|15
679631|NCT01662310|2202320|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
679632|NCT01662310|2202321|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
679633|NCT01662310|2202322|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
679634|NCT01662310|2202323|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
679635|NCT01662310|2202324|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
679636|NCT01662310|2202320|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
679637|NCT01662310|2202321|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
679638|NCT01662310|2202322|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
679639|NCT01662310|2202323|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
679640|NCT01662310|2202324|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
679641|NCT01662310|2202320|P5|Run-In or Stabilization Phase|Adverse Event|0
679642|NCT01662310|2202321|P4|Run-In or Stabilization Phase|Adverse Event|0
679643|NCT01662310|2202322|P3|Run-In or Stabilization Phase|Adverse Event|0
679644|NCT01662310|2202323|P2|Run-In or Stabilization Phase|Adverse Event|0
679645|NCT01662310|2202324|P1|Run-In or Stabilization Phase|Adverse Event|11
679646|NCT01662102|2202380|P2|Overall Study|Sponsor's decision|0
679647|NCT01662102|2202381|P1|Overall Study|Sponsor's decision|1
679648|NCT01662063|2202389|P3|Overall Study|Not Specified|0
679649|NCT01662063|2202390|P2|Overall Study|Not Specified|1
679650|NCT01662063|2202391|P1|Overall Study|Not Specified|0
679651|NCT01662063|2202389|P3|Overall Study|Physician Decision|0
679652|NCT01662063|2202390|P2|Overall Study|Physician Decision|2
679653|NCT01662063|2202391|P1|Overall Study|Physician Decision|0
679654|NCT01662063|2202389|P3|Overall Study|Withdrawal by Subject|1
679655|NCT01662063|2202390|P2|Overall Study|Withdrawal by Subject|4
679656|NCT01662063|2202391|P1|Overall Study|Withdrawal by Subject|2
679657|NCT01662063|2202389|P3|Overall Study|Protocol Violation|0
679658|NCT01662063|2202390|P2|Overall Study|Protocol Violation|0
679659|NCT01662063|2202391|P1|Overall Study|Protocol Violation|1
679660|NCT01662063|2202389|P3|Overall Study|Lost to Follow-up|0
679661|NCT01662063|2202390|P2|Overall Study|Lost to Follow-up|4
679662|NCT01662063|2202391|P1|Overall Study|Lost to Follow-up|0
679663|NCT01662063|2202389|P3|Overall Study|Lack of Efficacy|0
679664|NCT01662063|2202390|P2|Overall Study|Lack of Efficacy|6
679665|NCT01662063|2202391|P1|Overall Study|Lack of Efficacy|1
679666|NCT01662063|2202389|P3|Overall Study|Adverse Event or Intercurrent Illness|0
679667|NCT01662063|2202390|P2|Overall Study|Adverse Event or Intercurrent Illness|12
679668|NCT01662063|2202391|P1|Overall Study|Adverse Event or Intercurrent Illness|1
679669|NCT01662024|2202470|P1|Overall Study|Withdrawal by Subject|3
679670|NCT01662024|2202470|P1|Overall Study|Pregnancy|2
889009|NCT01661972|2822968|P2|Overall Study|Withdrawal by Subject|1
889010|NCT01661972|2822969|P1|Overall Study|Withdrawal by Subject|0
679677|NCT01661933|2202493|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
679678|NCT01661933|2202493|P1|Low-dose Gluten Challenge|Physician Decision|2
679679|NCT01661790|2202508|P2|Overall Study|Lost to Follow-up|2
679680|NCT01661790|2202509|P1|Overall Study|Lost to Follow-up|0
679681|NCT01661205|2202552|P1|Overall Study|Physician Decision|2
679682|NCT01661179|2202563|P1|Overall Study|Other Eligibility criteria|4
679683|NCT01661179|2202563|P1|Overall Study|Withdrawal by Subject|1
679684|NCT01661179|2202563|P1|Overall Study|Death|1
679685|NCT01661140|2202567|P3|Double-Blind Period|Administrative/Other|6
679686|NCT01661140|2202568|P2|Double-Blind Period|Administrative/Other|7
679687|NCT01661140|2202569|P1|Double-Blind Period|Administrative/Other|0
679688|NCT01661140|2202567|P3|Double-Blind Period|Sponsor Termination|17
679689|NCT01661140|2202568|P2|Double-Blind Period|Sponsor Termination|14
679690|NCT01661140|2202569|P1|Double-Blind Period|Sponsor Termination|0
679691|NCT01661140|2202567|P3|Double-Blind Period|Investigator's Decision|2
679692|NCT01661140|2202568|P2|Double-Blind Period|Investigator's Decision|1
679693|NCT01661140|2202569|P1|Double-Blind Period|Investigator's Decision|0
679694|NCT01661140|2202567|P3|Double-Blind Period|Withdrawal by Subject|3
679695|NCT01661140|2202568|P2|Double-Blind Period|Withdrawal by Subject|1
679696|NCT01661140|2202569|P1|Double-Blind Period|Withdrawal by Subject|0
679697|NCT01661140|2202567|P3|Double-Blind Period|Protocol Violation|3
679698|NCT01661140|2202568|P2|Double-Blind Period|Protocol Violation|2
679699|NCT01661140|2202569|P1|Double-Blind Period|Protocol Violation|0
679700|NCT01661140|2202567|P3|Double-Blind Period|Adverse Event|18
679701|NCT01661140|2202568|P2|Double-Blind Period|Adverse Event|16
679702|NCT01661140|2202569|P1|Double-Blind Period|Adverse Event|0
679703|NCT01661140|2202567|P3|Double-Blind Period|Refused Treatment|1
679704|NCT01661140|2202568|P2|Double-Blind Period|Refused Treatment|0
679705|NCT01661140|2202569|P1|Double-Blind Period|Refused Treatment|0
679706|NCT01661140|2202567|P3|Open-Label Period|Lost to Follow-up|0
679707|NCT01661140|2202568|P2|Open-Label Period|Lost to Follow-up|0
679708|NCT01661140|2202569|P1|Open-Label Period|Lost to Follow-up|2
679709|NCT01661140|2202567|P3|Open-Label Period|Did not meet EULAR criteria|0
679710|NCT01661140|2202568|P2|Open-Label Period|Did not meet EULAR criteria|0
679711|NCT01661140|2202569|P1|Open-Label Period|Did not meet EULAR criteria|1
679712|NCT01661140|2202567|P3|Open-Label Period|Sponsor termination|0
679713|NCT01661140|2202568|P2|Open-Label Period|Sponsor termination|0
679714|NCT01661140|2202569|P1|Open-Label Period|Sponsor termination|16
679715|NCT01661140|2202567|P3|Open-Label Period|Administrative/Other|0
679716|NCT01661140|2202568|P2|Open-Label Period|Administrative/Other|0
679717|NCT01661140|2202569|P1|Open-Label Period|Administrative/Other|1
679718|NCT01661140|2202567|P3|Open-Label Period|Death|0
679719|NCT01661140|2202568|P2|Open-Label Period|Death|0
679720|NCT01661140|2202569|P1|Open-Label Period|Death|1
679721|NCT01661140|2202567|P3|Open-Label Period|Investigator Decision|0
679722|NCT01661140|2202568|P2|Open-Label Period|Investigator Decision|0
679723|NCT01661140|2202569|P1|Open-Label Period|Investigator Decision|3
679724|NCT01661140|2202567|P3|Open-Label Period|Withdrawal by Subject|0
679725|NCT01661140|2202568|P2|Open-Label Period|Withdrawal by Subject|0
679726|NCT01661140|2202569|P1|Open-Label Period|Withdrawal by Subject|5
679727|NCT01661140|2202567|P3|Open-Label Period|Protocol Violation|0
679728|NCT01661140|2202568|P2|Open-Label Period|Protocol Violation|0
679729|NCT01661140|2202569|P1|Open-Label Period|Protocol Violation|3
679730|NCT01661140|2202567|P3|Open-Label Period|Adverse Event|0
679731|NCT01661140|2202568|P2|Open-Label Period|Adverse Event|0
679732|NCT01661140|2202569|P1|Open-Label Period|Adverse Event|44
679733|NCT01661062|2202615|P1|Overall Study|Withdrawal by Subject|2
679734|NCT01661062|2202615|P1|Overall Study|Completed Treatment Off Study|3
679735|NCT01660906|2202620|P1|Overall Study|Discontinued due to study drug toxicity|3
679736|NCT01660763|2202703|P2|Overall Study|Patient ready for early discharge|4
679737|NCT01660763|2202704|P1|Overall Study|Patient ready for early discharge|28
679738|NCT01660763|2202703|P2|Overall Study|Withdrawal by Subject|0
679739|NCT01660763|2202704|P1|Overall Study|Withdrawal by Subject|4
679740|NCT01660763|2202703|P2|Overall Study|Protocol Violation|0
679741|NCT01660763|2202704|P1|Overall Study|Protocol Violation|1
679742|NCT01660763|2202703|P2|Overall Study|Adverse Event|7
679743|NCT01660763|2202704|P1|Overall Study|Adverse Event|22
679744|NCT01660763|2202703|P2|Overall Study|Lack of Efficacy|50
679745|NCT01660763|2202704|P1|Overall Study|Lack of Efficacy|45
679746|NCT01660334|2202749|P1|Overall Study|Lost to Follow-up|1
679747|NCT01659021|2202988|P2|Overall Study|Still on Study|1
679748|NCT01659021|2202989|P1|Overall Study|Still on Study|34
679749|NCT01659021|2202988|P2|Overall Study|Withdrawal by Subject|16
679750|NCT01659021|2202989|P1|Overall Study|Withdrawal by Subject|18
679751|NCT01659021|2202988|P2|Overall Study|Physician Decision|16
679752|NCT01659021|2202989|P1|Overall Study|Physician Decision|32
679753|NCT01659021|2202988|P2|Overall Study|Other?|1
679754|NCT01659021|2202989|P1|Overall Study|Other?|1
679755|NCT01659021|2202988|P2|Overall Study|Lost to Follow-up|0
679756|NCT01659021|2202989|P1|Overall Study|Lost to Follow-up|1
679757|NCT01659021|2202988|P2|Overall Study|Adverse Event|3
679758|NCT01659021|2202989|P1|Overall Study|Adverse Event|2
679759|NCT01658943|2203007|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
679760|NCT01658943|2203008|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
679761|NCT01658943|2203007|P2|Overall Study|Not eligible|9
679762|NCT01658943|2203008|P1|Overall Study|Not eligible|7
679763|NCT01658943|2203007|P2|Overall Study|not protocol specified|1
679764|NCT01658943|2203008|P1|Overall Study|not protocol specified|4
679765|NCT01658943|2203007|P2|Overall Study|Death|2
679766|NCT01658943|2203008|P1|Overall Study|Death|4
679767|NCT01658943|2203007|P2|Overall Study|Progression/Relapse|40
679768|NCT01658943|2203008|P1|Overall Study|Progression/Relapse|39
679769|NCT01658943|2203007|P2|Overall Study|Withdrawal by Subject|2
679770|NCT01658943|2203008|P1|Overall Study|Withdrawal by Subject|9
679771|NCT01658943|2203007|P2|Overall Study|Adverse Event|13
679772|NCT01658943|2203008|P1|Overall Study|Adverse Event|6
679773|NCT01658904|2203023|P3|Overall Study|Principal Investigator discretion|0
679774|NCT01658904|2203024|P2|Overall Study|Principal Investigator discretion|0
679775|NCT01658904|2203025|P1|Overall Study|Principal Investigator discretion|2
679776|NCT01660022|2203048|P6|First Sequence (7 Days)|Protocol Violation|1
679777|NCT01660022|2203049|P5|First Sequence (7 Days)|Protocol Violation|0
679778|NCT01660022|2203050|P4|First Sequence (7 Days)|Protocol Violation|0
679779|NCT01660022|2203051|P3|First Sequence (7 Days)|Protocol Violation|0
679780|NCT01660022|2203052|P2|First Sequence (7 Days)|Protocol Violation|0
679781|NCT01660022|2203053|P1|First Sequence (7 Days)|Protocol Violation|0
679782|NCT01660022|2203048|P6|First Sequence (7 Days)|Adverse Event|3
679783|NCT01660022|2203049|P5|First Sequence (7 Days)|Adverse Event|1
679784|NCT01660022|2203050|P4|First Sequence (7 Days)|Adverse Event|0
679785|NCT01660022|2203051|P3|First Sequence (7 Days)|Adverse Event|0
679786|NCT01660022|2203052|P2|First Sequence (7 Days)|Adverse Event|0
679787|NCT01660022|2203053|P1|First Sequence (7 Days)|Adverse Event|0
679788|NCT01660022|2203048|P6|First Sequence (7 Days)|Withdrawal by Subject|0
679789|NCT01660022|2203049|P5|First Sequence (7 Days)|Withdrawal by Subject|0
679790|NCT01660022|2203050|P4|First Sequence (7 Days)|Withdrawal by Subject|1
679791|NCT01660022|2203051|P3|First Sequence (7 Days)|Withdrawal by Subject|0
679792|NCT01660022|2203052|P2|First Sequence (7 Days)|Withdrawal by Subject|1
679793|NCT01660022|2203053|P1|First Sequence (7 Days)|Withdrawal by Subject|0
679794|NCT01659996|2203112|P3|Overall Study|Withdrawal by Subject|5
679795|NCT01659996|2203113|P2|Overall Study|Withdrawal by Subject|1
679796|NCT01659996|2203114|P1|Overall Study|Withdrawal by Subject|4
679797|NCT01659996|2203112|P3|Overall Study|Adverse Event|1
679798|NCT01659996|2203113|P2|Overall Study|Adverse Event|0
679799|NCT01659996|2203114|P1|Overall Study|Adverse Event|0
679800|NCT01659996|2203112|P3|Overall Study|Lost to Follow-up|2
679801|NCT01659996|2203113|P2|Overall Study|Lost to Follow-up|3
679802|NCT01659996|2203114|P1|Overall Study|Lost to Follow-up|1
679803|NCT01659996|2203112|P3|Overall Study|Protocol Violation|3
679804|NCT01659996|2203113|P2|Overall Study|Protocol Violation|3
679805|NCT01659996|2203114|P1|Overall Study|Protocol Violation|3
679806|NCT01659853|2203146|P2|Washout , 3 to 7 Days|Protocol Violation|0
679807|NCT01659853|2203147|P1|Washout , 3 to 7 Days|Protocol Violation|1
679808|NCT01659853|2203146|P2|Washout , 3 to 7 Days|Adverse Event|0
679809|NCT01659853|2203147|P1|Washout , 3 to 7 Days|Adverse Event|1
679810|NCT01659736|2203157|P2|3-month Follow-up|Lost to Follow-up|1
679811|NCT01659736|2203158|P1|3-month Follow-up|Lost to Follow-up|0
679812|NCT01659736|2203157|P2|Treatment Period|Withdrawal by Subject|0
679813|NCT01659736|2203158|P1|Treatment Period|Withdrawal by Subject|1
679814|NCT01659736|2203157|P2|Treatment Period|Protocol Violation|1
679815|NCT01659736|2203158|P1|Treatment Period|Protocol Violation|3
679816|NCT01659736|2203157|P2|Treatment Period|Adverse Event|1
679817|NCT01659736|2203158|P1|Treatment Period|Adverse Event|1
679818|NCT01659567|2203172|P1|Overall Study|Unspecified|13
679819|NCT01659567|2203172|P1|Overall Study|Progression of the main disease|1
679820|NCT01659567|2203172|P1|Overall Study|Withdrawal by Subject|64
679821|NCT01659567|2203172|P1|Overall Study|Good result at early stage of treatment|5
679822|NCT01659567|2203172|P1|Overall Study|Adverse Event|12
679823|NCT01659567|2203172|P1|Overall Study|Switched to Pegferon|6
679824|NCT01659567|2203172|P1|Overall Study|Lack of Efficacy|22
679825|NCT01659554|2203189|P1|Overall Study|Study Termination|4
679826|NCT01659320|2203196|P1|Overall Study|Physician Decision|1
679827|NCT01659320|2203196|P1|Overall Study|Withdrawal by Subject|2
679828|NCT01659125|2203215|P1|Overall Study|Failed to Start Treatment|2
679829|NCT01659125|2203215|P1|Overall Study|Time Constraints|2
679830|NCT01659125|2203215|P1|Overall Study|Technical Problem|1
679831|NCT01659125|2203215|P1|Overall Study|Lost to Follow-up|7
679832|NCT01659125|2203215|P1|Overall Study|Withdrawal by Subject|2
889011|NCT01661972|2822968|P2|Overall Study|Death during Treatment period|1
679834|NCT01658735|2203240|P3|Overall Study|Withdrawal by Subject|3
679835|NCT01658735|2203241|P2|Overall Study|Withdrawal by Subject|5
679836|NCT01658735|2203242|P1|Overall Study|Withdrawal by Subject|3
679837|NCT01658735|2203240|P3|Overall Study|Protocol Violation|0
679838|NCT01658735|2203241|P2|Overall Study|Protocol Violation|1
679839|NCT01658735|2203242|P1|Overall Study|Protocol Violation|0
679840|NCT01658735|2203240|P3|Overall Study|Lost to Follow-up|0
679841|NCT01658735|2203241|P2|Overall Study|Lost to Follow-up|1
679842|NCT01658735|2203242|P1|Overall Study|Lost to Follow-up|1
679843|NCT01658735|2203240|P3|Overall Study|Lack of Efficacy|1
679844|NCT01658735|2203241|P2|Overall Study|Lack of Efficacy|0
679845|NCT01658735|2203242|P1|Overall Study|Lack of Efficacy|1
679846|NCT01658579|2203284|P4|Treatment Period B|Unspecified|1
679847|NCT01658579|2203285|P3|Treatment Period B|Unspecified|0
679848|NCT01658579|2203286|P2|Treatment Period B|Unspecified|0
679849|NCT01658579|2203287|P1|Treatment Period B|Unspecified|0
679850|NCT01658579|2203284|P4|Treatment Period A|Adverse Event|0
679851|NCT01658579|2203285|P3|Treatment Period A|Adverse Event|0
679852|NCT01658579|2203286|P2|Treatment Period A|Adverse Event|0
679853|NCT01658579|2203287|P1|Treatment Period A|Adverse Event|1
679854|NCT01658579|2203284|P4|Treatment Period A|Unspecified|1
679855|NCT01658579|2203285|P3|Treatment Period A|Unspecified|1
679856|NCT01658579|2203286|P2|Treatment Period A|Unspecified|0
679857|NCT01658579|2203287|P1|Treatment Period A|Unspecified|0
679858|NCT01658514|2203315|P3|Overall Study|Protocol Violation|2
679859|NCT01658514|2203316|P2|Overall Study|Protocol Violation|0
679860|NCT01658514|2203317|P1|Overall Study|Protocol Violation|1
679861|NCT01658436|2203328|P2|Overall Study|Death|0
679862|NCT01658436|2203329|P1|Overall Study|Death|1
679863|NCT01658436|2203328|P2|Overall Study|Subject/guardian decision|1
679864|NCT01658436|2203329|P1|Overall Study|Subject/guardian decision|0
679865|NCT01658436|2203328|P2|Overall Study|Study terminated by sponsor|1
679866|NCT01658436|2203329|P1|Overall Study|Study terminated by sponsor|0
679867|NCT01658436|2203328|P2|Overall Study|Progressive disease|4
679868|NCT01658436|2203329|P1|Overall Study|Progressive disease|12
679869|NCT01658436|2203328|P2|Overall Study|Physician Decision|0
679870|NCT01658436|2203329|P1|Overall Study|Physician Decision|1
679871|NCT01658436|2203328|P2|Overall Study|Adverse Event|5
679872|NCT01658436|2203329|P1|Overall Study|Adverse Event|6
679873|NCT01658072|2203338|P2|Overall Study|Protocol Violation|2
679874|NCT01658072|2203339|P1|Overall Study|Protocol Violation|4
679875|NCT01658020|2203347|P2|Overall Study|Protocol Violation|1
679876|NCT01658020|2203348|P1|Overall Study|Protocol Violation|0
679877|NCT01658020|2203347|P2|Overall Study|Withdrawal by Subject|5
679878|NCT01658020|2203348|P1|Overall Study|Withdrawal by Subject|4
679879|NCT01658020|2203347|P2|Overall Study|Lost to Follow-up|0
679880|NCT01658020|2203348|P1|Overall Study|Lost to Follow-up|1
679881|NCT01658020|2203347|P2|Overall Study|Adverse Event|3
679882|NCT01658020|2203348|P1|Overall Study|Adverse Event|3
679883|NCT01657903|2203364|P1|Overall Study|Withdrawal by Subject|1
679884|NCT01657903|2203364|P1|Overall Study|Lost to Follow-up|1
679885|NCT01657877|2203386|P1|Overall Study|Other Reason|2
679886|NCT01657877|2203386|P1|Overall Study|Adverse Event|2
679887|NCT01657877|2203386|P1|Overall Study|Protocol Violation|6
679888|NCT01657877|2203386|P1|Overall Study|Withdrawal by Subject|4
679889|NCT01657461|2203405|P2|Overall Study|Withdrawal by Subject|3
679890|NCT01657461|2203406|P1|Overall Study|Withdrawal by Subject|1
679891|NCT01657461|2203405|P2|Overall Study|Physician Decision|2
679892|NCT01657461|2203406|P1|Overall Study|Physician Decision|0
679893|NCT01657461|2203405|P2|Overall Study|Lost to Follow-up|3
679894|NCT01657461|2203406|P1|Overall Study|Lost to Follow-up|0
679895|NCT01657461|2203405|P2|Overall Study|Death|12
679896|NCT01657461|2203406|P1|Overall Study|Death|9
679897|NCT01657370|2203436|P6|Overall Study|Lost to Follow-up|1
679898|NCT01657370|2203437|P5|Overall Study|Lost to Follow-up|0
679899|NCT01657370|2203438|P4|Overall Study|Lost to Follow-up|0
679900|NCT01657370|2203439|P3|Overall Study|Lost to Follow-up|1
679901|NCT01657370|2203440|P2|Overall Study|Lost to Follow-up|0
679902|NCT01657370|2203441|P1|Overall Study|Lost to Follow-up|2
679903|NCT01657370|2203436|P6|Overall Study|Protocol Violation|0
679904|NCT01657370|2203437|P5|Overall Study|Protocol Violation|0
679905|NCT01657370|2203438|P4|Overall Study|Protocol Violation|1
679906|NCT01657370|2203439|P3|Overall Study|Protocol Violation|1
679907|NCT01657370|2203440|P2|Overall Study|Protocol Violation|1
679908|NCT01657370|2203441|P1|Overall Study|Protocol Violation|1
679909|NCT01657370|2203436|P6|Overall Study|Adverse Event|0
679910|NCT01657370|2203437|P5|Overall Study|Adverse Event|1
679911|NCT01657370|2203438|P4|Overall Study|Adverse Event|0
679912|NCT01657370|2203439|P3|Overall Study|Adverse Event|0
679913|NCT01657370|2203440|P2|Overall Study|Adverse Event|0
679914|NCT01657370|2203441|P1|Overall Study|Adverse Event|0
679915|NCT01657370|2203436|P6|Overall Study|Lack of Qualifying Event|2
679916|NCT01657370|2203437|P5|Overall Study|Lack of Qualifying Event|1
679917|NCT01657370|2203438|P4|Overall Study|Lack of Qualifying Event|2
679918|NCT01657370|2203439|P3|Overall Study|Lack of Qualifying Event|3
679919|NCT01657370|2203440|P2|Overall Study|Lack of Qualifying Event|0
679920|NCT01657370|2203441|P1|Overall Study|Lack of Qualifying Event|1
679921|NCT01657370|2203436|P6|Overall Study|Physician Decision|0
679922|NCT01657370|2203437|P5|Overall Study|Physician Decision|5
679923|NCT01657370|2203438|P4|Overall Study|Physician Decision|2
679924|NCT01657370|2203439|P3|Overall Study|Physician Decision|1
679925|NCT01657370|2203440|P2|Overall Study|Physician Decision|3
679926|NCT01657370|2203441|P1|Overall Study|Physician Decision|2
679927|NCT01657370|2203436|P6|Overall Study|Withdrawal by Subject|1
679928|NCT01657370|2203437|P5|Overall Study|Withdrawal by Subject|0
679929|NCT01657370|2203438|P4|Overall Study|Withdrawal by Subject|0
679930|NCT01657370|2203439|P3|Overall Study|Withdrawal by Subject|1
679931|NCT01657370|2203440|P2|Overall Study|Withdrawal by Subject|0
679932|NCT01657370|2203441|P1|Overall Study|Withdrawal by Subject|0
679933|NCT01657292|2203523|P1|Overall Study|Change of therapy|1
679934|NCT01657292|2203523|P1|Overall Study|Violation of eligibility criteria|1
679935|NCT01657292|2203523|P1|Overall Study|Withdrawal by Subject|2
679936|NCT01657292|2203523|P1|Overall Study|Adverse Event|6
679937|NCT01657032|2203532|P2|Overall Study|Lost to Follow-up|7
679938|NCT01657032|2203533|P1|Overall Study|Lost to Follow-up|0
679939|NCT01657019|2203559|P1|Overall Study|Not Specified|58
679940|NCT01657019|2203559|P1|Overall Study|Lack of Efficacy|3
679941|NCT01657019|2203559|P1|Overall Study|Protocol Violation|6
679942|NCT01657019|2203559|P1|Overall Study|Lost to Follow-up|48
679943|NCT01657019|2203559|P1|Overall Study|Adverse Event|55
679944|NCT01657019|2203559|P1|Overall Study|Withdrawal by Subject|65
679945|NCT01656967|2203573|P2|Overall Study|unsuccessful ETT insertion|2
679946|NCT01656967|2203574|P1|Overall Study|unsuccessful ETT insertion|3
679947|NCT01656967|2203573|P2|Overall Study|faulty monitor|0
679948|NCT01656967|2203574|P1|Overall Study|faulty monitor|1
679949|NCT01656889|2203596|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
679950|NCT01656889|2203597|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
679951|NCT01656889|2203596|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
679952|NCT01656889|2203597|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
679953|NCT01656889|2203596|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
679954|NCT01656889|2203597|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
679955|NCT01656889|2203596|P2|Post Treatment Follow-Up, 3 Months|Death|5
679956|NCT01656889|2203597|P1|Post Treatment Follow-Up, 3 Months|Death|1
679957|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Moved out of the area|2
679958|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Moved out of the area|0
679959|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Protocol Violation|1
679960|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Protocol Violation|0
679961|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
679962|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
679963|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
679964|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
679965|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Death|1
679966|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Death|0
679967|NCT01656889|2203596|P2|Treatment Period, 12 Weeks|Adverse Event|4
679968|NCT01656889|2203597|P1|Treatment Period, 12 Weeks|Adverse Event|10
679969|NCT01656850|2203617|P2|First Intervention (3 Months)|Withdrawal by Subject|4
679970|NCT01656850|2203618|P1|First Intervention (3 Months)|Withdrawal by Subject|3
679971|NCT01656759|2203709|P2|Overall Study|Protocol Violation|3
679972|NCT01656759|2203710|P1|Overall Study|Protocol Violation|2
679973|NCT01656434|2203741|P2|Overall Study|Withdrawal by Subject|7
679974|NCT01656434|2203742|P1|Overall Study|Withdrawal by Subject|64
679975|NCT01656434|2203741|P2|Overall Study|Participant withdrew consent|9
679976|NCT01656434|2203742|P1|Overall Study|Participant withdrew consent|28
679977|NCT01656434|2203741|P2|Overall Study|Participant moved|12
679978|NCT01656434|2203742|P1|Overall Study|Participant moved|40
679979|NCT01656434|2203741|P2|Overall Study|Non-compliance with protocol|15
679980|NCT01656434|2203742|P1|Overall Study|Non-compliance with protocol|39
679981|NCT01656434|2203741|P2|Overall Study|Part. discontinued; unrelated to drug|10
679982|NCT01656434|2203742|P1|Overall Study|Part. discontinued; unrelated to drug|55
679983|NCT01656434|2203741|P2|Overall Study|Participant discontinued; drug related|4
679984|NCT01656434|2203742|P1|Overall Study|Participant discontinued; drug related|13
679985|NCT01656434|2203741|P2|Overall Study|Study terminated by sponsor|348
679986|NCT01656434|2203742|P1|Overall Study|Study terminated by sponsor|1501
679987|NCT01656434|2203741|P2|Overall Study|Non-compliance with study drug|9
679988|NCT01656434|2203742|P1|Overall Study|Non-compliance with study drug|48
679989|NCT01656434|2203741|P2|Overall Study|Physician Decision|2
679990|NCT01656434|2203742|P1|Overall Study|Physician Decision|7
679991|NCT01656434|2203741|P2|Overall Study|Pregnancy|10
679992|NCT01656434|2203742|P1|Overall Study|Pregnancy|45
679993|NCT01656434|2203741|P2|Overall Study|Pregnancy wish|6
679994|NCT01656434|2203742|P1|Overall Study|Pregnancy wish|18
679995|NCT01656434|2203741|P2|Overall Study|Protocol Violation|0
679996|NCT01656434|2203742|P1|Overall Study|Protocol Violation|7
679997|NCT01656434|2203741|P2|Overall Study|Screen failure|0
679998|NCT01656434|2203742|P1|Overall Study|Screen failure|2
679999|NCT01656434|2203741|P2|Overall Study|Site discontinued study participation|9
680000|NCT01656434|2203742|P1|Overall Study|Site discontinued study participation|24
680001|NCT01656434|2203741|P2|Overall Study|Lost to Follow-up|76
680002|NCT01656434|2203742|P1|Overall Study|Lost to Follow-up|309
680003|NCT01656434|2203741|P2|Overall Study|Enrollment terminated at trial site|0
680004|NCT01656434|2203742|P1|Overall Study|Enrollment terminated at trial site|2
680005|NCT01656434|2203741|P2|Overall Study|Adverse Event|63
680006|NCT01656434|2203742|P1|Overall Study|Adverse Event|199
680007|NCT01656408|2203768|P10|Overall Study|Physician Decision|3
680008|NCT01656408|2203769|P9|Overall Study|Physician Decision|1
680009|NCT01656408|2203770|P8|Overall Study|Physician Decision|1
680010|NCT01656408|2203771|P7|Overall Study|Physician Decision|0
680011|NCT01656408|2203772|P6|Overall Study|Physician Decision|1
680012|NCT01656408|2203773|P5|Overall Study|Physician Decision|1
680013|NCT01656408|2203774|P4|Overall Study|Physician Decision|0
680014|NCT01656408|2203775|P3|Overall Study|Physician Decision|1
680015|NCT01656408|2203776|P2|Overall Study|Physician Decision|0
680016|NCT01656408|2203777|P1|Overall Study|Physician Decision|1
680017|NCT01656408|2203768|P10|Overall Study|Adverse Event|0
680018|NCT01656408|2203769|P9|Overall Study|Adverse Event|1
680019|NCT01656408|2203770|P8|Overall Study|Adverse Event|0
680020|NCT01656408|2203771|P7|Overall Study|Adverse Event|1
680021|NCT01656408|2203772|P6|Overall Study|Adverse Event|1
680022|NCT01656408|2203773|P5|Overall Study|Adverse Event|0
680023|NCT01656408|2203774|P4|Overall Study|Adverse Event|0
680024|NCT01656408|2203775|P3|Overall Study|Adverse Event|1
680025|NCT01656408|2203776|P2|Overall Study|Adverse Event|0
680026|NCT01656408|2203777|P1|Overall Study|Adverse Event|0
680027|NCT01656304|2203966|P1|Overall Study|Ineligible, uncontrolled hypertension|1
680028|NCT01656161|2204004|P1|Overall Study|Withdrawal by Subject|1
680029|NCT01656161|2204004|P1|Overall Study|Protocol Violation|1
680030|NCT01656161|2204004|P1|Overall Study|Adverse Event|2
680031|NCT01656161|2204004|P1|Overall Study|Death|3
680032|NCT01655498|2204022|P1|Overall Study|Withdrawal by Subject|1
680033|NCT01655498|2204022|P1|Overall Study|Protocol Violation|2
680034|NCT01655498|2204022|P1|Overall Study|Unrelated health issue|2
680035|NCT01655381|2204029|P1|Overall Study|Insufficient Treatment Response|1
680036|NCT01655381|2204029|P1|Overall Study|Moved to Another City|1
680037|NCT01655381|2204029|P1|Overall Study|Investigator Decision|1
680038|NCT01654666|2204110|P3|Overall Study|Withdrawal by Subject|1
680039|NCT01654666|2204111|P2|Overall Study|Withdrawal by Subject|4
680040|NCT01654666|2204112|P1|Overall Study|Withdrawal by Subject|4
680041|NCT01654666|2204110|P3|Overall Study|Lost to Follow-up|5
680042|NCT01654666|2204111|P2|Overall Study|Lost to Follow-up|5
680043|NCT01654666|2204112|P1|Overall Study|Lost to Follow-up|4
680044|NCT01654666|2204110|P3|Overall Study|Protocol Violation|8
680045|NCT01654666|2204111|P2|Overall Study|Protocol Violation|4
680046|NCT01654666|2204112|P1|Overall Study|Protocol Violation|7
680047|NCT01654601|2204137|P2|2nd Administration|Protocol Violation|1
680048|NCT01654601|2204138|P1|2nd Administration|Protocol Violation|0
680049|NCT01654601|2204137|P2|2nd Administration|Adverse Event|0
680050|NCT01654601|2204138|P1|2nd Administration|Adverse Event|1
680051|NCT01654601|2204137|P2|1st Administration|Protocol Violation|2
680052|NCT01654601|2204138|P1|1st Administration|Protocol Violation|0
680053|NCT01654601|2204137|P2|1st Administration|Withdrawal by Subject|0
680054|NCT01654601|2204138|P1|1st Administration|Withdrawal by Subject|2
680055|NCT01654549|2204152|P2|Overall Study|H.pylori eradication not successful|1
680056|NCT01654549|2204153|P1|Overall Study|H.pylori eradication not successful|0
680057|NCT01654536|2204165|P2|Overall Study|Withdrawal by Subject|25
680058|NCT01654536|2204166|P1|Overall Study|Withdrawal by Subject|27
680059|NCT01654536|2204165|P2|Overall Study|Physician Decision|8
680060|NCT01654536|2204166|P1|Overall Study|Physician Decision|12
680061|NCT01654536|2204165|P2|Overall Study|Lost to Follow-up|5
680062|NCT01654536|2204166|P1|Overall Study|Lost to Follow-up|5
680063|NCT01654523|2204202|P1|Overall Study|Withdrawal by Subject|1
680064|NCT01654302|2204208|P2|Second Intervention (Day 7)|Lost to Follow-up|1
680065|NCT01654302|2204209|P1|Second Intervention (Day 7)|Lost to Follow-up|1
680066|NCT01654276|2204215|P1|Overall Study|Withdrawal by Subject|1
680067|NCT01654276|2204215|P1|Overall Study|Lost to Follow-up|4
680068|NCT01654276|2204215|P1|Overall Study|Lack of Efficacy|1
680069|NCT01654250|2204269|P2|Overall Study|Lost to Follow-up|0
680070|NCT01654250|2204270|P1|Overall Study|Lost to Follow-up|1
680071|NCT01654224|2204287|P2|Overall Study|Insufficient blood sample|2
680072|NCT01654224|2204288|P1|Overall Study|Insufficient blood sample|3
680073|NCT01654224|2204287|P2|Overall Study|Did not receive allocation|8
680074|NCT01654224|2204288|P1|Overall Study|Did not receive allocation|1
680075|NCT01654224|2204287|P2|Overall Study|Lost to Follow-up|2
680076|NCT01654224|2204288|P1|Overall Study|Lost to Follow-up|2
680077|NCT01653782|2204314|P3|Overall Study|Lost to Follow-up|2
680078|NCT01653782|2204315|P2|Overall Study|Lost to Follow-up|3
680079|NCT01653782|2204316|P1|Overall Study|Lost to Follow-up|7
680080|NCT01653782|2204314|P3|Overall Study|Withdrawal by Subject|4
680081|NCT01653782|2204315|P2|Overall Study|Withdrawal by Subject|15
680082|NCT01653782|2204316|P1|Overall Study|Withdrawal by Subject|9
680083|NCT01653743|2204326|P2|Overall Study|Investigator discretion|0
680084|NCT01653743|2204327|P1|Overall Study|Investigator discretion|3
680085|NCT01653743|2204326|P2|Overall Study|Withdrawal by Subject|0
680086|NCT01653743|2204327|P1|Overall Study|Withdrawal by Subject|1
680087|NCT01653262|2204374|P1|Overall Study|AE, non-serious non-fatal|1
680088|NCT01653262|2204374|P1|Overall Study|SAE, non-fatal|1
680089|NCT01653262|2204374|P1|Overall Study|Lack of Efficacy|1
680090|NCT01653158|2204387|P8|Overall Study|Withdrawal by Subject|0
680091|NCT01653158|2204388|P7|Overall Study|Withdrawal by Subject|0
680092|NCT01653158|2204389|P6|Overall Study|Withdrawal by Subject|0
680093|NCT01653158|2204390|P5|Overall Study|Withdrawal by Subject|0
680094|NCT01653158|2204391|P4|Overall Study|Withdrawal by Subject|0
680095|NCT01653158|2204392|P3|Overall Study|Withdrawal by Subject|0
680096|NCT01653158|2204393|P2|Overall Study|Withdrawal by Subject|0
680097|NCT01653158|2204394|P1|Overall Study|Withdrawal by Subject|1
680098|NCT01653158|2204387|P8|Overall Study|Progressive disease|9
680099|NCT01653158|2204388|P7|Overall Study|Progressive disease|2
680100|NCT01653158|2204389|P6|Overall Study|Progressive disease|1
680101|NCT01653158|2204390|P5|Overall Study|Progressive disease|1
680102|NCT01653158|2204391|P4|Overall Study|Progressive disease|0
680103|NCT01653158|2204392|P3|Overall Study|Progressive disease|0
680104|NCT01653158|2204393|P2|Overall Study|Progressive disease|0
680105|NCT01653158|2204394|P1|Overall Study|Progressive disease|0
680106|NCT01653158|2204387|P8|Overall Study|Unspecified|1
680107|NCT01653158|2204388|P7|Overall Study|Unspecified|0
680108|NCT01653158|2204389|P6|Overall Study|Unspecified|0
680109|NCT01653158|2204390|P5|Overall Study|Unspecified|0
680110|NCT01653158|2204391|P4|Overall Study|Unspecified|0
680111|NCT01653158|2204392|P3|Overall Study|Unspecified|0
680112|NCT01653158|2204393|P2|Overall Study|Unspecified|0
680113|NCT01653158|2204394|P1|Overall Study|Unspecified|0
680114|NCT01653158|2204387|P8|Overall Study|Adverse Event|3
680115|NCT01653158|2204388|P7|Overall Study|Adverse Event|0
680116|NCT01653158|2204389|P6|Overall Study|Adverse Event|0
680117|NCT01653158|2204390|P5|Overall Study|Adverse Event|0
680118|NCT01653158|2204391|P4|Overall Study|Adverse Event|1
680119|NCT01653158|2204392|P3|Overall Study|Adverse Event|0
680120|NCT01653158|2204393|P2|Overall Study|Adverse Event|0
680121|NCT01653158|2204394|P1|Overall Study|Adverse Event|0
680122|NCT01653158|2204387|P8|Overall Study|Death|2
680123|NCT01653158|2204388|P7|Overall Study|Death|0
680124|NCT01653158|2204389|P6|Overall Study|Death|0
680125|NCT01653158|2204390|P5|Overall Study|Death|0
680126|NCT01653158|2204391|P4|Overall Study|Death|1
680127|NCT01653158|2204392|P3|Overall Study|Death|0
680128|NCT01653158|2204393|P2|Overall Study|Death|0
680129|NCT01653158|2204394|P1|Overall Study|Death|0
680130|NCT01653132|2204666|P2|First Intervention|Protocol Violation|0
680131|NCT01653132|2204667|P1|First Intervention|Protocol Violation|1
680132|NCT01652885|2204717|P1|Overall Study|Adverse Event|1
680133|NCT01652729|2204745|P3|Overall Study|Administrative|0
680134|NCT01652729|2204746|P2|Overall Study|Administrative|0
680135|NCT01652729|2204747|P1|Overall Study|Administrative|1
680136|NCT01652729|2204745|P3|Overall Study|Lost to Follow-up|3
680137|NCT01652729|2204746|P2|Overall Study|Lost to Follow-up|6
680138|NCT01652729|2204747|P1|Overall Study|Lost to Follow-up|6
680139|NCT01652729|2204745|P3|Overall Study|Protocol Violation|0
680140|NCT01652729|2204746|P2|Overall Study|Protocol Violation|0
680141|NCT01652729|2204747|P1|Overall Study|Protocol Violation|1
680142|NCT01652729|2204745|P3|Overall Study|Physician Decision|1
680143|NCT01652729|2204746|P2|Overall Study|Physician Decision|0
680144|NCT01652729|2204747|P1|Overall Study|Physician Decision|1
680145|NCT01652729|2204745|P3|Overall Study|Adverse Event|3
680146|NCT01652729|2204746|P2|Overall Study|Adverse Event|0
680147|NCT01652729|2204747|P1|Overall Study|Adverse Event|4
680148|NCT01652729|2204745|P3|Overall Study|Withdrawal by Subject|7
680149|NCT01652729|2204746|P2|Overall Study|Withdrawal by Subject|7
680150|NCT01652729|2204747|P1|Overall Study|Withdrawal by Subject|14
680151|NCT01652716|2204769|P2|Overall Study|Withdrawal by Subject|18
680152|NCT01652716|2204770|P1|Overall Study|Withdrawal by Subject|33
680153|NCT01652716|2204769|P2|Overall Study|Adverse Event|10
680154|NCT01652716|2204770|P1|Overall Study|Adverse Event|7
680155|NCT01652716|2204769|P2|Overall Study|Protocol Violation|1
680156|NCT01652716|2204770|P1|Overall Study|Protocol Violation|2
680157|NCT01652716|2204769|P2|Overall Study|Lost to Follow-up|11
680158|NCT01652716|2204770|P1|Overall Study|Lost to Follow-up|12
680159|NCT01652716|2204769|P2|Overall Study|Investigator decision|4
680160|NCT01652716|2204770|P1|Overall Study|Investigator decision|1
680161|NCT01652716|2204769|P2|Overall Study|Administrative|2
680162|NCT01652716|2204770|P1|Overall Study|Administrative|0
680163|NCT01652716|2204769|P2|Overall Study|Loss of glucose control|0
680164|NCT01652716|2204770|P1|Overall Study|Loss of glucose control|1
680165|NCT01652703|2204790|P6|Overall Study|Other|1
680166|NCT01652703|2204791|P5|Overall Study|Other|1
680167|NCT01652703|2204792|P4|Overall Study|Other|1
680168|NCT01652703|2204793|P3|Overall Study|Other|0
680169|NCT01652703|2204794|P2|Overall Study|Other|0
680170|NCT01652703|2204795|P1|Overall Study|Other|0
680171|NCT01652703|2204790|P6|Overall Study|Withdrawal by Subject|1
680172|NCT01652703|2204791|P5|Overall Study|Withdrawal by Subject|0
680173|NCT01652703|2204792|P4|Overall Study|Withdrawal by Subject|1
680174|NCT01652703|2204793|P3|Overall Study|Withdrawal by Subject|3
680175|NCT01652703|2204794|P2|Overall Study|Withdrawal by Subject|1
680176|NCT01652703|2204795|P1|Overall Study|Withdrawal by Subject|0
680177|NCT01652690|2204853|P2|Overall Study|Death|2
680178|NCT01652690|2204854|P1|Overall Study|Death|5
680179|NCT01652690|2204853|P2|Overall Study|Lost to Follow-up|6
680180|NCT01652690|2204854|P1|Overall Study|Lost to Follow-up|6
680181|NCT01652690|2204853|P2|Overall Study|Other|9
680182|NCT01652690|2204854|P1|Overall Study|Other|8
680183|NCT01652690|2204853|P2|Overall Study|Withdrawal by Subject|4
680184|NCT01652690|2204854|P1|Overall Study|Withdrawal by Subject|16
680185|NCT01652664|2204888|P2|Overall Study|Inadequate IOP control|0
680186|NCT01652664|2204889|P1|Overall Study|Inadequate IOP control|1
680187|NCT01652664|2204888|P2|Overall Study|Treatment Failure|1
680188|NCT01652664|2204889|P1|Overall Study|Treatment Failure|5
680189|NCT01652573|2204898|P2|Overall Study|Adverse Event|1
680190|NCT01652573|2204899|P1|Overall Study|Adverse Event|0
680191|NCT01652287|2204954|P2|Overall Study|Withdrawal by Subject|0
680192|NCT01652287|2204955|P1|Overall Study|Withdrawal by Subject|2
680193|NCT01651949|2204975|P3|Overall Study|Withdrawal by Subject|9
680194|NCT01651949|2204976|P2|Overall Study|Withdrawal by Subject|18
680195|NCT01651949|2204977|P1|Overall Study|Withdrawal by Subject|17
680196|NCT01651949|2204975|P3|Overall Study|Screen failure|0
680197|NCT01651949|2204976|P2|Overall Study|Screen failure|2
680198|NCT01651949|2204977|P1|Overall Study|Screen failure|2
680199|NCT01651949|2204975|P3|Overall Study|Adverse Event|1
680200|NCT01651949|2204976|P2|Overall Study|Adverse Event|2
680201|NCT01651949|2204977|P1|Overall Study|Adverse Event|0
680202|NCT01651949|2204975|P3|Overall Study|Physician Decision|0
680203|NCT01651949|2204976|P2|Overall Study|Physician Decision|2
680204|NCT01651949|2204977|P1|Overall Study|Physician Decision|0
680205|NCT01651949|2204975|P3|Overall Study|Protocol Violation|1
680206|NCT01651949|2204976|P2|Overall Study|Protocol Violation|2
680207|NCT01651949|2204977|P1|Overall Study|Protocol Violation|0
680208|NCT01651949|2204975|P3|Overall Study|Lost to Follow-up|20
680209|NCT01651949|2204976|P2|Overall Study|Lost to Follow-up|56
680210|NCT01651949|2204977|P1|Overall Study|Lost to Follow-up|30
680211|NCT01651949|2204975|P3|Overall Study|Unknown status|0
680212|NCT01651949|2204976|P2|Overall Study|Unknown status|4
680213|NCT01651949|2204977|P1|Overall Study|Unknown status|4
680214|NCT01651936|2204997|P3|Extension Study|Study terminated by sponsor|13
680215|NCT01651936|2204998|P2|Extension Study|Study terminated by sponsor|0
680216|NCT01651936|2204999|P1|Extension Study|Study terminated by sponsor|0
680217|NCT01651936|2204997|P3|Extension Study|Lack of Efficacy|1
680218|NCT01651936|2204998|P2|Extension Study|Lack of Efficacy|0
680219|NCT01651936|2204999|P1|Extension Study|Lack of Efficacy|0
680220|NCT01651936|2204997|P3|Base Study|Study terminated by sponsor|0
680221|NCT01651936|2204998|P2|Base Study|Study terminated by sponsor|16
680222|NCT01651936|2204999|P1|Base Study|Study terminated by sponsor|21
680223|NCT01651936|2204997|P3|Base Study|Early Escape|0
680224|NCT01651936|2204998|P2|Base Study|Early Escape|8
680225|NCT01651936|2204999|P1|Base Study|Early Escape|2
680226|NCT01651936|2204997|P3|Base Study|Withdrawal by Subject|0
680227|NCT01651936|2204998|P2|Base Study|Withdrawal by Subject|1
680228|NCT01651936|2204999|P1|Base Study|Withdrawal by Subject|1
680229|NCT01651936|2204997|P3|Base Study|Adverse Event|0
680230|NCT01651936|2204998|P2|Base Study|Adverse Event|0
680231|NCT01651936|2204999|P1|Base Study|Adverse Event|3
680232|NCT01651780|2205022|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
680233|NCT01651780|2205023|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
680234|NCT01651780|2205022|P2|Overall Study|Lost to Follow-up|2
680235|NCT01651780|2205023|P1|Overall Study|Lost to Follow-up|1
680236|NCT01651780|2205022|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
680237|NCT01651780|2205023|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
680238|NCT01651780|2205022|P2|Overall Study|Withdrawal by Subject|0
680239|NCT01651780|2205023|P1|Overall Study|Withdrawal by Subject|2
680240|NCT01651780|2205022|P2|Overall Study|Reason Not Specified: No 30-day visit|2
680241|NCT01651780|2205023|P1|Overall Study|Reason Not Specified: No 30-day visit|2
680242|NCT01651780|2205022|P2|Overall Study|Physician decision: No 30-day visit|1
680243|NCT01651780|2205023|P1|Overall Study|Physician decision: No 30-day visit|2
680244|NCT01651260|2205073|P1|Overall Study|unable to apply product|3
680245|NCT01651208|2205080|P2|Overall Study|Lost to Follow-up|16
680246|NCT01651208|2205081|P1|Overall Study|Lost to Follow-up|14
680247|NCT01651000|2205098|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
680248|NCT01651000|2205099|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
680249|NCT01651000|2205098|P2|Overall Study|Administrative reason|0
680250|NCT01651000|2205099|P1|Overall Study|Administrative reason|1
680251|NCT01651000|2205098|P2|Overall Study|Physician Decision|0
680252|NCT01651000|2205099|P1|Overall Study|Physician Decision|1
680253|NCT01651000|2205098|P2|Overall Study|Lack of Efficacy|1
680254|NCT01651000|2205099|P1|Overall Study|Lack of Efficacy|1
680255|NCT01651000|2205098|P2|Overall Study|Subject noncompliance|3
680256|NCT01651000|2205099|P1|Overall Study|Subject noncompliance|0
680257|NCT01651000|2205098|P2|Overall Study|Withdrawal by Subject|10
680258|NCT01651000|2205099|P1|Overall Study|Withdrawal by Subject|2
680259|NCT01651000|2205098|P2|Overall Study|Protocol Violation|3
680260|NCT01651000|2205099|P1|Overall Study|Protocol Violation|0
680261|NCT01651000|2205098|P2|Overall Study|Lost to Follow-up|2
680262|NCT01651000|2205099|P1|Overall Study|Lost to Follow-up|3
680263|NCT01651000|2205098|P2|Overall Study|Adverse Event|8
680264|NCT01651000|2205099|P1|Overall Study|Adverse Event|2
680265|NCT01650831|2205111|P1|Overall Study|Screen failure|1
680266|NCT01650805|2205121|P2|Overall Study|Withdrawal by Subject|0
680267|NCT01650805|2205122|P1|Overall Study|Withdrawal by Subject|1
680268|NCT01650779|2205132|P1|Overall Study|Withdrawal by Subject|1
680269|NCT01650519|2205141|P2|Overall Study|Withdrawal by Subject|0
680270|NCT01650519|2205142|P1|Overall Study|Withdrawal by Subject|1
680271|NCT01650285|2205202|P1|Overall Study|Adverse Event|1
680272|NCT01650246|2205206|P1|Overall Study|Lack of Efficacy|30
680273|NCT01650246|2205206|P1|Overall Study|Death|1
680274|NCT01650246|2205206|P1|Overall Study|Withdrawal by Subject|26
680275|NCT01650246|2205206|P1|Overall Study|Lost to Follow-up|5
680276|NCT01650246|2205206|P1|Overall Study|Sponsor terminated study|53
680277|NCT01650246|2205206|P1|Overall Study|Protocol Violation|5
680278|NCT01650246|2205206|P1|Overall Study|Adverse Event|23
889012|NCT01661972|2822969|P1|Overall Study|Death during Treatment period|1
889013|NCT01661972|2822968|P2|Overall Study|Adverse Event|2
889014|NCT01661972|2822969|P1|Overall Study|Adverse Event|1
889015|NCT01649271|2822981|P2|Overall Study|Other than stated above|0
889016|NCT01649271|2822982|P1|Overall Study|Other than stated above|1
889017|NCT01649271|2822981|P2|Overall Study|Withdrawal by Subject|0
889018|NCT01649271|2822982|P1|Overall Study|Withdrawal by Subject|1
889019|NCT01649271|2822981|P2|Overall Study|Other Adverse Event|2
889020|NCT01649271|2822982|P1|Overall Study|Other Adverse Event|0
889021|NCT01649271|2822981|P2|Overall Study|Progressive disease|5
889022|NCT01649271|2822982|P1|Overall Study|Progressive disease|4
680297|NCT01649804|2205246|P1|Overall Study|Administrative/Other|8
680298|NCT01649791|2205258|P1|Overall Study|Adverse Event|1
680299|NCT01649791|2205258|P1|Overall Study|Disease Progression|2
680300|NCT01649557|2205268|P3|Overall Study|Lack of Efficacy|0
680301|NCT01649557|2205269|P2|Overall Study|Lack of Efficacy|0
680302|NCT01649557|2205270|P1|Overall Study|Lack of Efficacy|5
680303|NCT01649557|2205268|P3|Overall Study|Protocol deviation|0
680304|NCT01649557|2205269|P2|Overall Study|Protocol deviation|2
680305|NCT01649557|2205270|P1|Overall Study|Protocol deviation|0
680306|NCT01649557|2205268|P3|Overall Study|Withdrawal by Subject|4
680307|NCT01649557|2205269|P2|Overall Study|Withdrawal by Subject|5
680308|NCT01649557|2205270|P1|Overall Study|Withdrawal by Subject|15
680309|NCT01649557|2205268|P3|Overall Study|Physician Decision|1
680310|NCT01649557|2205269|P2|Overall Study|Physician Decision|2
680311|NCT01649557|2205270|P1|Overall Study|Physician Decision|8
680312|NCT01649557|2205268|P3|Overall Study|Met withdrawal criteria|0
680313|NCT01649557|2205269|P2|Overall Study|Met withdrawal criteria|0
680314|NCT01649557|2205270|P1|Overall Study|Met withdrawal criteria|4
680315|NCT01649557|2205268|P3|Overall Study|Adverse Event|1
680316|NCT01649557|2205269|P2|Overall Study|Adverse Event|5
680317|NCT01649557|2205270|P1|Overall Study|Adverse Event|7
680318|NCT01649557|2205268|P3|Overall Study|Lost to Follow-up|3
680319|NCT01649557|2205269|P2|Overall Study|Lost to Follow-up|0
680320|NCT01649557|2205270|P1|Overall Study|Lost to Follow-up|5
680321|NCT01649297|2205332|P5|Overall Study|For other reason|0
680322|NCT01649297|2205333|P4|Overall Study|For other reason|0
680323|NCT01649297|2205334|P3|Overall Study|For other reason|2
680324|NCT01649297|2205335|P2|Overall Study|For other reason|1
680325|NCT01649297|2205336|P1|Overall Study|For other reason|4
680326|NCT01649297|2205332|P5|Overall Study|Patient withdrawal (not due to AE)|1
680327|NCT01649297|2205333|P4|Overall Study|Patient withdrawal (not due to AE)|1
680328|NCT01649297|2205334|P3|Overall Study|Patient withdrawal (not due to AE)|4
680329|NCT01649297|2205335|P2|Overall Study|Patient withdrawal (not due to AE)|6
680330|NCT01649297|2205336|P1|Overall Study|Patient withdrawal (not due to AE)|3
680331|NCT01649297|2205332|P5|Overall Study|Lost to Follow-up|0
680332|NCT01649297|2205333|P4|Overall Study|Lost to Follow-up|3
680333|NCT01649297|2205334|P3|Overall Study|Lost to Follow-up|4
680334|NCT01649297|2205335|P2|Overall Study|Lost to Follow-up|1
680335|NCT01649297|2205336|P1|Overall Study|Lost to Follow-up|1
680336|NCT01649297|2205332|P5|Overall Study|Non compliant with Protocol|1
680337|NCT01649297|2205333|P4|Overall Study|Non compliant with Protocol|2
680338|NCT01649297|2205334|P3|Overall Study|Non compliant with Protocol|3
680339|NCT01649297|2205335|P2|Overall Study|Non compliant with Protocol|0
680340|NCT01649297|2205336|P1|Overall Study|Non compliant with Protocol|1
680341|NCT01649297|2205332|P5|Overall Study|Lack of Efficacy|1
680342|NCT01649297|2205333|P4|Overall Study|Lack of Efficacy|0
680343|NCT01649297|2205334|P3|Overall Study|Lack of Efficacy|0
680344|NCT01649297|2205335|P2|Overall Study|Lack of Efficacy|0
680345|NCT01649297|2205336|P1|Overall Study|Lack of Efficacy|0
680346|NCT01649297|2205332|P5|Overall Study|Adverse Event|1
680347|NCT01649297|2205333|P4|Overall Study|Adverse Event|13
680348|NCT01649297|2205334|P3|Overall Study|Adverse Event|4
680349|NCT01649297|2205335|P2|Overall Study|Adverse Event|5
680350|NCT01649297|2205336|P1|Overall Study|Adverse Event|5
680351|NCT01649232|2205355|P2|Overall Study|Physician Decision|0
680352|NCT01649232|2205356|P1|Overall Study|Physician Decision|2
680353|NCT01648790|2205408|P5|Treatment 3|Withdrawal by Subject|0
680354|NCT01648790|2205409|P4|Treatment 3|Withdrawal by Subject|1
680355|NCT01648790|2205410|P3|Treatment 3|Withdrawal by Subject|0
680356|NCT01648790|2205411|P2|Treatment 3|Withdrawal by Subject|0
680357|NCT01648790|2205412|P1|Treatment 3|Withdrawal by Subject|0
680358|NCT01648699|2205433|P1|Overall Study|Unspecified/unable to complete 4 visits|2
680359|NCT01648699|2205433|P1|Overall Study|Lost to Follow-up|2
680360|NCT01648699|2205433|P1|Overall Study|Death|1
680361|NCT01648582|2205462|P3|Overall Study|Sponsor Decision|1
680362|NCT01648582|2205463|P2|Overall Study|Sponsor Decision|1
680363|NCT01648582|2205464|P1|Overall Study|Sponsor Decision|0
680364|NCT01648582|2205462|P3|Overall Study|Death|0
680365|NCT01648582|2205463|P2|Overall Study|Death|0
680366|NCT01648582|2205464|P1|Overall Study|Death|1
680367|NCT01648582|2205462|P3|Overall Study|Physician Decision|3
680368|NCT01648582|2205463|P2|Overall Study|Physician Decision|1
680369|NCT01648582|2205464|P1|Overall Study|Physician Decision|0
680370|NCT01648582|2205462|P3|Overall Study|Withdrawal by Subject|17
680371|NCT01648582|2205463|P2|Overall Study|Withdrawal by Subject|17
680372|NCT01648582|2205464|P1|Overall Study|Withdrawal by Subject|15
680373|NCT01648582|2205462|P3|Overall Study|Protocol Violation|1
680374|NCT01648582|2205463|P2|Overall Study|Protocol Violation|2
680375|NCT01648582|2205464|P1|Overall Study|Protocol Violation|1
680376|NCT01648582|2205462|P3|Overall Study|Lost to Follow-up|8
680377|NCT01648582|2205463|P2|Overall Study|Lost to Follow-up|6
680378|NCT01648582|2205464|P1|Overall Study|Lost to Follow-up|9
680379|NCT01648582|2205462|P3|Overall Study|Adverse Event|2
680380|NCT01648582|2205463|P2|Overall Study|Adverse Event|11
680381|NCT01648582|2205464|P1|Overall Study|Adverse Event|6
680382|NCT01648140|2205568|P4|Overall Study|Lost to Follow-up|0
680383|NCT01648140|2205569|P3|Overall Study|Lost to Follow-up|2
680384|NCT01648140|2205570|P2|Overall Study|Lost to Follow-up|1
680385|NCT01648140|2205571|P1|Overall Study|Lost to Follow-up|2
680386|NCT01648140|2205568|P4|Overall Study|Withdrawal by Subject|2
680387|NCT01648140|2205569|P3|Overall Study|Withdrawal by Subject|3
680388|NCT01648140|2205570|P2|Overall Study|Withdrawal by Subject|3
680389|NCT01648140|2205571|P1|Overall Study|Withdrawal by Subject|2
680390|NCT01648140|2205568|P4|Overall Study|Adverse Event|0
680391|NCT01648140|2205569|P3|Overall Study|Adverse Event|2
680392|NCT01648140|2205570|P2|Overall Study|Adverse Event|1
680393|NCT01648140|2205571|P1|Overall Study|Adverse Event|3
680394|NCT01648140|2205568|P4|Overall Study|Lack of Efficacy|0
680395|NCT01648140|2205569|P3|Overall Study|Lack of Efficacy|1
680396|NCT01648140|2205570|P2|Overall Study|Lack of Efficacy|7
680397|NCT01648140|2205571|P1|Overall Study|Lack of Efficacy|4
680398|NCT01648140|2205568|P4|Overall Study|Physician Decision|0
680399|NCT01648140|2205569|P3|Overall Study|Physician Decision|0
680400|NCT01648140|2205570|P2|Overall Study|Physician Decision|0
680401|NCT01648140|2205571|P1|Overall Study|Physician Decision|1
680402|NCT01648101|2205736|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
680403|NCT01648101|2205737|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
680404|NCT01648101|2205738|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
680405|NCT01648101|2205736|P3|Transition Phase (4 Weeks)|Study Terminated|0
680406|NCT01648101|2205737|P2|Transition Phase (4 Weeks)|Study Terminated|0
680407|NCT01648101|2205738|P1|Transition Phase (4 Weeks)|Study Terminated|1
680408|NCT01648101|2205736|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
680409|NCT01648101|2205737|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
680410|NCT01648101|2205738|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
680411|NCT01648101|2205736|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
680412|NCT01648101|2205737|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
680413|NCT01648101|2205738|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
680414|NCT01648101|2205736|P3|Transition Phase (4 Weeks)|Adverse Event|2
680415|NCT01648101|2205737|P2|Transition Phase (4 Weeks)|Adverse Event|3
680416|NCT01648101|2205738|P1|Transition Phase (4 Weeks)|Adverse Event|4
680417|NCT01648101|2205736|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
680418|NCT01648101|2205737|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
680419|NCT01648101|2205738|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
680420|NCT01648101|2205736|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
680421|NCT01648101|2205737|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
680422|NCT01648101|2205738|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
680423|NCT01648101|2205736|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
680424|NCT01648101|2205737|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
680425|NCT01648101|2205738|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
680426|NCT01648101|2205736|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
680427|NCT01648101|2205737|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
680428|NCT01648101|2205738|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
680429|NCT01648101|2205736|P3|Titration Phase (4 Weeks)|Adverse Event|3
680430|NCT01648101|2205737|P2|Titration Phase (4 Weeks)|Adverse Event|2
680431|NCT01648101|2205738|P1|Titration Phase (4 Weeks)|Adverse Event|0
680432|NCT01648101|2205736|P3|Titration Phase (4 Weeks)|Protocol Violation|2
680433|NCT01648101|2205737|P2|Titration Phase (4 Weeks)|Protocol Violation|1
680434|NCT01648101|2205738|P1|Titration Phase (4 Weeks)|Protocol Violation|2
680435|NCT01647711|2205825|P5|Overall Study|Other reason not defined|0
680436|NCT01647711|2205826|P4|Overall Study|Other reason not defined|1
680437|NCT01647711|2205827|P3|Overall Study|Other reason not defined|1
680438|NCT01647711|2205828|P2|Overall Study|Other reason not defined|1
680439|NCT01647711|2205829|P1|Overall Study|Other reason not defined|0
680440|NCT01647711|2205825|P5|Overall Study|Refused to continue taking medication|1
680441|NCT01647711|2205826|P4|Overall Study|Refused to continue taking medication|2
680442|NCT01647711|2205827|P3|Overall Study|Refused to continue taking medication|0
680443|NCT01647711|2205828|P2|Overall Study|Refused to continue taking medication|0
680444|NCT01647711|2205829|P1|Overall Study|Refused to continue taking medication|0
680445|NCT01647711|2205825|P5|Overall Study|Protocol Violation|1
680446|NCT01647711|2205826|P4|Overall Study|Protocol Violation|0
680447|NCT01647711|2205827|P3|Overall Study|Protocol Violation|0
680448|NCT01647711|2205828|P2|Overall Study|Protocol Violation|0
680449|NCT01647711|2205829|P1|Overall Study|Protocol Violation|0
680450|NCT01647711|2205825|P5|Overall Study|Other adverse event|2
680451|NCT01647711|2205826|P4|Overall Study|Other adverse event|0
680452|NCT01647711|2205827|P3|Overall Study|Other adverse event|2
680453|NCT01647711|2205828|P2|Overall Study|Other adverse event|0
680454|NCT01647711|2205829|P1|Overall Study|Other adverse event|0
680455|NCT01647711|2205825|P5|Overall Study|Progressive disease|2
680456|NCT01647711|2205826|P4|Overall Study|Progressive disease|8
680457|NCT01647711|2205827|P3|Overall Study|Progressive disease|6
680458|NCT01647711|2205828|P2|Overall Study|Progressive disease|2
680459|NCT01647711|2205829|P1|Overall Study|Progressive disease|6
680460|NCT01647542|2205857|P3|Overall Study|Death|1
680461|NCT01647542|2205858|P2|Overall Study|Death|0
680462|NCT01647542|2205859|P1|Overall Study|Death|0
680463|NCT01647542|2205857|P3|Overall Study|Lack of Efficacy|0
680464|NCT01647542|2205858|P2|Overall Study|Lack of Efficacy|1
680465|NCT01647542|2205859|P1|Overall Study|Lack of Efficacy|1
680466|NCT01647542|2205857|P3|Overall Study|Study Termination|65
680467|NCT01647542|2205858|P2|Overall Study|Study Termination|61
680468|NCT01647542|2205859|P1|Overall Study|Study Termination|64
680469|NCT01647542|2205857|P3|Overall Study|Withdrawal by Subject|0
680470|NCT01647542|2205858|P2|Overall Study|Withdrawal by Subject|4
680471|NCT01647542|2205859|P1|Overall Study|Withdrawal by Subject|6
680472|NCT01647542|2205857|P3|Overall Study|Lost to Follow-up|2
680473|NCT01647542|2205858|P2|Overall Study|Lost to Follow-up|2
680474|NCT01647542|2205859|P1|Overall Study|Lost to Follow-up|0
680475|NCT01647542|2205857|P3|Overall Study|Adverse Event|4
680476|NCT01647542|2205858|P2|Overall Study|Adverse Event|5
680477|NCT01647542|2205859|P1|Overall Study|Adverse Event|4
680478|NCT01647542|2205857|P3|Overall Study|Major Protocol Deviation|0
680479|NCT01647542|2205858|P2|Overall Study|Major Protocol Deviation|0
680480|NCT01647542|2205859|P1|Overall Study|Major Protocol Deviation|1
680481|NCT01646827|2205904|P2|Overall Study|Withdrawal by Subject|0
680482|NCT01646827|2205905|P1|Overall Study|Withdrawal by Subject|1
680483|NCT01646827|2205904|P2|Overall Study|Physician Decision|2
680484|NCT01646827|2205905|P1|Overall Study|Physician Decision|1
680485|NCT01646827|2205904|P2|Overall Study|Lost to Follow-up|3
680486|NCT01646827|2205905|P1|Overall Study|Lost to Follow-up|0
680487|NCT01646398|2205992|P2|Overall Study|Withdrawal by Subject|0
680488|NCT01646398|2205993|P1|Overall Study|Withdrawal by Subject|1
680489|NCT01646385|2206009|P2|Overall Study|Switched to alternate biologic|649
680490|NCT01646385|2206010|P1|Overall Study|Switched to alternate biologic|636
680491|NCT01646385|2206009|P2|Overall Study|Death|222
680492|NCT01646385|2206010|P1|Overall Study|Death|202
680493|NCT01646320|2206043|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
680494|NCT01646320|2206044|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
680495|NCT01646320|2206043|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
680496|NCT01646320|2206044|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
680497|NCT01646320|2206043|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
680498|NCT01646320|2206044|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
680499|NCT01646320|2206043|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
680500|NCT01646320|2206044|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
680501|NCT01646320|2206043|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
680502|NCT01646320|2206044|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
680503|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
680504|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
680505|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
680506|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
680507|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
680508|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
680509|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
680510|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
680511|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
680512|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
680513|NCT01646320|2206043|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
680514|NCT01646320|2206044|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
680515|NCT01646268|2206060|P2|Overall Study|Other|0
680516|NCT01646268|2206061|P1|Overall Study|Other|2
680517|NCT01646268|2206060|P2|Overall Study|Withdrawal by Subject|5
680518|NCT01646268|2206061|P1|Overall Study|Withdrawal by Subject|2
680519|NCT01646268|2206060|P2|Overall Study|Protocol Violation|1
680520|NCT01646268|2206061|P1|Overall Study|Protocol Violation|0
680521|NCT01646268|2206060|P2|Overall Study|Lack of Efficacy|3
680522|NCT01646268|2206061|P1|Overall Study|Lack of Efficacy|1
680523|NCT01646268|2206060|P2|Overall Study|Adverse Event|7
680524|NCT01646268|2206061|P1|Overall Study|Adverse Event|6
680525|NCT01646255|2206075|P2|Overall Study|Inclusion Criteria Deviation|0
680526|NCT01646255|2206076|P1|Overall Study|Inclusion Criteria Deviation|1
680527|NCT01646255|2206075|P2|Overall Study|Compliance is not well|0
680528|NCT01646255|2206076|P1|Overall Study|Compliance is not well|1
680529|NCT01646255|2206075|P2|Overall Study|Withdrawal by Subject|6
680530|NCT01646255|2206076|P1|Overall Study|Withdrawal by Subject|10
680531|NCT01646255|2206075|P2|Overall Study|Lack of Efficacy|0
680532|NCT01646255|2206076|P1|Overall Study|Lack of Efficacy|2
680533|NCT01646255|2206075|P2|Overall Study|Adverse Event|8
680534|NCT01646255|2206076|P1|Overall Study|Adverse Event|7
889049|NCT01611558|2823112|P1|Maintenance Phase|Study drug toxicity|1
889050|NCT01611558|2823112|P1|Maintenance Phase|Withdrawal by Subject|1
889051|NCT01611558|2823112|P1|Induction Phase|Death|1
889052|NCT01611558|2823112|P1|Induction Phase|Adverse event unrelated to study drug|1
889053|NCT01611558|2823112|P1|Induction Phase|Not reported|5
680559|NCT01646138|2206207|P5|Overall Study|Lost to Follow-up|2
680560|NCT01646138|2206208|P4|Overall Study|Lost to Follow-up|0
680561|NCT01646138|2206209|P3|Overall Study|Lost to Follow-up|0
680562|NCT01646138|2206210|P2|Overall Study|Lost to Follow-up|0
680563|NCT01646138|2206211|P1|Overall Study|Lost to Follow-up|0
680564|NCT01646125|2206225|P2|Overall Study|Subject/Guardian decision|1
680565|NCT01646125|2206226|P1|Overall Study|Subject/Guardian decision|1
680566|NCT01646125|2206225|P2|Overall Study|Study terminated by sponsor|1
680567|NCT01646125|2206226|P1|Overall Study|Study terminated by sponsor|2
680568|NCT01646125|2206225|P2|Overall Study|Progressive disease|16
680569|NCT01646125|2206226|P1|Overall Study|Progressive disease|22
680570|NCT01646125|2206225|P2|Overall Study|Physician Decision|3
680571|NCT01646125|2206226|P1|Overall Study|Physician Decision|1
680572|NCT01646125|2206225|P2|Overall Study|Death|1
680573|NCT01646125|2206226|P1|Overall Study|Death|1
680574|NCT01646125|2206225|P2|Overall Study|Adverse Event|1
680575|NCT01646125|2206226|P1|Overall Study|Adverse Event|2
680576|NCT01646125|2206225|P2|Overall Study|Untreated|5
680577|NCT01646125|2206226|P1|Overall Study|Untreated|2
680578|NCT01646073|2206251|P2|Period B (12 Weeks)|Lost to Follow-up|1
680579|NCT01646073|2206252|P1|Period B (12 Weeks)|Lost to Follow-up|0
680580|NCT01646073|2206251|P2|Period B (12 Weeks)|Withdrawal by Subject|5
680581|NCT01646073|2206252|P1|Period B (12 Weeks)|Withdrawal by Subject|1
680582|NCT01646073|2206251|P2|Period B (12 Weeks)|Adverse Event|7
680583|NCT01646073|2206252|P1|Period B (12 Weeks)|Adverse Event|0
680584|NCT01646073|2206251|P2|Period A (12 Weeks)|Not Specified|1
680585|NCT01646073|2206252|P1|Period A (12 Weeks)|Not Specified|0
680586|NCT01646073|2206251|P2|Period A (12 Weeks)|Protocol Violation|1
680587|NCT01646073|2206252|P1|Period A (12 Weeks)|Protocol Violation|0
680588|NCT01646073|2206251|P2|Period A (12 Weeks)|Lack of Efficacy|0
680589|NCT01646073|2206252|P1|Period A (12 Weeks)|Lack of Efficacy|1
680590|NCT01646073|2206251|P2|Period A (12 Weeks)|Withdrawal by Subject|1
680591|NCT01646073|2206252|P1|Period A (12 Weeks)|Withdrawal by Subject|1
680592|NCT01646073|2206251|P2|Period A (12 Weeks)|Adverse Event|2
680593|NCT01646073|2206252|P1|Period A (12 Weeks)|Adverse Event|0
680594|NCT01646021|2206293|P2|Overall Study|Withdrawal by Subject|13
680595|NCT01646021|2206294|P1|Overall Study|Withdrawal by Subject|6
680596|NCT01646021|2206293|P2|Overall Study|Lost to Follow-up|2
680597|NCT01646021|2206294|P1|Overall Study|Lost to Follow-up|1
680598|NCT01646021|2206293|P2|Overall Study|Death|63
680599|NCT01646021|2206294|P1|Overall Study|Death|59
680600|NCT01645735|2206327|P2|Overall Study|Adverse Event|1
889054|NCT01611558|2823112|P1|Induction Phase|Disease progression|14
889055|NCT01611558|2823112|P1|Induction Phase|Study drug toxicity|17
889056|NCT01611259|2823118|P1|Overall Study|Withdrawal by Subject|7
889057|NCT01611259|2823118|P1|Overall Study|Adverse Event|4
889058|NCT01611259|2823118|P1|Overall Study|Lack of Efficacy|2
680601|NCT01645735|2206328|P1|Overall Study|Adverse Event|0
680602|NCT01645735|2206327|P2|Overall Study|Protocol Violation|0
680603|NCT01645735|2206328|P1|Overall Study|Protocol Violation|1
680604|NCT01645735|2206327|P2|Overall Study|Withdrawal by Subject|0
680605|NCT01645735|2206328|P1|Overall Study|Withdrawal by Subject|1
680606|NCT01645735|2206327|P2|Overall Study|Physician Decision|0
680607|NCT01645735|2206328|P1|Overall Study|Physician Decision|2
680608|NCT01645280|2206370|P5|Overall Study|Treatment not completed/Completed f/u|2
680609|NCT01645280|2206371|P4|Overall Study|Treatment not completed/Completed f/u|0
680610|NCT01645280|2206372|P3|Overall Study|Treatment not completed/Completed f/u|2
680611|NCT01645280|2206373|P2|Overall Study|Treatment not completed/Completed f/u|1
680612|NCT01645280|2206374|P1|Overall Study|Treatment not completed/Completed f/u|1
680613|NCT01645280|2206370|P5|Overall Study|Unspecified|0
680614|NCT01645280|2206371|P4|Overall Study|Unspecified|0
680615|NCT01645280|2206372|P3|Overall Study|Unspecified|2
680616|NCT01645280|2206373|P2|Overall Study|Unspecified|1
680617|NCT01645280|2206374|P1|Overall Study|Unspecified|1
680618|NCT01645280|2206370|P5|Overall Study|Lost to Follow-up|1
680619|NCT01645280|2206371|P4|Overall Study|Lost to Follow-up|2
680620|NCT01645280|2206372|P3|Overall Study|Lost to Follow-up|0
680621|NCT01645280|2206373|P2|Overall Study|Lost to Follow-up|0
680622|NCT01645280|2206374|P1|Overall Study|Lost to Follow-up|0
680623|NCT01645280|2206370|P5|Overall Study|Withdrawal by Subject|5
680624|NCT01645280|2206371|P4|Overall Study|Withdrawal by Subject|4
680625|NCT01645280|2206372|P3|Overall Study|Withdrawal by Subject|2
680626|NCT01645280|2206373|P2|Overall Study|Withdrawal by Subject|0
680627|NCT01645280|2206374|P1|Overall Study|Withdrawal by Subject|4
680628|NCT01645280|2206370|P5|Overall Study|Death|0
680629|NCT01645280|2206371|P4|Overall Study|Death|0
680630|NCT01645280|2206372|P3|Overall Study|Death|0
680631|NCT01645280|2206373|P2|Overall Study|Death|1
680632|NCT01645280|2206374|P1|Overall Study|Death|0
680633|NCT01645176|2206402|P1|Overall Study|did not complete final MRI|1
680634|NCT01645176|2206402|P1|Overall Study|Lack of Efficacy|4
680635|NCT01645111|2206406|P1|Overall Study|Did not require Clevidipine|15
680636|NCT01644734|2206445|P1|Overall Study|Missing documentation|238
680637|NCT01644734|2206445|P1|Overall Study|Reasons other than stated above|7
680638|NCT01644734|2206445|P1|Overall Study|Lost to Follow-up|17
680639|NCT01644734|2206445|P1|Overall Study|Adverse Event|4
680640|NCT01644643|2206459|P4|Overall Study|Other Eligibility criteria|2
680641|NCT01644643|2206460|P3|Overall Study|Other Eligibility criteria|0
680642|NCT01644643|2206461|P2|Overall Study|Other Eligibility criteria|0
680643|NCT01644643|2206462|P1|Overall Study|Other Eligibility criteria|0
680644|NCT01644643|2206459|P4|Overall Study|Withdrawal by Subject|1
680645|NCT01644643|2206460|P3|Overall Study|Withdrawal by Subject|2
680646|NCT01644643|2206461|P2|Overall Study|Withdrawal by Subject|0
680647|NCT01644643|2206462|P1|Overall Study|Withdrawal by Subject|1
680648|NCT01644643|2206459|P4|Overall Study|Lost to Follow-up|4
680649|NCT01644643|2206460|P3|Overall Study|Lost to Follow-up|0
680650|NCT01644643|2206461|P2|Overall Study|Lost to Follow-up|0
680651|NCT01644643|2206462|P1|Overall Study|Lost to Follow-up|0
680652|NCT01644643|2206459|P4|Overall Study|Death|3
680653|NCT01644643|2206460|P3|Overall Study|Death|3
680654|NCT01644643|2206461|P2|Overall Study|Death|0
680655|NCT01644643|2206462|P1|Overall Study|Death|1
680656|NCT01644617|2206627|P3|Overall Study|Adverse Event|6
680657|NCT01644617|2206628|P2|Overall Study|Adverse Event|0
680658|NCT01644617|2206629|P1|Overall Study|Adverse Event|3
680659|NCT01644617|2206627|P3|Overall Study|Lost to Follow-up|0
680660|NCT01644617|2206628|P2|Overall Study|Lost to Follow-up|1
680661|NCT01644617|2206629|P1|Overall Study|Lost to Follow-up|0
680662|NCT01644617|2206627|P3|Overall Study|Withdrawal by Subject|1
680663|NCT01644617|2206628|P2|Overall Study|Withdrawal by Subject|4
680664|NCT01644617|2206629|P1|Overall Study|Withdrawal by Subject|3
680686|NCT01644474|2206754|P2|Overall Study|Protocol Violation|0
680687|NCT01644474|2206755|P1|Overall Study|Protocol Violation|1
680688|NCT01644474|2206754|P2|Overall Study|Site scheduling error|1
680689|NCT01644474|2206755|P1|Overall Study|Site scheduling error|1
680690|NCT01644474|2206754|P2|Overall Study|Adverse Event|5
680691|NCT01644474|2206755|P1|Overall Study|Adverse Event|4
680692|NCT01644474|2206754|P2|Overall Study|Participant moved|1
680693|NCT01644474|2206755|P1|Overall Study|Participant moved|0
680694|NCT01644474|2206754|P2|Overall Study|Consent withdrawn by participant|1
680695|NCT01644474|2206755|P1|Overall Study|Consent withdrawn by participant|0
680696|NCT01644474|2206754|P2|Overall Study|Poor compliance to protocol|0
680697|NCT01644474|2206755|P1|Overall Study|Poor compliance to protocol|1
680698|NCT01644188|2206939|P2|Overall Study|Other than specified above|7
680699|NCT01644188|2206940|P1|Overall Study|Other than specified above|6
680700|NCT01644188|2206939|P2|Overall Study|Site closure|1
680701|NCT01644188|2206940|P1|Overall Study|Site closure|1
680702|NCT01644188|2206939|P2|Overall Study|Last visit outside protocol visit window|16
680703|NCT01644188|2206940|P1|Overall Study|Last visit outside protocol visit window|14
680704|NCT01644188|2206939|P2|Overall Study|Death|3
680705|NCT01644188|2206940|P1|Overall Study|Death|4
680706|NCT01644188|2206939|P2|Overall Study|Lost to Follow-up|0
680707|NCT01644188|2206940|P1|Overall Study|Lost to Follow-up|1
680708|NCT01644188|2206939|P2|Overall Study|Selection criteria finally not met|0
680709|NCT01644188|2206940|P1|Overall Study|Selection criteria finally not met|2
680710|NCT01644188|2206939|P2|Overall Study|Consent withdrawn by participant|7
680711|NCT01644188|2206940|P1|Overall Study|Consent withdrawn by participant|14
680712|NCT01644188|2206939|P2|Overall Study|Related to auto-injector administration|2
680713|NCT01644188|2206940|P1|Overall Study|Related to auto-injector administration|2
680714|NCT01644188|2206939|P2|Overall Study|Participant moved|2
680715|NCT01644188|2206940|P1|Overall Study|Participant moved|7
680716|NCT01644188|2206939|P2|Overall Study|Physician Decision|3
680717|NCT01644188|2206940|P1|Overall Study|Physician Decision|1
680718|NCT01644188|2206939|P2|Overall Study|Poor compliance to protocol|14
680719|NCT01644188|2206940|P1|Overall Study|Poor compliance to protocol|26
680720|NCT01644188|2206939|P2|Overall Study|Adverse Event|20
680721|NCT01644188|2206940|P1|Overall Study|Adverse Event|44
680722|NCT01644175|2206998|P2|Overall Study|Other than specified above|3
680723|NCT01644175|2206999|P1|Overall Study|Other than specified above|0
680724|NCT01644175|2206998|P2|Overall Study|Lost to Follow-up|0
680725|NCT01644175|2206999|P1|Overall Study|Lost to Follow-up|1
680726|NCT01644175|2206998|P2|Overall Study|Site closure|2
680727|NCT01644175|2206999|P1|Overall Study|Site closure|2
680728|NCT01644175|2206998|P2|Overall Study|Selection criteria finally not met|1
680729|NCT01644175|2206999|P1|Overall Study|Selection criteria finally not met|0
680730|NCT01644175|2206998|P2|Overall Study|Last visit outside protocol visit window|11
680731|NCT01644175|2206999|P1|Overall Study|Last visit outside protocol visit window|4
680732|NCT01644175|2206998|P2|Overall Study|Related to Autoinjector Administration|1
680733|NCT01644175|2206999|P1|Overall Study|Related to Autoinjector Administration|2
680734|NCT01644175|2206998|P2|Overall Study|Consent withdrawn by participant|4
680735|NCT01644175|2206999|P1|Overall Study|Consent withdrawn by participant|3
680736|NCT01644175|2206998|P2|Overall Study|Participant Moved|2
680737|NCT01644175|2206999|P1|Overall Study|Participant Moved|1
680738|NCT01644175|2206998|P2|Overall Study|Physician Decision|2
680739|NCT01644175|2206999|P1|Overall Study|Physician Decision|1
680740|NCT01644175|2206998|P2|Overall Study|Poor compliance to protocol|10
680741|NCT01644175|2206999|P1|Overall Study|Poor compliance to protocol|9
680742|NCT01644175|2206998|P2|Overall Study|Death|2
680743|NCT01644175|2206999|P1|Overall Study|Death|1
680744|NCT01644175|2206998|P2|Overall Study|Adverse Event|13
680745|NCT01644175|2206999|P1|Overall Study|Adverse Event|8
680746|NCT01644175|2206998|P2|Overall Study|Randomized But Not Treated|2
680747|NCT01644175|2206999|P1|Overall Study|Randomized But Not Treated|0
680748|NCT01643928|2207059|P5|Overall Study|Adverse Event|2
680749|NCT01643928|2207060|P4|Overall Study|Adverse Event|1
680750|NCT01643928|2207061|P3|Overall Study|Adverse Event|0
680751|NCT01643928|2207062|P2|Overall Study|Adverse Event|1
680752|NCT01643928|2207063|P1|Overall Study|Adverse Event|2
680753|NCT01643928|2207059|P5|Overall Study|Unspecified|0
680754|NCT01643928|2207060|P4|Overall Study|Unspecified|0
680755|NCT01643928|2207061|P3|Overall Study|Unspecified|1
680756|NCT01643928|2207062|P2|Overall Study|Unspecified|1
680757|NCT01643928|2207063|P1|Overall Study|Unspecified|5
680758|NCT01643928|2207059|P5|Overall Study|Pregnancy|0
680759|NCT01643928|2207060|P4|Overall Study|Pregnancy|1
680760|NCT01643928|2207061|P3|Overall Study|Pregnancy|0
680761|NCT01643928|2207062|P2|Overall Study|Pregnancy|0
680762|NCT01643928|2207063|P1|Overall Study|Pregnancy|0
680763|NCT01643928|2207059|P5|Overall Study|Withdrawal by Subject|0
680764|NCT01643928|2207060|P4|Overall Study|Withdrawal by Subject|1
680765|NCT01643928|2207061|P3|Overall Study|Withdrawal by Subject|0
680766|NCT01643928|2207062|P2|Overall Study|Withdrawal by Subject|0
680767|NCT01643928|2207063|P1|Overall Study|Withdrawal by Subject|2
680768|NCT01643928|2207059|P5|Overall Study|Lost to Follow-up|0
680769|NCT01643928|2207060|P4|Overall Study|Lost to Follow-up|0
680770|NCT01643928|2207061|P3|Overall Study|Lost to Follow-up|2
680771|NCT01643928|2207062|P2|Overall Study|Lost to Follow-up|0
680772|NCT01643928|2207063|P1|Overall Study|Lost to Follow-up|1
680773|NCT01643798|2207358|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
680774|NCT01643798|2207359|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
680775|NCT01643668|2207370|P1|Overall Study|Death|1
680776|NCT01643044|2207410|P2|Overall Study|Delivered outside of hospital|2
680777|NCT01643044|2207411|P1|Overall Study|Delivered outside of hospital|1
680778|NCT01643044|2207410|P2|Overall Study|Miscarried baby|2
680779|NCT01643044|2207411|P1|Overall Study|Miscarried baby|2
680780|NCT01643044|2207410|P2|Overall Study|Lost to Follow-up|1
680781|NCT01643044|2207411|P1|Overall Study|Lost to Follow-up|1
680782|NCT01642914|2207420|P3|Overall Study|Other Reason|0
680783|NCT01642914|2207421|P2|Overall Study|Other Reason|0
680784|NCT01642914|2207422|P1|Overall Study|Other Reason|1
680785|NCT01642914|2207420|P3|Overall Study|Lost to Follow-up|7
680786|NCT01642914|2207421|P2|Overall Study|Lost to Follow-up|3
680787|NCT01642914|2207422|P1|Overall Study|Lost to Follow-up|5
680788|NCT01642914|2207420|P3|Overall Study|Withdrawal by Subject|10
680789|NCT01642914|2207421|P2|Overall Study|Withdrawal by Subject|5
680790|NCT01642914|2207422|P1|Overall Study|Withdrawal by Subject|5
680791|NCT01642914|2207420|P3|Overall Study|Protocol Violation|6
680792|NCT01642914|2207421|P2|Overall Study|Protocol Violation|13
680793|NCT01642914|2207422|P1|Overall Study|Protocol Violation|15
680794|NCT01642914|2207420|P3|Overall Study|Lack of Efficacy|2
680795|NCT01642914|2207421|P2|Overall Study|Lack of Efficacy|4
680796|NCT01642914|2207422|P1|Overall Study|Lack of Efficacy|9
680797|NCT01642914|2207420|P3|Overall Study|Adverse Event|15
680798|NCT01642914|2207421|P2|Overall Study|Adverse Event|7
680799|NCT01642914|2207422|P1|Overall Study|Adverse Event|11
680800|NCT01642732|2207497|P1|Overall Study|Withdrawal by Subject|1
680801|NCT01642615|2207502|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
680802|NCT01642615|2207503|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
680803|NCT01642615|2207504|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
680804|NCT01642615|2207502|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
680805|NCT01642615|2207503|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
680806|NCT01642615|2207504|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
680807|NCT01642615|2207502|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
680808|NCT01642615|2207503|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
680809|NCT01642615|2207504|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
680810|NCT01642615|2207502|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
680811|NCT01642615|2207503|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
680812|NCT01642615|2207504|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
680813|NCT01642615|2207502|P3|Open Label Maintenance Phase|Did not receive treatment|0
680814|NCT01642615|2207503|P2|Open Label Maintenance Phase|Did not receive treatment|0
680815|NCT01642615|2207504|P1|Open Label Maintenance Phase|Did not receive treatment|1
680816|NCT01642615|2207502|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
680817|NCT01642615|2207503|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
680818|NCT01642615|2207504|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
680819|NCT01642615|2207502|P3|Open Label Maintenance Phase|Lost to Follow-up|0
680820|NCT01642615|2207503|P2|Open Label Maintenance Phase|Lost to Follow-up|0
680821|NCT01642615|2207504|P1|Open Label Maintenance Phase|Lost to Follow-up|1
680822|NCT01642615|2207502|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
680823|NCT01642615|2207503|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
680824|NCT01642615|2207504|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
680825|NCT01642615|2207502|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
680826|NCT01642615|2207503|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
680827|NCT01642615|2207504|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
680828|NCT01642602|2207518|P1|Overall Study|Adverse Event|2
680829|NCT01642589|2207525|P2|Overall Study|Withdrawal by Subject|1
680830|NCT01642589|2207526|P1|Overall Study|Withdrawal by Subject|1
680831|NCT01642407|2207565|P1|Overall Study|Insufficient clinical response|2
680832|NCT01642277|2207609|P2|Overall Study|Withdrawal by Subject|0
680833|NCT01642277|2207610|P1|Overall Study|Withdrawal by Subject|11
680834|NCT01642277|2207609|P2|Overall Study|Protocol Violation|0
680835|NCT01642277|2207610|P1|Overall Study|Protocol Violation|1
680836|NCT01642277|2207609|P2|Overall Study|Physician Decision|0
680837|NCT01642277|2207610|P1|Overall Study|Physician Decision|2
680838|NCT01642277|2207609|P2|Overall Study|Adverse Event|0
680839|NCT01642277|2207610|P1|Overall Study|Adverse Event|10
680840|NCT01642212|2207642|P5|Open-label Extension|Not Specified|1
680841|NCT01642212|2207643|P4|Open-label Extension|Not Specified|0
680842|NCT01642212|2207644|P3|Open-label Extension|Not Specified|0
680843|NCT01642212|2207645|P2|Open-label Extension|Not Specified|0
680844|NCT01642212|2207646|P1|Open-label Extension|Not Specified|0
680845|NCT01642212|2207642|P5|Open-label Extension|Lost to Follow-up|1
680846|NCT01642212|2207643|P4|Open-label Extension|Lost to Follow-up|0
680847|NCT01642212|2207644|P3|Open-label Extension|Lost to Follow-up|0
680848|NCT01642212|2207645|P2|Open-label Extension|Lost to Follow-up|0
680849|NCT01642212|2207646|P1|Open-label Extension|Lost to Follow-up|0
680850|NCT01642212|2207642|P5|Open-label Extension|Consent Withdrawn|2
680851|NCT01642212|2207643|P4|Open-label Extension|Consent Withdrawn|0
680852|NCT01642212|2207644|P3|Open-label Extension|Consent Withdrawn|0
680853|NCT01642212|2207645|P2|Open-label Extension|Consent Withdrawn|0
680854|NCT01642212|2207646|P1|Open-label Extension|Consent Withdrawn|0
680855|NCT01642212|2207642|P5|Open-label Extension|Sponsor Decision|4
680856|NCT01642212|2207643|P4|Open-label Extension|Sponsor Decision|7
680857|NCT01642212|2207644|P3|Open-label Extension|Sponsor Decision|0
680858|NCT01642212|2207645|P2|Open-label Extension|Sponsor Decision|0
680859|NCT01642212|2207646|P1|Open-label Extension|Sponsor Decision|0
680860|NCT01642212|2207642|P5|Open-label Extension|Adverse Event|0
680861|NCT01642212|2207643|P4|Open-label Extension|Adverse Event|3
680862|NCT01642212|2207644|P3|Open-label Extension|Adverse Event|0
680863|NCT01642212|2207645|P2|Open-label Extension|Adverse Event|0
680864|NCT01642212|2207646|P1|Open-label Extension|Adverse Event|0
680865|NCT01642212|2207642|P5|Double-blind Treatment|Adverse Event|0
680866|NCT01642212|2207643|P4|Double-blind Treatment|Adverse Event|0
680867|NCT01642212|2207644|P3|Double-blind Treatment|Adverse Event|1
680868|NCT01642212|2207645|P2|Double-blind Treatment|Adverse Event|0
680869|NCT01642212|2207646|P1|Double-blind Treatment|Adverse Event|0
680870|NCT01642212|2207642|P5|Double-blind Treatment|Non-compliance|0
680871|NCT01642212|2207643|P4|Double-blind Treatment|Non-compliance|0
680872|NCT01642212|2207644|P3|Double-blind Treatment|Non-compliance|0
680873|NCT01642212|2207645|P2|Double-blind Treatment|Non-compliance|1
680874|NCT01642212|2207646|P1|Double-blind Treatment|Non-compliance|0
680875|NCT01642212|2207642|P5|Double-blind Treatment|Not Specified|0
680876|NCT01642212|2207643|P4|Double-blind Treatment|Not Specified|0
680877|NCT01642212|2207644|P3|Double-blind Treatment|Not Specified|1
680878|NCT01642212|2207645|P2|Double-blind Treatment|Not Specified|2
680879|NCT01642212|2207646|P1|Double-blind Treatment|Not Specified|0
680880|NCT01642212|2207642|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
680881|NCT01642212|2207643|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
680882|NCT01642212|2207644|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
680883|NCT01642212|2207645|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
680884|NCT01642212|2207646|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
680885|NCT01642004|2207735|P2|Treatment|Missing from data|1
680886|NCT01642004|2207736|P1|Treatment|Missing from data|0
680887|NCT01642004|2207735|P2|Treatment|Unspecified|2
680888|NCT01642004|2207736|P1|Treatment|Unspecified|1
680889|NCT01642004|2207735|P2|Treatment|No longer meets study criteria|2
680890|NCT01642004|2207736|P1|Treatment|No longer meets study criteria|1
680891|NCT01642004|2207735|P2|Treatment|Poor/non-compliance|0
680892|NCT01642004|2207736|P1|Treatment|Poor/non-compliance|1
680893|NCT01642004|2207735|P2|Treatment|Maximum clinical benefit|7
680894|NCT01642004|2207736|P1|Treatment|Maximum clinical benefit|2
680895|NCT01642004|2207735|P2|Treatment|Withdrawal by Subject|9
680896|NCT01642004|2207736|P1|Treatment|Withdrawal by Subject|5
680897|NCT01642004|2207735|P2|Treatment|Adverse event unrelated to study drug|13
680898|NCT01642004|2207736|P1|Treatment|Adverse event unrelated to study drug|6
680899|NCT01642004|2207735|P2|Treatment|Death|0
680900|NCT01642004|2207736|P1|Treatment|Death|1
680901|NCT01642004|2207735|P2|Treatment|Study drug toxicity|13
680902|NCT01642004|2207736|P1|Treatment|Study drug toxicity|5
680903|NCT01642004|2207735|P2|Treatment|Disease progression|80
680904|NCT01642004|2207736|P1|Treatment|Disease progression|88
680905|NCT01642004|2207735|P2|Randomization|No longer meets study criteria|2
680906|NCT01642004|2207736|P1|Randomization|No longer meets study criteria|2
680907|NCT01642004|2207735|P2|Randomization|Withdrawal by Subject|6
680908|NCT01642004|2207736|P1|Randomization|Withdrawal by Subject|1
680909|NCT01642004|2207735|P2|Randomization|Adverse Event unrelated to study drug|0
680910|NCT01642004|2207736|P1|Randomization|Adverse Event unrelated to study drug|1
680911|NCT01641991|2207770|P4|Overall Study|no longer eligible|4
680912|NCT01641991|2207771|P3|Overall Study|no longer eligible|0
680913|NCT01641991|2207772|P2|Overall Study|no longer eligible|1
680914|NCT01641991|2207773|P1|Overall Study|no longer eligible|2
680915|NCT01641991|2207770|P4|Overall Study|Pregnancy|0
680916|NCT01641991|2207771|P3|Overall Study|Pregnancy|1
680917|NCT01641991|2207772|P2|Overall Study|Pregnancy|0
680918|NCT01641991|2207773|P1|Overall Study|Pregnancy|0
680919|NCT01641991|2207770|P4|Overall Study|Protocol Violation|0
680920|NCT01641991|2207771|P3|Overall Study|Protocol Violation|3
680921|NCT01641991|2207772|P2|Overall Study|Protocol Violation|1
680922|NCT01641991|2207773|P1|Overall Study|Protocol Violation|1
680923|NCT01641991|2207770|P4|Overall Study|Lost to Follow-up|1
680924|NCT01641991|2207771|P3|Overall Study|Lost to Follow-up|3
680925|NCT01641991|2207772|P2|Overall Study|Lost to Follow-up|2
680926|NCT01641991|2207773|P1|Overall Study|Lost to Follow-up|0
680927|NCT01641991|2207770|P4|Overall Study|Adverse Event|1
680928|NCT01641991|2207771|P3|Overall Study|Adverse Event|2
680929|NCT01641991|2207772|P2|Overall Study|Adverse Event|1
680930|NCT01641991|2207773|P1|Overall Study|Adverse Event|2
680931|NCT01641991|2207770|P4|Overall Study|Withdrawal by Subject|5
680932|NCT01641991|2207771|P3|Overall Study|Withdrawal by Subject|1
680933|NCT01641991|2207772|P2|Overall Study|Withdrawal by Subject|2
680934|NCT01641991|2207773|P1|Overall Study|Withdrawal by Subject|4
680935|NCT01641991|2207770|P4|Overall Study|Physician Decision|5
680936|NCT01641991|2207771|P3|Overall Study|Physician Decision|7
680937|NCT01641991|2207772|P2|Overall Study|Physician Decision|1
680938|NCT01641991|2207773|P1|Overall Study|Physician Decision|0
680939|NCT01641952|2207857|P1|Overall Study|Adverse Event|6
680940|NCT01641952|2207857|P1|Overall Study|Lost to Follow-up|28
680941|NCT01641939|2207873|P3|Overall Study|Study Terminated by Sponsor|3
680942|NCT01641939|2207874|P2|Overall Study|Study Terminated by Sponsor|28
680943|NCT01641939|2207875|P1|Overall Study|Study Terminated by Sponsor|10
680944|NCT01641939|2207873|P3|Overall Study|Withdrawal by Subject|5
680945|NCT01641939|2207874|P2|Overall Study|Withdrawal by Subject|11
680946|NCT01641939|2207875|P1|Overall Study|Withdrawal by Subject|14
680947|NCT01641939|2207873|P3|Overall Study|Lost to Follow-up|1
680948|NCT01641939|2207874|P2|Overall Study|Lost to Follow-up|2
680949|NCT01641939|2207875|P1|Overall Study|Lost to Follow-up|3
680950|NCT01641939|2207873|P3|Overall Study|Death|61
680951|NCT01641939|2207874|P2|Overall Study|Death|187
680952|NCT01641939|2207875|P1|Overall Study|Death|90
680953|NCT01641926|2207918|P4|Overall Study|Not Treated|0
680954|NCT01641926|2207919|P3|Overall Study|Not Treated|1
680955|NCT01641926|2207920|P2|Overall Study|Not Treated|1
680956|NCT01641926|2207921|P1|Overall Study|Not Treated|1
680957|NCT01641926|2207918|P4|Overall Study|Withdrawal by Subject|1
680958|NCT01641926|2207919|P3|Overall Study|Withdrawal by Subject|6
680959|NCT01641926|2207920|P2|Overall Study|Withdrawal by Subject|5
680960|NCT01641926|2207921|P1|Overall Study|Withdrawal by Subject|13
680961|NCT01641926|2207918|P4|Overall Study|Protocol Violation|1
680962|NCT01641926|2207919|P3|Overall Study|Protocol Violation|0
680963|NCT01641926|2207920|P2|Overall Study|Protocol Violation|0
680964|NCT01641926|2207921|P1|Overall Study|Protocol Violation|1
680965|NCT01641926|2207918|P4|Overall Study|Physician Decision|1
680966|NCT01641926|2207919|P3|Overall Study|Physician Decision|0
680967|NCT01641926|2207920|P2|Overall Study|Physician Decision|5
680968|NCT01641926|2207921|P1|Overall Study|Physician Decision|6
680969|NCT01641926|2207918|P4|Overall Study|Lost to Follow-up|0
680970|NCT01641926|2207919|P3|Overall Study|Lost to Follow-up|1
680971|NCT01641926|2207920|P2|Overall Study|Lost to Follow-up|2
680972|NCT01641926|2207921|P1|Overall Study|Lost to Follow-up|2
680973|NCT01641926|2207918|P4|Overall Study|Adverse Event|1
680974|NCT01641926|2207919|P3|Overall Study|Adverse Event|3
680975|NCT01641926|2207920|P2|Overall Study|Adverse Event|2
680976|NCT01641926|2207921|P1|Overall Study|Adverse Event|5
680977|NCT01641900|2207949|P2|Overall Study|Withdrawal by Subject|2
680978|NCT01641900|2207950|P1|Overall Study|Withdrawal by Subject|2
680979|NCT01641861|2207962|P2|Overall Study|Died due to drowning|1
680980|NCT01641861|2207963|P1|Overall Study|Died due to drowning|0
680981|NCT01641861|2207962|P2|Overall Study|Lost the tooth due to normal exfoliation|8
680982|NCT01641861|2207963|P1|Overall Study|Lost the tooth due to normal exfoliation|14
680983|NCT01641861|2207962|P2|Overall Study|Lost to Follow-up|16
680984|NCT01641861|2207963|P1|Overall Study|Lost to Follow-up|21
680985|NCT01641822|2207984|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
680986|NCT01641822|2207985|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
680987|NCT01641822|2207986|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
680988|NCT01641822|2207984|P3|Comparative Phase|Withdrew consent|7
680989|NCT01641822|2207985|P2|Comparative Phase|Withdrew consent|3
680990|NCT01641822|2207986|P1|Comparative Phase|Withdrew consent|0
680991|NCT01641822|2207984|P3|Comparative Phase|Adverse event, serious fatal|0
680992|NCT01641822|2207985|P2|Comparative Phase|Adverse event, serious fatal|1
680993|NCT01641822|2207986|P1|Comparative Phase|Adverse event, serious fatal|0
680994|NCT01641822|2207984|P3|Comparative Phase|Pregnancy|1
680995|NCT01641822|2207985|P2|Comparative Phase|Pregnancy|0
680996|NCT01641822|2207986|P1|Comparative Phase|Pregnancy|0
680997|NCT01641822|2207984|P3|Comparative Phase|Investigator's discretion|1
680998|NCT01641822|2207985|P2|Comparative Phase|Investigator's discretion|0
680999|NCT01641822|2207986|P1|Comparative Phase|Investigator's discretion|0
681000|NCT01641822|2207984|P3|Comparative Phase|Noncompliance with study drug|0
681001|NCT01641822|2207985|P2|Comparative Phase|Noncompliance with study drug|1
681002|NCT01641822|2207986|P1|Comparative Phase|Noncompliance with study drug|0
681003|NCT01641822|2207984|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
681004|NCT01641822|2207985|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
681005|NCT01641822|2207986|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
681006|NCT01641822|2207984|P3|Run-in Phase|Withdrew consent|0
681007|NCT01641822|2207985|P2|Run-in Phase|Withdrew consent|0
681008|NCT01641822|2207986|P1|Run-in Phase|Withdrew consent|1
681009|NCT01641822|2207984|P3|Run-in Phase|Adverse Event|0
681010|NCT01641822|2207985|P2|Run-in Phase|Adverse Event|0
681011|NCT01641822|2207986|P1|Run-in Phase|Adverse Event|3
681012|NCT01641822|2207984|P3|Run-in Phase|Noncompliance with study drug|0
681013|NCT01641822|2207985|P2|Run-in Phase|Noncompliance with study drug|0
681014|NCT01641822|2207986|P1|Run-in Phase|Noncompliance with study drug|1
681015|NCT01641692|2208003|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
681016|NCT01641692|2208004|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
681017|NCT01641692|2208005|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
681018|NCT01641692|2208006|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
681019|NCT01641692|2208007|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
681020|NCT01641692|2208008|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
681021|NCT01641692|2208009|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
681022|NCT01641692|2208010|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
681023|NCT01641692|2208003|P8|Washout Period 3 or Follow-up|Protocol Violation|0
681024|NCT01641692|2208004|P7|Washout Period 3 or Follow-up|Protocol Violation|0
681025|NCT01641692|2208005|P6|Washout Period 3 or Follow-up|Protocol Violation|1
681026|NCT01641692|2208006|P5|Washout Period 3 or Follow-up|Protocol Violation|0
681027|NCT01641692|2208007|P4|Washout Period 3 or Follow-up|Protocol Violation|0
681028|NCT01641692|2208008|P3|Washout Period 3 or Follow-up|Protocol Violation|0
681029|NCT01641692|2208009|P2|Washout Period 3 or Follow-up|Protocol Violation|0
681030|NCT01641692|2208010|P1|Washout Period 3 or Follow-up|Protocol Violation|0
681031|NCT01641692|2208003|P8|Treatment Period 3|Lost to Follow-up|0
681032|NCT01641692|2208004|P7|Treatment Period 3|Lost to Follow-up|0
681033|NCT01641692|2208005|P6|Treatment Period 3|Lost to Follow-up|0
681034|NCT01641692|2208006|P5|Treatment Period 3|Lost to Follow-up|0
681035|NCT01641692|2208007|P4|Treatment Period 3|Lost to Follow-up|0
681036|NCT01641692|2208008|P3|Treatment Period 3|Lost to Follow-up|0
681037|NCT01641692|2208009|P2|Treatment Period 3|Lost to Follow-up|1
681038|NCT01641692|2208010|P1|Treatment Period 3|Lost to Follow-up|0
681039|NCT01641692|2208003|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
681040|NCT01641692|2208004|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
681041|NCT01641692|2208005|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
681042|NCT01641692|2208006|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
681043|NCT01641692|2208007|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
681044|NCT01641692|2208008|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
681045|NCT01641692|2208009|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
681046|NCT01641692|2208010|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
681047|NCT01641692|2208003|P8|Treatment Period 3|Protocol Violation|0
681048|NCT01641692|2208004|P7|Treatment Period 3|Protocol Violation|0
681049|NCT01641692|2208005|P6|Treatment Period 3|Protocol Violation|0
681050|NCT01641692|2208006|P5|Treatment Period 3|Protocol Violation|0
681051|NCT01641692|2208007|P4|Treatment Period 3|Protocol Violation|0
681052|NCT01641692|2208008|P3|Treatment Period 3|Protocol Violation|1
681053|NCT01641692|2208009|P2|Treatment Period 3|Protocol Violation|0
681054|NCT01641692|2208010|P1|Treatment Period 3|Protocol Violation|0
681055|NCT01641692|2208003|P8|Treatment Period 3|Adverse Event|0
681056|NCT01641692|2208004|P7|Treatment Period 3|Adverse Event|1
681057|NCT01641692|2208005|P6|Treatment Period 3|Adverse Event|0
681058|NCT01641692|2208006|P5|Treatment Period 3|Adverse Event|0
681059|NCT01641692|2208007|P4|Treatment Period 3|Adverse Event|0
681060|NCT01641692|2208008|P3|Treatment Period 3|Adverse Event|0
681061|NCT01641692|2208009|P2|Treatment Period 3|Adverse Event|0
681062|NCT01641692|2208010|P1|Treatment Period 3|Adverse Event|0
681063|NCT01641692|2208003|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
681064|NCT01641692|2208004|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
681065|NCT01641692|2208005|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
681066|NCT01641692|2208006|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
681067|NCT01641692|2208007|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
681068|NCT01641692|2208008|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
681069|NCT01641692|2208009|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
681070|NCT01641692|2208010|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
681071|NCT01641692|2208003|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681072|NCT01641692|2208004|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
681073|NCT01641692|2208005|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681074|NCT01641692|2208006|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
681075|NCT01641692|2208007|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681076|NCT01641692|2208008|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681077|NCT01641692|2208009|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681078|NCT01641692|2208010|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
681079|NCT01641692|2208003|P8|Treatment Period 2|Withdrawal by Subject|1
681080|NCT01641692|2208004|P7|Treatment Period 2|Withdrawal by Subject|0
681081|NCT01641692|2208005|P6|Treatment Period 2|Withdrawal by Subject|1
681082|NCT01641692|2208006|P5|Treatment Period 2|Withdrawal by Subject|0
681083|NCT01641692|2208007|P4|Treatment Period 2|Withdrawal by Subject|0
681084|NCT01641692|2208008|P3|Treatment Period 2|Withdrawal by Subject|0
681085|NCT01641692|2208009|P2|Treatment Period 2|Withdrawal by Subject|0
681086|NCT01641692|2208010|P1|Treatment Period 2|Withdrawal by Subject|1
681087|NCT01641692|2208003|P8|Treatment Period 2|Lost to Follow-up|0
681088|NCT01641692|2208004|P7|Treatment Period 2|Lost to Follow-up|0
681089|NCT01641692|2208005|P6|Treatment Period 2|Lost to Follow-up|1
681090|NCT01641692|2208006|P5|Treatment Period 2|Lost to Follow-up|0
681091|NCT01641692|2208007|P4|Treatment Period 2|Lost to Follow-up|0
681092|NCT01641692|2208008|P3|Treatment Period 2|Lost to Follow-up|0
681093|NCT01641692|2208009|P2|Treatment Period 2|Lost to Follow-up|0
681094|NCT01641692|2208010|P1|Treatment Period 2|Lost to Follow-up|0
681095|NCT01641692|2208003|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
681096|NCT01641692|2208004|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
681097|NCT01641692|2208005|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
681098|NCT01641692|2208006|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
681099|NCT01641692|2208007|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
681100|NCT01641692|2208008|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
681101|NCT01641692|2208009|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
681102|NCT01641692|2208010|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
681103|NCT01641692|2208003|P8|Treatment Period 2|Lack of Efficacy|0
681104|NCT01641692|2208004|P7|Treatment Period 2|Lack of Efficacy|0
681105|NCT01641692|2208005|P6|Treatment Period 2|Lack of Efficacy|0
681106|NCT01641692|2208006|P5|Treatment Period 2|Lack of Efficacy|0
681107|NCT01641692|2208007|P4|Treatment Period 2|Lack of Efficacy|0
681108|NCT01641692|2208008|P3|Treatment Period 2|Lack of Efficacy|0
681109|NCT01641692|2208009|P2|Treatment Period 2|Lack of Efficacy|0
681110|NCT01641692|2208010|P1|Treatment Period 2|Lack of Efficacy|1
681111|NCT01641692|2208003|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
681112|NCT01641692|2208004|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
681113|NCT01641692|2208005|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
681114|NCT01641692|2208006|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
681115|NCT01641692|2208007|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
681116|NCT01641692|2208008|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
681117|NCT01641692|2208009|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
681118|NCT01641692|2208010|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
681119|NCT01641692|2208003|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
681120|NCT01641692|2208004|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
681121|NCT01641692|2208005|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
681122|NCT01641692|2208006|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
681123|NCT01641692|2208007|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
681124|NCT01641692|2208008|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
681125|NCT01641692|2208009|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
681126|NCT01641692|2208010|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
681127|NCT01641692|2208003|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
681128|NCT01641692|2208004|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
681129|NCT01641692|2208005|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
681130|NCT01641692|2208006|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
681131|NCT01641692|2208007|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
681132|NCT01641692|2208008|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
681133|NCT01641692|2208009|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
681134|NCT01641692|2208010|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
681135|NCT01641692|2208003|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
681136|NCT01641692|2208004|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
681137|NCT01641692|2208005|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
681138|NCT01641692|2208006|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
681139|NCT01641692|2208007|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
681140|NCT01641692|2208008|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
681141|NCT01641692|2208009|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
681142|NCT01641692|2208010|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
681143|NCT01641692|2208003|P8|Treatment Period 1|Withdrawal by Subject|1
681144|NCT01641692|2208004|P7|Treatment Period 1|Withdrawal by Subject|0
681145|NCT01641692|2208005|P6|Treatment Period 1|Withdrawal by Subject|2
681146|NCT01641692|2208006|P5|Treatment Period 1|Withdrawal by Subject|0
681147|NCT01641692|2208007|P4|Treatment Period 1|Withdrawal by Subject|0
681148|NCT01641692|2208008|P3|Treatment Period 1|Withdrawal by Subject|0
681149|NCT01641692|2208009|P2|Treatment Period 1|Withdrawal by Subject|0
681150|NCT01641692|2208010|P1|Treatment Period 1|Withdrawal by Subject|0
681151|NCT01641692|2208003|P8|Treatment Period 1|Physician Decision|0
681152|NCT01641692|2208004|P7|Treatment Period 1|Physician Decision|0
681153|NCT01641692|2208005|P6|Treatment Period 1|Physician Decision|0
681154|NCT01641692|2208006|P5|Treatment Period 1|Physician Decision|1
681155|NCT01641692|2208007|P4|Treatment Period 1|Physician Decision|0
681156|NCT01641692|2208008|P3|Treatment Period 1|Physician Decision|0
681157|NCT01641692|2208009|P2|Treatment Period 1|Physician Decision|0
681158|NCT01641692|2208010|P1|Treatment Period 1|Physician Decision|0
681159|NCT01641692|2208003|P8|Treatment Period 1|Lost to Follow-up|0
681160|NCT01641692|2208004|P7|Treatment Period 1|Lost to Follow-up|0
681161|NCT01641692|2208005|P6|Treatment Period 1|Lost to Follow-up|0
681162|NCT01641692|2208006|P5|Treatment Period 1|Lost to Follow-up|0
681163|NCT01641692|2208007|P4|Treatment Period 1|Lost to Follow-up|0
681164|NCT01641692|2208008|P3|Treatment Period 1|Lost to Follow-up|1
681165|NCT01641692|2208009|P2|Treatment Period 1|Lost to Follow-up|0
681166|NCT01641692|2208010|P1|Treatment Period 1|Lost to Follow-up|0
681167|NCT01641692|2208003|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
681168|NCT01641692|2208004|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
681169|NCT01641692|2208005|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
681170|NCT01641692|2208006|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
681171|NCT01641692|2208007|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
681172|NCT01641692|2208008|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
681173|NCT01641692|2208009|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
681174|NCT01641692|2208010|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
681175|NCT01641692|2208003|P8|Treatment Period 1|Protocol Violation|0
681176|NCT01641692|2208004|P7|Treatment Period 1|Protocol Violation|0
681177|NCT01641692|2208005|P6|Treatment Period 1|Protocol Violation|0
681178|NCT01641692|2208006|P5|Treatment Period 1|Protocol Violation|2
681179|NCT01641692|2208007|P4|Treatment Period 1|Protocol Violation|0
681180|NCT01641692|2208008|P3|Treatment Period 1|Protocol Violation|0
681181|NCT01641692|2208009|P2|Treatment Period 1|Protocol Violation|0
681182|NCT01641692|2208010|P1|Treatment Period 1|Protocol Violation|1
681183|NCT01641692|2208003|P8|Treatment Period 1|Lack of Efficacy|1
681184|NCT01641692|2208004|P7|Treatment Period 1|Lack of Efficacy|0
681185|NCT01641692|2208005|P6|Treatment Period 1|Lack of Efficacy|0
681186|NCT01641692|2208006|P5|Treatment Period 1|Lack of Efficacy|0
681187|NCT01641692|2208007|P4|Treatment Period 1|Lack of Efficacy|0
681188|NCT01641692|2208008|P3|Treatment Period 1|Lack of Efficacy|0
681189|NCT01641692|2208009|P2|Treatment Period 1|Lack of Efficacy|0
681190|NCT01641692|2208010|P1|Treatment Period 1|Lack of Efficacy|0
681191|NCT01641692|2208003|P8|Treatment Period 1|Adverse Event|0
681192|NCT01641692|2208004|P7|Treatment Period 1|Adverse Event|0
681193|NCT01641692|2208005|P6|Treatment Period 1|Adverse Event|0
681194|NCT01641692|2208006|P5|Treatment Period 1|Adverse Event|0
681195|NCT01641692|2208007|P4|Treatment Period 1|Adverse Event|0
681196|NCT01641692|2208008|P3|Treatment Period 1|Adverse Event|0
681197|NCT01641692|2208009|P2|Treatment Period 1|Adverse Event|0
681198|NCT01641692|2208010|P1|Treatment Period 1|Adverse Event|1
681199|NCT01641640|2208210|P1|Overall Study|Adverse Event|1
681200|NCT01641640|2208210|P1|Overall Study|Withdrawal by Subject|2
681201|NCT01641640|2208210|P1|Overall Study|Lost to Follow-up|3
681202|NCT01641640|2208210|P1|Overall Study|Efficacy failure|29
681203|NCT01641640|2208210|P1|Overall Study|Enrolled but not treated|1
889059|NCT01611259|2823118|P1|Overall Study|Physician Decision|1
681210|NCT01641237|2208228|P4|Period III|Lost to Follow-up|0
681211|NCT01641237|2208229|P3|Period III|Lost to Follow-up|0
681212|NCT01641237|2208230|P2|Period III|Lost to Follow-up|0
681213|NCT01641237|2208231|P1|Period III|Lost to Follow-up|1
681214|NCT01641237|2208228|P4|Period II|Withdrawal by Subject|0
681215|NCT01641237|2208229|P3|Period II|Withdrawal by Subject|0
681216|NCT01641237|2208230|P2|Period II|Withdrawal by Subject|0
681217|NCT01641237|2208231|P1|Period II|Withdrawal by Subject|1
681218|NCT01641159|2208255|P2|Overall Study|Withdrawal by Subject|1
681219|NCT01641159|2208256|P1|Overall Study|Withdrawal by Subject|0
681220|NCT01641159|2208255|P2|Overall Study|Lost to Follow-up|1
681221|NCT01641159|2208256|P1|Overall Study|Lost to Follow-up|2
681222|NCT01641133|2208267|P3|Overall Study|Lost to Follow-up|2
681223|NCT01641133|2208268|P2|Overall Study|Lost to Follow-up|2
681224|NCT01641133|2208269|P1|Overall Study|Lost to Follow-up|0
681225|NCT01641133|2208267|P3|Overall Study|Withdrawal by Subject|3
681226|NCT01641133|2208268|P2|Overall Study|Withdrawal by Subject|3
681227|NCT01641133|2208269|P1|Overall Study|Withdrawal by Subject|5
681228|NCT01641133|2208267|P3|Overall Study|Adverse Event|1
681229|NCT01641133|2208268|P2|Overall Study|Adverse Event|0
681230|NCT01641133|2208269|P1|Overall Study|Adverse Event|0
681231|NCT01641133|2208267|P3|Overall Study|Migrated/moved from study area|1
681232|NCT01641133|2208268|P2|Overall Study|Migrated/moved from study area|3
681233|NCT01641133|2208269|P1|Overall Study|Migrated/moved from study area|5
681234|NCT01641133|2208267|P3|Overall Study|Protocol Violation|1
681235|NCT01641133|2208268|P2|Overall Study|Protocol Violation|1
681236|NCT01641133|2208269|P1|Overall Study|Protocol Violation|0
681237|NCT01641081|2208319|P10|Period 5|Adverse Event|0
681238|NCT01641081|2208320|P9|Period 5|Adverse Event|0
681239|NCT01641081|2208321|P8|Period 5|Adverse Event|0
681240|NCT01641081|2208322|P7|Period 5|Adverse Event|0
681241|NCT01641081|2208323|P6|Period 5|Adverse Event|0
681242|NCT01641081|2208324|P5|Period 5|Adverse Event|0
681243|NCT01641081|2208325|P4|Period 5|Adverse Event|0
681244|NCT01641081|2208326|P3|Period 5|Adverse Event|2
681245|NCT01641081|2208327|P2|Period 5|Adverse Event|0
681246|NCT01641081|2208328|P1|Period 5|Adverse Event|0
681247|NCT01641081|2208319|P10|Period 4|Adverse Event|0
681248|NCT01641081|2208320|P9|Period 4|Adverse Event|0
681249|NCT01641081|2208321|P8|Period 4|Adverse Event|0
681250|NCT01641081|2208322|P7|Period 4|Adverse Event|0
681251|NCT01641081|2208323|P6|Period 4|Adverse Event|0
681252|NCT01641081|2208324|P5|Period 4|Adverse Event|0
681253|NCT01641081|2208325|P4|Period 4|Adverse Event|1
681254|NCT01641081|2208326|P3|Period 4|Adverse Event|0
681255|NCT01641081|2208327|P2|Period 4|Adverse Event|1
681256|NCT01641081|2208328|P1|Period 4|Adverse Event|0
681257|NCT01641081|2208319|P10|Period 3|Withdrawal by Subject|0
681258|NCT01641081|2208320|P9|Period 3|Withdrawal by Subject|1
681259|NCT01641081|2208321|P8|Period 3|Withdrawal by Subject|0
681260|NCT01641081|2208322|P7|Period 3|Withdrawal by Subject|0
681261|NCT01641081|2208323|P6|Period 3|Withdrawal by Subject|0
681262|NCT01641081|2208324|P5|Period 3|Withdrawal by Subject|0
681263|NCT01641081|2208325|P4|Period 3|Withdrawal by Subject|0
681264|NCT01641081|2208326|P3|Period 3|Withdrawal by Subject|0
681265|NCT01641081|2208327|P2|Period 3|Withdrawal by Subject|0
681266|NCT01641081|2208328|P1|Period 3|Withdrawal by Subject|0
681267|NCT01641081|2208319|P10|Period 3|Adverse Event|0
681268|NCT01641081|2208320|P9|Period 3|Adverse Event|0
681269|NCT01641081|2208321|P8|Period 3|Adverse Event|0
681270|NCT01641081|2208322|P7|Period 3|Adverse Event|0
681271|NCT01641081|2208323|P6|Period 3|Adverse Event|0
681272|NCT01641081|2208324|P5|Period 3|Adverse Event|0
681273|NCT01641081|2208325|P4|Period 3|Adverse Event|0
681274|NCT01641081|2208326|P3|Period 3|Adverse Event|1
681275|NCT01641081|2208327|P2|Period 3|Adverse Event|0
681276|NCT01641081|2208328|P1|Period 3|Adverse Event|0
681277|NCT01641081|2208319|P10|Period 2|Protocol Violation|0
681278|NCT01641081|2208320|P9|Period 2|Protocol Violation|0
681279|NCT01641081|2208321|P8|Period 2|Protocol Violation|0
681280|NCT01641081|2208322|P7|Period 2|Protocol Violation|0
681281|NCT01641081|2208323|P6|Period 2|Protocol Violation|0
681282|NCT01641081|2208324|P5|Period 2|Protocol Violation|0
681283|NCT01641081|2208325|P4|Period 2|Protocol Violation|0
681284|NCT01641081|2208326|P3|Period 2|Protocol Violation|0
681285|NCT01641081|2208327|P2|Period 2|Protocol Violation|0
681286|NCT01641081|2208328|P1|Period 2|Protocol Violation|1
681287|NCT01641081|2208319|P10|Period 2|Withdrawal by Subject|0
681288|NCT01641081|2208320|P9|Period 2|Withdrawal by Subject|0
681289|NCT01641081|2208321|P8|Period 2|Withdrawal by Subject|0
681290|NCT01641081|2208322|P7|Period 2|Withdrawal by Subject|2
681291|NCT01641081|2208323|P6|Period 2|Withdrawal by Subject|0
681292|NCT01641081|2208324|P5|Period 2|Withdrawal by Subject|0
681293|NCT01641081|2208325|P4|Period 2|Withdrawal by Subject|1
681294|NCT01641081|2208326|P3|Period 2|Withdrawal by Subject|0
681295|NCT01641081|2208327|P2|Period 2|Withdrawal by Subject|0
681296|NCT01641081|2208328|P1|Period 2|Withdrawal by Subject|0
681297|NCT01641081|2208319|P10|Period 2|Adverse Event|0
681298|NCT01641081|2208320|P9|Period 2|Adverse Event|0
681299|NCT01641081|2208321|P8|Period 2|Adverse Event|0
681300|NCT01641081|2208322|P7|Period 2|Adverse Event|0
681301|NCT01641081|2208323|P6|Period 2|Adverse Event|1
681302|NCT01641081|2208324|P5|Period 2|Adverse Event|0
681303|NCT01641081|2208325|P4|Period 2|Adverse Event|0
681304|NCT01641081|2208326|P3|Period 2|Adverse Event|0
681305|NCT01641081|2208327|P2|Period 2|Adverse Event|0
681306|NCT01641081|2208328|P1|Period 2|Adverse Event|0
681307|NCT01641081|2208319|P10|Period 1|Adverse Event|0
681308|NCT01641081|2208320|P9|Period 1|Adverse Event|0
681309|NCT01641081|2208321|P8|Period 1|Adverse Event|2
681310|NCT01641081|2208322|P7|Period 1|Adverse Event|0
681311|NCT01641081|2208323|P6|Period 1|Adverse Event|0
681312|NCT01641081|2208324|P5|Period 1|Adverse Event|0
681313|NCT01641081|2208325|P4|Period 1|Adverse Event|0
681314|NCT01641081|2208326|P3|Period 1|Adverse Event|0
681315|NCT01641081|2208327|P2|Period 1|Adverse Event|0
681316|NCT01641081|2208328|P1|Period 1|Adverse Event|1
681317|NCT01641081|2208319|P10|Period 1|Protocol Violation|0
681318|NCT01641081|2208320|P9|Period 1|Protocol Violation|0
681319|NCT01641081|2208321|P8|Period 1|Protocol Violation|1
681320|NCT01641081|2208322|P7|Period 1|Protocol Violation|0
681321|NCT01641081|2208323|P6|Period 1|Protocol Violation|0
681322|NCT01641081|2208324|P5|Period 1|Protocol Violation|1
681323|NCT01641081|2208325|P4|Period 1|Protocol Violation|0
681324|NCT01641081|2208326|P3|Period 1|Protocol Violation|0
681325|NCT01641081|2208327|P2|Period 1|Protocol Violation|0
681326|NCT01641081|2208328|P1|Period 1|Protocol Violation|0
681327|NCT01641081|2208319|P10|Period 1|Sponsor request (potential unblinding)|0
681328|NCT01641081|2208320|P9|Period 1|Sponsor request (potential unblinding)|0
681329|NCT01641081|2208321|P8|Period 1|Sponsor request (potential unblinding)|0
681330|NCT01641081|2208322|P7|Period 1|Sponsor request (potential unblinding)|1
681331|NCT01641081|2208323|P6|Period 1|Sponsor request (potential unblinding)|0
681332|NCT01641081|2208324|P5|Period 1|Sponsor request (potential unblinding)|0
681333|NCT01641081|2208325|P4|Period 1|Sponsor request (potential unblinding)|0
681334|NCT01641081|2208326|P3|Period 1|Sponsor request (potential unblinding)|0
681335|NCT01641081|2208327|P2|Period 1|Sponsor request (potential unblinding)|0
681336|NCT01641081|2208328|P1|Period 1|Sponsor request (potential unblinding)|0
681337|NCT01640964|2208348|P3|Overall Study|Protocol Deviation|2
681338|NCT01640964|2208349|P2|Overall Study|Protocol Deviation|1
681339|NCT01640964|2208350|P1|Overall Study|Protocol Deviation|1
681340|NCT01640964|2208348|P3|Overall Study|Lost to Follow-up|1
681341|NCT01640964|2208349|P2|Overall Study|Lost to Follow-up|0
681342|NCT01640964|2208350|P1|Overall Study|Lost to Follow-up|0
681343|NCT01640925|2208367|P2|Overall Study|Previously enrolled in this trial|11
681344|NCT01640925|2208368|P1|Overall Study|Previously enrolled in this trial|13
681345|NCT01640925|2208367|P2|Overall Study|Withdrawal by Subject|0
681346|NCT01640925|2208368|P1|Overall Study|Withdrawal by Subject|1
681347|NCT01640353|2208388|P1|Overall Study|Physician Decision|1
681348|NCT01640353|2208388|P1|Overall Study|Lost to Follow-up|12
681349|NCT01640353|2208388|P1|Overall Study|Early site termination|3
681350|NCT01640353|2208388|P1|Overall Study|Death|2
681351|NCT01640353|2208388|P1|Overall Study|Withdrawal by Subject|5
681352|NCT01640353|2208388|P1|Overall Study|Withdrawn from analysis at term site|12
681353|NCT01640353|2208388|P1|Overall Study|Withdrew prior to treatment|10
681354|NCT01640314|2208436|P2|Overall Study|Protocol Violation|1
681355|NCT01640314|2208437|P1|Overall Study|Protocol Violation|0
681356|NCT01640184|2208475|P3|Overall Study|Protocol Violation|1
681357|NCT01640184|2208476|P2|Overall Study|Protocol Violation|0
681358|NCT01640184|2208477|P1|Overall Study|Protocol Violation|0
681359|NCT01640184|2208475|P3|Overall Study|Withdrawal by Subject|1
681360|NCT01640184|2208476|P2|Overall Study|Withdrawal by Subject|1
681361|NCT01640184|2208477|P1|Overall Study|Withdrawal by Subject|0
681362|NCT01640184|2208475|P3|Overall Study|Physician Decision|0
681363|NCT01640184|2208476|P2|Overall Study|Physician Decision|0
681364|NCT01640184|2208477|P1|Overall Study|Physician Decision|3
681365|NCT01640184|2208475|P3|Overall Study|Lost to Follow-up|0
681366|NCT01640184|2208476|P2|Overall Study|Lost to Follow-up|1
681367|NCT01640184|2208477|P1|Overall Study|Lost to Follow-up|4
681368|NCT01640184|2208475|P3|Overall Study|Death|0
681369|NCT01640184|2208476|P2|Overall Study|Death|0
681370|NCT01640184|2208477|P1|Overall Study|Death|1
681371|NCT01640054|2208506|P1|Overall Study|Adverse Event|2
681372|NCT01640054|2208506|P1|Overall Study|Lack of Efficacy|3
681373|NCT01640054|2208506|P1|Overall Study|Study-specific disc criteria|1
681374|NCT01639833|2208516|P2|Overall Study|Withdrawal by Subject|2
681375|NCT01639833|2208517|P1|Overall Study|Withdrawal by Subject|2
681376|NCT01639833|2208516|P2|Overall Study|Death|2
681377|NCT01639833|2208517|P1|Overall Study|Death|4
681382|NCT01639729|2208541|P6|Overall Study|Withdrawal by Subject|0
681383|NCT01639729|2208542|P5|Overall Study|Withdrawal by Subject|0
681384|NCT01639729|2208543|P4|Overall Study|Withdrawal by Subject|1
681385|NCT01639729|2208544|P3|Overall Study|Withdrawal by Subject|1
681386|NCT01639729|2208545|P2|Overall Study|Withdrawal by Subject|0
681387|NCT01639729|2208546|P1|Overall Study|Withdrawal by Subject|1
681388|NCT01639703|2208568|P1|Overall Study|Other reason|7
681389|NCT01639703|2208568|P1|Overall Study|Withdrawal by Subject|5
681390|NCT01639560|2208611|P2|Overall Study|Adverse Event|2
681391|NCT01639560|2208612|P1|Overall Study|Adverse Event|0
681392|NCT01639560|2208611|P2|Overall Study|Lost to Follow-up|11
681393|NCT01639560|2208612|P1|Overall Study|Lost to Follow-up|9
681394|NCT01639560|2208611|P2|Overall Study|Lack of Efficacy|2
681395|NCT01639560|2208612|P1|Overall Study|Lack of Efficacy|1
681396|NCT01639560|2208611|P2|Overall Study|Withdrawal by Subject|14
681397|NCT01639560|2208612|P1|Overall Study|Withdrawal by Subject|9
681398|NCT01639469|2208626|P2|Overall Study|Lost to Follow-up|1
681399|NCT01639469|2208627|P1|Overall Study|Lost to Follow-up|1
681400|NCT01639469|2208626|P2|Overall Study|Death|2
681401|NCT01639469|2208627|P1|Overall Study|Death|4
681402|NCT01639144|2208732|P2|Overall Study|Met postoperative exclusion criteria|3
681403|NCT01639144|2208733|P1|Overall Study|Met postoperative exclusion criteria|4
681404|NCT01639144|2208732|P2|Overall Study|Physician Decision|0
681405|NCT01639144|2208733|P1|Overall Study|Physician Decision|2
681406|NCT01639144|2208732|P2|Overall Study|Withdrawal by Subject|2
681407|NCT01639144|2208733|P1|Overall Study|Withdrawal by Subject|4
681418|NCT01638000|2208828|P2|Overall Study|Miscellaneous|2
681419|NCT01638000|2208829|P1|Overall Study|Miscellaneous|2
681420|NCT01638000|2208828|P2|Overall Study|Withdrawal by Subject|24
681421|NCT01638000|2208829|P1|Overall Study|Withdrawal by Subject|21
681422|NCT01638000|2208828|P2|Overall Study|Protocol Violation|13
681423|NCT01638000|2208829|P1|Overall Study|Protocol Violation|11
681424|NCT01638000|2208828|P2|Overall Study|Lack of Efficacy|6
681425|NCT01638000|2208829|P1|Overall Study|Lack of Efficacy|5
681426|NCT01638000|2208828|P2|Overall Study|Adverse Event|16
681427|NCT01638000|2208829|P1|Overall Study|Adverse Event|14
681428|NCT01638000|2208828|P2|Overall Study|Randomized but Never Received Drug|10
681429|NCT01638000|2208829|P1|Overall Study|Randomized but Never Received Drug|7
681432|NCT01637922|2208952|P2|Overall Study|Lost to Follow-up|0
681433|NCT01637922|2208953|P1|Overall Study|Lost to Follow-up|2
681434|NCT01637922|2208952|P2|Overall Study|Withdrawal by Subject|3
681435|NCT01637922|2208953|P1|Overall Study|Withdrawal by Subject|0
681436|NCT01637922|2208952|P2|Overall Study|Protocol Violation|1
681437|NCT01637922|2208953|P1|Overall Study|Protocol Violation|0
681438|NCT01637922|2208952|P2|Overall Study|Adverse Event|1
681439|NCT01637922|2208953|P1|Overall Study|Adverse Event|0
681440|NCT01637584|2208978|P2|Overall Study|Withdrawal by Subject|3
681441|NCT01637584|2208979|P1|Overall Study|Withdrawal by Subject|1
681442|NCT01637272|2208986|P1|Overall Study|Protocol Violation|2
681443|NCT01637272|2208986|P1|Overall Study|Administrative problems|1
681444|NCT01637272|2208986|P1|Overall Study|completed core, did not enter ext. phase|4
681445|NCT01637272|2208986|P1|Overall Study|Lost to Follow-up|2
681446|NCT01637272|2208986|P1|Overall Study|Withdrawal by Subject|3
681447|NCT01637272|2208986|P1|Overall Study|Unsatisfactory therapeutic effect|2
681448|NCT01637272|2208986|P1|Overall Study|Adverse Event|6
681449|NCT01636986|2209066|P2|Overall Study|Corneal Staining|1
681450|NCT01636986|2209067|P1|Overall Study|Corneal Staining|0
681451|NCT01636986|2209066|P2|Overall Study|Withdrawal by Subject|1
681452|NCT01636986|2209067|P1|Overall Study|Withdrawal by Subject|0
681453|NCT01636960|2209073|P1|Maintenance Phase|Progressive disease|1
681454|NCT01636960|2209073|P1|Maintenance Phase|Adverse Event|3
681455|NCT01636960|2209073|P1|Maintenance Phase|Continued drug after regulatory approval|3
681456|NCT01636960|2209073|P1|Induction Phase|Adverse Event|2
681457|NCT01636947|2209081|P2|Overall Study|Did Not Meet Eligibility Criteria|4
681458|NCT01636947|2209082|P1|Overall Study|Did Not Meet Eligibility Criteria|1
681459|NCT01636947|2209081|P2|Overall Study|Adverse Event|1
681460|NCT01636947|2209082|P1|Overall Study|Adverse Event|1
681461|NCT01636947|2209081|P2|Overall Study|Withdrawal by Subject|3
681462|NCT01636947|2209082|P1|Overall Study|Withdrawal by Subject|3
681463|NCT01636947|2209081|P2|Overall Study|Protocol Violation|1
681464|NCT01636947|2209082|P1|Overall Study|Protocol Violation|1
681465|NCT01636947|2209081|P2|Overall Study|Lost to Follow-up|0
681466|NCT01636947|2209082|P1|Overall Study|Lost to Follow-up|4
681467|NCT01636947|2209081|P2|Overall Study|Not Treated|2
681468|NCT01636947|2209082|P1|Overall Study|Not Treated|2
681469|NCT01636778|2209102|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
681470|NCT01636778|2209103|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
681471|NCT01636778|2209104|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
681472|NCT01636778|2209102|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
681473|NCT01636778|2209103|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
681474|NCT01636778|2209104|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
681475|NCT01636778|2209102|P3|Follow-up Period After Part 2|Other|1
681476|NCT01636778|2209103|P2|Follow-up Period After Part 2|Other|0
681477|NCT01636778|2209104|P1|Follow-up Period After Part 2|Other|0
681478|NCT01636778|2209102|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
681479|NCT01636778|2209103|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
681480|NCT01636778|2209104|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
681481|NCT01636778|2209102|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
681482|NCT01636778|2209103|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
681483|NCT01636778|2209104|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
681484|NCT01636778|2209102|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
681485|NCT01636778|2209103|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
681486|NCT01636778|2209104|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
681487|NCT01636778|2209102|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
681488|NCT01636778|2209103|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
681489|NCT01636778|2209104|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
681490|NCT01636778|2209102|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
681491|NCT01636778|2209103|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
681492|NCT01636778|2209104|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
681493|NCT01636713|2209175|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
681494|NCT01636713|2209176|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
681495|NCT01636713|2209177|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
681496|NCT01636713|2209175|P3|Overall Study|Withdrawal by Subject|8
681497|NCT01636713|2209176|P2|Overall Study|Withdrawal by Subject|4
681498|NCT01636713|2209177|P1|Overall Study|Withdrawal by Subject|5
681499|NCT01636713|2209175|P3|Overall Study|Lost to Follow-up|1
681500|NCT01636713|2209176|P2|Overall Study|Lost to Follow-up|0
681501|NCT01636713|2209177|P1|Overall Study|Lost to Follow-up|0
681502|NCT01636713|2209175|P3|Overall Study|Protocol Violation|1
681503|NCT01636713|2209176|P2|Overall Study|Protocol Violation|0
681504|NCT01636713|2209177|P1|Overall Study|Protocol Violation|3
681505|NCT01636713|2209175|P3|Overall Study|Lack of Efficacy|2
681506|NCT01636713|2209176|P2|Overall Study|Lack of Efficacy|6
681507|NCT01636713|2209177|P1|Overall Study|Lack of Efficacy|6
681508|NCT01636713|2209175|P3|Overall Study|Adverse Event|7
681509|NCT01636713|2209176|P2|Overall Study|Adverse Event|16
681510|NCT01636713|2209177|P1|Overall Study|Adverse Event|16
681511|NCT01636362|2209227|P1|Overall Study|Withdrawal by Subject|1
681512|NCT01636362|2209227|P1|Overall Study|Subject healed, not returning|1
681513|NCT01636362|2209227|P1|Overall Study|Physician Decision|6
681514|NCT01636258|2209235|P2|Overall Study|Lost to Follow-up|0
681515|NCT01636258|2209236|P1|Overall Study|Lost to Follow-up|1
681516|NCT01636076|2209276|P2|Overall Study|Withdrawal by Subject|10
681517|NCT01636076|2209277|P1|Overall Study|Withdrawal by Subject|7
681518|NCT01636076|2209276|P2|Overall Study|Adverse Event|11
681519|NCT01636076|2209277|P1|Overall Study|Adverse Event|6
681520|NCT01636076|2209276|P2|Overall Study|Non-compliance with study treatment|1
681521|NCT01636076|2209277|P1|Overall Study|Non-compliance with study treatment|1
681522|NCT01636076|2209276|P2|Overall Study|Physician Decision|1
681523|NCT01636076|2209277|P1|Overall Study|Physician Decision|1
681524|NCT01636076|2209276|P2|Overall Study|Lost to Follow-up|0
681525|NCT01636076|2209277|P1|Overall Study|Lost to Follow-up|1
681526|NCT01636076|2209276|P2|Overall Study|Lack of Efficacy|1
681527|NCT01636076|2209277|P1|Overall Study|Lack of Efficacy|0
681528|NCT01636076|2209276|P2|Overall Study|Terminated by sponsor|1
681529|NCT01636076|2209277|P1|Overall Study|Terminated by sponsor|1
681530|NCT01635933|2209348|P2|Overall Study|No longer had transportation|1
681531|NCT01635933|2209349|P1|Overall Study|No longer had transportation|0
681532|NCT01635933|2209348|P2|Overall Study|Noncompliance|1
681533|NCT01635933|2209349|P1|Overall Study|Noncompliance|0
681534|NCT01635933|2209348|P2|Overall Study|Subject decision|1
681535|NCT01635933|2209349|P1|Overall Study|Subject decision|1
681536|NCT01635933|2209348|P2|Overall Study|Lost to Follow-up|5
681537|NCT01635933|2209349|P1|Overall Study|Lost to Follow-up|0
681538|NCT01635933|2209348|P2|Overall Study|Adverse Event|0
681539|NCT01635933|2209349|P1|Overall Study|Adverse Event|1
681540|NCT01635920|2209361|P2|Overall Study|Subject decision|0
681541|NCT01635920|2209362|P1|Overall Study|Subject decision|2
681542|NCT01635920|2209361|P2|Overall Study|Lost to Follow-up|1
681543|NCT01635920|2209362|P1|Overall Study|Lost to Follow-up|0
681544|NCT01635920|2209361|P2|Overall Study|Adverse Event|0
681545|NCT01635920|2209362|P1|Overall Study|Adverse Event|1
681546|NCT01635855|2209375|P1|Overall Study|Withdrawal by Subject|4
681547|NCT01635764|2209384|P1|Overall Study|Not Specified|28
681548|NCT01635764|2209384|P1|Overall Study|Lost to Follow-up|53
681549|NCT01635764|2209384|P1|Overall Study|Withdrew Consent|67
681550|NCT01635764|2209384|P1|Overall Study|Protocol Deviation|1
681551|NCT01635764|2209384|P1|Overall Study|Exceed Protocol-specified Interventions|2
681552|NCT01635764|2209384|P1|Overall Study|Lack of Efficacy|76
681553|NCT01635764|2209384|P1|Overall Study|Adverse Event|46
681554|NCT01635218|2209450|P3|Overall Study|Lost to Follow-up|6
681555|NCT01635218|2209451|P2|Overall Study|Lost to Follow-up|7
681556|NCT01635218|2209452|P1|Overall Study|Lost to Follow-up|3
681557|NCT01634854|2209487|P2|Overall Study|Cesarean delivery|7
681558|NCT01634854|2209488|P1|Overall Study|Cesarean delivery|2
681559|NCT01634659|2209508|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
681560|NCT01634659|2209509|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
681561|NCT01634659|2209508|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
681562|NCT01634659|2209509|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
681563|NCT01634555|2209539|P1|Overall Study|Ongoing receiving treatment|13
681564|NCT01634555|2209539|P1|Overall Study|Physician Decision|1
681565|NCT01634555|2209539|P1|Overall Study|Adverse Event|3
681566|NCT01634360|2209549|P2|Overall Study|Study termination by sponsor|44
681567|NCT01634360|2209550|P1|Overall Study|Study termination by sponsor|18
681568|NCT01634360|2209549|P2|Overall Study|Not specified|20
681569|NCT01634360|2209550|P1|Overall Study|Not specified|3
681570|NCT01634360|2209549|P2|Overall Study|Lack of Efficacy|14
681571|NCT01634360|2209550|P1|Overall Study|Lack of Efficacy|4
681572|NCT01634360|2209549|P2|Overall Study|Protocol Violation|1
681573|NCT01634360|2209550|P1|Overall Study|Protocol Violation|1
681574|NCT01634360|2209549|P2|Overall Study|subject withdrew consent|23
681575|NCT01634360|2209550|P1|Overall Study|subject withdrew consent|13
681576|NCT01634360|2209549|P2|Overall Study|Adverse Event|34
681577|NCT01634360|2209550|P1|Overall Study|Adverse Event|10
681578|NCT01634243|2209579|P2|Overall Study|Lack of Efficacy|0
681579|NCT01634243|2209580|P1|Overall Study|Lack of Efficacy|1
681580|NCT01634243|2209579|P2|Overall Study|Adverse Event|5
681581|NCT01634243|2209580|P1|Overall Study|Adverse Event|5
681582|NCT01634165|2209606|P4|Period 2|Adverse Event|0
681583|NCT01634165|2209607|P3|Period 2|Adverse Event|0
681584|NCT01634165|2209608|P2|Period 2|Adverse Event|1
681585|NCT01634165|2209609|P1|Period 2|Adverse Event|0
681586|NCT01634152|2209642|P3|Overall Study|Other reason not defined above|1
681587|NCT01634152|2209643|P2|Overall Study|Other reason not defined above|0
681588|NCT01634152|2209644|P1|Overall Study|Other reason not defined above|1
681589|NCT01634152|2209642|P3|Overall Study|Not treated|0
681590|NCT01634152|2209643|P2|Overall Study|Not treated|1
681591|NCT01634152|2209644|P1|Overall Study|Not treated|0
681592|NCT01634152|2209642|P3|Overall Study|Consent withdrawn not due to AE|1
681593|NCT01634152|2209643|P2|Overall Study|Consent withdrawn not due to AE|0
681594|NCT01634152|2209644|P1|Overall Study|Consent withdrawn not due to AE|1
681595|NCT01634152|2209642|P3|Overall Study|Adverse Event|2
681596|NCT01634152|2209643|P2|Overall Study|Adverse Event|0
681597|NCT01634152|2209644|P1|Overall Study|Adverse Event|2
681598|NCT01634139|2209727|P3|Overall Study|Not treated|0
681599|NCT01634139|2209728|P2|Overall Study|Not treated|1
681600|NCT01634139|2209729|P1|Overall Study|Not treated|1
681601|NCT01634139|2209727|P3|Overall Study|Lost to Follow-up|0
681602|NCT01634139|2209728|P2|Overall Study|Lost to Follow-up|2
681603|NCT01634139|2209729|P1|Overall Study|Lost to Follow-up|0
681604|NCT01634139|2209727|P3|Overall Study|Other|3
681605|NCT01634139|2209728|P2|Overall Study|Other|0
681606|NCT01634139|2209729|P1|Overall Study|Other|4
681607|NCT01634139|2209727|P3|Overall Study|Consent withdrawn not due to AE|2
681608|NCT01634139|2209728|P2|Overall Study|Consent withdrawn not due to AE|3
681609|NCT01634139|2209729|P1|Overall Study|Consent withdrawn not due to AE|4
681610|NCT01634139|2209727|P3|Overall Study|Non compliant with protocol|0
681611|NCT01634139|2209728|P2|Overall Study|Non compliant with protocol|0
681612|NCT01634139|2209729|P1|Overall Study|Non compliant with protocol|1
681613|NCT01634113|2209830|P3|Overall Study|Not treated|1
681614|NCT01634113|2209831|P2|Overall Study|Not treated|0
681615|NCT01634113|2209832|P1|Overall Study|Not treated|0
681616|NCT01634100|2209876|P6|Overall Study|Withdrawal by Subject|0
681617|NCT01634100|2209877|P5|Overall Study|Withdrawal by Subject|0
681618|NCT01634100|2209878|P4|Overall Study|Withdrawal by Subject|0
681619|NCT01634100|2209879|P3|Overall Study|Withdrawal by Subject|1
681620|NCT01634100|2209880|P2|Overall Study|Withdrawal by Subject|0
681621|NCT01634100|2209881|P1|Overall Study|Withdrawal by Subject|1
681622|NCT01633944|2209897|P3|Double-blind Treatment Phase|Not specified|0
681623|NCT01633944|2209898|P2|Double-blind Treatment Phase|Not specified|7
681624|NCT01633944|2209899|P1|Double-blind Treatment Phase|Not specified|0
681625|NCT01633944|2209897|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
681626|NCT01633944|2209898|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
681627|NCT01633944|2209899|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
681628|NCT01633944|2209897|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
681629|NCT01633944|2209898|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
681630|NCT01633944|2209899|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
681631|NCT01633944|2209897|P3|Double-blind Treatment Phase|Lost to Follow-up|9
681632|NCT01633944|2209898|P2|Double-blind Treatment Phase|Lost to Follow-up|4
681633|NCT01633944|2209899|P1|Double-blind Treatment Phase|Lost to Follow-up|0
681634|NCT01633944|2209897|P3|Double-blind Treatment Phase|Protocol Violation|10
681635|NCT01633944|2209898|P2|Double-blind Treatment Phase|Protocol Violation|7
681636|NCT01633944|2209899|P1|Double-blind Treatment Phase|Protocol Violation|0
681637|NCT01633944|2209897|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
681638|NCT01633944|2209898|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
681639|NCT01633944|2209899|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
681640|NCT01633944|2209897|P3|Double-blind Treatment Phase|Lack of Efficacy|23
681641|NCT01633944|2209898|P2|Double-blind Treatment Phase|Lack of Efficacy|8
681642|NCT01633944|2209899|P1|Double-blind Treatment Phase|Lack of Efficacy|0
681643|NCT01633944|2209897|P3|Double-blind Treatment Phase|Adverse Event|7
681644|NCT01633944|2209898|P2|Double-blind Treatment Phase|Adverse Event|13
681645|NCT01633944|2209899|P1|Double-blind Treatment Phase|Adverse Event|0
681646|NCT01633944|2209897|P3|Open-label Titration Phase|Not specified|0
681647|NCT01633944|2209898|P2|Open-label Titration Phase|Not specified|0
681648|NCT01633944|2209899|P1|Open-label Titration Phase|Not specified|68
681649|NCT01633944|2209897|P3|Open-label Titration Phase|Lost to Follow-up|0
681650|NCT01633944|2209898|P2|Open-label Titration Phase|Lost to Follow-up|0
681651|NCT01633944|2209899|P1|Open-label Titration Phase|Lost to Follow-up|22
681652|NCT01633944|2209897|P3|Open-label Titration Phase|Protocol Violation|0
681653|NCT01633944|2209898|P2|Open-label Titration Phase|Protocol Violation|0
681654|NCT01633944|2209899|P1|Open-label Titration Phase|Protocol Violation|24
681655|NCT01633944|2209897|P3|Open-label Titration Phase|Withdrawal by Subject|0
681656|NCT01633944|2209898|P2|Open-label Titration Phase|Withdrawal by Subject|0
681657|NCT01633944|2209899|P1|Open-label Titration Phase|Withdrawal by Subject|34
681658|NCT01633944|2209897|P3|Open-label Titration Phase|Lack of Efficacy|0
681659|NCT01633944|2209898|P2|Open-label Titration Phase|Lack of Efficacy|0
681660|NCT01633944|2209899|P1|Open-label Titration Phase|Lack of Efficacy|33
681661|NCT01633944|2209897|P3|Open-label Titration Phase|Adverse Event|0
681662|NCT01633944|2209898|P2|Open-label Titration Phase|Adverse Event|0
681663|NCT01633944|2209899|P1|Open-label Titration Phase|Adverse Event|109
681664|NCT01633788|2209967|P4|Overall Study|Other Reasons|7
681665|NCT01633788|2209968|P3|Overall Study|Other Reasons|3
681666|NCT01633788|2209969|P2|Overall Study|Other Reasons|2
681667|NCT01633788|2209970|P1|Overall Study|Other Reasons|0
681668|NCT01633788|2209967|P4|Overall Study|Protocol Violation|0
681669|NCT01633788|2209968|P3|Overall Study|Protocol Violation|1
681670|NCT01633788|2209969|P2|Overall Study|Protocol Violation|0
681671|NCT01633788|2209970|P1|Overall Study|Protocol Violation|1
681672|NCT01633788|2209967|P4|Overall Study|Personal Reasons|3
681673|NCT01633788|2209968|P3|Overall Study|Personal Reasons|1
681674|NCT01633788|2209969|P2|Overall Study|Personal Reasons|1
681675|NCT01633788|2209970|P1|Overall Study|Personal Reasons|3
681676|NCT01633788|2209967|P4|Overall Study|Lost to Follow-up|0
681677|NCT01633788|2209968|P3|Overall Study|Lost to Follow-up|2
681678|NCT01633788|2209969|P2|Overall Study|Lost to Follow-up|2
681679|NCT01633788|2209970|P1|Overall Study|Lost to Follow-up|2
681680|NCT01633788|2209967|P4|Overall Study|Adverse Event|3
681681|NCT01633788|2209968|P3|Overall Study|Adverse Event|3
681682|NCT01633788|2209969|P2|Overall Study|Adverse Event|3
681683|NCT01633788|2209970|P1|Overall Study|Adverse Event|1
681694|NCT01632878|2210025|P1|Treatment|no information on study completion|43
681695|NCT01632878|2210025|P1|Treatment|missing information|4
681696|NCT01632878|2210025|P1|Treatment|Physician Decision|34
681697|NCT01632878|2210025|P1|Treatment|Withdrawal by Subject|36
681698|NCT01632878|2210025|P1|Treatment|Lost to Follow-up|41
681699|NCT01632878|2210025|P1|Screening|Physician Decision|268
681700|NCT01632800|2210029|P1|Overall Study|Subject did not fit in apparatus|1
681701|NCT01632150|2210109|P1|Overall Study|Moved to compassionate program|2
681702|NCT01632150|2210109|P1|Overall Study|Patient underwent autologous transplant|1
681703|NCT01632150|2210109|P1|Overall Study|Withdrawal by Subject|2
681704|NCT01632150|2210109|P1|Overall Study|Unrelated adverse event|7
681705|NCT01632150|2210109|P1|Overall Study|Study drug toxicity|1
681706|NCT01632150|2210109|P1|Overall Study|Disease progression|27
681707|NCT01632020|2210118|P2|Overall Study|Adverse Event|0
681708|NCT01632020|2210119|P1|Overall Study|Adverse Event|1
681709|NCT01632020|2210118|P2|Overall Study|Withdrawal by Subject|0
681710|NCT01632020|2210119|P1|Overall Study|Withdrawal by Subject|1
681711|NCT01631864|2210138|P2|Overall Study|Adverse Event|3
681712|NCT01631864|2210139|P1|Overall Study|Adverse Event|2
681713|NCT01631864|2210138|P2|Overall Study|Withdrawal by Subject|1
681714|NCT01631864|2210139|P1|Overall Study|Withdrawal by Subject|0
681715|NCT01631825|2210151|P1|Overall Study|Physician Decision|2
681716|NCT01631825|2210151|P1|Overall Study|Discontinuation criteria|1
681717|NCT01631825|2210151|P1|Overall Study|Protocol Violation|4
681718|NCT01631825|2210151|P1|Overall Study|Withdrawal by Subject|9
681719|NCT01631825|2210151|P1|Overall Study|Lack of Efficacy|7
681720|NCT01631825|2210151|P1|Overall Study|Adverse Event|42
681721|NCT01631812|2210171|P1|Overall Study|Physician Decision|3
681722|NCT01631812|2210171|P1|Overall Study|Withdrawal by Subject|4
681723|NCT01631812|2210171|P1|Overall Study|Lack of Efficacy|5
681724|NCT01631812|2210171|P1|Overall Study|Adverse Event|25
681725|NCT01631435|2210309|P1|Overall Study|incomplete study procedure|5
681726|NCT01631435|2210309|P1|Overall Study|Withdrawal by Subject|2
681727|NCT01631435|2210309|P1|Overall Study|Adverse Event|2
681728|NCT01631227|2210323|P2|Overall Study|administrative|1
681729|NCT01631227|2210324|P1|Overall Study|administrative|2
681730|NCT01631227|2210323|P2|Overall Study|Adverse Event|0
681731|NCT01631227|2210324|P1|Overall Study|Adverse Event|1
681732|NCT01631227|2210323|P2|Overall Study|withdrawn consent|21
681733|NCT01631227|2210324|P1|Overall Study|withdrawn consent|27
681734|NCT01630135|2210390|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
681735|NCT01630135|2210391|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
681736|NCT01629823|2210455|P3|Washout Period|Protocol Violation|0
681737|NCT01629823|2210456|P2|Washout Period|Protocol Violation|1
681738|NCT01629823|2210457|P1|Washout Period|Protocol Violation|0
681739|NCT01629823|2210455|P3|Washout Period|Pregnancy|0
681740|NCT01629823|2210456|P2|Washout Period|Pregnancy|0
681741|NCT01629823|2210457|P1|Washout Period|Pregnancy|1
681742|NCT01629823|2210455|P3|Washout Period|Safety|0
681743|NCT01629823|2210456|P2|Washout Period|Safety|5
681744|NCT01629823|2210457|P1|Washout Period|Safety|2
681745|NCT01629823|2210455|P3|Trial Period|Failed to hold medication|1
681746|NCT01629823|2210456|P2|Trial Period|Failed to hold medication|0
681747|NCT01629823|2210457|P1|Trial Period|Failed to hold medication|0
681748|NCT01629823|2210455|P3|Trial Period|Out-of-window visit|0
681749|NCT01629823|2210456|P2|Trial Period|Out-of-window visit|2
681750|NCT01629823|2210457|P1|Trial Period|Out-of-window visit|0
681751|NCT01629823|2210455|P3|Trial Period|Adverse Event|0
681752|NCT01629823|2210456|P2|Trial Period|Adverse Event|1
681753|NCT01629823|2210457|P1|Trial Period|Adverse Event|0
681754|NCT01629823|2210455|P3|Trial Period|Pregnancy|0
681755|NCT01629823|2210456|P2|Trial Period|Pregnancy|0
681756|NCT01629823|2210457|P1|Trial Period|Pregnancy|1
681757|NCT01629823|2210455|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
681758|NCT01629823|2210456|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
681759|NCT01629823|2210457|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
681760|NCT01629823|2210455|P3|Trial Period|Missed visit|8
681761|NCT01629823|2210456|P2|Trial Period|Missed visit|9
681762|NCT01629823|2210457|P1|Trial Period|Missed visit|11
681763|NCT01629706|2210492|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
681764|NCT01629706|2210492|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
681765|NCT01629706|2210492|P1|Phase 2 Habitual|Relocation prior to Dispense|1
681766|NCT01629706|2210492|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
681767|NCT01629706|2210492|P1|Phase 2 Habitual|Screen Failure|6
681768|NCT01629706|2210492|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
681769|NCT01629706|2210492|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
681770|NCT01629706|2210492|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
681771|NCT01629706|2210492|P1|Phase 1 PureVision|Screen Failure|4
681772|NCT01629693|2210520|P2|Overall Study|Subject decision unrelated to AE|1
681773|NCT01629693|2210521|P1|Overall Study|Subject decision unrelated to AE|0
681774|NCT01629693|2210520|P2|Overall Study|Poor comfort of study lenses|2
681775|NCT01629693|2210521|P1|Overall Study|Poor comfort of study lenses|0
681776|NCT01629693|2210520|P2|Overall Study|Investigator decision|1
681777|NCT01629693|2210521|P1|Overall Study|Investigator decision|0
681778|NCT01629693|2210520|P2|Overall Study|Adverse Event|0
681779|NCT01629693|2210521|P1|Overall Study|Adverse Event|1
681780|NCT01629693|2210520|P2|Overall Study|Withdrawal by Subject|2
681781|NCT01629693|2210521|P1|Overall Study|Withdrawal by Subject|2
681782|NCT01629693|2210520|P2|Overall Study|Lost to Follow-up|4
681783|NCT01629693|2210521|P1|Overall Study|Lost to Follow-up|2
681784|NCT01629667|2210530|P3|Overall Study|Code break|0
681785|NCT01629667|2210531|P2|Overall Study|Code break|0
681786|NCT01629667|2210532|P1|Overall Study|Code break|1
681787|NCT01629667|2210530|P3|Overall Study|Enrolled in another clinical study|0
681788|NCT01629667|2210531|P2|Overall Study|Enrolled in another clinical study|1
681789|NCT01629667|2210532|P1|Overall Study|Enrolled in another clinical study|0
681790|NCT01629667|2210530|P3|Overall Study|Site error in safety follow-up|1
681791|NCT01629667|2210531|P2|Overall Study|Site error in safety follow-up|0
681792|NCT01629667|2210532|P1|Overall Study|Site error in safety follow-up|0
681793|NCT01629667|2210530|P3|Overall Study|Started other medicine|1
681794|NCT01629667|2210531|P2|Overall Study|Started other medicine|0
681795|NCT01629667|2210532|P1|Overall Study|Started other medicine|1
681796|NCT01629667|2210530|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
681797|NCT01629667|2210531|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
681798|NCT01629667|2210532|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
681799|NCT01629667|2210530|P3|Overall Study|Requiring lung transplant|3
681800|NCT01629667|2210531|P2|Overall Study|Requiring lung transplant|1
681801|NCT01629667|2210532|P1|Overall Study|Requiring lung transplant|2
681802|NCT01629667|2210530|P3|Overall Study|Ongoing AE worsening right heart failure|0
681803|NCT01629667|2210531|P2|Overall Study|Ongoing AE worsening right heart failure|1
681804|NCT01629667|2210532|P1|Overall Study|Ongoing AE worsening right heart failure|0
681805|NCT01629667|2210530|P3|Overall Study|Randomized, not treated|0
681806|NCT01629667|2210531|P2|Overall Study|Randomized, not treated|1
681807|NCT01629667|2210532|P1|Overall Study|Randomized, not treated|2
681808|NCT01629667|2210530|P3|Overall Study|Death|3
681809|NCT01629667|2210531|P2|Overall Study|Death|5
681810|NCT01629667|2210532|P1|Overall Study|Death|1
681811|NCT01629667|2210530|P3|Overall Study|Withdrawal by Subject|28
681812|NCT01629667|2210531|P2|Overall Study|Withdrawal by Subject|20
681813|NCT01629667|2210532|P1|Overall Study|Withdrawal by Subject|31
681814|NCT01629667|2210530|P3|Overall Study|Lost to Follow-up|1
681815|NCT01629667|2210531|P2|Overall Study|Lost to Follow-up|1
681816|NCT01629667|2210532|P1|Overall Study|Lost to Follow-up|0
681817|NCT01629589|2210616|P2|Overall Study|Did not receive study vaccine|1
681818|NCT01629589|2210617|P1|Overall Study|Did not receive study vaccine|0
681819|NCT01629589|2210616|P2|Overall Study|Withdrawal by Subject|3
681820|NCT01629589|2210617|P1|Overall Study|Withdrawal by Subject|2
681821|NCT01629589|2210616|P2|Overall Study|Lost to Follow-up|1
681822|NCT01629589|2210617|P1|Overall Study|Lost to Follow-up|2
681823|NCT01629589|2210616|P2|Overall Study|Protocol Violation|2
681824|NCT01629589|2210617|P1|Overall Study|Protocol Violation|4
681825|NCT01628965|2210656|P1|Overall Study|Discontinuation criteria|8
681826|NCT01628965|2210656|P1|Overall Study|Lost to Follow-up|1
681827|NCT01628965|2210656|P1|Overall Study|Withdrawal by Subject|3
681828|NCT01628965|2210656|P1|Overall Study|Lack of Efficacy|7
681829|NCT01628965|2210656|P1|Overall Study|Adverse Event|30
681830|NCT01628926|2210665|P3|Overall Study|Physician Decision|1
681831|NCT01628926|2210666|P2|Overall Study|Physician Decision|2
681832|NCT01628926|2210667|P1|Overall Study|Physician Decision|2
681833|NCT01628926|2210665|P3|Overall Study|Discontinuation criteria|0
681834|NCT01628926|2210666|P2|Overall Study|Discontinuation criteria|4
681835|NCT01628926|2210667|P1|Overall Study|Discontinuation criteria|3
681836|NCT01628926|2210665|P3|Overall Study|Protocol Violation|0
681837|NCT01628926|2210666|P2|Overall Study|Protocol Violation|1
681838|NCT01628926|2210667|P1|Overall Study|Protocol Violation|0
681839|NCT01628926|2210665|P3|Overall Study|Withdrawal by Subject|2
681840|NCT01628926|2210666|P2|Overall Study|Withdrawal by Subject|4
681841|NCT01628926|2210667|P1|Overall Study|Withdrawal by Subject|6
681842|NCT01628926|2210665|P3|Overall Study|Lack of Efficacy|5
681843|NCT01628926|2210666|P2|Overall Study|Lack of Efficacy|1
681844|NCT01628926|2210667|P1|Overall Study|Lack of Efficacy|2
681845|NCT01628926|2210665|P3|Overall Study|Adverse Event|9
681846|NCT01628926|2210666|P2|Overall Study|Adverse Event|11
681847|NCT01628926|2210667|P1|Overall Study|Adverse Event|13
681848|NCT01628913|2210716|P2|Overall Study|Physician Decision|3
681849|NCT01628913|2210717|P1|Overall Study|Physician Decision|1
681850|NCT01628913|2210716|P2|Overall Study|Withdrawal by Subject|0
681851|NCT01628913|2210717|P1|Overall Study|Withdrawal by Subject|1
681852|NCT01628913|2210716|P2|Overall Study|study terminated by Sponsor|9
681853|NCT01628913|2210717|P1|Overall Study|study terminated by Sponsor|4
681854|NCT01628913|2210716|P2|Overall Study|Death|0
681855|NCT01628913|2210717|P1|Overall Study|Death|1
681856|NCT01628913|2210716|P2|Overall Study|Protocol Violation|0
681857|NCT01628913|2210717|P1|Overall Study|Protocol Violation|1
681858|NCT01628913|2210716|P2|Overall Study|Disease Progression|14
681859|NCT01628913|2210717|P1|Overall Study|Disease Progression|11
681860|NCT01628913|2210716|P2|Overall Study|Adverse Event|5
681861|NCT01628913|2210717|P1|Overall Study|Adverse Event|12
681862|NCT01628848|2210731|P2|Overall Study|Physician Decision|1
681863|NCT01628848|2210732|P1|Overall Study|Physician Decision|3
681864|NCT01628848|2210731|P2|Overall Study|Withdrawal by Subject|2
681865|NCT01628848|2210732|P1|Overall Study|Withdrawal by Subject|0
681866|NCT01628848|2210731|P2|Overall Study|Lack of Efficacy|4
681867|NCT01628848|2210732|P1|Overall Study|Lack of Efficacy|0
681868|NCT01628848|2210731|P2|Overall Study|Adverse Event|7
681869|NCT01628848|2210732|P1|Overall Study|Adverse Event|9
681870|NCT01628692|2210766|P6|Overall Study|Completed 12 Week only|1
681871|NCT01628692|2210767|P5|Overall Study|Completed 12 Week only|0
681872|NCT01628692|2210768|P4|Overall Study|Completed 12 Week only|0
681873|NCT01628692|2210769|P3|Overall Study|Completed 12 Week only|0
681874|NCT01628692|2210770|P2|Overall Study|Completed 12 Week only|0
681875|NCT01628692|2210771|P1|Overall Study|Completed 12 Week only|0
681876|NCT01628692|2210766|P6|Overall Study|Administrative reason by sponsor|1
681877|NCT01628692|2210767|P5|Overall Study|Administrative reason by sponsor|0
681878|NCT01628692|2210768|P4|Overall Study|Administrative reason by sponsor|0
681879|NCT01628692|2210769|P3|Overall Study|Administrative reason by sponsor|0
681880|NCT01628692|2210770|P2|Overall Study|Administrative reason by sponsor|0
681881|NCT01628692|2210771|P1|Overall Study|Administrative reason by sponsor|0
681882|NCT01628692|2210766|P6|Overall Study|Poor compliance/noncompliance|0
681883|NCT01628692|2210767|P5|Overall Study|Poor compliance/noncompliance|0
681884|NCT01628692|2210768|P4|Overall Study|Poor compliance/noncompliance|0
681885|NCT01628692|2210769|P3|Overall Study|Poor compliance/noncompliance|0
681886|NCT01628692|2210770|P2|Overall Study|Poor compliance/noncompliance|0
681887|NCT01628692|2210771|P1|Overall Study|Poor compliance/noncompliance|1
681888|NCT01628692|2210766|P6|Overall Study|Death|0
681889|NCT01628692|2210767|P5|Overall Study|Death|0
681890|NCT01628692|2210768|P4|Overall Study|Death|0
681891|NCT01628692|2210769|P3|Overall Study|Death|0
681892|NCT01628692|2210770|P2|Overall Study|Death|1
681893|NCT01628692|2210771|P1|Overall Study|Death|0
681894|NCT01628692|2210766|P6|Overall Study|Withdrawal by Subject|0
681895|NCT01628692|2210767|P5|Overall Study|Withdrawal by Subject|0
681896|NCT01628692|2210768|P4|Overall Study|Withdrawal by Subject|0
681897|NCT01628692|2210769|P3|Overall Study|Withdrawal by Subject|1
681898|NCT01628692|2210770|P2|Overall Study|Withdrawal by Subject|1
681899|NCT01628692|2210771|P1|Overall Study|Withdrawal by Subject|0
681900|NCT01628692|2210766|P6|Overall Study|Adverse Event|0
681901|NCT01628692|2210767|P5|Overall Study|Adverse Event|0
681902|NCT01628692|2210768|P4|Overall Study|Adverse Event|0
681903|NCT01628692|2210769|P3|Overall Study|Adverse Event|2
681904|NCT01628692|2210770|P2|Overall Study|Adverse Event|0
681905|NCT01628692|2210771|P1|Overall Study|Adverse Event|2
681906|NCT01628692|2210766|P6|Overall Study|Lack of Efficacy|7
681907|NCT01628692|2210767|P5|Overall Study|Lack of Efficacy|4
681908|NCT01628692|2210768|P4|Overall Study|Lack of Efficacy|1
681909|NCT01628692|2210769|P3|Overall Study|Lack of Efficacy|5
681910|NCT01628692|2210770|P2|Overall Study|Lack of Efficacy|4
681911|NCT01628692|2210771|P1|Overall Study|Lack of Efficacy|4
681912|NCT01628510|2210839|P2|Overall Study|Death|1
681913|NCT01628510|2210840|P1|Overall Study|Death|3
681914|NCT01628510|2210839|P2|Overall Study|Withdrawal by Subject|4
681915|NCT01628510|2210840|P1|Overall Study|Withdrawal by Subject|0
681916|NCT01628367|2210848|P2|Overall Study|Adverse Event|0
681917|NCT01628367|2210849|P1|Overall Study|Adverse Event|1
681918|NCT01627860|2210895|P2|Overall Study|Protocol Violation|0
681919|NCT01627860|2210896|P1|Overall Study|Protocol Violation|1
681920|NCT01627860|2210895|P2|Overall Study|Seizure frequency doubled|1
681921|NCT01627860|2210896|P1|Overall Study|Seizure frequency doubled|0
681922|NCT01627860|2210895|P2|Overall Study|Withdrawal by Subject|1
681923|NCT01627860|2210896|P1|Overall Study|Withdrawal by Subject|2
681924|NCT01627860|2210895|P2|Overall Study|Adverse Event|4
681925|NCT01627860|2210896|P1|Overall Study|Adverse Event|9
681926|NCT01627782|2210910|P4|Overall Study|Randomized But Not Treated|0
681927|NCT01627782|2210911|P3|Overall Study|Randomized But Not Treated|0
681928|NCT01627782|2210912|P2|Overall Study|Randomized But Not Treated|0
681929|NCT01627782|2210913|P1|Overall Study|Randomized But Not Treated|1
681930|NCT01627782|2210910|P4|Overall Study|Unspecified|3
681931|NCT01627782|2210911|P3|Overall Study|Unspecified|0
681932|NCT01627782|2210912|P2|Overall Study|Unspecified|2
681933|NCT01627782|2210913|P1|Overall Study|Unspecified|0
681934|NCT01627782|2210910|P4|Overall Study|Withdrawal by Subject|0
681935|NCT01627782|2210911|P3|Overall Study|Withdrawal by Subject|0
681936|NCT01627782|2210912|P2|Overall Study|Withdrawal by Subject|1
681937|NCT01627782|2210913|P1|Overall Study|Withdrawal by Subject|2
681938|NCT01627782|2210910|P4|Overall Study|Protocol Violation|0
681939|NCT01627782|2210911|P3|Overall Study|Protocol Violation|0
681940|NCT01627782|2210912|P2|Overall Study|Protocol Violation|0
681941|NCT01627782|2210913|P1|Overall Study|Protocol Violation|1
681942|NCT01627782|2210910|P4|Overall Study|Lack of Efficacy|2
681943|NCT01627782|2210911|P3|Overall Study|Lack of Efficacy|15
681944|NCT01627782|2210912|P2|Overall Study|Lack of Efficacy|1
681945|NCT01627782|2210913|P1|Overall Study|Lack of Efficacy|11
681946|NCT01627782|2210910|P4|Overall Study|Adverse Event|1
681947|NCT01627782|2210911|P3|Overall Study|Adverse Event|0
681948|NCT01627782|2210912|P2|Overall Study|Adverse Event|2
681949|NCT01627782|2210913|P1|Overall Study|Adverse Event|1
681950|NCT01627561|2210971|P2|Overall Study|Withdrawal by Subject|2
681951|NCT01627561|2210972|P1|Overall Study|Withdrawal by Subject|0
681952|NCT01627561|2210971|P2|Overall Study|Migrated/moved from study area|1
681953|NCT01627561|2210972|P1|Overall Study|Migrated/moved from study area|0
681954|NCT01627340|2211020|P2|Overall Study|Withdrawal by Subject|0
681955|NCT01627340|2211021|P1|Overall Study|Withdrawal by Subject|2
681956|NCT01627340|2211020|P2|Overall Study|Pregnancy|0
681957|NCT01627340|2211021|P1|Overall Study|Pregnancy|1
681958|NCT01627340|2211020|P2|Overall Study|Lost to Follow-up|4
681959|NCT01627340|2211021|P1|Overall Study|Lost to Follow-up|8
681960|NCT01627340|2211020|P2|Overall Study|Adverse Event|0
681961|NCT01627340|2211021|P1|Overall Study|Adverse Event|1
681976|NCT01627249|2211053|P3|Overall Study|Missed Visit|0
681977|NCT01627249|2211054|P2|Overall Study|Missed Visit|1
681978|NCT01627249|2211055|P1|Overall Study|Missed Visit|1
681979|NCT01627249|2211053|P3|Overall Study|Withdrawal by Subject|9
681980|NCT01627249|2211054|P2|Overall Study|Withdrawal by Subject|6
681981|NCT01627249|2211055|P1|Overall Study|Withdrawal by Subject|12
681982|NCT01627249|2211053|P3|Overall Study|Death|3
681983|NCT01627249|2211054|P2|Overall Study|Death|5
681984|NCT01627249|2211055|P1|Overall Study|Death|3
681985|NCT01626690|2211176|P2|Overall Study|Adverse Event|0
681986|NCT01626690|2211177|P1|Overall Study|Adverse Event|1
681987|NCT01626690|2211176|P2|Overall Study|Protocol Violation|0
681988|NCT01626690|2211177|P1|Overall Study|Protocol Violation|1
681989|NCT01626456|2211199|P2|Overall Study|Incarceration|2
681990|NCT01626456|2211200|P1|Overall Study|Incarceration|0
681991|NCT01626456|2211199|P2|Overall Study|Site Closure|3
681992|NCT01626456|2211200|P1|Overall Study|Site Closure|2
681993|NCT01626456|2211199|P2|Overall Study|Protocol Violation|1
681994|NCT01626456|2211200|P1|Overall Study|Protocol Violation|1
681995|NCT01626456|2211199|P2|Overall Study|Physician Decision|4
681996|NCT01626456|2211200|P1|Overall Study|Physician Decision|1
681997|NCT01626456|2211199|P2|Overall Study|Lack of Efficacy|7
681998|NCT01626456|2211200|P1|Overall Study|Lack of Efficacy|6
681999|NCT01626456|2211199|P2|Overall Study|Lost to Follow-up|27
682000|NCT01626456|2211200|P1|Overall Study|Lost to Follow-up|2
682001|NCT01626456|2211199|P2|Overall Study|Adverse Event|27
682002|NCT01626456|2211200|P1|Overall Study|Adverse Event|2
682003|NCT01626456|2211199|P2|Overall Study|Withdrawal by Subject|46
682004|NCT01626456|2211200|P1|Overall Study|Withdrawal by Subject|21
682005|NCT01626391|2211230|P2|Overall Study|Withdrawal by Subject|0
682006|NCT01626391|2211231|P1|Overall Study|Withdrawal by Subject|1
682007|NCT01626391|2211230|P2|Overall Study|Physician Decision|0
682008|NCT01626391|2211231|P1|Overall Study|Physician Decision|1
682009|NCT01626118|2211241|P4|Overall Study|Investigator Decision|0
682010|NCT01626118|2211242|P3|Overall Study|Investigator Decision|0
682011|NCT01626118|2211243|P2|Overall Study|Investigator Decision|1
682012|NCT01626118|2211244|P1|Overall Study|Investigator Decision|0
682013|NCT01626118|2211241|P4|Overall Study|Adverse Event|0
682014|NCT01626118|2211242|P3|Overall Study|Adverse Event|1
682015|NCT01626118|2211243|P2|Overall Study|Adverse Event|1
682016|NCT01626118|2211244|P1|Overall Study|Adverse Event|0
682017|NCT01626118|2211241|P4|Overall Study|Lost to Follow-up|0
682018|NCT01626118|2211242|P3|Overall Study|Lost to Follow-up|0
682019|NCT01626118|2211243|P2|Overall Study|Lost to Follow-up|0
682020|NCT01626118|2211244|P1|Overall Study|Lost to Follow-up|1
682021|NCT01626118|2211241|P4|Overall Study|Lack of Efficacy|3
682022|NCT01626118|2211242|P3|Overall Study|Lack of Efficacy|1
682023|NCT01626118|2211243|P2|Overall Study|Lack of Efficacy|0
682024|NCT01626118|2211244|P1|Overall Study|Lack of Efficacy|1
682025|NCT01625910|2211290|P2|Overall Study|Lost to Follow-up|4
682026|NCT01625910|2211291|P1|Overall Study|Lost to Follow-up|3
682027|NCT01625845|2211301|P2|Overall Study|Withdrawal by Subject|0
682028|NCT01625845|2211302|P1|Overall Study|Withdrawal by Subject|2
682029|NCT01625845|2211301|P2|Overall Study|Lost to Follow-up|1
682030|NCT01625845|2211302|P1|Overall Study|Lost to Follow-up|2
682031|NCT01625845|2211301|P2|Overall Study|Adverse Event|2
682032|NCT01625845|2211302|P1|Overall Study|Adverse Event|1
682033|NCT01625689|2211322|P2|Overall Study|Migration|1
682034|NCT01625689|2211323|P1|Overall Study|Migration|2
682035|NCT01625377|2211359|P2|Overall Study|Abnormal laboratory values|0
682036|NCT01625377|2211360|P1|Overall Study|Abnormal laboratory values|1
682037|NCT01625377|2211359|P2|Overall Study|Unsatisfactory therapeutic effect|1
682038|NCT01625377|2211360|P1|Overall Study|Unsatisfactory therapeutic effect|0
682039|NCT01625377|2211359|P2|Overall Study|Graft loss|0
682040|NCT01625377|2211360|P1|Overall Study|Graft loss|1
682041|NCT01625377|2211359|P2|Overall Study|Adverse Event|16
682042|NCT01625377|2211360|P1|Overall Study|Adverse Event|3
682043|NCT01625377|2211359|P2|Overall Study|Protocol Violation|3
682044|NCT01625377|2211360|P1|Overall Study|Protocol Violation|0
682045|NCT01625377|2211359|P2|Overall Study|Administrative Problem|1
682046|NCT01625377|2211360|P1|Overall Study|Administrative Problem|1
682047|NCT01625377|2211359|P2|Overall Study|Death|1
682048|NCT01625377|2211360|P1|Overall Study|Death|1
682049|NCT01625338|2211393|P3|Overall Study|Study Discontinued by Sponsor|1
682050|NCT01625338|2211394|P2|Overall Study|Study Discontinued by Sponsor|0
682051|NCT01625338|2211395|P1|Overall Study|Study Discontinued by Sponsor|0
682052|NCT01625338|2211393|P3|Overall Study|Adverse Event|1
682053|NCT01625338|2211394|P2|Overall Study|Adverse Event|0
682054|NCT01625338|2211395|P1|Overall Study|Adverse Event|1
682055|NCT01625338|2211393|P3|Overall Study|Subject Withdrew Consent|2
682056|NCT01625338|2211394|P2|Overall Study|Subject Withdrew Consent|0
682057|NCT01625338|2211395|P1|Overall Study|Subject Withdrew Consent|1
682058|NCT01625338|2211393|P3|Overall Study|Investigator Decision|1
682059|NCT01625338|2211394|P2|Overall Study|Investigator Decision|2
682060|NCT01625338|2211395|P1|Overall Study|Investigator Decision|0
682061|NCT01625338|2211393|P3|Overall Study|Lost to Follow-up|2
682062|NCT01625338|2211394|P2|Overall Study|Lost to Follow-up|3
682063|NCT01625338|2211395|P1|Overall Study|Lost to Follow-up|3
682064|NCT01625338|2211393|P3|Overall Study|Efficacy Failure|31
682065|NCT01625338|2211394|P2|Overall Study|Efficacy Failure|39
682066|NCT01625338|2211395|P1|Overall Study|Efficacy Failure|27
682067|NCT01625338|2211393|P3|Overall Study|Enrolled but not Treated|1
682068|NCT01625338|2211394|P2|Overall Study|Enrolled but not Treated|0
682069|NCT01625338|2211395|P1|Overall Study|Enrolled but not Treated|0
889080|NCT01582971|2823318|P2|Overall Study|Other|13
889081|NCT01582971|2823319|P1|Overall Study|Other|15
889082|NCT01582971|2823318|P2|Overall Study|Withdrawal by Subject|2
889083|NCT01582971|2823319|P1|Overall Study|Withdrawal by Subject|4
682096|NCT01624467|2211492|P1|Overall Study|Subject Withdrew from Treatment|1
682097|NCT01624467|2211492|P1|Overall Study|Per Sponsor Requirement|1
682098|NCT01624467|2211492|P1|Overall Study|Progressive Disease|19
682099|NCT01624467|2211492|P1|Overall Study|Adverse Event|7
682100|NCT01624467|2211492|P1|Overall Study|Lost to Follow-up|1
682101|NCT01624467|2211492|P1|Overall Study|Withdrawal by Subject|2
682102|NCT01624259|2211531|P2|Overall Study|Abnormal laboratory measure|0
682103|NCT01624259|2211532|P1|Overall Study|Abnormal laboratory measure|3
682104|NCT01624259|2211531|P2|Overall Study|Lost to Follow-up|3
682105|NCT01624259|2211532|P1|Overall Study|Lost to Follow-up|2
682106|NCT01624259|2211531|P2|Overall Study|Physician Decision|1
682107|NCT01624259|2211532|P1|Overall Study|Physician Decision|1
682108|NCT01624259|2211531|P2|Overall Study|Withdrawal by Subject|7
682109|NCT01624259|2211532|P1|Overall Study|Withdrawal by Subject|5
682110|NCT01624259|2211531|P2|Overall Study|Protocol Violation|2
682111|NCT01624259|2211532|P1|Overall Study|Protocol Violation|1
682112|NCT01624259|2211531|P2|Overall Study|Adverse Event|18
682113|NCT01624259|2211532|P1|Overall Study|Adverse Event|18
889084|NCT01582971|2823318|P2|Overall Study|Lost to Follow-up|21
889085|NCT01582971|2823319|P1|Overall Study|Lost to Follow-up|18
889086|NCT01582971|2823318|P2|Overall Study|Death|1
889087|NCT01582971|2823319|P1|Overall Study|Death|2
889088|NCT01569022|2823337|P2|Second Intervention|Lost to Follow-up|2
682119|NCT01623830|2211634|P2|Overall Study|Exclusion from Study|2
682120|NCT01623830|2211635|P1|Overall Study|Exclusion from Study|1
682121|NCT01623830|2211634|P2|Overall Study|Withdrawal by Subject|7
682122|NCT01623830|2211635|P1|Overall Study|Withdrawal by Subject|6
682123|NCT01623271|2211676|P1|Overall Study|Withdrawal by Subject|2
682124|NCT01623154|2211680|P1|Overall Study|Did not drink Pranactin Citric|4
682125|NCT01623115|2211688|P2|Overall Study|Other than specified above|3
682126|NCT01623115|2211689|P1|Overall Study|Other than specified above|0
682127|NCT01623115|2211688|P2|Overall Study|Death|4
682128|NCT01623115|2211689|P1|Overall Study|Death|0
682129|NCT01623115|2211688|P2|Overall Study|Site closure|7
682130|NCT01623115|2211689|P1|Overall Study|Site closure|1
682131|NCT01623115|2211688|P2|Overall Study|Last visit outside protocol visit window|26
682132|NCT01623115|2211689|P1|Overall Study|Last visit outside protocol visit window|14
682133|NCT01623115|2211688|P2|Overall Study|Related to study drug administration|2
682134|NCT01623115|2211689|P1|Overall Study|Related to study drug administration|0
682135|NCT01623115|2211688|P2|Overall Study|Consent withdrawn by participant|6
682136|NCT01623115|2211689|P1|Overall Study|Consent withdrawn by participant|2
682137|NCT01623115|2211688|P2|Overall Study|Poor compliance to protocol|10
682138|NCT01623115|2211689|P1|Overall Study|Poor compliance to protocol|4
682139|NCT01623115|2211688|P2|Overall Study|Adverse Event|13
682140|NCT01623115|2211689|P1|Overall Study|Adverse Event|10
682141|NCT01623115|2211688|P2|Overall Study|Participants moved|5
682142|NCT01623115|2211689|P1|Overall Study|Participants moved|1
682143|NCT01623115|2211688|P2|Overall Study|Physician Decision|0
682144|NCT01623115|2211689|P1|Overall Study|Physician Decision|1
682145|NCT01623115|2211688|P2|Overall Study|Randomized but not treated|1
889089|NCT01569022|2823338|P1|Second Intervention|Lost to Follow-up|2
682146|NCT01623115|2211689|P1|Overall Study|Randomized but not treated|0
682147|NCT01623050|2211749|P1|Overall Study|Lost to Follow-up|9
682148|NCT01622673|2211763|P6|Treatment Period 3|Protocol Violation|0
682149|NCT01622673|2211764|P5|Treatment Period 3|Protocol Violation|0
682150|NCT01622673|2211765|P4|Treatment Period 3|Protocol Violation|0
682151|NCT01622673|2211766|P3|Treatment Period 3|Protocol Violation|0
682152|NCT01622673|2211767|P2|Treatment Period 3|Protocol Violation|1
682153|NCT01622673|2211768|P1|Treatment Period 3|Protocol Violation|0
682154|NCT01622673|2211763|P6|Treatment Period 2|Withdrawal by Subject|0
682155|NCT01622673|2211764|P5|Treatment Period 2|Withdrawal by Subject|0
682156|NCT01622673|2211765|P4|Treatment Period 2|Withdrawal by Subject|1
682157|NCT01622673|2211766|P3|Treatment Period 2|Withdrawal by Subject|0
682158|NCT01622673|2211767|P2|Treatment Period 2|Withdrawal by Subject|0
682159|NCT01622673|2211768|P1|Treatment Period 2|Withdrawal by Subject|0
682160|NCT01622673|2211763|P6|Treatment Period 1|Protocol Violation|0
682161|NCT01622673|2211764|P5|Treatment Period 1|Protocol Violation|0
682162|NCT01622673|2211765|P4|Treatment Period 1|Protocol Violation|0
682163|NCT01622673|2211766|P3|Treatment Period 1|Protocol Violation|0
682164|NCT01622673|2211767|P2|Treatment Period 1|Protocol Violation|1
682165|NCT01622673|2211768|P1|Treatment Period 1|Protocol Violation|0
682166|NCT01622673|2211763|P6|Treatment Period 1|Withdrawal by Subject|0
682167|NCT01622673|2211764|P5|Treatment Period 1|Withdrawal by Subject|0
682168|NCT01622673|2211765|P4|Treatment Period 1|Withdrawal by Subject|1
682169|NCT01622673|2211766|P3|Treatment Period 1|Withdrawal by Subject|0
682170|NCT01622673|2211767|P2|Treatment Period 1|Withdrawal by Subject|0
682171|NCT01622673|2211768|P1|Treatment Period 1|Withdrawal by Subject|0
682172|NCT01622660|2211803|P1|Overall Study|Adverse Event|1
682173|NCT01622231|2211838|P1|Overall Study|Withdrawal by Subject|1
682174|NCT01622231|2211838|P1|Overall Study|Physician Decision|1
889090|NCT01569022|2823337|P2|First Intervention|Lost to Follow-up|1
889091|NCT01569022|2823338|P1|First Intervention|Lost to Follow-up|2
889092|NCT01553916|2823350|P1|Overall Study|Pre-treatment MRI metastatic disease|1
889093|NCT01553916|2823350|P1|Overall Study|Withdrawal by Subject|2
889109|NCT01491737|2823557|P2|Overall Study|Reason not specified|3
889110|NCT01491737|2823558|P1|Overall Study|Reason not specified|2
889111|NCT01491737|2823557|P2|Overall Study|Death|28
889112|NCT01491737|2823558|P1|Overall Study|Death|33
889113|NCT01491737|2823557|P2|Overall Study|Lost to Follow-up|6
889114|NCT01491737|2823558|P1|Overall Study|Lost to Follow-up|1
889115|NCT01491737|2823557|P2|Overall Study|Withdrawal of consent|13
889116|NCT01491737|2823558|P1|Overall Study|Withdrawal of consent|13
682205|NCT01621191|2212048|P1|Overall Study|Site Removed From Study|1
682206|NCT01621191|2212048|P1|Overall Study|Lost to Follow-up|1
682207|NCT01621191|2212048|P1|Overall Study|Lack of Efficacy|6
682208|NCT01621191|2212048|P1|Overall Study|Withdrawal by Subject|8
682209|NCT01621191|2212048|P1|Overall Study|Adverse Event|9
682210|NCT01621178|2212062|P3|Overall Study|Physician Decision|5
682211|NCT01621178|2212063|P2|Overall Study|Physician Decision|2
682212|NCT01621178|2212064|P1|Overall Study|Physician Decision|3
682213|NCT01621178|2212062|P3|Overall Study|Withdrawal by Subject|17
682214|NCT01621178|2212063|P2|Overall Study|Withdrawal by Subject|14
682215|NCT01621178|2212064|P1|Overall Study|Withdrawal by Subject|8
682216|NCT01621178|2212062|P3|Overall Study|Lost to Follow-up|1
682217|NCT01621178|2212063|P2|Overall Study|Lost to Follow-up|1
682218|NCT01621178|2212064|P1|Overall Study|Lost to Follow-up|1
682219|NCT01621178|2212062|P3|Overall Study|Death|1
682220|NCT01621178|2212063|P2|Overall Study|Death|4
682221|NCT01621178|2212064|P1|Overall Study|Death|2
682222|NCT01621178|2212062|P3|Overall Study|Adverse Event|7
682223|NCT01621178|2212063|P2|Overall Study|Adverse Event|1
682224|NCT01621178|2212064|P1|Overall Study|Adverse Event|1
682225|NCT01621126|2212111|P1|Overall Study|Physician Decision|6
682226|NCT01620489|2212132|P2|Overall Study|Unclassified|2
682227|NCT01620489|2212133|P1|Overall Study|Unclassified|1
682228|NCT01620489|2212132|P2|Overall Study|Withdrawal Criteria|25
682229|NCT01620489|2212133|P1|Overall Study|Withdrawal Criteria|17
682230|NCT01620489|2212132|P2|Overall Study|Protocol Violation|3
682231|NCT01620489|2212133|P1|Overall Study|Protocol Violation|0
682232|NCT01620489|2212132|P2|Overall Study|Adverse Event|4
682233|NCT01620489|2212133|P1|Overall Study|Adverse Event|17
682234|NCT01620255|2212154|P5|Overall Study|Withdrawn at discretion of investigator|1
682235|NCT01620255|2212155|P4|Overall Study|Withdrawn at discretion of investigator|0
682236|NCT01620255|2212156|P3|Overall Study|Withdrawn at discretion of investigator|0
682237|NCT01620255|2212157|P2|Overall Study|Withdrawn at discretion of investigator|0
682238|NCT01620255|2212158|P1|Overall Study|Withdrawn at discretion of investigator|0
682239|NCT01620255|2212154|P5|Overall Study|Adverse Event|1
682240|NCT01620255|2212155|P4|Overall Study|Adverse Event|1
682241|NCT01620255|2212156|P3|Overall Study|Adverse Event|0
682242|NCT01620255|2212157|P2|Overall Study|Adverse Event|4
682243|NCT01620255|2212158|P1|Overall Study|Adverse Event|0
682244|NCT01620255|2212154|P5|Overall Study|Non-compliance|0
682245|NCT01620255|2212155|P4|Overall Study|Non-compliance|0
682246|NCT01620255|2212156|P3|Overall Study|Non-compliance|0
682247|NCT01620255|2212157|P2|Overall Study|Non-compliance|1
682248|NCT01620255|2212158|P1|Overall Study|Non-compliance|0
682249|NCT01620255|2212154|P5|Overall Study|Participant underwent fecal transplant|0
682250|NCT01620255|2212155|P4|Overall Study|Participant underwent fecal transplant|0
682251|NCT01620255|2212156|P3|Overall Study|Participant underwent fecal transplant|1
682252|NCT01620255|2212157|P2|Overall Study|Participant underwent fecal transplant|0
682253|NCT01620255|2212158|P1|Overall Study|Participant underwent fecal transplant|0
682254|NCT01620255|2212154|P5|Overall Study|Withdrawal by Subject|4
682255|NCT01620255|2212155|P4|Overall Study|Withdrawal by Subject|2
682256|NCT01620255|2212156|P3|Overall Study|Withdrawal by Subject|1
682257|NCT01620255|2212157|P2|Overall Study|Withdrawal by Subject|1
682258|NCT01620255|2212158|P1|Overall Study|Withdrawal by Subject|4
682259|NCT01620177|2212235|P1|Overall Study|Randomized, Not Active due to Scheduling|1
682260|NCT01620177|2212235|P1|Overall Study|Physician Decision|2
682261|NCT01620177|2212235|P1|Overall Study|Lost to Follow-up|7
682262|NCT01620177|2212235|P1|Overall Study|Withdrawal by Subject|26
682263|NCT01620177|2212235|P1|Overall Study|Failure at Screening Visit|43
682264|NCT01620138|2212260|P2|Overall Study|Adverse Event|0
682265|NCT01620138|2212261|P1|Overall Study|Adverse Event|2
682266|NCT01620138|2212260|P2|Overall Study|Lack of Efficacy|0
682267|NCT01620138|2212261|P1|Overall Study|Lack of Efficacy|1
682268|NCT01620138|2212260|P2|Overall Study|Withdrawal by Subject|0
682269|NCT01620138|2212261|P1|Overall Study|Withdrawal by Subject|3
682270|NCT01620086|2212269|P3|Overall Study|Physician Decision|0
682271|NCT01620086|2212270|P2|Overall Study|Physician Decision|0
682272|NCT01620086|2212271|P1|Overall Study|Physician Decision|1
682273|NCT01620086|2212269|P3|Overall Study|failed study criteria|0
682274|NCT01620086|2212270|P2|Overall Study|failed study criteria|4
682275|NCT01620086|2212271|P1|Overall Study|failed study criteria|1
682276|NCT01620086|2212269|P3|Overall Study|Withdrawal by Subject|0
682277|NCT01620086|2212270|P2|Overall Study|Withdrawal by Subject|3
682278|NCT01620086|2212271|P1|Overall Study|Withdrawal by Subject|3
682279|NCT01620060|2212290|P1|Overall Study|Per Sponsor Decision|2
682280|NCT01620060|2212290|P1|Overall Study|Family emergency|1
682281|NCT01620060|2212290|P1|Overall Study|Did not comply with Study Produre|1
682282|NCT01620060|2212290|P1|Overall Study|Withdrawal by Subject|1
682283|NCT01620060|2212290|P1|Overall Study|Protocol Violation|1
682284|NCT01620060|2212290|P1|Overall Study|Adverse Event|9
682285|NCT01619878|2212309|P1|Follow-up at 12 Months of Age|Death|2
682286|NCT01619878|2212309|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
682287|NCT01619878|2212309|P1|6 Week Follow-up Phase|Adverse Event|1
682288|NCT01619800|2212323|P2|Overall Study|study terminated|0
682289|NCT01619800|2212324|P1|Overall Study|study terminated|2
682290|NCT01619787|2212332|P1|Overall Study|Lost to Follow-up|5
682291|NCT01619579|2212349|P2|Overall Study|Withdrawal by Subject|3
682292|NCT01619579|2212350|P1|Overall Study|Withdrawal by Subject|0
682293|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
682294|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
682295|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
682296|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
682297|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Death|0
682298|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Death|1
682299|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
682300|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
682301|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Adverse Event|3
682302|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Adverse Event|2
682303|NCT01619059|2212362|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
682304|NCT01619059|2212363|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
682305|NCT01619059|2212362|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
682306|NCT01619059|2212363|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
682307|NCT01619059|2212362|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
682308|NCT01619059|2212363|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
682309|NCT01619059|2212362|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
682310|NCT01619059|2212363|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
682311|NCT01619059|2212362|P2|Short-Term (ST) Treatment Period|Adverse Event|0
682312|NCT01619059|2212363|P1|Short-Term (ST) Treatment Period|Adverse Event|1
682313|NCT01618968|2212379|P4|Overall Study|Death|1
682314|NCT01618968|2212380|P3|Overall Study|Death|0
682315|NCT01618968|2212381|P2|Overall Study|Death|0
682316|NCT01618968|2212382|P1|Overall Study|Death|0
682317|NCT01618968|2212379|P4|Overall Study|Adverse Event|0
682318|NCT01618968|2212380|P3|Overall Study|Adverse Event|0
682319|NCT01618968|2212381|P2|Overall Study|Adverse Event|0
682320|NCT01618968|2212382|P1|Overall Study|Adverse Event|1
682321|NCT01618864|2212449|P1|Overall Study|Lost to Follow-up|2
682322|NCT01618864|2212449|P1|Overall Study|Withdrawal by Subject|2
682323|NCT01618838|2212458|P1|Overall Study|slow accrual, trial closed prematurely.|4
682324|NCT01618708|2212464|P2|Overall Study|Randomized but not treated|2
682325|NCT01618708|2212465|P1|Overall Study|Randomized but not treated|3
682326|NCT01618708|2212464|P2|Overall Study|Other than specified above|1
682327|NCT01618708|2212465|P1|Overall Study|Other than specified above|1
682328|NCT01618708|2212464|P2|Overall Study|Technical problems|0
682329|NCT01618708|2212465|P1|Overall Study|Technical problems|2
682330|NCT01618708|2212464|P2|Overall Study|Lack of Efficacy|8
682331|NCT01618708|2212465|P1|Overall Study|Lack of Efficacy|8
682332|NCT01618708|2212464|P2|Overall Study|Withdrawal by Subject|22
682333|NCT01618708|2212465|P1|Overall Study|Withdrawal by Subject|17
682334|NCT01618708|2212464|P2|Overall Study|Lost to Follow-up|3
682335|NCT01618708|2212465|P1|Overall Study|Lost to Follow-up|3
682336|NCT01618708|2212464|P2|Overall Study|Adverse Event|10
682337|NCT01618708|2212465|P1|Overall Study|Adverse Event|10
682338|NCT01618669|2212479|P2|Overall Study|Miscellaneous Reason|1
682339|NCT01618669|2212480|P1|Overall Study|Miscellaneous Reason|0
682340|NCT01618669|2212479|P2|Overall Study|Withdrawal by Subject|9
682341|NCT01618669|2212480|P1|Overall Study|Withdrawal by Subject|9
682342|NCT01618669|2212479|P2|Overall Study|Protocol Violation|3
682343|NCT01618669|2212480|P1|Overall Study|Protocol Violation|5
682344|NCT01618669|2212479|P2|Overall Study|Adverse Event|7
682345|NCT01618669|2212480|P1|Overall Study|Adverse Event|16
682346|NCT01618669|2212479|P2|Overall Study|Randomized but Never Received Study Drug|2
682347|NCT01618669|2212480|P1|Overall Study|Randomized but Never Received Study Drug|3
682348|NCT01618669|2212479|P2|Overall Study|Lost to Follow-up|1
682349|NCT01618669|2212480|P1|Overall Study|Lost to Follow-up|1
682350|NCT01618266|2212533|P1|Overall Study|Protocol Violation|43
682351|NCT01618266|2212533|P1|Overall Study|Lack of Efficacy|23
682352|NCT01618266|2212533|P1|Overall Study|Other reasons|11
682353|NCT01618266|2212533|P1|Overall Study|Treatment satisfaction|10
682354|NCT01618266|2212533|P1|Overall Study|Lost to Follow-up|9
682355|NCT01618214|2212570|P2|Overall Study|Unclassified|5
682356|NCT01618214|2212571|P1|Overall Study|Unclassified|4
682357|NCT01618214|2212570|P2|Overall Study|Withdrawal Criteria|2
682358|NCT01618214|2212571|P1|Overall Study|Withdrawal Criteria|1
682359|NCT01618214|2212570|P2|Overall Study|Protocol Violation|4
682360|NCT01618214|2212571|P1|Overall Study|Protocol Violation|1
682361|NCT01618214|2212570|P2|Overall Study|Lack of Efficacy|1
682362|NCT01618214|2212571|P1|Overall Study|Lack of Efficacy|1
682363|NCT01618214|2212570|P2|Overall Study|Adverse Event|1
682364|NCT01618214|2212571|P1|Overall Study|Adverse Event|3
682373|NCT01618019|2212608|P2|Overall Study|Withdrawal by Subject|14
682374|NCT01618019|2212609|P1|Overall Study|Withdrawal by Subject|14
682375|NCT01617681|2212633|P5|Period 2 Open Label|Withdrawal by Subject|3
682376|NCT01617681|2212634|P4|Period 2 Open Label|Withdrawal by Subject|0
682377|NCT01617681|2212635|P3|Period 2 Open Label|Withdrawal by Subject|0
682378|NCT01617681|2212636|P2|Period 2 Open Label|Withdrawal by Subject|0
682379|NCT01617681|2212637|P1|Period 2 Open Label|Withdrawal by Subject|0
682380|NCT01617681|2212633|P5|Period 2 Open Label|Adverse Event|3
682381|NCT01617681|2212634|P4|Period 2 Open Label|Adverse Event|0
682382|NCT01617681|2212635|P3|Period 2 Open Label|Adverse Event|0
682383|NCT01617681|2212636|P2|Period 2 Open Label|Adverse Event|0
682384|NCT01617681|2212637|P1|Period 2 Open Label|Adverse Event|0
682385|NCT01617681|2212633|P5|Period 1 Double Blind|Withdrawal by Subject|0
682386|NCT01617681|2212634|P4|Period 1 Double Blind|Withdrawal by Subject|0
682387|NCT01617681|2212635|P3|Period 1 Double Blind|Withdrawal by Subject|1
682388|NCT01617681|2212636|P2|Period 1 Double Blind|Withdrawal by Subject|1
682389|NCT01617681|2212637|P1|Period 1 Double Blind|Withdrawal by Subject|1
682390|NCT01617681|2212633|P5|Period 1 Double Blind|Adverse Event|0
682391|NCT01617681|2212634|P4|Period 1 Double Blind|Adverse Event|2
682392|NCT01617681|2212635|P3|Period 1 Double Blind|Adverse Event|0
682393|NCT01617681|2212636|P2|Period 1 Double Blind|Adverse Event|0
682394|NCT01617681|2212637|P1|Period 1 Double Blind|Adverse Event|2
682395|NCT01617668|2212658|P4|Overall Study|Subject/guardian decision|1
682396|NCT01617668|2212659|P3|Overall Study|Subject/guardian decision|2
682397|NCT01617668|2212660|P2|Overall Study|Subject/guardian decision|3
682398|NCT01617668|2212661|P1|Overall Study|Subject/guardian decision|1
682399|NCT01617668|2212658|P4|Overall Study|Progressive Disease|9
682400|NCT01617668|2212659|P3|Overall Study|Progressive Disease|6
682401|NCT01617668|2212660|P2|Overall Study|Progressive Disease|4
682402|NCT01617668|2212661|P1|Overall Study|Progressive Disease|4
682403|NCT01617668|2212658|P4|Overall Study|Physician Decision|0
682404|NCT01617668|2212659|P3|Overall Study|Physician Decision|3
682405|NCT01617668|2212660|P2|Overall Study|Physician Decision|2
682406|NCT01617668|2212661|P1|Overall Study|Physician Decision|1
682407|NCT01617668|2212658|P4|Overall Study|Adverse Event|5
682408|NCT01617668|2212659|P3|Overall Study|Adverse Event|12
682409|NCT01617668|2212660|P2|Overall Study|Adverse Event|0
682410|NCT01617668|2212661|P1|Overall Study|Adverse Event|7
682411|NCT01617655|2212702|P2|Overall Study|Other than specified above|2
682412|NCT01617655|2212703|P1|Overall Study|Other than specified above|1
682413|NCT01617655|2212702|P2|Overall Study|Site closure|5
682414|NCT01617655|2212703|P1|Overall Study|Site closure|3
682415|NCT01617655|2212702|P2|Overall Study|Last visit outside protocol visit window|10
682416|NCT01617655|2212703|P1|Overall Study|Last visit outside protocol visit window|1
682417|NCT01617655|2212702|P2|Overall Study|Consent withdrawn by participant|1
682418|NCT01617655|2212703|P1|Overall Study|Consent withdrawn by participant|1
682419|NCT01617655|2212702|P2|Overall Study|Participants moved|4
682420|NCT01617655|2212703|P1|Overall Study|Participants moved|0
682421|NCT01617655|2212702|P2|Overall Study|Poor compliance to protocol|4
682422|NCT01617655|2212703|P1|Overall Study|Poor compliance to protocol|1
682423|NCT01617655|2212702|P2|Overall Study|Adverse Event|3
682424|NCT01617655|2212703|P1|Overall Study|Adverse Event|2
682425|NCT01617447|2212788|P2|Overall Study|Physician Decision|2
682426|NCT01617447|2212789|P1|Overall Study|Physician Decision|0
682427|NCT01617447|2212788|P2|Overall Study|Adverse Event|1
682428|NCT01617447|2212789|P1|Overall Study|Adverse Event|0
682429|NCT01617434|2212797|P2|Overall Study|Unclassified|4
682430|NCT01617434|2212798|P1|Overall Study|Unclassified|3
682431|NCT01617434|2212797|P2|Overall Study|Withdrawal Criteria|37
682432|NCT01617434|2212798|P1|Overall Study|Withdrawal Criteria|12
682433|NCT01617434|2212797|P2|Overall Study|Protocol Violation|7
682434|NCT01617434|2212798|P1|Overall Study|Protocol Violation|8
682435|NCT01617434|2212797|P2|Overall Study|Adverse Event|3
682436|NCT01617434|2212798|P1|Overall Study|Adverse Event|12
682437|NCT01617187|2212830|P4|Treatment Through Study Completion|Protocol Violation|1
682438|NCT01617187|2212831|P3|Treatment Through Study Completion|Protocol Violation|0
682439|NCT01617187|2212832|P2|Treatment Through Study Completion|Protocol Violation|0
682440|NCT01617187|2212833|P1|Treatment Through Study Completion|Protocol Violation|1
682441|NCT01617187|2212830|P4|Treatment Through Study Completion|Withdrawal by Subject|6
682442|NCT01617187|2212831|P3|Treatment Through Study Completion|Withdrawal by Subject|3
682443|NCT01617187|2212832|P2|Treatment Through Study Completion|Withdrawal by Subject|8
682444|NCT01617187|2212833|P1|Treatment Through Study Completion|Withdrawal by Subject|5
682445|NCT01617187|2212830|P4|Treatment Through Study Completion|Lost to Follow-up|2
682446|NCT01617187|2212831|P3|Treatment Through Study Completion|Lost to Follow-up|2
682447|NCT01617187|2212832|P2|Treatment Through Study Completion|Lost to Follow-up|2
682448|NCT01617187|2212833|P1|Treatment Through Study Completion|Lost to Follow-up|4
682449|NCT01617187|2212830|P4|Treatment Through Study Completion|Adverse Event|1
682450|NCT01617187|2212831|P3|Treatment Through Study Completion|Adverse Event|0
682451|NCT01617187|2212832|P2|Treatment Through Study Completion|Adverse Event|1
682452|NCT01617187|2212833|P1|Treatment Through Study Completion|Adverse Event|1
682453|NCT01617187|2212830|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
682454|NCT01617187|2212831|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
682455|NCT01617187|2212832|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
682456|NCT01617187|2212833|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
682457|NCT01617187|2212830|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
682458|NCT01617187|2212831|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
682459|NCT01617187|2212832|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
682460|NCT01617187|2212833|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
682461|NCT01617187|2212830|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
682462|NCT01617187|2212831|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
682463|NCT01617187|2212832|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
682464|NCT01617187|2212833|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
682465|NCT01617070|2212903|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
682466|NCT01617005|2212921|P1|Overall Study|Lack of motivation for treatment|1
682467|NCT01617005|2212921|P1|Overall Study|Pregnancy|1
682468|NCT01616953|2212930|P2|Overall Study|lack of bone and soft tissue|0
682469|NCT01616953|2212931|P1|Overall Study|lack of bone and soft tissue|1
682470|NCT01616953|2212930|P2|Overall Study|Lost to Follow-up|0
682471|NCT01616953|2212931|P1|Overall Study|Lost to Follow-up|1
682472|NCT01616771|2212939|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
682473|NCT01616459|2212964|P4|Overall Study|Other reason|0
682474|NCT01616459|2212965|P3|Overall Study|Other reason|1
682475|NCT01616459|2212966|P2|Overall Study|Other reason|1
682476|NCT01616459|2212967|P1|Overall Study|Other reason|0
682477|NCT01616459|2212964|P4|Overall Study|Withdrawal by Subject|4
682478|NCT01616459|2212965|P3|Overall Study|Withdrawal by Subject|4
682479|NCT01616459|2212966|P2|Overall Study|Withdrawal by Subject|4
682480|NCT01616459|2212967|P1|Overall Study|Withdrawal by Subject|2
682481|NCT01616459|2212964|P4|Overall Study|Protocol Violation|2
682482|NCT01616459|2212965|P3|Overall Study|Protocol Violation|0
682483|NCT01616459|2212966|P2|Overall Study|Protocol Violation|0
682484|NCT01616459|2212967|P1|Overall Study|Protocol Violation|0
682485|NCT01616459|2212964|P4|Overall Study|Lost to Follow-up|2
682486|NCT01616459|2212965|P3|Overall Study|Lost to Follow-up|3
682487|NCT01616459|2212966|P2|Overall Study|Lost to Follow-up|11
682488|NCT01616459|2212967|P1|Overall Study|Lost to Follow-up|1
682489|NCT01616459|2212964|P4|Overall Study|Adverse Event|0
682490|NCT01616459|2212965|P3|Overall Study|Adverse Event|2
682491|NCT01616459|2212966|P2|Overall Study|Adverse Event|1
682492|NCT01616459|2212967|P1|Overall Study|Adverse Event|1
682493|NCT01616173|2213056|P3|Overall Study|Lost to Follow-up|0
682494|NCT01616173|2213057|P2|Overall Study|Lost to Follow-up|2
682495|NCT01616173|2213058|P1|Overall Study|Lost to Follow-up|0
682496|NCT01615939|2213086|P2|Overall Study|Lost to Follow-up|0
682497|NCT01615939|2213087|P1|Overall Study|Lost to Follow-up|5
682498|NCT01615822|2213100|P3|Period 2|Lost to Follow-up|2
682499|NCT01615822|2213101|P2|Period 2|Lost to Follow-up|1
682500|NCT01615822|2213102|P1|Period 2|Lost to Follow-up|0
682501|NCT01615822|2213100|P3|Period 1|Adverse Event|0
682502|NCT01615822|2213101|P2|Period 1|Adverse Event|1
682503|NCT01615822|2213102|P1|Period 1|Adverse Event|1
682504|NCT01615822|2213100|P3|Period 1|Withdrawal by Subject|0
682505|NCT01615822|2213101|P2|Period 1|Withdrawal by Subject|1
682506|NCT01615822|2213102|P1|Period 1|Withdrawal by Subject|0
682507|NCT01615328|2213148|P2|Overall Study|Lost to Follow-up|5
682508|NCT01615328|2213149|P1|Overall Study|Lost to Follow-up|3
682509|NCT01615263|2213161|P2|Overall Study|Post-randomization exclusion|2
682510|NCT01615263|2213162|P1|Overall Study|Post-randomization exclusion|0
682511|NCT01615198|2213176|P2|Overall Study|Adverse Event|5
682512|NCT01615198|2213177|P1|Overall Study|Adverse Event|11
682513|NCT01615198|2213176|P2|Overall Study|Lack of Efficacy|6
682514|NCT01615198|2213177|P1|Overall Study|Lack of Efficacy|1
682515|NCT01615198|2213176|P2|Overall Study|Lost to Follow-up|1
682516|NCT01615198|2213177|P1|Overall Study|Lost to Follow-up|1
682517|NCT01615198|2213176|P2|Overall Study|Physician Decision|1
682518|NCT01615198|2213177|P1|Overall Study|Physician Decision|5
682519|NCT01615198|2213176|P2|Overall Study|Protocol deviation|1
682520|NCT01615198|2213177|P1|Overall Study|Protocol deviation|1
682521|NCT01615198|2213176|P2|Overall Study|Withdrawal by Subject|5
682522|NCT01615198|2213177|P1|Overall Study|Withdrawal by Subject|5
682553|NCT01614886|2213237|P2|Overall Study|Protocol deviation|2
682554|NCT01614886|2213238|P1|Overall Study|Protocol deviation|0
682555|NCT01614886|2213237|P2|Overall Study|Death|0
682556|NCT01614886|2213238|P1|Overall Study|Death|1
682557|NCT01614886|2213237|P2|Overall Study|Withdrawal by Subject|4
682558|NCT01614886|2213238|P1|Overall Study|Withdrawal by Subject|4
682559|NCT01614886|2213237|P2|Overall Study|Adverse Event|20
682560|NCT01614886|2213238|P1|Overall Study|Adverse Event|15
682561|NCT01614795|2213256|P4|Overall Study|Ineligible|0
682562|NCT01614795|2213257|P3|Overall Study|Ineligible|0
682563|NCT01614795|2213258|P2|Overall Study|Ineligible|1
682564|NCT01614795|2213259|P1|Overall Study|Ineligible|0
682565|NCT01614795|2213256|P4|Overall Study|Withdrawal by Subject|2
682566|NCT01614795|2213257|P3|Overall Study|Withdrawal by Subject|0
682567|NCT01614795|2213258|P2|Overall Study|Withdrawal by Subject|1
682568|NCT01614795|2213259|P1|Overall Study|Withdrawal by Subject|0
682569|NCT01614795|2213256|P4|Overall Study|Physician Decision|1
682570|NCT01614795|2213257|P3|Overall Study|Physician Decision|1
682571|NCT01614795|2213258|P2|Overall Study|Physician Decision|0
682572|NCT01614795|2213259|P1|Overall Study|Physician Decision|1
682573|NCT01614795|2213256|P4|Overall Study|Lack of Efficacy|8
682574|NCT01614795|2213257|P3|Overall Study|Lack of Efficacy|9
682575|NCT01614795|2213258|P2|Overall Study|Lack of Efficacy|10
682576|NCT01614795|2213259|P1|Overall Study|Lack of Efficacy|10
682577|NCT01614795|2213256|P4|Overall Study|Adverse Event|1
682578|NCT01614795|2213257|P3|Overall Study|Adverse Event|1
682579|NCT01614795|2213258|P2|Overall Study|Adverse Event|0
682580|NCT01614795|2213259|P1|Overall Study|Adverse Event|0
682581|NCT01614769|2213269|P6|Period 3|Withdrawal by Subject|0
682582|NCT01614769|2213270|P5|Period 3|Withdrawal by Subject|0
682583|NCT01614769|2213271|P4|Period 3|Withdrawal by Subject|0
682584|NCT01614769|2213272|P3|Period 3|Withdrawal by Subject|1
682585|NCT01614769|2213273|P2|Period 3|Withdrawal by Subject|0
682586|NCT01614769|2213274|P1|Period 3|Withdrawal by Subject|0
682587|NCT01614769|2213269|P6|Period 1|Withdrawal by Subject|0
682588|NCT01614769|2213270|P5|Period 1|Withdrawal by Subject|0
682589|NCT01614769|2213271|P4|Period 1|Withdrawal by Subject|0
682590|NCT01614769|2213272|P3|Period 1|Withdrawal by Subject|0
682591|NCT01614769|2213273|P2|Period 1|Withdrawal by Subject|0
682592|NCT01614769|2213274|P1|Period 1|Withdrawal by Subject|1
682593|NCT01614769|2213269|P6|Period 1|Protocol Violation|0
682594|NCT01614769|2213270|P5|Period 1|Protocol Violation|0
682595|NCT01614769|2213271|P4|Period 1|Protocol Violation|1
682596|NCT01614769|2213272|P3|Period 1|Protocol Violation|0
682597|NCT01614769|2213273|P2|Period 1|Protocol Violation|0
682598|NCT01614769|2213274|P1|Period 1|Protocol Violation|0
682599|NCT01614769|2213269|P6|Period 1|Discontinued due to Hypoglycemia|1
682600|NCT01614769|2213270|P5|Period 1|Discontinued due to Hypoglycemia|0
682601|NCT01614769|2213271|P4|Period 1|Discontinued due to Hypoglycemia|1
682602|NCT01614769|2213272|P3|Period 1|Discontinued due to Hypoglycemia|0
682603|NCT01614769|2213273|P2|Period 1|Discontinued due to Hypoglycemia|0
682604|NCT01614769|2213274|P1|Period 1|Discontinued due to Hypoglycemia|0
682605|NCT01614600|2213296|P1|Overall Study|Protocol deviation|1
682606|NCT01614600|2213296|P1|Overall Study|Unable to remove lens at the end of day|1
682607|NCT01614600|2213296|P1|Overall Study|Discomfort|1
682608|NCT01614600|2213296|P1|Overall Study|Unacceptable fit|1
682609|NCT01614470|2213327|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
682610|NCT01614470|2213328|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
682611|NCT01614470|2213329|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
682612|NCT01614470|2213327|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
682613|NCT01614470|2213328|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
682614|NCT01614470|2213329|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
682615|NCT01614457|2213351|P2|Overall Study|Pregnancy (Self or Partner)|0
682616|NCT01614457|2213352|P1|Overall Study|Pregnancy (Self or Partner)|1
682617|NCT01614457|2213351|P2|Overall Study|Non-Compliance|0
682618|NCT01614457|2213352|P1|Overall Study|Non-Compliance|1
682619|NCT01614249|2213370|P2|Overall Study|Lost to Follow-up|23
682620|NCT01614249|2213371|P1|Overall Study|Lost to Follow-up|11
682622|NCT01613599|2213382|P1|Overall Study|Ongoing|81
682623|NCT01613599|2213382|P1|Overall Study|Reason not specified|2
682624|NCT01613599|2213382|P1|Overall Study|Withdrawal by Subject|6
682625|NCT01613599|2213382|P1|Overall Study|Lost to Follow-up|2
682626|NCT01613599|2213382|P1|Overall Study|Death|6
682627|NCT01613417|2213397|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
682628|NCT01613417|2213398|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
682629|NCT01613378|2213435|P1|Overall Study|Other Reason|4
682630|NCT01613378|2213435|P1|Overall Study|Lost to Follow-up|1
682631|NCT01613378|2213435|P1|Overall Study|Death|2
682632|NCT01613378|2213435|P1|Overall Study|Withdrawal by Subject|8
682633|NCT01613378|2213435|P1|Overall Study|Adverse Event|11
682634|NCT01613378|2213435|P1|Overall Study|Lack of Efficacy|13
682635|NCT01613326|2213465|P2|Overall Study|Protocol Violation|1
682636|NCT01613326|2213466|P1|Overall Study|Protocol Violation|0
682637|NCT01613326|2213465|P2|Overall Study|Administrative|2
682638|NCT01613326|2213466|P1|Overall Study|Administrative|0
682639|NCT01613326|2213465|P2|Overall Study|Lost to Follow-up|1
682640|NCT01613326|2213466|P1|Overall Study|Lost to Follow-up|0
682641|NCT01613326|2213465|P2|Overall Study|Lack of Efficacy|1
682642|NCT01613326|2213466|P1|Overall Study|Lack of Efficacy|0
682643|NCT01613326|2213465|P2|Overall Study|inability to use device|0
682644|NCT01613326|2213466|P1|Overall Study|inability to use device|1
682645|NCT01613326|2213465|P2|Overall Study|Abnormal test procedure result(s)|0
682646|NCT01613326|2213466|P1|Overall Study|Abnormal test procedure result(s)|2
682647|NCT01613326|2213465|P2|Overall Study|Withdrawal by Subject|4
682648|NCT01613326|2213466|P1|Overall Study|Withdrawal by Subject|3
682649|NCT01613326|2213465|P2|Overall Study|Adverse Event|5
682650|NCT01613326|2213466|P1|Overall Study|Adverse Event|7
682651|NCT01613248|2213523|P6|Overall Study|Pregnancy|0
682652|NCT01613248|2213524|P5|Overall Study|Pregnancy|0
682653|NCT01613248|2213525|P4|Overall Study|Pregnancy|1
682654|NCT01613248|2213526|P3|Overall Study|Pregnancy|0
682655|NCT01613248|2213527|P2|Overall Study|Pregnancy|0
682656|NCT01613248|2213528|P1|Overall Study|Pregnancy|0
682657|NCT01613248|2213523|P6|Overall Study|Lack of Qualifying Event|18
682658|NCT01613248|2213524|P5|Overall Study|Lack of Qualifying Event|15
682659|NCT01613248|2213525|P4|Overall Study|Lack of Qualifying Event|11
682660|NCT01613248|2213526|P3|Overall Study|Lack of Qualifying Event|10
682661|NCT01613248|2213527|P2|Overall Study|Lack of Qualifying Event|11
682662|NCT01613248|2213528|P1|Overall Study|Lack of Qualifying Event|9
682663|NCT01613248|2213523|P6|Overall Study|Physician Decision|6
682664|NCT01613248|2213524|P5|Overall Study|Physician Decision|7
682665|NCT01613248|2213525|P4|Overall Study|Physician Decision|4
682666|NCT01613248|2213526|P3|Overall Study|Physician Decision|9
682667|NCT01613248|2213527|P2|Overall Study|Physician Decision|8
682668|NCT01613248|2213528|P1|Overall Study|Physician Decision|8
682669|NCT01613248|2213523|P6|Overall Study|Study Terminated by Sponsor|11
682670|NCT01613248|2213524|P5|Overall Study|Study Terminated by Sponsor|9
682671|NCT01613248|2213525|P4|Overall Study|Study Terminated by Sponsor|8
682672|NCT01613248|2213526|P3|Overall Study|Study Terminated by Sponsor|8
682673|NCT01613248|2213527|P2|Overall Study|Study Terminated by Sponsor|6
682674|NCT01613248|2213528|P1|Overall Study|Study Terminated by Sponsor|4
682675|NCT01613248|2213523|P6|Overall Study|Lost to Follow-up|2
682676|NCT01613248|2213524|P5|Overall Study|Lost to Follow-up|4
682677|NCT01613248|2213525|P4|Overall Study|Lost to Follow-up|8
682678|NCT01613248|2213526|P3|Overall Study|Lost to Follow-up|4
682679|NCT01613248|2213527|P2|Overall Study|Lost to Follow-up|7
682680|NCT01613248|2213528|P1|Overall Study|Lost to Follow-up|5
682681|NCT01613248|2213523|P6|Overall Study|Withdrawal by Subject|1
682682|NCT01613248|2213524|P5|Overall Study|Withdrawal by Subject|0
682683|NCT01613248|2213525|P4|Overall Study|Withdrawal by Subject|5
682684|NCT01613248|2213526|P3|Overall Study|Withdrawal by Subject|2
682685|NCT01613248|2213527|P2|Overall Study|Withdrawal by Subject|2
682686|NCT01613248|2213528|P1|Overall Study|Withdrawal by Subject|3
682687|NCT01613248|2213523|P6|Overall Study|Adverse Event|0
682688|NCT01613248|2213524|P5|Overall Study|Adverse Event|0
682689|NCT01613248|2213525|P4|Overall Study|Adverse Event|1
682690|NCT01613248|2213526|P3|Overall Study|Adverse Event|0
682691|NCT01613248|2213527|P2|Overall Study|Adverse Event|0
682692|NCT01613248|2213528|P1|Overall Study|Adverse Event|0
682693|NCT01613131|2213628|P2|Overall Study|Withdrawal by Subject|5
682694|NCT01613131|2213629|P1|Overall Study|Withdrawal by Subject|3
682695|NCT01613027|2213657|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
682696|NCT01613027|2213657|P1|Overall Study|Lack of Efficacy|1
682697|NCT01613027|2213657|P1|Overall Study|Switched Physician|1
682698|NCT01613027|2213657|P1|Overall Study|Lost to Follow-up|5
682699|NCT01612858|2213687|P2|Overall Study|Withdrawal by Subject|1
682700|NCT01612858|2213688|P1|Overall Study|Withdrawal by Subject|5
682701|NCT01612702|2213725|P2|Overall Study|Protocol Violation|11
682702|NCT01612702|2213726|P1|Overall Study|Protocol Violation|11
682703|NCT01612676|2213740|P4|Overall Study|Protocol Violation|0
682704|NCT01612676|2213741|P3|Overall Study|Protocol Violation|0
682705|NCT01612676|2213742|P2|Overall Study|Protocol Violation|1
682706|NCT01612676|2213743|P1|Overall Study|Protocol Violation|0
682707|NCT01612676|2213740|P4|Overall Study|Adverse Event|3
682708|NCT01612676|2213741|P3|Overall Study|Adverse Event|1
682709|NCT01612676|2213742|P2|Overall Study|Adverse Event|3
682710|NCT01612676|2213743|P1|Overall Study|Adverse Event|2
682711|NCT01612156|2213821|P2|Overall Study|Protocol Violation|0
682712|NCT01612156|2213822|P1|Overall Study|Protocol Violation|2
682713|NCT01612000|2213834|P4|Overall Study|Withdrawal by Subject|2
682714|NCT01612000|2213835|P3|Overall Study|Withdrawal by Subject|2
682715|NCT01612000|2213836|P2|Overall Study|Withdrawal by Subject|1
682716|NCT01612000|2213837|P1|Overall Study|Withdrawal by Subject|3
682717|NCT01612000|2213834|P4|Overall Study|Physician Decision|0
682718|NCT01612000|2213835|P3|Overall Study|Physician Decision|1
682719|NCT01612000|2213836|P2|Overall Study|Physician Decision|0
682720|NCT01612000|2213837|P1|Overall Study|Physician Decision|0
682721|NCT01612000|2213834|P4|Overall Study|Lost to Follow-up|8
682722|NCT01612000|2213835|P3|Overall Study|Lost to Follow-up|4
682723|NCT01612000|2213836|P2|Overall Study|Lost to Follow-up|4
682724|NCT01612000|2213837|P1|Overall Study|Lost to Follow-up|6
682725|NCT01611974|2213862|P3|Overall Study|Withdrawal by Subject|4
682726|NCT01611974|2213863|P2|Overall Study|Withdrawal by Subject|1
682727|NCT01611974|2213864|P1|Overall Study|Withdrawal by Subject|0
682728|NCT01611974|2213862|P3|Overall Study|Physician Decision|2
682729|NCT01611974|2213863|P2|Overall Study|Physician Decision|1
682730|NCT01611974|2213864|P1|Overall Study|Physician Decision|5
682731|NCT01611974|2213862|P3|Overall Study|Lost to Follow-up|0
682732|NCT01611974|2213863|P2|Overall Study|Lost to Follow-up|1
682733|NCT01611974|2213864|P1|Overall Study|Lost to Follow-up|0
682734|NCT01611974|2213862|P3|Overall Study|Death|10
682735|NCT01611974|2213863|P2|Overall Study|Death|12
682736|NCT01611974|2213864|P1|Overall Study|Death|10
682737|NCT01611883|2213910|P2|Overall Study|Adverse Event|1
682738|NCT01611883|2213911|P1|Overall Study|Adverse Event|1
682739|NCT01611857|2213937|P2|Overall Study|Withdrawal by Subject|2
682740|NCT01611857|2213938|P1|Overall Study|Withdrawal by Subject|0
682752|NCT01610791|2214011|P1|Overall Study|Not determined|5
682753|NCT01610791|2214011|P1|Overall Study|Death|1
682754|NCT01610791|2214011|P1|Overall Study|Adverse event and Investigator decision|1
682755|NCT01610791|2214011|P1|Overall Study|Physician Decision|1
682756|NCT01610791|2214011|P1|Overall Study|Adverse Event|6
682757|NCT01610791|2214011|P1|Overall Study|Lost to Follow-up|7
682758|NCT01610713|2214034|P2|Overall Study|Lost to Follow-up|1
682759|NCT01610713|2214035|P1|Overall Study|Lost to Follow-up|0
682760|NCT01610713|2214034|P2|Overall Study|adv. to use original dose/amitriptyline|0
682761|NCT01610713|2214035|P1|Overall Study|adv. to use original dose/amitriptyline|1
682762|NCT01610713|2214034|P2|Overall Study|low mood and poor motivation|0
682763|NCT01610713|2214035|P1|Overall Study|low mood and poor motivation|1
682764|NCT01610713|2214034|P2|Overall Study|Lack of Efficacy|0
682765|NCT01610713|2214035|P1|Overall Study|Lack of Efficacy|1
682766|NCT01610713|2214034|P2|Overall Study|Adverse Event|0
682767|NCT01610713|2214035|P1|Overall Study|Adverse Event|3
682768|NCT01610700|2214093|P2|Overall Study|subject took one dose of street cannabis|1
682769|NCT01610700|2214094|P1|Overall Study|subject took one dose of street cannabis|0
682770|NCT01610700|2214093|P2|Overall Study|Withdrawal by Subject|1
682771|NCT01610700|2214094|P1|Overall Study|Withdrawal by Subject|0
682772|NCT01610700|2214093|P2|Overall Study|Adverse Event|1
682773|NCT01610700|2214094|P1|Overall Study|Adverse Event|3
682774|NCT01610687|2214148|P1|Overall Study|Felt more alter without study medication|1
682775|NCT01610687|2214148|P1|Overall Study|Cannabis affecting job|1
682776|NCT01610687|2214148|P1|Overall Study|Death|1
682777|NCT01610687|2214148|P1|Overall Study|Unable to make journey|1
682778|NCT01610687|2214148|P1|Overall Study|Symptom control without study medication|2
682779|NCT01610687|2214148|P1|Overall Study|Lost to Follow-up|4
682780|NCT01610687|2214148|P1|Overall Study|Withdrawal by Subject|7
682781|NCT01610687|2214148|P1|Overall Study|Moved out of area|6
682782|NCT01610687|2214148|P1|Overall Study|Adverse Event|18
682783|NCT01610687|2214148|P1|Overall Study|Lack of Efficacy|26
682784|NCT01610596|2214161|P2|Overall Study|Lost to Follow-up|1
682785|NCT01610596|2214162|P1|Overall Study|Lost to Follow-up|0
682786|NCT01610557|2214220|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
682787|NCT01610557|2214221|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
682788|NCT01610557|2214222|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
682789|NCT01610557|2214223|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
682790|NCT01610557|2214224|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
682791|NCT01610557|2214220|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
682792|NCT01610557|2214221|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
682793|NCT01610557|2214222|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
682794|NCT01610557|2214223|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
682795|NCT01610557|2214224|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
682798|NCT01610297|2214249|P1|Overall Study|Lost to Follow-up|1
682799|NCT01610167|2214260|P3|Overall Study|Scheduling conflict.|2
682800|NCT01610167|2214261|P2|Overall Study|Scheduling conflict.|0
682801|NCT01610167|2214262|P1|Overall Study|Scheduling conflict.|0
682802|NCT01610076|2214299|P2|Overall Study|Lost to Follow-up|4
682803|NCT01610076|2214300|P1|Overall Study|Lost to Follow-up|3
682804|NCT01610076|2214299|P2|Overall Study|Technical issue with video|1
682805|NCT01610076|2214300|P1|Overall Study|Technical issue with video|0
682806|NCT01610063|2214311|P2|Overall Study|Lost to Follow-up|20
682807|NCT01610063|2214312|P1|Overall Study|Lost to Follow-up|42
682808|NCT01610037|2214335|P3|Treatment and Follow up Period|Lost to Follow-up|4
682809|NCT01610037|2214336|P2|Treatment and Follow up Period|Lost to Follow-up|6
682810|NCT01610037|2214337|P1|Treatment and Follow up Period|Lost to Follow-up|1
682811|NCT01610037|2214335|P3|Treatment and Follow up Period|Administrative problems|2
682812|NCT01610037|2214336|P2|Treatment and Follow up Period|Administrative problems|3
682813|NCT01610037|2214337|P1|Treatment and Follow up Period|Administrative problems|1
682814|NCT01610037|2214335|P3|Treatment and Follow up Period|Death|4
682815|NCT01610037|2214336|P2|Treatment and Follow up Period|Death|5
682816|NCT01610037|2214337|P1|Treatment and Follow up Period|Death|10
682817|NCT01610037|2214335|P3|Treatment and Follow up Period|Subject withdrew consent|16
682818|NCT01610037|2214336|P2|Treatment and Follow up Period|Subject withdrew consent|14
682819|NCT01610037|2214337|P1|Treatment and Follow up Period|Subject withdrew consent|13
682820|NCT01610037|2214335|P3|All Patients|Abnormal test procedure result(s)|3
682821|NCT01610037|2214336|P2|All Patients|Abnormal test procedure result(s)|1
682822|NCT01610037|2214337|P1|All Patients|Abnormal test procedure result(s)|0
682823|NCT01610037|2214335|P3|All Patients|Lost to Follow-up|0
682824|NCT01610037|2214336|P2|All Patients|Lost to Follow-up|0
682825|NCT01610037|2214337|P1|All Patients|Lost to Follow-up|1
682826|NCT01610037|2214335|P3|All Patients|Administrative problems|4
682827|NCT01610037|2214336|P2|All Patients|Administrative problems|4
682828|NCT01610037|2214337|P1|All Patients|Administrative problems|1
682829|NCT01610037|2214335|P3|All Patients|Abnormal laboratory value|0
682830|NCT01610037|2214336|P2|All Patients|Abnormal laboratory value|1
682831|NCT01610037|2214337|P1|All Patients|Abnormal laboratory value|1
682832|NCT01610037|2214335|P3|All Patients|Protocol deviation|3
682833|NCT01610037|2214336|P2|All Patients|Protocol deviation|3
682834|NCT01610037|2214337|P1|All Patients|Protocol deviation|4
682835|NCT01610037|2214335|P3|All Patients|Death|1
682836|NCT01610037|2214336|P2|All Patients|Death|2
682837|NCT01610037|2214337|P1|All Patients|Death|4
682838|NCT01610037|2214335|P3|All Patients|Unsatisfactory therapeutic effect|27
682839|NCT01610037|2214336|P2|All Patients|Unsatisfactory therapeutic effect|8
682840|NCT01610037|2214337|P1|All Patients|Unsatisfactory therapeutic effect|9
682841|NCT01610037|2214335|P3|All Patients|Withdrawal by Subject|20
682842|NCT01610037|2214336|P2|All Patients|Withdrawal by Subject|10
682843|NCT01610037|2214337|P1|All Patients|Withdrawal by Subject|12
682844|NCT01610037|2214335|P3|All Patients|Adverse Event|26
682845|NCT01610037|2214336|P2|All Patients|Adverse Event|22
682846|NCT01610037|2214337|P1|All Patients|Adverse Event|27
682847|NCT01609790|2214390|P3|Overall Study|Protocol Violation|8
682848|NCT01609790|2214391|P2|Overall Study|Protocol Violation|7
682849|NCT01609790|2214392|P1|Overall Study|Protocol Violation|1
682850|NCT01609582|2214410|P2|Overall Study|Randomized, but not treated|3
682851|NCT01609582|2214411|P1|Overall Study|Randomized, but not treated|0
682852|NCT01609582|2214410|P2|Overall Study|Other|10
682853|NCT01609582|2214411|P1|Overall Study|Other|9
682854|NCT01609582|2214410|P2|Overall Study|Study Terminated by Sponsor|1548
682855|NCT01609582|2214411|P1|Overall Study|Study Terminated by Sponsor|1543
682856|NCT01609582|2214410|P2|Overall Study|Withdrawal by Subject|15
682857|NCT01609582|2214411|P1|Overall Study|Withdrawal by Subject|21
682858|NCT01609582|2214410|P2|Overall Study|Lost to Follow-up|10
682859|NCT01609582|2214411|P1|Overall Study|Lost to Follow-up|10
682860|NCT01609582|2214410|P2|Overall Study|Adverse Event|18
682861|NCT01609582|2214411|P1|Overall Study|Adverse Event|20
682862|NCT01609543|2214419|P1|Overall Study|Death|7
682863|NCT01609543|2214419|P1|Overall Study|Protocol Violation|1
682864|NCT01609543|2214419|P1|Overall Study|Withdrawal by Subject|1
682865|NCT01609543|2214419|P1|Overall Study|Adverse Event|5
682866|NCT01609543|2214419|P1|Overall Study|Disease Progression|28
682867|NCT01609478|2214428|P3|Overall Study|Withdrawal by Subject|2
682868|NCT01609478|2214429|P2|Overall Study|Withdrawal by Subject|0
682869|NCT01609478|2214430|P1|Overall Study|Withdrawal by Subject|2
682870|NCT01609478|2214428|P3|Overall Study|Physician Decision|1
682871|NCT01609478|2214429|P2|Overall Study|Physician Decision|0
682872|NCT01609478|2214430|P1|Overall Study|Physician Decision|1
682873|NCT01609478|2214428|P3|Overall Study|Non-Compliance with study treatment|0
682874|NCT01609478|2214429|P2|Overall Study|Non-Compliance with study treatment|0
682875|NCT01609478|2214430|P1|Overall Study|Non-Compliance with study treatment|1
682876|NCT01609478|2214428|P3|Overall Study|Protocol Deviation|1
682877|NCT01609478|2214429|P2|Overall Study|Protocol Deviation|1
682878|NCT01609478|2214430|P1|Overall Study|Protocol Deviation|0
682879|NCT01609478|2214428|P3|Overall Study|Adverse Event|5
682880|NCT01609478|2214429|P2|Overall Study|Adverse Event|1
682881|NCT01609478|2214430|P1|Overall Study|Adverse Event|3
682882|NCT01609257|2214496|P2|Overall Study|Non-compliance/Protocol deviation|6
682883|NCT01609257|2214497|P1|Overall Study|Non-compliance/Protocol deviation|4
682884|NCT01609257|2214496|P2|Overall Study|Voluntary Withdrawal by Subject|1
682885|NCT01609257|2214497|P1|Overall Study|Voluntary Withdrawal by Subject|0
682886|NCT01609257|2214496|P2|Overall Study|Lost to Follow-up|1
682887|NCT01609257|2214497|P1|Overall Study|Lost to Follow-up|2
682888|NCT01609062|2214569|P2|Extension Phase|Anticipated surgery & transition to EAP|1
682889|NCT01609062|2214570|P1|Extension Phase|Anticipated surgery & transition to EAP|0
682890|NCT01609062|2214569|P2|Extension Phase|Discontinued drug and then was pregnant|0
682891|NCT01609062|2214570|P1|Extension Phase|Discontinued drug and then was pregnant|1
682892|NCT01609062|2214569|P2|Extension Phase|Terminated by Sponsor|9
682893|NCT01609062|2214570|P1|Extension Phase|Terminated by Sponsor|14
682894|NCT01609023|2214613|P1|Overall Study|Personal reasons|1
682895|NCT01609023|2214613|P1|Overall Study|Death|2
682896|NCT01609023|2214613|P1|Overall Study|Physician Decision|2
682897|NCT01609023|2214613|P1|Overall Study|Disease progression|10
682898|NCT01609023|2214613|P1|Overall Study|Toxicity|3
682899|NCT01609023|2214613|P1|Overall Study|Lost to Follow-up|8
682900|NCT01609023|2214613|P1|Overall Study|Withdrawal by Subject|4
682901|NCT01609023|2214613|P1|Overall Study|Lack of Efficacy|3
682902|NCT01609010|2214625|P2|Overall Study|Lost to Follow-up|1
682903|NCT01609010|2214626|P1|Overall Study|Lost to Follow-up|1
682904|NCT01609010|2214625|P2|Overall Study|New cancer|0
682905|NCT01609010|2214626|P1|Overall Study|New cancer|1
682906|NCT01609010|2214625|P2|Overall Study|Protocol Violation|1
682907|NCT01609010|2214626|P1|Overall Study|Protocol Violation|1
682908|NCT01609010|2214625|P2|Overall Study|Pathology review|1
682909|NCT01609010|2214626|P1|Overall Study|Pathology review|2
682910|NCT01609010|2214625|P2|Overall Study|Other malignancy|0
682911|NCT01609010|2214626|P1|Overall Study|Other malignancy|1
682912|NCT01609010|2214625|P2|Overall Study|Not specified|0
682913|NCT01609010|2214626|P1|Overall Study|Not specified|2
682914|NCT01609010|2214625|P2|Overall Study|Withdrawal by Subject|2
682915|NCT01609010|2214626|P1|Overall Study|Withdrawal by Subject|2
682916|NCT01609010|2214625|P2|Overall Study|Adverse Event|6
682917|NCT01609010|2214626|P1|Overall Study|Adverse Event|3
682918|NCT01609010|2214625|P2|Overall Study|Progressive disease (PD)|10
682919|NCT01609010|2214626|P1|Overall Study|Progressive disease (PD)|8
682920|NCT01609010|2214625|P2|Overall Study|Stable disease (SD)|16
682921|NCT01609010|2214626|P1|Overall Study|Stable disease (SD)|22
682922|NCT01608724|2214687|P1|Overall Study|Safety reasons|1
682923|NCT01608724|2214687|P1|Overall Study|bood sugar too high, etc.|3
682924|NCT01608724|2214687|P1|Overall Study|Protocol Violation|6
682925|NCT01608724|2214687|P1|Overall Study|Adverse Event|29
682926|NCT01608724|2214687|P1|Overall Study|Study-specific discontinuation criteria|32
682927|NCT01608724|2214687|P1|Overall Study|Lost to Follow-up|41
682928|NCT01608724|2214687|P1|Overall Study|Withdrawal by Subject|131
682929|NCT01608321|2214719|P2|Overall Study|Withdrawal by Subject|0
682930|NCT01608321|2214720|P1|Overall Study|Withdrawal by Subject|1
682931|NCT01608308|2214728|P2|Overall Study|pretreatment medical and billing reasons|2
682932|NCT01608308|2214729|P1|Overall Study|pretreatment medical and billing reasons|0
682933|NCT01607593|2214928|P1|Overall Study|Unspecified|4
682934|NCT01607593|2214928|P1|Overall Study|Continuation|33
682935|NCT01607593|2214928|P1|Overall Study|Lost to Follow-up|25
682936|NCT01607593|2214928|P1|Overall Study|Lack of Efficacy|16
682937|NCT01607593|2214928|P1|Overall Study|Adverse Event|15
682938|NCT01607476|2214937|P3|Overall Study|Lost to Follow-up|2
682939|NCT01607476|2214938|P2|Overall Study|Lost to Follow-up|0
682940|NCT01607476|2214939|P1|Overall Study|Lost to Follow-up|0
682941|NCT01607476|2214937|P3|Overall Study|Withdrawal by Subject|1
682942|NCT01607476|2214938|P2|Overall Study|Withdrawal by Subject|0
682943|NCT01607476|2214939|P1|Overall Study|Withdrawal by Subject|1
682944|NCT01607398|2215033|P2|Overall Study|Severe COPD|0
682945|NCT01607398|2215034|P1|Overall Study|Severe COPD|2
682946|NCT01607398|2215033|P2|Overall Study|Adverse Event|2
682947|NCT01607398|2215034|P1|Overall Study|Adverse Event|0
682949|NCT01606800|2215151|P2|Overall Study|Missing completion status|0
682950|NCT01606800|2215152|P1|Overall Study|Missing completion status|2
682951|NCT01606800|2215151|P2|Overall Study|Participant withdrew consent|1
682952|NCT01606800|2215152|P1|Overall Study|Participant withdrew consent|0
682953|NCT01606800|2215151|P2|Overall Study|Adverse Event|1
682954|NCT01606800|2215152|P1|Overall Study|Adverse Event|3
682955|NCT01606748|2215160|P2|Overall Study|Withdrawal by Subject|0
682956|NCT01606748|2215161|P1|Overall Study|Withdrawal by Subject|1
682957|NCT01606748|2215160|P2|Overall Study|Progressive Disease|0
682958|NCT01606748|2215161|P1|Overall Study|Progressive Disease|1
682959|NCT01606748|2215160|P2|Overall Study|Adverse Event|0
682960|NCT01606748|2215161|P1|Overall Study|Adverse Event|1
682961|NCT01606670|2215202|P1|Overall Study|Other Reason|2
682962|NCT01606670|2215202|P1|Overall Study|Withdrawal by Subject|3
682963|NCT01606670|2215202|P1|Overall Study|Lost to Follow-up|3
682964|NCT01606670|2215202|P1|Overall Study|Lack of Efficacy|2
682965|NCT01606670|2215202|P1|Overall Study|Adverse Event|6
682966|NCT01606319|2215212|P2|Overall Study|Adverse Event|4
682967|NCT01606319|2215213|P1|Overall Study|Adverse Event|1
682968|NCT01606319|2215212|P2|Overall Study|Lack of Efficacy|8
682969|NCT01606319|2215213|P1|Overall Study|Lack of Efficacy|6
682970|NCT01606319|2215212|P2|Overall Study|Physician Decision|2
682971|NCT01606319|2215213|P1|Overall Study|Physician Decision|1
682972|NCT01606319|2215212|P2|Overall Study|Withdrawal by Subject|12
682973|NCT01606319|2215213|P1|Overall Study|Withdrawal by Subject|9
682974|NCT01606319|2215212|P2|Overall Study|Lost to Follow-up|14
682975|NCT01606319|2215213|P1|Overall Study|Lost to Follow-up|17
682976|NCT01606306|2215231|P6|Overall Study|Physician Decision|0
682977|NCT01606306|2215232|P5|Overall Study|Physician Decision|0
682978|NCT01606306|2215233|P4|Overall Study|Physician Decision|0
682979|NCT01606306|2215234|P3|Overall Study|Physician Decision|0
682980|NCT01606306|2215235|P2|Overall Study|Physician Decision|2
682981|NCT01606306|2215236|P1|Overall Study|Physician Decision|1
682982|NCT01606306|2215231|P6|Overall Study|Withdrawal by Subject|4
682983|NCT01606306|2215232|P5|Overall Study|Withdrawal by Subject|5
682984|NCT01606306|2215233|P4|Overall Study|Withdrawal by Subject|4
682985|NCT01606306|2215234|P3|Overall Study|Withdrawal by Subject|4
682986|NCT01606306|2215235|P2|Overall Study|Withdrawal by Subject|3
682987|NCT01606306|2215236|P1|Overall Study|Withdrawal by Subject|4
682988|NCT01606306|2215231|P6|Overall Study|Lost to Follow-up|5
682989|NCT01606306|2215232|P5|Overall Study|Lost to Follow-up|3
682990|NCT01606306|2215233|P4|Overall Study|Lost to Follow-up|4
682991|NCT01606306|2215234|P3|Overall Study|Lost to Follow-up|5
682992|NCT01606306|2215235|P2|Overall Study|Lost to Follow-up|4
682993|NCT01606306|2215236|P1|Overall Study|Lost to Follow-up|7
682994|NCT01606306|2215231|P6|Overall Study|Adverse Event|0
682995|NCT01606306|2215232|P5|Overall Study|Adverse Event|2
682996|NCT01606306|2215233|P4|Overall Study|Adverse Event|1
682997|NCT01606306|2215234|P3|Overall Study|Adverse Event|1
682998|NCT01606306|2215235|P2|Overall Study|Adverse Event|0
682999|NCT01606306|2215236|P1|Overall Study|Adverse Event|1
683000|NCT01606306|2215231|P6|Overall Study|Lack of Efficacy|2
683001|NCT01606306|2215232|P5|Overall Study|Lack of Efficacy|1
683002|NCT01606306|2215233|P4|Overall Study|Lack of Efficacy|4
683003|NCT01606306|2215234|P3|Overall Study|Lack of Efficacy|4
683004|NCT01606306|2215235|P2|Overall Study|Lack of Efficacy|1
683005|NCT01606306|2215236|P1|Overall Study|Lack of Efficacy|2
683006|NCT01606254|2215246|P4|Overall Study|Adverse Event|1
683007|NCT01606254|2215247|P3|Overall Study|Adverse Event|0
683008|NCT01606254|2215248|P2|Overall Study|Adverse Event|1
683009|NCT01606254|2215249|P1|Overall Study|Adverse Event|1
683010|NCT01606254|2215246|P4|Overall Study|Withdrawal by Subject|2
683011|NCT01606254|2215247|P3|Overall Study|Withdrawal by Subject|0
683012|NCT01606254|2215248|P2|Overall Study|Withdrawal by Subject|3
683013|NCT01606254|2215249|P1|Overall Study|Withdrawal by Subject|1
683014|NCT01606228|2215331|P1|Overall Study|Adverse Event|1
683015|NCT01606228|2215331|P1|Overall Study|Lack of Efficacy|2
683016|NCT01606228|2215331|P1|Overall Study|Non-compliant|3
683017|NCT01606228|2215331|P1|Overall Study|Withdrawal by Subject|3
683018|NCT01606228|2215331|P1|Overall Study|Lost to Follow-up|20
683019|NCT01606202|2215348|P2|Overall Study|Problems with administration|1
683020|NCT01606202|2215349|P1|Overall Study|Problems with administration|0
683021|NCT01606202|2215348|P2|Overall Study|Personal problems|1
683022|NCT01606202|2215349|P1|Overall Study|Personal problems|0
683023|NCT01606202|2215348|P2|Overall Study|Withdrawal by Subject|1
683024|NCT01606202|2215349|P1|Overall Study|Withdrawal by Subject|2
683025|NCT01606202|2215348|P2|Overall Study|Adverse Event|0
683026|NCT01606202|2215349|P1|Overall Study|Adverse Event|5
683027|NCT01606189|2215381|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
683028|NCT01606189|2215382|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
683029|NCT01606189|2215383|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
683030|NCT01606189|2215384|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
683031|NCT01606189|2215385|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
683032|NCT01606189|2215386|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
683033|NCT01606189|2215381|P6|Second Intenvention (14-20 Days)|Adverse Event|1
683034|NCT01606189|2215382|P5|Second Intenvention (14-20 Days)|Adverse Event|0
683035|NCT01606189|2215383|P4|Second Intenvention (14-20 Days)|Adverse Event|0
683036|NCT01606189|2215384|P3|Second Intenvention (14-20 Days)|Adverse Event|0
683037|NCT01606189|2215385|P2|Second Intenvention (14-20 Days)|Adverse Event|0
683038|NCT01606189|2215386|P1|Second Intenvention (14-20 Days)|Adverse Event|0
683039|NCT01606176|2215420|P2|Overall Study|Withdrawal by Subject|0
683040|NCT01606176|2215421|P1|Overall Study|Withdrawal by Subject|1
683041|NCT01606176|2215420|P2|Overall Study|Disease progression|0
683042|NCT01606176|2215421|P1|Overall Study|Disease progression|1
683043|NCT01606176|2215420|P2|Overall Study|Adverse Event|3
683044|NCT01606176|2215421|P1|Overall Study|Adverse Event|2
683045|NCT01606137|2215466|P1|Overall Study|Unable to collect consistent data|1
683046|NCT01606137|2215466|P1|Overall Study|Patient moving|1
683047|NCT01606137|2215466|P1|Overall Study|Unable to tolerate study med. taste|1
683048|NCT01606137|2215466|P1|Overall Study|Personal reasons|1
683049|NCT01606137|2215466|P1|Overall Study|Patient leaving country|1
683050|NCT01606137|2215466|P1|Overall Study|Wanted to try another treatment|1
683051|NCT01606137|2215466|P1|Overall Study|Not enough improvement|4
683052|NCT01606137|2215466|P1|Overall Study|Spray causes nausea|1
683053|NCT01606137|2215466|P1|Overall Study|Increased bilirubin|1
683054|NCT01606137|2215466|P1|Overall Study|multiple sclerosis less stable|1
683055|NCT01606137|2215466|P1|Overall Study|Issues with driving|4
683056|NCT01606137|2215466|P1|Overall Study|Decreased/no pain|4
683057|NCT01606137|2215466|P1|Overall Study|Death|1
683058|NCT01606137|2215466|P1|Overall Study|Patient non-compliance|9
683059|NCT01606137|2215466|P1|Overall Study|Protocol Violation|1
683060|NCT01606137|2215466|P1|Overall Study|Lost to Follow-up|15
683061|NCT01606137|2215466|P1|Overall Study|Lack of Efficacy|56
683062|NCT01606137|2215466|P1|Overall Study|Withdrawal by Subject|74
683063|NCT01606137|2215466|P1|Overall Study|Adverse Event|85
683064|NCT01606007|2215500|P3|Overall Study|Poor/Non-compliance|0
683065|NCT01606007|2215501|P2|Overall Study|Poor/Non-compliance|0
683066|NCT01606007|2215502|P1|Overall Study|Poor/Non-compliance|1
683067|NCT01606007|2215500|P3|Overall Study|Lost to Follow-up|5
683068|NCT01606007|2215501|P2|Overall Study|Lost to Follow-up|8
683069|NCT01606007|2215502|P1|Overall Study|Lost to Follow-up|6
683070|NCT01606007|2215500|P3|Overall Study|discontinue study treatment|1
683071|NCT01606007|2215501|P2|Overall Study|discontinue study treatment|2
683072|NCT01606007|2215502|P1|Overall Study|discontinue study treatment|0
683073|NCT01606007|2215500|P3|Overall Study|Adverse Event|1
683074|NCT01606007|2215501|P2|Overall Study|Adverse Event|1
683075|NCT01606007|2215502|P1|Overall Study|Adverse Event|0
683076|NCT01606007|2215500|P3|Overall Study|Withdrawal by Subject|1
683077|NCT01606007|2215501|P2|Overall Study|Withdrawal by Subject|6
683078|NCT01606007|2215502|P1|Overall Study|Withdrawal by Subject|8
683079|NCT01606007|2215500|P3|Overall Study|Pregnancy|1
683080|NCT01606007|2215501|P2|Overall Study|Pregnancy|1
683081|NCT01606007|2215502|P1|Overall Study|Pregnancy|0
683082|NCT01606007|2215500|P3|Overall Study|Reason 'Other' in the protocol|1
683083|NCT01606007|2215501|P2|Overall Study|Reason 'Other' in the protocol|1
683084|NCT01606007|2215502|P1|Overall Study|Reason 'Other' in the protocol|0
683085|NCT01605916|2215537|P5|Overall Study|Withdrawal by Subject|2
683086|NCT01605916|2215538|P4|Overall Study|Withdrawal by Subject|0
683087|NCT01605916|2215539|P3|Overall Study|Withdrawal by Subject|0
683088|NCT01605916|2215540|P2|Overall Study|Withdrawal by Subject|1
683089|NCT01605916|2215541|P1|Overall Study|Withdrawal by Subject|1
683090|NCT01605916|2215537|P5|Overall Study|Lack of Efficacy|4
683091|NCT01605916|2215538|P4|Overall Study|Lack of Efficacy|5
683092|NCT01605916|2215539|P3|Overall Study|Lack of Efficacy|3
683093|NCT01605916|2215540|P2|Overall Study|Lack of Efficacy|3
683094|NCT01605916|2215541|P1|Overall Study|Lack of Efficacy|2
683095|NCT01605916|2215537|P5|Overall Study|Adverse Event|0
683096|NCT01605916|2215538|P4|Overall Study|Adverse Event|1
683097|NCT01605916|2215539|P3|Overall Study|Adverse Event|0
683098|NCT01605916|2215540|P2|Overall Study|Adverse Event|0
683099|NCT01605916|2215541|P1|Overall Study|Adverse Event|1
683100|NCT01605877|2215614|P1|Overall Study|Withdrawal by Subject|1
683101|NCT01605825|2215678|P2|Overall Study|Non-Compliance with Protocol|0
683102|NCT01605825|2215679|P1|Overall Study|Non-Compliance with Protocol|3
683103|NCT01605825|2215678|P2|Overall Study|Non-Compliance -Investigational Drug|0
683104|NCT01605825|2215679|P1|Overall Study|Non-Compliance -Investigational Drug|3
683105|NCT01605825|2215678|P2|Overall Study|Withdrawal by Subject|1
683106|NCT01605825|2215679|P1|Overall Study|Withdrawal by Subject|0
683107|NCT01605825|2215678|P2|Overall Study|Adverse Event|2
683108|NCT01605825|2215679|P1|Overall Study|Adverse Event|4
683109|NCT01605799|2215687|P2|Overall Study|Withdrawal by Subject|1
683110|NCT01605799|2215688|P1|Overall Study|Withdrawal by Subject|2
683111|NCT01605617|2215703|P2|Washout Period of 4 Weeks|Study Terminated|1
683112|NCT01605617|2215704|P1|Washout Period of 4 Weeks|Study Terminated|2
683113|NCT01605617|2215703|P2|First Intervention|Adverse Event|1
683114|NCT01605617|2215704|P1|First Intervention|Adverse Event|0
683115|NCT01605461|2215763|P1|Overall Study|Withdrawal by Subject|1
683116|NCT01605461|2215763|P1|Overall Study|Lost to Follow-up|3
683117|NCT01605370|2215774|P2|Overall Study|Adverse Event|0
683118|NCT01605370|2215775|P1|Overall Study|Adverse Event|1
683119|NCT01604941|2215810|P6|Overall Study|Early Study Termination|0
683120|NCT01604941|2215811|P5|Overall Study|Early Study Termination|0
683121|NCT01604941|2215812|P4|Overall Study|Early Study Termination|3
683122|NCT01604941|2215813|P3|Overall Study|Early Study Termination|3
683123|NCT01604941|2215814|P2|Overall Study|Early Study Termination|2
683124|NCT01604941|2215815|P1|Overall Study|Early Study Termination|9
683125|NCT01604941|2215810|P6|Overall Study|Participant Decision|2
683126|NCT01604941|2215811|P5|Overall Study|Participant Decision|0
683127|NCT01604941|2215812|P4|Overall Study|Participant Decision|0
683128|NCT01604941|2215813|P3|Overall Study|Participant Decision|0
683129|NCT01604941|2215814|P2|Overall Study|Participant Decision|0
683130|NCT01604941|2215815|P1|Overall Study|Participant Decision|0
683131|NCT01604941|2215810|P6|Overall Study|Non-compliance|0
683132|NCT01604941|2215811|P5|Overall Study|Non-compliance|0
683133|NCT01604941|2215812|P4|Overall Study|Non-compliance|0
683134|NCT01604941|2215813|P3|Overall Study|Non-compliance|0
683135|NCT01604941|2215814|P2|Overall Study|Non-compliance|0
683136|NCT01604941|2215815|P1|Overall Study|Non-compliance|1
683137|NCT01604941|2215810|P6|Overall Study|Adverse Event|5
683138|NCT01604941|2215811|P5|Overall Study|Adverse Event|1
683139|NCT01604941|2215812|P4|Overall Study|Adverse Event|0
683140|NCT01604941|2215813|P3|Overall Study|Adverse Event|0
683141|NCT01604941|2215814|P2|Overall Study|Adverse Event|2
683142|NCT01604941|2215815|P1|Overall Study|Adverse Event|1
683143|NCT01604850|2215843|P2|Overall Study|Subject withdrew consent|0
683144|NCT01604850|2215844|P1|Overall Study|Subject withdrew consent|1
683145|NCT01604850|2215843|P2|Overall Study|Lost to Follow-up|0
683146|NCT01604850|2215844|P1|Overall Study|Lost to Follow-up|1
683147|NCT01604850|2215843|P2|Overall Study|Efficacy Failure|29
683148|NCT01604850|2215844|P1|Overall Study|Efficacy Failure|50
683149|NCT01604850|2215843|P2|Overall Study|Enrolled but never treated|1
683150|NCT01604850|2215844|P1|Overall Study|Enrolled but never treated|0
683151|NCT01604278|2215868|P2|Overall Study|Protocol Deviation|3
683152|NCT01604278|2215869|P1|Overall Study|Protocol Deviation|5
683153|NCT01604278|2215868|P2|Overall Study|Adverse Event|5
683154|NCT01604278|2215869|P1|Overall Study|Adverse Event|3
683155|NCT01604278|2215868|P2|Overall Study|Withdrawal by Subject|3
683156|NCT01604278|2215869|P1|Overall Study|Withdrawal by Subject|3
683157|NCT01604278|2215868|P2|Overall Study|Administrative problems|1
683158|NCT01604278|2215869|P1|Overall Study|Administrative problems|2
683159|NCT01604278|2215868|P2|Overall Study|Lost to Follow-up|0
683160|NCT01604278|2215869|P1|Overall Study|Lost to Follow-up|1
683161|NCT01604278|2215868|P2|Overall Study|Lack of Efficacy|1
683162|NCT01604278|2215869|P1|Overall Study|Lack of Efficacy|0
683163|NCT01604265|2215895|P2|Overall Study|Withdrawal by Subject|0
683164|NCT01604265|2215896|P1|Overall Study|Withdrawal by Subject|1
683165|NCT01604265|2215895|P2|Overall Study|Adverse Event|0
683166|NCT01604265|2215896|P1|Overall Study|Adverse Event|1
683167|NCT01603875|2216007|P3|Overall Study|Protocol Violation|0
683168|NCT01603875|2216008|P2|Overall Study|Protocol Violation|1
683169|NCT01603875|2216009|P1|Overall Study|Protocol Violation|0
683170|NCT01603875|2216007|P3|Overall Study|Lost to Follow-up|6
683171|NCT01603875|2216008|P2|Overall Study|Lost to Follow-up|3
683172|NCT01603875|2216009|P1|Overall Study|Lost to Follow-up|4
683173|NCT01603875|2216007|P3|Overall Study|Preexisting rabies antibody|3
683174|NCT01603875|2216008|P2|Overall Study|Preexisting rabies antibody|4
683175|NCT01603875|2216009|P1|Overall Study|Preexisting rabies antibody|3
683176|NCT01603459|2216029|P1|Overall Study|Administrative reason|1
683177|NCT01603459|2216029|P1|Overall Study|Non-compliance|1
683178|NCT01603459|2216029|P1|Overall Study|Predefined discontinuation criteria|3
683179|NCT01603459|2216029|P1|Overall Study|Lost to Follow-up|3
683180|NCT01603459|2216029|P1|Overall Study|Withdrawal by Subject|5
683181|NCT01603459|2216029|P1|Overall Study|Adverse Event|5
683182|NCT01603394|2216180|P1|Overall Study|Adverse Event|1
683183|NCT01603277|2216197|P2|Overall Study|Non-Compliance|1
683184|NCT01603277|2216198|P1|Overall Study|Non-Compliance|2
683185|NCT01603277|2216197|P2|Overall Study|Withdrawal by Subject|4
683186|NCT01603277|2216198|P1|Overall Study|Withdrawal by Subject|5
683187|NCT01603277|2216197|P2|Overall Study|Protocol Violation|10
683188|NCT01603277|2216198|P1|Overall Study|Protocol Violation|6
683189|NCT01603277|2216197|P2|Overall Study|Physician Decision|1
683190|NCT01603277|2216198|P1|Overall Study|Physician Decision|0
683191|NCT01603277|2216197|P2|Overall Study|Adverse Event|2
683192|NCT01603277|2216198|P1|Overall Study|Adverse Event|1
683193|NCT01603121|2216204|P2|Second Intervention, 10 Hours|Adverse Event|0
683194|NCT01603121|2216205|P1|Second Intervention, 10 Hours|Adverse Event|1
683195|NCT01603082|2216217|P2|Overall Study|Failed inclusion criterion after dosed|0
683196|NCT01603082|2216218|P1|Overall Study|Failed inclusion criterion after dosed|1
683197|NCT01603082|2216217|P2|Overall Study|Withdrawal by Subject|0
683198|NCT01603082|2216218|P1|Overall Study|Withdrawal by Subject|1
683199|NCT01603082|2216217|P2|Overall Study|Adverse Event|1
683200|NCT01603082|2216218|P1|Overall Study|Adverse Event|0
683201|NCT01603043|2216259|P2|Overall Study|Study Futility|3
683202|NCT01603043|2216260|P1|Overall Study|Study Futility|7
683203|NCT01602965|2216272|P2|Overall Study|Lost to Follow-up|2
683204|NCT01602965|2216273|P1|Overall Study|Lost to Follow-up|4
683205|NCT01602744|2216281|P2|Overall Study|Lost to Follow-up|8
683206|NCT01602744|2216282|P1|Overall Study|Lost to Follow-up|13
683207|NCT01602744|2216281|P2|Overall Study|Death|15
683208|NCT01602744|2216282|P1|Overall Study|Death|17
683209|NCT01602562|2216306|P2|Overall Study|Withdrawal by Subject|1
683210|NCT01602562|2216307|P1|Overall Study|Withdrawal by Subject|1
683211|NCT01602562|2216306|P2|Overall Study|Physician Decision|1
683212|NCT01602562|2216307|P1|Overall Study|Physician Decision|1
683213|NCT01602562|2216306|P2|Overall Study|Adverse Event|1
683214|NCT01602562|2216307|P1|Overall Study|Adverse Event|3
683215|NCT01602549|2216343|P2|Overall Study|Withdrawal by Subject|0
683216|NCT01602549|2216344|P1|Overall Study|Withdrawal by Subject|1
683217|NCT01602549|2216343|P2|Overall Study|Protocol Violation|1
683218|NCT01602549|2216344|P1|Overall Study|Protocol Violation|0
683219|NCT01602510|2216423|P3|Randomized Phase|Withdrawal by Subject|7
683220|NCT01602510|2216424|P2|Randomized Phase|Withdrawal by Subject|6
683221|NCT01602510|2216425|P1|Randomized Phase|Withdrawal by Subject|0
683222|NCT01602510|2216423|P3|Randomized Phase|Physician Decision|2
683223|NCT01602510|2216424|P2|Randomized Phase|Physician Decision|0
683224|NCT01602510|2216425|P1|Randomized Phase|Physician Decision|0
683225|NCT01602510|2216423|P3|Randomized Phase|Lost to Follow-up|3
683226|NCT01602510|2216424|P2|Randomized Phase|Lost to Follow-up|1
683227|NCT01602510|2216425|P1|Randomized Phase|Lost to Follow-up|0
683228|NCT01602510|2216423|P3|Randomized Phase|Met protocol-defined stopping criteria|48
683229|NCT01602510|2216424|P2|Randomized Phase|Met protocol-defined stopping criteria|58
683230|NCT01602510|2216425|P1|Randomized Phase|Met protocol-defined stopping criteria|0
683231|NCT01602510|2216423|P3|Randomized Phase|Protocol Violation|3
683232|NCT01602510|2216424|P2|Randomized Phase|Protocol Violation|3
683233|NCT01602510|2216425|P1|Randomized Phase|Protocol Violation|0
683234|NCT01602510|2216423|P3|Randomized Phase|Lack of Efficacy|4
683235|NCT01602510|2216424|P2|Randomized Phase|Lack of Efficacy|4
683236|NCT01602510|2216425|P1|Randomized Phase|Lack of Efficacy|0
683237|NCT01602510|2216423|P3|Randomized Phase|Adverse Event|6
683238|NCT01602510|2216424|P2|Randomized Phase|Adverse Event|2
683239|NCT01602510|2216425|P1|Randomized Phase|Adverse Event|0
683240|NCT01602510|2216423|P3|Open Label Phase|Withdrawal by Subject|0
683241|NCT01602510|2216424|P2|Open Label Phase|Withdrawal by Subject|0
683242|NCT01602510|2216425|P1|Open Label Phase|Withdrawal by Subject|57
683243|NCT01602510|2216423|P3|Open Label Phase|Physician Decision|0
683244|NCT01602510|2216424|P2|Open Label Phase|Physician Decision|0
683245|NCT01602510|2216425|P1|Open Label Phase|Physician Decision|19
683246|NCT01602510|2216423|P3|Open Label Phase|Lost to Follow-up|0
683247|NCT01602510|2216424|P2|Open Label Phase|Lost to Follow-up|0
683248|NCT01602510|2216425|P1|Open Label Phase|Lost to Follow-up|22
683249|NCT01602510|2216423|P3|Open Label Phase|Met protocol-defined stopping criteria|0
683250|NCT01602510|2216424|P2|Open Label Phase|Met protocol-defined stopping criteria|0
683251|NCT01602510|2216425|P1|Open Label Phase|Met protocol-defined stopping criteria|122
683252|NCT01602510|2216423|P3|Open Label Phase|Protocol Violation|0
683253|NCT01602510|2216424|P2|Open Label Phase|Protocol Violation|0
683254|NCT01602510|2216425|P1|Open Label Phase|Protocol Violation|15
683255|NCT01602510|2216423|P3|Open Label Phase|Lack of Efficacy|0
683256|NCT01602510|2216424|P2|Open Label Phase|Lack of Efficacy|0
683257|NCT01602510|2216425|P1|Open Label Phase|Lack of Efficacy|22
683258|NCT01602510|2216423|P3|Open Label Phase|Adverse Event|0
683259|NCT01602510|2216424|P2|Open Label Phase|Adverse Event|0
683260|NCT01602510|2216425|P1|Open Label Phase|Adverse Event|46
683261|NCT01602484|2216451|P2|Overall Study|Airway issues unrelated to study|1
683262|NCT01602484|2216452|P1|Overall Study|Airway issues unrelated to study|0
683263|NCT01602380|2216470|P2|Overall Study|Eligibility criteria not fulfilled|3
683264|NCT01602380|2216471|P1|Overall Study|Eligibility criteria not fulfilled|2
683265|NCT01602380|2216470|P2|Overall Study|Lost to Follow-up|1
683266|NCT01602380|2216471|P1|Overall Study|Lost to Follow-up|6
683267|NCT01602380|2216470|P2|Overall Study|Withdrawal by Subject|29
683268|NCT01602380|2216471|P1|Overall Study|Withdrawal by Subject|22
683269|NCT01602380|2216470|P2|Overall Study|Death|68
683270|NCT01602380|2216471|P1|Overall Study|Death|63
683271|NCT01602341|2216495|P2|Overall Study|Adverse Event|1
683272|NCT01602341|2216496|P1|Overall Study|Adverse Event|0
683273|NCT01601821|2216563|P2|Overall Study|Unspecified|1
683274|NCT01601821|2216564|P1|Overall Study|Unspecified|5
683275|NCT01601821|2216563|P2|Overall Study|Study Events|1
683276|NCT01601821|2216564|P1|Overall Study|Study Events|7
683277|NCT01601821|2216563|P2|Overall Study|Graft Loss|6
683278|NCT01601821|2216564|P1|Overall Study|Graft Loss|6
683279|NCT01601821|2216563|P2|Overall Study|Withdrawal by Subject|0
683280|NCT01601821|2216564|P1|Overall Study|Withdrawal by Subject|1
683281|NCT01601821|2216563|P2|Overall Study|Lost to Follow-up|14
683282|NCT01601821|2216564|P1|Overall Study|Lost to Follow-up|6
683283|NCT01601821|2216563|P2|Overall Study|Protocol Violation|2
683284|NCT01601821|2216564|P1|Overall Study|Protocol Violation|2
683285|NCT01601821|2216563|P2|Overall Study|Death|5
683286|NCT01601821|2216564|P1|Overall Study|Death|2
683287|NCT01601704|2216600|P2|Overall Study|Randomized but not dispensed study med|4
683288|NCT01601704|2216601|P1|Overall Study|Randomized but not dispensed study med|1
683289|NCT01601470|2216619|P1|Period 2 - LCZ696|Physician Decision|1
683290|NCT01601132|2216681|P1|Overall Study|Protocol deviation|1
683291|NCT01601132|2216681|P1|Overall Study|Patient withdrew consent|1
683292|NCT01600885|2216715|P2|First Period|moved out of area|0
683293|NCT01600885|2216716|P1|First Period|moved out of area|1
683294|NCT01600885|2216715|P2|First Period|Adverse Event|1
683295|NCT01600885|2216716|P1|First Period|Adverse Event|1
683308|NCT01600326|2216810|P2|Overall Study|Lost to Follow-up|1
683309|NCT01600326|2216811|P1|Overall Study|Lost to Follow-up|1
683310|NCT01600092|2216887|P2|Overall Study|Randomized but not vaccinated|3
683311|NCT01600092|2216888|P1|Overall Study|Randomized but not vaccinated|3
683312|NCT01600092|2216887|P2|Overall Study|Physician Decision|1
683313|NCT01600092|2216888|P1|Overall Study|Physician Decision|1
683314|NCT01600092|2216887|P2|Overall Study|Withdrawal by parent/guardian|6
683315|NCT01600092|2216888|P1|Overall Study|Withdrawal by parent/guardian|8
683316|NCT01600092|2216887|P2|Overall Study|Lost to Follow-up|6
683317|NCT01600092|2216888|P1|Overall Study|Lost to Follow-up|4
683318|NCT01600092|2216887|P2|Overall Study|Adverse Event|0
683319|NCT01600092|2216888|P1|Overall Study|Adverse Event|2
683320|NCT01600053|2216902|P1|Overall Study|trial will not meet the interim endpoint|9
683321|NCT01600053|2216902|P1|Overall Study|Adverse Event|2
683322|NCT01600014|2216907|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
683323|NCT01600014|2216908|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
683324|NCT01600014|2216907|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
683325|NCT01600014|2216908|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
683326|NCT01600014|2216907|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
683327|NCT01600014|2216908|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
683328|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
683329|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
683330|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
683331|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
683332|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
683333|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
683334|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
683335|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
683336|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
683337|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
683338|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
683339|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
683340|NCT01600014|2216907|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
683341|NCT01600014|2216908|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
683342|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
683343|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
683344|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
683345|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
683346|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
683347|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
683348|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Other|0
683349|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Other|27
683350|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
683351|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
683352|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
683353|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
683354|NCT01600014|2216907|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
683355|NCT01600014|2216908|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
683356|NCT01599806|2216936|P2|Overall Study|Other Eligibility criteria|9
683357|NCT01599806|2216937|P1|Overall Study|Other Eligibility criteria|11
683358|NCT01599806|2216936|P2|Overall Study|Withdrawal by Subject|12
683359|NCT01599806|2216937|P1|Overall Study|Withdrawal by Subject|12
683360|NCT01599806|2216936|P2|Overall Study|Lost to Follow-up|20
683361|NCT01599806|2216937|P1|Overall Study|Lost to Follow-up|20
683362|NCT01599650|2217070|P3|Overall Study|Adverse Event|4
683363|NCT01599650|2217071|P2|Overall Study|Adverse Event|8
683364|NCT01599650|2217072|P1|Overall Study|Adverse Event|3
683365|NCT01599650|2217070|P3|Overall Study|Withdrawal by Subject|10
683366|NCT01599650|2217071|P2|Overall Study|Withdrawal by Subject|11
683367|NCT01599650|2217072|P1|Overall Study|Withdrawal by Subject|11
683368|NCT01599650|2217070|P3|Overall Study|Lost to Follow-up|3
683369|NCT01599650|2217071|P2|Overall Study|Lost to Follow-up|3
683370|NCT01599650|2217072|P1|Overall Study|Lost to Follow-up|3
683371|NCT01599650|2217070|P3|Overall Study|Death|2
683372|NCT01599650|2217071|P2|Overall Study|Death|1
683373|NCT01599650|2217072|P1|Overall Study|Death|2
683374|NCT01599650|2217070|P3|Overall Study|Protocol Violation|0
683375|NCT01599650|2217071|P2|Overall Study|Protocol Violation|3
683376|NCT01599650|2217072|P1|Overall Study|Protocol Violation|0
683377|NCT01599650|2217070|P3|Overall Study|Physician Decision|7
683378|NCT01599650|2217071|P2|Overall Study|Physician Decision|0
683379|NCT01599650|2217072|P1|Overall Study|Physician Decision|2
683380|NCT01599650|2217070|P3|Overall Study|Administrative issue|1
683381|NCT01599650|2217071|P2|Overall Study|Administrative issue|0
683382|NCT01599650|2217072|P1|Overall Study|Administrative issue|1
683383|NCT01599637|2217111|P3|Overall Study|Adverse Event|0
683384|NCT01599637|2217112|P2|Overall Study|Adverse Event|0
683385|NCT01599637|2217113|P1|Overall Study|Adverse Event|1
683386|NCT01599637|2217111|P3|Overall Study|administrative problems|0
683387|NCT01599637|2217112|P2|Overall Study|administrative problems|2
683388|NCT01599637|2217113|P1|Overall Study|administrative problems|0
683389|NCT01599585|2217160|P2|Overall Study|randomized did not start treatment|3
683390|NCT01599585|2217161|P1|Overall Study|randomized did not start treatment|3
683391|NCT01599585|2217160|P2|Overall Study|Lost to Follow-up|5
683392|NCT01599585|2217161|P1|Overall Study|Lost to Follow-up|3
683393|NCT01599585|2217160|P2|Overall Study|Withdrawal by Subject|9
683394|NCT01599585|2217161|P1|Overall Study|Withdrawal by Subject|16
683395|NCT01599325|2217199|P1|Overall Study|Unspecified|2
683396|NCT01599325|2217199|P1|Overall Study|Lack of Therapeutic Effect|9
683397|NCT01599325|2217199|P1|Overall Study|Protocol Violation|1
683398|NCT01599325|2217199|P1|Overall Study|Death|13
683399|NCT01599325|2217199|P1|Overall Study|Withdrawal by Subject|20
683400|NCT01599325|2217199|P1|Overall Study|Disease Progression|7
683401|NCT01599325|2217199|P1|Overall Study|Adverse Event|5
683402|NCT01599234|2217221|P2|Overall Study|Pregnancy|1
683403|NCT01599234|2217222|P1|Overall Study|Pregnancy|0
683404|NCT01599234|2217221|P2|Overall Study|Contra-indication discovered|1
683405|NCT01599234|2217222|P1|Overall Study|Contra-indication discovered|0
683406|NCT01599234|2217221|P2|Overall Study|Patient would not stop driving|0
683407|NCT01599234|2217222|P1|Overall Study|Patient would not stop driving|1
683408|NCT01599234|2217221|P2|Overall Study|Death|0
683409|NCT01599234|2217222|P1|Overall Study|Death|1
683410|NCT01599234|2217221|P2|Overall Study|Sponsor request as creatinine levels <50|1
683411|NCT01599234|2217222|P1|Overall Study|Sponsor request as creatinine levels <50|0
683412|NCT01599234|2217221|P2|Overall Study|Unable to operate spray|0
683413|NCT01599234|2217222|P1|Overall Study|Unable to operate spray|1
683414|NCT01599234|2217221|P2|Overall Study|Lack of Efficacy|4
683415|NCT01599234|2217222|P1|Overall Study|Lack of Efficacy|2
683416|NCT01599234|2217221|P2|Overall Study|Lost to Follow-up|2
683417|NCT01599234|2217222|P1|Overall Study|Lost to Follow-up|1
683418|NCT01599234|2217221|P2|Overall Study|Withdrawal by Subject|1
683419|NCT01599234|2217222|P1|Overall Study|Withdrawal by Subject|2
683420|NCT01599234|2217221|P2|Overall Study|Adverse Event|5
683421|NCT01599234|2217222|P1|Overall Study|Adverse Event|9
683422|NCT01599104|2217247|P3|Overall Study|Adverse Event|12
683423|NCT01599104|2217248|P2|Overall Study|Adverse Event|6
683424|NCT01599104|2217249|P1|Overall Study|Adverse Event|7
683425|NCT01599104|2217247|P3|Overall Study|Lack of Efficacy|10
683426|NCT01599104|2217248|P2|Overall Study|Lack of Efficacy|4
683427|NCT01599104|2217249|P1|Overall Study|Lack of Efficacy|4
683428|NCT01599104|2217247|P3|Overall Study|Non-compliance with study treatment|0
683429|NCT01599104|2217248|P2|Overall Study|Non-compliance with study treatment|1
683430|NCT01599104|2217249|P1|Overall Study|Non-compliance with study treatment|0
683431|NCT01599104|2217247|P3|Overall Study|Physician Decision|2
683432|NCT01599104|2217248|P2|Overall Study|Physician Decision|2
683433|NCT01599104|2217249|P1|Overall Study|Physician Decision|3
683434|NCT01599104|2217247|P3|Overall Study|Technical Problems|0
683435|NCT01599104|2217248|P2|Overall Study|Technical Problems|0
683436|NCT01599104|2217249|P1|Overall Study|Technical Problems|1
683437|NCT01599104|2217247|P3|Overall Study|Withdrawal by Subject|2
683438|NCT01599104|2217248|P2|Overall Study|Withdrawal by Subject|1
683439|NCT01599104|2217249|P1|Overall Study|Withdrawal by Subject|1
683440|NCT01598987|2217287|P1|Baseline to 24 Month|Lost to Follow-up|1
683441|NCT01598987|2217287|P1|Baseline to 24 Month|Administrative problems|2
683442|NCT01598987|2217287|P1|Baseline to 24 Month|Withdrawal by Subject|5
683443|NCT01598987|2217287|P1|Baseline to Month 12|Withdrawal by Subject|4
683444|NCT01598987|2217287|P1|Baseline to Month 12|Administrative problems|2
683445|NCT01598610|2217336|P1|Overall Study|Adverse Event|1
683446|NCT01598532|2217353|P1|Overall Study|Did not meet inclusion criteria|8
683447|NCT01598532|2217353|P1|Overall Study|Lost to Follow-up|3
683448|NCT01598506|2217362|P1|Overall Study|Withdrawal by Subject|2
683449|NCT01598129|2217402|P1|Overall Study|Withdrawal by Subject|1
683450|NCT01598129|2217402|P1|Overall Study|Deterioration of WHO status to WHO 4|2
683451|NCT01598129|2217402|P1|Overall Study|Disease progression|6
683452|NCT01597908|2217424|P2|Overall Study|Ongoing|202
683453|NCT01597908|2217425|P1|Overall Study|Ongoing|236
683454|NCT01597908|2217424|P2|Overall Study|Withdrawal by Subject|18
683455|NCT01597908|2217425|P1|Overall Study|Withdrawal by Subject|10
683456|NCT01597908|2217424|P2|Overall Study|Physician Decision|1
683457|NCT01597908|2217425|P1|Overall Study|Physician Decision|2
683458|NCT01597908|2217424|P2|Overall Study|Lost to Follow-up|9
683459|NCT01597908|2217425|P1|Overall Study|Lost to Follow-up|4
683460|NCT01597908|2217424|P2|Overall Study|Death|122
683461|NCT01597908|2217425|P1|Overall Study|Death|100
683470|NCT01597635|2217462|P3|Part B|Withdrawal by Subject|0
683471|NCT01597635|2217463|P2|Part B|Withdrawal by Subject|1
683472|NCT01597635|2217464|P1|Part B|Withdrawal by Subject|0
683473|NCT01597635|2217462|P3|Part B|Protocol-defined stopping criteria|3
683474|NCT01597635|2217463|P2|Part B|Protocol-defined stopping criteria|4
683475|NCT01597635|2217464|P1|Part B|Protocol-defined stopping criteria|0
683476|NCT01597635|2217462|P3|Part B|Protocol Violation|0
683477|NCT01597635|2217463|P2|Part B|Protocol Violation|1
683478|NCT01597635|2217464|P1|Part B|Protocol Violation|0
683479|NCT01597635|2217462|P3|Part B|Adverse Event|1
683480|NCT01597635|2217463|P2|Part B|Adverse Event|0
683481|NCT01597635|2217464|P1|Part B|Adverse Event|0
683482|NCT01597635|2217462|P3|Part A|Adverse Event|0
683483|NCT01597635|2217463|P2|Part A|Adverse Event|0
683484|NCT01597635|2217464|P1|Part A|Adverse Event|3
683485|NCT01597596|2217529|P2|Overall Study|Physician Decision|1
683486|NCT01597596|2217530|P1|Overall Study|Physician Decision|0
683487|NCT01597596|2217529|P2|Overall Study|Study terminated by sponsor|0
683488|NCT01597596|2217530|P1|Overall Study|Study terminated by sponsor|1
683489|NCT01597492|2217544|P2|Overall Study|Other Reason|0
683490|NCT01597492|2217545|P1|Overall Study|Other Reason|2
683491|NCT01597492|2217544|P2|Overall Study|Lost to Follow-up|2
683492|NCT01597492|2217545|P1|Overall Study|Lost to Follow-up|0
683493|NCT01597492|2217544|P2|Overall Study|Adverse Event|0
683494|NCT01597492|2217545|P1|Overall Study|Adverse Event|3
683495|NCT01597492|2217544|P2|Overall Study|Withdrawal by Subject|2
683496|NCT01597492|2217545|P1|Overall Study|Withdrawal by Subject|1
683497|NCT01597479|2217553|P2|Overall Study|Lost to Follow-up|0
683498|NCT01597479|2217554|P1|Overall Study|Lost to Follow-up|1
683499|NCT01597479|2217553|P2|Overall Study|Protocol Violation|0
683500|NCT01597479|2217554|P1|Overall Study|Protocol Violation|1
683501|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683502|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683503|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
683504|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683505|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683506|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683507|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683508|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683509|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683510|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683511|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683512|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683513|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
683514|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683515|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
683516|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
683517|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
683518|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
683519|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683740|NCT01594762|2218102|P2|Overall Study|Withdrawal by Subject|0
683520|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
683521|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683522|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683523|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683524|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683525|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683526|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
683527|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
683528|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
683529|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
683530|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
683531|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
683532|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
683533|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
683534|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
683535|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
683536|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
683537|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
683538|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
683539|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
683540|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
683541|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683542|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
683543|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
683544|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
683545|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683546|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683547|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683548|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
683549|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683550|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683551|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683552|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
683553|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
683554|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
683555|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
683556|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
683557|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
683558|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
683559|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
683560|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
683561|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
683562|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
683563|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
683564|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
683565|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
683566|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
683567|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
683568|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
683569|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
683570|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
683571|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
683572|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
683573|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
683574|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
683575|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
683576|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
683577|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
683578|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
683579|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
683580|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
683581|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
683582|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683583|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
683584|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683585|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
683586|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683587|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683588|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683589|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683590|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683591|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
683592|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683593|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683594|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683595|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
683596|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683597|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
683598|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
683599|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
683600|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
683601|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683602|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683603|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683604|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
683605|NCT01597245|2217576|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683606|NCT01597245|2217577|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683607|NCT01597245|2217578|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683608|NCT01597245|2217579|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683609|NCT01597245|2217580|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683610|NCT01597245|2217581|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683611|NCT01597245|2217582|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
683612|NCT01597245|2217583|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
683613|NCT01597245|2217584|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683614|NCT01597245|2217585|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683615|NCT01597245|2217586|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683616|NCT01597245|2217587|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683617|NCT01597245|2217588|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
683618|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683619|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683620|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683621|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683622|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683623|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683624|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683625|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683626|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683627|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
683628|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
683629|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
683630|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
683631|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
683632|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
683633|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
683634|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
683635|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
683636|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
683637|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
683638|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
683639|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
683640|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
683641|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
683642|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
683643|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
683644|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683645|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683646|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683647|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683648|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683649|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683650|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683651|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683652|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683653|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
683654|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
683655|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
683656|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
683657|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683658|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683659|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683741|NCT01594762|2218103|P1|Overall Study|Withdrawal by Subject|1
683660|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683661|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683662|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683663|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683664|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683665|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
683666|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
683667|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
683668|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
683669|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
683670|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683671|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683672|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683673|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683674|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683675|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683676|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683677|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683678|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
683679|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
683680|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
683681|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
683682|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
683683|NCT01597245|2217576|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
683684|NCT01597245|2217577|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
683685|NCT01597245|2217578|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
683686|NCT01597245|2217579|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
683687|NCT01597245|2217580|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
683688|NCT01597245|2217581|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
683689|NCT01597245|2217582|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
683690|NCT01597245|2217583|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
683691|NCT01597245|2217584|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
683692|NCT01597245|2217585|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
683693|NCT01597245|2217586|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
683694|NCT01597245|2217587|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
683695|NCT01597245|2217588|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
683696|NCT01597050|2217711|P2|Overall Study|Withdrawal by Subject|0
683697|NCT01597050|2217712|P1|Overall Study|Withdrawal by Subject|1
683698|NCT01596972|2217720|P2|Overall Study|Withdrawal by Subject|1
683699|NCT01596972|2217721|P1|Overall Study|Withdrawal by Subject|0
683700|NCT01596972|2217720|P2|Overall Study|Lost to Follow-up|4
683701|NCT01596972|2217721|P1|Overall Study|Lost to Follow-up|0
683702|NCT01596972|2217720|P2|Overall Study|Physician Decision|9
683703|NCT01596972|2217721|P1|Overall Study|Physician Decision|1
683704|NCT01596582|2217744|P2|Overall Study|Missing all outcome data|1
683705|NCT01596582|2217745|P1|Overall Study|Missing all outcome data|1
683706|NCT01596582|2217744|P2|Overall Study|Deemed ineligible after study visit|6
683707|NCT01596582|2217745|P1|Overall Study|Deemed ineligible after study visit|3
683708|NCT01596504|2217772|P3|Overall Study|Withdrawal by Subject|0
683709|NCT01596504|2217773|P2|Overall Study|Withdrawal by Subject|0
683710|NCT01596504|2217774|P1|Overall Study|Withdrawal by Subject|1
683711|NCT01596504|2217772|P3|Overall Study|Adverse Event|1
683712|NCT01596504|2217773|P2|Overall Study|Adverse Event|2
683713|NCT01596504|2217774|P1|Overall Study|Adverse Event|1
683714|NCT01596504|2217772|P3|Overall Study|Participant's Private Reason|0
683715|NCT01596504|2217773|P2|Overall Study|Participant's Private Reason|1
683716|NCT01596504|2217774|P1|Overall Study|Participant's Private Reason|0
683717|NCT01596062|2217846|P3|Overall Study|Lack of Efficacy|1
683718|NCT01596062|2217847|P2|Overall Study|Lack of Efficacy|0
683719|NCT01596062|2217848|P1|Overall Study|Lack of Efficacy|0
683720|NCT01596062|2217846|P3|Overall Study|Adverse Event|2
683721|NCT01596062|2217847|P2|Overall Study|Adverse Event|0
683722|NCT01596062|2217848|P1|Overall Study|Adverse Event|1
683723|NCT01595438|2217911|P2|Overall Study|Other Eligibility criteria|9
683724|NCT01595438|2217912|P1|Overall Study|Other Eligibility criteria|11
683725|NCT01595438|2217911|P2|Overall Study|Withdrawal by Subject|12
683726|NCT01595438|2217912|P1|Overall Study|Withdrawal by Subject|12
683727|NCT01595438|2217911|P2|Overall Study|Lost to Follow-up|20
683728|NCT01595438|2217912|P1|Overall Study|Lost to Follow-up|20
683729|NCT01594970|2218081|P3|Overall Study|Lost to Follow-up|37
683730|NCT01594970|2218082|P2|Overall Study|Lost to Follow-up|54
683731|NCT01594970|2218083|P1|Overall Study|Lost to Follow-up|54
683732|NCT01594970|2218081|P3|Overall Study|Adverse Event|23
683733|NCT01594970|2218082|P2|Overall Study|Adverse Event|23
683734|NCT01594970|2218083|P1|Overall Study|Adverse Event|17
683735|NCT01594970|2218081|P3|Overall Study|Non-Adverse Event Related|6
683736|NCT01594970|2218082|P2|Overall Study|Non-Adverse Event Related|5
683737|NCT01594970|2218083|P1|Overall Study|Non-Adverse Event Related|4
683738|NCT01594762|2218102|P2|Overall Study|Lost to Follow-up|10
683739|NCT01594762|2218103|P1|Overall Study|Lost to Follow-up|10
683742|NCT01594749|2218115|P2|Overall Study|Lost Source Documentation|0
683743|NCT01594749|2218116|P1|Overall Study|Lost Source Documentation|1
683744|NCT01594749|2218115|P2|Overall Study|Not Treated|10
683745|NCT01594749|2218116|P1|Overall Study|Not Treated|4
683746|NCT01594749|2218115|P2|Overall Study|Death|3
683747|NCT01594749|2218116|P1|Overall Study|Death|9
683748|NCT01594749|2218115|P2|Overall Study|Lost to Follow-up|0
683749|NCT01594749|2218116|P1|Overall Study|Lost to Follow-up|1
683750|NCT01594749|2218115|P2|Overall Study|Non-compliance with Protocol|1
683751|NCT01594749|2218116|P1|Overall Study|Non-compliance with Protocol|0
683752|NCT01594749|2218115|P2|Overall Study|Physician Decision|1
683753|NCT01594749|2218116|P1|Overall Study|Physician Decision|1
683754|NCT01594749|2218115|P2|Overall Study|Protocol Violation|0
683755|NCT01594749|2218116|P1|Overall Study|Protocol Violation|2
683756|NCT01594749|2218115|P2|Overall Study|Withdrawal by Subject|2
683757|NCT01594749|2218116|P1|Overall Study|Withdrawal by Subject|2
683758|NCT01594749|2218115|P2|Overall Study|Adverse Event|1
683759|NCT01594749|2218116|P1|Overall Study|Adverse Event|2
683761|NCT01594125|2218292|P5|Overall Study|Progressive Disease|7
683762|NCT01594125|2218293|P4|Overall Study|Progressive Disease|3
683763|NCT01594125|2218294|P3|Overall Study|Progressive Disease|3
683764|NCT01594125|2218295|P2|Overall Study|Progressive Disease|12
683765|NCT01594125|2218296|P1|Overall Study|Progressive Disease|3
683766|NCT01594125|2218292|P5|Overall Study|Withdrawal by Subject|0
683767|NCT01594125|2218293|P4|Overall Study|Withdrawal by Subject|1
683768|NCT01594125|2218294|P3|Overall Study|Withdrawal by Subject|0
683769|NCT01594125|2218295|P2|Overall Study|Withdrawal by Subject|0
683770|NCT01594125|2218296|P1|Overall Study|Withdrawal by Subject|1
683771|NCT01593787|2218356|P3|Overall Study|Adverse Event|0
683772|NCT01593787|2218357|P2|Overall Study|Adverse Event|0
683773|NCT01593787|2218358|P1|Overall Study|Adverse Event|1
683774|NCT01592864|2218436|P2|Overall Study|Withdrawal by Subject|1
683775|NCT01592864|2218437|P1|Overall Study|Withdrawal by Subject|0
683776|NCT01592786|2218468|P1|Overall Study|Other|3
683777|NCT01592786|2218468|P1|Overall Study|Lost to Follow-up|19
683778|NCT01592786|2218468|P1|Overall Study|Withdrawal by Subject|23
683779|NCT01592786|2218468|P1|Overall Study|Protocol Violation|14
683780|NCT01592786|2218468|P1|Overall Study|Lack of Efficacy|19
683781|NCT01592786|2218468|P1|Overall Study|Adverse Event|60
683782|NCT01592773|2218472|P1|Overall Study|Other Reason|1
683783|NCT01592773|2218472|P1|Overall Study|Inclusion/exclusion not meet|1
683784|NCT01592773|2218472|P1|Overall Study|Protocol Violation|2
683785|NCT01592773|2218472|P1|Overall Study|Lack of Efficacy|9
683786|NCT01592773|2218472|P1|Overall Study|Adverse Event|17
683787|NCT01592773|2218472|P1|Overall Study|Lost to Follow-up|19
683788|NCT01592773|2218472|P1|Overall Study|Withdrawal by Subject|35
683789|NCT01592773|2218472|P1|Overall Study|Study Terminated by Sponsor|582
683790|NCT01592760|2218479|P3|24-hour Follow-Up|Lost to Follow-up|2
683791|NCT01592760|2218480|P2|24-hour Follow-Up|Lost to Follow-up|3
683792|NCT01592760|2218481|P1|24-hour Follow-Up|Lost to Follow-up|4
683793|NCT01592708|2218524|P2|Overall Study|Protocol Violation|0
683794|NCT01592708|2218525|P1|Overall Study|Protocol Violation|3
683795|NCT01592695|2218541|P2|Overall Study|Lost to Follow-up|4
683796|NCT01592695|2218542|P1|Overall Study|Lost to Follow-up|8
683797|NCT01592344|2218586|P2|Overall Study|not available at primary outcome visit|4
683798|NCT01592344|2218587|P1|Overall Study|not available at primary outcome visit|2
683799|NCT01592344|2218586|P2|Overall Study|Lack of Efficacy|0
683800|NCT01592344|2218587|P1|Overall Study|Lack of Efficacy|1
683801|NCT01592344|2218586|P2|Overall Study|Adverse Event|1
683802|NCT01592344|2218587|P1|Overall Study|Adverse Event|1
683803|NCT01592292|2218601|P4|Overall Study|Not specified|1
683804|NCT01592292|2218602|P3|Overall Study|Not specified|2
683805|NCT01592292|2218603|P2|Overall Study|Not specified|1
683806|NCT01592292|2218604|P1|Overall Study|Not specified|1
683807|NCT01592292|2218601|P4|Overall Study|Withdrew consent|0
683808|NCT01592292|2218602|P3|Overall Study|Withdrew consent|0
683809|NCT01592292|2218603|P2|Overall Study|Withdrew consent|1
683810|NCT01592292|2218604|P1|Overall Study|Withdrew consent|2
683811|NCT01592292|2218601|P4|Overall Study|Follow-up loss|0
683812|NCT01592292|2218602|P3|Overall Study|Follow-up loss|1
683813|NCT01592292|2218603|P2|Overall Study|Follow-up loss|3
683814|NCT01592292|2218604|P1|Overall Study|Follow-up loss|3
683815|NCT01592045|2218649|P2|Overall Study|Moved out of country|0
683816|NCT01592045|2218650|P1|Overall Study|Moved out of country|2
683817|NCT01592045|2218649|P2|Overall Study|Withdrawal by Subject|0
683818|NCT01592045|2218650|P1|Overall Study|Withdrawal by Subject|1
683819|NCT01592045|2218649|P2|Overall Study|Adverse Event|1
683820|NCT01592045|2218650|P1|Overall Study|Adverse Event|1
683821|NCT01592045|2218649|P2|Overall Study|Disease Progression|1
683822|NCT01592045|2218650|P1|Overall Study|Disease Progression|1
683823|NCT01591863|2218668|P1|Overall Study|Lack of Efficacy|1
683824|NCT01591863|2218668|P1|Overall Study|recurrence|9
683825|NCT01591863|2218668|P1|Overall Study|Withdrawal by Subject|1
683826|NCT01591863|2218668|P1|Overall Study|Adverse Event|3
683827|NCT01591681|2218695|P1|Overall Study|Failed to use system during run-in|1
683828|NCT01591681|2218695|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
683829|NCT01591616|2218721|P1|Overall Study|Withdrawal by Subject|1
683830|NCT01591499|2218862|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
683831|NCT01591499|2218863|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
683832|NCT01591499|2218864|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
683833|NCT01591499|2218865|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
683834|NCT01591499|2218862|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
683835|NCT01591499|2218863|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
683836|NCT01591499|2218864|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
683837|NCT01591499|2218865|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
683838|NCT01591499|2218862|P4|Baseline Visit|Withdrawal by Subject|2
683839|NCT01591499|2218863|P3|Baseline Visit|Withdrawal by Subject|0
683840|NCT01591499|2218864|P2|Baseline Visit|Withdrawal by Subject|2
683841|NCT01591499|2218865|P1|Baseline Visit|Withdrawal by Subject|0
683842|NCT01591460|2218931|P1|Overall Study|Protocol Violation|1
683843|NCT01591460|2218931|P1|Overall Study|Withdrawal by Subject|1
683844|NCT01591460|2218931|P1|Overall Study|Participant Refusal|3
683845|NCT01591460|2218931|P1|Overall Study|Noncompliance|1
683846|NCT01591460|2218931|P1|Overall Study|Lost to Follow-up|1
683847|NCT01591460|2218931|P1|Overall Study|Treatment Discontinued by Error|1
683848|NCT01591460|2218931|P1|Overall Study|Rebound or Breakthrough|3
683849|NCT01591460|2218931|P1|Overall Study|Futility Rule (Week 24)|3
683850|NCT01591460|2218931|P1|Overall Study|Futility Rule (Week 12)|7
683851|NCT01591460|2218931|P1|Overall Study|Adverse Event or Intercurrent Illness|5
683852|NCT01591382|2219022|P2|Overall Study|Participant Opted for Morphine PCA|1
683853|NCT01591382|2219023|P1|Overall Study|Participant Opted for Morphine PCA|1
683854|NCT01591382|2219022|P2|Overall Study|Discharged Prior to Study Completion|1
683855|NCT01591382|2219023|P1|Overall Study|Discharged Prior to Study Completion|2
683856|NCT01590888|2219147|P3|Overall Study|Lost to Follow-up|0
683857|NCT01590888|2219148|P2|Overall Study|Lost to Follow-up|0
683858|NCT01590888|2219149|P1|Overall Study|Lost to Follow-up|1
683859|NCT01590888|2219147|P3|Overall Study|Adverse Event|1
683860|NCT01590888|2219148|P2|Overall Study|Adverse Event|0
683861|NCT01590888|2219149|P1|Overall Study|Adverse Event|3
683862|NCT01590810|2219213|P5|Overall Study|Physician Decision|0
683863|NCT01590810|2219214|P4|Overall Study|Physician Decision|0
683864|NCT01590810|2219215|P3|Overall Study|Physician Decision|1
683865|NCT01590810|2219216|P2|Overall Study|Physician Decision|1
683866|NCT01590810|2219217|P1|Overall Study|Physician Decision|0
683867|NCT01590797|2219362|P2|Overall Study|Other Protocol Specified Criteria|4
683868|NCT01590797|2219363|P1|Overall Study|Other Protocol Specified Criteria|2
683869|NCT01590797|2219362|P2|Overall Study|Withdrawal by Subject|5
683870|NCT01590797|2219363|P1|Overall Study|Withdrawal by Subject|7
683871|NCT01590797|2219362|P2|Overall Study|Protocol Violation|1
683872|NCT01590797|2219363|P1|Overall Study|Protocol Violation|4
683873|NCT01590797|2219362|P2|Overall Study|Lost to Follow-up|1
683874|NCT01590797|2219363|P1|Overall Study|Lost to Follow-up|0
683875|NCT01590797|2219362|P2|Overall Study|Lack of Efficacy|2
683876|NCT01590797|2219363|P1|Overall Study|Lack of Efficacy|0
683877|NCT01590797|2219362|P2|Overall Study|Adverse Event|3
683878|NCT01590797|2219363|P1|Overall Study|Adverse Event|4
683879|NCT01590771|2219379|P2|Overall Study|Adverse Event|7
683880|NCT01590771|2219380|P1|Overall Study|Adverse Event|3
683881|NCT01590771|2219379|P2|Overall Study|Lack of Efficacy|0
683882|NCT01590771|2219380|P1|Overall Study|Lack of Efficacy|1
683883|NCT01590771|2219379|P2|Overall Study|Lost to Follow-up|1
683884|NCT01590771|2219380|P1|Overall Study|Lost to Follow-up|1
683885|NCT01590771|2219379|P2|Overall Study|Protocol Violation|2
683886|NCT01590771|2219380|P1|Overall Study|Protocol Violation|1
683887|NCT01590771|2219379|P2|Overall Study|Withdrawal by Subject|15
683888|NCT01590771|2219380|P1|Overall Study|Withdrawal by Subject|8
683889|NCT01590771|2219379|P2|Overall Study|Other Protocol Specified Criteria|14
683890|NCT01590771|2219380|P1|Overall Study|Other Protocol Specified Criteria|5
683891|NCT01590758|2219408|P2|Overall Study|Lost to Follow-up|2
683892|NCT01590758|2219409|P1|Overall Study|Lost to Follow-up|4
683893|NCT01590758|2219408|P2|Overall Study|Physician Decision|2
683894|NCT01590758|2219409|P1|Overall Study|Physician Decision|1
683895|NCT01590758|2219408|P2|Overall Study|Withdrawal by Subject|3
683896|NCT01590758|2219409|P1|Overall Study|Withdrawal by Subject|0
683897|NCT01590563|2219419|P1|Overall Study|simple uterine hyperplasia - not related|1
683898|NCT01590212|2219443|P3|Overall Study|Lost to Follow-up|3
683899|NCT01590212|2219444|P2|Overall Study|Lost to Follow-up|2
683900|NCT01590212|2219445|P1|Overall Study|Lost to Follow-up|1
683901|NCT01590212|2219443|P3|Overall Study|Withdrawal by Subject|2
683902|NCT01590212|2219444|P2|Overall Study|Withdrawal by Subject|2
683903|NCT01590212|2219445|P1|Overall Study|Withdrawal by Subject|2
683904|NCT01589822|2219489|P3|Overall Study|Missed 90 day visit|1
683905|NCT01589822|2219490|P2|Overall Study|Missed 90 day visit|1
683906|NCT01589822|2219491|P1|Overall Study|Missed 90 day visit|2
683907|NCT01589822|2219489|P3|Overall Study|Death|0
683908|NCT01589822|2219490|P2|Overall Study|Death|0
683909|NCT01589822|2219491|P1|Overall Study|Death|1
683910|NCT01589822|2219489|P3|Overall Study|Withdrawal by Subject|0
683911|NCT01589822|2219490|P2|Overall Study|Withdrawal by Subject|2
683912|NCT01589822|2219491|P1|Overall Study|Withdrawal by Subject|1
683913|NCT01589653|2219510|P2|Overall Study|Unclassified|3
683914|NCT01589653|2219511|P1|Overall Study|Unclassified|0
683915|NCT01589653|2219510|P2|Overall Study|Withdrawal criteria|7
683916|NCT01589653|2219511|P1|Overall Study|Withdrawal criteria|4
683917|NCT01589653|2219510|P2|Overall Study|Protocol Violation|1
683918|NCT01589653|2219511|P1|Overall Study|Protocol Violation|3
683919|NCT01589497|2219559|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
683920|NCT01589497|2219560|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
683921|NCT01589497|2219561|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
683922|NCT01589497|2219562|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
683923|NCT01589497|2219559|P4|Overall Study|Death|0
683924|NCT01589497|2219560|P3|Overall Study|Death|0
683925|NCT01589497|2219561|P2|Overall Study|Death|0
683926|NCT01589497|2219562|P1|Overall Study|Death|1
683927|NCT01589497|2219559|P4|Overall Study|Withdrawal by Subject|1
683928|NCT01589497|2219560|P3|Overall Study|Withdrawal by Subject|0
683929|NCT01589497|2219561|P2|Overall Study|Withdrawal by Subject|1
683930|NCT01589497|2219562|P1|Overall Study|Withdrawal by Subject|0
683931|NCT01589445|2219600|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
683932|NCT01589445|2219600|P1|002 (Metformin)-3 Months|Adverse Event|2
683933|NCT01589445|2219600|P1|002 (Metformin)-3 Months|Protocol Violation|2
683934|NCT01589445|2219600|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
683935|NCT01589445|2219600|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
683936|NCT01589445|2219600|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
683937|NCT01589445|2219600|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
683938|NCT01589445|2219600|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
683939|NCT01589445|2219600|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
683940|NCT01589445|2219600|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
683941|NCT01589237|2219620|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
683942|NCT01589237|2219621|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
683943|NCT01589237|2219622|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
683944|NCT01589237|2219623|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
683945|NCT01589237|2219620|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
683946|NCT01589237|2219621|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
683947|NCT01589237|2219622|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
683948|NCT01589237|2219623|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
683949|NCT01589237|2219620|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
683950|NCT01589237|2219621|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
683951|NCT01589237|2219622|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
683952|NCT01589237|2219623|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
683953|NCT01589237|2219620|P4|Part A (52 Weeks)|Subject/guardian decision|0
683954|NCT01589237|2219621|P3|Part A (52 Weeks)|Subject/guardian decision|2
683955|NCT01589237|2219622|P2|Part A (52 Weeks)|Subject/guardian decision|3
683956|NCT01589237|2219623|P1|Part A (52 Weeks)|Subject/guardian decision|2
683957|NCT01588951|2219672|P3|Overall Study|Ineligible in retrospect|1
683958|NCT01588951|2219673|P2|Overall Study|Ineligible in retrospect|0
683959|NCT01588951|2219674|P1|Overall Study|Ineligible in retrospect|0
683960|NCT01588548|2219700|P6|Overall Study|Condition Under Investigation Worsened|3
683961|NCT01588548|2219701|P5|Overall Study|Condition Under Investigation Worsened|3
683962|NCT01588548|2219702|P4|Overall Study|Condition Under Investigation Worsened|4
683963|NCT01588548|2219703|P3|Overall Study|Condition Under Investigation Worsened|4
683964|NCT01588548|2219704|P2|Overall Study|Condition Under Investigation Worsened|6
683965|NCT01588548|2219705|P1|Overall Study|Condition Under Investigation Worsened|3
683966|NCT01588548|2219700|P6|Overall Study|Adverse Event|0
683967|NCT01588548|2219701|P5|Overall Study|Adverse Event|1
683968|NCT01588548|2219702|P4|Overall Study|Adverse Event|2
683969|NCT01588548|2219703|P3|Overall Study|Adverse Event|1
683970|NCT01588548|2219704|P2|Overall Study|Adverse Event|0
683971|NCT01588548|2219705|P1|Overall Study|Adverse Event|0
683972|NCT01588548|2219700|P6|Overall Study|Withdrawal by Subject|3
683973|NCT01588548|2219701|P5|Overall Study|Withdrawal by Subject|2
683974|NCT01588548|2219702|P4|Overall Study|Withdrawal by Subject|1
683975|NCT01588548|2219703|P3|Overall Study|Withdrawal by Subject|1
683976|NCT01588548|2219704|P2|Overall Study|Withdrawal by Subject|1
683977|NCT01588548|2219705|P1|Overall Study|Withdrawal by Subject|0
683978|NCT01588496|2219722|P3|Overall Study|Withdrawal by Subject|0
683979|NCT01588496|2219723|P2|Overall Study|Withdrawal by Subject|1
683980|NCT01588496|2219724|P1|Overall Study|Withdrawal by Subject|0
683981|NCT01588405|2219763|P1|Overall Study|Clinical Worsening|1
683982|NCT01588405|2219763|P1|Overall Study|Adverse Event|1
683983|NCT01588353|2219790|P3|Step3|Adverse Event|2
683984|NCT01588353|2219791|P2|Step3|Adverse Event|0
683985|NCT01588353|2219792|P1|Step3|Adverse Event|0
683986|NCT01588353|2219790|P3|Step2|Withdrawal by Subject|0
683987|NCT01588353|2219791|P2|Step2|Withdrawal by Subject|1
683988|NCT01588353|2219792|P1|Step2|Withdrawal by Subject|0
683989|NCT01588106|2219835|P2|Overall Study|Withdrawal by Subject|4
683990|NCT01588106|2219836|P1|Overall Study|Withdrawal by Subject|5
683991|NCT01587989|2219844|P3|Randomized Study Treatment|Physician Decision|1
683992|NCT01587989|2219845|P2|Randomized Study Treatment|Physician Decision|0
683993|NCT01587989|2219846|P1|Randomized Study Treatment|Physician Decision|0
683994|NCT01587989|2219844|P3|Randomized Study Treatment|Screening failure|0
683995|NCT01587989|2219845|P2|Randomized Study Treatment|Screening failure|1
683996|NCT01587989|2219846|P1|Randomized Study Treatment|Screening failure|0
683997|NCT01587989|2219844|P3|Randomized Study Treatment|Withdrawal by Subject|0
683998|NCT01587989|2219845|P2|Randomized Study Treatment|Withdrawal by Subject|1
683999|NCT01587989|2219846|P1|Randomized Study Treatment|Withdrawal by Subject|0
684000|NCT01587989|2219844|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
684001|NCT01587989|2219845|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
684002|NCT01587989|2219846|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
684003|NCT01587989|2219844|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
684004|NCT01587989|2219845|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
684005|NCT01587989|2219846|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
684006|NCT01587989|2219844|P3|12-Week Open-Label Run-In Period|Physician Decision|0
684007|NCT01587989|2219845|P2|12-Week Open-Label Run-In Period|Physician Decision|0
684008|NCT01587989|2219846|P1|12-Week Open-Label Run-In Period|Physician Decision|7
684025|NCT01587885|2220011|P2|Treatment Period 1|Protocol Violation|2
684026|NCT01587885|2220012|P1|Treatment Period 1|Protocol Violation|0
684027|NCT01587885|2220011|P2|Treatment Period 1|Failure to Return|1
684028|NCT01587885|2220012|P1|Treatment Period 1|Failure to Return|0
684029|NCT01587651|2220028|P3|Overall Study|Withdrawal by Subject|0
684030|NCT01587651|2220029|P2|Overall Study|Withdrawal by Subject|1
684031|NCT01587651|2220030|P1|Overall Study|Withdrawal by Subject|0
684032|NCT01587651|2220028|P3|Overall Study|Protocol Violation|1
684033|NCT01587651|2220029|P2|Overall Study|Protocol Violation|1
684034|NCT01587651|2220030|P1|Overall Study|Protocol Violation|0
684035|NCT01587651|2220028|P3|Overall Study|Adverse Event|0
684036|NCT01587651|2220029|P2|Overall Study|Adverse Event|1
684037|NCT01587651|2220030|P1|Overall Study|Adverse Event|0
684038|NCT01587118|2220057|P1|Overall Study|nonresponse|1
684039|NCT01587118|2220057|P1|Overall Study|Relocation|1
684040|NCT01587118|2220057|P1|Overall Study|Lost to Follow-up|2
684041|NCT01587118|2220057|P1|Overall Study|Adverse Event|3
684042|NCT01587079|2220081|P1|Overall Study|Adverse Event|14
684043|NCT01587079|2220081|P1|Overall Study|Withdrawal by Subject|7
684044|NCT01587079|2220081|P1|Overall Study|Physician Decision|2
684045|NCT01587079|2220081|P1|Overall Study|Lost to Follow-up|2
684046|NCT01587079|2220081|P1|Overall Study|Protocol Violation|5
684047|NCT01587079|2220081|P1|Overall Study|Protocol-specified criteria|9
684048|NCT01587014|2220212|P1|Overall Study|Death|2
684049|NCT01587001|2220219|P2|Overall Study|Insufficient samples to complete testing|1
684050|NCT01587001|2220220|P1|Overall Study|Insufficient samples to complete testing|4
684051|NCT01587001|2220219|P2|Overall Study|Lost to Follow-up|0
684052|NCT01587001|2220220|P1|Overall Study|Lost to Follow-up|2
684053|NCT01586819|2220268|P2|Overall Study|Withdrawal by Subject|0
684054|NCT01586819|2220269|P1|Overall Study|Withdrawal by Subject|1
684055|NCT01586806|2220280|P3|Overall Study|Lost to Follow-up|2
684056|NCT01586806|2220281|P2|Overall Study|Lost to Follow-up|3
684057|NCT01586806|2220282|P1|Overall Study|Lost to Follow-up|2
684058|NCT01586806|2220280|P3|Overall Study|Withdrawal by Subject|0
684059|NCT01586806|2220281|P2|Overall Study|Withdrawal by Subject|0
684060|NCT01586806|2220282|P1|Overall Study|Withdrawal by Subject|1
684061|NCT01586806|2220280|P3|Overall Study|Protocol Violation|0
684062|NCT01586806|2220281|P2|Overall Study|Protocol Violation|1
684063|NCT01586806|2220282|P1|Overall Study|Protocol Violation|0
684064|NCT01586364|2220302|P1|Overall Study|Other-Not specified|1
684065|NCT01586364|2220302|P1|Overall Study|Other-PI discretion, site closing|2
684066|NCT01586364|2220302|P1|Overall Study|Other-Site closure due to PI illness|1
684067|NCT01586364|2220302|P1|Overall Study|Other-Subject wasn't getting much relief|1
684068|NCT01586364|2220302|P1|Overall Study|Other-Did not feel better post-treatment|1
684069|NCT01586364|2220302|P1|Overall Study|Lack of Efficacy|1
684070|NCT01586364|2220302|P1|Overall Study|Protocol Violation|16
684071|NCT01586364|2220302|P1|Overall Study|Lost to Follow-up|17
684072|NCT01586364|2220302|P1|Overall Study|Adverse Event|37
684073|NCT01586364|2220302|P1|Overall Study|Withdrawal by Subject|40
684074|NCT01586338|2220355|P1|Overall Study|Unspecified|1
684075|NCT01586338|2220355|P1|Overall Study|Withdrawal by participant|3
684076|NCT01586338|2220355|P1|Overall Study|Lost to Follow-up|1
684077|NCT01586338|2220355|P1|Overall Study|Adverse Event|3
684078|NCT01586195|2220378|P1|Overall Study|Reason not specified|9
684079|NCT01586195|2220378|P1|Overall Study|Started new anti-melanoma therapy|1
684080|NCT01586195|2220378|P1|Overall Study|Withdrawal of Consent|5
684081|NCT01586195|2220378|P1|Overall Study|Death|11
684082|NCT01585987|2220401|P2|Treated|Poor/Non-Compliance|1
684083|NCT01585987|2220402|P1|Treated|Poor/Non-Compliance|0
684084|NCT01585987|2220401|P2|Treated|Subject Request|1
684085|NCT01585987|2220402|P1|Treated|Subject Request|0
684086|NCT01585987|2220401|P2|Treated|Non-Specified|2
684087|NCT01585987|2220402|P1|Treated|Non-Specified|1
684088|NCT01585987|2220401|P2|Treated|Maximum Clinical Benefit|1
684089|NCT01585987|2220402|P1|Treated|Maximum Clinical Benefit|0
684090|NCT01585987|2220401|P2|Treated|Lost to Follow-up|1
684091|NCT01585987|2220402|P1|Treated|Lost to Follow-up|0
684092|NCT01585987|2220401|P2|Treated|Death|0
684093|NCT01585987|2220402|P1|Treated|Death|1
684094|NCT01585987|2220401|P2|Treated|Withdrawal by Subject|2
684095|NCT01585987|2220402|P1|Treated|Withdrawal by Subject|1
684096|NCT01585987|2220401|P2|Treated|Adverse Event|0
684097|NCT01585987|2220402|P1|Treated|Adverse Event|3
684098|NCT01585987|2220401|P2|Treated|Study Drug Toxicity|5
684099|NCT01585987|2220402|P1|Treated|Study Drug Toxicity|9
684100|NCT01585987|2220401|P2|Treated|Disease Progression|36
684101|NCT01585987|2220402|P1|Treated|Disease Progression|39
684102|NCT01585987|2220401|P2|Randomized|No longer met criteria|2
684103|NCT01585987|2220402|P1|Randomized|No longer met criteria|0
684104|NCT01585987|2220401|P2|Randomized|Withdrawal by Subject|4
684105|NCT01585987|2220402|P1|Randomized|Withdrawal by Subject|0
684106|NCT01585961|2220417|P1|Overall Study|Ablation cancelled for slow-heal wound|1
684107|NCT01585961|2220417|P1|Overall Study|Lost to Follow-up|23
684108|NCT01585961|2220417|P1|Overall Study|Withdrawal by Subject|1
684109|NCT01585961|2220417|P1|Overall Study|Decision to use non-study catheter|1
684110|NCT01585961|2220417|P1|Overall Study|Physician Decision|1
684111|NCT01585961|2220417|P1|Overall Study|Death|6
684112|NCT01585584|2220494|P1|Overall Study|Physician Decision|2
684113|NCT01585584|2220494|P1|Overall Study|Withdrawal by Subject|1
684114|NCT01585584|2220494|P1|Overall Study|Lack of Efficacy|1
684115|NCT01585558|2220501|P3|Overall Study|Lack of Efficacy|1
684116|NCT01585558|2220502|P2|Overall Study|Lack of Efficacy|0
684117|NCT01585558|2220503|P1|Overall Study|Lack of Efficacy|0
684118|NCT01585558|2220501|P3|Overall Study|Protocol Violation|2
684119|NCT01585558|2220502|P2|Overall Study|Protocol Violation|3
684120|NCT01585558|2220503|P1|Overall Study|Protocol Violation|4
684121|NCT01585558|2220501|P3|Overall Study|Adverse Event|1
684122|NCT01585558|2220502|P2|Overall Study|Adverse Event|4
684123|NCT01585558|2220503|P1|Overall Study|Adverse Event|3
684124|NCT01585558|2220501|P3|Overall Study|Lost to Follow-up|3
684125|NCT01585558|2220502|P2|Overall Study|Lost to Follow-up|0
684126|NCT01585558|2220503|P1|Overall Study|Lost to Follow-up|2
684127|NCT01585558|2220501|P3|Overall Study|Withdrawal by Subject|8
684128|NCT01585558|2220502|P2|Overall Study|Withdrawal by Subject|5
684129|NCT01585558|2220503|P1|Overall Study|Withdrawal by Subject|4
684132|NCT01585272|2220762|P1|Overall Study|Withdrawal by Subject|10
684133|NCT01585272|2220762|P1|Overall Study|Protocol Violation|7
684134|NCT01585272|2220762|P1|Overall Study|Adverse Event|22
684135|NCT01585246|2220775|P5|Overall Study|Other|0
684136|NCT01585246|2220776|P4|Overall Study|Other|1
684137|NCT01585246|2220777|P3|Overall Study|Other|1
684138|NCT01585246|2220778|P2|Overall Study|Other|1
684139|NCT01585246|2220779|P1|Overall Study|Other|0
684140|NCT01585246|2220775|P5|Overall Study|Withdrawal by Subject|1
684141|NCT01585246|2220776|P4|Overall Study|Withdrawal by Subject|2
684142|NCT01585246|2220777|P3|Overall Study|Withdrawal by Subject|1
684143|NCT01585246|2220778|P2|Overall Study|Withdrawal by Subject|0
684144|NCT01585246|2220779|P1|Overall Study|Withdrawal by Subject|0
684145|NCT01585246|2220775|P5|Overall Study|Protocol Violation|1
684146|NCT01585246|2220776|P4|Overall Study|Protocol Violation|0
684147|NCT01585246|2220777|P3|Overall Study|Protocol Violation|0
684148|NCT01585246|2220778|P2|Overall Study|Protocol Violation|0
684149|NCT01585246|2220779|P1|Overall Study|Protocol Violation|0
684150|NCT01585246|2220775|P5|Overall Study|Lost to Follow-up|0
684151|NCT01585246|2220776|P4|Overall Study|Lost to Follow-up|1
684152|NCT01585246|2220777|P3|Overall Study|Lost to Follow-up|2
684153|NCT01585246|2220778|P2|Overall Study|Lost to Follow-up|0
684154|NCT01585246|2220779|P1|Overall Study|Lost to Follow-up|0
684155|NCT01585038|2220796|P2|Overall Study|Adverse Event|2
684156|NCT01585038|2220797|P1|Overall Study|Adverse Event|2
684157|NCT01584843|2220813|P6|Second Treatment Period|Withdrawal by Subject|1
684158|NCT01584843|2220814|P5|Second Treatment Period|Withdrawal by Subject|0
684159|NCT01584843|2220815|P4|Second Treatment Period|Withdrawal by Subject|0
684160|NCT01584843|2220816|P3|Second Treatment Period|Withdrawal by Subject|0
684161|NCT01584843|2220817|P2|Second Treatment Period|Withdrawal by Subject|0
684162|NCT01584843|2220818|P1|Second Treatment Period|Withdrawal by Subject|0
684163|NCT01584843|2220813|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
684164|NCT01584843|2220814|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
684165|NCT01584843|2220815|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
684166|NCT01584843|2220816|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
684167|NCT01584843|2220817|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
684168|NCT01584843|2220818|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
684169|NCT01584843|2220813|P6|First Treatment Period|Protocol Violation|1
684170|NCT01584843|2220814|P5|First Treatment Period|Protocol Violation|0
684171|NCT01584843|2220815|P4|First Treatment Period|Protocol Violation|0
684172|NCT01584843|2220816|P3|First Treatment Period|Protocol Violation|0
684173|NCT01584843|2220817|P2|First Treatment Period|Protocol Violation|0
684174|NCT01584843|2220818|P1|First Treatment Period|Protocol Violation|0
684175|NCT01584843|2220813|P6|First Treatment Period|Adverse Event|0
684176|NCT01584843|2220814|P5|First Treatment Period|Adverse Event|0
684177|NCT01584843|2220815|P4|First Treatment Period|Adverse Event|0
684178|NCT01584843|2220816|P3|First Treatment Period|Adverse Event|1
684179|NCT01584843|2220817|P2|First Treatment Period|Adverse Event|0
684180|NCT01584843|2220818|P1|First Treatment Period|Adverse Event|0
684181|NCT01584648|2220929|P2|Overall Study|Ongoing|147
684182|NCT01584648|2220930|P1|Overall Study|Ongoing|154
684183|NCT01584648|2220929|P2|Overall Study|Death|55
684184|NCT01584648|2220930|P1|Overall Study|Death|40
684185|NCT01584648|2220929|P2|Overall Study|Withdrawal by Subject|5
684186|NCT01584648|2220930|P1|Overall Study|Withdrawal by Subject|11
684187|NCT01584648|2220929|P2|Overall Study|Physician Decision|2
684188|NCT01584648|2220930|P1|Overall Study|Physician Decision|2
684189|NCT01584648|2220929|P2|Overall Study|Lost to Follow-up|3
684190|NCT01584648|2220930|P1|Overall Study|Lost to Follow-up|4
684191|NCT01584232|2221035|P2|Overall Study|Lost to Follow-up|0
684192|NCT01584232|2221036|P1|Overall Study|Lost to Follow-up|1
684193|NCT01584232|2221035|P2|Overall Study|Physician Decision|1
684194|NCT01584232|2221036|P1|Overall Study|Physician Decision|2
684195|NCT01584232|2221035|P2|Overall Study|Withdrawal by Subject|1
684196|NCT01584232|2221036|P1|Overall Study|Withdrawal by Subject|2
684197|NCT01584232|2221035|P2|Overall Study|Adverse Event|1
684198|NCT01584232|2221036|P1|Overall Study|Adverse Event|3
684199|NCT01583530|2221082|P6|Overall Study|Lack of compliance|0
684200|NCT01583530|2221083|P5|Overall Study|Lack of compliance|1
684201|NCT01583530|2221084|P4|Overall Study|Lack of compliance|0
684202|NCT01583530|2221085|P3|Overall Study|Lack of compliance|0
684203|NCT01583530|2221086|P2|Overall Study|Lack of compliance|0
684204|NCT01583530|2221087|P1|Overall Study|Lack of compliance|0
684205|NCT01583530|2221082|P6|Overall Study|Lost to Follow-up|0
684206|NCT01583530|2221083|P5|Overall Study|Lost to Follow-up|3
684207|NCT01583530|2221084|P4|Overall Study|Lost to Follow-up|0
684208|NCT01583530|2221085|P3|Overall Study|Lost to Follow-up|0
684209|NCT01583530|2221086|P2|Overall Study|Lost to Follow-up|0
684210|NCT01583530|2221087|P1|Overall Study|Lost to Follow-up|0
684211|NCT01583530|2221082|P6|Overall Study|Withdrawal by Subject|2
684212|NCT01583530|2221083|P5|Overall Study|Withdrawal by Subject|1
684213|NCT01583530|2221084|P4|Overall Study|Withdrawal by Subject|1
684214|NCT01583530|2221085|P3|Overall Study|Withdrawal by Subject|0
684215|NCT01583530|2221086|P2|Overall Study|Withdrawal by Subject|3
684216|NCT01583530|2221087|P1|Overall Study|Withdrawal by Subject|0
684217|NCT01583530|2221082|P6|Overall Study|Adverse Event|1
684218|NCT01583530|2221083|P5|Overall Study|Adverse Event|0
684219|NCT01583530|2221084|P4|Overall Study|Adverse Event|0
684220|NCT01583530|2221085|P3|Overall Study|Adverse Event|0
684221|NCT01583530|2221086|P2|Overall Study|Adverse Event|0
684222|NCT01583530|2221087|P1|Overall Study|Adverse Event|0
684223|NCT01583374|2221149|P3|Overall Study|Unspecified|0
684224|NCT01583374|2221150|P2|Overall Study|Unspecified|1
684225|NCT01583374|2221151|P1|Overall Study|Unspecified|0
684226|NCT01583374|2221149|P3|Overall Study|Protocol Violation|3
684227|NCT01583374|2221150|P2|Overall Study|Protocol Violation|0
684228|NCT01583374|2221151|P1|Overall Study|Protocol Violation|0
684229|NCT01583374|2221149|P3|Overall Study|Lost to Follow-up|0
684230|NCT01583374|2221150|P2|Overall Study|Lost to Follow-up|2
684231|NCT01583374|2221151|P1|Overall Study|Lost to Follow-up|1
684232|NCT01583374|2221149|P3|Overall Study|Withdrawal by Subject|5
684233|NCT01583374|2221150|P2|Overall Study|Withdrawal by Subject|3
684234|NCT01583374|2221151|P1|Overall Study|Withdrawal by Subject|8
684235|NCT01583374|2221149|P3|Overall Study|Non-compliance with study drug|0
684236|NCT01583374|2221150|P2|Overall Study|Non-compliance with study drug|1
684237|NCT01583374|2221151|P1|Overall Study|Non-compliance with study drug|1
684238|NCT01583374|2221149|P3|Overall Study|Lack of Efficacy|5
684239|NCT01583374|2221150|P2|Overall Study|Lack of Efficacy|2
684240|NCT01583374|2221151|P1|Overall Study|Lack of Efficacy|3
684241|NCT01583374|2221149|P3|Overall Study|Adverse Event|12
684242|NCT01583374|2221150|P2|Overall Study|Adverse Event|7
684243|NCT01583374|2221151|P1|Overall Study|Adverse Event|6
684244|NCT01583218|2221163|P2|Overall Study|Withdraw of consent on day of random|0
684245|NCT01583218|2221164|P1|Overall Study|Withdraw of consent on day of random|1
684246|NCT01583218|2221163|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
684247|NCT01583218|2221164|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
684248|NCT01583218|2221163|P2|Overall Study|Patient was randomized due to mistake|0
684249|NCT01583218|2221164|P1|Overall Study|Patient was randomized due to mistake|1
684250|NCT01583218|2221163|P2|Overall Study|Patient was early terminated from study|1
684251|NCT01583218|2221164|P1|Overall Study|Patient was early terminated from study|0
684252|NCT01583218|2221163|P2|Overall Study|Patient deemed ineligible after random|0
684253|NCT01583218|2221164|P1|Overall Study|Patient deemed ineligible after random|2
684254|NCT01583218|2221163|P2|Overall Study|Patient was assessed via phone in person|0
684255|NCT01583218|2221164|P1|Overall Study|Patient was assessed via phone in person|1
684256|NCT01583218|2221163|P2|Overall Study|Patient randomized but not dosed|16
684257|NCT01583218|2221164|P1|Overall Study|Patient randomized but not dosed|17
684258|NCT01583218|2221163|P2|Overall Study|Patient did not wish to attend visits|1
684259|NCT01583218|2221164|P1|Overall Study|Patient did not wish to attend visits|0
684260|NCT01583218|2221163|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
684261|NCT01583218|2221164|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
684262|NCT01583218|2221163|P2|Overall Study|Cannot contact patient directly|2
684263|NCT01583218|2221164|P1|Overall Study|Cannot contact patient directly|1
684264|NCT01583218|2221163|P2|Overall Study|Patient /Family decision|0
684265|NCT01583218|2221164|P1|Overall Study|Patient /Family decision|3
684266|NCT01583218|2221163|P2|Overall Study|Adverse event or serious adverse event|3
684267|NCT01583218|2221164|P1|Overall Study|Adverse event or serious adverse event|3
684268|NCT01583218|2221163|P2|Overall Study|Lost to Follow-up|17
684269|NCT01583218|2221164|P1|Overall Study|Lost to Follow-up|11
684270|NCT01583218|2221163|P2|Overall Study|Death|211
684271|NCT01583218|2221164|P1|Overall Study|Death|206
684272|NCT01583218|2221163|P2|Overall Study|Withdrawal by Subject|29
684273|NCT01583218|2221164|P1|Overall Study|Withdrawal by Subject|43
889169|NCT01475721|2823602|P2|Overall Study|Withdrawal by Subject|8
889170|NCT01475721|2823603|P1|Overall Study|Withdrawal by Subject|8
889171|NCT01475721|2823602|P2|Overall Study|Death|6
889172|NCT01475721|2823603|P1|Overall Study|Death|3
684282|NCT01582945|2221212|P1|Overall Study|Scheduling conflicts|1
684283|NCT01582945|2221212|P1|Overall Study|Intolerable side-effects|1
684284|NCT01582854|2221226|P2|Overall Study|Other Miscellaneous Reason|0
684285|NCT01582854|2221227|P1|Overall Study|Other Miscellaneous Reason|1
684286|NCT01582854|2221226|P2|Overall Study|General Anaesthesia|1
684287|NCT01582854|2221227|P1|Overall Study|General Anaesthesia|0
684288|NCT01582854|2221226|P2|Overall Study|Carotid or Neurosurgery|1
684289|NCT01582854|2221227|P1|Overall Study|Carotid or Neurosurgery|0
684290|NCT01582854|2221226|P2|Overall Study|Disallowed Concomitant Medication|2
684291|NCT01582854|2221227|P1|Overall Study|Disallowed Concomitant Medication|3
684292|NCT01582854|2221226|P2|Overall Study|Recurrent Stroke|8
684293|NCT01582854|2221227|P1|Overall Study|Recurrent Stroke|13
684294|NCT01582854|2221226|P2|Overall Study|Physician Decision|1
684295|NCT01582854|2221227|P1|Overall Study|Physician Decision|0
684296|NCT01582854|2221226|P2|Overall Study|Lost to Follow-up|2
684297|NCT01582854|2221227|P1|Overall Study|Lost to Follow-up|1
684298|NCT01582854|2221226|P2|Overall Study|Withdrawal by Participant|11
684299|NCT01582854|2221227|P1|Overall Study|Withdrawal by Participant|8
684300|NCT01582854|2221226|P2|Overall Study|Adverse Event|3
684301|NCT01582854|2221227|P1|Overall Study|Adverse Event|2
684302|NCT01582854|2221226|P2|Overall Study|Death|5
684303|NCT01582854|2221227|P1|Overall Study|Death|8
684304|NCT01582789|2221255|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
684305|NCT01582789|2221256|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
684306|NCT01582308|2221314|P10|Period 4|Physician Decision|1
684307|NCT01582308|2221315|P9|Period 4|Physician Decision|0
684308|NCT01582308|2221316|P8|Period 4|Physician Decision|0
684309|NCT01582308|2221317|P7|Period 4|Physician Decision|0
684310|NCT01582308|2221318|P6|Period 4|Physician Decision|1
684311|NCT01582308|2221319|P5|Period 4|Physician Decision|0
684312|NCT01582308|2221320|P4|Period 4|Physician Decision|0
684313|NCT01582308|2221321|P3|Period 4|Physician Decision|0
684314|NCT01582308|2221322|P2|Period 4|Physician Decision|0
684315|NCT01582308|2221323|P1|Period 4|Physician Decision|1
684316|NCT01582308|2221314|P10|10-day Washout Following Period 1|Physician Decision|0
684317|NCT01582308|2221315|P9|10-day Washout Following Period 1|Physician Decision|0
684318|NCT01582308|2221316|P8|10-day Washout Following Period 1|Physician Decision|0
684319|NCT01582308|2221317|P7|10-day Washout Following Period 1|Physician Decision|0
684320|NCT01582308|2221318|P6|10-day Washout Following Period 1|Physician Decision|0
684321|NCT01582308|2221319|P5|10-day Washout Following Period 1|Physician Decision|1
684322|NCT01582308|2221320|P4|10-day Washout Following Period 1|Physician Decision|0
684323|NCT01582308|2221321|P3|10-day Washout Following Period 1|Physician Decision|0
684324|NCT01582308|2221322|P2|10-day Washout Following Period 1|Physician Decision|0
684325|NCT01582308|2221323|P1|10-day Washout Following Period 1|Physician Decision|0
684326|NCT01582308|2221314|P10|Period 1|Withdrawal by Subject|0
684327|NCT01582308|2221315|P9|Period 1|Withdrawal by Subject|0
684328|NCT01582308|2221316|P8|Period 1|Withdrawal by Subject|0
684329|NCT01582308|2221317|P7|Period 1|Withdrawal by Subject|1
684330|NCT01582308|2221318|P6|Period 1|Withdrawal by Subject|0
684331|NCT01582308|2221319|P5|Period 1|Withdrawal by Subject|0
684332|NCT01582308|2221320|P4|Period 1|Withdrawal by Subject|0
684333|NCT01582308|2221321|P3|Period 1|Withdrawal by Subject|0
684334|NCT01582308|2221322|P2|Period 1|Withdrawal by Subject|0
684335|NCT01582308|2221323|P1|Period 1|Withdrawal by Subject|0
684336|NCT01582282|2221351|P3|Overall Study|fasting blood glucose outside Protocol|0
684337|NCT01582282|2221352|P2|Overall Study|fasting blood glucose outside Protocol|1
684338|NCT01582282|2221353|P1|Overall Study|fasting blood glucose outside Protocol|0
684339|NCT01582282|2221351|P3|Overall Study|Lost to Follow-up|0
684340|NCT01582282|2221352|P2|Overall Study|Lost to Follow-up|0
684341|NCT01582282|2221353|P1|Overall Study|Lost to Follow-up|1
684342|NCT01582282|2221351|P3|Overall Study|Adverse Event|0
684343|NCT01582282|2221352|P2|Overall Study|Adverse Event|1
684344|NCT01582282|2221353|P1|Overall Study|Adverse Event|1
684345|NCT01582243|2221376|P1|Overall Study|Lost to Follow-up|1
684346|NCT01582243|2221376|P1|Overall Study|Adverse Event|1
684347|NCT01582243|2221376|P1|Overall Study|Withdrawal by Subject|1
684348|NCT01582178|2221387|P2|Overall Study|Physician Decision|5
684349|NCT01582178|2221388|P1|Overall Study|Physician Decision|6
684350|NCT01582100|2221409|P1|Overall Study|Withdrawal by Subject|1
684351|NCT01582100|2221409|P1|Overall Study|Adverse Event|1
684352|NCT01582009|2221413|P1|Overall Study|Physician Decision|1
684353|NCT01582009|2221413|P1|Overall Study|Withdrawal by Subject|1
684354|NCT01581931|2221421|P2|Washout|Adverse Event|1
684355|NCT01581931|2221422|P1|Washout|Adverse Event|0
684356|NCT01581684|2221446|P10|Overall Study|Other reason not defined|0
684357|NCT01581684|2221447|P9|Overall Study|Other reason not defined|1
684358|NCT01581684|2221448|P8|Overall Study|Other reason not defined|0
684359|NCT01581684|2221449|P7|Overall Study|Other reason not defined|0
684360|NCT01581684|2221450|P6|Overall Study|Other reason not defined|0
684361|NCT01581684|2221451|P5|Overall Study|Other reason not defined|0
684362|NCT01581684|2221452|P4|Overall Study|Other reason not defined|0
684363|NCT01581684|2221453|P3|Overall Study|Other reason not defined|0
684364|NCT01581684|2221454|P2|Overall Study|Other reason not defined|0
684365|NCT01581684|2221455|P1|Overall Study|Other reason not defined|0
684368|NCT01581307|2221704|P1|Overall Study|Withdrawal by Subject|1
684369|NCT01581281|2221713|P3|Overall Study|Early Study Closure|12
684370|NCT01581281|2221714|P2|Overall Study|Early Study Closure|6
684371|NCT01581281|2221715|P1|Overall Study|Early Study Closure|15
684372|NCT01581021|2221737|P2|Overall Study|Lack of Efficacy|1
684373|NCT01581021|2221738|P1|Overall Study|Lack of Efficacy|0
684374|NCT01581021|2221737|P2|Overall Study|Lenke 6 Classification|1
684375|NCT01581021|2221738|P1|Overall Study|Lenke 6 Classification|0
684376|NCT01581021|2221737|P2|Overall Study|Not Randomized|2
684377|NCT01581021|2221738|P1|Overall Study|Not Randomized|1
684378|NCT01581021|2221737|P2|Overall Study|Neuromuscular|1
684379|NCT01581021|2221738|P1|Overall Study|Neuromuscular|2
684380|NCT01581021|2221737|P2|Overall Study|More than 2 hooks in thoracic|0
684381|NCT01581021|2221738|P1|Overall Study|More than 2 hooks in thoracic|3
684382|NCT01581021|2221737|P2|Overall Study|Lost to Follow-up|6
684383|NCT01581021|2221738|P1|Overall Study|Lost to Follow-up|4
684384|NCT01580995|2221764|P2|Overall Study|Lost to Follow-up|2
684385|NCT01580995|2221765|P1|Overall Study|Lost to Follow-up|2
684386|NCT01580488|2221818|P1|Overall Study|Withdrawal by Subject|1
684387|NCT01580020|2221959|P4|Overall Study|Lost to Follow-up|0
684388|NCT01580020|2221960|P3|Overall Study|Lost to Follow-up|1
684389|NCT01580020|2221961|P2|Overall Study|Lost to Follow-up|0
684390|NCT01580020|2221962|P1|Overall Study|Lost to Follow-up|0
684391|NCT01580020|2221959|P4|Overall Study|Administrative Problems|0
684392|NCT01580020|2221960|P3|Overall Study|Administrative Problems|1
684393|NCT01580020|2221961|P2|Overall Study|Administrative Problems|0
684394|NCT01580020|2221962|P1|Overall Study|Administrative Problems|0
684395|NCT01580020|2221959|P4|Overall Study|Adverse Event|1
684396|NCT01580020|2221960|P3|Overall Study|Adverse Event|1
684397|NCT01580020|2221961|P2|Overall Study|Adverse Event|1
684398|NCT01580020|2221962|P1|Overall Study|Adverse Event|1
684399|NCT01580020|2221959|P4|Overall Study|Withdrawal by Subject|0
684400|NCT01580020|2221960|P3|Overall Study|Withdrawal by Subject|1
684401|NCT01580020|2221961|P2|Overall Study|Withdrawal by Subject|1
684402|NCT01580020|2221962|P1|Overall Study|Withdrawal by Subject|0
684403|NCT01580020|2221959|P4|Overall Study|Lack of Efficacy|1
684404|NCT01580020|2221960|P3|Overall Study|Lack of Efficacy|0
684405|NCT01580020|2221961|P2|Overall Study|Lack of Efficacy|5
684406|NCT01580020|2221962|P1|Overall Study|Lack of Efficacy|0
684407|NCT01579916|2222006|P2|Overall Study|Death|0
684408|NCT01579916|2222007|P1|Overall Study|Death|1
684409|NCT01579916|2222006|P2|Overall Study|Withdrawal by Subject|1
684410|NCT01579916|2222007|P1|Overall Study|Withdrawal by Subject|1
684411|NCT01579916|2222006|P2|Overall Study|Lost to Follow-up|1
684412|NCT01579916|2222007|P1|Overall Study|Lost to Follow-up|6
684413|NCT01578850|2222035|P3|Period 2|Unspecified Reasons|0
684414|NCT01578850|2222036|P2|Period 2|Unspecified Reasons|1
684415|NCT01578850|2222037|P1|Period 2|Unspecified Reasons|0
684416|NCT01578850|2222035|P3|Period 2|Study Terminated by Sponsor|4
684417|NCT01578850|2222036|P2|Period 2|Study Terminated by Sponsor|5
684418|NCT01578850|2222037|P1|Period 2|Study Terminated by Sponsor|0
684419|NCT01578850|2222035|P3|Period 2|Withdrawal by Subject|2
684420|NCT01578850|2222036|P2|Period 2|Withdrawal by Subject|2
684421|NCT01578850|2222037|P1|Period 2|Withdrawal by Subject|0
684422|NCT01578850|2222035|P3|Period 2|Lost to Follow-up|2
684423|NCT01578850|2222036|P2|Period 2|Lost to Follow-up|1
684424|NCT01578850|2222037|P1|Period 2|Lost to Follow-up|0
684425|NCT01578850|2222035|P3|Period 2|Adverse Event|6
684426|NCT01578850|2222036|P2|Period 2|Adverse Event|3
684427|NCT01578850|2222037|P1|Period 2|Adverse Event|0
684428|NCT01578850|2222035|P3|Period 2|Insufficient Clinical Response|0
684429|NCT01578850|2222036|P2|Period 2|Insufficient Clinical Response|1
684430|NCT01578850|2222037|P1|Period 2|Insufficient Clinical Response|0
684431|NCT01578850|2222035|P3|Period 1|Study Terminated by Sponsor|0
684432|NCT01578850|2222036|P2|Period 1|Study Terminated by Sponsor|0
684433|NCT01578850|2222037|P1|Period 1|Study Terminated by Sponsor|3
684434|NCT01578850|2222035|P3|Period 1|Withdrawal by Subject|0
684435|NCT01578850|2222036|P2|Period 1|Withdrawal by Subject|0
684436|NCT01578850|2222037|P1|Period 1|Withdrawal by Subject|9
684437|NCT01578850|2222035|P3|Period 1|Does Not Meet Entrance Criteria|0
684438|NCT01578850|2222036|P2|Period 1|Does Not Meet Entrance Criteria|0
684439|NCT01578850|2222037|P1|Period 1|Does Not Meet Entrance Criteria|12
684440|NCT01578850|2222035|P3|Period 1|Death|0
684441|NCT01578850|2222036|P2|Period 1|Death|0
684442|NCT01578850|2222037|P1|Period 1|Death|1
684443|NCT01578850|2222035|P3|Period 1|Adverse Event|0
684444|NCT01578850|2222036|P2|Period 1|Adverse Event|0
684445|NCT01578850|2222037|P1|Period 1|Adverse Event|11
684446|NCT01578850|2222035|P3|Period 1|Insufficient Clinical Response|0
684447|NCT01578850|2222036|P2|Period 1|Insufficient Clinical Response|0
684448|NCT01578850|2222037|P1|Period 1|Insufficient Clinical Response|1
684449|NCT01579578|2222113|P2|Overall Study|Ongoing|0
684450|NCT01579578|2222114|P1|Overall Study|Ongoing|3
684451|NCT01579578|2222113|P2|Overall Study|Eligibility criteria|9
684452|NCT01579578|2222114|P1|Overall Study|Eligibility criteria|3
684453|NCT01579578|2222113|P2|Overall Study|Withdrawal by Subject|1
684454|NCT01579578|2222114|P1|Overall Study|Withdrawal by Subject|2
684455|NCT01579578|2222113|P2|Overall Study|Lost to Follow-up|1
684456|NCT01579578|2222114|P1|Overall Study|Lost to Follow-up|1
684457|NCT01579578|2222113|P2|Overall Study|Death|1
684458|NCT01579578|2222114|P1|Overall Study|Death|4
684459|NCT01579565|2222126|P2|Treated|declined to return for final visit|1
684460|NCT01579565|2222127|P1|Treated|declined to return for final visit|0
684461|NCT01579565|2222126|P2|Treated|Lost to Follow-up|1
684462|NCT01579565|2222127|P1|Treated|Lost to Follow-up|2
684463|NCT01579565|2222126|P2|Treated|Physician Decision|1
684464|NCT01579565|2222127|P1|Treated|Physician Decision|0
684465|NCT01579565|2222126|P2|Randomized|prohibited preoperative medication|1
684466|NCT01579565|2222127|P1|Randomized|prohibited preoperative medication|0
684467|NCT01579565|2222126|P2|Randomized|prohibited preoperative eating|0
684468|NCT01579565|2222127|P1|Randomized|prohibited preoperative eating|1
684469|NCT01579565|2222126|P2|Randomized|inadequate preoperative pupil dilation|1
684470|NCT01579565|2222127|P1|Randomized|inadequate preoperative pupil dilation|0
684471|NCT01579565|2222126|P2|Randomized|Withdrawal by Subject|0
684472|NCT01579565|2222127|P1|Randomized|Withdrawal by Subject|3
684473|NCT01579565|2222126|P2|Randomized|Adverse Event|3
684474|NCT01579565|2222127|P1|Randomized|Adverse Event|1
684475|NCT01579474|2222161|P6|Overall Study|Withdrawal by Subject|0
684476|NCT01579474|2222162|P5|Overall Study|Withdrawal by Subject|0
684477|NCT01579474|2222163|P4|Overall Study|Withdrawal by Subject|0
684478|NCT01579474|2222164|P3|Overall Study|Withdrawal by Subject|0
684479|NCT01579474|2222165|P2|Overall Study|Withdrawal by Subject|0
684480|NCT01579474|2222166|P1|Overall Study|Withdrawal by Subject|1
684481|NCT01579474|2222161|P6|Overall Study|Lack of Efficacy|0
684482|NCT01579474|2222162|P5|Overall Study|Lack of Efficacy|1
684483|NCT01579474|2222163|P4|Overall Study|Lack of Efficacy|0
684484|NCT01579474|2222164|P3|Overall Study|Lack of Efficacy|0
684485|NCT01579474|2222165|P2|Overall Study|Lack of Efficacy|0
684486|NCT01579474|2222166|P1|Overall Study|Lack of Efficacy|1
684487|NCT01579474|2222161|P6|Overall Study|Adverse Event|1
684488|NCT01579474|2222162|P5|Overall Study|Adverse Event|0
684489|NCT01579474|2222163|P4|Overall Study|Adverse Event|0
684490|NCT01579474|2222164|P3|Overall Study|Adverse Event|2
684491|NCT01579474|2222165|P2|Overall Study|Adverse Event|13
684492|NCT01579474|2222166|P1|Overall Study|Adverse Event|1
684493|NCT01579006|2222313|P1|Overall Study|Scheduled surgery|1
684494|NCT01579006|2222313|P1|Overall Study|Due to participant's health fund|1
684495|NCT01579006|2222313|P1|Overall Study|Non-compliance|3
684496|NCT01579006|2222313|P1|Overall Study|Withdrawal by Subject|5
684497|NCT01579006|2222313|P1|Overall Study|Adverse Event|13
684498|NCT01579006|2222313|P1|Overall Study|Lack of Efficacy|10
684499|NCT01578785|2222363|P2|Overall Study|Study terminated by sponsor|118
684500|NCT01578785|2222364|P1|Overall Study|Study terminated by sponsor|59
684501|NCT01578785|2222363|P2|Overall Study|Withdrawal by Subject|1
684502|NCT01578785|2222364|P1|Overall Study|Withdrawal by Subject|0
684503|NCT01578330|2222394|P1|Overall Study|Protocol Violation|5
684504|NCT01578330|2222394|P1|Overall Study|Adverse Event|2
684505|NCT01578187|2222410|P1|Usability Phase|Withdrawal by Subject|1
684506|NCT01577758|2222444|P8|mCRC Expansion Phase|Progression Disease|19
684507|NCT01577758|2222445|P7|mCRC Expansion Phase|Progression Disease|0
684508|NCT01577758|2222446|P6|mCRC Expansion Phase|Progression Disease|0
684509|NCT01577758|2222447|P5|mCRC Expansion Phase|Progression Disease|0
684510|NCT01577758|2222448|P4|mCRC Expansion Phase|Progression Disease|0
684511|NCT01577758|2222449|P3|mCRC Expansion Phase|Progression Disease|0
684512|NCT01577758|2222450|P2|mCRC Expansion Phase|Progression Disease|0
684513|NCT01577758|2222451|P1|mCRC Expansion Phase|Progression Disease|0
684514|NCT01577758|2222444|P8|mCRC Expansion Phase|Withdrawal by Subject|2
684515|NCT01577758|2222445|P7|mCRC Expansion Phase|Withdrawal by Subject|0
684516|NCT01577758|2222446|P6|mCRC Expansion Phase|Withdrawal by Subject|0
684517|NCT01577758|2222447|P5|mCRC Expansion Phase|Withdrawal by Subject|0
684518|NCT01577758|2222448|P4|mCRC Expansion Phase|Withdrawal by Subject|0
684519|NCT01577758|2222449|P3|mCRC Expansion Phase|Withdrawal by Subject|0
684520|NCT01577758|2222450|P2|mCRC Expansion Phase|Withdrawal by Subject|0
684521|NCT01577758|2222451|P1|mCRC Expansion Phase|Withdrawal by Subject|0
684522|NCT01577758|2222444|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
684523|NCT01577758|2222445|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
684524|NCT01577758|2222446|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
684525|NCT01577758|2222447|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
684526|NCT01577758|2222448|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
684527|NCT01577758|2222449|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
684528|NCT01577758|2222450|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
684529|NCT01577758|2222451|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
684530|NCT01577758|2222444|P8|Dose Escalation Phase|Progression Disease|0
684531|NCT01577758|2222445|P7|Dose Escalation Phase|Progression Disease|0
684532|NCT01577758|2222446|P6|Dose Escalation Phase|Progression Disease|0
684533|NCT01577758|2222447|P5|Dose Escalation Phase|Progression Disease|5
684534|NCT01577758|2222448|P4|Dose Escalation Phase|Progression Disease|2
684535|NCT01577758|2222449|P3|Dose Escalation Phase|Progression Disease|1
684536|NCT01577758|2222450|P2|Dose Escalation Phase|Progression Disease|2
684537|NCT01577758|2222451|P1|Dose Escalation Phase|Progression Disease|2
684538|NCT01577758|2222444|P8|Dose Escalation Phase|Withdrawal by Subject|0
684539|NCT01577758|2222445|P7|Dose Escalation Phase|Withdrawal by Subject|0
684540|NCT01577758|2222446|P6|Dose Escalation Phase|Withdrawal by Subject|1
684541|NCT01577758|2222447|P5|Dose Escalation Phase|Withdrawal by Subject|0
684542|NCT01577758|2222448|P4|Dose Escalation Phase|Withdrawal by Subject|0
684543|NCT01577758|2222449|P3|Dose Escalation Phase|Withdrawal by Subject|0
684544|NCT01577758|2222450|P2|Dose Escalation Phase|Withdrawal by Subject|0
684545|NCT01577758|2222451|P1|Dose Escalation Phase|Withdrawal by Subject|0
684546|NCT01577758|2222444|P8|Dose Escalation Phase|Symptomatic Deterioration|0
684547|NCT01577758|2222445|P7|Dose Escalation Phase|Symptomatic Deterioration|0
684548|NCT01577758|2222446|P6|Dose Escalation Phase|Symptomatic Deterioration|1
684549|NCT01577758|2222447|P5|Dose Escalation Phase|Symptomatic Deterioration|1
684550|NCT01577758|2222448|P4|Dose Escalation Phase|Symptomatic Deterioration|0
684551|NCT01577758|2222449|P3|Dose Escalation Phase|Symptomatic Deterioration|1
684552|NCT01577758|2222450|P2|Dose Escalation Phase|Symptomatic Deterioration|0
684553|NCT01577758|2222451|P1|Dose Escalation Phase|Symptomatic Deterioration|0
684554|NCT01577758|2222444|P8|Dose Escalation Phase|Adverse Event|0
684555|NCT01577758|2222445|P7|Dose Escalation Phase|Adverse Event|1
684556|NCT01577758|2222446|P6|Dose Escalation Phase|Adverse Event|2
684557|NCT01577758|2222447|P5|Dose Escalation Phase|Adverse Event|0
684558|NCT01577758|2222448|P4|Dose Escalation Phase|Adverse Event|0
684559|NCT01577758|2222449|P3|Dose Escalation Phase|Adverse Event|0
684560|NCT01577758|2222450|P2|Dose Escalation Phase|Adverse Event|0
684561|NCT01577758|2222451|P1|Dose Escalation Phase|Adverse Event|0
684562|NCT01577745|2222490|P6|Overall Study|Alternative Therapy|0
684563|NCT01577745|2222491|P5|Overall Study|Alternative Therapy|1
684564|NCT01577745|2222492|P4|Overall Study|Alternative Therapy|1
684565|NCT01577745|2222493|P3|Overall Study|Alternative Therapy|0
684566|NCT01577745|2222494|P2|Overall Study|Alternative Therapy|0
684567|NCT01577745|2222495|P1|Overall Study|Alternative Therapy|0
684568|NCT01577745|2222490|P6|Overall Study|Lost to Follow-up|1
684569|NCT01577745|2222491|P5|Overall Study|Lost to Follow-up|0
684570|NCT01577745|2222492|P4|Overall Study|Lost to Follow-up|0
684571|NCT01577745|2222493|P3|Overall Study|Lost to Follow-up|0
684572|NCT01577745|2222494|P2|Overall Study|Lost to Follow-up|0
684573|NCT01577745|2222495|P1|Overall Study|Lost to Follow-up|0
684574|NCT01577745|2222490|P6|Overall Study|Physician Decision|0
684575|NCT01577745|2222491|P5|Overall Study|Physician Decision|1
684576|NCT01577745|2222492|P4|Overall Study|Physician Decision|1
684577|NCT01577745|2222493|P3|Overall Study|Physician Decision|0
684578|NCT01577745|2222494|P2|Overall Study|Physician Decision|0
684579|NCT01577745|2222495|P1|Overall Study|Physician Decision|0
684580|NCT01577745|2222490|P6|Overall Study|Death|3
684581|NCT01577745|2222491|P5|Overall Study|Death|1
684582|NCT01577745|2222492|P4|Overall Study|Death|1
684583|NCT01577745|2222493|P3|Overall Study|Death|2
684584|NCT01577745|2222494|P2|Overall Study|Death|2
684585|NCT01577745|2222495|P1|Overall Study|Death|3
684586|NCT01577745|2222490|P6|Overall Study|Withdrawal by Subject|0
684587|NCT01577745|2222491|P5|Overall Study|Withdrawal by Subject|2
684588|NCT01577745|2222492|P4|Overall Study|Withdrawal by Subject|3
684589|NCT01577745|2222493|P3|Overall Study|Withdrawal by Subject|0
684590|NCT01577745|2222494|P2|Overall Study|Withdrawal by Subject|1
684591|NCT01577745|2222495|P1|Overall Study|Withdrawal by Subject|0
684592|NCT01577381|2222679|P4|Overall Study|Ongoing at Date of Cut-Off|0
684593|NCT01577381|2222680|P3|Overall Study|Ongoing at Date of Cut-Off|1
684594|NCT01577381|2222681|P2|Overall Study|Ongoing at Date of Cut-Off|2
684595|NCT01577381|2222682|P1|Overall Study|Ongoing at Date of Cut-Off|0
684596|NCT01577381|2222679|P4|Overall Study|Discontinued|2
684597|NCT01577381|2222680|P3|Overall Study|Discontinued|2
684598|NCT01577381|2222681|P2|Overall Study|Discontinued|1
684599|NCT01577381|2222682|P1|Overall Study|Discontinued|2
684600|NCT01577186|2222820|P1|Overall Study|Unspecified|2
684601|NCT01577186|2222820|P1|Overall Study|Non-Compliant|8
684602|NCT01577186|2222820|P1|Overall Study|Ineligible to Continue|15
684603|NCT01577186|2222820|P1|Overall Study|Insufficient Response|18
684604|NCT01577186|2222820|P1|Overall Study|Withdrawal by Subject|35
684605|NCT01577186|2222820|P1|Overall Study|Lost to Follow-up|28
684606|NCT01577186|2222820|P1|Overall Study|Death|1
684607|NCT01577186|2222820|P1|Overall Study|Adverse Event|23
684608|NCT01577160|2222828|P1|Overall Study|Unspecified|9
684609|NCT01577160|2222828|P1|Overall Study|Subject Uncooperative|7
684610|NCT01577160|2222828|P1|Overall Study|Withdrawal by Subject|18
684611|NCT01577160|2222828|P1|Overall Study|Lost to Follow-up|40
684612|NCT01577160|2222828|P1|Overall Study|Lack of Efficacy|15
684613|NCT01577160|2222828|P1|Overall Study|Adverse Event|9
684614|NCT01576718|2222874|P7|Treatment Period|Noncompliance to study medication|1
684615|NCT01576718|2222875|P6|Treatment Period|Noncompliance to study medication|1
684616|NCT01576718|2222876|P5|Treatment Period|Noncompliance to study medication|0
684617|NCT01576718|2222877|P4|Treatment Period|Noncompliance to study medication|0
684618|NCT01576718|2222878|P3|Treatment Period|Noncompliance to study medication|0
684619|NCT01576718|2222879|P2|Treatment Period|Noncompliance to study medication|0
684620|NCT01576718|2222880|P1|Treatment Period|Noncompliance to study medication|0
684621|NCT01576718|2222874|P7|Treatment Period|Lost to Follow-up|0
684622|NCT01576718|2222875|P6|Treatment Period|Lost to Follow-up|0
684623|NCT01576718|2222876|P5|Treatment Period|Lost to Follow-up|1
684624|NCT01576718|2222877|P4|Treatment Period|Lost to Follow-up|0
684625|NCT01576718|2222878|P3|Treatment Period|Lost to Follow-up|0
684626|NCT01576718|2222879|P2|Treatment Period|Lost to Follow-up|0
684627|NCT01576718|2222880|P1|Treatment Period|Lost to Follow-up|0
684628|NCT01576718|2222874|P7|Treatment Period|Met stopping criteria|15
684629|NCT01576718|2222875|P6|Treatment Period|Met stopping criteria|33
684630|NCT01576718|2222876|P5|Treatment Period|Met stopping criteria|16
684631|NCT01576718|2222877|P4|Treatment Period|Met stopping criteria|19
684632|NCT01576718|2222878|P3|Treatment Period|Met stopping criteria|13
684633|NCT01576718|2222879|P2|Treatment Period|Met stopping criteria|16
684634|NCT01576718|2222880|P1|Treatment Period|Met stopping criteria|0
684635|NCT01576718|2222874|P7|Treatment Period|Sponsor request|0
684636|NCT01576718|2222875|P6|Treatment Period|Sponsor request|1
684637|NCT01576718|2222876|P5|Treatment Period|Sponsor request|0
684638|NCT01576718|2222877|P4|Treatment Period|Sponsor request|0
684639|NCT01576718|2222878|P3|Treatment Period|Sponsor request|0
684640|NCT01576718|2222879|P2|Treatment Period|Sponsor request|1
684641|NCT01576718|2222880|P1|Treatment Period|Sponsor request|0
684642|NCT01576718|2222874|P7|Treatment Period|Protocol Violation|12
684643|NCT01576718|2222875|P6|Treatment Period|Protocol Violation|8
684644|NCT01576718|2222876|P5|Treatment Period|Protocol Violation|6
684645|NCT01576718|2222877|P4|Treatment Period|Protocol Violation|10
684646|NCT01576718|2222878|P3|Treatment Period|Protocol Violation|4
684647|NCT01576718|2222879|P2|Treatment Period|Protocol Violation|5
684648|NCT01576718|2222880|P1|Treatment Period|Protocol Violation|0
684649|NCT01576718|2222874|P7|Treatment Period|Physician Decision|0
684650|NCT01576718|2222875|P6|Treatment Period|Physician Decision|0
684651|NCT01576718|2222876|P5|Treatment Period|Physician Decision|1
684652|NCT01576718|2222877|P4|Treatment Period|Physician Decision|1
684653|NCT01576718|2222878|P3|Treatment Period|Physician Decision|1
684654|NCT01576718|2222879|P2|Treatment Period|Physician Decision|1
684655|NCT01576718|2222880|P1|Treatment Period|Physician Decision|0
684656|NCT01576718|2222874|P7|Treatment Period|Withdrawal by Subject|2
684657|NCT01576718|2222875|P6|Treatment Period|Withdrawal by Subject|4
684658|NCT01576718|2222876|P5|Treatment Period|Withdrawal by Subject|2
684659|NCT01576718|2222877|P4|Treatment Period|Withdrawal by Subject|0
684660|NCT01576718|2222878|P3|Treatment Period|Withdrawal by Subject|1
684661|NCT01576718|2222879|P2|Treatment Period|Withdrawal by Subject|1
684662|NCT01576718|2222880|P1|Treatment Period|Withdrawal by Subject|0
684663|NCT01576718|2222874|P7|Treatment Period|Adverse Event|0
684664|NCT01576718|2222875|P6|Treatment Period|Adverse Event|1
684665|NCT01576718|2222876|P5|Treatment Period|Adverse Event|1
684666|NCT01576718|2222877|P4|Treatment Period|Adverse Event|1
684667|NCT01576718|2222878|P3|Treatment Period|Adverse Event|1
684668|NCT01576718|2222879|P2|Treatment Period|Adverse Event|1
684669|NCT01576718|2222880|P1|Treatment Period|Adverse Event|0
684670|NCT01576718|2222874|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684671|NCT01576718|2222875|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684672|NCT01576718|2222876|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684673|NCT01576718|2222877|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684674|NCT01576718|2222878|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684675|NCT01576718|2222879|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
684676|NCT01576718|2222880|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
684677|NCT01576718|2222874|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684678|NCT01576718|2222875|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684679|NCT01576718|2222876|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684680|NCT01576718|2222877|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684681|NCT01576718|2222878|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684682|NCT01576718|2222879|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
684683|NCT01576718|2222880|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
684684|NCT01576718|2222874|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684685|NCT01576718|2222875|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684686|NCT01576718|2222876|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684687|NCT01576718|2222877|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684688|NCT01576718|2222878|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684689|NCT01576718|2222879|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
684690|NCT01576718|2222880|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
684691|NCT01576718|2222874|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684692|NCT01576718|2222875|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684693|NCT01576718|2222876|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684694|NCT01576718|2222877|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684695|NCT01576718|2222878|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684696|NCT01576718|2222879|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
684697|NCT01576718|2222880|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
684698|NCT01576718|2222874|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684699|NCT01576718|2222875|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684700|NCT01576718|2222876|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684701|NCT01576718|2222877|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684702|NCT01576718|2222878|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684703|NCT01576718|2222879|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
684704|NCT01576718|2222880|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
684705|NCT01576367|2222981|P1|Overall Study|Moved to commercial use after 6 months|1
684706|NCT01576367|2222981|P1|Overall Study|Unsatisfactory therapeutic effect|2
684707|NCT01576341|2222989|P1|Overall Study|Other|12
684708|NCT01576341|2222989|P1|Overall Study|Protocol Violation|12
684709|NCT01576341|2222989|P1|Overall Study|Kidney transplantation|10
684710|NCT01576341|2222989|P1|Overall Study|Lost to Follow-up|2
684711|NCT01576341|2222989|P1|Overall Study|Physician Decision|2
684712|NCT01576341|2222989|P1|Overall Study|Death|21
684713|NCT01576341|2222989|P1|Overall Study|Adverse Event|10
684714|NCT01576341|2222989|P1|Overall Study|Withdrawal by Subject|24
684715|NCT01576159|2223000|P4|Overall Study|Protocol Violation|0
684716|NCT01576159|2223001|P3|Overall Study|Protocol Violation|0
684717|NCT01576159|2223002|P2|Overall Study|Protocol Violation|0
684718|NCT01576159|2223003|P1|Overall Study|Protocol Violation|1
684719|NCT01576159|2223000|P4|Overall Study|Lost to Follow-up|1
684720|NCT01576159|2223001|P3|Overall Study|Lost to Follow-up|0
684721|NCT01576159|2223002|P2|Overall Study|Lost to Follow-up|0
684722|NCT01576159|2223003|P1|Overall Study|Lost to Follow-up|0
684723|NCT01576159|2223000|P4|Overall Study|Physician Decision|0
684724|NCT01576159|2223001|P3|Overall Study|Physician Decision|1
684725|NCT01576159|2223002|P2|Overall Study|Physician Decision|0
684726|NCT01576159|2223003|P1|Overall Study|Physician Decision|0
684727|NCT01576159|2223000|P4|Overall Study|Withdrawal by Subject|0
684728|NCT01576159|2223001|P3|Overall Study|Withdrawal by Subject|0
684729|NCT01576159|2223002|P2|Overall Study|Withdrawal by Subject|1
684730|NCT01576159|2223003|P1|Overall Study|Withdrawal by Subject|0
684731|NCT01576146|2223021|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
684732|NCT01576146|2223021|P1|Extension Period 2|Renal Transplant|1
684733|NCT01576146|2223021|P1|Extension Period 2|Adverse Event|1
684734|NCT01576146|2223021|P1|Extension Period 2|Death|1
684735|NCT01576146|2223021|P1|Extension Period 2|Sponsor Decision|13
684736|NCT01576146|2223021|P1|Extension Period 1|Renal Transplant|1
684737|NCT01576146|2223021|P1|Extension Period 1|Parathyroidectomy|1
684738|NCT01576146|2223021|P1|Extension Period 1|Lost to Follow-up|1
684739|NCT01576146|2223021|P1|Extension Period 1|Withdrawal by Subject|1
684740|NCT01576146|2223021|P1|Extension Period 1|Physician Decision|2
684741|NCT01576146|2223021|P1|Extension Period 1|Death|2
684742|NCT01576146|2223021|P1|Extension Period 1|Adverse Event|2
684743|NCT01576042|2223054|P2|Overall Study|Physician Decision|0
684744|NCT01576042|2223055|P1|Overall Study|Physician Decision|2
684745|NCT01575899|2223091|P3|Overall Study|Protocol Violation|0
684746|NCT01575899|2223092|P2|Overall Study|Protocol Violation|1
684747|NCT01575899|2223093|P1|Overall Study|Protocol Violation|2
684748|NCT01575899|2223091|P3|Overall Study|Lost to Follow-up|2
684749|NCT01575899|2223092|P2|Overall Study|Lost to Follow-up|4
684750|NCT01575899|2223093|P1|Overall Study|Lost to Follow-up|3
684751|NCT01575769|2223103|P1|Overall Study|Study terminated by sponsor|40
684752|NCT01575769|2223103|P1|Overall Study|Adverse Event|1
684753|NCT01575561|2223146|P1|Overall Study|administration|1
684754|NCT01575561|2223146|P1|Overall Study|Withdrawal by Subject|11
684755|NCT01575561|2223146|P1|Overall Study|Protocol Violation|4
684756|NCT01575561|2223146|P1|Overall Study|Lost to Follow-up|6
684757|NCT01575561|2223146|P1|Overall Study|Lack of Efficacy|8
684758|NCT01575561|2223146|P1|Overall Study|Adverse Event|9
684759|NCT01575197|2223169|P3|Overall Study|Protocol Violation|1
684760|NCT01575197|2223170|P2|Overall Study|Protocol Violation|1
684761|NCT01575197|2223171|P1|Overall Study|Protocol Violation|2
684762|NCT01575197|2223169|P3|Overall Study|Withdrawal by Subject|1
684763|NCT01575197|2223170|P2|Overall Study|Withdrawal by Subject|1
684764|NCT01575197|2223171|P1|Overall Study|Withdrawal by Subject|0
684765|NCT01575197|2223169|P3|Overall Study|Lost to Follow-up|0
684766|NCT01575197|2223170|P2|Overall Study|Lost to Follow-up|1
684767|NCT01575197|2223171|P1|Overall Study|Lost to Follow-up|0
684768|NCT01575197|2223169|P3|Overall Study|SAE|0
684769|NCT01575197|2223170|P2|Overall Study|SAE|1
684770|NCT01575197|2223171|P1|Overall Study|SAE|0
684771|NCT01575197|2223169|P3|Overall Study|Migration out of study area|4
684772|NCT01575197|2223170|P2|Overall Study|Migration out of study area|5
684773|NCT01575197|2223171|P1|Overall Study|Migration out of study area|1
684774|NCT01575054|2223193|P2|Overall Study|Adverse Event|8
684775|NCT01575054|2223194|P1|Overall Study|Adverse Event|9
684776|NCT01575054|2223193|P2|Overall Study|Lost to Follow-up|3
684777|NCT01575054|2223194|P1|Overall Study|Lost to Follow-up|3
684778|NCT01575054|2223193|P2|Overall Study|Personal Reasons|11
684779|NCT01575054|2223194|P1|Overall Study|Personal Reasons|10
684780|NCT01575054|2223193|P2|Overall Study|Protocol Violation|1
684781|NCT01575054|2223194|P1|Overall Study|Protocol Violation|2
684782|NCT01575054|2223193|P2|Overall Study|Other Reasons|3
684783|NCT01575054|2223194|P1|Overall Study|Other Reasons|5
684784|NCT01575028|2223210|P2|Overall Study|Physician Decision|1
684785|NCT01575028|2223211|P1|Overall Study|Physician Decision|0
684786|NCT01574703|2223221|P4|Overall Study|Death|0
684787|NCT01574703|2223222|P3|Overall Study|Death|1
684788|NCT01574703|2223223|P2|Overall Study|Death|1
684789|NCT01574703|2223224|P1|Overall Study|Death|2
684790|NCT01574703|2223221|P4|Overall Study|Lost to Follow-up|35
684791|NCT01574703|2223222|P3|Overall Study|Lost to Follow-up|46
684792|NCT01574703|2223223|P2|Overall Study|Lost to Follow-up|41
684793|NCT01574703|2223224|P1|Overall Study|Lost to Follow-up|43
684794|NCT01574703|2223221|P4|Overall Study|Met Withdrawal Criteria|0
684795|NCT01574703|2223222|P3|Overall Study|Met Withdrawal Criteria|1
684796|NCT01574703|2223223|P2|Overall Study|Met Withdrawal Criteria|1
684797|NCT01574703|2223224|P1|Overall Study|Met Withdrawal Criteria|0
684798|NCT01574703|2223221|P4|Overall Study|Withdrawal by Subject|61
684799|NCT01574703|2223222|P3|Overall Study|Withdrawal by Subject|36
684800|NCT01574703|2223223|P2|Overall Study|Withdrawal by Subject|52
684801|NCT01574703|2223224|P1|Overall Study|Withdrawal by Subject|53
684802|NCT01574703|2223221|P4|Overall Study|Unspecified Reason|16
684803|NCT01574703|2223222|P3|Overall Study|Unspecified Reason|20
684804|NCT01574703|2223223|P2|Overall Study|Unspecified Reason|15
684805|NCT01574703|2223224|P1|Overall Study|Unspecified Reason|27
684806|NCT01574703|2223221|P4|Overall Study|Protocol Violation|1
684807|NCT01574703|2223222|P3|Overall Study|Protocol Violation|0
684808|NCT01574703|2223223|P2|Overall Study|Protocol Violation|0
684809|NCT01574703|2223224|P1|Overall Study|Protocol Violation|0
684810|NCT01574703|2223221|P4|Overall Study|Adverse Event|1
684811|NCT01574703|2223222|P3|Overall Study|Adverse Event|1
684812|NCT01574703|2223223|P2|Overall Study|Adverse Event|2
684813|NCT01574703|2223224|P1|Overall Study|Adverse Event|0
684814|NCT01574651|2223268|P2|Overall Study|Withdrawal by Subject|10
684815|NCT01574651|2223269|P1|Overall Study|Withdrawal by Subject|9
684816|NCT01574651|2223268|P2|Overall Study|Protocol Violation|5
684817|NCT01574651|2223269|P1|Overall Study|Protocol Violation|3
684818|NCT01574651|2223268|P2|Overall Study|Unsatisfactory therapeutic effect|0
684819|NCT01574651|2223269|P1|Overall Study|Unsatisfactory therapeutic effect|6
684820|NCT01574651|2223268|P2|Overall Study|Abnormal test procedure result(s)|1
684821|NCT01574651|2223269|P1|Overall Study|Abnormal test procedure result(s)|1
684822|NCT01574651|2223268|P2|Overall Study|Abnormal laboratory value(s)|0
684823|NCT01574651|2223269|P1|Overall Study|Abnormal laboratory value(s)|1
684824|NCT01574651|2223268|P2|Overall Study|Adverse Event|27
684825|NCT01574651|2223269|P1|Overall Study|Adverse Event|36
684826|NCT01574651|2223268|P2|Overall Study|Patient's inability to use the device|1
684827|NCT01574651|2223269|P1|Overall Study|Patient's inability to use the device|0
684828|NCT01574651|2223268|P2|Overall Study|Death|3
684829|NCT01574651|2223269|P1|Overall Study|Death|3
684830|NCT01574651|2223268|P2|Overall Study|Administrative problems|1
684831|NCT01574651|2223269|P1|Overall Study|Administrative problems|0
684832|NCT01574651|2223268|P2|Overall Study|Lost to Follow-up|4
684833|NCT01574651|2223269|P1|Overall Study|Lost to Follow-up|2
684834|NCT01574612|2223291|P1|Overall Study|Lost to Follow-up|2
684835|NCT01574612|2223291|P1|Overall Study|Withdrawal by Subject|1
684836|NCT01574612|2223291|P1|Overall Study|non compliant with drug|2
684837|NCT01574612|2223291|P1|Overall Study|Adverse Event|3
684838|NCT01574326|2223297|P2|Overall Study|Other: Mainly kidney transplant|8
684839|NCT01574326|2223298|P1|Overall Study|Other: Mainly kidney transplant|8
684840|NCT01574326|2223297|P2|Overall Study|Adverse Event|3
684841|NCT01574326|2223298|P1|Overall Study|Adverse Event|1
684842|NCT01574326|2223297|P2|Overall Study|Physician Decision|3
684843|NCT01574326|2223298|P1|Overall Study|Physician Decision|5
684844|NCT01574326|2223297|P2|Overall Study|Withdrawal by Participant|4
684845|NCT01574326|2223298|P1|Overall Study|Withdrawal by Participant|2
684846|NCT01574326|2223297|P2|Overall Study|Randomized but not treated|1
684847|NCT01574326|2223298|P1|Overall Study|Randomized but not treated|0
684848|NCT01574248|2223311|P2|Overall Study|Missing primary endpoint data|0
684849|NCT01574248|2223312|P1|Overall Study|Missing primary endpoint data|1
684850|NCT01574248|2223311|P2|Overall Study|Withdrawal by Subject|0
684851|NCT01574248|2223312|P1|Overall Study|Withdrawal by Subject|2
684852|NCT01574079|2223356|P2|Overall Study|Lost to Follow-up|0
684853|NCT01574079|2223357|P1|Overall Study|Lost to Follow-up|1
684854|NCT01574079|2223356|P2|Overall Study|Physician Decision|2
684855|NCT01574079|2223357|P1|Overall Study|Physician Decision|0
684856|NCT01573910|2223369|P2|Overall Study|Patient decision unrelated to Advs Event|11
684857|NCT01573910|2223370|P1|Overall Study|Patient decision unrelated to Advs Event|11
684858|NCT01573910|2223369|P2|Overall Study|Protocol Violation|0
684859|NCT01573910|2223370|P1|Overall Study|Protocol Violation|3
684860|NCT01573910|2223369|P2|Overall Study|Withdrawal by Subject|1
684861|NCT01573910|2223370|P1|Overall Study|Withdrawal by Subject|0
684862|NCT01573910|2223369|P2|Overall Study|Lost to Follow-up|1
684863|NCT01573910|2223370|P1|Overall Study|Lost to Follow-up|2
684864|NCT01573910|2223369|P2|Overall Study|Adverse Event|4
684865|NCT01573910|2223370|P1|Overall Study|Adverse Event|4
684866|NCT01573767|2223382|P4|Overall Study|Withdrawal by Subject|0
684867|NCT01573767|2223383|P3|Overall Study|Withdrawal by Subject|0
684868|NCT01573767|2223384|P2|Overall Study|Withdrawal by Subject|1
684869|NCT01573767|2223385|P1|Overall Study|Withdrawal by Subject|0
684870|NCT01573767|2223382|P4|Overall Study|Physician Decision|2
684871|NCT01573767|2223383|P3|Overall Study|Physician Decision|0
684872|NCT01573767|2223384|P2|Overall Study|Physician Decision|2
684873|NCT01573767|2223385|P1|Overall Study|Physician Decision|1
684874|NCT01573767|2223382|P4|Overall Study|Lost to Follow-up|1
684875|NCT01573767|2223383|P3|Overall Study|Lost to Follow-up|1
684876|NCT01573767|2223384|P2|Overall Study|Lost to Follow-up|1
684877|NCT01573767|2223385|P1|Overall Study|Lost to Follow-up|0
684878|NCT01573767|2223382|P4|Overall Study|Protocol Violation|3
684879|NCT01573767|2223383|P3|Overall Study|Protocol Violation|1
684880|NCT01573767|2223384|P2|Overall Study|Protocol Violation|1
684881|NCT01573767|2223385|P1|Overall Study|Protocol Violation|3
684882|NCT01573767|2223382|P4|Overall Study|Lack of Efficacy|17
684883|NCT01573767|2223383|P3|Overall Study|Lack of Efficacy|12
684884|NCT01573767|2223384|P2|Overall Study|Lack of Efficacy|15
684885|NCT01573767|2223385|P1|Overall Study|Lack of Efficacy|18
684886|NCT01573767|2223382|P4|Overall Study|Adverse Event|1
684887|NCT01573767|2223383|P3|Overall Study|Adverse Event|0
684888|NCT01573767|2223384|P2|Overall Study|Adverse Event|1
684889|NCT01573767|2223385|P1|Overall Study|Adverse Event|0
684890|NCT01573624|2223419|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684891|NCT01573624|2223420|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684892|NCT01573624|2223421|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684893|NCT01573624|2223422|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684894|NCT01573624|2223423|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684895|NCT01573624|2223424|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
684896|NCT01573624|2223425|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
684897|NCT01573624|2223419|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
684898|NCT01573624|2223420|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
684899|NCT01573624|2223421|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
684900|NCT01573624|2223422|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
684901|NCT01573624|2223423|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
684902|NCT01573624|2223424|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
684903|NCT01573624|2223425|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
684904|NCT01573624|2223419|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684905|NCT01573624|2223420|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684906|NCT01573624|2223421|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684907|NCT01573624|2223422|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684908|NCT01573624|2223423|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684909|NCT01573624|2223424|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
684910|NCT01573624|2223425|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
684911|NCT01573624|2223419|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
684912|NCT01573624|2223420|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
684913|NCT01573624|2223421|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
684914|NCT01573624|2223422|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
684915|NCT01573624|2223423|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
684916|NCT01573624|2223424|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
684917|NCT01573624|2223425|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
684918|NCT01573624|2223419|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
684919|NCT01573624|2223420|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
684920|NCT01573624|2223421|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
684921|NCT01573624|2223422|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
684922|NCT01573624|2223423|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
684923|NCT01573624|2223424|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
684924|NCT01573624|2223425|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
684925|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
684926|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
684927|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
684928|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
684929|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
684930|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
684931|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
684932|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
684933|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
684934|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
684935|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
684936|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
684937|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
684938|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
684939|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684940|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684941|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684942|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684943|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684944|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
684945|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
684946|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684947|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684948|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684949|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684950|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684951|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
684952|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
684953|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
684954|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
684955|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
684956|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
684957|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
684958|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
684959|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
684960|NCT01573624|2223419|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
684961|NCT01573624|2223420|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
684962|NCT01573624|2223421|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
684963|NCT01573624|2223422|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
684964|NCT01573624|2223423|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
684965|NCT01573624|2223424|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
684966|NCT01573624|2223425|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
684967|NCT01573624|2223419|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684968|NCT01573624|2223420|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684969|NCT01573624|2223421|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684970|NCT01573624|2223422|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684971|NCT01573624|2223423|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684972|NCT01573624|2223424|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
684973|NCT01573624|2223425|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
684974|NCT01573624|2223419|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
684975|NCT01573624|2223420|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
684976|NCT01573624|2223421|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
684977|NCT01573624|2223422|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
684978|NCT01573624|2223423|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
684979|NCT01573624|2223424|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
684980|NCT01573624|2223425|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
684981|NCT01573624|2223419|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684982|NCT01573624|2223420|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684983|NCT01573624|2223421|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684984|NCT01573624|2223422|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684985|NCT01573624|2223423|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684986|NCT01573624|2223424|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
684987|NCT01573624|2223425|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
684988|NCT01573624|2223419|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
684989|NCT01573624|2223420|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
684990|NCT01573624|2223421|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
684991|NCT01573624|2223422|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
684992|NCT01573624|2223423|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
684993|NCT01573624|2223424|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
684994|NCT01573624|2223425|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
684995|NCT01573624|2223419|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
684996|NCT01573624|2223420|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
684997|NCT01573624|2223421|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
684998|NCT01573624|2223422|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
684999|NCT01573624|2223423|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
685000|NCT01573624|2223424|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
685001|NCT01573624|2223425|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
685002|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
685003|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
685004|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
685005|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
685006|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
685007|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
685008|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
685009|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
685010|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
685011|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
685012|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
685013|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
685014|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
685015|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
685016|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685017|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
685018|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685019|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685020|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685021|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685022|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
685023|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
685024|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
685025|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
685026|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
685027|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
685028|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
685029|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
685030|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
685031|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
685032|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
685033|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
685034|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
685035|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
685036|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
685037|NCT01573624|2223419|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685038|NCT01573624|2223420|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
685039|NCT01573624|2223421|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685040|NCT01573624|2223422|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685041|NCT01573624|2223423|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685042|NCT01573624|2223424|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685043|NCT01573624|2223425|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
685044|NCT01573624|2223419|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
685045|NCT01573624|2223420|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
685046|NCT01573624|2223421|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
685047|NCT01573624|2223422|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
685048|NCT01573624|2223423|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
685049|NCT01573624|2223424|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
685050|NCT01573624|2223425|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
685051|NCT01573624|2223419|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
685052|NCT01573624|2223420|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
685053|NCT01573624|2223421|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
685054|NCT01573624|2223422|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
685055|NCT01573624|2223423|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
685056|NCT01573624|2223424|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
685057|NCT01573624|2223425|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
685058|NCT01573624|2223419|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685059|NCT01573624|2223420|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685060|NCT01573624|2223421|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685061|NCT01573624|2223422|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685062|NCT01573624|2223423|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685063|NCT01573624|2223424|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
685064|NCT01573624|2223425|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
685065|NCT01573624|2223419|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
685066|NCT01573624|2223420|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
685067|NCT01573624|2223421|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
685068|NCT01573624|2223422|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
685069|NCT01573624|2223423|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
685070|NCT01573624|2223424|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
685071|NCT01573624|2223425|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
685072|NCT01573624|2223419|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
685073|NCT01573624|2223420|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
685074|NCT01573624|2223421|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
685075|NCT01573624|2223422|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
685076|NCT01573624|2223423|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
685077|NCT01573624|2223424|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
685078|NCT01573624|2223425|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
685079|NCT01573000|2223514|P2|Long-Term Follow-Up|Lost to Follow-up|1
685080|NCT01573000|2223515|P1|Long-Term Follow-Up|Lost to Follow-up|0
685081|NCT01573000|2223514|P2|Long-Term Follow-Up|Death|0
685082|NCT01573000|2223515|P1|Long-Term Follow-Up|Death|3
685083|NCT01573000|2223514|P2|Crossover Phase|Death|3
685084|NCT01573000|2223515|P1|Crossover Phase|Death|0
685085|NCT01573000|2223514|P2|Crossover Phase|Lost to Follow-up|2
685086|NCT01573000|2223515|P1|Crossover Phase|Lost to Follow-up|0
685087|NCT01573000|2223514|P2|Crossover Phase|Lack of Efficacy|13
685088|NCT01573000|2223515|P1|Crossover Phase|Lack of Efficacy|0
685089|NCT01573000|2223514|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
685090|NCT01573000|2223515|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
685091|NCT01573000|2223514|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
685092|NCT01573000|2223515|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
685093|NCT01573000|2223514|P2|Dosimetric and Therapeutic Treatment|Death|1
685094|NCT01573000|2223515|P1|Dosimetric and Therapeutic Treatment|Death|0
685095|NCT01573000|2223514|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
685096|NCT01573000|2223515|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
685097|NCT01573000|2223514|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
685098|NCT01573000|2223515|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
685099|NCT01572948|2223611|P2|Overall Study|unable to contact|1
685100|NCT01572948|2223612|P1|Overall Study|unable to contact|0
685101|NCT01572948|2223611|P2|Overall Study|Lost to Follow-up|0
685102|NCT01572948|2223612|P1|Overall Study|Lost to Follow-up|1
685103|NCT01572792|2223633|P5|Extension Study|Site termination/COPD exacerbation/other|6
685104|NCT01572792|2223634|P4|Extension Study|Site termination/COPD exacerbation/other|6
685105|NCT01572792|2223635|P3|Extension Study|Site termination/COPD exacerbation/other|4
685106|NCT01572792|2223636|P2|Extension Study|Site termination/COPD exacerbation/other|8
685107|NCT01572792|2223637|P1|Extension Study|Site termination/COPD exacerbation/other|3
685108|NCT01572792|2223633|P5|Extension Study|Adverse Event|4
685109|NCT01572792|2223634|P4|Extension Study|Adverse Event|6
685110|NCT01572792|2223635|P3|Extension Study|Adverse Event|5
685111|NCT01572792|2223636|P2|Extension Study|Adverse Event|6
685112|NCT01572792|2223637|P1|Extension Study|Adverse Event|7
685113|NCT01572792|2223633|P5|Extension Study|Lack of Efficacy|2
685114|NCT01572792|2223634|P4|Extension Study|Lack of Efficacy|2
685115|NCT01572792|2223635|P3|Extension Study|Lack of Efficacy|3
685116|NCT01572792|2223636|P2|Extension Study|Lack of Efficacy|3
685117|NCT01572792|2223637|P1|Extension Study|Lack of Efficacy|2
685118|NCT01572792|2223633|P5|Extension Study|Protocol Violation|3
685119|NCT01572792|2223634|P4|Extension Study|Protocol Violation|4
685120|NCT01572792|2223635|P3|Extension Study|Protocol Violation|3
685121|NCT01572792|2223636|P2|Extension Study|Protocol Violation|4
685122|NCT01572792|2223637|P1|Extension Study|Protocol Violation|0
685123|NCT01572792|2223633|P5|Extension Study|Withdrawal by Subject|14
685124|NCT01572792|2223634|P4|Extension Study|Withdrawal by Subject|8
685125|NCT01572792|2223635|P3|Extension Study|Withdrawal by Subject|11
685126|NCT01572792|2223636|P2|Extension Study|Withdrawal by Subject|6
685127|NCT01572792|2223637|P1|Extension Study|Withdrawal by Subject|7
685128|NCT01572792|2223633|P5|Extension Study|Lost to Follow-up|3
685129|NCT01572792|2223634|P4|Extension Study|Lost to Follow-up|3
685130|NCT01572792|2223635|P3|Extension Study|Lost to Follow-up|0
685131|NCT01572792|2223636|P2|Extension Study|Lost to Follow-up|2
685132|NCT01572792|2223637|P1|Extension Study|Lost to Follow-up|6
685133|NCT01572792|2223633|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
685134|NCT01572792|2223634|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
685135|NCT01572792|2223635|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
685136|NCT01572792|2223636|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
685137|NCT01572792|2223637|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
685138|NCT01572792|2223633|P5|Lead-in Study|Adverse Event|14
685139|NCT01572792|2223634|P4|Lead-in Study|Adverse Event|16
685140|NCT01572792|2223635|P3|Lead-in Study|Adverse Event|22
685141|NCT01572792|2223636|P2|Lead-in Study|Adverse Event|21
685142|NCT01572792|2223637|P1|Lead-in Study|Adverse Event|21
685143|NCT01572792|2223633|P5|Lead-in Study|Lack of Efficacy|10
685144|NCT01572792|2223634|P4|Lead-in Study|Lack of Efficacy|8
685145|NCT01572792|2223635|P3|Lead-in Study|Lack of Efficacy|4
685146|NCT01572792|2223636|P2|Lead-in Study|Lack of Efficacy|5
685147|NCT01572792|2223637|P1|Lead-in Study|Lack of Efficacy|20
685148|NCT01572792|2223633|P5|Lead-in Study|Protocol Violation|21
685149|NCT01572792|2223634|P4|Lead-in Study|Protocol Violation|13
685150|NCT01572792|2223635|P3|Lead-in Study|Protocol Violation|12
685151|NCT01572792|2223636|P2|Lead-in Study|Protocol Violation|10
685152|NCT01572792|2223637|P1|Lead-in Study|Protocol Violation|19
685153|NCT01572792|2223633|P5|Lead-in Study|Withdrawal by Subject|11
685154|NCT01572792|2223634|P4|Lead-in Study|Withdrawal by Subject|24
685155|NCT01572792|2223635|P3|Lead-in Study|Withdrawal by Subject|12
685156|NCT01572792|2223636|P2|Lead-in Study|Withdrawal by Subject|11
685157|NCT01572792|2223637|P1|Lead-in Study|Withdrawal by Subject|22
685158|NCT01572792|2223633|P5|Lead-in Study|Lost to Follow-up|4
685159|NCT01572792|2223634|P4|Lead-in Study|Lost to Follow-up|2
685160|NCT01572792|2223635|P3|Lead-in Study|Lost to Follow-up|4
685161|NCT01572792|2223636|P2|Lead-in Study|Lost to Follow-up|9
685162|NCT01572792|2223637|P1|Lead-in Study|Lost to Follow-up|5
685163|NCT01572740|2223686|P2|Overall Study|unclassified|3
685164|NCT01572740|2223687|P1|Overall Study|unclassified|4
685165|NCT01572740|2223686|P2|Overall Study|Withdrawal by Subject|1
685166|NCT01572740|2223687|P1|Overall Study|Withdrawal by Subject|1
685167|NCT01572740|2223686|P2|Overall Study|Adverse Event|1
685168|NCT01572740|2223687|P1|Overall Study|Adverse Event|1
685169|NCT01572727|2223717|P2|Overall Study|Untreated|7
685170|NCT01572727|2223718|P1|Overall Study|Untreated|4
685171|NCT01572727|2223717|P2|Overall Study|Death|2
685172|NCT01572727|2223718|P1|Overall Study|Death|2
685173|NCT01572727|2223717|P2|Overall Study|Parent/guardian decision|9
685174|NCT01572727|2223718|P1|Overall Study|Parent/guardian decision|14
685175|NCT01572727|2223717|P2|Overall Study|Study terminated by sponsor|83
685176|NCT01572727|2223718|P1|Overall Study|Study terminated by sponsor|61
685177|NCT01572727|2223717|P2|Overall Study|Protocol Violation|1
685178|NCT01572727|2223718|P1|Overall Study|Protocol Violation|0
685179|NCT01572727|2223717|P2|Overall Study|Progressive disease|82
685180|NCT01572727|2223718|P1|Overall Study|Progressive disease|59
685181|NCT01572727|2223717|P2|Overall Study|Physician Decision|9
685182|NCT01572727|2223718|P1|Overall Study|Physician Decision|23
685183|NCT01572727|2223717|P2|Overall Study|Lost to Follow-up|1
685184|NCT01572727|2223718|P1|Overall Study|Lost to Follow-up|1
685185|NCT01572727|2223717|P2|Overall Study|Adverse Event|15
685186|NCT01572727|2223718|P1|Overall Study|Adverse Event|43
685187|NCT01572675|2223740|P2|Overall Study|Lost to Follow-up|27
685188|NCT01572675|2223741|P1|Overall Study|Lost to Follow-up|22
685189|NCT01572675|2223740|P2|Overall Study|Missing data|4
685190|NCT01572675|2223741|P1|Overall Study|Missing data|1
685191|NCT01572675|2223740|P2|Overall Study|Rheumatologist new evaluation|1
685192|NCT01572675|2223741|P1|Overall Study|Rheumatologist new evaluation|0
685193|NCT01572675|2223740|P2|Overall Study|Unknown reason|1
685194|NCT01572675|2223741|P1|Overall Study|Unknown reason|1
685195|NCT01572675|2223740|P2|Overall Study|Other disease detected|1
685196|NCT01572675|2223741|P1|Overall Study|Other disease detected|1
685197|NCT01572675|2223740|P2|Overall Study|Death unrelated to coxibs|1
685198|NCT01572675|2223741|P1|Overall Study|Death unrelated to coxibs|1
685199|NCT01572675|2223740|P2|Overall Study|Physician Decision|2
685200|NCT01572675|2223741|P1|Overall Study|Physician Decision|2
685201|NCT01572675|2223740|P2|Overall Study|Withdrawal by Subject|1
685202|NCT01572675|2223741|P1|Overall Study|Withdrawal by Subject|5
685203|NCT01572675|2223740|P2|Overall Study|Surgical intervention|6
685204|NCT01572675|2223741|P1|Overall Study|Surgical intervention|3
685205|NCT01572675|2223740|P2|Overall Study|Improved symptoms|2
685206|NCT01572675|2223741|P1|Overall Study|Improved symptoms|8
685207|NCT01572675|2223740|P2|Overall Study|Intolerance|5
685208|NCT01572675|2223741|P1|Overall Study|Intolerance|6
685209|NCT01572675|2223740|P2|Overall Study|Lack of Efficacy|31
685210|NCT01572675|2223741|P1|Overall Study|Lack of Efficacy|31
685211|NCT01572675|2223740|P2|Overall Study|Recovery|23
685212|NCT01572675|2223741|P1|Overall Study|Recovery|16
685213|NCT01572675|2223740|P2|Overall Study|End of prescribed treatment|118
685214|NCT01572675|2223741|P1|Overall Study|End of prescribed treatment|140
685215|NCT01571453|2223869|P2|Overall Study|Administrative or other reason(s)|3
685216|NCT01571453|2223870|P1|Overall Study|Administrative or other reason(s)|4
685217|NCT01571453|2223869|P2|Overall Study|Lost to Follow-up|2
685218|NCT01571453|2223870|P1|Overall Study|Lost to Follow-up|4
685219|NCT01571453|2223869|P2|Overall Study|Withdrawal of consent|13
685220|NCT01571453|2223870|P1|Overall Study|Withdrawal of consent|5
685221|NCT01571453|2223869|P2|Overall Study|Protocol Violation|5
685222|NCT01571453|2223870|P1|Overall Study|Protocol Violation|1
685223|NCT01571453|2223869|P2|Overall Study|Non-compliance|4
685224|NCT01571453|2223870|P1|Overall Study|Non-compliance|2
685225|NCT01571453|2223869|P2|Overall Study|Lack of Efficacy|3
685226|NCT01571453|2223870|P1|Overall Study|Lack of Efficacy|8
685227|NCT01571453|2223869|P2|Overall Study|Adverse Event|32
685228|NCT01571453|2223870|P1|Overall Study|Adverse Event|14
685229|NCT01571362|2223886|P3|Double-Blind Treatment Period|Other - unspecified|1
685230|NCT01571362|2223887|P2|Double-Blind Treatment Period|Other - unspecified|6
685231|NCT01571362|2223888|P1|Double-Blind Treatment Period|Other - unspecified|0
685232|NCT01571362|2223886|P3|Double-Blind Treatment Period|Insufficient clinical response|4
685233|NCT01571362|2223887|P2|Double-Blind Treatment Period|Insufficient clinical response|16
685234|NCT01571362|2223888|P1|Double-Blind Treatment Period|Insufficient clinical response|0
685235|NCT01571362|2223886|P3|Double-Blind Treatment Period|Lost to Follow-up|6
685236|NCT01571362|2223887|P2|Double-Blind Treatment Period|Lost to Follow-up|3
685237|NCT01571362|2223888|P1|Double-Blind Treatment Period|Lost to Follow-up|0
685238|NCT01571362|2223886|P3|Double-Blind Treatment Period|Adverse Event|14
685239|NCT01571362|2223887|P2|Double-Blind Treatment Period|Adverse Event|9
685240|NCT01571362|2223888|P1|Double-Blind Treatment Period|Adverse Event|0
685241|NCT01571362|2223886|P3|Double-Blind Treatment Period|Protocol Violation|9
685242|NCT01571362|2223887|P2|Double-Blind Treatment Period|Protocol Violation|8
685243|NCT01571362|2223888|P1|Double-Blind Treatment Period|Protocol Violation|0
685244|NCT01571362|2223886|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
685245|NCT01571362|2223887|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
685246|NCT01571362|2223888|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
685247|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
685248|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
685249|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
685250|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
685251|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
685252|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
685253|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
685254|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
685255|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
685256|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Adverse Event|0
685257|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Adverse Event|0
685258|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Adverse Event|57
685259|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
685260|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
685261|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
685262|NCT01571362|2223886|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
685263|NCT01571362|2223887|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
685264|NCT01571362|2223888|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
685265|NCT01571232|2224060|P2|Overall Study|Withdrawal by Subject|0
685266|NCT01571232|2224061|P1|Overall Study|Withdrawal by Subject|1
685267|NCT01571232|2224060|P2|Overall Study|Lost to Follow-up|1
685268|NCT01571232|2224061|P1|Overall Study|Lost to Follow-up|0
685269|NCT01570751|2224073|P2|Period B (16 Weeks)|Protocol Violation|1
685270|NCT01570751|2224074|P1|Period B (16 Weeks)|Protocol Violation|0
685271|NCT01570751|2224073|P2|Period B (16 Weeks)|Adverse Event|0
685272|NCT01570751|2224074|P1|Period B (16 Weeks)|Adverse Event|1
685273|NCT01570751|2224073|P2|Period A (16 Weeks)|Unclassified|3
685274|NCT01570751|2224074|P1|Period A (16 Weeks)|Unclassified|2
685275|NCT01570751|2224073|P2|Period A (16 Weeks)|Withdrawal criteria|1
685276|NCT01570751|2224074|P1|Period A (16 Weeks)|Withdrawal criteria|0
685277|NCT01570751|2224073|P2|Period A (16 Weeks)|Protocol Violation|1
685278|NCT01570751|2224074|P1|Period A (16 Weeks)|Protocol Violation|1
685279|NCT01570686|2224092|P2|Overall Study|Unsatisfactory therapeutic effect|1
685280|NCT01570686|2224093|P1|Overall Study|Unsatisfactory therapeutic effect|2
685281|NCT01570686|2224092|P2|Overall Study|Withdrawal by Subject|4
685282|NCT01570686|2224093|P1|Overall Study|Withdrawal by Subject|4
685283|NCT01570686|2224092|P2|Overall Study|Protocol Deviation|0
685284|NCT01570686|2224093|P1|Overall Study|Protocol Deviation|3
685285|NCT01570686|2224092|P2|Overall Study|Lost to Follow-up|3
685286|NCT01570686|2224093|P1|Overall Study|Lost to Follow-up|4
685287|NCT01570686|2224092|P2|Overall Study|Adverse Event|6
685288|NCT01570686|2224093|P1|Overall Study|Adverse Event|8
685289|NCT01570686|2224092|P2|Overall Study|Administrative problems|1
685290|NCT01570686|2224093|P1|Overall Study|Administrative problems|0
685291|NCT01570686|2224092|P2|Overall Study|Abnormal test procedure result(s)|1
685292|NCT01570686|2224093|P1|Overall Study|Abnormal test procedure result(s)|1
685293|NCT01570309|2224129|P2|Overall Study|Withdrawal by Subject|3
685294|NCT01570309|2224130|P1|Overall Study|Withdrawal by Subject|3
685295|NCT01570244|2224144|P1|Microgynon+Faldaprevir|Adverse Event|1
685302|NCT01569841|2224205|P2|Period A (6 Weeks)|Withdrawal by Subject|1
685303|NCT01569841|2224206|P1|Period A (6 Weeks)|Withdrawal by Subject|0
685304|NCT01569763|2224295|P2|Overall Study|Adverse Event|0
685305|NCT01569763|2224296|P1|Overall Study|Adverse Event|1
685306|NCT01569763|2224295|P2|Overall Study|Lack of Efficacy|7
685307|NCT01569763|2224296|P1|Overall Study|Lack of Efficacy|2
685308|NCT01569568|2224308|P2|Overall Study|Physician Decision|2
685309|NCT01569568|2224309|P1|Overall Study|Physician Decision|0
685310|NCT01569464|2224332|P2|Overall Study|Other|1
685311|NCT01569464|2224333|P1|Overall Study|Other|1
685312|NCT01569464|2224332|P2|Overall Study|Withdrawal by Subject|1
685313|NCT01569464|2224333|P1|Overall Study|Withdrawal by Subject|1
685314|NCT01569464|2224332|P2|Overall Study|Lost to Follow-up|3
685315|NCT01569464|2224333|P1|Overall Study|Lost to Follow-up|2
685316|NCT01569464|2224332|P2|Overall Study|Protocol Violation|0
685317|NCT01569464|2224333|P1|Overall Study|Protocol Violation|1
685318|NCT01569464|2224332|P2|Overall Study|Lack of Efficacy|0
685319|NCT01569464|2224333|P1|Overall Study|Lack of Efficacy|1
685320|NCT01569464|2224332|P2|Overall Study|Adverse Event|0
685321|NCT01569464|2224333|P1|Overall Study|Adverse Event|4
685322|NCT01569438|2224371|P2|Overall Study|Protocol Violation|0
685323|NCT01569438|2224372|P1|Overall Study|Protocol Violation|1
685324|NCT01569438|2224371|P2|Overall Study|Withdrawal by Subject|1
685325|NCT01569438|2224372|P1|Overall Study|Withdrawal by Subject|0
685326|NCT01569438|2224371|P2|Overall Study|Lack of Efficacy|1
685327|NCT01569438|2224372|P1|Overall Study|Lack of Efficacy|1
685328|NCT01569438|2224371|P2|Overall Study|Adverse Event|7
685329|NCT01569438|2224372|P1|Overall Study|Adverse Event|0
685330|NCT01569152|2224386|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
685331|NCT01569152|2224387|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
685332|NCT01569152|2224388|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
685333|NCT01569152|2224386|P3|Safety Extension, Period 3|Physician Decision|2
685334|NCT01569152|2224387|P2|Safety Extension, Period 3|Physician Decision|0
685335|NCT01569152|2224388|P1|Safety Extension, Period 3|Physician Decision|0
685336|NCT01569152|2224386|P3|Safety Extension, Period 3|Withdrawal by Subject|2
685337|NCT01569152|2224387|P2|Safety Extension, Period 3|Withdrawal by Subject|0
685338|NCT01569152|2224388|P1|Safety Extension, Period 3|Withdrawal by Subject|0
685339|NCT01569152|2224386|P3|Safety Extension, Period 3|Adverse Event|4
685340|NCT01569152|2224387|P2|Safety Extension, Period 3|Adverse Event|0
685341|NCT01569152|2224388|P1|Safety Extension, Period 3|Adverse Event|0
685342|NCT01569152|2224386|P3|Phase IIa, Period 1|Withdrawal by Subject|0
685343|NCT01569152|2224387|P2|Phase IIa, Period 1|Withdrawal by Subject|1
685344|NCT01569152|2224388|P1|Phase IIa, Period 1|Withdrawal by Subject|2
685345|NCT01569152|2224386|P3|Phase IIa, Period 1|Protocol Violation|0
685346|NCT01569152|2224387|P2|Phase IIa, Period 1|Protocol Violation|1
685347|NCT01569152|2224388|P1|Phase IIa, Period 1|Protocol Violation|0
685348|NCT01569152|2224386|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
685349|NCT01569152|2224387|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
685350|NCT01569152|2224388|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
685351|NCT01569152|2224386|P3|Phase IIa, Period 1|Lost to Follow-up|0
685352|NCT01569152|2224387|P2|Phase IIa, Period 1|Lost to Follow-up|0
685353|NCT01569152|2224388|P1|Phase IIa, Period 1|Lost to Follow-up|1
685354|NCT01569152|2224386|P3|Phase IIa, Period 1|Adverse Event|0
685355|NCT01569152|2224387|P2|Phase IIa, Period 1|Adverse Event|0
685356|NCT01569152|2224388|P1|Phase IIa, Period 1|Adverse Event|4
685357|NCT01569152|2224386|P3|Phase IIa, Period 1|Early Escape|0
685358|NCT01569152|2224387|P2|Phase IIa, Period 1|Early Escape|22
685359|NCT01569152|2224388|P1|Phase IIa, Period 1|Early Escape|5
685360|NCT01569074|2224524|P5|Overall Study|Adverse Event|0
685361|NCT01569074|2224525|P4|Overall Study|Adverse Event|0
685362|NCT01569074|2224526|P3|Overall Study|Adverse Event|3
685363|NCT01569074|2224527|P2|Overall Study|Adverse Event|0
685364|NCT01569074|2224528|P1|Overall Study|Adverse Event|1
685365|NCT01569074|2224524|P5|Overall Study|eg change in circumstances|1
685366|NCT01569074|2224525|P4|Overall Study|eg change in circumstances|1
685367|NCT01569074|2224526|P3|Overall Study|eg change in circumstances|0
685368|NCT01569074|2224527|P2|Overall Study|eg change in circumstances|2
685369|NCT01569074|2224528|P1|Overall Study|eg change in circumstances|0
685370|NCT01569074|2224524|P5|Overall Study|Severe non-compliance to protocol|0
685371|NCT01569074|2224525|P4|Overall Study|Severe non-compliance to protocol|0
685372|NCT01569074|2224526|P3|Overall Study|Severe non-compliance to protocol|1
685373|NCT01569074|2224527|P2|Overall Study|Severe non-compliance to protocol|0
685374|NCT01569074|2224528|P1|Overall Study|Severe non-compliance to protocol|0
685375|NCT01569074|2224524|P5|Overall Study|Study-specific discontinuation criteria|0
685376|NCT01569074|2224525|P4|Overall Study|Study-specific discontinuation criteria|0
685377|NCT01569074|2224526|P3|Overall Study|Study-specific discontinuation criteria|0
685378|NCT01569074|2224527|P2|Overall Study|Study-specific discontinuation criteria|1
685379|NCT01569074|2224528|P1|Overall Study|Study-specific discontinuation criteria|0
685380|NCT01569074|2224524|P5|Overall Study|Study stopped|7
685381|NCT01569074|2224525|P4|Overall Study|Study stopped|7
685382|NCT01569074|2224526|P3|Overall Study|Study stopped|8
685383|NCT01569074|2224527|P2|Overall Study|Study stopped|6
685384|NCT01569074|2224528|P1|Overall Study|Study stopped|6
685385|NCT01568892|2224608|P2|Open-label Phase|Ongoing|15
685386|NCT01568892|2224609|P1|Open-label Phase|Ongoing|12
685387|NCT01568892|2224608|P2|Open-label Phase|Lack of Efficacy|1
685388|NCT01568892|2224609|P1|Open-label Phase|Lack of Efficacy|0
685389|NCT01568892|2224608|P2|Open-label Phase|Adverse Event|0
685390|NCT01568892|2224609|P1|Open-label Phase|Adverse Event|1
685391|NCT01568866|2224647|P2|Overall Study|Randomized but Not Dosed|1
685392|NCT01568866|2224648|P1|Overall Study|Randomized but Not Dosed|9
685393|NCT01568866|2224647|P2|Overall Study|Lost to Follow-up|0
685394|NCT01568866|2224648|P1|Overall Study|Lost to Follow-up|1
685395|NCT01568866|2224647|P2|Overall Study|Protocol Non-compliance|4
685396|NCT01568866|2224648|P1|Overall Study|Protocol Non-compliance|1
685397|NCT01568866|2224647|P2|Overall Study|Death|13
685398|NCT01568866|2224648|P1|Overall Study|Death|9
685399|NCT01568866|2224647|P2|Overall Study|Withdrawal by Subject|6
685400|NCT01568866|2224648|P1|Overall Study|Withdrawal by Subject|19
685401|NCT01568866|2224647|P2|Overall Study|Physician Decision|18
685402|NCT01568866|2224648|P1|Overall Study|Physician Decision|35
685403|NCT01568866|2224647|P2|Overall Study|Patient Request|40
685404|NCT01568866|2224648|P1|Overall Study|Patient Request|45
685405|NCT01568866|2224647|P2|Overall Study|Adverse Event|65
685406|NCT01568866|2224648|P1|Overall Study|Adverse Event|73
685407|NCT01568866|2224647|P2|Overall Study|Disease Progression|117
685408|NCT01568866|2224648|P1|Overall Study|Disease Progression|168
685409|NCT01568593|2224679|P2|Overall Study|Adverse Event|2
685410|NCT01568593|2224680|P1|Overall Study|Adverse Event|3
685411|NCT01568593|2224679|P2|Overall Study|Lack of Efficacy|1
685412|NCT01568593|2224680|P1|Overall Study|Lack of Efficacy|4
685413|NCT01568112|2224700|P4|Overall Study|Withdrawal by Physician|1
685414|NCT01568112|2224701|P3|Overall Study|Withdrawal by Physician|1
685415|NCT01568112|2224702|P2|Overall Study|Withdrawal by Physician|0
685416|NCT01568112|2224703|P1|Overall Study|Withdrawal by Physician|1
685417|NCT01568112|2224700|P4|Overall Study|Withdrawal by Subject|7
685418|NCT01568112|2224701|P3|Overall Study|Withdrawal by Subject|0
685419|NCT01568112|2224702|P2|Overall Study|Withdrawal by Subject|3
685420|NCT01568112|2224703|P1|Overall Study|Withdrawal by Subject|2
685421|NCT01568112|2224700|P4|Overall Study|Lost to Follow-up|1
685422|NCT01568112|2224701|P3|Overall Study|Lost to Follow-up|0
685423|NCT01568112|2224702|P2|Overall Study|Lost to Follow-up|0
685424|NCT01568112|2224703|P1|Overall Study|Lost to Follow-up|0
685425|NCT01568112|2224700|P4|Overall Study|Withdrew due to Adverse Event|3
685426|NCT01568112|2224701|P3|Overall Study|Withdrew due to Adverse Event|6
685427|NCT01568112|2224702|P2|Overall Study|Withdrew due to Adverse Event|4
685428|NCT01568112|2224703|P1|Overall Study|Withdrew due to Adverse Event|2
685429|NCT01568112|2224700|P4|Overall Study|Randomized But Not Treated|0
685430|NCT01568112|2224701|P3|Overall Study|Randomized But Not Treated|0
685431|NCT01568112|2224702|P2|Overall Study|Randomized But Not Treated|1
685432|NCT01568112|2224703|P1|Overall Study|Randomized But Not Treated|0
685433|NCT01568047|2224861|P4|Overall Study|Adverse Event|1
685434|NCT01568047|2224862|P3|Overall Study|Adverse Event|1
685435|NCT01568047|2224863|P2|Overall Study|Adverse Event|0
685436|NCT01568047|2224864|P1|Overall Study|Adverse Event|0
685437|NCT01568047|2224861|P4|Overall Study|Withdrawal by Subject|0
685438|NCT01568047|2224862|P3|Overall Study|Withdrawal by Subject|0
685439|NCT01568047|2224863|P2|Overall Study|Withdrawal by Subject|1
685440|NCT01568047|2224864|P1|Overall Study|Withdrawal by Subject|0
685441|NCT01568047|2224861|P4|Overall Study|Ineligibility|0
685442|NCT01568047|2224862|P3|Overall Study|Ineligibility|0
685443|NCT01568047|2224863|P2|Overall Study|Ineligibility|0
685444|NCT01568047|2224864|P1|Overall Study|Ineligibility|1
685445|NCT01568034|2224882|P4|Overall Study|Withdrawal by Subject|0
685446|NCT01568034|2224883|P3|Overall Study|Withdrawal by Subject|0
685447|NCT01568034|2224884|P2|Overall Study|Withdrawal by Subject|0
685448|NCT01568034|2224885|P1|Overall Study|Withdrawal by Subject|1
685449|NCT01567852|2224932|P2|Overall Study|ECT discontinued|1
685450|NCT01567852|2224933|P1|Overall Study|ECT discontinued|1
685451|NCT01567852|2224932|P2|Overall Study|Withdrawal by Subject|6
685452|NCT01567852|2224933|P1|Overall Study|Withdrawal by Subject|3
685453|NCT01567826|2224951|P2|Overall Study|Lost to Follow-up|2
685454|NCT01567826|2224952|P1|Overall Study|Lost to Follow-up|3
685455|NCT01567163|2224981|P1|Overall Study|Lost to Follow-up|2
685456|NCT01567163|2224981|P1|Overall Study|Progressive Disease|2
685457|NCT01566981|2225021|P2|Overall Study|Lost to Follow-up|8
685458|NCT01566981|2225022|P1|Overall Study|Lost to Follow-up|5
685459|NCT01566721|2225053|P2|Overall Study|Withdrew Prior to Treatment|1
685460|NCT01566721|2225054|P1|Overall Study|Withdrew Prior to Treatment|3
685461|NCT01566721|2225053|P2|Overall Study|Not Specified|4
685462|NCT01566721|2225054|P1|Overall Study|Not Specified|10
685463|NCT01566721|2225053|P2|Overall Study|Death|3
685464|NCT01566721|2225054|P1|Overall Study|Death|6
685465|NCT01566721|2225053|P2|Overall Study|Lost to Follow-up|0
685466|NCT01566721|2225054|P1|Overall Study|Lost to Follow-up|18
685467|NCT01566721|2225053|P2|Overall Study|Disease Progression/Recurrence|28
685468|NCT01566721|2225054|P1|Overall Study|Disease Progression/Recurrence|123
685469|NCT01566721|2225053|P2|Overall Study|Withdrawal by Subject|15
685470|NCT01566721|2225054|P1|Overall Study|Withdrawal by Subject|58
685471|NCT01566721|2225053|P2|Overall Study|Ongoing Study|659
685472|NCT01566721|2225054|P1|Overall Study|Ongoing Study|1649
685473|NCT01566604|2225136|P2|Overall Study|Withdrawal by Subject|6
685474|NCT01566604|2225137|P1|Overall Study|Withdrawal by Subject|9
685475|NCT01566604|2225136|P2|Overall Study|Adverse Event|2
685476|NCT01566604|2225137|P1|Overall Study|Adverse Event|4
685477|NCT01566604|2225136|P2|Overall Study|Death|1
685478|NCT01566604|2225137|P1|Overall Study|Death|4
685479|NCT01566604|2225136|P2|Overall Study|Abnormal laboratory value|0
685480|NCT01566604|2225137|P1|Overall Study|Abnormal laboratory value|2
685481|NCT01566604|2225136|P2|Overall Study|Protocol deviation|0
685482|NCT01566604|2225137|P1|Overall Study|Protocol deviation|2
685483|NCT01566604|2225136|P2|Overall Study|Lack of Efficacy|2
685484|NCT01566604|2225137|P1|Overall Study|Lack of Efficacy|1
685485|NCT01566604|2225136|P2|Overall Study|Administrative problems|0
685486|NCT01566604|2225137|P1|Overall Study|Administrative problems|1
685487|NCT01566604|2225136|P2|Overall Study|Patient's inability to use the device|0
685488|NCT01566604|2225137|P1|Overall Study|Patient's inability to use the device|1
685489|NCT01566435|2225293|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
685490|NCT01566149|2225366|P2|Overall Study|Withdrawal by Subject|0
685491|NCT01566149|2225367|P1|Overall Study|Withdrawal by Subject|1
685492|NCT01566149|2225366|P2|Overall Study|Protocol Violation|1
685493|NCT01566149|2225367|P1|Overall Study|Protocol Violation|0
685494|NCT01566149|2225366|P2|Overall Study|Non-compliance with study medication|0
685495|NCT01566149|2225367|P1|Overall Study|Non-compliance with study medication|2
685496|NCT01566149|2225366|P2|Overall Study|Adverse Event|1
685497|NCT01566149|2225367|P1|Overall Study|Adverse Event|0
685498|NCT01565993|2225400|P2|Overall Study|Physician Decision|3
685499|NCT01565993|2225401|P1|Overall Study|Physician Decision|0
685500|NCT01565980|2225409|P2|Overall Study|Withdrawal by Subject|3
685501|NCT01565980|2225410|P1|Overall Study|Withdrawal by Subject|0
685502|NCT01565980|2225409|P2|Overall Study|stopped medical treatment|0
685503|NCT01565980|2225410|P1|Overall Study|stopped medical treatment|1
685504|NCT01565980|2225409|P2|Overall Study|health complications|1
685505|NCT01565980|2225410|P1|Overall Study|health complications|1
685506|NCT01565980|2225409|P2|Overall Study|Lost to Follow-up|0
685507|NCT01565980|2225410|P1|Overall Study|Lost to Follow-up|1
685508|NCT01565980|2225409|P2|Overall Study|Death|0
685509|NCT01565980|2225410|P1|Overall Study|Death|1
685510|NCT01565889|2225469|P6|Part B|Lost to Follow-up|1
685511|NCT01565889|2225470|P5|Part B|Lost to Follow-up|0
685512|NCT01565889|2225471|P4|Part B|Lost to Follow-up|0
685513|NCT01565889|2225472|P3|Part B|Lost to Follow-up|0
685514|NCT01565889|2225473|P2|Part B|Lost to Follow-up|0
685515|NCT01565889|2225474|P1|Part B|Lost to Follow-up|0
685516|NCT01565889|2225469|P6|Part B|Lack of Efficacy|2
685517|NCT01565889|2225470|P5|Part B|Lack of Efficacy|0
685518|NCT01565889|2225471|P4|Part B|Lack of Efficacy|0
685519|NCT01565889|2225472|P3|Part B|Lack of Efficacy|0
685520|NCT01565889|2225473|P2|Part B|Lack of Efficacy|0
685521|NCT01565889|2225474|P1|Part B|Lack of Efficacy|0
685522|NCT01565889|2225469|P6|Part B|Withdrawal by Subject|1
685523|NCT01565889|2225470|P5|Part B|Withdrawal by Subject|0
685524|NCT01565889|2225471|P4|Part B|Withdrawal by Subject|0
685525|NCT01565889|2225472|P3|Part B|Withdrawal by Subject|0
685526|NCT01565889|2225473|P2|Part B|Withdrawal by Subject|0
685527|NCT01565889|2225474|P1|Part B|Withdrawal by Subject|0
685528|NCT01565889|2225469|P6|Part A|Withdrawal by Subject|0
685529|NCT01565889|2225470|P5|Part A|Withdrawal by Subject|0
685530|NCT01565889|2225471|P4|Part A|Withdrawal by Subject|0
685531|NCT01565889|2225472|P3|Part A|Withdrawal by Subject|0
685532|NCT01565889|2225473|P2|Part A|Withdrawal by Subject|0
685533|NCT01565889|2225474|P1|Part A|Withdrawal by Subject|1
685534|NCT01565850|2225505|P2|Overall Study|Withdrew Consent|2
685535|NCT01565850|2225506|P1|Overall Study|Withdrew Consent|4
685536|NCT01565850|2225505|P2|Overall Study|Participant noncompliance|0
685537|NCT01565850|2225506|P1|Overall Study|Participant noncompliance|2
685538|NCT01565850|2225505|P2|Overall Study|Investigator’s Discretion|1
685539|NCT01565850|2225506|P1|Overall Study|Investigator’s Discretion|2
685540|NCT01565850|2225505|P2|Overall Study|Lost to Follow-up|4
685541|NCT01565850|2225506|P1|Overall Study|Lost to Follow-up|12
685542|NCT01565850|2225505|P2|Overall Study|Adverse Event|1
685543|NCT01565850|2225506|P1|Overall Study|Adverse Event|0
685544|NCT01565707|2225526|P4|Overall Study|Miscellaneous|2
685545|NCT01565707|2225527|P3|Overall Study|Miscellaneous|0
685546|NCT01565707|2225528|P2|Overall Study|Miscellaneous|1
685547|NCT01565707|2225529|P1|Overall Study|Miscellaneous|1
685548|NCT01565707|2225526|P4|Overall Study|Randomized but not evaluable|0
685549|NCT01565707|2225527|P3|Overall Study|Randomized but not evaluable|0
685550|NCT01565707|2225528|P2|Overall Study|Randomized but not evaluable|0
685551|NCT01565707|2225529|P1|Overall Study|Randomized but not evaluable|2
685552|NCT01565707|2225526|P4|Overall Study|Withdrawal by Subject|1
685553|NCT01565707|2225527|P3|Overall Study|Withdrawal by Subject|1
685554|NCT01565707|2225528|P2|Overall Study|Withdrawal by Subject|1
685555|NCT01565707|2225529|P1|Overall Study|Withdrawal by Subject|3
685556|NCT01565707|2225526|P4|Overall Study|Protocol Violation|1
685557|NCT01565707|2225527|P3|Overall Study|Protocol Violation|0
685558|NCT01565707|2225528|P2|Overall Study|Protocol Violation|0
685559|NCT01565707|2225529|P1|Overall Study|Protocol Violation|1
685560|NCT01565707|2225526|P4|Overall Study|Lost to Follow-up|0
685561|NCT01565707|2225527|P3|Overall Study|Lost to Follow-up|0
685562|NCT01565707|2225528|P2|Overall Study|Lost to Follow-up|0
685563|NCT01565707|2225529|P1|Overall Study|Lost to Follow-up|1
685564|NCT01565707|2225526|P4|Overall Study|Adverse Event|1
685565|NCT01565707|2225527|P3|Overall Study|Adverse Event|2
685566|NCT01565707|2225528|P2|Overall Study|Adverse Event|6
685567|NCT01565707|2225529|P1|Overall Study|Adverse Event|1
685568|NCT01565564|2225633|P2|Overall Study|Lost to Follow-up|1
685569|NCT01565564|2225634|P1|Overall Study|Lost to Follow-up|5
685570|NCT01565343|2225684|P3|Overall Study|Administrative decision/technical issues|0
685571|NCT01565343|2225685|P2|Overall Study|Administrative decision/technical issues|0
685572|NCT01565343|2225686|P1|Overall Study|Administrative decision/technical issues|1
685573|NCT01565291|2225716|P2|Overall Study|Withdrawal by Subject|0
685574|NCT01565291|2225717|P1|Overall Study|Withdrawal by Subject|1
685575|NCT01565148|2225729|P4|Overall Study|Physician Decision|0
685576|NCT01565148|2225730|P3|Overall Study|Physician Decision|0
685577|NCT01565148|2225731|P2|Overall Study|Physician Decision|5
685578|NCT01565148|2225732|P1|Overall Study|Physician Decision|2
685579|NCT01565148|2225729|P4|Overall Study|Death|0
685580|NCT01565148|2225730|P3|Overall Study|Death|1
685581|NCT01565148|2225731|P2|Overall Study|Death|0
685582|NCT01565148|2225732|P1|Overall Study|Death|0
685583|NCT01565148|2225729|P4|Overall Study|Rescue Therapy|8
685584|NCT01565148|2225730|P3|Overall Study|Rescue Therapy|5
685585|NCT01565148|2225731|P2|Overall Study|Rescue Therapy|5
685586|NCT01565148|2225732|P1|Overall Study|Rescue Therapy|8
685587|NCT01565148|2225729|P4|Overall Study|Lost to Follow-up|3
685588|NCT01565148|2225730|P3|Overall Study|Lost to Follow-up|0
685589|NCT01565148|2225731|P2|Overall Study|Lost to Follow-up|4
685590|NCT01565148|2225732|P1|Overall Study|Lost to Follow-up|4
685591|NCT01565148|2225729|P4|Overall Study|Withdrawal by Subject|2
685592|NCT01565148|2225730|P3|Overall Study|Withdrawal by Subject|1
685593|NCT01565148|2225731|P2|Overall Study|Withdrawal by Subject|1
685594|NCT01565148|2225732|P1|Overall Study|Withdrawal by Subject|1
685595|NCT01565083|2225768|P2|Overall Study|Unspecified|5
685596|NCT01565083|2225769|P1|Overall Study|Unspecified|3
685597|NCT01565083|2225768|P2|Overall Study|Death|23
685598|NCT01565083|2225769|P1|Overall Study|Death|22
685599|NCT01565083|2225768|P2|Overall Study|Lost to Follow-up|7
685600|NCT01565083|2225769|P1|Overall Study|Lost to Follow-up|2
685601|NCT01565083|2225768|P2|Overall Study|Withdrawal by Subject|4
685602|NCT01565083|2225769|P1|Overall Study|Withdrawal by Subject|6
685603|NCT01564862|2225806|P3|Overall Study|Other reason(s)|0
685604|NCT01564862|2225807|P2|Overall Study|Other reason(s)|0
685605|NCT01564862|2225808|P1|Overall Study|Other reason(s)|1
685606|NCT01564862|2225806|P3|Overall Study|Lack of Efficacy|6
685607|NCT01564862|2225807|P2|Overall Study|Lack of Efficacy|5
685608|NCT01564862|2225808|P1|Overall Study|Lack of Efficacy|1
685609|NCT01564862|2225806|P3|Overall Study|Voluntary Withdrawal|8
685610|NCT01564862|2225807|P2|Overall Study|Voluntary Withdrawal|6
685611|NCT01564862|2225808|P1|Overall Study|Voluntary Withdrawal|9
685612|NCT01564862|2225806|P3|Overall Study|Lost to Follow-up|6
685613|NCT01564862|2225807|P2|Overall Study|Lost to Follow-up|8
685614|NCT01564862|2225808|P1|Overall Study|Lost to Follow-up|10
685615|NCT01564862|2225806|P3|Overall Study|Major Protocol Deviation|4
685616|NCT01564862|2225807|P2|Overall Study|Major Protocol Deviation|3
685617|NCT01564862|2225808|P1|Overall Study|Major Protocol Deviation|3
685618|NCT01564862|2225806|P3|Overall Study|Pretreatment Event or Adverse Event|6
685619|NCT01564862|2225807|P2|Overall Study|Pretreatment Event or Adverse Event|12
685620|NCT01564862|2225808|P1|Overall Study|Pretreatment Event or Adverse Event|6
685621|NCT01564758|2225857|P1|Overall Study|Unspecified|3
685622|NCT01564758|2225857|P1|Overall Study|Adverse Event|3
685623|NCT01564758|2225857|P1|Overall Study|Death|8
685624|NCT01564732|2225864|P2|Overall Study|Early termination by the study sponsor|5
685625|NCT01564732|2225865|P1|Overall Study|Early termination by the study sponsor|6
685626|NCT01564537|2225900|P2|Overall Study|Other Miscellaneous Reasons|2
685627|NCT01564537|2225901|P1|Overall Study|Other Miscellaneous Reasons|1
685628|NCT01564537|2225900|P2|Overall Study|Lost to Follow-up|0
685629|NCT01564537|2225901|P1|Overall Study|Lost to Follow-up|1
685630|NCT01564537|2225900|P2|Overall Study|Withdrawal by Participant|4
685631|NCT01564537|2225901|P1|Overall Study|Withdrawal by Participant|4
685632|NCT01564459|2225924|P3|Double-blind Treatment|Adverse Event|1
685633|NCT01564459|2225925|P2|Double-blind Treatment|Adverse Event|0
685634|NCT01564459|2225926|P1|Double-blind Treatment|Adverse Event|0
685635|NCT01564459|2225924|P3|Run-In|Withdrawal by Subject|0
685636|NCT01564459|2225925|P2|Run-In|Withdrawal by Subject|0
685637|NCT01564459|2225926|P1|Run-In|Withdrawal by Subject|1
685638|NCT01564459|2225924|P3|Run-In|Protocol Violation|0
685639|NCT01564459|2225925|P2|Run-In|Protocol Violation|0
685640|NCT01564459|2225926|P1|Run-In|Protocol Violation|1
685641|NCT01564459|2225924|P3|Run-In|Non-compliance with study drug|0
685642|NCT01564459|2225925|P2|Run-In|Non-compliance with study drug|0
685643|NCT01564459|2225926|P1|Run-In|Non-compliance with study drug|2
685644|NCT01564459|2225924|P3|Run-In|Lost to Follow-up|0
685645|NCT01564459|2225925|P2|Run-In|Lost to Follow-up|0
685646|NCT01564459|2225926|P1|Run-In|Lost to Follow-up|1
685647|NCT01564459|2225924|P3|Run-In|Adverse Event|0
685648|NCT01564459|2225925|P2|Run-In|Adverse Event|0
685649|NCT01564459|2225926|P1|Run-In|Adverse Event|7
685650|NCT01564407|2225950|P5|Overall Study|funding lost, study ended|0
685651|NCT01564407|2225951|P4|Overall Study|funding lost, study ended|1
685652|NCT01564407|2225952|P3|Overall Study|funding lost, study ended|0
685653|NCT01564407|2225953|P2|Overall Study|funding lost, study ended|0
685654|NCT01564407|2225954|P1|Overall Study|funding lost, study ended|0
685655|NCT01564407|2225950|P5|Overall Study|Withdrawal by Subject|0
685656|NCT01564407|2225951|P4|Overall Study|Withdrawal by Subject|0
685657|NCT01564407|2225952|P3|Overall Study|Withdrawal by Subject|0
685658|NCT01564407|2225953|P2|Overall Study|Withdrawal by Subject|1
685659|NCT01564407|2225954|P1|Overall Study|Withdrawal by Subject|0
685660|NCT01564407|2225950|P5|Overall Study|Lost to Follow-up|0
685661|NCT01564407|2225951|P4|Overall Study|Lost to Follow-up|0
685662|NCT01564407|2225952|P3|Overall Study|Lost to Follow-up|0
685663|NCT01564407|2225953|P2|Overall Study|Lost to Follow-up|1
685664|NCT01564407|2225954|P1|Overall Study|Lost to Follow-up|0
685665|NCT01564394|2225995|P2|Overall Study|Withdrawal by Subject|10
685666|NCT01564394|2225996|P1|Overall Study|Withdrawal by Subject|6
685667|NCT01563978|2226010|P2|Overall Study|Adverse Event|2
685668|NCT01563978|2226011|P1|Overall Study|Adverse Event|1
685669|NCT01563978|2226010|P2|Overall Study|Dev. of study specific discont. criteria|0
685670|NCT01563978|2226011|P1|Overall Study|Dev. of study specific discont. criteria|1
685671|NCT01563978|2226010|P2|Overall Study|Lost to Follow-up|0
685672|NCT01563978|2226011|P1|Overall Study|Lost to Follow-up|1
685673|NCT01563978|2226010|P2|Overall Study|Physician Decision|0
685674|NCT01563978|2226011|P1|Overall Study|Physician Decision|1
685675|NCT01563536|2226037|P2|Overall Study|Lost to Follow-up|0
685676|NCT01563536|2226038|P1|Overall Study|Lost to Follow-up|1
685677|NCT01563536|2226037|P2|Overall Study|Withdrawal by Subject|2
685678|NCT01563536|2226038|P1|Overall Study|Withdrawal by Subject|0
685679|NCT01563185|2226097|P1|Overall Study|Non-Compliance with study drug|1
685680|NCT01563185|2226097|P1|Overall Study|Withdrawal by Subject|1
685681|NCT01563172|2226111|P1|Overall Study|Other (Not specified)|1
685682|NCT01563172|2226111|P1|Overall Study|Other (Protocol deviation)|5
685683|NCT01563172|2226111|P1|Overall Study|Lost to Follow-up|2
685684|NCT01563172|2226111|P1|Overall Study|Adverse Event|5
685685|NCT01563029|2226217|P5|Overall Study|Withdrawal by Subject|3
685686|NCT01563029|2226218|P4|Overall Study|Withdrawal by Subject|4
685687|NCT01563029|2226219|P3|Overall Study|Withdrawal by Subject|3
685688|NCT01563029|2226220|P2|Overall Study|Withdrawal by Subject|1
685689|NCT01563029|2226221|P1|Overall Study|Withdrawal by Subject|4
685690|NCT01563029|2226217|P5|Overall Study|Physician Decision|2
685691|NCT01563029|2226218|P4|Overall Study|Physician Decision|4
685692|NCT01563029|2226219|P3|Overall Study|Physician Decision|2
685693|NCT01563029|2226220|P2|Overall Study|Physician Decision|5
685694|NCT01563029|2226221|P1|Overall Study|Physician Decision|3
685695|NCT01563029|2226217|P5|Overall Study|Lost to Follow-up|1
685696|NCT01563029|2226218|P4|Overall Study|Lost to Follow-up|1
685697|NCT01563029|2226219|P3|Overall Study|Lost to Follow-up|1
685698|NCT01563029|2226220|P2|Overall Study|Lost to Follow-up|0
685699|NCT01563029|2226221|P1|Overall Study|Lost to Follow-up|1
685700|NCT01563029|2226217|P5|Overall Study|Protocol defined stopping criteria|0
685701|NCT01563029|2226218|P4|Overall Study|Protocol defined stopping criteria|0
685702|NCT01563029|2226219|P3|Overall Study|Protocol defined stopping criteria|0
685703|NCT01563029|2226220|P2|Overall Study|Protocol defined stopping criteria|0
685704|NCT01563029|2226221|P1|Overall Study|Protocol defined stopping criteria|1
685705|NCT01563029|2226217|P5|Overall Study|Protocol Violation|3
685706|NCT01563029|2226218|P4|Overall Study|Protocol Violation|1
685707|NCT01563029|2226219|P3|Overall Study|Protocol Violation|3
685708|NCT01563029|2226220|P2|Overall Study|Protocol Violation|2
685709|NCT01563029|2226221|P1|Overall Study|Protocol Violation|1
685710|NCT01563029|2226217|P5|Overall Study|Lack of Efficacy|19
685711|NCT01563029|2226218|P4|Overall Study|Lack of Efficacy|21
685712|NCT01563029|2226219|P3|Overall Study|Lack of Efficacy|23
685713|NCT01563029|2226220|P2|Overall Study|Lack of Efficacy|16
685714|NCT01563029|2226221|P1|Overall Study|Lack of Efficacy|42
685715|NCT01563029|2226217|P5|Overall Study|Adverse Event|1
685716|NCT01563029|2226218|P4|Overall Study|Adverse Event|2
685717|NCT01563029|2226219|P3|Overall Study|Adverse Event|1
685718|NCT01563029|2226220|P2|Overall Study|Adverse Event|0
685719|NCT01563029|2226221|P1|Overall Study|Adverse Event|1
685720|NCT01562873|2226287|P2|Overall Study|Clinical PD and adverse event|0
685721|NCT01562873|2226288|P1|Overall Study|Clinical PD and adverse event|1
685722|NCT01562873|2226287|P2|Overall Study|Clinical Disease Progression|0
685723|NCT01562873|2226288|P1|Overall Study|Clinical Disease Progression|9
685724|NCT01562873|2226287|P2|Overall Study|Adverse Event|0
685725|NCT01562873|2226288|P1|Overall Study|Adverse Event|1
685726|NCT01562873|2226287|P2|Overall Study|Disease Progression per RECIST|0
685727|NCT01562873|2226288|P1|Overall Study|Disease Progression per RECIST|10
685728|NCT01562743|2226300|P1|Overall Study|Physician Decision|2
685729|NCT01562743|2226300|P1|Overall Study|Lost to Follow-up|2
685730|NCT01562743|2226300|P1|Overall Study|Discontinuation criteria|2
685731|NCT01562743|2226300|P1|Overall Study|Protocol Violation|1
685732|NCT01562743|2226300|P1|Overall Study|Withdrawal by Subject|13
685733|NCT01562743|2226300|P1|Overall Study|Lack of Efficacy|3
685734|NCT01562743|2226300|P1|Overall Study|Adverse Event|29
685735|NCT01562613|2226319|P1|Overall Study|Withdrawal by Subject|2
685736|NCT01562613|2226319|P1|Overall Study|Lost to Follow-up|2
685737|NCT01562548|2226329|P4|Overall Study|Lost to Follow-up|0
685738|NCT01562548|2226330|P3|Overall Study|Lost to Follow-up|1
685739|NCT01562548|2226331|P2|Overall Study|Lost to Follow-up|0
685740|NCT01562548|2226332|P1|Overall Study|Lost to Follow-up|0
685741|NCT01562327|2226382|P1|Overall Study|Infusion not received at 6 month window|4
685742|NCT01562327|2226382|P1|Overall Study|Participant drop-out|1
685743|NCT01562327|2226382|P1|Overall Study|Lack of Efficacy|1
685744|NCT01562327|2226382|P1|Overall Study|Adverse Event|2
685745|NCT01562314|2226412|P2|Overall Study|Withdrawal by Subject|1
685746|NCT01562314|2226413|P1|Overall Study|Withdrawal by Subject|0
685747|NCT01562314|2226412|P2|Overall Study|Met Withdrawal Criteria|2
685748|NCT01562314|2226413|P1|Overall Study|Met Withdrawal Criteria|3
685749|NCT01562314|2226412|P2|Overall Study|Adverse Event|5
685750|NCT01562314|2226413|P1|Overall Study|Adverse Event|10
685751|NCT01562275|2226500|P13|Stage 2|Progression of Disease|4
685752|NCT01562275|2226501|P12|Stage 2|Progression of Disease|12
685753|NCT01562275|2226502|P11|Stage 2|Progression of Disease|0
685754|NCT01562275|2226503|P10|Stage 2|Progression of Disease|0
685755|NCT01562275|2226504|P9|Stage 2|Progression of Disease|0
685756|NCT01562275|2226505|P8|Stage 2|Progression of Disease|0
685757|NCT01562275|2226506|P7|Stage 2|Progression of Disease|0
685758|NCT01562275|2226507|P6|Stage 2|Progression of Disease|0
685759|NCT01562275|2226508|P5|Stage 2|Progression of Disease|0
685760|NCT01562275|2226509|P4|Stage 2|Progression of Disease|0
685761|NCT01562275|2226510|P3|Stage 2|Progression of Disease|0
685762|NCT01562275|2226511|P2|Stage 2|Progression of Disease|0
685763|NCT01562275|2226512|P1|Stage 2|Progression of Disease|0
685764|NCT01562275|2226500|P13|Stage 2|Death|1
685765|NCT01562275|2226501|P12|Stage 2|Death|2
685766|NCT01562275|2226502|P11|Stage 2|Death|0
685767|NCT01562275|2226503|P10|Stage 2|Death|0
685768|NCT01562275|2226504|P9|Stage 2|Death|0
685769|NCT01562275|2226505|P8|Stage 2|Death|0
685770|NCT01562275|2226506|P7|Stage 2|Death|0
685771|NCT01562275|2226507|P6|Stage 2|Death|0
685772|NCT01562275|2226508|P5|Stage 2|Death|0
685773|NCT01562275|2226509|P4|Stage 2|Death|0
685774|NCT01562275|2226510|P3|Stage 2|Death|0
685775|NCT01562275|2226511|P2|Stage 2|Death|0
685776|NCT01562275|2226512|P1|Stage 2|Death|0
685777|NCT01562275|2226500|P13|Stage 1|Withdrawal by Subject|0
685778|NCT01562275|2226501|P12|Stage 1|Withdrawal by Subject|0
685779|NCT01562275|2226502|P11|Stage 1|Withdrawal by Subject|0
685780|NCT01562275|2226503|P10|Stage 1|Withdrawal by Subject|1
685781|NCT01562275|2226504|P9|Stage 1|Withdrawal by Subject|0
685782|NCT01562275|2226505|P8|Stage 1|Withdrawal by Subject|0
685783|NCT01562275|2226506|P7|Stage 1|Withdrawal by Subject|1
685784|NCT01562275|2226507|P6|Stage 1|Withdrawal by Subject|0
685785|NCT01562275|2226508|P5|Stage 1|Withdrawal by Subject|0
685786|NCT01562275|2226509|P4|Stage 1|Withdrawal by Subject|2
685787|NCT01562275|2226510|P3|Stage 1|Withdrawal by Subject|0
685788|NCT01562275|2226511|P2|Stage 1|Withdrawal by Subject|1
685789|NCT01562275|2226512|P1|Stage 1|Withdrawal by Subject|0
685790|NCT01562275|2226500|P13|Stage 1|Progression of Disease|0
685791|NCT01562275|2226501|P12|Stage 1|Progression of Disease|0
685792|NCT01562275|2226502|P11|Stage 1|Progression of Disease|3
685793|NCT01562275|2226503|P10|Stage 1|Progression of Disease|5
685794|NCT01562275|2226504|P9|Stage 1|Progression of Disease|2
685795|NCT01562275|2226505|P8|Stage 1|Progression of Disease|7
685796|NCT01562275|2226506|P7|Stage 1|Progression of Disease|1
685797|NCT01562275|2226507|P6|Stage 1|Progression of Disease|4
685798|NCT01562275|2226508|P5|Stage 1|Progression of Disease|2
685799|NCT01562275|2226509|P4|Stage 1|Progression of Disease|1
685800|NCT01562275|2226510|P3|Stage 1|Progression of Disease|2
685801|NCT01562275|2226511|P2|Stage 1|Progression of Disease|6
685802|NCT01562275|2226512|P1|Stage 1|Progression of Disease|2
685803|NCT01562275|2226500|P13|Stage 1|Physician Decision|0
685804|NCT01562275|2226501|P12|Stage 1|Physician Decision|0
685805|NCT01562275|2226502|P11|Stage 1|Physician Decision|0
685806|NCT01562275|2226503|P10|Stage 1|Physician Decision|0
685807|NCT01562275|2226504|P9|Stage 1|Physician Decision|1
685808|NCT01562275|2226505|P8|Stage 1|Physician Decision|0
685809|NCT01562275|2226506|P7|Stage 1|Physician Decision|1
685810|NCT01562275|2226507|P6|Stage 1|Physician Decision|0
685811|NCT01562275|2226508|P5|Stage 1|Physician Decision|1
685812|NCT01562275|2226509|P4|Stage 1|Physician Decision|0
685813|NCT01562275|2226510|P3|Stage 1|Physician Decision|0
685814|NCT01562275|2226511|P2|Stage 1|Physician Decision|0
685815|NCT01562275|2226512|P1|Stage 1|Physician Decision|0
685816|NCT01562275|2226500|P13|Stage 1|Non Compliance|0
685817|NCT01562275|2226501|P12|Stage 1|Non Compliance|0
685818|NCT01562275|2226502|P11|Stage 1|Non Compliance|0
685819|NCT01562275|2226503|P10|Stage 1|Non Compliance|0
685820|NCT01562275|2226504|P9|Stage 1|Non Compliance|0
685821|NCT01562275|2226505|P8|Stage 1|Non Compliance|0
685822|NCT01562275|2226506|P7|Stage 1|Non Compliance|0
685823|NCT01562275|2226507|P6|Stage 1|Non Compliance|0
685824|NCT01562275|2226508|P5|Stage 1|Non Compliance|0
685825|NCT01562275|2226509|P4|Stage 1|Non Compliance|0
685826|NCT01562275|2226510|P3|Stage 1|Non Compliance|1
685827|NCT01562275|2226511|P2|Stage 1|Non Compliance|0
685828|NCT01562275|2226512|P1|Stage 1|Non Compliance|0
685829|NCT01562275|2226500|P13|Stage 1|Death|0
685830|NCT01562275|2226501|P12|Stage 1|Death|0
685831|NCT01562275|2226502|P11|Stage 1|Death|0
685832|NCT01562275|2226503|P10|Stage 1|Death|0
685833|NCT01562275|2226504|P9|Stage 1|Death|0
685834|NCT01562275|2226505|P8|Stage 1|Death|0
685835|NCT01562275|2226506|P7|Stage 1|Death|0
685836|NCT01562275|2226507|P6|Stage 1|Death|0
685837|NCT01562275|2226508|P5|Stage 1|Death|0
685838|NCT01562275|2226509|P4|Stage 1|Death|0
685839|NCT01562275|2226510|P3|Stage 1|Death|0
685840|NCT01562275|2226511|P2|Stage 1|Death|0
685841|NCT01562275|2226512|P1|Stage 1|Death|1
685842|NCT01562275|2226500|P13|Stage 1|Adverse Event|0
685843|NCT01562275|2226501|P12|Stage 1|Adverse Event|0
685844|NCT01562275|2226502|P11|Stage 1|Adverse Event|0
685845|NCT01562275|2226503|P10|Stage 1|Adverse Event|1
685846|NCT01562275|2226504|P9|Stage 1|Adverse Event|0
685847|NCT01562275|2226505|P8|Stage 1|Adverse Event|0
685848|NCT01562275|2226506|P7|Stage 1|Adverse Event|0
685849|NCT01562275|2226507|P6|Stage 1|Adverse Event|0
685850|NCT01562275|2226508|P5|Stage 1|Adverse Event|1
685851|NCT01562275|2226509|P4|Stage 1|Adverse Event|1
685852|NCT01562275|2226510|P3|Stage 1|Adverse Event|0
685853|NCT01562275|2226511|P2|Stage 1|Adverse Event|0
685854|NCT01562275|2226512|P1|Stage 1|Adverse Event|0
685855|NCT01561898|2226655|P4|Overall Study|Physician Decision|1
685856|NCT01561898|2226656|P3|Overall Study|Physician Decision|7
685857|NCT01561898|2226657|P2|Overall Study|Physician Decision|5
685858|NCT01561898|2226658|P1|Overall Study|Physician Decision|1
685859|NCT01561898|2226655|P4|Overall Study|Adverse Event|9
685860|NCT01561898|2226656|P3|Overall Study|Adverse Event|14
685861|NCT01561898|2226657|P2|Overall Study|Adverse Event|19
685862|NCT01561898|2226658|P1|Overall Study|Adverse Event|1
685863|NCT01561898|2226655|P4|Overall Study|Lost to Follow-up|0
685864|NCT01561898|2226656|P3|Overall Study|Lost to Follow-up|1
685865|NCT01561898|2226657|P2|Overall Study|Lost to Follow-up|0
685866|NCT01561898|2226658|P1|Overall Study|Lost to Follow-up|0
685867|NCT01561898|2226655|P4|Overall Study|Worsening of complications|0
685868|NCT01561898|2226656|P3|Overall Study|Worsening of complications|0
685869|NCT01561898|2226657|P2|Overall Study|Worsening of complications|1
685870|NCT01561898|2226658|P1|Overall Study|Worsening of complications|0
685871|NCT01561898|2226655|P4|Overall Study|Lack of Efficacy|5
685872|NCT01561898|2226656|P3|Overall Study|Lack of Efficacy|10
685873|NCT01561898|2226657|P2|Overall Study|Lack of Efficacy|8
685874|NCT01561898|2226658|P1|Overall Study|Lack of Efficacy|0
685875|NCT01561898|2226655|P4|Overall Study|Withdrawal by Subject|5
685876|NCT01561898|2226656|P3|Overall Study|Withdrawal by Subject|12
685877|NCT01561898|2226657|P2|Overall Study|Withdrawal by Subject|8
685878|NCT01561898|2226658|P1|Overall Study|Withdrawal by Subject|0
685879|NCT01561560|2226704|P2|Second Two Weeks of Wear|Adverse Event|1
685880|NCT01561560|2226705|P1|Second Two Weeks of Wear|Adverse Event|0
685881|NCT01561560|2226704|P2|First Two Weeks of Wear|Adverse Event|1
685882|NCT01561560|2226705|P1|First Two Weeks of Wear|Adverse Event|0
685883|NCT01561560|2226704|P2|First Two Weeks of Wear|Time/job conflict|1
685884|NCT01561560|2226705|P1|First Two Weeks of Wear|Time/job conflict|0
685885|NCT01561313|2226734|P2|Overall Study|Adverse event and withdrawal by subject|0
685886|NCT01561313|2226735|P1|Overall Study|Adverse event and withdrawal by subject|1
685887|NCT01561313|2226734|P2|Overall Study|Withdrawal by Subject|0
685888|NCT01561313|2226735|P1|Overall Study|Withdrawal by Subject|1
685889|NCT01561300|2226753|P2|Run in on Placebo|Adverse Event|0
685890|NCT01561300|2226754|P1|Run in on Placebo|Adverse Event|1
685891|NCT01561079|2226765|P1|Overall Study|Protocol Violation|2
685892|NCT01561079|2226765|P1|Overall Study|Withdrawal by Subject|59
685893|NCT01561079|2226765|P1|Overall Study|Physician Decision|17
685894|NCT01560988|2226808|P2|Washout (Six Weeks)|Lost to Follow-up|2
685895|NCT01560988|2226809|P1|Washout (Six Weeks)|Lost to Follow-up|2
685896|NCT01560988|2226808|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
685897|NCT01560988|2226809|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
685898|NCT01560988|2226808|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
685899|NCT01560988|2226809|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
685900|NCT01560819|2226842|P2|Overall Study|Physician Decision|0
685901|NCT01560819|2226843|P1|Overall Study|Physician Decision|1
685902|NCT01560507|2226850|P3|Overall Study|Withdrawal by Subject|0
685903|NCT01560507|2226851|P2|Overall Study|Withdrawal by Subject|1
685904|NCT01560507|2226852|P1|Overall Study|Withdrawal by Subject|1
685905|NCT01560507|2226850|P3|Overall Study|Lost to Follow-up|2
685906|NCT01560507|2226851|P2|Overall Study|Lost to Follow-up|1
685907|NCT01560507|2226852|P1|Overall Study|Lost to Follow-up|3
685908|NCT01560429|2226865|P2|Overall Study|Protocol Violation|6
685909|NCT01560429|2226866|P1|Overall Study|Protocol Violation|3
685910|NCT01560403|2226876|P2|Overall Study|Lost to Follow-up|1
685911|NCT01560403|2226877|P1|Overall Study|Lost to Follow-up|0
685912|NCT01560234|2226895|P8|Overall Study|Lost to Follow-up|2
685913|NCT01560234|2226896|P7|Overall Study|Lost to Follow-up|0
685914|NCT01560234|2226897|P6|Overall Study|Lost to Follow-up|2
685915|NCT01560234|2226898|P5|Overall Study|Lost to Follow-up|0
685916|NCT01560234|2226899|P4|Overall Study|Lost to Follow-up|0
685917|NCT01560234|2226900|P3|Overall Study|Lost to Follow-up|1
685918|NCT01560234|2226901|P2|Overall Study|Lost to Follow-up|0
685919|NCT01560234|2226902|P1|Overall Study|Lost to Follow-up|3
685920|NCT01559935|2226980|P1|Maintenance Phase|Non-compliance|2
685921|NCT01559935|2226980|P1|Maintenance Phase|Withdrawal by Subject|5
685922|NCT01559935|2226980|P1|Maintenance Phase|Lack of Efficacy|18
685923|NCT01559935|2226980|P1|Maintenance Phase|Toxicity|1
685924|NCT01559935|2226980|P1|Maintenance Phase|Remains on study|28
685925|NCT01559935|2226980|P1|BiRD Phase|Withdrawal by Subject|2
685926|NCT01559935|2226980|P1|BiRD Phase|Lack of Efficacy|1
685927|NCT01559935|2226980|P1|BiRD Phase|Toxicity|1
685928|NCT01559935|2226980|P1|Car Phase|non-compliance|1
685929|NCT01559935|2226980|P1|Car Phase|Insurance|1
685930|NCT01559935|2226980|P1|Car Phase|Per protocol|1
685931|NCT01559935|2226980|P1|Car Phase|Withdrawal by Subject|2
685932|NCT01559935|2226980|P1|Car Phase|Physician Decision|1
685933|NCT01559935|2226980|P1|Car Phase|Lost to Follow-up|1
685934|NCT01559935|2226980|P1|Car Phase|Lack of Efficacy|2
685935|NCT01559935|2226980|P1|Car Phase|Death|1
685936|NCT01559935|2226980|P1|Car Phase|Toxicity|4
685937|NCT01559844|2227016|P1|Overall Study|No Longer A Transplant Candidate|3
685938|NCT01559844|2227016|P1|Overall Study|Efficacy Failure|10
685939|NCT01559844|2227016|P1|Overall Study|Death|5
685940|NCT01559844|2227016|P1|Overall Study|Consent Withdrawn|7
685941|NCT01559675|2227029|P2|Overall Study|2nd operation on same patient excluded|12
685942|NCT01559675|2227030|P1|Overall Study|2nd operation on same patient excluded|14
685943|NCT01559675|2227029|P2|Overall Study|Protocol Violation|2
685944|NCT01559675|2227030|P1|Overall Study|Protocol Violation|1
685945|NCT01559454|2227061|P2|Overall Study|Lack of Efficacy|1
685946|NCT01559454|2227062|P1|Overall Study|Lack of Efficacy|0
685947|NCT01559454|2227061|P2|Overall Study|Protocol Violation|1
685948|NCT01559454|2227062|P1|Overall Study|Protocol Violation|0
685949|NCT01559454|2227061|P2|Overall Study|Physician Decision|1
685950|NCT01559454|2227062|P1|Overall Study|Physician Decision|0
685951|NCT01559454|2227061|P2|Overall Study|Withdrawal by Subject|1
685952|NCT01559454|2227062|P1|Overall Study|Withdrawal by Subject|0
685953|NCT01559454|2227061|P2|Overall Study|Lost to Follow-up|2
685954|NCT01559454|2227062|P1|Overall Study|Lost to Follow-up|3
685955|NCT01559311|2227081|P3|Overall Study|Adverse Event|1
685956|NCT01559311|2227082|P2|Overall Study|Adverse Event|0
685957|NCT01559311|2227083|P1|Overall Study|Adverse Event|0
685958|NCT01559311|2227081|P3|Overall Study|Lost to Follow-up|2
685959|NCT01559311|2227082|P2|Overall Study|Lost to Follow-up|3
685960|NCT01559311|2227083|P1|Overall Study|Lost to Follow-up|0
685961|NCT01559311|2227081|P3|Overall Study|Death|3
685962|NCT01559311|2227082|P2|Overall Study|Death|2
685963|NCT01559311|2227083|P1|Overall Study|Death|0
685964|NCT01559311|2227081|P3|Overall Study|Withdrawal by Subject|0
685965|NCT01559311|2227082|P2|Overall Study|Withdrawal by Subject|1
685966|NCT01559311|2227083|P1|Overall Study|Withdrawal by Subject|2
685967|NCT01559311|2227081|P3|Overall Study|Difficulty in cannulating the lateral ve|0
685968|NCT01559311|2227082|P2|Overall Study|Difficulty in cannulating the lateral ve|0
685969|NCT01559311|2227083|P1|Overall Study|Difficulty in cannulating the lateral ve|1
685970|NCT01559311|2227081|P3|Overall Study|Protocol Violation|2
685971|NCT01559311|2227082|P2|Overall Study|Protocol Violation|0
685972|NCT01559311|2227083|P1|Overall Study|Protocol Violation|0
685973|NCT01559116|2227094|P1|Overall Study|other than stated above|9
685974|NCT01559116|2227094|P1|Overall Study|Withdrawal by Subject|4
685975|NCT01559116|2227094|P1|Overall Study|Protocol Violation|1
685976|NCT01559116|2227094|P1|Overall Study|Lost to Follow-up|1
685977|NCT01559116|2227094|P1|Overall Study|Lack of Efficacy|1
685978|NCT01559116|2227094|P1|Overall Study|Adverse Event|10
685979|NCT01559012|2227177|P2|Overall Study|Withdrawal by Subject|1
685980|NCT01559012|2227178|P1|Overall Study|Withdrawal by Subject|0
685981|NCT01558739|2227214|P1|Overall Study|Protocol Violation|1
685982|NCT01558739|2227214|P1|Overall Study|Disease Progression|4
685983|NCT01558739|2227214|P1|Overall Study|Death|3
685984|NCT01558739|2227214|P1|Overall Study|Withdrawal by Subject|2
685985|NCT01558739|2227214|P1|Overall Study|Adverse Event|7
685986|NCT01558674|2227239|P2|Part 1|Withdrawal by Subject|0
685987|NCT01558674|2227240|P1|Part 1|Withdrawal by Subject|1
685988|NCT01558674|2227239|P2|Part 1|Study Terminated by Sponsor|0
685989|NCT01558674|2227240|P1|Part 1|Study Terminated by Sponsor|10
685990|NCT01558596|2227286|P2|Overall Study|Protocol Violation|0
685991|NCT01558596|2227287|P1|Overall Study|Protocol Violation|1
685992|NCT01558596|2227286|P2|Overall Study|surgery elsewhere or cancelled|1
685993|NCT01558596|2227287|P1|Overall Study|surgery elsewhere or cancelled|1
685994|NCT01558596|2227286|P2|Overall Study|Withdrawal by Subject|0
685995|NCT01558596|2227287|P1|Overall Study|Withdrawal by Subject|1
685996|NCT01558297|2227302|P3|Overall Study|Withdrawal by Subject|1
685997|NCT01558297|2227303|P2|Overall Study|Withdrawal by Subject|2
685998|NCT01558297|2227304|P1|Overall Study|Withdrawal by Subject|2
685999|NCT01558271|2227321|P3|Overall Study|Physician Decision|1
686000|NCT01558271|2227322|P2|Overall Study|Physician Decision|2
686001|NCT01558271|2227323|P1|Overall Study|Physician Decision|0
686002|NCT01558271|2227321|P3|Overall Study|Withdrawal by Subject|12
686003|NCT01558271|2227322|P2|Overall Study|Withdrawal by Subject|6
686004|NCT01558271|2227323|P1|Overall Study|Withdrawal by Subject|10
686005|NCT01558271|2227321|P3|Overall Study|Protocol Violation|0
686006|NCT01558271|2227322|P2|Overall Study|Protocol Violation|0
686007|NCT01558271|2227323|P1|Overall Study|Protocol Violation|1
686008|NCT01558271|2227321|P3|Overall Study|Lost to Follow-up|0
686009|NCT01558271|2227322|P2|Overall Study|Lost to Follow-up|0
686010|NCT01558271|2227323|P1|Overall Study|Lost to Follow-up|1
686011|NCT01558271|2227321|P3|Overall Study|Adverse Event|4
686012|NCT01558271|2227322|P2|Overall Study|Adverse Event|3
686013|NCT01558271|2227323|P1|Overall Study|Adverse Event|6
686014|NCT01558089|2227389|P1|Overall Study|Withdrawal by Subject|6
686015|NCT01558089|2227389|P1|Overall Study|Lost to Follow-up|5
686016|NCT01558089|2227389|P1|Overall Study|Lack of Efficacy|1
686017|NCT01558089|2227389|P1|Overall Study|Adverse Event|1
686018|NCT01557946|2227406|P2|Overall Study|Adverse Event|0
686019|NCT01557946|2227407|P1|Overall Study|Adverse Event|3
686020|NCT01557920|2227413|P2|Overall Study|Lack of Efficacy|0
686021|NCT01557920|2227414|P1|Overall Study|Lack of Efficacy|1
686022|NCT01557920|2227413|P2|Overall Study|Withdrawal by Subject|3
686023|NCT01557920|2227414|P1|Overall Study|Withdrawal by Subject|2
686024|NCT01557842|2227477|P2|Overall Study|Not Ablated|0
686025|NCT01557842|2227478|P1|Overall Study|Not Ablated|2
686026|NCT01557842|2227477|P2|Overall Study|Study Terminated by Sponsor|4
686027|NCT01557842|2227478|P1|Overall Study|Study Terminated by Sponsor|3
686028|NCT01557842|2227477|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
686029|NCT01557842|2227478|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
686030|NCT01557842|2227477|P2|Overall Study|Lack of Efficacy|1
686031|NCT01557842|2227478|P1|Overall Study|Lack of Efficacy|0
686032|NCT01557842|2227477|P2|Overall Study|Death|0
686033|NCT01557842|2227478|P1|Overall Study|Death|1
686034|NCT01557842|2227477|P2|Overall Study|Lost to Follow-up|1
686035|NCT01557842|2227478|P1|Overall Study|Lost to Follow-up|0
686036|NCT01557582|2227527|P1|Overall Study|Operator error|2
686037|NCT01557582|2227527|P1|Overall Study|Protocol Violation|4
686038|NCT01557569|2227535|P2|Overall Study|noncompliance with rules of residential|1
686039|NCT01557569|2227536|P1|Overall Study|noncompliance with rules of residential|0
686040|NCT01557569|2227535|P2|Overall Study|Withdrawal by Subject|5
686041|NCT01557569|2227536|P1|Overall Study|Withdrawal by Subject|3
686042|NCT01557569|2227535|P2|Overall Study|high blood pressure|1
686043|NCT01557569|2227536|P1|Overall Study|high blood pressure|0
686044|NCT01557569|2227535|P2|Overall Study|Adverse Event|0
686045|NCT01557569|2227536|P1|Overall Study|Adverse Event|2
686046|NCT01557504|2227544|P2|Overall Study|Physician Decision|0
686047|NCT01557504|2227545|P1|Overall Study|Physician Decision|1
686048|NCT01557348|2227570|P2|Overall Study|Administrative|11
686049|NCT01557348|2227571|P1|Overall Study|Administrative|18
686050|NCT01557348|2227570|P2|Overall Study|Lost to Follow-up|22
686051|NCT01557348|2227571|P1|Overall Study|Lost to Follow-up|26
686052|NCT01557348|2227570|P2|Overall Study|Withdrawal by Subject|4
686053|NCT01557348|2227571|P1|Overall Study|Withdrawal by Subject|5
686054|NCT01557348|2227570|P2|Overall Study|Insufficient Therapeutic Response|28
686055|NCT01557348|2227571|P1|Overall Study|Insufficient Therapeutic Response|13
686056|NCT01557348|2227570|P2|Overall Study|Death|4
686057|NCT01557348|2227571|P1|Overall Study|Death|7
686058|NCT01557348|2227570|P2|Overall Study|Infusion reaction event|5
686059|NCT01557348|2227571|P1|Overall Study|Infusion reaction event|5
686060|NCT01557348|2227570|P2|Overall Study|Adverse Event|16
686061|NCT01557348|2227571|P1|Overall Study|Adverse Event|6
686062|NCT01557283|2227688|P1|Overall Study|Unspecified|6
686063|NCT01557283|2227688|P1|Overall Study|Worsening of psoriasis|1
686064|NCT01557283|2227688|P1|Overall Study|Participant’s weight too high for dose|1
686065|NCT01557283|2227688|P1|Overall Study|Withdrawal by Subject|1
686066|NCT01557283|2227688|P1|Overall Study|Non-compliance|1
686067|NCT01557283|2227688|P1|Overall Study|Lack of Efficacy|1
686068|NCT01557283|2227688|P1|Overall Study|Adverse Event|7
686069|NCT01557283|2227688|P1|Overall Study|Non-responder|19
686070|NCT01557283|2227688|P1|Overall Study|Lost to Follow-up|7
889185|NCT01462344|2823646|P2|Overall Study|Lost to Follow-up|7
889186|NCT01462344|2823647|P1|Overall Study|Lost to Follow-up|7
889187|NCT01462344|2823646|P2|Overall Study|Protocol Violation|53
889188|NCT01462344|2823647|P1|Overall Study|Protocol Violation|68
889189|NCT01462344|2823646|P2|Overall Study|Lack of Efficacy|6
889190|NCT01462344|2823647|P1|Overall Study|Lack of Efficacy|5
889191|NCT01462344|2823646|P2|Overall Study|Asthma Exacerbation|35
889192|NCT01462344|2823647|P1|Overall Study|Asthma Exacerbation|34
686085|NCT01556997|2227716|P3|Overall Study|Not specified|7
686086|NCT01556997|2227717|P2|Overall Study|Not specified|3
686087|NCT01556997|2227718|P1|Overall Study|Not specified|2
686088|NCT01556997|2227716|P3|Overall Study|Withdrawal by Subject|8
686089|NCT01556997|2227717|P2|Overall Study|Withdrawal by Subject|6
686090|NCT01556997|2227718|P1|Overall Study|Withdrawal by Subject|7
686091|NCT01556997|2227716|P3|Overall Study|Physician Decision|1
686092|NCT01556997|2227717|P2|Overall Study|Physician Decision|1
686093|NCT01556997|2227718|P1|Overall Study|Physician Decision|1
686094|NCT01556997|2227716|P3|Overall Study|Lost to Follow-up|4
686095|NCT01556997|2227717|P2|Overall Study|Lost to Follow-up|6
686096|NCT01556997|2227718|P1|Overall Study|Lost to Follow-up|6
686097|NCT01556997|2227716|P3|Overall Study|Adverse Event|12
686098|NCT01556997|2227717|P2|Overall Study|Adverse Event|12
686099|NCT01556997|2227718|P1|Overall Study|Adverse Event|10
686100|NCT01556932|2227729|P2|Time Point 60 Minutes|Withdrawal by Subject|1
686101|NCT01556932|2227730|P1|Time Point 60 Minutes|Withdrawal by Subject|1
686102|NCT01556763|2227756|P3|Overall Study|Withdrawal by Subject|0
686103|NCT01556763|2227757|P2|Overall Study|Withdrawal by Subject|1
686104|NCT01556763|2227758|P1|Overall Study|Withdrawal by Subject|0
686105|NCT01556165|2227871|P2|Overall Study|Withdrawal of Consent|1
686106|NCT01556165|2227872|P1|Overall Study|Withdrawal of Consent|7
686107|NCT01556165|2227871|P2|Overall Study|Protocol Violation|3
686108|NCT01556165|2227872|P1|Overall Study|Protocol Violation|0
686109|NCT01556165|2227871|P2|Overall Study|Adverse Event|3
686110|NCT01556165|2227872|P1|Overall Study|Adverse Event|5
686111|NCT01555983|2227897|P6|Overall Study|Withdrawal by Subject|1
686112|NCT01555983|2227898|P5|Overall Study|Withdrawal by Subject|1
686113|NCT01555983|2227899|P4|Overall Study|Withdrawal by Subject|0
686114|NCT01555983|2227900|P3|Overall Study|Withdrawal by Subject|0
686115|NCT01555983|2227901|P2|Overall Study|Withdrawal by Subject|0
686116|NCT01555983|2227902|P1|Overall Study|Withdrawal by Subject|1
686117|NCT01555931|2227912|P2|Overall Study|Lost to Follow-up|5
686118|NCT01555931|2227913|P1|Overall Study|Lost to Follow-up|2
686119|NCT01555463|2227944|P2|Follow up|Other reason|3
686120|NCT01555463|2227945|P1|Follow up|Other reason|3
686121|NCT01555463|2227944|P2|Follow up|Protocol Violation|4
686122|NCT01555463|2227945|P1|Follow up|Protocol Violation|2
686123|NCT01555463|2227944|P2|Follow up|Lost to Follow-up|10
686124|NCT01555463|2227945|P1|Follow up|Lost to Follow-up|9
686125|NCT01555463|2227944|P2|Follow up|Withdrawal by Subject|22
686126|NCT01555463|2227945|P1|Follow up|Withdrawal by Subject|22
686127|NCT01555463|2227944|P2|Follow up|Death|1
686128|NCT01555463|2227945|P1|Follow up|Death|0
686129|NCT01555463|2227944|P2|Follow up|Adverse Event|5
686130|NCT01555463|2227945|P1|Follow up|Adverse Event|2
686131|NCT01555463|2227944|P2|Treatment|Other reason|3
686132|NCT01555463|2227945|P1|Treatment|Other reason|2
686133|NCT01555463|2227944|P2|Treatment|Protocol Violation|5
686134|NCT01555463|2227945|P1|Treatment|Protocol Violation|4
686135|NCT01555463|2227944|P2|Treatment|Lost to Follow-up|23
686136|NCT01555463|2227945|P1|Treatment|Lost to Follow-up|28
686137|NCT01555463|2227944|P2|Treatment|Withdrawal by Subject|36
686138|NCT01555463|2227945|P1|Treatment|Withdrawal by Subject|24
686139|NCT01555463|2227944|P2|Treatment|Adverse Event|12
686140|NCT01555463|2227945|P1|Treatment|Adverse Event|6
686141|NCT01555164|2227987|P2|Overall Study|Subject Withdrew Consent|11
686142|NCT01555164|2227988|P1|Overall Study|Subject Withdrew Consent|6
686143|NCT01555164|2227987|P2|Overall Study|Subject Non-compliance|6
686144|NCT01555164|2227988|P1|Overall Study|Subject Non-compliance|14
686145|NCT01555164|2227987|P2|Overall Study|Protocol Violation|5
686146|NCT01555164|2227988|P1|Overall Study|Protocol Violation|9
686147|NCT01555164|2227987|P2|Overall Study|Lost to Follow-up|3
686148|NCT01555164|2227988|P1|Overall Study|Lost to Follow-up|4
686149|NCT01555164|2227987|P2|Overall Study|Investigator's Discretion|2
686150|NCT01555164|2227988|P1|Overall Study|Investigator's Discretion|2
686151|NCT01555164|2227987|P2|Overall Study|Hyperglycemia|1
686152|NCT01555164|2227988|P1|Overall Study|Hyperglycemia|0
686153|NCT01555164|2227987|P2|Overall Study|Adverse Event|7
686154|NCT01555164|2227988|P1|Overall Study|Adverse Event|5
686155|NCT01555151|2228002|P4|Overall Study|Lost to Follow-up|1
686156|NCT01555151|2228003|P3|Overall Study|Lost to Follow-up|0
686157|NCT01555151|2228004|P2|Overall Study|Lost to Follow-up|0
686158|NCT01555151|2228005|P1|Overall Study|Lost to Follow-up|0
686159|NCT01555151|2228002|P4|Overall Study|Adverse Event|2
686160|NCT01555151|2228003|P3|Overall Study|Adverse Event|1
686161|NCT01555151|2228004|P2|Overall Study|Adverse Event|2
686162|NCT01555151|2228005|P1|Overall Study|Adverse Event|1
686163|NCT01555151|2228002|P4|Overall Study|Protocol Violation|5
686164|NCT01555151|2228003|P3|Overall Study|Protocol Violation|3
686165|NCT01555151|2228004|P2|Overall Study|Protocol Violation|3
686166|NCT01555151|2228005|P1|Overall Study|Protocol Violation|3
686167|NCT01555151|2228002|P4|Overall Study|Administrative|0
686168|NCT01555151|2228003|P3|Overall Study|Administrative|2
686169|NCT01555151|2228004|P2|Overall Study|Administrative|1
686170|NCT01555151|2228005|P1|Overall Study|Administrative|3
686171|NCT01555151|2228002|P4|Overall Study|Withdrawal by Subject|2
686172|NCT01555151|2228003|P3|Overall Study|Withdrawal by Subject|0
686173|NCT01555151|2228004|P2|Overall Study|Withdrawal by Subject|2
686174|NCT01555151|2228005|P1|Overall Study|Withdrawal by Subject|6
686175|NCT01555138|2228058|P2|Overall Study|Adverse Event|14
686176|NCT01555138|2228059|P1|Overall Study|Adverse Event|14
686177|NCT01555138|2228058|P2|Overall Study|Withdrawal by Subject|15
686178|NCT01555138|2228059|P1|Overall Study|Withdrawal by Subject|16
686179|NCT01555138|2228058|P2|Overall Study|Administrative problems|0
686180|NCT01555138|2228059|P1|Overall Study|Administrative problems|8
686181|NCT01555138|2228058|P2|Overall Study|Protocol Violation|3
686182|NCT01555138|2228059|P1|Overall Study|Protocol Violation|5
686183|NCT01555138|2228058|P2|Overall Study|Lack of Efficacy|2
686184|NCT01555138|2228059|P1|Overall Study|Lack of Efficacy|2
686185|NCT01555138|2228058|P2|Overall Study|Abnormal Lab reults|3
686186|NCT01555138|2228059|P1|Overall Study|Abnormal Lab reults|1
686187|NCT01555138|2228058|P2|Overall Study|Lost to Follow-up|0
686188|NCT01555138|2228059|P1|Overall Study|Lost to Follow-up|1
686189|NCT01555138|2228058|P2|Overall Study|Death|1
686190|NCT01555138|2228059|P1|Overall Study|Death|0
686191|NCT01555073|2228089|P4|Overall Study|Lost to Follow-up|5
686192|NCT01555073|2228090|P3|Overall Study|Lost to Follow-up|0
686193|NCT01555073|2228091|P2|Overall Study|Lost to Follow-up|2
686194|NCT01555073|2228092|P1|Overall Study|Lost to Follow-up|1
686195|NCT01554904|2228119|P1|Overall Study|Had sleep apnea on Home Study 1|1
686196|NCT01554904|2228119|P1|Overall Study|Withdrawal by Subject|3
686197|NCT01554579|2228139|P2|Overall Study|Withdrawal by Subject|1
686198|NCT01554579|2228140|P1|Overall Study|Withdrawal by Subject|2
686199|NCT01554579|2228139|P2|Overall Study|Lack of Efficacy|1
686200|NCT01554579|2228140|P1|Overall Study|Lack of Efficacy|2
686201|NCT01554579|2228139|P2|Overall Study|Adverse Event|25
686202|NCT01554579|2228140|P1|Overall Study|Adverse Event|6
686203|NCT01554241|2228154|P4|Overall Study|Withdrawal by Subject|0
686204|NCT01554241|2228155|P3|Overall Study|Withdrawal by Subject|2
686205|NCT01554241|2228156|P2|Overall Study|Withdrawal by Subject|0
686206|NCT01554241|2228157|P1|Overall Study|Withdrawal by Subject|0
686207|NCT01554241|2228154|P4|Overall Study|protocol specified change in eGFR|0
686208|NCT01554241|2228155|P3|Overall Study|protocol specified change in eGFR|1
686209|NCT01554241|2228156|P2|Overall Study|protocol specified change in eGFR|0
686210|NCT01554241|2228157|P1|Overall Study|protocol specified change in eGFR|0
686211|NCT01554241|2228154|P4|Overall Study|protocol specified renal stone|1
686212|NCT01554241|2228155|P3|Overall Study|protocol specified renal stone|0
686213|NCT01554241|2228156|P2|Overall Study|protocol specified renal stone|0
686214|NCT01554241|2228157|P1|Overall Study|protocol specified renal stone|0
686215|NCT01554241|2228154|P4|Overall Study|Death|0
686216|NCT01554241|2228155|P3|Overall Study|Death|1
686217|NCT01554241|2228156|P2|Overall Study|Death|1
686218|NCT01554241|2228157|P1|Overall Study|Death|3
686219|NCT01554176|2228173|P5|Run-out Phase|Protocol Violation|0
686220|NCT01554176|2228174|P4|Run-out Phase|Protocol Violation|1
686221|NCT01554176|2228175|P3|Run-out Phase|Protocol Violation|0
686222|NCT01554176|2228176|P2|Run-out Phase|Protocol Violation|0
686223|NCT01554176|2228177|P1|Run-out Phase|Protocol Violation|0
686224|NCT01554176|2228173|P5|Treatment Phase|Lost to Follow-up|0
686225|NCT01554176|2228174|P4|Treatment Phase|Lost to Follow-up|0
686226|NCT01554176|2228175|P3|Treatment Phase|Lost to Follow-up|0
686227|NCT01554176|2228176|P2|Treatment Phase|Lost to Follow-up|0
686228|NCT01554176|2228177|P1|Treatment Phase|Lost to Follow-up|3
686229|NCT01554176|2228173|P5|Treatment Phase|Withdrawal by Subject|0
686230|NCT01554176|2228174|P4|Treatment Phase|Withdrawal by Subject|0
686231|NCT01554176|2228175|P3|Treatment Phase|Withdrawal by Subject|0
686232|NCT01554176|2228176|P2|Treatment Phase|Withdrawal by Subject|0
686233|NCT01554176|2228177|P1|Treatment Phase|Withdrawal by Subject|1
686234|NCT01554176|2228173|P5|Treatment Phase|Non-compliance with study drug|0
686235|NCT01554176|2228174|P4|Treatment Phase|Non-compliance with study drug|0
686236|NCT01554176|2228175|P3|Treatment Phase|Non-compliance with study drug|0
686237|NCT01554176|2228176|P2|Treatment Phase|Non-compliance with study drug|0
686238|NCT01554176|2228177|P1|Treatment Phase|Non-compliance with study drug|1
686239|NCT01554176|2228173|P5|Treatment Phase|Adverse event, non-fatal|0
686240|NCT01554176|2228174|P4|Treatment Phase|Adverse event, non-fatal|0
686241|NCT01554176|2228175|P3|Treatment Phase|Adverse event, non-fatal|0
686242|NCT01554176|2228176|P2|Treatment Phase|Adverse event, non-fatal|1
686243|NCT01554176|2228177|P1|Treatment Phase|Adverse event, non-fatal|1
686244|NCT01554176|2228173|P5|Treatment Phase|Lack of Efficacy|0
686245|NCT01554176|2228174|P4|Treatment Phase|Lack of Efficacy|0
686246|NCT01554176|2228175|P3|Treatment Phase|Lack of Efficacy|0
686247|NCT01554176|2228176|P2|Treatment Phase|Lack of Efficacy|1
686248|NCT01554176|2228177|P1|Treatment Phase|Lack of Efficacy|0
686249|NCT01554176|2228173|P5|Treatment Phase|Physician Decision|0
686250|NCT01554176|2228174|P4|Treatment Phase|Physician Decision|0
686251|NCT01554176|2228175|P3|Treatment Phase|Physician Decision|0
686252|NCT01554176|2228176|P2|Treatment Phase|Physician Decision|1
686253|NCT01554176|2228177|P1|Treatment Phase|Physician Decision|1
686254|NCT01554176|2228173|P5|Treatment Phase|Protocol Violation|0
686255|NCT01554176|2228174|P4|Treatment Phase|Protocol Violation|0
686256|NCT01554176|2228175|P3|Treatment Phase|Protocol Violation|0
686257|NCT01554176|2228176|P2|Treatment Phase|Protocol Violation|2
686258|NCT01554176|2228177|P1|Treatment Phase|Protocol Violation|1
686259|NCT01554163|2228204|P2|Overall Study|Not Treated|0
686260|NCT01554163|2228205|P1|Overall Study|Not Treated|1
686261|NCT01554163|2228204|P2|Overall Study|Withdrawal by Subject|5
686262|NCT01554163|2228205|P1|Overall Study|Withdrawal by Subject|1
686263|NCT01554163|2228204|P2|Overall Study|Protocol Violation|4
686264|NCT01554163|2228205|P1|Overall Study|Protocol Violation|0
686265|NCT01554163|2228204|P2|Overall Study|Non-Compliance With Study Drug|1
686266|NCT01554163|2228205|P1|Overall Study|Non-Compliance With Study Drug|1
686267|NCT01554163|2228204|P2|Overall Study|Lost to Follow-up|0
686268|NCT01554163|2228205|P1|Overall Study|Lost to Follow-up|1
686269|NCT01554163|2228204|P2|Overall Study|Lack of Efficacy|0
686270|NCT01554163|2228205|P1|Overall Study|Lack of Efficacy|1
686271|NCT01554163|2228204|P2|Overall Study|Adverse Event|0
686272|NCT01554163|2228205|P1|Overall Study|Adverse Event|3
686273|NCT01553851|2228223|P1|Overall Study|constipation|1
686274|NCT01553851|2228223|P1|Overall Study|Adverse Event|2
686275|NCT01552772|2228235|P1|Overall Study|Protocol Deviation|1
686276|NCT01552772|2228235|P1|Overall Study|Adverse Event|1
686277|NCT01552772|2228235|P1|Overall Study|Lost to Follow-up|2
686282|NCT01552681|2228264|P2|Overall Study|Subject moved away|1
686283|NCT01552681|2228265|P1|Overall Study|Subject moved away|0
686284|NCT01552681|2228264|P2|Overall Study|Physician Decision|0
686285|NCT01552681|2228265|P1|Overall Study|Physician Decision|1
686286|NCT01552681|2228264|P2|Overall Study|Withdrawal by Subject|0
686287|NCT01552681|2228265|P1|Overall Study|Withdrawal by Subject|4
686288|NCT01553318|2228329|P2|Overall Study|Protocol Violation|2
686289|NCT01553318|2228330|P1|Overall Study|Protocol Violation|3
686290|NCT01552954|2228365|P2|Overall Study|diagnosed DM|0
686291|NCT01552954|2228366|P1|Overall Study|diagnosed DM|1
686292|NCT01552954|2228365|P2|Overall Study|Protocol Violation|2
686293|NCT01552954|2228366|P1|Overall Study|Protocol Violation|1
686294|NCT01552954|2228365|P2|Overall Study|Withdrawal by Subject|1
686295|NCT01552954|2228366|P1|Overall Study|Withdrawal by Subject|1
686296|NCT01552954|2228365|P2|Overall Study|Lost to Follow-up|1
686297|NCT01552954|2228366|P1|Overall Study|Lost to Follow-up|1
686298|NCT01552954|2228365|P2|Overall Study|Adverse Event|2
686299|NCT01552954|2228366|P1|Overall Study|Adverse Event|1
686300|NCT01552928|2228382|P4|Period 3|Adverse Event|0
686301|NCT01552928|2228383|P3|Period 3|Adverse Event|1
686302|NCT01552928|2228384|P2|Period 3|Adverse Event|0
686303|NCT01552928|2228385|P1|Period 3|Adverse Event|0
686304|NCT01552915|2228432|P3|Overall Study|Not specified|6
686305|NCT01552915|2228433|P2|Overall Study|Not specified|0
686306|NCT01552915|2228434|P1|Overall Study|Not specified|2
686307|NCT01552915|2228432|P3|Overall Study|Lack of Efficacy|4
686308|NCT01552915|2228433|P2|Overall Study|Lack of Efficacy|1
686309|NCT01552915|2228434|P1|Overall Study|Lack of Efficacy|8
686310|NCT01552915|2228432|P3|Overall Study|Protocol Violation|4
686311|NCT01552915|2228433|P2|Overall Study|Protocol Violation|4
686312|NCT01552915|2228434|P1|Overall Study|Protocol Violation|0
686313|NCT01552915|2228432|P3|Overall Study|Withdrawal by Subject|5
686314|NCT01552915|2228433|P2|Overall Study|Withdrawal by Subject|4
686315|NCT01552915|2228434|P1|Overall Study|Withdrawal by Subject|6
686316|NCT01552915|2228432|P3|Overall Study|Lost to Follow-up|5
686317|NCT01552915|2228433|P2|Overall Study|Lost to Follow-up|6
686318|NCT01552915|2228434|P1|Overall Study|Lost to Follow-up|4
686319|NCT01552915|2228432|P3|Overall Study|Adverse Event|3
686320|NCT01552915|2228433|P2|Overall Study|Adverse Event|14
686321|NCT01552915|2228434|P1|Overall Study|Adverse Event|3
686322|NCT01552902|2228457|P3|Overall Study|Unspecified|3
686323|NCT01552902|2228458|P2|Overall Study|Unspecified|4
686324|NCT01552902|2228459|P1|Overall Study|Unspecified|3
686325|NCT01552902|2228457|P3|Overall Study|Lost to Follow-up|6
686326|NCT01552902|2228458|P2|Overall Study|Lost to Follow-up|3
686327|NCT01552902|2228459|P1|Overall Study|Lost to Follow-up|1
686328|NCT01552902|2228457|P3|Overall Study|Withdrawal by Subject|6
686329|NCT01552902|2228458|P2|Overall Study|Withdrawal by Subject|9
686330|NCT01552902|2228459|P1|Overall Study|Withdrawal by Subject|1
686331|NCT01552902|2228457|P3|Overall Study|Lack of Efficacy|1
686332|NCT01552902|2228458|P2|Overall Study|Lack of Efficacy|3
686333|NCT01552902|2228459|P1|Overall Study|Lack of Efficacy|4
686334|NCT01552902|2228457|P3|Overall Study|Protocol Violation|3
686335|NCT01552902|2228458|P2|Overall Study|Protocol Violation|3
686336|NCT01552902|2228459|P1|Overall Study|Protocol Violation|3
686337|NCT01552902|2228457|P3|Overall Study|Adverse Event|14
686338|NCT01552902|2228458|P2|Overall Study|Adverse Event|15
686339|NCT01552902|2228459|P1|Overall Study|Adverse Event|1
686340|NCT01552603|2228509|P1|Overall Study|Physician Decision|1
686341|NCT01552057|2228540|P2|Overall Study|Physician Decision|0
686342|NCT01552057|2228541|P1|Overall Study|Physician Decision|1
686343|NCT01552057|2228540|P2|Overall Study|Entry Criteria Not Met|2
686344|NCT01552057|2228541|P1|Overall Study|Entry Criteria Not Met|2
686345|NCT01552057|2228540|P2|Overall Study|Withdrawal by Subject|8
686346|NCT01552057|2228541|P1|Overall Study|Withdrawal by Subject|5
686347|NCT01552057|2228540|P2|Overall Study|Lack of Efficacy|23
686348|NCT01552057|2228541|P1|Overall Study|Lack of Efficacy|8
686349|NCT01552057|2228540|P2|Overall Study|Adverse Event|15
686350|NCT01552057|2228541|P1|Overall Study|Adverse Event|14
686351|NCT01551758|2228607|P2|Overall Study|Withdrawal by Subject|17
686352|NCT01551758|2228608|P1|Overall Study|Withdrawal by Subject|14
686353|NCT01551758|2228607|P2|Overall Study|Physician Decision|3
686354|NCT01551758|2228608|P1|Overall Study|Physician Decision|9
686355|NCT01551758|2228607|P2|Overall Study|Lost to Follow-up|25
686356|NCT01551758|2228608|P1|Overall Study|Lost to Follow-up|29
686357|NCT01551758|2228607|P2|Overall Study|Met Protocol-defined stopping criteria|10
686358|NCT01551758|2228608|P1|Overall Study|Met Protocol-defined stopping criteria|8
686359|NCT01551758|2228607|P2|Overall Study|Protocol Violation|6
686360|NCT01551758|2228608|P1|Overall Study|Protocol Violation|5
686361|NCT01551758|2228607|P2|Overall Study|Lack of Efficacy|1
686362|NCT01551758|2228608|P1|Overall Study|Lack of Efficacy|0
686363|NCT01551758|2228607|P2|Overall Study|Adverse Event|43
686364|NCT01551758|2228608|P1|Overall Study|Adverse Event|29
686365|NCT01551693|2228648|P2|Overall Study|Withdrawal by Subject|1
686366|NCT01551693|2228649|P1|Overall Study|Withdrawal by Subject|0
686367|NCT01551693|2228648|P2|Overall Study|Adverse Event|1
686368|NCT01551693|2228649|P1|Overall Study|Adverse Event|0
686369|NCT01551693|2228648|P2|Overall Study|Disease Progression|0
686370|NCT01551693|2228649|P1|Overall Study|Disease Progression|1
686371|NCT01551355|2228665|P6|Overall Study|Lost to Follow-up|6
686372|NCT01551355|2228666|P5|Overall Study|Lost to Follow-up|9
686373|NCT01551355|2228667|P4|Overall Study|Lost to Follow-up|24
686374|NCT01551355|2228668|P3|Overall Study|Lost to Follow-up|34
686375|NCT01551355|2228669|P2|Overall Study|Lost to Follow-up|49
686376|NCT01551355|2228670|P1|Overall Study|Lost to Follow-up|51
686377|NCT01551303|2228684|P2|Overall Study|failed awareness check on vision test|7
686378|NCT01551303|2228685|P1|Overall Study|failed awareness check on vision test|4
686379|NCT01551173|2228699|P2|Overall Study|Not specified|3
686380|NCT01551173|2228700|P1|Overall Study|Not specified|5
686381|NCT01551173|2228699|P2|Overall Study|Lost to Follow-up|7
686382|NCT01551173|2228700|P1|Overall Study|Lost to Follow-up|5
686383|NCT01551173|2228699|P2|Overall Study|Adverse Event|6
686384|NCT01551173|2228700|P1|Overall Study|Adverse Event|7
686385|NCT01551173|2228699|P2|Overall Study|Withdrawal by Subject|16
686386|NCT01551173|2228700|P1|Overall Study|Withdrawal by Subject|11
686387|NCT01550965|2228777|P1|Overall Study|Not Specified|13
686388|NCT01550965|2228777|P1|Overall Study|Lack of Efficacy|59
686389|NCT01550965|2228777|P1|Overall Study|Lost to Follow-up|2
686390|NCT01550965|2228777|P1|Overall Study|Withdrawal by Subject|10
686391|NCT01550965|2228777|P1|Overall Study|Adverse Event|26
686392|NCT01550744|2228817|P3|Double-Blind|unspecified|10
686393|NCT01550744|2228818|P2|Double-Blind|unspecified|2
686394|NCT01550744|2228819|P1|Double-Blind|unspecified|0
686395|NCT01550744|2228817|P3|Double-Blind|Pregnancy|3
686396|NCT01550744|2228818|P2|Double-Blind|Pregnancy|0
686397|NCT01550744|2228819|P1|Double-Blind|Pregnancy|0
686398|NCT01550744|2228817|P3|Double-Blind|Protocol Violation|4
686399|NCT01550744|2228818|P2|Double-Blind|Protocol Violation|0
686400|NCT01550744|2228819|P1|Double-Blind|Protocol Violation|0
686401|NCT01550744|2228817|P3|Double-Blind|Lack of Efficacy|8
686402|NCT01550744|2228818|P2|Double-Blind|Lack of Efficacy|2
686403|NCT01550744|2228819|P1|Double-Blind|Lack of Efficacy|0
686404|NCT01550744|2228817|P3|Double-Blind|Death|0
686405|NCT01550744|2228818|P2|Double-Blind|Death|1
686406|NCT01550744|2228819|P1|Double-Blind|Death|0
686407|NCT01550744|2228817|P3|Double-Blind|Adverse Event|15
686408|NCT01550744|2228818|P2|Double-Blind|Adverse Event|4
686409|NCT01550744|2228819|P1|Double-Blind|Adverse Event|0
686410|NCT01550744|2228817|P3|Double-Blind|Withdrawal by Subject|15
686411|NCT01550744|2228818|P2|Double-Blind|Withdrawal by Subject|2
686412|NCT01550744|2228819|P1|Double-Blind|Withdrawal by Subject|0
686413|NCT01550744|2228817|P3|Double-Blind|Lost to Follow-up|12
686414|NCT01550744|2228818|P2|Double-Blind|Lost to Follow-up|6
686415|NCT01550744|2228819|P1|Double-Blind|Lost to Follow-up|0
686416|NCT01550744|2228817|P3|Open-Label|unspecified|0
686417|NCT01550744|2228818|P2|Open-Label|unspecified|0
686418|NCT01550744|2228819|P1|Open-Label|unspecified|1
686419|NCT01550744|2228817|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
686420|NCT01550744|2228818|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
686421|NCT01550744|2228819|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
686422|NCT01550744|2228817|P3|Open-Label|Not all 3 study drug injections received|0
686423|NCT01550744|2228818|P2|Open-Label|Not all 3 study drug injections received|0
686424|NCT01550744|2228819|P1|Open-Label|Not all 3 study drug injections received|2
686425|NCT01550744|2228817|P3|Open-Label|Protocol Violation|0
686426|NCT01550744|2228818|P2|Open-Label|Protocol Violation|0
686427|NCT01550744|2228819|P1|Open-Label|Protocol Violation|4
686428|NCT01550744|2228817|P3|Open-Label|Lack of Efficacy|0
686429|NCT01550744|2228818|P2|Open-Label|Lack of Efficacy|0
686430|NCT01550744|2228819|P1|Open-Label|Lack of Efficacy|4
686431|NCT01550744|2228817|P3|Open-Label|Adverse Event|0
686432|NCT01550744|2228818|P2|Open-Label|Adverse Event|0
686433|NCT01550744|2228819|P1|Open-Label|Adverse Event|11
686434|NCT01550744|2228817|P3|Open-Label|Withdrawal by Subject|0
686435|NCT01550744|2228818|P2|Open-Label|Withdrawal by Subject|0
686436|NCT01550744|2228819|P1|Open-Label|Withdrawal by Subject|13
686437|NCT01550744|2228817|P3|Open-Label|Lost to Follow-up|0
686438|NCT01550744|2228818|P2|Open-Label|Lost to Follow-up|0
686439|NCT01550744|2228819|P1|Open-Label|Lost to Follow-up|7
686440|NCT01550289|2228872|P2|Overall Study|Withdrawal by Subject|3
686441|NCT01550289|2228873|P1|Overall Study|Withdrawal by Subject|11
686442|NCT01550289|2228872|P2|Overall Study|Lost to Follow-up|1
686443|NCT01550289|2228873|P1|Overall Study|Lost to Follow-up|1
686444|NCT01550289|2228872|P2|Overall Study|Protocol Violation|0
686445|NCT01550289|2228873|P1|Overall Study|Protocol Violation|1
686446|NCT01549964|2228924|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
686447|NCT01549964|2228925|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
686448|NCT01549964|2228926|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
686449|NCT01549964|2228927|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
686450|NCT01549964|2228924|P4|80-Week Extension Period|Lost to Follow-up|1
686451|NCT01549964|2228925|P3|80-Week Extension Period|Lost to Follow-up|2
686452|NCT01549964|2228926|P2|80-Week Extension Period|Lost to Follow-up|0
686453|NCT01549964|2228927|P1|80-Week Extension Period|Lost to Follow-up|1
686454|NCT01549964|2228924|P4|80-Week Extension Period|Voluntary Withdrawal|2
686455|NCT01549964|2228925|P3|80-Week Extension Period|Voluntary Withdrawal|4
686456|NCT01549964|2228926|P2|80-Week Extension Period|Voluntary Withdrawal|1
686457|NCT01549964|2228927|P1|80-Week Extension Period|Voluntary Withdrawal|0
686458|NCT01549964|2228924|P4|80-Week Extension Period|Study Terminated by Sponsor|132
686459|NCT01549964|2228925|P3|80-Week Extension Period|Study Terminated by Sponsor|132
686460|NCT01549964|2228926|P2|80-Week Extension Period|Study Terminated by Sponsor|137
686461|NCT01549964|2228927|P1|80-Week Extension Period|Study Terminated by Sponsor|65
686462|NCT01549964|2228924|P4|80-Week Extension Period|Pregnancy|0
686463|NCT01549964|2228925|P3|80-Week Extension Period|Pregnancy|1
686464|NCT01549964|2228926|P2|80-Week Extension Period|Pregnancy|0
686465|NCT01549964|2228927|P1|80-Week Extension Period|Pregnancy|0
686466|NCT01549964|2228924|P4|24-Week Treatment Period|Completion Status Unknown|0
686467|NCT01549964|2228925|P3|24-Week Treatment Period|Completion Status Unknown|1
686468|NCT01549964|2228926|P2|24-Week Treatment Period|Completion Status Unknown|0
686469|NCT01549964|2228927|P1|24-Week Treatment Period|Completion Status Unknown|1
686470|NCT01549964|2228924|P4|24-Week Treatment Period|Randomized but Not Treated|1
686471|NCT01549964|2228925|P3|24-Week Treatment Period|Randomized but Not Treated|0
686472|NCT01549964|2228926|P2|24-Week Treatment Period|Randomized but Not Treated|0
686473|NCT01549964|2228927|P1|24-Week Treatment Period|Randomized but Not Treated|0
686474|NCT01549964|2228924|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
686475|NCT01549964|2228925|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
686476|NCT01549964|2228926|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
686477|NCT01549964|2228927|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
686478|NCT01549964|2228924|P4|24-Week Treatment Period|Other|0
686479|NCT01549964|2228925|P3|24-Week Treatment Period|Other|1
686480|NCT01549964|2228926|P2|24-Week Treatment Period|Other|0
686481|NCT01549964|2228927|P1|24-Week Treatment Period|Other|1
686482|NCT01549964|2228924|P4|24-Week Treatment Period|Lack of Efficacy|1
686483|NCT01549964|2228925|P3|24-Week Treatment Period|Lack of Efficacy|1
686484|NCT01549964|2228926|P2|24-Week Treatment Period|Lack of Efficacy|0
686485|NCT01549964|2228927|P1|24-Week Treatment Period|Lack of Efficacy|1
686486|NCT01549964|2228924|P4|24-Week Treatment Period|Lost to Follow-up|2
686487|NCT01549964|2228925|P3|24-Week Treatment Period|Lost to Follow-up|1
686488|NCT01549964|2228926|P2|24-Week Treatment Period|Lost to Follow-up|0
686489|NCT01549964|2228927|P1|24-Week Treatment Period|Lost to Follow-up|1
686490|NCT01549964|2228924|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
686491|NCT01549964|2228925|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
686492|NCT01549964|2228926|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
686493|NCT01549964|2228927|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
686494|NCT01549964|2228924|P4|24-Week Treatment Period|Voluntary Withdrawal|8
686495|NCT01549964|2228925|P3|24-Week Treatment Period|Voluntary Withdrawal|3
686496|NCT01549964|2228926|P2|24-Week Treatment Period|Voluntary Withdrawal|3
686497|NCT01549964|2228927|P1|24-Week Treatment Period|Voluntary Withdrawal|6
686498|NCT01549964|2228924|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
686499|NCT01549964|2228925|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
686500|NCT01549964|2228926|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
686501|NCT01549964|2228927|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
686502|NCT01549951|2228945|P1|Overall Study|Other|2
686503|NCT01549951|2228945|P1|Overall Study|Symptomatic deterioration|1
686504|NCT01549951|2228945|P1|Overall Study|Progressive disease|29
686505|NCT01549951|2228945|P1|Overall Study|Unsatisfactory therapeutic response|1
686506|NCT01549951|2228945|P1|Overall Study|Withdrawal by Subject|2
686507|NCT01549951|2228945|P1|Overall Study|Adverse Event|15
686508|NCT01549873|2228972|P2|Overall Study|Physician Decision|1
686509|NCT01549873|2228973|P1|Overall Study|Physician Decision|0
686510|NCT01549860|2228985|P2|Overall Study|Physician Decision|1
686511|NCT01549860|2228986|P1|Overall Study|Physician Decision|1
686512|NCT01549860|2228985|P2|Overall Study|Withdrawal by Subject|0
686513|NCT01549860|2228986|P1|Overall Study|Withdrawal by Subject|1
686514|NCT01549613|2228998|P2|Overall Study|Lost to Follow-up|11
686515|NCT01549613|2228999|P1|Overall Study|Lost to Follow-up|11
686516|NCT01549392|2229018|P2|Overall Study|Withdrawal by Subject|0
686517|NCT01549392|2229019|P1|Overall Study|Withdrawal by Subject|1
686518|NCT01549275|2229038|P2|Overall Study|Lost to Follow-up|0
686519|NCT01549275|2229039|P1|Overall Study|Lost to Follow-up|1
686520|NCT01549041|2229062|P2|Overall Study|Adverse Event|4
686521|NCT01549041|2229063|P1|Overall Study|Adverse Event|0
686522|NCT01549041|2229062|P2|Overall Study|Lack of Efficacy|4
686523|NCT01549041|2229063|P1|Overall Study|Lack of Efficacy|2
686524|NCT01548638|2229110|P1|Overall Study|Withdrawal by Subject|1
686525|NCT01548638|2229110|P1|Overall Study|Protocol Violation|3
686526|NCT01548573|2229117|P1|Overall Study|Withdrawal by Subject|2
686527|NCT01548573|2229117|P1|Overall Study|Death|3
686528|NCT01548417|2229126|P2|Overall Study|Withdrawal by Subject|2
686529|NCT01548417|2229127|P1|Overall Study|Withdrawal by Subject|0
686530|NCT01548287|2229139|P5|Randomized Period|Adverse Event|0
686531|NCT01548287|2229140|P4|Randomized Period|Adverse Event|0
686532|NCT01548287|2229141|P3|Randomized Period|Adverse Event|5
686533|NCT01548287|2229142|P2|Randomized Period|Adverse Event|2
686534|NCT01548287|2229143|P1|Randomized Period|Adverse Event|0
686535|NCT01548287|2229139|P5|Randomized Period|Did not meet inclusion criteria|0
686536|NCT01548287|2229140|P4|Randomized Period|Did not meet inclusion criteria|0
686537|NCT01548287|2229141|P3|Randomized Period|Did not meet inclusion criteria|2
686538|NCT01548287|2229142|P2|Randomized Period|Did not meet inclusion criteria|0
686539|NCT01548287|2229143|P1|Randomized Period|Did not meet inclusion criteria|0
686540|NCT01548287|2229139|P5|Screening|Did not meet eligibility criteria|74
686541|NCT01548287|2229140|P4|Screening|Did not meet eligibility criteria|0
686542|NCT01548287|2229141|P3|Screening|Did not meet eligibility criteria|0
686543|NCT01548287|2229142|P2|Screening|Did not meet eligibility criteria|0
686544|NCT01548287|2229143|P1|Screening|Did not meet eligibility criteria|0
686545|NCT01548287|2229139|P5|Screening|No reason provided|9
686546|NCT01548287|2229140|P4|Screening|No reason provided|0
686547|NCT01548287|2229141|P3|Screening|No reason provided|0
686548|NCT01548287|2229142|P2|Screening|No reason provided|0
686549|NCT01548287|2229143|P1|Screening|No reason provided|0
686550|NCT01547728|2229189|P1|Overall Study|Screen failure|39
686551|NCT01547728|2229189|P1|Overall Study|Drug not ready for subject|1
686552|NCT01547728|2229189|P1|Overall Study|Change in procedure and equipment|1
686553|NCT01547598|2229298|P2|Overall Study|Other Miscellaneous Reasons|1
686554|NCT01547598|2229299|P1|Overall Study|Other Miscellaneous Reasons|2
686555|NCT01547598|2229298|P2|Overall Study|Protocol Violation|1
686556|NCT01547598|2229299|P1|Overall Study|Protocol Violation|1
686557|NCT01547598|2229298|P2|Overall Study|Adverse Event|1
686558|NCT01547598|2229299|P1|Overall Study|Adverse Event|1
686559|NCT01547598|2229298|P2|Overall Study|Lost to Follow-up|1
686560|NCT01547598|2229299|P1|Overall Study|Lost to Follow-up|1
686561|NCT01547598|2229298|P2|Overall Study|Withdrew consent|1
686562|NCT01547598|2229299|P1|Overall Study|Withdrew consent|1
686565|NCT01547130|2229395|P2|Overall Study|Lost to Follow-up|5
686566|NCT01547130|2229396|P1|Overall Study|Lost to Follow-up|9
686567|NCT01546922|2229410|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
686568|NCT01546922|2229411|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
686569|NCT01546922|2229410|P2|Second Period of 10 Weeks|Protocol Violation|1
686570|NCT01546922|2229411|P1|Second Period of 10 Weeks|Protocol Violation|3
686571|NCT01546922|2229410|P2|First Period of 10 Weeks|Investigator's judgment|0
686572|NCT01546922|2229411|P1|First Period of 10 Weeks|Investigator's judgment|1
686573|NCT01546922|2229410|P2|First Period of 10 Weeks|Withdrawal by Subject|1
686574|NCT01546922|2229411|P1|First Period of 10 Weeks|Withdrawal by Subject|1
686575|NCT01546922|2229410|P2|First Period of 10 Weeks|Protocol Violation|1
686576|NCT01546922|2229411|P1|First Period of 10 Weeks|Protocol Violation|3
686577|NCT01546883|2229417|P1|Overall Study|other unrelated illness|1
686578|NCT01546883|2229417|P1|Overall Study|early closure of study|2
686579|NCT01546883|2229417|P1|Overall Study|Lost to Follow-up|2
686580|NCT01546883|2229417|P1|Overall Study|Adverse Event|4
686581|NCT01546883|2229417|P1|Overall Study|Withdrawal by Subject|3
686582|NCT01546688|2229423|P2|Overall Study|Lack of Efficacy|0
686583|NCT01546688|2229424|P1|Overall Study|Lack of Efficacy|1
686584|NCT01546688|2229423|P2|Overall Study|Withdrawal by Subject|1
686585|NCT01546688|2229424|P1|Overall Study|Withdrawal by Subject|2
686586|NCT01546688|2229423|P2|Overall Study|Adverse Event|4
686587|NCT01546688|2229424|P1|Overall Study|Adverse Event|0
686588|NCT01546649|2229456|P2|Overall Study|Withdrawal by Subject|2
686589|NCT01546649|2229457|P1|Overall Study|Withdrawal by Subject|1
686590|NCT01546649|2229456|P2|Overall Study|Discovery of secondary cancer|1
686591|NCT01546649|2229457|P1|Overall Study|Discovery of secondary cancer|0
686592|NCT01546649|2229456|P2|Overall Study|Recurrence|1
686593|NCT01546649|2229457|P1|Overall Study|Recurrence|1
686594|NCT01546649|2229456|P2|Overall Study|Lack of Efficacy|0
686595|NCT01546649|2229457|P1|Overall Study|Lack of Efficacy|1
686596|NCT01546649|2229456|P2|Overall Study|Protocol Violation|0
686597|NCT01546649|2229457|P1|Overall Study|Protocol Violation|1
686598|NCT01546649|2229456|P2|Overall Study|Adverse Event|5
686599|NCT01546649|2229457|P1|Overall Study|Adverse Event|4
686600|NCT01546623|2229492|P2|Overall Study|Did Not Receive Study Drug|1
686601|NCT01546623|2229493|P1|Overall Study|Did Not Receive Study Drug|1
686602|NCT01546623|2229492|P2|Overall Study|High Prostate specific antigen|1
686603|NCT01546623|2229493|P1|Overall Study|High Prostate specific antigen|2
686604|NCT01546623|2229492|P2|Overall Study|Major Protocol Deviation|1
686605|NCT01546623|2229493|P1|Overall Study|Major Protocol Deviation|1
686606|NCT01546623|2229492|P2|Overall Study|Adverse Event|3
686607|NCT01546623|2229493|P1|Overall Study|Adverse Event|2
686608|NCT01545388|2229522|P3|Overall Study|Not specified|0
686609|NCT01545388|2229523|P2|Overall Study|Not specified|1
686610|NCT01545388|2229524|P1|Overall Study|Not specified|1
686611|NCT01545388|2229522|P3|Overall Study|Withdrawal by Subject|2
686612|NCT01545388|2229523|P2|Overall Study|Withdrawal by Subject|4
686613|NCT01545388|2229524|P1|Overall Study|Withdrawal by Subject|1
686614|NCT01545388|2229522|P3|Overall Study|Participant moved or relocated|0
686615|NCT01545388|2229523|P2|Overall Study|Participant moved or relocated|0
686616|NCT01545388|2229524|P1|Overall Study|Participant moved or relocated|1
686617|NCT01545388|2229522|P3|Overall Study|Lack of Efficacy|5
686618|NCT01545388|2229523|P2|Overall Study|Lack of Efficacy|2
686619|NCT01545388|2229524|P1|Overall Study|Lack of Efficacy|3
686620|NCT01545388|2229522|P3|Overall Study|Adverse Event|1
686621|NCT01545388|2229523|P2|Overall Study|Adverse Event|4
686622|NCT01545388|2229524|P1|Overall Study|Adverse Event|2
686623|NCT01545375|2229543|P2|Overall Study|Withdrawal by Subject|55
686624|NCT01545375|2229544|P1|Overall Study|Withdrawal by Subject|58
686625|NCT01545375|2229543|P2|Overall Study|Protocol Violation|3
686626|NCT01545375|2229544|P1|Overall Study|Protocol Violation|3
686627|NCT01545375|2229543|P2|Overall Study|Lost to Follow-up|31
686628|NCT01545375|2229544|P1|Overall Study|Lost to Follow-up|34
686629|NCT01545375|2229543|P2|Overall Study|Adverse Event|1
686630|NCT01545375|2229544|P1|Overall Study|Adverse Event|2
686631|NCT01546519|2229596|P4|Overall Study|Withdrawal by Subject|0
686632|NCT01546519|2229597|P3|Overall Study|Withdrawal by Subject|0
686633|NCT01546519|2229598|P2|Overall Study|Withdrawal by Subject|0
686634|NCT01546519|2229599|P1|Overall Study|Withdrawal by Subject|1
686635|NCT01546519|2229596|P4|Overall Study|Physician Decision|3
686636|NCT01546519|2229597|P3|Overall Study|Physician Decision|2
686637|NCT01546519|2229598|P2|Overall Study|Physician Decision|5
686638|NCT01546519|2229599|P1|Overall Study|Physician Decision|6
686639|NCT01546519|2229596|P4|Overall Study|related to disease progression|1
686640|NCT01546519|2229597|P3|Overall Study|related to disease progression|2
686641|NCT01546519|2229598|P2|Overall Study|related to disease progression|2
686642|NCT01546519|2229599|P1|Overall Study|related to disease progression|2
686643|NCT01546519|2229596|P4|Overall Study|Death|1
686644|NCT01546519|2229597|P3|Overall Study|Death|3
686645|NCT01546519|2229598|P2|Overall Study|Death|1
686646|NCT01546519|2229599|P1|Overall Study|Death|0
686647|NCT01546519|2229596|P4|Overall Study|Adverse Event|1
686648|NCT01546519|2229597|P3|Overall Study|Adverse Event|1
686649|NCT01546519|2229598|P2|Overall Study|Adverse Event|0
686650|NCT01546519|2229599|P1|Overall Study|Adverse Event|0
686651|NCT01546207|2229664|P1|Overall Study|Death|1
686652|NCT01546155|2229677|P1|Overall Study|could not tolerate long scan duration|3
686653|NCT01546142|2229683|P2|Overall Study|Subject Randomized but Not Treated|0
686654|NCT01546142|2229684|P1|Overall Study|Subject Randomized but Not Treated|1
686655|NCT01546142|2229683|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
686656|NCT01546142|2229684|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
686657|NCT01546142|2229683|P2|Overall Study|Lost to Follow-up|15
686658|NCT01546142|2229684|P1|Overall Study|Lost to Follow-up|20
686659|NCT01546142|2229683|P2|Overall Study|Adverse Event|3
686660|NCT01546142|2229684|P1|Overall Study|Adverse Event|6
686661|NCT01546142|2229683|P2|Overall Study|Subject Noncompliance|1
686662|NCT01546142|2229684|P1|Overall Study|Subject Noncompliance|1
686663|NCT01546142|2229683|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
686664|NCT01546142|2229684|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
686665|NCT01544920|2229844|P2|Overall Study|Withdrawal by Subject|4
686666|NCT01544920|2229845|P1|Overall Study|Withdrawal by Subject|4
686667|NCT01544920|2229844|P2|Overall Study|Physician Decision|1
686668|NCT01544920|2229845|P1|Overall Study|Physician Decision|4
686669|NCT01544920|2229844|P2|Overall Study|Protocol Violation|2
686670|NCT01544920|2229845|P1|Overall Study|Protocol Violation|0
686671|NCT01544920|2229844|P2|Overall Study|Lost to Follow-up|12
686672|NCT01544920|2229845|P1|Overall Study|Lost to Follow-up|11
686673|NCT01544920|2229844|P2|Overall Study|Death|1
686674|NCT01544920|2229845|P1|Overall Study|Death|0
686675|NCT01544920|2229844|P2|Overall Study|Adverse Event|3
686676|NCT01544920|2229845|P1|Overall Study|Adverse Event|0
686677|NCT01544582|2229856|P4|Analysis Population|Participant in Jail|0
686678|NCT01544582|2229857|P3|Analysis Population|Participant in Jail|1
686679|NCT01544582|2229858|P2|Analysis Population|Participant in Jail|0
686680|NCT01544582|2229859|P1|Analysis Population|Participant in Jail|0
686681|NCT01544582|2229856|P4|Analysis Population|Programmed Surgery|0
686682|NCT01544582|2229857|P3|Analysis Population|Programmed Surgery|0
686683|NCT01544582|2229858|P2|Analysis Population|Programmed Surgery|1
686684|NCT01544582|2229859|P1|Analysis Population|Programmed Surgery|0
686685|NCT01544582|2229856|P4|Analysis Population|Poor Participant Compliance|0
686686|NCT01544582|2229857|P3|Analysis Population|Poor Participant Compliance|0
686687|NCT01544582|2229858|P2|Analysis Population|Poor Participant Compliance|1
686688|NCT01544582|2229859|P1|Analysis Population|Poor Participant Compliance|0
686689|NCT01544582|2229856|P4|Analysis Population|Poor Adherence|0
686690|NCT01544582|2229857|P3|Analysis Population|Poor Adherence|1
686691|NCT01544582|2229858|P2|Analysis Population|Poor Adherence|0
686692|NCT01544582|2229859|P1|Analysis Population|Poor Adherence|0
686693|NCT01544582|2229856|P4|Analysis Population|No Social Insurance|0
686694|NCT01544582|2229857|P3|Analysis Population|No Social Insurance|1
686695|NCT01544582|2229858|P2|Analysis Population|No Social Insurance|0
686696|NCT01544582|2229859|P1|Analysis Population|No Social Insurance|0
686697|NCT01544582|2229856|P4|Analysis Population|Liver Transplantation|0
686698|NCT01544582|2229857|P3|Analysis Population|Liver Transplantation|1
686699|NCT01544582|2229858|P2|Analysis Population|Liver Transplantation|0
686700|NCT01544582|2229859|P1|Analysis Population|Liver Transplantation|0
686701|NCT01544582|2229856|P4|Analysis Population|Intolerance|0
686702|NCT01544582|2229857|P3|Analysis Population|Intolerance|0
686703|NCT01544582|2229858|P2|Analysis Population|Intolerance|1
686704|NCT01544582|2229859|P1|Analysis Population|Intolerance|0
686705|NCT01544582|2229856|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
686706|NCT01544582|2229857|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
686707|NCT01544582|2229858|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
686708|NCT01544582|2229859|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
686709|NCT01544582|2229856|P4|Analysis Population|Bad Tolerance to Treatment|0
686710|NCT01544582|2229857|P3|Analysis Population|Bad Tolerance to Treatment|2
686711|NCT01544582|2229858|P2|Analysis Population|Bad Tolerance to Treatment|0
686712|NCT01544582|2229859|P1|Analysis Population|Bad Tolerance to Treatment|0
686713|NCT01544582|2229856|P4|Analysis Population|Lost to Follow-up|5
686714|NCT01544582|2229857|P3|Analysis Population|Lost to Follow-up|6
686715|NCT01544582|2229858|P2|Analysis Population|Lost to Follow-up|6
686716|NCT01544582|2229859|P1|Analysis Population|Lost to Follow-up|0
686717|NCT01544582|2229856|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
686718|NCT01544582|2229857|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
686719|NCT01544582|2229858|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
686720|NCT01544582|2229859|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
686721|NCT01544582|2229856|P4|Analysis Population|Effectiveness Reason|12
686722|NCT01544582|2229857|P3|Analysis Population|Effectiveness Reason|29
686723|NCT01544582|2229858|P2|Analysis Population|Effectiveness Reason|48
686724|NCT01544582|2229859|P1|Analysis Population|Effectiveness Reason|0
686725|NCT01544582|2229856|P4|Analysis Population|Safety Reason|8
686726|NCT01544582|2229857|P3|Analysis Population|Safety Reason|31
686727|NCT01544582|2229858|P2|Analysis Population|Safety Reason|33
686728|NCT01544582|2229859|P1|Analysis Population|Safety Reason|0
686729|NCT01544582|2229856|P4|Analysis Population|Physician Decision|9
686730|NCT01544582|2229857|P3|Analysis Population|Physician Decision|10
686731|NCT01544582|2229858|P2|Analysis Population|Physician Decision|13
686732|NCT01544582|2229859|P1|Analysis Population|Physician Decision|0
686733|NCT01544582|2229856|P4|Analysis Population|Participant Refuses to Continue Study|4
686734|NCT01544582|2229857|P3|Analysis Population|Participant Refuses to Continue Study|17
686735|NCT01544582|2229858|P2|Analysis Population|Participant Refuses to Continue Study|15
686736|NCT01544582|2229859|P1|Analysis Population|Participant Refuses to Continue Study|0
686737|NCT01544582|2229856|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
686738|NCT01544582|2229857|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
686739|NCT01544582|2229858|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
686740|NCT01544582|2229859|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
686741|NCT01544582|2229856|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
686742|NCT01544582|2229857|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
686743|NCT01544582|2229858|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
686744|NCT01544582|2229859|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
686745|NCT01544478|2229917|P1|Overall Study|Withdrawal by Subject|52
686746|NCT01544478|2229917|P1|Overall Study|Pregnancy|1
686747|NCT01544478|2229917|P1|Overall Study|Physician Decision|15
686748|NCT01544478|2229917|P1|Overall Study|Lost to Follow-up|48
686749|NCT01544478|2229917|P1|Overall Study|Death|1
686750|NCT01544478|2229917|P1|Overall Study|Adverse Event|1
686751|NCT01544348|2229960|P8|Overall Study|Physician Decision|0
686752|NCT01544348|2229961|P7|Overall Study|Physician Decision|0
686753|NCT01544348|2229962|P6|Overall Study|Physician Decision|1
686754|NCT01544348|2229963|P5|Overall Study|Physician Decision|0
686755|NCT01544348|2229964|P4|Overall Study|Physician Decision|0
686756|NCT01544348|2229965|P3|Overall Study|Physician Decision|0
686757|NCT01544348|2229966|P2|Overall Study|Physician Decision|0
686758|NCT01544348|2229967|P1|Overall Study|Physician Decision|0
686759|NCT01544348|2229960|P8|Overall Study|Withdrawal by Subject|0
686760|NCT01544348|2229961|P7|Overall Study|Withdrawal by Subject|1
686761|NCT01544348|2229962|P6|Overall Study|Withdrawal by Subject|2
686762|NCT01544348|2229963|P5|Overall Study|Withdrawal by Subject|1
686763|NCT01544348|2229964|P4|Overall Study|Withdrawal by Subject|0
686764|NCT01544348|2229965|P3|Overall Study|Withdrawal by Subject|0
686765|NCT01544348|2229966|P2|Overall Study|Withdrawal by Subject|0
686766|NCT01544348|2229967|P1|Overall Study|Withdrawal by Subject|1
686767|NCT01544348|2229960|P8|Overall Study|Lost to Follow-up|0
686768|NCT01544348|2229961|P7|Overall Study|Lost to Follow-up|1
686769|NCT01544348|2229962|P6|Overall Study|Lost to Follow-up|0
686770|NCT01544348|2229963|P5|Overall Study|Lost to Follow-up|0
686771|NCT01544348|2229964|P4|Overall Study|Lost to Follow-up|0
686772|NCT01544348|2229965|P3|Overall Study|Lost to Follow-up|0
686773|NCT01544348|2229966|P2|Overall Study|Lost to Follow-up|0
686774|NCT01544348|2229967|P1|Overall Study|Lost to Follow-up|1
686775|NCT01544309|2230009|P2|Overall Study|Administered prohibit prior medication|0
686776|NCT01544309|2230010|P1|Overall Study|Administered prohibit prior medication|1
686777|NCT01544309|2230009|P2|Overall Study|Not performed pre-dose examination|2
686778|NCT01544309|2230010|P1|Overall Study|Not performed pre-dose examination|1
686779|NCT01544309|2230009|P2|Overall Study|Physician Decision|1
686780|NCT01544309|2230010|P1|Overall Study|Physician Decision|4
686781|NCT01544309|2230009|P2|Overall Study|Protocol Violation|1
686782|NCT01544309|2230010|P1|Overall Study|Protocol Violation|2
686783|NCT01544309|2230009|P2|Overall Study|Withdrawal by Subject|7
686784|NCT01544309|2230010|P1|Overall Study|Withdrawal by Subject|12
889193|NCT01462344|2823646|P2|Overall Study|Adverse Event|23
889194|NCT01462344|2823647|P1|Overall Study|Adverse Event|24
889195|NCT01462344|2823646|P2|Overall Study|Withdrawal by Subject|226
889196|NCT01462344|2823647|P1|Overall Study|Withdrawal by Subject|245
889197|NCT01443026|2823669|P2|Overall Study|Lost to Follow-up|1
889198|NCT01443026|2823670|P1|Overall Study|Lost to Follow-up|2
889199|NCT01443026|2823669|P2|Overall Study|Withdrawal by Subject|3
889200|NCT01443026|2823670|P1|Overall Study|Withdrawal by Subject|0
889201|NCT01443026|2823669|P2|Overall Study|Death|1
889202|NCT01443026|2823670|P1|Overall Study|Death|0
686803|NCT01544114|2230162|P3|Overall Study|Protocol Violation|0
686804|NCT01544114|2230163|P2|Overall Study|Protocol Violation|1
686805|NCT01544114|2230164|P1|Overall Study|Protocol Violation|0
686806|NCT01544114|2230162|P3|Overall Study|Adverse Event|2
686807|NCT01544114|2230163|P2|Overall Study|Adverse Event|1
686808|NCT01544114|2230164|P1|Overall Study|Adverse Event|1
686809|NCT01544114|2230162|P3|Overall Study|Lost to Follow-up|0
686810|NCT01544114|2230163|P2|Overall Study|Lost to Follow-up|2
686811|NCT01544114|2230164|P1|Overall Study|Lost to Follow-up|0
686812|NCT01544114|2230162|P3|Overall Study|Withdrawal by Subject|3
686813|NCT01544114|2230163|P2|Overall Study|Withdrawal by Subject|0
686814|NCT01544114|2230164|P1|Overall Study|Withdrawal by Subject|0
686815|NCT01543958|2230247|P1|Overall Study|ART initiation|1
686816|NCT01543958|2230247|P1|Overall Study|Loss to follow-up|3
686817|NCT01543828|2230302|P2|Treatment 2|Lost to Follow-up|0
686818|NCT01543828|2230303|P1|Treatment 2|Lost to Follow-up|1
686819|NCT01543685|2230316|P5|Overall Study|Adverse Event|2
686820|NCT01543685|2230317|P4|Overall Study|Adverse Event|0
686821|NCT01543685|2230318|P3|Overall Study|Adverse Event|0
686822|NCT01543685|2230319|P2|Overall Study|Adverse Event|1
686823|NCT01543685|2230320|P1|Overall Study|Adverse Event|2
686824|NCT01543685|2230316|P5|Overall Study|Lack of Efficacy|2
686825|NCT01543685|2230317|P4|Overall Study|Lack of Efficacy|0
686826|NCT01543685|2230318|P3|Overall Study|Lack of Efficacy|2
686827|NCT01543685|2230319|P2|Overall Study|Lack of Efficacy|2
686828|NCT01543685|2230320|P1|Overall Study|Lack of Efficacy|1
686829|NCT01543503|2230392|P2|Overall Study|Screen failure|0
686830|NCT01543503|2230393|P1|Overall Study|Screen failure|1
686831|NCT01543503|2230392|P2|Overall Study|Participant went to United States|0
686832|NCT01543503|2230393|P1|Overall Study|Participant went to United States|1
686833|NCT01543503|2230392|P2|Overall Study|Participant consented to another study|2
686834|NCT01543503|2230393|P1|Overall Study|Participant consented to another study|0
686835|NCT01543503|2230392|P2|Overall Study|Moved to other rheumatologic site|1
686836|NCT01543503|2230393|P1|Overall Study|Moved to other rheumatologic site|0
686837|NCT01543503|2230392|P2|Overall Study|Participant did not attend a visit|0
686838|NCT01543503|2230393|P1|Overall Study|Participant did not attend a visit|1
686839|NCT01543503|2230392|P2|Overall Study|Site stopped participation|1
686840|NCT01543503|2230393|P1|Overall Study|Site stopped participation|5
686841|NCT01543503|2230392|P2|Overall Study|Participant recruited after closing date|1
686842|NCT01543503|2230393|P1|Overall Study|Participant recruited after closing date|0
686843|NCT01543503|2230392|P2|Overall Study|Investigator did not wish to participate|1
686844|NCT01543503|2230393|P1|Overall Study|Investigator did not wish to participate|1
686845|NCT01543503|2230392|P2|Overall Study|Participant decision to stop treatment|0
686846|NCT01543503|2230393|P1|Overall Study|Participant decision to stop treatment|1
686847|NCT01543503|2230392|P2|Overall Study|Participant moved to Scotland|0
686848|NCT01543503|2230393|P1|Overall Study|Participant moved to Scotland|1
686849|NCT01543503|2230392|P2|Overall Study|Participant transferred to another city|0
686850|NCT01543503|2230393|P1|Overall Study|Participant transferred to another city|1
686851|NCT01543503|2230392|P2|Overall Study|Participant will not return for visits|2
686852|NCT01543503|2230393|P1|Overall Study|Participant will not return for visits|0
686853|NCT01543503|2230392|P2|Overall Study|Participant moved to another city|0
686854|NCT01543503|2230393|P1|Overall Study|Participant moved to another city|2
686855|NCT01543503|2230392|P2|Overall Study|Incorrect medication received|0
686856|NCT01543503|2230393|P1|Overall Study|Incorrect medication received|1
686857|NCT01543503|2230392|P2|Overall Study|Refused to continue treatment|0
686858|NCT01543503|2230393|P1|Overall Study|Refused to continue treatment|7
686859|NCT01543503|2230392|P2|Overall Study|Participant did not complete last visit|2
686860|NCT01543503|2230393|P1|Overall Study|Participant did not complete last visit|0
686861|NCT01543503|2230392|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
686862|NCT01543503|2230393|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
686863|NCT01543503|2230392|P2|Overall Study|Intolerance to the biologic treatment|1
686864|NCT01543503|2230393|P1|Overall Study|Intolerance to the biologic treatment|0
686865|NCT01543503|2230392|P2|Overall Study|Change of jobs|1
686866|NCT01543503|2230393|P1|Overall Study|Change of jobs|0
686867|NCT01543503|2230392|P2|Overall Study|Participant withdrew informed consent|10
686868|NCT01543503|2230393|P1|Overall Study|Participant withdrew informed consent|8
686869|NCT01543503|2230392|P2|Overall Study|Lack of Efficacy|16
686870|NCT01543503|2230393|P1|Overall Study|Lack of Efficacy|4
686871|NCT01543503|2230392|P2|Overall Study|Adverse Event|13
686872|NCT01543503|2230393|P1|Overall Study|Adverse Event|9
686873|NCT01543503|2230392|P2|Overall Study|Lost to Follow-up|36
686874|NCT01543503|2230393|P1|Overall Study|Lost to Follow-up|32
686875|NCT01543204|2230437|P1|Overall Study|Lost to Follow-up|1
686876|NCT01543204|2230437|P1|Overall Study|Requirement for Alternative Therapy|1
686877|NCT01543204|2230437|P1|Overall Study|Withdrawal by Subject|4
686878|NCT01543204|2230437|P1|Overall Study|Adverse Event|1
686879|NCT01543204|2230437|P1|Overall Study|Non-compliance|1
686880|NCT01542788|2230529|P2|Overall Study|Withdrawal by Subject|0
686881|NCT01542788|2230530|P1|Overall Study|Withdrawal by Subject|1
686882|NCT01542788|2230529|P2|Overall Study|Physician Decision|0
686883|NCT01542788|2230530|P1|Overall Study|Physician Decision|1
686884|NCT01542788|2230529|P2|Overall Study|Protocol Violation|0
686885|NCT01542788|2230530|P1|Overall Study|Protocol Violation|2
686886|NCT01542788|2230529|P2|Overall Study|Death|0
686887|NCT01542788|2230530|P1|Overall Study|Death|3
686888|NCT01542788|2230529|P2|Overall Study|Lost to Follow-up|0
686889|NCT01542788|2230530|P1|Overall Study|Lost to Follow-up|5
686890|NCT01542788|2230529|P2|Overall Study|Lack of Efficacy|71
686891|NCT01542788|2230530|P1|Overall Study|Lack of Efficacy|41
686892|NCT01542788|2230529|P2|Overall Study|Randomized but Not Treated|0
686893|NCT01542788|2230530|P1|Overall Study|Randomized but Not Treated|2
686918|NCT01542528|2230629|P2|Overall Study|Withdrawal by Subject|6
686919|NCT01542528|2230630|P1|Overall Study|Withdrawal by Subject|9
686920|NCT01542528|2230629|P2|Overall Study|Physician Decision|0
686921|NCT01542528|2230630|P1|Overall Study|Physician Decision|1
686922|NCT01542528|2230629|P2|Overall Study|Lost to Follow-up|1
686923|NCT01542528|2230630|P1|Overall Study|Lost to Follow-up|2
686924|NCT01542034|2230699|P2|Overall Study|Lost to Follow-up|6
686925|NCT01542034|2230700|P1|Overall Study|Lost to Follow-up|7
686926|NCT01542034|2230699|P2|Overall Study|Adverse Event|2
686927|NCT01542034|2230700|P1|Overall Study|Adverse Event|2
686928|NCT01542034|2230699|P2|Overall Study|Subject Noncompliance|0
686929|NCT01542034|2230700|P1|Overall Study|Subject Noncompliance|1
686930|NCT01542034|2230699|P2|Overall Study|Administrative decision|3
686931|NCT01542034|2230700|P1|Overall Study|Administrative decision|0
686932|NCT01542034|2230699|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
686933|NCT01542034|2230700|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
686934|NCT01541969|2230714|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
686935|NCT01541969|2230715|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
686936|NCT01541969|2230714|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
686937|NCT01541969|2230715|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
686938|NCT01541969|2230714|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
686939|NCT01541969|2230715|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
686940|NCT01541969|2230714|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
686941|NCT01541969|2230715|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
686942|NCT01541969|2230714|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
686943|NCT01541969|2230715|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
686944|NCT01541969|2230714|P2|Double-blind (0-12 Weeks)|Adverse Event|0
686945|NCT01541969|2230715|P1|Double-blind (0-12 Weeks)|Adverse Event|2
686946|NCT01541969|2230714|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
686947|NCT01541969|2230715|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
686948|NCT01541969|2230714|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
686949|NCT01541969|2230715|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
686950|NCT01541969|2230714|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
686951|NCT01541969|2230715|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
686952|NCT01541969|2230714|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
686953|NCT01541969|2230715|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
686954|NCT01541930|2230731|P1|Overall Study|Withdrawal by Subject|1
686955|NCT01541917|2230753|P2|Overall Study|Withdrawal by Subject|7
686956|NCT01541917|2230754|P1|Overall Study|Withdrawal by Subject|13
686957|NCT01541917|2230753|P2|Overall Study|Lost to Follow-up|2
686958|NCT01541917|2230754|P1|Overall Study|Lost to Follow-up|2
686959|NCT01541865|2230770|P1|Overall Study|Protocol Violation|1
686960|NCT01541865|2230770|P1|Overall Study|Adverse Event|1
686961|NCT01541865|2230770|P1|Overall Study|Withdrawal by Subject|9
686962|NCT01541865|2230770|P1|Overall Study|Lost to Follow-up|11
686963|NCT01541826|2230788|P3|Overall Study|Withdrawal by Subject|0
686964|NCT01541826|2230789|P2|Overall Study|Withdrawal by Subject|0
686965|NCT01541826|2230790|P1|Overall Study|Withdrawal by Subject|2
686966|NCT01541826|2230788|P3|Overall Study|Lost to Follow-up|0
686967|NCT01541826|2230789|P2|Overall Study|Lost to Follow-up|3
686968|NCT01541826|2230790|P1|Overall Study|Lost to Follow-up|2
686969|NCT01541644|2230872|P1|Overall Study|Withdrawal by Subject|3
686970|NCT01541397|2230891|P2|Overall Study|Study ended prior to data collection|2
686971|NCT01541397|2230892|P1|Overall Study|Study ended prior to data collection|4
686972|NCT01541371|2230917|P1|Overall Study|Unspecified|6
686973|NCT01541371|2230917|P1|Overall Study|Study medication non-compliance|3
686974|NCT01541371|2230917|P1|Overall Study|Protocol Violation|6
686975|NCT01541371|2230917|P1|Overall Study|Lack of Efficacy|12
686976|NCT01541371|2230917|P1|Overall Study|Adverse Event|15
686977|NCT01541371|2230917|P1|Overall Study|Lost to Follow-up|21
686978|NCT01541371|2230917|P1|Overall Study|Withdrawal by Subject|14
686979|NCT01541254|2230946|P1|Overall Study|alternate stent used|1
686980|NCT01541254|2230946|P1|Overall Study|stent not required|1
686981|NCT01541254|2230946|P1|Overall Study|GI bleed prior to procedure|1
686982|NCT01541254|2230946|P1|Overall Study|enrolled after study closed|1
686983|NCT01541254|2230946|P1|Overall Study|excluded - metal allergy|1
686984|NCT01541254|2230946|P1|Overall Study|Withdrawal by Subject|1
686985|NCT01540981|2230953|P2|Overall Study|Withdrawal by Subject|0
686986|NCT01540981|2230954|P1|Overall Study|Withdrawal by Subject|1
686987|NCT01540851|2230964|P2|Overall Study|Withdrawal by Subject|3
686988|NCT01540851|2230965|P1|Overall Study|Withdrawal by Subject|7
686989|NCT01540851|2230964|P2|Overall Study|Lost to Follow-up|15
686990|NCT01540851|2230965|P1|Overall Study|Lost to Follow-up|14
686991|NCT01540487|2231105|P2|Overall Study|Protocol Violation|0
686992|NCT01540487|2231106|P1|Overall Study|Protocol Violation|1
889203|NCT01443026|2823669|P2|Overall Study|Physician Decision|0
889204|NCT01443026|2823670|P1|Overall Study|Physician Decision|1
686995|NCT01539642|2231252|P2|Overall Study|Withdrawal by Subject|2
686996|NCT01539642|2231253|P1|Overall Study|Withdrawal by Subject|2
686997|NCT01539642|2231252|P2|Overall Study|Adverse Event|4
686998|NCT01539642|2231253|P1|Overall Study|Adverse Event|6
686999|NCT01539642|2231252|P2|Overall Study|Patient ready for early discharge|7
687000|NCT01539642|2231253|P1|Overall Study|Patient ready for early discharge|8
687001|NCT01539642|2231252|P2|Overall Study|Lack of Efficacy|18
687002|NCT01539642|2231253|P1|Overall Study|Lack of Efficacy|20
687003|NCT01539538|2231270|P2|Overall Study|PCA no longer required or PCA problem|7
687004|NCT01539538|2231271|P1|Overall Study|PCA no longer required or PCA problem|3
687005|NCT01539538|2231270|P2|Overall Study|Withdrawal by Subject|3
687006|NCT01539538|2231271|P1|Overall Study|Withdrawal by Subject|2
687007|NCT01539538|2231270|P2|Overall Study|Lack of Efficacy|16
687008|NCT01539538|2231271|P1|Overall Study|Lack of Efficacy|13
687009|NCT01539538|2231270|P2|Overall Study|Adverse Event|18
687010|NCT01539538|2231271|P1|Overall Study|Adverse Event|13
687011|NCT01539525|2231280|P3|Overall Study|Protocol Violation|4
687012|NCT01539525|2231281|P2|Overall Study|Protocol Violation|1
687013|NCT01539525|2231282|P1|Overall Study|Protocol Violation|1
687014|NCT01539525|2231280|P3|Overall Study|Withdrawal by Subject|2
687015|NCT01539525|2231281|P2|Overall Study|Withdrawal by Subject|3
687016|NCT01539525|2231282|P1|Overall Study|Withdrawal by Subject|0
687017|NCT01539525|2231280|P3|Overall Study|Lost to Follow-up|11
687018|NCT01539525|2231281|P2|Overall Study|Lost to Follow-up|12
687019|NCT01539525|2231282|P1|Overall Study|Lost to Follow-up|19
687020|NCT01539512|2231301|P2|Overall Study|Richter's Transformation|0
687021|NCT01539512|2231302|P1|Overall Study|Richter's Transformation|1
687022|NCT01539512|2231301|P2|Overall Study|Withdrawal by Subject|5
687023|NCT01539512|2231302|P1|Overall Study|Withdrawal by Subject|12
687024|NCT01539512|2231301|P2|Overall Study|Physician Decision|1
687025|NCT01539512|2231302|P1|Overall Study|Physician Decision|1
687026|NCT01539512|2231301|P2|Overall Study|Adverse Event|7
687027|NCT01539512|2231302|P1|Overall Study|Adverse Event|9
687028|NCT01539317|2231318|P2|Overall Study|Screening Error. Deleted from analysis.|0
687029|NCT01539317|2231319|P1|Overall Study|Screening Error. Deleted from analysis.|1
687030|NCT01539083|2231349|P3|After Randomization (TP and VTP)|Progressive Disease|2
687031|NCT01539083|2231350|P2|After Randomization (TP and VTP)|Progressive Disease|3
687032|NCT01539083|2231351|P1|After Randomization (TP and VTP)|Progressive Disease|0
687033|NCT01539083|2231349|P3|After Randomization (TP and VTP)|Death|6
687034|NCT01539083|2231350|P2|After Randomization (TP and VTP)|Death|4
687035|NCT01539083|2231351|P1|After Randomization (TP and VTP)|Death|0
687036|NCT01539083|2231349|P3|After Randomization (TP and VTP)|Adverse Event|0
687037|NCT01539083|2231350|P2|After Randomization (TP and VTP)|Adverse Event|1
687038|NCT01539083|2231351|P1|After Randomization (TP and VTP)|Adverse Event|0
687039|NCT01539083|2231349|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
687040|NCT01539083|2231350|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
687041|NCT01539083|2231351|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
687042|NCT01539083|2231349|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
687043|NCT01539083|2231350|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
687044|NCT01539083|2231351|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
687045|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Unspecified|0
687046|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Unspecified|0
687047|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Unspecified|5
687048|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Progressive Disease|0
687049|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Progressive Disease|0
687050|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Progressive Disease|8
687051|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Physician Decision|0
687052|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Physician Decision|0
687053|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Physician Decision|14
687054|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Protocol Violation|0
687055|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Protocol Violation|0
687056|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Protocol Violation|2
687057|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Death|0
687058|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Death|0
687059|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Death|6
687060|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Adverse Event|0
687061|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Adverse Event|0
687062|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Adverse Event|14
687063|NCT01539083|2231349|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
687064|NCT01539083|2231350|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
687065|NCT01539083|2231351|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
687066|NCT01538472|2231393|P1|Overall Study|Death|1
687067|NCT01538472|2231393|P1|Overall Study|Disease Progression|3
687068|NCT01537783|2231427|P2|Overall Study|Lost to Follow-up|2
687069|NCT01537783|2231428|P1|Overall Study|Lost to Follow-up|11
687070|NCT01537549|2231479|P1|Overall Study|Withdrawal by Subject|2
687071|NCT01537549|2231479|P1|Overall Study|Lost to Follow-up|1
687072|NCT01537432|2231487|P2|Overall Study|Unsatisfactory therapeutic effect|0
687073|NCT01537432|2231488|P1|Overall Study|Unsatisfactory therapeutic effect|1
687074|NCT01537432|2231487|P2|Overall Study|Adverse Event|0
687075|NCT01537432|2231488|P1|Overall Study|Adverse Event|1
687076|NCT01537432|2231487|P2|Overall Study|Administrative problems|0
687077|NCT01537432|2231488|P1|Overall Study|Administrative problems|1
687078|NCT01537432|2231487|P2|Overall Study|Withdrawal by Subject|1
687079|NCT01537432|2231488|P1|Overall Study|Withdrawal by Subject|0
687080|NCT01537432|2231487|P2|Overall Study|Lost to Follow-up|1
687081|NCT01537432|2231488|P1|Overall Study|Lost to Follow-up|3
687082|NCT01537302|2231524|P1|Overall Study|Withdrawal by Subject|1
687083|NCT01537302|2231524|P1|Overall Study|Lost to Follow-up|1
687084|NCT01537198|2231531|P1|Overall Study|Not Specified|111
687085|NCT01537198|2231531|P1|Overall Study|No Further Visits to the Clinic|37
687086|NCT01537198|2231531|P1|Overall Study|Adverse Event|4
687087|NCT01537198|2231531|P1|Overall Study|RSV infection|2
687088|NCT01537133|2231560|P4|Overall Study|Lost to Follow-up|0
687089|NCT01537133|2231561|P3|Overall Study|Lost to Follow-up|0
687090|NCT01537133|2231562|P2|Overall Study|Lost to Follow-up|0
687091|NCT01537133|2231563|P1|Overall Study|Lost to Follow-up|1
687092|NCT01537133|2231560|P4|Overall Study|Withdrawal by Subject|0
687093|NCT01537133|2231561|P3|Overall Study|Withdrawal by Subject|0
687094|NCT01537133|2231562|P2|Overall Study|Withdrawal by Subject|0
687095|NCT01537133|2231563|P1|Overall Study|Withdrawal by Subject|2
687096|NCT01537120|2231579|P1|3 Weeks Placebo|Withdrawal by Subject|1
687097|NCT01537120|2231579|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
687098|NCT01537081|2231592|P3|Overall Study|Assigned but never dosed|0
687099|NCT01537081|2231593|P2|Overall Study|Assigned but never dosed|0
687100|NCT01537081|2231594|P1|Overall Study|Assigned but never dosed|1
687101|NCT01537081|2231592|P3|Overall Study|Sponsor decision|0
687102|NCT01537081|2231593|P2|Overall Study|Sponsor decision|1
687103|NCT01537081|2231594|P1|Overall Study|Sponsor decision|0
687104|NCT01537081|2231592|P3|Overall Study|Physician Decision|0
687105|NCT01537081|2231593|P2|Overall Study|Physician Decision|6
687106|NCT01537081|2231594|P1|Overall Study|Physician Decision|5
687107|NCT01537081|2231592|P3|Overall Study|Withdrawal by Subject|3
687108|NCT01537081|2231593|P2|Overall Study|Withdrawal by Subject|11
687109|NCT01537081|2231594|P1|Overall Study|Withdrawal by Subject|6
687110|NCT01537081|2231592|P3|Overall Study|Protocol Violation|2
687111|NCT01537081|2231593|P2|Overall Study|Protocol Violation|2
687112|NCT01537081|2231594|P1|Overall Study|Protocol Violation|3
687113|NCT01537081|2231592|P3|Overall Study|Lost to Follow-up|9
687114|NCT01537081|2231593|P2|Overall Study|Lost to Follow-up|15
687115|NCT01537081|2231594|P1|Overall Study|Lost to Follow-up|17
687116|NCT01537081|2231592|P3|Overall Study|Lack of Efficacy|0
687117|NCT01537081|2231593|P2|Overall Study|Lack of Efficacy|1
687118|NCT01537081|2231594|P1|Overall Study|Lack of Efficacy|2
687119|NCT01537081|2231592|P3|Overall Study|Adverse Event|2
687120|NCT01537081|2231593|P2|Overall Study|Adverse Event|2
687121|NCT01537081|2231594|P1|Overall Study|Adverse Event|5
687122|NCT01537068|2231607|P2|Overall Study|Lack of Efficacy|0
687123|NCT01537068|2231608|P1|Overall Study|Lack of Efficacy|1
687124|NCT01537068|2231607|P2|Overall Study|Withdrawal by Subject|1
687125|NCT01537068|2231608|P1|Overall Study|Withdrawal by Subject|1
687126|NCT01537068|2231607|P2|Overall Study|Adverse Event|1
687127|NCT01537068|2231608|P1|Overall Study|Adverse Event|0
687128|NCT01537068|2231607|P2|Overall Study|Lost to Follow-up|1
687129|NCT01537068|2231608|P1|Overall Study|Lost to Follow-up|2
687130|NCT01537042|2231620|P2|Overall Study|Other|1
687131|NCT01537042|2231621|P1|Overall Study|Other|0
687132|NCT01537042|2231620|P2|Overall Study|Protocol Violation|1
687133|NCT01537042|2231621|P1|Overall Study|Protocol Violation|0
687134|NCT01537042|2231620|P2|Overall Study|Lack of Efficacy|1
687135|NCT01537042|2231621|P1|Overall Study|Lack of Efficacy|0
687136|NCT01537042|2231620|P2|Overall Study|Adverse Event|2
687137|NCT01537042|2231621|P1|Overall Study|Adverse Event|0
687138|NCT01536951|2231659|P9|Second Intervention and Washout Period 2|Adverse Event|0
687139|NCT01536951|2231660|P8|Second Intervention and Washout Period 2|Adverse Event|1
687140|NCT01536951|2231661|P7|Second Intervention and Washout Period 2|Adverse Event|0
687141|NCT01536951|2231662|P6|Second Intervention and Washout Period 2|Adverse Event|0
687142|NCT01536951|2231663|P5|Second Intervention and Washout Period 2|Adverse Event|0
687143|NCT01536951|2231664|P4|Second Intervention and Washout Period 2|Adverse Event|0
687144|NCT01536951|2231665|P3|Second Intervention and Washout Period 2|Adverse Event|0
687145|NCT01536951|2231666|P2|Second Intervention and Washout Period 2|Adverse Event|0
687146|NCT01536951|2231667|P1|Second Intervention and Washout Period 2|Adverse Event|0
687147|NCT01536951|2231659|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
687148|NCT01536951|2231660|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
687149|NCT01536951|2231661|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
687150|NCT01536951|2231662|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
687151|NCT01536951|2231663|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
687152|NCT01536951|2231664|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
687153|NCT01536951|2231665|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
687154|NCT01536951|2231666|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
687155|NCT01536951|2231667|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
687156|NCT01536860|2231724|P3|Washout Period (3 Days)|Lost to Follow-up|0
687157|NCT01536860|2231725|P2|Washout Period (3 Days)|Lost to Follow-up|0
687158|NCT01536860|2231726|P1|Washout Period (3 Days)|Lost to Follow-up|1
687159|NCT01536704|2231734|P4|Washout Period 3|Adverse Event|0
687160|NCT01536704|2231735|P3|Washout Period 3|Adverse Event|1
687161|NCT01536704|2231736|P2|Washout Period 3|Adverse Event|0
687162|NCT01536704|2231737|P1|Washout Period 3|Adverse Event|0
687163|NCT01536704|2231734|P4|Period 3|Adverse Event|1
687164|NCT01536704|2231735|P3|Period 3|Adverse Event|0
687165|NCT01536704|2231736|P2|Period 3|Adverse Event|0
687166|NCT01536704|2231737|P1|Period 3|Adverse Event|0
687167|NCT01536704|2231734|P4|Washout Period 2|Withdrawal by Subject|1
687168|NCT01536704|2231735|P3|Washout Period 2|Withdrawal by Subject|0
687169|NCT01536704|2231736|P2|Washout Period 2|Withdrawal by Subject|0
687170|NCT01536704|2231737|P1|Washout Period 2|Withdrawal by Subject|0
687171|NCT01536704|2231734|P4|Washout Period 2|Adverse Event|0
687172|NCT01536704|2231735|P3|Washout Period 2|Adverse Event|0
687173|NCT01536704|2231736|P2|Washout Period 2|Adverse Event|0
687174|NCT01536704|2231737|P1|Washout Period 2|Adverse Event|1
687175|NCT01536704|2231734|P4|Washout Period 1|Withdrawal by Subject|0
687176|NCT01536704|2231735|P3|Washout Period 1|Withdrawal by Subject|0
687177|NCT01536704|2231736|P2|Washout Period 1|Withdrawal by Subject|2
687178|NCT01536704|2231737|P1|Washout Period 1|Withdrawal by Subject|1
687179|NCT01536587|2231767|P1|Overall Study|Adverse Event|2
687180|NCT01536574|2231806|P2|Overall Study|Lack of Efficacy|0
687181|NCT01536574|2231807|P1|Overall Study|Lack of Efficacy|1
687182|NCT01536574|2231806|P2|Overall Study|Withdrawal by Subject|2
687183|NCT01536574|2231807|P1|Overall Study|Withdrawal by Subject|1
687184|NCT01536574|2231806|P2|Overall Study|Adverse Event|5
687185|NCT01536574|2231807|P1|Overall Study|Adverse Event|4
687186|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
687187|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Death|2
687188|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
687189|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
687190|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
687191|NCT01536561|2231825|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
687192|NCT01536418|2231902|P2|Overall Study|Withdrawal by Subject|3
687193|NCT01536418|2231903|P1|Overall Study|Withdrawal by Subject|5
687194|NCT01536418|2231902|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
687195|NCT01536418|2231903|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
687196|NCT01536418|2231902|P2|Overall Study|Adverse Event|4
687197|NCT01536418|2231903|P1|Overall Study|Adverse Event|9
687198|NCT01536418|2231902|P2|Overall Study|Lack of Efficacy|16
687199|NCT01536418|2231903|P1|Overall Study|Lack of Efficacy|10
687200|NCT01536418|2231902|P2|Overall Study|Study closed/terminated|37
687201|NCT01536418|2231903|P1|Overall Study|Study closed/terminated|41
687202|NCT01536418|2231902|P2|Overall Study|Physician Decision|3
687203|NCT01536418|2231903|P1|Overall Study|Physician Decision|1
687204|NCT01536418|2231902|P2|Overall Study|Protocol Violation|3
687205|NCT01536418|2231903|P1|Overall Study|Protocol Violation|2
687206|NCT01536405|2231923|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
687207|NCT01536405|2231924|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
687208|NCT01536405|2231923|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
687209|NCT01536405|2231924|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
687210|NCT01536405|2231923|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
687211|NCT01536405|2231924|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
687212|NCT01536405|2231923|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
687213|NCT01536405|2231924|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
687214|NCT01536405|2231923|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
687215|NCT01536405|2231924|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
687216|NCT01536405|2231923|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
687217|NCT01536405|2231924|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
687218|NCT01536405|2231923|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
687219|NCT01536405|2231924|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
687220|NCT01536405|2231923|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
687221|NCT01536405|2231924|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
687222|NCT01536405|2231923|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
687223|NCT01536405|2231924|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
687224|NCT01536405|2231923|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
687225|NCT01536405|2231924|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
687226|NCT01536405|2231923|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
687227|NCT01536405|2231924|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
687228|NCT01536405|2231923|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
687229|NCT01536405|2231924|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
687230|NCT01536405|2231923|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
687231|NCT01536405|2231924|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
687232|NCT01536379|2231962|P2|Overall Study|Withdrawal by Subject|1
687233|NCT01536379|2231963|P1|Overall Study|Withdrawal by Subject|1
687234|NCT01536379|2231962|P2|Overall Study|Adverse Event|2
687235|NCT01536379|2231963|P1|Overall Study|Adverse Event|1
687236|NCT01536262|2232055|P3|Overall Study|Other than stated above|0
687237|NCT01536262|2232056|P2|Overall Study|Other than stated above|0
687238|NCT01536262|2232057|P1|Overall Study|Other than stated above|1
687239|NCT01536262|2232055|P3|Overall Study|Withdrawal by Subject|0
687240|NCT01536262|2232056|P2|Overall Study|Withdrawal by Subject|1
687241|NCT01536262|2232057|P1|Overall Study|Withdrawal by Subject|1
687242|NCT01536262|2232055|P3|Overall Study|Adverse Event|2
687243|NCT01536262|2232056|P2|Overall Study|Adverse Event|1
687244|NCT01536262|2232057|P1|Overall Study|Adverse Event|6
687245|NCT01536171|2232099|P1|Overall Study|Withdrawal by Subject|1
687246|NCT01536145|2232104|P11|Overall Study|Adverse Event|3
687247|NCT01536145|2232105|P10|Overall Study|Adverse Event|0
687248|NCT01536145|2232106|P9|Overall Study|Adverse Event|0
687249|NCT01536145|2232107|P8|Overall Study|Adverse Event|2
687250|NCT01536145|2232108|P7|Overall Study|Adverse Event|0
687251|NCT01536145|2232109|P6|Overall Study|Adverse Event|0
687252|NCT01536145|2232110|P5|Overall Study|Adverse Event|0
687253|NCT01536145|2232111|P4|Overall Study|Adverse Event|0
687254|NCT01536145|2232112|P3|Overall Study|Adverse Event|0
687255|NCT01536145|2232113|P2|Overall Study|Adverse Event|0
687256|NCT01536145|2232114|P1|Overall Study|Adverse Event|0
687257|NCT01536145|2232104|P11|Overall Study|Death|0
687258|NCT01536145|2232105|P10|Overall Study|Death|0
687259|NCT01536145|2232106|P9|Overall Study|Death|0
687260|NCT01536145|2232107|P8|Overall Study|Death|0
687261|NCT01536145|2232108|P7|Overall Study|Death|1
687262|NCT01536145|2232109|P6|Overall Study|Death|0
687263|NCT01536145|2232110|P5|Overall Study|Death|0
687264|NCT01536145|2232111|P4|Overall Study|Death|0
687265|NCT01536145|2232112|P3|Overall Study|Death|0
687266|NCT01536145|2232113|P2|Overall Study|Death|0
687267|NCT01536145|2232114|P1|Overall Study|Death|0
687268|NCT01536145|2232104|P11|Overall Study|Unspecified|2
687269|NCT01536145|2232105|P10|Overall Study|Unspecified|3
687270|NCT01536145|2232106|P9|Overall Study|Unspecified|0
687271|NCT01536145|2232107|P8|Overall Study|Unspecified|0
687272|NCT01536145|2232108|P7|Overall Study|Unspecified|0
687273|NCT01536145|2232109|P6|Overall Study|Unspecified|0
687274|NCT01536145|2232110|P5|Overall Study|Unspecified|1
687275|NCT01536145|2232111|P4|Overall Study|Unspecified|0
687276|NCT01536145|2232112|P3|Overall Study|Unspecified|0
687277|NCT01536145|2232113|P2|Overall Study|Unspecified|0
687278|NCT01536145|2232114|P1|Overall Study|Unspecified|0
687279|NCT01536145|2232104|P11|Overall Study|Withdrawal by Subject|2
687280|NCT01536145|2232105|P10|Overall Study|Withdrawal by Subject|0
687281|NCT01536145|2232106|P9|Overall Study|Withdrawal by Subject|2
687282|NCT01536145|2232107|P8|Overall Study|Withdrawal by Subject|0
687283|NCT01536145|2232108|P7|Overall Study|Withdrawal by Subject|0
687284|NCT01536145|2232109|P6|Overall Study|Withdrawal by Subject|1
687285|NCT01536145|2232110|P5|Overall Study|Withdrawal by Subject|0
687286|NCT01536145|2232111|P4|Overall Study|Withdrawal by Subject|0
687287|NCT01536145|2232112|P3|Overall Study|Withdrawal by Subject|1
687288|NCT01536145|2232113|P2|Overall Study|Withdrawal by Subject|0
687289|NCT01536145|2232114|P1|Overall Study|Withdrawal by Subject|0
687290|NCT01536145|2232104|P11|Overall Study|Progressive disease|3
687291|NCT01536145|2232105|P10|Overall Study|Progressive disease|3
687292|NCT01536145|2232106|P9|Overall Study|Progressive disease|1
687293|NCT01536145|2232107|P8|Overall Study|Progressive disease|2
687294|NCT01536145|2232108|P7|Overall Study|Progressive disease|1
687295|NCT01536145|2232109|P6|Overall Study|Progressive disease|2
687296|NCT01536145|2232110|P5|Overall Study|Progressive disease|1
687297|NCT01536145|2232111|P4|Overall Study|Progressive disease|2
687298|NCT01536145|2232112|P3|Overall Study|Progressive disease|1
687299|NCT01536145|2232113|P2|Overall Study|Progressive disease|4
687300|NCT01536145|2232114|P1|Overall Study|Progressive disease|3
687301|NCT01536119|2232221|P2|Overall Study|Lost to Follow-up|14
687302|NCT01536119|2232222|P1|Overall Study|Lost to Follow-up|17
687303|NCT01536093|2232248|P2|Overall Study|Withdrawal by Subject|1
687304|NCT01536093|2232249|P1|Overall Study|Withdrawal by Subject|0
687305|NCT01536093|2232248|P2|Overall Study|absence of maternal colostrum|0
687306|NCT01536093|2232249|P1|Overall Study|absence of maternal colostrum|2
687307|NCT01536093|2232248|P2|Overall Study|Death|2
687308|NCT01536093|2232249|P1|Overall Study|Death|1
687309|NCT01536067|2232265|P1|Overall Study|Disease Progression|1
687310|NCT01536015|2232278|P2|Overall Study|Study closure|5
687311|NCT01536015|2232279|P1|Overall Study|Study closure|5
687312|NCT01536015|2232278|P2|Overall Study|Inclusion Criterion not met|0
687313|NCT01536015|2232279|P1|Overall Study|Inclusion Criterion not met|2
687314|NCT01536015|2232278|P2|Overall Study|Lost to Follow-up|1
687315|NCT01536015|2232279|P1|Overall Study|Lost to Follow-up|0
687316|NCT01536015|2232278|P2|Overall Study|Adverse Event|4
687317|NCT01536015|2232279|P1|Overall Study|Adverse Event|1
687318|NCT01535807|2232306|P2|Overall Study|Data collection error|1
687319|NCT01535807|2232307|P1|Overall Study|Data collection error|1
687320|NCT01535807|2232306|P2|Overall Study|Withdrawal by Subject|1
687321|NCT01535807|2232307|P1|Overall Study|Withdrawal by Subject|1
687322|NCT01535729|2232313|P1|Overall Study|No participant record available|5
687323|NCT01535729|2232313|P1|Overall Study|Not treated|9
687324|NCT01535729|2232313|P1|Overall Study|Screening failure|1
687325|NCT01535729|2232313|P1|Overall Study|Protocol Violation|11
687326|NCT01535729|2232313|P1|Overall Study|NSCLC grade IV histology not confirmed|20
687327|NCT01535729|2232313|P1|Overall Study|No previous chemotherapy|33
687328|NCT01535729|2232313|P1|Overall Study|Did not sign informed consent|1
687329|NCT01535729|2232313|P1|Overall Study|Unspecified|19
687330|NCT01535729|2232313|P1|Overall Study|Death|52
687331|NCT01535729|2232313|P1|Overall Study|Lost to Follow-up|8
687332|NCT01535729|2232313|P1|Overall Study|Discontinued treatment|25
687333|NCT01535729|2232313|P1|Overall Study|Disease progression|230
687334|NCT01535729|2232313|P1|Overall Study|Withdrawal by Subject|2
687335|NCT01535638|2232354|P6|Treatment 3 (Single Dose)|Protocol Violation|0
687336|NCT01535638|2232355|P5|Treatment 3 (Single Dose)|Protocol Violation|0
687337|NCT01535638|2232356|P4|Treatment 3 (Single Dose)|Protocol Violation|1
687338|NCT01535638|2232357|P3|Treatment 3 (Single Dose)|Protocol Violation|0
687339|NCT01535638|2232358|P2|Treatment 3 (Single Dose)|Protocol Violation|0
687340|NCT01535638|2232359|P1|Treatment 3 (Single Dose)|Protocol Violation|0
687341|NCT01535638|2232354|P6|Treatment 1 (Single Dose)|Protocol Violation|1
687342|NCT01535638|2232355|P5|Treatment 1 (Single Dose)|Protocol Violation|0
687343|NCT01535638|2232356|P4|Treatment 1 (Single Dose)|Protocol Violation|0
687344|NCT01535638|2232357|P3|Treatment 1 (Single Dose)|Protocol Violation|0
687345|NCT01535638|2232358|P2|Treatment 1 (Single Dose)|Protocol Violation|0
687346|NCT01535638|2232359|P1|Treatment 1 (Single Dose)|Protocol Violation|0
687347|NCT01535599|2232373|P2|Overall Study|Noncompliance|1
687348|NCT01535599|2232374|P1|Overall Study|Noncompliance|0
687349|NCT01535599|2232373|P2|Overall Study|Stopped medication|1
687350|NCT01535599|2232374|P1|Overall Study|Stopped medication|0
687351|NCT01535599|2232373|P2|Overall Study|Unspecified|0
687352|NCT01535599|2232374|P1|Overall Study|Unspecified|1
687353|NCT01535599|2232373|P2|Overall Study|Did not use product|0
687354|NCT01535599|2232374|P1|Overall Study|Did not use product|1
687355|NCT01535599|2232373|P2|Overall Study|Randomized in Error|4
687356|NCT01535599|2232374|P1|Overall Study|Randomized in Error|2
687357|NCT01535599|2232373|P2|Overall Study|BL Culture + for Yeast//Fungi|1
687358|NCT01535599|2232374|P1|Overall Study|BL Culture + for Yeast//Fungi|0
687359|NCT01535599|2232373|P2|Overall Study|BL Culture + for Group A Strep|1
687360|NCT01535599|2232374|P1|Overall Study|BL Culture + for Group A Strep|0
687361|NCT01535599|2232373|P2|Overall Study|Treatment Failure|66
687362|NCT01535599|2232374|P1|Overall Study|Treatment Failure|33
687363|NCT01535599|2232373|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
687364|NCT01535599|2232374|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
687365|NCT01535599|2232373|P2|Overall Study|Lost to Follow-up|4
687366|NCT01535599|2232374|P1|Overall Study|Lost to Follow-up|3
687367|NCT01535599|2232373|P2|Overall Study|Adverse Event|15
687368|NCT01535599|2232374|P1|Overall Study|Adverse Event|6
687369|NCT01535560|2232386|P2|Overall Study|Randomized in Error|1
687370|NCT01535560|2232387|P1|Overall Study|Randomized in Error|0
687371|NCT01535560|2232386|P2|Overall Study|Other|1
687372|NCT01535560|2232387|P1|Overall Study|Other|0
687373|NCT01535560|2232386|P2|Overall Study|Treatment Failure|83
687374|NCT01535560|2232387|P1|Overall Study|Treatment Failure|21
687375|NCT01535560|2232386|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
687376|NCT01535560|2232387|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
687377|NCT01535560|2232386|P2|Overall Study|Lost to Follow-up|3
687378|NCT01535560|2232387|P1|Overall Study|Lost to Follow-up|1
687379|NCT01535560|2232386|P2|Overall Study|Adverse Event|7
687380|NCT01535560|2232387|P1|Overall Study|Adverse Event|12
687381|NCT01535261|2232430|P1|Overall Study|Adverse Event|12
687382|NCT01535261|2232430|P1|Overall Study|Withdrawal by Subject|14
687383|NCT01535261|2232430|P1|Overall Study|Lost to Follow-up|8
687384|NCT01535261|2232430|P1|Overall Study|Death|5
687385|NCT01535261|2232430|P1|Overall Study|Protocol Violation|3
687386|NCT01535261|2232430|P1|Overall Study|Physician Decision|8
687387|NCT01535235|2232443|P2|Overall Study|Adverse Event|0
687388|NCT01535235|2232444|P1|Overall Study|Adverse Event|1
687389|NCT01535222|2232458|P6|Overall Study|Inclusion/exclusion|0
687390|NCT01535222|2232459|P5|Overall Study|Inclusion/exclusion|0
687391|NCT01535222|2232460|P4|Overall Study|Inclusion/exclusion|0
687392|NCT01535222|2232461|P3|Overall Study|Inclusion/exclusion|1
687393|NCT01535222|2232462|P2|Overall Study|Inclusion/exclusion|0
687394|NCT01535222|2232463|P1|Overall Study|Inclusion/exclusion|0
687395|NCT01535040|2232494|P2|Overall Study|Multiple Reasons|1
687396|NCT01535040|2232495|P1|Overall Study|Multiple Reasons|1
687397|NCT01535040|2232494|P2|Overall Study|Toxicity|5
687398|NCT01535040|2232495|P1|Overall Study|Toxicity|7
687399|NCT01535040|2232494|P2|Overall Study|Never Started|4
687400|NCT01535040|2232495|P1|Overall Study|Never Started|9
687401|NCT01535040|2232494|P2|Overall Study|Withdrawal by Subject|10
687402|NCT01535040|2232495|P1|Overall Study|Withdrawal by Subject|13
687403|NCT01535040|2232494|P2|Overall Study|Physician Decision|1
687404|NCT01535040|2232495|P1|Overall Study|Physician Decision|0
687405|NCT01534962|2232536|P4|Overall Study|Discontinued at AF recurrence|31
687406|NCT01534962|2232537|P3|Overall Study|Discontinued at AF recurrence|24
687407|NCT01534962|2232538|P2|Overall Study|Discontinued at AF recurrence|26
687408|NCT01534962|2232539|P1|Overall Study|Discontinued at AF recurrence|35
687409|NCT01534962|2232536|P4|Overall Study|Randomized but did not start treatment|1
687410|NCT01534962|2232537|P3|Overall Study|Randomized but did not start treatment|0
687411|NCT01534962|2232538|P2|Overall Study|Randomized but did not start treatment|0
687412|NCT01534962|2232539|P1|Overall Study|Randomized but did not start treatment|2
687413|NCT01534676|2232596|P2|Overall Study|Study closed due to poor enrollment|1
687414|NCT01534676|2232597|P1|Overall Study|Study closed due to poor enrollment|2
687415|NCT01534637|2232603|P1|Overall Study|Liver Mets before treatment|1
687416|NCT01534637|2232603|P1|Overall Study|Adverse Event|1
687417|NCT01534637|2232603|P1|Overall Study|Withdrawal by Subject|1
687418|NCT01534637|2232603|P1|Overall Study|Lack of Efficacy|3
687419|NCT01534637|2232603|P1|Overall Study|Physician Decision|3
687420|NCT01534533|2232613|P4|Overall Study|Withdrawal by Subject|1
687421|NCT01534533|2232614|P3|Overall Study|Withdrawal by Subject|4
687422|NCT01534533|2232615|P2|Overall Study|Withdrawal by Subject|3
687423|NCT01534533|2232616|P1|Overall Study|Withdrawal by Subject|5
687424|NCT01534533|2232613|P4|Overall Study|Lost to Follow-up|3
687425|NCT01534533|2232614|P3|Overall Study|Lost to Follow-up|4
687426|NCT01534533|2232615|P2|Overall Study|Lost to Follow-up|0
687427|NCT01534533|2232616|P1|Overall Study|Lost to Follow-up|3
687428|NCT01534520|2232644|P2|Overall Study|Adverse Event|1
687429|NCT01534520|2232645|P1|Overall Study|Adverse Event|0
687430|NCT01534351|2232660|P3|Overall Study|Study Terminated Early|0
687431|NCT01534351|2232661|P2|Overall Study|Study Terminated Early|0
687432|NCT01534351|2232662|P1|Overall Study|Study Terminated Early|1
687433|NCT01534208|2232681|P2|Overall Study|Needed prohibited meds|0
687434|NCT01534208|2232682|P1|Overall Study|Needed prohibited meds|1
687435|NCT01534208|2232681|P2|Overall Study|PCP decision|0
687436|NCT01534208|2232682|P1|Overall Study|PCP decision|1
687437|NCT01534208|2232681|P2|Overall Study|Eligibility error|0
687438|NCT01534208|2232682|P1|Overall Study|Eligibility error|3
687439|NCT01534208|2232681|P2|Overall Study|Lab assessment|1
687440|NCT01534208|2232682|P1|Overall Study|Lab assessment|2
687441|NCT01534208|2232681|P2|Overall Study|Subject relocation|0
687442|NCT01534208|2232682|P1|Overall Study|Subject relocation|2
687443|NCT01534208|2232681|P2|Overall Study|Sponsor decision|1
687444|NCT01534208|2232682|P1|Overall Study|Sponsor decision|4
687445|NCT01534208|2232681|P2|Overall Study|Protocol Violation|2
687446|NCT01534208|2232682|P1|Overall Study|Protocol Violation|2
687447|NCT01534208|2232681|P2|Overall Study|Lack of Efficacy|3
687448|NCT01534208|2232682|P1|Overall Study|Lack of Efficacy|0
687449|NCT01534208|2232681|P2|Overall Study|Physician Decision|0
687450|NCT01534208|2232682|P1|Overall Study|Physician Decision|2
687451|NCT01534208|2232681|P2|Overall Study|Adverse Event|8
687452|NCT01534208|2232682|P1|Overall Study|Adverse Event|15
687453|NCT01534208|2232681|P2|Overall Study|Withdrawal by Subject|20
687454|NCT01534208|2232682|P1|Overall Study|Withdrawal by Subject|6
687455|NCT01534208|2232681|P2|Overall Study|Lost to Follow-up|14
687456|NCT01534208|2232682|P1|Overall Study|Lost to Follow-up|19
687457|NCT01534182|2232700|P2|Overall Study|Adverse Event|3
687458|NCT01534182|2232701|P1|Overall Study|Adverse Event|7
687459|NCT01534182|2232700|P2|Overall Study|Withdrawal by Subject|7
687460|NCT01534182|2232701|P1|Overall Study|Withdrawal by Subject|4
687461|NCT01534182|2232700|P2|Overall Study|Administrative problems|0
687462|NCT01534182|2232701|P1|Overall Study|Administrative problems|1
687463|NCT01534078|2232732|P1|Overall Study|Withdrawal by Subject|1
687464|NCT01534078|2232732|P1|Overall Study|Death|1
687465|NCT01533935|2232748|P5|Overall Study|Other reason not defined above|1
687466|NCT01533935|2232749|P4|Overall Study|Other reason not defined above|0
687467|NCT01533935|2232750|P3|Overall Study|Other reason not defined above|1
687468|NCT01533935|2232751|P2|Overall Study|Other reason not defined above|0
687469|NCT01533935|2232752|P1|Overall Study|Other reason not defined above|1
687470|NCT01533935|2232748|P5|Overall Study|Withdrawal by Subject|4
687471|NCT01533935|2232749|P4|Overall Study|Withdrawal by Subject|2
687472|NCT01533935|2232750|P3|Overall Study|Withdrawal by Subject|5
687473|NCT01533935|2232751|P2|Overall Study|Withdrawal by Subject|4
687474|NCT01533935|2232752|P1|Overall Study|Withdrawal by Subject|0
687475|NCT01533935|2232748|P5|Overall Study|Lost to Follow-up|0
687476|NCT01533935|2232749|P4|Overall Study|Lost to Follow-up|0
687477|NCT01533935|2232750|P3|Overall Study|Lost to Follow-up|1
687478|NCT01533935|2232751|P2|Overall Study|Lost to Follow-up|0
687479|NCT01533935|2232752|P1|Overall Study|Lost to Follow-up|0
687480|NCT01533935|2232748|P5|Overall Study|Protocol Violation|0
687481|NCT01533935|2232749|P4|Overall Study|Protocol Violation|0
687482|NCT01533935|2232750|P3|Overall Study|Protocol Violation|0
687483|NCT01533935|2232751|P2|Overall Study|Protocol Violation|2
687484|NCT01533935|2232752|P1|Overall Study|Protocol Violation|0
687485|NCT01533935|2232748|P5|Overall Study|Adverse Event|3
687486|NCT01533935|2232749|P4|Overall Study|Adverse Event|5
687487|NCT01533935|2232750|P3|Overall Study|Adverse Event|1
687488|NCT01533935|2232751|P2|Overall Study|Adverse Event|7
687489|NCT01533935|2232752|P1|Overall Study|Adverse Event|5
687490|NCT01533922|2232779|P5|Overall Study|Other reason not defined above|0
687491|NCT01533922|2232780|P4|Overall Study|Other reason not defined above|0
687492|NCT01533922|2232781|P3|Overall Study|Other reason not defined above|1
687493|NCT01533922|2232782|P2|Overall Study|Other reason not defined above|0
687494|NCT01533922|2232783|P1|Overall Study|Other reason not defined above|2
687495|NCT01533922|2232779|P5|Overall Study|Withdrawal by Subject|1
687496|NCT01533922|2232780|P4|Overall Study|Withdrawal by Subject|2
687497|NCT01533922|2232781|P3|Overall Study|Withdrawal by Subject|2
687498|NCT01533922|2232782|P2|Overall Study|Withdrawal by Subject|1
687499|NCT01533922|2232783|P1|Overall Study|Withdrawal by Subject|3
687500|NCT01533922|2232779|P5|Overall Study|Protocol Violation|1
687501|NCT01533922|2232780|P4|Overall Study|Protocol Violation|0
687502|NCT01533922|2232781|P3|Overall Study|Protocol Violation|0
687503|NCT01533922|2232782|P2|Overall Study|Protocol Violation|3
687504|NCT01533922|2232783|P1|Overall Study|Protocol Violation|0
687505|NCT01533922|2232779|P5|Overall Study|Lack of Efficacy|0
687506|NCT01533922|2232780|P4|Overall Study|Lack of Efficacy|0
687507|NCT01533922|2232781|P3|Overall Study|Lack of Efficacy|1
687508|NCT01533922|2232782|P2|Overall Study|Lack of Efficacy|0
687509|NCT01533922|2232783|P1|Overall Study|Lack of Efficacy|0
687510|NCT01533922|2232779|P5|Overall Study|Adverse Event|4
687511|NCT01533922|2232780|P4|Overall Study|Adverse Event|3
687512|NCT01533922|2232781|P3|Overall Study|Adverse Event|6
687513|NCT01533922|2232782|P2|Overall Study|Adverse Event|8
687514|NCT01533922|2232783|P1|Overall Study|Adverse Event|5
687515|NCT01533493|2232846|P2|Overall Study|Lost to Follow-up|0
687516|NCT01533493|2232847|P1|Overall Study|Lost to Follow-up|2
687517|NCT01533493|2232846|P2|Overall Study|Withdrawal by Subject|2
687518|NCT01533493|2232847|P1|Overall Study|Withdrawal by Subject|1
687519|NCT01533493|2232846|P2|Overall Study|Adverse Event|1
687520|NCT01533493|2232847|P1|Overall Study|Adverse Event|2
687521|NCT01533428|2232855|P2|Overall Study|Withdrawal by Subject|6
687522|NCT01533428|2232856|P1|Overall Study|Withdrawal by Subject|7
687523|NCT01533428|2232855|P2|Overall Study|Lost to Follow-up|1
687524|NCT01533428|2232856|P1|Overall Study|Lost to Follow-up|2
687525|NCT01533428|2232855|P2|Overall Study|Adverse Event|1
687526|NCT01533428|2232856|P1|Overall Study|Adverse Event|0
687527|NCT01533246|2232902|P1|Overall Study|Withdrawal by Subject|1
687528|NCT01533246|2232902|P1|Overall Study|Adverse Event|1
687529|NCT01533181|2232913|P2|Overall Study|Patient withdrawal pre-active treatment|0
687530|NCT01533181|2232914|P1|Overall Study|Patient withdrawal pre-active treatment|1
687531|NCT01533181|2232913|P2|Overall Study|Disease progression pre-active treatment|1
687532|NCT01533181|2232914|P1|Overall Study|Disease progression pre-active treatment|0
687533|NCT01532999|2233031|P2|Overall Study|New job|2
687534|NCT01532999|2233032|P1|Overall Study|New job|0
687535|NCT01532999|2233031|P2|Overall Study|incarcerated|1
687536|NCT01532999|2233032|P1|Overall Study|incarcerated|0
687537|NCT01532999|2233031|P2|Overall Study|Adverse Event|1
687538|NCT01532999|2233032|P1|Overall Study|Adverse Event|0
687539|NCT01532999|2233031|P2|Overall Study|no show for week 9 assessments|4
687540|NCT01532999|2233032|P1|Overall Study|no show for week 9 assessments|6
687541|NCT01532999|2233031|P2|Overall Study|substantial noncompliance|0
687542|NCT01532999|2233032|P1|Overall Study|substantial noncompliance|2
687543|NCT01532999|2233031|P2|Overall Study|should not have been randomized|0
687544|NCT01532999|2233032|P1|Overall Study|should not have been randomized|1
687545|NCT01532999|2233031|P2|Overall Study|Relocated|0
687546|NCT01532999|2233032|P1|Overall Study|Relocated|2
687547|NCT01532999|2233031|P2|Overall Study|Withdrawal by Subject|0
687548|NCT01532999|2233032|P1|Overall Study|Withdrawal by Subject|5
687549|NCT01532999|2233031|P2|Overall Study|Physician Decision|2
687550|NCT01532999|2233032|P1|Overall Study|Physician Decision|1
687551|NCT01532999|2233031|P2|Overall Study|Lost to Follow-up|8
687552|NCT01532999|2233032|P1|Overall Study|Lost to Follow-up|14
687553|NCT01532934|2233114|P2|Overall Study|In controlled environment|2
687554|NCT01532934|2233115|P1|Overall Study|In controlled environment|3
687555|NCT01532934|2233114|P2|Overall Study|Lost to Follow-up|11
687556|NCT01532934|2233115|P1|Overall Study|Lost to Follow-up|11
687557|NCT01532869|2233127|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
687558|NCT01532869|2233128|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
687559|NCT01532869|2233127|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
687560|NCT01532869|2233128|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
687561|NCT01532869|2233127|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
687562|NCT01532869|2233128|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
687563|NCT01532869|2233127|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
687564|NCT01532869|2233128|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
687565|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
687566|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
687567|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
687568|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
687569|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
687570|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
687571|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
687572|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
687573|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
687574|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
687575|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
687576|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
687577|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
687578|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
687579|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
687580|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
687581|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
687582|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
687583|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
687584|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
687585|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
687586|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
687587|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
687588|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
687589|NCT01532869|2233127|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
687590|NCT01532869|2233128|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
687591|NCT01532570|2233181|P4|Overall Study|Withdrawal by Subject|0
687592|NCT01532570|2233182|P3|Overall Study|Withdrawal by Subject|0
687593|NCT01532570|2233183|P2|Overall Study|Withdrawal by Subject|1
687594|NCT01532570|2233184|P1|Overall Study|Withdrawal by Subject|0
687595|NCT01532570|2233181|P4|Overall Study|Lack of Efficacy|0
687596|NCT01532570|2233182|P3|Overall Study|Lack of Efficacy|0
687597|NCT01532570|2233183|P2|Overall Study|Lack of Efficacy|0
687598|NCT01532570|2233184|P1|Overall Study|Lack of Efficacy|1
687599|NCT01532414|2233229|P3|Overall Study|Withdrawn by sponsor|0
687600|NCT01532414|2233230|P2|Overall Study|Withdrawn by sponsor|0
687601|NCT01532414|2233231|P1|Overall Study|Withdrawn by sponsor|1
687602|NCT01532414|2233229|P3|Overall Study|Unable to complete 24 hour PK|1
687603|NCT01532414|2233230|P2|Overall Study|Unable to complete 24 hour PK|0
687604|NCT01532414|2233231|P1|Overall Study|Unable to complete 24 hour PK|0
687605|NCT01532414|2233229|P3|Overall Study|Adverse Event|1
687606|NCT01532414|2233230|P2|Overall Study|Adverse Event|1
687607|NCT01532414|2233231|P1|Overall Study|Adverse Event|0
687608|NCT01532414|2233229|P3|Overall Study|No V6 semen sample|0
687609|NCT01532414|2233230|P2|Overall Study|No V6 semen sample|1
687610|NCT01532414|2233231|P1|Overall Study|No V6 semen sample|0
687611|NCT01532414|2233229|P3|Overall Study|Withdrawal by Subject|0
687612|NCT01532414|2233230|P2|Overall Study|Withdrawal by Subject|0
687613|NCT01532414|2233231|P1|Overall Study|Withdrawal by Subject|3
687614|NCT01532414|2233229|P3|Overall Study|Lost to Follow-up|1
687615|NCT01532414|2233230|P2|Overall Study|Lost to Follow-up|0
687616|NCT01532414|2233231|P1|Overall Study|Lost to Follow-up|3
687617|NCT01531998|2233297|P1|Overall Study|Withdrawal by Subject|3
687618|NCT01531725|2233302|P1|Overall Study|Protocol Violation|5
687619|NCT01531387|2233309|P2|Overall Study|Early termination of study|11
687620|NCT01531387|2233310|P1|Overall Study|Early termination of study|11
687621|NCT01531205|2233402|P1|Overall Study|Did not proceed to surgery|1
687622|NCT01530997|2233411|P1|Overall Study|Withdrawal by Subject|1
687623|NCT01530997|2233411|P1|Overall Study|Physician Decision|1
687624|NCT01530464|2233455|P2|Washout (24h)|Withdrawal by Subject|1
687625|NCT01530464|2233456|P1|Washout (24h)|Withdrawal by Subject|0
687626|NCT01530464|2233455|P2|Washout (24h)|Withdrawal by Subject|0
687627|NCT01530464|2233456|P1|Washout (24h)|Withdrawal by Subject|1
687628|NCT01530334|2233508|P1|Overall Study|Progressive disease|47
687629|NCT01530334|2233508|P1|Overall Study|unknown reason|1
687630|NCT01530334|2233508|P1|Overall Study|Adverse Event|3
687631|NCT01530087|2233542|P1|Overall Study|Physician Decision|2
687632|NCT01529645|2233564|P10|Overall Study|Withdrawal by Subject|0
687633|NCT01529645|2233565|P9|Overall Study|Withdrawal by Subject|0
687634|NCT01529645|2233566|P8|Overall Study|Withdrawal by Subject|0
687635|NCT01529645|2233567|P7|Overall Study|Withdrawal by Subject|0
687636|NCT01529645|2233568|P6|Overall Study|Withdrawal by Subject|1
687637|NCT01529645|2233569|P5|Overall Study|Withdrawal by Subject|1
687638|NCT01529645|2233570|P4|Overall Study|Withdrawal by Subject|1
687639|NCT01529645|2233571|P3|Overall Study|Withdrawal by Subject|0
687640|NCT01529645|2233572|P2|Overall Study|Withdrawal by Subject|0
687641|NCT01529645|2233573|P1|Overall Study|Withdrawal by Subject|2
687642|NCT01529645|2233564|P10|Overall Study|SAE - Premature contractions|0
687643|NCT01529645|2233565|P9|Overall Study|SAE - Premature contractions|0
687644|NCT01529645|2233566|P8|Overall Study|SAE - Premature contractions|0
687645|NCT01529645|2233567|P7|Overall Study|SAE - Premature contractions|0
687646|NCT01529645|2233568|P6|Overall Study|SAE - Premature contractions|0
687647|NCT01529645|2233569|P5|Overall Study|SAE - Premature contractions|0
687648|NCT01529645|2233570|P4|Overall Study|SAE - Premature contractions|0
687649|NCT01529645|2233571|P3|Overall Study|SAE - Premature contractions|1
687650|NCT01529645|2233572|P2|Overall Study|SAE - Premature contractions|0
687651|NCT01529645|2233573|P1|Overall Study|SAE - Premature contractions|0
687652|NCT01529645|2233564|P10|Overall Study|Lost to Follow-up|0
687653|NCT01529645|2233565|P9|Overall Study|Lost to Follow-up|1
687654|NCT01529645|2233566|P8|Overall Study|Lost to Follow-up|0
687655|NCT01529645|2233567|P7|Overall Study|Lost to Follow-up|2
687656|NCT01529645|2233568|P6|Overall Study|Lost to Follow-up|0
687657|NCT01529645|2233569|P5|Overall Study|Lost to Follow-up|1
687658|NCT01529645|2233570|P4|Overall Study|Lost to Follow-up|1
687659|NCT01529645|2233571|P3|Overall Study|Lost to Follow-up|1
687660|NCT01529645|2233572|P2|Overall Study|Lost to Follow-up|1
687661|NCT01529645|2233573|P1|Overall Study|Lost to Follow-up|0
687662|NCT01529632|2233671|P2|Overall Study|Adverse Event|1
687663|NCT01529632|2233672|P1|Overall Study|Adverse Event|1
687664|NCT01529632|2233671|P2|Overall Study|Protocol Violation|1
687665|NCT01529632|2233672|P1|Overall Study|Protocol Violation|0
687666|NCT01529632|2233671|P2|Overall Study|Administrative problem|1
687667|NCT01529632|2233672|P1|Overall Study|Administrative problem|2
687668|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Unspecified|2
687669|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Unspecified|9
687670|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Unspecified|0
687671|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Unspecified|0
687672|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Protocol Violation|0
687673|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Protocol Violation|1
687674|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Protocol Violation|0
687675|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Protocol Violation|0
687676|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
687677|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
687678|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
687679|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
687680|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Pregnancy|0
687681|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Pregnancy|1
687682|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Pregnancy|0
687683|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Pregnancy|0
687684|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
687685|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
687686|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
687687|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
687688|NCT01529515|2233692|P4|DOUBLE BLIND PHASE|Adverse Event|0
687689|NCT01529515|2233693|P3|DOUBLE BLIND PHASE|Adverse Event|1
687690|NCT01529515|2233694|P2|DOUBLE BLIND PHASE|Adverse Event|0
687691|NCT01529515|2233695|P1|DOUBLE BLIND PHASE|Adverse Event|0
687692|NCT01529515|2233692|P4|MAINTENANCE PHASE|Unspecified|0
687693|NCT01529515|2233693|P3|MAINTENANCE PHASE|Unspecified|0
687694|NCT01529515|2233694|P2|MAINTENANCE PHASE|Unspecified|10
687695|NCT01529515|2233695|P1|MAINTENANCE PHASE|Unspecified|0
687696|NCT01529515|2233692|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
687697|NCT01529515|2233693|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
687698|NCT01529515|2233694|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
687699|NCT01529515|2233695|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
687700|NCT01529515|2233692|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
687701|NCT01529515|2233693|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
687702|NCT01529515|2233694|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
687703|NCT01529515|2233695|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
687704|NCT01529515|2233692|P4|MAINTENANCE PHASE|Protocol Violation|0
687705|NCT01529515|2233693|P3|MAINTENANCE PHASE|Protocol Violation|0
687706|NCT01529515|2233694|P2|MAINTENANCE PHASE|Protocol Violation|12
687707|NCT01529515|2233695|P1|MAINTENANCE PHASE|Protocol Violation|0
687708|NCT01529515|2233692|P4|MAINTENANCE PHASE|Lost to Follow-up|0
687709|NCT01529515|2233693|P3|MAINTENANCE PHASE|Lost to Follow-up|0
687710|NCT01529515|2233694|P2|MAINTENANCE PHASE|Lost to Follow-up|5
687711|NCT01529515|2233695|P1|MAINTENANCE PHASE|Lost to Follow-up|0
687712|NCT01529515|2233692|P4|MAINTENANCE PHASE|Lack of Efficacy|0
687713|NCT01529515|2233693|P3|MAINTENANCE PHASE|Lack of Efficacy|0
687714|NCT01529515|2233694|P2|MAINTENANCE PHASE|Lack of Efficacy|9
687715|NCT01529515|2233695|P1|MAINTENANCE PHASE|Lack of Efficacy|0
687716|NCT01529515|2233692|P4|MAINTENANCE PHASE|Adverse Event|0
687717|NCT01529515|2233693|P3|MAINTENANCE PHASE|Adverse Event|0
687718|NCT01529515|2233694|P2|MAINTENANCE PHASE|Adverse Event|10
687719|NCT01529515|2233695|P1|MAINTENANCE PHASE|Adverse Event|0
687720|NCT01529515|2233692|P4|TRANSITION PHASE|Unspecified|0
687721|NCT01529515|2233693|P3|TRANSITION PHASE|Unspecified|0
687722|NCT01529515|2233694|P2|TRANSITION PHASE|Unspecified|0
687723|NCT01529515|2233695|P1|TRANSITION PHASE|Unspecified|9
687724|NCT01529515|2233692|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
687725|NCT01529515|2233693|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
687726|NCT01529515|2233694|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
687727|NCT01529515|2233695|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
687728|NCT01529515|2233692|P4|TRANSITION PHASE|Withdrawal by Subject|0
687729|NCT01529515|2233693|P3|TRANSITION PHASE|Withdrawal by Subject|0
687730|NCT01529515|2233694|P2|TRANSITION PHASE|Withdrawal by Subject|0
687731|NCT01529515|2233695|P1|TRANSITION PHASE|Withdrawal by Subject|51
687732|NCT01529515|2233692|P4|TRANSITION PHASE|Protocol Violation|0
687733|NCT01529515|2233693|P3|TRANSITION PHASE|Protocol Violation|0
687734|NCT01529515|2233694|P2|TRANSITION PHASE|Protocol Violation|0
687735|NCT01529515|2233695|P1|TRANSITION PHASE|Protocol Violation|4
687736|NCT01529515|2233692|P4|TRANSITION PHASE|Lost to Follow-up|0
687737|NCT01529515|2233693|P3|TRANSITION PHASE|Lost to Follow-up|0
687738|NCT01529515|2233694|P2|TRANSITION PHASE|Lost to Follow-up|0
687739|NCT01529515|2233695|P1|TRANSITION PHASE|Lost to Follow-up|19
687740|NCT01529515|2233692|P4|TRANSITION PHASE|Lack of Efficacy|0
687741|NCT01529515|2233693|P3|TRANSITION PHASE|Lack of Efficacy|0
687742|NCT01529515|2233694|P2|TRANSITION PHASE|Lack of Efficacy|0
687743|NCT01529515|2233695|P1|TRANSITION PHASE|Lack of Efficacy|19
687744|NCT01529515|2233692|P4|TRANSITION PHASE|Death|0
687745|NCT01529515|2233693|P3|TRANSITION PHASE|Death|0
687746|NCT01529515|2233694|P2|TRANSITION PHASE|Death|0
687747|NCT01529515|2233695|P1|TRANSITION PHASE|Death|1
687748|NCT01529515|2233692|P4|TRANSITION PHASE|Adverse Event|0
687749|NCT01529515|2233693|P3|TRANSITION PHASE|Adverse Event|0
687750|NCT01529515|2233694|P2|TRANSITION PHASE|Adverse Event|0
687751|NCT01529515|2233695|P1|TRANSITION PHASE|Adverse Event|16
687752|NCT01529385|2233742|P2|Overall Study|Lost to Follow-up|1
687753|NCT01529385|2233743|P1|Overall Study|Lost to Follow-up|2
687754|NCT01529268|2233769|P2|Overall Study|Moved|0
687755|NCT01529268|2233770|P1|Overall Study|Moved|3
687756|NCT01529268|2233769|P2|Overall Study|Lost to Follow-up|3
687757|NCT01529268|2233770|P1|Overall Study|Lost to Follow-up|9
687758|NCT01529112|2233832|P2|Overall Study|Withdrawal by Subject|3
687759|NCT01529112|2233833|P1|Overall Study|Withdrawal by Subject|7
687760|NCT01529112|2233832|P2|Overall Study|Protocol Violation|0
687761|NCT01529112|2233833|P1|Overall Study|Protocol Violation|1
687762|NCT01529112|2233832|P2|Overall Study|Death|38
687763|NCT01529112|2233833|P1|Overall Study|Death|59
687764|NCT01529112|2233832|P2|Overall Study|Adverse Event|0
687765|NCT01529112|2233833|P1|Overall Study|Adverse Event|2
687766|NCT01528969|2233860|P2|Overall Study|absent from the school at baseline|0
687767|NCT01528969|2233861|P1|Overall Study|absent from the school at baseline|2
687768|NCT01528735|2233884|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
687769|NCT01528735|2233885|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
687770|NCT01528735|2233884|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
687771|NCT01528735|2233885|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
687772|NCT01528696|2233987|P2|Overall Study|See detailed description|19
687773|NCT01528696|2233988|P1|Overall Study|See detailed description|18
687774|NCT01528605|2234004|P6|Overall Study|Death|0
687775|NCT01528605|2234005|P5|Overall Study|Death|0
687776|NCT01528605|2234006|P4|Overall Study|Death|0
687777|NCT01528605|2234007|P3|Overall Study|Death|0
687778|NCT01528605|2234008|P2|Overall Study|Death|0
687779|NCT01528605|2234009|P1|Overall Study|Death|1
687780|NCT01528605|2234004|P6|Overall Study|Lost to Follow-up|0
687781|NCT01528605|2234005|P5|Overall Study|Lost to Follow-up|0
687782|NCT01528605|2234006|P4|Overall Study|Lost to Follow-up|1
687783|NCT01528605|2234007|P3|Overall Study|Lost to Follow-up|1
687784|NCT01528605|2234008|P2|Overall Study|Lost to Follow-up|0
687785|NCT01528605|2234009|P1|Overall Study|Lost to Follow-up|1
687786|NCT01528345|2234039|P2|Overall Study|Subject/Guardian Decision|0
687787|NCT01528345|2234040|P1|Overall Study|Subject/Guardian Decision|5
687788|NCT01528345|2234039|P2|Overall Study|Study Terminated by Sponsor|8
687789|NCT01528345|2234040|P1|Overall Study|Study Terminated by Sponsor|4
687790|NCT01528345|2234039|P2|Overall Study|Progressive Disease|40
687791|NCT01528345|2234040|P1|Overall Study|Progressive Disease|26
687792|NCT01528345|2234039|P2|Overall Study|Non-compliance with study treatment|0
687793|NCT01528345|2234040|P1|Overall Study|Non-compliance with study treatment|1
687794|NCT01528345|2234039|P2|Overall Study|Death|1
687795|NCT01528345|2234040|P1|Overall Study|Death|1
687796|NCT01528345|2234039|P2|Overall Study|Adverse Event|1
687797|NCT01528345|2234040|P1|Overall Study|Adverse Event|10
687798|NCT01527487|2234130|P2|Overall Study|Death|1
687799|NCT01527487|2234131|P1|Overall Study|Death|0
687800|NCT01527487|2234130|P2|Overall Study|Adverse Event|1
687801|NCT01527487|2234131|P1|Overall Study|Adverse Event|1
687802|NCT01527487|2234130|P2|Overall Study|Disease Progression|1
687803|NCT01527487|2234131|P1|Overall Study|Disease Progression|4
687804|NCT01527487|2234130|P2|Overall Study|MD Discretion/Lack of Efficacy|4
687805|NCT01527487|2234131|P1|Overall Study|MD Discretion/Lack of Efficacy|3
687806|NCT01527370|2234143|P1|Overall Study|Death|1
687807|NCT01527370|2234143|P1|Overall Study|Physician Decision|1
687808|NCT01527370|2234143|P1|Overall Study|Withdrawal by Subject|4
687809|NCT01527006|2234162|P2|Extension Phase|Not Specified|3
687810|NCT01527006|2234163|P1|Extension Phase|Not Specified|0
687811|NCT01527006|2234162|P2|Extension Phase|Inadequate therapeutic effect|1
687812|NCT01527006|2234163|P1|Extension Phase|Inadequate therapeutic effect|1
687813|NCT01527006|2234162|P2|Extension Phase|Subject Choice|1
687814|NCT01527006|2234163|P1|Extension Phase|Subject Choice|1
687815|NCT01527006|2234162|P2|Extension Phase|Lost to Follow-up|1
687816|NCT01527006|2234163|P1|Extension Phase|Lost to Follow-up|0
687817|NCT01527006|2234162|P2|Extension Phase|Adverse Event|2
687818|NCT01527006|2234163|P1|Extension Phase|Adverse Event|4
687819|NCT01527006|2234162|P2|Core Study|Not Specified|2
687820|NCT01527006|2234163|P1|Core Study|Not Specified|0
687821|NCT01527006|2234162|P2|Core Study|Withdrawal by Subject|1
687822|NCT01527006|2234163|P1|Core Study|Withdrawal by Subject|0
687823|NCT01527006|2234162|P2|Core Study|Inadequate Therapeutic Effect|0
687824|NCT01527006|2234163|P1|Core Study|Inadequate Therapeutic Effect|1
687825|NCT01527006|2234162|P2|Core Study|Subject Choice|0
687826|NCT01527006|2234163|P1|Core Study|Subject Choice|1
687827|NCT01527006|2234162|P2|Core Study|Lost to Follow-up|1
687828|NCT01527006|2234163|P1|Core Study|Lost to Follow-up|0
687829|NCT01527006|2234162|P2|Core Study|Adverse Event|2
687830|NCT01527006|2234163|P1|Core Study|Adverse Event|0
687831|NCT01526785|2234230|P1|Overall Study|Withdrawal by Subject|2
687832|NCT01526785|2234230|P1|Overall Study|Physician Decision|1
687833|NCT01526785|2234230|P1|Overall Study|Death|2
687834|NCT01526785|2234230|P1|Overall Study|Study Terminated by Sponsor|8
687835|NCT01526733|2234240|P2|Phase 1|Withdrawal by Subject|1
687836|NCT01526733|2234241|P1|Phase 1|Withdrawal by Subject|1
687837|NCT01526733|2234240|P2|Phase 1|Protocol Violation|0
687838|NCT01526733|2234241|P1|Phase 1|Protocol Violation|1
687839|NCT01526551|2234263|P1|Overall Study|Lack of returned parental consent form|424
687840|NCT01526148|2234310|P2|Overall Study|Incarcerated|2
687841|NCT01526148|2234311|P1|Overall Study|Incarcerated|0
687842|NCT01526148|2234310|P2|Overall Study|Moved out of state|0
687843|NCT01526148|2234311|P1|Overall Study|Moved out of state|1
687844|NCT01526148|2234310|P2|Overall Study|Unable to discontinue concomitant med|0
687845|NCT01526148|2234311|P1|Overall Study|Unable to discontinue concomitant med|1
687846|NCT01526148|2234310|P2|Overall Study|Unstable Medical Condition|0
687847|NCT01526148|2234311|P1|Overall Study|Unstable Medical Condition|1
687848|NCT01526148|2234310|P2|Overall Study|Withdrawal by Subject|0
687849|NCT01526148|2234311|P1|Overall Study|Withdrawal by Subject|2
687850|NCT01526148|2234310|P2|Overall Study|Lost to Follow-up|6
687851|NCT01526148|2234311|P1|Overall Study|Lost to Follow-up|3
687852|NCT01526148|2234310|P2|Overall Study|Adverse Event|5
687853|NCT01526148|2234311|P1|Overall Study|Adverse Event|6
687854|NCT01525849|2234328|P2|Overall Study|Anatomic exclusion criteria identified|3
687855|NCT01525849|2234329|P1|Overall Study|Anatomic exclusion criteria identified|0
687856|NCT01525849|2234328|P2|Overall Study|Unrelated medical issue (not treated)|2
687857|NCT01525849|2234329|P1|Overall Study|Unrelated medical issue (not treated)|1
687858|NCT01525849|2234328|P2|Overall Study|Withdrawal by Subject|9
687859|NCT01525849|2234329|P1|Overall Study|Withdrawal by Subject|1
687860|NCT01525849|2234328|P2|Overall Study|Lost to Follow-up|2
687861|NCT01525849|2234329|P1|Overall Study|Lost to Follow-up|3
687862|NCT01525641|2234385|P1|Overall Study|Other than stated above|7
687863|NCT01525641|2234385|P1|Overall Study|Lost to follow-up (Changing hospital)|19
687864|NCT01525641|2234385|P1|Overall Study|Lost to follow-up (Unknown reason)|10
687865|NCT01525641|2234385|P1|Overall Study|Lost to follow-up (relocation)|1
687866|NCT01525641|2234385|P1|Overall Study|Improvement|5
687867|NCT01525641|2234385|P1|Overall Study|Lack of Efficacy|24
687868|NCT01525641|2234385|P1|Overall Study|Adverse Event|73
687869|NCT01525641|2234385|P1|Overall Study|No visit since the first visit|16
687870|NCT01525641|2234385|P1|Overall Study|Case report form not collected|25
687871|NCT01525628|2234399|P5|Overall Study|Other reason not defined above|0
687872|NCT01525628|2234400|P4|Overall Study|Other reason not defined above|3
687873|NCT01525628|2234401|P3|Overall Study|Other reason not defined above|0
687874|NCT01525628|2234402|P2|Overall Study|Other reason not defined above|0
687875|NCT01525628|2234403|P1|Overall Study|Other reason not defined above|0
687876|NCT01525628|2234399|P5|Overall Study|Withdrawal by Subject|0
687877|NCT01525628|2234400|P4|Overall Study|Withdrawal by Subject|0
687878|NCT01525628|2234401|P3|Overall Study|Withdrawal by Subject|0
687879|NCT01525628|2234402|P2|Overall Study|Withdrawal by Subject|1
687880|NCT01525628|2234403|P1|Overall Study|Withdrawal by Subject|0
687881|NCT01525628|2234399|P5|Overall Study|Lost to Follow-up|0
687882|NCT01525628|2234400|P4|Overall Study|Lost to Follow-up|0
687883|NCT01525628|2234401|P3|Overall Study|Lost to Follow-up|0
687884|NCT01525628|2234402|P2|Overall Study|Lost to Follow-up|1
687885|NCT01525628|2234403|P1|Overall Study|Lost to Follow-up|1
687886|NCT01525628|2234399|P5|Overall Study|Protocol Violation|0
687887|NCT01525628|2234400|P4|Overall Study|Protocol Violation|0
687888|NCT01525628|2234401|P3|Overall Study|Protocol Violation|1
687889|NCT01525628|2234402|P2|Overall Study|Protocol Violation|0
687890|NCT01525628|2234403|P1|Overall Study|Protocol Violation|0
687891|NCT01525628|2234399|P5|Overall Study|Lack of Efficacy|2
687892|NCT01525628|2234400|P4|Overall Study|Lack of Efficacy|1
687893|NCT01525628|2234401|P3|Overall Study|Lack of Efficacy|2
687894|NCT01525628|2234402|P2|Overall Study|Lack of Efficacy|2
687895|NCT01525628|2234403|P1|Overall Study|Lack of Efficacy|0
687896|NCT01525628|2234399|P5|Overall Study|Adverse Event|1
687897|NCT01525628|2234400|P4|Overall Study|Adverse Event|0
687898|NCT01525628|2234401|P3|Overall Study|Adverse Event|2
687899|NCT01525628|2234402|P2|Overall Study|Adverse Event|1
687900|NCT01525628|2234403|P1|Overall Study|Adverse Event|1
687901|NCT01525615|2234470|P3|Overall Study|Other reason not described above|1
687902|NCT01525615|2234471|P2|Overall Study|Other reason not described above|0
687903|NCT01525615|2234472|P1|Overall Study|Other reason not described above|1
687904|NCT01525615|2234470|P3|Overall Study|Withdrawal by Subject|0
687905|NCT01525615|2234471|P2|Overall Study|Withdrawal by Subject|0
687906|NCT01525615|2234472|P1|Overall Study|Withdrawal by Subject|1
687907|NCT01525615|2234470|P3|Overall Study|Lost to Follow-up|0
687908|NCT01525615|2234471|P2|Overall Study|Lost to Follow-up|0
687909|NCT01525615|2234472|P1|Overall Study|Lost to Follow-up|1
687910|NCT01525615|2234470|P3|Overall Study|Adverse Event|5
687911|NCT01525615|2234471|P2|Overall Study|Adverse Event|7
687912|NCT01525615|2234472|P1|Overall Study|Adverse Event|11
687913|NCT01525550|2234528|P2|Overall Study|Ongoing|23
687914|NCT01525550|2234529|P1|Overall Study|Ongoing|45
687915|NCT01525550|2234528|P2|Overall Study|Other Unspecified|2
687916|NCT01525550|2234529|P1|Overall Study|Other Unspecified|0
687917|NCT01525550|2234528|P2|Overall Study|Death|19
687918|NCT01525550|2234529|P1|Overall Study|Death|10
687919|NCT01525550|2234528|P2|Overall Study|Lost to Follow-up|1
687920|NCT01525550|2234529|P1|Overall Study|Lost to Follow-up|4
687921|NCT01525550|2234528|P2|Overall Study|Withdrawal by Subject|0
687922|NCT01525550|2234529|P1|Overall Study|Withdrawal by Subject|2
687923|NCT01525407|2234600|P2|Overall Study|Delay in Transplant|0
687924|NCT01525407|2234601|P1|Overall Study|Delay in Transplant|1
687925|NCT01525407|2234600|P2|Overall Study|Transplant was delayed|1
687926|NCT01525407|2234601|P1|Overall Study|Transplant was delayed|0
687927|NCT01525407|2234600|P2|Overall Study|Withdrawal by Subject|1
687928|NCT01525407|2234601|P1|Overall Study|Withdrawal by Subject|0
687929|NCT01525407|2234600|P2|Overall Study|Change in recipient treatment plan|2
687930|NCT01525407|2234601|P1|Overall Study|Change in recipient treatment plan|2
687931|NCT01525238|2234618|P3|Overall Study|Withdrawal by Subject|0
687932|NCT01525238|2234619|P2|Overall Study|Withdrawal by Subject|0
687933|NCT01525238|2234620|P1|Overall Study|Withdrawal by Subject|1
687934|NCT01525225|2234685|P1|Enrollment|Not Specified|1
687935|NCT01525225|2234685|P1|Enrollment|No longer met study criteria|1
687936|NCT01524913|2234702|P3|Overall Study|Lost to Follow-up|0
687937|NCT01524913|2234703|P2|Overall Study|Lost to Follow-up|0
687938|NCT01524913|2234704|P1|Overall Study|Lost to Follow-up|4
687939|NCT01524900|2234726|P5|Overall Study|No reason documented|0
687940|NCT01524900|2234727|P4|Overall Study|No reason documented|1
687941|NCT01524900|2234728|P3|Overall Study|No reason documented|0
687942|NCT01524900|2234729|P2|Overall Study|No reason documented|1
687943|NCT01524900|2234730|P1|Overall Study|No reason documented|2
687944|NCT01524900|2234726|P5|Overall Study|Other reason than stated above|0
687945|NCT01524900|2234727|P4|Overall Study|Other reason than stated above|0
687946|NCT01524900|2234728|P3|Overall Study|Other reason than stated above|0
687947|NCT01524900|2234729|P2|Overall Study|Other reason than stated above|1
687948|NCT01524900|2234730|P1|Overall Study|Other reason than stated above|1
687949|NCT01524900|2234726|P5|Overall Study|Lost to Follow-up|0
687950|NCT01524900|2234727|P4|Overall Study|Lost to Follow-up|0
687951|NCT01524900|2234728|P3|Overall Study|Lost to Follow-up|1
687952|NCT01524900|2234729|P2|Overall Study|Lost to Follow-up|12
687953|NCT01524900|2234730|P1|Overall Study|Lost to Follow-up|3
687972|NCT01524796|2234821|P1|Overall Study|Adverse Event and Lack of Efficacy|1
687973|NCT01524796|2234821|P1|Overall Study|Switch to carbamazapine|1
687974|NCT01524796|2234821|P1|Overall Study|Nervous about confidentiality|1
687975|NCT01524796|2234821|P1|Overall Study|Gall stone surgery|1
687976|NCT01524796|2234821|P1|Overall Study|Deterioration of pains|1
687977|NCT01524796|2234821|P1|Overall Study|Move|1
687978|NCT01524796|2234821|P1|Overall Study|Withdrawal by Subject|4
687979|NCT01524796|2234821|P1|Overall Study|The price|1
687980|NCT01524796|2234821|P1|Overall Study|Lost to Follow-up|1
687981|NCT01524796|2234821|P1|Overall Study|Lack of Efficacy|3
687982|NCT01524796|2234821|P1|Overall Study|Adverse Event|13
687995|NCT01524770|2234859|P2|First Intervention|Protocol Violation|0
687996|NCT01524770|2234860|P1|First Intervention|Protocol Violation|1
687997|NCT01524770|2234859|P2|First Intervention|Adverse Event|1
687998|NCT01524770|2234860|P1|First Intervention|Adverse Event|1
687999|NCT01524770|2234859|P2|First Intervention|Withdrawal by Subject|0
688000|NCT01524770|2234860|P1|First Intervention|Withdrawal by Subject|1
688001|NCT01524627|2234872|P2|Overall Study|Lost to Follow-up|1
688002|NCT01524627|2234873|P1|Overall Study|Lost to Follow-up|1
688003|NCT01524627|2234872|P2|Overall Study|Physician Decision|1
688004|NCT01524627|2234873|P1|Overall Study|Physician Decision|0
688005|NCT01524198|2234900|P2|Overall Study|Withdrawal by Subject|10
688006|NCT01524198|2234901|P1|Overall Study|Withdrawal by Subject|15
688007|NCT01524198|2234900|P2|Overall Study|Protocol Violation|6
688008|NCT01524198|2234901|P1|Overall Study|Protocol Violation|8
688009|NCT01523886|2234941|P2|Overall Study|surgery cancelled|1
688010|NCT01523886|2234942|P1|Overall Study|surgery cancelled|0
688011|NCT01523873|2234948|P1|Overall Study|Protocol Violation|422
688012|NCT01523756|2234955|P2|Test Period 2|Withdrawal by Subject|1
688013|NCT01523756|2234956|P1|Test Period 2|Withdrawal by Subject|0
688014|NCT01523756|2234955|P2|Test Period 1|Adverse Event|0
688015|NCT01523756|2234956|P1|Test Period 1|Adverse Event|1
688016|NCT01523756|2234955|P2|Baseline Period|Adverse Event|1
688017|NCT01523756|2234956|P1|Baseline Period|Adverse Event|0
688018|NCT01523743|2234964|P2|Period 2|Adverse Event|0
688019|NCT01523743|2234965|P1|Period 2|Adverse Event|1
688020|NCT01523743|2234964|P2|Period 2|Withdrawal by Subject|2
688021|NCT01523743|2234965|P1|Period 2|Withdrawal by Subject|0
688022|NCT01523743|2234964|P2|Period 1|Felt unable to empty bladder|0
688023|NCT01523743|2234965|P1|Period 1|Felt unable to empty bladder|1
688024|NCT01523743|2234964|P2|Period 1|Lack of Efficacy|0
688025|NCT01523743|2234965|P1|Period 1|Lack of Efficacy|1
688026|NCT01523743|2234964|P2|Period 1|Lost to Follow-up|0
688027|NCT01523743|2234965|P1|Period 1|Lost to Follow-up|1
688028|NCT01523743|2234964|P2|Period 1|Withdrawal by Subject|2
688029|NCT01523743|2234965|P1|Period 1|Withdrawal by Subject|6
688030|NCT01523743|2234964|P2|Period 1|Adverse Event|0
688031|NCT01523743|2234965|P1|Period 1|Adverse Event|1
688032|NCT01523587|2234988|P2|Overall Study|Randomised but not treated|2
688033|NCT01523587|2234989|P1|Overall Study|Randomised but not treated|6
688034|NCT01523587|2234988|P2|Overall Study|no reason given|3
688035|NCT01523587|2234989|P1|Overall Study|no reason given|2
688036|NCT01523587|2234988|P2|Overall Study|Withdrawal by Subject|12
688037|NCT01523587|2234989|P1|Overall Study|Withdrawal by Subject|23
688038|NCT01523587|2234988|P2|Overall Study|Lost to Follow-up|2
688039|NCT01523587|2234989|P1|Overall Study|Lost to Follow-up|2
688040|NCT01523587|2234988|P2|Overall Study|Non Compliance with protocol|1
688041|NCT01523587|2234989|P1|Overall Study|Non Compliance with protocol|2
688042|NCT01523587|2234988|P2|Overall Study|Adverse Event|34
688043|NCT01523587|2234989|P1|Overall Study|Adverse Event|52
688044|NCT01523457|2235009|P2|Overall Study|Withdrawal by Subject|2
688045|NCT01523457|2235010|P1|Overall Study|Withdrawal by Subject|7
688046|NCT01523392|2235028|P2|Washout Period - 10 to 14 Days|Adverse Event|0
688047|NCT01523392|2235029|P1|Washout Period - 10 to 14 Days|Adverse Event|1
688048|NCT01523392|2235028|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
688049|NCT01523392|2235029|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
688050|NCT01523392|2235028|P2|Treatment Period 1|Withdrawal by Subject|0
688051|NCT01523392|2235029|P1|Treatment Period 1|Withdrawal by Subject|2
688052|NCT01523366|2235045|P2|Treatment Period 2|Not completed at least 7 days treatment|0
688053|NCT01523366|2235046|P1|Treatment Period 2|Not completed at least 7 days treatment|1
688054|NCT01523366|2235045|P2|Treatment Period 1|Withdrawal by Subject|0
688055|NCT01523366|2235046|P1|Treatment Period 1|Withdrawal by Subject|1
688056|NCT01523301|2235062|P2|Overall Study|Other Reason|2
688057|NCT01523301|2235063|P1|Overall Study|Other Reason|0
688058|NCT01523301|2235062|P2|Overall Study|Withdrawal by Subject|8
688059|NCT01523301|2235063|P1|Overall Study|Withdrawal by Subject|6
688060|NCT01523301|2235062|P2|Overall Study|Lost to Follow-up|0
688061|NCT01523301|2235063|P1|Overall Study|Lost to Follow-up|1
688062|NCT01523301|2235062|P2|Overall Study|Protocol Violation|4
688063|NCT01523301|2235063|P1|Overall Study|Protocol Violation|3
688064|NCT01523301|2235062|P2|Overall Study|Lack of Efficacy|2
688065|NCT01523301|2235063|P1|Overall Study|Lack of Efficacy|0
688066|NCT01523301|2235062|P2|Overall Study|Adverse Event|16
688067|NCT01523301|2235063|P1|Overall Study|Adverse Event|25
688068|NCT01522976|2235084|P3|Overall Study|Not protocol specified|27
688069|NCT01522976|2235085|P2|Overall Study|Not protocol specified|27
688070|NCT01522976|2235086|P1|Overall Study|Not protocol specified|22
688071|NCT01522976|2235084|P3|Overall Study|Refusal unrelated to adverse event|14
688072|NCT01522976|2235085|P2|Overall Study|Refusal unrelated to adverse event|13
688073|NCT01522976|2235086|P1|Overall Study|Refusal unrelated to adverse event|10
688074|NCT01522976|2235084|P3|Overall Study|Adverse Event|18
688075|NCT01522976|2235085|P2|Overall Study|Adverse Event|7
688076|NCT01522976|2235086|P1|Overall Study|Adverse Event|17
688077|NCT01522976|2235084|P3|Overall Study|Disease progression|25
688078|NCT01522976|2235085|P2|Overall Study|Disease progression|30
688079|NCT01522976|2235086|P1|Overall Study|Disease progression|28
688080|NCT01522976|2235084|P3|Overall Study|Still on treatment|6
688081|NCT01522976|2235085|P2|Overall Study|Still on treatment|9
688082|NCT01522976|2235086|P1|Overall Study|Still on treatment|9
688083|NCT01522976|2235084|P3|Overall Study|Death|2
688084|NCT01522976|2235085|P2|Overall Study|Death|6
688085|NCT01522976|2235086|P1|Overall Study|Death|7
688086|NCT01522976|2235084|P3|Overall Study|Ineligible|1
688087|NCT01522976|2235085|P2|Overall Study|Ineligible|0
688088|NCT01522976|2235086|P1|Overall Study|Ineligible|4
688089|NCT01522456|2235163|P1|Overall Study|Tolerability Assessment|1
688090|NCT01522456|2235163|P1|Overall Study|Pregnancy|1
688091|NCT01522456|2235163|P1|Overall Study|Withdrawal by Subject|2
688092|NCT01522456|2235163|P1|Overall Study|Lost to Follow-up|2
688093|NCT01522456|2235163|P1|Overall Study|Adverse Event|2
688094|NCT01522235|2235231|P2|Overall Study|Physician Decision|1
688095|NCT01522235|2235232|P1|Overall Study|Physician Decision|1
688096|NCT01521923|2235263|P4|Overall Study|AE, captured in Period 1|1
688097|NCT01521923|2235264|P3|Overall Study|AE, captured in Period 1|0
688098|NCT01521923|2235265|P2|Overall Study|AE, captured in Period 1|1
688099|NCT01521923|2235266|P1|Overall Study|AE, captured in Period 1|0
688100|NCT01521923|2235263|P4|Overall Study|Other|6
688101|NCT01521923|2235264|P3|Overall Study|Other|3
688102|NCT01521923|2235265|P2|Overall Study|Other|1
688103|NCT01521923|2235266|P1|Overall Study|Other|2
688104|NCT01521923|2235263|P4|Overall Study|Withdrawal by Subject|2
688105|NCT01521923|2235264|P3|Overall Study|Withdrawal by Subject|1
688106|NCT01521923|2235265|P2|Overall Study|Withdrawal by Subject|1
688107|NCT01521923|2235266|P1|Overall Study|Withdrawal by Subject|1
688108|NCT01521923|2235263|P4|Overall Study|Lost to Follow-up|1
688109|NCT01521923|2235264|P3|Overall Study|Lost to Follow-up|2
688110|NCT01521923|2235265|P2|Overall Study|Lost to Follow-up|0
688111|NCT01521923|2235266|P1|Overall Study|Lost to Follow-up|1
688112|NCT01521923|2235263|P4|Overall Study|Protocol Violation|0
688113|NCT01521923|2235264|P3|Overall Study|Protocol Violation|1
688114|NCT01521923|2235265|P2|Overall Study|Protocol Violation|0
688115|NCT01521923|2235266|P1|Overall Study|Protocol Violation|0
688116|NCT01521923|2235263|P4|Overall Study|Lack of Efficacy|0
688117|NCT01521923|2235264|P3|Overall Study|Lack of Efficacy|0
688118|NCT01521923|2235265|P2|Overall Study|Lack of Efficacy|1
688119|NCT01521923|2235266|P1|Overall Study|Lack of Efficacy|1
688120|NCT01521923|2235263|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
688121|NCT01521923|2235264|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
688122|NCT01521923|2235265|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
688123|NCT01521923|2235266|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
688124|NCT01521923|2235263|P4|Overall Study|AE, non-serious, non-fatal|2
688125|NCT01521923|2235264|P3|Overall Study|AE, non-serious, non-fatal|6
688126|NCT01521923|2235265|P2|Overall Study|AE, non-serious, non-fatal|3
688127|NCT01521923|2235266|P1|Overall Study|AE, non-serious, non-fatal|1
688128|NCT01521923|2235263|P4|Overall Study|SAE, non-fatal|0
688129|NCT01521923|2235264|P3|Overall Study|SAE, non-fatal|2
688130|NCT01521923|2235265|P2|Overall Study|SAE, non-fatal|2
688131|NCT01521923|2235266|P1|Overall Study|SAE, non-fatal|0
688132|NCT01521923|2235263|P4|Overall Study|AE, serious fatal|0
688133|NCT01521923|2235264|P3|Overall Study|AE, serious fatal|0
688134|NCT01521923|2235265|P2|Overall Study|AE, serious fatal|0
688135|NCT01521923|2235266|P1|Overall Study|AE, serious fatal|1
688136|NCT01521897|2235386|P1|Overall Study|Lost to Follow-up|5
688137|NCT01521897|2235386|P1|Overall Study|Protocol Violation|18
688138|NCT01521884|2235398|P1|Overall Study|Lost to Follow-up|4
688139|NCT01521884|2235398|P1|Overall Study|Participant non-eligible|1
688140|NCT01521884|2235398|P1|Overall Study|Protocol Violation|3
688141|NCT01521884|2235398|P1|Overall Study|Physician Decision|2
688142|NCT01521884|2235398|P1|Overall Study|Withdrawal by Subject|1
688143|NCT01521884|2235398|P1|Overall Study|Pregnancy|1
688144|NCT01521884|2235398|P1|Overall Study|Adverse Event|5
688145|NCT01521884|2235398|P1|Overall Study|Non Responders|10
688146|NCT01521559|2235495|P2|Overall Study|Other|2
688147|NCT01521559|2235496|P1|Overall Study|Other|1
688148|NCT01521559|2235495|P2|Overall Study|Protocol Violation|0
688149|NCT01521559|2235496|P1|Overall Study|Protocol Violation|1
688150|NCT01521559|2235495|P2|Overall Study|Lost to Follow-up|1
688151|NCT01521559|2235496|P1|Overall Study|Lost to Follow-up|3
688152|NCT01521559|2235495|P2|Overall Study|Withdrawal by Subject|11
688153|NCT01521559|2235496|P1|Overall Study|Withdrawal by Subject|9
688154|NCT01521559|2235495|P2|Overall Study|Death|0
688155|NCT01521559|2235496|P1|Overall Study|Death|1
688156|NCT01521559|2235495|P2|Overall Study|Adverse Event|4
688157|NCT01521559|2235496|P1|Overall Study|Adverse Event|0
688158|NCT01521507|2235519|P2|Stage 2: Observational Design|Physician Decision|0
688159|NCT01521507|2235520|P1|Stage 2: Observational Design|Physician Decision|1
688160|NCT01521507|2235519|P2|Stage 2: Observational Design|Withdrawal by Subject|1
688161|NCT01521507|2235520|P1|Stage 2: Observational Design|Withdrawal by Subject|3
688162|NCT01521507|2235519|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
688163|NCT01521507|2235520|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
688164|NCT01521507|2235519|P2|Stage 1: Randomized Design|Lost to Follow-up|2
688165|NCT01521507|2235520|P1|Stage 1: Randomized Design|Lost to Follow-up|0
688166|NCT01521507|2235519|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
688167|NCT01521507|2235520|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
688168|NCT01521507|2235519|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
688169|NCT01521507|2235520|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
688170|NCT01521364|2235537|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
688171|NCT01521364|2235537|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
688172|NCT01520987|2235613|P8|Overall Study|Withdrawal by Subject|0
688173|NCT01520987|2235614|P7|Overall Study|Withdrawal by Subject|0
688174|NCT01520987|2235615|P6|Overall Study|Withdrawal by Subject|1
688175|NCT01520987|2235616|P5|Overall Study|Withdrawal by Subject|0
688176|NCT01520987|2235617|P4|Overall Study|Withdrawal by Subject|0
688177|NCT01520987|2235618|P3|Overall Study|Withdrawal by Subject|0
688178|NCT01520987|2235619|P2|Overall Study|Withdrawal by Subject|0
688179|NCT01520987|2235620|P1|Overall Study|Withdrawal by Subject|1
688180|NCT01520922|2235680|P2|Survival Follow-up|Withdrawal by Subject|0
688181|NCT01520922|2235681|P1|Survival Follow-up|Withdrawal by Subject|1
688182|NCT01520922|2235680|P2|Follow up|Lost to Follow-up|1
688183|NCT01520922|2235681|P1|Follow up|Lost to Follow-up|0
688184|NCT01520922|2235680|P2|Treatment Phase|Adverse Event|5
688185|NCT01520922|2235681|P1|Treatment Phase|Adverse Event|3
688186|NCT01520922|2235680|P2|Treatment Phase|Progression|2
688187|NCT01520922|2235681|P1|Treatment Phase|Progression|0
688188|NCT01520922|2235680|P2|Treatment Phase|Physician Decision|1
688189|NCT01520922|2235681|P1|Treatment Phase|Physician Decision|2
688190|NCT01520909|2235743|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
688191|NCT01520909|2235744|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
688192|NCT01520909|2235745|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
688193|NCT01520909|2235743|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
688194|NCT01520909|2235744|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
688195|NCT01520909|2235745|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
688196|NCT01520909|2235743|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
688197|NCT01520909|2235744|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
688198|NCT01520909|2235745|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
688199|NCT01520909|2235743|P3|Part 1 (Randomized Period)|Adverse Event|0
688200|NCT01520909|2235744|P2|Part 1 (Randomized Period)|Adverse Event|2
688201|NCT01520909|2235745|P1|Part 1 (Randomized Period)|Adverse Event|1
688202|NCT01520714|2235862|P2|Overall Study|Lack of Efficacy|1
688203|NCT01520714|2235863|P1|Overall Study|Lack of Efficacy|0
688204|NCT01520714|2235862|P2|Overall Study|Adverse Event|2
688205|NCT01520714|2235863|P1|Overall Study|Adverse Event|0
688206|NCT01520714|2235862|P2|Overall Study|Protocol Violation|3
688207|NCT01520714|2235863|P1|Overall Study|Protocol Violation|0
688208|NCT01520506|2235888|P1|Overall Study|Withdrawal by Subject|1
688209|NCT01520506|2235888|P1|Overall Study|Lost to Follow-up|1
688210|NCT01520506|2235888|P1|Overall Study|Missed Visit|4
688211|NCT01520402|2235939|P1|Overall Study|Physician Decision|3
688212|NCT01520402|2235939|P1|Overall Study|Withdrawal by Subject|2
688228|NCT01519934|2236061|P1|Overall Study|Lost to Follow-up|3
688229|NCT01519921|2236070|P2|Overall Study|High alanine aminotransferase (ALT)|1
688230|NCT01519921|2236071|P1|Overall Study|High alanine aminotransferase (ALT)|0
688231|NCT01519921|2236070|P2|Overall Study|Treatment refusal|1
688232|NCT01519921|2236071|P1|Overall Study|Treatment refusal|2
688233|NCT01519921|2236070|P2|Overall Study|Lost to Follow-up|1
688234|NCT01519921|2236071|P1|Overall Study|Lost to Follow-up|2
688235|NCT01519921|2236070|P2|Overall Study|Withdrawal by Subject|0
688236|NCT01519921|2236071|P1|Overall Study|Withdrawal by Subject|3
688237|NCT01519921|2236070|P2|Overall Study|Lack of Efficacy|3
688238|NCT01519921|2236071|P1|Overall Study|Lack of Efficacy|4
688239|NCT01519921|2236070|P2|Overall Study|Adverse Event|9
688240|NCT01519921|2236071|P1|Overall Study|Adverse Event|10
688241|NCT01519817|2236120|P4|Overall Study|Off study due to infection|1
688242|NCT01519817|2236121|P3|Overall Study|Off study due to infection|0
688243|NCT01519817|2236122|P2|Overall Study|Off study due to infection|0
688244|NCT01519817|2236123|P1|Overall Study|Off study due to infection|0
688245|NCT01519817|2236120|P4|Overall Study|Withdrawal by Subject|0
688246|NCT01519817|2236121|P3|Overall Study|Withdrawal by Subject|0
688247|NCT01519817|2236122|P2|Overall Study|Withdrawal by Subject|0
688248|NCT01519817|2236123|P1|Overall Study|Withdrawal by Subject|1
688249|NCT01519791|2236163|P2|Overall Study|Lost to Follow-up|14
688250|NCT01519791|2236164|P1|Overall Study|Lost to Follow-up|6
688251|NCT01519791|2236163|P2|Overall Study|Withdrawal by Subject|37
688252|NCT01519791|2236164|P1|Overall Study|Withdrawal by Subject|15
688253|NCT01519791|2236163|P2|Overall Study|AE, non-serious non-fatal|31
688254|NCT01519791|2236164|P1|Overall Study|AE, non-serious non-fatal|12
688255|NCT01519791|2236163|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
688256|NCT01519791|2236164|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
688257|NCT01519791|2236163|P2|Overall Study|AE, serious fatal|1
688258|NCT01519791|2236164|P1|Overall Study|AE, serious fatal|0
688259|NCT01519791|2236163|P2|Overall Study|SAE, non-fatal|22
688260|NCT01519791|2236164|P1|Overall Study|SAE, non-fatal|6
688261|NCT01519791|2236163|P2|Overall Study|Lack of Efficacy|20
688262|NCT01519791|2236164|P1|Overall Study|Lack of Efficacy|16
688263|NCT01519791|2236163|P2|Overall Study|subjects randomized in error|0
688264|NCT01519791|2236164|P1|Overall Study|subjects randomized in error|2
688265|NCT01519791|2236163|P2|Overall Study|Other Reason|222
688266|NCT01519791|2236164|P1|Overall Study|Other Reason|87
688267|NCT01519791|2236163|P2|Overall Study|Protocol Violation|19
688268|NCT01519791|2236164|P1|Overall Study|Protocol Violation|6
688269|NCT01519791|2236163|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
688270|NCT01519791|2236164|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
688271|NCT01519778|2236228|P1|Overall Study|Physician Decision|1
688272|NCT01519778|2236228|P1|Overall Study|Lost to Follow-up|10
688273|NCT01519778|2236228|P1|Overall Study|Withdrawal by Subject|3
688274|NCT01519765|2236234|P2|Overall Study|Withdrawal by Subject|1
688275|NCT01519765|2236235|P1|Overall Study|Withdrawal by Subject|0
688276|NCT01519765|2236234|P2|Overall Study|Protocol Violation|0
688277|NCT01519765|2236235|P1|Overall Study|Protocol Violation|1
688278|NCT01519765|2236234|P2|Overall Study|Lack of Efficacy|0
688279|NCT01519765|2236235|P1|Overall Study|Lack of Efficacy|2
688280|NCT01519765|2236234|P2|Overall Study|Adverse Event|1
688281|NCT01519765|2236235|P1|Overall Study|Adverse Event|0
688282|NCT01519700|2236313|P4|Overall Study|Other Reason|4
688283|NCT01519700|2236314|P3|Overall Study|Other Reason|0
688284|NCT01519700|2236315|P2|Overall Study|Other Reason|2
688285|NCT01519700|2236316|P1|Overall Study|Other Reason|2
688286|NCT01519700|2236313|P4|Overall Study|Withdrawal by Subject|2
688287|NCT01519700|2236314|P3|Overall Study|Withdrawal by Subject|3
688288|NCT01519700|2236315|P2|Overall Study|Withdrawal by Subject|3
688289|NCT01519700|2236316|P1|Overall Study|Withdrawal by Subject|5
688290|NCT01519700|2236313|P4|Overall Study|Physician Decision|0
688291|NCT01519700|2236314|P3|Overall Study|Physician Decision|3
688292|NCT01519700|2236315|P2|Overall Study|Physician Decision|1
688293|NCT01519700|2236316|P1|Overall Study|Physician Decision|1
688294|NCT01519700|2236313|P4|Overall Study|Lost to Follow-up|1
688295|NCT01519700|2236314|P3|Overall Study|Lost to Follow-up|1
688296|NCT01519700|2236315|P2|Overall Study|Lost to Follow-up|0
688297|NCT01519700|2236316|P1|Overall Study|Lost to Follow-up|0
688298|NCT01519700|2236313|P4|Overall Study|Death|0
688299|NCT01519700|2236314|P3|Overall Study|Death|0
688300|NCT01519700|2236315|P2|Overall Study|Death|0
688301|NCT01519700|2236316|P1|Overall Study|Death|1
688302|NCT01519674|2236351|P3|Overall Study|Unsclassified|3
688303|NCT01519674|2236352|P2|Overall Study|Unsclassified|4
688304|NCT01519674|2236353|P1|Overall Study|Unsclassified|10
688305|NCT01519674|2236351|P3|Overall Study|Withdrawal Criteria|7
688306|NCT01519674|2236352|P2|Overall Study|Withdrawal Criteria|2
688307|NCT01519674|2236353|P1|Overall Study|Withdrawal Criteria|7
688308|NCT01519674|2236351|P3|Overall Study|Protocol Violation|1
688309|NCT01519674|2236352|P2|Overall Study|Protocol Violation|3
688310|NCT01519674|2236353|P1|Overall Study|Protocol Violation|0
688311|NCT01519674|2236351|P3|Overall Study|Lack of Efficacy|1
688312|NCT01519674|2236352|P2|Overall Study|Lack of Efficacy|1
688313|NCT01519674|2236353|P1|Overall Study|Lack of Efficacy|1
688314|NCT01519674|2236351|P3|Overall Study|Adverse Event|0
688315|NCT01519674|2236352|P2|Overall Study|Adverse Event|3
688316|NCT01519674|2236353|P1|Overall Study|Adverse Event|3
688317|NCT01519661|2236391|P1|Overall Study|Adverse Event|29
688318|NCT01519661|2236391|P1|Overall Study|Lack of Efficacy|6
688319|NCT01519661|2236391|P1|Overall Study|Withdrawal by Subject|17
688320|NCT01519661|2236391|P1|Overall Study|Lost to Follow-up|3
688321|NCT01519661|2236391|P1|Overall Study|Protocol deviation|6
688322|NCT01519518|2236417|P2|Overall Study|Consent not available|10
688323|NCT01519518|2236418|P1|Overall Study|Consent not available|7
688324|NCT01519427|2236443|P1|Overall Study|disease progression|2
688325|NCT01519323|2236450|P2|Overall Study|Study terminated by sponsor|1
688326|NCT01519323|2236451|P1|Overall Study|Study terminated by sponsor|0
688327|NCT01519323|2236450|P2|Overall Study|Death|2
688328|NCT01519323|2236451|P1|Overall Study|Death|3
688329|NCT01519245|2236511|P2|Overall Study|Met exclusion criteria, not analysed|2
688330|NCT01519245|2236512|P1|Overall Study|Met exclusion criteria, not analysed|1
688333|NCT01519167|2236538|P2|Overall Study|Physician Decision|1
688334|NCT01519167|2236539|P1|Overall Study|Physician Decision|0
688335|NCT01519167|2236538|P2|Overall Study|Medical condition changes&deep sedation|2
688336|NCT01519167|2236539|P1|Overall Study|Medical condition changes&deep sedation|0
688337|NCT01519167|2236538|P2|Overall Study|Lack of Efficacy|1
688338|NCT01519167|2236539|P1|Overall Study|Lack of Efficacy|0
688339|NCT01519167|2236538|P2|Overall Study|Adverse Event|1
688340|NCT01519167|2236539|P1|Overall Study|Adverse Event|0
688341|NCT01519167|2236538|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
688342|NCT01519167|2236539|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
688343|NCT01519089|2236565|P2|Overall Study|Not received study drug|1
688344|NCT01519089|2236566|P1|Overall Study|Not received study drug|0
688345|NCT01519089|2236565|P2|Overall Study|Unspecified|6
688346|NCT01519089|2236566|P1|Overall Study|Unspecified|2
688347|NCT01519089|2236565|P2|Overall Study|Withdrawal by Subject|2
688348|NCT01519089|2236566|P1|Overall Study|Withdrawal by Subject|0
688349|NCT01519089|2236565|P2|Overall Study|Lost to Follow-up|0
688350|NCT01519089|2236566|P1|Overall Study|Lost to Follow-up|1
688351|NCT01519089|2236565|P2|Overall Study|Lack of Efficacy|2
688352|NCT01519089|2236566|P1|Overall Study|Lack of Efficacy|0
688353|NCT01519089|2236565|P2|Overall Study|Adverse Event|4
688354|NCT01519089|2236566|P1|Overall Study|Adverse Event|4
688355|NCT01518946|2236687|P3|Randomized Phase (First Intervention)|Not specified|0
688356|NCT01518946|2236688|P2|Randomized Phase (First Intervention)|Not specified|1
688357|NCT01518946|2236689|P1|Randomized Phase (First Intervention)|Not specified|0
688358|NCT01518946|2236687|P3|Open-label Phase|Not specified|0
688359|NCT01518946|2236688|P2|Open-label Phase|Not specified|0
688360|NCT01518946|2236689|P1|Open-label Phase|Not specified|4
688361|NCT01518322|2236700|P1|Overall Study|FeNO measurement was missing|13
688362|NCT01518257|2236721|P2|Overall Study|Other Miscellaneous Reason|0
688363|NCT01518257|2236722|P1|Overall Study|Other Miscellaneous Reason|1
688364|NCT01518257|2236721|P2|Overall Study|Lost to Follow-up|0
688365|NCT01518257|2236722|P1|Overall Study|Lost to Follow-up|1
688366|NCT01518244|2236744|P1|Overall Study|Adverse Event|3
688367|NCT01518192|2236752|P3|Overall Study|Lost to Follow-up|35
688368|NCT01518192|2236753|P2|Overall Study|Lost to Follow-up|26
688369|NCT01518192|2236754|P1|Overall Study|Lost to Follow-up|29
688370|NCT01518153|2236775|P3|Donor Lymphocyte Infusion|Death|1
688371|NCT01518153|2236776|P2|Donor Lymphocyte Infusion|Death|2
688372|NCT01518153|2236777|P1|Donor Lymphocyte Infusion|Death|0
688373|NCT01518153|2236775|P3|Stem Cell Transplant|Adverse Event|0
688374|NCT01518153|2236776|P2|Stem Cell Transplant|Adverse Event|0
688375|NCT01518153|2236777|P1|Stem Cell Transplant|Adverse Event|1
688376|NCT01518153|2236775|P3|Stem Cell Transplant|Secondary graft failure|0
688377|NCT01518153|2236776|P2|Stem Cell Transplant|Secondary graft failure|0
688378|NCT01518153|2236777|P1|Stem Cell Transplant|Secondary graft failure|1
688379|NCT01518153|2236775|P3|Stem Cell Transplant|Death|0
688380|NCT01518153|2236776|P2|Stem Cell Transplant|Death|0
688381|NCT01518153|2236777|P1|Stem Cell Transplant|Death|2
688382|NCT01518153|2236775|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
688383|NCT01518153|2236776|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
688384|NCT01518153|2236777|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
688385|NCT01517984|2236788|P4|Overall Study|Ineligible for randomization|0
688386|NCT01517984|2236789|P3|Overall Study|Ineligible for randomization|0
688387|NCT01517984|2236790|P2|Overall Study|Ineligible for randomization|14
688388|NCT01517984|2236791|P1|Overall Study|Ineligible for randomization|0
688389|NCT01517984|2236788|P4|Overall Study|Screen Failure|0
688390|NCT01517984|2236789|P3|Overall Study|Screen Failure|0
688391|NCT01517984|2236790|P2|Overall Study|Screen Failure|0
688392|NCT01517984|2236791|P1|Overall Study|Screen Failure|4
688393|NCT01517984|2236788|P4|Overall Study|Withdrawal by Subject|1
688394|NCT01517984|2236789|P3|Overall Study|Withdrawal by Subject|4
688395|NCT01517984|2236790|P2|Overall Study|Withdrawal by Subject|8
688396|NCT01517984|2236791|P1|Overall Study|Withdrawal by Subject|1
688397|NCT01517984|2236788|P4|Overall Study|Lost to Follow-up|0
688398|NCT01517984|2236789|P3|Overall Study|Lost to Follow-up|0
688399|NCT01517984|2236790|P2|Overall Study|Lost to Follow-up|1
688400|NCT01517984|2236791|P1|Overall Study|Lost to Follow-up|0
688401|NCT01517750|2236828|P4|Overall Study|Lost to Follow-up|1
688402|NCT01517750|2236829|P3|Overall Study|Lost to Follow-up|4
688403|NCT01517750|2236830|P2|Overall Study|Lost to Follow-up|2
688404|NCT01517750|2236831|P1|Overall Study|Lost to Follow-up|1
688405|NCT01517412|2236868|P2|Overall Study|Other than specified above|5
688406|NCT01517412|2236869|P1|Overall Study|Other than specified above|8
688407|NCT01517412|2236868|P2|Overall Study|Poor compliance to protocol|3
688408|NCT01517412|2236869|P1|Overall Study|Poor compliance to protocol|8
688409|NCT01517412|2236868|P2|Overall Study|Lack of Efficacy|5
688410|NCT01517412|2236869|P1|Overall Study|Lack of Efficacy|10
688411|NCT01517412|2236868|P2|Overall Study|Adverse Event|11
688412|NCT01517412|2236869|P1|Overall Study|Adverse Event|10
688413|NCT01517373|2236898|P6|Treatment Period|Medication error without AEs|2
688414|NCT01517373|2236899|P5|Treatment Period|Medication error without AEs|0
688415|NCT01517373|2236900|P4|Treatment Period|Medication error without AEs|1
688416|NCT01517373|2236901|P3|Treatment Period|Medication error without AEs|2
688417|NCT01517373|2236902|P2|Treatment Period|Medication error without AEs|0
688418|NCT01517373|2236903|P1|Treatment Period|Medication error without AEs|0
688419|NCT01517373|2236898|P6|Treatment Period|Lack of Efficacy|0
688420|NCT01517373|2236899|P5|Treatment Period|Lack of Efficacy|2
688421|NCT01517373|2236900|P4|Treatment Period|Lack of Efficacy|3
688422|NCT01517373|2236901|P3|Treatment Period|Lack of Efficacy|1
688423|NCT01517373|2236902|P2|Treatment Period|Lack of Efficacy|1
688424|NCT01517373|2236903|P1|Treatment Period|Lack of Efficacy|0
688425|NCT01517373|2236898|P6|Treatment Period|Protocol Violation|0
688426|NCT01517373|2236899|P5|Treatment Period|Protocol Violation|1
688427|NCT01517373|2236900|P4|Treatment Period|Protocol Violation|0
688428|NCT01517373|2236901|P3|Treatment Period|Protocol Violation|0
688429|NCT01517373|2236902|P2|Treatment Period|Protocol Violation|0
688430|NCT01517373|2236903|P1|Treatment Period|Protocol Violation|0
688431|NCT01517373|2236898|P6|Treatment Period|Unspecified|0
688432|NCT01517373|2236899|P5|Treatment Period|Unspecified|1
688433|NCT01517373|2236900|P4|Treatment Period|Unspecified|0
688434|NCT01517373|2236901|P3|Treatment Period|Unspecified|0
688435|NCT01517373|2236902|P2|Treatment Period|Unspecified|0
688436|NCT01517373|2236903|P1|Treatment Period|Unspecified|0
688437|NCT01517373|2236898|P6|Treatment Period|Withdrawal by Subject|3
688438|NCT01517373|2236899|P5|Treatment Period|Withdrawal by Subject|2
688439|NCT01517373|2236900|P4|Treatment Period|Withdrawal by Subject|2
688440|NCT01517373|2236901|P3|Treatment Period|Withdrawal by Subject|2
688441|NCT01517373|2236902|P2|Treatment Period|Withdrawal by Subject|3
688442|NCT01517373|2236903|P1|Treatment Period|Withdrawal by Subject|0
688443|NCT01517373|2236898|P6|Treatment Period|Lost to Follow-up|0
688444|NCT01517373|2236899|P5|Treatment Period|Lost to Follow-up|0
688445|NCT01517373|2236900|P4|Treatment Period|Lost to Follow-up|1
688446|NCT01517373|2236901|P3|Treatment Period|Lost to Follow-up|1
688447|NCT01517373|2236902|P2|Treatment Period|Lost to Follow-up|0
688448|NCT01517373|2236903|P1|Treatment Period|Lost to Follow-up|0
688449|NCT01517373|2236898|P6|Treatment Period|Adverse Event|2
688450|NCT01517373|2236899|P5|Treatment Period|Adverse Event|0
688451|NCT01517373|2236900|P4|Treatment Period|Adverse Event|0
688452|NCT01517373|2236901|P3|Treatment Period|Adverse Event|0
688453|NCT01517373|2236902|P2|Treatment Period|Adverse Event|0
688454|NCT01517373|2236903|P1|Treatment Period|Adverse Event|0
688455|NCT01517373|2236898|P6|Run-in Period|Unspecified|0
688456|NCT01517373|2236899|P5|Run-in Period|Unspecified|0
688457|NCT01517373|2236900|P4|Run-in Period|Unspecified|0
688458|NCT01517373|2236901|P3|Run-in Period|Unspecified|0
688459|NCT01517373|2236902|P2|Run-in Period|Unspecified|0
688460|NCT01517373|2236903|P1|Run-in Period|Unspecified|1
688461|NCT01517373|2236898|P6|Run-in Period|Sponsor Decision|0
688462|NCT01517373|2236899|P5|Run-in Period|Sponsor Decision|0
688463|NCT01517373|2236900|P4|Run-in Period|Sponsor Decision|0
688464|NCT01517373|2236901|P3|Run-in Period|Sponsor Decision|0
688465|NCT01517373|2236902|P2|Run-in Period|Sponsor Decision|0
688466|NCT01517373|2236903|P1|Run-in Period|Sponsor Decision|3
688467|NCT01517373|2236898|P6|Run-in Period|Withdrawal by Subject|0
688468|NCT01517373|2236899|P5|Run-in Period|Withdrawal by Subject|0
688469|NCT01517373|2236900|P4|Run-in Period|Withdrawal by Subject|0
688470|NCT01517373|2236901|P3|Run-in Period|Withdrawal by Subject|0
688471|NCT01517373|2236902|P2|Run-in Period|Withdrawal by Subject|0
688472|NCT01517373|2236903|P1|Run-in Period|Withdrawal by Subject|12
688473|NCT01517373|2236898|P6|Run-in Period|Lost to Follow-up|0
688474|NCT01517373|2236899|P5|Run-in Period|Lost to Follow-up|0
688475|NCT01517373|2236900|P4|Run-in Period|Lost to Follow-up|0
688476|NCT01517373|2236901|P3|Run-in Period|Lost to Follow-up|0
688477|NCT01517373|2236902|P2|Run-in Period|Lost to Follow-up|0
688478|NCT01517373|2236903|P1|Run-in Period|Lost to Follow-up|1
688479|NCT01517373|2236898|P6|Run-in Period|Did not meet eligibility criteria|0
688480|NCT01517373|2236899|P5|Run-in Period|Did not meet eligibility criteria|0
688481|NCT01517373|2236900|P4|Run-in Period|Did not meet eligibility criteria|0
688482|NCT01517373|2236901|P3|Run-in Period|Did not meet eligibility criteria|0
688483|NCT01517373|2236902|P2|Run-in Period|Did not meet eligibility criteria|0
688484|NCT01517373|2236903|P1|Run-in Period|Did not meet eligibility criteria|34
688485|NCT01517373|2236898|P6|Run-in Period|Adverse Event|0
688486|NCT01517373|2236899|P5|Run-in Period|Adverse Event|0
688487|NCT01517373|2236900|P4|Run-in Period|Adverse Event|0
688488|NCT01517373|2236901|P3|Run-in Period|Adverse Event|0
688489|NCT01517373|2236902|P2|Run-in Period|Adverse Event|0
688490|NCT01517373|2236903|P1|Run-in Period|Adverse Event|5
688491|NCT01517373|2236898|P6|Run-in Period|Death|0
688492|NCT01517373|2236899|P5|Run-in Period|Death|0
688493|NCT01517373|2236900|P4|Run-in Period|Death|0
688494|NCT01517373|2236901|P3|Run-in Period|Death|0
688495|NCT01517373|2236902|P2|Run-in Period|Death|0
688496|NCT01517373|2236903|P1|Run-in Period|Death|1
688497|NCT01517295|2236973|P2|Overall Study|Physician Decision|0
688498|NCT01517295|2236974|P1|Overall Study|Physician Decision|1
688499|NCT01517282|2236988|P4|Overall Study|Physician Decision|0
688500|NCT01517282|2236989|P3|Overall Study|Physician Decision|0
688501|NCT01517282|2236990|P2|Overall Study|Physician Decision|0
688502|NCT01517282|2236991|P1|Overall Study|Physician Decision|1
688503|NCT01517282|2236988|P4|Overall Study|Consent withdrawn|1
688504|NCT01517282|2236989|P3|Overall Study|Consent withdrawn|1
688505|NCT01517282|2236990|P2|Overall Study|Consent withdrawn|1
688506|NCT01517282|2236991|P1|Overall Study|Consent withdrawn|0
688507|NCT01517178|2237025|P2|Period 2|E.g. study termination|2
688508|NCT01517178|2237026|P1|Period 2|E.g. study termination|2
688509|NCT01517178|2237025|P2|Period 2|Withdrawal by Subject|0
688510|NCT01517178|2237026|P1|Period 2|Withdrawal by Subject|3
688511|NCT01517178|2237025|P2|Period 2|Adverse Event|0
688512|NCT01517178|2237026|P1|Period 2|Adverse Event|1
688513|NCT01517178|2237025|P2|Period 1|Withdrawal by Subject|1
688514|NCT01517178|2237026|P1|Period 1|Withdrawal by Subject|0
688515|NCT01517178|2237025|P2|Period 1|E.g. study termination|1
688516|NCT01517178|2237026|P1|Period 1|E.g. study termination|3
688517|NCT01517178|2237025|P2|Period 1|Lack of Efficacy|1
688518|NCT01517178|2237026|P1|Period 1|Lack of Efficacy|0
688519|NCT01517178|2237025|P2|Period 1|Adverse Event|2
688520|NCT01517178|2237026|P1|Period 1|Adverse Event|1
688521|NCT01516970|2237045|P2|Overall Study|Unspecified|7
688522|NCT01516970|2237046|P1|Overall Study|Unspecified|9
688523|NCT01516970|2237045|P2|Overall Study|Withdrawal by Subject|1
688524|NCT01516970|2237046|P1|Overall Study|Withdrawal by Subject|1
688525|NCT01516970|2237045|P2|Overall Study|Adverse Event|5
688526|NCT01516970|2237046|P1|Overall Study|Adverse Event|1
688527|NCT01516970|2237045|P2|Overall Study|Lost to Follow-up|8
688528|NCT01516970|2237046|P1|Overall Study|Lost to Follow-up|7
688529|NCT01516892|2237058|P1|Overall Study|Missing|1
688530|NCT01516892|2237058|P1|Overall Study|Other Miscellaneous Reasons|43
688531|NCT01516892|2237058|P1|Overall Study|Protocol Violation|60
688532|NCT01516892|2237058|P1|Overall Study|Subject Withdrew Consent|92
688533|NCT01516892|2237058|P1|Overall Study|Lost to Follow-up|82
688534|NCT01516892|2237058|P1|Overall Study|Pregnancy|5
688535|NCT01516892|2237058|P1|Overall Study|Lack of Efficacy|35
688536|NCT01516892|2237058|P1|Overall Study|Adverse Event|25
688537|NCT01516879|2237066|P2|Overall Study|Other|10
688538|NCT01516879|2237067|P1|Overall Study|Other|5
688539|NCT01516879|2237066|P2|Overall Study|Lost to Follow-up|11
688540|NCT01516879|2237067|P1|Overall Study|Lost to Follow-up|2
688541|NCT01516879|2237066|P2|Overall Study|Death|2
688542|NCT01516879|2237067|P1|Overall Study|Death|0
688543|NCT01516879|2237066|P2|Overall Study|Withdrawal by Subject|11
688544|NCT01516879|2237067|P1|Overall Study|Withdrawal by Subject|9
688545|NCT01516749|2237101|P1|Follow-up Off Therapy|Lost to Follow-up|1
688546|NCT01516749|2237101|P1|Active Therapy|Lost to Follow-up|1
688547|NCT01516736|2237110|P2|Overall Study|Other (not specified)|1
688548|NCT01516736|2237111|P1|Overall Study|Other (not specified)|0
688549|NCT01516736|2237110|P2|Overall Study|Protocol Violation|1
688550|NCT01516736|2237111|P1|Overall Study|Protocol Violation|0
688551|NCT01516736|2237110|P2|Overall Study|Lack of Efficacy|0
688552|NCT01516736|2237111|P1|Overall Study|Lack of Efficacy|1
688553|NCT01516736|2237110|P2|Overall Study|Physician Decision|1
688554|NCT01516736|2237111|P1|Overall Study|Physician Decision|2
688555|NCT01516736|2237110|P2|Overall Study|Death|1
688556|NCT01516736|2237111|P1|Overall Study|Death|3
688557|NCT01516736|2237110|P2|Overall Study|Adverse Event|5
688558|NCT01516736|2237111|P1|Overall Study|Adverse Event|4
688559|NCT01516736|2237110|P2|Overall Study|Withdrawal by Subject|4
688560|NCT01516736|2237111|P1|Overall Study|Withdrawal by Subject|10
688561|NCT01516437|2237148|P4|Overall Study|Reason not specified|1
688562|NCT01516437|2237149|P3|Overall Study|Reason not specified|1
688563|NCT01516437|2237150|P2|Overall Study|Reason not specified|0
688564|NCT01516437|2237151|P1|Overall Study|Reason not specified|0
688565|NCT01516034|2237214|P1|Overall Study|Lack of Efficacy|7
688566|NCT01516034|2237214|P1|Overall Study|Physician Decision|1
688567|NCT01516008|2237221|P3|Overall Study|Reason not specified|1
688568|NCT01516008|2237222|P2|Overall Study|Reason not specified|0
688569|NCT01516008|2237223|P1|Overall Study|Reason not specified|0
688570|NCT01516008|2237221|P3|Overall Study|Protocol Violation|0
688571|NCT01516008|2237222|P2|Overall Study|Protocol Violation|0
688572|NCT01516008|2237223|P1|Overall Study|Protocol Violation|1
688573|NCT01516008|2237221|P3|Overall Study|Lack of Efficacy|10
688574|NCT01516008|2237222|P2|Overall Study|Lack of Efficacy|14
688575|NCT01516008|2237223|P1|Overall Study|Lack of Efficacy|44
688576|NCT01516008|2237221|P3|Overall Study|Adverse Event|7
688577|NCT01516008|2237222|P2|Overall Study|Adverse Event|2
688578|NCT01516008|2237223|P1|Overall Study|Adverse Event|0
688579|NCT01515865|2237319|P3|Part B (Open-label)|Not Specified|0
688580|NCT01515865|2237320|P2|Part B (Open-label)|Not Specified|0
688581|NCT01515865|2237321|P1|Part B (Open-label)|Not Specified|1
688582|NCT01515865|2237319|P3|Part B (Open-label)|Withdrawal by Subject|0
688583|NCT01515865|2237320|P2|Part B (Open-label)|Withdrawal by Subject|0
688584|NCT01515865|2237321|P1|Part B (Open-label)|Withdrawal by Subject|1
688585|NCT01515865|2237319|P3|Part A (Open-label)|Not Specified|0
688586|NCT01515865|2237320|P2|Part A (Open-label)|Not Specified|0
688587|NCT01515865|2237321|P1|Part A (Open-label)|Not Specified|3
688588|NCT01515423|2237389|P3|DOUBLE BLIND|Blind broken by investigator|0
688589|NCT01515423|2237390|P2|DOUBLE BLIND|Blind broken by investigator|1
688590|NCT01515423|2237391|P1|DOUBLE BLIND|Blind broken by investigator|0
688591|NCT01515423|2237389|P3|DOUBLE BLIND|Unspecified|12
688592|NCT01515423|2237390|P2|DOUBLE BLIND|Unspecified|6
688593|NCT01515423|2237391|P1|DOUBLE BLIND|Unspecified|0
688594|NCT01515423|2237389|P3|DOUBLE BLIND|Withdrawal by Subject|53
688595|NCT01515423|2237390|P2|DOUBLE BLIND|Withdrawal by Subject|50
688596|NCT01515423|2237391|P1|DOUBLE BLIND|Withdrawal by Subject|0
688597|NCT01515423|2237389|P3|DOUBLE BLIND|Pregnancy|0
688598|NCT01515423|2237390|P2|DOUBLE BLIND|Pregnancy|2
688599|NCT01515423|2237391|P1|DOUBLE BLIND|Pregnancy|0
688600|NCT01515423|2237389|P3|DOUBLE BLIND|Lost to Follow-up|12
688601|NCT01515423|2237390|P2|DOUBLE BLIND|Lost to Follow-up|7
688602|NCT01515423|2237391|P1|DOUBLE BLIND|Lost to Follow-up|0
688603|NCT01515423|2237389|P3|DOUBLE BLIND|Death|2
688604|NCT01515423|2237390|P2|DOUBLE BLIND|Death|1
688605|NCT01515423|2237391|P1|DOUBLE BLIND|Death|0
688606|NCT01515423|2237389|P3|DOUBLE BLIND|Adverse Event|13
688607|NCT01515423|2237390|P2|DOUBLE BLIND|Adverse Event|15
688608|NCT01515423|2237391|P1|DOUBLE BLIND|Adverse Event|0
688609|NCT01515423|2237389|P3|Open Label Phase|Unspecified|0
688610|NCT01515423|2237390|P2|Open Label Phase|Unspecified|0
688611|NCT01515423|2237391|P1|Open Label Phase|Unspecified|28
688612|NCT01515423|2237389|P3|Open Label Phase|excluded from DB Phase|0
688613|NCT01515423|2237390|P2|Open Label Phase|excluded from DB Phase|0
688614|NCT01515423|2237391|P1|Open Label Phase|excluded from DB Phase|70
688615|NCT01515423|2237389|P3|Open Label Phase|Withdrawal by Subject|0
688616|NCT01515423|2237390|P2|Open Label Phase|Withdrawal by Subject|0
688617|NCT01515423|2237391|P1|Open Label Phase|Withdrawal by Subject|118
688618|NCT01515423|2237389|P3|Open Label Phase|Lost to Follow-up|0
688619|NCT01515423|2237390|P2|Open Label Phase|Lost to Follow-up|0
688620|NCT01515423|2237391|P1|Open Label Phase|Lost to Follow-up|21
688621|NCT01515423|2237389|P3|Open Label Phase|Lack of Efficacy|0
688622|NCT01515423|2237390|P2|Open Label Phase|Lack of Efficacy|0
688623|NCT01515423|2237391|P1|Open Label Phase|Lack of Efficacy|117
688624|NCT01515423|2237389|P3|Open Label Phase|Death|0
688625|NCT01515423|2237390|P2|Open Label Phase|Death|0
688626|NCT01515423|2237391|P1|Open Label Phase|Death|2
688627|NCT01515423|2237389|P3|Open Label Phase|Adverse Event|0
688628|NCT01515423|2237390|P2|Open Label Phase|Adverse Event|0
688629|NCT01515423|2237391|P1|Open Label Phase|Adverse Event|57
688662|NCT01514864|2237520|P2|Overall Study|Study drug toxicity|0
688663|NCT01514864|2237521|P1|Overall Study|Study drug toxicity|2
688664|NCT01514864|2237520|P2|Overall Study|Disease progression|5
688665|NCT01514864|2237521|P1|Overall Study|Disease progression|7
688667|NCT01514461|2237575|P3|Overall Study|Death|0
688668|NCT01514461|2237576|P2|Overall Study|Death|0
688669|NCT01514461|2237577|P1|Overall Study|Death|1
688670|NCT01514461|2237575|P3|Overall Study|Patient/guardian decision|1
688671|NCT01514461|2237576|P2|Overall Study|Patient/guardian decision|1
688672|NCT01514461|2237577|P1|Overall Study|Patient/guardian decision|1
688673|NCT01514461|2237575|P3|Overall Study|Physician Decision|0
688674|NCT01514461|2237576|P2|Overall Study|Physician Decision|1
688675|NCT01514461|2237577|P1|Overall Study|Physician Decision|1
688676|NCT01514461|2237575|P3|Overall Study|Adverse Event|3
688677|NCT01514461|2237576|P2|Overall Study|Adverse Event|1
688678|NCT01514461|2237577|P1|Overall Study|Adverse Event|2
688679|NCT01514448|2237616|P2|Overall Study|New Cancer Therapy|0
688680|NCT01514448|2237617|P1|Overall Study|New Cancer Therapy|1
688681|NCT01514448|2237616|P2|Overall Study|Lost to Follow-up|0
688682|NCT01514448|2237617|P1|Overall Study|Lost to Follow-up|2
688683|NCT01514448|2237616|P2|Overall Study|Withdrawal by Subject|0
688684|NCT01514448|2237617|P1|Overall Study|Withdrawal by Subject|2
688685|NCT01514448|2237616|P2|Overall Study|Death|8
688686|NCT01514448|2237617|P1|Overall Study|Death|7
688687|NCT01514422|2237632|P1|Overall Study|Lost to Follow-up|1
688688|NCT01514240|2237650|P2|Overall Study|Subject Decision|7
688689|NCT01514240|2237651|P1|Overall Study|Subject Decision|2
688690|NCT01514240|2237650|P2|Overall Study|Adverse Event|4
688691|NCT01514240|2237651|P1|Overall Study|Adverse Event|4
688692|NCT01514136|2237764|P8|Test Period 2; Test C*|Protocol Violation|0
688693|NCT01514136|2237765|P7|Test Period 2; Test C*|Protocol Violation|1
688694|NCT01514136|2237766|P6|Test Period 2; Test C*|Protocol Violation|0
688695|NCT01514136|2237767|P5|Test Period 2; Test C*|Protocol Violation|0
688696|NCT01514136|2237768|P4|Test Period 2; Test C*|Protocol Violation|0
688697|NCT01514136|2237769|P3|Test Period 2; Test C*|Protocol Violation|0
688698|NCT01514136|2237770|P2|Test Period 2; Test C*|Protocol Violation|0
688699|NCT01514136|2237771|P1|Test Period 2; Test C*|Protocol Violation|0
688700|NCT01514136|2237764|P8|Test Period 2; Test C*|holiday|0
688701|NCT01514136|2237765|P7|Test Period 2; Test C*|holiday|1
688702|NCT01514136|2237766|P6|Test Period 2; Test C*|holiday|0
688703|NCT01514136|2237767|P5|Test Period 2; Test C*|holiday|0
688704|NCT01514136|2237768|P4|Test Period 2; Test C*|holiday|0
688705|NCT01514136|2237769|P3|Test Period 2; Test C*|holiday|0
688706|NCT01514136|2237770|P2|Test Period 2; Test C*|holiday|0
688707|NCT01514136|2237771|P1|Test Period 2; Test C*|holiday|0
688708|NCT01514136|2237764|P8|Test Period 2; Test C*|Withdrawal by Subject|0
688709|NCT01514136|2237765|P7|Test Period 2; Test C*|Withdrawal by Subject|1
688710|NCT01514136|2237766|P6|Test Period 2; Test C*|Withdrawal by Subject|0
688711|NCT01514136|2237767|P5|Test Period 2; Test C*|Withdrawal by Subject|0
688712|NCT01514136|2237768|P4|Test Period 2; Test C*|Withdrawal by Subject|0
688713|NCT01514136|2237769|P3|Test Period 2; Test C*|Withdrawal by Subject|0
688714|NCT01514136|2237770|P2|Test Period 2; Test C*|Withdrawal by Subject|0
688715|NCT01514136|2237771|P1|Test Period 2; Test C*|Withdrawal by Subject|0
688716|NCT01514136|2237764|P8|Test Period 2; Test B*|Withdrawal by Subject|0
688717|NCT01514136|2237765|P7|Test Period 2; Test B*|Withdrawal by Subject|0
688718|NCT01514136|2237766|P6|Test Period 2; Test B*|Withdrawal by Subject|2
688719|NCT01514136|2237767|P5|Test Period 2; Test B*|Withdrawal by Subject|0
688720|NCT01514136|2237768|P4|Test Period 2; Test B*|Withdrawal by Subject|0
688721|NCT01514136|2237769|P3|Test Period 2; Test B*|Withdrawal by Subject|0
688722|NCT01514136|2237770|P2|Test Period 2; Test B*|Withdrawal by Subject|0
688723|NCT01514136|2237771|P1|Test Period 2; Test B*|Withdrawal by Subject|0
688724|NCT01514136|2237764|P8|Test Period 2; Test A*|Holiday|0
688725|NCT01514136|2237765|P7|Test Period 2; Test A*|Holiday|0
688726|NCT01514136|2237766|P6|Test Period 2; Test A*|Holiday|0
688727|NCT01514136|2237767|P5|Test Period 2; Test A*|Holiday|1
688728|NCT01514136|2237768|P4|Test Period 2; Test A*|Holiday|0
688729|NCT01514136|2237769|P3|Test Period 2; Test A*|Holiday|0
688730|NCT01514136|2237770|P2|Test Period 2; Test A*|Holiday|0
688731|NCT01514136|2237771|P1|Test Period 2; Test A*|Holiday|0
688732|NCT01514136|2237764|P8|Test Period 2; Test A*|Adverse Event|0
688733|NCT01514136|2237765|P7|Test Period 2; Test A*|Adverse Event|0
688734|NCT01514136|2237766|P6|Test Period 2; Test A*|Adverse Event|0
688735|NCT01514136|2237767|P5|Test Period 2; Test A*|Adverse Event|1
688736|NCT01514136|2237768|P4|Test Period 2; Test A*|Adverse Event|0
688737|NCT01514136|2237769|P3|Test Period 2; Test A*|Adverse Event|0
688738|NCT01514136|2237770|P2|Test Period 2; Test A*|Adverse Event|0
688739|NCT01514136|2237771|P1|Test Period 2; Test A*|Adverse Event|0
688740|NCT01514136|2237764|P8|Test Period 1; Test D|Subject took a break due to holiday|0
688741|NCT01514136|2237765|P7|Test Period 1; Test D|Subject took a break due to holiday|0
688742|NCT01514136|2237766|P6|Test Period 1; Test D|Subject took a break due to holiday|0
688743|NCT01514136|2237767|P5|Test Period 1; Test D|Subject took a break due to holiday|0
688744|NCT01514136|2237768|P4|Test Period 1; Test D|Subject took a break due to holiday|2
688745|NCT01514136|2237769|P3|Test Period 1; Test D|Subject took a break due to holiday|0
688746|NCT01514136|2237770|P2|Test Period 1; Test D|Subject took a break due to holiday|0
688747|NCT01514136|2237771|P1|Test Period 1; Test D|Subject took a break due to holiday|0
688748|NCT01514136|2237764|P8|Test Period 1; Test B|Withdrawal by Subject|0
688749|NCT01514136|2237765|P7|Test Period 1; Test B|Withdrawal by Subject|0
688750|NCT01514136|2237766|P6|Test Period 1; Test B|Withdrawal by Subject|0
688751|NCT01514136|2237767|P5|Test Period 1; Test B|Withdrawal by Subject|0
688752|NCT01514136|2237768|P4|Test Period 1; Test B|Withdrawal by Subject|0
688753|NCT01514136|2237769|P3|Test Period 1; Test B|Withdrawal by Subject|0
688754|NCT01514136|2237770|P2|Test Period 1; Test B|Withdrawal by Subject|1
688755|NCT01514136|2237771|P1|Test Period 1; Test B|Withdrawal by Subject|0
688756|NCT01514136|2237764|P8|Test Period 1; Test A|Break from study holiday|0
688757|NCT01514136|2237765|P7|Test Period 1; Test A|Break from study holiday|0
688758|NCT01514136|2237766|P6|Test Period 1; Test A|Break from study holiday|0
688759|NCT01514136|2237767|P5|Test Period 1; Test A|Break from study holiday|0
688760|NCT01514136|2237768|P4|Test Period 1; Test A|Break from study holiday|0
688761|NCT01514136|2237769|P3|Test Period 1; Test A|Break from study holiday|0
688762|NCT01514136|2237770|P2|Test Period 1; Test A|Break from study holiday|0
688763|NCT01514136|2237771|P1|Test Period 1; Test A|Break from study holiday|2
688764|NCT01514136|2237764|P8|Test Period 1; Test A|Protocol Violation|0
688765|NCT01514136|2237765|P7|Test Period 1; Test A|Protocol Violation|0
688766|NCT01514136|2237766|P6|Test Period 1; Test A|Protocol Violation|0
688767|NCT01514136|2237767|P5|Test Period 1; Test A|Protocol Violation|0
688768|NCT01514136|2237768|P4|Test Period 1; Test A|Protocol Violation|0
688769|NCT01514136|2237769|P3|Test Period 1; Test A|Protocol Violation|0
688770|NCT01514136|2237770|P2|Test Period 1; Test A|Protocol Violation|0
688771|NCT01514136|2237771|P1|Test Period 1; Test A|Protocol Violation|1
688772|NCT01513590|2237839|P2|Overall Study|Unclassified|10
688773|NCT01513590|2237840|P1|Overall Study|Unclassified|5
688774|NCT01513590|2237839|P2|Overall Study|Withdrawal Criteria|0
688775|NCT01513590|2237840|P1|Overall Study|Withdrawal Criteria|3
688776|NCT01513590|2237839|P2|Overall Study|Adverse Event|3
688777|NCT01513590|2237840|P1|Overall Study|Adverse Event|2
688778|NCT01513473|2237860|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
688779|NCT01513473|2237861|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
688780|NCT01513473|2237860|P2|Extension Trial (26 Weeks)|Adverse Event|1
688781|NCT01513473|2237861|P1|Extension Trial (26 Weeks)|Adverse Event|0
688782|NCT01513473|2237860|P2|Main Trial (26 Weeks)|Unclassified|2
688783|NCT01513473|2237861|P1|Main Trial (26 Weeks)|Unclassified|0
688784|NCT01513473|2237860|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
688785|NCT01513473|2237861|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
688786|NCT01513473|2237860|P2|Main Trial (26 Weeks)|Adverse Event|2
688787|NCT01513473|2237861|P1|Main Trial (26 Weeks)|Adverse Event|0
688788|NCT01513460|2237888|P3|Overall Study|Abnormal test procedure|0
688789|NCT01513460|2237889|P2|Overall Study|Abnormal test procedure|0
688790|NCT01513460|2237890|P1|Overall Study|Abnormal test procedure|1
688791|NCT01513460|2237888|P3|Overall Study|Adverse Event|23
688792|NCT01513460|2237889|P2|Overall Study|Adverse Event|18
688793|NCT01513460|2237890|P1|Overall Study|Adverse Event|16
688794|NCT01513460|2237888|P3|Overall Study|Withdrawal by Subject|21
688795|NCT01513460|2237889|P2|Overall Study|Withdrawal by Subject|8
688796|NCT01513460|2237890|P1|Overall Study|Withdrawal by Subject|7
688797|NCT01513460|2237888|P3|Overall Study|Protocol deviations|3
688798|NCT01513460|2237889|P2|Overall Study|Protocol deviations|4
688799|NCT01513460|2237890|P1|Overall Study|Protocol deviations|3
688800|NCT01513460|2237888|P3|Overall Study|Lack of Efficacy|5
688801|NCT01513460|2237889|P2|Overall Study|Lack of Efficacy|2
688802|NCT01513460|2237890|P1|Overall Study|Lack of Efficacy|1
688803|NCT01513460|2237888|P3|Overall Study|Abnormal laboratory value|1
688804|NCT01513460|2237889|P2|Overall Study|Abnormal laboratory value|0
688805|NCT01513460|2237890|P1|Overall Study|Abnormal laboratory value|1
688806|NCT01513460|2237888|P3|Overall Study|Lost to Follow-up|2
688807|NCT01513460|2237889|P2|Overall Study|Lost to Follow-up|0
688808|NCT01513460|2237890|P1|Overall Study|Lost to Follow-up|0
688809|NCT01513460|2237888|P3|Overall Study|Death|1
688810|NCT01513460|2237889|P2|Overall Study|Death|0
688811|NCT01513460|2237890|P1|Overall Study|Death|0
688812|NCT01513330|2237925|P2|Standard Care First,|not known|0
688813|NCT01513330|2237926|P1|Standard Care First,|not known|1
688814|NCT01513330|2237925|P2|Standard Care First,|Withdrawal by Subject|2
688815|NCT01513330|2237926|P1|Standard Care First,|Withdrawal by Subject|1
688816|NCT01513330|2237925|P2|Standard Care First,|Lack of Efficacy|2
688817|NCT01513330|2237926|P1|Standard Care First,|Lack of Efficacy|2
688818|NCT01513330|2237925|P2|SenSura Mio First,|not known|0
688819|NCT01513330|2237926|P1|SenSura Mio First,|not known|1
688820|NCT01513330|2237925|P2|SenSura Mio First,|Withdrawal by Subject|1
688821|NCT01513330|2237926|P1|SenSura Mio First,|Withdrawal by Subject|1
688822|NCT01513330|2237925|P2|SenSura Mio First,|Lack of Efficacy|1
688823|NCT01513330|2237926|P1|SenSura Mio First,|Lack of Efficacy|0
688824|NCT01513330|2237925|P2|SenSura Mio First,|Adverse Event|0
688825|NCT01513330|2237926|P1|SenSura Mio First,|Adverse Event|2
688826|NCT01513317|2237934|P2|Overall Study|Not specified|1
688827|NCT01513317|2237935|P1|Overall Study|Not specified|0
688828|NCT01513317|2237934|P2|Overall Study|Study terminated by sponsor|18
688829|NCT01513317|2237935|P1|Overall Study|Study terminated by sponsor|18
688830|NCT01513317|2237934|P2|Overall Study|Death|1
688831|NCT01513317|2237935|P1|Overall Study|Death|1
688832|NCT01513317|2237934|P2|Overall Study|Withdrawal by Subject|4
688833|NCT01513317|2237935|P1|Overall Study|Withdrawal by Subject|15
688834|NCT01513291|2237953|P5|Run-out Period|Withdrawal by Subject|0
688835|NCT01513291|2237954|P4|Run-out Period|Withdrawal by Subject|1
688836|NCT01513291|2237955|P3|Run-out Period|Withdrawal by Subject|0
688837|NCT01513291|2237956|P2|Run-out Period|Withdrawal by Subject|0
688838|NCT01513291|2237957|P1|Run-out Period|Withdrawal by Subject|0
688839|NCT01513291|2237953|P5|Run-out Period|Lost to Follow-up|0
688840|NCT01513291|2237954|P4|Run-out Period|Lost to Follow-up|1
688841|NCT01513291|2237955|P3|Run-out Period|Lost to Follow-up|0
688842|NCT01513291|2237956|P2|Run-out Period|Lost to Follow-up|0
688843|NCT01513291|2237957|P1|Run-out Period|Lost to Follow-up|0
688844|NCT01513291|2237953|P5|Treatment Period|Randomized not treated|0
688845|NCT01513291|2237954|P4|Treatment Period|Randomized not treated|0
688846|NCT01513291|2237955|P3|Treatment Period|Randomized not treated|0
688847|NCT01513291|2237956|P2|Treatment Period|Randomized not treated|2
688848|NCT01513291|2237957|P1|Treatment Period|Randomized not treated|0
688849|NCT01513291|2237953|P5|Treatment Period|Withdrawal by Subject|0
688850|NCT01513291|2237954|P4|Treatment Period|Withdrawal by Subject|0
688851|NCT01513291|2237955|P3|Treatment Period|Withdrawal by Subject|0
688852|NCT01513291|2237956|P2|Treatment Period|Withdrawal by Subject|5
688853|NCT01513291|2237957|P1|Treatment Period|Withdrawal by Subject|8
688854|NCT01513291|2237953|P5|Treatment Period|Protocol Violation|0
688855|NCT01513291|2237954|P4|Treatment Period|Protocol Violation|0
688856|NCT01513291|2237955|P3|Treatment Period|Protocol Violation|0
688857|NCT01513291|2237956|P2|Treatment Period|Protocol Violation|2
688858|NCT01513291|2237957|P1|Treatment Period|Protocol Violation|1
688859|NCT01513291|2237953|P5|Treatment Period|Physician Decision|0
688860|NCT01513291|2237954|P4|Treatment Period|Physician Decision|0
688861|NCT01513291|2237955|P3|Treatment Period|Physician Decision|0
688862|NCT01513291|2237956|P2|Treatment Period|Physician Decision|0
688863|NCT01513291|2237957|P1|Treatment Period|Physician Decision|1
688864|NCT01513291|2237953|P5|Treatment Period|Lost to Follow-up|0
688865|NCT01513291|2237954|P4|Treatment Period|Lost to Follow-up|0
688866|NCT01513291|2237955|P3|Treatment Period|Lost to Follow-up|0
688867|NCT01513291|2237956|P2|Treatment Period|Lost to Follow-up|3
688868|NCT01513291|2237957|P1|Treatment Period|Lost to Follow-up|2
688869|NCT01513291|2237953|P5|Treatment Period|Lack of Efficacy|0
688870|NCT01513291|2237954|P4|Treatment Period|Lack of Efficacy|0
688871|NCT01513291|2237955|P3|Treatment Period|Lack of Efficacy|0
688872|NCT01513291|2237956|P2|Treatment Period|Lack of Efficacy|0
688873|NCT01513291|2237957|P1|Treatment Period|Lack of Efficacy|3
688874|NCT01513291|2237953|P5|Treatment Period|Adverse Event|0
688875|NCT01513291|2237954|P4|Treatment Period|Adverse Event|0
688876|NCT01513291|2237955|P3|Treatment Period|Adverse Event|0
688877|NCT01513291|2237956|P2|Treatment Period|Adverse Event|4
688878|NCT01513291|2237957|P1|Treatment Period|Adverse Event|8
688879|NCT01513239|2237985|P3|Overall Study|Withdrawal by Subject|42
688880|NCT01513239|2237986|P2|Overall Study|Withdrawal by Subject|29
688881|NCT01513239|2237987|P1|Overall Study|Withdrawal by Subject|27
688882|NCT01513239|2237985|P3|Overall Study|Technical Problems|0
688883|NCT01513239|2237986|P2|Overall Study|Technical Problems|2
688884|NCT01513239|2237987|P1|Overall Study|Technical Problems|1
688885|NCT01513239|2237985|P3|Overall Study|Protocol Violation|2
688886|NCT01513239|2237986|P2|Overall Study|Protocol Violation|2
688887|NCT01513239|2237987|P1|Overall Study|Protocol Violation|2
688888|NCT01513239|2237985|P3|Overall Study|Physician Decision|4
688889|NCT01513239|2237986|P2|Overall Study|Physician Decision|4
688890|NCT01513239|2237987|P1|Overall Study|Physician Decision|4
688891|NCT01513239|2237985|P3|Overall Study|Lost to Follow-up|6
688892|NCT01513239|2237986|P2|Overall Study|Lost to Follow-up|10
688893|NCT01513239|2237987|P1|Overall Study|Lost to Follow-up|11
688894|NCT01513239|2237985|P3|Overall Study|Death|32
688895|NCT01513239|2237986|P2|Overall Study|Death|22
688896|NCT01513239|2237987|P1|Overall Study|Death|29
688897|NCT01513239|2237985|P3|Overall Study|Adverse Event|2
688898|NCT01513239|2237986|P2|Overall Study|Adverse Event|1
688899|NCT01513239|2237987|P1|Overall Study|Adverse Event|1
688900|NCT01513148|2238037|P2|Overall Study|Protocol Violation|2
688901|NCT01513148|2238038|P1|Overall Study|Protocol Violation|2
688902|NCT01512979|2238105|P2|Overall Study|Reason other than stated above|9
688903|NCT01512979|2238106|P1|Overall Study|Reason other than stated above|13
688904|NCT01512979|2238105|P2|Overall Study|Withdrawal by Subject|2
688905|NCT01512979|2238106|P1|Overall Study|Withdrawal by Subject|1
688906|NCT01512979|2238105|P2|Overall Study|Lost to Follow-up|5
688907|NCT01512979|2238106|P1|Overall Study|Lost to Follow-up|2
688908|NCT01512979|2238105|P2|Overall Study|Protocol Violation|4
688909|NCT01512979|2238106|P1|Overall Study|Protocol Violation|1
688910|NCT01512979|2238105|P2|Overall Study|Adverse Event|2
688911|NCT01512979|2238106|P1|Overall Study|Adverse Event|2
688912|NCT01512745|2238153|P2|Overall Study|Protocol Violation|0
688913|NCT01512745|2238154|P1|Overall Study|Protocol Violation|1
688914|NCT01512745|2238153|P2|Overall Study|Lack of Efficacy|2
688915|NCT01512745|2238154|P1|Overall Study|Lack of Efficacy|2
688916|NCT01512745|2238153|P2|Overall Study|Lost to Follow-up|0
688917|NCT01512745|2238154|P1|Overall Study|Lost to Follow-up|4
688918|NCT01512745|2238153|P2|Overall Study|Withdrawal by Subject|2
688919|NCT01512745|2238154|P1|Overall Study|Withdrawal by Subject|2
688920|NCT01512745|2238153|P2|Overall Study|Death|13
688921|NCT01512745|2238154|P1|Overall Study|Death|9
688922|NCT01512745|2238153|P2|Overall Study|Adverse Event|3
688923|NCT01512745|2238154|P1|Overall Study|Adverse Event|22
688924|NCT01512368|2238168|P1|Overall Study|Protocol Violation|3
688925|NCT01512160|2238204|P4|Overall Study|Withdrawal by Subject|1
688926|NCT01512160|2238205|P3|Overall Study|Withdrawal by Subject|0
688927|NCT01512160|2238206|P2|Overall Study|Withdrawal by Subject|0
688928|NCT01512160|2238207|P1|Overall Study|Withdrawal by Subject|1
688929|NCT01512160|2238204|P4|Overall Study|Lost to Follow-up|0
688930|NCT01512160|2238205|P3|Overall Study|Lost to Follow-up|0
688931|NCT01512160|2238206|P2|Overall Study|Lost to Follow-up|0
688932|NCT01512160|2238207|P1|Overall Study|Lost to Follow-up|1
688933|NCT01512108|2238299|P2|Overall Study|Unclassified|3
688934|NCT01512108|2238300|P1|Overall Study|Unclassified|11
688935|NCT01512108|2238299|P2|Overall Study|Withdrawal Criteria|0
688936|NCT01512108|2238300|P1|Overall Study|Withdrawal Criteria|1
688937|NCT01512108|2238299|P2|Overall Study|Protocol Violation|2
688938|NCT01512108|2238300|P1|Overall Study|Protocol Violation|1
688939|NCT01512108|2238299|P2|Overall Study|Adverse Event|4
688940|NCT01512108|2238300|P1|Overall Study|Adverse Event|9
688941|NCT01511939|2238326|P3|Overall Study|Withdrawal by Subject|0
688942|NCT01511939|2238327|P2|Overall Study|Withdrawal by Subject|1
688943|NCT01511939|2238328|P1|Overall Study|Withdrawal by Subject|2
688944|NCT01511536|2238357|P3|Phase 2|Unspecified|9
688945|NCT01511536|2238358|P2|Phase 2|Unspecified|0
688946|NCT01511536|2238359|P1|Phase 2|Unspecified|0
688947|NCT01511536|2238357|P3|Phase 1|Unspecified|0
688948|NCT01511536|2238358|P2|Phase 1|Unspecified|1
688949|NCT01511536|2238359|P1|Phase 1|Unspecified|0
688950|NCT01511445|2238381|P2|Overall Study|Protocol Violation|0
688951|NCT01511445|2238382|P1|Overall Study|Protocol Violation|1
688952|NCT01511445|2238381|P2|Overall Study|Protocol Violation|3
688953|NCT01511445|2238382|P1|Overall Study|Protocol Violation|1
688954|NCT01511445|2238381|P2|Overall Study|Lost to Follow-up|1
688955|NCT01511445|2238382|P1|Overall Study|Lost to Follow-up|3
688956|NCT01511107|2238402|P2|Overall Study|Withdrawal by Subject|20
688957|NCT01511107|2238403|P1|Overall Study|Withdrawal by Subject|9
688958|NCT01511107|2238402|P2|Overall Study|Lost to Follow-up|19
688959|NCT01511107|2238403|P1|Overall Study|Lost to Follow-up|10
688960|NCT01511107|2238402|P2|Overall Study|Ineligible|2
688961|NCT01511107|2238403|P1|Overall Study|Ineligible|3
688962|NCT01510912|2238470|P1|Overall Study|Other, including joint replacement|5
688963|NCT01510912|2238470|P1|Overall Study|Lost to Follow-up|26
688964|NCT01510912|2238470|P1|Overall Study|Protocol Violation|27
688965|NCT01510912|2238470|P1|Overall Study|Physician Decision|1
688966|NCT01510912|2238470|P1|Overall Study|Withdrawal by Subject|49
688967|NCT01510912|2238470|P1|Overall Study|Non-compliance with trial drug|23
688968|NCT01510912|2238470|P1|Overall Study|Lack of Efficacy|12
688969|NCT01510912|2238470|P1|Overall Study|Adverse Event|99
688970|NCT01510769|2238486|P3|Overall Study|Death|0
688971|NCT01510769|2238487|P2|Overall Study|Death|1
688972|NCT01510769|2238488|P1|Overall Study|Death|1
688973|NCT01510769|2238486|P3|Overall Study|Withdrawal by Subject|3
688974|NCT01510769|2238487|P2|Overall Study|Withdrawal by Subject|4
688975|NCT01510769|2238488|P1|Overall Study|Withdrawal by Subject|3
688976|NCT01510769|2238486|P3|Overall Study|Lost to Follow-up|5
688977|NCT01510769|2238487|P2|Overall Study|Lost to Follow-up|1
688978|NCT01510769|2238488|P1|Overall Study|Lost to Follow-up|5
688979|NCT01510769|2238486|P3|Overall Study|Protocol Violation|9
688980|NCT01510769|2238487|P2|Overall Study|Protocol Violation|10
688981|NCT01510769|2238488|P1|Overall Study|Protocol Violation|11
688982|NCT01510769|2238486|P3|Overall Study|Gout Flare|1
688983|NCT01510769|2238487|P2|Overall Study|Gout Flare|3
688984|NCT01510769|2238488|P1|Overall Study|Gout Flare|0
688985|NCT01510769|2238486|P3|Overall Study|Adverse Event|4
688986|NCT01510769|2238487|P2|Overall Study|Adverse Event|6
688987|NCT01510769|2238488|P1|Overall Study|Adverse Event|7
688988|NCT01510756|2238505|P1|Overall Study|Physician Decision|1
688989|NCT01510756|2238505|P1|Overall Study|Lack of Efficacy|2
688990|NCT01510756|2238505|P1|Overall Study|Death|1
688991|NCT01510717|2238513|P2|Overall Study|Withdrawal by Subject|2
688992|NCT01510717|2238514|P1|Overall Study|Withdrawal by Subject|0
688993|NCT01510717|2238513|P2|Overall Study|Lost to Follow-up|1
688994|NCT01510717|2238514|P1|Overall Study|Lost to Follow-up|0
688995|NCT01510717|2238513|P2|Overall Study|Death|0
688996|NCT01510717|2238514|P1|Overall Study|Death|1
688997|NCT01510717|2238513|P2|Overall Study|Adverse Event|2
688998|NCT01510717|2238514|P1|Overall Study|Adverse Event|1
688999|NCT01510158|2238634|P3|Overall Study|Death|0
689000|NCT01510158|2238635|P2|Overall Study|Death|0
689001|NCT01510158|2238636|P1|Overall Study|Death|1
689002|NCT01510158|2238634|P3|Overall Study|Withdrawal by Subject|10
689003|NCT01510158|2238635|P2|Overall Study|Withdrawal by Subject|13
689004|NCT01510158|2238636|P1|Overall Study|Withdrawal by Subject|10
689005|NCT01510158|2238634|P3|Overall Study|Lost to Follow-up|9
689006|NCT01510158|2238635|P2|Overall Study|Lost to Follow-up|16
689007|NCT01510158|2238636|P1|Overall Study|Lost to Follow-up|13
689008|NCT01510158|2238634|P3|Overall Study|Sponsor terminated study.|2
689009|NCT01510158|2238635|P2|Overall Study|Sponsor terminated study.|0
689010|NCT01510158|2238636|P1|Overall Study|Sponsor terminated study.|2
689011|NCT01510158|2238634|P3|Overall Study|Protocol Violation|24
689012|NCT01510158|2238635|P2|Overall Study|Protocol Violation|16
689013|NCT01510158|2238636|P1|Overall Study|Protocol Violation|17
689014|NCT01510158|2238634|P3|Overall Study|Gout flare|0
689015|NCT01510158|2238635|P2|Overall Study|Gout flare|0
689016|NCT01510158|2238636|P1|Overall Study|Gout flare|1
689017|NCT01510158|2238634|P3|Overall Study|Adverse Event|5
689018|NCT01510158|2238635|P2|Overall Study|Adverse Event|8
689019|NCT01510158|2238636|P1|Overall Study|Adverse Event|7
689020|NCT01510145|2238650|P1|Overall Study|Relative reported subject withdrew|1
689021|NCT01510145|2238650|P1|Overall Study|Withdrawal by Subject|6
689022|NCT01510145|2238650|P1|Overall Study|Lost to Follow-up|5
689023|NCT01510145|2238650|P1|Overall Study|Adverse Event|6
689024|NCT01509664|2238684|P2|Overall Study|Lost to Follow-up|21
689025|NCT01509664|2238685|P1|Overall Study|Lost to Follow-up|15
689026|NCT01509079|2238760|P2|Overall Study|started an excluded medication|1
689027|NCT01509079|2238761|P1|Overall Study|started an excluded medication|0
689028|NCT01509079|2238760|P2|Overall Study|Lack of Efficacy|2
689029|NCT01509079|2238761|P1|Overall Study|Lack of Efficacy|0
689030|NCT01509053|2238777|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
689031|NCT01509053|2238777|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
689032|NCT01509053|2238777|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
689033|NCT01509053|2238777|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
689034|NCT01509053|2238777|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
689035|NCT01509053|2238777|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
689036|NCT01508936|2238839|P2|Overall Study|Data from 2 sites deemed invalid|11
689037|NCT01508936|2238840|P1|Overall Study|Data from 2 sites deemed invalid|4
689038|NCT01508936|2238839|P2|Overall Study|Not specified|5
689039|NCT01508936|2238840|P1|Overall Study|Not specified|0
689040|NCT01508936|2238839|P2|Overall Study|Lost to Follow-up|9
689041|NCT01508936|2238840|P1|Overall Study|Lost to Follow-up|2
689042|NCT01508936|2238839|P2|Overall Study|Protocol Violation|3
689043|NCT01508936|2238840|P1|Overall Study|Protocol Violation|2
689044|NCT01508936|2238839|P2|Overall Study|Withdrawal by Subject|18
689045|NCT01508936|2238840|P1|Overall Study|Withdrawal by Subject|4
689046|NCT01508936|2238839|P2|Overall Study|Lack of Efficacy|1
689047|NCT01508936|2238840|P1|Overall Study|Lack of Efficacy|0
689048|NCT01508936|2238839|P2|Overall Study|Adverse Event|32
689049|NCT01508936|2238840|P1|Overall Study|Adverse Event|11
889232|NCT01372410|2823753|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
889233|NCT01372410|2823754|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
889234|NCT01372410|2823755|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
889235|NCT01372410|2823756|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
889236|NCT01372410|2823757|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
889237|NCT01372410|2823758|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
889238|NCT01372410|2823759|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
889239|NCT01372410|2823760|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
889240|NCT01372410|2823753|P8|Treatment Period 3 (7 Days)|Adverse Event|0
889241|NCT01372410|2823754|P7|Treatment Period 3 (7 Days)|Adverse Event|0
889242|NCT01372410|2823755|P6|Treatment Period 3 (7 Days)|Adverse Event|0
889243|NCT01372410|2823756|P5|Treatment Period 3 (7 Days)|Adverse Event|0
889244|NCT01372410|2823757|P4|Treatment Period 3 (7 Days)|Adverse Event|0
889245|NCT01372410|2823758|P3|Treatment Period 3 (7 Days)|Adverse Event|1
689066|NCT01508702|2238915|P2|Overall Study|Withdrawal by Subject|7
689067|NCT01508702|2238916|P1|Overall Study|Withdrawal by Subject|11
689068|NCT01508702|2238915|P2|Overall Study|Lost to Follow-up|2
689069|NCT01508702|2238916|P1|Overall Study|Lost to Follow-up|1
689070|NCT01508702|2238915|P2|Overall Study|Protocol Violation|1
689071|NCT01508702|2238916|P1|Overall Study|Protocol Violation|2
689072|NCT01508702|2238915|P2|Overall Study|Gout flare|0
689073|NCT01508702|2238916|P1|Overall Study|Gout flare|2
689074|NCT01508702|2238915|P2|Overall Study|Adverse Event|3
689075|NCT01508702|2238916|P1|Overall Study|Adverse Event|7
689076|NCT01508676|2238924|P2|Phase II (2 Weeks)|Medication Exclusion|0
689077|NCT01508676|2238925|P1|Phase II (2 Weeks)|Medication Exclusion|1
689078|NCT01508676|2238924|P2|Phase II (2 Weeks)|Skin Sensitivity|1
689079|NCT01508676|2238925|P1|Phase II (2 Weeks)|Skin Sensitivity|0
689080|NCT01508676|2238924|P2|Phase I (2 Weeks)|Positive Drug Screen|2
689081|NCT01508676|2238925|P1|Phase I (2 Weeks)|Positive Drug Screen|0
689082|NCT01508676|2238924|P2|Phase I (2 Weeks)|Wrong Pain Type|0
689083|NCT01508676|2238925|P1|Phase I (2 Weeks)|Wrong Pain Type|1
689084|NCT01508676|2238924|P2|Phase I (2 Weeks)|Medication Exclusion|1
689085|NCT01508676|2238925|P1|Phase I (2 Weeks)|Medication Exclusion|1
689086|NCT01508325|2238946|P2|Overall Study|Unspecified|2
689087|NCT01508325|2238947|P1|Overall Study|Unspecified|2
689088|NCT01508325|2238946|P2|Overall Study|Lost to Follow-up|6
689089|NCT01508325|2238947|P1|Overall Study|Lost to Follow-up|5
689090|NCT01508325|2238946|P2|Overall Study|Adverse Event|0
689091|NCT01508325|2238947|P1|Overall Study|Adverse Event|1
689092|NCT01508325|2238946|P2|Overall Study|Physician Decision|1
689093|NCT01508325|2238947|P1|Overall Study|Physician Decision|2
689094|NCT01508325|2238946|P2|Overall Study|Protocol Violation|3
689095|NCT01508325|2238947|P1|Overall Study|Protocol Violation|0
689096|NCT01508325|2238946|P2|Overall Study|Withdrawal by Subject|9
689097|NCT01508325|2238947|P1|Overall Study|Withdrawal by Subject|8
689098|NCT01508169|2238977|P2|Overall Study|Lost to Follow-up|2
689099|NCT01508169|2238978|P1|Overall Study|Lost to Follow-up|1
689100|NCT01508169|2238977|P2|Overall Study|Withdrawal by Subject|0
689101|NCT01508169|2238978|P1|Overall Study|Withdrawal by Subject|1
689102|NCT01508169|2238977|P2|Overall Study|Adverse Event|0
689103|NCT01508169|2238978|P1|Overall Study|Adverse Event|1
689104|NCT01508130|2238992|P2|Overall Study|Administrative|3
689105|NCT01508130|2238993|P1|Overall Study|Administrative|14
689106|NCT01508130|2238992|P2|Overall Study|Insufficient therapeutic response|23
689107|NCT01508130|2238993|P1|Overall Study|Insufficient therapeutic response|74
689108|NCT01508130|2238992|P2|Overall Study|Subject’s substantial non-compliance|9
689109|NCT01508130|2238993|P1|Overall Study|Subject’s substantial non-compliance|25
689110|NCT01508130|2238992|P2|Overall Study|Withdrawal by Subject|3
689111|NCT01508130|2238993|P1|Overall Study|Withdrawal by Subject|3
689112|NCT01508130|2238992|P2|Overall Study|Lost to Follow-up|2
689113|NCT01508130|2238993|P1|Overall Study|Lost to Follow-up|25
689114|NCT01508130|2238992|P2|Overall Study|Protocol Violation|0
689115|NCT01508130|2238993|P1|Overall Study|Protocol Violation|2
689116|NCT01508130|2238992|P2|Overall Study|Death|1
689117|NCT01508130|2238993|P1|Overall Study|Death|3
689118|NCT01508130|2238992|P2|Overall Study|Adverse Event|28
689119|NCT01508130|2238993|P1|Overall Study|Adverse Event|81
689122|NCT01507831|2239104|P2|Overall Study|Unspecified|6
689123|NCT01507831|2239105|P1|Overall Study|Unspecified|3
689124|NCT01507831|2239104|P2|Overall Study|Potential lost to follow-up|0
689125|NCT01507831|2239105|P1|Overall Study|Potential lost to follow-up|3
689126|NCT01507831|2239104|P2|Overall Study|Site closure|3
689127|NCT01507831|2239105|P1|Overall Study|Site closure|0
689128|NCT01507831|2239104|P2|Overall Study|Selection criteria finally not met|1
689129|NCT01507831|2239105|P1|Overall Study|Selection criteria finally not met|0
689130|NCT01507831|2239104|P2|Overall Study|Last visit outside protocol visit window|143
689131|NCT01507831|2239105|P1|Overall Study|Last visit outside protocol visit window|51
689132|NCT01507831|2239104|P2|Overall Study|Related to study drug administration|14
689133|NCT01507831|2239105|P1|Overall Study|Related to study drug administration|5
689134|NCT01507831|2239104|P2|Overall Study|Consent withdrawn by participant|72
689135|NCT01507831|2239105|P1|Overall Study|Consent withdrawn by participant|34
689136|NCT01507831|2239104|P2|Overall Study|Participant moved|19
689137|NCT01507831|2239105|P1|Overall Study|Participant moved|5
689138|NCT01507831|2239104|P2|Overall Study|Physician Decision|4
689139|NCT01507831|2239105|P1|Overall Study|Physician Decision|0
689140|NCT01507831|2239104|P2|Overall Study|Poor compliance to protocol|60
689141|NCT01507831|2239105|P1|Overall Study|Poor compliance to protocol|38
689142|NCT01507831|2239104|P2|Overall Study|Death|2
689143|NCT01507831|2239105|P1|Overall Study|Death|6
689144|NCT01507831|2239104|P2|Overall Study|Adverse Event|113
689145|NCT01507831|2239105|P1|Overall Study|Adverse Event|48
689146|NCT01507831|2239104|P2|Overall Study|Randomized but not treated|3
689147|NCT01507831|2239105|P1|Overall Study|Randomized but not treated|0
689148|NCT01507662|2239175|P2|Overall Study|Proxy interview done|3
689149|NCT01507662|2239176|P1|Overall Study|Proxy interview done|2
689150|NCT01507662|2239175|P2|Overall Study|Lost to Follow-up|523
689151|NCT01507662|2239176|P1|Overall Study|Lost to Follow-up|498
689152|NCT01507662|2239175|P2|Overall Study|Withdrawal by Subject|287
689153|NCT01507662|2239176|P1|Overall Study|Withdrawal by Subject|290
689154|NCT01507662|2239175|P2|Overall Study|Death|18
689155|NCT01507662|2239176|P1|Overall Study|Death|26
689156|NCT01507246|2239201|P2|Overall Study|Required different surgical procedures|1
689157|NCT01507246|2239202|P1|Overall Study|Required different surgical procedures|2
689158|NCT01507090|2239300|P1|Overall Study|incomplete dataset|18
689159|NCT01507051|2239339|P4|Overall Study|Adverse Event|0
689160|NCT01507051|2239340|P3|Overall Study|Adverse Event|0
689161|NCT01507051|2239341|P2|Overall Study|Adverse Event|0
689162|NCT01507051|2239342|P1|Overall Study|Adverse Event|1
689163|NCT01507051|2239339|P4|Overall Study|Physician Decision|1
689164|NCT01507051|2239340|P3|Overall Study|Physician Decision|0
689165|NCT01507051|2239341|P2|Overall Study|Physician Decision|0
689166|NCT01507051|2239342|P1|Overall Study|Physician Decision|0
689167|NCT01507051|2239339|P4|Overall Study|Withdrawal by Subject|6
689168|NCT01507051|2239340|P3|Overall Study|Withdrawal by Subject|1
689169|NCT01507051|2239341|P2|Overall Study|Withdrawal by Subject|3
689170|NCT01507051|2239342|P1|Overall Study|Withdrawal by Subject|1
689171|NCT01506960|2239460|P1|Overall Study|Did not meet angiographic criteria|47
689172|NCT01506947|2239466|P1|Overall Study|Did Not Meet Eligibility Criteria|3
689173|NCT01506947|2239466|P1|Overall Study|Death|1
689174|NCT01506947|2239466|P1|Overall Study|Adverse Event|5
689175|NCT01506947|2239466|P1|Overall Study|Lost to Follow-up|7
689176|NCT01506908|2239484|P2|Overall Study|Adverse Event|0
689177|NCT01506908|2239485|P1|Overall Study|Adverse Event|1
689178|NCT01506882|2239503|P2|Overall Study|Other Reason|0
689179|NCT01506882|2239504|P1|Overall Study|Other Reason|2
689180|NCT01506882|2239503|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
689181|NCT01506882|2239504|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
689182|NCT01506882|2239503|P2|Overall Study|AE, non-serious non-fatal|1
689183|NCT01506882|2239504|P1|Overall Study|AE, non-serious non-fatal|3
689184|NCT01506882|2239503|P2|Overall Study|SAE, non-fatal|0
689185|NCT01506882|2239504|P1|Overall Study|SAE, non-fatal|2
689186|NCT01506882|2239503|P2|Overall Study|Withdrawal by Subject|3
689187|NCT01506882|2239504|P1|Overall Study|Withdrawal by Subject|9
689188|NCT01506882|2239503|P2|Overall Study|Lost to Follow-up|0
689189|NCT01506882|2239504|P1|Overall Study|Lost to Follow-up|1
689190|NCT01506882|2239503|P2|Overall Study|Lack of Efficacy|3
689191|NCT01506882|2239504|P1|Overall Study|Lack of Efficacy|4
689192|NCT01506726|2239518|P2|Overall Study|Adverse Event|2
689193|NCT01506726|2239519|P1|Overall Study|Adverse Event|1
689194|NCT01506596|2239559|P1|Overall Study|ineligible pathology|1
689195|NCT01506323|2239573|P2|Overall Study|Started another treatment|0
689196|NCT01506323|2239574|P1|Overall Study|Started another treatment|1
689197|NCT01506323|2239573|P2|Overall Study|Schedule or Transportation conflict|0
689198|NCT01506323|2239574|P1|Overall Study|Schedule or Transportation conflict|8
689199|NCT01506323|2239573|P2|Overall Study|Moved out of area|2
689200|NCT01506323|2239574|P1|Overall Study|Moved out of area|5
689201|NCT01506323|2239573|P2|Overall Study|Lack of Efficacy|3
689202|NCT01506323|2239574|P1|Overall Study|Lack of Efficacy|1
689203|NCT01506323|2239573|P2|Overall Study|Withdrawal by Subject|4
689204|NCT01506323|2239574|P1|Overall Study|Withdrawal by Subject|4
689205|NCT01506323|2239573|P2|Overall Study|Lost to Follow-up|4
689206|NCT01506323|2239574|P1|Overall Study|Lost to Follow-up|5
689207|NCT01506193|2239603|P3|Overall Study|Lost to Follow-up|3
689208|NCT01506193|2239604|P2|Overall Study|Lost to Follow-up|3
689209|NCT01506193|2239605|P1|Overall Study|Lost to Follow-up|8
689210|NCT01506193|2239603|P3|Overall Study|Withdrawal by Subject|8
689211|NCT01506193|2239604|P2|Overall Study|Withdrawal by Subject|1
689212|NCT01506193|2239605|P1|Overall Study|Withdrawal by Subject|5
689213|NCT01506193|2239603|P3|Overall Study|Adverse event, non-fatal|1
689214|NCT01506193|2239604|P2|Overall Study|Adverse event, non-fatal|0
689215|NCT01506193|2239605|P1|Overall Study|Adverse event, non-fatal|0
689216|NCT01506193|2239603|P3|Overall Study|Migrated/moved from study area|1
689217|NCT01506193|2239604|P2|Overall Study|Migrated/moved from study area|0
689218|NCT01506193|2239605|P1|Overall Study|Migrated/moved from study area|0
689219|NCT01506193|2239603|P3|Overall Study|Protocol Violation|1
689220|NCT01506193|2239604|P2|Overall Study|Protocol Violation|0
689221|NCT01506193|2239605|P1|Overall Study|Protocol Violation|1
689222|NCT01505881|2239638|P2|Overall Study|Withdrawal by Subject|0
689223|NCT01505881|2239639|P1|Overall Study|Withdrawal by Subject|2
689224|NCT01505881|2239638|P2|Overall Study|Lost to Follow-up|0
689225|NCT01505881|2239639|P1|Overall Study|Lost to Follow-up|2
689226|NCT01505881|2239638|P2|Overall Study|Adverse Event|1
689227|NCT01505881|2239639|P1|Overall Study|Adverse Event|0
689228|NCT01505647|2239662|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
689229|NCT01505647|2239663|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
689230|NCT01505647|2239662|P2|Day 43 Through Day 182 Follow-up|Death|1
689231|NCT01505647|2239663|P1|Day 43 Through Day 182 Follow-up|Death|0
689232|NCT01505647|2239662|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
689233|NCT01505647|2239663|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
689234|NCT01505647|2239662|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
689235|NCT01505647|2239663|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
689236|NCT01505647|2239662|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
689237|NCT01505647|2239663|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
689238|NCT01505608|2239679|P2|Phase II|Protocol Violation|1
689239|NCT01505608|2239680|P1|Phase II|Protocol Violation|0
689240|NCT01505608|2239679|P2|Phase II|Lack of Efficacy|1
689241|NCT01505608|2239680|P1|Phase II|Lack of Efficacy|2
689242|NCT01505608|2239679|P2|Phase I|Withdrawal by Subject|1
689243|NCT01505608|2239680|P1|Phase I|Withdrawal by Subject|0
689244|NCT01505608|2239679|P2|Phase I|Adverse Event|1
689245|NCT01505608|2239680|P1|Phase I|Adverse Event|0
689246|NCT01505608|2239679|P2|Phase I|Lack of Efficacy|4
689247|NCT01505608|2239680|P1|Phase I|Lack of Efficacy|0
689248|NCT01505387|2239715|P2|Overall Study|Withdrawal by Subject|1
689249|NCT01505387|2239716|P1|Overall Study|Withdrawal by Subject|1
689250|NCT01505387|2239715|P2|Overall Study|Protocol Violation|0
689251|NCT01505387|2239716|P1|Overall Study|Protocol Violation|1
689252|NCT01505374|2239722|P2|Overall Study|Lost to Follow-up|0
689253|NCT01505374|2239723|P1|Overall Study|Lost to Follow-up|1
689254|NCT01505114|2239741|P4|Overall Study|investigator decision|0
689255|NCT01505114|2239742|P3|Overall Study|investigator decision|1
689256|NCT01505114|2239743|P2|Overall Study|investigator decision|0
689257|NCT01505114|2239744|P1|Overall Study|investigator decision|1
689258|NCT01505114|2239741|P4|Overall Study|staff safety concerns|1
689259|NCT01505114|2239742|P3|Overall Study|staff safety concerns|0
689260|NCT01505114|2239743|P2|Overall Study|staff safety concerns|0
689261|NCT01505114|2239744|P1|Overall Study|staff safety concerns|0
689262|NCT01505114|2239741|P4|Overall Study|inadvertent enrollment due to peanut all|1
689263|NCT01505114|2239742|P3|Overall Study|inadvertent enrollment due to peanut all|0
689264|NCT01505114|2239743|P2|Overall Study|inadvertent enrollment due to peanut all|0
689265|NCT01505114|2239744|P1|Overall Study|inadvertent enrollment due to peanut all|0
689266|NCT01505114|2239741|P4|Overall Study|relocated|3
689267|NCT01505114|2239742|P3|Overall Study|relocated|2
689268|NCT01505114|2239743|P2|Overall Study|relocated|2
689269|NCT01505114|2239744|P1|Overall Study|relocated|4
689270|NCT01505114|2239741|P4|Overall Study|Lost to Follow-up|7
689271|NCT01505114|2239742|P3|Overall Study|Lost to Follow-up|8
689272|NCT01505114|2239743|P2|Overall Study|Lost to Follow-up|5
689273|NCT01505114|2239744|P1|Overall Study|Lost to Follow-up|11
689274|NCT01505114|2239741|P4|Overall Study|unable to adhere to visit schedule|3
689275|NCT01505114|2239742|P3|Overall Study|unable to adhere to visit schedule|3
689276|NCT01505114|2239743|P2|Overall Study|unable to adhere to visit schedule|2
689277|NCT01505114|2239744|P1|Overall Study|unable to adhere to visit schedule|3
689278|NCT01505114|2239741|P4|Overall Study|Death|1
689279|NCT01505114|2239742|P3|Overall Study|Death|0
689280|NCT01505114|2239743|P2|Overall Study|Death|0
689281|NCT01505114|2239744|P1|Overall Study|Death|1
689282|NCT01505114|2239741|P4|Overall Study|Withdrawal by Subject|7
689283|NCT01505114|2239742|P3|Overall Study|Withdrawal by Subject|4
689284|NCT01505114|2239743|P2|Overall Study|Withdrawal by Subject|4
689285|NCT01505114|2239744|P1|Overall Study|Withdrawal by Subject|5
689286|NCT01504971|2239758|P1|Overall Study|Physician Decision|13
689287|NCT01504867|2239787|P2|Overall Study|Consent revoked|1
689288|NCT01504867|2239788|P1|Overall Study|Consent revoked|5
689289|NCT01504867|2239787|P2|Overall Study|Inclusion criteria not met|2
689290|NCT01504867|2239788|P1|Overall Study|Inclusion criteria not met|2
689291|NCT01503021|2239841|P2|Overall Study|Moved, received transplant, etc.|7
689292|NCT01503021|2239842|P1|Overall Study|Moved, received transplant, etc.|5
689293|NCT01503021|2239841|P2|Overall Study|Withdrawal by Subject|8
689294|NCT01503021|2239842|P1|Overall Study|Withdrawal by Subject|9
689295|NCT01503021|2239841|P2|Overall Study|Protocol Violation|3
689296|NCT01503021|2239842|P1|Overall Study|Protocol Violation|1
689297|NCT01503021|2239841|P2|Overall Study|Physician Decision|0
689298|NCT01503021|2239842|P1|Overall Study|Physician Decision|3
689299|NCT01503021|2239841|P2|Overall Study|Lost to Follow-up|0
689300|NCT01503021|2239842|P1|Overall Study|Lost to Follow-up|2
689301|NCT01503021|2239841|P2|Overall Study|Death|2
689302|NCT01503021|2239842|P1|Overall Study|Death|0
689303|NCT01503021|2239841|P2|Overall Study|Adverse Event|6
689304|NCT01503021|2239842|P1|Overall Study|Adverse Event|7
689305|NCT01502709|2239919|P2|Overall Study|Lost to Follow-up|0
689306|NCT01502709|2239920|P1|Overall Study|Lost to Follow-up|4
689307|NCT01502644|2239933|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
689308|NCT01502644|2239934|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
689309|NCT01502644|2239935|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
689310|NCT01502644|2239936|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
689311|NCT01502644|2239933|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
689312|NCT01502644|2239934|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
689313|NCT01502644|2239935|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
689314|NCT01502644|2239936|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
689315|NCT01502644|2239933|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
689316|NCT01502644|2239934|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
689317|NCT01502644|2239935|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
689318|NCT01502644|2239936|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
689319|NCT01502644|2239933|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
689320|NCT01502644|2239934|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
689321|NCT01502644|2239935|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
689322|NCT01502644|2239936|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
689323|NCT01502644|2239933|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
689324|NCT01502644|2239934|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
689325|NCT01502644|2239935|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
689326|NCT01502644|2239936|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
689327|NCT01502423|2239946|P2|Overall Study|Withdrawal by Subject|1
689328|NCT01502423|2239947|P1|Overall Study|Withdrawal by Subject|0
689329|NCT01502410|2239969|P4|Overall Study|Withdrawal by Subject|0
689330|NCT01502410|2239970|P3|Overall Study|Withdrawal by Subject|0
689331|NCT01502410|2239971|P2|Overall Study|Withdrawal by Subject|0
689332|NCT01502410|2239972|P1|Overall Study|Withdrawal by Subject|2
689333|NCT01502410|2239969|P4|Overall Study|Physician Decision|0
689334|NCT01502410|2239970|P3|Overall Study|Physician Decision|0
689335|NCT01502410|2239971|P2|Overall Study|Physician Decision|1
689336|NCT01502410|2239972|P1|Overall Study|Physician Decision|0
689337|NCT01502410|2239969|P4|Overall Study|Lack of Efficacy|0
689338|NCT01502410|2239970|P3|Overall Study|Lack of Efficacy|0
689339|NCT01502410|2239971|P2|Overall Study|Lack of Efficacy|7
689340|NCT01502410|2239972|P1|Overall Study|Lack of Efficacy|7
689341|NCT01502410|2239969|P4|Overall Study|Adverse Event|0
689342|NCT01502410|2239970|P3|Overall Study|Adverse Event|0
689343|NCT01502410|2239971|P2|Overall Study|Adverse Event|2
689344|NCT01502410|2239972|P1|Overall Study|Adverse Event|1
689345|NCT01502371|2239985|P5|Overall Study|Excluded Medication|1
689346|NCT01502371|2239986|P4|Overall Study|Excluded Medication|0
689347|NCT01502371|2239987|P3|Overall Study|Excluded Medication|1
689348|NCT01502371|2239988|P2|Overall Study|Excluded Medication|1
689349|NCT01502371|2239989|P1|Overall Study|Excluded Medication|0
689350|NCT01502371|2239985|P5|Overall Study|Protocol Violation|10
689351|NCT01502371|2239986|P4|Overall Study|Protocol Violation|5
689352|NCT01502371|2239987|P3|Overall Study|Protocol Violation|6
689353|NCT01502371|2239988|P2|Overall Study|Protocol Violation|5
689354|NCT01502371|2239989|P1|Overall Study|Protocol Violation|9
689355|NCT01502371|2239985|P5|Overall Study|Technical Problems|1
689356|NCT01502371|2239986|P4|Overall Study|Technical Problems|4
689357|NCT01502371|2239987|P3|Overall Study|Technical Problems|2
689358|NCT01502371|2239988|P2|Overall Study|Technical Problems|0
689359|NCT01502371|2239989|P1|Overall Study|Technical Problems|1
689360|NCT01502371|2239985|P5|Overall Study|Noncompliance with Study Drug|1
689361|NCT01502371|2239986|P4|Overall Study|Noncompliance with Study Drug|2
689362|NCT01502371|2239987|P3|Overall Study|Noncompliance with Study Drug|1
689363|NCT01502371|2239988|P2|Overall Study|Noncompliance with Study Drug|0
689364|NCT01502371|2239989|P1|Overall Study|Noncompliance with Study Drug|0
689365|NCT01502371|2239985|P5|Overall Study|Physician Decision|1
689366|NCT01502371|2239986|P4|Overall Study|Physician Decision|0
689367|NCT01502371|2239987|P3|Overall Study|Physician Decision|0
689368|NCT01502371|2239988|P2|Overall Study|Physician Decision|0
689369|NCT01502371|2239989|P1|Overall Study|Physician Decision|3
689370|NCT01502371|2239985|P5|Overall Study|Lack of Efficacy|4
689371|NCT01502371|2239986|P4|Overall Study|Lack of Efficacy|2
689372|NCT01502371|2239987|P3|Overall Study|Lack of Efficacy|2
689373|NCT01502371|2239988|P2|Overall Study|Lack of Efficacy|3
689374|NCT01502371|2239989|P1|Overall Study|Lack of Efficacy|3
689375|NCT01502371|2239985|P5|Overall Study|Treatment Failure|30
689376|NCT01502371|2239986|P4|Overall Study|Treatment Failure|19
689377|NCT01502371|2239987|P3|Overall Study|Treatment Failure|12
689378|NCT01502371|2239988|P2|Overall Study|Treatment Failure|20
689379|NCT01502371|2239989|P1|Overall Study|Treatment Failure|22
689380|NCT01502371|2239985|P5|Overall Study|Adverse Event|3
689381|NCT01502371|2239986|P4|Overall Study|Adverse Event|4
689382|NCT01502371|2239987|P3|Overall Study|Adverse Event|0
689383|NCT01502371|2239988|P2|Overall Study|Adverse Event|1
689384|NCT01502371|2239989|P1|Overall Study|Adverse Event|2
689385|NCT01502371|2239985|P5|Overall Study|Withdrawal by Subject|1
689386|NCT01502371|2239986|P4|Overall Study|Withdrawal by Subject|1
689387|NCT01502371|2239987|P3|Overall Study|Withdrawal by Subject|1
689388|NCT01502371|2239988|P2|Overall Study|Withdrawal by Subject|2
689389|NCT01502371|2239989|P1|Overall Study|Withdrawal by Subject|1
689390|NCT01502228|2240029|P1|Overall Study|Death|1
689391|NCT01502033|2240034|P1|Overall Study|1 participant went back to school|1
689392|NCT01502033|2240034|P1|Overall Study|1 participant had worsening depression|1
689393|NCT01502033|2240034|P1|Overall Study|1 participant had scalp discomfort|1
689394|NCT01501110|2240053|P2|Overall Study|Death|1
689395|NCT01501110|2240054|P1|Overall Study|Death|0
689396|NCT01500720|2240078|P2|Overall Study|Unspecified|8
689397|NCT01500720|2240079|P1|Overall Study|Unspecified|4
689398|NCT01500720|2240078|P2|Overall Study|Randomized But Not Treated|1
689399|NCT01500720|2240079|P1|Overall Study|Randomized But Not Treated|1
689400|NCT01500694|2240093|P2|Overall Study|Unspecified|3
689401|NCT01500694|2240094|P1|Overall Study|Unspecified|9
689402|NCT01500694|2240093|P2|Overall Study|Lack of Efficacy|5
689403|NCT01500694|2240094|P1|Overall Study|Lack of Efficacy|14
689404|NCT01500694|2240093|P2|Overall Study|Lost to Follow-up|3
689405|NCT01500694|2240094|P1|Overall Study|Lost to Follow-up|2
689406|NCT01500694|2240093|P2|Overall Study|Withdrawal by Subject|14
689407|NCT01500694|2240094|P1|Overall Study|Withdrawal by Subject|23
689408|NCT01500694|2240093|P2|Overall Study|Protocol Violation|1
689409|NCT01500694|2240094|P1|Overall Study|Protocol Violation|0
689410|NCT01500694|2240093|P2|Overall Study|Adverse Event|3
689411|NCT01500694|2240094|P1|Overall Study|Adverse Event|4
689412|NCT01500629|2240120|P2|Washout Period of 14 to 30 Days|Pregnancy|0
689413|NCT01500629|2240121|P1|Washout Period of 14 to 30 Days|Pregnancy|1
689414|NCT01500434|2240205|P1|Overall Study|Missed 12-month follow-up|5
689415|NCT01500434|2240205|P1|Overall Study|Withdrawal by Subject|1
689416|NCT01500434|2240205|P1|Overall Study|Death|1
689417|NCT01500382|2240238|P4|Washout Period|Study site went out of business|0
689418|NCT01500382|2240239|P3|Washout Period|Study site went out of business|1
689419|NCT01500382|2240240|P2|Washout Period|Study site went out of business|0
689420|NCT01500382|2240241|P1|Washout Period|Study site went out of business|0
689421|NCT01500317|2240266|P3|Overall Study|Withdrawal by Subject|0
689422|NCT01500317|2240267|P2|Overall Study|Withdrawal by Subject|2
689423|NCT01500317|2240268|P1|Overall Study|Withdrawal by Subject|3
689424|NCT01500278|2240290|P2|Week 13 - Week 104|Adverse Event|54
689425|NCT01500278|2240291|P1|Week 13 - Week 104|Adverse Event|54
689426|NCT01500278|2240290|P2|Week 13 - Week 104|Death|4
689427|NCT01500278|2240291|P1|Week 13 - Week 104|Death|2
689428|NCT01500278|2240290|P2|Week 13 - Week 104|Not completed|1
689429|NCT01500278|2240291|P1|Week 13 - Week 104|Not completed|0
689430|NCT01500278|2240290|P2|Week 13 - Week 104|Personal reason|1
689431|NCT01500278|2240291|P1|Week 13 - Week 104|Personal reason|0
689432|NCT01500278|2240290|P2|Week 13 - Week 104|Medical monitor decision|2
689433|NCT01500278|2240291|P1|Week 13 - Week 104|Medical monitor decision|0
689434|NCT01500278|2240290|P2|Week 13 - Week 104|Sponsor decision|2
689435|NCT01500278|2240291|P1|Week 13 - Week 104|Sponsor decision|0
689436|NCT01500278|2240290|P2|Week 13 - Week 104|Relocation|1
689437|NCT01500278|2240291|P1|Week 13 - Week 104|Relocation|0
689438|NCT01500278|2240290|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
689439|NCT01500278|2240291|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
689440|NCT01500278|2240290|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
689441|NCT01500278|2240291|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
689442|NCT01500278|2240290|P2|Week 13 - Week 104|Principal investigator retiring|0
689443|NCT01500278|2240291|P1|Week 13 - Week 104|Principal investigator retiring|1
689444|NCT01500278|2240290|P2|Week 13 - Week 104|Protocol deviation|0
689445|NCT01500278|2240291|P1|Week 13 - Week 104|Protocol deviation|1
689446|NCT01500278|2240290|P2|Week 13 - Week 104|Exclusion criteria not met|0
689447|NCT01500278|2240291|P1|Week 13 - Week 104|Exclusion criteria not met|1
689448|NCT01500278|2240290|P2|Week 13 - Week 104|Withdrawn in error|0
689449|NCT01500278|2240291|P1|Week 13 - Week 104|Withdrawn in error|1
689450|NCT01500278|2240290|P2|Week 13 - Week 104|Sponsor request|0
689451|NCT01500278|2240291|P1|Week 13 - Week 104|Sponsor request|4
689452|NCT01500278|2240290|P2|Week 13 - Week 104|False positive test|2
689453|NCT01500278|2240291|P1|Week 13 - Week 104|False positive test|1
689454|NCT01500278|2240290|P2|Week 13 - Week 104|Recurrent infections|0
689455|NCT01500278|2240291|P1|Week 13 - Week 104|Recurrent infections|1
689456|NCT01500278|2240290|P2|Week 13 - Week 104|Non/bad compliance|5
689457|NCT01500278|2240291|P1|Week 13 - Week 104|Non/bad compliance|7
689458|NCT01500278|2240290|P2|Week 13 - Week 104|Week 24 Non-Responder|16
689459|NCT01500278|2240291|P1|Week 13 - Week 104|Week 24 Non-Responder|20
689460|NCT01500278|2240290|P2|Week 13 - Week 104|Withdrawal by Subject|13
689461|NCT01500278|2240291|P1|Week 13 - Week 104|Withdrawal by Subject|22
689462|NCT01500278|2240290|P2|Week 13 - Week 104|Lost to Follow-up|5
689463|NCT01500278|2240291|P1|Week 13 - Week 104|Lost to Follow-up|6
689464|NCT01500278|2240290|P2|Week 13 - Week 104|Protocol Violation|6
689465|NCT01500278|2240291|P1|Week 13 - Week 104|Protocol Violation|6
689466|NCT01500278|2240290|P2|Week 13 - Week 104|Lack of Efficacy|12
689467|NCT01500278|2240291|P1|Week 13 - Week 104|Lack of Efficacy|11
689468|NCT01500278|2240290|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
689469|NCT01500278|2240291|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
689470|NCT01500278|2240290|P2|Week 0 - Week 12|Other serious disease|1
689471|NCT01500278|2240291|P1|Week 0 - Week 12|Other serious disease|0
689472|NCT01500278|2240290|P2|Week 0 - Week 12|Personal reason|1
689473|NCT01500278|2240291|P1|Week 0 - Week 12|Personal reason|0
689474|NCT01500278|2240290|P2|Week 0 - Week 12|Sponsor decision|0
689475|NCT01500278|2240291|P1|Week 0 - Week 12|Sponsor decision|1
689476|NCT01500278|2240290|P2|Week 0 - Week 12|Prior history of serious disease|0
689477|NCT01500278|2240291|P1|Week 0 - Week 12|Prior history of serious disease|1
689478|NCT01500278|2240290|P2|Week 0 - Week 12|Investigator decision|0
689479|NCT01500278|2240291|P1|Week 0 - Week 12|Investigator decision|1
689480|NCT01500278|2240290|P2|Week 0 - Week 12|Exclusion criteria not met|0
689481|NCT01500278|2240291|P1|Week 0 - Week 12|Exclusion criteria not met|1
689482|NCT01500278|2240290|P2|Week 0 - Week 12|Patient decision|0
689483|NCT01500278|2240291|P1|Week 0 - Week 12|Patient decision|1
689484|NCT01500278|2240290|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
689485|NCT01500278|2240291|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
689486|NCT01500278|2240290|P2|Week 0 - Week 12|Withdrawal by Subject|2
689487|NCT01500278|2240291|P1|Week 0 - Week 12|Withdrawal by Subject|7
689488|NCT01500278|2240290|P2|Week 0 - Week 12|Lost to Follow-up|1
689489|NCT01500278|2240291|P1|Week 0 - Week 12|Lost to Follow-up|1
689490|NCT01500278|2240290|P2|Week 0 - Week 12|Protocol Violation|16
689491|NCT01500278|2240291|P1|Week 0 - Week 12|Protocol Violation|10
689492|NCT01500278|2240290|P2|Week 0 - Week 12|Lack of Efficacy|1
689493|NCT01500278|2240291|P1|Week 0 - Week 12|Lack of Efficacy|0
689494|NCT01500252|2240315|P2|Overall Study|Lost to Follow-up|4
689495|NCT01500252|2240316|P1|Overall Study|Lost to Follow-up|5
689496|NCT01500252|2240315|P2|Overall Study|Death|2
689497|NCT01500252|2240316|P1|Overall Study|Death|4
689498|NCT01500226|2240342|P2|Overall Study|Other Reasons|16
689499|NCT01500226|2240343|P1|Overall Study|Other Reasons|19
689500|NCT01500226|2240342|P2|Overall Study|Lost to Follow-up|5
689501|NCT01500226|2240343|P1|Overall Study|Lost to Follow-up|9
689502|NCT01500226|2240342|P2|Overall Study|Lack of Efficacy|30
689503|NCT01500226|2240343|P1|Overall Study|Lack of Efficacy|14
689504|NCT01500226|2240342|P2|Overall Study|Physician Decision|15
689505|NCT01500226|2240343|P1|Overall Study|Physician Decision|17
689506|NCT01500226|2240342|P2|Overall Study|Protocol Violation|39
689507|NCT01500226|2240343|P1|Overall Study|Protocol Violation|53
689508|NCT01500226|2240342|P2|Overall Study|Disease Progression|14
689509|NCT01500226|2240343|P1|Overall Study|Disease Progression|16
689510|NCT01500226|2240342|P2|Overall Study|Death|4
689511|NCT01500226|2240343|P1|Overall Study|Death|12
689512|NCT01500226|2240342|P2|Overall Study|Withdrawal by Subject|96
689513|NCT01500226|2240343|P1|Overall Study|Withdrawal by Subject|93
689514|NCT01500226|2240342|P2|Overall Study|Chemo Completed or Change in Therapy|237
689515|NCT01500226|2240343|P1|Overall Study|Chemo Completed or Change in Therapy|235
689516|NCT01500226|2240342|P2|Overall Study|Adverse Event|38
689517|NCT01500226|2240343|P1|Overall Study|Adverse Event|31
689518|NCT01500213|2240355|P2|Overall Study|Other Reasons|5
689519|NCT01500213|2240356|P1|Overall Study|Other Reasons|7
689520|NCT01500213|2240355|P2|Overall Study|Lost to Follow-up|6
689521|NCT01500213|2240356|P1|Overall Study|Lost to Follow-up|3
689522|NCT01500213|2240355|P2|Overall Study|Lack of Efficacy|7
689523|NCT01500213|2240356|P1|Overall Study|Lack of Efficacy|9
689524|NCT01500213|2240355|P2|Overall Study|Physician Decision|10
689525|NCT01500213|2240356|P1|Overall Study|Physician Decision|12
689526|NCT01500213|2240355|P2|Overall Study|Protocol Violation|19
689527|NCT01500213|2240356|P1|Overall Study|Protocol Violation|19
689528|NCT01500213|2240355|P2|Overall Study|Disease Progression|21
689529|NCT01500213|2240356|P1|Overall Study|Disease Progression|13
689530|NCT01500213|2240355|P2|Overall Study|Death|3
689531|NCT01500213|2240356|P1|Overall Study|Death|7
689532|NCT01500213|2240355|P2|Overall Study|Withdrawal by Subject|37
689533|NCT01500213|2240356|P1|Overall Study|Withdrawal by Subject|28
689534|NCT01500213|2240355|P2|Overall Study|Chemo Completed or Change in Therapy|81
689535|NCT01500213|2240356|P1|Overall Study|Chemo Completed or Change in Therapy|84
689536|NCT01500213|2240355|P2|Overall Study|Adverse Event|35
689537|NCT01500213|2240356|P1|Overall Study|Adverse Event|35
689538|NCT01500135|2240368|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
689539|NCT01500135|2240369|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
689540|NCT01500135|2240368|P2|Overall Study|Participant was a Safety Concern|0
689541|NCT01500135|2240369|P1|Overall Study|Participant was a Safety Concern|1
689542|NCT01500135|2240368|P2|Overall Study|Patient Missed Scheduled Appointments|1
689543|NCT01500135|2240369|P1|Overall Study|Patient Missed Scheduled Appointments|0
689544|NCT01500135|2240368|P2|Overall Study|Principal Investigator (PI) Discretion|0
689545|NCT01500135|2240369|P1|Overall Study|Principal Investigator (PI) Discretion|1
689546|NCT01500135|2240368|P2|Overall Study|Fatal Adverse Event (AE)|5
689547|NCT01500135|2240369|P1|Overall Study|Fatal Adverse Event (AE)|5
689548|NCT01500135|2240368|P2|Overall Study|Lost to Follow-up|4
689549|NCT01500135|2240369|P1|Overall Study|Lost to Follow-up|6
689550|NCT01500135|2240368|P2|Overall Study|Withdrawal of Consent|0
689551|NCT01500135|2240369|P1|Overall Study|Withdrawal of Consent|4
689552|NCT01500083|2240394|P2|Overall Study|Other Reasons|5
689553|NCT01500083|2240395|P1|Overall Study|Other Reasons|2
689554|NCT01500083|2240394|P2|Overall Study|Investigator Discretion|8
689555|NCT01500083|2240395|P1|Overall Study|Investigator Discretion|3
689556|NCT01500083|2240394|P2|Overall Study|Disease Progression|10
689557|NCT01500083|2240395|P1|Overall Study|Disease Progression|2
689558|NCT01500083|2240394|P2|Overall Study|Withdrawal of Consent|1
689559|NCT01500083|2240395|P1|Overall Study|Withdrawal of Consent|0
689560|NCT01500083|2240394|P2|Overall Study|Lost to Follow-up|0
689561|NCT01500083|2240395|P1|Overall Study|Lost to Follow-up|1
689562|NCT01500083|2240394|P2|Overall Study|Death|2
689563|NCT01500083|2240395|P1|Overall Study|Death|0
689564|NCT01500083|2240394|P2|Overall Study|Adverse Event|17
689565|NCT01500083|2240395|P1|Overall Study|Adverse Event|4
689566|NCT01500031|2240401|P1|Overall Study|Withdrawal by Subject|4
689567|NCT01500031|2240401|P1|Overall Study|Death|1
689568|NCT01499849|2240436|P2|Overall Study|Other Reasons|30
689569|NCT01499849|2240437|P1|Overall Study|Other Reasons|27
689570|NCT01499849|2240436|P2|Overall Study|Lost to Follow-up|3
689571|NCT01499849|2240437|P1|Overall Study|Lost to Follow-up|6
689572|NCT01499849|2240436|P2|Overall Study|Lack of Efficacy|4
689573|NCT01499849|2240437|P1|Overall Study|Lack of Efficacy|3
689574|NCT01499849|2240436|P2|Overall Study|Physician Decision|19
689575|NCT01499849|2240437|P1|Overall Study|Physician Decision|20
689576|NCT01499849|2240436|P2|Overall Study|Protocol Violation|11
689577|NCT01499849|2240437|P1|Overall Study|Protocol Violation|11
689578|NCT01499849|2240436|P2|Overall Study|Disease Progression|10
689579|NCT01499849|2240437|P1|Overall Study|Disease Progression|11
689580|NCT01499849|2240436|P2|Overall Study|Death|7
689581|NCT01499849|2240437|P1|Overall Study|Death|5
689582|NCT01499849|2240436|P2|Overall Study|Withdrawal by Subject|43
689583|NCT01499849|2240437|P1|Overall Study|Withdrawal by Subject|43
689584|NCT01499849|2240436|P2|Overall Study|Chemo completed or Change in Therapy|67
689585|NCT01499849|2240437|P1|Overall Study|Chemo completed or Change in Therapy|70
689586|NCT01499849|2240436|P2|Overall Study|Adverse Event|32
689587|NCT01499849|2240437|P1|Overall Study|Adverse Event|28
689588|NCT01499810|2240447|P1|Overall Study|Withdrawal by Subject|1
689589|NCT01499810|2240447|P1|Overall Study|Protocol Violation|1
689590|NCT01499810|2240447|P1|Overall Study|Lost to Follow-up|10
689591|NCT01499667|2240497|P3|Overall Study|Lack of Efficacy|0
689592|NCT01499667|2240498|P2|Overall Study|Lack of Efficacy|0
689593|NCT01499667|2240499|P1|Overall Study|Lack of Efficacy|2
689594|NCT01499667|2240497|P3|Overall Study|Withdrawal by Subject|1
689595|NCT01499667|2240498|P2|Overall Study|Withdrawal by Subject|1
689596|NCT01499667|2240499|P1|Overall Study|Withdrawal by Subject|2
689597|NCT01499667|2240497|P3|Overall Study|Adverse Event|2
689598|NCT01499667|2240498|P2|Overall Study|Adverse Event|2
689599|NCT01499667|2240499|P1|Overall Study|Adverse Event|0
689600|NCT01499667|2240497|P3|Overall Study|Protocol Violation|2
689601|NCT01499667|2240498|P2|Overall Study|Protocol Violation|3
689602|NCT01499667|2240499|P1|Overall Study|Protocol Violation|1
689603|NCT01499667|2240497|P3|Overall Study|administrative problems|5
689604|NCT01499667|2240498|P2|Overall Study|administrative problems|5
689605|NCT01499667|2240499|P1|Overall Study|administrative problems|4
689606|NCT01499576|2240547|P1|Overall Study|Withdrawal by Subject|9
689607|NCT01499576|2240547|P1|Overall Study|Physician Decision|12
689608|NCT01499355|2240561|P4|Double-Blind Period|Lost to Follow-up|0
689609|NCT01499355|2240562|P3|Double-Blind Period|Lost to Follow-up|0
689610|NCT01499355|2240563|P2|Double-Blind Period|Lost to Follow-up|1
689611|NCT01499355|2240564|P1|Double-Blind Period|Lost to Follow-up|0
689612|NCT01499355|2240561|P4|Double-Blind Period|Consent Withdrawn|2
689613|NCT01499355|2240562|P3|Double-Blind Period|Consent Withdrawn|1
689614|NCT01499355|2240563|P2|Double-Blind Period|Consent Withdrawn|0
689615|NCT01499355|2240564|P1|Double-Blind Period|Consent Withdrawn|0
689616|NCT01499355|2240561|P4|Double-Blind Period|Investigator Decision|3
689617|NCT01499355|2240562|P3|Double-Blind Period|Investigator Decision|3
689618|NCT01499355|2240563|P2|Double-Blind Period|Investigator Decision|0
689619|NCT01499355|2240564|P1|Double-Blind Period|Investigator Decision|0
689620|NCT01499355|2240561|P4|Double-Blind Period|Death|0
689621|NCT01499355|2240562|P3|Double-Blind Period|Death|0
689622|NCT01499355|2240563|P2|Double-Blind Period|Death|1
689623|NCT01499355|2240564|P1|Double-Blind Period|Death|0
689624|NCT01499355|2240561|P4|Double-Blind Period|Not Specified|2
689625|NCT01499355|2240562|P3|Double-Blind Period|Not Specified|2
689626|NCT01499355|2240563|P2|Double-Blind Period|Not Specified|1
689627|NCT01499355|2240564|P1|Double-Blind Period|Not Specified|0
689628|NCT01499355|2240561|P4|Double-Blind Period|Study Termination|14
689629|NCT01499355|2240562|P3|Double-Blind Period|Study Termination|16
689630|NCT01499355|2240563|P2|Double-Blind Period|Study Termination|18
689631|NCT01499355|2240564|P1|Double-Blind Period|Study Termination|0
689632|NCT01499355|2240561|P4|Double-Blind Period|Adverse Event|2
689633|NCT01499355|2240562|P3|Double-Blind Period|Adverse Event|3
689634|NCT01499355|2240563|P2|Double-Blind Period|Adverse Event|2
689635|NCT01499355|2240564|P1|Double-Blind Period|Adverse Event|0
689636|NCT01499355|2240561|P4|Run-In Period|Adverse Event|0
689637|NCT01499355|2240562|P3|Run-In Period|Adverse Event|0
689638|NCT01499355|2240563|P2|Run-In Period|Adverse Event|0
689639|NCT01499355|2240564|P1|Run-In Period|Adverse Event|8
689640|NCT01499355|2240561|P4|Run-In Period|Consent Withdrawn|0
689641|NCT01499355|2240562|P3|Run-In Period|Consent Withdrawn|0
689642|NCT01499355|2240563|P2|Run-In Period|Consent Withdrawn|0
689643|NCT01499355|2240564|P1|Run-In Period|Consent Withdrawn|1
689644|NCT01499355|2240561|P4|Run-In Period|Investigator Decision|0
689645|NCT01499355|2240562|P3|Run-In Period|Investigator Decision|0
689646|NCT01499355|2240563|P2|Run-In Period|Investigator Decision|0
689647|NCT01499355|2240564|P1|Run-In Period|Investigator Decision|2
689648|NCT01499355|2240561|P4|Run-In Period|Death|0
689649|NCT01499355|2240562|P3|Run-In Period|Death|0
689650|NCT01499355|2240563|P2|Run-In Period|Death|0
689651|NCT01499355|2240564|P1|Run-In Period|Death|2
689652|NCT01499355|2240561|P4|Run-In Period|Not Specified|0
689653|NCT01499355|2240562|P3|Run-In Period|Not Specified|0
689654|NCT01499355|2240563|P2|Run-In Period|Not Specified|0
689655|NCT01499355|2240564|P1|Run-In Period|Not Specified|3
689656|NCT01499355|2240561|P4|Run-In Period|Study Termination|0
689657|NCT01499355|2240562|P3|Run-In Period|Study Termination|0
689658|NCT01499355|2240563|P2|Run-In Period|Study Termination|0
689659|NCT01499355|2240564|P1|Run-In Period|Study Termination|15
689660|NCT01499303|2240597|P2|Overall Study|Other|1
689661|NCT01499303|2240598|P1|Overall Study|Other|0
689662|NCT01499303|2240597|P2|Overall Study|Adverse Event|4
689663|NCT01499303|2240598|P1|Overall Study|Adverse Event|1
689664|NCT01499303|2240597|P2|Overall Study|Withdrawal by Subject|1
689665|NCT01499303|2240598|P1|Overall Study|Withdrawal by Subject|0
689666|NCT01499303|2240597|P2|Overall Study|Ongoing|1
689667|NCT01499303|2240598|P1|Overall Study|Ongoing|2
689668|NCT01499290|2240606|P2|Overall Study|Adverse Event|7
689669|NCT01499290|2240607|P1|Overall Study|Adverse Event|14
689670|NCT01499290|2240606|P2|Overall Study|Lack of Efficacy|8
689671|NCT01499290|2240607|P1|Overall Study|Lack of Efficacy|7
689672|NCT01499290|2240606|P2|Overall Study|Condition improved/subject recovered|0
689673|NCT01499290|2240607|P1|Overall Study|Condition improved/subject recovered|1
689674|NCT01499290|2240606|P2|Overall Study|Not specified in study report|5
689675|NCT01499290|2240607|P1|Overall Study|Not specified in study report|11
689676|NCT01499290|2240606|P2|Overall Study|Withdrawal by Subject|15
689677|NCT01499290|2240607|P1|Overall Study|Withdrawal by Subject|22
689678|NCT01499277|2240657|P2|Overall Study|Lack of therapeutic response and other|7
689679|NCT01499277|2240658|P1|Overall Study|Lack of therapeutic response and other|8
689680|NCT01499277|2240657|P2|Overall Study|Withdrawal by Subject|6
689681|NCT01499277|2240658|P1|Overall Study|Withdrawal by Subject|16
689682|NCT01499277|2240657|P2|Overall Study|Protocol Violation|3
689683|NCT01499277|2240658|P1|Overall Study|Protocol Violation|2
689684|NCT01499277|2240657|P2|Overall Study|Lost to Follow-up|8
689685|NCT01499277|2240658|P1|Overall Study|Lost to Follow-up|15
689686|NCT01499277|2240657|P2|Overall Study|Death|2
689687|NCT01499277|2240658|P1|Overall Study|Death|3
689688|NCT01499277|2240657|P2|Overall Study|Adverse Event|6
689689|NCT01499277|2240658|P1|Overall Study|Adverse Event|3
689690|NCT01499199|2240680|P1|Overall Study|Lack of Efficacy|1
689691|NCT01499199|2240680|P1|Overall Study|Adverse Event|1
689692|NCT01499134|2240727|P2|Overall Study|Withdrawal by Subject|1
689693|NCT01499134|2240728|P1|Overall Study|Withdrawal by Subject|0
689694|NCT01499095|2240750|P2|Overall Study|Perceived Lack of Efficacy|1
689695|NCT01499095|2240751|P1|Overall Study|Perceived Lack of Efficacy|1
689696|NCT01499095|2240750|P2|Overall Study|Change in Injection Schedule|0
689697|NCT01499095|2240751|P1|Overall Study|Change in Injection Schedule|2
689698|NCT01499095|2240750|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
689699|NCT01499095|2240751|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
689700|NCT01499095|2240750|P2|Overall Study|Hypoglycemia|1
689701|NCT01499095|2240751|P1|Overall Study|Hypoglycemia|3
689702|NCT01499095|2240750|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
689703|NCT01499095|2240751|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
689704|NCT01499095|2240750|P2|Overall Study|Lost to Follow-up|4
689705|NCT01499095|2240751|P1|Overall Study|Lost to Follow-up|6
689706|NCT01499095|2240750|P2|Overall Study|Diverse Reasons|25
689707|NCT01499095|2240751|P1|Overall Study|Diverse Reasons|22
689708|NCT01499095|2240750|P2|Overall Study|Received Rescue Therapy|40
689709|NCT01499095|2240751|P1|Overall Study|Received Rescue Therapy|32
689710|NCT01499095|2240750|P2|Overall Study|Protocol Violation|7
689711|NCT01499095|2240751|P1|Overall Study|Protocol Violation|6
689712|NCT01499095|2240750|P2|Overall Study|Lack of Efficacy|1
689713|NCT01499095|2240751|P1|Overall Study|Lack of Efficacy|2
689714|NCT01499095|2240750|P2|Overall Study|Adverse Event|7
689715|NCT01499095|2240751|P1|Overall Study|Adverse Event|12
689716|NCT01499095|2240750|P2|Overall Study|Randomized But Not Treated|1
689717|NCT01499095|2240751|P1|Overall Study|Randomized But Not Treated|1
689718|NCT01499082|2240781|P2|Overall Study|Lost to Follow-up|3
689719|NCT01499082|2240782|P1|Overall Study|Lost to Follow-up|1
689720|NCT01499082|2240781|P2|Overall Study|Hypoglycemia|3
689721|NCT01499082|2240782|P1|Overall Study|Hypoglycemia|2
689722|NCT01499082|2240781|P2|Overall Study|Site Closure for Noncompliance|2
689723|NCT01499082|2240782|P1|Overall Study|Site Closure for Noncompliance|5
689724|NCT01499082|2240781|P2|Overall Study|Diverse Reasons|14
689725|NCT01499082|2240782|P1|Overall Study|Diverse Reasons|18
689726|NCT01499082|2240781|P2|Overall Study|Protocol Violation|8
689727|NCT01499082|2240782|P1|Overall Study|Protocol Violation|6
689728|NCT01499082|2240781|P2|Overall Study|Lack of Efficacy|1
689729|NCT01499082|2240782|P1|Overall Study|Lack of Efficacy|1
689730|NCT01499082|2240781|P2|Overall Study|Adverse Event|16
689731|NCT01499082|2240782|P1|Overall Study|Adverse Event|12
689732|NCT01499082|2240781|P2|Overall Study|Randomized but not Treated|1
689733|NCT01499082|2240782|P1|Overall Study|Randomized but not Treated|0
689734|NCT01498822|2240812|P2|Overall Study|Lost to Follow-up|3
689735|NCT01498822|2240813|P1|Overall Study|Lost to Follow-up|8
689736|NCT01498822|2240812|P2|Overall Study|Withdrawal by Subject|25
689737|NCT01498822|2240813|P1|Overall Study|Withdrawal by Subject|15
689738|NCT01498822|2240812|P2|Overall Study|Adverse Event, serious fatal|1
689739|NCT01498822|2240813|P1|Overall Study|Adverse Event, serious fatal|1
689740|NCT01498822|2240812|P2|Overall Study|SAE, non-fatal|2
689741|NCT01498822|2240813|P1|Overall Study|SAE, non-fatal|2
689742|NCT01498822|2240812|P2|Overall Study|AE, non-serious non-fatal|17
689743|NCT01498822|2240813|P1|Overall Study|AE, non-serious non-fatal|8
689744|NCT01498822|2240812|P2|Overall Study|Lack of Efficacy|2
689745|NCT01498822|2240813|P1|Overall Study|Lack of Efficacy|7
689746|NCT01498822|2240812|P2|Overall Study|Other Reason|2
689747|NCT01498822|2240813|P1|Overall Study|Other Reason|5
689748|NCT01498822|2240812|P2|Overall Study|Protocol Violation|4
689749|NCT01498822|2240813|P1|Overall Study|Protocol Violation|8
689750|NCT01498692|2240840|P1|Overall Study|Missed 12-month visit|3
689751|NCT01498692|2240840|P1|Overall Study|Withdrawal by Subject|1
689752|NCT01498692|2240840|P1|Overall Study|Death|4
689753|NCT01498679|2240871|P2|Overall Study|Withdrawal by Subject|4
689754|NCT01498679|2240872|P1|Overall Study|Withdrawal by Subject|12
689755|NCT01498679|2240871|P2|Overall Study|Physician Decision|2
689756|NCT01498679|2240872|P1|Overall Study|Physician Decision|0
689757|NCT01498679|2240871|P2|Overall Study|Protocol Violation|0
689758|NCT01498679|2240872|P1|Overall Study|Protocol Violation|4
689759|NCT01498679|2240871|P2|Overall Study|Lack of Efficacy|12
689760|NCT01498679|2240872|P1|Overall Study|Lack of Efficacy|72
689761|NCT01498679|2240871|P2|Overall Study|Adverse Event|4
689762|NCT01498679|2240872|P1|Overall Study|Adverse Event|1
689763|NCT01498653|2240888|P2|Overall Study|Withdrawal by Subject|3
689764|NCT01498653|2240889|P1|Overall Study|Withdrawal by Subject|2
689765|NCT01498653|2240888|P2|Overall Study|Physician Decision|0
689766|NCT01498653|2240889|P1|Overall Study|Physician Decision|2
689767|NCT01498653|2240888|P2|Overall Study|Lost to Follow-up|0
689768|NCT01498653|2240889|P1|Overall Study|Lost to Follow-up|1
689769|NCT01498653|2240888|P2|Overall Study|Protocol Violation|4
689770|NCT01498653|2240889|P1|Overall Study|Protocol Violation|0
689771|NCT01498653|2240888|P2|Overall Study|Lack of Efficacy|26
689772|NCT01498653|2240889|P1|Overall Study|Lack of Efficacy|12
689773|NCT01498653|2240888|P2|Overall Study|Adverse Event|2
689774|NCT01498653|2240889|P1|Overall Study|Adverse Event|2
689775|NCT01498640|2240903|P1|Overall Study|not specified|3
689776|NCT01498640|2240903|P1|Overall Study|Death|1
689777|NCT01498640|2240903|P1|Overall Study|Lost to Follow-up|1
689778|NCT01498575|2240933|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
689779|NCT01498575|2240934|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
689780|NCT01498575|2240933|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
689781|NCT01498575|2240934|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
689782|NCT01498575|2240933|P2|Overall Sample|Withdrawal by Subject|14
689783|NCT01498575|2240934|P1|Overall Sample|Withdrawal by Subject|60
689784|NCT01498458|2240951|P1|Overall Study|Physician Decision|3
689785|NCT01498458|2240951|P1|Overall Study|Adverse Event|4
689786|NCT01498185|2241006|P5|Overall Study|No longer met criteria, etc|2
689787|NCT01498185|2241007|P4|Overall Study|No longer met criteria, etc|0
689788|NCT01498185|2241008|P3|Overall Study|No longer met criteria, etc|0
689789|NCT01498185|2241009|P2|Overall Study|No longer met criteria, etc|0
689790|NCT01498185|2241010|P1|Overall Study|No longer met criteria, etc|0
689791|NCT01498185|2241006|P5|Overall Study|Withdrawal by Subject|1
689792|NCT01498185|2241007|P4|Overall Study|Withdrawal by Subject|2
689793|NCT01498185|2241008|P3|Overall Study|Withdrawal by Subject|0
689794|NCT01498185|2241009|P2|Overall Study|Withdrawal by Subject|1
689795|NCT01498185|2241010|P1|Overall Study|Withdrawal by Subject|1
689796|NCT01498185|2241006|P5|Overall Study|Adverse Event|0
689797|NCT01498185|2241007|P4|Overall Study|Adverse Event|1
689798|NCT01498185|2241008|P3|Overall Study|Adverse Event|0
689799|NCT01498185|2241009|P2|Overall Study|Adverse Event|0
689800|NCT01498185|2241010|P1|Overall Study|Adverse Event|0
689801|NCT01498120|2241050|P1|Overall Study|Unspecified|4
689802|NCT01498120|2241050|P1|Overall Study|AE, non-serious non-fatal|3
689803|NCT01498120|2241050|P1|Overall Study|Withdrawal by Subject|5
689804|NCT01498120|2241050|P1|Overall Study|Lost to Follow-up|1
689805|NCT01498068|2241057|P2|Overall Study|Withdrawal by Subject|1
689806|NCT01498068|2241058|P1|Overall Study|Withdrawal by Subject|1
689807|NCT01497938|2241076|P2|Overall Study|Device Violation|0
689808|NCT01497938|2241077|P1|Overall Study|Device Violation|1
689809|NCT01497938|2241076|P2|Overall Study|Withdrawal by Subject|0
689810|NCT01497938|2241077|P1|Overall Study|Withdrawal by Subject|4
689811|NCT01497938|2241076|P2|Overall Study|Physician Decision|1
689812|NCT01497938|2241077|P1|Overall Study|Physician Decision|0
689813|NCT01497938|2241076|P2|Overall Study|Adverse Event|1
689814|NCT01497938|2241077|P1|Overall Study|Adverse Event|0
689815|NCT01497899|2241089|P4|Open-Label Extension Phase|Lost to Follow-up|5
689816|NCT01497899|2241090|P3|Open-Label Extension Phase|Lost to Follow-up|5
689817|NCT01497899|2241091|P2|Open-Label Extension Phase|Lost to Follow-up|3
689818|NCT01497899|2241092|P1|Open-Label Extension Phase|Lost to Follow-up|9
689819|NCT01497899|2241089|P4|Open-Label Extension Phase|Protocol Violation|0
689820|NCT01497899|2241090|P3|Open-Label Extension Phase|Protocol Violation|1
689821|NCT01497899|2241091|P2|Open-Label Extension Phase|Protocol Violation|0
689822|NCT01497899|2241092|P1|Open-Label Extension Phase|Protocol Violation|0
689823|NCT01497899|2241089|P4|Open-Label Extension Phase|Pregnancy|0
689824|NCT01497899|2241090|P3|Open-Label Extension Phase|Pregnancy|1
689825|NCT01497899|2241091|P2|Open-Label Extension Phase|Pregnancy|1
689826|NCT01497899|2241092|P1|Open-Label Extension Phase|Pregnancy|0
689827|NCT01497899|2241089|P4|Open-Label Extension Phase|Withdrew Consent|0
689828|NCT01497899|2241090|P3|Open-Label Extension Phase|Withdrew Consent|2
689829|NCT01497899|2241091|P2|Open-Label Extension Phase|Withdrew Consent|3
689830|NCT01497899|2241092|P1|Open-Label Extension Phase|Withdrew Consent|8
689831|NCT01497899|2241089|P4|Open-Label Extension Phase|Death|0
689832|NCT01497899|2241090|P3|Open-Label Extension Phase|Death|0
689833|NCT01497899|2241091|P2|Open-Label Extension Phase|Death|0
689834|NCT01497899|2241092|P1|Open-Label Extension Phase|Death|1
689835|NCT01497899|2241089|P4|Open-Label Extension Phase|Adverse Event|0
689836|NCT01497899|2241090|P3|Open-Label Extension Phase|Adverse Event|0
689837|NCT01497899|2241091|P2|Open-Label Extension Phase|Adverse Event|0
689838|NCT01497899|2241092|P1|Open-Label Extension Phase|Adverse Event|1
689839|NCT01497899|2241089|P4|Double-Blind Phase|Subject Non-Compliance|0
689840|NCT01497899|2241090|P3|Double-Blind Phase|Subject Non-Compliance|0
689841|NCT01497899|2241091|P2|Double-Blind Phase|Subject Non-Compliance|1
689842|NCT01497899|2241092|P1|Double-Blind Phase|Subject Non-Compliance|0
689843|NCT01497899|2241089|P4|Double-Blind Phase|Lost to Follow-up|0
689844|NCT01497899|2241090|P3|Double-Blind Phase|Lost to Follow-up|0
689845|NCT01497899|2241091|P2|Double-Blind Phase|Lost to Follow-up|2
689846|NCT01497899|2241092|P1|Double-Blind Phase|Lost to Follow-up|3
689847|NCT01497899|2241089|P4|Double-Blind Phase|Withdrew Consent|0
689848|NCT01497899|2241090|P3|Double-Blind Phase|Withdrew Consent|0
689849|NCT01497899|2241091|P2|Double-Blind Phase|Withdrew Consent|1
689850|NCT01497899|2241092|P1|Double-Blind Phase|Withdrew Consent|0
689851|NCT01497899|2241089|P4|Double-Blind Phase|Investigator's Discretion|0
689852|NCT01497899|2241090|P3|Double-Blind Phase|Investigator's Discretion|0
689853|NCT01497899|2241091|P2|Double-Blind Phase|Investigator's Discretion|0
689854|NCT01497899|2241092|P1|Double-Blind Phase|Investigator's Discretion|1
689855|NCT01497899|2241089|P4|Double-Blind Phase|Lack of Efficacy|0
689856|NCT01497899|2241090|P3|Double-Blind Phase|Lack of Efficacy|0
689857|NCT01497899|2241091|P2|Double-Blind Phase|Lack of Efficacy|1
689858|NCT01497899|2241092|P1|Double-Blind Phase|Lack of Efficacy|0
689859|NCT01497899|2241089|P4|Double-Blind Phase|Adverse Event|0
689860|NCT01497899|2241090|P3|Double-Blind Phase|Adverse Event|0
689861|NCT01497899|2241091|P2|Double-Blind Phase|Adverse Event|0
689862|NCT01497899|2241092|P1|Double-Blind Phase|Adverse Event|1
689863|NCT01497899|2241089|P4|Double-Blind Phase|Randomized but not Treated|0
689864|NCT01497899|2241090|P3|Double-Blind Phase|Randomized but not Treated|0
689865|NCT01497899|2241091|P2|Double-Blind Phase|Randomized but not Treated|0
689866|NCT01497899|2241092|P1|Double-Blind Phase|Randomized but not Treated|1
689867|NCT01497366|2241120|P2|Overall Study|Randomized but not treated|21
689868|NCT01497366|2241121|P1|Overall Study|Randomized but not treated|7
689869|NCT01497366|2241120|P2|Overall Study|Death|1
689870|NCT01497366|2241121|P1|Overall Study|Death|1
689871|NCT01497366|2241120|P2|Overall Study|Other|0
689872|NCT01497366|2241121|P1|Overall Study|Other|5
689873|NCT01497366|2241120|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
689874|NCT01497366|2241121|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
689875|NCT01497366|2241120|P2|Overall Study|Withdrawal by Subject|6
689876|NCT01497366|2241121|P1|Overall Study|Withdrawal by Subject|6
689877|NCT01497366|2241120|P2|Overall Study|Lost to Follow-up|10
689878|NCT01497366|2241121|P1|Overall Study|Lost to Follow-up|11
689879|NCT01497366|2241120|P2|Overall Study|Virologic failure|50
689880|NCT01497366|2241121|P1|Overall Study|Virologic failure|2
689881|NCT01497275|2241139|P1|Overall Study|Adverse Event|1
689882|NCT01497275|2241139|P1|Overall Study|Death|1
689883|NCT01497262|2241146|P1|Overall Study|Protocol Violation|1
689884|NCT01497262|2241146|P1|Overall Study|Adverse Event|2
689885|NCT01497262|2241146|P1|Overall Study|Withdrawal by Subject|2
689886|NCT01497262|2241146|P1|Overall Study|Physician Decision|1
689887|NCT01497262|2241146|P1|Overall Study|Abnormal Test Procedure Result|1
689888|NCT01497262|2241146|P1|Overall Study|Abnormal Lab Values|4
689889|NCT01497197|2241153|P2|Overall Study|Unspecified|1
689890|NCT01497197|2241154|P1|Overall Study|Unspecified|3
689891|NCT01497197|2241153|P2|Overall Study|All embryos discarded|3
689892|NCT01497197|2241154|P1|Overall Study|All embryos discarded|0
689893|NCT01497197|2241153|P2|Overall Study|Intention to freeze all embryos|1
689894|NCT01497197|2241154|P1|Overall Study|Intention to freeze all embryos|0
689895|NCT01497197|2241153|P2|Overall Study|No fertilisation|5
689896|NCT01497197|2241154|P1|Overall Study|No fertilisation|6
689897|NCT01497197|2241153|P2|Overall Study|No oocytes retrieved|2
689898|NCT01497197|2241154|P1|Overall Study|No oocytes retrieved|3
689899|NCT01497197|2241153|P2|Overall Study|Risk of OHSS|0
689900|NCT01497197|2241154|P1|Overall Study|Risk of OHSS|1
689901|NCT01497197|2241153|P2|Overall Study|Excessive/lack of response to treatment|0
689902|NCT01497197|2241154|P1|Overall Study|Excessive/lack of response to treatment|1
689903|NCT01497197|2241153|P2|Overall Study|Withdrawal by Subject|1
689904|NCT01497197|2241154|P1|Overall Study|Withdrawal by Subject|2
689905|NCT01497197|2241153|P2|Overall Study|Protocol Violation|2
689906|NCT01497197|2241154|P1|Overall Study|Protocol Violation|0
689907|NCT01497197|2241153|P2|Overall Study|Lost to Follow-up|0
689908|NCT01497197|2241154|P1|Overall Study|Lost to Follow-up|1
689909|NCT01496807|2241207|P1|Overall Study|Change in diagnosis|1
689910|NCT01496807|2241207|P1|Overall Study|Participant preference/toxicity|8
689911|NCT01496807|2241207|P1|Overall Study|Progressive Disease|21
689912|NCT01496469|2241219|P2|Overall Study|Other|1
689913|NCT01496469|2241220|P1|Overall Study|Other|1
689914|NCT01496469|2241219|P2|Overall Study|BP exceeds protocol limits|2
689915|NCT01496469|2241220|P1|Overall Study|BP exceeds protocol limits|1
689916|NCT01496469|2241219|P2|Overall Study|Withdrawal by Subject|4
689917|NCT01496469|2241220|P1|Overall Study|Withdrawal by Subject|4
689918|NCT01496469|2241219|P2|Overall Study|Lost to Follow-up|1
689919|NCT01496469|2241220|P1|Overall Study|Lost to Follow-up|1
689920|NCT01496469|2241219|P2|Overall Study|Protocol Violation|0
689921|NCT01496469|2241220|P1|Overall Study|Protocol Violation|2
689922|NCT01496469|2241219|P2|Overall Study|Adverse Event|0
689923|NCT01496469|2241220|P1|Overall Study|Adverse Event|1
689924|NCT01496456|2241230|P1|Overall Study|Lost to Follow-up|7
689925|NCT01496456|2241230|P1|Overall Study|Protocol Violation|1
689926|NCT01496430|2241243|P3|Overall Study|Other|0
689927|NCT01496430|2241244|P2|Overall Study|Other|0
689928|NCT01496430|2241245|P1|Overall Study|Other|2
689929|NCT01496430|2241243|P3|Overall Study|Principal Investigator Discretion|1
689930|NCT01496430|2241244|P2|Overall Study|Principal Investigator Discretion|1
689931|NCT01496430|2241245|P1|Overall Study|Principal Investigator Discretion|0
689932|NCT01496430|2241243|P3|Overall Study|Voluntary Withdrawal|6
689933|NCT01496430|2241244|P2|Overall Study|Voluntary Withdrawal|1
689934|NCT01496430|2241245|P1|Overall Study|Voluntary Withdrawal|2
689935|NCT01496430|2241243|P3|Overall Study|Lost to Follow-up|1
689936|NCT01496430|2241244|P2|Overall Study|Lost to Follow-up|3
689937|NCT01496430|2241245|P1|Overall Study|Lost to Follow-up|2
689938|NCT01496430|2241243|P3|Overall Study|Major Protocol Deviation|1
689939|NCT01496430|2241244|P2|Overall Study|Major Protocol Deviation|0
689940|NCT01496430|2241245|P1|Overall Study|Major Protocol Deviation|0
689941|NCT01496430|2241243|P3|Overall Study|Adverse Event|1
689942|NCT01496430|2241244|P2|Overall Study|Adverse Event|0
689943|NCT01496430|2241245|P1|Overall Study|Adverse Event|0
689944|NCT01496287|2241357|P1|Overall Study|Incomplete anesthesia|5
689945|NCT01496287|2241357|P1|Overall Study|Lost to Follow-up|1
689946|NCT01496274|2241367|P2|Overall Study|Lost to Follow-up|3
689947|NCT01496274|2241368|P1|Overall Study|Lost to Follow-up|0
689948|NCT01496274|2241367|P2|Overall Study|Withdrawal by Subject|0
689949|NCT01496274|2241368|P1|Overall Study|Withdrawal by Subject|2
689950|NCT01496274|2241367|P2|Overall Study|Adverse Event|1
689951|NCT01496274|2241368|P1|Overall Study|Adverse Event|1
689952|NCT01496274|2241367|P2|Overall Study|Protocol Violation|1
689953|NCT01496274|2241368|P1|Overall Study|Protocol Violation|0
689954|NCT01496183|2241413|P2|Overall Study|Withdrawal by Subject|1
689955|NCT01496183|2241414|P1|Overall Study|Withdrawal by Subject|0
689956|NCT01496183|2241413|P2|Overall Study|Physician Decision|1
689957|NCT01496183|2241414|P1|Overall Study|Physician Decision|3
689958|NCT01495975|2241463|P2|Overall Study|Lost to Follow-up|0
689959|NCT01495975|2241464|P1|Overall Study|Lost to Follow-up|1
689960|NCT01495793|2241588|P1|Overall Study|Violation of inclusion criteria|1
689961|NCT01495793|2241588|P1|Overall Study|Lost to Follow-up|1
689962|NCT01495702|2241601|P2|Randomized Phase|Protocol Violation|1
689963|NCT01495702|2241602|P1|Randomized Phase|Protocol Violation|3
689964|NCT01495702|2241601|P2|Randomized Phase|Participant Noncompliance|0
689965|NCT01495702|2241602|P1|Randomized Phase|Participant Noncompliance|1
689966|NCT01495702|2241601|P2|Randomized Phase|Lost to Follow-up|3
689967|NCT01495702|2241602|P1|Randomized Phase|Lost to Follow-up|4
689968|NCT01495702|2241601|P2|Randomized Phase|Withdrew Consent|18
689969|NCT01495702|2241602|P1|Randomized Phase|Withdrew Consent|10
689970|NCT01495702|2241601|P2|Randomized Phase|Investigators Discretion|0
689971|NCT01495702|2241602|P1|Randomized Phase|Investigators Discretion|2
689972|NCT01495702|2241601|P2|Randomized Phase|Lack of Efficacy|0
689973|NCT01495702|2241602|P1|Randomized Phase|Lack of Efficacy|2
689974|NCT01495702|2241601|P2|Randomized Phase|Death|0
689975|NCT01495702|2241602|P1|Randomized Phase|Death|1
689976|NCT01495702|2241601|P2|Randomized Phase|Adverse Event|2
689977|NCT01495702|2241602|P1|Randomized Phase|Adverse Event|2
689978|NCT01495702|2241601|P2|Randomized Phase|Randomized But Not Treated|4
689979|NCT01495702|2241602|P1|Randomized Phase|Randomized But Not Treated|1
689980|NCT01495000|2241673|P2|Overall Study|Withdrawal by Subject|10
689981|NCT01495000|2241674|P1|Overall Study|Withdrawal by Subject|10
689982|NCT01495000|2241673|P2|Overall Study|Protocol Violation|0
689983|NCT01495000|2241674|P1|Overall Study|Protocol Violation|1
689984|NCT01495000|2241673|P2|Overall Study|Lost to Follow-up|2
689985|NCT01495000|2241674|P1|Overall Study|Lost to Follow-up|2
689986|NCT01494987|2241716|P2|Overall Study|Subject Withdrew Consent|3
689987|NCT01494987|2241717|P1|Overall Study|Subject Withdrew Consent|2
689988|NCT01494987|2241716|P2|Overall Study|Subject Non-Compliance|10
689989|NCT01494987|2241717|P1|Overall Study|Subject Non-Compliance|9
689990|NCT01494987|2241716|P2|Overall Study|Protocol Violation|3
689991|NCT01494987|2241717|P1|Overall Study|Protocol Violation|3
689992|NCT01494987|2241716|P2|Overall Study|Lost to Follow-up|1
689993|NCT01494987|2241717|P1|Overall Study|Lost to Follow-up|1
689994|NCT01494987|2241716|P2|Overall Study|Investigator's Discretion|2
689995|NCT01494987|2241717|P1|Overall Study|Investigator's Discretion|1
689996|NCT01494987|2241716|P2|Overall Study|Hyperglycemia|4
689997|NCT01494987|2241717|P1|Overall Study|Hyperglycemia|6
689998|NCT01494987|2241716|P2|Overall Study|Adverse Event|5
689999|NCT01494987|2241717|P1|Overall Study|Adverse Event|6
690000|NCT01494818|2241731|P2|Overall Study|Lost to Follow-up|0
690001|NCT01494818|2241732|P1|Overall Study|Lost to Follow-up|1
690002|NCT01494818|2241731|P2|Overall Study|Relocation|2
690003|NCT01494818|2241732|P1|Overall Study|Relocation|1
690004|NCT01494649|2241763|P2|Overall Study|Lost to Follow-up|1
690005|NCT01494649|2241764|P1|Overall Study|Lost to Follow-up|0
690006|NCT01494610|2241780|P2|Period 4|Protocol Violation|0
690007|NCT01494610|2241781|P1|Period 4|Protocol Violation|1
690008|NCT01494610|2241780|P2|Period 3|Withdrawal by Subject|0
690009|NCT01494610|2241781|P1|Period 3|Withdrawal by Subject|1
690010|NCT01494610|2241780|P2|Period 3|Adverse Event|0
690011|NCT01494610|2241781|P1|Period 3|Adverse Event|1
690012|NCT01494610|2241780|P2|Period 1|Withdrawal by Subject|1
690013|NCT01494610|2241781|P1|Period 1|Withdrawal by Subject|1
690014|NCT01494584|2241849|P1|Overall Study|Study Closed/Terminated|1
690015|NCT01494532|2241981|P6|Overall Study|Withdrawal by Subject|0
690016|NCT01494532|2241982|P5|Overall Study|Withdrawal by Subject|2
690017|NCT01494532|2241983|P4|Overall Study|Withdrawal by Subject|3
690018|NCT01494532|2241984|P3|Overall Study|Withdrawal by Subject|4
690019|NCT01494532|2241985|P2|Overall Study|Withdrawal by Subject|1
690020|NCT01494532|2241986|P1|Overall Study|Withdrawal by Subject|3
690021|NCT01494532|2241981|P6|Overall Study|Physician Decision|0
690022|NCT01494532|2241982|P5|Overall Study|Physician Decision|0
690023|NCT01494532|2241983|P4|Overall Study|Physician Decision|2
690024|NCT01494532|2241984|P3|Overall Study|Physician Decision|1
690025|NCT01494532|2241985|P2|Overall Study|Physician Decision|1
690026|NCT01494532|2241986|P1|Overall Study|Physician Decision|0
690027|NCT01494532|2241981|P6|Overall Study|Lost to Follow-up|0
690028|NCT01494532|2241982|P5|Overall Study|Lost to Follow-up|0
690029|NCT01494532|2241983|P4|Overall Study|Lost to Follow-up|2
690030|NCT01494532|2241984|P3|Overall Study|Lost to Follow-up|0
690031|NCT01494532|2241985|P2|Overall Study|Lost to Follow-up|0
690032|NCT01494532|2241986|P1|Overall Study|Lost to Follow-up|1
690033|NCT01494532|2241981|P6|Overall Study|Protocol-defined stopping criteria|0
690034|NCT01494532|2241982|P5|Overall Study|Protocol-defined stopping criteria|0
690035|NCT01494532|2241983|P4|Overall Study|Protocol-defined stopping criteria|0
690036|NCT01494532|2241984|P3|Overall Study|Protocol-defined stopping criteria|1
690037|NCT01494532|2241985|P2|Overall Study|Protocol-defined stopping criteria|0
690038|NCT01494532|2241986|P1|Overall Study|Protocol-defined stopping criteria|0
690039|NCT01494532|2241981|P6|Overall Study|Protocol deviation|0
690040|NCT01494532|2241982|P5|Overall Study|Protocol deviation|3
690041|NCT01494532|2241983|P4|Overall Study|Protocol deviation|2
690042|NCT01494532|2241984|P3|Overall Study|Protocol deviation|3
690043|NCT01494532|2241985|P2|Overall Study|Protocol deviation|1
690044|NCT01494532|2241986|P1|Overall Study|Protocol deviation|2
690045|NCT01494532|2241981|P6|Overall Study|Lack of Efficacy|0
690046|NCT01494532|2241982|P5|Overall Study|Lack of Efficacy|2
690047|NCT01494532|2241983|P4|Overall Study|Lack of Efficacy|0
690048|NCT01494532|2241984|P3|Overall Study|Lack of Efficacy|0
690049|NCT01494532|2241985|P2|Overall Study|Lack of Efficacy|0
690050|NCT01494532|2241986|P1|Overall Study|Lack of Efficacy|0
690051|NCT01494532|2241981|P6|Overall Study|Adverse Event|0
690052|NCT01494532|2241982|P5|Overall Study|Adverse Event|5
690053|NCT01494532|2241983|P4|Overall Study|Adverse Event|6
690054|NCT01494532|2241984|P3|Overall Study|Adverse Event|8
690055|NCT01494532|2241985|P2|Overall Study|Adverse Event|1
690056|NCT01494532|2241986|P1|Overall Study|Adverse Event|4
690057|NCT01494506|2242141|P3|Overall Study|Other|1
690058|NCT01494506|2242142|P2|Overall Study|Other|3
690059|NCT01494506|2242143|P1|Overall Study|Other|0
690060|NCT01494506|2242141|P3|Overall Study|Sponsor Decision|1
690061|NCT01494506|2242142|P2|Overall Study|Sponsor Decision|0
690062|NCT01494506|2242143|P1|Overall Study|Sponsor Decision|0
690063|NCT01494506|2242141|P3|Overall Study|Clinical Deterioration|13
690064|NCT01494506|2242142|P2|Overall Study|Clinical Deterioration|17
690065|NCT01494506|2242143|P1|Overall Study|Clinical Deterioration|21
690066|NCT01494506|2242141|P3|Overall Study|Withdrawal by Subject|14
690067|NCT01494506|2242142|P2|Overall Study|Withdrawal by Subject|20
690068|NCT01494506|2242143|P1|Overall Study|Withdrawal by Subject|17
690069|NCT01494506|2242141|P3|Overall Study|Physician Decision|4
690070|NCT01494506|2242142|P2|Overall Study|Physician Decision|5
690071|NCT01494506|2242143|P1|Overall Study|Physician Decision|7
690072|NCT01494506|2242141|P3|Overall Study|Death|2
690073|NCT01494506|2242142|P2|Overall Study|Death|5
690074|NCT01494506|2242143|P1|Overall Study|Death|9
690075|NCT01494506|2242141|P3|Overall Study|Adverse Event|11
690076|NCT01494506|2242142|P2|Overall Study|Adverse Event|10
690077|NCT01494506|2242143|P1|Overall Study|Adverse Event|17
690078|NCT01494506|2242141|P3|Overall Study|Lack of Efficacy|57
690079|NCT01494506|2242142|P2|Overall Study|Lack of Efficacy|83
690080|NCT01494506|2242143|P1|Overall Study|Lack of Efficacy|77
690081|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
690082|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
690083|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
690084|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
690085|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
690086|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
690087|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
690088|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
690089|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
690090|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
690091|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
690092|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
690093|NCT01494467|2242180|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
690094|NCT01494467|2242181|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
690095|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
690096|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
690097|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Other|1
690098|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Other|1
690099|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
690100|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
690101|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
690102|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
690103|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
690104|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
690105|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
690106|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
690107|NCT01494467|2242180|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
690108|NCT01494467|2242181|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
690109|NCT01494350|2242206|P1|Overall Study|Worsening of lesion|1
690110|NCT01494298|2242216|P2|Overall Study|Protocol Violation|8
690111|NCT01494298|2242217|P1|Overall Study|Protocol Violation|2
690112|NCT01493687|2242242|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
690113|NCT01493687|2242243|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
690114|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
690115|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
690116|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
690117|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
690118|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
690119|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
690120|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
690121|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
690122|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
690123|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
690124|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
690125|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
690126|NCT01493687|2242242|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
690127|NCT01493687|2242243|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
690128|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
690129|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
690130|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
690131|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
690132|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
690133|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
690134|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
690135|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
690136|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
690137|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
690138|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
690139|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
690140|NCT01493687|2242242|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
690141|NCT01493687|2242243|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
690142|NCT01493557|2242262|P3|Adding the Second Strategy|Withdrawal by Subject|0
690143|NCT01493557|2242263|P2|Adding the Second Strategy|Withdrawal by Subject|1
690144|NCT01493557|2242264|P1|Adding the Second Strategy|Withdrawal by Subject|0
690145|NCT01493557|2242262|P3|Adding the Second Strategy|Other adverse event|0
690146|NCT01493557|2242263|P2|Adding the Second Strategy|Other adverse event|2
690147|NCT01493557|2242264|P1|Adding the Second Strategy|Other adverse event|1
690148|NCT01493557|2242262|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
690149|NCT01493557|2242263|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
690150|NCT01493557|2242264|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
690151|NCT01493557|2242262|P3|Randomized to Management Strategies|Other than stated above|0
690152|NCT01493557|2242263|P2|Randomized to Management Strategies|Other than stated above|3
690153|NCT01493557|2242264|P1|Randomized to Management Strategies|Other than stated above|1
690154|NCT01493557|2242262|P3|Randomized to Management Strategies|Withdrawal by Subject|0
690155|NCT01493557|2242263|P2|Randomized to Management Strategies|Withdrawal by Subject|1
690156|NCT01493557|2242264|P1|Randomized to Management Strategies|Withdrawal by Subject|0
690157|NCT01493557|2242262|P3|Randomized to Management Strategies|Protocol Violation|0
690158|NCT01493557|2242263|P2|Randomized to Management Strategies|Protocol Violation|0
690159|NCT01493557|2242264|P1|Randomized to Management Strategies|Protocol Violation|3
690160|NCT01493557|2242262|P3|Randomized to Management Strategies|Other adverse event|0
690161|NCT01493557|2242263|P2|Randomized to Management Strategies|Other adverse event|5
690162|NCT01493557|2242264|P1|Randomized to Management Strategies|Other adverse event|8
690163|NCT01493557|2242262|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
690164|NCT01493557|2242263|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
690245|NCT01492426|2242388|P1|Treatment|Lack of Efficacy|38
690165|NCT01493557|2242264|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
690166|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Other than stated above|21
690167|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Other than stated above|0
690168|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Other than stated above|0
690169|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Early termination|34
690170|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Early termination|0
690171|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Early termination|0
690172|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
690173|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
690174|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
690175|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
690176|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
690177|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
690178|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Protocol Violation|1
690179|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Protocol Violation|0
690180|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Protocol Violation|0
690181|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Other adverse event|54
690182|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Other adverse event|0
690183|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Other adverse event|0
690184|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
690185|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
690186|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
690187|NCT01493557|2242262|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
690188|NCT01493557|2242263|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
690189|NCT01493557|2242264|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
690190|NCT01493531|2242292|P3|Overall Study|Death|0
690191|NCT01493531|2242293|P2|Overall Study|Death|1
690192|NCT01493531|2242294|P1|Overall Study|Death|0
690193|NCT01493531|2242292|P3|Overall Study|Withdrawal by Subject|11
690194|NCT01493531|2242293|P2|Overall Study|Withdrawal by Subject|13
690195|NCT01493531|2242294|P1|Overall Study|Withdrawal by Subject|16
690196|NCT01493531|2242292|P3|Overall Study|Lost to Follow-up|11
690197|NCT01493531|2242293|P2|Overall Study|Lost to Follow-up|7
690198|NCT01493531|2242294|P1|Overall Study|Lost to Follow-up|5
690199|NCT01493531|2242292|P3|Overall Study|Sponsor terminated study|3
690200|NCT01493531|2242293|P2|Overall Study|Sponsor terminated study|2
690201|NCT01493531|2242294|P1|Overall Study|Sponsor terminated study|5
690202|NCT01493531|2242292|P3|Overall Study|Protocol Violation|12
690203|NCT01493531|2242293|P2|Overall Study|Protocol Violation|15
690204|NCT01493531|2242294|P1|Overall Study|Protocol Violation|8
690205|NCT01493531|2242292|P3|Overall Study|Gout flare|2
690206|NCT01493531|2242293|P2|Overall Study|Gout flare|0
690207|NCT01493531|2242294|P1|Overall Study|Gout flare|3
690208|NCT01493531|2242292|P3|Overall Study|Adverse Event|9
690209|NCT01493531|2242293|P2|Overall Study|Adverse Event|12
690210|NCT01493531|2242294|P1|Overall Study|Adverse Event|4
690211|NCT01493427|2242308|P1|Overall Study|Other|2
690212|NCT01493427|2242308|P1|Overall Study|Inability to Follow Instructions|2
690213|NCT01493427|2242308|P1|Overall Study|Lost to Follow-up|2
690214|NCT01493427|2242308|P1|Overall Study|Personal Reasons|4
690215|NCT01493427|2242308|P1|Overall Study|Adverse Event|10
690216|NCT01493089|2242319|P2|Overall Study|Physician Decision|1
690217|NCT01493089|2242320|P1|Overall Study|Physician Decision|0
690218|NCT01493089|2242319|P2|Overall Study|Withdrawal by Subject|0
690219|NCT01493089|2242320|P1|Overall Study|Withdrawal by Subject|1
690220|NCT01493089|2242319|P2|Overall Study|Protocol Violation|2
690221|NCT01493089|2242320|P1|Overall Study|Protocol Violation|2
690222|NCT01492439|2242338|P2|Overall Study|Withdrew from RTE|9
690223|NCT01492439|2242339|P1|Overall Study|Withdrew from RTE|4
690224|NCT01492426|2242387|P2|Follow-Up|Lost to Follow-up|6
690225|NCT01492426|2242388|P1|Follow-Up|Lost to Follow-up|12
690226|NCT01492426|2242387|P2|Follow-Up|Participant Withdrew Consent|1
690227|NCT01492426|2242388|P1|Follow-Up|Participant Withdrew Consent|6
690228|NCT01492426|2242387|P2|Follow-Up|Unspecified|2
690229|NCT01492426|2242388|P1|Follow-Up|Unspecified|4
690230|NCT01492426|2242387|P2|Follow-Up|Death|0
690231|NCT01492426|2242388|P1|Follow-Up|Death|1
690232|NCT01492426|2242387|P2|Follow-Up|Protocol Requires no Follow-Up|1
690233|NCT01492426|2242388|P1|Follow-Up|Protocol Requires no Follow-Up|2
690234|NCT01492426|2242387|P2|Treatment|Participant does not meet study criteria|0
690235|NCT01492426|2242388|P1|Treatment|Participant does not meet study criteria|1
690236|NCT01492426|2242387|P2|Treatment|Lost to Follow-up|4
690237|NCT01492426|2242388|P1|Treatment|Lost to Follow-up|9
690238|NCT01492426|2242387|P2|Treatment|Subject requested discontinue study drug|3
690239|NCT01492426|2242388|P1|Treatment|Subject requested discontinue study drug|7
690240|NCT01492426|2242387|P2|Treatment|Poor compliance/noncompliance|0
690241|NCT01492426|2242388|P1|Treatment|Poor compliance/noncompliance|1
690242|NCT01492426|2242387|P2|Treatment|Participant withdrew consent|2
690243|NCT01492426|2242388|P1|Treatment|Participant withdrew consent|1
690244|NCT01492426|2242387|P2|Treatment|Lack of Efficacy|5
690246|NCT01492426|2242387|P2|Treatment|Adverse Event|25
690247|NCT01492426|2242388|P1|Treatment|Adverse Event|25
690248|NCT01492426|2242387|P2|Treatment|Unspecified|0
690249|NCT01492426|2242388|P1|Treatment|Unspecified|1
690250|NCT01492426|2242387|P2|Treatment|Death|1
690251|NCT01492426|2242388|P1|Treatment|Death|0
690252|NCT01492400|2242406|P2|Overall Study|Adverse Event|5
690253|NCT01492400|2242407|P1|Overall Study|Adverse Event|10
690254|NCT01492400|2242406|P2|Overall Study|Lack of Efficacy|1
690255|NCT01492400|2242407|P1|Overall Study|Lack of Efficacy|1
690256|NCT01492400|2242406|P2|Overall Study|Pregnancy|1
690257|NCT01492400|2242407|P1|Overall Study|Pregnancy|0
690258|NCT01492400|2242406|P2|Overall Study|Lost to Follow-up|1
690259|NCT01492400|2242407|P1|Overall Study|Lost to Follow-up|3
690260|NCT01492400|2242406|P2|Overall Study|Personal Reasons|5
690261|NCT01492400|2242407|P1|Overall Study|Personal Reasons|0
690262|NCT01492400|2242406|P2|Overall Study|Miscellaneous Reasons|3
690263|NCT01492400|2242407|P1|Overall Study|Miscellaneous Reasons|2
690264|NCT01492088|2242420|P3|Overall Study|Reason Not Specified|12
690265|NCT01492088|2242421|P2|Overall Study|Reason Not Specified|6
690266|NCT01492088|2242422|P1|Overall Study|Reason Not Specified|2
690267|NCT01492088|2242420|P3|Overall Study|Death|1
690268|NCT01492088|2242421|P2|Overall Study|Death|6
690269|NCT01492088|2242422|P1|Overall Study|Death|1
690270|NCT01492088|2242420|P3|Overall Study|Withdrawal by Patient|0
690271|NCT01492088|2242421|P2|Overall Study|Withdrawal by Patient|2
690272|NCT01492088|2242422|P1|Overall Study|Withdrawal by Patient|0
690273|NCT01491919|2242492|P3|Overall Study|Insufficient PK sampling|1
690274|NCT01491919|2242493|P2|Overall Study|Insufficient PK sampling|2
690275|NCT01491919|2242494|P1|Overall Study|Insufficient PK sampling|1
690276|NCT01491802|2242540|P2|Overall Study|Withdrawal by Subject|1
690277|NCT01491802|2242541|P1|Overall Study|Withdrawal by Subject|0
690278|NCT01491802|2242540|P2|Overall Study|Adverse Event|1
690279|NCT01491802|2242541|P1|Overall Study|Adverse Event|1
889246|NCT01372410|2823759|P2|Treatment Period 3 (7 Days)|Adverse Event|0
889247|NCT01372410|2823760|P1|Treatment Period 3 (7 Days)|Adverse Event|0
889248|NCT01372410|2823753|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
889249|NCT01372410|2823754|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
889250|NCT01372410|2823755|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
889251|NCT01372410|2823756|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
889252|NCT01372410|2823757|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
690288|NCT01491672|2242592|P3|Overall Study|Death|0
690289|NCT01491672|2242593|P2|Overall Study|Death|4
690290|NCT01491672|2242594|P1|Overall Study|Death|0
690291|NCT01491672|2242592|P3|Overall Study|Protocol deviation|0
690292|NCT01491672|2242593|P2|Overall Study|Protocol deviation|1
690293|NCT01491672|2242594|P1|Overall Study|Protocol deviation|0
690294|NCT01491672|2242592|P3|Overall Study|Disease progression|6
690295|NCT01491672|2242593|P2|Overall Study|Disease progression|34
690296|NCT01491672|2242594|P1|Overall Study|Disease progression|42
690297|NCT01491672|2242592|P3|Overall Study|Adverse Event|4
690298|NCT01491672|2242593|P2|Overall Study|Adverse Event|10
690299|NCT01491672|2242594|P1|Overall Study|Adverse Event|8
690300|NCT01491672|2242592|P3|Overall Study|Withdrawal by Subject|0
690301|NCT01491672|2242593|P2|Overall Study|Withdrawal by Subject|7
690302|NCT01491672|2242594|P1|Overall Study|Withdrawal by Subject|6
690303|NCT01491672|2242592|P3|Overall Study|Lost to Follow-up|1
690304|NCT01491672|2242593|P2|Overall Study|Lost to Follow-up|4
690305|NCT01491672|2242594|P1|Overall Study|Lost to Follow-up|0
690306|NCT01491607|2242631|P1|Overall Study|Withdrawal by Subject|3
690307|NCT01491607|2242631|P1|Overall Study|Lost to Follow-up|7
690308|NCT01491035|2242840|P8|Overall Study|Lost to Follow-up|0
690309|NCT01491035|2242841|P7|Overall Study|Lost to Follow-up|0
690310|NCT01491035|2242842|P6|Overall Study|Lost to Follow-up|0
690311|NCT01491035|2242843|P5|Overall Study|Lost to Follow-up|1
690312|NCT01491035|2242844|P4|Overall Study|Lost to Follow-up|0
690313|NCT01491035|2242845|P3|Overall Study|Lost to Follow-up|0
690314|NCT01491035|2242846|P2|Overall Study|Lost to Follow-up|0
690315|NCT01491035|2242847|P1|Overall Study|Lost to Follow-up|0
690316|NCT01490866|2242948|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
690317|NCT01490866|2242948|P1|Axitinib Maintenance Therapy|Protocol Violation|2
690318|NCT01490866|2242948|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
690319|NCT01490866|2242948|P1|Axitinib Maintenance Therapy|Adverse Event|12
690320|NCT01490866|2242948|P1|Axitinib Maintenance Therapy|Disease Progression|30
690321|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
690322|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
690323|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
690324|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
690325|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
690326|NCT01490866|2242948|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
690327|NCT01490840|2242959|P2|Phase 2|Adverse Event|1
690328|NCT01490840|2242960|P1|Phase 2|Adverse Event|1
690329|NCT01490840|2242959|P2|Phase 2|Lost to Follow-up|1
690330|NCT01490840|2242960|P1|Phase 2|Lost to Follow-up|1
690331|NCT01490840|2242959|P2|Phase 2|Permanent interruption of fingolimod|1
690332|NCT01490840|2242960|P1|Phase 2|Permanent interruption of fingolimod|0
690333|NCT01490840|2242959|P2|Phase 2|Withdrawal by Subject|3
690334|NCT01490840|2242960|P1|Phase 2|Withdrawal by Subject|4
690335|NCT01490840|2242959|P2|Phase 1|Visit 6a omitted|0
690336|NCT01490840|2242960|P1|Phase 1|Visit 6a omitted|1
690337|NCT01490840|2242959|P2|Phase 1|Withdrawal by Subject|5
690338|NCT01490840|2242960|P1|Phase 1|Withdrawal by Subject|6
690339|NCT01490840|2242959|P2|Phase 1|Adverse Event|1
690340|NCT01490840|2242960|P1|Phase 1|Adverse Event|2
690341|NCT01490840|2242959|P2|Phase 1|Lost to Follow-up|0
690342|NCT01490840|2242960|P1|Phase 1|Lost to Follow-up|1
690343|NCT01490697|2242984|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
690344|NCT01490697|2242985|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
690345|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
690346|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
690347|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
690348|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
690349|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
690350|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
690351|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
690352|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
690353|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
690354|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
690355|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
690356|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
690357|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
690358|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
690359|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
690360|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
690361|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
690362|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
690363|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
690364|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
690365|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Protocol Violation|0
690366|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Protocol Violation|1
690367|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Protocol Violation|0
690368|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Protocol Violation|0
690369|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Protocol Violation|0
690370|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Protocol Violation|0
690371|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Protocol Violation|0
690372|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Protocol Violation|0
690373|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Protocol Violation|0
690374|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Protocol Violation|0
690375|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Protocol Violation|0
690376|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Protocol Violation|0
690377|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Protocol Violation|0
690378|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Protocol Violation|0
690379|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Protocol Violation|0
690380|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Protocol Violation|0
690381|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Protocol Violation|0
690382|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Protocol Violation|0
690383|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Protocol Violation|0
690384|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Protocol Violation|0
690385|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Physician Decision|1
690386|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Physician Decision|1
690387|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Physician Decision|0
690388|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Physician Decision|0
690389|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Physician Decision|0
690390|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Physician Decision|0
690391|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Physician Decision|0
690392|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Physician Decision|0
690393|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Physician Decision|0
690394|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Physician Decision|0
690395|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Physician Decision|0
690396|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Physician Decision|0
690397|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Physician Decision|0
690398|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Physician Decision|0
690399|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Physician Decision|0
690400|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Physician Decision|0
690401|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Physician Decision|0
690402|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Physician Decision|0
690403|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Physician Decision|0
690404|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Physician Decision|0
690405|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
690406|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
690407|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
690408|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
690409|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
690410|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
690411|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
690412|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
690413|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
690414|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
690415|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
690416|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
690417|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
690418|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
690419|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
690420|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
690421|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
690422|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
690423|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
690424|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
690425|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
690426|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
690427|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
690428|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
690429|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
690430|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
690431|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
690432|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
690433|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
690434|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
690435|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
690436|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
690437|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
690438|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
690439|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
690440|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
690441|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
690442|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
690443|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
690444|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
690445|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Death|0
690446|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Death|1
690447|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Death|0
690448|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Death|0
690449|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Death|0
690450|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Death|0
690451|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Death|0
690452|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Death|0
690453|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Death|0
690454|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Death|0
690455|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Death|0
690456|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Death|0
690457|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Death|0
690458|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Death|0
690459|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Death|0
690460|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Death|0
690461|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Death|0
690462|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Death|0
690463|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Death|0
690464|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Death|0
690465|NCT01490632|2242998|P20|Part D: Re-Treatment Period|Adverse Event|3
690466|NCT01490632|2242999|P19|Part D: Re-Treatment Period|Adverse Event|1
690467|NCT01490632|2243000|P18|Part D: Re-Treatment Period|Adverse Event|1
690468|NCT01490632|2243001|P17|Part D: Re-Treatment Period|Adverse Event|0
690469|NCT01490632|2243002|P16|Part D: Re-Treatment Period|Adverse Event|0
690470|NCT01490632|2243003|P15|Part D: Re-Treatment Period|Adverse Event|0
690471|NCT01490632|2243004|P14|Part D: Re-Treatment Period|Adverse Event|0
690472|NCT01490632|2243005|P13|Part D: Re-Treatment Period|Adverse Event|0
690473|NCT01490632|2243006|P12|Part D: Re-Treatment Period|Adverse Event|0
690474|NCT01490632|2243007|P11|Part D: Re-Treatment Period|Adverse Event|0
690475|NCT01490632|2243008|P10|Part D: Re-Treatment Period|Adverse Event|0
690476|NCT01490632|2243009|P9|Part D: Re-Treatment Period|Adverse Event|0
690477|NCT01490632|2243010|P8|Part D: Re-Treatment Period|Adverse Event|0
690478|NCT01490632|2243011|P7|Part D: Re-Treatment Period|Adverse Event|0
690479|NCT01490632|2243012|P6|Part D: Re-Treatment Period|Adverse Event|0
690480|NCT01490632|2243013|P5|Part D: Re-Treatment Period|Adverse Event|0
690481|NCT01490632|2243014|P4|Part D: Re-Treatment Period|Adverse Event|0
690482|NCT01490632|2243015|P3|Part D: Re-Treatment Period|Adverse Event|0
690483|NCT01490632|2243016|P2|Part D: Re-Treatment Period|Adverse Event|0
690484|NCT01490632|2243017|P1|Part D: Re-Treatment Period|Adverse Event|0
690485|NCT01490632|2242998|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690486|NCT01490632|2242999|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690487|NCT01490632|2243000|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690488|NCT01490632|2243001|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690489|NCT01490632|2243002|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
690490|NCT01490632|2243003|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
690491|NCT01490632|2243004|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
690492|NCT01490632|2243005|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
690493|NCT01490632|2243006|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690494|NCT01490632|2243007|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690495|NCT01490632|2243008|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690496|NCT01490632|2243009|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690497|NCT01490632|2243010|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690498|NCT01490632|2243011|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690499|NCT01490632|2243012|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690500|NCT01490632|2243013|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690501|NCT01490632|2243014|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690502|NCT01490632|2243015|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690503|NCT01490632|2243016|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690504|NCT01490632|2243017|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
690505|NCT01490632|2242998|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690506|NCT01490632|2242999|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690507|NCT01490632|2243000|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690508|NCT01490632|2243001|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690509|NCT01490632|2243002|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
690510|NCT01490632|2243003|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
690511|NCT01490632|2243004|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690512|NCT01490632|2243005|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690513|NCT01490632|2243006|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690514|NCT01490632|2243007|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690515|NCT01490632|2243008|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690516|NCT01490632|2243009|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690517|NCT01490632|2243010|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690518|NCT01490632|2243011|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690519|NCT01490632|2243012|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690520|NCT01490632|2243013|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690521|NCT01490632|2243014|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690522|NCT01490632|2243015|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690523|NCT01490632|2243016|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690524|NCT01490632|2243017|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
690525|NCT01490632|2242998|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690526|NCT01490632|2242999|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690527|NCT01490632|2243000|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690528|NCT01490632|2243001|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690529|NCT01490632|2243002|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690530|NCT01490632|2243003|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690531|NCT01490632|2243004|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
690532|NCT01490632|2243005|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690533|NCT01490632|2243006|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690534|NCT01490632|2243007|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690535|NCT01490632|2243008|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690536|NCT01490632|2243009|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690537|NCT01490632|2243010|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690538|NCT01490632|2243011|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690539|NCT01490632|2243012|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690540|NCT01490632|2243013|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690541|NCT01490632|2243014|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690542|NCT01490632|2243015|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690543|NCT01490632|2243016|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690544|NCT01490632|2243017|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
690545|NCT01490632|2242998|P20|Part C: Washout or Step-Down Period|Adverse Event|0
690546|NCT01490632|2242999|P19|Part C: Washout or Step-Down Period|Adverse Event|0
690547|NCT01490632|2243000|P18|Part C: Washout or Step-Down Period|Adverse Event|0
690548|NCT01490632|2243001|P17|Part C: Washout or Step-Down Period|Adverse Event|0
690549|NCT01490632|2243002|P16|Part C: Washout or Step-Down Period|Adverse Event|2
690550|NCT01490632|2243003|P15|Part C: Washout or Step-Down Period|Adverse Event|2
690551|NCT01490632|2243004|P14|Part C: Washout or Step-Down Period|Adverse Event|0
690552|NCT01490632|2243005|P13|Part C: Washout or Step-Down Period|Adverse Event|0
690553|NCT01490632|2243006|P12|Part C: Washout or Step-Down Period|Adverse Event|0
690554|NCT01490632|2243007|P11|Part C: Washout or Step-Down Period|Adverse Event|0
690555|NCT01490632|2243008|P10|Part C: Washout or Step-Down Period|Adverse Event|0
690556|NCT01490632|2243009|P9|Part C: Washout or Step-Down Period|Adverse Event|0
690557|NCT01490632|2243010|P8|Part C: Washout or Step-Down Period|Adverse Event|0
690558|NCT01490632|2243011|P7|Part C: Washout or Step-Down Period|Adverse Event|0
690559|NCT01490632|2243012|P6|Part C: Washout or Step-Down Period|Adverse Event|0
690560|NCT01490632|2243013|P5|Part C: Washout or Step-Down Period|Adverse Event|0
690561|NCT01490632|2243014|P4|Part C: Washout or Step-Down Period|Adverse Event|0
690562|NCT01490632|2243015|P3|Part C: Washout or Step-Down Period|Adverse Event|0
690563|NCT01490632|2243016|P2|Part C: Washout or Step-Down Period|Adverse Event|0
690564|NCT01490632|2243017|P1|Part C: Washout or Step-Down Period|Adverse Event|0
690565|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690566|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690567|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690568|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690569|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690570|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690571|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690572|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690573|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
690574|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
690575|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
690576|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
690577|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
690578|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
690579|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
690580|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690581|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690582|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690583|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690584|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
690585|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690586|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690587|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690588|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690589|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690590|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690591|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690592|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690593|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
690594|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
690595|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690596|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
690597|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690598|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
690599|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690600|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690601|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690602|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690603|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690604|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
690605|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
690606|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
690607|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
690608|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
690609|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
690610|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
690611|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
690612|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
690613|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
690614|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
690615|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
690616|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
690617|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
690618|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
690619|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
690620|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
690621|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
690622|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
690623|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
690624|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
690625|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Physician Decision|0
690626|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Physician Decision|0
690935|NCT01490086|2243446|P5|Overall Study|Lack of Efficacy|8
690627|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Physician Decision|0
690628|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Physician Decision|0
690629|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Physician Decision|0
690630|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Physician Decision|0
690631|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Physician Decision|0
690632|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Physician Decision|0
690633|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Physician Decision|0
690634|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Physician Decision|0
690635|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Physician Decision|0
690636|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Physician Decision|0
690637|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Physician Decision|0
690638|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Physician Decision|1
690639|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Physician Decision|0
690640|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Physician Decision|0
690641|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Physician Decision|0
690642|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Physician Decision|0
690643|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Physician Decision|0
690644|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Physician Decision|0
690645|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690646|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690647|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690648|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690649|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690650|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690651|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690652|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690653|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690654|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690655|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
690656|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690657|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690658|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
690659|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690660|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690661|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690662|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690663|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690664|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
690665|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690666|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690667|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690668|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690669|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690670|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690671|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690672|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690673|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690674|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
690675|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
690676|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
690677|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690678|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
690679|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690680|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690681|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690682|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690683|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690684|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
690685|NCT01490632|2242998|P20|Part B: Extension or Step-Up Period|Adverse Event|0
690686|NCT01490632|2242999|P19|Part B: Extension or Step-Up Period|Adverse Event|0
690687|NCT01490632|2243000|P18|Part B: Extension or Step-Up Period|Adverse Event|0
690688|NCT01490632|2243001|P17|Part B: Extension or Step-Up Period|Adverse Event|0
690689|NCT01490632|2243002|P16|Part B: Extension or Step-Up Period|Adverse Event|0
690690|NCT01490632|2243003|P15|Part B: Extension or Step-Up Period|Adverse Event|0
690691|NCT01490632|2243004|P14|Part B: Extension or Step-Up Period|Adverse Event|0
690692|NCT01490632|2243005|P13|Part B: Extension or Step-Up Period|Adverse Event|0
690693|NCT01490632|2243006|P12|Part B: Extension or Step-Up Period|Adverse Event|1
690694|NCT01490632|2243007|P11|Part B: Extension or Step-Up Period|Adverse Event|3
690695|NCT01490632|2243008|P10|Part B: Extension or Step-Up Period|Adverse Event|2
690696|NCT01490632|2243009|P9|Part B: Extension or Step-Up Period|Adverse Event|0
690697|NCT01490632|2243010|P8|Part B: Extension or Step-Up Period|Adverse Event|0
690698|NCT01490632|2243011|P7|Part B: Extension or Step-Up Period|Adverse Event|2
690699|NCT01490632|2243012|P6|Part B: Extension or Step-Up Period|Adverse Event|2
690700|NCT01490632|2243013|P5|Part B: Extension or Step-Up Period|Adverse Event|0
690701|NCT01490632|2243014|P4|Part B: Extension or Step-Up Period|Adverse Event|0
690702|NCT01490632|2243015|P3|Part B: Extension or Step-Up Period|Adverse Event|0
690703|NCT01490632|2243016|P2|Part B: Extension or Step-Up Period|Adverse Event|0
690704|NCT01490632|2243017|P1|Part B: Extension or Step-Up Period|Adverse Event|0
690705|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690706|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690707|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690708|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690709|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690710|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690711|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690712|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690713|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690714|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690715|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690716|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690717|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690718|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690719|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690720|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
690721|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690722|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690723|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690724|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
690725|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
690726|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
690727|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
690728|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
690729|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
690730|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
690731|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
690732|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
690733|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
690734|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
690735|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
690736|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
690737|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
690738|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
690739|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
690740|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
690741|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
690742|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
690743|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
690744|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
690745|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Sponsor Decision|0
690746|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Sponsor Decision|0
690747|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Sponsor Decision|0
690748|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Sponsor Decision|0
690749|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Sponsor Decision|0
690750|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Sponsor Decision|0
690751|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Sponsor Decision|0
690752|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Sponsor Decision|0
690753|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Sponsor Decision|0
690754|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Sponsor Decision|0
690755|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Sponsor Decision|0
690756|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Sponsor Decision|0
690757|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Sponsor Decision|0
690758|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Sponsor Decision|0
690759|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Sponsor Decision|0
690760|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Sponsor Decision|0
690761|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Sponsor Decision|0
690762|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Sponsor Decision|0
690763|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Sponsor Decision|0
690764|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Sponsor Decision|2
690765|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Physician Decision|0
690766|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Physician Decision|0
690767|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Physician Decision|0
690768|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Physician Decision|0
690769|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Physician Decision|0
690770|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Physician Decision|0
690771|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Physician Decision|0
690772|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Physician Decision|0
690773|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Physician Decision|0
690774|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Physician Decision|0
690775|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Physician Decision|0
690776|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Physician Decision|0
690777|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Physician Decision|0
690778|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Physician Decision|0
690779|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Physician Decision|0
690780|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Physician Decision|0
690781|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Physician Decision|1
690782|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Physician Decision|0
690783|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Physician Decision|1
690784|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Physician Decision|0
690785|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
690786|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
690787|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
690788|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
690789|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
690790|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
690791|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
690792|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
690793|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
690794|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
690795|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
690796|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
690797|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
690798|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
690799|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
690800|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
690801|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
690802|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
690803|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
690804|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
690805|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
690806|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
690807|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
690808|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
690809|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
690810|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
690811|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
690812|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
690813|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
690814|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
690815|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
690816|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
690817|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
690818|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
690819|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
690820|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
690821|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
690822|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
690823|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
690824|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
690825|NCT01490632|2242998|P20|Part A: Initial Treatment Period|Adverse Event|0
690826|NCT01490632|2242999|P19|Part A: Initial Treatment Period|Adverse Event|0
690827|NCT01490632|2243000|P18|Part A: Initial Treatment Period|Adverse Event|0
690828|NCT01490632|2243001|P17|Part A: Initial Treatment Period|Adverse Event|0
690829|NCT01490632|2243002|P16|Part A: Initial Treatment Period|Adverse Event|0
690830|NCT01490632|2243003|P15|Part A: Initial Treatment Period|Adverse Event|0
690831|NCT01490632|2243004|P14|Part A: Initial Treatment Period|Adverse Event|0
690832|NCT01490632|2243005|P13|Part A: Initial Treatment Period|Adverse Event|0
690833|NCT01490632|2243006|P12|Part A: Initial Treatment Period|Adverse Event|0
690834|NCT01490632|2243007|P11|Part A: Initial Treatment Period|Adverse Event|0
690835|NCT01490632|2243008|P10|Part A: Initial Treatment Period|Adverse Event|0
690836|NCT01490632|2243009|P9|Part A: Initial Treatment Period|Adverse Event|0
690837|NCT01490632|2243010|P8|Part A: Initial Treatment Period|Adverse Event|0
690838|NCT01490632|2243011|P7|Part A: Initial Treatment Period|Adverse Event|0
690839|NCT01490632|2243012|P6|Part A: Initial Treatment Period|Adverse Event|0
690840|NCT01490632|2243013|P5|Part A: Initial Treatment Period|Adverse Event|4
690841|NCT01490632|2243014|P4|Part A: Initial Treatment Period|Adverse Event|4
690842|NCT01490632|2243015|P3|Part A: Initial Treatment Period|Adverse Event|2
690843|NCT01490632|2243016|P2|Part A: Initial Treatment Period|Adverse Event|0
690844|NCT01490632|2243017|P1|Part A: Initial Treatment Period|Adverse Event|0
690845|NCT01490294|2243149|P4|Overall Study|Adverse Event|0
690846|NCT01490294|2243150|P3|Overall Study|Adverse Event|0
690847|NCT01490294|2243151|P2|Overall Study|Adverse Event|0
690848|NCT01490294|2243152|P1|Overall Study|Adverse Event|1
690849|NCT01490294|2243149|P4|Overall Study|Prematurely discontinuation|1
690850|NCT01490294|2243150|P3|Overall Study|Prematurely discontinuation|1
690851|NCT01490294|2243151|P2|Overall Study|Prematurely discontinuation|0
690852|NCT01490294|2243152|P1|Overall Study|Prematurely discontinuation|4
690853|NCT01490190|2243386|P1|Overall Study|Ring expulsion|2
690854|NCT01490190|2243386|P1|Overall Study|Inconvenience|1
690855|NCT01490190|2243386|P1|Overall Study|Relocation|1
690856|NCT01490190|2243386|P1|Overall Study|Lost to Follow-up|13
690857|NCT01490190|2243386|P1|Overall Study|Protocol Violation|5
690858|NCT01490190|2243386|P1|Overall Study|Adverse Event|17
690859|NCT01490190|2243386|P1|Overall Study|Withdrawal by Subject|9
690860|NCT01490125|2243413|P6|Period III|Lack of Efficacy|0
690861|NCT01490125|2243414|P5|Period III|Lack of Efficacy|1
690862|NCT01490125|2243415|P4|Period III|Lack of Efficacy|0
690863|NCT01490125|2243416|P3|Period III|Lack of Efficacy|0
690864|NCT01490125|2243417|P2|Period III|Lack of Efficacy|0
690865|NCT01490125|2243418|P1|Period III|Lack of Efficacy|0
690866|NCT01490125|2243413|P6|Period III|Death|0
690867|NCT01490125|2243414|P5|Period III|Death|0
690868|NCT01490125|2243415|P4|Period III|Death|1
690869|NCT01490125|2243416|P3|Period III|Death|0
690870|NCT01490125|2243417|P2|Period III|Death|0
690871|NCT01490125|2243418|P1|Period III|Death|0
690872|NCT01490125|2243413|P6|Period III|Adverse Event|0
690873|NCT01490125|2243414|P5|Period III|Adverse Event|0
690874|NCT01490125|2243415|P4|Period III|Adverse Event|1
690875|NCT01490125|2243416|P3|Period III|Adverse Event|0
690876|NCT01490125|2243417|P2|Period III|Adverse Event|1
690877|NCT01490125|2243418|P1|Period III|Adverse Event|3
690878|NCT01490125|2243413|P6|Period II|Withdrawal by Subject|0
690879|NCT01490125|2243414|P5|Period II|Withdrawal by Subject|0
690880|NCT01490125|2243415|P4|Period II|Withdrawal by Subject|0
690881|NCT01490125|2243416|P3|Period II|Withdrawal by Subject|0
690882|NCT01490125|2243417|P2|Period II|Withdrawal by Subject|0
690883|NCT01490125|2243418|P1|Period II|Withdrawal by Subject|1
690884|NCT01490125|2243413|P6|Period II|Lost to Follow-up|0
690885|NCT01490125|2243414|P5|Period II|Lost to Follow-up|0
690886|NCT01490125|2243415|P4|Period II|Lost to Follow-up|0
690887|NCT01490125|2243416|P3|Period II|Lost to Follow-up|0
690888|NCT01490125|2243417|P2|Period II|Lost to Follow-up|1
690889|NCT01490125|2243418|P1|Period II|Lost to Follow-up|0
690890|NCT01490125|2243413|P6|Period II|Protocol Violation|0
690891|NCT01490125|2243414|P5|Period II|Protocol Violation|0
690892|NCT01490125|2243415|P4|Period II|Protocol Violation|1
690893|NCT01490125|2243416|P3|Period II|Protocol Violation|1
690894|NCT01490125|2243417|P2|Period II|Protocol Violation|0
690895|NCT01490125|2243418|P1|Period II|Protocol Violation|0
690896|NCT01490125|2243413|P6|Period II|Adverse Event|2
690897|NCT01490125|2243414|P5|Period II|Adverse Event|4
690898|NCT01490125|2243415|P4|Period II|Adverse Event|2
690899|NCT01490125|2243416|P3|Period II|Adverse Event|2
690900|NCT01490125|2243417|P2|Period II|Adverse Event|3
690901|NCT01490125|2243418|P1|Period II|Adverse Event|2
690902|NCT01490125|2243413|P6|Period I|Withdrawal by Subject|1
690903|NCT01490125|2243414|P5|Period I|Withdrawal by Subject|2
690904|NCT01490125|2243415|P4|Period I|Withdrawal by Subject|1
690905|NCT01490125|2243416|P3|Period I|Withdrawal by Subject|2
690906|NCT01490125|2243417|P2|Period I|Withdrawal by Subject|3
690907|NCT01490125|2243418|P1|Period I|Withdrawal by Subject|1
690908|NCT01490125|2243413|P6|Period I|Protocol Violation|0
690909|NCT01490125|2243414|P5|Period I|Protocol Violation|0
690910|NCT01490125|2243415|P4|Period I|Protocol Violation|1
690911|NCT01490125|2243416|P3|Period I|Protocol Violation|1
690912|NCT01490125|2243417|P2|Period I|Protocol Violation|1
690913|NCT01490125|2243418|P1|Period I|Protocol Violation|1
690914|NCT01490125|2243413|P6|Period I|Adverse Event|4
690915|NCT01490125|2243414|P5|Period I|Adverse Event|2
690916|NCT01490125|2243415|P4|Period I|Adverse Event|3
690917|NCT01490125|2243416|P3|Period I|Adverse Event|1
690918|NCT01490125|2243417|P2|Period I|Adverse Event|1
690919|NCT01490125|2243418|P1|Period I|Adverse Event|4
690920|NCT01490086|2243446|P5|Overall Study|Subject left hospital|0
690921|NCT01490086|2243447|P4|Overall Study|Subject left hospital|1
690922|NCT01490086|2243448|P3|Overall Study|Subject left hospital|0
690923|NCT01490086|2243449|P2|Overall Study|Subject left hospital|1
690924|NCT01490086|2243450|P1|Overall Study|Subject left hospital|0
690925|NCT01490086|2243446|P5|Overall Study|Subject uncontrollable and abusive|0
690926|NCT01490086|2243447|P4|Overall Study|Subject uncontrollable and abusive|0
690927|NCT01490086|2243448|P3|Overall Study|Subject uncontrollable and abusive|0
690928|NCT01490086|2243449|P2|Overall Study|Subject uncontrollable and abusive|1
690929|NCT01490086|2243450|P1|Overall Study|Subject uncontrollable and abusive|0
690930|NCT01490086|2243446|P5|Overall Study|Worsening of symptoms|0
690931|NCT01490086|2243447|P4|Overall Study|Worsening of symptoms|1
690932|NCT01490086|2243448|P3|Overall Study|Worsening of symptoms|0
690933|NCT01490086|2243449|P2|Overall Study|Worsening of symptoms|1
690934|NCT01490086|2243450|P1|Overall Study|Worsening of symptoms|0
690936|NCT01490086|2243447|P4|Overall Study|Lack of Efficacy|0
690937|NCT01490086|2243448|P3|Overall Study|Lack of Efficacy|1
690938|NCT01490086|2243449|P2|Overall Study|Lack of Efficacy|3
690939|NCT01490086|2243450|P1|Overall Study|Lack of Efficacy|0
690940|NCT01490086|2243446|P5|Overall Study|Adverse Event|0
690941|NCT01490086|2243447|P4|Overall Study|Adverse Event|2
690942|NCT01490086|2243448|P3|Overall Study|Adverse Event|1
690943|NCT01490086|2243449|P2|Overall Study|Adverse Event|0
690944|NCT01490086|2243450|P1|Overall Study|Adverse Event|0
690945|NCT01490086|2243446|P5|Overall Study|Physician Decision|1
690946|NCT01490086|2243447|P4|Overall Study|Physician Decision|3
690947|NCT01490086|2243448|P3|Overall Study|Physician Decision|2
690948|NCT01490086|2243449|P2|Overall Study|Physician Decision|4
690949|NCT01490086|2243450|P1|Overall Study|Physician Decision|3
690950|NCT01490086|2243446|P5|Overall Study|Lost to Follow-up|1
690951|NCT01490086|2243447|P4|Overall Study|Lost to Follow-up|0
690952|NCT01490086|2243448|P3|Overall Study|Lost to Follow-up|0
690953|NCT01490086|2243449|P2|Overall Study|Lost to Follow-up|0
690954|NCT01490086|2243450|P1|Overall Study|Lost to Follow-up|0
690955|NCT01490086|2243446|P5|Overall Study|Abnormal laboratory findings|0
690956|NCT01490086|2243447|P4|Overall Study|Abnormal laboratory findings|0
690957|NCT01490086|2243448|P3|Overall Study|Abnormal laboratory findings|0
690958|NCT01490086|2243449|P2|Overall Study|Abnormal laboratory findings|0
690959|NCT01490086|2243450|P1|Overall Study|Abnormal laboratory findings|1
690960|NCT01490086|2243446|P5|Overall Study|Non-compliance|0
690961|NCT01490086|2243447|P4|Overall Study|Non-compliance|0
690962|NCT01490086|2243448|P3|Overall Study|Non-compliance|0
690963|NCT01490086|2243449|P2|Overall Study|Non-compliance|1
690964|NCT01490086|2243450|P1|Overall Study|Non-compliance|0
690965|NCT01490086|2243446|P5|Overall Study|Consent withdrawn|1
690966|NCT01490086|2243447|P4|Overall Study|Consent withdrawn|0
690967|NCT01490086|2243448|P3|Overall Study|Consent withdrawn|3
690968|NCT01490086|2243449|P2|Overall Study|Consent withdrawn|4
690969|NCT01490086|2243450|P1|Overall Study|Consent withdrawn|4
690970|NCT01490060|2243484|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
690971|NCT01490060|2243485|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
690972|NCT01490060|2243486|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
690973|NCT01490060|2243487|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
690974|NCT01490060|2243484|P4|Cycle 2|Non-Compliance|0
690975|NCT01490060|2243485|P3|Cycle 2|Non-Compliance|1
690976|NCT01490060|2243486|P2|Cycle 2|Non-Compliance|0
690977|NCT01490060|2243487|P1|Cycle 2|Non-Compliance|0
690978|NCT01490060|2243484|P4|Cycle 2|Change of Treatment|0
690979|NCT01490060|2243485|P3|Cycle 2|Change of Treatment|0
690980|NCT01490060|2243486|P2|Cycle 2|Change of Treatment|1
690981|NCT01490060|2243487|P1|Cycle 2|Change of Treatment|1
690982|NCT01490060|2243484|P4|Cycle 1|Treatment at Another Facility|1
690983|NCT01490060|2243485|P3|Cycle 1|Treatment at Another Facility|0
690984|NCT01490060|2243486|P2|Cycle 1|Treatment at Another Facility|0
690985|NCT01490060|2243487|P1|Cycle 1|Treatment at Another Facility|0
690986|NCT01490060|2243484|P4|Cycle 1|Withdrawal by Subject|1
690987|NCT01490060|2243485|P3|Cycle 1|Withdrawal by Subject|0
690988|NCT01490060|2243486|P2|Cycle 1|Withdrawal by Subject|0
690989|NCT01490060|2243487|P1|Cycle 1|Withdrawal by Subject|0
690990|NCT01490060|2243484|P4|Cycle 1|Insurance Denied|0
690991|NCT01490060|2243485|P3|Cycle 1|Insurance Denied|2
690992|NCT01490060|2243486|P2|Cycle 1|Insurance Denied|0
690993|NCT01490060|2243487|P1|Cycle 1|Insurance Denied|0
690994|NCT01490060|2243484|P4|Cycle 1|Change of Treatment|1
690995|NCT01490060|2243485|P3|Cycle 1|Change of Treatment|1
690996|NCT01490060|2243486|P2|Cycle 1|Change of Treatment|1
690997|NCT01490060|2243487|P1|Cycle 1|Change of Treatment|0
690998|NCT01489956|2243497|P3|Overall Study|Withdrawal by Subject|1
690999|NCT01489956|2243498|P2|Overall Study|Withdrawal by Subject|0
691000|NCT01489956|2243499|P1|Overall Study|Withdrawal by Subject|0
691001|NCT01489956|2243497|P3|Overall Study|Lost to Follow-up|0
691002|NCT01489956|2243498|P2|Overall Study|Lost to Follow-up|0
691003|NCT01489956|2243499|P1|Overall Study|Lost to Follow-up|1
691004|NCT01489891|2243536|P2|Overall Study|Endoscopy failure|0
691005|NCT01489891|2243537|P1|Overall Study|Endoscopy failure|1
691006|NCT01489527|2243675|P2|Overall Study|Not compliant|0
691007|NCT01489527|2243676|P1|Overall Study|Not compliant|1
691008|NCT01489527|2243675|P2|Overall Study|Procedures|0
691009|NCT01489527|2243676|P1|Overall Study|Procedures|1
691010|NCT01489527|2243675|P2|Overall Study|Lost to Follow-up|1
691011|NCT01489527|2243676|P1|Overall Study|Lost to Follow-up|5
691012|NCT01489527|2243675|P2|Overall Study|Withdrawal by Subject|4
691013|NCT01489527|2243676|P1|Overall Study|Withdrawal by Subject|0
691014|NCT01489527|2243675|P2|Overall Study|Participant moved|7
691015|NCT01489527|2243676|P1|Overall Study|Participant moved|6
691016|NCT01489527|2243675|P2|Overall Study|Pregnancy|14
691017|NCT01489527|2243676|P1|Overall Study|Pregnancy|9
691018|NCT01489358|2243693|P3|Overall Study|Lost to Follow-up|2
691019|NCT01489358|2243694|P2|Overall Study|Lost to Follow-up|0
691020|NCT01489358|2243695|P1|Overall Study|Lost to Follow-up|0
691021|NCT01489254|2243745|P4|Open-label Extension Part|Other reasons for not completing study|5
691022|NCT01489254|2243746|P3|Open-label Extension Part|Other reasons for not completing study|0
691023|NCT01489254|2243747|P2|Open-label Extension Part|Other reasons for not completing study|0
691024|NCT01489254|2243748|P1|Open-label Extension Part|Other reasons for not completing study|0
691025|NCT01489254|2243745|P4|Open-label Extension Part|Lost to Follow-up|9
691026|NCT01489254|2243746|P3|Open-label Extension Part|Lost to Follow-up|0
691027|NCT01489254|2243747|P2|Open-label Extension Part|Lost to Follow-up|0
691028|NCT01489254|2243748|P1|Open-label Extension Part|Lost to Follow-up|0
691029|NCT01489254|2243745|P4|Open-label Extension Part|Protocol Violation|1
691030|NCT01489254|2243746|P3|Open-label Extension Part|Protocol Violation|0
691031|NCT01489254|2243747|P2|Open-label Extension Part|Protocol Violation|0
691032|NCT01489254|2243748|P1|Open-label Extension Part|Protocol Violation|0
691033|NCT01489254|2243745|P4|Open-label Extension Part|Withdrawal by Subject|30
691034|NCT01489254|2243746|P3|Open-label Extension Part|Withdrawal by Subject|0
691035|NCT01489254|2243747|P2|Open-label Extension Part|Withdrawal by Subject|0
691036|NCT01489254|2243748|P1|Open-label Extension Part|Withdrawal by Subject|0
691037|NCT01489254|2243745|P4|Open-label Extension Part|Pregnancy|3
691038|NCT01489254|2243746|P3|Open-label Extension Part|Pregnancy|0
691039|NCT01489254|2243747|P2|Open-label Extension Part|Pregnancy|0
691040|NCT01489254|2243748|P1|Open-label Extension Part|Pregnancy|0
691041|NCT01489254|2243745|P4|Open-label Extension Part|Adverse Event|10
691042|NCT01489254|2243746|P3|Open-label Extension Part|Adverse Event|0
691043|NCT01489254|2243747|P2|Open-label Extension Part|Adverse Event|0
691044|NCT01489254|2243748|P1|Open-label Extension Part|Adverse Event|0
691045|NCT01489254|2243745|P4|Double-blind Part|Other reasons for not completing study|0
691046|NCT01489254|2243746|P3|Double-blind Part|Other reasons for not completing study|0
691047|NCT01489254|2243747|P2|Double-blind Part|Other reasons for not completing study|6
691048|NCT01489254|2243748|P1|Double-blind Part|Other reasons for not completing study|4
691049|NCT01489254|2243745|P4|Double-blind Part|Lost to Follow-up|0
691050|NCT01489254|2243746|P3|Double-blind Part|Lost to Follow-up|0
691051|NCT01489254|2243747|P2|Double-blind Part|Lost to Follow-up|2
691052|NCT01489254|2243748|P1|Double-blind Part|Lost to Follow-up|1
691053|NCT01489254|2243745|P4|Double-blind Part|Withdrawal by Subject|0
691054|NCT01489254|2243746|P3|Double-blind Part|Withdrawal by Subject|1
691055|NCT01489254|2243747|P2|Double-blind Part|Withdrawal by Subject|20
691056|NCT01489254|2243748|P1|Double-blind Part|Withdrawal by Subject|12
691057|NCT01489254|2243745|P4|Double-blind Part|Pregnancy|0
691058|NCT01489254|2243746|P3|Double-blind Part|Pregnancy|0
691059|NCT01489254|2243747|P2|Double-blind Part|Pregnancy|3
691060|NCT01489254|2243748|P1|Double-blind Part|Pregnancy|1
691061|NCT01489254|2243745|P4|Double-blind Part|Adverse Event|0
691062|NCT01489254|2243746|P3|Double-blind Part|Adverse Event|2
691063|NCT01489254|2243747|P2|Double-blind Part|Adverse Event|2
691064|NCT01489254|2243748|P1|Double-blind Part|Adverse Event|7
691065|NCT01489189|2243759|P2|Overall Study|Missed Visit|4
691066|NCT01489189|2243760|P1|Overall Study|Missed Visit|1
691067|NCT01489189|2243759|P2|Overall Study|Death|8
691068|NCT01489189|2243760|P1|Overall Study|Death|10
691069|NCT01489189|2243759|P2|Overall Study|Withdrawal by Subject|23
691070|NCT01489189|2243760|P1|Overall Study|Withdrawal by Subject|20
889253|NCT01372410|2823758|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
889254|NCT01372410|2823759|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
691073|NCT01488578|2243892|P1|Overall Study|Protocol Violation|1836
691074|NCT01488487|2243926|P1|Overall Study|Withdrawal by Subject|2
691075|NCT01488487|2243926|P1|Overall Study|Death|1
691076|NCT01488487|2243926|P1|Overall Study|Adverse Event|6
691077|NCT01488448|2243935|P2|Overall Study|Protocol Violation|3
691078|NCT01488448|2243936|P1|Overall Study|Protocol Violation|4
691079|NCT01488448|2243935|P2|Overall Study|Physician Decision|9
691080|NCT01488448|2243936|P1|Overall Study|Physician Decision|4
691081|NCT01488448|2243935|P2|Overall Study|Adverse Event|4
691082|NCT01488448|2243936|P1|Overall Study|Adverse Event|9
691083|NCT01488448|2243935|P2|Overall Study|Withdrawal by Subject|1
691084|NCT01488448|2243936|P1|Overall Study|Withdrawal by Subject|3
691085|NCT01488370|2243978|P3|Overall Study|Protocol Violation|1
691086|NCT01488370|2243979|P2|Overall Study|Protocol Violation|1
691087|NCT01488370|2243980|P1|Overall Study|Protocol Violation|0
691088|NCT01488071|2244027|P2|Overall Study|Administrative or Other Reason(s)|4
691089|NCT01488071|2244028|P1|Overall Study|Administrative or Other Reason(s)|5
691090|NCT01488071|2244027|P2|Overall Study|Lost to Follow-up|0
691091|NCT01488071|2244028|P1|Overall Study|Lost to Follow-up|1
691092|NCT01488071|2244027|P2|Overall Study|Withdrawal of Consent|12
691093|NCT01488071|2244028|P1|Overall Study|Withdrawal of Consent|14
691094|NCT01488071|2244027|P2|Overall Study|Protocol Violation|7
691095|NCT01488071|2244028|P1|Overall Study|Protocol Violation|5
691096|NCT01488071|2244027|P2|Overall Study|Non-compliance with study drug|0
691097|NCT01488071|2244028|P1|Overall Study|Non-compliance with study drug|2
691098|NCT01488071|2244027|P2|Overall Study|Lack of Efficacy|17
691099|NCT01488071|2244028|P1|Overall Study|Lack of Efficacy|11
691100|NCT01488071|2244027|P2|Overall Study|Adverse Event|23
691101|NCT01488071|2244028|P1|Overall Study|Adverse Event|15
691102|NCT01487863|2244108|P2|Overall Study|Death|19
691103|NCT01487863|2244109|P1|Overall Study|Death|19
691104|NCT01487577|2244126|P1|Overall Study|Became ineligible after signing consent|1
691105|NCT01487525|2244140|P2|Overall Study|Withdrawal by Subject|1
691106|NCT01487525|2244141|P1|Overall Study|Withdrawal by Subject|0
691107|NCT01486966|2244159|P2|Overall Study|Withdrawal by Subject|1
691108|NCT01486966|2244160|P1|Overall Study|Withdrawal by Subject|0
691109|NCT01486966|2244159|P2|Overall Study|Adverse Event|1
691110|NCT01486966|2244160|P1|Overall Study|Adverse Event|0
691111|NCT01486927|2244184|P1|Overall Study|Subject did not reach 6 mo of treatment|1
691112|NCT01486927|2244184|P1|Overall Study|Withdrawal by Subject|8
691113|NCT01486927|2244184|P1|Overall Study|50 Exposure days not reached|2
691114|NCT01486927|2244184|P1|Overall Study|Physician Decision|1
691115|NCT01486927|2244184|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
691116|NCT01486758|2244217|P2|Overall Study|Lost to Follow-up|1
691117|NCT01486758|2244218|P1|Overall Study|Lost to Follow-up|0
691118|NCT01486446|2244285|P2|Overall Study|Adverse Event|0
691119|NCT01486446|2244286|P1|Overall Study|Adverse Event|1
691120|NCT01486238|2244308|P2|Overall Study|Lost to Follow-up|3
691121|NCT01486238|2244309|P1|Overall Study|Lost to Follow-up|0
691122|NCT01486238|2244308|P2|Overall Study|Withdrawal by Subject|1
691123|NCT01486238|2244309|P1|Overall Study|Withdrawal by Subject|2
691124|NCT01486238|2244308|P2|Overall Study|Death|2
691125|NCT01486238|2244309|P1|Overall Study|Death|0
691126|NCT01486199|2244317|P2|Two Year Period Between Study Days|Physician Decision|0
691127|NCT01486199|2244318|P1|Two Year Period Between Study Days|Physician Decision|1
691128|NCT01485991|2244338|P2|Overall Study|randomized but not treated|2
691129|NCT01485991|2244339|P1|Overall Study|randomized but not treated|6
691130|NCT01485991|2244338|P2|Overall Study|Withdrawal by Subject|20
691131|NCT01485991|2244339|P1|Overall Study|Withdrawal by Subject|13
691132|NCT01485991|2244338|P2|Overall Study|Lost to Follow-up|10
691133|NCT01485991|2244339|P1|Overall Study|Lost to Follow-up|13
691134|NCT01485991|2244338|P2|Overall Study|Adverse Event|4
691135|NCT01485991|2244339|P1|Overall Study|Adverse Event|0
691136|NCT01485887|2244349|P1|Overall Study|Primary disease markedly improved|1
691137|NCT01485887|2244349|P1|Overall Study|Deterioration of primary disease|1
691138|NCT01485887|2244349|P1|Overall Study|Adverse Event|8
691139|NCT01485887|2244349|P1|Overall Study|Withdrawal by Subject|2
889255|NCT01372410|2823760|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
889256|NCT01372410|2823753|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
889257|NCT01372410|2823754|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
889258|NCT01372410|2823755|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
889259|NCT01372410|2823756|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
889260|NCT01372410|2823757|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
889261|NCT01372410|2823758|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
889262|NCT01372410|2823759|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
691148|NCT01485640|2244383|P1|Overall Study|Terminated by Sponsor|95
691149|NCT01485640|2244383|P1|Overall Study|Withdrawal by Subject|14
691150|NCT01485640|2244383|P1|Overall Study|Protocol Violation|1
691151|NCT01485640|2244383|P1|Overall Study|Lack of Efficacy|2
691152|NCT01485640|2244383|P1|Overall Study|Adverse Event|10
691153|NCT01485536|2244388|P1|Overall Study|Adverse Event|1
691154|NCT01485536|2244388|P1|Overall Study|Withdrawal by Subject|3
691155|NCT01485354|2244397|P1|Overall Study|Withdrawal by Subject|5
691156|NCT01485172|2244411|P6|Overall Study|Withdrawal by Subject|1
691157|NCT01485172|2244412|P5|Overall Study|Withdrawal by Subject|1
691158|NCT01485172|2244413|P4|Overall Study|Withdrawal by Subject|1
691159|NCT01485172|2244414|P3|Overall Study|Withdrawal by Subject|0
691160|NCT01485172|2244415|P2|Overall Study|Withdrawal by Subject|0
691161|NCT01485172|2244416|P1|Overall Study|Withdrawal by Subject|2
691162|NCT01485172|2244411|P6|Overall Study|Physician Decision|0
691163|NCT01485172|2244412|P5|Overall Study|Physician Decision|1
691164|NCT01485172|2244413|P4|Overall Study|Physician Decision|0
691165|NCT01485172|2244414|P3|Overall Study|Physician Decision|0
691166|NCT01485172|2244415|P2|Overall Study|Physician Decision|0
691167|NCT01485172|2244416|P1|Overall Study|Physician Decision|0
691168|NCT01485172|2244411|P6|Overall Study|Lost to Follow-up|1
691169|NCT01485172|2244412|P5|Overall Study|Lost to Follow-up|0
691170|NCT01485172|2244413|P4|Overall Study|Lost to Follow-up|0
691171|NCT01485172|2244414|P3|Overall Study|Lost to Follow-up|1
691172|NCT01485172|2244415|P2|Overall Study|Lost to Follow-up|0
691173|NCT01485172|2244416|P1|Overall Study|Lost to Follow-up|0
691174|NCT01485172|2244411|P6|Overall Study|Protocol defined stopping criteria|0
691175|NCT01485172|2244412|P5|Overall Study|Protocol defined stopping criteria|1
691176|NCT01485172|2244413|P4|Overall Study|Protocol defined stopping criteria|0
691177|NCT01485172|2244414|P3|Overall Study|Protocol defined stopping criteria|0
691178|NCT01485172|2244415|P2|Overall Study|Protocol defined stopping criteria|0
691179|NCT01485172|2244416|P1|Overall Study|Protocol defined stopping criteria|1
691180|NCT01485172|2244411|P6|Overall Study|Protocol Violation|0
691181|NCT01485172|2244412|P5|Overall Study|Protocol Violation|1
691182|NCT01485172|2244413|P4|Overall Study|Protocol Violation|5
691183|NCT01485172|2244414|P3|Overall Study|Protocol Violation|4
691184|NCT01485172|2244415|P2|Overall Study|Protocol Violation|0
691185|NCT01485172|2244416|P1|Overall Study|Protocol Violation|0
691186|NCT01485172|2244411|P6|Overall Study|Lack of Efficacy|0
691187|NCT01485172|2244412|P5|Overall Study|Lack of Efficacy|0
691188|NCT01485172|2244413|P4|Overall Study|Lack of Efficacy|0
691189|NCT01485172|2244414|P3|Overall Study|Lack of Efficacy|0
691190|NCT01485172|2244415|P2|Overall Study|Lack of Efficacy|0
691191|NCT01485172|2244416|P1|Overall Study|Lack of Efficacy|2
691192|NCT01485172|2244411|P6|Overall Study|Adverse Event|2
691193|NCT01485172|2244412|P5|Overall Study|Adverse Event|1
691194|NCT01485172|2244413|P4|Overall Study|Adverse Event|2
691195|NCT01485172|2244414|P3|Overall Study|Adverse Event|2
691196|NCT01485172|2244415|P2|Overall Study|Adverse Event|1
691197|NCT01485172|2244416|P1|Overall Study|Adverse Event|2
691198|NCT01485094|2244493|P3|Overall Study|Withdrawal by Subject|0
691199|NCT01485094|2244494|P2|Overall Study|Withdrawal by Subject|1
691200|NCT01485094|2244495|P1|Overall Study|Withdrawal by Subject|1
691201|NCT01485094|2244493|P3|Overall Study|Lost to Follow-up|0
691202|NCT01485094|2244494|P2|Overall Study|Lost to Follow-up|0
691203|NCT01485094|2244495|P1|Overall Study|Lost to Follow-up|1
691204|NCT01485094|2244493|P3|Overall Study|Adverse Event|1
691205|NCT01485094|2244494|P2|Overall Study|Adverse Event|1
691206|NCT01485094|2244495|P1|Overall Study|Adverse Event|1
691207|NCT01484977|2244536|P1|Overall Study|Lack of Compliance|1
691208|NCT01484977|2244536|P1|Overall Study|Low White Blood Cell Count|1
691209|NCT01484977|2244536|P1|Overall Study|Moving Overseas|1
691210|NCT01484977|2244536|P1|Overall Study|Subject Protocol Non-compliant|1
691211|NCT01484977|2244536|P1|Overall Study|Withdrawal by Subject|4
691212|NCT01484977|2244536|P1|Overall Study|Lost to Follow-up|1
691213|NCT01484977|2244536|P1|Overall Study|Protocol Violation|6
691214|NCT01484977|2244536|P1|Overall Study|Lack of Efficacy|4
691215|NCT01484977|2244536|P1|Overall Study|Adverse Event|8
691216|NCT01484951|2244540|P1|Overall Study|Non-Compliance|1
691217|NCT01484951|2244540|P1|Overall Study|Personal Reasons|1
691218|NCT01484951|2244540|P1|Overall Study|Adverse Event|3
691219|NCT01484938|2244545|P1|Overall Study|Noncompliance|1
691220|NCT01484938|2244545|P1|Overall Study|Lost to Follow-up|1
691221|NCT01484938|2244545|P1|Overall Study|Adverse Event|2
691222|NCT01484912|2244552|P2|Overall Study|Physician Decision|1
691223|NCT01484912|2244553|P1|Overall Study|Physician Decision|0
691224|NCT01484912|2244552|P2|Overall Study|Withdrawal by Subject|0
691225|NCT01484912|2244553|P1|Overall Study|Withdrawal by Subject|1
691226|NCT01484873|2244563|P1|Overall Study|Withdrawal by Subject|2
691227|NCT01484834|2244575|P4|Overall Study|Lost to Follow-up|4
691228|NCT01484834|2244576|P3|Overall Study|Lost to Follow-up|1
691229|NCT01484834|2244577|P2|Overall Study|Lost to Follow-up|8
691230|NCT01484834|2244578|P1|Overall Study|Lost to Follow-up|5
691231|NCT01484561|2244615|P2|Overall Study|Adverse Event|4
691232|NCT01484561|2244616|P1|Overall Study|Adverse Event|1
691233|NCT01484561|2244615|P2|Overall Study|Not specified|1
691234|NCT01484561|2244616|P1|Overall Study|Not specified|1
691235|NCT01484561|2244615|P2|Overall Study|Withdrawal by Subject|0
691236|NCT01484561|2244616|P1|Overall Study|Withdrawal by Subject|3
691237|NCT01484561|2244615|P2|Overall Study|Lost to Follow-up|0
691238|NCT01484561|2244616|P1|Overall Study|Lost to Follow-up|1
691239|NCT01484561|2244615|P2|Overall Study|Lack of Efficacy|1
691240|NCT01484561|2244616|P1|Overall Study|Lack of Efficacy|3
691293|NCT01484197|2244727|P4|Treatment Period 2|Subject withdrew consent|1
691294|NCT01484197|2244728|P3|Treatment Period 2|Subject withdrew consent|0
691295|NCT01484197|2244729|P2|Treatment Period 2|Subject withdrew consent|0
691296|NCT01484197|2244730|P1|Treatment Period 2|Subject withdrew consent|0
691297|NCT01484197|2244727|P4|Treatment Period 1|Adverse Event|0
691298|NCT01484197|2244728|P3|Treatment Period 1|Adverse Event|0
691299|NCT01484197|2244729|P2|Treatment Period 1|Adverse Event|0
691300|NCT01484197|2244730|P1|Treatment Period 1|Adverse Event|1
691301|NCT01484132|2244813|P1|Overall Study|No post-treatment urine sample collected|10
691302|NCT01484132|2244813|P1|Overall Study|No pre-treatment urine sample collected|1
691303|NCT01484132|2244813|P1|Overall Study|Ineligible|1
691304|NCT01484132|2244813|P1|Overall Study|Difficulty with time commitment|2
691305|NCT01484132|2244813|P1|Overall Study|Lost to Follow-up|8
691306|NCT01484054|2244821|P2|Period 1|Withdrawal by Subject|1
691307|NCT01484054|2244822|P1|Period 1|Withdrawal by Subject|0
691308|NCT01484028|2244840|P4|Period 1|Lens Discomfort|0
691309|NCT01484028|2244841|P3|Period 1|Lens Discomfort|0
691310|NCT01484028|2244842|P2|Period 1|Lens Discomfort|1
691311|NCT01484028|2244843|P1|Period 1|Lens Discomfort|0
691312|NCT01484028|2244840|P4|Period 1|Non-Compliance to Protocol|1
691313|NCT01484028|2244841|P3|Period 1|Non-Compliance to Protocol|0
691314|NCT01484028|2244842|P2|Period 1|Non-Compliance to Protocol|1
691315|NCT01484028|2244843|P1|Period 1|Non-Compliance to Protocol|0
691316|NCT01484028|2244840|P4|Period 1|Lost to Follow-up|0
691317|NCT01484028|2244841|P3|Period 1|Lost to Follow-up|0
691318|NCT01484028|2244842|P2|Period 1|Lost to Follow-up|1
691319|NCT01484028|2244843|P1|Period 1|Lost to Follow-up|0
691320|NCT01483937|2244936|P2|Overall Study|Withdrawal by Subject|3
691321|NCT01483937|2244937|P1|Overall Study|Withdrawal by Subject|4
691322|NCT01483924|2244964|P5|Overall Study|Sponsor concern over ECG result|0
691323|NCT01483924|2244965|P4|Overall Study|Sponsor concern over ECG result|1
691324|NCT01483924|2244966|P3|Overall Study|Sponsor concern over ECG result|0
691325|NCT01483924|2244967|P2|Overall Study|Sponsor concern over ECG result|0
691326|NCT01483924|2244968|P1|Overall Study|Sponsor concern over ECG result|0
691327|NCT01483924|2244964|P5|Overall Study|Non-compliance|1
691328|NCT01483924|2244965|P4|Overall Study|Non-compliance|1
691329|NCT01483924|2244966|P3|Overall Study|Non-compliance|0
691330|NCT01483924|2244967|P2|Overall Study|Non-compliance|0
691331|NCT01483924|2244968|P1|Overall Study|Non-compliance|0
691332|NCT01483924|2244964|P5|Overall Study|Adverse Event|0
691333|NCT01483924|2244965|P4|Overall Study|Adverse Event|1
691334|NCT01483924|2244966|P3|Overall Study|Adverse Event|1
691335|NCT01483924|2244967|P2|Overall Study|Adverse Event|0
691336|NCT01483924|2244968|P1|Overall Study|Adverse Event|0
691337|NCT01483924|2244964|P5|Overall Study|Withdrawal by Subject|1
691338|NCT01483924|2244965|P4|Overall Study|Withdrawal by Subject|1
691339|NCT01483924|2244966|P3|Overall Study|Withdrawal by Subject|0
691340|NCT01483924|2244967|P2|Overall Study|Withdrawal by Subject|0
691341|NCT01483924|2244968|P1|Overall Study|Withdrawal by Subject|2
691342|NCT01483820|2245016|P1|Overall Study|Death|1
691343|NCT01483820|2245016|P1|Overall Study|Adverse Event|1
691344|NCT01483820|2245016|P1|Overall Study|Lack of Efficacy|6
691345|NCT01483651|2245025|P6|Overall Study|Withdrawal by Subject|1
691346|NCT01483651|2245026|P5|Overall Study|Withdrawal by Subject|0
691347|NCT01483651|2245027|P4|Overall Study|Withdrawal by Subject|0
691348|NCT01483651|2245028|P3|Overall Study|Withdrawal by Subject|1
691349|NCT01483651|2245029|P2|Overall Study|Withdrawal by Subject|1
691350|NCT01483651|2245030|P1|Overall Study|Withdrawal by Subject|0
691351|NCT01483625|2245040|P2|Overall Study|Due to other reason|0
691352|NCT01483625|2245041|P1|Overall Study|Due to other reason|1
691353|NCT01483625|2245040|P2|Overall Study|Refused to continue medication|1
691354|NCT01483625|2245041|P1|Overall Study|Refused to continue medication|2
691355|NCT01483625|2245040|P2|Overall Study|Adverse Event|1
691356|NCT01483625|2245041|P1|Overall Study|Adverse Event|1
691357|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Unspecified|0
691358|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Unspecified|1
691359|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Unspecified|0
691360|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Unspecified|0
691361|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Unspecified|4
691362|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Unspecified|0
691363|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Unspecified|1
691364|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Unspecified|0
691365|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Unspecified|0
691366|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Unspecified|0
691367|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Unspecified|0
691368|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Unspecified|0
691369|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Unspecified|0
691370|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Unspecified|0
691371|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
691372|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
691373|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691374|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691375|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691376|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
691377|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691378|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691379|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691380|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691381|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691382|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691383|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691384|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
691385|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
691386|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691387|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691388|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
691389|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691390|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
691391|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691392|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691393|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691394|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691395|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691396|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691397|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691398|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
691399|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
691400|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691401|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
691402|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691403|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691404|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
691405|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691406|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691407|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691408|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691409|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691410|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691411|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691412|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
691413|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
691414|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
691415|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691416|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691417|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691418|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
691419|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
691420|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691421|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691422|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691423|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691424|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691425|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691426|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
691427|NCT01483599|2245064|P14|After Controlled Period(Week 16-Week 40)|Death|0
691428|NCT01483599|2245065|P13|After Controlled Period(Week 16-Week 40)|Death|0
691429|NCT01483599|2245066|P12|After Controlled Period(Week 16-Week 40)|Death|0
691430|NCT01483599|2245067|P11|After Controlled Period(Week 16-Week 40)|Death|0
691431|NCT01483599|2245068|P10|After Controlled Period(Week 16-Week 40)|Death|0
691432|NCT01483599|2245069|P9|After Controlled Period(Week 16-Week 40)|Death|1
691433|NCT01483599|2245070|P8|After Controlled Period(Week 16-Week 40)|Death|0
691434|NCT01483599|2245071|P7|After Controlled Period(Week 16-Week 40)|Death|0
691435|NCT01483599|2245072|P6|After Controlled Period(Week 16-Week 40)|Death|0
691436|NCT01483599|2245073|P5|After Controlled Period(Week 16-Week 40)|Death|0
691437|NCT01483599|2245074|P4|After Controlled Period(Week 16-Week 40)|Death|0
691438|NCT01483599|2245075|P3|After Controlled Period(Week 16-Week 40)|Death|0
691439|NCT01483599|2245076|P2|After Controlled Period(Week 16-Week 40)|Death|0
691440|NCT01483599|2245077|P1|After Controlled Period(Week 16-Week 40)|Death|0
691441|NCT01483599|2245064|P14|Controlled Period (CP) (up to Week 16)|Unspecified|0
691442|NCT01483599|2245065|P13|Controlled Period (CP) (up to Week 16)|Unspecified|0
691443|NCT01483599|2245066|P12|Controlled Period (CP) (up to Week 16)|Unspecified|0
691444|NCT01483599|2245067|P11|Controlled Period (CP) (up to Week 16)|Unspecified|0
691445|NCT01483599|2245068|P10|Controlled Period (CP) (up to Week 16)|Unspecified|0
691446|NCT01483599|2245069|P9|Controlled Period (CP) (up to Week 16)|Unspecified|0
691447|NCT01483599|2245070|P8|Controlled Period (CP) (up to Week 16)|Unspecified|0
691448|NCT01483599|2245071|P7|Controlled Period (CP) (up to Week 16)|Unspecified|0
691449|NCT01483599|2245072|P6|Controlled Period (CP) (up to Week 16)|Unspecified|0
691450|NCT01483599|2245073|P5|Controlled Period (CP) (up to Week 16)|Unspecified|1
691451|NCT01483599|2245074|P4|Controlled Period (CP) (up to Week 16)|Unspecified|1
691452|NCT01483599|2245075|P3|Controlled Period (CP) (up to Week 16)|Unspecified|0
691453|NCT01483599|2245076|P2|Controlled Period (CP) (up to Week 16)|Unspecified|2
691454|NCT01483599|2245077|P1|Controlled Period (CP) (up to Week 16)|Unspecified|0
691455|NCT01483599|2245064|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691456|NCT01483599|2245065|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691457|NCT01483599|2245066|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691458|NCT01483599|2245067|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691459|NCT01483599|2245068|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691460|NCT01483599|2245069|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691461|NCT01483599|2245070|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691462|NCT01483599|2245071|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691463|NCT01483599|2245072|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691464|NCT01483599|2245073|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691465|NCT01483599|2245074|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691466|NCT01483599|2245075|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691467|NCT01483599|2245076|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
691468|NCT01483599|2245077|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
691469|NCT01483599|2245064|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691470|NCT01483599|2245065|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691471|NCT01483599|2245066|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691472|NCT01483599|2245067|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691473|NCT01483599|2245068|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691474|NCT01483599|2245069|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691475|NCT01483599|2245070|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691476|NCT01483599|2245071|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
691477|NCT01483599|2245072|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691478|NCT01483599|2245073|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691479|NCT01483599|2245074|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
691480|NCT01483599|2245075|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691481|NCT01483599|2245076|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
691482|NCT01483599|2245077|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
691483|NCT01483599|2245064|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691484|NCT01483599|2245065|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691485|NCT01483599|2245066|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691486|NCT01483599|2245067|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691487|NCT01483599|2245068|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691488|NCT01483599|2245069|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691489|NCT01483599|2245070|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691490|NCT01483599|2245071|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
691491|NCT01483599|2245072|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
691492|NCT01483599|2245073|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
691493|NCT01483599|2245074|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
691494|NCT01483599|2245075|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691495|NCT01483599|2245076|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
691496|NCT01483599|2245077|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
691497|NCT01483183|2245167|P10|Overall Study|Withdrawal by Subject|1
691498|NCT01483183|2245168|P9|Overall Study|Withdrawal by Subject|0
691499|NCT01483183|2245169|P8|Overall Study|Withdrawal by Subject|0
691500|NCT01483183|2245170|P7|Overall Study|Withdrawal by Subject|0
691501|NCT01483183|2245171|P6|Overall Study|Withdrawal by Subject|0
691502|NCT01483183|2245172|P5|Overall Study|Withdrawal by Subject|0
691503|NCT01483183|2245173|P4|Overall Study|Withdrawal by Subject|0
691504|NCT01483183|2245174|P3|Overall Study|Withdrawal by Subject|0
691505|NCT01483183|2245175|P2|Overall Study|Withdrawal by Subject|0
691506|NCT01483183|2245176|P1|Overall Study|Withdrawal by Subject|0
691507|NCT01483183|2245167|P10|Overall Study|Physician Decision|0
691508|NCT01483183|2245168|P9|Overall Study|Physician Decision|0
691509|NCT01483183|2245169|P8|Overall Study|Physician Decision|0
691510|NCT01483183|2245170|P7|Overall Study|Physician Decision|2
691511|NCT01483183|2245171|P6|Overall Study|Physician Decision|0
691512|NCT01483183|2245172|P5|Overall Study|Physician Decision|0
691513|NCT01483183|2245173|P4|Overall Study|Physician Decision|0
691514|NCT01483183|2245174|P3|Overall Study|Physician Decision|0
691515|NCT01483183|2245175|P2|Overall Study|Physician Decision|0
691516|NCT01483183|2245176|P1|Overall Study|Physician Decision|0
691517|NCT01483118|2245246|P2|Overall Study|Lost to Follow-up|16
691518|NCT01483118|2245247|P1|Overall Study|Lost to Follow-up|12
691519|NCT01482910|2245259|P2|Overall Study|Death|0
691520|NCT01482910|2245260|P1|Overall Study|Death|1
691521|NCT01482910|2245259|P2|Overall Study|Withdrawal by Subject|2
691522|NCT01482910|2245260|P1|Overall Study|Withdrawal by Subject|7
691523|NCT01482910|2245259|P2|Overall Study|Protocol Violation|1
691524|NCT01482910|2245260|P1|Overall Study|Protocol Violation|1
691525|NCT01482910|2245259|P2|Overall Study|Lost to Follow-up|1
691526|NCT01482910|2245260|P1|Overall Study|Lost to Follow-up|0
691527|NCT01482910|2245259|P2|Overall Study|Adverse Event|5
691528|NCT01482910|2245260|P1|Overall Study|Adverse Event|6
691529|NCT01482884|2245272|P2|Overall Study|Withdrawal by Subject|13
691530|NCT01482884|2245273|P1|Overall Study|Withdrawal by Subject|8
691531|NCT01482884|2245272|P2|Overall Study|Adverse Event|1
691532|NCT01482884|2245273|P1|Overall Study|Adverse Event|2
691533|NCT01482884|2245272|P2|Overall Study|Lack of Efficacy|1
691534|NCT01482884|2245273|P1|Overall Study|Lack of Efficacy|0
691535|NCT01482884|2245272|P2|Overall Study|Lost to Follow-up|2
691536|NCT01482884|2245273|P1|Overall Study|Lost to Follow-up|2
691537|NCT01482884|2245272|P2|Overall Study|Protocol Violation|0
691538|NCT01482884|2245273|P1|Overall Study|Protocol Violation|1
691539|NCT01482884|2245272|P2|Overall Study|Medical decision due to lack of efficacy|1
691540|NCT01482884|2245273|P1|Overall Study|Medical decision due to lack of efficacy|0
691541|NCT01482819|2245299|P1|Overall Study|Lost to Follow-up|2
691542|NCT01482767|2245319|P2|Overall Study|Nurse error|0
691543|NCT01482767|2245320|P1|Overall Study|Nurse error|1
691544|NCT01482767|2245319|P2|Overall Study|Ineligible|5
691545|NCT01482767|2245320|P1|Overall Study|Ineligible|0
691546|NCT01482767|2245319|P2|Overall Study|Alternate HCV treatment|8
691547|NCT01482767|2245320|P1|Overall Study|Alternate HCV treatment|7
691548|NCT01482767|2245319|P2|Overall Study|Non-adherence to study requirements|7
691549|NCT01482767|2245320|P1|Overall Study|Non-adherence to study requirements|4
691550|NCT01482767|2245319|P2|Overall Study|Site closure|14
691551|NCT01482767|2245320|P1|Overall Study|Site closure|22
691552|NCT01482767|2245319|P2|Overall Study|Adverse Event|3
691553|NCT01482767|2245320|P1|Overall Study|Adverse Event|0
691554|NCT01482767|2245319|P2|Overall Study|Lost to Follow-up|6
691555|NCT01482767|2245320|P1|Overall Study|Lost to Follow-up|12
691556|NCT01482767|2245319|P2|Overall Study|Withdrawal by Subject|5
691557|NCT01482767|2245320|P1|Overall Study|Withdrawal by Subject|7
691558|NCT01482767|2245319|P2|Overall Study|Death|1
691559|NCT01482767|2245320|P1|Overall Study|Death|1
691560|NCT01482429|2245342|P2|Protocol|Protocol Violation|0
691561|NCT01482429|2245343|P1|Protocol|Protocol Violation|275
691562|NCT01482429|2245342|P2|Care Usual|Lost to Follow-up|1
691563|NCT01482429|2245343|P1|Care Usual|Lost to Follow-up|0
691564|NCT01482429|2245342|P2|Care Usual|Protocol Violation|172
691565|NCT01482429|2245343|P1|Care Usual|Protocol Violation|0
691566|NCT01482312|2245355|P3|Period 2, 90 Minutes of Wear|Unspecified|0
691567|NCT01482312|2245356|P2|Period 2, 90 Minutes of Wear|Unspecified|0
691568|NCT01482312|2245357|P1|Period 2, 90 Minutes of Wear|Unspecified|1
691569|NCT01482312|2245355|P3|Period 1, 90 Minutes of Wear|Unspecified|0
691570|NCT01482312|2245356|P2|Period 1, 90 Minutes of Wear|Unspecified|0
691571|NCT01482312|2245357|P1|Period 1, 90 Minutes of Wear|Unspecified|1
691572|NCT01482221|2245371|P3|Overall Study|Physician Decision|0
691573|NCT01482221|2245372|P2|Overall Study|Physician Decision|1
691574|NCT01482221|2245373|P1|Overall Study|Physician Decision|0
691575|NCT01482221|2245371|P3|Overall Study|Incorrect randomization|0
691576|NCT01482221|2245372|P2|Overall Study|Incorrect randomization|1
691577|NCT01482221|2245373|P1|Overall Study|Incorrect randomization|0
691578|NCT01482221|2245371|P3|Overall Study|Withdrawal by Subject|12
691579|NCT01482221|2245372|P2|Overall Study|Withdrawal by Subject|7
691580|NCT01482221|2245373|P1|Overall Study|Withdrawal by Subject|10
691581|NCT01482221|2245371|P3|Overall Study|Adverse Event|3
691582|NCT01482221|2245372|P2|Overall Study|Adverse Event|7
691583|NCT01482221|2245373|P1|Overall Study|Adverse Event|1
691584|NCT01482221|2245371|P3|Overall Study|Severe Non-Compliance to Protocol|1
691585|NCT01482221|2245372|P2|Overall Study|Severe Non-Compliance to Protocol|0
691586|NCT01482221|2245373|P1|Overall Study|Severe Non-Compliance to Protocol|1
691587|NCT01482221|2245371|P3|Overall Study|Condition under Investigation Worsened|4
691588|NCT01482221|2245372|P2|Overall Study|Condition under Investigation Worsened|2
691589|NCT01482221|2245373|P1|Overall Study|Condition under Investigation Worsened|3
691590|NCT01482221|2245371|P3|Overall Study|Study-Specific Withdrawal Criteria|1
691591|NCT01482221|2245372|P2|Overall Study|Study-Specific Withdrawal Criteria|0
691592|NCT01482221|2245373|P1|Overall Study|Study-Specific Withdrawal Criteria|2
691593|NCT01482221|2245371|P3|Overall Study|Lost to Follow-up|1
691594|NCT01482221|2245372|P2|Overall Study|Lost to Follow-up|2
691595|NCT01482221|2245373|P1|Overall Study|Lost to Follow-up|3
691596|NCT01482221|2245371|P3|Overall Study|Lack of Efficacy|1
691597|NCT01482221|2245372|P2|Overall Study|Lack of Efficacy|0
691598|NCT01482221|2245373|P1|Overall Study|Lack of Efficacy|1
691599|NCT01482065|2245449|P2|Overall Study|Withdrawal by Subject|1
691600|NCT01482065|2245450|P1|Overall Study|Withdrawal by Subject|0
691601|NCT01481896|2245471|P1|Overall Study|Lost to Follow-up|12
691602|NCT01481324|2245524|P3|Overall Study|Missing Data|2
691603|NCT01481324|2245525|P2|Overall Study|Missing Data|2
691604|NCT01481324|2245526|P1|Overall Study|Missing Data|0
691605|NCT01481116|2245545|P3|Overall Study|Hypoglycemic Event|0
691606|NCT01481116|2245546|P2|Overall Study|Hypoglycemic Event|0
691607|NCT01481116|2245547|P1|Overall Study|Hypoglycemic Event|4
691608|NCT01481116|2245545|P3|Overall Study|Death|0
691609|NCT01481116|2245546|P2|Overall Study|Death|1
691610|NCT01481116|2245547|P1|Overall Study|Death|2
691611|NCT01481116|2245545|P3|Overall Study|Investigator's Discretion|0
691612|NCT01481116|2245546|P2|Overall Study|Investigator's Discretion|0
691613|NCT01481116|2245547|P1|Overall Study|Investigator's Discretion|2
691614|NCT01481116|2245545|P3|Overall Study|Non-Compliant With Study Drug|1
691615|NCT01481116|2245546|P2|Overall Study|Non-Compliant With Study Drug|1
691616|NCT01481116|2245547|P1|Overall Study|Non-Compliant With Study Drug|0
691617|NCT01481116|2245545|P3|Overall Study|Sponsor Decision|3
691618|NCT01481116|2245546|P2|Overall Study|Sponsor Decision|1
691619|NCT01481116|2245547|P1|Overall Study|Sponsor Decision|0
691620|NCT01481116|2245545|P3|Overall Study|Investigator Decision|1
691621|NCT01481116|2245546|P2|Overall Study|Investigator Decision|2
691622|NCT01481116|2245547|P1|Overall Study|Investigator Decision|3
691623|NCT01481116|2245545|P3|Overall Study|Participant Moved Out of Country|1
691624|NCT01481116|2245546|P2|Overall Study|Participant Moved Out of Country|0
691625|NCT01481116|2245547|P1|Overall Study|Participant Moved Out of Country|1
691626|NCT01481116|2245545|P3|Overall Study|Participant Moved Out of Area|1
691627|NCT01481116|2245546|P2|Overall Study|Participant Moved Out of Area|0
691628|NCT01481116|2245547|P1|Overall Study|Participant Moved Out of Area|2
691629|NCT01481116|2245545|P3|Overall Study|Participant Started Taking Glipizide|0
691630|NCT01481116|2245546|P2|Overall Study|Participant Started Taking Glipizide|0
691631|NCT01481116|2245547|P1|Overall Study|Participant Started Taking Glipizide|1
691632|NCT01481116|2245545|P3|Overall Study|Unspecified|0
691633|NCT01481116|2245546|P2|Overall Study|Unspecified|1
691634|NCT01481116|2245547|P1|Overall Study|Unspecified|1
691635|NCT01481116|2245545|P3|Overall Study|Contraindications|0
691636|NCT01481116|2245546|P2|Overall Study|Contraindications|1
691637|NCT01481116|2245547|P1|Overall Study|Contraindications|1
691638|NCT01481116|2245545|P3|Overall Study|Lack of Efficacy|1
691639|NCT01481116|2245546|P2|Overall Study|Lack of Efficacy|3
691640|NCT01481116|2245547|P1|Overall Study|Lack of Efficacy|3
691641|NCT01481116|2245545|P3|Overall Study|Pregnancy|1
691642|NCT01481116|2245546|P2|Overall Study|Pregnancy|0
691643|NCT01481116|2245547|P1|Overall Study|Pregnancy|0
691644|NCT01481116|2245545|P3|Overall Study|Study Termination|713
691645|NCT01481116|2245546|P2|Overall Study|Study Termination|729
691646|NCT01481116|2245547|P1|Overall Study|Study Termination|730
691647|NCT01481116|2245545|P3|Overall Study|Withdrawal by Subject|37
691648|NCT01481116|2245546|P2|Overall Study|Withdrawal by Subject|33
691649|NCT01481116|2245547|P1|Overall Study|Withdrawal by Subject|37
691650|NCT01481116|2245545|P3|Overall Study|Lost to Follow-up|11
691651|NCT01481116|2245546|P2|Overall Study|Lost to Follow-up|12
691652|NCT01481116|2245547|P1|Overall Study|Lost to Follow-up|8
691653|NCT01481116|2245545|P3|Overall Study|Major Protocol Deviation|1
691654|NCT01481116|2245546|P2|Overall Study|Major Protocol Deviation|7
691655|NCT01481116|2245547|P1|Overall Study|Major Protocol Deviation|3
691656|NCT01481116|2245545|P3|Overall Study|Adverse Event|42
691657|NCT01481116|2245546|P2|Overall Study|Adverse Event|26
691658|NCT01481116|2245547|P1|Overall Study|Adverse Event|26
691659|NCT01480674|2245573|P1|Overall Study|visit not done|10
691660|NCT01480674|2245573|P1|Overall Study|Lost to Follow-up|2
691661|NCT01480674|2245573|P1|Overall Study|Death|23
691662|NCT01480596|2245587|P2|Overall Study|MG exacerbation or change in medication|2
691663|NCT01480596|2245588|P1|Overall Study|MG exacerbation or change in medication|2
691664|NCT01480596|2245587|P2|Overall Study|Adverse Event|0
691665|NCT01480596|2245588|P1|Overall Study|Adverse Event|3
691666|NCT01480284|2245636|P2|Overall Study|Physician Decision|0
691667|NCT01480284|2245637|P1|Overall Study|Physician Decision|1
691668|NCT01480284|2245636|P2|Overall Study|Lost to Follow-up|0
691669|NCT01480284|2245637|P1|Overall Study|Lost to Follow-up|1
691670|NCT01480284|2245636|P2|Overall Study|Study closed/terminated|0
691671|NCT01480284|2245637|P1|Overall Study|Study closed/terminated|3
691672|NCT01480284|2245636|P2|Overall Study|Adverse Event|0
691673|NCT01480284|2245637|P1|Overall Study|Adverse Event|1
691674|NCT01480284|2245636|P2|Overall Study|Withdrawal by Subject|0
691675|NCT01480284|2245637|P1|Overall Study|Withdrawal by Subject|2
691676|NCT01480076|2245720|P1|Overall Study|Not Specified|52
691677|NCT01480076|2245720|P1|Overall Study|Investigator Decision|13
691678|NCT01480076|2245720|P1|Overall Study|Lost to Follow-up|7
691679|NCT01480076|2245720|P1|Overall Study|Withdrawal by Subject|105
691680|NCT01480076|2245720|P1|Overall Study|Non-compliance With Study Protocol|15
691681|NCT01480076|2245720|P1|Overall Study|Disease Progression|5
691682|NCT01480076|2245720|P1|Overall Study|Death|2
691683|NCT01480076|2245720|P1|Overall Study|Adverse Event|39
691684|NCT01480076|2245720|P1|Overall Study|Run-in Failure|52
691685|NCT01479868|2245839|P1|Overall Study|Initiation of new HCV Therapy|1
691686|NCT01479868|2245839|P1|Overall Study|Sponsor's Decision|1
691687|NCT01479868|2245839|P1|Overall Study|Withdrawal by Subject|1
691688|NCT01479868|2245839|P1|Overall Study|Protocol Violation|1
691689|NCT01479868|2245839|P1|Overall Study|Lost to Follow-up|4
691690|NCT01479868|2245839|P1|Overall Study|Adverse Event|1
691691|NCT01479777|2245854|P1|Overall Study|Physician Decision|2
691692|NCT01479764|2245866|P2|Treated|Lost to Follow-up|2
691693|NCT01479764|2245867|P1|Treated|Lost to Follow-up|0
691694|NCT01479764|2245866|P2|Randomized|Withdrawal by Subject|0
691695|NCT01479764|2245867|P1|Randomized|Withdrawal by Subject|1
691696|NCT01479764|2245866|P2|Randomized|Adverse Event|1
691697|NCT01479764|2245867|P1|Randomized|Adverse Event|1
691698|NCT01479621|2245890|P7|Treatment Period|Met stopping criteria|6
691699|NCT01479621|2245891|P6|Treatment Period|Met stopping criteria|20
691700|NCT01479621|2245892|P5|Treatment Period|Met stopping criteria|9
691701|NCT01479621|2245893|P4|Treatment Period|Met stopping criteria|4
691702|NCT01479621|2245894|P3|Treatment Period|Met stopping criteria|7
691703|NCT01479621|2245895|P2|Treatment Period|Met stopping criteria|8
691704|NCT01479621|2245896|P1|Treatment Period|Met stopping criteria|0
691705|NCT01479621|2245890|P7|Treatment Period|Lost to Follow-up|1
691706|NCT01479621|2245891|P6|Treatment Period|Lost to Follow-up|2
691707|NCT01479621|2245892|P5|Treatment Period|Lost to Follow-up|2
691708|NCT01479621|2245893|P4|Treatment Period|Lost to Follow-up|0
691709|NCT01479621|2245894|P3|Treatment Period|Lost to Follow-up|1
691710|NCT01479621|2245895|P2|Treatment Period|Lost to Follow-up|0
691711|NCT01479621|2245896|P1|Treatment Period|Lost to Follow-up|0
691712|NCT01479621|2245890|P7|Treatment Period|Sponsor request subject to be withdrawn|3
691713|NCT01479621|2245891|P6|Treatment Period|Sponsor request subject to be withdrawn|1
691714|NCT01479621|2245892|P5|Treatment Period|Sponsor request subject to be withdrawn|1
691715|NCT01479621|2245893|P4|Treatment Period|Sponsor request subject to be withdrawn|1
691716|NCT01479621|2245894|P3|Treatment Period|Sponsor request subject to be withdrawn|3
691717|NCT01479621|2245895|P2|Treatment Period|Sponsor request subject to be withdrawn|2
691718|NCT01479621|2245896|P1|Treatment Period|Sponsor request subject to be withdrawn|0
691719|NCT01479621|2245890|P7|Treatment Period|Pregnancy|0
691720|NCT01479621|2245891|P6|Treatment Period|Pregnancy|0
691721|NCT01479621|2245892|P5|Treatment Period|Pregnancy|0
691722|NCT01479621|2245893|P4|Treatment Period|Pregnancy|0
691723|NCT01479621|2245894|P3|Treatment Period|Pregnancy|2
691724|NCT01479621|2245895|P2|Treatment Period|Pregnancy|0
691725|NCT01479621|2245896|P1|Treatment Period|Pregnancy|0
691726|NCT01479621|2245890|P7|Treatment Period|Protocol Violation|6
691727|NCT01479621|2245891|P6|Treatment Period|Protocol Violation|10
691728|NCT01479621|2245892|P5|Treatment Period|Protocol Violation|2
691729|NCT01479621|2245893|P4|Treatment Period|Protocol Violation|5
691730|NCT01479621|2245894|P3|Treatment Period|Protocol Violation|6
691731|NCT01479621|2245895|P2|Treatment Period|Protocol Violation|9
691732|NCT01479621|2245896|P1|Treatment Period|Protocol Violation|0
691733|NCT01479621|2245890|P7|Treatment Period|Non-compliance to study drug|1
691734|NCT01479621|2245891|P6|Treatment Period|Non-compliance to study drug|0
691735|NCT01479621|2245892|P5|Treatment Period|Non-compliance to study drug|0
691736|NCT01479621|2245893|P4|Treatment Period|Non-compliance to study drug|0
691737|NCT01479621|2245894|P3|Treatment Period|Non-compliance to study drug|0
691738|NCT01479621|2245895|P2|Treatment Period|Non-compliance to study drug|1
691739|NCT01479621|2245896|P1|Treatment Period|Non-compliance to study drug|0
691740|NCT01479621|2245890|P7|Treatment Period|Physician Decision|0
691741|NCT01479621|2245891|P6|Treatment Period|Physician Decision|1
691742|NCT01479621|2245892|P5|Treatment Period|Physician Decision|1
691743|NCT01479621|2245893|P4|Treatment Period|Physician Decision|0
691744|NCT01479621|2245894|P3|Treatment Period|Physician Decision|0
691745|NCT01479621|2245895|P2|Treatment Period|Physician Decision|0
691746|NCT01479621|2245896|P1|Treatment Period|Physician Decision|0
691747|NCT01479621|2245890|P7|Treatment Period|Withdrawal by Subject|1
691748|NCT01479621|2245891|P6|Treatment Period|Withdrawal by Subject|5
691749|NCT01479621|2245892|P5|Treatment Period|Withdrawal by Subject|5
691750|NCT01479621|2245893|P4|Treatment Period|Withdrawal by Subject|2
691751|NCT01479621|2245894|P3|Treatment Period|Withdrawal by Subject|2
691752|NCT01479621|2245895|P2|Treatment Period|Withdrawal by Subject|4
691753|NCT01479621|2245896|P1|Treatment Period|Withdrawal by Subject|0
691754|NCT01479621|2245890|P7|Treatment Period|Adverse Event|2
691755|NCT01479621|2245891|P6|Treatment Period|Adverse Event|2
691756|NCT01479621|2245892|P5|Treatment Period|Adverse Event|1
691757|NCT01479621|2245893|P4|Treatment Period|Adverse Event|0
691758|NCT01479621|2245894|P3|Treatment Period|Adverse Event|0
691759|NCT01479621|2245895|P2|Treatment Period|Adverse Event|0
691760|NCT01479621|2245896|P1|Treatment Period|Adverse Event|0
691761|NCT01479621|2245890|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691762|NCT01479621|2245891|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691763|NCT01479621|2245892|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691764|NCT01479621|2245893|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691765|NCT01479621|2245894|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691766|NCT01479621|2245895|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
691767|NCT01479621|2245896|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
691768|NCT01479621|2245890|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691769|NCT01479621|2245891|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691770|NCT01479621|2245892|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691771|NCT01479621|2245893|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691772|NCT01479621|2245894|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691773|NCT01479621|2245895|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
691774|NCT01479621|2245896|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
691775|NCT01479621|2245890|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691776|NCT01479621|2245891|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691777|NCT01479621|2245892|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691778|NCT01479621|2245893|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691779|NCT01479621|2245894|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691780|NCT01479621|2245895|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
691781|NCT01479621|2245896|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
691782|NCT01479621|2245890|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691783|NCT01479621|2245891|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691784|NCT01479621|2245892|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691785|NCT01479621|2245893|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691786|NCT01479621|2245894|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691787|NCT01479621|2245895|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
691788|NCT01479621|2245896|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
691789|NCT01479621|2245890|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691790|NCT01479621|2245891|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691791|NCT01479621|2245892|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691792|NCT01479621|2245893|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691793|NCT01479621|2245894|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691794|NCT01479621|2245895|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
691795|NCT01479621|2245896|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
691796|NCT01479595|2245984|P2|Overall Study|Adverse Event|1
691797|NCT01479595|2245985|P1|Overall Study|Adverse Event|2
691798|NCT01479595|2245984|P2|Overall Study|Protocol deviation|1
691799|NCT01479595|2245985|P1|Overall Study|Protocol deviation|0
691800|NCT01479530|2246030|P2|Overall Study|Withdrawal of Consent|2
691801|NCT01479530|2246031|P1|Overall Study|Withdrawal of Consent|3
691802|NCT01479530|2246030|P2|Overall Study|Protocol Violation|3
691803|NCT01479530|2246031|P1|Overall Study|Protocol Violation|2
691804|NCT01479530|2246030|P2|Overall Study|Lack of Efficacy|1
691805|NCT01479530|2246031|P1|Overall Study|Lack of Efficacy|0
691806|NCT01479530|2246030|P2|Overall Study|Adverse Event|6
691807|NCT01479530|2246031|P1|Overall Study|Adverse Event|5
691808|NCT01479374|2246068|P3|Overall Study|Other|5
691809|NCT01479374|2246069|P2|Overall Study|Other|4
691810|NCT01479374|2246070|P1|Overall Study|Other|0
691811|NCT01479374|2246068|P3|Overall Study|Decision Unrelated to Adverse Event|0
691812|NCT01479374|2246069|P2|Overall Study|Decision Unrelated to Adverse Event|1
691813|NCT01479374|2246070|P1|Overall Study|Decision Unrelated to Adverse Event|0
691814|NCT01479374|2246068|P3|Overall Study|Lost to Follow-up|0
691815|NCT01479374|2246069|P2|Overall Study|Lost to Follow-up|2
691816|NCT01479374|2246070|P1|Overall Study|Lost to Follow-up|1
691817|NCT01479374|2246068|P3|Overall Study|Adverse Event|0
691818|NCT01479374|2246069|P2|Overall Study|Adverse Event|1
691819|NCT01479374|2246070|P1|Overall Study|Adverse Event|2
691820|NCT01478971|2246135|P1|Peginesatide Treatment Period|Other|4
691821|NCT01478971|2246135|P1|Peginesatide Treatment Period|Lost to Follow-up|4
691822|NCT01478971|2246135|P1|Peginesatide Treatment Period|Death|4
691823|NCT01478971|2246135|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
691824|NCT01478971|2246135|P1|Peginesatide Treatment Period|Adverse Event|1
691825|NCT01478971|2246135|P1|Standard of Care Period|Other|4
691826|NCT01478971|2246135|P1|Standard of Care Period|Lost to Follow-up|9
691827|NCT01478971|2246135|P1|Standard of Care Period|Death|8
691828|NCT01478971|2246135|P1|Standard of Care Period|Withdrawal by Subject|3
691829|NCT01478971|2246135|P1|Standard of Care Period|Adverse Event|1
691830|NCT01478958|2246152|P3|Overall Study|Unable to comply|2
691831|NCT01478958|2246153|P2|Overall Study|Unable to comply|0
691832|NCT01478958|2246154|P1|Overall Study|Unable to comply|0
691833|NCT01478958|2246152|P3|Overall Study|Re-located|0
691834|NCT01478958|2246153|P2|Overall Study|Re-located|1
691835|NCT01478958|2246154|P1|Overall Study|Re-located|0
691836|NCT01478958|2246152|P3|Overall Study|Weight loss|0
691837|NCT01478958|2246153|P2|Overall Study|Weight loss|0
691838|NCT01478958|2246154|P1|Overall Study|Weight loss|1
691839|NCT01478958|2246152|P3|Overall Study|Withdrawal by Subject|1
691840|NCT01478958|2246153|P2|Overall Study|Withdrawal by Subject|1
691841|NCT01478958|2246154|P1|Overall Study|Withdrawal by Subject|1
691842|NCT01478828|2246162|P1|Overall Study|Adverse Event|1
691843|NCT01478620|2246167|P1|Overall Study|Lost to Follow-up|6
691844|NCT01478594|2246173|P2|Overall Study|Study Closed by Sponsor|5
691845|NCT01478594|2246174|P1|Overall Study|Study Closed by Sponsor|8
691846|NCT01478594|2246173|P2|Overall Study|Withdrawal by Subject|3
691847|NCT01478594|2246174|P1|Overall Study|Withdrawal by Subject|9
691848|NCT01478594|2246173|P2|Overall Study|Lost to Follow-up|1
691849|NCT01478594|2246174|P1|Overall Study|Lost to Follow-up|3
691850|NCT01478594|2246173|P2|Overall Study|Death|18
691851|NCT01478594|2246174|P1|Overall Study|Death|45
691852|NCT01478594|2246173|P2|Overall Study|Randomized but Never Received Study Drug|1
691853|NCT01478594|2246174|P1|Overall Study|Randomized but Never Received Study Drug|0
691854|NCT01478373|2246246|P1|Survival Phase|Progressive Disease|27
691855|NCT01478373|2246246|P1|Survival Phase|crossover to another study|2
691856|NCT01478373|2246246|P1|Survival Phase|Protocol Violation|1
691857|NCT01478373|2246246|P1|Survival Phase|Adverse Event|8
691858|NCT01478373|2246246|P1|Treatment Phase|Protocol Violation|1
691859|NCT01478360|2246259|P2|Overall Study|Administrative problems|2
691860|NCT01478360|2246260|P1|Overall Study|Administrative problems|1
691861|NCT01478360|2246259|P2|Overall Study|Adverse Event|1
691862|NCT01478360|2246260|P1|Overall Study|Adverse Event|0
691863|NCT01478360|2246259|P2|Overall Study|Lost to Follow-up|0
691864|NCT01478360|2246260|P1|Overall Study|Lost to Follow-up|1
691865|NCT01478347|2246266|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
691866|NCT01478347|2246266|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
691867|NCT01478347|2246266|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
691868|NCT01478113|2246284|P2|Overall Study|Physician Decision|0
691869|NCT01478113|2246285|P1|Overall Study|Physician Decision|1
691870|NCT01478113|2246284|P2|Overall Study|Withdrawal by Subject|1
691871|NCT01478113|2246285|P1|Overall Study|Withdrawal by Subject|0
691872|NCT01478087|2246303|P1|Overall Study|due to sponsor closing study|1
691873|NCT01478048|2246310|P2|Overall Study|Physician Decision|0
691874|NCT01478048|2246311|P1|Overall Study|Physician Decision|1
691875|NCT01478048|2246310|P2|Overall Study|Not reported|0
691876|NCT01478048|2246311|P1|Overall Study|Not reported|1
691877|NCT01478048|2246310|P2|Overall Study|no longer meets study criteria|0
691878|NCT01478048|2246311|P1|Overall Study|no longer meets study criteria|1
691879|NCT01478048|2246310|P2|Overall Study|poor/non-compliance|1
691880|NCT01478048|2246311|P1|Overall Study|poor/non-compliance|1
691881|NCT01478048|2246310|P2|Overall Study|non-specified|3
691882|NCT01478048|2246311|P1|Overall Study|non-specified|1
691883|NCT01478048|2246310|P2|Overall Study|Withdrawal by Subject|5
691884|NCT01478048|2246311|P1|Overall Study|Withdrawal by Subject|2
691885|NCT01478048|2246310|P2|Overall Study|subject request to discontinue treatment|5
691886|NCT01478048|2246311|P1|Overall Study|subject request to discontinue treatment|1
691887|NCT01478048|2246310|P2|Overall Study|Adverse Event|9
691888|NCT01478048|2246311|P1|Overall Study|Adverse Event|1
691889|NCT01478048|2246310|P2|Overall Study|study drug toxicity|13
691890|NCT01478048|2246311|P1|Overall Study|study drug toxicity|8
691891|NCT01478048|2246310|P2|Overall Study|Disease Progression|32
691892|NCT01478048|2246311|P1|Overall Study|Disease Progression|46
691893|NCT01477892|2246340|P2|Overall Study|Withdrawal by Subject|2
691894|NCT01477892|2246341|P1|Overall Study|Withdrawal by Subject|0
691895|NCT01477853|2246352|P3|Phase B|Study terminated by sponsor|11
691896|NCT01477853|2246353|P2|Phase B|Study terminated by sponsor|10
691897|NCT01477853|2246354|P1|Phase B|Study terminated by sponsor|12
691898|NCT01477853|2246352|P3|Phase B|Lost to Follow-up|0
691899|NCT01477853|2246353|P2|Phase B|Lost to Follow-up|1
691900|NCT01477853|2246354|P1|Phase B|Lost to Follow-up|0
691901|NCT01477853|2246352|P3|Phase A|Study terminated by sponsor|39
691902|NCT01477853|2246353|P2|Phase A|Study terminated by sponsor|40
691903|NCT01477853|2246354|P1|Phase A|Study terminated by sponsor|37
691904|NCT01477853|2246352|P3|Phase A|Physician Decision|1
691905|NCT01477853|2246353|P2|Phase A|Physician Decision|0
691906|NCT01477853|2246354|P1|Phase A|Physician Decision|1
691907|NCT01477853|2246352|P3|Phase A|Lost to Follow-up|2
691908|NCT01477853|2246353|P2|Phase A|Lost to Follow-up|3
691909|NCT01477853|2246354|P1|Phase A|Lost to Follow-up|4
691910|NCT01477853|2246352|P3|Phase A|Adverse Event|2
691911|NCT01477853|2246353|P2|Phase A|Adverse Event|2
691912|NCT01477853|2246354|P1|Phase A|Adverse Event|1
691913|NCT01477749|2246421|P1|Overall Study|Physician Decision|4
691914|NCT01477333|2246529|P1|Overall Study|Clinical Deterioration|1
691915|NCT01477333|2246529|P1|Overall Study|Withdrawal by Subject|1
691916|NCT01477333|2246529|P1|Overall Study|Adverse Event|1
691917|NCT01476722|2246561|P1|Overall Study|Adverse Event|1
691918|NCT01476696|2246568|P3|Overall Study|Withdrawal by Subject|0
691919|NCT01476696|2246569|P2|Overall Study|Withdrawal by Subject|0
691920|NCT01476696|2246570|P1|Overall Study|Withdrawal by Subject|1
691921|NCT01476696|2246568|P3|Overall Study|Sponsor decision|0
691922|NCT01476696|2246569|P2|Overall Study|Sponsor decision|1
691923|NCT01476696|2246570|P1|Overall Study|Sponsor decision|2
691924|NCT01476475|2246586|P2|Overall Study|Other reasons|2
691925|NCT01476475|2246587|P1|Overall Study|Other reasons|4
691926|NCT01476475|2246586|P2|Overall Study|Poor compliance to protocol|1
691927|NCT01476475|2246587|P1|Overall Study|Poor compliance to protocol|1
691928|NCT01476475|2246586|P2|Overall Study|Adverse Event|0
691929|NCT01476475|2246587|P1|Overall Study|Adverse Event|6
691930|NCT01475851|2247016|P2|Overall Study|Protocol defined stopping criteria|0
691931|NCT01475851|2247017|P1|Overall Study|Protocol defined stopping criteria|1
691932|NCT01475838|2247045|P2|Extension Phase|Participant Noncompliance|0
691933|NCT01475838|2247046|P1|Extension Phase|Participant Noncompliance|1
691934|NCT01475838|2247045|P2|Randomized Phase|Protocol Violation|4
691935|NCT01475838|2247046|P1|Randomized Phase|Protocol Violation|9
691936|NCT01475838|2247045|P2|Randomized Phase|Participant Noncompliance|5
691937|NCT01475838|2247046|P1|Randomized Phase|Participant Noncompliance|1
691938|NCT01475838|2247045|P2|Randomized Phase|Lost to Follow-up|4
691939|NCT01475838|2247046|P1|Randomized Phase|Lost to Follow-up|3
691940|NCT01475838|2247045|P2|Randomized Phase|Withdrew Consent|14
691941|NCT01475838|2247046|P1|Randomized Phase|Withdrew Consent|10
691942|NCT01475838|2247045|P2|Randomized Phase|Investigators Discretion|2
691943|NCT01475838|2247046|P1|Randomized Phase|Investigators Discretion|1
691944|NCT01475838|2247045|P2|Randomized Phase|Pregnancy|1
691945|NCT01475838|2247046|P1|Randomized Phase|Pregnancy|0
691946|NCT01475838|2247045|P2|Randomized Phase|Adverse Event|1
691947|NCT01475838|2247046|P1|Randomized Phase|Adverse Event|6
691948|NCT01475838|2247045|P2|Randomized Phase|Randomized but Not Treated|5
691949|NCT01475838|2247046|P1|Randomized Phase|Randomized but Not Treated|0
691950|NCT01475734|2247061|P2|Overall Study|Physician Decision|1
691951|NCT01475734|2247062|P1|Overall Study|Physician Decision|0
691952|NCT01475734|2247061|P2|Overall Study|Protocol Violation|0
691953|NCT01475734|2247062|P1|Overall Study|Protocol Violation|1
691954|NCT01475734|2247061|P2|Overall Study|Withdrawal by Subject|0
691955|NCT01475734|2247062|P1|Overall Study|Withdrawal by Subject|1
889263|NCT01372410|2823760|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
889264|NCT01372410|2823753|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
889265|NCT01372410|2823754|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
691960|NCT01475487|2247107|P2|Overall Study|had to leave early for personal reasons|1
691961|NCT01475487|2247108|P1|Overall Study|had to leave early for personal reasons|2
691962|NCT01475474|2247120|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
691963|NCT01475474|2247120|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
691964|NCT01475461|2247131|P7|Treatment Period|Adverse Event|0
691965|NCT01475461|2247132|P6|Treatment Period|Adverse Event|0
691966|NCT01475461|2247133|P5|Treatment Period|Adverse Event|0
691967|NCT01475461|2247134|P4|Treatment Period|Adverse Event|1
691968|NCT01475461|2247135|P3|Treatment Period|Adverse Event|0
691969|NCT01475461|2247136|P2|Treatment Period|Adverse Event|0
691970|NCT01475461|2247137|P1|Treatment Period|Adverse Event|0
691971|NCT01475461|2247131|P7|Treatment Period|Medication Error|0
691972|NCT01475461|2247132|P6|Treatment Period|Medication Error|0
691973|NCT01475461|2247133|P5|Treatment Period|Medication Error|0
691974|NCT01475461|2247134|P4|Treatment Period|Medication Error|1
691975|NCT01475461|2247135|P3|Treatment Period|Medication Error|0
691976|NCT01475461|2247136|P2|Treatment Period|Medication Error|0
691977|NCT01475461|2247137|P1|Treatment Period|Medication Error|0
691978|NCT01475461|2247131|P7|Treatment Period|Lack of Efficacy|0
691979|NCT01475461|2247132|P6|Treatment Period|Lack of Efficacy|1
691980|NCT01475461|2247133|P5|Treatment Period|Lack of Efficacy|1
691981|NCT01475461|2247134|P4|Treatment Period|Lack of Efficacy|2
691982|NCT01475461|2247135|P3|Treatment Period|Lack of Efficacy|0
691983|NCT01475461|2247136|P2|Treatment Period|Lack of Efficacy|2
691984|NCT01475461|2247137|P1|Treatment Period|Lack of Efficacy|0
691985|NCT01475461|2247131|P7|Treatment Period|Protocol Violation|1
691986|NCT01475461|2247132|P6|Treatment Period|Protocol Violation|0
691987|NCT01475461|2247133|P5|Treatment Period|Protocol Violation|0
691988|NCT01475461|2247134|P4|Treatment Period|Protocol Violation|0
691989|NCT01475461|2247135|P3|Treatment Period|Protocol Violation|0
691990|NCT01475461|2247136|P2|Treatment Period|Protocol Violation|1
691991|NCT01475461|2247137|P1|Treatment Period|Protocol Violation|0
691992|NCT01475461|2247131|P7|Treatment Period|Unspecified|0
691993|NCT01475461|2247132|P6|Treatment Period|Unspecified|0
691994|NCT01475461|2247133|P5|Treatment Period|Unspecified|0
691995|NCT01475461|2247134|P4|Treatment Period|Unspecified|0
691996|NCT01475461|2247135|P3|Treatment Period|Unspecified|0
691997|NCT01475461|2247136|P2|Treatment Period|Unspecified|1
691998|NCT01475461|2247137|P1|Treatment Period|Unspecified|0
691999|NCT01475461|2247131|P7|Treatment Period|Withdrawal by Subject|0
692000|NCT01475461|2247132|P6|Treatment Period|Withdrawal by Subject|2
692001|NCT01475461|2247133|P5|Treatment Period|Withdrawal by Subject|2
692002|NCT01475461|2247134|P4|Treatment Period|Withdrawal by Subject|0
692003|NCT01475461|2247135|P3|Treatment Period|Withdrawal by Subject|2
692004|NCT01475461|2247136|P2|Treatment Period|Withdrawal by Subject|2
692005|NCT01475461|2247137|P1|Treatment Period|Withdrawal by Subject|0
692006|NCT01475461|2247131|P7|Treatment Period|Lost to Follow-up|1
692007|NCT01475461|2247132|P6|Treatment Period|Lost to Follow-up|2
692008|NCT01475461|2247133|P5|Treatment Period|Lost to Follow-up|1
692009|NCT01475461|2247134|P4|Treatment Period|Lost to Follow-up|3
692010|NCT01475461|2247135|P3|Treatment Period|Lost to Follow-up|2
692011|NCT01475461|2247136|P2|Treatment Period|Lost to Follow-up|3
692012|NCT01475461|2247137|P1|Treatment Period|Lost to Follow-up|0
692013|NCT01475461|2247131|P7|Treatment Period|Death|0
692014|NCT01475461|2247132|P6|Treatment Period|Death|0
692015|NCT01475461|2247133|P5|Treatment Period|Death|0
692016|NCT01475461|2247134|P4|Treatment Period|Death|1
692017|NCT01475461|2247135|P3|Treatment Period|Death|0
692018|NCT01475461|2247136|P2|Treatment Period|Death|0
692019|NCT01475461|2247137|P1|Treatment Period|Death|0
692020|NCT01475461|2247131|P7|Run-in Period|Protocol Violation|0
692021|NCT01475461|2247132|P6|Run-in Period|Protocol Violation|0
692022|NCT01475461|2247133|P5|Run-in Period|Protocol Violation|0
692023|NCT01475461|2247134|P4|Run-in Period|Protocol Violation|0
692024|NCT01475461|2247135|P3|Run-in Period|Protocol Violation|0
692025|NCT01475461|2247136|P2|Run-in Period|Protocol Violation|0
692026|NCT01475461|2247137|P1|Run-in Period|Protocol Violation|4
692027|NCT01475461|2247131|P7|Run-in Period|Unspecified|0
692028|NCT01475461|2247132|P6|Run-in Period|Unspecified|0
692029|NCT01475461|2247133|P5|Run-in Period|Unspecified|0
692030|NCT01475461|2247134|P4|Run-in Period|Unspecified|0
692031|NCT01475461|2247135|P3|Run-in Period|Unspecified|0
692032|NCT01475461|2247136|P2|Run-in Period|Unspecified|0
692033|NCT01475461|2247137|P1|Run-in Period|Unspecified|3
692034|NCT01475461|2247131|P7|Run-in Period|Withdrawal by Subject|0
692035|NCT01475461|2247132|P6|Run-in Period|Withdrawal by Subject|0
692036|NCT01475461|2247133|P5|Run-in Period|Withdrawal by Subject|0
692037|NCT01475461|2247134|P4|Run-in Period|Withdrawal by Subject|0
692038|NCT01475461|2247135|P3|Run-in Period|Withdrawal by Subject|0
692039|NCT01475461|2247136|P2|Run-in Period|Withdrawal by Subject|0
692040|NCT01475461|2247137|P1|Run-in Period|Withdrawal by Subject|11
692041|NCT01475461|2247131|P7|Run-in Period|Lost to Follow-up|0
692042|NCT01475461|2247132|P6|Run-in Period|Lost to Follow-up|0
692043|NCT01475461|2247133|P5|Run-in Period|Lost to Follow-up|0
692044|NCT01475461|2247134|P4|Run-in Period|Lost to Follow-up|0
692045|NCT01475461|2247135|P3|Run-in Period|Lost to Follow-up|0
692046|NCT01475461|2247136|P2|Run-in Period|Lost to Follow-up|0
692047|NCT01475461|2247137|P1|Run-in Period|Lost to Follow-up|7
692048|NCT01475461|2247131|P7|Run-in Period|Not meet eligibility criteria|0
692049|NCT01475461|2247132|P6|Run-in Period|Not meet eligibility criteria|0
692050|NCT01475461|2247133|P5|Run-in Period|Not meet eligibility criteria|0
692051|NCT01475461|2247134|P4|Run-in Period|Not meet eligibility criteria|0
692052|NCT01475461|2247135|P3|Run-in Period|Not meet eligibility criteria|0
692053|NCT01475461|2247136|P2|Run-in Period|Not meet eligibility criteria|0
692054|NCT01475461|2247137|P1|Run-in Period|Not meet eligibility criteria|16
692055|NCT01475253|2247261|P4|Randomized, Blinded Study|Lost to Follow-up|0
692056|NCT01475253|2247262|P3|Randomized, Blinded Study|Lost to Follow-up|0
692057|NCT01475253|2247263|P2|Randomized, Blinded Study|Lost to Follow-up|0
692058|NCT01475253|2247264|P1|Randomized, Blinded Study|Lost to Follow-up|1
692059|NCT01475253|2247261|P4|Randomized, Blinded Study|Withdrawal by Subject|0
692060|NCT01475253|2247262|P3|Randomized, Blinded Study|Withdrawal by Subject|0
692061|NCT01475253|2247263|P2|Randomized, Blinded Study|Withdrawal by Subject|1
692062|NCT01475253|2247264|P1|Randomized, Blinded Study|Withdrawal by Subject|1
692063|NCT01475214|2247293|P3|Overall Study|Withdrawal by Subject|1
692064|NCT01475214|2247294|P2|Overall Study|Withdrawal by Subject|4
692065|NCT01475214|2247295|P1|Overall Study|Withdrawal by Subject|2
692066|NCT01475214|2247293|P3|Overall Study|Physician Decision|0
692067|NCT01475214|2247294|P2|Overall Study|Physician Decision|0
692068|NCT01475214|2247295|P1|Overall Study|Physician Decision|2
692069|NCT01475214|2247293|P3|Overall Study|Lost to Follow-up|1
692070|NCT01475214|2247294|P2|Overall Study|Lost to Follow-up|0
692071|NCT01475214|2247295|P1|Overall Study|Lost to Follow-up|1
692072|NCT01475097|2247320|P2|Overall Study|Protocol Violation|1
692073|NCT01475097|2247321|P1|Overall Study|Protocol Violation|1
692074|NCT01475071|2247329|P1|Overall Study|Lost to Follow-up|1
692075|NCT01475071|2247329|P1|Overall Study|Withdrawal by Subject|6
692076|NCT01475071|2247329|P1|Overall Study|Physician Decision|1
692077|NCT01474993|2247339|P2|Overall Study|Adverse Event|1
692078|NCT01474993|2247340|P1|Overall Study|Adverse Event|0
692079|NCT01474993|2247339|P2|Overall Study|Lost to Follow-up|2
692080|NCT01474993|2247340|P1|Overall Study|Lost to Follow-up|1
692081|NCT01474876|2247378|P3|Overall Study|Investigator's decision and pt request|0
692082|NCT01474876|2247379|P2|Overall Study|Investigator's decision and pt request|0
692083|NCT01474876|2247380|P1|Overall Study|Investigator's decision and pt request|1
692084|NCT01474876|2247378|P3|Overall Study|Patient's request|0
692085|NCT01474876|2247379|P2|Overall Study|Patient's request|5
692086|NCT01474876|2247380|P1|Overall Study|Patient's request|19
692087|NCT01474876|2247378|P3|Overall Study|Investigator's decision|0
692088|NCT01474876|2247379|P2|Overall Study|Investigator's decision|6
692089|NCT01474876|2247380|P1|Overall Study|Investigator's decision|28
692090|NCT01474876|2247378|P3|Overall Study|Lost to Follow-up|0
692091|NCT01474876|2247379|P2|Overall Study|Lost to Follow-up|4
692092|NCT01474876|2247380|P1|Overall Study|Lost to Follow-up|5
692093|NCT01474876|2247378|P3|Overall Study|Serious Adverse Event|0
692094|NCT01474876|2247379|P2|Overall Study|Serious Adverse Event|3
692095|NCT01474876|2247380|P1|Overall Study|Serious Adverse Event|2
692096|NCT01474876|2247378|P3|Overall Study|Adverse Event|0
692097|NCT01474876|2247379|P2|Overall Study|Adverse Event|5
692098|NCT01474876|2247380|P1|Overall Study|Adverse Event|11
692099|NCT01474772|2247426|P2|Follow-up|AE not Related to Study Drug|1
692100|NCT01474772|2247427|P1|Follow-up|AE not Related to Study Drug|0
692101|NCT01474772|2247426|P2|Period 2|Reason not Specified|2
692102|NCT01474772|2247427|P1|Period 2|Reason not Specified|0
692103|NCT01474772|2247426|P2|Period 2|Lost to Follow-up|1
692104|NCT01474772|2247427|P1|Period 2|Lost to Follow-up|1
692105|NCT01474772|2247426|P2|Period 2|Withdrawal by Subject|4
692106|NCT01474772|2247427|P1|Period 2|Withdrawal by Subject|3
692107|NCT01474772|2247426|P2|Period 2|Lack of Efficacy|0
692108|NCT01474772|2247427|P1|Period 2|Lack of Efficacy|1
692109|NCT01474772|2247426|P2|Period 2|AE not Related to Study Drug|1
692110|NCT01474772|2247427|P1|Period 2|AE not Related to Study Drug|4
692111|NCT01474772|2247426|P2|Period 2|AE Related to Study Drug|1
692112|NCT01474772|2247427|P1|Period 2|AE Related to Study Drug|0
692113|NCT01474772|2247426|P2|Period 2|Death|1
692114|NCT01474772|2247427|P1|Period 2|Death|0
692115|NCT01474772|2247426|P2|Washout|Reason not Specified|1
692116|NCT01474772|2247427|P1|Washout|Reason not Specified|0
692117|NCT01474772|2247426|P2|Washout|Lost to Follow-up|1
692118|NCT01474772|2247427|P1|Washout|Lost to Follow-up|0
692119|NCT01474772|2247426|P2|Washout|Withdrawal by Subject|0
692120|NCT01474772|2247427|P1|Washout|Withdrawal by Subject|1
692121|NCT01474772|2247426|P2|Washout|AE not Related to Study Drug|0
692122|NCT01474772|2247427|P1|Washout|AE not Related to Study Drug|2
692123|NCT01474772|2247426|P2|Period 1|Reason not Specified|1
692124|NCT01474772|2247427|P1|Period 1|Reason not Specified|1
692125|NCT01474772|2247426|P2|Period 1|Lost to Follow-up|0
692126|NCT01474772|2247427|P1|Period 1|Lost to Follow-up|1
692127|NCT01474772|2247426|P2|Period 1|Withdrawal by Subject|1
692128|NCT01474772|2247427|P1|Period 1|Withdrawal by Subject|3
692129|NCT01474772|2247426|P2|Period 1|AE not Related to Study Drug|0
692130|NCT01474772|2247427|P1|Period 1|AE not Related to Study Drug|1
692131|NCT01474772|2247426|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
692132|NCT01474772|2247427|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
692133|NCT01474746|2247477|P2|Overall Study|Withdrawal by Subject|1
692134|NCT01474746|2247478|P1|Overall Study|Withdrawal by Subject|2
692135|NCT01474746|2247477|P2|Overall Study|Lost to Follow-up|1
692136|NCT01474746|2247478|P1|Overall Study|Lost to Follow-up|1
692137|NCT01474681|2247542|P4|Overall Study|Death|6
692138|NCT01474681|2247543|P3|Overall Study|Death|2
692139|NCT01474681|2247544|P2|Overall Study|Death|3
692140|NCT01474681|2247545|P1|Overall Study|Death|0
692141|NCT01474551|2247596|P1|Overall Study|Death|1
692142|NCT01474538|2247602|P2|Treatment Period 2|Protocol Violation|0
692143|NCT01474538|2247603|P1|Treatment Period 2|Protocol Violation|1
692144|NCT01474538|2247602|P2|Treatment Period 2|Physician Decision|1
692145|NCT01474538|2247603|P1|Treatment Period 2|Physician Decision|0
692146|NCT01474538|2247602|P2|Treatment Period 2|Sponsor decision|0
692147|NCT01474538|2247603|P1|Treatment Period 2|Sponsor decision|1
692148|NCT01474538|2247602|P2|Treatment Period 2|Withdrawal by Subject|0
692149|NCT01474538|2247603|P1|Treatment Period 2|Withdrawal by Subject|2
692150|NCT01474538|2247602|P2|Treatment Period 2|Adverse Event|1
692151|NCT01474538|2247603|P1|Treatment Period 2|Adverse Event|1
692152|NCT01474538|2247602|P2|Treatment Period 2|Death|0
692153|NCT01474538|2247603|P1|Treatment Period 2|Death|1
692154|NCT01474538|2247602|P2|Treatment Period 1|Protocol Violation|1
692155|NCT01474538|2247603|P1|Treatment Period 1|Protocol Violation|0
692156|NCT01474538|2247602|P2|Treatment Period 1|Withdrawal by Subject|3
692157|NCT01474538|2247603|P1|Treatment Period 1|Withdrawal by Subject|1
692158|NCT01474538|2247602|P2|Treatment Period 1|Physician Decision|0
692159|NCT01474538|2247603|P1|Treatment Period 1|Physician Decision|1
692160|NCT01474538|2247602|P2|Treatment Period 1|Death|0
692161|NCT01474538|2247603|P1|Treatment Period 1|Death|1
692162|NCT01474512|2247620|P10|Maintenance Period|Treated but Discontinued in Induction|0
692163|NCT01474512|2247621|P9|Maintenance Period|Treated but Discontinued in Induction|0
692164|NCT01474512|2247622|P8|Maintenance Period|Treated but Discontinued in Induction|0
692165|NCT01474512|2247623|P7|Maintenance Period|Treated but Discontinued in Induction|0
692166|NCT01474512|2247624|P6|Maintenance Period|Treated but Discontinued in Induction|0
692167|NCT01474512|2247625|P5|Maintenance Period|Treated but Discontinued in Induction|1
692168|NCT01474512|2247626|P4|Maintenance Period|Treated but Discontinued in Induction|0
692169|NCT01474512|2247627|P3|Maintenance Period|Treated but Discontinued in Induction|0
692170|NCT01474512|2247628|P2|Maintenance Period|Treated but Discontinued in Induction|0
692171|NCT01474512|2247629|P1|Maintenance Period|Treated but Discontinued in Induction|0
692172|NCT01474512|2247620|P10|Maintenance Period|Protocol Violation|1
692173|NCT01474512|2247621|P9|Maintenance Period|Protocol Violation|0
692174|NCT01474512|2247622|P8|Maintenance Period|Protocol Violation|1
692175|NCT01474512|2247623|P7|Maintenance Period|Protocol Violation|0
692176|NCT01474512|2247624|P6|Maintenance Period|Protocol Violation|0
692177|NCT01474512|2247625|P5|Maintenance Period|Protocol Violation|0
692178|NCT01474512|2247626|P4|Maintenance Period|Protocol Violation|1
692179|NCT01474512|2247627|P3|Maintenance Period|Protocol Violation|0
692180|NCT01474512|2247628|P2|Maintenance Period|Protocol Violation|0
692181|NCT01474512|2247629|P1|Maintenance Period|Protocol Violation|0
692182|NCT01474512|2247620|P10|Maintenance Period|Lack of Efficacy|12
692183|NCT01474512|2247621|P9|Maintenance Period|Lack of Efficacy|11
692184|NCT01474512|2247622|P8|Maintenance Period|Lack of Efficacy|11
692185|NCT01474512|2247623|P7|Maintenance Period|Lack of Efficacy|0
692186|NCT01474512|2247624|P6|Maintenance Period|Lack of Efficacy|0
692187|NCT01474512|2247625|P5|Maintenance Period|Lack of Efficacy|0
692188|NCT01474512|2247626|P4|Maintenance Period|Lack of Efficacy|1
692189|NCT01474512|2247627|P3|Maintenance Period|Lack of Efficacy|0
692190|NCT01474512|2247628|P2|Maintenance Period|Lack of Efficacy|0
692191|NCT01474512|2247629|P1|Maintenance Period|Lack of Efficacy|0
692192|NCT01474512|2247620|P10|Maintenance Period|Clinical Relapse|0
692193|NCT01474512|2247621|P9|Maintenance Period|Clinical Relapse|0
692194|NCT01474512|2247622|P8|Maintenance Period|Clinical Relapse|0
692195|NCT01474512|2247623|P7|Maintenance Period|Clinical Relapse|0
692196|NCT01474512|2247624|P6|Maintenance Period|Clinical Relapse|0
692197|NCT01474512|2247625|P5|Maintenance Period|Clinical Relapse|0
692198|NCT01474512|2247626|P4|Maintenance Period|Clinical Relapse|1
692199|NCT01474512|2247627|P3|Maintenance Period|Clinical Relapse|0
692200|NCT01474512|2247628|P2|Maintenance Period|Clinical Relapse|0
692201|NCT01474512|2247629|P1|Maintenance Period|Clinical Relapse|0
692202|NCT01474512|2247620|P10|Maintenance Period|Investigator Decision|0
692203|NCT01474512|2247621|P9|Maintenance Period|Investigator Decision|0
692204|NCT01474512|2247622|P8|Maintenance Period|Investigator Decision|2
692205|NCT01474512|2247623|P7|Maintenance Period|Investigator Decision|0
692206|NCT01474512|2247624|P6|Maintenance Period|Investigator Decision|1
692207|NCT01474512|2247625|P5|Maintenance Period|Investigator Decision|0
692208|NCT01474512|2247626|P4|Maintenance Period|Investigator Decision|0
692209|NCT01474512|2247627|P3|Maintenance Period|Investigator Decision|0
692210|NCT01474512|2247628|P2|Maintenance Period|Investigator Decision|0
692211|NCT01474512|2247629|P1|Maintenance Period|Investigator Decision|0
692212|NCT01474512|2247620|P10|Maintenance Period|Death|0
692213|NCT01474512|2247621|P9|Maintenance Period|Death|0
692214|NCT01474512|2247622|P8|Maintenance Period|Death|0
692215|NCT01474512|2247623|P7|Maintenance Period|Death|0
692216|NCT01474512|2247624|P6|Maintenance Period|Death|2
692217|NCT01474512|2247625|P5|Maintenance Period|Death|0
692218|NCT01474512|2247626|P4|Maintenance Period|Death|0
692219|NCT01474512|2247627|P3|Maintenance Period|Death|0
692220|NCT01474512|2247628|P2|Maintenance Period|Death|0
692221|NCT01474512|2247629|P1|Maintenance Period|Death|0
692222|NCT01474512|2247620|P10|Maintenance Period|Lost to Follow-up|1
692223|NCT01474512|2247621|P9|Maintenance Period|Lost to Follow-up|1
692224|NCT01474512|2247622|P8|Maintenance Period|Lost to Follow-up|2
692225|NCT01474512|2247623|P7|Maintenance Period|Lost to Follow-up|0
692226|NCT01474512|2247624|P6|Maintenance Period|Lost to Follow-up|0
692227|NCT01474512|2247625|P5|Maintenance Period|Lost to Follow-up|3
692228|NCT01474512|2247626|P4|Maintenance Period|Lost to Follow-up|3
692229|NCT01474512|2247627|P3|Maintenance Period|Lost to Follow-up|0
692230|NCT01474512|2247628|P2|Maintenance Period|Lost to Follow-up|0
692231|NCT01474512|2247629|P1|Maintenance Period|Lost to Follow-up|0
692232|NCT01474512|2247620|P10|Maintenance Period|Withdrawal by Subject|1
692233|NCT01474512|2247621|P9|Maintenance Period|Withdrawal by Subject|3
692234|NCT01474512|2247622|P8|Maintenance Period|Withdrawal by Subject|6
692235|NCT01474512|2247623|P7|Maintenance Period|Withdrawal by Subject|1
692236|NCT01474512|2247624|P6|Maintenance Period|Withdrawal by Subject|3
692237|NCT01474512|2247625|P5|Maintenance Period|Withdrawal by Subject|2
692238|NCT01474512|2247626|P4|Maintenance Period|Withdrawal by Subject|6
692239|NCT01474512|2247627|P3|Maintenance Period|Withdrawal by Subject|0
692240|NCT01474512|2247628|P2|Maintenance Period|Withdrawal by Subject|0
692241|NCT01474512|2247629|P1|Maintenance Period|Withdrawal by Subject|0
692242|NCT01474512|2247620|P10|Maintenance Period|Adverse Event|3
692243|NCT01474512|2247621|P9|Maintenance Period|Adverse Event|1
692244|NCT01474512|2247622|P8|Maintenance Period|Adverse Event|19
692245|NCT01474512|2247623|P7|Maintenance Period|Adverse Event|0
692246|NCT01474512|2247624|P6|Maintenance Period|Adverse Event|7
692247|NCT01474512|2247625|P5|Maintenance Period|Adverse Event|2
692248|NCT01474512|2247626|P4|Maintenance Period|Adverse Event|4
692249|NCT01474512|2247627|P3|Maintenance Period|Adverse Event|0
692250|NCT01474512|2247628|P2|Maintenance Period|Adverse Event|0
692251|NCT01474512|2247629|P1|Maintenance Period|Adverse Event|0
692252|NCT01474512|2247620|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
692253|NCT01474512|2247621|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
692254|NCT01474512|2247622|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
692255|NCT01474512|2247623|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
692256|NCT01474512|2247624|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
692257|NCT01474512|2247625|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
692258|NCT01474512|2247626|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
692259|NCT01474512|2247627|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
692260|NCT01474512|2247628|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
692261|NCT01474512|2247629|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
692262|NCT01474512|2247620|P10|Induction Period|Lost to Follow-up|0
692263|NCT01474512|2247621|P9|Induction Period|Lost to Follow-up|0
692264|NCT01474512|2247622|P8|Induction Period|Lost to Follow-up|0
692265|NCT01474512|2247623|P7|Induction Period|Lost to Follow-up|0
692266|NCT01474512|2247624|P6|Induction Period|Lost to Follow-up|0
692267|NCT01474512|2247625|P5|Induction Period|Lost to Follow-up|0
692268|NCT01474512|2247626|P4|Induction Period|Lost to Follow-up|0
692269|NCT01474512|2247627|P3|Induction Period|Lost to Follow-up|2
692270|NCT01474512|2247628|P2|Induction Period|Lost to Follow-up|0
692271|NCT01474512|2247629|P1|Induction Period|Lost to Follow-up|1
692272|NCT01474512|2247620|P10|Induction Period|Sponsor Decision|0
692273|NCT01474512|2247621|P9|Induction Period|Sponsor Decision|0
692274|NCT01474512|2247622|P8|Induction Period|Sponsor Decision|0
692275|NCT01474512|2247623|P7|Induction Period|Sponsor Decision|0
692276|NCT01474512|2247624|P6|Induction Period|Sponsor Decision|0
692277|NCT01474512|2247625|P5|Induction Period|Sponsor Decision|0
692278|NCT01474512|2247626|P4|Induction Period|Sponsor Decision|0
692279|NCT01474512|2247627|P3|Induction Period|Sponsor Decision|1
692280|NCT01474512|2247628|P2|Induction Period|Sponsor Decision|1
692281|NCT01474512|2247629|P1|Induction Period|Sponsor Decision|1
692282|NCT01474512|2247620|P10|Induction Period|Protocol Violation|0
692283|NCT01474512|2247621|P9|Induction Period|Protocol Violation|0
692284|NCT01474512|2247622|P8|Induction Period|Protocol Violation|0
692285|NCT01474512|2247623|P7|Induction Period|Protocol Violation|0
692286|NCT01474512|2247624|P6|Induction Period|Protocol Violation|0
692287|NCT01474512|2247625|P5|Induction Period|Protocol Violation|0
692288|NCT01474512|2247626|P4|Induction Period|Protocol Violation|0
692289|NCT01474512|2247627|P3|Induction Period|Protocol Violation|0
692290|NCT01474512|2247628|P2|Induction Period|Protocol Violation|6
692291|NCT01474512|2247629|P1|Induction Period|Protocol Violation|3
692292|NCT01474512|2247620|P10|Induction Period|Withdrawal by Subject|0
692293|NCT01474512|2247621|P9|Induction Period|Withdrawal by Subject|0
692294|NCT01474512|2247622|P8|Induction Period|Withdrawal by Subject|0
692295|NCT01474512|2247623|P7|Induction Period|Withdrawal by Subject|0
692296|NCT01474512|2247624|P6|Induction Period|Withdrawal by Subject|0
692297|NCT01474512|2247625|P5|Induction Period|Withdrawal by Subject|0
692298|NCT01474512|2247626|P4|Induction Period|Withdrawal by Subject|0
692299|NCT01474512|2247627|P3|Induction Period|Withdrawal by Subject|5
692300|NCT01474512|2247628|P2|Induction Period|Withdrawal by Subject|6
692301|NCT01474512|2247629|P1|Induction Period|Withdrawal by Subject|6
692302|NCT01474512|2247620|P10|Induction Period|Lack of Efficacy|0
692303|NCT01474512|2247621|P9|Induction Period|Lack of Efficacy|0
692304|NCT01474512|2247622|P8|Induction Period|Lack of Efficacy|0
692305|NCT01474512|2247623|P7|Induction Period|Lack of Efficacy|0
692306|NCT01474512|2247624|P6|Induction Period|Lack of Efficacy|0
692307|NCT01474512|2247625|P5|Induction Period|Lack of Efficacy|0
692308|NCT01474512|2247626|P4|Induction Period|Lack of Efficacy|0
692309|NCT01474512|2247627|P3|Induction Period|Lack of Efficacy|0
692310|NCT01474512|2247628|P2|Induction Period|Lack of Efficacy|1
692311|NCT01474512|2247629|P1|Induction Period|Lack of Efficacy|7
692312|NCT01474512|2247620|P10|Induction Period|Adverse Event|0
692313|NCT01474512|2247621|P9|Induction Period|Adverse Event|0
692314|NCT01474512|2247622|P8|Induction Period|Adverse Event|0
692315|NCT01474512|2247623|P7|Induction Period|Adverse Event|0
692316|NCT01474512|2247624|P6|Induction Period|Adverse Event|0
692317|NCT01474512|2247625|P5|Induction Period|Adverse Event|0
692318|NCT01474512|2247626|P4|Induction Period|Adverse Event|0
692319|NCT01474512|2247627|P3|Induction Period|Adverse Event|10
692320|NCT01474512|2247628|P2|Induction Period|Adverse Event|10
692321|NCT01474512|2247629|P1|Induction Period|Adverse Event|6
692322|NCT01474434|2247698|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
692323|NCT01474434|2247699|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
692324|NCT01474434|2247700|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
692325|NCT01474434|2247701|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
692326|NCT01474434|2247698|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
692327|NCT01474434|2247699|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
692328|NCT01474434|2247700|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
692329|NCT01474434|2247701|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
692330|NCT01474434|2247698|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
692331|NCT01474434|2247699|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
692332|NCT01474434|2247700|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
692333|NCT01474434|2247701|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
692334|NCT01474317|2247743|P1|Overall Study|Subject ineligible for study|1
692335|NCT01474317|2247743|P1|Overall Study|Adverse Event|1
692336|NCT01474291|2247752|P1|Overall Study|Death|2
692337|NCT01474291|2247752|P1|Overall Study|No Reason Reported|10
692338|NCT01474291|2247752|P1|Overall Study|Patient No Longer Wanted to Participate|12
692339|NCT01474291|2247752|P1|Overall Study|Lost to Follow-up|29
692340|NCT01474291|2247752|P1|Overall Study|Adverse Event|53
692341|NCT01474291|2247752|P1|Overall Study|Lack of Treatment Efficacy|88
692342|NCT01474291|2247752|P1|Overall Study|Not Evaluable for Efficacy|26
692343|NCT01474239|2247796|P2|Overall Study|Withdrawal for Economic Reason|0
692344|NCT01474239|2247797|P1|Overall Study|Withdrawal for Economic Reason|1
692345|NCT01474239|2247796|P2|Overall Study|Clinical Disease Progression|1
692346|NCT01474239|2247797|P1|Overall Study|Clinical Disease Progression|7
692347|NCT01474239|2247796|P2|Overall Study|Death|1
692348|NCT01474239|2247797|P1|Overall Study|Death|1
692349|NCT01474239|2247796|P2|Overall Study|Withdrawal by Subject|2
692350|NCT01474239|2247797|P1|Overall Study|Withdrawal by Subject|1
692351|NCT01474239|2247796|P2|Overall Study|Adverse Event|3
692352|NCT01474239|2247797|P1|Overall Study|Adverse Event|12
692353|NCT01474239|2247796|P2|Overall Study|Disease Progression|25
692354|NCT01474239|2247797|P1|Overall Study|Disease Progression|37
692355|NCT01473953|2247991|P5|Overall Study|Unspecified|0
692356|NCT01473953|2247992|P4|Overall Study|Unspecified|0
692357|NCT01473953|2247993|P3|Overall Study|Unspecified|0
692358|NCT01473953|2247994|P2|Overall Study|Unspecified|0
692359|NCT01473953|2247995|P1|Overall Study|Unspecified|1
692360|NCT01473836|2248037|P1|Overall Study|Does not meet entrance criteria|1
692361|NCT01473836|2248037|P1|Overall Study|Lack of Efficacy|1
692362|NCT01473836|2248037|P1|Overall Study|Adverse Event|4
692363|NCT01473758|2248048|P4|Cycle 2|Adverse Event|0
692364|NCT01473758|2248049|P3|Cycle 2|Adverse Event|5
692365|NCT01473758|2248050|P2|Cycle 2|Adverse Event|0
692366|NCT01473758|2248051|P1|Cycle 2|Adverse Event|0
692367|NCT01473758|2248048|P4|Cycle 1|Withdrawal by Subject|0
692368|NCT01473758|2248049|P3|Cycle 1|Withdrawal by Subject|0
692369|NCT01473758|2248050|P2|Cycle 1|Withdrawal by Subject|1
692370|NCT01473758|2248051|P1|Cycle 1|Withdrawal by Subject|1
692371|NCT01473758|2248048|P4|Cycle 1|Adverse Event|0
692372|NCT01473758|2248049|P3|Cycle 1|Adverse Event|0
692373|NCT01473758|2248050|P2|Cycle 1|Adverse Event|2
692374|NCT01473758|2248051|P1|Cycle 1|Adverse Event|10
692375|NCT01473602|2248188|P2|Overall Study|Physician Decision|0
692376|NCT01473602|2248189|P1|Overall Study|Physician Decision|1
692377|NCT01473602|2248188|P2|Overall Study|Withdrawal by Subject|4
692378|NCT01473602|2248189|P1|Overall Study|Withdrawal by Subject|5
692379|NCT01473602|2248188|P2|Overall Study|Lost to Follow-up|1
692380|NCT01473602|2248189|P1|Overall Study|Lost to Follow-up|1
692381|NCT01473602|2248188|P2|Overall Study|Death|1
692382|NCT01473602|2248189|P1|Overall Study|Death|0
692383|NCT01473602|2248188|P2|Overall Study|Adverse Event|2
692384|NCT01473602|2248189|P1|Overall Study|Adverse Event|1
692385|NCT01473589|2248225|P2|Overall Study|Entry criteria not met|1
692386|NCT01473589|2248226|P1|Overall Study|Entry criteria not met|0
692387|NCT01473589|2248225|P2|Overall Study|Physician Decision|1
692388|NCT01473589|2248226|P1|Overall Study|Physician Decision|0
692389|NCT01473589|2248225|P2|Overall Study|Withdrawal by Subject|11
692390|NCT01473589|2248226|P1|Overall Study|Withdrawal by Subject|5
692391|NCT01473589|2248225|P2|Overall Study|Protocol Violation|0
692392|NCT01473589|2248226|P1|Overall Study|Protocol Violation|1
692393|NCT01473589|2248225|P2|Overall Study|Lost to Follow-up|2
692394|NCT01473589|2248226|P1|Overall Study|Lost to Follow-up|2
692395|NCT01473589|2248225|P2|Overall Study|Death|0
692396|NCT01473589|2248226|P1|Overall Study|Death|2
692397|NCT01473589|2248225|P2|Overall Study|Adverse Event|1
692398|NCT01473589|2248226|P1|Overall Study|Adverse Event|1
692399|NCT01473563|2248260|P1|Overall Study|Lost to FU post tx discontinuation|1
692400|NCT01473524|2248282|P3|Overall Study|Withdrawal by Subject|1
692401|NCT01473524|2248283|P2|Overall Study|Withdrawal by Subject|1
692402|NCT01473524|2248284|P1|Overall Study|Withdrawal by Subject|2
692403|NCT01473524|2248282|P3|Overall Study|Death|0
692404|NCT01473524|2248283|P2|Overall Study|Death|0
692405|NCT01473524|2248284|P1|Overall Study|Death|1
692406|NCT01473524|2248282|P3|Overall Study|Adverse Event|2
692407|NCT01473524|2248283|P2|Overall Study|Adverse Event|8
692408|NCT01473524|2248284|P1|Overall Study|Adverse Event|4
692409|NCT01473394|2248317|P2|Overall Study|Lost to Follow-up|11
692410|NCT01473394|2248318|P1|Overall Study|Lost to Follow-up|9
692411|NCT01473394|2248317|P2|Overall Study|Withdrew Consent|10
692412|NCT01473394|2248318|P1|Overall Study|Withdrew Consent|12
692413|NCT01473394|2248317|P2|Overall Study|Protocol Violation|5
692414|NCT01473394|2248318|P1|Overall Study|Protocol Violation|7
692415|NCT01473394|2248317|P2|Overall Study|Insufficient Therapeutic Response|1
692416|NCT01473394|2248318|P1|Overall Study|Insufficient Therapeutic Response|4
692417|NCT01473394|2248317|P2|Overall Study|Adverse Event|16
692418|NCT01473394|2248318|P1|Overall Study|Adverse Event|13
692419|NCT01473381|2248332|P4|Overall Study|Other Reasons|3
692420|NCT01473381|2248333|P3|Overall Study|Other Reasons|1
692421|NCT01473381|2248334|P2|Overall Study|Other Reasons|0
692422|NCT01473381|2248335|P1|Overall Study|Other Reasons|0
692423|NCT01473381|2248332|P4|Overall Study|Lost to Follow-up|23
692424|NCT01473381|2248333|P3|Overall Study|Lost to Follow-up|35
692425|NCT01473381|2248334|P2|Overall Study|Lost to Follow-up|28
692426|NCT01473381|2248335|P1|Overall Study|Lost to Follow-up|25
692427|NCT01473381|2248332|P4|Overall Study|Withdrawal of Consent|26
692428|NCT01473381|2248333|P3|Overall Study|Withdrawal of Consent|20
692429|NCT01473381|2248334|P2|Overall Study|Withdrawal of Consent|21
692430|NCT01473381|2248335|P1|Overall Study|Withdrawal of Consent|20
692431|NCT01473381|2248332|P4|Overall Study|Protocol Violation|17
692432|NCT01473381|2248333|P3|Overall Study|Protocol Violation|19
692433|NCT01473381|2248334|P2|Overall Study|Protocol Violation|23
692434|NCT01473381|2248335|P1|Overall Study|Protocol Violation|17
692435|NCT01473381|2248332|P4|Overall Study|Insufficient Therapeutic Response|3
692436|NCT01473381|2248333|P3|Overall Study|Insufficient Therapeutic Response|2
692437|NCT01473381|2248334|P2|Overall Study|Insufficient Therapeutic Response|1
692438|NCT01473381|2248335|P1|Overall Study|Insufficient Therapeutic Response|10
692439|NCT01473381|2248332|P4|Overall Study|Adverse Event|17
692440|NCT01473381|2248333|P3|Overall Study|Adverse Event|25
692441|NCT01473381|2248334|P2|Overall Study|Adverse Event|20
692442|NCT01473381|2248335|P1|Overall Study|Adverse Event|8
692443|NCT01472939|2248419|P4|Overall Study|Withdrawal by Subject|4
692444|NCT01472939|2248420|P3|Overall Study|Withdrawal by Subject|1
692445|NCT01472939|2248421|P2|Overall Study|Withdrawal by Subject|3
692446|NCT01472939|2248422|P1|Overall Study|Withdrawal by Subject|9
692447|NCT01472939|2248419|P4|Overall Study|Protocol Violation|1
692448|NCT01472939|2248420|P3|Overall Study|Protocol Violation|0
692449|NCT01472939|2248421|P2|Overall Study|Protocol Violation|3
692450|NCT01472939|2248422|P1|Overall Study|Protocol Violation|3
692451|NCT01472939|2248419|P4|Overall Study|Withdrawal By PI|0
692452|NCT01472939|2248420|P3|Overall Study|Withdrawal By PI|0
692453|NCT01472939|2248421|P2|Overall Study|Withdrawal By PI|0
692454|NCT01472939|2248422|P1|Overall Study|Withdrawal By PI|1
692455|NCT01472939|2248419|P4|Overall Study|Prohibited Medication|0
692456|NCT01472939|2248420|P3|Overall Study|Prohibited Medication|0
692457|NCT01472939|2248421|P2|Overall Study|Prohibited Medication|1
692458|NCT01472939|2248422|P1|Overall Study|Prohibited Medication|0
692459|NCT01472939|2248419|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
692460|NCT01472939|2248420|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
692461|NCT01472939|2248421|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
692462|NCT01472939|2248422|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
692463|NCT01472939|2248419|P4|Overall Study|Lost to Follow-up|0
692464|NCT01472939|2248420|P3|Overall Study|Lost to Follow-up|2
692465|NCT01472939|2248421|P2|Overall Study|Lost to Follow-up|0
692466|NCT01472939|2248422|P1|Overall Study|Lost to Follow-up|3
692467|NCT01472939|2248419|P4|Overall Study|Lack of Efficacy|1
692468|NCT01472939|2248420|P3|Overall Study|Lack of Efficacy|0
692469|NCT01472939|2248421|P2|Overall Study|Lack of Efficacy|0
692470|NCT01472939|2248422|P1|Overall Study|Lack of Efficacy|1
692471|NCT01472939|2248419|P4|Overall Study|Adverse Event|14
692472|NCT01472939|2248420|P3|Overall Study|Adverse Event|7
692473|NCT01472939|2248421|P2|Overall Study|Adverse Event|7
692474|NCT01472939|2248422|P1|Overall Study|Adverse Event|3
692475|NCT01472835|2248466|P2|Overall Study|Lost to Follow-up|0
692476|NCT01472835|2248467|P1|Overall Study|Lost to Follow-up|2
692477|NCT01472380|2248522|P1|1 Day Period Between Dosing|Protocol Violation|1
692478|NCT01472380|2248522|P1|Efavirenz Alone|Withdrawal by Subject|1
692479|NCT01472341|2248533|P1|Overall Study|Death|9
692480|NCT01472341|2248533|P1|Overall Study|Laboratory parameters unavailable|25
692481|NCT01472341|2248533|P1|Overall Study|Lost to Follow-up|52
692482|NCT01472341|2248533|P1|Overall Study|Withdrawal by Subject|39
692483|NCT01472341|2248533|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
692484|NCT01472341|2248533|P1|Overall Study|Started insulin therapy|55
692485|NCT01472289|2248539|P1|Overall Study|Death|2
692486|NCT01472185|2248551|P2|Overall Study|Subject Withdrew Consent|3
692487|NCT01472185|2248552|P1|Overall Study|Subject Withdrew Consent|6
692488|NCT01472185|2248551|P2|Overall Study|Subject Noncompliance|15
692489|NCT01472185|2248552|P1|Overall Study|Subject Noncompliance|8
692490|NCT01472185|2248551|P2|Overall Study|Protocol Violation|1
692491|NCT01472185|2248552|P1|Overall Study|Protocol Violation|5
692492|NCT01472185|2248551|P2|Overall Study|Lost to Follow-up|1
692493|NCT01472185|2248552|P1|Overall Study|Lost to Follow-up|4
692494|NCT01472185|2248551|P2|Overall Study|Investigator’s Discretion|1
692495|NCT01472185|2248552|P1|Overall Study|Investigator’s Discretion|3
692496|NCT01472185|2248551|P2|Overall Study|Hyperglycemia|2
692497|NCT01472185|2248552|P1|Overall Study|Hyperglycemia|5
692498|NCT01472185|2248551|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
692499|NCT01472185|2248552|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
692500|NCT01472185|2248551|P2|Overall Study|Randomized but Not Treated|1
692501|NCT01472185|2248552|P1|Overall Study|Randomized but Not Treated|0
692502|NCT01471782|2248572|P6|Overall Study|Death|1
692503|NCT01471782|2248573|P5|Overall Study|Death|0
692504|NCT01471782|2248574|P4|Overall Study|Death|0
692505|NCT01471782|2248575|P3|Overall Study|Death|0
692506|NCT01471782|2248576|P2|Overall Study|Death|0
692507|NCT01471782|2248577|P1|Overall Study|Death|0
692508|NCT01471782|2248572|P6|Overall Study|Withdrawal by Parent/Guardian|0
692509|NCT01471782|2248573|P5|Overall Study|Withdrawal by Parent/Guardian|1
692510|NCT01471782|2248574|P4|Overall Study|Withdrawal by Parent/Guardian|0
692511|NCT01471782|2248575|P3|Overall Study|Withdrawal by Parent/Guardian|0
692512|NCT01471782|2248576|P2|Overall Study|Withdrawal by Parent/Guardian|0
692513|NCT01471782|2248577|P1|Overall Study|Withdrawal by Parent/Guardian|0
692514|NCT01471782|2248572|P6|Overall Study|Physician Decision|8
692515|NCT01471782|2248573|P5|Overall Study|Physician Decision|3
692516|NCT01471782|2248574|P4|Overall Study|Physician Decision|0
692517|NCT01471782|2248575|P3|Overall Study|Physician Decision|0
692518|NCT01471782|2248576|P2|Overall Study|Physician Decision|0
692519|NCT01471782|2248577|P1|Overall Study|Physician Decision|0
692520|NCT01471782|2248572|P6|Overall Study|Disease Relapse|1
692521|NCT01471782|2248573|P5|Overall Study|Disease Relapse|2
692522|NCT01471782|2248574|P4|Overall Study|Disease Relapse|1
692523|NCT01471782|2248575|P3|Overall Study|Disease Relapse|0
692524|NCT01471782|2248576|P2|Overall Study|Disease Relapse|0
692525|NCT01471782|2248577|P1|Overall Study|Disease Relapse|0
692526|NCT01471782|2248572|P6|Overall Study|Change of Chemotherapy|4
692527|NCT01471782|2248573|P5|Overall Study|Change of Chemotherapy|1
692528|NCT01471782|2248574|P4|Overall Study|Change of Chemotherapy|0
692529|NCT01471782|2248575|P3|Overall Study|Change of Chemotherapy|0
692530|NCT01471782|2248576|P2|Overall Study|Change of Chemotherapy|1
692531|NCT01471782|2248577|P1|Overall Study|Change of Chemotherapy|1
692532|NCT01471782|2248572|P6|Overall Study|Other|5
692533|NCT01471782|2248573|P5|Overall Study|Other|6
692534|NCT01471782|2248574|P4|Overall Study|Other|1
692535|NCT01471782|2248575|P3|Overall Study|Other|1
692536|NCT01471782|2248576|P2|Overall Study|Other|0
692537|NCT01471782|2248577|P1|Overall Study|Other|0
692538|NCT01471782|2248572|P6|Overall Study|Adverse Event|1
692539|NCT01471782|2248573|P5|Overall Study|Adverse Event|3
692540|NCT01471782|2248574|P4|Overall Study|Adverse Event|2
692541|NCT01471782|2248575|P3|Overall Study|Adverse Event|2
692542|NCT01471782|2248576|P2|Overall Study|Adverse Event|1
692543|NCT01471782|2248577|P1|Overall Study|Adverse Event|1
692544|NCT01471782|2248572|P6|Overall Study|Lack of Efficacy|18
692545|NCT01471782|2248573|P5|Overall Study|Lack of Efficacy|5
692546|NCT01471782|2248574|P4|Overall Study|Lack of Efficacy|1
692547|NCT01471782|2248575|P3|Overall Study|Lack of Efficacy|1
692548|NCT01471782|2248576|P2|Overall Study|Lack of Efficacy|2
692549|NCT01471782|2248577|P1|Overall Study|Lack of Efficacy|1
692550|NCT01471782|2248572|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
692551|NCT01471782|2248573|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
692552|NCT01471782|2248574|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
692553|NCT01471782|2248575|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
692554|NCT01471782|2248576|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
692555|NCT01471782|2248577|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
692556|NCT01471691|2248631|P2|Overall Study|Lack of Efficacy|1
692557|NCT01471691|2248632|P1|Overall Study|Lack of Efficacy|0
692558|NCT01471574|2248651|P4|Follow-up Period|Follow-up no longer required|0
692559|NCT01471574|2248652|P3|Follow-up Period|Follow-up no longer required|0
692560|NCT01471574|2248653|P2|Follow-up Period|Follow-up no longer required|1
692561|NCT01471574|2248654|P1|Follow-up Period|Follow-up no longer required|0
692562|NCT01471574|2248651|P4|Follow-up Period|Death|0
692563|NCT01471574|2248652|P3|Follow-up Period|Death|1
692564|NCT01471574|2248653|P2|Follow-up Period|Death|0
692565|NCT01471574|2248654|P1|Follow-up Period|Death|0
692566|NCT01471574|2248651|P4|Follow-up Period|Lost to Follow-up|2
692567|NCT01471574|2248652|P3|Follow-up Period|Lost to Follow-up|3
692568|NCT01471574|2248653|P2|Follow-up Period|Lost to Follow-up|1
692569|NCT01471574|2248654|P1|Follow-up Period|Lost to Follow-up|4
692570|NCT01471574|2248651|P4|Follow-up Period|Withdrawal by Subject|1
692571|NCT01471574|2248652|P3|Follow-up Period|Withdrawal by Subject|3
692572|NCT01471574|2248653|P2|Follow-up Period|Withdrawal by Subject|0
692573|NCT01471574|2248654|P1|Follow-up Period|Withdrawal by Subject|3
692574|NCT01471574|2248651|P4|Treatment Period|Not specified|0
692575|NCT01471574|2248652|P3|Treatment Period|Not specified|0
692576|NCT01471574|2248653|P2|Treatment Period|Not specified|0
692577|NCT01471574|2248654|P1|Treatment Period|Not specified|1
692578|NCT01471574|2248651|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
692579|NCT01471574|2248652|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
692580|NCT01471574|2248653|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
692581|NCT01471574|2248654|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
692582|NCT01471574|2248651|P4|Treatment Period|Lost to Follow-up|0
692583|NCT01471574|2248652|P3|Treatment Period|Lost to Follow-up|2
692584|NCT01471574|2248653|P2|Treatment Period|Lost to Follow-up|2
692585|NCT01471574|2248654|P1|Treatment Period|Lost to Follow-up|1
692586|NCT01471574|2248651|P4|Treatment Period|Patient Requested Discontinue Study drug|1
692587|NCT01471574|2248652|P3|Treatment Period|Patient Requested Discontinue Study drug|1
692588|NCT01471574|2248653|P2|Treatment Period|Patient Requested Discontinue Study drug|0
692589|NCT01471574|2248654|P1|Treatment Period|Patient Requested Discontinue Study drug|4
692590|NCT01471574|2248651|P4|Treatment Period|Withdrawal by Subject|0
692591|NCT01471574|2248652|P3|Treatment Period|Withdrawal by Subject|1
692592|NCT01471574|2248653|P2|Treatment Period|Withdrawal by Subject|1
692593|NCT01471574|2248654|P1|Treatment Period|Withdrawal by Subject|5
692594|NCT01471574|2248651|P4|Treatment Period|Adverse Event|1
692595|NCT01471574|2248652|P3|Treatment Period|Adverse Event|6
692596|NCT01471574|2248653|P2|Treatment Period|Adverse Event|3
692597|NCT01471574|2248654|P1|Treatment Period|Adverse Event|7
692598|NCT01471574|2248651|P4|Treatment Period|Lack of Efficacy|1
692599|NCT01471574|2248652|P3|Treatment Period|Lack of Efficacy|14
692600|NCT01471574|2248653|P2|Treatment Period|Lack of Efficacy|4
692601|NCT01471574|2248654|P1|Treatment Period|Lack of Efficacy|12
692602|NCT01471379|2248686|P3|Overall Study|Study terminated|0
692603|NCT01471379|2248687|P2|Overall Study|Study terminated|1
692604|NCT01471379|2248688|P1|Overall Study|Study terminated|0
692605|NCT01471379|2248686|P3|Overall Study|Adverse Event|0
692606|NCT01471379|2248687|P2|Overall Study|Adverse Event|0
692607|NCT01471379|2248688|P1|Overall Study|Adverse Event|1
692608|NCT01471353|2248708|P1|Overall Study|remain on study|3
692609|NCT01471197|2248716|P2|Overall Study|Study Drug Toxicity|0
692610|NCT01471197|2248717|P1|Overall Study|Study Drug Toxicity|1
692611|NCT01471197|2248716|P2|Overall Study|Death|0
692612|NCT01471197|2248717|P1|Overall Study|Death|1
692613|NCT01471197|2248716|P2|Overall Study|Disease Progression|2
692614|NCT01471197|2248717|P1|Overall Study|Disease Progression|4
692615|NCT01471171|2248727|P2|Treatment Period 2|Adverse Event|0
692616|NCT01471171|2248728|P1|Treatment Period 2|Adverse Event|1
692617|NCT01471171|2248727|P2|Treatment Period 1|Adverse Event|1
692618|NCT01471171|2248728|P1|Treatment Period 1|Adverse Event|4
692619|NCT01471015|2248746|P3|Overall Study|Death|1
692620|NCT01471015|2248747|P2|Overall Study|Death|1
692621|NCT01471015|2248748|P1|Overall Study|Death|0
692622|NCT01470469|2248790|P2|Overall Study|Not specified|1
692623|NCT01470469|2248791|P1|Overall Study|Not specified|2
692624|NCT01470469|2248790|P2|Overall Study|Protocol Violation|1
692625|NCT01470469|2248791|P1|Overall Study|Protocol Violation|1
692626|NCT01470469|2248790|P2|Overall Study|Lost to Follow-up|2
692627|NCT01470469|2248791|P1|Overall Study|Lost to Follow-up|2
692628|NCT01470469|2248790|P2|Overall Study|Adverse Event|7
692629|NCT01470469|2248791|P1|Overall Study|Adverse Event|0
692630|NCT01470469|2248790|P2|Overall Study|Lack of Efficacy|7
692631|NCT01470469|2248791|P1|Overall Study|Lack of Efficacy|1
692632|NCT01470469|2248790|P2|Overall Study|Withdrawal by Subject|6
692633|NCT01470469|2248791|P1|Overall Study|Withdrawal by Subject|4
692634|NCT01470417|2248811|P2|Overall Study|Disease progression|2
692635|NCT01470417|2248812|P1|Overall Study|Disease progression|0
692636|NCT01470248|2248824|P1|Overall Study|Withdrawal by Subject|1
692637|NCT01470144|2248880|P1|Overall Study|Patient’s and investigator’s decision|1
692638|NCT01470144|2248880|P1|Overall Study|Lung transplant|6
692639|NCT01470144|2248880|P1|Overall Study|Death|1
692640|NCT01470144|2248880|P1|Overall Study|Adverse Event|2
692641|NCT01470001|2248921|P2|Overall Study|Withdrawal by Subject|1
692642|NCT01470001|2248922|P1|Overall Study|Withdrawal by Subject|2
692643|NCT01470001|2248921|P2|Overall Study|Physician Decision|0
692644|NCT01470001|2248922|P1|Overall Study|Physician Decision|2
692645|NCT01470001|2248921|P2|Overall Study|Lost to Follow-up|1
692646|NCT01470001|2248922|P1|Overall Study|Lost to Follow-up|1
692647|NCT01469819|2248932|P1|Overall Study|Technical malfunction of SmartPill data|3
692648|NCT01469819|2248932|P1|Overall Study|Could not swallow SmartPill|2
692649|NCT01469819|2248932|P1|Overall Study|Did not meet inclusionary criteria|2
692650|NCT01469819|2248932|P1|Overall Study|Withdrawal by Subject|1
692651|NCT01469637|2248956|P2|Second Intervention|Incarcerated|0
692652|NCT01469637|2248957|P1|Second Intervention|Incarcerated|1
692653|NCT01469637|2248956|P2|First Intervention|Unacceptable behavior|1
692654|NCT01469637|2248957|P1|First Intervention|Unacceptable behavior|0
692655|NCT01469546|2248965|P1|Received 5 mg Dose|Physician Decision|3
692656|NCT01469546|2248965|P1|Received 5 mg Dose|Progressive Disease|3
692657|NCT01469546|2248965|P1|Received 5 mg Dose|Protocol Violation|2
692658|NCT01469546|2248965|P1|Received 5 mg Dose|Death|2
692659|NCT01469546|2248965|P1|Received 5 mg Dose|Adverse Event|13
692660|NCT01469364|2248972|P1|Overall Study|Withdrawal by Subject|1
692661|NCT01469364|2248972|P1|Overall Study|Adverse Event|1
692662|NCT01469182|2249023|P2|Overall Study|Did not meet Protocol Eligibility|0
692663|NCT01469182|2249024|P1|Overall Study|Did not meet Protocol Eligibility|3
692664|NCT01469182|2249023|P2|Overall Study|Protocol Violation|2
692665|NCT01469182|2249024|P1|Overall Study|Protocol Violation|4
692666|NCT01469182|2249023|P2|Overall Study|Withdrawal by Subject|1
692667|NCT01469182|2249024|P1|Overall Study|Withdrawal by Subject|4
692668|NCT01469182|2249023|P2|Overall Study|Lost to Follow-up|0
692669|NCT01469182|2249024|P1|Overall Study|Lost to Follow-up|3
692670|NCT01469182|2249023|P2|Overall Study|Adverse Event|3
692671|NCT01469182|2249024|P1|Overall Study|Adverse Event|21
692672|NCT01469065|2249051|P5|Overall Study|Not specified|0
692673|NCT01469065|2249052|P4|Overall Study|Not specified|0
692674|NCT01469065|2249053|P3|Overall Study|Not specified|0
692675|NCT01469065|2249054|P2|Overall Study|Not specified|1
692676|NCT01469065|2249055|P1|Overall Study|Not specified|0
692677|NCT01469065|2249051|P5|Overall Study|Lack of Efficacy|1
692678|NCT01469065|2249052|P4|Overall Study|Lack of Efficacy|0
692679|NCT01469065|2249053|P3|Overall Study|Lack of Efficacy|0
692680|NCT01469065|2249054|P2|Overall Study|Lack of Efficacy|0
692681|NCT01469065|2249055|P1|Overall Study|Lack of Efficacy|0
692682|NCT01469052|2249151|P6|Overall Study|Unspecified|0
692683|NCT01469052|2249152|P5|Overall Study|Unspecified|1
692684|NCT01469052|2249153|P4|Overall Study|Unspecified|0
692685|NCT01469052|2249154|P3|Overall Study|Unspecified|0
692686|NCT01469052|2249155|P2|Overall Study|Unspecified|1
692687|NCT01469052|2249156|P1|Overall Study|Unspecified|0
692688|NCT01469052|2249151|P6|Overall Study|Moved to rollover protocol|1
692689|NCT01469052|2249152|P5|Overall Study|Moved to rollover protocol|0
692690|NCT01469052|2249153|P4|Overall Study|Moved to rollover protocol|0
692691|NCT01469052|2249154|P3|Overall Study|Moved to rollover protocol|1
692692|NCT01469052|2249155|P2|Overall Study|Moved to rollover protocol|0
692693|NCT01469052|2249156|P1|Overall Study|Moved to rollover protocol|1
692694|NCT01469052|2249151|P6|Overall Study|Lack of Efficacy|2
692695|NCT01469052|2249152|P5|Overall Study|Lack of Efficacy|0
692696|NCT01469052|2249153|P4|Overall Study|Lack of Efficacy|0
692697|NCT01469052|2249154|P3|Overall Study|Lack of Efficacy|0
692698|NCT01469052|2249155|P2|Overall Study|Lack of Efficacy|0
692699|NCT01469052|2249156|P1|Overall Study|Lack of Efficacy|0
692700|NCT01469052|2249151|P6|Overall Study|Progressive disease|2
692701|NCT01469052|2249152|P5|Overall Study|Progressive disease|7
692702|NCT01469052|2249153|P4|Overall Study|Progressive disease|3
692703|NCT01469052|2249154|P3|Overall Study|Progressive disease|5
692704|NCT01469052|2249155|P2|Overall Study|Progressive disease|0
692705|NCT01469052|2249156|P1|Overall Study|Progressive disease|3
692706|NCT01469052|2249151|P6|Overall Study|Adverse Event|1
692707|NCT01469052|2249152|P5|Overall Study|Adverse Event|0
692708|NCT01469052|2249153|P4|Overall Study|Adverse Event|2
692709|NCT01469052|2249154|P3|Overall Study|Adverse Event|0
692710|NCT01469052|2249155|P2|Overall Study|Adverse Event|3
692711|NCT01469052|2249156|P1|Overall Study|Adverse Event|2
692712|NCT01469000|2249218|P2|Overall Study|On treatment, not yet died or PD|7
692713|NCT01469000|2249219|P1|Overall Study|On treatment, not yet died or PD|23
692714|NCT01469000|2249218|P2|Overall Study|Entry Criteria Not Met|0
692715|NCT01469000|2249219|P1|Overall Study|Entry Criteria Not Met|1
692716|NCT01469000|2249218|P2|Overall Study|Physician Decision|1
692717|NCT01469000|2249219|P1|Overall Study|Physician Decision|0
692718|NCT01469000|2249218|P2|Overall Study|Withdrawal by Subject|1
692719|NCT01469000|2249219|P1|Overall Study|Withdrawal by Subject|9
692720|NCT01468818|2249252|P1|Overall Study|Death during treatment|2
692721|NCT01468311|2249310|P1|Overall Study|Withdrawal by Subject|1
692722|NCT01468311|2249310|P1|Overall Study|mobilization failure|1
692723|NCT01468233|2249322|P6|Treatment Period 2|Not specified|0
692724|NCT01468233|2249323|P5|Treatment Period 2|Not specified|1
692725|NCT01468233|2249324|P4|Treatment Period 2|Not specified|0
692726|NCT01468233|2249325|P3|Treatment Period 2|Not specified|3
692727|NCT01468233|2249326|P2|Treatment Period 2|Not specified|0
692728|NCT01468233|2249327|P1|Treatment Period 2|Not specified|0
692729|NCT01468233|2249322|P6|Treatment Period 2|Lost to Follow-up|0
692730|NCT01468233|2249323|P5|Treatment Period 2|Lost to Follow-up|2
692731|NCT01468233|2249324|P4|Treatment Period 2|Lost to Follow-up|0
692732|NCT01468233|2249325|P3|Treatment Period 2|Lost to Follow-up|3
692733|NCT01468233|2249326|P2|Treatment Period 2|Lost to Follow-up|0
692734|NCT01468233|2249327|P1|Treatment Period 2|Lost to Follow-up|0
692735|NCT01468233|2249322|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
692736|NCT01468233|2249323|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
692737|NCT01468233|2249324|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
692738|NCT01468233|2249325|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
692739|NCT01468233|2249326|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
692740|NCT01468233|2249327|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
692741|NCT01468233|2249322|P6|Treatment Period 2|Withdrawal by Subject|1
692742|NCT01468233|2249323|P5|Treatment Period 2|Withdrawal by Subject|1
692743|NCT01468233|2249324|P4|Treatment Period 2|Withdrawal by Subject|1
692744|NCT01468233|2249325|P3|Treatment Period 2|Withdrawal by Subject|9
692745|NCT01468233|2249326|P2|Treatment Period 2|Withdrawal by Subject|0
692746|NCT01468233|2249327|P1|Treatment Period 2|Withdrawal by Subject|0
692747|NCT01468233|2249322|P6|Treatment Period 2|Lack of Efficacy|1
692748|NCT01468233|2249323|P5|Treatment Period 2|Lack of Efficacy|0
692749|NCT01468233|2249324|P4|Treatment Period 2|Lack of Efficacy|2
692750|NCT01468233|2249325|P3|Treatment Period 2|Lack of Efficacy|9
692751|NCT01468233|2249326|P2|Treatment Period 2|Lack of Efficacy|0
692752|NCT01468233|2249327|P1|Treatment Period 2|Lack of Efficacy|0
692753|NCT01468233|2249322|P6|Treatment Period 2|Adverse Event|1
692754|NCT01468233|2249323|P5|Treatment Period 2|Adverse Event|2
692755|NCT01468233|2249324|P4|Treatment Period 2|Adverse Event|0
692756|NCT01468233|2249325|P3|Treatment Period 2|Adverse Event|3
692757|NCT01468233|2249326|P2|Treatment Period 2|Adverse Event|0
692758|NCT01468233|2249327|P1|Treatment Period 2|Adverse Event|0
692759|NCT01468233|2249322|P6|Treatment Period 1|Not specified|0
692760|NCT01468233|2249323|P5|Treatment Period 1|Not specified|0
692761|NCT01468233|2249324|P4|Treatment Period 1|Not specified|0
692762|NCT01468233|2249325|P3|Treatment Period 1|Not specified|0
692763|NCT01468233|2249326|P2|Treatment Period 1|Not specified|1
692764|NCT01468233|2249327|P1|Treatment Period 1|Not specified|1
692765|NCT01468233|2249322|P6|Treatment Period 1|Lost to Follow-up|0
692766|NCT01468233|2249323|P5|Treatment Period 1|Lost to Follow-up|0
692767|NCT01468233|2249324|P4|Treatment Period 1|Lost to Follow-up|0
692768|NCT01468233|2249325|P3|Treatment Period 1|Lost to Follow-up|0
692769|NCT01468233|2249326|P2|Treatment Period 1|Lost to Follow-up|0
692770|NCT01468233|2249327|P1|Treatment Period 1|Lost to Follow-up|3
692771|NCT01468233|2249322|P6|Treatment Period 1|Withdrawal by Subject|0
692772|NCT01468233|2249323|P5|Treatment Period 1|Withdrawal by Subject|0
692773|NCT01468233|2249324|P4|Treatment Period 1|Withdrawal by Subject|0
692774|NCT01468233|2249325|P3|Treatment Period 1|Withdrawal by Subject|0
692775|NCT01468233|2249326|P2|Treatment Period 1|Withdrawal by Subject|4
692776|NCT01468233|2249327|P1|Treatment Period 1|Withdrawal by Subject|3
692777|NCT01468233|2249322|P6|Treatment Period 1|Adverse Event|0
692778|NCT01468233|2249323|P5|Treatment Period 1|Adverse Event|0
692779|NCT01468233|2249324|P4|Treatment Period 1|Adverse Event|0
692780|NCT01468233|2249325|P3|Treatment Period 1|Adverse Event|0
692781|NCT01468233|2249326|P2|Treatment Period 1|Adverse Event|3
692782|NCT01468233|2249327|P1|Treatment Period 1|Adverse Event|5
692783|NCT01468207|2249349|P6|Treatment Period 2|Not specified|2
692784|NCT01468207|2249350|P5|Treatment Period 2|Not specified|1
692785|NCT01468207|2249351|P4|Treatment Period 2|Not specified|1
692786|NCT01468207|2249352|P3|Treatment Period 2|Not specified|5
692787|NCT01468207|2249353|P2|Treatment Period 2|Not specified|0
692788|NCT01468207|2249354|P1|Treatment Period 2|Not specified|0
692789|NCT01468207|2249349|P6|Treatment Period 2|Lost to Follow-up|0
692790|NCT01468207|2249350|P5|Treatment Period 2|Lost to Follow-up|0
692791|NCT01468207|2249351|P4|Treatment Period 2|Lost to Follow-up|1
692792|NCT01468207|2249352|P3|Treatment Period 2|Lost to Follow-up|5
692793|NCT01468207|2249353|P2|Treatment Period 2|Lost to Follow-up|0
692794|NCT01468207|2249354|P1|Treatment Period 2|Lost to Follow-up|0
692795|NCT01468207|2249349|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
692796|NCT01468207|2249350|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
692797|NCT01468207|2249351|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
692798|NCT01468207|2249352|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
692799|NCT01468207|2249353|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
692800|NCT01468207|2249354|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
692801|NCT01468207|2249349|P6|Treatment Period 2|Withdrawal by Subject|2
692802|NCT01468207|2249350|P5|Treatment Period 2|Withdrawal by Subject|0
692803|NCT01468207|2249351|P4|Treatment Period 2|Withdrawal by Subject|0
692804|NCT01468207|2249352|P3|Treatment Period 2|Withdrawal by Subject|5
692805|NCT01468207|2249353|P2|Treatment Period 2|Withdrawal by Subject|0
692806|NCT01468207|2249354|P1|Treatment Period 2|Withdrawal by Subject|0
692807|NCT01468207|2249349|P6|Treatment Period 2|Lack of Efficacy|2
692808|NCT01468207|2249350|P5|Treatment Period 2|Lack of Efficacy|0
692809|NCT01468207|2249351|P4|Treatment Period 2|Lack of Efficacy|1
692810|NCT01468207|2249352|P3|Treatment Period 2|Lack of Efficacy|1
692811|NCT01468207|2249353|P2|Treatment Period 2|Lack of Efficacy|0
692812|NCT01468207|2249354|P1|Treatment Period 2|Lack of Efficacy|0
692813|NCT01468207|2249349|P6|Treatment Period 2|Adverse Event|1
692814|NCT01468207|2249350|P5|Treatment Period 2|Adverse Event|2
692815|NCT01468207|2249351|P4|Treatment Period 2|Adverse Event|1
692816|NCT01468207|2249352|P3|Treatment Period 2|Adverse Event|6
692817|NCT01468207|2249353|P2|Treatment Period 2|Adverse Event|0
692818|NCT01468207|2249354|P1|Treatment Period 2|Adverse Event|0
692819|NCT01468207|2249349|P6|Treatment Period 1|Not specified|0
692820|NCT01468207|2249350|P5|Treatment Period 1|Not specified|0
692821|NCT01468207|2249351|P4|Treatment Period 1|Not specified|0
692822|NCT01468207|2249352|P3|Treatment Period 1|Not specified|0
692823|NCT01468207|2249353|P2|Treatment Period 1|Not specified|2
692824|NCT01468207|2249354|P1|Treatment Period 1|Not specified|0
692825|NCT01468207|2249349|P6|Treatment Period 1|Lost to Follow-up|0
692826|NCT01468207|2249350|P5|Treatment Period 1|Lost to Follow-up|0
692827|NCT01468207|2249351|P4|Treatment Period 1|Lost to Follow-up|0
692828|NCT01468207|2249352|P3|Treatment Period 1|Lost to Follow-up|0
692829|NCT01468207|2249353|P2|Treatment Period 1|Lost to Follow-up|1
692830|NCT01468207|2249354|P1|Treatment Period 1|Lost to Follow-up|2
692831|NCT01468207|2249349|P6|Treatment Period 1|Withdrawal by Subject|0
692832|NCT01468207|2249350|P5|Treatment Period 1|Withdrawal by Subject|0
692833|NCT01468207|2249351|P4|Treatment Period 1|Withdrawal by Subject|0
692834|NCT01468207|2249352|P3|Treatment Period 1|Withdrawal by Subject|0
692835|NCT01468207|2249353|P2|Treatment Period 1|Withdrawal by Subject|4
692836|NCT01468207|2249354|P1|Treatment Period 1|Withdrawal by Subject|5
692837|NCT01468207|2249349|P6|Treatment Period 1|Protocol Violation|0
692838|NCT01468207|2249350|P5|Treatment Period 1|Protocol Violation|0
692839|NCT01468207|2249351|P4|Treatment Period 1|Protocol Violation|0
692840|NCT01468207|2249352|P3|Treatment Period 1|Protocol Violation|0
692841|NCT01468207|2249353|P2|Treatment Period 1|Protocol Violation|1
692842|NCT01468207|2249354|P1|Treatment Period 1|Protocol Violation|1
692843|NCT01468207|2249349|P6|Treatment Period 1|Adverse Event|0
692844|NCT01468207|2249350|P5|Treatment Period 1|Adverse Event|0
692845|NCT01468207|2249351|P4|Treatment Period 1|Adverse Event|0
692846|NCT01468207|2249352|P3|Treatment Period 1|Adverse Event|0
692847|NCT01468207|2249353|P2|Treatment Period 1|Adverse Event|0
692848|NCT01468207|2249354|P1|Treatment Period 1|Adverse Event|1
692849|NCT01468181|2249379|P5|Overall Study|Withdrawal by Subject|0
692850|NCT01468181|2249380|P4|Overall Study|Withdrawal by Subject|0
692851|NCT01468181|2249381|P3|Overall Study|Withdrawal by Subject|0
692852|NCT01468181|2249382|P2|Overall Study|Withdrawal by Subject|1
692853|NCT01468181|2249383|P1|Overall Study|Withdrawal by Subject|0
692854|NCT01468181|2249379|P5|Overall Study|Lost to Follow-up|1
692855|NCT01468181|2249380|P4|Overall Study|Lost to Follow-up|0
692856|NCT01468181|2249381|P3|Overall Study|Lost to Follow-up|1
692857|NCT01468181|2249382|P2|Overall Study|Lost to Follow-up|0
692858|NCT01468181|2249383|P1|Overall Study|Lost to Follow-up|0
692859|NCT01468181|2249379|P5|Overall Study|Physician Decision|1
692860|NCT01468181|2249380|P4|Overall Study|Physician Decision|1
692861|NCT01468181|2249381|P3|Overall Study|Physician Decision|0
692862|NCT01468181|2249382|P2|Overall Study|Physician Decision|0
692863|NCT01468181|2249383|P1|Overall Study|Physician Decision|0
692864|NCT01468181|2249379|P5|Overall Study|Protocol Violation|1
692865|NCT01468181|2249380|P4|Overall Study|Protocol Violation|0
692866|NCT01468181|2249381|P3|Overall Study|Protocol Violation|1
692867|NCT01468181|2249382|P2|Overall Study|Protocol Violation|0
692868|NCT01468181|2249383|P1|Overall Study|Protocol Violation|2
692869|NCT01468181|2249379|P5|Overall Study|Adverse Event|2
692870|NCT01468181|2249380|P4|Overall Study|Adverse Event|2
692871|NCT01468181|2249381|P3|Overall Study|Adverse Event|6
692872|NCT01468181|2249382|P2|Overall Study|Adverse Event|1
692873|NCT01468181|2249383|P1|Overall Study|Adverse Event|8
692874|NCT01468077|2249432|P2|Overall Study|Physician Decision|0
692875|NCT01468077|2249433|P1|Overall Study|Physician Decision|1
692876|NCT01468077|2249432|P2|Overall Study|Lack of Efficacy|1
692877|NCT01468077|2249433|P1|Overall Study|Lack of Efficacy|1
692878|NCT01468077|2249432|P2|Overall Study|Adverse Event|2
692879|NCT01468077|2249433|P1|Overall Study|Adverse Event|2
692880|NCT01467960|2249486|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
692881|NCT01467960|2249487|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
692882|NCT01467960|2249488|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
692883|NCT01467960|2249489|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
692884|NCT01467960|2249490|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
692885|NCT01467960|2249491|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
692886|NCT01467713|2249550|P4|Overall Study|Reason not Specified|7
692887|NCT01467713|2249551|P3|Overall Study|Reason not Specified|8
692888|NCT01467713|2249552|P2|Overall Study|Reason not Specified|11
692889|NCT01467713|2249553|P1|Overall Study|Reason not Specified|6
692890|NCT01467713|2249550|P4|Overall Study|Relapse|35
692891|NCT01467713|2249551|P3|Overall Study|Relapse|28
692892|NCT01467713|2249552|P2|Overall Study|Relapse|25
692893|NCT01467713|2249553|P1|Overall Study|Relapse|35
692894|NCT01467713|2249550|P4|Overall Study|Pregnancy|3
692895|NCT01467713|2249551|P3|Overall Study|Pregnancy|1
692896|NCT01467713|2249552|P2|Overall Study|Pregnancy|1
692897|NCT01467713|2249553|P1|Overall Study|Pregnancy|0
692898|NCT01467713|2249550|P4|Overall Study|Study Termination|29
692899|NCT01467713|2249551|P3|Overall Study|Study Termination|28
692900|NCT01467713|2249552|P2|Overall Study|Study Termination|33
692901|NCT01467713|2249553|P1|Overall Study|Study Termination|23
692902|NCT01467713|2249550|P4|Overall Study|Voluntary Withdrawal|20
692903|NCT01467713|2249551|P3|Overall Study|Voluntary Withdrawal|21
692904|NCT01467713|2249552|P2|Overall Study|Voluntary Withdrawal|14
692905|NCT01467713|2249553|P1|Overall Study|Voluntary Withdrawal|18
692906|NCT01467713|2249550|P4|Overall Study|Lost to Follow-up|9
692907|NCT01467713|2249551|P3|Overall Study|Lost to Follow-up|6
692908|NCT01467713|2249552|P2|Overall Study|Lost to Follow-up|12
692909|NCT01467713|2249553|P1|Overall Study|Lost to Follow-up|9
692910|NCT01467713|2249550|P4|Overall Study|Major Protocol Deviation|1
692911|NCT01467713|2249551|P3|Overall Study|Major Protocol Deviation|4
692912|NCT01467713|2249552|P2|Overall Study|Major Protocol Deviation|4
692913|NCT01467713|2249553|P1|Overall Study|Major Protocol Deviation|2
692914|NCT01467713|2249550|P4|Overall Study|Pretreatment Event or Adverse Event|5
692915|NCT01467713|2249551|P3|Overall Study|Pretreatment Event or Adverse Event|6
692916|NCT01467713|2249552|P2|Overall Study|Pretreatment Event or Adverse Event|4
692917|NCT01467713|2249553|P1|Overall Study|Pretreatment Event or Adverse Event|9
692918|NCT01467700|2249607|P4|Overall Study|Reason not Specified|8
692919|NCT01467700|2249608|P3|Overall Study|Reason not Specified|2
692920|NCT01467700|2249609|P2|Overall Study|Reason not Specified|3
692921|NCT01467700|2249610|P1|Overall Study|Reason not Specified|1
692922|NCT01467700|2249607|P4|Overall Study|Lack of Efficacy|1
692923|NCT01467700|2249608|P3|Overall Study|Lack of Efficacy|2
692924|NCT01467700|2249609|P2|Overall Study|Lack of Efficacy|0
692925|NCT01467700|2249610|P1|Overall Study|Lack of Efficacy|2
692926|NCT01467700|2249607|P4|Overall Study|Pregnancy|0
692927|NCT01467700|2249608|P3|Overall Study|Pregnancy|1
692928|NCT01467700|2249609|P2|Overall Study|Pregnancy|1
692929|NCT01467700|2249610|P1|Overall Study|Pregnancy|0
692930|NCT01467700|2249607|P4|Overall Study|Study Termination|7
692931|NCT01467700|2249608|P3|Overall Study|Study Termination|10
692932|NCT01467700|2249609|P2|Overall Study|Study Termination|5
692933|NCT01467700|2249610|P1|Overall Study|Study Termination|6
692934|NCT01467700|2249607|P4|Overall Study|Voluntary Withdrawal|2
692935|NCT01467700|2249608|P3|Overall Study|Voluntary Withdrawal|6
692936|NCT01467700|2249609|P2|Overall Study|Voluntary Withdrawal|7
692937|NCT01467700|2249610|P1|Overall Study|Voluntary Withdrawal|5
692938|NCT01467700|2249607|P4|Overall Study|Lost to Follow-up|3
692939|NCT01467700|2249608|P3|Overall Study|Lost to Follow-up|2
692940|NCT01467700|2249609|P2|Overall Study|Lost to Follow-up|5
692941|NCT01467700|2249610|P1|Overall Study|Lost to Follow-up|6
692942|NCT01467700|2249607|P4|Overall Study|Major Protocol Deviation|3
692943|NCT01467700|2249608|P3|Overall Study|Major Protocol Deviation|2
692944|NCT01467700|2249609|P2|Overall Study|Major Protocol Deviation|3
692945|NCT01467700|2249610|P1|Overall Study|Major Protocol Deviation|3
692946|NCT01467700|2249607|P4|Overall Study|Pretreatment Event or Adverse Event|3
692947|NCT01467700|2249608|P3|Overall Study|Pretreatment Event or Adverse Event|2
692948|NCT01467700|2249609|P2|Overall Study|Pretreatment Event or Adverse Event|4
692949|NCT01467700|2249610|P1|Overall Study|Pretreatment Event or Adverse Event|6
692950|NCT01467661|2249652|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
692951|NCT01467661|2249652|P1|Overall Study|Lack of Efficacy|3
692952|NCT01467661|2249652|P1|Overall Study|Withdrawal by Subject|1
692953|NCT01467661|2249652|P1|Overall Study|Adverse Event|16
692954|NCT01467583|2249672|P3|Overall Study|Protocol Violation|2
692955|NCT01467583|2249673|P2|Overall Study|Protocol Violation|0
692956|NCT01467583|2249674|P1|Overall Study|Protocol Violation|0
692957|NCT01467583|2249672|P3|Overall Study|Withdrawal by Subject|0
692958|NCT01467583|2249673|P2|Overall Study|Withdrawal by Subject|0
692959|NCT01467583|2249674|P1|Overall Study|Withdrawal by Subject|1
692960|NCT01467583|2249672|P3|Overall Study|Death|0
692961|NCT01467583|2249673|P2|Overall Study|Death|1
692962|NCT01467583|2249674|P1|Overall Study|Death|1
692963|NCT01467570|2249687|P2|Overall Study|Lost to Follow-up|9
692964|NCT01467570|2249688|P1|Overall Study|Lost to Follow-up|8
692965|NCT01467505|2249725|P2|Overall Study|Study Terminated by Sponsor|3
692966|NCT01467505|2249726|P1|Overall Study|Study Terminated by Sponsor|28
692967|NCT01467505|2249725|P2|Overall Study|Withdrawal by Subject|0
692968|NCT01467505|2249726|P1|Overall Study|Withdrawal by Subject|4
692969|NCT01467505|2249725|P2|Overall Study|Adverse Event|0
692970|NCT01467505|2249726|P1|Overall Study|Adverse Event|1
692971|NCT01467492|2249758|P2|Overall Study|Enrolled But Not Treated|0
692972|NCT01467492|2249759|P1|Overall Study|Enrolled But Not Treated|1
692973|NCT01467492|2249758|P2|Overall Study|Undefined|0
692974|NCT01467492|2249759|P1|Overall Study|Undefined|2
692975|NCT01467492|2249758|P2|Overall Study|Lost to Follow-up|2
692976|NCT01467492|2249759|P1|Overall Study|Lost to Follow-up|3
692977|NCT01467492|2249758|P2|Overall Study|Adverse Event|3
692978|NCT01467492|2249759|P1|Overall Study|Adverse Event|4
692979|NCT01467492|2249758|P2|Overall Study|Study Terminated by Sponsor|4
692980|NCT01467492|2249759|P1|Overall Study|Study Terminated by Sponsor|6
692981|NCT01467492|2249758|P2|Overall Study|Withdrawal by Subject|4
692982|NCT01467492|2249759|P1|Overall Study|Withdrawal by Subject|6
692983|NCT01467479|2249783|P3|Overall Study|Unspecified|0
692984|NCT01467479|2249784|P2|Overall Study|Unspecified|0
692985|NCT01467479|2249785|P1|Overall Study|Unspecified|1
692986|NCT01467479|2249783|P3|Overall Study|Study Terminated by Sponsor|3
692987|NCT01467479|2249784|P2|Overall Study|Study Terminated by Sponsor|3
692988|NCT01467479|2249785|P1|Overall Study|Study Terminated by Sponsor|1
692989|NCT01467479|2249783|P3|Overall Study|Withdrawal of Consent|7
692990|NCT01467479|2249784|P2|Overall Study|Withdrawal of Consent|7
692991|NCT01467479|2249785|P1|Overall Study|Withdrawal of Consent|3
692992|NCT01467479|2249783|P3|Overall Study|Lost to Follow-up|3
692993|NCT01467479|2249784|P2|Overall Study|Lost to Follow-up|5
692994|NCT01467479|2249785|P1|Overall Study|Lost to Follow-up|2
692995|NCT01467479|2249783|P3|Overall Study|Death|1
692996|NCT01467479|2249784|P2|Overall Study|Death|0
692997|NCT01467479|2249785|P1|Overall Study|Death|0
692998|NCT01467479|2249783|P3|Overall Study|Adverse Event|0
692999|NCT01467479|2249784|P2|Overall Study|Adverse Event|2
693000|NCT01467479|2249785|P1|Overall Study|Adverse Event|1
693001|NCT01467479|2249783|P3|Overall Study|No Study Medication|2
693002|NCT01467479|2249784|P2|Overall Study|No Study Medication|0
693003|NCT01467479|2249785|P1|Overall Study|No Study Medication|1
693004|NCT01467076|2249815|P3|Overall Study|Lost to Follow-up|0
693005|NCT01467076|2249816|P2|Overall Study|Lost to Follow-up|0
693006|NCT01467076|2249817|P1|Overall Study|Lost to Follow-up|1
693007|NCT01466881|2249834|P1|Overall Study|Other reason not protocol specified|5
693008|NCT01466881|2249834|P1|Overall Study|Death|4
693009|NCT01466881|2249834|P1|Overall Study|Progression/relapse|20
693010|NCT01466881|2249834|P1|Overall Study|Adverse Event|6
693011|NCT01466881|2249834|P1|Overall Study|Ineligible|5
693012|NCT01466790|2249851|P8|Overall Study|Withdrawal by Subject|1
693013|NCT01466790|2249852|P7|Overall Study|Withdrawal by Subject|1
693014|NCT01466790|2249853|P6|Overall Study|Withdrawal by Subject|0
693015|NCT01466790|2249854|P5|Overall Study|Withdrawal by Subject|1
693016|NCT01466790|2249855|P4|Overall Study|Withdrawal by Subject|0
693017|NCT01466790|2249856|P3|Overall Study|Withdrawal by Subject|0
693018|NCT01466790|2249857|P2|Overall Study|Withdrawal by Subject|1
693019|NCT01466790|2249858|P1|Overall Study|Withdrawal by Subject|1
693020|NCT01466790|2249851|P8|Overall Study|Lost to Follow-up|0
693021|NCT01466790|2249852|P7|Overall Study|Lost to Follow-up|0
693022|NCT01466790|2249853|P6|Overall Study|Lost to Follow-up|0
693023|NCT01466790|2249854|P5|Overall Study|Lost to Follow-up|0
693024|NCT01466790|2249855|P4|Overall Study|Lost to Follow-up|0
693025|NCT01466790|2249856|P3|Overall Study|Lost to Follow-up|0
693026|NCT01466790|2249857|P2|Overall Study|Lost to Follow-up|0
693027|NCT01466790|2249858|P1|Overall Study|Lost to Follow-up|2
693028|NCT01466790|2249851|P8|Overall Study|Adverse Event|0
693029|NCT01466790|2249852|P7|Overall Study|Adverse Event|0
693030|NCT01466790|2249853|P6|Overall Study|Adverse Event|0
693031|NCT01466790|2249854|P5|Overall Study|Adverse Event|2
693032|NCT01466790|2249855|P4|Overall Study|Adverse Event|0
693033|NCT01466790|2249856|P3|Overall Study|Adverse Event|0
693034|NCT01466790|2249857|P2|Overall Study|Adverse Event|0
693035|NCT01466790|2249858|P1|Overall Study|Adverse Event|1
693036|NCT01466673|2249943|P2|Overall Study|Adverse Event|1
693037|NCT01466673|2249944|P1|Overall Study|Adverse Event|2
693038|NCT01466673|2249943|P2|Overall Study|Lost to Follow-up|5
693039|NCT01466673|2249944|P1|Overall Study|Lost to Follow-up|3
693040|NCT01466673|2249943|P2|Overall Study|Non-compliance with study treatment|0
693041|NCT01466673|2249944|P1|Overall Study|Non-compliance with study treatment|2
889266|NCT01372410|2823755|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
889267|NCT01372410|2823756|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
889268|NCT01372410|2823757|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
889269|NCT01372410|2823758|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
889270|NCT01372410|2823759|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
889271|NCT01372410|2823760|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
889272|NCT01372410|2823753|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
889273|NCT01372410|2823754|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
889274|NCT01372410|2823755|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
889275|NCT01372410|2823756|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
889276|NCT01372410|2823757|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
889277|NCT01372410|2823758|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
693054|NCT01466595|2249997|P2|Overall Study|Withdrawal by Subject|1
693055|NCT01466595|2249998|P1|Overall Study|Withdrawal by Subject|0
693056|NCT01466491|2250092|P4|Overall Study|Missing Data|0
693057|NCT01466491|2250093|P3|Overall Study|Missing Data|1
693058|NCT01466491|2250094|P2|Overall Study|Missing Data|0
693059|NCT01466491|2250095|P1|Overall Study|Missing Data|0
693060|NCT01466491|2250092|P4|Overall Study|Protocol Violation|0
693061|NCT01466491|2250093|P3|Overall Study|Protocol Violation|2
693062|NCT01466491|2250094|P2|Overall Study|Protocol Violation|3
693063|NCT01466491|2250095|P1|Overall Study|Protocol Violation|0
889278|NCT01372410|2823759|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
889279|NCT01372410|2823760|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
889280|NCT01372410|2823753|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889281|NCT01372410|2823754|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
889282|NCT01372410|2823755|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889283|NCT01372410|2823756|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889284|NCT01372410|2823757|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889285|NCT01372410|2823758|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889286|NCT01372410|2823759|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889287|NCT01372410|2823760|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
889288|NCT01372410|2823753|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889289|NCT01372410|2823754|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889290|NCT01372410|2823755|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889291|NCT01372410|2823756|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
693082|NCT01466348|2250181|P2|Period I - First Intervention|Withdrawal by Subject|1
693083|NCT01466348|2250182|P1|Period I - First Intervention|Withdrawal by Subject|0
693084|NCT01466270|2250210|P2|Overall Study|Multiple|1
693085|NCT01466270|2250211|P1|Overall Study|Multiple|1
693086|NCT01466270|2250210|P2|Overall Study|Toxicity|1
693087|NCT01466270|2250211|P1|Overall Study|Toxicity|4
693088|NCT01466270|2250210|P2|Overall Study|Progression|0
693089|NCT01466270|2250211|P1|Overall Study|Progression|1
693090|NCT01466270|2250210|P2|Overall Study|Lost to Follow-up|3
693091|NCT01466270|2250211|P1|Overall Study|Lost to Follow-up|1
693092|NCT01466270|2250210|P2|Overall Study|Physician Decision|0
693093|NCT01466270|2250211|P1|Overall Study|Physician Decision|1
693094|NCT01466270|2250210|P2|Overall Study|Withdrawal by Subject|1
693095|NCT01466270|2250211|P1|Overall Study|Withdrawal by Subject|4
693096|NCT01466192|2250223|P1|Overall Study|Withdrawal by Subject|3
693097|NCT01466192|2250223|P1|Overall Study|Physician Decision|1
693098|NCT01466179|2250227|P1|Overall Study|Other|3
693099|NCT01466179|2250227|P1|Overall Study|Protocol Violation|2
693100|NCT01466179|2250227|P1|Overall Study|Withdrawal by Subject|7
693101|NCT01466179|2250227|P1|Overall Study|Death|7
693102|NCT01466179|2250227|P1|Overall Study|Lack of Efficacy|14
693103|NCT01466179|2250227|P1|Overall Study|Disease relapse|23
693104|NCT01466179|2250227|P1|Overall Study|Adverse Event|32
693105|NCT01466179|2250227|P1|Overall Study|Progressive disease|43
693106|NCT01466179|2250227|P1|Overall Study|Physician Decision|46
693107|NCT01466179|2250227|P1|Overall Study|Ongoing in core study|2
693108|NCT01466153|2250250|P3|Overall Study|Other-Unspecified|2
693109|NCT01466153|2250251|P2|Overall Study|Other-Unspecified|4
693110|NCT01466153|2250252|P1|Overall Study|Other-Unspecified|6
693111|NCT01466153|2250250|P3|Overall Study|Randomized-Not Treated|4
693112|NCT01466153|2250251|P2|Overall Study|Randomized-Not Treated|3
693113|NCT01466153|2250252|P1|Overall Study|Randomized-Not Treated|2
693114|NCT01466153|2250250|P3|Overall Study|Investigator Discretion|2
693115|NCT01466153|2250251|P2|Overall Study|Investigator Discretion|2
693116|NCT01466153|2250252|P1|Overall Study|Investigator Discretion|3
693117|NCT01466153|2250250|P3|Overall Study|Withdrawal of Consent|0
693118|NCT01466153|2250251|P2|Overall Study|Withdrawal of Consent|0
693119|NCT01466153|2250252|P1|Overall Study|Withdrawal of Consent|2
693120|NCT01466153|2250250|P3|Overall Study|Adverse Event|17
693121|NCT01466153|2250251|P2|Overall Study|Adverse Event|13
693122|NCT01466153|2250252|P1|Overall Study|Adverse Event|14
693123|NCT01466153|2250250|P3|Overall Study|Disease Progression|0
693124|NCT01466153|2250251|P2|Overall Study|Disease Progression|2
693125|NCT01466153|2250252|P1|Overall Study|Disease Progression|2
693126|NCT01466062|2250307|P1|Overall Study|Withdrawal by Subject|1
693127|NCT01466062|2250307|P1|Overall Study|Adverse Event|1
889292|NCT01372410|2823757|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889293|NCT01372410|2823758|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889294|NCT01372410|2823759|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889295|NCT01372410|2823760|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
889296|NCT01372410|2823753|P8|Treatment Period 1 (7 Days)|Adverse Event|0
889297|NCT01372410|2823754|P7|Treatment Period 1 (7 Days)|Adverse Event|1
889298|NCT01372410|2823755|P6|Treatment Period 1 (7 Days)|Adverse Event|0
889299|NCT01372410|2823756|P5|Treatment Period 1 (7 Days)|Adverse Event|0
889300|NCT01372410|2823757|P4|Treatment Period 1 (7 Days)|Adverse Event|0
889301|NCT01372410|2823758|P3|Treatment Period 1 (7 Days)|Adverse Event|0
889302|NCT01372410|2823759|P2|Treatment Period 1 (7 Days)|Adverse Event|1
889303|NCT01372410|2823760|P1|Treatment Period 1 (7 Days)|Adverse Event|0
889304|NCT01372410|2823753|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
889305|NCT01372410|2823754|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
889306|NCT01372410|2823755|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
889307|NCT01372410|2823756|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
889308|NCT01372410|2823757|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
889309|NCT01372410|2823758|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
889310|NCT01372410|2823759|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
889311|NCT01372410|2823760|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
889312|NCT01369355|2823810|P6|Overall Study|Not Treated|0
889313|NCT01369355|2823811|P5|Overall Study|Not Treated|0
889314|NCT01369355|2823812|P4|Overall Study|Not Treated|0
693154|NCT01465958|2250341|P2|Subcutaneous (SC) Phase|Adverse Event|1
693155|NCT01465958|2250342|P1|Subcutaneous (SC) Phase|Adverse Event|0
693156|NCT01465958|2250341|P2|Run-in Phase|Protocol Violation|0
693157|NCT01465958|2250342|P1|Run-in Phase|Protocol Violation|1
693158|NCT01465802|2250355|P5|Overall Study|Death|2
693159|NCT01465802|2250356|P4|Overall Study|Death|10
693160|NCT01465802|2250357|P3|Overall Study|Death|0
693161|NCT01465802|2250358|P2|Overall Study|Death|12
693162|NCT01465802|2250359|P1|Overall Study|Death|15
693163|NCT01465802|2250355|P5|Overall Study|Reason not specified|2
693164|NCT01465802|2250356|P4|Overall Study|Reason not specified|10
693165|NCT01465802|2250357|P3|Overall Study|Reason not specified|0
693166|NCT01465802|2250358|P2|Overall Study|Reason not specified|4
693167|NCT01465802|2250359|P1|Overall Study|Reason not specified|9
693168|NCT01465802|2250355|P5|Overall Study|Lost to Follow-up|0
693169|NCT01465802|2250356|P4|Overall Study|Lost to Follow-up|0
693170|NCT01465802|2250357|P3|Overall Study|Lost to Follow-up|0
693171|NCT01465802|2250358|P2|Overall Study|Lost to Follow-up|1
693172|NCT01465802|2250359|P1|Overall Study|Lost to Follow-up|1
693173|NCT01465802|2250355|P5|Overall Study|Withdrawal by Subject|1
693174|NCT01465802|2250356|P4|Overall Study|Withdrawal by Subject|8
693175|NCT01465802|2250357|P3|Overall Study|Withdrawal by Subject|0
693176|NCT01465802|2250358|P2|Overall Study|Withdrawal by Subject|7
693177|NCT01465802|2250359|P1|Overall Study|Withdrawal by Subject|7
693178|NCT01465802|2250355|P5|Overall Study|Study terminated by sponsor|7
693179|NCT01465802|2250356|P4|Overall Study|Study terminated by sponsor|1
693180|NCT01465802|2250357|P3|Overall Study|Study terminated by sponsor|0
693181|NCT01465802|2250358|P2|Overall Study|Study terminated by sponsor|0
693182|NCT01465802|2250359|P1|Overall Study|Study terminated by sponsor|1
693183|NCT01465763|2250411|P3|Overall Study|Death|0
693184|NCT01465763|2250412|P2|Overall Study|Death|0
693185|NCT01465763|2250413|P1|Overall Study|Death|1
693186|NCT01465763|2250411|P3|Overall Study|Protocol Violation|1
693187|NCT01465763|2250412|P2|Overall Study|Protocol Violation|1
693188|NCT01465763|2250413|P1|Overall Study|Protocol Violation|4
693189|NCT01465763|2250411|P3|Overall Study|Unspecified|0
693190|NCT01465763|2250412|P2|Overall Study|Unspecified|0
693191|NCT01465763|2250413|P1|Overall Study|Unspecified|2
693192|NCT01465763|2250411|P3|Overall Study|Adverse Event|1
693193|NCT01465763|2250412|P2|Overall Study|Adverse Event|0
693194|NCT01465763|2250413|P1|Overall Study|Adverse Event|9
693195|NCT01465763|2250411|P3|Overall Study|Insufficient Clinical Response|1
693196|NCT01465763|2250412|P2|Overall Study|Insufficient Clinical Response|0
693197|NCT01465763|2250413|P1|Overall Study|Insufficient Clinical Response|11
693198|NCT01465763|2250411|P3|Overall Study|Withdrawal by Subject|1
693199|NCT01465763|2250412|P2|Overall Study|Withdrawal by Subject|0
693200|NCT01465763|2250413|P1|Overall Study|Withdrawal by Subject|4
693201|NCT01465386|2250483|P1|Overall Study|Adverse Event|1
693202|NCT01465386|2250483|P1|Overall Study|Lack of Efficacy|3
693203|NCT01465347|2250487|P2|Overall Study|Admitted to hospice|1
693204|NCT01465347|2250488|P1|Overall Study|Admitted to hospice|0
693205|NCT01465347|2250487|P2|Overall Study|Physician Decision|1
693206|NCT01465347|2250488|P1|Overall Study|Physician Decision|0
693207|NCT01465347|2250487|P2|Overall Study|Withdrawal by Subject|1
693208|NCT01465347|2250488|P1|Overall Study|Withdrawal by Subject|1
693209|NCT01465230|2250498|P1|Overall Study|Withdrawal by Subject|2
693210|NCT01465178|2250504|P2|Overall Study|Withdrawal by Subject|0
693211|NCT01465178|2250505|P1|Overall Study|Withdrawal by Subject|1
693212|NCT01465022|2250529|P3|Overall Study|Not Randomized|70
693213|NCT01465022|2250530|P2|Overall Study|Not Randomized|0
693214|NCT01465022|2250531|P1|Overall Study|Not Randomized|0
693215|NCT01465022|2250529|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
693216|NCT01465022|2250530|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
693217|NCT01465022|2250531|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
693218|NCT01465022|2250529|P3|Overall Study|Lost to Follow-up|0
693219|NCT01465022|2250530|P2|Overall Study|Lost to Follow-up|14
693220|NCT01465022|2250531|P1|Overall Study|Lost to Follow-up|15
693221|NCT01464931|2250565|P2|Overall Study|Withdrawal by Subject|0
693222|NCT01464931|2250566|P1|Overall Study|Withdrawal by Subject|1
693223|NCT01464879|2250603|P1|Overall Study|Non-compliance|1
693224|NCT01464879|2250603|P1|Overall Study|Physician Decision|1
693225|NCT01464827|2250664|P14|Overall Study|Not Treated|2
693226|NCT01464827|2250665|P13|Overall Study|Not Treated|0
693227|NCT01464827|2250666|P12|Overall Study|Not Treated|1
693228|NCT01464827|2250667|P11|Overall Study|Not Treated|0
693229|NCT01464827|2250668|P10|Overall Study|Not Treated|2
693230|NCT01464827|2250669|P9|Overall Study|Not Treated|0
693231|NCT01464827|2250670|P8|Overall Study|Not Treated|0
693232|NCT01464827|2250671|P7|Overall Study|Not Treated|1
693233|NCT01464827|2250672|P6|Overall Study|Not Treated|0
693234|NCT01464827|2250673|P5|Overall Study|Not Treated|1
693235|NCT01464827|2250674|P4|Overall Study|Not Treated|0
693236|NCT01464827|2250675|P3|Overall Study|Not Treated|0
693237|NCT01464827|2250676|P2|Overall Study|Not Treated|2
693238|NCT01464827|2250677|P1|Overall Study|Not Treated|0
693239|NCT01464827|2250664|P14|Overall Study|Other|0
693240|NCT01464827|2250665|P13|Overall Study|Other|1
693241|NCT01464827|2250666|P12|Overall Study|Other|0
693242|NCT01464827|2250667|P11|Overall Study|Other|2
693243|NCT01464827|2250668|P10|Overall Study|Other|1
693244|NCT01464827|2250669|P9|Overall Study|Other|3
693245|NCT01464827|2250670|P8|Overall Study|Other|0
693246|NCT01464827|2250671|P7|Overall Study|Other|1
693247|NCT01464827|2250672|P6|Overall Study|Other|0
693248|NCT01464827|2250673|P5|Overall Study|Other|3
693249|NCT01464827|2250674|P4|Overall Study|Other|2
693250|NCT01464827|2250675|P3|Overall Study|Other|0
693251|NCT01464827|2250676|P2|Overall Study|Other|3
693252|NCT01464827|2250677|P1|Overall Study|Other|2
693253|NCT01464827|2250664|P14|Overall Study|Lost to Follow-up|1
693254|NCT01464827|2250665|P13|Overall Study|Lost to Follow-up|0
693255|NCT01464827|2250666|P12|Overall Study|Lost to Follow-up|1
693256|NCT01464827|2250667|P11|Overall Study|Lost to Follow-up|0
693257|NCT01464827|2250668|P10|Overall Study|Lost to Follow-up|0
693258|NCT01464827|2250669|P9|Overall Study|Lost to Follow-up|0
693259|NCT01464827|2250670|P8|Overall Study|Lost to Follow-up|2
693260|NCT01464827|2250671|P7|Overall Study|Lost to Follow-up|2
693261|NCT01464827|2250672|P6|Overall Study|Lost to Follow-up|1
693262|NCT01464827|2250673|P5|Overall Study|Lost to Follow-up|3
693263|NCT01464827|2250674|P4|Overall Study|Lost to Follow-up|2
693264|NCT01464827|2250675|P3|Overall Study|Lost to Follow-up|0
693265|NCT01464827|2250676|P2|Overall Study|Lost to Follow-up|2
693266|NCT01464827|2250677|P1|Overall Study|Lost to Follow-up|0
693267|NCT01464827|2250664|P14|Overall Study|Withdrawal by Subject|0
693268|NCT01464827|2250665|P13|Overall Study|Withdrawal by Subject|0
693269|NCT01464827|2250666|P12|Overall Study|Withdrawal by Subject|0
693270|NCT01464827|2250667|P11|Overall Study|Withdrawal by Subject|0
693271|NCT01464827|2250668|P10|Overall Study|Withdrawal by Subject|0
693272|NCT01464827|2250669|P9|Overall Study|Withdrawal by Subject|0
693273|NCT01464827|2250670|P8|Overall Study|Withdrawal by Subject|1
693274|NCT01464827|2250671|P7|Overall Study|Withdrawal by Subject|0
693275|NCT01464827|2250672|P6|Overall Study|Withdrawal by Subject|0
693276|NCT01464827|2250673|P5|Overall Study|Withdrawal by Subject|1
693277|NCT01464827|2250674|P4|Overall Study|Withdrawal by Subject|0
693278|NCT01464827|2250675|P3|Overall Study|Withdrawal by Subject|0
693279|NCT01464827|2250676|P2|Overall Study|Withdrawal by Subject|0
693280|NCT01464827|2250677|P1|Overall Study|Withdrawal by Subject|1
693281|NCT01464827|2250664|P14|Overall Study|Adverse Event|0
693282|NCT01464827|2250665|P13|Overall Study|Adverse Event|1
693283|NCT01464827|2250666|P12|Overall Study|Adverse Event|0
693284|NCT01464827|2250667|P11|Overall Study|Adverse Event|0
693285|NCT01464827|2250668|P10|Overall Study|Adverse Event|0
693286|NCT01464827|2250669|P9|Overall Study|Adverse Event|0
693287|NCT01464827|2250670|P8|Overall Study|Adverse Event|0
693288|NCT01464827|2250671|P7|Overall Study|Adverse Event|0
693289|NCT01464827|2250672|P6|Overall Study|Adverse Event|0
693290|NCT01464827|2250673|P5|Overall Study|Adverse Event|0
693291|NCT01464827|2250674|P4|Overall Study|Adverse Event|0
693292|NCT01464827|2250675|P3|Overall Study|Adverse Event|0
693293|NCT01464827|2250676|P2|Overall Study|Adverse Event|0
693294|NCT01464827|2250677|P1|Overall Study|Adverse Event|0
693295|NCT01464788|2250724|P3|Overall Study|Patient had hemorrhage after tPA started|0
693296|NCT01464788|2250725|P2|Overall Study|Patient had hemorrhage after tPA started|1
693297|NCT01464788|2250726|P1|Overall Study|Patient had hemorrhage after tPA started|0
693298|NCT01464788|2250724|P3|Overall Study|Lost to Follow-up|0
693299|NCT01464788|2250725|P2|Overall Study|Lost to Follow-up|1
693300|NCT01464788|2250726|P1|Overall Study|Lost to Follow-up|0
693301|NCT01464619|2250739|P2|Overall Study|Lost to Follow-up|4
693302|NCT01464619|2250740|P1|Overall Study|Lost to Follow-up|3
693303|NCT01464424|2250760|P2|Period 1, First 6 Weeks|Adverse Event|1
693304|NCT01464424|2250761|P1|Period 1, First 6 Weeks|Adverse Event|0
693305|NCT01464307|2250783|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
693306|NCT01464307|2250784|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
693307|NCT01464307|2250783|P2|Open-Label Extension Period|Non-compliance|0
693308|NCT01464307|2250784|P1|Open-Label Extension Period|Non-compliance|9
693309|NCT01464307|2250783|P2|Open-Label Extension Period|Lost to Follow-up|0
693310|NCT01464307|2250784|P1|Open-Label Extension Period|Lost to Follow-up|1
693311|NCT01464307|2250783|P2|Open-Label Extension Period|Death|0
693312|NCT01464307|2250784|P1|Open-Label Extension Period|Death|1
693313|NCT01464307|2250783|P2|Open-Label Extension Period|Lack of Efficacy|0
693314|NCT01464307|2250784|P1|Open-Label Extension Period|Lack of Efficacy|5
693315|NCT01464307|2250783|P2|Open-Label Extension Period|Withdrawal by Subject|0
693316|NCT01464307|2250784|P1|Open-Label Extension Period|Withdrawal by Subject|14
693317|NCT01464307|2250783|P2|Open-Label Extension Period|Adverse Event|0
693318|NCT01464307|2250784|P1|Open-Label Extension Period|Adverse Event|15
693319|NCT01464307|2250783|P2|Main Period|Predefined discontinuation criteria|1
693320|NCT01464307|2250784|P1|Main Period|Predefined discontinuation criteria|2
693321|NCT01464307|2250783|P2|Main Period|Withdrawal by Subject|2
693322|NCT01464307|2250784|P1|Main Period|Withdrawal by Subject|5
693323|NCT01464307|2250783|P2|Main Period|Lack of Efficacy|0
693324|NCT01464307|2250784|P1|Main Period|Lack of Efficacy|2
693325|NCT01464307|2250783|P2|Main Period|Adverse Event|1
693326|NCT01464307|2250784|P1|Main Period|Adverse Event|6
693327|NCT01464307|2250783|P2|Main Period|Death|1
693328|NCT01464307|2250784|P1|Main Period|Death|0
693329|NCT01464255|2250799|P2|Overall Study|unresolve corneal staining|1
693330|NCT01464255|2250800|P1|Overall Study|unresolve corneal staining|0
693331|NCT01464021|2250845|P1|Overall Study|various|11
693332|NCT01464021|2250845|P1|Overall Study|Lack of Efficacy|1
693333|NCT01464021|2250845|P1|Overall Study|Lost to Follow-up|1
693334|NCT01464021|2250845|P1|Overall Study|Withdrawal by Subject|13
693335|NCT01463982|2250861|P4|Overall Study|Treatment delay over 5 week|0
693336|NCT01463982|2250862|P3|Overall Study|Treatment delay over 5 week|1
693337|NCT01463982|2250863|P2|Overall Study|Treatment delay over 5 week|0
693338|NCT01463982|2250864|P1|Overall Study|Treatment delay over 5 week|0
693339|NCT01463982|2250861|P4|Overall Study|Withdrawal by Subject|0
693340|NCT01463982|2250862|P3|Overall Study|Withdrawal by Subject|1
693341|NCT01463982|2250863|P2|Overall Study|Withdrawal by Subject|1
693342|NCT01463982|2250864|P1|Overall Study|Withdrawal by Subject|0
693343|NCT01463878|2250880|P2|Overall Study|no longer met criteria for tube feed|2
693344|NCT01463878|2250881|P1|Overall Study|no longer met criteria for tube feed|2
693345|NCT01463696|2250895|P8|Overall Study|Not Treated|0
693346|NCT01463696|2250896|P7|Overall Study|Not Treated|1
693347|NCT01463696|2250897|P6|Overall Study|Not Treated|0
693348|NCT01463696|2250898|P5|Overall Study|Not Treated|0
693349|NCT01463696|2250899|P4|Overall Study|Not Treated|0
693350|NCT01463696|2250900|P3|Overall Study|Not Treated|0
693351|NCT01463696|2250901|P2|Overall Study|Not Treated|0
693352|NCT01463696|2250902|P1|Overall Study|Not Treated|0
693353|NCT01463696|2250895|P8|Overall Study|Withdrawal by Subject|0
693354|NCT01463696|2250896|P7|Overall Study|Withdrawal by Subject|2
693355|NCT01463696|2250897|P6|Overall Study|Withdrawal by Subject|1
693356|NCT01463696|2250898|P5|Overall Study|Withdrawal by Subject|1
693357|NCT01463696|2250899|P4|Overall Study|Withdrawal by Subject|1
693358|NCT01463696|2250900|P3|Overall Study|Withdrawal by Subject|0
693359|NCT01463696|2250901|P2|Overall Study|Withdrawal by Subject|0
693360|NCT01463696|2250902|P1|Overall Study|Withdrawal by Subject|0
693361|NCT01463696|2250895|P8|Overall Study|Progressive Disease|2
693362|NCT01463696|2250896|P7|Overall Study|Progressive Disease|4
693363|NCT01463696|2250897|P6|Overall Study|Progressive Disease|1
693364|NCT01463696|2250898|P5|Overall Study|Progressive Disease|0
693365|NCT01463696|2250899|P4|Overall Study|Progressive Disease|1
693366|NCT01463696|2250900|P3|Overall Study|Progressive Disease|0
693367|NCT01463696|2250901|P2|Overall Study|Progressive Disease|1
693368|NCT01463696|2250902|P1|Overall Study|Progressive Disease|0
693369|NCT01463696|2250895|P8|Overall Study|Lost to Follow-up|0
693370|NCT01463696|2250896|P7|Overall Study|Lost to Follow-up|0
693371|NCT01463696|2250897|P6|Overall Study|Lost to Follow-up|0
693372|NCT01463696|2250898|P5|Overall Study|Lost to Follow-up|0
693373|NCT01463696|2250899|P4|Overall Study|Lost to Follow-up|0
693374|NCT01463696|2250900|P3|Overall Study|Lost to Follow-up|1
693375|NCT01463696|2250901|P2|Overall Study|Lost to Follow-up|0
693376|NCT01463696|2250902|P1|Overall Study|Lost to Follow-up|0
693377|NCT01463696|2250895|P8|Overall Study|Adverse Event|2
693378|NCT01463696|2250896|P7|Overall Study|Adverse Event|3
693379|NCT01463696|2250897|P6|Overall Study|Adverse Event|1
693380|NCT01463696|2250898|P5|Overall Study|Adverse Event|0
693381|NCT01463696|2250899|P4|Overall Study|Adverse Event|2
693382|NCT01463696|2250900|P3|Overall Study|Adverse Event|0
693383|NCT01463696|2250901|P2|Overall Study|Adverse Event|1
693384|NCT01463696|2250902|P1|Overall Study|Adverse Event|0
693385|NCT01463683|2250955|P3|Overall Study|Withdrawal by Subject|2
693386|NCT01463683|2250956|P2|Overall Study|Withdrawal by Subject|17
693387|NCT01463683|2250957|P1|Overall Study|Withdrawal by Subject|5
693388|NCT01463683|2250955|P3|Overall Study|Pregnancy|1
693389|NCT01463683|2250956|P2|Overall Study|Pregnancy|2
693390|NCT01463683|2250957|P1|Overall Study|Pregnancy|2
693391|NCT01463683|2250955|P3|Overall Study|Physician Decision|1
693392|NCT01463683|2250956|P2|Overall Study|Physician Decision|3
693393|NCT01463683|2250957|P1|Overall Study|Physician Decision|0
693394|NCT01463683|2250955|P3|Overall Study|Lost to Follow-up|7
693395|NCT01463683|2250956|P2|Overall Study|Lost to Follow-up|9
693396|NCT01463683|2250957|P1|Overall Study|Lost to Follow-up|10
693397|NCT01463683|2250955|P3|Overall Study|Adverse Event|0
693398|NCT01463683|2250956|P2|Overall Study|Adverse Event|0
693399|NCT01463683|2250957|P1|Overall Study|Adverse Event|2
889315|NCT01369355|2823813|P3|Overall Study|Not Treated|1
889316|NCT01369355|2823814|P2|Overall Study|Not Treated|0
889317|NCT01369355|2823815|P1|Overall Study|Not Treated|0
889318|NCT01369355|2823810|P6|Overall Study|Other|0
693404|NCT01463293|2250994|P3|Overall Study|Other|2
693405|NCT01463293|2250995|P2|Overall Study|Other|0
693406|NCT01463293|2250996|P1|Overall Study|Other|0
693407|NCT01463293|2250994|P3|Overall Study|Withdrawal by Subject|5
693408|NCT01463293|2250995|P2|Overall Study|Withdrawal by Subject|10
693409|NCT01463293|2250996|P1|Overall Study|Withdrawal by Subject|4
693410|NCT01463293|2250994|P3|Overall Study|Adverse Event|0
693411|NCT01463293|2250995|P2|Overall Study|Adverse Event|2
693412|NCT01463293|2250996|P1|Overall Study|Adverse Event|1
693413|NCT01463293|2250994|P3|Overall Study|Lost to Follow-up|5
693414|NCT01463293|2250995|P2|Overall Study|Lost to Follow-up|4
693415|NCT01463293|2250996|P1|Overall Study|Lost to Follow-up|1
693416|NCT01463111|2251004|P1|Overall Study|Physician Decision|2
693417|NCT01463111|2251004|P1|Overall Study|Lost to Follow-up|5
693418|NCT01463111|2251004|P1|Overall Study|Withdrawal by Subject|2
693419|NCT01463033|2251014|P2|Overall Study|Death|2
693420|NCT01463033|2251015|P1|Overall Study|Death|3
693421|NCT01463033|2251014|P2|Overall Study|Lost to Follow-up|4
693422|NCT01463033|2251015|P1|Overall Study|Lost to Follow-up|4
693423|NCT01463007|2251022|P1|Overall Study|Physician Decision|1
693424|NCT01462942|2251033|P5|Overall Study|Protocol Violation|6
693425|NCT01462942|2251034|P4|Overall Study|Protocol Violation|9
693426|NCT01462942|2251035|P3|Overall Study|Protocol Violation|9
693427|NCT01462942|2251036|P2|Overall Study|Protocol Violation|6
693428|NCT01462942|2251037|P1|Overall Study|Protocol Violation|4
693429|NCT01462942|2251033|P5|Overall Study|Lost to Follow-up|1
693430|NCT01462942|2251034|P4|Overall Study|Lost to Follow-up|1
693431|NCT01462942|2251035|P3|Overall Study|Lost to Follow-up|1
693432|NCT01462942|2251036|P2|Overall Study|Lost to Follow-up|1
693433|NCT01462942|2251037|P1|Overall Study|Lost to Follow-up|0
693434|NCT01462942|2251033|P5|Overall Study|Lack of Efficacy|3
693435|NCT01462942|2251034|P4|Overall Study|Lack of Efficacy|5
889319|NCT01369355|2823811|P5|Overall Study|Other|1
693436|NCT01462942|2251035|P3|Overall Study|Lack of Efficacy|4
693437|NCT01462942|2251036|P2|Overall Study|Lack of Efficacy|0
693438|NCT01462942|2251037|P1|Overall Study|Lack of Efficacy|6
693439|NCT01462942|2251033|P5|Overall Study|Withdrawal by Subject|19
693440|NCT01462942|2251034|P4|Overall Study|Withdrawal by Subject|16
693441|NCT01462942|2251035|P3|Overall Study|Withdrawal by Subject|14
693442|NCT01462942|2251036|P2|Overall Study|Withdrawal by Subject|10
693443|NCT01462942|2251037|P1|Overall Study|Withdrawal by Subject|14
693444|NCT01462942|2251033|P5|Overall Study|Other, including COPD exacerbation|5
693445|NCT01462942|2251034|P4|Overall Study|Other, including COPD exacerbation|8
693446|NCT01462942|2251035|P3|Overall Study|Other, including COPD exacerbation|2
693447|NCT01462942|2251036|P2|Overall Study|Other, including COPD exacerbation|5
693448|NCT01462942|2251037|P1|Overall Study|Other, including COPD exacerbation|3
693449|NCT01462942|2251033|P5|Overall Study|Adverse Event|11
693450|NCT01462942|2251034|P4|Overall Study|Adverse Event|11
693451|NCT01462942|2251035|P3|Overall Study|Adverse Event|10
693452|NCT01462942|2251036|P2|Overall Study|Adverse Event|12
693453|NCT01462942|2251037|P1|Overall Study|Adverse Event|7
693454|NCT01462929|2251067|P3|Overall Study|Lack of Efficacy|1
693455|NCT01462929|2251068|P2|Overall Study|Lack of Efficacy|0
693456|NCT01462929|2251069|P1|Overall Study|Lack of Efficacy|0
693457|NCT01462929|2251067|P3|Overall Study|Withdrawal by Subject|0
693458|NCT01462929|2251068|P2|Overall Study|Withdrawal by Subject|1
693459|NCT01462929|2251069|P1|Overall Study|Withdrawal by Subject|2
693460|NCT01462929|2251067|P3|Overall Study|Adverse Event|4
693461|NCT01462929|2251068|P2|Overall Study|Adverse Event|3
693462|NCT01462929|2251069|P1|Overall Study|Adverse Event|3
693463|NCT01462695|2251110|P2|Overall Study|Inevaluable (did not receive study drug)|0
693464|NCT01462695|2251111|P1|Overall Study|Inevaluable (did not receive study drug)|1
693465|NCT01462695|2251110|P2|Overall Study|Withdrawal by Subject|0
693466|NCT01462695|2251111|P1|Overall Study|Withdrawal by Subject|2
693467|NCT01462695|2251110|P2|Overall Study|Physician Decision|0
693468|NCT01462695|2251111|P1|Overall Study|Physician Decision|5
693469|NCT01462695|2251110|P2|Overall Study|Lack of Efficacy|12
693470|NCT01462695|2251111|P1|Overall Study|Lack of Efficacy|6
693471|NCT01462695|2251110|P2|Overall Study|Death|0
693472|NCT01462695|2251111|P1|Overall Study|Death|2
693473|NCT01462695|2251110|P2|Overall Study|Adverse Event|1
693474|NCT01462695|2251111|P1|Overall Study|Adverse Event|1
693475|NCT01462435|2251121|P4|Overall Study|Lost to Follow-up|1
693476|NCT01462435|2251122|P3|Overall Study|Lost to Follow-up|0
693477|NCT01462435|2251123|P2|Overall Study|Lost to Follow-up|0
693478|NCT01462435|2251124|P1|Overall Study|Lost to Follow-up|0
693479|NCT01462435|2251121|P4|Overall Study|Withdrawal by Subject|1
693480|NCT01462435|2251122|P3|Overall Study|Withdrawal by Subject|0
693481|NCT01462435|2251123|P2|Overall Study|Withdrawal by Subject|0
693482|NCT01462435|2251124|P1|Overall Study|Withdrawal by Subject|0
693483|NCT01462435|2251121|P4|Overall Study|Physician Decision|0
693484|NCT01462435|2251122|P3|Overall Study|Physician Decision|1
693485|NCT01462435|2251123|P2|Overall Study|Physician Decision|0
693486|NCT01462435|2251124|P1|Overall Study|Physician Decision|0
693487|NCT01462435|2251121|P4|Overall Study|Lack of Efficacy|3
693488|NCT01462435|2251122|P3|Overall Study|Lack of Efficacy|0
693489|NCT01462435|2251123|P2|Overall Study|Lack of Efficacy|0
693490|NCT01462435|2251124|P1|Overall Study|Lack of Efficacy|1
693491|NCT01462370|2251162|P2|Overall Study|Withdrawal by Subject|3
693492|NCT01462370|2251163|P1|Overall Study|Withdrawal by Subject|0
693493|NCT01462370|2251162|P2|Overall Study|Physician Decision|1
693494|NCT01462370|2251163|P1|Overall Study|Physician Decision|0
693495|NCT01462370|2251162|P2|Overall Study|Lack of Qualifying Event|1
693496|NCT01462370|2251163|P1|Overall Study|Lack of Qualifying Event|1
693497|NCT01462357|2251198|P3|Month 24|Migrated/moved from study area|0
693498|NCT01462357|2251199|P2|Month 24|Migrated/moved from study area|2
693499|NCT01462357|2251200|P1|Month 24|Migrated/moved from study area|0
693500|NCT01462357|2251198|P3|Month 24|Lost to Follow-up|6
693501|NCT01462357|2251199|P2|Month 24|Lost to Follow-up|4
693502|NCT01462357|2251200|P1|Month 24|Lost to Follow-up|2
693503|NCT01462357|2251198|P3|Month 24|Withdrawal by Subject|3
693504|NCT01462357|2251199|P2|Month 24|Withdrawal by Subject|8
693505|NCT01462357|2251200|P1|Month 24|Withdrawal by Subject|2
693506|NCT01462357|2251198|P3|Month 18|Unspecified|1
693507|NCT01462357|2251199|P2|Month 18|Unspecified|1
693508|NCT01462357|2251200|P1|Month 18|Unspecified|0
693509|NCT01462357|2251198|P3|Month 18|Lost to Follow-up|5
693510|NCT01462357|2251199|P2|Month 18|Lost to Follow-up|4
693511|NCT01462357|2251200|P1|Month 18|Lost to Follow-up|1
693512|NCT01462357|2251198|P3|Month 18|Withdrawal by Subject|3
693513|NCT01462357|2251199|P2|Month 18|Withdrawal by Subject|6
693514|NCT01462357|2251200|P1|Month 18|Withdrawal by Subject|2
693515|NCT01462357|2251198|P3|Month 12|Lost to Follow-up|5
693516|NCT01462357|2251199|P2|Month 12|Lost to Follow-up|4
693517|NCT01462357|2251200|P1|Month 12|Lost to Follow-up|1
693518|NCT01462357|2251198|P3|Month 12|Withdrawal by Subject|3
693519|NCT01462357|2251199|P2|Month 12|Withdrawal by Subject|6
693520|NCT01462357|2251200|P1|Month 12|Withdrawal by Subject|2
693521|NCT01462357|2251198|P3|Month 7|Withdrawal by Subject|6
693522|NCT01462357|2251199|P2|Month 7|Withdrawal by Subject|5
693523|NCT01462357|2251200|P1|Month 7|Withdrawal by Subject|1
889320|NCT01369355|2823812|P4|Overall Study|Other|0
889321|NCT01369355|2823813|P3|Overall Study|Other|0
889322|NCT01369355|2823814|P2|Overall Study|Other|0
889323|NCT01369355|2823815|P1|Overall Study|Other|0
889324|NCT01369355|2823810|P6|Overall Study|Withdrawal by Subject|22
889325|NCT01369355|2823811|P5|Overall Study|Withdrawal by Subject|8
889326|NCT01369355|2823812|P4|Overall Study|Withdrawal by Subject|6
889327|NCT01369355|2823813|P3|Overall Study|Withdrawal by Subject|7
889328|NCT01369355|2823814|P2|Overall Study|Withdrawal by Subject|2
889329|NCT01369355|2823815|P1|Overall Study|Withdrawal by Subject|6
889330|NCT01369355|2823810|P6|Overall Study|Lost to Follow-up|6
889331|NCT01369355|2823811|P5|Overall Study|Lost to Follow-up|5
693536|NCT01462318|2251296|P3|Extension Phase|Adverse Event|22
693537|NCT01462318|2251297|P2|Extension Phase|Adverse Event|0
693538|NCT01462318|2251298|P1|Extension Phase|Adverse Event|0
693539|NCT01462318|2251296|P3|Extension Phase|Investigator Decision|5
693540|NCT01462318|2251297|P2|Extension Phase|Investigator Decision|0
693541|NCT01462318|2251298|P1|Extension Phase|Investigator Decision|0
693542|NCT01462318|2251296|P3|Extension Phase|Withdrawal by Subject|15
693543|NCT01462318|2251297|P2|Extension Phase|Withdrawal by Subject|0
693544|NCT01462318|2251298|P1|Extension Phase|Withdrawal by Subject|0
693545|NCT01462318|2251296|P3|Extension Phase|Disease Progression|1
693546|NCT01462318|2251297|P2|Extension Phase|Disease Progression|0
693547|NCT01462318|2251298|P1|Extension Phase|Disease Progression|0
693548|NCT01462318|2251296|P3|Extension Phase|Not Specified|1
693549|NCT01462318|2251297|P2|Extension Phase|Not Specified|0
693550|NCT01462318|2251298|P1|Extension Phase|Not Specified|0
693551|NCT01462318|2251296|P3|Extension Phase|Lost to Follow-up|1
693552|NCT01462318|2251297|P2|Extension Phase|Lost to Follow-up|0
693553|NCT01462318|2251298|P1|Extension Phase|Lost to Follow-up|0
693554|NCT01462318|2251296|P3|Main Study / TP-DI Study|Adverse Event|0
693555|NCT01462318|2251297|P2|Main Study / TP-DI Study|Adverse Event|0
693556|NCT01462318|2251298|P1|Main Study / TP-DI Study|Adverse Event|4
693557|NCT01462318|2251296|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
693558|NCT01462318|2251297|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
693559|NCT01462318|2251298|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
693560|NCT01462318|2251296|P3|Main Study / TP-DI Study|Not Specified|0
693561|NCT01462318|2251297|P2|Main Study / TP-DI Study|Not Specified|0
693562|NCT01462318|2251298|P1|Main Study / TP-DI Study|Not Specified|2
693563|NCT01462266|2251321|P2|Overall Study|Screen failure|1
693564|NCT01462266|2251322|P1|Overall Study|Screen failure|1
693565|NCT01462266|2251321|P2|Overall Study|Withdrawal by Subject|2
693566|NCT01462266|2251322|P1|Overall Study|Withdrawal by Subject|7
693567|NCT01462266|2251321|P2|Overall Study|Protocol Violation|3
693568|NCT01462266|2251322|P1|Overall Study|Protocol Violation|1
693569|NCT01462266|2251321|P2|Overall Study|Physician Decision|5
693570|NCT01462266|2251322|P1|Overall Study|Physician Decision|2
693571|NCT01462266|2251321|P2|Overall Study|Creatinine and eGFR, excluded medication|4
693572|NCT01462266|2251322|P1|Overall Study|Creatinine and eGFR, excluded medication|8
693573|NCT01462266|2251321|P2|Overall Study|Non-compliance with study drug|0
693574|NCT01462266|2251322|P1|Overall Study|Non-compliance with study drug|3
693575|NCT01462266|2251321|P2|Overall Study|Lost to Follow-up|3
693576|NCT01462266|2251322|P1|Overall Study|Lost to Follow-up|4
693577|NCT01462266|2251321|P2|Overall Study|Lack of Efficacy|2
693578|NCT01462266|2251322|P1|Overall Study|Lack of Efficacy|0
693579|NCT01462266|2251321|P2|Overall Study|Death|1
693580|NCT01462266|2251322|P1|Overall Study|Death|2
693581|NCT01462266|2251321|P2|Overall Study|Adverse Event|6
693582|NCT01462266|2251322|P1|Overall Study|Adverse Event|7
693583|NCT01462227|2251338|P4|Second Assignment|Protocol Violation|0
693584|NCT01462227|2251339|P3|Second Assignment|Protocol Violation|1
693585|NCT01462227|2251340|P2|Second Assignment|Protocol Violation|1
693586|NCT01462227|2251341|P1|Second Assignment|Protocol Violation|0
693587|NCT01462227|2251338|P4|Second Assignment|Lost to Follow-up|0
693588|NCT01462227|2251339|P3|Second Assignment|Lost to Follow-up|0
693589|NCT01462227|2251340|P2|Second Assignment|Lost to Follow-up|0
693590|NCT01462227|2251341|P1|Second Assignment|Lost to Follow-up|1
693591|NCT01462162|2251359|P1|Overall Study|Unspecified|2
693592|NCT01462162|2251359|P1|Overall Study|Abnormal laboratory parameters|1
693593|NCT01462162|2251359|P1|Overall Study|Lack of Efficacy|4
693594|NCT01462162|2251359|P1|Overall Study|Adverse Event|5
693595|NCT01462084|2251384|P2|Overall Study|Protocol Violation|1
693596|NCT01462084|2251385|P1|Overall Study|Protocol Violation|1
693597|NCT01462084|2251384|P2|Overall Study|Withdrawal by Subject|0
693598|NCT01462084|2251385|P1|Overall Study|Withdrawal by Subject|1
693599|NCT01462045|2251396|P3|Overall Study|Family matter|0
693600|NCT01462045|2251397|P2|Overall Study|Family matter|1
693601|NCT01462045|2251398|P1|Overall Study|Family matter|0
693602|NCT01461993|2251412|P3|Overall Study|Unspecified|6
693603|NCT01461993|2251413|P2|Overall Study|Unspecified|15
693604|NCT01461993|2251414|P1|Overall Study|Unspecified|13
693605|NCT01461993|2251412|P3|Overall Study|Did not meet entrance criteria|0
693606|NCT01461993|2251413|P2|Overall Study|Did not meet entrance criteria|3
693607|NCT01461993|2251414|P1|Overall Study|Did not meet entrance criteria|2
693608|NCT01461993|2251412|P3|Overall Study|No longer met eligibility criteria|10
693609|NCT01461993|2251413|P2|Overall Study|No longer met eligibility criteria|18
693610|NCT01461993|2251414|P1|Overall Study|No longer met eligibility criteria|13
693611|NCT01461993|2251412|P3|Overall Study|Adverse Event|3
693612|NCT01461993|2251413|P2|Overall Study|Adverse Event|11
693613|NCT01461993|2251414|P1|Overall Study|Adverse Event|9
693614|NCT01461993|2251412|P3|Overall Study|Protocol Violation|7
693615|NCT01461993|2251413|P2|Overall Study|Protocol Violation|9
693616|NCT01461993|2251414|P1|Overall Study|Protocol Violation|10
693617|NCT01461993|2251412|P3|Overall Study|Lost to Follow-up|22
693618|NCT01461993|2251413|P2|Overall Study|Lost to Follow-up|48
693619|NCT01461993|2251414|P1|Overall Study|Lost to Follow-up|44
693620|NCT01461993|2251412|P3|Overall Study|Withdrawal by Subject|16
693621|NCT01461993|2251413|P2|Overall Study|Withdrawal by Subject|53
693622|NCT01461993|2251414|P1|Overall Study|Withdrawal by Subject|60
693623|NCT01461980|2251439|P3|Overall Study|Randomized but not vaccinated|7
693624|NCT01461980|2251440|P2|Overall Study|Randomized but not vaccinated|8
693625|NCT01461980|2251441|P1|Overall Study|Randomized but not vaccinated|4
693626|NCT01461980|2251439|P3|Overall Study|No longer willing to participate|54
693627|NCT01461980|2251440|P2|Overall Study|No longer willing to participate|38
693628|NCT01461980|2251441|P1|Overall Study|No longer willing to participate|52
693629|NCT01461980|2251439|P3|Overall Study|Lost to Follow-up|51
693630|NCT01461980|2251440|P2|Overall Study|Lost to Follow-up|53
693631|NCT01461980|2251441|P1|Overall Study|Lost to Follow-up|52
693632|NCT01461980|2251439|P3|Overall Study|No longer meets eligibility criteria|19
693633|NCT01461980|2251440|P2|Overall Study|No longer meets eligibility criteria|9
693634|NCT01461980|2251441|P1|Overall Study|No longer meets eligibility criteria|18
693635|NCT01461980|2251439|P3|Overall Study|Protocol Violation|16
693636|NCT01461980|2251440|P2|Overall Study|Protocol Violation|19
693637|NCT01461980|2251441|P1|Overall Study|Protocol Violation|12
693638|NCT01461980|2251439|P3|Overall Study|Adverse Event|6
693639|NCT01461980|2251440|P2|Overall Study|Adverse Event|5
693640|NCT01461980|2251441|P1|Overall Study|Adverse Event|12
693641|NCT01461980|2251439|P3|Overall Study|Medication error|6
693642|NCT01461980|2251440|P2|Overall Study|Medication error|5
693643|NCT01461980|2251441|P1|Overall Study|Medication error|7
693644|NCT01461980|2251439|P3|Overall Study|Unspecified|6
693645|NCT01461980|2251440|P2|Overall Study|Unspecified|8
693646|NCT01461980|2251441|P1|Overall Study|Unspecified|9
693647|NCT01461811|2251473|P2|Overall Study|Noncompliance|1
693648|NCT01461811|2251474|P1|Overall Study|Noncompliance|1
693649|NCT01461811|2251473|P2|Overall Study|Subject decision unrelated to an AE|1
693650|NCT01461811|2251474|P1|Overall Study|Subject decision unrelated to an AE|1
693651|NCT01461811|2251473|P2|Overall Study|Adverse Event|1
693652|NCT01461811|2251474|P1|Overall Study|Adverse Event|2
693655|NCT01461551|2251542|P3|Overall Study|Physician Decision|2
693656|NCT01461551|2251543|P2|Overall Study|Physician Decision|1
693657|NCT01461551|2251544|P1|Overall Study|Physician Decision|2
693658|NCT01461538|2251555|P3|Overall Study|Withdrawal by Subject|0
693659|NCT01461538|2251556|P2|Overall Study|Withdrawal by Subject|1
693660|NCT01461538|2251557|P1|Overall Study|Withdrawal by Subject|1
693661|NCT01461538|2251555|P3|Overall Study|Study Stopped by Sponsor|0
693662|NCT01461538|2251556|P2|Overall Study|Study Stopped by Sponsor|1
693663|NCT01461538|2251557|P1|Overall Study|Study Stopped by Sponsor|2
693664|NCT01461538|2251555|P3|Overall Study|Death|2
693665|NCT01461538|2251556|P2|Overall Study|Death|6
693666|NCT01461538|2251557|P1|Overall Study|Death|15
693667|NCT01461369|2251615|P3|Overall Study|Withdrawal by Subject|2
693668|NCT01461369|2251616|P2|Overall Study|Withdrawal by Subject|3
693669|NCT01461369|2251617|P1|Overall Study|Withdrawal by Subject|1
693670|NCT01461369|2251615|P3|Overall Study|Protocol Violation|2
693671|NCT01461369|2251616|P2|Overall Study|Protocol Violation|2
693672|NCT01461369|2251617|P1|Overall Study|Protocol Violation|1
693673|NCT01461369|2251615|P3|Overall Study|Adverse Event|4
693674|NCT01461369|2251616|P2|Overall Study|Adverse Event|12
693675|NCT01461369|2251617|P1|Overall Study|Adverse Event|9
693676|NCT01461369|2251615|P3|Overall Study|Lost to Follow-up|3
693677|NCT01461369|2251616|P2|Overall Study|Lost to Follow-up|0
693678|NCT01461369|2251617|P1|Overall Study|Lost to Follow-up|0
693679|NCT01461369|2251615|P3|Overall Study|Lack of Efficacy|6
693680|NCT01461369|2251616|P2|Overall Study|Lack of Efficacy|0
693681|NCT01461369|2251617|P1|Overall Study|Lack of Efficacy|2
693682|NCT01461096|2251642|P2|Overall Study|Lost to Follow-up|4
693683|NCT01461096|2251643|P1|Overall Study|Lost to Follow-up|8
693684|NCT01461096|2251642|P2|Overall Study|Subj not willing to adhere to reqs|4
693685|NCT01461096|2251643|P1|Overall Study|Subj not willing to adhere to reqs|3
693686|NCT01461096|2251642|P2|Overall Study|Withdrawal by Subject|3
693687|NCT01461096|2251643|P1|Overall Study|Withdrawal by Subject|5
693688|NCT01461096|2251642|P2|Overall Study|Site is closing|30
693689|NCT01461096|2251643|P1|Overall Study|Site is closing|27
693690|NCT01461096|2251642|P2|Overall Study|Subj not able to get to clinic|13
693691|NCT01461096|2251643|P1|Overall Study|Subj not able to get to clinic|15
693692|NCT01461096|2251642|P2|Overall Study|Severe debilitation, unable to continue|1
693693|NCT01461096|2251643|P1|Overall Study|Severe debilitation, unable to continue|1
693694|NCT01461096|2251642|P2|Overall Study|Death|6
693695|NCT01461096|2251643|P1|Overall Study|Death|3
693696|NCT01461057|2251659|P2|Overall Study|Physician Decision|1
693697|NCT01461057|2251660|P1|Overall Study|Physician Decision|0
693698|NCT01461057|2251659|P2|Overall Study|Withdrawal by Subject|3
693699|NCT01461057|2251660|P1|Overall Study|Withdrawal by Subject|2
693700|NCT01461057|2251659|P2|Overall Study|Death|8
693701|NCT01461057|2251660|P1|Overall Study|Death|7
693702|NCT01461057|2251659|P2|Overall Study|Currently in safety follow up|3
693703|NCT01461057|2251660|P1|Overall Study|Currently in safety follow up|4
693704|NCT01461057|2251659|P2|Overall Study|Currently in treatment|0
693705|NCT01461057|2251660|P1|Overall Study|Currently in treatment|2
693706|NCT01461044|2251670|P2|Overall Study|Lost to Follow-up|5
693707|NCT01461044|2251671|P1|Overall Study|Lost to Follow-up|12
693708|NCT01461044|2251670|P2|Overall Study|Death|35
693709|NCT01461044|2251671|P1|Overall Study|Death|58
693710|NCT01460628|2251771|P1|Overall Study|Withdrawal by Subject|2
693711|NCT01460628|2251771|P1|Overall Study|Adverse Event|3
693712|NCT01460446|2251783|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
693713|NCT01460446|2251784|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
693714|NCT01460446|2251783|P2|Overall Study|Pregnancy|0
693715|NCT01460446|2251784|P1|Overall Study|Pregnancy|1
693716|NCT01460446|2251783|P2|Overall Study|Surgery/Illness|1
693717|NCT01460446|2251784|P1|Overall Study|Surgery/Illness|1
693718|NCT01460446|2251783|P2|Overall Study|Non-compliance & Consent Withdrawn|3
693719|NCT01460446|2251784|P1|Overall Study|Non-compliance & Consent Withdrawn|1
693720|NCT01460446|2251783|P2|Overall Study|Consent Withdrawn|4
693721|NCT01460446|2251784|P1|Overall Study|Consent Withdrawn|0
693722|NCT01460446|2251783|P2|Overall Study|Non-compliance|9
693723|NCT01460446|2251784|P1|Overall Study|Non-compliance|2
693724|NCT01460342|2251813|P2|Overall Study|Lack of Efficacy|0
693725|NCT01460342|2251814|P1|Overall Study|Lack of Efficacy|1
693726|NCT01460342|2251813|P2|Overall Study|Physician Decision|3
693727|NCT01460342|2251814|P1|Overall Study|Physician Decision|1
693728|NCT01460342|2251813|P2|Overall Study|Withdrawal by Subject|4
693729|NCT01460342|2251814|P1|Overall Study|Withdrawal by Subject|3
693730|NCT01460342|2251813|P2|Overall Study|Protocol Violation|1
693731|NCT01460342|2251814|P1|Overall Study|Protocol Violation|0
693732|NCT01460342|2251813|P2|Overall Study|Lost to Follow-up|2
693733|NCT01460342|2251814|P1|Overall Study|Lost to Follow-up|1
693734|NCT01460342|2251813|P2|Overall Study|Adverse Event|4
693735|NCT01460342|2251814|P1|Overall Study|Adverse Event|5
693736|NCT01460290|2251845|P1|Overall Study|Elevated liver function|1
693737|NCT01460290|2251845|P1|Overall Study|Adverse Event|3
693738|NCT01459913|2251869|P4|Overall Study|Did Not Meet Inclusion Criteria|1
693739|NCT01459913|2251870|P3|Overall Study|Did Not Meet Inclusion Criteria|0
693740|NCT01459913|2251871|P2|Overall Study|Did Not Meet Inclusion Criteria|0
693741|NCT01459913|2251872|P1|Overall Study|Did Not Meet Inclusion Criteria|0
693742|NCT01459913|2251869|P4|Overall Study|Unspecified|1
693743|NCT01459913|2251870|P3|Overall Study|Unspecified|3
693744|NCT01459913|2251871|P2|Overall Study|Unspecified|0
693745|NCT01459913|2251872|P1|Overall Study|Unspecified|0
693746|NCT01459913|2251869|P4|Overall Study|Study Terminated by Sponsor|11
693747|NCT01459913|2251870|P3|Overall Study|Study Terminated by Sponsor|9
693748|NCT01459913|2251871|P2|Overall Study|Study Terminated by Sponsor|15
693749|NCT01459913|2251872|P1|Overall Study|Study Terminated by Sponsor|30
693750|NCT01459913|2251869|P4|Overall Study|Physician Decision|0
693751|NCT01459913|2251870|P3|Overall Study|Physician Decision|0
693752|NCT01459913|2251871|P2|Overall Study|Physician Decision|1
693753|NCT01459913|2251872|P1|Overall Study|Physician Decision|0
693754|NCT01459913|2251869|P4|Overall Study|Non- Compliance|3
693755|NCT01459913|2251870|P3|Overall Study|Non- Compliance|0
693756|NCT01459913|2251871|P2|Overall Study|Non- Compliance|0
693757|NCT01459913|2251872|P1|Overall Study|Non- Compliance|0
693758|NCT01459913|2251869|P4|Overall Study|Death|1
693759|NCT01459913|2251870|P3|Overall Study|Death|0
693760|NCT01459913|2251871|P2|Overall Study|Death|0
693761|NCT01459913|2251872|P1|Overall Study|Death|0
693762|NCT01459913|2251869|P4|Overall Study|Lost to Follow-up|8
693763|NCT01459913|2251870|P3|Overall Study|Lost to Follow-up|1
693764|NCT01459913|2251871|P2|Overall Study|Lost to Follow-up|4
693765|NCT01459913|2251872|P1|Overall Study|Lost to Follow-up|7
693766|NCT01459913|2251869|P4|Overall Study|Withdrawal by Subject|5
693767|NCT01459913|2251870|P3|Overall Study|Withdrawal by Subject|0
693768|NCT01459913|2251871|P2|Overall Study|Withdrawal by Subject|0
693769|NCT01459913|2251872|P1|Overall Study|Withdrawal by Subject|4
693770|NCT01459913|2251869|P4|Overall Study|Adverse Event|3
693771|NCT01459913|2251870|P3|Overall Study|Adverse Event|0
693772|NCT01459913|2251871|P2|Overall Study|Adverse Event|0
693773|NCT01459913|2251872|P1|Overall Study|Adverse Event|0
693774|NCT01459796|2251903|P2|Overall Study|Decision by the sponsor|108
693775|NCT01459796|2251904|P1|Overall Study|Decision by the sponsor|75
693776|NCT01459796|2251903|P2|Overall Study|Reason unspecified|2
693777|NCT01459796|2251904|P1|Overall Study|Reason unspecified|1
693778|NCT01459796|2251903|P2|Overall Study|Lost to Follow-up|4
693779|NCT01459796|2251904|P1|Overall Study|Lost to Follow-up|5
693780|NCT01459796|2251903|P2|Overall Study|Withdrawal by Subject|3
693781|NCT01459796|2251904|P1|Overall Study|Withdrawal by Subject|6
693782|NCT01459796|2251903|P2|Overall Study|Adverse Event|5
693783|NCT01459796|2251904|P1|Overall Study|Adverse Event|5
693784|NCT01459796|2251903|P2|Overall Study|Non compliance with protocol|4
693785|NCT01459796|2251904|P1|Overall Study|Non compliance with protocol|2
693786|NCT01459783|2251922|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
693787|NCT01459783|2251923|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
693788|NCT01459783|2251922|P2|6 Months to 12 Months|Lost to Follow-up|7
693789|NCT01459783|2251923|P1|6 Months to 12 Months|Lost to Follow-up|2
693790|NCT01459783|2251922|P2|6 Months to 12 Months|Withdrawal by Subject|5
693791|NCT01459783|2251923|P1|6 Months to 12 Months|Withdrawal by Subject|6
693792|NCT01459783|2251922|P2|6 Months to 12 Months|Death|1
693793|NCT01459783|2251923|P1|6 Months to 12 Months|Death|0
693794|NCT01459783|2251922|P2|Baseline to 6 Months|Lost to Follow-up|14
693795|NCT01459783|2251923|P1|Baseline to 6 Months|Lost to Follow-up|19
693796|NCT01459783|2251922|P2|Baseline to 6 Months|Withdrawal by Subject|6
693797|NCT01459783|2251923|P1|Baseline to 6 Months|Withdrawal by Subject|12
693798|NCT01459783|2251922|P2|Baseline to 6 Months|Death|0
693799|NCT01459783|2251923|P1|Baseline to 6 Months|Death|1
693800|NCT01459068|2252135|P2|Overall Study|Death|1
693801|NCT01459068|2252136|P1|Overall Study|Death|0
693802|NCT01459068|2252135|P2|Overall Study|Lost to Follow-up|15
693803|NCT01459068|2252136|P1|Overall Study|Lost to Follow-up|31
693804|NCT01459068|2252135|P2|Overall Study|Withdrawal by Subject|18
693805|NCT01459068|2252136|P1|Overall Study|Withdrawal by Subject|8
693806|NCT01459016|2252152|P1|Overall Study|Amendment Discontinuation Criteria|4
693807|NCT01459016|2252152|P1|Overall Study|Withdrawal by Subject|11
693808|NCT01458951|2252169|P3|Overall Study|Insufficient Clinical Response|11
693809|NCT01458951|2252170|P2|Overall Study|Insufficient Clinical Response|0
693810|NCT01458951|2252171|P1|Overall Study|Insufficient Clinical Response|17
693811|NCT01458951|2252169|P3|Overall Study|Adverse Event|2
693812|NCT01458951|2252170|P2|Overall Study|Adverse Event|0
693813|NCT01458951|2252171|P1|Overall Study|Adverse Event|7
693814|NCT01458951|2252169|P3|Overall Study|Withdrawal by Subject|2
693815|NCT01458951|2252170|P2|Overall Study|Withdrawal by Subject|0
693816|NCT01458951|2252171|P1|Overall Study|Withdrawal by Subject|2
693817|NCT01458951|2252169|P3|Overall Study|Protocol Violation|0
693818|NCT01458951|2252170|P2|Overall Study|Protocol Violation|1
693819|NCT01458951|2252171|P1|Overall Study|Protocol Violation|5
693820|NCT01458951|2252169|P3|Overall Study|Unspecified|0
693821|NCT01458951|2252170|P2|Overall Study|Unspecified|0
693822|NCT01458951|2252171|P1|Overall Study|Unspecified|1
693823|NCT01458639|2252196|P1|Overall Study|Inability to obtain subject blood sample|1
693824|NCT01458639|2252196|P1|Overall Study|Equipment issue|1
693825|NCT01458639|2252196|P1|Overall Study|Physician Decision|4
693826|NCT01458587|2252208|P2|Overall Study|Withdrawal by Subject|0
693827|NCT01458587|2252209|P1|Overall Study|Withdrawal by Subject|1
693828|NCT01458574|2252372|P3|Overall Study|Randomized but not treated|0
693829|NCT01458574|2252373|P2|Overall Study|Randomized but not treated|1
693830|NCT01458574|2252374|P1|Overall Study|Randomized but not treated|0
693831|NCT01458574|2252372|P3|Overall Study|Unspecified|0
693832|NCT01458574|2252373|P2|Overall Study|Unspecified|1
693833|NCT01458574|2252374|P1|Overall Study|Unspecified|2
693834|NCT01458574|2252372|P3|Overall Study|Withdrawal by Subject|5
693835|NCT01458574|2252373|P2|Overall Study|Withdrawal by Subject|3
693836|NCT01458574|2252374|P1|Overall Study|Withdrawal by Subject|6
693837|NCT01458574|2252372|P3|Overall Study|Protocol Violation|0
693838|NCT01458574|2252373|P2|Overall Study|Protocol Violation|1
693839|NCT01458574|2252374|P1|Overall Study|Protocol Violation|0
693840|NCT01458574|2252372|P3|Overall Study|Pregnancy|0
693841|NCT01458574|2252373|P2|Overall Study|Pregnancy|1
693842|NCT01458574|2252374|P1|Overall Study|Pregnancy|1
693843|NCT01458574|2252372|P3|Overall Study|Lost to Follow-up|1
693844|NCT01458574|2252373|P2|Overall Study|Lost to Follow-up|2
693845|NCT01458574|2252374|P1|Overall Study|Lost to Follow-up|3
693846|NCT01458574|2252372|P3|Overall Study|Lack of Efficacy|132
693847|NCT01458574|2252373|P2|Overall Study|Lack of Efficacy|53
693848|NCT01458574|2252374|P1|Overall Study|Lack of Efficacy|70
693849|NCT01458574|2252372|P3|Overall Study|Adverse Event|7
693850|NCT01458574|2252373|P2|Overall Study|Adverse Event|9
693851|NCT01458574|2252374|P1|Overall Study|Adverse Event|5
693852|NCT01458535|2252504|P6|Overall Study|Adverse Event|0
693853|NCT01458535|2252505|P5|Overall Study|Adverse Event|0
693854|NCT01458535|2252506|P4|Overall Study|Adverse Event|1
693855|NCT01458535|2252507|P3|Overall Study|Adverse Event|0
693856|NCT01458535|2252508|P2|Overall Study|Adverse Event|0
693857|NCT01458535|2252509|P1|Overall Study|Adverse Event|0
693858|NCT01458535|2252504|P6|Overall Study|Lost to Follow-up|2
693859|NCT01458535|2252505|P5|Overall Study|Lost to Follow-up|2
693860|NCT01458535|2252506|P4|Overall Study|Lost to Follow-up|3
693861|NCT01458535|2252507|P3|Overall Study|Lost to Follow-up|0
693862|NCT01458535|2252508|P2|Overall Study|Lost to Follow-up|2
693863|NCT01458535|2252509|P1|Overall Study|Lost to Follow-up|0
693864|NCT01458535|2252504|P6|Overall Study|Withdrawal by Subject|1
693865|NCT01458535|2252505|P5|Overall Study|Withdrawal by Subject|1
693866|NCT01458535|2252506|P4|Overall Study|Withdrawal by Subject|0
693867|NCT01458535|2252507|P3|Overall Study|Withdrawal by Subject|2
693868|NCT01458535|2252508|P2|Overall Study|Withdrawal by Subject|0
693869|NCT01458535|2252509|P1|Overall Study|Withdrawal by Subject|0
693870|NCT01458535|2252504|P6|Overall Study|Other|1
693871|NCT01458535|2252505|P5|Overall Study|Other|1
693872|NCT01458535|2252506|P4|Overall Study|Other|0
693873|NCT01458535|2252507|P3|Overall Study|Other|0
693874|NCT01458535|2252508|P2|Overall Study|Other|0
693875|NCT01458535|2252509|P1|Overall Study|Other|0
693876|NCT01458392|2252562|P3|Overall Study|Patient unwilling to comply with protoco|2
693877|NCT01458392|2252563|P2|Overall Study|Patient unwilling to comply with protoco|0
693878|NCT01458392|2252564|P1|Overall Study|Patient unwilling to comply with protoco|0
693879|NCT01458392|2252562|P3|Overall Study|At the discretion of the sponsor|7
693880|NCT01458392|2252563|P2|Overall Study|At the discretion of the sponsor|2
693881|NCT01458392|2252564|P1|Overall Study|At the discretion of the sponsor|0
693882|NCT01458392|2252562|P3|Overall Study|Death|22
693883|NCT01458392|2252563|P2|Overall Study|Death|11
693884|NCT01458392|2252564|P1|Overall Study|Death|2
693885|NCT01458275|2252592|P3|Overall Study|Withdrawal by Subject|1
693886|NCT01458275|2252593|P2|Overall Study|Withdrawal by Subject|2
693887|NCT01458275|2252594|P1|Overall Study|Withdrawal by Subject|3
693888|NCT01458275|2252592|P3|Overall Study|Protocol Violation|2
693889|NCT01458275|2252593|P2|Overall Study|Protocol Violation|5
693890|NCT01458275|2252594|P1|Overall Study|Protocol Violation|5
693891|NCT01458275|2252592|P3|Overall Study|Lost to Follow-up|5
693892|NCT01458275|2252593|P2|Overall Study|Lost to Follow-up|2
693893|NCT01458275|2252594|P1|Overall Study|Lost to Follow-up|3
693894|NCT01458275|2252592|P3|Overall Study|Adverse Event|1
693895|NCT01458275|2252593|P2|Overall Study|Adverse Event|4
693896|NCT01458275|2252594|P1|Overall Study|Adverse Event|3
693897|NCT01458249|2252636|P1|Overall Study|Ongoing|1
693898|NCT01458249|2252636|P1|Overall Study|Not specified|2
693899|NCT01458249|2252636|P1|Overall Study|Adverse Event|4
693900|NCT01458249|2252636|P1|Overall Study|Not treated|1
693901|NCT01458210|2252655|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
693902|NCT01458210|2252655|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
693903|NCT01458210|2252655|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
693904|NCT01458210|2252655|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
693905|NCT01458171|2252672|P1|Overall Study|Adverse Event|1
693906|NCT01458106|2252695|P2|Overall Study|Withdrawn Per Protocol|1
693907|NCT01458106|2252696|P1|Overall Study|Withdrawn Per Protocol|0
693908|NCT01458106|2252695|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
693909|NCT01458106|2252696|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
693910|NCT01458106|2252695|P2|Overall Study|Withdrawal by Subject|0
693911|NCT01458106|2252696|P1|Overall Study|Withdrawal by Subject|2
693912|NCT01457950|2252773|P4|Open-Label Phase|Withdrawal by Subject|0
693913|NCT01457950|2252774|P3|Open-Label Phase|Withdrawal by Subject|2
693914|NCT01457950|2252775|P2|Open-Label Phase|Withdrawal by Subject|0
693915|NCT01457950|2252776|P1|Open-Label Phase|Withdrawal by Subject|0
693916|NCT01457950|2252773|P4|Open-Label Phase|Protocol Violation|1
693917|NCT01457950|2252774|P3|Open-Label Phase|Protocol Violation|0
693918|NCT01457950|2252775|P2|Open-Label Phase|Protocol Violation|0
693919|NCT01457950|2252776|P1|Open-Label Phase|Protocol Violation|0
693920|NCT01457950|2252773|P4|Open-Label Phase|Adverse Event|1
693921|NCT01457950|2252774|P3|Open-Label Phase|Adverse Event|0
693922|NCT01457950|2252775|P2|Open-Label Phase|Adverse Event|0
693923|NCT01457950|2252776|P1|Open-Label Phase|Adverse Event|0
693924|NCT01457950|2252773|P4|Double-Blind Phase|Withdrawal by Subject|0
693925|NCT01457950|2252774|P3|Double-Blind Phase|Withdrawal by Subject|0
693926|NCT01457950|2252775|P2|Double-Blind Phase|Withdrawal by Subject|2
693927|NCT01457950|2252776|P1|Double-Blind Phase|Withdrawal by Subject|6
693928|NCT01457950|2252773|P4|Double-Blind Phase|Protocol Violation|0
693929|NCT01457950|2252774|P3|Double-Blind Phase|Protocol Violation|0
693930|NCT01457950|2252775|P2|Double-Blind Phase|Protocol Violation|1
693931|NCT01457950|2252776|P1|Double-Blind Phase|Protocol Violation|2
693932|NCT01457950|2252773|P4|Double-Blind Phase|Continuation Criteria Not Met|0
693933|NCT01457950|2252774|P3|Double-Blind Phase|Continuation Criteria Not Met|0
693934|NCT01457950|2252775|P2|Double-Blind Phase|Continuation Criteria Not Met|0
693935|NCT01457950|2252776|P1|Double-Blind Phase|Continuation Criteria Not Met|1
693936|NCT01457846|2252858|P2|Overall Study|Lost to Follow-up|0
693937|NCT01457846|2252859|P1|Overall Study|Lost to Follow-up|1
693938|NCT01457846|2252858|P2|Overall Study|Withdrawal by Subject|1
693939|NCT01457846|2252859|P1|Overall Study|Withdrawal by Subject|1
693940|NCT01457846|2252858|P2|Overall Study|Unclassified reason for not completed|10
693941|NCT01457846|2252859|P1|Overall Study|Unclassified reason for not completed|11
693942|NCT01457846|2252858|P2|Overall Study|Death|16
693943|NCT01457846|2252859|P1|Overall Study|Death|27
693944|NCT01457846|2252858|P2|Overall Study|Did not receive treatment|1
693945|NCT01457846|2252859|P1|Overall Study|Did not receive treatment|0
693946|NCT01457846|2252858|P2|Overall Study|Death before treatment|2
693947|NCT01457846|2252859|P1|Overall Study|Death before treatment|1
693948|NCT01457703|2252875|P2|Overall Study|Withdrawal by Subject|4
693949|NCT01457703|2252876|P1|Overall Study|Withdrawal by Subject|1
693950|NCT01457703|2252875|P2|Overall Study|Screen Failure|7
693951|NCT01457703|2252876|P1|Overall Study|Screen Failure|5
693952|NCT01457339|2252973|P2|Period 6 (250 mg)|Personal appointment|1
693953|NCT01457339|2252974|P1|Period 6 (250 mg)|Personal appointment|0
693954|NCT01457339|2252973|P2|Period 6 (250 mg)|Family Emergency|0
693955|NCT01457339|2252974|P1|Period 6 (250 mg)|Family Emergency|1
693956|NCT01457339|2252973|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
693957|NCT01457339|2252974|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
693958|NCT01457339|2252973|P2|Period 3 (100 mg)|Adverse Event|1
693959|NCT01457339|2252974|P1|Period 3 (100 mg)|Adverse Event|0
693960|NCT01457053|2253140|P2|Overall Study|Unable to undergo selected treatment|1
693961|NCT01457053|2253141|P1|Overall Study|Unable to undergo selected treatment|1
693962|NCT01457014|2253147|P4|First Night|Withdrawal by Subject|0
693963|NCT01457014|2253148|P3|First Night|Withdrawal by Subject|0
693964|NCT01457014|2253149|P2|First Night|Withdrawal by Subject|0
693965|NCT01457014|2253150|P1|First Night|Withdrawal by Subject|3
693966|NCT01457014|2253147|P4|First Night|Didn't meet inclusion/exclusion criteria|0
693967|NCT01457014|2253148|P3|First Night|Didn't meet inclusion/exclusion criteria|0
693968|NCT01457014|2253149|P2|First Night|Didn't meet inclusion/exclusion criteria|0
693969|NCT01457014|2253150|P1|First Night|Didn't meet inclusion/exclusion criteria|37
693970|NCT01456962|2253167|P2|Overall Study|Lost to Follow-up|1
693971|NCT01456962|2253168|P1|Overall Study|Lost to Follow-up|2
693972|NCT01456936|2253178|P4|Overall Study|Randomized but not treated|21
693973|NCT01456936|2253179|P3|Overall Study|Randomized but not treated|16
693974|NCT01456936|2253180|P2|Overall Study|Randomized but not treated|28
693975|NCT01456936|2253181|P1|Overall Study|Randomized but not treated|21
693976|NCT01456936|2253178|P4|Overall Study|Death|3
693977|NCT01456936|2253179|P3|Overall Study|Death|1
693978|NCT01456936|2253180|P2|Overall Study|Death|3
693979|NCT01456936|2253181|P1|Overall Study|Death|0
693980|NCT01456936|2253178|P4|Overall Study|Adverse event (study drug unrelated)|9
693981|NCT01456936|2253179|P3|Overall Study|Adverse event (study drug unrelated)|9
693982|NCT01456936|2253180|P2|Overall Study|Adverse event (study drug unrelated)|7
693983|NCT01456936|2253181|P1|Overall Study|Adverse event (study drug unrelated)|9
693984|NCT01456936|2253178|P4|Overall Study|Adverse event (study drug)|17
693985|NCT01456936|2253179|P3|Overall Study|Adverse event (study drug)|26
693986|NCT01456936|2253180|P2|Overall Study|Adverse event (study drug)|21
693987|NCT01456936|2253181|P1|Overall Study|Adverse event (study drug)|25
693988|NCT01456936|2253178|P4|Overall Study|Medication error|1
693989|NCT01456936|2253179|P3|Overall Study|Medication error|0
693990|NCT01456936|2253180|P2|Overall Study|Medication error|1
693991|NCT01456936|2253181|P1|Overall Study|Medication error|0
693992|NCT01456936|2253178|P4|Overall Study|Lost to Follow-up|127
693993|NCT01456936|2253179|P3|Overall Study|Lost to Follow-up|144
693994|NCT01456936|2253180|P2|Overall Study|Lost to Follow-up|126
693995|NCT01456936|2253181|P1|Overall Study|Lost to Follow-up|135
693996|NCT01456936|2253178|P4|Overall Study|No longer willing to participate|248
693997|NCT01456936|2253179|P3|Overall Study|No longer willing to participate|224
693998|NCT01456936|2253180|P2|Overall Study|No longer willing to participate|218
693999|NCT01456936|2253181|P1|Overall Study|No longer willing to participate|195
694000|NCT01456936|2253178|P4|Overall Study|Insufficient clinical response|13
694001|NCT01456936|2253179|P3|Overall Study|Insufficient clinical response|14
694002|NCT01456936|2253180|P2|Overall Study|Insufficient clinical response|4
694003|NCT01456936|2253181|P1|Overall Study|Insufficient clinical response|4
694004|NCT01456936|2253178|P4|Overall Study|Pregnancy|1
694005|NCT01456936|2253179|P3|Overall Study|Pregnancy|0
694006|NCT01456936|2253180|P2|Overall Study|Pregnancy|0
694007|NCT01456936|2253181|P1|Overall Study|Pregnancy|1
694008|NCT01456936|2253178|P4|Overall Study|Protocol Violation|5
694009|NCT01456936|2253179|P3|Overall Study|Protocol Violation|5
694010|NCT01456936|2253180|P2|Overall Study|Protocol Violation|2
694011|NCT01456936|2253181|P1|Overall Study|Protocol Violation|4
694012|NCT01456936|2253178|P4|Overall Study|No longer meets eligibility criteria|5
694013|NCT01456936|2253179|P3|Overall Study|No longer meets eligibility criteria|6
694014|NCT01456936|2253180|P2|Overall Study|No longer meets eligibility criteria|8
694015|NCT01456936|2253181|P1|Overall Study|No longer meets eligibility criteria|4
694016|NCT01456936|2253178|P4|Overall Study|Other reason|33
694017|NCT01456936|2253179|P3|Overall Study|Other reason|36
694018|NCT01456936|2253180|P2|Overall Study|Other reason|30
694019|NCT01456936|2253181|P1|Overall Study|Other reason|41
694020|NCT01456780|2253290|P3|Overall Study|Lost to Follow-up|0
694021|NCT01456780|2253291|P2|Overall Study|Lost to Follow-up|3
694022|NCT01456780|2253292|P1|Overall Study|Lost to Follow-up|3
694023|NCT01456195|2253325|P3|Overall Study|Other Reasons|3
694024|NCT01456195|2253326|P2|Overall Study|Other Reasons|1
694025|NCT01456195|2253327|P1|Overall Study|Other Reasons|2
694026|NCT01456195|2253325|P3|Overall Study|Lack of Efficacy|0
694027|NCT01456195|2253326|P2|Overall Study|Lack of Efficacy|1
694028|NCT01456195|2253327|P1|Overall Study|Lack of Efficacy|0
694029|NCT01456195|2253325|P3|Overall Study|Voluntary Withdrawal|7
694030|NCT01456195|2253326|P2|Overall Study|Voluntary Withdrawal|3
694031|NCT01456195|2253327|P1|Overall Study|Voluntary Withdrawal|5
694032|NCT01456195|2253325|P3|Overall Study|Lost to Follow-up|3
694033|NCT01456195|2253326|P2|Overall Study|Lost to Follow-up|1
694034|NCT01456195|2253327|P1|Overall Study|Lost to Follow-up|3
694035|NCT01456195|2253325|P3|Overall Study|Pretreatment Event/Adverse Event|1
694036|NCT01456195|2253326|P2|Overall Study|Pretreatment Event/Adverse Event|4
694037|NCT01456195|2253327|P1|Overall Study|Pretreatment Event/Adverse Event|1
694038|NCT01456169|2253347|P3|Overall Study|Other|0
694039|NCT01456169|2253348|P2|Overall Study|Other|1
694040|NCT01456169|2253349|P1|Overall Study|Other|1
694041|NCT01456169|2253347|P3|Overall Study|Lack of Efficacy|0
694042|NCT01456169|2253348|P2|Overall Study|Lack of Efficacy|0
694043|NCT01456169|2253349|P1|Overall Study|Lack of Efficacy|2
694044|NCT01456169|2253347|P3|Overall Study|Voluntary Withdrawal|2
694045|NCT01456169|2253348|P2|Overall Study|Voluntary Withdrawal|0
694046|NCT01456169|2253349|P1|Overall Study|Voluntary Withdrawal|3
694047|NCT01456169|2253347|P3|Overall Study|Major Protocol Deviation|3
694048|NCT01456169|2253348|P2|Overall Study|Major Protocol Deviation|2
694049|NCT01456169|2253349|P1|Overall Study|Major Protocol Deviation|3
694050|NCT01456169|2253347|P3|Overall Study|Adverse Event|7
694051|NCT01456169|2253348|P2|Overall Study|Adverse Event|2
694052|NCT01456169|2253349|P1|Overall Study|Adverse Event|1
694053|NCT01456130|2253409|P1|Overall Study|Other|1
694054|NCT01456130|2253409|P1|Overall Study|Lack of Efficacy|4
694055|NCT01456130|2253409|P1|Overall Study|Voluntary Withdrawal|1
694056|NCT01456130|2253409|P1|Overall Study|Adverse Event|4
694057|NCT01456052|2253419|P3|Overall Study|Treatment Failure|1
694058|NCT01456052|2253420|P2|Overall Study|Treatment Failure|1
694059|NCT01456052|2253421|P1|Overall Study|Treatment Failure|0
694060|NCT01456052|2253419|P3|Overall Study|Physician Decision|1
694061|NCT01456052|2253420|P2|Overall Study|Physician Decision|0
694062|NCT01456052|2253421|P1|Overall Study|Physician Decision|1
694063|NCT01456052|2253419|P3|Overall Study|Protocol Violation|0
694064|NCT01456052|2253420|P2|Overall Study|Protocol Violation|1
694065|NCT01456052|2253421|P1|Overall Study|Protocol Violation|0
694066|NCT01456052|2253419|P3|Overall Study|Consent withdrawn|1
694067|NCT01456052|2253420|P2|Overall Study|Consent withdrawn|2
694068|NCT01456052|2253421|P1|Overall Study|Consent withdrawn|0
694069|NCT01456052|2253419|P3|Overall Study|Adverse Event|2
694070|NCT01456052|2253420|P2|Overall Study|Adverse Event|1
694071|NCT01456052|2253421|P1|Overall Study|Adverse Event|1
694072|NCT01456039|2253441|P3|Phase 2 (Second Step)|Unspecified|1
694073|NCT01456039|2253442|P2|Phase 2 (Second Step)|Unspecified|0
694074|NCT01456039|2253443|P1|Phase 2 (Second Step)|Unspecified|0
694075|NCT01456039|2253441|P3|Phase 2 (Second Step)|Protocol Violation|1
694076|NCT01456039|2253442|P2|Phase 2 (Second Step)|Protocol Violation|0
694077|NCT01456039|2253443|P1|Phase 2 (Second Step)|Protocol Violation|0
694078|NCT01456039|2253441|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
694079|NCT01456039|2253442|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
694080|NCT01456039|2253443|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
694081|NCT01456039|2253441|P3|Phase 2 (Second Step)|Adverse Event|10
694082|NCT01456039|2253442|P2|Phase 2 (Second Step)|Adverse Event|0
694083|NCT01456039|2253443|P1|Phase 2 (Second Step)|Adverse Event|0
694084|NCT01456039|2253441|P3|Phase 2 (Second Step)|Disease Progression|17
694085|NCT01456039|2253442|P2|Phase 2 (Second Step)|Disease Progression|0
694086|NCT01456039|2253443|P1|Phase 2 (Second Step)|Disease Progression|0
694087|NCT01456039|2253441|P3|Phase 1 (First Step)|Not specified|0
694088|NCT01456039|2253442|P2|Phase 1 (First Step)|Not specified|1
694089|NCT01456039|2253443|P1|Phase 1 (First Step)|Not specified|0
694090|NCT01456039|2253441|P3|Phase 1 (First Step)|Adverse Event|0
694091|NCT01456039|2253442|P2|Phase 1 (First Step)|Adverse Event|3
694092|NCT01456039|2253443|P1|Phase 1 (First Step)|Adverse Event|0
694093|NCT01456039|2253441|P3|Phase 1 (First Step)|Withdrawal by Subject|0
694094|NCT01456039|2253442|P2|Phase 1 (First Step)|Withdrawal by Subject|2
694095|NCT01456039|2253443|P1|Phase 1 (First Step)|Withdrawal by Subject|1
694096|NCT01456039|2253441|P3|Phase 1 (First Step)|Disease Progression|0
694097|NCT01456039|2253442|P2|Phase 1 (First Step)|Disease Progression|1
694098|NCT01456039|2253443|P1|Phase 1 (First Step)|Disease Progression|1
694099|NCT01455428|2253586|P2|Overall Study|Unspecified|4
694100|NCT01455428|2253587|P1|Overall Study|Unspecified|2
694101|NCT01455428|2253586|P2|Overall Study|Did not receive treatment|1
694102|NCT01455428|2253587|P1|Overall Study|Did not receive treatment|1
694103|NCT01455428|2253586|P2|Overall Study|Insufficient clinical response|2
694104|NCT01455428|2253587|P1|Overall Study|Insufficient clinical response|0
694105|NCT01455428|2253586|P2|Overall Study|Did not meet entrance criteria|2
694106|NCT01455428|2253587|P1|Overall Study|Did not meet entrance criteria|0
694107|NCT01455428|2253586|P2|Overall Study|Withdrawal by Subject|5
694108|NCT01455428|2253587|P1|Overall Study|Withdrawal by Subject|2
694109|NCT01455428|2253586|P2|Overall Study|Lost to Follow-up|1
694110|NCT01455428|2253587|P1|Overall Study|Lost to Follow-up|1
694111|NCT01455428|2253586|P2|Overall Study|Adverse Event|2
694112|NCT01455428|2253587|P1|Overall Study|Adverse Event|6
694113|NCT01455428|2253586|P2|Overall Study|Protocol Violation|1
694114|NCT01455428|2253587|P1|Overall Study|Protocol Violation|2
694115|NCT01455415|2253643|P2|Follow-up|Unspecified Reason|0
694116|NCT01455415|2253644|P1|Follow-up|Unspecified Reason|1
694117|NCT01455415|2253643|P2|Follow-up|Withdrawal by Subject|0
694118|NCT01455415|2253644|P1|Follow-up|Withdrawal by Subject|2
694119|NCT01455415|2253643|P2|Follow-up|Lack of Efficacy|1
694120|NCT01455415|2253644|P1|Follow-up|Lack of Efficacy|0
694121|NCT01455415|2253643|P2|Follow-up|AE Related to Study Drug|1
694122|NCT01455415|2253644|P1|Follow-up|AE Related to Study Drug|0
694123|NCT01455415|2253643|P2|Period 2|Protocol Violation|0
694124|NCT01455415|2253644|P1|Period 2|Protocol Violation|2
694125|NCT01455415|2253643|P2|Period 2|Unspecified Reason|3
694126|NCT01455415|2253644|P1|Period 2|Unspecified Reason|2
694127|NCT01455415|2253643|P2|Period 2|Withdrawal by Subject|3
694128|NCT01455415|2253644|P1|Period 2|Withdrawal by Subject|2
694129|NCT01455415|2253643|P2|Period 2|Lack of Efficacy|0
694130|NCT01455415|2253644|P1|Period 2|Lack of Efficacy|2
694131|NCT01455415|2253643|P2|Period 2|AE Not Related to Study Drug|1
694132|NCT01455415|2253644|P1|Period 2|AE Not Related to Study Drug|2
694133|NCT01455415|2253643|P2|Period 2|Lost to Follow-up|1
694134|NCT01455415|2253644|P1|Period 2|Lost to Follow-up|2
694135|NCT01455415|2253643|P2|Period 2|AE Related to Study Drug|2
694136|NCT01455415|2253644|P1|Period 2|AE Related to Study Drug|1
694137|NCT01455415|2253643|P2|Washout|Protocol Violation|1
694138|NCT01455415|2253644|P1|Washout|Protocol Violation|0
694139|NCT01455415|2253643|P2|Washout|Unspecified Reason|2
694140|NCT01455415|2253644|P1|Washout|Unspecified Reason|1
694141|NCT01455415|2253643|P2|Washout|AE Not Related to Study Drug|3
694142|NCT01455415|2253644|P1|Washout|AE Not Related to Study Drug|2
694143|NCT01455415|2253643|P2|Washout|Drug Error not Associated to AE|1
694144|NCT01455415|2253644|P1|Washout|Drug Error not Associated to AE|2
694145|NCT01455415|2253643|P2|Washout|Lost to Follow-up|0
694146|NCT01455415|2253644|P1|Washout|Lost to Follow-up|1
694147|NCT01455415|2253643|P2|Washout|AE Related to Study Drug|0
694148|NCT01455415|2253644|P1|Washout|AE Related to Study Drug|2
694149|NCT01455415|2253643|P2|Period 1|Protocol Violation|2
694150|NCT01455415|2253644|P1|Period 1|Protocol Violation|0
694151|NCT01455415|2253643|P2|Period 1|Unspecified Reason|1
694152|NCT01455415|2253644|P1|Period 1|Unspecified Reason|1
694153|NCT01455415|2253643|P2|Period 1|Withdrawal by Subject|5
694154|NCT01455415|2253644|P1|Period 1|Withdrawal by Subject|4
694155|NCT01455415|2253643|P2|Period 1|AE Not Related to Study Drug|6
694156|NCT01455415|2253644|P1|Period 1|AE Not Related to Study Drug|2
694157|NCT01455415|2253643|P2|Period 1|Drug Error not Associated to AE|1
694158|NCT01455415|2253644|P1|Period 1|Drug Error not Associated to AE|0
694159|NCT01455415|2253643|P2|Period 1|Lost To Follow-up Related to Study Drug|3
694160|NCT01455415|2253644|P1|Period 1|Lost To Follow-up Related to Study Drug|3
694161|NCT01455415|2253643|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
694162|NCT01455415|2253644|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
694163|NCT01455220|2253694|P1|Overall Study|screen fail|30
694164|NCT01455194|2253704|P4|Overall Study|Miscellaneous|4
694165|NCT01455194|2253705|P3|Overall Study|Miscellaneous|1
694166|NCT01455194|2253706|P2|Overall Study|Miscellaneous|5
694167|NCT01455194|2253707|P1|Overall Study|Miscellaneous|4
694168|NCT01455194|2253704|P4|Overall Study|Discontinuation criterion fulfilled|2
694169|NCT01455194|2253705|P3|Overall Study|Discontinuation criterion fulfilled|0
694170|NCT01455194|2253706|P2|Overall Study|Discontinuation criterion fulfilled|2
694171|NCT01455194|2253707|P1|Overall Study|Discontinuation criterion fulfilled|3
694172|NCT01455194|2253704|P4|Overall Study|Pregnancy|0
694173|NCT01455194|2253705|P3|Overall Study|Pregnancy|1
694174|NCT01455194|2253706|P2|Overall Study|Pregnancy|1
694175|NCT01455194|2253707|P1|Overall Study|Pregnancy|0
694176|NCT01455194|2253704|P4|Overall Study|Lost to Follow-up|1
694177|NCT01455194|2253705|P3|Overall Study|Lost to Follow-up|1
694178|NCT01455194|2253706|P2|Overall Study|Lost to Follow-up|0
694179|NCT01455194|2253707|P1|Overall Study|Lost to Follow-up|2
694180|NCT01455194|2253704|P4|Overall Study|Withdrawal by Subject|9
694181|NCT01455194|2253705|P3|Overall Study|Withdrawal by Subject|12
694182|NCT01455194|2253706|P2|Overall Study|Withdrawal by Subject|16
694183|NCT01455194|2253707|P1|Overall Study|Withdrawal by Subject|21
694184|NCT01455194|2253704|P4|Overall Study|Adverse Event|3
694185|NCT01455194|2253705|P3|Overall Study|Adverse Event|1
694186|NCT01455194|2253706|P2|Overall Study|Adverse Event|1
694187|NCT01455194|2253707|P1|Overall Study|Adverse Event|1
694188|NCT01455194|2253704|P4|Overall Study|Deterioration in asthma|9
694189|NCT01455194|2253705|P3|Overall Study|Deterioration in asthma|14
694190|NCT01455194|2253706|P2|Overall Study|Deterioration in asthma|6
694191|NCT01455194|2253707|P1|Overall Study|Deterioration in asthma|12
694192|NCT01455194|2253704|P4|Overall Study|Randomisation Failure|0
694193|NCT01455194|2253705|P3|Overall Study|Randomisation Failure|0
694194|NCT01455194|2253706|P2|Overall Study|Randomisation Failure|0
694195|NCT01455194|2253707|P1|Overall Study|Randomisation Failure|90
694196|NCT01455194|2253704|P4|Overall Study|Screen Failure|0
694197|NCT01455194|2253705|P3|Overall Study|Screen Failure|0
694198|NCT01455194|2253706|P2|Overall Study|Screen Failure|0
694199|NCT01455194|2253707|P1|Overall Study|Screen Failure|20
694200|NCT01455012|2253770|P2|Overall Study|Unknown reason|0
694201|NCT01455012|2253771|P1|Overall Study|Unknown reason|2
694202|NCT01455012|2253770|P2|Overall Study|Withdrawal by Subject|1
694203|NCT01455012|2253771|P1|Overall Study|Withdrawal by Subject|3
694204|NCT01455012|2253770|P2|Overall Study|Lack of Efficacy|1
694205|NCT01455012|2253771|P1|Overall Study|Lack of Efficacy|6
694206|NCT01455012|2253770|P2|Overall Study|Adverse Event|2
694207|NCT01455012|2253771|P1|Overall Study|Adverse Event|0
694208|NCT01454934|2253838|P2|Overall Study|Ongoing, survival follow-up|2
694209|NCT01454934|2253839|P1|Overall Study|Ongoing, survival follow-up|1
694210|NCT01454934|2253838|P2|Overall Study|Not treated|2
694211|NCT01454934|2253839|P1|Overall Study|Not treated|1
694212|NCT01454934|2253838|P2|Overall Study|Not specified|16
694213|NCT01454934|2253839|P1|Overall Study|Not specified|5
694214|NCT01454934|2253838|P2|Overall Study|Clinical progression|25
694215|NCT01454934|2253839|P1|Overall Study|Clinical progression|28
694216|NCT01454934|2253838|P2|Overall Study|Withdrawn consent|5
694217|NCT01454934|2253839|P1|Overall Study|Withdrawn consent|2
694218|NCT01454934|2253838|P2|Overall Study|Lost to Follow-up|1
694219|NCT01454934|2253839|P1|Overall Study|Lost to Follow-up|0
694220|NCT01454934|2253838|P2|Overall Study|Withdrawal by Subject|15
694221|NCT01454934|2253839|P1|Overall Study|Withdrawal by Subject|11
694222|NCT01454934|2253838|P2|Overall Study|Adverse Event|24
694223|NCT01454934|2253839|P1|Overall Study|Adverse Event|28
694224|NCT01454934|2253838|P2|Overall Study|Disease progression|180
694225|NCT01454934|2253839|P1|Overall Study|Disease progression|194
694226|NCT01454830|2253851|P2|Overall Study|Withdrawal - no polysomnography|2
694227|NCT01454830|2253852|P1|Overall Study|Withdrawal - no polysomnography|3
694228|NCT01454830|2253851|P2|Overall Study|Post-allocation Exclude-other treatment|7
694229|NCT01454830|2253852|P1|Overall Study|Post-allocation Exclude-other treatment|6
694230|NCT01454830|2253851|P2|Overall Study|Post-allocation Exclude-refused PAP|2
694231|NCT01454830|2253852|P1|Overall Study|Post-allocation Exclude-refused PAP|0
694232|NCT01454830|2253851|P2|Overall Study|Post-allocation Exclude- AHI<10|12
694233|NCT01454830|2253852|P1|Overall Study|Post-allocation Exclude- AHI<10|18
694234|NCT01454830|2253851|P2|Overall Study|Withdrawal by Subject|4
694235|NCT01454830|2253852|P1|Overall Study|Withdrawal by Subject|4
694236|NCT01454778|2253883|P1|Overall Study|Death|1
694237|NCT01454778|2253883|P1|Overall Study|Lost to Follow-up|2
694238|NCT01454726|2253894|P2|Overall Study|Withdrawal by Subject|1
694239|NCT01454726|2253895|P1|Overall Study|Withdrawal by Subject|0
694240|NCT01454583|2253904|P3|3rd Year|Lost to Follow-up|297
694241|NCT01454583|2253905|P2|3rd Year|Lost to Follow-up|512
694242|NCT01454583|2253906|P1|3rd Year|Lost to Follow-up|1959
694243|NCT01454583|2253904|P3|2nd Year|Lost to Follow-up|737
694244|NCT01454583|2253905|P2|2nd Year|Lost to Follow-up|1049
694245|NCT01454583|2253906|P1|2nd Year|Lost to Follow-up|3965
694246|NCT01454583|2253904|P3|1st Year|Lost to Follow-up|180
694247|NCT01454583|2253905|P2|1st Year|Lost to Follow-up|318
694248|NCT01454583|2253906|P1|1st Year|Lost to Follow-up|1057
694249|NCT01454531|2253974|P1|Overall Study|Other|1
694250|NCT01454531|2253974|P1|Overall Study|Delay in IMP administration|1
694251|NCT01454531|2253974|P1|Overall Study|Physician Decision|1
694252|NCT01454531|2253974|P1|Overall Study|Lost to Follow-up|1
694253|NCT01454531|2253974|P1|Overall Study|Withdrawal by Subject|5
694254|NCT01454531|2253974|P1|Overall Study|Adverse Event|14
694255|NCT01454401|2254010|P1|Overall Study|non-adherence|1
694256|NCT01454401|2254010|P1|Overall Study|osteomyelitis|2
694257|NCT01454401|2254010|P1|Overall Study|hospitalised|1
694258|NCT01454401|2254010|P1|Overall Study|Death|1
694259|NCT01454063|2254023|P2|Randomized|Protocol Violation|1
694260|NCT01454063|2254024|P1|Randomized|Protocol Violation|0
694261|NCT01454063|2254023|P2|Randomized|Adverse Event|1
694262|NCT01454063|2254024|P1|Randomized|Adverse Event|1
694263|NCT01453998|2254045|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
694264|NCT01453998|2254046|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
694265|NCT01453998|2254047|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
694266|NCT01453946|2254112|P1|Overall Study|Adverse Event|3
694267|NCT01453946|2254112|P1|Overall Study|Lack of Efficacy|3
694268|NCT01453946|2254112|P1|Overall Study|Protocol Violation|2
694269|NCT01453946|2254112|P1|Overall Study|Did not receive drug for the taper phase|1
694270|NCT01453855|2254129|P2|Overall Study|Other|1
694271|NCT01453855|2254130|P1|Overall Study|Other|0
694272|NCT01453855|2254129|P2|Overall Study|Inadequate Control of IOP|5
694273|NCT01453855|2254130|P1|Overall Study|Inadequate Control of IOP|1
694274|NCT01453855|2254129|P2|Overall Study|Noncompliance|0
694275|NCT01453855|2254130|P1|Overall Study|Noncompliance|1
694276|NCT01453855|2254129|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
694277|NCT01453855|2254130|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
694278|NCT01453855|2254129|P2|Overall Study|Lost to Follow-up|1
694279|NCT01453855|2254130|P1|Overall Study|Lost to Follow-up|2
694280|NCT01453855|2254129|P2|Overall Study|Adverse Event|4
694281|NCT01453855|2254130|P1|Overall Study|Adverse Event|3
694282|NCT01453725|2254138|P2|Overall Study|Physician Decision|1
694283|NCT01453725|2254139|P1|Overall Study|Physician Decision|1
694284|NCT01453725|2254138|P2|Overall Study|Pregnancy|0
694285|NCT01453725|2254139|P1|Overall Study|Pregnancy|1
694286|NCT01453725|2254138|P2|Overall Study|Pregnancy Wish|2
694287|NCT01453725|2254139|P1|Overall Study|Pregnancy Wish|0
694288|NCT01453725|2254138|P2|Overall Study|Withdrawal by Subject|3
694289|NCT01453725|2254139|P1|Overall Study|Withdrawal by Subject|2
694290|NCT01453725|2254138|P2|Overall Study|Protocol Violation|0
694291|NCT01453725|2254139|P1|Overall Study|Protocol Violation|1
694292|NCT01453725|2254138|P2|Overall Study|Non-compliance With Protocol|2
694293|NCT01453725|2254139|P1|Overall Study|Non-compliance With Protocol|1
694294|NCT01453725|2254138|P2|Overall Study|Lost to Follow-up|0
694295|NCT01453725|2254139|P1|Overall Study|Lost to Follow-up|4
694296|NCT01453725|2254138|P2|Overall Study|Adverse Event|3
694297|NCT01453725|2254139|P1|Overall Study|Adverse Event|3
694298|NCT01453595|2254162|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
694299|NCT01453595|2254163|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
694300|NCT01453595|2254164|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
694301|NCT01453374|2254283|P1|Overall Study|Incarcerated|2
694302|NCT01453374|2254283|P1|Overall Study|Withdrawal by Subject|5
694303|NCT01453374|2254283|P1|Overall Study|Lost to Follow-up|3
694304|NCT01453374|2254283|P1|Overall Study|Lack of Efficacy|1
694305|NCT01453374|2254283|P1|Overall Study|Adverse Event|7
889332|NCT01369355|2823812|P4|Overall Study|Lost to Follow-up|2
889333|NCT01369355|2823813|P3|Overall Study|Lost to Follow-up|1
889334|NCT01369355|2823814|P2|Overall Study|Lost to Follow-up|0
889335|NCT01369355|2823815|P1|Overall Study|Lost to Follow-up|1
889336|NCT01369355|2823810|P6|Overall Study|Protocol Violation|2
889337|NCT01369355|2823811|P5|Overall Study|Protocol Violation|0
889338|NCT01369355|2823812|P4|Overall Study|Protocol Violation|0
889339|NCT01369355|2823813|P3|Overall Study|Protocol Violation|1
694315|NCT01453296|2254320|P2|Treatment Period 2|Withdrawal by Subject|0
694316|NCT01453296|2254321|P1|Treatment Period 2|Withdrawal by Subject|1
694317|NCT01453296|2254320|P2|Treatment Period 2|Adverse Event|0
694318|NCT01453296|2254321|P1|Treatment Period 2|Adverse Event|1
694319|NCT01453296|2254320|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
694320|NCT01453296|2254321|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
694321|NCT01453296|2254320|P2|Treatment Period 1|Adverse Event|1
694322|NCT01453296|2254321|P1|Treatment Period 1|Adverse Event|0
694323|NCT01453049|2254421|P2|Overall Study|Randomized in Error|0
694324|NCT01453049|2254422|P1|Overall Study|Randomized in Error|1
694325|NCT01453049|2254421|P2|Overall Study|Withdrawal by Subject|0
694326|NCT01453049|2254422|P1|Overall Study|Withdrawal by Subject|1
694327|NCT01453049|2254421|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
694328|NCT01453049|2254422|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
694329|NCT01453049|2254421|P2|Overall Study|Lost to Follow-up|1
694330|NCT01453049|2254422|P1|Overall Study|Lost to Follow-up|2
694331|NCT01453049|2254421|P2|Overall Study|Protocol Violation|5
694332|NCT01453049|2254422|P1|Overall Study|Protocol Violation|2
694333|NCT01453036|2254495|P3|Overall Study|Lost to Follow-up|31
694334|NCT01453036|2254496|P2|Overall Study|Lost to Follow-up|115
694335|NCT01453036|2254497|P1|Overall Study|Lost to Follow-up|26
694336|NCT01453023|2254505|P2|Treatment Period 2|Protocol Violation|1
694337|NCT01453023|2254506|P1|Treatment Period 2|Protocol Violation|0
694338|NCT01453023|2254505|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
694339|NCT01453023|2254506|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
694340|NCT01453023|2254505|P2|Treatment Period (TP) 1|Protocol Violation|0
694341|NCT01453023|2254506|P1|Treatment Period (TP) 1|Protocol Violation|1
889340|NCT01369355|2823814|P2|Overall Study|Protocol Violation|1
889341|NCT01369355|2823815|P1|Overall Study|Protocol Violation|0
889342|NCT01369355|2823810|P6|Overall Study|Lack of Efficacy|217
889343|NCT01369355|2823811|P5|Overall Study|Lack of Efficacy|126
889344|NCT01369355|2823812|P4|Overall Study|Lack of Efficacy|15
889345|NCT01369355|2823813|P3|Overall Study|Lack of Efficacy|15
889346|NCT01369355|2823814|P2|Overall Study|Lack of Efficacy|14
889347|NCT01369355|2823815|P1|Overall Study|Lack of Efficacy|15
889348|NCT01369355|2823810|P6|Overall Study|Adverse Event|25
889349|NCT01369355|2823811|P5|Overall Study|Adverse Event|14
889350|NCT01369355|2823812|P4|Overall Study|Adverse Event|7
889351|NCT01369355|2823813|P3|Overall Study|Adverse Event|6
889352|NCT01369355|2823814|P2|Overall Study|Adverse Event|12
889353|NCT01369355|2823815|P1|Overall Study|Adverse Event|9
889354|NCT01366092|2823841|P1|Overall Study|Withdrawal by Subject|1
889355|NCT01366092|2823841|P1|Overall Study|Physician Decision|1
889356|NCT01366092|2823841|P1|Overall Study|Progressive cGVHD|2
889357|NCT01362140|2823881|P2|Overall Study|Discontinued Without Receiving Treatment|1
889358|NCT01362140|2823882|P1|Overall Study|Discontinued Without Receiving Treatment|0
889359|NCT01362140|2823881|P2|Overall Study|Protocol-specified Criteria|2
889360|NCT01362140|2823882|P1|Overall Study|Protocol-specified Criteria|1
889361|NCT01362140|2823881|P2|Overall Study|Other|1
889362|NCT01362140|2823882|P1|Overall Study|Other|1
889363|NCT01362140|2823881|P2|Overall Study|Death|1
889364|NCT01362140|2823882|P1|Overall Study|Death|2
889365|NCT01362140|2823881|P2|Overall Study|Administrative Decision|1
889366|NCT01362140|2823882|P1|Overall Study|Administrative Decision|0
889367|NCT01362140|2823881|P2|Overall Study|Withdrawal by Subject|3
889368|NCT01362140|2823882|P1|Overall Study|Withdrawal by Subject|3
889369|NCT01362140|2823881|P2|Overall Study|Adverse Event|2
889370|NCT01362140|2823882|P1|Overall Study|Adverse Event|2
889371|NCT01362140|2823881|P2|Overall Study|Noncompliance|0
889372|NCT01362140|2823882|P1|Overall Study|Noncompliance|1
889373|NCT01350141|2823907|P3|Overall Study|Randomized but not treated|0
889374|NCT01350141|2823908|P2|Overall Study|Randomized but not treated|0
889375|NCT01350141|2823909|P1|Overall Study|Randomized but not treated|1
889376|NCT01350141|2823907|P3|Overall Study|Withdrawal by Subject|0
889377|NCT01350141|2823908|P2|Overall Study|Withdrawal by Subject|0
889378|NCT01350141|2823909|P1|Overall Study|Withdrawal by Subject|1
694381|NCT01452347|2254596|P2|Overall Study|Other reason not defined above|0
694382|NCT01452347|2254597|P1|Overall Study|Other reason not defined above|2
694383|NCT01452347|2254596|P2|Overall Study|Not treated|3
694384|NCT01452347|2254597|P1|Overall Study|Not treated|6
694385|NCT01452347|2254596|P2|Overall Study|Withdrawal by Subject|3
694386|NCT01452347|2254597|P1|Overall Study|Withdrawal by Subject|3
694387|NCT01452347|2254596|P2|Overall Study|Lost to Follow-up|0
694388|NCT01452347|2254597|P1|Overall Study|Lost to Follow-up|2
694389|NCT01452347|2254596|P2|Overall Study|Non compliance protocol|0
694390|NCT01452347|2254597|P1|Overall Study|Non compliance protocol|2
694391|NCT01452347|2254596|P2|Overall Study|Adverse Event|1
694392|NCT01452347|2254597|P1|Overall Study|Adverse Event|2
694393|NCT01452152|2254629|P3|Overall Study|Study termination by sponsor|4
694394|NCT01452152|2254630|P2|Overall Study|Study termination by sponsor|0
694395|NCT01452152|2254631|P1|Overall Study|Study termination by sponsor|5
694396|NCT01451931|2254667|P3|Overall Study|Withdrawal by Subject|22
694397|NCT01451931|2254668|P2|Overall Study|Withdrawal by Subject|22
889379|NCT01350141|2823907|P3|Overall Study|Lost to Follow-up|1
889380|NCT01350141|2823908|P2|Overall Study|Lost to Follow-up|0
889381|NCT01350141|2823909|P1|Overall Study|Lost to Follow-up|1
694398|NCT01451931|2254669|P1|Overall Study|Withdrawal by Subject|16
694399|NCT01451931|2254667|P3|Overall Study|Lost to Follow-up|21
694400|NCT01451931|2254668|P2|Overall Study|Lost to Follow-up|36
694401|NCT01451931|2254669|P1|Overall Study|Lost to Follow-up|17
694402|NCT01451814|2254691|P2|Overall Study|Lost to Follow-up|4
694403|NCT01451814|2254692|P1|Overall Study|Lost to Follow-up|5
694404|NCT01451814|2254691|P2|Overall Study|Withdrawal by Subject|1
694405|NCT01451814|2254692|P1|Overall Study|Withdrawal by Subject|1
694406|NCT01451762|2254724|P3|Overall Study|Lost to Follow-up|6
694407|NCT01451762|2254725|P2|Overall Study|Lost to Follow-up|6
694408|NCT01451762|2254726|P1|Overall Study|Lost to Follow-up|3
694409|NCT01451749|2254736|P2|Overall Study|Withdrawal by Subject|1
694410|NCT01451749|2254737|P1|Overall Study|Withdrawal by Subject|0
694411|NCT01451749|2254736|P2|Overall Study|Adverse Event|0
694412|NCT01451749|2254737|P1|Overall Study|Adverse Event|2
694413|NCT01451749|2254736|P2|Overall Study|Meet the exclusion criteria,and|1
694414|NCT01451749|2254737|P1|Overall Study|Meet the exclusion criteria,and|1
694415|NCT01451749|2254736|P2|Overall Study|Lost to Follow-up|5
694416|NCT01451749|2254737|P1|Overall Study|Lost to Follow-up|15
694417|NCT01451749|2254736|P2|Overall Study|Protocol Violation|7
694418|NCT01451749|2254737|P1|Overall Study|Protocol Violation|14
694419|NCT01451723|2254749|P2|Overall Study|study halted|5
694420|NCT01451723|2254750|P1|Overall Study|study halted|6
694421|NCT01451645|2254760|P2|Overall Study|Lost to Follow-up|3
694422|NCT01451645|2254761|P1|Overall Study|Lost to Follow-up|4
694423|NCT01451645|2254760|P2|Overall Study|Withdrawal by Subject|2
694424|NCT01451645|2254761|P1|Overall Study|Withdrawal by Subject|4
694425|NCT01451645|2254760|P2|Overall Study|Adverse Event|3
694426|NCT01451645|2254761|P1|Overall Study|Adverse Event|0
694427|NCT01451645|2254760|P2|Overall Study|Protocol Violation|0
694428|NCT01451645|2254761|P1|Overall Study|Protocol Violation|1
694429|NCT01451554|2254832|P2|Overall Study|Withdrawal by Subject|9
694430|NCT01451554|2254833|P1|Overall Study|Withdrawal by Subject|14
694431|NCT01451541|2254844|P3|Overall Study|randomization error, noncompliance|8
694432|NCT01451541|2254845|P2|Overall Study|randomization error, noncompliance|10
694433|NCT01451541|2254846|P1|Overall Study|randomization error, noncompliance|11
694434|NCT01451541|2254844|P3|Overall Study|Withdrawal by Subject|6
694435|NCT01451541|2254845|P2|Overall Study|Withdrawal by Subject|8
694436|NCT01451541|2254846|P1|Overall Study|Withdrawal by Subject|15
694437|NCT01451541|2254844|P3|Overall Study|Lost to Follow-up|7
694438|NCT01451541|2254845|P2|Overall Study|Lost to Follow-up|4
694439|NCT01451541|2254846|P1|Overall Study|Lost to Follow-up|4
694440|NCT01451541|2254844|P3|Overall Study|Lack of Efficacy|0
694441|NCT01451541|2254845|P2|Overall Study|Lack of Efficacy|0
694442|NCT01451541|2254846|P1|Overall Study|Lack of Efficacy|2
694443|NCT01451541|2254844|P3|Overall Study|Adverse Event|6
694444|NCT01451541|2254845|P2|Overall Study|Adverse Event|3
694445|NCT01451541|2254846|P1|Overall Study|Adverse Event|4
694446|NCT01451437|2254895|P9|Overall Study|Withdrawal by Subject|0
694447|NCT01451437|2254896|P8|Overall Study|Withdrawal by Subject|0
694448|NCT01451437|2254897|P7|Overall Study|Withdrawal by Subject|1
694449|NCT01451437|2254898|P6|Overall Study|Withdrawal by Subject|0
694450|NCT01451437|2254899|P5|Overall Study|Withdrawal by Subject|1
694451|NCT01451437|2254900|P4|Overall Study|Withdrawal by Subject|0
694452|NCT01451437|2254901|P3|Overall Study|Withdrawal by Subject|0
694453|NCT01451437|2254902|P2|Overall Study|Withdrawal by Subject|0
694454|NCT01451437|2254903|P1|Overall Study|Withdrawal by Subject|0
694455|NCT01451437|2254895|P9|Overall Study|Protocol Violation|0
694456|NCT01451437|2254896|P8|Overall Study|Protocol Violation|0
694457|NCT01451437|2254897|P7|Overall Study|Protocol Violation|1
694458|NCT01451437|2254898|P6|Overall Study|Protocol Violation|0
694459|NCT01451437|2254899|P5|Overall Study|Protocol Violation|0
694460|NCT01451437|2254900|P4|Overall Study|Protocol Violation|0
694461|NCT01451437|2254901|P3|Overall Study|Protocol Violation|0
694462|NCT01451437|2254902|P2|Overall Study|Protocol Violation|0
694463|NCT01451437|2254903|P1|Overall Study|Protocol Violation|0
694464|NCT01451437|2254895|P9|Overall Study|Disease Progression|3
694465|NCT01451437|2254896|P8|Overall Study|Disease Progression|1
694466|NCT01451437|2254897|P7|Overall Study|Disease Progression|3
694467|NCT01451437|2254898|P6|Overall Study|Disease Progression|2
694468|NCT01451437|2254899|P5|Overall Study|Disease Progression|3
694469|NCT01451437|2254900|P4|Overall Study|Disease Progression|1
694470|NCT01451437|2254901|P3|Overall Study|Disease Progression|1
694471|NCT01451437|2254902|P2|Overall Study|Disease Progression|0
694472|NCT01451437|2254903|P1|Overall Study|Disease Progression|0
694473|NCT01451437|2254895|P9|Overall Study|Physician Decision|0
694474|NCT01451437|2254896|P8|Overall Study|Physician Decision|0
694475|NCT01451437|2254897|P7|Overall Study|Physician Decision|0
694476|NCT01451437|2254898|P6|Overall Study|Physician Decision|0
694477|NCT01451437|2254899|P5|Overall Study|Physician Decision|0
694478|NCT01451437|2254900|P4|Overall Study|Physician Decision|0
694479|NCT01451437|2254901|P3|Overall Study|Physician Decision|2
694480|NCT01451437|2254902|P2|Overall Study|Physician Decision|1
694481|NCT01451437|2254903|P1|Overall Study|Physician Decision|1
694482|NCT01451437|2254895|P9|Overall Study|Adverse Event|1
694483|NCT01451437|2254896|P8|Overall Study|Adverse Event|2
694484|NCT01451437|2254897|P7|Overall Study|Adverse Event|1
694485|NCT01451437|2254898|P6|Overall Study|Adverse Event|1
694486|NCT01451437|2254899|P5|Overall Study|Adverse Event|0
694487|NCT01451437|2254900|P4|Overall Study|Adverse Event|0
694488|NCT01451437|2254901|P3|Overall Study|Adverse Event|0
694489|NCT01451437|2254902|P2|Overall Study|Adverse Event|0
694490|NCT01451437|2254903|P1|Overall Study|Adverse Event|0
694491|NCT01451424|2255035|P4|Overall Study|Adverse Event|1
694492|NCT01451424|2255036|P3|Overall Study|Adverse Event|0
694493|NCT01451424|2255037|P2|Overall Study|Adverse Event|0
694494|NCT01451424|2255038|P1|Overall Study|Adverse Event|0
694495|NCT01451424|2255035|P4|Overall Study|Physician Decision|1
694496|NCT01451424|2255036|P3|Overall Study|Physician Decision|1
694497|NCT01451424|2255037|P2|Overall Study|Physician Decision|0
694498|NCT01451424|2255038|P1|Overall Study|Physician Decision|0
694499|NCT01451424|2255035|P4|Overall Study|Lost to Follow-up|1
694500|NCT01451424|2255036|P3|Overall Study|Lost to Follow-up|0
694501|NCT01451424|2255037|P2|Overall Study|Lost to Follow-up|1
694502|NCT01451424|2255038|P1|Overall Study|Lost to Follow-up|0
694503|NCT01451424|2255035|P4|Overall Study|Withdrawal by Subject|2
694504|NCT01451424|2255036|P3|Overall Study|Withdrawal by Subject|0
694505|NCT01451424|2255037|P2|Overall Study|Withdrawal by Subject|1
694506|NCT01451424|2255038|P1|Overall Study|Withdrawal by Subject|1
694507|NCT01451398|2255096|P2|Overall Study|Lack of Efficacy|1
694508|NCT01451398|2255097|P1|Overall Study|Lack of Efficacy|0
694509|NCT01451398|2255096|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
694510|NCT01451398|2255097|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
694511|NCT01451398|2255096|P2|Overall Study|Moved out of country|1
694512|NCT01451398|2255097|P1|Overall Study|Moved out of country|0
694513|NCT01451398|2255096|P2|Overall Study|Non-compliance with protocol|1
694514|NCT01451398|2255097|P1|Overall Study|Non-compliance with protocol|1
694515|NCT01451398|2255096|P2|Overall Study|Non-compliance with study drug|3
694516|NCT01451398|2255097|P1|Overall Study|Non-compliance with study drug|1
694517|NCT01451398|2255096|P2|Overall Study|Lost to Follow-up|4
694518|NCT01451398|2255097|P1|Overall Study|Lost to Follow-up|6
694519|NCT01451398|2255096|P2|Overall Study|Withdrawal by Subject|14
694520|NCT01451398|2255097|P1|Overall Study|Withdrawal by Subject|10
694521|NCT01451398|2255096|P2|Overall Study|Physician Decision|1
694522|NCT01451398|2255097|P1|Overall Study|Physician Decision|1
694523|NCT01451398|2255096|P2|Overall Study|Protocol Violation|2
694524|NCT01451398|2255097|P1|Overall Study|Protocol Violation|1
694525|NCT01451398|2255096|P2|Overall Study|Adverse Event|9
694526|NCT01451398|2255097|P1|Overall Study|Adverse Event|7
694527|NCT01451203|2255131|P2|Post-treatment Period|Investigator decision|1
694528|NCT01451203|2255132|P1|Post-treatment Period|Investigator decision|0
694529|NCT01451203|2255131|P2|Post-treatment Period|Adverse Event|1
694530|NCT01451203|2255132|P1|Post-treatment Period|Adverse Event|0
694531|NCT01451203|2255131|P2|Post-treatment Period|Lack of Efficacy|28
694532|NCT01451203|2255132|P1|Post-treatment Period|Lack of Efficacy|12
694533|NCT01451203|2255131|P2|Post-treatment Period|Consent withdrawn|4
694534|NCT01451203|2255132|P1|Post-treatment Period|Consent withdrawn|2
694535|NCT01451203|2255131|P2|Double-blind Treatment Period|Investigator decision|0
694536|NCT01451203|2255132|P1|Double-blind Treatment Period|Investigator decision|2
694537|NCT01451203|2255131|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
694538|NCT01451203|2255132|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
694539|NCT01451203|2255131|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
694540|NCT01451203|2255132|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
694541|NCT01451203|2255131|P2|Double-blind Treatment Period|Adverse Event|9
694542|NCT01451203|2255132|P1|Double-blind Treatment Period|Adverse Event|6
694543|NCT01451203|2255131|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
694544|NCT01451203|2255132|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
694545|NCT01451203|2255131|P2|Double-blind Treatment Period|Lack of Efficacy|36
694546|NCT01451203|2255132|P1|Double-blind Treatment Period|Lack of Efficacy|71
694547|NCT01451203|2255131|P2|Double-blind Treatment Period|Consent Withdrawn|2
694548|NCT01451203|2255132|P1|Double-blind Treatment Period|Consent Withdrawn|3
694549|NCT01451203|2255131|P2|Double-blind Treatment Period|Did not receive treatment|2
694550|NCT01451203|2255132|P1|Double-blind Treatment Period|Did not receive treatment|1
694551|NCT01450813|2255150|P4|Overall Study|Physician Decision|3
694552|NCT01450813|2255151|P3|Overall Study|Physician Decision|0
694553|NCT01450813|2255152|P2|Overall Study|Physician Decision|1
694554|NCT01450813|2255153|P1|Overall Study|Physician Decision|1
694555|NCT01450800|2255167|P2|Overall Study|Protocol Violation|3
694556|NCT01450800|2255168|P1|Overall Study|Protocol Violation|1
694557|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
694558|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
694559|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Not reported|1
694560|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Not reported|0
694561|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
694562|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
694563|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
694564|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
694565|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
694566|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
694567|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
694568|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
694569|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Death|6
694570|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Death|5
694571|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
694572|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|11
694573|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
694574|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|14
694575|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
694576|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|25
694577|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
694578|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Study drug toxicity|85
694579|NCT01450761|2255203|P2|Treatment With Blinded Study Therapy|Disease progression|409
694580|NCT01450761|2255204|P1|Treatment With Blinded Study Therapy|Disease progression|314
694581|NCT01450761|2255203|P2|Lead-in Chemotherapy|Lost to Follow-up|0
694582|NCT01450761|2255204|P1|Lead-in Chemotherapy|Lost to Follow-up|2
694583|NCT01450761|2255203|P2|Lead-in Chemotherapy|Unspecified|2
694584|NCT01450761|2255204|P1|Lead-in Chemotherapy|Unspecified|2
694585|NCT01450761|2255203|P2|Lead-in Chemotherapy|Death|3
694586|NCT01450761|2255204|P1|Lead-in Chemotherapy|Death|3
694587|NCT01450761|2255203|P2|Lead-in Chemotherapy|No longer meets study criteria|7
694588|NCT01450761|2255204|P1|Lead-in Chemotherapy|No longer meets study criteria|3
694589|NCT01450761|2255203|P2|Lead-in Chemotherapy|Study drug toxicity|10
694590|NCT01450761|2255204|P1|Lead-in Chemotherapy|Study drug toxicity|6
694591|NCT01450761|2255203|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
694592|NCT01450761|2255204|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
694593|NCT01450761|2255203|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
694594|NCT01450761|2255204|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
694595|NCT01450761|2255203|P2|Lead-in Chemotherapy|Disease progression|32
694596|NCT01450761|2255204|P1|Lead-in Chemotherapy|Disease progression|33
694597|NCT01450761|2255203|P2|Randomization|Unspecified|1
694598|NCT01450761|2255204|P1|Randomization|Unspecified|0
694599|NCT01450761|2255203|P2|Randomization|Adverse Event unrelated to study drug|0
694600|NCT01450761|2255204|P1|Randomization|Adverse Event unrelated to study drug|1
694601|NCT01450761|2255203|P2|Randomization|Disease progression|2
694602|NCT01450761|2255204|P1|Randomization|Disease progression|0
694603|NCT01450761|2255203|P2|Randomization|Withdrawal by Subject|0
694604|NCT01450761|2255204|P1|Randomization|Withdrawal by Subject|2
694605|NCT01450761|2255203|P2|Randomization|Subject no longer meets study criteria|2
694606|NCT01450761|2255204|P1|Randomization|Subject no longer meets study criteria|1
694607|NCT01450696|2255216|P2|Overall Study|Study Terminated by Sponsor|58
694608|NCT01450696|2255217|P1|Overall Study|Study Terminated by Sponsor|53
694609|NCT01450696|2255216|P2|Overall Study|Withdrawal by Subject|2
694610|NCT01450696|2255217|P1|Overall Study|Withdrawal by Subject|13
694611|NCT01450696|2255216|P2|Overall Study|Non-Compliance|0
694612|NCT01450696|2255217|P1|Overall Study|Non-Compliance|1
694613|NCT01450696|2255216|P2|Overall Study|Lost to Follow-up|3
694614|NCT01450696|2255217|P1|Overall Study|Lost to Follow-up|3
694615|NCT01450696|2255216|P2|Overall Study|Death|84
694616|NCT01450696|2255217|P1|Overall Study|Death|77
694617|NCT01450696|2255216|P2|Overall Study|Never Treated|1
694618|NCT01450696|2255217|P1|Overall Study|Never Treated|1
694619|NCT01450683|2255239|P1|Overall Study|Adverse Event|2
694620|NCT01450631|2255245|P2|Overall Study|Withdrawal by Subject|0
694621|NCT01450631|2255246|P1|Overall Study|Withdrawal by Subject|1
694622|NCT01450631|2255245|P2|Overall Study|Lost to Follow-up|4
694623|NCT01450631|2255246|P1|Overall Study|Lost to Follow-up|2
694624|NCT01450007|2255377|P3|Overall Study|Adverse Event|0
694625|NCT01450007|2255378|P2|Overall Study|Adverse Event|1
694626|NCT01450007|2255379|P1|Overall Study|Adverse Event|0
694627|NCT01450007|2255377|P3|Overall Study|Protocol Violation|1
694628|NCT01450007|2255378|P2|Overall Study|Protocol Violation|1
694629|NCT01450007|2255379|P1|Overall Study|Protocol Violation|0
694630|NCT01450007|2255377|P3|Overall Study|Late exclusion before treatment|2
694631|NCT01450007|2255378|P2|Overall Study|Late exclusion before treatment|3
694632|NCT01450007|2255379|P1|Overall Study|Late exclusion before treatment|2
694633|NCT01449955|2255398|P2|Overall Study|Withdrawal by Subject|2
694634|NCT01449955|2255399|P1|Overall Study|Withdrawal by Subject|1
889382|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
889383|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
889384|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
889385|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
889386|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Physician Decision|1
889387|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Physician Decision|1
889388|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Physician Decision|3
889389|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Physician Decision|0
889390|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
889391|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
889392|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
889393|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
694651|NCT01449812|2255447|P3|Overall Study|Lost to Follow-up|0
694652|NCT01449812|2255448|P2|Overall Study|Lost to Follow-up|0
694653|NCT01449812|2255449|P1|Overall Study|Lost to Follow-up|1
694654|NCT01449812|2255447|P3|Overall Study|Withdrawal by Subject|1
694655|NCT01449812|2255448|P2|Overall Study|Withdrawal by Subject|0
694656|NCT01449812|2255449|P1|Overall Study|Withdrawal by Subject|0
694657|NCT01449812|2255447|P3|Overall Study|Migrated/moved from study area|0
694658|NCT01449812|2255448|P2|Overall Study|Migrated/moved from study area|0
694659|NCT01449812|2255449|P1|Overall Study|Migrated/moved from study area|1
694660|NCT01449721|2255564|P2|Overall Study|Physician Decision|1
694661|NCT01449721|2255565|P1|Overall Study|Physician Decision|0
694662|NCT01449721|2255564|P2|Overall Study|Physician Decision|1
694663|NCT01449721|2255565|P1|Overall Study|Physician Decision|0
694664|NCT01449708|2255577|P2|Overall Study|respiratory failure|0
694665|NCT01449708|2255578|P1|Overall Study|respiratory failure|1
694666|NCT01449708|2255577|P2|Overall Study|surgical complication|2
694667|NCT01449708|2255578|P1|Overall Study|surgical complication|1
694668|NCT01449708|2255577|P2|Overall Study|Protocol Violation|1
694669|NCT01449708|2255578|P1|Overall Study|Protocol Violation|0
694670|NCT01449682|2255589|P2|Overall Study|Adverse Event|0
694671|NCT01449682|2255590|P1|Overall Study|Adverse Event|1
694672|NCT01449682|2255589|P2|Overall Study|Death|1
694673|NCT01449682|2255590|P1|Overall Study|Death|0
694674|NCT01449539|2255602|P1|Overall Study|Toxicity not study related|1
694675|NCT01449539|2255602|P1|Overall Study|Withdrawal by Subject|3
694676|NCT01449526|2255608|P2|Overall Study|Cannot maintain visits|1
694677|NCT01449526|2255609|P1|Overall Study|Cannot maintain visits|0
694678|NCT01449526|2255608|P2|Overall Study|Lack of Motivation|1
694679|NCT01449526|2255609|P1|Overall Study|Lack of Motivation|0
694680|NCT01449526|2255608|P2|Overall Study|Symptoms/complaints|1
694681|NCT01449526|2255609|P1|Overall Study|Symptoms/complaints|0
694682|NCT01449526|2255608|P2|Overall Study|Withdrawal by Subject|1
694683|NCT01449526|2255609|P1|Overall Study|Withdrawal by Subject|1
694684|NCT01449526|2255608|P2|Overall Study|Lost to Follow-up|2
694685|NCT01449526|2255609|P1|Overall Study|Lost to Follow-up|1
694686|NCT01449461|2255678|P6|Overall Study|Reason not specified|1
694687|NCT01449461|2255679|P5|Overall Study|Reason not specified|0
694688|NCT01449461|2255680|P4|Overall Study|Reason not specified|3
694689|NCT01449461|2255681|P3|Overall Study|Reason not specified|0
694690|NCT01449461|2255682|P2|Overall Study|Reason not specified|1
694691|NCT01449461|2255683|P1|Overall Study|Reason not specified|0
694692|NCT01449461|2255678|P6|Overall Study|Clinical progressive disease|3
694693|NCT01449461|2255679|P5|Overall Study|Clinical progressive disease|3
694694|NCT01449461|2255680|P4|Overall Study|Clinical progressive disease|0
694695|NCT01449461|2255681|P3|Overall Study|Clinical progressive disease|0
694696|NCT01449461|2255682|P2|Overall Study|Clinical progressive disease|1
694697|NCT01449461|2255683|P1|Overall Study|Clinical progressive disease|2
694698|NCT01449461|2255678|P6|Overall Study|Documented progressive disease|5
694699|NCT01449461|2255679|P5|Overall Study|Documented progressive disease|21
694700|NCT01449461|2255680|P4|Overall Study|Documented progressive disease|11
694701|NCT01449461|2255681|P3|Overall Study|Documented progressive disease|14
694702|NCT01449461|2255682|P2|Overall Study|Documented progressive disease|6
694703|NCT01449461|2255683|P1|Overall Study|Documented progressive disease|4
694704|NCT01449461|2255678|P6|Overall Study|Death|1
694705|NCT01449461|2255679|P5|Overall Study|Death|4
694706|NCT01449461|2255680|P4|Overall Study|Death|0
694707|NCT01449461|2255681|P3|Overall Study|Death|0
694708|NCT01449461|2255682|P2|Overall Study|Death|1
694709|NCT01449461|2255683|P1|Overall Study|Death|0
694710|NCT01449461|2255678|P6|Overall Study|Adverse Event|3
694711|NCT01449461|2255679|P5|Overall Study|Adverse Event|3
694712|NCT01449461|2255680|P4|Overall Study|Adverse Event|3
694713|NCT01449461|2255681|P3|Overall Study|Adverse Event|2
694714|NCT01449461|2255682|P2|Overall Study|Adverse Event|3
694715|NCT01449461|2255683|P1|Overall Study|Adverse Event|0
694716|NCT01449461|2255678|P6|Overall Study|Ongoing|2
694717|NCT01449461|2255679|P5|Overall Study|Ongoing|17
694718|NCT01449461|2255680|P4|Overall Study|Ongoing|15
694719|NCT01449461|2255681|P3|Overall Study|Ongoing|2
694720|NCT01449461|2255682|P2|Overall Study|Ongoing|6
694721|NCT01449461|2255683|P1|Overall Study|Ongoing|0
694722|NCT01449370|2255820|P25|Overall Study|Death|1
694723|NCT01449370|2255821|P24|Overall Study|Death|0
694724|NCT01449370|2255822|P23|Overall Study|Death|0
694725|NCT01449370|2255823|P22|Overall Study|Death|0
694726|NCT01449370|2255824|P21|Overall Study|Death|0
694727|NCT01449370|2255825|P20|Overall Study|Death|0
694728|NCT01449370|2255826|P19|Overall Study|Death|0
694729|NCT01449370|2255827|P18|Overall Study|Death|0
694730|NCT01449370|2255828|P17|Overall Study|Death|0
694731|NCT01449370|2255829|P16|Overall Study|Death|0
694732|NCT01449370|2255830|P15|Overall Study|Death|0
694733|NCT01449370|2255831|P14|Overall Study|Death|0
694734|NCT01449370|2255832|P13|Overall Study|Death|0
694735|NCT01449370|2255833|P12|Overall Study|Death|0
694736|NCT01449370|2255834|P11|Overall Study|Death|0
694737|NCT01449370|2255835|P10|Overall Study|Death|0
694738|NCT01449370|2255836|P9|Overall Study|Death|0
694739|NCT01449370|2255837|P8|Overall Study|Death|0
694740|NCT01449370|2255838|P7|Overall Study|Death|0
694741|NCT01449370|2255839|P6|Overall Study|Death|0
694742|NCT01449370|2255840|P5|Overall Study|Death|0
694743|NCT01449370|2255841|P4|Overall Study|Death|0
694744|NCT01449370|2255842|P3|Overall Study|Death|0
694745|NCT01449370|2255843|P2|Overall Study|Death|0
694746|NCT01449370|2255844|P1|Overall Study|Death|0
694747|NCT01449370|2255820|P25|Overall Study|Medication Prohibited by Protocol|0
694748|NCT01449370|2255821|P24|Overall Study|Medication Prohibited by Protocol|1
694749|NCT01449370|2255822|P23|Overall Study|Medication Prohibited by Protocol|0
694750|NCT01449370|2255823|P22|Overall Study|Medication Prohibited by Protocol|0
694751|NCT01449370|2255824|P21|Overall Study|Medication Prohibited by Protocol|0
694752|NCT01449370|2255825|P20|Overall Study|Medication Prohibited by Protocol|0
694753|NCT01449370|2255826|P19|Overall Study|Medication Prohibited by Protocol|0
694754|NCT01449370|2255827|P18|Overall Study|Medication Prohibited by Protocol|0
694755|NCT01449370|2255828|P17|Overall Study|Medication Prohibited by Protocol|0
694756|NCT01449370|2255829|P16|Overall Study|Medication Prohibited by Protocol|0
694757|NCT01449370|2255830|P15|Overall Study|Medication Prohibited by Protocol|0
694758|NCT01449370|2255831|P14|Overall Study|Medication Prohibited by Protocol|0
694759|NCT01449370|2255832|P13|Overall Study|Medication Prohibited by Protocol|0
694760|NCT01449370|2255833|P12|Overall Study|Medication Prohibited by Protocol|0
694761|NCT01449370|2255834|P11|Overall Study|Medication Prohibited by Protocol|0
694762|NCT01449370|2255835|P10|Overall Study|Medication Prohibited by Protocol|0
694763|NCT01449370|2255836|P9|Overall Study|Medication Prohibited by Protocol|0
694764|NCT01449370|2255837|P8|Overall Study|Medication Prohibited by Protocol|0
694765|NCT01449370|2255838|P7|Overall Study|Medication Prohibited by Protocol|0
694766|NCT01449370|2255839|P6|Overall Study|Medication Prohibited by Protocol|0
694767|NCT01449370|2255840|P5|Overall Study|Medication Prohibited by Protocol|0
694768|NCT01449370|2255841|P4|Overall Study|Medication Prohibited by Protocol|0
694769|NCT01449370|2255842|P3|Overall Study|Medication Prohibited by Protocol|0
694770|NCT01449370|2255843|P2|Overall Study|Medication Prohibited by Protocol|0
694771|NCT01449370|2255844|P1|Overall Study|Medication Prohibited by Protocol|0
694772|NCT01449370|2255820|P25|Overall Study|Other|0
694773|NCT01449370|2255821|P24|Overall Study|Other|1
694774|NCT01449370|2255822|P23|Overall Study|Other|1
694775|NCT01449370|2255823|P22|Overall Study|Other|0
694776|NCT01449370|2255824|P21|Overall Study|Other|0
694777|NCT01449370|2255825|P20|Overall Study|Other|0
694778|NCT01449370|2255826|P19|Overall Study|Other|0
694779|NCT01449370|2255827|P18|Overall Study|Other|0
694780|NCT01449370|2255828|P17|Overall Study|Other|0
694781|NCT01449370|2255829|P16|Overall Study|Other|0
694782|NCT01449370|2255830|P15|Overall Study|Other|0
694783|NCT01449370|2255831|P14|Overall Study|Other|0
694784|NCT01449370|2255832|P13|Overall Study|Other|0
694785|NCT01449370|2255833|P12|Overall Study|Other|0
694786|NCT01449370|2255834|P11|Overall Study|Other|0
694787|NCT01449370|2255835|P10|Overall Study|Other|1
694788|NCT01449370|2255836|P9|Overall Study|Other|1
694789|NCT01449370|2255837|P8|Overall Study|Other|0
694790|NCT01449370|2255838|P7|Overall Study|Other|0
694791|NCT01449370|2255839|P6|Overall Study|Other|0
694792|NCT01449370|2255840|P5|Overall Study|Other|0
694793|NCT01449370|2255841|P4|Overall Study|Other|0
694794|NCT01449370|2255842|P3|Overall Study|Other|0
694795|NCT01449370|2255843|P2|Overall Study|Other|0
694796|NCT01449370|2255844|P1|Overall Study|Other|0
694797|NCT01449370|2255820|P25|Overall Study|Lost to Follow-up|0
694798|NCT01449370|2255821|P24|Overall Study|Lost to Follow-up|0
694799|NCT01449370|2255822|P23|Overall Study|Lost to Follow-up|0
694800|NCT01449370|2255823|P22|Overall Study|Lost to Follow-up|0
694801|NCT01449370|2255824|P21|Overall Study|Lost to Follow-up|1
694802|NCT01449370|2255825|P20|Overall Study|Lost to Follow-up|0
694803|NCT01449370|2255826|P19|Overall Study|Lost to Follow-up|0
694804|NCT01449370|2255827|P18|Overall Study|Lost to Follow-up|0
694805|NCT01449370|2255828|P17|Overall Study|Lost to Follow-up|0
694806|NCT01449370|2255829|P16|Overall Study|Lost to Follow-up|0
694807|NCT01449370|2255830|P15|Overall Study|Lost to Follow-up|0
694808|NCT01449370|2255831|P14|Overall Study|Lost to Follow-up|0
694809|NCT01449370|2255832|P13|Overall Study|Lost to Follow-up|0
694810|NCT01449370|2255833|P12|Overall Study|Lost to Follow-up|0
694811|NCT01449370|2255834|P11|Overall Study|Lost to Follow-up|0
694812|NCT01449370|2255835|P10|Overall Study|Lost to Follow-up|0
694813|NCT01449370|2255836|P9|Overall Study|Lost to Follow-up|0
694814|NCT01449370|2255837|P8|Overall Study|Lost to Follow-up|0
694815|NCT01449370|2255838|P7|Overall Study|Lost to Follow-up|0
694816|NCT01449370|2255839|P6|Overall Study|Lost to Follow-up|0
694817|NCT01449370|2255840|P5|Overall Study|Lost to Follow-up|0
694818|NCT01449370|2255841|P4|Overall Study|Lost to Follow-up|0
694819|NCT01449370|2255842|P3|Overall Study|Lost to Follow-up|0
694820|NCT01449370|2255843|P2|Overall Study|Lost to Follow-up|0
694821|NCT01449370|2255844|P1|Overall Study|Lost to Follow-up|0
694822|NCT01449370|2255820|P25|Overall Study|Participant Decision|1
694823|NCT01449370|2255821|P24|Overall Study|Participant Decision|0
694824|NCT01449370|2255822|P23|Overall Study|Participant Decision|0
694825|NCT01449370|2255823|P22|Overall Study|Participant Decision|1
694826|NCT01449370|2255824|P21|Overall Study|Participant Decision|0
694827|NCT01449370|2255825|P20|Overall Study|Participant Decision|0
694828|NCT01449370|2255826|P19|Overall Study|Participant Decision|1
694829|NCT01449370|2255827|P18|Overall Study|Participant Decision|0
694830|NCT01449370|2255828|P17|Overall Study|Participant Decision|3
694831|NCT01449370|2255829|P16|Overall Study|Participant Decision|1
694832|NCT01449370|2255830|P15|Overall Study|Participant Decision|0
694833|NCT01449370|2255831|P14|Overall Study|Participant Decision|1
694834|NCT01449370|2255832|P13|Overall Study|Participant Decision|1
694835|NCT01449370|2255833|P12|Overall Study|Participant Decision|0
694836|NCT01449370|2255834|P11|Overall Study|Participant Decision|0
694837|NCT01449370|2255835|P10|Overall Study|Participant Decision|0
694838|NCT01449370|2255836|P9|Overall Study|Participant Decision|1
694839|NCT01449370|2255837|P8|Overall Study|Participant Decision|1
694840|NCT01449370|2255838|P7|Overall Study|Participant Decision|0
694841|NCT01449370|2255839|P6|Overall Study|Participant Decision|0
694842|NCT01449370|2255840|P5|Overall Study|Participant Decision|0
694843|NCT01449370|2255841|P4|Overall Study|Participant Decision|0
694844|NCT01449370|2255842|P3|Overall Study|Participant Decision|0
694845|NCT01449370|2255843|P2|Overall Study|Participant Decision|0
694846|NCT01449370|2255844|P1|Overall Study|Participant Decision|0
694847|NCT01449370|2255820|P25|Overall Study|Adverse Event|3
694848|NCT01449370|2255821|P24|Overall Study|Adverse Event|1
694849|NCT01449370|2255822|P23|Overall Study|Adverse Event|0
694850|NCT01449370|2255823|P22|Overall Study|Adverse Event|1
694851|NCT01449370|2255824|P21|Overall Study|Adverse Event|0
694852|NCT01449370|2255825|P20|Overall Study|Adverse Event|1
694853|NCT01449370|2255826|P19|Overall Study|Adverse Event|1
694854|NCT01449370|2255827|P18|Overall Study|Adverse Event|0
694855|NCT01449370|2255828|P17|Overall Study|Adverse Event|0
694856|NCT01449370|2255829|P16|Overall Study|Adverse Event|1
694857|NCT01449370|2255830|P15|Overall Study|Adverse Event|0
694858|NCT01449370|2255831|P14|Overall Study|Adverse Event|2
694859|NCT01449370|2255832|P13|Overall Study|Adverse Event|0
694860|NCT01449370|2255833|P12|Overall Study|Adverse Event|0
694861|NCT01449370|2255834|P11|Overall Study|Adverse Event|0
694862|NCT01449370|2255835|P10|Overall Study|Adverse Event|1
694863|NCT01449370|2255836|P9|Overall Study|Adverse Event|1
694864|NCT01449370|2255837|P8|Overall Study|Adverse Event|0
694865|NCT01449370|2255838|P7|Overall Study|Adverse Event|0
694866|NCT01449370|2255839|P6|Overall Study|Adverse Event|0
694867|NCT01449370|2255840|P5|Overall Study|Adverse Event|0
694868|NCT01449370|2255841|P4|Overall Study|Adverse Event|1
694869|NCT01449370|2255842|P3|Overall Study|Adverse Event|0
694870|NCT01449370|2255843|P2|Overall Study|Adverse Event|2
694871|NCT01449370|2255844|P1|Overall Study|Adverse Event|1
694872|NCT01449370|2255820|P25|Overall Study|Disease Progression|3
694873|NCT01449370|2255821|P24|Overall Study|Disease Progression|7
694874|NCT01449370|2255822|P23|Overall Study|Disease Progression|3
694875|NCT01449370|2255823|P22|Overall Study|Disease Progression|2
694876|NCT01449370|2255824|P21|Overall Study|Disease Progression|5
694877|NCT01449370|2255825|P20|Overall Study|Disease Progression|2
694878|NCT01449370|2255826|P19|Overall Study|Disease Progression|1
694879|NCT01449370|2255827|P18|Overall Study|Disease Progression|3
694880|NCT01449370|2255828|P17|Overall Study|Disease Progression|4
694881|NCT01449370|2255829|P16|Overall Study|Disease Progression|1
694882|NCT01449370|2255830|P15|Overall Study|Disease Progression|3
694883|NCT01449370|2255831|P14|Overall Study|Disease Progression|8
694884|NCT01449370|2255832|P13|Overall Study|Disease Progression|2
694885|NCT01449370|2255833|P12|Overall Study|Disease Progression|3
694886|NCT01449370|2255834|P11|Overall Study|Disease Progression|3
694887|NCT01449370|2255835|P10|Overall Study|Disease Progression|1
694888|NCT01449370|2255836|P9|Overall Study|Disease Progression|9
694889|NCT01449370|2255837|P8|Overall Study|Disease Progression|2
694890|NCT01449370|2255838|P7|Overall Study|Disease Progression|3
694891|NCT01449370|2255839|P6|Overall Study|Disease Progression|3
694892|NCT01449370|2255840|P5|Overall Study|Disease Progression|3
694893|NCT01449370|2255841|P4|Overall Study|Disease Progression|3
694894|NCT01449370|2255842|P3|Overall Study|Disease Progression|8
694895|NCT01449370|2255843|P2|Overall Study|Disease Progression|4
694896|NCT01449370|2255844|P1|Overall Study|Disease Progression|5
694897|NCT01449279|2256222|P1|Overall Study|Toxicity|2
694898|NCT01449279|2256222|P1|Overall Study|Lack of Efficacy|5
694899|NCT01449006|2256247|P2|Overall Study|Protocol Violation|0
694900|NCT01449006|2256248|P1|Overall Study|Protocol Violation|1
694901|NCT01449006|2256247|P2|Overall Study|Withdrawal by Subject|0
694902|NCT01449006|2256248|P1|Overall Study|Withdrawal by Subject|1
694903|NCT01449006|2256247|P2|Overall Study|Lost to Follow-up|0
694904|NCT01449006|2256248|P1|Overall Study|Lost to Follow-up|1
694905|NCT01448850|2256262|P2|Overall Study|Unspecified|12
694906|NCT01448850|2256263|P1|Overall Study|Unspecified|15
694907|NCT01448850|2256262|P2|Overall Study|Lost to Follow-up|1
694908|NCT01448850|2256263|P1|Overall Study|Lost to Follow-up|3
694909|NCT01448850|2256262|P2|Overall Study|Withdrawal by Subject|21
694910|NCT01448850|2256263|P1|Overall Study|Withdrawal by Subject|13
694911|NCT01448850|2256262|P2|Overall Study|Death|6
694912|NCT01448850|2256263|P1|Overall Study|Death|3
694921|NCT01448616|2256310|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
694922|NCT01448616|2256311|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
694923|NCT01448616|2256312|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
694924|NCT01448616|2256313|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
694925|NCT01448616|2256310|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
694926|NCT01448616|2256311|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
694927|NCT01448616|2256312|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
694928|NCT01448616|2256313|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
694929|NCT01448616|2256310|P4|Study Drug (Treatment Phase)|Adverse Event|0
694930|NCT01448616|2256311|P3|Study Drug (Treatment Phase)|Adverse Event|1
694931|NCT01448616|2256312|P2|Study Drug (Treatment Phase)|Adverse Event|1
694932|NCT01448616|2256313|P1|Study Drug (Treatment Phase)|Adverse Event|0
694933|NCT01448616|2256310|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
694934|NCT01448616|2256311|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
694935|NCT01448616|2256312|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
694936|NCT01448616|2256313|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
694937|NCT01448616|2256310|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
694938|NCT01448616|2256311|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
694939|NCT01448616|2256312|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
694940|NCT01448616|2256313|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
694941|NCT01448213|2256360|P2|Overall Study|Protocol Violation|2
694942|NCT01448213|2256361|P1|Overall Study|Protocol Violation|1
694943|NCT01448213|2256360|P2|Overall Study|Adverse Event|10
694944|NCT01448213|2256361|P1|Overall Study|Adverse Event|4
694945|NCT01448213|2256360|P2|Overall Study|Lost to Follow-up|10
694946|NCT01448213|2256361|P1|Overall Study|Lost to Follow-up|12
694947|NCT01448057|2256371|P2|Overall Study|Withdrawal by Subject|0
694948|NCT01448057|2256372|P1|Overall Study|Withdrawal by Subject|2
694949|NCT01448057|2256371|P2|Overall Study|Adverse Event|2
694950|NCT01448057|2256372|P1|Overall Study|Adverse Event|0
694951|NCT01448057|2256371|P2|Overall Study|Lost to Follow-up|0
694952|NCT01448057|2256372|P1|Overall Study|Lost to Follow-up|3
694953|NCT01448057|2256371|P2|Overall Study|Protocol Violation|2
694954|NCT01448057|2256372|P1|Overall Study|Protocol Violation|3
694955|NCT01448044|2256382|P2|Follow Up Period|not specified|11
694956|NCT01448044|2256383|P1|Follow Up Period|not specified|5
694957|NCT01448044|2256382|P2|Follow Up Period|Lost to Follow-up|2
694958|NCT01448044|2256383|P1|Follow Up Period|Lost to Follow-up|6
694959|NCT01448044|2256382|P2|Follow Up Period|Withdrawal by Subject|1
694960|NCT01448044|2256383|P1|Follow Up Period|Withdrawal by Subject|1
694961|NCT01448044|2256382|P2|Treatment Period|Other reason|0
694962|NCT01448044|2256383|P1|Treatment Period|Other reason|2
694963|NCT01448044|2256382|P2|Treatment Period|Lost to Follow-up|1
694964|NCT01448044|2256383|P1|Treatment Period|Lost to Follow-up|2
694965|NCT01448044|2256382|P2|Treatment Period|Participant does not meet study criteria|0
694966|NCT01448044|2256383|P1|Treatment Period|Participant does not meet study criteria|1
694967|NCT01448044|2256382|P2|Treatment Period|Completed 24 weeks treatment period only|0
694968|NCT01448044|2256383|P1|Treatment Period|Completed 24 weeks treatment period only|8
694969|NCT01448044|2256382|P2|Treatment Period|Subject requested discontinue study drug|0
694970|NCT01448044|2256383|P1|Treatment Period|Subject requested discontinue study drug|1
694971|NCT01448044|2256382|P2|Treatment Period|Lack of Efficacy|12
694972|NCT01448044|2256383|P1|Treatment Period|Lack of Efficacy|5
694973|NCT01448044|2256382|P2|Treatment Period|Adverse Event|3
694974|NCT01448044|2256383|P1|Treatment Period|Adverse Event|4
694975|NCT01447927|2256399|P2|Overall Study|Withdrawal by Subject|0
694976|NCT01447927|2256400|P1|Overall Study|Withdrawal by Subject|1
694977|NCT01447927|2256399|P2|Overall Study|Adverse Event|3
694978|NCT01447927|2256400|P1|Overall Study|Adverse Event|4
694979|NCT01447719|2256430|P1|Overall Study|Family withdrew autopsy consent|7
694980|NCT01447719|2256430|P1|Overall Study|Withdrawal by Subject|2
694981|NCT01447719|2256430|P1|Overall Study|Subject still living at end of study|79
694982|NCT01447719|2256430|P1|Overall Study|Invalid image or not imaged|3
694983|NCT01447719|2256430|P1|Overall Study|Image acquisition failure|2
694984|NCT01447576|2256456|P1|Overall Study|Physician Decision|6
694985|NCT01447576|2256456|P1|Overall Study|Lack of Efficacy|68
694986|NCT01447576|2256456|P1|Overall Study|Protocol deviation|83
694987|NCT01447576|2256456|P1|Overall Study|Withdrawal by Subject|100
694988|NCT01447576|2256456|P1|Overall Study|Participant met withdrawal criteria|40
694989|NCT01447576|2256456|P1|Overall Study|Adverse Event|127
694990|NCT01447576|2256456|P1|Overall Study|Lost to Follow-up|52
694991|NCT01447446|2256489|P6|Overall Study|Reason not Specified|0
694992|NCT01447446|2256490|P5|Overall Study|Reason not Specified|1
694993|NCT01447446|2256491|P4|Overall Study|Reason not Specified|1
694994|NCT01447446|2256492|P3|Overall Study|Reason not Specified|1
694995|NCT01447446|2256493|P2|Overall Study|Reason not Specified|1
694996|NCT01447446|2256494|P1|Overall Study|Reason not Specified|1
694997|NCT01447446|2256489|P6|Overall Study|New Treatment Started|0
694998|NCT01447446|2256490|P5|Overall Study|New Treatment Started|2
694999|NCT01447446|2256491|P4|Overall Study|New Treatment Started|0
695000|NCT01447446|2256492|P3|Overall Study|New Treatment Started|1
695001|NCT01447446|2256493|P2|Overall Study|New Treatment Started|2
695002|NCT01447446|2256494|P1|Overall Study|New Treatment Started|8
695003|NCT01447446|2256489|P6|Overall Study|SVR12 Assessment|5
695004|NCT01447446|2256490|P5|Overall Study|SVR12 Assessment|5
695005|NCT01447446|2256491|P4|Overall Study|SVR12 Assessment|1
695006|NCT01447446|2256492|P3|Overall Study|SVR12 Assessment|2
695007|NCT01447446|2256493|P2|Overall Study|SVR12 Assessment|1
695008|NCT01447446|2256494|P1|Overall Study|SVR12 Assessment|13
695009|NCT01447446|2256489|P6|Overall Study|Administrative/Other|4
695010|NCT01447446|2256490|P5|Overall Study|Administrative/Other|33
695011|NCT01447446|2256491|P4|Overall Study|Administrative/Other|2
695012|NCT01447446|2256492|P3|Overall Study|Administrative/Other|10
695013|NCT01447446|2256493|P2|Overall Study|Administrative/Other|9
695014|NCT01447446|2256494|P1|Overall Study|Administrative/Other|34
695015|NCT01447446|2256489|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
695016|NCT01447446|2256490|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
695017|NCT01447446|2256491|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
695018|NCT01447446|2256492|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
695019|NCT01447446|2256493|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
695020|NCT01447446|2256494|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
695021|NCT01447446|2256489|P6|Overall Study|Failure to Return/Consent Withdrawn|9
695022|NCT01447446|2256490|P5|Overall Study|Failure to Return/Consent Withdrawn|69
695023|NCT01447446|2256491|P4|Overall Study|Failure to Return/Consent Withdrawn|7
695024|NCT01447446|2256492|P3|Overall Study|Failure to Return/Consent Withdrawn|31
695025|NCT01447446|2256493|P2|Overall Study|Failure to Return/Consent Withdrawn|78
695026|NCT01447446|2256494|P1|Overall Study|Failure to Return/Consent Withdrawn|357
695027|NCT01447446|2256489|P6|Overall Study|Adverse Event|0
695028|NCT01447446|2256490|P5|Overall Study|Adverse Event|2
695029|NCT01447446|2256491|P4|Overall Study|Adverse Event|0
695030|NCT01447446|2256492|P3|Overall Study|Adverse Event|1
695031|NCT01447446|2256493|P2|Overall Study|Adverse Event|0
695032|NCT01447446|2256494|P1|Overall Study|Adverse Event|3
695033|NCT01447446|2256489|P6|Overall Study|Death|0
695034|NCT01447446|2256490|P5|Overall Study|Death|7
695035|NCT01447446|2256491|P4|Overall Study|Death|1
695036|NCT01447446|2256492|P3|Overall Study|Death|2
695037|NCT01447446|2256493|P2|Overall Study|Death|3
695038|NCT01447446|2256494|P1|Overall Study|Death|6
695039|NCT01447433|2256584|P2|Overall Study|Protocol Violation|1
695040|NCT01447433|2256585|P1|Overall Study|Protocol Violation|1
695041|NCT01447433|2256584|P2|Overall Study|Withdrawal by Subject|3
695042|NCT01447433|2256585|P1|Overall Study|Withdrawal by Subject|3
695043|NCT01447433|2256584|P2|Overall Study|Lost to Follow-up|2
695044|NCT01447433|2256585|P1|Overall Study|Lost to Follow-up|0
695045|NCT01447420|2256612|P3|Overall Study|Lack of Efficacy|8
695046|NCT01447420|2256613|P2|Overall Study|Lack of Efficacy|19
695047|NCT01447420|2256614|P1|Overall Study|Lack of Efficacy|1
695048|NCT01447420|2256612|P3|Overall Study|Withdrawal by Subject|0
695049|NCT01447420|2256613|P2|Overall Study|Withdrawal by Subject|1
695050|NCT01447420|2256614|P1|Overall Study|Withdrawal by Subject|4
695051|NCT01447420|2256612|P3|Overall Study|Protocol Violation|0
695052|NCT01447420|2256613|P2|Overall Study|Protocol Violation|3
695053|NCT01447420|2256614|P1|Overall Study|Protocol Violation|3
695054|NCT01447420|2256612|P3|Overall Study|Adverse Event|2
695055|NCT01447420|2256613|P2|Overall Study|Adverse Event|4
695056|NCT01447420|2256614|P1|Overall Study|Adverse Event|2
695057|NCT01446796|2256727|P2|Overall Study|Withdrawal by Subject|0
695058|NCT01446796|2256728|P1|Overall Study|Withdrawal by Subject|1
695059|NCT01446419|2256753|P2|Overall Study|Terminated per protocol|0
695060|NCT01446419|2256754|P1|Overall Study|Terminated per protocol|3
695061|NCT01446419|2256753|P2|Overall Study|Withdrawal by Subject|1
695062|NCT01446419|2256754|P1|Overall Study|Withdrawal by Subject|1
695063|NCT01446419|2256753|P2|Overall Study|Death|0
695064|NCT01446419|2256754|P1|Overall Study|Death|1
695065|NCT01446289|2256768|P4|Overall Study|Withdrawal by Subject|0
695066|NCT01446289|2256769|P3|Overall Study|Withdrawal by Subject|1
695067|NCT01446289|2256770|P2|Overall Study|Withdrawal by Subject|0
695068|NCT01446289|2256771|P1|Overall Study|Withdrawal by Subject|1
695069|NCT01446237|2256814|P1|Overall Study|Withdrawal by Subject|7
695070|NCT01446237|2256814|P1|Overall Study|Lost to Follow-up|2
695071|NCT01446237|2256814|P1|Overall Study|Adverse Event|1
695072|NCT01446003|2256822|P2|Period 2|Adverse Event|0
695073|NCT01446003|2256823|P1|Period 2|Adverse Event|1
695074|NCT01446003|2256822|P2|Period 1|Protocol Violation|0
695075|NCT01446003|2256823|P1|Period 1|Protocol Violation|2
695076|NCT01445951|2256844|P3|Overall Study|Cough|0
695077|NCT01445951|2256845|P2|Overall Study|Cough|1
695078|NCT01445951|2256846|P1|Overall Study|Cough|0
695079|NCT01445951|2256844|P3|Overall Study|Sponsor decision - subject travel|0
695080|NCT01445951|2256845|P2|Overall Study|Sponsor decision - subject travel|1
695081|NCT01445951|2256846|P1|Overall Study|Sponsor decision - subject travel|0
695082|NCT01445951|2256844|P3|Overall Study|Non-compliance with protocol|0
695083|NCT01445951|2256845|P2|Overall Study|Non-compliance with protocol|1
695084|NCT01445951|2256846|P1|Overall Study|Non-compliance with protocol|0
695085|NCT01445951|2256844|P3|Overall Study|Non-compliance with study drug|0
695086|NCT01445951|2256845|P2|Overall Study|Non-compliance with study drug|2
695087|NCT01445951|2256846|P1|Overall Study|Non-compliance with study drug|1
695088|NCT01445951|2256844|P3|Overall Study|Death|1
695089|NCT01445951|2256845|P2|Overall Study|Death|0
695090|NCT01445951|2256846|P1|Overall Study|Death|0
695091|NCT01445951|2256844|P3|Overall Study|Pregnancy|4
695092|NCT01445951|2256845|P2|Overall Study|Pregnancy|1
695093|NCT01445951|2256846|P1|Overall Study|Pregnancy|0
695094|NCT01445951|2256844|P3|Overall Study|Lost to Follow-up|4
695095|NCT01445951|2256845|P2|Overall Study|Lost to Follow-up|2
695096|NCT01445951|2256846|P1|Overall Study|Lost to Follow-up|1
695097|NCT01445951|2256844|P3|Overall Study|Physician Decision|0
695098|NCT01445951|2256845|P2|Overall Study|Physician Decision|1
695099|NCT01445951|2256846|P1|Overall Study|Physician Decision|3
695100|NCT01445951|2256844|P3|Overall Study|Withdrawal by Subject|8
695101|NCT01445951|2256845|P2|Overall Study|Withdrawal by Subject|16
695102|NCT01445951|2256846|P1|Overall Study|Withdrawal by Subject|21
695103|NCT01445951|2256844|P3|Overall Study|Protocol Violation|2
695104|NCT01445951|2256845|P2|Overall Study|Protocol Violation|2
695105|NCT01445951|2256846|P1|Overall Study|Protocol Violation|2
695106|NCT01445951|2256844|P3|Overall Study|Adverse Event|0
695107|NCT01445951|2256845|P2|Overall Study|Adverse Event|9
695108|NCT01445951|2256846|P1|Overall Study|Adverse Event|16
695109|NCT01445847|2256914|P2|Overall Study|Missed Data|0
695110|NCT01445847|2256915|P1|Overall Study|Missed Data|1
695111|NCT01445847|2256914|P2|Overall Study|Protocol Violation|14
695112|NCT01445847|2256915|P1|Overall Study|Protocol Violation|13
695113|NCT01445769|2256921|P1|Overall Study|Lost to Follow-up|5
695114|NCT01445769|2256921|P1|Overall Study|Disease Progression|1
695115|NCT01445769|2256921|P1|Overall Study|Consent Withdrawn|2
695116|NCT01445678|2256941|P2|Overall Study|Withdrawal by Subject|5
695117|NCT01445678|2256942|P1|Overall Study|Withdrawal by Subject|9
695118|NCT01445678|2256941|P2|Overall Study|Protocol Violation|1
695119|NCT01445678|2256942|P1|Overall Study|Protocol Violation|1
695120|NCT01445678|2256941|P2|Overall Study|Lost to Follow-up|5
695121|NCT01445678|2256942|P1|Overall Study|Lost to Follow-up|8
695122|NCT01445678|2256941|P2|Overall Study|Lack of Efficacy|2
695123|NCT01445678|2256942|P1|Overall Study|Lack of Efficacy|0
695124|NCT01445678|2256941|P2|Overall Study|Adverse Event|8
695125|NCT01445678|2256942|P1|Overall Study|Adverse Event|12
695126|NCT01445652|2256960|P2|Overall Study|Adverse Event|0
695127|NCT01445652|2256961|P1|Overall Study|Adverse Event|1
695128|NCT01445652|2256960|P2|Overall Study|Failed teach session|0
695129|NCT01445652|2256961|P1|Overall Study|Failed teach session|2
695130|NCT01445652|2256960|P2|Overall Study|Failed to attend scheduled visit|3
695131|NCT01445652|2256961|P1|Overall Study|Failed to attend scheduled visit|2
695132|NCT01445652|2256960|P2|Overall Study|Not comfortable in lenses|0
695133|NCT01445652|2256961|P1|Overall Study|Not comfortable in lenses|5
695134|NCT01445613|2256979|P1|1-year Follow-up|Received a non-study stent|2
695135|NCT01445613|2256979|P1|1-year Follow-up|Physician Decision|2
695136|NCT01445613|2256979|P1|1-year Follow-up|Death|30
695137|NCT01445613|2256979|P1|1-year Follow-up|Lost to Follow-up|2
695138|NCT01445613|2256979|P1|1-year Follow-up|Missed visit|29
695139|NCT01445613|2256979|P1|1-year Follow-up|Withdrawal by Subject|12
695140|NCT01445613|2256979|P1|30-day Follow-up|Death|3
695141|NCT01445613|2256979|P1|30-day Follow-up|Missed visit|23
695142|NCT01445613|2256979|P1|30-day Follow-up|Physician Decision|3
695143|NCT01445613|2256979|P1|30-day Follow-up|Withdrawal by Subject|6
695144|NCT01445548|2256997|P1|Overall Study|Adverse Event|1
695145|NCT01444898|2257051|P1|Overall Study|Withdrawal by Subject|1
695146|NCT01444781|2257066|P3|Overall Study|Withdrawal by Subject|2
695147|NCT01444781|2257067|P2|Overall Study|Withdrawal by Subject|1
695148|NCT01444781|2257068|P1|Overall Study|Withdrawal by Subject|3
695149|NCT01444781|2257066|P3|Overall Study|Lost to Follow-up|1
695150|NCT01444781|2257067|P2|Overall Study|Lost to Follow-up|3
695151|NCT01444781|2257068|P1|Overall Study|Lost to Follow-up|0
695152|NCT01444651|2257108|P2|Overall Study|Missing data|1
695153|NCT01444651|2257109|P1|Overall Study|Missing data|1
695154|NCT01444651|2257108|P2|Overall Study|Non-fasting|1
695155|NCT01444651|2257109|P1|Overall Study|Non-fasting|2
695156|NCT01444651|2257108|P2|Overall Study|Lost to Follow-up|5
695157|NCT01444651|2257109|P1|Overall Study|Lost to Follow-up|5
695158|NCT01444651|2257108|P2|Overall Study|Adverse Event|2
695159|NCT01444651|2257109|P1|Overall Study|Adverse Event|3
695160|NCT01444456|2257125|P1|Overall Study|Not treated|104
695161|NCT01444456|2257125|P1|Overall Study|Other|18
695162|NCT01444456|2257125|P1|Overall Study|Ineligibility determined|23
695163|NCT01444456|2257125|P1|Overall Study|Death|73
695164|NCT01444456|2257125|P1|Overall Study|Lost to Follow-up|37
695165|NCT01444456|2257125|P1|Overall Study|Physician Decision|9
695166|NCT01444456|2257125|P1|Overall Study|Withdrawal by Subject|21
695167|NCT01444430|2257136|P2|Overall Study|CRF termination module not completed.|1
695168|NCT01444430|2257137|P1|Overall Study|CRF termination module not completed.|0
695169|NCT01444430|2257136|P2|Overall Study|Lost to Follow-up|0
695170|NCT01444430|2257137|P1|Overall Study|Lost to Follow-up|2
695171|NCT01444430|2257136|P2|Overall Study|Death|8
695172|NCT01444430|2257137|P1|Overall Study|Death|6
695173|NCT01444430|2257136|P2|Overall Study|Withdrawal by Subject|72
695174|NCT01444430|2257137|P1|Overall Study|Withdrawal by Subject|53
695175|NCT01444417|2257159|P2|Overall Study|Withdrawal by Subject|0
695176|NCT01444417|2257160|P1|Overall Study|Withdrawal by Subject|2
695177|NCT01444417|2257159|P2|Overall Study|Ineligibility Determined|1
695178|NCT01444417|2257160|P1|Overall Study|Ineligibility Determined|0
695179|NCT01444391|2257176|P1|Overall Study|Death|1
695180|NCT01444378|2257184|P1|Overall Study|Missed Visits|10
695181|NCT01444378|2257184|P1|Overall Study|Administrative Closure Of The Study|2
695182|NCT01444378|2257184|P1|Overall Study|Death|3
695183|NCT01444378|2257184|P1|Overall Study|Withdrawal by Subject|1
695184|NCT01444378|2257184|P1|Overall Study|Lost to Follow-up|1
695185|NCT01444300|2257296|P2|Overall Study|Adverse Event|0
695186|NCT01444300|2257297|P1|Overall Study|Adverse Event|4
695187|NCT01444092|2257329|P1|Overall Study|Other Eligibility criteria|7
695188|NCT01444092|2257329|P1|Overall Study|Withdrawal by Subject|1
695189|NCT01444092|2257329|P1|Overall Study|Protocol Violation|1
695190|NCT01444092|2257329|P1|Overall Study|Adverse Event|8
695191|NCT01443923|2257337|P2|Overall Study|Adverse Event|0
695192|NCT01443923|2257338|P1|Overall Study|Adverse Event|1
695193|NCT01443858|2257355|P3|Overall Study|Lost to Follow-up|2
695194|NCT01443858|2257356|P2|Overall Study|Lost to Follow-up|5
695195|NCT01443858|2257357|P1|Overall Study|Lost to Follow-up|5
695196|NCT01443858|2257355|P3|Overall Study|Lack of Efficacy|0
695197|NCT01443858|2257356|P2|Overall Study|Lack of Efficacy|0
695198|NCT01443858|2257357|P1|Overall Study|Lack of Efficacy|1
695199|NCT01443858|2257355|P3|Overall Study|Withdrawal by Subject|5
695200|NCT01443858|2257356|P2|Overall Study|Withdrawal by Subject|8
695201|NCT01443858|2257357|P1|Overall Study|Withdrawal by Subject|9
695202|NCT01443845|2257379|P2|Overall Study|Lost to Follow-up|13
695203|NCT01443845|2257380|P1|Overall Study|Lost to Follow-up|9
695204|NCT01443845|2257379|P2|Overall Study|Military Conflict - Site Terminated|21
695205|NCT01443845|2257380|P1|Overall Study|Military Conflict - Site Terminated|20
695206|NCT01443845|2257379|P2|Overall Study|Withdrawal by Subject|67
695207|NCT01443845|2257380|P1|Overall Study|Withdrawal by Subject|63
695208|NCT01443845|2257379|P2|Overall Study|Adverse Event|138
695209|NCT01443845|2257380|P1|Overall Study|Adverse Event|64
695210|NCT01443845|2257379|P2|Overall Study|Lack of Efficacy|5
695211|NCT01443845|2257380|P1|Overall Study|Lack of Efficacy|10
695212|NCT01443845|2257379|P2|Overall Study|Deterioration in pulmonary function|4
695213|NCT01443845|2257380|P1|Overall Study|Deterioration in pulmonary function|1
695214|NCT01443845|2257379|P2|Overall Study|Other reasons, such as COPD exacerbation|44
695215|NCT01443845|2257380|P1|Overall Study|Other reasons, such as COPD exacerbation|44
695216|NCT01443845|2257379|P2|Overall Study|Protocol Violation|45
695217|NCT01443845|2257380|P1|Overall Study|Protocol Violation|43
695218|NCT01443403|2257401|P4|Overall Study|Other - Miscellaneous|1
695219|NCT01443403|2257402|P3|Overall Study|Other - Miscellaneous|0
695220|NCT01443403|2257403|P2|Overall Study|Other - Miscellaneous|0
695221|NCT01443403|2257404|P1|Overall Study|Other - Miscellaneous|1
695222|NCT01443403|2257401|P4|Overall Study|Use of Prohibited Treatment|0
695223|NCT01443403|2257402|P3|Overall Study|Use of Prohibited Treatment|0
695224|NCT01443403|2257403|P2|Overall Study|Use of Prohibited Treatment|3
695225|NCT01443403|2257404|P1|Overall Study|Use of Prohibited Treatment|2
695226|NCT01443403|2257401|P4|Overall Study|Protocol Violation|1
695227|NCT01443403|2257402|P3|Overall Study|Protocol Violation|1
695228|NCT01443403|2257403|P2|Overall Study|Protocol Violation|1
695229|NCT01443403|2257404|P1|Overall Study|Protocol Violation|2
695230|NCT01443403|2257401|P4|Overall Study|Lost to Follow-up|1
695231|NCT01443403|2257402|P3|Overall Study|Lost to Follow-up|0
695232|NCT01443403|2257403|P2|Overall Study|Lost to Follow-up|0
695233|NCT01443403|2257404|P1|Overall Study|Lost to Follow-up|0
695234|NCT01443403|2257401|P4|Overall Study|Withdrawal by Subject|1
695235|NCT01443403|2257402|P3|Overall Study|Withdrawal by Subject|2
695236|NCT01443403|2257403|P2|Overall Study|Withdrawal by Subject|1
695237|NCT01443403|2257404|P1|Overall Study|Withdrawal by Subject|0
695238|NCT01443403|2257401|P4|Overall Study|Adverse Event|5
695239|NCT01443403|2257402|P3|Overall Study|Adverse Event|4
695240|NCT01443403|2257403|P2|Overall Study|Adverse Event|1
695241|NCT01443403|2257404|P1|Overall Study|Adverse Event|1
695242|NCT01443364|2257551|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
695243|NCT01443364|2257551|P1|Overall Study|AE, non-serious non-fatal|8
695244|NCT01443364|2257551|P1|Overall Study|SAE, non-fatal|6
695245|NCT01443364|2257551|P1|Overall Study|Other Reason|4
695246|NCT01443364|2257551|P1|Overall Study|Withdrawal by Subject|5
695247|NCT01443364|2257551|P1|Overall Study|Lost to Follow-up|3
695248|NCT01443364|2257551|P1|Overall Study|Lack of Efficacy|14
695249|NCT01443130|2257680|P6|Overall Study|Death of Subject's Infant|0
695250|NCT01443130|2257681|P5|Overall Study|Death of Subject's Infant|0
695251|NCT01443130|2257682|P4|Overall Study|Death of Subject's Infant|0
695252|NCT01443130|2257683|P3|Overall Study|Death of Subject's Infant|11
695253|NCT01443130|2257684|P2|Overall Study|Death of Subject's Infant|10
695254|NCT01443130|2257685|P1|Overall Study|Death of Subject's Infant|5
695255|NCT01443130|2257680|P6|Overall Study|Withdrawal by Subject|2
695256|NCT01443130|2257681|P5|Overall Study|Withdrawal by Subject|7
695257|NCT01443130|2257682|P4|Overall Study|Withdrawal by Subject|7
695258|NCT01443130|2257683|P3|Overall Study|Withdrawal by Subject|12
695259|NCT01443130|2257684|P2|Overall Study|Withdrawal by Subject|14
695260|NCT01443130|2257685|P1|Overall Study|Withdrawal by Subject|15
695261|NCT01443130|2257680|P6|Overall Study|Protocol Violation|3
695262|NCT01443130|2257681|P5|Overall Study|Protocol Violation|2
695263|NCT01443130|2257682|P4|Overall Study|Protocol Violation|2
695264|NCT01443130|2257683|P3|Overall Study|Protocol Violation|3
695265|NCT01443130|2257684|P2|Overall Study|Protocol Violation|1
695266|NCT01443130|2257685|P1|Overall Study|Protocol Violation|2
695267|NCT01443130|2257680|P6|Overall Study|Adverse Event|0
695268|NCT01443130|2257681|P5|Overall Study|Adverse Event|0
695269|NCT01443130|2257682|P4|Overall Study|Adverse Event|0
695270|NCT01443130|2257683|P3|Overall Study|Adverse Event|1
695271|NCT01443130|2257684|P2|Overall Study|Adverse Event|1
695272|NCT01443130|2257685|P1|Overall Study|Adverse Event|2
695273|NCT01443130|2257680|P6|Overall Study|Death|8
695274|NCT01443130|2257681|P5|Overall Study|Death|10
695275|NCT01443130|2257682|P4|Overall Study|Death|7
695276|NCT01443130|2257683|P3|Overall Study|Death|0
695277|NCT01443130|2257684|P2|Overall Study|Death|1
695278|NCT01443130|2257685|P1|Overall Study|Death|0
695279|NCT01443130|2257680|P6|Overall Study|Lost to Follow-up|21
695280|NCT01443130|2257681|P5|Overall Study|Lost to Follow-up|25
695281|NCT01443130|2257682|P4|Overall Study|Lost to Follow-up|23
695282|NCT01443130|2257683|P3|Overall Study|Lost to Follow-up|50
695283|NCT01443130|2257684|P2|Overall Study|Lost to Follow-up|42
695284|NCT01443130|2257685|P1|Overall Study|Lost to Follow-up|44
695285|NCT01443078|2257735|P1|Overall Study|Patient had brain mets|1
695286|NCT01443078|2257735|P1|Overall Study|Withdrawal by Subject|1
695287|NCT01443078|2257735|P1|Overall Study|Responded to neoadjuvant platinum txt|27
889394|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
889395|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
889396|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
889397|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
889398|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
695296|NCT01442779|2257757|P1|Overall Study|Non-compliance|1
695297|NCT01442779|2257757|P1|Overall Study|Death|3
695298|NCT01442779|2257757|P1|Overall Study|Withdrawal by Subject|3
695299|NCT01442688|2257765|P2|Second Intervention|Adverse Event|0
695300|NCT01442688|2257766|P1|Second Intervention|Adverse Event|1
695301|NCT01442688|2257765|P2|First Intervention|subject incarcerated|0
695302|NCT01442688|2257766|P1|First Intervention|subject incarcerated|1
695303|NCT01442688|2257765|P2|First Intervention|Withdrawal by Subject|0
695304|NCT01442688|2257766|P1|First Intervention|Withdrawal by Subject|1
695305|NCT01442675|2257774|P1|Overall Study|Withdrawal by Subject|4
695306|NCT01442675|2257774|P1|Overall Study|Lost to Follow-up|2
695307|NCT01442675|2257774|P1|Overall Study|Protocol Violation|6
695308|NCT01442493|2257786|P2|Overall Study|withdrawn from study|2
695309|NCT01442493|2257787|P1|Overall Study|withdrawn from study|3
695310|NCT01442376|2257808|P3|Overall Study|Not eligible for subsequent cycles|0
695311|NCT01442376|2257809|P2|Overall Study|Not eligible for subsequent cycles|2
695312|NCT01442376|2257810|P1|Overall Study|Not eligible for subsequent cycles|1
695313|NCT01442376|2257808|P3|Overall Study|Patients not treated|1
695314|NCT01442376|2257809|P2|Overall Study|Patients not treated|3
695315|NCT01442376|2257810|P1|Overall Study|Patients not treated|2
695316|NCT01442376|2257808|P3|Overall Study|Withdrawal of consent|1
695317|NCT01442376|2257809|P2|Overall Study|Withdrawal of consent|0
695318|NCT01442376|2257810|P1|Overall Study|Withdrawal of consent|0
695319|NCT01442376|2257808|P3|Overall Study|Death|1
695320|NCT01442376|2257809|P2|Overall Study|Death|1
695321|NCT01442376|2257810|P1|Overall Study|Death|0
695322|NCT01442376|2257808|P3|Overall Study|Adverse Event|2
695323|NCT01442376|2257809|P2|Overall Study|Adverse Event|3
695324|NCT01442376|2257810|P1|Overall Study|Adverse Event|0
695325|NCT01442181|2257823|P2|Overall Study|atrial fibrillation not noted|1
695326|NCT01442181|2257824|P1|Overall Study|atrial fibrillation not noted|0
695327|NCT01442181|2257823|P2|Overall Study|patient in an additional study|0
695328|NCT01442181|2257824|P1|Overall Study|patient in an additional study|1
695329|NCT01442181|2257823|P2|Overall Study|Lost to Follow-up|1
695330|NCT01442181|2257824|P1|Overall Study|Lost to Follow-up|1
695331|NCT01442181|2257823|P2|Overall Study|low ejection factor|1
695332|NCT01442181|2257824|P1|Overall Study|low ejection factor|0
695333|NCT01442181|2257823|P2|Overall Study|no insurance for surgery|0
695334|NCT01442181|2257824|P1|Overall Study|no insurance for surgery|1
695335|NCT01442181|2257823|P2|Overall Study|patient refused surgery|0
695336|NCT01442181|2257824|P1|Overall Study|patient refused surgery|1
695337|NCT01442155|2257848|P1|Overall Study|Lost to Follow-up|2
695338|NCT01442155|2257848|P1|Overall Study|Adverse Event|2
695339|NCT01442155|2257848|P1|Overall Study|Recurrence|26
695340|NCT01442155|2257848|P1|Overall Study|Complete remission|35
695341|NCT01442103|2257864|P1|Overall Study|Lost to Follow-up|2
695342|NCT01442064|2257874|P6|Overall Study|Condition mandated other intervention|2
695343|NCT01442064|2257875|P5|Overall Study|Condition mandated other intervention|0
695344|NCT01442064|2257876|P4|Overall Study|Condition mandated other intervention|0
695345|NCT01442064|2257877|P3|Overall Study|Condition mandated other intervention|2
695346|NCT01442064|2257878|P2|Overall Study|Condition mandated other intervention|1
695347|NCT01442064|2257879|P1|Overall Study|Condition mandated other intervention|1
695348|NCT01442064|2257874|P6|Overall Study|Subject non-compliance|2
695349|NCT01442064|2257875|P5|Overall Study|Subject non-compliance|0
695350|NCT01442064|2257876|P4|Overall Study|Subject non-compliance|0
695351|NCT01442064|2257877|P3|Overall Study|Subject non-compliance|0
695352|NCT01442064|2257878|P2|Overall Study|Subject non-compliance|0
695353|NCT01442064|2257879|P1|Overall Study|Subject non-compliance|0
695354|NCT01442064|2257874|P6|Overall Study|Sponsor decision|87
695355|NCT01442064|2257875|P5|Overall Study|Sponsor decision|95
695356|NCT01442064|2257876|P4|Overall Study|Sponsor decision|88
695357|NCT01442064|2257877|P3|Overall Study|Sponsor decision|92
695358|NCT01442064|2257878|P2|Overall Study|Sponsor decision|88
695359|NCT01442064|2257879|P1|Overall Study|Sponsor decision|82
695360|NCT01442064|2257874|P6|Overall Study|Withdrawal by Subject|1
695361|NCT01442064|2257875|P5|Overall Study|Withdrawal by Subject|2
695362|NCT01442064|2257876|P4|Overall Study|Withdrawal by Subject|2
695363|NCT01442064|2257877|P3|Overall Study|Withdrawal by Subject|2
695364|NCT01442064|2257878|P2|Overall Study|Withdrawal by Subject|3
695365|NCT01442064|2257879|P1|Overall Study|Withdrawal by Subject|6
695366|NCT01442064|2257874|P6|Overall Study|Physician Decision|1
695367|NCT01442064|2257875|P5|Overall Study|Physician Decision|3
695368|NCT01442064|2257876|P4|Overall Study|Physician Decision|3
695369|NCT01442064|2257877|P3|Overall Study|Physician Decision|2
695370|NCT01442064|2257878|P2|Overall Study|Physician Decision|1
695371|NCT01442064|2257879|P1|Overall Study|Physician Decision|1
695372|NCT01442064|2257874|P6|Overall Study|Lost to Follow-up|3
695373|NCT01442064|2257875|P5|Overall Study|Lost to Follow-up|3
695374|NCT01442064|2257876|P4|Overall Study|Lost to Follow-up|1
695375|NCT01442064|2257877|P3|Overall Study|Lost to Follow-up|1
695376|NCT01442064|2257878|P2|Overall Study|Lost to Follow-up|5
695377|NCT01442064|2257879|P1|Overall Study|Lost to Follow-up|5
695378|NCT01442064|2257874|P6|Overall Study|Death|3
695379|NCT01442064|2257875|P5|Overall Study|Death|1
695380|NCT01442064|2257876|P4|Overall Study|Death|3
695381|NCT01442064|2257877|P3|Overall Study|Death|3
695382|NCT01442064|2257878|P2|Overall Study|Death|1
695383|NCT01442064|2257879|P1|Overall Study|Death|0
695384|NCT01442064|2257874|P6|Overall Study|Adverse Event|0
695385|NCT01442064|2257875|P5|Overall Study|Adverse Event|2
695386|NCT01442064|2257876|P4|Overall Study|Adverse Event|1
695387|NCT01442064|2257877|P3|Overall Study|Adverse Event|2
695388|NCT01442064|2257878|P2|Overall Study|Adverse Event|2
695389|NCT01442064|2257879|P1|Overall Study|Adverse Event|2
695390|NCT01442038|2257916|P2|Overall Study|Study Terminated By Sponsor|3
695391|NCT01442038|2257917|P1|Overall Study|Study Terminated By Sponsor|2
695392|NCT01442038|2257916|P2|Overall Study|Investigator's Discretion|16
695393|NCT01442038|2257917|P1|Overall Study|Investigator's Discretion|13
695394|NCT01442038|2257916|P2|Overall Study|Protocol Deviation|20
695395|NCT01442038|2257917|P1|Overall Study|Protocol Deviation|9
695396|NCT01442038|2257916|P2|Overall Study|Adverse Event|15
695397|NCT01442038|2257917|P1|Overall Study|Adverse Event|26
695398|NCT01442038|2257916|P2|Overall Study|Lost to Follow-up|51
695399|NCT01442038|2257917|P1|Overall Study|Lost to Follow-up|37
695400|NCT01442038|2257916|P2|Overall Study|Participant Withdrew Consent|102
695401|NCT01442038|2257917|P1|Overall Study|Participant Withdrew Consent|137
695402|NCT01442038|2257916|P2|Overall Study|Investigator-Initiated Early Closure|43
695403|NCT01442038|2257917|P1|Overall Study|Investigator-Initiated Early Closure|44
695404|NCT01442038|2257916|P2|Overall Study|Death|29
695405|NCT01442038|2257917|P1|Overall Study|Death|35
695406|NCT01441973|2257931|P2|Overall Study|Nonrelated cardiac amyloidosis|1
695407|NCT01441973|2257932|P1|Overall Study|Nonrelated cardiac amyloidosis|0
695408|NCT01441973|2257931|P2|Overall Study|Poor compliance/noncompliance|1
695409|NCT01441973|2257932|P1|Overall Study|Poor compliance/noncompliance|0
695410|NCT01441973|2257931|P2|Overall Study|Patient request to discontinue treatment|1
695411|NCT01441973|2257932|P1|Overall Study|Patient request to discontinue treatment|1
695412|NCT01441973|2257931|P2|Overall Study|Adverse event unrelated to study drug|0
695413|NCT01441973|2257932|P1|Overall Study|Adverse event unrelated to study drug|3
695414|NCT01441973|2257931|P2|Overall Study|Disease progression|2
695415|NCT01441973|2257932|P1|Overall Study|Disease progression|4
695416|NCT01441960|2257946|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
695417|NCT01441960|2257947|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
695418|NCT01441960|2257946|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
695419|NCT01441960|2257947|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
695420|NCT01441960|2257946|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
695421|NCT01441960|2257947|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
695422|NCT01441765|2257968|P2|Overall Study|Death|0
695423|NCT01441765|2257969|P1|Overall Study|Death|1
695424|NCT01441596|2257986|P3|Overall Study|Not treated|1
695425|NCT01441596|2257987|P2|Overall Study|Not treated|1
695426|NCT01441596|2257988|P1|Overall Study|Not treated|0
695427|NCT01441596|2257986|P3|Overall Study|Withdrawal by Subject|2
695428|NCT01441596|2257987|P2|Overall Study|Withdrawal by Subject|0
695429|NCT01441596|2257988|P1|Overall Study|Withdrawal by Subject|4
695430|NCT01441596|2257986|P3|Overall Study|Other reason not defined below|1
695431|NCT01441596|2257987|P2|Overall Study|Other reason not defined below|2
695432|NCT01441596|2257988|P1|Overall Study|Other reason not defined below|0
695433|NCT01441440|2258035|P3|Overall Study|Difficllty in keeping the schedule|0
695434|NCT01441440|2258036|P2|Overall Study|Difficllty in keeping the schedule|1
695435|NCT01441440|2258037|P1|Overall Study|Difficllty in keeping the schedule|1
695436|NCT01441440|2258035|P3|Overall Study|Work-related matter|0
695437|NCT01441440|2258036|P2|Overall Study|Work-related matter|1
695438|NCT01441440|2258037|P1|Overall Study|Work-related matter|0
695439|NCT01441440|2258035|P3|Overall Study|Moving|1
695440|NCT01441440|2258036|P2|Overall Study|Moving|1
695441|NCT01441440|2258037|P1|Overall Study|Moving|0
695442|NCT01441440|2258035|P3|Overall Study|Lack of Efficacy|1
695443|NCT01441440|2258036|P2|Overall Study|Lack of Efficacy|0
695444|NCT01441440|2258037|P1|Overall Study|Lack of Efficacy|1
695445|NCT01441440|2258035|P3|Overall Study|Pregnancy|0
695446|NCT01441440|2258036|P2|Overall Study|Pregnancy|0
695447|NCT01441440|2258037|P1|Overall Study|Pregnancy|1
695448|NCT01441440|2258035|P3|Overall Study|Withdrawal by Subject|9
695449|NCT01441440|2258036|P2|Overall Study|Withdrawal by Subject|9
695450|NCT01441440|2258037|P1|Overall Study|Withdrawal by Subject|11
695451|NCT01441440|2258035|P3|Overall Study|Lost to Follow-up|1
695452|NCT01441440|2258036|P2|Overall Study|Lost to Follow-up|2
695453|NCT01441440|2258037|P1|Overall Study|Lost to Follow-up|0
695454|NCT01441440|2258035|P3|Overall Study|Adverse Event|9
695455|NCT01441440|2258036|P2|Overall Study|Adverse Event|9
695456|NCT01441440|2258037|P1|Overall Study|Adverse Event|2
695457|NCT01441440|2258035|P3|Overall Study|Death|1
695458|NCT01441440|2258036|P2|Overall Study|Death|0
695459|NCT01441440|2258037|P1|Overall Study|Death|1
695460|NCT01441414|2258060|P1|Overall Study|Subject refused further follow-up|1
695461|NCT01441414|2258060|P1|Overall Study|Study terminated by sponsor|2
695462|NCT01441414|2258060|P1|Overall Study|Other reasons|3
695463|NCT01441414|2258060|P1|Overall Study|Participant died|9
695464|NCT01441180|2258139|P3|Overall Study|Discontinued|2
695465|NCT01441180|2258140|P2|Overall Study|Discontinued|0
695466|NCT01441180|2258141|P1|Overall Study|Discontinued|0
695467|NCT01441180|2258139|P3|Overall Study|Lost to Follow-up|1
695468|NCT01441180|2258140|P2|Overall Study|Lost to Follow-up|1
695469|NCT01441180|2258141|P1|Overall Study|Lost to Follow-up|1
695470|NCT01441102|2258152|P1|Overall Study|Withdrawal by Subject|2
695471|NCT01441102|2258152|P1|Overall Study|Adverse Event|1
695472|NCT01440972|2258192|P2|Overall Study|Withdrawal by Subject|2
695473|NCT01440972|2258193|P1|Overall Study|Withdrawal by Subject|3
695474|NCT01440946|2258217|P2|Overall Study|Physician Decision|0
695475|NCT01440946|2258218|P1|Overall Study|Physician Decision|1
695476|NCT01440946|2258217|P2|Overall Study|Lost to Follow-up|1
695477|NCT01440946|2258218|P1|Overall Study|Lost to Follow-up|1
695478|NCT01440881|2258257|P2|Overall Study|Death|1
695479|NCT01440881|2258258|P1|Overall Study|Death|0
695480|NCT01440647|2258299|P2|Overall Study|Death|3
695481|NCT01440647|2258300|P1|Overall Study|Death|2
695482|NCT01440595|2258319|P3|Overall Study|Study terminated by sponsor.|1
695483|NCT01440595|2258320|P2|Overall Study|Study terminated by sponsor.|2
695484|NCT01440595|2258321|P1|Overall Study|Study terminated by sponsor.|1
695485|NCT01440595|2258319|P3|Overall Study|Lost to Follow-up|0
695486|NCT01440595|2258320|P2|Overall Study|Lost to Follow-up|1
695487|NCT01440595|2258321|P1|Overall Study|Lost to Follow-up|0
695488|NCT01440569|2258341|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
695489|NCT01440569|2258342|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
695490|NCT01440569|2258341|P2|Open-Label Rollover Phase|Lost to Follow-up|3
695491|NCT01440569|2258342|P1|Open-Label Rollover Phase|Lost to Follow-up|26
695492|NCT01440569|2258341|P2|Open-Label Rollover Phase|Withdrew Consent|1
695493|NCT01440569|2258342|P1|Open-Label Rollover Phase|Withdrew Consent|11
695494|NCT01440569|2258341|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
695495|NCT01440569|2258342|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
695496|NCT01440569|2258341|P2|Open-Label Rollover Phase|Lack of Efficacy|0
695497|NCT01440569|2258342|P1|Open-Label Rollover Phase|Lack of Efficacy|2
695498|NCT01440569|2258341|P2|Open-Label Rollover Phase|Pregnancy|0
695499|NCT01440569|2258342|P1|Open-Label Rollover Phase|Pregnancy|1
695500|NCT01440569|2258341|P2|Open-Label Rollover Phase|Adverse Event|0
695501|NCT01440569|2258342|P1|Open-Label Rollover Phase|Adverse Event|3
695502|NCT01440569|2258341|P2|Main Study|Protocol Violation|0
695503|NCT01440569|2258342|P1|Main Study|Protocol Violation|1
695504|NCT01440569|2258341|P2|Main Study|Subject Non-Compliance|0
695505|NCT01440569|2258342|P1|Main Study|Subject Non-Compliance|3
695506|NCT01440569|2258341|P2|Main Study|Lost to Follow-up|2
695507|NCT01440569|2258342|P1|Main Study|Lost to Follow-up|13
695508|NCT01440569|2258341|P2|Main Study|Withdrew Consent|1
695509|NCT01440569|2258342|P1|Main Study|Withdrew Consent|7
695510|NCT01440569|2258341|P2|Main Study|Investigator's Discretion|1
695511|NCT01440569|2258342|P1|Main Study|Investigator's Discretion|1
695512|NCT01440569|2258341|P2|Main Study|Pregnancy|0
695513|NCT01440569|2258342|P1|Main Study|Pregnancy|1
695514|NCT01440569|2258341|P2|Main Study|Adverse Event|0
695515|NCT01440569|2258342|P1|Main Study|Adverse Event|9
695516|NCT01440569|2258341|P2|Main Study|Enrolled but not treated|0
695517|NCT01440569|2258342|P1|Main Study|Enrolled but not treated|1
695518|NCT01440517|2258377|P1|Overall Study|Subject withdrawn prior to dosing|1
695519|NCT01440374|2258408|P4|Part 3: Extension|Physician Decision|14
695520|NCT01440374|2258409|P3|Part 3: Extension|Physician Decision|0
695521|NCT01440374|2258410|P2|Part 3: Extension|Physician Decision|0
695522|NCT01440374|2258411|P1|Part 3: Extension|Physician Decision|0
695523|NCT01440374|2258408|P4|Part 3: Extension|Adverse Event|13
695524|NCT01440374|2258409|P3|Part 3: Extension|Adverse Event|0
695525|NCT01440374|2258410|P2|Part 3: Extension|Adverse Event|0
695526|NCT01440374|2258411|P1|Part 3: Extension|Adverse Event|0
695527|NCT01440374|2258408|P4|Part 3: Extension|Withdrawal by Subject|5
695528|NCT01440374|2258409|P3|Part 3: Extension|Withdrawal by Subject|0
695529|NCT01440374|2258410|P2|Part 3: Extension|Withdrawal by Subject|0
695530|NCT01440374|2258411|P1|Part 3: Extension|Withdrawal by Subject|0
695531|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Not treated|0
695532|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Not treated|1
695533|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Not treated|0
695534|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Not treated|0
695535|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Adverse Event|0
695536|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Adverse Event|31
695537|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Adverse Event|7
695538|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Adverse Event|0
695539|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
695540|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
695541|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
695542|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
695543|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Protocol Violation|0
695544|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Protocol Violation|1
695545|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Protocol Violation|0
695546|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Protocol Violation|0
695547|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
695548|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
695549|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
695550|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
695551|NCT01440374|2258408|P4|Part 2; Double-blind Phase|Physician Decision|0
695552|NCT01440374|2258409|P3|Part 2; Double-blind Phase|Physician Decision|17
695553|NCT01440374|2258410|P2|Part 2; Double-blind Phase|Physician Decision|8
695554|NCT01440374|2258411|P1|Part 2; Double-blind Phase|Physician Decision|0
695555|NCT01440374|2258408|P4|Part 1: Open-label Phase|Physician Decision|0
695556|NCT01440374|2258409|P3|Part 1: Open-label Phase|Physician Decision|0
695557|NCT01440374|2258410|P2|Part 1: Open-label Phase|Physician Decision|0
695558|NCT01440374|2258411|P1|Part 1: Open-label Phase|Physician Decision|1
695559|NCT01440374|2258408|P4|Part 1: Open-label Phase|Adverse Event|0
695560|NCT01440374|2258409|P3|Part 1: Open-label Phase|Adverse Event|0
695561|NCT01440374|2258410|P2|Part 1: Open-label Phase|Adverse Event|0
695562|NCT01440374|2258411|P1|Part 1: Open-label Phase|Adverse Event|5
695563|NCT01440322|2258446|P2|Overall Study|Other Non-Product Related|0
695564|NCT01440322|2258447|P1|Overall Study|Other Non-Product Related|1
695565|NCT01440322|2258446|P2|Overall Study|Unrelated Medical Problem|1
695566|NCT01440322|2258447|P1|Overall Study|Unrelated Medical Problem|0
695567|NCT01440322|2258446|P2|Overall Study|Other Product Related|0
695568|NCT01440322|2258447|P1|Overall Study|Other Product Related|1
695569|NCT01440322|2258446|P2|Overall Study|Unacceptable Subjective Vision|0
695570|NCT01440322|2258447|P1|Overall Study|Unacceptable Subjective Vision|1
695571|NCT01440322|2258446|P2|Overall Study|Symptoms and Problems|0
695572|NCT01440322|2258447|P1|Overall Study|Symptoms and Problems|1
695573|NCT01440322|2258446|P2|Overall Study|Biomicroscopy|0
695574|NCT01440322|2258447|P1|Overall Study|Biomicroscopy|1
695575|NCT01440322|2258446|P2|Overall Study|Discomfort|0
695576|NCT01440322|2258447|P1|Overall Study|Discomfort|2
695577|NCT01440283|2258469|P1|Overall Study|Physician Decision|3
695578|NCT01440283|2258469|P1|Overall Study|Withdrawal by Subject|4
695579|NCT01440283|2258469|P1|Overall Study|Death|3
695580|NCT01440101|2258484|P3|Overall Study|Not Specified|0
695581|NCT01440101|2258485|P2|Overall Study|Not Specified|1
695582|NCT01440101|2258486|P1|Overall Study|Not Specified|0
695583|NCT01440101|2258484|P3|Overall Study|Withdrawal by Subject|1
695584|NCT01440101|2258485|P2|Overall Study|Withdrawal by Subject|3
695585|NCT01440101|2258486|P1|Overall Study|Withdrawal by Subject|0
695586|NCT01440101|2258484|P3|Overall Study|Adverse Event|0
695587|NCT01440101|2258485|P2|Overall Study|Adverse Event|0
695588|NCT01440101|2258486|P1|Overall Study|Adverse Event|2
695589|NCT01440049|2258519|P1|Overall Study|Adverse Event|5
695590|NCT01439971|2258551|P5|Overall Study|Required number in cohort dosed|1
695591|NCT01439971|2258552|P4|Overall Study|Required number in cohort dosed|0
695592|NCT01439971|2258553|P3|Overall Study|Required number in cohort dosed|2
695593|NCT01439971|2258554|P2|Overall Study|Required number in cohort dosed|1
695594|NCT01439971|2258555|P1|Overall Study|Required number in cohort dosed|0
695595|NCT01439945|2258735|P4|Double-Blind Treatment Phase|Ineligible|1
695596|NCT01439945|2258736|P3|Double-Blind Treatment Phase|Ineligible|0
695597|NCT01439945|2258737|P2|Double-Blind Treatment Phase|Ineligible|2
695598|NCT01439945|2258738|P1|Double-Blind Treatment Phase|Ineligible|1
695599|NCT01439945|2258735|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
695600|NCT01439945|2258736|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
695601|NCT01439945|2258737|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
695602|NCT01439945|2258738|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
695603|NCT01439867|2258763|P2|Overall Study|Protocol-specified Criteria|0
695604|NCT01439867|2258764|P1|Overall Study|Protocol-specified Criteria|1
695605|NCT01439867|2258763|P2|Overall Study|Administrative Decision|5
695606|NCT01439867|2258764|P1|Overall Study|Administrative Decision|4
695607|NCT01439867|2258763|P2|Overall Study|Withdrawal by Subject|2
695608|NCT01439867|2258764|P1|Overall Study|Withdrawal by Subject|1
695609|NCT01439867|2258763|P2|Overall Study|Non-compliance|1
695610|NCT01439867|2258764|P1|Overall Study|Non-compliance|0
695611|NCT01439724|2258805|P2|Overall Study|missing consultation|8
695612|NCT01439724|2258806|P1|Overall Study|missing consultation|9
889399|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
889400|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
889401|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
889402|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
889403|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
889404|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
889405|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
695623|NCT01439282|2258869|P2|Overall Study|Not specified|1
695624|NCT01439282|2258870|P1|Overall Study|Not specified|1
695625|NCT01439282|2258869|P2|Overall Study|Withdrawal by Subject|0
695626|NCT01439282|2258870|P1|Overall Study|Withdrawal by Subject|2
695627|NCT01439282|2258869|P2|Overall Study|Adverse Event|0
695628|NCT01439282|2258870|P1|Overall Study|Adverse Event|5
695629|NCT01439204|2258880|P2|Overall Study|poor/non-compliance|0
695630|NCT01439204|2258881|P1|Overall Study|poor/non-compliance|3
695631|NCT01439204|2258880|P2|Overall Study|No longer meets study criteria|0
695632|NCT01439204|2258881|P1|Overall Study|No longer meets study criteria|1
695633|NCT01439204|2258880|P2|Overall Study|Lost to Follow-up|2
695634|NCT01439204|2258881|P1|Overall Study|Lost to Follow-up|0
695635|NCT01439204|2258880|P2|Overall Study|Withdrawal by Subject|1
695636|NCT01439204|2258881|P1|Overall Study|Withdrawal by Subject|0
889406|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
889407|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
889408|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
889409|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
695643|NCT01439126|2258930|P2|Overall Study|Other-Miscellaneous|12
695644|NCT01439126|2258931|P1|Overall Study|Other-Miscellaneous|12
695645|NCT01439126|2258930|P2|Overall Study|Other-Use of prohibited treatment|2
695646|NCT01439126|2258931|P1|Overall Study|Other-Use of prohibited treatment|0
695647|NCT01439126|2258930|P2|Overall Study|Lost to Follow-up|3
695648|NCT01439126|2258931|P1|Overall Study|Lost to Follow-up|6
695649|NCT01439126|2258930|P2|Overall Study|Protocol Violation|4
695650|NCT01439126|2258931|P1|Overall Study|Protocol Violation|6
695651|NCT01439126|2258930|P2|Overall Study|Withdrawal by Subject|21
695652|NCT01439126|2258931|P1|Overall Study|Withdrawal by Subject|5
695653|NCT01439126|2258930|P2|Overall Study|Adverse Event|0
695654|NCT01439126|2258931|P1|Overall Study|Adverse Event|2
695655|NCT01438996|2258969|P3|Overall Study|Not meeting Inclusion Criteria|0
695656|NCT01438996|2258970|P2|Overall Study|Not meeting Inclusion Criteria|1
695657|NCT01438996|2258971|P1|Overall Study|Not meeting Inclusion Criteria|4
695658|NCT01438814|2259005|P2|Overall Study|Not specified|4
695659|NCT01438814|2259006|P1|Overall Study|Not specified|2
695660|NCT01438814|2259005|P2|Overall Study|Withdrawal by Subject|2
695661|NCT01438814|2259006|P1|Overall Study|Withdrawal by Subject|4
695662|NCT01438814|2259005|P2|Overall Study|Lost to Follow-up|3
695663|NCT01438814|2259006|P1|Overall Study|Lost to Follow-up|4
695664|NCT01438814|2259005|P2|Overall Study|Protocol Violation|2
695665|NCT01438814|2259006|P1|Overall Study|Protocol Violation|1
695666|NCT01438814|2259005|P2|Overall Study|Adverse Event|3
695667|NCT01438814|2259006|P1|Overall Study|Adverse Event|3
695668|NCT01438541|2259042|P1|Overall Study|discharge from the hospital|5
695669|NCT01438541|2259042|P1|Overall Study|Withdrawal by Subject|1
695670|NCT01438541|2259042|P1|Overall Study|Physician Decision|1
695671|NCT01438489|2259051|P3|Overall Study|Inadequate venous access|0
695672|NCT01438489|2259052|P2|Overall Study|Inadequate venous access|2
695673|NCT01438489|2259053|P1|Overall Study|Inadequate venous access|0
695674|NCT01438489|2259051|P3|Overall Study|Did not complete all 3 follow-up visits|2
695675|NCT01438489|2259052|P2|Overall Study|Did not complete all 3 follow-up visits|5
695676|NCT01438489|2259053|P1|Overall Study|Did not complete all 3 follow-up visits|2
695677|NCT01438489|2259051|P3|Overall Study|Received prohibited medication|0
695678|NCT01438489|2259052|P2|Overall Study|Received prohibited medication|0
695679|NCT01438489|2259053|P1|Overall Study|Received prohibited medication|1
695680|NCT01438489|2259051|P3|Overall Study|AE/SAEs|1
695681|NCT01438489|2259052|P2|Overall Study|AE/SAEs|1
695682|NCT01438489|2259053|P1|Overall Study|AE/SAEs|2
695683|NCT01438489|2259051|P3|Overall Study|Investigator decision|0
695684|NCT01438489|2259052|P2|Overall Study|Investigator decision|1
695685|NCT01438489|2259053|P1|Overall Study|Investigator decision|0
695686|NCT01438489|2259051|P3|Overall Study|Subject choice/Subject moved|1
695687|NCT01438489|2259052|P2|Overall Study|Subject choice/Subject moved|1
695688|NCT01438489|2259053|P1|Overall Study|Subject choice/Subject moved|2
695689|NCT01438489|2259051|P3|Overall Study|Sponsor decision|4
695690|NCT01438489|2259052|P2|Overall Study|Sponsor decision|1
695691|NCT01438489|2259053|P1|Overall Study|Sponsor decision|4
695692|NCT01438489|2259051|P3|Overall Study|Death|1
695693|NCT01438489|2259052|P2|Overall Study|Death|0
695694|NCT01438489|2259053|P1|Overall Study|Death|0
695695|NCT01438489|2259051|P3|Overall Study|Withdrawal by Subject|8
695696|NCT01438489|2259052|P2|Overall Study|Withdrawal by Subject|3
695697|NCT01438489|2259053|P1|Overall Study|Withdrawal by Subject|11
695698|NCT01438489|2259051|P3|Overall Study|Lost to Follow-up|2
695699|NCT01438489|2259052|P2|Overall Study|Lost to Follow-up|2
695700|NCT01438489|2259053|P1|Overall Study|Lost to Follow-up|4
695701|NCT01438424|2259096|P1|Overall Study|Participant noncompliance|20
695702|NCT01438424|2259096|P1|Overall Study|No longer met inclusion criteria|1
695703|NCT01438424|2259096|P1|Overall Study|Pregnancy|7
695704|NCT01438424|2259096|P1|Overall Study|Need for drug prohibited by protocol|14
695705|NCT01438424|2259096|P1|Overall Study|Abnormal laboratory test result|14
695706|NCT01438424|2259096|P1|Overall Study|Lost to Follow-up|17
695707|NCT01438424|2259096|P1|Overall Study|Adverse Event|17
695708|NCT01438424|2259096|P1|Overall Study|Death|22
695709|NCT01438424|2259096|P1|Overall Study|Progression of chronic hepatitis B|22
695710|NCT01438424|2259096|P1|Overall Study|Withdrawal by Subject|104
695711|NCT01438424|2259096|P1|Overall Study|Not identified|55
695712|NCT01438424|2259096|P1|Overall Study|Minimal virologic response|95
695713|NCT01438424|2259096|P1|Overall Study|Continuing treatment|29
695714|NCT01438307|2259134|P2|Overall Study|Death|1
695715|NCT01438307|2259135|P1|Overall Study|Death|1
695716|NCT01438294|2259149|P2|Overall Study|Lost to Follow-up|7
695717|NCT01438294|2259150|P1|Overall Study|Lost to Follow-up|3
695718|NCT01438177|2259193|P1|Overall Study|Initiation of new therapy|1
695719|NCT01438177|2259193|P1|Overall Study|Withdrawal by Subject|1
695720|NCT01438151|2259199|P1|Overall Study|study terminated|8
695721|NCT01438060|2259205|P2|On Study Beyond Week 140|Other Reason|3
695722|NCT01438060|2259206|P1|On Study Beyond Week 140|Other Reason|0
695723|NCT01438060|2259205|P2|On Study Beyond Week 140|Death|1
695724|NCT01438060|2259206|P1|On Study Beyond Week 140|Death|0
695725|NCT01438060|2259205|P2|On Study Beyond Week 140|Withdrawal by Subject|1
695726|NCT01438060|2259206|P1|On Study Beyond Week 140|Withdrawal by Subject|0
695727|NCT01438060|2259205|P2|On Study Beyond Week 140|Lack of Efficacy|1
695728|NCT01438060|2259206|P1|On Study Beyond Week 140|Lack of Efficacy|0
695729|NCT01438060|2259205|P2|On Study Beyond Week 140|Adverse Event|2
695730|NCT01438060|2259206|P1|On Study Beyond Week 140|Adverse Event|0
695731|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
695732|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
695733|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Death|12
695734|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Death|22
695735|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
695736|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
695737|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
695738|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
695739|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
695740|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
695741|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
695742|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
695743|NCT01438060|2259205|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
695744|NCT01438060|2259206|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
695745|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
695746|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
695747|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
695748|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
695749|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
695750|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
695751|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
695752|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
695753|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
695754|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
695755|NCT01438060|2259205|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
695756|NCT01438060|2259206|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
695757|NCT01437995|2259287|P3|Overall Study|Lost to Follow-up|20
695758|NCT01437995|2259288|P2|Overall Study|Lost to Follow-up|18
695759|NCT01437995|2259289|P1|Overall Study|Lost to Follow-up|11
695760|NCT01437943|2259311|P2|Overall Study|Adverse Event|0
695761|NCT01437943|2259312|P1|Overall Study|Adverse Event|2
695762|NCT01437943|2259311|P2|Overall Study|Subject expressed pregnancy plans|0
695763|NCT01437943|2259312|P1|Overall Study|Subject expressed pregnancy plans|1
695764|NCT01437943|2259311|P2|Overall Study|Aliskiren trials terminated by Novartis|2
695765|NCT01437943|2259312|P1|Overall Study|Aliskiren trials terminated by Novartis|4
695766|NCT01437878|2259320|P2|Overall Study|Withdrawal by Subject|0
695767|NCT01437878|2259321|P1|Overall Study|Withdrawal by Subject|1
695768|NCT01437540|2259363|P2|Overall Study|Withdrawal by Subject|15
695769|NCT01437540|2259364|P1|Overall Study|Withdrawal by Subject|31
695770|NCT01437540|2259363|P2|Overall Study|Adverse Event|13
695771|NCT01437540|2259364|P1|Overall Study|Adverse Event|26
695772|NCT01437540|2259363|P2|Overall Study|Protocol Violation|12
695773|NCT01437540|2259364|P1|Overall Study|Protocol Violation|24
695774|NCT01437540|2259363|P2|Overall Study|Lack of Efficacy|11
695775|NCT01437540|2259364|P1|Overall Study|Lack of Efficacy|23
695776|NCT01437540|2259363|P2|Overall Study|Lost to Follow-up|5
695777|NCT01437540|2259364|P1|Overall Study|Lost to Follow-up|3
695778|NCT01437540|2259363|P2|Overall Study|COPD exacerbation|3
695779|NCT01437540|2259364|P1|Overall Study|COPD exacerbation|13
695780|NCT01437540|2259363|P2|Overall Study|Not listed below|6
695781|NCT01437540|2259364|P1|Overall Study|Not listed below|7
695782|NCT01437423|2259391|P1|Overall Study|Off label usage|3
695783|NCT01437423|2259391|P1|Overall Study|Lost to Follow-up|12
695784|NCT01437397|2259403|P5|Overall Study|Site termination/COPD exacerbation/other|14
695785|NCT01437397|2259404|P4|Overall Study|Site termination/COPD exacerbation/other|9
695786|NCT01437397|2259405|P3|Overall Study|Site termination/COPD exacerbation/other|9
695787|NCT01437397|2259406|P2|Overall Study|Site termination/COPD exacerbation/other|8
695788|NCT01437397|2259407|P1|Overall Study|Site termination/COPD exacerbation/other|10
695789|NCT01437397|2259403|P5|Overall Study|Adverse Event|21
695790|NCT01437397|2259404|P4|Overall Study|Adverse Event|14
695791|NCT01437397|2259405|P3|Overall Study|Adverse Event|16
695792|NCT01437397|2259406|P2|Overall Study|Adverse Event|22
695793|NCT01437397|2259407|P1|Overall Study|Adverse Event|21
695794|NCT01437397|2259403|P5|Overall Study|Lack of Efficacy|20
695795|NCT01437397|2259404|P4|Overall Study|Lack of Efficacy|10
695796|NCT01437397|2259405|P3|Overall Study|Lack of Efficacy|8
695797|NCT01437397|2259406|P2|Overall Study|Lack of Efficacy|4
695798|NCT01437397|2259407|P1|Overall Study|Lack of Efficacy|5
695799|NCT01437397|2259403|P5|Overall Study|Protocol Violation|19
695800|NCT01437397|2259404|P4|Overall Study|Protocol Violation|21
695801|NCT01437397|2259405|P3|Overall Study|Protocol Violation|13
695802|NCT01437397|2259406|P2|Overall Study|Protocol Violation|12
695803|NCT01437397|2259407|P1|Overall Study|Protocol Violation|10
695804|NCT01437397|2259403|P5|Overall Study|Withdrawal by Subject|22
695805|NCT01437397|2259404|P4|Overall Study|Withdrawal by Subject|11
695806|NCT01437397|2259405|P3|Overall Study|Withdrawal by Subject|24
695807|NCT01437397|2259406|P2|Overall Study|Withdrawal by Subject|12
695808|NCT01437397|2259407|P1|Overall Study|Withdrawal by Subject|11
695809|NCT01437397|2259403|P5|Overall Study|Lost to Follow-up|5
695810|NCT01437397|2259404|P4|Overall Study|Lost to Follow-up|4
695811|NCT01437397|2259405|P3|Overall Study|Lost to Follow-up|2
695812|NCT01437397|2259406|P2|Overall Study|Lost to Follow-up|4
695813|NCT01437397|2259407|P1|Overall Study|Lost to Follow-up|9
695814|NCT01437319|2259434|P3|Phase II|Protocol Violation|0
695815|NCT01437319|2259435|P2|Phase II|Protocol Violation|1
695816|NCT01437319|2259436|P1|Phase II|Protocol Violation|0
695817|NCT01437319|2259434|P3|Phase II|Study related symptoms/complaints|19
695818|NCT01437319|2259435|P2|Phase II|Study related symptoms/complaints|28
695819|NCT01437319|2259436|P1|Phase II|Study related symptoms/complaints|0
695820|NCT01437319|2259434|P3|Phase II|Lost to Follow-up|2
695821|NCT01437319|2259435|P2|Phase II|Lost to Follow-up|7
695822|NCT01437319|2259436|P1|Phase II|Lost to Follow-up|0
695823|NCT01437319|2259434|P3|Phase II|Withdrawal by Subject|16
695824|NCT01437319|2259435|P2|Phase II|Withdrawal by Subject|8
695825|NCT01437319|2259436|P1|Phase II|Withdrawal by Subject|0
695826|NCT01437319|2259434|P3|Phase I|Withdrawal by Subject|0
695827|NCT01437319|2259435|P2|Phase I|Withdrawal by Subject|0
695828|NCT01437319|2259436|P1|Phase I|Withdrawal by Subject|25
695829|NCT01437319|2259434|P3|Phase I|Study related symptoms/complaints|0
695830|NCT01437319|2259435|P2|Phase I|Study related symptoms/complaints|0
695831|NCT01437319|2259436|P1|Phase I|Study related symptoms/complaints|27
695832|NCT01437319|2259434|P3|Phase I|Protocol Violation|0
695833|NCT01437319|2259435|P2|Phase I|Protocol Violation|0
695834|NCT01437319|2259436|P1|Phase I|Protocol Violation|1
695835|NCT01437319|2259434|P3|Phase I|Lost to Follow-up|0
695836|NCT01437319|2259435|P2|Phase I|Lost to Follow-up|0
695837|NCT01437319|2259436|P1|Phase I|Lost to Follow-up|2
695838|NCT01437267|2259451|P6|Overall Study|Protocol Violation|0
695839|NCT01437267|2259452|P5|Overall Study|Protocol Violation|0
695840|NCT01437267|2259453|P4|Overall Study|Protocol Violation|0
695841|NCT01437267|2259454|P3|Overall Study|Protocol Violation|0
695842|NCT01437267|2259455|P2|Overall Study|Protocol Violation|1
695843|NCT01437267|2259456|P1|Overall Study|Protocol Violation|0
695844|NCT01437267|2259451|P6|Overall Study|Withdrawal by Subject|0
695845|NCT01437267|2259452|P5|Overall Study|Withdrawal by Subject|0
695846|NCT01437267|2259453|P4|Overall Study|Withdrawal by Subject|1
695847|NCT01437267|2259454|P3|Overall Study|Withdrawal by Subject|0
695848|NCT01437267|2259455|P2|Overall Study|Withdrawal by Subject|0
695849|NCT01437267|2259456|P1|Overall Study|Withdrawal by Subject|0
695850|NCT01437111|2259499|P1|Overall Study|Protocol Violation|1
695851|NCT01437111|2259499|P1|Overall Study|Lost to Follow-up|5
695852|NCT01437111|2259499|P1|Overall Study|Physician Decision|1
695853|NCT01437111|2259499|P1|Overall Study|Not reported|5
695854|NCT01437111|2259499|P1|Overall Study|Withdrawal by Subject|4
695855|NCT01437111|2259499|P1|Overall Study|Adverse Event|2
695856|NCT01436643|2259577|P4|Core Phase (16 Weeks)|Protocol Violation|0
695857|NCT01436643|2259578|P3|Core Phase (16 Weeks)|Protocol Violation|1
695858|NCT01436643|2259579|P2|Core Phase (16 Weeks)|Protocol Violation|1
695859|NCT01436643|2259580|P1|Core Phase (16 Weeks)|Protocol Violation|1
695860|NCT01436643|2259577|P4|Core Phase (16 Weeks)|Abnormal Test result|0
695861|NCT01436643|2259578|P3|Core Phase (16 Weeks)|Abnormal Test result|1
695862|NCT01436643|2259579|P2|Core Phase (16 Weeks)|Abnormal Test result|0
695863|NCT01436643|2259580|P1|Core Phase (16 Weeks)|Abnormal Test result|0
695864|NCT01436643|2259577|P4|Core Phase (16 Weeks)|Adverse Event|0
695865|NCT01436643|2259578|P3|Core Phase (16 Weeks)|Adverse Event|1
695866|NCT01436643|2259579|P2|Core Phase (16 Weeks)|Adverse Event|3
695867|NCT01436643|2259580|P1|Core Phase (16 Weeks)|Adverse Event|0
695868|NCT01436643|2259577|P4|2-week Pre-treatment|Protocol Violation|4
695869|NCT01436643|2259578|P3|2-week Pre-treatment|Protocol Violation|0
695870|NCT01436643|2259579|P2|2-week Pre-treatment|Protocol Violation|0
695871|NCT01436643|2259580|P1|2-week Pre-treatment|Protocol Violation|0
695872|NCT01436643|2259577|P4|2-week Pre-treatment|Adverse Event|5
695873|NCT01436643|2259578|P3|2-week Pre-treatment|Adverse Event|0
695874|NCT01436643|2259579|P2|2-week Pre-treatment|Adverse Event|0
695875|NCT01436643|2259580|P1|2-week Pre-treatment|Adverse Event|0
695876|NCT01436643|2259577|P4|2-week Pre-treatment|Abnormal test result|1
695877|NCT01436643|2259578|P3|2-week Pre-treatment|Abnormal test result|0
695878|NCT01436643|2259579|P2|2-week Pre-treatment|Abnormal test result|0
695879|NCT01436643|2259580|P1|2-week Pre-treatment|Abnormal test result|0
695880|NCT01436500|2259615|P5|Overall Study|not specified|0
695881|NCT01436500|2259616|P4|Overall Study|not specified|1
695882|NCT01436500|2259617|P3|Overall Study|not specified|0
695883|NCT01436500|2259618|P2|Overall Study|not specified|1
695884|NCT01436500|2259619|P1|Overall Study|not specified|0
695885|NCT01436500|2259615|P5|Overall Study|discontinued study drug|0
695886|NCT01436500|2259616|P4|Overall Study|discontinued study drug|0
695887|NCT01436500|2259617|P3|Overall Study|discontinued study drug|0
695888|NCT01436500|2259618|P2|Overall Study|discontinued study drug|0
695889|NCT01436500|2259619|P1|Overall Study|discontinued study drug|1
695890|NCT01436500|2259615|P5|Overall Study|initiation of dialysis|1
695891|NCT01436500|2259616|P4|Overall Study|initiation of dialysis|0
695892|NCT01436500|2259617|P3|Overall Study|initiation of dialysis|0
695893|NCT01436500|2259618|P2|Overall Study|initiation of dialysis|0
695894|NCT01436500|2259619|P1|Overall Study|initiation of dialysis|0
695895|NCT01436500|2259615|P5|Overall Study|liver transplant|0
695896|NCT01436500|2259616|P4|Overall Study|liver transplant|0
695897|NCT01436500|2259617|P3|Overall Study|liver transplant|0
695898|NCT01436500|2259618|P2|Overall Study|liver transplant|0
695899|NCT01436500|2259619|P1|Overall Study|liver transplant|1
695900|NCT01436500|2259615|P5|Overall Study|Physician Decision|0
695901|NCT01436500|2259616|P4|Overall Study|Physician Decision|0
695902|NCT01436500|2259617|P3|Overall Study|Physician Decision|1
695903|NCT01436500|2259618|P2|Overall Study|Physician Decision|0
695904|NCT01436500|2259619|P1|Overall Study|Physician Decision|0
695905|NCT01436500|2259615|P5|Overall Study|Withdrawal by Subject|2
695906|NCT01436500|2259616|P4|Overall Study|Withdrawal by Subject|0
695907|NCT01436500|2259617|P3|Overall Study|Withdrawal by Subject|2
695908|NCT01436500|2259618|P2|Overall Study|Withdrawal by Subject|0
695909|NCT01436500|2259619|P1|Overall Study|Withdrawal by Subject|0
695910|NCT01436500|2259615|P5|Overall Study|Adverse Event|1
695911|NCT01436500|2259616|P4|Overall Study|Adverse Event|0
695912|NCT01436500|2259617|P3|Overall Study|Adverse Event|2
695913|NCT01436500|2259618|P2|Overall Study|Adverse Event|2
695914|NCT01436500|2259619|P1|Overall Study|Adverse Event|0
695915|NCT01436500|2259615|P5|Overall Study|Death|0
695916|NCT01436500|2259616|P4|Overall Study|Death|0
695917|NCT01436500|2259617|P3|Overall Study|Death|0
695918|NCT01436500|2259618|P2|Overall Study|Death|0
695919|NCT01436500|2259619|P1|Overall Study|Death|1
695920|NCT01436370|2259669|P8|Overall Study|Lost to Follow-up|0
695921|NCT01436370|2259670|P7|Overall Study|Lost to Follow-up|0
695922|NCT01436370|2259671|P6|Overall Study|Lost to Follow-up|0
695923|NCT01436370|2259672|P5|Overall Study|Lost to Follow-up|1
695924|NCT01436370|2259673|P4|Overall Study|Lost to Follow-up|0
695925|NCT01436370|2259674|P3|Overall Study|Lost to Follow-up|0
695926|NCT01436370|2259675|P2|Overall Study|Lost to Follow-up|0
695927|NCT01436370|2259676|P1|Overall Study|Lost to Follow-up|0
695928|NCT01436305|2259757|P3|Overall Study|Withdrawal by Subject|0
695929|NCT01436305|2259758|P2|Overall Study|Withdrawal by Subject|3
695930|NCT01436305|2259759|P1|Overall Study|Withdrawal by Subject|1
695931|NCT01436305|2259757|P3|Overall Study|Lost to Follow-up|0
695932|NCT01436305|2259758|P2|Overall Study|Lost to Follow-up|1
695933|NCT01436305|2259759|P1|Overall Study|Lost to Follow-up|0
695934|NCT01436305|2259757|P3|Overall Study|Death|0
695935|NCT01436305|2259758|P2|Overall Study|Death|0
695936|NCT01436305|2259759|P1|Overall Study|Death|1
695937|NCT01436253|2259886|P1|Overall Study|Not meeting all eligibility criteria|117
695938|NCT01436253|2259886|P1|Overall Study|Lost to Follow-up|182
695939|NCT01436201|2259891|P1|Overall Study|Protocol Violation|1
695940|NCT01436201|2259891|P1|Overall Study|Withdrawal by Subject|1
695941|NCT01436201|2259891|P1|Overall Study|Adverse Event|2
695942|NCT01436175|2259901|P1|Overall Study|Unspecified|826
695943|NCT01436175|2259901|P1|Overall Study|Met blood pressure or pulse withdrawal|63
695944|NCT01436175|2259901|P1|Overall Study|Lack of Efficacy|24
695945|NCT01436175|2259901|P1|Overall Study|Lost to Follow-up|89
695946|NCT01436175|2259901|P1|Overall Study|Withdrawal by Subject|108
695947|NCT01436175|2259901|P1|Overall Study|Protocol Violation|49
695948|NCT01436175|2259901|P1|Overall Study|Adverse Event|111
695949|NCT01436162|2259928|P3|Randomized Phase|Not Specified|4
695950|NCT01436162|2259929|P2|Randomized Phase|Not Specified|5
695951|NCT01436162|2259930|P1|Randomized Phase|Not Specified|2
695952|NCT01436162|2259928|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
695953|NCT01436162|2259929|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
695954|NCT01436162|2259930|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
695955|NCT01436162|2259928|P3|Randomized Phase|Lack of Efficacy|1
695956|NCT01436162|2259929|P2|Randomized Phase|Lack of Efficacy|1
695957|NCT01436162|2259930|P1|Randomized Phase|Lack of Efficacy|0
695958|NCT01436162|2259928|P3|Randomized Phase|Lost to Follow-up|4
695959|NCT01436162|2259929|P2|Randomized Phase|Lost to Follow-up|5
695960|NCT01436162|2259930|P1|Randomized Phase|Lost to Follow-up|17
695961|NCT01436162|2259928|P3|Randomized Phase|Withdrawal by Subject|8
695962|NCT01436162|2259929|P2|Randomized Phase|Withdrawal by Subject|9
695963|NCT01436162|2259930|P1|Randomized Phase|Withdrawal by Subject|16
695964|NCT01436162|2259928|P3|Randomized Phase|Protocol Violation|2
695965|NCT01436162|2259929|P2|Randomized Phase|Protocol Violation|4
695966|NCT01436162|2259930|P1|Randomized Phase|Protocol Violation|4
695967|NCT01436162|2259928|P3|Randomized Phase|Adverse Event|6
695968|NCT01436162|2259929|P2|Randomized Phase|Adverse Event|5
695969|NCT01436162|2259930|P1|Randomized Phase|Adverse Event|1
695970|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Not Specified|0
695971|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Not Specified|0
695972|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Not Specified|107
695973|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
695974|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
695975|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
695976|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
695977|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
695978|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
695979|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
695980|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
695981|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
695982|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Protocol Violation|0
695983|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Protocol Violation|0
695984|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Protocol Violation|24
695985|NCT01436162|2259928|P3|Single-blind Lead-in Phase|Adverse Event|0
695986|NCT01436162|2259929|P2|Single-blind Lead-in Phase|Adverse Event|0
695987|NCT01436162|2259930|P1|Single-blind Lead-in Phase|Adverse Event|26
695988|NCT01436149|2259964|P3|Randomized Phase|Not Specified|11
695989|NCT01436149|2259965|P2|Randomized Phase|Not Specified|5
695990|NCT01436149|2259966|P1|Randomized Phase|Not Specified|12
695991|NCT01436149|2259964|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
695992|NCT01436149|2259965|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
695993|NCT01436149|2259966|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
695994|NCT01436149|2259964|P3|Randomized Phase|Lack of Efficacy|1
695995|NCT01436149|2259965|P2|Randomized Phase|Lack of Efficacy|0
695996|NCT01436149|2259966|P1|Randomized Phase|Lack of Efficacy|0
695997|NCT01436149|2259964|P3|Randomized Phase|Lost to Follow-up|6
695998|NCT01436149|2259965|P2|Randomized Phase|Lost to Follow-up|5
695999|NCT01436149|2259966|P1|Randomized Phase|Lost to Follow-up|34
696000|NCT01436149|2259964|P3|Randomized Phase|Withdrawal by Subject|10
696001|NCT01436149|2259965|P2|Randomized Phase|Withdrawal by Subject|10
696002|NCT01436149|2259966|P1|Randomized Phase|Withdrawal by Subject|16
696003|NCT01436149|2259964|P3|Randomized Phase|Protocol Violation|0
696004|NCT01436149|2259965|P2|Randomized Phase|Protocol Violation|5
696005|NCT01436149|2259966|P1|Randomized Phase|Protocol Violation|4
696006|NCT01436149|2259964|P3|Randomized Phase|Adverse Event|11
696007|NCT01436149|2259965|P2|Randomized Phase|Adverse Event|10
696008|NCT01436149|2259966|P1|Randomized Phase|Adverse Event|9
696009|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Not Specified|0
696010|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Not Specified|0
696011|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Not Specified|119
696012|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
696013|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
696014|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
696015|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
696016|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
696017|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
696018|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696019|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696020|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
696021|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Protocol Violation|0
696022|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Protocol Violation|0
696023|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Protocol Violation|29
696024|NCT01436149|2259964|P3|Antidepressant Lead-in Phase|Adverse Event|0
696025|NCT01436149|2259965|P2|Antidepressant Lead-in Phase|Adverse Event|0
696026|NCT01436149|2259966|P1|Antidepressant Lead-in Phase|Adverse Event|39
696027|NCT01436110|2259997|P3|Overall Study|Did Not Receive Trial Medication|3
696028|NCT01436110|2259998|P2|Overall Study|Did Not Receive Trial Medication|0
696029|NCT01436110|2259999|P1|Overall Study|Did Not Receive Trial Medication|1
696030|NCT01436110|2259997|P3|Overall Study|Protocol Violation|1
696031|NCT01436110|2259998|P2|Overall Study|Protocol Violation|1
696032|NCT01436110|2259999|P1|Overall Study|Protocol Violation|3
696033|NCT01436110|2259997|P3|Overall Study|Lost to Follow-up|3
696034|NCT01436110|2259998|P2|Overall Study|Lost to Follow-up|1
696035|NCT01436110|2259999|P1|Overall Study|Lost to Follow-up|1
696036|NCT01436110|2259997|P3|Overall Study|Physician Decision|1
696037|NCT01436110|2259998|P2|Overall Study|Physician Decision|1
696038|NCT01436110|2259999|P1|Overall Study|Physician Decision|3
696039|NCT01436110|2259997|P3|Overall Study|Adverse Event|2
696040|NCT01436110|2259998|P2|Overall Study|Adverse Event|1
696041|NCT01436110|2259999|P1|Overall Study|Adverse Event|2
696042|NCT01436110|2259997|P3|Overall Study|Withdrawal by Subject|4
696043|NCT01436110|2259998|P2|Overall Study|Withdrawal by Subject|8
696044|NCT01436110|2259999|P1|Overall Study|Withdrawal by Subject|6
696045|NCT01436110|2259997|P3|Overall Study|Lack of Efficacy|9
696046|NCT01436110|2259998|P2|Overall Study|Lack of Efficacy|14
696047|NCT01436110|2259999|P1|Overall Study|Lack of Efficacy|23
696048|NCT01436084|2260022|P1|Overall Study|Early Closure of Study|1
696049|NCT01436084|2260022|P1|Overall Study|Withdrawal by Subject|1
696050|NCT01436084|2260022|P1|Overall Study|Disease Progression|2
696051|NCT01436071|2260028|P2|Overall Study|Did Not Receive Trial Medication|3
696052|NCT01436071|2260029|P1|Overall Study|Did Not Receive Trial Medication|3
696053|NCT01436071|2260028|P2|Overall Study|Withdrawal by Subject|2
696054|NCT01436071|2260029|P1|Overall Study|Withdrawal by Subject|2
696055|NCT01436071|2260028|P2|Overall Study|Physician Decision|0
696056|NCT01436071|2260029|P1|Overall Study|Physician Decision|1
696057|NCT01436071|2260028|P2|Overall Study|Lost to Follow-up|1
696058|NCT01436071|2260029|P1|Overall Study|Lost to Follow-up|3
696059|NCT01436071|2260028|P2|Overall Study|Protocol Violation|1
696060|NCT01436071|2260029|P1|Overall Study|Protocol Violation|0
696061|NCT01436071|2260028|P2|Overall Study|Lack of Efficacy|7
696062|NCT01436071|2260029|P1|Overall Study|Lack of Efficacy|16
696063|NCT01436071|2260028|P2|Overall Study|Adverse Event|0
696064|NCT01436071|2260029|P1|Overall Study|Adverse Event|1
696065|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Administrative|2
696066|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Administrative|5
696067|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Administrative|0
696068|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
696069|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
696070|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
696071|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
696072|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
696073|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
696074|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
696075|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
696076|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
696077|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
696078|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
696079|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
696080|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
696081|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
696082|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
696083|NCT01435928|2260071|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
696084|NCT01435928|2260072|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
696085|NCT01435928|2260073|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
696086|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Administrative|0
696087|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Administrative|0
696088|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Administrative|14
696089|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
696090|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
696091|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
696092|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
696093|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
696094|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
696095|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
696096|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
696097|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
696098|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
696099|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
696100|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
696101|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
696102|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
696103|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
696104|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
696105|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
696106|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
696107|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Death|0
696108|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Death|0
696109|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Death|1
696110|NCT01435928|2260071|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
696111|NCT01435928|2260072|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
696112|NCT01435928|2260073|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
696113|NCT01435798|2260100|P1|Overall Study|Withdrawal by Subject|1
696114|NCT01435759|2260119|P6|Double-blind Phase|Not Specified|0
696115|NCT01435759|2260120|P5|Double-blind Phase|Not Specified|0
696116|NCT01435759|2260121|P4|Double-blind Phase|Not Specified|2
696117|NCT01435759|2260122|P3|Double-blind Phase|Not Specified|0
696118|NCT01435759|2260123|P2|Double-blind Phase|Not Specified|2
696119|NCT01435759|2260124|P1|Double-blind Phase|Not Specified|8
696120|NCT01435759|2260119|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
696121|NCT01435759|2260120|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
696122|NCT01435759|2260121|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
696123|NCT01435759|2260122|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
696124|NCT01435759|2260123|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
696125|NCT01435759|2260124|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
696126|NCT01435759|2260119|P6|Double-blind Phase|Lost to Follow-up|3
696127|NCT01435759|2260120|P5|Double-blind Phase|Lost to Follow-up|3
696128|NCT01435759|2260121|P4|Double-blind Phase|Lost to Follow-up|0
696129|NCT01435759|2260122|P3|Double-blind Phase|Lost to Follow-up|2
696130|NCT01435759|2260123|P2|Double-blind Phase|Lost to Follow-up|1
696131|NCT01435759|2260124|P1|Double-blind Phase|Lost to Follow-up|31
696132|NCT01435759|2260119|P6|Double-blind Phase|Withdrawal by Subject|2
696133|NCT01435759|2260120|P5|Double-blind Phase|Withdrawal by Subject|2
696134|NCT01435759|2260121|P4|Double-blind Phase|Withdrawal by Subject|4
696135|NCT01435759|2260122|P3|Double-blind Phase|Withdrawal by Subject|3
696136|NCT01435759|2260123|P2|Double-blind Phase|Withdrawal by Subject|4
696137|NCT01435759|2260124|P1|Double-blind Phase|Withdrawal by Subject|17
696138|NCT01435759|2260119|P6|Double-blind Phase|Protocol Violation|1
696139|NCT01435759|2260120|P5|Double-blind Phase|Protocol Violation|0
696140|NCT01435759|2260121|P4|Double-blind Phase|Protocol Violation|2
696141|NCT01435759|2260122|P3|Double-blind Phase|Protocol Violation|1
696142|NCT01435759|2260123|P2|Double-blind Phase|Protocol Violation|0
696143|NCT01435759|2260124|P1|Double-blind Phase|Protocol Violation|2
696144|NCT01435759|2260119|P6|Double-blind Phase|Adverse Event|3
696145|NCT01435759|2260120|P5|Double-blind Phase|Adverse Event|1
696146|NCT01435759|2260121|P4|Double-blind Phase|Adverse Event|1
696147|NCT01435759|2260122|P3|Double-blind Phase|Adverse Event|1
696148|NCT01435759|2260123|P2|Double-blind Phase|Adverse Event|0
696149|NCT01435759|2260124|P1|Double-blind Phase|Adverse Event|7
696150|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Not Specified|0
696151|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Not Specified|0
696152|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Not Specified|0
696153|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Not Specified|0
696154|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Not Specified|0
696155|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Not Specified|119
696156|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
696157|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
696158|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
696159|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
696160|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
696161|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
696162|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
696163|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
696164|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
696165|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
696166|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
696167|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
696168|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696169|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696170|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696171|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696172|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
696173|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
696174|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Protocol Violation|0
696175|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Protocol Violation|0
696176|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Protocol Violation|0
696177|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Protocol Violation|0
696178|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Protocol Violation|0
696179|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Protocol Violation|16
696180|NCT01435759|2260119|P6|Antidepressant Lead-in Phase|Adverse Event|0
696181|NCT01435759|2260120|P5|Antidepressant Lead-in Phase|Adverse Event|0
696182|NCT01435759|2260121|P4|Antidepressant Lead-in Phase|Adverse Event|0
696183|NCT01435759|2260122|P3|Antidepressant Lead-in Phase|Adverse Event|0
696184|NCT01435759|2260123|P2|Antidepressant Lead-in Phase|Adverse Event|0
696185|NCT01435759|2260124|P1|Antidepressant Lead-in Phase|Adverse Event|40
696186|NCT01435655|2260151|P1|Overall Study|Unspecified|1
696187|NCT01435655|2260151|P1|Overall Study|Death|2
696188|NCT01435577|2260165|P2|Overall Study|Alternative treatment started|1
696189|NCT01435577|2260166|P1|Overall Study|Alternative treatment started|0
696190|NCT01435577|2260165|P2|Overall Study|Lack of Efficacy|51
696191|NCT01435577|2260166|P1|Overall Study|Lack of Efficacy|7
696192|NCT01435577|2260165|P2|Overall Study|Adverse Event|0
696193|NCT01435577|2260166|P1|Overall Study|Adverse Event|10
696194|NCT01435460|2260216|P2|Overall Study|Did not meet eligibility criteria|0
696195|NCT01435460|2260217|P1|Overall Study|Did not meet eligibility criteria|2
696196|NCT01435460|2260216|P2|Overall Study|Protocol Violation|1
696197|NCT01435460|2260217|P1|Overall Study|Protocol Violation|0
696198|NCT01435460|2260216|P2|Overall Study|Withdrawal by Subject|3
696199|NCT01435460|2260217|P1|Overall Study|Withdrawal by Subject|1
696200|NCT01435460|2260216|P2|Overall Study|Lost to Follow-up|1
696201|NCT01435460|2260217|P1|Overall Study|Lost to Follow-up|6
696202|NCT01435460|2260216|P2|Overall Study|Adverse Event|1
696203|NCT01435460|2260217|P1|Overall Study|Adverse Event|2
696206|NCT01435122|2260246|P1|Overall Study|Early withdrawal due to toxicity|8
696207|NCT01435031|2260255|P1|ITT at 1 Year|Lost to Follow-up|5
696208|NCT01435031|2260255|P1|ITT at 1 Year|Withdrawal by Subject|2
696209|NCT01435031|2260255|P1|ITT at 1 Year|Death|1
696210|NCT01435031|2260255|P1|ITT at 6 Months|Lost to Follow-up|3
696211|NCT01435031|2260255|P1|ITT at 6 Months|Death|2
696212|NCT01435031|2260255|P1|ITT at 1 Month|Lost to Follow-up|4
696213|NCT01435031|2260255|P1|ITT at 1 Month|Death|1
696214|NCT01435031|2260255|P1|ITT at 1 Month|Withdrawal by Subject|1
696215|NCT01434823|2260335|P2|Overall Study|Incomplete data in medical record|7
696216|NCT01434823|2260336|P1|Overall Study|Incomplete data in medical record|4
696217|NCT01434693|2260354|P4|Overall Study|Lost to Follow-up|0
696218|NCT01434693|2260355|P3|Overall Study|Lost to Follow-up|0
696219|NCT01434693|2260356|P2|Overall Study|Lost to Follow-up|0
696220|NCT01434693|2260357|P1|Overall Study|Lost to Follow-up|1
696221|NCT01434693|2260354|P4|Overall Study|Withdrawal by Subject|1
696222|NCT01434693|2260355|P3|Overall Study|Withdrawal by Subject|1
696223|NCT01434693|2260356|P2|Overall Study|Withdrawal by Subject|0
696224|NCT01434693|2260357|P1|Overall Study|Withdrawal by Subject|1
696225|NCT01434693|2260354|P4|Overall Study|Adverse Event|0
696226|NCT01434693|2260355|P3|Overall Study|Adverse Event|0
696227|NCT01434693|2260356|P2|Overall Study|Adverse Event|0
696228|NCT01434693|2260357|P1|Overall Study|Adverse Event|1
696229|NCT01434680|2260371|P4|Overall Study|Protocol Violation|0
696230|NCT01434680|2260372|P3|Overall Study|Protocol Violation|0
696231|NCT01434680|2260373|P2|Overall Study|Protocol Violation|1
696232|NCT01434680|2260374|P1|Overall Study|Protocol Violation|1
696233|NCT01434680|2260371|P4|Overall Study|Lost to Follow-up|0
696234|NCT01434680|2260372|P3|Overall Study|Lost to Follow-up|0
696235|NCT01434680|2260373|P2|Overall Study|Lost to Follow-up|1
696236|NCT01434680|2260374|P1|Overall Study|Lost to Follow-up|1
696237|NCT01434680|2260371|P4|Overall Study|Withdrawal by Subject|0
696238|NCT01434680|2260372|P3|Overall Study|Withdrawal by Subject|2
696239|NCT01434680|2260373|P2|Overall Study|Withdrawal by Subject|0
696240|NCT01434680|2260374|P1|Overall Study|Withdrawal by Subject|1
696241|NCT01434654|2260391|P2|Overall Study|Lost to Follow-up|0
696242|NCT01434654|2260392|P1|Overall Study|Lost to Follow-up|1
696243|NCT01434654|2260391|P2|Overall Study|Withdrawal by Subject|0
696244|NCT01434654|2260392|P1|Overall Study|Withdrawal by Subject|1
696245|NCT01433549|2260488|P2|Phase 2: Second Study Product|Adverse Event|1
696246|NCT01433549|2260489|P1|Phase 2: Second Study Product|Adverse Event|0
696247|NCT01433471|2260499|P2|Overall Study|Withdrawal by Subject|1
696248|NCT01433471|2260500|P1|Overall Study|Withdrawal by Subject|0
696249|NCT01433354|2260516|P1|Overall Study|Subject Withdrew Consent|3
696250|NCT01433354|2260516|P1|Overall Study|Lack of Efficacy|17
696251|NCT01433354|2260516|P1|Overall Study|Protocol Violation|2
696252|NCT01433354|2260516|P1|Overall Study|Administrative problems|90
696253|NCT01433354|2260516|P1|Overall Study|Lost to Follow-up|1
696254|NCT01433354|2260516|P1|Overall Study|Adverse Event|6
696255|NCT01433263|2260532|P2|Overall Study|Withdrawal by Subject|7
696256|NCT01433263|2260533|P1|Overall Study|Withdrawal by Subject|10
696257|NCT01433263|2260532|P2|Overall Study|Protocol Deviation|0
696258|NCT01433263|2260533|P1|Overall Study|Protocol Deviation|1
696259|NCT01433263|2260532|P2|Overall Study|Lost to Follow-up|1
696260|NCT01433263|2260533|P1|Overall Study|Lost to Follow-up|0
696261|NCT01433263|2260532|P2|Overall Study|Death|3
696262|NCT01433263|2260533|P1|Overall Study|Death|5
696263|NCT01433263|2260532|P2|Overall Study|Adverse Event|1
696264|NCT01433263|2260533|P1|Overall Study|Adverse Event|3
696265|NCT01433250|2260562|P2|Overall Study|Withdrawal by Subject|2
696266|NCT01433250|2260563|P1|Overall Study|Withdrawal by Subject|3
696267|NCT01433250|2260562|P2|Overall Study|Protocol Violation|1
696268|NCT01433250|2260563|P1|Overall Study|Protocol Violation|0
696269|NCT01433172|2260582|P3|Overall Study|Death|0
696270|NCT01433172|2260583|P2|Overall Study|Death|2
696271|NCT01433172|2260584|P1|Overall Study|Death|0
696272|NCT01433172|2260582|P3|Overall Study|Disease Progression|1
696273|NCT01433172|2260583|P2|Overall Study|Disease Progression|0
696274|NCT01433172|2260584|P1|Overall Study|Disease Progression|0
696275|NCT01433172|2260582|P3|Overall Study|Withdrawal by Subject|0
696276|NCT01433172|2260583|P2|Overall Study|Withdrawal by Subject|1
696277|NCT01433172|2260584|P1|Overall Study|Withdrawal by Subject|0
696278|NCT01433159|2260596|P2|Overall Study|Protocol Violation|1
696279|NCT01433159|2260597|P1|Overall Study|Protocol Violation|0
696280|NCT01433159|2260596|P2|Overall Study|Physician Decision|0
696281|NCT01433159|2260597|P1|Overall Study|Physician Decision|1
696282|NCT01433159|2260596|P2|Overall Study|Adverse Event|0
696283|NCT01433159|2260597|P1|Overall Study|Adverse Event|1
696284|NCT01433055|2260629|P2|Overall Study|Severely elevated triglycerides at entry|0
696285|NCT01433055|2260630|P1|Overall Study|Severely elevated triglycerides at entry|1
696286|NCT01433055|2260629|P2|Overall Study|Diagnosed with cancer unrelated to study|0
696287|NCT01433055|2260630|P1|Overall Study|Diagnosed with cancer unrelated to study|1
696288|NCT01432938|2260652|P2|Second Intervention|Adverse Event|0
696289|NCT01432938|2260653|P1|Second Intervention|Adverse Event|1
696290|NCT01432938|2260652|P2|First Intervention|Physician Decision|0
696291|NCT01432938|2260653|P1|First Intervention|Physician Decision|1
696292|NCT01432938|2260652|P2|First Intervention|Protocol Violation|0
696293|NCT01432938|2260653|P1|First Intervention|Protocol Violation|1
696294|NCT01432756|2260683|P4|Overall Study|Lost to Follow-up|1
696295|NCT01432756|2260684|P3|Overall Study|Lost to Follow-up|2
696296|NCT01432756|2260685|P2|Overall Study|Lost to Follow-up|0
696297|NCT01432756|2260686|P1|Overall Study|Lost to Follow-up|1
696298|NCT01432626|2260694|P1|Overall Study|Imaging agent not available|1
696299|NCT01432626|2260694|P1|Overall Study|Only 1 image competed|2
696300|NCT01432626|2260694|P1|Overall Study|Withdrawal by Subject|2
696301|NCT01432626|2260694|P1|Overall Study|LV function recovered|2
696302|NCT01432600|2260701|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
696303|NCT01432600|2260702|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
696304|NCT01432600|2260703|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
696305|NCT01432574|2260719|P1|Overall Study|Not interested|1
696306|NCT01432574|2260719|P1|Overall Study|Moved|2
696307|NCT01432457|2260765|P3|Overall Study|Did not take study drug|3
696308|NCT01432457|2260766|P2|Overall Study|Did not take study drug|6
696309|NCT01432457|2260767|P1|Overall Study|Did not take study drug|6
696310|NCT01432457|2260765|P3|Overall Study|Reasons not defined|4
696311|NCT01432457|2260766|P2|Overall Study|Reasons not defined|3
696312|NCT01432457|2260767|P1|Overall Study|Reasons not defined|2
696313|NCT01432457|2260765|P3|Overall Study|Withdrawal by Subject|9
696314|NCT01432457|2260766|P2|Overall Study|Withdrawal by Subject|11
696315|NCT01432457|2260767|P1|Overall Study|Withdrawal by Subject|6
696316|NCT01432457|2260765|P3|Overall Study|Protocol Violation|6
696317|NCT01432457|2260766|P2|Overall Study|Protocol Violation|2
696318|NCT01432457|2260767|P1|Overall Study|Protocol Violation|3
696319|NCT01432457|2260765|P3|Overall Study|Lost to Follow-up|20
696320|NCT01432457|2260766|P2|Overall Study|Lost to Follow-up|15
696321|NCT01432457|2260767|P1|Overall Study|Lost to Follow-up|11
696322|NCT01432457|2260765|P3|Overall Study|Lack of Efficacy|1
696323|NCT01432457|2260766|P2|Overall Study|Lack of Efficacy|1
696324|NCT01432457|2260767|P1|Overall Study|Lack of Efficacy|2
696325|NCT01432457|2260765|P3|Overall Study|Adverse Event|16
696326|NCT01432457|2260766|P2|Overall Study|Adverse Event|10
696327|NCT01432457|2260767|P1|Overall Study|Adverse Event|7
696328|NCT01432444|2260796|P3|Extension Phase|Withdrawal by Subject|13
696329|NCT01432444|2260797|P2|Extension Phase|Withdrawal by Subject|0
696330|NCT01432444|2260798|P1|Extension Phase|Withdrawal by Subject|0
696331|NCT01432444|2260796|P3|Extension Phase|Physician Decision|1
696332|NCT01432444|2260797|P2|Extension Phase|Physician Decision|0
696333|NCT01432444|2260798|P1|Extension Phase|Physician Decision|0
696334|NCT01432444|2260796|P3|Extension Phase|Met Withdrawal Criteria|144
696335|NCT01432444|2260797|P2|Extension Phase|Met Withdrawal Criteria|0
696336|NCT01432444|2260798|P1|Extension Phase|Met Withdrawal Criteria|0
696337|NCT01432444|2260796|P3|Extension Phase|Sponsor Discontinued Trial|7
696338|NCT01432444|2260797|P2|Extension Phase|Sponsor Discontinued Trial|0
696339|NCT01432444|2260798|P1|Extension Phase|Sponsor Discontinued Trial|0
696340|NCT01432444|2260796|P3|Extension Phase|Adverse Event|10
696341|NCT01432444|2260797|P2|Extension Phase|Adverse Event|0
696342|NCT01432444|2260798|P1|Extension Phase|Adverse Event|0
696343|NCT01432444|2260796|P3|Extension Phase|Lost to Follow-up|17
696344|NCT01432444|2260797|P2|Extension Phase|Lost to Follow-up|0
696345|NCT01432444|2260798|P1|Extension Phase|Lost to Follow-up|0
696346|NCT01432444|2260796|P3|Treatment Phase|Lack of Efficacy|0
696347|NCT01432444|2260797|P2|Treatment Phase|Lack of Efficacy|10
696348|NCT01432444|2260798|P1|Treatment Phase|Lack of Efficacy|0
696349|NCT01432444|2260796|P3|Treatment Phase|Protocol Deviation|0
696350|NCT01432444|2260797|P2|Treatment Phase|Protocol Deviation|3
696351|NCT01432444|2260798|P1|Treatment Phase|Protocol Deviation|0
696352|NCT01432444|2260796|P3|Treatment Phase|Withdrawal by Subject|0
696353|NCT01432444|2260797|P2|Treatment Phase|Withdrawal by Subject|41
696354|NCT01432444|2260798|P1|Treatment Phase|Withdrawal by Subject|0
696355|NCT01432444|2260796|P3|Treatment Phase|Physician Decision|0
696356|NCT01432444|2260797|P2|Treatment Phase|Physician Decision|5
696357|NCT01432444|2260798|P1|Treatment Phase|Physician Decision|0
696358|NCT01432444|2260796|P3|Treatment Phase|Met Withdrawal Criteria|0
696359|NCT01432444|2260797|P2|Treatment Phase|Met Withdrawal Criteria|11
696360|NCT01432444|2260798|P1|Treatment Phase|Met Withdrawal Criteria|0
696361|NCT01432444|2260796|P3|Treatment Phase|Adverse Event|0
696362|NCT01432444|2260797|P2|Treatment Phase|Adverse Event|37
696363|NCT01432444|2260798|P1|Treatment Phase|Adverse Event|0
696364|NCT01432444|2260796|P3|Treatment Phase|Lost to Follow-up|0
696365|NCT01432444|2260797|P2|Treatment Phase|Lost to Follow-up|33
696366|NCT01432444|2260798|P1|Treatment Phase|Lost to Follow-up|0
696367|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
696368|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
696369|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
696370|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
696371|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
696372|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
696373|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
696374|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
696375|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
696376|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Physician Decision|0
696377|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Physician Decision|0
696378|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Physician Decision|8
696379|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
696380|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
696381|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
696382|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Adverse Event|0
696383|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Adverse Event|0
696384|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Adverse Event|16
696385|NCT01432444|2260796|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
696386|NCT01432444|2260797|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
696387|NCT01432444|2260798|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
696388|NCT01432366|2260824|P1|Overall Study|Unspecified|14
696389|NCT01432366|2260824|P1|Overall Study|Investigator Forget to Complete Visits|1
696390|NCT01432366|2260824|P1|Overall Study|Site Closed|20
696391|NCT01432366|2260824|P1|Overall Study|Lack of Efficacy|1
696392|NCT01432366|2260824|P1|Overall Study|Lost to Follow-up|13
696393|NCT01432366|2260824|P1|Overall Study|Pregnancy|1
696394|NCT01432366|2260824|P1|Overall Study|Withdrawal Due to Non-Compliance|3
696395|NCT01432366|2260824|P1|Overall Study|Adverse Event|8
696396|NCT01432366|2260824|P1|Overall Study|Non-Responder|7
696397|NCT01432327|2260846|P4|Posttest 1 Year|Allergic reaction|1
696398|NCT01432327|2260847|P3|Posttest 1 Year|Allergic reaction|1
696399|NCT01432327|2260848|P2|Posttest 1 Year|Allergic reaction|0
696400|NCT01432327|2260849|P1|Posttest 1 Year|Allergic reaction|0
696401|NCT01432327|2260846|P4|Posttest 1 Year|Lost to Follow-up|2
696402|NCT01432327|2260847|P3|Posttest 1 Year|Lost to Follow-up|4
696403|NCT01432327|2260848|P2|Posttest 1 Year|Lost to Follow-up|0
696404|NCT01432327|2260849|P1|Posttest 1 Year|Lost to Follow-up|0
696405|NCT01432327|2260846|P4|Posttest 1 Year|Measurement have to take place in future|20
696406|NCT01432327|2260847|P3|Posttest 1 Year|Measurement have to take place in future|15
696407|NCT01432327|2260848|P2|Posttest 1 Year|Measurement have to take place in future|28
696408|NCT01432327|2260849|P1|Posttest 1 Year|Measurement have to take place in future|24
696409|NCT01432327|2260846|P4|Posttest 6 Months|Withdrawal by Subject|0
696410|NCT01432327|2260847|P3|Posttest 6 Months|Withdrawal by Subject|1
696411|NCT01432327|2260848|P2|Posttest 6 Months|Withdrawal by Subject|0
696412|NCT01432327|2260849|P1|Posttest 6 Months|Withdrawal by Subject|0
696413|NCT01432327|2260846|P4|Posttest 6 Months|Allergic reaction|0
696414|NCT01432327|2260847|P3|Posttest 6 Months|Allergic reaction|1
696415|NCT01432327|2260848|P2|Posttest 6 Months|Allergic reaction|0
696416|NCT01432327|2260849|P1|Posttest 6 Months|Allergic reaction|0
696417|NCT01432327|2260846|P4|Posttest 6 Months|Lost to Follow-up|2
696418|NCT01432327|2260847|P3|Posttest 6 Months|Lost to Follow-up|3
696419|NCT01432327|2260848|P2|Posttest 6 Months|Lost to Follow-up|0
696420|NCT01432327|2260849|P1|Posttest 6 Months|Lost to Follow-up|0
696421|NCT01432327|2260846|P4|Posttest 3 Months|Allergic reaction|0
696422|NCT01432327|2260847|P3|Posttest 3 Months|Allergic reaction|0
696423|NCT01432327|2260848|P2|Posttest 3 Months|Allergic reaction|2
696424|NCT01432327|2260849|P1|Posttest 3 Months|Allergic reaction|0
696425|NCT01432327|2260846|P4|Posttest 3 Months|Lost to Follow-up|1
696426|NCT01432327|2260847|P3|Posttest 3 Months|Lost to Follow-up|2
696427|NCT01432327|2260848|P2|Posttest 3 Months|Lost to Follow-up|0
696428|NCT01432327|2260849|P1|Posttest 3 Months|Lost to Follow-up|1
696429|NCT01432327|2260846|P4|Posttest 3 Months|depression|0
696430|NCT01432327|2260847|P3|Posttest 3 Months|depression|0
696431|NCT01432327|2260848|P2|Posttest 3 Months|depression|0
696432|NCT01432327|2260849|P1|Posttest 3 Months|depression|3
696433|NCT01432275|2260859|P2|ADC With Calculator (10 Days)|Protocol Violation|1
696434|NCT01432275|2260860|P1|ADC With Calculator (10 Days)|Protocol Violation|0
696435|NCT01432275|2260859|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
696436|NCT01432275|2260860|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
696437|NCT01432275|2260859|P2|ADC With Calculator (10 Days)|Physician Decision|1
696438|NCT01432275|2260860|P1|ADC With Calculator (10 Days)|Physician Decision|1
696439|NCT01432275|2260859|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
696440|NCT01432275|2260860|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
696441|NCT01432275|2260859|P2|Second BG Meter System (7 Days)|Physician Decision|1
696442|NCT01432275|2260860|P1|Second BG Meter System (7 Days)|Physician Decision|0
696443|NCT01432275|2260859|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
696444|NCT01432275|2260860|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
696445|NCT01432275|2260859|P2|Second BG Meter System (7 Days)|Adverse Event|1
696446|NCT01432275|2260860|P1|Second BG Meter System (7 Days)|Adverse Event|1
696447|NCT01432275|2260859|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
696448|NCT01432275|2260860|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
696449|NCT01432275|2260859|P2|First BG Meter System (7 Days)|Adverse Event|2
696450|NCT01432275|2260860|P1|First BG Meter System (7 Days)|Adverse Event|0
696451|NCT01432262|2260869|P2|Overall Study|Withdrawal by Subject|1
696452|NCT01432262|2260870|P1|Overall Study|Withdrawal by Subject|2
696453|NCT01431976|2260964|P1|Overall Study|Withdrawal by Subject|1
696454|NCT01431976|2260964|P1|Overall Study|Physician Decision|1
696455|NCT01431976|2260964|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
696456|NCT01431976|2260964|P1|Overall Study|Lack of Efficacy|2
696457|NCT01431976|2260964|P1|Overall Study|Adverse Event|6
696458|NCT01431963|2260975|P1|Overall Study|Withdrawal by Subject|3
696459|NCT01431963|2260975|P1|Overall Study|Physician Decision|4
696460|NCT01431963|2260975|P1|Overall Study|Protocol-defined Stopping Criteria|2
696461|NCT01431963|2260975|P1|Overall Study|Protocol Violation|1
696462|NCT01431963|2260975|P1|Overall Study|Lack of Efficacy|7
696463|NCT01431963|2260975|P1|Overall Study|Adverse Event|18
696464|NCT01431950|2260983|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
696465|NCT01431950|2260984|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
696466|NCT01431950|2260983|P2|Overall Study|Lost to Follow-up|1
696467|NCT01431950|2260984|P1|Overall Study|Lost to Follow-up|0
696468|NCT01431950|2260983|P2|Overall Study|Lack of Efficacy|1
696469|NCT01431950|2260984|P1|Overall Study|Lack of Efficacy|2
696470|NCT01431950|2260983|P2|Overall Study|Physician Decision|1
696471|NCT01431950|2260984|P1|Overall Study|Physician Decision|2
696472|NCT01431950|2260983|P2|Overall Study|Adverse Event|2
696473|NCT01431950|2260984|P1|Overall Study|Adverse Event|2
696474|NCT01431950|2260983|P2|Overall Study|Protocol Violation|3
696475|NCT01431950|2260984|P1|Overall Study|Protocol Violation|2
696476|NCT01431950|2260983|P2|Overall Study|Withdrawal by Subject|3
696477|NCT01431950|2260984|P1|Overall Study|Withdrawal by Subject|4
696478|NCT01431950|2260983|P2|Overall Study|Study Site Closed/Terminated|3
696479|NCT01431950|2260984|P1|Overall Study|Study Site Closed/Terminated|7
696480|NCT01431716|2261022|P1|Overall Study|Withdrawal of consent|1
696481|NCT01431521|2261047|P4|Overall Study|Withdrawal by Subject|0
696482|NCT01431521|2261048|P3|Overall Study|Withdrawal by Subject|1
696483|NCT01431521|2261049|P2|Overall Study|Withdrawal by Subject|0
696484|NCT01431521|2261050|P1|Overall Study|Withdrawal by Subject|0
696485|NCT01431508|2261071|P1|Overall Study|Unable to Follow Protocol Procedures|1
696486|NCT01431508|2261071|P1|Overall Study|Lack of Efficacy|1
696487|NCT01431287|2261122|P5|Overall Study|not stated above|1
696488|NCT01431287|2261123|P4|Overall Study|not stated above|2
696489|NCT01431287|2261124|P3|Overall Study|not stated above|2
696490|NCT01431287|2261125|P2|Overall Study|not stated above|2
696491|NCT01431287|2261126|P1|Overall Study|not stated above|4
696492|NCT01431287|2261122|P5|Overall Study|Consent withdrawn not due to AE|29
696493|NCT01431287|2261123|P4|Overall Study|Consent withdrawn not due to AE|19
696494|NCT01431287|2261124|P3|Overall Study|Consent withdrawn not due to AE|34
696495|NCT01431287|2261125|P2|Overall Study|Consent withdrawn not due to AE|30
696496|NCT01431287|2261126|P1|Overall Study|Consent withdrawn not due to AE|29
696497|NCT01431287|2261122|P5|Overall Study|Lost to Follow-up|1
696498|NCT01431287|2261123|P4|Overall Study|Lost to Follow-up|3
696499|NCT01431287|2261124|P3|Overall Study|Lost to Follow-up|2
696500|NCT01431287|2261125|P2|Overall Study|Lost to Follow-up|3
696501|NCT01431287|2261126|P1|Overall Study|Lost to Follow-up|0
696502|NCT01431287|2261122|P5|Overall Study|Non compliant with protocol|5
696503|NCT01431287|2261123|P4|Overall Study|Non compliant with protocol|6
696504|NCT01431287|2261124|P3|Overall Study|Non compliant with protocol|5
696505|NCT01431287|2261125|P2|Overall Study|Non compliant with protocol|6
696506|NCT01431287|2261126|P1|Overall Study|Non compliant with protocol|6
696507|NCT01431287|2261122|P5|Overall Study|Adverse Event|41
696508|NCT01431287|2261123|P4|Overall Study|Adverse Event|33
696509|NCT01431287|2261124|P3|Overall Study|Adverse Event|53
696510|NCT01431287|2261125|P2|Overall Study|Adverse Event|57
696511|NCT01431287|2261126|P1|Overall Study|Adverse Event|59
696512|NCT01431287|2261122|P5|Overall Study|not treated|0
696513|NCT01431287|2261123|P4|Overall Study|not treated|0
696514|NCT01431287|2261124|P3|Overall Study|not treated|1
696515|NCT01431287|2261125|P2|Overall Study|not treated|0
696516|NCT01431287|2261126|P1|Overall Study|not treated|0
696517|NCT01431274|2261288|P5|Overall Study|Other reason not stated above|4
696518|NCT01431274|2261289|P4|Overall Study|Other reason not stated above|2
696519|NCT01431274|2261290|P3|Overall Study|Other reason not stated above|7
696520|NCT01431274|2261291|P2|Overall Study|Other reason not stated above|5
696521|NCT01431274|2261292|P1|Overall Study|Other reason not stated above|6
696522|NCT01431274|2261288|P5|Overall Study|Lost to Follow-up|0
696523|NCT01431274|2261289|P4|Overall Study|Lost to Follow-up|4
696524|NCT01431274|2261290|P3|Overall Study|Lost to Follow-up|1
696525|NCT01431274|2261291|P2|Overall Study|Lost to Follow-up|7
696526|NCT01431274|2261292|P1|Overall Study|Lost to Follow-up|6
696527|NCT01431274|2261288|P5|Overall Study|Non compliant with protocol|4
696528|NCT01431274|2261289|P4|Overall Study|Non compliant with protocol|4
696529|NCT01431274|2261290|P3|Overall Study|Non compliant with protocol|4
696530|NCT01431274|2261291|P2|Overall Study|Non compliant with protocol|8
696531|NCT01431274|2261292|P1|Overall Study|Non compliant with protocol|5
696532|NCT01431274|2261288|P5|Overall Study|Consent withdrawn not due to AE|11
696533|NCT01431274|2261289|P4|Overall Study|Consent withdrawn not due to AE|20
696534|NCT01431274|2261290|P3|Overall Study|Consent withdrawn not due to AE|17
696535|NCT01431274|2261291|P2|Overall Study|Consent withdrawn not due to AE|20
696536|NCT01431274|2261292|P1|Overall Study|Consent withdrawn not due to AE|29
696537|NCT01431274|2261288|P5|Overall Study|Adverse Event|37
696538|NCT01431274|2261289|P4|Overall Study|Adverse Event|30
696539|NCT01431274|2261290|P3|Overall Study|Adverse Event|43
696540|NCT01431274|2261291|P2|Overall Study|Adverse Event|37
696541|NCT01431274|2261292|P1|Overall Study|Adverse Event|51
696542|NCT01431144|2261470|P2|Overall Study|Implant mobility and removal|0
696543|NCT01431144|2261471|P1|Overall Study|Implant mobility and removal|2
696544|NCT01431079|2261490|P2|Overall Study|Lost to Follow-up|39
696545|NCT01431079|2261491|P1|Overall Study|Lost to Follow-up|35
696546|NCT01430754|2261570|P2|Run-In Phase|Lost to Follow-up|0
696547|NCT01430754|2261571|P1|Run-In Phase|Lost to Follow-up|1
696548|NCT01430754|2261570|P2|Run-In Phase|Withdrawal by Subject|0
696549|NCT01430754|2261571|P1|Run-In Phase|Withdrawal by Subject|2
696550|NCT01430754|2261570|P2|Run-In Phase|Other|0
696551|NCT01430754|2261571|P1|Run-In Phase|Other|2
696552|NCT01430754|2261570|P2|Run-In Phase|Adverse Event|0
696553|NCT01430754|2261571|P1|Run-In Phase|Adverse Event|2
696554|NCT01430754|2261570|P2|Run-In Phase|Protocol Violation|0
696555|NCT01430754|2261571|P1|Run-In Phase|Protocol Violation|6
696556|NCT01430754|2261570|P2|Run-In Phase|Circadian Period Ineligible|0
696557|NCT01430754|2261571|P1|Run-In Phase|Circadian Period Ineligible|24
696558|NCT01430624|2261629|P3|Overall Study|technical or eligibility|2
696559|NCT01430624|2261630|P2|Overall Study|technical or eligibility|5
696560|NCT01430624|2261631|P1|Overall Study|technical or eligibility|5
696561|NCT01430624|2261629|P3|Overall Study|Lost to Follow-up|27
696562|NCT01430624|2261630|P2|Overall Study|Lost to Follow-up|29
696563|NCT01430624|2261631|P1|Overall Study|Lost to Follow-up|23
696564|NCT01430611|2261662|P2|Overall Study|Withdrawal by Subject|14
696565|NCT01430611|2261663|P1|Overall Study|Withdrawal by Subject|15
696566|NCT01430611|2261662|P2|Overall Study|Lost to Follow-up|0
696567|NCT01430611|2261663|P1|Overall Study|Lost to Follow-up|1
696568|NCT01430611|2261662|P2|Overall Study|Protocol Violation|0
696569|NCT01430611|2261663|P1|Overall Study|Protocol Violation|1
696570|NCT01430611|2261662|P2|Overall Study|Adverse Event|1
696571|NCT01430611|2261663|P1|Overall Study|Adverse Event|0
696572|NCT01430585|2261681|P1|Overall Study|Unspecified|7
696573|NCT01430585|2261681|P1|Overall Study|Study Terminated by Sponsor|3
696574|NCT01430585|2261681|P1|Overall Study|Objective Progression or Relapse|3
696575|NCT01430585|2261681|P1|Overall Study|Death|1
696576|NCT01430468|2261716|P2|Overall Study|Withdrawal by Subject|1
696577|NCT01430468|2261717|P1|Overall Study|Withdrawal by Subject|1
696578|NCT01430468|2261716|P2|Overall Study|Physician Decision|1
696579|NCT01430468|2261717|P1|Overall Study|Physician Decision|2
696580|NCT01430403|2261726|P3|Overall Study|Withdrawal by Subject|3
696581|NCT01430403|2261727|P2|Overall Study|Withdrawal by Subject|1
696582|NCT01430403|2261728|P1|Overall Study|Withdrawal by Subject|9
696583|NCT01430403|2261726|P3|Overall Study|Protocol Violation|2
696584|NCT01430403|2261727|P2|Overall Study|Protocol Violation|3
696585|NCT01430403|2261728|P1|Overall Study|Protocol Violation|2
696586|NCT01430403|2261726|P3|Overall Study|Physician Decision|0
696587|NCT01430403|2261727|P2|Overall Study|Physician Decision|0
696588|NCT01430403|2261728|P1|Overall Study|Physician Decision|1
696589|NCT01430403|2261726|P3|Overall Study|Lost to Follow-up|3
696590|NCT01430403|2261727|P2|Overall Study|Lost to Follow-up|5
696591|NCT01430403|2261728|P1|Overall Study|Lost to Follow-up|5
696592|NCT01430130|2261826|P1|Overall Study|Infection on Control Side of Incision|1
696593|NCT01430130|2261826|P1|Overall Study|Lost to Follow-up|1
696594|NCT01430104|2261832|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
696595|NCT01429623|2261868|P2|Overall Study|No post baseline data|4
696596|NCT01429623|2261869|P1|Overall Study|No post baseline data|4
696597|NCT01429623|2261868|P2|Overall Study|Conversion to Alzheimer's disease|21
696598|NCT01429623|2261869|P1|Overall Study|Conversion to Alzheimer's disease|14
696599|NCT01429623|2261868|P2|Overall Study|Assorted|2
696600|NCT01429623|2261869|P1|Overall Study|Assorted|1
696601|NCT01429623|2261868|P2|Overall Study|Protocol Violation|2
696602|NCT01429623|2261869|P1|Overall Study|Protocol Violation|3
696603|NCT01429623|2261868|P2|Overall Study|Physician Decision|3
696604|NCT01429623|2261869|P1|Overall Study|Physician Decision|2
696605|NCT01429623|2261868|P2|Overall Study|Withdrawal by Subject|13
696606|NCT01429623|2261869|P1|Overall Study|Withdrawal by Subject|19
696607|NCT01429623|2261868|P2|Overall Study|Adverse Event|14
696608|NCT01429623|2261869|P1|Overall Study|Adverse Event|7
696609|NCT01429623|2261868|P2|Overall Study|Death|0
696610|NCT01429623|2261869|P1|Overall Study|Death|1
696611|NCT01429584|2261883|P2|Overall Study|Protocol Violation|1
696612|NCT01429584|2261884|P1|Overall Study|Protocol Violation|0
696613|NCT01429584|2261883|P2|Overall Study|Withdrawal by Subject|0
696614|NCT01429584|2261884|P1|Overall Study|Withdrawal by Subject|1
696615|NCT01429441|2261915|P2|Overall Study|Withdrawal by Subject|18
696616|NCT01429441|2261916|P1|Overall Study|Withdrawal by Subject|27
696617|NCT01429441|2261915|P2|Overall Study|Physician Decision|0
696618|NCT01429441|2261916|P1|Overall Study|Physician Decision|1
696619|NCT01429441|2261915|P2|Overall Study|Lost to Follow-up|2
696620|NCT01429441|2261916|P1|Overall Study|Lost to Follow-up|5
696621|NCT01429441|2261915|P2|Overall Study|Death|2
696622|NCT01429441|2261916|P1|Overall Study|Death|0
696623|NCT01429441|2261915|P2|Overall Study|Adverse Event|1
696624|NCT01429441|2261916|P1|Overall Study|Adverse Event|5
696625|NCT01429077|2261931|P2|Overall Study|Lost to Follow-up|3
696626|NCT01429077|2261932|P1|Overall Study|Lost to Follow-up|0
696627|NCT01429051|2261955|P1|Tolerability Phase|Other|2
696628|NCT01429051|2261955|P1|Tolerability Phase|Physician Decision|1
696629|NCT01429051|2261955|P1|Tolerability Phase|Withdrawal by Subject|5
696630|NCT01429051|2261955|P1|Tolerability Phase|Adverse Event|2
696631|NCT01429051|2261955|P1|Tolerability Phase|Death|5
696632|NCT01429051|2261955|P1|Efficacy Phase|Death|1
696633|NCT01429051|2261955|P1|Efficacy Phase|Adverse Event|1
696634|NCT01429051|2261955|P1|Titration Phase|Less than 3 BTP episodes per week|2
696635|NCT01429051|2261955|P1|Titration Phase|Unsuccessful titration at any dose|1
696636|NCT01429051|2261955|P1|Titration Phase|Physician Decision|1
696637|NCT01429051|2261955|P1|Titration Phase|Withdrawal by Subject|7
696638|NCT01429051|2261955|P1|Titration Phase|Death|1
696639|NCT01428882|2261978|P2|Overall Study|Protocol Violation|3
696640|NCT01428882|2261979|P1|Overall Study|Protocol Violation|4
696641|NCT01428882|2261978|P2|Overall Study|Lack of Efficacy|7
696642|NCT01428882|2261979|P1|Overall Study|Lack of Efficacy|2
696643|NCT01428713|2262002|P2|Overall Study|Adverse Event|2
696644|NCT01428713|2262003|P1|Overall Study|Adverse Event|0
696645|NCT01428713|2262002|P2|Overall Study|Withdrawal by Subject|1
696646|NCT01428713|2262003|P1|Overall Study|Withdrawal by Subject|1
696647|NCT01428713|2262002|P2|Overall Study|Non-compliance|2
696648|NCT01428713|2262003|P1|Overall Study|Non-compliance|2
696649|NCT01428661|2262012|P3|Open Label Extension|**Various|185
696650|NCT01428661|2262013|P2|Open Label Extension|**Various|0
696651|NCT01428661|2262014|P1|Open Label Extension|**Various|0
696652|NCT01428661|2262012|P3|Open Label Extension|Lack of Efficacy|24
696653|NCT01428661|2262013|P2|Open Label Extension|Lack of Efficacy|0
696654|NCT01428661|2262014|P1|Open Label Extension|Lack of Efficacy|0
696655|NCT01428661|2262012|P3|Open Label Extension|Withdrawal by Subject|49
696656|NCT01428661|2262013|P2|Open Label Extension|Withdrawal by Subject|0
696657|NCT01428661|2262014|P1|Open Label Extension|Withdrawal by Subject|0
696658|NCT01428661|2262012|P3|Open Label Extension|Lost to Follow-up|38
696659|NCT01428661|2262013|P2|Open Label Extension|Lost to Follow-up|0
696660|NCT01428661|2262014|P1|Open Label Extension|Lost to Follow-up|0
696661|NCT01428661|2262012|P3|Open Label Extension|Adverse Event|15
696662|NCT01428661|2262013|P2|Open Label Extension|Adverse Event|0
696663|NCT01428661|2262014|P1|Open Label Extension|Adverse Event|0
696664|NCT01428661|2262012|P3|Open Label Extension|Protocol Violation|9
696665|NCT01428661|2262013|P2|Open Label Extension|Protocol Violation|0
696666|NCT01428661|2262014|P1|Open Label Extension|Protocol Violation|0
696667|NCT01428661|2262012|P3|Double-Masked Phase|*Various|0
696668|NCT01428661|2262013|P2|Double-Masked Phase|*Various|6
696669|NCT01428661|2262014|P1|Double-Masked Phase|*Various|1
696670|NCT01428661|2262012|P3|Double-Masked Phase|Lack of Efficacy|0
696671|NCT01428661|2262013|P2|Double-Masked Phase|Lack of Efficacy|1
696672|NCT01428661|2262014|P1|Double-Masked Phase|Lack of Efficacy|2
696673|NCT01428661|2262012|P3|Double-Masked Phase|Withdrawal by Subject|0
696674|NCT01428661|2262013|P2|Double-Masked Phase|Withdrawal by Subject|20
696675|NCT01428661|2262014|P1|Double-Masked Phase|Withdrawal by Subject|18
696676|NCT01428661|2262012|P3|Double-Masked Phase|Lost to Follow-up|0
696677|NCT01428661|2262013|P2|Double-Masked Phase|Lost to Follow-up|14
696678|NCT01428661|2262014|P1|Double-Masked Phase|Lost to Follow-up|14
696679|NCT01428661|2262012|P3|Double-Masked Phase|Adverse Event|0
696680|NCT01428661|2262013|P2|Double-Masked Phase|Adverse Event|4
696681|NCT01428661|2262014|P1|Double-Masked Phase|Adverse Event|13
696682|NCT01428661|2262012|P3|Double-Masked Phase|Protocol Violation|0
696683|NCT01428661|2262013|P2|Double-Masked Phase|Protocol Violation|4
696684|NCT01428661|2262014|P1|Double-Masked Phase|Protocol Violation|9
696685|NCT01428583|2262022|P1|Overall Study|Unspecified|6
696686|NCT01428583|2262022|P1|Overall Study|Sponsor’s request|3
696687|NCT01428583|2262022|P1|Overall Study|Confirmed positive urine drug test|8
696688|NCT01428583|2262022|P1|Overall Study|Non-compliant|25
696689|NCT01428583|2262022|P1|Overall Study|Physician Decision|12
696690|NCT01428583|2262022|P1|Overall Study|Protocol Violation|1
696691|NCT01428583|2262022|P1|Overall Study|Pregnancy|1
696692|NCT01428583|2262022|P1|Overall Study|Death|1
696693|NCT01428583|2262022|P1|Overall Study|Lost to Follow-up|17
696694|NCT01428583|2262022|P1|Overall Study|Lack of Efficacy|37
696695|NCT01428583|2262022|P1|Overall Study|Withdrawal by Subject|51
696696|NCT01428583|2262022|P1|Overall Study|Adverse Event|75
696703|NCT01428115|2262086|P1|Overall Study|Withdrawal by Subject|4
696704|NCT01428115|2262086|P1|Overall Study|Protocol Violation|3
696705|NCT01428115|2262086|P1|Overall Study|Pregnancy|1
696706|NCT01428115|2262086|P1|Overall Study|Lost to Follow-up|10
696707|NCT01428115|2262086|P1|Overall Study|Lack of Efficacy|3
696708|NCT01428076|2262101|P2|Overall Study|Adverse Event|1
696709|NCT01428076|2262102|P1|Overall Study|Adverse Event|0
696710|NCT01428063|2262113|P3|Overall Study|No longer meets study criteria|0
696711|NCT01428063|2262114|P2|Overall Study|No longer meets study criteria|1
696712|NCT01428063|2262115|P1|Overall Study|No longer meets study criteria|0
696713|NCT01428063|2262113|P3|Overall Study|Lost to Follow-up|0
696714|NCT01428063|2262114|P2|Overall Study|Lost to Follow-up|2
696715|NCT01428063|2262115|P1|Overall Study|Lost to Follow-up|0
696716|NCT01428063|2262113|P3|Overall Study|Adverse Event|0
696717|NCT01428063|2262114|P2|Overall Study|Adverse Event|3
696718|NCT01428063|2262115|P1|Overall Study|Adverse Event|2
696719|NCT01428063|2262113|P3|Overall Study|Lack of Efficacy|1
696720|NCT01428063|2262114|P2|Overall Study|Lack of Efficacy|4
696721|NCT01428063|2262115|P1|Overall Study|Lack of Efficacy|8
696722|NCT01427933|2262186|P2|Overall Study|Investigator's Decision|0
696723|NCT01427933|2262187|P1|Overall Study|Investigator's Decision|1
696724|NCT01427933|2262186|P2|Overall Study|Not Specified|0
696725|NCT01427933|2262187|P1|Overall Study|Not Specified|1
696726|NCT01427933|2262186|P2|Overall Study|Lost to Follow-up|5
696727|NCT01427933|2262187|P1|Overall Study|Lost to Follow-up|1
696728|NCT01427933|2262186|P2|Overall Study|Withdrawal by Subject|8
696729|NCT01427933|2262187|P1|Overall Study|Withdrawal by Subject|5
696730|NCT01427920|2262207|P2|Overall Study|Unclassified|8
696731|NCT01427920|2262208|P1|Overall Study|Unclassified|2
696732|NCT01427920|2262207|P2|Overall Study|Withdrawal Criteria|4
696733|NCT01427920|2262208|P1|Overall Study|Withdrawal Criteria|4
696734|NCT01427920|2262207|P2|Overall Study|Protocol Violation|3
696735|NCT01427920|2262208|P1|Overall Study|Protocol Violation|1
696736|NCT01427920|2262207|P2|Overall Study|Lack of Efficacy|0
696737|NCT01427920|2262208|P1|Overall Study|Lack of Efficacy|1
696738|NCT01427920|2262207|P2|Overall Study|Adverse Event|2
696739|NCT01427920|2262208|P1|Overall Study|Adverse Event|1
696740|NCT01427907|2262228|P2|Overall Study|Withdrawal by Subject|4
696741|NCT01427907|2262229|P1|Overall Study|Withdrawal by Subject|3
696742|NCT01427803|2262250|P2|Overall Study|did not take product|0
696743|NCT01427803|2262251|P1|Overall Study|did not take product|1
696744|NCT01427803|2262250|P2|Overall Study|Physician Decision|0
696745|NCT01427803|2262251|P1|Overall Study|Physician Decision|3
696746|NCT01427803|2262250|P2|Overall Study|Protocol Violation|0
696747|NCT01427803|2262251|P1|Overall Study|Protocol Violation|1
696748|NCT01427803|2262250|P2|Overall Study|Unable to complete full treatment period|0
696749|NCT01427803|2262251|P1|Overall Study|Unable to complete full treatment period|6
696750|NCT01427803|2262250|P2|Overall Study|Withdrawal by Subject|0
696751|NCT01427803|2262251|P1|Overall Study|Withdrawal by Subject|20
696752|NCT01427803|2262250|P2|Overall Study|Lost to Follow-up|26
696753|NCT01427803|2262251|P1|Overall Study|Lost to Follow-up|32
696754|NCT01427751|2262265|P2|Overall Study|Other miscellaneous reasons|4
696755|NCT01427751|2262266|P1|Overall Study|Other miscellaneous reasons|6
696756|NCT01427751|2262265|P2|Overall Study|Death|0
696757|NCT01427751|2262266|P1|Overall Study|Death|2
696758|NCT01427751|2262265|P2|Overall Study|Protocol Violation|4
696759|NCT01427751|2262266|P1|Overall Study|Protocol Violation|6
696760|NCT01427751|2262265|P2|Overall Study|Withdrawal of consent|2
696761|NCT01427751|2262266|P1|Overall Study|Withdrawal of consent|2
696762|NCT01427751|2262265|P2|Overall Study|Lost to Follow-up|1
696763|NCT01427751|2262266|P1|Overall Study|Lost to Follow-up|3
696764|NCT01427751|2262265|P2|Overall Study|No further treatment benefit expected|1
696765|NCT01427751|2262266|P1|Overall Study|No further treatment benefit expected|5
696766|NCT01427751|2262265|P2|Overall Study|Adverse Event|2
696767|NCT01427751|2262266|P1|Overall Study|Adverse Event|18
696768|NCT01427738|2262286|P2|Overall Study|Lost to Follow-up|5
696769|NCT01427738|2262287|P1|Overall Study|Lost to Follow-up|1
696770|NCT01427738|2262286|P2|Overall Study|Subject not willing to adhere to reqs|2
696771|NCT01427738|2262287|P1|Overall Study|Subject not willing to adhere to reqs|1
696772|NCT01427738|2262286|P2|Overall Study|Withdrawal by Subject|2
696773|NCT01427738|2262287|P1|Overall Study|Withdrawal by Subject|0
696774|NCT01427738|2262286|P2|Overall Study|Subject unable to get to clinic|2
696775|NCT01427738|2262287|P1|Overall Study|Subject unable to get to clinic|5
696776|NCT01427738|2262286|P2|Overall Study|Severe debilitation, unable to continue|1
696777|NCT01427738|2262287|P1|Overall Study|Severe debilitation, unable to continue|0
696778|NCT01427738|2262286|P2|Overall Study|Death|9
696779|NCT01427738|2262287|P1|Overall Study|Death|12
696780|NCT01427309|2262350|P4|Overall Study|Withdrawal by Subject|55
696781|NCT01427309|2262351|P3|Overall Study|Withdrawal by Subject|61
696782|NCT01427309|2262352|P2|Overall Study|Withdrawal by Subject|148
696783|NCT01427309|2262353|P1|Overall Study|Withdrawal by Subject|148
696784|NCT01427309|2262350|P4|Overall Study|Serious adverse event|61
696785|NCT01427309|2262351|P3|Overall Study|Serious adverse event|50
696786|NCT01427309|2262352|P2|Overall Study|Serious adverse event|45
696787|NCT01427309|2262353|P1|Overall Study|Serious adverse event|52
696788|NCT01427309|2262350|P4|Overall Study|Adverse Event|1
696789|NCT01427309|2262351|P3|Overall Study|Adverse Event|3
696790|NCT01427309|2262352|P2|Overall Study|Adverse Event|0
696791|NCT01427309|2262353|P1|Overall Study|Adverse Event|0
696792|NCT01427309|2262350|P4|Overall Study|Protocol Violation|124
696793|NCT01427309|2262351|P3|Overall Study|Protocol Violation|125
696794|NCT01427309|2262352|P2|Overall Study|Protocol Violation|69
696795|NCT01427309|2262353|P1|Overall Study|Protocol Violation|42
696796|NCT01427309|2262350|P4|Overall Study|Lost to Follow-up|135
696797|NCT01427309|2262351|P3|Overall Study|Lost to Follow-up|122
696798|NCT01427309|2262352|P2|Overall Study|Lost to Follow-up|145
696799|NCT01427309|2262353|P1|Overall Study|Lost to Follow-up|130
696800|NCT01426958|2262391|P1|Overall Study|Adverse Event|2
696801|NCT01426854|2262420|P2|Overall Study|Other|2
696802|NCT01426854|2262421|P1|Overall Study|Other|3
696803|NCT01426854|2262420|P2|Overall Study|Protocol Deviation|1
696804|NCT01426854|2262421|P1|Overall Study|Protocol Deviation|0
696805|NCT01426854|2262420|P2|Overall Study|Treatment Failure|16
696806|NCT01426854|2262421|P1|Overall Study|Treatment Failure|0
696807|NCT01426854|2262420|P2|Overall Study|Noncompliance|1
696808|NCT01426854|2262421|P1|Overall Study|Noncompliance|0
696809|NCT01426854|2262420|P2|Overall Study|Lost to Follow-up|0
696810|NCT01426854|2262421|P1|Overall Study|Lost to Follow-up|3
696811|NCT01426854|2262420|P2|Overall Study|Subject Decision Unrelated to AE|6
696812|NCT01426854|2262421|P1|Overall Study|Subject Decision Unrelated to AE|5
696813|NCT01426854|2262420|P2|Overall Study|Adverse Event|5
696814|NCT01426854|2262421|P1|Overall Study|Adverse Event|1
696815|NCT01426789|2262431|P6|Part 2|Adverse Event|0
696816|NCT01426789|2262432|P5|Part 2|Adverse Event|1
696817|NCT01426789|2262433|P4|Part 2|Adverse Event|0
696818|NCT01426789|2262434|P3|Part 2|Adverse Event|2
696819|NCT01426789|2262435|P2|Part 2|Adverse Event|0
696820|NCT01426789|2262436|P1|Part 2|Adverse Event|0
696821|NCT01426789|2262431|P6|Part 2|Lack of Efficacy|0
696822|NCT01426789|2262432|P5|Part 2|Lack of Efficacy|2
696823|NCT01426789|2262433|P4|Part 2|Lack of Efficacy|0
696824|NCT01426789|2262434|P3|Part 2|Lack of Efficacy|5
696825|NCT01426789|2262435|P2|Part 2|Lack of Efficacy|0
696826|NCT01426789|2262436|P1|Part 2|Lack of Efficacy|0
696827|NCT01426789|2262431|P6|Part 2|Withdrawal by Subject|0
696828|NCT01426789|2262432|P5|Part 2|Withdrawal by Subject|2
696829|NCT01426789|2262433|P4|Part 2|Withdrawal by Subject|1
696830|NCT01426789|2262434|P3|Part 2|Withdrawal by Subject|0
696831|NCT01426789|2262435|P2|Part 2|Withdrawal by Subject|0
696832|NCT01426789|2262436|P1|Part 2|Withdrawal by Subject|0
696833|NCT01426789|2262431|P6|Part 2|Lost to Follow-up|0
696834|NCT01426789|2262432|P5|Part 2|Lost to Follow-up|1
696835|NCT01426789|2262433|P4|Part 2|Lost to Follow-up|0
696836|NCT01426789|2262434|P3|Part 2|Lost to Follow-up|4
696837|NCT01426789|2262435|P2|Part 2|Lost to Follow-up|0
696838|NCT01426789|2262436|P1|Part 2|Lost to Follow-up|0
696839|NCT01426789|2262431|P6|Part 2|Administrative problems|0
696840|NCT01426789|2262432|P5|Part 2|Administrative problems|1
696841|NCT01426789|2262433|P4|Part 2|Administrative problems|0
696842|NCT01426789|2262434|P3|Part 2|Administrative problems|2
696843|NCT01426789|2262435|P2|Part 2|Administrative problems|0
696844|NCT01426789|2262436|P1|Part 2|Administrative problems|0
696845|NCT01426789|2262431|P6|Part 2|Death|0
696846|NCT01426789|2262432|P5|Part 2|Death|1
696847|NCT01426789|2262433|P4|Part 2|Death|0
696848|NCT01426789|2262434|P3|Part 2|Death|1
696849|NCT01426789|2262435|P2|Part 2|Death|0
696850|NCT01426789|2262436|P1|Part 2|Death|0
696851|NCT01426789|2262431|P6|Part 2|Protocol deviation|0
696852|NCT01426789|2262432|P5|Part 2|Protocol deviation|0
696853|NCT01426789|2262433|P4|Part 2|Protocol deviation|0
696854|NCT01426789|2262434|P3|Part 2|Protocol deviation|1
696855|NCT01426789|2262435|P2|Part 2|Protocol deviation|0
696856|NCT01426789|2262436|P1|Part 2|Protocol deviation|0
696857|NCT01426789|2262431|P6|Part 1|Adverse Event|0
696858|NCT01426789|2262432|P5|Part 1|Adverse Event|0
696859|NCT01426789|2262433|P4|Part 1|Adverse Event|0
696860|NCT01426789|2262434|P3|Part 1|Adverse Event|0
696861|NCT01426789|2262435|P2|Part 1|Adverse Event|0
696862|NCT01426789|2262436|P1|Part 1|Adverse Event|3
696863|NCT01426789|2262431|P6|Part 1|Lack of Efficacy|0
696864|NCT01426789|2262432|P5|Part 1|Lack of Efficacy|0
696865|NCT01426789|2262433|P4|Part 1|Lack of Efficacy|0
696866|NCT01426789|2262434|P3|Part 1|Lack of Efficacy|0
696867|NCT01426789|2262435|P2|Part 1|Lack of Efficacy|1
696868|NCT01426789|2262436|P1|Part 1|Lack of Efficacy|2
696869|NCT01426789|2262431|P6|Part 1|Lost to Follow-up|0
696870|NCT01426789|2262432|P5|Part 1|Lost to Follow-up|0
696871|NCT01426789|2262433|P4|Part 1|Lost to Follow-up|0
696872|NCT01426789|2262434|P3|Part 1|Lost to Follow-up|0
696873|NCT01426789|2262435|P2|Part 1|Lost to Follow-up|2
696874|NCT01426789|2262436|P1|Part 1|Lost to Follow-up|1
696875|NCT01426789|2262431|P6|Part 1|Protocol deviation|0
696876|NCT01426789|2262432|P5|Part 1|Protocol deviation|0
696877|NCT01426789|2262433|P4|Part 1|Protocol deviation|0
696878|NCT01426789|2262434|P3|Part 1|Protocol deviation|0
696879|NCT01426789|2262435|P2|Part 1|Protocol deviation|1
696880|NCT01426789|2262436|P1|Part 1|Protocol deviation|0
696881|NCT01426438|2262481|P2|Overall Study|Missed Scan|2
696882|NCT01426438|2262482|P1|Overall Study|Missed Scan|2
696883|NCT01426438|2262481|P2|Overall Study|Poor scan quality|2
696884|NCT01426438|2262482|P1|Overall Study|Poor scan quality|3
696885|NCT01426438|2262481|P2|Overall Study|Off study Treatment|3
696886|NCT01426438|2262482|P1|Overall Study|Off study Treatment|9
696887|NCT01426438|2262481|P2|Overall Study|Lost to Follow-up|3
696888|NCT01426438|2262482|P1|Overall Study|Lost to Follow-up|1
696889|NCT01426425|2262514|P1|Overall Study|Met inclusion/exclusion, not treated|2
696890|NCT01426425|2262514|P1|Overall Study|Inclusion/exclusion criteria not met|151
696891|NCT01426425|2262514|P1|Overall Study|Exited prior to EP study|22
696892|NCT01426373|2262520|P1|Overall Study|Miscellaneous Reasons|4
696893|NCT01426373|2262520|P1|Overall Study|Participant Convenience|10
696894|NCT01426373|2262520|P1|Overall Study|Lost to Follow-up|14
696895|NCT01426373|2262520|P1|Overall Study|Adverse Event|6
696896|NCT01426347|2262553|P2|Overall Study|Withdrawal by Subject|0
696897|NCT01426347|2262554|P1|Overall Study|Withdrawal by Subject|5
696898|NCT01426347|2262553|P2|Overall Study|Protocol Violation|0
696899|NCT01426347|2262554|P1|Overall Study|Protocol Violation|2
696900|NCT01426347|2262553|P2|Overall Study|Lost to Follow-up|3
696901|NCT01426347|2262554|P1|Overall Study|Lost to Follow-up|0
696902|NCT01426269|2262562|P3|Period 2: 40 Weeks|Relapsed|18
696903|NCT01426269|2262563|P2|Period 2: 40 Weeks|Relapsed|9
696904|NCT01426269|2262564|P1|Period 2: 40 Weeks|Relapsed|0
696905|NCT01426269|2262562|P3|Period 2: 40 Weeks|Site closed|5
696906|NCT01426269|2262563|P2|Period 2: 40 Weeks|Site closed|6
696907|NCT01426269|2262564|P1|Period 2: 40 Weeks|Site closed|0
696908|NCT01426269|2262562|P3|Period 2: 40 Weeks|Lost to Follow-up|6
696909|NCT01426269|2262563|P2|Period 2: 40 Weeks|Lost to Follow-up|8
696910|NCT01426269|2262564|P1|Period 2: 40 Weeks|Lost to Follow-up|0
696911|NCT01426269|2262562|P3|Period 2: 40 Weeks|Protocol Violation|5
696912|NCT01426269|2262563|P2|Period 2: 40 Weeks|Protocol Violation|5
696913|NCT01426269|2262564|P1|Period 2: 40 Weeks|Protocol Violation|0
696914|NCT01426269|2262562|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
696915|NCT01426269|2262563|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
696916|NCT01426269|2262564|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
696917|NCT01426269|2262562|P3|Period 2: 40 Weeks|Adverse Event|2
696918|NCT01426269|2262563|P2|Period 2: 40 Weeks|Adverse Event|1
696919|NCT01426269|2262564|P1|Period 2: 40 Weeks|Adverse Event|0
696920|NCT01426269|2262562|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
696921|NCT01426269|2262563|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
696922|NCT01426269|2262564|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
696923|NCT01426269|2262562|P3|Eligibility for Period 2, Randomization|Did not qualify|0
696924|NCT01426269|2262563|P2|Eligibility for Period 2, Randomization|Did not qualify|0
696925|NCT01426269|2262564|P1|Eligibility for Period 2, Randomization|Did not qualify|42
696926|NCT01426269|2262562|P3|Period 1: 12 Weeks|Pregnancy|0
696927|NCT01426269|2262563|P2|Period 1: 12 Weeks|Pregnancy|0
696928|NCT01426269|2262564|P1|Period 1: 12 Weeks|Pregnancy|1
696929|NCT01426269|2262562|P3|Period 1: 12 Weeks|Lost to Follow-up|0
696930|NCT01426269|2262563|P2|Period 1: 12 Weeks|Lost to Follow-up|0
696931|NCT01426269|2262564|P1|Period 1: 12 Weeks|Lost to Follow-up|22
696932|NCT01426269|2262562|P3|Period 1: 12 Weeks|Protocol Violation|0
696933|NCT01426269|2262563|P2|Period 1: 12 Weeks|Protocol Violation|0
696934|NCT01426269|2262564|P1|Period 1: 12 Weeks|Protocol Violation|5
696935|NCT01426269|2262562|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
696936|NCT01426269|2262563|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
696937|NCT01426269|2262564|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
696938|NCT01426269|2262562|P3|Period 1: 12 Weeks|Adverse Event|0
696939|NCT01426269|2262563|P2|Period 1: 12 Weeks|Adverse Event|0
696940|NCT01426269|2262564|P1|Period 1: 12 Weeks|Adverse Event|5
696941|NCT01426113|2262599|P2|Overall Study|Adverse Event|1
696942|NCT01426113|2262600|P1|Overall Study|Adverse Event|0
696943|NCT01426113|2262599|P2|Overall Study|Study Discontinued|1
696944|NCT01426113|2262600|P1|Overall Study|Study Discontinued|1
696945|NCT01425814|2262646|P6|Period 5|Stability criteria not fulfilled|1
696946|NCT01425814|2262647|P5|Period 5|Stability criteria not fulfilled|0
696947|NCT01425814|2262648|P4|Period 5|Stability criteria not fulfilled|0
696948|NCT01425814|2262649|P3|Period 5|Stability criteria not fulfilled|1
696949|NCT01425814|2262650|P2|Period 5|Stability criteria not fulfilled|0
696950|NCT01425814|2262651|P1|Period 5|Stability criteria not fulfilled|0
696951|NCT01425814|2262646|P6|Period 4|Adverse Event|0
696952|NCT01425814|2262647|P5|Period 4|Adverse Event|0
696953|NCT01425814|2262648|P4|Period 4|Adverse Event|0
696954|NCT01425814|2262649|P3|Period 4|Adverse Event|1
696955|NCT01425814|2262650|P2|Period 4|Adverse Event|0
696956|NCT01425814|2262651|P1|Period 4|Adverse Event|1
696957|NCT01425814|2262646|P6|Period 3|Adverse Event|1
696958|NCT01425814|2262647|P5|Period 3|Adverse Event|0
696959|NCT01425814|2262648|P4|Period 3|Adverse Event|0
696960|NCT01425814|2262649|P3|Period 3|Adverse Event|0
696961|NCT01425814|2262650|P2|Period 3|Adverse Event|0
696962|NCT01425814|2262651|P1|Period 3|Adverse Event|0
696963|NCT01425814|2262646|P6|Period 2|Stability criteria not fulfilled|0
696964|NCT01425814|2262647|P5|Period 2|Stability criteria not fulfilled|0
696965|NCT01425814|2262648|P4|Period 2|Stability criteria not fulfilled|0
696966|NCT01425814|2262649|P3|Period 2|Stability criteria not fulfilled|0
696967|NCT01425814|2262650|P2|Period 2|Stability criteria not fulfilled|1
696968|NCT01425814|2262651|P1|Period 2|Stability criteria not fulfilled|0
696969|NCT01425814|2262646|P6|Period 1|Stability criteria not fulfilled|0
696970|NCT01425814|2262647|P5|Period 1|Stability criteria not fulfilled|0
696971|NCT01425814|2262648|P4|Period 1|Stability criteria not fulfilled|0
696972|NCT01425814|2262649|P3|Period 1|Stability criteria not fulfilled|0
696973|NCT01425814|2262650|P2|Period 1|Stability criteria not fulfilled|1
696974|NCT01425814|2262651|P1|Period 1|Stability criteria not fulfilled|0
696975|NCT01425749|2262745|P2|Overall Study|progression of melanoma|1
696976|NCT01425749|2262746|P1|Overall Study|progression of melanoma|0
696977|NCT01425632|2262764|P3|Overall Study|Withdrawal by Subject|1
696978|NCT01425632|2262765|P2|Overall Study|Withdrawal by Subject|0
696979|NCT01425632|2262766|P1|Overall Study|Withdrawal by Subject|0
696980|NCT01425632|2262764|P3|Overall Study|Protocol Violation|2
696981|NCT01425632|2262765|P2|Overall Study|Protocol Violation|0
696982|NCT01425632|2262766|P1|Overall Study|Protocol Violation|0
696983|NCT01425632|2262764|P3|Overall Study|Physician Decision|0
696984|NCT01425632|2262765|P2|Overall Study|Physician Decision|0
696985|NCT01425632|2262766|P1|Overall Study|Physician Decision|1
696986|NCT01425632|2262764|P3|Overall Study|Adverse Event|1
696987|NCT01425632|2262765|P2|Overall Study|Adverse Event|1
696988|NCT01425632|2262766|P1|Overall Study|Adverse Event|0
696989|NCT01425528|2262776|P2|Overall Study|Withdrawal by Subject|1
696990|NCT01425528|2262777|P1|Overall Study|Withdrawal by Subject|1
696991|NCT01425463|2262785|P2|Overall Study|Unknown Reason|7
696992|NCT01425463|2262786|P1|Overall Study|Unknown Reason|4
696993|NCT01425463|2262785|P2|Overall Study|Withdrawal by Subject|5
696994|NCT01425463|2262786|P1|Overall Study|Withdrawal by Subject|7
696995|NCT01425463|2262785|P2|Overall Study|Lost to Follow-up|2
696996|NCT01425463|2262786|P1|Overall Study|Lost to Follow-up|5
696997|NCT01425463|2262785|P2|Overall Study|Protocol Violation|2
696998|NCT01425463|2262786|P1|Overall Study|Protocol Violation|2
696999|NCT01425463|2262785|P2|Overall Study|Lack of Efficacy|1
697000|NCT01425463|2262786|P1|Overall Study|Lack of Efficacy|1
697001|NCT01425463|2262785|P2|Overall Study|Adverse Event|7
697002|NCT01425463|2262786|P1|Overall Study|Adverse Event|5
697003|NCT01425359|2262802|P2|Overall Study|Did Not Meet Qualifying Criteria|5
697004|NCT01425359|2262803|P1|Overall Study|Did Not Meet Qualifying Criteria|3
697005|NCT01425359|2262802|P2|Overall Study|Investigator’s Discretion|0
697006|NCT01425359|2262803|P1|Overall Study|Investigator’s Discretion|2
697007|NCT01425359|2262802|P2|Overall Study|Subject Withdrew Consent|2
697008|NCT01425359|2262803|P1|Overall Study|Subject Withdrew Consent|1
697009|NCT01425359|2262802|P2|Overall Study|Protocol Violation|2
697010|NCT01425359|2262803|P1|Overall Study|Protocol Violation|1
697011|NCT01425359|2262802|P2|Overall Study|Unsatisfactory Response|0
697012|NCT01425359|2262803|P1|Overall Study|Unsatisfactory Response|1
697013|NCT01425359|2262802|P2|Overall Study|Death|1
697014|NCT01425359|2262803|P1|Overall Study|Death|0
697015|NCT01425359|2262802|P2|Overall Study|Revascularization|1
697016|NCT01425359|2262803|P1|Overall Study|Revascularization|0
697017|NCT01425359|2262802|P2|Overall Study|Adverse Event|8
697018|NCT01425359|2262803|P1|Overall Study|Adverse Event|9
697019|NCT01425359|2262802|P2|Overall Study|Randomized but Not Treated|3
697020|NCT01425359|2262803|P1|Overall Study|Randomized but Not Treated|2
697021|NCT01425268|2262834|P2|Overall Study|Physician Decision|0
697022|NCT01425268|2262835|P1|Overall Study|Physician Decision|1
697023|NCT01425268|2262834|P2|Overall Study|Sponsor Decision|0
697024|NCT01425268|2262835|P1|Overall Study|Sponsor Decision|5
697025|NCT01425268|2262834|P2|Overall Study|Withdrawal by Subject|0
697026|NCT01425268|2262835|P1|Overall Study|Withdrawal by Subject|2
697027|NCT01425203|2262856|P3|Crossover Phase|Other virologic failure criteria|3
697028|NCT01425203|2262857|P2|Crossover Phase|Other virologic failure criteria|0
697029|NCT01425203|2262858|P1|Crossover Phase|Other virologic failure criteria|0
697030|NCT01425203|2262856|P3|Crossover Phase|Failure at futility timepoint|3
697031|NCT01425203|2262857|P2|Crossover Phase|Failure at futility timepoint|0
697032|NCT01425203|2262858|P1|Crossover Phase|Failure at futility timepoint|0
697033|NCT01425203|2262856|P3|Treatment Phase|Did not receive treatment|0
697034|NCT01425203|2262857|P2|Treatment Phase|Did not receive treatment|1
697035|NCT01425203|2262858|P1|Treatment Phase|Did not receive treatment|0
697036|NCT01425203|2262856|P3|Treatment Phase|Unidentified reasons|0
697037|NCT01425203|2262857|P2|Treatment Phase|Unidentified reasons|5
697038|NCT01425203|2262858|P1|Treatment Phase|Unidentified reasons|11
697039|NCT01425203|2262856|P3|Treatment Phase|Other virologic failure criteria|0
697040|NCT01425203|2262857|P2|Treatment Phase|Other virologic failure criteria|3
697041|NCT01425203|2262858|P1|Treatment Phase|Other virologic failure criteria|5
697042|NCT01425203|2262856|P3|Treatment Phase|Failure at futility timepoint|0
697043|NCT01425203|2262857|P2|Treatment Phase|Failure at futility timepoint|27
697044|NCT01425203|2262858|P1|Treatment Phase|Failure at futility timepoint|8
697045|NCT01425203|2262856|P3|Treatment Phase|DC during PR Lead-in Phase|0
697046|NCT01425203|2262857|P2|Treatment Phase|DC during PR Lead-in Phase|1
697047|NCT01425203|2262858|P1|Treatment Phase|DC during PR Lead-in Phase|3
697048|NCT01425190|2262875|P3|Overall Study|Full dose not consumed.|0
697049|NCT01425190|2262876|P2|Overall Study|Full dose not consumed.|0
697050|NCT01425190|2262877|P1|Overall Study|Full dose not consumed.|1
697051|NCT01424930|2262913|P2|Overall Study|Reason not specified|6
697052|NCT01424930|2262914|P1|Overall Study|Reason not specified|0
697053|NCT01424930|2262913|P2|Overall Study|Screen Failure|1
697054|NCT01424930|2262914|P1|Overall Study|Screen Failure|0
697055|NCT01424930|2262913|P2|Overall Study|Progressive Disease|6
697056|NCT01424930|2262914|P1|Overall Study|Progressive Disease|3
697057|NCT01424930|2262913|P2|Overall Study|Death|0
697058|NCT01424930|2262914|P1|Overall Study|Death|1
697059|NCT01424930|2262913|P2|Overall Study|Adverse Event|1
697060|NCT01424930|2262914|P1|Overall Study|Adverse Event|0
697061|NCT01424813|2262928|P2|Overall Study|not specified|2
697062|NCT01424813|2262929|P1|Overall Study|not specified|1
697063|NCT01424813|2262928|P2|Overall Study|Protocol Violation|0
697064|NCT01424813|2262929|P1|Overall Study|Protocol Violation|1
697065|NCT01424813|2262928|P2|Overall Study|Withdrawal by Subject|0
697066|NCT01424813|2262929|P1|Overall Study|Withdrawal by Subject|3
697067|NCT01424644|2262949|P2|Overall Study|Unable to Classify|0
697068|NCT01424644|2262950|P1|Overall Study|Unable to Classify|1
697069|NCT01424644|2262949|P2|Overall Study|Administrative Reason|0
697070|NCT01424644|2262950|P1|Overall Study|Administrative Reason|1
697071|NCT01424644|2262949|P2|Overall Study|Protocol Violation|3
697072|NCT01424644|2262950|P1|Overall Study|Protocol Violation|4
697073|NCT01424644|2262949|P2|Overall Study|Lost to Follow-up|12
697074|NCT01424644|2262950|P1|Overall Study|Lost to Follow-up|16
697075|NCT01424644|2262949|P2|Overall Study|Withdrawal by Subject|12
697076|NCT01424644|2262950|P1|Overall Study|Withdrawal by Subject|9
697077|NCT01424644|2262949|P2|Overall Study|Adverse Event|0
697078|NCT01424644|2262950|P1|Overall Study|Adverse Event|2
697079|NCT01423617|2262966|P2|Overall Study|Lost to Follow-up|1
697080|NCT01423617|2262967|P1|Overall Study|Lost to Follow-up|0
697081|NCT01424501|2262987|P6|Overall Study|Lost to Follow-up|0
697082|NCT01424501|2262988|P5|Overall Study|Lost to Follow-up|0
697083|NCT01424501|2262989|P4|Overall Study|Lost to Follow-up|0
697084|NCT01424501|2262990|P3|Overall Study|Lost to Follow-up|1
697085|NCT01424501|2262991|P2|Overall Study|Lost to Follow-up|0
697086|NCT01424501|2262992|P1|Overall Study|Lost to Follow-up|0
697087|NCT01424501|2262987|P6|Overall Study|Withdrawal by Subject|0
697088|NCT01424501|2262988|P5|Overall Study|Withdrawal by Subject|0
697089|NCT01424501|2262989|P4|Overall Study|Withdrawal by Subject|0
697090|NCT01424501|2262990|P3|Overall Study|Withdrawal by Subject|1
697091|NCT01424501|2262991|P2|Overall Study|Withdrawal by Subject|1
697092|NCT01424501|2262992|P1|Overall Study|Withdrawal by Subject|1
697093|NCT01424306|2263156|P6|Overall Study|Protocol Violation|0
697094|NCT01424306|2263157|P5|Overall Study|Protocol Violation|1
697095|NCT01424306|2263158|P4|Overall Study|Protocol Violation|0
697096|NCT01424306|2263159|P3|Overall Study|Protocol Violation|0
697097|NCT01424306|2263160|P2|Overall Study|Protocol Violation|0
697098|NCT01424306|2263161|P1|Overall Study|Protocol Violation|0
697099|NCT01424228|2263210|P2|Overall Study|Unplanned journey|1
697100|NCT01424228|2263211|P1|Overall Study|Unplanned journey|0
697101|NCT01424228|2263210|P2|Overall Study|Worsening of symptoms|0
697102|NCT01424228|2263211|P1|Overall Study|Worsening of symptoms|1
697103|NCT01424228|2263210|P2|Overall Study|Non-compliance|0
697104|NCT01424228|2263211|P1|Overall Study|Non-compliance|2
697105|NCT01424228|2263210|P2|Overall Study|inclusion/exclusion criteria not met|2
697106|NCT01424228|2263211|P1|Overall Study|inclusion/exclusion criteria not met|2
697107|NCT01424228|2263210|P2|Overall Study|Lack of Efficacy|7
697108|NCT01424228|2263211|P1|Overall Study|Lack of Efficacy|5
697109|NCT01424228|2263210|P2|Overall Study|Sponsor's decision|12
697110|NCT01424228|2263211|P1|Overall Study|Sponsor's decision|9
697111|NCT01424228|2263210|P2|Overall Study|Adverse Event|14
697112|NCT01424228|2263211|P1|Overall Study|Adverse Event|10
697113|NCT01424228|2263210|P2|Overall Study|Withdrawal by Subject|11
697114|NCT01424228|2263211|P1|Overall Study|Withdrawal by Subject|27
697115|NCT01424189|2263251|P2|Overall Study|Death|1
697116|NCT01424189|2263252|P1|Overall Study|Death|3
697117|NCT01424189|2263251|P2|Overall Study|Subject moved|0
697118|NCT01424189|2263252|P1|Overall Study|Subject moved|1
697119|NCT01424189|2263251|P2|Overall Study|Withdrawal by Subject|4
697120|NCT01424189|2263252|P1|Overall Study|Withdrawal by Subject|4
697121|NCT01424189|2263251|P2|Overall Study|Lost to Follow-up|1
697122|NCT01424189|2263252|P1|Overall Study|Lost to Follow-up|4
697123|NCT01424189|2263251|P2|Overall Study|Adverse Event|0
697124|NCT01424189|2263252|P1|Overall Study|Adverse Event|1
697125|NCT01423916|2263293|P3|Overall Study|Protocol Deviation|0
697126|NCT01423916|2263294|P2|Overall Study|Protocol Deviation|0
697127|NCT01423916|2263295|P1|Overall Study|Protocol Deviation|1
697128|NCT01423916|2263293|P3|Overall Study|Withdrawal by Subject|3
697129|NCT01423916|2263294|P2|Overall Study|Withdrawal by Subject|10
697130|NCT01423916|2263295|P1|Overall Study|Withdrawal by Subject|3
697131|NCT01423916|2263293|P3|Overall Study|Physician Decision|1
697132|NCT01423916|2263294|P2|Overall Study|Physician Decision|0
697133|NCT01423916|2263295|P1|Overall Study|Physician Decision|1
697134|NCT01423916|2263293|P3|Overall Study|Met Withdrawal Criteria|1
697135|NCT01423916|2263294|P2|Overall Study|Met Withdrawal Criteria|1
697136|NCT01423916|2263295|P1|Overall Study|Met Withdrawal Criteria|1
697137|NCT01423916|2263293|P3|Overall Study|Adverse Event|2
697138|NCT01423916|2263294|P2|Overall Study|Adverse Event|9
697139|NCT01423916|2263295|P1|Overall Study|Adverse Event|5
697140|NCT01423604|2263370|P2|Randomized|Patient decision|9
697141|NCT01423604|2263371|P1|Randomized|Patient decision|5
697142|NCT01423604|2263370|P2|Randomized|Other - unspecified|31
697143|NCT01423604|2263371|P1|Randomized|Other - unspecified|37
697144|NCT01423604|2263370|P2|Randomized|Physician Decision|13
697145|NCT01423604|2263371|P1|Randomized|Physician Decision|16
697146|NCT01423604|2263370|P2|Randomized|Death|0
697147|NCT01423604|2263371|P1|Randomized|Death|1
697148|NCT01423604|2263370|P2|Randomized|Adverse Event|10
697149|NCT01423604|2263371|P1|Randomized|Adverse Event|4
697150|NCT01423604|2263370|P2|Safety Run-In|Patient decision|0
697151|NCT01423604|2263371|P1|Safety Run-In|Patient decision|1
697152|NCT01423604|2263370|P2|Safety Run-In|Disease progression|0
697153|NCT01423604|2263371|P1|Safety Run-In|Disease progression|3
697154|NCT01423604|2263370|P2|Safety Run-In|Physician Decision|0
697155|NCT01423604|2263371|P1|Safety Run-In|Physician Decision|1
697156|NCT01423604|2263370|P2|Safety Run-In|Death|0
697157|NCT01423604|2263371|P1|Safety Run-In|Death|1
697158|NCT01423604|2263370|P2|Safety Run-In|Adverse Event|0
697159|NCT01423604|2263371|P1|Safety Run-In|Adverse Event|3
889410|NCT01336608|2823946|P4|24-week, Double-blind Treatment Period|Adverse Event|7
889411|NCT01336608|2823947|P3|24-week, Double-blind Treatment Period|Adverse Event|6
889412|NCT01336608|2823948|P2|24-week, Double-blind Treatment Period|Adverse Event|8
889413|NCT01336608|2823949|P1|24-week, Double-blind Treatment Period|Adverse Event|0
697165|NCT01423084|2263408|P2|Overall Study|Withdrawal by Subject|3
697166|NCT01423084|2263409|P1|Overall Study|Withdrawal by Subject|2
697167|NCT01423084|2263408|P2|Overall Study|Adverse Event|1
697168|NCT01423084|2263409|P1|Overall Study|Adverse Event|0
697169|NCT01422915|2263439|P1|Overall Study|Adverse Event|1
697170|NCT01422889|2263444|P1|Overall Study|No Data Entered for Study Stent|9
697171|NCT01422876|2263459|P10|Week 52|Death|0
697172|NCT01422876|2263460|P9|Week 52|Death|1
697173|NCT01422876|2263461|P8|Week 52|Death|3
697174|NCT01422876|2263462|P7|Week 52|Death|1
697175|NCT01422876|2263463|P6|Week 52|Death|0
697176|NCT01422876|2263464|P5|Week 52|Death|0
697177|NCT01422876|2263465|P4|Week 52|Death|1
697178|NCT01422876|2263466|P3|Week 52|Death|0
697179|NCT01422876|2263467|P2|Week 52|Death|1
697180|NCT01422876|2263468|P1|Week 52|Death|0
697181|NCT01422876|2263459|P10|Week 52|Consent withdrawn|9
697182|NCT01422876|2263460|P9|Week 52|Consent withdrawn|13
697183|NCT01422876|2263461|P8|Week 52|Consent withdrawn|12
697184|NCT01422876|2263462|P7|Week 52|Consent withdrawn|10
697185|NCT01422876|2263463|P6|Week 52|Consent withdrawn|12
697186|NCT01422876|2263464|P5|Week 52|Consent withdrawn|7
697187|NCT01422876|2263465|P4|Week 52|Consent withdrawn|12
697188|NCT01422876|2263466|P3|Week 52|Consent withdrawn|6
697189|NCT01422876|2263467|P2|Week 52|Consent withdrawn|4
697190|NCT01422876|2263468|P1|Week 52|Consent withdrawn|9
697191|NCT01422876|2263459|P10|Week 52|Lost to Follow-up|8
697192|NCT01422876|2263460|P9|Week 52|Lost to Follow-up|7
697193|NCT01422876|2263461|P8|Week 52|Lost to Follow-up|8
697194|NCT01422876|2263462|P7|Week 52|Lost to Follow-up|5
697195|NCT01422876|2263463|P6|Week 52|Lost to Follow-up|5
697196|NCT01422876|2263464|P5|Week 52|Lost to Follow-up|8
697197|NCT01422876|2263465|P4|Week 52|Lost to Follow-up|5
697198|NCT01422876|2263466|P3|Week 52|Lost to Follow-up|7
697199|NCT01422876|2263467|P2|Week 52|Lost to Follow-up|5
697200|NCT01422876|2263468|P1|Week 52|Lost to Follow-up|3
697201|NCT01422876|2263459|P10|Week 24|Death|0
697202|NCT01422876|2263460|P9|Week 24|Death|0
697203|NCT01422876|2263461|P8|Week 24|Death|0
697204|NCT01422876|2263462|P7|Week 24|Death|0
697205|NCT01422876|2263463|P6|Week 24|Death|0
697206|NCT01422876|2263464|P5|Week 24|Death|0
697207|NCT01422876|2263465|P4|Week 24|Death|0
697208|NCT01422876|2263466|P3|Week 24|Death|0
697209|NCT01422876|2263467|P2|Week 24|Death|1
697210|NCT01422876|2263468|P1|Week 24|Death|0
697211|NCT01422876|2263459|P10|Week 24|Consent withdrawn|6
697212|NCT01422876|2263460|P9|Week 24|Consent withdrawn|3
697213|NCT01422876|2263461|P8|Week 24|Consent withdrawn|4
697214|NCT01422876|2263462|P7|Week 24|Consent withdrawn|5
697215|NCT01422876|2263463|P6|Week 24|Consent withdrawn|6
697216|NCT01422876|2263464|P5|Week 24|Consent withdrawn|5
697217|NCT01422876|2263465|P4|Week 24|Consent withdrawn|4
697218|NCT01422876|2263466|P3|Week 24|Consent withdrawn|3
697219|NCT01422876|2263467|P2|Week 24|Consent withdrawn|1
697220|NCT01422876|2263468|P1|Week 24|Consent withdrawn|5
697221|NCT01422876|2263459|P10|Week 24|Lost to Follow-up|4
697222|NCT01422876|2263460|P9|Week 24|Lost to Follow-up|3
697223|NCT01422876|2263461|P8|Week 24|Lost to Follow-up|3
697224|NCT01422876|2263462|P7|Week 24|Lost to Follow-up|1
697225|NCT01422876|2263463|P6|Week 24|Lost to Follow-up|0
697226|NCT01422876|2263464|P5|Week 24|Lost to Follow-up|2
697227|NCT01422876|2263465|P4|Week 24|Lost to Follow-up|4
697228|NCT01422876|2263466|P3|Week 24|Lost to Follow-up|2
697229|NCT01422876|2263467|P2|Week 24|Lost to Follow-up|1
697230|NCT01422876|2263468|P1|Week 24|Lost to Follow-up|1
697231|NCT01422850|2263515|P1|Overall Study|Physician Decision|3
697232|NCT01422824|2263521|P1|Overall Study|Lost to Follow-up|37
697233|NCT01422824|2263521|P1|Overall Study|Case record form not evaluated|1
697234|NCT01422720|2263526|P1|Overall Study|Ineligibility|1
697235|NCT01422720|2263526|P1|Overall Study|Withdrawal by Subject|4
697236|NCT01422720|2263526|P1|Overall Study|Lack of Efficacy|1
697237|NCT01422720|2263526|P1|Overall Study|Adverse Event|16
889414|NCT01336608|2823946|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
889415|NCT01336608|2823947|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
697246|NCT01422382|2263612|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
697247|NCT01422304|2263628|P2|Overall Study|Not Treated|11
697248|NCT01422304|2263629|P1|Overall Study|Not Treated|3
697249|NCT01422304|2263628|P2|Overall Study|Did Not Meet Protocol Eligibility|2
697250|NCT01422304|2263629|P1|Overall Study|Did Not Meet Protocol Eligibility|0
697251|NCT01422304|2263628|P2|Overall Study|Withdrawal by Subject|2
697252|NCT01422304|2263629|P1|Overall Study|Withdrawal by Subject|4
697253|NCT01422304|2263628|P2|Overall Study|Protocol Violation|0
697254|NCT01422304|2263629|P1|Overall Study|Protocol Violation|1
697255|NCT01422304|2263628|P2|Overall Study|Never Entered Follow-up|1
697256|NCT01422304|2263629|P1|Overall Study|Never Entered Follow-up|2
697257|NCT01422304|2263628|P2|Overall Study|Lost to Follow-up|20
697258|NCT01422304|2263629|P1|Overall Study|Lost to Follow-up|14
697259|NCT01422304|2263628|P2|Overall Study|Adverse Event|1
697260|NCT01422304|2263629|P1|Overall Study|Adverse Event|0
697261|NCT01422239|2263661|P2|Overall Study|Lost to Follow-up|3
697262|NCT01422239|2263662|P1|Overall Study|Lost to Follow-up|4
697263|NCT01422213|2263684|P3|Overall Study|Administrative or Other Reason(s)|2
697264|NCT01422213|2263685|P2|Overall Study|Administrative or Other Reason(s)|4
697265|NCT01422213|2263686|P1|Overall Study|Administrative or Other Reason(s)|5
697266|NCT01422213|2263684|P3|Overall Study|Lost to Follow-up|5
697267|NCT01422213|2263685|P2|Overall Study|Lost to Follow-up|3
697268|NCT01422213|2263686|P1|Overall Study|Lost to Follow-up|3
697269|NCT01422213|2263684|P3|Overall Study|Withdrawal of Consent|5
697270|NCT01422213|2263685|P2|Overall Study|Withdrawal of Consent|3
697271|NCT01422213|2263686|P1|Overall Study|Withdrawal of Consent|7
697272|NCT01422213|2263684|P3|Overall Study|Protocol Violation|4
697273|NCT01422213|2263685|P2|Overall Study|Protocol Violation|2
697274|NCT01422213|2263686|P1|Overall Study|Protocol Violation|0
697275|NCT01422213|2263684|P3|Overall Study|Non-compliance with study drug|0
697276|NCT01422213|2263685|P2|Overall Study|Non-compliance with study drug|1
697277|NCT01422213|2263686|P1|Overall Study|Non-compliance with study drug|0
697278|NCT01422213|2263684|P3|Overall Study|Lack of Efficacy|2
697279|NCT01422213|2263685|P2|Overall Study|Lack of Efficacy|2
697280|NCT01422213|2263686|P1|Overall Study|Lack of Efficacy|10
697281|NCT01422213|2263684|P3|Overall Study|Adverse Event|11
697282|NCT01422213|2263685|P2|Overall Study|Adverse Event|7
697283|NCT01422213|2263686|P1|Overall Study|Adverse Event|8
697284|NCT01422187|2263747|P3|Overall Study|Lost to Follow-up|0
697285|NCT01422187|2263748|P2|Overall Study|Lost to Follow-up|1
697286|NCT01422187|2263749|P1|Overall Study|Lost to Follow-up|0
697287|NCT01422187|2263747|P3|Overall Study|Personal reason|0
697288|NCT01422187|2263748|P2|Overall Study|Personal reason|0
697289|NCT01422187|2263749|P1|Overall Study|Personal reason|1
697290|NCT01421719|2263780|P1|Overall Study|Withdrawal by Subject|4
697291|NCT01421667|2263789|P4|Overall Study|Lost to Follow-up|0
697292|NCT01421667|2263790|P3|Overall Study|Lost to Follow-up|0
697293|NCT01421667|2263791|P2|Overall Study|Lost to Follow-up|1
697294|NCT01421667|2263792|P1|Overall Study|Lost to Follow-up|0
697295|NCT01421667|2263789|P4|Overall Study|Withdrawal by Subject|1
697296|NCT01421667|2263790|P3|Overall Study|Withdrawal by Subject|2
697297|NCT01421667|2263791|P2|Overall Study|Withdrawal by Subject|1
697298|NCT01421667|2263792|P1|Overall Study|Withdrawal by Subject|0
697299|NCT01421641|2263853|P2|Overall Study|Protocol Violation|2
697300|NCT01421641|2263854|P1|Overall Study|Protocol Violation|2
697301|NCT01421511|2263876|P2|Overall Study|Death|1
697302|NCT01421511|2263877|P1|Overall Study|Death|1
697303|NCT01421511|2263876|P2|Overall Study|Withdrawal by Subject|5
697304|NCT01421511|2263877|P1|Overall Study|Withdrawal by Subject|6
697305|NCT01421511|2263876|P2|Overall Study|Physician Decision|1
697306|NCT01421511|2263877|P1|Overall Study|Physician Decision|0
697307|NCT01421511|2263876|P2|Overall Study|Randomized but didn't receive study drug|7
697308|NCT01421511|2263877|P1|Overall Study|Randomized but didn't receive study drug|1
697309|NCT01421511|2263876|P2|Overall Study|Lost to Follow-up|14
697310|NCT01421511|2263877|P1|Overall Study|Lost to Follow-up|11
697311|NCT01421459|2263927|P2|Overall Study|Withdrawal by Subject|16
697312|NCT01421459|2263928|P1|Overall Study|Withdrawal by Subject|12
697313|NCT01421459|2263927|P2|Overall Study|Protocol Violation|5
697314|NCT01421459|2263928|P1|Overall Study|Protocol Violation|8
697315|NCT01421459|2263927|P2|Overall Study|Physician Decision|9
697316|NCT01421459|2263928|P1|Overall Study|Physician Decision|9
697317|NCT01421459|2263927|P2|Overall Study|Lost to Follow-up|9
697318|NCT01421459|2263928|P1|Overall Study|Lost to Follow-up|8
697319|NCT01421459|2263927|P2|Overall Study|Lack of Efficacy|2
697320|NCT01421459|2263928|P1|Overall Study|Lack of Efficacy|1
697321|NCT01421459|2263927|P2|Overall Study|Death|1
697322|NCT01421459|2263928|P1|Overall Study|Death|1
697323|NCT01421459|2263927|P2|Overall Study|Adverse Event|10
697324|NCT01421459|2263928|P1|Overall Study|Adverse Event|6
697325|NCT01421303|2263966|P1|Overall Study|Withdrawal by Subject|1
697326|NCT01421303|2263966|P1|Overall Study|Unspecified|7
697327|NCT01421303|2263966|P1|Overall Study|Non compliance with study procedure|1
697328|NCT01421303|2263966|P1|Overall Study|Lost to Follow-up|13
697329|NCT01421277|2263993|P2|Overall Study|Incomplete baseline data|31
697330|NCT01421277|2263994|P1|Overall Study|Incomplete baseline data|0
697331|NCT01421277|2263993|P2|Overall Study|Lack of qualifying event|61
697332|NCT01421277|2263994|P1|Overall Study|Lack of qualifying event|0
697333|NCT01421147|2264006|P2|Extension Period|Withdrawal by Subject|3
697334|NCT01421147|2264007|P1|Extension Period|Withdrawal by Subject|5
697335|NCT01421147|2264006|P2|Extension Period|Physician Decision|0
697336|NCT01421147|2264007|P1|Extension Period|Physician Decision|1
697337|NCT01421147|2264006|P2|Extension Period|Lost to Follow-up|5
697338|NCT01421147|2264007|P1|Extension Period|Lost to Follow-up|2
697339|NCT01421147|2264006|P2|Extension Period|Death|1
697340|NCT01421147|2264007|P1|Extension Period|Death|0
697341|NCT01421147|2264006|P2|Extension Period|Adverse Event|2
697342|NCT01421147|2264007|P1|Extension Period|Adverse Event|0
697343|NCT01421147|2264006|P2|Treatment Period|Withdrawal by Subject|5
697344|NCT01421147|2264007|P1|Treatment Period|Withdrawal by Subject|10
697345|NCT01421147|2264006|P2|Treatment Period|Physician Decision|2
697346|NCT01421147|2264007|P1|Treatment Period|Physician Decision|2
697347|NCT01421147|2264006|P2|Treatment Period|Lost to Follow-up|1
697348|NCT01421147|2264007|P1|Treatment Period|Lost to Follow-up|2
697349|NCT01421147|2264006|P2|Treatment Period|Adverse Event|3
697350|NCT01421147|2264007|P1|Treatment Period|Adverse Event|2
697351|NCT01421134|2264039|P2|Overall Study|Lost to Follow-up|1
697352|NCT01421134|2264040|P1|Overall Study|Lost to Follow-up|1
697353|NCT01421134|2264039|P2|Overall Study|Administrative|1
697354|NCT01421134|2264040|P1|Overall Study|Administrative|0
697355|NCT01421134|2264039|P2|Overall Study|Withdrawal by Subject|1
697356|NCT01421134|2264040|P1|Overall Study|Withdrawal by Subject|1
697357|NCT01421134|2264039|P2|Overall Study|Protocol Violation|3
697358|NCT01421134|2264040|P1|Overall Study|Protocol Violation|0
697359|NCT01421134|2264039|P2|Overall Study|Lack of Efficacy|4
697360|NCT01421134|2264040|P1|Overall Study|Lack of Efficacy|2
697361|NCT01421134|2264039|P2|Overall Study|Adverse Event|5
697362|NCT01421134|2264040|P1|Overall Study|Adverse Event|3
889416|NCT01336608|2823948|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
889417|NCT01336608|2823949|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
889418|NCT01336608|2823946|P4|2-week, Single-blind Run-In Period|Physician Decision|0
889419|NCT01336608|2823947|P3|2-week, Single-blind Run-In Period|Physician Decision|0
889420|NCT01336608|2823948|P2|2-week, Single-blind Run-In Period|Physician Decision|0
889421|NCT01336608|2823949|P1|2-week, Single-blind Run-In Period|Physician Decision|1
889422|NCT01336608|2823946|P4|2-week, Single-blind Run-In Period|Adverse Event|0
889423|NCT01336608|2823947|P3|2-week, Single-blind Run-In Period|Adverse Event|0
889424|NCT01336608|2823948|P2|2-week, Single-blind Run-In Period|Adverse Event|0
697375|NCT01420081|2264119|P9|Overall Study|Other Reasons|0
697376|NCT01420081|2264120|P8|Overall Study|Other Reasons|0
697377|NCT01420081|2264121|P7|Overall Study|Other Reasons|0
697378|NCT01420081|2264122|P6|Overall Study|Other Reasons|0
697379|NCT01420081|2264123|P5|Overall Study|Other Reasons|0
697380|NCT01420081|2264124|P4|Overall Study|Other Reasons|0
697381|NCT01420081|2264125|P3|Overall Study|Other Reasons|1
697382|NCT01420081|2264126|P2|Overall Study|Other Reasons|0
697383|NCT01420081|2264127|P1|Overall Study|Other Reasons|0
697384|NCT01420081|2264119|P9|Overall Study|Subject Refused Futher Follow-up|0
697385|NCT01420081|2264120|P8|Overall Study|Subject Refused Futher Follow-up|0
697386|NCT01420081|2264121|P7|Overall Study|Subject Refused Futher Follow-up|0
697387|NCT01420081|2264122|P6|Overall Study|Subject Refused Futher Follow-up|0
697388|NCT01420081|2264123|P5|Overall Study|Subject Refused Futher Follow-up|1
697389|NCT01420081|2264124|P4|Overall Study|Subject Refused Futher Follow-up|0
697390|NCT01420081|2264125|P3|Overall Study|Subject Refused Futher Follow-up|1
697391|NCT01420081|2264126|P2|Overall Study|Subject Refused Futher Follow-up|0
697392|NCT01420081|2264127|P1|Overall Study|Subject Refused Futher Follow-up|0
697393|NCT01420081|2264119|P9|Overall Study|Study Terminated by Sponsor|2
697394|NCT01420081|2264120|P8|Overall Study|Study Terminated by Sponsor|2
697395|NCT01420081|2264121|P7|Overall Study|Study Terminated by Sponsor|3
697396|NCT01420081|2264122|P6|Overall Study|Study Terminated by Sponsor|7
697397|NCT01420081|2264123|P5|Overall Study|Study Terminated by Sponsor|11
697398|NCT01420081|2264124|P4|Overall Study|Study Terminated by Sponsor|3
697399|NCT01420081|2264125|P3|Overall Study|Study Terminated by Sponsor|1
697400|NCT01420081|2264126|P2|Overall Study|Study Terminated by Sponsor|1
697401|NCT01420081|2264127|P1|Overall Study|Study Terminated by Sponsor|2
697402|NCT01420081|2264119|P9|Overall Study|Lost to Follow-up|0
697403|NCT01420081|2264120|P8|Overall Study|Lost to Follow-up|0
697404|NCT01420081|2264121|P7|Overall Study|Lost to Follow-up|0
697405|NCT01420081|2264122|P6|Overall Study|Lost to Follow-up|1
697406|NCT01420081|2264123|P5|Overall Study|Lost to Follow-up|1
697407|NCT01420081|2264124|P4|Overall Study|Lost to Follow-up|0
697408|NCT01420081|2264125|P3|Overall Study|Lost to Follow-up|0
697409|NCT01420081|2264126|P2|Overall Study|Lost to Follow-up|0
697410|NCT01420081|2264127|P1|Overall Study|Lost to Follow-up|0
697411|NCT01420081|2264119|P9|Overall Study|Death|1
697412|NCT01420081|2264120|P8|Overall Study|Death|1
697413|NCT01420081|2264121|P7|Overall Study|Death|0
697414|NCT01420081|2264122|P6|Overall Study|Death|12
697415|NCT01420081|2264123|P5|Overall Study|Death|7
697416|NCT01420081|2264124|P4|Overall Study|Death|0
697417|NCT01420081|2264125|P3|Overall Study|Death|8
697418|NCT01420081|2264126|P2|Overall Study|Death|0
697419|NCT01420081|2264127|P1|Overall Study|Death|1
697420|NCT01419769|2264246|P1|Overall Study|Not evaluable due to pigtail stents|1
697421|NCT01419769|2264246|P1|Overall Study|Did not receive the AXIOS stent|3
697422|NCT01419314|2264267|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
697423|NCT01419314|2264268|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
697424|NCT01419314|2264267|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
697425|NCT01419314|2264268|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
697426|NCT01419314|2264267|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
697427|NCT01419314|2264268|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
697428|NCT01419236|2264309|P2|Overall Study|Entry Criteria Not Met|0
697429|NCT01419236|2264310|P1|Overall Study|Entry Criteria Not Met|1
697430|NCT01419236|2264309|P2|Overall Study|Withdrawal by Subject|4
697431|NCT01419236|2264310|P1|Overall Study|Withdrawal by Subject|1
697432|NCT01419236|2264309|P2|Overall Study|Physician Decision|0
697433|NCT01419236|2264310|P1|Overall Study|Physician Decision|1
697434|NCT01419236|2264309|P2|Overall Study|Lost to Follow-up|0
697435|NCT01419236|2264310|P1|Overall Study|Lost to Follow-up|1
697436|NCT01419236|2264309|P2|Overall Study|Lack of Efficacy|1
697437|NCT01419236|2264310|P1|Overall Study|Lack of Efficacy|0
697438|NCT01419236|2264309|P2|Overall Study|Adverse Event|0
697439|NCT01419236|2264310|P1|Overall Study|Adverse Event|1
697440|NCT01419197|2264334|P2|Overall Study|Lost to Follow-up|4
697441|NCT01419197|2264335|P1|Overall Study|Lost to Follow-up|14
697442|NCT01419197|2264334|P2|Overall Study|Reason Not Specified|1
697443|NCT01419197|2264335|P1|Overall Study|Reason Not Specified|0
697444|NCT01419197|2264334|P2|Overall Study|Study Completed by Sponsor|34
697445|NCT01419197|2264335|P1|Overall Study|Study Completed by Sponsor|103
697446|NCT01419197|2264334|P2|Overall Study|Withdrawal by Subject|32
697447|NCT01419197|2264335|P1|Overall Study|Withdrawal by Subject|33
697448|NCT01419197|2264334|P2|Overall Study|Non-compliance|1
697449|NCT01419197|2264335|P1|Overall Study|Non-compliance|3
697450|NCT01419197|2264334|P2|Overall Study|Physician Decision|4
697451|NCT01419197|2264335|P1|Overall Study|Physician Decision|4
697452|NCT01419197|2264334|P2|Overall Study|Death|122
697453|NCT01419197|2264335|P1|Overall Study|Death|247
697454|NCT01419184|2264360|P2|Overall Study|Participant randomized, not treated|0
697455|NCT01419184|2264361|P1|Overall Study|Participant randomized, not treated|1
697456|NCT01419184|2264360|P2|Overall Study|No IRLOS-No adverse event treatment date|1
697457|NCT01419184|2264361|P1|Overall Study|No IRLOS-No adverse event treatment date|0
697458|NCT01419184|2264360|P2|Overall Study|No IRLOS-non trial antibiotic used|2
697459|NCT01419184|2264361|P1|Overall Study|No IRLOS-non trial antibiotic used|1
697460|NCT01419184|2264360|P2|Overall Study|No IRLOS-randomized, not treated|4
697461|NCT01419184|2264361|P1|Overall Study|No IRLOS-randomized, not treated|2
697462|NCT01419184|2264360|P2|Overall Study|No IRLOS-No in-patient end date reported|6
697463|NCT01419184|2264361|P1|Overall Study|No IRLOS-No in-patient end date reported|3
697464|NCT01419184|2264360|P2|Overall Study|Site data not available|2
697465|NCT01419184|2264361|P1|Overall Study|Site data not available|3
697466|NCT01418937|2264399|P1|Overall Study|Withdrawal by Subject|1
697467|NCT01418937|2264399|P1|Overall Study|Pregnancy|1
697468|NCT01418937|2264399|P1|Overall Study|Protocol Violation|1
697469|NCT01418937|2264399|P1|Overall Study|Lost to Follow-up|5
697470|NCT01418365|2264430|P2|Second Intervention|Withdrawal by Subject|1
697471|NCT01418365|2264431|P1|Second Intervention|Withdrawal by Subject|0
697472|NCT01418365|2264430|P2|First Intervention|Non-compliance|0
697473|NCT01418365|2264431|P1|First Intervention|Non-compliance|1
697474|NCT01418365|2264430|P2|First Intervention|Withdrawal by Subject|1
697475|NCT01418365|2264431|P1|First Intervention|Withdrawal by Subject|0
697476|NCT01418209|2264442|P3|Overall Study|Did not provide hot flash diary data|3
697477|NCT01418209|2264443|P2|Overall Study|Did not provide hot flash diary data|3
697478|NCT01418209|2264444|P1|Overall Study|Did not provide hot flash diary data|1
697479|NCT01418209|2264442|P3|Overall Study|Withdrawal by Subject|1
697480|NCT01418209|2264443|P2|Overall Study|Withdrawal by Subject|0
697481|NCT01418209|2264444|P1|Overall Study|Withdrawal by Subject|1
697482|NCT01417481|2264498|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
697483|NCT01417481|2264499|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
697484|NCT01417377|2264564|P1|Overall Study|Enrolled, but not treated|1
697485|NCT01417377|2264564|P1|Overall Study|Lost to Follow-up|12
697486|NCT01417195|2264573|P2|Overall Study|No transfer due to elevated progesterone|0
697487|NCT01417195|2264574|P1|Overall Study|No transfer due to elevated progesterone|1
697488|NCT01417195|2264573|P2|Overall Study|No transfer due to risk of OHSS|0
697489|NCT01417195|2264574|P1|Overall Study|No transfer due to risk of OHSS|1
697490|NCT01417195|2264573|P2|Overall Study|No embryos for transfer|1
697491|NCT01417195|2264574|P1|Overall Study|No embryos for transfer|0
697492|NCT01417195|2264573|P2|Overall Study|Stimulation failure|0
697493|NCT01417195|2264574|P1|Overall Study|Stimulation failure|1
697494|NCT01417156|2264590|P1|Overall Study|Protocol Violation|2
697495|NCT01417156|2264590|P1|Overall Study|Adverse Event|12
697496|NCT01417104|2264600|P2|Overall Study|Adverse Event|0
697497|NCT01417104|2264601|P1|Overall Study|Adverse Event|1
697498|NCT01417104|2264600|P2|Overall Study|Failure to make contact|1
697499|NCT01417104|2264601|P1|Overall Study|Failure to make contact|0
697500|NCT01417104|2264600|P2|Overall Study|Withdrawal by Subject|1
697501|NCT01417104|2264601|P1|Overall Study|Withdrawal by Subject|5
697502|NCT01417078|2264611|P1|Overall Study|Withdrawal by Subject|1
697503|NCT01416610|2264634|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
697504|NCT01416610|2264634|P1|Overall Study|Lost to Follow-up|7
697505|NCT01416610|2264634|P1|Overall Study|Withdrawal by Subject|13
697506|NCT01416610|2264634|P1|Overall Study|No reason given|5
697507|NCT01416610|2264634|P1|Overall Study|Lack of Efficacy|4
697508|NCT01416610|2264634|P1|Overall Study|Adverse Event -Patient decision|3
697509|NCT01416610|2264634|P1|Overall Study|Adverse Event|4
697510|NCT01416571|2264688|P1|Overall Study|Lost to Follow-up|2
697511|NCT01416272|2264715|P1|Overall Study|Study related complaints|1
697512|NCT01416272|2264715|P1|Overall Study|Lost to Follow-up|1
697513|NCT01416272|2264715|P1|Overall Study|Unacceptable distance visual acuity|2
697514|NCT01416181|2264723|P2|Part 2|Lost to Follow-up|2
697515|NCT01416181|2264724|P1|Part 2|Lost to Follow-up|2
697516|NCT01416181|2264723|P2|Part 2|Lack of Efficacy|1
697517|NCT01416181|2264724|P1|Part 2|Lack of Efficacy|4
697518|NCT01416181|2264723|P2|Part 2|Withdrawal by Subject|5
697519|NCT01416181|2264724|P1|Part 2|Withdrawal by Subject|14
697520|NCT01416181|2264723|P2|Part 2|Investigator Decision|7
697521|NCT01416181|2264724|P1|Part 2|Investigator Decision|6
697522|NCT01416181|2264723|P2|Part 2|Not Specified|267
697523|NCT01416181|2264724|P1|Part 2|Not Specified|234
697524|NCT01416181|2264723|P2|Part 2|Adverse Event|4
697525|NCT01416181|2264724|P1|Part 2|Adverse Event|11
697526|NCT01416181|2264723|P2|Part 1|Ongoing in Follow-Up|8
697527|NCT01416181|2264724|P1|Part 1|Ongoing in Follow-Up|14
697528|NCT01416181|2264723|P2|Part 1|Adverse Event|18
697529|NCT01416181|2264724|P1|Part 1|Adverse Event|15
697530|NCT01416181|2264723|P2|Part 1|Lost to Follow-up|1
697531|NCT01416181|2264724|P1|Part 1|Lost to Follow-up|1
697532|NCT01416181|2264723|P2|Part 1|Lack of Efficacy|8
697533|NCT01416181|2264724|P1|Part 1|Lack of Efficacy|16
697534|NCT01416181|2264723|P2|Part 1|Withdrawal by Subject|48
697535|NCT01416181|2264724|P1|Part 1|Withdrawal by Subject|74
697536|NCT01416181|2264723|P2|Part 1|Investigator Decision|6
697537|NCT01416181|2264724|P1|Part 1|Investigator Decision|7
697538|NCT01416181|2264723|P2|Part 1|Death|1
697539|NCT01416181|2264724|P1|Part 1|Death|0
697540|NCT01416181|2264723|P2|Part 1|Not Specified|24
697541|NCT01416181|2264724|P1|Part 1|Not Specified|10
697542|NCT01416155|2264786|P1|Overall Study|Not specified|7
697543|NCT01416155|2264786|P1|Overall Study|Investigator decision|8
697544|NCT01416155|2264786|P1|Overall Study|Withdrawal by Subject|33
697545|NCT01416155|2264786|P1|Overall Study|Positive for anti-BG00002 antibodies|2
697546|NCT01416155|2264786|P1|Overall Study|Adverse Event|8
697547|NCT01416142|2264793|P3|PureVision2 HD|Inability to maintain lens wear|1
697548|NCT01416142|2264794|P2|PureVision2 HD|Inability to maintain lens wear|0
697549|NCT01416142|2264795|P1|PureVision2 HD|Inability to maintain lens wear|0
697550|NCT01415986|2264822|P1|Overall Study|Lost to Follow-up|1
697551|NCT01415921|2264839|P2|Overall Study|Other|0
697552|NCT01415921|2264840|P1|Overall Study|Other|2
697553|NCT01415921|2264839|P2|Overall Study|Withdrawal by Subject|1
697554|NCT01415921|2264840|P1|Overall Study|Withdrawal by Subject|0
697555|NCT01415921|2264839|P2|Overall Study|Physician Decision|1
697556|NCT01415921|2264840|P1|Overall Study|Physician Decision|1
697557|NCT01415921|2264839|P2|Overall Study|Adverse Event|1
697558|NCT01415921|2264840|P1|Overall Study|Adverse Event|0
697559|NCT01415908|2264850|P2|Overall Study|Withdrawal by Subject|0
697560|NCT01415908|2264851|P1|Overall Study|Withdrawal by Subject|1
697561|NCT01415531|2264888|P2|Overall Study|Other Reasons|2
697562|NCT01415531|2264889|P1|Overall Study|Other Reasons|3
697563|NCT01415531|2264888|P2|Overall Study|Lack of Compliance|4
697564|NCT01415531|2264889|P1|Overall Study|Lack of Compliance|1
697565|NCT01415531|2264888|P2|Overall Study|Lost to Follow-up|14
697566|NCT01415531|2264889|P1|Overall Study|Lost to Follow-up|6
697567|NCT01415531|2264888|P2|Overall Study|Withdrawal by Subject|4
697568|NCT01415531|2264889|P1|Overall Study|Withdrawal by Subject|5
697569|NCT01415531|2264888|P2|Overall Study|Protocol Violation|1
697570|NCT01415531|2264889|P1|Overall Study|Protocol Violation|0
697571|NCT01415531|2264888|P2|Overall Study|Lack of Efficacy|2
697572|NCT01415531|2264889|P1|Overall Study|Lack of Efficacy|3
697573|NCT01415531|2264888|P2|Overall Study|Adverse Event|10
697574|NCT01415531|2264889|P1|Overall Study|Adverse Event|7
697575|NCT01415518|2264899|P2|Overall Study|Condition under Investigation Worsened|1
697576|NCT01415518|2264900|P1|Overall Study|Condition under Investigation Worsened|1
697577|NCT01415518|2264899|P2|Overall Study|Death|1
697578|NCT01415518|2264900|P1|Overall Study|Death|1
697579|NCT01415518|2264899|P2|Overall Study|Adverse Event|4
697580|NCT01415518|2264900|P1|Overall Study|Adverse Event|3
697581|NCT01415518|2264899|P2|Overall Study|Lost to Follow-up|5
697582|NCT01415518|2264900|P1|Overall Study|Lost to Follow-up|3
697583|NCT01415518|2264899|P2|Overall Study|Protocol Violation|8
697584|NCT01415518|2264900|P1|Overall Study|Protocol Violation|6
697585|NCT01415518|2264899|P2|Overall Study|Withdrawal by Subject|12
697586|NCT01415518|2264900|P1|Overall Study|Withdrawal by Subject|2
697587|NCT01415401|2265000|P1|Overall Study|Terminated by Sponsor|1
697588|NCT01415401|2265000|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
697589|NCT01415401|2265000|P1|Overall Study|Adverse Event|5
697590|NCT01415349|2265005|P2|Treatment Period 1|Withdrawal by Subject|1
697591|NCT01415349|2265006|P1|Treatment Period 1|Withdrawal by Subject|0
697592|NCT01415349|2265005|P2|Treatment Period 1|Adverse Event|1
697593|NCT01415349|2265006|P1|Treatment Period 1|Adverse Event|0
697599|NCT01412983|2265067|P2|1st Period|Inability to maintain wear|1
697600|NCT01412983|2265068|P1|1st Period|Inability to maintain wear|0
697601|NCT01412983|2265067|P2|1st Period|Unacceptable lens movement|1
697602|NCT01412983|2265068|P1|1st Period|Unacceptable lens movement|0
697603|NCT01412983|2265067|P2|1st Period|Positive slit lamp finding|1
697604|NCT01412983|2265068|P1|1st Period|Positive slit lamp finding|0
697605|NCT01412983|2265067|P2|1st Period|Ineligible|1
697606|NCT01412983|2265068|P1|1st Period|Ineligible|0
697607|NCT01414205|2265093|P2|Overall Study|Randomized but not Treated|1
697608|NCT01414205|2265094|P1|Overall Study|Randomized but not Treated|1
697609|NCT01414205|2265093|P2|Overall Study|Physician Decision|1
697610|NCT01414205|2265094|P1|Overall Study|Physician Decision|0
697611|NCT01414205|2265093|P2|Overall Study|Lost to Follow-up|4
697612|NCT01414205|2265094|P1|Overall Study|Lost to Follow-up|1
697613|NCT01414205|2265093|P2|Overall Study|Death|1
697614|NCT01414205|2265094|P1|Overall Study|Death|5
697615|NCT01414166|2265163|P2|Overall Study|Withdrawal by Subject|5
697616|NCT01414166|2265164|P1|Overall Study|Withdrawal by Subject|3
697617|NCT01414166|2265163|P2|Overall Study|Study terminated by Sponsor|75
697618|NCT01414166|2265164|P1|Overall Study|Study terminated by Sponsor|68
697619|NCT01414166|2265163|P2|Overall Study|Protocol Violation|0
697620|NCT01414166|2265164|P1|Overall Study|Protocol Violation|2
697621|NCT01414166|2265163|P2|Overall Study|Physician Decision|0
697622|NCT01414166|2265164|P1|Overall Study|Physician Decision|2
697623|NCT01414166|2265163|P2|Overall Study|Non-compliance with study drug|0
697624|NCT01414166|2265164|P1|Overall Study|Non-compliance with study drug|2
697625|NCT01414166|2265163|P2|Overall Study|Lost to Follow-up|1
697626|NCT01414166|2265164|P1|Overall Study|Lost to Follow-up|4
697627|NCT01414166|2265163|P2|Overall Study|Adverse Event|2
697628|NCT01414166|2265164|P1|Overall Study|Adverse Event|10
697629|NCT01414114|2265227|P1|Overall Study|Other|2
697630|NCT01414114|2265227|P1|Overall Study|Withdrawal by Subject|1
697631|NCT01414114|2265227|P1|Overall Study|Adverse Event|2
697632|NCT01413958|2265283|P2|Overall Study|Lost to Follow-up|1
697633|NCT01413958|2265284|P1|Overall Study|Lost to Follow-up|0
697634|NCT01413542|2265335|P4|Overall Study|Adverse Event|1
697635|NCT01413542|2265336|P3|Overall Study|Adverse Event|0
697636|NCT01413542|2265337|P2|Overall Study|Adverse Event|0
697637|NCT01413542|2265338|P1|Overall Study|Adverse Event|0
697638|NCT01413542|2265335|P4|Overall Study|Physician Decision|0
697639|NCT01413542|2265336|P3|Overall Study|Physician Decision|3
697640|NCT01413542|2265337|P2|Overall Study|Physician Decision|0
697641|NCT01413542|2265338|P1|Overall Study|Physician Decision|1
697642|NCT01413360|2265360|P1|Overall Study|Adverse Event|1
697643|NCT01413360|2265360|P1|Overall Study|Lost to Follow-up|2
697644|NCT01413204|2265368|P3|Overall Study|Fasting plasma glucose level increased|10
697645|NCT01413204|2265369|P2|Overall Study|Fasting plasma glucose level increased|0
697646|NCT01413204|2265370|P1|Overall Study|Fasting plasma glucose level increased|1
697647|NCT01413204|2265368|P3|Overall Study|Clearly not eligible for the study|1
697648|NCT01413204|2265369|P2|Overall Study|Clearly not eligible for the study|0
697649|NCT01413204|2265370|P1|Overall Study|Clearly not eligible for the study|0
697650|NCT01413204|2265368|P3|Overall Study|Withdrawal by Subject|4
697651|NCT01413204|2265369|P2|Overall Study|Withdrawal by Subject|4
697652|NCT01413204|2265370|P1|Overall Study|Withdrawal by Subject|1
697653|NCT01413204|2265368|P3|Overall Study|Physician Decision|2
697654|NCT01413204|2265369|P2|Overall Study|Physician Decision|0
697655|NCT01413204|2265370|P1|Overall Study|Physician Decision|3
697656|NCT01413204|2265368|P3|Overall Study|Adverse Event|2
697657|NCT01413204|2265369|P2|Overall Study|Adverse Event|2
697658|NCT01413204|2265370|P1|Overall Study|Adverse Event|1
697659|NCT01413191|2265378|P1|Overall Study|Death|1
697660|NCT01413191|2265378|P1|Overall Study|Disease Progression|5
697661|NCT01413191|2265378|P1|Overall Study|Lost to Follow-up|5
697662|NCT01412957|2265384|P2|Overall Study|Death|133
697663|NCT01412957|2265385|P1|Overall Study|Death|136
697664|NCT01412957|2265384|P2|Overall Study|Lost to Follow-up|2
697665|NCT01412957|2265385|P1|Overall Study|Lost to Follow-up|7
697666|NCT01412957|2265384|P2|Overall Study|Withdrawal by Subject|22
697667|NCT01412957|2265385|P1|Overall Study|Withdrawal by Subject|6
697668|NCT01412944|2265407|P6|Entire: IV + Maintenance|Adverse Event|0
697669|NCT01412944|2265408|P5|Entire: IV + Maintenance|Adverse Event|0
697670|NCT01412944|2265409|P4|Entire: IV + Maintenance|Adverse Event|0
697671|NCT01412944|2265410|P3|Entire: IV + Maintenance|Adverse Event|0
697672|NCT01412944|2265411|P2|Entire: IV + Maintenance|Adverse Event|1
697673|NCT01412944|2265412|P1|Entire: IV + Maintenance|Adverse Event|0
697674|NCT01412944|2265407|P6|Entire: IV + Maintenance|Lack of Efficacy|0
697675|NCT01412944|2265408|P5|Entire: IV + Maintenance|Lack of Efficacy|0
697676|NCT01412944|2265409|P4|Entire: IV + Maintenance|Lack of Efficacy|0
697677|NCT01412944|2265410|P3|Entire: IV + Maintenance|Lack of Efficacy|0
697678|NCT01412944|2265411|P2|Entire: IV + Maintenance|Lack of Efficacy|1
697679|NCT01412944|2265412|P1|Entire: IV + Maintenance|Lack of Efficacy|0
697680|NCT01412944|2265407|P6|Entire: IV + Maintenance|Lost to Follow-up|0
697681|NCT01412944|2265408|P5|Entire: IV + Maintenance|Lost to Follow-up|0
697682|NCT01412944|2265409|P4|Entire: IV + Maintenance|Lost to Follow-up|0
697683|NCT01412944|2265410|P3|Entire: IV + Maintenance|Lost to Follow-up|0
697684|NCT01412944|2265411|P2|Entire: IV + Maintenance|Lost to Follow-up|1
697685|NCT01412944|2265412|P1|Entire: IV + Maintenance|Lost to Follow-up|0
697686|NCT01412944|2265407|P6|Entire: IV + Maintenance|Protocol deviation|0
697687|NCT01412944|2265408|P5|Entire: IV + Maintenance|Protocol deviation|0
697688|NCT01412944|2265409|P4|Entire: IV + Maintenance|Protocol deviation|0
697689|NCT01412944|2265410|P3|Entire: IV + Maintenance|Protocol deviation|0
697690|NCT01412944|2265411|P2|Entire: IV + Maintenance|Protocol deviation|1
697691|NCT01412944|2265412|P1|Entire: IV + Maintenance|Protocol deviation|0
697692|NCT01412944|2265407|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
697693|NCT01412944|2265408|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
697694|NCT01412944|2265409|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
697695|NCT01412944|2265410|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
697696|NCT01412944|2265411|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
697697|NCT01412944|2265412|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
697698|NCT01412944|2265407|P6|Entire: IV + Maintenance|Lack of Efficacy|0
697699|NCT01412944|2265408|P5|Entire: IV + Maintenance|Lack of Efficacy|1
697700|NCT01412944|2265409|P4|Entire: IV + Maintenance|Lack of Efficacy|0
697701|NCT01412944|2265410|P3|Entire: IV + Maintenance|Lack of Efficacy|0
697702|NCT01412944|2265411|P2|Entire: IV + Maintenance|Lack of Efficacy|0
697703|NCT01412944|2265412|P1|Entire: IV + Maintenance|Lack of Efficacy|0
697704|NCT01412944|2265407|P6|Entire: IV + Maintenance|Lost to Follow-up|1
697705|NCT01412944|2265408|P5|Entire: IV + Maintenance|Lost to Follow-up|0
697706|NCT01412944|2265409|P4|Entire: IV + Maintenance|Lost to Follow-up|0
697707|NCT01412944|2265410|P3|Entire: IV + Maintenance|Lost to Follow-up|0
697708|NCT01412944|2265411|P2|Entire: IV + Maintenance|Lost to Follow-up|0
697709|NCT01412944|2265412|P1|Entire: IV + Maintenance|Lost to Follow-up|0
697710|NCT01412944|2265407|P6|Entire: IV + Maintenance|Protocol deviation|1
697711|NCT01412944|2265408|P5|Entire: IV + Maintenance|Protocol deviation|0
697712|NCT01412944|2265409|P4|Entire: IV + Maintenance|Protocol deviation|0
697713|NCT01412944|2265410|P3|Entire: IV + Maintenance|Protocol deviation|0
697714|NCT01412944|2265411|P2|Entire: IV + Maintenance|Protocol deviation|0
697715|NCT01412944|2265412|P1|Entire: IV + Maintenance|Protocol deviation|0
697716|NCT01412944|2265407|P6|Entire: IV + Maintenance|Adverse Event|0
697717|NCT01412944|2265408|P5|Entire: IV + Maintenance|Adverse Event|1
697718|NCT01412944|2265409|P4|Entire: IV + Maintenance|Adverse Event|0
697719|NCT01412944|2265410|P3|Entire: IV + Maintenance|Adverse Event|0
697720|NCT01412944|2265411|P2|Entire: IV + Maintenance|Adverse Event|0
697721|NCT01412944|2265412|P1|Entire: IV + Maintenance|Adverse Event|0
697722|NCT01412944|2265407|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
697723|NCT01412944|2265408|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
697724|NCT01412944|2265409|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
697725|NCT01412944|2265410|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
697726|NCT01412944|2265411|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
697727|NCT01412944|2265412|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
697728|NCT01412944|2265407|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
697729|NCT01412944|2265408|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
697730|NCT01412944|2265409|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
697731|NCT01412944|2265410|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
697732|NCT01412944|2265411|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
697733|NCT01412944|2265412|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
697734|NCT01412944|2265407|P6|IV: Per CAIN457A2307|Protocol deviation|0
697735|NCT01412944|2265408|P5|IV: Per CAIN457A2307|Protocol deviation|0
697736|NCT01412944|2265409|P4|IV: Per CAIN457A2307|Protocol deviation|0
697737|NCT01412944|2265410|P3|IV: Per CAIN457A2307|Protocol deviation|0
697738|NCT01412944|2265411|P2|IV: Per CAIN457A2307|Protocol deviation|1
697739|NCT01412944|2265412|P1|IV: Per CAIN457A2307|Protocol deviation|0
697740|NCT01412944|2265407|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
697741|NCT01412944|2265408|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
697742|NCT01412944|2265409|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
697743|NCT01412944|2265410|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
697744|NCT01412944|2265411|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
697745|NCT01412944|2265412|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
697746|NCT01412944|2265407|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
697747|NCT01412944|2265408|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
697748|NCT01412944|2265409|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
697749|NCT01412944|2265410|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
697750|NCT01412944|2265411|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
697751|NCT01412944|2265412|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
697752|NCT01412944|2265407|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
697753|NCT01412944|2265408|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
697754|NCT01412944|2265409|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
697755|NCT01412944|2265410|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
697756|NCT01412944|2265411|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
697757|NCT01412944|2265412|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
697758|NCT01412944|2265407|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
697759|NCT01412944|2265408|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
697760|NCT01412944|2265409|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
697761|NCT01412944|2265410|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
697762|NCT01412944|2265411|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
697763|NCT01412944|2265412|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
697764|NCT01412879|2265458|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
697765|NCT01412879|2265459|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
697766|NCT01412879|2265460|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
697767|NCT01412879|2265458|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
697768|NCT01412879|2265459|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
697769|NCT01412879|2265460|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
697770|NCT01412879|2265458|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
697771|NCT01412879|2265459|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
697772|NCT01412879|2265460|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
697773|NCT01412879|2265458|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
697774|NCT01412879|2265459|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
697775|NCT01412879|2265460|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
697776|NCT01412879|2265458|P3|Initial Registration (Induction Therapy)|Adverse Event|0
697777|NCT01412879|2265459|P2|Initial Registration (Induction Therapy)|Adverse Event|3
697778|NCT01412879|2265460|P1|Initial Registration (Induction Therapy)|Adverse Event|5
697779|NCT01412801|2265480|P6|Overall Study|Relocated to another area|0
697780|NCT01412801|2265481|P5|Overall Study|Relocated to another area|0
697781|NCT01412801|2265482|P4|Overall Study|Relocated to another area|0
697782|NCT01412801|2265483|P3|Overall Study|Relocated to another area|2
697783|NCT01412801|2265484|P2|Overall Study|Relocated to another area|0
697784|NCT01412801|2265485|P1|Overall Study|Relocated to another area|0
697785|NCT01412801|2265480|P6|Overall Study|Withdrawal by Subject|0
697786|NCT01412801|2265481|P5|Overall Study|Withdrawal by Subject|0
697787|NCT01412801|2265482|P4|Overall Study|Withdrawal by Subject|0
697788|NCT01412801|2265483|P3|Overall Study|Withdrawal by Subject|1
697789|NCT01412801|2265484|P2|Overall Study|Withdrawal by Subject|2
697790|NCT01412801|2265485|P1|Overall Study|Withdrawal by Subject|3
697791|NCT01412801|2265480|P6|Overall Study|Lost to Follow-up|1
697792|NCT01412801|2265481|P5|Overall Study|Lost to Follow-up|1
697793|NCT01412801|2265482|P4|Overall Study|Lost to Follow-up|0
697794|NCT01412801|2265483|P3|Overall Study|Lost to Follow-up|4
697795|NCT01412801|2265484|P2|Overall Study|Lost to Follow-up|2
697796|NCT01412801|2265485|P1|Overall Study|Lost to Follow-up|1
697797|NCT01412801|2265480|P6|Overall Study|Death|2
697798|NCT01412801|2265481|P5|Overall Study|Death|2
697799|NCT01412801|2265482|P4|Overall Study|Death|4
697800|NCT01412801|2265483|P3|Overall Study|Death|0
697801|NCT01412801|2265484|P2|Overall Study|Death|1
697802|NCT01412801|2265485|P1|Overall Study|Death|0
697803|NCT01412424|2265633|P1|Extension Treatment Period|Patient Request|2
697804|NCT01412424|2265633|P1|Extension Treatment Period|Treatment Failure|2
697805|NCT01412424|2265633|P1|Extension Treatment Period|Adverse Event|2
697806|NCT01412424|2265633|P1|Core Treatment Period|Sponsor Request|1
697807|NCT01412424|2265633|P1|Core Treatment Period|Lost to Follow-up|2
697808|NCT01412424|2265633|P1|Core Treatment Period|Patient Request|5
697809|NCT01412424|2265633|P1|Core Treatment Period|Adverse Event|21
697810|NCT01412424|2265633|P1|Core Treatment Period|Treatment Failure|24
697811|NCT01412333|2265651|P2|Overall Study|Lost to Follow-up|6
697812|NCT01412333|2265652|P1|Overall Study|Lost to Follow-up|10
697813|NCT01412333|2265651|P2|Overall Study|Adverse Event|16
697814|NCT01412333|2265652|P1|Overall Study|Adverse Event|25
697815|NCT01412333|2265651|P2|Overall Study|Consent withdrawn by participant|12
697816|NCT01412333|2265652|P1|Overall Study|Consent withdrawn by participant|25
697817|NCT01412333|2265651|P2|Overall Study|Pregnancy|0
697818|NCT01412333|2265652|P1|Overall Study|Pregnancy|3
697819|NCT01412333|2265651|P2|Overall Study|Lack of Efficacy|6
697820|NCT01412333|2265652|P1|Overall Study|Lack of Efficacy|15
697821|NCT01412333|2265651|P2|Overall Study|Non-compliance|3
697822|NCT01412333|2265652|P1|Overall Study|Non-compliance|1
697823|NCT01412333|2265651|P2|Overall Study|Protocol Violation|1
697824|NCT01412333|2265652|P1|Overall Study|Protocol Violation|1
697825|NCT01412333|2265651|P2|Overall Study|Non-compliance with study drug|1
697826|NCT01412333|2265652|P1|Overall Study|Non-compliance with study drug|1
697827|NCT01412333|2265651|P2|Overall Study|Reason not specified|10
697828|NCT01412333|2265652|P1|Overall Study|Reason not specified|16
697829|NCT01412333|2265651|P2|Overall Study|Physician Decision|1
697830|NCT01412333|2265652|P1|Overall Study|Physician Decision|0
697831|NCT01412333|2265651|P2|Overall Study|Death|1
697832|NCT01412333|2265652|P1|Overall Study|Death|1
697833|NCT01412229|2265712|P1|Overall Study|Physician Decision|1
697834|NCT01412151|2265728|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
697835|NCT01412151|2265728|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
697836|NCT01412151|2265728|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
697837|NCT01412151|2265728|P1|Week 0 - 306 - Treatment Period|Death|1
697838|NCT01411891|2265739|P2|Overall Study|Catheter dislodgement or loss to follow-|2
697839|NCT01411891|2265740|P1|Overall Study|Catheter dislodgement or loss to follow-|3
889425|NCT01336608|2823949|P1|2-week, Single-blind Run-In Period|Adverse Event|1
889426|NCT01336608|2823946|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
889427|NCT01336608|2823947|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
889428|NCT01336608|2823948|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
889429|NCT01336608|2823949|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
889430|NCT01336608|2823946|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
889431|NCT01336608|2823947|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
889432|NCT01336608|2823948|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
889433|NCT01336608|2823949|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
889446|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
889447|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
889448|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
889449|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
889450|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
889451|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
889452|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
889453|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
889454|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
889455|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
889456|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
697872|NCT01411228|2265859|P3|Overall Study|Withdrawal by Subject|0
697873|NCT01411228|2265860|P2|Overall Study|Withdrawal by Subject|0
697874|NCT01411228|2265861|P1|Overall Study|Withdrawal by Subject|1
697875|NCT01411228|2265859|P3|Overall Study|Lost to Follow-up|1
697876|NCT01411228|2265860|P2|Overall Study|Lost to Follow-up|0
697877|NCT01411228|2265861|P1|Overall Study|Lost to Follow-up|0
697878|NCT01411215|2265883|P2|Overall Study|Screen failure|1
697879|NCT01411215|2265884|P1|Overall Study|Screen failure|0
697880|NCT01411215|2265883|P2|Overall Study|Unspecified|17
697881|NCT01411215|2265884|P1|Overall Study|Unspecified|12
697882|NCT01411215|2265883|P2|Overall Study|Withdrawal by Subject|21
697883|NCT01411215|2265884|P1|Overall Study|Withdrawal by Subject|34
697884|NCT01411215|2265883|P2|Overall Study|Protocol Violation|5
697885|NCT01411215|2265884|P1|Overall Study|Protocol Violation|3
697886|NCT01411215|2265883|P2|Overall Study|Study terminated by sponsor|15
697887|NCT01411215|2265884|P1|Overall Study|Study terminated by sponsor|2
697888|NCT01411215|2265883|P2|Overall Study|Did not meet entrance criteria|1
697889|NCT01411215|2265884|P1|Overall Study|Did not meet entrance criteria|0
697890|NCT01411215|2265883|P2|Overall Study|Lost to Follow-up|18
697891|NCT01411215|2265884|P1|Overall Study|Lost to Follow-up|12
697892|NCT01411215|2265883|P2|Overall Study|Lack of Efficacy|4
697893|NCT01411215|2265884|P1|Overall Study|Lack of Efficacy|2
697894|NCT01411215|2265883|P2|Overall Study|Adverse Event|2
697895|NCT01411215|2265884|P1|Overall Study|Adverse Event|1
697896|NCT01410604|2265943|P2|Overall Study|Physician Decision|1
697897|NCT01410604|2265944|P1|Overall Study|Physician Decision|0
697898|NCT01410604|2265943|P2|Overall Study|Lost to Follow-up|0
697899|NCT01410604|2265944|P1|Overall Study|Lost to Follow-up|1
697900|NCT01410604|2265943|P2|Overall Study|Adverse Event|1
697901|NCT01410604|2265944|P1|Overall Study|Adverse Event|2
697902|NCT01410474|2265980|P2|Overall Study|Withdrawal by Subject|1
697903|NCT01410474|2265981|P1|Overall Study|Withdrawal by Subject|0
697904|NCT01410448|2266004|P2|Overall Study|Death|3
697905|NCT01410448|2266005|P1|Overall Study|Death|2
697906|NCT01410448|2266004|P2|Overall Study|Protocol Violation|4
697907|NCT01410448|2266005|P1|Overall Study|Protocol Violation|0
697908|NCT01410448|2266004|P2|Overall Study|Withdrawal by Subject|2
697909|NCT01410448|2266005|P1|Overall Study|Withdrawal by Subject|3
697910|NCT01410448|2266004|P2|Overall Study|Lost to Follow-up|0
697911|NCT01410448|2266005|P1|Overall Study|Lost to Follow-up|1
697912|NCT01410448|2266004|P2|Overall Study|Administrative issues|1
697913|NCT01410448|2266005|P1|Overall Study|Administrative issues|2
697914|NCT01410448|2266004|P2|Overall Study|Graft loss|1
697915|NCT01410448|2266005|P1|Overall Study|Graft loss|4
697916|NCT01410448|2266004|P2|Overall Study|No conversion to everolimus|24
697917|NCT01410448|2266005|P1|Overall Study|No conversion to everolimus|0
697918|NCT01410357|2266070|P2|Overall Study|Lost to Follow-up|21
697919|NCT01410357|2266071|P1|Overall Study|Lost to Follow-up|23
697920|NCT01410357|2266070|P2|Overall Study|Withdrawal by Subject|2
697921|NCT01410357|2266071|P1|Overall Study|Withdrawal by Subject|1
697922|NCT01410357|2266070|P2|Overall Study|Death|1
697923|NCT01410357|2266071|P1|Overall Study|Death|2
697924|NCT01410240|2266128|P3|Overall Study|Missed week 6 assessments|1
697925|NCT01410240|2266129|P2|Overall Study|Missed week 6 assessments|1
697926|NCT01410240|2266130|P1|Overall Study|Missed week 6 assessments|1
697927|NCT01410240|2266128|P3|Overall Study|Physician Decision|1
697928|NCT01410240|2266129|P2|Overall Study|Physician Decision|0
697929|NCT01410240|2266130|P1|Overall Study|Physician Decision|0
697946|NCT01410110|2266276|P2|Overall Study|Withdrawal by Subject|2
697947|NCT01410110|2266277|P1|Overall Study|Withdrawal by Subject|4
697948|NCT01409993|2266301|P4|Overall Study|Lost to Follow-up|0
697949|NCT01409993|2266302|P3|Overall Study|Lost to Follow-up|0
697950|NCT01409993|2266303|P2|Overall Study|Lost to Follow-up|1
697951|NCT01409993|2266304|P1|Overall Study|Lost to Follow-up|0
697952|NCT01409993|2266301|P4|Overall Study|Withdrawal by Subject|4
697953|NCT01409993|2266302|P3|Overall Study|Withdrawal by Subject|0
697954|NCT01409993|2266303|P2|Overall Study|Withdrawal by Subject|0
697955|NCT01409993|2266304|P1|Overall Study|Withdrawal by Subject|0
697956|NCT01409993|2266301|P4|Overall Study|Adverse Event|1
697957|NCT01409993|2266302|P3|Overall Study|Adverse Event|3
697958|NCT01409993|2266303|P2|Overall Study|Adverse Event|4
697959|NCT01409993|2266304|P1|Overall Study|Adverse Event|4
697960|NCT01409837|2266324|P2|Overall Study|Physician Decision|1
697961|NCT01409837|2266325|P1|Overall Study|Physician Decision|0
697962|NCT01409837|2266324|P2|Overall Study|Lost to Follow-up|0
697963|NCT01409837|2266325|P1|Overall Study|Lost to Follow-up|1
697964|NCT01409837|2266324|P2|Overall Study|Withdrawal by Subject|1
697965|NCT01409837|2266325|P1|Overall Study|Withdrawal by Subject|2
697966|NCT01409707|2266350|P3|Overall Study|Withdrawal by Subject|16
697967|NCT01409707|2266351|P2|Overall Study|Withdrawal by Subject|17
697968|NCT01409707|2266352|P1|Overall Study|Withdrawal by Subject|5
697969|NCT01409564|2266364|P2|Overall Study|brain abnormalities found in T1 MR|2
697970|NCT01409564|2266365|P1|Overall Study|brain abnormalities found in T1 MR|1
697971|NCT01409564|2266364|P2|Overall Study|low medication compliance|3
697972|NCT01409564|2266365|P1|Overall Study|low medication compliance|4
697973|NCT01409434|2266383|P1|Overall Study|Protocol Violation|4
697974|NCT01409382|2266393|P2|Overall Study|Had a 2nd trimester loss after accident|0
697975|NCT01409382|2266394|P1|Overall Study|Had a 2nd trimester loss after accident|1
697976|NCT01409382|2266393|P2|Overall Study|Did not manage to get pregnant|70
697977|NCT01409382|2266394|P1|Overall Study|Did not manage to get pregnant|64
697978|NCT01409382|2266393|P2|Overall Study|Still pregnant when study ended|2
697979|NCT01409382|2266394|P1|Overall Study|Still pregnant when study ended|13
697980|NCT01409382|2266393|P2|Overall Study|Multiple pregnancy|4
697981|NCT01409382|2266394|P1|Overall Study|Multiple pregnancy|2
697982|NCT01409382|2266393|P2|Overall Study|Protocol Violation|3
697983|NCT01409382|2266394|P1|Overall Study|Protocol Violation|0
697984|NCT01409382|2266393|P2|Overall Study|Lost to Follow-up|1
697985|NCT01409382|2266394|P1|Overall Study|Lost to Follow-up|1
698007|NCT01408888|2266477|P2|Second Intervention|Adverse Event|0
698008|NCT01408888|2266478|P1|Second Intervention|Adverse Event|1
698009|NCT01408888|2266477|P2|Second Intervention|Withdrawal by Subject|0
698010|NCT01408888|2266478|P1|Second Intervention|Withdrawal by Subject|1
698011|NCT01408888|2266477|P2|First Intervention|Withdrawal by Subject|2
698012|NCT01408888|2266478|P1|First Intervention|Withdrawal by Subject|0
698013|NCT01408888|2266477|P2|First Intervention|Adverse Event|1
698014|NCT01408888|2266478|P1|First Intervention|Adverse Event|0
698015|NCT01408706|2266557|P2|Overall Study|Physician Decision|0
698016|NCT01408706|2266558|P1|Overall Study|Physician Decision|1
698017|NCT01408628|2266568|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
698018|NCT01408628|2266568|P1|Completed 6 Month Follow-Up|Protocol Violation|6
698019|NCT01408628|2266568|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
698020|NCT01408628|2266568|P1|Consented|Withdrawal by Subject|12
698021|NCT01408537|2266574|P1|Overall Study|Lost to Follow-up|3
698022|NCT01408537|2266574|P1|Overall Study|Protocol Violation|3
698023|NCT01408537|2266574|P1|Overall Study|Withdrawal by Subject|2
698024|NCT01408485|2266590|P1|Overall Study|Withdrawal by Subject|21
698025|NCT01408303|2266608|P3|Overall Study|Noncompliance|1
698026|NCT01408303|2266609|P2|Overall Study|Noncompliance|0
698027|NCT01408303|2266610|P1|Overall Study|Noncompliance|1
698028|NCT01408303|2266608|P3|Overall Study|Protocol Violation|0
698029|NCT01408303|2266609|P2|Overall Study|Protocol Violation|1
698030|NCT01408303|2266610|P1|Overall Study|Protocol Violation|0
698031|NCT01408303|2266608|P3|Overall Study|Withdrawal by Subject|1
698032|NCT01408303|2266609|P2|Overall Study|Withdrawal by Subject|3
698033|NCT01408303|2266610|P1|Overall Study|Withdrawal by Subject|2
698034|NCT01408303|2266608|P3|Overall Study|Lost to Follow-up|2
698035|NCT01408303|2266609|P2|Overall Study|Lost to Follow-up|1
698036|NCT01408303|2266610|P1|Overall Study|Lost to Follow-up|0
698037|NCT01408303|2266608|P3|Overall Study|Adverse Event|2
698038|NCT01408303|2266609|P2|Overall Study|Adverse Event|7
698039|NCT01408303|2266610|P1|Overall Study|Adverse Event|3
698040|NCT01408277|2266620|P2|Overall Study|Protocol Violation|0
698041|NCT01408277|2266621|P1|Overall Study|Protocol Violation|2
698042|NCT01408277|2266620|P2|Overall Study|Withdrawal by Subject|0
698043|NCT01408277|2266621|P1|Overall Study|Withdrawal by Subject|2
698044|NCT01408277|2266620|P2|Overall Study|Lost to Follow-up|0
698045|NCT01408277|2266621|P1|Overall Study|Lost to Follow-up|1
698046|NCT01408277|2266620|P2|Overall Study|Adverse Event|4
698047|NCT01408277|2266621|P1|Overall Study|Adverse Event|3
698048|NCT01407354|2266658|P2|First Intervention|Physician Decision|0
698049|NCT01407354|2266659|P1|First Intervention|Physician Decision|1
698050|NCT01407354|2266658|P2|First Intervention|Adverse Event|0
698051|NCT01407354|2266659|P1|First Intervention|Adverse Event|1
698052|NCT01407354|2266658|P2|First Intervention|Withdrawal by Subject|2
698053|NCT01407354|2266659|P1|First Intervention|Withdrawal by Subject|0
698054|NCT01407276|2266675|P8|Overall Study|Withdrawal by Subject|1
698055|NCT01407276|2266676|P7|Overall Study|Withdrawal by Subject|0
698056|NCT01407276|2266677|P6|Overall Study|Withdrawal by Subject|0
698057|NCT01407276|2266678|P5|Overall Study|Withdrawal by Subject|0
698058|NCT01407276|2266679|P4|Overall Study|Withdrawal by Subject|0
698059|NCT01407276|2266680|P3|Overall Study|Withdrawal by Subject|0
698060|NCT01407276|2266681|P2|Overall Study|Withdrawal by Subject|0
698061|NCT01407276|2266682|P1|Overall Study|Withdrawal by Subject|0
698062|NCT01406938|2266821|P6|Follow up|Lost to Follow-up|1
698063|NCT01406938|2266822|P5|Follow up|Lost to Follow-up|2
698064|NCT01406938|2266823|P4|Follow up|Lost to Follow-up|1
698065|NCT01406938|2266824|P3|Follow up|Lost to Follow-up|0
698066|NCT01406938|2266825|P2|Follow up|Lost to Follow-up|1
698067|NCT01406938|2266826|P1|Follow up|Lost to Follow-up|1
698068|NCT01406938|2266821|P6|Follow up|Physician Decision|1
698069|NCT01406938|2266822|P5|Follow up|Physician Decision|3
698070|NCT01406938|2266823|P4|Follow up|Physician Decision|0
698071|NCT01406938|2266824|P3|Follow up|Physician Decision|2
698072|NCT01406938|2266825|P2|Follow up|Physician Decision|0
698073|NCT01406938|2266826|P1|Follow up|Physician Decision|0
698074|NCT01406938|2266821|P6|Follow up|Protocol Violation|0
698075|NCT01406938|2266822|P5|Follow up|Protocol Violation|0
698076|NCT01406938|2266823|P4|Follow up|Protocol Violation|0
698077|NCT01406938|2266824|P3|Follow up|Protocol Violation|1
698078|NCT01406938|2266825|P2|Follow up|Protocol Violation|0
698079|NCT01406938|2266826|P1|Follow up|Protocol Violation|0
698080|NCT01406938|2266821|P6|Follow up|Patient/guardian decision|1
698081|NCT01406938|2266822|P5|Follow up|Patient/guardian decision|4
698082|NCT01406938|2266823|P4|Follow up|Patient/guardian decision|2
698083|NCT01406938|2266824|P3|Follow up|Patient/guardian decision|4
698084|NCT01406938|2266825|P2|Follow up|Patient/guardian decision|2
698085|NCT01406938|2266826|P1|Follow up|Patient/guardian decision|4
698086|NCT01406938|2266821|P6|Follow up|Lack of Efficacy|0
698087|NCT01406938|2266822|P5|Follow up|Lack of Efficacy|0
698088|NCT01406938|2266823|P4|Follow up|Lack of Efficacy|0
698089|NCT01406938|2266824|P3|Follow up|Lack of Efficacy|1
698090|NCT01406938|2266825|P2|Follow up|Lack of Efficacy|2
698091|NCT01406938|2266826|P1|Follow up|Lack of Efficacy|3
698092|NCT01406938|2266821|P6|Maintenance Period|Lack of Efficacy|5
698093|NCT01406938|2266822|P5|Maintenance Period|Lack of Efficacy|3
698094|NCT01406938|2266823|P4|Maintenance Period|Lack of Efficacy|1
698095|NCT01406938|2266824|P3|Maintenance Period|Lack of Efficacy|2
698096|NCT01406938|2266825|P2|Maintenance Period|Lack of Efficacy|0
698097|NCT01406938|2266826|P1|Maintenance Period|Lack of Efficacy|0
698098|NCT01406938|2266821|P6|Maintenance Period|Lost to Follow-up|0
698099|NCT01406938|2266822|P5|Maintenance Period|Lost to Follow-up|4
698100|NCT01406938|2266823|P4|Maintenance Period|Lost to Follow-up|0
698101|NCT01406938|2266824|P3|Maintenance Period|Lost to Follow-up|0
698102|NCT01406938|2266825|P2|Maintenance Period|Lost to Follow-up|0
698103|NCT01406938|2266826|P1|Maintenance Period|Lost to Follow-up|0
698104|NCT01406938|2266821|P6|Maintenance Period|Pregnancy|0
698105|NCT01406938|2266822|P5|Maintenance Period|Pregnancy|1
698106|NCT01406938|2266823|P4|Maintenance Period|Pregnancy|0
698107|NCT01406938|2266824|P3|Maintenance Period|Pregnancy|0
698108|NCT01406938|2266825|P2|Maintenance Period|Pregnancy|0
698109|NCT01406938|2266826|P1|Maintenance Period|Pregnancy|0
698110|NCT01406938|2266821|P6|Maintenance Period|Protocol Violation|2
698111|NCT01406938|2266822|P5|Maintenance Period|Protocol Violation|2
698112|NCT01406938|2266823|P4|Maintenance Period|Protocol Violation|2
698113|NCT01406938|2266824|P3|Maintenance Period|Protocol Violation|2
698114|NCT01406938|2266825|P2|Maintenance Period|Protocol Violation|0
698115|NCT01406938|2266826|P1|Maintenance Period|Protocol Violation|0
698116|NCT01406938|2266821|P6|Maintenance Period|Subject/guardian decision|7
698117|NCT01406938|2266822|P5|Maintenance Period|Subject/guardian decision|10
698118|NCT01406938|2266823|P4|Maintenance Period|Subject/guardian decision|7
698119|NCT01406938|2266824|P3|Maintenance Period|Subject/guardian decision|11
698120|NCT01406938|2266825|P2|Maintenance Period|Subject/guardian decision|0
698121|NCT01406938|2266826|P1|Maintenance Period|Subject/guardian decision|0
698122|NCT01406938|2266821|P6|Maintenance Period|Death|0
698123|NCT01406938|2266822|P5|Maintenance Period|Death|1
698124|NCT01406938|2266823|P4|Maintenance Period|Death|0
698125|NCT01406938|2266824|P3|Maintenance Period|Death|0
698126|NCT01406938|2266825|P2|Maintenance Period|Death|0
698127|NCT01406938|2266826|P1|Maintenance Period|Death|0
698128|NCT01406938|2266821|P6|Maintenance Period|Adverse Event|2
698129|NCT01406938|2266822|P5|Maintenance Period|Adverse Event|4
698130|NCT01406938|2266823|P4|Maintenance Period|Adverse Event|8
698131|NCT01406938|2266824|P3|Maintenance Period|Adverse Event|2
698132|NCT01406938|2266825|P2|Maintenance Period|Adverse Event|0
698133|NCT01406938|2266826|P1|Maintenance Period|Adverse Event|0
698134|NCT01406938|2266821|P6|Induction Period|Lost to Follow-up|0
698135|NCT01406938|2266822|P5|Induction Period|Lost to Follow-up|0
698136|NCT01406938|2266823|P4|Induction Period|Lost to Follow-up|0
698137|NCT01406938|2266824|P3|Induction Period|Lost to Follow-up|0
698138|NCT01406938|2266825|P2|Induction Period|Lost to Follow-up|3
698139|NCT01406938|2266826|P1|Induction Period|Lost to Follow-up|2
698140|NCT01406938|2266821|P6|Induction Period|Lack of Efficacy|0
698141|NCT01406938|2266822|P5|Induction Period|Lack of Efficacy|0
698142|NCT01406938|2266823|P4|Induction Period|Lack of Efficacy|0
698143|NCT01406938|2266824|P3|Induction Period|Lack of Efficacy|0
698144|NCT01406938|2266825|P2|Induction Period|Lack of Efficacy|0
698145|NCT01406938|2266826|P1|Induction Period|Lack of Efficacy|1
698146|NCT01406938|2266821|P6|Induction Period|Adverse Event|0
698147|NCT01406938|2266822|P5|Induction Period|Adverse Event|0
698148|NCT01406938|2266823|P4|Induction Period|Adverse Event|0
698149|NCT01406938|2266824|P3|Induction Period|Adverse Event|0
698150|NCT01406938|2266825|P2|Induction Period|Adverse Event|9
698151|NCT01406938|2266826|P1|Induction Period|Adverse Event|8
698152|NCT01406938|2266821|P6|Induction Period|Protocol deviation|0
698153|NCT01406938|2266822|P5|Induction Period|Protocol deviation|0
698154|NCT01406938|2266823|P4|Induction Period|Protocol deviation|0
698155|NCT01406938|2266824|P3|Induction Period|Protocol deviation|0
698156|NCT01406938|2266825|P2|Induction Period|Protocol deviation|0
698157|NCT01406938|2266826|P1|Induction Period|Protocol deviation|1
698158|NCT01406938|2266821|P6|Induction Period|Subject/guardian decision|0
698159|NCT01406938|2266822|P5|Induction Period|Subject/guardian decision|0
698160|NCT01406938|2266823|P4|Induction Period|Subject/guardian decision|0
698161|NCT01406938|2266824|P3|Induction Period|Subject/guardian decision|0
698162|NCT01406938|2266825|P2|Induction Period|Subject/guardian decision|8
698163|NCT01406938|2266826|P1|Induction Period|Subject/guardian decision|6
698164|NCT01406795|2266942|P1|Overall Study|Withdrawal by Subject|1
698165|NCT01406574|2266956|P4|Overall Study|Definite progression of primary disease|0
698166|NCT01406574|2266957|P3|Overall Study|Definite progression of primary disease|0
698167|NCT01406574|2266958|P2|Overall Study|Definite progression of primary disease|0
698168|NCT01406574|2266959|P1|Overall Study|Definite progression of primary disease|1
698169|NCT01406574|2266956|P4|Overall Study|Withdrawal by Subject|0
698170|NCT01406574|2266957|P3|Overall Study|Withdrawal by Subject|0
698171|NCT01406574|2266958|P2|Overall Study|Withdrawal by Subject|1
698172|NCT01406574|2266959|P1|Overall Study|Withdrawal by Subject|0
698173|NCT01406574|2266956|P4|Overall Study|Physician Decision|1
698174|NCT01406574|2266957|P3|Overall Study|Physician Decision|0
698175|NCT01406574|2266958|P2|Overall Study|Physician Decision|0
698176|NCT01406574|2266959|P1|Overall Study|Physician Decision|0
698177|NCT01406574|2266956|P4|Overall Study|Adverse Event|3
698178|NCT01406574|2266957|P3|Overall Study|Adverse Event|1
698179|NCT01406574|2266958|P2|Overall Study|Adverse Event|0
698180|NCT01406574|2266959|P1|Overall Study|Adverse Event|0
698181|NCT01406015|2266994|P2|Overall Study|Withdrawal by Subject|3
698182|NCT01406015|2266995|P1|Overall Study|Withdrawal by Subject|3
698183|NCT01405950|2267011|P4|Overall Study|Withdrawal by Subject|0
698184|NCT01405950|2267012|P3|Overall Study|Withdrawal by Subject|0
698185|NCT01405950|2267013|P2|Overall Study|Withdrawal by Subject|0
698186|NCT01405950|2267014|P1|Overall Study|Withdrawal by Subject|1
698187|NCT01405924|2267049|P1|Overall Study|Missing/Incomplete Data|2
698188|NCT01405924|2267049|P1|Overall Study|Protocol Violation|8
698189|NCT01405898|2267061|P2|Overall Study|Withdrawal by Subject|2
698190|NCT01405898|2267062|P1|Overall Study|Withdrawal by Subject|2
698191|NCT01405820|2267086|P6|Open-Label Treatment Period|Adverse Event|0
698192|NCT01405820|2267087|P5|Open-Label Treatment Period|Adverse Event|0
698193|NCT01405820|2267088|P4|Open-Label Treatment Period|Adverse Event|1
698194|NCT01405820|2267089|P3|Open-Label Treatment Period|Adverse Event|0
698195|NCT01405820|2267090|P2|Open-Label Treatment Period|Adverse Event|0
698196|NCT01405820|2267091|P1|Open-Label Treatment Period|Adverse Event|0
698197|NCT01405820|2267086|P6|Open-Label Treatment Period|Physician Decision|0
698198|NCT01405820|2267087|P5|Open-Label Treatment Period|Physician Decision|1
698199|NCT01405820|2267088|P4|Open-Label Treatment Period|Physician Decision|2
698200|NCT01405820|2267089|P3|Open-Label Treatment Period|Physician Decision|1
698201|NCT01405820|2267090|P2|Open-Label Treatment Period|Physician Decision|0
698202|NCT01405820|2267091|P1|Open-Label Treatment Period|Physician Decision|0
698203|NCT01405820|2267086|P6|Open-Label Treatment Period|Not Specified|1
698204|NCT01405820|2267087|P5|Open-Label Treatment Period|Not Specified|1
698205|NCT01405820|2267088|P4|Open-Label Treatment Period|Not Specified|1
698206|NCT01405820|2267089|P3|Open-Label Treatment Period|Not Specified|1
698207|NCT01405820|2267090|P2|Open-Label Treatment Period|Not Specified|1
698208|NCT01405820|2267091|P1|Open-Label Treatment Period|Not Specified|1
698209|NCT01405820|2267086|P6|Open-Label Treatment Period|Withdrawal by Subject|1
698210|NCT01405820|2267087|P5|Open-Label Treatment Period|Withdrawal by Subject|0
698211|NCT01405820|2267088|P4|Open-Label Treatment Period|Withdrawal by Subject|1
698212|NCT01405820|2267089|P3|Open-Label Treatment Period|Withdrawal by Subject|1
698213|NCT01405820|2267090|P2|Open-Label Treatment Period|Withdrawal by Subject|1
698214|NCT01405820|2267091|P1|Open-Label Treatment Period|Withdrawal by Subject|3
698215|NCT01405820|2267086|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
698216|NCT01405820|2267087|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
698217|NCT01405820|2267088|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
698218|NCT01405820|2267089|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
698219|NCT01405820|2267090|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
698220|NCT01405820|2267091|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
698221|NCT01405820|2267086|P6|Randomized Treatment Period|Death|0
698222|NCT01405820|2267087|P5|Randomized Treatment Period|Death|0
698223|NCT01405820|2267088|P4|Randomized Treatment Period|Death|1
698224|NCT01405820|2267089|P3|Randomized Treatment Period|Death|0
698225|NCT01405820|2267090|P2|Randomized Treatment Period|Death|0
698226|NCT01405820|2267091|P1|Randomized Treatment Period|Death|0
698227|NCT01405820|2267086|P6|Randomized Treatment Period|Treatment Arm Closed|28
698228|NCT01405820|2267087|P5|Randomized Treatment Period|Treatment Arm Closed|33
698229|NCT01405820|2267088|P4|Randomized Treatment Period|Treatment Arm Closed|36
698230|NCT01405820|2267089|P3|Randomized Treatment Period|Treatment Arm Closed|20
698231|NCT01405820|2267090|P2|Randomized Treatment Period|Treatment Arm Closed|0
698232|NCT01405820|2267091|P1|Randomized Treatment Period|Treatment Arm Closed|0
698233|NCT01405820|2267086|P6|Randomized Treatment Period|Incorrect Study Treatment|0
698234|NCT01405820|2267087|P5|Randomized Treatment Period|Incorrect Study Treatment|2
698235|NCT01405820|2267088|P4|Randomized Treatment Period|Incorrect Study Treatment|0
698236|NCT01405820|2267089|P3|Randomized Treatment Period|Incorrect Study Treatment|3
698237|NCT01405820|2267090|P2|Randomized Treatment Period|Incorrect Study Treatment|0
698238|NCT01405820|2267091|P1|Randomized Treatment Period|Incorrect Study Treatment|0
698239|NCT01405820|2267086|P6|Randomized Treatment Period|Rescue|8
698240|NCT01405820|2267087|P5|Randomized Treatment Period|Rescue|8
698241|NCT01405820|2267088|P4|Randomized Treatment Period|Rescue|10
698242|NCT01405820|2267089|P3|Randomized Treatment Period|Rescue|13
698243|NCT01405820|2267090|P2|Randomized Treatment Period|Rescue|1
698244|NCT01405820|2267091|P1|Randomized Treatment Period|Rescue|0
698245|NCT01405820|2267086|P6|Randomized Treatment Period|Physician Decision|0
698246|NCT01405820|2267087|P5|Randomized Treatment Period|Physician Decision|0
698247|NCT01405820|2267088|P4|Randomized Treatment Period|Physician Decision|0
698248|NCT01405820|2267089|P3|Randomized Treatment Period|Physician Decision|1
698249|NCT01405820|2267090|P2|Randomized Treatment Period|Physician Decision|2
698250|NCT01405820|2267091|P1|Randomized Treatment Period|Physician Decision|0
698251|NCT01405820|2267086|P6|Randomized Treatment Period|Not Specified|0
698252|NCT01405820|2267087|P5|Randomized Treatment Period|Not Specified|0
698253|NCT01405820|2267088|P4|Randomized Treatment Period|Not Specified|1
698254|NCT01405820|2267089|P3|Randomized Treatment Period|Not Specified|1
698255|NCT01405820|2267090|P2|Randomized Treatment Period|Not Specified|2
698256|NCT01405820|2267091|P1|Randomized Treatment Period|Not Specified|2
698257|NCT01405820|2267086|P6|Randomized Treatment Period|Withdrawal by Subject|0
698258|NCT01405820|2267087|P5|Randomized Treatment Period|Withdrawal by Subject|0
698259|NCT01405820|2267088|P4|Randomized Treatment Period|Withdrawal by Subject|2
698260|NCT01405820|2267089|P3|Randomized Treatment Period|Withdrawal by Subject|2
698261|NCT01405820|2267090|P2|Randomized Treatment Period|Withdrawal by Subject|2
698262|NCT01405820|2267091|P1|Randomized Treatment Period|Withdrawal by Subject|6
698263|NCT01405820|2267086|P6|Randomized Treatment Period|Adverse Event|1
698264|NCT01405820|2267087|P5|Randomized Treatment Period|Adverse Event|2
698265|NCT01405820|2267088|P4|Randomized Treatment Period|Adverse Event|0
698266|NCT01405820|2267089|P3|Randomized Treatment Period|Adverse Event|3
698267|NCT01405820|2267090|P2|Randomized Treatment Period|Adverse Event|3
698268|NCT01405820|2267091|P1|Randomized Treatment Period|Adverse Event|3
698269|NCT01405768|2267187|P2|Overall Study|Didn't complete questionnaire correctly|0
698270|NCT01405768|2267188|P1|Overall Study|Didn't complete questionnaire correctly|4
698271|NCT01405742|2267200|P2|Overall Study|Lost to Follow-up|0
698272|NCT01405742|2267201|P1|Overall Study|Lost to Follow-up|1
698273|NCT01405560|2267211|P1|Overall Study|Physician Decision|1
698274|NCT01405508|2267226|P4|Overall Study|AE, non-serious non-fatal|0
698275|NCT01405508|2267227|P3|Overall Study|AE, non-serious non-fatal|0
698276|NCT01405508|2267228|P2|Overall Study|AE, non-serious non-fatal|1
698277|NCT01405508|2267229|P1|Overall Study|AE, non-serious non-fatal|1
698278|NCT01405027|2267269|P2|Overall Study|Other or Unknown|25
698279|NCT01405027|2267270|P1|Overall Study|Other or Unknown|12
698280|NCT01405027|2267269|P2|Overall Study|Death|0
698281|NCT01405027|2267270|P1|Overall Study|Death|1
698282|NCT01405027|2267269|P2|Overall Study|Investigator judgement|2
698283|NCT01405027|2267270|P1|Overall Study|Investigator judgement|0
698284|NCT01405027|2267269|P2|Overall Study|Lost to Follow-up|24
698285|NCT01405027|2267270|P1|Overall Study|Lost to Follow-up|16
698286|NCT01405027|2267269|P2|Overall Study|Withdrawn consent|0
698287|NCT01405027|2267270|P1|Overall Study|Withdrawn consent|3
698288|NCT01404988|2267287|P3|Overall Study|Lost to Follow-up|1
698289|NCT01404988|2267288|P2|Overall Study|Lost to Follow-up|2
698290|NCT01404988|2267289|P1|Overall Study|Lost to Follow-up|1
698291|NCT01404988|2267287|P3|Overall Study|Withdrawal by Subject|0
698292|NCT01404988|2267288|P2|Overall Study|Withdrawal by Subject|2
698293|NCT01404988|2267289|P1|Overall Study|Withdrawal by Subject|2
698294|NCT01404988|2267287|P3|Overall Study|Adverse Event|0
698295|NCT01404988|2267288|P2|Overall Study|Adverse Event|0
698296|NCT01404988|2267289|P1|Overall Study|Adverse Event|1
698297|NCT01404988|2267287|P3|Overall Study|Death|2
698298|NCT01404988|2267288|P2|Overall Study|Death|0
698299|NCT01404988|2267289|P1|Overall Study|Death|2
698300|NCT01404234|2267417|P1|Overall Study|Withdrawal by Subject|2
698301|NCT01404208|2267433|P2|Overall Study|Discontinued|0
698302|NCT01404208|2267434|P1|Overall Study|Discontinued|3
698303|NCT01403987|2267499|P3|Overall Study|Residents forgot their secret PIN|18
698304|NCT01403987|2267500|P2|Overall Study|Residents forgot their secret PIN|17
698305|NCT01403987|2267501|P1|Overall Study|Residents forgot their secret PIN|18
698306|NCT01403805|2267517|P2|Overall Study|Death|1
698307|NCT01403805|2267518|P1|Overall Study|Death|0
698308|NCT01403805|2267517|P2|Overall Study|Lost to Follow-up|2
698309|NCT01403805|2267518|P1|Overall Study|Lost to Follow-up|0
698310|NCT01403805|2267517|P2|Overall Study|Withdrawal by Subject|4
698311|NCT01403805|2267518|P1|Overall Study|Withdrawal by Subject|0
698312|NCT01403194|2267562|P1|Overall Study|Lost to Follow-up|8
698313|NCT01403194|2267562|P1|Overall Study|Screen Failure|2
698314|NCT01403051|2267574|P2|Overall Study|Lost to Follow-up|5
698315|NCT01403051|2267575|P1|Overall Study|Lost to Follow-up|5
698316|NCT01403051|2267574|P2|Overall Study|Withdrawal by Subject|1
698317|NCT01403051|2267575|P1|Overall Study|Withdrawal by Subject|2
698318|NCT01403051|2267574|P2|Overall Study|Death|0
698319|NCT01403051|2267575|P1|Overall Study|Death|1
698320|NCT01403051|2267574|P2|Overall Study|Protocol Violation|0
698321|NCT01403051|2267575|P1|Overall Study|Protocol Violation|2
698322|NCT01402986|2267611|P4|Overall Study|Unspecified|6
698323|NCT01402986|2267612|P3|Overall Study|Unspecified|1
698324|NCT01402986|2267613|P2|Overall Study|Unspecified|5
698325|NCT01402986|2267614|P1|Overall Study|Unspecified|2
698326|NCT01402986|2267611|P4|Overall Study|Lost to Follow-up|1
698327|NCT01402986|2267612|P3|Overall Study|Lost to Follow-up|0
698328|NCT01402986|2267613|P2|Overall Study|Lost to Follow-up|0
698329|NCT01402986|2267614|P1|Overall Study|Lost to Follow-up|0
698330|NCT01402986|2267611|P4|Overall Study|Death|2
698331|NCT01402986|2267612|P3|Overall Study|Death|0
698332|NCT01402986|2267613|P2|Overall Study|Death|0
698333|NCT01402986|2267614|P1|Overall Study|Death|0
698334|NCT01402986|2267611|P4|Overall Study|Withdrawal by Subject|13
698335|NCT01402986|2267612|P3|Overall Study|Withdrawal by Subject|7
698336|NCT01402986|2267613|P2|Overall Study|Withdrawal by Subject|10
698337|NCT01402986|2267614|P1|Overall Study|Withdrawal by Subject|7
698338|NCT01402947|2267749|P2|First Intervention|Adverse Event|1
698339|NCT01402947|2267750|P1|First Intervention|Adverse Event|0
698340|NCT01402869|2267761|P3|Overall Study|Required Tooth Extraction|1
698341|NCT01402869|2267762|P2|Overall Study|Required Tooth Extraction|0
698342|NCT01402869|2267763|P1|Overall Study|Required Tooth Extraction|0
698343|NCT01402817|2267777|P1|Overall Study|Study Suspended by FDA|8
698344|NCT01402817|2267777|P1|Overall Study|Withdrawal by Subject|3
698345|NCT01402700|2267782|P1|Overall Study|Missed Visit|1
698346|NCT01402700|2267782|P1|Overall Study|Withdrawal by Subject|3
698347|NCT01402700|2267782|P1|Overall Study|Death|3
698348|NCT01402570|2267786|P1|Overall Study|Adverse Event|1
698349|NCT01402284|2267814|P1|Overall Study|Non compliance|2
698350|NCT01402284|2267814|P1|Overall Study|Disease progression on study|9
698351|NCT01402284|2267814|P1|Overall Study|Physician Decision|1
698352|NCT01402284|2267814|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
698353|NCT01402284|2267814|P1|Overall Study|Withdrawal consent|1
698354|NCT01402102|2267896|P2|Overall Study|Withdrawal by Subject|2
698355|NCT01402102|2267897|P1|Overall Study|Withdrawal by Subject|0
698356|NCT01402102|2267896|P2|Overall Study|Insufficiency of compliance|1
698357|NCT01402102|2267897|P1|Overall Study|Insufficiency of compliance|1
698358|NCT01402102|2267896|P2|Overall Study|Protocol Violation|0
698359|NCT01402102|2267897|P1|Overall Study|Protocol Violation|1
698360|NCT01402063|2267917|P2|Overall Study|Withdrawal by Subject|3
698361|NCT01402063|2267918|P1|Overall Study|Withdrawal by Subject|3
698362|NCT01401842|2267947|P2|Overall Study|other/unknown|17
698363|NCT01401842|2267948|P1|Overall Study|other/unknown|28
698364|NCT01401842|2267947|P2|Overall Study|on profile|5
698365|NCT01401842|2267948|P1|Overall Study|on profile|9
698366|NCT01401842|2267947|P2|Overall Study|invalid follow-up strength data|4
698367|NCT01401842|2267948|P1|Overall Study|invalid follow-up strength data|1
698368|NCT01401842|2267947|P2|Overall Study|discharged from US Army|4
698369|NCT01401842|2267948|P1|Overall Study|discharged from US Army|3
698370|NCT01401842|2267947|P2|Overall Study|changed companies|34
698371|NCT01401842|2267948|P1|Overall Study|changed companies|20
698372|NCT01401842|2267947|P2|Overall Study|academic reason|1
698373|NCT01401842|2267948|P1|Overall Study|academic reason|4
698374|NCT01401842|2267947|P2|Overall Study|Withdrawal by Subject|2
698375|NCT01401842|2267948|P1|Overall Study|Withdrawal by Subject|3
698376|NCT01401647|2267961|P3|Overall Study|Lost to Follow-up|1
698377|NCT01401647|2267962|P2|Overall Study|Lost to Follow-up|3
698378|NCT01401647|2267963|P1|Overall Study|Lost to Follow-up|3
698379|NCT01401647|2267961|P3|Overall Study|Withdrawal by Subject|2
698380|NCT01401647|2267962|P2|Overall Study|Withdrawal by Subject|5
698381|NCT01401647|2267963|P1|Overall Study|Withdrawal by Subject|1
698382|NCT01401478|2268018|P1|Overall Study|Serious adverse event|1
698383|NCT01401478|2268018|P1|Overall Study|Low intact parathyroid hormone|1
698384|NCT01401478|2268018|P1|Overall Study|Hyperphosphatemia and adverse event|1
698385|NCT01401478|2268018|P1|Overall Study|Blood samples not available|1
698386|NCT01401478|2268018|P1|Overall Study|Withdrawal by Subject|3
698387|NCT01401478|2268018|P1|Overall Study|Kidney transplantation|3
698388|NCT01401478|2268018|P1|Overall Study|Lost to Follow-up|5
698389|NCT01401478|2268018|P1|Overall Study|Hyperphosphatemia|5
698390|NCT01401478|2268018|P1|Overall Study|Adverse Event|5
698391|NCT01401478|2268018|P1|Overall Study|Study drug not available|6
698392|NCT01401465|2268031|P2|Treatment Period 2|Withdrawal by Subject|1
698393|NCT01401465|2268032|P1|Treatment Period 2|Withdrawal by Subject|0
698394|NCT01401465|2268031|P2|Treatment Period 2|Lost to Follow-up|1
698395|NCT01401465|2268032|P1|Treatment Period 2|Lost to Follow-up|0
698396|NCT01401465|2268031|P2|Treatment Period 1|Scheduling Difficulties|1
698397|NCT01401465|2268032|P1|Treatment Period 1|Scheduling Difficulties|1
698398|NCT01401465|2268031|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
698399|NCT01401465|2268032|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
698400|NCT01401465|2268031|P2|Treatment Period 1|Non-Compliance to Study Drug|0
698401|NCT01401465|2268032|P1|Treatment Period 1|Non-Compliance to Study Drug|1
698402|NCT01401465|2268031|P2|Treatment Period 1|Withdrawal by Subject|4
698403|NCT01401465|2268032|P1|Treatment Period 1|Withdrawal by Subject|1
698404|NCT01401465|2268031|P2|Treatment Period 1|Protocol Violation|0
698405|NCT01401465|2268032|P1|Treatment Period 1|Protocol Violation|5
698406|NCT01401465|2268031|P2|Treatment Period 1|Pregnancy|1
698407|NCT01401465|2268032|P1|Treatment Period 1|Pregnancy|0
698408|NCT01401465|2268031|P2|Treatment Period 1|Adverse Event|1
698409|NCT01401465|2268032|P1|Treatment Period 1|Adverse Event|4
698410|NCT01401452|2268095|P1|Overall Study|Participant withdrew consent|1
698411|NCT01401452|2268095|P1|Overall Study|Subject chose to discontinue treatment|1
698412|NCT01401452|2268095|P1|Overall Study|Subject withdrew because of Tx success|1
698413|NCT01401452|2268095|P1|Overall Study|Unsatisfactory output|1
698414|NCT01401452|2268095|P1|Overall Study|Treatment failure|1
698415|NCT01401452|2268095|P1|Overall Study|Discontinuation for personal reasons|1
698416|NCT01401452|2268095|P1|Overall Study|Participant stopped Tx|2
698417|NCT01401452|2268095|P1|Overall Study|Psoriatic arthritis|1
698418|NCT01401452|2268095|P1|Overall Study|Subject's wife wants to get pregnant|1
698419|NCT01401452|2268095|P1|Overall Study|Subject moved to another city|1
698420|NCT01401452|2268095|P1|Overall Study|Subject didn't return for routine visits|1
698421|NCT01401452|2268095|P1|Overall Study|Subject did not come to follow up visits|2
698422|NCT01401452|2268095|P1|Overall Study|No more visits within the 36 wk followup|4
698423|NCT01401452|2268095|P1|Overall Study|Tx stopped by psychiatrist|1
698424|NCT01401452|2268095|P1|Overall Study|Tx stopped due to financial reasons|1
698425|NCT01401452|2268095|P1|Overall Study|Participant developed breast cancer|1
698426|NCT01401452|2268095|P1|Overall Study|Lack of Efficacy|30
698427|NCT01401452|2268095|P1|Overall Study|Lost to Follow-up|12
698428|NCT01401452|2268095|P1|Overall Study|Adverse reaction|9
698429|NCT01401361|2268107|P1|Overall Study|Subject/family decision post procedure|2
698430|NCT01401361|2268107|P1|Overall Study|Lost to Follow-up|3
698431|NCT01401361|2268107|P1|Overall Study|Physician Decision|1
698432|NCT01401361|2268107|P1|Overall Study|Lack of Efficacy|6
698433|NCT01401361|2268107|P1|Overall Study|Withdrawal by Subject|16
698434|NCT01401322|2268113|P1|Overall Study|Physician Decision|1
698435|NCT01401322|2268113|P1|Overall Study|Withdrawal by Subject|1
698436|NCT01401283|2268119|P2|Overall Study|suspicion of malignant hyperthermia|1
698437|NCT01401283|2268120|P1|Overall Study|suspicion of malignant hyperthermia|0
698438|NCT01401283|2268119|P2|Overall Study|no central venous access|1
698439|NCT01401283|2268120|P1|Overall Study|no central venous access|0
698440|NCT01401283|2268119|P2|Overall Study|preoperative arrhythmia|0
698441|NCT01401283|2268120|P1|Overall Study|preoperative arrhythmia|5
698442|NCT01401283|2268119|P2|Overall Study|surgery cancelled|8
698443|NCT01401283|2268120|P1|Overall Study|surgery cancelled|5
698444|NCT01401153|2268186|P2|Second Test Day|illness|5
698445|NCT01401153|2268187|P1|Second Test Day|illness|0
698446|NCT01401153|2268186|P2|First Test Day|Learning disabilities; illness|10
698447|NCT01401153|2268187|P1|First Test Day|Learning disabilities; illness|1
698448|NCT01401062|2268234|P2|Overall Study|Withdrawal by Subject|1
698449|NCT01401062|2268235|P1|Overall Study|Withdrawal by Subject|1
698450|NCT01401062|2268234|P2|Overall Study|Physician Decision|0
698451|NCT01401062|2268235|P1|Overall Study|Physician Decision|1
698452|NCT01401062|2268234|P2|Overall Study|Death|7
698453|NCT01401062|2268235|P1|Overall Study|Death|9
698454|NCT01401010|2268258|P2|Overall Study|Could not interpret assay results|0
698455|NCT01401010|2268259|P1|Overall Study|Could not interpret assay results|1
698456|NCT01400958|2268284|P2|Overall Study|Adverse Event|0
698457|NCT01400958|2268285|P1|Overall Study|Adverse Event|1
698458|NCT01400958|2268284|P2|Overall Study|Withdrawal by Subject|1
698459|NCT01400958|2268285|P1|Overall Study|Withdrawal by Subject|0
698460|NCT01400958|2268284|P2|Overall Study|Physician Decision|1
698461|NCT01400958|2268285|P1|Overall Study|Physician Decision|0
698462|NCT01400932|2268295|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
698463|NCT01400932|2268296|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
698464|NCT01400932|2268295|P2|Overall Study|Protocol Deviation|1
698465|NCT01400932|2268296|P1|Overall Study|Protocol Deviation|0
698466|NCT01400932|2268295|P2|Overall Study|Lost to Follow-up|0
698467|NCT01400932|2268296|P1|Overall Study|Lost to Follow-up|1
698468|NCT01400932|2268295|P2|Overall Study|Withdrawal by Subject|6
698469|NCT01400932|2268296|P1|Overall Study|Withdrawal by Subject|2
698470|NCT01400932|2268295|P2|Overall Study|Lack of Efficacy|3
698471|NCT01400932|2268296|P1|Overall Study|Lack of Efficacy|0
698472|NCT01400932|2268295|P2|Overall Study|Adverse Event|5
698473|NCT01400932|2268296|P1|Overall Study|Adverse Event|10
698474|NCT01400919|2268318|P1|Overall Study|Missed visit|2
698475|NCT01400919|2268318|P1|Overall Study|Lost to Follow-up|2
698476|NCT01400919|2268318|P1|Overall Study|Withdrawal by Subject|4
698477|NCT01400893|2268361|P2|Overall Study|Lost to Follow-up|6
698478|NCT01400893|2268362|P1|Overall Study|Lost to Follow-up|0
698479|NCT01400893|2268361|P2|Overall Study|Death|21
698480|NCT01400893|2268362|P1|Overall Study|Death|27
698481|NCT01400841|2268374|P1|Extended Study Phase (2 Years)|Adverse Event|2
698482|NCT01400841|2268374|P1|Initial Study Phase (6 Months)|Death|1
698483|NCT01400698|2268412|P6|Overall Study|Unspecified|0
698484|NCT01400698|2268413|P5|Overall Study|Unspecified|1
698485|NCT01400698|2268414|P4|Overall Study|Unspecified|2
698486|NCT01400698|2268415|P3|Overall Study|Unspecified|0
698487|NCT01400698|2268416|P2|Overall Study|Unspecified|2
698488|NCT01400698|2268417|P1|Overall Study|Unspecified|4
698489|NCT01400698|2268412|P6|Overall Study|Adverse Event|0
698490|NCT01400698|2268413|P5|Overall Study|Adverse Event|0
698491|NCT01400698|2268414|P4|Overall Study|Adverse Event|0
698492|NCT01400698|2268415|P3|Overall Study|Adverse Event|0
698493|NCT01400698|2268416|P2|Overall Study|Adverse Event|0
698494|NCT01400698|2268417|P1|Overall Study|Adverse Event|1
698495|NCT01400698|2268412|P6|Overall Study|Non-compliance|0
698496|NCT01400698|2268413|P5|Overall Study|Non-compliance|0
698497|NCT01400698|2268414|P4|Overall Study|Non-compliance|1
698498|NCT01400698|2268415|P3|Overall Study|Non-compliance|0
698499|NCT01400698|2268416|P2|Overall Study|Non-compliance|1
698500|NCT01400698|2268417|P1|Overall Study|Non-compliance|0
698501|NCT01400698|2268412|P6|Overall Study|Protocol Violation|0
698502|NCT01400698|2268413|P5|Overall Study|Protocol Violation|1
698503|NCT01400698|2268414|P4|Overall Study|Protocol Violation|0
698504|NCT01400698|2268415|P3|Overall Study|Protocol Violation|0
698505|NCT01400698|2268416|P2|Overall Study|Protocol Violation|1
698506|NCT01400698|2268417|P1|Overall Study|Protocol Violation|0
698507|NCT01400698|2268412|P6|Overall Study|Withdrawal by Subject|3
698508|NCT01400698|2268413|P5|Overall Study|Withdrawal by Subject|1
698509|NCT01400698|2268414|P4|Overall Study|Withdrawal by Subject|4
698510|NCT01400698|2268415|P3|Overall Study|Withdrawal by Subject|0
698511|NCT01400698|2268416|P2|Overall Study|Withdrawal by Subject|2
698512|NCT01400698|2268417|P1|Overall Study|Withdrawal by Subject|8
698513|NCT01400698|2268412|P6|Overall Study|Lost to Follow-up|3
698514|NCT01400698|2268413|P5|Overall Study|Lost to Follow-up|4
698515|NCT01400698|2268414|P4|Overall Study|Lost to Follow-up|1
698516|NCT01400698|2268415|P3|Overall Study|Lost to Follow-up|2
698517|NCT01400698|2268416|P2|Overall Study|Lost to Follow-up|5
698518|NCT01400698|2268417|P1|Overall Study|Lost to Follow-up|2
698519|NCT01400516|2268441|P2|Primary Trial|Withdrawal by Subject|2
698520|NCT01400516|2268442|P1|Primary Trial|Withdrawal by Subject|0
698521|NCT01400451|2268455|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
698522|NCT01400451|2268456|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
698523|NCT01400451|2268457|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
698524|NCT01400451|2268455|P3|Combination Treatment (or Intended)|Disease Progression|1
698525|NCT01400451|2268456|P2|Combination Treatment (or Intended)|Disease Progression|1
698526|NCT01400451|2268457|P1|Combination Treatment (or Intended)|Disease Progression|3
698527|NCT01400451|2268455|P3|Combination Treatment (or Intended)|Adverse Event|0
698528|NCT01400451|2268456|P2|Combination Treatment (or Intended)|Adverse Event|0
698529|NCT01400451|2268457|P1|Combination Treatment (or Intended)|Adverse Event|1
698530|NCT01400451|2268455|P3|Combination Treatment (or Intended)|Drug Toxicity|0
698531|NCT01400451|2268456|P2|Combination Treatment (or Intended)|Drug Toxicity|1
698532|NCT01400451|2268457|P1|Combination Treatment (or Intended)|Drug Toxicity|0
698533|NCT01400451|2268455|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
698534|NCT01400451|2268456|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
698535|NCT01400451|2268457|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
698536|NCT01400425|2268471|P1|Overall Study|Withdrawal by Subject|10
698537|NCT01400412|2268484|P2|Overall Study|Never started study treatment|3
698538|NCT01400412|2268485|P1|Overall Study|Never started study treatment|0
698539|NCT01400412|2268484|P2|Overall Study|Unable to complete|3
698540|NCT01400412|2268485|P1|Overall Study|Unable to complete|3
698541|NCT01400412|2268484|P2|Overall Study|Withdrawal by Subject|4
698542|NCT01400412|2268485|P1|Overall Study|Withdrawal by Subject|3
698543|NCT01400412|2268484|P2|Overall Study|Lost to Follow-up|7
698544|NCT01400412|2268485|P1|Overall Study|Lost to Follow-up|4
698545|NCT01400243|2268531|P2|Overall Study|Protocol Violation|11
698546|NCT01400243|2268532|P1|Overall Study|Protocol Violation|8
889457|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
889458|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
889459|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
889460|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
889461|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
889462|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
889463|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
889464|NCT01323634|2824004|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
889465|NCT01323634|2824005|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
698557|NCT01400113|2268564|P2|Overall Study|Withdrawal by Subject|1
698558|NCT01400113|2268565|P1|Overall Study|Withdrawal by Subject|1
698559|NCT01399788|2268580|P2|First Intervention Period|Adverse Event|0
698560|NCT01399788|2268581|P1|First Intervention Period|Adverse Event|1
698561|NCT01399723|2268603|P2|Overall Study|Lost to Follow-up|1
698562|NCT01399723|2268604|P1|Overall Study|Lost to Follow-up|0
698563|NCT01399697|2268617|P3|Overall Study|Sponsor Decision|0
698564|NCT01399697|2268618|P2|Overall Study|Sponsor Decision|0
698565|NCT01399697|2268619|P1|Overall Study|Sponsor Decision|1
698566|NCT01399697|2268617|P3|Overall Study|Clinical RA remission|0
698567|NCT01399697|2268618|P2|Overall Study|Clinical RA remission|0
698568|NCT01399697|2268619|P1|Overall Study|Clinical RA remission|1
698569|NCT01399697|2268617|P3|Overall Study|Positive result for hepatitis B|0
698570|NCT01399697|2268618|P2|Overall Study|Positive result for hepatitis B|0
698571|NCT01399697|2268619|P1|Overall Study|Positive result for hepatitis B|1
698572|NCT01399697|2268617|P3|Overall Study|Inclusion Error|0
698573|NCT01399697|2268618|P2|Overall Study|Inclusion Error|0
698574|NCT01399697|2268619|P1|Overall Study|Inclusion Error|2
698575|NCT01399697|2268617|P3|Overall Study|Non-Compliant|0
698576|NCT01399697|2268618|P2|Overall Study|Non-Compliant|0
698577|NCT01399697|2268619|P1|Overall Study|Non-Compliant|1
698578|NCT01399697|2268617|P3|Overall Study|Protocol Violation|0
698579|NCT01399697|2268618|P2|Overall Study|Protocol Violation|0
698580|NCT01399697|2268619|P1|Overall Study|Protocol Violation|2
698581|NCT01399697|2268617|P3|Overall Study|Lack of Efficacy|1
698582|NCT01399697|2268618|P2|Overall Study|Lack of Efficacy|0
698583|NCT01399697|2268619|P1|Overall Study|Lack of Efficacy|9
698584|NCT01399697|2268617|P3|Overall Study|Investigator Decisión|2
698585|NCT01399697|2268618|P2|Overall Study|Investigator Decisión|0
698586|NCT01399697|2268619|P1|Overall Study|Investigator Decisión|1
698587|NCT01399697|2268617|P3|Overall Study|Withdrawal by Subject|0
698588|NCT01399697|2268618|P2|Overall Study|Withdrawal by Subject|0
698589|NCT01399697|2268619|P1|Overall Study|Withdrawal by Subject|8
698590|NCT01399697|2268617|P3|Overall Study|Lost to Follow-up|0
698591|NCT01399697|2268618|P2|Overall Study|Lost to Follow-up|0
698592|NCT01399697|2268619|P1|Overall Study|Lost to Follow-up|2
698593|NCT01399697|2268617|P3|Overall Study|Adverse Event|1
698594|NCT01399697|2268618|P2|Overall Study|Adverse Event|3
698595|NCT01399697|2268619|P1|Overall Study|Adverse Event|13
698596|NCT01399619|2268646|P4|Overall Study|Not treated|2
698597|NCT01399619|2268647|P3|Overall Study|Not treated|0
698598|NCT01399619|2268648|P2|Overall Study|Not treated|0
698599|NCT01399619|2268649|P1|Overall Study|Not treated|0
698600|NCT01399619|2268646|P4|Overall Study|Protocol Violation|1
698601|NCT01399619|2268647|P3|Overall Study|Protocol Violation|0
698602|NCT01399619|2268648|P2|Overall Study|Protocol Violation|0
698603|NCT01399619|2268649|P1|Overall Study|Protocol Violation|0
698604|NCT01399619|2268646|P4|Overall Study|Withdrawal by Subject|4
698605|NCT01399619|2268647|P3|Overall Study|Withdrawal by Subject|3
698606|NCT01399619|2268648|P2|Overall Study|Withdrawal by Subject|0
698607|NCT01399619|2268649|P1|Overall Study|Withdrawal by Subject|6
698608|NCT01399619|2268646|P4|Overall Study|Lack of Efficacy|0
698609|NCT01399619|2268647|P3|Overall Study|Lack of Efficacy|5
698610|NCT01399619|2268648|P2|Overall Study|Lack of Efficacy|0
698611|NCT01399619|2268649|P1|Overall Study|Lack of Efficacy|9
698612|NCT01399619|2268646|P4|Overall Study|Adverse Event|10
698613|NCT01399619|2268647|P3|Overall Study|Adverse Event|4
698614|NCT01399619|2268648|P2|Overall Study|Adverse Event|0
698615|NCT01399619|2268649|P1|Overall Study|Adverse Event|10
698616|NCT01399593|2268712|P2|Overall Study|Transplantectomy|1
698617|NCT01399593|2268713|P1|Overall Study|Transplantectomy|0
698618|NCT01399593|2268712|P2|Overall Study|Death|1
698619|NCT01399593|2268713|P1|Overall Study|Death|1
698620|NCT01399593|2268712|P2|Overall Study|Adverse Event|0
698621|NCT01399593|2268713|P1|Overall Study|Adverse Event|1
698622|NCT01399593|2268712|P2|Overall Study|Physician Decision|0
698623|NCT01399593|2268713|P1|Overall Study|Physician Decision|1
698624|NCT01399190|2268746|P1|Overall Study|Physician Decision|2
698625|NCT01399190|2268746|P1|Overall Study|Participant's Request|5
698626|NCT01399190|2268746|P1|Overall Study|Adverse Event|8
698627|NCT01399190|2268746|P1|Overall Study|Not Eligible for Final Analysis|5
698628|NCT01399125|2268754|P2|Overall Study|Protocol Deviation|2
698629|NCT01399125|2268755|P1|Overall Study|Protocol Deviation|5
698630|NCT01399125|2268754|P2|Overall Study|Death|1
698631|NCT01399125|2268755|P1|Overall Study|Death|0
698632|NCT01399125|2268754|P2|Overall Study|Administrative Problems|11
698633|NCT01399125|2268755|P1|Overall Study|Administrative Problems|7
698634|NCT01399125|2268754|P2|Overall Study|Lost to Follow-up|3
698635|NCT01399125|2268755|P1|Overall Study|Lost to Follow-up|2
698636|NCT01399125|2268754|P2|Overall Study|Withdrawal by Subject|8
698637|NCT01399125|2268755|P1|Overall Study|Withdrawal by Subject|5
698638|NCT01399125|2268754|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
698639|NCT01399125|2268755|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
698640|NCT01399125|2268754|P2|Overall Study|Abnormal Lab values|1
698641|NCT01399125|2268755|P1|Overall Study|Abnormal Lab values|0
698642|NCT01399125|2268754|P2|Overall Study|Adverse Event|30
698643|NCT01399125|2268755|P1|Overall Study|Adverse Event|32
698644|NCT01399099|2268769|P1|Overall Study|Miscellaneous|4
698645|NCT01399099|2268769|P1|Overall Study|Infection|1
698646|NCT01399099|2268769|P1|Overall Study|Skin Irritation|13
698647|NCT01399099|2268769|P1|Overall Study|Protocol Violation|1
698648|NCT01399099|2268769|P1|Overall Study|Physician Decision|1
698649|NCT01399099|2268769|P1|Overall Study|Lost to Follow-up|11
698650|NCT01399047|2268776|P2|Overall Study|Withdrawal by Subject|1
698651|NCT01399047|2268777|P1|Overall Study|Withdrawal by Subject|0
698652|NCT01398956|2268805|P1|Overall Study|Subject moved a long distance|1
698653|NCT01398956|2268805|P1|Overall Study|Withdrawal Criteria No.3|1
698654|NCT01398956|2268805|P1|Overall Study|AE, non-serious non-fatal|4
698655|NCT01398956|2268805|P1|Overall Study|Withdrawal by Subject|4
698656|NCT01398787|2268837|P1|Overall Study|Adverse Event|1
698657|NCT01398514|2268855|P2|Overall Study|Failure to show a conditioned response|3
698658|NCT01398514|2268856|P1|Overall Study|Failure to show a conditioned response|4
698659|NCT01398514|2268855|P2|Overall Study|Physiologic non-responsiveness|3
698660|NCT01398514|2268856|P1|Overall Study|Physiologic non-responsiveness|1
698661|NCT01398514|2268855|P2|Overall Study|Non-compliance with study procedures|0
698662|NCT01398514|2268856|P1|Overall Study|Non-compliance with study procedures|2
698663|NCT01398514|2268855|P2|Overall Study|Adverse Event|0
698664|NCT01398514|2268856|P1|Overall Study|Adverse Event|1
698665|NCT01398410|2268891|P2|Overall Study|Not Specified|29
698666|NCT01398410|2268892|P1|Overall Study|Not Specified|36
698667|NCT01398410|2268891|P2|Overall Study|Inadequate Therapeutic Effect|0
698668|NCT01398410|2268892|P1|Overall Study|Inadequate Therapeutic Effect|2
698669|NCT01398410|2268891|P2|Overall Study|Participants Choice|11
698670|NCT01398410|2268892|P1|Overall Study|Participants Choice|8
698671|NCT01398410|2268891|P2|Overall Study|Adverse Event|16
698672|NCT01398410|2268892|P1|Overall Study|Adverse Event|12
698673|NCT01398176|2268902|P2|Overall Study|Physician Decision|3
698674|NCT01398176|2268903|P1|Overall Study|Physician Decision|2
698675|NCT01398176|2268902|P2|Overall Study|Lost to Follow-up|3
698676|NCT01398176|2268903|P1|Overall Study|Lost to Follow-up|1
698677|NCT01397890|2268911|P2|Overall Study|Others|1
698678|NCT01397890|2268912|P1|Overall Study|Others|2
698679|NCT01397890|2268911|P2|Overall Study|Severe Non-Compliance to Protocol|1
698680|NCT01397890|2268912|P1|Overall Study|Severe Non-Compliance to Protocol|2
698681|NCT01397890|2268911|P2|Overall Study|Adverse Event|2
698682|NCT01397890|2268912|P1|Overall Study|Adverse Event|1
698683|NCT01397890|2268911|P2|Overall Study|Condition under Investigation Worsened|3
698684|NCT01397890|2268912|P1|Overall Study|Condition under Investigation Worsened|1
698685|NCT01397890|2268911|P2|Overall Study|Lost to Follow-up|4
698686|NCT01397890|2268912|P1|Overall Study|Lost to Follow-up|1
698687|NCT01397890|2268911|P2|Overall Study|Death|3
698688|NCT01397890|2268912|P1|Overall Study|Death|2
698689|NCT01397890|2268911|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
698690|NCT01397890|2268912|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
698691|NCT01397890|2268911|P2|Overall Study|Withdrawal by Subject|11
698692|NCT01397890|2268912|P1|Overall Study|Withdrawal by Subject|7
698693|NCT01397786|2268982|P3|Phase B|Lack of Efficacy|14
698694|NCT01397786|2268983|P2|Phase B|Lack of Efficacy|7
698695|NCT01397786|2268984|P1|Phase B|Lack of Efficacy|22
698696|NCT01397786|2268982|P3|Phase B|Protocol Deviation|4
698697|NCT01397786|2268983|P2|Phase B|Protocol Deviation|2
698698|NCT01397786|2268984|P1|Phase B|Protocol Deviation|1
698699|NCT01397786|2268982|P3|Phase B|Withdrawal by Subject|30
698700|NCT01397786|2268983|P2|Phase B|Withdrawal by Subject|45
698701|NCT01397786|2268984|P1|Phase B|Withdrawal by Subject|102
698702|NCT01397786|2268982|P3|Phase B|Physician Decision|3
698703|NCT01397786|2268983|P2|Phase B|Physician Decision|1
698704|NCT01397786|2268984|P1|Phase B|Physician Decision|9
698705|NCT01397786|2268982|P3|Phase B|Subject Met Withdrawal Criteria|38
698706|NCT01397786|2268983|P2|Phase B|Subject Met Withdrawal Criteria|5
698707|NCT01397786|2268984|P1|Phase B|Subject Met Withdrawal Criteria|38
698708|NCT01397786|2268982|P3|Phase B|Adverse Event|27
698709|NCT01397786|2268983|P2|Phase B|Adverse Event|23
698710|NCT01397786|2268984|P1|Phase B|Adverse Event|109
698711|NCT01397786|2268982|P3|Phase B|Lost to Follow-up|22
698712|NCT01397786|2268983|P2|Phase B|Lost to Follow-up|12
698713|NCT01397786|2268984|P1|Phase B|Lost to Follow-up|22
698714|NCT01397786|2268982|P3|Phase A|Lack of Efficacy|1
698715|NCT01397786|2268983|P2|Phase A|Lack of Efficacy|0
698716|NCT01397786|2268984|P1|Phase A|Lack of Efficacy|0
698717|NCT01397786|2268982|P3|Phase A|Withdrawal by Subject|5
698718|NCT01397786|2268983|P2|Phase A|Withdrawal by Subject|0
698719|NCT01397786|2268984|P1|Phase A|Withdrawal by Subject|0
698720|NCT01397786|2268982|P3|Phase A|Physician Decision|1
698721|NCT01397786|2268983|P2|Phase A|Physician Decision|0
698722|NCT01397786|2268984|P1|Phase A|Physician Decision|0
698723|NCT01397786|2268982|P3|Phase A|Subject Met Withdrawal Criteria|7
698724|NCT01397786|2268983|P2|Phase A|Subject Met Withdrawal Criteria|0
698725|NCT01397786|2268984|P1|Phase A|Subject Met Withdrawal Criteria|0
698726|NCT01397786|2268982|P3|Phase A|Adverse Event|8
698727|NCT01397786|2268983|P2|Phase A|Adverse Event|0
698728|NCT01397786|2268984|P1|Phase A|Adverse Event|0
698729|NCT01397786|2268982|P3|Phase A|Lost to Follow-up|6
698730|NCT01397786|2268983|P2|Phase A|Lost to Follow-up|0
698731|NCT01397786|2268984|P1|Phase A|Lost to Follow-up|0
698732|NCT01397747|2269050|P1|Overall Study|FIT excluded|34
698733|NCT01397747|2269050|P1|Overall Study|Colonoscopy excluded|304
698734|NCT01397747|2269050|P1|Overall Study|Multitarget DNA test excluded|689
698735|NCT01397461|2269082|P3|Overall Study|Not treated|1
698736|NCT01397461|2269083|P2|Overall Study|Not treated|0
698737|NCT01397461|2269084|P1|Overall Study|Not treated|0
698738|NCT01397461|2269082|P3|Overall Study|Lack of Efficacy|0
698739|NCT01397461|2269083|P2|Overall Study|Lack of Efficacy|3
698740|NCT01397461|2269084|P1|Overall Study|Lack of Efficacy|0
698741|NCT01397461|2269082|P3|Overall Study|Lost to Follow-up|1
698742|NCT01397461|2269083|P2|Overall Study|Lost to Follow-up|2
698743|NCT01397461|2269084|P1|Overall Study|Lost to Follow-up|0
698744|NCT01397461|2269082|P3|Overall Study|Withdrawal by Subject|0
698745|NCT01397461|2269083|P2|Overall Study|Withdrawal by Subject|1
698746|NCT01397461|2269084|P1|Overall Study|Withdrawal by Subject|2
698747|NCT01397448|2269095|P3|Overall Study|Not specified|4
698748|NCT01397448|2269096|P2|Overall Study|Not specified|7
698749|NCT01397448|2269097|P1|Overall Study|Not specified|8
698750|NCT01397448|2269095|P3|Overall Study|Lack of Efficacy|5
698751|NCT01397448|2269096|P2|Overall Study|Lack of Efficacy|0
698752|NCT01397448|2269097|P1|Overall Study|Lack of Efficacy|2
698753|NCT01397448|2269095|P3|Overall Study|Withdrawal by Subject|3
698754|NCT01397448|2269096|P2|Overall Study|Withdrawal by Subject|4
698755|NCT01397448|2269097|P1|Overall Study|Withdrawal by Subject|4
698756|NCT01397448|2269095|P3|Overall Study|Adverse Event|6
698757|NCT01397448|2269096|P2|Overall Study|Adverse Event|4
698758|NCT01397448|2269097|P1|Overall Study|Adverse Event|4
698759|NCT01397409|2269118|P10|Stage 3|Other Miscellaneous Reasons|0
698760|NCT01397409|2269119|P9|Stage 3|Other Miscellaneous Reasons|0
698761|NCT01397409|2269120|P8|Stage 3|Other Miscellaneous Reasons|1
698762|NCT01397409|2269121|P7|Stage 3|Other Miscellaneous Reasons|0
698763|NCT01397409|2269122|P6|Stage 3|Other Miscellaneous Reasons|0
698764|NCT01397409|2269123|P5|Stage 3|Other Miscellaneous Reasons|0
698765|NCT01397409|2269124|P4|Stage 3|Other Miscellaneous Reasons|0
698766|NCT01397409|2269125|P3|Stage 3|Other Miscellaneous Reasons|0
698767|NCT01397409|2269126|P2|Stage 3|Other Miscellaneous Reasons|0
698768|NCT01397409|2269127|P1|Stage 3|Other Miscellaneous Reasons|0
698769|NCT01397409|2269118|P10|Stage 3|Adverse Event|0
698770|NCT01397409|2269119|P9|Stage 3|Adverse Event|0
698771|NCT01397409|2269120|P8|Stage 3|Adverse Event|1
698772|NCT01397409|2269121|P7|Stage 3|Adverse Event|0
698773|NCT01397409|2269122|P6|Stage 3|Adverse Event|0
698774|NCT01397409|2269123|P5|Stage 3|Adverse Event|0
698775|NCT01397409|2269124|P4|Stage 3|Adverse Event|0
698776|NCT01397409|2269125|P3|Stage 3|Adverse Event|0
698777|NCT01397409|2269126|P2|Stage 3|Adverse Event|0
698778|NCT01397409|2269127|P1|Stage 3|Adverse Event|0
698779|NCT01397409|2269118|P10|Stage 2|Other Miscellaneous Reasons|0
698780|NCT01397409|2269119|P9|Stage 2|Other Miscellaneous Reasons|0
698781|NCT01397409|2269120|P8|Stage 2|Other Miscellaneous Reasons|0
698782|NCT01397409|2269121|P7|Stage 2|Other Miscellaneous Reasons|0
698783|NCT01397409|2269122|P6|Stage 2|Other Miscellaneous Reasons|1
698784|NCT01397409|2269123|P5|Stage 2|Other Miscellaneous Reasons|1
698785|NCT01397409|2269124|P4|Stage 2|Other Miscellaneous Reasons|0
698786|NCT01397409|2269125|P3|Stage 2|Other Miscellaneous Reasons|0
698787|NCT01397409|2269126|P2|Stage 2|Other Miscellaneous Reasons|0
698788|NCT01397409|2269127|P1|Stage 2|Other Miscellaneous Reasons|0
698789|NCT01397409|2269118|P10|Stage 2|Personal Reasons|0
698790|NCT01397409|2269119|P9|Stage 2|Personal Reasons|0
698791|NCT01397409|2269120|P8|Stage 2|Personal Reasons|0
698792|NCT01397409|2269121|P7|Stage 2|Personal Reasons|0
698793|NCT01397409|2269122|P6|Stage 2|Personal Reasons|0
698794|NCT01397409|2269123|P5|Stage 2|Personal Reasons|1
698795|NCT01397409|2269124|P4|Stage 2|Personal Reasons|0
698796|NCT01397409|2269125|P3|Stage 2|Personal Reasons|0
698797|NCT01397409|2269126|P2|Stage 2|Personal Reasons|0
698798|NCT01397409|2269127|P1|Stage 2|Personal Reasons|0
698799|NCT01397409|2269118|P10|Stage 2|Adverse Event|0
698800|NCT01397409|2269119|P9|Stage 2|Adverse Event|0
698801|NCT01397409|2269120|P8|Stage 2|Adverse Event|0
698802|NCT01397409|2269121|P7|Stage 2|Adverse Event|0
698803|NCT01397409|2269122|P6|Stage 2|Adverse Event|3
698804|NCT01397409|2269123|P5|Stage 2|Adverse Event|6
698805|NCT01397409|2269124|P4|Stage 2|Adverse Event|0
698806|NCT01397409|2269125|P3|Stage 2|Adverse Event|0
698807|NCT01397409|2269126|P2|Stage 2|Adverse Event|0
698808|NCT01397409|2269127|P1|Stage 2|Adverse Event|0
698809|NCT01397253|2269167|P2|Overall Study|Reviewed by only 1 pharmacist|149
698810|NCT01397253|2269168|P1|Overall Study|Reviewed by only 1 pharmacist|126
698811|NCT01397084|2269174|P1|Overall Study|Used other proton pump inhibitor|1
698812|NCT01397084|2269174|P1|Overall Study|Lost to Follow-up|1
698813|NCT01397084|2269174|P1|Overall Study|Withdrawal by Subject|1
698814|NCT01397084|2269174|P1|Overall Study|Adverse Event|2
698815|NCT01397084|2269174|P1|Overall Study|Protocol Violation|2
698816|NCT01397084|2269174|P1|Overall Study|Severe Non-Compliance to Protocol|1
698817|NCT01396525|2269181|P1|Overall Study|Lost to Follow-up|4
698818|NCT01396525|2269181|P1|Overall Study|Death|14
698819|NCT01396525|2269181|P1|Overall Study|Withdrawal by Subject|8
698820|NCT01396512|2269281|P2|Overall Study|Withdrawal by Subject|1
698821|NCT01396512|2269282|P1|Overall Study|Withdrawal by Subject|0
698822|NCT01396434|2269297|P3|Overall Study|Unspecified|0
698823|NCT01396434|2269298|P2|Overall Study|Unspecified|0
698824|NCT01396434|2269299|P1|Overall Study|Unspecified|10
698825|NCT01396434|2269297|P3|Overall Study|Lost to Follow-up|0
698826|NCT01396434|2269298|P2|Overall Study|Lost to Follow-up|0
698827|NCT01396434|2269299|P1|Overall Study|Lost to Follow-up|1
698828|NCT01396421|2269311|P4|Overall Study|Lack of Efficacy|18
698829|NCT01396421|2269312|P3|Overall Study|Lack of Efficacy|7
698830|NCT01396421|2269313|P2|Overall Study|Lack of Efficacy|17
698831|NCT01396421|2269314|P1|Overall Study|Lack of Efficacy|7
698832|NCT01396421|2269311|P4|Overall Study|Protocol Deviation|0
698833|NCT01396421|2269312|P3|Overall Study|Protocol Deviation|1
698834|NCT01396421|2269313|P2|Overall Study|Protocol Deviation|1
698835|NCT01396421|2269314|P1|Overall Study|Protocol Deviation|2
698836|NCT01396421|2269311|P4|Overall Study|Withdrawal by Subject|21
698837|NCT01396421|2269312|P3|Overall Study|Withdrawal by Subject|13
698838|NCT01396421|2269313|P2|Overall Study|Withdrawal by Subject|24
698839|NCT01396421|2269314|P1|Overall Study|Withdrawal by Subject|31
698840|NCT01396421|2269311|P4|Overall Study|Physician Decision|3
698841|NCT01396421|2269312|P3|Overall Study|Physician Decision|0
698842|NCT01396421|2269313|P2|Overall Study|Physician Decision|1
698843|NCT01396421|2269314|P1|Overall Study|Physician Decision|1
698844|NCT01396421|2269311|P4|Overall Study|Participant Met Withdrawal Criteria|0
698845|NCT01396421|2269312|P3|Overall Study|Participant Met Withdrawal Criteria|1
698846|NCT01396421|2269313|P2|Overall Study|Participant Met Withdrawal Criteria|0
698847|NCT01396421|2269314|P1|Overall Study|Participant Met Withdrawal Criteria|1
698848|NCT01396421|2269311|P4|Overall Study|Adverse Event|32
698849|NCT01396421|2269312|P3|Overall Study|Adverse Event|12
698850|NCT01396421|2269313|P2|Overall Study|Adverse Event|15
698851|NCT01396421|2269314|P1|Overall Study|Adverse Event|17
698852|NCT01396421|2269311|P4|Overall Study|Lost to Follow-up|1
698853|NCT01396421|2269312|P3|Overall Study|Lost to Follow-up|0
698854|NCT01396421|2269313|P2|Overall Study|Lost to Follow-up|0
698855|NCT01396421|2269314|P1|Overall Study|Lost to Follow-up|0
698856|NCT01396395|2269386|P2|Overall Study|Unspecified|1
698857|NCT01396395|2269387|P1|Overall Study|Unspecified|0
698858|NCT01396395|2269386|P2|Overall Study|Lost to Follow-up|11
698859|NCT01396395|2269387|P1|Overall Study|Lost to Follow-up|17
698860|NCT01396395|2269386|P2|Overall Study|Adverse Event|2
698861|NCT01396395|2269387|P1|Overall Study|Adverse Event|10
698862|NCT01396395|2269386|P2|Overall Study|Protocol Violation|1
698863|NCT01396395|2269387|P1|Overall Study|Protocol Violation|3
698864|NCT01396395|2269386|P2|Overall Study|Withdrawal by Subject|12
698865|NCT01396395|2269387|P1|Overall Study|Withdrawal by Subject|10
698866|NCT01396265|2269427|P1|Rifa+Afatinib|Withdrawal by Subject|1
698867|NCT01396187|2269516|P5|Overall Study|Unspecified|1
698868|NCT01396187|2269517|P4|Overall Study|Unspecified|0
698869|NCT01396187|2269518|P3|Overall Study|Unspecified|0
698870|NCT01396187|2269519|P2|Overall Study|Unspecified|1
698871|NCT01396187|2269520|P1|Overall Study|Unspecified|1
698872|NCT01396187|2269516|P5|Overall Study|Withdrawal by Subject|0
698873|NCT01396187|2269517|P4|Overall Study|Withdrawal by Subject|0
698874|NCT01396187|2269518|P3|Overall Study|Withdrawal by Subject|1
698875|NCT01396187|2269519|P2|Overall Study|Withdrawal by Subject|1
698876|NCT01396187|2269520|P1|Overall Study|Withdrawal by Subject|0
698877|NCT01396187|2269516|P5|Overall Study|Adverse Event|0
698878|NCT01396187|2269517|P4|Overall Study|Adverse Event|0
698879|NCT01396187|2269518|P3|Overall Study|Adverse Event|0
698880|NCT01396187|2269519|P2|Overall Study|Adverse Event|1
698881|NCT01396187|2269520|P1|Overall Study|Adverse Event|0
698882|NCT01396161|2269620|P7|Overall Study|unspecified|1
698883|NCT01396161|2269621|P6|Overall Study|unspecified|0
698884|NCT01396161|2269622|P5|Overall Study|unspecified|0
698885|NCT01396161|2269623|P4|Overall Study|unspecified|0
698886|NCT01396161|2269624|P3|Overall Study|unspecified|0
698887|NCT01396161|2269625|P2|Overall Study|unspecified|0
698888|NCT01396161|2269626|P1|Overall Study|unspecified|0
698889|NCT01396161|2269620|P7|Overall Study|Withdrawal by Subject|0
698890|NCT01396161|2269621|P6|Overall Study|Withdrawal by Subject|0
698891|NCT01396161|2269622|P5|Overall Study|Withdrawal by Subject|1
698892|NCT01396161|2269623|P4|Overall Study|Withdrawal by Subject|0
698893|NCT01396161|2269624|P3|Overall Study|Withdrawal by Subject|0
698894|NCT01396161|2269625|P2|Overall Study|Withdrawal by Subject|0
698895|NCT01396161|2269626|P1|Overall Study|Withdrawal by Subject|0
698896|NCT01396083|2269681|P2|Overall Study|Lost to Follow-up|0
698897|NCT01396083|2269682|P1|Overall Study|Lost to Follow-up|1
698898|NCT01396083|2269681|P2|Overall Study|Administrative problems|0
698899|NCT01396083|2269682|P1|Overall Study|Administrative problems|1
698900|NCT01396083|2269681|P2|Overall Study|Abnormal laboratory value(s)|0
698901|NCT01396083|2269682|P1|Overall Study|Abnormal laboratory value(s)|1
698902|NCT01396083|2269681|P2|Overall Study|Protocol deviation(s)|1
698903|NCT01396083|2269682|P1|Overall Study|Protocol deviation(s)|0
698904|NCT01396083|2269681|P2|Overall Study|Consent withdrawn|5
698905|NCT01396083|2269682|P1|Overall Study|Consent withdrawn|4
698906|NCT01396083|2269681|P2|Overall Study|Unsatisfactory therapeutic effect|13
698907|NCT01396083|2269682|P1|Overall Study|Unsatisfactory therapeutic effect|2
698908|NCT01396083|2269681|P2|Overall Study|Adverse Event|28
698909|NCT01396083|2269682|P1|Overall Study|Adverse Event|2
698910|NCT01396070|2269706|P1|Overall Study|Lack of Efficacy|4
698911|NCT01396070|2269706|P1|Overall Study|Physician Decision|3
698912|NCT01396070|2269706|P1|Overall Study|Adverse Event|8
698913|NCT01396070|2269706|P1|Overall Study|Death|2
698914|NCT01396070|2269706|P1|Overall Study|Withdrawal by Subject|2
698915|NCT01396057|2269715|P2|Overall Study|Consent withdrawn|2
698916|NCT01396057|2269716|P1|Overall Study|Consent withdrawn|3
698917|NCT01396057|2269715|P2|Overall Study|Protocol deviation|4
698918|NCT01396057|2269716|P1|Overall Study|Protocol deviation|4
698919|NCT01396057|2269715|P2|Overall Study|Unsatisfactory therapeutic effect|6
698920|NCT01396057|2269716|P1|Overall Study|Unsatisfactory therapeutic effect|2
698921|NCT01396057|2269715|P2|Overall Study|Adverse Event|6
698922|NCT01396057|2269716|P1|Overall Study|Adverse Event|2
698923|NCT01396005|2269765|P2|Overall Study|Non-compliance with protocol|1
698924|NCT01396005|2269766|P1|Overall Study|Non-compliance with protocol|0
698925|NCT01396005|2269765|P2|Overall Study|Withdrawal by Subject|1
698926|NCT01396005|2269766|P1|Overall Study|Withdrawal by Subject|0
698927|NCT01395914|2269797|P2|Overall Study|Lost to Follow-up|2
698928|NCT01395914|2269798|P1|Overall Study|Lost to Follow-up|6
698929|NCT01395914|2269797|P2|Overall Study|Study drug-related AE|0
698930|NCT01395914|2269798|P1|Overall Study|Study drug-related AE|1
698931|NCT01395914|2269797|P2|Overall Study|Withdrawal by patient|14
698932|NCT01395914|2269798|P1|Overall Study|Withdrawal by patient|27
698933|NCT01395914|2269797|P2|Overall Study|Other|3
698934|NCT01395914|2269798|P1|Overall Study|Other|9
698935|NCT01395914|2269797|P2|Overall Study|Death|17
698936|NCT01395914|2269798|P1|Overall Study|Death|23
698937|NCT01395914|2269797|P2|Overall Study|Unrelated to study drug AE|1
698938|NCT01395914|2269798|P1|Overall Study|Unrelated to study drug AE|6
698939|NCT01395901|2269812|P2|Overall Study|Withdrawal of consent|0
698940|NCT01395901|2269813|P1|Overall Study|Withdrawal of consent|1
698941|NCT01395901|2269812|P2|Overall Study|Adverse Event|1
698942|NCT01395901|2269813|P1|Overall Study|Adverse Event|0
698943|NCT01395901|2269812|P2|Overall Study|Randomized but not received study drug|4
698944|NCT01395901|2269813|P1|Overall Study|Randomized but not received study drug|5
698945|NCT01395901|2269812|P2|Overall Study|Lost to Follow-up|0
698946|NCT01395901|2269813|P1|Overall Study|Lost to Follow-up|4
698947|NCT01395888|2269829|P3|Treatment Period (TP)|Withdrawal by Subject|3
698948|NCT01395888|2269830|P2|Treatment Period (TP)|Withdrawal by Subject|2
698949|NCT01395888|2269831|P1|Treatment Period (TP)|Withdrawal by Subject|0
698950|NCT01395888|2269829|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
698951|NCT01395888|2269830|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
698952|NCT01395888|2269831|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
698953|NCT01395888|2269829|P3|Treatment Period (TP)|Protocol Violation|5
698954|NCT01395888|2269830|P2|Treatment Period (TP)|Protocol Violation|1
698955|NCT01395888|2269831|P1|Treatment Period (TP)|Protocol Violation|0
698956|NCT01395888|2269829|P3|Treatment Period (TP)|Lack of Efficacy|3
698957|NCT01395888|2269830|P2|Treatment Period (TP)|Lack of Efficacy|4
698958|NCT01395888|2269831|P1|Treatment Period (TP)|Lack of Efficacy|0
698959|NCT01395888|2269829|P3|Treatment Period (TP)|Adverse Event|6
698960|NCT01395888|2269830|P2|Treatment Period (TP)|Adverse Event|7
698961|NCT01395888|2269831|P1|Treatment Period (TP)|Adverse Event|0
698962|NCT01395888|2269829|P3|2-week Run-in Period|Withdrawal by Subject|0
698963|NCT01395888|2269830|P2|2-week Run-in Period|Withdrawal by Subject|0
698964|NCT01395888|2269831|P1|2-week Run-in Period|Withdrawal by Subject|4
698965|NCT01395888|2269829|P3|2-week Run-in Period|Protocol Violation|0
698966|NCT01395888|2269830|P2|2-week Run-in Period|Protocol Violation|0
698967|NCT01395888|2269831|P1|2-week Run-in Period|Protocol Violation|2
698968|NCT01395888|2269829|P3|2-week Run-in Period|Lost to Follow-up|0
698969|NCT01395888|2269830|P2|2-week Run-in Period|Lost to Follow-up|0
698970|NCT01395888|2269831|P1|2-week Run-in Period|Lost to Follow-up|1
698971|NCT01395888|2269829|P3|2-week Run-in Period|Continuation Criteria Not Met|0
698972|NCT01395888|2269830|P2|2-week Run-in Period|Continuation Criteria Not Met|0
698973|NCT01395888|2269831|P1|2-week Run-in Period|Continuation Criteria Not Met|13
698974|NCT01395888|2269829|P3|2-week Run-in Period|Adverse Event|0
698975|NCT01395888|2269830|P2|2-week Run-in Period|Adverse Event|0
698976|NCT01395888|2269831|P1|2-week Run-in Period|Adverse Event|2
698977|NCT01395823|2269839|P2|Overall Study|Withdrawal by Subject|4
698978|NCT01395823|2269840|P1|Overall Study|Withdrawal by Subject|5
698979|NCT01395823|2269839|P2|Overall Study|GI symptoms|0
698980|NCT01395823|2269840|P1|Overall Study|GI symptoms|1
698981|NCT01395823|2269839|P2|Overall Study|Transplant|0
698982|NCT01395823|2269840|P1|Overall Study|Transplant|1
698983|NCT01395823|2269839|P2|Overall Study|Lost to Follow-up|0
698984|NCT01395823|2269840|P1|Overall Study|Lost to Follow-up|1
698985|NCT01395823|2269839|P2|Overall Study|Physician Decision|1
698986|NCT01395823|2269840|P1|Overall Study|Physician Decision|3
698987|NCT01395823|2269839|P2|Overall Study|Death|4
698988|NCT01395823|2269840|P1|Overall Study|Death|4
698989|NCT01395784|2269877|P1|Overall Study|Physician Decision|5
698990|NCT01395784|2269877|P1|Overall Study|Withdrawal by Subject|3
698991|NCT01395784|2269877|P1|Overall Study|Lost to Follow-up|7
698992|NCT01395524|2269885|P3|Overall Study|Subject had spinal surgery|1
698993|NCT01395524|2269886|P2|Overall Study|Subject had spinal surgery|0
698994|NCT01395524|2269887|P1|Overall Study|Subject had spinal surgery|0
698995|NCT01395524|2269885|P3|Overall Study|Did not receive treatment|3
698996|NCT01395524|2269886|P2|Overall Study|Did not receive treatment|1
698997|NCT01395524|2269887|P1|Overall Study|Did not receive treatment|1
698998|NCT01395524|2269885|P3|Overall Study|Withdrawal by Subject|8
698999|NCT01395524|2269886|P2|Overall Study|Withdrawal by Subject|8
699000|NCT01395524|2269887|P1|Overall Study|Withdrawal by Subject|4
699001|NCT01395524|2269885|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
699002|NCT01395524|2269886|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
699003|NCT01395524|2269887|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
699004|NCT01395524|2269885|P3|Overall Study|Death|0
699005|NCT01395524|2269886|P2|Overall Study|Death|0
699006|NCT01395524|2269887|P1|Overall Study|Death|1
699007|NCT01395524|2269885|P3|Overall Study|Adverse Event|3
699008|NCT01395524|2269886|P2|Overall Study|Adverse Event|4
699009|NCT01395524|2269887|P1|Overall Study|Adverse Event|4
699010|NCT01395524|2269885|P3|Overall Study|Severe noncompliance with protocol|0
699011|NCT01395524|2269886|P2|Overall Study|Severe noncompliance with protocol|0
699012|NCT01395524|2269887|P1|Overall Study|Severe noncompliance with protocol|1
699013|NCT01395524|2269885|P3|Overall Study|Study-Specific Withdrawal Criteria|0
699014|NCT01395524|2269886|P2|Overall Study|Study-Specific Withdrawal Criteria|2
699015|NCT01395524|2269887|P1|Overall Study|Study-Specific Withdrawal Criteria|1
699016|NCT01395524|2269885|P3|Overall Study|Lost to Follow-up|1
699017|NCT01395524|2269886|P2|Overall Study|Lost to Follow-up|1
699018|NCT01395524|2269887|P1|Overall Study|Lost to Follow-up|3
699019|NCT01395524|2269885|P3|Overall Study|Non-compliance with study schedule|1
699020|NCT01395524|2269886|P2|Overall Study|Non-compliance with study schedule|0
699021|NCT01395524|2269887|P1|Overall Study|Non-compliance with study schedule|1
699022|NCT01395394|2269910|P3|Baseline Study Visit|Protocol Violation|0
699023|NCT01395394|2269911|P2|Baseline Study Visit|Protocol Violation|0
699024|NCT01395394|2269912|P1|Baseline Study Visit|Protocol Violation|1
699025|NCT01395368|2269923|P1|Overall Study|Withdrawal by Subject|2
699026|NCT01395368|2269923|P1|Overall Study|Physician Decision|14
699027|NCT01395017|2269945|P2|Overall Study|Sponsor discontinued study|4
699028|NCT01395017|2269946|P1|Overall Study|Sponsor discontinued study|1
699029|NCT01395017|2269945|P2|Overall Study|Disease progression|58
699030|NCT01395017|2269946|P1|Overall Study|Disease progression|42
699031|NCT01395017|2269945|P2|Overall Study|Death|3
699032|NCT01395017|2269946|P1|Overall Study|Death|4
699033|NCT01395017|2269945|P2|Overall Study|Protocol deviation|2
699034|NCT01395017|2269946|P1|Overall Study|Protocol deviation|1
699035|NCT01395017|2269945|P2|Overall Study|Withdrawal by Subject|8
699036|NCT01395017|2269946|P1|Overall Study|Withdrawal by Subject|14
699037|NCT01395017|2269945|P2|Overall Study|Physician Decision|15
699038|NCT01395017|2269946|P1|Overall Study|Physician Decision|11
699039|NCT01395017|2269945|P2|Overall Study|Adverse Event|12
699040|NCT01395017|2269946|P1|Overall Study|Adverse Event|26
699041|NCT01395017|2269945|P2|Overall Study|Lost to Follow-up|0
699042|NCT01395017|2269946|P1|Overall Study|Lost to Follow-up|1
699043|NCT01394991|2269956|P2|Overall Study|Prematurely Termination of Trial|10
699044|NCT01394991|2269957|P1|Overall Study|Prematurely Termination of Trial|9
699045|NCT01394991|2269956|P2|Overall Study|Disease Progression|7
699046|NCT01394991|2269957|P1|Overall Study|Disease Progression|7
699047|NCT01394991|2269956|P2|Overall Study|Chemotherapy Termination|15
699048|NCT01394991|2269957|P1|Overall Study|Chemotherapy Termination|10
699049|NCT01394991|2269956|P2|Overall Study|Withdrawal by Subject|17
699050|NCT01394991|2269957|P1|Overall Study|Withdrawal by Subject|20
699051|NCT01394991|2269956|P2|Overall Study|Protocol Violation|1
699052|NCT01394991|2269957|P1|Overall Study|Protocol Violation|1
699053|NCT01394991|2269956|P2|Overall Study|Physician Decision|3
699054|NCT01394991|2269957|P1|Overall Study|Physician Decision|1
699055|NCT01394991|2269956|P2|Overall Study|Lost to Follow-up|8
699056|NCT01394991|2269957|P1|Overall Study|Lost to Follow-up|6
699057|NCT01394991|2269956|P2|Overall Study|Lack of Efficacy|7
699058|NCT01394991|2269957|P1|Overall Study|Lack of Efficacy|5
699059|NCT01394991|2269956|P2|Overall Study|Adverse Event|4
699060|NCT01394991|2269957|P1|Overall Study|Adverse Event|0
699061|NCT01394978|2269979|P2|Overall Study|Death|7
699062|NCT01394978|2269980|P1|Overall Study|Death|6
699063|NCT01394978|2269979|P2|Overall Study|Lost to Follow-up|20
699064|NCT01394978|2269980|P1|Overall Study|Lost to Follow-up|13
699065|NCT01394978|2269979|P2|Overall Study|Withdrawal by Subject|4
699066|NCT01394978|2269980|P1|Overall Study|Withdrawal by Subject|2
699067|NCT01394718|2269997|P2|Overall Study|Met protocol-specific stopping criteria|1
699068|NCT01394718|2269998|P1|Overall Study|Met protocol-specific stopping criteria|2
699069|NCT01394276|2270034|P1|Overall Study|Symptoms of concurrent diseases|1
699070|NCT01394276|2270034|P1|Overall Study|unavailability of drug at the Hospital|2
699071|NCT01394276|2270034|P1|Overall Study|Pregnancy|1
699072|NCT01394276|2270034|P1|Overall Study|Participant moved to another site|1
699073|NCT01394276|2270034|P1|Overall Study|Lost to Follow-up|5
699074|NCT01394276|2270034|P1|Overall Study|Insufficient compliance|9
699075|NCT01394276|2270034|P1|Overall Study|Insufficient therapeutic effect|17
699076|NCT01394276|2270034|P1|Overall Study|Remission of disease|2
699077|NCT01394276|2270034|P1|Overall Study|Not related AEs|9
699078|NCT01394276|2270034|P1|Overall Study|Related Adverse event (AEs)|15
699079|NCT01394250|2270058|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
699080|NCT01394250|2270059|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
699081|NCT01394250|2270058|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
699082|NCT01394250|2270059|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
699083|NCT01394185|2270067|P6|Overall Study|Protocol Violation|1
699084|NCT01394185|2270068|P5|Overall Study|Protocol Violation|0
699085|NCT01394185|2270069|P4|Overall Study|Protocol Violation|1
699086|NCT01394185|2270070|P3|Overall Study|Protocol Violation|0
699087|NCT01394185|2270071|P2|Overall Study|Protocol Violation|0
699088|NCT01394185|2270072|P1|Overall Study|Protocol Violation|1
699089|NCT01394185|2270067|P6|Overall Study|Change in protocol|0
699090|NCT01394185|2270068|P5|Overall Study|Change in protocol|3
699091|NCT01394185|2270069|P4|Overall Study|Change in protocol|0
699092|NCT01394185|2270070|P3|Overall Study|Change in protocol|0
699093|NCT01394185|2270071|P2|Overall Study|Change in protocol|0
699094|NCT01394185|2270072|P1|Overall Study|Change in protocol|3
699095|NCT01394185|2270067|P6|Overall Study|Withdrawal by Subject|0
699096|NCT01394185|2270068|P5|Overall Study|Withdrawal by Subject|1
699097|NCT01394185|2270069|P4|Overall Study|Withdrawal by Subject|0
699098|NCT01394185|2270070|P3|Overall Study|Withdrawal by Subject|0
699099|NCT01394185|2270071|P2|Overall Study|Withdrawal by Subject|0
699100|NCT01394185|2270072|P1|Overall Study|Withdrawal by Subject|2
699101|NCT01393964|2270099|P3|Overall Study|Subject to receive non-protocol therapy|1
699102|NCT01393964|2270100|P2|Overall Study|Subject to receive non-protocol therapy|0
699103|NCT01393964|2270101|P1|Overall Study|Subject to receive non-protocol therapy|0
699104|NCT01393964|2270099|P3|Overall Study|Subject converted to roll-over study|0
699105|NCT01393964|2270100|P2|Overall Study|Subject converted to roll-over study|1
699106|NCT01393964|2270101|P1|Overall Study|Subject converted to roll-over study|0
699107|NCT01393964|2270099|P3|Overall Study|Investigator removed subject from study|0
699108|NCT01393964|2270100|P2|Overall Study|Investigator removed subject from study|1
699109|NCT01393964|2270101|P1|Overall Study|Investigator removed subject from study|0
699110|NCT01393964|2270099|P3|Overall Study|Subject plateaued in terms of effect|0
699111|NCT01393964|2270100|P2|Overall Study|Subject plateaued in terms of effect|0
699112|NCT01393964|2270101|P1|Overall Study|Subject plateaued in terms of effect|1
699113|NCT01393964|2270099|P3|Overall Study|Subject switched to commercial supply|2
699114|NCT01393964|2270100|P2|Overall Study|Subject switched to commercial supply|0
699115|NCT01393964|2270101|P1|Overall Study|Subject switched to commercial supply|1
699116|NCT01393964|2270099|P3|Overall Study|Subject decided to move to transplant|0
699117|NCT01393964|2270100|P2|Overall Study|Subject decided to move to transplant|0
699118|NCT01393964|2270101|P1|Overall Study|Subject decided to move to transplant|1
699119|NCT01393964|2270099|P3|Overall Study|Subject request stop study treatment|0
699120|NCT01393964|2270100|P2|Overall Study|Subject request stop study treatment|1
699121|NCT01393964|2270101|P1|Overall Study|Subject request stop study treatment|0
699122|NCT01393964|2270099|P3|Overall Study|Adverse event unrelated to study drug|0
699123|NCT01393964|2270100|P2|Overall Study|Adverse event unrelated to study drug|3
699124|NCT01393964|2270101|P1|Overall Study|Adverse event unrelated to study drug|0
699125|NCT01393964|2270099|P3|Overall Study|Withdrawal by Subject|1
699126|NCT01393964|2270100|P2|Overall Study|Withdrawal by Subject|0
699127|NCT01393964|2270101|P1|Overall Study|Withdrawal by Subject|0
699128|NCT01393964|2270099|P3|Overall Study|Study drug toxicity|0
699129|NCT01393964|2270100|P2|Overall Study|Study drug toxicity|0
699130|NCT01393964|2270101|P1|Overall Study|Study drug toxicity|1
699131|NCT01393964|2270099|P3|Overall Study|Disease Progression|5
699132|NCT01393964|2270100|P2|Overall Study|Disease Progression|3
699133|NCT01393964|2270101|P1|Overall Study|Disease Progression|4
699134|NCT01393899|2270142|P3|Overall Study|Adverse Event|3
699135|NCT01393899|2270143|P2|Overall Study|Adverse Event|5
699136|NCT01393899|2270144|P1|Overall Study|Adverse Event|1
699137|NCT01393899|2270142|P3|Overall Study|Lack of Efficacy|16
699138|NCT01393899|2270143|P2|Overall Study|Lack of Efficacy|21
699139|NCT01393899|2270144|P1|Overall Study|Lack of Efficacy|26
699140|NCT01393899|2270142|P3|Overall Study|Does not meet entrance criteria|1
699141|NCT01393899|2270143|P2|Overall Study|Does not meet entrance criteria|0
699142|NCT01393899|2270144|P1|Overall Study|Does not meet entrance criteria|1
699143|NCT01393899|2270142|P3|Overall Study|Lost to Follow-up|1
699144|NCT01393899|2270143|P2|Overall Study|Lost to Follow-up|0
699145|NCT01393899|2270144|P1|Overall Study|Lost to Follow-up|0
699146|NCT01393899|2270142|P3|Overall Study|Withdrawal by Subject|1
699147|NCT01393899|2270143|P2|Overall Study|Withdrawal by Subject|2
699148|NCT01393899|2270144|P1|Overall Study|Withdrawal by Subject|2
699149|NCT01393899|2270142|P3|Overall Study|Unspecified|0
699150|NCT01393899|2270143|P2|Overall Study|Unspecified|0
699151|NCT01393899|2270144|P1|Overall Study|Unspecified|1
699152|NCT01393899|2270142|P3|Overall Study|Study terminated by sponsor|1
699153|NCT01393899|2270143|P2|Overall Study|Study terminated by sponsor|0
699154|NCT01393899|2270144|P1|Overall Study|Study terminated by sponsor|1
699155|NCT01393743|2270198|P3|Extension Phase|Not specified|14
699156|NCT01393743|2270199|P2|Extension Phase|Not specified|0
699157|NCT01393743|2270200|P1|Extension Phase|Not specified|0
699158|NCT01393743|2270198|P3|Extension Phase|Pregnancy|1
699159|NCT01393743|2270199|P2|Extension Phase|Pregnancy|0
699160|NCT01393743|2270200|P1|Extension Phase|Pregnancy|0
699161|NCT01393743|2270198|P3|Extension Phase|Withdrawal by Subject|8
699162|NCT01393743|2270199|P2|Extension Phase|Withdrawal by Subject|0
699163|NCT01393743|2270200|P1|Extension Phase|Withdrawal by Subject|0
699164|NCT01393743|2270198|P3|Extension Phase|Inadequate therapeutic effect|7
699165|NCT01393743|2270199|P2|Extension Phase|Inadequate therapeutic effect|0
699166|NCT01393743|2270200|P1|Extension Phase|Inadequate therapeutic effect|0
699167|NCT01393743|2270198|P3|Extension Phase|Participant choice|16
699168|NCT01393743|2270199|P2|Extension Phase|Participant choice|0
699169|NCT01393743|2270200|P1|Extension Phase|Participant choice|0
699170|NCT01393743|2270198|P3|Extension Phase|Lost to Follow-up|2
699171|NCT01393743|2270199|P2|Extension Phase|Lost to Follow-up|0
699172|NCT01393743|2270200|P1|Extension Phase|Lost to Follow-up|0
699173|NCT01393743|2270198|P3|Extension Phase|Adverse Event|12
699174|NCT01393743|2270199|P2|Extension Phase|Adverse Event|0
699175|NCT01393743|2270200|P1|Extension Phase|Adverse Event|0
699176|NCT01393743|2270198|P3|Core Study|Inadequate therapeutic effect|0
699177|NCT01393743|2270199|P2|Core Study|Inadequate therapeutic effect|0
699178|NCT01393743|2270200|P1|Core Study|Inadequate therapeutic effect|2
699179|NCT01393743|2270198|P3|Core Study|Participant's Choice|0
699180|NCT01393743|2270199|P2|Core Study|Participant's Choice|3
699181|NCT01393743|2270200|P1|Core Study|Participant's Choice|2
699182|NCT01393743|2270198|P3|Core Study|Lost to Follow-up|0
699183|NCT01393743|2270199|P2|Core Study|Lost to Follow-up|1
699184|NCT01393743|2270200|P1|Core Study|Lost to Follow-up|1
699185|NCT01393743|2270198|P3|Core Study|Adverse Event|0
699186|NCT01393743|2270199|P2|Core Study|Adverse Event|9
699187|NCT01393743|2270200|P1|Core Study|Adverse Event|5
699188|NCT01393730|2270223|P1|Overall Study|Adverse Event|1
699189|NCT01393730|2270223|P1|Overall Study|Other|2
699190|NCT01393730|2270223|P1|Overall Study|Withdrawal by Subject|3
699191|NCT01393626|2270256|P4|Overall Study|Protocol Violation|0
699192|NCT01393626|2270257|P3|Overall Study|Protocol Violation|2
699193|NCT01393626|2270258|P2|Overall Study|Protocol Violation|0
699194|NCT01393626|2270259|P1|Overall Study|Protocol Violation|1
699195|NCT01393626|2270256|P4|Overall Study|Unspecified|0
699196|NCT01393626|2270257|P3|Overall Study|Unspecified|0
699197|NCT01393626|2270258|P2|Overall Study|Unspecified|0
699198|NCT01393626|2270259|P1|Overall Study|Unspecified|1
699199|NCT01393626|2270256|P4|Overall Study|Withdrawal by Subject|0
699200|NCT01393626|2270257|P3|Overall Study|Withdrawal by Subject|0
699201|NCT01393626|2270258|P2|Overall Study|Withdrawal by Subject|4
699202|NCT01393626|2270259|P1|Overall Study|Withdrawal by Subject|6
699203|NCT01393626|2270256|P4|Overall Study|Lost to Follow-up|0
699204|NCT01393626|2270257|P3|Overall Study|Lost to Follow-up|1
699205|NCT01393626|2270258|P2|Overall Study|Lost to Follow-up|1
699206|NCT01393626|2270259|P1|Overall Study|Lost to Follow-up|1
699207|NCT01393626|2270256|P4|Overall Study|Lack of Efficacy|1
699208|NCT01393626|2270257|P3|Overall Study|Lack of Efficacy|4
699209|NCT01393626|2270258|P2|Overall Study|Lack of Efficacy|6
699210|NCT01393626|2270259|P1|Overall Study|Lack of Efficacy|6
699211|NCT01393626|2270256|P4|Overall Study|Did not meet entrance criteria|0
699212|NCT01393626|2270257|P3|Overall Study|Did not meet entrance criteria|0
699213|NCT01393626|2270258|P2|Overall Study|Did not meet entrance criteria|0
699214|NCT01393626|2270259|P1|Overall Study|Did not meet entrance criteria|1
699215|NCT01393626|2270256|P4|Overall Study|Adverse Event|0
699216|NCT01393626|2270257|P3|Overall Study|Adverse Event|5
699217|NCT01393626|2270258|P2|Overall Study|Adverse Event|1
699218|NCT01393626|2270259|P1|Overall Study|Adverse Event|2
699219|NCT01393613|2270339|P4|Overall Study|Lack of Efficacy|21
699220|NCT01393613|2270340|P3|Overall Study|Lack of Efficacy|16
699221|NCT01393613|2270341|P2|Overall Study|Lack of Efficacy|20
699222|NCT01393613|2270342|P1|Overall Study|Lack of Efficacy|9
699223|NCT01393613|2270339|P4|Overall Study|Protocol Deviation|0
699224|NCT01393613|2270340|P3|Overall Study|Protocol Deviation|0
699225|NCT01393613|2270341|P2|Overall Study|Protocol Deviation|1
699226|NCT01393613|2270342|P1|Overall Study|Protocol Deviation|2
699227|NCT01393613|2270339|P4|Overall Study|Withdrawal by Subject|21
699228|NCT01393613|2270340|P3|Overall Study|Withdrawal by Subject|23
699229|NCT01393613|2270341|P2|Overall Study|Withdrawal by Subject|25
699230|NCT01393613|2270342|P1|Overall Study|Withdrawal by Subject|15
699231|NCT01393613|2270339|P4|Overall Study|Physician Decision|1
699232|NCT01393613|2270340|P3|Overall Study|Physician Decision|0
699233|NCT01393613|2270341|P2|Overall Study|Physician Decision|0
699234|NCT01393613|2270342|P1|Overall Study|Physician Decision|2
699235|NCT01393613|2270339|P4|Overall Study|Participant Met Withdrawal Criteria|1
699236|NCT01393613|2270340|P3|Overall Study|Participant Met Withdrawal Criteria|2
699237|NCT01393613|2270341|P2|Overall Study|Participant Met Withdrawal Criteria|0
699238|NCT01393613|2270342|P1|Overall Study|Participant Met Withdrawal Criteria|0
699239|NCT01393613|2270339|P4|Overall Study|Adverse Event|22
699240|NCT01393613|2270340|P3|Overall Study|Adverse Event|13
699241|NCT01393613|2270341|P2|Overall Study|Adverse Event|11
699242|NCT01393613|2270342|P1|Overall Study|Adverse Event|11
699243|NCT01393600|2270404|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
699244|NCT01393600|2270405|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
699245|NCT01393600|2270406|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
699246|NCT01393600|2270407|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
699247|NCT01393600|2270404|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
699248|NCT01393600|2270405|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
699249|NCT01393600|2270406|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
699250|NCT01393600|2270407|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
699251|NCT01393600|2270404|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
699252|NCT01393600|2270405|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
699253|NCT01393600|2270406|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
699254|NCT01393600|2270407|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
699255|NCT01393600|2270404|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
699256|NCT01393600|2270405|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
699257|NCT01393600|2270406|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
699258|NCT01393600|2270407|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
699259|NCT01393600|2270404|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
699260|NCT01393600|2270405|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
699261|NCT01393600|2270406|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
699262|NCT01393600|2270407|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
699263|NCT01393600|2270404|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
699264|NCT01393600|2270405|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
699265|NCT01393600|2270406|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
699266|NCT01393600|2270407|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
699267|NCT01393600|2270404|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
699268|NCT01393600|2270405|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
699269|NCT01393600|2270406|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
699270|NCT01393600|2270407|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
699271|NCT01393444|2270422|P1|Overall Study|Determined ineligible during screening.|2
699272|NCT01393444|2270422|P1|Overall Study|Withdrawal by Subject|1
699273|NCT01393106|2270442|P1|Overall Study|Lack of Efficacy|1
699274|NCT01393106|2270442|P1|Overall Study|Withdrawal by Subject|1
699275|NCT01393106|2270442|P1|Overall Study|Adverse Event|3
699276|NCT01392742|2270459|P1|Overall Study|Missing information|13
699277|NCT01392742|2270459|P1|Overall Study|Unspecified|3
699278|NCT01392742|2270459|P1|Overall Study|Protocol Violation|14
699279|NCT01392742|2270459|P1|Overall Study|Adverse event/intercurrent illness|17
699280|NCT01392742|2270459|P1|Overall Study|ITR and Protocol deviation|1
699281|NCT01392742|2270459|P1|Overall Study|Insufficient therapeutic response (ITR)|30
699282|NCT01392742|2270459|P1|Overall Study|Lost to Follow-up|34
699283|NCT01392742|2270459|P1|Overall Study|No treatment/no cooperation/withdrew|12
699284|NCT01392742|2270459|P1|Overall Study|Failure to return|35
699285|NCT01392742|2270459|P1|Overall Study|Premature study termination|42
699286|NCT01392677|2270505|P2|Overall Study|Other reason|2
699287|NCT01392677|2270506|P1|Overall Study|Other reason|3
699288|NCT01392677|2270505|P2|Overall Study|Incorrect enrollment|3
699289|NCT01392677|2270506|P1|Overall Study|Incorrect enrollment|2
699290|NCT01392677|2270505|P2|Overall Study|Withdrawal by Subject|2
699291|NCT01392677|2270506|P1|Overall Study|Withdrawal by Subject|0
699292|NCT01392677|2270505|P2|Overall Study|Adverse Event|1
699293|NCT01392677|2270506|P1|Overall Study|Adverse Event|3
889466|NCT01323634|2824006|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
889467|NCT01323634|2824004|P3|2-week Run-in Period|Adverse Event|0
889468|NCT01323634|2824005|P2|2-week Run-in Period|Adverse Event|0
889469|NCT01323634|2824006|P1|2-week Run-in Period|Adverse Event|1
889470|NCT01323634|2824004|P3|2-week Run-in Period|Protocol Violation|0
889471|NCT01323634|2824005|P2|2-week Run-in Period|Protocol Violation|0
889472|NCT01323634|2824006|P1|2-week Run-in Period|Protocol Violation|1
889473|NCT01323634|2824004|P3|2-week Run-in Period|Physician Decision|0
889474|NCT01323634|2824005|P2|2-week Run-in Period|Physician Decision|0
889475|NCT01323634|2824006|P1|2-week Run-in Period|Physician Decision|5
889476|NCT01323634|2824004|P3|2-week Run-in Period|Withdrawal by Subject|0
699306|NCT01392560|2270531|P1|Overall Study|discontinued during placebo run-in|2
699307|NCT01392560|2270531|P1|Overall Study|not entered|8
699308|NCT01392560|2270531|P1|Overall Study|Adverse Event|2
699309|NCT01392547|2270537|P1|Overall Study|Unclassified|1
699310|NCT01392547|2270537|P1|Overall Study|Withdrawal criteria|3
699311|NCT01392547|2270537|P1|Overall Study|Non-compliance|2
699312|NCT01392547|2270537|P1|Overall Study|Adverse Event|2
699313|NCT01392495|2270551|P1|Overall Study|Adverse Event|3
699314|NCT01392495|2270551|P1|Overall Study|Withdrawal by Subject|2
699315|NCT01392495|2270551|P1|Overall Study|Administrative problems|8
699316|NCT01392495|2270551|P1|Overall Study|Death|3
699317|NCT01392378|2270568|P5|Toddler Dose|Withdrawal by Parent|1
699318|NCT01392378|2270569|P4|Toddler Dose|Withdrawal by Parent|1
699319|NCT01392378|2270570|P3|Toddler Dose|Withdrawal by Parent|0
699320|NCT01392378|2270571|P2|Toddler Dose|Withdrawal by Parent|1
699321|NCT01392378|2270572|P1|Toddler Dose|Withdrawal by Parent|0
699322|NCT01392378|2270568|P5|Toddler Dose|Lost to Follow-up|0
699323|NCT01392378|2270569|P4|Toddler Dose|Lost to Follow-up|1
699324|NCT01392378|2270570|P3|Toddler Dose|Lost to Follow-up|0
699325|NCT01392378|2270571|P2|Toddler Dose|Lost to Follow-up|0
699326|NCT01392378|2270572|P1|Toddler Dose|Lost to Follow-up|0
699327|NCT01392378|2270568|P5|After Infant Series|Withdrawal by Parent|1
699328|NCT01392378|2270569|P4|After Infant Series|Withdrawal by Parent|0
699329|NCT01392378|2270570|P3|After Infant Series|Withdrawal by Parent|1
699330|NCT01392378|2270571|P2|After Infant Series|Withdrawal by Parent|1
699331|NCT01392378|2270572|P1|After Infant Series|Withdrawal by Parent|0
699332|NCT01392378|2270568|P5|After Infant Series|Lost to Follow-up|0
699333|NCT01392378|2270569|P4|After Infant Series|Lost to Follow-up|0
699334|NCT01392378|2270570|P3|After Infant Series|Lost to Follow-up|1
699335|NCT01392378|2270571|P2|After Infant Series|Lost to Follow-up|0
699336|NCT01392378|2270572|P1|After Infant Series|Lost to Follow-up|0
699337|NCT01392378|2270568|P5|Infant Series|Withdrawal by Parent|0
699338|NCT01392378|2270569|P4|Infant Series|Withdrawal by Parent|0
699339|NCT01392378|2270570|P3|Infant Series|Withdrawal by Parent|0
699340|NCT01392378|2270571|P2|Infant Series|Withdrawal by Parent|1
699341|NCT01392378|2270572|P1|Infant Series|Withdrawal by Parent|4
699342|NCT01392378|2270568|P5|Infant Series|Protocol Violation|0
699343|NCT01392378|2270569|P4|Infant Series|Protocol Violation|0
699344|NCT01392378|2270570|P3|Infant Series|Protocol Violation|0
699345|NCT01392378|2270571|P2|Infant Series|Protocol Violation|1
699346|NCT01392378|2270572|P1|Infant Series|Protocol Violation|0
699347|NCT01392378|2270568|P5|Infant Series|Lost to Follow-up|0
699348|NCT01392378|2270569|P4|Infant Series|Lost to Follow-up|1
699349|NCT01392378|2270570|P3|Infant Series|Lost to Follow-up|0
699350|NCT01392378|2270571|P2|Infant Series|Lost to Follow-up|0
699351|NCT01392378|2270572|P1|Infant Series|Lost to Follow-up|0
699352|NCT01392378|2270568|P5|Infant Series|Adverse Event|0
699353|NCT01392378|2270569|P4|Infant Series|Adverse Event|1
699354|NCT01392378|2270570|P3|Infant Series|Adverse Event|0
699355|NCT01392378|2270571|P2|Infant Series|Adverse Event|0
699356|NCT01392378|2270572|P1|Infant Series|Adverse Event|0
699357|NCT01392326|2270712|P3|Overall Study|Adverse Event|11
699358|NCT01392326|2270713|P2|Overall Study|Adverse Event|6
699359|NCT01392326|2270714|P1|Overall Study|Adverse Event|9
699360|NCT01392326|2270712|P3|Overall Study|Lack of Efficacy|15
699361|NCT01392326|2270713|P2|Overall Study|Lack of Efficacy|10
699362|NCT01392326|2270714|P1|Overall Study|Lack of Efficacy|14
699363|NCT01392326|2270712|P3|Overall Study|Lost to Follow-up|4
699364|NCT01392326|2270713|P2|Overall Study|Lost to Follow-up|3
699365|NCT01392326|2270714|P1|Overall Study|Lost to Follow-up|1
699366|NCT01392326|2270712|P3|Overall Study|Physician Decision|2
699367|NCT01392326|2270713|P2|Overall Study|Physician Decision|5
699368|NCT01392326|2270714|P1|Overall Study|Physician Decision|7
699369|NCT01392326|2270712|P3|Overall Study|Pregnancy|1
699370|NCT01392326|2270713|P2|Overall Study|Pregnancy|0
699371|NCT01392326|2270714|P1|Overall Study|Pregnancy|0
699372|NCT01392326|2270712|P3|Overall Study|Protocol Violation|0
699373|NCT01392326|2270713|P2|Overall Study|Protocol Violation|0
699374|NCT01392326|2270714|P1|Overall Study|Protocol Violation|2
699375|NCT01392326|2270712|P3|Overall Study|Withdrawal by Subject|15
699376|NCT01392326|2270713|P2|Overall Study|Withdrawal by Subject|11
699377|NCT01392326|2270714|P1|Overall Study|Withdrawal by Subject|12
699378|NCT01392326|2270712|P3|Overall Study|Death|0
699379|NCT01392326|2270713|P2|Overall Study|Death|0
699380|NCT01392326|2270714|P1|Overall Study|Death|2
699381|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
699382|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
699383|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
699384|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
699385|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
699386|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
699387|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Adverse Event|7
699388|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Adverse Event|0
699389|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Adverse Event|0
699390|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Death|4
699391|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Death|0
699392|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Death|0
699393|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Non-compliance|1
699394|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Non-compliance|0
699395|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Non-compliance|0
699396|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
699397|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
699398|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
699399|NCT01392300|2270751|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
699400|NCT01392300|2270752|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
699401|NCT01392300|2270753|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
699402|NCT01392300|2270751|P3|Main Period (MP)|Non-compliance|0
699403|NCT01392300|2270752|P2|Main Period (MP)|Non-compliance|0
699404|NCT01392300|2270753|P1|Main Period (MP)|Non-compliance|1
699405|NCT01392300|2270751|P3|Main Period (MP)|Lost to Follow-up|0
699406|NCT01392300|2270752|P2|Main Period (MP)|Lost to Follow-up|3
699407|NCT01392300|2270753|P1|Main Period (MP)|Lost to Follow-up|3
699408|NCT01392300|2270751|P3|Main Period (MP)|Withdrawal by Subject|0
699409|NCT01392300|2270752|P2|Main Period (MP)|Withdrawal by Subject|1
699410|NCT01392300|2270753|P1|Main Period (MP)|Withdrawal by Subject|5
699411|NCT01392300|2270751|P3|Main Period (MP)|Predefined discontinuation criteria|0
699501|NCT01390441|2271608|P3|Treatment Period|Adverse Event|1
699412|NCT01392300|2270752|P2|Main Period (MP)|Predefined discontinuation criteria|3
699413|NCT01392300|2270753|P1|Main Period (MP)|Predefined discontinuation criteria|2
699414|NCT01392170|2270933|P1|Overall Study|Ineligible|1
699415|NCT01392170|2270933|P1|Overall Study|Withdrawal by Subject|1
699416|NCT01391819|2270981|P1|Overall Study|Unspecified|9
699417|NCT01391819|2270981|P1|Overall Study|Death|3
699418|NCT01391819|2270981|P1|Overall Study|Lost to Follow-up|252
699419|NCT01391819|2270981|P1|Overall Study|Migrated/moved from study area|82
699420|NCT01391819|2270981|P1|Overall Study|Withdrawal by Subject|56
699421|NCT01391663|2271012|P4|Overall Study|Withdrawal by Subject|0
699422|NCT01391663|2271013|P3|Overall Study|Withdrawal by Subject|1
699423|NCT01391663|2271014|P2|Overall Study|Withdrawal by Subject|0
699424|NCT01391663|2271015|P1|Overall Study|Withdrawal by Subject|0
699425|NCT01391507|2271061|P4|Overall Study|Protocol Violation|2
699426|NCT01391507|2271062|P3|Overall Study|Protocol Violation|1
699427|NCT01391507|2271063|P2|Overall Study|Protocol Violation|1
699428|NCT01391507|2271064|P1|Overall Study|Protocol Violation|2
699429|NCT01391507|2271061|P4|Overall Study|Lack of Efficacy|1
699430|NCT01391507|2271062|P3|Overall Study|Lack of Efficacy|0
699431|NCT01391507|2271063|P2|Overall Study|Lack of Efficacy|0
699432|NCT01391507|2271064|P1|Overall Study|Lack of Efficacy|0
699433|NCT01391507|2271061|P4|Overall Study|Withdrawal by Subject|1
699434|NCT01391507|2271062|P3|Overall Study|Withdrawal by Subject|1
699435|NCT01391507|2271063|P2|Overall Study|Withdrawal by Subject|2
699436|NCT01391507|2271064|P1|Overall Study|Withdrawal by Subject|1
699437|NCT01391507|2271061|P4|Overall Study|Adverse Event|2
699438|NCT01391507|2271062|P3|Overall Study|Adverse Event|2
699439|NCT01391507|2271063|P2|Overall Study|Adverse Event|1
699440|NCT01391507|2271064|P1|Overall Study|Adverse Event|1
699441|NCT01391507|2271061|P4|Overall Study|Death|1
699442|NCT01391507|2271062|P3|Overall Study|Death|0
699443|NCT01391507|2271063|P2|Overall Study|Death|0
699444|NCT01391507|2271064|P1|Overall Study|Death|0
699445|NCT01391000|2271168|P2|Overall Study|Lost to Follow-up|0
699446|NCT01391000|2271169|P1|Overall Study|Lost to Follow-up|2
889477|NCT01323634|2824005|P2|2-week Run-in Period|Withdrawal by Subject|0
889478|NCT01323634|2824006|P1|2-week Run-in Period|Withdrawal by Subject|7
889479|NCT01323634|2824004|P3|2-week Run-in Period|Continuation Criteria not Met|0
889480|NCT01323634|2824005|P2|2-week Run-in Period|Continuation Criteria not Met|0
889481|NCT01323634|2824006|P1|2-week Run-in Period|Continuation Criteria not Met|73
889482|NCT01323634|2824004|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
889483|NCT01323634|2824005|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
889484|NCT01323634|2824006|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
889485|NCT01316900|2824098|P4|Overall Study|Withdrawal by Subject|9
889486|NCT01316900|2824099|P3|Overall Study|Withdrawal by Subject|6
699459|NCT01390857|2271250|P1|Overall Study|No Visit after the First Visit|7
699460|NCT01390857|2271250|P1|Overall Study|Lost to Follow-up|1
699461|NCT01390857|2271250|P1|Overall Study|Protocol Violation|2
699462|NCT01390844|2271261|P4|Follow-Up Phase|Non-Medical Reasons|0
699463|NCT01390844|2271262|P3|Follow-Up Phase|Non-Medical Reasons|1
699464|NCT01390844|2271263|P2|Follow-Up Phase|Non-Medical Reasons|1
699465|NCT01390844|2271264|P1|Follow-Up Phase|Non-Medical Reasons|1
699466|NCT01390844|2271261|P4|Treatment Phase|Non-GCP Compliant|3
699467|NCT01390844|2271262|P3|Treatment Phase|Non-GCP Compliant|10
699468|NCT01390844|2271263|P2|Treatment Phase|Non-GCP Compliant|0
699469|NCT01390844|2271264|P1|Treatment Phase|Non-GCP Compliant|0
699470|NCT01390844|2271261|P4|Treatment Phase|Non-Medical Reasons|1
699471|NCT01390844|2271262|P3|Treatment Phase|Non-Medical Reasons|8
699472|NCT01390844|2271263|P2|Treatment Phase|Non-Medical Reasons|1
699473|NCT01390844|2271264|P1|Treatment Phase|Non-Medical Reasons|5
699474|NCT01390844|2271261|P4|Treatment Phase|Treatment Failure|13
699475|NCT01390844|2271262|P3|Treatment Phase|Treatment Failure|10
699476|NCT01390844|2271263|P2|Treatment Phase|Treatment Failure|25
699477|NCT01390844|2271264|P1|Treatment Phase|Treatment Failure|23
699478|NCT01390844|2271261|P4|Treatment Phase|Adverse Event|2
699479|NCT01390844|2271262|P3|Treatment Phase|Adverse Event|3
699480|NCT01390844|2271263|P2|Treatment Phase|Adverse Event|2
699481|NCT01390844|2271264|P1|Treatment Phase|Adverse Event|12
699482|NCT01390779|2271591|P1|Overall Study|Physician Decision|1
699483|NCT01390649|2271596|P1|Overall Study|Physician Decision|1
699484|NCT01390441|2271606|P5|Extension Period|Protocol Violation|0
699485|NCT01390441|2271607|P4|Extension Period|Protocol Violation|1
699486|NCT01390441|2271608|P3|Extension Period|Protocol Violation|0
699487|NCT01390441|2271609|P2|Extension Period|Protocol Violation|1
699488|NCT01390441|2271610|P1|Extension Period|Protocol Violation|3
699489|NCT01390441|2271606|P5|Treatment Period|Lost to Follow-up|0
699490|NCT01390441|2271607|P4|Treatment Period|Lost to Follow-up|0
699491|NCT01390441|2271608|P3|Treatment Period|Lost to Follow-up|0
699492|NCT01390441|2271609|P2|Treatment Period|Lost to Follow-up|0
699493|NCT01390441|2271610|P1|Treatment Period|Lost to Follow-up|1
699494|NCT01390441|2271606|P5|Treatment Period|Withdrawal by Subject|1
699495|NCT01390441|2271607|P4|Treatment Period|Withdrawal by Subject|0
699496|NCT01390441|2271608|P3|Treatment Period|Withdrawal by Subject|1
699497|NCT01390441|2271609|P2|Treatment Period|Withdrawal by Subject|0
699498|NCT01390441|2271610|P1|Treatment Period|Withdrawal by Subject|0
699499|NCT01390441|2271606|P5|Treatment Period|Adverse Event|2
699500|NCT01390441|2271607|P4|Treatment Period|Adverse Event|1
699502|NCT01390441|2271609|P2|Treatment Period|Adverse Event|0
699503|NCT01390441|2271610|P1|Treatment Period|Adverse Event|0
699504|NCT01390441|2271606|P5|Treatment Period|Unknown due to early stopping of study|7
699505|NCT01390441|2271607|P4|Treatment Period|Unknown due to early stopping of study|11
699506|NCT01390441|2271608|P3|Treatment Period|Unknown due to early stopping of study|8
699507|NCT01390441|2271609|P2|Treatment Period|Unknown due to early stopping of study|0
699508|NCT01390441|2271610|P1|Treatment Period|Unknown due to early stopping of study|0
699509|NCT01390441|2271606|P5|Treatment Period|Lack of Efficacy|1
699510|NCT01390441|2271607|P4|Treatment Period|Lack of Efficacy|0
699511|NCT01390441|2271608|P3|Treatment Period|Lack of Efficacy|0
699512|NCT01390441|2271609|P2|Treatment Period|Lack of Efficacy|0
699513|NCT01390441|2271610|P1|Treatment Period|Lack of Efficacy|0
699514|NCT01390441|2271606|P5|Treatment Period|Physician Decision|0
699515|NCT01390441|2271607|P4|Treatment Period|Physician Decision|1
699516|NCT01390441|2271608|P3|Treatment Period|Physician Decision|0
699517|NCT01390441|2271609|P2|Treatment Period|Physician Decision|0
699518|NCT01390441|2271610|P1|Treatment Period|Physician Decision|0
699519|NCT01390441|2271606|P5|Treatment Period|Protocol Violation|0
699520|NCT01390441|2271607|P4|Treatment Period|Protocol Violation|0
699521|NCT01390441|2271608|P3|Treatment Period|Protocol Violation|0
699522|NCT01390441|2271609|P2|Treatment Period|Protocol Violation|1
699523|NCT01390441|2271610|P1|Treatment Period|Protocol Violation|0
699536|NCT01390402|2271743|P1|Overall Study|Disease Progression|4
699537|NCT01390402|2271743|P1|Overall Study|Death|1
889487|NCT01316900|2824100|P2|Overall Study|Withdrawal by Subject|8
889488|NCT01316900|2824101|P1|Overall Study|Withdrawal by Subject|7
889489|NCT01316900|2824098|P4|Overall Study|Lost to Follow-up|1
889490|NCT01316900|2824099|P3|Overall Study|Lost to Follow-up|1
699542|NCT01390181|2271779|P1|Overall Study|Study Terminated due to Low Accrual|3
699543|NCT01390181|2271779|P1|Overall Study|Lost to Follow-up|1
699544|NCT01390038|2271783|P1|Overall Study|Simpliciti System Removal|2
699545|NCT01390038|2271783|P1|Overall Study|Withdrawal by Subject|4
699546|NCT01390038|2271783|P1|Overall Study|Lost to Follow-up|1
699547|NCT01390038|2271783|P1|Overall Study|Death|1
699548|NCT01389973|2271793|P1|Overall Study|Unspecified|10
699549|NCT01389973|2271793|P1|Overall Study|Trial Stopped by Sponsor|9
699550|NCT01389973|2271793|P1|Overall Study|Lost to Follow-up|1
699551|NCT01389882|2271803|P2|Overall Study|Withdrawal by Subject|1
699552|NCT01389882|2271804|P1|Overall Study|Withdrawal by Subject|0
699553|NCT01389882|2271803|P2|Overall Study|Respiratory rate > 80/min during study|3
699554|NCT01389882|2271804|P1|Overall Study|Respiratory rate > 80/min during study|1
699555|NCT01389817|2271892|P2|Overall Study|Withdrawal by Subject|0
699556|NCT01389817|2271893|P1|Overall Study|Withdrawal by Subject|2
699557|NCT01389817|2271892|P2|Overall Study|Lost to Follow-up|0
699558|NCT01389817|2271893|P1|Overall Study|Lost to Follow-up|1
699559|NCT01389817|2271892|P2|Overall Study|Physician Decision|0
699560|NCT01389817|2271893|P1|Overall Study|Physician Decision|1
699579|NCT01389323|2271963|P1|Follow-up Period (up to 48 Weeks)|Unspecified|3
699580|NCT01389323|2271963|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
699581|NCT01389323|2271963|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
699582|NCT01389323|2271963|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
699583|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
699584|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
699585|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
699586|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
699587|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
699588|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
699589|NCT01389323|2271963|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
699590|NCT01389102|2272026|P6|Overall Study|Investigator Judgement|0
699591|NCT01389102|2272027|P5|Overall Study|Investigator Judgement|0
699592|NCT01389102|2272028|P4|Overall Study|Investigator Judgement|0
699593|NCT01389102|2272029|P3|Overall Study|Investigator Judgement|0
699594|NCT01389102|2272030|P2|Overall Study|Investigator Judgement|1
699595|NCT01389102|2272031|P1|Overall Study|Investigator Judgement|0
699596|NCT01389102|2272026|P6|Overall Study|Unavailable due to husband's illness|0
699597|NCT01389102|2272027|P5|Overall Study|Unavailable due to husband's illness|0
699598|NCT01389102|2272028|P4|Overall Study|Unavailable due to husband's illness|0
699599|NCT01389102|2272029|P3|Overall Study|Unavailable due to husband's illness|0
699600|NCT01389102|2272030|P2|Overall Study|Unavailable due to husband's illness|1
699601|NCT01389102|2272031|P1|Overall Study|Unavailable due to husband's illness|0
699602|NCT01389102|2272026|P6|Overall Study|Subject Moved|0
699603|NCT01389102|2272027|P5|Overall Study|Subject Moved|0
699604|NCT01389102|2272028|P4|Overall Study|Subject Moved|0
699605|NCT01389102|2272029|P3|Overall Study|Subject Moved|1
699606|NCT01389102|2272030|P2|Overall Study|Subject Moved|0
699607|NCT01389102|2272031|P1|Overall Study|Subject Moved|2
699608|NCT01389102|2272026|P6|Overall Study|Subject Traveling Out of Country|0
699609|NCT01389102|2272027|P5|Overall Study|Subject Traveling Out of Country|0
699610|NCT01389102|2272028|P4|Overall Study|Subject Traveling Out of Country|1
699611|NCT01389102|2272029|P3|Overall Study|Subject Traveling Out of Country|0
699612|NCT01389102|2272030|P2|Overall Study|Subject Traveling Out of Country|0
699613|NCT01389102|2272031|P1|Overall Study|Subject Traveling Out of Country|0
699614|NCT01389102|2272026|P6|Overall Study|Withdrawal by Subject|3
699615|NCT01389102|2272027|P5|Overall Study|Withdrawal by Subject|3
699616|NCT01389102|2272028|P4|Overall Study|Withdrawal by Subject|2
699617|NCT01389102|2272029|P3|Overall Study|Withdrawal by Subject|9
699618|NCT01389102|2272030|P2|Overall Study|Withdrawal by Subject|4
699619|NCT01389102|2272031|P1|Overall Study|Withdrawal by Subject|7
699620|NCT01389102|2272026|P6|Overall Study|Protocol Violation|1
699621|NCT01389102|2272027|P5|Overall Study|Protocol Violation|1
699622|NCT01389102|2272028|P4|Overall Study|Protocol Violation|0
699623|NCT01389102|2272029|P3|Overall Study|Protocol Violation|3
699624|NCT01389102|2272030|P2|Overall Study|Protocol Violation|0
699625|NCT01389102|2272031|P1|Overall Study|Protocol Violation|0
699626|NCT01389102|2272026|P6|Overall Study|Lost to Follow-up|1
699627|NCT01389102|2272027|P5|Overall Study|Lost to Follow-up|4
699628|NCT01389102|2272028|P4|Overall Study|Lost to Follow-up|2
699629|NCT01389102|2272029|P3|Overall Study|Lost to Follow-up|1
699630|NCT01389102|2272030|P2|Overall Study|Lost to Follow-up|1
699631|NCT01389102|2272031|P1|Overall Study|Lost to Follow-up|4
699632|NCT01389102|2272026|P6|Overall Study|Hurricane Katrina|1
699633|NCT01389102|2272027|P5|Overall Study|Hurricane Katrina|3
699634|NCT01389102|2272028|P4|Overall Study|Hurricane Katrina|0
699635|NCT01389102|2272029|P3|Overall Study|Hurricane Katrina|3
699636|NCT01389102|2272030|P2|Overall Study|Hurricane Katrina|2
699637|NCT01389102|2272031|P1|Overall Study|Hurricane Katrina|4
699638|NCT01389102|2272026|P6|Overall Study|Adverse Event|2
699639|NCT01389102|2272027|P5|Overall Study|Adverse Event|2
699640|NCT01389102|2272028|P4|Overall Study|Adverse Event|2
699641|NCT01389102|2272029|P3|Overall Study|Adverse Event|2
699642|NCT01389102|2272030|P2|Overall Study|Adverse Event|3
699643|NCT01389102|2272031|P1|Overall Study|Adverse Event|1
699644|NCT01388907|2272109|P2|Overall Study|Adverse Event|0
699645|NCT01388907|2272110|P1|Overall Study|Adverse Event|2
699646|NCT01388816|2272126|P4|Overall Study|Protocol Violation|0
699647|NCT01388816|2272127|P3|Overall Study|Protocol Violation|2
699648|NCT01388816|2272128|P2|Overall Study|Protocol Violation|0
699649|NCT01388816|2272129|P1|Overall Study|Protocol Violation|0
699650|NCT01388816|2272126|P4|Overall Study|Withdrawal by Subject|0
699651|NCT01388816|2272127|P3|Overall Study|Withdrawal by Subject|1
699652|NCT01388816|2272128|P2|Overall Study|Withdrawal by Subject|1
699653|NCT01388816|2272129|P1|Overall Study|Withdrawal by Subject|2
699654|NCT01388816|2272126|P4|Overall Study|Lost to Follow-up|0
699655|NCT01388816|2272127|P3|Overall Study|Lost to Follow-up|0
699656|NCT01388816|2272128|P2|Overall Study|Lost to Follow-up|1
699657|NCT01388816|2272129|P1|Overall Study|Lost to Follow-up|0
699658|NCT01388816|2272126|P4|Overall Study|Adverse Event|0
699659|NCT01388816|2272127|P3|Overall Study|Adverse Event|0
699660|NCT01388816|2272128|P2|Overall Study|Adverse Event|2
699661|NCT01388816|2272129|P1|Overall Study|Adverse Event|0
699662|NCT01388790|2272158|P1|Overall Study|Ongoing at data cut−off date|8
699663|NCT01388647|2272165|P2|Overall Study|Adverse Event|2
699664|NCT01388647|2272166|P1|Overall Study|Adverse Event|1
699665|NCT01388530|2272177|P1|Overall Study|Lost to Follow-up|5
699666|NCT01388491|2272186|P2|Overall Study|Pregnancy|0
699667|NCT01388491|2272187|P1|Overall Study|Pregnancy|1
699668|NCT01388491|2272186|P2|Overall Study|Noncompliance|0
699669|NCT01388491|2272187|P1|Overall Study|Noncompliance|2
699670|NCT01388491|2272186|P2|Overall Study|Protocol Violation|0
699671|NCT01388491|2272187|P1|Overall Study|Protocol Violation|2
699672|NCT01388491|2272186|P2|Overall Study|Lost to Follow-up|3
699673|NCT01388491|2272187|P1|Overall Study|Lost to Follow-up|4
699674|NCT01388491|2272186|P2|Overall Study|Withdrawal by Subject|10
699675|NCT01388491|2272187|P1|Overall Study|Withdrawal by Subject|6
699676|NCT01388491|2272186|P2|Overall Study|Sponsor Request|7
699677|NCT01388491|2272187|P1|Overall Study|Sponsor Request|9
699678|NCT01388491|2272186|P2|Overall Study|Adverse Event|9
699679|NCT01388491|2272187|P1|Overall Study|Adverse Event|10
699680|NCT01388361|2272222|P3|Overall Study|Unclassified|1
699681|NCT01388361|2272223|P2|Overall Study|Unclassified|0
699682|NCT01388361|2272224|P1|Overall Study|Unclassified|0
699683|NCT01388361|2272222|P3|Overall Study|Withdrawal criteria|10
699684|NCT01388361|2272223|P2|Overall Study|Withdrawal criteria|7
699685|NCT01388361|2272224|P1|Overall Study|Withdrawal criteria|12
699686|NCT01388361|2272222|P3|Overall Study|Protocol Violation|2
699687|NCT01388361|2272223|P2|Overall Study|Protocol Violation|0
699688|NCT01388361|2272224|P1|Overall Study|Protocol Violation|0
699689|NCT01388361|2272222|P3|Overall Study|Adverse Event|1
699690|NCT01388361|2272223|P2|Overall Study|Adverse Event|5
699691|NCT01388361|2272224|P1|Overall Study|Adverse Event|0
699692|NCT01388166|2272241|P1|Overall Study|Others than specified above|13
699693|NCT01388166|2272241|P1|Overall Study|Lost to Follow-up|30
699694|NCT01388166|2272241|P1|Overall Study|Adverse Event|16
699695|NCT01387789|2272247|P1|Overall Study|Lost to Follow-up|1
699696|NCT01387789|2272247|P1|Overall Study|Lack of Efficacy|2
699697|NCT01387789|2272247|P1|Overall Study|Adverse Event|5
699698|NCT01387737|2272261|P2|Overall Study|Clearly not eligible for the study|3
699699|NCT01387737|2272262|P1|Overall Study|Clearly not eligible for the study|1
699700|NCT01387737|2272261|P2|Overall Study|Withdrawal by Subject|31
699701|NCT01387737|2272262|P1|Overall Study|Withdrawal by Subject|27
699702|NCT01387737|2272261|P2|Overall Study|Physician Decision|10
699703|NCT01387737|2272262|P1|Overall Study|Physician Decision|3
699704|NCT01387737|2272261|P2|Overall Study|Lack of Efficacy|0
699705|NCT01387737|2272262|P1|Overall Study|Lack of Efficacy|1
699706|NCT01387737|2272261|P2|Overall Study|Adverse Event|30
699707|NCT01387737|2272262|P1|Overall Study|Adverse Event|20
699708|NCT01387594|2272296|P2|Overall Study|Lost to Follow-up|1
699709|NCT01387594|2272297|P1|Overall Study|Lost to Follow-up|0
699710|NCT01387594|2272296|P2|Overall Study|Withdrawal by Subject|2
699711|NCT01387594|2272297|P1|Overall Study|Withdrawal by Subject|0
699712|NCT01387542|2272325|P1|Overall Study|Lost to Follow-up|1
699713|NCT01387542|2272325|P1|Overall Study|Non-compliant|1
699714|NCT01387542|2272325|P1|Overall Study|Insufficient response|1
699715|NCT01387542|2272325|P1|Overall Study|Changed diagnosis|1
699716|NCT01387542|2272325|P1|Overall Study|Withdrawal by Subject|1
699717|NCT01387542|2272325|P1|Overall Study|Adverse Event|3
699718|NCT01387347|2272343|P2|Overall Study|Lost to Follow-up|1
699719|NCT01387347|2272344|P1|Overall Study|Lost to Follow-up|2
889491|NCT01316900|2824100|P2|Overall Study|Lost to Follow-up|0
889492|NCT01316900|2824101|P1|Overall Study|Lost to Follow-up|1
889493|NCT01316900|2824098|P4|Overall Study|Protocol-defined Stopping Criteria|5
889494|NCT01316900|2824099|P3|Overall Study|Protocol-defined Stopping Criteria|10
889495|NCT01316900|2824100|P2|Overall Study|Protocol-defined Stopping Criteria|3
889496|NCT01316900|2824101|P1|Overall Study|Protocol-defined Stopping Criteria|2
889497|NCT01316900|2824098|P4|Overall Study|Protocol Violation|0
889498|NCT01316900|2824099|P3|Overall Study|Protocol Violation|4
889499|NCT01316900|2824100|P2|Overall Study|Protocol Violation|1
889500|NCT01316900|2824101|P1|Overall Study|Protocol Violation|7
889501|NCT01316900|2824098|P4|Overall Study|Lack of Efficacy|7
889502|NCT01316900|2824099|P3|Overall Study|Lack of Efficacy|5
889503|NCT01316900|2824100|P2|Overall Study|Lack of Efficacy|9
889504|NCT01316900|2824101|P1|Overall Study|Lack of Efficacy|17
889505|NCT01316900|2824098|P4|Overall Study|Adverse Event|9
889506|NCT01316900|2824099|P3|Overall Study|Adverse Event|15
889507|NCT01316900|2824100|P2|Overall Study|Adverse Event|10
889508|NCT01316900|2824101|P1|Overall Study|Adverse Event|10
889509|NCT01316887|2824122|P3|Overall Study|Withdrawal by Subject|15
889510|NCT01316887|2824123|P2|Overall Study|Withdrawal by Subject|16
889511|NCT01316887|2824124|P1|Overall Study|Withdrawal by Subject|8
889512|NCT01316887|2824122|P3|Overall Study|Lost to Follow-up|5
699759|NCT01387074|2272439|P1|Overall Study|Lack of Efficacy|1
699760|NCT01387074|2272439|P1|Overall Study|Lost to Follow-up|7
699761|NCT01387022|2272452|P2|Overall Study|Lost to Follow-up|3
699762|NCT01387022|2272453|P1|Overall Study|Lost to Follow-up|0
699763|NCT01387022|2272452|P2|Overall Study|Death|1
699764|NCT01387022|2272453|P1|Overall Study|Death|1
699765|NCT01386944|2272480|P1|Overall Study|Unspecified reason|8
699766|NCT01386944|2272480|P1|Overall Study|Lost to Follow-up|8
699767|NCT01386944|2272480|P1|Overall Study|Lack of Efficacy|14
699768|NCT01386944|2272480|P1|Overall Study|Adverse Event|26
699769|NCT01386788|2272490|P1|Overall Study|Lost to Follow-up|2
699770|NCT01386606|2272510|P4|Overall Study|T levels too high|0
699771|NCT01386606|2272511|P3|Overall Study|T levels too high|1
699772|NCT01386606|2272512|P2|Overall Study|T levels too high|1
699773|NCT01386606|2272513|P1|Overall Study|T levels too high|0
699774|NCT01386606|2272510|P4|Overall Study|Unable to draw PK|0
699775|NCT01386606|2272511|P3|Overall Study|Unable to draw PK|0
699776|NCT01386606|2272512|P2|Overall Study|Unable to draw PK|0
699777|NCT01386606|2272513|P1|Overall Study|Unable to draw PK|1
699778|NCT01386606|2272510|P4|Overall Study|Subject incarcerated|0
699779|NCT01386606|2272511|P3|Overall Study|Subject incarcerated|0
699780|NCT01386606|2272512|P2|Overall Study|Subject incarcerated|1
699781|NCT01386606|2272513|P1|Overall Study|Subject incarcerated|0
699782|NCT01386606|2272510|P4|Overall Study|Lost to Follow-up|0
699783|NCT01386606|2272511|P3|Overall Study|Lost to Follow-up|0
699784|NCT01386606|2272512|P2|Overall Study|Lost to Follow-up|0
699785|NCT01386606|2272513|P1|Overall Study|Lost to Follow-up|2
699786|NCT01386606|2272510|P4|Overall Study|Protocol Violation|1
699787|NCT01386606|2272511|P3|Overall Study|Protocol Violation|1
699788|NCT01386606|2272512|P2|Overall Study|Protocol Violation|0
699789|NCT01386606|2272513|P1|Overall Study|Protocol Violation|1
699790|NCT01386606|2272510|P4|Overall Study|Withdrawal by Subject|0
699791|NCT01386606|2272511|P3|Overall Study|Withdrawal by Subject|1
699792|NCT01386606|2272512|P2|Overall Study|Withdrawal by Subject|1
699793|NCT01386606|2272513|P1|Overall Study|Withdrawal by Subject|0
699794|NCT01386606|2272510|P4|Overall Study|Adverse Event|0
699795|NCT01386606|2272511|P3|Overall Study|Adverse Event|0
699796|NCT01386606|2272512|P2|Overall Study|Adverse Event|1
699797|NCT01386606|2272513|P1|Overall Study|Adverse Event|0
699798|NCT01386125|2272553|P2|Overall Study|Participant Leaving Country|0
699799|NCT01386125|2272554|P1|Overall Study|Participant Leaving Country|1
699800|NCT01386125|2272553|P2|Overall Study|Lack of Efficacy|1
699801|NCT01386125|2272554|P1|Overall Study|Lack of Efficacy|0
699802|NCT01386125|2272553|P2|Overall Study|Adverse Event|5
699803|NCT01386125|2272554|P1|Overall Study|Adverse Event|2
699804|NCT01386125|2272553|P2|Overall Study|Withdrawal by Subject|12
699805|NCT01386125|2272554|P1|Overall Study|Withdrawal by Subject|13
699806|NCT01386125|2272553|P2|Overall Study|Disease Progress|2
699807|NCT01386125|2272554|P1|Overall Study|Disease Progress|1
699808|NCT01386125|2272553|P2|Overall Study|Protocol Violation|7
699809|NCT01386125|2272554|P1|Overall Study|Protocol Violation|5
699810|NCT01386125|2272553|P2|Overall Study|Physician Decision|1
699811|NCT01386125|2272554|P1|Overall Study|Physician Decision|0
699812|NCT01386125|2272553|P2|Overall Study|Lost to Follow-up|9
699813|NCT01386125|2272554|P1|Overall Study|Lost to Follow-up|3
699814|NCT01386008|2272562|P1|Overall Study|Adverse Event|3
699815|NCT01386008|2272562|P1|Overall Study|exited w/o incident /study discontinued|17
699816|NCT01385995|2272571|P2|Period 1, 2 Months|Physician Decision|0
699817|NCT01385995|2272572|P1|Period 1, 2 Months|Physician Decision|1
699830|NCT01385566|2272672|P6|Overall Study|Withdrawal by Subject|0
699831|NCT01385566|2272673|P5|Overall Study|Withdrawal by Subject|0
699832|NCT01385566|2272674|P4|Overall Study|Withdrawal by Subject|1
699833|NCT01385566|2272675|P3|Overall Study|Withdrawal by Subject|0
699834|NCT01385566|2272676|P2|Overall Study|Withdrawal by Subject|0
699835|NCT01385566|2272677|P1|Overall Study|Withdrawal by Subject|0
699836|NCT01385566|2272672|P6|Overall Study|Lost to Follow-up|0
699837|NCT01385566|2272673|P5|Overall Study|Lost to Follow-up|0
699838|NCT01385566|2272674|P4|Overall Study|Lost to Follow-up|0
699839|NCT01385566|2272675|P3|Overall Study|Lost to Follow-up|0
699840|NCT01385566|2272676|P2|Overall Study|Lost to Follow-up|0
699841|NCT01385566|2272677|P1|Overall Study|Lost to Follow-up|1
699842|NCT01385371|2272731|P2|Overall Study|Administrative|2
699843|NCT01385371|2272732|P1|Overall Study|Administrative|2
699844|NCT01385371|2272731|P2|Overall Study|Protocol Violation|21
699845|NCT01385371|2272732|P1|Overall Study|Protocol Violation|25
699846|NCT01385371|2272731|P2|Overall Study|Withdrawal by Subject|39
699847|NCT01385371|2272732|P1|Overall Study|Withdrawal by Subject|52
699848|NCT01385371|2272731|P2|Overall Study|Lost to Follow-up|16
699849|NCT01385371|2272732|P1|Overall Study|Lost to Follow-up|16
699850|NCT01385371|2272731|P2|Overall Study|Adverse Event|19
699851|NCT01385371|2272732|P1|Overall Study|Adverse Event|54
699852|NCT01385202|2272762|P1|Overall Study|Withdrawn|1
699853|NCT01385202|2272762|P1|Overall Study|Not Eligible|11
699854|NCT01385202|2272762|P1|Overall Study|Lost to Follow-up|6
699855|NCT01384760|2272830|P2|Overall Study|Protocol Violation|0
699856|NCT01384760|2272831|P1|Overall Study|Protocol Violation|16
699857|NCT01384760|2272830|P2|Overall Study|Lost to Follow-up|6
699858|NCT01384760|2272831|P1|Overall Study|Lost to Follow-up|0
699859|NCT01384292|2272851|P3|Part B|Severe non-compliance to protocol|0
699860|NCT01384292|2272852|P2|Part B|Severe non-compliance to protocol|0
699861|NCT01384292|2272853|P1|Part B|Severe non-compliance to protocol|1
699862|NCT01384019|2272865|P2|Overall Study|MRI refusal|6
699863|NCT01384019|2272866|P1|Overall Study|MRI refusal|6
699864|NCT01384019|2272865|P2|Overall Study|Death|0
699865|NCT01384019|2272866|P1|Overall Study|Death|1
699866|NCT01384019|2272865|P2|Overall Study|Withdrawal by Subject|0
699867|NCT01384019|2272866|P1|Overall Study|Withdrawal by Subject|3
699868|NCT01383993|2272875|P3|Overall Study|Marketed voriconazole in post-therapy|0
699869|NCT01383993|2272876|P2|Overall Study|Marketed voriconazole in post-therapy|0
699870|NCT01383993|2272877|P1|Overall Study|Marketed voriconazole in post-therapy|2
699871|NCT01383993|2272875|P3|Overall Study|Withdrawal by Subject|1
699872|NCT01383993|2272876|P2|Overall Study|Withdrawal by Subject|0
699873|NCT01383993|2272877|P1|Overall Study|Withdrawal by Subject|0
699874|NCT01383993|2272875|P3|Overall Study|Adverse Event|0
699875|NCT01383993|2272876|P2|Overall Study|Adverse Event|1
699876|NCT01383993|2272877|P1|Overall Study|Adverse Event|1
699877|NCT01383954|2272924|P1|Overall Study|Reason Not Specified|9
699878|NCT01383954|2272924|P1|Overall Study|Adverse Event|1
699879|NCT01383954|2272924|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
699880|NCT01383954|2272924|P1|Overall Study|Lack of Efficacy|2
889513|NCT01316887|2824123|P2|Overall Study|Lost to Follow-up|7
889514|NCT01316887|2824124|P1|Overall Study|Lost to Follow-up|1
889515|NCT01316887|2824122|P3|Overall Study|Study Closed/Terminated|3
889516|NCT01316887|2824123|P2|Overall Study|Study Closed/Terminated|4
889517|NCT01316887|2824124|P1|Overall Study|Study Closed/Terminated|2
889518|NCT01316887|2824122|P3|Overall Study|Protocol-defined Stopping Criteria|36
889519|NCT01316887|2824123|P2|Overall Study|Protocol-defined Stopping Criteria|37
889520|NCT01316887|2824124|P1|Overall Study|Protocol-defined Stopping Criteria|8
889521|NCT01316887|2824122|P3|Overall Study|Protocol Violation|6
889522|NCT01316887|2824123|P2|Overall Study|Protocol Violation|6
889523|NCT01316887|2824124|P1|Overall Study|Protocol Violation|2
889524|NCT01316887|2824122|P3|Overall Study|Lack of Efficacy|1
889525|NCT01316887|2824123|P2|Overall Study|Lack of Efficacy|3
889526|NCT01316887|2824124|P1|Overall Study|Lack of Efficacy|9
889527|NCT01316887|2824122|P3|Overall Study|Adverse Event|17
889528|NCT01316887|2824123|P2|Overall Study|Adverse Event|21
889529|NCT01316887|2824124|P1|Overall Study|Adverse Event|13
699911|NCT01383707|2272998|P1|Overall Study|Progressive disease|23
699912|NCT01383707|2272998|P1|Overall Study|Adverse Event|14
699913|NCT01383707|2272998|P1|Overall Study|Sponsor's decision|2
699914|NCT01383707|2272998|P1|Overall Study|Not specified|8
699915|NCT01383707|2272998|P1|Overall Study|Death|19
699916|NCT01383707|2272998|P1|Overall Study|Consent withdrawal|6
699917|NCT01383499|2273038|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
699918|NCT01383499|2273039|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
699919|NCT01383499|2273040|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
699920|NCT01383499|2273041|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
699921|NCT01383486|2273091|P1|Overall Study|Did not take any product|6
699922|NCT01383486|2273091|P1|Overall Study|Incomplete information for analysis|2
699923|NCT01383486|2273091|P1|Overall Study|Lost to Follow-up|10
699924|NCT01383356|2273168|P2|Period 1|Personal|2
699925|NCT01383356|2273169|P1|Period 1|Personal|0
699926|NCT01383356|2273168|P2|Period 1|Out of Range Mid-study-Test|1
699927|NCT01383356|2273169|P1|Period 1|Out of Range Mid-study-Test|0
699928|NCT01383356|2273168|P2|Period 1|Non-compliance|0
699929|NCT01383356|2273169|P1|Period 1|Non-compliance|3
699930|NCT01383356|2273168|P2|Period 1|Adverse Event|3
699931|NCT01383356|2273169|P1|Period 1|Adverse Event|5
699932|NCT01383174|2273199|P2|6 Month Assessment|Refused to complete|0
699933|NCT01383174|2273200|P1|6 Month Assessment|Refused to complete|4
699934|NCT01383174|2273199|P2|6 Month Assessment|Lost to Follow-up|1
699935|NCT01383174|2273200|P1|6 Month Assessment|Lost to Follow-up|1
699936|NCT01383174|2273199|P2|3 Month Assessment|Refused to complete|0
699937|NCT01383174|2273200|P1|3 Month Assessment|Refused to complete|4
699938|NCT01383174|2273199|P2|3 Month Assessment|Lost to Follow-up|0
699939|NCT01383174|2273200|P1|3 Month Assessment|Lost to Follow-up|2
699940|NCT01383174|2273199|P2|3 Month Assessment|Death|1
699941|NCT01383174|2273200|P1|3 Month Assessment|Death|0
699942|NCT01383096|2273227|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
699943|NCT01383096|2273228|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
699944|NCT01383096|2273229|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
699945|NCT01383096|2273227|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
699946|NCT01383096|2273228|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
699947|NCT01383096|2273229|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
699948|NCT01383096|2273227|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
699949|NCT01383096|2273228|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
699950|NCT01383096|2273229|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
699951|NCT01383096|2273227|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
699952|NCT01383096|2273228|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
699953|NCT01383096|2273229|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
699954|NCT01383096|2273227|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
699955|NCT01383096|2273228|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
699956|NCT01383096|2273229|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
699957|NCT01383096|2273227|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
699958|NCT01383096|2273228|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
699959|NCT01383096|2273229|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
699960|NCT01383096|2273227|P3|Third Intervention (8 Days)|Adverse Event|0
699961|NCT01383096|2273228|P2|Third Intervention (8 Days)|Adverse Event|0
699962|NCT01383096|2273229|P1|Third Intervention (8 Days)|Adverse Event|1
699963|NCT01383096|2273227|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
699964|NCT01383096|2273228|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
699965|NCT01383096|2273229|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
699966|NCT01383096|2273227|P3|Third Intervention (8 Days)|Elevated AST|0
699967|NCT01383096|2273228|P2|Third Intervention (8 Days)|Elevated AST|1
699968|NCT01383096|2273229|P1|Third Intervention (8 Days)|Elevated AST|0
699969|NCT01383096|2273227|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
699970|NCT01383096|2273228|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
699971|NCT01383096|2273229|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
699972|NCT01383096|2273227|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
699973|NCT01383096|2273228|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
699974|NCT01383096|2273229|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
699975|NCT01382940|2273297|P1|Overall Study|Protocol Violation|20
699976|NCT01382940|2273297|P1|Overall Study|Withdrawal by Subject|23
699977|NCT01382940|2273297|P1|Overall Study|Physician Decision|7
699978|NCT01382940|2273297|P1|Overall Study|Lost to Follow-up|4
699979|NCT01382940|2273297|P1|Overall Study|Adverse Event|19
699980|NCT01382446|2273359|P2|Overall Study|Removal from Mechanical Ventilation|3
699981|NCT01382446|2273360|P1|Overall Study|Removal from Mechanical Ventilation|3
699982|NCT01382446|2273359|P2|Overall Study|Withdrawal by Subject|1
699983|NCT01382446|2273360|P1|Overall Study|Withdrawal by Subject|0
699984|NCT01382251|2273387|P2|Overall Study|Contacted after study closed|1
699985|NCT01382251|2273388|P1|Overall Study|Contacted after study closed|1
699986|NCT01382251|2273387|P2|Overall Study|Lost to Follow-up|4
699987|NCT01382251|2273388|P1|Overall Study|Lost to Follow-up|4
699988|NCT01382251|2273387|P2|Overall Study|Surgeries cancelled or delayed|16
699989|NCT01382251|2273388|P1|Overall Study|Surgeries cancelled or delayed|16
699990|NCT01382225|2273401|P2|Overall Study|Other|2
699991|NCT01382225|2273402|P1|Overall Study|Other|4
699992|NCT01382225|2273401|P2|Overall Study|Subject Withdrew Consent|2
699993|NCT01382225|2273402|P1|Overall Study|Subject Withdrew Consent|5
699994|NCT01382225|2273401|P2|Overall Study|Protocol Violation|1
699995|NCT01382225|2273402|P1|Overall Study|Protocol Violation|2
699996|NCT01382225|2273401|P2|Overall Study|Adverse Event|2
699997|NCT01382225|2273402|P1|Overall Study|Adverse Event|3
699998|NCT01382212|2273424|P1|Overall Study|Withdrew consent|1
699999|NCT01382212|2273424|P1|Overall Study|Kidney transplant|1
700000|NCT01381926|2273487|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
700001|NCT01381926|2273488|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
700002|NCT01381926|2273487|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
700003|NCT01381926|2273488|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
700004|NCT01381900|2273501|P3|Overall Study|Early withdraw|1
700005|NCT01381900|2273502|P2|Overall Study|Early withdraw|1
700006|NCT01381900|2273503|P1|Overall Study|Early withdraw|3
700007|NCT01381900|2273501|P3|Overall Study|Withdrawal by Subject|1
700008|NCT01381900|2273502|P2|Overall Study|Withdrawal by Subject|0
700009|NCT01381900|2273503|P1|Overall Study|Withdrawal by Subject|0
700010|NCT01381900|2273501|P3|Overall Study|Protocol Violation|1
700011|NCT01381900|2273502|P2|Overall Study|Protocol Violation|1
700012|NCT01381900|2273503|P1|Overall Study|Protocol Violation|0
700013|NCT01381900|2273501|P3|Overall Study|Physician Decision|1
700014|NCT01381900|2273502|P2|Overall Study|Physician Decision|1
700015|NCT01381900|2273503|P1|Overall Study|Physician Decision|0
700016|NCT01381900|2273501|P3|Overall Study|Noncompliance with study drug|1
700017|NCT01381900|2273502|P2|Overall Study|Noncompliance with study drug|0
700018|NCT01381900|2273503|P1|Overall Study|Noncompliance with study drug|0
700019|NCT01381900|2273501|P3|Overall Study|Adverse Event|7
700020|NCT01381900|2273502|P2|Overall Study|Adverse Event|6
700021|NCT01381900|2273503|P1|Overall Study|Adverse Event|4
700022|NCT01381900|2273501|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
700023|NCT01381900|2273502|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
700024|NCT01381900|2273503|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
700025|NCT01381679|2273523|P1|Overall Study|Lost to Follow-up|885
700026|NCT01381679|2273523|P1|Overall Study|Adverse Event|3
700027|NCT01381575|2273538|P3|Overall Study|Withdrawal by Subject|4
700028|NCT01381575|2273539|P2|Overall Study|Withdrawal by Subject|0
700029|NCT01381575|2273540|P1|Overall Study|Withdrawal by Subject|0
700030|NCT01381575|2273538|P3|Overall Study|Protocol Violation|1
700031|NCT01381575|2273539|P2|Overall Study|Protocol Violation|0
700032|NCT01381575|2273540|P1|Overall Study|Protocol Violation|0
700033|NCT01381575|2273538|P3|Overall Study|Lost to Follow-up|1
700034|NCT01381575|2273539|P2|Overall Study|Lost to Follow-up|0
700035|NCT01381575|2273540|P1|Overall Study|Lost to Follow-up|0
700036|NCT01381575|2273538|P3|Overall Study|Adverse Event|1
700037|NCT01381575|2273539|P2|Overall Study|Adverse Event|0
700038|NCT01381575|2273540|P1|Overall Study|Adverse Event|0
700039|NCT01381575|2273538|P3|Overall Study|Unspecified|0
700040|NCT01381575|2273539|P2|Overall Study|Unspecified|10
700041|NCT01381575|2273540|P1|Overall Study|Unspecified|2
700042|NCT01381549|2273597|P3|Overall Study|Ineligible: No organisms isolated|1
700043|NCT01381549|2273598|P2|Overall Study|Ineligible: No organisms isolated|0
700044|NCT01381549|2273599|P1|Overall Study|Ineligible: No organisms isolated|0
700045|NCT01381016|2273725|P2|Overall Study|Physician Decision|2
700046|NCT01381016|2273726|P1|Overall Study|Physician Decision|0
700047|NCT01381016|2273725|P2|Overall Study|Withdrawal by Subject|1
700048|NCT01381016|2273726|P1|Overall Study|Withdrawal by Subject|0
700049|NCT01381016|2273725|P2|Overall Study|Screen Failure|2
700050|NCT01381016|2273726|P1|Overall Study|Screen Failure|2
700051|NCT01381016|2273725|P2|Overall Study|Lost to Follow-up|1
700052|NCT01381016|2273726|P1|Overall Study|Lost to Follow-up|1
700055|NCT01380782|2273749|P4|Overall Study|Withdrawal by Subject|1
700056|NCT01380782|2273750|P3|Overall Study|Withdrawal by Subject|1
700057|NCT01380782|2273751|P2|Overall Study|Withdrawal by Subject|0
700058|NCT01380782|2273752|P1|Overall Study|Withdrawal by Subject|0
700059|NCT01380782|2273749|P4|Overall Study|Physician Decision|0
700060|NCT01380782|2273750|P3|Overall Study|Physician Decision|0
700061|NCT01380782|2273751|P2|Overall Study|Physician Decision|0
700062|NCT01380782|2273752|P1|Overall Study|Physician Decision|1
700063|NCT01380782|2273749|P4|Overall Study|Lack of Efficacy|3
700064|NCT01380782|2273750|P3|Overall Study|Lack of Efficacy|10
700065|NCT01380782|2273751|P2|Overall Study|Lack of Efficacy|9
700066|NCT01380782|2273752|P1|Overall Study|Lack of Efficacy|10
700067|NCT01380782|2273749|P4|Overall Study|Death|0
700068|NCT01380782|2273750|P3|Overall Study|Death|0
700069|NCT01380782|2273751|P2|Overall Study|Death|0
700070|NCT01380782|2273752|P1|Overall Study|Death|1
700071|NCT01380782|2273749|P4|Overall Study|Adverse Event|0
700072|NCT01380782|2273750|P3|Overall Study|Adverse Event|0
700073|NCT01380782|2273751|P2|Overall Study|Adverse Event|1
700074|NCT01380782|2273752|P1|Overall Study|Adverse Event|0
700075|NCT01380769|2273775|P2|Overall Study|Protocol Violation|1
700076|NCT01380769|2273776|P1|Overall Study|Protocol Violation|0
700077|NCT01380769|2273775|P2|Overall Study|Adverse Event|1
700078|NCT01380769|2273776|P1|Overall Study|Adverse Event|1
700079|NCT01380769|2273775|P2|Overall Study|Physician Decision|1
700080|NCT01380769|2273776|P1|Overall Study|Physician Decision|1
700081|NCT01380769|2273775|P2|Overall Study|Withdrawal by Subject|11
700082|NCT01380769|2273776|P1|Overall Study|Withdrawal by Subject|7
700083|NCT01380730|2273792|P8|Overall Study|Death|0
700084|NCT01380730|2273793|P7|Overall Study|Death|0
700085|NCT01380730|2273794|P6|Overall Study|Death|0
700086|NCT01380730|2273795|P5|Overall Study|Death|1
700087|NCT01380730|2273796|P4|Overall Study|Death|0
700088|NCT01380730|2273797|P3|Overall Study|Death|0
700089|NCT01380730|2273798|P2|Overall Study|Death|0
700090|NCT01380730|2273799|P1|Overall Study|Death|0
700091|NCT01380379|2273866|P1|Overall Study|Pregnancy|1
700092|NCT01380327|2273879|P3|Overall Study|Questionable onset of epilepsy|1
700093|NCT01380327|2273880|P2|Overall Study|Questionable onset of epilepsy|0
700094|NCT01380327|2273881|P1|Overall Study|Questionable onset of epilepsy|0
700095|NCT01380327|2273879|P3|Overall Study|Housing situation precluded ability to k|1
700096|NCT01380327|2273880|P2|Overall Study|Housing situation precluded ability to k|0
700097|NCT01380327|2273881|P1|Overall Study|Housing situation precluded ability to k|0
700098|NCT01380327|2273879|P3|Overall Study|Withdrawal by Subject|1
700099|NCT01380327|2273880|P2|Overall Study|Withdrawal by Subject|0
700100|NCT01380327|2273881|P1|Overall Study|Withdrawal by Subject|0
700101|NCT01380327|2273879|P3|Overall Study|Protocol Violation|3
700102|NCT01380327|2273880|P2|Overall Study|Protocol Violation|2
700103|NCT01380327|2273881|P1|Overall Study|Protocol Violation|3
700104|NCT01380327|2273879|P3|Overall Study|Lost to Follow-up|1
700105|NCT01380327|2273880|P2|Overall Study|Lost to Follow-up|1
700106|NCT01380327|2273881|P1|Overall Study|Lost to Follow-up|0
700107|NCT01380145|2273912|P1|Overall Study|Progressive disease|4
700108|NCT01380093|2273920|P9|Treatment Phase: Third Intervention|Unspecified|1
700109|NCT01380093|2273921|P8|Treatment Phase: Third Intervention|Unspecified|0
700110|NCT01380093|2273922|P7|Treatment Phase: Third Intervention|Unspecified|0
700111|NCT01380093|2273923|P6|Treatment Phase: Third Intervention|Unspecified|0
700112|NCT01380093|2273924|P5|Treatment Phase: Third Intervention|Unspecified|0
700113|NCT01380093|2273925|P4|Treatment Phase: Third Intervention|Unspecified|0
700114|NCT01380093|2273926|P3|Treatment Phase: Third Intervention|Unspecified|0
700115|NCT01380093|2273927|P2|Treatment Phase: Third Intervention|Unspecified|0
700116|NCT01380093|2273928|P1|Treatment Phase: Third Intervention|Unspecified|0
700117|NCT01380093|2273920|P9|Treatment Phase: Third Intervention|Non-compliance|1
700118|NCT01380093|2273921|P8|Treatment Phase: Third Intervention|Non-compliance|0
700119|NCT01380093|2273922|P7|Treatment Phase: Third Intervention|Non-compliance|0
700120|NCT01380093|2273923|P6|Treatment Phase: Third Intervention|Non-compliance|0
700121|NCT01380093|2273924|P5|Treatment Phase: Third Intervention|Non-compliance|0
700122|NCT01380093|2273925|P4|Treatment Phase: Third Intervention|Non-compliance|0
700123|NCT01380093|2273926|P3|Treatment Phase: Third Intervention|Non-compliance|0
700124|NCT01380093|2273927|P2|Treatment Phase: Third Intervention|Non-compliance|0
700125|NCT01380093|2273928|P1|Treatment Phase: Third Intervention|Non-compliance|0
700126|NCT01380093|2273920|P9|Treatment Phase: Second Intervention|Unspecified|0
700127|NCT01380093|2273921|P8|Treatment Phase: Second Intervention|Unspecified|0
700128|NCT01380093|2273922|P7|Treatment Phase: Second Intervention|Unspecified|0
700129|NCT01380093|2273923|P6|Treatment Phase: Second Intervention|Unspecified|0
700130|NCT01380093|2273924|P5|Treatment Phase: Second Intervention|Unspecified|0
700131|NCT01380093|2273925|P4|Treatment Phase: Second Intervention|Unspecified|1
700132|NCT01380093|2273926|P3|Treatment Phase: Second Intervention|Unspecified|0
700133|NCT01380093|2273927|P2|Treatment Phase: Second Intervention|Unspecified|0
700134|NCT01380093|2273928|P1|Treatment Phase: Second Intervention|Unspecified|0
700135|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
700136|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
700137|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
700138|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
700139|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
700140|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
700141|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
700142|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
700143|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
700144|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Backup participant|0
700145|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Backup participant|0
700146|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Backup participant|0
700147|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Backup participant|0
700148|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Backup participant|0
700149|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Backup participant|0
700150|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Backup participant|1
700151|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Backup participant|0
700152|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Backup participant|0
700153|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700154|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700155|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700156|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700157|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700158|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700159|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
700160|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
700161|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
700162|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
700163|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
700164|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
700165|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
700166|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
700167|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
700168|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
700169|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
700170|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
700171|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700172|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700173|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700174|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700175|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700176|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700177|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700178|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
700179|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
700180|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
700181|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
700182|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
700183|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
700184|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
700185|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
700186|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
700187|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
700188|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
700189|NCT01380093|2273920|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
700190|NCT01380093|2273921|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
700191|NCT01380093|2273922|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
700192|NCT01380093|2273923|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
700193|NCT01380093|2273924|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
700194|NCT01380093|2273925|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
700195|NCT01380093|2273926|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
700196|NCT01380093|2273927|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
700197|NCT01380093|2273928|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
700198|NCT01380093|2273920|P9|Naloxone Challenge Phase|Screen failures|0
700199|NCT01380093|2273921|P8|Naloxone Challenge Phase|Screen failures|0
700200|NCT01380093|2273922|P7|Naloxone Challenge Phase|Screen failures|0
700201|NCT01380093|2273923|P6|Naloxone Challenge Phase|Screen failures|0
700202|NCT01380093|2273924|P5|Naloxone Challenge Phase|Screen failures|0
700203|NCT01380093|2273925|P4|Naloxone Challenge Phase|Screen failures|0
700204|NCT01380093|2273926|P3|Naloxone Challenge Phase|Screen failures|0
700205|NCT01380093|2273927|P2|Naloxone Challenge Phase|Screen failures|0
700206|NCT01380093|2273928|P1|Naloxone Challenge Phase|Screen failures|21
700207|NCT01380080|2274220|P2|Overall Study|Lost to Follow-up|0
700208|NCT01380080|2274221|P1|Overall Study|Lost to Follow-up|2
700209|NCT01380080|2274220|P2|Overall Study|Not willing to adhere to requirements|1
700210|NCT01380080|2274221|P1|Overall Study|Not willing to adhere to requirements|3
700211|NCT01380080|2274220|P2|Overall Study|Not able to get to clinic|0
700212|NCT01380080|2274221|P1|Overall Study|Not able to get to clinic|4
700213|NCT01380080|2274220|P2|Overall Study|Withdrawal by Subject|0
700214|NCT01380080|2274221|P1|Overall Study|Withdrawal by Subject|4
700215|NCT01380080|2274220|P2|Overall Study|Death|22
700216|NCT01380080|2274221|P1|Overall Study|Death|20
700217|NCT01379937|2274246|P4|Overall Study|Lost to Follow-up|0
700218|NCT01379937|2274247|P3|Overall Study|Lost to Follow-up|2
700219|NCT01379937|2274248|P2|Overall Study|Lost to Follow-up|2
700220|NCT01379937|2274249|P1|Overall Study|Lost to Follow-up|1
700221|NCT01379937|2274246|P4|Overall Study|Consent withdrawal|0
700222|NCT01379937|2274247|P3|Overall Study|Consent withdrawal|0
700223|NCT01379937|2274248|P2|Overall Study|Consent withdrawal|1
700224|NCT01379937|2274249|P1|Overall Study|Consent withdrawal|0
700225|NCT01379937|2274246|P4|Overall Study|Protocol Violation|1
700226|NCT01379937|2274247|P3|Overall Study|Protocol Violation|0
700227|NCT01379937|2274248|P2|Overall Study|Protocol Violation|0
700228|NCT01379937|2274249|P1|Overall Study|Protocol Violation|0
700229|NCT01379781|2274331|P2|Overall Study|Lost to Follow-up|8
700230|NCT01379781|2274332|P1|Overall Study|Lost to Follow-up|11
700231|NCT01379768|2274341|P3|Overall Study|Lost to Follow-up|0
700232|NCT01379768|2274342|P2|Overall Study|Lost to Follow-up|0
700233|NCT01379768|2274343|P1|Overall Study|Lost to Follow-up|2
700234|NCT01379768|2274341|P3|Overall Study|Adverse Event|0
700235|NCT01379768|2274342|P2|Overall Study|Adverse Event|1
700236|NCT01379768|2274343|P1|Overall Study|Adverse Event|1
700237|NCT01379703|2274366|P3|9 Months Through 18 Months|Reason Unknown|0
700238|NCT01379703|2274367|P2|9 Months Through 18 Months|Reason Unknown|23
700239|NCT01379703|2274368|P1|9 Months Through 18 Months|Reason Unknown|0
700240|NCT01379703|2274366|P3|9 Months Through 18 Months|Fatigue|0
700241|NCT01379703|2274367|P2|9 Months Through 18 Months|Fatigue|1
700242|NCT01379703|2274368|P1|9 Months Through 18 Months|Fatigue|0
700243|NCT01379703|2274366|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
700244|NCT01379703|2274367|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
700245|NCT01379703|2274368|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
700246|NCT01379703|2274366|P3|9 Months Through 18 Months|Patient Noncompliance|0
700247|NCT01379703|2274367|P2|9 Months Through 18 Months|Patient Noncompliance|4
700248|NCT01379703|2274368|P1|9 Months Through 18 Months|Patient Noncompliance|0
700249|NCT01379703|2274366|P3|9 Months Through 18 Months|Treatment failure|0
700250|NCT01379703|2274367|P2|9 Months Through 18 Months|Treatment failure|5
700251|NCT01379703|2274368|P1|9 Months Through 18 Months|Treatment failure|0
700252|NCT01379703|2274366|P3|9 Months Through 18 Months|Adverse Event|0
700253|NCT01379703|2274367|P2|9 Months Through 18 Months|Adverse Event|6
700254|NCT01379703|2274368|P1|9 Months Through 18 Months|Adverse Event|0
700255|NCT01379703|2274366|P3|9 Months Through 18 Months|Withdrawal by Subject|0
700256|NCT01379703|2274367|P2|9 Months Through 18 Months|Withdrawal by Subject|11
700257|NCT01379703|2274368|P1|9 Months Through 18 Months|Withdrawal by Subject|0
700258|NCT01379703|2274366|P3|9 Months Through 18 Months|Lost to Follow-up|0
700259|NCT01379703|2274367|P2|9 Months Through 18 Months|Lost to Follow-up|178
700260|NCT01379703|2274368|P1|9 Months Through 18 Months|Lost to Follow-up|0
700261|NCT01379703|2274366|P3|Study Start Through 9 Months|Reason unknown|24
700262|NCT01379703|2274367|P2|Study Start Through 9 Months|Reason unknown|31
700263|NCT01379703|2274368|P1|Study Start Through 9 Months|Reason unknown|2
700264|NCT01379703|2274366|P3|Study Start Through 9 Months|Increased triglycerides|0
700265|NCT01379703|2274367|P2|Study Start Through 9 Months|Increased triglycerides|1
700266|NCT01379703|2274368|P1|Study Start Through 9 Months|Increased triglycerides|0
700267|NCT01379703|2274366|P3|Study Start Through 9 Months|Poor general condition|0
700268|NCT01379703|2274367|P2|Study Start Through 9 Months|Poor general condition|1
700269|NCT01379703|2274368|P1|Study Start Through 9 Months|Poor general condition|0
700270|NCT01379703|2274366|P3|Study Start Through 9 Months|Medication not available|1
700271|NCT01379703|2274367|P2|Study Start Through 9 Months|Medication not available|2
700272|NCT01379703|2274368|P1|Study Start Through 9 Months|Medication not available|0
700273|NCT01379703|2274366|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
700274|NCT01379703|2274367|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
700275|NCT01379703|2274368|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
700276|NCT01379703|2274366|P3|Study Start Through 9 Months|Patient Noncompliance|1
700277|NCT01379703|2274367|P2|Study Start Through 9 Months|Patient Noncompliance|0
700278|NCT01379703|2274368|P1|Study Start Through 9 Months|Patient Noncompliance|0
700279|NCT01379703|2274366|P3|Study Start Through 9 Months|Treatment Failure|2
700280|NCT01379703|2274367|P2|Study Start Through 9 Months|Treatment Failure|2
700281|NCT01379703|2274368|P1|Study Start Through 9 Months|Treatment Failure|0
700282|NCT01379703|2274366|P3|Study Start Through 9 Months|Withdrawal by Subject|1
700283|NCT01379703|2274367|P2|Study Start Through 9 Months|Withdrawal by Subject|6
700284|NCT01379703|2274368|P1|Study Start Through 9 Months|Withdrawal by Subject|0
700285|NCT01379703|2274366|P3|Study Start Through 9 Months|Adverse Event|10
700286|NCT01379703|2274367|P2|Study Start Through 9 Months|Adverse Event|14
700287|NCT01379703|2274368|P1|Study Start Through 9 Months|Adverse Event|0
700288|NCT01379703|2274366|P3|Study Start Through 9 Months|Lost to Follow-up|104
700289|NCT01379703|2274367|P2|Study Start Through 9 Months|Lost to Follow-up|61
700290|NCT01379703|2274368|P1|Study Start Through 9 Months|Lost to Follow-up|2
700291|NCT01379534|2274468|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
700292|NCT01379534|2274469|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
700293|NCT01379534|2274468|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
700294|NCT01379534|2274469|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
700295|NCT01379534|2274468|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
700296|NCT01379534|2274469|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
700297|NCT01379534|2274468|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
700298|NCT01379534|2274469|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
700299|NCT01379534|2274468|P2|Treatment Phase|Adverse Event|7
700300|NCT01379534|2274469|P1|Treatment Phase|Adverse Event|7
700301|NCT01379534|2274468|P2|Treatment Phase|Progressive disease|22
700302|NCT01379534|2274469|P1|Treatment Phase|Progressive disease|13
700303|NCT01379534|2274468|P2|Treatment Phase|Withdrawal by Subject|2
700304|NCT01379534|2274469|P1|Treatment Phase|Withdrawal by Subject|2
700305|NCT01379521|2274489|P2|Post-Treatment Evaluations|Death|0
700306|NCT01379521|2274490|P1|Post-Treatment Evaluations|Death|1
700307|NCT01379521|2274489|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
700308|NCT01379521|2274490|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
700309|NCT01379521|2274489|P2|Post-Treatment Evaluations|Disease Progression|20
700310|NCT01379521|2274490|P1|Post-Treatment Evaluations|Disease Progression|22
700311|NCT01379521|2274489|P2|Overall Study -Treatment Period|Death|1
700312|NCT01379521|2274490|P1|Overall Study -Treatment Period|Death|2
700313|NCT01379521|2274489|P2|Overall Study -Treatment Period|Administrative Problems|0
700314|NCT01379521|2274490|P1|Overall Study -Treatment Period|Administrative Problems|1
700315|NCT01379521|2274489|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
700316|NCT01379521|2274490|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
700317|NCT01379521|2274489|P2|Overall Study -Treatment Period|Protocol Deviation|2
700318|NCT01379521|2274490|P1|Overall Study -Treatment Period|Protocol Deviation|0
700319|NCT01379521|2274489|P2|Overall Study -Treatment Period|New Cancer Therapy|0
700320|NCT01379521|2274490|P1|Overall Study -Treatment Period|New Cancer Therapy|1
700321|NCT01379521|2274489|P2|Overall Study -Treatment Period|Disease Progression|22
700322|NCT01379521|2274490|P1|Overall Study -Treatment Period|Disease Progression|23
700323|NCT01379521|2274489|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
700324|NCT01379521|2274490|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
700325|NCT01379521|2274489|P2|Overall Study -Treatment Period|Adverse Event|0
700326|NCT01379521|2274490|P1|Overall Study -Treatment Period|Adverse Event|3
700327|NCT01378975|2274560|P2|Overall Study|Withdrew Consent|3
700328|NCT01378975|2274561|P1|Overall Study|Withdrew Consent|4
700329|NCT01378975|2274560|P2|Overall Study|Lost to Follow-up|1
700330|NCT01378975|2274561|P1|Overall Study|Lost to Follow-up|4
700331|NCT01378975|2274560|P2|Overall Study|Investigator Request|0
700332|NCT01378975|2274561|P1|Overall Study|Investigator Request|1
700333|NCT01378975|2274560|P2|Overall Study|Death|46
700334|NCT01378975|2274561|P1|Overall Study|Death|77
700335|NCT01378962|2274587|P1|Overall Study|Unspecified|2
700336|NCT01378962|2274587|P1|Overall Study|Lost to Follow-up|1
700337|NCT01378962|2274587|P1|Overall Study|Death|14
700338|NCT01378429|2274613|P2|Overall Study|Noncompliance with study drug|0
700339|NCT01378429|2274614|P1|Overall Study|Noncompliance with study drug|1
700340|NCT01378325|2274656|P2|Overall Study|Protocol Violation|1
700341|NCT01378325|2274657|P1|Overall Study|Protocol Violation|0
700342|NCT01378195|2274674|P2|Overall Study|Lost to Follow-up|18
700343|NCT01378195|2274675|P1|Overall Study|Lost to Follow-up|29
700344|NCT01378117|2274688|P3|Overall Study|discharged before med given|1
700345|NCT01378117|2274689|P2|Overall Study|discharged before med given|0
700346|NCT01378117|2274690|P1|Overall Study|discharged before med given|2
700347|NCT01378117|2274688|P3|Overall Study|withdrawal|2
700348|NCT01378117|2274689|P2|Overall Study|withdrawal|1
700349|NCT01378117|2274690|P1|Overall Study|withdrawal|2
700350|NCT01378104|2274700|P2|Overall Study|Withdrawal by Subject|13
700351|NCT01378104|2274701|P1|Overall Study|Withdrawal by Subject|12
700352|NCT01378104|2274700|P2|Overall Study|Lack of Efficacy|5
700353|NCT01378104|2274701|P1|Overall Study|Lack of Efficacy|7
700354|NCT01378104|2274700|P2|Overall Study|Adverse Event|8
700355|NCT01378104|2274701|P1|Overall Study|Adverse Event|8
700356|NCT01377480|2274819|P4|Overall Study|Not specified|6
700357|NCT01377480|2274820|P3|Overall Study|Not specified|7
700358|NCT01377480|2274821|P2|Overall Study|Not specified|0
700359|NCT01377480|2274822|P1|Overall Study|Not specified|0
700360|NCT01377480|2274819|P4|Overall Study|Serious adverse event|1
700361|NCT01377480|2274820|P3|Overall Study|Serious adverse event|1
700362|NCT01377480|2274821|P2|Overall Study|Serious adverse event|0
700363|NCT01377480|2274822|P1|Overall Study|Serious adverse event|0
700364|NCT01377480|2274819|P4|Overall Study|Withdrawal by Subject|0
700365|NCT01377480|2274820|P3|Overall Study|Withdrawal by Subject|1
700366|NCT01377480|2274821|P2|Overall Study|Withdrawal by Subject|0
700367|NCT01377480|2274822|P1|Overall Study|Withdrawal by Subject|0
700368|NCT01377480|2274819|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
700369|NCT01377480|2274820|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
700370|NCT01377480|2274821|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
700371|NCT01377480|2274822|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
700372|NCT01377480|2274819|P4|Overall Study|Protocol Violation|4
700373|NCT01377480|2274820|P3|Overall Study|Protocol Violation|0
700374|NCT01377480|2274821|P2|Overall Study|Protocol Violation|0
700375|NCT01377480|2274822|P1|Overall Study|Protocol Violation|0
700376|NCT01377233|2274901|P5|Double-blind|Administrative or other|1
700377|NCT01377233|2274902|P4|Double-blind|Administrative or other|1
700378|NCT01377233|2274903|P3|Double-blind|Administrative or other|0
700379|NCT01377233|2274904|P2|Double-blind|Administrative or other|0
700380|NCT01377233|2274905|P1|Double-blind|Administrative or other|0
700381|NCT01377233|2274901|P5|Double-blind|Withdrawal by Subject|0
700382|NCT01377233|2274902|P4|Double-blind|Withdrawal by Subject|1
700383|NCT01377233|2274903|P3|Double-blind|Withdrawal by Subject|0
700384|NCT01377233|2274904|P2|Double-blind|Withdrawal by Subject|0
700385|NCT01377233|2274905|P1|Double-blind|Withdrawal by Subject|0
700386|NCT01377233|2274901|P5|Double-blind|Protocol Violation|1
700387|NCT01377233|2274902|P4|Double-blind|Protocol Violation|0
700388|NCT01377233|2274903|P3|Double-blind|Protocol Violation|0
700389|NCT01377233|2274904|P2|Double-blind|Protocol Violation|0
700390|NCT01377233|2274905|P1|Double-blind|Protocol Violation|0
700391|NCT01377233|2274901|P5|Double-blind|Adverse Event|0
700392|NCT01377233|2274902|P4|Double-blind|Adverse Event|2
700393|NCT01377233|2274903|P3|Double-blind|Adverse Event|2
700394|NCT01377233|2274904|P2|Double-blind|Adverse Event|1
700395|NCT01377233|2274905|P1|Double-blind|Adverse Event|0
700396|NCT01377233|2274901|P5|Open-label|Withdrawal by Subject|0
700397|NCT01377233|2274902|P4|Open-label|Withdrawal by Subject|0
700398|NCT01377233|2274903|P3|Open-label|Withdrawal by Subject|0
700399|NCT01377233|2274904|P2|Open-label|Withdrawal by Subject|0
700400|NCT01377233|2274905|P1|Open-label|Withdrawal by Subject|3
700401|NCT01377233|2274901|P5|Open-label|Adverse Event|0
700402|NCT01377233|2274902|P4|Open-label|Adverse Event|0
700403|NCT01377233|2274903|P3|Open-label|Adverse Event|0
700404|NCT01377233|2274904|P2|Open-label|Adverse Event|0
700405|NCT01377233|2274905|P1|Open-label|Adverse Event|1
700406|NCT01377194|2274932|P3|Overall Study|Lost to Follow-up|11
700407|NCT01377194|2274933|P2|Overall Study|Lost to Follow-up|8
700408|NCT01377194|2274934|P1|Overall Study|Lost to Follow-up|14
700409|NCT01377194|2274932|P3|Overall Study|Withdrawal by Subject|7
700410|NCT01377194|2274933|P2|Overall Study|Withdrawal by Subject|10
700411|NCT01377194|2274934|P1|Overall Study|Withdrawal by Subject|8
700412|NCT01377194|2274932|P3|Overall Study|Protocol Violation|6
700413|NCT01377194|2274933|P2|Overall Study|Protocol Violation|10
700414|NCT01377194|2274934|P1|Overall Study|Protocol Violation|4
700415|NCT01377194|2274932|P3|Overall Study|Lack of Efficacy|3
700416|NCT01377194|2274933|P2|Overall Study|Lack of Efficacy|3
700417|NCT01377194|2274934|P1|Overall Study|Lack of Efficacy|3
700418|NCT01377194|2274932|P3|Overall Study|Adverse Event|19
700419|NCT01377194|2274933|P2|Overall Study|Adverse Event|12
700420|NCT01377194|2274934|P1|Overall Study|Adverse Event|3
700421|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Adverse Event|1
700422|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Adverse Event|2
700423|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Adverse Event|0
700424|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
700425|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
700426|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
700427|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Physician Decision|0
700428|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Physician Decision|0
700429|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Physician Decision|1
700430|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
700431|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
700432|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
700433|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
700434|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
700435|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
700436|NCT01377012|2274948|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
700437|NCT01377012|2274949|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
700438|NCT01377012|2274950|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
700439|NCT01377012|2274948|P3|Core Study|Adverse Event|13
700440|NCT01377012|2274949|P2|Core Study|Adverse Event|14
700441|NCT01377012|2274950|P1|Core Study|Adverse Event|10
700442|NCT01377012|2274948|P3|Core Study|Death|1
700443|NCT01377012|2274949|P2|Core Study|Death|1
700444|NCT01377012|2274950|P1|Core Study|Death|1
700445|NCT01377012|2274948|P3|Core Study|Lack of Efficacy|37
700446|NCT01377012|2274949|P2|Core Study|Lack of Efficacy|28
700447|NCT01377012|2274950|P1|Core Study|Lack of Efficacy|41
700448|NCT01377012|2274948|P3|Core Study|Lost to Follow-up|4
700449|NCT01377012|2274949|P2|Core Study|Lost to Follow-up|5
700450|NCT01377012|2274950|P1|Core Study|Lost to Follow-up|7
700451|NCT01377012|2274948|P3|Core Study|No Longer require treatment|1
700452|NCT01377012|2274949|P2|Core Study|No Longer require treatment|0
700453|NCT01377012|2274950|P1|Core Study|No Longer require treatment|0
700454|NCT01377012|2274948|P3|Core Study|Non-Compliant with study treatment|1
700455|NCT01377012|2274949|P2|Core Study|Non-Compliant with study treatment|0
700456|NCT01377012|2274950|P1|Core Study|Non-Compliant with study treatment|0
700457|NCT01377012|2274948|P3|Core Study|Physician Decision|10
700458|NCT01377012|2274949|P2|Core Study|Physician Decision|4
700459|NCT01377012|2274950|P1|Core Study|Physician Decision|5
700460|NCT01377012|2274948|P3|Core Study|Pregnancy|1
700461|NCT01377012|2274949|P2|Core Study|Pregnancy|0
700462|NCT01377012|2274950|P1|Core Study|Pregnancy|0
700463|NCT01377012|2274948|P3|Core Study|Protocol Violation|2
700464|NCT01377012|2274949|P2|Core Study|Protocol Violation|3
700465|NCT01377012|2274950|P1|Core Study|Protocol Violation|7
700466|NCT01377012|2274948|P3|Core Study|Withdrawal by Subject|18
700467|NCT01377012|2274949|P2|Core Study|Withdrawal by Subject|23
700468|NCT01377012|2274950|P1|Core Study|Withdrawal by Subject|15
700469|NCT01377012|2274948|P3|Core Study|Technical problems|0
700470|NCT01377012|2274949|P2|Core Study|Technical problems|0
700471|NCT01377012|2274950|P1|Core Study|Technical problems|1
700472|NCT01377012|2274948|P3|Core Study|Study terminated by Sponsor|46
700473|NCT01377012|2274949|P2|Core Study|Study terminated by Sponsor|54
700474|NCT01377012|2274950|P1|Core Study|Study terminated by Sponsor|47
700475|NCT01376908|2274987|P2|Overall Study|Withdrawal by Subject|2
700476|NCT01376908|2274988|P1|Overall Study|Withdrawal by Subject|1
700477|NCT01376908|2274987|P2|Overall Study|Protocol Violation|1
700478|NCT01376908|2274988|P1|Overall Study|Protocol Violation|1
700479|NCT01376804|2275021|P1|Treatment Period|Patient did not receive study drug|1
700480|NCT01376804|2275021|P1|Treatment Period|Adverse Event|6
700481|NCT01376804|2275021|P1|Treatment Period|Withdrawal by Subject|1
700484|NCT01376388|2275094|P1|Overall Study|Withdrawal by Subject|3
700485|NCT01376388|2275094|P1|Overall Study|Lack of Efficacy|2
700486|NCT01376388|2275094|P1|Overall Study|Adverse Event|13
700487|NCT01376349|2275132|P3|Raondomized Treatment|Alternative Treatment|1
700488|NCT01376349|2275133|P2|Raondomized Treatment|Alternative Treatment|0
700489|NCT01376349|2275134|P1|Raondomized Treatment|Alternative Treatment|0
700490|NCT01376349|2275132|P3|Raondomized Treatment|Unkown|1
700491|NCT01376349|2275133|P2|Raondomized Treatment|Unkown|2
700492|NCT01376349|2275134|P1|Raondomized Treatment|Unkown|1
700493|NCT01376349|2275132|P3|Raondomized Treatment|Adverse Event|14
700494|NCT01376349|2275133|P2|Raondomized Treatment|Adverse Event|17
700495|NCT01376349|2275134|P1|Raondomized Treatment|Adverse Event|13
700496|NCT01376349|2275132|P3|Raondomized Treatment|Withdrawal by Subject|13
700497|NCT01376349|2275133|P2|Raondomized Treatment|Withdrawal by Subject|16
700498|NCT01376349|2275134|P1|Raondomized Treatment|Withdrawal by Subject|10
700499|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
700500|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
700501|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
700502|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
700503|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
700504|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Physician Decision|0
700505|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Physician Decision|1
700506|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Physician Decision|1
700507|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Physician Decision|0
700508|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Physician Decision|0
700509|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
700510|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
700511|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
700512|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
700513|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
700514|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
700515|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
700516|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
700517|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
700518|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
700519|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
700520|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
700521|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
700522|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
700523|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
700524|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
700525|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
700526|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
700527|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
700528|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
700529|NCT01376245|2275156|P5|24-week, Double-blind Treatment Period|Adverse Event|18
700530|NCT01376245|2275157|P4|24-week, Double-blind Treatment Period|Adverse Event|8
700531|NCT01376245|2275158|P3|24-week, Double-blind Treatment Period|Adverse Event|7
700532|NCT01376245|2275159|P2|24-week, Double-blind Treatment Period|Adverse Event|16
700533|NCT01376245|2275160|P1|24-week, Double-blind Treatment Period|Adverse Event|0
700534|NCT01376245|2275156|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
700535|NCT01376245|2275157|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
700536|NCT01376245|2275158|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
700537|NCT01376245|2275159|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
700538|NCT01376245|2275160|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
700539|NCT01376245|2275156|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
700540|NCT01376245|2275157|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
700541|NCT01376245|2275158|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
700542|NCT01376245|2275159|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
700543|NCT01376245|2275160|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
700544|NCT01376245|2275156|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
700545|NCT01376245|2275157|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
700546|NCT01376245|2275158|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
700547|NCT01376245|2275159|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
700548|NCT01376245|2275160|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
700549|NCT01376245|2275156|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
700550|NCT01376245|2275157|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
700551|NCT01376245|2275158|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
700552|NCT01376245|2275159|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
700553|NCT01376245|2275160|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
700554|NCT01376245|2275156|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
700555|NCT01376245|2275157|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
700556|NCT01376245|2275158|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
700557|NCT01376245|2275159|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
700558|NCT01376245|2275160|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
700559|NCT01376089|2275176|P2|Overall Study|Patient received no contrast media|4
700560|NCT01376089|2275177|P1|Overall Study|Patient received no contrast media|3
700561|NCT01376037|2275200|P2|Overall Study|Lost to Follow-up|2
700562|NCT01376037|2275201|P1|Overall Study|Lost to Follow-up|0
700563|NCT01375777|2275216|P9|Overall Study|Other|1
700564|NCT01375777|2275217|P8|Overall Study|Other|0
700565|NCT01375777|2275218|P7|Overall Study|Other|0
700566|NCT01375777|2275219|P6|Overall Study|Other|0
700567|NCT01375777|2275220|P5|Overall Study|Other|0
700568|NCT01375777|2275221|P4|Overall Study|Other|0
700569|NCT01375777|2275222|P3|Overall Study|Other|0
700570|NCT01375777|2275223|P2|Overall Study|Other|1
700571|NCT01375777|2275224|P1|Overall Study|Other|1
700572|NCT01375777|2275216|P9|Overall Study|Lost to Follow-up|0
700573|NCT01375777|2275217|P8|Overall Study|Lost to Follow-up|0
700574|NCT01375777|2275218|P7|Overall Study|Lost to Follow-up|1
700575|NCT01375777|2275219|P6|Overall Study|Lost to Follow-up|0
700576|NCT01375777|2275220|P5|Overall Study|Lost to Follow-up|0
700577|NCT01375777|2275221|P4|Overall Study|Lost to Follow-up|0
700578|NCT01375777|2275222|P3|Overall Study|Lost to Follow-up|0
700579|NCT01375777|2275223|P2|Overall Study|Lost to Follow-up|0
700580|NCT01375777|2275224|P1|Overall Study|Lost to Follow-up|1
700581|NCT01375777|2275216|P9|Overall Study|Withdrawal by Subject|1
700582|NCT01375777|2275217|P8|Overall Study|Withdrawal by Subject|2
700583|NCT01375777|2275218|P7|Overall Study|Withdrawal by Subject|1
700584|NCT01375777|2275219|P6|Overall Study|Withdrawal by Subject|1
700585|NCT01375777|2275220|P5|Overall Study|Withdrawal by Subject|1
700586|NCT01375777|2275221|P4|Overall Study|Withdrawal by Subject|0
700587|NCT01375777|2275222|P3|Overall Study|Withdrawal by Subject|1
700588|NCT01375777|2275223|P2|Overall Study|Withdrawal by Subject|2
700589|NCT01375777|2275224|P1|Overall Study|Withdrawal by Subject|0
700590|NCT01375764|2275294|P5|Overall Study|Other|0
700591|NCT01375764|2275295|P4|Overall Study|Other|1
700592|NCT01375764|2275296|P3|Overall Study|Other|0
700593|NCT01375764|2275297|P2|Overall Study|Other|0
700594|NCT01375764|2275298|P1|Overall Study|Other|0
700595|NCT01375764|2275294|P5|Overall Study|Withdrawal by Subject|1
700596|NCT01375764|2275295|P4|Overall Study|Withdrawal by Subject|0
700597|NCT01375764|2275296|P3|Overall Study|Withdrawal by Subject|0
700598|NCT01375764|2275297|P2|Overall Study|Withdrawal by Subject|0
700599|NCT01375764|2275298|P1|Overall Study|Withdrawal by Subject|2
700600|NCT01375764|2275294|P5|Overall Study|Lost to Follow-up|0
700601|NCT01375764|2275295|P4|Overall Study|Lost to Follow-up|0
700602|NCT01375764|2275296|P3|Overall Study|Lost to Follow-up|0
700603|NCT01375764|2275297|P2|Overall Study|Lost to Follow-up|1
700604|NCT01375764|2275298|P1|Overall Study|Lost to Follow-up|0
700605|NCT01375751|2275344|P3|Overall Study|Other|0
700606|NCT01375751|2275345|P2|Overall Study|Other|1
700607|NCT01375751|2275346|P1|Overall Study|Other|0
700608|NCT01375608|2275390|P1|Overall Study|Withdrawal by Subject|2
700610|NCT01375049|2275449|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
700611|NCT01375049|2275449|P1|Overall Study|Withdrawal by Subject|2
700612|NCT01375049|2275449|P1|Overall Study|Lost to Follow-up|1
700613|NCT01375049|2275449|P1|Overall Study|Adverse Event|2
700614|NCT01374971|2275464|P1|Overall Study|Withdrawal by Subject|1
700615|NCT01374919|2275469|P1|Overall Study|Withdrawal by Subject|2
700616|NCT01374568|2275488|P2|Overall Study|Lab unable to analyze BTM|2
700617|NCT01374568|2275489|P1|Overall Study|Lab unable to analyze BTM|0
700618|NCT01374451|2275499|P2|Overall Study|Administrative problems|0
700619|NCT01374451|2275500|P1|Overall Study|Administrative problems|1
700620|NCT01374425|2275546|P2|Overall Study|Not Specified|43
700621|NCT01374425|2275547|P1|Overall Study|Not Specified|41
700622|NCT01374425|2275546|P2|Overall Study|Lost to Follow-up|1
700623|NCT01374425|2275547|P1|Overall Study|Lost to Follow-up|2
700624|NCT01374425|2275546|P2|Overall Study|Sponsor Decision|1
700625|NCT01374425|2275547|P1|Overall Study|Sponsor Decision|0
700626|NCT01374425|2275546|P2|Overall Study|Protocol Violation|3
700627|NCT01374425|2275547|P1|Overall Study|Protocol Violation|2
700628|NCT01374425|2275546|P2|Overall Study|Refused Treatment|24
700629|NCT01374425|2275547|P1|Overall Study|Refused Treatment|10
700630|NCT01374425|2275546|P2|Overall Study|Withdrawal by Subject|7
700631|NCT01374425|2275547|P1|Overall Study|Withdrawal by Subject|6
700632|NCT01374425|2275546|P2|Overall Study|Death (Adverse Event)|4
700633|NCT01374425|2275547|P1|Overall Study|Death (Adverse Event)|2
700634|NCT01374425|2275546|P2|Overall Study|Death (Progression of Disease)|0
700635|NCT01374425|2275547|P1|Overall Study|Death (Progression of Disease)|1
700636|NCT01374425|2275546|P2|Overall Study|Adverse Event|18
700637|NCT01374425|2275547|P1|Overall Study|Adverse Event|29
700638|NCT01374425|2275546|P2|Overall Study|Clinical Disease Progression|6
700639|NCT01374425|2275547|P1|Overall Study|Clinical Disease Progression|9
700640|NCT01374425|2275546|P2|Overall Study|Radiographic Disease Progression|81
700641|NCT01374425|2275547|P1|Overall Study|Radiographic Disease Progression|86
700642|NCT01374269|2275627|P2|Overall Study|closed research|2
700643|NCT01374269|2275628|P1|Overall Study|closed research|1
700644|NCT01374269|2275627|P2|Overall Study|Lost to Follow-up|3
700645|NCT01374269|2275628|P1|Overall Study|Lost to Follow-up|1
700646|NCT01374269|2275627|P2|Overall Study|Withdrawal by Subject|0
700647|NCT01374269|2275628|P1|Overall Study|Withdrawal by Subject|4
700648|NCT01374178|2275756|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
700649|NCT01374178|2275757|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
700650|NCT01374178|2275756|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
700651|NCT01374178|2275757|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
700652|NCT01374087|2275775|P2|Overall Study|Not provided|13
700653|NCT01374087|2275776|P1|Overall Study|Not provided|13
700654|NCT01374087|2275775|P2|Overall Study|Disease progression|2
700655|NCT01374087|2275776|P1|Overall Study|Disease progression|2
700656|NCT01374087|2275775|P2|Overall Study|Adverse Event|1
700657|NCT01374087|2275776|P1|Overall Study|Adverse Event|0
700658|NCT01373918|2275786|P2|Overall Study|Physician Decision|1
700659|NCT01373918|2275787|P1|Overall Study|Physician Decision|0
700660|NCT01373346|2275831|P1|Overall Study|Death|1
700661|NCT01373294|2275854|P2|Overall Study|Adverse Event|0
700662|NCT01373294|2275855|P1|Overall Study|Adverse Event|1
700663|NCT01373281|2275864|P2|Overall Study|Serious adverse event|5
700664|NCT01373281|2275865|P1|Overall Study|Serious adverse event|6
700665|NCT01373281|2275864|P2|Overall Study|Adverse Event|4
700666|NCT01373281|2275865|P1|Overall Study|Adverse Event|4
700667|NCT01373281|2275864|P2|Overall Study|Lost to Follow-up|1
700668|NCT01373281|2275865|P1|Overall Study|Lost to Follow-up|4
700669|NCT01373281|2275864|P2|Overall Study|Protocol Violation|4
700670|NCT01373281|2275865|P1|Overall Study|Protocol Violation|13
700671|NCT01373281|2275864|P2|Overall Study|Withdrawal by Subject|31
700672|NCT01373281|2275865|P1|Overall Study|Withdrawal by Subject|52
700673|NCT01372995|2275884|P3|Overall Study|Physician Decision|1
700674|NCT01372995|2275885|P2|Overall Study|Physician Decision|0
700675|NCT01372995|2275886|P1|Overall Study|Physician Decision|0
700676|NCT01372995|2275884|P3|Overall Study|Spouse withdrew participant from study|0
700677|NCT01372995|2275885|P2|Overall Study|Spouse withdrew participant from study|1
700841|NCT01371838|2276170|P1|Overall Study|Withdrawal by Subject|27
700678|NCT01372995|2275886|P1|Overall Study|Spouse withdrew participant from study|0
700679|NCT01372878|2275933|P1|Overall Study|incomplete study procedure|104
700680|NCT01372878|2275933|P1|Overall Study|Protocol Violation|17
700681|NCT01372878|2275933|P1|Overall Study|Withdrawal by Subject|63
700682|NCT01372748|2275953|P2|Overall Study|Withdrawal by Subject|5
700683|NCT01372748|2275954|P1|Overall Study|Withdrawal by Subject|7
700684|NCT01372748|2275953|P2|Overall Study|Lost to Follow-up|34
700685|NCT01372748|2275954|P1|Overall Study|Lost to Follow-up|16
700686|NCT01372605|2275964|P2|Overall Study|Changed medical home|0
700687|NCT01372605|2275965|P1|Overall Study|Changed medical home|2
700688|NCT01372605|2275964|P2|Overall Study|Moved|0
700689|NCT01372605|2275965|P1|Overall Study|Moved|3
700690|NCT01372605|2275964|P2|Overall Study|Withdrawal by Subject|7
700691|NCT01372605|2275965|P1|Overall Study|Withdrawal by Subject|4
700692|NCT01372605|2275964|P2|Overall Study|Lost to Follow-up|1
700693|NCT01372605|2275965|P1|Overall Study|Lost to Follow-up|2
700694|NCT01372605|2275964|P2|Overall Study|Death|2
700695|NCT01372605|2275965|P1|Overall Study|Death|1
700696|NCT01372501|2275991|P1|Overall Study|Device migration|1
700697|NCT01372501|2275991|P1|Overall Study|Adverse Event|4
889574|NCT01301001|2824211|P2|Second Intervention|Withdrawal by Subject|0
889575|NCT01301001|2824212|P1|Second Intervention|Withdrawal by Subject|2
889576|NCT01301001|2824211|P2|Second Intervention|Adverse Event|0
889577|NCT01301001|2824212|P1|Second Intervention|Adverse Event|2
889578|NCT01301001|2824211|P2|First Intervention|Protocol Violation|1
889579|NCT01301001|2824212|P1|First Intervention|Protocol Violation|0
889580|NCT01301001|2824211|P2|First Intervention|Adverse Event|0
889581|NCT01301001|2824212|P1|First Intervention|Adverse Event|5
889582|NCT01301001|2824211|P2|First Intervention|Withdrawal by Subject|4
889583|NCT01301001|2824212|P1|First Intervention|Withdrawal by Subject|1
889584|NCT01301001|2824211|P2|First Intervention|Lost to Follow-up|4
889585|NCT01301001|2824212|P1|First Intervention|Lost to Follow-up|4
889586|NCT01298778|2824224|P2|Overall Study|not meet inclusion/exclusion criteria|1
889587|NCT01298778|2824225|P1|Overall Study|not meet inclusion/exclusion criteria|0
889588|NCT01298778|2824224|P2|Overall Study|Protocol Violation|1
889589|NCT01298778|2824225|P1|Overall Study|Protocol Violation|0
889590|NCT01298778|2824224|P2|Overall Study|Withdrawal by Subject|1
889591|NCT01298778|2824225|P1|Overall Study|Withdrawal by Subject|0
889592|NCT01298778|2824224|P2|Overall Study|Incorrect use of VAS|0
889593|NCT01298778|2824225|P1|Overall Study|Incorrect use of VAS|1
889594|NCT01298778|2824224|P2|Overall Study|Lost to Follow-up|3
889595|NCT01298778|2824225|P1|Overall Study|Lost to Follow-up|2
889596|NCT01281124|2824264|P1|Overall Study|Death|1
889597|NCT01264679|2824281|P1|Overall Study|Withdrawal by Subject|1
889598|NCT01264679|2824281|P1|Overall Study|Sponsor's Suspension of Dosing|2
889599|NCT01264679|2824281|P1|Overall Study|Physician Decision|1
889600|NCT01264679|2824281|P1|Overall Study|Participation in Another Clinical Trial|1
889601|NCT01261780|2824289|P2|Overall Study|Event not related to subject|2
889602|NCT01261780|2824290|P1|Overall Study|Event not related to subject|1
889603|NCT01261780|2824289|P2|Overall Study|Withdrawal by Subject|0
889604|NCT01261780|2824290|P1|Overall Study|Withdrawal by Subject|1
889605|NCT01256502|2824298|P1|Overall Study|Protocol deviation|1
889606|NCT01256502|2824298|P1|Overall Study|Personal reasons|5
889607|NCT01256502|2824298|P1|Overall Study|Had scaffold removed|4
889617|NCT01248715|2824345|P2|Overall Study|Not influenza positive|510
889618|NCT01248715|2824346|P1|Overall Study|Not influenza positive|501
889619|NCT01248130|2824366|P2|Overall Study|Ineligible|0
889620|NCT01248130|2824367|P1|Overall Study|Ineligible|1
889621|NCT01248130|2824366|P2|Overall Study|Protocol Violation|0
889622|NCT01248130|2824367|P1|Overall Study|Protocol Violation|1
889623|NCT01239381|2824375|P1|Overall Study|Withdrawal by Subject|1
889624|NCT01239381|2824375|P1|Overall Study|Protocol Violation|1
889625|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889626|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889627|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
889628|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
700778|NCT01372384|2276058|P1|Overall Study|Progression of disease|3
700779|NCT01372150|2276081|P3|Overall Study|Randomized but not treated|0
700780|NCT01372150|2276082|P2|Overall Study|Randomized but not treated|1
700781|NCT01372150|2276083|P1|Overall Study|Randomized but not treated|0
700782|NCT01372150|2276081|P3|Overall Study|Adverse Event|2
700783|NCT01372150|2276082|P2|Overall Study|Adverse Event|1
700784|NCT01372150|2276083|P1|Overall Study|Adverse Event|2
700785|NCT01372150|2276081|P3|Overall Study|Other|2
700786|NCT01372150|2276082|P2|Overall Study|Other|0
700787|NCT01372150|2276083|P1|Overall Study|Other|1
700788|NCT01372150|2276081|P3|Overall Study|Withdrawal by Subject|2
700789|NCT01372150|2276082|P2|Overall Study|Withdrawal by Subject|7
700790|NCT01372150|2276083|P1|Overall Study|Withdrawal by Subject|2
700791|NCT01372150|2276081|P3|Overall Study|Protocol Violation|3
700792|NCT01372150|2276082|P2|Overall Study|Protocol Violation|0
700793|NCT01372150|2276083|P1|Overall Study|Protocol Violation|1
700794|NCT01372150|2276081|P3|Overall Study|Lost to Follow-up|6
700795|NCT01372150|2276082|P2|Overall Study|Lost to Follow-up|5
700796|NCT01372150|2276083|P1|Overall Study|Lost to Follow-up|4
700797|NCT01372150|2276081|P3|Overall Study|Lack of Efficacy|1
700798|NCT01372150|2276082|P2|Overall Study|Lack of Efficacy|0
700799|NCT01372150|2276083|P1|Overall Study|Lack of Efficacy|3
700800|NCT01371994|2276102|P2|Overall Study|Miscellaneous Reasons|4
700801|NCT01371994|2276103|P1|Overall Study|Miscellaneous Reasons|6
700802|NCT01371994|2276102|P2|Overall Study|Physician Decision|1
700803|NCT01371994|2276103|P1|Overall Study|Physician Decision|1
700804|NCT01371994|2276102|P2|Overall Study|Randomized but Never Received Study Drug|6
700805|NCT01371994|2276103|P1|Overall Study|Randomized but Never Received Study Drug|6
700806|NCT01371994|2276102|P2|Overall Study|Protocol Violation|17
700807|NCT01371994|2276103|P1|Overall Study|Protocol Violation|24
700808|NCT01371994|2276102|P2|Overall Study|Lost to Follow-up|1
700809|NCT01371994|2276103|P1|Overall Study|Lost to Follow-up|1
700810|NCT01371994|2276102|P2|Overall Study|Withdrawal by Subject|7
700811|NCT01371994|2276103|P1|Overall Study|Withdrawal by Subject|13
700812|NCT01371994|2276102|P2|Overall Study|Lack of Efficacy|0
700813|NCT01371994|2276103|P1|Overall Study|Lack of Efficacy|3
700814|NCT01371994|2276102|P2|Overall Study|Adverse Event|6
700815|NCT01371994|2276103|P1|Overall Study|Adverse Event|3
700816|NCT01371877|2276147|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
700817|NCT01371877|2276148|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
700818|NCT01371851|2276160|P2|Overall Study|Blood Pressure outside study parameters|0
700819|NCT01371851|2276161|P1|Overall Study|Blood Pressure outside study parameters|2
700820|NCT01371851|2276160|P2|Overall Study|non study related adverse event|0
700821|NCT01371851|2276161|P1|Overall Study|non study related adverse event|1
700822|NCT01371851|2276160|P2|Overall Study|was arrested and put in jail|1
700823|NCT01371851|2276161|P1|Overall Study|was arrested and put in jail|0
700824|NCT01371851|2276160|P2|Overall Study|Lost to Follow-up|8
700825|NCT01371851|2276161|P1|Overall Study|Lost to Follow-up|5
700826|NCT01371838|2276169|P2|Overall Study|Surgery|0
700827|NCT01371838|2276170|P1|Overall Study|Surgery|1
700828|NCT01371838|2276169|P2|Overall Study|Lack of therapeutic response|1
700829|NCT01371838|2276170|P1|Overall Study|Lack of therapeutic response|0
700830|NCT01371838|2276169|P2|Overall Study|Last follow-up visit not conducted|0
700831|NCT01371838|2276170|P1|Overall Study|Last follow-up visit not conducted|2
700832|NCT01371838|2276169|P2|Overall Study|Investigator Decision|8
700833|NCT01371838|2276170|P1|Overall Study|Investigator Decision|3
700834|NCT01371838|2276169|P2|Overall Study|Protocol Violation|0
700835|NCT01371838|2276170|P1|Overall Study|Protocol Violation|3
700836|NCT01371838|2276169|P2|Overall Study|Death|4
700837|NCT01371838|2276170|P1|Overall Study|Death|3
700838|NCT01371838|2276169|P2|Overall Study|Lost to Follow-up|20
700839|NCT01371838|2276170|P1|Overall Study|Lost to Follow-up|10
700840|NCT01371838|2276169|P2|Overall Study|Withdrawal by Subject|33
889629|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
700843|NCT01371747|2276241|P6|Overall Study|Other Reasons|1
700844|NCT01371747|2276242|P5|Overall Study|Other Reasons|0
700845|NCT01371747|2276243|P4|Overall Study|Other Reasons|0
700846|NCT01371747|2276244|P3|Overall Study|Other Reasons|2
700847|NCT01371747|2276245|P2|Overall Study|Other Reasons|1
700848|NCT01371747|2276246|P1|Overall Study|Other Reasons|2
700849|NCT01371747|2276241|P6|Overall Study|Withdrawal by Subject|4
700850|NCT01371747|2276242|P5|Overall Study|Withdrawal by Subject|2
700851|NCT01371747|2276243|P4|Overall Study|Withdrawal by Subject|2
700852|NCT01371747|2276244|P3|Overall Study|Withdrawal by Subject|5
700853|NCT01371747|2276245|P2|Overall Study|Withdrawal by Subject|12
700854|NCT01371747|2276246|P1|Overall Study|Withdrawal by Subject|6
700855|NCT01371747|2276241|P6|Overall Study|Physician Decision|0
700856|NCT01371747|2276242|P5|Overall Study|Physician Decision|1
700857|NCT01371747|2276243|P4|Overall Study|Physician Decision|0
700858|NCT01371747|2276244|P3|Overall Study|Physician Decision|0
700859|NCT01371747|2276245|P2|Overall Study|Physician Decision|0
700860|NCT01371747|2276246|P1|Overall Study|Physician Decision|0
700861|NCT01371747|2276241|P6|Overall Study|Non-Compliance|1
700862|NCT01371747|2276242|P5|Overall Study|Non-Compliance|0
700863|NCT01371747|2276243|P4|Overall Study|Non-Compliance|0
700864|NCT01371747|2276244|P3|Overall Study|Non-Compliance|3
700865|NCT01371747|2276245|P2|Overall Study|Non-Compliance|4
700866|NCT01371747|2276246|P1|Overall Study|Non-Compliance|3
700867|NCT01371747|2276241|P6|Overall Study|Protocol Violation|0
700868|NCT01371747|2276242|P5|Overall Study|Protocol Violation|0
700869|NCT01371747|2276243|P4|Overall Study|Protocol Violation|0
700870|NCT01371747|2276244|P3|Overall Study|Protocol Violation|1
700871|NCT01371747|2276245|P2|Overall Study|Protocol Violation|0
700872|NCT01371747|2276246|P1|Overall Study|Protocol Violation|0
700873|NCT01371747|2276241|P6|Overall Study|Low Serum Potassium Results|3
700874|NCT01371747|2276242|P5|Overall Study|Low Serum Potassium Results|0
700875|NCT01371747|2276243|P4|Overall Study|Low Serum Potassium Results|1
700876|NCT01371747|2276244|P3|Overall Study|Low Serum Potassium Results|1
700877|NCT01371747|2276245|P2|Overall Study|Low Serum Potassium Results|1
700878|NCT01371747|2276246|P1|Overall Study|Low Serum Potassium Results|1
700879|NCT01371747|2276241|P6|Overall Study|High Serum Potassium Results|2
700880|NCT01371747|2276242|P5|Overall Study|High Serum Potassium Results|0
700881|NCT01371747|2276243|P4|Overall Study|High Serum Potassium Results|2
700882|NCT01371747|2276244|P3|Overall Study|High Serum Potassium Results|1
700883|NCT01371747|2276245|P2|Overall Study|High Serum Potassium Results|1
700884|NCT01371747|2276246|P1|Overall Study|High Serum Potassium Results|1
700885|NCT01371747|2276241|P6|Overall Study|Abnormal Renal Function|1
700886|NCT01371747|2276242|P5|Overall Study|Abnormal Renal Function|0
700887|NCT01371747|2276243|P4|Overall Study|Abnormal Renal Function|1
700888|NCT01371747|2276244|P3|Overall Study|Abnormal Renal Function|0
700889|NCT01371747|2276245|P2|Overall Study|Abnormal Renal Function|2
700890|NCT01371747|2276246|P1|Overall Study|Abnormal Renal Function|0
700891|NCT01371747|2276241|P6|Overall Study|Death|0
700892|NCT01371747|2276242|P5|Overall Study|Death|2
700893|NCT01371747|2276243|P4|Overall Study|Death|1
700894|NCT01371747|2276244|P3|Overall Study|Death|4
700895|NCT01371747|2276245|P2|Overall Study|Death|0
700896|NCT01371747|2276246|P1|Overall Study|Death|1
700897|NCT01371747|2276241|P6|Overall Study|Adverse Event|2
700898|NCT01371747|2276242|P5|Overall Study|Adverse Event|2
700899|NCT01371747|2276243|P4|Overall Study|Adverse Event|2
700900|NCT01371747|2276244|P3|Overall Study|Adverse Event|7
700901|NCT01371747|2276245|P2|Overall Study|Adverse Event|2
700902|NCT01371747|2276246|P1|Overall Study|Adverse Event|4
700903|NCT01371734|2276311|P3|Overall Study|Lack of Efficacy|0
700904|NCT01371734|2276312|P2|Overall Study|Lack of Efficacy|2
700905|NCT01371734|2276313|P1|Overall Study|Lack of Efficacy|2
700906|NCT01371734|2276311|P3|Overall Study|Adverse Event|3
700907|NCT01371734|2276312|P2|Overall Study|Adverse Event|8
700908|NCT01371734|2276313|P1|Overall Study|Adverse Event|8
700909|NCT01371734|2276311|P3|Overall Study|Protocol Violation|2
700910|NCT01371734|2276312|P2|Overall Study|Protocol Violation|1
700911|NCT01371734|2276313|P1|Overall Study|Protocol Violation|3
700912|NCT01371734|2276311|P3|Overall Study|Lost to Follow-up|1
700913|NCT01371734|2276312|P2|Overall Study|Lost to Follow-up|3
700914|NCT01371734|2276313|P1|Overall Study|Lost to Follow-up|5
700915|NCT01371734|2276311|P3|Overall Study|Withdrawal by Subject|9
700916|NCT01371734|2276312|P2|Overall Study|Withdrawal by Subject|4
700917|NCT01371734|2276313|P1|Overall Study|Withdrawal by Subject|3
700918|NCT01371734|2276311|P3|Overall Study|Not specified|2
700919|NCT01371734|2276312|P2|Overall Study|Not specified|1
700920|NCT01371734|2276313|P1|Overall Study|Not specified|2
700921|NCT01371721|2276333|P3|Overall Study|Randomized but not treated|0
700922|NCT01371721|2276334|P2|Overall Study|Randomized but not treated|0
700923|NCT01371721|2276335|P1|Overall Study|Randomized but not treated|1
700924|NCT01371721|2276333|P3|Overall Study|Lack of Efficacy|3
700925|NCT01371721|2276334|P2|Overall Study|Lack of Efficacy|4
700926|NCT01371721|2276335|P1|Overall Study|Lack of Efficacy|2
700927|NCT01371721|2276333|P3|Overall Study|Not specified|0
700928|NCT01371721|2276334|P2|Overall Study|Not specified|3
700929|NCT01371721|2276335|P1|Overall Study|Not specified|2
700930|NCT01371721|2276333|P3|Overall Study|Withdrawal by Subject|11
700931|NCT01371721|2276334|P2|Overall Study|Withdrawal by Subject|7
700932|NCT01371721|2276335|P1|Overall Study|Withdrawal by Subject|5
700933|NCT01371721|2276333|P3|Overall Study|Lost to Follow-up|6
700934|NCT01371721|2276334|P2|Overall Study|Lost to Follow-up|2
700935|NCT01371721|2276335|P1|Overall Study|Lost to Follow-up|8
700936|NCT01371721|2276333|P3|Overall Study|Protocol Violation|5
700937|NCT01371721|2276334|P2|Overall Study|Protocol Violation|4
700938|NCT01371721|2276335|P1|Overall Study|Protocol Violation|6
700939|NCT01371721|2276333|P3|Overall Study|Adverse Event|5
700940|NCT01371721|2276334|P2|Overall Study|Adverse Event|4
700941|NCT01371721|2276335|P1|Overall Study|Adverse Event|5
700942|NCT01371708|2276368|P3|Overall Study|Started but did not receive treatment|1
700943|NCT01371708|2276369|P2|Overall Study|Started but did not receive treatment|0
700944|NCT01371708|2276370|P1|Overall Study|Started but did not receive treatment|1
700945|NCT01371708|2276368|P3|Overall Study|Adverse Event|12
700946|NCT01371708|2276369|P2|Overall Study|Adverse Event|8
700947|NCT01371708|2276370|P1|Overall Study|Adverse Event|5
700948|NCT01371708|2276368|P3|Overall Study|Not specified|4
700949|NCT01371708|2276369|P2|Overall Study|Not specified|2
700950|NCT01371708|2276370|P1|Overall Study|Not specified|3
700951|NCT01371708|2276368|P3|Overall Study|Medication error/not related to AE|0
700952|NCT01371708|2276369|P2|Overall Study|Medication error/not related to AE|1
700953|NCT01371708|2276370|P1|Overall Study|Medication error/not related to AE|0
700954|NCT01371708|2276368|P3|Overall Study|No longer willing to participate|13
700955|NCT01371708|2276369|P2|Overall Study|No longer willing to participate|7
700956|NCT01371708|2276370|P1|Overall Study|No longer willing to participate|7
700957|NCT01371708|2276368|P3|Overall Study|Protocol Violation|2
700958|NCT01371708|2276369|P2|Overall Study|Protocol Violation|1
700959|NCT01371708|2276370|P1|Overall Study|Protocol Violation|2
700960|NCT01371708|2276368|P3|Overall Study|Lost to Follow-up|7
700961|NCT01371708|2276369|P2|Overall Study|Lost to Follow-up|9
700962|NCT01371708|2276370|P1|Overall Study|Lost to Follow-up|5
700963|NCT01371708|2276368|P3|Overall Study|Insufficient clinical response|0
700964|NCT01371708|2276369|P2|Overall Study|Insufficient clinical response|2
700965|NCT01371708|2276370|P1|Overall Study|Insufficient clinical response|3
700966|NCT01371643|2276402|P2|Overall Study|Withdrawal by Subject|0
700967|NCT01371643|2276403|P1|Overall Study|Withdrawal by Subject|3
700968|NCT01371565|2276413|P1|Overall Study|Resection of neuroendocrine tumor|1
700969|NCT01371565|2276413|P1|Overall Study|Death|1
700970|NCT01371565|2276413|P1|Overall Study|Withdrawal by Subject|1
700971|NCT01371552|2276417|P6|Part 1, First 3 Days|Inconvenience|0
700972|NCT01371552|2276418|P5|Part 1, First 3 Days|Inconvenience|0
700973|NCT01371552|2276419|P4|Part 1, First 3 Days|Inconvenience|0
700974|NCT01371552|2276420|P3|Part 1, First 3 Days|Inconvenience|1
700975|NCT01371552|2276421|P2|Part 1, First 3 Days|Inconvenience|0
700976|NCT01371552|2276422|P1|Part 1, First 3 Days|Inconvenience|0
700977|NCT01371539|2276449|P2|Period Two: One Week|Time/job conflict|1
700978|NCT01371539|2276450|P1|Period Two: One Week|Time/job conflict|0
700979|NCT01371539|2276449|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
700980|NCT01371539|2276450|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
700981|NCT01371539|2276449|P2|Period Two: One Week|Lost to Follow-up|1
700982|NCT01371539|2276450|P1|Period Two: One Week|Lost to Follow-up|0
700983|NCT01371539|2276449|P2|Period One: One Week|Lost to Follow-up|1
700984|NCT01371539|2276450|P1|Period One: One Week|Lost to Follow-up|0
700985|NCT01371006|2276471|P2|Overall Study|Adverse Event|0
700986|NCT01371006|2276472|P1|Overall Study|Adverse Event|1
700987|NCT01370863|2276513|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
700988|NCT01370863|2276514|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
700989|NCT01370863|2276513|P2|Overall Study|Did not want second pH/MII monitoring|1
700990|NCT01370863|2276514|P1|Overall Study|Did not want second pH/MII monitoring|1
700991|NCT01370863|2276513|P2|Overall Study|Adverse Event|1
700992|NCT01370863|2276514|P1|Overall Study|Adverse Event|1
700993|NCT01370733|2276539|P2|Overall Study|Protocol Violation|3
700994|NCT01370733|2276540|P1|Overall Study|Protocol Violation|1
700995|NCT01370733|2276539|P2|Overall Study|Physician Decision|2
700996|NCT01370733|2276540|P1|Overall Study|Physician Decision|0
700997|NCT01370733|2276539|P2|Overall Study|Lack of Efficacy|5
700998|NCT01370733|2276540|P1|Overall Study|Lack of Efficacy|3
700999|NCT01370733|2276539|P2|Overall Study|Adverse Event|4
701000|NCT01370733|2276540|P1|Overall Study|Adverse Event|2
701001|NCT01370733|2276539|P2|Overall Study|Lost to Follow-up|0
701002|NCT01370733|2276540|P1|Overall Study|Lost to Follow-up|3
701003|NCT01370733|2276539|P2|Overall Study|Withdrawal by Subject|8
701004|NCT01370733|2276540|P1|Overall Study|Withdrawal by Subject|8
701005|NCT01370694|2276562|P1|Overall Study|Progressive disease|2
701006|NCT01370694|2276562|P1|Overall Study|Switched to rituximab|4
701007|NCT01370655|2276584|P12|Period 2|Withdrawal by Subject|0
701008|NCT01370655|2276585|P11|Period 2|Withdrawal by Subject|0
701009|NCT01370655|2276586|P10|Period 2|Withdrawal by Subject|0
701010|NCT01370655|2276587|P9|Period 2|Withdrawal by Subject|1
701011|NCT01370655|2276588|P8|Period 2|Withdrawal by Subject|0
701012|NCT01370655|2276589|P7|Period 2|Withdrawal by Subject|0
701013|NCT01370655|2276590|P6|Period 2|Withdrawal by Subject|0
701014|NCT01370655|2276591|P5|Period 2|Withdrawal by Subject|0
701015|NCT01370655|2276592|P4|Period 2|Withdrawal by Subject|0
701016|NCT01370655|2276593|P3|Period 2|Withdrawal by Subject|0
701017|NCT01370655|2276594|P2|Period 2|Withdrawal by Subject|0
701018|NCT01370655|2276595|P1|Period 2|Withdrawal by Subject|0
701019|NCT01370655|2276584|P12|Period 2|met protocol specified stopping criteria|0
701020|NCT01370655|2276585|P11|Period 2|met protocol specified stopping criteria|1
701021|NCT01370655|2276586|P10|Period 2|met protocol specified stopping criteria|0
701022|NCT01370655|2276587|P9|Period 2|met protocol specified stopping criteria|1
701023|NCT01370655|2276588|P8|Period 2|met protocol specified stopping criteria|0
701024|NCT01370655|2276589|P7|Period 2|met protocol specified stopping criteria|1
701025|NCT01370655|2276590|P6|Period 2|met protocol specified stopping criteria|0
701026|NCT01370655|2276591|P5|Period 2|met protocol specified stopping criteria|0
701027|NCT01370655|2276592|P4|Period 2|met protocol specified stopping criteria|0
701028|NCT01370655|2276593|P3|Period 2|met protocol specified stopping criteria|1
701029|NCT01370655|2276594|P2|Period 2|met protocol specified stopping criteria|0
701030|NCT01370655|2276595|P1|Period 2|met protocol specified stopping criteria|0
701031|NCT01370655|2276584|P12|Period 2|Adverse Event|0
701032|NCT01370655|2276585|P11|Period 2|Adverse Event|0
701033|NCT01370655|2276586|P10|Period 2|Adverse Event|0
701034|NCT01370655|2276587|P9|Period 2|Adverse Event|0
701035|NCT01370655|2276588|P8|Period 2|Adverse Event|1
701036|NCT01370655|2276589|P7|Period 2|Adverse Event|0
701037|NCT01370655|2276590|P6|Period 2|Adverse Event|0
701038|NCT01370655|2276591|P5|Period 2|Adverse Event|1
701039|NCT01370655|2276592|P4|Period 2|Adverse Event|0
701040|NCT01370655|2276593|P3|Period 2|Adverse Event|1
701041|NCT01370655|2276594|P2|Period 2|Adverse Event|0
701042|NCT01370655|2276595|P1|Period 2|Adverse Event|0
701043|NCT01370655|2276584|P12|Period 1|Adverse Event|0
701044|NCT01370655|2276585|P11|Period 1|Adverse Event|0
701045|NCT01370655|2276586|P10|Period 1|Adverse Event|0
701046|NCT01370655|2276587|P9|Period 1|Adverse Event|0
701047|NCT01370655|2276588|P8|Period 1|Adverse Event|0
701048|NCT01370655|2276589|P7|Period 1|Adverse Event|1
701049|NCT01370655|2276590|P6|Period 1|Adverse Event|0
701050|NCT01370655|2276591|P5|Period 1|Adverse Event|0
701051|NCT01370655|2276592|P4|Period 1|Adverse Event|0
701052|NCT01370655|2276593|P3|Period 1|Adverse Event|0
701053|NCT01370655|2276594|P2|Period 1|Adverse Event|0
701054|NCT01370655|2276595|P1|Period 1|Adverse Event|2
701055|NCT01370642|2276632|P3|Overall Study|Withdrawal by Subject|3
701056|NCT01370642|2276633|P2|Overall Study|Withdrawal by Subject|4
701057|NCT01370642|2276634|P1|Overall Study|Withdrawal by Subject|2
701058|NCT01370642|2276632|P3|Overall Study|Physician Decision|2
701059|NCT01370642|2276633|P2|Overall Study|Physician Decision|1
701060|NCT01370642|2276634|P1|Overall Study|Physician Decision|4
701061|NCT01370642|2276632|P3|Overall Study|Lost to Follow-up|1
701062|NCT01370642|2276633|P2|Overall Study|Lost to Follow-up|0
701063|NCT01370642|2276634|P1|Overall Study|Lost to Follow-up|0
701064|NCT01370642|2276632|P3|Overall Study|Detectable HCV RNA|22
701065|NCT01370642|2276633|P2|Overall Study|Detectable HCV RNA|0
701066|NCT01370642|2276634|P1|Overall Study|Detectable HCV RNA|0
701067|NCT01370642|2276632|P3|Overall Study|Adverse Event|1
701068|NCT01370642|2276633|P2|Overall Study|Adverse Event|1
701069|NCT01370642|2276634|P1|Overall Study|Adverse Event|2
701070|NCT01370616|2276665|P2|Overall Study|Withdrawal by Subject|34
701071|NCT01370616|2276666|P1|Overall Study|Withdrawal by Subject|34
701072|NCT01370616|2276665|P2|Overall Study|Technical Problems|5
701073|NCT01370616|2276666|P1|Overall Study|Technical Problems|3
701074|NCT01370616|2276665|P2|Overall Study|Recovery|0
701075|NCT01370616|2276666|P1|Overall Study|Recovery|1
701076|NCT01370616|2276665|P2|Overall Study|Progressive Disease|1
701077|NCT01370616|2276666|P1|Overall Study|Progressive Disease|0
701078|NCT01370616|2276665|P2|Overall Study|Physician Decision|6
701079|NCT01370616|2276666|P1|Overall Study|Physician Decision|6
701080|NCT01370616|2276665|P2|Overall Study|Lost to Follow-up|3
701081|NCT01370616|2276666|P1|Overall Study|Lost to Follow-up|0
701082|NCT01370616|2276665|P2|Overall Study|Lack of Efficacy|2
701083|NCT01370616|2276666|P1|Overall Study|Lack of Efficacy|6
701084|NCT01370616|2276665|P2|Overall Study|Death|0
701085|NCT01370616|2276666|P1|Overall Study|Death|1
701086|NCT01370616|2276665|P2|Overall Study|Adverse Event|16
701087|NCT01370616|2276666|P1|Overall Study|Adverse Event|11
701088|NCT01370603|2276690|P2|Period 2|Withdrawal by Subject|0
701089|NCT01370603|2276691|P1|Period 2|Withdrawal by Subject|1
701090|NCT01370603|2276690|P2|Period 2|Lost to Follow-up|0
701091|NCT01370603|2276691|P1|Period 2|Lost to Follow-up|1
701092|NCT01370603|2276690|P2|Period 2|Adverse Event|4
701093|NCT01370603|2276691|P1|Period 2|Adverse Event|1
701094|NCT01370603|2276690|P2|Crossover Washout|Non-compliance with Study Drug|2
701095|NCT01370603|2276691|P1|Crossover Washout|Non-compliance with Study Drug|0
701096|NCT01370603|2276690|P2|Crossover Washout|Withdrawal by Subject|1
701097|NCT01370603|2276691|P1|Crossover Washout|Withdrawal by Subject|4
701098|NCT01370603|2276690|P2|Crossover Washout|Protocol Violation|0
701099|NCT01370603|2276691|P1|Crossover Washout|Protocol Violation|1
701100|NCT01370603|2276690|P2|Crossover Washout|Lost to Follow-up|0
701101|NCT01370603|2276691|P1|Crossover Washout|Lost to Follow-up|2
701102|NCT01370603|2276690|P2|Crossover Washout|Adverse Event|1
701103|NCT01370603|2276691|P1|Crossover Washout|Adverse Event|2
701104|NCT01370603|2276690|P2|Period 1|Withdrawal by Subject|5
701105|NCT01370603|2276691|P1|Period 1|Withdrawal by Subject|5
701106|NCT01370603|2276690|P2|Period 1|Protocol Violation|2
701107|NCT01370603|2276691|P1|Period 1|Protocol Violation|2
701108|NCT01370603|2276690|P2|Period 1|Lost to Follow-up|0
701109|NCT01370603|2276691|P1|Period 1|Lost to Follow-up|2
701110|NCT01370603|2276690|P2|Period 1|Adverse Event|3
701111|NCT01370603|2276691|P1|Period 1|Adverse Event|5
701112|NCT01370590|2276709|P2|Period 2|Withdrawal by Subject|1
701113|NCT01370590|2276710|P1|Period 2|Withdrawal by Subject|1
701114|NCT01370590|2276709|P2|Period 2|Adverse Event|1
701115|NCT01370590|2276710|P1|Period 2|Adverse Event|0
701116|NCT01370590|2276709|P2|Crossover Washout Period|Withdrawal by Subject|2
701117|NCT01370590|2276710|P1|Crossover Washout Period|Withdrawal by Subject|2
701118|NCT01370590|2276709|P2|Crossover Washout Period|Non-compliance with Study Drug|0
701119|NCT01370590|2276710|P1|Crossover Washout Period|Non-compliance with Study Drug|1
701120|NCT01370590|2276709|P2|Crossover Washout Period|Lost to Follow-up|0
701121|NCT01370590|2276710|P1|Crossover Washout Period|Lost to Follow-up|2
701122|NCT01370590|2276709|P2|Crossover Washout Period|Adverse Event|4
701123|NCT01370590|2276710|P1|Crossover Washout Period|Adverse Event|1
701124|NCT01370590|2276709|P2|Period 1|Could not access randomization system|1
701125|NCT01370590|2276710|P1|Period 1|Could not access randomization system|0
701126|NCT01370590|2276709|P2|Period 1|Withdrawal by Subject|2
701127|NCT01370590|2276710|P1|Period 1|Withdrawal by Subject|4
701128|NCT01370590|2276709|P2|Period 1|Protocol Violation|2
701129|NCT01370590|2276710|P1|Period 1|Protocol Violation|2
701130|NCT01370590|2276709|P2|Period 1|Lost to Follow-up|2
701131|NCT01370590|2276710|P1|Period 1|Lost to Follow-up|2
701132|NCT01370590|2276709|P2|Period 1|Adverse Event|4
701133|NCT01370590|2276710|P1|Period 1|Adverse Event|8
701134|NCT01370538|2276728|P2|Overall Study|Lost to follow up|10
701135|NCT01370538|2276729|P1|Overall Study|Lost to follow up|6
701136|NCT01370538|2276728|P2|Overall Study|Development of study specific withdrawal|1
701137|NCT01370538|2276729|P1|Overall Study|Development of study specific withdrawal|1
701138|NCT01370538|2276728|P2|Overall Study|Protocol Violation|5
701139|NCT01370538|2276729|P1|Overall Study|Protocol Violation|8
701140|NCT01370538|2276728|P2|Overall Study|Adverse Event|0
701141|NCT01370538|2276729|P1|Overall Study|Adverse Event|1
701142|NCT01370538|2276728|P2|Overall Study|Eligibility criteria not fulfilled|1
701143|NCT01370538|2276729|P1|Overall Study|Eligibility criteria not fulfilled|0
701144|NCT01370538|2276728|P2|Overall Study|Voluntary Discontinuation by Subject|2
701145|NCT01370538|2276729|P1|Overall Study|Voluntary Discontinuation by Subject|3
701146|NCT01370525|2276745|P2|Overall Study|Lost to follow up|6
701147|NCT01370525|2276746|P1|Overall Study|Lost to follow up|2
701148|NCT01370525|2276745|P2|Overall Study|Protocol Violation|1
701149|NCT01370525|2276746|P1|Overall Study|Protocol Violation|2
701150|NCT01370525|2276745|P2|Overall Study|Adverse Event|1
701151|NCT01370525|2276746|P1|Overall Study|Adverse Event|0
701152|NCT01370525|2276745|P2|Overall Study|Eligibility criteria not fulfilled|0
701153|NCT01370525|2276746|P1|Overall Study|Eligibility criteria not fulfilled|2
701154|NCT01370525|2276745|P2|Overall Study|Voluntary Discontinuation by Subject|3
701155|NCT01370525|2276746|P1|Overall Study|Voluntary Discontinuation by Subject|2
701156|NCT01370408|2276770|P1|Overall Study|treatment failure|9
701157|NCT01370356|2276830|P2|Overall Study|AE Not Related to Study Drug|4
701158|NCT01370356|2276831|P1|Overall Study|AE Not Related to Study Drug|1
701159|NCT01370356|2276830|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
701160|NCT01370356|2276831|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
701161|NCT01370356|2276830|P2|Overall Study|Protocol Violation|3
701162|NCT01370356|2276831|P1|Overall Study|Protocol Violation|3
701163|NCT01370356|2276830|P2|Overall Study|Reason not specified|43
701164|NCT01370356|2276831|P1|Overall Study|Reason not specified|39
701165|NCT01370356|2276830|P2|Overall Study|Withdrawal by Subject|59
701166|NCT01370356|2276831|P1|Overall Study|Withdrawal by Subject|54
701167|NCT01370356|2276830|P2|Overall Study|Lost to Follow-up|81
701168|NCT01370356|2276831|P1|Overall Study|Lost to Follow-up|76
701169|NCT01370356|2276830|P2|Overall Study|Lack of Efficacy|28
701170|NCT01370356|2276831|P1|Overall Study|Lack of Efficacy|6
701171|NCT01370356|2276830|P2|Overall Study|Death|0
701172|NCT01370356|2276831|P1|Overall Study|Death|1
701173|NCT01370265|2276845|P2|First Intervention|Adverse Event|1
701174|NCT01370265|2276846|P1|First Intervention|Adverse Event|1
701175|NCT01370083|2276865|P2|Overall Study|Adverse Event|1
701176|NCT01370083|2276866|P1|Overall Study|Adverse Event|0
701177|NCT01370083|2276865|P2|Overall Study|Lost to Follow-up|0
701178|NCT01370083|2276866|P1|Overall Study|Lost to Follow-up|2
701179|NCT01370005|2276879|P3|Overall Study|Other reason not defined above|2
701180|NCT01370005|2276880|P2|Overall Study|Other reason not defined above|0
701181|NCT01370005|2276881|P1|Overall Study|Other reason not defined above|3
701182|NCT01370005|2276879|P3|Overall Study|Patient refusal to continue,not due toAE|0
701183|NCT01370005|2276880|P2|Overall Study|Patient refusal to continue,not due toAE|4
701184|NCT01370005|2276881|P1|Overall Study|Patient refusal to continue,not due toAE|5
701185|NCT01370005|2276879|P3|Overall Study|Lost to Follow-up|1
701186|NCT01370005|2276880|P2|Overall Study|Lost to Follow-up|1
701187|NCT01370005|2276881|P1|Overall Study|Lost to Follow-up|1
701188|NCT01370005|2276879|P3|Overall Study|Non compliant with protocol|2
701189|NCT01370005|2276880|P2|Overall Study|Non compliant with protocol|1
701190|NCT01370005|2276881|P1|Overall Study|Non compliant with protocol|0
701191|NCT01370005|2276879|P3|Overall Study|Lack of Efficacy|0
701192|NCT01370005|2276880|P2|Overall Study|Lack of Efficacy|0
701193|NCT01370005|2276881|P1|Overall Study|Lack of Efficacy|1
701194|NCT01370005|2276879|P3|Overall Study|Adverse Event|6
701195|NCT01370005|2276880|P2|Overall Study|Adverse Event|5
701196|NCT01370005|2276881|P1|Overall Study|Adverse Event|5
701197|NCT01370005|2276879|P3|Overall Study|Not treated|0
701198|NCT01370005|2276880|P2|Overall Study|Not treated|0
701199|NCT01370005|2276881|P1|Overall Study|Not treated|1
701200|NCT01369849|2276963|P3|Overall Study|Ineligible after receiving treatment|0
701201|NCT01369849|2276964|P2|Overall Study|Ineligible after receiving treatment|1
701202|NCT01369849|2276965|P1|Overall Study|Ineligible after receiving treatment|0
701203|NCT01369849|2276963|P3|Overall Study|Ineligible prior to treatment|1
701204|NCT01369849|2276964|P2|Overall Study|Ineligible prior to treatment|0
701205|NCT01369849|2276965|P1|Overall Study|Ineligible prior to treatment|0
701206|NCT01369784|2276987|P1|Overall Study|Protocol Violation|12
701207|NCT01369680|2277075|P4|Overall Study|Lost to Follow-up|2
701208|NCT01369680|2277076|P3|Overall Study|Lost to Follow-up|1
701209|NCT01369680|2277077|P2|Overall Study|Lost to Follow-up|0
701210|NCT01369680|2277078|P1|Overall Study|Lost to Follow-up|0
889630|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
701212|NCT01369615|2277105|P2|Overall Study|Lost to Follow-up|1
701213|NCT01369615|2277106|P1|Overall Study|Lost to Follow-up|0
701214|NCT01369615|2277105|P2|Overall Study|Withdrawal by Subject|1
701215|NCT01369615|2277106|P1|Overall Study|Withdrawal by Subject|0
701216|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
701217|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
701218|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|Death|1
701219|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|Death|0
701220|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
701221|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
701222|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
701223|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
701224|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
701225|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
701226|NCT01369485|2277114|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
701227|NCT01369485|2277115|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
701228|NCT01369485|2277114|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
701229|NCT01369485|2277115|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
701230|NCT01369485|2277114|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
701231|NCT01369485|2277115|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
701232|NCT01369485|2277114|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
701233|NCT01369485|2277115|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
701234|NCT01369485|2277114|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
701235|NCT01369485|2277115|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
889631|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889632|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
889633|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
889634|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889635|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889636|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889637|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889638|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889639|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889640|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
889641|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
889642|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
889643|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889644|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
889645|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889646|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889647|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889648|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
889649|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889650|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889651|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889652|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
889653|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889654|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889655|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889656|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
889657|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
889658|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889659|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889660|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
889661|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889662|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889663|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889664|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
889665|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
889666|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
889667|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889668|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
889669|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889670|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889671|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889672|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
889673|NCT01232283|2824400|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
889674|NCT01232283|2824401|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889675|NCT01232283|2824402|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
701296|NCT01369225|2277248|P6|Overall Study|Adverse Event|0
701297|NCT01369225|2277249|P5|Overall Study|Adverse Event|1
701298|NCT01369225|2277250|P4|Overall Study|Adverse Event|1
701299|NCT01369225|2277251|P3|Overall Study|Adverse Event|0
701300|NCT01369225|2277252|P2|Overall Study|Adverse Event|0
701301|NCT01369225|2277253|P1|Overall Study|Adverse Event|0
701302|NCT01369225|2277248|P6|Overall Study|Unspecified|0
701303|NCT01369225|2277249|P5|Overall Study|Unspecified|1
701304|NCT01369225|2277250|P4|Overall Study|Unspecified|0
701305|NCT01369225|2277251|P3|Overall Study|Unspecified|0
701306|NCT01369225|2277252|P2|Overall Study|Unspecified|0
701307|NCT01369225|2277253|P1|Overall Study|Unspecified|1
701308|NCT01369225|2277248|P6|Overall Study|Does Not Meet Entrance Criteria|0
701309|NCT01369225|2277249|P5|Overall Study|Does Not Meet Entrance Criteria|0
701310|NCT01369225|2277250|P4|Overall Study|Does Not Meet Entrance Criteria|0
701311|NCT01369225|2277251|P3|Overall Study|Does Not Meet Entrance Criteria|1
701312|NCT01369225|2277252|P2|Overall Study|Does Not Meet Entrance Criteria|0
701313|NCT01369225|2277253|P1|Overall Study|Does Not Meet Entrance Criteria|0
701314|NCT01369225|2277248|P6|Overall Study|Withdrawal by Subject|0
701315|NCT01369225|2277249|P5|Overall Study|Withdrawal by Subject|0
701316|NCT01369225|2277250|P4|Overall Study|Withdrawal by Subject|1
701317|NCT01369225|2277251|P3|Overall Study|Withdrawal by Subject|2
701318|NCT01369225|2277252|P2|Overall Study|Withdrawal by Subject|0
701319|NCT01369225|2277253|P1|Overall Study|Withdrawal by Subject|1
701324|NCT01368536|2277477|P3|Overall Study|Protocol deviation|1
701325|NCT01368536|2277478|P2|Overall Study|Protocol deviation|3
701326|NCT01368536|2277479|P1|Overall Study|Protocol deviation|0
701327|NCT01368536|2277477|P3|Overall Study|Administrative problems|35
701328|NCT01368536|2277478|P2|Overall Study|Administrative problems|39
701329|NCT01368536|2277479|P1|Overall Study|Administrative problems|34
701330|NCT01368536|2277477|P3|Overall Study|Lost to Follow-up|5
701331|NCT01368536|2277478|P2|Overall Study|Lost to Follow-up|3
701332|NCT01368536|2277479|P1|Overall Study|Lost to Follow-up|3
701333|NCT01368536|2277477|P3|Overall Study|Withdrawal by Subject|4
701334|NCT01368536|2277478|P2|Overall Study|Withdrawal by Subject|5
701335|NCT01368536|2277479|P1|Overall Study|Withdrawal by Subject|2
701336|NCT01368536|2277477|P3|Overall Study|No longer required study medication|1
701337|NCT01368536|2277478|P2|Overall Study|No longer required study medication|0
701338|NCT01368536|2277479|P1|Overall Study|No longer required study medication|0
701339|NCT01368536|2277477|P3|Overall Study|Unsatisfactory therapeutic effect|2
701340|NCT01368536|2277478|P2|Overall Study|Unsatisfactory therapeutic effect|2
701341|NCT01368536|2277479|P1|Overall Study|Unsatisfactory therapeutic effect|7
701342|NCT01368536|2277477|P3|Overall Study|Abnormal test procedure result(s)|1
701343|NCT01368536|2277478|P2|Overall Study|Abnormal test procedure result(s)|0
701344|NCT01368536|2277479|P1|Overall Study|Abnormal test procedure result(s)|0
701345|NCT01368536|2277477|P3|Overall Study|Abnormal laboratory value(s)|2
701346|NCT01368536|2277478|P2|Overall Study|Abnormal laboratory value(s)|1
701347|NCT01368536|2277479|P1|Overall Study|Abnormal laboratory value(s)|0
701348|NCT01368536|2277477|P3|Overall Study|Adverse Event|8
701349|NCT01368536|2277478|P2|Overall Study|Adverse Event|6
701350|NCT01368536|2277479|P1|Overall Study|Adverse Event|5
701351|NCT01368432|2277502|P2|Overall Study|Lost to Follow-up|1
701352|NCT01368432|2277503|P1|Overall Study|Lost to Follow-up|0
701353|NCT01368406|2277537|P2|Overall Study|started working|3
701354|NCT01368406|2277538|P1|Overall Study|started working|2
701355|NCT01368406|2277537|P2|Overall Study|relapse of the disease|2
701356|NCT01368406|2277538|P1|Overall Study|relapse of the disease|3
701357|NCT01368406|2277537|P2|Overall Study|Withdrawal by Subject|4
701358|NCT01368406|2277538|P1|Overall Study|Withdrawal by Subject|8
701359|NCT01368406|2277537|P2|Overall Study|Lost to Follow-up|4
701360|NCT01368406|2277538|P1|Overall Study|Lost to Follow-up|8
701361|NCT01368276|2277546|P2|Overall Study|Death|10
701362|NCT01368276|2277547|P1|Overall Study|Death|1
701363|NCT01368211|2277584|P2|Second Platelets Transfusion|No need for additional transfusion|2
701364|NCT01368211|2277585|P1|Second Platelets Transfusion|No need for additional transfusion|1
701365|NCT01368081|2277613|P13|Overall Study|Other reason not defined above|3
701366|NCT01368081|2277614|P12|Overall Study|Other reason not defined above|0
701367|NCT01368081|2277615|P11|Overall Study|Other reason not defined above|0
701368|NCT01368081|2277616|P10|Overall Study|Other reason not defined above|1
701369|NCT01368081|2277617|P9|Overall Study|Other reason not defined above|0
701370|NCT01368081|2277618|P8|Overall Study|Other reason not defined above|0
701371|NCT01368081|2277619|P7|Overall Study|Other reason not defined above|2
701372|NCT01368081|2277620|P6|Overall Study|Other reason not defined above|1
701373|NCT01368081|2277621|P5|Overall Study|Other reason not defined above|0
701374|NCT01368081|2277622|P4|Overall Study|Other reason not defined above|1
701375|NCT01368081|2277623|P3|Overall Study|Other reason not defined above|0
701376|NCT01368081|2277624|P2|Overall Study|Other reason not defined above|0
701377|NCT01368081|2277625|P1|Overall Study|Other reason not defined above|2
701378|NCT01368081|2277613|P13|Overall Study|Withdrawal by Subject|0
701379|NCT01368081|2277614|P12|Overall Study|Withdrawal by Subject|2
701380|NCT01368081|2277615|P11|Overall Study|Withdrawal by Subject|3
701381|NCT01368081|2277616|P10|Overall Study|Withdrawal by Subject|4
701382|NCT01368081|2277617|P9|Overall Study|Withdrawal by Subject|5
701383|NCT01368081|2277618|P8|Overall Study|Withdrawal by Subject|2
701384|NCT01368081|2277619|P7|Overall Study|Withdrawal by Subject|4
701385|NCT01368081|2277620|P6|Overall Study|Withdrawal by Subject|3
701386|NCT01368081|2277621|P5|Overall Study|Withdrawal by Subject|0
701387|NCT01368081|2277622|P4|Overall Study|Withdrawal by Subject|1
701388|NCT01368081|2277623|P3|Overall Study|Withdrawal by Subject|1
701389|NCT01368081|2277624|P2|Overall Study|Withdrawal by Subject|4
701390|NCT01368081|2277625|P1|Overall Study|Withdrawal by Subject|4
701391|NCT01368081|2277613|P13|Overall Study|Lost to Follow-up|1
701392|NCT01368081|2277614|P12|Overall Study|Lost to Follow-up|0
701393|NCT01368081|2277615|P11|Overall Study|Lost to Follow-up|0
701394|NCT01368081|2277616|P10|Overall Study|Lost to Follow-up|0
701395|NCT01368081|2277617|P9|Overall Study|Lost to Follow-up|0
701396|NCT01368081|2277618|P8|Overall Study|Lost to Follow-up|0
701397|NCT01368081|2277619|P7|Overall Study|Lost to Follow-up|0
701398|NCT01368081|2277620|P6|Overall Study|Lost to Follow-up|0
701399|NCT01368081|2277621|P5|Overall Study|Lost to Follow-up|0
701400|NCT01368081|2277622|P4|Overall Study|Lost to Follow-up|0
701401|NCT01368081|2277623|P3|Overall Study|Lost to Follow-up|0
701402|NCT01368081|2277624|P2|Overall Study|Lost to Follow-up|0
701403|NCT01368081|2277625|P1|Overall Study|Lost to Follow-up|0
701404|NCT01368081|2277613|P13|Overall Study|Protocol Violation|0
701405|NCT01368081|2277614|P12|Overall Study|Protocol Violation|0
701406|NCT01368081|2277615|P11|Overall Study|Protocol Violation|0
701407|NCT01368081|2277616|P10|Overall Study|Protocol Violation|0
701408|NCT01368081|2277617|P9|Overall Study|Protocol Violation|0
701409|NCT01368081|2277618|P8|Overall Study|Protocol Violation|1
701410|NCT01368081|2277619|P7|Overall Study|Protocol Violation|0
701411|NCT01368081|2277620|P6|Overall Study|Protocol Violation|1
701412|NCT01368081|2277621|P5|Overall Study|Protocol Violation|0
701413|NCT01368081|2277622|P4|Overall Study|Protocol Violation|0
701414|NCT01368081|2277623|P3|Overall Study|Protocol Violation|0
701415|NCT01368081|2277624|P2|Overall Study|Protocol Violation|0
701416|NCT01368081|2277625|P1|Overall Study|Protocol Violation|0
701417|NCT01368081|2277613|P13|Overall Study|Lack of Efficacy|0
701418|NCT01368081|2277614|P12|Overall Study|Lack of Efficacy|0
701419|NCT01368081|2277615|P11|Overall Study|Lack of Efficacy|0
701420|NCT01368081|2277616|P10|Overall Study|Lack of Efficacy|0
701421|NCT01368081|2277617|P9|Overall Study|Lack of Efficacy|0
701422|NCT01368081|2277618|P8|Overall Study|Lack of Efficacy|2
701423|NCT01368081|2277619|P7|Overall Study|Lack of Efficacy|0
701424|NCT01368081|2277620|P6|Overall Study|Lack of Efficacy|0
701425|NCT01368081|2277621|P5|Overall Study|Lack of Efficacy|0
701426|NCT01368081|2277622|P4|Overall Study|Lack of Efficacy|1
701427|NCT01368081|2277623|P3|Overall Study|Lack of Efficacy|0
701428|NCT01368081|2277624|P2|Overall Study|Lack of Efficacy|1
701429|NCT01368081|2277625|P1|Overall Study|Lack of Efficacy|0
701430|NCT01368081|2277613|P13|Overall Study|Adverse Event|3
701431|NCT01368081|2277614|P12|Overall Study|Adverse Event|1
701432|NCT01368081|2277615|P11|Overall Study|Adverse Event|6
701433|NCT01368081|2277616|P10|Overall Study|Adverse Event|5
701434|NCT01368081|2277617|P9|Overall Study|Adverse Event|3
701435|NCT01368081|2277618|P8|Overall Study|Adverse Event|2
701436|NCT01368081|2277619|P7|Overall Study|Adverse Event|6
701437|NCT01368081|2277620|P6|Overall Study|Adverse Event|5
701438|NCT01368081|2277621|P5|Overall Study|Adverse Event|2
701439|NCT01368081|2277622|P4|Overall Study|Adverse Event|2
701440|NCT01368081|2277623|P3|Overall Study|Adverse Event|3
701441|NCT01368081|2277624|P2|Overall Study|Adverse Event|4
701442|NCT01368081|2277625|P1|Overall Study|Adverse Event|4
701443|NCT01368042|2277679|P1|Overall Study|Transplanted|1
701444|NCT01368042|2277679|P1|Overall Study|Lost to Follow-up|4
701445|NCT01368042|2277679|P1|Overall Study|Protocol Violation|11
701446|NCT01368042|2277679|P1|Overall Study|Death|14
701447|NCT01367886|2277699|P1|Overall Study|Death|1
701448|NCT01367886|2277699|P1|Overall Study|Lack of Efficacy|2
701449|NCT01367886|2277699|P1|Overall Study|Lost to Follow-up|4
701450|NCT01367834|2277749|P2|Overall Study|Study was ended.|1
701451|NCT01367834|2277750|P1|Overall Study|Study was ended.|0
701452|NCT01367834|2277749|P2|Overall Study|Withdrawal by Subject|2
701453|NCT01367834|2277750|P1|Overall Study|Withdrawal by Subject|2
701454|NCT01367704|2277774|P2|Overall Study|Lost to Follow-up|161
701455|NCT01367704|2277775|P1|Overall Study|Lost to Follow-up|47
701456|NCT01367457|2277788|P3|Overall Study|Suspected DP/suspected active infection|0
701457|NCT01367457|2277789|P2|Overall Study|Suspected DP/suspected active infection|0
701458|NCT01367457|2277790|P1|Overall Study|Suspected DP/suspected active infection|1
701459|NCT01367457|2277788|P3|Overall Study|Palliative. Overall decline|0
701460|NCT01367457|2277789|P2|Overall Study|Palliative. Overall decline|0
701461|NCT01367457|2277790|P1|Overall Study|Palliative. Overall decline|1
701462|NCT01367457|2277788|P3|Overall Study|Patient's Wish|0
701463|NCT01367457|2277789|P2|Overall Study|Patient's Wish|0
701464|NCT01367457|2277790|P1|Overall Study|Patient's Wish|1
701465|NCT01367457|2277788|P3|Overall Study|CD, Suspected disease progression (DP)|0
701466|NCT01367457|2277789|P2|Overall Study|CD, Suspected disease progression (DP)|0
701467|NCT01367457|2277790|P1|Overall Study|CD, Suspected disease progression (DP)|1
701468|NCT01367457|2277788|P3|Overall Study|Death from septic shock|0
701469|NCT01367457|2277789|P2|Overall Study|Death from septic shock|0
701470|NCT01367457|2277790|P1|Overall Study|Death from septic shock|1
701471|NCT01367457|2277788|P3|Overall Study|Lost to Follow-up|0
701472|NCT01367457|2277789|P2|Overall Study|Lost to Follow-up|0
701473|NCT01367457|2277790|P1|Overall Study|Lost to Follow-up|1
701474|NCT01367457|2277788|P3|Overall Study|Rejection of treatment|0
701475|NCT01367457|2277789|P2|Overall Study|Rejection of treatment|0
701476|NCT01367457|2277790|P1|Overall Study|Rejection of treatment|1
701477|NCT01367457|2277788|P3|Overall Study|Overall decline|0
701478|NCT01367457|2277789|P2|Overall Study|Overall decline|0
701479|NCT01367457|2277790|P1|Overall Study|Overall decline|1
701480|NCT01367457|2277788|P3|Overall Study|Intestinal obstruction with necrosis|0
701481|NCT01367457|2277789|P2|Overall Study|Intestinal obstruction with necrosis|0
701482|NCT01367457|2277790|P1|Overall Study|Intestinal obstruction with necrosis|1
701483|NCT01367457|2277788|P3|Overall Study|No clinical benefit|0
701484|NCT01367457|2277789|P2|Overall Study|No clinical benefit|0
701485|NCT01367457|2277790|P1|Overall Study|No clinical benefit|1
701486|NCT01367457|2277788|P3|Overall Study|Stabilisation + frequent infections|0
701487|NCT01367457|2277789|P2|Overall Study|Stabilisation + frequent infections|0
701488|NCT01367457|2277790|P1|Overall Study|Stabilisation + frequent infections|1
701489|NCT01367457|2277788|P3|Overall Study|Overall status worsens to grade 4|0
701490|NCT01367457|2277789|P2|Overall Study|Overall status worsens to grade 4|0
701491|NCT01367457|2277790|P1|Overall Study|Overall status worsens to grade 4|1
701492|NCT01367457|2277788|P3|Overall Study|Uncontrolled pain|0
701493|NCT01367457|2277789|P2|Overall Study|Uncontrolled pain|0
701494|NCT01367457|2277790|P1|Overall Study|Uncontrolled pain|1
701495|NCT01367457|2277788|P3|Overall Study|CD, associated leukaemia|0
701496|NCT01367457|2277789|P2|Overall Study|CD, associated leukaemia|0
701497|NCT01367457|2277790|P1|Overall Study|CD, associated leukaemia|1
701498|NCT01367457|2277788|P3|Overall Study|Withdrawal by Subject|0
701499|NCT01367457|2277789|P2|Overall Study|Withdrawal by Subject|0
701500|NCT01367457|2277790|P1|Overall Study|Withdrawal by Subject|1
701501|NCT01367457|2277788|P3|Overall Study|Choledocolithiasis and pancreatitis|0
701502|NCT01367457|2277789|P2|Overall Study|Choledocolithiasis and pancreatitis|0
701503|NCT01367457|2277790|P1|Overall Study|Choledocolithiasis and pancreatitis|1
701504|NCT01367457|2277788|P3|Overall Study|low grade toxicities + stable disease|0
701505|NCT01367457|2277789|P2|Overall Study|low grade toxicities + stable disease|0
701506|NCT01367457|2277790|P1|Overall Study|low grade toxicities + stable disease|1
701507|NCT01367457|2277788|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
701508|NCT01367457|2277789|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
701509|NCT01367457|2277790|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
701510|NCT01367457|2277788|P3|Overall Study|Bleeding from cavernous haemangioma|0
701511|NCT01367457|2277789|P2|Overall Study|Bleeding from cavernous haemangioma|0
701512|NCT01367457|2277790|P1|Overall Study|Bleeding from cavernous haemangioma|1
701513|NCT01367457|2277788|P3|Overall Study|Investigator's opinion, stable disease|0
701514|NCT01367457|2277789|P2|Overall Study|Investigator's opinion, stable disease|0
701515|NCT01367457|2277790|P1|Overall Study|Investigator's opinion, stable disease|1
701516|NCT01367457|2277788|P3|Overall Study|Patient asks for rest + slow progression|0
701517|NCT01367457|2277789|P2|Overall Study|Patient asks for rest + slow progression|0
701518|NCT01367457|2277790|P1|Overall Study|Patient asks for rest + slow progression|1
701519|NCT01367457|2277788|P3|Overall Study|Progression|0
701520|NCT01367457|2277789|P2|Overall Study|Progression|0
701521|NCT01367457|2277790|P1|Overall Study|Progression|137
701522|NCT01367457|2277788|P3|Overall Study|Toxicity|0
701523|NCT01367457|2277789|P2|Overall Study|Toxicity|0
701524|NCT01367457|2277790|P1|Overall Study|Toxicity|16
701525|NCT01367457|2277788|P3|Overall Study|Progression and death|0
701526|NCT01367457|2277789|P2|Overall Study|Progression and death|0
701527|NCT01367457|2277790|P1|Overall Study|Progression and death|8
701528|NCT01367457|2277788|P3|Overall Study|Clinical decline (CD)|0
701529|NCT01367457|2277789|P2|Overall Study|Clinical decline (CD)|0
701530|NCT01367457|2277790|P1|Overall Study|Clinical decline (CD)|2
701531|NCT01367457|2277788|P3|Overall Study|Investigator's decision|0
701532|NCT01367457|2277789|P2|Overall Study|Investigator's decision|0
701533|NCT01367457|2277790|P1|Overall Study|Investigator's decision|2
701534|NCT01367457|2277788|P3|Overall Study|Death|0
701535|NCT01367457|2277789|P2|Overall Study|Death|0
701536|NCT01367457|2277790|P1|Overall Study|Death|2
701537|NCT01367249|2277812|P2|Overall Study|Not Specified|10
701538|NCT01367249|2277813|P1|Overall Study|Not Specified|3
701539|NCT01367249|2277812|P2|Overall Study|Withdrawal by Subject|6
701540|NCT01367249|2277813|P1|Overall Study|Withdrawal by Subject|6
701541|NCT01367158|2277832|P11|Overall Study|Protocol Violation|0
701542|NCT01367158|2277833|P10|Overall Study|Protocol Violation|0
701543|NCT01367158|2277834|P9|Overall Study|Protocol Violation|0
701544|NCT01367158|2277835|P8|Overall Study|Protocol Violation|0
701545|NCT01367158|2277836|P7|Overall Study|Protocol Violation|0
701546|NCT01367158|2277837|P6|Overall Study|Protocol Violation|0
701547|NCT01367158|2277838|P5|Overall Study|Protocol Violation|0
701548|NCT01367158|2277839|P4|Overall Study|Protocol Violation|0
701549|NCT01367158|2277840|P3|Overall Study|Protocol Violation|0
701550|NCT01367158|2277841|P2|Overall Study|Protocol Violation|1
701551|NCT01367158|2277842|P1|Overall Study|Protocol Violation|0
701552|NCT01367158|2277832|P11|Overall Study|Lost to Follow-up|1
701553|NCT01367158|2277833|P10|Overall Study|Lost to Follow-up|0
701554|NCT01367158|2277834|P9|Overall Study|Lost to Follow-up|0
701555|NCT01367158|2277835|P8|Overall Study|Lost to Follow-up|1
701556|NCT01367158|2277836|P7|Overall Study|Lost to Follow-up|0
701557|NCT01367158|2277837|P6|Overall Study|Lost to Follow-up|2
701558|NCT01367158|2277838|P5|Overall Study|Lost to Follow-up|0
701559|NCT01367158|2277839|P4|Overall Study|Lost to Follow-up|1
701560|NCT01367158|2277840|P3|Overall Study|Lost to Follow-up|0
701561|NCT01367158|2277841|P2|Overall Study|Lost to Follow-up|0
701562|NCT01367158|2277842|P1|Overall Study|Lost to Follow-up|0
701563|NCT01367158|2277832|P11|Overall Study|Withdrew consent|0
701564|NCT01367158|2277833|P10|Overall Study|Withdrew consent|0
701565|NCT01367158|2277834|P9|Overall Study|Withdrew consent|0
701566|NCT01367158|2277835|P8|Overall Study|Withdrew consent|1
701567|NCT01367158|2277836|P7|Overall Study|Withdrew consent|0
701568|NCT01367158|2277837|P6|Overall Study|Withdrew consent|0
701569|NCT01367158|2277838|P5|Overall Study|Withdrew consent|2
701570|NCT01367158|2277839|P4|Overall Study|Withdrew consent|0
701571|NCT01367158|2277840|P3|Overall Study|Withdrew consent|1
701572|NCT01367158|2277841|P2|Overall Study|Withdrew consent|2
701573|NCT01367158|2277842|P1|Overall Study|Withdrew consent|0
701574|NCT01367119|2277986|P2|Overall Study|Withdrawal by Subject|1
701575|NCT01367119|2277987|P1|Overall Study|Withdrawal by Subject|1
701576|NCT01367119|2277986|P2|Overall Study|Adverse Event|0
701577|NCT01367119|2277987|P1|Overall Study|Adverse Event|1
701578|NCT01366846|2278042|P4|Overall Study|Scheduling Conflicts|0
701579|NCT01366846|2278043|P3|Overall Study|Scheduling Conflicts|1
701580|NCT01366846|2278044|P2|Overall Study|Scheduling Conflicts|0
701581|NCT01366846|2278045|P1|Overall Study|Scheduling Conflicts|0
701582|NCT01366846|2278042|P4|Overall Study|Communication Difficulties|1
701583|NCT01366846|2278043|P3|Overall Study|Communication Difficulties|0
701584|NCT01366846|2278044|P2|Overall Study|Communication Difficulties|4
701585|NCT01366846|2278045|P1|Overall Study|Communication Difficulties|1
701586|NCT01366846|2278042|P4|Overall Study|Withdrawal by Subject|0
701587|NCT01366846|2278043|P3|Overall Study|Withdrawal by Subject|0
701588|NCT01366846|2278044|P2|Overall Study|Withdrawal by Subject|0
701589|NCT01366846|2278045|P1|Overall Study|Withdrawal by Subject|2
701590|NCT01366638|2278068|P3|Overall Study|Not specified|0
701591|NCT01366638|2278069|P2|Overall Study|Not specified|0
701592|NCT01366638|2278070|P1|Overall Study|Not specified|1
701593|NCT01366638|2278068|P3|Overall Study|Withdrawal by Subject|6
701594|NCT01366638|2278069|P2|Overall Study|Withdrawal by Subject|0
701595|NCT01366638|2278070|P1|Overall Study|Withdrawal by Subject|0
701605|NCT01366521|2278159|P4|Overall Study|Withdrawal by Subject|0
701606|NCT01366521|2278160|P3|Overall Study|Withdrawal by Subject|0
701607|NCT01366521|2278161|P2|Overall Study|Withdrawal by Subject|1
701608|NCT01366521|2278162|P1|Overall Study|Withdrawal by Subject|0
701609|NCT01366521|2278159|P4|Overall Study|Physician Decision|0
701610|NCT01366521|2278160|P3|Overall Study|Physician Decision|1
701611|NCT01366521|2278161|P2|Overall Study|Physician Decision|0
701612|NCT01366521|2278162|P1|Overall Study|Physician Decision|0
701613|NCT01366521|2278159|P4|Overall Study|Protocol Violation|0
701614|NCT01366521|2278160|P3|Overall Study|Protocol Violation|1
701615|NCT01366521|2278161|P2|Overall Study|Protocol Violation|0
701616|NCT01366521|2278162|P1|Overall Study|Protocol Violation|0
701617|NCT01366521|2278159|P4|Overall Study|Adverse Event|0
701618|NCT01366521|2278160|P3|Overall Study|Adverse Event|0
701619|NCT01366521|2278161|P2|Overall Study|Adverse Event|0
701620|NCT01366521|2278162|P1|Overall Study|Adverse Event|1
701621|NCT01366443|2278237|P1|Overall Study|Under 18 yo|1
701622|NCT01366443|2278237|P1|Overall Study|Lost to Follow-up|2
701623|NCT01366209|2278251|P2|Overall Study|Withdrew consent|3
701624|NCT01366209|2278252|P1|Overall Study|Withdrew consent|4
701625|NCT01366209|2278251|P2|Overall Study|Sponsors decision|1
701626|NCT01366209|2278252|P1|Overall Study|Sponsors decision|0
701627|NCT01366209|2278251|P2|Overall Study|Physician Decision|0
701628|NCT01366209|2278252|P1|Overall Study|Physician Decision|1
701629|NCT01366209|2278251|P2|Overall Study|Lost to Follow-up|1
701630|NCT01366209|2278252|P1|Overall Study|Lost to Follow-up|2
701631|NCT01366209|2278251|P2|Overall Study|Lung transplantation|1
701632|NCT01366209|2278252|P1|Overall Study|Lung transplantation|6
701633|NCT01366209|2278251|P2|Overall Study|Death|19
701634|NCT01366209|2278252|P1|Overall Study|Death|12
701635|NCT01366209|2278251|P2|Overall Study|Withdrawal by Subject|4
701636|NCT01366209|2278252|P1|Overall Study|Withdrawal by Subject|4
701637|NCT01366209|2278251|P2|Overall Study|Adverse Event|7
701638|NCT01366209|2278252|P1|Overall Study|Adverse Event|6
889676|NCT01232283|2824403|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
889677|NCT01232283|2824404|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889678|NCT01232283|2824405|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
701642|NCT01365910|2278278|P1|Overall Study|pt did not get tx, nausea/vomiting|1
701643|NCT01365910|2278278|P1|Overall Study|other complicating disease|1
701644|NCT01365910|2278278|P1|Overall Study|Adverse Event|3
701645|NCT01365910|2278278|P1|Overall Study|disease progression|18
701646|NCT01365910|2278278|P1|Overall Study|Withdrawal by Subject|7
701647|NCT01365546|2278373|P1|Overall Study|Study termination|1
701648|NCT01365546|2278373|P1|Overall Study|Screen failure|9
701649|NCT01365546|2278373|P1|Overall Study|Withdrawal by Subject|1
701650|NCT01365507|2278383|P2|Overall Study|Unclassified|4
701651|NCT01365507|2278384|P1|Overall Study|Unclassified|1
701652|NCT01365507|2278383|P2|Overall Study|Withdrawal Criteria|5
701653|NCT01365507|2278384|P1|Overall Study|Withdrawal Criteria|8
701654|NCT01365494|2278400|P2|Overall Study|Lost to Follow-up|2
701655|NCT01365494|2278401|P1|Overall Study|Lost to Follow-up|1
701656|NCT01365494|2278400|P2|Overall Study|Withdrawal by Subject|1
701657|NCT01365494|2278401|P1|Overall Study|Withdrawal by Subject|0
701658|NCT01365494|2278400|P2|Overall Study|Adverse Event|0
701659|NCT01365494|2278401|P1|Overall Study|Adverse Event|1
701660|NCT01365481|2278417|P4|Overall Study|Unsatisfactory therapeutic effect|0
701661|NCT01365481|2278418|P3|Overall Study|Unsatisfactory therapeutic effect|1
701662|NCT01365481|2278419|P2|Overall Study|Unsatisfactory therapeutic effect|0
701663|NCT01365481|2278420|P1|Overall Study|Unsatisfactory therapeutic effect|0
701664|NCT01365481|2278417|P4|Overall Study|Protocol deviation|1
701665|NCT01365481|2278418|P3|Overall Study|Protocol deviation|0
701666|NCT01365481|2278419|P2|Overall Study|Protocol deviation|1
701667|NCT01365481|2278420|P1|Overall Study|Protocol deviation|0
701668|NCT01365481|2278417|P4|Overall Study|Administrative problems|0
701669|NCT01365481|2278418|P3|Overall Study|Administrative problems|0
701670|NCT01365481|2278419|P2|Overall Study|Administrative problems|1
701671|NCT01365481|2278420|P1|Overall Study|Administrative problems|0
701672|NCT01365481|2278417|P4|Overall Study|Abnormal laboratory value(s)|0
701673|NCT01365481|2278418|P3|Overall Study|Abnormal laboratory value(s)|0
701674|NCT01365481|2278419|P2|Overall Study|Abnormal laboratory value(s)|1
701675|NCT01365481|2278420|P1|Overall Study|Abnormal laboratory value(s)|0
701676|NCT01365481|2278417|P4|Overall Study|Lost to Follow-up|3
701677|NCT01365481|2278418|P3|Overall Study|Lost to Follow-up|2
701678|NCT01365481|2278419|P2|Overall Study|Lost to Follow-up|1
701679|NCT01365481|2278420|P1|Overall Study|Lost to Follow-up|1
701680|NCT01365481|2278417|P4|Overall Study|Withdrawal by Subject|1
701681|NCT01365481|2278418|P3|Overall Study|Withdrawal by Subject|1
701682|NCT01365481|2278419|P2|Overall Study|Withdrawal by Subject|2
701683|NCT01365481|2278420|P1|Overall Study|Withdrawal by Subject|0
701684|NCT01365481|2278417|P4|Overall Study|Adverse Event|2
701685|NCT01365481|2278418|P3|Overall Study|Adverse Event|0
701686|NCT01365481|2278419|P2|Overall Study|Adverse Event|9
701687|NCT01365481|2278420|P1|Overall Study|Adverse Event|6
701688|NCT01365468|2278440|P2|Overall Study|Lost to Follow-up|0
701689|NCT01365468|2278441|P1|Overall Study|Lost to Follow-up|2
701690|NCT01365468|2278440|P2|Overall Study|Disease progression|0
701691|NCT01365468|2278441|P1|Overall Study|Disease progression|1
701692|NCT01365468|2278440|P2|Overall Study|Physician Decision|0
701693|NCT01365468|2278441|P1|Overall Study|Physician Decision|1
701694|NCT01365455|2278456|P5|Maintenance Period|Subject/guardian decision|1
701695|NCT01365455|2278457|P4|Maintenance Period|Subject/guardian decision|4
701696|NCT01365455|2278458|P3|Maintenance Period|Subject/guardian decision|2
701697|NCT01365455|2278459|P2|Maintenance Period|Subject/guardian decision|6
701698|NCT01365455|2278460|P1|Maintenance Period|Subject/guardian decision|4
701699|NCT01365455|2278456|P5|Maintenance Period|Protocol deviation|0
701700|NCT01365455|2278457|P4|Maintenance Period|Protocol deviation|0
701701|NCT01365455|2278458|P3|Maintenance Period|Protocol deviation|0
701702|NCT01365455|2278459|P2|Maintenance Period|Protocol deviation|1
701703|NCT01365455|2278460|P1|Maintenance Period|Protocol deviation|1
701704|NCT01365455|2278456|P5|Maintenance Period|Pregnancy|2
701705|NCT01365455|2278457|P4|Maintenance Period|Pregnancy|0
701706|NCT01365455|2278458|P3|Maintenance Period|Pregnancy|0
701707|NCT01365455|2278459|P2|Maintenance Period|Pregnancy|4
701708|NCT01365455|2278460|P1|Maintenance Period|Pregnancy|0
701709|NCT01365455|2278456|P5|Maintenance Period|Physician Decision|1
701710|NCT01365455|2278457|P4|Maintenance Period|Physician Decision|0
701711|NCT01365455|2278458|P3|Maintenance Period|Physician Decision|0
701712|NCT01365455|2278459|P2|Maintenance Period|Physician Decision|1
701713|NCT01365455|2278460|P1|Maintenance Period|Physician Decision|0
701714|NCT01365455|2278456|P5|Maintenance Period|Non-compliance with study treatment|0
701715|NCT01365455|2278457|P4|Maintenance Period|Non-compliance with study treatment|1
701716|NCT01365455|2278458|P3|Maintenance Period|Non-compliance with study treatment|0
701717|NCT01365455|2278459|P2|Maintenance Period|Non-compliance with study treatment|0
701718|NCT01365455|2278460|P1|Maintenance Period|Non-compliance with study treatment|0
701719|NCT01365455|2278456|P5|Maintenance Period|Lost to Follow-up|3
701720|NCT01365455|2278457|P4|Maintenance Period|Lost to Follow-up|0
701721|NCT01365455|2278458|P3|Maintenance Period|Lost to Follow-up|0
701722|NCT01365455|2278459|P2|Maintenance Period|Lost to Follow-up|4
701723|NCT01365455|2278460|P1|Maintenance Period|Lost to Follow-up|2
701724|NCT01365455|2278456|P5|Maintenance Period|Lack of Efficacy|2
701725|NCT01365455|2278457|P4|Maintenance Period|Lack of Efficacy|2
701726|NCT01365455|2278458|P3|Maintenance Period|Lack of Efficacy|0
701727|NCT01365455|2278459|P2|Maintenance Period|Lack of Efficacy|2
701728|NCT01365455|2278460|P1|Maintenance Period|Lack of Efficacy|10
701729|NCT01365455|2278456|P5|Maintenance Period|Adverse Event|4
701730|NCT01365455|2278457|P4|Maintenance Period|Adverse Event|2
701731|NCT01365455|2278458|P3|Maintenance Period|Adverse Event|1
701732|NCT01365455|2278459|P2|Maintenance Period|Adverse Event|5
701733|NCT01365455|2278460|P1|Maintenance Period|Adverse Event|12
701734|NCT01365455|2278456|P5|Induction Period|Lost to Follow-up|0
701735|NCT01365455|2278457|P4|Induction Period|Lost to Follow-up|0
701736|NCT01365455|2278458|P3|Induction Period|Lost to Follow-up|3
701737|NCT01365455|2278459|P2|Induction Period|Lost to Follow-up|0
701738|NCT01365455|2278460|P1|Induction Period|Lost to Follow-up|0
701739|NCT01365455|2278456|P5|Induction Period|Subject/guardian decision|0
701740|NCT01365455|2278457|P4|Induction Period|Subject/guardian decision|0
701741|NCT01365455|2278458|P3|Induction Period|Subject/guardian decision|8
701742|NCT01365455|2278459|P2|Induction Period|Subject/guardian decision|1
701743|NCT01365455|2278460|P1|Induction Period|Subject/guardian decision|9
701744|NCT01365455|2278456|P5|Induction Period|Protocol deviation|0
701745|NCT01365455|2278457|P4|Induction Period|Protocol deviation|0
701746|NCT01365455|2278458|P3|Induction Period|Protocol deviation|1
701747|NCT01365455|2278459|P2|Induction Period|Protocol deviation|1
701748|NCT01365455|2278460|P1|Induction Period|Protocol deviation|0
701749|NCT01365455|2278456|P5|Induction Period|Pregnancy|0
701750|NCT01365455|2278457|P4|Induction Period|Pregnancy|0
701751|NCT01365455|2278458|P3|Induction Period|Pregnancy|0
701752|NCT01365455|2278459|P2|Induction Period|Pregnancy|1
701753|NCT01365455|2278460|P1|Induction Period|Pregnancy|0
701754|NCT01365455|2278456|P5|Induction Period|Lack of Efficacy|0
701755|NCT01365455|2278457|P4|Induction Period|Lack of Efficacy|0
701756|NCT01365455|2278458|P3|Induction Period|Lack of Efficacy|0
701757|NCT01365455|2278459|P2|Induction Period|Lack of Efficacy|1
701758|NCT01365455|2278460|P1|Induction Period|Lack of Efficacy|1
701759|NCT01365455|2278456|P5|Induction Period|Adverse Event|0
701760|NCT01365455|2278457|P4|Induction Period|Adverse Event|0
701761|NCT01365455|2278458|P3|Induction Period|Adverse Event|4
701762|NCT01365455|2278459|P2|Induction Period|Adverse Event|3
701763|NCT01365455|2278460|P1|Induction Period|Adverse Event|5
701764|NCT01365273|2278550|P2|Overall Study|Physician Decision|0
701765|NCT01365273|2278551|P1|Overall Study|Physician Decision|1
701766|NCT01365273|2278550|P2|Overall Study|Protocol Violation|1
701767|NCT01365273|2278551|P1|Overall Study|Protocol Violation|0
701768|NCT01365273|2278550|P2|Overall Study|Lost to Follow-up|0
701769|NCT01365273|2278551|P1|Overall Study|Lost to Follow-up|1
701770|NCT01365130|2278561|P1|Overall Study|Progression/worsening of Dx prior to txt|2
701771|NCT01365091|2278569|P4|Period 2|Adverse Event|0
701772|NCT01365091|2278570|P3|Period 2|Adverse Event|1
701773|NCT01365091|2278571|P2|Period 2|Adverse Event|0
701774|NCT01365091|2278572|P1|Period 2|Adverse Event|0
701775|NCT01365091|2278569|P4|Period 2|Withdrawal by Subject|0
701776|NCT01365091|2278570|P3|Period 2|Withdrawal by Subject|0
701777|NCT01365091|2278571|P2|Period 2|Withdrawal by Subject|0
701778|NCT01365091|2278572|P1|Period 2|Withdrawal by Subject|1
701779|NCT01365091|2278569|P4|Period 1|Personal reasons|0
701780|NCT01365091|2278570|P3|Period 1|Personal reasons|1
701781|NCT01365091|2278571|P2|Period 1|Personal reasons|0
701782|NCT01365091|2278572|P1|Period 1|Personal reasons|0
701783|NCT01365091|2278569|P4|Period 1|Withdrawal by Subject|0
701784|NCT01365091|2278570|P3|Period 1|Withdrawal by Subject|0
701785|NCT01365091|2278571|P2|Period 1|Withdrawal by Subject|1
701786|NCT01365091|2278572|P1|Period 1|Withdrawal by Subject|0
701787|NCT01365091|2278569|P4|Period 1|No longer met study criteria|0
701788|NCT01365091|2278570|P3|Period 1|No longer met study criteria|0
701789|NCT01365091|2278571|P2|Period 1|No longer met study criteria|1
701790|NCT01365091|2278572|P1|Period 1|No longer met study criteria|0
701791|NCT01365091|2278569|P4|Period 1|Positive test result for drugs of abuse|0
701792|NCT01365091|2278570|P3|Period 1|Positive test result for drugs of abuse|0
701793|NCT01365091|2278571|P2|Period 1|Positive test result for drugs of abuse|0
701794|NCT01365091|2278572|P1|Period 1|Positive test result for drugs of abuse|1
701795|NCT01365091|2278569|P4|Period 1|Adverse Event|3
701796|NCT01365091|2278570|P3|Period 1|Adverse Event|2
701797|NCT01365091|2278571|P2|Period 1|Adverse Event|0
701798|NCT01365091|2278572|P1|Period 1|Adverse Event|1
701799|NCT01365052|2278600|P2|Overall Study|Adverse Event|4
701800|NCT01365052|2278601|P1|Overall Study|Adverse Event|4
701801|NCT01365039|2278617|P2|Overall Study|Study related symptoms and complaints|0
701802|NCT01365039|2278618|P1|Overall Study|Study related symptoms and complaints|1
701803|NCT01364922|2278629|P3|Double-Blind (DB) Period|Other, Unspecified|0
701804|NCT01364922|2278630|P2|Double-Blind (DB) Period|Other, Unspecified|1
701805|NCT01364922|2278631|P1|Double-Blind (DB) Period|Other, Unspecified|0
701806|NCT01364922|2278629|P3|Double-Blind (DB) Period|Adverse Event|1
701807|NCT01364922|2278630|P2|Double-Blind (DB) Period|Adverse Event|0
701808|NCT01364922|2278631|P1|Double-Blind (DB) Period|Adverse Event|0
701809|NCT01364922|2278629|P3|Double-Blind (DB) Period|Subject Noncompliant|0
701810|NCT01364922|2278630|P2|Double-Blind (DB) Period|Subject Noncompliant|1
701811|NCT01364922|2278631|P1|Double-Blind (DB) Period|Subject Noncompliant|0
701812|NCT01364922|2278629|P3|Double-Blind (DB) Period|Lack of Efficacy|4
701813|NCT01364922|2278630|P2|Double-Blind (DB) Period|Lack of Efficacy|3
701814|NCT01364922|2278631|P1|Double-Blind (DB) Period|Lack of Efficacy|0
701815|NCT01364922|2278629|P3|Open-label (OL) Period|Other, Unspecified|0
701816|NCT01364922|2278630|P2|Open-label (OL) Period|Other, Unspecified|0
701817|NCT01364922|2278631|P1|Open-label (OL) Period|Other, Unspecified|1
701818|NCT01364922|2278629|P3|Open-label (OL) Period|Lost to Follow-up|0
701819|NCT01364922|2278630|P2|Open-label (OL) Period|Lost to Follow-up|0
701820|NCT01364922|2278631|P1|Open-label (OL) Period|Lost to Follow-up|1
701821|NCT01364922|2278629|P3|Open-label (OL) Period|Lack of Efficacy|0
701822|NCT01364922|2278630|P2|Open-label (OL) Period|Lack of Efficacy|0
701823|NCT01364922|2278631|P1|Open-label (OL) Period|Lack of Efficacy|3
701824|NCT01364922|2278629|P3|Open-label (OL) Period|Withdrawal by Subject|0
701825|NCT01364922|2278630|P2|Open-label (OL) Period|Withdrawal by Subject|0
701826|NCT01364922|2278631|P1|Open-label (OL) Period|Withdrawal by Subject|4
701827|NCT01364922|2278629|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
701828|NCT01364922|2278630|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
701829|NCT01364922|2278631|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
701830|NCT01364922|2278629|P3|Open-label (OL) Period|Adverse Event|0
701831|NCT01364922|2278630|P2|Open-label (OL) Period|Adverse Event|0
701832|NCT01364922|2278631|P1|Open-label (OL) Period|Adverse Event|7
701833|NCT01364727|2278658|P1|Overall Study|Not Eligible|2
701834|NCT01364649|2278666|P2|Overall Study|Other|1
701835|NCT01364649|2278667|P1|Overall Study|Other|4
701836|NCT01364649|2278666|P2|Overall Study|Lost to Follow-up|13
701837|NCT01364649|2278667|P1|Overall Study|Lost to Follow-up|12
701838|NCT01364649|2278666|P2|Overall Study|Withdrawal of Consent|7
701839|NCT01364649|2278667|P1|Overall Study|Withdrawal of Consent|9
701840|NCT01364649|2278666|P2|Overall Study|Protocol Deviations|8
701841|NCT01364649|2278667|P1|Overall Study|Protocol Deviations|4
701842|NCT01364649|2278666|P2|Overall Study|Non-compliance with Investigational Drug|0
701843|NCT01364649|2278667|P1|Overall Study|Non-compliance with Investigational Drug|1
701844|NCT01364649|2278666|P2|Overall Study|Lack of Efficacy|0
701845|NCT01364649|2278667|P1|Overall Study|Lack of Efficacy|6
701846|NCT01364649|2278666|P2|Overall Study|Pretreatment Event or Adverse Event|14
701847|NCT01364649|2278667|P1|Overall Study|Pretreatment Event or Adverse Event|20
701848|NCT01364428|2278689|P2|Overall Study|Other|3
701849|NCT01364428|2278690|P1|Overall Study|Other|3
701850|NCT01364428|2278689|P2|Overall Study|Withdrawal Criteria|10
701851|NCT01364428|2278690|P1|Overall Study|Withdrawal Criteria|14
701852|NCT01364428|2278689|P2|Overall Study|Protocol Violation|0
701853|NCT01364428|2278690|P1|Overall Study|Protocol Violation|2
701854|NCT01364428|2278689|P2|Overall Study|Adverse Event|2
701855|NCT01364428|2278690|P1|Overall Study|Adverse Event|1
701856|NCT01364389|2278707|P3|Overall Study|Adverse Event|0
701857|NCT01364389|2278708|P2|Overall Study|Adverse Event|0
701858|NCT01364389|2278709|P1|Overall Study|Adverse Event|1
701859|NCT01364389|2278707|P3|Overall Study|Administrative problems|0
701860|NCT01364389|2278708|P2|Overall Study|Administrative problems|0
701861|NCT01364389|2278709|P1|Overall Study|Administrative problems|1
701862|NCT01364389|2278707|P3|Overall Study|Protocol deviation|1
701863|NCT01364389|2278708|P2|Overall Study|Protocol deviation|0
701864|NCT01364389|2278709|P1|Overall Study|Protocol deviation|0
701865|NCT01364389|2278707|P3|Overall Study|Withdrawal by Subject|0
701866|NCT01364389|2278708|P2|Overall Study|Withdrawal by Subject|1
701867|NCT01364389|2278709|P1|Overall Study|Withdrawal by Subject|0
701868|NCT01364298|2278728|P2|Overall Study|Unspecified|3
701869|NCT01364298|2278729|P1|Overall Study|Unspecified|1
701870|NCT01364298|2278728|P2|Overall Study|Withdrawal by Subject|3
701871|NCT01364298|2278729|P1|Overall Study|Withdrawal by Subject|3
701872|NCT01364298|2278728|P2|Overall Study|Lost to Follow-up|10
701873|NCT01364298|2278729|P1|Overall Study|Lost to Follow-up|5
701874|NCT01364298|2278728|P2|Overall Study|Lack of Efficacy|0
701875|NCT01364298|2278729|P1|Overall Study|Lack of Efficacy|1
701876|NCT01364298|2278728|P2|Overall Study|Lack of adherence to treatment|3
701877|NCT01364298|2278729|P1|Overall Study|Lack of adherence to treatment|1
701878|NCT01364298|2278728|P2|Overall Study|Adverse Event|4
701879|NCT01364298|2278729|P1|Overall Study|Adverse Event|3
701880|NCT01363986|2278771|P1|Overall Study|Disease progression|1
701881|NCT01363908|2278781|P2|Chronic Dosing (CD) Phase|Early study termination|3
701882|NCT01363908|2278782|P1|Chronic Dosing (CD) Phase|Early study termination|9
701883|NCT01363908|2278781|P2|Chronic Dosing (CD) Phase|Physician Decision|1
701884|NCT01363908|2278782|P1|Chronic Dosing (CD) Phase|Physician Decision|0
701885|NCT01363908|2278781|P2|Chronic Dosing (CD) Phase|Patient decision|1
701886|NCT01363908|2278782|P1|Chronic Dosing (CD) Phase|Patient decision|0
701887|NCT01363908|2278781|P2|Chronic Dosing (CD) Phase|Adverse Event|1
701888|NCT01363908|2278782|P1|Chronic Dosing (CD) Phase|Adverse Event|1
701889|NCT01363765|2278818|P2|Overall Study|smear during intervention|0
701890|NCT01363765|2278819|P1|Overall Study|smear during intervention|2170
701891|NCT01363765|2278818|P2|Overall Study|age not recorded (used for cross-linkage|354
701892|NCT01363765|2278819|P1|Overall Study|age not recorded (used for cross-linkage|117
701893|NCT01363765|2278818|P2|Overall Study|non-resident|76
701894|NCT01363765|2278819|P1|Overall Study|non-resident|156
701895|NCT01363765|2278818|P2|Overall Study|duplicate records|3177
701896|NCT01363765|2278819|P1|Overall Study|duplicate records|736
701897|NCT01363765|2278818|P2|Overall Study|non-diagnostic|1124
701898|NCT01363765|2278819|P1|Overall Study|non-diagnostic|2621
701899|NCT01363713|2278831|P1|Overall Study|Withdrawal by Subject|2
701900|NCT01363713|2278831|P1|Overall Study|Protocol Violation|3
701901|NCT01363713|2278831|P1|Overall Study|Adverse Event|1
701902|NCT01363700|2278840|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
701903|NCT01363700|2278841|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
701904|NCT01363700|2278842|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
701905|NCT01363700|2278843|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
701906|NCT01363700|2278844|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
701907|NCT01363661|2278863|P2|Overall Study|Lost to Follow-up|1
701908|NCT01363661|2278864|P1|Overall Study|Lost to Follow-up|3
701909|NCT01363661|2278863|P2|Overall Study|Protocol Violation|0
701910|NCT01363661|2278864|P1|Overall Study|Protocol Violation|1
701911|NCT01363661|2278863|P2|Overall Study|Withdrawal by Subject|1
701912|NCT01363661|2278864|P1|Overall Study|Withdrawal by Subject|1
701913|NCT01363661|2278863|P2|Overall Study|Adverse Event|2
701914|NCT01363661|2278864|P1|Overall Study|Adverse Event|9
701915|NCT01363440|2278905|P3|Overall Study|Other|2
701916|NCT01363440|2278906|P2|Overall Study|Other|5
701917|NCT01363440|2278907|P1|Overall Study|Other|4
701918|NCT01363440|2278905|P3|Overall Study|Lost to Follow-up|5
701919|NCT01363440|2278906|P2|Overall Study|Lost to Follow-up|4
701920|NCT01363440|2278907|P1|Overall Study|Lost to Follow-up|2
701921|NCT01363440|2278905|P3|Overall Study|Withdrawal by Subject|11
701922|NCT01363440|2278906|P2|Overall Study|Withdrawal by Subject|11
701923|NCT01363440|2278907|P1|Overall Study|Withdrawal by Subject|9
701924|NCT01363440|2278905|P3|Overall Study|Death|5
701925|NCT01363440|2278906|P2|Overall Study|Death|7
701926|NCT01363440|2278907|P1|Overall Study|Death|3
701927|NCT01363440|2278905|P3|Overall Study|Adverse Event|4
701928|NCT01363440|2278906|P2|Overall Study|Adverse Event|4
701929|NCT01363440|2278907|P1|Overall Study|Adverse Event|5
701930|NCT01363349|2278953|P2|Overall Study|missing|2
701931|NCT01363349|2278954|P1|Overall Study|missing|1
701932|NCT01363349|2278953|P2|Overall Study|Not reported|37
701933|NCT01363349|2278954|P1|Overall Study|Not reported|36
701934|NCT01363349|2278953|P2|Overall Study|Lost to Follow-up|6
701935|NCT01363349|2278954|P1|Overall Study|Lost to Follow-up|5
701936|NCT01363349|2278953|P2|Overall Study|Withdrawal by Subject|6
701937|NCT01363349|2278954|P1|Overall Study|Withdrawal by Subject|14
701938|NCT01363349|2278953|P2|Overall Study|Non compliance/Protocol deviations|2
701939|NCT01363349|2278954|P1|Overall Study|Non compliance/Protocol deviations|2
701940|NCT01363349|2278953|P2|Overall Study|Lack of Efficacy|10
701941|NCT01363349|2278954|P1|Overall Study|Lack of Efficacy|3
701942|NCT01363349|2278953|P2|Overall Study|Adverse Event|7
701943|NCT01363349|2278954|P1|Overall Study|Adverse Event|6
701944|NCT01363297|2278965|P5|Overall Study|Death|30
701945|NCT01363297|2278966|P4|Overall Study|Death|10
701946|NCT01363297|2278967|P3|Overall Study|Death|6
701947|NCT01363297|2278968|P2|Overall Study|Death|6
701948|NCT01363297|2278969|P1|Overall Study|Death|3
701949|NCT01363297|2278965|P5|Overall Study|Not specified|1
701950|NCT01363297|2278966|P4|Overall Study|Not specified|0
701951|NCT01363297|2278967|P3|Overall Study|Not specified|0
701952|NCT01363297|2278968|P2|Overall Study|Not specified|0
701953|NCT01363297|2278969|P1|Overall Study|Not specified|0
701954|NCT01363076|2279061|P2|Overall Study|Withdrawal by Subject|1
701955|NCT01363076|2279062|P1|Overall Study|Withdrawal by Subject|0
701956|NCT01363011|2279094|P2|Extension Phase|Rolled Over to Another Gilead Study|1
701957|NCT01363011|2279095|P1|Extension Phase|Rolled Over to Another Gilead Study|2
701958|NCT01363011|2279094|P2|Extension Phase|Lost to Follow-up|2
701959|NCT01363011|2279095|P1|Extension Phase|Lost to Follow-up|0
701960|NCT01363011|2279094|P2|Extension Phase|Withdrew Consent|1
701961|NCT01363011|2279095|P1|Extension Phase|Withdrew Consent|0
701962|NCT01363011|2279094|P2|Extension Phase|Investigator's Discretion|2
701963|NCT01363011|2279095|P1|Extension Phase|Investigator's Discretion|2
701964|NCT01363011|2279094|P2|Extension Phase|Lack of Efficacy|1
701965|NCT01363011|2279095|P1|Extension Phase|Lack of Efficacy|0
701966|NCT01363011|2279094|P2|Extension Phase|Adverse Event|1
701967|NCT01363011|2279095|P1|Extension Phase|Adverse Event|1
701968|NCT01363011|2279094|P2|Main Study|Protocol Violation|1
701969|NCT01363011|2279095|P1|Main Study|Protocol Violation|0
701970|NCT01363011|2279094|P2|Main Study|Withdrew Consent|4
701971|NCT01363011|2279095|P1|Main Study|Withdrew Consent|1
701972|NCT01363011|2279094|P2|Main Study|Investigator's Discretion|1
701973|NCT01363011|2279095|P1|Main Study|Investigator's Discretion|1
701974|NCT01363011|2279094|P2|Main Study|Adverse Event|3
701975|NCT01363011|2279095|P1|Main Study|Adverse Event|2
701976|NCT01362608|2279220|P2|Overall Study|Adverse Event|2
701977|NCT01362608|2279221|P1|Overall Study|Adverse Event|0
701978|NCT01362608|2279220|P2|Overall Study|Lack of Efficacy|2
701979|NCT01362608|2279221|P1|Overall Study|Lack of Efficacy|0
701980|NCT01362608|2279220|P2|Overall Study|Withdrawal by Subject|2
701981|NCT01362608|2279221|P1|Overall Study|Withdrawal by Subject|1
701982|NCT01362608|2279220|P2|Overall Study|Lost to Follow-up|1
701983|NCT01362608|2279221|P1|Overall Study|Lost to Follow-up|3
701984|NCT01362608|2279220|P2|Overall Study|Protocol Violation|1
701985|NCT01362608|2279221|P1|Overall Study|Protocol Violation|0
701986|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
701987|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
701988|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
701989|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
701990|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
701991|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
701992|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
701993|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
701994|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
701995|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
701996|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
701997|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
701998|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
701999|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
702000|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
702001|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
702002|NCT01362530|2279259|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
702003|NCT01362530|2279260|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
702004|NCT01362530|2279259|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
702005|NCT01362530|2279260|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
702006|NCT01362530|2279259|P2|Base Study (Cycle 1)|Protocol Violation|0
702007|NCT01362530|2279260|P1|Base Study (Cycle 1)|Protocol Violation|2
702008|NCT01362530|2279259|P2|Base Study (Cycle 1)|Physician Decision|1
702009|NCT01362530|2279260|P1|Base Study (Cycle 1)|Physician Decision|0
702010|NCT01362530|2279259|P2|Base Study (Cycle 1)|Adverse Event|0
702011|NCT01362530|2279260|P1|Base Study (Cycle 1)|Adverse Event|2
702012|NCT01362517|2279273|P1|Overall Study|Lost to Follow-up|1
702013|NCT01362517|2279273|P1|Overall Study|Protocol Violation|1
702014|NCT01362491|2279284|P3|Overall Study|Ineligible|0
702015|NCT01362491|2279285|P2|Overall Study|Ineligible|0
702016|NCT01362491|2279286|P1|Overall Study|Ineligible|1
702017|NCT01362439|2279334|P1|Overall Study|Participant who withdrew consent|8
702018|NCT01362439|2279334|P1|Overall Study|Study medication non-compliant|1
702019|NCT01362439|2279334|P1|Overall Study|Lost to Follow-up|2
702020|NCT01362439|2279334|P1|Overall Study|Lack of Efficacy|3
702021|NCT01362439|2279334|P1|Overall Study|Adverse Event|1
702022|NCT01362348|2279349|P1|Overall Study|Study closed/terminated|5
702023|NCT01362348|2279349|P1|Overall Study|Protocol-defined stopping criteria|9
702024|NCT01362296|2279368|P4|Crossover Phase|Study Closed/Terminated|0
702025|NCT01362296|2279369|P3|Crossover Phase|Study Closed/Terminated|1
702026|NCT01362296|2279370|P2|Crossover Phase|Study Closed/Terminated|0
702027|NCT01362296|2279371|P1|Crossover Phase|Study Closed/Terminated|0
702028|NCT01362296|2279368|P4|Crossover Phase|Adverse Event|0
702029|NCT01362296|2279369|P3|Crossover Phase|Adverse Event|4
702030|NCT01362296|2279370|P2|Crossover Phase|Adverse Event|0
702031|NCT01362296|2279371|P1|Crossover Phase|Adverse Event|0
702032|NCT01362296|2279368|P4|Crossover Phase|Withdrawal by Subject|1
702033|NCT01362296|2279369|P3|Crossover Phase|Withdrawal by Subject|2
702034|NCT01362296|2279370|P2|Crossover Phase|Withdrawal by Subject|0
702035|NCT01362296|2279371|P1|Crossover Phase|Withdrawal by Subject|0
702036|NCT01362296|2279368|P4|Crossover Phase|PD including Death due to PD|1
702037|NCT01362296|2279369|P3|Crossover Phase|PD including Death due to PD|16
702038|NCT01362296|2279370|P2|Crossover Phase|PD including Death due to PD|0
702039|NCT01362296|2279371|P1|Crossover Phase|PD including Death due to PD|0
702040|NCT01362296|2279368|P4|Randomized Phase (RP)|Study Closed/Terminated|0
702041|NCT01362296|2279369|P3|Randomized Phase (RP)|Study Closed/Terminated|0
702042|NCT01362296|2279370|P2|Randomized Phase (RP)|Study Closed/Terminated|1
702043|NCT01362296|2279371|P1|Randomized Phase (RP)|Study Closed/Terminated|8
702044|NCT01362296|2279368|P4|Randomized Phase (RP)|Adverse Event|0
702045|NCT01362296|2279369|P3|Randomized Phase (RP)|Adverse Event|0
702046|NCT01362296|2279370|P2|Randomized Phase (RP)|Adverse Event|4
702047|NCT01362296|2279371|P1|Randomized Phase (RP)|Adverse Event|20
702048|NCT01362296|2279368|P4|Randomized Phase (RP)|Withdrawal by Subject|0
702049|NCT01362296|2279369|P3|Randomized Phase (RP)|Withdrawal by Subject|0
702050|NCT01362296|2279370|P2|Randomized Phase (RP)|Withdrawal by Subject|1
702051|NCT01362296|2279371|P1|Randomized Phase (RP)|Withdrawal by Subject|2
702052|NCT01362296|2279368|P4|Randomized Phase (RP)|Physician Decision|0
702053|NCT01362296|2279369|P3|Randomized Phase (RP)|Physician Decision|0
702054|NCT01362296|2279370|P2|Randomized Phase (RP)|Physician Decision|9
702055|NCT01362296|2279371|P1|Randomized Phase (RP)|Physician Decision|1
702056|NCT01362296|2279368|P4|Randomized Phase (RP)|PD including Death due to PD|0
702057|NCT01362296|2279369|P3|Randomized Phase (RP)|PD including Death due to PD|0
702058|NCT01362296|2279370|P2|Randomized Phase (RP)|PD including Death due to PD|28
702059|NCT01362296|2279371|P1|Randomized Phase (RP)|PD including Death due to PD|56
702060|NCT01362244|2279419|P2|Overall Study|Protocol Defined Stopping Criteria|1
702061|NCT01362244|2279420|P1|Overall Study|Protocol Defined Stopping Criteria|0
702062|NCT01362244|2279419|P2|Overall Study|Did not Meet Continuation Criteria|11
702063|NCT01362244|2279420|P1|Overall Study|Did not Meet Continuation Criteria|17
702064|NCT01362244|2279419|P2|Overall Study|Withdrawal by Subject|1
702065|NCT01362244|2279420|P1|Overall Study|Withdrawal by Subject|2
702066|NCT01362244|2279419|P2|Overall Study|Protocol Violation|1
702067|NCT01362244|2279420|P1|Overall Study|Protocol Violation|5
702068|NCT01362244|2279419|P2|Overall Study|Lost to Follow-up|2
702069|NCT01362244|2279420|P1|Overall Study|Lost to Follow-up|0
702070|NCT01362244|2279419|P2|Overall Study|Lack of Efficacy|11
702071|NCT01362244|2279420|P1|Overall Study|Lack of Efficacy|5
702072|NCT01362244|2279419|P2|Overall Study|Adverse Event|5
702073|NCT01362244|2279420|P1|Overall Study|Adverse Event|3
889679|NCT01232283|2824406|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889680|NCT01232283|2824407|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
889681|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Other|0
889682|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Other|0
889683|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Other|0
889684|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Other|0
889685|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Other|0
889686|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Other|2
889687|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Other|0
889688|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Other|0
889689|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889690|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889691|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889692|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889693|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
702090|NCT01362062|2279557|P2|Overall Study|Had significant improvement|0
702091|NCT01362062|2279558|P1|Overall Study|Had significant improvement|9
702092|NCT01362062|2279557|P2|Overall Study|Detected with Spondylo-arthritis|0
702093|NCT01362062|2279558|P1|Overall Study|Detected with Spondylo-arthritis|1
702094|NCT01362062|2279557|P2|Overall Study|Non-compliant participant|0
702095|NCT01362062|2279558|P1|Overall Study|Non-compliant participant|2
702096|NCT01362062|2279557|P2|Overall Study|Withdrawal by Subject|0
702097|NCT01362062|2279558|P1|Overall Study|Withdrawal by Subject|2
702098|NCT01362062|2279557|P2|Overall Study|Lost to Follow-up|0
702099|NCT01362062|2279558|P1|Overall Study|Lost to Follow-up|11
702100|NCT01362062|2279557|P2|Overall Study|Adverse Event|0
702101|NCT01362062|2279558|P1|Overall Study|Adverse Event|1
702102|NCT01362049|2279579|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
702103|NCT01362049|2279580|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
702104|NCT01362049|2279581|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
702105|NCT01362049|2279582|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
702106|NCT01362049|2279579|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
702107|NCT01362049|2279580|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
702108|NCT01362049|2279581|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
702109|NCT01362049|2279582|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
702110|NCT01361594|2279647|P2|Overall Study|Withdrawal by Subject|2
702111|NCT01361594|2279648|P1|Overall Study|Withdrawal by Subject|1
702112|NCT01361568|2279662|P6|Overall Study|Withdrawal by Subject|1
702113|NCT01361568|2279663|P5|Overall Study|Withdrawal by Subject|0
702114|NCT01361568|2279664|P4|Overall Study|Withdrawal by Subject|0
702115|NCT01361568|2279665|P3|Overall Study|Withdrawal by Subject|0
702116|NCT01361568|2279666|P2|Overall Study|Withdrawal by Subject|1
702117|NCT01361568|2279667|P1|Overall Study|Withdrawal by Subject|2
702118|NCT01361568|2279662|P6|Overall Study|Physician Decision|1
702119|NCT01361568|2279663|P5|Overall Study|Physician Decision|0
702120|NCT01361568|2279664|P4|Overall Study|Physician Decision|0
702121|NCT01361568|2279665|P3|Overall Study|Physician Decision|0
702122|NCT01361568|2279666|P2|Overall Study|Physician Decision|0
702123|NCT01361568|2279667|P1|Overall Study|Physician Decision|0
702124|NCT01361568|2279662|P6|Overall Study|Adverse Event|0
702125|NCT01361568|2279663|P5|Overall Study|Adverse Event|1
702126|NCT01361568|2279664|P4|Overall Study|Adverse Event|0
702127|NCT01361568|2279665|P3|Overall Study|Adverse Event|0
702128|NCT01361568|2279666|P2|Overall Study|Adverse Event|0
702129|NCT01361568|2279667|P1|Overall Study|Adverse Event|0
702130|NCT01361464|2279697|P1|Overall Study|Withdrawal by Subject|2
702131|NCT01361464|2279697|P1|Overall Study|Death|1
702132|NCT01361308|2279706|P2|Overall Study|Not Specified|1
702133|NCT01361308|2279707|P1|Overall Study|Not Specified|0
702134|NCT01361308|2279706|P2|Overall Study|Failed C-SSRS|2
702135|NCT01361308|2279707|P1|Overall Study|Failed C-SSRS|5
702136|NCT01361308|2279706|P2|Overall Study|Eligibility Criteria Not Met|3
702137|NCT01361308|2279707|P1|Overall Study|Eligibility Criteria Not Met|2
702138|NCT01361308|2279706|P2|Overall Study|Adverse Event|4
702139|NCT01361308|2279707|P1|Overall Study|Adverse Event|8
702140|NCT01361308|2279706|P2|Overall Study|Lost to Follow-up|4
702141|NCT01361308|2279707|P1|Overall Study|Lost to Follow-up|5
702142|NCT01361308|2279706|P2|Overall Study|Protocol Violation|0
702143|NCT01361308|2279707|P1|Overall Study|Protocol Violation|1
702144|NCT01361308|2279706|P2|Overall Study|Lack of Efficacy|0
702145|NCT01361308|2279707|P1|Overall Study|Lack of Efficacy|2
702146|NCT01361308|2279706|P2|Overall Study|Physician Decision|3
702147|NCT01361308|2279707|P1|Overall Study|Physician Decision|3
702148|NCT01361308|2279706|P2|Overall Study|Withdrawal by Subject|13
702149|NCT01361308|2279707|P1|Overall Study|Withdrawal by Subject|9
702150|NCT01361178|2279749|P2|Overall Study|Death|0
702151|NCT01361178|2279750|P1|Overall Study|Death|13
702152|NCT01361126|2279758|P2|Overall Study|Sponsor decision|2
702153|NCT01361126|2279759|P1|Overall Study|Sponsor decision|0
702154|NCT01361009|2279792|P1|Overall Study|Protocol Violation|116
702155|NCT01360996|2279802|P3|Overall Study|Noncompliant|0
702156|NCT01360996|2279803|P2|Overall Study|Noncompliant|0
702157|NCT01360996|2279804|P1|Overall Study|Noncompliant|2
702158|NCT01360996|2279802|P3|Overall Study|Withdrawal by Subject|2
702159|NCT01360996|2279803|P2|Overall Study|Withdrawal by Subject|3
702160|NCT01360996|2279804|P1|Overall Study|Withdrawal by Subject|4
702161|NCT01360840|2279826|P3|Overall Study|Ongoing at data cut-off|9
702162|NCT01360840|2279827|P2|Overall Study|Ongoing at data cut-off|10
702163|NCT01360840|2279828|P1|Overall Study|Ongoing at data cut-off|10
702164|NCT01360645|2279880|P4|Phase A+|Protocol Deviation|4
702165|NCT01360645|2279881|P3|Phase A+|Protocol Deviation|0
702166|NCT01360645|2279882|P2|Phase A+|Protocol Deviation|0
702167|NCT01360645|2279883|P1|Phase A+|Protocol Deviation|0
702168|NCT01360645|2279880|P4|Phase A+|Withdrawal by Subject|5
702169|NCT01360645|2279881|P3|Phase A+|Withdrawal by Subject|0
702170|NCT01360645|2279882|P2|Phase A+|Withdrawal by Subject|0
702171|NCT01360645|2279883|P1|Phase A+|Withdrawal by Subject|0
702172|NCT01360645|2279880|P4|Phase A+|Physician Decision|2
702173|NCT01360645|2279881|P3|Phase A+|Physician Decision|0
702174|NCT01360645|2279882|P2|Phase A+|Physician Decision|0
702175|NCT01360645|2279883|P1|Phase A+|Physician Decision|0
702176|NCT01360645|2279880|P4|Phase A+|Met Withdrawal Criteria|4
702177|NCT01360645|2279881|P3|Phase A+|Met Withdrawal Criteria|0
702178|NCT01360645|2279882|P2|Phase A+|Met Withdrawal Criteria|0
702179|NCT01360645|2279883|P1|Phase A+|Met Withdrawal Criteria|0
702180|NCT01360645|2279880|P4|Phase A+|Adverse Event|2
702181|NCT01360645|2279881|P3|Phase A+|Adverse Event|0
702182|NCT01360645|2279882|P2|Phase A+|Adverse Event|0
702183|NCT01360645|2279883|P1|Phase A+|Adverse Event|0
702184|NCT01360645|2279880|P4|Phase A+|Lost to Follow-up|7
702185|NCT01360645|2279881|P3|Phase A+|Lost to Follow-up|0
702186|NCT01360645|2279882|P2|Phase A+|Lost to Follow-up|0
702187|NCT01360645|2279883|P1|Phase A+|Lost to Follow-up|0
702188|NCT01360645|2279880|P4|Phase B (6 Weeks)|Protocol Deviation|0
702189|NCT01360645|2279881|P3|Phase B (6 Weeks)|Protocol Deviation|3
702190|NCT01360645|2279882|P2|Phase B (6 Weeks)|Protocol Deviation|1
702191|NCT01360645|2279883|P1|Phase B (6 Weeks)|Protocol Deviation|0
702192|NCT01360645|2279880|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
702193|NCT01360645|2279881|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
702194|NCT01360645|2279882|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
702195|NCT01360645|2279883|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
702196|NCT01360645|2279880|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
702197|NCT01360645|2279881|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
702198|NCT01360645|2279882|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
702199|NCT01360645|2279883|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
702200|NCT01360645|2279880|P4|Phase B (6 Weeks)|Adverse Event|0
702201|NCT01360645|2279881|P3|Phase B (6 Weeks)|Adverse Event|0
702202|NCT01360645|2279882|P2|Phase B (6 Weeks)|Adverse Event|6
702203|NCT01360645|2279883|P1|Phase B (6 Weeks)|Adverse Event|0
702204|NCT01360645|2279880|P4|Phase B (6 Weeks)|Lost to Follow-up|0
702205|NCT01360645|2279881|P3|Phase B (6 Weeks)|Lost to Follow-up|0
702206|NCT01360645|2279882|P2|Phase B (6 Weeks)|Lost to Follow-up|1
702207|NCT01360645|2279883|P1|Phase B (6 Weeks)|Lost to Follow-up|0
702208|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
702209|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
702210|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
702211|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
702212|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
702213|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
702214|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
702215|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
702216|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
702217|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
702218|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
702219|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
702220|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
702221|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
702222|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
702223|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
702224|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
702225|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
702226|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
702227|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
702228|NCT01360645|2279880|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
702229|NCT01360645|2279881|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
702230|NCT01360645|2279882|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
702231|NCT01360645|2279883|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
702232|NCT01360632|2279938|P5|Phase A+|Protocol Deviation|3
702233|NCT01360632|2279939|P4|Phase A+|Protocol Deviation|0
702234|NCT01360632|2279940|P3|Phase A+|Protocol Deviation|0
702235|NCT01360632|2279941|P2|Phase A+|Protocol Deviation|0
702236|NCT01360632|2279942|P1|Phase A+|Protocol Deviation|0
702237|NCT01360632|2279938|P5|Phase A+|Withdrawal by Subject|8
702238|NCT01360632|2279939|P4|Phase A+|Withdrawal by Subject|0
702239|NCT01360632|2279940|P3|Phase A+|Withdrawal by Subject|0
702240|NCT01360632|2279941|P2|Phase A+|Withdrawal by Subject|0
702241|NCT01360632|2279942|P1|Phase A+|Withdrawal by Subject|0
702242|NCT01360632|2279938|P5|Phase A+|Physician Decision|3
702243|NCT01360632|2279939|P4|Phase A+|Physician Decision|0
702244|NCT01360632|2279940|P3|Phase A+|Physician Decision|0
702245|NCT01360632|2279941|P2|Phase A+|Physician Decision|0
702246|NCT01360632|2279942|P1|Phase A+|Physician Decision|0
702247|NCT01360632|2279938|P5|Phase A+|Met Withdrawal Criteria|7
702248|NCT01360632|2279939|P4|Phase A+|Met Withdrawal Criteria|0
702249|NCT01360632|2279940|P3|Phase A+|Met Withdrawal Criteria|0
702250|NCT01360632|2279941|P2|Phase A+|Met Withdrawal Criteria|0
702251|NCT01360632|2279942|P1|Phase A+|Met Withdrawal Criteria|0
702252|NCT01360632|2279938|P5|Phase A+|Adverse Event|2
702253|NCT01360632|2279939|P4|Phase A+|Adverse Event|0
702254|NCT01360632|2279940|P3|Phase A+|Adverse Event|0
702255|NCT01360632|2279941|P2|Phase A+|Adverse Event|0
702256|NCT01360632|2279942|P1|Phase A+|Adverse Event|0
702257|NCT01360632|2279938|P5|Phase A+|Lost to Follow-up|2
702258|NCT01360632|2279939|P4|Phase A+|Lost to Follow-up|0
702259|NCT01360632|2279940|P3|Phase A+|Lost to Follow-up|0
702260|NCT01360632|2279941|P2|Phase A+|Lost to Follow-up|0
702261|NCT01360632|2279942|P1|Phase A+|Lost to Follow-up|0
702262|NCT01360632|2279938|P5|Phase B (6 Weeks)|Lack of Efficacy|0
702263|NCT01360632|2279939|P4|Phase B (6 Weeks)|Lack of Efficacy|0
702264|NCT01360632|2279940|P3|Phase B (6 Weeks)|Lack of Efficacy|0
702265|NCT01360632|2279941|P2|Phase B (6 Weeks)|Lack of Efficacy|1
702266|NCT01360632|2279942|P1|Phase B (6 Weeks)|Lack of Efficacy|0
702267|NCT01360632|2279938|P5|Phase B (6 Weeks)|Protocol Deviation|0
702268|NCT01360632|2279939|P4|Phase B (6 Weeks)|Protocol Deviation|1
702269|NCT01360632|2279940|P3|Phase B (6 Weeks)|Protocol Deviation|4
702270|NCT01360632|2279941|P2|Phase B (6 Weeks)|Protocol Deviation|1
702271|NCT01360632|2279942|P1|Phase B (6 Weeks)|Protocol Deviation|0
702272|NCT01360632|2279938|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
702273|NCT01360632|2279939|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
702274|NCT01360632|2279940|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
702275|NCT01360632|2279941|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
702276|NCT01360632|2279942|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
702277|NCT01360632|2279938|P5|Phase B (6 Weeks)|Physician Decision|0
702278|NCT01360632|2279939|P4|Phase B (6 Weeks)|Physician Decision|1
702279|NCT01360632|2279940|P3|Phase B (6 Weeks)|Physician Decision|0
702280|NCT01360632|2279941|P2|Phase B (6 Weeks)|Physician Decision|0
702281|NCT01360632|2279942|P1|Phase B (6 Weeks)|Physician Decision|0
702282|NCT01360632|2279938|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
702283|NCT01360632|2279939|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
702284|NCT01360632|2279940|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
702285|NCT01360632|2279941|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
702286|NCT01360632|2279942|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
702287|NCT01360632|2279938|P5|Phase B (6 Weeks)|Adverse Event|0
702288|NCT01360632|2279939|P4|Phase B (6 Weeks)|Adverse Event|3
702289|NCT01360632|2279940|P3|Phase B (6 Weeks)|Adverse Event|9
702290|NCT01360632|2279941|P2|Phase B (6 Weeks)|Adverse Event|3
702291|NCT01360632|2279942|P1|Phase B (6 Weeks)|Adverse Event|0
702292|NCT01360632|2279938|P5|Phase B (6 Weeks)|Lost to Follow-up|0
702293|NCT01360632|2279939|P4|Phase B (6 Weeks)|Lost to Follow-up|0
702294|NCT01360632|2279940|P3|Phase B (6 Weeks)|Lost to Follow-up|1
702295|NCT01360632|2279941|P2|Phase B (6 Weeks)|Lost to Follow-up|1
702296|NCT01360632|2279942|P1|Phase B (6 Weeks)|Lost to Follow-up|0
702297|NCT01360632|2279938|P5|Phase A (8 Weeks)|Protocol Deviation|0
702298|NCT01360632|2279939|P4|Phase A (8 Weeks)|Protocol Deviation|0
702299|NCT01360632|2279940|P3|Phase A (8 Weeks)|Protocol Deviation|0
702300|NCT01360632|2279941|P2|Phase A (8 Weeks)|Protocol Deviation|0
702301|NCT01360632|2279942|P1|Phase A (8 Weeks)|Protocol Deviation|39
702302|NCT01360632|2279938|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
702303|NCT01360632|2279939|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
702304|NCT01360632|2279940|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
702305|NCT01360632|2279941|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
702306|NCT01360632|2279942|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
702307|NCT01360632|2279938|P5|Phase A (8 Weeks)|Physician Decision|0
702308|NCT01360632|2279939|P4|Phase A (8 Weeks)|Physician Decision|0
702309|NCT01360632|2279940|P3|Phase A (8 Weeks)|Physician Decision|0
702310|NCT01360632|2279941|P2|Phase A (8 Weeks)|Physician Decision|0
702311|NCT01360632|2279942|P1|Phase A (8 Weeks)|Physician Decision|10
702312|NCT01360632|2279938|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
702313|NCT01360632|2279939|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
702314|NCT01360632|2279940|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
702315|NCT01360632|2279941|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
702316|NCT01360632|2279942|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
702317|NCT01360632|2279938|P5|Phase A (8 Weeks)|Adverse Event|0
702318|NCT01360632|2279939|P4|Phase A (8 Weeks)|Adverse Event|0
702319|NCT01360632|2279940|P3|Phase A (8 Weeks)|Adverse Event|0
702320|NCT01360632|2279941|P2|Phase A (8 Weeks)|Adverse Event|0
702321|NCT01360632|2279942|P1|Phase A (8 Weeks)|Adverse Event|60
702322|NCT01360632|2279938|P5|Phase A (8 Weeks)|Lost to Follow-up|0
702323|NCT01360632|2279939|P4|Phase A (8 Weeks)|Lost to Follow-up|0
702324|NCT01360632|2279940|P3|Phase A (8 Weeks)|Lost to Follow-up|0
702325|NCT01360632|2279941|P2|Phase A (8 Weeks)|Lost to Follow-up|0
702326|NCT01360632|2279942|P1|Phase A (8 Weeks)|Lost to Follow-up|27
702327|NCT01360554|2280021|P2|Overall Study|Randomized but not treated.|3
702328|NCT01360554|2280022|P1|Overall Study|Randomized but not treated.|3
702329|NCT01360554|2280021|P2|Overall Study|Other, not specified|0
702330|NCT01360554|2280022|P1|Overall Study|Other, not specified|1
702331|NCT01360554|2280021|P2|Overall Study|Study terminated by sponsor|37
702332|NCT01360554|2280022|P1|Overall Study|Study terminated by sponsor|49
702333|NCT01360554|2280021|P2|Overall Study|Withdrawal by Subject|24
702334|NCT01360554|2280022|P1|Overall Study|Withdrawal by Subject|23
702335|NCT01360554|2280021|P2|Overall Study|Lost to Follow-up|4
702336|NCT01360554|2280022|P1|Overall Study|Lost to Follow-up|4
702337|NCT01360554|2280021|P2|Overall Study|Death|371
702338|NCT01360554|2280022|P1|Overall Study|Death|359
702339|NCT01360021|2280074|P3|Overall Study|Adverse Event|3
702340|NCT01360021|2280075|P2|Overall Study|Adverse Event|3
702341|NCT01360021|2280076|P1|Overall Study|Adverse Event|2
702342|NCT01360021|2280074|P3|Overall Study|Withdrawal by Subject|2
702343|NCT01360021|2280075|P2|Overall Study|Withdrawal by Subject|0
702344|NCT01360021|2280076|P1|Overall Study|Withdrawal by Subject|4
702345|NCT01360021|2280074|P3|Overall Study|Protocol Violation|1
702346|NCT01360021|2280075|P2|Overall Study|Protocol Violation|0
702347|NCT01360021|2280076|P1|Overall Study|Protocol Violation|0
702348|NCT01360021|2280074|P3|Overall Study|Eligibility criteria + other|1
702349|NCT01360021|2280075|P2|Overall Study|Eligibility criteria + other|1
702350|NCT01360021|2280076|P1|Overall Study|Eligibility criteria + other|2
702351|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
702352|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
702353|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
702354|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
702355|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
702356|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
702357|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
702358|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
702359|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
702360|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
702361|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
702362|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
702363|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
702364|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
702365|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
702366|NCT01359943|2280102|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
702367|NCT01359943|2280103|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
702368|NCT01359943|2280104|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
702369|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
702370|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
702371|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
702372|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
702373|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
702374|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
702375|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
702376|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
702377|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
702378|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
702379|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
702380|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
702381|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
702382|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
702383|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
702384|NCT01359943|2280102|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
702385|NCT01359943|2280103|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
702386|NCT01359943|2280104|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
702387|NCT01359943|2280102|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
702388|NCT01359943|2280103|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
702389|NCT01359943|2280104|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
702390|NCT01359943|2280102|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
702391|NCT01359943|2280103|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
702392|NCT01359943|2280104|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
702393|NCT01359943|2280102|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
702394|NCT01359943|2280103|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
702395|NCT01359943|2280104|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
702396|NCT01359904|2280152|P2|Overall Study|Withdrawal by Subject|0
702397|NCT01359904|2280153|P1|Overall Study|Withdrawal by Subject|1
702398|NCT01359644|2280207|P10|Follow-up Period|Lost to Follow-up|0
702399|NCT01359644|2280208|P9|Follow-up Period|Lost to Follow-up|0
702400|NCT01359644|2280209|P8|Follow-up Period|Lost to Follow-up|2
702401|NCT01359644|2280210|P7|Follow-up Period|Lost to Follow-up|1
702402|NCT01359644|2280211|P6|Follow-up Period|Lost to Follow-up|0
702403|NCT01359644|2280212|P5|Follow-up Period|Lost to Follow-up|0
702404|NCT01359644|2280213|P4|Follow-up Period|Lost to Follow-up|0
702405|NCT01359644|2280214|P3|Follow-up Period|Lost to Follow-up|0
702406|NCT01359644|2280215|P2|Follow-up Period|Lost to Follow-up|0
702407|NCT01359644|2280216|P1|Follow-up Period|Lost to Follow-up|0
702408|NCT01359644|2280207|P10|Follow-up Period|Withdrawal by Subject|0
702409|NCT01359644|2280208|P9|Follow-up Period|Withdrawal by Subject|0
702410|NCT01359644|2280209|P8|Follow-up Period|Withdrawal by Subject|0
702411|NCT01359644|2280210|P7|Follow-up Period|Withdrawal by Subject|0
702412|NCT01359644|2280211|P6|Follow-up Period|Withdrawal by Subject|1
702413|NCT01359644|2280212|P5|Follow-up Period|Withdrawal by Subject|0
702414|NCT01359644|2280213|P4|Follow-up Period|Withdrawal by Subject|0
702415|NCT01359644|2280214|P3|Follow-up Period|Withdrawal by Subject|0
702416|NCT01359644|2280215|P2|Follow-up Period|Withdrawal by Subject|0
702417|NCT01359644|2280216|P1|Follow-up Period|Withdrawal by Subject|0
702418|NCT01359644|2280207|P10|Treatment Period|Lost to Follow-up|0
702419|NCT01359644|2280208|P9|Treatment Period|Lost to Follow-up|0
702420|NCT01359644|2280209|P8|Treatment Period|Lost to Follow-up|0
702421|NCT01359644|2280210|P7|Treatment Period|Lost to Follow-up|0
702422|NCT01359644|2280211|P6|Treatment Period|Lost to Follow-up|1
702423|NCT01359644|2280212|P5|Treatment Period|Lost to Follow-up|0
702424|NCT01359644|2280213|P4|Treatment Period|Lost to Follow-up|0
702425|NCT01359644|2280214|P3|Treatment Period|Lost to Follow-up|0
702426|NCT01359644|2280215|P2|Treatment Period|Lost to Follow-up|0
702427|NCT01359644|2280216|P1|Treatment Period|Lost to Follow-up|0
702428|NCT01359644|2280207|P10|Treatment Period|Adverse Event|0
702429|NCT01359644|2280208|P9|Treatment Period|Adverse Event|0
702430|NCT01359644|2280209|P8|Treatment Period|Adverse Event|0
702431|NCT01359644|2280210|P7|Treatment Period|Adverse Event|0
702432|NCT01359644|2280211|P6|Treatment Period|Adverse Event|1
702433|NCT01359644|2280212|P5|Treatment Period|Adverse Event|0
702434|NCT01359644|2280213|P4|Treatment Period|Adverse Event|0
702435|NCT01359644|2280214|P3|Treatment Period|Adverse Event|1
702436|NCT01359644|2280215|P2|Treatment Period|Adverse Event|0
702437|NCT01359644|2280216|P1|Treatment Period|Adverse Event|0
702438|NCT01359644|2280207|P10|Treatment Period|Lack of Efficacy|0
702439|NCT01359644|2280208|P9|Treatment Period|Lack of Efficacy|0
702440|NCT01359644|2280209|P8|Treatment Period|Lack of Efficacy|0
702441|NCT01359644|2280210|P7|Treatment Period|Lack of Efficacy|0
702442|NCT01359644|2280211|P6|Treatment Period|Lack of Efficacy|0
702443|NCT01359644|2280212|P5|Treatment Period|Lack of Efficacy|0
702444|NCT01359644|2280213|P4|Treatment Period|Lack of Efficacy|0
702445|NCT01359644|2280214|P3|Treatment Period|Lack of Efficacy|0
702446|NCT01359644|2280215|P2|Treatment Period|Lack of Efficacy|1
702447|NCT01359644|2280216|P1|Treatment Period|Lack of Efficacy|0
702448|NCT01359449|2280260|P2|Overall Study|Withdrawal by Subject|2
702449|NCT01359449|2280261|P1|Overall Study|Withdrawal by Subject|3
702450|NCT01359449|2280260|P2|Overall Study|Protocol Violation|2
702451|NCT01359449|2280261|P1|Overall Study|Protocol Violation|0
702452|NCT01359449|2280260|P2|Overall Study|Lost to Follow-up|0
702453|NCT01359449|2280261|P1|Overall Study|Lost to Follow-up|1
702454|NCT01359254|2280307|P2|Overall Study|Death|0
702455|NCT01359254|2280308|P1|Overall Study|Death|1
702456|NCT01359150|2280318|P2|Overall Study|Unspecified|0
702457|NCT01359150|2280319|P1|Overall Study|Unspecified|1
702458|NCT01359150|2280318|P2|Overall Study|Adverse Event|3
702459|NCT01359150|2280319|P1|Overall Study|Adverse Event|4
702460|NCT01359150|2280318|P2|Overall Study|Withdrawal by Subject|1
702461|NCT01359150|2280319|P1|Overall Study|Withdrawal by Subject|1
702462|NCT01359150|2280318|P2|Overall Study|Lack of Efficacy|1
702463|NCT01359150|2280319|P1|Overall Study|Lack of Efficacy|1
702464|NCT01358864|2280356|P8|Overall Study|Not treated|0
702465|NCT01358864|2280357|P7|Overall Study|Not treated|1
702466|NCT01358864|2280358|P6|Overall Study|Not treated|0
702467|NCT01358864|2280359|P5|Overall Study|Not treated|0
702468|NCT01358864|2280360|P4|Overall Study|Not treated|0
702469|NCT01358864|2280361|P3|Overall Study|Not treated|0
702470|NCT01358864|2280362|P2|Overall Study|Not treated|0
702471|NCT01358864|2280363|P1|Overall Study|Not treated|0
702472|NCT01358864|2280356|P8|Overall Study|Other reason not defined above|0
702473|NCT01358864|2280357|P7|Overall Study|Other reason not defined above|2
702474|NCT01358864|2280358|P6|Overall Study|Other reason not defined above|0
702475|NCT01358864|2280359|P5|Overall Study|Other reason not defined above|0
702476|NCT01358864|2280360|P4|Overall Study|Other reason not defined above|0
702477|NCT01358864|2280361|P3|Overall Study|Other reason not defined above|0
702478|NCT01358864|2280362|P2|Overall Study|Other reason not defined above|0
702479|NCT01358864|2280363|P1|Overall Study|Other reason not defined above|2
702480|NCT01358864|2280356|P8|Overall Study|Withdrawal by Subject|3
702481|NCT01358864|2280357|P7|Overall Study|Withdrawal by Subject|1
702482|NCT01358864|2280358|P6|Overall Study|Withdrawal by Subject|1
702483|NCT01358864|2280359|P5|Overall Study|Withdrawal by Subject|0
702484|NCT01358864|2280360|P4|Overall Study|Withdrawal by Subject|0
702485|NCT01358864|2280361|P3|Overall Study|Withdrawal by Subject|2
702486|NCT01358864|2280362|P2|Overall Study|Withdrawal by Subject|4
702487|NCT01358864|2280363|P1|Overall Study|Withdrawal by Subject|3
702488|NCT01358864|2280356|P8|Overall Study|Lost to Follow-up|1
702489|NCT01358864|2280357|P7|Overall Study|Lost to Follow-up|0
702490|NCT01358864|2280358|P6|Overall Study|Lost to Follow-up|0
702491|NCT01358864|2280359|P5|Overall Study|Lost to Follow-up|0
702492|NCT01358864|2280360|P4|Overall Study|Lost to Follow-up|0
702493|NCT01358864|2280361|P3|Overall Study|Lost to Follow-up|1
702494|NCT01358864|2280362|P2|Overall Study|Lost to Follow-up|0
702495|NCT01358864|2280363|P1|Overall Study|Lost to Follow-up|0
702496|NCT01358864|2280356|P8|Overall Study|Lack of Efficacy|44
702497|NCT01358864|2280357|P7|Overall Study|Lack of Efficacy|49
702498|NCT01358864|2280358|P6|Overall Study|Lack of Efficacy|4
702499|NCT01358864|2280359|P5|Overall Study|Lack of Efficacy|7
702500|NCT01358864|2280360|P4|Overall Study|Lack of Efficacy|19
702501|NCT01358864|2280361|P3|Overall Study|Lack of Efficacy|4
702502|NCT01358864|2280362|P2|Overall Study|Lack of Efficacy|3
702503|NCT01358864|2280363|P1|Overall Study|Lack of Efficacy|26
702504|NCT01358864|2280356|P8|Overall Study|Adverse Event|7
702505|NCT01358864|2280357|P7|Overall Study|Adverse Event|12
702506|NCT01358864|2280358|P6|Overall Study|Adverse Event|8
702507|NCT01358864|2280359|P5|Overall Study|Adverse Event|4
702508|NCT01358864|2280360|P4|Overall Study|Adverse Event|0
702509|NCT01358864|2280361|P3|Overall Study|Adverse Event|9
702510|NCT01358864|2280362|P2|Overall Study|Adverse Event|6
702511|NCT01358864|2280363|P1|Overall Study|Adverse Event|0
702512|NCT01358825|2280454|P2|Overall Study|Blood sample not drawn|1
702513|NCT01358825|2280455|P1|Overall Study|Blood sample not drawn|0
702514|NCT01358760|2280479|P3|Overall Study|Entry criteria not met/Non-compliance|16
702515|NCT01358760|2280480|P2|Overall Study|Entry criteria not met/Non-compliance|12
702516|NCT01358760|2280481|P1|Overall Study|Entry criteria not met/Non-compliance|12
702517|NCT01358760|2280479|P3|Overall Study|Physician Decision|1
702518|NCT01358760|2280480|P2|Overall Study|Physician Decision|0
702519|NCT01358760|2280481|P1|Overall Study|Physician Decision|1
702520|NCT01358760|2280479|P3|Overall Study|Withdrawal by Subject|2
702521|NCT01358760|2280480|P2|Overall Study|Withdrawal by Subject|3
702522|NCT01358760|2280481|P1|Overall Study|Withdrawal by Subject|5
702523|NCT01358760|2280479|P3|Overall Study|Lost to Follow-up|3
702524|NCT01358760|2280480|P2|Overall Study|Lost to Follow-up|1
702525|NCT01358760|2280481|P1|Overall Study|Lost to Follow-up|1
702526|NCT01358760|2280479|P3|Overall Study|Adverse Event|3
702527|NCT01358760|2280480|P2|Overall Study|Adverse Event|4
702528|NCT01358760|2280481|P1|Overall Study|Adverse Event|3
702529|NCT01358734|2280516|P3|Overall Study|Not Specified|4
702530|NCT01358734|2280517|P2|Overall Study|Not Specified|5
702531|NCT01358734|2280518|P1|Overall Study|Not Specified|2
702532|NCT01358734|2280516|P3|Overall Study|Non-compliance with study drug|1
702533|NCT01358734|2280517|P2|Overall Study|Non-compliance with study drug|0
702534|NCT01358734|2280518|P1|Overall Study|Non-compliance with study drug|0
702535|NCT01358734|2280516|P3|Overall Study|Progressive Disease|13
702536|NCT01358734|2280517|P2|Overall Study|Progressive Disease|11
702537|NCT01358734|2280518|P1|Overall Study|Progressive Disease|5
702538|NCT01358734|2280516|P3|Overall Study|Death|2
702539|NCT01358734|2280517|P2|Overall Study|Death|7
702540|NCT01358734|2280518|P1|Overall Study|Death|3
702541|NCT01358734|2280516|P3|Overall Study|Withdrawal by Subject|3
702542|NCT01358734|2280517|P2|Overall Study|Withdrawal by Subject|6
702543|NCT01358734|2280518|P1|Overall Study|Withdrawal by Subject|1
702544|NCT01358734|2280516|P3|Overall Study|Lack of Efficacy|3
702545|NCT01358734|2280517|P2|Overall Study|Lack of Efficacy|1
702546|NCT01358734|2280518|P1|Overall Study|Lack of Efficacy|0
702547|NCT01358734|2280516|P3|Overall Study|Adverse Event|3
702548|NCT01358734|2280517|P2|Overall Study|Adverse Event|7
702549|NCT01358734|2280518|P1|Overall Study|Adverse Event|4
702550|NCT01358708|2280537|P2|Double-Blind Treatment Phase|Protocol Violation|0
702551|NCT01358708|2280538|P1|Double-Blind Treatment Phase|Protocol Violation|1
702552|NCT01358708|2280537|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
702553|NCT01358708|2280538|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
702554|NCT01357551|2280559|P2|Overall Study|Lost to Follow-up|6
702555|NCT01357551|2280560|P1|Overall Study|Lost to Follow-up|16
702556|NCT01357551|2280559|P2|Overall Study|Death|1
702557|NCT01357551|2280560|P1|Overall Study|Death|0
702558|NCT01357551|2280559|P2|Overall Study|Withdrawal by Subject|4
702559|NCT01357551|2280560|P1|Overall Study|Withdrawal by Subject|6
702560|NCT01358578|2280576|P6|Follow-up Period|Physician Decision|0
702561|NCT01358578|2280577|P5|Follow-up Period|Physician Decision|0
702562|NCT01358578|2280578|P4|Follow-up Period|Physician Decision|2
702563|NCT01358578|2280579|P3|Follow-up Period|Physician Decision|0
702564|NCT01358578|2280580|P2|Follow-up Period|Physician Decision|1
702565|NCT01358578|2280581|P1|Follow-up Period|Physician Decision|1
702566|NCT01358578|2280576|P6|Follow-up Period|Withdrawal by Subject|0
702567|NCT01358578|2280577|P5|Follow-up Period|Withdrawal by Subject|0
702568|NCT01358578|2280578|P4|Follow-up Period|Withdrawal by Subject|12
702569|NCT01358578|2280579|P3|Follow-up Period|Withdrawal by Subject|1
702570|NCT01358578|2280580|P2|Follow-up Period|Withdrawal by Subject|3
702571|NCT01358578|2280581|P1|Follow-up Period|Withdrawal by Subject|3
702572|NCT01358578|2280576|P6|Follow-up Period|Pregnancy|0
702573|NCT01358578|2280577|P5|Follow-up Period|Pregnancy|0
702574|NCT01358578|2280578|P4|Follow-up Period|Pregnancy|0
702575|NCT01358578|2280579|P3|Follow-up Period|Pregnancy|0
702576|NCT01358578|2280580|P2|Follow-up Period|Pregnancy|0
702577|NCT01358578|2280581|P1|Follow-up Period|Pregnancy|1
702578|NCT01358578|2280576|P6|Follow-up Period|non- compliance with study treatment|0
702579|NCT01358578|2280577|P5|Follow-up Period|non- compliance with study treatment|0
702580|NCT01358578|2280578|P4|Follow-up Period|non- compliance with study treatment|0
702581|NCT01358578|2280579|P3|Follow-up Period|non- compliance with study treatment|0
702582|NCT01358578|2280580|P2|Follow-up Period|non- compliance with study treatment|0
702583|NCT01358578|2280581|P1|Follow-up Period|non- compliance with study treatment|1
702584|NCT01358578|2280576|P6|Follow-up Period|Lost to Follow-up|0
702585|NCT01358578|2280577|P5|Follow-up Period|Lost to Follow-up|0
702586|NCT01358578|2280578|P4|Follow-up Period|Lost to Follow-up|4
702587|NCT01358578|2280579|P3|Follow-up Period|Lost to Follow-up|0
702588|NCT01358578|2280580|P2|Follow-up Period|Lost to Follow-up|1
702589|NCT01358578|2280581|P1|Follow-up Period|Lost to Follow-up|0
702590|NCT01358578|2280576|P6|Follow-up Period|Lack of Efficacy|0
702591|NCT01358578|2280577|P5|Follow-up Period|Lack of Efficacy|0
702592|NCT01358578|2280578|P4|Follow-up Period|Lack of Efficacy|1
702593|NCT01358578|2280579|P3|Follow-up Period|Lack of Efficacy|4
702594|NCT01358578|2280580|P2|Follow-up Period|Lack of Efficacy|0
702595|NCT01358578|2280581|P1|Follow-up Period|Lack of Efficacy|3
702596|NCT01358578|2280576|P6|Follow-up Period|Adverse Event|0
702597|NCT01358578|2280577|P5|Follow-up Period|Adverse Event|0
702598|NCT01358578|2280578|P4|Follow-up Period|Adverse Event|0
702599|NCT01358578|2280579|P3|Follow-up Period|Adverse Event|0
702600|NCT01358578|2280580|P2|Follow-up Period|Adverse Event|1
702601|NCT01358578|2280581|P1|Follow-up Period|Adverse Event|1
702602|NCT01358578|2280576|P6|Maintenance Period|Withdrawal by Subject|3
702603|NCT01358578|2280577|P5|Maintenance Period|Withdrawal by Subject|6
702604|NCT01358578|2280578|P4|Maintenance Period|Withdrawal by Subject|15
702605|NCT01358578|2280579|P3|Maintenance Period|Withdrawal by Subject|2
702606|NCT01358578|2280580|P2|Maintenance Period|Withdrawal by Subject|7
702607|NCT01358578|2280581|P1|Maintenance Period|Withdrawal by Subject|12
702608|NCT01358578|2280576|P6|Maintenance Period|Protocol deviation|2
702609|NCT01358578|2280577|P5|Maintenance Period|Protocol deviation|2
702610|NCT01358578|2280578|P4|Maintenance Period|Protocol deviation|2
702611|NCT01358578|2280579|P3|Maintenance Period|Protocol deviation|0
702612|NCT01358578|2280580|P2|Maintenance Period|Protocol deviation|4
702613|NCT01358578|2280581|P1|Maintenance Period|Protocol deviation|7
702614|NCT01358578|2280576|P6|Maintenance Period|Pregnancy|0
702615|NCT01358578|2280577|P5|Maintenance Period|Pregnancy|0
702616|NCT01358578|2280578|P4|Maintenance Period|Pregnancy|0
702617|NCT01358578|2280579|P3|Maintenance Period|Pregnancy|0
702618|NCT01358578|2280580|P2|Maintenance Period|Pregnancy|0
702619|NCT01358578|2280581|P1|Maintenance Period|Pregnancy|1
702620|NCT01358578|2280576|P6|Maintenance Period|Physician Decision|0
702621|NCT01358578|2280577|P5|Maintenance Period|Physician Decision|0
702622|NCT01358578|2280578|P4|Maintenance Period|Physician Decision|1
702623|NCT01358578|2280579|P3|Maintenance Period|Physician Decision|0
702624|NCT01358578|2280580|P2|Maintenance Period|Physician Decision|1
702625|NCT01358578|2280581|P1|Maintenance Period|Physician Decision|0
702626|NCT01358578|2280576|P6|Maintenance Period|Non-compliance with study treatment|2
702627|NCT01358578|2280577|P5|Maintenance Period|Non-compliance with study treatment|1
702628|NCT01358578|2280578|P4|Maintenance Period|Non-compliance with study treatment|2
702629|NCT01358578|2280579|P3|Maintenance Period|Non-compliance with study treatment|0
702630|NCT01358578|2280580|P2|Maintenance Period|Non-compliance with study treatment|1
702631|NCT01358578|2280581|P1|Maintenance Period|Non-compliance with study treatment|3
702632|NCT01358578|2280576|P6|Maintenance Period|Lost to Follow-up|1
702633|NCT01358578|2280577|P5|Maintenance Period|Lost to Follow-up|1
702634|NCT01358578|2280578|P4|Maintenance Period|Lost to Follow-up|5
702635|NCT01358578|2280579|P3|Maintenance Period|Lost to Follow-up|0
702636|NCT01358578|2280580|P2|Maintenance Period|Lost to Follow-up|0
702637|NCT01358578|2280581|P1|Maintenance Period|Lost to Follow-up|4
702638|NCT01358578|2280576|P6|Maintenance Period|Lack of Efficacy|0
702639|NCT01358578|2280577|P5|Maintenance Period|Lack of Efficacy|3
702640|NCT01358578|2280578|P4|Maintenance Period|Lack of Efficacy|11
702641|NCT01358578|2280579|P3|Maintenance Period|Lack of Efficacy|0
702642|NCT01358578|2280580|P2|Maintenance Period|Lack of Efficacy|2
702643|NCT01358578|2280581|P1|Maintenance Period|Lack of Efficacy|10
702644|NCT01358578|2280576|P6|Maintenance Period|Adverse Event|3
702645|NCT01358578|2280577|P5|Maintenance Period|Adverse Event|4
702646|NCT01358578|2280578|P4|Maintenance Period|Adverse Event|6
702647|NCT01358578|2280579|P3|Maintenance Period|Adverse Event|0
702648|NCT01358578|2280580|P2|Maintenance Period|Adverse Event|7
702649|NCT01358578|2280581|P1|Maintenance Period|Adverse Event|2
702650|NCT01358578|2280576|P6|Induction Period|Withdrawal by Subject|0
702651|NCT01358578|2280577|P5|Induction Period|Withdrawal by Subject|0
702652|NCT01358578|2280578|P4|Induction Period|Withdrawal by Subject|6
702653|NCT01358578|2280579|P3|Induction Period|Withdrawal by Subject|10
702654|NCT01358578|2280580|P2|Induction Period|Withdrawal by Subject|5
702655|NCT01358578|2280581|P1|Induction Period|Withdrawal by Subject|5
702656|NCT01358578|2280576|P6|Induction Period|technical problems|0
702657|NCT01358578|2280577|P5|Induction Period|technical problems|0
702658|NCT01358578|2280578|P4|Induction Period|technical problems|1
702659|NCT01358578|2280579|P3|Induction Period|technical problems|1
702660|NCT01358578|2280580|P2|Induction Period|technical problems|0
702661|NCT01358578|2280581|P1|Induction Period|technical problems|0
702662|NCT01358578|2280576|P6|Induction Period|Protocol Deviation|0
702663|NCT01358578|2280577|P5|Induction Period|Protocol Deviation|0
702664|NCT01358578|2280578|P4|Induction Period|Protocol Deviation|3
702665|NCT01358578|2280579|P3|Induction Period|Protocol Deviation|0
702666|NCT01358578|2280580|P2|Induction Period|Protocol Deviation|5
702667|NCT01358578|2280581|P1|Induction Period|Protocol Deviation|3
702668|NCT01358578|2280576|P6|Induction Period|Physician Decision|0
702669|NCT01358578|2280577|P5|Induction Period|Physician Decision|0
702670|NCT01358578|2280578|P4|Induction Period|Physician Decision|0
702671|NCT01358578|2280579|P3|Induction Period|Physician Decision|2
702672|NCT01358578|2280580|P2|Induction Period|Physician Decision|1
702673|NCT01358578|2280581|P1|Induction Period|Physician Decision|2
702674|NCT01358578|2280576|P6|Induction Period|Lost to Follow-up|0
702675|NCT01358578|2280577|P5|Induction Period|Lost to Follow-up|0
702676|NCT01358578|2280578|P4|Induction Period|Lost to Follow-up|4
702677|NCT01358578|2280579|P3|Induction Period|Lost to Follow-up|1
702678|NCT01358578|2280580|P2|Induction Period|Lost to Follow-up|0
702679|NCT01358578|2280581|P1|Induction Period|Lost to Follow-up|0
702680|NCT01358578|2280576|P6|Induction Period|Lack of Efficacy|0
702681|NCT01358578|2280577|P5|Induction Period|Lack of Efficacy|0
702682|NCT01358578|2280578|P4|Induction Period|Lack of Efficacy|1
702683|NCT01358578|2280579|P3|Induction Period|Lack of Efficacy|9
702684|NCT01358578|2280580|P2|Induction Period|Lack of Efficacy|0
702685|NCT01358578|2280581|P1|Induction Period|Lack of Efficacy|0
702686|NCT01358578|2280576|P6|Induction Period|Adverse Event|0
702687|NCT01358578|2280577|P5|Induction Period|Adverse Event|0
702688|NCT01358578|2280578|P4|Induction Period|Adverse Event|6
702689|NCT01358578|2280579|P3|Induction Period|Adverse Event|2
702690|NCT01358578|2280580|P2|Induction Period|Adverse Event|4
702691|NCT01358578|2280581|P1|Induction Period|Adverse Event|2
702692|NCT01358526|2280633|P3|Double-blind Phase|Administrative|10
702693|NCT01358526|2280634|P2|Double-blind Phase|Administrative|6
702694|NCT01358526|2280635|P1|Double-blind Phase|Administrative|0
702695|NCT01358526|2280633|P3|Double-blind Phase|Confirmed or suspected diversion|6
702696|NCT01358526|2280634|P2|Double-blind Phase|Confirmed or suspected diversion|5
702697|NCT01358526|2280635|P1|Double-blind Phase|Confirmed or suspected diversion|0
702698|NCT01358526|2280633|P3|Double-blind Phase|Lack of Efficacy|73
702699|NCT01358526|2280634|P2|Double-blind Phase|Lack of Efficacy|31
702700|NCT01358526|2280635|P1|Double-blind Phase|Lack of Efficacy|0
702701|NCT01358526|2280633|P3|Double-blind Phase|Lost to Follow-up|1
702702|NCT01358526|2280634|P2|Double-blind Phase|Lost to Follow-up|4
702703|NCT01358526|2280635|P1|Double-blind Phase|Lost to Follow-up|0
702704|NCT01358526|2280633|P3|Double-blind Phase|Withdrawal by Subject|8
702705|NCT01358526|2280634|P2|Double-blind Phase|Withdrawal by Subject|10
702706|NCT01358526|2280635|P1|Double-blind Phase|Withdrawal by Subject|0
702707|NCT01358526|2280633|P3|Double-blind Phase|Adverse Event|23
702708|NCT01358526|2280634|P2|Double-blind Phase|Adverse Event|24
702709|NCT01358526|2280635|P1|Double-blind Phase|Adverse Event|0
702710|NCT01358526|2280633|P3|Open-label Titration Period|Did not qualify|0
702711|NCT01358526|2280634|P2|Open-label Titration Period|Did not qualify|0
702712|NCT01358526|2280635|P1|Open-label Titration Period|Did not qualify|178
702713|NCT01358526|2280633|P3|Open-label Titration Period|Administrative|0
702714|NCT01358526|2280634|P2|Open-label Titration Period|Administrative|0
702715|NCT01358526|2280635|P1|Open-label Titration Period|Administrative|8
702716|NCT01358526|2280633|P3|Open-label Titration Period|Confirmed or suspected diversion|0
702717|NCT01358526|2280634|P2|Open-label Titration Period|Confirmed or suspected diversion|0
702718|NCT01358526|2280635|P1|Open-label Titration Period|Confirmed or suspected diversion|16
702719|NCT01358526|2280633|P3|Open-label Titration Period|Lack of Efficacy|0
702720|NCT01358526|2280634|P2|Open-label Titration Period|Lack of Efficacy|0
702721|NCT01358526|2280635|P1|Open-label Titration Period|Lack of Efficacy|107
702722|NCT01358526|2280633|P3|Open-label Titration Period|Lost to Follow-up|0
702723|NCT01358526|2280634|P2|Open-label Titration Period|Lost to Follow-up|0
702724|NCT01358526|2280635|P1|Open-label Titration Period|Lost to Follow-up|25
702725|NCT01358526|2280633|P3|Open-label Titration Period|Withdrawal by Subject|0
702726|NCT01358526|2280634|P2|Open-label Titration Period|Withdrawal by Subject|0
702727|NCT01358526|2280635|P1|Open-label Titration Period|Withdrawal by Subject|65
702728|NCT01358526|2280633|P3|Open-label Titration Period|Adverse Event|0
702729|NCT01358526|2280634|P2|Open-label Titration Period|Adverse Event|0
702730|NCT01358526|2280635|P1|Open-label Titration Period|Adverse Event|95
702731|NCT01358357|2280652|P3|Double-Blind Phase|Administrative|0
702732|NCT01358357|2280653|P2|Double-Blind Phase|Administrative|1
702733|NCT01358357|2280654|P1|Double-Blind Phase|Administrative|0
702734|NCT01358357|2280652|P3|Double-Blind Phase|Recurrence of mood event|0
702735|NCT01358357|2280653|P2|Double-Blind Phase|Recurrence of mood event|64
702736|NCT01358357|2280654|P1|Double-Blind Phase|Recurrence of mood event|48
702737|NCT01358357|2280652|P3|Double-Blind Phase|Terminated at study completion|0
702738|NCT01358357|2280653|P2|Double-Blind Phase|Terminated at study completion|0
702739|NCT01358357|2280654|P1|Double-Blind Phase|Terminated at study completion|2
702740|NCT01358357|2280652|P3|Double-Blind Phase|Protocol Violation|0
702741|NCT01358357|2280653|P2|Double-Blind Phase|Protocol Violation|12
702742|NCT01358357|2280654|P1|Double-Blind Phase|Protocol Violation|16
702743|NCT01358357|2280652|P3|Double-Blind Phase|Protocol Violation|0
702744|NCT01358357|2280653|P2|Double-Blind Phase|Protocol Violation|11
702745|NCT01358357|2280654|P1|Double-Blind Phase|Protocol Violation|1
702746|NCT01358357|2280652|P3|Double-Blind Phase|Lost to Follow-up|0
702747|NCT01358357|2280653|P2|Double-Blind Phase|Lost to Follow-up|7
702748|NCT01358357|2280654|P1|Double-Blind Phase|Lost to Follow-up|5
702749|NCT01358357|2280652|P3|Double-Blind Phase|Adverse Event|0
702750|NCT01358357|2280653|P2|Double-Blind Phase|Adverse Event|5
702751|NCT01358357|2280654|P1|Double-Blind Phase|Adverse Event|8
702752|NCT01358357|2280652|P3|Open Label Phase|Mood episode|42
702753|NCT01358357|2280653|P2|Open Label Phase|Mood episode|0
702754|NCT01358357|2280654|P1|Open Label Phase|Mood episode|0
702755|NCT01358357|2280652|P3|Open Label Phase|Terminated at study completion|5
702756|NCT01358357|2280653|P2|Open Label Phase|Terminated at study completion|0
702757|NCT01358357|2280654|P1|Open Label Phase|Terminated at study completion|0
702758|NCT01358357|2280652|P3|Open Label Phase|Did not meet criteria for DB phase|16
702759|NCT01358357|2280653|P2|Open Label Phase|Did not meet criteria for DB phase|0
702760|NCT01358357|2280654|P1|Open Label Phase|Did not meet criteria for DB phase|0
702761|NCT01358357|2280652|P3|Open Label Phase|Withdrawal by Subject|112
702762|NCT01358357|2280653|P2|Open Label Phase|Withdrawal by Subject|0
702763|NCT01358357|2280654|P1|Open Label Phase|Withdrawal by Subject|0
702764|NCT01358357|2280652|P3|Open Label Phase|Protocol Violation|45
702765|NCT01358357|2280653|P2|Open Label Phase|Protocol Violation|0
702766|NCT01358357|2280654|P1|Open Label Phase|Protocol Violation|0
702767|NCT01358357|2280652|P3|Open Label Phase|Lost to Follow-up|76
702768|NCT01358357|2280653|P2|Open Label Phase|Lost to Follow-up|0
702769|NCT01358357|2280654|P1|Open Label Phase|Lost to Follow-up|0
702770|NCT01358357|2280652|P3|Open Label Phase|Lack of Efficacy|107
702771|NCT01358357|2280653|P2|Open Label Phase|Lack of Efficacy|0
702772|NCT01358357|2280654|P1|Open Label Phase|Lack of Efficacy|0
702773|NCT01358357|2280652|P3|Open Label Phase|Adverse Event|59
702774|NCT01358357|2280653|P2|Open Label Phase|Adverse Event|0
702775|NCT01358357|2280654|P1|Open Label Phase|Adverse Event|0
702776|NCT01358175|2280690|P3|Overall Study|Adverse Event|11
702777|NCT01358175|2280691|P2|Overall Study|Adverse Event|11
702778|NCT01358175|2280692|P1|Overall Study|Adverse Event|6
702779|NCT01358175|2280690|P3|Overall Study|Lack of Efficacy|6
702780|NCT01358175|2280691|P2|Overall Study|Lack of Efficacy|8
702781|NCT01358175|2280692|P1|Overall Study|Lack of Efficacy|3
702782|NCT01358175|2280690|P3|Overall Study|Lost to Follow-up|3
702783|NCT01358175|2280691|P2|Overall Study|Lost to Follow-up|1
702784|NCT01358175|2280692|P1|Overall Study|Lost to Follow-up|1
702785|NCT01358175|2280690|P3|Overall Study|Non Compliance with Study Treatment|1
702786|NCT01358175|2280691|P2|Overall Study|Non Compliance with Study Treatment|1
702787|NCT01358175|2280692|P1|Overall Study|Non Compliance with Study Treatment|0
702788|NCT01358175|2280690|P3|Overall Study|Physician Decision|0
702789|NCT01358175|2280691|P2|Overall Study|Physician Decision|0
702790|NCT01358175|2280692|P1|Overall Study|Physician Decision|1
702791|NCT01358175|2280690|P3|Overall Study|Pregnancy|0
702792|NCT01358175|2280691|P2|Overall Study|Pregnancy|1
702793|NCT01358175|2280692|P1|Overall Study|Pregnancy|0
702794|NCT01358175|2280690|P3|Overall Study|Technical issues|0
702795|NCT01358175|2280691|P2|Overall Study|Technical issues|1
702796|NCT01358175|2280692|P1|Overall Study|Technical issues|0
702797|NCT01358175|2280690|P3|Overall Study|Withdrawal by Subject|10
702798|NCT01358175|2280691|P2|Overall Study|Withdrawal by Subject|5
702799|NCT01358175|2280692|P1|Overall Study|Withdrawal by Subject|9
702800|NCT01358175|2280690|P3|Overall Study|Death|1
702801|NCT01358175|2280691|P2|Overall Study|Death|0
702802|NCT01358175|2280692|P1|Overall Study|Death|1
702803|NCT01357980|2280729|P4|Overall Study|Consent withdrawn|0
702804|NCT01357980|2280730|P3|Overall Study|Consent withdrawn|1
702805|NCT01357980|2280731|P2|Overall Study|Consent withdrawn|0
702806|NCT01357980|2280732|P1|Overall Study|Consent withdrawn|0
702807|NCT01357980|2280729|P4|Overall Study|Lack of Efficacy|0
702808|NCT01357980|2280730|P3|Overall Study|Lack of Efficacy|0
702809|NCT01357980|2280731|P2|Overall Study|Lack of Efficacy|1
702810|NCT01357980|2280732|P1|Overall Study|Lack of Efficacy|0
702811|NCT01357915|2280776|P2|Overall Study|Lost to Follow-up|0
702812|NCT01357915|2280777|P1|Overall Study|Lost to Follow-up|3
702813|NCT01357889|2280792|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
702814|NCT01357889|2280793|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
702815|NCT01357889|2280792|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
702816|NCT01357889|2280793|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
702817|NCT01357889|2280792|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
702818|NCT01357889|2280793|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
702819|NCT01357889|2280792|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
702820|NCT01357889|2280793|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
702821|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
702822|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
702823|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
702824|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
702825|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
702826|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
702827|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
702828|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
702829|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
702830|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
702831|NCT01357889|2280792|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
702832|NCT01357889|2280793|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
702833|NCT01357889|2280792|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
702834|NCT01357889|2280793|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
702835|NCT01357889|2280792|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
702836|NCT01357889|2280793|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
702837|NCT01357889|2280792|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
702838|NCT01357889|2280793|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
702839|NCT01357850|2280837|P4|Overall Study|Lost to Follow-up|0
702840|NCT01357850|2280838|P3|Overall Study|Lost to Follow-up|0
702841|NCT01357850|2280839|P2|Overall Study|Lost to Follow-up|0
702842|NCT01357850|2280840|P1|Overall Study|Lost to Follow-up|1
702843|NCT01357655|2280931|P2|Overall Study|Subject Withdrew Consent|0
702844|NCT01357655|2280932|P1|Overall Study|Subject Withdrew Consent|1
702845|NCT01357655|2280931|P2|Overall Study|Study Drug Toxicity|0
702846|NCT01357655|2280932|P1|Overall Study|Study Drug Toxicity|11
702847|NCT01357655|2280931|P2|Overall Study|Reason Unspecified|0
702848|NCT01357655|2280932|P1|Overall Study|Reason Unspecified|1
702849|NCT01357655|2280931|P2|Overall Study|Maximum Clinical Benefit|0
702850|NCT01357655|2280932|P1|Overall Study|Maximum Clinical Benefit|2
702851|NCT01357655|2280931|P2|Overall Study|Lost to Follow-up|0
702852|NCT01357655|2280932|P1|Overall Study|Lost to Follow-up|2
702853|NCT01357655|2280931|P2|Overall Study|Disease Progression|0
702854|NCT01357655|2280932|P1|Overall Study|Disease Progression|1
702855|NCT01357655|2280931|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
702856|NCT01357655|2280932|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
702857|NCT01357655|2280931|P2|Overall Study|Administrative Reason by Sponsor|0
702858|NCT01357655|2280932|P1|Overall Study|Administrative Reason by Sponsor|45
702859|NCT01357616|2280949|P2|Overall Study|Withdrawal by Subject|0
702860|NCT01357616|2280950|P1|Overall Study|Withdrawal by Subject|1
702861|NCT01357616|2280949|P2|Overall Study|Decision Unrelated to Adverse Event|1
702862|NCT01357616|2280950|P1|Overall Study|Decision Unrelated to Adverse Event|3
702863|NCT01357616|2280949|P2|Overall Study|Inadequate Control of IOP|2
702864|NCT01357616|2280950|P1|Overall Study|Inadequate Control of IOP|1
702865|NCT01357616|2280949|P2|Overall Study|Protocol Violation|2
702866|NCT01357616|2280950|P1|Overall Study|Protocol Violation|0
702867|NCT01357616|2280949|P2|Overall Study|Lost to Follow-up|3
702868|NCT01357616|2280950|P1|Overall Study|Lost to Follow-up|4
702869|NCT01357616|2280949|P2|Overall Study|Adverse Event|1
702870|NCT01357616|2280950|P1|Overall Study|Adverse Event|1
702871|NCT01357239|2280977|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
702872|NCT01357239|2280978|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
702873|NCT01357239|2280979|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
702874|NCT01357239|2280980|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
702875|NCT01357239|2280977|P4|Stratum II: Partially-Methylated|Adverse Event|1
702876|NCT01357239|2280978|P3|Stratum II: Partially-Methylated|Adverse Event|0
702877|NCT01357239|2280979|P2|Stratum II: Partially-Methylated|Adverse Event|0
702878|NCT01357239|2280980|P1|Stratum II: Partially-Methylated|Adverse Event|0
702879|NCT01357239|2280977|P4|Stratum I: Fully-Methylated|Adverse Event|0
702880|NCT01357239|2280978|P3|Stratum I: Fully-Methylated|Adverse Event|1
702881|NCT01357239|2280979|P2|Stratum I: Fully-Methylated|Adverse Event|0
702882|NCT01357239|2280980|P1|Stratum I: Fully-Methylated|Adverse Event|0
702883|NCT01357239|2280977|P4|Stratum: All Patients|Subject withdrew consent|1
702884|NCT01357239|2280978|P3|Stratum: All Patients|Subject withdrew consent|1
702885|NCT01357239|2280979|P2|Stratum: All Patients|Subject withdrew consent|0
702886|NCT01357239|2280980|P1|Stratum: All Patients|Subject withdrew consent|0
702887|NCT01357239|2280977|P4|Stratum: All Patients|Adverse Event|1
702888|NCT01357239|2280978|P3|Stratum: All Patients|Adverse Event|1
702889|NCT01357239|2280979|P2|Stratum: All Patients|Adverse Event|0
702890|NCT01357239|2280980|P1|Stratum: All Patients|Adverse Event|0
702891|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
702892|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
702893|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
702894|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
702895|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
702896|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
702897|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
702898|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
702899|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
702900|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
702901|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
702902|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
702903|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
702904|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
702905|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
702906|NCT01357161|2281038|P3|Part 2 (Double-Blind Comparison)|Death|19
702907|NCT01357161|2281039|P2|Part 2 (Double-Blind Comparison)|Death|22
702908|NCT01357161|2281040|P1|Part 2 (Double-Blind Comparison)|Death|0
702909|NCT01357161|2281038|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
702910|NCT01357161|2281039|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
702911|NCT01357161|2281040|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
702912|NCT01357161|2281038|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
702913|NCT01357161|2281039|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
702914|NCT01357161|2281040|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
702915|NCT01357161|2281038|P3|Part 1 (Open Label Run-in)|Physician Decision|0
702916|NCT01357161|2281039|P2|Part 1 (Open Label Run-in)|Physician Decision|0
702917|NCT01357161|2281040|P1|Part 1 (Open Label Run-in)|Physician Decision|1
702918|NCT01357161|2281038|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
702919|NCT01357161|2281039|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
702920|NCT01357161|2281040|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
702921|NCT01357161|2281038|P3|Part 1 (Open Label Run-in)|Death|0
702922|NCT01357161|2281039|P2|Part 1 (Open Label Run-in)|Death|0
702923|NCT01357161|2281040|P1|Part 1 (Open Label Run-in)|Death|5
702924|NCT01356966|2281092|P2|Overall Study|Physician Decision|0
702925|NCT01356966|2281093|P1|Overall Study|Physician Decision|1
702926|NCT01356966|2281092|P2|Overall Study|Withdrawal by Subject|2
702927|NCT01356966|2281093|P1|Overall Study|Withdrawal by Subject|1
702928|NCT01356940|2281105|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
702929|NCT01356940|2281106|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
702930|NCT01356940|2281105|P2|First Intervention (28 Days)|Adverse Event|0
702931|NCT01356940|2281106|P1|First Intervention (28 Days)|Adverse Event|1
702932|NCT01356602|2281128|P3|Overall Study|Adverse Event|1
702933|NCT01356602|2281129|P2|Overall Study|Adverse Event|1
702934|NCT01356602|2281130|P1|Overall Study|Adverse Event|0
702935|NCT01356602|2281128|P3|Overall Study|Lack of Efficacy|4
702936|NCT01356602|2281129|P2|Overall Study|Lack of Efficacy|1
702937|NCT01356602|2281130|P1|Overall Study|Lack of Efficacy|0
702938|NCT01356602|2281128|P3|Overall Study|Withdrawal by Subject|7
702939|NCT01356602|2281129|P2|Overall Study|Withdrawal by Subject|3
702940|NCT01356602|2281130|P1|Overall Study|Withdrawal by Subject|4
702941|NCT01356602|2281128|P3|Overall Study|Lost to Follow-up|6
702942|NCT01356602|2281129|P2|Overall Study|Lost to Follow-up|5
702943|NCT01356602|2281130|P1|Overall Study|Lost to Follow-up|4
702944|NCT01356602|2281128|P3|Overall Study|Administrative Problems|5
702945|NCT01356602|2281129|P2|Overall Study|Administrative Problems|4
702946|NCT01356602|2281130|P1|Overall Study|Administrative Problems|1
702947|NCT01356602|2281128|P3|Overall Study|Protocol Deviation|1
702948|NCT01356602|2281129|P2|Overall Study|Protocol Deviation|1
702949|NCT01356602|2281130|P1|Overall Study|Protocol Deviation|0
702950|NCT01356589|2281189|P1|Overall Study|Dose data not recorded|2
702951|NCT01356589|2281189|P1|Overall Study|Enrolled, but not treated|3
702952|NCT01356407|2281246|P2|Overall Study|Not complete Endoscopy|2
702953|NCT01356407|2281247|P1|Overall Study|Not complete Endoscopy|2
702954|NCT01356407|2281246|P2|Overall Study|Could not afford IMP administration|1
702955|NCT01356407|2281247|P1|Overall Study|Could not afford IMP administration|0
702956|NCT01356407|2281246|P2|Overall Study|Patient Withdrew Consent|1
702957|NCT01356407|2281247|P1|Overall Study|Patient Withdrew Consent|2
702958|NCT01356407|2281246|P2|Overall Study|Lost to Follow-up|0
702959|NCT01356407|2281247|P1|Overall Study|Lost to Follow-up|2
702960|NCT01355679|2281285|P1|Overall Study|benign tumor types found at biopsy|2
702961|NCT01355627|2281294|P2|Overall Study|Other|1
702962|NCT01355627|2281295|P1|Overall Study|Other|1
702963|NCT01355627|2281294|P2|Overall Study|Fatal Adverse Event|23
702964|NCT01355627|2281295|P1|Overall Study|Fatal Adverse Event|19
702965|NCT01355627|2281294|P2|Overall Study|Lost to Follow-up|7
702966|NCT01355627|2281295|P1|Overall Study|Lost to Follow-up|8
702967|NCT01355627|2281294|P2|Overall Study|Request By the Patient to Discontinue|7
702968|NCT01355627|2281295|P1|Overall Study|Request By the Patient to Discontinue|5
702969|NCT01355523|2281334|P2|Overall Study|Adverse Event|2
702970|NCT01355523|2281335|P1|Overall Study|Adverse Event|0
702971|NCT01355523|2281334|P2|Overall Study|Protocol Violation|2
702972|NCT01355523|2281335|P1|Overall Study|Protocol Violation|0
702973|NCT01355523|2281334|P2|Overall Study|Lost to Follow-up|2
702974|NCT01355523|2281335|P1|Overall Study|Lost to Follow-up|0
702975|NCT01355523|2281334|P2|Overall Study|Withdrawal by Subject|4
702976|NCT01355523|2281335|P1|Overall Study|Withdrawal by Subject|1
702977|NCT01355302|2281411|P3|Phase 1b|Study terminated by sponsor|0
702978|NCT01355302|2281412|P2|Phase 1b|Study terminated by sponsor|0
702979|NCT01355302|2281413|P1|Phase 1b|Study terminated by sponsor|2
702980|NCT01355302|2281411|P3|Phase 1b|Death|0
702981|NCT01355302|2281412|P2|Phase 1b|Death|0
702982|NCT01355302|2281413|P1|Phase 1b|Death|4
702983|NCT01355081|2281454|P3|Overall Study|Non Compliance with Study Medication|0
702984|NCT01355081|2281455|P2|Overall Study|Non Compliance with Study Medication|1
702985|NCT01355081|2281456|P1|Overall Study|Non Compliance with Study Medication|0
702986|NCT01355081|2281454|P3|Overall Study|Lack of Efficacy|1
702987|NCT01355081|2281455|P2|Overall Study|Lack of Efficacy|1
702988|NCT01355081|2281456|P1|Overall Study|Lack of Efficacy|2
702989|NCT01355081|2281454|P3|Overall Study|Withdrawal of Consent|3
702990|NCT01355081|2281455|P2|Overall Study|Withdrawal of Consent|3
702991|NCT01355081|2281456|P1|Overall Study|Withdrawal of Consent|2
702992|NCT01355081|2281454|P3|Overall Study|Lost to Follow-up|1
702993|NCT01355081|2281455|P2|Overall Study|Lost to Follow-up|0
702994|NCT01355081|2281456|P1|Overall Study|Lost to Follow-up|0
702995|NCT01355081|2281454|P3|Overall Study|Major Protocol Deviation|0
702996|NCT01355081|2281455|P2|Overall Study|Major Protocol Deviation|1
702997|NCT01355081|2281456|P1|Overall Study|Major Protocol Deviation|0
702998|NCT01355081|2281454|P3|Overall Study|Pretreatment Event or Adverse Event|6
702999|NCT01355081|2281455|P2|Overall Study|Pretreatment Event or Adverse Event|4
703000|NCT01355081|2281456|P1|Overall Study|Pretreatment Event or Adverse Event|3
703001|NCT01355068|2281479|P2|First Intervention Period|Withdrawal by Subject|1
703002|NCT01355068|2281480|P1|First Intervention Period|Withdrawal by Subject|0
703003|NCT01355068|2281479|P2|First Intervention Period|Adverse Event|1
703004|NCT01355068|2281480|P1|First Intervention Period|Adverse Event|0
703005|NCT01354938|2281503|P1|Overall Study|Lost to Follow-up|1
703006|NCT01354899|2281509|P1|Overall Study|Protocol Violation|1
703007|NCT01354899|2281509|P1|Overall Study|discharge from the hospital|2
889694|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
889695|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889696|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
889697|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889698|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889699|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889700|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889701|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
889702|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
889703|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889704|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
889705|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889706|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889707|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889708|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889709|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889710|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
889711|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
703029|NCT01354314|2281556|P4|Overall Study|Less than 90% Adherence|4
703030|NCT01354314|2281557|P3|Overall Study|Less than 90% Adherence|6
703031|NCT01354314|2281558|P2|Overall Study|Less than 90% Adherence|2
703032|NCT01354314|2281559|P1|Overall Study|Less than 90% Adherence|4
703033|NCT01354314|2281556|P4|Overall Study|Protocol Violation|0
703034|NCT01354314|2281557|P3|Overall Study|Protocol Violation|0
703035|NCT01354314|2281558|P2|Overall Study|Protocol Violation|1
703036|NCT01354314|2281559|P1|Overall Study|Protocol Violation|1
703037|NCT01354314|2281556|P4|Overall Study|Adverse Event|1
703038|NCT01354314|2281557|P3|Overall Study|Adverse Event|0
703039|NCT01354314|2281558|P2|Overall Study|Adverse Event|0
703040|NCT01354314|2281559|P1|Overall Study|Adverse Event|0
703041|NCT01354314|2281556|P4|Overall Study|Withdrawal by Subject|0
703042|NCT01354314|2281557|P3|Overall Study|Withdrawal by Subject|1
703043|NCT01354314|2281558|P2|Overall Study|Withdrawal by Subject|0
703044|NCT01354314|2281559|P1|Overall Study|Withdrawal by Subject|0
703045|NCT01354314|2281556|P4|Overall Study|Lost to Follow-up|1
703046|NCT01354314|2281557|P3|Overall Study|Lost to Follow-up|1
703047|NCT01354314|2281558|P2|Overall Study|Lost to Follow-up|0
703048|NCT01354314|2281559|P1|Overall Study|Lost to Follow-up|1
703049|NCT01354223|2281695|P2|Overall Study|Withdrawal by Subject|1
703050|NCT01354223|2281696|P1|Overall Study|Withdrawal by Subject|3
703051|NCT01354132|2281755|P2|1 Month Post Study Medication|Withdrawal by Subject|3
703052|NCT01354132|2281756|P1|1 Month Post Study Medication|Withdrawal by Subject|1
703053|NCT01354132|2281755|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
703054|NCT01354132|2281756|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
703055|NCT01354132|2281755|P2|Double Blind (Visits 1-7)|Adverse Event|0
703056|NCT01354132|2281756|P1|Double Blind (Visits 1-7)|Adverse Event|1
703057|NCT01354132|2281755|P2|Randomization|Withdrawal by Subject|1
703058|NCT01354132|2281756|P1|Randomization|Withdrawal by Subject|0
703059|NCT01354132|2281755|P2|Randomization|Physician Decision|0
703060|NCT01354132|2281756|P1|Randomization|Physician Decision|1
703061|NCT01354106|2281794|P1|Overall Study|Withdrawal by Subject|2
703062|NCT01354028|2281800|P2|Overall Study|No quiet alert state|1
703063|NCT01354028|2281801|P1|Overall Study|No quiet alert state|0
703064|NCT01354028|2281800|P2|Overall Study|Discharged before study start|2
703065|NCT01354028|2281801|P1|Overall Study|Discharged before study start|2
703066|NCT01354028|2281800|P2|Overall Study|Physician Decision|2
703067|NCT01354028|2281801|P1|Overall Study|Physician Decision|0
703068|NCT01353963|2281837|P1|Overall Study|Adverse Event|2
703069|NCT01353911|2281855|P8|Overall Study|Status Not Recorded|0
703070|NCT01353911|2281856|P7|Overall Study|Status Not Recorded|0
703071|NCT01353911|2281857|P6|Overall Study|Status Not Recorded|0
703072|NCT01353911|2281858|P5|Overall Study|Status Not Recorded|0
703073|NCT01353911|2281859|P4|Overall Study|Status Not Recorded|0
703074|NCT01353911|2281860|P3|Overall Study|Status Not Recorded|1
703075|NCT01353911|2281861|P2|Overall Study|Status Not Recorded|0
703076|NCT01353911|2281862|P1|Overall Study|Status Not Recorded|4
703077|NCT01353911|2281855|P8|Overall Study|Withdrawal by Subject|9
703078|NCT01353911|2281856|P7|Overall Study|Withdrawal by Subject|3
703079|NCT01353911|2281857|P6|Overall Study|Withdrawal by Subject|3
703080|NCT01353911|2281858|P5|Overall Study|Withdrawal by Subject|2
703081|NCT01353911|2281859|P4|Overall Study|Withdrawal by Subject|2
703082|NCT01353911|2281860|P3|Overall Study|Withdrawal by Subject|4
703083|NCT01353911|2281861|P2|Overall Study|Withdrawal by Subject|3
703084|NCT01353911|2281862|P1|Overall Study|Withdrawal by Subject|2
703085|NCT01353911|2281855|P8|Overall Study|Lost to Follow-up|6
703086|NCT01353911|2281856|P7|Overall Study|Lost to Follow-up|3
703087|NCT01353911|2281857|P6|Overall Study|Lost to Follow-up|4
703088|NCT01353911|2281858|P5|Overall Study|Lost to Follow-up|4
703089|NCT01353911|2281859|P4|Overall Study|Lost to Follow-up|0
703090|NCT01353911|2281860|P3|Overall Study|Lost to Follow-up|4
703091|NCT01353911|2281861|P2|Overall Study|Lost to Follow-up|6
703092|NCT01353911|2281862|P1|Overall Study|Lost to Follow-up|2
703093|NCT01353898|2281942|P6|Overall Study|Study site terminated|1
703094|NCT01353898|2281943|P5|Overall Study|Study site terminated|0
703095|NCT01353898|2281944|P4|Overall Study|Study site terminated|0
703096|NCT01353898|2281945|P3|Overall Study|Study site terminated|0
703097|NCT01353898|2281946|P2|Overall Study|Study site terminated|0
703098|NCT01353898|2281947|P1|Overall Study|Study site terminated|0
703099|NCT01353859|2281973|P1|Overall Study|Lack of Efficacy|1
703100|NCT01353859|2281973|P1|Overall Study|Adverse Event|3
703101|NCT01353664|2281986|P1|Overall Study|Disease Progression|16
703102|NCT01353664|2281986|P1|Overall Study|Unspecified|3
703103|NCT01353586|2281992|P2|Overall Study|Neurological exam not done|1
703104|NCT01353586|2281993|P1|Overall Study|Neurological exam not done|0
703105|NCT01353586|2281992|P2|Overall Study|Never had insertion of study catheter|1
703106|NCT01353586|2281993|P1|Overall Study|Never had insertion of study catheter|4
703107|NCT01353586|2281992|P2|Overall Study|Procedure terminated prior to ablation|0
703108|NCT01353586|2281993|P1|Overall Study|Procedure terminated prior to ablation|3
703109|NCT01353508|2282011|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
703110|NCT01353508|2282012|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
703111|NCT01353508|2282013|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
703112|NCT01353508|2282014|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
703113|NCT01353508|2282011|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
703114|NCT01353508|2282012|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
703115|NCT01353508|2282013|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
703116|NCT01353508|2282014|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
703117|NCT01353274|2282092|P1|Overall Study|No case report form (CRF) collected|28
703118|NCT01353222|2282102|P2|Overall Study|Site closed research department|0
703119|NCT01353222|2282103|P1|Overall Study|Site closed research department|1
703120|NCT01353222|2282102|P2|Overall Study|Study Terminated|37
703121|NCT01353222|2282103|P1|Overall Study|Study Terminated|31
703122|NCT01353222|2282102|P2|Overall Study|Withdrawal by Subject|5
703123|NCT01353222|2282103|P1|Overall Study|Withdrawal by Subject|8
703124|NCT01353222|2282102|P2|Overall Study|Death|30
703125|NCT01353222|2282103|P1|Overall Study|Death|30
703126|NCT01352845|2282137|P2|Overall Study|Death|0
703127|NCT01352845|2282138|P1|Overall Study|Death|3
703128|NCT01352845|2282137|P2|Overall Study|Protocol Violation|6
703129|NCT01352845|2282138|P1|Overall Study|Protocol Violation|12
703130|NCT01352845|2282137|P2|Overall Study|Unspecified|7
703131|NCT01352845|2282138|P1|Overall Study|Unspecified|17
703132|NCT01352845|2282137|P2|Overall Study|Adverse Event|6
703133|NCT01352845|2282138|P1|Overall Study|Adverse Event|22
703134|NCT01352845|2282137|P2|Overall Study|Pregnancy|7
703135|NCT01352845|2282138|P1|Overall Study|Pregnancy|27
703136|NCT01352845|2282137|P2|Overall Study|No Longer Meets Eligibility Criteria|11
703137|NCT01352845|2282138|P1|Overall Study|No Longer Meets Eligibility Criteria|24
703138|NCT01352845|2282137|P2|Overall Study|Withdrawal by Subject|16
703139|NCT01352845|2282138|P1|Overall Study|Withdrawal by Subject|48
703140|NCT01352845|2282137|P2|Overall Study|No Longer Willing to Participate|58
703141|NCT01352845|2282138|P1|Overall Study|No Longer Willing to Participate|205
703142|NCT01352845|2282137|P2|Overall Study|Lost to Follow-up|92
703143|NCT01352845|2282138|P1|Overall Study|Lost to Follow-up|313
703144|NCT01352793|2282227|P2|Overall Study|No longer meets eligibility criteria|15
703145|NCT01352793|2282228|P1|Overall Study|No longer meets eligibility criteria|25
703146|NCT01352793|2282227|P2|Overall Study|Randomized but not vaccinated|0
703147|NCT01352793|2282228|P1|Overall Study|Randomized but not vaccinated|8
703148|NCT01352793|2282227|P2|Overall Study|Death|0
703149|NCT01352793|2282228|P1|Overall Study|Death|1
703150|NCT01352793|2282227|P2|Overall Study|Medication error|2
703151|NCT01352793|2282228|P1|Overall Study|Medication error|2
703152|NCT01352793|2282227|P2|Overall Study|Unspecified|7
703153|NCT01352793|2282228|P1|Overall Study|Unspecified|25
703154|NCT01352793|2282227|P2|Overall Study|Pregnancy|8
703155|NCT01352793|2282228|P1|Overall Study|Pregnancy|26
703156|NCT01352793|2282227|P2|Overall Study|Physician Decision|0
703157|NCT01352793|2282228|P1|Overall Study|Physician Decision|1
703158|NCT01352793|2282227|P2|Overall Study|Adverse Event|10
703159|NCT01352793|2282228|P1|Overall Study|Adverse Event|44
703160|NCT01352793|2282227|P2|Overall Study|Protocol Violation|23
703161|NCT01352793|2282228|P1|Overall Study|Protocol Violation|44
703162|NCT01352793|2282227|P2|Overall Study|Withdrawal by Subject|55
703163|NCT01352793|2282228|P1|Overall Study|Withdrawal by Subject|120
703164|NCT01352793|2282227|P2|Overall Study|Lost to Follow-up|125
703165|NCT01352793|2282228|P1|Overall Study|Lost to Follow-up|289
703166|NCT01352741|2282252|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
703167|NCT01352741|2282253|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
703168|NCT01352741|2282252|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
703169|NCT01352741|2282253|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
703170|NCT01352741|2282252|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
703171|NCT01352741|2282253|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
703172|NCT01352741|2282252|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
703173|NCT01352741|2282253|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
703174|NCT01352741|2282252|P2|Double-blind Comparative Period|Not Specified|2
703175|NCT01352741|2282253|P1|Double-blind Comparative Period|Not Specified|1
703176|NCT01352741|2282252|P2|Double-blind Comparative Period|Withdrawal of consent|3
703177|NCT01352741|2282253|P1|Double-blind Comparative Period|Withdrawal of consent|8
703178|NCT01352741|2282252|P2|Double-blind Comparative Period|Death|1
703179|NCT01352741|2282253|P1|Double-blind Comparative Period|Death|0
703180|NCT01352741|2282252|P2|Double-blind Comparative Period|Lost to Follow-up|0
703181|NCT01352741|2282253|P1|Double-blind Comparative Period|Lost to Follow-up|1
703182|NCT01352741|2282252|P2|Double-blind Comparative Period|Adverse Event|17
703183|NCT01352741|2282253|P1|Double-blind Comparative Period|Adverse Event|16
703184|NCT01352741|2282252|P2|Double-blind Comparative Period|Lack of Efficacy|3
703185|NCT01352741|2282253|P1|Double-blind Comparative Period|Lack of Efficacy|0
703186|NCT01352741|2282252|P2|Double-blind Comparative Period|Protocol Violation|0
703187|NCT01352741|2282253|P1|Double-blind Comparative Period|Protocol Violation|2
703188|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Not Specified|0
703189|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Not Specified|4
703190|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
703191|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
703192|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
703193|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
703194|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Adverse Event|0
703195|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Adverse Event|34
703196|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
703197|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
703198|NCT01352741|2282252|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
703199|NCT01352741|2282253|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
703200|NCT01352715|2282347|P2|Overall Study|major ineligibility|1
703201|NCT01352715|2282348|P1|Overall Study|major ineligibility|2
703202|NCT01352715|2282347|P2|Overall Study|no final visit in closeout period|12
703203|NCT01352715|2282348|P1|Overall Study|no final visit in closeout period|15
703204|NCT01352715|2282347|P2|Overall Study|site closure|15
703205|NCT01352715|2282348|P1|Overall Study|site closure|16
703206|NCT01352715|2282347|P2|Overall Study|Withdrawal by Subject|8
703207|NCT01352715|2282348|P1|Overall Study|Withdrawal by Subject|4
703208|NCT01352715|2282347|P2|Overall Study|Lost to Follow-up|7
703209|NCT01352715|2282348|P1|Overall Study|Lost to Follow-up|5
703210|NCT01352715|2282347|P2|Overall Study|Death|3
703211|NCT01352715|2282348|P1|Overall Study|Death|3
703212|NCT01352585|2282370|P1|Overall Study|Not specified|7
703213|NCT01352585|2282370|P1|Overall Study|Lost to Follow-up|1
703214|NCT01352585|2282370|P1|Overall Study|Adverse Event|3
703215|NCT01352507|2282387|P2|Treatment Period 2|Lack of Efficacy|0
703216|NCT01352507|2282388|P1|Treatment Period 2|Lack of Efficacy|1
703217|NCT01352507|2282387|P2|Treatment Period 2|Withdrawal by Subject|3
703218|NCT01352507|2282388|P1|Treatment Period 2|Withdrawal by Subject|4
703219|NCT01352507|2282387|P2|Treatment Period 2|Entry Criteria Not Met|0
703220|NCT01352507|2282388|P1|Treatment Period 2|Entry Criteria Not Met|1
703221|NCT01352507|2282387|P2|Washout Period|Withdrawal by Subject|1
703222|NCT01352507|2282388|P1|Washout Period|Withdrawal by Subject|0
703223|NCT01352507|2282387|P2|Treatment Period 1|Physician Decision|0
703224|NCT01352507|2282388|P1|Treatment Period 1|Physician Decision|1
703225|NCT01352507|2282387|P2|Treatment Period 1|Withdrawal by Subject|5
703226|NCT01352507|2282388|P1|Treatment Period 1|Withdrawal by Subject|7
703227|NCT01352507|2282387|P2|Treatment Period 1|Lost to Follow-up|4
703228|NCT01352507|2282388|P1|Treatment Period 1|Lost to Follow-up|3
703229|NCT01352507|2282387|P2|Treatment Period 1|Adverse Event|0
703230|NCT01352507|2282388|P1|Treatment Period 1|Adverse Event|3
703231|NCT01352416|2282441|P4|Overall Study|Physician Decision|1
703232|NCT01352416|2282442|P3|Overall Study|Physician Decision|2
703233|NCT01352416|2282443|P2|Overall Study|Physician Decision|2
703234|NCT01352416|2282444|P1|Overall Study|Physician Decision|1
703249|NCT01351623|2282509|P1|Overall Study|Death|2
703250|NCT01351623|2282509|P1|Overall Study|Withdrawal by Subject|1
703251|NCT01351623|2282509|P1|Overall Study|Adverse Event|4
703252|NCT01351623|2282509|P1|Overall Study|Protocol Violation|2
703253|NCT01351415|2282535|P2|Overall Study|Never Started|5
703254|NCT01351415|2282536|P1|Overall Study|Never Started|5
703255|NCT01351415|2282535|P2|Overall Study|Reason unknown|2
703256|NCT01351415|2282536|P1|Overall Study|Reason unknown|0
703257|NCT01351415|2282535|P2|Overall Study|Physician Decision|3
703258|NCT01351415|2282536|P1|Overall Study|Physician Decision|2
703259|NCT01351415|2282535|P2|Overall Study|Death|187
703260|NCT01351415|2282536|P1|Overall Study|Death|190
703261|NCT01351415|2282535|P2|Overall Study|Lost to Follow-up|7
703262|NCT01351415|2282536|P1|Overall Study|Lost to Follow-up|5
703263|NCT01351415|2282535|P2|Overall Study|Trial termination by the Sponsor|19
703264|NCT01351415|2282536|P1|Overall Study|Trial termination by the Sponsor|28
703265|NCT01351415|2282535|P2|Overall Study|Withdrawal by Subject|17
703266|NCT01351415|2282536|P1|Overall Study|Withdrawal by Subject|15
703267|NCT01351025|2282614|P2|Week 24 - 44|unable to get to clinic|1
703268|NCT01351025|2282615|P1|Week 24 - 44|unable to get to clinic|1
703269|NCT01351025|2282614|P2|Week 24 - 44|Site closed|1
703270|NCT01351025|2282615|P1|Week 24 - 44|Site closed|0
703271|NCT01351025|2282614|P2|Week 24 - 44|Lost to Follow-up|2
703272|NCT01351025|2282615|P1|Week 24 - 44|Lost to Follow-up|0
703273|NCT01351025|2282614|P2|Week 0 - 20|Withdrawal by Subject|0
703274|NCT01351025|2282615|P1|Week 0 - 20|Withdrawal by Subject|1
703275|NCT01351025|2282614|P2|Week 0 - 20|Lost to Follow-up|1
703276|NCT01351025|2282615|P1|Week 0 - 20|Lost to Follow-up|2
703277|NCT01350999|2282648|P3|Overall Study|Difficulty Making it to Study Visit|5
703278|NCT01350999|2282649|P2|Overall Study|Difficulty Making it to Study Visit|1
703279|NCT01350999|2282650|P1|Overall Study|Difficulty Making it to Study Visit|1
703280|NCT01350999|2282648|P3|Overall Study|Voluntary withdrawal|6
703281|NCT01350999|2282649|P2|Overall Study|Voluntary withdrawal|4
703282|NCT01350999|2282650|P1|Overall Study|Voluntary withdrawal|3
703283|NCT01350999|2282648|P3|Overall Study|Adverse Event|10
703284|NCT01350999|2282649|P2|Overall Study|Adverse Event|9
703285|NCT01350999|2282650|P1|Overall Study|Adverse Event|4
703286|NCT01350973|2282688|P3|Overall Study|Voluntary Withdrawal|1
703287|NCT01350973|2282689|P2|Overall Study|Voluntary Withdrawal|1
703288|NCT01350973|2282690|P1|Overall Study|Voluntary Withdrawal|2
703289|NCT01350973|2282688|P3|Overall Study|Adverse Event|7
703290|NCT01350973|2282689|P2|Overall Study|Adverse Event|7
703291|NCT01350973|2282690|P1|Overall Study|Adverse Event|4
889712|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
889713|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889714|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889715|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889716|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889717|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
889718|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
889719|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889720|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
889721|NCT01232283|2824400|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
889722|NCT01232283|2824401|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
889723|NCT01232283|2824402|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
889724|NCT01232283|2824403|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
889725|NCT01232283|2824404|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
889726|NCT01232283|2824405|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
889727|NCT01232283|2824406|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
889728|NCT01232283|2824407|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
703312|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
703313|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
703314|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
703315|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
703316|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
703317|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
703318|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
703319|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
703320|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
703321|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
703322|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
703323|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
703324|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
703325|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
703326|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
703327|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
703328|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
703329|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
703330|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
703331|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
703332|NCT01350804|2282754|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
703333|NCT01350804|2282755|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
703334|NCT01350804|2282756|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
703335|NCT01350804|2282757|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
703336|NCT01350804|2282754|P4|Core Study|Adverse Event|8
703337|NCT01350804|2282755|P3|Core Study|Adverse Event|8
703338|NCT01350804|2282756|P2|Core Study|Adverse Event|10
703339|NCT01350804|2282757|P1|Core Study|Adverse Event|8
703340|NCT01350804|2282754|P4|Core Study|Death|0
703341|NCT01350804|2282755|P3|Core Study|Death|1
703342|NCT01350804|2282756|P2|Core Study|Death|1
703343|NCT01350804|2282757|P1|Core Study|Death|1
703344|NCT01350804|2282754|P4|Core Study|Lack of Efficacy|5
703345|NCT01350804|2282755|P3|Core Study|Lack of Efficacy|18
703346|NCT01350804|2282756|P2|Core Study|Lack of Efficacy|19
703347|NCT01350804|2282757|P1|Core Study|Lack of Efficacy|16
703348|NCT01350804|2282754|P4|Core Study|Lost to Follow-up|1
703349|NCT01350804|2282755|P3|Core Study|Lost to Follow-up|2
703350|NCT01350804|2282756|P2|Core Study|Lost to Follow-up|0
703351|NCT01350804|2282757|P1|Core Study|Lost to Follow-up|3
703352|NCT01350804|2282754|P4|Core Study|Physician Decision|3
703353|NCT01350804|2282755|P3|Core Study|Physician Decision|1
703354|NCT01350804|2282756|P2|Core Study|Physician Decision|0
703355|NCT01350804|2282757|P1|Core Study|Physician Decision|1
703356|NCT01350804|2282754|P4|Core Study|Protocol deviation|0
703357|NCT01350804|2282755|P3|Core Study|Protocol deviation|1
703358|NCT01350804|2282756|P2|Core Study|Protocol deviation|0
703359|NCT01350804|2282757|P1|Core Study|Protocol deviation|1
703360|NCT01350804|2282754|P4|Core Study|Study terminated by Sponsor|2
703361|NCT01350804|2282755|P3|Core Study|Study terminated by Sponsor|0
703362|NCT01350804|2282756|P2|Core Study|Study terminated by Sponsor|0
703363|NCT01350804|2282757|P1|Core Study|Study terminated by Sponsor|0
703364|NCT01350804|2282754|P4|Core Study|Withdrawal by Subject|7
703365|NCT01350804|2282755|P3|Core Study|Withdrawal by Subject|16
703366|NCT01350804|2282756|P2|Core Study|Withdrawal by Subject|17
703367|NCT01350804|2282757|P1|Core Study|Withdrawal by Subject|11
703368|NCT01350544|2282854|P2|Overall Study|Lost to Follow-up|15
703369|NCT01350544|2282855|P1|Overall Study|Lost to Follow-up|18
703370|NCT01350544|2282854|P2|Overall Study|Incarceration|0
703371|NCT01350544|2282855|P1|Overall Study|Incarceration|1
703372|NCT01350544|2282854|P2|Overall Study|Withdrawal by Subject|1
703373|NCT01350544|2282855|P1|Overall Study|Withdrawal by Subject|0
703374|NCT01350544|2282854|P2|Overall Study|Medical Issues|1
703375|NCT01350544|2282855|P1|Overall Study|Medical Issues|1
703376|NCT01350544|2282854|P2|Overall Study|Moved out of LA County|2
703377|NCT01350544|2282855|P1|Overall Study|Moved out of LA County|2
703378|NCT01350544|2282854|P2|Overall Study|Death|2
703379|NCT01350544|2282855|P1|Overall Study|Death|1
703380|NCT01350544|2282854|P2|Overall Study|Administrative Withdrawal|1
703381|NCT01350544|2282855|P1|Overall Study|Administrative Withdrawal|0
703382|NCT01350414|2282870|P1|Overall Study|Physician Decision|2
703383|NCT01350414|2282870|P1|Overall Study|Withdrawal by Subject|4
703384|NCT01350414|2282870|P1|Overall Study|Lost to Follow-up|13
703385|NCT01350271|2282909|P3|Overall Study|Lost to Follow-up|26
703386|NCT01350271|2282910|P2|Overall Study|Lost to Follow-up|17
703387|NCT01350271|2282911|P1|Overall Study|Lost to Follow-up|21
703388|NCT01350128|2282950|P1|Overall Study|Lost to Follow-up|2
703389|NCT01350128|2282950|P1|Overall Study|Physician Decision|1
703390|NCT01350128|2282950|P1|Overall Study|Protocol discontinuation criteria|8
703391|NCT01350128|2282950|P1|Overall Study|Withdrawal by Subject|3
703392|NCT01350115|2283014|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
703393|NCT01350115|2283015|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
703394|NCT01350115|2283014|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
703395|NCT01350115|2283015|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
703396|NCT01350115|2283014|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
703397|NCT01350115|2283015|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
703398|NCT01349959|2283046|P1|Overall Study|Patients are followed for survival|7
703399|NCT01349907|2283077|P2|Overall Study|Administrative|1
703400|NCT01349907|2283078|P1|Overall Study|Administrative|1
703401|NCT01349907|2283077|P2|Overall Study|Protocol Violation|13
703402|NCT01349907|2283078|P1|Overall Study|Protocol Violation|33
703403|NCT01349907|2283077|P2|Overall Study|Withdrawal by Subject|8
703404|NCT01349907|2283078|P1|Overall Study|Withdrawal by Subject|30
703405|NCT01349907|2283077|P2|Overall Study|Lost to Follow-up|6
703406|NCT01349907|2283078|P1|Overall Study|Lost to Follow-up|25
703407|NCT01349907|2283077|P2|Overall Study|Treatment failure|4
703408|NCT01349907|2283078|P1|Overall Study|Treatment failure|13
703409|NCT01349907|2283077|P2|Overall Study|Adverse Event|11
703410|NCT01349907|2283078|P1|Overall Study|Adverse Event|37
703411|NCT01349829|2283116|P2|Overall Study|Migrated/moved|7
703412|NCT01349829|2283117|P1|Overall Study|Migrated/moved|2
703413|NCT01349829|2283116|P2|Overall Study|Consent withdrawal|8
703414|NCT01349829|2283117|P1|Overall Study|Consent withdrawal|3
703415|NCT01349829|2283116|P2|Overall Study|Lost to Follow-up|8
703416|NCT01349829|2283117|P1|Overall Study|Lost to Follow-up|4
703417|NCT01349816|2283135|P1|Overall Study|Protocol-specified criteria|8
703418|NCT01349816|2283135|P1|Overall Study|Protocol Violation|1
703419|NCT01349816|2283135|P1|Overall Study|Lost to Follow-up|2
703420|NCT01349816|2283135|P1|Overall Study|Adverse Event|14
703421|NCT01349816|2283135|P1|Overall Study|Physician Decision|1
703422|NCT01349816|2283135|P1|Overall Study|Withdrawal by Subject|4
703423|NCT01349803|2283201|P4|Overall Study|Protocol-specified criteria|0
703424|NCT01349803|2283202|P3|Overall Study|Protocol-specified criteria|3
703425|NCT01349803|2283203|P2|Overall Study|Protocol-specified criteria|1
703426|NCT01349803|2283204|P1|Overall Study|Protocol-specified criteria|0
703427|NCT01349803|2283201|P4|Overall Study|Withdrawal by Subject|0
703428|NCT01349803|2283202|P3|Overall Study|Withdrawal by Subject|0
703429|NCT01349803|2283203|P2|Overall Study|Withdrawal by Subject|0
703430|NCT01349803|2283204|P1|Overall Study|Withdrawal by Subject|1
703431|NCT01349803|2283201|P4|Overall Study|Adverse Event|2
703432|NCT01349803|2283202|P3|Overall Study|Adverse Event|0
703433|NCT01349803|2283203|P2|Overall Study|Adverse Event|0
703434|NCT01349803|2283204|P1|Overall Study|Adverse Event|0
703435|NCT01349790|2283274|P1|Overall Study|Lost to Follow-up|1
703436|NCT01349790|2283274|P1|Overall Study|Adverse Event|1
703437|NCT01349790|2283274|P1|Overall Study|Withdrawal by Patient|2
703438|NCT01349790|2283274|P1|Overall Study|Death|2
703439|NCT01349790|2283274|P1|Overall Study|Investigator Judgement|3
703440|NCT01349595|2283295|P2|Overall Study|Lack of funding|2
703441|NCT01349595|2283296|P1|Overall Study|Lack of funding|2
703442|NCT01349465|2283313|P2|Overall Study|Subject Ineligible To Continue The Trial|19
703443|NCT01349465|2283314|P1|Overall Study|Subject Ineligible To Continue The Trial|0
703444|NCT01349465|2283313|P2|Overall Study|Withdrawal by Subject|2
703445|NCT01349465|2283314|P1|Overall Study|Withdrawal by Subject|4
703446|NCT01349465|2283313|P2|Overall Study|Lost to Follow-up|1
703447|NCT01349465|2283314|P1|Overall Study|Lost to Follow-up|10
703448|NCT01349465|2283313|P2|Overall Study|Death|0
703449|NCT01349465|2283314|P1|Overall Study|Death|3
703450|NCT01349465|2283313|P2|Overall Study|Adverse Event|0
703451|NCT01349465|2283314|P1|Overall Study|Adverse Event|1
703452|NCT01349192|2283335|P2|Overall Study|Failure to adhere to Protocol|0
703453|NCT01349192|2283336|P1|Overall Study|Failure to adhere to Protocol|2
703454|NCT01349192|2283335|P2|Overall Study|Lost to Follow-up|3
703455|NCT01349192|2283336|P1|Overall Study|Lost to Follow-up|1
703456|NCT01349192|2283335|P2|Overall Study|Withdrawal by Subject|2
703457|NCT01349192|2283336|P1|Overall Study|Withdrawal by Subject|0
703458|NCT01349192|2283335|P2|Overall Study|Protocol Violation|1
703459|NCT01349192|2283336|P1|Overall Study|Protocol Violation|0
703460|NCT01348854|2283361|P2|Overall Study|Withdrawal by Subject|0
703461|NCT01348854|2283362|P1|Overall Study|Withdrawal by Subject|1
703462|NCT01348854|2283361|P2|Overall Study|Lost to Follow-up|1
703463|NCT01348854|2283362|P1|Overall Study|Lost to Follow-up|2
703464|NCT01348789|2283370|P1|Overall Study|Withdrawal by Subject|2
703465|NCT01348789|2283370|P1|Overall Study|Protocol Violation|2
703466|NCT01348776|2283381|P1|Overall Study|Lost to Follow-up|3
703467|NCT01348425|2283412|P2|Overall Study|Imaging was not taken.|1
703468|NCT01348425|2283413|P1|Overall Study|Imaging was not taken.|1
703469|NCT01348165|2283425|P7|Overall Study|Adverse Event|1
703470|NCT01348165|2283426|P6|Overall Study|Adverse Event|0
703471|NCT01348165|2283427|P5|Overall Study|Adverse Event|0
703472|NCT01348165|2283428|P4|Overall Study|Adverse Event|0
703473|NCT01348165|2283429|P3|Overall Study|Adverse Event|0
703474|NCT01348165|2283430|P2|Overall Study|Adverse Event|0
703475|NCT01348165|2283431|P1|Overall Study|Adverse Event|0
703476|NCT01348139|2283560|P6|Period 1|Adverse Event|0
703477|NCT01348139|2283561|P5|Period 1|Adverse Event|0
703478|NCT01348139|2283562|P4|Period 1|Adverse Event|0
703479|NCT01348139|2283563|P3|Period 1|Adverse Event|0
703480|NCT01348139|2283564|P2|Period 1|Adverse Event|0
703481|NCT01348139|2283565|P1|Period 1|Adverse Event|1
703482|NCT01348100|2283646|P7|Overall Study|Administrative Problems|1
703483|NCT01348100|2283647|P6|Overall Study|Administrative Problems|1
703484|NCT01348100|2283648|P5|Overall Study|Administrative Problems|0
703485|NCT01348100|2283649|P4|Overall Study|Administrative Problems|0
703486|NCT01348100|2283650|P3|Overall Study|Administrative Problems|0
703487|NCT01348100|2283651|P2|Overall Study|Administrative Problems|0
703488|NCT01348100|2283652|P1|Overall Study|Administrative Problems|0
703489|NCT01348100|2283646|P7|Overall Study|Lost to Follow-up|1
703490|NCT01348100|2283647|P6|Overall Study|Lost to Follow-up|0
703491|NCT01348100|2283648|P5|Overall Study|Lost to Follow-up|0
703492|NCT01348100|2283649|P4|Overall Study|Lost to Follow-up|0
703493|NCT01348100|2283650|P3|Overall Study|Lost to Follow-up|0
703494|NCT01348100|2283651|P2|Overall Study|Lost to Follow-up|0
703495|NCT01348100|2283652|P1|Overall Study|Lost to Follow-up|0
703496|NCT01348100|2283646|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
703497|NCT01348100|2283647|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
703498|NCT01348100|2283648|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
703499|NCT01348100|2283649|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
703500|NCT01348100|2283650|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
703501|NCT01348100|2283651|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
703502|NCT01348100|2283652|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
703503|NCT01348100|2283646|P7|Overall Study|Protocol Deviation|0
703504|NCT01348100|2283647|P6|Overall Study|Protocol Deviation|0
703505|NCT01348100|2283648|P5|Overall Study|Protocol Deviation|0
703506|NCT01348100|2283649|P4|Overall Study|Protocol Deviation|1
703507|NCT01348100|2283650|P3|Overall Study|Protocol Deviation|0
703508|NCT01348100|2283651|P2|Overall Study|Protocol Deviation|0
703509|NCT01348100|2283652|P1|Overall Study|Protocol Deviation|0
703510|NCT01348100|2283646|P7|Overall Study|Subject Withdrew Consent|1
703511|NCT01348100|2283647|P6|Overall Study|Subject Withdrew Consent|0
703512|NCT01348100|2283648|P5|Overall Study|Subject Withdrew Consent|1
703513|NCT01348100|2283649|P4|Overall Study|Subject Withdrew Consent|0
703514|NCT01348100|2283650|P3|Overall Study|Subject Withdrew Consent|2
703515|NCT01348100|2283651|P2|Overall Study|Subject Withdrew Consent|0
703516|NCT01348100|2283652|P1|Overall Study|Subject Withdrew Consent|0
703517|NCT01348087|2283697|P1|Overall Study|Adverse Event|25
703518|NCT01348087|2283697|P1|Overall Study|Subject withdrew consent|7
703519|NCT01348087|2283697|P1|Overall Study|Lost to Follow-up|1
703520|NCT01348087|2283697|P1|Overall Study|protocol deviation|1
703521|NCT01348087|2283697|P1|Overall Study|Administrative problems|79
703522|NCT01348087|2283697|P1|Overall Study|Unsatisfactory therapeutic effect|35
703523|NCT01347931|2283711|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
703524|NCT01347879|2283723|P2|Overall Study|Not known|3
703525|NCT01347879|2283724|P1|Overall Study|Not known|2
703526|NCT01347879|2283723|P2|Overall Study|Withdrawal by Subject|2
703527|NCT01347879|2283724|P1|Overall Study|Withdrawal by Subject|3
703528|NCT01347879|2283723|P2|Overall Study|Lost to Follow-up|0
703529|NCT01347879|2283724|P1|Overall Study|Lost to Follow-up|2
703530|NCT01347879|2283723|P2|Overall Study|Adverse Event|12
703531|NCT01347879|2283724|P1|Overall Study|Adverse Event|0
703532|NCT01347840|2283756|P1|Overall Study|Withdrawal by Subject|1
703533|NCT00000135|2283793|P2|Overall Study|Death|14
703534|NCT00000135|2283794|P1|Overall Study|Death|27
703535|NCT00000378|2283842|P2|Overall Study|Lack of Efficacy|14
703536|NCT00000378|2283843|P1|Overall Study|Lack of Efficacy|16
703537|NCT00000620|2283914|P8|Overall Study|missed closeout visit|16
703538|NCT00000620|2283915|P7|Overall Study|missed closeout visit|13
703539|NCT00000620|2283916|P6|Overall Study|missed closeout visit|28
703540|NCT00000620|2283917|P5|Overall Study|missed closeout visit|26
703541|NCT00000620|2283918|P4|Overall Study|missed closeout visit|11
703542|NCT00000620|2283919|P3|Overall Study|missed closeout visit|16
703543|NCT00000620|2283920|P2|Overall Study|missed closeout visit|28
703544|NCT00000620|2283921|P1|Overall Study|missed closeout visit|22
703545|NCT00000620|2283914|P8|Overall Study|Withdrawal by Subject|21
703546|NCT00000620|2283915|P7|Overall Study|Withdrawal by Subject|32
703547|NCT00000620|2283916|P6|Overall Study|Withdrawal by Subject|32
703548|NCT00000620|2283917|P5|Overall Study|Withdrawal by Subject|30
703549|NCT00000620|2283918|P4|Overall Study|Withdrawal by Subject|27
703550|NCT00000620|2283919|P3|Overall Study|Withdrawal by Subject|28
703551|NCT00000620|2283920|P2|Overall Study|Withdrawal by Subject|27
703552|NCT00000620|2283921|P1|Overall Study|Withdrawal by Subject|40
703553|NCT00000620|2283914|P8|Overall Study|Lost to Follow-up|14
703554|NCT00000620|2283915|P7|Overall Study|Lost to Follow-up|13
703555|NCT00000620|2283916|P6|Overall Study|Lost to Follow-up|15
703556|NCT00000620|2283917|P5|Overall Study|Lost to Follow-up|15
703557|NCT00000620|2283918|P4|Overall Study|Lost to Follow-up|14
703558|NCT00000620|2283919|P3|Overall Study|Lost to Follow-up|14
703559|NCT00000620|2283920|P2|Overall Study|Lost to Follow-up|14
703560|NCT00000620|2283921|P1|Overall Study|Lost to Follow-up|14
703561|NCT00000620|2283914|P8|Overall Study|Death|95
703562|NCT00000620|2283915|P7|Overall Study|Death|91
703563|NCT00000620|2283916|P6|Overall Study|Death|77
703564|NCT00000620|2283917|P5|Overall Study|Death|64
703565|NCT00000620|2283918|P4|Overall Study|Death|126
703566|NCT00000620|2283919|P3|Overall Study|Death|112
703567|NCT00000620|2283920|P2|Overall Study|Death|67
703568|NCT00000620|2283921|P1|Overall Study|Death|86
703569|NCT00001566|2283941|P1|Overall Study|unable to complete initial apheresis|1
703570|NCT00001566|2283941|P1|Overall Study|Lost to Follow-up|1
703571|NCT00001566|2283941|P1|Overall Study|Death|13
703572|NCT00001566|2283941|P1|Overall Study|stopped after C3 due to symptomatic PD|1
703573|NCT00001566|2283941|P1|Overall Study|patients' choice to discontinue protocol|3
703574|NCT00001575|2283953|P1|Overall Study|Withdrawn/deaths|23
703575|NCT00001575|2283953|P1|Overall Study|Screening failures-Ph I portion|22
889729|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889730|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889731|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889732|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889733|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
889734|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
703584|NCT00001703|2284024|P1|Overall Study|recurrent disease|2
703585|NCT00001703|2284024|P1|Overall Study|No evidence of disease|1
703586|NCT00001703|2284024|P1|Overall Study|progressed disease|2
703587|NCT00001723|2284031|P2|Overall Study|medication intolerance|2
703588|NCT00001723|2284032|P1|Overall Study|medication intolerance|1
703589|NCT00001723|2284031|P2|Overall Study|Lost to Follow-up|2
703590|NCT00001723|2284032|P1|Overall Study|Lost to Follow-up|2
703591|NCT00001723|2284031|P2|Overall Study|Lack of family interest|5
703592|NCT00001723|2284032|P1|Overall Study|Lack of family interest|4
703593|NCT00001723|2284031|P2|Overall Study|Lack of Efficacy|7
703594|NCT00001723|2284032|P1|Overall Study|Lack of Efficacy|6
703595|NCT00001941|2284048|P5|Overall Study|not treated- rapidly progressing disease|1
703596|NCT00001941|2284049|P4|Overall Study|not treated- rapidly progressing disease|0
703597|NCT00001941|2284050|P3|Overall Study|not treated- rapidly progressing disease|0
703598|NCT00001941|2284051|P2|Overall Study|not treated- rapidly progressing disease|0
703599|NCT00001941|2284052|P1|Overall Study|not treated- rapidly progressing disease|0
703600|NCT00001959|2284059|P1|Overall Study|non-compliance|1
703601|NCT00001959|2284059|P1|Overall Study|disabling sedation|1
703602|NCT00001959|2284059|P1|Overall Study|newly diagnosed colon cancer|1
703603|NCT00001962|2284065|P1|Overall Study|Adverse Event|1
703604|NCT00001962|2284065|P1|Overall Study|Lost to Follow-up|2
703605|NCT00001962|2284065|P1|Overall Study|Death|1
703606|NCT00001962|2284065|P1|Overall Study|Lack of Accrual|6
703607|NCT00001962|2284065|P1|Overall Study|Lack of Efficacy|18
703608|NCT00001262|2284082|P3|Overall Study|Withdrawal by Subject|0
703609|NCT00001262|2284083|P2|Overall Study|Withdrawal by Subject|3
703610|NCT00001262|2284084|P1|Overall Study|Withdrawal by Subject|0
703611|NCT00001262|2284082|P3|Overall Study|Death|0
703612|NCT00001262|2284083|P2|Overall Study|Death|11
703613|NCT00001262|2284084|P1|Overall Study|Death|10
703614|NCT00001213|2284131|P1|Overall Study|Death|18
703615|NCT00001832|2284150|P15|Treatment Period|Not treated|0
703616|NCT00001832|2284151|P14|Treatment Period|Not treated|0
703617|NCT00001832|2284152|P13|Treatment Period|Not treated|0
703618|NCT00001832|2284153|P12|Treatment Period|Not treated|0
703619|NCT00001832|2284154|P11|Treatment Period|Not treated|0
703620|NCT00001832|2284155|P10|Treatment Period|Not treated|0
703621|NCT00001832|2284156|P9|Treatment Period|Not treated|0
703622|NCT00001832|2284157|P8|Treatment Period|Not treated|1
703623|NCT00001832|2284158|P7|Treatment Period|Not treated|0
703624|NCT00001832|2284159|P6|Treatment Period|Not treated|0
703625|NCT00001832|2284160|P5|Treatment Period|Not treated|0
703626|NCT00001832|2284161|P4|Treatment Period|Not treated|0
703627|NCT00001832|2284162|P3|Treatment Period|Not treated|0
703628|NCT00001832|2284163|P2|Treatment Period|Not treated|0
703629|NCT00001832|2284164|P1|Treatment Period|Not treated|0
703630|NCT00001832|2284150|P15|Treatment Period|Death during treatment|0
703631|NCT00001832|2284151|P14|Treatment Period|Death during treatment|0
703632|NCT00001832|2284152|P13|Treatment Period|Death during treatment|0
703633|NCT00001832|2284153|P12|Treatment Period|Death during treatment|0
703634|NCT00001832|2284154|P11|Treatment Period|Death during treatment|0
703635|NCT00001832|2284155|P10|Treatment Period|Death during treatment|0
703636|NCT00001832|2284156|P9|Treatment Period|Death during treatment|0
703637|NCT00001832|2284157|P8|Treatment Period|Death during treatment|0
703638|NCT00001832|2284158|P7|Treatment Period|Death during treatment|0
703639|NCT00001832|2284159|P6|Treatment Period|Death during treatment|1
703640|NCT00001832|2284160|P5|Treatment Period|Death during treatment|0
703641|NCT00001832|2284161|P4|Treatment Period|Death during treatment|0
703642|NCT00001832|2284162|P3|Treatment Period|Death during treatment|0
703643|NCT00001832|2284163|P2|Treatment Period|Death during treatment|0
703644|NCT00001832|2284164|P1|Treatment Period|Death during treatment|0
703645|NCT00001832|2284150|P15|Apheresis Period|not able to manufacture treatment cells|0
703646|NCT00001832|2284151|P14|Apheresis Period|not able to manufacture treatment cells|0
703647|NCT00001832|2284152|P13|Apheresis Period|not able to manufacture treatment cells|0
703648|NCT00001832|2284153|P12|Apheresis Period|not able to manufacture treatment cells|0
703649|NCT00001832|2284154|P11|Apheresis Period|not able to manufacture treatment cells|0
703650|NCT00001832|2284155|P10|Apheresis Period|not able to manufacture treatment cells|0
703651|NCT00001832|2284156|P9|Apheresis Period|not able to manufacture treatment cells|0
703652|NCT00001832|2284157|P8|Apheresis Period|not able to manufacture treatment cells|0
703653|NCT00001832|2284158|P7|Apheresis Period|not able to manufacture treatment cells|0
703654|NCT00001832|2284159|P6|Apheresis Period|not able to manufacture treatment cells|0
703655|NCT00001832|2284160|P5|Apheresis Period|not able to manufacture treatment cells|0
703656|NCT00001832|2284161|P4|Apheresis Period|not able to manufacture treatment cells|0
703657|NCT00001832|2284162|P3|Apheresis Period|not able to manufacture treatment cells|0
703658|NCT00001832|2284163|P2|Apheresis Period|not able to manufacture treatment cells|0
703659|NCT00001832|2284164|P1|Apheresis Period|not able to manufacture treatment cells|60
703660|NCT00002525|2284210|P2|Overall Study|Never start protocol therapy|0
703661|NCT00002525|2284211|P1|Overall Study|Never start protocol therapy|8
703662|NCT00002525|2284210|P2|Overall Study|Other|0
703663|NCT00002525|2284211|P1|Overall Study|Other|26
703664|NCT00002525|2284210|P2|Overall Study|Error|0
703665|NCT00002525|2284211|P1|Overall Study|Error|6
703666|NCT00002525|2284210|P2|Overall Study|Duke's A, B1, D disease|0
703667|NCT00002525|2284211|P1|Overall Study|Duke's A, B1, D disease|92
703668|NCT00002525|2284210|P2|Overall Study|Other complicating disease|0
703669|NCT00002525|2284211|P1|Overall Study|Other complicating disease|1
703670|NCT00002525|2284210|P2|Overall Study|Start non-protocol therapy|0
703671|NCT00002525|2284211|P1|Overall Study|Start non-protocol therapy|1
703672|NCT00002525|2284210|P2|Overall Study|Withdrawal by Subject|0
703673|NCT00002525|2284211|P1|Overall Study|Withdrawal by Subject|11
703674|NCT00002525|2284210|P2|Overall Study|Death|0
703675|NCT00002525|2284211|P1|Overall Study|Death|5
703676|NCT00002525|2284210|P2|Overall Study|Adverse Event|0
703677|NCT00002525|2284211|P1|Overall Study|Adverse Event|36
703678|NCT00002540|2284227|P2|Overall Study|Refused Screen (Prostate Screening)|2433
703679|NCT00002540|2284228|P1|Overall Study|Refused Screen (Prostate Screening)|0
703680|NCT00002540|2284227|P2|Overall Study|Refused ASU (Control)|0
703681|NCT00002540|2284228|P1|Overall Study|Refused ASU (Control)|597
703682|NCT00002540|2284227|P2|Overall Study|Died Before ASU (Control)|0
703683|NCT00002540|2284228|P1|Overall Study|Died Before ASU (Control)|202
703684|NCT00002540|2284227|P2|Overall Study|Died Before Randomization|6
703685|NCT00002540|2284228|P1|Overall Study|Died Before Randomization|2
703686|NCT00002540|2284227|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
703687|NCT00002540|2284228|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
703688|NCT00002558|2284256|P2|Overall Study|Withdrawal by Subject|1
703689|NCT00002558|2284257|P1|Overall Study|Withdrawal by Subject|0
703690|NCT00002597|2284265|P2|Overall Study|Withdrawal by Subject|6
703691|NCT00002597|2284266|P1|Overall Study|Withdrawal by Subject|7
703692|NCT00002597|2284265|P2|Overall Study|Protocol Violation|17
703693|NCT00002597|2284266|P1|Overall Study|Protocol Violation|19
703694|NCT00002651|2284298|P3|Consolidation and Randomization|not eligible|112
703695|NCT00002651|2284299|P2|Consolidation and Randomization|not eligible|102
703696|NCT00002651|2284300|P1|Consolidation and Randomization|not eligible|0
703697|NCT00002651|2284298|P3|Consolidation and Randomization|not specified|313
703698|NCT00002651|2284299|P2|Consolidation and Randomization|not specified|314
703699|NCT00002651|2284300|P1|Consolidation and Randomization|not specified|0
703700|NCT00002651|2284298|P3|Consolidation and Randomization|Death|48
703701|NCT00002651|2284299|P2|Consolidation and Randomization|Death|38
703702|NCT00002651|2284300|P1|Consolidation and Randomization|Death|0
703703|NCT00002651|2284298|P3|Consolidation and Randomization|Progression/relapse|298
703704|NCT00002651|2284299|P2|Consolidation and Randomization|Progression/relapse|295
703705|NCT00002651|2284300|P1|Consolidation and Randomization|Progression/relapse|0
703706|NCT00002651|2284298|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
703707|NCT00002651|2284299|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
703708|NCT00002651|2284300|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
703709|NCT00002651|2284298|P3|Consolidation and Randomization|Adverse Event|14
703710|NCT00002651|2284299|P2|Consolidation and Randomization|Adverse Event|36
703711|NCT00002651|2284300|P1|Consolidation and Randomization|Adverse Event|0
703712|NCT00002651|2284298|P3|Induction|not eligible|0
703713|NCT00002651|2284299|P2|Induction|not eligible|0
703714|NCT00002651|2284300|P1|Induction|not eligible|90
703715|NCT00002651|2284298|P3|Induction|not specified|0
703716|NCT00002651|2284299|P2|Induction|not specified|0
703717|NCT00002651|2284300|P1|Induction|not specified|823
703718|NCT00002651|2284298|P3|Induction|Death|0
703719|NCT00002651|2284299|P2|Induction|Death|0
703720|NCT00002651|2284300|P1|Induction|Death|62
703721|NCT00002651|2284298|P3|Induction|Progression/relapse|0
703722|NCT00002651|2284299|P2|Induction|Progression/relapse|0
703723|NCT00002651|2284300|P1|Induction|Progression/relapse|274
703724|NCT00002651|2284298|P3|Induction|Refusal unrelated to adverse event|0
703725|NCT00002651|2284299|P2|Induction|Refusal unrelated to adverse event|0
703726|NCT00002651|2284300|P1|Induction|Refusal unrelated to adverse event|50
703727|NCT00002651|2284298|P3|Induction|Adverse Event|0
703728|NCT00002651|2284299|P2|Induction|Adverse Event|0
703729|NCT00002651|2284300|P1|Induction|Adverse Event|44
703730|NCT00002766|2284318|P2|Overall Study|Protocol Violation|0
703731|NCT00002766|2284319|P1|Overall Study|Protocol Violation|1
703732|NCT00002766|2284318|P2|Overall Study|Adverse Event|1
703733|NCT00002766|2284319|P1|Overall Study|Adverse Event|1
703734|NCT00002766|2284318|P2|Overall Study|Patient Not Treated|2
703735|NCT00002766|2284319|P1|Overall Study|Patient Not Treated|1
703736|NCT00002766|2284318|P2|Overall Study|Withdrawal by Subject|1
703737|NCT00002766|2284319|P1|Overall Study|Withdrawal by Subject|0
703738|NCT00002842|2284325|P1|Overall Study|ineligible for surgical resection|27
703739|NCT00002850|2284332|P3|Overall Study|Withdrawal by Subject|0
703740|NCT00002850|2284333|P2|Overall Study|Withdrawal by Subject|1
703741|NCT00002850|2284334|P1|Overall Study|Withdrawal by Subject|0
703742|NCT00002850|2284332|P3|Overall Study|Protocol Violation|1
703743|NCT00002850|2284333|P2|Overall Study|Protocol Violation|0
703744|NCT00002850|2284334|P1|Overall Study|Protocol Violation|1
703745|NCT00002850|2284332|P3|Overall Study|Death|3
703746|NCT00002850|2284333|P2|Overall Study|Death|1
703747|NCT00002850|2284334|P1|Overall Study|Death|4
703748|NCT00002874|2284344|P2|Overall Study|Protocol Violation|34
703749|NCT00002874|2284345|P1|Overall Study|Protocol Violation|44
703750|NCT00002874|2284344|P2|Overall Study|Withdrawal by Subject|1
703751|NCT00002874|2284345|P1|Overall Study|Withdrawal by Subject|1
703752|NCT00002931|2284367|P1|Overall Study|rapidly progressing disease during|2
703753|NCT00003138|2284379|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
703754|NCT00003138|2284380|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
703755|NCT00003138|2284379|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
703756|NCT00003138|2284380|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
703757|NCT00003138|2284379|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
703758|NCT00003138|2284380|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
703759|NCT00003138|2284379|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
703760|NCT00003138|2284380|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
703761|NCT00003138|2284379|P2|Step 1|Never started treatment|0
703762|NCT00003138|2284380|P1|Step 1|Never started treatment|1
703763|NCT00003138|2284379|P2|Step 1|Reasons off treatment not documented|57
703764|NCT00003138|2284380|P1|Step 1|Reasons off treatment not documented|60
703765|NCT00003199|2284393|P1|Overall Study|Screen fail|15
703766|NCT00003199|2284393|P1|Overall Study|Lack of insurance clearance|2
703767|NCT00003199|2284393|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
703768|NCT00003222|2284401|P2|Overall Study|Physician Decision|1
703769|NCT00003222|2284402|P1|Overall Study|Physician Decision|0
703770|NCT00003377|2284446|P5|Period II|Ureteral stent complications|1
703771|NCT00003377|2284447|P4|Period II|Ureteral stent complications|0
703772|NCT00003377|2284448|P3|Period II|Ureteral stent complications|0
703773|NCT00003377|2284449|P2|Period II|Ureteral stent complications|0
703774|NCT00003377|2284450|P1|Period II|Ureteral stent complications|0
703775|NCT00003377|2284446|P5|Period I|Dose Limiting Toxicity(DLT)|0
703776|NCT00003377|2284447|P4|Period I|Dose Limiting Toxicity(DLT)|1
703777|NCT00003377|2284448|P3|Period I|Dose Limiting Toxicity(DLT)|1
703778|NCT00003377|2284449|P2|Period I|Dose Limiting Toxicity(DLT)|0
703779|NCT00003377|2284450|P1|Period I|Dose Limiting Toxicity(DLT)|0
703796|NCT00003457|2284477|P1|Overall Study|Not evaluable|9
703797|NCT00003458|2284482|P1|Overall Study|Not evaluable|4
703798|NCT00003470|2284507|P1|Overall Study|Not evaluable|6
703799|NCT00003473|2284512|P1|Overall Study|Three patients were not evaluable.|3
703800|NCT00003475|2284517|P1|Overall Study|Not evaluable|13
703801|NCT00003476|2284522|P1|Overall Study|Not evaluable|1
703802|NCT00003477|2284527|P1|Overall Study|Not evalauable|4
703803|NCT00003479|2284532|P1|Overall Study|Not evaluable|3
703804|NCT00003483|2284537|P1|Overall Study|Not evaluable|1
703805|NCT00003537|2284542|P1|Overall Study|Not evalauable|1
703806|NCT00003590|2284547|P1|Overall Study|Physician Decision|1
703807|NCT00003590|2284547|P1|Overall Study|Death|1
703808|NCT00003590|2284547|P1|Overall Study|Lack of Efficacy|11
703809|NCT00003590|2284547|P1|Overall Study|Withdrawal by Subject|1
703810|NCT00003590|2284547|P1|Overall Study|Adverse Event|7
703811|NCT00003590|2284547|P1|Overall Study|Ineligible Patient|1
889735|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
703813|NCT00003782|2284565|P3|Overall Study|No follow up data|26
703814|NCT00003782|2284566|P2|Overall Study|No follow up data|31
703815|NCT00003782|2284567|P1|Overall Study|No follow up data|30
703816|NCT00003298|2284582|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
703817|NCT00003298|2284582|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
703818|NCT00003298|2284582|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
703819|NCT00003298|2284582|P1|Step 2 (Adjuvant Therapy)|Death|1
703820|NCT00003298|2284582|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
703821|NCT00003298|2284582|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
703822|NCT00003298|2284582|P1|Re-register to Step 2 After Surgery|Reason unknown|1
703823|NCT00003298|2284582|P1|Re-register to Step 2 After Surgery|Other complications|2
703824|NCT00003298|2284582|P1|Re-register to Step 2 After Surgery|Positive margins|5
703825|NCT00003298|2284582|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
703826|NCT00003298|2284582|P1|Surgery|Unevaluable and off study|2
703827|NCT00003298|2284582|P1|Surgery|Progression before surgery|2
703828|NCT00003298|2284582|P1|Surgery|Unresectable at surgery|3
703829|NCT00003298|2284582|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
703830|NCT00003298|2284582|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
703831|NCT00003869|2284592|P2|Overall Study|Alternative treatmnt, medical problems|4
703832|NCT00003869|2284593|P1|Overall Study|Alternative treatmnt, medical problems|5
703833|NCT00003869|2284592|P2|Overall Study|Death|2
703834|NCT00003869|2284593|P1|Overall Study|Death|1
703835|NCT00003869|2284592|P2|Overall Study|Withdrawal by Subject|3
703836|NCT00003869|2284593|P1|Overall Study|Withdrawal by Subject|21
703837|NCT00003869|2284592|P2|Overall Study|Adverse Event|3
703838|NCT00003869|2284593|P1|Overall Study|Adverse Event|14
703839|NCT00003875|2284609|P1|Overall Study|Screen Failed|1
703840|NCT00003895|2284618|P2|Overall Study|Withdrawal by Subject|3
703841|NCT00003895|2284619|P1|Overall Study|Withdrawal by Subject|0
703842|NCT00003895|2284618|P2|Overall Study|Patient Vacation|0
703843|NCT00003895|2284619|P1|Overall Study|Patient Vacation|2
703844|NCT00003895|2284618|P2|Overall Study|Lack of Efficacy|1
703845|NCT00003895|2284619|P1|Overall Study|Lack of Efficacy|1
703846|NCT00003895|2284618|P2|Overall Study|Adverse Event|0
703847|NCT00003895|2284619|P1|Overall Study|Adverse Event|4
703848|NCT00003896|2284625|P1|Overall Study|ineligible|5
703849|NCT00003896|2284625|P1|Overall Study|not protocol specified|3
703850|NCT00003896|2284625|P1|Overall Study|Death|3
703851|NCT00003896|2284625|P1|Overall Study|Lack of Efficacy|1
703852|NCT00003896|2284625|P1|Overall Study|Withdrawal by Subject|1
703853|NCT00003896|2284625|P1|Overall Study|Adverse Event|16
703854|NCT00004228|2284654|P7|Overall Study|ineligible|5
703855|NCT00004228|2284655|P6|Overall Study|ineligible|2
703856|NCT00004228|2284656|P5|Overall Study|ineligible|1
703857|NCT00004228|2284657|P4|Overall Study|ineligible|1
703858|NCT00004228|2284658|P3|Overall Study|ineligible|4
703859|NCT00004228|2284659|P2|Overall Study|ineligible|2
703860|NCT00004228|2284660|P1|Overall Study|ineligible|4
703861|NCT00004228|2284654|P7|Overall Study|Other|0
703862|NCT00004228|2284655|P6|Overall Study|Other|0
703863|NCT00004228|2284656|P5|Overall Study|Other|0
703864|NCT00004228|2284657|P4|Overall Study|Other|0
703865|NCT00004228|2284658|P3|Overall Study|Other|1
703866|NCT00004228|2284659|P2|Overall Study|Other|0
703867|NCT00004228|2284660|P1|Overall Study|Other|0
703868|NCT00004228|2284654|P7|Overall Study|Withdrawal by Subject|2
703869|NCT00004228|2284655|P6|Overall Study|Withdrawal by Subject|1
703870|NCT00004228|2284656|P5|Overall Study|Withdrawal by Subject|2
703871|NCT00004228|2284657|P4|Overall Study|Withdrawal by Subject|0
703872|NCT00004228|2284658|P3|Overall Study|Withdrawal by Subject|1
703873|NCT00004228|2284659|P2|Overall Study|Withdrawal by Subject|0
703874|NCT00004228|2284660|P1|Overall Study|Withdrawal by Subject|3
703875|NCT00004228|2284654|P7|Overall Study|Protocol Violation|0
703876|NCT00004228|2284655|P6|Overall Study|Protocol Violation|2
703877|NCT00004228|2284656|P5|Overall Study|Protocol Violation|1
703878|NCT00004228|2284657|P4|Overall Study|Protocol Violation|1
703879|NCT00004228|2284658|P3|Overall Study|Protocol Violation|2
703880|NCT00004228|2284659|P2|Overall Study|Protocol Violation|5
703881|NCT00004228|2284660|P1|Overall Study|Protocol Violation|0
703882|NCT00004228|2284654|P7|Overall Study|Physician Decision|1
703883|NCT00004228|2284655|P6|Overall Study|Physician Decision|1
703884|NCT00004228|2284656|P5|Overall Study|Physician Decision|1
703885|NCT00004228|2284657|P4|Overall Study|Physician Decision|2
703886|NCT00004228|2284658|P3|Overall Study|Physician Decision|3
703887|NCT00004228|2284659|P2|Overall Study|Physician Decision|0
703888|NCT00004228|2284660|P1|Overall Study|Physician Decision|1
703889|NCT00004228|2284654|P7|Overall Study|Lost to Follow-up|0
703890|NCT00004228|2284655|P6|Overall Study|Lost to Follow-up|0
703891|NCT00004228|2284656|P5|Overall Study|Lost to Follow-up|0
703892|NCT00004228|2284657|P4|Overall Study|Lost to Follow-up|0
703893|NCT00004228|2284658|P3|Overall Study|Lost to Follow-up|1
703894|NCT00004228|2284659|P2|Overall Study|Lost to Follow-up|0
703895|NCT00004228|2284660|P1|Overall Study|Lost to Follow-up|0
703896|NCT00004228|2284654|P7|Overall Study|Lack of Efficacy|4
703897|NCT00004228|2284655|P6|Overall Study|Lack of Efficacy|8
703898|NCT00004228|2284656|P5|Overall Study|Lack of Efficacy|9
703899|NCT00004228|2284657|P4|Overall Study|Lack of Efficacy|3
703900|NCT00004228|2284658|P3|Overall Study|Lack of Efficacy|5
703901|NCT00004228|2284659|P2|Overall Study|Lack of Efficacy|6
703902|NCT00004228|2284660|P1|Overall Study|Lack of Efficacy|1
703903|NCT00004228|2284654|P7|Overall Study|Death|0
703904|NCT00004228|2284655|P6|Overall Study|Death|0
703905|NCT00004228|2284656|P5|Overall Study|Death|1
703906|NCT00004228|2284657|P4|Overall Study|Death|0
703907|NCT00004228|2284658|P3|Overall Study|Death|2
703908|NCT00004228|2284659|P2|Overall Study|Death|1
703909|NCT00004228|2284660|P1|Overall Study|Death|0
703910|NCT00004228|2284654|P7|Overall Study|Adverse Event|0
703911|NCT00004228|2284655|P6|Overall Study|Adverse Event|0
703912|NCT00004228|2284656|P5|Overall Study|Adverse Event|1
703913|NCT00004228|2284657|P4|Overall Study|Adverse Event|0
703914|NCT00004228|2284658|P3|Overall Study|Adverse Event|0
703915|NCT00004228|2284659|P2|Overall Study|Adverse Event|1
703916|NCT00004228|2284660|P1|Overall Study|Adverse Event|0
703917|NCT00003631|2284686|P3|Overall Study|Evaluable for toxicity only|2
703918|NCT00003631|2284687|P2|Overall Study|Evaluable for toxicity only|0
703919|NCT00003631|2284688|P1|Overall Study|Evaluable for toxicity only|0
703920|NCT00003631|2284686|P3|Overall Study|Death|1
703921|NCT00003631|2284687|P2|Overall Study|Death|0
703922|NCT00003631|2284688|P1|Overall Study|Death|0
703923|NCT00003631|2284686|P3|Overall Study|Adverse Event|5
703924|NCT00003631|2284687|P2|Overall Study|Adverse Event|1
703925|NCT00003631|2284688|P1|Overall Study|Adverse Event|1
703926|NCT00003631|2284686|P3|Overall Study|Protocol Violation|0
703927|NCT00003631|2284687|P2|Overall Study|Protocol Violation|0
703928|NCT00003631|2284688|P1|Overall Study|Protocol Violation|1
703929|NCT00003631|2284686|P3|Overall Study|Patient not treated|1
703930|NCT00003631|2284687|P2|Overall Study|Patient not treated|0
703931|NCT00003631|2284688|P1|Overall Study|Patient not treated|1
703932|NCT00003641|2284698|P2|Overall Study|Never started interferon|12
703933|NCT00003641|2284699|P1|Overall Study|Never started interferon|567
703934|NCT00003641|2284698|P2|Overall Study|Should not receive interferon therapy|0
703935|NCT00003641|2284699|P1|Overall Study|Should not receive interferon therapy|2
703936|NCT00003641|2284698|P2|Overall Study|Unknown/missing|22
703937|NCT00003641|2284699|P1|Overall Study|Unknown/missing|0
703938|NCT00003641|2284698|P2|Overall Study|Disease progression|2
703939|NCT00003641|2284699|P1|Overall Study|Disease progression|0
703940|NCT00003641|2284698|P2|Overall Study|Adverse Event|38
703941|NCT00003641|2284699|P1|Overall Study|Adverse Event|0
703942|NCT00003641|2284698|P2|Overall Study|Withdrawal by Subject|100
703943|NCT00003641|2284699|P1|Overall Study|Withdrawal by Subject|0
703944|NCT00004412|2284710|P3|Randomized Period|Moved to Crossover Period|0
703945|NCT00004412|2284711|P2|Randomized Period|Moved to Crossover Period|0
703946|NCT00004412|2284712|P1|Randomized Period|Moved to Crossover Period|3
703947|NCT00004859|2284722|P2|Overall Study|Not specified|21
703948|NCT00004859|2284723|P1|Overall Study|Not specified|13
703949|NCT00004859|2284722|P2|Overall Study|missing data|11
703950|NCT00004859|2284723|P1|Overall Study|missing data|14
703951|NCT00004859|2284722|P2|Overall Study|error|1
703952|NCT00004859|2284723|P1|Overall Study|error|3
703953|NCT00004859|2284722|P2|Overall Study|other disease|3
703954|NCT00004859|2284723|P1|Overall Study|other disease|0
703955|NCT00004859|2284722|P2|Overall Study|Protocol Violation|2
703956|NCT00004859|2284723|P1|Overall Study|Protocol Violation|2
703957|NCT00004859|2284722|P2|Overall Study|Withdrawal by Subject|33
703958|NCT00004859|2284723|P1|Overall Study|Withdrawal by Subject|7
703959|NCT00004859|2284722|P2|Overall Study|Death|5
703960|NCT00004859|2284723|P1|Overall Study|Death|5
703961|NCT00004859|2284722|P2|Overall Study|Adverse Event|93
703962|NCT00004859|2284723|P1|Overall Study|Adverse Event|31
703963|NCT00004859|2284722|P2|Overall Study|Lack of Efficacy|113
703964|NCT00004859|2284723|P1|Overall Study|Lack of Efficacy|43
703965|NCT00004888|2284735|P2|Overall Study|Toxic death|0
703966|NCT00004888|2284736|P1|Overall Study|Toxic death|1
703967|NCT00004888|2284735|P2|Overall Study|Death without progressive disease|1
703968|NCT00004888|2284736|P1|Overall Study|Death without progressive disease|0
703969|NCT00004888|2284735|P2|Overall Study|Progressive Disease|9
703970|NCT00004888|2284736|P1|Overall Study|Progressive Disease|4
703971|NCT00004888|2284735|P2|Overall Study|Physician Decision|1
703972|NCT00004888|2284736|P1|Overall Study|Physician Decision|1
703973|NCT00004888|2284735|P2|Overall Study|Withdrawal by Subject|3
703974|NCT00004888|2284736|P1|Overall Study|Withdrawal by Subject|0
703975|NCT00004888|2284735|P2|Overall Study|Adverse Event|10
703976|NCT00004888|2284736|P1|Overall Study|Adverse Event|5
703977|NCT00004978|2284754|P2|Overall Study|site closure - not in analysis cohort|20
703978|NCT00004978|2284755|P1|Overall Study|site closure - not in analysis cohort|19
703979|NCT00004978|2284754|P2|Overall Study|Withdrawal by Subject|26
703980|NCT00004978|2284755|P1|Overall Study|Withdrawal by Subject|17
703981|NCT00004978|2284754|P2|Overall Study|Lost to Follow-up|108
703982|NCT00004978|2284755|P1|Overall Study|Lost to Follow-up|101
703983|NCT00004978|2284754|P2|Overall Study|Death|116
703984|NCT00004978|2284755|P1|Overall Study|Death|107
703985|NCT00004980|2284781|P2|Overall Study|Physician Decision|1
703986|NCT00004980|2284782|P1|Overall Study|Physician Decision|0
703987|NCT00004980|2284781|P2|Overall Study|memory difficulties|1
703988|NCT00004980|2284782|P1|Overall Study|memory difficulties|1
703989|NCT00004980|2284781|P2|Overall Study|Withdrawal by Subject|0
703990|NCT00004980|2284782|P1|Overall Study|Withdrawal by Subject|1
703991|NCT00003901|2284794|P1|Overall Study|Medical problems|6
703992|NCT00003901|2284794|P1|Overall Study|Chest X-Ray not done prior registration|1
703993|NCT00003901|2284794|P1|Overall Study|CT Scan not within protocol requirement|2
703994|NCT00003901|2284794|P1|Overall Study|Ineligible|6
703995|NCT00003901|2284794|P1|Overall Study|Withdrawal by Subject|1
703996|NCT00003901|2284794|P1|Overall Study|Adverse Event|1
703997|NCT00003907|2284807|P2|Overall Study|ineligible or not treated|2
703998|NCT00003907|2284808|P1|Overall Study|ineligible or not treated|2
703999|NCT00003907|2284807|P2|Overall Study|Not specified|3
704000|NCT00003907|2284808|P1|Overall Study|Not specified|1
704001|NCT00003907|2284807|P2|Overall Study|Complicating disease|0
704002|NCT00003907|2284808|P1|Overall Study|Complicating disease|1
704003|NCT00003907|2284807|P2|Overall Study|Progressive disease|4
704004|NCT00003907|2284808|P1|Overall Study|Progressive disease|4
704005|NCT00003907|2284807|P2|Overall Study|Withdrawal by Subject|3
704006|NCT00003907|2284808|P1|Overall Study|Withdrawal by Subject|1
704007|NCT00003907|2284807|P2|Overall Study|Death|0
704008|NCT00003907|2284808|P1|Overall Study|Death|2
704009|NCT00003907|2284807|P2|Overall Study|Adverse Event|11
704010|NCT00003907|2284808|P1|Overall Study|Adverse Event|2
704011|NCT00004562|2284882|P2|Overall Study|Lost to Follow-up|91
704012|NCT00004562|2284883|P1|Overall Study|Lost to Follow-up|102
704013|NCT00004563|2284893|P2|Overall Study|Death|3
704014|NCT00004563|2284894|P1|Overall Study|Death|2
704015|NCT00004563|2284893|P2|Overall Study|Lack of Efficacy|5
704016|NCT00004563|2284894|P1|Overall Study|Lack of Efficacy|3
704017|NCT00004563|2284893|P2|Overall Study|Withdrawal by Subject|16
704018|NCT00004563|2284894|P1|Overall Study|Withdrawal by Subject|20
704019|NCT00004635|2284906|P2|Period Two|discrepancy in data entry|1
704020|NCT00004635|2284907|P1|Period Two|discrepancy in data entry|0
704021|NCT00004635|2284906|P2|Period Two|Lost to Follow-up|0
704022|NCT00004635|2284907|P1|Period Two|Lost to Follow-up|1
704023|NCT00004635|2284906|P2|Period Two|secondary malignancy|1
704024|NCT00004635|2284907|P1|Period Two|secondary malignancy|1
704025|NCT00004635|2284906|P2|Period Two|travel issues|1
704026|NCT00004635|2284907|P1|Period Two|travel issues|0
704027|NCT00004635|2284906|P2|Period Two|health problem|1
704028|NCT00004635|2284907|P1|Period Two|health problem|1
704029|NCT00004635|2284906|P2|Period Two|refused|2
704030|NCT00004635|2284907|P1|Period Two|refused|0
704031|NCT00004635|2284906|P2|Period Two|Adverse Event|0
704032|NCT00004635|2284907|P1|Period Two|Adverse Event|1
704033|NCT00004635|2284906|P2|Period Two|progression|3
704034|NCT00004635|2284907|P1|Period Two|progression|2
704035|NCT00004635|2284906|P2|Period One|discrepancy in data entry|1
704036|NCT00004635|2284907|P1|Period One|discrepancy in data entry|0
704037|NCT00004635|2284906|P2|Period One|health problem|1
704038|NCT00004635|2284907|P1|Period One|health problem|0
704039|NCT00004635|2284906|P2|Period One|progressed|2
704040|NCT00004635|2284907|P1|Period One|progressed|0
704041|NCT00004635|2284906|P2|Period One|second malignancy|0
704042|NCT00004635|2284907|P1|Period One|second malignancy|1
704043|NCT00004635|2284906|P2|Period One|PSA did not go <5 ng/mL|0
704044|NCT00004635|2284907|P1|Period One|PSA did not go <5 ng/mL|1
704045|NCT00004635|2284906|P2|Period One|Protocol Violation|0
704046|NCT00004635|2284907|P1|Period One|Protocol Violation|1
704047|NCT00004635|2284906|P2|Period One|Withdrawal by Subject|1
704048|NCT00004635|2284907|P1|Period One|Withdrawal by Subject|1
704049|NCT00004635|2284906|P2|Period One|refused|1
704050|NCT00004635|2284907|P1|Period One|refused|2
704051|NCT00004732|2284919|P2|Overall Study|Lost to Follow-up|47
704052|NCT00004732|2284920|P1|Overall Study|Lost to Follow-up|33
704053|NCT00004732|2284919|P2|Overall Study|Withdrawal by Subject|64
704054|NCT00004732|2284920|P1|Overall Study|Withdrawal by Subject|36
704055|NCT00005047|2284932|P4|Overall Study|Lack of Efficacy|0
704056|NCT00005047|2284933|P3|Overall Study|Lack of Efficacy|0
704057|NCT00005047|2284934|P2|Overall Study|Lack of Efficacy|0
704058|NCT00005047|2284935|P1|Overall Study|Lack of Efficacy|1
704059|NCT00005047|2284932|P4|Overall Study|Lost to Follow-up|0
704060|NCT00005047|2284933|P3|Overall Study|Lost to Follow-up|0
704061|NCT00005047|2284934|P2|Overall Study|Lost to Follow-up|0
704062|NCT00005047|2284935|P1|Overall Study|Lost to Follow-up|1
704063|NCT00005047|2284932|P4|Overall Study|Adverse Event|0
704064|NCT00005047|2284933|P3|Overall Study|Adverse Event|0
704065|NCT00005047|2284934|P2|Overall Study|Adverse Event|0
704066|NCT00005047|2284935|P1|Overall Study|Adverse Event|5
704067|NCT00005047|2284932|P4|Overall Study|Withdrawal by Subject|0
704068|NCT00005047|2284933|P3|Overall Study|Withdrawal by Subject|0
704069|NCT00005047|2284934|P2|Overall Study|Withdrawal by Subject|0
704070|NCT00005047|2284935|P1|Overall Study|Withdrawal by Subject|12
704071|NCT00005879|2284951|P2|Overall Study|Withdrawal by Subject|10
704072|NCT00005879|2284952|P1|Overall Study|Withdrawal by Subject|8
704073|NCT00005906|2284979|P1|Overall Study|Lack of Efficacy|3
704074|NCT00005908|2284985|P2|Overall Study|Withdrawal by Subject|0
704075|NCT00005908|2284986|P1|Overall Study|Withdrawal by Subject|1
704076|NCT00005937|2284995|P1|Overall Study|Lack of Efficacy|5
704077|NCT00005947|2285001|P2|Overall Study|Site Closure|0
704078|NCT00005947|2285002|P1|Overall Study|Site Closure|1
704079|NCT00005947|2285001|P2|Overall Study|Patient Refused to Continue|1
704080|NCT00005947|2285002|P1|Overall Study|Patient Refused to Continue|2
704081|NCT00005947|2285001|P2|Overall Study|Death|40
704082|NCT00005947|2285002|P1|Overall Study|Death|54
704083|NCT00005957|2285012|P2|Overall Study|Crossover to the other arm|19
704084|NCT00005957|2285013|P1|Overall Study|Crossover to the other arm|5
704085|NCT00005957|2285012|P2|Overall Study|No treated|9
704086|NCT00005957|2285013|P1|Overall Study|No treated|3
704087|NCT00006011|2285024|P3|Overall Study|Ineligible|9
704088|NCT00006011|2285025|P2|Overall Study|Ineligible|16
704089|NCT00006011|2285026|P1|Overall Study|Ineligible|18
704090|NCT00006011|2285024|P3|Overall Study|Not specified|5
704091|NCT00006011|2285025|P2|Overall Study|Not specified|2
704092|NCT00006011|2285026|P1|Overall Study|Not specified|4
704093|NCT00006011|2285024|P3|Overall Study|Death|2
704094|NCT00006011|2285025|P2|Overall Study|Death|1
704095|NCT00006011|2285026|P1|Overall Study|Death|0
704096|NCT00006011|2285024|P3|Overall Study|Adverse Event|5
704097|NCT00006011|2285025|P2|Overall Study|Adverse Event|39
704098|NCT00006011|2285026|P1|Overall Study|Adverse Event|15
704099|NCT00006011|2285024|P3|Overall Study|Refused further treatment|26
704100|NCT00006011|2285025|P2|Overall Study|Refused further treatment|13
704101|NCT00006011|2285026|P1|Overall Study|Refused further treatment|15
704102|NCT00006011|2285024|P3|Overall Study|Disease progression|26
704103|NCT00006011|2285025|P2|Overall Study|Disease progression|6
704104|NCT00006011|2285026|P1|Overall Study|Disease progression|13
704105|NCT00006409|2285038|P6|Post-3 Year Intervention|Protocol Violation|62
704106|NCT00006409|2285039|P5|Post-3 Year Intervention|Protocol Violation|62
704107|NCT00006409|2285040|P4|Post-3 Year Intervention|Protocol Violation|0
704108|NCT00006409|2285041|P3|Post-3 Year Intervention|Protocol Violation|0
704109|NCT00006409|2285042|P2|Post-3 Year Intervention|Protocol Violation|0
704110|NCT00006409|2285043|P1|Post-3 Year Intervention|Protocol Violation|0
704111|NCT00006409|2285038|P6|Post-2 Year Intervention|Protocol Violation|0
704112|NCT00006409|2285039|P5|Post-2 Year Intervention|Protocol Violation|0
704113|NCT00006409|2285040|P4|Post-2 Year Intervention|Protocol Violation|168
704114|NCT00006409|2285041|P3|Post-2 Year Intervention|Protocol Violation|251
704115|NCT00006409|2285042|P2|Post-2 Year Intervention|Protocol Violation|0
704116|NCT00006409|2285043|P1|Post-2 Year Intervention|Protocol Violation|0
704117|NCT00006409|2285038|P6|Baseline|Protocol Violation|0
704118|NCT00006409|2285039|P5|Baseline|Protocol Violation|0
704119|NCT00006409|2285040|P4|Baseline|Protocol Violation|0
704120|NCT00006409|2285041|P3|Baseline|Protocol Violation|0
704121|NCT00006409|2285042|P2|Baseline|Protocol Violation|70
704122|NCT00006409|2285043|P1|Baseline|Protocol Violation|48
704123|NCT00006478|2285063|P1|Overall Study|Physician Decision|6
704124|NCT00006478|2285063|P1|Overall Study|Vaccine could not be produced|1
704125|NCT00006489|2285071|P4|Overall Study|Death|1
704126|NCT00006489|2285072|P3|Overall Study|Death|0
704127|NCT00006489|2285073|P2|Overall Study|Death|0
704128|NCT00006489|2285074|P1|Overall Study|Death|0
704129|NCT00006489|2285071|P4|Overall Study|Scheduling Conflict|1
704130|NCT00006489|2285072|P3|Overall Study|Scheduling Conflict|2
704131|NCT00006489|2285073|P2|Overall Study|Scheduling Conflict|3
704132|NCT00006489|2285074|P1|Overall Study|Scheduling Conflict|0
704133|NCT00006489|2285071|P4|Overall Study|Withdrawal by Subject|6
704134|NCT00006489|2285072|P3|Overall Study|Withdrawal by Subject|9
704135|NCT00006489|2285073|P2|Overall Study|Withdrawal by Subject|9
704136|NCT00006489|2285074|P1|Overall Study|Withdrawal by Subject|10
704137|NCT00006489|2285071|P4|Overall Study|Adverse Event|3
704138|NCT00006489|2285072|P3|Overall Study|Adverse Event|4
704139|NCT00006489|2285073|P2|Overall Study|Adverse Event|2
704140|NCT00006489|2285074|P1|Overall Study|Adverse Event|3
704141|NCT00006604|2285099|P17|Overall Study|Other Reason|0
704142|NCT00006604|2285100|P16|Overall Study|Other Reason|0
704143|NCT00006604|2285101|P15|Overall Study|Other Reason|0
704144|NCT00006604|2285102|P14|Overall Study|Other Reason|0
704145|NCT00006604|2285103|P13|Overall Study|Other Reason|0
704146|NCT00006604|2285104|P12|Overall Study|Other Reason|0
704147|NCT00006604|2285105|P11|Overall Study|Other Reason|0
704148|NCT00006604|2285106|P10|Overall Study|Other Reason|1
704149|NCT00006604|2285107|P9|Overall Study|Other Reason|0
704150|NCT00006604|2285108|P8|Overall Study|Other Reason|0
704151|NCT00006604|2285109|P7|Overall Study|Other Reason|0
704152|NCT00006604|2285110|P6|Overall Study|Other Reason|1
704153|NCT00006604|2285111|P5|Overall Study|Other Reason|0
704154|NCT00006604|2285112|P4|Overall Study|Other Reason|0
704155|NCT00006604|2285113|P3|Overall Study|Other Reason|0
704156|NCT00006604|2285114|P2|Overall Study|Other Reason|0
704157|NCT00006604|2285115|P1|Overall Study|Other Reason|0
704158|NCT00006604|2285099|P17|Overall Study|Lost to Follow-up|3
704159|NCT00006604|2285100|P16|Overall Study|Lost to Follow-up|1
704160|NCT00006604|2285101|P15|Overall Study|Lost to Follow-up|0
704161|NCT00006604|2285102|P14|Overall Study|Lost to Follow-up|0
704162|NCT00006604|2285103|P13|Overall Study|Lost to Follow-up|0
704163|NCT00006604|2285104|P12|Overall Study|Lost to Follow-up|0
704164|NCT00006604|2285105|P11|Overall Study|Lost to Follow-up|0
704165|NCT00006604|2285106|P10|Overall Study|Lost to Follow-up|2
704166|NCT00006604|2285107|P9|Overall Study|Lost to Follow-up|0
704167|NCT00006604|2285108|P8|Overall Study|Lost to Follow-up|1
704168|NCT00006604|2285109|P7|Overall Study|Lost to Follow-up|0
704169|NCT00006604|2285110|P6|Overall Study|Lost to Follow-up|0
704170|NCT00006604|2285111|P5|Overall Study|Lost to Follow-up|0
704171|NCT00006604|2285112|P4|Overall Study|Lost to Follow-up|0
704172|NCT00006604|2285113|P3|Overall Study|Lost to Follow-up|0
704173|NCT00006604|2285114|P2|Overall Study|Lost to Follow-up|0
704174|NCT00006604|2285115|P1|Overall Study|Lost to Follow-up|0
704175|NCT00006604|2285099|P17|Overall Study|Subj/parent not willing to adhere to req|4
704176|NCT00006604|2285100|P16|Overall Study|Subj/parent not willing to adhere to req|3
704177|NCT00006604|2285101|P15|Overall Study|Subj/parent not willing to adhere to req|3
704178|NCT00006604|2285102|P14|Overall Study|Subj/parent not willing to adhere to req|2
704179|NCT00006604|2285103|P13|Overall Study|Subj/parent not willing to adhere to req|0
704180|NCT00006604|2285104|P12|Overall Study|Subj/parent not willing to adhere to req|0
704181|NCT00006604|2285105|P11|Overall Study|Subj/parent not willing to adhere to req|3
704182|NCT00006604|2285106|P10|Overall Study|Subj/parent not willing to adhere to req|6
704183|NCT00006604|2285107|P9|Overall Study|Subj/parent not willing to adhere to req|0
704184|NCT00006604|2285108|P8|Overall Study|Subj/parent not willing to adhere to req|1
704185|NCT00006604|2285109|P7|Overall Study|Subj/parent not willing to adhere to req|3
704186|NCT00006604|2285110|P6|Overall Study|Subj/parent not willing to adhere to req|0
704187|NCT00006604|2285111|P5|Overall Study|Subj/parent not willing to adhere to req|0
704188|NCT00006604|2285112|P4|Overall Study|Subj/parent not willing to adhere to req|3
704189|NCT00006604|2285113|P3|Overall Study|Subj/parent not willing to adhere to req|1
704190|NCT00006604|2285114|P2|Overall Study|Subj/parent not willing to adhere to req|0
704191|NCT00006604|2285115|P1|Overall Study|Subj/parent not willing to adhere to req|0
704192|NCT00006604|2285099|P17|Overall Study|Withdrawal by Subject|1
704193|NCT00006604|2285100|P16|Overall Study|Withdrawal by Subject|0
704194|NCT00006604|2285101|P15|Overall Study|Withdrawal by Subject|1
704195|NCT00006604|2285102|P14|Overall Study|Withdrawal by Subject|2
704196|NCT00006604|2285103|P13|Overall Study|Withdrawal by Subject|1
704197|NCT00006604|2285104|P12|Overall Study|Withdrawal by Subject|0
704198|NCT00006604|2285105|P11|Overall Study|Withdrawal by Subject|2
704199|NCT00006604|2285106|P10|Overall Study|Withdrawal by Subject|3
704200|NCT00006604|2285107|P9|Overall Study|Withdrawal by Subject|1
704201|NCT00006604|2285108|P8|Overall Study|Withdrawal by Subject|0
704202|NCT00006604|2285109|P7|Overall Study|Withdrawal by Subject|2
704203|NCT00006604|2285110|P6|Overall Study|Withdrawal by Subject|2
704204|NCT00006604|2285111|P5|Overall Study|Withdrawal by Subject|1
704205|NCT00006604|2285112|P4|Overall Study|Withdrawal by Subject|0
704206|NCT00006604|2285113|P3|Overall Study|Withdrawal by Subject|2
704207|NCT00006604|2285114|P2|Overall Study|Withdrawal by Subject|0
704208|NCT00006604|2285115|P1|Overall Study|Withdrawal by Subject|1
704209|NCT00006604|2285099|P17|Overall Study|Site closing|1
704210|NCT00006604|2285100|P16|Overall Study|Site closing|0
704211|NCT00006604|2285101|P15|Overall Study|Site closing|0
704212|NCT00006604|2285102|P14|Overall Study|Site closing|1
704213|NCT00006604|2285103|P13|Overall Study|Site closing|1
704214|NCT00006604|2285104|P12|Overall Study|Site closing|1
704215|NCT00006604|2285105|P11|Overall Study|Site closing|0
704216|NCT00006604|2285106|P10|Overall Study|Site closing|0
704217|NCT00006604|2285107|P9|Overall Study|Site closing|0
704218|NCT00006604|2285108|P8|Overall Study|Site closing|1
704219|NCT00006604|2285109|P7|Overall Study|Site closing|0
704220|NCT00006604|2285110|P6|Overall Study|Site closing|0
704221|NCT00006604|2285111|P5|Overall Study|Site closing|0
704222|NCT00006604|2285112|P4|Overall Study|Site closing|1
704223|NCT00006604|2285113|P3|Overall Study|Site closing|1
704224|NCT00006604|2285114|P2|Overall Study|Site closing|0
704225|NCT00006604|2285115|P1|Overall Study|Site closing|0
704226|NCT00006604|2285099|P17|Overall Study|Subj/Parent not able to get to clinic|0
704227|NCT00006604|2285100|P16|Overall Study|Subj/Parent not able to get to clinic|0
704228|NCT00006604|2285101|P15|Overall Study|Subj/Parent not able to get to clinic|3
704229|NCT00006604|2285102|P14|Overall Study|Subj/Parent not able to get to clinic|1
704230|NCT00006604|2285103|P13|Overall Study|Subj/Parent not able to get to clinic|1
704231|NCT00006604|2285104|P12|Overall Study|Subj/Parent not able to get to clinic|1
704232|NCT00006604|2285105|P11|Overall Study|Subj/Parent not able to get to clinic|2
704233|NCT00006604|2285106|P10|Overall Study|Subj/Parent not able to get to clinic|1
704234|NCT00006604|2285107|P9|Overall Study|Subj/Parent not able to get to clinic|0
704235|NCT00006604|2285108|P8|Overall Study|Subj/Parent not able to get to clinic|0
704236|NCT00006604|2285109|P7|Overall Study|Subj/Parent not able to get to clinic|1
704237|NCT00006604|2285110|P6|Overall Study|Subj/Parent not able to get to clinic|0
704238|NCT00006604|2285111|P5|Overall Study|Subj/Parent not able to get to clinic|1
704239|NCT00006604|2285112|P4|Overall Study|Subj/Parent not able to get to clinic|1
704240|NCT00006604|2285113|P3|Overall Study|Subj/Parent not able to get to clinic|0
704241|NCT00006604|2285114|P2|Overall Study|Subj/Parent not able to get to clinic|0
704242|NCT00006604|2285115|P1|Overall Study|Subj/Parent not able to get to clinic|0
704243|NCT00006604|2285099|P17|Overall Study|Severe debilitation, unable to continue|0
704244|NCT00006604|2285100|P16|Overall Study|Severe debilitation, unable to continue|0
704245|NCT00006604|2285101|P15|Overall Study|Severe debilitation, unable to continue|2
704246|NCT00006604|2285102|P14|Overall Study|Severe debilitation, unable to continue|0
704247|NCT00006604|2285103|P13|Overall Study|Severe debilitation, unable to continue|1
704248|NCT00006604|2285104|P12|Overall Study|Severe debilitation, unable to continue|2
704249|NCT00006604|2285105|P11|Overall Study|Severe debilitation, unable to continue|0
704250|NCT00006604|2285106|P10|Overall Study|Severe debilitation, unable to continue|5
704251|NCT00006604|2285107|P9|Overall Study|Severe debilitation, unable to continue|0
704252|NCT00006604|2285108|P8|Overall Study|Severe debilitation, unable to continue|0
704253|NCT00006604|2285109|P7|Overall Study|Severe debilitation, unable to continue|3
704254|NCT00006604|2285110|P6|Overall Study|Severe debilitation, unable to continue|0
704255|NCT00006604|2285111|P5|Overall Study|Severe debilitation, unable to continue|0
704256|NCT00006604|2285112|P4|Overall Study|Severe debilitation, unable to continue|0
704257|NCT00006604|2285113|P3|Overall Study|Severe debilitation, unable to continue|0
704258|NCT00006604|2285114|P2|Overall Study|Severe debilitation, unable to continue|0
704259|NCT00006604|2285115|P1|Overall Study|Severe debilitation, unable to continue|0
704260|NCT00006604|2285099|P17|Overall Study|Death|0
704261|NCT00006604|2285100|P16|Overall Study|Death|0
704262|NCT00006604|2285101|P15|Overall Study|Death|0
704263|NCT00006604|2285102|P14|Overall Study|Death|0
704264|NCT00006604|2285103|P13|Overall Study|Death|0
704265|NCT00006604|2285104|P12|Overall Study|Death|1
704266|NCT00006604|2285105|P11|Overall Study|Death|1
704267|NCT00006604|2285106|P10|Overall Study|Death|1
704268|NCT00006604|2285107|P9|Overall Study|Death|0
704269|NCT00006604|2285108|P8|Overall Study|Death|0
704270|NCT00006604|2285109|P7|Overall Study|Death|0
704271|NCT00006604|2285110|P6|Overall Study|Death|0
704272|NCT00006604|2285111|P5|Overall Study|Death|0
704273|NCT00006604|2285112|P4|Overall Study|Death|0
704274|NCT00006604|2285113|P3|Overall Study|Death|0
704275|NCT00006604|2285114|P2|Overall Study|Death|0
704276|NCT00006604|2285115|P1|Overall Study|Death|0
704277|NCT00006604|2285099|P17|Overall Study|Randomization entry error-no RX, no FU|0
704278|NCT00006604|2285100|P16|Overall Study|Randomization entry error-no RX, no FU|0
704279|NCT00006604|2285101|P15|Overall Study|Randomization entry error-no RX, no FU|0
704280|NCT00006604|2285102|P14|Overall Study|Randomization entry error-no RX, no FU|0
704281|NCT00006604|2285103|P13|Overall Study|Randomization entry error-no RX, no FU|0
704282|NCT00006604|2285104|P12|Overall Study|Randomization entry error-no RX, no FU|1
704283|NCT00006604|2285105|P11|Overall Study|Randomization entry error-no RX, no FU|0
704284|NCT00006604|2285106|P10|Overall Study|Randomization entry error-no RX, no FU|0
704285|NCT00006604|2285107|P9|Overall Study|Randomization entry error-no RX, no FU|0
704286|NCT00006604|2285108|P8|Overall Study|Randomization entry error-no RX, no FU|0
704287|NCT00006604|2285109|P7|Overall Study|Randomization entry error-no RX, no FU|0
704288|NCT00006604|2285110|P6|Overall Study|Randomization entry error-no RX, no FU|0
704289|NCT00006604|2285111|P5|Overall Study|Randomization entry error-no RX, no FU|0
704290|NCT00006604|2285112|P4|Overall Study|Randomization entry error-no RX, no FU|0
704291|NCT00006604|2285113|P3|Overall Study|Randomization entry error-no RX, no FU|0
704292|NCT00006604|2285114|P2|Overall Study|Randomization entry error-no RX, no FU|0
704293|NCT00006604|2285115|P1|Overall Study|Randomization entry error-no RX, no FU|0
704294|NCT00006604|2285099|P17|Overall Study|Met study objective - no further FU|0
704295|NCT00006604|2285100|P16|Overall Study|Met study objective - no further FU|1
704296|NCT00006604|2285101|P15|Overall Study|Met study objective - no further FU|1
704297|NCT00006604|2285102|P14|Overall Study|Met study objective - no further FU|0
704298|NCT00006604|2285103|P13|Overall Study|Met study objective - no further FU|0
704299|NCT00006604|2285104|P12|Overall Study|Met study objective - no further FU|0
704300|NCT00006604|2285105|P11|Overall Study|Met study objective - no further FU|0
704301|NCT00006604|2285106|P10|Overall Study|Met study objective - no further FU|0
704302|NCT00006604|2285107|P9|Overall Study|Met study objective - no further FU|0
704303|NCT00006604|2285108|P8|Overall Study|Met study objective - no further FU|0
704304|NCT00006604|2285109|P7|Overall Study|Met study objective - no further FU|0
704305|NCT00006604|2285110|P6|Overall Study|Met study objective - no further FU|0
704306|NCT00006604|2285111|P5|Overall Study|Met study objective - no further FU|0
704307|NCT00006604|2285112|P4|Overall Study|Met study objective - no further FU|0
704308|NCT00006604|2285113|P3|Overall Study|Met study objective - no further FU|0
704309|NCT00006604|2285114|P2|Overall Study|Met study objective - no further FU|0
704310|NCT00006604|2285115|P1|Overall Study|Met study objective - no further FU|1
704311|NCT00006721|2285232|P3|Overall Study|Eligible but no Treatment Received|0
704312|NCT00006721|2285233|P2|Overall Study|Eligible but no Treatment Received|0
704313|NCT00006721|2285234|P1|Overall Study|Eligible but no Treatment Received|1
704314|NCT00006721|2285232|P3|Overall Study|Ineligible|10
704315|NCT00006721|2285233|P2|Overall Study|Ineligible|12
704316|NCT00006721|2285234|P1|Overall Study|Ineligible|2
704317|NCT00006721|2285232|P3|Overall Study|Other - Not Protocol Specified|7
704318|NCT00006721|2285233|P2|Overall Study|Other - Not Protocol Specified|7
704319|NCT00006721|2285234|P1|Overall Study|Other - Not Protocol Specified|0
704320|NCT00006721|2285232|P3|Overall Study|Death|2
704321|NCT00006721|2285233|P2|Overall Study|Death|1
704322|NCT00006721|2285234|P1|Overall Study|Death|0
704323|NCT00006721|2285232|P3|Overall Study|Progression/Relapse|2
704324|NCT00006721|2285233|P2|Overall Study|Progression/Relapse|1
704325|NCT00006721|2285234|P1|Overall Study|Progression/Relapse|0
704326|NCT00006721|2285232|P3|Overall Study|Refusal Unrelated to Adverse Event|8
704327|NCT00006721|2285233|P2|Overall Study|Refusal Unrelated to Adverse Event|0
704328|NCT00006721|2285234|P1|Overall Study|Refusal Unrelated to Adverse Event|1
704329|NCT00006721|2285232|P3|Overall Study|Adverse Event|4
704330|NCT00006721|2285233|P2|Overall Study|Adverse Event|4
704331|NCT00006721|2285234|P1|Overall Study|Adverse Event|0
704332|NCT00006903|2285254|P3|Overall Study|Ineligible|2
704333|NCT00006903|2285255|P2|Overall Study|Ineligible|1
704334|NCT00006903|2285256|P1|Overall Study|Ineligible|10
704335|NCT00006903|2285254|P3|Overall Study|Patient never treated|1
704336|NCT00006903|2285255|P2|Overall Study|Patient never treated|0
704337|NCT00006903|2285256|P1|Overall Study|Patient never treated|0
704338|NCT00006903|2285254|P3|Overall Study|Death|0
704339|NCT00006903|2285255|P2|Overall Study|Death|1
704340|NCT00006903|2285256|P1|Overall Study|Death|0
704341|NCT00006903|2285254|P3|Overall Study|Adverse Event|1
704342|NCT00006903|2285255|P2|Overall Study|Adverse Event|0
704343|NCT00006903|2285256|P1|Overall Study|Adverse Event|0
704344|NCT00006903|2285254|P3|Overall Study|Refused further treatment|1
704345|NCT00006903|2285255|P2|Overall Study|Refused further treatment|2
704346|NCT00006903|2285256|P1|Overall Study|Refused further treatment|0
704347|NCT00006903|2285254|P3|Overall Study|Still receiving treatment|1
704348|NCT00006903|2285255|P2|Overall Study|Still receiving treatment|0
704349|NCT00006903|2285256|P1|Overall Study|Still receiving treatment|0
704350|NCT00006916|2285261|P1|Overall Study|Complication of device insertion|1
704351|NCT00006916|2285261|P1|Overall Study|Device not inserted|4
704352|NCT00007345|2285267|P2|Overall Study|Death on study|1
704353|NCT00007345|2285268|P1|Overall Study|Death on study|1
704354|NCT00007345|2285267|P2|Overall Study|Intercurrent illness|0
704355|NCT00007345|2285268|P1|Overall Study|Intercurrent illness|1
704356|NCT00007345|2285267|P2|Overall Study|Switched to alternative treatment|3
704357|NCT00007345|2285268|P1|Overall Study|Switched to alternative treatment|0
704358|NCT00007345|2285267|P2|Overall Study|Refused further treatment|7
704359|NCT00007345|2285268|P1|Overall Study|Refused further treatment|0
704360|NCT00007475|2285289|P4|Overall Study|Adverse Event|0
704361|NCT00007475|2285290|P3|Overall Study|Adverse Event|0
704362|NCT00007475|2285291|P2|Overall Study|Adverse Event|0
704363|NCT00007475|2285292|P1|Overall Study|Adverse Event|3
704364|NCT00007475|2285289|P4|Overall Study|Withdrawal by Subject|0
704365|NCT00007475|2285290|P3|Overall Study|Withdrawal by Subject|0
704366|NCT00007475|2285291|P2|Overall Study|Withdrawal by Subject|0
704367|NCT00007475|2285292|P1|Overall Study|Withdrawal by Subject|1
704368|NCT00010803|2285345|P2|Overall Study|Withdrawal by Subject|98
704369|NCT00010803|2285346|P1|Overall Study|Withdrawal by Subject|97
704370|NCT00012012|2285379|P2|Overall Study|Withdrawal by Subject|2
704371|NCT00012012|2285380|P1|Overall Study|Withdrawal by Subject|0
704372|NCT00012012|2285379|P2|Overall Study|Protocol Violation|1
704373|NCT00012012|2285380|P1|Overall Study|Protocol Violation|1
704374|NCT00006237|2285438|P2|Overall Study|Not protocol specified|5
704375|NCT00006237|2285439|P1|Overall Study|Not protocol specified|14
704376|NCT00006237|2285438|P2|Overall Study|Withdrawal by Subject|1
704377|NCT00006237|2285439|P1|Overall Study|Withdrawal by Subject|0
704378|NCT00006237|2285438|P2|Overall Study|Not eligible|20
704379|NCT00006237|2285439|P1|Overall Study|Not eligible|9
704380|NCT00006237|2285438|P2|Overall Study|Progression/relapse|2
704381|NCT00006237|2285439|P1|Overall Study|Progression/relapse|54
704382|NCT00006237|2285438|P2|Overall Study|Refusal unrelated to adverse effects|4
704383|NCT00006237|2285439|P1|Overall Study|Refusal unrelated to adverse effects|8
704384|NCT00006237|2285438|P2|Overall Study|Death|0
704385|NCT00006237|2285439|P1|Overall Study|Death|1
704386|NCT00006237|2285438|P2|Overall Study|Adverse Event|29
704387|NCT00006237|2285439|P1|Overall Study|Adverse Event|39
704388|NCT00006289|2285460|P2|Second Intervention (5 Weeks)|Protocol Violation|1
704389|NCT00006289|2285461|P1|Second Intervention (5 Weeks)|Protocol Violation|1
704390|NCT00006289|2285460|P2|First Intervention (5 Weeks)|Adverse Event|0
704391|NCT00006289|2285461|P1|First Intervention (5 Weeks)|Adverse Event|1
704392|NCT00006305|2285481|P4|Overall Study|Withdrawal by Subject|14
704393|NCT00006305|2285482|P3|Overall Study|Withdrawal by Subject|15
704394|NCT00006305|2285483|P2|Overall Study|Withdrawal by Subject|10
704395|NCT00006305|2285484|P1|Overall Study|Withdrawal by Subject|17
704396|NCT00006389|2285498|P1|Overall Study|Adverse Event|1
704397|NCT00006392|2285508|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
704398|NCT00006392|2285509|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
704399|NCT00006392|2285510|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
704400|NCT00006392|2285511|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
704401|NCT00006392|2285508|P4|Overall Study|Ineligible|5
704402|NCT00006392|2285509|P3|Overall Study|Ineligible|5
704403|NCT00006392|2285510|P2|Overall Study|Ineligible|3
704404|NCT00006392|2285511|P1|Overall Study|Ineligible|11
704405|NCT00014495|2285545|P4|Overall Study|Clinical deterioration|1
704406|NCT00014495|2285546|P3|Overall Study|Clinical deterioration|0
704407|NCT00014495|2285547|P2|Overall Study|Clinical deterioration|0
704408|NCT00014495|2285548|P1|Overall Study|Clinical deterioration|0
704409|NCT00014495|2285545|P4|Overall Study|Death|0
704410|NCT00014495|2285546|P3|Overall Study|Death|1
704411|NCT00014495|2285547|P2|Overall Study|Death|0
704412|NCT00014495|2285548|P1|Overall Study|Death|0
704413|NCT00014911|2285559|P1|Overall Study|Immunosuppression-related Side Effects|1
704414|NCT00014911|2285559|P1|Overall Study|Unknown Reasons|2
704415|NCT00014911|2285559|P1|Overall Study|Withdrawal by Subject|6
704416|NCT00014911|2285559|P1|Overall Study|Lost to Follow-up|1
704417|NCT00014911|2285559|P1|Overall Study|Adverse Event|1
704418|NCT00015457|2285568|P2|Second Intervention|Withdrawal by Subject|0
704419|NCT00015457|2285569|P1|Second Intervention|Withdrawal by Subject|1
704420|NCT00015457|2285568|P2|First Intervention|Lack of Efficacy|1
704421|NCT00015457|2285569|P1|First Intervention|Lack of Efficacy|0
704422|NCT00015457|2285568|P2|First Intervention|Adverse Event|2
704423|NCT00015457|2285569|P1|First Intervention|Adverse Event|0
704424|NCT00016354|2285583|P8|Overall Study|Lack of Efficacy|1
704425|NCT00016354|2285584|P7|Overall Study|Lack of Efficacy|0
704426|NCT00016354|2285585|P6|Overall Study|Lack of Efficacy|0
704427|NCT00016354|2285586|P5|Overall Study|Lack of Efficacy|0
704428|NCT00016354|2285587|P4|Overall Study|Lack of Efficacy|0
704429|NCT00016354|2285588|P3|Overall Study|Lack of Efficacy|0
704430|NCT00016354|2285589|P2|Overall Study|Lack of Efficacy|0
704431|NCT00016354|2285590|P1|Overall Study|Lack of Efficacy|0
704432|NCT00006164|2285615|P2|Overall Study|Withdrew or lost to follow-up|81
704433|NCT00006164|2285616|P1|Overall Study|Withdrew or lost to follow-up|70
889736|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
704436|NCT00008138|2285682|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
704437|NCT00008138|2285682|P1|Post-Cytoreduction Chemotherapy|Progression|1
704438|NCT00008138|2285682|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
704439|NCT00008138|2285682|P1|Interval Debulking|Withdrawal by Subject|2
704440|NCT00008138|2285682|P1|Neoadjuvant Chemotherapy|not protocol specified|8
704441|NCT00008138|2285682|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
704442|NCT00008138|2285682|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
704443|NCT00008138|2285682|P1|Neoadjuvant Chemotherapy|Adverse Event|3
704444|NCT00008385|2285690|P2|Overall Study|Not start protocol therapy|175
704445|NCT00008385|2285691|P1|Overall Study|Not start protocol therapy|44
704446|NCT00008385|2285690|P2|Overall Study|Not specified|212
704447|NCT00008385|2285691|P1|Overall Study|Not specified|105
704448|NCT00008385|2285690|P2|Overall Study|Maximum dose reached|2
704449|NCT00008385|2285691|P1|Overall Study|Maximum dose reached|0
704450|NCT00008385|2285690|P2|Overall Study|Other complicating disease|30
704451|NCT00008385|2285691|P1|Overall Study|Other complicating disease|17
704452|NCT00008385|2285690|P2|Overall Study|Start non-protocol therapy|1
704453|NCT00008385|2285691|P1|Overall Study|Start non-protocol therapy|3
704454|NCT00008385|2285690|P2|Overall Study|Withdrawal by Subject|157
704455|NCT00008385|2285691|P1|Overall Study|Withdrawal by Subject|67
704456|NCT00008385|2285690|P2|Overall Study|Death|18
704457|NCT00008385|2285691|P1|Overall Study|Death|12
704458|NCT00008385|2285690|P2|Overall Study|Adverse Event|20
704459|NCT00008385|2285691|P1|Overall Study|Adverse Event|8
704460|NCT00008385|2285690|P2|Overall Study|Progressive disease|117
704461|NCT00008385|2285691|P1|Overall Study|Progressive disease|52
704462|NCT00008385|2285690|P2|Overall Study|Off treatment reasons not reported|70
704463|NCT00008385|2285691|P1|Overall Study|Off treatment reasons not reported|79
704464|NCT00009737|2285703|P2|Overall Study|Administrative/Other Reasons|1
704465|NCT00009737|2285704|P1|Overall Study|Administrative/Other Reasons|7
704466|NCT00009737|2285703|P2|Overall Study|Lost to Follow-up|1
704467|NCT00009737|2285704|P1|Overall Study|Lost to Follow-up|1
704468|NCT00009737|2285703|P2|Overall Study|Refused Treatment|16
704469|NCT00009737|2285704|P1|Overall Study|Refused Treatment|15
704470|NCT00009737|2285703|P2|Overall Study|Other Protocol Violation|0
704471|NCT00009737|2285704|P1|Overall Study|Other Protocol Violation|1
704472|NCT00009737|2285703|P2|Overall Study|Violation of Selection Criteria at Entry|9
704473|NCT00009737|2285704|P1|Overall Study|Violation of Selection Criteria at Entry|13
704474|NCT00009737|2285703|P2|Overall Study|Lack of Efficacy|15
704475|NCT00009737|2285704|P1|Overall Study|Lack of Efficacy|17
704476|NCT00009737|2285703|P2|Overall Study|Death|6
704477|NCT00009737|2285704|P1|Overall Study|Death|4
704478|NCT00009737|2285703|P2|Overall Study|Adverse Event|75
704479|NCT00009737|2285704|P1|Overall Study|Adverse Event|112
704480|NCT00010257|2285722|P2|Overall Study|Withdrawal by Subject|0
704481|NCT00010257|2285723|P1|Overall Study|Withdrawal by Subject|1
704482|NCT00019604|2285737|P1|Overall Study|Details for other not available|4
704483|NCT00019604|2285737|P1|Overall Study|Unable to evaluate|1
704484|NCT00019604|2285737|P1|Overall Study|Too much disease|1
704485|NCT00019604|2285737|P1|Overall Study|Pt going to immunotherapy study|1
704486|NCT00019604|2285737|P1|Overall Study|Started new chemo regimen|1
704487|NCT00019604|2285737|P1|Overall Study|Resectable disease|1
704488|NCT00019604|2285737|P1|Overall Study|Non compliant|1
704489|NCT00019604|2285737|P1|Overall Study|Non compliant on systemic CH|1
704490|NCT00019604|2285737|P1|Overall Study|Move to a different study|1
704491|NCT00019604|2285737|P1|Overall Study|Going to have liver transplant|1
704492|NCT00019604|2285737|P1|Overall Study|Carcinoid tumor, not treatable|1
704493|NCT00019604|2285737|P1|Overall Study|Refused treatment|1
704494|NCT00019604|2285737|P1|Overall Study|Progressive disease|23
704495|NCT00019604|2285737|P1|Overall Study|Death|1
704496|NCT00021229|2285767|P3|Overall Study|Punctate hemmorrhage post RT|0
704497|NCT00021229|2285768|P2|Overall Study|Punctate hemmorrhage post RT|0
704498|NCT00021229|2285769|P1|Overall Study|Punctate hemmorrhage post RT|2
704499|NCT00021229|2285767|P3|Overall Study|Physician Decision|1
704500|NCT00021229|2285768|P2|Overall Study|Physician Decision|0
704501|NCT00021229|2285769|P1|Overall Study|Physician Decision|0
704502|NCT00021229|2285767|P3|Overall Study|Protocol Violation|0
704503|NCT00021229|2285768|P2|Overall Study|Protocol Violation|1
704504|NCT00021229|2285769|P1|Overall Study|Protocol Violation|1
704505|NCT00021229|2285767|P3|Overall Study|Progressive Disease|12
704506|NCT00021229|2285768|P2|Overall Study|Progressive Disease|19
704507|NCT00021229|2285769|P1|Overall Study|Progressive Disease|15
704508|NCT00021229|2285767|P3|Overall Study|Withdrawal by Subject|1
704509|NCT00021229|2285768|P2|Overall Study|Withdrawal by Subject|7
704510|NCT00021229|2285769|P1|Overall Study|Withdrawal by Subject|7
704511|NCT00021229|2285767|P3|Overall Study|Death|0
704512|NCT00021229|2285768|P2|Overall Study|Death|1
704513|NCT00021229|2285769|P1|Overall Study|Death|0
704514|NCT00021229|2285767|P3|Overall Study|Adverse Event|2
704515|NCT00021229|2285768|P2|Overall Study|Adverse Event|5
704516|NCT00021229|2285769|P1|Overall Study|Adverse Event|10
704517|NCT00021255|2285798|P3|Overall Study|Randomized but not treated|18
704518|NCT00021255|2285799|P2|Overall Study|Randomized but not treated|2
704519|NCT00021255|2285800|P1|Overall Study|Randomized but not treated|28
704520|NCT00021255|2285798|P3|Overall Study|Missing|13
704521|NCT00021255|2285799|P2|Overall Study|Missing|27
704522|NCT00021255|2285800|P1|Overall Study|Missing|0
704523|NCT00021255|2285798|P3|Overall Study|Other than specified above|19
704524|NCT00021255|2285799|P2|Overall Study|Other than specified above|38
704525|NCT00021255|2285800|P1|Overall Study|Other than specified above|0
704526|NCT00021255|2285798|P3|Overall Study|Protocol Violation|0
704527|NCT00021255|2285799|P2|Overall Study|Protocol Violation|2
704528|NCT00021255|2285800|P1|Overall Study|Protocol Violation|0
704529|NCT00021255|2285798|P3|Overall Study|Adverse Event|18
704530|NCT00021255|2285799|P2|Overall Study|Adverse Event|30
704531|NCT00021255|2285800|P1|Overall Study|Adverse Event|46
704532|NCT00021255|2285798|P3|Overall Study|Herceptin toxicity|6
704533|NCT00021255|2285799|P2|Overall Study|Herceptin toxicity|22
704534|NCT00021255|2285800|P1|Overall Study|Herceptin toxicity|0
704535|NCT00021255|2285798|P3|Overall Study|Cardiac toxicity|32
704536|NCT00021255|2285799|P2|Overall Study|Cardiac toxicity|61
704537|NCT00021255|2285800|P1|Overall Study|Cardiac toxicity|0
704538|NCT00021255|2285798|P3|Overall Study|Lost to Follow-up|3
704539|NCT00021255|2285799|P2|Overall Study|Lost to Follow-up|2
704540|NCT00021255|2285800|P1|Overall Study|Lost to Follow-up|0
704541|NCT00021255|2285798|P3|Overall Study|Withdrawal by Subject|26
704542|NCT00021255|2285799|P2|Overall Study|Withdrawal by Subject|64
704543|NCT00021255|2285800|P1|Overall Study|Withdrawal by Subject|41
704544|NCT00021255|2285798|P3|Overall Study|Second primary malignancy|1
704545|NCT00021255|2285799|P2|Overall Study|Second primary malignancy|4
704546|NCT00021255|2285800|P1|Overall Study|Second primary malignancy|0
704547|NCT00021255|2285798|P3|Overall Study|Breast cancer relapse|11
704548|NCT00021255|2285799|P2|Overall Study|Breast cancer relapse|18
704549|NCT00021255|2285800|P1|Overall Study|Breast cancer relapse|5
704550|NCT00021255|2285798|P3|Overall Study|Death|2
704551|NCT00021255|2285799|P2|Overall Study|Death|0
704552|NCT00021255|2285800|P1|Overall Study|Death|1
704553|NCT00021541|2285816|P2|Period 2-crossover|Pts that did not progress|3
704554|NCT00021541|2285817|P1|Period 2-crossover|Pts that did not progress|2
704555|NCT00021541|2285816|P2|Period 2-crossover|non-adherence|0
704556|NCT00021541|2285817|P1|Period 2-crossover|non-adherence|1
704557|NCT00021541|2285816|P2|Period 2-crossover|Adverse Event|2
704558|NCT00021541|2285817|P1|Period 2-crossover|Adverse Event|2
704559|NCT00021541|2285816|P2|Period 2-crossover|Withdrawal by Subject|4
704560|NCT00021541|2285817|P1|Period 2-crossover|Withdrawal by Subject|3
704561|NCT00021541|2285816|P2|Period 2-crossover|refused phase B|2
704562|NCT00021541|2285817|P1|Period 2-crossover|refused phase B|2
704563|NCT00021541|2285816|P2|Period 1-First Treatment|Ineligible|2
704564|NCT00021541|2285817|P1|Period 1-First Treatment|Ineligible|0
704565|NCT00021541|2285816|P2|Period 1-First Treatment|Pts that did not progress|2
704566|NCT00021541|2285817|P1|Period 1-First Treatment|Pts that did not progress|2
704567|NCT00021541|2285816|P2|Period 1-First Treatment|Death|0
704568|NCT00021541|2285817|P1|Period 1-First Treatment|Death|1
704569|NCT00021541|2285816|P2|Period 1-First Treatment|non-adherence|0
704570|NCT00021541|2285817|P1|Period 1-First Treatment|non-adherence|3
704571|NCT00021541|2285816|P2|Period 1-First Treatment|Adverse Event|1
704572|NCT00021541|2285817|P1|Period 1-First Treatment|Adverse Event|2
704573|NCT00021541|2285816|P2|Period 1-First Treatment|Withdrawal by Subject|3
704574|NCT00021541|2285817|P1|Period 1-First Treatment|Withdrawal by Subject|3
704575|NCT00013611|2285825|P2|Overall Study|Lost to Follow-up|100
704576|NCT00013611|2285826|P1|Overall Study|Lost to Follow-up|91
704577|NCT00022516|2285848|P2|Overall Study|Incomplete documentation|27
704578|NCT00022516|2285849|P1|Overall Study|Incomplete documentation|0
704579|NCT00022516|2285848|P2|Overall Study|Withdrawal by Subject|113
704580|NCT00022516|2285849|P1|Overall Study|Withdrawal by Subject|2
704581|NCT00022516|2285848|P2|Overall Study|Protocol Violation|3
704582|NCT00022516|2285849|P1|Overall Study|Protocol Violation|1
704583|NCT00022516|2285848|P2|Overall Study|Physician Decision|1
704584|NCT00022516|2285849|P1|Overall Study|Physician Decision|0
704585|NCT00022516|2285848|P2|Overall Study|Lack of Efficacy|27
704586|NCT00022516|2285849|P1|Overall Study|Lack of Efficacy|0
704587|NCT00022516|2285848|P2|Overall Study|Adverse Event|59
704588|NCT00022516|2285849|P1|Overall Study|Adverse Event|0
704591|NCT00022672|2285869|P2|Extension Phase|Other|1
704592|NCT00022672|2285870|P1|Extension Phase|Other|1
704593|NCT00022672|2285869|P2|Extension Phase|Refused Treatment|2
704594|NCT00022672|2285870|P1|Extension Phase|Refused Treatment|0
704595|NCT00022672|2285869|P2|Extension Phase|Insufficient Therapeutic Response|44
704596|NCT00022672|2285870|P1|Extension Phase|Insufficient Therapeutic Response|1
704597|NCT00022672|2285869|P2|Extension Phase|Death|1
704598|NCT00022672|2285870|P1|Extension Phase|Death|0
704599|NCT00022672|2285869|P2|Extension Phase|Adverse Event|3
704600|NCT00022672|2285870|P1|Extension Phase|Adverse Event|1
704601|NCT00022672|2285869|P2|Main Phase: 24 Months|Other|0
704602|NCT00022672|2285870|P1|Main Phase: 24 Months|Other|1
704603|NCT00022672|2285869|P2|Main Phase: 24 Months|Failure to Return|1
704604|NCT00022672|2285870|P1|Main Phase: 24 Months|Failure to Return|1
704605|NCT00022672|2285869|P2|Main Phase: 24 Months|Refused Treatment|4
704606|NCT00022672|2285870|P1|Main Phase: 24 Months|Refused Treatment|3
704607|NCT00022672|2285869|P2|Main Phase: 24 Months|Other Protocol Violation|0
704608|NCT00022672|2285870|P1|Main Phase: 24 Months|Other Protocol Violation|1
704609|NCT00022672|2285869|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
704610|NCT00022672|2285870|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
704611|NCT00022672|2285869|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
704612|NCT00022672|2285870|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
704613|NCT00022672|2285869|P2|Main Phase: 24 Months|Death|3
704614|NCT00022672|2285870|P1|Main Phase: 24 Months|Death|0
704615|NCT00022672|2285869|P2|Main Phase: 24 Months|Adverse Event|0
704616|NCT00022672|2285870|P1|Main Phase: 24 Months|Adverse Event|6
704617|NCT00022698|2285905|P2|Overall Study|Administrative /other|7
704618|NCT00022698|2285906|P1|Overall Study|Administrative /other|1
704619|NCT00022698|2285905|P2|Overall Study|Insufficient therapeutic response|14
704620|NCT00022698|2285906|P1|Overall Study|Insufficient therapeutic response|2
704621|NCT00022698|2285905|P2|Overall Study|Refused treatment|2
704622|NCT00022698|2285906|P1|Overall Study|Refused treatment|0
704623|NCT00022698|2285905|P2|Overall Study|Failure to return|1
704624|NCT00022698|2285906|P1|Overall Study|Failure to return|0
704625|NCT00022698|2285905|P2|Overall Study|Death|2
704626|NCT00022698|2285906|P1|Overall Study|Death|0
704627|NCT00022698|2285905|P2|Overall Study|Adverse Event|9
704628|NCT00022698|2285906|P1|Overall Study|Adverse Event|5
704629|NCT00022763|2285931|P2|Overall Study|Admin|2
704630|NCT00022763|2285932|P1|Overall Study|Admin|3
704631|NCT00022763|2285931|P2|Overall Study|Insufficient Therapy|0
704632|NCT00022763|2285932|P1|Overall Study|Insufficient Therapy|1
704633|NCT00022763|2285931|P2|Overall Study|Withdrawal by Subject|7
704634|NCT00022763|2285932|P1|Overall Study|Withdrawal by Subject|4
704635|NCT00022763|2285931|P2|Overall Study|Lost to Follow-up|3
704636|NCT00022763|2285932|P1|Overall Study|Lost to Follow-up|0
704637|NCT00022763|2285931|P2|Overall Study|Death|1
704638|NCT00022763|2285932|P1|Overall Study|Death|0
704639|NCT00022763|2285931|P2|Overall Study|Injection Site Reactions|2
704640|NCT00022763|2285932|P1|Overall Study|Injection Site Reactions|0
704641|NCT00022763|2285931|P2|Overall Study|Adverse Event|2
704642|NCT00022763|2285932|P1|Overall Study|Adverse Event|1
704643|NCT00023322|2285972|P1|Overall Study|Lost to Follow-up|1
704644|NCT00023452|2285979|P2|Overall Study|Other|69
704645|NCT00023452|2285980|P1|Overall Study|Other|204
704646|NCT00023452|2285979|P2|Overall Study|Pregnant|20
704647|NCT00023452|2285980|P1|Overall Study|Pregnant|53
704648|NCT00023452|2285979|P2|Overall Study|Refused Treatment (continued follow-up)|224
704649|NCT00023452|2285980|P1|Overall Study|Refused Treatment (continued follow-up)|225
704650|NCT00023452|2285979|P2|Overall Study|Physician Decision|21
704651|NCT00023452|2285980|P1|Overall Study|Physician Decision|49
704652|NCT00023452|2285979|P2|Overall Study|Lost to Follow-up|60
704653|NCT00023452|2285980|P1|Overall Study|Lost to Follow-up|293
704654|NCT00023452|2285979|P2|Overall Study|Adverse Event|196
704655|NCT00023452|2285980|P1|Overall Study|Adverse Event|139
704656|NCT00023452|2285979|P2|Overall Study|Withdrawal by Subject|54
704657|NCT00023452|2285980|P1|Overall Study|Withdrawal by Subject|66
704658|NCT00023452|2285979|P2|Overall Study|Death|0
704659|NCT00023452|2285980|P1|Overall Study|Death|2
704660|NCT00023452|2285979|P2|Overall Study|Out of Window|69
704661|NCT00023452|2285980|P1|Overall Study|Out of Window|129
704662|NCT00023452|2285979|P2|Overall Study|Ineligible for Study|159
704663|NCT00023452|2285980|P1|Overall Study|Ineligible for Study|163
704664|NCT00023595|2286009|P5|10 Year Follow up|Lost to Follow-up|0
704665|NCT00023595|2286010|P4|10 Year Follow up|Lost to Follow-up|0
704666|NCT00023595|2286011|P3|10 Year Follow up|Lost to Follow-up|3
704667|NCT00023595|2286012|P2|10 Year Follow up|Lost to Follow-up|10
704668|NCT00023595|2286013|P1|10 Year Follow up|Lost to Follow-up|12
704669|NCT00023595|2286009|P5|5 Year Follow up|Lost to Follow-up|3
704670|NCT00023595|2286010|P4|5 Year Follow up|Lost to Follow-up|7
704671|NCT00023595|2286011|P3|5 Year Follow up|Lost to Follow-up|1
704672|NCT00023595|2286012|P2|5 Year Follow up|Lost to Follow-up|2
704673|NCT00023595|2286013|P1|5 Year Follow up|Lost to Follow-up|2
704674|NCT00023673|2286225|P4|Overall Study|Patient withdrew consent|1
704675|NCT00023673|2286226|P3|Overall Study|Patient withdrew consent|0
704676|NCT00023673|2286227|P2|Overall Study|Patient withdrew consent|0
704677|NCT00023673|2286228|P1|Overall Study|Patient withdrew consent|0
704678|NCT00023673|2286225|P4|Overall Study|Ineligible / no protocol treatment|1
704679|NCT00023673|2286226|P3|Overall Study|Ineligible / no protocol treatment|0
704680|NCT00023673|2286227|P2|Overall Study|Ineligible / no protocol treatment|0
704681|NCT00023673|2286228|P1|Overall Study|Ineligible / no protocol treatment|0
704686|NCT00023764|2286250|P1|Overall Study|delay in obtaining staging images|1
704687|NCT00023764|2286250|P1|Overall Study|patient received other treatment|1
704688|NCT00023764|2286250|P1|Overall Study|Progression of disease|6
704689|NCT00023764|2286250|P1|Overall Study|Withdrawal by Subject|1
704690|NCT00023764|2286250|P1|Overall Study|Adverse Event|4
704691|NCT00023764|2286250|P1|Overall Study|Other|1
704692|NCT00024167|2286273|P2|Overall Study|Death|47
704693|NCT00024167|2286274|P1|Overall Study|Death|53
704694|NCT00024258|2286283|P1|Overall Study|Disease Progression|8
704695|NCT00024258|2286283|P1|Overall Study|Withdrawal by Subject|1
704702|NCT00025259|2286306|P7|Overall Study|Adverse Event|0
704703|NCT00025259|2286307|P6|Overall Study|Adverse Event|0
704704|NCT00025259|2286308|P5|Overall Study|Adverse Event|0
704705|NCT00025259|2286309|P4|Overall Study|Adverse Event|0
704706|NCT00025259|2286310|P3|Overall Study|Adverse Event|0
704707|NCT00025259|2286311|P2|Overall Study|Adverse Event|0
704708|NCT00025259|2286312|P1|Overall Study|Adverse Event|1
704709|NCT00025259|2286306|P7|Overall Study|Randomization error|2
704710|NCT00025259|2286307|P6|Overall Study|Randomization error|7
704711|NCT00025259|2286308|P5|Overall Study|Randomization error|1
704712|NCT00025259|2286309|P4|Overall Study|Randomization error|0
704713|NCT00025259|2286310|P3|Overall Study|Randomization error|0
704714|NCT00025259|2286311|P2|Overall Study|Randomization error|0
704715|NCT00025259|2286312|P1|Overall Study|Randomization error|1
704716|NCT00025259|2286306|P7|Overall Study|Ineligible|1
704717|NCT00025259|2286307|P6|Overall Study|Ineligible|0
704718|NCT00025259|2286308|P5|Overall Study|Ineligible|6
704719|NCT00025259|2286309|P4|Overall Study|Ineligible|0
704720|NCT00025259|2286310|P3|Overall Study|Ineligible|0
704721|NCT00025259|2286311|P2|Overall Study|Ineligible|1
704722|NCT00025259|2286312|P1|Overall Study|Ineligible|14
704723|NCT00025259|2286306|P7|Overall Study|Withdrawal by Subject|3
704724|NCT00025259|2286307|P6|Overall Study|Withdrawal by Subject|8
704725|NCT00025259|2286308|P5|Overall Study|Withdrawal by Subject|11
704726|NCT00025259|2286309|P4|Overall Study|Withdrawal by Subject|14
704727|NCT00025259|2286310|P3|Overall Study|Withdrawal by Subject|6
704728|NCT00025259|2286311|P2|Overall Study|Withdrawal by Subject|27
704729|NCT00025259|2286312|P1|Overall Study|Withdrawal by Subject|9
704730|NCT00025259|2286306|P7|Overall Study|Protocol Violation|3
704731|NCT00025259|2286307|P6|Overall Study|Protocol Violation|1
704732|NCT00025259|2286308|P5|Overall Study|Protocol Violation|2
704733|NCT00025259|2286309|P4|Overall Study|Protocol Violation|1
704734|NCT00025259|2286310|P3|Overall Study|Protocol Violation|2
704735|NCT00025259|2286311|P2|Overall Study|Protocol Violation|2
704736|NCT00025259|2286312|P1|Overall Study|Protocol Violation|3
704737|NCT00025259|2286306|P7|Overall Study|Physician Decision|1
704738|NCT00025259|2286307|P6|Overall Study|Physician Decision|2
704739|NCT00025259|2286308|P5|Overall Study|Physician Decision|4
704740|NCT00025259|2286309|P4|Overall Study|Physician Decision|5
704741|NCT00025259|2286310|P3|Overall Study|Physician Decision|0
704742|NCT00025259|2286311|P2|Overall Study|Physician Decision|1
704743|NCT00025259|2286312|P1|Overall Study|Physician Decision|12
704744|NCT00025259|2286306|P7|Overall Study|Lost to Follow-up|1
704745|NCT00025259|2286307|P6|Overall Study|Lost to Follow-up|3
704746|NCT00025259|2286308|P5|Overall Study|Lost to Follow-up|1
704747|NCT00025259|2286309|P4|Overall Study|Lost to Follow-up|13
704748|NCT00025259|2286310|P3|Overall Study|Lost to Follow-up|13
704749|NCT00025259|2286311|P2|Overall Study|Lost to Follow-up|9
704750|NCT00025259|2286312|P1|Overall Study|Lost to Follow-up|2
704751|NCT00025259|2286306|P7|Overall Study|Lack of Efficacy|38
704752|NCT00025259|2286307|P6|Overall Study|Lack of Efficacy|30
704753|NCT00025259|2286308|P5|Overall Study|Lack of Efficacy|11
704754|NCT00025259|2286309|P4|Overall Study|Lack of Efficacy|78
704755|NCT00025259|2286310|P3|Overall Study|Lack of Efficacy|60
704756|NCT00025259|2286311|P2|Overall Study|Lack of Efficacy|46
704757|NCT00025259|2286312|P1|Overall Study|Lack of Efficacy|2
704758|NCT00025259|2286306|P7|Overall Study|Death|2
704759|NCT00025259|2286307|P6|Overall Study|Death|1
704760|NCT00025259|2286308|P5|Overall Study|Death|0
704761|NCT00025259|2286309|P4|Overall Study|Death|3
704762|NCT00025259|2286310|P3|Overall Study|Death|0
704763|NCT00025259|2286311|P2|Overall Study|Death|3
704764|NCT00025259|2286312|P1|Overall Study|Death|1
704769|NCT00025662|2286362|P1|Overall Study|Technical failure of manipulation|1
704770|NCT00025662|2286362|P1|Overall Study|Withdrawal by Subject|2
704771|NCT00027378|2286372|P2|Overall Study|Physician Decision|3
704772|NCT00027378|2286373|P1|Overall Study|Physician Decision|0
704773|NCT00027560|2286381|P1|Overall Study|Withdrawal by Subject|1
704774|NCT00027846|2286393|P3|Overall Study|Neuraxis dissemination during/after ther|5
704775|NCT00027846|2286394|P2|Overall Study|Neuraxis dissemination during/after ther|2
704776|NCT00027846|2286395|P1|Overall Study|Neuraxis dissemination during/after ther|0
704777|NCT00027846|2286393|P3|Overall Study|Entry into another COG therapeutic study|2
704778|NCT00027846|2286394|P2|Overall Study|Entry into another COG therapeutic study|5
704779|NCT00027846|2286395|P1|Overall Study|Entry into another COG therapeutic study|0
704780|NCT00027846|2286393|P3|Overall Study|Ineligible for study|14
704781|NCT00027846|2286394|P2|Overall Study|Ineligible for study|6
704782|NCT00027846|2286395|P1|Overall Study|Ineligible for study|2
704783|NCT00027846|2286393|P3|Overall Study|Withdrawal by Subject|7
704784|NCT00027846|2286394|P2|Overall Study|Withdrawal by Subject|14
704785|NCT00027846|2286395|P1|Overall Study|Withdrawal by Subject|0
704786|NCT00027846|2286393|P3|Overall Study|Lost to Follow-up|9
704787|NCT00027846|2286394|P2|Overall Study|Lost to Follow-up|41
704788|NCT00027846|2286395|P1|Overall Study|Lost to Follow-up|0
704789|NCT00028002|2286413|P1|Overall Study|Ineligible|8
704790|NCT00028002|2286413|P1|Overall Study|Withdrawal by Subject|3
704791|NCT00028769|2286430|P1|Overall Study|Not Analyzable|1
704792|NCT00028769|2286430|P1|Overall Study|Ineligible|5
704793|NCT00028769|2286430|P1|Overall Study|Other - Not Protocol Specified|1
704794|NCT00028769|2286430|P1|Overall Study|Progression or Death|31
704795|NCT00028769|2286430|P1|Overall Study|Refusal Unrelated to Adverse Events|1
704796|NCT00028769|2286430|P1|Overall Study|Adverse Event|2
704797|NCT00029146|2286447|P2|Overall Study|Lost to Follow-up|1
704798|NCT00029146|2286448|P1|Overall Study|Lost to Follow-up|2
704799|NCT00022633|2286512|P2|Overall Study|Ineligible|0
704800|NCT00022633|2286513|P1|Overall Study|Ineligible|4
704801|NCT00022633|2286512|P2|Overall Study|Other - not protocol specified|2
704802|NCT00022633|2286513|P1|Overall Study|Other - not protocol specified|3
704803|NCT00022633|2286512|P2|Overall Study|Death|0
704804|NCT00022633|2286513|P1|Overall Study|Death|4
704805|NCT00022633|2286512|P2|Overall Study|Progression/relapse|2
704806|NCT00022633|2286513|P1|Overall Study|Progression/relapse|9
704807|NCT00022633|2286512|P2|Overall Study|Refusal unrelated to adverse event|0
704808|NCT00022633|2286513|P1|Overall Study|Refusal unrelated to adverse event|1
704809|NCT00022633|2286512|P2|Overall Study|Adverse Event|1
704810|NCT00022633|2286513|P1|Overall Study|Adverse Event|11
704811|NCT00032487|2286547|P2|Overall Study|Had other reason|12
704812|NCT00032487|2286548|P1|Overall Study|Had other reason|12
704813|NCT00032487|2286547|P2|Overall Study|Lost to Follow-up|58
704814|NCT00032487|2286548|P1|Overall Study|Lost to Follow-up|57
704815|NCT00032487|2286547|P2|Overall Study|Adverse Event|7
704816|NCT00032487|2286548|P1|Overall Study|Adverse Event|3
704817|NCT00032487|2286547|P2|Overall Study|Withdrawal by Subject|43
704818|NCT00032487|2286548|P1|Overall Study|Withdrawal by Subject|67
704819|NCT00033293|2286586|P2|Overall Study|Treatment refused|6
704820|NCT00033293|2286587|P1|Overall Study|Treatment refused|0
704821|NCT00033293|2286586|P2|Overall Study|Could not be weaned from steroid therapy|1
704822|NCT00033293|2286587|P1|Overall Study|Could not be weaned from steroid therapy|1
704823|NCT00033293|2286586|P2|Overall Study|Withdrawal by Subject|0
704824|NCT00033293|2286587|P1|Overall Study|Withdrawal by Subject|1
704825|NCT00033293|2286586|P2|Overall Study|Physician Decision|1
704826|NCT00033293|2286587|P1|Overall Study|Physician Decision|3
704827|NCT00033293|2286586|P2|Overall Study|Lost to Follow-up|1
704828|NCT00033293|2286587|P1|Overall Study|Lost to Follow-up|0
704829|NCT00033293|2286586|P2|Overall Study|Lack of Efficacy|8
704830|NCT00033293|2286587|P1|Overall Study|Lack of Efficacy|5
704831|NCT00033293|2286586|P2|Overall Study|Death|1
704832|NCT00033293|2286587|P1|Overall Study|Death|0
704833|NCT00033371|2286607|P2|Overall Study|Disease Progression|1
704834|NCT00033371|2286608|P1|Overall Study|Disease Progression|0
704835|NCT00033371|2286607|P2|Overall Study|Withdrawal by Subject|3
704836|NCT00033371|2286608|P1|Overall Study|Withdrawal by Subject|3
704837|NCT00033371|2286607|P2|Overall Study|Lost to Follow-up|1
704838|NCT00033371|2286608|P1|Overall Study|Lost to Follow-up|2
704839|NCT00033371|2286607|P2|Overall Study|Adverse Event|5
704840|NCT00033371|2286608|P1|Overall Study|Adverse Event|1
704841|NCT00033514|2286616|P2|Overall Study|Withdrawal by Subject|3
704842|NCT00033514|2286617|P1|Overall Study|Withdrawal by Subject|0
704843|NCT00033514|2286616|P2|Overall Study|Lost to Follow-up|1
704844|NCT00033514|2286617|P1|Overall Study|Lost to Follow-up|1
704845|NCT00033540|2286625|P1|Overall Study|Never received treatment|2
704846|NCT00033540|2286625|P1|Overall Study|Ineligible|3
704847|NCT00033540|2286625|P1|Overall Study|Not specified|5
704848|NCT00033540|2286625|P1|Overall Study|Withdrawal by Subject|6
704849|NCT00033540|2286625|P1|Overall Study|Progression|26
704850|NCT00033540|2286625|P1|Overall Study|Death|1
704851|NCT00033540|2286625|P1|Overall Study|Adverse Event|14
704852|NCT00033631|2286635|P2|Overall Study|Withdrawal by Subject|4
704853|NCT00033631|2286636|P1|Overall Study|Withdrawal by Subject|4
704854|NCT00033631|2286635|P2|Overall Study|Protocol Violation|11
704855|NCT00033631|2286636|P1|Overall Study|Protocol Violation|14
704856|NCT00033657|2286656|P2|Adjuvant Chemotherapy|Other|2
704857|NCT00033657|2286657|P1|Adjuvant Chemotherapy|Other|0
704858|NCT00033657|2286656|P2|Adjuvant Chemotherapy|alternative therapy|0
704859|NCT00033657|2286657|P1|Adjuvant Chemotherapy|alternative therapy|1
704860|NCT00033657|2286656|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
704861|NCT00033657|2286657|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
704862|NCT00033657|2286656|P2|Adjuvant Chemotherapy|Death|1
704863|NCT00033657|2286657|P1|Adjuvant Chemotherapy|Death|2
704864|NCT00033657|2286656|P2|Adjuvant Chemotherapy|Adverse Event|10
704865|NCT00033657|2286657|P1|Adjuvant Chemotherapy|Adverse Event|7
704866|NCT00033657|2286656|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
704867|NCT00033657|2286657|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
704868|NCT00033657|2286656|P2|Surgical Resection|not complete resection|3
704869|NCT00033657|2286657|P1|Surgical Resection|not complete resection|0
704870|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
704871|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
704872|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Ineligible|4
704873|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Ineligible|8
704874|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|other complicating disease|1
704875|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|other complicating disease|0
704876|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
704877|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
704878|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Death|1
704879|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Death|1
704880|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Adverse Event|2
704881|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Adverse Event|0
704882|NCT00033657|2286656|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
704883|NCT00033657|2286657|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
704884|NCT00025883|2286684|P1|Overall Study|didn't reach 6 months of Metreleptin|10
704885|NCT00025883|2286684|P1|Overall Study|Adverse Event|1
704886|NCT00025883|2286684|P1|Overall Study|Death|1
704887|NCT00025883|2286684|P1|Overall Study|no baseline data|1
704888|NCT00025883|2286684|P1|Overall Study|had atypical progeriod lipodystrophy|4
704889|NCT00026312|2286715|P2|Overall Study|Refusal by patient/parent/guardian|59
704890|NCT00026312|2286716|P1|Overall Study|Refusal by patient/parent/guardian|8
704891|NCT00026312|2286715|P2|Overall Study|Entry onto another COG study|1
704892|NCT00026312|2286716|P1|Overall Study|Entry onto another COG study|0
704893|NCT00026312|2286715|P2|Overall Study|Ineligible|5
704894|NCT00026312|2286716|P1|Overall Study|Ineligible|4
704895|NCT00026312|2286715|P2|Overall Study|Withdrawal by Subject|6
704896|NCT00026312|2286716|P1|Overall Study|Withdrawal by Subject|1
704897|NCT00026312|2286715|P2|Overall Study|Protocol Violation|3
704898|NCT00026312|2286716|P1|Overall Study|Protocol Violation|0
704899|NCT00026312|2286715|P2|Overall Study|Physician Decision|37
704900|NCT00026312|2286716|P1|Overall Study|Physician Decision|1
704901|NCT00026312|2286715|P2|Overall Study|Lost to Follow-up|5
704902|NCT00026312|2286716|P1|Overall Study|Lost to Follow-up|0
704903|NCT00026312|2286715|P2|Overall Study|Lack of Efficacy|114
704904|NCT00026312|2286716|P1|Overall Study|Lack of Efficacy|19
704905|NCT00026312|2286715|P2|Overall Study|Death|7
704906|NCT00026312|2286716|P1|Overall Study|Death|1
704907|NCT00026312|2286715|P2|Overall Study|Adverse Event|32
704908|NCT00026312|2286716|P1|Overall Study|Adverse Event|0
704909|NCT00026494|2286735|P4|Overall Study|Clinical progression|0
704910|NCT00026494|2286736|P3|Overall Study|Clinical progression|3
704911|NCT00026494|2286737|P2|Overall Study|Clinical progression|0
704912|NCT00026494|2286738|P1|Overall Study|Clinical progression|0
704913|NCT00026494|2286735|P4|Overall Study|Patient not treated|0
704914|NCT00026494|2286736|P3|Overall Study|Patient not treated|2
704915|NCT00026494|2286737|P2|Overall Study|Patient not treated|0
704916|NCT00026494|2286738|P1|Overall Study|Patient not treated|0
704917|NCT00026494|2286735|P4|Overall Study|Patient non-compliance|0
704918|NCT00026494|2286736|P3|Overall Study|Patient non-compliance|0
704919|NCT00026494|2286737|P2|Overall Study|Patient non-compliance|0
704920|NCT00026494|2286738|P1|Overall Study|Patient non-compliance|1
704921|NCT00026494|2286735|P4|Overall Study|Withdrawal by Subject|0
704922|NCT00026494|2286736|P3|Overall Study|Withdrawal by Subject|1
704923|NCT00026494|2286737|P2|Overall Study|Withdrawal by Subject|0
704924|NCT00026494|2286738|P1|Overall Study|Withdrawal by Subject|1
704925|NCT00027027|2286753|P5|Overall Study|Withdrawal by Subject|1
704926|NCT00027027|2286754|P4|Overall Study|Withdrawal by Subject|0
704927|NCT00027027|2286755|P3|Overall Study|Withdrawal by Subject|0
704928|NCT00027027|2286756|P2|Overall Study|Withdrawal by Subject|0
704929|NCT00027027|2286757|P1|Overall Study|Withdrawal by Subject|0
704930|NCT00027027|2286753|P5|Overall Study|Physician Decision Due To PD|5
704931|NCT00027027|2286754|P4|Overall Study|Physician Decision Due To PD|3
704932|NCT00027027|2286755|P3|Overall Study|Physician Decision Due To PD|2
704933|NCT00027027|2286756|P2|Overall Study|Physician Decision Due To PD|3
704934|NCT00027027|2286757|P1|Overall Study|Physician Decision Due To PD|2
704935|NCT00027027|2286753|P5|Overall Study|PD Requiring Surgery|0
704936|NCT00027027|2286754|P4|Overall Study|PD Requiring Surgery|0
704937|NCT00027027|2286755|P3|Overall Study|PD Requiring Surgery|1
704938|NCT00027027|2286756|P2|Overall Study|PD Requiring Surgery|0
704939|NCT00027027|2286757|P1|Overall Study|PD Requiring Surgery|0
704940|NCT00027027|2286753|P5|Overall Study|Clinical Symptoms Progression not PD|0
704941|NCT00027027|2286754|P4|Overall Study|Clinical Symptoms Progression not PD|0
704942|NCT00027027|2286755|P3|Overall Study|Clinical Symptoms Progression not PD|0
704943|NCT00027027|2286756|P2|Overall Study|Clinical Symptoms Progression not PD|0
704944|NCT00027027|2286757|P1|Overall Study|Clinical Symptoms Progression not PD|1
704945|NCT00027027|2286753|P5|Overall Study|Admitted for Signs of PD|1
704946|NCT00027027|2286754|P4|Overall Study|Admitted for Signs of PD|0
704947|NCT00027027|2286755|P3|Overall Study|Admitted for Signs of PD|0
704948|NCT00027027|2286756|P2|Overall Study|Admitted for Signs of PD|0
704949|NCT00027027|2286757|P1|Overall Study|Admitted for Signs of PD|0
704950|NCT00027027|2286753|P5|Overall Study|Adverse Event|1
704951|NCT00027027|2286754|P4|Overall Study|Adverse Event|0
704952|NCT00027027|2286755|P3|Overall Study|Adverse Event|1
704953|NCT00027027|2286756|P2|Overall Study|Adverse Event|0
704954|NCT00027027|2286757|P1|Overall Study|Adverse Event|0
704955|NCT00035555|2286805|P3|Overall Study|Received cyclosporin in error|1
704956|NCT00035555|2286806|P2|Overall Study|Received cyclosporin in error|0
704957|NCT00035555|2286807|P1|Overall Study|Received cyclosporin in error|0
704958|NCT00035555|2286805|P3|Overall Study|Investigator deemed not a good candidate|1
704959|NCT00035555|2286806|P2|Overall Study|Investigator deemed not a good candidate|0
704960|NCT00035555|2286807|P1|Overall Study|Investigator deemed not a good candidate|0
704961|NCT00035555|2286805|P3|Overall Study|Withdrawal by Subject|2
704962|NCT00035555|2286806|P2|Overall Study|Withdrawal by Subject|0
704963|NCT00035555|2286807|P1|Overall Study|Withdrawal by Subject|2
704964|NCT00035555|2286805|P3|Overall Study|Treatment failure/lack of efficacy|3
704965|NCT00035555|2286806|P2|Overall Study|Treatment failure/lack of efficacy|5
704966|NCT00035555|2286807|P1|Overall Study|Treatment failure/lack of efficacy|7
704967|NCT00035555|2286805|P3|Overall Study|Prohibited medication|0
704968|NCT00035555|2286806|P2|Overall Study|Prohibited medication|1
704969|NCT00035555|2286807|P1|Overall Study|Prohibited medication|1
704970|NCT00035555|2286805|P3|Overall Study|Noncompliance|1
704971|NCT00035555|2286806|P2|Overall Study|Noncompliance|1
704972|NCT00035555|2286807|P1|Overall Study|Noncompliance|0
704973|NCT00035555|2286805|P3|Overall Study|Lost to Follow-up|1
704974|NCT00035555|2286806|P2|Overall Study|Lost to Follow-up|0
704975|NCT00035555|2286807|P1|Overall Study|Lost to Follow-up|0
704976|NCT00035555|2286805|P3|Overall Study|Death|2
704977|NCT00035555|2286806|P2|Overall Study|Death|0
704978|NCT00035555|2286807|P1|Overall Study|Death|0
704979|NCT00035555|2286805|P3|Overall Study|Allograft loss|2
704980|NCT00035555|2286806|P2|Overall Study|Allograft loss|1
704981|NCT00035555|2286807|P1|Overall Study|Allograft loss|1
704982|NCT00035555|2286805|P3|Overall Study|Adverse Event|9
704983|NCT00035555|2286806|P2|Overall Study|Adverse Event|8
704984|NCT00035555|2286807|P1|Overall Study|Adverse Event|5
704985|NCT00035815|2286850|P2|Overall Study|Withdrawal by Subject|11
704986|NCT00035815|2286851|P1|Overall Study|Withdrawal by Subject|17
704987|NCT00035932|2286864|P3|Overall Study|Lack of Efficacy|28
704988|NCT00035932|2286865|P2|Overall Study|Lack of Efficacy|33
704989|NCT00035932|2286866|P1|Overall Study|Lack of Efficacy|33
704990|NCT00035932|2286864|P3|Overall Study|Study Termination by Sponsor|0
704991|NCT00035932|2286865|P2|Overall Study|Study Termination by Sponsor|0
704992|NCT00035932|2286866|P1|Overall Study|Study Termination by Sponsor|1
704993|NCT00035932|2286864|P3|Overall Study|Withdrawal by Subject|0
704994|NCT00035932|2286865|P2|Overall Study|Withdrawal by Subject|5
704995|NCT00035932|2286866|P1|Overall Study|Withdrawal by Subject|1
704996|NCT00035932|2286864|P3|Overall Study|Protocol Violation While on Study|2
704997|NCT00035932|2286865|P2|Overall Study|Protocol Violation While on Study|1
704998|NCT00035932|2286866|P1|Overall Study|Protocol Violation While on Study|0
704999|NCT00035932|2286864|P3|Overall Study|Noncompliance|6
705000|NCT00035932|2286865|P2|Overall Study|Noncompliance|7
705001|NCT00035932|2286866|P1|Overall Study|Noncompliance|6
705002|NCT00035932|2286864|P3|Overall Study|Lost to Follow-up|3
705003|NCT00035932|2286865|P2|Overall Study|Lost to Follow-up|4
705004|NCT00035932|2286866|P1|Overall Study|Lost to Follow-up|4
705005|NCT00035932|2286864|P3|Overall Study|Disease Progression / Relapse|0
705006|NCT00035932|2286865|P2|Overall Study|Disease Progression / Relapse|1
705007|NCT00035932|2286866|P1|Overall Study|Disease Progression / Relapse|1
705008|NCT00035932|2286864|P3|Overall Study|Death|1
705009|NCT00035932|2286865|P2|Overall Study|Death|0
705010|NCT00035932|2286866|P1|Overall Study|Death|0
705011|NCT00035932|2286864|P3|Overall Study|Adverse Event|9
705012|NCT00035932|2286865|P2|Overall Study|Adverse Event|9
705013|NCT00035932|2286866|P1|Overall Study|Adverse Event|10
705014|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
705015|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
705016|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Too early switch|103
705017|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Too early switch|0
705018|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
705019|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
705020|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Protocol Violation|91
705021|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Protocol Violation|23
705022|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
705023|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
705024|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Treatment refusal|208
705025|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Treatment refusal|113
705026|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Unspecified|288
705027|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Unspecified|277
705028|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Adverse Event|782
705029|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Adverse Event|501
705030|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
705031|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
705032|NCT00036270|2286992|P2|Study Treatment to 5 Year Report|Ongoing|736
705033|NCT00036270|2286993|P1|Study Treatment to 5 Year Report|Ongoing|1081
705034|NCT00036270|2286992|P2|Randomized to Study Treatment|Withdrawal by Subject|7
705035|NCT00036270|2286993|P1|Randomized to Study Treatment|Withdrawal by Subject|6
705036|NCT00037830|2287027|P3|Overall Study|Unrelated Medical Problem|0
705037|NCT00037830|2287028|P2|Overall Study|Unrelated Medical Problem|0
705038|NCT00037830|2287029|P1|Overall Study|Unrelated Medical Problem|2
705039|NCT00037830|2287027|P3|Overall Study|Protocol Violation|0
705040|NCT00037830|2287028|P2|Overall Study|Protocol Violation|2
705041|NCT00037830|2287029|P1|Overall Study|Protocol Violation|2
705042|NCT00037830|2287027|P3|Overall Study|Withdrawal by Subject|1
705043|NCT00037830|2287028|P2|Overall Study|Withdrawal by Subject|5
705044|NCT00037830|2287029|P1|Overall Study|Withdrawal by Subject|4
705045|NCT00037830|2287027|P3|Overall Study|Adverse Event|0
705046|NCT00037830|2287028|P2|Overall Study|Adverse Event|0
705047|NCT00037830|2287029|P1|Overall Study|Adverse Event|2
705048|NCT00030823|2287050|P1|Overall Study|Withdrawal by Subject|1
705049|NCT00030901|2287056|P3|Randomization|Ineligible|14
705050|NCT00030901|2287057|P2|Randomization|Ineligible|15
705051|NCT00030901|2287058|P1|Randomization|Ineligible|0
705052|NCT00030901|2287056|P3|Randomization|Other|33
705053|NCT00030901|2287057|P2|Randomization|Other|36
705054|NCT00030901|2287058|P1|Randomization|Other|0
705055|NCT00030901|2287056|P3|Randomization|Death|3
705056|NCT00030901|2287057|P2|Randomization|Death|1
705057|NCT00030901|2287058|P1|Randomization|Death|0
705058|NCT00030901|2287056|P3|Randomization|Progression/Relapse|21
705059|NCT00030901|2287057|P2|Randomization|Progression/Relapse|22
705060|NCT00030901|2287058|P1|Randomization|Progression/Relapse|0
705061|NCT00030901|2287056|P3|Randomization|Refusal Unrelated to Adverse Event|10
705062|NCT00030901|2287057|P2|Randomization|Refusal Unrelated to Adverse Event|16
705063|NCT00030901|2287058|P1|Randomization|Refusal Unrelated to Adverse Event|0
705064|NCT00030901|2287056|P3|Randomization|Adverse Event|7
705065|NCT00030901|2287057|P2|Randomization|Adverse Event|11
705066|NCT00030901|2287058|P1|Randomization|Adverse Event|0
705067|NCT00030901|2287056|P3|Initial Registration|Ineligible|0
705068|NCT00030901|2287057|P2|Initial Registration|Ineligible|0
705069|NCT00030901|2287058|P1|Initial Registration|Ineligible|167
705070|NCT00031447|2287073|P2|Overall Study|Disruption of blinded study drug supply|4
705071|NCT00031447|2287074|P1|Overall Study|Disruption of blinded study drug supply|7
705072|NCT00031447|2287073|P2|Overall Study|Re-activation of Disease|1
705073|NCT00031447|2287074|P1|Overall Study|Re-activation of Disease|2
705074|NCT00031447|2287073|P2|Overall Study|Non-compliant|1
705075|NCT00031447|2287074|P1|Overall Study|Non-compliant|1
705076|NCT00031447|2287073|P2|Overall Study|Lost to Follow-up|1
705077|NCT00031447|2287074|P1|Overall Study|Lost to Follow-up|0
705078|NCT00031460|2287088|P2|Overall Study|Confirmed unevaluable|1
705079|NCT00031460|2287089|P1|Overall Study|Confirmed unevaluable|0
705080|NCT00031460|2287088|P2|Overall Study|Disruption of blinded drug supply|0
705081|NCT00031460|2287089|P1|Overall Study|Disruption of blinded drug supply|2
705082|NCT00031460|2287088|P2|Overall Study|Reactivation of Disease|9
705083|NCT00031460|2287089|P1|Overall Study|Reactivation of Disease|5
705084|NCT00031460|2287088|P2|Overall Study|Death|1
705085|NCT00031460|2287089|P1|Overall Study|Death|0
705086|NCT00031460|2287088|P2|Overall Study|Non-Compliant|1
705087|NCT00031460|2287089|P1|Overall Study|Non-Compliant|1
705088|NCT00031460|2287088|P2|Overall Study|Withdrawal by Subject|1
705089|NCT00031460|2287089|P1|Overall Study|Withdrawal by Subject|1
705090|NCT00031460|2287088|P2|Overall Study|Lost to Follow-up|1
705091|NCT00031460|2287089|P1|Overall Study|Lost to Follow-up|0
889737|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889738|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889739|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889740|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889741|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889742|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
889743|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
889744|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
889745|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889746|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
705108|NCT00031694|2287141|P1|Overall Study|Withdrawal by Subject|5
705109|NCT00031694|2287141|P1|Overall Study|Death|2
705110|NCT00031694|2287141|P1|Overall Study|Adverse Event|12
705111|NCT00038103|2287147|P2|Overall Study|Randomized/never treated|0
705112|NCT00038103|2287148|P1|Overall Study|Randomized/never treated|2
705113|NCT00038103|2287147|P2|Overall Study|Sponsor Decision|1
705114|NCT00038103|2287148|P1|Overall Study|Sponsor Decision|0
705115|NCT00038103|2287147|P2|Overall Study|Protocol Violation|2
705116|NCT00038103|2287148|P1|Overall Study|Protocol Violation|0
705117|NCT00038103|2287147|P2|Overall Study|Lost to Follow-up|3
705118|NCT00038103|2287148|P1|Overall Study|Lost to Follow-up|0
705119|NCT00038103|2287147|P2|Overall Study|Withdrawal by Subject|3
705120|NCT00038103|2287148|P1|Overall Study|Withdrawal by Subject|0
705121|NCT00038103|2287147|P2|Overall Study|Lack of Efficacy|41
705122|NCT00038103|2287148|P1|Overall Study|Lack of Efficacy|48
705123|NCT00038103|2287147|P2|Overall Study|Adverse Event|6
705124|NCT00038103|2287148|P1|Overall Study|Adverse Event|5
705125|NCT00040664|2287168|P4|Overall Study|Non-viability of oral suspension|0
705126|NCT00040664|2287169|P3|Overall Study|Non-viability of oral suspension|1
705127|NCT00040664|2287170|P2|Overall Study|Non-viability of oral suspension|0
705128|NCT00040664|2287171|P1|Overall Study|Non-viability of oral suspension|1
705129|NCT00040664|2287168|P4|Overall Study|Change of formulation|0
705130|NCT00040664|2287169|P3|Overall Study|Change of formulation|0
705131|NCT00040664|2287170|P2|Overall Study|Change of formulation|2
705132|NCT00040664|2287171|P1|Overall Study|Change of formulation|2
705133|NCT00040664|2287168|P4|Overall Study|Pharmacokinetic target not achieved|1
705134|NCT00040664|2287169|P3|Overall Study|Pharmacokinetic target not achieved|0
705135|NCT00040664|2287170|P2|Overall Study|Pharmacokinetic target not achieved|1
705136|NCT00040664|2287171|P1|Overall Study|Pharmacokinetic target not achieved|2
705137|NCT00040664|2287168|P4|Overall Study|Poor taste|0
705138|NCT00040664|2287169|P3|Overall Study|Poor taste|2
705139|NCT00040664|2287170|P2|Overall Study|Poor taste|0
705140|NCT00040664|2287171|P1|Overall Study|Poor taste|2
705141|NCT00040664|2287168|P4|Overall Study|Medication adherence/compliance problems|5
705142|NCT00040664|2287169|P3|Overall Study|Medication adherence/compliance problems|1
705143|NCT00040664|2287170|P2|Overall Study|Medication adherence/compliance problems|2
705144|NCT00040664|2287171|P1|Overall Study|Medication adherence/compliance problems|8
705145|NCT00040664|2287168|P4|Overall Study|Pregnancy|3
705146|NCT00040664|2287169|P3|Overall Study|Pregnancy|0
705147|NCT00040664|2287170|P2|Overall Study|Pregnancy|0
705148|NCT00040664|2287171|P1|Overall Study|Pregnancy|3
705149|NCT00040664|2287168|P4|Overall Study|Withdrawal by Subject|4
705150|NCT00040664|2287169|P3|Overall Study|Withdrawal by Subject|3
705151|NCT00040664|2287170|P2|Overall Study|Withdrawal by Subject|0
705152|NCT00040664|2287171|P1|Overall Study|Withdrawal by Subject|7
705153|NCT00040664|2287168|P4|Overall Study|Protocol Violation|1
705154|NCT00040664|2287169|P3|Overall Study|Protocol Violation|0
705155|NCT00040664|2287170|P2|Overall Study|Protocol Violation|1
705156|NCT00040664|2287171|P1|Overall Study|Protocol Violation|2
705157|NCT00040664|2287168|P4|Overall Study|Lost to Follow-up|2
705158|NCT00040664|2287169|P3|Overall Study|Lost to Follow-up|0
705159|NCT00040664|2287170|P2|Overall Study|Lost to Follow-up|2
705160|NCT00040664|2287171|P1|Overall Study|Lost to Follow-up|4
705161|NCT00040664|2287168|P4|Overall Study|Insufficient CD4 response|0
705162|NCT00040664|2287169|P3|Overall Study|Insufficient CD4 response|1
705163|NCT00040664|2287170|P2|Overall Study|Insufficient CD4 response|0
705164|NCT00040664|2287171|P1|Overall Study|Insufficient CD4 response|1
705165|NCT00040664|2287168|P4|Overall Study|Lack of Efficacy|4
705166|NCT00040664|2287169|P3|Overall Study|Lack of Efficacy|3
705167|NCT00040664|2287170|P2|Overall Study|Lack of Efficacy|2
705168|NCT00040664|2287171|P1|Overall Study|Lack of Efficacy|9
705169|NCT00040664|2287168|P4|Overall Study|Adverse Event|7
705170|NCT00040664|2287169|P3|Overall Study|Adverse Event|2
705171|NCT00040664|2287170|P2|Overall Study|Adverse Event|3
705172|NCT00040664|2287171|P1|Overall Study|Adverse Event|12
705173|NCT00040742|2287223|P4|Overall Study|Other medical|5
705174|NCT00040742|2287224|P3|Overall Study|Other medical|5
705175|NCT00040742|2287225|P2|Overall Study|Other medical|5
705176|NCT00040742|2287226|P1|Overall Study|Other medical|7
705177|NCT00040742|2287223|P4|Overall Study|Incomplete Forms|5
705178|NCT00040742|2287224|P3|Overall Study|Incomplete Forms|4
705179|NCT00040742|2287225|P2|Overall Study|Incomplete Forms|10
705180|NCT00040742|2287226|P1|Overall Study|Incomplete Forms|6
705181|NCT00040742|2287223|P4|Overall Study|Chemotoxicity|2
705182|NCT00040742|2287224|P3|Overall Study|Chemotoxicity|5
705183|NCT00040742|2287225|P2|Overall Study|Chemotoxicity|3
705184|NCT00040742|2287226|P1|Overall Study|Chemotoxicity|4
705185|NCT00040742|2287223|P4|Overall Study|Withdrawal by Subject|13
705186|NCT00040742|2287224|P3|Overall Study|Withdrawal by Subject|10
705187|NCT00040742|2287225|P2|Overall Study|Withdrawal by Subject|15
705188|NCT00040742|2287226|P1|Overall Study|Withdrawal by Subject|7
705189|NCT00040742|2287223|P4|Overall Study|Adverse Event|9
705190|NCT00040742|2287224|P3|Overall Study|Adverse Event|21
705191|NCT00040742|2287225|P2|Overall Study|Adverse Event|16
705192|NCT00040742|2287226|P1|Overall Study|Adverse Event|15
705193|NCT00040742|2287223|P4|Overall Study|Death|0
705194|NCT00040742|2287224|P3|Overall Study|Death|1
705195|NCT00040742|2287225|P2|Overall Study|Death|0
705196|NCT00040742|2287226|P1|Overall Study|Death|0
705197|NCT00041067|2287296|P1|Overall Study|Ineligible|2
705198|NCT00041067|2287296|P1|Overall Study|Other reasons|23
705199|NCT00041067|2287296|P1|Overall Study|Patient refusal|12
705200|NCT00041067|2287296|P1|Overall Study|Progression|19
705201|NCT00041067|2287296|P1|Overall Study|Adverse Event|20
705202|NCT00041080|2287305|P2|Overall Study|Ineligible|0
705203|NCT00041080|2287306|P1|Overall Study|Ineligible|1
705204|NCT00041080|2287305|P2|Overall Study|Did not start therapy|1
705205|NCT00041080|2287306|P1|Overall Study|Did not start therapy|1
705206|NCT00041080|2287305|P2|Overall Study|Concommitant Illness/Other|2
705207|NCT00041080|2287306|P1|Overall Study|Concommitant Illness/Other|1
705208|NCT00041080|2287305|P2|Overall Study|Withdrawal by Subject|6
705209|NCT00041080|2287306|P1|Overall Study|Withdrawal by Subject|6
705210|NCT00041080|2287305|P2|Overall Study|Adverse Event|1
705211|NCT00041080|2287306|P1|Overall Study|Adverse Event|21
705212|NCT00041132|2287339|P1|Overall Study|Physician Decision|2
705213|NCT00041132|2287339|P1|Overall Study|Withdrawal by Subject|1
705214|NCT00041132|2287339|P1|Overall Study|Not Eligible|7
705215|NCT00041132|2287339|P1|Overall Study|Death|1
705216|NCT00041132|2287339|P1|Overall Study|Adverse Event|19
705217|NCT00041470|2287354|P1|Overall Study|Loss of Funding|38
705218|NCT00041756|2287375|P5|Overall Study|Data Monitoring Committee Recommendation|21
705219|NCT00041756|2287376|P4|Overall Study|Data Monitoring Committee Recommendation|0
705220|NCT00041756|2287377|P3|Overall Study|Data Monitoring Committee Recommendation|0
705221|NCT00041756|2287378|P2|Overall Study|Data Monitoring Committee Recommendation|0
705222|NCT00041756|2287379|P1|Overall Study|Data Monitoring Committee Recommendation|0
705223|NCT00041756|2287375|P5|Overall Study|Unable to meet protocol criteria|1
705224|NCT00041756|2287376|P4|Overall Study|Unable to meet protocol criteria|0
705225|NCT00041756|2287377|P3|Overall Study|Unable to meet protocol criteria|1
705226|NCT00041756|2287378|P2|Overall Study|Unable to meet protocol criteria|0
705227|NCT00041756|2287379|P1|Overall Study|Unable to meet protocol criteria|0
705228|NCT00041756|2287375|P5|Overall Study|Lost to Follow-up|0
705229|NCT00041756|2287376|P4|Overall Study|Lost to Follow-up|1
705230|NCT00041756|2287377|P3|Overall Study|Lost to Follow-up|0
705231|NCT00041756|2287378|P2|Overall Study|Lost to Follow-up|1
705232|NCT00041756|2287379|P1|Overall Study|Lost to Follow-up|0
705233|NCT00041756|2287375|P5|Overall Study|Withdrawal by Subject|3
705234|NCT00041756|2287376|P4|Overall Study|Withdrawal by Subject|2
705235|NCT00041756|2287377|P3|Overall Study|Withdrawal by Subject|4
705236|NCT00041756|2287378|P2|Overall Study|Withdrawal by Subject|3
705237|NCT00041756|2287379|P1|Overall Study|Withdrawal by Subject|3
705238|NCT00041756|2287375|P5|Overall Study|Protocol Violation|1
705239|NCT00041756|2287376|P4|Overall Study|Protocol Violation|2
705240|NCT00041756|2287377|P3|Overall Study|Protocol Violation|2
705241|NCT00041756|2287378|P2|Overall Study|Protocol Violation|1
705242|NCT00041756|2287379|P1|Overall Study|Protocol Violation|1
705243|NCT00041756|2287375|P5|Overall Study|Adverse Event|34
705244|NCT00041756|2287376|P4|Overall Study|Adverse Event|11
705245|NCT00041756|2287377|P3|Overall Study|Adverse Event|6
705246|NCT00041756|2287378|P2|Overall Study|Adverse Event|10
705247|NCT00041756|2287379|P1|Overall Study|Adverse Event|4
705248|NCT00042432|2287438|P2|Overall Study|Other|0
705249|NCT00042432|2287439|P1|Overall Study|Other|2
705250|NCT00042432|2287438|P2|Overall Study|Initiation of maintenance dialysis|1
705251|NCT00042432|2287439|P1|Overall Study|Initiation of maintenance dialysis|1
705252|NCT00042432|2287438|P2|Overall Study|Ineligibility determined|0
705253|NCT00042432|2287439|P1|Overall Study|Ineligibility determined|1
705254|NCT00042432|2287438|P2|Overall Study|Death|2
705255|NCT00042432|2287439|P1|Overall Study|Death|0
705256|NCT00042432|2287438|P2|Overall Study|Withdrawal by Subject|3
705257|NCT00042432|2287439|P1|Overall Study|Withdrawal by Subject|1
705258|NCT00042432|2287438|P2|Overall Study|Adverse Event|1
705259|NCT00042432|2287439|P1|Overall Study|Adverse Event|4
705260|NCT00042939|2287449|P2|Overall Study|Did not start treatment|1
705261|NCT00042939|2287450|P1|Overall Study|Did not start treatment|2
705262|NCT00042939|2287449|P2|Overall Study|Treatment break > 4 weeks|1
705263|NCT00042939|2287450|P1|Overall Study|Treatment break > 4 weeks|0
705264|NCT00042939|2287449|P2|Overall Study|Still on treatment|0
705265|NCT00042939|2287450|P1|Overall Study|Still on treatment|1
705266|NCT00042939|2287449|P2|Overall Study|Patient non-compliance|0
705267|NCT00042939|2287450|P1|Overall Study|Patient non-compliance|1
705268|NCT00042939|2287449|P2|Overall Study|Rising ca 19-9|0
705269|NCT00042939|2287450|P1|Overall Study|Rising ca 19-9|1
705270|NCT00042939|2287449|P2|Overall Study|QOL diminished|0
705271|NCT00042939|2287450|P1|Overall Study|QOL diminished|1
705272|NCT00042939|2287449|P2|Overall Study|Deterioration of health|4
705273|NCT00042939|2287450|P1|Overall Study|Deterioration of health|3
705274|NCT00042939|2287449|P2|Overall Study|Ineligible|2
705275|NCT00042939|2287450|P1|Overall Study|Ineligible|2
705276|NCT00042939|2287449|P2|Overall Study|Other disease|0
705277|NCT00042939|2287450|P1|Overall Study|Other disease|1
705278|NCT00042939|2287449|P2|Overall Study|Withdrawal by Subject|4
705279|NCT00042939|2287450|P1|Overall Study|Withdrawal by Subject|3
705280|NCT00042939|2287449|P2|Overall Study|Death|2
705281|NCT00042939|2287450|P1|Overall Study|Death|3
705282|NCT00042939|2287449|P2|Overall Study|Adverse Event|7
705283|NCT00042939|2287450|P1|Overall Study|Adverse Event|6
705284|NCT00042991|2287471|P7|Overall Study|Alternative Therapy|0
705285|NCT00042991|2287472|P6|Overall Study|Alternative Therapy|0
705286|NCT00042991|2287473|P5|Overall Study|Alternative Therapy|1
705287|NCT00042991|2287474|P4|Overall Study|Alternative Therapy|0
705288|NCT00042991|2287475|P3|Overall Study|Alternative Therapy|0
705289|NCT00042991|2287476|P2|Overall Study|Alternative Therapy|0
705290|NCT00042991|2287477|P1|Overall Study|Alternative Therapy|0
705291|NCT00042991|2287471|P7|Overall Study|Disease Progression|2
705292|NCT00042991|2287472|P6|Overall Study|Disease Progression|4
705293|NCT00042991|2287473|P5|Overall Study|Disease Progression|1
705294|NCT00042991|2287474|P4|Overall Study|Disease Progression|2
705295|NCT00042991|2287475|P3|Overall Study|Disease Progression|2
705296|NCT00042991|2287476|P2|Overall Study|Disease Progression|29
705297|NCT00042991|2287477|P1|Overall Study|Disease Progression|5
705298|NCT00042991|2287471|P7|Overall Study|Withdrawal by Subject|0
705299|NCT00042991|2287472|P6|Overall Study|Withdrawal by Subject|0
705300|NCT00042991|2287473|P5|Overall Study|Withdrawal by Subject|1
705301|NCT00042991|2287474|P4|Overall Study|Withdrawal by Subject|0
705302|NCT00042991|2287475|P3|Overall Study|Withdrawal by Subject|2
705303|NCT00042991|2287476|P2|Overall Study|Withdrawal by Subject|7
705304|NCT00042991|2287477|P1|Overall Study|Withdrawal by Subject|0
705305|NCT00042991|2287471|P7|Overall Study|Adverse Event|0
705306|NCT00042991|2287472|P6|Overall Study|Adverse Event|1
705307|NCT00042991|2287473|P5|Overall Study|Adverse Event|0
705308|NCT00042991|2287474|P4|Overall Study|Adverse Event|0
705309|NCT00042991|2287475|P3|Overall Study|Adverse Event|2
705310|NCT00042991|2287476|P2|Overall Study|Adverse Event|4
705311|NCT00042991|2287477|P1|Overall Study|Adverse Event|1
705312|NCT00043186|2287527|P9|Overall Study|Other|0
705313|NCT00043186|2287528|P8|Overall Study|Other|0
705314|NCT00043186|2287529|P7|Overall Study|Other|0
705315|NCT00043186|2287530|P6|Overall Study|Other|0
705316|NCT00043186|2287531|P5|Overall Study|Other|0
705317|NCT00043186|2287532|P4|Overall Study|Other|1
705318|NCT00043186|2287533|P3|Overall Study|Other|1
705319|NCT00043186|2287534|P2|Overall Study|Other|0
705320|NCT00043186|2287535|P1|Overall Study|Other|0
705321|NCT00043186|2287527|P9|Overall Study|Noncompliance|0
705322|NCT00043186|2287528|P8|Overall Study|Noncompliance|0
705323|NCT00043186|2287529|P7|Overall Study|Noncompliance|0
705324|NCT00043186|2287530|P6|Overall Study|Noncompliance|0
705325|NCT00043186|2287531|P5|Overall Study|Noncompliance|0
705326|NCT00043186|2287532|P4|Overall Study|Noncompliance|1
705327|NCT00043186|2287533|P3|Overall Study|Noncompliance|1
705328|NCT00043186|2287534|P2|Overall Study|Noncompliance|0
705329|NCT00043186|2287535|P1|Overall Study|Noncompliance|0
705330|NCT00043186|2287527|P9|Overall Study|Lost to Follow-up|2
705331|NCT00043186|2287528|P8|Overall Study|Lost to Follow-up|1
705332|NCT00043186|2287529|P7|Overall Study|Lost to Follow-up|1
705333|NCT00043186|2287530|P6|Overall Study|Lost to Follow-up|1
705334|NCT00043186|2287531|P5|Overall Study|Lost to Follow-up|1
705335|NCT00043186|2287532|P4|Overall Study|Lost to Follow-up|1
705336|NCT00043186|2287533|P3|Overall Study|Lost to Follow-up|1
705337|NCT00043186|2287534|P2|Overall Study|Lost to Follow-up|5
705338|NCT00043186|2287535|P1|Overall Study|Lost to Follow-up|3
705339|NCT00043186|2287527|P9|Overall Study|Ineligibility determined|1
705340|NCT00043186|2287528|P8|Overall Study|Ineligibility determined|0
705341|NCT00043186|2287529|P7|Overall Study|Ineligibility determined|0
705342|NCT00043186|2287530|P6|Overall Study|Ineligibility determined|0
705343|NCT00043186|2287531|P5|Overall Study|Ineligibility determined|0
705344|NCT00043186|2287532|P4|Overall Study|Ineligibility determined|0
705345|NCT00043186|2287533|P3|Overall Study|Ineligibility determined|0
705346|NCT00043186|2287534|P2|Overall Study|Ineligibility determined|0
705347|NCT00043186|2287535|P1|Overall Study|Ineligibility determined|0
705348|NCT00043186|2287527|P9|Overall Study|Disease progression|0
705349|NCT00043186|2287528|P8|Overall Study|Disease progression|4
705350|NCT00043186|2287529|P7|Overall Study|Disease progression|0
705351|NCT00043186|2287530|P6|Overall Study|Disease progression|0
705352|NCT00043186|2287531|P5|Overall Study|Disease progression|0
705353|NCT00043186|2287532|P4|Overall Study|Disease progression|3
705354|NCT00043186|2287533|P3|Overall Study|Disease progression|0
705355|NCT00043186|2287534|P2|Overall Study|Disease progression|0
705356|NCT00043186|2287535|P1|Overall Study|Disease progression|1
705357|NCT00043186|2287527|P9|Overall Study|Death|0
705358|NCT00043186|2287528|P8|Overall Study|Death|0
705359|NCT00043186|2287529|P7|Overall Study|Death|2
705360|NCT00043186|2287530|P6|Overall Study|Death|0
705361|NCT00043186|2287531|P5|Overall Study|Death|0
705362|NCT00043186|2287532|P4|Overall Study|Death|0
705363|NCT00043186|2287533|P3|Overall Study|Death|1
705364|NCT00043186|2287534|P2|Overall Study|Death|0
705365|NCT00043186|2287535|P1|Overall Study|Death|0
705366|NCT00043186|2287527|P9|Overall Study|Withdrawal by Subject|10
705367|NCT00043186|2287528|P8|Overall Study|Withdrawal by Subject|9
705368|NCT00043186|2287529|P7|Overall Study|Withdrawal by Subject|12
705369|NCT00043186|2287530|P6|Overall Study|Withdrawal by Subject|6
705370|NCT00043186|2287531|P5|Overall Study|Withdrawal by Subject|14
705371|NCT00043186|2287532|P4|Overall Study|Withdrawal by Subject|13
705372|NCT00043186|2287533|P3|Overall Study|Withdrawal by Subject|11
705373|NCT00043186|2287534|P2|Overall Study|Withdrawal by Subject|8
705374|NCT00043186|2287535|P1|Overall Study|Withdrawal by Subject|11
705375|NCT00043186|2287527|P9|Overall Study|Adverse Event|3
705376|NCT00043186|2287528|P8|Overall Study|Adverse Event|1
705377|NCT00043186|2287529|P7|Overall Study|Adverse Event|2
705378|NCT00043186|2287530|P6|Overall Study|Adverse Event|1
705379|NCT00043186|2287531|P5|Overall Study|Adverse Event|2
705380|NCT00043186|2287532|P4|Overall Study|Adverse Event|3
705381|NCT00043186|2287533|P3|Overall Study|Adverse Event|2
705382|NCT00043186|2287534|P2|Overall Study|Adverse Event|2
705383|NCT00043186|2287535|P1|Overall Study|Adverse Event|2
705384|NCT00043186|2287527|P9|Overall Study|Physician Decision|1
705385|NCT00043186|2287528|P8|Overall Study|Physician Decision|1
705386|NCT00043186|2287529|P7|Overall Study|Physician Decision|0
705387|NCT00043186|2287530|P6|Overall Study|Physician Decision|0
705388|NCT00043186|2287531|P5|Overall Study|Physician Decision|1
705389|NCT00043186|2287532|P4|Overall Study|Physician Decision|0
705390|NCT00043186|2287533|P3|Overall Study|Physician Decision|3
705391|NCT00043186|2287534|P2|Overall Study|Physician Decision|0
705392|NCT00043186|2287535|P1|Overall Study|Physician Decision|0
705393|NCT00046930|2287863|P2|Overall Study|Ineligible|4
705394|NCT00046930|2287864|P1|Overall Study|Ineligible|12
705395|NCT00047008|2287879|P2|Overall Study|Ineligible|8
705396|NCT00047008|2287880|P1|Overall Study|Ineligible|9
705397|NCT00047008|2287879|P2|Overall Study|Withdrawn consent|3
705398|NCT00047008|2287880|P1|Overall Study|Withdrawn consent|2
705399|NCT00047320|2287886|P1|Overall Study|Ineligible|3
705400|NCT00047320|2287886|P1|Overall Study|Withdrawal by Subject|6
705401|NCT00047320|2287886|P1|Overall Study|Physician Decision|8
705402|NCT00047320|2287886|P1|Overall Study|Lost to Follow-up|1
705403|NCT00047320|2287886|P1|Overall Study|Lack of Efficacy|10
705404|NCT00047385|2287892|P2|Overall Study|Eligible for screening but had no screen|492
705405|NCT00047385|2287893|P1|Overall Study|Eligible for screening but had no screen|260
705406|NCT00047385|2287892|P2|Overall Study|Lung Cancer diagnosed before screening|3
705407|NCT00047385|2287893|P1|Overall Study|Lung Cancer diagnosed before screening|5
705408|NCT00047385|2287892|P2|Overall Study|Death before any screening|5
705409|NCT00047385|2287893|P1|Overall Study|Death before any screening|2
705410|NCT00047463|2287913|P2|Overall Study|Withdrawal by Subject|3
705411|NCT00047463|2287914|P1|Overall Study|Withdrawal by Subject|0
705412|NCT00047879|2287949|P2|Overall Study|Progressive disease|3
705413|NCT00047879|2287950|P1|Overall Study|Progressive disease|4
705414|NCT00048035|2287966|P8|Extension Year 2|Early Withdrawals|3
705415|NCT00048035|2287967|P7|Extension Year 2|Early Withdrawals|3
705416|NCT00048035|2287968|P6|Extension Year 2|Early Withdrawals|0
705417|NCT00048035|2287969|P5|Extension Year 2|Early Withdrawals|0
705418|NCT00048035|2287970|P4|Extension Year 2|Early Withdrawals|0
705419|NCT00048035|2287971|P3|Extension Year 2|Early Withdrawals|0
705420|NCT00048035|2287972|P2|Extension Year 2|Early Withdrawals|0
705421|NCT00048035|2287973|P1|Extension Year 2|Early Withdrawals|0
705422|NCT00048035|2287966|P8|Extension Year 1|Early Withdrawals|11
705423|NCT00048035|2287967|P7|Extension Year 1|Early Withdrawals|11
705424|NCT00048035|2287968|P6|Extension Year 1|Early Withdrawals|0
705425|NCT00048035|2287969|P5|Extension Year 1|Early Withdrawals|0
705426|NCT00048035|2287970|P4|Extension Year 1|Early Withdrawals|0
705427|NCT00048035|2287971|P3|Extension Year 1|Early Withdrawals|0
705428|NCT00048035|2287972|P2|Extension Year 1|Early Withdrawals|0
705429|NCT00048035|2287973|P1|Extension Year 1|Early Withdrawals|0
705430|NCT00048035|2287966|P8|Core Period|Early Withdrawals|0
705431|NCT00048035|2287967|P7|Core Period|Early Withdrawals|0
705432|NCT00048035|2287968|P6|Core Period|Early Withdrawals|1
705433|NCT00048035|2287969|P5|Core Period|Early Withdrawals|1
705434|NCT00048035|2287970|P4|Core Period|Early Withdrawals|1
705435|NCT00048035|2287971|P3|Core Period|Early Withdrawals|1
705436|NCT00048035|2287972|P2|Core Period|Early Withdrawals|2
705437|NCT00048035|2287973|P1|Core Period|Early Withdrawals|4
705438|NCT00048061|2288013|P4|Overall Study|Early improvement|0
705439|NCT00048061|2288014|P3|Overall Study|Early improvement|3
705440|NCT00048061|2288015|P2|Overall Study|Early improvement|5
705441|NCT00048061|2288016|P1|Overall Study|Early improvement|6
705442|NCT00048061|2288013|P4|Overall Study|Did not follow-up|5
705443|NCT00048061|2288014|P3|Overall Study|Did not follow-up|4
705444|NCT00048061|2288015|P2|Overall Study|Did not follow-up|5
705445|NCT00048061|2288016|P1|Overall Study|Did not follow-up|5
705446|NCT00048061|2288013|P4|Overall Study|Withdrawal by Subject|32
705447|NCT00048061|2288014|P3|Overall Study|Withdrawal by Subject|29
705448|NCT00048061|2288015|P2|Overall Study|Withdrawal by Subject|29
705449|NCT00048061|2288016|P1|Overall Study|Withdrawal by Subject|20
705450|NCT00048061|2288013|P4|Overall Study|Lost to Follow-up|5
705451|NCT00048061|2288014|P3|Overall Study|Lost to Follow-up|4
705452|NCT00048061|2288015|P2|Overall Study|Lost to Follow-up|2
705453|NCT00048061|2288016|P1|Overall Study|Lost to Follow-up|3
705454|NCT00048061|2288013|P4|Overall Study|Adverse Event|37
705455|NCT00048061|2288014|P3|Overall Study|Adverse Event|44
705456|NCT00048061|2288015|P2|Overall Study|Adverse Event|32
705457|NCT00048061|2288016|P1|Overall Study|Adverse Event|41
705458|NCT00048074|2288089|P3|Overall Study|Social reasons|0
705459|NCT00048074|2288090|P2|Overall Study|Social reasons|0
705460|NCT00048074|2288091|P1|Overall Study|Social reasons|1
705461|NCT00048074|2288089|P3|Overall Study|Out of station|1
705462|NCT00048074|2288090|P2|Overall Study|Out of station|1
705463|NCT00048074|2288091|P1|Overall Study|Out of station|0
705464|NCT00048074|2288089|P3|Overall Study|Poor compliance|0
705465|NCT00048074|2288090|P2|Overall Study|Poor compliance|1
705466|NCT00048074|2288091|P1|Overall Study|Poor compliance|0
705467|NCT00048074|2288089|P3|Overall Study|Husband ill|0
705468|NCT00048074|2288090|P2|Overall Study|Husband ill|1
705469|NCT00048074|2288091|P1|Overall Study|Husband ill|0
705470|NCT00048074|2288089|P3|Overall Study|Study participation was terminated|0
705471|NCT00048074|2288090|P2|Overall Study|Study participation was terminated|1
705472|NCT00048074|2288091|P1|Overall Study|Study participation was terminated|0
705473|NCT00048074|2288089|P3|Overall Study|Protocol Violation|0
705474|NCT00048074|2288090|P2|Overall Study|Protocol Violation|3
705475|NCT00048074|2288091|P1|Overall Study|Protocol Violation|1
705476|NCT00048074|2288089|P3|Overall Study|Withdrawal by Subject|35
705477|NCT00048074|2288090|P2|Overall Study|Withdrawal by Subject|30
705478|NCT00048074|2288091|P1|Overall Study|Withdrawal by Subject|28
705479|NCT00048074|2288089|P3|Overall Study|Lost to Follow-up|6
705480|NCT00048074|2288090|P2|Overall Study|Lost to Follow-up|6
705481|NCT00048074|2288091|P1|Overall Study|Lost to Follow-up|2
705482|NCT00048074|2288089|P3|Overall Study|Death|2
705483|NCT00048074|2288090|P2|Overall Study|Death|3
705484|NCT00048074|2288091|P1|Overall Study|Death|3
705485|NCT00048074|2288089|P3|Overall Study|Adverse Event|53
705486|NCT00048074|2288090|P2|Overall Study|Adverse Event|41
705487|NCT00048074|2288091|P1|Overall Study|Adverse Event|46
705488|NCT00048165|2288146|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
705489|NCT00048165|2288147|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
705490|NCT00048165|2288146|P2|Completed 12 Months Study|Death|1
705491|NCT00048165|2288147|P1|Completed 12 Months Study|Death|2
705492|NCT00048165|2288146|P2|Completed 12 Months Study|Administration/Other|2
705493|NCT00048165|2288147|P1|Completed 12 Months Study|Administration/Other|0
705494|NCT00048165|2288146|P2|Completed 6 Months Study|Did not receive study drug|6
705495|NCT00048165|2288147|P1|Completed 6 Months Study|Did not receive study drug|6
705496|NCT00048165|2288146|P2|Completed 6 Months Study|Violation criteria|2
705497|NCT00048165|2288147|P1|Completed 6 Months Study|Violation criteria|0
705498|NCT00048165|2288146|P2|Completed 6 Months Study|Refused treatment|5
705499|NCT00048165|2288147|P1|Completed 6 Months Study|Refused treatment|5
705500|NCT00048165|2288146|P2|Completed 6 Months Study|Other violation|6
705501|NCT00048165|2288147|P1|Completed 6 Months Study|Other violation|4
705502|NCT00048165|2288146|P2|Completed 6 Months Study|Insufficient therapy|4
705503|NCT00048165|2288147|P1|Completed 6 Months Study|Insufficient therapy|1
705504|NCT00048165|2288146|P2|Completed 6 Months Study|Death|6
705505|NCT00048165|2288147|P1|Completed 6 Months Study|Death|12
705506|NCT00048165|2288146|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
705507|NCT00048165|2288147|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
705508|NCT00048165|2288146|P2|Completed 6 Months Study|Abnormality of laboratory test|0
705509|NCT00048165|2288147|P1|Completed 6 Months Study|Abnormality of laboratory test|1
705510|NCT00048165|2288146|P2|Completed 6 Months Study|Administration/Other|8
705511|NCT00048165|2288147|P1|Completed 6 Months Study|Administration/Other|8
705512|NCT00048347|2288179|P1|Overall Study|Screen failure|2
705513|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
705514|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
705515|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705516|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705517|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705518|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705519|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705520|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
705521|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
705522|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
705523|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705524|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705525|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705526|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705527|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705528|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
705529|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
705530|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
705531|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705532|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705533|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705534|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705535|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705536|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
705537|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
705538|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
705539|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705540|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705541|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705542|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705543|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705544|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
705545|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
705546|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
705547|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705548|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705549|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705550|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705551|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705552|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
705553|NCT00048542|2288187|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
705554|NCT00048542|2288188|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
705555|NCT00048542|2288189|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705556|NCT00048542|2288190|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705557|NCT00048542|2288191|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705558|NCT00048542|2288192|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705559|NCT00048542|2288193|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705560|NCT00048542|2288194|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
705561|NCT00048542|2288187|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
705562|NCT00048542|2288188|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
705563|NCT00048542|2288189|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
705564|NCT00048542|2288190|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
705565|NCT00048542|2288191|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
705566|NCT00048542|2288192|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
705567|NCT00048542|2288193|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
705568|NCT00048542|2288194|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
705569|NCT00048542|2288187|P8|Open-Label Extension BSA Phase|Adverse Event|0
705570|NCT00048542|2288188|P7|Open-Label Extension BSA Phase|Adverse Event|0
705571|NCT00048542|2288189|P6|Open-Label Extension BSA Phase|Adverse Event|1
705572|NCT00048542|2288190|P5|Open-Label Extension BSA Phase|Adverse Event|1
705573|NCT00048542|2288191|P4|Open-Label Extension BSA Phase|Adverse Event|0
705574|NCT00048542|2288192|P3|Open-Label Extension BSA Phase|Adverse Event|0
705575|NCT00048542|2288193|P2|Open-Label Extension BSA Phase|Adverse Event|0
705576|NCT00048542|2288194|P1|Open-Label Extension BSA Phase|Adverse Event|0
705577|NCT00048542|2288187|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
705578|NCT00048542|2288188|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
705579|NCT00048542|2288189|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
705580|NCT00048542|2288190|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
705581|NCT00048542|2288191|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
705582|NCT00048542|2288192|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
705583|NCT00048542|2288193|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
705584|NCT00048542|2288194|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
705585|NCT00048542|2288187|P8|Open-Label Extension BSA Phase|Protocol Violation|0
705586|NCT00048542|2288188|P7|Open-Label Extension BSA Phase|Protocol Violation|0
705587|NCT00048542|2288189|P6|Open-Label Extension BSA Phase|Protocol Violation|1
705588|NCT00048542|2288190|P5|Open-Label Extension BSA Phase|Protocol Violation|0
705589|NCT00048542|2288191|P4|Open-Label Extension BSA Phase|Protocol Violation|0
705590|NCT00048542|2288192|P3|Open-Label Extension BSA Phase|Protocol Violation|0
705591|NCT00048542|2288193|P2|Open-Label Extension BSA Phase|Protocol Violation|0
705592|NCT00048542|2288194|P1|Open-Label Extension BSA Phase|Protocol Violation|0
705593|NCT00048542|2288187|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705594|NCT00048542|2288188|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705595|NCT00048542|2288189|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
705596|NCT00048542|2288190|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
705597|NCT00048542|2288191|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705598|NCT00048542|2288192|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705599|NCT00048542|2288193|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705600|NCT00048542|2288194|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
705601|NCT00048542|2288187|P8|Double-Blind Phase|Randomized in error|0
705602|NCT00048542|2288188|P7|Double-Blind Phase|Randomized in error|0
705603|NCT00048542|2288189|P6|Double-Blind Phase|Randomized in error|0
705604|NCT00048542|2288190|P5|Double-Blind Phase|Randomized in error|0
705605|NCT00048542|2288191|P4|Double-Blind Phase|Randomized in error|0
705606|NCT00048542|2288192|P3|Double-Blind Phase|Randomized in error|0
705607|NCT00048542|2288193|P2|Double-Blind Phase|Randomized in error|0
705608|NCT00048542|2288194|P1|Double-Blind Phase|Randomized in error|1
705609|NCT00048542|2288187|P8|Double-Blind Phase|Sponsor request or decision|0
705610|NCT00048542|2288188|P7|Double-Blind Phase|Sponsor request or decision|0
705611|NCT00048542|2288189|P6|Double-Blind Phase|Sponsor request or decision|0
705612|NCT00048542|2288190|P5|Double-Blind Phase|Sponsor request or decision|0
705613|NCT00048542|2288191|P4|Double-Blind Phase|Sponsor request or decision|0
705614|NCT00048542|2288192|P3|Double-Blind Phase|Sponsor request or decision|0
705615|NCT00048542|2288193|P2|Double-Blind Phase|Sponsor request or decision|0
705616|NCT00048542|2288194|P1|Double-Blind Phase|Sponsor request or decision|2
705617|NCT00048542|2288187|P8|Double-Blind Phase|Protocol Violation|0
705618|NCT00048542|2288188|P7|Double-Blind Phase|Protocol Violation|0
705619|NCT00048542|2288189|P6|Double-Blind Phase|Protocol Violation|0
705620|NCT00048542|2288190|P5|Double-Blind Phase|Protocol Violation|0
705621|NCT00048542|2288191|P4|Double-Blind Phase|Protocol Violation|0
705622|NCT00048542|2288192|P3|Double-Blind Phase|Protocol Violation|1
705623|NCT00048542|2288193|P2|Double-Blind Phase|Protocol Violation|0
705624|NCT00048542|2288194|P1|Double-Blind Phase|Protocol Violation|0
705625|NCT00048542|2288187|P8|Double-Blind Phase|Withdrawal by Subject|0
705626|NCT00048542|2288188|P7|Double-Blind Phase|Withdrawal by Subject|0
705627|NCT00048542|2288189|P6|Double-Blind Phase|Withdrawal by Subject|0
705628|NCT00048542|2288190|P5|Double-Blind Phase|Withdrawal by Subject|0
705629|NCT00048542|2288191|P4|Double-Blind Phase|Withdrawal by Subject|0
705630|NCT00048542|2288192|P3|Double-Blind Phase|Withdrawal by Subject|0
705631|NCT00048542|2288193|P2|Double-Blind Phase|Withdrawal by Subject|1
705632|NCT00048542|2288194|P1|Double-Blind Phase|Withdrawal by Subject|0
705633|NCT00048568|2288262|P3|Open-Label Period|Lost to Follow-up|7
705634|NCT00048568|2288263|P2|Open-Label Period|Lost to Follow-up|0
705635|NCT00048568|2288264|P1|Open-Label Period|Lost to Follow-up|0
705636|NCT00048568|2288262|P3|Open-Label Period|Unknown Reasons|25
705637|NCT00048568|2288263|P2|Open-Label Period|Unknown Reasons|0
705638|NCT00048568|2288264|P1|Open-Label Period|Unknown Reasons|0
705639|NCT00048568|2288262|P3|Open-Label Period|Administrative Decision By Sponsor|1
705640|NCT00048568|2288263|P2|Open-Label Period|Administrative Decision By Sponsor|0
705641|NCT00048568|2288264|P1|Open-Label Period|Administrative Decision By Sponsor|0
705642|NCT00048568|2288262|P3|Open-Label Period|No Longer Met Study Criteria|2
705643|NCT00048568|2288263|P2|Open-Label Period|No Longer Met Study Criteria|0
705644|NCT00048568|2288264|P1|Open-Label Period|No Longer Met Study Criteria|0
705645|NCT00048568|2288262|P3|Open-Label Period|Pregnancy|5
705646|NCT00048568|2288263|P2|Open-Label Period|Pregnancy|0
705647|NCT00048568|2288264|P1|Open-Label Period|Pregnancy|0
705648|NCT00048568|2288262|P3|Open-Label Period|Withdrawal by Subject|26
705649|NCT00048568|2288263|P2|Open-Label Period|Withdrawal by Subject|0
705650|NCT00048568|2288264|P1|Open-Label Period|Withdrawal by Subject|0
705651|NCT00048568|2288262|P3|Open-Label Period|Lack of Efficacy|32
705652|NCT00048568|2288263|P2|Open-Label Period|Lack of Efficacy|0
705653|NCT00048568|2288264|P1|Open-Label Period|Lack of Efficacy|0
705654|NCT00048568|2288262|P3|Open-Label Period|Adverse Event|49
705655|NCT00048568|2288263|P2|Open-Label Period|Adverse Event|0
705656|NCT00048568|2288264|P1|Open-Label Period|Adverse Event|0
705657|NCT00048568|2288262|P3|Open-Label Period|Death|13
705658|NCT00048568|2288263|P2|Open-Label Period|Death|0
705659|NCT00048568|2288264|P1|Open-Label Period|Death|0
705660|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
705661|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
705662|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
705663|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
705664|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
705665|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
705666|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
705667|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
705668|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
705669|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
705670|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
705671|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
705672|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
705673|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
705674|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
705675|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
705676|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
705677|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
705678|NCT00048568|2288262|P3|Double-Blind Period Days 170 to 365|Death|0
705679|NCT00048568|2288263|P2|Double-Blind Period Days 170 to 365|Death|1
705680|NCT00048568|2288264|P1|Double-Blind Period Days 170 to 365|Death|1
705681|NCT00048568|2288262|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
705682|NCT00048568|2288263|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
705683|NCT00048568|2288264|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
705684|NCT00048568|2288262|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
705685|NCT00048568|2288263|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
705686|NCT00048568|2288264|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
705687|NCT00048568|2288262|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
705688|NCT00048568|2288263|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
705689|NCT00048568|2288264|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
705690|NCT00048568|2288262|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
705691|NCT00048568|2288263|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
705692|NCT00048568|2288264|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
705693|NCT00048568|2288262|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
705694|NCT00048568|2288263|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
705695|NCT00048568|2288264|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
705696|NCT00048581|2288554|P3|Open-Label Period|Study Ended By Sponsor|1
705697|NCT00048581|2288555|P2|Open-Label Period|Study Ended By Sponsor|0
705698|NCT00048581|2288556|P1|Open-Label Period|Study Ended By Sponsor|0
705699|NCT00048581|2288554|P3|Open-Label Period|Primary Investigator Retired|2
705700|NCT00048581|2288555|P2|Open-Label Period|Primary Investigator Retired|0
705701|NCT00048581|2288556|P1|Open-Label Period|Primary Investigator Retired|0
705702|NCT00048581|2288554|P3|Open-Label Period|Problem With Transportation To Site|1
705703|NCT00048581|2288555|P2|Open-Label Period|Problem With Transportation To Site|0
705704|NCT00048581|2288556|P1|Open-Label Period|Problem With Transportation To Site|0
705705|NCT00048581|2288554|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
705706|NCT00048581|2288555|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
705707|NCT00048581|2288556|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
705708|NCT00048581|2288554|P3|Open-Label Period|Study Site Closure|2
705709|NCT00048581|2288555|P2|Open-Label Period|Study Site Closure|0
705710|NCT00048581|2288556|P1|Open-Label Period|Study Site Closure|0
705711|NCT00048581|2288554|P3|Open-Label Period|Pregnancy|7
705712|NCT00048581|2288555|P2|Open-Label Period|Pregnancy|0
705713|NCT00048581|2288556|P1|Open-Label Period|Pregnancy|0
705714|NCT00048581|2288554|P3|Open-Label Period|Poor/Non-compliance|5
705715|NCT00048581|2288555|P2|Open-Label Period|Poor/Non-compliance|0
705716|NCT00048581|2288556|P1|Open-Label Period|Poor/Non-compliance|0
705717|NCT00048581|2288554|P3|Open-Label Period|No Longer Meets Study Criteria|2
705718|NCT00048581|2288555|P2|Open-Label Period|No Longer Meets Study Criteria|0
705719|NCT00048581|2288556|P1|Open-Label Period|No Longer Meets Study Criteria|0
705720|NCT00048581|2288554|P3|Open-Label Period|Withdrawal by Subject|20
705721|NCT00048581|2288555|P2|Open-Label Period|Withdrawal by Subject|0
705722|NCT00048581|2288556|P1|Open-Label Period|Withdrawal by Subject|0
705723|NCT00048581|2288554|P3|Open-Label Period|Lost to Follow-up|14
705724|NCT00048581|2288555|P2|Open-Label Period|Lost to Follow-up|0
705725|NCT00048581|2288556|P1|Open-Label Period|Lost to Follow-up|0
705726|NCT00048581|2288554|P3|Open-Label Period|Lack of Efficacy|69
705727|NCT00048581|2288555|P2|Open-Label Period|Lack of Efficacy|0
705728|NCT00048581|2288556|P1|Open-Label Period|Lack of Efficacy|0
705729|NCT00048581|2288554|P3|Open-Label Period|Adverse Event|37
705730|NCT00048581|2288555|P2|Open-Label Period|Adverse Event|0
705731|NCT00048581|2288556|P1|Open-Label Period|Adverse Event|0
705732|NCT00048581|2288554|P3|Open-Label Period|Death|4
705733|NCT00048581|2288555|P2|Open-Label Period|Death|0
705734|NCT00048581|2288556|P1|Open-Label Period|Death|0
705735|NCT00048581|2288554|P3|Double-Blind Period|Investigator Decision|0
705736|NCT00048581|2288555|P2|Double-Blind Period|Investigator Decision|0
705737|NCT00048581|2288556|P1|Double-Blind Period|Investigator Decision|1
705738|NCT00048581|2288554|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
705739|NCT00048581|2288555|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
705740|NCT00048581|2288556|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
705741|NCT00048581|2288554|P3|Double-Blind Period|Withdrawal by Subject|0
705742|NCT00048581|2288555|P2|Double-Blind Period|Withdrawal by Subject|2
705743|NCT00048581|2288556|P1|Double-Blind Period|Withdrawal by Subject|5
705744|NCT00048581|2288554|P3|Double-Blind Period|Lost to Follow-up|0
705745|NCT00048581|2288555|P2|Double-Blind Period|Lost to Follow-up|0
705746|NCT00048581|2288556|P1|Double-Blind Period|Lost to Follow-up|5
705747|NCT00048581|2288554|P3|Double-Blind Period|Lack of Efficacy|0
705748|NCT00048581|2288555|P2|Double-Blind Period|Lack of Efficacy|27
705749|NCT00048581|2288556|P1|Double-Blind Period|Lack of Efficacy|14
705750|NCT00048581|2288554|P3|Double-Blind Period|Adverse Event|0
705751|NCT00048581|2288555|P2|Double-Blind Period|Adverse Event|5
705752|NCT00048581|2288556|P1|Double-Blind Period|Adverse Event|9
705753|NCT00048724|2288723|P2|Overall Study|Administrative|1
705754|NCT00048724|2288724|P1|Overall Study|Administrative|1
705755|NCT00048724|2288723|P2|Overall Study|Did Not Meet Protocol Eligibility|2
705756|NCT00048724|2288724|P1|Overall Study|Did Not Meet Protocol Eligibility|2
705757|NCT00048724|2288723|P2|Overall Study|Noncompliance With Protocol|12
705758|NCT00048724|2288724|P1|Overall Study|Noncompliance With Protocol|4
705759|NCT00048724|2288723|P2|Overall Study|Protocol-defined Clinical Event|32
705760|NCT00048724|2288724|P1|Overall Study|Protocol-defined Clinical Event|17
705761|NCT00048724|2288723|P2|Overall Study|Lost to Follow-up|5
705762|NCT00048724|2288724|P1|Overall Study|Lost to Follow-up|5
705763|NCT00048724|2288723|P2|Overall Study|Withdrawal by Subject|54
705764|NCT00048724|2288724|P1|Overall Study|Withdrawal by Subject|34
705765|NCT00048724|2288723|P2|Overall Study|Adverse Event|12
705766|NCT00048724|2288724|P1|Overall Study|Adverse Event|53
705767|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Surgery|1
705768|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Surgery|0
705769|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Surgery|0
705770|NCT00048932|2288749|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
705771|NCT00048932|2288750|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
705772|NCT00048932|2288751|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
705773|NCT00048932|2288749|P3|Open Label Period (OL)|Site Staff Issues|2
705774|NCT00048932|2288750|P2|Open Label Period (OL)|Site Staff Issues|0
705775|NCT00048932|2288751|P1|Open Label Period (OL)|Site Staff Issues|0
705776|NCT00048932|2288749|P3|Open Label Period (OL)|Investigator Decision|4
705777|NCT00048932|2288750|P2|Open Label Period (OL)|Investigator Decision|0
705778|NCT00048932|2288751|P1|Open Label Period (OL)|Investigator Decision|0
705779|NCT00048932|2288749|P3|Open Label Period (OL)|Medication Lost Efficacy|1
705780|NCT00048932|2288750|P2|Open Label Period (OL)|Medication Lost Efficacy|0
705781|NCT00048932|2288751|P1|Open Label Period (OL)|Medication Lost Efficacy|0
705782|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
705783|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
705784|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
705785|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
705786|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
705787|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
705788|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
705789|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
705790|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
705791|NCT00048932|2288749|P3|Open Label Period (OL)|Patient Decision|4
705792|NCT00048932|2288750|P2|Open Label Period (OL)|Patient Decision|0
705793|NCT00048932|2288751|P1|Open Label Period (OL)|Patient Decision|0
705794|NCT00048932|2288749|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
705795|NCT00048932|2288750|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
705796|NCT00048932|2288751|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
705797|NCT00048932|2288749|P3|Open Label Period (OL)|Trial Terminated|1
705798|NCT00048932|2288750|P2|Open Label Period (OL)|Trial Terminated|0
705799|NCT00048932|2288751|P1|Open Label Period (OL)|Trial Terminated|0
705800|NCT00048932|2288749|P3|Open Label Period (OL)|Site Closure|3
705801|NCT00048932|2288750|P2|Open Label Period (OL)|Site Closure|0
705802|NCT00048932|2288751|P1|Open Label Period (OL)|Site Closure|0
705803|NCT00048932|2288749|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
705804|NCT00048932|2288750|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
705805|NCT00048932|2288751|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
705806|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Relocated|6
705807|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Relocated|0
705808|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Relocated|0
705809|NCT00048932|2288749|P3|Open Label Period (OL)|Participant Transportation Issues|1
705810|NCT00048932|2288750|P2|Open Label Period (OL)|Participant Transportation Issues|0
705811|NCT00048932|2288751|P1|Open Label Period (OL)|Participant Transportation Issues|0
705812|NCT00048932|2288749|P3|Open Label Period (OL)|Investigator Retiring|2
705813|NCT00048932|2288750|P2|Open Label Period (OL)|Investigator Retiring|0
705814|NCT00048932|2288751|P1|Open Label Period (OL)|Investigator Retiring|0
705815|NCT00048932|2288749|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
705816|NCT00048932|2288750|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
705817|NCT00048932|2288751|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
705818|NCT00048932|2288749|P3|Open Label Period (OL)|Pregnancy|6
705819|NCT00048932|2288750|P2|Open Label Period (OL)|Pregnancy|0
705820|NCT00048932|2288751|P1|Open Label Period (OL)|Pregnancy|0
705821|NCT00048932|2288749|P3|Open Label Period (OL)|Poor/Non-Compliance|13
705822|NCT00048932|2288750|P2|Open Label Period (OL)|Poor/Non-Compliance|0
705823|NCT00048932|2288751|P1|Open Label Period (OL)|Poor/Non-Compliance|0
705824|NCT00048932|2288749|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
705825|NCT00048932|2288750|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
705826|NCT00048932|2288751|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
705827|NCT00048932|2288749|P3|Open Label Period (OL)|Withdrawal by Subject|117
705828|NCT00048932|2288750|P2|Open Label Period (OL)|Withdrawal by Subject|0
705829|NCT00048932|2288751|P1|Open Label Period (OL)|Withdrawal by Subject|0
705830|NCT00048932|2288749|P3|Open Label Period (OL)|Lost to Follow-up|27
705831|NCT00048932|2288750|P2|Open Label Period (OL)|Lost to Follow-up|0
705832|NCT00048932|2288751|P1|Open Label Period (OL)|Lost to Follow-up|0
705833|NCT00048932|2288749|P3|Open Label Period (OL)|Lack of Efficacy|81
705834|NCT00048932|2288750|P2|Open Label Period (OL)|Lack of Efficacy|0
705835|NCT00048932|2288751|P1|Open Label Period (OL)|Lack of Efficacy|0
705836|NCT00048932|2288749|P3|Open Label Period (OL)|Adverse Event|103
705837|NCT00048932|2288750|P2|Open Label Period (OL)|Adverse Event|0
705838|NCT00048932|2288751|P1|Open Label Period (OL)|Adverse Event|0
705839|NCT00048932|2288749|P3|Open Label Period (OL)|Death|25
705840|NCT00048932|2288750|P2|Open Label Period (OL)|Death|0
705841|NCT00048932|2288751|P1|Open Label Period (OL)|Death|0
705842|NCT00048932|2288749|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
705843|NCT00048932|2288750|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
705844|NCT00048932|2288751|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
705845|NCT00048932|2288749|P3|Double Blind Period (DB)|Withdrawal by Subject|0
705846|NCT00048932|2288750|P2|Double Blind Period (DB)|Withdrawal by Subject|10
705847|NCT00048932|2288751|P1|Double Blind Period (DB)|Withdrawal by Subject|24
705848|NCT00048932|2288749|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
705849|NCT00048932|2288750|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
705850|NCT00048932|2288751|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
705851|NCT00048932|2288749|P3|Double Blind Period (DB)|Pregnancy|0
705852|NCT00048932|2288750|P2|Double Blind Period (DB)|Pregnancy|0
705853|NCT00048932|2288751|P1|Double Blind Period (DB)|Pregnancy|1
705854|NCT00048932|2288749|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
705855|NCT00048932|2288750|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
705856|NCT00048932|2288751|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
705857|NCT00048932|2288749|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
705858|NCT00048932|2288750|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
705859|NCT00048932|2288751|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
705860|NCT00048932|2288749|P3|Double Blind Period (DB)|Relocation|0
705861|NCT00048932|2288750|P2|Double Blind Period (DB)|Relocation|0
705862|NCT00048932|2288751|P1|Double Blind Period (DB)|Relocation|1
705863|NCT00048932|2288749|P3|Double Blind Period (DB)|Lost to Follow-up|0
705864|NCT00048932|2288750|P2|Double Blind Period (DB)|Lost to Follow-up|4
705865|NCT00048932|2288751|P1|Double Blind Period (DB)|Lost to Follow-up|3
705866|NCT00048932|2288749|P3|Double Blind Period (DB)|Lack of Efficacy|0
705867|NCT00048932|2288750|P2|Double Blind Period (DB)|Lack of Efficacy|44
705868|NCT00048932|2288751|P1|Double Blind Period (DB)|Lack of Efficacy|26
705869|NCT00048932|2288749|P3|Double Blind Period (DB)|Death|0
705870|NCT00048932|2288750|P2|Double Blind Period (DB)|Death|3
705871|NCT00048932|2288751|P1|Double Blind Period (DB)|Death|5
705872|NCT00048932|2288749|P3|Double Blind Period (DB)|Adverse Event|0
705873|NCT00048932|2288750|P2|Double Blind Period (DB)|Adverse Event|19
705874|NCT00048932|2288751|P1|Double Blind Period (DB)|Adverse Event|51
705875|NCT00048932|2288749|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
705876|NCT00048932|2288750|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
705877|NCT00048932|2288751|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
705878|NCT00048997|2288777|P2|Overall Study|Withdrawal by Subject|1
705879|NCT00048997|2288778|P1|Overall Study|Withdrawal by Subject|6
705880|NCT00048997|2288777|P2|Overall Study|Protocol Violation|2
705881|NCT00048997|2288778|P1|Overall Study|Protocol Violation|7
705882|NCT00049127|2288797|P5|Overall Study|Withdrawal by Subject|0
705883|NCT00049127|2288798|P4|Overall Study|Withdrawal by Subject|0
705884|NCT00049127|2288799|P3|Overall Study|Withdrawal by Subject|1
705885|NCT00049127|2288800|P2|Overall Study|Withdrawal by Subject|0
705886|NCT00049127|2288801|P1|Overall Study|Withdrawal by Subject|0
705887|NCT00049257|2288828|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
705888|NCT00049257|2288828|P1|Carboplatin, Paclitaxel|Death|2
705889|NCT00049257|2288828|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
705890|NCT00049257|2288828|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
705891|NCT00049322|2288837|P2|Overall Study|refused angio|3
705892|NCT00049322|2288838|P1|Overall Study|refused angio|0
705893|NCT00049322|2288837|P2|Overall Study|Adverse Event|0
705894|NCT00049322|2288838|P1|Overall Study|Adverse Event|1
705895|NCT00049322|2288837|P2|Overall Study|disease burden|3
705896|NCT00049322|2288838|P1|Overall Study|disease burden|0
705897|NCT00049517|2288858|P6|Conditioning/Transplant|Reasons not reported|5
705898|NCT00049517|2288859|P5|Conditioning/Transplant|Reasons not reported|5
705899|NCT00049517|2288860|P4|Conditioning/Transplant|Reasons not reported|15
705900|NCT00049517|2288861|P3|Conditioning/Transplant|Reasons not reported|18
705901|NCT00049517|2288862|P2|Conditioning/Transplant|Reasons not reported|31
705902|NCT00049517|2288863|P1|Conditioning/Transplant|Reasons not reported|25
705903|NCT00049517|2288858|P6|Conditioning/Transplant|Other complicating disease|1
705904|NCT00049517|2288859|P5|Conditioning/Transplant|Other complicating disease|0
705905|NCT00049517|2288860|P4|Conditioning/Transplant|Other complicating disease|4
705906|NCT00049517|2288861|P3|Conditioning/Transplant|Other complicating disease|0
705907|NCT00049517|2288862|P2|Conditioning/Transplant|Other complicating disease|0
705908|NCT00049517|2288863|P1|Conditioning/Transplant|Other complicating disease|2
705909|NCT00049517|2288858|P6|Conditioning/Transplant|Alternative therapy|0
705910|NCT00049517|2288859|P5|Conditioning/Transplant|Alternative therapy|1
705911|NCT00049517|2288860|P4|Conditioning/Transplant|Alternative therapy|1
705912|NCT00049517|2288861|P3|Conditioning/Transplant|Alternative therapy|2
705913|NCT00049517|2288862|P2|Conditioning/Transplant|Alternative therapy|4
705914|NCT00049517|2288863|P1|Conditioning/Transplant|Alternative therapy|4
705915|NCT00049517|2288858|P6|Conditioning/Transplant|Withdrawal by Subject|0
705916|NCT00049517|2288859|P5|Conditioning/Transplant|Withdrawal by Subject|0
705917|NCT00049517|2288860|P4|Conditioning/Transplant|Withdrawal by Subject|7
705918|NCT00049517|2288861|P3|Conditioning/Transplant|Withdrawal by Subject|4
705919|NCT00049517|2288862|P2|Conditioning/Transplant|Withdrawal by Subject|8
705920|NCT00049517|2288863|P1|Conditioning/Transplant|Withdrawal by Subject|4
705921|NCT00049517|2288858|P6|Conditioning/Transplant|Death|0
705922|NCT00049517|2288859|P5|Conditioning/Transplant|Death|0
705923|NCT00049517|2288860|P4|Conditioning/Transplant|Death|2
705924|NCT00049517|2288861|P3|Conditioning/Transplant|Death|0
705925|NCT00049517|2288862|P2|Conditioning/Transplant|Death|0
705926|NCT00049517|2288863|P1|Conditioning/Transplant|Death|1
705927|NCT00049517|2288858|P6|Conditioning/Transplant|Adverse Event|0
705928|NCT00049517|2288859|P5|Conditioning/Transplant|Adverse Event|0
705929|NCT00049517|2288860|P4|Conditioning/Transplant|Adverse Event|8
705930|NCT00049517|2288861|P3|Conditioning/Transplant|Adverse Event|4
705931|NCT00049517|2288862|P2|Conditioning/Transplant|Adverse Event|1
705932|NCT00049517|2288863|P1|Conditioning/Transplant|Adverse Event|2
705933|NCT00049517|2288858|P6|Conditioning/Transplant|Disease progression|0
705934|NCT00049517|2288859|P5|Conditioning/Transplant|Disease progression|0
705935|NCT00049517|2288860|P4|Conditioning/Transplant|Disease progression|6
705936|NCT00049517|2288861|P3|Conditioning/Transplant|Disease progression|10
705937|NCT00049517|2288862|P2|Conditioning/Transplant|Disease progression|6
705938|NCT00049517|2288863|P1|Conditioning/Transplant|Disease progression|14
705939|NCT00049517|2288858|P6|Induction|Reasons not reported|25
705940|NCT00049517|2288859|P5|Induction|Reasons not reported|22
705941|NCT00049517|2288860|P4|Induction|Reasons not reported|0
705942|NCT00049517|2288861|P3|Induction|Reasons not reported|0
705943|NCT00049517|2288862|P2|Induction|Reasons not reported|0
705944|NCT00049517|2288863|P1|Induction|Reasons not reported|0
705945|NCT00049517|2288858|P6|Induction|Other complicating disease|0
705946|NCT00049517|2288859|P5|Induction|Other complicating disease|3
705947|NCT00049517|2288860|P4|Induction|Other complicating disease|0
705948|NCT00049517|2288861|P3|Induction|Other complicating disease|0
705949|NCT00049517|2288862|P2|Induction|Other complicating disease|0
705950|NCT00049517|2288863|P1|Induction|Other complicating disease|0
705951|NCT00049517|2288858|P6|Induction|Alternative therapy|2
705952|NCT00049517|2288859|P5|Induction|Alternative therapy|2
705953|NCT00049517|2288860|P4|Induction|Alternative therapy|0
705954|NCT00049517|2288861|P3|Induction|Alternative therapy|0
705955|NCT00049517|2288862|P2|Induction|Alternative therapy|0
705956|NCT00049517|2288863|P1|Induction|Alternative therapy|0
705957|NCT00049517|2288858|P6|Induction|Withdrawal by Subject|3
705958|NCT00049517|2288859|P5|Induction|Withdrawal by Subject|1
705959|NCT00049517|2288860|P4|Induction|Withdrawal by Subject|0
705960|NCT00049517|2288861|P3|Induction|Withdrawal by Subject|0
705961|NCT00049517|2288862|P2|Induction|Withdrawal by Subject|0
705962|NCT00049517|2288863|P1|Induction|Withdrawal by Subject|0
705963|NCT00049517|2288858|P6|Induction|Death|6
705964|NCT00049517|2288859|P5|Induction|Death|9
705965|NCT00049517|2288860|P4|Induction|Death|0
705966|NCT00049517|2288861|P3|Induction|Death|0
705967|NCT00049517|2288862|P2|Induction|Death|0
705968|NCT00049517|2288863|P1|Induction|Death|0
705969|NCT00049517|2288858|P6|Induction|Adverse Event|7
705970|NCT00049517|2288859|P5|Induction|Adverse Event|5
705971|NCT00049517|2288860|P4|Induction|Adverse Event|0
705972|NCT00049517|2288861|P3|Induction|Adverse Event|0
705973|NCT00049517|2288862|P2|Induction|Adverse Event|0
705974|NCT00049517|2288863|P1|Induction|Adverse Event|0
705975|NCT00049517|2288858|P6|Induction|Disease progression|11
705976|NCT00049517|2288859|P5|Induction|Disease progression|18
705977|NCT00049517|2288860|P4|Induction|Disease progression|0
705978|NCT00049517|2288861|P3|Induction|Disease progression|0
705979|NCT00049517|2288862|P2|Induction|Disease progression|0
705980|NCT00049517|2288863|P1|Induction|Disease progression|0
705981|NCT00049530|2288873|P1|Overall Study|ineligible|3
705982|NCT00049530|2288873|P1|Overall Study|symptomatic deterioration|1
705983|NCT00049530|2288873|P1|Overall Study|Death|1
705984|NCT00049530|2288873|P1|Overall Study|Adverse Event|2
705985|NCT00049530|2288873|P1|Overall Study|Lack of Efficacy|25
705986|NCT00049543|2288882|P2|Overall Study|still on treatment|9
705987|NCT00049543|2288883|P1|Overall Study|still on treatment|2
705988|NCT00038467|2288895|P2|Overall Study|Unspecified|28
705989|NCT00038467|2288896|P1|Overall Study|Unspecified|26
705990|NCT00038467|2288895|P2|Overall Study|Randomized, but not treated|35
705991|NCT00038467|2288896|P1|Overall Study|Randomized, but not treated|31
705992|NCT00038467|2288895|P2|Overall Study|Recurrence|179
705993|NCT00038467|2288896|P1|Overall Study|Recurrence|109
705994|NCT00038467|2288895|P2|Overall Study|Lost to Follow-up|10
705995|NCT00038467|2288896|P1|Overall Study|Lost to Follow-up|15
705996|NCT00038467|2288895|P2|Overall Study|Death|16
705997|NCT00038467|2288896|P1|Overall Study|Death|22
705998|NCT00038467|2288895|P2|Overall Study|Protocol Violation|22
705999|NCT00038467|2288896|P1|Overall Study|Protocol Violation|19
706000|NCT00038467|2288895|P2|Overall Study|Withdrawal by Subject|107
706001|NCT00038467|2288896|P1|Overall Study|Withdrawal by Subject|150
706002|NCT00038467|2288895|P2|Overall Study|Adverse Event|145
706003|NCT00038467|2288896|P1|Overall Study|Adverse Event|170
706004|NCT00038948|2288968|P2|Overall Study|Lack of Efficacy|6
706005|NCT00038948|2288969|P1|Overall Study|Lack of Efficacy|3
706006|NCT00038948|2288968|P2|Overall Study|Protocol Violation|7
706007|NCT00038948|2288969|P1|Overall Study|Protocol Violation|3
706008|NCT00038948|2288968|P2|Overall Study|Withdrawal by Subject|10
706009|NCT00038948|2288969|P1|Overall Study|Withdrawal by Subject|23
706010|NCT00038948|2288968|P2|Overall Study|Nonmedical event|7
706011|NCT00038948|2288969|P1|Overall Study|Nonmedical event|5
706012|NCT00038948|2288968|P2|Overall Study|Lost to Follow-up|4
706013|NCT00038948|2288969|P1|Overall Study|Lost to Follow-up|4
706014|NCT00038948|2288968|P2|Overall Study|Adverse Event|43
706015|NCT00038948|2288969|P1|Overall Study|Adverse Event|131
706016|NCT00039130|2288981|P1|Overall Study|Physician Decision|3
706017|NCT00039130|2288981|P1|Overall Study|Subsequent treatment|2
706018|NCT00039130|2288981|P1|Overall Study|Progression|2
706019|NCT00039130|2288981|P1|Overall Study|Withdrawal by Subject|3
706020|NCT00039130|2288981|P1|Overall Study|Death|9
706021|NCT00039130|2288981|P1|Overall Study|Adverse Event|11
706022|NCT00039377|2288991|P4|Initial Registration|Withdrawal by Subject|0
706023|NCT00039377|2288992|P3|Initial Registration|Withdrawal by Subject|0
706024|NCT00039377|2288993|P2|Initial Registration|Withdrawal by Subject|0
706025|NCT00039377|2288994|P1|Initial Registration|Withdrawal by Subject|3
706026|NCT00039377|2288991|P4|Initial Registration|Received non-protocol therapy|0
706027|NCT00039377|2288992|P3|Initial Registration|Received non-protocol therapy|0
706028|NCT00039377|2288993|P2|Initial Registration|Received non-protocol therapy|0
706029|NCT00039377|2288994|P1|Initial Registration|Received non-protocol therapy|11
706030|NCT00039377|2288991|P4|Initial Registration|Relapsed|0
706031|NCT00039377|2288992|P3|Initial Registration|Relapsed|0
706032|NCT00039377|2288993|P2|Initial Registration|Relapsed|0
706033|NCT00039377|2288994|P1|Initial Registration|Relapsed|6
706034|NCT00039377|2288991|P4|Initial Registration|Adverse Event|0
706035|NCT00039377|2288992|P3|Initial Registration|Adverse Event|0
706036|NCT00039377|2288993|P2|Initial Registration|Adverse Event|0
706037|NCT00039377|2288994|P1|Initial Registration|Adverse Event|2
706038|NCT00039741|2289010|P4|Overall Study|Missed final visit|2
706039|NCT00039741|2289011|P3|Overall Study|Missed final visit|2
706040|NCT00039741|2289012|P2|Overall Study|Missed final visit|1
706041|NCT00039741|2289013|P1|Overall Study|Missed final visit|2
706042|NCT00039741|2289010|P4|Overall Study|Withdrew consent|1
706043|NCT00039741|2289011|P3|Overall Study|Withdrew consent|0
706044|NCT00039741|2289012|P2|Overall Study|Withdrew consent|5
706045|NCT00039741|2289013|P1|Overall Study|Withdrew consent|0
706046|NCT00039741|2289010|P4|Overall Study|Non-compliance with protocol|0
706047|NCT00039741|2289011|P3|Overall Study|Non-compliance with protocol|1
706048|NCT00039741|2289012|P2|Overall Study|Non-compliance with protocol|0
706049|NCT00039741|2289013|P1|Overall Study|Non-compliance with protocol|1
706050|NCT00039741|2289010|P4|Overall Study|Moved|6
706051|NCT00039741|2289011|P3|Overall Study|Moved|3
706052|NCT00039741|2289012|P2|Overall Study|Moved|2
706053|NCT00039741|2289013|P1|Overall Study|Moved|3
706054|NCT00039741|2289010|P4|Overall Study|Not able to get to clinic|3
706055|NCT00039741|2289011|P3|Overall Study|Not able to get to clinic|0
706056|NCT00039741|2289012|P2|Overall Study|Not able to get to clinic|2
706057|NCT00039741|2289013|P1|Overall Study|Not able to get to clinic|5
706058|NCT00039741|2289010|P4|Overall Study|Confounding medical condition|0
706059|NCT00039741|2289011|P3|Overall Study|Confounding medical condition|0
706060|NCT00039741|2289012|P2|Overall Study|Confounding medical condition|0
706061|NCT00039741|2289013|P1|Overall Study|Confounding medical condition|1
706062|NCT00039741|2289010|P4|Overall Study|Lost to Follow-up|2
706063|NCT00039741|2289011|P3|Overall Study|Lost to Follow-up|5
706064|NCT00039741|2289012|P2|Overall Study|Lost to Follow-up|1
706065|NCT00039741|2289013|P1|Overall Study|Lost to Follow-up|3
706066|NCT00039741|2289010|P4|Overall Study|Death|0
706067|NCT00039741|2289011|P3|Overall Study|Death|0
706068|NCT00039741|2289012|P2|Overall Study|Death|1
706069|NCT00039741|2289013|P1|Overall Study|Death|0
706070|NCT00039871|2289055|P1|Overall Study|Never entered follow-up|7
706071|NCT00039871|2289055|P1|Overall Study|Discontinued at Week 12 per protocol|1061
706072|NCT00039871|2289055|P1|Overall Study|Administrative|1
706073|NCT00039871|2289055|P1|Overall Study|Did not meet eligibility criteria|11
706074|NCT00039871|2289055|P1|Overall Study|Withdrawal by Subject|97
706075|NCT00039871|2289055|P1|Overall Study|Protocol Violation|24
706076|NCT00039871|2289055|P1|Overall Study|Lost to Follow-up|18
706077|NCT00039871|2289055|P1|Overall Study|Adverse Event|165
706078|NCT00040365|2289061|P1|Overall Study|Lost to Follow-up|3
706079|NCT00040365|2289061|P1|Overall Study|Progressive disease|7
706080|NCT00040365|2289061|P1|Overall Study|Death|1
706081|NCT00049842|2289072|P2|Follow-up Phase|Not specified|4
706082|NCT00049842|2289073|P1|Follow-up Phase|Not specified|1
706083|NCT00049842|2289072|P2|Follow-up Phase|Adverse Event|1
706084|NCT00049842|2289073|P1|Follow-up Phase|Adverse Event|6
706085|NCT00049842|2289072|P2|Treatment Phase|Did not meet protocol eligibility|1
706086|NCT00049842|2289073|P1|Treatment Phase|Did not meet protocol eligibility|0
706087|NCT00049842|2289072|P2|Treatment Phase|Administrative|3
706088|NCT00049842|2289073|P1|Treatment Phase|Administrative|0
706089|NCT00049842|2289072|P2|Treatment Phase|Lost to Follow-up|8
706090|NCT00049842|2289073|P1|Treatment Phase|Lost to Follow-up|4
706091|NCT00049842|2289072|P2|Treatment Phase|Non-compliance with protocol|8
706092|NCT00049842|2289073|P1|Treatment Phase|Non-compliance with protocol|7
706093|NCT00049842|2289072|P2|Treatment Phase|Withdrawal by Subject|46
706094|NCT00049842|2289073|P1|Treatment Phase|Withdrawal by Subject|35
706095|NCT00049842|2289072|P2|Treatment Phase|Adverse Event|12
706096|NCT00049842|2289073|P1|Treatment Phase|Adverse Event|47
706097|NCT00050011|2289091|P2|Overall Study|Unknown - Reason is missing|2
706098|NCT00050011|2289092|P1|Overall Study|Unknown - Reason is missing|0
706099|NCT00050011|2289091|P2|Overall Study|Death|4
706100|NCT00050011|2289092|P1|Overall Study|Death|7
706101|NCT00050011|2289091|P2|Overall Study|Administrative problems|6
706102|NCT00050011|2289092|P1|Overall Study|Administrative problems|10
706103|NCT00050011|2289091|P2|Overall Study|Lost to Follow-up|9
706104|NCT00050011|2289092|P1|Overall Study|Lost to Follow-up|7
706105|NCT00050011|2289091|P2|Overall Study|Withdrawal by Subject|26
706106|NCT00050011|2289092|P1|Overall Study|Withdrawal by Subject|34
706107|NCT00050011|2289091|P2|Overall Study|Protocol Violation|10
706108|NCT00050011|2289092|P1|Overall Study|Protocol Violation|4
706109|NCT00050011|2289091|P2|Overall Study|Participant condition no longer required|0
706110|NCT00050011|2289092|P1|Overall Study|Participant condition no longer required|1
706111|NCT00050011|2289091|P2|Overall Study|Lack of Efficacy|21
706112|NCT00050011|2289092|P1|Overall Study|Lack of Efficacy|16
706113|NCT00050011|2289091|P2|Overall Study|Abnormal test procedure results|1
706114|NCT00050011|2289092|P1|Overall Study|Abnormal test procedure results|0
706115|NCT00050011|2289091|P2|Overall Study|Abnormal laboratory value(s)|1
706116|NCT00050011|2289092|P1|Overall Study|Abnormal laboratory value(s)|1
706117|NCT00050011|2289091|P2|Overall Study|Adverse Event|46
706118|NCT00050011|2289092|P1|Overall Study|Adverse Event|41
706119|NCT00050622|2289112|P1|Overall Study|Adverse Event|1
706120|NCT00050778|2289151|P3|Overall Study|Familial and personal reasons|0
706121|NCT00050778|2289152|P2|Overall Study|Familial and personal reasons|0
706122|NCT00050778|2289153|P1|Overall Study|Familial and personal reasons|1
706123|NCT00050778|2289151|P3|Overall Study|Randomized but not treated|2
706124|NCT00050778|2289152|P2|Overall Study|Randomized but not treated|5
706125|NCT00050778|2289153|P1|Overall Study|Randomized but not treated|4
706126|NCT00050778|2289151|P3|Overall Study|Withdrawal by Subject|4
706127|NCT00050778|2289152|P2|Overall Study|Withdrawal by Subject|8
706128|NCT00050778|2289153|P1|Overall Study|Withdrawal by Subject|6
706129|NCT00050778|2289151|P3|Overall Study|Protocol Violation|1
706130|NCT00050778|2289152|P2|Overall Study|Protocol Violation|0
706131|NCT00050778|2289153|P1|Overall Study|Protocol Violation|2
706132|NCT00050778|2289151|P3|Overall Study|Physician Decision|2
706133|NCT00050778|2289152|P2|Overall Study|Physician Decision|0
706134|NCT00050778|2289153|P1|Overall Study|Physician Decision|3
706135|NCT00050778|2289151|P3|Overall Study|Lost to Follow-up|4
706136|NCT00050778|2289152|P2|Overall Study|Lost to Follow-up|2
706137|NCT00050778|2289153|P1|Overall Study|Lost to Follow-up|0
706138|NCT00050778|2289151|P3|Overall Study|Lack of Efficacy|2
706139|NCT00050778|2289152|P2|Overall Study|Lack of Efficacy|2
706140|NCT00050778|2289153|P1|Overall Study|Lack of Efficacy|16
706141|NCT00050778|2289151|P3|Overall Study|Death|1
706142|NCT00050778|2289152|P2|Overall Study|Death|1
706143|NCT00050778|2289153|P1|Overall Study|Death|0
706144|NCT00050778|2289151|P3|Overall Study|Adverse Event|2
706145|NCT00050778|2289152|P2|Overall Study|Adverse Event|3
706146|NCT00050778|2289153|P1|Overall Study|Adverse Event|13
706147|NCT00050960|2289181|P2|Overall Study|Death|15
706148|NCT00050960|2289182|P1|Overall Study|Death|13
706149|NCT00050960|2289181|P2|Overall Study|Non-compliance|1
706150|NCT00050960|2289182|P1|Overall Study|Non-compliance|3
706151|NCT00050960|2289181|P2|Overall Study|Administrative|46
706152|NCT00050960|2289182|P1|Overall Study|Administrative|31
706153|NCT00050960|2289181|P2|Overall Study|Withdrawal by Subject|18
706154|NCT00050960|2289182|P1|Overall Study|Withdrawal by Subject|23
706155|NCT00050960|2289181|P2|Overall Study|Lost to Follow-up|1
706156|NCT00050960|2289182|P1|Overall Study|Lost to Follow-up|0
706157|NCT00050960|2289181|P2|Overall Study|Adverse Event|61
706158|NCT00050960|2289182|P1|Overall Study|Adverse Event|62
706159|NCT00050960|2289181|P2|Overall Study|Complete Response|2
706160|NCT00050960|2289182|P1|Overall Study|Complete Response|0
706161|NCT00050960|2289181|P2|Overall Study|Partial Response|19
706162|NCT00050960|2289182|P1|Overall Study|Partial Response|14
706163|NCT00050960|2289181|P2|Overall Study|Stable Disease|48
706164|NCT00050960|2289182|P1|Overall Study|Stable Disease|19
706165|NCT00050960|2289181|P2|Overall Study|Progressive Disease|93
706166|NCT00050960|2289182|P1|Overall Study|Progressive Disease|137
706167|NCT00051025|2289194|P2|Overall Study|Death|1
706168|NCT00051025|2289195|P1|Overall Study|Death|0
706169|NCT00051025|2289194|P2|Overall Study|Withdrawal by Subject|1
706170|NCT00051025|2289195|P1|Overall Study|Withdrawal by Subject|0
706171|NCT00051025|2289194|P2|Overall Study|Adverse Event|1
706172|NCT00051025|2289195|P1|Overall Study|Adverse Event|1
706173|NCT00051025|2289194|P2|Overall Study|Progressive Disease|1
706174|NCT00051025|2289195|P1|Overall Study|Progressive Disease|1
889747|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889748|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889749|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889750|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
889751|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
889752|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
889753|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889754|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
706183|NCT00051558|2289246|P2|Overall Study|Physician Decision|0
706184|NCT00051558|2289247|P1|Overall Study|Physician Decision|5
706185|NCT00051558|2289246|P2|Overall Study|Significant Lab Value|0
706186|NCT00051558|2289247|P1|Overall Study|Significant Lab Value|2
706187|NCT00051558|2289246|P2|Overall Study|Unspecified|1
706188|NCT00051558|2289247|P1|Overall Study|Unspecified|2
706189|NCT00051558|2289246|P2|Overall Study|Sponsor Decision|1
706190|NCT00051558|2289247|P1|Overall Study|Sponsor Decision|6
706191|NCT00051558|2289246|P2|Overall Study|Protocol Entry Criteria Unmet|2
706192|NCT00051558|2289247|P1|Overall Study|Protocol Entry Criteria Unmet|1
706193|NCT00051558|2289246|P2|Overall Study|Protocol Violation|4
706194|NCT00051558|2289247|P1|Overall Study|Protocol Violation|3
706195|NCT00051558|2289246|P2|Overall Study|Lost to Follow-up|13
706196|NCT00051558|2289247|P1|Overall Study|Lost to Follow-up|4
706197|NCT00051558|2289246|P2|Overall Study|Death|15
706198|NCT00051558|2289247|P1|Overall Study|Death|9
706199|NCT00051558|2289246|P2|Overall Study|Withdrawal by Subject|42
706200|NCT00051558|2289247|P1|Overall Study|Withdrawal by Subject|29
706201|NCT00051558|2289246|P2|Overall Study|Adverse Event|18
706202|NCT00051558|2289247|P1|Overall Study|Adverse Event|30
706203|NCT00051636|2289283|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
706204|NCT00051636|2289284|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
706205|NCT00051636|2289283|P2|Period 2- Extended Observation Period|Death|5
706206|NCT00051636|2289284|P1|Period 2- Extended Observation Period|Death|4
706207|NCT00051636|2289283|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
706208|NCT00051636|2289284|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
706209|NCT00051636|2289283|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
706210|NCT00051636|2289284|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
706211|NCT00051636|2289283|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
706212|NCT00051636|2289284|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
706213|NCT00051636|2289283|P2|Period 1 - Core|Lost to Follow-up|2
706214|NCT00051636|2289284|P1|Period 1 - Core|Lost to Follow-up|0
706215|NCT00051636|2289283|P2|Period 1 - Core|Withdrawal by Subject|2
706216|NCT00051636|2289284|P1|Period 1 - Core|Withdrawal by Subject|1
706217|NCT00051636|2289283|P2|Period 1 - Core|Protocol Violation|0
706218|NCT00051636|2289284|P1|Period 1 - Core|Protocol Violation|1
706219|NCT00051636|2289283|P2|Period 1 - Core|Adverse Event|2
706220|NCT00051636|2289284|P1|Period 1 - Core|Adverse Event|2
706221|NCT00052715|2289332|P1|Overall Study|wrong histology|1
706222|NCT00052962|2289341|P2|Overall Study|Not randomized/not evaluable|0
706223|NCT00052962|2289342|P1|Overall Study|Not randomized/not evaluable|1
706224|NCT00052962|2289341|P2|Overall Study|Not evaluable|2
706225|NCT00052962|2289342|P1|Overall Study|Not evaluable|0
889755|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889756|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889757|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889758|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
889759|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
889760|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
889761|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889762|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
706238|NCT00044512|2289376|P1|Follow Up|Lost to Follow-up|2
706239|NCT00045032|2289399|P3|Overall Study|Not Specified|105
706240|NCT00045032|2289400|P2|Overall Study|Not Specified|84
706241|NCT00045032|2289401|P1|Overall Study|Not Specified|93
706242|NCT00045032|2289399|P3|Overall Study|Failure to Return|61
706243|NCT00045032|2289400|P2|Overall Study|Failure to Return|62
706244|NCT00045032|2289401|P1|Overall Study|Failure to Return|57
706245|NCT00045032|2289399|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
706246|NCT00045032|2289400|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
706247|NCT00045032|2289401|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
706248|NCT00045032|2289399|P3|Overall Study|Other Protocol Violation|1
706249|NCT00045032|2289400|P2|Overall Study|Other Protocol Violation|0
706250|NCT00045032|2289401|P1|Overall Study|Other Protocol Violation|2
706251|NCT00045032|2289399|P3|Overall Study|Violation of Selection Criteria at Entry|6
706252|NCT00045032|2289400|P2|Overall Study|Violation of Selection Criteria at Entry|6
706253|NCT00045032|2289401|P1|Overall Study|Violation of Selection Criteria at Entry|3
706254|NCT00045032|2289399|P3|Overall Study|Insufficient Therapeutic Response|445
706255|NCT00045032|2289400|P2|Overall Study|Insufficient Therapeutic Response|437
706256|NCT00045032|2289401|P1|Overall Study|Insufficient Therapeutic Response|542
706257|NCT00045032|2289399|P3|Overall Study|Death|17
706258|NCT00045032|2289400|P2|Overall Study|Death|24
706259|NCT00045032|2289401|P1|Overall Study|Death|22
706260|NCT00045032|2289399|P3|Overall Study|Adverse Event/Intercurrent Illness|7
706261|NCT00045032|2289400|P2|Overall Study|Adverse Event/Intercurrent Illness|2
706262|NCT00045032|2289401|P1|Overall Study|Adverse Event/Intercurrent Illness|2
706263|NCT00045110|2289531|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
706264|NCT00045110|2289532|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
706265|NCT00045110|2289533|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
706266|NCT00045110|2289531|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
706267|NCT00045110|2289532|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
706268|NCT00045110|2289533|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
706269|NCT00045110|2289531|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
706270|NCT00045110|2289532|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
706271|NCT00045110|2289533|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
706272|NCT00045162|2289581|P2|Overall Study|Not specified|16
706273|NCT00045162|2289582|P1|Overall Study|Not specified|21
706274|NCT00045162|2289581|P2|Overall Study|Withdrawal by Subject|3
706275|NCT00045162|2289582|P1|Overall Study|Withdrawal by Subject|5
706276|NCT00045162|2289581|P2|Overall Study|Death|10
706277|NCT00045162|2289582|P1|Overall Study|Death|10
706278|NCT00045162|2289581|P2|Overall Study|Lack of Efficacy|29
706279|NCT00045162|2289582|P1|Overall Study|Lack of Efficacy|32
706280|NCT00045162|2289581|P2|Overall Study|Adverse Event|50
706281|NCT00045162|2289582|P1|Overall Study|Adverse Event|55
706282|NCT00045162|2289581|P2|Overall Study|Not treated|2
706283|NCT00045162|2289582|P1|Overall Study|Not treated|7
706284|NCT00045162|2289581|P2|Overall Study|Ineligible|8
706285|NCT00045162|2289582|P1|Overall Study|Ineligible|12
706286|NCT00045305|2289594|P1|Overall Study|site error|2
706287|NCT00045305|2289594|P1|Overall Study|Death|3
706288|NCT00045305|2289594|P1|Overall Study|Adverse Event|3
706289|NCT00045305|2289594|P1|Overall Study|Lack of Efficacy|6
706290|NCT00045630|2289616|P1|Overall Study|Ineligible|2
706291|NCT00045630|2289616|P1|Overall Study|Death|1
706292|NCT00045630|2289616|P1|Overall Study|Progression/relapse|1
706293|NCT00045630|2289616|P1|Overall Study|Refusal unrelated to adverse event|1
706294|NCT00045630|2289616|P1|Overall Study|Adverse Event|1
889763|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889764|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
706298|NCT00045734|2289650|P1|Overall Study|Protocol Violation|1
706299|NCT00045942|2289671|P9|PKC412A2104E2|Death|0
706300|NCT00045942|2289672|P8|PKC412A2104E2|Death|0
706301|NCT00045942|2289673|P7|PKC412A2104E2|Death|2
706302|NCT00045942|2289674|P6|PKC412A2104E2|Death|1
706303|NCT00045942|2289675|P5|PKC412A2104E2|Death|0
706304|NCT00045942|2289676|P4|PKC412A2104E2|Death|0
706305|NCT00045942|2289677|P3|PKC412A2104E2|Death|0
706306|NCT00045942|2289678|P2|PKC412A2104E2|Death|0
706307|NCT00045942|2289679|P1|PKC412A2104E2|Death|0
706308|NCT00045942|2289671|P9|PKC412A2104E2|Adverse Event|0
706309|NCT00045942|2289672|P8|PKC412A2104E2|Adverse Event|1
706310|NCT00045942|2289673|P7|PKC412A2104E2|Adverse Event|3
706311|NCT00045942|2289674|P6|PKC412A2104E2|Adverse Event|4
706312|NCT00045942|2289675|P5|PKC412A2104E2|Adverse Event|0
706313|NCT00045942|2289676|P4|PKC412A2104E2|Adverse Event|0
706314|NCT00045942|2289677|P3|PKC412A2104E2|Adverse Event|0
706315|NCT00045942|2289678|P2|PKC412A2104E2|Adverse Event|0
706316|NCT00045942|2289679|P1|PKC412A2104E2|Adverse Event|0
706317|NCT00045942|2289671|P9|PKC412A2104E2|Lack of Efficacy|6
706318|NCT00045942|2289672|P8|PKC412A2104E2|Lack of Efficacy|2
706319|NCT00045942|2289673|P7|PKC412A2104E2|Lack of Efficacy|2
706320|NCT00045942|2289674|P6|PKC412A2104E2|Lack of Efficacy|3
706321|NCT00045942|2289675|P5|PKC412A2104E2|Lack of Efficacy|0
706322|NCT00045942|2289676|P4|PKC412A2104E2|Lack of Efficacy|0
706323|NCT00045942|2289677|P3|PKC412A2104E2|Lack of Efficacy|0
706324|NCT00045942|2289678|P2|PKC412A2104E2|Lack of Efficacy|0
706325|NCT00045942|2289679|P1|PKC412A2104E2|Lack of Efficacy|0
706326|NCT00045942|2289671|P9|PKC412A2104E2|Withdrawal by Subject|0
706327|NCT00045942|2289672|P8|PKC412A2104E2|Withdrawal by Subject|1
706328|NCT00045942|2289673|P7|PKC412A2104E2|Withdrawal by Subject|0
706329|NCT00045942|2289674|P6|PKC412A2104E2|Withdrawal by Subject|1
706330|NCT00045942|2289675|P5|PKC412A2104E2|Withdrawal by Subject|0
706331|NCT00045942|2289676|P4|PKC412A2104E2|Withdrawal by Subject|0
706332|NCT00045942|2289677|P3|PKC412A2104E2|Withdrawal by Subject|0
706333|NCT00045942|2289678|P2|PKC412A2104E2|Withdrawal by Subject|0
706334|NCT00045942|2289679|P1|PKC412A2104E2|Withdrawal by Subject|0
706335|NCT00045942|2289671|P9|PKC412A2104E2|Lost to Follow-up|0
706336|NCT00045942|2289672|P8|PKC412A2104E2|Lost to Follow-up|3
706337|NCT00045942|2289673|P7|PKC412A2104E2|Lost to Follow-up|0
706338|NCT00045942|2289674|P6|PKC412A2104E2|Lost to Follow-up|0
706339|NCT00045942|2289675|P5|PKC412A2104E2|Lost to Follow-up|0
706340|NCT00045942|2289676|P4|PKC412A2104E2|Lost to Follow-up|0
706341|NCT00045942|2289677|P3|PKC412A2104E2|Lost to Follow-up|0
706342|NCT00045942|2289678|P2|PKC412A2104E2|Lost to Follow-up|0
706343|NCT00045942|2289679|P1|PKC412A2104E2|Lost to Follow-up|0
706344|NCT00045942|2289671|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706345|NCT00045942|2289672|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706346|NCT00045942|2289673|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706347|NCT00045942|2289674|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706348|NCT00045942|2289675|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706349|NCT00045942|2289676|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
706350|NCT00045942|2289677|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
706351|NCT00045942|2289678|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706352|NCT00045942|2289679|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
706353|NCT00045942|2289671|P9|PKC412A2104E1|Death|0
706354|NCT00045942|2289672|P8|PKC412A2104E1|Death|0
706355|NCT00045942|2289673|P7|PKC412A2104E1|Death|0
706356|NCT00045942|2289674|P6|PKC412A2104E1|Death|0
706357|NCT00045942|2289675|P5|PKC412A2104E1|Death|1
706358|NCT00045942|2289676|P4|PKC412A2104E1|Death|1
706359|NCT00045942|2289677|P3|PKC412A2104E1|Death|1
706360|NCT00045942|2289678|P2|PKC412A2104E1|Death|4
706361|NCT00045942|2289679|P1|PKC412A2104E1|Death|0
706362|NCT00045942|2289671|P9|PKC412A2104E1|Adverse Event|0
706363|NCT00045942|2289672|P8|PKC412A2104E1|Adverse Event|0
706364|NCT00045942|2289673|P7|PKC412A2104E1|Adverse Event|0
706365|NCT00045942|2289674|P6|PKC412A2104E1|Adverse Event|0
706366|NCT00045942|2289675|P5|PKC412A2104E1|Adverse Event|6
706367|NCT00045942|2289676|P4|PKC412A2104E1|Adverse Event|3
706368|NCT00045942|2289677|P3|PKC412A2104E1|Adverse Event|1
706369|NCT00045942|2289678|P2|PKC412A2104E1|Adverse Event|1
706370|NCT00045942|2289679|P1|PKC412A2104E1|Adverse Event|0
706371|NCT00045942|2289671|P9|PKC412A2104E1|Abnormal laboratory value|0
706372|NCT00045942|2289672|P8|PKC412A2104E1|Abnormal laboratory value|0
706373|NCT00045942|2289673|P7|PKC412A2104E1|Abnormal laboratory value|0
706374|NCT00045942|2289674|P6|PKC412A2104E1|Abnormal laboratory value|0
706375|NCT00045942|2289675|P5|PKC412A2104E1|Abnormal laboratory value|0
706376|NCT00045942|2289676|P4|PKC412A2104E1|Abnormal laboratory value|0
706377|NCT00045942|2289677|P3|PKC412A2104E1|Abnormal laboratory value|0
706378|NCT00045942|2289678|P2|PKC412A2104E1|Abnormal laboratory value|1
706379|NCT00045942|2289679|P1|PKC412A2104E1|Abnormal laboratory value|0
706380|NCT00045942|2289671|P9|PKC412A2104E1|Lack of Efficacy|0
706381|NCT00045942|2289672|P8|PKC412A2104E1|Lack of Efficacy|0
706382|NCT00045942|2289673|P7|PKC412A2104E1|Lack of Efficacy|0
706383|NCT00045942|2289674|P6|PKC412A2104E1|Lack of Efficacy|0
706384|NCT00045942|2289675|P5|PKC412A2104E1|Lack of Efficacy|17
706385|NCT00045942|2289676|P4|PKC412A2104E1|Lack of Efficacy|23
706386|NCT00045942|2289677|P3|PKC412A2104E1|Lack of Efficacy|11
706387|NCT00045942|2289678|P2|PKC412A2104E1|Lack of Efficacy|11
706388|NCT00045942|2289679|P1|PKC412A2104E1|Lack of Efficacy|0
706389|NCT00045942|2289671|P9|PKC412A2104E1|Condition no longer requires study drug|0
706390|NCT00045942|2289672|P8|PKC412A2104E1|Condition no longer requires study drug|0
706391|NCT00045942|2289673|P7|PKC412A2104E1|Condition no longer requires study drug|0
706392|NCT00045942|2289674|P6|PKC412A2104E1|Condition no longer requires study drug|0
706393|NCT00045942|2289675|P5|PKC412A2104E1|Condition no longer requires study drug|1
706394|NCT00045942|2289676|P4|PKC412A2104E1|Condition no longer requires study drug|0
706395|NCT00045942|2289677|P3|PKC412A2104E1|Condition no longer requires study drug|1
706396|NCT00045942|2289678|P2|PKC412A2104E1|Condition no longer requires study drug|1
706397|NCT00045942|2289679|P1|PKC412A2104E1|Condition no longer requires study drug|0
706398|NCT00045942|2289671|P9|PKC412A2104E1|Withdrawal by Subject|0
706399|NCT00045942|2289672|P8|PKC412A2104E1|Withdrawal by Subject|0
706400|NCT00045942|2289673|P7|PKC412A2104E1|Withdrawal by Subject|0
706401|NCT00045942|2289674|P6|PKC412A2104E1|Withdrawal by Subject|0
706402|NCT00045942|2289675|P5|PKC412A2104E1|Withdrawal by Subject|2
706403|NCT00045942|2289676|P4|PKC412A2104E1|Withdrawal by Subject|5
706404|NCT00045942|2289677|P3|PKC412A2104E1|Withdrawal by Subject|2
706405|NCT00045942|2289678|P2|PKC412A2104E1|Withdrawal by Subject|0
706406|NCT00045942|2289679|P1|PKC412A2104E1|Withdrawal by Subject|0
706407|NCT00045942|2289671|P9|PKC412A2104 (Core)|Death|0
706408|NCT00045942|2289672|P8|PKC412A2104 (Core)|Death|0
706409|NCT00045942|2289673|P7|PKC412A2104 (Core)|Death|0
706410|NCT00045942|2289674|P6|PKC412A2104 (Core)|Death|0
706411|NCT00045942|2289675|P5|PKC412A2104 (Core)|Death|0
706412|NCT00045942|2289676|P4|PKC412A2104 (Core)|Death|0
706413|NCT00045942|2289677|P3|PKC412A2104 (Core)|Death|0
706414|NCT00045942|2289678|P2|PKC412A2104 (Core)|Death|0
706415|NCT00045942|2289679|P1|PKC412A2104 (Core)|Death|1
706416|NCT00045942|2289671|P9|PKC412A2104 (Core)|Lack of Efficacy|0
706417|NCT00045942|2289672|P8|PKC412A2104 (Core)|Lack of Efficacy|0
706418|NCT00045942|2289673|P7|PKC412A2104 (Core)|Lack of Efficacy|0
706419|NCT00045942|2289674|P6|PKC412A2104 (Core)|Lack of Efficacy|0
706420|NCT00045942|2289675|P5|PKC412A2104 (Core)|Lack of Efficacy|0
706421|NCT00045942|2289676|P4|PKC412A2104 (Core)|Lack of Efficacy|0
706422|NCT00045942|2289677|P3|PKC412A2104 (Core)|Lack of Efficacy|0
706423|NCT00045942|2289678|P2|PKC412A2104 (Core)|Lack of Efficacy|0
706424|NCT00045942|2289679|P1|PKC412A2104 (Core)|Lack of Efficacy|13
706425|NCT00045942|2289671|P9|PKC412A2104 (Core)|Adverse Event|0
706426|NCT00045942|2289672|P8|PKC412A2104 (Core)|Adverse Event|0
706427|NCT00045942|2289673|P7|PKC412A2104 (Core)|Adverse Event|0
706428|NCT00045942|2289674|P6|PKC412A2104 (Core)|Adverse Event|0
706429|NCT00045942|2289675|P5|PKC412A2104 (Core)|Adverse Event|0
706430|NCT00045942|2289676|P4|PKC412A2104 (Core)|Adverse Event|0
706431|NCT00045942|2289677|P3|PKC412A2104 (Core)|Adverse Event|0
706432|NCT00045942|2289678|P2|PKC412A2104 (Core)|Adverse Event|0
706433|NCT00045942|2289679|P1|PKC412A2104 (Core)|Adverse Event|5
706434|NCT00045942|2289671|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
706435|NCT00045942|2289672|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
706436|NCT00045942|2289673|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
706437|NCT00045942|2289674|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
706438|NCT00045942|2289675|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
706439|NCT00045942|2289676|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
706440|NCT00045942|2289677|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
706441|NCT00045942|2289678|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
706442|NCT00045942|2289679|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
706443|NCT00046839|2289860|P2|Overall Study|Withdrawal of consent|0
706444|NCT00046839|2289861|P1|Overall Study|Withdrawal of consent|1
706445|NCT00046839|2289860|P2|Overall Study|Ineligible / No protocol treatment|2
706446|NCT00046839|2289861|P1|Overall Study|Ineligible / No protocol treatment|0
706447|NCT00046891|2289870|P2|Overall Study|Adverse Event|5
706448|NCT00046891|2289871|P1|Overall Study|Adverse Event|5
706449|NCT00046891|2289870|P2|Overall Study|Withdrawal by Subject|15
706450|NCT00046891|2289871|P1|Overall Study|Withdrawal by Subject|18
706451|NCT00046891|2289870|P2|Overall Study|Ineligible|1
706452|NCT00046891|2289871|P1|Overall Study|Ineligible|1
706453|NCT00046891|2289870|P2|Overall Study|Cancels|9
706454|NCT00046891|2289871|P1|Overall Study|Cancels|5
706458|NCT00053417|2289898|P4|Overall Study|Lost to Follow-up|0
706459|NCT00053417|2289899|P3|Overall Study|Lost to Follow-up|0
706460|NCT00053417|2289900|P2|Overall Study|Lost to Follow-up|1
706461|NCT00053417|2289901|P1|Overall Study|Lost to Follow-up|1
706462|NCT00053417|2289898|P4|Overall Study|Withdrawal by Subject|0
706463|NCT00053417|2289899|P3|Overall Study|Withdrawal by Subject|0
706464|NCT00053417|2289900|P2|Overall Study|Withdrawal by Subject|1
706465|NCT00053417|2289901|P1|Overall Study|Withdrawal by Subject|0
706466|NCT00053417|2289898|P4|Overall Study|Non-Compliance|1
706467|NCT00053417|2289899|P3|Overall Study|Non-Compliance|0
706468|NCT00053417|2289900|P2|Overall Study|Non-Compliance|0
706469|NCT00053417|2289901|P1|Overall Study|Non-Compliance|0
706470|NCT00053417|2289898|P4|Overall Study|Adverse Event|5
706471|NCT00053417|2289899|P3|Overall Study|Adverse Event|1
706472|NCT00053417|2289900|P2|Overall Study|Adverse Event|0
706473|NCT00053417|2289901|P1|Overall Study|Adverse Event|1
706474|NCT00057941|2290062|P2|Overall Study|Ineligible|5
706475|NCT00057941|2290063|P1|Overall Study|Ineligible|2
706476|NCT00057941|2290062|P2|Overall Study|insurance, symptomatic deterioration|3
706477|NCT00057941|2290063|P1|Overall Study|insurance, symptomatic deterioration|1
706478|NCT00057941|2290062|P2|Overall Study|still on treatment|1
706479|NCT00057941|2290063|P1|Overall Study|still on treatment|3
706480|NCT00057941|2290062|P2|Overall Study|Withdrawal by Subject|1
706481|NCT00057941|2290063|P1|Overall Study|Withdrawal by Subject|6
706482|NCT00057941|2290062|P2|Overall Study|Lack of Efficacy|53
706483|NCT00057941|2290063|P1|Overall Study|Lack of Efficacy|54
706484|NCT00057941|2290062|P2|Overall Study|Adverse Event|9
706485|NCT00057941|2290063|P1|Overall Study|Adverse Event|7
706486|NCT00057941|2290062|P2|Overall Study|Death|2
706487|NCT00057941|2290063|P1|Overall Study|Death|1
706488|NCT00057954|2290069|P1|Overall Study|Disease progression|1
706489|NCT00057954|2290069|P1|Overall Study|Death|1
706490|NCT00058214|2290091|P1|Overall Study|Adverse Event|1
706491|NCT00058539|2290113|P1|Overall Study|Death|1
706492|NCT00058539|2290113|P1|Overall Study|Physician Decision|9
706493|NCT00058539|2290113|P1|Overall Study|Withdrawal by Subject|5
706494|NCT00058539|2290113|P1|Overall Study|Adverse Event|3
706495|NCT00058539|2290113|P1|Overall Study|Disease progression|24
706496|NCT00058552|2290125|P2|Overall Study|Clinical disease progression|4
706497|NCT00058552|2290126|P1|Overall Study|Clinical disease progression|0
706498|NCT00058552|2290125|P2|Overall Study|Physician Decision|5
706499|NCT00058552|2290126|P1|Overall Study|Physician Decision|2
706500|NCT00058552|2290125|P2|Overall Study|Withdrawal by Subject|5
706501|NCT00058552|2290126|P1|Overall Study|Withdrawal by Subject|3
706502|NCT00058552|2290125|P2|Overall Study|Adverse Event|2
706503|NCT00058552|2290126|P1|Overall Study|Adverse Event|4
706504|NCT00058552|2290125|P2|Overall Study|Disease progression|44
706505|NCT00058552|2290126|P1|Overall Study|Disease progression|52
706506|NCT00058552|2290125|P2|Overall Study|Died prior to receiving treatment|2
706507|NCT00058552|2290126|P1|Overall Study|Died prior to receiving treatment|4
706508|NCT00058825|2290144|P1|Overall Study|Death|3
706509|NCT00058825|2290144|P1|Overall Study|Graft Failure|5
706510|NCT00058825|2290144|P1|Overall Study|Progressive Disease|5
706511|NCT00058825|2290144|P1|Overall Study|Relapse|9
706512|NCT00059215|2290162|P4|Overall Study|Physician Decision|1
706513|NCT00059215|2290163|P3|Overall Study|Physician Decision|1
706514|NCT00059215|2290164|P2|Overall Study|Physician Decision|2
706515|NCT00059215|2290165|P1|Overall Study|Physician Decision|1
706516|NCT00059215|2290162|P4|Overall Study|Protocol entry criteria not met|2
706517|NCT00059215|2290163|P3|Overall Study|Protocol entry criteria not met|0
706518|NCT00059215|2290164|P2|Overall Study|Protocol entry criteria not met|1
706519|NCT00059215|2290165|P1|Overall Study|Protocol entry criteria not met|1
706520|NCT00059215|2290162|P4|Overall Study|Protocol Violation|0
706521|NCT00059215|2290163|P3|Overall Study|Protocol Violation|1
706522|NCT00059215|2290164|P2|Overall Study|Protocol Violation|0
706523|NCT00059215|2290165|P1|Overall Study|Protocol Violation|1
706524|NCT00059215|2290162|P4|Overall Study|Withdrawal by Subject|3
706525|NCT00059215|2290163|P3|Overall Study|Withdrawal by Subject|1
706526|NCT00059215|2290164|P2|Overall Study|Withdrawal by Subject|4
706527|NCT00059215|2290165|P1|Overall Study|Withdrawal by Subject|4
706528|NCT00059215|2290162|P4|Overall Study|Lost to Follow-up|0
706529|NCT00059215|2290163|P3|Overall Study|Lost to Follow-up|0
706530|NCT00059215|2290164|P2|Overall Study|Lost to Follow-up|2
706531|NCT00059215|2290165|P1|Overall Study|Lost to Follow-up|1
706532|NCT00059215|2290162|P4|Overall Study|Death|0
706533|NCT00059215|2290163|P3|Overall Study|Death|3
706534|NCT00059215|2290164|P2|Overall Study|Death|0
706535|NCT00059215|2290165|P1|Overall Study|Death|0
706536|NCT00059215|2290162|P4|Overall Study|Adverse Event|9
706537|NCT00059215|2290163|P3|Overall Study|Adverse Event|9
706538|NCT00059215|2290164|P2|Overall Study|Adverse Event|5
706539|NCT00059215|2290165|P1|Overall Study|Adverse Event|5
706540|NCT00059332|2290193|P2|Overall Study|Lost to Follow-up|1
706541|NCT00059332|2290194|P1|Overall Study|Lost to Follow-up|1
706542|NCT00059332|2290193|P2|Overall Study|Withdrawal by Subject|1
706543|NCT00059332|2290194|P1|Overall Study|Withdrawal by Subject|2
706544|NCT00059787|2290257|P1|Overall Study|Other|4
706545|NCT00059787|2290257|P1|Overall Study|ineligible|1
706546|NCT00059787|2290257|P1|Overall Study|disease progression|2
706547|NCT00059787|2290257|P1|Overall Study|Adverse Event|13
706548|NCT00059839|2290267|P2|Overall Study|Ineligible|3
706549|NCT00059839|2290268|P1|Overall Study|Ineligible|1
706550|NCT00059839|2290267|P2|Overall Study|Withdrawal by Subject|6
706551|NCT00059839|2290268|P1|Overall Study|Withdrawal by Subject|1
706552|NCT00059839|2290267|P2|Overall Study|Physician Decision|2
706553|NCT00059839|2290268|P1|Overall Study|Physician Decision|1
706554|NCT00059839|2290267|P2|Overall Study|Lost to Follow-up|0
706555|NCT00059839|2290268|P1|Overall Study|Lost to Follow-up|2
706556|NCT00059839|2290267|P2|Overall Study|Lack of Efficacy|5
706557|NCT00059839|2290268|P1|Overall Study|Lack of Efficacy|6
706558|NCT00059839|2290267|P2|Overall Study|Death|1
706559|NCT00059839|2290268|P1|Overall Study|Death|1
706560|NCT00060840|2290313|P2|Overall Study|Other|0
706561|NCT00060840|2290314|P1|Overall Study|Other|1
706562|NCT00060840|2290313|P2|Overall Study|Physician Decision|0
706563|NCT00060840|2290314|P1|Overall Study|Physician Decision|1
706564|NCT00060840|2290313|P2|Overall Study|Subinvestigator unavailable|1
706565|NCT00060840|2290314|P1|Overall Study|Subinvestigator unavailable|0
706566|NCT00060840|2290313|P2|Overall Study|Withdrawal by Subject|1
706567|NCT00060840|2290314|P1|Overall Study|Withdrawal by Subject|0
706568|NCT00060840|2290313|P2|Overall Study|Death|1
706569|NCT00060840|2290314|P1|Overall Study|Death|0
706570|NCT00060840|2290313|P2|Overall Study|Change in surgical plan|6
706571|NCT00060840|2290314|P1|Overall Study|Change in surgical plan|2
706572|NCT00043550|2290323|P3|Overall Study|Withdrawal by Subject|20
706573|NCT00043550|2290324|P2|Overall Study|Withdrawal by Subject|12
706574|NCT00043550|2290325|P1|Overall Study|Withdrawal by Subject|22
706575|NCT00043979|2290335|P3|Period 1|recipient with progressive disease|3
706576|NCT00043979|2290336|P2|Period 1|recipient with progressive disease|4
706577|NCT00043979|2290337|P1|Period 1|recipient with progressive disease|7
706578|NCT00050167|2290431|P2|Overall Study|not eligible not invasive|1
706579|NCT00050167|2290432|P1|Overall Study|not eligible not invasive|1
706580|NCT00060944|2290440|P2|Overall Study|randomized but not treated|4
706581|NCT00060944|2290441|P1|Overall Study|randomized but not treated|6
706582|NCT00060944|2290440|P2|Overall Study|Not specified|4
706583|NCT00060944|2290441|P1|Overall Study|Not specified|2
706584|NCT00060944|2290440|P2|Overall Study|Treatment Switch|13
706585|NCT00060944|2290441|P1|Overall Study|Treatment Switch|0
706586|NCT00060944|2290440|P2|Overall Study|Subject Ineligible To Continue|1
706587|NCT00060944|2290441|P1|Overall Study|Subject Ineligible To Continue|2
706588|NCT00060944|2290440|P2|Overall Study|Lost to Follow-up|0
706589|NCT00060944|2290441|P1|Overall Study|Lost to Follow-up|1
706590|NCT00060944|2290440|P2|Overall Study|Disease Progression|94
706591|NCT00060944|2290441|P1|Overall Study|Disease Progression|93
706592|NCT00060944|2290440|P2|Overall Study|Withdrawal by Subject|5
706593|NCT00060944|2290441|P1|Overall Study|Withdrawal by Subject|18
706594|NCT00060944|2290440|P2|Overall Study|Death|3
706595|NCT00060944|2290441|P1|Overall Study|Death|2
706596|NCT00060944|2290440|P2|Overall Study|Adverse Event|10
706597|NCT00060944|2290441|P1|Overall Study|Adverse Event|12
706598|NCT00061048|2290455|P1|Overall Study|disease progression|20
706599|NCT00061048|2290455|P1|Overall Study|Adverse Event|2
706600|NCT00061633|2290465|P2|Overall Study|Never received study treatment|2
706601|NCT00061633|2290466|P1|Overall Study|Never received study treatment|0
706602|NCT00061633|2290465|P2|Overall Study|Other|1
706603|NCT00061633|2290466|P1|Overall Study|Other|1
706604|NCT00061633|2290465|P2|Overall Study|Lost to Follow-up|4
706605|NCT00061633|2290466|P1|Overall Study|Lost to Follow-up|1
706606|NCT00061633|2290465|P2|Overall Study|Withdrawal by Subject|2
706607|NCT00061633|2290466|P1|Overall Study|Withdrawal by Subject|2
706608|NCT00061633|2290465|P2|Overall Study|Adverse Event|2
706609|NCT00061633|2290466|P1|Overall Study|Adverse Event|1
706610|NCT00061932|2290479|P2|Overall Study|Withdrawal by Subject|4
706611|NCT00061932|2290480|P1|Overall Study|Withdrawal by Subject|13
706612|NCT00061945|2290488|P2|Course IV: Alemtuzumab|Early exits|15
706613|NCT00061945|2290489|P1|Course IV: Alemtuzumab|Early exits|6
706614|NCT00061945|2290488|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
706615|NCT00061945|2290489|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
706616|NCT00061945|2290488|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
706617|NCT00061945|2290489|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
706618|NCT00061945|2290488|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
706619|NCT00061945|2290489|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
706620|NCT00062010|2290497|P1|Overall Study|Ineligible|3
706621|NCT00062374|2290503|P1|Overall Study|Not treated|12
706622|NCT00062439|2290508|P1|Consolidation Chemotherapy|Adverse Event|2
706623|NCT00062439|2290508|P1|Surgery|Adverse Event|2
706624|NCT00062439|2290508|P1|Surgery|Death|1
706625|NCT00062439|2290508|P1|Surgery|Physician Decision|4
706626|NCT00062439|2290508|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
706627|NCT00062439|2290508|P1|Post Chemoradiation Assessment|Physician Decision|1
706628|NCT00062439|2290508|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
706629|NCT00062439|2290508|P1|Post Chemoradiation Assessment|Disease progression|2
706630|NCT00062439|2290508|P1|Post Chemoradiation Assessment|Death|1
706631|NCT00062439|2290508|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
706632|NCT00062439|2290508|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
706633|NCT00062439|2290508|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
706634|NCT00062439|2290508|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
706635|NCT00062647|2290522|P2|Overall Study|Never received study treatment|1
706636|NCT00062647|2290523|P1|Overall Study|Never received study treatment|1
706637|NCT00062647|2290522|P2|Overall Study|Other|4
706638|NCT00062647|2290523|P1|Overall Study|Other|4
706639|NCT00062647|2290522|P2|Overall Study|Failed continuation criteria|2
706640|NCT00062647|2290523|P1|Overall Study|Failed continuation criteria|4
706641|NCT00062647|2290522|P2|Overall Study|Lost to Follow-up|2
706642|NCT00062647|2290523|P1|Overall Study|Lost to Follow-up|1
706643|NCT00062647|2290522|P2|Overall Study|Protocol Violation|0
706644|NCT00062647|2290523|P1|Overall Study|Protocol Violation|1
706645|NCT00062647|2290522|P2|Overall Study|Withdrawal by Subject|1
706646|NCT00062647|2290523|P1|Overall Study|Withdrawal by Subject|2
706647|NCT00062647|2290522|P2|Overall Study|Adverse Event|1
706648|NCT00062647|2290523|P1|Overall Study|Adverse Event|1
706649|NCT00062647|2290522|P2|Overall Study|Death|2
706650|NCT00062647|2290523|P1|Overall Study|Death|2
706651|NCT00062751|2290550|P5|Overall Study|Death|0
706652|NCT00062751|2290551|P4|Overall Study|Death|0
706653|NCT00062751|2290552|P3|Overall Study|Death|1
706654|NCT00062751|2290553|P2|Overall Study|Death|0
706655|NCT00062751|2290554|P1|Overall Study|Death|1
706656|NCT00062751|2290550|P5|Overall Study|Symptomatic deterioration|1
706657|NCT00062751|2290551|P4|Overall Study|Symptomatic deterioration|0
706658|NCT00062751|2290552|P3|Overall Study|Symptomatic deterioration|0
706659|NCT00062751|2290553|P2|Overall Study|Symptomatic deterioration|1
706660|NCT00062751|2290554|P1|Overall Study|Symptomatic deterioration|1
706661|NCT00062751|2290550|P5|Overall Study|Withdrawal by Subject|0
706662|NCT00062751|2290551|P4|Overall Study|Withdrawal by Subject|1
706663|NCT00062751|2290552|P3|Overall Study|Withdrawal by Subject|2
706664|NCT00062751|2290553|P2|Overall Study|Withdrawal by Subject|2
706665|NCT00062751|2290554|P1|Overall Study|Withdrawal by Subject|1
706666|NCT00062751|2290550|P5|Overall Study|Unspecified|1
706667|NCT00062751|2290551|P4|Overall Study|Unspecified|0
706668|NCT00062751|2290552|P3|Overall Study|Unspecified|1
706669|NCT00062751|2290553|P2|Overall Study|Unspecified|3
706670|NCT00062751|2290554|P1|Overall Study|Unspecified|2
706671|NCT00062751|2290550|P5|Overall Study|Adverse Event|2
706672|NCT00062751|2290551|P4|Overall Study|Adverse Event|2
706673|NCT00062751|2290552|P3|Overall Study|Adverse Event|2
706674|NCT00062751|2290553|P2|Overall Study|Adverse Event|7
706675|NCT00062751|2290554|P1|Overall Study|Adverse Event|4
706676|NCT00062751|2290550|P5|Overall Study|Disease progression|2
706677|NCT00062751|2290551|P4|Overall Study|Disease progression|2
706678|NCT00062751|2290552|P3|Overall Study|Disease progression|24
706679|NCT00062751|2290553|P2|Overall Study|Disease progression|17
706680|NCT00062751|2290554|P1|Overall Study|Disease progression|24
706681|NCT00063154|2290630|P1|Overall Study|Did not receive treatment|8
706682|NCT00063154|2290630|P1|Overall Study|Reason unspecified|1
706683|NCT00063154|2290630|P1|Overall Study|Death|3
706684|NCT00063154|2290630|P1|Overall Study|Physician Decision|10
706685|NCT00063154|2290630|P1|Overall Study|Adverse Event|2
706686|NCT00063154|2290630|P1|Overall Study|Disease progression|27
706687|NCT00063258|2290645|P2|Overall Study|Lack of Efficacy|0
706688|NCT00063258|2290646|P1|Overall Study|Lack of Efficacy|2
706689|NCT00063258|2290645|P2|Overall Study|Physician Decision|0
706690|NCT00063258|2290646|P1|Overall Study|Physician Decision|2
706691|NCT00063934|2290749|P1|Overall Study|Ineligible|1
706692|NCT00063986|2290755|P1|Overall Study|Intra-operatively ineligible|4
706693|NCT00063986|2290755|P1|Overall Study|Ineligible|1
706694|NCT00063986|2290755|P1|Overall Study|Withdrawal by Subject|1
706695|NCT00064025|2290767|P1|Overall Study|Inevaluable|3
706696|NCT00064025|2290767|P1|Overall Study|Ineligible|4
706697|NCT00055471|2290799|P3|Period 1: Dose Escalation Period|Disease progression|0
706698|NCT00055471|2290800|P2|Period 1: Dose Escalation Period|Disease progression|1
706699|NCT00055471|2290801|P1|Period 1: Dose Escalation Period|Disease progression|0
706700|NCT00055471|2290799|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
706701|NCT00055471|2290800|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
706702|NCT00055471|2290801|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
706703|NCT00055471|2290799|P3|Period 1: Dose Escalation Period|Adverse Event|2
706704|NCT00055471|2290800|P2|Period 1: Dose Escalation Period|Adverse Event|1
706705|NCT00055471|2290801|P1|Period 1: Dose Escalation Period|Adverse Event|0
706706|NCT00055497|2290831|P4|Overall Study|Other|11
706707|NCT00055497|2290832|P3|Overall Study|Other|0
706708|NCT00055497|2290833|P2|Overall Study|Other|0
706709|NCT00055497|2290834|P1|Overall Study|Other|0
706710|NCT00055497|2290831|P4|Overall Study|Administrative Reasons|1
706711|NCT00055497|2290832|P3|Overall Study|Administrative Reasons|0
706712|NCT00055497|2290833|P2|Overall Study|Administrative Reasons|0
706713|NCT00055497|2290834|P1|Overall Study|Administrative Reasons|0
706714|NCT00055497|2290831|P4|Overall Study|Lack of Efficacy|27
706715|NCT00055497|2290832|P3|Overall Study|Lack of Efficacy|0
706716|NCT00055497|2290833|P2|Overall Study|Lack of Efficacy|0
706717|NCT00055497|2290834|P1|Overall Study|Lack of Efficacy|1
706718|NCT00055497|2290831|P4|Overall Study|Protocol Violation|3
706719|NCT00055497|2290832|P3|Overall Study|Protocol Violation|0
706720|NCT00055497|2290833|P2|Overall Study|Protocol Violation|0
706721|NCT00055497|2290834|P1|Overall Study|Protocol Violation|0
706722|NCT00055497|2290831|P4|Overall Study|Lost to Follow-up|5
706723|NCT00055497|2290832|P3|Overall Study|Lost to Follow-up|0
706724|NCT00055497|2290833|P2|Overall Study|Lost to Follow-up|1
706725|NCT00055497|2290834|P1|Overall Study|Lost to Follow-up|0
706726|NCT00055497|2290831|P4|Overall Study|Withdrawal by Subject|15
706727|NCT00055497|2290832|P3|Overall Study|Withdrawal by Subject|1
706728|NCT00055497|2290833|P2|Overall Study|Withdrawal by Subject|1
706729|NCT00055497|2290834|P1|Overall Study|Withdrawal by Subject|3
706730|NCT00055497|2290831|P4|Overall Study|Adverse Event|28
706731|NCT00055497|2290832|P3|Overall Study|Adverse Event|1
706732|NCT00055497|2290833|P2|Overall Study|Adverse Event|1
706733|NCT00055497|2290834|P1|Overall Study|Adverse Event|1
706734|NCT00055601|2290878|P2|Overall Study|No protocol treatment received|1
706735|NCT00055601|2290879|P1|Overall Study|No protocol treatment received|1
706736|NCT00055601|2290878|P2|Overall Study|Protocol Violation|1
706737|NCT00055601|2290879|P1|Overall Study|Protocol Violation|1
889765|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889766|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889767|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
889768|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
889769|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889770|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889771|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889772|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889773|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889774|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
889775|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
889776|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
889777|NCT01232283|2824400|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889778|NCT01232283|2824401|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889779|NCT01232283|2824402|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889780|NCT01232283|2824403|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889781|NCT01232283|2824404|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889782|NCT01232283|2824405|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
889783|NCT01232283|2824406|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
889784|NCT01232283|2824407|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
889785|NCT01218204|2824439|P4|Part B Pooled Treatment Arm|Protocol Violation|1
889786|NCT01218204|2824440|P3|Part B Pooled Treatment Arm|Protocol Violation|0
889787|NCT01218204|2824441|P2|Part B Pooled Treatment Arm|Protocol Violation|0
889788|NCT01218204|2824442|P1|Part B Pooled Treatment Arm|Protocol Violation|0
889789|NCT01218204|2824439|P4|Part B Pooled Treatment Arm|Adverse Event|2
889790|NCT01218204|2824440|P3|Part B Pooled Treatment Arm|Adverse Event|0
889791|NCT01218204|2824441|P2|Part B Pooled Treatment Arm|Adverse Event|0
889792|NCT01218204|2824442|P1|Part B Pooled Treatment Arm|Adverse Event|0
889793|NCT01218204|2824439|P4|Part B Run-in|Withdrawal by Subject|0
889794|NCT01218204|2824440|P3|Part B Run-in|Withdrawal by Subject|3
706768|NCT00056316|2290915|P2|Overall Study|Death/NH placement of pt|1
706769|NCT00056316|2290916|P1|Overall Study|Death/NH placement of pt|1
706770|NCT00056316|2290915|P2|Overall Study|Withdrawal by Subject|2
706771|NCT00056316|2290916|P1|Overall Study|Withdrawal by Subject|2
706772|NCT00056407|2290930|P2|Overall Study|Missing|34
706773|NCT00056407|2290931|P1|Overall Study|Missing|25
706774|NCT00056407|2290930|P2|Overall Study|"Listed as Other on Case Report Form"|60
706775|NCT00056407|2290931|P1|Overall Study|"Listed as Other on Case Report Form"|98
706776|NCT00056407|2290930|P2|Overall Study|Diagnosed with Prostate Cancer|166
706777|NCT00056407|2290931|P1|Overall Study|Diagnosed with Prostate Cancer|202
706778|NCT00056407|2290930|P2|Overall Study|Protocol Violation|95
706779|NCT00056407|2290931|P1|Overall Study|Protocol Violation|104
706780|NCT00056407|2290930|P2|Overall Study|Lost to Follow-up|113
706781|NCT00056407|2290931|P1|Overall Study|Lost to Follow-up|123
706782|NCT00056407|2290930|P2|Overall Study|Withdrawal by Subject|361
706783|NCT00056407|2290931|P1|Overall Study|Withdrawal by Subject|377
706784|NCT00056407|2290930|P2|Overall Study|Adverse Event|364
706785|NCT00056407|2290931|P1|Overall Study|Adverse Event|282
706786|NCT00056862|2291027|P2|Overall Study|Protocol Violation|0
706787|NCT00056862|2291028|P1|Overall Study|Protocol Violation|1
706788|NCT00057330|2291044|P2|Overall Study|Unspecified|206
706789|NCT00057330|2291045|P1|Overall Study|Unspecified|260
706790|NCT00057330|2291044|P2|Overall Study|Physician Decision|0
706791|NCT00057330|2291045|P1|Overall Study|Physician Decision|1
706792|NCT00057330|2291044|P2|Overall Study|Lost to Follow-up|617
706793|NCT00057330|2291045|P1|Overall Study|Lost to Follow-up|745
706794|NCT00057330|2291044|P2|Overall Study|Withdrawal by Subject|84
706795|NCT00057330|2291045|P1|Overall Study|Withdrawal by Subject|115
706796|NCT00057330|2291044|P2|Overall Study|Protocol Violation|1
706797|NCT00057330|2291045|P1|Overall Study|Protocol Violation|1
706798|NCT00057330|2291044|P2|Overall Study|Death|0
706799|NCT00057330|2291045|P1|Overall Study|Death|1
706800|NCT00057330|2291044|P2|Overall Study|Adverse Event|12
706801|NCT00057330|2291045|P1|Overall Study|Adverse Event|9
706802|NCT00057746|2291125|P3|Overall Study|Withdrawal by Subject|1
706803|NCT00057746|2291126|P2|Overall Study|Withdrawal by Subject|0
706804|NCT00057746|2291127|P1|Overall Study|Withdrawal by Subject|0
706805|NCT00057811|2291141|P2|Overall Study|Inevaluable|2
706806|NCT00057811|2291142|P1|Overall Study|Inevaluable|1
706807|NCT00057811|2291141|P2|Overall Study|Ineligible|2
706808|NCT00057811|2291142|P1|Overall Study|Ineligible|4
706809|NCT00057811|2291141|P2|Overall Study|Withdrawal by Subject|4
706810|NCT00057811|2291142|P1|Overall Study|Withdrawal by Subject|3
706811|NCT00057811|2291141|P2|Overall Study|Physician Decision|0
706812|NCT00057811|2291142|P1|Overall Study|Physician Decision|1
706813|NCT00057811|2291141|P2|Overall Study|Lack of Efficacy|4
706814|NCT00057811|2291142|P1|Overall Study|Lack of Efficacy|1
706815|NCT00057837|2291156|P2|Overall Study|Never started treatment|1
706816|NCT00057837|2291157|P1|Overall Study|Never started treatment|1
706817|NCT00057837|2291156|P2|Overall Study|Ineligible|3
706818|NCT00057837|2291157|P1|Overall Study|Ineligible|3
706819|NCT00057837|2291156|P2|Overall Study|Physician Decision|0
706820|NCT00057837|2291157|P1|Overall Study|Physician Decision|1
706821|NCT00057837|2291156|P2|Overall Study|Other complicating disease|1
706822|NCT00057837|2291157|P1|Overall Study|Other complicating disease|2
706823|NCT00057837|2291156|P2|Overall Study|Alternative therapy|1
706824|NCT00057837|2291157|P1|Overall Study|Alternative therapy|0
706825|NCT00057837|2291156|P2|Overall Study|Withdrawal by Subject|3
706826|NCT00057837|2291157|P1|Overall Study|Withdrawal by Subject|5
706827|NCT00057837|2291156|P2|Overall Study|Death|4
706828|NCT00057837|2291157|P1|Overall Study|Death|5
706829|NCT00057837|2291156|P2|Overall Study|Adverse Event|12
706830|NCT00057837|2291157|P1|Overall Study|Adverse Event|2
706831|NCT00057837|2291156|P2|Overall Study|Progression/relapse|14
706832|NCT00057837|2291157|P1|Overall Study|Progression/relapse|12
706833|NCT00057863|2291167|P1|Overall Study|Withdrawal by Subject|2
706834|NCT00057863|2291167|P1|Overall Study|Death|1
706835|NCT00057876|2291176|P2|Overall Study|other complicating disease|0
706836|NCT00057876|2291177|P1|Overall Study|other complicating disease|1
706837|NCT00057876|2291176|P2|Overall Study|other reason|2
706838|NCT00057876|2291177|P1|Overall Study|other reason|2
706839|NCT00057876|2291176|P2|Overall Study|Ineligible|2
706840|NCT00057876|2291177|P1|Overall Study|Ineligible|1
706841|NCT00057876|2291176|P2|Overall Study|Lack of Efficacy|8
706842|NCT00057876|2291177|P1|Overall Study|Lack of Efficacy|10
706843|NCT00057876|2291176|P2|Overall Study|Withdrawal by Subject|6
706844|NCT00057876|2291177|P1|Overall Study|Withdrawal by Subject|5
706845|NCT00057876|2291176|P2|Overall Study|Death|1
706846|NCT00057876|2291177|P1|Overall Study|Death|2
706847|NCT00057876|2291176|P2|Overall Study|Adverse Event|8
706848|NCT00057876|2291177|P1|Overall Study|Adverse Event|8
706849|NCT00064259|2291187|P4|Overall Study|Adverse Event|1
706850|NCT00064259|2291188|P3|Overall Study|Adverse Event|0
889795|NCT01218204|2824441|P2|Part B Run-in|Withdrawal by Subject|0
706851|NCT00064259|2291189|P2|Overall Study|Adverse Event|0
706852|NCT00064259|2291190|P1|Overall Study|Adverse Event|1
706853|NCT00064298|2291196|P2|Overall Study|Disease Progression|1
706854|NCT00064298|2291197|P1|Overall Study|Disease Progression|2
706855|NCT00064298|2291196|P2|Overall Study|Death|1
706856|NCT00064298|2291197|P1|Overall Study|Death|0
706857|NCT00064298|2291196|P2|Overall Study|Lost to Follow-up|2
706858|NCT00064298|2291197|P1|Overall Study|Lost to Follow-up|2
706859|NCT00064298|2291196|P2|Overall Study|Withdrawal by Subject|1
706860|NCT00064298|2291197|P1|Overall Study|Withdrawal by Subject|2
706861|NCT00064350|2291208|P3|Cross-Over|Other|0
706862|NCT00064350|2291209|P2|Cross-Over|Other|2
706863|NCT00064350|2291210|P1|Cross-Over|Other|0
706864|NCT00064350|2291208|P3|Cross-Over|Ineligible or never started treatment|0
706865|NCT00064350|2291209|P2|Cross-Over|Ineligible or never started treatment|6
706866|NCT00064350|2291210|P1|Cross-Over|Ineligible or never started treatment|3
706867|NCT00064350|2291208|P3|Cross-Over|Withdrawal by Subject|0
706868|NCT00064350|2291209|P2|Cross-Over|Withdrawal by Subject|2
706869|NCT00064350|2291210|P1|Cross-Over|Withdrawal by Subject|2
706870|NCT00064350|2291208|P3|Cross-Over|Death|0
706871|NCT00064350|2291209|P2|Cross-Over|Death|3
706872|NCT00064350|2291210|P1|Cross-Over|Death|1
706873|NCT00064350|2291208|P3|Cross-Over|Adverse Event|0
706874|NCT00064350|2291209|P2|Cross-Over|Adverse Event|1
706875|NCT00064350|2291210|P1|Cross-Over|Adverse Event|0
706876|NCT00064350|2291208|P3|Randomization|Other|0
706877|NCT00064350|2291209|P2|Randomization|Other|0
706878|NCT00064350|2291210|P1|Randomization|Other|5
706879|NCT00064350|2291208|P3|Randomization|Ineligible or never started treatment|0
706880|NCT00064350|2291209|P2|Randomization|Ineligible or never started treatment|15
706881|NCT00064350|2291210|P1|Randomization|Ineligible or never started treatment|9
706882|NCT00064350|2291208|P3|Randomization|Withdrawal by Subject|0
706883|NCT00064350|2291209|P2|Randomization|Withdrawal by Subject|0
706884|NCT00064350|2291210|P1|Randomization|Withdrawal by Subject|1
706885|NCT00064350|2291208|P3|Randomization|Death|0
706886|NCT00064350|2291209|P2|Randomization|Death|0
706887|NCT00064350|2291210|P1|Randomization|Death|3
706888|NCT00064350|2291208|P3|Randomization|Adverse Event|0
706889|NCT00064350|2291209|P2|Randomization|Adverse Event|3
706890|NCT00064350|2291210|P1|Randomization|Adverse Event|8
706891|NCT00064350|2291208|P3|Induction Treatment|Other|13
706892|NCT00064350|2291209|P2|Induction Treatment|Other|0
706893|NCT00064350|2291210|P1|Induction Treatment|Other|0
706894|NCT00064350|2291208|P3|Induction Treatment|Ineligible or never started treatment|34
706895|NCT00064350|2291209|P2|Induction Treatment|Ineligible or never started treatment|6
706896|NCT00064350|2291210|P1|Induction Treatment|Ineligible or never started treatment|3
706897|NCT00064350|2291208|P3|Induction Treatment|Withdrawal by Subject|21
706898|NCT00064350|2291209|P2|Induction Treatment|Withdrawal by Subject|0
706899|NCT00064350|2291210|P1|Induction Treatment|Withdrawal by Subject|0
706900|NCT00064350|2291208|P3|Induction Treatment|Death|9
706901|NCT00064350|2291209|P2|Induction Treatment|Death|0
706902|NCT00064350|2291210|P1|Induction Treatment|Death|0
706903|NCT00064350|2291208|P3|Induction Treatment|Adverse Event|49
706904|NCT00064350|2291209|P2|Induction Treatment|Adverse Event|2
706905|NCT00064350|2291210|P1|Induction Treatment|Adverse Event|0
706906|NCT00064350|2291208|P3|Induction Treatment|Disease Progression|110
706907|NCT00064350|2291209|P2|Induction Treatment|Disease Progression|1
706908|NCT00064350|2291210|P1|Induction Treatment|Disease Progression|5
706909|NCT00064987|2291227|P2|Overall Study|Physician Decision|0
706910|NCT00064987|2291228|P1|Overall Study|Physician Decision|3
706919|NCT00065156|2291257|P1|Overall Study|Secondary Malign Disease|1
706920|NCT00065156|2291257|P1|Overall Study|Loss of Response|1
706921|NCT00065156|2291257|P1|Overall Study|Non-Compliance|2
706922|NCT00065156|2291257|P1|Overall Study|Investigator Decision|2
706923|NCT00065156|2291257|P1|Overall Study|Disease Progression|7
706924|NCT00065156|2291257|P1|Overall Study|Study Closed by Sponsor|2
706925|NCT00065156|2291257|P1|Overall Study|Death|11
706926|NCT00065156|2291257|P1|Overall Study|Lost to Follow-up|1
706927|NCT00065156|2291257|P1|Overall Study|Withdrawal by Subject|8
706928|NCT00065156|2291257|P1|Overall Study|Lack of Efficacy|52
706929|NCT00065156|2291257|P1|Overall Study|Adverse Event|37
706930|NCT00065260|2291274|P2|Overall Study|Death|1
706931|NCT00065260|2291275|P1|Overall Study|Death|0
706932|NCT00065429|2291288|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706933|NCT00065429|2291289|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706934|NCT00065429|2291290|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
706935|NCT00065429|2291291|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706936|NCT00065429|2291292|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706937|NCT00065429|2291293|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706938|NCT00065429|2291294|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
706939|NCT00065429|2291288|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706940|NCT00065429|2291289|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706941|NCT00065429|2291290|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
706942|NCT00065429|2291291|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706943|NCT00065429|2291292|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706944|NCT00065429|2291293|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706945|NCT00065429|2291294|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
706946|NCT00065429|2291288|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
706947|NCT00065429|2291289|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
706948|NCT00065429|2291290|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
706949|NCT00065429|2291291|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
706950|NCT00065429|2291292|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
706951|NCT00065429|2291293|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
706952|NCT00065429|2291294|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
706953|NCT00065429|2291288|P7|Phase I - May 2001 - Oct 2002|Death|0
706954|NCT00065429|2291289|P6|Phase I - May 2001 - Oct 2002|Death|0
706955|NCT00065429|2291290|P5|Phase I - May 2001 - Oct 2002|Death|1
706956|NCT00065429|2291291|P4|Phase I - May 2001 - Oct 2002|Death|0
706957|NCT00065429|2291292|P3|Phase I - May 2001 - Oct 2002|Death|0
706958|NCT00065429|2291293|P2|Phase I - May 2001 - Oct 2002|Death|0
706959|NCT00065429|2291294|P1|Phase I - May 2001 - Oct 2002|Death|0
706960|NCT00065429|2291288|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
706961|NCT00065429|2291289|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
706962|NCT00065429|2291290|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
706963|NCT00065429|2291291|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
706964|NCT00065429|2291292|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
706965|NCT00065429|2291293|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
706966|NCT00065429|2291294|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
706967|NCT00065429|2291288|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706968|NCT00065429|2291289|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706969|NCT00065429|2291290|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706970|NCT00065429|2291291|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706971|NCT00065429|2291292|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
706972|NCT00065429|2291293|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706973|NCT00065429|2291294|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
706974|NCT00065429|2291288|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706975|NCT00065429|2291289|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
706976|NCT00065429|2291290|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706977|NCT00065429|2291291|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706978|NCT00065429|2291292|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706979|NCT00065429|2291293|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706980|NCT00065429|2291294|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
706981|NCT00065442|2291308|P2|Overall Study|Withdrawal by Subject|9
706982|NCT00065442|2291309|P1|Overall Study|Withdrawal by Subject|3
706983|NCT00065442|2291308|P2|Overall Study|Death|210
706984|NCT00065442|2291309|P1|Overall Study|Death|121
706985|NCT00065442|2291308|P2|Overall Study|Lost to Follow-up|1
706986|NCT00065442|2291309|P1|Overall Study|Lost to Follow-up|1
706987|NCT00065468|2291320|P3|Overall Study|Unspecified|18
706988|NCT00065468|2291321|P2|Overall Study|Unspecified|24
706989|NCT00065468|2291322|P1|Overall Study|Unspecified|14
706990|NCT00065468|2291320|P3|Overall Study|Disease progression|1
706991|NCT00065468|2291321|P2|Overall Study|Disease progression|0
706992|NCT00065468|2291322|P1|Overall Study|Disease progression|0
706993|NCT00065468|2291320|P3|Overall Study|Discontinuation of study by Sponsor|13
706994|NCT00065468|2291321|P2|Overall Study|Discontinuation of study by Sponsor|9
706995|NCT00065468|2291322|P1|Overall Study|Discontinuation of study by Sponsor|13
706996|NCT00065468|2291320|P3|Overall Study|Lost to Follow-up|2
706997|NCT00065468|2291321|P2|Overall Study|Lost to Follow-up|3
706998|NCT00065468|2291322|P1|Overall Study|Lost to Follow-up|5
706999|NCT00065468|2291320|P3|Overall Study|Withdrawal by Subject|5
707000|NCT00065468|2291321|P2|Overall Study|Withdrawal by Subject|4
707001|NCT00065468|2291322|P1|Overall Study|Withdrawal by Subject|3
707002|NCT00065468|2291320|P3|Overall Study|Death|171
707003|NCT00065468|2291321|P2|Overall Study|Death|169
707004|NCT00065468|2291322|P1|Overall Study|Death|172
707005|NCT00065507|2291353|P2|Overall Study|Subject No Longer Meets Study Criteria|0
707006|NCT00065507|2291354|P1|Overall Study|Subject No Longer Meets Study Criteria|1
707007|NCT00065507|2291353|P2|Overall Study|Subject Withdrew Consent|1
707008|NCT00065507|2291354|P1|Overall Study|Subject Withdrew Consent|2
707009|NCT00065507|2291353|P2|Overall Study|Lost to Follow-up|0
707010|NCT00065507|2291354|P1|Overall Study|Lost to Follow-up|3
707011|NCT00065507|2291353|P2|Overall Study|Poor/Non-compliance|2
707012|NCT00065507|2291354|P1|Overall Study|Poor/Non-compliance|3
707013|NCT00065507|2291353|P2|Overall Study|Lack of Efficacy|6
707014|NCT00065507|2291354|P1|Overall Study|Lack of Efficacy|0
707015|NCT00065507|2291353|P2|Overall Study|Adverse Event|3
707016|NCT00065507|2291354|P1|Overall Study|Adverse Event|4
707017|NCT00065507|2291353|P2|Overall Study|Death|17
707018|NCT00065507|2291354|P1|Overall Study|Death|16
707019|NCT00066066|2291477|P6|Overall Study|Lost to Follow-up|5
707020|NCT00066066|2291478|P5|Overall Study|Lost to Follow-up|3
707021|NCT00066066|2291479|P4|Overall Study|Lost to Follow-up|4
707022|NCT00066066|2291480|P3|Overall Study|Lost to Follow-up|7
707023|NCT00066066|2291481|P2|Overall Study|Lost to Follow-up|4
707024|NCT00066066|2291482|P1|Overall Study|Lost to Follow-up|6
707025|NCT00066170|2291500|P4|Overall Study|Other|0
707026|NCT00066170|2291501|P3|Overall Study|Other|2
707027|NCT00066170|2291502|P2|Overall Study|Other|5
707028|NCT00066170|2291503|P1|Overall Study|Other|1
707029|NCT00066170|2291500|P4|Overall Study|Protocol Violation|0
707030|NCT00066170|2291501|P3|Overall Study|Protocol Violation|0
707031|NCT00066170|2291502|P2|Overall Study|Protocol Violation|0
707032|NCT00066170|2291503|P1|Overall Study|Protocol Violation|3
707033|NCT00066170|2291500|P4|Overall Study|Non-Compliance with Trial Medicine|1
707034|NCT00066170|2291501|P3|Overall Study|Non-Compliance with Trial Medicine|0
707035|NCT00066170|2291502|P2|Overall Study|Non-Compliance with Trial Medicine|0
707036|NCT00066170|2291503|P1|Overall Study|Non-Compliance with Trial Medicine|1
707037|NCT00066170|2291500|P4|Overall Study|Lost to Follow-up|0
707038|NCT00066170|2291501|P3|Overall Study|Lost to Follow-up|0
707039|NCT00066170|2291502|P2|Overall Study|Lost to Follow-up|1
707040|NCT00066170|2291503|P1|Overall Study|Lost to Follow-up|0
707041|NCT00066170|2291500|P4|Overall Study|Serious Adverse Event|1
707042|NCT00066170|2291501|P3|Overall Study|Serious Adverse Event|1
707043|NCT00066170|2291502|P2|Overall Study|Serious Adverse Event|0
707044|NCT00066170|2291503|P1|Overall Study|Serious Adverse Event|0
707045|NCT00066170|2291500|P4|Overall Study|Adverse Event|7
707046|NCT00066170|2291501|P3|Overall Study|Adverse Event|1
707047|NCT00066170|2291502|P2|Overall Study|Adverse Event|4
707048|NCT00066170|2291503|P1|Overall Study|Adverse Event|2
707049|NCT00066222|2291513|P1|Overall Study|No protocol treatment received|1
707050|NCT00066365|2291519|P2|Overall Study|Ineligible|2
707051|NCT00066365|2291520|P1|Overall Study|Ineligible|4
707052|NCT00066365|2291519|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
707053|NCT00066365|2291520|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
707054|NCT00066365|2291519|P2|Overall Study|Physician Decision|0
707055|NCT00066365|2291520|P1|Overall Study|Physician Decision|1
707056|NCT00066365|2291519|P2|Overall Study|Lack of Efficacy|12
707057|NCT00066365|2291520|P1|Overall Study|Lack of Efficacy|15
707058|NCT00066365|2291519|P2|Overall Study|Adverse Event|0
707059|NCT00066365|2291520|P1|Overall Study|Adverse Event|1
707060|NCT00066469|2291548|P1|Overall Study|ineligible|1
707061|NCT00066469|2291548|P1|Overall Study|Withdrawal by Subject|1
707062|NCT00066469|2291548|P1|Overall Study|Physician Decision|1
707063|NCT00066469|2291548|P1|Overall Study|Lost to Follow-up|1
707064|NCT00066469|2291548|P1|Overall Study|Lack of Efficacy|9
707065|NCT00066469|2291548|P1|Overall Study|Death|3
889796|NCT01218204|2824442|P1|Part B Run-in|Withdrawal by Subject|0
889797|NCT01218204|2824439|P4|Part B Run-in|Protocol Violation|0
707068|NCT00066690|2291564|P3|Overall Study|Treatment Ongoing|282
707069|NCT00066690|2291565|P2|Overall Study|Treatment Ongoing|278
707070|NCT00066690|2291566|P1|Overall Study|Treatment Ongoing|246
707071|NCT00066690|2291564|P3|Overall Study|Withdrawal by Subject|49
707072|NCT00066690|2291565|P2|Overall Study|Withdrawal by Subject|55
707073|NCT00066690|2291566|P1|Overall Study|Withdrawal by Subject|50
707074|NCT00066690|2291564|P3|Overall Study|Lost to Follow-up|29
707075|NCT00066690|2291565|P2|Overall Study|Lost to Follow-up|21
707076|NCT00066690|2291566|P1|Overall Study|Lost to Follow-up|40
707077|NCT00066690|2291564|P3|Overall Study|Lack of Efficacy|76
707078|NCT00066690|2291565|P2|Overall Study|Lack of Efficacy|110
707079|NCT00066690|2291566|P1|Overall Study|Lack of Efficacy|114
707080|NCT00066690|2291564|P3|Overall Study|Death|2
707081|NCT00066690|2291565|P2|Overall Study|Death|0
707082|NCT00066690|2291566|P1|Overall Study|Death|3
707083|NCT00066690|2291564|P3|Overall Study|Adverse Event|126
707084|NCT00066690|2291565|P2|Overall Study|Adverse Event|58
707085|NCT00066690|2291566|P1|Overall Study|Adverse Event|145
707086|NCT00066703|2291582|P2|Overall Study|Treatment ongoing|311
707087|NCT00066703|2291583|P1|Overall Study|Treatment ongoing|346
707088|NCT00066703|2291582|P2|Overall Study|Withdrawal by Subject|63
707089|NCT00066703|2291583|P1|Overall Study|Withdrawal by Subject|38
707090|NCT00066703|2291582|P2|Overall Study|Lost to Follow-up|28
707091|NCT00066703|2291583|P1|Overall Study|Lost to Follow-up|31
707092|NCT00066703|2291582|P2|Overall Study|Lack of Efficacy|69
707093|NCT00066703|2291583|P1|Overall Study|Lack of Efficacy|114
707094|NCT00066703|2291582|P2|Overall Study|Death|0
707095|NCT00066703|2291583|P1|Overall Study|Death|3
707096|NCT00066703|2291582|P2|Overall Study|Adverse Event|111
707097|NCT00066703|2291583|P1|Overall Study|Adverse Event|80
707098|NCT00066742|2291593|P1|Consolidation Chemotherapy|Ineligible|2
707099|NCT00066742|2291593|P1|Consolidation Chemotherapy|not protocol specified|1
707100|NCT00066742|2291593|P1|Induction Chemoradiotherapy|Ineligible|3
707101|NCT00066742|2291593|P1|Induction Chemoradiotherapy|not protocol specified|2
707102|NCT00066742|2291593|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
707103|NCT00066742|2291593|P1|Induction Chemoradiotherapy|Adverse Event|21
707104|NCT00066742|2291593|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
707105|NCT00066807|2291615|P2|Overall Study|Study was terminated early|15
707106|NCT00066807|2291616|P1|Overall Study|Study was terminated early|14
707107|NCT00067470|2291681|P2|Overall Study|Withdrawal by Subject|1
707108|NCT00067470|2291682|P1|Overall Study|Withdrawal by Subject|0
707109|NCT00053846|2291694|P2|Overall Study|Pills too large|1
707110|NCT00053846|2291695|P1|Overall Study|Pills too large|0
707111|NCT00053846|2291694|P2|Overall Study|Quit due to side effects|3
707112|NCT00053846|2291695|P1|Overall Study|Quit due to side effects|1
707113|NCT00053846|2291694|P2|Overall Study|Did not return data|2
707114|NCT00053846|2291695|P1|Overall Study|Did not return data|1
707115|NCT00053846|2291694|P2|Overall Study|Became ineligible|1
707116|NCT00053846|2291695|P1|Overall Study|Became ineligible|3
707117|NCT00053846|2291694|P2|Overall Study|Expired|0
707118|NCT00053846|2291695|P1|Overall Study|Expired|5
707119|NCT00053846|2291694|P2|Overall Study|Became too ill|7
707120|NCT00053846|2291695|P1|Overall Study|Became too ill|8
707121|NCT00053846|2291694|P2|Overall Study|Changed mind|13
707122|NCT00053846|2291695|P1|Overall Study|Changed mind|8
707123|NCT00054132|2291709|P1|Overall Study|Not Treated|1
707124|NCT00054275|2291718|P1|Overall Study|Physician Decision|1
707125|NCT00054275|2291718|P1|Overall Study|Progressive disease in cycle 1|1
707126|NCT00054275|2291718|P1|Overall Study|Adverse Event|5
707127|NCT00054275|2291718|P1|Overall Study|Withdrawal by Subject|4
707128|NCT00054327|2291730|P6|Overall Study|Engraftment failure|0
707129|NCT00054327|2291731|P5|Overall Study|Engraftment failure|0
707130|NCT00054327|2291732|P4|Overall Study|Engraftment failure|0
707131|NCT00054327|2291733|P3|Overall Study|Engraftment failure|0
707132|NCT00054327|2291734|P2|Overall Study|Engraftment failure|0
707133|NCT00054327|2291735|P1|Overall Study|Engraftment failure|1
707134|NCT00054639|2291773|P1|Overall Study|Physician Decision|1
707135|NCT00054639|2291773|P1|Overall Study|Lack of Efficacy|1
707136|NCT00054691|2291786|P1|Overall Study|Noncompliant|1
707137|NCT00054691|2291786|P1|Overall Study|Unmeasurable Disease|2
707138|NCT00054704|2291793|P2|Overall Study|Lost to Follow-up|0
707139|NCT00054704|2291794|P1|Overall Study|Lost to Follow-up|1
707140|NCT00054704|2291793|P2|Overall Study|Adverse Event|2
707141|NCT00054704|2291794|P1|Overall Study|Adverse Event|3
707142|NCT00054704|2291793|P2|Overall Study|Lack of Efficacy|3
707143|NCT00054704|2291794|P1|Overall Study|Lack of Efficacy|1
707144|NCT00054717|2291802|P2|Overall Study|Other reason not defined above|217
707145|NCT00054717|2291803|P1|Overall Study|Other reason not defined above|117
707146|NCT00054717|2291802|P2|Overall Study|Withdrawal by Subject|20
707147|NCT00054717|2291803|P1|Overall Study|Withdrawal by Subject|32
707148|NCT00054717|2291802|P2|Overall Study|Lost to Follow-up|13
707149|NCT00054717|2291803|P1|Overall Study|Lost to Follow-up|23
707150|NCT00054717|2291802|P2|Overall Study|Protocol Violation|19
707151|NCT00054717|2291803|P1|Overall Study|Protocol Violation|18
707152|NCT00054717|2291802|P2|Overall Study|Adverse Event|22
707153|NCT00054717|2291803|P1|Overall Study|Adverse Event|70
707154|NCT00054717|2291802|P2|Overall Study|Randomized but not treated|8
707155|NCT00054717|2291803|P1|Overall Study|Randomized but not treated|2
707156|NCT00069641|2292039|P3|Overall Study|Death|1
707157|NCT00069641|2292040|P2|Overall Study|Death|0
707158|NCT00069641|2292041|P1|Overall Study|Death|1
707159|NCT00069784|2292068|P2|Overall Study|Other|0
707160|NCT00069784|2292069|P1|Overall Study|Other|17
707161|NCT00069784|2292068|P2|Overall Study|Withdrawal by Subject|0
707162|NCT00069784|2292069|P1|Overall Study|Withdrawal by Subject|1090
707163|NCT00069784|2292068|P2|Overall Study|Adverse Event|0
707164|NCT00069784|2292069|P1|Overall Study|Adverse Event|105
707165|NCT00069823|2292089|P2|Overall Study|Did not have follow-up diary cards|3
707166|NCT00069823|2292090|P1|Overall Study|Did not have follow-up diary cards|6
707167|NCT00069953|2292130|P1|Overall Study|Protocol Violation|2
707168|NCT00070018|2292134|P1|Overall Study|Withdrawal by Subject|1
707169|NCT00070018|2292134|P1|Overall Study|Lack of Efficacy|1
707170|NCT00070018|2292134|P1|Overall Study|Adverse Event|2
707171|NCT00070109|2292143|P5|Overall Study|removed from prot thpy prior to chemo|0
707172|NCT00070109|2292144|P4|Overall Study|removed from prot thpy prior to chemo|1
707173|NCT00070109|2292145|P3|Overall Study|removed from prot thpy prior to chemo|0
707174|NCT00070109|2292146|P2|Overall Study|removed from prot thpy prior to chemo|0
707175|NCT00070109|2292147|P1|Overall Study|removed from prot thpy prior to chemo|0
707176|NCT00070109|2292143|P5|Overall Study|Adverse Event|2
707177|NCT00070109|2292144|P4|Overall Study|Adverse Event|4
707178|NCT00070109|2292145|P3|Overall Study|Adverse Event|2
707179|NCT00070109|2292146|P2|Overall Study|Adverse Event|0
707180|NCT00070109|2292147|P1|Overall Study|Adverse Event|0
707181|NCT00070109|2292143|P5|Overall Study|Withdrawal by Subject|0
707182|NCT00070109|2292144|P4|Overall Study|Withdrawal by Subject|0
707183|NCT00070109|2292145|P3|Overall Study|Withdrawal by Subject|1
707184|NCT00070109|2292146|P2|Overall Study|Withdrawal by Subject|1
707185|NCT00070109|2292147|P1|Overall Study|Withdrawal by Subject|0
707186|NCT00070109|2292143|P5|Overall Study|Physician Decision|0
707187|NCT00070109|2292144|P4|Overall Study|Physician Decision|0
707188|NCT00070109|2292145|P3|Overall Study|Physician Decision|0
707189|NCT00070109|2292146|P2|Overall Study|Physician Decision|0
707190|NCT00070109|2292147|P1|Overall Study|Physician Decision|1
707191|NCT00070109|2292143|P5|Overall Study|Lack of Efficacy|5
707192|NCT00070109|2292144|P4|Overall Study|Lack of Efficacy|15
707193|NCT00070109|2292145|P3|Overall Study|Lack of Efficacy|5
707194|NCT00070109|2292146|P2|Overall Study|Lack of Efficacy|4
707195|NCT00070109|2292147|P1|Overall Study|Lack of Efficacy|6
707196|NCT00070109|2292143|P5|Overall Study|Death|1
707197|NCT00070109|2292144|P4|Overall Study|Death|0
707198|NCT00070109|2292145|P3|Overall Study|Death|0
707199|NCT00070109|2292146|P2|Overall Study|Death|1
707200|NCT00070109|2292147|P1|Overall Study|Death|1
707201|NCT00070291|2292166|P1|Step 2|Adverse Event|1
707202|NCT00070291|2292166|P1|Step 1|Adverse Event|1
707203|NCT00070291|2292166|P1|Step 1|Withdrawal by Subject|1
889798|NCT01218204|2824440|P3|Part B Run-in|Protocol Violation|2
889799|NCT01218204|2824441|P2|Part B Run-in|Protocol Violation|0
889800|NCT01218204|2824442|P1|Part B Run-in|Protocol Violation|0
889801|NCT01218204|2824439|P4|Part B Run-in|Adverse Event|0
889802|NCT01218204|2824440|P3|Part B Run-in|Adverse Event|1
889803|NCT01218204|2824441|P2|Part B Run-in|Adverse Event|0
889804|NCT01218204|2824442|P1|Part B Run-in|Adverse Event|0
889805|NCT01218204|2824439|P4|Part B Washout|Did not meet continuation criteria|0
889806|NCT01218204|2824440|P3|Part B Washout|Did not meet continuation criteria|0
889807|NCT01218204|2824441|P2|Part B Washout|Did not meet continuation criteria|112
889808|NCT01218204|2824442|P1|Part B Washout|Did not meet continuation criteria|0
889809|NCT01218204|2824439|P4|Part B Washout|Reached defined stopping criteria|0
889810|NCT01218204|2824440|P3|Part B Washout|Reached defined stopping criteria|0
889811|NCT01218204|2824441|P2|Part B Washout|Reached defined stopping criteria|2
889812|NCT01218204|2824442|P1|Part B Washout|Reached defined stopping criteria|0
889813|NCT01218204|2824439|P4|Part B Washout|Withdrawal by Subject|0
889814|NCT01218204|2824440|P3|Part B Washout|Withdrawal by Subject|0
889815|NCT01218204|2824441|P2|Part B Washout|Withdrawal by Subject|14
889816|NCT01218204|2824442|P1|Part B Washout|Withdrawal by Subject|0
889817|NCT01218204|2824439|P4|Part B Washout|Physician Decision|0
889818|NCT01218204|2824440|P3|Part B Washout|Physician Decision|0
889819|NCT01218204|2824441|P2|Part B Washout|Physician Decision|14
889820|NCT01218204|2824442|P1|Part B Washout|Physician Decision|0
889821|NCT01218204|2824439|P4|Part B Washout|Lost to Follow-up|0
889822|NCT01218204|2824440|P3|Part B Washout|Lost to Follow-up|0
889823|NCT01218204|2824441|P2|Part B Washout|Lost to Follow-up|2
889824|NCT01218204|2824442|P1|Part B Washout|Lost to Follow-up|0
889825|NCT01218204|2824439|P4|Part B Washout|Adverse Event|0
889826|NCT01218204|2824440|P3|Part B Washout|Adverse Event|0
889827|NCT01218204|2824441|P2|Part B Washout|Adverse Event|1
889828|NCT01218204|2824442|P1|Part B Washout|Adverse Event|0
889829|NCT01194440|2824711|P1|Overall Study|Lost to Follow-up|1
889830|NCT01194440|2824711|P1|Overall Study|Withdrawal by Subject|2
889831|NCT01194440|2824711|P1|Overall Study|Adverse Event|9
889832|NCT01190228|2824718|P3|Overall Study|Withdrawal by Subject|0
889833|NCT01190228|2824719|P2|Overall Study|Withdrawal by Subject|0
889834|NCT01190228|2824720|P1|Overall Study|Withdrawal by Subject|1
707241|NCT00070564|2292213|P6|Overall Study|Not reported|0
707242|NCT00070564|2292214|P5|Overall Study|Not reported|1
707243|NCT00070564|2292215|P4|Overall Study|Not reported|0
707244|NCT00070564|2292216|P3|Overall Study|Not reported|0
707245|NCT00070564|2292217|P2|Overall Study|Not reported|0
707246|NCT00070564|2292218|P1|Overall Study|Not reported|0
707247|NCT00070564|2292213|P6|Overall Study|Withdrawal by Subject|8
707248|NCT00070564|2292214|P5|Overall Study|Withdrawal by Subject|8
707249|NCT00070564|2292215|P4|Overall Study|Withdrawal by Subject|30
707250|NCT00070564|2292216|P3|Overall Study|Withdrawal by Subject|23
707251|NCT00070564|2292217|P2|Overall Study|Withdrawal by Subject|37
707252|NCT00070564|2292218|P1|Overall Study|Withdrawal by Subject|26
707253|NCT00070564|2292213|P6|Overall Study|Other, not protocol specified|7
707254|NCT00070564|2292214|P5|Overall Study|Other, not protocol specified|6
707255|NCT00070564|2292215|P4|Overall Study|Other, not protocol specified|19
707256|NCT00070564|2292216|P3|Overall Study|Other, not protocol specified|14
707257|NCT00070564|2292217|P2|Overall Study|Other, not protocol specified|15
707258|NCT00070564|2292218|P1|Overall Study|Other, not protocol specified|17
707259|NCT00070564|2292213|P6|Overall Study|Death|1
707260|NCT00070564|2292214|P5|Overall Study|Death|0
707261|NCT00070564|2292215|P4|Overall Study|Death|3
707262|NCT00070564|2292216|P3|Overall Study|Death|5
707263|NCT00070564|2292217|P2|Overall Study|Death|1
707264|NCT00070564|2292218|P1|Overall Study|Death|4
707265|NCT00070564|2292213|P6|Overall Study|Adverse Event|36
707266|NCT00070564|2292214|P5|Overall Study|Adverse Event|63
707267|NCT00070564|2292215|P4|Overall Study|Adverse Event|108
707268|NCT00070564|2292216|P3|Overall Study|Adverse Event|120
707269|NCT00070564|2292217|P2|Overall Study|Adverse Event|142
707270|NCT00070564|2292218|P1|Overall Study|Adverse Event|150
707271|NCT00070564|2292213|P6|Overall Study|Delinquent|0
707272|NCT00070564|2292214|P5|Overall Study|Delinquent|0
707273|NCT00070564|2292215|P4|Overall Study|Delinquent|0
707274|NCT00070564|2292216|P3|Overall Study|Delinquent|2
707275|NCT00070564|2292217|P2|Overall Study|Delinquent|4
707276|NCT00070564|2292218|P1|Overall Study|Delinquent|1
707277|NCT00070564|2292213|P6|Overall Study|Progression|0
707278|NCT00070564|2292214|P5|Overall Study|Progression|1
707279|NCT00070564|2292215|P4|Overall Study|Progression|7
707280|NCT00070564|2292216|P3|Overall Study|Progression|7
707281|NCT00070564|2292217|P2|Overall Study|Progression|4
707282|NCT00070564|2292218|P1|Overall Study|Progression|2
707283|NCT00070941|2292263|P3|Overall Study|Adverse Event|4
707284|NCT00070941|2292264|P2|Overall Study|Adverse Event|8
707285|NCT00070941|2292265|P1|Overall Study|Adverse Event|10
707286|NCT00071006|2292273|P1|Overall Study|Unspecified|3
707287|NCT00071006|2292273|P1|Overall Study|Withdrawal by Subject|1
707288|NCT00071006|2292273|P1|Overall Study|Adverse Event|1
707289|NCT00071006|2292273|P1|Overall Study|Lack of Efficacy|7
707290|NCT00071032|2292285|P2|Overall Study|Missing Primary Outcome|1
707291|NCT00071032|2292286|P1|Overall Study|Missing Primary Outcome|0
707292|NCT00071032|2292285|P2|Overall Study|Withdrawal by Subject|6
707293|NCT00071032|2292286|P1|Overall Study|Withdrawal by Subject|8
889835|NCT01190228|2824718|P3|Overall Study|Protocol Violation|0
707294|NCT00071032|2292285|P2|Overall Study|Lost to Follow-up|1
707295|NCT00071032|2292286|P1|Overall Study|Lost to Follow-up|1
707296|NCT00071058|2292294|P1|Overall Study|brain tumor-removed from study|1
707297|NCT00071110|2292301|P2|Overall Study|Protocol Violation|4
707298|NCT00071110|2292302|P1|Overall Study|Protocol Violation|0
707299|NCT00071396|2292314|P1|Overall Study|Physician Decision|2
707300|NCT00071396|2292314|P1|Overall Study|Withdrawal by Subject|1
707301|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
707302|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
707303|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
707304|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
707305|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
707306|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
707307|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
707308|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
707309|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Pregnancy|1
707310|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Pregnancy|0
707311|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Pregnancy|0
707312|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Pregnancy|0
707313|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
707314|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707315|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707316|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707317|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
707318|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
707319|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
707320|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
707321|NCT00071487|2292322|P4|24-Week Open-Label Extension Period|Adverse Event|6
707322|NCT00071487|2292323|P3|24-Week Open-Label Extension Period|Adverse Event|1
707323|NCT00071487|2292324|P2|24-Week Open-Label Extension Period|Adverse Event|0
707324|NCT00071487|2292325|P1|24-Week Open-Label Extension Period|Adverse Event|0
707325|NCT00071487|2292322|P4|52-Week Double-Blind Period|Lack of Compliance|3
707326|NCT00071487|2292323|P3|52-Week Double-Blind Period|Lack of Compliance|3
707327|NCT00071487|2292324|P2|52-Week Double-Blind Period|Lack of Compliance|3
707328|NCT00071487|2292325|P1|52-Week Double-Blind Period|Lack of Compliance|6
707329|NCT00071487|2292322|P4|52-Week Double-Blind Period|Death|0
707330|NCT00071487|2292323|P3|52-Week Double-Blind Period|Death|0
707331|NCT00071487|2292324|P2|52-Week Double-Blind Period|Death|1
707332|NCT00071487|2292325|P1|52-Week Double-Blind Period|Death|0
707333|NCT00071487|2292322|P4|52-Week Double-Blind Period|Protocol Violation|0
707334|NCT00071487|2292323|P3|52-Week Double-Blind Period|Protocol Violation|1
707335|NCT00071487|2292324|P2|52-Week Double-Blind Period|Protocol Violation|1
707336|NCT00071487|2292325|P1|52-Week Double-Blind Period|Protocol Violation|0
707337|NCT00071487|2292322|P4|52-Week Double-Blind Period|Pregnancy|0
707338|NCT00071487|2292323|P3|52-Week Double-Blind Period|Pregnancy|0
707339|NCT00071487|2292324|P2|52-Week Double-Blind Period|Pregnancy|1
707340|NCT00071487|2292325|P1|52-Week Double-Blind Period|Pregnancy|0
707341|NCT00071487|2292322|P4|52-Week Double-Blind Period|Lost to Follow-up|2
707342|NCT00071487|2292323|P3|52-Week Double-Blind Period|Lost to Follow-up|2
707343|NCT00071487|2292324|P2|52-Week Double-Blind Period|Lost to Follow-up|0
707344|NCT00071487|2292325|P1|52-Week Double-Blind Period|Lost to Follow-up|0
707345|NCT00071487|2292322|P4|52-Week Double-Blind Period|Physician Decision|0
707346|NCT00071487|2292323|P3|52-Week Double-Blind Period|Physician Decision|0
707347|NCT00071487|2292324|P2|52-Week Double-Blind Period|Physician Decision|0
707348|NCT00071487|2292325|P1|52-Week Double-Blind Period|Physician Decision|1
707349|NCT00071487|2292322|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
707350|NCT00071487|2292323|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
707351|NCT00071487|2292324|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
707352|NCT00071487|2292325|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
707353|NCT00071487|2292322|P4|52-Week Double-Blind Period|Lack of Efficacy|1
707354|NCT00071487|2292323|P3|52-Week Double-Blind Period|Lack of Efficacy|0
707355|NCT00071487|2292324|P2|52-Week Double-Blind Period|Lack of Efficacy|2
707356|NCT00071487|2292325|P1|52-Week Double-Blind Period|Lack of Efficacy|1
707357|NCT00071487|2292322|P4|52-Week Double-Blind Period|Adverse Event|8
707358|NCT00071487|2292323|P3|52-Week Double-Blind Period|Adverse Event|4
707359|NCT00071487|2292324|P2|52-Week Double-Blind Period|Adverse Event|8
707360|NCT00071487|2292325|P1|52-Week Double-Blind Period|Adverse Event|5
707361|NCT00071513|2292371|P2|Follow-up Assessment|Withdrawal by Subject|6
707362|NCT00071513|2292372|P1|Follow-up Assessment|Withdrawal by Subject|6
707363|NCT00071513|2292371|P2|Intervention Component|Withdrawal by Subject|3
707364|NCT00071513|2292372|P1|Intervention Component|Withdrawal by Subject|2
707365|NCT00071760|2292399|P1|Overall Study|Ongoing|25
707366|NCT00071760|2292399|P1|Overall Study|Study Team Rec./Resistance|1
707367|NCT00071760|2292399|P1|Overall Study|Investigator's Recommendation (Rec.)|4
707368|NCT00071760|2292399|P1|Overall Study|Relocation|1
707369|NCT00071760|2292399|P1|Overall Study|Unavailability of RTV|8
707370|NCT00071760|2292399|P1|Overall Study|Pulmonary Tuberculosis|1
707371|NCT00071760|2292399|P1|Overall Study|Insufficient Viral Load Response|3
707372|NCT00071760|2292399|P1|Overall Study|Withdrawal by Subject|3
707373|NCT00071760|2292399|P1|Overall Study|Protocol Violation|1
707374|NCT00071760|2292399|P1|Overall Study|Lost to Follow-up|4
707375|NCT00071760|2292399|P1|Overall Study|Adverse Event|3
707376|NCT00071799|2292460|P2|Overall Study|Not Documented|2
707377|NCT00071799|2292461|P1|Overall Study|Not Documented|0
707378|NCT00071799|2292460|P2|Overall Study|Different Central+Local Pathology Review|1
707379|NCT00071799|2292461|P1|Overall Study|Different Central+Local Pathology Review|0
707380|NCT00071799|2292460|P2|Overall Study|Disease Progression|20
707381|NCT00071799|2292461|P1|Overall Study|Disease Progression|23
707382|NCT00071799|2292460|P2|Overall Study|Lack of Efficacy|18
707383|NCT00071799|2292461|P1|Overall Study|Lack of Efficacy|11
707384|NCT00071799|2292460|P2|Overall Study|Physician Decision|2
707385|NCT00071799|2292461|P1|Overall Study|Physician Decision|0
707386|NCT00071799|2292460|P2|Overall Study|Withdrawal by Subject|37
707387|NCT00071799|2292461|P1|Overall Study|Withdrawal by Subject|15
707388|NCT00071799|2292460|P2|Overall Study|Lost to Follow-up|1
707389|NCT00071799|2292461|P1|Overall Study|Lost to Follow-up|1
707390|NCT00071799|2292460|P2|Overall Study|Protocol Violation|7
707391|NCT00071799|2292461|P1|Overall Study|Protocol Violation|1
707392|NCT00071799|2292460|P2|Overall Study|Adverse Event|10
707393|NCT00071799|2292461|P1|Overall Study|Adverse Event|19
707394|NCT00071812|2292505|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
707395|NCT00071812|2292506|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
707396|NCT00071812|2292507|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
707397|NCT00071812|2292508|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
707398|NCT00071812|2292505|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
707399|NCT00071812|2292506|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707400|NCT00071812|2292507|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707401|NCT00071812|2292508|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
707402|NCT00071812|2292505|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
707403|NCT00071812|2292506|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
707404|NCT00071812|2292507|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
707405|NCT00071812|2292508|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
707406|NCT00071812|2292505|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
707407|NCT00071812|2292506|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
707408|NCT00071812|2292507|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
707409|NCT00071812|2292508|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
707410|NCT00071812|2292505|P4|24-Week Open-Label Extension Period|Adverse Event|7
707411|NCT00071812|2292506|P3|24-Week Open-Label Extension Period|Adverse Event|0
707412|NCT00071812|2292507|P2|24-Week Open-Label Extension Period|Adverse Event|0
707413|NCT00071812|2292508|P1|24-Week Open-Label Extension Period|Adverse Event|0
707414|NCT00071812|2292505|P4|24-Week Double-Blind Period|Protocol Violation|1
707415|NCT00071812|2292506|P3|24-Week Double-Blind Period|Protocol Violation|0
707416|NCT00071812|2292507|P2|24-Week Double-Blind Period|Protocol Violation|0
707417|NCT00071812|2292508|P1|24-Week Double-Blind Period|Protocol Violation|0
707418|NCT00071812|2292505|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
707419|NCT00071812|2292506|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
707420|NCT00071812|2292507|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
707421|NCT00071812|2292508|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
707422|NCT00071812|2292505|P4|24-Week Double-Blind Period|Lost to Follow-up|0
707423|NCT00071812|2292506|P3|24-Week Double-Blind Period|Lost to Follow-up|1
707424|NCT00071812|2292507|P2|24-Week Double-Blind Period|Lost to Follow-up|1
707425|NCT00071812|2292508|P1|24-Week Double-Blind Period|Lost to Follow-up|0
707426|NCT00071812|2292505|P4|24-Week Double-Blind Period|Lack of Efficacy|1
707427|NCT00071812|2292506|P3|24-Week Double-Blind Period|Lack of Efficacy|2
707428|NCT00071812|2292507|P2|24-Week Double-Blind Period|Lack of Efficacy|1
707429|NCT00071812|2292508|P1|24-Week Double-Blind Period|Lack of Efficacy|3
707430|NCT00071812|2292505|P4|24-Week Double-Blind Period|Adverse Event|4
707431|NCT00071812|2292506|P3|24-Week Double-Blind Period|Adverse Event|4
707432|NCT00071812|2292507|P2|24-Week Double-Blind Period|Adverse Event|3
707433|NCT00071812|2292508|P1|24-Week Double-Blind Period|Adverse Event|2
707434|NCT00071981|2292565|P4|Overall Study|others (not specified in the study)|0
707435|NCT00071981|2292566|P3|Overall Study|others (not specified in the study)|2
707436|NCT00071981|2292567|P2|Overall Study|others (not specified in the study)|2
707437|NCT00071981|2292568|P1|Overall Study|others (not specified in the study)|0
707438|NCT00071981|2292565|P4|Overall Study|No protocol therapy|0
707439|NCT00071981|2292566|P3|Overall Study|No protocol therapy|1
707440|NCT00071981|2292567|P2|Overall Study|No protocol therapy|5
707441|NCT00071981|2292568|P1|Overall Study|No protocol therapy|2
707442|NCT00071981|2292565|P4|Overall Study|Withdrawal by Subject|0
707443|NCT00071981|2292566|P3|Overall Study|Withdrawal by Subject|0
707444|NCT00071981|2292567|P2|Overall Study|Withdrawal by Subject|1
707445|NCT00071981|2292568|P1|Overall Study|Withdrawal by Subject|3
707446|NCT00071981|2292565|P4|Overall Study|Death|1
707447|NCT00071981|2292566|P3|Overall Study|Death|1
707448|NCT00071981|2292567|P2|Overall Study|Death|0
707449|NCT00071981|2292568|P1|Overall Study|Death|0
707450|NCT00071981|2292565|P4|Overall Study|Adverse Event|1
707451|NCT00071981|2292566|P3|Overall Study|Adverse Event|3
707452|NCT00071981|2292567|P2|Overall Study|Adverse Event|4
707453|NCT00071981|2292568|P1|Overall Study|Adverse Event|4
707454|NCT00071981|2292565|P4|Overall Study|Lack of Efficacy|43
707455|NCT00071981|2292566|P3|Overall Study|Lack of Efficacy|30
707456|NCT00071981|2292567|P2|Overall Study|Lack of Efficacy|29
707457|NCT00071981|2292568|P1|Overall Study|Lack of Efficacy|37
707458|NCT00072176|2292596|P2|Overall Study|Protocol Violation|1
707459|NCT00072176|2292597|P1|Overall Study|Protocol Violation|0
707460|NCT00072176|2292596|P2|Overall Study|Withdrawal by Subject|0
707461|NCT00072176|2292597|P1|Overall Study|Withdrawal by Subject|1
707462|NCT00072189|2292605|P1|Overall Study|Withdrawal by Subject|1
707463|NCT00064662|2292613|P2|Overall Study|Administratively withdrawn|2
707464|NCT00064662|2292614|P1|Overall Study|Administratively withdrawn|2
707465|NCT00064662|2292613|P2|Overall Study|Withdrawal by Subject|14
707466|NCT00064662|2292614|P1|Overall Study|Withdrawal by Subject|14
707467|NCT00064662|2292613|P2|Overall Study|Lost to Follow-up|44
707468|NCT00064662|2292614|P1|Overall Study|Lost to Follow-up|57
707469|NCT00064662|2292613|P2|Overall Study|Death|1
707470|NCT00064662|2292614|P1|Overall Study|Death|1
707471|NCT00064701|2292625|P3|Clinical Continuation Phase|Patient opted out|1
707472|NCT00064701|2292626|P2|Clinical Continuation Phase|Patient opted out|0
707473|NCT00064701|2292627|P1|Clinical Continuation Phase|Patient opted out|0
707474|NCT00064701|2292625|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
707475|NCT00064701|2292626|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
707476|NCT00064701|2292627|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
707477|NCT00064701|2292625|P3|Clinical Continuation Phase|Discharged to nursing home|0
707478|NCT00064701|2292626|P2|Clinical Continuation Phase|Discharged to nursing home|1
707479|NCT00064701|2292627|P1|Clinical Continuation Phase|Discharged to nursing home|0
707480|NCT00064701|2292625|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
707481|NCT00064701|2292626|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
707482|NCT00064701|2292627|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
707483|NCT00064701|2292625|P3|Clinical Continuation Phase|Pancreas transplant|0
707484|NCT00064701|2292626|P2|Clinical Continuation Phase|Pancreas transplant|0
707485|NCT00064701|2292627|P1|Clinical Continuation Phase|Pancreas transplant|1
707486|NCT00064701|2292625|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
707487|NCT00064701|2292626|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
707488|NCT00064701|2292627|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
707489|NCT00064701|2292625|P3|Clinical Continuation Phase|Physician Decision|0
707490|NCT00064701|2292626|P2|Clinical Continuation Phase|Physician Decision|3
707491|NCT00064701|2292627|P1|Clinical Continuation Phase|Physician Decision|1
707492|NCT00064701|2292625|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
707493|NCT00064701|2292626|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
707494|NCT00064701|2292627|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
707495|NCT00064701|2292625|P3|Clinical Continuation Phase|Sponsor discontinued study|79
707496|NCT00064701|2292626|P2|Clinical Continuation Phase|Sponsor discontinued study|129
707497|NCT00064701|2292627|P1|Clinical Continuation Phase|Sponsor discontinued study|113
707498|NCT00064701|2292625|P3|Clinical Continuation Phase|Rejection|2
707499|NCT00064701|2292626|P2|Clinical Continuation Phase|Rejection|2
707500|NCT00064701|2292627|P1|Clinical Continuation Phase|Rejection|1
707501|NCT00064701|2292625|P3|Clinical Continuation Phase|Graft Failure|2
707502|NCT00064701|2292626|P2|Clinical Continuation Phase|Graft Failure|5
707503|NCT00064701|2292627|P1|Clinical Continuation Phase|Graft Failure|5
707504|NCT00064701|2292625|P3|Clinical Continuation Phase|Lost to Follow-up|6
707505|NCT00064701|2292626|P2|Clinical Continuation Phase|Lost to Follow-up|3
707506|NCT00064701|2292627|P1|Clinical Continuation Phase|Lost to Follow-up|6
707507|NCT00064701|2292625|P3|Clinical Continuation Phase|Withdrawal by Subject|22
707508|NCT00064701|2292626|P2|Clinical Continuation Phase|Withdrawal by Subject|3
707509|NCT00064701|2292627|P1|Clinical Continuation Phase|Withdrawal by Subject|22
707510|NCT00064701|2292625|P3|Clinical Continuation Phase|Non-compliance|7
707511|NCT00064701|2292626|P2|Clinical Continuation Phase|Non-compliance|6
707512|NCT00064701|2292627|P1|Clinical Continuation Phase|Non-compliance|8
707513|NCT00064701|2292625|P3|Clinical Continuation Phase|Adverse Event|14
707514|NCT00064701|2292626|P2|Clinical Continuation Phase|Adverse Event|21
707515|NCT00064701|2292627|P1|Clinical Continuation Phase|Adverse Event|12
707516|NCT00064701|2292625|P3|One Year Post-transplant|Pancreas transplant|1
707517|NCT00064701|2292626|P2|One Year Post-transplant|Pancreas transplant|0
707518|NCT00064701|2292627|P1|One Year Post-transplant|Pancreas transplant|0
707519|NCT00064701|2292625|P3|One Year Post-transplant|Poor absorption|0
707520|NCT00064701|2292626|P2|One Year Post-transplant|Poor absorption|1
707521|NCT00064701|2292627|P1|One Year Post-transplant|Poor absorption|0
707522|NCT00064701|2292625|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
707523|NCT00064701|2292626|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
707524|NCT00064701|2292627|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
707525|NCT00064701|2292625|P3|One Year Post-transplant|Incorrect study drug dispensed|0
707526|NCT00064701|2292626|P2|One Year Post-transplant|Incorrect study drug dispensed|1
707527|NCT00064701|2292627|P1|One Year Post-transplant|Incorrect study drug dispensed|0
707528|NCT00064701|2292625|P3|One Year Post-transplant|Acute tubular necrosis|0
707529|NCT00064701|2292626|P2|One Year Post-transplant|Acute tubular necrosis|0
707530|NCT00064701|2292627|P1|One Year Post-transplant|Acute tubular necrosis|1
707531|NCT00064701|2292625|P3|One Year Post-transplant|Converted to rapamycin|0
707532|NCT00064701|2292626|P2|One Year Post-transplant|Converted to rapamycin|0
707533|NCT00064701|2292627|P1|One Year Post-transplant|Converted to rapamycin|1
707534|NCT00064701|2292625|P3|One Year Post-transplant|Lost to Follow-up|0
707535|NCT00064701|2292626|P2|One Year Post-transplant|Lost to Follow-up|0
707536|NCT00064701|2292627|P1|One Year Post-transplant|Lost to Follow-up|1
707537|NCT00064701|2292625|P3|One Year Post-transplant|Withdrawal by Subject|1
707538|NCT00064701|2292626|P2|One Year Post-transplant|Withdrawal by Subject|4
707539|NCT00064701|2292627|P1|One Year Post-transplant|Withdrawal by Subject|0
707540|NCT00064701|2292625|P3|One Year Post-transplant|Graft Failure|1
707541|NCT00064701|2292626|P2|One Year Post-transplant|Graft Failure|2
707542|NCT00064701|2292627|P1|One Year Post-transplant|Graft Failure|3
707543|NCT00064701|2292625|P3|One Year Post-transplant|Non-compliance|5
707544|NCT00064701|2292626|P2|One Year Post-transplant|Non-compliance|2
707545|NCT00064701|2292627|P1|One Year Post-transplant|Non-compliance|4
707546|NCT00064701|2292625|P3|One Year Post-transplant|Rejection|16
707547|NCT00064701|2292626|P2|One Year Post-transplant|Rejection|1
707548|NCT00064701|2292627|P1|One Year Post-transplant|Rejection|0
707549|NCT00064701|2292625|P3|One Year Post-transplant|Adverse Event|37
707550|NCT00064701|2292626|P2|One Year Post-transplant|Adverse Event|19
707551|NCT00064701|2292627|P1|One Year Post-transplant|Adverse Event|23
707552|NCT00064701|2292625|P3|One Year Post-transplant|Did not receive study drug|11
707553|NCT00064701|2292626|P2|One Year Post-transplant|Did not receive study drug|12
707554|NCT00064701|2292627|P1|One Year Post-transplant|Did not receive study drug|7
889836|NCT01190228|2824719|P2|Overall Study|Protocol Violation|0
889837|NCT01190228|2824720|P1|Overall Study|Protocol Violation|4
889838|NCT01183260|2824743|P2|Overall Study|Death|0
889839|NCT01183260|2824744|P1|Overall Study|Death|1
889840|NCT01183260|2824743|P2|Overall Study|Revised within 30 days|1
889841|NCT01183260|2824744|P1|Overall Study|Revised within 30 days|0
707561|NCT00064792|2292710|P2|Overall Study|Adverse Event|0
707562|NCT00064792|2292711|P1|Overall Study|Adverse Event|3
707563|NCT00064792|2292710|P2|Overall Study|Withdrawal by Subject|0
707564|NCT00064792|2292711|P1|Overall Study|Withdrawal by Subject|2
707565|NCT00072280|2292732|P2|Follow-up|Early termination of study|2
707566|NCT00072280|2292733|P1|Follow-up|Early termination of study|2
707567|NCT00072280|2292732|P2|Treatment|Found ineligible|2
707568|NCT00072280|2292733|P1|Treatment|Found ineligible|1
707569|NCT00072293|2292740|P2|Overall Study|Withdrawal by Subject|1
707570|NCT00072293|2292741|P1|Overall Study|Withdrawal by Subject|0
707571|NCT00072293|2292740|P2|Overall Study|Lost to Follow-up|1
707572|NCT00072293|2292741|P1|Overall Study|Lost to Follow-up|1
707573|NCT00072475|2292758|P1|Overall Study|Patient/Investigator Decision|4
707574|NCT00072475|2292758|P1|Overall Study|Withdrawal by Subject|46
707575|NCT00072475|2292758|P1|Overall Study|Death|3
707576|NCT00072475|2292758|P1|Overall Study|Adverse Event|44
707577|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
707578|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
707579|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
707580|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
707581|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
707582|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
707583|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
707584|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
707585|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
707586|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
707587|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
707588|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
707589|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
707590|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
707591|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
707592|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
707593|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
707594|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
707595|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
707596|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
707597|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
707598|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
707599|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
707600|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
707601|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
707602|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
707603|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
707604|NCT00073307|2292781|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
707605|NCT00073307|2292782|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
707606|NCT00073307|2292783|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
707607|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
707608|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
707609|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
707610|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
707611|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
707612|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
707613|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
707614|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
707615|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
707616|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
707617|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
707618|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
707619|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
707620|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
707621|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
707622|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
707623|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
707624|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
707625|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
707626|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
707627|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
707628|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
707629|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
707630|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
707631|NCT00073307|2292781|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
707632|NCT00073307|2292782|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
707633|NCT00073307|2292783|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
707634|NCT00073528|2292816|P2|Overall Study|Ongoing|344
707635|NCT00073528|2292817|P1|Overall Study|Ongoing|349
707636|NCT00073528|2292816|P2|Overall Study|Non-compliance|1
707637|NCT00073528|2292817|P1|Overall Study|Non-compliance|0
707638|NCT00073528|2292816|P2|Overall Study|Enrolled in Error|1
707639|NCT00073528|2292817|P1|Overall Study|Enrolled in Error|0
707640|NCT00073528|2292816|P2|Overall Study|Participant Was Unblinded|1
707641|NCT00073528|2292817|P1|Overall Study|Participant Was Unblinded|0
707642|NCT00073528|2292816|P2|Overall Study|Progressive Disease|1
707643|NCT00073528|2292817|P1|Overall Study|Progressive Disease|0
707644|NCT00073528|2292816|P2|Overall Study|Randomized in Error; Not Treated|0
707645|NCT00073528|2292817|P1|Overall Study|Randomized in Error; Not Treated|2
707646|NCT00073528|2292816|P2|Overall Study|Mastectomy Intervention|0
707647|NCT00073528|2292817|P1|Overall Study|Mastectomy Intervention|1
707648|NCT00073528|2292816|P2|Overall Study|Death|238
707649|NCT00073528|2292817|P1|Overall Study|Death|229
707650|NCT00073528|2292816|P2|Overall Study|Protocol Violation|5
707651|NCT00073528|2292817|P1|Overall Study|Protocol Violation|3
707652|NCT00073528|2292816|P2|Overall Study|Lost to Follow-up|22
707653|NCT00073528|2292817|P1|Overall Study|Lost to Follow-up|26
707654|NCT00073528|2292816|P2|Overall Study|Withdrawal by Subject|29
707655|NCT00073528|2292817|P1|Overall Study|Withdrawal by Subject|34
707656|NCT00073918|2292891|P1|Overall Study|Eligibility requirement not met-low CD20|1
707657|NCT00073918|2292891|P1|Overall Study|Rapid disease progression|2
707658|NCT00073918|2292891|P1|Overall Study|Eligibility requirement not met - HAMA+|1
707659|NCT00073983|2292898|P1|Overall Study|not evaluable|1
707660|NCT00074152|2292922|P2|Overall Study|Lack of Efficacy|24
707661|NCT00074152|2292923|P1|Overall Study|Lack of Efficacy|34
707662|NCT00074152|2292922|P2|Overall Study|Death|9
707663|NCT00074152|2292923|P1|Overall Study|Death|21
707664|NCT00074412|2292944|P2|Overall Study|Lost to Follow-up|58
707665|NCT00074412|2292945|P1|Overall Study|Lost to Follow-up|52
707666|NCT00074412|2292944|P2|Overall Study|Death|26
707667|NCT00074412|2292945|P1|Overall Study|Death|30
707668|NCT00074581|2292961|P2|Overall Study|Other|19
707669|NCT00074581|2292962|P1|Overall Study|Other|14
707670|NCT00074581|2292961|P2|Overall Study|Ended relationship w. index participant|106
707671|NCT00074581|2292962|P1|Overall Study|Ended relationship w. index participant|117
707672|NCT00074581|2292961|P2|Overall Study|Lost to Follow-up|11
707673|NCT00074581|2292962|P1|Overall Study|Lost to Follow-up|16
707674|NCT00074581|2292961|P2|Overall Study|Were withdrawn by investigator|2
707675|NCT00074581|2292962|P1|Overall Study|Were withdrawn by investigator|5
707676|NCT00074581|2292961|P2|Overall Study|Relocated|9
707677|NCT00074581|2292962|P1|Overall Study|Relocated|14
707678|NCT00074581|2292961|P2|Overall Study|Unable to adhere to visit schedule|14
707679|NCT00074581|2292962|P1|Overall Study|Unable to adhere to visit schedule|13
707680|NCT00074581|2292961|P2|Overall Study|Withdrawal by Subject|49
707681|NCT00074581|2292962|P1|Overall Study|Withdrawal by Subject|50
707682|NCT00074581|2292961|P2|Overall Study|Death|16
707683|NCT00074581|2292962|P1|Overall Study|Death|15
707684|NCT00074711|2292972|P2|Overall Study|Participant stopped study drug|6
707685|NCT00074711|2292973|P1|Overall Study|Participant stopped study drug|4
707686|NCT00074711|2292972|P2|Overall Study|Lost to Follow-up|8
707687|NCT00074711|2292973|P1|Overall Study|Lost to Follow-up|10
707688|NCT00074711|2292972|P2|Overall Study|Withdrawal by Subject|1
707689|NCT00074711|2292973|P1|Overall Study|Withdrawal by Subject|1
707690|NCT00074958|2293023|P1|Overall Study|Adverse Event|1
707691|NCT00074984|2293030|P2|Overall Study|Patient Withdrawn Per Protocol|3
707692|NCT00074984|2293031|P1|Overall Study|Patient Withdrawn Per Protocol|0
707693|NCT00074984|2293030|P2|Overall Study|Withdrawal by Subject|3
707694|NCT00074984|2293031|P1|Overall Study|Withdrawal by Subject|2
707695|NCT00074984|2293030|P2|Overall Study|Death|2
707696|NCT00074984|2293031|P1|Overall Study|Death|1
707697|NCT00075023|2293048|P2|Pilot Study|Withdrawal by Subject|0
707698|NCT00075023|2293049|P1|Pilot Study|Withdrawal by Subject|1
707699|NCT00075023|2293048|P2|Pilot Study|Physician Decision|2
707700|NCT00075023|2293049|P1|Pilot Study|Physician Decision|1
707701|NCT00075218|2293072|P3|Open-Label Treatment|enrolled in a separate continuation|9
707702|NCT00075218|2293073|P2|Open-Label Treatment|enrolled in a separate continuation|0
707703|NCT00075218|2293074|P1|Open-Label Treatment|enrolled in a separate continuation|0
707704|NCT00075218|2293072|P3|Open-Label Treatment|Protocol Violation|1
707705|NCT00075218|2293073|P2|Open-Label Treatment|Protocol Violation|0
707706|NCT00075218|2293074|P1|Open-Label Treatment|Protocol Violation|0
707707|NCT00075218|2293072|P3|Open-Label Treatment|Decision of Sponsor|8
707708|NCT00075218|2293073|P2|Open-Label Treatment|Decision of Sponsor|0
707709|NCT00075218|2293074|P1|Open-Label Treatment|Decision of Sponsor|0
707710|NCT00075218|2293072|P3|Open-Label Treatment|Withdrawal by Subject|12
707711|NCT00075218|2293073|P2|Open-Label Treatment|Withdrawal by Subject|0
707712|NCT00075218|2293074|P1|Open-Label Treatment|Withdrawal by Subject|0
707713|NCT00075218|2293072|P3|Open-Label Treatment|Adverse Event|51
707714|NCT00075218|2293073|P2|Open-Label Treatment|Adverse Event|0
707715|NCT00075218|2293074|P1|Open-Label Treatment|Adverse Event|0
707716|NCT00075218|2293072|P3|Open-Label Treatment|Lack of Efficacy|174
707717|NCT00075218|2293073|P2|Open-Label Treatment|Lack of Efficacy|0
707718|NCT00075218|2293074|P1|Open-Label Treatment|Lack of Efficacy|0
707719|NCT00075218|2293072|P3|Double-Blind Treatment|No study medication taken|0
707720|NCT00075218|2293073|P2|Double-Blind Treatment|No study medication taken|0
707721|NCT00075218|2293074|P1|Double-Blind Treatment|No study medication taken|2
707722|NCT00075218|2293072|P3|Double-Blind Treatment|Decision of Sponsor|0
707723|NCT00075218|2293073|P2|Double-Blind Treatment|Decision of Sponsor|1
707724|NCT00075218|2293074|P1|Double-Blind Treatment|Decision of Sponsor|0
707725|NCT00075218|2293072|P3|Double-Blind Treatment|Lack of Efficacy|0
707726|NCT00075218|2293073|P2|Double-Blind Treatment|Lack of Efficacy|6
707727|NCT00075218|2293074|P1|Double-Blind Treatment|Lack of Efficacy|58
707728|NCT00075218|2293072|P3|Double-Blind Treatment|Lost to Follow-up|0
707729|NCT00075218|2293073|P2|Double-Blind Treatment|Lost to Follow-up|0
707730|NCT00075218|2293074|P1|Double-Blind Treatment|Lost to Follow-up|1
707731|NCT00075218|2293072|P3|Double-Blind Treatment|Withdrawal by Subject|0
707732|NCT00075218|2293073|P2|Double-Blind Treatment|Withdrawal by Subject|4
707733|NCT00075218|2293074|P1|Double-Blind Treatment|Withdrawal by Subject|7
707734|NCT00075218|2293072|P3|Double-Blind Treatment|Adverse Event|0
707735|NCT00075218|2293073|P2|Double-Blind Treatment|Adverse Event|4
707736|NCT00075218|2293074|P1|Double-Blind Treatment|Adverse Event|23
707737|NCT00075270|2293109|P2|Overall Study|Missing|13
707738|NCT00075270|2293110|P1|Overall Study|Missing|26
707739|NCT00075270|2293109|P2|Overall Study|Other/Unknown|5
707740|NCT00075270|2293110|P1|Overall Study|Other/Unknown|9
707741|NCT00075270|2293109|P2|Overall Study|Death|215
707742|NCT00075270|2293110|P1|Overall Study|Death|198
707743|NCT00075270|2293109|P2|Overall Study|Protocol Violation|2
707744|NCT00075270|2293110|P1|Overall Study|Protocol Violation|0
707745|NCT00075270|2293109|P2|Overall Study|Lost to Follow-up|28
707746|NCT00075270|2293110|P1|Overall Study|Lost to Follow-up|25
707747|NCT00075270|2293109|P2|Overall Study|Withdrawal by Subject|21
707748|NCT00075270|2293110|P1|Overall Study|Withdrawal by Subject|28
707751|NCT00075478|2293162|P2|Overall Study|Physician Decision|1
707752|NCT00075478|2293163|P1|Overall Study|Physician Decision|0
707753|NCT00075478|2293162|P2|Overall Study|not eligible|0
707754|NCT00075478|2293163|P1|Overall Study|not eligible|1
707755|NCT00075504|2293185|P2|Overall Study|Withdrawal by Subject|7
707756|NCT00075504|2293186|P1|Overall Study|Withdrawal by Subject|9
707757|NCT00075582|2293198|P2|Overall Study|Ineligible for study|16
707758|NCT00075582|2293199|P1|Overall Study|Ineligible for study|36
707759|NCT00075582|2293198|P2|Overall Study|Withdrawal by Subject|2
707760|NCT00075582|2293199|P1|Overall Study|Withdrawal by Subject|2
707761|NCT00075582|2293198|P2|Overall Study|Physician Decision|8
707762|NCT00075582|2293199|P1|Overall Study|Physician Decision|5
707763|NCT00075582|2293198|P2|Overall Study|Lack of Efficacy|8
707764|NCT00075582|2293199|P1|Overall Study|Lack of Efficacy|4
707765|NCT00075582|2293198|P2|Overall Study|Adverse Event|1
707766|NCT00075582|2293199|P1|Overall Study|Adverse Event|3
707767|NCT00075725|2293225|P12|Overall Study|Pt incarcerated|0
707768|NCT00075725|2293226|P11|Overall Study|Pt incarcerated|0
707769|NCT00075725|2293227|P10|Overall Study|Pt incarcerated|0
707770|NCT00075725|2293228|P9|Overall Study|Pt incarcerated|0
707771|NCT00075725|2293229|P8|Overall Study|Pt incarcerated|1
707772|NCT00075725|2293230|P7|Overall Study|Pt incarcerated|0
707773|NCT00075725|2293231|P6|Overall Study|Pt incarcerated|0
707774|NCT00075725|2293232|P5|Overall Study|Pt incarcerated|0
707775|NCT00075725|2293233|P4|Overall Study|Pt incarcerated|0
707776|NCT00075725|2293234|P3|Overall Study|Pt incarcerated|0
707777|NCT00075725|2293235|P2|Overall Study|Pt incarcerated|0
707778|NCT00075725|2293236|P1|Overall Study|Pt incarcerated|0
707779|NCT00075725|2293225|P12|Overall Study|Pt care terminated due to pt behavior|0
707780|NCT00075725|2293226|P11|Overall Study|Pt care terminated due to pt behavior|0
707781|NCT00075725|2293227|P10|Overall Study|Pt care terminated due to pt behavior|0
707782|NCT00075725|2293228|P9|Overall Study|Pt care terminated due to pt behavior|0
707783|NCT00075725|2293229|P8|Overall Study|Pt care terminated due to pt behavior|1
707784|NCT00075725|2293230|P7|Overall Study|Pt care terminated due to pt behavior|0
707785|NCT00075725|2293231|P6|Overall Study|Pt care terminated due to pt behavior|0
707786|NCT00075725|2293232|P5|Overall Study|Pt care terminated due to pt behavior|0
707787|NCT00075725|2293233|P4|Overall Study|Pt care terminated due to pt behavior|0
707788|NCT00075725|2293234|P3|Overall Study|Pt care terminated due to pt behavior|0
707789|NCT00075725|2293235|P2|Overall Study|Pt care terminated due to pt behavior|0
707790|NCT00075725|2293236|P1|Overall Study|Pt care terminated due to pt behavior|0
707791|NCT00075725|2293225|P12|Overall Study|Other complications|0
707792|NCT00075725|2293226|P11|Overall Study|Other complications|0
707793|NCT00075725|2293227|P10|Overall Study|Other complications|0
707794|NCT00075725|2293228|P9|Overall Study|Other complications|0
707795|NCT00075725|2293229|P8|Overall Study|Other complications|0
707796|NCT00075725|2293230|P7|Overall Study|Other complications|0
707797|NCT00075725|2293231|P6|Overall Study|Other complications|1
707798|NCT00075725|2293232|P5|Overall Study|Other complications|0
707799|NCT00075725|2293233|P4|Overall Study|Other complications|0
707800|NCT00075725|2293234|P3|Overall Study|Other complications|0
707801|NCT00075725|2293235|P2|Overall Study|Other complications|0
707802|NCT00075725|2293236|P1|Overall Study|Other complications|0
707803|NCT00075725|2293225|P12|Overall Study|Study Closure|0
707804|NCT00075725|2293226|P11|Overall Study|Study Closure|0
707805|NCT00075725|2293227|P10|Overall Study|Study Closure|0
707806|NCT00075725|2293228|P9|Overall Study|Study Closure|0
707807|NCT00075725|2293229|P8|Overall Study|Study Closure|1
707808|NCT00075725|2293230|P7|Overall Study|Study Closure|0
707809|NCT00075725|2293231|P6|Overall Study|Study Closure|3
707810|NCT00075725|2293232|P5|Overall Study|Study Closure|1
707811|NCT00075725|2293233|P4|Overall Study|Study Closure|0
707812|NCT00075725|2293234|P3|Overall Study|Study Closure|0
707813|NCT00075725|2293235|P2|Overall Study|Study Closure|0
707814|NCT00075725|2293236|P1|Overall Study|Study Closure|1
707815|NCT00075725|2293225|P12|Overall Study|Institution Terminated|0
707816|NCT00075725|2293226|P11|Overall Study|Institution Terminated|0
707817|NCT00075725|2293227|P10|Overall Study|Institution Terminated|0
707818|NCT00075725|2293228|P9|Overall Study|Institution Terminated|0
707819|NCT00075725|2293229|P8|Overall Study|Institution Terminated|3
707820|NCT00075725|2293230|P7|Overall Study|Institution Terminated|0
707821|NCT00075725|2293231|P6|Overall Study|Institution Terminated|0
707822|NCT00075725|2293232|P5|Overall Study|Institution Terminated|1
707823|NCT00075725|2293233|P4|Overall Study|Institution Terminated|0
707824|NCT00075725|2293234|P3|Overall Study|Institution Terminated|0
707825|NCT00075725|2293235|P2|Overall Study|Institution Terminated|0
707826|NCT00075725|2293236|P1|Overall Study|Institution Terminated|0
707827|NCT00075725|2293225|P12|Overall Study|Pt relocated|0
707828|NCT00075725|2293226|P11|Overall Study|Pt relocated|0
707829|NCT00075725|2293227|P10|Overall Study|Pt relocated|0
707830|NCT00075725|2293228|P9|Overall Study|Pt relocated|1
707831|NCT00075725|2293229|P8|Overall Study|Pt relocated|2
707832|NCT00075725|2293230|P7|Overall Study|Pt relocated|1
707833|NCT00075725|2293231|P6|Overall Study|Pt relocated|1
707834|NCT00075725|2293232|P5|Overall Study|Pt relocated|0
707835|NCT00075725|2293233|P4|Overall Study|Pt relocated|2
707836|NCT00075725|2293234|P3|Overall Study|Pt relocated|0
707837|NCT00075725|2293235|P2|Overall Study|Pt relocated|0
707838|NCT00075725|2293236|P1|Overall Study|Pt relocated|0
707839|NCT00075725|2293225|P12|Overall Study|Pt received additional steroids|0
707840|NCT00075725|2293226|P11|Overall Study|Pt received additional steroids|0
707841|NCT00075725|2293227|P10|Overall Study|Pt received additional steroids|0
707842|NCT00075725|2293228|P9|Overall Study|Pt received additional steroids|0
707843|NCT00075725|2293229|P8|Overall Study|Pt received additional steroids|0
707844|NCT00075725|2293230|P7|Overall Study|Pt received additional steroids|0
707845|NCT00075725|2293231|P6|Overall Study|Pt received additional steroids|0
707846|NCT00075725|2293232|P5|Overall Study|Pt received additional steroids|0
707847|NCT00075725|2293233|P4|Overall Study|Pt received additional steroids|1
707848|NCT00075725|2293234|P3|Overall Study|Pt received additional steroids|0
707849|NCT00075725|2293235|P2|Overall Study|Pt received additional steroids|0
707850|NCT00075725|2293236|P1|Overall Study|Pt received additional steroids|0
707851|NCT00075725|2293225|P12|Overall Study|Pt went to transplant|0
707852|NCT00075725|2293226|P11|Overall Study|Pt went to transplant|0
707853|NCT00075725|2293227|P10|Overall Study|Pt went to transplant|0
707854|NCT00075725|2293228|P9|Overall Study|Pt went to transplant|0
707855|NCT00075725|2293229|P8|Overall Study|Pt went to transplant|0
707856|NCT00075725|2293230|P7|Overall Study|Pt went to transplant|0
707857|NCT00075725|2293231|P6|Overall Study|Pt went to transplant|1
707858|NCT00075725|2293232|P5|Overall Study|Pt went to transplant|0
707859|NCT00075725|2293233|P4|Overall Study|Pt went to transplant|1
707860|NCT00075725|2293234|P3|Overall Study|Pt went to transplant|0
707861|NCT00075725|2293235|P2|Overall Study|Pt went to transplant|0
707862|NCT00075725|2293236|P1|Overall Study|Pt went to transplant|0
707863|NCT00075725|2293225|P12|Overall Study|specimen(s) not submitted|0
707864|NCT00075725|2293226|P11|Overall Study|specimen(s) not submitted|0
707865|NCT00075725|2293227|P10|Overall Study|specimen(s) not submitted|0
707866|NCT00075725|2293228|P9|Overall Study|specimen(s) not submitted|0
707867|NCT00075725|2293229|P8|Overall Study|specimen(s) not submitted|0
707868|NCT00075725|2293230|P7|Overall Study|specimen(s) not submitted|0
707869|NCT00075725|2293231|P6|Overall Study|specimen(s) not submitted|0
707870|NCT00075725|2293232|P5|Overall Study|specimen(s) not submitted|0
707871|NCT00075725|2293233|P4|Overall Study|specimen(s) not submitted|0
707872|NCT00075725|2293234|P3|Overall Study|specimen(s) not submitted|2
707873|NCT00075725|2293235|P2|Overall Study|specimen(s) not submitted|0
707874|NCT00075725|2293236|P1|Overall Study|specimen(s) not submitted|0
707875|NCT00075725|2293225|P12|Overall Study|Unsuccessful institutional transfer|0
707876|NCT00075725|2293226|P11|Overall Study|Unsuccessful institutional transfer|0
707877|NCT00075725|2293227|P10|Overall Study|Unsuccessful institutional transfer|1
707878|NCT00075725|2293228|P9|Overall Study|Unsuccessful institutional transfer|0
707879|NCT00075725|2293229|P8|Overall Study|Unsuccessful institutional transfer|0
707880|NCT00075725|2293230|P7|Overall Study|Unsuccessful institutional transfer|0
707881|NCT00075725|2293231|P6|Overall Study|Unsuccessful institutional transfer|0
707882|NCT00075725|2293232|P5|Overall Study|Unsuccessful institutional transfer|0
707883|NCT00075725|2293233|P4|Overall Study|Unsuccessful institutional transfer|0
707884|NCT00075725|2293234|P3|Overall Study|Unsuccessful institutional transfer|2
707885|NCT00075725|2293235|P2|Overall Study|Unsuccessful institutional transfer|0
707886|NCT00075725|2293236|P1|Overall Study|Unsuccessful institutional transfer|0
707887|NCT00075725|2293225|P12|Overall Study|Clinic chart lost unable to recreate|0
707888|NCT00075725|2293226|P11|Overall Study|Clinic chart lost unable to recreate|0
707889|NCT00075725|2293227|P10|Overall Study|Clinic chart lost unable to recreate|0
707890|NCT00075725|2293228|P9|Overall Study|Clinic chart lost unable to recreate|0
707891|NCT00075725|2293229|P8|Overall Study|Clinic chart lost unable to recreate|0
707892|NCT00075725|2293230|P7|Overall Study|Clinic chart lost unable to recreate|0
707893|NCT00075725|2293231|P6|Overall Study|Clinic chart lost unable to recreate|0
707894|NCT00075725|2293232|P5|Overall Study|Clinic chart lost unable to recreate|0
707895|NCT00075725|2293233|P4|Overall Study|Clinic chart lost unable to recreate|0
707896|NCT00075725|2293234|P3|Overall Study|Clinic chart lost unable to recreate|1
707897|NCT00075725|2293235|P2|Overall Study|Clinic chart lost unable to recreate|0
707898|NCT00075725|2293236|P1|Overall Study|Clinic chart lost unable to recreate|0
707899|NCT00075725|2293225|P12|Overall Study|Pt trying to find a BM donor|0
707900|NCT00075725|2293226|P11|Overall Study|Pt trying to find a BM donor|0
707901|NCT00075725|2293227|P10|Overall Study|Pt trying to find a BM donor|0
707902|NCT00075725|2293228|P9|Overall Study|Pt trying to find a BM donor|0
707903|NCT00075725|2293229|P8|Overall Study|Pt trying to find a BM donor|0
707904|NCT00075725|2293230|P7|Overall Study|Pt trying to find a BM donor|0
707905|NCT00075725|2293231|P6|Overall Study|Pt trying to find a BM donor|0
707906|NCT00075725|2293232|P5|Overall Study|Pt trying to find a BM donor|0
707907|NCT00075725|2293233|P4|Overall Study|Pt trying to find a BM donor|0
707908|NCT00075725|2293234|P3|Overall Study|Pt trying to find a BM donor|0
707909|NCT00075725|2293235|P2|Overall Study|Pt trying to find a BM donor|1
707910|NCT00075725|2293236|P1|Overall Study|Pt trying to find a BM donor|0
707911|NCT00075725|2293225|P12|Overall Study|Other|3
707912|NCT00075725|2293226|P11|Overall Study|Other|0
707913|NCT00075725|2293227|P10|Overall Study|Other|1
707914|NCT00075725|2293228|P9|Overall Study|Other|2
707915|NCT00075725|2293229|P8|Overall Study|Other|9
707916|NCT00075725|2293230|P7|Overall Study|Other|2
707917|NCT00075725|2293231|P6|Overall Study|Other|4
707918|NCT00075725|2293232|P5|Overall Study|Other|1
707919|NCT00075725|2293233|P4|Overall Study|Other|1
707920|NCT00075725|2293234|P3|Overall Study|Other|1
707921|NCT00075725|2293235|P2|Overall Study|Other|2
707922|NCT00075725|2293236|P1|Overall Study|Other|4
707923|NCT00075725|2293225|P12|Overall Study|Inevaluable|0
707924|NCT00075725|2293226|P11|Overall Study|Inevaluable|1
707925|NCT00075725|2293227|P10|Overall Study|Inevaluable|0
707926|NCT00075725|2293228|P9|Overall Study|Inevaluable|2
707927|NCT00075725|2293229|P8|Overall Study|Inevaluable|11
707928|NCT00075725|2293230|P7|Overall Study|Inevaluable|1
707929|NCT00075725|2293231|P6|Overall Study|Inevaluable|9
707930|NCT00075725|2293232|P5|Overall Study|Inevaluable|2
707931|NCT00075725|2293233|P4|Overall Study|Inevaluable|2
707932|NCT00075725|2293234|P3|Overall Study|Inevaluable|4
707933|NCT00075725|2293235|P2|Overall Study|Inevaluable|1
707934|NCT00075725|2293236|P1|Overall Study|Inevaluable|1
707935|NCT00075725|2293225|P12|Overall Study|Pt has very high risk ALL characteristic|3
707936|NCT00075725|2293226|P11|Overall Study|Pt has very high risk ALL characteristic|0
707937|NCT00075725|2293227|P10|Overall Study|Pt has very high risk ALL characteristic|1
707938|NCT00075725|2293228|P9|Overall Study|Pt has very high risk ALL characteristic|29
707939|NCT00075725|2293229|P8|Overall Study|Pt has very high risk ALL characteristic|74
707940|NCT00075725|2293230|P7|Overall Study|Pt has very high risk ALL characteristic|23
708020|NCT00075725|2293226|P11|Overall Study|Patient off treatment|0
707941|NCT00075725|2293231|P6|Overall Study|Pt has very high risk ALL characteristic|75
707942|NCT00075725|2293232|P5|Overall Study|Pt has very high risk ALL characteristic|11
707943|NCT00075725|2293233|P4|Overall Study|Pt has very high risk ALL characteristic|18
707944|NCT00075725|2293234|P3|Overall Study|Pt has very high risk ALL characteristic|26
707945|NCT00075725|2293235|P2|Overall Study|Pt has very high risk ALL characteristic|11
707946|NCT00075725|2293236|P1|Overall Study|Pt has very high risk ALL characteristic|15
707947|NCT00075725|2293225|P12|Overall Study|MRD positive after extended ind|0
707948|NCT00075725|2293226|P11|Overall Study|MRD positive after extended ind|0
707949|NCT00075725|2293227|P10|Overall Study|MRD positive after extended ind|0
707950|NCT00075725|2293228|P9|Overall Study|MRD positive after extended ind|0
707951|NCT00075725|2293229|P8|Overall Study|MRD positive after extended ind|1
707952|NCT00075725|2293230|P7|Overall Study|MRD positive after extended ind|0
707953|NCT00075725|2293231|P6|Overall Study|MRD positive after extended ind|2
707954|NCT00075725|2293232|P5|Overall Study|MRD positive after extended ind|1
707955|NCT00075725|2293233|P4|Overall Study|MRD positive after extended ind|0
707956|NCT00075725|2293234|P3|Overall Study|MRD positive after extended ind|1
707957|NCT00075725|2293235|P2|Overall Study|MRD positive after extended ind|1
707958|NCT00075725|2293236|P1|Overall Study|MRD positive after extended ind|0
707959|NCT00075725|2293225|P12|Overall Study|Insurance issues|0
707960|NCT00075725|2293226|P11|Overall Study|Insurance issues|0
707961|NCT00075725|2293227|P10|Overall Study|Insurance issues|0
707962|NCT00075725|2293228|P9|Overall Study|Insurance issues|0
707963|NCT00075725|2293229|P8|Overall Study|Insurance issues|1
707964|NCT00075725|2293230|P7|Overall Study|Insurance issues|0
707965|NCT00075725|2293231|P6|Overall Study|Insurance issues|1
707966|NCT00075725|2293232|P5|Overall Study|Insurance issues|1
707967|NCT00075725|2293233|P4|Overall Study|Insurance issues|1
707968|NCT00075725|2293234|P3|Overall Study|Insurance issues|0
707969|NCT00075725|2293235|P2|Overall Study|Insurance issues|1
707970|NCT00075725|2293236|P1|Overall Study|Insurance issues|0
707971|NCT00075725|2293225|P12|Overall Study|Pt age out of range for treatment|0
707972|NCT00075725|2293226|P11|Overall Study|Pt age out of range for treatment|0
707973|NCT00075725|2293227|P10|Overall Study|Pt age out of range for treatment|0
707974|NCT00075725|2293228|P9|Overall Study|Pt age out of range for treatment|0
707975|NCT00075725|2293229|P8|Overall Study|Pt age out of range for treatment|1
707976|NCT00075725|2293230|P7|Overall Study|Pt age out of range for treatment|0
707977|NCT00075725|2293231|P6|Overall Study|Pt age out of range for treatment|1
707978|NCT00075725|2293232|P5|Overall Study|Pt age out of range for treatment|0
707979|NCT00075725|2293233|P4|Overall Study|Pt age out of range for treatment|0
707980|NCT00075725|2293234|P3|Overall Study|Pt age out of range for treatment|0
707981|NCT00075725|2293235|P2|Overall Study|Pt age out of range for treatment|1
707982|NCT00075725|2293236|P1|Overall Study|Pt age out of range for treatment|0
707983|NCT00075725|2293225|P12|Overall Study|Pt non compliant with therapy|0
707984|NCT00075725|2293226|P11|Overall Study|Pt non compliant with therapy|0
707985|NCT00075725|2293227|P10|Overall Study|Pt non compliant with therapy|0
707986|NCT00075725|2293228|P9|Overall Study|Pt non compliant with therapy|3
707987|NCT00075725|2293229|P8|Overall Study|Pt non compliant with therapy|5
707988|NCT00075725|2293230|P7|Overall Study|Pt non compliant with therapy|2
707989|NCT00075725|2293231|P6|Overall Study|Pt non compliant with therapy|14
707990|NCT00075725|2293232|P5|Overall Study|Pt non compliant with therapy|2
707991|NCT00075725|2293233|P4|Overall Study|Pt non compliant with therapy|0
707992|NCT00075725|2293234|P3|Overall Study|Pt non compliant with therapy|1
707993|NCT00075725|2293235|P2|Overall Study|Pt non compliant with therapy|1
707994|NCT00075725|2293236|P1|Overall Study|Pt non compliant with therapy|2
707995|NCT00075725|2293225|P12|Overall Study|Pt/Guardian refused RT therapy|0
707996|NCT00075725|2293226|P11|Overall Study|Pt/Guardian refused RT therapy|0
707997|NCT00075725|2293227|P10|Overall Study|Pt/Guardian refused RT therapy|0
707998|NCT00075725|2293228|P9|Overall Study|Pt/Guardian refused RT therapy|0
707999|NCT00075725|2293229|P8|Overall Study|Pt/Guardian refused RT therapy|0
708000|NCT00075725|2293230|P7|Overall Study|Pt/Guardian refused RT therapy|0
708001|NCT00075725|2293231|P6|Overall Study|Pt/Guardian refused RT therapy|0
708002|NCT00075725|2293232|P5|Overall Study|Pt/Guardian refused RT therapy|1
708003|NCT00075725|2293233|P4|Overall Study|Pt/Guardian refused RT therapy|2
708004|NCT00075725|2293234|P3|Overall Study|Pt/Guardian refused RT therapy|1
708005|NCT00075725|2293235|P2|Overall Study|Pt/Guardian refused RT therapy|0
708006|NCT00075725|2293236|P1|Overall Study|Pt/Guardian refused RT therapy|1
708007|NCT00075725|2293225|P12|Overall Study|Ineligible or wrong diagnosis|4
708008|NCT00075725|2293226|P11|Overall Study|Ineligible or wrong diagnosis|2
708009|NCT00075725|2293227|P10|Overall Study|Ineligible or wrong diagnosis|1
708010|NCT00075725|2293228|P9|Overall Study|Ineligible or wrong diagnosis|10
708011|NCT00075725|2293229|P8|Overall Study|Ineligible or wrong diagnosis|9
708012|NCT00075725|2293230|P7|Overall Study|Ineligible or wrong diagnosis|6
708013|NCT00075725|2293231|P6|Overall Study|Ineligible or wrong diagnosis|17
708014|NCT00075725|2293232|P5|Overall Study|Ineligible or wrong diagnosis|3
708015|NCT00075725|2293233|P4|Overall Study|Ineligible or wrong diagnosis|10
708016|NCT00075725|2293234|P3|Overall Study|Ineligible or wrong diagnosis|3
708017|NCT00075725|2293235|P2|Overall Study|Ineligible or wrong diagnosis|3
708018|NCT00075725|2293236|P1|Overall Study|Ineligible or wrong diagnosis|8
708019|NCT00075725|2293225|P12|Overall Study|Patient off treatment|0
708021|NCT00075725|2293227|P10|Overall Study|Patient off treatment|0
708022|NCT00075725|2293228|P9|Overall Study|Patient off treatment|1
708023|NCT00075725|2293229|P8|Overall Study|Patient off treatment|2
708024|NCT00075725|2293230|P7|Overall Study|Patient off treatment|0
708025|NCT00075725|2293231|P6|Overall Study|Patient off treatment|0
708026|NCT00075725|2293232|P5|Overall Study|Patient off treatment|1
708027|NCT00075725|2293233|P4|Overall Study|Patient off treatment|2
708028|NCT00075725|2293234|P3|Overall Study|Patient off treatment|1
708029|NCT00075725|2293235|P2|Overall Study|Patient off treatment|0
708030|NCT00075725|2293236|P1|Overall Study|Patient off treatment|0
708031|NCT00075725|2293225|P12|Overall Study|Disease Progression, all other reasons|5
708032|NCT00075725|2293226|P11|Overall Study|Disease Progression, all other reasons|0
708033|NCT00075725|2293227|P10|Overall Study|Disease Progression, all other reasons|4
708034|NCT00075725|2293228|P9|Overall Study|Disease Progression, all other reasons|21
708035|NCT00075725|2293229|P8|Overall Study|Disease Progression, all other reasons|46
708036|NCT00075725|2293230|P7|Overall Study|Disease Progression, all other reasons|20
708037|NCT00075725|2293231|P6|Overall Study|Disease Progression, all other reasons|59
708038|NCT00075725|2293232|P5|Overall Study|Disease Progression, all other reasons|21
708039|NCT00075725|2293233|P4|Overall Study|Disease Progression, all other reasons|6
708040|NCT00075725|2293234|P3|Overall Study|Disease Progression, all other reasons|33
708041|NCT00075725|2293235|P2|Overall Study|Disease Progression, all other reasons|5
708042|NCT00075725|2293236|P1|Overall Study|Disease Progression, all other reasons|17
708043|NCT00075725|2293225|P12|Overall Study|Withdrawal by Subject|0
708044|NCT00075725|2293226|P11|Overall Study|Withdrawal by Subject|0
708045|NCT00075725|2293227|P10|Overall Study|Withdrawal by Subject|2
708046|NCT00075725|2293228|P9|Overall Study|Withdrawal by Subject|10
708047|NCT00075725|2293229|P8|Overall Study|Withdrawal by Subject|31
708048|NCT00075725|2293230|P7|Overall Study|Withdrawal by Subject|7
708049|NCT00075725|2293231|P6|Overall Study|Withdrawal by Subject|27
708050|NCT00075725|2293232|P5|Overall Study|Withdrawal by Subject|6
708051|NCT00075725|2293233|P4|Overall Study|Withdrawal by Subject|10
708052|NCT00075725|2293234|P3|Overall Study|Withdrawal by Subject|6
708053|NCT00075725|2293235|P2|Overall Study|Withdrawal by Subject|3
708054|NCT00075725|2293236|P1|Overall Study|Withdrawal by Subject|12
708055|NCT00075725|2293225|P12|Overall Study|Protocol Violation|1
708056|NCT00075725|2293226|P11|Overall Study|Protocol Violation|0
708057|NCT00075725|2293227|P10|Overall Study|Protocol Violation|0
708058|NCT00075725|2293228|P9|Overall Study|Protocol Violation|3
708059|NCT00075725|2293229|P8|Overall Study|Protocol Violation|2
708060|NCT00075725|2293230|P7|Overall Study|Protocol Violation|1
708061|NCT00075725|2293231|P6|Overall Study|Protocol Violation|2
708062|NCT00075725|2293232|P5|Overall Study|Protocol Violation|3
708063|NCT00075725|2293233|P4|Overall Study|Protocol Violation|3
708064|NCT00075725|2293234|P3|Overall Study|Protocol Violation|0
708065|NCT00075725|2293235|P2|Overall Study|Protocol Violation|1
708066|NCT00075725|2293236|P1|Overall Study|Protocol Violation|1
708067|NCT00075725|2293225|P12|Overall Study|Pregnancy|0
708068|NCT00075725|2293226|P11|Overall Study|Pregnancy|0
708069|NCT00075725|2293227|P10|Overall Study|Pregnancy|0
708070|NCT00075725|2293228|P9|Overall Study|Pregnancy|0
708071|NCT00075725|2293229|P8|Overall Study|Pregnancy|1
708072|NCT00075725|2293230|P7|Overall Study|Pregnancy|0
708073|NCT00075725|2293231|P6|Overall Study|Pregnancy|1
708074|NCT00075725|2293232|P5|Overall Study|Pregnancy|0
708075|NCT00075725|2293233|P4|Overall Study|Pregnancy|0
708076|NCT00075725|2293234|P3|Overall Study|Pregnancy|0
708077|NCT00075725|2293235|P2|Overall Study|Pregnancy|0
708078|NCT00075725|2293236|P1|Overall Study|Pregnancy|0
708079|NCT00075725|2293225|P12|Overall Study|Physician Decision|0
708080|NCT00075725|2293226|P11|Overall Study|Physician Decision|1
708081|NCT00075725|2293227|P10|Overall Study|Physician Decision|0
708082|NCT00075725|2293228|P9|Overall Study|Physician Decision|5
708083|NCT00075725|2293229|P8|Overall Study|Physician Decision|17
708084|NCT00075725|2293230|P7|Overall Study|Physician Decision|3
708085|NCT00075725|2293231|P6|Overall Study|Physician Decision|19
708086|NCT00075725|2293232|P5|Overall Study|Physician Decision|4
708087|NCT00075725|2293233|P4|Overall Study|Physician Decision|8
708088|NCT00075725|2293234|P3|Overall Study|Physician Decision|5
708089|NCT00075725|2293235|P2|Overall Study|Physician Decision|6
708090|NCT00075725|2293236|P1|Overall Study|Physician Decision|2
708091|NCT00075725|2293225|P12|Overall Study|Lost to Follow-up|0
708092|NCT00075725|2293226|P11|Overall Study|Lost to Follow-up|0
708093|NCT00075725|2293227|P10|Overall Study|Lost to Follow-up|0
708094|NCT00075725|2293228|P9|Overall Study|Lost to Follow-up|1
708095|NCT00075725|2293229|P8|Overall Study|Lost to Follow-up|4
708096|NCT00075725|2293230|P7|Overall Study|Lost to Follow-up|2
708097|NCT00075725|2293231|P6|Overall Study|Lost to Follow-up|13
708098|NCT00075725|2293232|P5|Overall Study|Lost to Follow-up|0
708099|NCT00075725|2293233|P4|Overall Study|Lost to Follow-up|1
708100|NCT00075725|2293234|P3|Overall Study|Lost to Follow-up|4
708101|NCT00075725|2293235|P2|Overall Study|Lost to Follow-up|1
708102|NCT00075725|2293236|P1|Overall Study|Lost to Follow-up|1
708103|NCT00075725|2293225|P12|Overall Study|Death|0
708104|NCT00075725|2293226|P11|Overall Study|Death|3
708105|NCT00075725|2293227|P10|Overall Study|Death|4
708106|NCT00075725|2293228|P9|Overall Study|Death|14
708107|NCT00075725|2293229|P8|Overall Study|Death|22
708108|NCT00075725|2293230|P7|Overall Study|Death|4
708109|NCT00075725|2293231|P6|Overall Study|Death|25
708110|NCT00075725|2293232|P5|Overall Study|Death|3
708111|NCT00075725|2293233|P4|Overall Study|Death|2
708112|NCT00075725|2293234|P3|Overall Study|Death|10
708113|NCT00075725|2293235|P2|Overall Study|Death|5
708114|NCT00075725|2293236|P1|Overall Study|Death|3
708115|NCT00075725|2293225|P12|Overall Study|Adverse Event|2
708116|NCT00075725|2293226|P11|Overall Study|Adverse Event|2
708117|NCT00075725|2293227|P10|Overall Study|Adverse Event|4
708118|NCT00075725|2293228|P9|Overall Study|Adverse Event|15
708119|NCT00075725|2293229|P8|Overall Study|Adverse Event|51
708120|NCT00075725|2293230|P7|Overall Study|Adverse Event|3
708121|NCT00075725|2293231|P6|Overall Study|Adverse Event|38
708122|NCT00075725|2293232|P5|Overall Study|Adverse Event|4
708123|NCT00075725|2293233|P4|Overall Study|Adverse Event|8
708124|NCT00075725|2293234|P3|Overall Study|Adverse Event|20
708125|NCT00075725|2293235|P2|Overall Study|Adverse Event|6
708126|NCT00075725|2293236|P1|Overall Study|Adverse Event|6
708127|NCT00075764|2293327|P2|Overall Study|Under review|1
708128|NCT00075764|2293328|P1|Overall Study|Under review|0
708129|NCT00075764|2293327|P2|Overall Study|Not protocol specified|19
708130|NCT00075764|2293328|P1|Overall Study|Not protocol specified|27
708131|NCT00075764|2293327|P2|Overall Study|Delinquent|2
708132|NCT00075764|2293328|P1|Overall Study|Delinquent|4
708133|NCT00075764|2293327|P2|Overall Study|Still on treatment|15
708134|NCT00075764|2293328|P1|Overall Study|Still on treatment|8
708135|NCT00075764|2293327|P2|Overall Study|Progression|274
708136|NCT00075764|2293328|P1|Overall Study|Progression|269
708137|NCT00075764|2293327|P2|Overall Study|Withdrawal by Subject|18
708138|NCT00075764|2293328|P1|Overall Study|Withdrawal by Subject|28
708139|NCT00075764|2293327|P2|Overall Study|Death|8
708140|NCT00075764|2293328|P1|Overall Study|Death|4
708141|NCT00075764|2293327|P2|Overall Study|Adverse Event|12
708142|NCT00075764|2293328|P1|Overall Study|Adverse Event|5
708145|NCT00067990|2293447|P2|Overall Study|Withdrawal by Subject|12
708146|NCT00067990|2293448|P1|Overall Study|Withdrawal by Subject|4
708147|NCT00067990|2293447|P2|Overall Study|ESRD, Non IF/TA|3
708148|NCT00067990|2293448|P1|Overall Study|ESRD, Non IF/TA|1
708149|NCT00067990|2293447|P2|Overall Study|Death|7
708150|NCT00067990|2293448|P1|Overall Study|Death|5
708151|NCT00068107|2293456|P1|Overall Study|Withdrawal by Subject|1
708152|NCT00068107|2293456|P1|Overall Study|Death|2
708153|NCT00068107|2293456|P1|Overall Study|end-stage renal disease|6
708154|NCT00068237|2293467|P1|Overall Study|No protocol treatment received|2
708155|NCT00068237|2293467|P1|Overall Study|Ineligible|3
708156|NCT00068380|2293497|P1|Overall Study|Adverse Event|2
708157|NCT00068380|2293497|P1|Overall Study|Withdrawal by Subject|3
708158|NCT00068393|2293501|P1|Overall Study|Quality of life worsening|1
708159|NCT00068393|2293501|P1|Overall Study|Alternative treatment|1
708160|NCT00068393|2293501|P1|Overall Study|Withdrawal by Subject|3
708161|NCT00068393|2293501|P1|Overall Study|Death|3
708162|NCT00068393|2293501|P1|Overall Study|Adverse Event|2
708163|NCT00068419|2293507|P1|Overall Study|Ineligible|11
708164|NCT00068419|2293507|P1|Overall Study|Withdrawal by Subject|14
708165|NCT00068419|2293507|P1|Overall Study|Physician Decision|7
708166|NCT00068419|2293507|P1|Overall Study|Lost to Follow-up|1
708167|NCT00068419|2293507|P1|Overall Study|Lack of Efficacy|24
708168|NCT00068419|2293507|P1|Overall Study|Adverse Event|3
708169|NCT00068588|2293518|P3|Overall Study|Poor KPS|1
708170|NCT00068588|2293519|P2|Overall Study|Poor KPS|0
708171|NCT00068588|2293520|P1|Overall Study|Poor KPS|0
708172|NCT00068588|2293518|P3|Overall Study|Withdrawal by Subject|1
708173|NCT00068588|2293519|P2|Overall Study|Withdrawal by Subject|0
708174|NCT00068588|2293520|P1|Overall Study|Withdrawal by Subject|0
708175|NCT00068588|2293518|P3|Overall Study|Adverse Event|2
708176|NCT00068588|2293519|P2|Overall Study|Adverse Event|0
708177|NCT00068588|2293520|P1|Overall Study|Adverse Event|0
708178|NCT00068601|2293532|P2|Overall Study|Missing primary outcome data|34
708179|NCT00068601|2293533|P1|Overall Study|Missing primary outcome data|30
708180|NCT00068601|2293532|P2|Overall Study|Lost to Follow-up|2
708181|NCT00068601|2293533|P1|Overall Study|Lost to Follow-up|3
708182|NCT00068601|2293532|P2|Overall Study|Death|3
708183|NCT00068601|2293533|P1|Overall Study|Death|11
708184|NCT00068601|2293532|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
708185|NCT00068601|2293533|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
708186|NCT00068601|2293532|P2|Overall Study|Not evaluable: withdrew consent|4
708187|NCT00068601|2293533|P1|Overall Study|Not evaluable: withdrew consent|5
708188|NCT00068601|2293532|P2|Overall Study|Ineligible|13
708189|NCT00068601|2293533|P1|Overall Study|Ineligible|11
708190|NCT00068822|2293566|P2|First Randomized Intervention|Lost to Follow-up|2
708191|NCT00068822|2293567|P1|First Randomized Intervention|Lost to Follow-up|1
708192|NCT00069095|2293583|P6|Follow-up Phase|Death|101
708193|NCT00069095|2293584|P5|Follow-up Phase|Death|92
708194|NCT00069095|2293585|P4|Follow-up Phase|Death|112
708195|NCT00069095|2293586|P3|Follow-up Phase|Death|120
708196|NCT00069095|2293587|P2|Follow-up Phase|Death|206
708197|NCT00069095|2293588|P1|Follow-up Phase|Death|174
708198|NCT00069095|2293583|P6|Post-study Treatment Phase|Investigator decision|1
708199|NCT00069095|2293584|P5|Post-study Treatment Phase|Investigator decision|0
708200|NCT00069095|2293585|P4|Post-study Treatment Phase|Investigator decision|0
708201|NCT00069095|2293586|P3|Post-study Treatment Phase|Investigator decision|0
708202|NCT00069095|2293587|P2|Post-study Treatment Phase|Investigator decision|0
708203|NCT00069095|2293588|P1|Post-study Treatment Phase|Investigator decision|0
708204|NCT00069095|2293583|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
708205|NCT00069095|2293584|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
708206|NCT00069095|2293585|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
708207|NCT00069095|2293586|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
708208|NCT00069095|2293587|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
708209|NCT00069095|2293588|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
708210|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
708211|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
708212|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
708213|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
708214|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
708215|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
708216|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant had progressive disease|0
708217|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant had progressive disease|1
708218|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant had progressive disease|0
708219|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant had progressive disease|0
708220|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant had progressive disease|0
708221|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant had progressive disease|0
708222|NCT00069095|2293583|P6|Post-study Treatment Phase|Death|0
708223|NCT00069095|2293584|P5|Post-study Treatment Phase|Death|1
708224|NCT00069095|2293585|P4|Post-study Treatment Phase|Death|0
708225|NCT00069095|2293586|P3|Post-study Treatment Phase|Death|0
708226|NCT00069095|2293587|P2|Post-study Treatment Phase|Death|0
708227|NCT00069095|2293588|P1|Post-study Treatment Phase|Death|0
708228|NCT00069095|2293583|P6|Post-study Treatment Phase|Surgery|0
708229|NCT00069095|2293584|P5|Post-study Treatment Phase|Surgery|1
708230|NCT00069095|2293585|P4|Post-study Treatment Phase|Surgery|1
708231|NCT00069095|2293586|P3|Post-study Treatment Phase|Surgery|0
708232|NCT00069095|2293587|P2|Post-study Treatment Phase|Surgery|0
708233|NCT00069095|2293588|P1|Post-study Treatment Phase|Surgery|0
708234|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant completed treatment|0
708235|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant completed treatment|0
708236|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant completed treatment|1
708237|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant completed treatment|0
708238|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant completed treatment|0
708239|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant completed treatment|0
708240|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
708241|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
708242|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
708243|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
708244|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
708245|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
708246|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant will start new treatment|0
708247|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant will start new treatment|0
708248|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant will start new treatment|0
708249|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant will start new treatment|1
708250|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant will start new treatment|0
708251|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant will start new treatment|0
708252|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant withdrew consent|0
708253|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant withdrew consent|0
708254|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant withdrew consent|0
708255|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant withdrew consent|1
708256|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant withdrew consent|0
708257|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant withdrew consent|0
708258|NCT00069095|2293583|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
708259|NCT00069095|2293584|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
708260|NCT00069095|2293585|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
708261|NCT00069095|2293586|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
708262|NCT00069095|2293587|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
708263|NCT00069095|2293588|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
708264|NCT00069095|2293583|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
708265|NCT00069095|2293584|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
708266|NCT00069095|2293585|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
708267|NCT00069095|2293586|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
708268|NCT00069095|2293587|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
708269|NCT00069095|2293588|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
708270|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant had complete response|0
708271|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant had complete response|0
708272|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant had complete response|0
708273|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant had complete response|0
708274|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant had complete response|1
708275|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant had complete response|1
708276|NCT00069095|2293583|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
708277|NCT00069095|2293584|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
708278|NCT00069095|2293585|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
708279|NCT00069095|2293586|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
708280|NCT00069095|2293587|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
708281|NCT00069095|2293588|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
708282|NCT00069095|2293583|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
708283|NCT00069095|2293584|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
708284|NCT00069095|2293585|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
708285|NCT00069095|2293586|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
708286|NCT00069095|2293587|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
708287|NCT00069095|2293588|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
708288|NCT00069095|2293583|P6|Post-study Treatment Phase|Eligible for surgery|0
708289|NCT00069095|2293584|P5|Post-study Treatment Phase|Eligible for surgery|0
708290|NCT00069095|2293585|P4|Post-study Treatment Phase|Eligible for surgery|0
708291|NCT00069095|2293586|P3|Post-study Treatment Phase|Eligible for surgery|0
708292|NCT00069095|2293587|P2|Post-study Treatment Phase|Eligible for surgery|0
708293|NCT00069095|2293588|P1|Post-study Treatment Phase|Eligible for surgery|2
708294|NCT00069095|2293583|P6|Post-study Treatment Phase|Adverse Event|1
708295|NCT00069095|2293584|P5|Post-study Treatment Phase|Adverse Event|5
708296|NCT00069095|2293585|P4|Post-study Treatment Phase|Adverse Event|0
708297|NCT00069095|2293586|P3|Post-study Treatment Phase|Adverse Event|1
708298|NCT00069095|2293587|P2|Post-study Treatment Phase|Adverse Event|3
708299|NCT00069095|2293588|P1|Post-study Treatment Phase|Adverse Event|2
708300|NCT00069095|2293583|P6|Post-study Treatment Phase|Missing reason|17
708301|NCT00069095|2293584|P5|Post-study Treatment Phase|Missing reason|18
708302|NCT00069095|2293585|P4|Post-study Treatment Phase|Missing reason|8
708303|NCT00069095|2293586|P3|Post-study Treatment Phase|Missing reason|12
708304|NCT00069095|2293587|P2|Post-study Treatment Phase|Missing reason|3
708305|NCT00069095|2293588|P1|Post-study Treatment Phase|Missing reason|1
708306|NCT00069095|2293583|P6|Primary Treatment Phase|Violation criteria|5
708307|NCT00069095|2293584|P5|Primary Treatment Phase|Violation criteria|1
708308|NCT00069095|2293585|P4|Primary Treatment Phase|Violation criteria|3
708309|NCT00069095|2293586|P3|Primary Treatment Phase|Violation criteria|4
708310|NCT00069095|2293587|P2|Primary Treatment Phase|Violation criteria|2
708311|NCT00069095|2293588|P1|Primary Treatment Phase|Violation criteria|0
708312|NCT00069095|2293583|P6|Primary Treatment Phase|Other Violation|1
708313|NCT00069095|2293584|P5|Primary Treatment Phase|Other Violation|0
708314|NCT00069095|2293585|P4|Primary Treatment Phase|Other Violation|1
708315|NCT00069095|2293586|P3|Primary Treatment Phase|Other Violation|1
708316|NCT00069095|2293587|P2|Primary Treatment Phase|Other Violation|1
708317|NCT00069095|2293588|P1|Primary Treatment Phase|Other Violation|0
708318|NCT00069095|2293583|P6|Primary Treatment Phase|Withdrew|9
708319|NCT00069095|2293584|P5|Primary Treatment Phase|Withdrew|4
708320|NCT00069095|2293585|P4|Primary Treatment Phase|Withdrew|2
708321|NCT00069095|2293586|P3|Primary Treatment Phase|Withdrew|8
708322|NCT00069095|2293587|P2|Primary Treatment Phase|Withdrew|3
708323|NCT00069095|2293588|P1|Primary Treatment Phase|Withdrew|2
708324|NCT00069095|2293583|P6|Primary Treatment Phase|Refused treatment|27
708325|NCT00069095|2293584|P5|Primary Treatment Phase|Refused treatment|24
708326|NCT00069095|2293585|P4|Primary Treatment Phase|Refused treatment|31
708327|NCT00069095|2293586|P3|Primary Treatment Phase|Refused treatment|17
708328|NCT00069095|2293587|P2|Primary Treatment Phase|Refused treatment|26
708329|NCT00069095|2293588|P1|Primary Treatment Phase|Refused treatment|15
708330|NCT00069095|2293583|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
708331|NCT00069095|2293584|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
708332|NCT00069095|2293585|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
708333|NCT00069095|2293586|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
708334|NCT00069095|2293587|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
708335|NCT00069095|2293588|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
708336|NCT00069095|2293583|P6|Primary Treatment Phase|Failure to return|2
708337|NCT00069095|2293584|P5|Primary Treatment Phase|Failure to return|0
708338|NCT00069095|2293585|P4|Primary Treatment Phase|Failure to return|0
708339|NCT00069095|2293586|P3|Primary Treatment Phase|Failure to return|0
708340|NCT00069095|2293587|P2|Primary Treatment Phase|Failure to return|5
708341|NCT00069095|2293588|P1|Primary Treatment Phase|Failure to return|5
708342|NCT00069095|2293583|P6|Primary Treatment Phase|Death|8
708343|NCT00069095|2293584|P5|Primary Treatment Phase|Death|8
708344|NCT00069095|2293585|P4|Primary Treatment Phase|Death|5
708345|NCT00069095|2293586|P3|Primary Treatment Phase|Death|2
708346|NCT00069095|2293587|P2|Primary Treatment Phase|Death|8
708347|NCT00069095|2293588|P1|Primary Treatment Phase|Death|14
708348|NCT00069095|2293583|P6|Primary Treatment Phase|Adverse Event|101
708349|NCT00069095|2293584|P5|Primary Treatment Phase|Adverse Event|109
708350|NCT00069095|2293585|P4|Primary Treatment Phase|Adverse Event|72
708351|NCT00069095|2293586|P3|Primary Treatment Phase|Adverse Event|71
708352|NCT00069095|2293587|P2|Primary Treatment Phase|Adverse Event|92
708353|NCT00069095|2293588|P1|Primary Treatment Phase|Adverse Event|99
708354|NCT00069095|2293583|P6|Primary Treatment Phase|Admin/Other|42
708355|NCT00069095|2293584|P5|Primary Treatment Phase|Admin/Other|48
708356|NCT00069095|2293585|P4|Primary Treatment Phase|Admin/Other|45
708357|NCT00069095|2293586|P3|Primary Treatment Phase|Admin/Other|31
708358|NCT00069095|2293587|P2|Primary Treatment Phase|Admin/Other|38
708359|NCT00069095|2293588|P1|Primary Treatment Phase|Admin/Other|29
708360|NCT00069095|2293583|P6|Primary Treatment Phase|Ongoing|4
708361|NCT00069095|2293584|P5|Primary Treatment Phase|Ongoing|7
708362|NCT00069095|2293585|P4|Primary Treatment Phase|Ongoing|7
708363|NCT00069095|2293586|P3|Primary Treatment Phase|Ongoing|5
708364|NCT00069095|2293587|P2|Primary Treatment Phase|Ongoing|0
708365|NCT00069095|2293588|P1|Primary Treatment Phase|Ongoing|0
708366|NCT00069108|2293642|P2|Overall Study|Refused treatment|10
708367|NCT00069108|2293643|P1|Overall Study|Refused treatment|5
708368|NCT00069108|2293642|P2|Overall Study|Violation criteria|4
708369|NCT00069108|2293643|P1|Overall Study|Violation criteria|1
708370|NCT00069108|2293642|P2|Overall Study|Insufficient therapy|144
708371|NCT00069108|2293643|P1|Overall Study|Insufficient therapy|117
708372|NCT00069108|2293642|P2|Overall Study|Administration|4
708373|NCT00069108|2293643|P1|Overall Study|Administration|15
708374|NCT00069108|2293642|P2|Overall Study|Death|6
708375|NCT00069108|2293643|P1|Overall Study|Death|6
708376|NCT00069108|2293642|P2|Overall Study|Adverse Event|42
708377|NCT00069108|2293643|P1|Overall Study|Adverse Event|64
708378|NCT00069108|2293642|P2|Overall Study|Withdrawal by Subject|9
708379|NCT00069108|2293643|P1|Overall Study|Withdrawal by Subject|5
708380|NCT00069121|2293671|P2|Overall Study|Lost to Follow-up|57
708381|NCT00069121|2293672|P1|Overall Study|Lost to Follow-up|57
708382|NCT00069121|2293671|P2|Overall Study|Withdrawal by Subject|22
708383|NCT00069121|2293672|P1|Overall Study|Withdrawal by Subject|20
708384|NCT00069121|2293671|P2|Overall Study|Death|197
708385|NCT00069121|2293672|P1|Overall Study|Death|225
889842|NCT01183260|2824743|P2|Overall Study|Withdrawal by Subject|1
889843|NCT01183260|2824744|P1|Overall Study|Withdrawal by Subject|1
889844|NCT01183260|2824743|P2|Overall Study|Intraop screen failure|0
889845|NCT01183260|2824744|P1|Overall Study|Intraop screen failure|2
889846|NCT01181895|2824755|P3|Overall Study|Withdrawal by Subject|5
889847|NCT01181895|2824756|P2|Overall Study|Withdrawal by Subject|0
889848|NCT01181895|2824757|P1|Overall Study|Withdrawal by Subject|3
889849|NCT01181895|2824755|P3|Overall Study|Investigator Discretion|1
889850|NCT01181895|2824756|P2|Overall Study|Investigator Discretion|2
708395|NCT00069264|2293715|P1|Overall Study|Discon Therapy|3
708396|NCT00069264|2293715|P1|Overall Study|Withdrawal by Subject|3
708397|NCT00069264|2293715|P1|Overall Study|Progressive Disease|23
708398|NCT00069264|2293715|P1|Overall Study|Adverse Event|3
708399|NCT00069277|2293719|P1|Overall Study|Physician Decision|2
708400|NCT00069277|2293719|P1|Overall Study|Progressive Disease|15
708401|NCT00069277|2293719|P1|Overall Study|Withdrawal by Subject|1
708402|NCT00069277|2293719|P1|Overall Study|Adverse Event|3
708403|NCT00075881|2293747|P1|Overall Study|never start protocol therapy|1
708404|NCT00075881|2293747|P1|Overall Study|Ineligible|1
708405|NCT00075881|2293747|P1|Overall Study|missing data|2
708406|NCT00075881|2293747|P1|Overall Study|other|4
708407|NCT00075881|2293747|P1|Overall Study|other complicating disease|3
708408|NCT00075881|2293747|P1|Overall Study|Protocol Violation|4
708409|NCT00075881|2293747|P1|Overall Study|Withdrawal by Subject|2
708410|NCT00075881|2293747|P1|Overall Study|Death|1
708411|NCT00075881|2293747|P1|Overall Study|Adverse Event|7
708412|NCT00075881|2293747|P1|Overall Study|Lack of Efficacy|18
708413|NCT00075946|2293758|P5|Overall Study|Other|0
708414|NCT00075946|2293759|P4|Overall Study|Other|2
708415|NCT00075946|2293760|P3|Overall Study|Other|0
708416|NCT00075946|2293761|P2|Overall Study|Other|13
708417|NCT00075946|2293762|P1|Overall Study|Other|5
708418|NCT00075946|2293758|P5|Overall Study|Time to progression less than 6 months|0
708419|NCT00075946|2293759|P4|Overall Study|Time to progression less than 6 months|3
708420|NCT00075946|2293760|P3|Overall Study|Time to progression less than 6 months|8
708421|NCT00075946|2293761|P2|Overall Study|Time to progression less than 6 months|30
708422|NCT00075946|2293762|P1|Overall Study|Time to progression less than 6 months|15
708423|NCT00075946|2293758|P5|Overall Study|No response to retreatment|0
708424|NCT00075946|2293759|P4|Overall Study|No response to retreatment|0
708425|NCT00075946|2293760|P3|Overall Study|No response to retreatment|2
708426|NCT00075946|2293761|P2|Overall Study|No response to retreatment|0
708427|NCT00075946|2293762|P1|Overall Study|No response to retreatment|23
708428|NCT00075946|2293758|P5|Overall Study|Other complicating disease|0
708429|NCT00075946|2293759|P4|Overall Study|Other complicating disease|4
708430|NCT00075946|2293760|P3|Overall Study|Other complicating disease|1
708431|NCT00075946|2293761|P2|Overall Study|Other complicating disease|13
708432|NCT00075946|2293762|P1|Overall Study|Other complicating disease|7
708433|NCT00075946|2293758|P5|Overall Study|Alternative therapy|0
708434|NCT00075946|2293759|P4|Overall Study|Alternative therapy|0
708435|NCT00075946|2293760|P3|Overall Study|Alternative therapy|5
889851|NCT01181895|2824757|P1|Overall Study|Investigator Discretion|1
708436|NCT00075946|2293761|P2|Overall Study|Alternative therapy|2
708437|NCT00075946|2293762|P1|Overall Study|Alternative therapy|16
708438|NCT00075946|2293758|P5|Overall Study|Withdrawal by Subject|0
708439|NCT00075946|2293759|P4|Overall Study|Withdrawal by Subject|9
708440|NCT00075946|2293760|P3|Overall Study|Withdrawal by Subject|4
708441|NCT00075946|2293761|P2|Overall Study|Withdrawal by Subject|58
708442|NCT00075946|2293762|P1|Overall Study|Withdrawal by Subject|23
708443|NCT00075946|2293758|P5|Overall Study|Death|0
708444|NCT00075946|2293759|P4|Overall Study|Death|0
708445|NCT00075946|2293760|P3|Overall Study|Death|0
708446|NCT00075946|2293761|P2|Overall Study|Death|1
708447|NCT00075946|2293762|P1|Overall Study|Death|0
708448|NCT00075946|2293758|P5|Overall Study|Adverse Event|0
708449|NCT00075946|2293759|P4|Overall Study|Adverse Event|2
708450|NCT00075946|2293760|P3|Overall Study|Adverse Event|0
708451|NCT00075946|2293761|P2|Overall Study|Adverse Event|10
708452|NCT00075946|2293762|P1|Overall Study|Adverse Event|2
708453|NCT00075946|2293758|P5|Overall Study|Still on treatment at time of analysis|0
708454|NCT00075946|2293759|P4|Overall Study|Still on treatment at time of analysis|9
708455|NCT00075946|2293760|P3|Overall Study|Still on treatment at time of analysis|3
708456|NCT00075946|2293761|P2|Overall Study|Still on treatment at time of analysis|19
708457|NCT00075946|2293762|P1|Overall Study|Still on treatment at time of analysis|52
708458|NCT00075946|2293758|P5|Overall Study|Incorrectly randomized (no response)|0
708459|NCT00075946|2293759|P4|Overall Study|Incorrectly randomized (no response)|1
708460|NCT00075946|2293760|P3|Overall Study|Incorrectly randomized (no response)|5
708461|NCT00075946|2293761|P2|Overall Study|Incorrectly randomized (no response)|5
708462|NCT00075946|2293762|P1|Overall Study|Incorrectly randomized (no response)|5
708463|NCT00075946|2293758|P5|Overall Study|Did not achieve response after induction|182
708464|NCT00075946|2293759|P4|Overall Study|Did not achieve response after induction|0
708465|NCT00075946|2293760|P3|Overall Study|Did not achieve response after induction|0
708466|NCT00075946|2293761|P2|Overall Study|Did not achieve response after induction|0
708467|NCT00075946|2293762|P1|Overall Study|Did not achieve response after induction|0
708468|NCT00075946|2293758|P5|Overall Study|Path ineligible: undetermined histology|6
708469|NCT00075946|2293759|P4|Overall Study|Path ineligible: undetermined histology|0
708470|NCT00075946|2293760|P3|Overall Study|Path ineligible: undetermined histology|0
708471|NCT00075946|2293761|P2|Overall Study|Path ineligible: undetermined histology|0
708472|NCT00075946|2293762|P1|Overall Study|Path ineligible: undetermined histology|0
708473|NCT00076011|2293777|P1|Overall Study|Ongoing|1
708474|NCT00076011|2293777|P1|Overall Study|Unspecified|11
708475|NCT00076011|2293777|P1|Overall Study|Study terminated by sponsor|3
708476|NCT00076011|2293777|P1|Overall Study|Withdrawal by Subject|1
708477|NCT00076011|2293777|P1|Overall Study|Lack of Efficacy|25
708478|NCT00076011|2293777|P1|Overall Study|Adverse Event|10
708479|NCT00076011|2293777|P1|Overall Study|Death|1
708480|NCT00076024|2293788|P4|Phase 2, Open-label|Unspecified|2
708481|NCT00076024|2293789|P3|Phase 2, Open-label|Unspecified|0
708482|NCT00076024|2293790|P2|Phase 2, Open-label|Unspecified|0
708483|NCT00076024|2293791|P1|Phase 2, Open-label|Unspecified|0
708484|NCT00076024|2293788|P4|Phase 2, Open-label|Withdrawal by Subject|1
708485|NCT00076024|2293789|P3|Phase 2, Open-label|Withdrawal by Subject|0
708486|NCT00076024|2293790|P2|Phase 2, Open-label|Withdrawal by Subject|0
708487|NCT00076024|2293791|P1|Phase 2, Open-label|Withdrawal by Subject|0
708488|NCT00076024|2293788|P4|Phase 2, Open-label|Lack of Efficacy|11
708489|NCT00076024|2293789|P3|Phase 2, Open-label|Lack of Efficacy|0
708490|NCT00076024|2293790|P2|Phase 2, Open-label|Lack of Efficacy|0
708491|NCT00076024|2293791|P1|Phase 2, Open-label|Lack of Efficacy|0
708492|NCT00076024|2293788|P4|Phase 2, Open-label|Adverse Event|2
708493|NCT00076024|2293789|P3|Phase 2, Open-label|Adverse Event|0
708494|NCT00076024|2293790|P2|Phase 2, Open-label|Adverse Event|0
708495|NCT00076024|2293791|P1|Phase 2, Open-label|Adverse Event|0
708496|NCT00076024|2293788|P4|Phase 2, Double-blind|Randomized but not treated|0
708497|NCT00076024|2293789|P3|Phase 2, Double-blind|Randomized but not treated|0
708498|NCT00076024|2293790|P2|Phase 2, Double-blind|Randomized but not treated|1
708499|NCT00076024|2293791|P1|Phase 2, Double-blind|Randomized but not treated|0
708500|NCT00076024|2293788|P4|Phase 2, Double-blind|Un-specified|0
708501|NCT00076024|2293789|P3|Phase 2, Double-blind|Un-specified|6
708502|NCT00076024|2293790|P2|Phase 2, Double-blind|Un-specified|14
708503|NCT00076024|2293791|P1|Phase 2, Double-blind|Un-specified|0
708504|NCT00076024|2293788|P4|Phase 2, Double-blind|Adverse Event|0
708505|NCT00076024|2293789|P3|Phase 2, Double-blind|Adverse Event|6
708506|NCT00076024|2293790|P2|Phase 2, Double-blind|Adverse Event|25
708507|NCT00076024|2293791|P1|Phase 2, Double-blind|Adverse Event|0
708508|NCT00076024|2293788|P4|Phase 2, Double-blind|Withdrawal by Subject|0
708509|NCT00076024|2293789|P3|Phase 2, Double-blind|Withdrawal by Subject|4
708510|NCT00076024|2293790|P2|Phase 2, Double-blind|Withdrawal by Subject|13
708511|NCT00076024|2293791|P1|Phase 2, Double-blind|Withdrawal by Subject|0
708512|NCT00076024|2293788|P4|Phase 2, Double-blind|Lack of Efficacy|0
708513|NCT00076024|2293789|P3|Phase 2, Double-blind|Lack of Efficacy|40
708514|NCT00076024|2293790|P2|Phase 2, Double-blind|Lack of Efficacy|59
708515|NCT00076024|2293791|P1|Phase 2, Double-blind|Lack of Efficacy|0
708516|NCT00076024|2293788|P4|Phase 1, Lead-in|Clinical progression|0
708517|NCT00076024|2293789|P3|Phase 1, Lead-in|Clinical progression|0
708518|NCT00076024|2293790|P2|Phase 1, Lead-in|Clinical progression|0
708519|NCT00076024|2293791|P1|Phase 1, Lead-in|Clinical progression|1
708520|NCT00076024|2293788|P4|Phase 1, Lead-in|Adverse Event|0
708521|NCT00076024|2293789|P3|Phase 1, Lead-in|Adverse Event|0
708522|NCT00076024|2293790|P2|Phase 1, Lead-in|Adverse Event|0
708523|NCT00076024|2293791|P1|Phase 1, Lead-in|Adverse Event|1
708524|NCT00076024|2293788|P4|Phase 1, Lead-in|Lack of Efficacy|0
708525|NCT00076024|2293789|P3|Phase 1, Lead-in|Lack of Efficacy|0
708526|NCT00076024|2293790|P2|Phase 1, Lead-in|Lack of Efficacy|0
708527|NCT00076024|2293791|P1|Phase 1, Lead-in|Lack of Efficacy|4
708528|NCT00078312|2293864|P1|Overall Study|Miscellaneous|33
708529|NCT00078312|2293864|P1|Overall Study|Withdrawal by Subject|33
708530|NCT00078312|2293864|P1|Overall Study|Protocol Violation|3
708531|NCT00078312|2293864|P1|Overall Study|Physician Decision|9
708532|NCT00078312|2293864|P1|Overall Study|Lost to Follow-up|41
708533|NCT00078312|2293864|P1|Overall Study|Lack of Efficacy|15
708534|NCT00078312|2293864|P1|Overall Study|Adverse Event|43
708535|NCT00078325|2293871|P3|Overall Study|Miscellaneous|1
708536|NCT00078325|2293872|P2|Overall Study|Miscellaneous|1
708537|NCT00078325|2293873|P1|Overall Study|Miscellaneous|1
708538|NCT00078325|2293871|P3|Overall Study|Physician Decision|1
708539|NCT00078325|2293872|P2|Overall Study|Physician Decision|0
708540|NCT00078325|2293873|P1|Overall Study|Physician Decision|2
708541|NCT00078325|2293871|P3|Overall Study|Lost to Follow-up|1
708542|NCT00078325|2293872|P2|Overall Study|Lost to Follow-up|1
708543|NCT00078325|2293873|P1|Overall Study|Lost to Follow-up|0
708544|NCT00078325|2293871|P3|Overall Study|Withdrawal by Subject|3
708545|NCT00078325|2293872|P2|Overall Study|Withdrawal by Subject|5
708546|NCT00078325|2293873|P1|Overall Study|Withdrawal by Subject|1
708547|NCT00078325|2293871|P3|Overall Study|Protocol Violation|0
708548|NCT00078325|2293872|P2|Overall Study|Protocol Violation|2
708549|NCT00078325|2293873|P1|Overall Study|Protocol Violation|2
708550|NCT00078325|2293871|P3|Overall Study|Adverse Event|5
708551|NCT00078325|2293872|P2|Overall Study|Adverse Event|10
708552|NCT00078325|2293873|P1|Overall Study|Adverse Event|15
708553|NCT00078377|2293887|P3|Overall Study|Miscellaneous|1
708554|NCT00078377|2293888|P2|Overall Study|Miscellaneous|6
708555|NCT00078377|2293889|P1|Overall Study|Miscellaneous|2
708556|NCT00078377|2293887|P3|Overall Study|Withdrawal by Subject|4
708557|NCT00078377|2293888|P2|Overall Study|Withdrawal by Subject|4
708558|NCT00078377|2293889|P1|Overall Study|Withdrawal by Subject|3
708559|NCT00078377|2293887|P3|Overall Study|Physician Decision|0
708560|NCT00078377|2293888|P2|Overall Study|Physician Decision|0
708561|NCT00078377|2293889|P1|Overall Study|Physician Decision|2
708562|NCT00078377|2293887|P3|Overall Study|Lost to Follow-up|1
708563|NCT00078377|2293888|P2|Overall Study|Lost to Follow-up|1
708564|NCT00078377|2293889|P1|Overall Study|Lost to Follow-up|0
708565|NCT00078377|2293887|P3|Overall Study|Lack of Efficacy|2
708566|NCT00078377|2293888|P2|Overall Study|Lack of Efficacy|0
708567|NCT00078377|2293889|P1|Overall Study|Lack of Efficacy|2
708568|NCT00078377|2293887|P3|Overall Study|Adverse Event|1
708569|NCT00078377|2293888|P2|Overall Study|Adverse Event|5
708570|NCT00078377|2293889|P1|Overall Study|Adverse Event|2
708571|NCT00078767|2294021|P2|Overall Study|Withdrawal by Subject|1
708572|NCT00078767|2294022|P1|Overall Study|Withdrawal by Subject|1
708573|NCT00078949|2294040|P4|Maintenance|No treated|3
708574|NCT00078949|2294041|P3|Maintenance|No treated|3
708575|NCT00078949|2294042|P2|Maintenance|No treated|0
708576|NCT00078949|2294043|P1|Maintenance|No treated|0
708577|NCT00078949|2294040|P4|Salvage|No treated|0
708578|NCT00078949|2294041|P3|Salvage|No treated|0
708579|NCT00078949|2294042|P2|Salvage|No treated|5
708580|NCT00078949|2294043|P1|Salvage|No treated|4
708581|NCT00079040|2294068|P1|Overall Study|Ineligible|1
708582|NCT00079040|2294068|P1|Overall Study|Withdrew before treatment|1
708583|NCT00079183|2294074|P1|Overall Study|Specimen collection non-compliance|1
708584|NCT00079183|2294074|P1|Overall Study|Study medication non-compliance|2
708585|NCT00079183|2294074|P1|Overall Study|Withdrawal by Subject|4
708586|NCT00079274|2294096|P7|Overall Study|Not Specified|0
708587|NCT00079274|2294097|P6|Overall Study|Not Specified|2
708588|NCT00079274|2294098|P5|Overall Study|Not Specified|1
708589|NCT00079274|2294099|P4|Overall Study|Not Specified|55
708590|NCT00079274|2294100|P3|Overall Study|Not Specified|5
708591|NCT00079274|2294101|P2|Overall Study|Not Specified|7
708592|NCT00079274|2294102|P1|Overall Study|Not Specified|43
708593|NCT00079274|2294096|P7|Overall Study|Cytogenetic resistance|0
708594|NCT00079274|2294097|P6|Overall Study|Cytogenetic resistance|0
708595|NCT00079274|2294098|P5|Overall Study|Cytogenetic resistance|0
708596|NCT00079274|2294099|P4|Overall Study|Cytogenetic resistance|2
708597|NCT00079274|2294100|P3|Overall Study|Cytogenetic resistance|0
708598|NCT00079274|2294101|P2|Overall Study|Cytogenetic resistance|0
708599|NCT00079274|2294102|P1|Overall Study|Cytogenetic resistance|0
708600|NCT00079274|2294096|P7|Overall Study|Death|0
708601|NCT00079274|2294097|P6|Overall Study|Death|0
708602|NCT00079274|2294098|P5|Overall Study|Death|0
708603|NCT00079274|2294099|P4|Overall Study|Death|15
708604|NCT00079274|2294100|P3|Overall Study|Death|1
708605|NCT00079274|2294101|P2|Overall Study|Death|0
708606|NCT00079274|2294102|P1|Overall Study|Death|4
708607|NCT00079274|2294096|P7|Overall Study|Other Medical Problems|0
708608|NCT00079274|2294097|P6|Overall Study|Other Medical Problems|0
708609|NCT00079274|2294098|P5|Overall Study|Other Medical Problems|0
708610|NCT00079274|2294099|P4|Overall Study|Other Medical Problems|7
708611|NCT00079274|2294100|P3|Overall Study|Other Medical Problems|0
708612|NCT00079274|2294101|P2|Overall Study|Other Medical Problems|1
708613|NCT00079274|2294102|P1|Overall Study|Other Medical Problems|6
708614|NCT00079274|2294096|P7|Overall Study|Alternate Treatment|0
708615|NCT00079274|2294097|P6|Overall Study|Alternate Treatment|0
708616|NCT00079274|2294098|P5|Overall Study|Alternate Treatment|0
708617|NCT00079274|2294099|P4|Overall Study|Alternate Treatment|3
708618|NCT00079274|2294100|P3|Overall Study|Alternate Treatment|0
708619|NCT00079274|2294101|P2|Overall Study|Alternate Treatment|1
708620|NCT00079274|2294102|P1|Overall Study|Alternate Treatment|6
708621|NCT00079274|2294096|P7|Overall Study|Recurrence|0
708622|NCT00079274|2294097|P6|Overall Study|Recurrence|2
708623|NCT00079274|2294098|P5|Overall Study|Recurrence|0
708624|NCT00079274|2294099|P4|Overall Study|Recurrence|15
708625|NCT00079274|2294100|P3|Overall Study|Recurrence|1
708626|NCT00079274|2294101|P2|Overall Study|Recurrence|0
708627|NCT00079274|2294102|P1|Overall Study|Recurrence|21
708628|NCT00079274|2294096|P7|Overall Study|Adverse Event|0
708629|NCT00079274|2294097|P6|Overall Study|Adverse Event|8
708630|NCT00079274|2294098|P5|Overall Study|Adverse Event|7
708631|NCT00079274|2294099|P4|Overall Study|Adverse Event|184
708632|NCT00079274|2294100|P3|Overall Study|Adverse Event|8
708633|NCT00079274|2294101|P2|Overall Study|Adverse Event|8
708634|NCT00079274|2294102|P1|Overall Study|Adverse Event|130
708635|NCT00079274|2294096|P7|Overall Study|Withdrawal by Subject|0
708636|NCT00079274|2294097|P6|Overall Study|Withdrawal by Subject|8
708637|NCT00079274|2294098|P5|Overall Study|Withdrawal by Subject|7
708638|NCT00079274|2294099|P4|Overall Study|Withdrawal by Subject|163
708639|NCT00079274|2294100|P3|Overall Study|Withdrawal by Subject|12
708640|NCT00079274|2294101|P2|Overall Study|Withdrawal by Subject|10
708641|NCT00079274|2294102|P1|Overall Study|Withdrawal by Subject|111
708642|NCT00079339|2294128|P3|Overall Study|Disease progression|2
708643|NCT00079339|2294129|P2|Overall Study|Disease progression|28
708644|NCT00079339|2294130|P1|Overall Study|Disease progression|3
708645|NCT00079339|2294128|P3|Overall Study|Withdrawal by Subject|1
708646|NCT00079339|2294129|P2|Overall Study|Withdrawal by Subject|4
708647|NCT00079339|2294130|P1|Overall Study|Withdrawal by Subject|0
708648|NCT00079339|2294128|P3|Overall Study|Non-compliance|1
708649|NCT00079339|2294129|P2|Overall Study|Non-compliance|0
708650|NCT00079339|2294130|P1|Overall Study|Non-compliance|0
708651|NCT00079339|2294128|P3|Overall Study|Death|0
708652|NCT00079339|2294129|P2|Overall Study|Death|0
708653|NCT00079339|2294130|P1|Overall Study|Death|1
708654|NCT00079339|2294128|P3|Overall Study|Adverse Event|2
708655|NCT00079339|2294129|P2|Overall Study|Adverse Event|7
708656|NCT00079339|2294130|P1|Overall Study|Adverse Event|1
708657|NCT00079391|2294144|P1|Overall Study|Withdrawal by Subject|1
708658|NCT00079417|2294153|P1|Overall Study|ineligible|1
708659|NCT00079417|2294153|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
708660|NCT00079417|2294153|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
708661|NCT00079417|2294153|P1|Overall Study|Physician Decision|5
708662|NCT00079677|2294159|P2|Overall Study|Miscellaneous|0
708663|NCT00079677|2294160|P1|Overall Study|Miscellaneous|2
708664|NCT00079677|2294159|P2|Overall Study|Withdrawal by Subject|3
708665|NCT00079677|2294160|P1|Overall Study|Withdrawal by Subject|5
708666|NCT00079677|2294159|P2|Overall Study|Protocol Violation|3
708667|NCT00079677|2294160|P1|Overall Study|Protocol Violation|2
708668|NCT00079677|2294159|P2|Overall Study|Physician Decision|0
708669|NCT00079677|2294160|P1|Overall Study|Physician Decision|3
708670|NCT00079677|2294159|P2|Overall Study|Lost to Follow-up|2
708671|NCT00079677|2294160|P1|Overall Study|Lost to Follow-up|2
708672|NCT00079677|2294159|P2|Overall Study|Lack of Efficacy|0
708673|NCT00079677|2294160|P1|Overall Study|Lack of Efficacy|1
708674|NCT00079677|2294159|P2|Overall Study|Adverse Event|6
708675|NCT00079677|2294160|P1|Overall Study|Adverse Event|5
708676|NCT00079781|2294171|P3|Follow-up Period|Death|1
708677|NCT00079781|2294172|P2|Follow-up Period|Death|0
708678|NCT00079781|2294173|P1|Follow-up Period|Death|0
708679|NCT00079781|2294171|P3|Follow-up Period|Lost to Follow-up|0
708680|NCT00079781|2294172|P2|Follow-up Period|Lost to Follow-up|0
708681|NCT00079781|2294173|P1|Follow-up Period|Lost to Follow-up|1
708682|NCT00079781|2294171|P3|Follow-up Period|Withdrawal by Subject|1
708683|NCT00079781|2294172|P2|Follow-up Period|Withdrawal by Subject|0
708684|NCT00079781|2294173|P1|Follow-up Period|Withdrawal by Subject|3
708685|NCT00079781|2294171|P3|Pre-implant Period|Did not meet I/E criteria|1
708686|NCT00079781|2294172|P2|Pre-implant Period|Did not meet I/E criteria|1
708687|NCT00079781|2294173|P1|Pre-implant Period|Did not meet I/E criteria|1
708688|NCT00079781|2294171|P3|Pre-implant Period|Withdrawal by Subject|0
708689|NCT00079781|2294172|P2|Pre-implant Period|Withdrawal by Subject|0
708690|NCT00079781|2294173|P1|Pre-implant Period|Withdrawal by Subject|2
708691|NCT00079937|2294182|P2|Overall Study|Administrative problems|11
708692|NCT00079937|2294183|P1|Overall Study|Administrative problems|22
708693|NCT00079937|2294182|P2|Overall Study|Lost to Follow-up|5
708694|NCT00079937|2294183|P1|Overall Study|Lost to Follow-up|12
708695|NCT00079937|2294182|P2|Overall Study|Withdrawal by Subject|7
708696|NCT00079937|2294183|P1|Overall Study|Withdrawal by Subject|21
708697|NCT00079937|2294182|P2|Overall Study|Protocol Violation|6
708698|NCT00079937|2294183|P1|Overall Study|Protocol Violation|8
708699|NCT00079937|2294182|P2|Overall Study|Subject no longer requires study drug|0
708700|NCT00079937|2294183|P1|Overall Study|Subject no longer requires study drug|3
708701|NCT00079937|2294182|P2|Overall Study|Unsatisfactory therapeutic effect|2
708702|NCT00079937|2294183|P1|Overall Study|Unsatisfactory therapeutic effect|1
708703|NCT00079937|2294182|P2|Overall Study|Adverse Event|1
708704|NCT00079937|2294183|P1|Overall Study|Adverse Event|2
708705|NCT00080119|2294203|P4|Overall Study|Lost to Follow-up|14
708706|NCT00080119|2294204|P3|Overall Study|Lost to Follow-up|19
708707|NCT00080119|2294205|P2|Overall Study|Lost to Follow-up|19
708708|NCT00080119|2294206|P1|Overall Study|Lost to Follow-up|16
708709|NCT00080119|2294203|P4|Overall Study|Unwilling to adhere to study requirement|1
708710|NCT00080119|2294204|P3|Overall Study|Unwilling to adhere to study requirement|5
708711|NCT00080119|2294205|P2|Overall Study|Unwilling to adhere to study requirement|2
708712|NCT00080119|2294206|P1|Overall Study|Unwilling to adhere to study requirement|3
708713|NCT00080119|2294203|P4|Overall Study|Consent withdrawn|6
708714|NCT00080119|2294204|P3|Overall Study|Consent withdrawn|4
708715|NCT00080119|2294205|P2|Overall Study|Consent withdrawn|17
708716|NCT00080119|2294206|P1|Overall Study|Consent withdrawn|13
708717|NCT00080119|2294203|P4|Overall Study|Unable to get to clinic|1
708718|NCT00080119|2294204|P3|Overall Study|Unable to get to clinic|7
708719|NCT00080119|2294205|P2|Overall Study|Unable to get to clinic|24
708720|NCT00080119|2294206|P1|Overall Study|Unable to get to clinic|24
708721|NCT00080119|2294203|P4|Overall Study|Discontinued because of study closure|141
708722|NCT00080119|2294204|P3|Overall Study|Discontinued because of study closure|130
708723|NCT00080119|2294205|P2|Overall Study|Discontinued because of study closure|0
708724|NCT00080119|2294206|P1|Overall Study|Discontinued because of study closure|0
708725|NCT00080223|2294238|P1|Overall Study|Physician Decision|1
708726|NCT00080223|2294238|P1|Overall Study|Participant unwilling to continue|2
708727|NCT00080223|2294238|P1|Overall Study|Non-compliance With Study Treatment|7
708728|NCT00080223|2294238|P1|Overall Study|Lung Transplantation|9
708729|NCT00080223|2294238|P1|Overall Study|Withdrawal by Subject|13
708730|NCT00080223|2294238|P1|Overall Study|Death|21
708731|NCT00080223|2294238|P1|Overall Study|Adverse Event|23
708732|NCT00080288|2294248|P2|Overall Study|Miscellaneous|11
708733|NCT00080288|2294249|P1|Overall Study|Miscellaneous|11
708734|NCT00080288|2294248|P2|Overall Study|Withdrawal by Subject|16
708735|NCT00080288|2294249|P1|Overall Study|Withdrawal by Subject|3
708736|NCT00080288|2294248|P2|Overall Study|Physician Decision|2
708737|NCT00080288|2294249|P1|Overall Study|Physician Decision|6
708738|NCT00080288|2294248|P2|Overall Study|Lost to Follow-up|5
708739|NCT00080288|2294249|P1|Overall Study|Lost to Follow-up|3
708740|NCT00080288|2294248|P2|Overall Study|Adverse Event|4
708741|NCT00080288|2294249|P1|Overall Study|Adverse Event|7
708742|NCT00080301|2294259|P2|Overall Study|Still on Treatment as of CSR date|1
708743|NCT00080301|2294260|P1|Overall Study|Still on Treatment as of CSR date|0
708744|NCT00080301|2294259|P2|Overall Study|Randomized but Never Treated|10
708745|NCT00080301|2294260|P1|Overall Study|Randomized but Never Treated|5
708746|NCT00080483|2294291|P2|Overall Study|Physician Decision|1
708747|NCT00080483|2294292|P1|Overall Study|Physician Decision|1
708748|NCT00080483|2294291|P2|Overall Study|Lost to Follow-up|1
708749|NCT00080483|2294292|P1|Overall Study|Lost to Follow-up|1
708750|NCT00073008|2294314|P2|Overall Study|"Other selected on Case Report Form"|5
708751|NCT00073008|2294315|P1|Overall Study|"Other selected on Case Report Form"|7
708752|NCT00073008|2294314|P2|Overall Study|Death|47
708753|NCT00073008|2294315|P1|Overall Study|Death|46
708754|NCT00073008|2294314|P2|Overall Study|Lost to Follow-up|3
708755|NCT00073008|2294315|P1|Overall Study|Lost to Follow-up|1
708756|NCT00073008|2294314|P2|Overall Study|Withdrawal by Subject|2
708757|NCT00073008|2294315|P1|Overall Study|Withdrawal by Subject|2
708758|NCT00073008|2294314|P2|Overall Study|Missing|6
708759|NCT00073008|2294315|P1|Overall Study|Missing|6
708760|NCT00073021|2294347|P2|Overall Study|Lack of Efficacy|5
708761|NCT00073021|2294348|P1|Overall Study|Lack of Efficacy|11
708762|NCT00073021|2294347|P2|Overall Study|Physician Decision|1
708763|NCT00073021|2294348|P1|Overall Study|Physician Decision|3
708764|NCT00073021|2294347|P2|Overall Study|Withdrawal by Subject|5
708765|NCT00073021|2294348|P1|Overall Study|Withdrawal by Subject|6
708766|NCT00073021|2294347|P2|Overall Study|Adverse Event|4
708767|NCT00073021|2294348|P1|Overall Study|Adverse Event|4
708768|NCT00073021|2294347|P2|Overall Study|Protocol Violation|1
708769|NCT00073021|2294348|P1|Overall Study|Protocol Violation|2
708770|NCT00080899|2294387|P1|Overall Study|Adverse Event|1
708771|NCT00080938|2294401|P1|Overall Study|Ineligible|4
708772|NCT00080938|2294401|P1|Overall Study|Not started protocol therapy|1
708773|NCT00080938|2294401|P1|Overall Study|other disease|1
708774|NCT00080938|2294401|P1|Overall Study|Lack of Efficacy|7
708775|NCT00080938|2294401|P1|Overall Study|Death|2
708776|NCT00080938|2294401|P1|Overall Study|Withdrawal by Subject|6
708777|NCT00080938|2294401|P1|Overall Study|Adverse Event|3
708778|NCT00081497|2294410|P2|Overall Study|Non-compliance|1
708779|NCT00081497|2294411|P1|Overall Study|Non-compliance|0
708780|NCT00081497|2294410|P2|Overall Study|Withdrawal by Subject|0
708781|NCT00081497|2294411|P1|Overall Study|Withdrawal by Subject|1
708782|NCT00081497|2294410|P2|Overall Study|Death|1
708783|NCT00081497|2294411|P1|Overall Study|Death|0
708784|NCT00081497|2294410|P2|Overall Study|Adverse Event|0
708785|NCT00081497|2294411|P1|Overall Study|Adverse Event|2
708786|NCT00081653|2294428|P2|Overall Study|Loss of bone mass|2
708787|NCT00081653|2294429|P1|Overall Study|Loss of bone mass|0
708788|NCT00081653|2294428|P2|Overall Study|Participant leaving country|0
708789|NCT00081653|2294429|P1|Overall Study|Participant leaving country|1
708790|NCT00081653|2294428|P2|Overall Study|Bone loss|0
708791|NCT00081653|2294429|P1|Overall Study|Bone loss|2
708792|NCT00081653|2294428|P2|Overall Study|Low bone mineral density|0
708793|NCT00081653|2294429|P1|Overall Study|Low bone mineral density|1
708794|NCT00081653|2294428|P2|Overall Study|Refused Treatment|14
708795|NCT00081653|2294429|P1|Overall Study|Refused Treatment|18
708796|NCT00081653|2294428|P2|Overall Study|Lost to Follow-up|4
708797|NCT00081653|2294429|P1|Overall Study|Lost to Follow-up|2
708798|NCT00081653|2294428|P2|Overall Study|Adverse Event|17
708799|NCT00081653|2294429|P1|Overall Study|Adverse Event|23
708800|NCT00081731|2294447|P2|Overall Study|scientific integrity issue|8
708801|NCT00081731|2294448|P1|Overall Study|scientific integrity issue|8
708802|NCT00081770|2294469|P3|Overall Study|Not Specified|8
708803|NCT00081770|2294470|P2|Overall Study|Not Specified|7
708804|NCT00081770|2294471|P1|Overall Study|Not Specified|2
708805|NCT00081770|2294469|P3|Overall Study|Administrative|1
708806|NCT00081770|2294470|P2|Overall Study|Administrative|0
708807|NCT00081770|2294471|P1|Overall Study|Administrative|1
708808|NCT00081770|2294469|P3|Overall Study|Did not meet protocol eligibility|3
708809|NCT00081770|2294470|P2|Overall Study|Did not meet protocol eligibility|0
708810|NCT00081770|2294471|P1|Overall Study|Did not meet protocol eligibility|2
708811|NCT00081770|2294469|P3|Overall Study|Withdrawal by Subject|42
708812|NCT00081770|2294470|P2|Overall Study|Withdrawal by Subject|40
708813|NCT00081770|2294471|P1|Overall Study|Withdrawal by Subject|45
708814|NCT00081770|2294469|P3|Overall Study|Protocol Violation|10
708815|NCT00081770|2294470|P2|Overall Study|Protocol Violation|10
708816|NCT00081770|2294471|P1|Overall Study|Protocol Violation|15
708817|NCT00081770|2294469|P3|Overall Study|Lost to Follow-up|45
708818|NCT00081770|2294470|P2|Overall Study|Lost to Follow-up|34
708819|NCT00081770|2294471|P1|Overall Study|Lost to Follow-up|45
708820|NCT00081770|2294469|P3|Overall Study|Lack of Efficacy|211
708821|NCT00081770|2294470|P2|Overall Study|Lack of Efficacy|357
708822|NCT00081770|2294471|P1|Overall Study|Lack of Efficacy|262
708823|NCT00081770|2294469|P3|Overall Study|Adverse Event|136
708824|NCT00081770|2294470|P2|Overall Study|Adverse Event|98
708825|NCT00081770|2294471|P1|Overall Study|Adverse Event|130
708826|NCT00082173|2294515|P2|Overall Study|Culture negative or resistant at baselin|6
708827|NCT00082173|2294516|P1|Overall Study|Culture negative or resistant at baselin|5
708828|NCT00082173|2294515|P2|Overall Study|Adverse Event|0
708829|NCT00082173|2294516|P1|Overall Study|Adverse Event|1
708830|NCT00082173|2294515|P2|Overall Study|Lost to Follow-up|0
708831|NCT00082173|2294516|P1|Overall Study|Lost to Follow-up|1
708832|NCT00082173|2294515|P2|Overall Study|Withdrawal by Subject|5
708833|NCT00082173|2294516|P1|Overall Study|Withdrawal by Subject|3
708834|NCT00082355|2294551|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
708835|NCT00082355|2294551|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
708836|NCT00082355|2294551|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
708837|NCT00082368|2294556|P1|Overall Study|Not treated-pt had poor IV access|1
708838|NCT00082381|2294563|P2|Overall Study|Loss of Glucose Control|0
708839|NCT00082381|2294564|P1|Overall Study|Loss of Glucose Control|4
708840|NCT00082381|2294563|P2|Overall Study|Protocol Violation|11
708841|NCT00082381|2294564|P1|Overall Study|Protocol Violation|10
708842|NCT00082381|2294563|P2|Overall Study|Physician Decision|2
708843|NCT00082381|2294564|P1|Overall Study|Physician Decision|1
708844|NCT00082381|2294563|P2|Overall Study|Patient Decision|4
708845|NCT00082381|2294564|P1|Overall Study|Patient Decision|8
708846|NCT00082381|2294563|P2|Overall Study|Lost to Follow-up|7
708847|NCT00082381|2294564|P1|Overall Study|Lost to Follow-up|5
708848|NCT00082381|2294563|P2|Overall Study|Adverse Event|2
708849|NCT00082381|2294564|P1|Overall Study|Adverse Event|27
708850|NCT00082407|2294584|P2|Overall Study|Lost to Follow-up|3
708851|NCT00082407|2294585|P1|Overall Study|Lost to Follow-up|0
708852|NCT00082407|2294584|P2|Overall Study|Death|1
708853|NCT00082407|2294585|P1|Overall Study|Death|2
708854|NCT00082407|2294584|P2|Overall Study|Loss of Glucose Control|2
708855|NCT00082407|2294585|P1|Overall Study|Loss of Glucose Control|2
708856|NCT00082407|2294584|P2|Overall Study|Physician Decision|3
708857|NCT00082407|2294585|P1|Overall Study|Physician Decision|5
708858|NCT00082407|2294584|P2|Overall Study|Patient Decision|6
708859|NCT00082407|2294585|P1|Overall Study|Patient Decision|13
708860|NCT00082407|2294584|P2|Overall Study|Protocol Violation|12
708861|NCT00082407|2294585|P1|Overall Study|Protocol Violation|14
708862|NCT00082407|2294584|P2|Overall Study|Adverse Event|0
708863|NCT00082407|2294585|P1|Overall Study|Adverse Event|20
708864|NCT00082433|2294605|P2|Overall Study|Impending surgery|1
708865|NCT00082433|2294606|P1|Overall Study|Impending surgery|0
708866|NCT00082433|2294605|P2|Overall Study|New primary cancer|0
708867|NCT00082433|2294606|P1|Overall Study|New primary cancer|1
708868|NCT00082433|2294605|P2|Overall Study|Noncompliance|1
708869|NCT00082433|2294606|P1|Overall Study|Noncompliance|2
708870|NCT00082433|2294605|P2|Overall Study|Ineligible|1
708871|NCT00082433|2294606|P1|Overall Study|Ineligible|2
708872|NCT00082433|2294605|P2|Overall Study|Not Treated|11
708873|NCT00082433|2294606|P1|Overall Study|Not Treated|12
708874|NCT00082433|2294605|P2|Overall Study|Still On Treatment|1
708875|NCT00082433|2294606|P1|Overall Study|Still On Treatment|2
708876|NCT00082433|2294605|P2|Overall Study|Withdrawal by Subject|30
708877|NCT00082433|2294606|P1|Overall Study|Withdrawal by Subject|55
708878|NCT00082433|2294605|P2|Overall Study|Study Drug Toxicity|66
708879|NCT00082433|2294606|P1|Overall Study|Study Drug Toxicity|179
708880|NCT00082433|2294605|P2|Overall Study|Lost to Follow-up|2
708881|NCT00082433|2294606|P1|Overall Study|Lost to Follow-up|1
708882|NCT00082433|2294605|P2|Overall Study|Physician Decision|61
708883|NCT00082433|2294606|P1|Overall Study|Physician Decision|50
708884|NCT00082433|2294605|P2|Overall Study|Disease Progression/Relapse|388
708885|NCT00082433|2294606|P1|Overall Study|Disease Progression/Relapse|270
708886|NCT00082433|2294605|P2|Overall Study|Death|18
708887|NCT00082433|2294606|P1|Overall Study|Death|8
708888|NCT00082433|2294605|P2|Overall Study|Adverse Event|17
708889|NCT00082433|2294606|P1|Overall Study|Adverse Event|12
708890|NCT00082758|2294627|P3|Overall Study|Protocol Violation|0
708891|NCT00082758|2294628|P2|Overall Study|Protocol Violation|1
708892|NCT00082758|2294629|P1|Overall Study|Protocol Violation|0
708893|NCT00082758|2294627|P3|Overall Study|Withdrawal by Subject|0
708894|NCT00082758|2294628|P2|Overall Study|Withdrawal by Subject|0
708895|NCT00082758|2294629|P1|Overall Study|Withdrawal by Subject|3
708896|NCT00082758|2294627|P3|Overall Study|Physician Decision|0
708897|NCT00082758|2294628|P2|Overall Study|Physician Decision|1
708898|NCT00082758|2294629|P1|Overall Study|Physician Decision|0
708899|NCT00082758|2294627|P3|Overall Study|Lack of Efficacy|0
708900|NCT00082758|2294628|P2|Overall Study|Lack of Efficacy|13
708901|NCT00082758|2294629|P1|Overall Study|Lack of Efficacy|12
708902|NCT00082758|2294627|P3|Overall Study|Adverse Event|0
708903|NCT00082758|2294628|P2|Overall Study|Adverse Event|2
708904|NCT00082758|2294629|P1|Overall Study|Adverse Event|0
708905|NCT00082810|2294637|P1|Overall Study|Withdrawal by Subject|4
708906|NCT00082810|2294637|P1|Overall Study|Progressive disease|24
708907|NCT00082810|2294637|P1|Overall Study|Adverse Event|3
708914|NCT00083226|2294681|P1|Overall Study|ineligible or not receiving treatment|4
708915|NCT00083226|2294681|P1|Overall Study|Other|2
708916|NCT00083226|2294681|P1|Overall Study|Withdrawal by Subject|4
708917|NCT00083226|2294681|P1|Overall Study|Death|4
708918|NCT00083226|2294681|P1|Overall Study|Adverse Event|9
708919|NCT00083226|2294681|P1|Overall Study|Lack of Efficacy|19
708920|NCT00083616|2294700|P1|Overall Study|Other|6
708921|NCT00083616|2294700|P1|Overall Study|Non-compliance|1
708922|NCT00083616|2294700|P1|Overall Study|Ineligibility determined|2
708923|NCT00083616|2294700|P1|Overall Study|Withdrawal by Subject|3
708924|NCT00083616|2294700|P1|Overall Study|Physician Decision|2
708925|NCT00083616|2294700|P1|Overall Study|Lost to Follow-up|1
708926|NCT00083616|2294700|P1|Overall Study|Disease Progression|16
708927|NCT00083759|2294724|P2|Overall Study|Other|13
708928|NCT00083759|2294725|P1|Overall Study|Other|14
708929|NCT00083759|2294724|P2|Overall Study|Sponsor's Discretion|29
708930|NCT00083759|2294725|P1|Overall Study|Sponsor's Discretion|28
708931|NCT00083759|2294724|P2|Overall Study|Non-Compliance|0
708932|NCT00083759|2294725|P1|Overall Study|Non-Compliance|1
708933|NCT00083759|2294724|P2|Overall Study|Subject Withdrew Consent|2
708934|NCT00083759|2294725|P1|Overall Study|Subject Withdrew Consent|2
708935|NCT00083759|2294724|P2|Overall Study|Inadequate Therapeutic Response|35
708936|NCT00083759|2294725|P1|Overall Study|Inadequate Therapeutic Response|32
708937|NCT00083759|2294724|P2|Overall Study|Death|1
708938|NCT00083759|2294725|P1|Overall Study|Death|1
708939|NCT00083759|2294724|P2|Overall Study|Lost to Follow-up|0
708940|NCT00083759|2294725|P1|Overall Study|Lost to Follow-up|1
708941|NCT00083759|2294724|P2|Overall Study|Adverse Event|3
708942|NCT00083759|2294725|P1|Overall Study|Adverse Event|5
708943|NCT00083889|2294735|P2|Overall Study|Crossover to SU011248|25
708944|NCT00083889|2294736|P1|Overall Study|Crossover to SU011248|0
708945|NCT00083889|2294735|P2|Overall Study|Completed on marketed sunitinub|0
708946|NCT00083889|2294736|P1|Overall Study|Completed on marketed sunitinub|3
708947|NCT00083889|2294735|P2|Overall Study|Randomized: did not take study drug|15
708948|NCT00083889|2294736|P1|Overall Study|Randomized: did not take study drug|0
708949|NCT00083889|2294735|P2|Overall Study|Decision of sponsor|4
708950|NCT00083889|2294736|P1|Overall Study|Decision of sponsor|32
708951|NCT00083889|2294735|P2|Overall Study|Lack of Efficacy|219
708952|NCT00083889|2294736|P1|Overall Study|Lack of Efficacy|240
708953|NCT00083889|2294735|P2|Overall Study|Withdrawal by Subject|24
708954|NCT00083889|2294736|P1|Overall Study|Withdrawal by Subject|22
708955|NCT00083889|2294735|P2|Overall Study|Protocol Violation|2
708956|NCT00083889|2294736|P1|Overall Study|Protocol Violation|2
708957|NCT00083889|2294735|P2|Overall Study|Adverse Event|86
708958|NCT00083889|2294736|P1|Overall Study|Adverse Event|76
889852|NCT01181895|2824755|P3|Overall Study|Lost to Follow-up|2
889853|NCT01181895|2824756|P2|Overall Study|Lost to Follow-up|1
889854|NCT01181895|2824757|P1|Overall Study|Lost to Follow-up|0
889855|NCT01181895|2824755|P3|Overall Study|Protocol Violation|0
889856|NCT01181895|2824756|P2|Overall Study|Protocol Violation|1
889857|NCT01181895|2824757|P1|Overall Study|Protocol Violation|2
889858|NCT01181895|2824755|P3|Overall Study|Lack of Efficacy|9
889859|NCT01181895|2824756|P2|Overall Study|Lack of Efficacy|9
889860|NCT01181895|2824757|P1|Overall Study|Lack of Efficacy|8
889861|NCT01181895|2824755|P3|Overall Study|Adverse Event|1
889862|NCT01181895|2824756|P2|Overall Study|Adverse Event|1
889863|NCT01181895|2824757|P1|Overall Study|Adverse Event|3
889864|NCT01175356|2824786|P1|Overall Study|Initiation other tx prior to completion|9
708973|NCT00084084|2294794|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
708974|NCT00084084|2294794|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
708975|NCT00084136|2294805|P3|NRTI Comparison|Not reason above|0
708976|NCT00084136|2294806|P2|NRTI Comparison|Not reason above|0
708977|NCT00084136|2294807|P1|NRTI Comparison|Not reason above|1
708978|NCT00084136|2294805|P3|NRTI Comparison|Clinic site closed|14
708979|NCT00084136|2294806|P2|NRTI Comparison|Clinic site closed|0
708980|NCT00084136|2294807|P1|NRTI Comparison|Clinic site closed|12
708981|NCT00084136|2294805|P3|NRTI Comparison|Withdrawal by Subject|38
708982|NCT00084136|2294806|P2|NRTI Comparison|Withdrawal by Subject|0
708983|NCT00084136|2294807|P1|NRTI Comparison|Withdrawal by Subject|54
708984|NCT00084136|2294805|P3|NRTI Comparison|Lost to Follow-up|12
708985|NCT00084136|2294806|P2|NRTI Comparison|Lost to Follow-up|0
708986|NCT00084136|2294807|P1|NRTI Comparison|Lost to Follow-up|14
708987|NCT00084136|2294805|P3|NRTI Comparison|Death|18
708988|NCT00084136|2294806|P2|NRTI Comparison|Death|0
708989|NCT00084136|2294807|P1|NRTI Comparison|Death|20
708990|NCT00084136|2294805|P3|PI Comparison|Clinic site closed|0
708991|NCT00084136|2294806|P2|PI Comparison|Clinic site closed|0
708992|NCT00084136|2294807|P1|PI Comparison|Clinic site closed|1
708993|NCT00084136|2294805|P3|PI Comparison|Withdrawal by Subject|0
708994|NCT00084136|2294806|P2|PI Comparison|Withdrawal by Subject|30
708995|NCT00084136|2294807|P1|PI Comparison|Withdrawal by Subject|33
708996|NCT00084136|2294805|P3|PI Comparison|Lost to Follow-up|0
708997|NCT00084136|2294806|P2|PI Comparison|Lost to Follow-up|8
708998|NCT00084136|2294807|P1|PI Comparison|Lost to Follow-up|11
708999|NCT00084136|2294805|P3|PI Comparison|Death|0
709000|NCT00084136|2294806|P2|PI Comparison|Death|9
709001|NCT00084136|2294807|P1|PI Comparison|Death|10
709002|NCT00076336|2294877|P2|Overall Study|Treatment failure|5
709003|NCT00076336|2294878|P1|Overall Study|Treatment failure|4
709004|NCT00076336|2294877|P2|Overall Study|Virologic Breakthrough|16
709005|NCT00076336|2294878|P1|Overall Study|Virologic Breakthrough|14
709006|NCT00076336|2294877|P2|Overall Study|Liver Transplantation|3
709007|NCT00076336|2294878|P1|Overall Study|Liver Transplantation|3
709008|NCT00076336|2294877|P2|Overall Study|Patient, Investigator, Sponsor request|6
709009|NCT00076336|2294878|P1|Overall Study|Patient, Investigator, Sponsor request|8
709010|NCT00076336|2294877|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
709011|NCT00076336|2294878|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
709012|NCT00076336|2294877|P2|Overall Study|Non-Compliance|0
709013|NCT00076336|2294878|P1|Overall Study|Non-Compliance|2
709014|NCT00076336|2294877|P2|Overall Study|Lost to Follow-up|4
709015|NCT00076336|2294878|P1|Overall Study|Lost to Follow-up|4
709016|NCT00076336|2294877|P2|Overall Study|Adverse Event|4
709017|NCT00076336|2294878|P1|Overall Study|Adverse Event|4
709018|NCT00076336|2294877|P2|Overall Study|Death|17
709019|NCT00076336|2294878|P1|Overall Study|Death|13
709020|NCT00076570|2294894|P2|Overall Study|Drug intolerance|8
709021|NCT00076570|2294895|P1|Overall Study|Drug intolerance|8
709022|NCT00076752|2294925|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
709023|NCT00076752|2294925|P1|Overall Study|Death|2
709024|NCT00076804|2294946|P2|Overall Study|Early study Closure|32
709025|NCT00076804|2294947|P1|Overall Study|Early study Closure|32
709026|NCT00076804|2294946|P2|Overall Study|Withdrawal by Subject|8
709027|NCT00076804|2294947|P1|Overall Study|Withdrawal by Subject|10
709028|NCT00076804|2294946|P2|Overall Study|Lost to Follow-up|9
709029|NCT00076804|2294947|P1|Overall Study|Lost to Follow-up|9
709030|NCT00076804|2294946|P2|Overall Study|Death|20
709031|NCT00076804|2294947|P1|Overall Study|Death|9
709032|NCT00076999|2294963|P5|Overall Study|Other reason (not specified)|13
709033|NCT00076999|2294964|P4|Overall Study|Other reason (not specified)|1
709034|NCT00076999|2294965|P3|Overall Study|Other reason (not specified)|4
709035|NCT00076999|2294966|P2|Overall Study|Other reason (not specified)|8
709036|NCT00076999|2294967|P1|Overall Study|Other reason (not specified)|8
709037|NCT00076999|2294963|P5|Overall Study|Withdrawal by Subject|1
709038|NCT00076999|2294964|P4|Overall Study|Withdrawal by Subject|0
709039|NCT00076999|2294965|P3|Overall Study|Withdrawal by Subject|3
709040|NCT00076999|2294966|P2|Overall Study|Withdrawal by Subject|4
709041|NCT00076999|2294967|P1|Overall Study|Withdrawal by Subject|0
709042|NCT00076999|2294963|P5|Overall Study|Lost to Follow-up|0
709043|NCT00076999|2294964|P4|Overall Study|Lost to Follow-up|0
709044|NCT00076999|2294965|P3|Overall Study|Lost to Follow-up|0
709045|NCT00076999|2294966|P2|Overall Study|Lost to Follow-up|1
709046|NCT00076999|2294967|P1|Overall Study|Lost to Follow-up|2
709047|NCT00076999|2294963|P5|Overall Study|Protocol Violation|9
709048|NCT00076999|2294964|P4|Overall Study|Protocol Violation|0
709049|NCT00076999|2294965|P3|Overall Study|Protocol Violation|4
709050|NCT00076999|2294966|P2|Overall Study|Protocol Violation|3
709051|NCT00076999|2294967|P1|Overall Study|Protocol Violation|0
709052|NCT00076999|2294963|P5|Overall Study|Adverse Event|2
709053|NCT00076999|2294964|P4|Overall Study|Adverse Event|0
709054|NCT00076999|2294965|P3|Overall Study|Adverse Event|6
709055|NCT00076999|2294966|P2|Overall Study|Adverse Event|8
709056|NCT00076999|2294967|P1|Overall Study|Adverse Event|2
709057|NCT00077207|2295084|P1|Overall Study|Ineligible|1
709058|NCT00077207|2295084|P1|Overall Study|Withdrawal by Subject|6
709059|NCT00077207|2295084|P1|Overall Study|Physician Decision|6
709060|NCT00077207|2295084|P1|Overall Study|Lack of Efficacy|12
709061|NCT00077207|2295084|P1|Overall Study|Adverse Event|5
709062|NCT00077376|2295089|P1|Overall Study|Insurance ran out|1
709063|NCT00077376|2295089|P1|Overall Study|Surgery|1
709064|NCT00077376|2295089|P1|Overall Study|Symptomatic deterioration|1
709065|NCT00077376|2295089|P1|Overall Study|Still on treatment|1
709066|NCT00077376|2295089|P1|Overall Study|Complicating disease|1
709067|NCT00077376|2295089|P1|Overall Study|Alternative therapy|5
709068|NCT00077376|2295089|P1|Overall Study|Physician Decision|1
709069|NCT00077376|2295089|P1|Overall Study|Death|1
709070|NCT00077376|2295089|P1|Overall Study|Withdrawal by Subject|2
709071|NCT00077376|2295089|P1|Overall Study|Adverse Event|8
709072|NCT00077610|2295103|P3|Overall Study|Sponsors decision to withdraw|1
709073|NCT00077610|2295104|P2|Overall Study|Sponsors decision to withdraw|0
709074|NCT00077610|2295105|P1|Overall Study|Sponsors decision to withdraw|0
709075|NCT00077610|2295103|P3|Overall Study|Financial issues|0
709076|NCT00077610|2295104|P2|Overall Study|Financial issues|1
709077|NCT00077610|2295105|P1|Overall Study|Financial issues|0
709078|NCT00077610|2295103|P3|Overall Study|Relocation|5
709079|NCT00077610|2295104|P2|Overall Study|Relocation|8
709080|NCT00077610|2295105|P1|Overall Study|Relocation|0
709081|NCT00077610|2295103|P3|Overall Study|Change in dialysis modality|0
709082|NCT00077610|2295104|P2|Overall Study|Change in dialysis modality|0
709083|NCT00077610|2295105|P1|Overall Study|Change in dialysis modality|1
709084|NCT00077610|2295103|P3|Overall Study|Transfer to other center for surgery|0
709085|NCT00077610|2295104|P2|Overall Study|Transfer to other center for surgery|0
709086|NCT00077610|2295105|P1|Overall Study|Transfer to other center for surgery|1
709087|NCT00077610|2295103|P3|Overall Study|Transfer to satellite unit|0
709088|NCT00077610|2295104|P2|Overall Study|Transfer to satellite unit|0
709089|NCT00077610|2295105|P1|Overall Study|Transfer to satellite unit|1
709090|NCT00077610|2295103|P3|Overall Study|Transferred to nursing home|1
709091|NCT00077610|2295104|P2|Overall Study|Transferred to nursing home|0
709092|NCT00077610|2295105|P1|Overall Study|Transferred to nursing home|0
709093|NCT00077610|2295103|P3|Overall Study|Transferred to other unit|1
709094|NCT00077610|2295104|P2|Overall Study|Transferred to other unit|0
709095|NCT00077610|2295105|P1|Overall Study|Transferred to other unit|0
709096|NCT00077610|2295103|P3|Overall Study|Given Epogen in hospital|0
709097|NCT00077610|2295104|P2|Overall Study|Given Epogen in hospital|0
709098|NCT00077610|2295105|P1|Overall Study|Given Epogen in hospital|1
709099|NCT00077610|2295103|P3|Overall Study|Worsening of health condition|0
709100|NCT00077610|2295104|P2|Overall Study|Worsening of health condition|1
709101|NCT00077610|2295105|P1|Overall Study|Worsening of health condition|1
709102|NCT00077610|2295103|P3|Overall Study|Principal Investigator's decision|1
709103|NCT00077610|2295104|P2|Overall Study|Principal Investigator's decision|0
709104|NCT00077610|2295105|P1|Overall Study|Principal Investigator's decision|1
709105|NCT00077610|2295103|P3|Overall Study|Multiple blood transfusions|1
709106|NCT00077610|2295104|P2|Overall Study|Multiple blood transfusions|0
709107|NCT00077610|2295105|P1|Overall Study|Multiple blood transfusions|0
709108|NCT00077610|2295103|P3|Overall Study|Insufficient Therapeutic Response|0
709109|NCT00077610|2295104|P2|Overall Study|Insufficient Therapeutic Response|0
709110|NCT00077610|2295105|P1|Overall Study|Insufficient Therapeutic Response|1
709111|NCT00077610|2295103|P3|Overall Study|Withdrew from dialysis care|3
709112|NCT00077610|2295104|P2|Overall Study|Withdrew from dialysis care|0
709113|NCT00077610|2295105|P1|Overall Study|Withdrew from dialysis care|5
709114|NCT00077610|2295103|P3|Overall Study|Renal transplant|11
709115|NCT00077610|2295104|P2|Overall Study|Renal transplant|15
709116|NCT00077610|2295105|P1|Overall Study|Renal transplant|12
709117|NCT00077610|2295103|P3|Overall Study|Death|13
709118|NCT00077610|2295104|P2|Overall Study|Death|13
709119|NCT00077610|2295105|P1|Overall Study|Death|17
709120|NCT00077610|2295103|P3|Overall Study|Withdrawal by Subject|6
709121|NCT00077610|2295104|P2|Overall Study|Withdrawal by Subject|10
709122|NCT00077610|2295105|P1|Overall Study|Withdrawal by Subject|4
709123|NCT00077610|2295103|P3|Overall Study|Lost to Follow-up|2
709124|NCT00077610|2295104|P2|Overall Study|Lost to Follow-up|1
709125|NCT00077610|2295105|P1|Overall Study|Lost to Follow-up|0
709126|NCT00077610|2295103|P3|Overall Study|Adverse Event|1
709127|NCT00077610|2295104|P2|Overall Study|Adverse Event|7
709128|NCT00077610|2295105|P1|Overall Study|Adverse Event|9
709129|NCT00077623|2295137|P3|Overall Study|Failure to return|0
709130|NCT00077623|2295138|P2|Overall Study|Failure to return|0
709131|NCT00077623|2295139|P1|Overall Study|Failure to return|1
709132|NCT00077623|2295137|P3|Overall Study|Death|11
709133|NCT00077623|2295138|P2|Overall Study|Death|18
709134|NCT00077623|2295139|P1|Overall Study|Death|12
709135|NCT00077623|2295137|P3|Overall Study|Insufficient therapeutic response|0
709136|NCT00077623|2295138|P2|Overall Study|Insufficient therapeutic response|0
709137|NCT00077623|2295139|P1|Overall Study|Insufficient therapeutic response|2
709138|NCT00077623|2295137|P3|Overall Study|Other-Non safety reason|19
709139|NCT00077623|2295138|P2|Overall Study|Other-Non safety reason|15
709140|NCT00077623|2295139|P1|Overall Study|Other-Non safety reason|18
709141|NCT00077623|2295137|P3|Overall Study|Withdrawal by Subject|1
709142|NCT00077623|2295138|P2|Overall Study|Withdrawal by Subject|10
709143|NCT00077623|2295139|P1|Overall Study|Withdrawal by Subject|2
709144|NCT00077623|2295137|P3|Overall Study|Adverse Event|1
709145|NCT00077623|2295138|P2|Overall Study|Adverse Event|0
709146|NCT00077623|2295139|P1|Overall Study|Adverse Event|1
709147|NCT00077636|2295173|P2|Overall Study|Abnormality Of Laboratory Test|2
709148|NCT00077636|2295174|P1|Overall Study|Abnormality Of Laboratory Test|3
709149|NCT00077636|2295173|P2|Overall Study|Lost to Follow-up|18
709150|NCT00077636|2295174|P1|Overall Study|Lost to Follow-up|10
709151|NCT00077636|2295173|P2|Overall Study|Protocol Violation|2
709152|NCT00077636|2295174|P1|Overall Study|Protocol Violation|0
709153|NCT00077636|2295173|P2|Overall Study|Adverse Event|34
709154|NCT00077636|2295174|P1|Overall Study|Adverse Event|17
709155|NCT00077636|2295173|P2|Overall Study|Withdrawal by Subject|2
709156|NCT00077636|2295174|P1|Overall Study|Withdrawal by Subject|2
709157|NCT00077636|2295173|P2|Overall Study|Admin|3
709158|NCT00077636|2295174|P1|Overall Study|Admin|3
709159|NCT00077636|2295173|P2|Overall Study|Refused Treatment|31
709160|NCT00077636|2295174|P1|Overall Study|Refused Treatment|9
709161|NCT00077649|2295196|P4|Overall Study|Randomized but never dosed|0
709162|NCT00077649|2295197|P3|Overall Study|Randomized but never dosed|0
709163|NCT00077649|2295198|P2|Overall Study|Randomized but never dosed|0
709164|NCT00077649|2295199|P1|Overall Study|Randomized but never dosed|1
709165|NCT00077649|2295196|P4|Overall Study|Abnormality of Laboratory Test|2
709166|NCT00077649|2295197|P3|Overall Study|Abnormality of Laboratory Test|1
709167|NCT00077649|2295198|P2|Overall Study|Abnormality of Laboratory Test|2
709168|NCT00077649|2295199|P1|Overall Study|Abnormality of Laboratory Test|1
709169|NCT00077649|2295196|P4|Overall Study|Lost to Follow-up|2
709170|NCT00077649|2295197|P3|Overall Study|Lost to Follow-up|3
709171|NCT00077649|2295198|P2|Overall Study|Lost to Follow-up|2
709172|NCT00077649|2295199|P1|Overall Study|Lost to Follow-up|2
709173|NCT00077649|2295196|P4|Overall Study|Withdrawal by Subject|2
709174|NCT00077649|2295197|P3|Overall Study|Withdrawal by Subject|1
709175|NCT00077649|2295198|P2|Overall Study|Withdrawal by Subject|1
709176|NCT00077649|2295199|P1|Overall Study|Withdrawal by Subject|0
709177|NCT00077649|2295196|P4|Overall Study|Lack of Efficacy|2
709178|NCT00077649|2295197|P3|Overall Study|Lack of Efficacy|3
709179|NCT00077649|2295198|P2|Overall Study|Lack of Efficacy|3
709180|NCT00077649|2295199|P1|Overall Study|Lack of Efficacy|5
709181|NCT00077649|2295196|P4|Overall Study|Adverse Event|9
709182|NCT00077649|2295197|P3|Overall Study|Adverse Event|7
709183|NCT00077649|2295198|P2|Overall Study|Adverse Event|1
709184|NCT00077649|2295199|P1|Overall Study|Adverse Event|5
709185|NCT00077675|2295247|P2|Overall Study|Never received study treatment|3
709186|NCT00077675|2295248|P1|Overall Study|Never received study treatment|3
709187|NCT00077675|2295247|P2|Overall Study|Other|1
709188|NCT00077675|2295248|P1|Overall Study|Other|0
709189|NCT00077675|2295247|P2|Overall Study|Withdrawal by Subject|0
709190|NCT00077675|2295248|P1|Overall Study|Withdrawal by Subject|1
709191|NCT00077675|2295247|P2|Overall Study|Lost to Follow-up|3
709192|NCT00077675|2295248|P1|Overall Study|Lost to Follow-up|6
709193|NCT00077675|2295247|P2|Overall Study|Adverse Event|2
709194|NCT00077675|2295248|P1|Overall Study|Adverse Event|1
709195|NCT00077766|2295256|P2|Overall Study|Participants Vacation|1
709196|NCT00077766|2295257|P1|Overall Study|Participants Vacation|2
709197|NCT00077766|2295256|P2|Overall Study|Stop Dialysis|1
709198|NCT00077766|2295257|P1|Overall Study|Stop Dialysis|0
709199|NCT00077766|2295256|P2|Overall Study|Started Nocturnal Dialysis|1
709200|NCT00077766|2295257|P1|Overall Study|Started Nocturnal Dialysis|0
709201|NCT00077766|2295256|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
709202|NCT00077766|2295257|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
709203|NCT00077766|2295256|P2|Overall Study|Dialysis|1
709204|NCT00077766|2295257|P1|Overall Study|Dialysis|0
709205|NCT00077766|2295256|P2|Overall Study|Dialysis Discontinued|0
709206|NCT00077766|2295257|P1|Overall Study|Dialysis Discontinued|1
709207|NCT00077766|2295256|P2|Overall Study|Participant's decision|0
709208|NCT00077766|2295257|P1|Overall Study|Participant's decision|1
709209|NCT00077766|2295256|P2|Overall Study|Investigators Discretion|0
709210|NCT00077766|2295257|P1|Overall Study|Investigators Discretion|1
709211|NCT00077766|2295256|P2|Overall Study|Transplantation|1
709212|NCT00077766|2295257|P1|Overall Study|Transplantation|5
709213|NCT00077766|2295256|P2|Overall Study|Kidney Transplantation|5
709214|NCT00077766|2295257|P1|Overall Study|Kidney Transplantation|9
709215|NCT00077766|2295256|P2|Overall Study|Protocol Violation|0
709216|NCT00077766|2295257|P1|Overall Study|Protocol Violation|1
709217|NCT00077766|2295256|P2|Overall Study|Lost to Follow-up|0
709218|NCT00077766|2295257|P1|Overall Study|Lost to Follow-up|2
709219|NCT00077766|2295256|P2|Overall Study|Death|10
709220|NCT00077766|2295257|P1|Overall Study|Death|12
709221|NCT00077766|2295256|P2|Overall Study|Withdrawal by Subject|3
709222|NCT00077766|2295257|P1|Overall Study|Withdrawal by Subject|4
709223|NCT00077766|2295256|P2|Overall Study|Adverse Event|1
709224|NCT00077766|2295257|P1|Overall Study|Adverse Event|1
709225|NCT00077857|2295277|P2|Overall Study|Other|13
709226|NCT00077857|2295278|P1|Overall Study|Other|15
709227|NCT00077857|2295277|P2|Overall Study|Failure to return|5
709228|NCT00077857|2295278|P1|Overall Study|Failure to return|5
709229|NCT00077857|2295277|P2|Overall Study|Refused treatment|21
709230|NCT00077857|2295278|P1|Overall Study|Refused treatment|29
709231|NCT00077857|2295277|P2|Overall Study|Other protocol violation|1
709232|NCT00077857|2295278|P1|Overall Study|Other protocol violation|0
709233|NCT00077857|2295277|P2|Overall Study|Violation of selection criteria at entry|1
709234|NCT00077857|2295278|P1|Overall Study|Violation of selection criteria at entry|3
709235|NCT00077857|2295277|P2|Overall Study|Insufficient therapeutic response|128
709236|NCT00077857|2295278|P1|Overall Study|Insufficient therapeutic response|112
709237|NCT00077857|2295277|P2|Overall Study|Death|3
709238|NCT00077857|2295278|P1|Overall Study|Death|7
709239|NCT00077857|2295277|P2|Overall Study|Adverse Event|32
709240|NCT00077857|2295278|P1|Overall Study|Adverse Event|30
709241|NCT00077974|2295301|P1|Overall Study|Decision of Sponsor|2
709242|NCT00077974|2295301|P1|Overall Study|Lack of Efficacy|76
709243|NCT00077974|2295301|P1|Overall Study|Withdrawal by Subject|3
709244|NCT00077974|2295301|P1|Overall Study|Protocol Violation|1
709245|NCT00077974|2295301|P1|Overall Study|Adverse Event|22
709246|NCT00084266|2295318|P2|Overall Study|Randomized not treated|20
709247|NCT00084266|2295319|P1|Overall Study|Randomized not treated|21
709248|NCT00084266|2295318|P2|Overall Study|Unspecified|344
709249|NCT00084266|2295319|P1|Overall Study|Unspecified|360
709250|NCT00084266|2295318|P2|Overall Study|Participant not willing to participate|8
709251|NCT00084266|2295319|P1|Overall Study|Participant not willing to participate|3
709252|NCT00084266|2295318|P2|Overall Study|Lost to Follow-up|3
709253|NCT00084266|2295319|P1|Overall Study|Lost to Follow-up|5
709254|NCT00084266|2295318|P2|Overall Study|Lack of Efficacy|4
709255|NCT00084266|2295319|P1|Overall Study|Lack of Efficacy|2
709256|NCT00084266|2295318|P2|Overall Study|Adverse Event|5
709257|NCT00084266|2295319|P1|Overall Study|Adverse Event|8
709258|NCT00084266|2295318|P2|Overall Study|Death|39
709259|NCT00084266|2295319|P1|Overall Study|Death|42
709260|NCT00084318|2295355|P2|Overall Study|No protocol treatment|0
709261|NCT00084318|2295356|P1|Overall Study|No protocol treatment|2
709262|NCT00084318|2295355|P2|Overall Study|Protocol Violation|11
709263|NCT00084318|2295356|P1|Overall Study|Protocol Violation|15
709264|NCT00084318|2295355|P2|Overall Study|Withdrawal by Subject|2
709265|NCT00084318|2295356|P1|Overall Study|Withdrawal by Subject|5
709266|NCT00084487|2295408|P1|Overall Study|Death|1
709267|NCT00088153|2295418|P2|Overall Study|Lost to Follow-up|12
709268|NCT00088153|2295419|P1|Overall Study|Lost to Follow-up|11
709269|NCT00088153|2295418|P2|Overall Study|Withdrawal by Subject|10
709270|NCT00088153|2295419|P1|Overall Study|Withdrawal by Subject|10
709271|NCT00088153|2295418|P2|Overall Study|Physician Decision|3
709272|NCT00088153|2295419|P1|Overall Study|Physician Decision|3
709273|NCT00088166|2295431|P2|Overall Study|Withdrawal by Subject|5
709274|NCT00088166|2295432|P1|Overall Study|Withdrawal by Subject|5
709275|NCT00088166|2295431|P2|Overall Study|Patient deterioration|39
709276|NCT00088166|2295432|P1|Overall Study|Patient deterioration|29
709277|NCT00088166|2295431|P2|Overall Study|Protocol Violation|5
709278|NCT00088166|2295432|P1|Overall Study|Protocol Violation|1
709279|NCT00088166|2295431|P2|Overall Study|Physician Decision|1
709280|NCT00088166|2295432|P1|Overall Study|Physician Decision|4
709281|NCT00088166|2295431|P2|Overall Study|Lost to Follow-up|1
709282|NCT00088166|2295432|P1|Overall Study|Lost to Follow-up|0
709283|NCT00088166|2295431|P2|Overall Study|Death|1
709284|NCT00088166|2295432|P1|Overall Study|Death|3
709285|NCT00088166|2295431|P2|Overall Study|Adverse Event|9
709286|NCT00088166|2295432|P1|Overall Study|Adverse Event|11
709287|NCT00088374|2295463|P1|Overall Study|patient received <1 cycle only of 17AAG|1
709288|NCT00088374|2295463|P1|Overall Study|patient did not receive any 17AAG|1
709289|NCT00088465|2295472|P1|Overall Study|Death|11
709290|NCT00088465|2295472|P1|Overall Study|Protocol Violation|17
709291|NCT00088465|2295472|P1|Overall Study|Lack of Efficacy|27
709292|NCT00088465|2295472|P1|Overall Study|Sponsor Decision|37
709293|NCT00088465|2295472|P1|Overall Study|Physician Decision|45
709294|NCT00088465|2295472|P1|Overall Study|Lost to Follow-up|57
709295|NCT00088465|2295472|P1|Overall Study|Adverse Event|77
709296|NCT00088465|2295472|P1|Overall Study|Withdrawal by Subject|290
709297|NCT00088530|2295497|P2|Overall Study|Patient never treated|0
709298|NCT00088530|2295498|P1|Overall Study|Patient never treated|1
709299|NCT00088530|2295497|P2|Overall Study|Sponsor decision|1
709300|NCT00088530|2295498|P1|Overall Study|Sponsor decision|0
709301|NCT00088530|2295497|P2|Overall Study|Physician Decision|0
709302|NCT00088530|2295498|P1|Overall Study|Physician Decision|2
709303|NCT00088530|2295497|P2|Overall Study|Lost to Follow-up|0
709304|NCT00088530|2295498|P1|Overall Study|Lost to Follow-up|2
709305|NCT00088530|2295497|P2|Overall Study|Withdrawal by Subject|5
709306|NCT00088530|2295498|P1|Overall Study|Withdrawal by Subject|2
709307|NCT00088530|2295497|P2|Overall Study|Adverse Event|9
709308|NCT00088530|2295498|P1|Overall Study|Adverse Event|15
709309|NCT00088530|2295497|P2|Overall Study|Progressive/Relapsed Disease|39
709310|NCT00088530|2295498|P1|Overall Study|Progressive/Relapsed Disease|28
709311|NCT00088595|2295510|P1|Overall Study|New Cancer Therapy|2
709312|NCT00088595|2295510|P1|Overall Study|Ongoing (After Core)|7
709313|NCT00088595|2295510|P1|Overall Study|Withdrawal by Subject|8
709314|NCT00088595|2295510|P1|Overall Study|Adverse Event|11
709315|NCT00088881|2295545|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
709316|NCT00088881|2295545|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
709317|NCT00088881|2295545|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
709318|NCT00088881|2295545|P1|Step 1 - R-CHOP|Physician Decision|1
709319|NCT00088881|2295545|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
709320|NCT00088881|2295545|P1|Step 1 - R-CHOP|Adverse Event|1
709321|NCT00088881|2295545|P1|Step 1 - R-CHOP|Patient ineligible|9
709322|NCT00088907|2295556|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
709323|NCT00088907|2295557|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
709324|NCT00088907|2295556|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
709325|NCT00088907|2295557|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
709326|NCT00088907|2295556|P2|Single Gefitinib Treatment (Step 2)|Death|0
709327|NCT00088907|2295557|P1|Single Gefitinib Treatment (Step 2)|Death|1
709328|NCT00088907|2295556|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
709329|NCT00088907|2295557|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
709330|NCT00088907|2295556|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
709331|NCT00088907|2295557|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
709332|NCT00088907|2295556|P2|Randomized Study (Step 1)|unknown/not specify|13
709333|NCT00088907|2295557|P1|Randomized Study (Step 1)|unknown/not specify|24
709334|NCT00088907|2295556|P2|Randomized Study (Step 1)|complicating disease|1
709335|NCT00088907|2295557|P1|Randomized Study (Step 1)|complicating disease|3
709336|NCT00088907|2295556|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
709337|NCT00088907|2295557|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
709338|NCT00088907|2295556|P2|Randomized Study (Step 1)|Death|12
709339|NCT00088907|2295557|P1|Randomized Study (Step 1)|Death|11
709340|NCT00088907|2295556|P2|Randomized Study (Step 1)|Adverse Event|19
709341|NCT00088907|2295557|P1|Randomized Study (Step 1)|Adverse Event|14
709342|NCT00088907|2295556|P2|Randomized Study (Step 1)|Lack of Efficacy|62
709343|NCT00088907|2295557|P1|Randomized Study (Step 1)|Lack of Efficacy|55
709344|NCT00089076|2295605|P1|Overall Study|Progression|7
709345|NCT00089076|2295605|P1|Overall Study|Withdrawal by Subject|2
709346|NCT00089076|2295605|P1|Overall Study|Alternate Therapy|1
709347|NCT00089141|2295618|P2|Overall Study|Termination of trial|24
709348|NCT00089141|2295619|P1|Overall Study|Termination of trial|18
709349|NCT00089297|2295641|P1|Overall Study|Non-compliance|1
709350|NCT00089297|2295641|P1|Overall Study|IRB approval not ready|1
709351|NCT00089297|2295641|P1|Overall Study|Secondary malignancy|1
709352|NCT00089297|2295641|P1|Overall Study|Ineligible|11
709353|NCT00089297|2295641|P1|Overall Study|Disease progression|2
709354|NCT00089297|2295641|P1|Overall Study|Withdrawal by Subject|12
709355|NCT00089297|2295641|P1|Overall Study|Death|1
709356|NCT00089297|2295641|P1|Overall Study|Adverse Event|9
709357|NCT00089479|2295669|P2|Overall Study|Lost to Follow-up|107
709358|NCT00089479|2295670|P1|Overall Study|Lost to Follow-up|137
709359|NCT00089479|2295669|P2|Overall Study|Withdrawal by Subject|107
709360|NCT00089479|2295670|P1|Overall Study|Withdrawal by Subject|86
709361|NCT00089479|2295669|P2|Overall Study|Death|75
709362|NCT00089479|2295670|P1|Overall Study|Death|108
709363|NCT00089505|2295698|P4|Overall Study|Protocol Violation|0
709364|NCT00089505|2295699|P3|Overall Study|Protocol Violation|1
709365|NCT00089505|2295700|P2|Overall Study|Protocol Violation|0
709366|NCT00089505|2295701|P1|Overall Study|Protocol Violation|0
709367|NCT00089505|2295698|P4|Overall Study|Physician Decision|0
709368|NCT00089505|2295699|P3|Overall Study|Physician Decision|0
709369|NCT00089505|2295700|P2|Overall Study|Physician Decision|0
709370|NCT00089505|2295701|P1|Overall Study|Physician Decision|1
709371|NCT00089505|2295698|P4|Overall Study|Lost to Follow-up|7
709372|NCT00089505|2295699|P3|Overall Study|Lost to Follow-up|9
709373|NCT00089505|2295700|P2|Overall Study|Lost to Follow-up|1
709374|NCT00089505|2295701|P1|Overall Study|Lost to Follow-up|1
709375|NCT00089505|2295698|P4|Overall Study|Withdrawal by Subject|6
709376|NCT00089505|2295699|P3|Overall Study|Withdrawal by Subject|6
709377|NCT00089505|2295700|P2|Overall Study|Withdrawal by Subject|0
709378|NCT00089505|2295701|P1|Overall Study|Withdrawal by Subject|3
709379|NCT00089505|2295698|P4|Overall Study|Death|8
709380|NCT00089505|2295699|P3|Overall Study|Death|5
709381|NCT00089505|2295700|P2|Overall Study|Death|1
709382|NCT00089505|2295701|P1|Overall Study|Death|4
709383|NCT00089544|2295745|P2|Overall Study|Ineligible|0
709384|NCT00089544|2295746|P1|Overall Study|Ineligible|1
709385|NCT00089583|2295758|P2|Overall Study|Participant Incarcerated|1
709386|NCT00089583|2295759|P1|Overall Study|Participant Incarcerated|0
709387|NCT00089583|2295758|P2|Overall Study|Necessity to Use Prohibited Drug|0
709388|NCT00089583|2295759|P1|Overall Study|Necessity to Use Prohibited Drug|1
709389|NCT00089583|2295758|P2|Overall Study|Start of Disallowed Medication|1
709390|NCT00089583|2295759|P1|Overall Study|Start of Disallowed Medication|0
709391|NCT00089583|2295758|P2|Overall Study|Principal Investigator Decision|10
709392|NCT00089583|2295759|P1|Overall Study|Principal Investigator Decision|0
709393|NCT00089583|2295758|P2|Overall Study|Protocol Violation|3
709394|NCT00089583|2295759|P1|Overall Study|Protocol Violation|0
709395|NCT00089583|2295758|P2|Overall Study|Reason Not Provided|1
709396|NCT00089583|2295759|P1|Overall Study|Reason Not Provided|0
709397|NCT00089583|2295758|P2|Overall Study|Participant Management Criteria Met|1
709398|NCT00089583|2295759|P1|Overall Study|Participant Management Criteria Met|0
709399|NCT00089583|2295758|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
709400|NCT00089583|2295759|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
709401|NCT00089583|2295758|P2|Overall Study|Non-Compliance|4
709402|NCT00089583|2295759|P1|Overall Study|Non-Compliance|0
709403|NCT00089583|2295758|P2|Overall Study|Participant Refused Study Medication|2
709404|NCT00089583|2295759|P1|Overall Study|Participant Refused Study Medication|0
709405|NCT00089583|2295758|P2|Overall Study|Participant (Par) Didn't Take Medication|0
709406|NCT00089583|2295759|P1|Overall Study|Participant (Par) Didn't Take Medication|1
709407|NCT00089583|2295758|P2|Overall Study|Withdrawal by Subject|4
709408|NCT00089583|2295759|P1|Overall Study|Withdrawal by Subject|0
709409|NCT00089583|2295758|P2|Overall Study|Insufficient Viral Load Response|5
709410|NCT00089583|2295759|P1|Overall Study|Insufficient Viral Load Response|5
709411|NCT00089583|2295758|P2|Overall Study|Adverse Event|3
709412|NCT00089583|2295759|P1|Overall Study|Adverse Event|0
709415|NCT00089635|2295871|P1|Overall Study|Not specified|2
709416|NCT00089635|2295871|P1|Overall Study|Ineligibility determined|1
709417|NCT00089635|2295871|P1|Overall Study|Withdrawal by Subject|6
709418|NCT00089635|2295871|P1|Overall Study|Lost to Follow-up|3
709419|NCT00089635|2295871|P1|Overall Study|Disease Progression|12
709420|NCT00089635|2295871|P1|Overall Study|Death|17
709421|NCT00089635|2295871|P1|Overall Study|Adverse Event|2
709422|NCT00089648|2295883|P1|Overall Study|Lack of Efficacy|33
709423|NCT00089648|2295883|P1|Overall Study|Withdrawal by Subject|1
709424|NCT00089648|2295883|P1|Overall Study|Adverse Event|7
709425|NCT00089661|2295901|P2|Overall Study|Other|1
709426|NCT00089661|2295902|P1|Overall Study|Other|2
709427|NCT00089661|2295901|P2|Overall Study|Noncompliance|4
709428|NCT00089661|2295902|P1|Overall Study|Noncompliance|2
709429|NCT00089661|2295901|P2|Overall Study|Ineligibility determined|4
709430|NCT00089661|2295902|P1|Overall Study|Ineligibility determined|4
709431|NCT00089661|2295901|P2|Overall Study|Disease progression|3
709432|NCT00089661|2295902|P1|Overall Study|Disease progression|1
709433|NCT00089661|2295901|P2|Overall Study|Withdrawal by Subject|9
709434|NCT00089661|2295902|P1|Overall Study|Withdrawal by Subject|11
709435|NCT00089661|2295901|P2|Overall Study|Lost to Follow-up|3
709436|NCT00089661|2295902|P1|Overall Study|Lost to Follow-up|0
709437|NCT00089661|2295901|P2|Overall Study|Death|0
709438|NCT00089661|2295902|P1|Overall Study|Death|1
709439|NCT00089661|2295901|P2|Overall Study|Adverse Event|2
709440|NCT00089661|2295902|P1|Overall Study|Adverse Event|0
709441|NCT00089674|2295920|P2|Overall Study|Requirement for alternative therapy|4
709442|NCT00089674|2295921|P1|Overall Study|Requirement for alternative therapy|14
709443|NCT00089674|2295920|P2|Overall Study|Other|9
709444|NCT00089674|2295921|P1|Overall Study|Other|5
709445|NCT00089674|2295920|P2|Overall Study|Noncompliance|3
709446|NCT00089674|2295921|P1|Overall Study|Noncompliance|7
709447|NCT00089674|2295920|P2|Overall Study|Lost to Follow-up|17
709448|NCT00089674|2295921|P1|Overall Study|Lost to Follow-up|21
709449|NCT00089674|2295920|P2|Overall Study|Ineligibility determined|10
709450|NCT00089674|2295921|P1|Overall Study|Ineligibility determined|8
709451|NCT00089674|2295920|P2|Overall Study|Disease progression|23
709452|NCT00089674|2295921|P1|Overall Study|Disease progression|21
709453|NCT00089674|2295920|P2|Overall Study|Death|43
709454|NCT00089674|2295921|P1|Overall Study|Death|43
709455|NCT00089674|2295920|P2|Overall Study|Withdrawal by Subject|127
709456|NCT00089674|2295921|P1|Overall Study|Withdrawal by Subject|143
709457|NCT00089674|2295920|P2|Overall Study|Adverse Event|29
709458|NCT00089674|2295921|P1|Overall Study|Adverse Event|23
709459|NCT00089674|2295920|P2|Overall Study|Physician Decision|2
709460|NCT00089674|2295921|P1|Overall Study|Physician Decision|4
709461|NCT00089778|2295969|P3|Overall Study|Protocol Violation|1
709462|NCT00089778|2295970|P2|Overall Study|Protocol Violation|0
709463|NCT00089778|2295971|P1|Overall Study|Protocol Violation|0
709464|NCT00089791|2295984|P2|Overall Study|Requirement for alternative therapy|4
709465|NCT00089791|2295985|P1|Overall Study|Requirement for alternative therapy|7
709466|NCT00089791|2295984|P2|Overall Study|Protocol deviation|10
709467|NCT00089791|2295985|P1|Overall Study|Protocol deviation|12
709468|NCT00089791|2295984|P2|Overall Study|Other|32
709469|NCT00089791|2295985|P1|Overall Study|Other|20
709470|NCT00089791|2295984|P2|Overall Study|Noncompliance|13
709471|NCT00089791|2295985|P1|Overall Study|Noncompliance|17
709472|NCT00089791|2295984|P2|Overall Study|Lost to Follow-up|57
709473|NCT00089791|2295985|P1|Overall Study|Lost to Follow-up|57
709474|NCT00089791|2295984|P2|Overall Study|Ineligibility determined|9
709475|NCT00089791|2295985|P1|Overall Study|Ineligibility determined|12
709476|NCT00089791|2295984|P2|Overall Study|Disease progression|3
709477|NCT00089791|2295985|P1|Overall Study|Disease progression|7
709478|NCT00089791|2295984|P2|Overall Study|Death|62
709479|NCT00089791|2295985|P1|Overall Study|Death|78
709480|NCT00089791|2295984|P2|Overall Study|Withdrawal by Subject|344
709481|NCT00089791|2295985|P1|Overall Study|Withdrawal by Subject|403
709482|NCT00089791|2295984|P2|Overall Study|Adverse Event|93
709483|NCT00089791|2295985|P1|Overall Study|Adverse Event|81
709484|NCT00089791|2295984|P2|Overall Study|Physician Decision|3
709485|NCT00089791|2295985|P1|Overall Study|Physician Decision|6
709486|NCT00089843|2295999|P4|Overall Study|Physician Decision|1
709487|NCT00089843|2296000|P3|Overall Study|Physician Decision|0
709488|NCT00089843|2296001|P2|Overall Study|Physician Decision|0
709489|NCT00089843|2296002|P1|Overall Study|Physician Decision|1
709490|NCT00089843|2295999|P4|Overall Study|Withdrawal by Subject|6
709491|NCT00089843|2296000|P3|Overall Study|Withdrawal by Subject|5
709492|NCT00089843|2296001|P2|Overall Study|Withdrawal by Subject|4
709493|NCT00089843|2296002|P1|Overall Study|Withdrawal by Subject|1
709494|NCT00089895|2296014|P2|Overall Study|Missing|2
709495|NCT00089895|2296015|P1|Overall Study|Missing|4
709496|NCT00089895|2296014|P2|Overall Study|Not otherwise specified|8
709497|NCT00089895|2296015|P1|Overall Study|Not otherwise specified|4
709498|NCT00089895|2296014|P2|Overall Study|Exclusion criteria met|6
709499|NCT00089895|2296015|P1|Overall Study|Exclusion criteria met|6
709500|NCT00089895|2296014|P2|Overall Study|Physician Decision|7
709501|NCT00089895|2296015|P1|Overall Study|Physician Decision|3
709502|NCT00089895|2296014|P2|Overall Study|Bleeding|2
709503|NCT00089895|2296015|P1|Overall Study|Bleeding|0
709504|NCT00089895|2296014|P2|Overall Study|Surgery|1
709505|NCT00089895|2296015|P1|Overall Study|Surgery|0
709506|NCT00089895|2296014|P2|Overall Study|Technical reason|2
709507|NCT00089895|2296015|P1|Overall Study|Technical reason|7
709508|NCT00089895|2296014|P2|Overall Study|Consent Withdrawn|14
709509|NCT00089895|2296015|P1|Overall Study|Consent Withdrawn|11
709510|NCT00089986|2296026|P3|Overall Study|Withdrawal by Subject|2
709511|NCT00089986|2296027|P2|Overall Study|Withdrawal by Subject|6
709512|NCT00089986|2296028|P1|Overall Study|Withdrawal by Subject|3
709513|NCT00089986|2296026|P3|Overall Study|Do not resuscitate (DNR)|1
709514|NCT00089986|2296027|P2|Overall Study|Do not resuscitate (DNR)|0
709515|NCT00089986|2296028|P1|Overall Study|Do not resuscitate (DNR)|0
709516|NCT00089986|2296026|P3|Overall Study|Family decision|0
709517|NCT00089986|2296027|P2|Overall Study|Family decision|1
709518|NCT00089986|2296028|P1|Overall Study|Family decision|0
709519|NCT00089986|2296026|P3|Overall Study|Enrollment in another study|0
709520|NCT00089986|2296027|P2|Overall Study|Enrollment in another study|1
709521|NCT00089986|2296028|P1|Overall Study|Enrollment in another study|0
709522|NCT00089986|2296026|P3|Overall Study|Investigator decision to withdrew|0
709523|NCT00089986|2296027|P2|Overall Study|Investigator decision to withdrew|1
709524|NCT00089986|2296028|P1|Overall Study|Investigator decision to withdrew|0
709525|NCT00089986|2296026|P3|Overall Study|Hemohlobin stopping rule|0
709526|NCT00089986|2296027|P2|Overall Study|Hemohlobin stopping rule|1
709527|NCT00089986|2296028|P1|Overall Study|Hemohlobin stopping rule|0
709528|NCT00089986|2296026|P3|Overall Study|Subject withdrew but agreed follow up|0
709529|NCT00089986|2296027|P2|Overall Study|Subject withdrew but agreed follow up|2
709530|NCT00089986|2296028|P1|Overall Study|Subject withdrew but agreed follow up|1
709531|NCT00089986|2296026|P3|Overall Study|Patient transferred to another hospital|0
709532|NCT00089986|2296027|P2|Overall Study|Patient transferred to another hospital|1
709533|NCT00089986|2296028|P1|Overall Study|Patient transferred to another hospital|2
709534|NCT00089986|2296026|P3|Overall Study|Protocol Violation|0
709535|NCT00089986|2296027|P2|Overall Study|Protocol Violation|1
709536|NCT00089986|2296028|P1|Overall Study|Protocol Violation|0
709537|NCT00089986|2296026|P3|Overall Study|Lost to Follow-up|1
709538|NCT00089986|2296027|P2|Overall Study|Lost to Follow-up|1
709539|NCT00089986|2296028|P1|Overall Study|Lost to Follow-up|3
709540|NCT00089986|2296026|P3|Overall Study|Adverse Event|6
709541|NCT00089986|2296027|P2|Overall Study|Adverse Event|9
709542|NCT00089986|2296028|P1|Overall Study|Adverse Event|6
709543|NCT00089999|2296047|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
709544|NCT00089999|2296048|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
709545|NCT00089999|2296047|P2|Overall Study|Patient Underwent Surgery|0
709546|NCT00089999|2296048|P1|Overall Study|Patient Underwent Surgery|2
709547|NCT00089999|2296047|P2|Overall Study|Physician Decision|2
709548|NCT00089999|2296048|P1|Overall Study|Physician Decision|2
709549|NCT00089999|2296047|P2|Overall Study|Clinical Progression|2
709550|NCT00089999|2296048|P1|Overall Study|Clinical Progression|1
709551|NCT00089999|2296047|P2|Overall Study|Poor General Condition|0
709552|NCT00089999|2296048|P1|Overall Study|Poor General Condition|1
709553|NCT00089999|2296047|P2|Overall Study|Death|3
709554|NCT00089999|2296048|P1|Overall Study|Death|3
709555|NCT00089999|2296047|P2|Overall Study|Symptomatic Progression of Cancer|5
709556|NCT00089999|2296048|P1|Overall Study|Symptomatic Progression of Cancer|2
709557|NCT00089999|2296047|P2|Overall Study|Radiological Progression of Cancer|44
709558|NCT00089999|2296048|P1|Overall Study|Radiological Progression of Cancer|52
709559|NCT00089999|2296047|P2|Overall Study|Lost to Follow-up|1
709560|NCT00089999|2296048|P1|Overall Study|Lost to Follow-up|2
709561|NCT00089999|2296047|P2|Overall Study|Withdrawal by Subject|4
709562|NCT00089999|2296048|P1|Overall Study|Withdrawal by Subject|0
709563|NCT00089999|2296047|P2|Overall Study|Adverse Event|7
709564|NCT00089999|2296048|P1|Overall Study|Adverse Event|4
709565|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Other|0
709566|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Other|1
709567|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Other|0
709568|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Jailed|0
709569|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Jailed|1
709570|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Jailed|0
709571|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
709572|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
709573|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
709574|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Depression|0
709575|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Depression|1
709576|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Depression|0
709577|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
709578|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
709579|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
709580|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
709581|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
709582|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
709583|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Back Pain|0
709584|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Back Pain|1
709585|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Back Pain|0
709586|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
709587|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
709588|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
709589|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
709590|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
709591|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
709592|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
709593|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
709594|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
709595|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Gyneomastia|0
709596|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Gyneomastia|0
709597|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Gyneomastia|1
709598|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Death|1
709599|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Death|0
709600|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Death|1
709601|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
709602|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
709603|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
709604|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Enrollment Error|2
709605|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Enrollment Error|0
709606|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Enrollment Error|1
709607|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Loss of Libido|0
709608|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Loss of Libido|0
709609|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Loss of Libido|1
709610|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
709611|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
709612|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
709613|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
709614|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
709615|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
709616|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
709617|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
709618|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
709619|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
709620|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
709621|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
709622|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Participant relocated|1
709623|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Participant relocated|3
709624|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Participant relocated|2
709625|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
709626|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
709627|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
709628|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Loss of Contact|2
709629|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Loss of Contact|0
709630|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Loss of Contact|4
709631|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
709632|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
709633|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
709634|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
709635|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
709636|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
709637|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Protocol Violation|17
709638|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Protocol Violation|18
709639|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Protocol Violation|18
709640|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
709641|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
709642|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
709643|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
709644|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
709645|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
709646|NCT00090103|2296108|P3|16-Week Safety Follow-up Period|Adverse Event|44
709647|NCT00090103|2296109|P2|16-Week Safety Follow-up Period|Adverse Event|39
709648|NCT00090103|2296110|P1|16-Week Safety Follow-up Period|Adverse Event|34
709649|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
709650|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
709651|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
709652|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
709653|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
709654|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
709655|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
709656|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
709657|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
709658|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
709659|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
709660|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
709661|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
709662|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
709663|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
709664|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
709665|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
709666|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
709667|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
709668|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
709669|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
709670|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
709671|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
709672|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
709673|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
709674|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
709675|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
709676|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
709677|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
709678|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
709679|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
709680|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
709681|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
709682|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
709683|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
709684|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
709685|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
709686|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
709687|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
709688|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
709689|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
709690|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
709691|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
709692|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
709693|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
709694|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
709695|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
709696|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
709697|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
709698|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
709699|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
709700|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
709701|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
709702|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
709703|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
709704|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
709705|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
709706|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
709707|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
709708|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
709709|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
709710|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
709711|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
709712|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
709713|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
709714|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
709715|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
709716|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
709717|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
709718|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
709719|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
709720|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
709721|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
709722|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
709723|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
709724|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
709725|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
709726|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
709727|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
709728|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
709729|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
709730|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
709731|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
709732|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
709733|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
709734|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
709735|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
709736|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
709737|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
709738|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
709739|NCT00090103|2296108|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
709740|NCT00090103|2296109|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
709741|NCT00090103|2296110|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
709742|NCT00090142|2296208|P2|Treatment Period II|Not Specified|0
709743|NCT00090142|2296209|P1|Treatment Period II|Not Specified|1
709744|NCT00090142|2296208|P2|Treatment Period I|Not Specified|1
709745|NCT00090142|2296209|P1|Treatment Period I|Not Specified|0
709746|NCT00090142|2296208|P2|Treatment Period I|Withdrawal by Subject|0
709747|NCT00090142|2296209|P1|Treatment Period I|Withdrawal by Subject|2
709748|NCT00090142|2296208|P2|Treatment Period I|Protocol Violation|0
709749|NCT00090142|2296209|P1|Treatment Period I|Protocol Violation|2
709750|NCT00090142|2296208|P2|Treatment Period I|Lost to Follow-up|2
709751|NCT00090142|2296209|P1|Treatment Period I|Lost to Follow-up|1
709752|NCT00090220|2296239|P6|Long-term Follow-up (EXT2)|Other|0
709753|NCT00090220|2296240|P5|Long-term Follow-up (EXT2)|Other|1
709754|NCT00090220|2296241|P4|Long-term Follow-up (EXT2)|Other|0
709755|NCT00090220|2296242|P3|Long-term Follow-up (EXT2)|Other|0
709756|NCT00090220|2296243|P2|Long-term Follow-up (EXT2)|Other|0
709757|NCT00090220|2296244|P1|Long-term Follow-up (EXT2)|Other|0
709758|NCT00090220|2296239|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
709759|NCT00090220|2296240|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
709760|NCT00090220|2296241|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
709761|NCT00090220|2296242|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
709762|NCT00090220|2296243|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
709763|NCT00090220|2296244|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
709764|NCT00090220|2296239|P6|Long-term Follow-up (EXT2)|Death|1
709765|NCT00090220|2296240|P5|Long-term Follow-up (EXT2)|Death|1
709766|NCT00090220|2296241|P4|Long-term Follow-up (EXT2)|Death|0
709767|NCT00090220|2296242|P3|Long-term Follow-up (EXT2)|Death|0
709768|NCT00090220|2296243|P2|Long-term Follow-up (EXT2)|Death|0
709769|NCT00090220|2296244|P1|Long-term Follow-up (EXT2)|Death|0
709770|NCT00090220|2296239|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
709771|NCT00090220|2296240|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
709772|NCT00090220|2296241|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
709773|NCT00090220|2296242|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
709774|NCT00090220|2296243|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
709775|NCT00090220|2296244|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
709776|NCT00090220|2296239|P6|Extension 1 (EXT1)|Other reason|0
709777|NCT00090220|2296240|P5|Extension 1 (EXT1)|Other reason|0
709778|NCT00090220|2296241|P4|Extension 1 (EXT1)|Other reason|0
709779|NCT00090220|2296242|P3|Extension 1 (EXT1)|Other reason|2
709780|NCT00090220|2296243|P2|Extension 1 (EXT1)|Other reason|0
709781|NCT00090220|2296244|P1|Extension 1 (EXT1)|Other reason|0
709782|NCT00090220|2296239|P6|Extension 1 (EXT1)|Protocol Violation|0
709783|NCT00090220|2296240|P5|Extension 1 (EXT1)|Protocol Violation|0
709784|NCT00090220|2296241|P4|Extension 1 (EXT1)|Protocol Violation|1
709785|NCT00090220|2296242|P3|Extension 1 (EXT1)|Protocol Violation|0
709786|NCT00090220|2296243|P2|Extension 1 (EXT1)|Protocol Violation|0
709787|NCT00090220|2296244|P1|Extension 1 (EXT1)|Protocol Violation|0
709788|NCT00090220|2296239|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
709789|NCT00090220|2296240|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
709790|NCT00090220|2296241|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
709791|NCT00090220|2296242|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
709792|NCT00090220|2296243|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
709793|NCT00090220|2296244|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
709794|NCT00090220|2296239|P6|Extension 1 (EXT1)|Moved|0
709795|NCT00090220|2296240|P5|Extension 1 (EXT1)|Moved|0
709796|NCT00090220|2296241|P4|Extension 1 (EXT1)|Moved|1
709797|NCT00090220|2296242|P3|Extension 1 (EXT1)|Moved|2
709798|NCT00090220|2296243|P2|Extension 1 (EXT1)|Moved|0
709799|NCT00090220|2296244|P1|Extension 1 (EXT1)|Moved|0
709800|NCT00090220|2296239|P6|Extension 1 (EXT1)|Lost to Follow-up|0
709801|NCT00090220|2296240|P5|Extension 1 (EXT1)|Lost to Follow-up|0
709802|NCT00090220|2296241|P4|Extension 1 (EXT1)|Lost to Follow-up|0
709803|NCT00090220|2296242|P3|Extension 1 (EXT1)|Lost to Follow-up|22
709804|NCT00090220|2296243|P2|Extension 1 (EXT1)|Lost to Follow-up|0
709805|NCT00090220|2296244|P1|Extension 1 (EXT1)|Lost to Follow-up|0
709806|NCT00090220|2296239|P6|Extension 1 (EXT1)|Adverse Event|0
709807|NCT00090220|2296240|P5|Extension 1 (EXT1)|Adverse Event|0
709808|NCT00090220|2296241|P4|Extension 1 (EXT1)|Adverse Event|0
709809|NCT00090220|2296242|P3|Extension 1 (EXT1)|Adverse Event|4
709810|NCT00090220|2296243|P2|Extension 1 (EXT1)|Adverse Event|0
709811|NCT00090220|2296244|P1|Extension 1 (EXT1)|Adverse Event|0
709812|NCT00090220|2296239|P6|Base Study Follow-up Period|Unspecified|0
709813|NCT00090220|2296240|P5|Base Study Follow-up Period|Unspecified|0
709814|NCT00090220|2296241|P4|Base Study Follow-up Period|Unspecified|0
709815|NCT00090220|2296242|P3|Base Study Follow-up Period|Unspecified|0
709816|NCT00090220|2296243|P2|Base Study Follow-up Period|Unspecified|21
709817|NCT00090220|2296244|P1|Base Study Follow-up Period|Unspecified|19
709818|NCT00090220|2296239|P6|Base Study Follow-up Period|Patient Moved|0
709819|NCT00090220|2296240|P5|Base Study Follow-up Period|Patient Moved|0
709820|NCT00090220|2296241|P4|Base Study Follow-up Period|Patient Moved|0
709821|NCT00090220|2296242|P3|Base Study Follow-up Period|Patient Moved|0
709822|NCT00090220|2296243|P2|Base Study Follow-up Period|Patient Moved|28
709823|NCT00090220|2296244|P1|Base Study Follow-up Period|Patient Moved|20
709824|NCT00090220|2296239|P6|Base Study Follow-up Period|Withdrawal by Subject|0
709825|NCT00090220|2296240|P5|Base Study Follow-up Period|Withdrawal by Subject|0
709826|NCT00090220|2296241|P4|Base Study Follow-up Period|Withdrawal by Subject|0
709827|NCT00090220|2296242|P3|Base Study Follow-up Period|Withdrawal by Subject|0
709828|NCT00090220|2296243|P2|Base Study Follow-up Period|Withdrawal by Subject|36
709829|NCT00090220|2296244|P1|Base Study Follow-up Period|Withdrawal by Subject|27
709830|NCT00090220|2296239|P6|Base Study Follow-up Period|Lost to Follow-up|0
709831|NCT00090220|2296240|P5|Base Study Follow-up Period|Lost to Follow-up|0
709832|NCT00090220|2296241|P4|Base Study Follow-up Period|Lost to Follow-up|0
709833|NCT00090220|2296242|P3|Base Study Follow-up Period|Lost to Follow-up|0
709834|NCT00090220|2296243|P2|Base Study Follow-up Period|Lost to Follow-up|78
709835|NCT00090220|2296244|P1|Base Study Follow-up Period|Lost to Follow-up|88
709836|NCT00090220|2296239|P6|Base Study Follow-up Period|Adverse Event|0
709837|NCT00090220|2296240|P5|Base Study Follow-up Period|Adverse Event|0
709838|NCT00090220|2296241|P4|Base Study Follow-up Period|Adverse Event|0
709839|NCT00090220|2296242|P3|Base Study Follow-up Period|Adverse Event|0
709840|NCT00090220|2296243|P2|Base Study Follow-up Period|Adverse Event|1
709841|NCT00090220|2296244|P1|Base Study Follow-up Period|Adverse Event|6
709842|NCT00090220|2296239|P6|Base Study Vaccination Period|Unspecified|0
709843|NCT00090220|2296240|P5|Base Study Vaccination Period|Unspecified|0
709844|NCT00090220|2296241|P4|Base Study Vaccination Period|Unspecified|0
709845|NCT00090220|2296242|P3|Base Study Vaccination Period|Unspecified|0
709846|NCT00090220|2296243|P2|Base Study Vaccination Period|Unspecified|4
709847|NCT00090220|2296244|P1|Base Study Vaccination Period|Unspecified|4
709848|NCT00090220|2296239|P6|Base Study Vaccination Period|Patient Moved|0
709849|NCT00090220|2296240|P5|Base Study Vaccination Period|Patient Moved|0
709850|NCT00090220|2296241|P4|Base Study Vaccination Period|Patient Moved|0
709851|NCT00090220|2296242|P3|Base Study Vaccination Period|Patient Moved|0
709852|NCT00090220|2296243|P2|Base Study Vaccination Period|Patient Moved|2
709853|NCT00090220|2296244|P1|Base Study Vaccination Period|Patient Moved|6
709854|NCT00090220|2296239|P6|Base Study Vaccination Period|Withdrawal by Subject|0
709855|NCT00090220|2296240|P5|Base Study Vaccination Period|Withdrawal by Subject|0
709856|NCT00090220|2296241|P4|Base Study Vaccination Period|Withdrawal by Subject|0
709857|NCT00090220|2296242|P3|Base Study Vaccination Period|Withdrawal by Subject|0
709858|NCT00090220|2296243|P2|Base Study Vaccination Period|Withdrawal by Subject|27
709859|NCT00090220|2296244|P1|Base Study Vaccination Period|Withdrawal by Subject|23
709860|NCT00090220|2296239|P6|Base Study Vaccination Period|Lost to Follow-up|0
709861|NCT00090220|2296240|P5|Base Study Vaccination Period|Lost to Follow-up|0
709862|NCT00090220|2296241|P4|Base Study Vaccination Period|Lost to Follow-up|0
709863|NCT00090220|2296242|P3|Base Study Vaccination Period|Lost to Follow-up|0
709864|NCT00090220|2296243|P2|Base Study Vaccination Period|Lost to Follow-up|28
709865|NCT00090220|2296244|P1|Base Study Vaccination Period|Lost to Follow-up|24
709866|NCT00090220|2296239|P6|Base Study Vaccination Period|Adverse Event|0
709867|NCT00090220|2296240|P5|Base Study Vaccination Period|Adverse Event|0
709868|NCT00090220|2296241|P4|Base Study Vaccination Period|Adverse Event|0
709869|NCT00090220|2296242|P3|Base Study Vaccination Period|Adverse Event|0
709870|NCT00090220|2296243|P2|Base Study Vaccination Period|Adverse Event|1
709871|NCT00090220|2296244|P1|Base Study Vaccination Period|Adverse Event|6
709872|NCT00090220|2296239|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
709873|NCT00090220|2296240|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
709874|NCT00090220|2296241|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
709875|NCT00090220|2296242|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
709876|NCT00090220|2296243|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
709877|NCT00090220|2296244|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
709878|NCT00090233|2296338|P2|Overall Study|Data not available at data cut-off point|1563
709879|NCT00090233|2296339|P1|Overall Study|Data not available at data cut-off point|1552
709880|NCT00090233|2296338|P2|Overall Study|Not Specified|1160
709881|NCT00090233|2296339|P1|Overall Study|Not Specified|1211
709882|NCT00090233|2296338|P2|Overall Study|Moved|189
709883|NCT00090233|2296339|P1|Overall Study|Moved|203
709884|NCT00090233|2296338|P2|Overall Study|Withdrawal by Subject|211
709885|NCT00090233|2296339|P1|Overall Study|Withdrawal by Subject|182
709886|NCT00090233|2296338|P2|Overall Study|Protocol Violation|1022
709887|NCT00090233|2296339|P1|Overall Study|Protocol Violation|960
709888|NCT00090233|2296338|P2|Overall Study|Lost to Follow-up|95
709889|NCT00090233|2296339|P1|Overall Study|Lost to Follow-up|68
709890|NCT00090233|2296338|P2|Overall Study|Adverse Event|198
709891|NCT00090233|2296339|P1|Overall Study|Adverse Event|214
709892|NCT00090233|2296338|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
709893|NCT00090233|2296339|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
709894|NCT00090259|2296363|P2|Overall Study|Investigator site closed|7
709895|NCT00090259|2296364|P1|Overall Study|Investigator site closed|11
709896|NCT00090259|2296363|P2|Overall Study|Withdrawal by Subject|15
709897|NCT00090259|2296364|P1|Overall Study|Withdrawal by Subject|21
709898|NCT00090259|2296363|P2|Overall Study|Lost to Follow-up|26
709899|NCT00090259|2296364|P1|Overall Study|Lost to Follow-up|30
709900|NCT00090285|2296380|P4|Extension 1|Moved|0
709901|NCT00090285|2296381|P3|Extension 1|Moved|3
709902|NCT00090285|2296382|P2|Extension 1|Moved|0
709903|NCT00090285|2296383|P1|Extension 1|Moved|0
709904|NCT00090285|2296380|P4|Extension 1|Other Reason|0
709905|NCT00090285|2296381|P3|Extension 1|Other Reason|4
709906|NCT00090285|2296382|P2|Extension 1|Other Reason|0
709907|NCT00090285|2296383|P1|Extension 1|Other Reason|0
709908|NCT00090285|2296380|P4|Extension 1|Withdrawal by Subject|1
709909|NCT00090285|2296381|P3|Extension 1|Withdrawal by Subject|13
709910|NCT00090285|2296382|P2|Extension 1|Withdrawal by Subject|0
709911|NCT00090285|2296383|P1|Extension 1|Withdrawal by Subject|0
709912|NCT00090285|2296380|P4|Extension 1|Lost to Follow-up|0
709913|NCT00090285|2296381|P3|Extension 1|Lost to Follow-up|35
709914|NCT00090285|2296382|P2|Extension 1|Lost to Follow-up|0
709915|NCT00090285|2296383|P1|Extension 1|Lost to Follow-up|0
709916|NCT00090285|2296380|P4|Extension 1|Adverse Event|0
709917|NCT00090285|2296381|P3|Extension 1|Adverse Event|2
709918|NCT00090285|2296382|P2|Extension 1|Adverse Event|0
709919|NCT00090285|2296383|P1|Extension 1|Adverse Event|0
709920|NCT00090285|2296380|P4|Base Study Follow-up Period|Subject Incarcerated|0
709921|NCT00090285|2296381|P3|Base Study Follow-up Period|Subject Incarcerated|0
709922|NCT00090285|2296382|P2|Base Study Follow-up Period|Subject Incarcerated|2
709923|NCT00090285|2296383|P1|Base Study Follow-up Period|Subject Incarcerated|0
709924|NCT00090285|2296380|P4|Base Study Follow-up Period|Uncooperative|0
709925|NCT00090285|2296381|P3|Base Study Follow-up Period|Uncooperative|0
709926|NCT00090285|2296382|P2|Base Study Follow-up Period|Uncooperative|4
709927|NCT00090285|2296383|P1|Base Study Follow-up Period|Uncooperative|3
709928|NCT00090285|2296380|P4|Base Study Follow-up Period|Protocol Violation|0
709929|NCT00090285|2296381|P3|Base Study Follow-up Period|Protocol Violation|0
709930|NCT00090285|2296382|P2|Base Study Follow-up Period|Protocol Violation|0
709931|NCT00090285|2296383|P1|Base Study Follow-up Period|Protocol Violation|1
709932|NCT00090285|2296380|P4|Base Study Follow-up Period|Unspecified|0
709933|NCT00090285|2296381|P3|Base Study Follow-up Period|Unspecified|0
709934|NCT00090285|2296382|P2|Base Study Follow-up Period|Unspecified|0
709935|NCT00090285|2296383|P1|Base Study Follow-up Period|Unspecified|2
709936|NCT00090285|2296380|P4|Base Study Follow-up Period|Moved|0
709937|NCT00090285|2296381|P3|Base Study Follow-up Period|Moved|0
709938|NCT00090285|2296382|P2|Base Study Follow-up Period|Moved|36
709939|NCT00090285|2296383|P1|Base Study Follow-up Period|Moved|41
709940|NCT00090285|2296380|P4|Base Study Follow-up Period|Withdrawal by Subject|0
709941|NCT00090285|2296381|P3|Base Study Follow-up Period|Withdrawal by Subject|0
709942|NCT00090285|2296382|P2|Base Study Follow-up Period|Withdrawal by Subject|64
709943|NCT00090285|2296383|P1|Base Study Follow-up Period|Withdrawal by Subject|53
709944|NCT00090285|2296380|P4|Base Study Follow-up Period|Lost to Follow-up|0
709945|NCT00090285|2296381|P3|Base Study Follow-up Period|Lost to Follow-up|0
709946|NCT00090285|2296382|P2|Base Study Follow-up Period|Lost to Follow-up|226
709947|NCT00090285|2296383|P1|Base Study Follow-up Period|Lost to Follow-up|232
709948|NCT00090285|2296380|P4|Base Study Follow-up Period|Adverse Event|0
709949|NCT00090285|2296381|P3|Base Study Follow-up Period|Adverse Event|0
709950|NCT00090285|2296382|P2|Base Study Follow-up Period|Adverse Event|10
709951|NCT00090285|2296383|P1|Base Study Follow-up Period|Adverse Event|3
709952|NCT00090285|2296380|P4|Base Study Vaccination Period|HIV positive|0
709953|NCT00090285|2296381|P3|Base Study Vaccination Period|HIV positive|0
709954|NCT00090285|2296382|P2|Base Study Vaccination Period|HIV positive|1
709955|NCT00090285|2296383|P1|Base Study Vaccination Period|HIV positive|1
709956|NCT00090285|2296380|P4|Base Study Vaccination Period|Subject Incarcerated|0
709957|NCT00090285|2296381|P3|Base Study Vaccination Period|Subject Incarcerated|0
709958|NCT00090285|2296382|P2|Base Study Vaccination Period|Subject Incarcerated|2
709959|NCT00090285|2296383|P1|Base Study Vaccination Period|Subject Incarcerated|2
709960|NCT00090285|2296380|P4|Base Study Vaccination Period|Unspecified|0
709961|NCT00090285|2296381|P3|Base Study Vaccination Period|Unspecified|0
709962|NCT00090285|2296382|P2|Base Study Vaccination Period|Unspecified|2
709963|NCT00090285|2296383|P1|Base Study Vaccination Period|Unspecified|2
709964|NCT00090285|2296380|P4|Base Study Vaccination Period|Site Terminated|0
709965|NCT00090285|2296381|P3|Base Study Vaccination Period|Site Terminated|0
709966|NCT00090285|2296382|P2|Base Study Vaccination Period|Site Terminated|0
709967|NCT00090285|2296383|P1|Base Study Vaccination Period|Site Terminated|1
709968|NCT00090285|2296380|P4|Base Study Vaccination Period|Moved|0
709969|NCT00090285|2296381|P3|Base Study Vaccination Period|Moved|0
709970|NCT00090285|2296382|P2|Base Study Vaccination Period|Moved|21
709971|NCT00090285|2296383|P1|Base Study Vaccination Period|Moved|20
709972|NCT00090285|2296380|P4|Base Study Vaccination Period|Uncooperative|0
709973|NCT00090285|2296381|P3|Base Study Vaccination Period|Uncooperative|0
709974|NCT00090285|2296382|P2|Base Study Vaccination Period|Uncooperative|2
709975|NCT00090285|2296383|P1|Base Study Vaccination Period|Uncooperative|2
709976|NCT00090285|2296380|P4|Base Study Vaccination Period|Withdrawal by Subject|0
709977|NCT00090285|2296381|P3|Base Study Vaccination Period|Withdrawal by Subject|0
709978|NCT00090285|2296382|P2|Base Study Vaccination Period|Withdrawal by Subject|69
709979|NCT00090285|2296383|P1|Base Study Vaccination Period|Withdrawal by Subject|64
709980|NCT00090285|2296380|P4|Base Study Vaccination Period|Protocol Violation|0
709981|NCT00090285|2296381|P3|Base Study Vaccination Period|Protocol Violation|0
709982|NCT00090285|2296382|P2|Base Study Vaccination Period|Protocol Violation|3
709983|NCT00090285|2296383|P1|Base Study Vaccination Period|Protocol Violation|2
709984|NCT00090285|2296380|P4|Base Study Vaccination Period|Lost to Follow-up|0
709985|NCT00090285|2296381|P3|Base Study Vaccination Period|Lost to Follow-up|0
709986|NCT00090285|2296382|P2|Base Study Vaccination Period|Lost to Follow-up|112
709987|NCT00090285|2296383|P1|Base Study Vaccination Period|Lost to Follow-up|111
709988|NCT00090285|2296380|P4|Base Study Vaccination Period|Adverse Event|0
709989|NCT00090285|2296381|P3|Base Study Vaccination Period|Adverse Event|0
709990|NCT00090285|2296382|P2|Base Study Vaccination Period|Adverse Event|4
709991|NCT00090285|2296383|P1|Base Study Vaccination Period|Adverse Event|2
709992|NCT00090285|2296380|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
709993|NCT00090285|2296381|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
709994|NCT00090285|2296382|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
709995|NCT00090285|2296383|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
709996|NCT00090363|2296403|P3|Overall Study|Continuing on study off treatment|16
709997|NCT00090363|2296404|P2|Overall Study|Continuing on study off treatment|13
709998|NCT00090363|2296405|P1|Overall Study|Continuing on study off treatment|14
709999|NCT00090363|2296403|P3|Overall Study|Reasons not specified|1
710000|NCT00090363|2296404|P2|Overall Study|Reasons not specified|1
710001|NCT00090363|2296405|P1|Overall Study|Reasons not specified|2
710002|NCT00090363|2296403|P3|Overall Study|Consent expired|9
710003|NCT00090363|2296404|P2|Overall Study|Consent expired|10
710004|NCT00090363|2296405|P1|Overall Study|Consent expired|7
710005|NCT00090363|2296403|P3|Overall Study|Eligibility criteria not fulfilled|1
710006|NCT00090363|2296404|P2|Overall Study|Eligibility criteria not fulfilled|0
710007|NCT00090363|2296405|P1|Overall Study|Eligibility criteria not fulfilled|0
710008|NCT00090363|2296403|P3|Overall Study|Study-specific discontinuation criteria|62
710009|NCT00090363|2296404|P2|Overall Study|Study-specific discontinuation criteria|74
710010|NCT00090363|2296405|P1|Overall Study|Study-specific discontinuation criteria|75
710011|NCT00090363|2296403|P3|Overall Study|Withdrawal by Subject|6
710012|NCT00090363|2296404|P2|Overall Study|Withdrawal by Subject|7
710013|NCT00090363|2296405|P1|Overall Study|Withdrawal by Subject|7
710014|NCT00090363|2296403|P3|Overall Study|Lost to Follow-up|1
710015|NCT00090363|2296404|P2|Overall Study|Lost to Follow-up|2
710016|NCT00090363|2296405|P1|Overall Study|Lost to Follow-up|1
710017|NCT00090402|2296428|P3|Overall Study|stopped taking study medication|1
710018|NCT00090402|2296429|P2|Overall Study|stopped taking study medication|0
710019|NCT00090402|2296430|P1|Overall Study|stopped taking study medication|1
710020|NCT00090402|2296428|P3|Overall Study|subject moved|0
710021|NCT00090402|2296429|P2|Overall Study|subject moved|1
710022|NCT00090402|2296430|P1|Overall Study|subject moved|0
710023|NCT00090402|2296428|P3|Overall Study|Death|0
710024|NCT00090402|2296429|P2|Overall Study|Death|1
710025|NCT00090402|2296430|P1|Overall Study|Death|1
710026|NCT00090493|2296444|P1|Overall Study|Physician Decision|2
710027|NCT00090519|2296450|P2|Overall Study|Sponsor Decision|1
710028|NCT00090519|2296451|P1|Overall Study|Sponsor Decision|3
710029|NCT00090519|2296450|P2|Overall Study|Physician Decision|3
710030|NCT00090519|2296451|P1|Overall Study|Physician Decision|2
710031|NCT00090519|2296450|P2|Overall Study|Withdrawal by Subject|29
710032|NCT00090519|2296451|P1|Overall Study|Withdrawal by Subject|28
710033|NCT00090519|2296450|P2|Overall Study|Lost to Follow-up|29
710034|NCT00090519|2296451|P1|Overall Study|Lost to Follow-up|26
710035|NCT00090519|2296450|P2|Overall Study|Death|9
710036|NCT00090519|2296451|P1|Overall Study|Death|9
710037|NCT00090519|2296450|P2|Overall Study|Adverse Event|4
710038|NCT00090519|2296451|P1|Overall Study|Adverse Event|5
710039|NCT00090545|2296477|P2|Overall Study|Adverse Event|2
710040|NCT00090545|2296478|P1|Overall Study|Adverse Event|0
710041|NCT00090545|2296477|P2|Overall Study|Death|1
710042|NCT00090545|2296478|P1|Overall Study|Death|0
710043|NCT00090545|2296477|P2|Overall Study|Refused further treatment|4
710044|NCT00090545|2296478|P1|Overall Study|Refused further treatment|1
710045|NCT00090545|2296477|P2|Overall Study|Disease progression on study|17
710046|NCT00090545|2296478|P1|Overall Study|Disease progression on study|21
710047|NCT00090584|2296488|P2|Baseline to 8 Months|Lost to Follow-up|41
710048|NCT00090584|2296489|P1|Baseline to 8 Months|Lost to Follow-up|44
710049|NCT00090584|2296488|P2|Baseline to 10 Weeks|Lost to Follow-up|12
710050|NCT00090584|2296489|P1|Baseline to 10 Weeks|Lost to Follow-up|15
710051|NCT00090610|2296521|P2|Overall Study|Withdrawal by Subject|1
710052|NCT00090610|2296522|P1|Overall Study|Withdrawal by Subject|1
710053|NCT00090753|2296538|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
710054|NCT00090753|2296539|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
710055|NCT00090753|2296538|P2|Extended Treatment Period|Mircera Commercialization|93
710056|NCT00090753|2296539|P1|Extended Treatment Period|Mircera Commercialization|188
710057|NCT00090753|2296538|P2|Extended Treatment Period|Renal Transplant|12
710058|NCT00090753|2296539|P1|Extended Treatment Period|Renal Transplant|15
710059|NCT00090753|2296538|P2|Extended Treatment Period|Lost to Follow-up|1
710060|NCT00090753|2296539|P1|Extended Treatment Period|Lost to Follow-up|3
710061|NCT00090753|2296538|P2|Extended Treatment Period|Refused Treatment|12
710062|NCT00090753|2296539|P1|Extended Treatment Period|Refused Treatment|18
710063|NCT00090753|2296538|P2|Extended Treatment Period|Lack of Efficacy|0
710064|NCT00090753|2296539|P1|Extended Treatment Period|Lack of Efficacy|1
710065|NCT00090753|2296538|P2|Extended Treatment Period|Death|30
710066|NCT00090753|2296539|P1|Extended Treatment Period|Death|58
710067|NCT00090753|2296538|P2|Extended Treatment Period|Adverse Event|0
710068|NCT00090753|2296539|P1|Extended Treatment Period|Adverse Event|11
710069|NCT00090753|2296538|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
710070|NCT00090753|2296539|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
710071|NCT00090753|2296538|P2|First Treatment Period|Mircera Commercialization|0
710072|NCT00090753|2296539|P1|First Treatment Period|Mircera Commercialization|1
710073|NCT00090753|2296538|P2|First Treatment Period|Renal Transplant|50
710074|NCT00090753|2296539|P1|First Treatment Period|Renal Transplant|70
710075|NCT00090753|2296538|P2|First Treatment Period|Lost to Follow-up|4
710076|NCT00090753|2296539|P1|First Treatment Period|Lost to Follow-up|4
710077|NCT00090753|2296538|P2|First Treatment Period|Refused Treatment|25
710078|NCT00090753|2296539|P1|First Treatment Period|Refused Treatment|32
710079|NCT00090753|2296538|P2|First Treatment Period|Lack of Efficacy|1
710080|NCT00090753|2296539|P1|First Treatment Period|Lack of Efficacy|2
710081|NCT00090753|2296538|P2|First Treatment Period|Death|62
710082|NCT00090753|2296539|P1|First Treatment Period|Death|88
710083|NCT00090753|2296538|P2|First Treatment Period|Adverse Event|8
710084|NCT00090753|2296539|P1|First Treatment Period|Adverse Event|20
710085|NCT00081159|2296549|P2|Overall Study|Lost to Follow-up|1
710086|NCT00081159|2296550|P1|Overall Study|Lost to Follow-up|2
710087|NCT00081159|2296549|P2|Overall Study|Myelosuppression prior to treatment|1
710088|NCT00081159|2296550|P1|Overall Study|Myelosuppression prior to treatment|0
710089|NCT00081159|2296549|P2|Overall Study|Withdrawal by Subject|3
710090|NCT00081159|2296550|P1|Overall Study|Withdrawal by Subject|0
710091|NCT00081263|2296562|P2|Overall Study|Inadequate data|10
710092|NCT00081263|2296563|P1|Overall Study|Inadequate data|5
710093|NCT00081263|2296562|P2|Overall Study|Never treated|5
710094|NCT00081263|2296563|P1|Overall Study|Never treated|4
710095|NCT00081263|2296562|P2|Overall Study|Inadequate pathology|1
710096|NCT00081263|2296563|P1|Overall Study|Inadequate pathology|0
710097|NCT00081263|2296562|P2|Overall Study|improper pre-protocol therapy|1
710098|NCT00081263|2296563|P1|Overall Study|improper pre-protocol therapy|0
710099|NCT00081263|2296562|P2|Overall Study|wrong cell type|5
710100|NCT00081263|2296563|P1|Overall Study|wrong cell type|7
710101|NCT00081263|2296562|P2|Overall Study|clerical error|0
710102|NCT00081263|2296563|P1|Overall Study|clerical error|1
710103|NCT00081289|2296573|P2|Overall Study|Ineligible / no protocol treatment|4
710104|NCT00081289|2296574|P1|Overall Study|Ineligible / no protocol treatment|3
710105|NCT00081289|2296573|P2|Overall Study|Accrued prior to chemotherapy amendment|17
710106|NCT00081289|2296574|P1|Overall Study|Accrued prior to chemotherapy amendment|18
710107|NCT00081458|2296626|P3|Overall Study|Randomized but not dosed|1
710108|NCT00081458|2296627|P2|Overall Study|Randomized but not dosed|0
710109|NCT00081458|2296628|P1|Overall Study|Randomized but not dosed|0
710110|NCT00081458|2296626|P3|Overall Study|Withdrawal by Subject|1
710111|NCT00081458|2296627|P2|Overall Study|Withdrawal by Subject|3
710112|NCT00081458|2296628|P1|Overall Study|Withdrawal by Subject|0
710113|NCT00081458|2296626|P3|Overall Study|Adverse Event|2
710114|NCT00081458|2296627|P2|Overall Study|Adverse Event|5
710115|NCT00081458|2296628|P1|Overall Study|Adverse Event|1
710116|NCT00090766|2296642|P3|Overall Study|Lost to Follow-up|2
710117|NCT00090766|2296643|P2|Overall Study|Lost to Follow-up|0
710118|NCT00090766|2296644|P1|Overall Study|Lost to Follow-up|2
710119|NCT00090766|2296642|P3|Overall Study|Admin|0
710120|NCT00090766|2296643|P2|Overall Study|Admin|2
710121|NCT00090766|2296644|P1|Overall Study|Admin|0
710122|NCT00090766|2296642|P3|Overall Study|Death|0
710123|NCT00090766|2296643|P2|Overall Study|Death|0
710124|NCT00090766|2296644|P1|Overall Study|Death|1
710125|NCT00090766|2296642|P3|Overall Study|Nephrectomy Planned|1
710126|NCT00090766|2296643|P2|Overall Study|Nephrectomy Planned|0
710127|NCT00090766|2296644|P1|Overall Study|Nephrectomy Planned|0
710128|NCT00090779|2296686|P2|Step 3|Off extended study due to study closure|3
710129|NCT00090779|2296687|P1|Step 3|Off extended study due to study closure|4
710130|NCT00090779|2296686|P2|Step 3|Initiation of ART and off extended study|2
710131|NCT00090779|2296687|P1|Step 3|Initiation of ART and off extended study|3
710132|NCT00090779|2296686|P2|Step 2|Non-compliance to study requirements|1
710133|NCT00090779|2296687|P1|Step 2|Non-compliance to study requirements|0
710134|NCT00090779|2296686|P2|Step 2|Subject relocated|1
710135|NCT00090779|2296687|P1|Step 2|Subject relocated|0
710136|NCT00090779|2296686|P2|Step 2|Off study per study closure|16
710137|NCT00090779|2296687|P1|Step 2|Off study per study closure|6
710138|NCT00090779|2296686|P2|Step 1|Subject relocated|8
710139|NCT00090779|2296687|P1|Step 1|Subject relocated|2
710140|NCT00090779|2296686|P2|Step 1|Non-compliance to study requirements|1
710141|NCT00090779|2296687|P1|Step 1|Non-compliance to study requirements|0
710142|NCT00090779|2296686|P2|Step 1|Pregnancy|0
710143|NCT00090779|2296687|P1|Step 1|Pregnancy|1
710144|NCT00090779|2296686|P2|Step 1|Physician Decision|0
710145|NCT00090779|2296687|P1|Step 1|Physician Decision|1
710146|NCT00090779|2296686|P2|Step 1|Death|2
710147|NCT00090779|2296687|P1|Step 1|Death|0
710148|NCT00090779|2296686|P2|Step 1|Lost to Follow-up|2
710149|NCT00090779|2296687|P1|Step 1|Lost to Follow-up|3
710150|NCT00090779|2296686|P2|Step 1|Withdrawal by Subject|2
710151|NCT00090779|2296687|P1|Step 1|Withdrawal by Subject|4
710152|NCT00090857|2296719|P2|Overall Study|Adverse Event|2
710153|NCT00090857|2296720|P1|Overall Study|Adverse Event|2
710154|NCT00090857|2296719|P2|Overall Study|Withdrawal by Subject|0
710155|NCT00090857|2296720|P1|Overall Study|Withdrawal by Subject|2
710156|NCT00090857|2296719|P2|Overall Study|Lost to Follow-up|1
710157|NCT00090857|2296720|P1|Overall Study|Lost to Follow-up|0
710158|NCT00090987|2296748|P1|Overall Study|Incarcerated|1
710159|NCT00090987|2296748|P1|Overall Study|Non-compliance|4
710160|NCT00090987|2296748|P1|Overall Study|alternative therapy|1
710161|NCT00090987|2296748|P1|Overall Study|Withdrawal by Subject|3
710162|NCT00090987|2296748|P1|Overall Study|Lack of Efficacy|7
710163|NCT00090987|2296748|P1|Overall Study|Adverse Event|5
710164|NCT00091026|2296754|P2|Overall Study|Unknown-never received treatment|1
710165|NCT00091026|2296755|P1|Overall Study|Unknown-never received treatment|0
710166|NCT00091026|2296754|P2|Overall Study|Patient withdrew and never received trea|2
710167|NCT00091026|2296755|P1|Overall Study|Patient withdrew and never received trea|0
710168|NCT00091026|2296754|P2|Overall Study|Patient deemed non eligible-never receiv|0
710169|NCT00091026|2296755|P1|Overall Study|Patient deemed non eligible-never receiv|1
710170|NCT00091169|2296767|P2|Overall Study|Not start protocol therapy|17
710171|NCT00091169|2296768|P1|Overall Study|Not start protocol therapy|26
710172|NCT00091169|2296767|P2|Overall Study|Other|4
710173|NCT00091169|2296768|P1|Overall Study|Other|3
710174|NCT00091169|2296767|P2|Overall Study|Withdrawal by Subject|13
710175|NCT00091169|2296768|P1|Overall Study|Withdrawal by Subject|10
710176|NCT00091169|2296767|P2|Overall Study|Death|1
710177|NCT00091169|2296768|P1|Overall Study|Death|4
710178|NCT00091169|2296767|P2|Overall Study|Adverse Event|17
710179|NCT00091169|2296768|P1|Overall Study|Adverse Event|11
710180|NCT00091169|2296767|P2|Overall Study|Disease progression|1
710181|NCT00091169|2296768|P1|Overall Study|Disease progression|3
710182|NCT00094536|2296801|P1|Treatment and Follow-up|Unable to attend visits|1
710183|NCT00094536|2296801|P1|Treatment and Follow-up|Subject non-compliance|9
710184|NCT00094536|2296801|P1|Treatment and Follow-up|Withdrawal by Subject|1
710185|NCT00094536|2296801|P1|Treatment and Follow-up|Lost to Follow-up|7
710186|NCT00094536|2296801|P1|Treatment and Follow-up|Lack of Efficacy|9
710187|NCT00094536|2296801|P1|Treatment and Follow-up|Adverse Event|4
710188|NCT00094536|2296801|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
710189|NCT00094575|2296807|P2|Overall Study|Death|146
710190|NCT00094575|2296808|P1|Overall Study|Death|146
710191|NCT00094653|2296831|P3|Overall Study|Protocol Violation|1
710192|NCT00094653|2296832|P2|Overall Study|Protocol Violation|0
710193|NCT00094653|2296833|P1|Overall Study|Protocol Violation|0
710194|NCT00094653|2296831|P3|Overall Study|Lost to Follow-up|1
710195|NCT00094653|2296832|P2|Overall Study|Lost to Follow-up|2
710196|NCT00094653|2296833|P1|Overall Study|Lost to Follow-up|3
710197|NCT00094653|2296831|P3|Overall Study|Not specified|2
710198|NCT00094653|2296832|P2|Overall Study|Not specified|2
710199|NCT00094653|2296833|P1|Overall Study|Not specified|2
710200|NCT00094653|2296831|P3|Overall Study|Subject Withdrew Consent|3
710201|NCT00094653|2296832|P2|Overall Study|Subject Withdrew Consent|2
710202|NCT00094653|2296833|P1|Overall Study|Subject Withdrew Consent|10
710203|NCT00094653|2296831|P3|Overall Study|Death|119
710204|NCT00094653|2296832|P2|Overall Study|Death|100
710205|NCT00094653|2296833|P1|Overall Study|Death|306
710206|NCT00094757|2296897|P3|Overall Study|Protocol specified discontinuation|0
710207|NCT00094757|2296898|P2|Overall Study|Protocol specified discontinuation|3
710208|NCT00094757|2296899|P1|Overall Study|Protocol specified discontinuation|1
710209|NCT00094757|2296897|P3|Overall Study|Unspecified|1
710210|NCT00094757|2296898|P2|Overall Study|Unspecified|3
710211|NCT00094757|2296899|P1|Overall Study|Unspecified|3
710212|NCT00094757|2296897|P3|Overall Study|Withdrawal by Subject|5
710213|NCT00094757|2296898|P2|Overall Study|Withdrawal by Subject|21
710214|NCT00094757|2296899|P1|Overall Study|Withdrawal by Subject|14
710215|NCT00094757|2296897|P3|Overall Study|Protocol Violation|3
710216|NCT00094757|2296898|P2|Overall Study|Protocol Violation|5
710217|NCT00094757|2296899|P1|Overall Study|Protocol Violation|8
710218|NCT00094757|2296897|P3|Overall Study|Patient Moved|1
710219|NCT00094757|2296898|P2|Overall Study|Patient Moved|1
710220|NCT00094757|2296899|P1|Overall Study|Patient Moved|2
710221|NCT00094757|2296897|P3|Overall Study|Lost to Follow-up|6
710222|NCT00094757|2296898|P2|Overall Study|Lost to Follow-up|5
710223|NCT00094757|2296899|P1|Overall Study|Lost to Follow-up|3
710224|NCT00094757|2296897|P3|Overall Study|Lack of Efficacy|8
710225|NCT00094757|2296898|P2|Overall Study|Lack of Efficacy|15
710226|NCT00094757|2296899|P1|Overall Study|Lack of Efficacy|11
710227|NCT00094757|2296897|P3|Overall Study|Adverse Event|6
710228|NCT00094757|2296898|P2|Overall Study|Adverse Event|9
710229|NCT00094757|2296899|P1|Overall Study|Adverse Event|11
710230|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Unspecified|23
710231|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Unspecified|15
710232|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
710233|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
710234|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
710235|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
710236|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
710237|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
710238|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
710239|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
710240|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
710241|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
710242|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
710243|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
710244|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
710245|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
710246|NCT00094770|2296918|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
710247|NCT00094770|2296919|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
710248|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Unspecified|11
710249|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Unspecified|10
710250|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
710251|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
710252|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
710253|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
710254|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
710255|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
710256|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
710257|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
710258|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
710259|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
710260|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
710261|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
710262|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
710263|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
710264|NCT00094770|2296918|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
710265|NCT00094770|2296919|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
710266|NCT00094809|2296949|P2|Overall Study|Other|1
710267|NCT00094809|2296950|P1|Overall Study|Other|1
710268|NCT00094809|2296949|P2|Overall Study|Study drug not received|8
710269|NCT00094809|2296950|P1|Overall Study|Study drug not received|2
710270|NCT00094809|2296949|P2|Overall Study|Informed consent signed after treatment|0
710271|NCT00094809|2296950|P1|Overall Study|Informed consent signed after treatment|1
710272|NCT00094809|2296949|P2|Overall Study|Other|4
710273|NCT00094809|2296950|P1|Overall Study|Other|2
710274|NCT00094809|2296949|P2|Overall Study|Protocol-specified criteria|1
710275|NCT00094809|2296950|P1|Overall Study|Protocol-specified criteria|1
710276|NCT00094809|2296949|P2|Overall Study|Death|25
710277|NCT00094809|2296950|P1|Overall Study|Death|19
710278|NCT00094809|2296949|P2|Overall Study|Lost to Follow-up|6
710279|NCT00094809|2296950|P1|Overall Study|Lost to Follow-up|6
710280|NCT00094809|2296949|P2|Overall Study|Physician Decision|5
710281|NCT00094809|2296950|P1|Overall Study|Physician Decision|3
710282|NCT00094809|2296949|P2|Overall Study|Disease progression|3
710283|NCT00094809|2296950|P1|Overall Study|Disease progression|3
710284|NCT00094809|2296949|P2|Overall Study|Withdrawal by Subject|9
710285|NCT00094809|2296950|P1|Overall Study|Withdrawal by Subject|8
710286|NCT00094809|2296949|P2|Overall Study|Adverse Event|1
710287|NCT00094809|2296950|P1|Overall Study|Adverse Event|3
710288|NCT00094809|2296949|P2|Overall Study|Noncompliance|0
710289|NCT00094809|2296950|P1|Overall Study|Noncompliance|1
710290|NCT00094809|2296949|P2|Overall Study|Protocol deviation|2
710291|NCT00094809|2296950|P1|Overall Study|Protocol deviation|2
710292|NCT00094835|2296981|P7|Overall Study|Other|0
710293|NCT00094835|2296982|P6|Overall Study|Other|0
710294|NCT00094835|2296983|P5|Overall Study|Other|0
710295|NCT00094835|2296984|P4|Overall Study|Other|1
710296|NCT00094835|2296985|P3|Overall Study|Other|1
710297|NCT00094835|2296986|P2|Overall Study|Other|1
710298|NCT00094835|2296987|P1|Overall Study|Other|1
710299|NCT00094835|2296981|P7|Overall Study|Non-compliance|1
710300|NCT00094835|2296982|P6|Overall Study|Non-compliance|2
710301|NCT00094835|2296983|P5|Overall Study|Non-compliance|2
710302|NCT00094835|2296984|P4|Overall Study|Non-compliance|0
710303|NCT00094835|2296985|P3|Overall Study|Non-compliance|2
710304|NCT00094835|2296986|P2|Overall Study|Non-compliance|2
710305|NCT00094835|2296987|P1|Overall Study|Non-compliance|1
710306|NCT00094835|2296981|P7|Overall Study|Death|0
710307|NCT00094835|2296982|P6|Overall Study|Death|0
710308|NCT00094835|2296983|P5|Overall Study|Death|1
710309|NCT00094835|2296984|P4|Overall Study|Death|0
710310|NCT00094835|2296985|P3|Overall Study|Death|0
710311|NCT00094835|2296986|P2|Overall Study|Death|0
710312|NCT00094835|2296987|P1|Overall Study|Death|1
710313|NCT00094835|2296981|P7|Overall Study|Lost to Follow-up|0
710314|NCT00094835|2296982|P6|Overall Study|Lost to Follow-up|0
710315|NCT00094835|2296983|P5|Overall Study|Lost to Follow-up|1
710316|NCT00094835|2296984|P4|Overall Study|Lost to Follow-up|0
710317|NCT00094835|2296985|P3|Overall Study|Lost to Follow-up|0
710318|NCT00094835|2296986|P2|Overall Study|Lost to Follow-up|0
710319|NCT00094835|2296987|P1|Overall Study|Lost to Follow-up|0
710320|NCT00094835|2296981|P7|Overall Study|Withdrawal by Subject|1
710321|NCT00094835|2296982|P6|Overall Study|Withdrawal by Subject|0
710322|NCT00094835|2296983|P5|Overall Study|Withdrawal by Subject|0
710323|NCT00094835|2296984|P4|Overall Study|Withdrawal by Subject|0
710324|NCT00094835|2296985|P3|Overall Study|Withdrawal by Subject|0
710325|NCT00094835|2296986|P2|Overall Study|Withdrawal by Subject|0
710326|NCT00094835|2296987|P1|Overall Study|Withdrawal by Subject|0
710327|NCT00094835|2296981|P7|Overall Study|Physician Decision|0
710328|NCT00094835|2296982|P6|Overall Study|Physician Decision|1
710329|NCT00094835|2296983|P5|Overall Study|Physician Decision|0
710330|NCT00094835|2296984|P4|Overall Study|Physician Decision|0
710331|NCT00094835|2296985|P3|Overall Study|Physician Decision|0
710332|NCT00094835|2296986|P2|Overall Study|Physician Decision|0
710333|NCT00094835|2296987|P1|Overall Study|Physician Decision|1
710334|NCT00094861|2297065|P2|Overall Study|Other|0
710335|NCT00094861|2297066|P1|Overall Study|Other|3
710336|NCT00094861|2297065|P2|Overall Study|Death|2
710337|NCT00094861|2297066|P1|Overall Study|Death|4
710338|NCT00094861|2297065|P2|Overall Study|Lost to Follow-up|1
710339|NCT00094861|2297066|P1|Overall Study|Lost to Follow-up|0
710340|NCT00094861|2297065|P2|Overall Study|Physician Decision|1
710341|NCT00094861|2297066|P1|Overall Study|Physician Decision|1
710342|NCT00094861|2297065|P2|Overall Study|Withdrawal by Subject|3
710343|NCT00094861|2297066|P1|Overall Study|Withdrawal by Subject|5
710344|NCT00094861|2297065|P2|Overall Study|Adverse Event|2
710345|NCT00094861|2297066|P1|Overall Study|Adverse Event|5
710350|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Protocol Violation|1
710351|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Protocol Violation|0
710352|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
710353|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
710354|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Death|1
710355|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Death|3
710356|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Patient Moved|0
710357|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Patient Moved|1
710358|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
710359|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
710360|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
710361|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
710362|NCT00095056|2297197|P2|Phase B (Weeks 12-54)|Adverse Event|2
710363|NCT00095056|2297198|P1|Phase B (Weeks 12-54)|Adverse Event|2
710364|NCT00095056|2297197|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
710365|NCT00095056|2297198|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
710366|NCT00095056|2297197|P2|Phase A (Weeks 0-12)|Death|0
710367|NCT00095056|2297198|P1|Phase A (Weeks 0-12)|Death|1
710368|NCT00095056|2297197|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
710369|NCT00095056|2297198|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
710370|NCT00095056|2297197|P2|Phase A (Weeks 0-12)|Adverse Event|1
710371|NCT00095056|2297198|P1|Phase A (Weeks 0-12)|Adverse Event|1
710372|NCT00095121|2297208|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
710373|NCT00095121|2297209|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
710374|NCT00095121|2297208|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
710375|NCT00095121|2297209|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
710376|NCT00095147|2297256|P5|Long-term Extension Period|Leaving country|1
710377|NCT00095147|2297257|P4|Long-term Extension Period|Leaving country|0
710378|NCT00095147|2297258|P3|Long-term Extension Period|Leaving country|0
710379|NCT00095147|2297259|P2|Long-term Extension Period|Leaving country|0
710380|NCT00095147|2297260|P1|Long-term Extension Period|Leaving country|0
710381|NCT00095147|2297256|P5|Long-term Extension Period|Participant chose to use Revellex|1
710382|NCT00095147|2297257|P4|Long-term Extension Period|Participant chose to use Revellex|0
710383|NCT00095147|2297258|P3|Long-term Extension Period|Participant chose to use Revellex|0
710384|NCT00095147|2297259|P2|Long-term Extension Period|Participant chose to use Revellex|0
710385|NCT00095147|2297260|P1|Long-term Extension Period|Participant chose to use Revellex|0
710386|NCT00095147|2297256|P5|Long-term Extension Period|No longer meets study criteria|1
710387|NCT00095147|2297257|P4|Long-term Extension Period|No longer meets study criteria|0
710388|NCT00095147|2297258|P3|Long-term Extension Period|No longer meets study criteria|0
710389|NCT00095147|2297259|P2|Long-term Extension Period|No longer meets study criteria|0
710390|NCT00095147|2297260|P1|Long-term Extension Period|No longer meets study criteria|0
710391|NCT00095147|2297256|P5|Long-term Extension Period|Pregnancy|1
710392|NCT00095147|2297257|P4|Long-term Extension Period|Pregnancy|0
710393|NCT00095147|2297258|P3|Long-term Extension Period|Pregnancy|0
710394|NCT00095147|2297259|P2|Long-term Extension Period|Pregnancy|0
710395|NCT00095147|2297260|P1|Long-term Extension Period|Pregnancy|0
710396|NCT00095147|2297256|P5|Long-term Extension Period|Withdrawal of consent|12
710397|NCT00095147|2297257|P4|Long-term Extension Period|Withdrawal of consent|0
710398|NCT00095147|2297258|P3|Long-term Extension Period|Withdrawal of consent|0
710399|NCT00095147|2297259|P2|Long-term Extension Period|Withdrawal of consent|0
710400|NCT00095147|2297260|P1|Long-term Extension Period|Withdrawal of consent|0
710401|NCT00095147|2297256|P5|Long-term Extension Period|Lost to Follow-up|6
710402|NCT00095147|2297257|P4|Long-term Extension Period|Lost to Follow-up|0
710403|NCT00095147|2297258|P3|Long-term Extension Period|Lost to Follow-up|0
710404|NCT00095147|2297259|P2|Long-term Extension Period|Lost to Follow-up|0
710405|NCT00095147|2297260|P1|Long-term Extension Period|Lost to Follow-up|0
710406|NCT00095147|2297256|P5|Long-term Extension Period|Lack of Efficacy|9
710407|NCT00095147|2297257|P4|Long-term Extension Period|Lack of Efficacy|0
710408|NCT00095147|2297258|P3|Long-term Extension Period|Lack of Efficacy|0
710409|NCT00095147|2297259|P2|Long-term Extension Period|Lack of Efficacy|0
710410|NCT00095147|2297260|P1|Long-term Extension Period|Lack of Efficacy|0
710411|NCT00095147|2297256|P5|Long-term Extension Period|Adverse Event|11
710412|NCT00095147|2297257|P4|Long-term Extension Period|Adverse Event|0
710413|NCT00095147|2297258|P3|Long-term Extension Period|Adverse Event|0
710414|NCT00095147|2297259|P2|Long-term Extension Period|Adverse Event|0
710415|NCT00095147|2297260|P1|Long-term Extension Period|Adverse Event|0
710416|NCT00095147|2297256|P5|Long-term Extension Period|Death|3
710417|NCT00095147|2297257|P4|Long-term Extension Period|Death|0
710418|NCT00095147|2297258|P3|Long-term Extension Period|Death|0
710419|NCT00095147|2297259|P2|Long-term Extension Period|Death|0
710420|NCT00095147|2297260|P1|Long-term Extension Period|Death|0
710421|NCT00095147|2297256|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
710422|NCT00095147|2297257|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
710423|NCT00095147|2297258|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
710424|NCT00095147|2297259|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
710425|NCT00095147|2297260|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
710426|NCT00095147|2297256|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
710427|NCT00095147|2297257|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
710428|NCT00095147|2297258|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
710429|NCT00095147|2297259|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
710430|NCT00095147|2297260|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
710431|NCT00095147|2297256|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
710432|NCT00095147|2297257|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
710433|NCT00095147|2297258|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
710434|NCT00095147|2297259|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
710435|NCT00095147|2297260|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
710436|NCT00095147|2297256|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
710437|NCT00095147|2297257|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
710438|NCT00095147|2297258|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
710439|NCT00095147|2297259|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
710440|NCT00095147|2297260|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
710441|NCT00095147|2297256|P5|Double-blind Period 2 (Days 198-365)|Death|0
710442|NCT00095147|2297257|P4|Double-blind Period 2 (Days 198-365)|Death|1
710443|NCT00095147|2297258|P3|Double-blind Period 2 (Days 198-365)|Death|0
710444|NCT00095147|2297259|P2|Double-blind Period 2 (Days 198-365)|Death|1
710445|NCT00095147|2297260|P1|Double-blind Period 2 (Days 198-365)|Death|0
710446|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
710447|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
710448|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
710449|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
710450|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
710451|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
710452|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
710453|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
710454|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
710455|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
710456|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
710457|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
710458|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
710459|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
710460|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
710461|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
710462|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
710463|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
710464|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
710465|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
710466|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
710467|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
710468|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
710469|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
710470|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
710471|NCT00095147|2297256|P5|Double-blind Period 1 (Days 1-197)|Death|0
710472|NCT00095147|2297257|P4|Double-blind Period 1 (Days 1-197)|Death|0
710473|NCT00095147|2297258|P3|Double-blind Period 1 (Days 1-197)|Death|0
710474|NCT00095147|2297259|P2|Double-blind Period 1 (Days 1-197)|Death|0
710475|NCT00095147|2297260|P1|Double-blind Period 1 (Days 1-197)|Death|1
710476|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Not Specified|8
710477|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Not Specified|6
710478|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Not Specified|4
710479|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Not Specified|0
710480|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Not Specified|0
710481|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Not Specified|0
710482|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
710483|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
710484|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
710485|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
710486|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
710487|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
710488|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
710489|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
710490|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
710491|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
710492|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
710493|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
710494|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
710495|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
710496|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
710497|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
710498|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
710499|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
710500|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
710501|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
710502|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
710503|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
710504|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
710505|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
710506|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
710507|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
710508|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
710509|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
710510|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
710511|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
710512|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
710513|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
710514|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
710515|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
710516|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
710517|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
710518|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
710519|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
710520|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
710521|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
710522|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
710523|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
710524|NCT00095173|2297453|P6|Open-Label Extension Phase (Period C)|Death|1
710525|NCT00095173|2297454|P5|Open-Label Extension Phase (Period C)|Death|0
710526|NCT00095173|2297455|P4|Open-Label Extension Phase (Period C)|Death|0
710527|NCT00095173|2297456|P3|Open-Label Extension Phase (Period C)|Death|0
710528|NCT00095173|2297457|P2|Open-Label Extension Phase (Period C)|Death|0
710529|NCT00095173|2297458|P1|Open-Label Extension Phase (Period C)|Death|0
710530|NCT00095173|2297453|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
710531|NCT00095173|2297454|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
710532|NCT00095173|2297455|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
710533|NCT00095173|2297456|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
710534|NCT00095173|2297457|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
710535|NCT00095173|2297458|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
710536|NCT00095173|2297453|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
710537|NCT00095173|2297454|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
710538|NCT00095173|2297455|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
710539|NCT00095173|2297456|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
710540|NCT00095173|2297457|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
710541|NCT00095173|2297458|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
710542|NCT00095173|2297453|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
710543|NCT00095173|2297454|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
710544|NCT00095173|2297455|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
710545|NCT00095173|2297456|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
710546|NCT00095173|2297457|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
710547|NCT00095173|2297458|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
710548|NCT00095173|2297453|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
710549|NCT00095173|2297454|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
710550|NCT00095173|2297455|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
710551|NCT00095173|2297456|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
710552|NCT00095173|2297457|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
710553|NCT00095173|2297458|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
710554|NCT00095173|2297453|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
710555|NCT00095173|2297454|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
710556|NCT00095173|2297455|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
710557|NCT00095173|2297456|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
710558|NCT00095173|2297457|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
710559|NCT00095173|2297458|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
710560|NCT00095173|2297453|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
710561|NCT00095173|2297454|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
710562|NCT00095173|2297455|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
710563|NCT00095173|2297456|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
710564|NCT00095173|2297457|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
710565|NCT00095173|2297458|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
710566|NCT00095199|2297497|P4|Overall Study|Data inadvertently lost by site|0
710567|NCT00095199|2297498|P3|Overall Study|Data inadvertently lost by site|0
710568|NCT00095199|2297499|P2|Overall Study|Data inadvertently lost by site|0
710569|NCT00095199|2297500|P1|Overall Study|Data inadvertently lost by site|1
710570|NCT00095199|2297497|P4|Overall Study|Primary tumor removed in other surgery|0
710571|NCT00095199|2297498|P3|Overall Study|Primary tumor removed in other surgery|0
710572|NCT00095199|2297499|P2|Overall Study|Primary tumor removed in other surgery|1
710573|NCT00095199|2297500|P1|Overall Study|Primary tumor removed in other surgery|0
710574|NCT00095199|2297497|P4|Overall Study|Started radiotherapy regimen|0
710575|NCT00095199|2297498|P3|Overall Study|Started radiotherapy regimen|0
710576|NCT00095199|2297499|P2|Overall Study|Started radiotherapy regimen|1
710577|NCT00095199|2297500|P1|Overall Study|Started radiotherapy regimen|0
710578|NCT00095199|2297497|P4|Overall Study|Started Palliative Radiotherapy|0
710579|NCT00095199|2297498|P3|Overall Study|Started Palliative Radiotherapy|0
710580|NCT00095199|2297499|P2|Overall Study|Started Palliative Radiotherapy|0
710581|NCT00095199|2297500|P1|Overall Study|Started Palliative Radiotherapy|1
710582|NCT00095199|2297497|P4|Overall Study|Not eligible|1
710583|NCT00095199|2297498|P3|Overall Study|Not eligible|0
710584|NCT00095199|2297499|P2|Overall Study|Not eligible|7
710585|NCT00095199|2297500|P1|Overall Study|Not eligible|1
710586|NCT00095199|2297497|P4|Overall Study|Physician Decision|1
710587|NCT00095199|2297498|P3|Overall Study|Physician Decision|1
710588|NCT00095199|2297499|P2|Overall Study|Physician Decision|6
710589|NCT00095199|2297500|P1|Overall Study|Physician Decision|5
710590|NCT00095199|2297497|P4|Overall Study|Surgery needed could not start in 7 days|0
710591|NCT00095199|2297498|P3|Overall Study|Surgery needed could not start in 7 days|1
710592|NCT00095199|2297499|P2|Overall Study|Surgery needed could not start in 7 days|0
710593|NCT00095199|2297500|P1|Overall Study|Surgery needed could not start in 7 days|0
710594|NCT00095199|2297497|P4|Overall Study|Liver function test results elevated|1
710595|NCT00095199|2297498|P3|Overall Study|Liver function test results elevated|1
710596|NCT00095199|2297499|P2|Overall Study|Liver function test results elevated|0
710597|NCT00095199|2297500|P1|Overall Study|Liver function test results elevated|0
710598|NCT00095199|2297497|P4|Overall Study|Protocol Violation|0
710599|NCT00095199|2297498|P3|Overall Study|Protocol Violation|2
710600|NCT00095199|2297499|P2|Overall Study|Protocol Violation|4
710601|NCT00095199|2297500|P1|Overall Study|Protocol Violation|4
710602|NCT00095199|2297497|P4|Overall Study|Withdrawal by Subject|22
710603|NCT00095199|2297498|P3|Overall Study|Withdrawal by Subject|13
710604|NCT00095199|2297499|P2|Overall Study|Withdrawal by Subject|16
710605|NCT00095199|2297500|P1|Overall Study|Withdrawal by Subject|21
710606|NCT00095199|2297497|P4|Overall Study|Death|9
710607|NCT00095199|2297498|P3|Overall Study|Death|11
710608|NCT00095199|2297499|P2|Overall Study|Death|6
710609|NCT00095199|2297500|P1|Overall Study|Death|10
710610|NCT00095199|2297497|P4|Overall Study|Progressive disease|98
710611|NCT00095199|2297498|P3|Overall Study|Progressive disease|105
710612|NCT00095199|2297499|P2|Overall Study|Progressive disease|179
710613|NCT00095199|2297500|P1|Overall Study|Progressive disease|213
710614|NCT00095199|2297497|P4|Overall Study|Adverse Event|11
710615|NCT00095199|2297498|P3|Overall Study|Adverse Event|26
710616|NCT00095199|2297499|P2|Overall Study|Adverse Event|22
710617|NCT00095199|2297500|P1|Overall Study|Adverse Event|40
710618|NCT00095212|2297540|P2|Overall Study|Withdrawal by Subject|3
710619|NCT00095212|2297541|P1|Overall Study|Withdrawal by Subject|1
710620|NCT00095238|2297569|P2|Overall Study|Other Reasons|88
710621|NCT00095238|2297570|P1|Overall Study|Other Reasons|87
710622|NCT00095238|2297569|P2|Overall Study|Missing|0
710623|NCT00095238|2297570|P1|Overall Study|Missing|1
710624|NCT00095238|2297569|P2|Overall Study|Study terminated by sponsor|1
710625|NCT00095238|2297570|P1|Overall Study|Study terminated by sponsor|0
710626|NCT00095238|2297569|P2|Overall Study|No longer met study criteria|5
710627|NCT00095238|2297570|P1|Overall Study|No longer met study criteria|4
710628|NCT00095238|2297569|P2|Overall Study|Noncompliance|45
710629|NCT00095238|2297570|P1|Overall Study|Noncompliance|44
710630|NCT00095238|2297569|P2|Overall Study|Lost to Follow-up|24
710631|NCT00095238|2297570|P1|Overall Study|Lost to Follow-up|19
710632|NCT00095238|2297569|P2|Overall Study|Death|170
710633|NCT00095238|2297570|P1|Overall Study|Death|154
710634|NCT00095238|2297569|P2|Overall Study|Subject Withdrew Consent|223
710635|NCT00095238|2297570|P1|Overall Study|Subject Withdrew Consent|208
710636|NCT00095238|2297569|P2|Overall Study|Adverse Event|287
710637|NCT00095238|2297570|P1|Overall Study|Adverse Event|331
710638|NCT00095238|2297569|P2|Overall Study|Lack of Efficacy|9
710639|NCT00095238|2297570|P1|Overall Study|Lack of Efficacy|9
710640|NCT00095303|2297632|P2|Follow Up Study|Lost to Follow-up|58
710641|NCT00095303|2297633|P1|Follow Up Study|Lost to Follow-up|59
710642|NCT00095303|2297632|P2|Main Study|Lost to Follow-up|87
710643|NCT00095303|2297633|P1|Main Study|Lost to Follow-up|91
710644|NCT00095498|2297702|P3|Overall Study|Requirement for alternative therapy|2
710645|NCT00095498|2297703|P2|Overall Study|Requirement for alternative therapy|0
710646|NCT00095498|2297704|P1|Overall Study|Requirement for alternative therapy|1
710647|NCT00095498|2297702|P3|Overall Study|Protocol Violation|1
710648|NCT00095498|2297703|P2|Overall Study|Protocol Violation|0
710649|NCT00095498|2297704|P1|Overall Study|Protocol Violation|0
710650|NCT00095498|2297702|P3|Overall Study|Other|6
710651|NCT00095498|2297703|P2|Overall Study|Other|7
710652|NCT00095498|2297704|P1|Overall Study|Other|6
710653|NCT00095498|2297702|P3|Overall Study|Noncompliance|1
710654|NCT00095498|2297703|P2|Overall Study|Noncompliance|0
710655|NCT00095498|2297704|P1|Overall Study|Noncompliance|1
710656|NCT00095498|2297702|P3|Overall Study|Lost to Follow-up|2
710657|NCT00095498|2297703|P2|Overall Study|Lost to Follow-up|1
710658|NCT00095498|2297704|P1|Overall Study|Lost to Follow-up|1
710659|NCT00095498|2297702|P3|Overall Study|Ineligibility determined|2
710660|NCT00095498|2297703|P2|Overall Study|Ineligibility determined|0
710661|NCT00095498|2297704|P1|Overall Study|Ineligibility determined|3
710662|NCT00095498|2297702|P3|Overall Study|Disease progression|1
710663|NCT00095498|2297703|P2|Overall Study|Disease progression|1
710664|NCT00095498|2297704|P1|Overall Study|Disease progression|0
710665|NCT00095498|2297702|P3|Overall Study|Withdrawal by Subject|15
710666|NCT00095498|2297703|P2|Overall Study|Withdrawal by Subject|16
710667|NCT00095498|2297704|P1|Overall Study|Withdrawal by Subject|15
710668|NCT00095498|2297702|P3|Overall Study|Adverse Event|1
710669|NCT00095498|2297703|P2|Overall Study|Adverse Event|0
710670|NCT00095498|2297704|P1|Overall Study|Adverse Event|1
710671|NCT00095498|2297702|P3|Overall Study|Physician Decision|8
710672|NCT00095498|2297703|P2|Overall Study|Physician Decision|10
710673|NCT00095498|2297704|P1|Overall Study|Physician Decision|9
710674|NCT00095576|2298140|P2|Overall Study|Subject moved|36
710675|NCT00095576|2298141|P1|Overall Study|Subject moved|30
710676|NCT00095576|2298140|P2|Overall Study|Site terminated|67
710677|NCT00095576|2298141|P1|Overall Study|Site terminated|75
710678|NCT00095576|2298140|P2|Overall Study|Option to switch to a rollover study|1099
710679|NCT00095576|2298141|P1|Overall Study|Option to switch to a rollover study|1097
710680|NCT00095576|2298140|P2|Overall Study|Withdrawal by Subject|47
710681|NCT00095576|2298141|P1|Overall Study|Withdrawal by Subject|34
710682|NCT00095576|2298140|P2|Overall Study|Protocol Violation|0
710683|NCT00095576|2298141|P1|Overall Study|Protocol Violation|1
710684|NCT00095576|2298140|P2|Overall Study|Lost to Follow-up|229
710685|NCT00095576|2298141|P1|Overall Study|Lost to Follow-up|233
710686|NCT00095576|2298140|P2|Overall Study|Adverse Event|3
710687|NCT00095576|2298141|P1|Overall Study|Adverse Event|5
710688|NCT00095628|2298153|P1|Overall Study|Disease progression prior to treatment|1
710689|NCT00095836|2298185|P1|Overall Study|Death|2
710690|NCT00095836|2298185|P1|Overall Study|Adverse Event|1
710691|NCT00095836|2298185|P1|Overall Study|Lost to Follow-up|1
710692|NCT00095940|2298210|P9|Lapatinib Continuation/Phase II|Adverse Event|0
710693|NCT00095940|2298211|P8|Lapatinib Continuation/Phase II|Adverse Event|1
710694|NCT00095940|2298212|P7|Lapatinib Continuation/Phase II|Adverse Event|0
710695|NCT00095940|2298213|P6|Lapatinib Continuation/Phase II|Adverse Event|0
710696|NCT00095940|2298214|P5|Lapatinib Continuation/Phase II|Adverse Event|0
710697|NCT00095940|2298215|P4|Lapatinib Continuation/Phase II|Adverse Event|0
710782|NCT00096356|2298375|P2|Overall Study|Withdrawal by Subject|23
710698|NCT00095940|2298216|P3|Lapatinib Continuation/Phase II|Adverse Event|0
710699|NCT00095940|2298217|P2|Lapatinib Continuation/Phase II|Adverse Event|0
710700|NCT00095940|2298218|P1|Lapatinib Continuation/Phase II|Adverse Event|0
710701|NCT00095940|2298210|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
710702|NCT00095940|2298211|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
710703|NCT00095940|2298212|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
710704|NCT00095940|2298213|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
710705|NCT00095940|2298214|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
710706|NCT00095940|2298215|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
710707|NCT00095940|2298216|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
710708|NCT00095940|2298217|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
710709|NCT00095940|2298218|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
710710|NCT00095940|2298210|P9|Lapatinib Continuation/Phase II|Disease Progression|12
710711|NCT00095940|2298211|P8|Lapatinib Continuation/Phase II|Disease Progression|1
710712|NCT00095940|2298212|P7|Lapatinib Continuation/Phase II|Disease Progression|2
710713|NCT00095940|2298213|P6|Lapatinib Continuation/Phase II|Disease Progression|13
710714|NCT00095940|2298214|P5|Lapatinib Continuation/Phase II|Disease Progression|0
710715|NCT00095940|2298215|P4|Lapatinib Continuation/Phase II|Disease Progression|0
710716|NCT00095940|2298216|P3|Lapatinib Continuation/Phase II|Disease Progression|15
710717|NCT00095940|2298217|P2|Lapatinib Continuation/Phase II|Disease Progression|1
710718|NCT00095940|2298218|P1|Lapatinib Continuation/Phase II|Disease Progression|1
710720|NCT00096018|2298248|P2|Overall Study|Miscellaneous|1
710721|NCT00096018|2298249|P1|Overall Study|Miscellaneous|2
710722|NCT00096018|2298248|P2|Overall Study|Withdrawal by Subject|2
710723|NCT00096018|2298249|P1|Overall Study|Withdrawal by Subject|0
710724|NCT00096018|2298248|P2|Overall Study|Death|1
710725|NCT00096018|2298249|P1|Overall Study|Death|0
710726|NCT00096018|2298248|P2|Overall Study|Adverse Event|5
710727|NCT00096018|2298249|P1|Overall Study|Adverse Event|0
710728|NCT00096018|2298248|P2|Overall Study|Miscellaneous (not treated)|2
710729|NCT00096018|2298249|P1|Overall Study|Miscellaneous (not treated)|0
710730|NCT00096018|2298248|P2|Overall Study|Became Ineligible (not treated)|3
710731|NCT00096018|2298249|P1|Overall Study|Became Ineligible (not treated)|0
710732|NCT00096031|2298257|P1|Overall Study|Not protocol specified|5
710733|NCT00096031|2298257|P1|Overall Study|Ineligible|8
710734|NCT00096031|2298257|P1|Overall Study|Withdrawal by Subject|1
710735|NCT00096031|2298257|P1|Overall Study|Death|4
710736|NCT00096031|2298257|P1|Overall Study|Lack of Efficacy|42
710737|NCT00096031|2298257|P1|Overall Study|Adverse Event|3
710738|NCT00096044|2298263|P1|Overall Study|Disease Progression|4
710739|NCT00096044|2298263|P1|Overall Study|Adverse Event|21
710740|NCT00096044|2298263|P1|Overall Study|Withdrawal by Subject|9
710741|NCT00096135|2298284|P2|Overall Study|Ineligible|0
710742|NCT00096135|2298285|P1|Overall Study|Ineligible|2
710743|NCT00096135|2298284|P2|Overall Study|Other, specify|3
710744|NCT00096135|2298285|P1|Overall Study|Other, specify|15
710745|NCT00096135|2298284|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
710746|NCT00096135|2298285|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
710747|NCT00096135|2298284|P2|Overall Study|Refusal of further protocol therapy|1
710748|NCT00096135|2298285|P1|Overall Study|Refusal of further protocol therapy|4
710749|NCT00096135|2298284|P2|Overall Study|Physician Decision|4
710750|NCT00096135|2298285|P1|Overall Study|Physician Decision|20
710751|NCT00096174|2298328|P1|Overall Study|other reason|8
710752|NCT00096174|2298328|P1|Overall Study|Ineligible|6
710753|NCT00096174|2298328|P1|Overall Study|Not started protocol therapy|3
710754|NCT00096174|2298328|P1|Overall Study|Withdrawal by Subject|15
710755|NCT00096174|2298328|P1|Overall Study|Death|6
710756|NCT00096174|2298328|P1|Overall Study|Adverse Event|15
710757|NCT00096174|2298328|P1|Overall Study|Lack of Efficacy|9
710758|NCT00096200|2298337|P3|Overall Study|Ineligible pathology|0
710759|NCT00096200|2298338|P2|Overall Study|Ineligible pathology|1
710760|NCT00096200|2298339|P1|Overall Study|Ineligible pathology|0
710761|NCT00096200|2298337|P3|Overall Study|Withdrawal by Subject|0
710762|NCT00096200|2298338|P2|Overall Study|Withdrawal by Subject|2
710763|NCT00096200|2298339|P1|Overall Study|Withdrawal by Subject|1
710764|NCT00096200|2298337|P3|Overall Study|Adverse Event|0
710765|NCT00096200|2298338|P2|Overall Study|Adverse Event|4
710766|NCT00096200|2298339|P1|Overall Study|Adverse Event|0
710767|NCT00096226|2298347|P1|Overall Study|Surgery but inadequate nodal sampling|1
710768|NCT00096226|2298347|P1|Overall Study|Surgical restaging not performed|13
710769|NCT00096226|2298347|P1|Overall Study|Protocol treatment not started|1
710770|NCT00096226|2298347|P1|Overall Study|Ineligible|2
710771|NCT00096265|2298354|P3|Overall Study|Ineligible|0
710772|NCT00096265|2298355|P2|Overall Study|Ineligible|0
710773|NCT00096265|2298356|P1|Overall Study|Ineligible|1
710774|NCT00096278|2298366|P2|Overall Study|Patient not at risk for primary endpoint|2
710775|NCT00096278|2298367|P1|Overall Study|Patient not at risk for primary endpoint|3
710776|NCT00096278|2298366|P2|Overall Study|No follow-up data|18
710777|NCT00096278|2298367|P1|Overall Study|No follow-up data|15
710778|NCT00096356|2298375|P2|Overall Study|multiple reasons|18
710779|NCT00096356|2298376|P1|Overall Study|multiple reasons|10
710780|NCT00096356|2298375|P2|Overall Study|Lack of Efficacy|0
710781|NCT00096356|2298376|P1|Overall Study|Lack of Efficacy|1
710783|NCT00096356|2298376|P1|Overall Study|Withdrawal by Subject|17
710784|NCT00096356|2298375|P2|Overall Study|Physician Decision|3
710785|NCT00096356|2298376|P1|Overall Study|Physician Decision|5
710786|NCT00096356|2298375|P2|Overall Study|Adverse Event|9
710787|NCT00096356|2298376|P1|Overall Study|Adverse Event|11
710788|NCT00096382|2298388|P2|Overall Study|Death during treatment|0
710789|NCT00096382|2298389|P1|Overall Study|Death during treatment|1
710790|NCT00096382|2298388|P2|Overall Study|Not treated|0
710791|NCT00096382|2298389|P1|Overall Study|Not treated|1
710793|NCT00096486|2298416|P4|Overall Study|Not Treated|1
710794|NCT00096486|2298417|P3|Overall Study|Not Treated|1
710795|NCT00096486|2298418|P2|Overall Study|Not Treated|0
710796|NCT00096486|2298419|P1|Overall Study|Not Treated|0
710797|NCT00096486|2298416|P4|Overall Study|Withdrawal by Subject|1
710798|NCT00096486|2298417|P3|Overall Study|Withdrawal by Subject|1
710799|NCT00096486|2298418|P2|Overall Study|Withdrawal by Subject|0
710800|NCT00096486|2298419|P1|Overall Study|Withdrawal by Subject|0
710801|NCT00096538|2298429|P1|Overall Study|Withdrawal by Subject|1
710802|NCT00096785|2298440|P2|Overall Study|Relocated|0
710803|NCT00096785|2298441|P1|Overall Study|Relocated|1
710804|NCT00096785|2298440|P2|Overall Study|Withdrawal by Subject|1
710805|NCT00096785|2298441|P1|Overall Study|Withdrawal by Subject|0
710806|NCT00096785|2298440|P2|Overall Study|Lost to Follow-up|0
710807|NCT00096785|2298441|P1|Overall Study|Lost to Follow-up|1
710808|NCT00096941|2298465|P1|Overall Study|disease progression|3
710809|NCT00096954|2298472|P2|Overall Study|Lost to Follow-up|5
710810|NCT00096954|2298473|P1|Overall Study|Lost to Follow-up|8
710811|NCT00096954|2298472|P2|Overall Study|Non-compliance|3
710812|NCT00096954|2298473|P1|Overall Study|Non-compliance|0
710813|NCT00096954|2298472|P2|Overall Study|Initiation of immunotherapy|0
710814|NCT00096954|2298473|P1|Overall Study|Initiation of immunotherapy|1
710815|NCT00096954|2298472|P2|Overall Study|Pregnancy|1
710816|NCT00096954|2298473|P1|Overall Study|Pregnancy|1
710817|NCT00096954|2298472|P2|Overall Study|Sponsors Decision|1
710818|NCT00096954|2298473|P1|Overall Study|Sponsors Decision|1
710819|NCT00096954|2298472|P2|Overall Study|Physician Decision|1
710820|NCT00096954|2298473|P1|Overall Study|Physician Decision|1
710821|NCT00096954|2298472|P2|Overall Study|Withdrawal by Subject|8
710822|NCT00096954|2298473|P1|Overall Study|Withdrawal by Subject|9
710823|NCT00096954|2298472|P2|Overall Study|Adverse Event|1
710824|NCT00096954|2298473|P1|Overall Study|Adverse Event|3
710825|NCT00096993|2298487|P2|Overall Study|Other unspecified|1
710826|NCT00096993|2298488|P1|Overall Study|Other unspecified|1
710827|NCT00096993|2298487|P2|Overall Study|Non-compliance|1
710828|NCT00096993|2298488|P1|Overall Study|Non-compliance|0
710829|NCT00096993|2298487|P2|Overall Study|Physician Decision|1
710830|NCT00096993|2298488|P1|Overall Study|Physician Decision|2
710831|NCT00096993|2298487|P2|Overall Study|Subject's decision|1
710832|NCT00096993|2298488|P1|Overall Study|Subject's decision|3
710833|NCT00096993|2298487|P2|Overall Study|Adverse Event|8
710834|NCT00096993|2298488|P1|Overall Study|Adverse Event|2
710835|NCT00096993|2298487|P2|Overall Study|Disease progression|53
710836|NCT00096993|2298488|P1|Overall Study|Disease progression|56
710837|NCT00096993|2298487|P2|Overall Study|Death|0
710838|NCT00096993|2298488|P1|Overall Study|Death|1
710839|NCT00085423|2298502|P1|Overall Study|screen failure|1
710840|NCT00085423|2298502|P1|Overall Study|Withdrawal by Subject|1
710841|NCT00085540|2298514|P2|Overall Study|Protocol Violation|1
710842|NCT00085540|2298515|P1|Overall Study|Protocol Violation|0
710843|NCT00085540|2298514|P2|Overall Study|Withdrawal by Subject|1
710844|NCT00085540|2298515|P1|Overall Study|Withdrawal by Subject|0
710845|NCT00085566|2298525|P3|Overall Study|Clinical progression|1
710846|NCT00085566|2298526|P2|Overall Study|Clinical progression|0
710847|NCT00085566|2298527|P1|Overall Study|Clinical progression|0
710848|NCT00085566|2298525|P3|Overall Study|Patient Not treated|3
710849|NCT00085566|2298526|P2|Overall Study|Patient Not treated|0
710850|NCT00085566|2298527|P1|Overall Study|Patient Not treated|0
710851|NCT00085566|2298525|P3|Overall Study|Adverse Event|10
710852|NCT00085566|2298526|P2|Overall Study|Adverse Event|0
710853|NCT00085566|2298527|P1|Overall Study|Adverse Event|0
710854|NCT00085631|2298535|P3|Overall Study|Missing Data|7
710855|NCT00085631|2298536|P2|Overall Study|Missing Data|11
710856|NCT00085631|2298537|P1|Overall Study|Missing Data|4
710857|NCT00085644|2298546|P3|Open-Label Period|Personal reason|4
710858|NCT00085644|2298547|P2|Open-Label Period|Personal reason|0
710859|NCT00085644|2298548|P1|Open-Label Period|Personal reason|0
710860|NCT00085644|2298546|P3|Open-Label Period|Protocol Violation|4
710861|NCT00085644|2298547|P2|Open-Label Period|Protocol Violation|0
710862|NCT00085644|2298548|P1|Open-Label Period|Protocol Violation|0
710863|NCT00085644|2298546|P3|Open-Label Period|Contemplating pregnancy|3
710864|NCT00085644|2298547|P2|Open-Label Period|Contemplating pregnancy|0
710865|NCT00085644|2298548|P1|Open-Label Period|Contemplating pregnancy|0
710866|NCT00085644|2298546|P3|Open-Label Period|Pregnancy|3
710867|NCT00085644|2298547|P2|Open-Label Period|Pregnancy|0
710868|NCT00085644|2298548|P1|Open-Label Period|Pregnancy|0
710869|NCT00085644|2298546|P3|Open-Label Period|Lack of Efficacy|15
710870|NCT00085644|2298547|P2|Open-Label Period|Lack of Efficacy|0
710871|NCT00085644|2298548|P1|Open-Label Period|Lack of Efficacy|0
710872|NCT00085644|2298546|P3|Open-Label Period|Lost to Follow-up|13
710873|NCT00085644|2298547|P2|Open-Label Period|Lost to Follow-up|0
710874|NCT00085644|2298548|P1|Open-Label Period|Lost to Follow-up|0
710875|NCT00085644|2298546|P3|Open-Label Period|Withdrawal by Subject|29
710876|NCT00085644|2298547|P2|Open-Label Period|Withdrawal by Subject|0
710877|NCT00085644|2298548|P1|Open-Label Period|Withdrawal by Subject|0
710878|NCT00085644|2298546|P3|Open-Label Period|Adverse Event|38
710879|NCT00085644|2298547|P2|Open-Label Period|Adverse Event|0
710880|NCT00085644|2298548|P1|Open-Label Period|Adverse Event|0
710881|NCT00085644|2298546|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
710882|NCT00085644|2298547|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
710883|NCT00085644|2298548|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
710884|NCT00085644|2298546|P3|Double-Blind Period|Contemplating pregnancy|0
710885|NCT00085644|2298547|P2|Double-Blind Period|Contemplating pregnancy|0
710886|NCT00085644|2298548|P1|Double-Blind Period|Contemplating pregnancy|1
710887|NCT00085644|2298546|P3|Double-Blind Period|Lack/loss of efficacy|0
710888|NCT00085644|2298547|P2|Double-Blind Period|Lack/loss of efficacy|2
710889|NCT00085644|2298548|P1|Double-Blind Period|Lack/loss of efficacy|2
710890|NCT00085644|2298546|P3|Double-Blind Period|Lost to Follow-up|0
710891|NCT00085644|2298547|P2|Double-Blind Period|Lost to Follow-up|1
710892|NCT00085644|2298548|P1|Double-Blind Period|Lost to Follow-up|2
710893|NCT00085644|2298546|P3|Double-Blind Period|Withdrawal by Subject|0
710894|NCT00085644|2298547|P2|Double-Blind Period|Withdrawal by Subject|0
710895|NCT00085644|2298548|P1|Double-Blind Period|Withdrawal by Subject|3
710896|NCT00085644|2298546|P3|Double-Blind Period|Adverse Event|0
710897|NCT00085644|2298547|P2|Double-Blind Period|Adverse Event|2
710898|NCT00085644|2298548|P1|Double-Blind Period|Adverse Event|5
710899|NCT00085709|2298591|P2|Overall Study|Withdrawal by Subject|1
710900|NCT00085709|2298592|P1|Overall Study|Withdrawal by Subject|2
710901|NCT00085709|2298591|P2|Overall Study|Not eligible|19
710902|NCT00085709|2298592|P1|Overall Study|Not eligible|19
710903|NCT00085709|2298591|P2|Overall Study|Not protocol specified|22
710904|NCT00085709|2298592|P1|Overall Study|Not protocol specified|12
710905|NCT00085709|2298591|P2|Overall Study|Progression|4
710906|NCT00085709|2298592|P1|Overall Study|Progression|3
710907|NCT00085709|2298591|P2|Overall Study|Refusal unrelated to adverse events|2
710908|NCT00085709|2298592|P1|Overall Study|Refusal unrelated to adverse events|1
710909|NCT00085709|2298591|P2|Overall Study|Death|2
710910|NCT00085709|2298592|P1|Overall Study|Death|8
710911|NCT00085709|2298591|P2|Overall Study|Adverse Event|0
710912|NCT00085709|2298592|P1|Overall Study|Adverse Event|8
710913|NCT00085735|2298612|P6|Overall Study|Pt transferred to inst w/out study open|0
710914|NCT00085735|2298613|P5|Overall Study|Pt transferred to inst w/out study open|0
710915|NCT00085735|2298614|P4|Overall Study|Pt transferred to inst w/out study open|0
710916|NCT00085735|2298615|P3|Overall Study|Pt transferred to inst w/out study open|0
710917|NCT00085735|2298616|P2|Overall Study|Pt transferred to inst w/out study open|0
710918|NCT00085735|2298617|P1|Overall Study|Pt transferred to inst w/out study open|1
710919|NCT00085735|2298612|P6|Overall Study|Reason not documented|0
710920|NCT00085735|2298613|P5|Overall Study|Reason not documented|1
710921|NCT00085735|2298614|P4|Overall Study|Reason not documented|0
710922|NCT00085735|2298615|P3|Overall Study|Reason not documented|1
710923|NCT00085735|2298616|P2|Overall Study|Reason not documented|0
710924|NCT00085735|2298617|P1|Overall Study|Reason not documented|1
710925|NCT00085735|2298612|P6|Overall Study|Excess residual disease|4
710926|NCT00085735|2298613|P5|Overall Study|Excess residual disease|1
710927|NCT00085735|2298614|P4|Overall Study|Excess residual disease|1
710928|NCT00085735|2298615|P3|Overall Study|Excess residual disease|1
710929|NCT00085735|2298616|P2|Overall Study|Excess residual disease|2
710930|NCT00085735|2298617|P1|Overall Study|Excess residual disease|2
710931|NCT00085735|2298612|P6|Overall Study|Patient ineligible|8
710932|NCT00085735|2298613|P5|Overall Study|Patient ineligible|17
710933|NCT00085735|2298614|P4|Overall Study|Patient ineligible|7
710934|NCT00085735|2298615|P3|Overall Study|Patient ineligible|3
710935|NCT00085735|2298616|P2|Overall Study|Patient ineligible|0
710936|NCT00085735|2298617|P1|Overall Study|Patient ineligible|1
710937|NCT00085735|2298612|P6|Overall Study|Withdrawal by Subject|8
710938|NCT00085735|2298613|P5|Overall Study|Withdrawal by Subject|7
710939|NCT00085735|2298614|P4|Overall Study|Withdrawal by Subject|5
710940|NCT00085735|2298615|P3|Overall Study|Withdrawal by Subject|4
710941|NCT00085735|2298616|P2|Overall Study|Withdrawal by Subject|0
710942|NCT00085735|2298617|P1|Overall Study|Withdrawal by Subject|1
710943|NCT00085735|2298612|P6|Overall Study|Protocol Violation|0
710944|NCT00085735|2298613|P5|Overall Study|Protocol Violation|0
710945|NCT00085735|2298614|P4|Overall Study|Protocol Violation|0
710946|NCT00085735|2298615|P3|Overall Study|Protocol Violation|0
710947|NCT00085735|2298616|P2|Overall Study|Protocol Violation|0
710948|NCT00085735|2298617|P1|Overall Study|Protocol Violation|1
710949|NCT00085735|2298612|P6|Overall Study|Physician Decision|8
710950|NCT00085735|2298613|P5|Overall Study|Physician Decision|11
710951|NCT00085735|2298614|P4|Overall Study|Physician Decision|3
710952|NCT00085735|2298615|P3|Overall Study|Physician Decision|2
710953|NCT00085735|2298616|P2|Overall Study|Physician Decision|3
710954|NCT00085735|2298617|P1|Overall Study|Physician Decision|2
710955|NCT00085735|2298612|P6|Overall Study|Lost to Follow-up|0
710956|NCT00085735|2298613|P5|Overall Study|Lost to Follow-up|1
710957|NCT00085735|2298614|P4|Overall Study|Lost to Follow-up|0
710958|NCT00085735|2298615|P3|Overall Study|Lost to Follow-up|0
710959|NCT00085735|2298616|P2|Overall Study|Lost to Follow-up|1
710960|NCT00085735|2298617|P1|Overall Study|Lost to Follow-up|0
710961|NCT00085735|2298612|P6|Overall Study|Lack of Efficacy|3
710962|NCT00085735|2298613|P5|Overall Study|Lack of Efficacy|4
710963|NCT00085735|2298614|P4|Overall Study|Lack of Efficacy|3
710964|NCT00085735|2298615|P3|Overall Study|Lack of Efficacy|6
710965|NCT00085735|2298616|P2|Overall Study|Lack of Efficacy|4
710966|NCT00085735|2298617|P1|Overall Study|Lack of Efficacy|2
710967|NCT00085735|2298612|P6|Overall Study|Adverse Event|0
710968|NCT00085735|2298613|P5|Overall Study|Adverse Event|0
710969|NCT00085735|2298614|P4|Overall Study|Adverse Event|0
710970|NCT00085735|2298615|P3|Overall Study|Adverse Event|0
710971|NCT00085735|2298616|P2|Overall Study|Adverse Event|0
710972|NCT00085735|2298617|P1|Overall Study|Adverse Event|1
710973|NCT00085917|2298658|P2|Overall Study|Adverse Event|3
710974|NCT00085917|2298659|P1|Overall Study|Adverse Event|4
710975|NCT00086047|2298671|P2|Overall Study|Physician Decision|1
710976|NCT00086047|2298672|P1|Overall Study|Physician Decision|0
710977|NCT00086047|2298671|P2|Overall Study|Lost to Follow-up|6
710978|NCT00086047|2298672|P1|Overall Study|Lost to Follow-up|7
710979|NCT00086190|2298692|P3|Overall Study|Worsening depression|2
710980|NCT00086190|2298693|P2|Overall Study|Worsening depression|0
710981|NCT00086190|2298694|P1|Overall Study|Worsening depression|0
710982|NCT00086190|2298692|P3|Overall Study|Moved|0
710983|NCT00086190|2298693|P2|Overall Study|Moved|0
710984|NCT00086190|2298694|P1|Overall Study|Moved|1
710985|NCT00086190|2298692|P3|Overall Study|Protocol Violation|0
710986|NCT00086190|2298693|P2|Overall Study|Protocol Violation|0
710987|NCT00086190|2298694|P1|Overall Study|Protocol Violation|1
710988|NCT00086190|2298692|P3|Overall Study|Withdrawal by Subject|2
710989|NCT00086190|2298693|P2|Overall Study|Withdrawal by Subject|2
710990|NCT00086190|2298694|P1|Overall Study|Withdrawal by Subject|0
710991|NCT00086190|2298692|P3|Overall Study|Adverse Event|2
710992|NCT00086190|2298693|P2|Overall Study|Adverse Event|2
710993|NCT00086190|2298694|P1|Overall Study|Adverse Event|6
710994|NCT00086281|2298765|P15|Phase 2|Adverse Event|0
710995|NCT00086281|2298766|P14|Phase 2|Adverse Event|1
710996|NCT00086281|2298767|P13|Phase 2|Adverse Event|1
710997|NCT00086281|2298768|P12|Phase 2|Adverse Event|0
710998|NCT00086281|2298769|P11|Phase 2|Adverse Event|0
710999|NCT00086281|2298770|P10|Phase 2|Adverse Event|0
711000|NCT00086281|2298771|P9|Phase 2|Adverse Event|0
711001|NCT00086281|2298772|P8|Phase 2|Adverse Event|0
711002|NCT00086281|2298773|P7|Phase 2|Adverse Event|0
711003|NCT00086281|2298774|P6|Phase 2|Adverse Event|0
711004|NCT00086281|2298775|P5|Phase 2|Adverse Event|0
711005|NCT00086281|2298776|P4|Phase 2|Adverse Event|0
711006|NCT00086281|2298777|P3|Phase 2|Adverse Event|0
711007|NCT00086281|2298778|P2|Phase 2|Adverse Event|0
711008|NCT00086281|2298779|P1|Phase 2|Adverse Event|0
711009|NCT00086281|2298765|P15|Phase 1|Serious Adverse Event|1
711010|NCT00086281|2298766|P14|Phase 1|Serious Adverse Event|0
711011|NCT00086281|2298767|P13|Phase 1|Serious Adverse Event|0
711012|NCT00086281|2298768|P12|Phase 1|Serious Adverse Event|0
711013|NCT00086281|2298769|P11|Phase 1|Serious Adverse Event|0
711014|NCT00086281|2298770|P10|Phase 1|Serious Adverse Event|0
711015|NCT00086281|2298771|P9|Phase 1|Serious Adverse Event|0
711016|NCT00086281|2298772|P8|Phase 1|Serious Adverse Event|0
711017|NCT00086281|2298773|P7|Phase 1|Serious Adverse Event|0
711018|NCT00086281|2298774|P6|Phase 1|Serious Adverse Event|0
711019|NCT00086281|2298775|P5|Phase 1|Serious Adverse Event|0
711020|NCT00086281|2298776|P4|Phase 1|Serious Adverse Event|0
711021|NCT00086281|2298777|P3|Phase 1|Serious Adverse Event|0
711022|NCT00086281|2298778|P2|Phase 1|Serious Adverse Event|0
711023|NCT00086281|2298779|P1|Phase 1|Serious Adverse Event|0
711024|NCT00086281|2298765|P15|Phase 1|Protocol Violation|0
711025|NCT00086281|2298766|P14|Phase 1|Protocol Violation|0
711026|NCT00086281|2298767|P13|Phase 1|Protocol Violation|0
711027|NCT00086281|2298768|P12|Phase 1|Protocol Violation|0
711028|NCT00086281|2298769|P11|Phase 1|Protocol Violation|1
711029|NCT00086281|2298770|P10|Phase 1|Protocol Violation|0
711030|NCT00086281|2298771|P9|Phase 1|Protocol Violation|0
711031|NCT00086281|2298772|P8|Phase 1|Protocol Violation|0
711032|NCT00086281|2298773|P7|Phase 1|Protocol Violation|0
711033|NCT00086281|2298774|P6|Phase 1|Protocol Violation|0
711034|NCT00086281|2298775|P5|Phase 1|Protocol Violation|0
711035|NCT00086281|2298776|P4|Phase 1|Protocol Violation|0
711036|NCT00086281|2298777|P3|Phase 1|Protocol Violation|0
711037|NCT00086281|2298778|P2|Phase 1|Protocol Violation|0
711038|NCT00086281|2298779|P1|Phase 1|Protocol Violation|0
711039|NCT00086281|2298765|P15|Phase 1|Adverse Event|2
711040|NCT00086281|2298766|P14|Phase 1|Adverse Event|1
711041|NCT00086281|2298767|P13|Phase 1|Adverse Event|1
711042|NCT00086281|2298768|P12|Phase 1|Adverse Event|1
711043|NCT00086281|2298769|P11|Phase 1|Adverse Event|2
711044|NCT00086281|2298770|P10|Phase 1|Adverse Event|1
711045|NCT00086281|2298771|P9|Phase 1|Adverse Event|0
711046|NCT00086281|2298772|P8|Phase 1|Adverse Event|0
711047|NCT00086281|2298773|P7|Phase 1|Adverse Event|0
711048|NCT00086281|2298774|P6|Phase 1|Adverse Event|0
711049|NCT00086281|2298775|P5|Phase 1|Adverse Event|0
711050|NCT00086281|2298776|P4|Phase 1|Adverse Event|0
711051|NCT00086281|2298777|P3|Phase 1|Adverse Event|0
711052|NCT00086281|2298778|P2|Phase 1|Adverse Event|0
711053|NCT00086281|2298779|P1|Phase 1|Adverse Event|0
711054|NCT00086307|2298792|P3|Overall Study|Withdrawal by Subject|2
711055|NCT00086307|2298793|P2|Overall Study|Withdrawal by Subject|0
711056|NCT00086307|2298794|P1|Overall Study|Withdrawal by Subject|0
711057|NCT00086307|2298792|P3|Overall Study|Fatigue and difficulty falling asleep|1
711058|NCT00086307|2298793|P2|Overall Study|Fatigue and difficulty falling asleep|0
711059|NCT00086307|2298794|P1|Overall Study|Fatigue and difficulty falling asleep|0
711060|NCT00086307|2298792|P3|Overall Study|Suicidal ideation|1
711061|NCT00086307|2298793|P2|Overall Study|Suicidal ideation|0
711062|NCT00086307|2298794|P1|Overall Study|Suicidal ideation|0
711063|NCT00086307|2298792|P3|Overall Study|Constipation and sleepiness|1
711064|NCT00086307|2298793|P2|Overall Study|Constipation and sleepiness|0
711065|NCT00086307|2298794|P1|Overall Study|Constipation and sleepiness|0
711066|NCT00086307|2298792|P3|Overall Study|Nausea and headaches|1
711067|NCT00086307|2298793|P2|Overall Study|Nausea and headaches|0
711068|NCT00086307|2298794|P1|Overall Study|Nausea and headaches|0
711069|NCT00086307|2298792|P3|Overall Study|Shortness of breath and muscle spasms|0
711070|NCT00086307|2298793|P2|Overall Study|Shortness of breath and muscle spasms|0
711071|NCT00086307|2298794|P1|Overall Study|Shortness of breath and muscle spasms|1
711072|NCT00086307|2298792|P3|Overall Study|Lack of Efficacy|2
711073|NCT00086307|2298793|P2|Overall Study|Lack of Efficacy|1
711074|NCT00086307|2298794|P1|Overall Study|Lack of Efficacy|1
711075|NCT00086346|2298804|P2|Patients Dosed With Test Article|Lack of Efficacy|0
711076|NCT00086346|2298805|P1|Patients Dosed With Test Article|Lack of Efficacy|11
711077|NCT00086346|2298804|P2|Patients Dosed With Test Article|Protocol Violation|3
711078|NCT00086346|2298805|P1|Patients Dosed With Test Article|Protocol Violation|11
711079|NCT00086346|2298804|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
711080|NCT00086346|2298805|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
711081|NCT00086346|2298804|P2|Patients Dosed With Test Article|Nonmedical event|3
711082|NCT00086346|2298805|P1|Patients Dosed With Test Article|Nonmedical event|7
711083|NCT00086346|2298804|P2|Patients Dosed With Test Article|Lost to Follow-up|3
711084|NCT00086346|2298805|P1|Patients Dosed With Test Article|Lost to Follow-up|1
711085|NCT00086346|2298804|P2|Patients Dosed With Test Article|Adverse Event|11
711086|NCT00086346|2298805|P1|Patients Dosed With Test Article|Adverse Event|94
711087|NCT00086346|2298804|P2|Randomization|Did not receive test article|4
711088|NCT00086346|2298805|P1|Randomization|Did not receive test article|4
711089|NCT00086385|2298821|P4|Overall Study|Death|1
711090|NCT00086385|2298822|P3|Overall Study|Death|1
711091|NCT00086385|2298823|P2|Overall Study|Death|2
711092|NCT00086385|2298824|P1|Overall Study|Death|2
711093|NCT00086411|2298838|P4|Overall Study|Lost to Follow-up|12
711094|NCT00086411|2298839|P3|Overall Study|Lost to Follow-up|13
711095|NCT00086411|2298840|P2|Overall Study|Lost to Follow-up|11
711096|NCT00086411|2298841|P1|Overall Study|Lost to Follow-up|11
711097|NCT00086502|2298868|P2|Overall Study|Patient Accidentally Unblinded|0
711098|NCT00086502|2298869|P1|Overall Study|Patient Accidentally Unblinded|1
711099|NCT00086502|2298868|P2|Overall Study|Protocol Discontinuation Criteria|3
711100|NCT00086502|2298869|P1|Overall Study|Protocol Discontinuation Criteria|1
711101|NCT00086502|2298868|P2|Overall Study|Patient Moved|1
711102|NCT00086502|2298869|P1|Overall Study|Patient Moved|1
711103|NCT00086502|2298868|P2|Overall Study|Withdrawal by Subject|6
711104|NCT00086502|2298869|P1|Overall Study|Withdrawal by Subject|5
711105|NCT00086502|2298868|P2|Overall Study|Protocol Violation|3
711106|NCT00086502|2298869|P1|Overall Study|Protocol Violation|3
711107|NCT00086502|2298868|P2|Overall Study|Pregnancy|1
711108|NCT00086502|2298869|P1|Overall Study|Pregnancy|0
711109|NCT00086502|2298868|P2|Overall Study|Physician Decision|1
711110|NCT00086502|2298869|P1|Overall Study|Physician Decision|1
711111|NCT00086502|2298868|P2|Overall Study|Lost to Follow-up|1
711112|NCT00086502|2298869|P1|Overall Study|Lost to Follow-up|3
711113|NCT00086502|2298868|P2|Overall Study|Lack of Efficacy|2
711114|NCT00086502|2298869|P1|Overall Study|Lack of Efficacy|0
711115|NCT00086502|2298868|P2|Overall Study|Adverse Event|2
711116|NCT00086502|2298869|P1|Overall Study|Adverse Event|11
711117|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Discontinued in error|0
711118|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Discontinued in error|1
711119|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
711120|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
711121|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
711122|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
711123|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Patient Died|1
711124|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Patient Died|3
711125|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
711126|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
711127|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
711128|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
711129|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Patient Moved|2
711130|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Patient Moved|2
711131|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
711132|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
711133|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Protocol Violation|0
711134|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Protocol Violation|1
711135|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Physician Decision|0
711136|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Physician Decision|3
711137|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
711138|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
711139|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
711140|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
711141|NCT00086515|2298879|P2|Phase B (Weeks 24-104)|Adverse Event|10
711142|NCT00086515|2298880|P1|Phase B (Weeks 24-104)|Adverse Event|16
711143|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
711144|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
711145|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Poor compliance|0
711146|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Poor compliance|1
711147|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
711148|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
711149|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
711150|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
711151|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Protocol Violation|1
711152|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Protocol Violation|0
711153|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
711154|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
711155|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
711156|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
711157|NCT00086515|2298879|P2|Phase A to Phase B Transition Period|Adverse Event|1
711158|NCT00086515|2298880|P1|Phase A to Phase B Transition Period|Adverse Event|2
711159|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
711160|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
711161|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
711162|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
711163|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Poor compliance|0
711164|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Poor compliance|1
711165|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
711166|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
711167|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Patient Moved|3
711168|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Patient Moved|2
711169|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
711170|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
711171|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Protocol Violation|1
711172|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Protocol Violation|3
711173|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
711174|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
711175|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
711176|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
711177|NCT00086515|2298879|P2|Phase A (Weeks 0-24)|Adverse Event|9
711178|NCT00086515|2298880|P1|Phase A (Weeks 0-24)|Adverse Event|17
711179|NCT00086580|2298892|P2|Observation Period|Not specified|7
711180|NCT00086580|2298893|P1|Observation Period|Not specified|8
711181|NCT00086580|2298892|P2|Observation Period|Death|55
711182|NCT00086580|2298893|P1|Observation Period|Death|33
711183|NCT00086580|2298892|P2|Observation Period|Withdrawal by Subject|2
711184|NCT00086580|2298893|P1|Observation Period|Withdrawal by Subject|4
711185|NCT00086580|2298892|P2|Observation Period|Unable to comply with protocol|1
711186|NCT00086580|2298893|P1|Observation Period|Unable to comply with protocol|1
711187|NCT00086580|2298892|P2|Follow-up Period|Not specified|6
711188|NCT00086580|2298893|P1|Follow-up Period|Not specified|7
711189|NCT00086580|2298892|P2|Follow-up Period|Death|7
711190|NCT00086580|2298893|P1|Follow-up Period|Death|13
711191|NCT00086580|2298892|P2|Follow-up Period|AE - not related|0
711192|NCT00086580|2298893|P1|Follow-up Period|AE - not related|1
711193|NCT00086580|2298892|P2|Follow-up Period|Physician Decision|1
711194|NCT00086580|2298893|P1|Follow-up Period|Physician Decision|0
711195|NCT00086580|2298892|P2|Follow-up Period|Withdrawal by Subject|6
711196|NCT00086580|2298893|P1|Follow-up Period|Withdrawal by Subject|6
711197|NCT00086580|2298892|P2|Follow-up Period|Unable to comply with protocol|0
711198|NCT00086580|2298893|P1|Follow-up Period|Unable to comply with protocol|5
711199|NCT00086580|2298892|P2|Follow-up Period|Disease progression|99
711200|NCT00086580|2298893|P1|Follow-up Period|Disease progression|72
711201|NCT00086580|2298892|P2|Treatment Period|Not specified|3
711202|NCT00086580|2298893|P1|Treatment Period|Not specified|5
711203|NCT00086580|2298892|P2|Treatment Period|Death|7
711204|NCT00086580|2298893|P1|Treatment Period|Death|5
711205|NCT00086580|2298892|P2|Treatment Period|Anemia or thrombocytopenia|4
711206|NCT00086580|2298893|P1|Treatment Period|Anemia or thrombocytopenia|1
711207|NCT00086580|2298892|P2|Treatment Period|Toxicity - treatment related|15
711208|NCT00086580|2298893|P1|Treatment Period|Toxicity - treatment related|15
711209|NCT00086580|2298892|P2|Treatment Period|AE - not treatment related|7
711210|NCT00086580|2298893|P1|Treatment Period|AE - not treatment related|7
711211|NCT00086580|2298892|P2|Treatment Period|Physician Decision|7
711212|NCT00086580|2298893|P1|Treatment Period|Physician Decision|13
711213|NCT00086580|2298892|P2|Treatment Period|Withdrawal by Subject|8
711214|NCT00086580|2298893|P1|Treatment Period|Withdrawal by Subject|7
711215|NCT00086580|2298892|P2|Treatment Period|Unable to comply with protocol|1
711216|NCT00086580|2298893|P1|Treatment Period|Unable to comply with protocol|3
711217|NCT00086580|2298892|P2|Treatment Period|Disease progression|8
711218|NCT00086580|2298893|P1|Treatment Period|Disease progression|9
711219|NCT00086619|2298939|P2|Overall Study|Protocol Violation|1
711220|NCT00086619|2298940|P1|Overall Study|Protocol Violation|1
711221|NCT00086619|2298939|P2|Overall Study|Adverse Event|10
711222|NCT00086619|2298940|P1|Overall Study|Adverse Event|8
711223|NCT00086619|2298939|P2|Overall Study|Withdrawal by Subject|6
711224|NCT00086619|2298940|P1|Overall Study|Withdrawal by Subject|6
711225|NCT00086684|2298951|P3|Overall Study|Not specified|3
711226|NCT00086684|2298952|P2|Overall Study|Not specified|2
711227|NCT00086684|2298953|P1|Overall Study|Not specified|4
711228|NCT00086684|2298951|P3|Overall Study|WITHDRAWAL OF CONSENT|5
711229|NCT00086684|2298952|P2|Overall Study|WITHDRAWAL OF CONSENT|7
711230|NCT00086684|2298953|P1|Overall Study|WITHDRAWAL OF CONSENT|5
711231|NCT00086684|2298951|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
711232|NCT00086684|2298952|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
711233|NCT00086684|2298953|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
711234|NCT00086684|2298951|P3|Overall Study|NONCOMPLIANCE|6
711235|NCT00086684|2298952|P2|Overall Study|NONCOMPLIANCE|7
711236|NCT00086684|2298953|P1|Overall Study|NONCOMPLIANCE|5
711237|NCT00086684|2298951|P3|Overall Study|Withdrawal by Subject|10
711238|NCT00086684|2298952|P2|Overall Study|Withdrawal by Subject|4
711239|NCT00086684|2298953|P1|Overall Study|Withdrawal by Subject|0
711240|NCT00086684|2298951|P3|Overall Study|Protocol Violation|0
711241|NCT00086684|2298952|P2|Overall Study|Protocol Violation|3
711242|NCT00086684|2298953|P1|Overall Study|Protocol Violation|8
711243|NCT00086684|2298951|P3|Overall Study|Lost to Follow-up|10
711244|NCT00086684|2298952|P2|Overall Study|Lost to Follow-up|8
711245|NCT00086684|2298953|P1|Overall Study|Lost to Follow-up|15
711246|NCT00086684|2298951|P3|Overall Study|Lack of Efficacy|5
711247|NCT00086684|2298952|P2|Overall Study|Lack of Efficacy|6
711248|NCT00086684|2298953|P1|Overall Study|Lack of Efficacy|6
711249|NCT00086684|2298951|P3|Overall Study|Adverse Event|14
711250|NCT00086684|2298952|P2|Overall Study|Adverse Event|17
711251|NCT00086684|2298953|P1|Overall Study|Adverse Event|12
711252|NCT00086996|2298976|P1|Overall Study|not eligible|5
711253|NCT00086996|2298976|P1|Overall Study|not specified|6
711254|NCT00086996|2298976|P1|Overall Study|Withdrawal by Subject|13
711255|NCT00086996|2298976|P1|Overall Study|progression/relapse|7
711256|NCT00086996|2298976|P1|Overall Study|Death|4
711257|NCT00086996|2298976|P1|Overall Study|Adverse Event|29
711258|NCT00087139|2298986|P3|Overall Study|Extradural disease|1
711259|NCT00087139|2298987|P2|Overall Study|Extradural disease|0
711260|NCT00087139|2298988|P1|Overall Study|Extradural disease|0
711261|NCT00087139|2298986|P3|Overall Study|Response achieved|0
711262|NCT00087139|2298987|P2|Overall Study|Response achieved|1
711263|NCT00087139|2298988|P1|Overall Study|Response achieved|0
711264|NCT00087139|2298986|P3|Overall Study|Use of coumadin|0
711265|NCT00087139|2298987|P2|Overall Study|Use of coumadin|0
711266|NCT00087139|2298988|P1|Overall Study|Use of coumadin|1
711267|NCT00087139|2298986|P3|Overall Study|Symptomatic deterioration|3
711268|NCT00087139|2298987|P2|Overall Study|Symptomatic deterioration|1
711269|NCT00087139|2298988|P1|Overall Study|Symptomatic deterioration|1
711270|NCT00087139|2298986|P3|Overall Study|Ineligible|4
711271|NCT00087139|2298987|P2|Overall Study|Ineligible|7
711272|NCT00087139|2298988|P1|Overall Study|Ineligible|4
711273|NCT00087139|2298986|P3|Overall Study|Disease progression|12
711274|NCT00087139|2298987|P2|Overall Study|Disease progression|19
711275|NCT00087139|2298988|P1|Overall Study|Disease progression|9
711276|NCT00087139|2298986|P3|Overall Study|Physician Decision|1
711277|NCT00087139|2298987|P2|Overall Study|Physician Decision|1
711278|NCT00087139|2298988|P1|Overall Study|Physician Decision|1
711279|NCT00087139|2298986|P3|Overall Study|Withdrawal by Subject|2
711280|NCT00087139|2298987|P2|Overall Study|Withdrawal by Subject|2
711281|NCT00087139|2298988|P1|Overall Study|Withdrawal by Subject|3
711282|NCT00087139|2298986|P3|Overall Study|Death|0
711283|NCT00087139|2298987|P2|Overall Study|Death|1
711284|NCT00087139|2298988|P1|Overall Study|Death|2
711285|NCT00087139|2298986|P3|Overall Study|Adverse Event|13
711286|NCT00087139|2298987|P2|Overall Study|Adverse Event|17
711287|NCT00087139|2298988|P1|Overall Study|Adverse Event|18
711288|NCT00087152|2299003|P1|Overall Study|Ineligible|6
711289|NCT00087438|2299009|P1|Overall Study|Ineligible / No protocol treatment|4
711290|NCT00087490|2299015|P2|Overall Study|Randomized but not treated|18
711291|NCT00087490|2299016|P1|Overall Study|Randomized but not treated|7
711292|NCT00087490|2299015|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
711293|NCT00087490|2299016|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
711294|NCT00087490|2299015|P2|Overall Study|Protocol Violation or (/) Unspecified|201
711295|NCT00087490|2299016|P1|Overall Study|Protocol Violation or (/) Unspecified|214
711296|NCT00087490|2299015|P2|Overall Study|Lack of Efficacy|2
711297|NCT00087490|2299016|P1|Overall Study|Lack of Efficacy|0
711298|NCT00087490|2299015|P2|Overall Study|Adverse Event|8
711299|NCT00087490|2299016|P1|Overall Study|Adverse Event|3
711300|NCT00087490|2299015|P2|Overall Study|Death|4
711301|NCT00087490|2299016|P1|Overall Study|Death|6
711302|NCT00087516|2299053|P4|Overall Study|Unspecified|0
711303|NCT00087516|2299054|P3|Overall Study|Unspecified|1
711304|NCT00087516|2299055|P2|Overall Study|Unspecified|0
711305|NCT00087516|2299056|P1|Overall Study|Unspecified|0
711306|NCT00087516|2299053|P4|Overall Study|Recommendation of Primary Care Physician|1
711307|NCT00087516|2299054|P3|Overall Study|Recommendation of Primary Care Physician|0
711308|NCT00087516|2299055|P2|Overall Study|Recommendation of Primary Care Physician|0
711309|NCT00087516|2299056|P1|Overall Study|Recommendation of Primary Care Physician|0
711310|NCT00087516|2299053|P4|Overall Study|Patient was non-compliant|0
711311|NCT00087516|2299054|P3|Overall Study|Patient was non-compliant|0
711312|NCT00087516|2299055|P2|Overall Study|Patient was non-compliant|1
711313|NCT00087516|2299056|P1|Overall Study|Patient was non-compliant|3
711314|NCT00087516|2299053|P4|Overall Study|Patient moved|0
711315|NCT00087516|2299054|P3|Overall Study|Patient moved|1
711316|NCT00087516|2299055|P2|Overall Study|Patient moved|2
711317|NCT00087516|2299056|P1|Overall Study|Patient moved|3
711318|NCT00087516|2299053|P4|Overall Study|Protocol specified discontinuation|26
711319|NCT00087516|2299054|P3|Overall Study|Protocol specified discontinuation|33
711320|NCT00087516|2299055|P2|Overall Study|Protocol specified discontinuation|33
711321|NCT00087516|2299056|P1|Overall Study|Protocol specified discontinuation|35
711322|NCT00087516|2299053|P4|Overall Study|Site terminated|0
711323|NCT00087516|2299054|P3|Overall Study|Site terminated|1
711324|NCT00087516|2299055|P2|Overall Study|Site terminated|2
711325|NCT00087516|2299056|P1|Overall Study|Site terminated|0
711326|NCT00087516|2299053|P4|Overall Study|Withdrawal by Subject|12
711327|NCT00087516|2299054|P3|Overall Study|Withdrawal by Subject|11
711328|NCT00087516|2299055|P2|Overall Study|Withdrawal by Subject|27
711329|NCT00087516|2299056|P1|Overall Study|Withdrawal by Subject|16
711330|NCT00087516|2299053|P4|Overall Study|Protocol Violation|6
711331|NCT00087516|2299054|P3|Overall Study|Protocol Violation|3
711332|NCT00087516|2299055|P2|Overall Study|Protocol Violation|8
711333|NCT00087516|2299056|P1|Overall Study|Protocol Violation|4
711334|NCT00087516|2299053|P4|Overall Study|Lost to Follow-up|5
711335|NCT00087516|2299054|P3|Overall Study|Lost to Follow-up|5
711336|NCT00087516|2299055|P2|Overall Study|Lost to Follow-up|6
711337|NCT00087516|2299056|P1|Overall Study|Lost to Follow-up|8
711338|NCT00087516|2299053|P4|Overall Study|Lack of Efficacy|29
711339|NCT00087516|2299054|P3|Overall Study|Lack of Efficacy|39
711340|NCT00087516|2299055|P2|Overall Study|Lack of Efficacy|80
711341|NCT00087516|2299056|P1|Overall Study|Lack of Efficacy|82
711342|NCT00087516|2299053|P4|Overall Study|Adverse Event|6
711343|NCT00087516|2299054|P3|Overall Study|Adverse Event|3
711344|NCT00087516|2299055|P2|Overall Study|Adverse Event|10
711345|NCT00087516|2299056|P1|Overall Study|Adverse Event|10
711346|NCT00087529|2299085|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
711347|NCT00087529|2299086|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
711348|NCT00087529|2299085|P2|Overall Study|Disease Progression|4
711349|NCT00087529|2299086|P1|Overall Study|Disease Progression|5
711350|NCT00087529|2299085|P2|Overall Study|Participant Noncompliance|1
711351|NCT00087529|2299086|P1|Overall Study|Participant Noncompliance|0
711352|NCT00087529|2299085|P2|Overall Study|Initiation of Excluded Therapy|1
711353|NCT00087529|2299086|P1|Overall Study|Initiation of Excluded Therapy|0
711354|NCT00087529|2299085|P2|Overall Study|Physician Decision|8
711355|NCT00087529|2299086|P1|Overall Study|Physician Decision|4
711356|NCT00087529|2299085|P2|Overall Study|Participant Decision|37
711357|NCT00087529|2299086|P1|Overall Study|Participant Decision|14
711358|NCT00087529|2299085|P2|Overall Study|Lost to Follow-up|3
711359|NCT00087529|2299086|P1|Overall Study|Lost to Follow-up|2
711360|NCT00087529|2299085|P2|Overall Study|Pregnancy|1
711361|NCT00087529|2299086|P1|Overall Study|Pregnancy|0
711362|NCT00087529|2299085|P2|Overall Study|Adverse Event|8
711363|NCT00087529|2299086|P1|Overall Study|Adverse Event|0
711364|NCT00087529|2299085|P2|Overall Study|Death|0
711365|NCT00087529|2299086|P1|Overall Study|Death|1
711366|NCT00087555|2299101|P3|Overall Study|Patient wanted to go back on Med|0
711367|NCT00087555|2299102|P2|Overall Study|Patient wanted to go back on Med|0
711368|NCT00087555|2299103|P1|Overall Study|Patient wanted to go back on Med|1
711369|NCT00087555|2299101|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
711370|NCT00087555|2299102|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
711371|NCT00087555|2299103|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
711372|NCT00087555|2299101|P3|Overall Study|Non Compliance|1
711373|NCT00087555|2299102|P2|Overall Study|Non Compliance|0
711374|NCT00087555|2299103|P1|Overall Study|Non Compliance|0
711375|NCT00087555|2299101|P3|Overall Study|Lack of Efficacy|1
711376|NCT00087555|2299102|P2|Overall Study|Lack of Efficacy|0
711377|NCT00087555|2299103|P1|Overall Study|Lack of Efficacy|2
711378|NCT00087555|2299101|P3|Overall Study|Withdrawal by Subject|1
711379|NCT00087555|2299102|P2|Overall Study|Withdrawal by Subject|2
711380|NCT00087555|2299103|P1|Overall Study|Withdrawal by Subject|3
711381|NCT00087555|2299101|P3|Overall Study|Pregnancy|1
711382|NCT00087555|2299102|P2|Overall Study|Pregnancy|1
711383|NCT00087555|2299103|P1|Overall Study|Pregnancy|0
711384|NCT00087555|2299101|P3|Overall Study|Screen Failure|0
711385|NCT00087555|2299102|P2|Overall Study|Screen Failure|1
711386|NCT00087555|2299103|P1|Overall Study|Screen Failure|1
711387|NCT00087555|2299101|P3|Overall Study|Protocol Violation|2
711388|NCT00087555|2299102|P2|Overall Study|Protocol Violation|0
711389|NCT00087555|2299103|P1|Overall Study|Protocol Violation|0
711390|NCT00087555|2299101|P3|Overall Study|Non - Compliance|0
711391|NCT00087555|2299102|P2|Overall Study|Non - Compliance|0
711392|NCT00087555|2299103|P1|Overall Study|Non - Compliance|1
711393|NCT00087555|2299101|P3|Overall Study|Lost to Follow-up|1
711394|NCT00087555|2299102|P2|Overall Study|Lost to Follow-up|1
711395|NCT00087555|2299103|P1|Overall Study|Lost to Follow-up|0
711396|NCT00087555|2299101|P3|Overall Study|Adverse Event|14
711397|NCT00087555|2299102|P2|Overall Study|Adverse Event|6
711398|NCT00087555|2299103|P1|Overall Study|Adverse Event|3
711399|NCT00087568|2299113|P2|Overall Study|Lack of Efficacy|1
711400|NCT00087568|2299114|P1|Overall Study|Lack of Efficacy|24
711401|NCT00087568|2299113|P2|Overall Study|Lost to Follow-up|0
711402|NCT00087568|2299114|P1|Overall Study|Lost to Follow-up|1
711403|NCT00087568|2299113|P2|Overall Study|Withdrawal by Subject|1
711404|NCT00087568|2299114|P1|Overall Study|Withdrawal by Subject|1
711405|NCT00087568|2299113|P2|Overall Study|Adverse Event|0
711406|NCT00087568|2299114|P1|Overall Study|Adverse Event|4
711407|NCT00087594|2299140|P2|Overall Study|Lack of Efficacy|5
711408|NCT00087594|2299141|P1|Overall Study|Lack of Efficacy|2
711409|NCT00087594|2299140|P2|Overall Study|Withdrawal by Subject|2
711410|NCT00087594|2299141|P1|Overall Study|Withdrawal by Subject|4
711411|NCT00087594|2299140|P2|Overall Study|Lost to Follow-up|2
711412|NCT00087594|2299141|P1|Overall Study|Lost to Follow-up|0
711413|NCT00087594|2299140|P2|Overall Study|Adverse Event|3
711414|NCT00087594|2299141|P1|Overall Study|Adverse Event|2
711415|NCT00087607|2299175|P2|Overall Study|Violation of Selection Criteria at Entry|1
711416|NCT00087607|2299176|P1|Overall Study|Violation of Selection Criteria at Entry|0
711417|NCT00087607|2299175|P2|Overall Study|Other Protocol Violation|2
711418|NCT00087607|2299176|P1|Overall Study|Other Protocol Violation|5
711419|NCT00087607|2299175|P2|Overall Study|Refused Treatment|7
711420|NCT00087607|2299176|P1|Overall Study|Refused Treatment|5
711421|NCT00087607|2299175|P2|Overall Study|Administrative|12
711422|NCT00087607|2299176|P1|Overall Study|Administrative|12
711423|NCT00087607|2299175|P2|Overall Study|Withdrew Consent|16
711424|NCT00087607|2299176|P1|Overall Study|Withdrew Consent|12
711425|NCT00087607|2299175|P2|Overall Study|Failure to return|17
711426|NCT00087607|2299176|P1|Overall Study|Failure to return|21
711427|NCT00087607|2299175|P2|Overall Study|Insufficient Therapeutic Response|42
711428|NCT00087607|2299176|P1|Overall Study|Insufficient Therapeutic Response|53
711429|NCT00087607|2299175|P2|Overall Study|Death|1
711430|NCT00087607|2299176|P1|Overall Study|Death|0
711431|NCT00087607|2299175|P2|Overall Study|Adverse Event|24
711432|NCT00087607|2299176|P1|Overall Study|Adverse Event|14
711433|NCT00087646|2299229|P4|Overall Study|Violation of Selection Criteria at Entry|1
711434|NCT00087646|2299230|P3|Overall Study|Violation of Selection Criteria at Entry|0
711435|NCT00087646|2299231|P2|Overall Study|Violation of Selection Criteria at Entry|0
711436|NCT00087646|2299232|P1|Overall Study|Violation of Selection Criteria at Entry|1
711437|NCT00087646|2299229|P4|Overall Study|Other Protocol Violation|0
711438|NCT00087646|2299230|P3|Overall Study|Other Protocol Violation|0
711439|NCT00087646|2299231|P2|Overall Study|Other Protocol Violation|1
711440|NCT00087646|2299232|P1|Overall Study|Other Protocol Violation|3
711441|NCT00087646|2299229|P4|Overall Study|Administrative/Other|2
711442|NCT00087646|2299230|P3|Overall Study|Administrative/Other|1
711443|NCT00087646|2299231|P2|Overall Study|Administrative/Other|1
711444|NCT00087646|2299232|P1|Overall Study|Administrative/Other|6
711445|NCT00087646|2299229|P4|Overall Study|Failure to Return|3
711446|NCT00087646|2299230|P3|Overall Study|Failure to Return|2
711447|NCT00087646|2299231|P2|Overall Study|Failure to Return|2
711448|NCT00087646|2299232|P1|Overall Study|Failure to Return|5
711449|NCT00087646|2299229|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
711450|NCT00087646|2299230|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
711451|NCT00087646|2299231|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
711452|NCT00087646|2299232|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
711453|NCT00087646|2299229|P4|Overall Study|Insufficient therapeutic response|51
711454|NCT00087646|2299230|P3|Overall Study|Insufficient therapeutic response|38
711455|NCT00087646|2299231|P2|Overall Study|Insufficient therapeutic response|24
711456|NCT00087646|2299232|P1|Overall Study|Insufficient therapeutic response|64
711457|NCT00087646|2299229|P4|Overall Study|Withdrawal by Subject|2
711458|NCT00087646|2299230|P3|Overall Study|Withdrawal by Subject|2
711459|NCT00087646|2299231|P2|Overall Study|Withdrawal by Subject|1
711460|NCT00087646|2299232|P1|Overall Study|Withdrawal by Subject|6
711461|NCT00087646|2299229|P4|Overall Study|Death|0
711462|NCT00087646|2299230|P3|Overall Study|Death|0
711463|NCT00087646|2299231|P2|Overall Study|Death|1
711464|NCT00087646|2299232|P1|Overall Study|Death|0
711465|NCT00087646|2299229|P4|Overall Study|Adverse Event|20
711466|NCT00087646|2299230|P3|Overall Study|Adverse Event|18
711467|NCT00087646|2299231|P2|Overall Study|Adverse Event|6
711468|NCT00087646|2299232|P1|Overall Study|Adverse Event|37
711469|NCT00087685|2299262|P1|Overall Study|Withdrawal by Subject|3
711470|NCT00087685|2299262|P1|Overall Study|Progressive Disease|5
711471|NCT00087685|2299262|P1|Overall Study|Non-Compliance|1
711472|NCT00087685|2299262|P1|Overall Study|Adverse Event|5
711473|NCT00087698|2299267|P1|Overall Study|Protocol Violation|1
711474|NCT00087698|2299267|P1|Overall Study|Death from Study Drug Toxicity|2
711475|NCT00087698|2299267|P1|Overall Study|Death from Study Disease|2
711476|NCT00087698|2299267|P1|Overall Study|Clinical Relapse|1
711477|NCT00087698|2299267|P1|Overall Study|Protocol Entry Criteria Not Met|2
711650|NCT00098293|2299610|P4|Open-label (OL) Phase|Death|0
711478|NCT00087698|2299267|P1|Overall Study|Lack of Efficacy, Physician Perception|3
711479|NCT00087698|2299267|P1|Overall Study|Withdrawal by Subject|4
711480|NCT00087698|2299267|P1|Overall Study|Adverse Event|4
711481|NCT00087698|2299267|P1|Overall Study|Death from Other Causes|3
711482|NCT00087698|2299267|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
711483|NCT00097370|2299291|P1|Stage 3|Lost to Follow-up|1
711484|NCT00097370|2299291|P1|Stage 3|Sponsor Terminated Study|52
711485|NCT00097370|2299291|P1|Stage 3|Lack of Efficacy|1
711486|NCT00097370|2299291|P1|Stage 3|Withdrawal by Subject|3
711487|NCT00097370|2299291|P1|Stage 3|Adverse Event|2
711488|NCT00097370|2299291|P1|Stage 2|Lost to Follow-up|1
711489|NCT00097370|2299291|P1|Stage 2|Sponsor Terminated Study|2
711490|NCT00097370|2299291|P1|Stage 2|Pregnancy|1
711491|NCT00097370|2299291|P1|Stage 2|Lack of Efficacy|3
711492|NCT00097370|2299291|P1|Stage 2|Withdrawal by Subject|1
711493|NCT00097370|2299291|P1|Stage 2|Adverse Event|5
711494|NCT00097370|2299291|P1|Stage 1|Lack of Efficacy|2
711495|NCT00097370|2299291|P1|Stage 1|Withdrawal by Subject|1
711496|NCT00097370|2299291|P1|Stage 1|Adverse Event|3
711497|NCT00097500|2299319|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
711498|NCT00097500|2299320|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
711499|NCT00097500|2299319|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
711500|NCT00097500|2299320|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
711501|NCT00097500|2299319|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
711502|NCT00097500|2299320|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
711503|NCT00097500|2299319|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
711504|NCT00097500|2299320|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
711505|NCT00097500|2299319|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
711506|NCT00097500|2299320|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
711507|NCT00097500|2299319|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
711508|NCT00097500|2299320|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
711509|NCT00097500|2299319|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
711510|NCT00097500|2299320|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
711511|NCT00097539|2299349|P7|Overall Study|Reason not Specified|2
711512|NCT00097539|2299350|P6|Overall Study|Reason not Specified|40
711513|NCT00097539|2299351|P5|Overall Study|Reason not Specified|11
711514|NCT00097539|2299352|P4|Overall Study|Reason not Specified|21
711515|NCT00097539|2299353|P3|Overall Study|Reason not Specified|53
711516|NCT00097539|2299354|P2|Overall Study|Reason not Specified|49
711517|NCT00097539|2299355|P1|Overall Study|Reason not Specified|111
711518|NCT00097539|2299349|P7|Overall Study|Reasons Other Than Above|34
711519|NCT00097539|2299350|P6|Overall Study|Reasons Other Than Above|1244
711520|NCT00097539|2299351|P5|Overall Study|Reasons Other Than Above|361
711521|NCT00097539|2299352|P4|Overall Study|Reasons Other Than Above|692
711522|NCT00097539|2299353|P3|Overall Study|Reasons Other Than Above|1757
711523|NCT00097539|2299354|P2|Overall Study|Reasons Other Than Above|1382
711524|NCT00097539|2299355|P1|Overall Study|Reasons Other Than Above|3602
711525|NCT00097539|2299349|P7|Overall Study|Death|0
711526|NCT00097539|2299350|P6|Overall Study|Death|3
711527|NCT00097539|2299351|P5|Overall Study|Death|1
711528|NCT00097539|2299352|P4|Overall Study|Death|0
711529|NCT00097539|2299353|P3|Overall Study|Death|0
711530|NCT00097539|2299354|P2|Overall Study|Death|7
711531|NCT00097539|2299355|P1|Overall Study|Death|2
711532|NCT00097539|2299349|P7|Overall Study|Adverse Event|1
711533|NCT00097539|2299350|P6|Overall Study|Adverse Event|59
711534|NCT00097539|2299351|P5|Overall Study|Adverse Event|30
711535|NCT00097539|2299352|P4|Overall Study|Adverse Event|27
711536|NCT00097539|2299353|P3|Overall Study|Adverse Event|37
711537|NCT00097539|2299354|P2|Overall Study|Adverse Event|133
711538|NCT00097539|2299355|P1|Overall Study|Adverse Event|78
711539|NCT00097539|2299349|P7|Overall Study|Lack of Efficacy|5
711540|NCT00097539|2299350|P6|Overall Study|Lack of Efficacy|228
711541|NCT00097539|2299351|P5|Overall Study|Lack of Efficacy|45
711542|NCT00097539|2299352|P4|Overall Study|Lack of Efficacy|105
711543|NCT00097539|2299353|P3|Overall Study|Lack of Efficacy|202
711544|NCT00097539|2299354|P2|Overall Study|Lack of Efficacy|122
711545|NCT00097539|2299355|P1|Overall Study|Lack of Efficacy|249
711546|NCT00097539|2299349|P7|Overall Study|Participant Non-compliant|18
711547|NCT00097539|2299350|P6|Overall Study|Participant Non-compliant|543
711548|NCT00097539|2299351|P5|Overall Study|Participant Non-compliant|136
711549|NCT00097539|2299352|P4|Overall Study|Participant Non-compliant|353
711550|NCT00097539|2299353|P3|Overall Study|Participant Non-compliant|1067
711551|NCT00097539|2299354|P2|Overall Study|Participant Non-compliant|567
711552|NCT00097539|2299355|P1|Overall Study|Participant Non-compliant|2140
711553|NCT00097539|2299349|P7|Overall Study|Withdrawal by Subject|3
711554|NCT00097539|2299350|P6|Overall Study|Withdrawal by Subject|229
711555|NCT00097539|2299351|P5|Overall Study|Withdrawal by Subject|68
711556|NCT00097539|2299352|P4|Overall Study|Withdrawal by Subject|217
711557|NCT00097539|2299353|P3|Overall Study|Withdrawal by Subject|346
711558|NCT00097539|2299354|P2|Overall Study|Withdrawal by Subject|323
711559|NCT00097539|2299355|P1|Overall Study|Withdrawal by Subject|925
711560|NCT00097539|2299349|P7|Overall Study|Status Unknown (Or no final evaluation)|108
711561|NCT00097539|2299350|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
711562|NCT00097539|2299351|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
711563|NCT00097539|2299352|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
711564|NCT00097539|2299353|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
711565|NCT00097539|2299354|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
711566|NCT00097539|2299355|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
711567|NCT00097591|2299401|P2|Overall Study|Other|3
711568|NCT00097591|2299402|P1|Overall Study|Other|0
711569|NCT00097591|2299401|P2|Overall Study|Lost to follow up|10
711570|NCT00097591|2299402|P1|Overall Study|Lost to follow up|6
711571|NCT00097591|2299401|P2|Overall Study|Unable to attend termination visit|51
711572|NCT00097591|2299402|P1|Overall Study|Unable to attend termination visit|53
711573|NCT00097591|2299401|P2|Overall Study|Less than 6 months on study drug|7
711574|NCT00097591|2299402|P1|Overall Study|Less than 6 months on study drug|9
711575|NCT00097591|2299401|P2|Overall Study|Withdrawal of consent|323
711576|NCT00097591|2299402|P1|Overall Study|Withdrawal of consent|342
711577|NCT00097721|2299454|P2|Overall Study|Reason not given|1
711578|NCT00097721|2299455|P1|Overall Study|Reason not given|1
711579|NCT00097721|2299454|P2|Overall Study|Physician Decision|3
711580|NCT00097721|2299455|P1|Overall Study|Physician Decision|1
711581|NCT00097721|2299454|P2|Overall Study|Progressive Disease|27
711582|NCT00097721|2299455|P1|Overall Study|Progressive Disease|55
711583|NCT00097721|2299454|P2|Overall Study|Withdrawal by Subject|1
711584|NCT00097721|2299455|P1|Overall Study|Withdrawal by Subject|6
711585|NCT00097721|2299454|P2|Overall Study|Adverse Event|1
711586|NCT00097721|2299455|P1|Overall Study|Adverse Event|8
711587|NCT00097773|2299473|P4|Overall Study|Other|0
711588|NCT00097773|2299474|P3|Overall Study|Other|2
711589|NCT00097773|2299475|P2|Overall Study|Other|0
711590|NCT00097773|2299476|P1|Overall Study|Other|1
711591|NCT00097773|2299473|P4|Overall Study|Adverse Event|0
711592|NCT00097773|2299474|P3|Overall Study|Adverse Event|0
711593|NCT00097773|2299475|P2|Overall Study|Adverse Event|1
711594|NCT00097773|2299476|P1|Overall Study|Adverse Event|0
711595|NCT00097773|2299473|P4|Overall Study|Withdrawal by Subject|1
711596|NCT00097773|2299474|P3|Overall Study|Withdrawal by Subject|3
711597|NCT00097773|2299475|P2|Overall Study|Withdrawal by Subject|3
711598|NCT00097773|2299476|P1|Overall Study|Withdrawal by Subject|3
711599|NCT00097773|2299473|P4|Overall Study|Physician Decision|1
711600|NCT00097773|2299474|P3|Overall Study|Physician Decision|3
711601|NCT00097773|2299475|P2|Overall Study|Physician Decision|2
711602|NCT00097773|2299476|P1|Overall Study|Physician Decision|2
711603|NCT00097773|2299473|P4|Overall Study|Lost to Follow-up|1
711604|NCT00097773|2299474|P3|Overall Study|Lost to Follow-up|0
711605|NCT00097773|2299475|P2|Overall Study|Lost to Follow-up|2
711606|NCT00097773|2299476|P1|Overall Study|Lost to Follow-up|2
711607|NCT00097786|2299498|P4|Overall Study|lost to follow-up for all-cause death|310
711608|NCT00097786|2299499|P3|Overall Study|lost to follow-up for all-cause death|313
711609|NCT00097786|2299500|P2|Overall Study|lost to follow-up for all-cause death|292
711610|NCT00097786|2299501|P1|Overall Study|lost to follow-up for all-cause death|296
711611|NCT00097981|2299521|P2|Overall Study|Other|13
711612|NCT00097981|2299522|P1|Overall Study|Other|19
711613|NCT00097981|2299521|P2|Overall Study|Transplant planned|27
711614|NCT00097981|2299522|P1|Overall Study|Transplant planned|28
711615|NCT00097981|2299521|P2|Overall Study|Disease Progression|2
711616|NCT00097981|2299522|P1|Overall Study|Disease Progression|8
711617|NCT00097981|2299521|P2|Overall Study|Physician Decision|1
711618|NCT00097981|2299522|P1|Overall Study|Physician Decision|7
711619|NCT00097981|2299521|P2|Overall Study|Death|4
711620|NCT00097981|2299522|P1|Overall Study|Death|2
711621|NCT00097981|2299521|P2|Overall Study|Protocol Violation|1
711622|NCT00097981|2299522|P1|Overall Study|Protocol Violation|1
711623|NCT00097981|2299521|P2|Overall Study|Withdrawal by Subject|8
711624|NCT00097981|2299522|P1|Overall Study|Withdrawal by Subject|10
711625|NCT00097981|2299521|P2|Overall Study|Adverse Event|44
711626|NCT00097981|2299522|P1|Overall Study|Adverse Event|31
711627|NCT00098254|2299587|P1|Overall Study|Death|1
711628|NCT00098254|2299587|P1|Overall Study|Adverse Event|2
711629|NCT00098293|2299609|P5|Supplemental Phase (SP)|Unspecified|22
711630|NCT00098293|2299610|P4|Supplemental Phase (SP)|Unspecified|0
711631|NCT00098293|2299611|P3|Supplemental Phase (SP)|Unspecified|0
711632|NCT00098293|2299612|P2|Supplemental Phase (SP)|Unspecified|0
711633|NCT00098293|2299613|P1|Supplemental Phase (SP)|Unspecified|0
711634|NCT00098293|2299609|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
711635|NCT00098293|2299610|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
711636|NCT00098293|2299611|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
711637|NCT00098293|2299612|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
711638|NCT00098293|2299613|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
711639|NCT00098293|2299609|P5|Supplemental Phase (SP)|Lost to Follow-up|2
711640|NCT00098293|2299610|P4|Supplemental Phase (SP)|Lost to Follow-up|0
711641|NCT00098293|2299611|P3|Supplemental Phase (SP)|Lost to Follow-up|0
711642|NCT00098293|2299612|P2|Supplemental Phase (SP)|Lost to Follow-up|0
711643|NCT00098293|2299613|P1|Supplemental Phase (SP)|Lost to Follow-up|0
711644|NCT00098293|2299609|P5|Supplemental Phase (SP)|Death|1
711645|NCT00098293|2299610|P4|Supplemental Phase (SP)|Death|0
711646|NCT00098293|2299611|P3|Supplemental Phase (SP)|Death|0
711647|NCT00098293|2299612|P2|Supplemental Phase (SP)|Death|0
711648|NCT00098293|2299613|P1|Supplemental Phase (SP)|Death|0
711649|NCT00098293|2299609|P5|Open-label (OL) Phase|Death|0
711651|NCT00098293|2299611|P3|Open-label (OL) Phase|Death|3
711652|NCT00098293|2299612|P2|Open-label (OL) Phase|Death|2
711653|NCT00098293|2299613|P1|Open-label (OL) Phase|Death|0
711654|NCT00098293|2299609|P5|Open-label (OL) Phase|Participant Defaulted|0
711655|NCT00098293|2299610|P4|Open-label (OL) Phase|Participant Defaulted|20
711656|NCT00098293|2299611|P3|Open-label (OL) Phase|Participant Defaulted|16
711657|NCT00098293|2299612|P2|Open-label (OL) Phase|Participant Defaulted|6
711658|NCT00098293|2299613|P1|Open-label (OL) Phase|Participant Defaulted|0
711659|NCT00098293|2299609|P5|Open-label (OL) Phase|Protocol Violation|0
711660|NCT00098293|2299610|P4|Open-label (OL) Phase|Protocol Violation|16
711661|NCT00098293|2299611|P3|Open-label (OL) Phase|Protocol Violation|13
711662|NCT00098293|2299612|P2|Open-label (OL) Phase|Protocol Violation|6
711663|NCT00098293|2299613|P1|Open-label (OL) Phase|Protocol Violation|0
711664|NCT00098293|2299609|P5|Open-label (OL) Phase|Pregnancy|0
711665|NCT00098293|2299610|P4|Open-label (OL) Phase|Pregnancy|3
711666|NCT00098293|2299611|P3|Open-label (OL) Phase|Pregnancy|0
711667|NCT00098293|2299612|P2|Open-label (OL) Phase|Pregnancy|1
711668|NCT00098293|2299613|P1|Open-label (OL) Phase|Pregnancy|0
711669|NCT00098293|2299609|P5|Open-label (OL) Phase|Lack of Efficacy|0
711670|NCT00098293|2299610|P4|Open-label (OL) Phase|Lack of Efficacy|20
711671|NCT00098293|2299611|P3|Open-label (OL) Phase|Lack of Efficacy|2
711672|NCT00098293|2299612|P2|Open-label (OL) Phase|Lack of Efficacy|7
711673|NCT00098293|2299613|P1|Open-label (OL) Phase|Lack of Efficacy|0
711674|NCT00098293|2299609|P5|Open-label (OL) Phase|Adverse Event|0
711675|NCT00098293|2299610|P4|Open-label (OL) Phase|Adverse Event|6
711676|NCT00098293|2299611|P3|Open-label (OL) Phase|Adverse Event|7
711677|NCT00098293|2299612|P2|Open-label (OL) Phase|Adverse Event|3
711678|NCT00098293|2299613|P1|Open-label (OL) Phase|Adverse Event|0
711679|NCT00098293|2299609|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
711680|NCT00098293|2299610|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
711681|NCT00098293|2299611|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
711682|NCT00098293|2299612|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
711683|NCT00098293|2299613|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
711684|NCT00098293|2299609|P5|Double-blind (DB) Phase|Terminated by sponsor|0
711685|NCT00098293|2299610|P4|Double-blind (DB) Phase|Terminated by sponsor|0
711686|NCT00098293|2299611|P3|Double-blind (DB) Phase|Terminated by sponsor|0
711687|NCT00098293|2299612|P2|Double-blind (DB) Phase|Terminated by sponsor|0
711688|NCT00098293|2299613|P1|Double-blind (DB) Phase|Terminated by sponsor|135
711689|NCT00098293|2299609|P5|Double-blind (DB) Phase|Protocol Violation|0
711690|NCT00098293|2299610|P4|Double-blind (DB) Phase|Protocol Violation|0
711691|NCT00098293|2299611|P3|Double-blind (DB) Phase|Protocol Violation|22
711692|NCT00098293|2299612|P2|Double-blind (DB) Phase|Protocol Violation|18
711693|NCT00098293|2299613|P1|Double-blind (DB) Phase|Protocol Violation|2
711694|NCT00098293|2299609|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
711695|NCT00098293|2299610|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
711696|NCT00098293|2299611|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
711697|NCT00098293|2299612|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
711698|NCT00098293|2299613|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
711699|NCT00098293|2299609|P5|Double-blind (DB) Phase|Death|0
711700|NCT00098293|2299610|P4|Double-blind (DB) Phase|Death|0
711701|NCT00098293|2299611|P3|Double-blind (DB) Phase|Death|2
711702|NCT00098293|2299612|P2|Double-blind (DB) Phase|Death|2
711703|NCT00098293|2299613|P1|Double-blind (DB) Phase|Death|1
711704|NCT00098293|2299609|P5|Double-blind (DB) Phase|Lack of Efficacy|0
711705|NCT00098293|2299610|P4|Double-blind (DB) Phase|Lack of Efficacy|0
711706|NCT00098293|2299611|P3|Double-blind (DB) Phase|Lack of Efficacy|30
711707|NCT00098293|2299612|P2|Double-blind (DB) Phase|Lack of Efficacy|64
711708|NCT00098293|2299613|P1|Double-blind (DB) Phase|Lack of Efficacy|11
711709|NCT00098293|2299609|P5|Double-blind (DB) Phase|Participant Defaulted|0
711710|NCT00098293|2299610|P4|Double-blind (DB) Phase|Participant Defaulted|0
711711|NCT00098293|2299611|P3|Double-blind (DB) Phase|Participant Defaulted|36
711712|NCT00098293|2299612|P2|Double-blind (DB) Phase|Participant Defaulted|40
711713|NCT00098293|2299613|P1|Double-blind (DB) Phase|Participant Defaulted|11
711714|NCT00098293|2299609|P5|Double-blind (DB) Phase|Pregnancy|0
711715|NCT00098293|2299610|P4|Double-blind (DB) Phase|Pregnancy|0
711716|NCT00098293|2299611|P3|Double-blind (DB) Phase|Pregnancy|9
711717|NCT00098293|2299612|P2|Double-blind (DB) Phase|Pregnancy|7
711718|NCT00098293|2299613|P1|Double-blind (DB) Phase|Pregnancy|0
711719|NCT00098293|2299609|P5|Double-blind (DB) Phase|Adverse Event|0
711720|NCT00098293|2299610|P4|Double-blind (DB) Phase|Adverse Event|0
711721|NCT00098293|2299611|P3|Double-blind (DB) Phase|Adverse Event|60
711722|NCT00098293|2299612|P2|Double-blind (DB) Phase|Adverse Event|27
711723|NCT00098293|2299613|P1|Double-blind (DB) Phase|Adverse Event|14
711724|NCT00098306|2299669|P7|Observational Phase|Un-specified|4
711725|NCT00098306|2299670|P6|Observational Phase|Un-specified|7
711726|NCT00098306|2299671|P5|Observational Phase|Un-specified|0
711727|NCT00098306|2299672|P4|Observational Phase|Un-specified|0
711728|NCT00098306|2299673|P3|Observational Phase|Un-specified|0
711729|NCT00098306|2299674|P2|Observational Phase|Un-specified|0
711730|NCT00098306|2299675|P1|Observational Phase|Un-specified|0
711731|NCT00098306|2299669|P7|Observational Phase|Participant defaulted|18
711732|NCT00098306|2299670|P6|Observational Phase|Participant defaulted|34
711733|NCT00098306|2299671|P5|Observational Phase|Participant defaulted|0
711734|NCT00098306|2299672|P4|Observational Phase|Participant defaulted|0
711735|NCT00098306|2299673|P3|Observational Phase|Participant defaulted|0
711736|NCT00098306|2299674|P2|Observational Phase|Participant defaulted|0
711737|NCT00098306|2299675|P1|Observational Phase|Participant defaulted|0
711738|NCT00098306|2299669|P7|Observational Phase|Death|4
711739|NCT00098306|2299670|P6|Observational Phase|Death|5
711740|NCT00098306|2299671|P5|Observational Phase|Death|0
711741|NCT00098306|2299672|P4|Observational Phase|Death|0
711742|NCT00098306|2299673|P3|Observational Phase|Death|0
711743|NCT00098306|2299674|P2|Observational Phase|Death|0
711744|NCT00098306|2299675|P1|Observational Phase|Death|0
711745|NCT00098306|2299669|P7|Open Label|Ongoing at cut-off date|0
711746|NCT00098306|2299670|P6|Open Label|Ongoing at cut-off date|0
711747|NCT00098306|2299671|P5|Open Label|Ongoing at cut-off date|62
711748|NCT00098306|2299672|P4|Open Label|Ongoing at cut-off date|269
711749|NCT00098306|2299673|P3|Open Label|Ongoing at cut-off date|0
711750|NCT00098306|2299674|P2|Open Label|Ongoing at cut-off date|0
711751|NCT00098306|2299675|P1|Open Label|Ongoing at cut-off date|0
711752|NCT00098306|2299669|P7|Open Label|Un-specified|0
711753|NCT00098306|2299670|P6|Open Label|Un-specified|0
711754|NCT00098306|2299671|P5|Open Label|Un-specified|0
711755|NCT00098306|2299672|P4|Open Label|Un-specified|15
711756|NCT00098306|2299673|P3|Open Label|Un-specified|0
711757|NCT00098306|2299674|P2|Open Label|Un-specified|0
711758|NCT00098306|2299675|P1|Open Label|Un-specified|0
711759|NCT00098306|2299669|P7|Open Label|Participant defaulted|0
711760|NCT00098306|2299670|P6|Open Label|Participant defaulted|0
711761|NCT00098306|2299671|P5|Open Label|Participant defaulted|0
711762|NCT00098306|2299672|P4|Open Label|Participant defaulted|24
711763|NCT00098306|2299673|P3|Open Label|Participant defaulted|0
711764|NCT00098306|2299674|P2|Open Label|Participant defaulted|0
711765|NCT00098306|2299675|P1|Open Label|Participant defaulted|0
711766|NCT00098306|2299669|P7|Open Label|Death|0
711767|NCT00098306|2299670|P6|Open Label|Death|0
711768|NCT00098306|2299671|P5|Open Label|Death|0
711769|NCT00098306|2299672|P4|Open Label|Death|4
711770|NCT00098306|2299673|P3|Open Label|Death|0
711771|NCT00098306|2299674|P2|Open Label|Death|0
711772|NCT00098306|2299675|P1|Open Label|Death|0
711773|NCT00098306|2299669|P7|Open Label|Adverse Event|0
711774|NCT00098306|2299670|P6|Open Label|Adverse Event|0
711775|NCT00098306|2299671|P5|Open Label|Adverse Event|0
711776|NCT00098306|2299672|P4|Open Label|Adverse Event|2
711777|NCT00098306|2299673|P3|Open Label|Adverse Event|0
711778|NCT00098306|2299674|P2|Open Label|Adverse Event|0
711779|NCT00098306|2299675|P1|Open Label|Adverse Event|0
711780|NCT00098306|2299669|P7|Open Label|Lack of Efficacy|0
711781|NCT00098306|2299670|P6|Open Label|Lack of Efficacy|0
711782|NCT00098306|2299671|P5|Open Label|Lack of Efficacy|0
711783|NCT00098306|2299672|P4|Open Label|Lack of Efficacy|13
711784|NCT00098306|2299673|P3|Open Label|Lack of Efficacy|0
711785|NCT00098306|2299674|P2|Open Label|Lack of Efficacy|0
711786|NCT00098306|2299675|P1|Open Label|Lack of Efficacy|0
711787|NCT00098306|2299669|P7|Double Blind|Un-specified|0
711788|NCT00098306|2299670|P6|Double Blind|Un-specified|0
711789|NCT00098306|2299671|P5|Double Blind|Un-specified|0
711790|NCT00098306|2299672|P4|Double Blind|Un-specified|0
711791|NCT00098306|2299673|P3|Double Blind|Un-specified|11
711792|NCT00098306|2299674|P2|Double Blind|Un-specified|3
711793|NCT00098306|2299675|P1|Double Blind|Un-specified|7
711794|NCT00098306|2299669|P7|Double Blind|Participant defaulted|0
711795|NCT00098306|2299670|P6|Double Blind|Participant defaulted|0
711796|NCT00098306|2299671|P5|Double Blind|Participant defaulted|0
711797|NCT00098306|2299672|P4|Double Blind|Participant defaulted|0
711798|NCT00098306|2299673|P3|Double Blind|Participant defaulted|11
711799|NCT00098306|2299674|P2|Double Blind|Participant defaulted|18
711800|NCT00098306|2299675|P1|Double Blind|Participant defaulted|19
711801|NCT00098306|2299669|P7|Double Blind|Death|0
711802|NCT00098306|2299670|P6|Double Blind|Death|0
711803|NCT00098306|2299671|P5|Double Blind|Death|0
711804|NCT00098306|2299672|P4|Double Blind|Death|0
711805|NCT00098306|2299673|P3|Double Blind|Death|1
711806|NCT00098306|2299674|P2|Double Blind|Death|4
711807|NCT00098306|2299675|P1|Double Blind|Death|1
711808|NCT00098306|2299669|P7|Double Blind|Lack of Efficacy|0
711809|NCT00098306|2299670|P6|Double Blind|Lack of Efficacy|0
711810|NCT00098306|2299671|P5|Double Blind|Lack of Efficacy|0
711811|NCT00098306|2299672|P4|Double Blind|Lack of Efficacy|0
711812|NCT00098306|2299673|P3|Double Blind|Lack of Efficacy|17
711813|NCT00098306|2299674|P2|Double Blind|Lack of Efficacy|34
711814|NCT00098306|2299675|P1|Double Blind|Lack of Efficacy|43
711815|NCT00098306|2299669|P7|Double Blind|Adverse Event|0
711816|NCT00098306|2299670|P6|Double Blind|Adverse Event|0
711817|NCT00098306|2299671|P5|Double Blind|Adverse Event|0
711818|NCT00098306|2299672|P4|Double Blind|Adverse Event|0
711819|NCT00098306|2299673|P3|Double Blind|Adverse Event|6
711820|NCT00098306|2299674|P2|Double Blind|Adverse Event|10
711821|NCT00098306|2299675|P1|Double Blind|Adverse Event|11
711822|NCT00098306|2299669|P7|Double Blind|Ongoing at cut-off date|0
711823|NCT00098306|2299670|P6|Double Blind|Ongoing at cut-off date|0
711824|NCT00098306|2299671|P5|Double Blind|Ongoing at cut-off date|0
711825|NCT00098306|2299672|P4|Double Blind|Ongoing at cut-off date|0
711826|NCT00098306|2299673|P3|Double Blind|Ongoing at cut-off date|72
711827|NCT00098306|2299674|P2|Double Blind|Ongoing at cut-off date|166
711828|NCT00098306|2299675|P1|Double Blind|Ongoing at cut-off date|151
711829|NCT00098306|2299669|P7|Double Blind|Randomized, not treated|0
711830|NCT00098306|2299670|P6|Double Blind|Randomized, not treated|0
711831|NCT00098306|2299671|P5|Double Blind|Randomized, not treated|0
711832|NCT00098306|2299672|P4|Double Blind|Randomized, not treated|0
711833|NCT00098306|2299673|P3|Double Blind|Randomized, not treated|2
711834|NCT00098306|2299674|P2|Double Blind|Randomized, not treated|5
711835|NCT00098306|2299675|P1|Double Blind|Randomized, not treated|9
711836|NCT00098345|2299738|P1|Overall Study|progression|4
711837|NCT00098345|2299738|P1|Overall Study|Withdrawal by Subject|2
711838|NCT00098345|2299738|P1|Overall Study|Adverse Event|7
889865|NCT01175356|2824786|P1|Overall Study|Inadequate stem cell for transplant|1
889866|NCT01175356|2824786|P1|Overall Study|On other COG study w/tumor tx intent|7
889867|NCT01175356|2824786|P1|Overall Study|Pts MIBG non-avid after enrollment|2
889868|NCT01175356|2824786|P1|Overall Study|Refusal by patient/parent/guardian|6
889869|NCT01175356|2824786|P1|Overall Study|Treatment Slot Not Available|18
889870|NCT01175356|2824786|P1|Overall Study|Ineligible|1
889871|NCT01175356|2824786|P1|Overall Study|Physician Decision|23
889872|NCT01175356|2824786|P1|Overall Study|Lost to Follow-up|1
889873|NCT01175356|2824786|P1|Overall Study|Lack of Efficacy|12
889874|NCT01175356|2824786|P1|Overall Study|Death|1
889875|NCT01173055|2824794|P2|Period 2 - Day 64 to 112|Adverse Event|1
889876|NCT01173055|2824795|P1|Period 2 - Day 64 to 112|Adverse Event|0
889877|NCT01173055|2824794|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
889878|NCT01173055|2824795|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
889905|NCT01163851|2824938|P2|Overall Study|Enrolled but not treated|0
889906|NCT01163851|2824939|P1|Overall Study|Enrolled but not treated|1
889907|NCT01163851|2824938|P2|Overall Study|Site Closure|1
889908|NCT01163851|2824939|P1|Overall Study|Site Closure|0
889927|NCT01155375|2825047|P2|Overall Study|Adverse Event|0
889928|NCT01155375|2825048|P1|Overall Study|Adverse Event|1
889929|NCT01155388|2825058|P2|Overall Study|Adverse Event|0
889930|NCT01155388|2825059|P1|Overall Study|Adverse Event|1
889931|NCT01124422|2825108|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
889932|NCT01124422|2825109|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
889933|NCT01124422|2825110|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
889934|NCT01124422|2825108|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
889935|NCT01124422|2825109|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
889936|NCT01124422|2825110|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
889937|NCT01124422|2825108|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
889938|NCT01124422|2825109|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
889939|NCT01124422|2825110|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
889940|NCT01124422|2825108|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
889941|NCT01124422|2825109|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
889942|NCT01124422|2825110|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
889943|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
889944|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
889945|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
889946|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
889947|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
889948|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
889949|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
889950|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
889951|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
889952|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Physician Decision|0
889953|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Physician Decision|0
889954|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Physician Decision|4
889955|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Adverse Event|0
889956|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Adverse Event|0
889957|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Adverse Event|7
889958|NCT01124422|2825108|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
889959|NCT01124422|2825109|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
889960|NCT01124422|2825110|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
889961|NCT01120184|2825155|P3|Overall Study|Death|169
889962|NCT01120184|2825156|P2|Overall Study|Death|176
889963|NCT01120184|2825157|P1|Overall Study|Death|170
889964|NCT01120184|2825155|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
889965|NCT01120184|2825156|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
889966|NCT01120184|2825157|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
711955|NCT00098722|2299802|P7|Observation Phase|Unspecified|10
711956|NCT00098722|2299803|P6|Observation Phase|Unspecified|21
711957|NCT00098722|2299804|P5|Observation Phase|Unspecified|0
711958|NCT00098722|2299805|P4|Observation Phase|Unspecified|0
711959|NCT00098722|2299806|P3|Observation Phase|Unspecified|0
711960|NCT00098722|2299807|P2|Observation Phase|Unspecified|0
711961|NCT00098722|2299808|P1|Observation Phase|Unspecified|0
711962|NCT00098722|2299802|P7|Observation Phase|Participant defaulted|4
711963|NCT00098722|2299803|P6|Observation Phase|Participant defaulted|17
711964|NCT00098722|2299804|P5|Observation Phase|Participant defaulted|0
711965|NCT00098722|2299805|P4|Observation Phase|Participant defaulted|0
711966|NCT00098722|2299806|P3|Observation Phase|Participant defaulted|0
711967|NCT00098722|2299807|P2|Observation Phase|Participant defaulted|0
711968|NCT00098722|2299808|P1|Observation Phase|Participant defaulted|0
711969|NCT00098722|2299802|P7|Observation Phase|Lack of Efficacy|0
711970|NCT00098722|2299803|P6|Observation Phase|Lack of Efficacy|2
711971|NCT00098722|2299804|P5|Observation Phase|Lack of Efficacy|0
711972|NCT00098722|2299805|P4|Observation Phase|Lack of Efficacy|0
711973|NCT00098722|2299806|P3|Observation Phase|Lack of Efficacy|0
711974|NCT00098722|2299807|P2|Observation Phase|Lack of Efficacy|0
711975|NCT00098722|2299808|P1|Observation Phase|Lack of Efficacy|0
711976|NCT00098722|2299802|P7|Observation Phase|Death|3
711977|NCT00098722|2299803|P6|Observation Phase|Death|5
711978|NCT00098722|2299804|P5|Observation Phase|Death|0
711979|NCT00098722|2299805|P4|Observation Phase|Death|0
711980|NCT00098722|2299806|P3|Observation Phase|Death|0
711981|NCT00098722|2299807|P2|Observation Phase|Death|0
711982|NCT00098722|2299808|P1|Observation Phase|Death|0
711983|NCT00098722|2299802|P7|Open Label Phase|Unspecified|0
711984|NCT00098722|2299803|P6|Open Label Phase|Unspecified|0
711985|NCT00098722|2299804|P5|Open Label Phase|Unspecified|0
711986|NCT00098722|2299805|P4|Open Label Phase|Unspecified|18
711987|NCT00098722|2299806|P3|Open Label Phase|Unspecified|0
711988|NCT00098722|2299807|P2|Open Label Phase|Unspecified|0
711989|NCT00098722|2299808|P1|Open Label Phase|Unspecified|0
711990|NCT00098722|2299802|P7|Open Label Phase|Ongoing at cut-off date|0
711991|NCT00098722|2299803|P6|Open Label Phase|Ongoing at cut-off date|0
711992|NCT00098722|2299804|P5|Open Label Phase|Ongoing at cut-off date|50
711993|NCT00098722|2299805|P4|Open Label Phase|Ongoing at cut-off date|220
711994|NCT00098722|2299806|P3|Open Label Phase|Ongoing at cut-off date|0
711995|NCT00098722|2299807|P2|Open Label Phase|Ongoing at cut-off date|0
711996|NCT00098722|2299808|P1|Open Label Phase|Ongoing at cut-off date|0
711997|NCT00098722|2299802|P7|Open Label Phase|Participant defaulted|0
711998|NCT00098722|2299803|P6|Open Label Phase|Participant defaulted|0
711999|NCT00098722|2299804|P5|Open Label Phase|Participant defaulted|0
712000|NCT00098722|2299805|P4|Open Label Phase|Participant defaulted|18
712001|NCT00098722|2299806|P3|Open Label Phase|Participant defaulted|0
712002|NCT00098722|2299807|P2|Open Label Phase|Participant defaulted|0
712003|NCT00098722|2299808|P1|Open Label Phase|Participant defaulted|0
712004|NCT00098722|2299802|P7|Open Label Phase|Pregnancy|0
712005|NCT00098722|2299803|P6|Open Label Phase|Pregnancy|0
712006|NCT00098722|2299804|P5|Open Label Phase|Pregnancy|0
712007|NCT00098722|2299805|P4|Open Label Phase|Pregnancy|1
712008|NCT00098722|2299806|P3|Open Label Phase|Pregnancy|0
712009|NCT00098722|2299807|P2|Open Label Phase|Pregnancy|0
712010|NCT00098722|2299808|P1|Open Label Phase|Pregnancy|0
712011|NCT00098722|2299802|P7|Open Label Phase|Lack of Efficacy|0
712012|NCT00098722|2299803|P6|Open Label Phase|Lack of Efficacy|0
712013|NCT00098722|2299804|P5|Open Label Phase|Lack of Efficacy|0
712014|NCT00098722|2299805|P4|Open Label Phase|Lack of Efficacy|8
712015|NCT00098722|2299806|P3|Open Label Phase|Lack of Efficacy|0
712016|NCT00098722|2299807|P2|Open Label Phase|Lack of Efficacy|0
712017|NCT00098722|2299808|P1|Open Label Phase|Lack of Efficacy|0
712018|NCT00098722|2299802|P7|Open Label Phase|Death|0
712019|NCT00098722|2299803|P6|Open Label Phase|Death|0
712020|NCT00098722|2299804|P5|Open Label Phase|Death|0
712021|NCT00098722|2299805|P4|Open Label Phase|Death|2
712022|NCT00098722|2299806|P3|Open Label Phase|Death|0
712023|NCT00098722|2299807|P2|Open Label Phase|Death|0
712024|NCT00098722|2299808|P1|Open Label Phase|Death|0
712025|NCT00098722|2299802|P7|Open Label Phase|Adverse Event|0
712026|NCT00098722|2299803|P6|Open Label Phase|Adverse Event|0
712027|NCT00098722|2299804|P5|Open Label Phase|Adverse Event|0
712028|NCT00098722|2299805|P4|Open Label Phase|Adverse Event|5
712029|NCT00098722|2299806|P3|Open Label Phase|Adverse Event|0
712030|NCT00098722|2299807|P2|Open Label Phase|Adverse Event|0
712031|NCT00098722|2299808|P1|Open Label Phase|Adverse Event|0
712032|NCT00098722|2299802|P7|Double Blind Phase|Unspecified|0
712033|NCT00098722|2299803|P6|Double Blind Phase|Unspecified|0
712034|NCT00098722|2299804|P5|Double Blind Phase|Unspecified|0
712035|NCT00098722|2299805|P4|Double Blind Phase|Unspecified|0
712036|NCT00098722|2299806|P3|Double Blind Phase|Unspecified|7
712037|NCT00098722|2299807|P2|Double Blind Phase|Unspecified|8
712038|NCT00098722|2299808|P1|Double Blind Phase|Unspecified|7
712039|NCT00098722|2299802|P7|Double Blind Phase|Ongoing at cut-off date|0
712040|NCT00098722|2299803|P6|Double Blind Phase|Ongoing at cut-off date|0
712041|NCT00098722|2299804|P5|Double Blind Phase|Ongoing at cut-off date|0
712042|NCT00098722|2299805|P4|Double Blind Phase|Ongoing at cut-off date|0
712043|NCT00098722|2299806|P3|Double Blind Phase|Ongoing at cut-off date|57
712044|NCT00098722|2299807|P2|Double Blind Phase|Ongoing at cut-off date|137
712045|NCT00098722|2299808|P1|Double Blind Phase|Ongoing at cut-off date|128
712046|NCT00098722|2299802|P7|Double Blind Phase|Randomized, not treated|0
712047|NCT00098722|2299803|P6|Double Blind Phase|Randomized, not treated|0
712048|NCT00098722|2299804|P5|Double Blind Phase|Randomized, not treated|0
712049|NCT00098722|2299805|P4|Double Blind Phase|Randomized, not treated|0
712050|NCT00098722|2299806|P3|Double Blind Phase|Randomized, not treated|3
712051|NCT00098722|2299807|P2|Double Blind Phase|Randomized, not treated|3
712052|NCT00098722|2299808|P1|Double Blind Phase|Randomized, not treated|4
712053|NCT00098722|2299802|P7|Double Blind Phase|Pregnancy|0
712054|NCT00098722|2299803|P6|Double Blind Phase|Pregnancy|0
712055|NCT00098722|2299804|P5|Double Blind Phase|Pregnancy|0
712056|NCT00098722|2299805|P4|Double Blind Phase|Pregnancy|0
712057|NCT00098722|2299806|P3|Double Blind Phase|Pregnancy|0
712058|NCT00098722|2299807|P2|Double Blind Phase|Pregnancy|0
712059|NCT00098722|2299808|P1|Double Blind Phase|Pregnancy|1
712060|NCT00098722|2299802|P7|Double Blind Phase|Participant defaulted|0
712061|NCT00098722|2299803|P6|Double Blind Phase|Participant defaulted|0
712062|NCT00098722|2299804|P5|Double Blind Phase|Participant defaulted|0
712063|NCT00098722|2299805|P4|Double Blind Phase|Participant defaulted|0
712064|NCT00098722|2299806|P3|Double Blind Phase|Participant defaulted|9
712065|NCT00098722|2299807|P2|Double Blind Phase|Participant defaulted|11
712066|NCT00098722|2299808|P1|Double Blind Phase|Participant defaulted|16
712067|NCT00098722|2299802|P7|Double Blind Phase|Lack of Efficacy|0
712068|NCT00098722|2299803|P6|Double Blind Phase|Lack of Efficacy|0
712069|NCT00098722|2299804|P5|Double Blind Phase|Lack of Efficacy|0
712070|NCT00098722|2299805|P4|Double Blind Phase|Lack of Efficacy|0
712071|NCT00098722|2299806|P3|Double Blind Phase|Lack of Efficacy|15
712072|NCT00098722|2299807|P2|Double Blind Phase|Lack of Efficacy|23
712073|NCT00098722|2299808|P1|Double Blind Phase|Lack of Efficacy|21
712074|NCT00098722|2299802|P7|Double Blind Phase|Death|0
712075|NCT00098722|2299803|P6|Double Blind Phase|Death|0
712076|NCT00098722|2299804|P5|Double Blind Phase|Death|0
712077|NCT00098722|2299805|P4|Double Blind Phase|Death|0
712078|NCT00098722|2299806|P3|Double Blind Phase|Death|0
712079|NCT00098722|2299807|P2|Double Blind Phase|Death|5
712080|NCT00098722|2299808|P1|Double Blind Phase|Death|2
712081|NCT00098722|2299802|P7|Double Blind Phase|Adverse Event|0
712082|NCT00098722|2299803|P6|Double Blind Phase|Adverse Event|0
712083|NCT00098722|2299804|P5|Double Blind Phase|Adverse Event|0
712084|NCT00098722|2299805|P4|Double Blind Phase|Adverse Event|0
712085|NCT00098722|2299806|P3|Double Blind Phase|Adverse Event|3
712086|NCT00098722|2299807|P2|Double Blind Phase|Adverse Event|7
712087|NCT00098722|2299808|P1|Double Blind Phase|Adverse Event|7
712088|NCT00098748|2299874|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
712089|NCT00098748|2299875|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
712090|NCT00098748|2299876|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
712091|NCT00098748|2299874|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
712092|NCT00098748|2299875|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
712093|NCT00098748|2299876|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
712094|NCT00098748|2299874|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
712095|NCT00098748|2299875|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
712096|NCT00098748|2299876|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
712097|NCT00098748|2299874|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
712098|NCT00098748|2299875|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
712099|NCT00098748|2299876|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
712100|NCT00098748|2299874|P3|Continued on Open-Label Treatment|Adverse Event|0
712101|NCT00098748|2299875|P2|Continued on Open-Label Treatment|Adverse Event|1
712102|NCT00098748|2299876|P1|Continued on Open-Label Treatment|Adverse Event|0
712103|NCT00098748|2299874|P3|Received Study Treatment|Subject defaulted|4
712104|NCT00098748|2299875|P2|Received Study Treatment|Subject defaulted|4
712105|NCT00098748|2299876|P1|Received Study Treatment|Subject defaulted|3
712106|NCT00098748|2299874|P3|Received Study Treatment|Unspecified|6
712107|NCT00098748|2299875|P2|Received Study Treatment|Unspecified|2
712108|NCT00098748|2299876|P1|Received Study Treatment|Unspecified|2
712109|NCT00098748|2299874|P3|Received Study Treatment|Lack of Efficacy|27
712110|NCT00098748|2299875|P2|Received Study Treatment|Lack of Efficacy|27
712111|NCT00098748|2299876|P1|Received Study Treatment|Lack of Efficacy|40
712112|NCT00098748|2299874|P3|Received Study Treatment|Adverse Event|5
712113|NCT00098748|2299875|P2|Received Study Treatment|Adverse Event|2
712114|NCT00098748|2299876|P1|Received Study Treatment|Adverse Event|1
712115|NCT00098748|2299874|P3|Received Study Treatment|Death|2
712116|NCT00098748|2299875|P2|Received Study Treatment|Death|1
712117|NCT00098748|2299876|P1|Received Study Treatment|Death|2
712118|NCT00098748|2299874|P3|Assigned to Study Treatment|Randomized, but not treated|2
712119|NCT00098748|2299875|P2|Assigned to Study Treatment|Randomized, but not treated|2
712120|NCT00098748|2299876|P1|Assigned to Study Treatment|Randomized, but not treated|0
712121|NCT00098774|2299929|P1|Overall Study|Physician Decision|2
712122|NCT00098774|2299929|P1|Overall Study|Failed (to respond) during induction|4
712123|NCT00098774|2299929|P1|Overall Study|Withdrawal by Subject|1
712124|NCT00098774|2299929|P1|Overall Study|Disease Progression|9
712125|NCT00098774|2299929|P1|Overall Study|Adverse Event|2
712126|NCT00098787|2299939|P3|Overall Study|Other|9
712127|NCT00098787|2299940|P2|Overall Study|Other|6
712128|NCT00098787|2299941|P1|Overall Study|Other|7
712129|NCT00098787|2299939|P3|Overall Study|Alternative therapy|13
712130|NCT00098787|2299940|P2|Overall Study|Alternative therapy|13
712131|NCT00098787|2299941|P1|Overall Study|Alternative therapy|8
712132|NCT00098787|2299939|P3|Overall Study|Withdrawal by Subject|6
712133|NCT00098787|2299940|P2|Overall Study|Withdrawal by Subject|12
712134|NCT00098787|2299941|P1|Overall Study|Withdrawal by Subject|4
712135|NCT00098787|2299939|P3|Overall Study|Death|0
712136|NCT00098787|2299940|P2|Overall Study|Death|1
712137|NCT00098787|2299941|P1|Overall Study|Death|6
712138|NCT00098787|2299939|P3|Overall Study|Adverse Event|8
712139|NCT00098787|2299940|P2|Overall Study|Adverse Event|17
712140|NCT00098787|2299941|P1|Overall Study|Adverse Event|8
712141|NCT00098787|2299939|P3|Overall Study|Disease progression|23
712142|NCT00098787|2299940|P2|Overall Study|Disease progression|17
712143|NCT00098787|2299941|P1|Overall Study|Disease progression|28
712144|NCT00098787|2299939|P3|Overall Study|Ineligible|3
712145|NCT00098787|2299940|P2|Overall Study|Ineligible|7
712146|NCT00098787|2299941|P1|Overall Study|Ineligible|9
712147|NCT00098787|2299939|P3|Overall Study|Never started treatment|1
712148|NCT00098787|2299940|P2|Overall Study|Never started treatment|2
712149|NCT00098787|2299941|P1|Overall Study|Never started treatment|3
712150|NCT00098813|2299955|P1|Overall Study|Reversal of RAI resistance|1
712151|NCT00098813|2299955|P1|Overall Study|Other complicating disease|1
712152|NCT00098813|2299955|P1|Overall Study|Progression of Disease|1
712153|NCT00098813|2299955|P1|Overall Study|Withdrawal by Subject|7
712154|NCT00098813|2299955|P1|Overall Study|Protocol Violation|1
712155|NCT00098813|2299955|P1|Overall Study|Death|8
712172|NCT00098865|2299972|P1|Overall Study|Alternative Therapy|1
712173|NCT00098865|2299972|P1|Overall Study|Adverse Event|2
712174|NCT00098865|2299972|P1|Overall Study|Progressive Disease|6
712175|NCT00099268|2300000|P2|Overall Study|Death|1
712176|NCT00099268|2300001|P1|Overall Study|Death|3
712177|NCT00099268|2300000|P2|Overall Study|Administrative problems|4
712178|NCT00099268|2300001|P1|Overall Study|Administrative problems|4
712179|NCT00099268|2300000|P2|Overall Study|Lack of Efficacy|18
712180|NCT00099268|2300001|P1|Overall Study|Lack of Efficacy|5
712181|NCT00099268|2300000|P2|Overall Study|Lost to Follow-up|4
712182|NCT00099268|2300001|P1|Overall Study|Lost to Follow-up|6
712183|NCT00099268|2300000|P2|Overall Study|Protocol Violation|8
712184|NCT00099268|2300001|P1|Overall Study|Protocol Violation|9
712185|NCT00099268|2300000|P2|Overall Study|Adverse Event|19
712186|NCT00099268|2300001|P1|Overall Study|Adverse Event|19
712187|NCT00099268|2300000|P2|Overall Study|Withdrawal by Subject|28
712188|NCT00099268|2300001|P1|Overall Study|Withdrawal by Subject|46
712189|NCT00099359|2300020|P3|Overall Study|moved out of area|4
712190|NCT00099359|2300021|P2|Overall Study|moved out of area|7
712191|NCT00099359|2300022|P1|Overall Study|moved out of area|9
712192|NCT00099359|2300020|P3|Overall Study|Lost to Follow-up|24
712193|NCT00099359|2300021|P2|Overall Study|Lost to Follow-up|24
712194|NCT00099359|2300022|P1|Overall Study|Lost to Follow-up|15
712195|NCT00099359|2300020|P3|Overall Study|Withdrawal by Subject|23
712196|NCT00099359|2300021|P2|Overall Study|Withdrawal by Subject|19
712197|NCT00099359|2300022|P1|Overall Study|Withdrawal by Subject|19
712198|NCT00099359|2300020|P3|Overall Study|Death|17
712199|NCT00099359|2300021|P2|Overall Study|Death|15
712200|NCT00099359|2300022|P1|Overall Study|Death|11
712201|NCT00099437|2300045|P2|Overall Study|Ongoing in FU but not on treatment|45
712202|NCT00099437|2300046|P1|Overall Study|Ongoing in FU but not on treatment|37
712203|NCT00099437|2300045|P2|Overall Study|Withdrawal by Subject|10
712204|NCT00099437|2300046|P1|Overall Study|Withdrawal by Subject|6
712205|NCT00099437|2300045|P2|Overall Study|Death|261
712206|NCT00099437|2300046|P1|Overall Study|Death|293
712207|NCT00099437|2300045|P2|Overall Study|Lost to Follow-up|33
712208|NCT00099437|2300046|P1|Overall Study|Lost to Follow-up|30
712209|NCT00099632|2300072|P6|Overall Study|Protocol Violation|1
712210|NCT00099632|2300073|P5|Overall Study|Protocol Violation|0
712211|NCT00099632|2300074|P4|Overall Study|Protocol Violation|0
712212|NCT00099632|2300075|P3|Overall Study|Protocol Violation|0
712213|NCT00099632|2300076|P2|Overall Study|Protocol Violation|0
712214|NCT00099632|2300077|P1|Overall Study|Protocol Violation|0
712215|NCT00099632|2300072|P6|Overall Study|Withdrawal by Subject|1
712216|NCT00099632|2300073|P5|Overall Study|Withdrawal by Subject|0
712217|NCT00099632|2300074|P4|Overall Study|Withdrawal by Subject|0
712218|NCT00099632|2300075|P3|Overall Study|Withdrawal by Subject|0
712219|NCT00099632|2300076|P2|Overall Study|Withdrawal by Subject|1
712220|NCT00099632|2300077|P1|Overall Study|Withdrawal by Subject|0
712221|NCT00099632|2300072|P6|Overall Study|Lost to Follow-up|0
712222|NCT00099632|2300073|P5|Overall Study|Lost to Follow-up|1
712223|NCT00099632|2300074|P4|Overall Study|Lost to Follow-up|1
712224|NCT00099632|2300075|P3|Overall Study|Lost to Follow-up|3
712225|NCT00099632|2300076|P2|Overall Study|Lost to Follow-up|0
712226|NCT00099632|2300077|P1|Overall Study|Lost to Follow-up|1
712227|NCT00099983|2300117|P2|Overall Study|Other issue|0
712228|NCT00099983|2300118|P1|Overall Study|Other issue|1
712229|NCT00099983|2300117|P2|Overall Study|Intolerant of burden of visits|1
712230|NCT00099983|2300118|P1|Overall Study|Intolerant of burden of visits|0
712231|NCT00099983|2300117|P2|Overall Study|Incarcerated|1
712232|NCT00099983|2300118|P1|Overall Study|Incarcerated|0
712233|NCT00099983|2300117|P2|Overall Study|Other psychiatric problem|0
712234|NCT00099983|2300118|P1|Overall Study|Other psychiatric problem|1
712235|NCT00099983|2300117|P2|Overall Study|Moved|0
712236|NCT00099983|2300118|P1|Overall Study|Moved|1
712237|NCT00099983|2300117|P2|Overall Study|Unable to return for appointments|1
712238|NCT00099983|2300118|P1|Overall Study|Unable to return for appointments|1
712239|NCT00099983|2300117|P2|Overall Study|Lack of Efficacy|1
712240|NCT00099983|2300118|P1|Overall Study|Lack of Efficacy|0
712241|NCT00099983|2300117|P2|Overall Study|Adverse Event|1
712242|NCT00099983|2300118|P1|Overall Study|Adverse Event|1
712243|NCT00099983|2300117|P2|Overall Study|Withdrawal by Subject|2
712244|NCT00099983|2300118|P1|Overall Study|Withdrawal by Subject|3
712245|NCT00099983|2300117|P2|Overall Study|Missing Source Documents|15
712246|NCT00099983|2300118|P1|Overall Study|Missing Source Documents|14
712247|NCT00099983|2300117|P2|Overall Study|Lost to Follow-up|3
712248|NCT00099983|2300118|P1|Overall Study|Lost to Follow-up|2
712249|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
712250|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
712251|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
712252|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
712253|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
712254|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
712255|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
712256|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
712257|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
712258|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
712259|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
712260|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
712261|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
712262|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
712263|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
712264|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
712265|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
712266|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
712267|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
712268|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
712269|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
712270|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
712271|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
712272|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
712273|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
712274|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
712275|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
712276|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
712277|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
712278|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
712279|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
712280|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
712281|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
712282|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
712283|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
712284|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
712285|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
712286|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
712287|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
712288|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
712289|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
712290|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
712291|NCT00100048|2300129|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
712292|NCT00100048|2300130|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
712293|NCT00100048|2300131|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
712294|NCT00100048|2300132|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
712295|NCT00100048|2300133|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
712296|NCT00100048|2300134|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
712297|NCT00084617|2300241|P1|Overall Study|Protocol Violation|1
712298|NCT00084617|2300241|P1|Overall Study|Lack of Efficacy|1
712299|NCT00084617|2300241|P1|Overall Study|Withdrawal by Subject|7
712300|NCT00084682|2300247|P1|Overall Study|Withdrawal by Subject|1
712301|NCT00084747|2300251|P1|Overall Study|Withdrawal by Subject|2
712302|NCT00084747|2300251|P1|Overall Study|Death|3
712303|NCT00084747|2300251|P1|Overall Study|Relapsed|8
712304|NCT00084838|2300256|P1|Overall Study|Ineligible|4
712305|NCT00084838|2300256|P1|Overall Study|Pt Non-Compliance|1
712306|NCT00084838|2300256|P1|Overall Study|Progressive Disease|4
712307|NCT00084838|2300256|P1|Overall Study|Withdrawal by Subject|1
712308|NCT00084838|2300256|P1|Overall Study|Adverse Event|2
712309|NCT00084838|2300256|P1|Overall Study|Death|1
712310|NCT00084864|2300282|P4|Overall Study|Adverse Event|0
712311|NCT00084864|2300283|P3|Overall Study|Adverse Event|0
712312|NCT00084864|2300284|P2|Overall Study|Adverse Event|0
712313|NCT00084864|2300285|P1|Overall Study|Adverse Event|1
712314|NCT00085098|2300313|P2|Overall Study|Ineligible|1
712315|NCT00085098|2300314|P1|Overall Study|Ineligible|1
712316|NCT00085098|2300313|P2|Overall Study|Withdrawal by Subject|1
712317|NCT00085098|2300314|P1|Overall Study|Withdrawal by Subject|0
712318|NCT00085202|2300322|P2|Overall Study|Progressive disease|11
712319|NCT00085202|2300323|P1|Overall Study|Progressive disease|1
712320|NCT00085202|2300322|P2|Overall Study|Physician Decision|1
712321|NCT00085202|2300323|P1|Overall Study|Physician Decision|4
712322|NCT00085202|2300322|P2|Overall Study|Withdrawal by Subject|1
712323|NCT00085202|2300323|P1|Overall Study|Withdrawal by Subject|2
712324|NCT00085202|2300322|P2|Overall Study|Non-specified|5
712325|NCT00085202|2300323|P1|Overall Study|Non-specified|3
712326|NCT00085202|2300322|P2|Overall Study|Excessive toxicity|5
712327|NCT00085202|2300323|P1|Overall Study|Excessive toxicity|6
712328|NCT00085202|2300322|P2|Overall Study|Bone involvement confirmed by bone scan|1
712329|NCT00085202|2300323|P1|Overall Study|Bone involvement confirmed by bone scan|0
712330|NCT00085202|2300322|P2|Overall Study|Still on therapy|0
712331|NCT00085202|2300323|P1|Overall Study|Still on therapy|2
712332|NCT00091390|2300384|P1|Overall Study|Protocol Violation|2
712333|NCT00091390|2300384|P1|Overall Study|Withdrawal by Subject|2
712334|NCT00091442|2300390|P2|Overall Study|Not Specified|6
712335|NCT00091442|2300391|P1|Overall Study|Not Specified|2
712336|NCT00091442|2300390|P2|Overall Study|Lost to Follow-up|3
712337|NCT00091442|2300391|P1|Overall Study|Lost to Follow-up|1
712338|NCT00091442|2300390|P2|Overall Study|Death|7
712339|NCT00091442|2300391|P1|Overall Study|Death|9
712340|NCT00091442|2300390|P2|Overall Study|2cycles therapy beyond Complete response|16
712341|NCT00091442|2300391|P1|Overall Study|2cycles therapy beyond Complete response|9
712342|NCT00091442|2300390|P2|Overall Study|Adverse Event|48
712343|NCT00091442|2300391|P1|Overall Study|Adverse Event|29
712344|NCT00091442|2300390|P2|Overall Study|Withdrawal by Subject|46
712345|NCT00091442|2300391|P1|Overall Study|Withdrawal by Subject|38
712346|NCT00091442|2300390|P2|Overall Study|Physician Decision|58
712347|NCT00091442|2300391|P1|Overall Study|Physician Decision|61
712348|NCT00091442|2300390|P2|Overall Study|Progressive Disease|189
712349|NCT00091442|2300391|P1|Overall Study|Progressive Disease|220
712350|NCT00091949|2300420|P2|Overall Study|Lost to Follow-up|41
712351|NCT00091949|2300421|P1|Overall Study|Lost to Follow-up|58
712352|NCT00091949|2300420|P2|Overall Study|Withdrawal by Subject|110
712353|NCT00091949|2300421|P1|Overall Study|Withdrawal by Subject|117
712354|NCT00092118|2300463|P2|Overall Study|Not Specified|5
712355|NCT00092118|2300464|P1|Overall Study|Not Specified|6
712356|NCT00092118|2300463|P2|Overall Study|Withdrawal by Subject|10
712357|NCT00092118|2300464|P1|Overall Study|Withdrawal by Subject|4
712358|NCT00092118|2300463|P2|Overall Study|Protocol Violation|25
712359|NCT00092118|2300464|P1|Overall Study|Protocol Violation|23
712360|NCT00092118|2300463|P2|Overall Study|Lost to Follow-up|3
712361|NCT00092118|2300464|P1|Overall Study|Lost to Follow-up|4
712362|NCT00092118|2300463|P2|Overall Study|Lack of Efficacy|14
712363|NCT00092118|2300464|P1|Overall Study|Lack of Efficacy|12
712364|NCT00092118|2300463|P2|Overall Study|Adverse Event|32
712365|NCT00092118|2300464|P1|Overall Study|Adverse Event|35
712366|NCT00092131|2300474|P2|Treatment Period II|Adverse Event|1
712367|NCT00092131|2300475|P1|Treatment Period II|Adverse Event|0
712368|NCT00092131|2300474|P2|Treatment Period I|Adverse Event|0
712369|NCT00092131|2300475|P1|Treatment Period I|Adverse Event|1
712370|NCT00092417|2300505|P2|Overall Study|Not Specified|0
712371|NCT00092417|2300506|P1|Overall Study|Not Specified|1
712372|NCT00092417|2300505|P2|Overall Study|Withdrawal by Subject|1
712373|NCT00092417|2300506|P1|Overall Study|Withdrawal by Subject|2
712374|NCT00092417|2300505|P2|Overall Study|Lost to Follow-up|0
712375|NCT00092417|2300506|P1|Overall Study|Lost to Follow-up|2
712376|NCT00092443|2300522|P2|Overall Study|Not Specified|13
712377|NCT00092443|2300523|P1|Overall Study|Not Specified|17
712378|NCT00092443|2300522|P2|Overall Study|Moved|5
712379|NCT00092443|2300523|P1|Overall Study|Moved|5
712380|NCT00092443|2300522|P2|Overall Study|Withdrawal by Subject|11
712381|NCT00092443|2300523|P1|Overall Study|Withdrawal by Subject|9
712382|NCT00092443|2300522|P2|Overall Study|Protocol Violation|9
712383|NCT00092443|2300523|P1|Overall Study|Protocol Violation|11
712384|NCT00092443|2300522|P2|Overall Study|Lost to Follow-up|3
712385|NCT00092443|2300523|P1|Overall Study|Lost to Follow-up|7
712386|NCT00092443|2300522|P2|Overall Study|Adverse Event|13
712387|NCT00092443|2300523|P1|Overall Study|Adverse Event|9
712388|NCT00092456|2300543|P4|Overall Study|Not Specified|0
712389|NCT00092456|2300544|P3|Overall Study|Not Specified|3
712390|NCT00092456|2300545|P2|Overall Study|Not Specified|2
712391|NCT00092456|2300546|P1|Overall Study|Not Specified|4
712392|NCT00092456|2300543|P4|Overall Study|Moved|1
712393|NCT00092456|2300544|P3|Overall Study|Moved|0
712394|NCT00092456|2300545|P2|Overall Study|Moved|1
712395|NCT00092456|2300546|P1|Overall Study|Moved|1
712396|NCT00092456|2300543|P4|Overall Study|Withdrawal by Subject|6
712397|NCT00092456|2300544|P3|Overall Study|Withdrawal by Subject|16
712398|NCT00092456|2300545|P2|Overall Study|Withdrawal by Subject|5
712399|NCT00092456|2300546|P1|Overall Study|Withdrawal by Subject|13
712400|NCT00092456|2300543|P4|Overall Study|Protocol Violation|6
712401|NCT00092456|2300544|P3|Overall Study|Protocol Violation|8
712402|NCT00092456|2300545|P2|Overall Study|Protocol Violation|7
712403|NCT00092456|2300546|P1|Overall Study|Protocol Violation|5
712404|NCT00092456|2300543|P4|Overall Study|Lost to Follow-up|2
712405|NCT00092456|2300544|P3|Overall Study|Lost to Follow-up|1
712406|NCT00092456|2300545|P2|Overall Study|Lost to Follow-up|2
712407|NCT00092456|2300546|P1|Overall Study|Lost to Follow-up|2
712408|NCT00092456|2300543|P4|Overall Study|Adverse Event|1
712409|NCT00092456|2300544|P3|Overall Study|Adverse Event|1
712410|NCT00092456|2300545|P2|Overall Study|Adverse Event|0
712411|NCT00092456|2300546|P1|Overall Study|Adverse Event|0
712412|NCT00092495|2300596|P5|Base Study Follow-up Period|Withdrawal by Subject|0
712413|NCT00092495|2300597|P4|Base Study Follow-up Period|Withdrawal by Subject|0
712414|NCT00092495|2300598|P3|Base Study Follow-up Period|Withdrawal by Subject|0
712415|NCT00092495|2300599|P2|Base Study Follow-up Period|Withdrawal by Subject|0
712416|NCT00092495|2300600|P1|Base Study Follow-up Period|Withdrawal by Subject|2
712417|NCT00092495|2300596|P5|Base Study Follow-up Period|Lost to Follow-up|0
712418|NCT00092495|2300597|P4|Base Study Follow-up Period|Lost to Follow-up|12
712419|NCT00092495|2300598|P3|Base Study Follow-up Period|Lost to Follow-up|3
712420|NCT00092495|2300599|P2|Base Study Follow-up Period|Lost to Follow-up|3
712421|NCT00092495|2300600|P1|Base Study Follow-up Period|Lost to Follow-up|1
712422|NCT00092495|2300596|P5|Base Study Follow-up Period|Extended|0
712423|NCT00092495|2300597|P4|Base Study Follow-up Period|Extended|2
712424|NCT00092495|2300598|P3|Base Study Follow-up Period|Extended|1
712425|NCT00092495|2300599|P2|Base Study Follow-up Period|Extended|0
712426|NCT00092495|2300600|P1|Base Study Follow-up Period|Extended|0
712427|NCT00092495|2300596|P5|Base Study Vaccination Period|Withdrawal by Subject|0
712428|NCT00092495|2300597|P4|Base Study Vaccination Period|Withdrawal by Subject|25
712429|NCT00092495|2300598|P3|Base Study Vaccination Period|Withdrawal by Subject|14
712430|NCT00092495|2300599|P2|Base Study Vaccination Period|Withdrawal by Subject|10
712431|NCT00092495|2300600|P1|Base Study Vaccination Period|Withdrawal by Subject|9
712432|NCT00092495|2300596|P5|Base Study Vaccination Period|Protocol Violation|0
712433|NCT00092495|2300597|P4|Base Study Vaccination Period|Protocol Violation|0
712434|NCT00092495|2300598|P3|Base Study Vaccination Period|Protocol Violation|0
712435|NCT00092495|2300599|P2|Base Study Vaccination Period|Protocol Violation|0
712436|NCT00092495|2300600|P1|Base Study Vaccination Period|Protocol Violation|1
712437|NCT00092495|2300596|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
712438|NCT00092495|2300597|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
712439|NCT00092495|2300598|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
712440|NCT00092495|2300599|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
712441|NCT00092495|2300600|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
712442|NCT00092495|2300596|P5|Base Study Vaccination Period|Pregnancy|0
712443|NCT00092495|2300597|P4|Base Study Vaccination Period|Pregnancy|0
712444|NCT00092495|2300598|P3|Base Study Vaccination Period|Pregnancy|0
712445|NCT00092495|2300599|P2|Base Study Vaccination Period|Pregnancy|0
712446|NCT00092495|2300600|P1|Base Study Vaccination Period|Pregnancy|2
712447|NCT00092495|2300596|P5|Base Study Vaccination Period|Unspecified|0
712448|NCT00092495|2300597|P4|Base Study Vaccination Period|Unspecified|2
712449|NCT00092495|2300598|P3|Base Study Vaccination Period|Unspecified|0
712450|NCT00092495|2300599|P2|Base Study Vaccination Period|Unspecified|1
712451|NCT00092495|2300600|P1|Base Study Vaccination Period|Unspecified|1
712452|NCT00092495|2300596|P5|Base Study Vaccination Period|Moved|0
712453|NCT00092495|2300597|P4|Base Study Vaccination Period|Moved|2
712454|NCT00092495|2300598|P3|Base Study Vaccination Period|Moved|2
712455|NCT00092495|2300599|P2|Base Study Vaccination Period|Moved|1
712456|NCT00092495|2300600|P1|Base Study Vaccination Period|Moved|3
712457|NCT00092495|2300596|P5|Base Study Vaccination Period|Lost to Follow-up|0
712458|NCT00092495|2300597|P4|Base Study Vaccination Period|Lost to Follow-up|36
712459|NCT00092495|2300598|P3|Base Study Vaccination Period|Lost to Follow-up|11
712460|NCT00092495|2300599|P2|Base Study Vaccination Period|Lost to Follow-up|6
712461|NCT00092495|2300600|P1|Base Study Vaccination Period|Lost to Follow-up|16
712462|NCT00092495|2300596|P5|Base Study Vaccination Period|Adverse Event|0
712463|NCT00092495|2300597|P4|Base Study Vaccination Period|Adverse Event|3
712464|NCT00092495|2300598|P3|Base Study Vaccination Period|Adverse Event|0
712465|NCT00092495|2300599|P2|Base Study Vaccination Period|Adverse Event|0
712466|NCT00092495|2300600|P1|Base Study Vaccination Period|Adverse Event|1
712467|NCT00092495|2300596|P5|Base Study Vaccination Period|*Pregnancy|0
712468|NCT00092495|2300597|P4|Base Study Vaccination Period|*Pregnancy|7
712469|NCT00092495|2300598|P3|Base Study Vaccination Period|*Pregnancy|5
712470|NCT00092495|2300599|P2|Base Study Vaccination Period|*Pregnancy|2
712471|NCT00092495|2300600|P1|Base Study Vaccination Period|*Pregnancy|0
712472|NCT00092495|2300596|P5|Base Study Vaccination Period|*Other reasons|0
712473|NCT00092495|2300597|P4|Base Study Vaccination Period|*Other reasons|1
712474|NCT00092495|2300598|P3|Base Study Vaccination Period|*Other reasons|0
712475|NCT00092495|2300599|P2|Base Study Vaccination Period|*Other reasons|0
712476|NCT00092495|2300600|P1|Base Study Vaccination Period|*Other reasons|1
712477|NCT00092495|2300596|P5|Base Study Vaccination Period|*Clinical AE|0
712478|NCT00092495|2300597|P4|Base Study Vaccination Period|*Clinical AE|2
712479|NCT00092495|2300598|P3|Base Study Vaccination Period|*Clinical AE|1
712480|NCT00092495|2300599|P2|Base Study Vaccination Period|*Clinical AE|0
712481|NCT00092495|2300600|P1|Base Study Vaccination Period|*Clinical AE|1
712482|NCT00092495|2300596|P5|Base Study Vaccination Period|Extended|0
712483|NCT00092495|2300597|P4|Base Study Vaccination Period|Extended|1
712484|NCT00092495|2300598|P3|Base Study Vaccination Period|Extended|0
712485|NCT00092495|2300599|P2|Base Study Vaccination Period|Extended|0
712486|NCT00092495|2300600|P1|Base Study Vaccination Period|Extended|0
712487|NCT00092495|2300596|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
712488|NCT00092495|2300597|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
712489|NCT00092495|2300598|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
712490|NCT00092495|2300599|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
712491|NCT00092495|2300600|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
712492|NCT00092521|2300665|P4|Extension Study (Group 4)|Unable/unwilling to return|25
712493|NCT00092521|2300666|P3|Extension Study (Group 4)|Unable/unwilling to return|0
712494|NCT00092521|2300667|P2|Extension Study (Group 4)|Unable/unwilling to return|0
712495|NCT00092521|2300668|P1|Extension Study (Group 4)|Unable/unwilling to return|0
712496|NCT00092521|2300665|P4|Extension Study (Group 4)|Site Terminated|4
712497|NCT00092521|2300666|P3|Extension Study (Group 4)|Site Terminated|0
712498|NCT00092521|2300667|P2|Extension Study (Group 4)|Site Terminated|0
712499|NCT00092521|2300668|P1|Extension Study (Group 4)|Site Terminated|0
712500|NCT00092521|2300665|P4|Extension Study (Group 4)|Moved|16
712501|NCT00092521|2300666|P3|Extension Study (Group 4)|Moved|0
712502|NCT00092521|2300667|P2|Extension Study (Group 4)|Moved|0
712503|NCT00092521|2300668|P1|Extension Study (Group 4)|Moved|0
712504|NCT00092521|2300665|P4|Extension Study (Group 4)|Withdrawal by Subject|46
712505|NCT00092521|2300666|P3|Extension Study (Group 4)|Withdrawal by Subject|0
712506|NCT00092521|2300667|P2|Extension Study (Group 4)|Withdrawal by Subject|0
712507|NCT00092521|2300668|P1|Extension Study (Group 4)|Withdrawal by Subject|0
712508|NCT00092521|2300665|P4|Extension Study (Group 4)|Protocol Violation|2
712509|NCT00092521|2300666|P3|Extension Study (Group 4)|Protocol Violation|0
712510|NCT00092521|2300667|P2|Extension Study (Group 4)|Protocol Violation|0
712511|NCT00092521|2300668|P1|Extension Study (Group 4)|Protocol Violation|0
712512|NCT00092521|2300665|P4|Extension Study (Group 4)|Pregnancy|4
712513|NCT00092521|2300666|P3|Extension Study (Group 4)|Pregnancy|0
712514|NCT00092521|2300667|P2|Extension Study (Group 4)|Pregnancy|0
712515|NCT00092521|2300668|P1|Extension Study (Group 4)|Pregnancy|0
712516|NCT00092521|2300665|P4|Extension Study (Group 4)|Lost to Follow-up|87
712517|NCT00092521|2300666|P3|Extension Study (Group 4)|Lost to Follow-up|0
712518|NCT00092521|2300667|P2|Extension Study (Group 4)|Lost to Follow-up|0
712519|NCT00092521|2300668|P1|Extension Study (Group 4)|Lost to Follow-up|0
712520|NCT00092521|2300665|P4|Extension Study (Group 4)|Adverse Event|2
712521|NCT00092521|2300666|P3|Extension Study (Group 4)|Adverse Event|0
712522|NCT00092521|2300667|P2|Extension Study (Group 4)|Adverse Event|0
712523|NCT00092521|2300668|P1|Extension Study (Group 4)|Adverse Event|0
712524|NCT00092521|2300665|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
712525|NCT00092521|2300666|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
712526|NCT00092521|2300667|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
712527|NCT00092521|2300668|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
712528|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Visits Compressed|0
712529|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Visits Compressed|5
712530|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Visits Compressed|0
712531|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Visits Compressed|5
712532|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Travel|0
712533|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Travel|0
712534|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Travel|0
712535|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Travel|2
712536|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Site Terminated|0
712537|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Site Terminated|3
712538|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Site Terminated|0
712539|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Site Terminated|3
712540|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Moved|0
712541|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Moved|28
712542|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Moved|2
712543|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Moved|32
712544|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
712545|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
712546|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
712547|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
712548|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Protocol Violation|0
712549|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Protocol Violation|5
712550|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Protocol Violation|1
712551|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Protocol Violation|1
712552|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
712553|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
712554|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
712555|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
712556|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Death|0
712557|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Death|1
712558|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Death|0
712559|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Death|2
712560|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Adverse Event|0
712561|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Adverse Event|0
712562|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Adverse Event|0
712563|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Adverse Event|1
712564|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Subjects in Extension|0
712565|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Subjects in Extension|412
712566|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Subjects in Extension|109
712567|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Subjects in Extension|13
712568|NCT00092521|2300665|P4|Follow-Up (After Month 7)|Subjects Continuing|0
712569|NCT00092521|2300666|P3|Follow-Up (After Month 7)|Subjects Continuing|35
712570|NCT00092521|2300667|P2|Follow-Up (After Month 7)|Subjects Continuing|4
712571|NCT00092521|2300668|P1|Follow-Up (After Month 7)|Subjects Continuing|34
712572|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
712573|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
712574|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
712575|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
712576|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
712577|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
712578|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
712579|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
712580|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Moved|0
712581|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Moved|18
712582|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Moved|1
712583|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Moved|14
712584|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
712585|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
712586|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
712587|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
712588|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
712589|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
712590|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
712591|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
712592|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
712593|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
712594|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
712595|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
712596|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Death|0
712597|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Death|1
712598|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Death|0
712599|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Death|0
712600|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
712601|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
712602|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
712603|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
712604|NCT00092521|2300665|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
712605|NCT00092521|2300666|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
712606|NCT00092521|2300667|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
712607|NCT00092521|2300668|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
712608|NCT00092534|2300680|P3|Extension Study|Protocol Deviation|15
712609|NCT00092534|2300681|P2|Extension Study|Protocol Deviation|0
712610|NCT00092534|2300682|P1|Extension Study|Protocol Deviation|0
712611|NCT00092534|2300680|P3|Extension Study|Study Ended|29
712612|NCT00092534|2300681|P2|Extension Study|Study Ended|0
712613|NCT00092534|2300682|P1|Extension Study|Study Ended|0
712614|NCT00092534|2300680|P3|Extension Study|Site Closed|21
712615|NCT00092534|2300681|P2|Extension Study|Site Closed|0
712616|NCT00092534|2300682|P1|Extension Study|Site Closed|0
712617|NCT00092534|2300680|P3|Extension Study|Travel|2
712618|NCT00092534|2300681|P2|Extension Study|Travel|0
712619|NCT00092534|2300682|P1|Extension Study|Travel|0
712620|NCT00092534|2300680|P3|Extension Study|Moved|6
712621|NCT00092534|2300681|P2|Extension Study|Moved|0
712622|NCT00092534|2300682|P1|Extension Study|Moved|0
712623|NCT00092534|2300680|P3|Extension Study|Withdrawal by Subject|18
712624|NCT00092534|2300681|P2|Extension Study|Withdrawal by Subject|0
712625|NCT00092534|2300682|P1|Extension Study|Withdrawal by Subject|0
712626|NCT00092534|2300680|P3|Extension Study|Pregnancy|12
712627|NCT00092534|2300681|P2|Extension Study|Pregnancy|0
712628|NCT00092534|2300682|P1|Extension Study|Pregnancy|0
712629|NCT00092534|2300680|P3|Extension Study|Physician Decision|1
712630|NCT00092534|2300681|P2|Extension Study|Physician Decision|0
712631|NCT00092534|2300682|P1|Extension Study|Physician Decision|0
712632|NCT00092534|2300680|P3|Extension Study|Lost to Follow-up|41
712633|NCT00092534|2300681|P2|Extension Study|Lost to Follow-up|0
712634|NCT00092534|2300682|P1|Extension Study|Lost to Follow-up|0
712635|NCT00092534|2300680|P3|Base Study Follow Up Period|Subjects in extension|0
712636|NCT00092534|2300681|P2|Base Study Follow Up Period|Subjects in extension|371
712637|NCT00092534|2300682|P1|Base Study Follow Up Period|Subjects in extension|15
712638|NCT00092534|2300680|P3|Base Study Follow Up Period|Subjects continuing|0
712639|NCT00092534|2300681|P2|Base Study Follow Up Period|Subjects continuing|31
712640|NCT00092534|2300682|P1|Base Study Follow Up Period|Subjects continuing|27
712641|NCT00092534|2300680|P3|Base Study Follow Up Period|Site Closed|0
712642|NCT00092534|2300681|P2|Base Study Follow Up Period|Site Closed|2
712643|NCT00092534|2300682|P1|Base Study Follow Up Period|Site Closed|0
712644|NCT00092534|2300680|P3|Base Study Follow Up Period|Travel|0
712645|NCT00092534|2300681|P2|Base Study Follow Up Period|Travel|7
712646|NCT00092534|2300682|P1|Base Study Follow Up Period|Travel|10
712647|NCT00092534|2300680|P3|Base Study Follow Up Period|Moved|0
712648|NCT00092534|2300681|P2|Base Study Follow Up Period|Moved|58
712649|NCT00092534|2300682|P1|Base Study Follow Up Period|Moved|62
712650|NCT00092534|2300680|P3|Base Study Follow Up Period|Withdrawal by Subject|0
712651|NCT00092534|2300681|P2|Base Study Follow Up Period|Withdrawal by Subject|62
712652|NCT00092534|2300682|P1|Base Study Follow Up Period|Withdrawal by Subject|71
712653|NCT00092534|2300680|P3|Base Study Follow Up Period|Protocol Violation|0
712654|NCT00092534|2300681|P2|Base Study Follow Up Period|Protocol Violation|2
712655|NCT00092534|2300682|P1|Base Study Follow Up Period|Protocol Violation|1
712656|NCT00092534|2300680|P3|Base Study Follow Up Period|Pregnancy|0
712657|NCT00092534|2300681|P2|Base Study Follow Up Period|Pregnancy|10
712658|NCT00092534|2300682|P1|Base Study Follow Up Period|Pregnancy|6
712659|NCT00092534|2300680|P3|Base Study Follow Up Period|Lost to Follow-up|0
712660|NCT00092534|2300681|P2|Base Study Follow Up Period|Lost to Follow-up|146
712661|NCT00092534|2300682|P1|Base Study Follow Up Period|Lost to Follow-up|120
712662|NCT00092534|2300680|P3|Base Study Follow Up Period|Death|0
712663|NCT00092534|2300681|P2|Base Study Follow Up Period|Death|1
712664|NCT00092534|2300682|P1|Base Study Follow Up Period|Death|2
712665|NCT00092534|2300680|P3|Base Study Follow Up Period|Adverse Event|0
712666|NCT00092534|2300681|P2|Base Study Follow Up Period|Adverse Event|4
712667|NCT00092534|2300682|P1|Base Study Follow Up Period|Adverse Event|2
712668|NCT00092534|2300680|P3|Base Study Vaccination Period|Site Closed|0
712669|NCT00092534|2300681|P2|Base Study Vaccination Period|Site Closed|1
712670|NCT00092534|2300682|P1|Base Study Vaccination Period|Site Closed|0
712671|NCT00092534|2300680|P3|Base Study Vaccination Period|Travel|0
712672|NCT00092534|2300681|P2|Base Study Vaccination Period|Travel|0
712673|NCT00092534|2300682|P1|Base Study Vaccination Period|Travel|1
712674|NCT00092534|2300680|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
712675|NCT00092534|2300681|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
712676|NCT00092534|2300682|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
712677|NCT00092534|2300680|P3|Base Study Vaccination Period|Moved|0
712678|NCT00092534|2300681|P2|Base Study Vaccination Period|Moved|12
712679|NCT00092534|2300682|P1|Base Study Vaccination Period|Moved|14
712680|NCT00092534|2300680|P3|Base Study Vaccination Period|Withdrawal by Subject|0
712681|NCT00092534|2300681|P2|Base Study Vaccination Period|Withdrawal by Subject|58
712682|NCT00092534|2300682|P1|Base Study Vaccination Period|Withdrawal by Subject|85
712683|NCT00092534|2300680|P3|Base Study Vaccination Period|Protocol Violation|0
712684|NCT00092534|2300681|P2|Base Study Vaccination Period|Protocol Violation|1
712685|NCT00092534|2300682|P1|Base Study Vaccination Period|Protocol Violation|2
712686|NCT00092534|2300680|P3|Base Study Vaccination Period|Pregnancy|0
712687|NCT00092534|2300681|P2|Base Study Vaccination Period|Pregnancy|7
712688|NCT00092534|2300682|P1|Base Study Vaccination Period|Pregnancy|9
712689|NCT00092534|2300680|P3|Base Study Vaccination Period|Physician Decision|0
712690|NCT00092534|2300681|P2|Base Study Vaccination Period|Physician Decision|0
712691|NCT00092534|2300682|P1|Base Study Vaccination Period|Physician Decision|1
712692|NCT00092534|2300680|P3|Base Study Vaccination Period|Lost to Follow-up|0
712693|NCT00092534|2300681|P2|Base Study Vaccination Period|Lost to Follow-up|37
712694|NCT00092534|2300682|P1|Base Study Vaccination Period|Lost to Follow-up|41
712695|NCT00092534|2300680|P3|Base Study Vaccination Period|Death|0
712696|NCT00092534|2300681|P2|Base Study Vaccination Period|Death|4
712697|NCT00092534|2300682|P1|Base Study Vaccination Period|Death|5
712698|NCT00092534|2300680|P3|Base Study Vaccination Period|Adverse Event|0
712699|NCT00092534|2300681|P2|Base Study Vaccination Period|Adverse Event|1
712700|NCT00092534|2300682|P1|Base Study Vaccination Period|Adverse Event|3
712701|NCT00092534|2300680|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
712702|NCT00092534|2300681|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
712703|NCT00092534|2300682|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
712704|NCT00092547|2300699|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
712705|NCT00092547|2300700|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
712706|NCT00092547|2300701|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
712707|NCT00092547|2300699|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
712708|NCT00092547|2300700|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
712709|NCT00092547|2300701|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
712710|NCT00092547|2300699|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
712711|NCT00092547|2300700|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
712712|NCT00092547|2300701|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
712713|NCT00092547|2300699|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
712714|NCT00092547|2300700|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
712715|NCT00092547|2300701|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
712716|NCT00092547|2300699|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
712717|NCT00092547|2300700|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
712718|NCT00092547|2300701|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
712719|NCT00092547|2300699|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
712720|NCT00092547|2300700|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
712721|NCT00092547|2300701|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
712722|NCT00092547|2300699|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
712723|NCT00092547|2300700|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
712724|NCT00092547|2300701|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
712725|NCT00092547|2300699|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
712726|NCT00092547|2300700|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
712727|NCT00092547|2300701|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
712728|NCT00092547|2300699|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
712729|NCT00092547|2300700|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
712730|NCT00092547|2300701|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
712731|NCT00092547|2300699|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
712732|NCT00092547|2300700|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
712733|NCT00092547|2300701|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
712734|NCT00092547|2300699|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
712735|NCT00092547|2300700|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
712736|NCT00092547|2300701|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
712737|NCT00092547|2300699|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
712738|NCT00092547|2300700|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
712739|NCT00092547|2300701|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
712740|NCT00092547|2300699|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
712741|NCT00092547|2300700|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
712742|NCT00092547|2300701|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
712743|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
712744|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
712745|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
712746|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
712747|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
712748|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
712749|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
712750|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
712751|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
712752|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
712753|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
712754|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
712755|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
712756|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
712757|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
712758|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
712759|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
712760|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
712761|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
712762|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
712763|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
712764|NCT00092547|2300699|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
712765|NCT00092547|2300700|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
712766|NCT00092547|2300701|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
712767|NCT00092677|2300745|P2|Overall Study|Adminstrative|9
712768|NCT00092677|2300746|P1|Overall Study|Adminstrative|5
712769|NCT00092677|2300745|P2|Overall Study|Lost to Follow-up|2
712770|NCT00092677|2300746|P1|Overall Study|Lost to Follow-up|0
712771|NCT00093015|2300790|P2|Overall Study|Death|385
712772|NCT00093015|2300791|P1|Overall Study|Death|375
712773|NCT00093015|2300790|P2|Overall Study|Lost to Follow-up|108
712774|NCT00093015|2300791|P1|Overall Study|Lost to Follow-up|96
712775|NCT00093015|2300790|P2|Overall Study|Withdrawal by Subject|171
712776|NCT00093015|2300791|P1|Overall Study|Withdrawal by Subject|194
712777|NCT00093145|2300848|P1|Overall Study|Other|1
712778|NCT00093145|2300848|P1|Overall Study|Withdrawal by Subject|9
712779|NCT00093145|2300848|P1|Overall Study|Physician Decision|5
712780|NCT00093145|2300848|P1|Overall Study|Unacceptable Toxicity Only|2
712781|NCT00093470|2300865|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
712782|NCT00093470|2300866|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
712783|NCT00093470|2300865|P2|Overall Study|Never started treatment|0
712784|NCT00093470|2300866|P1|Overall Study|Never started treatment|1
712785|NCT00093470|2300865|P2|Overall Study|Physician Decision|0
712786|NCT00093470|2300866|P1|Overall Study|Physician Decision|2
712787|NCT00093470|2300865|P2|Overall Study|Other complicating disease|0
712788|NCT00093470|2300866|P1|Overall Study|Other complicating disease|3
712789|NCT00093470|2300865|P2|Overall Study|Alternative therapy|0
712790|NCT00093470|2300866|P1|Overall Study|Alternative therapy|2
712791|NCT00093470|2300865|P2|Overall Study|Withdrawal by Subject|0
712792|NCT00093470|2300866|P1|Overall Study|Withdrawal by Subject|8
712793|NCT00093470|2300865|P2|Overall Study|Death|0
712794|NCT00093470|2300866|P1|Overall Study|Death|2
712795|NCT00093470|2300865|P2|Overall Study|Adverse Event|0
712796|NCT00093470|2300866|P1|Overall Study|Adverse Event|15
712797|NCT00093470|2300865|P2|Overall Study|Disease progression|0
712798|NCT00093470|2300866|P1|Overall Study|Disease progression|39
712799|NCT00093496|2300876|P2|Overall Study|Protocol Violation|3
712800|NCT00093496|2300877|P1|Overall Study|Protocol Violation|1
712801|NCT00093808|2300906|P1|Overall Study|Protocol Violation|1
712802|NCT00093808|2300906|P1|Overall Study|Cancel participation before receiving tx|1
712803|NCT00094055|2300924|P1|Overall Study|Withdrawal by Subject|9
712804|NCT00094055|2300924|P1|Overall Study|roll-over to another study|14
712805|NCT00094055|2300924|P1|Overall Study|clinical progression|1
712806|NCT00094055|2300924|P1|Overall Study|progressive disease|2
712807|NCT00094055|2300924|P1|Overall Study|Lost to Follow-up|2
712808|NCT00094055|2300924|P1|Overall Study|Lack of Efficacy|17
712809|NCT00094055|2300924|P1|Overall Study|Death|4
712810|NCT00094055|2300924|P1|Overall Study|Adverse Event|11
712811|NCT00094094|2300933|P1|Overall Study|Adverse Event|7
712812|NCT00094094|2300933|P1|Overall Study|Lack of Efficacy|23
712813|NCT00094094|2300933|P1|Overall Study|Death|2
712814|NCT00094107|2300942|P1|Overall Study|Withdrawal due to Disease Progression|1
712815|NCT00094107|2300942|P1|Overall Study|Adverse Event|3
712816|NCT00094107|2300942|P1|Overall Study|Death|5
712817|NCT00094107|2300942|P1|Overall Study|Lack of Efficacy|23
712818|NCT00094172|2300953|P2|Overall Study|Started other MS therapy due to disease|0
712819|NCT00094172|2300954|P1|Overall Study|Started other MS therapy due to disease|1
712820|NCT00094172|2300953|P2|Overall Study|Primary endpoint met.|0
712821|NCT00094172|2300954|P1|Overall Study|Primary endpoint met.|1
712822|NCT00094172|2300953|P2|Overall Study|Withdrawal by Subject|5
712823|NCT00094172|2300954|P1|Overall Study|Withdrawal by Subject|10
712824|NCT00094172|2300953|P2|Overall Study|Protocol Violation|1
712825|NCT00094172|2300954|P1|Overall Study|Protocol Violation|0
712826|NCT00094172|2300953|P2|Overall Study|Lost to Follow-up|0
712827|NCT00094172|2300954|P1|Overall Study|Lost to Follow-up|2
712828|NCT00094172|2300953|P2|Overall Study|Adverse Event|1
712829|NCT00094172|2300954|P1|Overall Study|Adverse Event|0
712830|NCT00094302|2300966|P2|Overall Study|Death|246
712831|NCT00094302|2300967|P1|Overall Study|Death|266
712832|NCT00094302|2300966|P2|Overall Study|Withdrawal by Subject|111
712833|NCT00094302|2300967|P1|Overall Study|Withdrawal by Subject|103
712834|NCT00094302|2300966|P2|Overall Study|Physician Decision|8
712835|NCT00094302|2300967|P1|Overall Study|Physician Decision|5
712836|NCT00094302|2300966|P2|Overall Study|Lost to Follow-up|41
712837|NCT00094302|2300967|P1|Overall Study|Lost to Follow-up|43
889967|NCT01120184|2825155|P3|Overall Study|Sponsor Decision to Terminate Study|143
712839|NCT00094458|2301032|P6|OLE: Open-Label Extension|Patient decision|0
712840|NCT00094458|2301033|P5|OLE: Open-Label Extension|Patient decision|1
712841|NCT00094458|2301034|P4|OLE: Open-Label Extension|Patient decision|0
712842|NCT00094458|2301035|P3|OLE: Open-Label Extension|Patient decision|0
712843|NCT00094458|2301036|P2|OLE: Open-Label Extension|Patient decision|0
712844|NCT00094458|2301037|P1|OLE: Open-Label Extension|Patient decision|0
712845|NCT00094458|2301032|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
712846|NCT00094458|2301033|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
712847|NCT00094458|2301034|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
712848|NCT00094458|2301035|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
712849|NCT00094458|2301036|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
712850|NCT00094458|2301037|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
712851|NCT00094458|2301032|P6|OLE: Open-Label Extension|Adverse Event|4
712852|NCT00094458|2301033|P5|OLE: Open-Label Extension|Adverse Event|3
712853|NCT00094458|2301034|P4|OLE: Open-Label Extension|Adverse Event|0
712854|NCT00094458|2301035|P3|OLE: Open-Label Extension|Adverse Event|0
712855|NCT00094458|2301036|P2|OLE: Open-Label Extension|Adverse Event|0
712856|NCT00094458|2301037|P1|OLE: Open-Label Extension|Adverse Event|0
712857|NCT00094458|2301032|P6|Study Extension: Week 30 Through Week 50|Unspecified|0
712858|NCT00094458|2301033|P5|Study Extension: Week 30 Through Week 50|Unspecified|0
712859|NCT00094458|2301034|P4|Study Extension: Week 30 Through Week 50|Unspecified|0
712860|NCT00094458|2301035|P3|Study Extension: Week 30 Through Week 50|Unspecified|3
712861|NCT00094458|2301036|P2|Study Extension: Week 30 Through Week 50|Unspecified|2
712862|NCT00094458|2301037|P1|Study Extension: Week 30 Through Week 50|Unspecified|1
712863|NCT00094458|2301032|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
712864|NCT00094458|2301033|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
712865|NCT00094458|2301034|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
712866|NCT00094458|2301035|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
712867|NCT00094458|2301036|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
712868|NCT00094458|2301037|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
712869|NCT00094458|2301032|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
712870|NCT00094458|2301033|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
712871|NCT00094458|2301034|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
712872|NCT00094458|2301035|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
712873|NCT00094458|2301036|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
712874|NCT00094458|2301037|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
712875|NCT00094458|2301032|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
712876|NCT00094458|2301033|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
712877|NCT00094458|2301034|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
712878|NCT00094458|2301035|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
712879|NCT00094458|2301036|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
712880|NCT00094458|2301037|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
712881|NCT00094458|2301032|P6|Main Study: Through Week 30|Unspecified|0
712882|NCT00094458|2301033|P5|Main Study: Through Week 30|Unspecified|0
712883|NCT00094458|2301034|P4|Main Study: Through Week 30|Unspecified|0
712884|NCT00094458|2301035|P3|Main Study: Through Week 30|Unspecified|9
712885|NCT00094458|2301036|P2|Main Study: Through Week 30|Unspecified|16
712886|NCT00094458|2301037|P1|Main Study: Through Week 30|Unspecified|19
712887|NCT00094458|2301032|P6|Main Study: Through Week 30|Death|0
712888|NCT00094458|2301033|P5|Main Study: Through Week 30|Death|0
712889|NCT00094458|2301034|P4|Main Study: Through Week 30|Death|0
712890|NCT00094458|2301035|P3|Main Study: Through Week 30|Death|0
712891|NCT00094458|2301036|P2|Main Study: Through Week 30|Death|0
712892|NCT00094458|2301037|P1|Main Study: Through Week 30|Death|1
712893|NCT00094458|2301032|P6|Main Study: Through Week 30|Adverse Event|0
712894|NCT00094458|2301033|P5|Main Study: Through Week 30|Adverse Event|0
712895|NCT00094458|2301034|P4|Main Study: Through Week 30|Adverse Event|0
712896|NCT00094458|2301035|P3|Main Study: Through Week 30|Adverse Event|28
712897|NCT00094458|2301036|P2|Main Study: Through Week 30|Adverse Event|20
712898|NCT00094458|2301037|P1|Main Study: Through Week 30|Adverse Event|38
712899|NCT00094458|2301032|P6|Main Study: Through Week 30|Withdrawal by Subject|0
712900|NCT00094458|2301033|P5|Main Study: Through Week 30|Withdrawal by Subject|0
712901|NCT00094458|2301034|P4|Main Study: Through Week 30|Withdrawal by Subject|0
712902|NCT00094458|2301035|P3|Main Study: Through Week 30|Withdrawal by Subject|7
712903|NCT00094458|2301036|P2|Main Study: Through Week 30|Withdrawal by Subject|9
712904|NCT00094458|2301037|P1|Main Study: Through Week 30|Withdrawal by Subject|18
712905|NCT00094458|2301032|P6|Main Study: Through Week 30|Lost to Follow-up|0
712906|NCT00094458|2301033|P5|Main Study: Through Week 30|Lost to Follow-up|0
712907|NCT00094458|2301034|P4|Main Study: Through Week 30|Lost to Follow-up|0
712908|NCT00094458|2301035|P3|Main Study: Through Week 30|Lost to Follow-up|2
712909|NCT00094458|2301036|P2|Main Study: Through Week 30|Lost to Follow-up|5
712910|NCT00094458|2301037|P1|Main Study: Through Week 30|Lost to Follow-up|5
712911|NCT00094458|2301032|P6|Main Study: Through Week 30|Eligibility criteria not met|0
712912|NCT00094458|2301033|P5|Main Study: Through Week 30|Eligibility criteria not met|0
712913|NCT00094458|2301034|P4|Main Study: Through Week 30|Eligibility criteria not met|0
712914|NCT00094458|2301035|P3|Main Study: Through Week 30|Eligibility criteria not met|2
712915|NCT00094458|2301036|P2|Main Study: Through Week 30|Eligibility criteria not met|8
712916|NCT00094458|2301037|P1|Main Study: Through Week 30|Eligibility criteria not met|3
712917|NCT00100178|2301078|P3|Overall Study|Physician Decision|3
712918|NCT00100178|2301079|P2|Overall Study|Physician Decision|1
712919|NCT00100178|2301080|P1|Overall Study|Physician Decision|6
712920|NCT00100178|2301078|P3|Overall Study|Withdrawal by Subject|1
712921|NCT00100178|2301079|P2|Overall Study|Withdrawal by Subject|1
712922|NCT00100178|2301080|P1|Overall Study|Withdrawal by Subject|1
712923|NCT00100178|2301078|P3|Overall Study|Adverse Event|1
712924|NCT00100178|2301079|P2|Overall Study|Adverse Event|2
712925|NCT00100178|2301080|P1|Overall Study|Adverse Event|2
712926|NCT00100178|2301078|P3|Overall Study|Lost to Follow-up|5
712927|NCT00100178|2301079|P2|Overall Study|Lost to Follow-up|6
712928|NCT00100178|2301080|P1|Overall Study|Lost to Follow-up|0
712929|NCT00100789|2301153|P1|Overall Study|Never received treatment|1
712930|NCT00100789|2301153|P1|Overall Study|Ineligible|3
712931|NCT00100789|2301153|P1|Overall Study|Not protocol specified|5
712932|NCT00100789|2301153|P1|Overall Study|Death|2
712933|NCT00100789|2301153|P1|Overall Study|Progression/relapse|42
712934|NCT00100789|2301153|P1|Overall Study|Withdrawal by Subject|1
712935|NCT00100789|2301153|P1|Overall Study|Adverse Event|10
712936|NCT00100802|2301160|P1|Overall Study|Ineligible|12
712937|NCT00100802|2301160|P1|Overall Study|Withdrawal by Subject|5
712938|NCT00100802|2301160|P1|Overall Study|Protocol Violation|1
712939|NCT00100802|2301160|P1|Overall Study|Physician Decision|5
712940|NCT00100802|2301160|P1|Overall Study|Lack of Efficacy|47
712941|NCT00100802|2301160|P1|Overall Study|Death|1
712942|NCT00100802|2301160|P1|Overall Study|Adverse Event|9
712943|NCT00100815|2301165|P1|Overall Study|not specified|3
712944|NCT00100815|2301165|P1|Overall Study|Death|4
712945|NCT00100815|2301165|P1|Overall Study|Adverse Event|18
712946|NCT00100815|2301165|P1|Overall Study|Progression|24
712947|NCT00100932|2301180|P2|Overall Study|Not specified|2
712948|NCT00100932|2301181|P1|Overall Study|Not specified|5
712949|NCT00100932|2301180|P2|Overall Study|Physician Decision|5
712950|NCT00100932|2301181|P1|Overall Study|Physician Decision|7
712951|NCT00100932|2301180|P2|Overall Study|Progressive Disease|18
712952|NCT00100932|2301181|P1|Overall Study|Progressive Disease|44
712953|NCT00100932|2301180|P2|Overall Study|Withdrawal by Subject|0
712954|NCT00100932|2301181|P1|Overall Study|Withdrawal by Subject|6
712955|NCT00100932|2301180|P2|Overall Study|Adverse Event|2
712956|NCT00100932|2301181|P1|Overall Study|Adverse Event|11
712957|NCT00101101|2301204|P1|Overall Study|never received vaccine|20
712958|NCT00101166|2301210|P1|Overall Study|progressive disease|10
712959|NCT00101192|2301218|P1|Overall Study|Inevaluable|1
712960|NCT00101192|2301218|P1|Overall Study|Ineligible|6
712961|NCT00101283|2301224|P2|Overall Study|Prostate Cancer Recurrence|1
712962|NCT00101283|2301225|P1|Overall Study|Prostate Cancer Recurrence|0
712963|NCT00101283|2301224|P2|Overall Study|Insurance Refusal|1
712964|NCT00101283|2301225|P1|Overall Study|Insurance Refusal|0
712965|NCT00101283|2301224|P2|Overall Study|Withdrawal by Subject|1
712966|NCT00101283|2301225|P1|Overall Study|Withdrawal by Subject|0
712967|NCT00101400|2301244|P1|Survival Follow-Up|Alive|7
712968|NCT00101439|2301263|P2|Period 2|Withdrawal by Subject|2
712969|NCT00101439|2301264|P1|Period 2|Withdrawal by Subject|0
712970|NCT00101452|2301275|P3|Overall Study|Other|12
712971|NCT00101452|2301276|P2|Overall Study|Other|16
712972|NCT00101452|2301277|P1|Overall Study|Other|15
712973|NCT00101452|2301275|P3|Overall Study|Protocol Violation|3
712974|NCT00101452|2301276|P2|Overall Study|Protocol Violation|1
712975|NCT00101452|2301277|P1|Overall Study|Protocol Violation|2
712976|NCT00101452|2301275|P3|Overall Study|Physician Decision|2
712977|NCT00101452|2301276|P2|Overall Study|Physician Decision|3
712978|NCT00101452|2301277|P1|Overall Study|Physician Decision|0
712979|NCT00101452|2301275|P3|Overall Study|Baseline Fail|2
712980|NCT00101452|2301276|P2|Overall Study|Baseline Fail|1
712981|NCT00101452|2301277|P1|Overall Study|Baseline Fail|2
712982|NCT00101452|2301275|P3|Overall Study|Withdrawal by Subject|9
712983|NCT00101452|2301276|P2|Overall Study|Withdrawal by Subject|14
712984|NCT00101452|2301277|P1|Overall Study|Withdrawal by Subject|10
712985|NCT00101452|2301275|P3|Overall Study|Lost to Follow-up|14
712986|NCT00101452|2301276|P2|Overall Study|Lost to Follow-up|8
712987|NCT00101452|2301277|P1|Overall Study|Lost to Follow-up|13
712988|NCT00101452|2301275|P3|Overall Study|Adverse Event|1
712989|NCT00101452|2301276|P2|Overall Study|Adverse Event|0
712990|NCT00101452|2301277|P1|Overall Study|Adverse Event|2
712991|NCT00101582|2301291|P2|Overall Study|Other|1
712992|NCT00101582|2301292|P1|Overall Study|Other|0
712993|NCT00101582|2301291|P2|Overall Study|Death|5
712994|NCT00101582|2301292|P1|Overall Study|Death|3
712995|NCT00101582|2301291|P2|Overall Study|Physician Decision|0
712996|NCT00101582|2301292|P1|Overall Study|Physician Decision|1
712997|NCT00101582|2301291|P2|Overall Study|Withdrawal by Subject|4
712998|NCT00101582|2301292|P1|Overall Study|Withdrawal by Subject|6
712999|NCT00101582|2301291|P2|Overall Study|Adverse Event|4
713000|NCT00101582|2301292|P1|Overall Study|Adverse Event|1
713001|NCT00101582|2301291|P2|Overall Study|Ineligibility determined|1
713002|NCT00101582|2301292|P1|Overall Study|Ineligibility determined|0
713003|NCT00101686|2301392|P10|Overall Study|Withdrawal by Subject|9
713004|NCT00101686|2301393|P9|Overall Study|Withdrawal by Subject|8
713005|NCT00101686|2301394|P8|Overall Study|Withdrawal by Subject|7
713006|NCT00101686|2301395|P7|Overall Study|Withdrawal by Subject|7
713007|NCT00101686|2301396|P6|Overall Study|Withdrawal by Subject|7
713008|NCT00101686|2301397|P5|Overall Study|Withdrawal by Subject|8
713009|NCT00101686|2301398|P4|Overall Study|Withdrawal by Subject|8
713010|NCT00101686|2301399|P3|Overall Study|Withdrawal by Subject|6
713011|NCT00101686|2301400|P2|Overall Study|Withdrawal by Subject|8
713012|NCT00101686|2301401|P1|Overall Study|Withdrawal by Subject|9
713013|NCT00101686|2301392|P10|Overall Study|Other|3
713014|NCT00101686|2301393|P9|Overall Study|Other|3
713015|NCT00101686|2301394|P8|Overall Study|Other|5
713016|NCT00101686|2301395|P7|Overall Study|Other|1
713017|NCT00101686|2301396|P6|Overall Study|Other|12
713018|NCT00101686|2301397|P5|Overall Study|Other|2
713019|NCT00101686|2301398|P4|Overall Study|Other|6
713020|NCT00101686|2301399|P3|Overall Study|Other|1
713021|NCT00101686|2301400|P2|Overall Study|Other|4
713022|NCT00101686|2301401|P1|Overall Study|Other|1
713023|NCT00101686|2301392|P10|Overall Study|Physician Decision|1
713024|NCT00101686|2301393|P9|Overall Study|Physician Decision|1
713025|NCT00101686|2301394|P8|Overall Study|Physician Decision|5
713026|NCT00101686|2301395|P7|Overall Study|Physician Decision|5
713027|NCT00101686|2301396|P6|Overall Study|Physician Decision|9
713028|NCT00101686|2301397|P5|Overall Study|Physician Decision|8
713029|NCT00101686|2301398|P4|Overall Study|Physician Decision|7
713030|NCT00101686|2301399|P3|Overall Study|Physician Decision|6
713031|NCT00101686|2301400|P2|Overall Study|Physician Decision|13
713032|NCT00101686|2301401|P1|Overall Study|Physician Decision|10
713033|NCT00101686|2301392|P10|Overall Study|intercurrent non-cancer related illness|1
713034|NCT00101686|2301393|P9|Overall Study|intercurrent non-cancer related illness|1
713035|NCT00101686|2301394|P8|Overall Study|intercurrent non-cancer related illness|0
713036|NCT00101686|2301395|P7|Overall Study|intercurrent non-cancer related illness|1
713037|NCT00101686|2301396|P6|Overall Study|intercurrent non-cancer related illness|3
713038|NCT00101686|2301397|P5|Overall Study|intercurrent non-cancer related illness|1
713039|NCT00101686|2301398|P4|Overall Study|intercurrent non-cancer related illness|0
713040|NCT00101686|2301399|P3|Overall Study|intercurrent non-cancer related illness|2
713041|NCT00101686|2301400|P2|Overall Study|intercurrent non-cancer related illness|0
713042|NCT00101686|2301401|P1|Overall Study|intercurrent non-cancer related illness|0
713043|NCT00101686|2301392|P10|Overall Study|Randomized but did not receive treament|1
713044|NCT00101686|2301393|P9|Overall Study|Randomized but did not receive treament|0
713045|NCT00101686|2301394|P8|Overall Study|Randomized but did not receive treament|1
713046|NCT00101686|2301395|P7|Overall Study|Randomized but did not receive treament|0
713047|NCT00101686|2301396|P6|Overall Study|Randomized but did not receive treament|2
713048|NCT00101686|2301397|P5|Overall Study|Randomized but did not receive treament|2
713049|NCT00101686|2301398|P4|Overall Study|Randomized but did not receive treament|2
713050|NCT00101686|2301399|P3|Overall Study|Randomized but did not receive treament|2
713051|NCT00101686|2301400|P2|Overall Study|Randomized but did not receive treament|6
713052|NCT00101686|2301401|P1|Overall Study|Randomized but did not receive treament|1
713053|NCT00101686|2301392|P10|Overall Study|unacceptable toxicity|4
713054|NCT00101686|2301393|P9|Overall Study|unacceptable toxicity|1
713055|NCT00101686|2301394|P8|Overall Study|unacceptable toxicity|2
713056|NCT00101686|2301395|P7|Overall Study|unacceptable toxicity|4
713057|NCT00101686|2301396|P6|Overall Study|unacceptable toxicity|10
713058|NCT00101686|2301397|P5|Overall Study|unacceptable toxicity|16
713059|NCT00101686|2301398|P4|Overall Study|unacceptable toxicity|6
713060|NCT00101686|2301399|P3|Overall Study|unacceptable toxicity|10
713061|NCT00101686|2301400|P2|Overall Study|unacceptable toxicity|9
713062|NCT00101686|2301401|P1|Overall Study|unacceptable toxicity|3
713063|NCT00101686|2301392|P10|Overall Study|>3 week delay treatment due toxicity|0
713064|NCT00101686|2301393|P9|Overall Study|>3 week delay treatment due toxicity|3
713065|NCT00101686|2301394|P8|Overall Study|>3 week delay treatment due toxicity|1
713066|NCT00101686|2301395|P7|Overall Study|>3 week delay treatment due toxicity|2
713067|NCT00101686|2301396|P6|Overall Study|>3 week delay treatment due toxicity|3
713068|NCT00101686|2301397|P5|Overall Study|>3 week delay treatment due toxicity|7
713069|NCT00101686|2301398|P4|Overall Study|>3 week delay treatment due toxicity|2
713070|NCT00101686|2301399|P3|Overall Study|>3 week delay treatment due toxicity|1
713071|NCT00101686|2301400|P2|Overall Study|>3 week delay treatment due toxicity|2
713072|NCT00101686|2301401|P1|Overall Study|>3 week delay treatment due toxicity|6
713073|NCT00101686|2301392|P10|Overall Study|initiation other anti-cancer treatment|3
713074|NCT00101686|2301393|P9|Overall Study|initiation other anti-cancer treatment|3
713075|NCT00101686|2301394|P8|Overall Study|initiation other anti-cancer treatment|2
713076|NCT00101686|2301395|P7|Overall Study|initiation other anti-cancer treatment|2
713077|NCT00101686|2301396|P6|Overall Study|initiation other anti-cancer treatment|1
713078|NCT00101686|2301397|P5|Overall Study|initiation other anti-cancer treatment|1
713079|NCT00101686|2301398|P4|Overall Study|initiation other anti-cancer treatment|3
713080|NCT00101686|2301399|P3|Overall Study|initiation other anti-cancer treatment|4
713081|NCT00101686|2301400|P2|Overall Study|initiation other anti-cancer treatment|3
713082|NCT00101686|2301401|P1|Overall Study|initiation other anti-cancer treatment|4
713083|NCT00101686|2301392|P10|Overall Study|Progressive Disease|8
713084|NCT00101686|2301393|P9|Overall Study|Progressive Disease|10
713085|NCT00101686|2301394|P8|Overall Study|Progressive Disease|7
713086|NCT00101686|2301395|P7|Overall Study|Progressive Disease|5
713087|NCT00101686|2301396|P6|Overall Study|Progressive Disease|25
713088|NCT00101686|2301397|P5|Overall Study|Progressive Disease|28
713089|NCT00101686|2301398|P4|Overall Study|Progressive Disease|38
713090|NCT00101686|2301399|P3|Overall Study|Progressive Disease|37
713091|NCT00101686|2301400|P2|Overall Study|Progressive Disease|28
713092|NCT00101686|2301401|P1|Overall Study|Progressive Disease|37
713093|NCT00101868|2301498|P2|Overall Study|Lost to Follow-up|13
713094|NCT00101868|2301499|P1|Overall Study|Lost to Follow-up|8
713095|NCT00101868|2301498|P2|Overall Study|Protocol Violation|0
713096|NCT00101868|2301499|P1|Overall Study|Protocol Violation|3
713097|NCT00101868|2301498|P2|Overall Study|Withdrawal by Subject|9
713098|NCT00101868|2301499|P1|Overall Study|Withdrawal by Subject|8
713099|NCT00101868|2301498|P2|Overall Study|Death|10
713100|NCT00101868|2301499|P1|Overall Study|Death|10
713101|NCT00101907|2301515|P6|Overall Study|Withdrawal by Subject|0
713102|NCT00101907|2301516|P5|Overall Study|Withdrawal by Subject|1
713103|NCT00101907|2301517|P4|Overall Study|Withdrawal by Subject|0
713104|NCT00101907|2301518|P3|Overall Study|Withdrawal by Subject|1
713105|NCT00101907|2301519|P2|Overall Study|Withdrawal by Subject|0
713106|NCT00101907|2301520|P1|Overall Study|Withdrawal by Subject|1
713107|NCT00101907|2301515|P6|Overall Study|Physician Decision|0
713108|NCT00101907|2301516|P5|Overall Study|Physician Decision|1
713109|NCT00101907|2301517|P4|Overall Study|Physician Decision|1
713110|NCT00101907|2301518|P3|Overall Study|Physician Decision|0
713111|NCT00101907|2301519|P2|Overall Study|Physician Decision|0
713112|NCT00101907|2301520|P1|Overall Study|Physician Decision|0
713113|NCT00101907|2301515|P6|Overall Study|Death|0
713114|NCT00101907|2301516|P5|Overall Study|Death|3
713115|NCT00101907|2301517|P4|Overall Study|Death|0
713116|NCT00101907|2301518|P3|Overall Study|Death|0
713117|NCT00101907|2301519|P2|Overall Study|Death|1
713118|NCT00101907|2301520|P1|Overall Study|Death|0
713119|NCT00101907|2301515|P6|Overall Study|Adverse Event|0
713120|NCT00101907|2301516|P5|Overall Study|Adverse Event|0
713121|NCT00101907|2301517|P4|Overall Study|Adverse Event|0
713122|NCT00101907|2301518|P3|Overall Study|Adverse Event|0
713123|NCT00101907|2301519|P2|Overall Study|Adverse Event|0
713124|NCT00101907|2301520|P1|Overall Study|Adverse Event|1
713125|NCT00102063|2301586|P3|Overall Study|Protocol Violation|1
713126|NCT00102063|2301587|P2|Overall Study|Protocol Violation|1
713127|NCT00102063|2301588|P1|Overall Study|Protocol Violation|0
713128|NCT00102063|2301586|P3|Overall Study|Lost to Follow-up|1
713129|NCT00102063|2301587|P2|Overall Study|Lost to Follow-up|0
713130|NCT00102063|2301588|P1|Overall Study|Lost to Follow-up|0
713131|NCT00102063|2301586|P3|Overall Study|Withdrawal by Subject|5
713132|NCT00102063|2301587|P2|Overall Study|Withdrawal by Subject|12
713133|NCT00102063|2301588|P1|Overall Study|Withdrawal by Subject|4
713134|NCT00102063|2301586|P3|Overall Study|Adverse Event|2
713135|NCT00102063|2301587|P2|Overall Study|Adverse Event|4
713136|NCT00102063|2301588|P1|Overall Study|Adverse Event|7
713137|NCT00102063|2301586|P3|Overall Study|Lack of Efficacy|1
713138|NCT00102063|2301587|P2|Overall Study|Lack of Efficacy|1
713139|NCT00102063|2301588|P1|Overall Study|Lack of Efficacy|5
713140|NCT00102440|2301620|P3|Overall Study|Protocol Violation|1
713141|NCT00102440|2301621|P2|Overall Study|Protocol Violation|2
713142|NCT00102440|2301622|P1|Overall Study|Protocol Violation|7
713143|NCT00102440|2301620|P3|Overall Study|Other|14
713144|NCT00102440|2301621|P2|Overall Study|Other|14
713145|NCT00102440|2301622|P1|Overall Study|Other|11
713146|NCT00102440|2301620|P3|Overall Study|Personal Reason(s)|13
713147|NCT00102440|2301621|P2|Overall Study|Personal Reason(s)|13
713148|NCT00102440|2301622|P1|Overall Study|Personal Reason(s)|19
713149|NCT00102440|2301620|P3|Overall Study|Gout Flare|9
713150|NCT00102440|2301621|P2|Overall Study|Gout Flare|28
713151|NCT00102440|2301622|P1|Overall Study|Gout Flare|10
713152|NCT00102440|2301620|P3|Overall Study|Adverse Event|8
713153|NCT00102440|2301621|P2|Overall Study|Adverse Event|23
713154|NCT00102440|2301622|P1|Overall Study|Adverse Event|16
713155|NCT00102440|2301620|P3|Overall Study|Lost to Follow-up|21
713156|NCT00102440|2301621|P2|Overall Study|Lost to Follow-up|18
713157|NCT00102440|2301622|P1|Overall Study|Lost to Follow-up|25
713158|NCT00102531|2301677|P2|Overall Study|Physician Decision|1
713159|NCT00102531|2301678|P1|Overall Study|Physician Decision|0
713160|NCT00102531|2301677|P2|Overall Study|Disease Progression|9
713161|NCT00102531|2301678|P1|Overall Study|Disease Progression|5
713162|NCT00102531|2301677|P2|Overall Study|Adverse Event|1
713163|NCT00102531|2301678|P1|Overall Study|Adverse Event|0
713164|NCT00102596|2301684|P2|Part A|Adverse Event|0
713165|NCT00102596|2301685|P1|Part A|Adverse Event|1
713166|NCT00102596|2301684|P2|Part A|Screen failures|0
713167|NCT00102596|2301685|P1|Part A|Screen failures|6
713168|NCT00102687|2301697|P5|Maintenance Period|Death|1
713169|NCT00102687|2301698|P4|Maintenance Period|Death|1
713170|NCT00102687|2301699|P3|Maintenance Period|Death|0
713171|NCT00102687|2301700|P2|Maintenance Period|Death|0
713172|NCT00102687|2301701|P1|Maintenance Period|Death|0
713173|NCT00102687|2301697|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
713174|NCT00102687|2301698|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
713175|NCT00102687|2301699|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
713176|NCT00102687|2301700|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
713177|NCT00102687|2301701|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
713178|NCT00102687|2301697|P5|Maintenance Period|Sponsor decision|0
713179|NCT00102687|2301698|P4|Maintenance Period|Sponsor decision|0
713180|NCT00102687|2301699|P3|Maintenance Period|Sponsor decision|0
713181|NCT00102687|2301700|P2|Maintenance Period|Sponsor decision|0
713182|NCT00102687|2301701|P1|Maintenance Period|Sponsor decision|0
713183|NCT00102687|2301697|P5|Maintenance Period|Physician Decision|4
713184|NCT00102687|2301698|P4|Maintenance Period|Physician Decision|0
713185|NCT00102687|2301699|P3|Maintenance Period|Physician Decision|3
713186|NCT00102687|2301700|P2|Maintenance Period|Physician Decision|2
713187|NCT00102687|2301701|P1|Maintenance Period|Physician Decision|1
713188|NCT00102687|2301697|P5|Maintenance Period|Protocol Violation|0
713189|NCT00102687|2301698|P4|Maintenance Period|Protocol Violation|0
713190|NCT00102687|2301699|P3|Maintenance Period|Protocol Violation|0
713191|NCT00102687|2301700|P2|Maintenance Period|Protocol Violation|0
713192|NCT00102687|2301701|P1|Maintenance Period|Protocol Violation|0
713193|NCT00102687|2301697|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
713194|NCT00102687|2301698|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
713195|NCT00102687|2301699|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
713196|NCT00102687|2301700|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
713197|NCT00102687|2301701|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
713198|NCT00102687|2301697|P5|Maintenance Period|Adverse Event|3
713199|NCT00102687|2301698|P4|Maintenance Period|Adverse Event|1
713200|NCT00102687|2301699|P3|Maintenance Period|Adverse Event|0
713201|NCT00102687|2301700|P2|Maintenance Period|Adverse Event|0
713202|NCT00102687|2301701|P1|Maintenance Period|Adverse Event|1
713203|NCT00102687|2301697|P5|Maintenance Period|Withdrawal by Subject|1
713204|NCT00102687|2301698|P4|Maintenance Period|Withdrawal by Subject|3
713205|NCT00102687|2301699|P3|Maintenance Period|Withdrawal by Subject|2
713206|NCT00102687|2301700|P2|Maintenance Period|Withdrawal by Subject|0
713207|NCT00102687|2301701|P1|Maintenance Period|Withdrawal by Subject|4
713208|NCT00102687|2301697|P5|Initial Period|Death|0
713209|NCT00102687|2301698|P4|Initial Period|Death|0
713210|NCT00102687|2301699|P3|Initial Period|Death|1
713211|NCT00102687|2301700|P2|Initial Period|Death|1
713212|NCT00102687|2301701|P1|Initial Period|Death|1
713213|NCT00102687|2301697|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
713214|NCT00102687|2301698|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
713215|NCT00102687|2301699|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
713216|NCT00102687|2301700|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
713217|NCT00102687|2301701|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
713218|NCT00102687|2301697|P5|Initial Period|Sponsor's decision|0
713219|NCT00102687|2301698|P4|Initial Period|Sponsor's decision|0
713220|NCT00102687|2301699|P3|Initial Period|Sponsor's decision|1
713221|NCT00102687|2301700|P2|Initial Period|Sponsor's decision|1
713222|NCT00102687|2301701|P1|Initial Period|Sponsor's decision|0
713223|NCT00102687|2301697|P5|Initial Period|Physician Decision|0
713224|NCT00102687|2301698|P4|Initial Period|Physician Decision|0
713225|NCT00102687|2301699|P3|Initial Period|Physician Decision|6
713226|NCT00102687|2301700|P2|Initial Period|Physician Decision|9
713227|NCT00102687|2301701|P1|Initial Period|Physician Decision|2
713228|NCT00102687|2301697|P5|Initial Period|Protocol Violation|0
713229|NCT00102687|2301698|P4|Initial Period|Protocol Violation|0
713230|NCT00102687|2301699|P3|Initial Period|Protocol Violation|2
713231|NCT00102687|2301700|P2|Initial Period|Protocol Violation|0
713232|NCT00102687|2301701|P1|Initial Period|Protocol Violation|0
713233|NCT00102687|2301697|P5|Initial Period|Transformation to AML (blast > 30%)|0
713234|NCT00102687|2301698|P4|Initial Period|Transformation to AML (blast > 30%)|0
713235|NCT00102687|2301699|P3|Initial Period|Transformation to AML (blast > 30%)|0
713236|NCT00102687|2301700|P2|Initial Period|Transformation to AML (blast > 30%)|3
713237|NCT00102687|2301701|P1|Initial Period|Transformation to AML (blast > 30%)|1
713238|NCT00102687|2301697|P5|Initial Period|Adverse Event|0
713239|NCT00102687|2301698|P4|Initial Period|Adverse Event|0
713240|NCT00102687|2301699|P3|Initial Period|Adverse Event|9
713241|NCT00102687|2301700|P2|Initial Period|Adverse Event|7
713242|NCT00102687|2301701|P1|Initial Period|Adverse Event|4
713243|NCT00102687|2301697|P5|Initial Period|Withdrawal by Subject|0
713244|NCT00102687|2301698|P4|Initial Period|Withdrawal by Subject|0
713245|NCT00102687|2301699|P3|Initial Period|Withdrawal by Subject|5
713246|NCT00102687|2301700|P2|Initial Period|Withdrawal by Subject|3
713247|NCT00102687|2301701|P1|Initial Period|Withdrawal by Subject|6
713248|NCT00102804|2301767|P2|Overall Study|Alive, Receiving Treatment|2
713249|NCT00102804|2301768|P1|Overall Study|Alive, Receiving Treatment|7
713250|NCT00102804|2301767|P2|Overall Study|Sponsor Decision|0
713251|NCT00102804|2301768|P1|Overall Study|Sponsor Decision|1
713252|NCT00102804|2301767|P2|Overall Study|Satisfactory Response|0
713253|NCT00102804|2301768|P1|Overall Study|Satisfactory Response|2
713254|NCT00102804|2301767|P2|Overall Study|Protocol Violation|1
713255|NCT00102804|2301768|P1|Overall Study|Protocol Violation|2
713256|NCT00102804|2301767|P2|Overall Study|Lost to Follow-up|1
713257|NCT00102804|2301768|P1|Overall Study|Lost to Follow-up|4
713258|NCT00102804|2301767|P2|Overall Study|Enrollment Criteria Not Met|0
713259|NCT00102804|2301768|P1|Overall Study|Enrollment Criteria Not Met|6
713260|NCT00102804|2301767|P2|Overall Study|Death|6
713261|NCT00102804|2301768|P1|Overall Study|Death|5
713262|NCT00102804|2301767|P2|Overall Study|Physician Decision|6
713263|NCT00102804|2301768|P1|Overall Study|Physician Decision|24
713264|NCT00102804|2301767|P2|Overall Study|Adverse Event|3
713265|NCT00102804|2301768|P1|Overall Study|Adverse Event|37
713266|NCT00102804|2301767|P2|Overall Study|Withdrawal by Subject|7
713267|NCT00102804|2301768|P1|Overall Study|Withdrawal by Subject|46
713268|NCT00102804|2301767|P2|Overall Study|Progressive Disease (PD)|196
713269|NCT00102804|2301768|P1|Overall Study|Progressive Disease (PD)|307
713270|NCT00103012|2301789|P3|Overall Study|Subject non-compliant with medications|1
713271|NCT00103012|2301790|P2|Overall Study|Subject non-compliant with medications|0
713272|NCT00103012|2301791|P1|Overall Study|Subject non-compliant with medications|0
713273|NCT00103012|2301789|P3|Overall Study|Adverse Event|1
713274|NCT00103012|2301790|P2|Overall Study|Adverse Event|0
713275|NCT00103012|2301791|P1|Overall Study|Adverse Event|0
713276|NCT00103012|2301789|P3|Overall Study|Pregnancy|0
713277|NCT00103012|2301790|P2|Overall Study|Pregnancy|0
713278|NCT00103012|2301791|P1|Overall Study|Pregnancy|1
713279|NCT00103012|2301789|P3|Overall Study|Withdrawal by Subject|2
713280|NCT00103012|2301790|P2|Overall Study|Withdrawal by Subject|1
713281|NCT00103012|2301791|P1|Overall Study|Withdrawal by Subject|2
713282|NCT00103142|2301806|P2|Overall Study|Progression of disease|1
713283|NCT00103142|2301807|P1|Overall Study|Progression of disease|2
713284|NCT00103142|2301806|P2|Overall Study|Adverse Event|0
713285|NCT00103142|2301807|P1|Overall Study|Adverse Event|1
713286|NCT00091572|2301824|P2|Overall Study|Toxicity (Related AE)|9
713287|NCT00091572|2301825|P1|Overall Study|Toxicity (Related AE)|53
713288|NCT00091572|2301824|P2|Overall Study|Major Protocol Violation|0
713289|NCT00091572|2301825|P1|Overall Study|Major Protocol Violation|2
713290|NCT00091572|2301824|P2|Overall Study|Ongoing (still on treatment)|12
713291|NCT00091572|2301825|P1|Overall Study|Ongoing (still on treatment)|8
713292|NCT00091572|2301824|P2|Overall Study|Other Reason|13
713293|NCT00091572|2301825|P1|Overall Study|Other Reason|6
713294|NCT00091572|2301824|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
713295|NCT00091572|2301825|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
713296|NCT00091572|2301824|P2|Overall Study|Death not due to malignancy/toxicity|3
713297|NCT00091572|2301825|P1|Overall Study|Death not due to malignancy/toxicity|1
713298|NCT00091572|2301824|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
713299|NCT00091572|2301825|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
713300|NCT00091572|2301824|P2|Overall Study|Lost to Follow-up|1
713301|NCT00091572|2301825|P1|Overall Study|Lost to Follow-up|1
713302|NCT00091793|2301839|P2|Overall Study|Other|0
713303|NCT00091793|2301840|P1|Overall Study|Other|2
713304|NCT00091793|2301839|P2|Overall Study|Noncompliance|0
713305|NCT00091793|2301840|P1|Overall Study|Noncompliance|2
713306|NCT00091793|2301839|P2|Overall Study|Lost to Follow-up|5
713307|NCT00091793|2301840|P1|Overall Study|Lost to Follow-up|7
713308|NCT00091793|2301839|P2|Overall Study|Ineligibility determined|0
713309|NCT00091793|2301840|P1|Overall Study|Ineligibility determined|2
713310|NCT00091793|2301839|P2|Overall Study|Withdrawal by Subject|15
713311|NCT00091793|2301840|P1|Overall Study|Withdrawal by Subject|10
713312|NCT00091793|2301839|P2|Overall Study|Adverse Event|2
713313|NCT00091793|2301840|P1|Overall Study|Adverse Event|1
713314|NCT00091819|2301864|P2|Overall Study|Never received study treatment|4
713315|NCT00091819|2301865|P1|Overall Study|Never received study treatment|3
713316|NCT00091819|2301864|P2|Overall Study|Other|3
713317|NCT00091819|2301865|P1|Overall Study|Other|2
713318|NCT00091819|2301864|P2|Overall Study|Protocol Violation|2
713319|NCT00091819|2301865|P1|Overall Study|Protocol Violation|1
713320|NCT00091819|2301864|P2|Overall Study|Withdrawal by Subject|8
713321|NCT00091819|2301865|P1|Overall Study|Withdrawal by Subject|5
713322|NCT00091819|2301864|P2|Overall Study|Lost to Follow-up|23
713323|NCT00091819|2301865|P1|Overall Study|Lost to Follow-up|26
713324|NCT00091819|2301864|P2|Overall Study|Death|5
713325|NCT00091819|2301865|P1|Overall Study|Death|4
713326|NCT00091819|2301864|P2|Overall Study|Adverse Event|1
713327|NCT00091819|2301865|P1|Overall Study|Adverse Event|1
713328|NCT00091832|2301877|P6|Overall Study|Protocol Violation|1
713329|NCT00091832|2301878|P5|Overall Study|Protocol Violation|0
713330|NCT00091832|2301879|P4|Overall Study|Protocol Violation|0
713331|NCT00091832|2301880|P3|Overall Study|Protocol Violation|1
713332|NCT00091832|2301881|P2|Overall Study|Protocol Violation|0
713333|NCT00091832|2301882|P1|Overall Study|Protocol Violation|0
713334|NCT00091832|2301877|P6|Overall Study|Other|0
713335|NCT00091832|2301878|P5|Overall Study|Other|0
713336|NCT00091832|2301879|P4|Overall Study|Other|0
713337|NCT00091832|2301880|P3|Overall Study|Other|2
713338|NCT00091832|2301881|P2|Overall Study|Other|1
713339|NCT00091832|2301882|P1|Overall Study|Other|0
713340|NCT00091832|2301877|P6|Overall Study|Noncompliance|0
713341|NCT00091832|2301878|P5|Overall Study|Noncompliance|0
713342|NCT00091832|2301879|P4|Overall Study|Noncompliance|0
713343|NCT00091832|2301880|P3|Overall Study|Noncompliance|0
713344|NCT00091832|2301881|P2|Overall Study|Noncompliance|1
713345|NCT00091832|2301882|P1|Overall Study|Noncompliance|0
713346|NCT00091832|2301877|P6|Overall Study|Lost to Follow-up|1
713347|NCT00091832|2301878|P5|Overall Study|Lost to Follow-up|2
713348|NCT00091832|2301879|P4|Overall Study|Lost to Follow-up|3
713349|NCT00091832|2301880|P3|Overall Study|Lost to Follow-up|3
713350|NCT00091832|2301881|P2|Overall Study|Lost to Follow-up|0
713351|NCT00091832|2301882|P1|Overall Study|Lost to Follow-up|1
713352|NCT00091832|2301877|P6|Overall Study|Ineligibility Determined|0
713353|NCT00091832|2301878|P5|Overall Study|Ineligibility Determined|1
713354|NCT00091832|2301879|P4|Overall Study|Ineligibility Determined|0
713355|NCT00091832|2301880|P3|Overall Study|Ineligibility Determined|1
713356|NCT00091832|2301881|P2|Overall Study|Ineligibility Determined|0
713357|NCT00091832|2301882|P1|Overall Study|Ineligibility Determined|0
713358|NCT00091832|2301877|P6|Overall Study|Disease Progression|2
713359|NCT00091832|2301878|P5|Overall Study|Disease Progression|1
713360|NCT00091832|2301879|P4|Overall Study|Disease Progression|1
713361|NCT00091832|2301880|P3|Overall Study|Disease Progression|0
713362|NCT00091832|2301881|P2|Overall Study|Disease Progression|0
713363|NCT00091832|2301882|P1|Overall Study|Disease Progression|2
713364|NCT00091832|2301877|P6|Overall Study|Death|6
713365|NCT00091832|2301878|P5|Overall Study|Death|5
713366|NCT00091832|2301879|P4|Overall Study|Death|8
713367|NCT00091832|2301880|P3|Overall Study|Death|5
713368|NCT00091832|2301881|P2|Overall Study|Death|4
713369|NCT00091832|2301882|P1|Overall Study|Death|6
713370|NCT00091832|2301877|P6|Overall Study|Withdrawal by Subject|1
713371|NCT00091832|2301878|P5|Overall Study|Withdrawal by Subject|3
713372|NCT00091832|2301879|P4|Overall Study|Withdrawal by Subject|1
713373|NCT00091832|2301880|P3|Overall Study|Withdrawal by Subject|0
713374|NCT00091832|2301881|P2|Overall Study|Withdrawal by Subject|5
713375|NCT00091832|2301882|P1|Overall Study|Withdrawal by Subject|4
713376|NCT00091832|2301877|P6|Overall Study|Adverse Event|0
713377|NCT00091832|2301878|P5|Overall Study|Adverse Event|3
713378|NCT00091832|2301879|P4|Overall Study|Adverse Event|1
713379|NCT00091832|2301880|P3|Overall Study|Adverse Event|0
713380|NCT00091832|2301881|P2|Overall Study|Adverse Event|0
713381|NCT00091832|2301882|P1|Overall Study|Adverse Event|0
713382|NCT00091832|2301877|P6|Overall Study|Physician Decision|0
713383|NCT00091832|2301878|P5|Overall Study|Physician Decision|0
713384|NCT00091832|2301879|P4|Overall Study|Physician Decision|0
713385|NCT00091832|2301880|P3|Overall Study|Physician Decision|0
713386|NCT00091832|2301881|P2|Overall Study|Physician Decision|0
713387|NCT00091832|2301882|P1|Overall Study|Physician Decision|1
713388|NCT00103207|2301998|P1|Overall Study|Diagnosis of BAC not confirmed|27
713389|NCT00103207|2301998|P1|Overall Study|Ineligible|4
713390|NCT00103207|2301998|P1|Overall Study|Other complicating disease|1
713391|NCT00103207|2301998|P1|Overall Study|Withdrawal by Subject|2
713392|NCT00103207|2301998|P1|Overall Study|Death|1
713393|NCT00103207|2301998|P1|Overall Study|Adverse Event|3
713394|NCT00103259|2302010|P2|Overall Study|ineligible/no protocol therapy|6
713395|NCT00103259|2302011|P1|Overall Study|ineligible/no protocol therapy|4
713396|NCT00103259|2302010|P2|Overall Study|other (reasons were not specified)|1
713397|NCT00103259|2302011|P1|Overall Study|other (reasons were not specified)|2
713398|NCT00103259|2302010|P2|Overall Study|alternative therapy|0
713399|NCT00103259|2302011|P1|Overall Study|alternative therapy|1
713400|NCT00103259|2302010|P2|Overall Study|Withdrawal by Subject|3
713401|NCT00103259|2302011|P1|Overall Study|Withdrawal by Subject|2
713402|NCT00103259|2302010|P2|Overall Study|Death|2
713403|NCT00103259|2302011|P1|Overall Study|Death|3
713404|NCT00103311|2302025|P2|Overall Study|Adverse Event|0
713405|NCT00103311|2302026|P1|Overall Study|Adverse Event|1
713406|NCT00103311|2302025|P2|Overall Study|Withdrawal by Subject|1
713407|NCT00103311|2302026|P1|Overall Study|Withdrawal by Subject|2
713408|NCT00103311|2302025|P2|Overall Study|Lost to Follow-up|0
713409|NCT00103311|2302026|P1|Overall Study|Lost to Follow-up|1
713410|NCT00103506|2302038|P2|Overall Study|Withdrawal by Subject|21
713411|NCT00103506|2302039|P1|Overall Study|Withdrawal by Subject|18
713412|NCT00103506|2302038|P2|Overall Study|Lost to Follow-up|13
713413|NCT00103506|2302039|P1|Overall Study|Lost to Follow-up|13
713414|NCT00103506|2302038|P2|Overall Study|Death|253
713415|NCT00103506|2302039|P1|Overall Study|Death|257
713416|NCT00103506|2302038|P2|Overall Study|Study closed by sponsor|37
713417|NCT00103506|2302039|P1|Overall Study|Study closed by sponsor|34
713418|NCT00105534|2302051|P2|Overall Study|Other Reason|2
713419|NCT00105534|2302052|P1|Overall Study|Other Reason|0
713420|NCT00105534|2302051|P2|Overall Study|Treatment unmasked|0
713421|NCT00105534|2302052|P1|Overall Study|Treatment unmasked|1
713422|NCT00105534|2302051|P2|Overall Study|Lack of Efficacy|15
713423|NCT00105534|2302052|P1|Overall Study|Lack of Efficacy|7
713424|NCT00105534|2302051|P2|Overall Study|Lost to Follow-up|1
713425|NCT00105534|2302052|P1|Overall Study|Lost to Follow-up|5
713426|NCT00105534|2302051|P2|Overall Study|Withdrawal by Subject|6
713427|NCT00105534|2302052|P1|Overall Study|Withdrawal by Subject|6
713428|NCT00105534|2302051|P2|Overall Study|Protocol Violation|4
713429|NCT00105534|2302052|P1|Overall Study|Protocol Violation|1
713430|NCT00105534|2302051|P2|Overall Study|Adverse Event|5
713431|NCT00105534|2302052|P1|Overall Study|Adverse Event|2
889968|NCT01120184|2825156|P2|Overall Study|Sponsor Decision to Terminate Study|144
713433|NCT00105586|2302082|P2|Overall Study|Physician Decision|13
713434|NCT00105586|2302083|P1|Overall Study|Physician Decision|13
713435|NCT00105586|2302082|P2|Overall Study|Adverse Event|3
713436|NCT00105586|2302083|P1|Overall Study|Adverse Event|4
713437|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
713438|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
713439|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
713440|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
713441|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Death|0
713442|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Death|0
713443|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
713444|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
713445|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
713446|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
713447|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
713448|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
713449|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
713450|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
713451|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
713452|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
713453|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
713454|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
713455|NCT00105989|2302091|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
713456|NCT00105989|2302092|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
713457|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
713458|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
713459|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
713460|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
713461|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Death|0
713462|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Death|0
713463|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
713464|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
713465|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
713466|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
713467|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
713468|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
713469|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
713470|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
713471|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
713472|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
713473|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
713474|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
713475|NCT00105989|2302091|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
713476|NCT00105989|2302092|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
713477|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
713478|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
713479|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
713480|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
713481|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Death|0
713482|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Death|1
713483|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Physician Decision|0
713484|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Physician Decision|0
713485|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
713486|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
713487|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
713488|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
713489|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
713490|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
713491|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
713492|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
713493|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
713494|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
713495|NCT00105989|2302091|P2|Acute - Open Label: Week 0-10|Adverse Event|0
713496|NCT00105989|2302092|P1|Acute - Open Label: Week 0-10|Adverse Event|33
713497|NCT00106002|2302206|P1|Overall Study|Ineligible after Registration|1
713498|NCT00106002|2302206|P1|Overall Study|Did not take any study drug|1
713499|NCT00106028|2302216|P2|Overall Study|Lost to Follow-up|1
713500|NCT00106028|2302217|P1|Overall Study|Lost to Follow-up|0
713501|NCT00106028|2302216|P2|Overall Study|Withdrawal by Subject|8
713502|NCT00106028|2302217|P1|Overall Study|Withdrawal by Subject|2
713503|NCT00106028|2302216|P2|Overall Study|Protocol Violation|1
713504|NCT00106028|2302217|P1|Overall Study|Protocol Violation|1
713505|NCT00106028|2302216|P2|Overall Study|Adverse Event|2
713506|NCT00106028|2302217|P1|Overall Study|Adverse Event|3
713507|NCT00106080|2302313|P2|Overall Study|Withdrew/Loss to follow-up|27
713508|NCT00106080|2302314|P1|Overall Study|Withdrew/Loss to follow-up|43
713509|NCT00106184|2302354|P2|Overall Study|Withdrawal by Subject|2
713510|NCT00106184|2302355|P1|Overall Study|Withdrawal by Subject|3
713511|NCT00106249|2302367|P2|Overall Study|Lost to Follow-up|2
713512|NCT00106249|2302368|P1|Overall Study|Lost to Follow-up|3
713513|NCT00106353|2302380|P7|Part 2|Physician Decision|0
713514|NCT00106353|2302381|P6|Part 2|Physician Decision|1
713515|NCT00106353|2302382|P5|Part 2|Physician Decision|0
713516|NCT00106353|2302383|P4|Part 2|Physician Decision|0
713517|NCT00106353|2302384|P3|Part 2|Physician Decision|0
713518|NCT00106353|2302385|P2|Part 2|Physician Decision|0
713519|NCT00106353|2302386|P1|Part 2|Physician Decision|0
713520|NCT00106353|2302380|P7|Part 2|Withdrawal by Subject|0
713521|NCT00106353|2302381|P6|Part 2|Withdrawal by Subject|0
713522|NCT00106353|2302382|P5|Part 2|Withdrawal by Subject|1
713523|NCT00106353|2302383|P4|Part 2|Withdrawal by Subject|0
713524|NCT00106353|2302384|P3|Part 2|Withdrawal by Subject|0
713525|NCT00106353|2302385|P2|Part 2|Withdrawal by Subject|0
713526|NCT00106353|2302386|P1|Part 2|Withdrawal by Subject|0
713527|NCT00106353|2302380|P7|Part 2|Unspecified|1
713528|NCT00106353|2302381|P6|Part 2|Unspecified|1
713529|NCT00106353|2302382|P5|Part 2|Unspecified|1
713530|NCT00106353|2302383|P4|Part 2|Unspecified|0
713531|NCT00106353|2302384|P3|Part 2|Unspecified|0
713532|NCT00106353|2302385|P2|Part 2|Unspecified|0
713533|NCT00106353|2302386|P1|Part 2|Unspecified|0
713534|NCT00106353|2302380|P7|Part 2|Adverse Event|1
713535|NCT00106353|2302381|P6|Part 2|Adverse Event|2
713536|NCT00106353|2302382|P5|Part 2|Adverse Event|0
713537|NCT00106353|2302383|P4|Part 2|Adverse Event|0
713538|NCT00106353|2302384|P3|Part 2|Adverse Event|0
713539|NCT00106353|2302385|P2|Part 2|Adverse Event|0
713540|NCT00106353|2302386|P1|Part 2|Adverse Event|0
713541|NCT00106353|2302380|P7|Part 2|Symptomatic deterioration|0
713542|NCT00106353|2302381|P6|Part 2|Symptomatic deterioration|0
713543|NCT00106353|2302382|P5|Part 2|Symptomatic deterioration|3
713544|NCT00106353|2302383|P4|Part 2|Symptomatic deterioration|0
713545|NCT00106353|2302384|P3|Part 2|Symptomatic deterioration|0
713546|NCT00106353|2302385|P2|Part 2|Symptomatic deterioration|0
713547|NCT00106353|2302386|P1|Part 2|Symptomatic deterioration|0
713548|NCT00106353|2302380|P7|Part 2|Death|1
713549|NCT00106353|2302381|P6|Part 2|Death|0
713550|NCT00106353|2302382|P5|Part 2|Death|3
713551|NCT00106353|2302383|P4|Part 2|Death|0
713552|NCT00106353|2302384|P3|Part 2|Death|0
713553|NCT00106353|2302385|P2|Part 2|Death|0
713554|NCT00106353|2302386|P1|Part 2|Death|0
713555|NCT00106353|2302380|P7|Part 2|Disease progression|13
713556|NCT00106353|2302381|P6|Part 2|Disease progression|14
713557|NCT00106353|2302382|P5|Part 2|Disease progression|8
713558|NCT00106353|2302383|P4|Part 2|Disease progression|0
713559|NCT00106353|2302384|P3|Part 2|Disease progression|0
713560|NCT00106353|2302385|P2|Part 2|Disease progression|0
713561|NCT00106353|2302386|P1|Part 2|Disease progression|0
713562|NCT00106353|2302380|P7|Part 1|Adverse Event|0
713563|NCT00106353|2302381|P6|Part 1|Adverse Event|0
713564|NCT00106353|2302382|P5|Part 1|Adverse Event|0
713565|NCT00106353|2302383|P4|Part 1|Adverse Event|1
713566|NCT00106353|2302384|P3|Part 1|Adverse Event|0
713567|NCT00106353|2302385|P2|Part 1|Adverse Event|0
713568|NCT00106353|2302386|P1|Part 1|Adverse Event|0
713569|NCT00106353|2302380|P7|Part 1|Entered follow-up phase|0
713570|NCT00106353|2302381|P6|Part 1|Entered follow-up phase|0
713571|NCT00106353|2302382|P5|Part 1|Entered follow-up phase|0
713572|NCT00106353|2302383|P4|Part 1|Entered follow-up phase|1
713573|NCT00106353|2302384|P3|Part 1|Entered follow-up phase|0
713574|NCT00106353|2302385|P2|Part 1|Entered follow-up phase|1
713575|NCT00106353|2302386|P1|Part 1|Entered follow-up phase|1
713576|NCT00106353|2302380|P7|Part 1|Symptomatic deterioration|0
713577|NCT00106353|2302381|P6|Part 1|Symptomatic deterioration|0
713578|NCT00106353|2302382|P5|Part 1|Symptomatic deterioration|0
713579|NCT00106353|2302383|P4|Part 1|Symptomatic deterioration|0
713580|NCT00106353|2302384|P3|Part 1|Symptomatic deterioration|1
713581|NCT00106353|2302385|P2|Part 1|Symptomatic deterioration|0
713582|NCT00106353|2302386|P1|Part 1|Symptomatic deterioration|0
713583|NCT00106353|2302380|P7|Part 1|Withdrawal by Subject|0
713584|NCT00106353|2302381|P6|Part 1|Withdrawal by Subject|0
713585|NCT00106353|2302382|P5|Part 1|Withdrawal by Subject|0
713586|NCT00106353|2302383|P4|Part 1|Withdrawal by Subject|2
713587|NCT00106353|2302384|P3|Part 1|Withdrawal by Subject|1
713588|NCT00106353|2302385|P2|Part 1|Withdrawal by Subject|0
713589|NCT00106353|2302386|P1|Part 1|Withdrawal by Subject|0
713590|NCT00106353|2302380|P7|Part 1|Disease progression|0
713591|NCT00106353|2302381|P6|Part 1|Disease progression|0
713592|NCT00106353|2302382|P5|Part 1|Disease progression|0
713593|NCT00106353|2302383|P4|Part 1|Disease progression|3
713594|NCT00106353|2302384|P3|Part 1|Disease progression|1
713595|NCT00106353|2302385|P2|Part 1|Disease progression|4
713596|NCT00106353|2302386|P1|Part 1|Disease progression|3
713597|NCT00106626|2302843|P4|Overall Study|> 14 day delay in therapy start|0
713598|NCT00106626|2302844|P3|Overall Study|> 14 day delay in therapy start|0
713599|NCT00106626|2302845|P2|Overall Study|> 14 day delay in therapy start|1
713600|NCT00106626|2302846|P1|Overall Study|> 14 day delay in therapy start|0
713601|NCT00106626|2302843|P4|Overall Study|Received radiation on new therapy|0
713602|NCT00106626|2302844|P3|Overall Study|Received radiation on new therapy|0
713603|NCT00106626|2302845|P2|Overall Study|Received radiation on new therapy|0
713693|NCT00107120|2303166|P2|Overall Study|Pregnancy|1
713604|NCT00106626|2302846|P1|Overall Study|Received radiation on new therapy|1
713605|NCT00106626|2302843|P4|Overall Study|Progressive Disease|10
713606|NCT00106626|2302844|P3|Overall Study|Progressive Disease|9
713607|NCT00106626|2302845|P2|Overall Study|Progressive Disease|1
713608|NCT00106626|2302846|P1|Overall Study|Progressive Disease|4
713609|NCT00106626|2302843|P4|Overall Study|Adverse Event|3
713610|NCT00106626|2302844|P3|Overall Study|Adverse Event|3
713611|NCT00106626|2302845|P2|Overall Study|Adverse Event|4
713612|NCT00106626|2302846|P1|Overall Study|Adverse Event|5
713613|NCT00106639|2302864|P3|Overall Study|Participant defaulted|1
713614|NCT00106639|2302865|P2|Overall Study|Participant defaulted|1
713615|NCT00106639|2302866|P1|Overall Study|Participant defaulted|0
713616|NCT00106639|2302864|P3|Overall Study|Withdrawal by Subject|0
713617|NCT00106639|2302865|P2|Overall Study|Withdrawal by Subject|1
713618|NCT00106639|2302866|P1|Overall Study|Withdrawal by Subject|0
713619|NCT00106639|2302864|P3|Overall Study|Protocol Violation|0
713620|NCT00106639|2302865|P2|Overall Study|Protocol Violation|1
713621|NCT00106639|2302866|P1|Overall Study|Protocol Violation|0
713622|NCT00106639|2302864|P3|Overall Study|Adverse Event|1
713623|NCT00106639|2302865|P2|Overall Study|Adverse Event|4
713624|NCT00106639|2302866|P1|Overall Study|Adverse Event|3
713625|NCT00106704|2302991|P2|Overall Study|Laboratory test|1
713626|NCT00106704|2302992|P1|Overall Study|Laboratory test|1
713627|NCT00106704|2302991|P2|Overall Study|Unable to re-enter US|0
713628|NCT00106704|2302992|P1|Overall Study|Unable to re-enter US|1
713629|NCT00106704|2302991|P2|Overall Study|Patient Received Glycemic Medication|41
713630|NCT00106704|2302992|P1|Overall Study|Patient Received Glycemic Medication|22
713631|NCT00106704|2302991|P2|Overall Study|Planned major surgery|0
713632|NCT00106704|2302992|P1|Overall Study|Planned major surgery|1
713633|NCT00106704|2302991|P2|Overall Study|Site terminated|1
713634|NCT00106704|2302992|P1|Overall Study|Site terminated|0
713635|NCT00106704|2302991|P2|Overall Study|Patient moved|0
713636|NCT00106704|2302992|P1|Overall Study|Patient moved|1
713637|NCT00106704|2302991|P2|Overall Study|Withdrawal by Subject|21
713638|NCT00106704|2302992|P1|Overall Study|Withdrawal by Subject|14
713639|NCT00106704|2302991|P2|Overall Study|Protocol Violation|7
713640|NCT00106704|2302992|P1|Overall Study|Protocol Violation|4
713641|NCT00106704|2302991|P2|Overall Study|Pregnancy|0
713642|NCT00106704|2302992|P1|Overall Study|Pregnancy|1
713643|NCT00106704|2302991|P2|Overall Study|Lost to Follow-up|3
713644|NCT00106704|2302992|P1|Overall Study|Lost to Follow-up|7
713645|NCT00106704|2302991|P2|Overall Study|Lack of Efficacy|69
713646|NCT00106704|2302992|P1|Overall Study|Lack of Efficacy|67
713647|NCT00106704|2302991|P2|Overall Study|Death|1
713648|NCT00106704|2302992|P1|Overall Study|Death|2
713649|NCT00106704|2302991|P2|Overall Study|Adverse Event|7
713650|NCT00106704|2302992|P1|Overall Study|Adverse Event|10
713651|NCT00106964|2303073|P3|Overall Study|Required disallowed medication|0
713652|NCT00106964|2303074|P2|Overall Study|Required disallowed medication|1
713653|NCT00106964|2303075|P1|Overall Study|Required disallowed medication|0
713654|NCT00106964|2303073|P3|Overall Study|Did not meet eligibility criteria|2
713655|NCT00106964|2303074|P2|Overall Study|Did not meet eligibility criteria|2
713656|NCT00106964|2303075|P1|Overall Study|Did not meet eligibility criteria|0
713657|NCT00106964|2303073|P3|Overall Study|Failure to adhere|0
713658|NCT00106964|2303074|P2|Overall Study|Failure to adhere|0
713659|NCT00106964|2303075|P1|Overall Study|Failure to adhere|2
713660|NCT00106964|2303073|P3|Overall Study|Site Funding Terminated|1
713661|NCT00106964|2303074|P2|Overall Study|Site Funding Terminated|1
713662|NCT00106964|2303075|P1|Overall Study|Site Funding Terminated|0
713663|NCT00106964|2303073|P3|Overall Study|Incarceration|0
713664|NCT00106964|2303074|P2|Overall Study|Incarceration|1
713665|NCT00106964|2303075|P1|Overall Study|Incarceration|0
713666|NCT00106964|2303073|P3|Overall Study|Death|0
713667|NCT00106964|2303074|P2|Overall Study|Death|1
713668|NCT00106964|2303075|P1|Overall Study|Death|1
713669|NCT00106964|2303073|P3|Overall Study|Pregnancy|2
713670|NCT00106964|2303074|P2|Overall Study|Pregnancy|3
713671|NCT00106964|2303075|P1|Overall Study|Pregnancy|2
713672|NCT00106964|2303073|P3|Overall Study|Lost to Follow-up|2
713673|NCT00106964|2303074|P2|Overall Study|Lost to Follow-up|6
713674|NCT00106964|2303075|P1|Overall Study|Lost to Follow-up|8
713675|NCT00107042|2303100|P2|Overall Study|Disallowed medications|2
713676|NCT00107042|2303101|P1|Overall Study|Disallowed medications|0
713677|NCT00107042|2303100|P2|Overall Study|vaccinated outside window|1
713678|NCT00107042|2303101|P1|Overall Study|vaccinated outside window|1
713679|NCT00107042|2303100|P2|Overall Study|Inadvertent enrollment|1
713680|NCT00107042|2303101|P1|Overall Study|Inadvertent enrollment|0
713681|NCT00107042|2303100|P2|Overall Study|Pregnancy|1
713682|NCT00107042|2303101|P1|Overall Study|Pregnancy|1
713683|NCT00107042|2303100|P2|Overall Study|Moved out of area|3
713684|NCT00107042|2303101|P1|Overall Study|Moved out of area|5
713685|NCT00107042|2303100|P2|Overall Study|Withdrawal by Subject|1
713686|NCT00107042|2303101|P1|Overall Study|Withdrawal by Subject|6
713687|NCT00107042|2303100|P2|Overall Study|Lost to Follow-up|7
713688|NCT00107042|2303101|P1|Overall Study|Lost to Follow-up|9
713689|NCT00107120|2303166|P2|Overall Study|death of parent|1
713690|NCT00107120|2303167|P1|Overall Study|death of parent|0
713691|NCT00107120|2303166|P2|Overall Study|moving away from site|1
713692|NCT00107120|2303167|P1|Overall Study|moving away from site|1
713694|NCT00107120|2303167|P1|Overall Study|Pregnancy|0
713695|NCT00107120|2303166|P2|Overall Study|Lost to Follow-up|6
713696|NCT00107120|2303167|P1|Overall Study|Lost to Follow-up|8
713697|NCT00107120|2303166|P2|Overall Study|Withdrawal by Subject|9
713698|NCT00107120|2303167|P1|Overall Study|Withdrawal by Subject|8
713699|NCT00107120|2303166|P2|Overall Study|Protocol Violation|0
713700|NCT00107120|2303167|P1|Overall Study|Protocol Violation|3
713701|NCT00107120|2303166|P2|Overall Study|Lack of Efficacy|5
713702|NCT00107120|2303167|P1|Overall Study|Lack of Efficacy|5
713703|NCT00107120|2303166|P2|Overall Study|Adverse Event|1
713704|NCT00107120|2303167|P1|Overall Study|Adverse Event|4
713705|NCT00107172|2303179|P2|Overall Study|Other Reason|3
713706|NCT00107172|2303180|P1|Overall Study|Other Reason|4
713707|NCT00107172|2303179|P2|Overall Study|Death|2
713708|NCT00107172|2303180|P1|Overall Study|Death|0
713709|NCT00107172|2303179|P2|Overall Study|Withdrawal by Subject|0
713710|NCT00107172|2303180|P1|Overall Study|Withdrawal by Subject|1
713711|NCT00107198|2303208|P1|Overall Study|Ineligible|5
713712|NCT00107198|2303208|P1|Overall Study|Withdrawal by Subject|6
713713|NCT00107198|2303208|P1|Overall Study|Protocol Violation|1
713714|NCT00107198|2303208|P1|Overall Study|Lost to Follow-up|12
713715|NCT00107198|2303208|P1|Overall Study|Lack of Efficacy|28
713716|NCT00107276|2303216|P1|Overall Study|Ineligible|16
713717|NCT00107276|2303216|P1|Overall Study|Death|1
713718|NCT00107276|2303216|P1|Overall Study|Patient refusal|1
713719|NCT00107276|2303216|P1|Overall Study|M.D. decision|2
713720|NCT00107276|2303216|P1|Overall Study|Adverse Event|6
713721|NCT00107276|2303216|P1|Overall Study|Progression|46
713722|NCT00107315|2303222|P1|Overall Study|Withdrawal by Subject|2
713723|NCT00107315|2303222|P1|Overall Study|Adverse Event|4
713724|NCT00107315|2303222|P1|Overall Study|Disease Progression|9
713725|NCT00107380|2303229|P1|Overall Study|Ineligible|2
713726|NCT00107380|2303229|P1|Overall Study|Other - not protocol specified|7
713727|NCT00107380|2303229|P1|Overall Study|Death|3
713728|NCT00107380|2303229|P1|Overall Study|Progression/relapse|4
713729|NCT00107380|2303229|P1|Overall Study|Refusal Unrelated to Adverse Event|7
713730|NCT00107380|2303229|P1|Overall Study|Adverse Event|7
713731|NCT00107614|2303262|P1|Overall Study|Death|2
713732|NCT00107614|2303262|P1|Overall Study|Physician Decision|10
713733|NCT00107653|2303268|P2|Overall Study|Administrative Reasons|3
713734|NCT00107653|2303269|P1|Overall Study|Administrative Reasons|3
713735|NCT00107653|2303268|P2|Overall Study|Lost to Follow-up|5
713736|NCT00107653|2303269|P1|Overall Study|Lost to Follow-up|13
713737|NCT00107653|2303268|P2|Overall Study|Withdrawal by Subject|13
713738|NCT00107653|2303269|P1|Overall Study|Withdrawal by Subject|12
713739|NCT00107653|2303268|P2|Overall Study|Protocol Violation|0
713740|NCT00107653|2303269|P1|Overall Study|Protocol Violation|1
713741|NCT00107653|2303268|P2|Overall Study|Violation of Selection Criteria at Entry|1
713742|NCT00107653|2303269|P1|Overall Study|Violation of Selection Criteria at Entry|1
713743|NCT00107653|2303268|P2|Overall Study|Insufficient Therapeutic Response|11
713744|NCT00107653|2303269|P1|Overall Study|Insufficient Therapeutic Response|25
713745|NCT00107653|2303268|P2|Overall Study|Adverse Event|43
713746|NCT00107653|2303269|P1|Overall Study|Adverse Event|24
713747|NCT00107783|2303317|P2|Overall Study|Second hip replacement|1
713748|NCT00107783|2303318|P1|Overall Study|Second hip replacement|1
713749|NCT00107783|2303317|P2|Overall Study|Withdrawal by Subject|0
713750|NCT00107783|2303318|P1|Overall Study|Withdrawal by Subject|2
713751|NCT00107783|2303317|P2|Overall Study|Death|1
713752|NCT00107783|2303318|P1|Overall Study|Death|0
713753|NCT00107783|2303317|P2|Overall Study|Adverse Event|2
713754|NCT00107783|2303318|P1|Overall Study|Adverse Event|0
713755|NCT00107900|2303338|P6|Overall Study|Administrative Reasons|0
713756|NCT00107900|2303339|P5|Overall Study|Administrative Reasons|2
713757|NCT00107900|2303340|P4|Overall Study|Administrative Reasons|2
713758|NCT00107900|2303341|P3|Overall Study|Administrative Reasons|2
713759|NCT00107900|2303342|P2|Overall Study|Administrative Reasons|0
713760|NCT00107900|2303343|P1|Overall Study|Administrative Reasons|1
713761|NCT00107900|2303338|P6|Overall Study|Withdrawal by Subject|1
713762|NCT00107900|2303339|P5|Overall Study|Withdrawal by Subject|1
713763|NCT00107900|2303340|P4|Overall Study|Withdrawal by Subject|0
713764|NCT00107900|2303341|P3|Overall Study|Withdrawal by Subject|5
713765|NCT00107900|2303342|P2|Overall Study|Withdrawal by Subject|0
713766|NCT00107900|2303343|P1|Overall Study|Withdrawal by Subject|1
713767|NCT00107900|2303338|P6|Overall Study|Protocol Violation|0
713768|NCT00107900|2303339|P5|Overall Study|Protocol Violation|7
713769|NCT00107900|2303340|P4|Overall Study|Protocol Violation|5
713770|NCT00107900|2303341|P3|Overall Study|Protocol Violation|5
713771|NCT00107900|2303342|P2|Overall Study|Protocol Violation|0
713772|NCT00107900|2303343|P1|Overall Study|Protocol Violation|1
713773|NCT00107900|2303338|P6|Overall Study|Lost to Follow-up|5
713774|NCT00107900|2303339|P5|Overall Study|Lost to Follow-up|5
713775|NCT00107900|2303340|P4|Overall Study|Lost to Follow-up|2
713776|NCT00107900|2303341|P3|Overall Study|Lost to Follow-up|3
713777|NCT00107900|2303342|P2|Overall Study|Lost to Follow-up|1
713778|NCT00107900|2303343|P1|Overall Study|Lost to Follow-up|4
713779|NCT00107900|2303338|P6|Overall Study|Death|0
713780|NCT00107900|2303339|P5|Overall Study|Death|1
713781|NCT00107900|2303340|P4|Overall Study|Death|0
713782|NCT00107900|2303341|P3|Overall Study|Death|0
713783|NCT00107900|2303342|P2|Overall Study|Death|0
713784|NCT00107900|2303343|P1|Overall Study|Death|0
713785|NCT00107900|2303338|P6|Overall Study|Adverse Event|3
713786|NCT00107900|2303339|P5|Overall Study|Adverse Event|5
713787|NCT00107900|2303340|P4|Overall Study|Adverse Event|3
713788|NCT00107900|2303341|P3|Overall Study|Adverse Event|10
713789|NCT00107900|2303342|P2|Overall Study|Adverse Event|2
713790|NCT00107900|2303343|P1|Overall Study|Adverse Event|3
713791|NCT00107952|2303377|P2|Overall Study|Never received study treatment|6
713792|NCT00107952|2303378|P1|Overall Study|Never received study treatment|9
713793|NCT00107952|2303377|P2|Overall Study|Other|5
713794|NCT00107952|2303378|P1|Overall Study|Other|2
713795|NCT00107952|2303377|P2|Overall Study|Withdrawal by Subject|6
713796|NCT00107952|2303378|P1|Overall Study|Withdrawal by Subject|9
713797|NCT00107952|2303377|P2|Overall Study|Lost to Follow-up|3
713798|NCT00107952|2303378|P1|Overall Study|Lost to Follow-up|0
713799|NCT00107952|2303377|P2|Overall Study|Death|61
713800|NCT00107952|2303378|P1|Overall Study|Death|75
713801|NCT00107978|2303386|P2|Overall Study|Other|4
713802|NCT00107978|2303387|P1|Overall Study|Other|5
713803|NCT00107978|2303386|P2|Overall Study|Protocol Violation|1
713804|NCT00107978|2303387|P1|Overall Study|Protocol Violation|0
713805|NCT00107978|2303386|P2|Overall Study|Withdrawal by Subject|9
713806|NCT00107978|2303387|P1|Overall Study|Withdrawal by Subject|4
713807|NCT00107978|2303386|P2|Overall Study|Lost to Follow-up|28
713808|NCT00107978|2303387|P1|Overall Study|Lost to Follow-up|20
713809|NCT00107978|2303386|P2|Overall Study|Death|3
713810|NCT00107978|2303387|P1|Overall Study|Death|3
713811|NCT00107978|2303386|P2|Overall Study|Adverse Event|5
713812|NCT00107978|2303387|P1|Overall Study|Adverse Event|1
713813|NCT00107991|2303393|P1|18-Week Post Treatment Assessment|Adverse Event|2
713814|NCT00107991|2303393|P1|12 Week Treatment Period|Incarcerated|1
713815|NCT00107991|2303393|P1|12 Week Treatment Period|Protocol Violation|1
713816|NCT00107991|2303393|P1|12 Week Treatment Period|Adverse Event|1
713817|NCT00107991|2303393|P1|12 Week Treatment Period|Lack of Efficacy|2
713818|NCT00107991|2303393|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
713819|NCT00107991|2303393|P1|Eligibility Assessment|chronic uncontrolled asthma|1
713820|NCT00107991|2303393|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
713821|NCT00107991|2303393|P1|Eligibility Assessment|Abnormal labs|2
713822|NCT00107991|2303393|P1|Eligibility Assessment|Postive PPD|4
713823|NCT00107991|2303393|P1|Eligibility Assessment|Unwilling to participate|7
713824|NCT00107991|2303393|P1|Eligibility Assessment|Disease not severe enough|7
713825|NCT00108069|2303403|P2|Overall Study|Progessive disease|11
713826|NCT00108069|2303404|P1|Overall Study|Progessive disease|27
713827|NCT00108069|2303403|P2|Overall Study|Death|0
713828|NCT00108069|2303404|P1|Overall Study|Death|1
713829|NCT00108069|2303403|P2|Overall Study|Withdrawal by Subject|0
713830|NCT00108069|2303404|P1|Overall Study|Withdrawal by Subject|1
713831|NCT00108069|2303403|P2|Overall Study|Adverse Event|1
713832|NCT00108069|2303404|P1|Overall Study|Adverse Event|1
713833|NCT00108069|2303403|P2|Overall Study|Never rec'd study drug|1
713834|NCT00108069|2303404|P1|Overall Study|Never rec'd study drug|0
713835|NCT00108082|2303421|P3|Overall Study|Blood Pressure Not Controlled|0
713836|NCT00108082|2303422|P2|Overall Study|Blood Pressure Not Controlled|0
713837|NCT00108082|2303423|P1|Overall Study|Blood Pressure Not Controlled|1
713838|NCT00108082|2303421|P3|Overall Study|Investigator Not at Site|0
713839|NCT00108082|2303422|P2|Overall Study|Investigator Not at Site|0
713840|NCT00108082|2303423|P1|Overall Study|Investigator Not at Site|1
713841|NCT00108082|2303421|P3|Overall Study|Subject Left Site Location|0
713842|NCT00108082|2303422|P2|Overall Study|Subject Left Site Location|0
713843|NCT00108082|2303423|P1|Overall Study|Subject Left Site Location|1
713844|NCT00108082|2303421|P3|Overall Study|Study Medication Not Tapered|0
713845|NCT00108082|2303422|P2|Overall Study|Study Medication Not Tapered|1
713846|NCT00108082|2303423|P1|Overall Study|Study Medication Not Tapered|0
713847|NCT00108082|2303421|P3|Overall Study|Protocol Amendment|0
713848|NCT00108082|2303422|P2|Overall Study|Protocol Amendment|1
713849|NCT00108082|2303423|P1|Overall Study|Protocol Amendment|0
713850|NCT00108082|2303421|P3|Overall Study|Site Closed Study|0
713851|NCT00108082|2303422|P2|Overall Study|Site Closed Study|2
713852|NCT00108082|2303423|P1|Overall Study|Site Closed Study|0
713853|NCT00108082|2303421|P3|Overall Study|Stopped Study Medication|1
713854|NCT00108082|2303422|P2|Overall Study|Stopped Study Medication|0
713855|NCT00108082|2303423|P1|Overall Study|Stopped Study Medication|0
713856|NCT00108082|2303421|P3|Overall Study|Non-compliance|2
713857|NCT00108082|2303422|P2|Overall Study|Non-compliance|0
713858|NCT00108082|2303423|P1|Overall Study|Non-compliance|1
713859|NCT00108082|2303421|P3|Overall Study|Incorrectly Randomized|2
713860|NCT00108082|2303422|P2|Overall Study|Incorrectly Randomized|0
713861|NCT00108082|2303423|P1|Overall Study|Incorrectly Randomized|0
713862|NCT00108082|2303421|P3|Overall Study|Woman of Child-bearing Potential|2
713863|NCT00108082|2303422|P2|Overall Study|Woman of Child-bearing Potential|0
713864|NCT00108082|2303423|P1|Overall Study|Woman of Child-bearing Potential|2
713865|NCT00108082|2303421|P3|Overall Study|Amendment 4: > Month 12|5
713866|NCT00108082|2303422|P2|Overall Study|Amendment 4: > Month 12|7
713867|NCT00108082|2303423|P1|Overall Study|Amendment 4: > Month 12|5
713868|NCT00108082|2303421|P3|Overall Study|Lack of Efficacy|2
713869|NCT00108082|2303422|P2|Overall Study|Lack of Efficacy|1
713870|NCT00108082|2303423|P1|Overall Study|Lack of Efficacy|3
713871|NCT00108082|2303421|P3|Overall Study|Protocol Violation|0
713872|NCT00108082|2303422|P2|Overall Study|Protocol Violation|2
713873|NCT00108082|2303423|P1|Overall Study|Protocol Violation|1
713874|NCT00108082|2303421|P3|Overall Study|Consent Withdrawn|5
713875|NCT00108082|2303422|P2|Overall Study|Consent Withdrawn|3
713876|NCT00108082|2303423|P1|Overall Study|Consent Withdrawn|3
713877|NCT00108082|2303421|P3|Overall Study|Lost to Follow-up|7
713878|NCT00108082|2303422|P2|Overall Study|Lost to Follow-up|3
713879|NCT00108082|2303423|P1|Overall Study|Lost to Follow-up|6
713880|NCT00108082|2303421|P3|Overall Study|Adverse Event|17
713881|NCT00108082|2303422|P2|Overall Study|Adverse Event|12
713882|NCT00108082|2303423|P1|Overall Study|Adverse Event|14
713883|NCT00108160|2303472|P2|Overall Study|Protocol Violation|5
713884|NCT00108160|2303473|P1|Overall Study|Protocol Violation|9
713885|NCT00108160|2303472|P2|Overall Study|Withdrawal by Subject|2
713886|NCT00108160|2303473|P1|Overall Study|Withdrawal by Subject|4
713887|NCT00108160|2303472|P2|Overall Study|Death|2
713888|NCT00108160|2303473|P1|Overall Study|Death|1
713889|NCT00108160|2303472|P2|Overall Study|Lost to Follow-up|12
713890|NCT00108160|2303473|P1|Overall Study|Lost to Follow-up|25
713891|NCT00108355|2303524|P2|Overall Study|Loculated ascites, limiting paracentesis|1
713892|NCT00108355|2303525|P1|Overall Study|Loculated ascites, limiting paracentesis|1
713893|NCT00108355|2303524|P2|Overall Study|Peritonitis at index paracentesis|1
713894|NCT00108355|2303525|P1|Overall Study|Peritonitis at index paracentesis|1
713895|NCT00108433|2303535|P2|Overall Study|Unspecified|14
713896|NCT00108433|2303536|P1|Overall Study|Unspecified|14
713897|NCT00108433|2303535|P2|Overall Study|Adverse Event|1
713898|NCT00108433|2303536|P1|Overall Study|Adverse Event|3
713899|NCT00108433|2303535|P2|Overall Study|Death|0
713900|NCT00108433|2303536|P1|Overall Study|Death|3
713901|NCT00108433|2303535|P2|Overall Study|Lack of Efficacy|2
713902|NCT00108433|2303536|P1|Overall Study|Lack of Efficacy|1
713903|NCT00110890|2303552|P2|Overall Study|Did not enter follow-up phase|4
713904|NCT00110890|2303553|P1|Overall Study|Did not enter follow-up phase|10
713905|NCT00110890|2303552|P2|Overall Study|Parathyroidectomy|1
713906|NCT00110890|2303553|P1|Overall Study|Parathyroidectomy|0
713907|NCT00110890|2303552|P2|Overall Study|Disease progression|1
713908|NCT00110890|2303553|P1|Overall Study|Disease progression|0
713909|NCT00110890|2303552|P2|Overall Study|Requirement for alternative therapy|1
713910|NCT00110890|2303553|P1|Overall Study|Requirement for alternative therapy|0
713911|NCT00110890|2303552|P2|Overall Study|Ineligibility determined|0
713912|NCT00110890|2303553|P1|Overall Study|Ineligibility determined|3
713913|NCT00110890|2303552|P2|Overall Study|Other|23
713914|NCT00110890|2303553|P1|Overall Study|Other|34
713915|NCT00110890|2303552|P2|Overall Study|Invest. Product Commercially Available|110
713916|NCT00110890|2303553|P1|Overall Study|Invest. Product Commercially Available|217
713917|NCT00110890|2303552|P2|Overall Study|Kidney Transplant|12
713918|NCT00110890|2303553|P1|Overall Study|Kidney Transplant|16
713919|NCT00110890|2303552|P2|Overall Study|Noncompliance|0
713920|NCT00110890|2303553|P1|Overall Study|Noncompliance|10
713921|NCT00110890|2303552|P2|Overall Study|Protocol Deviation|0
713922|NCT00110890|2303553|P1|Overall Study|Protocol Deviation|1
713923|NCT00110890|2303552|P2|Overall Study|Withdrawal by Subject|5
713924|NCT00110890|2303553|P1|Overall Study|Withdrawal by Subject|17
713925|NCT00110890|2303552|P2|Overall Study|Physician Decision|5
713926|NCT00110890|2303553|P1|Overall Study|Physician Decision|4
713927|NCT00110890|2303552|P2|Overall Study|Lost to Follow-up|1
713928|NCT00110890|2303553|P1|Overall Study|Lost to Follow-up|3
713929|NCT00110890|2303552|P2|Overall Study|Death|9
713930|NCT00110890|2303553|P1|Overall Study|Death|16
713931|NCT00110890|2303552|P2|Overall Study|Adverse Event|7
713932|NCT00110890|2303553|P1|Overall Study|Adverse Event|30
713933|NCT00110994|2303569|P2|Long Term Follow-up|Death|17
713934|NCT00110994|2303570|P1|Long Term Follow-up|Death|19
713935|NCT00110994|2303569|P2|Active Follow-up|Other reasons|2
713936|NCT00110994|2303570|P1|Active Follow-up|Other reasons|0
713937|NCT00110994|2303569|P2|Active Follow-up|Disease progression/recurrence/replace|0
713938|NCT00110994|2303570|P1|Active Follow-up|Disease progression/recurrence/replace|1
713939|NCT00110994|2303569|P2|Double-blind (DB) Treatment|other reasons|3
713940|NCT00110994|2303570|P1|Double-blind (DB) Treatment|other reasons|2
713941|NCT00110994|2303569|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
713942|NCT00110994|2303570|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
713943|NCT00110994|2303569|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
713944|NCT00110994|2303570|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
713945|NCT00110994|2303569|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
713946|NCT00110994|2303570|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
713947|NCT00110994|2303569|P2|Double-blind (DB) Treatment|Death|0
713948|NCT00110994|2303570|P1|Double-blind (DB) Treatment|Death|1
713949|NCT00110994|2303569|P2|Double-blind (DB) Treatment|Adverse Event|0
713950|NCT00110994|2303570|P1|Double-blind (DB) Treatment|Adverse Event|3
713951|NCT00111007|2303596|P2|Long Term Follow-up|Missing|3
713952|NCT00111007|2303597|P1|Long Term Follow-up|Missing|10
713953|NCT00111007|2303596|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
713954|NCT00111007|2303597|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
713955|NCT00111007|2303596|P2|Long Term Follow-up|Withdrawal by Subject|1
713956|NCT00111007|2303597|P1|Long Term Follow-up|Withdrawal by Subject|0
713957|NCT00111007|2303596|P2|Long Term Follow-up|Lost to Follow-up|1
713958|NCT00111007|2303597|P1|Long Term Follow-up|Lost to Follow-up|1
713959|NCT00111007|2303596|P2|Long Term Follow-up|Death|39
713960|NCT00111007|2303597|P1|Long Term Follow-up|Death|34
713961|NCT00111007|2303596|P2|Active Follow-up|Disease progression/recurrence/relapse|2
713962|NCT00111007|2303597|P1|Active Follow-up|Disease progression/recurrence/relapse|3
713963|NCT00111007|2303596|P2|Active Follow-up|Death|0
713964|NCT00111007|2303597|P1|Active Follow-up|Death|2
713965|NCT00111007|2303596|P2|Active Follow-up|Adverse Event|0
713966|NCT00111007|2303597|P1|Active Follow-up|Adverse Event|1
713967|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Primary reason with other category|1
713968|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Primary reason with other category|0
713969|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
713970|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
713971|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
713972|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
713973|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Relapse|0
713974|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Relapse|1
713975|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
713976|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
713977|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
713978|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
713979|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Protocol Violation|1
713980|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Protocol Violation|0
713981|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Death|2
713982|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Death|5
713983|NCT00111007|2303596|P2|Double-blind (DB) Treatment|Adverse Event|4
713984|NCT00111007|2303597|P1|Double-blind (DB) Treatment|Adverse Event|12
713985|NCT00111761|2303623|P2|Part 2|Other|0
713986|NCT00111761|2303624|P1|Part 2|Other|1
713987|NCT00111761|2303623|P2|Part 2|Protocol-specified criteria|0
713988|NCT00111761|2303624|P1|Part 2|Protocol-specified criteria|1
713989|NCT00111761|2303623|P2|Part 2|Disease progression|0
713990|NCT00111761|2303624|P1|Part 2|Disease progression|3
713991|NCT00111761|2303623|P2|Part 2|Death|0
713992|NCT00111761|2303624|P1|Part 2|Death|1
713993|NCT00111761|2303623|P2|Part 2|Physician Decision|0
713994|NCT00111761|2303624|P1|Part 2|Physician Decision|1
713995|NCT00111761|2303623|P2|Part 2|Adverse Event|0
713996|NCT00111761|2303624|P1|Part 2|Adverse Event|1
713997|NCT00111761|2303623|P2|Part 1|Withdrawal by Subject|1
713998|NCT00111761|2303624|P1|Part 1|Withdrawal by Subject|0
713999|NCT00111761|2303623|P2|Part 1|Other|1
714000|NCT00111761|2303624|P1|Part 1|Other|0
714001|NCT00111761|2303623|P2|Part 1|Death|2
714002|NCT00111761|2303624|P1|Part 1|Death|0
714003|NCT00111761|2303623|P2|Part 1|Physician Decision|1
714004|NCT00111761|2303624|P1|Part 1|Physician Decision|0
714005|NCT00111813|2303641|P6|Overall Study|Not specified|0
714006|NCT00111813|2303642|P5|Overall Study|Not specified|0
714007|NCT00111813|2303643|P4|Overall Study|Not specified|0
714008|NCT00111813|2303644|P3|Overall Study|Not specified|1
714009|NCT00111813|2303645|P2|Overall Study|Not specified|0
714010|NCT00111813|2303646|P1|Overall Study|Not specified|0
714011|NCT00111813|2303641|P6|Overall Study|Lack of Efficacy|1
714012|NCT00111813|2303642|P5|Overall Study|Lack of Efficacy|0
714013|NCT00111813|2303643|P4|Overall Study|Lack of Efficacy|0
714014|NCT00111813|2303644|P3|Overall Study|Lack of Efficacy|0
714015|NCT00111813|2303645|P2|Overall Study|Lack of Efficacy|0
714016|NCT00111813|2303646|P1|Overall Study|Lack of Efficacy|0
714017|NCT00111813|2303641|P6|Overall Study|Progressive disease|3
714018|NCT00111813|2303642|P5|Overall Study|Progressive disease|4
714019|NCT00111813|2303643|P4|Overall Study|Progressive disease|3
714020|NCT00111813|2303644|P3|Overall Study|Progressive disease|5
714021|NCT00111813|2303645|P2|Overall Study|Progressive disease|1
714022|NCT00111813|2303646|P1|Overall Study|Progressive disease|2
714023|NCT00111813|2303641|P6|Overall Study|Adverse Event|2
714024|NCT00111813|2303642|P5|Overall Study|Adverse Event|2
714025|NCT00111813|2303643|P4|Overall Study|Adverse Event|2
714026|NCT00111813|2303644|P3|Overall Study|Adverse Event|4
714027|NCT00111813|2303645|P2|Overall Study|Adverse Event|2
714028|NCT00111813|2303646|P1|Overall Study|Adverse Event|1
714029|NCT00111917|2303681|P2|Overall Study|Withdrawal by Subject|1
714030|NCT00111917|2303682|P1|Overall Study|Withdrawal by Subject|1
714031|NCT00112047|2303696|P2|Atripla Phase|Not specified|1
714032|NCT00112047|2303697|P1|Atripla Phase|Not specified|3
714033|NCT00112047|2303696|P2|Atripla Phase|Non-compliance|0
714034|NCT00112047|2303697|P1|Atripla Phase|Non-compliance|1
714035|NCT00112047|2303696|P2|Atripla Phase|Sub-optimal virological response|1
714036|NCT00112047|2303697|P1|Atripla Phase|Sub-optimal virological response|0
714037|NCT00112047|2303696|P2|Atripla Phase|Withdrew consent|7
714038|NCT00112047|2303697|P1|Atripla Phase|Withdrew consent|7
714039|NCT00112047|2303696|P2|Atripla Phase|Death|2
714040|NCT00112047|2303697|P1|Atripla Phase|Death|0
714041|NCT00112047|2303696|P2|Atripla Phase|Pregnancy|1
714042|NCT00112047|2303697|P1|Atripla Phase|Pregnancy|0
714043|NCT00112047|2303696|P2|Atripla Phase|Lost to Follow-up|7
714044|NCT00112047|2303697|P1|Atripla Phase|Lost to Follow-up|5
714045|NCT00112047|2303696|P2|Atripla Phase|Adverse Event|1
714046|NCT00112047|2303697|P1|Atripla Phase|Adverse Event|2
714047|NCT00112047|2303696|P2|Randomized Phase|High Hepatitis B DNA|1
714048|NCT00112047|2303697|P1|Randomized Phase|High Hepatitis B DNA|0
714049|NCT00112047|2303696|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
714050|NCT00112047|2303697|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
714051|NCT00112047|2303696|P2|Randomized Phase|Moved out of State|1
714052|NCT00112047|2303697|P1|Randomized Phase|Moved out of State|0
714053|NCT00112047|2303696|P2|Randomized Phase|Incarceration|2
714054|NCT00112047|2303697|P1|Randomized Phase|Incarceration|3
714055|NCT00112047|2303696|P2|Randomized Phase|Inability to swallow pills|1
714056|NCT00112047|2303697|P1|Randomized Phase|Inability to swallow pills|0
714057|NCT00112047|2303696|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
714058|NCT00112047|2303697|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
714059|NCT00112047|2303696|P2|Randomized Phase|Death|3
714060|NCT00112047|2303697|P1|Randomized Phase|Death|1
714061|NCT00112047|2303696|P2|Randomized Phase|Pregnancy|1
714062|NCT00112047|2303697|P1|Randomized Phase|Pregnancy|3
714063|NCT00112047|2303696|P2|Randomized Phase|Protocol Violation|0
714064|NCT00112047|2303697|P1|Randomized Phase|Protocol Violation|2
714065|NCT00112047|2303696|P2|Randomized Phase|Noncompliance|4
714066|NCT00112047|2303697|P1|Randomized Phase|Noncompliance|8
714067|NCT00112047|2303696|P2|Randomized Phase|Sub-optimal virological response|13
714068|NCT00112047|2303697|P1|Randomized Phase|Sub-optimal virological response|3
714069|NCT00112047|2303696|P2|Randomized Phase|Withrawal of consent|18
714070|NCT00112047|2303697|P1|Randomized Phase|Withrawal of consent|10
714071|NCT00112047|2303696|P2|Randomized Phase|Adverse Event|10
714072|NCT00112047|2303697|P1|Randomized Phase|Adverse Event|10
714073|NCT00112047|2303696|P2|Randomized Phase|Lost to Follow-up|33
714074|NCT00112047|2303697|P1|Randomized Phase|Lost to Follow-up|26
714075|NCT00112294|2303980|P2|Overall Study|Still on study|0
714076|NCT00112294|2303981|P1|Overall Study|Still on study|5
714077|NCT00112359|2304021|P2|Overall Study|Other|0
714078|NCT00112359|2304022|P1|Overall Study|Other|3
714079|NCT00112359|2304021|P2|Overall Study|Personal/administrative|1
714080|NCT00112359|2304022|P1|Overall Study|Personal/administrative|1
714081|NCT00112359|2304021|P2|Overall Study|Lost to Follow-up|1
714082|NCT00112359|2304022|P1|Overall Study|Lost to Follow-up|0
714083|NCT00112359|2304021|P2|Overall Study|Related adverse event|3
714084|NCT00112359|2304022|P1|Overall Study|Related adverse event|5
714085|NCT00112359|2304021|P2|Overall Study|Trial drug intolerance (adverse event)|0
714086|NCT00112359|2304022|P1|Overall Study|Trial drug intolerance (adverse event)|2
714087|NCT00112359|2304021|P2|Overall Study|Unrelated adverse event|8
714088|NCT00112359|2304022|P1|Overall Study|Unrelated adverse event|16
714089|NCT00112385|2304048|P2|Overall Study|Withdrawal by Subject|1
714090|NCT00112385|2304049|P1|Overall Study|Withdrawal by Subject|0
714091|NCT00112385|2304048|P2|Overall Study|Lost to Follow-up|0
714092|NCT00112385|2304049|P1|Overall Study|Lost to Follow-up|1
714093|NCT00112437|2304142|P15|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714094|NCT00112437|2304143|P14|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714095|NCT00112437|2304144|P13|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714096|NCT00112437|2304145|P12|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714097|NCT00112437|2304146|P11|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714098|NCT00112437|2304147|P10|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714099|NCT00112437|2304148|P9|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714100|NCT00112437|2304149|P8|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714101|NCT00112437|2304150|P7|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
714102|NCT00112437|2304151|P6|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
714103|NCT00112437|2304152|P5|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714104|NCT00112437|2304153|P4|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714105|NCT00112437|2304154|P3|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714106|NCT00112437|2304155|P2|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714107|NCT00112437|2304156|P1|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
714108|NCT00112437|2304142|P15|12 Month Extension (Year 3)|Withdrawal by Subject|0
714109|NCT00112437|2304143|P14|12 Month Extension (Year 3)|Withdrawal by Subject|0
714110|NCT00112437|2304144|P13|12 Month Extension (Year 3)|Withdrawal by Subject|0
714111|NCT00112437|2304145|P12|12 Month Extension (Year 3)|Withdrawal by Subject|0
714112|NCT00112437|2304146|P11|12 Month Extension (Year 3)|Withdrawal by Subject|0
714113|NCT00112437|2304147|P10|12 Month Extension (Year 3)|Withdrawal by Subject|1
714114|NCT00112437|2304148|P9|12 Month Extension (Year 3)|Withdrawal by Subject|0
714115|NCT00112437|2304149|P8|12 Month Extension (Year 3)|Withdrawal by Subject|0
714116|NCT00112437|2304150|P7|12 Month Extension (Year 3)|Withdrawal by Subject|3
714117|NCT00112437|2304151|P6|12 Month Extension (Year 3)|Withdrawal by Subject|0
714118|NCT00112437|2304152|P5|12 Month Extension (Year 3)|Withdrawal by Subject|0
714119|NCT00112437|2304153|P4|12 Month Extension (Year 3)|Withdrawal by Subject|0
714120|NCT00112437|2304154|P3|12 Month Extension (Year 3)|Withdrawal by Subject|0
714121|NCT00112437|2304155|P2|12 Month Extension (Year 3)|Withdrawal by Subject|0
714122|NCT00112437|2304156|P1|12 Month Extension (Year 3)|Withdrawal by Subject|0
714123|NCT00112437|2304142|P15|12 Month Extension (Year 3)|Protocol Violation|0
714124|NCT00112437|2304143|P14|12 Month Extension (Year 3)|Protocol Violation|0
714125|NCT00112437|2304144|P13|12 Month Extension (Year 3)|Protocol Violation|0
714126|NCT00112437|2304145|P12|12 Month Extension (Year 3)|Protocol Violation|0
714127|NCT00112437|2304146|P11|12 Month Extension (Year 3)|Protocol Violation|1
714128|NCT00112437|2304147|P10|12 Month Extension (Year 3)|Protocol Violation|0
714129|NCT00112437|2304148|P9|12 Month Extension (Year 3)|Protocol Violation|0
714130|NCT00112437|2304149|P8|12 Month Extension (Year 3)|Protocol Violation|0
714131|NCT00112437|2304150|P7|12 Month Extension (Year 3)|Protocol Violation|0
714132|NCT00112437|2304151|P6|12 Month Extension (Year 3)|Protocol Violation|0
714133|NCT00112437|2304152|P5|12 Month Extension (Year 3)|Protocol Violation|0
714134|NCT00112437|2304153|P4|12 Month Extension (Year 3)|Protocol Violation|0
714135|NCT00112437|2304154|P3|12 Month Extension (Year 3)|Protocol Violation|0
714136|NCT00112437|2304155|P2|12 Month Extension (Year 3)|Protocol Violation|0
714137|NCT00112437|2304156|P1|12 Month Extension (Year 3)|Protocol Violation|0
714138|NCT00112437|2304142|P15|12 Month Extension (Year 3)|Lost to Follow-up|0
714139|NCT00112437|2304143|P14|12 Month Extension (Year 3)|Lost to Follow-up|0
714140|NCT00112437|2304144|P13|12 Month Extension (Year 3)|Lost to Follow-up|0
714141|NCT00112437|2304145|P12|12 Month Extension (Year 3)|Lost to Follow-up|0
714142|NCT00112437|2304146|P11|12 Month Extension (Year 3)|Lost to Follow-up|1
714143|NCT00112437|2304147|P10|12 Month Extension (Year 3)|Lost to Follow-up|0
714144|NCT00112437|2304148|P9|12 Month Extension (Year 3)|Lost to Follow-up|0
714145|NCT00112437|2304149|P8|12 Month Extension (Year 3)|Lost to Follow-up|0
714146|NCT00112437|2304150|P7|12 Month Extension (Year 3)|Lost to Follow-up|0
714147|NCT00112437|2304151|P6|12 Month Extension (Year 3)|Lost to Follow-up|0
714148|NCT00112437|2304152|P5|12 Month Extension (Year 3)|Lost to Follow-up|0
714149|NCT00112437|2304153|P4|12 Month Extension (Year 3)|Lost to Follow-up|0
714150|NCT00112437|2304154|P3|12 Month Extension (Year 3)|Lost to Follow-up|0
714151|NCT00112437|2304155|P2|12 Month Extension (Year 3)|Lost to Follow-up|0
714152|NCT00112437|2304156|P1|12 Month Extension (Year 3)|Lost to Follow-up|0
714153|NCT00112437|2304142|P15|12 Month Extension (Year 3)|Lack of Efficacy|0
714154|NCT00112437|2304143|P14|12 Month Extension (Year 3)|Lack of Efficacy|2
714155|NCT00112437|2304144|P13|12 Month Extension (Year 3)|Lack of Efficacy|0
714156|NCT00112437|2304145|P12|12 Month Extension (Year 3)|Lack of Efficacy|0
714157|NCT00112437|2304146|P11|12 Month Extension (Year 3)|Lack of Efficacy|1
714158|NCT00112437|2304147|P10|12 Month Extension (Year 3)|Lack of Efficacy|0
714159|NCT00112437|2304148|P9|12 Month Extension (Year 3)|Lack of Efficacy|1
714160|NCT00112437|2304149|P8|12 Month Extension (Year 3)|Lack of Efficacy|0
714161|NCT00112437|2304150|P7|12 Month Extension (Year 3)|Lack of Efficacy|1
714162|NCT00112437|2304151|P6|12 Month Extension (Year 3)|Lack of Efficacy|0
714163|NCT00112437|2304152|P5|12 Month Extension (Year 3)|Lack of Efficacy|0
714164|NCT00112437|2304153|P4|12 Month Extension (Year 3)|Lack of Efficacy|0
714165|NCT00112437|2304154|P3|12 Month Extension (Year 3)|Lack of Efficacy|0
714166|NCT00112437|2304155|P2|12 Month Extension (Year 3)|Lack of Efficacy|0
714167|NCT00112437|2304156|P1|12 Month Extension (Year 3)|Lack of Efficacy|0
714168|NCT00112437|2304142|P15|12 Month Extension (Year 3)|Adverse Event|1
714169|NCT00112437|2304143|P14|12 Month Extension (Year 3)|Adverse Event|0
714170|NCT00112437|2304144|P13|12 Month Extension (Year 3)|Adverse Event|1
714171|NCT00112437|2304145|P12|12 Month Extension (Year 3)|Adverse Event|3
714172|NCT00112437|2304146|P11|12 Month Extension (Year 3)|Adverse Event|1
714173|NCT00112437|2304147|P10|12 Month Extension (Year 3)|Adverse Event|0
714174|NCT00112437|2304148|P9|12 Month Extension (Year 3)|Adverse Event|0
714175|NCT00112437|2304149|P8|12 Month Extension (Year 3)|Adverse Event|0
714176|NCT00112437|2304150|P7|12 Month Extension (Year 3)|Adverse Event|0
714177|NCT00112437|2304151|P6|12 Month Extension (Year 3)|Adverse Event|1
714178|NCT00112437|2304152|P5|12 Month Extension (Year 3)|Adverse Event|0
714179|NCT00112437|2304153|P4|12 Month Extension (Year 3)|Adverse Event|0
714180|NCT00112437|2304154|P3|12 Month Extension (Year 3)|Adverse Event|0
714181|NCT00112437|2304155|P2|12 Month Extension (Year 3)|Adverse Event|0
714182|NCT00112437|2304156|P1|12 Month Extension (Year 3)|Adverse Event|0
714183|NCT00112437|2304142|P15|12 Month Extension|Moved|0
714184|NCT00112437|2304143|P14|12 Month Extension|Moved|0
714185|NCT00112437|2304144|P13|12 Month Extension|Moved|0
714186|NCT00112437|2304145|P12|12 Month Extension|Moved|0
714187|NCT00112437|2304146|P11|12 Month Extension|Moved|0
714188|NCT00112437|2304147|P10|12 Month Extension|Moved|0
714189|NCT00112437|2304148|P9|12 Month Extension|Moved|0
714190|NCT00112437|2304149|P8|12 Month Extension|Moved|0
714191|NCT00112437|2304150|P7|12 Month Extension|Moved|0
714192|NCT00112437|2304151|P6|12 Month Extension|Moved|0
714193|NCT00112437|2304152|P5|12 Month Extension|Moved|1
714194|NCT00112437|2304153|P4|12 Month Extension|Moved|0
714195|NCT00112437|2304154|P3|12 Month Extension|Moved|0
714196|NCT00112437|2304155|P2|12 Month Extension|Moved|0
714197|NCT00112437|2304156|P1|12 Month Extension|Moved|0
714198|NCT00112437|2304142|P15|12 Month Extension|patient was out of windows|0
714199|NCT00112437|2304143|P14|12 Month Extension|patient was out of windows|0
714200|NCT00112437|2304144|P13|12 Month Extension|patient was out of windows|0
714201|NCT00112437|2304145|P12|12 Month Extension|patient was out of windows|0
714202|NCT00112437|2304146|P11|12 Month Extension|patient was out of windows|0
714203|NCT00112437|2304147|P10|12 Month Extension|patient was out of windows|0
714204|NCT00112437|2304148|P9|12 Month Extension|patient was out of windows|0
714205|NCT00112437|2304149|P8|12 Month Extension|patient was out of windows|0
714206|NCT00112437|2304150|P7|12 Month Extension|patient was out of windows|0
714207|NCT00112437|2304151|P6|12 Month Extension|patient was out of windows|0
714208|NCT00112437|2304152|P5|12 Month Extension|patient was out of windows|1
714209|NCT00112437|2304153|P4|12 Month Extension|patient was out of windows|0
714210|NCT00112437|2304154|P3|12 Month Extension|patient was out of windows|0
714211|NCT00112437|2304155|P2|12 Month Extension|patient was out of windows|0
714212|NCT00112437|2304156|P1|12 Month Extension|patient was out of windows|0
714213|NCT00112437|2304142|P15|12 Month Extension|Patient stopped taking medication|0
714214|NCT00112437|2304143|P14|12 Month Extension|Patient stopped taking medication|0
714215|NCT00112437|2304144|P13|12 Month Extension|Patient stopped taking medication|0
714216|NCT00112437|2304145|P12|12 Month Extension|Patient stopped taking medication|0
714217|NCT00112437|2304146|P11|12 Month Extension|Patient stopped taking medication|0
714218|NCT00112437|2304147|P10|12 Month Extension|Patient stopped taking medication|0
714219|NCT00112437|2304148|P9|12 Month Extension|Patient stopped taking medication|0
714220|NCT00112437|2304149|P8|12 Month Extension|Patient stopped taking medication|0
714221|NCT00112437|2304150|P7|12 Month Extension|Patient stopped taking medication|0
714222|NCT00112437|2304151|P6|12 Month Extension|Patient stopped taking medication|0
714223|NCT00112437|2304152|P5|12 Month Extension|Patient stopped taking medication|1
714224|NCT00112437|2304153|P4|12 Month Extension|Patient stopped taking medication|0
714225|NCT00112437|2304154|P3|12 Month Extension|Patient stopped taking medication|0
714226|NCT00112437|2304155|P2|12 Month Extension|Patient stopped taking medication|0
714227|NCT00112437|2304156|P1|12 Month Extension|Patient stopped taking medication|0
714228|NCT00112437|2304142|P15|12 Month Extension|Withdrawal by Subject|0
714229|NCT00112437|2304143|P14|12 Month Extension|Withdrawal by Subject|0
714230|NCT00112437|2304144|P13|12 Month Extension|Withdrawal by Subject|0
714231|NCT00112437|2304145|P12|12 Month Extension|Withdrawal by Subject|0
714232|NCT00112437|2304146|P11|12 Month Extension|Withdrawal by Subject|0
714233|NCT00112437|2304147|P10|12 Month Extension|Withdrawal by Subject|0
714234|NCT00112437|2304148|P9|12 Month Extension|Withdrawal by Subject|0
714235|NCT00112437|2304149|P8|12 Month Extension|Withdrawal by Subject|0
714236|NCT00112437|2304150|P7|12 Month Extension|Withdrawal by Subject|0
714237|NCT00112437|2304151|P6|12 Month Extension|Withdrawal by Subject|0
714238|NCT00112437|2304152|P5|12 Month Extension|Withdrawal by Subject|1
714239|NCT00112437|2304153|P4|12 Month Extension|Withdrawal by Subject|4
714240|NCT00112437|2304154|P3|12 Month Extension|Withdrawal by Subject|2
714241|NCT00112437|2304155|P2|12 Month Extension|Withdrawal by Subject|1
714242|NCT00112437|2304156|P1|12 Month Extension|Withdrawal by Subject|1
714243|NCT00112437|2304142|P15|12 Month Extension|Protocol Violation|0
714244|NCT00112437|2304143|P14|12 Month Extension|Protocol Violation|0
714245|NCT00112437|2304144|P13|12 Month Extension|Protocol Violation|0
714246|NCT00112437|2304145|P12|12 Month Extension|Protocol Violation|0
714247|NCT00112437|2304146|P11|12 Month Extension|Protocol Violation|0
714248|NCT00112437|2304147|P10|12 Month Extension|Protocol Violation|0
714249|NCT00112437|2304148|P9|12 Month Extension|Protocol Violation|0
714250|NCT00112437|2304149|P8|12 Month Extension|Protocol Violation|0
714251|NCT00112437|2304150|P7|12 Month Extension|Protocol Violation|0
714252|NCT00112437|2304151|P6|12 Month Extension|Protocol Violation|0
714253|NCT00112437|2304152|P5|12 Month Extension|Protocol Violation|0
714254|NCT00112437|2304153|P4|12 Month Extension|Protocol Violation|1
714255|NCT00112437|2304154|P3|12 Month Extension|Protocol Violation|0
714256|NCT00112437|2304155|P2|12 Month Extension|Protocol Violation|0
714257|NCT00112437|2304156|P1|12 Month Extension|Protocol Violation|0
714258|NCT00112437|2304142|P15|12 Month Extension|Lost to Follow-up|0
714259|NCT00112437|2304143|P14|12 Month Extension|Lost to Follow-up|0
714260|NCT00112437|2304144|P13|12 Month Extension|Lost to Follow-up|0
714261|NCT00112437|2304145|P12|12 Month Extension|Lost to Follow-up|0
714262|NCT00112437|2304146|P11|12 Month Extension|Lost to Follow-up|0
714263|NCT00112437|2304147|P10|12 Month Extension|Lost to Follow-up|0
714264|NCT00112437|2304148|P9|12 Month Extension|Lost to Follow-up|0
714265|NCT00112437|2304149|P8|12 Month Extension|Lost to Follow-up|0
714266|NCT00112437|2304150|P7|12 Month Extension|Lost to Follow-up|0
714267|NCT00112437|2304151|P6|12 Month Extension|Lost to Follow-up|0
714268|NCT00112437|2304152|P5|12 Month Extension|Lost to Follow-up|0
714269|NCT00112437|2304153|P4|12 Month Extension|Lost to Follow-up|1
714270|NCT00112437|2304154|P3|12 Month Extension|Lost to Follow-up|0
714271|NCT00112437|2304155|P2|12 Month Extension|Lost to Follow-up|0
714272|NCT00112437|2304156|P1|12 Month Extension|Lost to Follow-up|0
714273|NCT00112437|2304142|P15|12 Month Extension|Lack of Efficacy|0
714274|NCT00112437|2304143|P14|12 Month Extension|Lack of Efficacy|0
714275|NCT00112437|2304144|P13|12 Month Extension|Lack of Efficacy|0
714276|NCT00112437|2304145|P12|12 Month Extension|Lack of Efficacy|0
714277|NCT00112437|2304146|P11|12 Month Extension|Lack of Efficacy|0
714278|NCT00112437|2304147|P10|12 Month Extension|Lack of Efficacy|0
714279|NCT00112437|2304148|P9|12 Month Extension|Lack of Efficacy|0
714280|NCT00112437|2304149|P8|12 Month Extension|Lack of Efficacy|0
714281|NCT00112437|2304150|P7|12 Month Extension|Lack of Efficacy|0
714282|NCT00112437|2304151|P6|12 Month Extension|Lack of Efficacy|0
714283|NCT00112437|2304152|P5|12 Month Extension|Lack of Efficacy|2
714284|NCT00112437|2304153|P4|12 Month Extension|Lack of Efficacy|0
714285|NCT00112437|2304154|P3|12 Month Extension|Lack of Efficacy|0
714286|NCT00112437|2304155|P2|12 Month Extension|Lack of Efficacy|6
714287|NCT00112437|2304156|P1|12 Month Extension|Lack of Efficacy|1
714288|NCT00112437|2304142|P15|12 Month Extension|Adverse Event|0
714289|NCT00112437|2304143|P14|12 Month Extension|Adverse Event|0
714290|NCT00112437|2304144|P13|12 Month Extension|Adverse Event|0
714291|NCT00112437|2304145|P12|12 Month Extension|Adverse Event|0
714292|NCT00112437|2304146|P11|12 Month Extension|Adverse Event|0
714293|NCT00112437|2304147|P10|12 Month Extension|Adverse Event|0
714294|NCT00112437|2304148|P9|12 Month Extension|Adverse Event|0
714295|NCT00112437|2304149|P8|12 Month Extension|Adverse Event|0
714296|NCT00112437|2304150|P7|12 Month Extension|Adverse Event|0
714297|NCT00112437|2304151|P6|12 Month Extension|Adverse Event|0
714298|NCT00112437|2304152|P5|12 Month Extension|Adverse Event|7
714299|NCT00112437|2304153|P4|12 Month Extension|Adverse Event|1
714300|NCT00112437|2304154|P3|12 Month Extension|Adverse Event|6
714301|NCT00112437|2304155|P2|12 Month Extension|Adverse Event|2
714302|NCT00112437|2304156|P1|12 Month Extension|Adverse Event|1
714303|NCT00112437|2304142|P15|12 Month Base Study|DXA was lower by more than 8%|0
714304|NCT00112437|2304143|P14|12 Month Base Study|DXA was lower by more than 8%|0
714305|NCT00112437|2304144|P13|12 Month Base Study|DXA was lower by more than 8%|0
714306|NCT00112437|2304145|P12|12 Month Base Study|DXA was lower by more than 8%|0
714307|NCT00112437|2304146|P11|12 Month Base Study|DXA was lower by more than 8%|0
714308|NCT00112437|2304147|P10|12 Month Base Study|DXA was lower by more than 8%|0
714309|NCT00112437|2304148|P9|12 Month Base Study|DXA was lower by more than 8%|0
714310|NCT00112437|2304149|P8|12 Month Base Study|DXA was lower by more than 8%|0
714311|NCT00112437|2304150|P7|12 Month Base Study|DXA was lower by more than 8%|0
714312|NCT00112437|2304151|P6|12 Month Base Study|DXA was lower by more than 8%|0
714313|NCT00112437|2304152|P5|12 Month Base Study|DXA was lower by more than 8%|1
714314|NCT00112437|2304153|P4|12 Month Base Study|DXA was lower by more than 8%|0
714315|NCT00112437|2304154|P3|12 Month Base Study|DXA was lower by more than 8%|0
714316|NCT00112437|2304155|P2|12 Month Base Study|DXA was lower by more than 8%|0
714317|NCT00112437|2304156|P1|12 Month Base Study|DXA was lower by more than 8%|0
714318|NCT00112437|2304142|P15|12 Month Base Study|patient was unsure that they needed drug|0
714319|NCT00112437|2304143|P14|12 Month Base Study|patient was unsure that they needed drug|0
714320|NCT00112437|2304144|P13|12 Month Base Study|patient was unsure that they needed drug|0
714321|NCT00112437|2304145|P12|12 Month Base Study|patient was unsure that they needed drug|0
714322|NCT00112437|2304146|P11|12 Month Base Study|patient was unsure that they needed drug|0
714323|NCT00112437|2304147|P10|12 Month Base Study|patient was unsure that they needed drug|0
714324|NCT00112437|2304148|P9|12 Month Base Study|patient was unsure that they needed drug|0
714325|NCT00112437|2304149|P8|12 Month Base Study|patient was unsure that they needed drug|0
714326|NCT00112437|2304150|P7|12 Month Base Study|patient was unsure that they needed drug|0
714327|NCT00112437|2304151|P6|12 Month Base Study|patient was unsure that they needed drug|0
714328|NCT00112437|2304152|P5|12 Month Base Study|patient was unsure that they needed drug|0
714329|NCT00112437|2304153|P4|12 Month Base Study|patient was unsure that they needed drug|2
714330|NCT00112437|2304154|P3|12 Month Base Study|patient was unsure that they needed drug|0
714331|NCT00112437|2304155|P2|12 Month Base Study|patient was unsure that they needed drug|0
714332|NCT00112437|2304156|P1|12 Month Base Study|patient was unsure that they needed drug|0
714333|NCT00112437|2304142|P15|12 Month Base Study|moved|0
714334|NCT00112437|2304143|P14|12 Month Base Study|moved|0
714335|NCT00112437|2304144|P13|12 Month Base Study|moved|0
714336|NCT00112437|2304145|P12|12 Month Base Study|moved|0
714337|NCT00112437|2304146|P11|12 Month Base Study|moved|0
714338|NCT00112437|2304147|P10|12 Month Base Study|moved|0
714339|NCT00112437|2304148|P9|12 Month Base Study|moved|0
714340|NCT00112437|2304149|P8|12 Month Base Study|moved|0
714341|NCT00112437|2304150|P7|12 Month Base Study|moved|0
714342|NCT00112437|2304151|P6|12 Month Base Study|moved|0
714343|NCT00112437|2304152|P5|12 Month Base Study|moved|0
714344|NCT00112437|2304153|P4|12 Month Base Study|moved|0
714345|NCT00112437|2304154|P3|12 Month Base Study|moved|1
714346|NCT00112437|2304155|P2|12 Month Base Study|moved|1
714347|NCT00112437|2304156|P1|12 Month Base Study|moved|0
714348|NCT00112437|2304142|P15|12 Month Base Study|Withdrawal by Subject|0
714349|NCT00112437|2304143|P14|12 Month Base Study|Withdrawal by Subject|0
714350|NCT00112437|2304144|P13|12 Month Base Study|Withdrawal by Subject|0
714351|NCT00112437|2304145|P12|12 Month Base Study|Withdrawal by Subject|0
714352|NCT00112437|2304146|P11|12 Month Base Study|Withdrawal by Subject|0
714353|NCT00112437|2304147|P10|12 Month Base Study|Withdrawal by Subject|0
714354|NCT00112437|2304148|P9|12 Month Base Study|Withdrawal by Subject|0
714355|NCT00112437|2304149|P8|12 Month Base Study|Withdrawal by Subject|0
714356|NCT00112437|2304150|P7|12 Month Base Study|Withdrawal by Subject|0
714357|NCT00112437|2304151|P6|12 Month Base Study|Withdrawal by Subject|0
714358|NCT00112437|2304152|P5|12 Month Base Study|Withdrawal by Subject|7
714359|NCT00112437|2304153|P4|12 Month Base Study|Withdrawal by Subject|1
714360|NCT00112437|2304154|P3|12 Month Base Study|Withdrawal by Subject|2
714361|NCT00112437|2304155|P2|12 Month Base Study|Withdrawal by Subject|5
714362|NCT00112437|2304156|P1|12 Month Base Study|Withdrawal by Subject|5
714363|NCT00112437|2304142|P15|12 Month Base Study|Protocol Violation|0
714364|NCT00112437|2304143|P14|12 Month Base Study|Protocol Violation|0
714365|NCT00112437|2304144|P13|12 Month Base Study|Protocol Violation|0
714366|NCT00112437|2304145|P12|12 Month Base Study|Protocol Violation|0
714367|NCT00112437|2304146|P11|12 Month Base Study|Protocol Violation|0
714368|NCT00112437|2304147|P10|12 Month Base Study|Protocol Violation|0
714369|NCT00112437|2304148|P9|12 Month Base Study|Protocol Violation|0
714370|NCT00112437|2304149|P8|12 Month Base Study|Protocol Violation|0
714371|NCT00112437|2304150|P7|12 Month Base Study|Protocol Violation|0
714372|NCT00112437|2304151|P6|12 Month Base Study|Protocol Violation|0
714373|NCT00112437|2304152|P5|12 Month Base Study|Protocol Violation|1
714374|NCT00112437|2304153|P4|12 Month Base Study|Protocol Violation|1
714375|NCT00112437|2304154|P3|12 Month Base Study|Protocol Violation|3
714376|NCT00112437|2304155|P2|12 Month Base Study|Protocol Violation|0
714377|NCT00112437|2304156|P1|12 Month Base Study|Protocol Violation|1
714378|NCT00112437|2304142|P15|12 Month Base Study|Lost to Follow-up|0
714379|NCT00112437|2304143|P14|12 Month Base Study|Lost to Follow-up|0
714380|NCT00112437|2304144|P13|12 Month Base Study|Lost to Follow-up|0
714381|NCT00112437|2304145|P12|12 Month Base Study|Lost to Follow-up|0
714382|NCT00112437|2304146|P11|12 Month Base Study|Lost to Follow-up|0
714383|NCT00112437|2304147|P10|12 Month Base Study|Lost to Follow-up|0
714384|NCT00112437|2304148|P9|12 Month Base Study|Lost to Follow-up|0
714385|NCT00112437|2304149|P8|12 Month Base Study|Lost to Follow-up|0
714386|NCT00112437|2304150|P7|12 Month Base Study|Lost to Follow-up|0
714387|NCT00112437|2304151|P6|12 Month Base Study|Lost to Follow-up|0
714388|NCT00112437|2304152|P5|12 Month Base Study|Lost to Follow-up|0
714389|NCT00112437|2304153|P4|12 Month Base Study|Lost to Follow-up|0
714390|NCT00112437|2304154|P3|12 Month Base Study|Lost to Follow-up|0
714391|NCT00112437|2304155|P2|12 Month Base Study|Lost to Follow-up|1
714392|NCT00112437|2304156|P1|12 Month Base Study|Lost to Follow-up|0
714393|NCT00112437|2304142|P15|12 Month Base Study|Lack of Efficacy|0
714394|NCT00112437|2304143|P14|12 Month Base Study|Lack of Efficacy|0
714395|NCT00112437|2304144|P13|12 Month Base Study|Lack of Efficacy|0
714396|NCT00112437|2304145|P12|12 Month Base Study|Lack of Efficacy|0
714397|NCT00112437|2304146|P11|12 Month Base Study|Lack of Efficacy|0
714398|NCT00112437|2304147|P10|12 Month Base Study|Lack of Efficacy|0
714399|NCT00112437|2304148|P9|12 Month Base Study|Lack of Efficacy|0
714400|NCT00112437|2304149|P8|12 Month Base Study|Lack of Efficacy|0
714401|NCT00112437|2304150|P7|12 Month Base Study|Lack of Efficacy|0
714402|NCT00112437|2304151|P6|12 Month Base Study|Lack of Efficacy|0
714403|NCT00112437|2304152|P5|12 Month Base Study|Lack of Efficacy|0
714404|NCT00112437|2304153|P4|12 Month Base Study|Lack of Efficacy|0
714405|NCT00112437|2304154|P3|12 Month Base Study|Lack of Efficacy|0
714406|NCT00112437|2304155|P2|12 Month Base Study|Lack of Efficacy|1
714407|NCT00112437|2304156|P1|12 Month Base Study|Lack of Efficacy|0
714408|NCT00112437|2304142|P15|12 Month Base Study|Adverse Event|0
714409|NCT00112437|2304143|P14|12 Month Base Study|Adverse Event|0
714410|NCT00112437|2304144|P13|12 Month Base Study|Adverse Event|0
714411|NCT00112437|2304145|P12|12 Month Base Study|Adverse Event|0
714412|NCT00112437|2304146|P11|12 Month Base Study|Adverse Event|0
714413|NCT00112437|2304147|P10|12 Month Base Study|Adverse Event|0
714414|NCT00112437|2304148|P9|12 Month Base Study|Adverse Event|0
714415|NCT00112437|2304149|P8|12 Month Base Study|Adverse Event|0
714416|NCT00112437|2304150|P7|12 Month Base Study|Adverse Event|0
714417|NCT00112437|2304151|P6|12 Month Base Study|Adverse Event|0
714418|NCT00112437|2304152|P5|12 Month Base Study|Adverse Event|3
714419|NCT00112437|2304153|P4|12 Month Base Study|Adverse Event|4
714420|NCT00112437|2304154|P3|12 Month Base Study|Adverse Event|6
714421|NCT00112437|2304155|P2|12 Month Base Study|Adverse Event|10
714422|NCT00112437|2304156|P1|12 Month Base Study|Adverse Event|9
714423|NCT00112463|2304413|P1|Overall Study|Never started treatment|2
714424|NCT00112463|2304413|P1|Overall Study|Withdrawal by Subject|2
714425|NCT00112463|2304413|P1|Overall Study|Toxicity|3
714426|NCT00112463|2304413|P1|Overall Study|Second Primary|1
714427|NCT00112463|2304413|P1|Overall Study|Progression|30
714428|NCT00112463|2304413|P1|Overall Study|Physician Decision|1
714429|NCT00112489|2304420|P1|Overall Study|Ineligible|7
714430|NCT00112489|2304420|P1|Overall Study|Patient never treated|2
714431|NCT00112489|2304420|P1|Overall Study|Other, Not Specified|9
714432|NCT00112489|2304420|P1|Overall Study|Death|2
714433|NCT00112489|2304420|P1|Overall Study|Adverse Event|12
714434|NCT00112489|2304420|P1|Overall Study|Refused further treatment|8
714435|NCT00112736|2304469|P2|Overall Study|1 pt never had had RX due rapid decline|0
714436|NCT00112736|2304470|P1|Overall Study|1 pt never had had RX due rapid decline|1
714437|NCT00112840|2304486|P3|Overall Study|Protocol Violation|5
714438|NCT00112840|2304487|P2|Overall Study|Protocol Violation|0
714439|NCT00112840|2304488|P1|Overall Study|Protocol Violation|0
714440|NCT00112840|2304486|P3|Overall Study|Withdrawal by Subject|1
714441|NCT00112840|2304487|P2|Overall Study|Withdrawal by Subject|0
714442|NCT00112840|2304488|P1|Overall Study|Withdrawal by Subject|1
714443|NCT00112840|2304486|P3|Overall Study|Physician Decision|0
714444|NCT00112840|2304487|P2|Overall Study|Physician Decision|0
714445|NCT00112840|2304488|P1|Overall Study|Physician Decision|1
714446|NCT00112866|2304506|P2|Overall Study|did not start treatment post-op|2
714447|NCT00112866|2304507|P1|Overall Study|did not start treatment post-op|1
714448|NCT00112866|2304506|P2|Overall Study|Protocol Violation|0
714449|NCT00112866|2304507|P1|Overall Study|Protocol Violation|1
714450|NCT00112905|2304526|P1|Overall Study|performance status was deteiorating|1
714451|NCT00112905|2304526|P1|Overall Study|Alternative treatment|1
714452|NCT00112905|2304526|P1|Overall Study|Ineligibility|5
714453|NCT00112905|2304526|P1|Overall Study|Death|1
714454|NCT00112905|2304526|P1|Overall Study|Adverse Event|4
714455|NCT00113087|2304572|P2|Overall Study|Family or MD withdrew subject|5
714456|NCT00113087|2304573|P1|Overall Study|Family or MD withdrew subject|10
714457|NCT00113087|2304572|P2|Overall Study|Death or Transplant|16
714458|NCT00113087|2304573|P1|Overall Study|Death or Transplant|14
714459|NCT00113269|2304647|P4|Overall Study|Unable to return for follow up|0
714460|NCT00113269|2304648|P3|Overall Study|Unable to return for follow up|0
714461|NCT00113269|2304649|P2|Overall Study|Unable to return for follow up|1
714462|NCT00113269|2304650|P1|Overall Study|Unable to return for follow up|2
714463|NCT00113269|2304647|P4|Overall Study|Did not meet eligibility criteria|1
714464|NCT00113269|2304648|P3|Overall Study|Did not meet eligibility criteria|0
714465|NCT00113269|2304649|P2|Overall Study|Did not meet eligibility criteria|0
714466|NCT00113269|2304650|P1|Overall Study|Did not meet eligibility criteria|1
714467|NCT00113269|2304647|P4|Overall Study|Withdrew consent, Prednisone initiated|1
714468|NCT00113269|2304648|P3|Overall Study|Withdrew consent, Prednisone initiated|0
714469|NCT00113269|2304649|P2|Overall Study|Withdrew consent, Prednisone initiated|0
714470|NCT00113269|2304650|P1|Overall Study|Withdrew consent, Prednisone initiated|0
714471|NCT00113269|2304647|P4|Overall Study|Received pancreas transplant|2
714472|NCT00113269|2304648|P3|Overall Study|Received pancreas transplant|0
714473|NCT00113269|2304649|P2|Overall Study|Received pancreas transplant|0
714474|NCT00113269|2304650|P1|Overall Study|Received pancreas transplant|0
714475|NCT00113269|2304647|P4|Overall Study|Moved|3
714476|NCT00113269|2304648|P3|Overall Study|Moved|0
714477|NCT00113269|2304649|P2|Overall Study|Moved|1
714478|NCT00113269|2304650|P1|Overall Study|Moved|0
714479|NCT00113269|2304647|P4|Overall Study|Discontinued due to rejection|0
714480|NCT00113269|2304648|P3|Overall Study|Discontinued due to rejection|1
714481|NCT00113269|2304649|P2|Overall Study|Discontinued due to rejection|0
714482|NCT00113269|2304650|P1|Overall Study|Discontinued due to rejection|0
714483|NCT00113269|2304647|P4|Overall Study|Sponsor elected to discontinue patient|1
714484|NCT00113269|2304648|P3|Overall Study|Sponsor elected to discontinue patient|0
714485|NCT00113269|2304649|P2|Overall Study|Sponsor elected to discontinue patient|0
714486|NCT00113269|2304650|P1|Overall Study|Sponsor elected to discontinue patient|1
714487|NCT00113269|2304647|P4|Overall Study|Lost to Follow-up|3
714488|NCT00113269|2304648|P3|Overall Study|Lost to Follow-up|6
714489|NCT00113269|2304649|P2|Overall Study|Lost to Follow-up|3
714490|NCT00113269|2304650|P1|Overall Study|Lost to Follow-up|2
714491|NCT00113269|2304647|P4|Overall Study|Protocol Violation|2
714492|NCT00113269|2304648|P3|Overall Study|Protocol Violation|4
714493|NCT00113269|2304649|P2|Overall Study|Protocol Violation|0
714494|NCT00113269|2304650|P1|Overall Study|Protocol Violation|1
714495|NCT00113269|2304647|P4|Overall Study|Graft loss|9
714496|NCT00113269|2304648|P3|Overall Study|Graft loss|4
714497|NCT00113269|2304649|P2|Overall Study|Graft loss|6
714498|NCT00113269|2304650|P1|Overall Study|Graft loss|6
714499|NCT00113269|2304647|P4|Overall Study|Withdrawal by Subject|2
714500|NCT00113269|2304648|P3|Overall Study|Withdrawal by Subject|4
714501|NCT00113269|2304649|P2|Overall Study|Withdrawal by Subject|3
714502|NCT00113269|2304650|P1|Overall Study|Withdrawal by Subject|4
714503|NCT00113269|2304647|P4|Overall Study|Adverse Event|7
714504|NCT00113269|2304648|P3|Overall Study|Adverse Event|11
714505|NCT00113269|2304649|P2|Overall Study|Adverse Event|7
714506|NCT00113269|2304650|P1|Overall Study|Adverse Event|2
714507|NCT00113269|2304647|P4|Overall Study|Did not meet eligibility – pre-treatment|2
714508|NCT00113269|2304648|P3|Overall Study|Did not meet eligibility – pre-treatment|0
714509|NCT00113269|2304649|P2|Overall Study|Did not meet eligibility – pre-treatment|0
714510|NCT00113269|2304650|P1|Overall Study|Did not meet eligibility – pre-treatment|0
714511|NCT00113269|2304647|P4|Overall Study|Death in operating room|1
714512|NCT00113269|2304648|P3|Overall Study|Death in operating room|0
714513|NCT00113269|2304649|P2|Overall Study|Death in operating room|0
714514|NCT00113269|2304650|P1|Overall Study|Death in operating room|0
714515|NCT00113269|2304647|P4|Overall Study|Early graft loss, technical|0
714516|NCT00113269|2304648|P3|Overall Study|Early graft loss, technical|2
714517|NCT00113269|2304649|P2|Overall Study|Early graft loss, technical|0
714518|NCT00113269|2304650|P1|Overall Study|Early graft loss, technical|0
714519|NCT00113269|2304647|P4|Overall Study|Not transplanted, recipient issues|4
714520|NCT00113269|2304648|P3|Overall Study|Not transplanted, recipient issues|7
714521|NCT00113269|2304649|P2|Overall Study|Not transplanted, recipient issues|1
714522|NCT00113269|2304650|P1|Overall Study|Not transplanted, recipient issues|2
714523|NCT00113269|2304647|P4|Overall Study|Not transplanted, donor issues|2
714524|NCT00113269|2304648|P3|Overall Study|Not transplanted, donor issues|2
714525|NCT00113269|2304649|P2|Overall Study|Not transplanted, donor issues|0
714526|NCT00113269|2304650|P1|Overall Study|Not transplanted, donor issues|4
714527|NCT00113295|2304702|P2|Overall Study|Unrelated Medical Illness|0
714528|NCT00113295|2304703|P1|Overall Study|Unrelated Medical Illness|1
714529|NCT00113295|2304702|P2|Overall Study|Adverse Event|1
714530|NCT00113295|2304703|P1|Overall Study|Adverse Event|4
714531|NCT00113360|2304726|P1|Overall Study|Did not meet eligibility criteria|3
714532|NCT00113360|2304726|P1|Overall Study|Subject required surgery|1
714533|NCT00113360|2304726|P1|Overall Study|Adverse Event|3
714534|NCT00113373|2304730|P1|Overall Study|Never Treated|1
714535|NCT00113373|2304730|P1|Overall Study|Ineligible: second primary|1
714536|NCT00113373|2304730|P1|Overall Study|Ineligible: wrong primary|1
714537|NCT00113386|2304738|P2|Overall Study|Unknown - Lost to Follow-Up|1
714538|NCT00113386|2304739|P1|Overall Study|Unknown - Lost to Follow-Up|2
714539|NCT00113386|2304738|P2|Overall Study|Ineligible|2
714540|NCT00113386|2304739|P1|Overall Study|Ineligible|1
714541|NCT00113386|2304738|P2|Overall Study|Toxicity|0
714542|NCT00113386|2304739|P1|Overall Study|Toxicity|3
714543|NCT00113386|2304738|P2|Overall Study|Physician Decision|1
714544|NCT00113386|2304739|P1|Overall Study|Physician Decision|0
714545|NCT00113386|2304738|P2|Overall Study|Withdrawal by Subject|0
714546|NCT00113386|2304739|P1|Overall Study|Withdrawal by Subject|1
714547|NCT00113399|2304747|P2|Overall Study|Other|1
714548|NCT00113399|2304748|P1|Overall Study|Other|0
714549|NCT00113399|2304747|P2|Overall Study|Complete Response|1
714550|NCT00113399|2304748|P1|Overall Study|Complete Response|0
714551|NCT00113399|2304747|P2|Overall Study|Withdrawal by Subject|2
714552|NCT00113399|2304748|P1|Overall Study|Withdrawal by Subject|1
714553|NCT00113399|2304747|P2|Overall Study|Death|1
714554|NCT00113399|2304748|P1|Overall Study|Death|1
714555|NCT00103610|2304756|P2|Overall Study|Noncompliance|1
714556|NCT00103610|2304757|P1|Overall Study|Noncompliance|0
714557|NCT00103610|2304756|P2|Overall Study|Failed mobilization|5
714558|NCT00103610|2304757|P1|Overall Study|Failed mobilization|1
714559|NCT00103610|2304756|P2|Overall Study|Other|7
714560|NCT00103610|2304757|P1|Overall Study|Other|2
714561|NCT00103610|2304756|P2|Overall Study|Adverse Event|2
714562|NCT00103610|2304757|P1|Overall Study|Adverse Event|2
714563|NCT00103610|2304756|P2|Overall Study|Lost to Follow-up|1
714564|NCT00103610|2304757|P1|Overall Study|Lost to Follow-up|3
714565|NCT00103610|2304756|P2|Overall Study|Elective Withdrawal|0
714566|NCT00103610|2304757|P1|Overall Study|Elective Withdrawal|4
714567|NCT00103610|2304756|P2|Overall Study|Death|12
714568|NCT00103610|2304757|P1|Overall Study|Death|16
714569|NCT00103610|2304756|P2|Overall Study|Entered Rescue Procedure|52
714570|NCT00103610|2304757|P1|Overall Study|Entered Rescue Procedure|10
714571|NCT00103662|2304781|P2|Overall Study|Intercurrent illness|0
714572|NCT00103662|2304782|P1|Overall Study|Intercurrent illness|1
714573|NCT00103662|2304781|P2|Overall Study|Failed mobilization|4
714574|NCT00103662|2304782|P1|Overall Study|Failed mobilization|0
714575|NCT00103662|2304781|P2|Overall Study|Other|9
714576|NCT00103662|2304782|P1|Overall Study|Other|6
714577|NCT00103662|2304781|P2|Overall Study|Lost to Follow-up|1
714578|NCT00103662|2304782|P1|Overall Study|Lost to Follow-up|0
714579|NCT00103662|2304781|P2|Overall Study|Elective Withdrawal|5
714580|NCT00103662|2304782|P1|Overall Study|Elective Withdrawal|5
714581|NCT00103662|2304781|P2|Overall Study|Death|7
714582|NCT00103662|2304782|P1|Overall Study|Death|7
714583|NCT00103662|2304781|P2|Overall Study|Entered Rescue Procedure|7
714584|NCT00103662|2304782|P1|Overall Study|Entered Rescue Procedure|0
714585|NCT00103740|2304808|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
714586|NCT00103740|2304809|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
714587|NCT00103740|2304808|P2|Period 2 - Extended Observation Period|Death|2
714588|NCT00103740|2304809|P1|Period 2 - Extended Observation Period|Death|6
714589|NCT00103740|2304808|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
714590|NCT00103740|2304809|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
714591|NCT00103740|2304808|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
714592|NCT00103740|2304809|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
714593|NCT00103740|2304808|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
714594|NCT00103740|2304809|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
714595|NCT00103740|2304808|P2|Period 1 - Core|Patient withdrew consent|2
714596|NCT00103740|2304809|P1|Period 1 - Core|Patient withdrew consent|3
714597|NCT00103740|2304808|P2|Period 1 - Core|Protocol Violation|2
714598|NCT00103740|2304809|P1|Period 1 - Core|Protocol Violation|3
714599|NCT00103740|2304808|P2|Period 1 - Core|Adverse Event|0
714600|NCT00103740|2304809|P1|Period 1 - Core|Adverse Event|1
714601|NCT00103857|2304876|P7|50-Week Extension Study|reason unspecified|0
714602|NCT00103857|2304877|P6|50-Week Extension Study|reason unspecified|0
714603|NCT00103857|2304878|P5|50-Week Extension Study|reason unspecified|1
714604|NCT00103857|2304879|P4|50-Week Extension Study|reason unspecified|0
714605|NCT00103857|2304880|P3|50-Week Extension Study|reason unspecified|0
714606|NCT00103857|2304881|P2|50-Week Extension Study|reason unspecified|0
714607|NCT00103857|2304882|P1|50-Week Extension Study|reason unspecified|0
714608|NCT00103857|2304876|P7|50-Week Extension Study|patient scheduled for elective surgery|0
714609|NCT00103857|2304877|P6|50-Week Extension Study|patient scheduled for elective surgery|0
714610|NCT00103857|2304878|P5|50-Week Extension Study|patient scheduled for elective surgery|0
714611|NCT00103857|2304879|P4|50-Week Extension Study|patient scheduled for elective surgery|0
714612|NCT00103857|2304880|P3|50-Week Extension Study|patient scheduled for elective surgery|1
714613|NCT00103857|2304881|P2|50-Week Extension Study|patient scheduled for elective surgery|0
714614|NCT00103857|2304882|P1|50-Week Extension Study|patient scheduled for elective surgery|0
714615|NCT00103857|2304876|P7|50-Week Extension Study|patient moved|0
714616|NCT00103857|2304877|P6|50-Week Extension Study|patient moved|0
714617|NCT00103857|2304878|P5|50-Week Extension Study|patient moved|0
714618|NCT00103857|2304879|P4|50-Week Extension Study|patient moved|2
714619|NCT00103857|2304880|P3|50-Week Extension Study|patient moved|1
714620|NCT00103857|2304881|P2|50-Week Extension Study|patient moved|0
714621|NCT00103857|2304882|P1|50-Week Extension Study|patient moved|0
714622|NCT00103857|2304876|P7|50-Week Extension Study|non-compliance with study procedures|0
714623|NCT00103857|2304877|P6|50-Week Extension Study|non-compliance with study procedures|0
714624|NCT00103857|2304878|P5|50-Week Extension Study|non-compliance with study procedures|1
714625|NCT00103857|2304879|P4|50-Week Extension Study|non-compliance with study procedures|1
714626|NCT00103857|2304880|P3|50-Week Extension Study|non-compliance with study procedures|0
714627|NCT00103857|2304881|P2|50-Week Extension Study|non-compliance with study procedures|0
714628|NCT00103857|2304882|P1|50-Week Extension Study|non-compliance with study procedures|1
714629|NCT00103857|2304876|P7|50-Week Extension Study|protocol discontinuation criteria|0
714630|NCT00103857|2304877|P6|50-Week Extension Study|protocol discontinuation criteria|3
714631|NCT00103857|2304878|P5|50-Week Extension Study|protocol discontinuation criteria|3
714632|NCT00103857|2304879|P4|50-Week Extension Study|protocol discontinuation criteria|2
714633|NCT00103857|2304880|P3|50-Week Extension Study|protocol discontinuation criteria|3
714634|NCT00103857|2304881|P2|50-Week Extension Study|protocol discontinuation criteria|2
714635|NCT00103857|2304882|P1|50-Week Extension Study|protocol discontinuation criteria|2
714636|NCT00103857|2304876|P7|50-Week Extension Study|Withdrawal by Subject|0
714637|NCT00103857|2304877|P6|50-Week Extension Study|Withdrawal by Subject|3
714638|NCT00103857|2304878|P5|50-Week Extension Study|Withdrawal by Subject|3
714639|NCT00103857|2304879|P4|50-Week Extension Study|Withdrawal by Subject|8
714640|NCT00103857|2304880|P3|50-Week Extension Study|Withdrawal by Subject|2
714641|NCT00103857|2304881|P2|50-Week Extension Study|Withdrawal by Subject|5
714642|NCT00103857|2304882|P1|50-Week Extension Study|Withdrawal by Subject|2
714643|NCT00103857|2304876|P7|50-Week Extension Study|Protocol Violation|0
714644|NCT00103857|2304877|P6|50-Week Extension Study|Protocol Violation|1
714645|NCT00103857|2304878|P5|50-Week Extension Study|Protocol Violation|0
714646|NCT00103857|2304879|P4|50-Week Extension Study|Protocol Violation|2
714647|NCT00103857|2304880|P3|50-Week Extension Study|Protocol Violation|1
714648|NCT00103857|2304881|P2|50-Week Extension Study|Protocol Violation|1
714649|NCT00103857|2304882|P1|50-Week Extension Study|Protocol Violation|1
714650|NCT00103857|2304876|P7|50-Week Extension Study|Pregnancy|0
714651|NCT00103857|2304877|P6|50-Week Extension Study|Pregnancy|0
714652|NCT00103857|2304878|P5|50-Week Extension Study|Pregnancy|1
714653|NCT00103857|2304879|P4|50-Week Extension Study|Pregnancy|0
714654|NCT00103857|2304880|P3|50-Week Extension Study|Pregnancy|1
714655|NCT00103857|2304881|P2|50-Week Extension Study|Pregnancy|0
714656|NCT00103857|2304882|P1|50-Week Extension Study|Pregnancy|0
714657|NCT00103857|2304876|P7|50-Week Extension Study|Physician Decision|0
714658|NCT00103857|2304877|P6|50-Week Extension Study|Physician Decision|0
714659|NCT00103857|2304878|P5|50-Week Extension Study|Physician Decision|0
714660|NCT00103857|2304879|P4|50-Week Extension Study|Physician Decision|0
714661|NCT00103857|2304880|P3|50-Week Extension Study|Physician Decision|1
714662|NCT00103857|2304881|P2|50-Week Extension Study|Physician Decision|1
714663|NCT00103857|2304882|P1|50-Week Extension Study|Physician Decision|0
714664|NCT00103857|2304876|P7|50-Week Extension Study|Lost to Follow-up|0
714665|NCT00103857|2304877|P6|50-Week Extension Study|Lost to Follow-up|3
714666|NCT00103857|2304878|P5|50-Week Extension Study|Lost to Follow-up|3
714667|NCT00103857|2304879|P4|50-Week Extension Study|Lost to Follow-up|4
714668|NCT00103857|2304880|P3|50-Week Extension Study|Lost to Follow-up|1
714669|NCT00103857|2304881|P2|50-Week Extension Study|Lost to Follow-up|0
714670|NCT00103857|2304882|P1|50-Week Extension Study|Lost to Follow-up|4
714671|NCT00103857|2304876|P7|50-Week Extension Study|Lack of Efficacy|0
714672|NCT00103857|2304877|P6|50-Week Extension Study|Lack of Efficacy|8
714673|NCT00103857|2304878|P5|50-Week Extension Study|Lack of Efficacy|8
714674|NCT00103857|2304879|P4|50-Week Extension Study|Lack of Efficacy|16
714675|NCT00103857|2304880|P3|50-Week Extension Study|Lack of Efficacy|13
714676|NCT00103857|2304881|P2|50-Week Extension Study|Lack of Efficacy|15
714677|NCT00103857|2304882|P1|50-Week Extension Study|Lack of Efficacy|26
714678|NCT00103857|2304876|P7|50-Week Extension Study|Death|0
714679|NCT00103857|2304877|P6|50-Week Extension Study|Death|1
714680|NCT00103857|2304878|P5|50-Week Extension Study|Death|0
714681|NCT00103857|2304879|P4|50-Week Extension Study|Death|1
714682|NCT00103857|2304880|P3|50-Week Extension Study|Death|0
714683|NCT00103857|2304881|P2|50-Week Extension Study|Death|0
714684|NCT00103857|2304882|P1|50-Week Extension Study|Death|0
714685|NCT00103857|2304876|P7|50-Week Extension Study|Adverse Event|0
714686|NCT00103857|2304877|P6|50-Week Extension Study|Adverse Event|1
714687|NCT00103857|2304878|P5|50-Week Extension Study|Adverse Event|1
714688|NCT00103857|2304879|P4|50-Week Extension Study|Adverse Event|0
714689|NCT00103857|2304880|P3|50-Week Extension Study|Adverse Event|2
714690|NCT00103857|2304881|P2|50-Week Extension Study|Adverse Event|3
714691|NCT00103857|2304882|P1|50-Week Extension Study|Adverse Event|2
714692|NCT00103857|2304876|P7|54-Week Base Study|patient intolerance to rescue therapy|0
714693|NCT00103857|2304877|P6|54-Week Base Study|patient intolerance to rescue therapy|0
714694|NCT00103857|2304878|P5|54-Week Base Study|patient intolerance to rescue therapy|0
714695|NCT00103857|2304879|P4|54-Week Base Study|patient intolerance to rescue therapy|0
714696|NCT00103857|2304880|P3|54-Week Base Study|patient intolerance to rescue therapy|0
714697|NCT00103857|2304881|P2|54-Week Base Study|patient intolerance to rescue therapy|0
714698|NCT00103857|2304882|P1|54-Week Base Study|patient intolerance to rescue therapy|1
714699|NCT00103857|2304876|P7|54-Week Base Study|site error|0
714700|NCT00103857|2304877|P6|54-Week Base Study|site error|1
714701|NCT00103857|2304878|P5|54-Week Base Study|site error|0
714702|NCT00103857|2304879|P4|54-Week Base Study|site error|0
714703|NCT00103857|2304880|P3|54-Week Base Study|site error|0
714704|NCT00103857|2304881|P2|54-Week Base Study|site error|0
714705|NCT00103857|2304882|P1|54-Week Base Study|site error|0
714706|NCT00103857|2304876|P7|54-Week Base Study|laboratory reporting error|0
714707|NCT00103857|2304877|P6|54-Week Base Study|laboratory reporting error|0
714708|NCT00103857|2304878|P5|54-Week Base Study|laboratory reporting error|1
714709|NCT00103857|2304879|P4|54-Week Base Study|laboratory reporting error|0
714710|NCT00103857|2304880|P3|54-Week Base Study|laboratory reporting error|0
714711|NCT00103857|2304881|P2|54-Week Base Study|laboratory reporting error|0
714712|NCT00103857|2304882|P1|54-Week Base Study|laboratory reporting error|0
714713|NCT00103857|2304876|P7|54-Week Base Study|patient incarcerated|0
714714|NCT00103857|2304877|P6|54-Week Base Study|patient incarcerated|1
714715|NCT00103857|2304878|P5|54-Week Base Study|patient incarcerated|1
714716|NCT00103857|2304879|P4|54-Week Base Study|patient incarcerated|0
714717|NCT00103857|2304880|P3|54-Week Base Study|patient incarcerated|0
714718|NCT00103857|2304881|P2|54-Week Base Study|patient incarcerated|0
714719|NCT00103857|2304882|P1|54-Week Base Study|patient incarcerated|0
714720|NCT00103857|2304876|P7|54-Week Base Study|non-compliance with study procedures|0
714721|NCT00103857|2304877|P6|54-Week Base Study|non-compliance with study procedures|2
714722|NCT00103857|2304878|P5|54-Week Base Study|non-compliance with study procedures|0
714723|NCT00103857|2304879|P4|54-Week Base Study|non-compliance with study procedures|0
714724|NCT00103857|2304880|P3|54-Week Base Study|non-compliance with study procedures|0
714725|NCT00103857|2304881|P2|54-Week Base Study|non-compliance with study procedures|2
714726|NCT00103857|2304882|P1|54-Week Base Study|non-compliance with study procedures|1
714727|NCT00103857|2304876|P7|54-Week Base Study|patient moved|0
714728|NCT00103857|2304877|P6|54-Week Base Study|patient moved|1
714729|NCT00103857|2304878|P5|54-Week Base Study|patient moved|3
714730|NCT00103857|2304879|P4|54-Week Base Study|patient moved|2
714731|NCT00103857|2304880|P3|54-Week Base Study|patient moved|1
714732|NCT00103857|2304881|P2|54-Week Base Study|patient moved|1
714733|NCT00103857|2304882|P1|54-Week Base Study|patient moved|0
714734|NCT00103857|2304876|P7|54-Week Base Study|protocol discontinuation criteria|5
714735|NCT00103857|2304877|P6|54-Week Base Study|protocol discontinuation criteria|3
714736|NCT00103857|2304878|P5|54-Week Base Study|protocol discontinuation criteria|5
714737|NCT00103857|2304879|P4|54-Week Base Study|protocol discontinuation criteria|6
714738|NCT00103857|2304880|P3|54-Week Base Study|protocol discontinuation criteria|2
714739|NCT00103857|2304881|P2|54-Week Base Study|protocol discontinuation criteria|5
714740|NCT00103857|2304882|P1|54-Week Base Study|protocol discontinuation criteria|2
714741|NCT00103857|2304876|P7|54-Week Base Study|Withdrawal by Subject|4
714742|NCT00103857|2304877|P6|54-Week Base Study|Withdrawal by Subject|15
714743|NCT00103857|2304878|P5|54-Week Base Study|Withdrawal by Subject|10
714744|NCT00103857|2304879|P4|54-Week Base Study|Withdrawal by Subject|15
714745|NCT00103857|2304880|P3|54-Week Base Study|Withdrawal by Subject|16
714746|NCT00103857|2304881|P2|54-Week Base Study|Withdrawal by Subject|16
714747|NCT00103857|2304882|P1|54-Week Base Study|Withdrawal by Subject|17
714748|NCT00103857|2304876|P7|54-Week Base Study|Protocol Violation|3
714749|NCT00103857|2304877|P6|54-Week Base Study|Protocol Violation|3
714750|NCT00103857|2304878|P5|54-Week Base Study|Protocol Violation|0
714751|NCT00103857|2304879|P4|54-Week Base Study|Protocol Violation|4
714752|NCT00103857|2304880|P3|54-Week Base Study|Protocol Violation|2
714753|NCT00103857|2304881|P2|54-Week Base Study|Protocol Violation|4
714754|NCT00103857|2304882|P1|54-Week Base Study|Protocol Violation|6
714755|NCT00103857|2304876|P7|54-Week Base Study|Pregnancy|1
714756|NCT00103857|2304877|P6|54-Week Base Study|Pregnancy|0
714757|NCT00103857|2304878|P5|54-Week Base Study|Pregnancy|1
714758|NCT00103857|2304879|P4|54-Week Base Study|Pregnancy|0
714759|NCT00103857|2304880|P3|54-Week Base Study|Pregnancy|0
714760|NCT00103857|2304881|P2|54-Week Base Study|Pregnancy|0
714761|NCT00103857|2304882|P1|54-Week Base Study|Pregnancy|1
714762|NCT00103857|2304876|P7|54-Week Base Study|Physician Decision|0
714763|NCT00103857|2304877|P6|54-Week Base Study|Physician Decision|0
714764|NCT00103857|2304878|P5|54-Week Base Study|Physician Decision|1
714765|NCT00103857|2304879|P4|54-Week Base Study|Physician Decision|0
714766|NCT00103857|2304880|P3|54-Week Base Study|Physician Decision|0
714767|NCT00103857|2304881|P2|54-Week Base Study|Physician Decision|1
714768|NCT00103857|2304882|P1|54-Week Base Study|Physician Decision|1
714769|NCT00103857|2304876|P7|54-Week Base Study|Lost to Follow-up|3
714770|NCT00103857|2304877|P6|54-Week Base Study|Lost to Follow-up|9
714771|NCT00103857|2304878|P5|54-Week Base Study|Lost to Follow-up|10
714772|NCT00103857|2304879|P4|54-Week Base Study|Lost to Follow-up|5
714773|NCT00103857|2304880|P3|54-Week Base Study|Lost to Follow-up|7
714774|NCT00103857|2304881|P2|54-Week Base Study|Lost to Follow-up|4
714775|NCT00103857|2304882|P1|54-Week Base Study|Lost to Follow-up|5
714776|NCT00103857|2304876|P7|54-Week Base Study|Lack of Efficacy|19
714777|NCT00103857|2304877|P6|54-Week Base Study|Lack of Efficacy|14
714778|NCT00103857|2304878|P5|54-Week Base Study|Lack of Efficacy|3
714779|NCT00103857|2304879|P4|54-Week Base Study|Lack of Efficacy|4
714780|NCT00103857|2304880|P3|54-Week Base Study|Lack of Efficacy|8
714781|NCT00103857|2304881|P2|54-Week Base Study|Lack of Efficacy|14
714782|NCT00103857|2304882|P1|54-Week Base Study|Lack of Efficacy|11
714783|NCT00103857|2304876|P7|54-Week Base Study|Death|0
714784|NCT00103857|2304877|P6|54-Week Base Study|Death|1
714785|NCT00103857|2304878|P5|54-Week Base Study|Death|1
714786|NCT00103857|2304879|P4|54-Week Base Study|Death|0
714787|NCT00103857|2304880|P3|54-Week Base Study|Death|0
714788|NCT00103857|2304881|P2|54-Week Base Study|Death|0
714789|NCT00103857|2304882|P1|54-Week Base Study|Death|0
714790|NCT00103857|2304876|P7|54-Week Base Study|Adverse Event|3
714791|NCT00103857|2304877|P6|54-Week Base Study|Adverse Event|11
714792|NCT00103857|2304878|P5|54-Week Base Study|Adverse Event|5
714793|NCT00103857|2304879|P4|54-Week Base Study|Adverse Event|6
714794|NCT00103857|2304880|P3|54-Week Base Study|Adverse Event|11
714795|NCT00103857|2304881|P2|54-Week Base Study|Adverse Event|9
714796|NCT00103857|2304882|P1|54-Week Base Study|Adverse Event|12
714797|NCT00104052|2304945|P1|Overall Study|Discontinuation unrelated to treatment|2
714798|NCT00104052|2304945|P1|Overall Study|Lack of Efficacy|26
714799|NCT00104052|2304945|P1|Overall Study|Adverse Event|1
714800|NCT00104104|2304951|P2|Overall Study|Death|6
714801|NCT00104104|2304952|P1|Overall Study|Death|9
714802|NCT00104104|2304951|P2|Overall Study|Administrative problems|13
714803|NCT00104104|2304952|P1|Overall Study|Administrative problems|12
714804|NCT00104104|2304951|P2|Overall Study|Lost to Follow-up|7
714805|NCT00104104|2304952|P1|Overall Study|Lost to Follow-up|3
714806|NCT00104104|2304951|P2|Overall Study|Withdrawal by Subject|15
714807|NCT00104104|2304952|P1|Overall Study|Withdrawal by Subject|11
714808|NCT00104104|2304951|P2|Overall Study|Protocol Violation|2
714809|NCT00104104|2304952|P1|Overall Study|Protocol Violation|5
714810|NCT00104104|2304951|P2|Overall Study|Condition no longer requires study drug|4
714811|NCT00104104|2304952|P1|Overall Study|Condition no longer requires study drug|7
714812|NCT00104104|2304951|P2|Overall Study|Lack of Efficacy|3
714813|NCT00104104|2304952|P1|Overall Study|Lack of Efficacy|0
714814|NCT00104104|2304951|P2|Overall Study|Abnormal laboratory value(s)|14
714815|NCT00104104|2304952|P1|Overall Study|Abnormal laboratory value(s)|20
714816|NCT00104104|2304951|P2|Overall Study|Adverse Event|8
714817|NCT00104104|2304952|P1|Overall Study|Adverse Event|8
714818|NCT00104247|2304979|P2|Overall Study|Noncompliant with dosing|1
714819|NCT00104247|2304980|P1|Overall Study|Noncompliant with dosing|0
714820|NCT00104247|2304979|P2|Overall Study|Withdrawal by Subject|0
714821|NCT00104247|2304980|P1|Overall Study|Withdrawal by Subject|1
714822|NCT00104299|2304988|P2|Overall Study|To have renal transplant|0
714823|NCT00104299|2304989|P1|Overall Study|To have renal transplant|1
714824|NCT00104299|2304988|P2|Overall Study|Physician Decision|1
714825|NCT00104299|2304989|P1|Overall Study|Physician Decision|1
714826|NCT00104299|2304988|P2|Overall Study|Withdrawal by Subject|6
714827|NCT00104299|2304989|P1|Overall Study|Withdrawal by Subject|2
714828|NCT00104299|2304988|P2|Overall Study|Death|2
714829|NCT00104299|2304989|P1|Overall Study|Death|2
714830|NCT00104299|2304988|P2|Overall Study|Adverse Event|1
714831|NCT00104299|2304989|P1|Overall Study|Adverse Event|3
714832|NCT00104416|2305011|P5|Continuation Phase|Non-compliance|1
714833|NCT00104416|2305012|P4|Continuation Phase|Non-compliance|0
714834|NCT00104416|2305013|P3|Continuation Phase|Non-compliance|0
714835|NCT00104416|2305014|P2|Continuation Phase|Non-compliance|0
714836|NCT00104416|2305015|P1|Continuation Phase|Non-compliance|0
714837|NCT00104416|2305011|P5|Continuation Phase|Pregnancy|0
714838|NCT00104416|2305012|P4|Continuation Phase|Pregnancy|1
714839|NCT00104416|2305013|P3|Continuation Phase|Pregnancy|1
714840|NCT00104416|2305014|P2|Continuation Phase|Pregnancy|0
714841|NCT00104416|2305015|P1|Continuation Phase|Pregnancy|0
714842|NCT00104416|2305011|P5|Continuation Phase|Withdrawal by Subject|1
714843|NCT00104416|2305012|P4|Continuation Phase|Withdrawal by Subject|1
714844|NCT00104416|2305013|P3|Continuation Phase|Withdrawal by Subject|2
714845|NCT00104416|2305014|P2|Continuation Phase|Withdrawal by Subject|0
714846|NCT00104416|2305015|P1|Continuation Phase|Withdrawal by Subject|0
714847|NCT00104416|2305011|P5|Continuation Phase|Lost to Follow-up|1
714848|NCT00104416|2305012|P4|Continuation Phase|Lost to Follow-up|0
714849|NCT00104416|2305013|P3|Continuation Phase|Lost to Follow-up|1
714850|NCT00104416|2305014|P2|Continuation Phase|Lost to Follow-up|0
714851|NCT00104416|2305015|P1|Continuation Phase|Lost to Follow-up|0
714852|NCT00104416|2305011|P5|Continuation Phase|Adverse Event|2
714853|NCT00104416|2305012|P4|Continuation Phase|Adverse Event|0
714854|NCT00104416|2305013|P3|Continuation Phase|Adverse Event|2
714855|NCT00104416|2305014|P2|Continuation Phase|Adverse Event|0
714856|NCT00104416|2305015|P1|Continuation Phase|Adverse Event|0
714857|NCT00104416|2305011|P5|Double-Blind Phase|Participant Did Not Take Drug|0
714858|NCT00104416|2305012|P4|Double-Blind Phase|Participant Did Not Take Drug|0
714859|NCT00104416|2305013|P3|Double-Blind Phase|Participant Did Not Take Drug|0
714860|NCT00104416|2305014|P2|Double-Blind Phase|Participant Did Not Take Drug|4
714861|NCT00104416|2305015|P1|Double-Blind Phase|Participant Did Not Take Drug|3
714862|NCT00104416|2305011|P5|Double-Blind Phase|Pregnancy|0
714863|NCT00104416|2305012|P4|Double-Blind Phase|Pregnancy|0
714864|NCT00104416|2305013|P3|Double-Blind Phase|Pregnancy|0
714865|NCT00104416|2305014|P2|Double-Blind Phase|Pregnancy|0
714866|NCT00104416|2305015|P1|Double-Blind Phase|Pregnancy|1
714867|NCT00104416|2305011|P5|Double-Blind Phase|Withdrawal by Subject|0
714868|NCT00104416|2305012|P4|Double-Blind Phase|Withdrawal by Subject|0
714869|NCT00104416|2305013|P3|Double-Blind Phase|Withdrawal by Subject|0
714870|NCT00104416|2305014|P2|Double-Blind Phase|Withdrawal by Subject|3
714871|NCT00104416|2305015|P1|Double-Blind Phase|Withdrawal by Subject|2
714872|NCT00104416|2305011|P5|Double-Blind Phase|Protocol Violation|0
714873|NCT00104416|2305012|P4|Double-Blind Phase|Protocol Violation|0
714874|NCT00104416|2305013|P3|Double-Blind Phase|Protocol Violation|0
714875|NCT00104416|2305014|P2|Double-Blind Phase|Protocol Violation|1
714876|NCT00104416|2305015|P1|Double-Blind Phase|Protocol Violation|0
714877|NCT00104416|2305011|P5|Double-Blind Phase|Lost to Follow-up|0
714878|NCT00104416|2305012|P4|Double-Blind Phase|Lost to Follow-up|0
714879|NCT00104416|2305013|P3|Double-Blind Phase|Lost to Follow-up|0
714880|NCT00104416|2305014|P2|Double-Blind Phase|Lost to Follow-up|1
714881|NCT00104416|2305015|P1|Double-Blind Phase|Lost to Follow-up|0
714882|NCT00104416|2305011|P5|Double-Blind Phase|Adverse Event|0
714883|NCT00104416|2305012|P4|Double-Blind Phase|Adverse Event|0
714884|NCT00104416|2305013|P3|Double-Blind Phase|Adverse Event|0
714885|NCT00104416|2305014|P2|Double-Blind Phase|Adverse Event|1
714886|NCT00104416|2305015|P1|Double-Blind Phase|Adverse Event|2
714887|NCT00104520|2305060|P2|Overall Study|Other|5
714888|NCT00104520|2305061|P1|Overall Study|Other|1
714889|NCT00104520|2305060|P2|Overall Study|Personal/administrative|1
714890|NCT00104520|2305061|P1|Overall Study|Personal/administrative|1
714891|NCT00104520|2305060|P2|Overall Study|Noncompliance|2
714892|NCT00104520|2305061|P1|Overall Study|Noncompliance|0
714893|NCT00104520|2305060|P2|Overall Study|Lost to Follow-up|0
714894|NCT00104520|2305061|P1|Overall Study|Lost to Follow-up|1
714895|NCT00104520|2305060|P2|Overall Study|Related adverse event|15
714896|NCT00104520|2305061|P1|Overall Study|Related adverse event|13
714897|NCT00104520|2305060|P2|Overall Study|Study drug intolerance|1
714898|NCT00104520|2305061|P1|Overall Study|Study drug intolerance|0
714899|NCT00104520|2305060|P2|Overall Study|Unrelated adverse event|47
714900|NCT00104520|2305061|P1|Overall Study|Unrelated adverse event|34
714901|NCT00104572|2305082|P3|Overall Study|Withdrawal by Subject|0
714902|NCT00104572|2305083|P2|Overall Study|Withdrawal by Subject|3
714903|NCT00104572|2305084|P1|Overall Study|Withdrawal by Subject|3
714904|NCT00104637|2305092|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
714905|NCT00104637|2305093|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
714906|NCT00104650|2305122|P3|Follow-up Period|Other|0
714907|NCT00104650|2305123|P2|Follow-up Period|Other|1
714908|NCT00104650|2305124|P1|Follow-up Period|Other|0
714909|NCT00104650|2305122|P3|Follow-up Period|Lost to Follow-up|2
714910|NCT00104650|2305123|P2|Follow-up Period|Lost to Follow-up|1
714911|NCT00104650|2305124|P1|Follow-up Period|Lost to Follow-up|0
714912|NCT00104650|2305122|P3|Follow-up Period|Disease progression|0
714913|NCT00104650|2305123|P2|Follow-up Period|Disease progression|1
714914|NCT00104650|2305124|P1|Follow-up Period|Disease progression|3
714915|NCT00104650|2305122|P3|Follow-up Period|Death|4
714916|NCT00104650|2305123|P2|Follow-up Period|Death|6
714917|NCT00104650|2305124|P1|Follow-up Period|Death|6
714918|NCT00104650|2305122|P3|Follow-up Period|Withdrawal by Subject|3
714919|NCT00104650|2305123|P2|Follow-up Period|Withdrawal by Subject|3
714920|NCT00104650|2305124|P1|Follow-up Period|Withdrawal by Subject|0
714921|NCT00104650|2305122|P3|Follow-up Period|Adverse Event|1
714922|NCT00104650|2305123|P2|Follow-up Period|Adverse Event|0
714923|NCT00104650|2305124|P1|Follow-up Period|Adverse Event|1
714924|NCT00104650|2305122|P3|Follow-up Period|Physician Decision|0
714925|NCT00104650|2305123|P2|Follow-up Period|Physician Decision|1
714926|NCT00104650|2305124|P1|Follow-up Period|Physician Decision|1
714927|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Protocol deviation|0
714928|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Protocol deviation|1
714929|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Protocol deviation|0
714930|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Other|0
714931|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Other|0
714932|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Other|1
714933|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
714934|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
714935|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
714936|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Disease progression|2
714937|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Disease progression|3
714938|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Disease progression|2
714939|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Death|6
714940|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Death|5
714941|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Death|7
714942|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
714943|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
714944|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
714945|NCT00104650|2305122|P3|Treatment Period (25 Weeks)|Physician Decision|1
714946|NCT00104650|2305123|P2|Treatment Period (25 Weeks)|Physician Decision|0
714947|NCT00104650|2305124|P1|Treatment Period (25 Weeks)|Physician Decision|0
714948|NCT00104728|2305156|P1|Overall Study|screen failures|19
714949|NCT00104871|2305161|P1|Overall Study|Not evaluable|1
714950|NCT00104884|2305166|P1|Overall Study|Disease progression|4
714951|NCT00105066|2305222|P2|Overall Study|Adverse Event|5
714952|NCT00105066|2305223|P1|Overall Study|Adverse Event|2
714953|NCT00105079|2305235|P2|Overall Study|not specified|1
714954|NCT00105079|2305236|P1|Overall Study|not specified|3
714955|NCT00105079|2305235|P2|Overall Study|Protocol Violation|0
714956|NCT00105079|2305236|P1|Overall Study|Protocol Violation|1
714957|NCT00105079|2305235|P2|Overall Study|Violation of selection criteria at entry|2
714958|NCT00105079|2305236|P1|Overall Study|Violation of selection criteria at entry|0
714959|NCT00105079|2305235|P2|Overall Study|Refused treatment|4
714960|NCT00105079|2305236|P1|Overall Study|Refused treatment|6
714961|NCT00105079|2305235|P2|Overall Study|Lack of Efficacy|3
714962|NCT00105079|2305236|P1|Overall Study|Lack of Efficacy|9
714963|NCT00105079|2305235|P2|Overall Study|Lost to Follow-up|12
714964|NCT00105079|2305236|P1|Overall Study|Lost to Follow-up|12
714965|NCT00105079|2305235|P2|Overall Study|Death|1
714966|NCT00105079|2305236|P1|Overall Study|Death|3
714967|NCT00105079|2305235|P2|Overall Study|Adverse Event|12
714968|NCT00105079|2305236|P1|Overall Study|Adverse Event|5
714969|NCT00105157|2305256|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
714970|NCT00105157|2305257|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
714971|NCT00105157|2305258|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
714972|NCT00105157|2305259|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
714973|NCT00105157|2305256|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
714974|NCT00105157|2305257|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
714975|NCT00105157|2305258|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
714976|NCT00105157|2305259|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
714977|NCT00105157|2305256|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
714978|NCT00105157|2305257|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
714979|NCT00105157|2305258|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
714980|NCT00105157|2305259|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
714981|NCT00105157|2305256|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
714982|NCT00105157|2305257|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
714983|NCT00105157|2305258|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
714984|NCT00105157|2305259|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
714985|NCT00105157|2305256|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
714986|NCT00105157|2305257|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
714987|NCT00105157|2305258|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
714988|NCT00105157|2305259|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
714989|NCT00105157|2305256|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
714990|NCT00105157|2305257|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
714991|NCT00105157|2305258|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
714992|NCT00105157|2305259|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
714993|NCT00105157|2305256|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
714994|NCT00105157|2305257|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
714995|NCT00105157|2305258|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
714996|NCT00105157|2305259|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
714997|NCT00105157|2305256|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
714998|NCT00105157|2305257|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
714999|NCT00105157|2305258|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
715000|NCT00105157|2305259|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
715001|NCT00105157|2305256|P4|Open-Label Continuation of DB|Lost to Follow-up|0
715002|NCT00105157|2305257|P3|Open-Label Continuation of DB|Lost to Follow-up|1
715003|NCT00105157|2305258|P2|Open-Label Continuation of DB|Lost to Follow-up|1
715004|NCT00105157|2305259|P1|Open-Label Continuation of DB|Lost to Follow-up|1
715005|NCT00105157|2305256|P4|Open-Label Continuation of DB|Lack of Efficacy|1
715006|NCT00105157|2305257|P3|Open-Label Continuation of DB|Lack of Efficacy|3
715007|NCT00105157|2305258|P2|Open-Label Continuation of DB|Lack of Efficacy|4
715008|NCT00105157|2305259|P1|Open-Label Continuation of DB|Lack of Efficacy|1
715009|NCT00105157|2305256|P4|Open-Label Continuation of DB|Adverse Event|0
715010|NCT00105157|2305257|P3|Open-Label Continuation of DB|Adverse Event|0
715011|NCT00105157|2305258|P2|Open-Label Continuation of DB|Adverse Event|1
715012|NCT00105157|2305259|P1|Open-Label Continuation of DB|Adverse Event|3
715013|NCT00105157|2305256|P4|Double-Blind (DB)|Lack of Efficacy|38
715014|NCT00105157|2305257|P3|Double-Blind (DB)|Lack of Efficacy|11
715015|NCT00105157|2305258|P2|Double-Blind (DB)|Lack of Efficacy|14
715016|NCT00105157|2305259|P1|Double-Blind (DB)|Lack of Efficacy|11
715017|NCT00105157|2305256|P4|Double-Blind (DB)|Adverse Event|1
715018|NCT00105157|2305257|P3|Double-Blind (DB)|Adverse Event|1
715019|NCT00105157|2305258|P2|Double-Blind (DB)|Adverse Event|0
715020|NCT00105157|2305259|P1|Double-Blind (DB)|Adverse Event|2
715021|NCT00105157|2305256|P4|Double-Blind (DB)|Never Treated|0
715022|NCT00105157|2305257|P3|Double-Blind (DB)|Never Treated|0
715023|NCT00105157|2305258|P2|Double-Blind (DB)|Never Treated|0
715024|NCT00105157|2305259|P1|Double-Blind (DB)|Never Treated|1
715025|NCT00105183|2305454|P3|Overall Study|Other reason|0
715026|NCT00105183|2305455|P2|Overall Study|Other reason|2
715027|NCT00105183|2305456|P1|Overall Study|Other reason|1
715028|NCT00105183|2305454|P3|Overall Study|Lost to Follow-up|1
715029|NCT00105183|2305455|P2|Overall Study|Lost to Follow-up|1
715030|NCT00105183|2305456|P1|Overall Study|Lost to Follow-up|0
715031|NCT00105183|2305454|P3|Overall Study|Physician Decision|3
715032|NCT00105183|2305455|P2|Overall Study|Physician Decision|2
715033|NCT00105183|2305456|P1|Overall Study|Physician Decision|1
715034|NCT00105183|2305454|P3|Overall Study|Withdrawal by Subject|4
715035|NCT00105183|2305455|P2|Overall Study|Withdrawal by Subject|1
715036|NCT00105183|2305456|P1|Overall Study|Withdrawal by Subject|1
715037|NCT00105183|2305454|P3|Overall Study|Death|15
715038|NCT00105183|2305455|P2|Overall Study|Death|13
715039|NCT00105183|2305456|P1|Overall Study|Death|19
715040|NCT00105196|2305490|P2|Overall Study|Subject became unblinded|1
715041|NCT00105196|2305491|P1|Overall Study|Subject became unblinded|0
715042|NCT00105196|2305490|P2|Overall Study|marijuana use|1
715043|NCT00105196|2305491|P1|Overall Study|marijuana use|0
715044|NCT00105196|2305490|P2|Overall Study|pending surgery|1
715045|NCT00105196|2305491|P1|Overall Study|pending surgery|0
715046|NCT00105196|2305490|P2|Overall Study|Protocol Violation|2
715047|NCT00105196|2305491|P1|Overall Study|Protocol Violation|5
715048|NCT00105196|2305490|P2|Overall Study|Poor/noncompliance|4
715049|NCT00105196|2305491|P1|Overall Study|Poor/noncompliance|3
715050|NCT00105196|2305490|P2|Overall Study|Lost to Follow-up|2
715051|NCT00105196|2305491|P1|Overall Study|Lost to Follow-up|3
715052|NCT00105196|2305490|P2|Overall Study|Withdrawal by Subject|6
715053|NCT00105196|2305491|P1|Overall Study|Withdrawal by Subject|6
715054|NCT00105196|2305490|P2|Overall Study|Adverse Event|3
715055|NCT00105196|2305491|P1|Overall Study|Adverse Event|11
715056|NCT00105196|2305490|P2|Overall Study|Lack of Efficacy|3
715057|NCT00105196|2305491|P1|Overall Study|Lack of Efficacy|2
715058|NCT00105235|2305511|P1|Overall Study|Withdrawal by Subject|2
715059|NCT00105235|2305511|P1|Overall Study|Physician Decision|1
715060|NCT00105235|2305511|P1|Overall Study|Death|4
715061|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
715062|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
715063|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
715064|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
715065|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
715066|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
715067|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
715068|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
715069|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
715070|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
715071|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
715072|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
715073|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
715074|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
715075|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
715076|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
715077|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
715078|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
715079|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
715080|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
715081|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
715082|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
715083|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
715084|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
715085|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
715086|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
715087|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
715088|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
715089|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
715090|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
715091|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
715092|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
715093|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
715094|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
715095|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
715096|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
715097|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
715098|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
715099|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
715100|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
715101|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
715102|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
715103|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
715104|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
715105|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
715106|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
715107|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
715108|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
715109|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
715110|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
715111|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
715112|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
715113|NCT00105443|2305524|P4|Follow-up and/or Open Label Nexavar|Death|4
715114|NCT00105443|2305525|P3|Follow-up and/or Open Label Nexavar|Death|219
715115|NCT00105443|2305526|P2|Follow-up and/or Open Label Nexavar|Death|7
715116|NCT00105443|2305527|P1|Follow-up and/or Open Label Nexavar|Death|180
715117|NCT00105443|2305524|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
715118|NCT00105443|2305525|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
715119|NCT00105443|2305526|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
715120|NCT00105443|2305527|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
715121|NCT00105443|2305524|P4|Double-Blind Treatment|Physician Decision|0
715122|NCT00105443|2305525|P3|Double-Blind Treatment|Physician Decision|2
715123|NCT00105443|2305526|P2|Double-Blind Treatment|Physician Decision|0
715124|NCT00105443|2305527|P1|Double-Blind Treatment|Physician Decision|1
715125|NCT00105443|2305524|P4|Double-Blind Treatment|Withdrawal by Subject|0
715126|NCT00105443|2305525|P3|Double-Blind Treatment|Withdrawal by Subject|7
715127|NCT00105443|2305526|P2|Double-Blind Treatment|Withdrawal by Subject|0
715128|NCT00105443|2305527|P1|Double-Blind Treatment|Withdrawal by Subject|8
715129|NCT00105443|2305524|P4|Double-Blind Treatment|Lost to Follow-up|0
715130|NCT00105443|2305525|P3|Double-Blind Treatment|Lost to Follow-up|1
715131|NCT00105443|2305526|P2|Double-Blind Treatment|Lost to Follow-up|0
715132|NCT00105443|2305527|P1|Double-Blind Treatment|Lost to Follow-up|0
715133|NCT00105443|2305524|P4|Double-Blind Treatment|Adverse Event|0
715134|NCT00105443|2305525|P3|Double-Blind Treatment|Adverse Event|0
715135|NCT00105443|2305526|P2|Double-Blind Treatment|Adverse Event|0
715136|NCT00105443|2305527|P1|Double-Blind Treatment|Adverse Event|1
715137|NCT00105469|2305556|P2|Overall Study|Other Reason|0
715138|NCT00105469|2305557|P1|Overall Study|Other Reason|4
715139|NCT00105469|2305556|P2|Overall Study|Lack of Efficacy|0
715140|NCT00105469|2305557|P1|Overall Study|Lack of Efficacy|2
715141|NCT00105469|2305556|P2|Overall Study|Lost to Follow-up|0
715142|NCT00105469|2305557|P1|Overall Study|Lost to Follow-up|1
715143|NCT00105469|2305556|P2|Overall Study|Withdrawal by Subject|3
715144|NCT00105469|2305557|P1|Overall Study|Withdrawal by Subject|2
715145|NCT00105469|2305556|P2|Overall Study|Protocol Violation|0
715146|NCT00105469|2305557|P1|Overall Study|Protocol Violation|4
715147|NCT00105469|2305556|P2|Overall Study|Adverse Event|8
715148|NCT00105469|2305557|P1|Overall Study|Adverse Event|9
715149|NCT00105482|2305567|P2|Overall Study|Withdrawn by PI|1
715150|NCT00105482|2305568|P1|Overall Study|Withdrawn by PI|1
715151|NCT00105482|2305567|P2|Overall Study|Scheduling Conflict|3
715152|NCT00105482|2305568|P1|Overall Study|Scheduling Conflict|2
715153|NCT00105482|2305567|P2|Overall Study|Lost Interest|32
715154|NCT00105482|2305568|P1|Overall Study|Lost Interest|29
715155|NCT00105482|2305567|P2|Overall Study|Withdrawal by Subject|1
715156|NCT00105482|2305568|P1|Overall Study|Withdrawal by Subject|0
715157|NCT00105482|2305567|P2|Overall Study|Lost to Follow-up|17
715158|NCT00105482|2305568|P1|Overall Study|Lost to Follow-up|26
715159|NCT00105482|2305567|P2|Overall Study|Adverse Event|1
715160|NCT00105482|2305568|P1|Overall Study|Adverse Event|1
715161|NCT00113490|2305602|P2|Overall Study|Lost to Follow-up|0
715162|NCT00113490|2305603|P1|Overall Study|Lost to Follow-up|1
715163|NCT00113490|2305602|P2|Overall Study|Withdrawal by Subject|3
715164|NCT00113490|2305603|P1|Overall Study|Withdrawal by Subject|1
715165|NCT00113516|2305616|P2|Part 2|Ongoing|1
715166|NCT00113516|2305617|P1|Part 2|Ongoing|0
715167|NCT00113516|2305616|P2|Part 2|Laboratory Abnormality|1
715168|NCT00113516|2305617|P1|Part 2|Laboratory Abnormality|0
715169|NCT00113516|2305616|P2|Part 2|Unspecified|3
715170|NCT00113516|2305617|P1|Part 2|Unspecified|0
715171|NCT00113516|2305616|P2|Part 2|Withdrawal by Subject|3
715172|NCT00113516|2305617|P1|Part 2|Withdrawal by Subject|0
715173|NCT00113516|2305616|P2|Part 2|Lack of Efficacy|37
715174|NCT00113516|2305617|P1|Part 2|Lack of Efficacy|0
715175|NCT00113516|2305616|P2|Part 2|Death|5
715176|NCT00113516|2305617|P1|Part 2|Death|0
715177|NCT00113516|2305616|P2|Part 2|Adverse Event|16
715178|NCT00113516|2305617|P1|Part 2|Adverse Event|0
715179|NCT00113516|2305616|P2|Part 1|Missing|0
715180|NCT00113516|2305617|P1|Part 1|Missing|65
715181|NCT00113516|2305616|P2|Part 1|Ongoing|0
715182|NCT00113516|2305617|P1|Part 1|Ongoing|1
715183|NCT00113516|2305616|P2|Part 1|Laboratory Abnormality|0
715184|NCT00113516|2305617|P1|Part 1|Laboratory Abnormality|1
715185|NCT00113516|2305616|P2|Part 1|Did Not Meet Entrance Criteria|0
715186|NCT00113516|2305617|P1|Part 1|Did Not Meet Entrance Criteria|1
715187|NCT00113516|2305616|P2|Part 1|Lack of Efficacy|0
715188|NCT00113516|2305617|P1|Part 1|Lack of Efficacy|2
715189|NCT00113516|2305616|P2|Part 1|Withdrawal by Subject|0
715190|NCT00113516|2305617|P1|Part 1|Withdrawal by Subject|2
715191|NCT00113516|2305616|P2|Part 1|Unspecified|0
715192|NCT00113516|2305617|P1|Part 1|Unspecified|3
715193|NCT00113516|2305616|P2|Part 1|Death|0
715194|NCT00113516|2305617|P1|Part 1|Death|3
715195|NCT00113516|2305616|P2|Part 1|Adverse Event|0
715196|NCT00113516|2305617|P1|Part 1|Adverse Event|6
715197|NCT00113529|2305658|P1|Overall Study|Withdrawal by Subject|4
715198|NCT00113529|2305658|P1|Overall Study|Decision of sponsor|6
715199|NCT00113529|2305658|P1|Overall Study|Lack of Efficacy|20
715200|NCT00113529|2305658|P1|Overall Study|Adverse Event|4
715201|NCT00113568|2305691|P1|Overall Study|Other|112
715202|NCT00113568|2305691|P1|Overall Study|Withdrawal by Subject|117
715203|NCT00113568|2305691|P1|Overall Study|Protocol Violation|32
715204|NCT00113568|2305691|P1|Overall Study|Lost to Follow-up|156
715205|NCT00113568|2305691|P1|Overall Study|Lack of Efficacy|30
715206|NCT00113568|2305691|P1|Overall Study|Death|1
715207|NCT00113568|2305691|P1|Overall Study|Adverse Event|97
715208|NCT00113607|2305705|P2|Overall Study|Unspecified|32
715209|NCT00113607|2305706|P1|Overall Study|Unspecified|43
715210|NCT00113607|2305705|P2|Overall Study|Complete Response (Confirmed)|24
715211|NCT00113607|2305706|P1|Overall Study|Complete Response (Confirmed)|14
715212|NCT00113607|2305705|P2|Overall Study|Disease Progression|142
715213|NCT00113607|2305706|P1|Overall Study|Disease Progression|180
715214|NCT00113607|2305705|P2|Overall Study|Lost to Follow-up|2
715215|NCT00113607|2305706|P1|Overall Study|Lost to Follow-up|0
715216|NCT00113607|2305705|P2|Overall Study|Withdrawal by Subject|58
715217|NCT00113607|2305706|P1|Overall Study|Withdrawal by Subject|50
715218|NCT00113607|2305705|P2|Overall Study|Death|8
715219|NCT00113607|2305706|P1|Overall Study|Death|8
715220|NCT00113607|2305705|P2|Overall Study|Adverse Event|71
715221|NCT00113607|2305706|P1|Overall Study|Adverse Event|40
715222|NCT00114127|2305737|P2|Overall Study|Withdrawal by Subject|3
715223|NCT00114127|2305738|P1|Overall Study|Withdrawal by Subject|1
715224|NCT00114127|2305737|P2|Overall Study|Lost to Follow-up|0
715225|NCT00114127|2305738|P1|Overall Study|Lost to Follow-up|1
715226|NCT00114127|2305737|P2|Overall Study|Adverse Event|1
715227|NCT00114127|2305738|P1|Overall Study|Adverse Event|2
715228|NCT00114166|2305746|P1|Overall Study|Wrong primary|1
715229|NCT00114244|2305754|P2|Overall Study|Withdrawal by Subject|2
715230|NCT00114244|2305755|P1|Overall Study|Withdrawal by Subject|0
715231|NCT00114244|2305754|P2|Overall Study|Adverse Event|5
715232|NCT00114244|2305755|P1|Overall Study|Adverse Event|2
715233|NCT00114530|2305797|P2|Overall Study|Ineligible|0
715234|NCT00114530|2305798|P1|Overall Study|Ineligible|1
715235|NCT00114530|2305797|P2|Overall Study|Subject decision after endpoint failure|1
715236|NCT00114530|2305798|P1|Overall Study|Subject decision after endpoint failure|0
715237|NCT00114530|2305797|P2|Overall Study|Breast Cancer|0
715238|NCT00114530|2305798|P1|Overall Study|Breast Cancer|1
715239|NCT00114530|2305797|P2|Overall Study|Withdrawal by Subject|6
715240|NCT00114530|2305798|P1|Overall Study|Withdrawal by Subject|2
715241|NCT00114530|2305797|P2|Overall Study|Physician Decision|1
715242|NCT00114530|2305798|P1|Overall Study|Physician Decision|1
715243|NCT00114530|2305797|P2|Overall Study|Lost to Follow-up|1
715244|NCT00114530|2305798|P1|Overall Study|Lost to Follow-up|1
715245|NCT00114530|2305797|P2|Overall Study|Death|11
715246|NCT00114530|2305798|P1|Overall Study|Death|3
715247|NCT00114634|2305903|P1|Overall Study|failure to return forms|3
889969|NCT01120184|2825157|P1|Overall Study|Sponsor Decision to Terminate Study|133
889970|NCT01120184|2825155|P3|Overall Study|Reason not Specified|12
889971|NCT01120184|2825156|P2|Overall Study|Reason not Specified|3
889972|NCT01120184|2825157|P1|Overall Study|Reason not Specified|8
889973|NCT01120184|2825155|P3|Overall Study|Physician Decision|3
889974|NCT01120184|2825156|P2|Overall Study|Physician Decision|1
889975|NCT01120184|2825157|P1|Overall Study|Physician Decision|9
889976|NCT01120184|2825155|P3|Overall Study|Lost to Follow-up|11
889977|NCT01120184|2825156|P2|Overall Study|Lost to Follow-up|13
889978|NCT01120184|2825157|P1|Overall Study|Lost to Follow-up|13
889979|NCT01120184|2825155|P3|Overall Study|Adverse Event|0
889980|NCT01120184|2825156|P2|Overall Study|Adverse Event|1
889981|NCT01120184|2825157|P1|Overall Study|Adverse Event|0
889982|NCT01111825|2825294|P4|Overall Study|Discontinuation by Sponsor|20
889983|NCT01111825|2825295|P3|Overall Study|Discontinuation by Sponsor|0
889984|NCT01111825|2825296|P2|Overall Study|Discontinuation by Sponsor|0
889985|NCT01111825|2825297|P1|Overall Study|Discontinuation by Sponsor|0
889986|NCT01111825|2825294|P4|Overall Study|Disease Progression|0
889987|NCT01111825|2825295|P3|Overall Study|Disease Progression|0
889988|NCT01111825|2825296|P2|Overall Study|Disease Progression|0
889989|NCT01111825|2825297|P1|Overall Study|Disease Progression|1
889990|NCT01111825|2825294|P4|Overall Study|Adverse Event|0
889991|NCT01111825|2825295|P3|Overall Study|Adverse Event|4
889992|NCT01111825|2825296|P2|Overall Study|Adverse Event|1
889993|NCT01111825|2825297|P1|Overall Study|Adverse Event|2
889994|NCT01111825|2825294|P4|Overall Study|Lost to Follow-up|1
889995|NCT01111825|2825295|P3|Overall Study|Lost to Follow-up|3
889996|NCT01111825|2825296|P2|Overall Study|Lost to Follow-up|0
889997|NCT01111825|2825297|P1|Overall Study|Lost to Follow-up|0
889998|NCT01111825|2825294|P4|Overall Study|Withdrawal by Subject|0
889999|NCT01111825|2825295|P3|Overall Study|Withdrawal by Subject|1
890000|NCT01111825|2825296|P2|Overall Study|Withdrawal by Subject|0
890001|NCT01111825|2825297|P1|Overall Study|Withdrawal by Subject|0
890002|NCT01110200|2825318|P2|Overall Study|Lost to Follow-up|7
890003|NCT01110200|2825319|P1|Overall Study|Lost to Follow-up|10
890004|NCT01110200|2825318|P2|Overall Study|Physician Decision|17
890005|NCT01110200|2825319|P1|Overall Study|Physician Decision|13
890006|NCT01110200|2825318|P2|Overall Study|Protocol Violation|12
890007|NCT01110200|2825319|P1|Overall Study|Protocol Violation|14
890008|NCT01110200|2825318|P2|Overall Study|Lack of Efficacy|25
890009|NCT01110200|2825319|P1|Overall Study|Lack of Efficacy|16
890010|NCT01110200|2825318|P2|Overall Study|Withdrawal by Subject|32
890011|NCT01110200|2825319|P1|Overall Study|Withdrawal by Subject|25
890012|NCT01110200|2825318|P2|Overall Study|Adverse Event|28
890013|NCT01110200|2825319|P1|Overall Study|Adverse Event|28
715296|NCT00114959|2305996|P1|Overall Study|Death|1
715297|NCT00114959|2305996|P1|Overall Study|Physician Decision|1
715298|NCT00114959|2305996|P1|Overall Study|Lack of Efficacy|6
715299|NCT00114972|2306005|P2|Overall Study|Lost to Follow-up|5
715300|NCT00114972|2306006|P1|Overall Study|Lost to Follow-up|8
715301|NCT00114972|2306005|P2|Overall Study|Withdrawal by Subject|7
715302|NCT00114972|2306006|P1|Overall Study|Withdrawal by Subject|40
715303|NCT00115063|2306028|P2|Overall Study|Death|0
715304|NCT00115063|2306029|P1|Overall Study|Death|1
715305|NCT00115063|2306028|P2|Overall Study|Lost to Follow-up|104
715306|NCT00115063|2306029|P1|Overall Study|Lost to Follow-up|98
715307|NCT00115349|2306060|P2|Overall Study|Study closed due to low enrollment.|9
715308|NCT00115349|2306061|P1|Overall Study|Study closed due to low enrollment.|11
715309|NCT00115739|2306067|P1|Overall Study|Lost to Follow-up|3
715310|NCT00115765|2306078|P4|Overall Study|Not specified|2
715311|NCT00115765|2306079|P3|Overall Study|Not specified|9
715312|NCT00115765|2306080|P2|Overall Study|Not specified|12
715313|NCT00115765|2306081|P1|Overall Study|Not specified|6
715314|NCT00115765|2306078|P4|Overall Study|Lost to Follow-up|1
715315|NCT00115765|2306079|P3|Overall Study|Lost to Follow-up|18
715316|NCT00115765|2306080|P2|Overall Study|Lost to Follow-up|20
715317|NCT00115765|2306081|P1|Overall Study|Lost to Follow-up|3
715318|NCT00115765|2306078|P4|Overall Study|Physician Decision|13
715319|NCT00115765|2306079|P3|Overall Study|Physician Decision|18
715320|NCT00115765|2306080|P2|Overall Study|Physician Decision|15
715321|NCT00115765|2306081|P1|Overall Study|Physician Decision|4
715322|NCT00115765|2306078|P4|Overall Study|Withdrawal by Subject|15
715323|NCT00115765|2306079|P3|Overall Study|Withdrawal by Subject|76
715324|NCT00115765|2306080|P2|Overall Study|Withdrawal by Subject|53
715325|NCT00115765|2306081|P1|Overall Study|Withdrawal by Subject|22
715326|NCT00115804|2306119|P1|Overall Study|Adverse Event|2
715327|NCT00115934|2306143|P2|Overall Study|Did not receive intervention|2
715328|NCT00115934|2306144|P1|Overall Study|Did not receive intervention|3
715329|NCT00115934|2306143|P2|Overall Study|Lost to Follow-up|0
715330|NCT00115934|2306144|P1|Overall Study|Lost to Follow-up|1
715331|NCT00116168|2306186|P4|Overall Study|Lost to Follow-up|0
715332|NCT00116168|2306187|P3|Overall Study|Lost to Follow-up|0
715333|NCT00116168|2306188|P2|Overall Study|Lost to Follow-up|5
715334|NCT00116168|2306189|P1|Overall Study|Lost to Follow-up|6
715335|NCT00116272|2306268|P2|Overall Study|Lost to Follow-up|6
715336|NCT00116272|2306269|P1|Overall Study|Lost to Follow-up|11
715341|NCT00108485|2306340|P2|Overall Study|Lost to Follow-up|2
715342|NCT00108485|2306341|P1|Overall Study|Lost to Follow-up|0
715343|NCT00108485|2306340|P2|Overall Study|Withdrawal by Subject|0
715344|NCT00108485|2306341|P1|Overall Study|Withdrawal by Subject|3
715345|NCT00108628|2306373|P2|Overall Study|Death|0
715346|NCT00108628|2306374|P1|Overall Study|Death|1
715347|NCT00108628|2306373|P2|Overall Study|Lack of Efficacy|1
715348|NCT00108628|2306374|P1|Overall Study|Lack of Efficacy|2
715349|NCT00108628|2306373|P2|Overall Study|Withdrawal by Subject|9
715350|NCT00108628|2306374|P1|Overall Study|Withdrawal by Subject|17
715351|NCT00108732|2306398|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
715352|NCT00108732|2306398|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
715353|NCT00108732|2306398|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
715354|NCT00108732|2306398|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
715355|NCT00108732|2306398|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
715356|NCT00108732|2306398|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
715357|NCT00108732|2306398|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
715358|NCT00108862|2306407|P2|Overall Study|Lost to Follow-up|19
715359|NCT00108862|2306408|P1|Overall Study|Lost to Follow-up|27
715360|NCT00108862|2306407|P2|Overall Study|Withdrawal by Subject|6
715361|NCT00108862|2306408|P1|Overall Study|Withdrawal by Subject|10
715362|NCT00108862|2306407|P2|Overall Study|Death|37
715363|NCT00108862|2306408|P1|Overall Study|Death|31
715364|NCT00108953|2306438|P2|Follow-up|Study terminated by sponsor|6
715365|NCT00108953|2306439|P1|Follow-up|Study terminated by sponsor|10
715366|NCT00108953|2306438|P2|Follow-up|Lost to Follow-up|1
715367|NCT00108953|2306439|P1|Follow-up|Lost to Follow-up|1
715368|NCT00108953|2306438|P2|Follow-up|Death|26
715369|NCT00108953|2306439|P1|Follow-up|Death|18
715370|NCT00109031|2306478|P4|Overall Study|Protocol Violation|0
715371|NCT00109031|2306479|P3|Overall Study|Protocol Violation|1
715372|NCT00109031|2306480|P2|Overall Study|Protocol Violation|0
715373|NCT00109031|2306481|P1|Overall Study|Protocol Violation|0
715374|NCT00109031|2306478|P4|Overall Study|Physician Decision|0
715375|NCT00109031|2306479|P3|Overall Study|Physician Decision|0
715376|NCT00109031|2306480|P2|Overall Study|Physician Decision|1
715377|NCT00109031|2306481|P1|Overall Study|Physician Decision|0
715378|NCT00109031|2306478|P4|Overall Study|Withdrawal by Subject|0
715379|NCT00109031|2306479|P3|Overall Study|Withdrawal by Subject|0
715380|NCT00109031|2306480|P2|Overall Study|Withdrawal by Subject|1
715381|NCT00109031|2306481|P1|Overall Study|Withdrawal by Subject|0
715382|NCT00109031|2306478|P4|Overall Study|Adverse Event|0
715383|NCT00109031|2306479|P3|Overall Study|Adverse Event|1
715384|NCT00109031|2306480|P2|Overall Study|Adverse Event|0
715385|NCT00109031|2306481|P1|Overall Study|Adverse Event|0
715386|NCT00109343|2306518|P3|Overall Study|Unspecified|1
715387|NCT00109343|2306519|P2|Overall Study|Unspecified|2
715388|NCT00109343|2306520|P1|Overall Study|Unspecified|5
715389|NCT00109343|2306518|P3|Overall Study|Subject Moved|1
715390|NCT00109343|2306519|P2|Overall Study|Subject Moved|2
715391|NCT00109343|2306520|P1|Overall Study|Subject Moved|6
715392|NCT00109343|2306518|P3|Overall Study|Withdrawal by Subject|10
715393|NCT00109343|2306519|P2|Overall Study|Withdrawal by Subject|11
715394|NCT00109343|2306520|P1|Overall Study|Withdrawal by Subject|15
715395|NCT00109343|2306518|P3|Overall Study|Protocol Violation|2
715396|NCT00109343|2306519|P2|Overall Study|Protocol Violation|2
715397|NCT00109343|2306520|P1|Overall Study|Protocol Violation|1
715398|NCT00109343|2306518|P3|Overall Study|Lost to Follow-up|14
715399|NCT00109343|2306519|P2|Overall Study|Lost to Follow-up|20
715400|NCT00109343|2306520|P1|Overall Study|Lost to Follow-up|35
715401|NCT00109343|2306518|P3|Overall Study|Lack of Efficacy|0
715402|NCT00109343|2306519|P2|Overall Study|Lack of Efficacy|0
715403|NCT00109343|2306520|P1|Overall Study|Lack of Efficacy|1
715404|NCT00109343|2306518|P3|Overall Study|Adverse Event|2
715405|NCT00109343|2306519|P2|Overall Study|Adverse Event|0
715406|NCT00109343|2306520|P1|Overall Study|Adverse Event|1
715407|NCT00109577|2306585|P2|Overall Study|Withdrawal by Subject|3
715408|NCT00109577|2306586|P1|Overall Study|Withdrawal by Subject|3
715409|NCT00109590|2306595|P3|Overall Study|Never Started Treatment|3
715410|NCT00109590|2306596|P2|Overall Study|Never Started Treatment|2
715411|NCT00109590|2306597|P1|Overall Study|Never Started Treatment|1
715412|NCT00109590|2306595|P3|Overall Study|Lost to Follow-up|1
715413|NCT00109590|2306596|P2|Overall Study|Lost to Follow-up|0
715414|NCT00109590|2306597|P1|Overall Study|Lost to Follow-up|1
715415|NCT00109733|2306639|P2|Overall Study|Could not commit time for study|1
715416|NCT00109733|2306640|P1|Overall Study|Could not commit time for study|1
715417|NCT00109733|2306639|P2|Overall Study|Non-compliant|1
715418|NCT00109733|2306640|P1|Overall Study|Non-compliant|0
715419|NCT00109733|2306639|P2|Overall Study|Stopped taking study drug|1
715420|NCT00109733|2306640|P1|Overall Study|Stopped taking study drug|1
715421|NCT00109733|2306639|P2|Overall Study|Protocol Violation|1
715422|NCT00109733|2306640|P1|Overall Study|Protocol Violation|0
715423|NCT00109772|2306656|P2|Open-label Extension|not specified|10
715424|NCT00109772|2306657|P1|Open-label Extension|not specified|4
715425|NCT00109772|2306656|P2|Open-label Extension|Protocol Violation|2
715426|NCT00109772|2306657|P1|Open-label Extension|Protocol Violation|2
715427|NCT00109772|2306656|P2|Open-label Extension|Death|1
715428|NCT00109772|2306657|P1|Open-label Extension|Death|0
715429|NCT00109772|2306656|P2|Open-label Extension|Lost to Follow-up|0
715430|NCT00109772|2306657|P1|Open-label Extension|Lost to Follow-up|1
715431|NCT00109772|2306656|P2|Open-label Extension|Withdrawal by Subject|6
715432|NCT00109772|2306657|P1|Open-label Extension|Withdrawal by Subject|9
715433|NCT00109772|2306656|P2|Open-label Extension|Lack of Efficacy|11
715434|NCT00109772|2306657|P1|Open-label Extension|Lack of Efficacy|19
715435|NCT00109772|2306656|P2|Open-label Extension|Adverse Event|19
715436|NCT00109772|2306657|P1|Open-label Extension|Adverse Event|10
715437|NCT00109772|2306656|P2|Double-blind Treatment|Withdrew prior to treatment|1
715438|NCT00109772|2306657|P1|Double-blind Treatment|Withdrew prior to treatment|3
715439|NCT00109772|2306656|P2|Double-blind Treatment|not specified|4
715440|NCT00109772|2306657|P1|Double-blind Treatment|not specified|0
715441|NCT00109772|2306656|P2|Double-blind Treatment|Protocol Violation|1
715442|NCT00109772|2306657|P1|Double-blind Treatment|Protocol Violation|0
715443|NCT00109772|2306656|P2|Double-blind Treatment|Lost to Follow-up|3
715444|NCT00109772|2306657|P1|Double-blind Treatment|Lost to Follow-up|2
715445|NCT00109772|2306656|P2|Double-blind Treatment|Withdrawal by Subject|1
715446|NCT00109772|2306657|P1|Double-blind Treatment|Withdrawal by Subject|2
715447|NCT00109772|2306656|P2|Double-blind Treatment|Lack of Efficacy|0
715448|NCT00109772|2306657|P1|Double-blind Treatment|Lack of Efficacy|1
715449|NCT00109772|2306656|P2|Double-blind Treatment|Adverse Event|5
715450|NCT00109772|2306657|P1|Double-blind Treatment|Adverse Event|14
715451|NCT00109837|2306695|P1|Overall Study|Ineligible|1
715452|NCT00109837|2306695|P1|Overall Study|Not treated|1
715453|NCT00109837|2306695|P1|Overall Study|BCR/ABL+ or Ph+|17
715454|NCT00109837|2306695|P1|Overall Study|Death|1
715455|NCT00109837|2306695|P1|Overall Study|Refusal unrelated to adverse effects|1
715456|NCT00109837|2306695|P1|Overall Study|Adverse Event|2
715457|NCT00109850|2306703|P1|Overall Study|Ineligible|1
715458|NCT00109850|2306703|P1|Overall Study|Death|2
715459|NCT00109850|2306703|P1|Overall Study|Adverse Event|1
715460|NCT00109928|2306720|P1|Overall Study|not eligible|1
715461|NCT00109928|2306720|P1|Overall Study|not protocol specified|2
715462|NCT00109928|2306720|P1|Overall Study|Death|2
715463|NCT00109928|2306720|P1|Overall Study|Progression|6
715464|NCT00109928|2306720|P1|Overall Study|Adverse Event|2
715465|NCT00109967|2306729|P2|Overall Study|Death|2
715466|NCT00109967|2306730|P1|Overall Study|Death|0
715467|NCT00109967|2306729|P2|Overall Study|Physician Decision|3
715468|NCT00109967|2306730|P1|Overall Study|Physician Decision|1
715469|NCT00109967|2306729|P2|Overall Study|Withdrawal by Subject|0
715470|NCT00109967|2306730|P1|Overall Study|Withdrawal by Subject|5
715471|NCT00109967|2306729|P2|Overall Study|Adverse Event|1
715472|NCT00109967|2306730|P1|Overall Study|Adverse Event|12
715473|NCT00109967|2306729|P2|Overall Study|Cancel Prior to Treatment|0
715474|NCT00109967|2306730|P1|Overall Study|Cancel Prior to Treatment|2
715475|NCT00110019|2306746|P2|Overall Study|other reasons|30
715476|NCT00110019|2306747|P1|Overall Study|other reasons|22
715477|NCT00110019|2306746|P2|Overall Study|Not start protocol therapy|16
715478|NCT00110019|2306747|P1|Overall Study|Not start protocol therapy|17
715479|NCT00110019|2306746|P2|Overall Study|symptom deterioration|16
715480|NCT00110019|2306747|P1|Overall Study|symptom deterioration|13
715481|NCT00110019|2306746|P2|Overall Study|complicating disease|1
715482|NCT00110019|2306747|P1|Overall Study|complicating disease|1
715483|NCT00110019|2306746|P2|Overall Study|alternative therapy|1
715484|NCT00110019|2306747|P1|Overall Study|alternative therapy|5
715485|NCT00110019|2306746|P2|Overall Study|Withdrawal by Subject|9
715486|NCT00110019|2306747|P1|Overall Study|Withdrawal by Subject|21
715487|NCT00110019|2306746|P2|Overall Study|Death|15
715488|NCT00110019|2306747|P1|Overall Study|Death|13
715489|NCT00110019|2306746|P2|Overall Study|Adverse Event|40
715490|NCT00110019|2306747|P1|Overall Study|Adverse Event|61
715491|NCT00110019|2306746|P2|Overall Study|Lack of Efficacy|285
715492|NCT00110019|2306747|P1|Overall Study|Lack of Efficacy|253
715493|NCT00110084|2306757|P1|Overall Study|Other|2
715494|NCT00110084|2306757|P1|Overall Study|Intercurrent Illness|1
715495|NCT00110084|2306757|P1|Overall Study|Alternate Therapy|5
715496|NCT00110084|2306757|P1|Overall Study|Patient Refusal|10
715497|NCT00110084|2306757|P1|Overall Study|Death|1
715498|NCT00110084|2306757|P1|Overall Study|Adverse Event|9
715499|NCT00110214|2306775|P2|Overall Study|Other (not specified)|75
715500|NCT00110214|2306776|P1|Overall Study|Other (not specified)|61
715501|NCT00110214|2306775|P2|Overall Study|Refused further treatment|65
715502|NCT00110214|2306776|P1|Overall Study|Refused further treatment|52
715503|NCT00110214|2306775|P2|Overall Study|Adverse Event|192
715504|NCT00110214|2306776|P1|Overall Study|Adverse Event|115
715505|NCT00110214|2306775|P2|Overall Study|Disease progression or death|151
715506|NCT00110214|2306776|P1|Overall Study|Disease progression or death|260
715507|NCT00110214|2306775|P2|Overall Study|Never started treatment|20
715508|NCT00110214|2306776|P1|Overall Study|Never started treatment|21
715509|NCT00110305|2306792|P2|Overall Study|Unspecified|2
715510|NCT00110305|2306793|P1|Overall Study|Unspecified|8
715511|NCT00110305|2306792|P2|Overall Study|Lost to Follow-up|3
715512|NCT00110305|2306793|P1|Overall Study|Lost to Follow-up|20
715513|NCT00110305|2306792|P2|Overall Study|Withdrawal by Subject|7
715514|NCT00110305|2306793|P1|Overall Study|Withdrawal by Subject|7
715515|NCT00110305|2306792|P2|Overall Study|Protocol Violation|1
715516|NCT00110305|2306793|P1|Overall Study|Protocol Violation|0
715517|NCT00110305|2306792|P2|Overall Study|Subject Reached A Virologic Endpoint|3
715518|NCT00110305|2306793|P1|Overall Study|Subject Reached A Virologic Endpoint|21
715519|NCT00110305|2306792|P2|Overall Study|Subject Ineligible To Continue The Trial|1
715520|NCT00110305|2306793|P1|Overall Study|Subject Ineligible To Continue The Trial|2
715521|NCT00110305|2306792|P2|Overall Study|Subject Non-Compliant|2
715522|NCT00110305|2306793|P1|Overall Study|Subject Non-Compliant|9
715523|NCT00110305|2306792|P2|Overall Study|Sponsors Decision|0
715524|NCT00110305|2306793|P1|Overall Study|Sponsors Decision|1
715525|NCT00110305|2306792|P2|Overall Study|Adverse Event|13
715526|NCT00110305|2306793|P1|Overall Study|Adverse Event|46
715527|NCT00110357|2306846|P2|Overall Study|Withdrawal by Subject|1
715528|NCT00110357|2306847|P1|Overall Study|Withdrawal by Subject|3
715529|NCT00110357|2306846|P2|Overall Study|Study Drug Toxicity|3
715530|NCT00110357|2306847|P1|Overall Study|Study Drug Toxicity|1
715531|NCT00110357|2306846|P2|Overall Study|Study Closure|0
715532|NCT00110357|2306847|P1|Overall Study|Study Closure|1
715533|NCT00110357|2306846|P2|Overall Study|Disease progression/relapse|15
715534|NCT00110357|2306847|P1|Overall Study|Disease progression/relapse|20
715535|NCT00110357|2306846|P2|Overall Study|Deterioration without progression|0
715536|NCT00110357|2306847|P1|Overall Study|Deterioration without progression|2
715537|NCT00110396|2306931|P1|Overall Study|Patient is to be administered copaxone|1
715538|NCT00110396|2306931|P1|Overall Study|The patient has refused to visit site|1
715539|NCT00110396|2306931|P1|Overall Study|The patient has refused|2
715540|NCT00110396|2306931|P1|Overall Study|Patient refused to come back|1
715541|NCT00110396|2306931|P1|Overall Study|Protocol Violation|2
715542|NCT00110396|2306931|P1|Overall Study|Pregnancy (Protocol violation)|2
715543|NCT00110396|2306931|P1|Overall Study|Pregnancy|1
715544|NCT00110396|2306931|P1|Overall Study|Participation in MS vaccine study|1
715545|NCT00110396|2306931|P1|Overall Study|Patient's decision|1
715546|NCT00110396|2306931|P1|Overall Study|Patient will|1
715547|NCT00110396|2306931|P1|Overall Study|Patient refused to participate|1
715548|NCT00110396|2306931|P1|Overall Study|Patient refused to continue|1
715549|NCT00110396|2306931|P1|Overall Study|Patient non-compliance|1
715550|NCT00110396|2306931|P1|Overall Study|Decided not to continue treatment|1
715551|NCT00110396|2306931|P1|Overall Study|Lack of Efficacy|1
715552|NCT00110396|2306931|P1|Overall Study|Initiated mitoxantrone therapy|1
715553|NCT00110396|2306931|P1|Overall Study|Administration of plasmapheresis|1
715554|NCT00110396|2306931|P1|Overall Study|Lost to Follow-up|1
715555|NCT00110396|2306931|P1|Overall Study|Adverse Event|15
715556|NCT00110617|2307043|P2|Overall Study|Did not receive study drug|12
715557|NCT00110617|2307044|P1|Overall Study|Did not receive study drug|0
715558|NCT00110617|2307043|P2|Overall Study|Death|1
715559|NCT00110617|2307044|P1|Overall Study|Death|1
715560|NCT00110617|2307043|P2|Overall Study|Administrative problems|5
715561|NCT00110617|2307044|P1|Overall Study|Administrative problems|6
715562|NCT00110617|2307043|P2|Overall Study|Lost to Follow-up|1
715563|NCT00110617|2307044|P1|Overall Study|Lost to Follow-up|9
715564|NCT00110617|2307043|P2|Overall Study|Withdrawal by Subject|4
715565|NCT00110617|2307044|P1|Overall Study|Withdrawal by Subject|10
715566|NCT00110617|2307043|P2|Overall Study|Protocol Violation|0
715567|NCT00110617|2307044|P1|Overall Study|Protocol Violation|5
715568|NCT00110617|2307043|P2|Overall Study|Patient no longer requires study drug|0
715569|NCT00110617|2307044|P1|Overall Study|Patient no longer requires study drug|1
715570|NCT00110617|2307043|P2|Overall Study|Lack of Efficacy|0
715571|NCT00110617|2307044|P1|Overall Study|Lack of Efficacy|1
715572|NCT00110617|2307043|P2|Overall Study|Abnormal Laboratory Value|2
715573|NCT00110617|2307044|P1|Overall Study|Abnormal Laboratory Value|4
715574|NCT00110617|2307043|P2|Overall Study|Adverse Event|4
715575|NCT00110617|2307044|P1|Overall Study|Adverse Event|2
715576|NCT00110812|2307060|P3|Extended Follow-up|Lost to Follow-up|1
715577|NCT00110812|2307061|P2|Extended Follow-up|Lost to Follow-up|3
715578|NCT00110812|2307062|P1|Extended Follow-up|Lost to Follow-up|1
715579|NCT00110812|2307060|P3|Extended Follow-up|Withdrawal by Subject|0
715580|NCT00110812|2307061|P2|Extended Follow-up|Withdrawal by Subject|1
715581|NCT00110812|2307062|P1|Extended Follow-up|Withdrawal by Subject|0
715582|NCT00110812|2307060|P3|Extended Follow-up|Death|3
715583|NCT00110812|2307061|P2|Extended Follow-up|Death|0
715584|NCT00110812|2307062|P1|Extended Follow-up|Death|1
715585|NCT00110812|2307060|P3|Main Study|Lost to Follow-up|10
715586|NCT00110812|2307061|P2|Main Study|Lost to Follow-up|11
715587|NCT00110812|2307062|P1|Main Study|Lost to Follow-up|8
715588|NCT00110812|2307060|P3|Main Study|Withdrawal by Subject|1
715589|NCT00110812|2307061|P2|Main Study|Withdrawal by Subject|0
715590|NCT00110812|2307062|P1|Main Study|Withdrawal by Subject|0
715591|NCT00110812|2307060|P3|Main Study|Death|2
715592|NCT00110812|2307061|P2|Main Study|Death|0
715593|NCT00110812|2307062|P1|Main Study|Death|0
715594|NCT00116649|2307105|P1|Overall Study|Protocol Specified|7
715595|NCT00116649|2307105|P1|Overall Study|Various Reasons|18
715596|NCT00116649|2307105|P1|Overall Study|Local Skin Reaction|9
715597|NCT00116649|2307105|P1|Overall Study|Withdrawal by Subject|68
715598|NCT00116649|2307105|P1|Overall Study|Lost to Follow-up|32
715599|NCT00116649|2307105|P1|Overall Study|Lack of Efficacy|1
715600|NCT00116649|2307105|P1|Overall Study|Adverse Event|20
715601|NCT00116688|2307112|P2|Overall Study|Other|0
715602|NCT00116688|2307113|P1|Overall Study|Other|11
715603|NCT00116688|2307112|P2|Overall Study|Pregnancy|0
715604|NCT00116688|2307113|P1|Overall Study|Pregnancy|1
715605|NCT00116688|2307112|P2|Overall Study|Protocol-specified criteria|0
715606|NCT00116688|2307113|P1|Overall Study|Protocol-specified criteria|3
715607|NCT00116688|2307112|P2|Overall Study|Death|0
715608|NCT00116688|2307113|P1|Overall Study|Death|15
715609|NCT00116688|2307112|P2|Overall Study|Lost to Follow-up|0
715610|NCT00116688|2307113|P1|Overall Study|Lost to Follow-up|3
715611|NCT00116688|2307112|P2|Overall Study|Physician Decision|0
715612|NCT00116688|2307113|P1|Overall Study|Physician Decision|7
715613|NCT00116688|2307112|P2|Overall Study|Requirement for alternative therapy|1
715614|NCT00116688|2307113|P1|Overall Study|Requirement for alternative therapy|11
715615|NCT00116688|2307112|P2|Overall Study|Withdrawal by Subject|2
715616|NCT00116688|2307113|P1|Overall Study|Withdrawal by Subject|26
715617|NCT00116688|2307112|P2|Overall Study|Adverse Event|0
715618|NCT00116688|2307113|P1|Overall Study|Adverse Event|11
715619|NCT00116688|2307112|P2|Overall Study|Noncompliance|1
715620|NCT00116688|2307113|P1|Overall Study|Noncompliance|3
715621|NCT00116688|2307112|P2|Overall Study|Protocol deviation|0
715622|NCT00116688|2307113|P1|Overall Study|Protocol deviation|1
715623|NCT00116753|2307131|P3|Overall Study|Dosing Error|0
715624|NCT00116753|2307132|P2|Overall Study|Dosing Error|1
715625|NCT00116753|2307133|P1|Overall Study|Dosing Error|0
715626|NCT00116753|2307131|P3|Overall Study|Progressive Parkinson's Disease|0
715627|NCT00116753|2307132|P2|Overall Study|Progressive Parkinson's Disease|0
715628|NCT00116753|2307133|P1|Overall Study|Progressive Parkinson's Disease|1
715629|NCT00116753|2307131|P3|Overall Study|Abnormal Echocardiogram|1
715630|NCT00116753|2307132|P2|Overall Study|Abnormal Echocardiogram|0
715631|NCT00116753|2307133|P1|Overall Study|Abnormal Echocardiogram|0
715632|NCT00116753|2307131|P3|Overall Study|Disease Progression|3
715633|NCT00116753|2307132|P2|Overall Study|Disease Progression|4
715634|NCT00116753|2307133|P1|Overall Study|Disease Progression|3
715635|NCT00116753|2307131|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
715636|NCT00116753|2307132|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
715637|NCT00116753|2307133|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
715638|NCT00116753|2307131|P3|Overall Study|Protocol Violation|1
715639|NCT00116753|2307132|P2|Overall Study|Protocol Violation|0
715640|NCT00116753|2307133|P1|Overall Study|Protocol Violation|0
715641|NCT00116753|2307131|P3|Overall Study|Lost to Follow-up|1
715642|NCT00116753|2307132|P2|Overall Study|Lost to Follow-up|2
715643|NCT00116753|2307133|P1|Overall Study|Lost to Follow-up|0
715644|NCT00116753|2307131|P3|Overall Study|Withdrawal by Subject|8
715645|NCT00116753|2307132|P2|Overall Study|Withdrawal by Subject|12
715646|NCT00116753|2307133|P1|Overall Study|Withdrawal by Subject|11
715647|NCT00116753|2307131|P3|Overall Study|Adverse Event|7
715648|NCT00116753|2307132|P2|Overall Study|Adverse Event|10
715649|NCT00116753|2307133|P1|Overall Study|Adverse Event|16
715650|NCT00116779|2307155|P2|Overall Study|Elevated PSA levels|2
715651|NCT00116779|2307156|P1|Overall Study|Elevated PSA levels|2
715652|NCT00116779|2307155|P2|Overall Study|Physician Decision|1
715653|NCT00116779|2307156|P1|Overall Study|Physician Decision|3
715654|NCT00116779|2307155|P2|Overall Study|Inadequate testosterone suppression|9
715655|NCT00116779|2307156|P1|Overall Study|Inadequate testosterone suppression|7
715656|NCT00116779|2307155|P2|Overall Study|Withdrawal by Subject|1
715657|NCT00116779|2307156|P1|Overall Study|Withdrawal by Subject|4
715658|NCT00116779|2307155|P2|Overall Study|Protocol Violation|4
715659|NCT00116779|2307156|P1|Overall Study|Protocol Violation|1
715660|NCT00116779|2307155|P2|Overall Study|Adverse Event|2
715661|NCT00116779|2307156|P1|Overall Study|Adverse Event|4
715662|NCT00116805|2307188|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
715663|NCT00116805|2307189|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
715664|NCT00116805|2307188|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
715665|NCT00116805|2307189|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
715666|NCT00116805|2307188|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
715667|NCT00116805|2307189|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
715668|NCT00116805|2307188|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
715669|NCT00116805|2307189|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
715670|NCT00116805|2307188|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
715671|NCT00116805|2307189|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
715672|NCT00116805|2307188|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
715673|NCT00116805|2307189|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
715674|NCT00116805|2307188|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
715675|NCT00116805|2307189|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
715676|NCT00116805|2307188|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
715677|NCT00116805|2307189|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
715678|NCT00116805|2307188|P2|Open-label Period Weeks 337 - 384|Completed Study|0
715679|NCT00116805|2307189|P1|Open-label Period Weeks 337 - 384|Completed Study|1
715680|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
715681|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
715682|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
715683|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
715684|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
715685|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
715686|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
715687|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
715688|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
715689|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
715690|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
715691|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
715692|NCT00116805|2307188|P2|Open-label Period Weeks 289 - 336|Completed Study|1
715693|NCT00116805|2307189|P1|Open-label Period Weeks 289 - 336|Completed Study|0
715694|NCT00116805|2307188|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
715695|NCT00116805|2307189|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
715696|NCT00116805|2307188|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
715697|NCT00116805|2307189|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
715698|NCT00116805|2307188|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
715699|NCT00116805|2307189|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
715700|NCT00116805|2307188|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
715701|NCT00116805|2307189|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
715702|NCT00116805|2307188|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
715703|NCT00116805|2307189|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
715704|NCT00116805|2307188|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
715705|NCT00116805|2307189|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
715706|NCT00116805|2307188|P2|Open-label Period Weeks 193 - 240|Completed Study|1
715707|NCT00116805|2307189|P1|Open-label Period Weeks 193 - 240|Completed Study|0
715708|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
715709|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
715710|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
715711|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
715712|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
715713|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
715714|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
715715|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
715716|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
715717|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
715718|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
715719|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
715720|NCT00116805|2307188|P2|Open-label Period Weeks 145 - 192|Completed Study|1
715721|NCT00116805|2307189|P1|Open-label Period Weeks 145 - 192|Completed Study|1
715722|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
715723|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
715724|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
715725|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
715726|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
715727|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
715728|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
715729|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
715730|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
715731|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
715732|NCT00116805|2307188|P2|Open-label Period Weeks 97 - 144|Completed Study|0
715733|NCT00116805|2307189|P1|Open-label Period Weeks 97 - 144|Completed Study|1
715734|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
715735|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
715736|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
715737|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
715738|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
715739|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
715740|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
715741|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
715742|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
715743|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
715744|NCT00116805|2307188|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
715745|NCT00116805|2307189|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
715746|NCT00116805|2307188|P2|Double-blind Period Through Week 48|Withdrew Consent|2
715747|NCT00116805|2307189|P1|Double-blind Period Through Week 48|Withdrew Consent|4
715748|NCT00116805|2307188|P2|Double-blind Period Through Week 48|Protocol Violation|1
715749|NCT00116805|2307189|P1|Double-blind Period Through Week 48|Protocol Violation|1
715750|NCT00116805|2307188|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
715751|NCT00116805|2307189|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
715752|NCT00116831|2307282|P2|Overall Study|Missing data for participant|0
715753|NCT00116831|2307283|P1|Overall Study|Missing data for participant|1
715754|NCT00116831|2307282|P2|Overall Study|Insufficient therapeutic effect|1
715755|NCT00116831|2307283|P1|Overall Study|Insufficient therapeutic effect|0
715756|NCT00116831|2307282|P2|Overall Study|Withdrawal by Subject|32
715757|NCT00116831|2307283|P1|Overall Study|Withdrawal by Subject|32
715758|NCT00116831|2307282|P2|Overall Study|Withdrawn investigational product|0
715759|NCT00116831|2307283|P1|Overall Study|Withdrawn investigational product|1
715760|NCT00116831|2307282|P2|Overall Study|Low haemoglobin on screening|0
715761|NCT00116831|2307283|P1|Overall Study|Low haemoglobin on screening|1
715762|NCT00116831|2307282|P2|Overall Study|Hypoglycaemic events|0
715763|NCT00116831|2307283|P1|Overall Study|Hypoglycaemic events|1
715764|NCT00116831|2307282|P2|Overall Study|Protocol Violation|6
715765|NCT00116831|2307283|P1|Overall Study|Protocol Violation|3
715766|NCT00116831|2307282|P2|Overall Study|Lost to Follow-up|6
715767|NCT00116831|2307283|P1|Overall Study|Lost to Follow-up|8
715768|NCT00116831|2307282|P2|Overall Study|Baseline IVUS determined unevaluable|11
715769|NCT00116831|2307283|P1|Overall Study|Baseline IVUS determined unevaluable|12
715770|NCT00116831|2307282|P2|Overall Study|Adverse Event|16
715771|NCT00116831|2307283|P1|Overall Study|Adverse Event|14
715772|NCT00117156|2307359|P1|Overall Study|Trt for Pre-Exist Second Primary|1
715773|NCT00117156|2307359|P1|Overall Study|Physician Decision|1
715774|NCT00117156|2307359|P1|Overall Study|Adverse Event|9
715775|NCT00117286|2307369|P2|Overall Study|Research site closing|2
715776|NCT00117286|2307370|P1|Overall Study|Research site closing|0
715777|NCT00117286|2307369|P2|Overall Study|Lack of Efficacy|1
715778|NCT00117286|2307370|P1|Overall Study|Lack of Efficacy|2
715779|NCT00117286|2307369|P2|Overall Study|Physician Decision|7
715780|NCT00117286|2307370|P1|Overall Study|Physician Decision|3
715781|NCT00117286|2307369|P2|Overall Study|Withdrawal by Subject|2
715782|NCT00117286|2307370|P1|Overall Study|Withdrawal by Subject|6
715783|NCT00117286|2307369|P2|Overall Study|Protocol Violation|3
715784|NCT00117286|2307370|P1|Overall Study|Protocol Violation|3
715785|NCT00117286|2307369|P2|Overall Study|Lost to Follow-up|0
715786|NCT00117286|2307370|P1|Overall Study|Lost to Follow-up|2
715787|NCT00117286|2307369|P2|Overall Study|Adverse Event|6
715788|NCT00117286|2307370|P1|Overall Study|Adverse Event|12
715789|NCT00117312|2307382|P4|Overall Study|Withdrawal by Subject|0
715790|NCT00117312|2307383|P3|Overall Study|Withdrawal by Subject|0
715791|NCT00117312|2307384|P2|Overall Study|Withdrawal by Subject|2
715792|NCT00117312|2307385|P1|Overall Study|Withdrawal by Subject|0
715793|NCT00117312|2307382|P4|Overall Study|Hepatic abnormality|1
715794|NCT00117312|2307383|P3|Overall Study|Hepatic abnormality|0
715795|NCT00117312|2307384|P2|Overall Study|Hepatic abnormality|1
715796|NCT00117312|2307385|P1|Overall Study|Hepatic abnormality|0
715797|NCT00117312|2307382|P4|Overall Study|PSA increase >= 10ng/mL|0
715798|NCT00117312|2307383|P3|Overall Study|PSA increase >= 10ng/mL|1
715799|NCT00117312|2307384|P2|Overall Study|PSA increase >= 10ng/mL|1
715800|NCT00117312|2307385|P1|Overall Study|PSA increase >= 10ng/mL|0
715801|NCT00117312|2307382|P4|Overall Study|PSA decrease <=50%|4
715802|NCT00117312|2307383|P3|Overall Study|PSA decrease <=50%|2
715803|NCT00117312|2307384|P2|Overall Study|PSA decrease <=50%|2
715804|NCT00117312|2307385|P1|Overall Study|PSA decrease <=50%|0
715805|NCT00117312|2307382|P4|Overall Study|Protocol Violation|0
715806|NCT00117312|2307383|P3|Overall Study|Protocol Violation|3
715807|NCT00117312|2307384|P2|Overall Study|Protocol Violation|1
715808|NCT00117312|2307385|P1|Overall Study|Protocol Violation|0
715809|NCT00117312|2307382|P4|Overall Study|Adverse Event|0
715810|NCT00117312|2307383|P3|Overall Study|Adverse Event|0
715811|NCT00117312|2307384|P2|Overall Study|Adverse Event|2
715812|NCT00117312|2307385|P1|Overall Study|Adverse Event|0
715813|NCT00117312|2307382|P4|Overall Study|Patient choice|1
715814|NCT00117312|2307383|P3|Overall Study|Patient choice|2
715815|NCT00117312|2307384|P2|Overall Study|Patient choice|0
715816|NCT00117312|2307385|P1|Overall Study|Patient choice|0
715817|NCT00117312|2307382|P4|Overall Study|Not specified|1
715818|NCT00117312|2307383|P3|Overall Study|Not specified|3
715819|NCT00117312|2307384|P2|Overall Study|Not specified|1
715820|NCT00117312|2307385|P1|Overall Study|Not specified|0
715821|NCT00117312|2307382|P4|Overall Study|Prostate-specific antigen increase >=25%|3
715822|NCT00117312|2307383|P3|Overall Study|Prostate-specific antigen increase >=25%|5
715823|NCT00117312|2307384|P2|Overall Study|Prostate-specific antigen increase >=25%|1
715824|NCT00117312|2307385|P1|Overall Study|Prostate-specific antigen increase >=25%|0
715825|NCT00117312|2307382|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
715826|NCT00117312|2307383|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
715827|NCT00117312|2307384|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
715828|NCT00117312|2307385|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
715829|NCT00117312|2307382|P4|Overall Study|Testosterone >1.0 ng/mL|9
715830|NCT00117312|2307383|P3|Overall Study|Testosterone >1.0 ng/mL|5
715831|NCT00117312|2307384|P2|Overall Study|Testosterone >1.0 ng/mL|9
715832|NCT00117312|2307385|P1|Overall Study|Testosterone >1.0 ng/mL|9
715833|NCT00117338|2307401|P2|Overall Study|Lack of Efficacy|1
715834|NCT00117338|2307402|P1|Overall Study|Lack of Efficacy|0
715835|NCT00117338|2307401|P2|Overall Study|Did not meet Inclusion Criteria|0
715836|NCT00117338|2307402|P1|Overall Study|Did not meet Inclusion Criteria|1
715837|NCT00117338|2307401|P2|Overall Study|Withdrawal by Subject|0
715838|NCT00117338|2307402|P1|Overall Study|Withdrawal by Subject|1
715839|NCT00117338|2307401|P2|Overall Study|Protocol Violation|2
715840|NCT00117338|2307402|P1|Overall Study|Protocol Violation|3
715841|NCT00117338|2307401|P2|Overall Study|Adverse Event|1
715842|NCT00117338|2307402|P1|Overall Study|Adverse Event|0
715878|NCT00117637|2307470|P2|Second Intervention (Period 2)|reason not reported|0
715879|NCT00117637|2307471|P1|Second Intervention (Period 2)|reason not reported|1
715880|NCT00117637|2307470|P2|Second Intervention (Period 2)|non compliant with study medication|1
715881|NCT00117637|2307471|P1|Second Intervention (Period 2)|non compliant with study medication|1
715882|NCT00117637|2307470|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
715883|NCT00117637|2307471|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
715884|NCT00117637|2307470|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
715885|NCT00117637|2307471|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
715886|NCT00117637|2307470|P2|Second Intervention (Period 2)|Protocol Violation|0
715887|NCT00117637|2307471|P1|Second Intervention (Period 2)|Protocol Violation|1
715888|NCT00117637|2307470|P2|Second Intervention (Period 2)|Lost to Follow-up|0
715889|NCT00117637|2307471|P1|Second Intervention (Period 2)|Lost to Follow-up|1
715890|NCT00117637|2307470|P2|Second Intervention (Period 2)|Adverse Event|9
715891|NCT00117637|2307471|P1|Second Intervention (Period 2)|Adverse Event|0
715892|NCT00117637|2307470|P2|First Intervention (Period 1)|reason not reported|1
715893|NCT00117637|2307471|P1|First Intervention (Period 1)|reason not reported|0
715894|NCT00117637|2307470|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
715895|NCT00117637|2307471|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
715896|NCT00117637|2307470|P2|First Intervention (Period 1)|protocol driven decision point|0
715897|NCT00117637|2307471|P1|First Intervention (Period 1)|protocol driven decision point|1
715898|NCT00117637|2307470|P2|First Intervention (Period 1)|study terminated by the sponsor|1
715899|NCT00117637|2307471|P1|First Intervention (Period 1)|study terminated by the sponsor|3
715900|NCT00117637|2307470|P2|First Intervention (Period 1)|Withdrawal by Subject|4
715901|NCT00117637|2307471|P1|First Intervention (Period 1)|Withdrawal by Subject|2
715902|NCT00117637|2307470|P2|First Intervention (Period 1)|Protocol Violation|0
715903|NCT00117637|2307471|P1|First Intervention (Period 1)|Protocol Violation|1
715904|NCT00117637|2307470|P2|First Intervention (Period 1)|Lost to Follow-up|2
715905|NCT00117637|2307471|P1|First Intervention (Period 1)|Lost to Follow-up|0
715906|NCT00117637|2307470|P2|First Intervention (Period 1)|Adverse Event|16
715907|NCT00117637|2307471|P1|First Intervention (Period 1)|Adverse Event|11
715908|NCT00117676|2307545|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
715909|NCT00117676|2307546|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
715910|NCT00117676|2307545|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
715911|NCT00117676|2307546|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
715912|NCT00117676|2307545|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
715913|NCT00117676|2307546|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
715914|NCT00117676|2307545|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
715915|NCT00117676|2307546|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
715916|NCT00117676|2307545|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
715917|NCT00117676|2307546|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
715918|NCT00117676|2307545|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
715919|NCT00117676|2307546|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
715920|NCT00117676|2307545|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
715921|NCT00117676|2307546|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
715922|NCT00117676|2307545|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
715923|NCT00117676|2307546|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
715924|NCT00117676|2307545|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
715925|NCT00117676|2307546|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
715926|NCT00117676|2307545|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
715927|NCT00117676|2307546|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
715928|NCT00117676|2307545|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
715929|NCT00117676|2307546|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
715930|NCT00117676|2307545|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
715931|NCT00117676|2307546|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
715932|NCT00117676|2307545|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
715933|NCT00117676|2307546|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
715934|NCT00117676|2307545|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
715935|NCT00117676|2307546|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
715936|NCT00117676|2307545|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
715937|NCT00117676|2307546|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
715938|NCT00117676|2307545|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
716015|NCT00118040|2307735|P3|Overall Study|Withdrawal by Subject|2
715939|NCT00117676|2307546|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
715940|NCT00117676|2307545|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
715941|NCT00117676|2307546|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
715942|NCT00117676|2307545|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
715943|NCT00117676|2307546|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
715944|NCT00117676|2307545|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
715945|NCT00117676|2307546|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
715946|NCT00117676|2307545|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
715947|NCT00117676|2307546|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
715948|NCT00117676|2307545|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
715949|NCT00117676|2307546|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
715950|NCT00117676|2307545|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
715951|NCT00117676|2307546|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
715952|NCT00117676|2307545|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
715953|NCT00117676|2307546|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
715954|NCT00117676|2307545|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
715955|NCT00117676|2307546|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
715956|NCT00117676|2307545|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
715957|NCT00117676|2307546|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
715958|NCT00117676|2307545|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
715959|NCT00117676|2307546|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
715960|NCT00117676|2307545|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
715961|NCT00117676|2307546|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
715962|NCT00117676|2307545|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
715963|NCT00117676|2307546|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
715964|NCT00117676|2307545|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
715965|NCT00117676|2307546|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
715966|NCT00117676|2307545|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
715967|NCT00117676|2307546|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
715968|NCT00117676|2307545|P2|Double-blind Period Through Week 48|Withdrew Consent|1
715969|NCT00117676|2307546|P1|Double-blind Period Through Week 48|Withdrew Consent|0
715970|NCT00117676|2307545|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
715971|NCT00117676|2307546|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
715972|NCT00117676|2307545|P2|Double-blind Period Through Week 48|Protocol Violation|1
715973|NCT00117676|2307546|P1|Double-blind Period Through Week 48|Protocol Violation|0
715974|NCT00117676|2307545|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
715975|NCT00117676|2307546|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
715976|NCT00117676|2307545|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
715977|NCT00117676|2307546|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
715978|NCT00117793|2307639|P1|Overall Study|Withdrawal by Subject|12
715979|NCT00117845|2307667|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
715980|NCT00117949|2307676|P4|Overall Study|Hepatic abnormalities|1
715981|NCT00117949|2307677|P3|Overall Study|Hepatic abnormalities|0
715982|NCT00117949|2307678|P2|Overall Study|Hepatic abnormalities|1
715983|NCT00117949|2307679|P1|Overall Study|Hepatic abnormalities|0
715984|NCT00117949|2307676|P4|Overall Study|PSA reduction <=50%|4
715985|NCT00117949|2307677|P3|Overall Study|PSA reduction <=50%|2
715986|NCT00117949|2307678|P2|Overall Study|PSA reduction <=50%|2
715987|NCT00117949|2307679|P1|Overall Study|PSA reduction <=50%|0
715988|NCT00117949|2307676|P4|Overall Study|PSA increase >=10ng/mL|0
715989|NCT00117949|2307677|P3|Overall Study|PSA increase >=10ng/mL|1
715990|NCT00117949|2307678|P2|Overall Study|PSA increase >=10ng/mL|1
715991|NCT00117949|2307679|P1|Overall Study|PSA increase >=10ng/mL|0
715992|NCT00117949|2307676|P4|Overall Study|Prostate-specific antigen increase >=25%|2
715993|NCT00117949|2307677|P3|Overall Study|Prostate-specific antigen increase >=25%|1
715994|NCT00117949|2307678|P2|Overall Study|Prostate-specific antigen increase >=25%|1
715995|NCT00117949|2307679|P1|Overall Study|Prostate-specific antigen increase >=25%|0
715996|NCT00117949|2307676|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
715997|NCT00117949|2307677|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
715998|NCT00117949|2307678|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
715999|NCT00117949|2307679|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
716000|NCT00117949|2307676|P4|Overall Study|Testosterone >1.0 ng/mL|15
716001|NCT00117949|2307677|P3|Overall Study|Testosterone >1.0 ng/mL|17
716002|NCT00117949|2307678|P2|Overall Study|Testosterone >1.0 ng/mL|18
716003|NCT00117949|2307679|P1|Overall Study|Testosterone >1.0 ng/mL|10
716004|NCT00117988|2307728|P1|Overall Study|Adverse Event|1
716005|NCT00117988|2307728|P1|Overall Study|Death|3
716006|NCT00118040|2307735|P3|Overall Study|Other|1
716007|NCT00118040|2307736|P2|Overall Study|Other|0
716008|NCT00118040|2307737|P1|Overall Study|Other|0
716009|NCT00118040|2307735|P3|Overall Study|Non-Compliant Participant|2
716010|NCT00118040|2307736|P2|Overall Study|Non-Compliant Participant|1
716011|NCT00118040|2307737|P1|Overall Study|Non-Compliant Participant|1
716012|NCT00118040|2307735|P3|Overall Study|Medical Contraindication|1
716013|NCT00118040|2307736|P2|Overall Study|Medical Contraindication|0
716014|NCT00118040|2307737|P1|Overall Study|Medical Contraindication|0
716016|NCT00118040|2307736|P2|Overall Study|Withdrawal by Subject|0
716017|NCT00118040|2307737|P1|Overall Study|Withdrawal by Subject|0
716018|NCT00118040|2307735|P3|Overall Study|Adverse Event|0
716019|NCT00118040|2307736|P2|Overall Study|Adverse Event|1
716020|NCT00118040|2307737|P1|Overall Study|Adverse Event|0
716021|NCT00118092|2307805|P1|Overall Study|Protocol Violation|1
716022|NCT00118092|2307805|P1|Overall Study|Withdrawal by Subject|1
716026|NCT00118287|2307846|P1|Overall Study|Muscle pain|1
716027|NCT00118287|2307846|P1|Overall Study|Intracranial haemorrhage|1
716028|NCT00118417|2307984|P2|Phase II (Weeks 6 to 12)|Remission|2
716029|NCT00118417|2307985|P1|Phase II (Weeks 6 to 12)|Remission|1
716030|NCT00118417|2307984|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
716031|NCT00118417|2307985|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
716032|NCT00118417|2307984|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
716033|NCT00118417|2307985|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
716034|NCT00118417|2307984|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
716035|NCT00118417|2307985|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
716036|NCT00118417|2307984|P2|Phase I (Weeks 0 to 6)|Remission|0
716037|NCT00118417|2307985|P1|Phase I (Weeks 0 to 6)|Remission|8
716038|NCT00118430|2307998|P3|Overall Study|Lost to Follow-up|28
716039|NCT00118430|2307999|P2|Overall Study|Lost to Follow-up|22
716040|NCT00118430|2308000|P1|Overall Study|Lost to Follow-up|15
716041|NCT00118430|2307998|P3|Overall Study|Withdrawal by Subject|0
716042|NCT00118430|2307999|P2|Overall Study|Withdrawal by Subject|2
716043|NCT00118430|2308000|P1|Overall Study|Withdrawal by Subject|6
716044|NCT00118482|2308017|P2|Overall Study|Withdrawal by Subject|22
716045|NCT00118482|2308018|P1|Overall Study|Withdrawal by Subject|23
716046|NCT00118482|2308017|P2|Overall Study|Lost to Follow-up|7
716047|NCT00118482|2308018|P1|Overall Study|Lost to Follow-up|7
716048|NCT00118703|2308113|P2|Overall Study|Lost to Follow-up|2
716049|NCT00118703|2308114|P1|Overall Study|Lost to Follow-up|1
716050|NCT00118703|2308113|P2|Overall Study|Withdrawal by Subject|5
716051|NCT00118703|2308114|P1|Overall Study|Withdrawal by Subject|2
716052|NCT00118703|2308113|P2|Overall Study|Participant took two different treatment|1
716053|NCT00118703|2308114|P1|Overall Study|Participant took two different treatment|0
716054|NCT00118703|2308113|P2|Overall Study|Adverse Event|1
716055|NCT00118703|2308114|P1|Overall Study|Adverse Event|1
716056|NCT00118703|2308113|P2|Overall Study|Protocol Violation|0
716057|NCT00118703|2308114|P1|Overall Study|Protocol Violation|1
716058|NCT00118898|2308158|P4|Overall Study|Not able to get to clinic|40
716059|NCT00118898|2308159|P3|Overall Study|Not able to get to clinic|31
716060|NCT00118898|2308160|P2|Overall Study|Not able to get to clinic|43
716061|NCT00118898|2308161|P1|Overall Study|Not able to get to clinic|34
716062|NCT00118898|2308158|P4|Overall Study|Not compliant with requirements|11
716063|NCT00118898|2308159|P3|Overall Study|Not compliant with requirements|11
716064|NCT00118898|2308160|P2|Overall Study|Not compliant with requirements|13
716065|NCT00118898|2308161|P1|Overall Study|Not compliant with requirements|11
716066|NCT00118898|2308158|P4|Overall Study|Severe debilitation|4
716067|NCT00118898|2308159|P3|Overall Study|Severe debilitation|6
716068|NCT00118898|2308160|P2|Overall Study|Severe debilitation|4
716069|NCT00118898|2308161|P1|Overall Study|Severe debilitation|1
716070|NCT00118898|2308158|P4|Overall Study|Site Closure|37
716071|NCT00118898|2308159|P3|Overall Study|Site Closure|28
716072|NCT00118898|2308160|P2|Overall Study|Site Closure|31
716073|NCT00118898|2308161|P1|Overall Study|Site Closure|33
716074|NCT00118898|2308158|P4|Overall Study|Withdrawal by Subject|8
716075|NCT00118898|2308159|P3|Overall Study|Withdrawal by Subject|8
716076|NCT00118898|2308160|P2|Overall Study|Withdrawal by Subject|5
716077|NCT00118898|2308161|P1|Overall Study|Withdrawal by Subject|10
716078|NCT00118898|2308158|P4|Overall Study|Lost to Follow-up|33
716079|NCT00118898|2308159|P3|Overall Study|Lost to Follow-up|33
716080|NCT00118898|2308160|P2|Overall Study|Lost to Follow-up|34
716081|NCT00118898|2308161|P1|Overall Study|Lost to Follow-up|26
716082|NCT00118898|2308158|P4|Overall Study|Death|8
716083|NCT00118898|2308159|P3|Overall Study|Death|6
716084|NCT00118898|2308160|P2|Overall Study|Death|11
716085|NCT00118898|2308161|P1|Overall Study|Death|6
716086|NCT00118911|2308257|P2|Overall Study|Withdrawal by Subject|5
716087|NCT00118911|2308258|P1|Overall Study|Withdrawal by Subject|2
716088|NCT00119015|2308268|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
716089|NCT00119015|2308269|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
716090|NCT00119015|2308270|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
716091|NCT00119262|2308311|P2|Overall Study|others|5
716092|NCT00119262|2308312|P1|Overall Study|others|0
716093|NCT00119262|2308311|P2|Overall Study|ineligble|2
716094|NCT00119262|2308312|P1|Overall Study|ineligble|1
716095|NCT00119262|2308311|P2|Overall Study|other disease|2
716096|NCT00119262|2308312|P1|Overall Study|other disease|0
716097|NCT00119262|2308311|P2|Overall Study|Adverse Event|35
716098|NCT00119262|2308312|P1|Overall Study|Adverse Event|33
716099|NCT00119262|2308311|P2|Overall Study|Withdrawal by Subject|11
716100|NCT00119262|2308312|P1|Overall Study|Withdrawal by Subject|12
716101|NCT00119262|2308311|P2|Overall Study|Lack of Efficacy|3
716102|NCT00119262|2308312|P1|Overall Study|Lack of Efficacy|0
716103|NCT00119379|2308324|P2|Overall Study|Adverse Event|1
716104|NCT00119379|2308325|P1|Overall Study|Adverse Event|4
716105|NCT00119405|2308349|P1|Overall Study|Withdrawal by Subject|1
716106|NCT00113763|2308355|P2|Overall Study|Ongoing|0
716107|NCT00113763|2308356|P1|Overall Study|Ongoing|1
716108|NCT00113763|2308355|P2|Overall Study|Non-compliance|0
716109|NCT00113763|2308356|P1|Overall Study|Non-compliance|1
716110|NCT00113763|2308355|P2|Overall Study|Not specified|6
716111|NCT00113763|2308356|P1|Overall Study|Not specified|27
716112|NCT00113763|2308355|P2|Overall Study|Withdrawal by Subject|4
716113|NCT00113763|2308356|P1|Overall Study|Withdrawal by Subject|1
716114|NCT00113763|2308355|P2|Overall Study|Lost to Follow-up|0
716115|NCT00113763|2308356|P1|Overall Study|Lost to Follow-up|10
716116|NCT00113763|2308355|P2|Overall Study|Disease Progression|14
716117|NCT00113763|2308356|P1|Overall Study|Disease Progression|28
716118|NCT00113763|2308355|P2|Overall Study|Adverse Event|2
716119|NCT00113763|2308356|P1|Overall Study|Adverse Event|5
716120|NCT00113841|2308382|P2|Overall Study|Non-compliant|0
716121|NCT00113841|2308383|P1|Overall Study|Non-compliant|1
716122|NCT00113841|2308382|P2|Overall Study|Disease progression|2
716123|NCT00113841|2308383|P1|Overall Study|Disease progression|0
716126|NCT00119678|2308457|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
716127|NCT00119678|2308458|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
716128|NCT00119678|2308457|P2|Open-label Treatment Period|Pregnancy|0
716129|NCT00119678|2308458|P1|Open-label Treatment Period|Pregnancy|1
716130|NCT00119678|2308457|P2|Open-label Treatment Period|Participants not meeting study criteria|0
716131|NCT00119678|2308458|P1|Open-label Treatment Period|Participants not meeting study criteria|2
716132|NCT00119678|2308457|P2|Open-label Treatment Period|Participant withdrew consent|0
716133|NCT00119678|2308458|P1|Open-label Treatment Period|Participant withdrew consent|4
716134|NCT00119678|2308457|P2|Open-label Treatment Period|Lost to Follow-up|0
716135|NCT00119678|2308458|P1|Open-label Treatment Period|Lost to Follow-up|3
716136|NCT00119678|2308457|P2|Open-label Treatment Period|Lack of Efficacy|0
716137|NCT00119678|2308458|P1|Open-label Treatment Period|Lack of Efficacy|9
716138|NCT00119678|2308457|P2|Open-label Treatment Period|Adverse Event|0
716139|NCT00119678|2308458|P1|Open-label Treatment Period|Adverse Event|3
716140|NCT00119678|2308457|P2|Open-label Treatment Period|Death|0
716141|NCT00119678|2308458|P1|Open-label Treatment Period|Death|1
716142|NCT00119678|2308457|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
716143|NCT00119678|2308458|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
716144|NCT00119678|2308457|P2|Double-blind Treatment Period|Not treated|2
716145|NCT00119678|2308458|P1|Double-blind Treatment Period|Not treated|1
716146|NCT00119678|2308457|P2|Double-blind Treatment Period|Pregnancy|2
716147|NCT00119678|2308458|P1|Double-blind Treatment Period|Pregnancy|0
716148|NCT00119678|2308457|P2|Double-blind Treatment Period|Poor/Non-compliance|0
716149|NCT00119678|2308458|P1|Double-blind Treatment Period|Poor/Non-compliance|3
716150|NCT00119678|2308457|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
716151|NCT00119678|2308458|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
716152|NCT00119678|2308457|P2|Double-blind Treatment Period|Participant withdrew consent|4
716153|NCT00119678|2308458|P1|Double-blind Treatment Period|Participant withdrew consent|4
716154|NCT00119678|2308457|P2|Double-blind Treatment Period|Lost to Follow-up|2
716155|NCT00119678|2308458|P1|Double-blind Treatment Period|Lost to Follow-up|1
716156|NCT00119678|2308457|P2|Double-blind Treatment Period|Lack of Efficacy|12
716157|NCT00119678|2308458|P1|Double-blind Treatment Period|Lack of Efficacy|21
716158|NCT00119678|2308457|P2|Double-blind Treatment Period|Adverse Event|1
716159|NCT00119678|2308458|P1|Double-blind Treatment Period|Adverse Event|7
716160|NCT00119678|2308457|P2|Double-blind Treatment Period|Death|0
716161|NCT00119678|2308458|P1|Double-blind Treatment Period|Death|1
716162|NCT00121134|2308508|P4|Overall Study|Patient Personal Reasons|0
716163|NCT00121134|2308509|P3|Overall Study|Patient Personal Reasons|0
716164|NCT00121134|2308510|P2|Overall Study|Patient Personal Reasons|1
716165|NCT00121134|2308511|P1|Overall Study|Patient Personal Reasons|0
716166|NCT00121134|2308508|P4|Overall Study|Intercurrent Illness|1
716167|NCT00121134|2308509|P3|Overall Study|Intercurrent Illness|0
716168|NCT00121134|2308510|P2|Overall Study|Intercurrent Illness|0
716169|NCT00121134|2308511|P1|Overall Study|Intercurrent Illness|0
716170|NCT00121134|2308508|P4|Overall Study|Treatment Delay|0
716171|NCT00121134|2308509|P3|Overall Study|Treatment Delay|0
716172|NCT00121134|2308510|P2|Overall Study|Treatment Delay|0
716173|NCT00121134|2308511|P1|Overall Study|Treatment Delay|1
716174|NCT00121134|2308508|P4|Overall Study|Physician Decision|1
716175|NCT00121134|2308509|P3|Overall Study|Physician Decision|4
716176|NCT00121134|2308510|P2|Overall Study|Physician Decision|4
716177|NCT00121134|2308511|P1|Overall Study|Physician Decision|6
716178|NCT00121134|2308508|P4|Overall Study|Toxicity|5
716179|NCT00121134|2308509|P3|Overall Study|Toxicity|13
716180|NCT00121134|2308510|P2|Overall Study|Toxicity|7
716181|NCT00121134|2308511|P1|Overall Study|Toxicity|4
716182|NCT00121134|2308508|P4|Overall Study|Progression of Disease|2
716183|NCT00121134|2308509|P3|Overall Study|Progression of Disease|4
716184|NCT00121134|2308510|P2|Overall Study|Progression of Disease|3
716185|NCT00121134|2308511|P1|Overall Study|Progression of Disease|5
716186|NCT00121199|2308526|P1|Overall Study|Ineligible|9
716187|NCT00121199|2308526|P1|Overall Study|Other - Not Protocol Specified|3
716188|NCT00121199|2308526|P1|Overall Study|Death|3
716189|NCT00121199|2308526|P1|Overall Study|Progression/Relapse|1
716190|NCT00121199|2308526|P1|Overall Study|Refusal Unrelated to Adverse Event|1
716191|NCT00121199|2308526|P1|Overall Study|Adverse Event|11
716192|NCT00121238|2308537|P1|Overall Study|Protocol Violation|2
716193|NCT00121238|2308537|P1|Overall Study|disease progression before intervention|1
716194|NCT00121485|2308558|P2|Overall Study|Crossover|2
716195|NCT00121485|2308559|P1|Overall Study|Crossover|0
716196|NCT00121485|2308558|P2|Overall Study|Not implanted|5
716197|NCT00121485|2308559|P1|Overall Study|Not implanted|1
890212|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
890213|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
890214|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
890215|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
890216|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
890217|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
890218|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
890219|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Physician Decision|1
890220|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Physician Decision|1
890221|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Physician Decision|3
890222|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Physician Decision|6
890223|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Physician Decision|1
890224|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Physician Decision|4
890225|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Physician Decision|0
890226|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
890227|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
890228|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
890229|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
890230|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
716360|NCT00121719|2308827|P14|Overall Study|Continuing/ongoing patients|0
716361|NCT00121719|2308828|P13|Overall Study|Continuing/ongoing patients|3
716362|NCT00121719|2308829|P12|Overall Study|Continuing/ongoing patients|1
716363|NCT00121719|2308830|P11|Overall Study|Continuing/ongoing patients|1
716364|NCT00121719|2308831|P10|Overall Study|Continuing/ongoing patients|0
716365|NCT00121719|2308832|P9|Overall Study|Continuing/ongoing patients|0
716366|NCT00121719|2308833|P8|Overall Study|Continuing/ongoing patients|1
716367|NCT00121719|2308834|P7|Overall Study|Continuing/ongoing patients|0
716368|NCT00121719|2308835|P6|Overall Study|Continuing/ongoing patients|0
716369|NCT00121719|2308836|P5|Overall Study|Continuing/ongoing patients|0
716370|NCT00121719|2308837|P4|Overall Study|Continuing/ongoing patients|0
716371|NCT00121719|2308838|P3|Overall Study|Continuing/ongoing patients|0
716372|NCT00121719|2308839|P2|Overall Study|Continuing/ongoing patients|0
716373|NCT00121719|2308840|P1|Overall Study|Continuing/ongoing patients|0
716374|NCT00121719|2308827|P14|Overall Study|Not specified|1
716375|NCT00121719|2308828|P13|Overall Study|Not specified|1
716376|NCT00121719|2308829|P12|Overall Study|Not specified|0
716377|NCT00121719|2308830|P11|Overall Study|Not specified|0
716378|NCT00121719|2308831|P10|Overall Study|Not specified|0
716379|NCT00121719|2308832|P9|Overall Study|Not specified|1
716380|NCT00121719|2308833|P8|Overall Study|Not specified|0
716381|NCT00121719|2308834|P7|Overall Study|Not specified|1
716382|NCT00121719|2308835|P6|Overall Study|Not specified|0
716383|NCT00121719|2308836|P5|Overall Study|Not specified|0
716384|NCT00121719|2308837|P4|Overall Study|Not specified|1
716385|NCT00121719|2308838|P3|Overall Study|Not specified|1
716386|NCT00121719|2308839|P2|Overall Study|Not specified|0
716387|NCT00121719|2308840|P1|Overall Study|Not specified|0
716388|NCT00121719|2308827|P14|Overall Study|Physician Decision|0
716389|NCT00121719|2308828|P13|Overall Study|Physician Decision|1
716390|NCT00121719|2308829|P12|Overall Study|Physician Decision|0
716391|NCT00121719|2308830|P11|Overall Study|Physician Decision|0
716392|NCT00121719|2308831|P10|Overall Study|Physician Decision|0
716393|NCT00121719|2308832|P9|Overall Study|Physician Decision|0
716394|NCT00121719|2308833|P8|Overall Study|Physician Decision|0
716395|NCT00121719|2308834|P7|Overall Study|Physician Decision|0
716396|NCT00121719|2308835|P6|Overall Study|Physician Decision|0
716397|NCT00121719|2308836|P5|Overall Study|Physician Decision|0
716398|NCT00121719|2308837|P4|Overall Study|Physician Decision|0
716399|NCT00121719|2308838|P3|Overall Study|Physician Decision|0
716400|NCT00121719|2308839|P2|Overall Study|Physician Decision|1
716401|NCT00121719|2308840|P1|Overall Study|Physician Decision|0
716402|NCT00121719|2308827|P14|Overall Study|Clinical deterioration|2
716403|NCT00121719|2308828|P13|Overall Study|Clinical deterioration|2
716404|NCT00121719|2308829|P12|Overall Study|Clinical deterioration|1
716405|NCT00121719|2308830|P11|Overall Study|Clinical deterioration|0
716406|NCT00121719|2308831|P10|Overall Study|Clinical deterioration|2
716407|NCT00121719|2308832|P9|Overall Study|Clinical deterioration|2
716408|NCT00121719|2308833|P8|Overall Study|Clinical deterioration|1
716409|NCT00121719|2308834|P7|Overall Study|Clinical deterioration|2
716410|NCT00121719|2308835|P6|Overall Study|Clinical deterioration|0
716411|NCT00121719|2308836|P5|Overall Study|Clinical deterioration|1
716412|NCT00121719|2308837|P4|Overall Study|Clinical deterioration|0
716413|NCT00121719|2308838|P3|Overall Study|Clinical deterioration|1
716414|NCT00121719|2308839|P2|Overall Study|Clinical deterioration|1
716415|NCT00121719|2308840|P1|Overall Study|Clinical deterioration|0
716416|NCT00121719|2308827|P14|Overall Study|Progressive disease|4
716417|NCT00121719|2308828|P13|Overall Study|Progressive disease|13
716418|NCT00121719|2308829|P12|Overall Study|Progressive disease|3
716419|NCT00121719|2308830|P11|Overall Study|Progressive disease|4
716420|NCT00121719|2308831|P10|Overall Study|Progressive disease|1
716421|NCT00121719|2308832|P9|Overall Study|Progressive disease|3
716422|NCT00121719|2308833|P8|Overall Study|Progressive disease|5
716423|NCT00121719|2308834|P7|Overall Study|Progressive disease|7
716424|NCT00121719|2308835|P6|Overall Study|Progressive disease|1
716425|NCT00121719|2308836|P5|Overall Study|Progressive disease|2
716426|NCT00121719|2308837|P4|Overall Study|Progressive disease|2
716427|NCT00121719|2308838|P3|Overall Study|Progressive disease|0
716428|NCT00121719|2308839|P2|Overall Study|Progressive disease|1
716429|NCT00121719|2308840|P1|Overall Study|Progressive disease|2
716430|NCT00121719|2308827|P14|Overall Study|Withdrawal by Subject|0
716431|NCT00121719|2308828|P13|Overall Study|Withdrawal by Subject|0
716432|NCT00121719|2308829|P12|Overall Study|Withdrawal by Subject|0
716433|NCT00121719|2308830|P11|Overall Study|Withdrawal by Subject|0
716434|NCT00121719|2308831|P10|Overall Study|Withdrawal by Subject|0
716435|NCT00121719|2308832|P9|Overall Study|Withdrawal by Subject|0
716436|NCT00121719|2308833|P8|Overall Study|Withdrawal by Subject|0
716437|NCT00121719|2308834|P7|Overall Study|Withdrawal by Subject|0
716438|NCT00121719|2308835|P6|Overall Study|Withdrawal by Subject|0
716439|NCT00121719|2308836|P5|Overall Study|Withdrawal by Subject|0
716440|NCT00121719|2308837|P4|Overall Study|Withdrawal by Subject|0
716441|NCT00121719|2308838|P3|Overall Study|Withdrawal by Subject|0
716442|NCT00121719|2308839|P2|Overall Study|Withdrawal by Subject|0
716443|NCT00121719|2308840|P1|Overall Study|Withdrawal by Subject|1
716444|NCT00121719|2308827|P14|Overall Study|Protocol deviation|0
716445|NCT00121719|2308828|P13|Overall Study|Protocol deviation|0
716446|NCT00121719|2308829|P12|Overall Study|Protocol deviation|0
716447|NCT00121719|2308830|P11|Overall Study|Protocol deviation|0
716448|NCT00121719|2308831|P10|Overall Study|Protocol deviation|0
716449|NCT00121719|2308832|P9|Overall Study|Protocol deviation|0
716450|NCT00121719|2308833|P8|Overall Study|Protocol deviation|0
716451|NCT00121719|2308834|P7|Overall Study|Protocol deviation|0
716452|NCT00121719|2308835|P6|Overall Study|Protocol deviation|0
716453|NCT00121719|2308836|P5|Overall Study|Protocol deviation|0
716454|NCT00121719|2308837|P4|Overall Study|Protocol deviation|0
716455|NCT00121719|2308838|P3|Overall Study|Protocol deviation|1
716456|NCT00121719|2308839|P2|Overall Study|Protocol deviation|0
716457|NCT00121719|2308840|P1|Overall Study|Protocol deviation|0
716458|NCT00121719|2308827|P14|Overall Study|Abnormal laboratory value|0
716459|NCT00121719|2308828|P13|Overall Study|Abnormal laboratory value|1
716460|NCT00121719|2308829|P12|Overall Study|Abnormal laboratory value|0
716461|NCT00121719|2308830|P11|Overall Study|Abnormal laboratory value|0
716462|NCT00121719|2308831|P10|Overall Study|Abnormal laboratory value|0
716463|NCT00121719|2308832|P9|Overall Study|Abnormal laboratory value|0
716464|NCT00121719|2308833|P8|Overall Study|Abnormal laboratory value|1
716465|NCT00121719|2308834|P7|Overall Study|Abnormal laboratory value|0
716466|NCT00121719|2308835|P6|Overall Study|Abnormal laboratory value|0
716467|NCT00121719|2308836|P5|Overall Study|Abnormal laboratory value|0
716468|NCT00121719|2308837|P4|Overall Study|Abnormal laboratory value|0
716469|NCT00121719|2308838|P3|Overall Study|Abnormal laboratory value|0
716470|NCT00121719|2308839|P2|Overall Study|Abnormal laboratory value|1
716471|NCT00121719|2308840|P1|Overall Study|Abnormal laboratory value|1
716472|NCT00121719|2308827|P14|Overall Study|Adverse Event|0
716473|NCT00121719|2308828|P13|Overall Study|Adverse Event|3
716474|NCT00121719|2308829|P12|Overall Study|Adverse Event|0
716475|NCT00121719|2308830|P11|Overall Study|Adverse Event|1
716476|NCT00121719|2308831|P10|Overall Study|Adverse Event|0
716477|NCT00121719|2308832|P9|Overall Study|Adverse Event|0
716478|NCT00121719|2308833|P8|Overall Study|Adverse Event|1
716479|NCT00121719|2308834|P7|Overall Study|Adverse Event|2
716480|NCT00121719|2308835|P6|Overall Study|Adverse Event|2
716481|NCT00121719|2308836|P5|Overall Study|Adverse Event|0
716482|NCT00121719|2308837|P4|Overall Study|Adverse Event|0
716483|NCT00121719|2308838|P3|Overall Study|Adverse Event|1
716484|NCT00121719|2308839|P2|Overall Study|Adverse Event|0
716485|NCT00121719|2308840|P1|Overall Study|Adverse Event|0
716486|NCT00122109|2309041|P2|Overall Study|Did not meet criteria|7
716487|NCT00122109|2309042|P1|Overall Study|Did not meet criteria|6
716488|NCT00122135|2309068|P2|Overall Study|Withdrawal by Subject|0
716489|NCT00122135|2309069|P1|Overall Study|Withdrawal by Subject|3
716490|NCT00122187|2309077|P2|Overall Study|Withdrew because of resource limitations|2
716491|NCT00122187|2309078|P1|Overall Study|Withdrew because of resource limitations|2
716492|NCT00122317|2309090|P1|Overall Study|Withdrawal by Subject|1
716493|NCT00122317|2309090|P1|Overall Study|patient non-compliance|1
716494|NCT00122317|2309090|P1|Overall Study|Physician Decision|2
716495|NCT00122317|2309090|P1|Overall Study|Adverse Event|4
716496|NCT00122317|2309090|P1|Overall Study|Death|3
716497|NCT00122382|2309190|P3|Open-Label Study|Withdrawal of Consent|4
716498|NCT00122382|2309191|P2|Open-Label Study|Withdrawal of Consent|0
716499|NCT00122382|2309192|P1|Open-Label Study|Withdrawal of Consent|0
716500|NCT00122382|2309190|P3|Open-Label Study|Poor/Non-Compliance|1
716501|NCT00122382|2309191|P2|Open-Label Study|Poor/Non-Compliance|0
716502|NCT00122382|2309192|P1|Open-Label Study|Poor/Non-Compliance|0
716503|NCT00122382|2309190|P3|Open-Label Study|Pregnancy|2
716504|NCT00122382|2309191|P2|Open-Label Study|Pregnancy|0
716505|NCT00122382|2309192|P1|Open-Label Study|Pregnancy|0
716506|NCT00122382|2309190|P3|Open-Label Study|Lost to Follow-up|3
716507|NCT00122382|2309191|P2|Open-Label Study|Lost to Follow-up|0
716508|NCT00122382|2309192|P1|Open-Label Study|Lost to Follow-up|0
716509|NCT00122382|2309190|P3|Open-Label Study|Lack of Efficacy|3
716510|NCT00122382|2309191|P2|Open-Label Study|Lack of Efficacy|0
716511|NCT00122382|2309192|P1|Open-Label Study|Lack of Efficacy|0
716512|NCT00122382|2309190|P3|Open-Label Study|Death|2
716513|NCT00122382|2309191|P2|Open-Label Study|Death|0
716514|NCT00122382|2309192|P1|Open-Label Study|Death|0
716515|NCT00122382|2309190|P3|Open-Label Study|Adverse Event|11
716516|NCT00122382|2309191|P2|Open-Label Study|Adverse Event|0
716517|NCT00122382|2309192|P1|Open-Label Study|Adverse Event|0
716518|NCT00122382|2309190|P3|Double-Blind Study|Randomized but not treated|0
716519|NCT00122382|2309191|P2|Double-Blind Study|Randomized but not treated|2
716520|NCT00122382|2309192|P1|Double-Blind Study|Randomized but not treated|0
716521|NCT00122382|2309190|P3|Double-Blind Study|Methotrexate Discontinued|0
716522|NCT00122382|2309191|P2|Double-Blind Study|Methotrexate Discontinued|1
716523|NCT00122382|2309192|P1|Double-Blind Study|Methotrexate Discontinued|0
716524|NCT00122382|2309190|P3|Double-Blind Study|Protocol Violation|0
716525|NCT00122382|2309191|P2|Double-Blind Study|Protocol Violation|0
716526|NCT00122382|2309192|P1|Double-Blind Study|Protocol Violation|1
716527|NCT00122382|2309190|P3|Double-Blind Study|Withdrawal of Consent|0
716528|NCT00122382|2309191|P2|Double-Blind Study|Withdrawal of Consent|3
716529|NCT00122382|2309192|P1|Double-Blind Study|Withdrawal of Consent|7
716530|NCT00122382|2309190|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
716531|NCT00122382|2309191|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
716532|NCT00122382|2309192|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
716533|NCT00122382|2309190|P3|Double-Blind Study|Pregnancy|0
716534|NCT00122382|2309191|P2|Double-Blind Study|Pregnancy|0
716535|NCT00122382|2309192|P1|Double-Blind Study|Pregnancy|2
716536|NCT00122382|2309190|P3|Double-Blind Study|Lost to Follow-up|0
716537|NCT00122382|2309191|P2|Double-Blind Study|Lost to Follow-up|1
716538|NCT00122382|2309192|P1|Double-Blind Study|Lost to Follow-up|2
716539|NCT00122382|2309190|P3|Double-Blind Study|Lack of Efficacy|0
716540|NCT00122382|2309191|P2|Double-Blind Study|Lack of Efficacy|8
716541|NCT00122382|2309192|P1|Double-Blind Study|Lack of Efficacy|0
716542|NCT00122382|2309190|P3|Double-Blind Study|Death|0
716543|NCT00122382|2309191|P2|Double-Blind Study|Death|2
716544|NCT00122382|2309192|P1|Double-Blind Study|Death|2
716545|NCT00122382|2309190|P3|Double-Blind Study|Adverse Event|0
716546|NCT00122382|2309191|P2|Double-Blind Study|Adverse Event|11
716547|NCT00122382|2309192|P1|Double-Blind Study|Adverse Event|9
716548|NCT00122460|2309269|P2|Overall Study|investigational study phase ongoing|1
716549|NCT00122460|2309270|P1|Overall Study|investigational study phase ongoing|7
716550|NCT00122681|2309294|P2|Overall Study|Personal reasons|147
716551|NCT00122681|2309295|P1|Overall Study|Personal reasons|150
716552|NCT00122681|2309294|P2|Overall Study|Withdrawal by Subject|251
716553|NCT00122681|2309295|P1|Overall Study|Withdrawal by Subject|257
716554|NCT00122681|2309294|P2|Overall Study|Protocol Violation|10
716555|NCT00122681|2309295|P1|Overall Study|Protocol Violation|7
716556|NCT00122681|2309294|P2|Overall Study|Lost to Follow-up|1097
716557|NCT00122681|2309295|P1|Overall Study|Lost to Follow-up|1080
716558|NCT00122681|2309294|P2|Overall Study|Adverse Event|16
716559|NCT00122681|2309295|P1|Overall Study|Adverse Event|20
716560|NCT00122954|2309369|P2|Overall Study|Protocol Violation|1
716561|NCT00122954|2309370|P1|Overall Study|Protocol Violation|0
716562|NCT00122954|2309369|P2|Overall Study|Withdrawal by Subject|2
716563|NCT00122954|2309370|P1|Overall Study|Withdrawal by Subject|2
716564|NCT00122980|2309380|P2|Overall Study|Study termination|35
716565|NCT00122980|2309381|P1|Overall Study|Study termination|27
716566|NCT00122980|2309380|P2|Overall Study|Adjudicated stroke (study endpoint)|0
716567|NCT00122980|2309381|P1|Overall Study|Adjudicated stroke (study endpoint)|7
716568|NCT00122980|2309380|P2|Overall Study|Withdrawal by Subject|3
716569|NCT00122980|2309381|P1|Overall Study|Withdrawal by Subject|2
716570|NCT00122980|2309380|P2|Overall Study|Protocol Violation|1
716571|NCT00122980|2309381|P1|Overall Study|Protocol Violation|5
716572|NCT00122980|2309380|P2|Overall Study|Physician Decision|0
716573|NCT00122980|2309381|P1|Overall Study|Physician Decision|2
716574|NCT00122980|2309380|P2|Overall Study|Death|1
716575|NCT00122980|2309381|P1|Overall Study|Death|0
716576|NCT00123422|2309444|P3|Overall Study|Lost to Follow-up|2
716577|NCT00123422|2309445|P2|Overall Study|Lost to Follow-up|2
716578|NCT00123422|2309446|P1|Overall Study|Lost to Follow-up|1
716579|NCT00123422|2309444|P3|Overall Study|Withdrawal by Subject|2
716580|NCT00123422|2309445|P2|Overall Study|Withdrawal by Subject|2
716581|NCT00123422|2309446|P1|Overall Study|Withdrawal by Subject|1
716582|NCT00123422|2309444|P3|Overall Study|Physician Decision|6
716583|NCT00123422|2309445|P2|Overall Study|Physician Decision|2
716584|NCT00123422|2309446|P1|Overall Study|Physician Decision|2
716585|NCT00123474|2309461|P4|As Treated at Study Closure|Withdrawal by Subject|16
716586|NCT00123474|2309462|P3|As Treated at Study Closure|Withdrawal by Subject|18
716587|NCT00123474|2309463|P2|As Treated at Study Closure|Withdrawal by Subject|19
716588|NCT00123474|2309464|P1|As Treated at Study Closure|Withdrawal by Subject|14
716589|NCT00123474|2309461|P4|As Treated at Study Closure|Study Drug Toxicity|51
716590|NCT00123474|2309462|P3|As Treated at Study Closure|Study Drug Toxicity|45
716591|NCT00123474|2309463|P2|As Treated at Study Closure|Study Drug Toxicity|45
716592|NCT00123474|2309464|P1|As Treated at Study Closure|Study Drug Toxicity|39
716593|NCT00123474|2309461|P4|As Treated at Study Closure|non-specified|60
716594|NCT00123474|2309462|P3|As Treated at Study Closure|non-specified|57
716595|NCT00123474|2309463|P2|As Treated at Study Closure|non-specified|47
716596|NCT00123474|2309464|P1|As Treated at Study Closure|non-specified|54
716597|NCT00123474|2309461|P4|As Treated at Study Closure|Investigator Request|5
716598|NCT00123474|2309462|P3|As Treated at Study Closure|Investigator Request|7
716599|NCT00123474|2309463|P2|As Treated at Study Closure|Investigator Request|6
716600|NCT00123474|2309464|P1|As Treated at Study Closure|Investigator Request|12
716601|NCT00123474|2309461|P4|As Treated at Study Closure|Disease Progression|27
716602|NCT00123474|2309462|P3|As Treated at Study Closure|Disease Progression|29
716603|NCT00123474|2309463|P2|As Treated at Study Closure|Disease Progression|42
716604|NCT00123474|2309464|P1|As Treated at Study Closure|Disease Progression|35
716605|NCT00123474|2309461|P4|As Treated at Study Closure|Adverse Event|8
716606|NCT00123474|2309462|P3|As Treated at Study Closure|Adverse Event|10
716607|NCT00123474|2309463|P2|As Treated at Study Closure|Adverse Event|4
716608|NCT00123474|2309464|P1|As Treated at Study Closure|Adverse Event|10
716609|NCT00123474|2309461|P4|As Treated at Study Closure|not reported when site closed|0
716610|NCT00123474|2309462|P3|As Treated at Study Closure|not reported when site closed|1
716611|NCT00123474|2309463|P2|As Treated at Study Closure|not reported when site closed|0
716612|NCT00123474|2309464|P1|As Treated at Study Closure|not reported when site closed|1
716613|NCT00123474|2309461|P4|Randomized to Treatment|Randomized, never treated|1
716614|NCT00123474|2309462|P3|Randomized to Treatment|Randomized, never treated|2
716615|NCT00123474|2309463|P2|Randomized to Treatment|Randomized, never treated|4
716616|NCT00123474|2309464|P1|Randomized to Treatment|Randomized, never treated|1
716617|NCT00123487|2309557|P2|Treated With Study Drug|Unknown (case report form lost)|1
716618|NCT00123487|2309558|P1|Treated With Study Drug|Unknown (case report form lost)|0
716619|NCT00123487|2309557|P2|Treated With Study Drug|Withdrawal by Subject|13
716620|NCT00123487|2309558|P1|Treated With Study Drug|Withdrawal by Subject|11
716621|NCT00123487|2309557|P2|Treated With Study Drug|Study Drug Toxicity|80
716622|NCT00123487|2309558|P1|Treated With Study Drug|Study Drug Toxicity|62
716623|NCT00123487|2309557|P2|Treated With Study Drug|Not Specified|58
716624|NCT00123487|2309558|P1|Treated With Study Drug|Not Specified|59
716625|NCT00123487|2309557|P2|Treated With Study Drug|Physician Decision|9
716626|NCT00123487|2309558|P1|Treated With Study Drug|Physician Decision|8
716627|NCT00123487|2309557|P2|Treated With Study Drug|Disease Progression|122
716628|NCT00123487|2309558|P1|Treated With Study Drug|Disease Progression|141
716629|NCT00123487|2309557|P2|Treated With Study Drug|Adverse Event|22
716630|NCT00123487|2309558|P1|Treated With Study Drug|Adverse Event|23
716631|NCT00123487|2309557|P2|Randomized|SAE prior to starting treatment|0
716632|NCT00123487|2309558|P1|Randomized|SAE prior to starting treatment|1
716633|NCT00123487|2309557|P2|Randomized|Death prior to starting treatment|1
716634|NCT00123487|2309558|P1|Randomized|Death prior to starting treatment|0
716635|NCT00123734|2309659|P1|Overall Study|Withdrawal by Subject|1
716636|NCT00123734|2309659|P1|Overall Study|Dropout|1
716637|NCT00123734|2309659|P1|Overall Study|Lost to Follow-up|3
716638|NCT00123734|2309659|P1|Overall Study|Death|3
716639|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Relocated|0
716640|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Relocated|1
716641|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
716642|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
716643|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Pregnancy|0
716644|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Pregnancy|1
716645|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
716646|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
716647|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
716648|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
716649|NCT00124449|2309692|P2|18-Month Untreated Observation Period|Adverse Event|1
716650|NCT00124449|2309693|P1|18-Month Untreated Observation Period|Adverse Event|0
716651|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
716652|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
716653|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Sponsor request|1
716654|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Sponsor request|0
716655|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
716656|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
716657|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
716658|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
716659|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
716660|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
716661|NCT00124449|2309692|P2|6-month Double-Blind Treatment Period|Adverse Event|0
716662|NCT00124449|2309693|P1|6-month Double-Blind Treatment Period|Adverse Event|1
716663|NCT00124462|2309728|P2|Overall Study|Device fitting, n=2, other hlth issues|1
716664|NCT00124462|2309729|P1|Overall Study|Device fitting, n=2, other hlth issues|1
716665|NCT00124462|2309728|P2|Overall Study|Withdrawal by Subject|5
716666|NCT00124462|2309729|P1|Overall Study|Withdrawal by Subject|4
716667|NCT00124462|2309728|P2|Overall Study|Physician Decision|4
716668|NCT00124462|2309729|P1|Overall Study|Physician Decision|3
716669|NCT00124462|2309728|P2|Overall Study|Lost to Follow-up|3
716670|NCT00124462|2309729|P1|Overall Study|Lost to Follow-up|3
716671|NCT00124618|2309743|P1|Overall Study|Ineligible|1
716672|NCT00124657|2309753|P3|Overall Study|Intercurrent illness|0
716673|NCT00124657|2309754|P2|Overall Study|Intercurrent illness|0
716674|NCT00124657|2309755|P1|Overall Study|Intercurrent illness|1
716675|NCT00124657|2309753|P3|Overall Study|Progressive disease|27
716676|NCT00124657|2309754|P2|Overall Study|Progressive disease|5
716677|NCT00124657|2309755|P1|Overall Study|Progressive disease|14
716678|NCT00124657|2309753|P3|Overall Study|Non-compliance|4
716679|NCT00124657|2309754|P2|Overall Study|Non-compliance|0
716680|NCT00124657|2309755|P1|Overall Study|Non-compliance|1
716681|NCT00124657|2309753|P3|Overall Study|Toxicity|1
716682|NCT00124657|2309754|P2|Overall Study|Toxicity|0
716683|NCT00124657|2309755|P1|Overall Study|Toxicity|0
716684|NCT00124709|2309792|P2|Overall Study|Lost to Follow-up|120
716685|NCT00124709|2309793|P1|Overall Study|Lost to Follow-up|114
716686|NCT00124709|2309792|P2|Overall Study|Withdrawal by Subject|136
716687|NCT00124709|2309793|P1|Overall Study|Withdrawal by Subject|127
716688|NCT00124709|2309792|P2|Overall Study|Protocol Violation|5
716689|NCT00124709|2309793|P1|Overall Study|Protocol Violation|3
716690|NCT00124709|2309792|P2|Overall Study|Lack of Efficacy|10
716691|NCT00124709|2309793|P1|Overall Study|Lack of Efficacy|5
716692|NCT00124709|2309792|P2|Overall Study|Adverse Event|0
716693|NCT00124709|2309793|P1|Overall Study|Adverse Event|3
716694|NCT00124709|2309792|P2|Overall Study|Randomized but did not take medication|1
716695|NCT00124709|2309793|P1|Overall Study|Randomized but did not take medication|3
716696|NCT00124748|2309872|P2|Overall Study|Death|3
716697|NCT00124748|2309873|P1|Overall Study|Death|1
716698|NCT00124748|2309872|P2|Overall Study|Administrative Problem(Study Terminated)|174
716699|NCT00124748|2309873|P1|Overall Study|Administrative Problem(Study Terminated)|101
716700|NCT00124748|2309872|P2|Overall Study|Lost to Follow-up|7
716701|NCT00124748|2309873|P1|Overall Study|Lost to Follow-up|2
716702|NCT00124748|2309872|P2|Overall Study|Withdrawal by Subject|15
716703|NCT00124748|2309873|P1|Overall Study|Withdrawal by Subject|5
716704|NCT00124748|2309872|P2|Overall Study|Protocol Violation|1
716705|NCT00124748|2309873|P1|Overall Study|Protocol Violation|3
716706|NCT00124748|2309872|P2|Overall Study|No longer requires study drug|1
716707|NCT00124748|2309873|P1|Overall Study|No longer requires study drug|1
716708|NCT00124748|2309872|P2|Overall Study|Lack of Efficacy|41
716709|NCT00124748|2309873|P1|Overall Study|Lack of Efficacy|20
716710|NCT00124748|2309872|P2|Overall Study|Abnormal Procedure|1
716711|NCT00124748|2309873|P1|Overall Study|Abnormal Procedure|0
716712|NCT00124748|2309872|P2|Overall Study|Abnormal laboratory Value|2
716713|NCT00124748|2309873|P1|Overall Study|Abnormal laboratory Value|2
716714|NCT00124748|2309872|P2|Overall Study|Adverse Event|39
716715|NCT00124748|2309873|P1|Overall Study|Adverse Event|8
716716|NCT00124943|2309919|P4|Phase II|Withdrawal by Subject|2
716717|NCT00124943|2309920|P3|Phase II|Withdrawal by Subject|0
716718|NCT00124943|2309921|P2|Phase II|Withdrawal by Subject|0
716719|NCT00124943|2309922|P1|Phase II|Withdrawal by Subject|0
716720|NCT00124943|2309919|P4|Phase II|Lost to Follow-up|1
716721|NCT00124943|2309920|P3|Phase II|Lost to Follow-up|0
716722|NCT00124943|2309921|P2|Phase II|Lost to Follow-up|0
716723|NCT00124943|2309922|P1|Phase II|Lost to Follow-up|0
716724|NCT00124943|2309919|P4|Phase II|Protocol Violation|1
716725|NCT00124943|2309920|P3|Phase II|Protocol Violation|0
716726|NCT00124943|2309921|P2|Phase II|Protocol Violation|0
716727|NCT00124943|2309922|P1|Phase II|Protocol Violation|0
716728|NCT00124943|2309919|P4|Phase II|Adverse Event|1
716729|NCT00124943|2309920|P3|Phase II|Adverse Event|0
716730|NCT00124943|2309921|P2|Phase II|Adverse Event|2
716731|NCT00124943|2309922|P1|Phase II|Adverse Event|0
716732|NCT00124982|2309962|P3|Long-term Period|Neurologist Recommendation|1
716733|NCT00124982|2309963|P2|Long-term Period|Neurologist Recommendation|0
716734|NCT00124982|2309964|P1|Long-term Period|Neurologist Recommendation|0
716735|NCT00124982|2309962|P3|Long-term Period|Administrative Reason by Sponsor|1
716736|NCT00124982|2309963|P2|Long-term Period|Administrative Reason by Sponsor|0
716737|NCT00124982|2309964|P1|Long-term Period|Administrative Reason by Sponsor|0
716738|NCT00124982|2309962|P3|Long-term Period|Poor/Non-compliance|2
716739|NCT00124982|2309963|P2|Long-term Period|Poor/Non-compliance|0
716740|NCT00124982|2309964|P1|Long-term Period|Poor/Non-compliance|0
716741|NCT00124982|2309962|P3|Long-term Period|Pregnancy|1
716742|NCT00124982|2309963|P2|Long-term Period|Pregnancy|0
716743|NCT00124982|2309964|P1|Long-term Period|Pregnancy|0
716744|NCT00124982|2309962|P3|Long-term Period|Withdrawal by Subject|16
716745|NCT00124982|2309963|P2|Long-term Period|Withdrawal by Subject|0
716746|NCT00124982|2309964|P1|Long-term Period|Withdrawal by Subject|0
716747|NCT00124982|2309962|P3|Long-term Period|Lost to Follow-up|4
716748|NCT00124982|2309963|P2|Long-term Period|Lost to Follow-up|0
716749|NCT00124982|2309964|P1|Long-term Period|Lost to Follow-up|0
716750|NCT00124982|2309962|P3|Long-term Period|Lack of Efficacy|46
716751|NCT00124982|2309963|P2|Long-term Period|Lack of Efficacy|0
716752|NCT00124982|2309964|P1|Long-term Period|Lack of Efficacy|0
716753|NCT00124982|2309962|P3|Long-term Period|Adverse Event|17
716754|NCT00124982|2309963|P2|Long-term Period|Adverse Event|0
716755|NCT00124982|2309964|P1|Long-term Period|Adverse Event|0
716756|NCT00124982|2309962|P3|Long-term Period|Death|1
716757|NCT00124982|2309963|P2|Long-term Period|Death|0
716758|NCT00124982|2309964|P1|Long-term Period|Death|0
716759|NCT00124982|2309962|P3|Short-term Period|Participant Had Lymphopenia|0
716760|NCT00124982|2309963|P2|Short-term Period|Participant Had Lymphopenia|0
716761|NCT00124982|2309964|P1|Short-term Period|Participant Had Lymphopenia|1
716762|NCT00124982|2309962|P3|Short-term Period|Investigator Decision-No Specific AE|0
716763|NCT00124982|2309963|P2|Short-term Period|Investigator Decision-No Specific AE|0
716764|NCT00124982|2309964|P1|Short-term Period|Investigator Decision-No Specific AE|1
716765|NCT00124982|2309962|P3|Short-term Period|Participant Chose Own Doctor|0
716766|NCT00124982|2309963|P2|Short-term Period|Participant Chose Own Doctor|1
716767|NCT00124982|2309964|P1|Short-term Period|Participant Chose Own Doctor|0
716768|NCT00124982|2309962|P3|Short-term Period|Participant Decision|0
716769|NCT00124982|2309963|P2|Short-term Period|Participant Decision|0
716770|NCT00124982|2309964|P1|Short-term Period|Participant Decision|1
716771|NCT00124982|2309962|P3|Short-term Period|No Longer Meets Study Criteria|0
716772|NCT00124982|2309963|P2|Short-term Period|No Longer Meets Study Criteria|2
716773|NCT00124982|2309964|P1|Short-term Period|No Longer Meets Study Criteria|1
716774|NCT00124982|2309962|P3|Short-term Period|Poor/Non-compliance|0
716775|NCT00124982|2309963|P2|Short-term Period|Poor/Non-compliance|1
716776|NCT00124982|2309964|P1|Short-term Period|Poor/Non-compliance|3
716777|NCT00124982|2309962|P3|Short-term Period|Withdrawal of Consent|0
716778|NCT00124982|2309963|P2|Short-term Period|Withdrawal of Consent|9
716779|NCT00124982|2309964|P1|Short-term Period|Withdrawal of Consent|7
716780|NCT00124982|2309962|P3|Short-term Period|Lost to Follow-up|0
716781|NCT00124982|2309963|P2|Short-term Period|Lost to Follow-up|5
716782|NCT00124982|2309964|P1|Short-term Period|Lost to Follow-up|8
716783|NCT00124982|2309962|P3|Short-term Period|Lack of Efficacy|0
716784|NCT00124982|2309963|P2|Short-term Period|Lack of Efficacy|73
716785|NCT00124982|2309964|P1|Short-term Period|Lack of Efficacy|32
716786|NCT00124982|2309962|P3|Short-term Period|Adverse Event|0
716787|NCT00124982|2309963|P2|Short-term Period|Adverse Event|22
716788|NCT00124982|2309964|P1|Short-term Period|Adverse Event|17
716789|NCT00124982|2309962|P3|Short-term Period|Death|0
716790|NCT00124982|2309963|P2|Short-term Period|Death|1
716791|NCT00124982|2309964|P1|Short-term Period|Death|1
716792|NCT00125138|2310079|P4|Overall Study|Sponsor decision-pt moved to assist care|1
716793|NCT00125138|2310080|P3|Overall Study|Sponsor decision-pt moved to assist care|0
716794|NCT00125138|2310081|P2|Overall Study|Sponsor decision-pt moved to assist care|0
716795|NCT00125138|2310082|P1|Overall Study|Sponsor decision-pt moved to assist care|0
716796|NCT00125138|2310079|P4|Overall Study|Lack of Efficacy|1
716797|NCT00125138|2310080|P3|Overall Study|Lack of Efficacy|0
716798|NCT00125138|2310081|P2|Overall Study|Lack of Efficacy|0
716799|NCT00125138|2310082|P1|Overall Study|Lack of Efficacy|0
716800|NCT00125138|2310079|P4|Overall Study|Withdrawal by Subject|1
716801|NCT00125138|2310080|P3|Overall Study|Withdrawal by Subject|1
716802|NCT00125138|2310081|P2|Overall Study|Withdrawal by Subject|3
716803|NCT00125138|2310082|P1|Overall Study|Withdrawal by Subject|2
716804|NCT00125138|2310079|P4|Overall Study|Adverse Event|2
716805|NCT00125138|2310080|P3|Overall Study|Adverse Event|3
716806|NCT00125138|2310081|P2|Overall Study|Adverse Event|0
716807|NCT00125138|2310082|P1|Overall Study|Adverse Event|1
716808|NCT00125164|2310100|P4|Overall Study|Withdrawal by Subject|1
716809|NCT00125164|2310101|P3|Overall Study|Withdrawal by Subject|1
716810|NCT00125164|2310102|P2|Overall Study|Withdrawal by Subject|0
716811|NCT00125164|2310103|P1|Overall Study|Withdrawal by Subject|2
716812|NCT00125164|2310100|P4|Overall Study|Lost to Follow-up|1
716813|NCT00125164|2310101|P3|Overall Study|Lost to Follow-up|1
716814|NCT00125164|2310102|P2|Overall Study|Lost to Follow-up|0
716815|NCT00125164|2310103|P1|Overall Study|Lost to Follow-up|0
716816|NCT00125164|2310100|P4|Overall Study|Adverse Event|4
716817|NCT00125164|2310101|P3|Overall Study|Adverse Event|2
716818|NCT00125164|2310102|P2|Overall Study|Adverse Event|0
716819|NCT00125164|2310103|P1|Overall Study|Adverse Event|0
716820|NCT00125190|2310153|P1|Overall Study|Non-compliance|2
716821|NCT00125190|2310153|P1|Overall Study|other|1
716822|NCT00125190|2310153|P1|Overall Study|Patient/Parent Decision|7
716823|NCT00125190|2310153|P1|Overall Study|Lost to Follow-up|4
716824|NCT00125190|2310153|P1|Overall Study|Adverse Event|1
716825|NCT00125242|2310169|P2|Overall Study|did not qualify|2
716826|NCT00125242|2310170|P1|Overall Study|did not qualify|7
716827|NCT00125268|2310177|P2|Overall Study|Withdrawal by Subject|1
716828|NCT00125268|2310178|P1|Overall Study|Withdrawal by Subject|1
716829|NCT00126126|2310308|P2|Overall Study|Lost to Follow-up|2
716830|NCT00126126|2310309|P1|Overall Study|Lost to Follow-up|0
716831|NCT00126191|2310319|P2|Overall Study|Death|1
716832|NCT00126191|2310320|P1|Overall Study|Death|0
716833|NCT00126191|2310319|P2|Overall Study|Physician Decision|1
716834|NCT00126191|2310320|P1|Overall Study|Physician Decision|0
716835|NCT00126425|2310330|P2|Overall Study|Unspecified|0
716836|NCT00126425|2310331|P1|Overall Study|Unspecified|5
716837|NCT00126425|2310330|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
716838|NCT00126425|2310331|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
716839|NCT00126425|2310330|P2|Overall Study|Adverse Event|0
716840|NCT00126425|2310331|P1|Overall Study|Adverse Event|1
716841|NCT00126425|2310330|P2|Overall Study|Protocol Violation|6
716842|NCT00126425|2310331|P1|Overall Study|Protocol Violation|9
716843|NCT00126425|2310330|P2|Overall Study|Lost to Follow-up|4
716844|NCT00126425|2310331|P1|Overall Study|Lost to Follow-up|8
716845|NCT00126425|2310330|P2|Overall Study|Withdrawal by Subject|1
716846|NCT00126425|2310331|P1|Overall Study|Withdrawal by Subject|17
716847|NCT00126438|2310339|P2|Overall Study|Withdrawal by Subject|2
716848|NCT00126438|2310340|P1|Overall Study|Withdrawal by Subject|3
716849|NCT00126438|2310339|P2|Overall Study|Protocol Violation|8
716850|NCT00126438|2310340|P1|Overall Study|Protocol Violation|8
716851|NCT00126438|2310339|P2|Overall Study|Lost to Follow-up|0
716852|NCT00126438|2310340|P1|Overall Study|Lost to Follow-up|22
716853|NCT00126438|2310339|P2|Overall Study|Withdrawal due to adverse event|0
716854|NCT00126438|2310340|P1|Overall Study|Withdrawal due to adverse event|1
716855|NCT00126490|2310346|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
716856|NCT00126503|2310356|P2|Overall Study|Physician Decision|1
716857|NCT00126503|2310357|P1|Overall Study|Physician Decision|2
716858|NCT00126503|2310356|P2|Overall Study|non-compliant|0
716859|NCT00126503|2310357|P1|Overall Study|non-compliant|1
716860|NCT00126503|2310356|P2|Overall Study|Adverse Event|3
716861|NCT00126503|2310357|P1|Overall Study|Adverse Event|13
716862|NCT00126503|2310356|P2|Overall Study|Death|0
716863|NCT00126503|2310357|P1|Overall Study|Death|3
716864|NCT00126503|2310356|P2|Overall Study|other complicating disease|1
716865|NCT00126503|2310357|P1|Overall Study|other complicating disease|4
716866|NCT00126503|2310356|P2|Overall Study|alternative therapy|1
716867|NCT00126503|2310357|P1|Overall Study|alternative therapy|1
716868|NCT00126503|2310356|P2|Overall Study|Withdrawal by Subject|1
716869|NCT00126503|2310357|P1|Overall Study|Withdrawal by Subject|0
716870|NCT00126503|2310356|P2|Overall Study|disease progression|14
716871|NCT00126503|2310357|P1|Overall Study|disease progression|23
716872|NCT00126555|2310369|P1|Overall Study|Progressive Disease|3
716873|NCT00126555|2310369|P1|Overall Study|Adverse Event|2
716874|NCT00126555|2310369|P1|Overall Study|Withdrawal by Subject|1
890231|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
890232|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
890233|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
890234|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
890235|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
890236|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
890237|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
716886|NCT00126594|2310414|P2|Overall Study|Disease Progression|24
716887|NCT00126594|2310415|P1|Overall Study|Disease Progression|29
716888|NCT00126594|2310414|P2|Overall Study|Non-compliance|1
716889|NCT00126594|2310415|P1|Overall Study|Non-compliance|0
716890|NCT00126594|2310414|P2|Overall Study|Adverse Event|5
716891|NCT00126594|2310415|P1|Overall Study|Adverse Event|7
716892|NCT00126594|2310414|P2|Overall Study|Physician Decision|3
716893|NCT00126594|2310415|P1|Overall Study|Physician Decision|1
716894|NCT00126594|2310414|P2|Overall Study|Withdrawal by Subject|4
716895|NCT00126594|2310415|P1|Overall Study|Withdrawal by Subject|0
716896|NCT00126594|2310414|P2|Overall Study|Ineligible|0
716897|NCT00126594|2310415|P1|Overall Study|Ineligible|2
716898|NCT00126659|2310433|P3|Overall Study|Adverse Event|2
716899|NCT00126659|2310434|P2|Overall Study|Adverse Event|0
716900|NCT00126659|2310435|P1|Overall Study|Adverse Event|0
716901|NCT00120042|2310486|P3|Overall Study|all completed protocl|0
716902|NCT00120042|2310487|P2|Overall Study|all completed protocl|0
716903|NCT00120042|2310488|P1|Overall Study|all completed protocl|0
716904|NCT00120250|2310496|P2|Overall Study|Protocol Violation|1
716905|NCT00120250|2310497|P1|Overall Study|Protocol Violation|0
716906|NCT00120250|2310496|P2|Overall Study|Lost to Follow-up|1
716907|NCT00120250|2310497|P1|Overall Study|Lost to Follow-up|1
716908|NCT00120289|2310512|P2|Overall Study|Withdrawal by Subject|13
716909|NCT00120289|2310513|P1|Overall Study|Withdrawal by Subject|14
716910|NCT00120289|2310512|P2|Overall Study|Lost to Follow-up|14
716911|NCT00120289|2310513|P1|Overall Study|Lost to Follow-up|11
716912|NCT00120289|2310512|P2|Overall Study|Death|82
716913|NCT00120289|2310513|P1|Overall Study|Death|96
716914|NCT00120406|2310527|P2|Overall Study|patient moved but has not withdrawn|1
716915|NCT00120406|2310528|P1|Overall Study|patient moved but has not withdrawn|0
716916|NCT00120406|2310527|P2|Overall Study|received non-study stent|2
716917|NCT00120406|2310528|P1|Overall Study|received non-study stent|0
716918|NCT00120406|2310527|P2|Overall Study|Lost to Follow-up|2
716919|NCT00120406|2310528|P1|Overall Study|Lost to Follow-up|5
716920|NCT00120406|2310527|P2|Overall Study|Withdrawal by Subject|7
716921|NCT00120406|2310528|P1|Overall Study|Withdrawal by Subject|5
716922|NCT00120406|2310527|P2|Overall Study|Death|4
716923|NCT00120406|2310528|P1|Overall Study|Death|9
716924|NCT00120627|2310563|P2|Overall Study|Withdrawal by Subject|5
716925|NCT00120627|2310564|P1|Overall Study|Withdrawal by Subject|5
716926|NCT00120874|2310590|P2|Overall Study|Death|1
716927|NCT00120874|2310591|P1|Overall Study|Death|0
716928|NCT00126776|2310629|P2|Overall Study|follow up complete on all patients|0
716929|NCT00126776|2310630|P1|Overall Study|follow up complete on all patients|0
716930|NCT00127036|2310636|P2|Overall Study|Screen Failure|0
716931|NCT00127036|2310637|P1|Overall Study|Screen Failure|2
716932|NCT00127036|2310636|P2|Overall Study|Insufficient Data for Analysis|11
716933|NCT00127036|2310637|P1|Overall Study|Insufficient Data for Analysis|6
716934|NCT00127101|2310653|P6|Continuation Phase|Withdrawal by Subject|1
716935|NCT00127101|2310654|P5|Continuation Phase|Withdrawal by Subject|2
716936|NCT00127101|2310655|P4|Continuation Phase|Withdrawal by Subject|0
716937|NCT00127101|2310656|P3|Continuation Phase|Withdrawal by Subject|1
716938|NCT00127101|2310657|P2|Continuation Phase|Withdrawal by Subject|0
716939|NCT00127101|2310658|P1|Continuation Phase|Withdrawal by Subject|0
716940|NCT00127101|2310653|P6|Continuation Phase|Lack of Efficacy|1
716941|NCT00127101|2310654|P5|Continuation Phase|Lack of Efficacy|0
716942|NCT00127101|2310655|P4|Continuation Phase|Lack of Efficacy|0
716943|NCT00127101|2310656|P3|Continuation Phase|Lack of Efficacy|0
716944|NCT00127101|2310657|P2|Continuation Phase|Lack of Efficacy|0
716945|NCT00127101|2310658|P1|Continuation Phase|Lack of Efficacy|0
716946|NCT00127101|2310653|P6|Continuation Phase|Adverse Event|1
716947|NCT00127101|2310654|P5|Continuation Phase|Adverse Event|1
716948|NCT00127101|2310655|P4|Continuation Phase|Adverse Event|0
716949|NCT00127101|2310656|P3|Continuation Phase|Adverse Event|0
716950|NCT00127101|2310657|P2|Continuation Phase|Adverse Event|0
716951|NCT00127101|2310658|P1|Continuation Phase|Adverse Event|0
716952|NCT00127101|2310653|P6|Base Protocol|Withdrawal by Subject|1
716953|NCT00127101|2310654|P5|Base Protocol|Withdrawal by Subject|0
716954|NCT00127101|2310655|P4|Base Protocol|Withdrawal by Subject|0
716955|NCT00127101|2310656|P3|Base Protocol|Withdrawal by Subject|1
716956|NCT00127101|2310657|P2|Base Protocol|Withdrawal by Subject|2
716957|NCT00127101|2310658|P1|Base Protocol|Withdrawal by Subject|1
716958|NCT00127101|2310653|P6|Base Protocol|Lack of Efficacy|0
716959|NCT00127101|2310654|P5|Base Protocol|Lack of Efficacy|2
716960|NCT00127101|2310655|P4|Base Protocol|Lack of Efficacy|0
716961|NCT00127101|2310656|P3|Base Protocol|Lack of Efficacy|0
716962|NCT00127101|2310657|P2|Base Protocol|Lack of Efficacy|0
716963|NCT00127101|2310658|P1|Base Protocol|Lack of Efficacy|1
716964|NCT00127101|2310653|P6|Base Protocol|Adverse Event|0
716965|NCT00127101|2310654|P5|Base Protocol|Adverse Event|0
716966|NCT00127101|2310655|P4|Base Protocol|Adverse Event|0
716967|NCT00127101|2310656|P3|Base Protocol|Adverse Event|1
716968|NCT00127101|2310657|P2|Base Protocol|Adverse Event|2
716969|NCT00127101|2310658|P1|Base Protocol|Adverse Event|0
716970|NCT00127166|2310680|P2|Period II|Patient did not perform Visit 6 exercise|0
716971|NCT00127166|2310681|P1|Period II|Patient did not perform Visit 6 exercise|1
716972|NCT00127166|2310680|P2|Period II|Withdrawal by Subject|0
716973|NCT00127166|2310681|P1|Period II|Withdrawal by Subject|2
716974|NCT00127166|2310680|P2|Washout Period|Patient did not meet inclusion criteria|1
716975|NCT00127166|2310681|P1|Washout Period|Patient did not meet inclusion criteria|0
716976|NCT00127166|2310680|P2|Period I|Patient did not meet inclusion criteria|0
716977|NCT00127166|2310681|P1|Period I|Patient did not meet inclusion criteria|1
716978|NCT00127166|2310680|P2|Period I|Withdrawal by Subject|0
716979|NCT00127166|2310681|P1|Period I|Withdrawal by Subject|2
716980|NCT00127166|2310680|P2|Period I|Protocol Violation|2
716981|NCT00127166|2310681|P1|Period I|Protocol Violation|0
716982|NCT00127192|2310700|P5|Overall Study|Adverse event in pre-treatment period|0
716983|NCT00127192|2310701|P4|Overall Study|Adverse event in pre-treatment period|0
716984|NCT00127192|2310702|P3|Overall Study|Adverse event in pre-treatment period|0
716985|NCT00127192|2310703|P2|Overall Study|Adverse event in pre-treatment period|0
716986|NCT00127192|2310704|P1|Overall Study|Adverse event in pre-treatment period|1
716987|NCT00127192|2310700|P5|Overall Study|Withdrawal by Subject|3
716988|NCT00127192|2310701|P4|Overall Study|Withdrawal by Subject|0
716989|NCT00127192|2310702|P3|Overall Study|Withdrawal by Subject|1
716990|NCT00127192|2310703|P2|Overall Study|Withdrawal by Subject|0
716991|NCT00127192|2310704|P1|Overall Study|Withdrawal by Subject|0
716992|NCT00127192|2310700|P5|Overall Study|Lack of Efficacy|2
716993|NCT00127192|2310701|P4|Overall Study|Lack of Efficacy|0
716994|NCT00127192|2310702|P3|Overall Study|Lack of Efficacy|0
716995|NCT00127192|2310703|P2|Overall Study|Lack of Efficacy|0
716996|NCT00127192|2310704|P1|Overall Study|Lack of Efficacy|2
716997|NCT00127192|2310700|P5|Overall Study|Adverse Event|0
716998|NCT00127192|2310701|P4|Overall Study|Adverse Event|1
716999|NCT00127192|2310702|P3|Overall Study|Adverse Event|1
717000|NCT00127192|2310703|P2|Overall Study|Adverse Event|1
717001|NCT00127192|2310704|P1|Overall Study|Adverse Event|0
717002|NCT00127413|2310739|P4|Overall Study|Lost to Follow-up|2
717003|NCT00127413|2310740|P3|Overall Study|Lost to Follow-up|8
717004|NCT00127413|2310741|P2|Overall Study|Lost to Follow-up|4
717005|NCT00127413|2310742|P1|Overall Study|Lost to Follow-up|6
717006|NCT00127660|2310765|P4|Overall Study|Protocol Violation|0
717007|NCT00127660|2310766|P3|Overall Study|Protocol Violation|5
717008|NCT00127660|2310767|P2|Overall Study|Protocol Violation|3
717009|NCT00127660|2310768|P1|Overall Study|Protocol Violation|3
717010|NCT00127712|2310780|P2|Overall Study|Lack of GI access to continue|0
717011|NCT00127712|2310781|P1|Overall Study|Lack of GI access to continue|2
717012|NCT00127712|2310780|P2|Overall Study|Adverse Event|0
717013|NCT00127712|2310781|P1|Overall Study|Adverse Event|3
717014|NCT00127803|2310826|P4|Overall Study|Lost to Follow-up|1
717015|NCT00127803|2310827|P3|Overall Study|Lost to Follow-up|0
717016|NCT00127803|2310828|P2|Overall Study|Lost to Follow-up|0
717017|NCT00127803|2310829|P1|Overall Study|Lost to Follow-up|0
717018|NCT00127803|2310826|P4|Overall Study|Withdrawal by Subject|0
717019|NCT00127803|2310827|P3|Overall Study|Withdrawal by Subject|0
717020|NCT00127803|2310828|P2|Overall Study|Withdrawal by Subject|0
717021|NCT00127803|2310829|P1|Overall Study|Withdrawal by Subject|1
717022|NCT00127803|2310826|P4|Overall Study|Adverse Event|0
717023|NCT00127803|2310827|P3|Overall Study|Adverse Event|0
717024|NCT00127803|2310828|P2|Overall Study|Adverse Event|0
717025|NCT00127803|2310829|P1|Overall Study|Adverse Event|2
717026|NCT00127842|2310847|P1|Overall Study|Other|5
717027|NCT00127842|2310847|P1|Overall Study|Protocol Violation|1
717028|NCT00127842|2310847|P1|Overall Study|Noncompliance|2
717029|NCT00127842|2310847|P1|Overall Study|Lack of Efficacy|12
717030|NCT00127842|2310847|P1|Overall Study|Lost to Follow-up|1
717031|NCT00127842|2310847|P1|Overall Study|Withdrawal by Subject|3
717032|NCT00127842|2310847|P1|Overall Study|Adverse Event|15
717033|NCT00127855|2310866|P5|Primary Vaccination Course|Unspecified|1
717034|NCT00127855|2310867|P4|Primary Vaccination Course|Unspecified|0
717035|NCT00127855|2310868|P3|Primary Vaccination Course|Unspecified|0
717036|NCT00127855|2310869|P2|Primary Vaccination Course|Unspecified|0
717037|NCT00127855|2310870|P1|Primary Vaccination Course|Unspecified|0
717038|NCT00127855|2310866|P5|Primary Vaccination Course|Lost to Follow-up|2
717039|NCT00127855|2310867|P4|Primary Vaccination Course|Lost to Follow-up|0
717040|NCT00127855|2310868|P3|Primary Vaccination Course|Lost to Follow-up|1
717041|NCT00127855|2310869|P2|Primary Vaccination Course|Lost to Follow-up|1
717042|NCT00127855|2310870|P1|Primary Vaccination Course|Lost to Follow-up|1
717043|NCT00127855|2310866|P5|Primary Vaccination Course|Withdrawal by Subject|1
717044|NCT00127855|2310867|P4|Primary Vaccination Course|Withdrawal by Subject|0
717045|NCT00127855|2310868|P3|Primary Vaccination Course|Withdrawal by Subject|0
717046|NCT00127855|2310869|P2|Primary Vaccination Course|Withdrawal by Subject|0
717047|NCT00127855|2310870|P1|Primary Vaccination Course|Withdrawal by Subject|1
717048|NCT00127855|2310866|P5|Primary Vaccination Course|Adverse Event|0
717049|NCT00127855|2310867|P4|Primary Vaccination Course|Adverse Event|0
717050|NCT00127855|2310868|P3|Primary Vaccination Course|Adverse Event|1
717051|NCT00127855|2310869|P2|Primary Vaccination Course|Adverse Event|0
717052|NCT00127855|2310870|P1|Primary Vaccination Course|Adverse Event|0
717053|NCT00127933|2311054|P2|Overall Study|Randomized but not dosed|0
717054|NCT00127933|2311055|P1|Overall Study|Randomized but not dosed|1
717055|NCT00128206|2311357|P2|Overall Study|Adverse Event|2
717056|NCT00128206|2311358|P1|Overall Study|Adverse Event|0
717057|NCT00128206|2311357|P2|Overall Study|Lost to Follow-up|118
717058|NCT00128206|2311358|P1|Overall Study|Lost to Follow-up|137
717059|NCT00128492|2311463|P2|Overall Study|Pregnancy|1
717060|NCT00128492|2311464|P1|Overall Study|Pregnancy|0
717061|NCT00128492|2311463|P2|Overall Study|Withdrawal by Subject|5
717062|NCT00128492|2311464|P1|Overall Study|Withdrawal by Subject|3
717063|NCT00128492|2311463|P2|Overall Study|Personal or administrative|22
717064|NCT00128492|2311464|P1|Overall Study|Personal or administrative|10
717065|NCT00128492|2311463|P2|Overall Study|Noncompliance|5
717066|NCT00128492|2311464|P1|Overall Study|Noncompliance|0
717067|NCT00128492|2311463|P2|Overall Study|Lost to Follow-up|5
717068|NCT00128492|2311464|P1|Overall Study|Lost to Follow-up|1
717069|NCT00128492|2311463|P2|Overall Study|Death|0
717070|NCT00128492|2311464|P1|Overall Study|Death|1
717071|NCT00128492|2311463|P2|Overall Study|AE related to study|4
717072|NCT00128492|2311464|P1|Overall Study|AE related to study|1
717073|NCT00128492|2311463|P2|Overall Study|Study drug intolerance (AE)|8
717074|NCT00128492|2311464|P1|Overall Study|Study drug intolerance (AE)|2
717075|NCT00128492|2311463|P2|Overall Study|AE unrelated to study|9
717076|NCT00128492|2311464|P1|Overall Study|AE unrelated to study|2
717077|NCT00128661|2311524|P2|Overall Study|Unspecified|8
717078|NCT00128661|2311525|P1|Overall Study|Unspecified|7
717079|NCT00128661|2311524|P2|Overall Study|Withdrawal by Subject|232
717080|NCT00128661|2311525|P1|Overall Study|Withdrawal by Subject|243
717081|NCT00128661|2311524|P2|Overall Study|Lost to Follow-up|7
717082|NCT00128661|2311525|P1|Overall Study|Lost to Follow-up|10
717083|NCT00128661|2311524|P2|Overall Study|Adverse Event|11
717084|NCT00128661|2311525|P1|Overall Study|Adverse Event|14
717085|NCT00128830|2311594|P1|Overall Study|Unspecified|9
717086|NCT00128830|2311594|P1|Overall Study|Discontinued or ineligible for study|2
717087|NCT00128830|2311594|P1|Overall Study|Non-compliant|4
717088|NCT00128830|2311594|P1|Overall Study|Reached a virologic endpoint|29
717089|NCT00128830|2311594|P1|Overall Study|Lost to Follow-up|4
717090|NCT00128830|2311594|P1|Overall Study|Withdrawal by Subject|14
717091|NCT00128830|2311594|P1|Overall Study|Adverse Event|10
717092|NCT00129116|2311636|P5|Booster Phase|Lost to Follow-up|1
717093|NCT00129116|2311637|P4|Booster Phase|Lost to Follow-up|0
717094|NCT00129116|2311638|P3|Booster Phase|Lost to Follow-up|0
717095|NCT00129116|2311639|P2|Booster Phase|Lost to Follow-up|0
717096|NCT00129116|2311640|P1|Booster Phase|Lost to Follow-up|2
717097|NCT00129116|2311636|P5|Primary Phase|Unspecified|0
717098|NCT00129116|2311637|P4|Primary Phase|Unspecified|0
717099|NCT00129116|2311638|P3|Primary Phase|Unspecified|1
717100|NCT00129116|2311639|P2|Primary Phase|Unspecified|0
717101|NCT00129116|2311640|P1|Primary Phase|Unspecified|0
717102|NCT00129116|2311636|P5|Primary Phase|Withdrawal by Subject|0
717103|NCT00129116|2311637|P4|Primary Phase|Withdrawal by Subject|0
717104|NCT00129116|2311638|P3|Primary Phase|Withdrawal by Subject|0
717105|NCT00129116|2311639|P2|Primary Phase|Withdrawal by Subject|1
717106|NCT00129116|2311640|P1|Primary Phase|Withdrawal by Subject|0
717107|NCT00129116|2311636|P5|Primary Phase|Adverse Event|0
717108|NCT00129116|2311637|P4|Primary Phase|Adverse Event|0
717109|NCT00129116|2311638|P3|Primary Phase|Adverse Event|0
717110|NCT00129116|2311639|P2|Primary Phase|Adverse Event|1
717111|NCT00129116|2311640|P1|Primary Phase|Adverse Event|1
717112|NCT00129116|2311636|P5|Primary Phase|Protocol Violation|0
717113|NCT00129116|2311637|P4|Primary Phase|Protocol Violation|0
717114|NCT00129116|2311638|P3|Primary Phase|Protocol Violation|0
717115|NCT00129116|2311639|P2|Primary Phase|Protocol Violation|1
717116|NCT00129116|2311640|P1|Primary Phase|Protocol Violation|0
717117|NCT00129116|2311636|P5|Primary Phase|Lost to Follow-up|1
717118|NCT00129116|2311637|P4|Primary Phase|Lost to Follow-up|1
717119|NCT00129116|2311638|P3|Primary Phase|Lost to Follow-up|0
717120|NCT00129116|2311639|P2|Primary Phase|Lost to Follow-up|1
717121|NCT00129116|2311640|P1|Primary Phase|Lost to Follow-up|1
717122|NCT00129129|2311905|P5|Fourth Dose Phase|Protocol Violation|0
717123|NCT00129129|2311906|P4|Fourth Dose Phase|Protocol Violation|1
717124|NCT00129129|2311907|P3|Fourth Dose Phase|Protocol Violation|0
717125|NCT00129129|2311908|P2|Fourth Dose Phase|Protocol Violation|0
717126|NCT00129129|2311909|P1|Fourth Dose Phase|Protocol Violation|0
717127|NCT00129129|2311905|P5|Fourth Dose Phase|Unspecified|1
717128|NCT00129129|2311906|P4|Fourth Dose Phase|Unspecified|1
717129|NCT00129129|2311907|P3|Fourth Dose Phase|Unspecified|0
717130|NCT00129129|2311908|P2|Fourth Dose Phase|Unspecified|0
717131|NCT00129129|2311909|P1|Fourth Dose Phase|Unspecified|0
717132|NCT00129129|2311905|P5|Fourth Dose Phase|Migration from study area|2
717133|NCT00129129|2311906|P4|Fourth Dose Phase|Migration from study area|0
717134|NCT00129129|2311907|P3|Fourth Dose Phase|Migration from study area|0
717135|NCT00129129|2311908|P2|Fourth Dose Phase|Migration from study area|0
717136|NCT00129129|2311909|P1|Fourth Dose Phase|Migration from study area|0
717137|NCT00129129|2311905|P5|Fourth Dose Phase|Withdrawal by Subject|1
717138|NCT00129129|2311906|P4|Fourth Dose Phase|Withdrawal by Subject|0
717139|NCT00129129|2311907|P3|Fourth Dose Phase|Withdrawal by Subject|0
717140|NCT00129129|2311908|P2|Fourth Dose Phase|Withdrawal by Subject|0
717141|NCT00129129|2311909|P1|Fourth Dose Phase|Withdrawal by Subject|0
717142|NCT00129129|2311905|P5|Fourth Dose Phase|Lost to Follow-up|2
717143|NCT00129129|2311906|P4|Fourth Dose Phase|Lost to Follow-up|2
717144|NCT00129129|2311907|P3|Fourth Dose Phase|Lost to Follow-up|0
717145|NCT00129129|2311908|P2|Fourth Dose Phase|Lost to Follow-up|0
717146|NCT00129129|2311909|P1|Fourth Dose Phase|Lost to Follow-up|4
717147|NCT00129129|2311905|P5|Primary Phase|Unspecified|0
717148|NCT00129129|2311906|P4|Primary Phase|Unspecified|0
717149|NCT00129129|2311907|P3|Primary Phase|Unspecified|0
717150|NCT00129129|2311908|P2|Primary Phase|Unspecified|5
717151|NCT00129129|2311909|P1|Primary Phase|Unspecified|2
717152|NCT00129129|2311905|P5|Primary Phase|Lost to Follow-up|0
717153|NCT00129129|2311906|P4|Primary Phase|Lost to Follow-up|0
717154|NCT00129129|2311907|P3|Primary Phase|Lost to Follow-up|0
717155|NCT00129129|2311908|P2|Primary Phase|Lost to Follow-up|6
717156|NCT00129129|2311909|P1|Primary Phase|Lost to Follow-up|8
717157|NCT00129129|2311905|P5|Primary Phase|Migration from study area|0
717158|NCT00129129|2311906|P4|Primary Phase|Migration from study area|0
717159|NCT00129129|2311907|P3|Primary Phase|Migration from study area|0
717160|NCT00129129|2311908|P2|Primary Phase|Migration from study area|3
717161|NCT00129129|2311909|P1|Primary Phase|Migration from study area|1
717162|NCT00129129|2311905|P5|Primary Phase|Withdrawal by Subject|0
717163|NCT00129129|2311906|P4|Primary Phase|Withdrawal by Subject|0
717164|NCT00129129|2311907|P3|Primary Phase|Withdrawal by Subject|0
717165|NCT00129129|2311908|P2|Primary Phase|Withdrawal by Subject|10
717166|NCT00129129|2311909|P1|Primary Phase|Withdrawal by Subject|12
717167|NCT00129129|2311905|P5|Primary Phase|Adverse Event|0
717168|NCT00129129|2311906|P4|Primary Phase|Adverse Event|0
717169|NCT00129129|2311907|P3|Primary Phase|Adverse Event|0
717170|NCT00129129|2311908|P2|Primary Phase|Adverse Event|1
717171|NCT00129129|2311909|P1|Primary Phase|Adverse Event|2
717172|NCT00129220|2312114|P3|Study Period III|Reason Not Specified|2
717173|NCT00129220|2312115|P2|Study Period III|Reason Not Specified|0
717174|NCT00129220|2312116|P1|Study Period III|Reason Not Specified|9
717175|NCT00129220|2312114|P3|Study Period III|Sponsor Decision|0
717176|NCT00129220|2312115|P2|Study Period III|Sponsor Decision|0
717177|NCT00129220|2312116|P1|Study Period III|Sponsor Decision|1
717178|NCT00129220|2312114|P3|Study Period III|Withdrawal by Subject|3
717179|NCT00129220|2312115|P2|Study Period III|Withdrawal by Subject|0
717180|NCT00129220|2312116|P1|Study Period III|Withdrawal by Subject|1
717181|NCT00129220|2312114|P3|Study Period III|Protocol Violation|2
717182|NCT00129220|2312115|P2|Study Period III|Protocol Violation|1
717183|NCT00129220|2312116|P1|Study Period III|Protocol Violation|1
717184|NCT00129220|2312114|P3|Study Period III|Adverse Event|3
717185|NCT00129220|2312115|P2|Study Period III|Adverse Event|0
717186|NCT00129220|2312116|P1|Study Period III|Adverse Event|1
717187|NCT00129220|2312114|P3|Study Period II|Reason Not Specified|5
717188|NCT00129220|2312115|P2|Study Period II|Reason Not Specified|0
717189|NCT00129220|2312116|P1|Study Period II|Reason Not Specified|2
717190|NCT00129220|2312114|P3|Study Period II|Withdrawal by Subject|4
717191|NCT00129220|2312115|P2|Study Period II|Withdrawal by Subject|3
717192|NCT00129220|2312116|P1|Study Period II|Withdrawal by Subject|1
717193|NCT00129220|2312114|P3|Study Period II|Physician Decision|0
717194|NCT00129220|2312115|P2|Study Period II|Physician Decision|1
717195|NCT00129220|2312116|P1|Study Period II|Physician Decision|0
717196|NCT00129220|2312114|P3|Study Period II|Protocol Violation|1
717197|NCT00129220|2312115|P2|Study Period II|Protocol Violation|2
717198|NCT00129220|2312116|P1|Study Period II|Protocol Violation|4
717199|NCT00129220|2312114|P3|Study Period II|Entry Criteria Not Met|2
717200|NCT00129220|2312115|P2|Study Period II|Entry Criteria Not Met|0
717201|NCT00129220|2312116|P1|Study Period II|Entry Criteria Not Met|2
717202|NCT00129220|2312114|P3|Study Period II|Lack of Efficacy|28
717203|NCT00129220|2312115|P2|Study Period II|Lack of Efficacy|1
717204|NCT00129220|2312116|P1|Study Period II|Lack of Efficacy|15
717205|NCT00129220|2312114|P3|Study Period II|Adverse Event|7
717206|NCT00129220|2312115|P2|Study Period II|Adverse Event|5
717207|NCT00129220|2312116|P1|Study Period II|Adverse Event|9
717208|NCT00129259|2312170|P2|Overall Study|Only available minimal phone assessments|1
717209|NCT00129259|2312171|P1|Overall Study|Only available minimal phone assessments|0
717210|NCT00129259|2312170|P2|Overall Study|Withdrawal by Subject|1
717211|NCT00129259|2312171|P1|Overall Study|Withdrawal by Subject|2
717212|NCT00129259|2312170|P2|Overall Study|Lost to Follow-up|1
717213|NCT00129259|2312171|P1|Overall Study|Lost to Follow-up|1
717214|NCT00129272|2312183|P2|Overall Study|Withdrawal by Subject|11
717215|NCT00129272|2312184|P1|Overall Study|Withdrawal by Subject|5
717216|NCT00129272|2312183|P2|Overall Study|Lost to Follow-up|11
717217|NCT00129272|2312184|P1|Overall Study|Lost to Follow-up|12
717218|NCT00129311|2312194|P2|Overall Study|Withdrawal by Subject|19
717219|NCT00129311|2312195|P1|Overall Study|Withdrawal by Subject|12
717220|NCT00129402|2312205|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
717221|NCT00129402|2312206|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717222|NCT00129402|2312207|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717223|NCT00129402|2312208|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717224|NCT00129402|2312209|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717225|NCT00129402|2312210|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717226|NCT00129402|2312211|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
717227|NCT00129402|2312205|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
717228|NCT00129402|2312206|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717229|NCT00129402|2312207|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717230|NCT00129402|2312208|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717231|NCT00129402|2312209|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717232|NCT00129402|2312210|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717233|NCT00129402|2312211|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
717234|NCT00129402|2312205|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
717235|NCT00129402|2312206|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717236|NCT00129402|2312207|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717237|NCT00129402|2312208|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717238|NCT00129402|2312209|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717239|NCT00129402|2312210|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717240|NCT00129402|2312211|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
717241|NCT00129402|2312205|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
717242|NCT00129402|2312206|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717243|NCT00129402|2312207|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717244|NCT00129402|2312208|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717245|NCT00129402|2312209|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717246|NCT00129402|2312210|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717247|NCT00129402|2312211|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
717248|NCT00129402|2312205|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
717249|NCT00129402|2312206|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
717250|NCT00129402|2312207|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
717251|NCT00129402|2312208|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
717252|NCT00129402|2312209|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
717253|NCT00129402|2312210|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
717254|NCT00129402|2312211|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
717255|NCT00129402|2312205|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
717256|NCT00129402|2312206|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
717257|NCT00129402|2312207|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
717258|NCT00129402|2312208|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
717259|NCT00129402|2312209|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
717260|NCT00129402|2312210|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
717261|NCT00129402|2312211|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
717262|NCT00129402|2312205|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717263|NCT00129402|2312206|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717264|NCT00129402|2312207|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717265|NCT00129402|2312208|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717266|NCT00129402|2312209|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
717267|NCT00129402|2312210|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717268|NCT00129402|2312211|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
717269|NCT00129402|2312205|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
717270|NCT00129402|2312206|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
717271|NCT00129402|2312207|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
717272|NCT00129402|2312208|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
717273|NCT00129402|2312209|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
717274|NCT00129402|2312210|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
717275|NCT00129402|2312211|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
717276|NCT00129402|2312205|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717277|NCT00129402|2312206|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717278|NCT00129402|2312207|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717279|NCT00129402|2312208|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717280|NCT00129402|2312209|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
717281|NCT00129402|2312210|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717282|NCT00129402|2312211|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
717283|NCT00129402|2312205|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
717284|NCT00129402|2312206|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
717285|NCT00129402|2312207|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
717286|NCT00129402|2312208|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
717287|NCT00129402|2312209|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
717288|NCT00129402|2312210|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
717289|NCT00129402|2312211|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
717290|NCT00129402|2312205|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717291|NCT00129402|2312206|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717292|NCT00129402|2312207|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717293|NCT00129402|2312208|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
717294|NCT00129402|2312209|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717295|NCT00129402|2312210|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717296|NCT00129402|2312211|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
717297|NCT00129402|2312205|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717298|NCT00129402|2312206|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
717299|NCT00129402|2312207|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717300|NCT00129402|2312208|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717301|NCT00129402|2312209|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717302|NCT00129402|2312210|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717303|NCT00129402|2312211|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
717304|NCT00129402|2312205|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
717305|NCT00129402|2312206|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
717306|NCT00129402|2312207|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
717307|NCT00129402|2312208|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
717308|NCT00129402|2312209|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
717309|NCT00129402|2312210|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
717310|NCT00129402|2312211|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
717311|NCT00129467|2312253|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
717312|NCT00129467|2312254|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
717313|NCT00129467|2312253|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
717314|NCT00129467|2312254|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
717315|NCT00129467|2312253|P2|Received Intervention|Dizzyness, fatigue|1
717316|NCT00129467|2312254|P1|Received Intervention|Dizzyness, fatigue|0
717317|NCT00129467|2312253|P2|Received Intervention|Intolerance to citalopram|1
717318|NCT00129467|2312254|P1|Received Intervention|Intolerance to citalopram|0
717319|NCT00129467|2312253|P2|Received Intervention|Nausea|0
717320|NCT00129467|2312254|P1|Received Intervention|Nausea|1
717321|NCT00129467|2312253|P2|Received Intervention|Withdrawal by Subject|0
717322|NCT00129467|2312254|P1|Received Intervention|Withdrawal by Subject|1
717323|NCT00129467|2312253|P2|Received Intervention|Delirium|0
717324|NCT00129467|2312254|P1|Received Intervention|Delirium|2
717325|NCT00129467|2312253|P2|Received Intervention|Cardiac SAE (hypertension)|1
717326|NCT00129467|2312254|P1|Received Intervention|Cardiac SAE (hypertension)|1
717327|NCT00129467|2312253|P2|Received Intervention|Death|1
717328|NCT00129467|2312254|P1|Received Intervention|Death|1
717329|NCT00129545|2312272|P3|Overall Study|Device not implanted|0
717330|NCT00129545|2312273|P2|Overall Study|Device not implanted|61
717331|NCT00129545|2312274|P1|Overall Study|Device not implanted|16
717332|NCT00129545|2312272|P3|Overall Study|Physician Decision|10
717333|NCT00129545|2312273|P2|Overall Study|Physician Decision|3
717334|NCT00129545|2312274|P1|Overall Study|Physician Decision|0
717335|NCT00129545|2312272|P3|Overall Study|Lost to Follow-up|13
717336|NCT00129545|2312273|P2|Overall Study|Lost to Follow-up|22
717337|NCT00129545|2312274|P1|Overall Study|Lost to Follow-up|2
717338|NCT00129545|2312272|P3|Overall Study|Withdrawal by Subject|44
717339|NCT00129545|2312273|P2|Overall Study|Withdrawal by Subject|18
717340|NCT00129545|2312274|P1|Overall Study|Withdrawal by Subject|3
717341|NCT00129545|2312272|P3|Overall Study|Death|44
717342|NCT00129545|2312273|P2|Overall Study|Death|60
717343|NCT00129545|2312274|P1|Overall Study|Death|5
717344|NCT00129623|2312286|P2|Overall Study|Uncertainty to return|1
717345|NCT00129623|2312287|P1|Overall Study|Uncertainty to return|0
717346|NCT00129623|2312286|P2|Overall Study|Relocated job out of state|0
717347|NCT00129623|2312287|P1|Overall Study|Relocated job out of state|1
717348|NCT00129623|2312286|P2|Overall Study|Failure to Return|1
717349|NCT00129623|2312287|P1|Overall Study|Failure to Return|1
717350|NCT00129623|2312286|P2|Overall Study|Refused Treatment|3
717351|NCT00129623|2312287|P1|Overall Study|Refused Treatment|5
717352|NCT00129623|2312286|P2|Overall Study|Adverse Event|7
717353|NCT00129623|2312287|P1|Overall Study|Adverse Event|3
717354|NCT00123955|2312311|P2|Overall Study|Death|1
717355|NCT00123955|2312312|P1|Overall Study|Death|0
717356|NCT00123955|2312311|P2|Overall Study|Withdrawal by Subject|3
717357|NCT00123955|2312312|P1|Overall Study|Withdrawal by Subject|4
717358|NCT00123955|2312311|P2|Overall Study|Adverse Event|0
717359|NCT00123955|2312312|P1|Overall Study|Adverse Event|1
717360|NCT00124020|2312320|P2|Overall Study|Transfer to another hospital|0
717361|NCT00124020|2312321|P1|Overall Study|Transfer to another hospital|2
717362|NCT00124020|2312320|P2|Overall Study|Other|1
717363|NCT00124020|2312321|P1|Overall Study|Other|1
717364|NCT00124020|2312320|P2|Overall Study|Lost to Follow-up|8
717365|NCT00124020|2312321|P1|Overall Study|Lost to Follow-up|5
717366|NCT00124020|2312320|P2|Overall Study|Withdrawal by Subject|11
717367|NCT00124020|2312321|P1|Overall Study|Withdrawal by Subject|13
717368|NCT00124020|2312320|P2|Overall Study|Death|71
717369|NCT00124020|2312321|P1|Overall Study|Death|67
717370|NCT00124072|2312331|P4|Overall Study|Death|480
717371|NCT00124072|2312332|P3|Overall Study|Death|471
717372|NCT00124072|2312333|P2|Overall Study|Death|484
717373|NCT00124072|2312334|P1|Overall Study|Death|499
717374|NCT00124072|2312331|P4|Overall Study|Lost to Follow-up for Morbidity|18
717375|NCT00124072|2312332|P3|Overall Study|Lost to Follow-up for Morbidity|19
717376|NCT00124072|2312333|P2|Overall Study|Lost to Follow-up for Morbidity|25
717377|NCT00124072|2312334|P1|Overall Study|Lost to Follow-up for Morbidity|15
717378|NCT00124072|2312331|P4|Overall Study|Lost to Follow-up for Mortality|2
717379|NCT00124072|2312332|P3|Overall Study|Lost to Follow-up for Mortality|2
717380|NCT00124072|2312333|P2|Overall Study|Lost to Follow-up for Mortality|3
717381|NCT00124072|2312334|P1|Overall Study|Lost to Follow-up for Mortality|0
717382|NCT00129766|2312369|P2|Overall Study|Lost to Follow-up|21
717383|NCT00129766|2312370|P1|Overall Study|Lost to Follow-up|26
717384|NCT00129766|2312369|P2|Overall Study|Withdrawal of consent|30
717385|NCT00129766|2312370|P1|Overall Study|Withdrawal of consent|31
717386|NCT00129766|2312369|P2|Overall Study|Death|8
717387|NCT00129766|2312370|P1|Overall Study|Death|3
717388|NCT00129961|2312410|P2|Overall Study|Missing Record|1
717389|NCT00129961|2312411|P1|Overall Study|Missing Record|0
717390|NCT00129961|2312410|P2|Overall Study|Withdrawal by Subject|1
717391|NCT00129961|2312411|P1|Overall Study|Withdrawal by Subject|2
717392|NCT00129961|2312410|P2|Overall Study|Physician Decision|0
717393|NCT00129961|2312411|P1|Overall Study|Physician Decision|1
717394|NCT00129961|2312410|P2|Overall Study|Withdrawal by Sponsor|20
717395|NCT00129961|2312411|P1|Overall Study|Withdrawal by Sponsor|14
717396|NCT00129961|2312410|P2|Overall Study|Death|1
717397|NCT00129961|2312411|P1|Overall Study|Death|1
717398|NCT00129961|2312410|P2|Overall Study|Adverse Event|0
717399|NCT00129961|2312411|P1|Overall Study|Adverse Event|1
717400|NCT00129974|2312445|P1|Overall Study|Other|1
717401|NCT00130247|2312476|P2|Overall Study|Not compliant with DOT|2
717402|NCT00130247|2312477|P1|Overall Study|Not compliant with DOT|0
717403|NCT00130247|2312476|P2|Overall Study|Post-randomization exclusion|2
717404|NCT00130247|2312477|P1|Overall Study|Post-randomization exclusion|1
717405|NCT00130247|2312476|P2|Overall Study|Pregnancy|0
717406|NCT00130247|2312477|P1|Overall Study|Pregnancy|1
717407|NCT00130286|2312497|P4|Overall Study|Missing lab specimens|0
717408|NCT00130286|2312498|P3|Overall Study|Missing lab specimens|0
717409|NCT00130286|2312499|P2|Overall Study|Missing lab specimens|2
717410|NCT00130286|2312500|P1|Overall Study|Missing lab specimens|0
717411|NCT00130286|2312497|P4|Overall Study|Adverse Event|0
717412|NCT00130286|2312498|P3|Overall Study|Adverse Event|2
717413|NCT00130286|2312499|P2|Overall Study|Adverse Event|0
717414|NCT00130286|2312500|P1|Overall Study|Adverse Event|0
717415|NCT00130286|2312497|P4|Overall Study|Withdrawal by Subject|2
717416|NCT00130286|2312498|P3|Overall Study|Withdrawal by Subject|2
717417|NCT00130286|2312499|P2|Overall Study|Withdrawal by Subject|1
717418|NCT00130286|2312500|P1|Overall Study|Withdrawal by Subject|0
717419|NCT00130520|2312518|P1|Overall Study|Did not meet re-treatment criteria|1
717420|NCT00130520|2312518|P1|Overall Study|Protocol non-compliance|1
717421|NCT00130520|2312518|P1|Overall Study|Disease Progression|23
717422|NCT00130520|2312518|P1|Overall Study|Withdrawal by Subject|1
717423|NCT00130520|2312518|P1|Overall Study|Physician Decision|1
717424|NCT00130520|2312518|P1|Overall Study|Death|1
717425|NCT00130520|2312518|P1|Overall Study|Adverse Event|11
717426|NCT00130637|2312524|P1|Overall Study|Withdrawal by Subject|1
717427|NCT00130637|2312524|P1|Overall Study|Adverse Event|2
717428|NCT00130689|2312529|P1|Overall Study|Ineligible|6
717429|NCT00130689|2312529|P1|Overall Study|Withdrawal by Subject|3
717430|NCT00130689|2312529|P1|Overall Study|Clinical Deterioration|4
717431|NCT00130689|2312529|P1|Overall Study|Death|1
717432|NCT00130689|2312529|P1|Overall Study|Progressive Disease|29
890238|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
890239|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
890240|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
717439|NCT00130793|2312559|P2|Overall Study|Withdrew consent|0
717440|NCT00130793|2312560|P1|Overall Study|Withdrew consent|2
717441|NCT00130793|2312559|P2|Overall Study|Lost to Follow-up|4
717442|NCT00130793|2312560|P1|Overall Study|Lost to Follow-up|1
717443|NCT00130832|2312572|P2|Overall Study|Unspecified|3
717444|NCT00130832|2312573|P1|Overall Study|Unspecified|0
717445|NCT00130832|2312572|P2|Overall Study|Moved|2
717446|NCT00130832|2312573|P1|Overall Study|Moved|2
717447|NCT00130832|2312572|P2|Overall Study|Withdrawal by Subject|1
717448|NCT00130832|2312573|P1|Overall Study|Withdrawal by Subject|6
717449|NCT00130832|2312572|P2|Overall Study|Protocol Violation|8
717450|NCT00130832|2312573|P1|Overall Study|Protocol Violation|6
717451|NCT00130832|2312572|P2|Overall Study|Lost to Follow-up|2
717452|NCT00130832|2312573|P1|Overall Study|Lost to Follow-up|1
717453|NCT00130832|2312572|P2|Overall Study|Adverse Event|1
717454|NCT00130832|2312573|P1|Overall Study|Adverse Event|1
717455|NCT00131248|2312592|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
717456|NCT00131248|2312593|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
717457|NCT00131352|2312601|P2|Repeat Treatment Period|Unspecified|0
717458|NCT00131352|2312602|P1|Repeat Treatment Period|Unspecified|1
717459|NCT00131352|2312601|P2|Repeat Treatment Period|Adverse Event|0
717460|NCT00131352|2312602|P1|Repeat Treatment Period|Adverse Event|1
717461|NCT00131352|2312601|P2|Initial Treatment Period|Unspecified|2
717462|NCT00131352|2312602|P1|Initial Treatment Period|Unspecified|0
717463|NCT00131352|2312601|P2|Initial Treatment Period|Lack of Efficacy|4
717464|NCT00131352|2312602|P1|Initial Treatment Period|Lack of Efficacy|6
717465|NCT00131352|2312601|P2|Initial Treatment Period|Withdrawal by Subject|1
717466|NCT00131352|2312602|P1|Initial Treatment Period|Withdrawal by Subject|1
717467|NCT00131352|2312601|P2|Initial Treatment Period|Non-compliant|2
717468|NCT00131352|2312602|P1|Initial Treatment Period|Non-compliant|1
717469|NCT00131352|2312601|P2|Initial Treatment Period|Adverse Event|3
717470|NCT00131352|2312602|P1|Initial Treatment Period|Adverse Event|1
717471|NCT00131508|2312664|P2|Overall Study|Withdrawal by Subject|2
717472|NCT00131508|2312665|P1|Overall Study|Withdrawal by Subject|1
717473|NCT00131508|2312664|P2|Overall Study|Non-Compliance|4
717474|NCT00131508|2312665|P1|Overall Study|Non-Compliance|2
717475|NCT00131508|2312664|P2|Overall Study|Disease progression|2
717476|NCT00131508|2312665|P1|Overall Study|Disease progression|0
717477|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Administrative reasons|0
717478|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Administrative reasons|1
717479|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Administrative reasons|0
717480|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Administrative reasons|0
717481|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Administrative reasons|2
717482|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Administrative reasons|4
717483|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
717484|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
717485|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
717486|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
717487|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
717488|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
717489|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Adverse Event|1
717490|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Adverse Event|0
717491|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Adverse Event|0
717492|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Adverse Event|0
717493|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Adverse Event|1
717494|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Adverse Event|0
717495|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
717496|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
717497|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
717498|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
717499|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
717500|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
717501|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Protocol Violation|0
717502|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Protocol Violation|0
717503|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Protocol Violation|0
717504|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Protocol Violation|1
717505|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Protocol Violation|1
717506|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Protocol Violation|0
717507|NCT00131664|2312701|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
717508|NCT00131664|2312702|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
717509|NCT00131664|2312703|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
717510|NCT00131664|2312704|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
717511|NCT00131664|2312705|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
717512|NCT00131664|2312706|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
717513|NCT00131664|2312701|P6|First Period (First 6 Months)|Administrative reasons|0
717514|NCT00131664|2312702|P5|First Period (First 6 Months)|Administrative reasons|0
717515|NCT00131664|2312703|P4|First Period (First 6 Months)|Administrative reasons|0
717516|NCT00131664|2312704|P3|First Period (First 6 Months)|Administrative reasons|5
717517|NCT00131664|2312705|P2|First Period (First 6 Months)|Administrative reasons|0
717518|NCT00131664|2312706|P1|First Period (First 6 Months)|Administrative reasons|2
717519|NCT00131664|2312701|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
717520|NCT00131664|2312702|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
717521|NCT00131664|2312703|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
717522|NCT00131664|2312704|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
717523|NCT00131664|2312705|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
717524|NCT00131664|2312706|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
717525|NCT00131664|2312701|P6|First Period (First 6 Months)|Adverse Event|0
717526|NCT00131664|2312702|P5|First Period (First 6 Months)|Adverse Event|0
717527|NCT00131664|2312703|P4|First Period (First 6 Months)|Adverse Event|0
717528|NCT00131664|2312704|P3|First Period (First 6 Months)|Adverse Event|5
717529|NCT00131664|2312705|P2|First Period (First 6 Months)|Adverse Event|4
717530|NCT00131664|2312706|P1|First Period (First 6 Months)|Adverse Event|9
717531|NCT00131664|2312701|P6|First Period (First 6 Months)|Withdrawal by Subject|0
717532|NCT00131664|2312702|P5|First Period (First 6 Months)|Withdrawal by Subject|0
717533|NCT00131664|2312703|P4|First Period (First 6 Months)|Withdrawal by Subject|0
717534|NCT00131664|2312704|P3|First Period (First 6 Months)|Withdrawal by Subject|2
717535|NCT00131664|2312705|P2|First Period (First 6 Months)|Withdrawal by Subject|6
717536|NCT00131664|2312706|P1|First Period (First 6 Months)|Withdrawal by Subject|4
717537|NCT00131664|2312701|P6|First Period (First 6 Months)|Protocol Violation|0
717538|NCT00131664|2312702|P5|First Period (First 6 Months)|Protocol Violation|0
717539|NCT00131664|2312703|P4|First Period (First 6 Months)|Protocol Violation|0
717540|NCT00131664|2312704|P3|First Period (First 6 Months)|Protocol Violation|1
717541|NCT00131664|2312705|P2|First Period (First 6 Months)|Protocol Violation|2
717542|NCT00131664|2312706|P1|First Period (First 6 Months)|Protocol Violation|2
717543|NCT00131664|2312701|P6|First Period (First 6 Months)|Death|0
717544|NCT00131664|2312702|P5|First Period (First 6 Months)|Death|0
717545|NCT00131664|2312703|P4|First Period (First 6 Months)|Death|0
717546|NCT00131664|2312704|P3|First Period (First 6 Months)|Death|0
717547|NCT00131664|2312705|P2|First Period (First 6 Months)|Death|1
717548|NCT00131664|2312706|P1|First Period (First 6 Months)|Death|0
717549|NCT00131664|2312701|P6|First Period (First 6 Months)|Lost to Follow-up|0
717550|NCT00131664|2312702|P5|First Period (First 6 Months)|Lost to Follow-up|0
717551|NCT00131664|2312703|P4|First Period (First 6 Months)|Lost to Follow-up|0
717552|NCT00131664|2312704|P3|First Period (First 6 Months)|Lost to Follow-up|3
717553|NCT00131664|2312705|P2|First Period (First 6 Months)|Lost to Follow-up|3
717554|NCT00131664|2312706|P1|First Period (First 6 Months)|Lost to Follow-up|7
717555|NCT00131911|2312821|P2|Overall Study|Withdrawal by Subject|0
717556|NCT00131911|2312822|P1|Overall Study|Withdrawal by Subject|1
717557|NCT00131937|2312835|P1|Overall Study|Alternative therapy|1
717558|NCT00131937|2312835|P1|Overall Study|Disease Progression|7
717559|NCT00131937|2312835|P1|Overall Study|Physician Decision|1
717560|NCT00131937|2312835|P1|Overall Study|Withdrawal by Subject|2
717561|NCT00131937|2312835|P1|Overall Study|Adverse Event|3
717562|NCT00132028|2312847|P1|Overall Study|Physician Decision|3
717563|NCT00132028|2312847|P1|Overall Study|not eligible|2
717564|NCT00132028|2312847|P1|Overall Study|Withdrawal by Subject|2
717565|NCT00132028|2312847|P1|Overall Study|Lack of Efficacy|11
717566|NCT00132028|2312847|P1|Overall Study|Death|2
717567|NCT00132028|2312847|P1|Overall Study|Adverse Event|7
717568|NCT00132132|2312855|P2|Overall Study|Lost to Follow-up|2
717569|NCT00132132|2312856|P1|Overall Study|Lost to Follow-up|7
717570|NCT00132314|2312866|P2|Overall Study|Refused intervention at baseline|7
717571|NCT00132314|2312867|P1|Overall Study|Refused intervention at baseline|2
717572|NCT00132314|2312866|P2|Overall Study|Lacked SSN|3
717573|NCT00132314|2312867|P1|Overall Study|Lacked SSN|1
717574|NCT00132314|2312866|P2|Overall Study|Lost to Follow-up|62
717575|NCT00132314|2312867|P1|Overall Study|Lost to Follow-up|70
717576|NCT00132496|2312877|P2|Overall Study|Physician Decision|0
717577|NCT00132496|2312878|P1|Overall Study|Physician Decision|1
717578|NCT00132496|2312877|P2|Overall Study|Withdrawal by Subject|2
717579|NCT00132496|2312878|P1|Overall Study|Withdrawal by Subject|1
717580|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
717581|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
717582|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
717583|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
717584|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
717585|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
717586|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
717587|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
717588|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
717589|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
717590|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
717591|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
717592|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
717593|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
717594|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
717595|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
717596|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
717597|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
717598|NCT00132678|2312886|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
717599|NCT00132678|2312887|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
717600|NCT00132678|2312888|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
717601|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Pregnancy|0
717602|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Pregnancy|0
717603|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Pregnancy|2
717604|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Physician Decision|0
717605|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Physician Decision|0
717606|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Physician Decision|1
717607|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
717608|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
717609|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
717610|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
717611|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
717612|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
717613|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
717614|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
717615|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
717616|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
717617|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
717618|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
717619|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Non responder|0
717620|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Non responder|0
717621|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Non responder|107
717622|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Adverse Event|0
717623|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Adverse Event|0
717624|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Adverse Event|12
717625|NCT00132678|2312886|P3|Period III (Open-Label Stabilization)|Death|0
717626|NCT00132678|2312887|P2|Period III (Open-Label Stabilization)|Death|0
717627|NCT00132678|2312888|P1|Period III (Open-Label Stabilization)|Death|2
717628|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
717629|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
717630|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
717631|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
717632|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
717633|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
717634|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
717635|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
717636|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
717637|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
717638|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
717639|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
717640|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
717641|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
717642|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
717643|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
717644|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
717645|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
717646|NCT00132678|2312886|P3|Period II (Open-Label Oral Risperidone)|Death|1
717647|NCT00132678|2312887|P2|Period II (Open-Label Oral Risperidone)|Death|0
717648|NCT00132678|2312888|P1|Period II (Open-Label Oral Risperidone)|Death|0
717649|NCT00132691|2312902|P2|Overall Study|Death|0
717650|NCT00132691|2312903|P1|Overall Study|Death|2
717651|NCT00132691|2312902|P2|Overall Study|Missed 2-year visit|4
717652|NCT00132691|2312903|P1|Overall Study|Missed 2-year visit|4
717653|NCT00132691|2312902|P2|Overall Study|Lost to Follow-up|8
717654|NCT00132691|2312903|P1|Overall Study|Lost to Follow-up|5
717655|NCT00132730|2312945|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
717656|NCT00132730|2312946|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
717657|NCT00132730|2312947|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
717658|NCT00132730|2312948|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
717659|NCT00132730|2312949|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
717660|NCT00132730|2312950|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
717661|NCT00132730|2312945|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
717662|NCT00132730|2312946|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
717663|NCT00132730|2312947|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
717664|NCT00132730|2312948|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
717665|NCT00132730|2312949|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
717666|NCT00132730|2312950|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
717667|NCT00132730|2312945|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
717668|NCT00132730|2312946|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
717669|NCT00132730|2312947|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
717670|NCT00132730|2312948|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
717671|NCT00132730|2312949|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
717672|NCT00132730|2312950|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
717673|NCT00132730|2312945|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
717674|NCT00132730|2312946|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
717675|NCT00132730|2312947|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
717676|NCT00132730|2312948|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
717677|NCT00132730|2312949|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
717678|NCT00132730|2312950|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
717679|NCT00132730|2312945|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
717680|NCT00132730|2312946|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
717681|NCT00132730|2312947|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
717682|NCT00132730|2312948|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
717683|NCT00132730|2312949|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
717684|NCT00132730|2312950|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
717685|NCT00132730|2312945|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
717686|NCT00132730|2312946|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
717687|NCT00132730|2312947|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
717688|NCT00132730|2312948|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
717689|NCT00132730|2312949|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
717690|NCT00132730|2312950|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
717691|NCT00132730|2312945|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
717692|NCT00132730|2312946|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
717693|NCT00132730|2312947|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
717694|NCT00132730|2312948|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
717695|NCT00132730|2312949|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
717696|NCT00132730|2312950|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
717697|NCT00132730|2312945|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
717698|NCT00132730|2312946|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
717699|NCT00132730|2312947|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
717700|NCT00132730|2312948|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
717701|NCT00132730|2312949|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
717702|NCT00132730|2312950|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
717703|NCT00132730|2312945|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
717704|NCT00132730|2312946|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
717705|NCT00132730|2312947|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
717706|NCT00132730|2312948|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
717707|NCT00132730|2312949|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
717708|NCT00132730|2312950|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
717709|NCT00132730|2312945|P6|Period II - 12-week Treatment (Base)|Other reasons|0
717710|NCT00132730|2312946|P5|Period II - 12-week Treatment (Base)|Other reasons|0
717711|NCT00132730|2312947|P4|Period II - 12-week Treatment (Base)|Other reasons|13
717712|NCT00132730|2312948|P3|Period II - 12-week Treatment (Base)|Other reasons|9
717713|NCT00132730|2312949|P2|Period II - 12-week Treatment (Base)|Other reasons|10
717714|NCT00132730|2312950|P1|Period II - 12-week Treatment (Base)|Other reasons|11
717715|NCT00132730|2312945|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
717716|NCT00132730|2312946|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
717717|NCT00132730|2312947|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
717718|NCT00132730|2312948|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
717719|NCT00132730|2312949|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
717720|NCT00132730|2312950|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
717721|NCT00132730|2312945|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
717722|NCT00132730|2312946|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
717723|NCT00132730|2312947|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
717724|NCT00132730|2312948|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
717725|NCT00132730|2312949|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
717726|NCT00132730|2312950|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
717727|NCT00132769|2312994|P2|Overall Study|Protocol Violation|1
717728|NCT00132769|2312995|P1|Overall Study|Protocol Violation|1
717729|NCT00132769|2312994|P2|Overall Study|Adverse Event|1
717730|NCT00132769|2312995|P1|Overall Study|Adverse Event|2
717731|NCT00132769|2312994|P2|Overall Study|Lack of Efficacy|6
717732|NCT00132769|2312995|P1|Overall Study|Lack of Efficacy|7
717733|NCT00132769|2312994|P2|Overall Study|Withdrawal by Subject|3
717734|NCT00132769|2312995|P1|Overall Study|Withdrawal by Subject|1
717735|NCT00132808|2313020|P3|Stratum II|Withdrawal by Subject|6
717736|NCT00132808|2313021|P2|Stratum II|Withdrawal by Subject|9
717737|NCT00132808|2313022|P1|Stratum II|Withdrawal by Subject|4
717738|NCT00132808|2313020|P3|Stratum II|Protocol Violation|1
717739|NCT00132808|2313021|P2|Stratum II|Protocol Violation|2
717740|NCT00132808|2313022|P1|Stratum II|Protocol Violation|0
717741|NCT00132808|2313020|P3|Stratum II|Lost to Follow-up|1
717742|NCT00132808|2313021|P2|Stratum II|Lost to Follow-up|2
717743|NCT00132808|2313022|P1|Stratum II|Lost to Follow-up|2
717744|NCT00132808|2313020|P3|Stratum II|Death|0
717745|NCT00132808|2313021|P2|Stratum II|Death|0
717746|NCT00132808|2313022|P1|Stratum II|Death|1
717747|NCT00132808|2313020|P3|Stratum II|Adverse Event|1
717748|NCT00132808|2313021|P2|Stratum II|Adverse Event|2
717749|NCT00132808|2313022|P1|Stratum II|Adverse Event|1
717750|NCT00132808|2313020|P3|Stratum I|Abnormal test procedure result (s)|1
717751|NCT00132808|2313021|P2|Stratum I|Abnormal test procedure result (s)|0
717752|NCT00132808|2313022|P1|Stratum I|Abnormal test procedure result (s)|0
717753|NCT00132808|2313020|P3|Stratum I|Withdrawal by Subject|3
717754|NCT00132808|2313021|P2|Stratum I|Withdrawal by Subject|7
717755|NCT00132808|2313022|P1|Stratum I|Withdrawal by Subject|4
717756|NCT00132808|2313020|P3|Stratum I|Lost to Follow-up|1
717757|NCT00132808|2313021|P2|Stratum I|Lost to Follow-up|4
717758|NCT00132808|2313022|P1|Stratum I|Lost to Follow-up|3
717759|NCT00132808|2313020|P3|Stratum I|Adverse Event|0
717760|NCT00132808|2313021|P2|Stratum I|Adverse Event|1
717761|NCT00132808|2313022|P1|Stratum I|Adverse Event|2
717762|NCT00132873|2313045|P1|Overall Study|Planned Pregnancy|1
717763|NCT00132873|2313045|P1|Overall Study|Withdrawal by Subject|3
717764|NCT00132873|2313045|P1|Overall Study|Lack of Efficacy|1
717765|NCT00132873|2313045|P1|Overall Study|Lost to Follow-up|1
717766|NCT00132873|2313045|P1|Overall Study|Adverse Event|3
717767|NCT00136916|2313100|P2|Overall Study|Discontinued in follow up period|0
717768|NCT00136916|2313101|P1|Overall Study|Discontinued in follow up period|3
717769|NCT00136916|2313100|P2|Overall Study|Unspecified|24
717770|NCT00136916|2313101|P1|Overall Study|Unspecified|22
717771|NCT00136916|2313100|P2|Overall Study|Withdrawal by Subject|46
717772|NCT00136916|2313101|P1|Overall Study|Withdrawal by Subject|44
717773|NCT00136916|2313100|P2|Overall Study|Lost to Follow-up|14
717774|NCT00136916|2313101|P1|Overall Study|Lost to Follow-up|12
717775|NCT00136916|2313100|P2|Overall Study|Lack of Efficacy|3
717776|NCT00136916|2313101|P1|Overall Study|Lack of Efficacy|13
717777|NCT00136916|2313100|P2|Overall Study|Laboratory abnormality|1
717778|NCT00136916|2313101|P1|Overall Study|Laboratory abnormality|0
717779|NCT00136916|2313100|P2|Overall Study|Adverse Event|8
717780|NCT00136916|2313101|P1|Overall Study|Adverse Event|27
717781|NCT00136916|2313100|P2|Overall Study|Death|3
717782|NCT00136916|2313101|P1|Overall Study|Death|1
717783|NCT00136916|2313100|P2|Overall Study|Never received study treatment|5
717784|NCT00136916|2313101|P1|Overall Study|Never received study treatment|3
717785|NCT00136955|2313155|P1|Overall Study|Incl. prog. disease, protocol violation|12
717786|NCT00136955|2313155|P1|Overall Study|Withdrawal by Subject|2
717787|NCT00136955|2313155|P1|Overall Study|Lost to Follow-up|1
717788|NCT00136955|2313155|P1|Overall Study|Adverse Event|8
717789|NCT00137046|2313164|P2|Overall Study|Withdrew prior to study treatment|1
717790|NCT00137046|2313165|P1|Overall Study|Withdrew prior to study treatment|1
717791|NCT00137046|2313164|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
717792|NCT00137046|2313165|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
717793|NCT00137046|2313164|P2|Overall Study|Withdrawal by Subject|42
717794|NCT00137046|2313165|P1|Overall Study|Withdrawal by Subject|33
717795|NCT00137046|2313164|P2|Overall Study|Unspecified|19
717796|NCT00137046|2313165|P1|Overall Study|Unspecified|23
717797|NCT00137046|2313164|P2|Overall Study|Lost to Follow-up|24
717798|NCT00137046|2313165|P1|Overall Study|Lost to Follow-up|8
717799|NCT00137046|2313164|P2|Overall Study|Lack of Efficacy|1
717800|NCT00137046|2313165|P1|Overall Study|Lack of Efficacy|13
717801|NCT00137046|2313164|P2|Overall Study|Laboratory Abnormality|0
717802|NCT00137046|2313165|P1|Overall Study|Laboratory Abnormality|2
717803|NCT00137046|2313164|P2|Overall Study|Adverse Event|5
717804|NCT00137046|2313165|P1|Overall Study|Adverse Event|16
717805|NCT00137046|2313164|P2|Overall Study|Death|1
717806|NCT00137046|2313165|P1|Overall Study|Death|2
717807|NCT00137111|2313217|P4|Total Therapy|Non Compliance|0
717808|NCT00137111|2313218|P3|Total Therapy|Non Compliance|0
717809|NCT00137111|2313219|P2|Total Therapy|Non Compliance|0
717810|NCT00137111|2313220|P1|Total Therapy|Non Compliance|5
717811|NCT00137111|2313217|P4|Total Therapy|Death|0
717812|NCT00137111|2313218|P3|Total Therapy|Death|0
717813|NCT00137111|2313219|P2|Total Therapy|Death|0
717814|NCT00137111|2313220|P1|Total Therapy|Death|35
717815|NCT00137267|2313234|P2|Overall Study|Lost to Follow-up|21
717816|NCT00137267|2313235|P1|Overall Study|Lost to Follow-up|15
717817|NCT00137423|2313260|P2|Overall Study|Death|1
717818|NCT00137423|2313261|P1|Overall Study|Death|0
717819|NCT00137423|2313260|P2|Overall Study|Lack of Efficacy|33
717820|NCT00137423|2313261|P1|Overall Study|Lack of Efficacy|31
717821|NCT00137423|2313260|P2|Overall Study|consent withdrawn|1
717822|NCT00137423|2313261|P1|Overall Study|consent withdrawn|1
717823|NCT00137423|2313260|P2|Overall Study|Adverse Event|9
717824|NCT00137423|2313261|P1|Overall Study|Adverse Event|7
717825|NCT00137436|2313281|P1|Overall Study|Unspecified|5
717826|NCT00137436|2313281|P1|Overall Study|Withdrawal by Subject|6
717827|NCT00137436|2313281|P1|Overall Study|Lack of Efficacy|17
717828|NCT00137436|2313281|P1|Overall Study|Death|2
717829|NCT00137436|2313281|P1|Overall Study|Adverse Event|13
717830|NCT00137449|2313300|P2|Overall Study|Withdrawal by Subject|1
717831|NCT00137449|2313301|P1|Overall Study|Withdrawal by Subject|1
717832|NCT00137449|2313300|P2|Overall Study|Adverse Event|1
717833|NCT00137449|2313301|P1|Overall Study|Adverse Event|3
717834|NCT00137449|2313300|P2|Overall Study|Death|3
717835|NCT00137449|2313301|P1|Overall Study|Death|4
717836|NCT00137449|2313300|P2|Overall Study|Disease Progression|13
717837|NCT00137449|2313301|P1|Overall Study|Disease Progression|8
717838|NCT00137631|2313340|P2|Overall Study|Lost to Follow-up|41
717839|NCT00137631|2313341|P1|Overall Study|Lost to Follow-up|37
717840|NCT00138073|2313389|P1|Overall Study|lack of resources|55
717841|NCT00138151|2313398|P1|Overall Study|Physician Decision|1
717842|NCT00138151|2313398|P1|Overall Study|Withdrawal by Subject|3
890241|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
890242|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
890243|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
717847|NCT00138658|2313502|P1|Overall Study|Withdrawal by Subject|5
717848|NCT00138658|2313502|P1|Overall Study|Physician Decision|11
717849|NCT00138658|2313502|P1|Overall Study|Disease Progression|21
717850|NCT00138658|2313502|P1|Overall Study|Death|1
717851|NCT00138658|2313502|P1|Overall Study|Adverse Event|23
717852|NCT00138671|2313514|P2|Overall Study|Other|3
717853|NCT00138671|2313515|P1|Overall Study|Other|3
717854|NCT00138671|2313514|P2|Overall Study|Withdrawal by Subject|5
717855|NCT00138671|2313515|P1|Overall Study|Withdrawal by Subject|3
717856|NCT00138671|2313514|P2|Overall Study|Lost to Follow-up|2
717857|NCT00138671|2313515|P1|Overall Study|Lost to Follow-up|1
717858|NCT00138671|2313514|P2|Overall Study|Adverse Event|3
717859|NCT00138671|2313515|P1|Overall Study|Adverse Event|6
717860|NCT00138671|2313514|P2|Overall Study|Death|3
717861|NCT00138671|2313515|P1|Overall Study|Death|0
717862|NCT00130039|2313567|P2|Overall Study|clinical events without follow up MRI|4
717863|NCT00130039|2313568|P1|Overall Study|clinical events without follow up MRI|5
717864|NCT00130039|2313567|P2|Overall Study|Physician Decision|0
717865|NCT00130039|2313568|P1|Overall Study|Physician Decision|3
717866|NCT00130039|2313567|P2|Overall Study|Adverse Event|2
717867|NCT00130039|2313568|P1|Overall Study|Adverse Event|4
717868|NCT00130039|2313567|P2|Overall Study|Lost to Follow-up|1
717869|NCT00130039|2313568|P1|Overall Study|Lost to Follow-up|3
717870|NCT00130039|2313567|P2|Overall Study|Withdrawal by Subject|11
717871|NCT00130039|2313568|P1|Overall Study|Withdrawal by Subject|15
717872|NCT00143247|2313584|P1|Overall Study|Other|12
717873|NCT00143247|2313584|P1|Overall Study|following inaccurate lab adverse event|1
717874|NCT00143247|2313584|P1|Overall Study|Lost to Follow-up|12
717875|NCT00143247|2313584|P1|Overall Study|Protocol Violation|15
717876|NCT00143247|2313584|P1|Overall Study|Study terminated by sponsor|31
717877|NCT00143247|2313584|P1|Overall Study|Withdrawal by Subject|55
717878|NCT00143247|2313584|P1|Overall Study|Lack of Efficacy|3
717879|NCT00143247|2313584|P1|Overall Study|Adverse Event|19
717880|NCT00143247|2313584|P1|Overall Study|Death|8
717881|NCT00143312|2313598|P1|Overall Study|Withdrawal by Subject|1
717882|NCT00143312|2313598|P1|Overall Study|Other|1
717883|NCT00143312|2313598|P1|Overall Study|Lost to Follow-up|1
717884|NCT00143312|2313598|P1|Overall Study|Adverse Event|2
717885|NCT00143312|2313598|P1|Overall Study|Death|11
717886|NCT00143390|2313610|P2|Overall Study|Other|2
717887|NCT00143390|2313611|P1|Overall Study|Other|1
717888|NCT00143390|2313610|P2|Overall Study|Adverse Event|8
717889|NCT00143390|2313611|P1|Overall Study|Adverse Event|9
717890|NCT00143390|2313610|P2|Overall Study|Study termination|15
717891|NCT00143390|2313611|P1|Overall Study|Study termination|10
717892|NCT00143390|2313610|P2|Overall Study|Protocol Violation|0
717893|NCT00143390|2313611|P1|Overall Study|Protocol Violation|2
717894|NCT00143390|2313610|P2|Overall Study|Progressive disease|115
717895|NCT00143390|2313611|P1|Overall Study|Progressive disease|119
717896|NCT00143390|2313610|P2|Overall Study|Withdrawal by Subject|4
717897|NCT00143390|2313611|P1|Overall Study|Withdrawal by Subject|4
717898|NCT00143390|2313610|P2|Overall Study|Not meeting entry criteria|5
717899|NCT00143390|2313611|P1|Overall Study|Not meeting entry criteria|2
717900|NCT00143390|2313610|P2|Overall Study|Death|0
717901|NCT00143390|2313611|P1|Overall Study|Death|2
717902|NCT00143403|2313629|P2|Overall Study|Randomized Not Treated|8
717903|NCT00143403|2313630|P1|Overall Study|Randomized Not Treated|7
717904|NCT00143403|2313629|P2|Overall Study|specified by site|9
717905|NCT00143403|2313630|P1|Overall Study|specified by site|4
717906|NCT00143403|2313629|P2|Overall Study|Protocol Violation|2
717907|NCT00143403|2313630|P1|Overall Study|Protocol Violation|2
717908|NCT00143403|2313629|P2|Overall Study|Relapse|7
717909|NCT00143403|2313630|P1|Overall Study|Relapse|15
717910|NCT00143403|2313629|P2|Overall Study|Withdrawal by Subject|12
717911|NCT00143403|2313630|P1|Overall Study|Withdrawal by Subject|3
717912|NCT00143403|2313629|P2|Overall Study|Death|0
717913|NCT00143403|2313630|P1|Overall Study|Death|1
717914|NCT00143403|2313629|P2|Overall Study|Adverse Event|8
717915|NCT00143403|2313630|P1|Overall Study|Adverse Event|3
717916|NCT00143455|2313642|P4|Cohort 2|Randomized But Not Treated|1
717917|NCT00143455|2313643|P3|Cohort 2|Randomized But Not Treated|1
717918|NCT00143455|2313644|P2|Cohort 2|Randomized But Not Treated|0
717919|NCT00143455|2313645|P1|Cohort 2|Randomized But Not Treated|0
717920|NCT00143455|2313642|P4|Cohort 2|Unspecified|6
717921|NCT00143455|2313643|P3|Cohort 2|Unspecified|7
717922|NCT00143455|2313644|P2|Cohort 2|Unspecified|0
717923|NCT00143455|2313645|P1|Cohort 2|Unspecified|0
717924|NCT00143455|2313642|P4|Cohort 2|Withdrawal by Subject|12
717925|NCT00143455|2313643|P3|Cohort 2|Withdrawal by Subject|13
717926|NCT00143455|2313644|P2|Cohort 2|Withdrawal by Subject|0
717927|NCT00143455|2313645|P1|Cohort 2|Withdrawal by Subject|0
717928|NCT00143455|2313642|P4|Cohort 2|Progressive Disease|27
717929|NCT00143455|2313643|P3|Cohort 2|Progressive Disease|20
717930|NCT00143455|2313644|P2|Cohort 2|Progressive Disease|0
717931|NCT00143455|2313645|P1|Cohort 2|Progressive Disease|0
717932|NCT00143455|2313642|P4|Cohort 2|Death|12
717933|NCT00143455|2313643|P3|Cohort 2|Death|20
717934|NCT00143455|2313644|P2|Cohort 2|Death|0
717935|NCT00143455|2313645|P1|Cohort 2|Death|0
717936|NCT00143455|2313642|P4|Cohort 2|Lost to Follow-up|4
717937|NCT00143455|2313643|P3|Cohort 2|Lost to Follow-up|1
717938|NCT00143455|2313644|P2|Cohort 2|Lost to Follow-up|0
717939|NCT00143455|2313645|P1|Cohort 2|Lost to Follow-up|0
717940|NCT00143455|2313642|P4|Cohort 2|Protocol Violation|1
717941|NCT00143455|2313643|P3|Cohort 2|Protocol Violation|1
717942|NCT00143455|2313644|P2|Cohort 2|Protocol Violation|0
717943|NCT00143455|2313645|P1|Cohort 2|Protocol Violation|0
717944|NCT00143455|2313642|P4|Cohort 2|No Longer Required Study Treatment|0
717945|NCT00143455|2313643|P3|Cohort 2|No Longer Required Study Treatment|1
717946|NCT00143455|2313644|P2|Cohort 2|No Longer Required Study Treatment|0
717947|NCT00143455|2313645|P1|Cohort 2|No Longer Required Study Treatment|0
717948|NCT00143455|2313642|P4|Cohort 2|Adverse Event|30
717949|NCT00143455|2313643|P3|Cohort 2|Adverse Event|42
717950|NCT00143455|2313644|P2|Cohort 2|Adverse Event|0
717951|NCT00143455|2313645|P1|Cohort 2|Adverse Event|0
717952|NCT00143455|2313642|P4|Cohort 1|Randomized But Not Treated|0
717953|NCT00143455|2313643|P3|Cohort 1|Randomized But Not Treated|0
717954|NCT00143455|2313644|P2|Cohort 1|Randomized But Not Treated|1
717955|NCT00143455|2313645|P1|Cohort 1|Randomized But Not Treated|0
717956|NCT00143455|2313642|P4|Cohort 1|Withdrawal by Subject|0
717957|NCT00143455|2313643|P3|Cohort 1|Withdrawal by Subject|0
717958|NCT00143455|2313644|P2|Cohort 1|Withdrawal by Subject|4
717959|NCT00143455|2313645|P1|Cohort 1|Withdrawal by Subject|1
717960|NCT00143455|2313642|P4|Cohort 1|Progressive Disease|0
717961|NCT00143455|2313643|P3|Cohort 1|Progressive Disease|0
717962|NCT00143455|2313644|P2|Cohort 1|Progressive Disease|6
717963|NCT00143455|2313645|P1|Cohort 1|Progressive Disease|0
717964|NCT00143455|2313642|P4|Cohort 1|Death|0
717965|NCT00143455|2313643|P3|Cohort 1|Death|0
717966|NCT00143455|2313644|P2|Cohort 1|Death|2
717967|NCT00143455|2313645|P1|Cohort 1|Death|5
717968|NCT00143455|2313642|P4|Cohort 1|Adverse Event|0
717969|NCT00143455|2313643|P3|Cohort 1|Adverse Event|0
717970|NCT00143455|2313644|P2|Cohort 1|Adverse Event|4
717971|NCT00143455|2313645|P1|Cohort 1|Adverse Event|8
717980|NCT00143598|2313712|P2|Overall Study|Death|36
717981|NCT00143598|2313713|P1|Overall Study|Death|36
717982|NCT00143598|2313712|P2|Overall Study|Withdrawal by Subject|37
717983|NCT00143598|2313713|P1|Overall Study|Withdrawal by Subject|33
717984|NCT00143598|2313712|P2|Overall Study|Lost to Follow-up|21
717985|NCT00143598|2313713|P1|Overall Study|Lost to Follow-up|23
717986|NCT00144027|2313749|P2|Overall Study|did not complete baseline assessment|6
717987|NCT00144027|2313750|P1|Overall Study|did not complete baseline assessment|0
717988|NCT00144027|2313749|P2|Overall Study|Withdrawal by Subject|2
717989|NCT00144027|2313750|P1|Overall Study|Withdrawal by Subject|2
717990|NCT00144027|2313749|P2|Overall Study|Lost to Follow-up|3
717991|NCT00144027|2313750|P1|Overall Study|Lost to Follow-up|1
717992|NCT00144170|2313758|P2|Overall Study|Other reason not defined above|316
717993|NCT00144170|2313759|P1|Overall Study|Other reason not defined above|211
717994|NCT00144170|2313758|P2|Overall Study|Withdrawal by Subject|13
717995|NCT00144170|2313759|P1|Overall Study|Withdrawal by Subject|29
717996|NCT00144170|2313758|P2|Overall Study|Lost to Follow-up|10
717997|NCT00144170|2313759|P1|Overall Study|Lost to Follow-up|5
717998|NCT00144170|2313758|P2|Overall Study|Protocol Violation|16
717999|NCT00144170|2313759|P1|Overall Study|Protocol Violation|23
718000|NCT00144170|2313758|P2|Overall Study|Adverse Event|41
718001|NCT00144170|2313759|P1|Overall Study|Adverse Event|84
718002|NCT00144300|2313949|P2|Overall Study|Other reason (not specified)|3
718003|NCT00144300|2313950|P1|Overall Study|Other reason (not specified)|1
718004|NCT00144300|2313949|P2|Overall Study|Withdrawal by Subject|6
718005|NCT00144300|2313950|P1|Overall Study|Withdrawal by Subject|6
718006|NCT00144300|2313949|P2|Overall Study|Lost to Follow-up|0
718007|NCT00144300|2313950|P1|Overall Study|Lost to Follow-up|3
718008|NCT00144300|2313949|P2|Overall Study|Protocol Violation|3
718009|NCT00144300|2313950|P1|Overall Study|Protocol Violation|1
718010|NCT00144300|2313949|P2|Overall Study|Adverse Event|16
718011|NCT00144300|2313950|P1|Overall Study|Adverse Event|18
718012|NCT00144339|2313998|P2|Overall Study|Other|60
718013|NCT00144339|2313999|P1|Overall Study|Other|58
718014|NCT00144339|2313998|P2|Overall Study|Lost to Follow-up|64
718015|NCT00144339|2313999|P1|Overall Study|Lost to Follow-up|76
718016|NCT00144339|2313998|P2|Overall Study|Withdrawal by Subject|300
718017|NCT00144339|2313999|P1|Overall Study|Withdrawal by Subject|403
718018|NCT00144339|2313998|P2|Overall Study|Protocol Violation|48
718019|NCT00144339|2313999|P1|Overall Study|Protocol Violation|75
718020|NCT00144339|2313998|P2|Overall Study|Adverse Event|627
718021|NCT00144339|2313999|P1|Overall Study|Adverse Event|746
718022|NCT00144781|2314218|P4|Overall Study|Non-compliant|0
718023|NCT00144781|2314219|P3|Overall Study|Non-compliant|0
718024|NCT00144781|2314220|P2|Overall Study|Non-compliant|1
718025|NCT00144781|2314221|P1|Overall Study|Non-compliant|0
718026|NCT00144781|2314218|P4|Overall Study|Adverse Event|0
718027|NCT00144781|2314219|P3|Overall Study|Adverse Event|0
718028|NCT00144781|2314220|P2|Overall Study|Adverse Event|1
718029|NCT00144781|2314221|P1|Overall Study|Adverse Event|0
718030|NCT00145119|2314249|P1|Overall Study|Death|45
718031|NCT00145327|2314302|P3|Overall Study|Missing – not stated|1
718032|NCT00145327|2314303|P2|Overall Study|Missing – not stated|0
718033|NCT00145327|2314304|P1|Overall Study|Missing – not stated|1
718034|NCT00145327|2314302|P3|Overall Study|Abnormal laboratory value(s)|2
718035|NCT00145327|2314303|P2|Overall Study|Abnormal laboratory value(s)|0
718036|NCT00145327|2314304|P1|Overall Study|Abnormal laboratory value(s)|1
718037|NCT00145327|2314302|P3|Overall Study|Protocol Violation|2
718038|NCT00145327|2314303|P2|Overall Study|Protocol Violation|0
718039|NCT00145327|2314304|P1|Overall Study|Protocol Violation|2
718040|NCT00145327|2314302|P3|Overall Study|Administrative problems|13
718041|NCT00145327|2314303|P2|Overall Study|Administrative problems|9
718042|NCT00145327|2314304|P1|Overall Study|Administrative problems|12
718043|NCT00145327|2314302|P3|Overall Study|Lost to Follow-up|14
718044|NCT00145327|2314303|P2|Overall Study|Lost to Follow-up|14
718045|NCT00145327|2314304|P1|Overall Study|Lost to Follow-up|9
718046|NCT00145327|2314302|P3|Overall Study|Adverse Event|22
718047|NCT00145327|2314303|P2|Overall Study|Adverse Event|11
718048|NCT00145327|2314304|P1|Overall Study|Adverse Event|14
718049|NCT00145327|2314302|P3|Overall Study|Death|30
718050|NCT00145327|2314303|P2|Overall Study|Death|18
718051|NCT00145327|2314304|P1|Overall Study|Death|26
718052|NCT00145327|2314302|P3|Overall Study|Withdrawal by Subject|164
718053|NCT00145327|2314303|P2|Overall Study|Withdrawal by Subject|72
718054|NCT00145327|2314304|P1|Overall Study|Withdrawal by Subject|77
718055|NCT00134563|2314405|P3|Overall Study|Reason other than above|5
718056|NCT00134563|2314406|P2|Overall Study|Reason other than above|2
718057|NCT00134563|2314407|P1|Overall Study|Reason other than above|0
718058|NCT00134563|2314405|P3|Overall Study|did not wish to continue|26
718059|NCT00134563|2314406|P2|Overall Study|did not wish to continue|32
718060|NCT00134563|2314407|P1|Overall Study|did not wish to continue|33
718061|NCT00134563|2314405|P3|Overall Study|progressive disease|2
718062|NCT00134563|2314406|P2|Overall Study|progressive disease|4
718063|NCT00134563|2314407|P1|Overall Study|progressive disease|11
718064|NCT00134563|2314405|P3|Overall Study|Lost to Follow-up|2
718065|NCT00134563|2314406|P2|Overall Study|Lost to Follow-up|0
718066|NCT00134563|2314407|P1|Overall Study|Lost to Follow-up|4
718067|NCT00134563|2314405|P3|Overall Study|Protocol Violation|5
718068|NCT00134563|2314406|P2|Overall Study|Protocol Violation|2
718069|NCT00134563|2314407|P1|Overall Study|Protocol Violation|3
718070|NCT00134563|2314405|P3|Overall Study|Lack of Efficacy|17
718071|NCT00134563|2314406|P2|Overall Study|Lack of Efficacy|14
718072|NCT00134563|2314407|P1|Overall Study|Lack of Efficacy|24
718073|NCT00134563|2314405|P3|Overall Study|Adverse Event|38
718074|NCT00134563|2314406|P2|Overall Study|Adverse Event|37
718075|NCT00134563|2314407|P1|Overall Study|Adverse Event|29
718076|NCT00134563|2314405|P3|Overall Study|Not treated due to protocol violation|1
718077|NCT00134563|2314406|P2|Overall Study|Not treated due to protocol violation|1
718078|NCT00134563|2314407|P1|Overall Study|Not treated due to protocol violation|0
718079|NCT00134719|2314433|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
718080|NCT00134719|2314434|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
718081|NCT00134719|2314435|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
718082|NCT00134719|2314433|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
718083|NCT00134719|2314434|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
718084|NCT00134719|2314435|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
718085|NCT00134719|2314433|P3|Primary Vaccination Phase|Lost to Follow-up|3
718086|NCT00134719|2314434|P2|Primary Vaccination Phase|Lost to Follow-up|3
718087|NCT00134719|2314435|P1|Primary Vaccination Phase|Lost to Follow-up|7
718088|NCT00134719|2314433|P3|Primary Vaccination Phase|Withdrawal by Subject|2
718089|NCT00134719|2314434|P2|Primary Vaccination Phase|Withdrawal by Subject|3
718090|NCT00134719|2314435|P1|Primary Vaccination Phase|Withdrawal by Subject|2
718091|NCT00134719|2314433|P3|Primary Vaccination Phase|Protocol Violation|0
718092|NCT00134719|2314434|P2|Primary Vaccination Phase|Protocol Violation|0
718093|NCT00134719|2314435|P1|Primary Vaccination Phase|Protocol Violation|1
718094|NCT00134719|2314433|P3|Primary Vaccination Phase|Adverse Event|0
718095|NCT00134719|2314434|P2|Primary Vaccination Phase|Adverse Event|0
718096|NCT00134719|2314435|P1|Primary Vaccination Phase|Adverse Event|4
718097|NCT00134784|2314567|P4|Overall Study|Withdrawal by Subject|1
718098|NCT00134784|2314568|P3|Overall Study|Withdrawal by Subject|2
718099|NCT00134784|2314569|P2|Overall Study|Withdrawal by Subject|2
718100|NCT00134784|2314570|P1|Overall Study|Withdrawal by Subject|2
718101|NCT00134901|2314579|P2|Overall Study|discontinued intervention|10
718102|NCT00134901|2314580|P1|Overall Study|discontinued intervention|12
718103|NCT00134901|2314579|P2|Overall Study|Lost to Follow-up|5
718104|NCT00134901|2314580|P1|Overall Study|Lost to Follow-up|5
718105|NCT00135330|2314596|P3|Overall Study|Sponsor Decision|0
718106|NCT00135330|2314597|P2|Overall Study|Sponsor Decision|1
718107|NCT00135330|2314598|P1|Overall Study|Sponsor Decision|0
718108|NCT00135330|2314596|P3|Overall Study|Patient Decision|4
718109|NCT00135330|2314597|P2|Overall Study|Patient Decision|1
718110|NCT00135330|2314598|P1|Overall Study|Patient Decision|5
718111|NCT00135330|2314596|P3|Overall Study|Protocol Violation|3
718112|NCT00135330|2314597|P2|Overall Study|Protocol Violation|3
718113|NCT00135330|2314598|P1|Overall Study|Protocol Violation|4
718114|NCT00135330|2314596|P3|Overall Study|Physician Decision|0
718115|NCT00135330|2314597|P2|Overall Study|Physician Decision|1
718116|NCT00135330|2314598|P1|Overall Study|Physician Decision|1
718117|NCT00135330|2314596|P3|Overall Study|Lost to Follow-up|3
718118|NCT00135330|2314597|P2|Overall Study|Lost to Follow-up|2
718119|NCT00135330|2314598|P1|Overall Study|Lost to Follow-up|0
718120|NCT00135330|2314596|P3|Overall Study|Adverse Event|1
718121|NCT00135330|2314597|P2|Overall Study|Adverse Event|5
718122|NCT00135330|2314598|P1|Overall Study|Adverse Event|2
718123|NCT00135356|2314692|P2|Overall Study|Withdrawal by Subject|4
718124|NCT00135356|2314693|P1|Overall Study|Withdrawal by Subject|2
718125|NCT00135356|2314692|P2|Overall Study|No longer meets study criteria|0
718126|NCT00135356|2314693|P1|Overall Study|No longer meets study criteria|2
718127|NCT00135356|2314692|P2|Overall Study|Poor/noncompliance|1
718128|NCT00135356|2314693|P1|Overall Study|Poor/noncompliance|1
718129|NCT00135356|2314692|P2|Overall Study|Change in antiviral regimen|1
718130|NCT00135356|2314693|P1|Overall Study|Change in antiviral regimen|0
718131|NCT00135356|2314692|P2|Overall Study|Surgery for abdominal fat|0
718132|NCT00135356|2314693|P1|Overall Study|Surgery for abdominal fat|1
718133|NCT00135356|2314692|P2|Overall Study|Lost to Follow-up|1
718134|NCT00135356|2314693|P1|Overall Study|Lost to Follow-up|3
718135|NCT00135356|2314692|P2|Overall Study|Lack of Efficacy|0
718136|NCT00135356|2314693|P1|Overall Study|Lack of Efficacy|2
718137|NCT00135356|2314692|P2|Overall Study|Adverse Event|2
718138|NCT00135356|2314693|P1|Overall Study|Adverse Event|6
718139|NCT00135694|2314736|P3|Overall Study|Ineligible for Random assignment|0
718140|NCT00135694|2314737|P2|Overall Study|Ineligible for Random assignment|0
718141|NCT00135694|2314738|P1|Overall Study|Ineligible for Random assignment|42
718142|NCT00135694|2314736|P3|Overall Study|Hepatitis C related reasons|0
718143|NCT00135694|2314737|P2|Overall Study|Hepatitis C related reasons|1
718144|NCT00135694|2314738|P1|Overall Study|Hepatitis C related reasons|39
718145|NCT00135694|2314736|P3|Overall Study|Protocol Violation|0
718146|NCT00135694|2314737|P2|Overall Study|Protocol Violation|1
718147|NCT00135694|2314738|P1|Overall Study|Protocol Violation|19
718148|NCT00135694|2314736|P3|Overall Study|Withdrawal by Subject|4
718149|NCT00135694|2314737|P2|Overall Study|Withdrawal by Subject|7
718150|NCT00135694|2314738|P1|Overall Study|Withdrawal by Subject|41
718151|NCT00135694|2314736|P3|Overall Study|Lost to Follow-up|1
718152|NCT00135694|2314737|P2|Overall Study|Lost to Follow-up|7
718153|NCT00135694|2314738|P1|Overall Study|Lost to Follow-up|8
718154|NCT00135694|2314736|P3|Overall Study|Death|2
718155|NCT00135694|2314737|P2|Overall Study|Death|1
718156|NCT00135694|2314738|P1|Overall Study|Death|14
718157|NCT00135694|2314736|P3|Overall Study|Adverse Event|0
718158|NCT00135694|2314737|P2|Overall Study|Adverse Event|4
718159|NCT00135694|2314738|P1|Overall Study|Adverse Event|17
718160|NCT00136084|2314779|P2|Overall Study|Withdrawal by Subject|1
718161|NCT00136084|2314780|P1|Overall Study|Withdrawal by Subject|5
718162|NCT00136084|2314779|P2|Overall Study|No Response|2
718163|NCT00136084|2314780|P1|Overall Study|No Response|1
718164|NCT00136084|2314779|P2|Overall Study|Lost to Follow-up|0
718165|NCT00136084|2314780|P1|Overall Study|Lost to Follow-up|2
718166|NCT00136084|2314779|P2|Overall Study|Relapse|23
718167|NCT00136084|2314780|P1|Overall Study|Relapse|20
718168|NCT00136084|2314779|P2|Overall Study|Unacceptable toxicity|11
718169|NCT00136084|2314780|P1|Overall Study|Unacceptable toxicity|8
718170|NCT00136084|2314779|P2|Overall Study|Death|5
718171|NCT00136084|2314780|P1|Overall Study|Death|12
718172|NCT00136318|2314795|P2|Overall Study|Withdrawal by Subject|2
718173|NCT00136318|2314796|P1|Overall Study|Withdrawal by Subject|2
718174|NCT00136318|2314795|P2|Overall Study|Adverse Event|5
718175|NCT00136318|2314796|P1|Overall Study|Adverse Event|5
718176|NCT00136357|2314812|P2|Overall Study|Withdrawal by Subject|2
718177|NCT00136357|2314813|P1|Overall Study|Withdrawal by Subject|3
718178|NCT00145496|2314821|P2|Overall Study|Other|13
718179|NCT00145496|2314822|P1|Overall Study|Other|25
718180|NCT00145496|2314821|P2|Overall Study|Lost to Follow-up|5
718181|NCT00145496|2314822|P1|Overall Study|Lost to Follow-up|12
718182|NCT00145496|2314821|P2|Overall Study|Withdrawal by Subject|26
718183|NCT00145496|2314822|P1|Overall Study|Withdrawal by Subject|32
718184|NCT00145496|2314821|P2|Overall Study|Lack of Efficacy|7
718185|NCT00145496|2314822|P1|Overall Study|Lack of Efficacy|12
718186|NCT00145496|2314821|P2|Overall Study|Adverse Event|30
718187|NCT00145496|2314822|P1|Overall Study|Adverse Event|42
718188|NCT00145509|2314834|P2|Overall Study|Reason not provided|1
718189|NCT00145509|2314835|P1|Overall Study|Reason not provided|2
718190|NCT00145509|2314834|P2|Overall Study|Withdrew Consent|7
718191|NCT00145509|2314835|P1|Overall Study|Withdrew Consent|2
718192|NCT00145509|2314834|P2|Overall Study|Lost to Follow-up|9
718193|NCT00145509|2314835|P1|Overall Study|Lost to Follow-up|5
718194|NCT00145509|2314834|P2|Overall Study|Lack of Efficacy|1
718195|NCT00145509|2314835|P1|Overall Study|Lack of Efficacy|3
718196|NCT00145509|2314834|P2|Overall Study|Adverse Event|3
718197|NCT00145509|2314835|P1|Overall Study|Adverse Event|10
718198|NCT00145574|2314850|P3|Open Label Long-term Extension|required restricted medicine|1
718199|NCT00145574|2314851|P2|Open Label Long-term Extension|required restricted medicine|0
718200|NCT00145574|2314852|P1|Open Label Long-term Extension|required restricted medicine|0
718201|NCT00145574|2314850|P3|Open Label Long-term Extension|Withdrawal by Subject|4
718202|NCT00145574|2314851|P2|Open Label Long-term Extension|Withdrawal by Subject|0
718203|NCT00145574|2314852|P1|Open Label Long-term Extension|Withdrawal by Subject|0
718204|NCT00145574|2314850|P3|Open Label Long-term Extension|Lost to Follow-up|1
718205|NCT00145574|2314851|P2|Open Label Long-term Extension|Lost to Follow-up|0
718206|NCT00145574|2314852|P1|Open Label Long-term Extension|Lost to Follow-up|0
718207|NCT00145574|2314850|P3|Open Label Long-term Extension|Adverse Event|5
718208|NCT00145574|2314851|P2|Open Label Long-term Extension|Adverse Event|0
718209|NCT00145574|2314852|P1|Open Label Long-term Extension|Adverse Event|0
718210|NCT00145574|2314850|P3|Double Blind|required restricted medicine|0
718211|NCT00145574|2314851|P2|Double Blind|required restricted medicine|1
718212|NCT00145574|2314852|P1|Double Blind|required restricted medicine|0
718213|NCT00145574|2314850|P3|Double Blind|Withdrawal by Subject|1
718214|NCT00145574|2314851|P2|Double Blind|Withdrawal by Subject|1
718215|NCT00145574|2314852|P1|Double Blind|Withdrawal by Subject|1
718216|NCT00145574|2314850|P3|Double Blind|Adverse Event|1
718217|NCT00145574|2314851|P2|Double Blind|Adverse Event|3
718218|NCT00145574|2314852|P1|Double Blind|Adverse Event|0
718219|NCT00145600|2314920|P4|Overall Study|Withdrawal by Subject|1
718220|NCT00145600|2314921|P3|Overall Study|Withdrawal by Subject|0
718221|NCT00145600|2314922|P2|Overall Study|Withdrawal by Subject|2
718222|NCT00145600|2314923|P1|Overall Study|Withdrawal by Subject|1
718223|NCT00145600|2314920|P4|Overall Study|Noncompliance|0
718224|NCT00145600|2314921|P3|Overall Study|Noncompliance|0
718225|NCT00145600|2314922|P2|Overall Study|Noncompliance|0
718226|NCT00145600|2314923|P1|Overall Study|Noncompliance|1
718227|NCT00145600|2314920|P4|Overall Study|Lost to Follow-up|4
718228|NCT00145600|2314921|P3|Overall Study|Lost to Follow-up|2
718229|NCT00145600|2314922|P2|Overall Study|Lost to Follow-up|6
718230|NCT00145600|2314923|P1|Overall Study|Lost to Follow-up|2
718231|NCT00145600|2314920|P4|Overall Study|Ineligible|5
718232|NCT00145600|2314921|P3|Overall Study|Ineligible|1
718233|NCT00145600|2314922|P2|Overall Study|Ineligible|0
718234|NCT00145600|2314923|P1|Overall Study|Ineligible|3
718235|NCT00145600|2314920|P4|Overall Study|Death|6
718236|NCT00145600|2314921|P3|Overall Study|Death|2
718237|NCT00145600|2314922|P2|Overall Study|Death|2
718238|NCT00145600|2314923|P1|Overall Study|Death|1
718239|NCT00145626|2315037|P1|Overall Study|Withdrawal by Subject|1
718240|NCT00145626|2315037|P1|Overall Study|Death|1
718241|NCT00145626|2315037|P1|Overall Study|Turned 2 years old before treatment|1
718242|NCT00145626|2315037|P1|Overall Study|Did not have NK infusions|2
718243|NCT00145795|2315090|P2|Overall Study|Adverse Event|0
718244|NCT00145795|2315091|P1|Overall Study|Adverse Event|1
718245|NCT00146757|2315115|P2|Overall Study|Adverse Event|0
718246|NCT00146757|2315116|P1|Overall Study|Adverse Event|1
718247|NCT00146757|2315115|P2|Overall Study|Death|0
718248|NCT00146757|2315116|P1|Overall Study|Death|1
718249|NCT00146770|2315135|P2|Overall Study|Withdrawal by Subject|0
718250|NCT00146770|2315136|P1|Overall Study|Withdrawal by Subject|2
718251|NCT00146770|2315135|P2|Overall Study|Pregnancy|0
718252|NCT00146770|2315136|P1|Overall Study|Pregnancy|1
718253|NCT00146770|2315135|P2|Overall Study|Adverse Event|0
718254|NCT00146770|2315136|P1|Overall Study|Adverse Event|2
718255|NCT00146848|2315157|P3|Post-randomization|Withdrawn|27
718256|NCT00146848|2315158|P2|Post-randomization|Withdrawn|32
718257|NCT00146848|2315159|P1|Post-randomization|Withdrawn|26
718258|NCT00146848|2315157|P3|Post-randomization|Lost to Follow-up|12
718259|NCT00146848|2315158|P2|Post-randomization|Lost to Follow-up|15
718260|NCT00146848|2315159|P1|Post-randomization|Lost to Follow-up|12
718261|NCT00146848|2315157|P3|Pre-randomization|Withdrawal by Subject|0
718262|NCT00146848|2315158|P2|Pre-randomization|Withdrawal by Subject|0
718263|NCT00146848|2315159|P1|Pre-randomization|Withdrawal by Subject|40
718264|NCT00146848|2315157|P3|Pre-randomization|Protocol Violation|0
718265|NCT00146848|2315158|P2|Pre-randomization|Protocol Violation|0
718266|NCT00146848|2315159|P1|Pre-randomization|Protocol Violation|172
718267|NCT00146848|2315157|P3|Pre-randomization|Physician Decision|0
718268|NCT00146848|2315158|P2|Pre-randomization|Physician Decision|0
718269|NCT00146848|2315159|P1|Pre-randomization|Physician Decision|8
718270|NCT00146848|2315157|P3|Pre-randomization|Lost to Follow-up|0
718271|NCT00146848|2315158|P2|Pre-randomization|Lost to Follow-up|0
718272|NCT00146848|2315159|P1|Pre-randomization|Lost to Follow-up|70
718273|NCT00146848|2315157|P3|Pre-randomization|Death|0
718274|NCT00146848|2315158|P2|Pre-randomization|Death|0
718275|NCT00146848|2315159|P1|Pre-randomization|Death|19
718276|NCT00147225|2315259|P6|Overall Study|Chemotherapy Changed|1
718277|NCT00147225|2315260|P5|Overall Study|Chemotherapy Changed|0
718278|NCT00147225|2315261|P4|Overall Study|Chemotherapy Changed|0
718279|NCT00147225|2315262|P3|Overall Study|Chemotherapy Changed|0
718280|NCT00147225|2315263|P2|Overall Study|Chemotherapy Changed|0
718281|NCT00147225|2315264|P1|Overall Study|Chemotherapy Changed|0
718282|NCT00147225|2315259|P6|Overall Study|Screen Failure|0
718283|NCT00147225|2315260|P5|Overall Study|Screen Failure|1
718284|NCT00147225|2315261|P4|Overall Study|Screen Failure|0
718285|NCT00147225|2315262|P3|Overall Study|Screen Failure|0
718286|NCT00147225|2315263|P2|Overall Study|Screen Failure|0
718287|NCT00147225|2315264|P1|Overall Study|Screen Failure|0
718288|NCT00147225|2315259|P6|Overall Study|Adverse Event|0
718289|NCT00147225|2315260|P5|Overall Study|Adverse Event|0
718290|NCT00147225|2315261|P4|Overall Study|Adverse Event|1
718291|NCT00147225|2315262|P3|Overall Study|Adverse Event|1
718292|NCT00147225|2315263|P2|Overall Study|Adverse Event|0
718293|NCT00147225|2315264|P1|Overall Study|Adverse Event|0
718294|NCT00147225|2315259|P6|Overall Study|Withdrawal by Subject|1
718295|NCT00147225|2315260|P5|Overall Study|Withdrawal by Subject|0
718296|NCT00147225|2315261|P4|Overall Study|Withdrawal by Subject|0
718297|NCT00147225|2315262|P3|Overall Study|Withdrawal by Subject|1
718298|NCT00147225|2315263|P2|Overall Study|Withdrawal by Subject|0
718299|NCT00147225|2315264|P1|Overall Study|Withdrawal by Subject|1
718300|NCT00147238|2315284|P1|Overall Study|Inevaluable|8
718301|NCT00147498|2315322|P4|Overall Study|Unspecified|3
718302|NCT00147498|2315323|P3|Overall Study|Unspecified|3
718303|NCT00147498|2315324|P2|Overall Study|Unspecified|1
718304|NCT00147498|2315325|P1|Overall Study|Unspecified|1
718305|NCT00147498|2315322|P4|Overall Study|Participant defaulted|3
718306|NCT00147498|2315323|P3|Overall Study|Participant defaulted|4
718307|NCT00147498|2315324|P2|Overall Study|Participant defaulted|1
718308|NCT00147498|2315325|P1|Overall Study|Participant defaulted|0
718309|NCT00147498|2315322|P4|Overall Study|Laboratory abnormality|0
718310|NCT00147498|2315323|P3|Overall Study|Laboratory abnormality|2
718311|NCT00147498|2315324|P2|Overall Study|Laboratory abnormality|0
718312|NCT00147498|2315325|P1|Overall Study|Laboratory abnormality|0
718313|NCT00147498|2315322|P4|Overall Study|Lack of Efficacy|8
718314|NCT00147498|2315323|P3|Overall Study|Lack of Efficacy|1
718315|NCT00147498|2315324|P2|Overall Study|Lack of Efficacy|1
718316|NCT00147498|2315325|P1|Overall Study|Lack of Efficacy|1
718317|NCT00147498|2315322|P4|Overall Study|Adverse Event|3
718318|NCT00147498|2315323|P3|Overall Study|Adverse Event|7
718319|NCT00147498|2315324|P2|Overall Study|Adverse Event|6
718320|NCT00147498|2315325|P1|Overall Study|Adverse Event|1
718321|NCT00147537|2315423|P11|Phase 2|Randomized but not treated|1
718322|NCT00147537|2315424|P10|Phase 2|Randomized but not treated|1
718323|NCT00147537|2315425|P9|Phase 2|Randomized but not treated|0
718324|NCT00147537|2315426|P8|Phase 2|Randomized but not treated|0
718325|NCT00147537|2315427|P7|Phase 2|Randomized but not treated|0
718326|NCT00147537|2315428|P6|Phase 2|Randomized but not treated|0
718327|NCT00147537|2315429|P5|Phase 2|Randomized but not treated|0
718328|NCT00147537|2315430|P4|Phase 2|Randomized but not treated|0
718329|NCT00147537|2315431|P3|Phase 2|Randomized but not treated|0
718330|NCT00147537|2315432|P2|Phase 2|Randomized but not treated|0
718331|NCT00147537|2315433|P1|Phase 2|Randomized but not treated|0
718332|NCT00147537|2315423|P11|Phase 2|Withdrawal by Subject|4
718333|NCT00147537|2315424|P10|Phase 2|Withdrawal by Subject|16
718334|NCT00147537|2315425|P9|Phase 2|Withdrawal by Subject|0
718335|NCT00147537|2315426|P8|Phase 2|Withdrawal by Subject|0
718336|NCT00147537|2315427|P7|Phase 2|Withdrawal by Subject|0
718337|NCT00147537|2315428|P6|Phase 2|Withdrawal by Subject|0
718338|NCT00147537|2315429|P5|Phase 2|Withdrawal by Subject|0
718339|NCT00147537|2315430|P4|Phase 2|Withdrawal by Subject|0
718340|NCT00147537|2315431|P3|Phase 2|Withdrawal by Subject|0
718341|NCT00147537|2315432|P2|Phase 2|Withdrawal by Subject|0
718342|NCT00147537|2315433|P1|Phase 2|Withdrawal by Subject|0
718343|NCT00147537|2315423|P11|Phase 2|unspecified|12
718344|NCT00147537|2315424|P10|Phase 2|unspecified|47
718345|NCT00147537|2315425|P9|Phase 2|unspecified|0
718346|NCT00147537|2315426|P8|Phase 2|unspecified|0
718347|NCT00147537|2315427|P7|Phase 2|unspecified|0
718348|NCT00147537|2315428|P6|Phase 2|unspecified|0
718349|NCT00147537|2315429|P5|Phase 2|unspecified|0
718350|NCT00147537|2315430|P4|Phase 2|unspecified|0
718351|NCT00147537|2315431|P3|Phase 2|unspecified|0
718352|NCT00147537|2315432|P2|Phase 2|unspecified|0
718353|NCT00147537|2315433|P1|Phase 2|unspecified|0
718354|NCT00147537|2315423|P11|Phase 2|Lost to Follow-up|4
718355|NCT00147537|2315424|P10|Phase 2|Lost to Follow-up|12
718356|NCT00147537|2315425|P9|Phase 2|Lost to Follow-up|0
718357|NCT00147537|2315426|P8|Phase 2|Lost to Follow-up|0
718358|NCT00147537|2315427|P7|Phase 2|Lost to Follow-up|0
718359|NCT00147537|2315428|P6|Phase 2|Lost to Follow-up|0
718360|NCT00147537|2315429|P5|Phase 2|Lost to Follow-up|0
718361|NCT00147537|2315430|P4|Phase 2|Lost to Follow-up|0
718362|NCT00147537|2315431|P3|Phase 2|Lost to Follow-up|0
718363|NCT00147537|2315432|P2|Phase 2|Lost to Follow-up|0
718364|NCT00147537|2315433|P1|Phase 2|Lost to Follow-up|0
718365|NCT00147537|2315423|P11|Phase 2|Death|31
718366|NCT00147537|2315424|P10|Phase 2|Death|85
718367|NCT00147537|2315425|P9|Phase 2|Death|0
718368|NCT00147537|2315426|P8|Phase 2|Death|0
718369|NCT00147537|2315427|P7|Phase 2|Death|0
718370|NCT00147537|2315428|P6|Phase 2|Death|0
718371|NCT00147537|2315429|P5|Phase 2|Death|0
718372|NCT00147537|2315430|P4|Phase 2|Death|0
718373|NCT00147537|2315431|P3|Phase 2|Death|0
718374|NCT00147537|2315432|P2|Phase 2|Death|0
718375|NCT00147537|2315433|P1|Phase 2|Death|0
718376|NCT00147537|2315423|P11|Phase 1b|Randomized but not treated|0
718377|NCT00147537|2315424|P10|Phase 1b|Randomized but not treated|0
718378|NCT00147537|2315425|P9|Phase 1b|Randomized but not treated|1
718379|NCT00147537|2315426|P8|Phase 1b|Randomized but not treated|0
718380|NCT00147537|2315427|P7|Phase 1b|Randomized but not treated|1
718381|NCT00147537|2315428|P6|Phase 1b|Randomized but not treated|0
718382|NCT00147537|2315429|P5|Phase 1b|Randomized but not treated|0
718383|NCT00147537|2315430|P4|Phase 1b|Randomized but not treated|0
718384|NCT00147537|2315431|P3|Phase 1b|Randomized but not treated|0
718385|NCT00147537|2315432|P2|Phase 1b|Randomized but not treated|0
718386|NCT00147537|2315433|P1|Phase 1b|Randomized but not treated|0
718387|NCT00147537|2315423|P11|Phase 1b|Withdrawal by Subject|0
718388|NCT00147537|2315424|P10|Phase 1b|Withdrawal by Subject|0
718389|NCT00147537|2315425|P9|Phase 1b|Withdrawal by Subject|2
718390|NCT00147537|2315426|P8|Phase 1b|Withdrawal by Subject|0
718391|NCT00147537|2315427|P7|Phase 1b|Withdrawal by Subject|0
718392|NCT00147537|2315428|P6|Phase 1b|Withdrawal by Subject|0
718393|NCT00147537|2315429|P5|Phase 1b|Withdrawal by Subject|0
718394|NCT00147537|2315430|P4|Phase 1b|Withdrawal by Subject|0
718395|NCT00147537|2315431|P3|Phase 1b|Withdrawal by Subject|0
718396|NCT00147537|2315432|P2|Phase 1b|Withdrawal by Subject|0
718397|NCT00147537|2315433|P1|Phase 1b|Withdrawal by Subject|0
718398|NCT00147537|2315423|P11|Phase 1b|unspecified|0
718399|NCT00147537|2315424|P10|Phase 1b|unspecified|0
718400|NCT00147537|2315425|P9|Phase 1b|unspecified|4
718401|NCT00147537|2315426|P8|Phase 1b|unspecified|4
718402|NCT00147537|2315427|P7|Phase 1b|unspecified|14
718403|NCT00147537|2315428|P6|Phase 1b|unspecified|1
718404|NCT00147537|2315429|P5|Phase 1b|unspecified|1
718405|NCT00147537|2315430|P4|Phase 1b|unspecified|1
718406|NCT00147537|2315431|P3|Phase 1b|unspecified|2
718407|NCT00147537|2315432|P2|Phase 1b|unspecified|0
718408|NCT00147537|2315433|P1|Phase 1b|unspecified|0
718409|NCT00147537|2315423|P11|Phase 1b|Lost to Follow-up|0
718410|NCT00147537|2315424|P10|Phase 1b|Lost to Follow-up|0
718411|NCT00147537|2315425|P9|Phase 1b|Lost to Follow-up|1
718412|NCT00147537|2315426|P8|Phase 1b|Lost to Follow-up|0
718413|NCT00147537|2315427|P7|Phase 1b|Lost to Follow-up|2
718414|NCT00147537|2315428|P6|Phase 1b|Lost to Follow-up|0
718415|NCT00147537|2315429|P5|Phase 1b|Lost to Follow-up|0
718416|NCT00147537|2315430|P4|Phase 1b|Lost to Follow-up|0
718417|NCT00147537|2315431|P3|Phase 1b|Lost to Follow-up|0
718418|NCT00147537|2315432|P2|Phase 1b|Lost to Follow-up|1
718419|NCT00147537|2315433|P1|Phase 1b|Lost to Follow-up|2
718420|NCT00147537|2315423|P11|Phase 1b|Death|0
718421|NCT00147537|2315424|P10|Phase 1b|Death|0
718422|NCT00147537|2315425|P9|Phase 1b|Death|9
718423|NCT00147537|2315426|P8|Phase 1b|Death|3
718424|NCT00147537|2315427|P7|Phase 1b|Death|1
718425|NCT00147537|2315428|P6|Phase 1b|Death|2
718426|NCT00147537|2315429|P5|Phase 1b|Death|2
718427|NCT00147537|2315430|P4|Phase 1b|Death|1
718428|NCT00147537|2315431|P3|Phase 1b|Death|2
718429|NCT00147537|2315432|P2|Phase 1b|Death|1
718430|NCT00147537|2315433|P1|Phase 1b|Death|0
718431|NCT00147745|2315615|P3|Overall Study|Withdrawal by Subject|0
718432|NCT00147745|2315616|P2|Overall Study|Withdrawal by Subject|0
718433|NCT00147745|2315617|P1|Overall Study|Withdrawal by Subject|1
718434|NCT00147823|2315637|P2|Overall Study|Did not receive vitoss due to infection|2
718435|NCT00147823|2315638|P1|Overall Study|Did not receive vitoss due to infection|6
718436|NCT00147823|2315637|P2|Overall Study|Withdrawal by Subject|1
718437|NCT00147823|2315638|P1|Overall Study|Withdrawal by Subject|0
718438|NCT00147823|2315637|P2|Overall Study|Physician Decision|0
718439|NCT00147823|2315638|P1|Overall Study|Physician Decision|1
718440|NCT00147823|2315637|P2|Overall Study|Lost to Follow-up|12
718441|NCT00147823|2315638|P1|Overall Study|Lost to Follow-up|6
718442|NCT00148109|2315672|P2|Overall Study|Withdrawal by Subject|0
718443|NCT00148109|2315673|P1|Overall Study|Withdrawal by Subject|2
718444|NCT00148109|2315672|P2|Overall Study|Adverse Event|2
718445|NCT00148109|2315673|P1|Overall Study|Adverse Event|0
718446|NCT00148109|2315672|P2|Overall Study|Lack of Efficacy|18
718447|NCT00148109|2315673|P1|Overall Study|Lack of Efficacy|10
718448|NCT00148122|2315683|P1|Overall Study|Withdrawal by Subject|2
718449|NCT00148317|2315689|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
718450|NCT00148317|2315689|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
718451|NCT00148317|2315689|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
718452|NCT00148759|2315716|P2|Overall Study|Lost to Follow-up|0
718453|NCT00148759|2315717|P1|Overall Study|Lost to Follow-up|1
718454|NCT00148759|2315716|P2|Overall Study|Withdrawal by Subject|1
718455|NCT00148759|2315717|P1|Overall Study|Withdrawal by Subject|1
718456|NCT00149214|2315759|P2|Overall Study|Progressive Disease|3
718457|NCT00149214|2315760|P1|Overall Study|Progressive Disease|7
718458|NCT00149214|2315759|P2|Overall Study|Sponsor Decision|1
718459|NCT00149214|2315760|P1|Overall Study|Sponsor Decision|0
718460|NCT00149214|2315759|P2|Overall Study|Physician Decision|3
718461|NCT00149214|2315760|P1|Overall Study|Physician Decision|3
718462|NCT00149214|2315759|P2|Overall Study|Withdrawal by Subject|1
718463|NCT00149214|2315760|P1|Overall Study|Withdrawal by Subject|4
718464|NCT00149214|2315759|P2|Overall Study|Adverse Event|9
718465|NCT00149214|2315760|P1|Overall Study|Adverse Event|12
718466|NCT00133705|2315923|P2|Overall Study|Withdrawal by Subject|3
718467|NCT00133705|2315924|P1|Overall Study|Withdrawal by Subject|2
718468|NCT00141037|2315957|P2|Overall Study|Graft Failure|4
718469|NCT00141037|2315958|P1|Overall Study|Graft Failure|3
718470|NCT00141037|2315957|P2|Overall Study|Moved from area|7
718471|NCT00141037|2315958|P1|Overall Study|Moved from area|1
718472|NCT00141037|2315957|P2|Overall Study|Other|1
718473|NCT00141037|2315958|P1|Overall Study|Other|0
718474|NCT00141037|2315957|P2|Overall Study|Withdrawal by Subject|1
718475|NCT00141037|2315958|P1|Overall Study|Withdrawal by Subject|2
718476|NCT00141037|2315957|P2|Overall Study|Protocol Violation|2
718477|NCT00141037|2315958|P1|Overall Study|Protocol Violation|0
718478|NCT00141037|2315957|P2|Overall Study|Lost to Follow-up|1
718479|NCT00141037|2315958|P1|Overall Study|Lost to Follow-up|3
718480|NCT00141037|2315957|P2|Overall Study|Physician Decision|2
718481|NCT00141037|2315958|P1|Overall Study|Physician Decision|1
718482|NCT00141102|2315968|P2|Overall Study|Death|2
718483|NCT00141102|2315969|P1|Overall Study|Death|2
718484|NCT00141102|2315968|P2|Overall Study|Randomized But Did Not Receive Treatment|9
718485|NCT00141102|2315969|P1|Overall Study|Randomized But Did Not Receive Treatment|15
718486|NCT00141102|2315968|P2|Overall Study|Withdrawal by Subject|142
718487|NCT00141102|2315969|P1|Overall Study|Withdrawal by Subject|112
718488|NCT00141102|2315968|P2|Overall Study|Unspecified|76
718489|NCT00141102|2315969|P1|Overall Study|Unspecified|87
718490|NCT00141102|2315968|P2|Overall Study|Lost to Follow-up|32
718491|NCT00141102|2315969|P1|Overall Study|Lost to Follow-up|29
718492|NCT00141102|2315968|P2|Overall Study|Lack of Efficacy|26
718493|NCT00141102|2315969|P1|Overall Study|Lack of Efficacy|21
718494|NCT00141102|2315968|P2|Overall Study|Laboratory Abnormality|33
718495|NCT00141102|2315969|P1|Overall Study|Laboratory Abnormality|9
718496|NCT00141102|2315968|P2|Overall Study|Adverse Event|305
718497|NCT00141102|2315969|P1|Overall Study|Adverse Event|233
718498|NCT00141219|2316013|P2|Overall Study|Withdrawal by Subject|2
718499|NCT00141219|2316014|P1|Overall Study|Withdrawal by Subject|6
718500|NCT00141219|2316013|P2|Overall Study|Lack of Efficacy|4
718501|NCT00141219|2316014|P1|Overall Study|Lack of Efficacy|5
718502|NCT00141219|2316013|P2|Overall Study|Adverse Event|6
718503|NCT00141219|2316014|P1|Overall Study|Adverse Event|8
718504|NCT00141219|2316013|P2|Overall Study|Protocol violations|4
718505|NCT00141219|2316014|P1|Overall Study|Protocol violations|5
718506|NCT00141271|2316067|P3|Overall Study|Other|5
718507|NCT00141271|2316068|P2|Overall Study|Other|12
718508|NCT00141271|2316069|P1|Overall Study|Other|11
718509|NCT00141271|2316067|P3|Overall Study|Withdrawal by Subject|10
718510|NCT00141271|2316068|P2|Overall Study|Withdrawal by Subject|9
718511|NCT00141271|2316069|P1|Overall Study|Withdrawal by Subject|14
718512|NCT00141271|2316067|P3|Overall Study|Lost to Follow-up|21
718513|NCT00141271|2316068|P2|Overall Study|Lost to Follow-up|15
718514|NCT00141271|2316069|P1|Overall Study|Lost to Follow-up|15
718515|NCT00141271|2316067|P3|Overall Study|Lack of Efficacy|3
718516|NCT00141271|2316068|P2|Overall Study|Lack of Efficacy|7
718517|NCT00141271|2316069|P1|Overall Study|Lack of Efficacy|7
718518|NCT00141271|2316067|P3|Overall Study|Laboratory Abnormality|1
718519|NCT00141271|2316068|P2|Overall Study|Laboratory Abnormality|1
718520|NCT00141271|2316069|P1|Overall Study|Laboratory Abnormality|2
718521|NCT00141271|2316067|P3|Overall Study|Adverse Event|17
718522|NCT00141271|2316068|P2|Overall Study|Adverse Event|19
718523|NCT00141271|2316069|P1|Overall Study|Adverse Event|31
718524|NCT00141297|2316190|P10|Overall Study|Transitioned|0
718525|NCT00141297|2316191|P9|Overall Study|Transitioned|0
718526|NCT00141297|2316192|P8|Overall Study|Transitioned|0
718527|NCT00141297|2316193|P7|Overall Study|Transitioned|0
718528|NCT00141297|2316194|P6|Overall Study|Transitioned|0
718529|NCT00141297|2316195|P5|Overall Study|Transitioned|1
718530|NCT00141297|2316196|P4|Overall Study|Transitioned|0
718531|NCT00141297|2316197|P3|Overall Study|Transitioned|0
718532|NCT00141297|2316198|P2|Overall Study|Transitioned|0
718533|NCT00141297|2316199|P1|Overall Study|Transitioned|0
718534|NCT00141297|2316190|P10|Overall Study|Progressive Disease|6
718535|NCT00141297|2316191|P9|Overall Study|Progressive Disease|15
718536|NCT00141297|2316192|P8|Overall Study|Progressive Disease|3
718537|NCT00141297|2316193|P7|Overall Study|Progressive Disease|3
718538|NCT00141297|2316194|P6|Overall Study|Progressive Disease|2
718539|NCT00141297|2316195|P5|Overall Study|Progressive Disease|15
718540|NCT00141297|2316196|P4|Overall Study|Progressive Disease|2
718541|NCT00141297|2316197|P3|Overall Study|Progressive Disease|6
718542|NCT00141297|2316198|P2|Overall Study|Progressive Disease|3
718543|NCT00141297|2316199|P1|Overall Study|Progressive Disease|2
718544|NCT00141297|2316190|P10|Overall Study|Unspecified|0
718545|NCT00141297|2316191|P9|Overall Study|Unspecified|2
718546|NCT00141297|2316192|P8|Overall Study|Unspecified|0
718547|NCT00141297|2316193|P7|Overall Study|Unspecified|0
718548|NCT00141297|2316194|P6|Overall Study|Unspecified|0
718549|NCT00141297|2316195|P5|Overall Study|Unspecified|5
718550|NCT00141297|2316196|P4|Overall Study|Unspecified|1
718551|NCT00141297|2316197|P3|Overall Study|Unspecified|0
718552|NCT00141297|2316198|P2|Overall Study|Unspecified|0
718553|NCT00141297|2316199|P1|Overall Study|Unspecified|0
718554|NCT00141297|2316190|P10|Overall Study|Withdrawal by Subject|0
718555|NCT00141297|2316191|P9|Overall Study|Withdrawal by Subject|1
718556|NCT00141297|2316192|P8|Overall Study|Withdrawal by Subject|0
718557|NCT00141297|2316193|P7|Overall Study|Withdrawal by Subject|0
718558|NCT00141297|2316194|P6|Overall Study|Withdrawal by Subject|0
718559|NCT00141297|2316195|P5|Overall Study|Withdrawal by Subject|0
718560|NCT00141297|2316196|P4|Overall Study|Withdrawal by Subject|0
718561|NCT00141297|2316197|P3|Overall Study|Withdrawal by Subject|0
718562|NCT00141297|2316198|P2|Overall Study|Withdrawal by Subject|0
718563|NCT00141297|2316199|P1|Overall Study|Withdrawal by Subject|0
718564|NCT00141297|2316190|P10|Overall Study|Death|0
718565|NCT00141297|2316191|P9|Overall Study|Death|1
718566|NCT00141297|2316192|P8|Overall Study|Death|0
718567|NCT00141297|2316193|P7|Overall Study|Death|0
718568|NCT00141297|2316194|P6|Overall Study|Death|0
718569|NCT00141297|2316195|P5|Overall Study|Death|0
718570|NCT00141297|2316196|P4|Overall Study|Death|0
718571|NCT00141297|2316197|P3|Overall Study|Death|0
718572|NCT00141297|2316198|P2|Overall Study|Death|0
718573|NCT00141297|2316199|P1|Overall Study|Death|1
718574|NCT00141297|2316190|P10|Overall Study|Adverse Event|0
718575|NCT00141297|2316191|P9|Overall Study|Adverse Event|1
718576|NCT00141297|2316192|P8|Overall Study|Adverse Event|1
718577|NCT00141297|2316193|P7|Overall Study|Adverse Event|0
718578|NCT00141297|2316194|P6|Overall Study|Adverse Event|1
718579|NCT00141297|2316195|P5|Overall Study|Adverse Event|1
718580|NCT00141297|2316196|P4|Overall Study|Adverse Event|0
718581|NCT00141297|2316197|P3|Overall Study|Adverse Event|1
718582|NCT00141297|2316198|P2|Overall Study|Adverse Event|0
718583|NCT00141297|2316199|P1|Overall Study|Adverse Event|0
718584|NCT00141453|2316476|P2|Overall Study|Protocol Violation|5
718585|NCT00141453|2316477|P1|Overall Study|Protocol Violation|6
718586|NCT00141518|2316492|P3|Overall Study|Lack of Efficacy|0
718587|NCT00141518|2316493|P2|Overall Study|Lack of Efficacy|0
718588|NCT00141518|2316494|P1|Overall Study|Lack of Efficacy|5
718589|NCT00141518|2316492|P3|Overall Study|Protocol Violation|2
718590|NCT00141518|2316493|P2|Overall Study|Protocol Violation|1
718591|NCT00141518|2316494|P1|Overall Study|Protocol Violation|1
718592|NCT00141518|2316492|P3|Overall Study|Withdrawal by Subject|2
718593|NCT00141518|2316493|P2|Overall Study|Withdrawal by Subject|0
718594|NCT00141518|2316494|P1|Overall Study|Withdrawal by Subject|2
718595|NCT00141518|2316492|P3|Overall Study|Adverse Event|2
718596|NCT00141518|2316493|P2|Overall Study|Adverse Event|5
718597|NCT00141518|2316494|P1|Overall Study|Adverse Event|7
718598|NCT00141518|2316492|P3|Overall Study|Withdrew Consent Prior to Treatment|0
718599|NCT00141518|2316493|P2|Overall Study|Withdrew Consent Prior to Treatment|0
718600|NCT00141518|2316494|P1|Overall Study|Withdrew Consent Prior to Treatment|1
718601|NCT00141726|2316681|P1|Overall Study|Completed <50% Scheduled Dosing|3
718602|NCT00141778|2316704|P3|Started Study Medication|Chest Discomfort|1
718603|NCT00141778|2316705|P2|Started Study Medication|Chest Discomfort|0
718604|NCT00141778|2316706|P1|Started Study Medication|Chest Discomfort|0
718605|NCT00141778|2316704|P3|Started Study Medication|Difficulty Swallowing|0
718606|NCT00141778|2316705|P2|Started Study Medication|Difficulty Swallowing|1
718607|NCT00141778|2316706|P1|Started Study Medication|Difficulty Swallowing|0
718608|NCT00141778|2316704|P3|Started Study Medication|Withdrawal by Subject|0
718609|NCT00141778|2316705|P2|Started Study Medication|Withdrawal by Subject|2
718610|NCT00141778|2316706|P1|Started Study Medication|Withdrawal by Subject|0
718611|NCT00141778|2316704|P3|Started Study Medication|Met safety criteria for discontinuation|3
718612|NCT00141778|2316705|P2|Started Study Medication|Met safety criteria for discontinuation|4
718613|NCT00141778|2316706|P1|Started Study Medication|Met safety criteria for discontinuation|2
718614|NCT00141778|2316704|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
718615|NCT00141778|2316705|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
718616|NCT00141778|2316706|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
718617|NCT00141817|2316748|P4|Overall Study|Parent request|0
718618|NCT00141817|2316749|P3|Overall Study|Parent request|0
718619|NCT00141817|2316750|P2|Overall Study|Parent request|0
718620|NCT00141817|2316751|P1|Overall Study|Parent request|1
718621|NCT00141817|2316748|P4|Overall Study|Protocol Violation|0
718622|NCT00141817|2316749|P3|Overall Study|Protocol Violation|1
718623|NCT00141817|2316750|P2|Overall Study|Protocol Violation|0
718624|NCT00141817|2316751|P1|Overall Study|Protocol Violation|0
718625|NCT00141921|2316789|P1|Overall Study|Other|8
718626|NCT00141921|2316789|P1|Overall Study|Ineligibility Determined|2
718627|NCT00141921|2316789|P1|Overall Study|Pregnancy|4
718628|NCT00141921|2316789|P1|Overall Study|Administrative Decision|2
718629|NCT00141921|2316789|P1|Overall Study|Adverse Event|5
718630|NCT00141921|2316789|P1|Overall Study|Protocol Deviation|7
718631|NCT00141921|2316789|P1|Overall Study|Disease Progression|7
718632|NCT00141921|2316789|P1|Overall Study|Noncompliance|17
718633|NCT00141921|2316789|P1|Overall Study|Lost to Follow-up|19
718634|NCT00141921|2316789|P1|Overall Study|Withdrawal by Subject|42
718635|NCT00141921|2316789|P1|Overall Study|Remain on Study|28
718636|NCT00142298|2316833|P10|Overall Study|Treatment Failure|0
718637|NCT00142298|2316834|P9|Overall Study|Treatment Failure|0
718638|NCT00142298|2316835|P8|Overall Study|Treatment Failure|0
718639|NCT00142298|2316836|P7|Overall Study|Treatment Failure|2
718640|NCT00142298|2316837|P6|Overall Study|Treatment Failure|2
718641|NCT00142298|2316838|P5|Overall Study|Treatment Failure|0
718642|NCT00142298|2316839|P4|Overall Study|Treatment Failure|0
718643|NCT00142298|2316840|P3|Overall Study|Treatment Failure|0
718644|NCT00142298|2316841|P2|Overall Study|Treatment Failure|0
718645|NCT00142298|2316842|P1|Overall Study|Treatment Failure|0
718646|NCT00142298|2316833|P10|Overall Study|Lost to Follow-up|0
718647|NCT00142298|2316834|P9|Overall Study|Lost to Follow-up|0
718648|NCT00142298|2316835|P8|Overall Study|Lost to Follow-up|0
718649|NCT00142298|2316836|P7|Overall Study|Lost to Follow-up|2
718650|NCT00142298|2316837|P6|Overall Study|Lost to Follow-up|0
718651|NCT00142298|2316838|P5|Overall Study|Lost to Follow-up|0
718652|NCT00142298|2316839|P4|Overall Study|Lost to Follow-up|0
718653|NCT00142298|2316840|P3|Overall Study|Lost to Follow-up|0
718654|NCT00142298|2316841|P2|Overall Study|Lost to Follow-up|0
718655|NCT00142298|2316842|P1|Overall Study|Lost to Follow-up|0
718656|NCT00142298|2316833|P10|Overall Study|Other- not specified|0
718657|NCT00142298|2316834|P9|Overall Study|Other- not specified|0
718658|NCT00142298|2316835|P8|Overall Study|Other- not specified|0
718659|NCT00142298|2316836|P7|Overall Study|Other- not specified|0
718660|NCT00142298|2316837|P6|Overall Study|Other- not specified|0
718661|NCT00142298|2316838|P5|Overall Study|Other- not specified|0
718662|NCT00142298|2316839|P4|Overall Study|Other- not specified|1
718663|NCT00142298|2316840|P3|Overall Study|Other- not specified|0
718664|NCT00142298|2316841|P2|Overall Study|Other- not specified|3
718665|NCT00142298|2316842|P1|Overall Study|Other- not specified|0
718666|NCT00142298|2316833|P10|Overall Study|Virologic breakthrough|0
718667|NCT00142298|2316834|P9|Overall Study|Virologic breakthrough|0
718668|NCT00142298|2316835|P8|Overall Study|Virologic breakthrough|0
718669|NCT00142298|2316836|P7|Overall Study|Virologic breakthrough|3
718670|NCT00142298|2316837|P6|Overall Study|Virologic breakthrough|3
718671|NCT00142298|2316838|P5|Overall Study|Virologic breakthrough|2
718672|NCT00142298|2316839|P4|Overall Study|Virologic breakthrough|7
718673|NCT00142298|2316840|P3|Overall Study|Virologic breakthrough|9
718674|NCT00142298|2316841|P2|Overall Study|Virologic breakthrough|23
718675|NCT00142298|2316842|P1|Overall Study|Virologic breakthrough|19
718676|NCT00142298|2316833|P10|Overall Study|Pregnancy|0
718677|NCT00142298|2316834|P9|Overall Study|Pregnancy|1
718678|NCT00142298|2316835|P8|Overall Study|Pregnancy|0
718679|NCT00142298|2316836|P7|Overall Study|Pregnancy|0
718680|NCT00142298|2316837|P6|Overall Study|Pregnancy|0
718681|NCT00142298|2316838|P5|Overall Study|Pregnancy|0
718682|NCT00142298|2316839|P4|Overall Study|Pregnancy|3
718683|NCT00142298|2316840|P3|Overall Study|Pregnancy|2
718684|NCT00142298|2316841|P2|Overall Study|Pregnancy|4
718685|NCT00142298|2316842|P1|Overall Study|Pregnancy|4
718686|NCT00142298|2316833|P10|Overall Study|Patient, Investigator,or Sponsor request|0
718687|NCT00142298|2316834|P9|Overall Study|Patient, Investigator,or Sponsor request|1
718688|NCT00142298|2316835|P8|Overall Study|Patient, Investigator,or Sponsor request|4
718689|NCT00142298|2316836|P7|Overall Study|Patient, Investigator,or Sponsor request|1
718690|NCT00142298|2316837|P6|Overall Study|Patient, Investigator,or Sponsor request|3
718691|NCT00142298|2316838|P5|Overall Study|Patient, Investigator,or Sponsor request|4
718692|NCT00142298|2316839|P4|Overall Study|Patient, Investigator,or Sponsor request|51
718693|NCT00142298|2316840|P3|Overall Study|Patient, Investigator,or Sponsor request|11
718694|NCT00142298|2316841|P2|Overall Study|Patient, Investigator,or Sponsor request|60
718695|NCT00142298|2316842|P1|Overall Study|Patient, Investigator,or Sponsor request|66
718696|NCT00142298|2316833|P10|Overall Study|Non-compliance|0
718697|NCT00142298|2316834|P9|Overall Study|Non-compliance|3
718698|NCT00142298|2316835|P8|Overall Study|Non-compliance|3
718699|NCT00142298|2316836|P7|Overall Study|Non-compliance|0
718700|NCT00142298|2316837|P6|Overall Study|Non-compliance|0
718701|NCT00142298|2316838|P5|Overall Study|Non-compliance|1
718702|NCT00142298|2316839|P4|Overall Study|Non-compliance|6
718703|NCT00142298|2316840|P3|Overall Study|Non-compliance|0
718704|NCT00142298|2316841|P2|Overall Study|Non-compliance|13
718705|NCT00142298|2316842|P1|Overall Study|Non-compliance|15
718706|NCT00142298|2316833|P10|Overall Study|Lack of Efficacy|0
718707|NCT00142298|2316834|P9|Overall Study|Lack of Efficacy|0
718708|NCT00142298|2316835|P8|Overall Study|Lack of Efficacy|1
718709|NCT00142298|2316836|P7|Overall Study|Lack of Efficacy|0
718710|NCT00142298|2316837|P6|Overall Study|Lack of Efficacy|0
718711|NCT00142298|2316838|P5|Overall Study|Lack of Efficacy|1
718712|NCT00142298|2316839|P4|Overall Study|Lack of Efficacy|12
718713|NCT00142298|2316840|P3|Overall Study|Lack of Efficacy|9
718714|NCT00142298|2316841|P2|Overall Study|Lack of Efficacy|62
718715|NCT00142298|2316842|P1|Overall Study|Lack of Efficacy|44
718716|NCT00142298|2316833|P10|Overall Study|Death|0
718717|NCT00142298|2316834|P9|Overall Study|Death|0
718718|NCT00142298|2316835|P8|Overall Study|Death|0
718719|NCT00142298|2316836|P7|Overall Study|Death|0
718720|NCT00142298|2316837|P6|Overall Study|Death|6
718721|NCT00142298|2316838|P5|Overall Study|Death|0
718722|NCT00142298|2316839|P4|Overall Study|Death|0
718723|NCT00142298|2316840|P3|Overall Study|Death|1
718724|NCT00142298|2316841|P2|Overall Study|Death|1
718725|NCT00142298|2316842|P1|Overall Study|Death|1
718726|NCT00142298|2316833|P10|Overall Study|Clinical disease progression|0
718727|NCT00142298|2316834|P9|Overall Study|Clinical disease progression|0
718728|NCT00142298|2316835|P8|Overall Study|Clinical disease progression|0
718729|NCT00142298|2316836|P7|Overall Study|Clinical disease progression|0
718730|NCT00142298|2316837|P6|Overall Study|Clinical disease progression|0
718731|NCT00142298|2316838|P5|Overall Study|Clinical disease progression|0
718732|NCT00142298|2316839|P4|Overall Study|Clinical disease progression|0
718733|NCT00142298|2316840|P3|Overall Study|Clinical disease progression|0
718734|NCT00142298|2316841|P2|Overall Study|Clinical disease progression|0
718735|NCT00142298|2316842|P1|Overall Study|Clinical disease progression|1
718736|NCT00142298|2316833|P10|Overall Study|Adverse Event|0
718737|NCT00142298|2316834|P9|Overall Study|Adverse Event|0
718738|NCT00142298|2316835|P8|Overall Study|Adverse Event|0
718739|NCT00142298|2316836|P7|Overall Study|Adverse Event|0
718740|NCT00142298|2316837|P6|Overall Study|Adverse Event|2
718741|NCT00142298|2316838|P5|Overall Study|Adverse Event|2
718742|NCT00142298|2316839|P4|Overall Study|Adverse Event|5
718743|NCT00142298|2316840|P3|Overall Study|Adverse Event|1
718744|NCT00142298|2316841|P2|Overall Study|Adverse Event|10
718745|NCT00142298|2316842|P1|Overall Study|Adverse Event|10
718746|NCT00142415|2316870|P6|Overall Study|Physician Decision|2
718747|NCT00142415|2316871|P5|Overall Study|Physician Decision|1
718748|NCT00142415|2316872|P4|Overall Study|Physician Decision|0
718749|NCT00142415|2316873|P3|Overall Study|Physician Decision|0
718750|NCT00142415|2316874|P2|Overall Study|Physician Decision|0
718751|NCT00142415|2316875|P1|Overall Study|Physician Decision|0
718752|NCT00142909|2316931|P2|Medications Begin|Withdrawal by Subject|0
718753|NCT00142909|2316932|P1|Medications Begin|Withdrawal by Subject|2
718754|NCT00142909|2316931|P2|Medications Begin|Withdrawal by Subject|3
718755|NCT00142909|2316932|P1|Medications Begin|Withdrawal by Subject|5
718756|NCT00142909|2316931|P2|Medications Begin|Protocol Violation|0
718757|NCT00142909|2316932|P1|Medications Begin|Protocol Violation|2
718758|NCT00142909|2316931|P2|Randomization|Various Reasons|10
718759|NCT00142909|2316932|P1|Randomization|Various Reasons|7
718760|NCT00142935|2316951|P3|Overall Study|Death|1
718761|NCT00142935|2316952|P2|Overall Study|Death|2
718762|NCT00142935|2316953|P1|Overall Study|Death|0
718763|NCT00142935|2316951|P3|Overall Study|Lost to Follow-up|5
718764|NCT00142935|2316952|P2|Overall Study|Lost to Follow-up|5
718765|NCT00142935|2316953|P1|Overall Study|Lost to Follow-up|2
718766|NCT00142935|2316951|P3|Overall Study|Other reason|1
718767|NCT00142935|2316952|P2|Overall Study|Other reason|1
718768|NCT00142935|2316953|P1|Overall Study|Other reason|1
718769|NCT00149994|2316978|P2|Overall Study|Protocol Violation|1
718770|NCT00149994|2316979|P1|Overall Study|Protocol Violation|0
718771|NCT00149994|2316978|P2|Overall Study|Administrative problems:|0
718772|NCT00149994|2316979|P1|Overall Study|Administrative problems:|1
718773|NCT00150176|2316987|P2|Overall Study|OTHER|13
718774|NCT00150176|2316988|P1|Overall Study|OTHER|11
718775|NCT00150176|2316987|P2|Overall Study|Lost to Follow-up|3
718776|NCT00150176|2316988|P1|Overall Study|Lost to Follow-up|3
718777|NCT00150176|2316987|P2|Overall Study|Withdrawal by Subject|12
718778|NCT00150176|2316988|P1|Overall Study|Withdrawal by Subject|19
718779|NCT00150176|2316987|P2|Overall Study|Relapse/Impending relapse, non-AE|39
718780|NCT00150176|2316988|P1|Overall Study|Relapse/Impending relapse, non-AE|10
718781|NCT00150176|2316987|P2|Overall Study|Adverse Event|53
718782|NCT00150176|2316988|P1|Overall Study|Adverse Event|16
718783|NCT00150345|2316999|P2|Overall Study|Unspecified|14
718784|NCT00150345|2317000|P1|Overall Study|Unspecified|12
718785|NCT00150345|2316999|P2|Overall Study|Laboratory abnormality|2
718786|NCT00150345|2317000|P1|Overall Study|Laboratory abnormality|1
718787|NCT00150345|2316999|P2|Overall Study|Withdrawal by Subject|4
718788|NCT00150345|2317000|P1|Overall Study|Withdrawal by Subject|3
718789|NCT00150345|2316999|P2|Overall Study|Lack of Efficacy|4
718790|NCT00150345|2317000|P1|Overall Study|Lack of Efficacy|5
718791|NCT00150345|2316999|P2|Overall Study|Adverse Event|6
718792|NCT00150345|2317000|P1|Overall Study|Adverse Event|8
718793|NCT00150345|2316999|P2|Overall Study|Death|2
718794|NCT00150345|2317000|P1|Overall Study|Death|5
718795|NCT00150462|2317073|P11|Overall Study|Other|1
718796|NCT00150462|2317074|P10|Overall Study|Other|1
718797|NCT00150462|2317075|P9|Overall Study|Other|0
718798|NCT00150462|2317076|P8|Overall Study|Other|0
718799|NCT00150462|2317077|P7|Overall Study|Other|0
718800|NCT00150462|2317078|P6|Overall Study|Other|0
718801|NCT00150462|2317079|P5|Overall Study|Other|0
718802|NCT00150462|2317080|P4|Overall Study|Other|0
718803|NCT00150462|2317081|P3|Overall Study|Other|0
718804|NCT00150462|2317082|P2|Overall Study|Other|0
718805|NCT00150462|2317083|P1|Overall Study|Other|0
718806|NCT00150462|2317073|P11|Overall Study|Physician Decision|0
718807|NCT00150462|2317074|P10|Overall Study|Physician Decision|0
718808|NCT00150462|2317075|P9|Overall Study|Physician Decision|0
718809|NCT00150462|2317076|P8|Overall Study|Physician Decision|0
718810|NCT00150462|2317077|P7|Overall Study|Physician Decision|0
718811|NCT00150462|2317078|P6|Overall Study|Physician Decision|0
718812|NCT00150462|2317079|P5|Overall Study|Physician Decision|0
718813|NCT00150462|2317080|P4|Overall Study|Physician Decision|1
718814|NCT00150462|2317081|P3|Overall Study|Physician Decision|1
718815|NCT00150462|2317082|P2|Overall Study|Physician Decision|0
718816|NCT00150462|2317083|P1|Overall Study|Physician Decision|0
718817|NCT00150462|2317073|P11|Overall Study|Adverse Event|0
718818|NCT00150462|2317074|P10|Overall Study|Adverse Event|1
718819|NCT00150462|2317075|P9|Overall Study|Adverse Event|0
718820|NCT00150462|2317076|P8|Overall Study|Adverse Event|2
718821|NCT00150462|2317077|P7|Overall Study|Adverse Event|0
718822|NCT00150462|2317078|P6|Overall Study|Adverse Event|0
718823|NCT00150462|2317079|P5|Overall Study|Adverse Event|0
718824|NCT00150462|2317080|P4|Overall Study|Adverse Event|1
718825|NCT00150462|2317081|P3|Overall Study|Adverse Event|0
718826|NCT00150462|2317082|P2|Overall Study|Adverse Event|0
718827|NCT00150462|2317083|P1|Overall Study|Adverse Event|0
718828|NCT00150462|2317073|P11|Overall Study|Death|0
718829|NCT00150462|2317074|P10|Overall Study|Death|0
718830|NCT00150462|2317075|P9|Overall Study|Death|1
718831|NCT00150462|2317076|P8|Overall Study|Death|0
718832|NCT00150462|2317077|P7|Overall Study|Death|0
718833|NCT00150462|2317078|P6|Overall Study|Death|0
718834|NCT00150462|2317079|P5|Overall Study|Death|0
718835|NCT00150462|2317080|P4|Overall Study|Death|0
718836|NCT00150462|2317081|P3|Overall Study|Death|0
718837|NCT00150462|2317082|P2|Overall Study|Death|1
718838|NCT00150462|2317083|P1|Overall Study|Death|0
718839|NCT00150462|2317073|P11|Overall Study|Withdrawal by Subject|0
718840|NCT00150462|2317074|P10|Overall Study|Withdrawal by Subject|1
718841|NCT00150462|2317075|P9|Overall Study|Withdrawal by Subject|0
718842|NCT00150462|2317076|P8|Overall Study|Withdrawal by Subject|1
718843|NCT00150462|2317077|P7|Overall Study|Withdrawal by Subject|0
718844|NCT00150462|2317078|P6|Overall Study|Withdrawal by Subject|2
718845|NCT00150462|2317079|P5|Overall Study|Withdrawal by Subject|1
718846|NCT00150462|2317080|P4|Overall Study|Withdrawal by Subject|0
718847|NCT00150462|2317081|P3|Overall Study|Withdrawal by Subject|1
718848|NCT00150462|2317082|P2|Overall Study|Withdrawal by Subject|1
718849|NCT00150462|2317083|P1|Overall Study|Withdrawal by Subject|0
718850|NCT00150462|2317073|P11|Overall Study|Disease Progression or Relapse|2
718851|NCT00150462|2317074|P10|Overall Study|Disease Progression or Relapse|3
718852|NCT00150462|2317075|P9|Overall Study|Disease Progression or Relapse|5
718853|NCT00150462|2317076|P8|Overall Study|Disease Progression or Relapse|5
718854|NCT00150462|2317077|P7|Overall Study|Disease Progression or Relapse|3
718855|NCT00150462|2317078|P6|Overall Study|Disease Progression or Relapse|2
718856|NCT00150462|2317079|P5|Overall Study|Disease Progression or Relapse|2
718857|NCT00150462|2317080|P4|Overall Study|Disease Progression or Relapse|1
718858|NCT00150462|2317081|P3|Overall Study|Disease Progression or Relapse|2
718859|NCT00150462|2317082|P2|Overall Study|Disease Progression or Relapse|1
718860|NCT00150462|2317083|P1|Overall Study|Disease Progression or Relapse|3
718861|NCT00150592|2317193|P2|Overall Study|Non-compliance|0
718862|NCT00150592|2317194|P1|Overall Study|Non-compliance|1
718863|NCT00150592|2317193|P2|Overall Study|Withdrawal by Subject|2
718864|NCT00150592|2317194|P1|Overall Study|Withdrawal by Subject|1
718865|NCT00150592|2317193|P2|Overall Study|Protocol Violation|0
718866|NCT00150592|2317194|P1|Overall Study|Protocol Violation|1
718867|NCT00150592|2317193|P2|Overall Study|Adverse Event|1
718868|NCT00150592|2317194|P1|Overall Study|Adverse Event|4
718869|NCT00150618|2317219|P5|Overall Study|Sponsor's decision|0
718870|NCT00150618|2317220|P4|Overall Study|Sponsor's decision|1
718871|NCT00150618|2317221|P3|Overall Study|Sponsor's decision|0
718872|NCT00150618|2317222|P2|Overall Study|Sponsor's decision|0
718873|NCT00150618|2317223|P1|Overall Study|Sponsor's decision|0
718874|NCT00150618|2317219|P5|Overall Study|Abnormal ECG|0
718875|NCT00150618|2317220|P4|Overall Study|Abnormal ECG|0
718876|NCT00150618|2317221|P3|Overall Study|Abnormal ECG|0
718877|NCT00150618|2317222|P2|Overall Study|Abnormal ECG|0
718878|NCT00150618|2317223|P1|Overall Study|Abnormal ECG|1
718879|NCT00150618|2317219|P5|Overall Study|Lack of compliance|1
718880|NCT00150618|2317220|P4|Overall Study|Lack of compliance|0
718881|NCT00150618|2317221|P3|Overall Study|Lack of compliance|1
718882|NCT00150618|2317222|P2|Overall Study|Lack of compliance|1
718883|NCT00150618|2317223|P1|Overall Study|Lack of compliance|2
718884|NCT00150618|2317219|P5|Overall Study|Physician Decision|1
718885|NCT00150618|2317220|P4|Overall Study|Physician Decision|0
718886|NCT00150618|2317221|P3|Overall Study|Physician Decision|0
718887|NCT00150618|2317222|P2|Overall Study|Physician Decision|2
718888|NCT00150618|2317223|P1|Overall Study|Physician Decision|0
718889|NCT00150618|2317219|P5|Overall Study|No study meds|2
718890|NCT00150618|2317220|P4|Overall Study|No study meds|0
718891|NCT00150618|2317221|P3|Overall Study|No study meds|0
718892|NCT00150618|2317222|P2|Overall Study|No study meds|0
718893|NCT00150618|2317223|P1|Overall Study|No study meds|0
718894|NCT00150618|2317219|P5|Overall Study|Lack of Efficacy|6
718895|NCT00150618|2317220|P4|Overall Study|Lack of Efficacy|4
718896|NCT00150618|2317221|P3|Overall Study|Lack of Efficacy|7
718897|NCT00150618|2317222|P2|Overall Study|Lack of Efficacy|4
718898|NCT00150618|2317223|P1|Overall Study|Lack of Efficacy|1
718899|NCT00150618|2317219|P5|Overall Study|Protocol Violation|1
718900|NCT00150618|2317220|P4|Overall Study|Protocol Violation|0
718901|NCT00150618|2317221|P3|Overall Study|Protocol Violation|0
718902|NCT00150618|2317222|P2|Overall Study|Protocol Violation|0
718903|NCT00150618|2317223|P1|Overall Study|Protocol Violation|1
718904|NCT00150618|2317219|P5|Overall Study|Lost to Follow-up|4
718905|NCT00150618|2317220|P4|Overall Study|Lost to Follow-up|8
718906|NCT00150618|2317221|P3|Overall Study|Lost to Follow-up|5
718907|NCT00150618|2317222|P2|Overall Study|Lost to Follow-up|1
718908|NCT00150618|2317223|P1|Overall Study|Lost to Follow-up|4
718909|NCT00150618|2317219|P5|Overall Study|Withdrawal by Subject|5
718910|NCT00150618|2317220|P4|Overall Study|Withdrawal by Subject|4
718911|NCT00150618|2317221|P3|Overall Study|Withdrawal by Subject|8
718912|NCT00150618|2317222|P2|Overall Study|Withdrawal by Subject|8
718913|NCT00150618|2317223|P1|Overall Study|Withdrawal by Subject|6
718914|NCT00150618|2317219|P5|Overall Study|Adverse Event|5
718915|NCT00150618|2317220|P4|Overall Study|Adverse Event|9
718916|NCT00150618|2317221|P3|Overall Study|Adverse Event|6
718917|NCT00150618|2317222|P2|Overall Study|Adverse Event|2
718918|NCT00150618|2317223|P1|Overall Study|Adverse Event|2
718919|NCT00150969|2317257|P2|24-48 Month Extension|Other Reason|91
718920|NCT00150969|2317258|P1|24-48 Month Extension|Other Reason|81
718921|NCT00150969|2317257|P2|24-48 Month Extension|Adverse Event|3
718922|NCT00150969|2317258|P1|24-48 Month Extension|Adverse Event|1
718923|NCT00150969|2317257|P2|24-48 Month Extension|Lack of Efficacy|1
718924|NCT00150969|2317258|P1|24-48 Month Extension|Lack of Efficacy|0
718925|NCT00150969|2317257|P2|24-48 Month Extension|Withdrawal by Subject|5
718926|NCT00150969|2317258|P1|24-48 Month Extension|Withdrawal by Subject|6
718927|NCT00150969|2317257|P2|24 Month Main Study|Withdrawal by Subject|4
718928|NCT00150969|2317258|P1|24 Month Main Study|Withdrawal by Subject|7
718929|NCT00150969|2317257|P2|24 Month Main Study|Protocol Violation|2
718930|NCT00150969|2317258|P1|24 Month Main Study|Protocol Violation|4
718931|NCT00150969|2317257|P2|24 Month Main Study|Lost to Follow-up|2
718932|NCT00150969|2317258|P1|24 Month Main Study|Lost to Follow-up|3
718933|NCT00150969|2317257|P2|24 Month Main Study|Lack of Efficacy|8
718934|NCT00150969|2317258|P1|24 Month Main Study|Lack of Efficacy|1
718935|NCT00150969|2317257|P2|24 Month Main Study|Death|1
718936|NCT00150969|2317258|P1|24 Month Main Study|Death|1
718937|NCT00150969|2317257|P2|24 Month Main Study|Adverse Event|4
718938|NCT00150969|2317258|P1|24 Month Main Study|Adverse Event|3
718939|NCT00151281|2317290|P1|Overall Study|Not evaluable|3
718940|NCT00151372|2317306|P2|Overall Study|Withdrawal by Subject|7
718941|NCT00151372|2317307|P1|Overall Study|Withdrawal by Subject|7
718942|NCT00151372|2317306|P2|Overall Study|Too sick medically to continue|6
718943|NCT00151372|2317307|P1|Overall Study|Too sick medically to continue|5
718944|NCT00151372|2317306|P2|Overall Study|Lost to Follow-up|5
718945|NCT00151372|2317307|P1|Overall Study|Lost to Follow-up|5
718946|NCT00151372|2317306|P2|Overall Study|Death|11
718947|NCT00151372|2317307|P1|Overall Study|Death|12
890244|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
890245|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
890246|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
890247|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
890248|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
718956|NCT00151476|2317327|P2|FAP Analyzed Subjects|Other study participation|1
718957|NCT00151476|2317328|P1|FAP Analyzed Subjects|Other study participation|0
718958|NCT00151476|2317327|P2|FAP Analyzed Subjects|Lost to Follow-up|2
718959|NCT00151476|2317328|P1|FAP Analyzed Subjects|Lost to Follow-up|0
718960|NCT00151476|2317327|P2|FAP Identified Subjects|Protocol Violation|1
718961|NCT00151476|2317328|P1|FAP Identified Subjects|Protocol Violation|0
718962|NCT00151775|2317388|P12|Period 4: Open Label|Protocol Violation|0
718963|NCT00151775|2317389|P11|Period 4: Open Label|Protocol Violation|0
718964|NCT00151775|2317390|P10|Period 4: Open Label|Protocol Violation|0
718965|NCT00151775|2317391|P9|Period 4: Open Label|Protocol Violation|0
718966|NCT00151775|2317392|P8|Period 4: Open Label|Protocol Violation|0
718967|NCT00151775|2317393|P7|Period 4: Open Label|Protocol Violation|0
718968|NCT00151775|2317394|P6|Period 4: Open Label|Protocol Violation|0
718969|NCT00151775|2317395|P5|Period 4: Open Label|Protocol Violation|1
718970|NCT00151775|2317396|P4|Period 4: Open Label|Protocol Violation|0
718971|NCT00151775|2317397|P3|Period 4: Open Label|Protocol Violation|0
718972|NCT00151775|2317398|P2|Period 4: Open Label|Protocol Violation|0
718973|NCT00151775|2317399|P1|Period 4: Open Label|Protocol Violation|0
718974|NCT00151775|2317388|P12|Period 4: Open Label|Physician Decision|0
718975|NCT00151775|2317389|P11|Period 4: Open Label|Physician Decision|0
718976|NCT00151775|2317390|P10|Period 4: Open Label|Physician Decision|2
718977|NCT00151775|2317391|P9|Period 4: Open Label|Physician Decision|0
718978|NCT00151775|2317392|P8|Period 4: Open Label|Physician Decision|0
718979|NCT00151775|2317393|P7|Period 4: Open Label|Physician Decision|0
718980|NCT00151775|2317394|P6|Period 4: Open Label|Physician Decision|0
718981|NCT00151775|2317395|P5|Period 4: Open Label|Physician Decision|0
718982|NCT00151775|2317396|P4|Period 4: Open Label|Physician Decision|0
718983|NCT00151775|2317397|P3|Period 4: Open Label|Physician Decision|0
718984|NCT00151775|2317398|P2|Period 4: Open Label|Physician Decision|0
718985|NCT00151775|2317399|P1|Period 4: Open Label|Physician Decision|0
718986|NCT00151775|2317388|P12|Period 4: Open Label|Other|0
718987|NCT00151775|2317389|P11|Period 4: Open Label|Other|0
718988|NCT00151775|2317390|P10|Period 4: Open Label|Other|3
718989|NCT00151775|2317391|P9|Period 4: Open Label|Other|0
718990|NCT00151775|2317392|P8|Period 4: Open Label|Other|0
718991|NCT00151775|2317393|P7|Period 4: Open Label|Other|0
718992|NCT00151775|2317394|P6|Period 4: Open Label|Other|0
718993|NCT00151775|2317395|P5|Period 4: Open Label|Other|1
718994|NCT00151775|2317396|P4|Period 4: Open Label|Other|0
718995|NCT00151775|2317397|P3|Period 4: Open Label|Other|0
718996|NCT00151775|2317398|P2|Period 4: Open Label|Other|0
718997|NCT00151775|2317399|P1|Period 4: Open Label|Other|0
718998|NCT00151775|2317388|P12|Period 4: Open Label|Non-compliance with protocol|0
718999|NCT00151775|2317389|P11|Period 4: Open Label|Non-compliance with protocol|0
719000|NCT00151775|2317390|P10|Period 4: Open Label|Non-compliance with protocol|4
719001|NCT00151775|2317391|P9|Period 4: Open Label|Non-compliance with protocol|0
719002|NCT00151775|2317392|P8|Period 4: Open Label|Non-compliance with protocol|0
719003|NCT00151775|2317393|P7|Period 4: Open Label|Non-compliance with protocol|0
719004|NCT00151775|2317394|P6|Period 4: Open Label|Non-compliance with protocol|0
719005|NCT00151775|2317395|P5|Period 4: Open Label|Non-compliance with protocol|4
719006|NCT00151775|2317396|P4|Period 4: Open Label|Non-compliance with protocol|0
719007|NCT00151775|2317397|P3|Period 4: Open Label|Non-compliance with protocol|0
719008|NCT00151775|2317398|P2|Period 4: Open Label|Non-compliance with protocol|0
719009|NCT00151775|2317399|P1|Period 4: Open Label|Non-compliance with protocol|0
719010|NCT00151775|2317388|P12|Period 4: Open Label|Lost to Follow-up|0
719011|NCT00151775|2317389|P11|Period 4: Open Label|Lost to Follow-up|0
719012|NCT00151775|2317390|P10|Period 4: Open Label|Lost to Follow-up|7
719013|NCT00151775|2317391|P9|Period 4: Open Label|Lost to Follow-up|0
719014|NCT00151775|2317392|P8|Period 4: Open Label|Lost to Follow-up|0
719015|NCT00151775|2317393|P7|Period 4: Open Label|Lost to Follow-up|0
719016|NCT00151775|2317394|P6|Period 4: Open Label|Lost to Follow-up|0
719017|NCT00151775|2317395|P5|Period 4: Open Label|Lost to Follow-up|17
719018|NCT00151775|2317396|P4|Period 4: Open Label|Lost to Follow-up|0
719019|NCT00151775|2317397|P3|Period 4: Open Label|Lost to Follow-up|0
719020|NCT00151775|2317398|P2|Period 4: Open Label|Lost to Follow-up|0
719021|NCT00151775|2317399|P1|Period 4: Open Label|Lost to Follow-up|0
719022|NCT00151775|2317388|P12|Period 4: Open Label|Adverse Event|0
719023|NCT00151775|2317389|P11|Period 4: Open Label|Adverse Event|0
719024|NCT00151775|2317390|P10|Period 4: Open Label|Adverse Event|2
719025|NCT00151775|2317391|P9|Period 4: Open Label|Adverse Event|0
719026|NCT00151775|2317392|P8|Period 4: Open Label|Adverse Event|0
719027|NCT00151775|2317393|P7|Period 4: Open Label|Adverse Event|0
719028|NCT00151775|2317394|P6|Period 4: Open Label|Adverse Event|0
719029|NCT00151775|2317395|P5|Period 4: Open Label|Adverse Event|1
719030|NCT00151775|2317396|P4|Period 4: Open Label|Adverse Event|0
719031|NCT00151775|2317397|P3|Period 4: Open Label|Adverse Event|0
719032|NCT00151775|2317398|P2|Period 4: Open Label|Adverse Event|0
719033|NCT00151775|2317399|P1|Period 4: Open Label|Adverse Event|0
719034|NCT00151775|2317388|P12|Period 4: Open Label|Withdrawal by Subject|0
719035|NCT00151775|2317389|P11|Period 4: Open Label|Withdrawal by Subject|0
719036|NCT00151775|2317390|P10|Period 4: Open Label|Withdrawal by Subject|2
719037|NCT00151775|2317391|P9|Period 4: Open Label|Withdrawal by Subject|0
719038|NCT00151775|2317392|P8|Period 4: Open Label|Withdrawal by Subject|0
719039|NCT00151775|2317393|P7|Period 4: Open Label|Withdrawal by Subject|0
719040|NCT00151775|2317394|P6|Period 4: Open Label|Withdrawal by Subject|0
719041|NCT00151775|2317395|P5|Period 4: Open Label|Withdrawal by Subject|5
719042|NCT00151775|2317396|P4|Period 4: Open Label|Withdrawal by Subject|0
719043|NCT00151775|2317397|P3|Period 4: Open Label|Withdrawal by Subject|0
719044|NCT00151775|2317398|P2|Period 4: Open Label|Withdrawal by Subject|0
719045|NCT00151775|2317399|P1|Period 4: Open Label|Withdrawal by Subject|0
719046|NCT00151775|2317388|P12|Period 4: Open Label|Increased blood pressure|0
719047|NCT00151775|2317389|P11|Period 4: Open Label|Increased blood pressure|0
719048|NCT00151775|2317390|P10|Period 4: Open Label|Increased blood pressure|1
719049|NCT00151775|2317391|P9|Period 4: Open Label|Increased blood pressure|0
719050|NCT00151775|2317392|P8|Period 4: Open Label|Increased blood pressure|0
719051|NCT00151775|2317393|P7|Period 4: Open Label|Increased blood pressure|0
719052|NCT00151775|2317394|P6|Period 4: Open Label|Increased blood pressure|0
719053|NCT00151775|2317395|P5|Period 4: Open Label|Increased blood pressure|1
719054|NCT00151775|2317396|P4|Period 4: Open Label|Increased blood pressure|0
719055|NCT00151775|2317397|P3|Period 4: Open Label|Increased blood pressure|0
719056|NCT00151775|2317398|P2|Period 4: Open Label|Increased blood pressure|0
719057|NCT00151775|2317399|P1|Period 4: Open Label|Increased blood pressure|0
719058|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
719059|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719060|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719061|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719062|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719063|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719064|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719065|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719066|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719067|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719068|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719069|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
719070|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719071|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719072|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719073|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719074|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719075|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719076|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719077|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719078|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719079|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
719080|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719081|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
719082|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
719083|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
719084|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
719085|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
719086|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
719087|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
719088|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
719089|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
719090|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
719091|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
719092|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
719093|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
719094|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719095|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719096|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719097|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719098|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719099|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
719100|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719101|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719102|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719103|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719104|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719105|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
719106|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Other|0
719107|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Other|0
719108|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Other|0
719109|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Other|0
719110|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Other|1
719111|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Other|0
719112|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Other|0
719113|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Other|0
719114|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Other|0
719115|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Other|1
719116|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Other|0
719117|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Other|0
719118|NCT00151775|2317388|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719119|NCT00151775|2317389|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719120|NCT00151775|2317390|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719121|NCT00151775|2317391|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719122|NCT00151775|2317392|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719123|NCT00151775|2317393|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719124|NCT00151775|2317394|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
719125|NCT00151775|2317395|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719126|NCT00151775|2317396|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719127|NCT00151775|2317397|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719128|NCT00151775|2317398|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719129|NCT00151775|2317399|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
719130|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719131|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719132|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719133|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719134|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719135|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
719136|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719137|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719138|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719139|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719140|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719141|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
719142|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
719143|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
719144|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
719145|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
719146|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
719147|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
719148|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
719149|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
719150|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
719151|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
719152|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
719153|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
719154|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
719155|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
719156|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
719157|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
719158|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
719159|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
719160|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
719161|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
719162|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
719163|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
719164|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
719165|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
719166|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|Other|0
719167|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|Other|0
719168|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|Other|0
719169|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|Other|0
719170|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|Other|0
719171|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|Other|1
719172|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|Other|0
719173|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|Other|0
719174|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|Other|0
719175|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|Other|0
719176|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|Other|0
719177|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|Other|0
719178|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719179|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719180|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719181|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719182|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719183|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719184|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719185|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719186|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719187|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719188|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
719189|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
719190|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719191|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
719192|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719193|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719194|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719195|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
719196|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719197|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719198|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719199|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719200|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
719201|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
719202|NCT00151775|2317388|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
719203|NCT00151775|2317389|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
719204|NCT00151775|2317390|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
719205|NCT00151775|2317391|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
719206|NCT00151775|2317392|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
719207|NCT00151775|2317393|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
719208|NCT00151775|2317394|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
719209|NCT00151775|2317395|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
719210|NCT00151775|2317396|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
719211|NCT00151775|2317397|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
719212|NCT00151775|2317398|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
719213|NCT00151775|2317399|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
719214|NCT00151892|2317468|P2|Overall Study|Lack of study medication at center|1
719215|NCT00151892|2317469|P1|Overall Study|Lack of study medication at center|0
719216|NCT00151892|2317468|P2|Overall Study|Used prohibited corticosteroids|0
719217|NCT00151892|2317469|P1|Overall Study|Used prohibited corticosteroids|1
719218|NCT00151892|2317468|P2|Overall Study|Did not return for a visit|0
719219|NCT00151892|2317469|P1|Overall Study|Did not return for a visit|1
719220|NCT00151892|2317468|P2|Overall Study|Pregnancy|1
719221|NCT00151892|2317469|P1|Overall Study|Pregnancy|0
719222|NCT00151892|2317468|P2|Overall Study|Non-compliance|1
719223|NCT00151892|2317469|P1|Overall Study|Non-compliance|0
719224|NCT00151892|2317468|P2|Overall Study|Protocol Violation|3
719225|NCT00151892|2317469|P1|Overall Study|Protocol Violation|3
719226|NCT00151892|2317468|P2|Overall Study|Adverse Event|3
719227|NCT00151892|2317469|P1|Overall Study|Adverse Event|6
719228|NCT00151892|2317468|P2|Overall Study|Lost to Follow-up|10
719229|NCT00151892|2317469|P1|Overall Study|Lost to Follow-up|5
719230|NCT00151892|2317468|P2|Overall Study|Patient request|7
719231|NCT00151892|2317469|P1|Overall Study|Patient request|10
719232|NCT00151892|2317468|P2|Overall Study|Lack of Efficacy|57
719233|NCT00151892|2317469|P1|Overall Study|Lack of Efficacy|50
719234|NCT00151996|2317485|P2|Overall Study|Sponsor's decision|2
719235|NCT00151996|2317486|P1|Overall Study|Sponsor's decision|0
719236|NCT00151996|2317485|P2|Overall Study|Protocol Violation|2
719237|NCT00151996|2317486|P1|Overall Study|Protocol Violation|1
719238|NCT00151996|2317485|P2|Overall Study|Withdrawal by Subject|1
719239|NCT00151996|2317486|P1|Overall Study|Withdrawal by Subject|1
719240|NCT00151996|2317485|P2|Overall Study|Adverse Event|2
719241|NCT00151996|2317486|P1|Overall Study|Adverse Event|3
719242|NCT00152009|2317504|P4|Overall Study|Sponsor's decision|3
719243|NCT00152009|2317505|P3|Overall Study|Sponsor's decision|1
719244|NCT00152009|2317506|P2|Overall Study|Sponsor's decision|3
719245|NCT00152009|2317507|P1|Overall Study|Sponsor's decision|3
719246|NCT00152009|2317504|P4|Overall Study|ECG abnormalities|1
719247|NCT00152009|2317505|P3|Overall Study|ECG abnormalities|2
719248|NCT00152009|2317506|P2|Overall Study|ECG abnormalities|2
719249|NCT00152009|2317507|P1|Overall Study|ECG abnormalities|2
719250|NCT00152009|2317504|P4|Overall Study|Lack of Efficacy|15
719251|NCT00152009|2317505|P3|Overall Study|Lack of Efficacy|7
719252|NCT00152009|2317506|P2|Overall Study|Lack of Efficacy|6
719253|NCT00152009|2317507|P1|Overall Study|Lack of Efficacy|8
719254|NCT00152009|2317504|P4|Overall Study|Lost to Follow-up|3
719255|NCT00152009|2317505|P3|Overall Study|Lost to Follow-up|3
719256|NCT00152009|2317506|P2|Overall Study|Lost to Follow-up|4
719257|NCT00152009|2317507|P1|Overall Study|Lost to Follow-up|2
719258|NCT00152009|2317504|P4|Overall Study|Withdrawal by Subject|9
719259|NCT00152009|2317505|P3|Overall Study|Withdrawal by Subject|4
719260|NCT00152009|2317506|P2|Overall Study|Withdrawal by Subject|3
719261|NCT00152009|2317507|P1|Overall Study|Withdrawal by Subject|2
719262|NCT00152009|2317504|P4|Overall Study|Protocol Violation|1
719263|NCT00152009|2317505|P3|Overall Study|Protocol Violation|0
719264|NCT00152009|2317506|P2|Overall Study|Protocol Violation|0
719265|NCT00152009|2317507|P1|Overall Study|Protocol Violation|3
719266|NCT00152009|2317504|P4|Overall Study|Adverse Event|1
719267|NCT00152009|2317505|P3|Overall Study|Adverse Event|20
719268|NCT00152009|2317506|P2|Overall Study|Adverse Event|13
719269|NCT00152009|2317507|P1|Overall Study|Adverse Event|9
719270|NCT00133952|2317546|P2|Overall Study|Sponsor Decision|1
719271|NCT00133952|2317547|P1|Overall Study|Sponsor Decision|0
719272|NCT00133952|2317546|P2|Overall Study|Physician Decision|3
719273|NCT00133952|2317547|P1|Overall Study|Physician Decision|4
719274|NCT00133952|2317546|P2|Overall Study|Withdrawal by Subject|4
719275|NCT00133952|2317547|P1|Overall Study|Withdrawal by Subject|20
719276|NCT00133952|2317546|P2|Overall Study|Protocol Violation|1
719277|NCT00133952|2317547|P1|Overall Study|Protocol Violation|1
719278|NCT00133952|2317546|P2|Overall Study|Protocol Entry Criteria Exclusion|1
719279|NCT00133952|2317547|P1|Overall Study|Protocol Entry Criteria Exclusion|4
719280|NCT00133952|2317546|P2|Overall Study|Lost to Follow-up|14
719281|NCT00133952|2317547|P1|Overall Study|Lost to Follow-up|9
719282|NCT00133952|2317546|P2|Overall Study|Death|2
719283|NCT00133952|2317547|P1|Overall Study|Death|3
719284|NCT00133952|2317546|P2|Overall Study|Adverse Event|2
719285|NCT00133952|2317547|P1|Overall Study|Adverse Event|1
719286|NCT00134056|2317616|P2|Eligible for Protocol Assigned Treatment|Not specified|56
719287|NCT00134056|2317617|P1|Eligible for Protocol Assigned Treatment|Not specified|55
719288|NCT00134056|2317616|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
719289|NCT00134056|2317617|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
719290|NCT00134056|2317616|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
719291|NCT00134056|2317617|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
719292|NCT00134056|2317616|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
719293|NCT00134056|2317617|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
719294|NCT00134056|2317616|P2|Randomization|Not eligible for assigned treatment|20
719295|NCT00134056|2317617|P1|Randomization|Not eligible for assigned treatment|22
719296|NCT00139477|2317639|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
719297|NCT00139477|2317640|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
719298|NCT00139477|2317639|P2|Second Intervention -6Months to 12Months|Relocation|0
719299|NCT00139477|2317640|P1|Second Intervention -6Months to 12Months|Relocation|1
719300|NCT00139477|2317639|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
719301|NCT00139477|2317640|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
719302|NCT00139477|2317639|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
719303|NCT00139477|2317640|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
719304|NCT00139477|2317639|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
719305|NCT00139477|2317640|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
719306|NCT00139477|2317639|P2|First Intervention -Baseline to 6Months|Relocation|2
719307|NCT00139477|2317640|P1|First Intervention -Baseline to 6Months|Relocation|1
719308|NCT00139477|2317639|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
719309|NCT00139477|2317640|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
719310|NCT00139659|2317662|P2|Overall Study|Withdrawal by Subject|10
719311|NCT00139659|2317663|P1|Overall Study|Withdrawal by Subject|14
719312|NCT00139659|2317662|P2|Overall Study|Reason not Specified|3
719313|NCT00139659|2317663|P1|Overall Study|Reason not Specified|6
719314|NCT00139659|2317662|P2|Overall Study|Lost to Follow-up|3
719315|NCT00139659|2317663|P1|Overall Study|Lost to Follow-up|7
719316|NCT00139659|2317662|P2|Overall Study|Lack of Efficacy|1
719317|NCT00139659|2317663|P1|Overall Study|Lack of Efficacy|1
719318|NCT00139659|2317662|P2|Overall Study|Adverse Event|1
719319|NCT00139659|2317663|P1|Overall Study|Adverse Event|12
719320|NCT00139737|2317739|P1|Overall Study|Screened, Not Treated|13
719321|NCT00139737|2317739|P1|Overall Study|Did Not Meet Entrance Criteria|1
719322|NCT00139737|2317739|P1|Overall Study|Withdrew During Screening Phase|8
719323|NCT00139737|2317739|P1|Overall Study|Protocol Violation|18
719324|NCT00139737|2317739|P1|Overall Study|Laboratory Abnormality|2
719325|NCT00139737|2317739|P1|Overall Study|Death|3
719326|NCT00139737|2317739|P1|Overall Study|Lost to Follow-up|8
719327|NCT00139737|2317739|P1|Overall Study|Lack of Efficacy|40
719328|NCT00139737|2317739|P1|Overall Study|Adverse Event|58
719329|NCT00139737|2317739|P1|Overall Study|Withdrawal by Subject|190
719330|NCT00139776|2317745|P4|Period III|Withdrawal by Subject|21
719331|NCT00139776|2317746|P3|Period III|Withdrawal by Subject|16
719332|NCT00139776|2317747|P2|Period III|Withdrawal by Subject|0
719333|NCT00139776|2317748|P1|Period III|Withdrawal by Subject|0
719334|NCT00139776|2317745|P4|Period III|Lost to Follow-up|4
719335|NCT00139776|2317746|P3|Period III|Lost to Follow-up|5
719336|NCT00139776|2317747|P2|Period III|Lost to Follow-up|0
719337|NCT00139776|2317748|P1|Period III|Lost to Follow-up|0
719338|NCT00139776|2317745|P4|Period III|Lack of Efficacy|24
719339|NCT00139776|2317746|P3|Period III|Lack of Efficacy|10
719340|NCT00139776|2317747|P2|Period III|Lack of Efficacy|0
719341|NCT00139776|2317748|P1|Period III|Lack of Efficacy|0
719342|NCT00139776|2317745|P4|Period III|Other|34
719343|NCT00139776|2317746|P3|Period III|Other|23
719344|NCT00139776|2317747|P2|Period III|Other|0
719345|NCT00139776|2317748|P1|Period III|Other|0
719346|NCT00139776|2317745|P4|Period III|Adverse Event|23
719347|NCT00139776|2317746|P3|Period III|Adverse Event|22
719348|NCT00139776|2317747|P2|Period III|Adverse Event|0
719349|NCT00139776|2317748|P1|Period III|Adverse Event|0
719350|NCT00139776|2317745|P4|Period II|Not Randomized into Period III|0
719351|NCT00139776|2317746|P3|Period II|Not Randomized into Period III|0
719352|NCT00139776|2317747|P2|Period II|Not Randomized into Period III|322
719353|NCT00139776|2317748|P1|Period II|Not Randomized into Period III|0
719354|NCT00139776|2317745|P4|Period I|Did not enter Period II|0
719355|NCT00139776|2317746|P3|Period I|Did not enter Period II|0
719356|NCT00139776|2317747|P2|Period I|Did not enter Period II|0
719357|NCT00139776|2317748|P1|Period I|Did not enter Period II|575
719358|NCT00140140|2317797|P3|Overall Study|Physician Decision|0
719359|NCT00140140|2317798|P2|Overall Study|Physician Decision|1
719360|NCT00140140|2317799|P1|Overall Study|Physician Decision|1
719361|NCT00140140|2317797|P3|Overall Study|Unacceptable toxicity|2
719362|NCT00140140|2317798|P2|Overall Study|Unacceptable toxicity|1
719363|NCT00140140|2317799|P1|Overall Study|Unacceptable toxicity|1
719364|NCT00140413|2317889|P2|Overall Study|Withdrawal by Subject|0
719365|NCT00140413|2317890|P1|Overall Study|Withdrawal by Subject|2
719366|NCT00140413|2317889|P2|Overall Study|Lost to Follow-up|0
719367|NCT00140413|2317890|P1|Overall Study|Lost to Follow-up|1
719368|NCT00140426|2317899|P2|Overall Study|Withdrawal by Subject|3
719369|NCT00140426|2317900|P1|Overall Study|Withdrawal by Subject|0
719370|NCT00146328|2317933|P3|Overall Study|Interaction with other medication|1
719371|NCT00146328|2317934|P2|Overall Study|Interaction with other medication|0
719372|NCT00146328|2317935|P1|Overall Study|Interaction with other medication|2
719373|NCT00146328|2317933|P3|Overall Study|Moved|0
719374|NCT00146328|2317934|P2|Overall Study|Moved|0
719375|NCT00146328|2317935|P1|Overall Study|Moved|2
719376|NCT00146328|2317933|P3|Overall Study|Death|1
719377|NCT00146328|2317934|P2|Overall Study|Death|1
719378|NCT00146328|2317935|P1|Overall Study|Death|0
719379|NCT00146328|2317933|P3|Overall Study|Enroll into other trial|2
719380|NCT00146328|2317934|P2|Overall Study|Enroll into other trial|4
719381|NCT00146328|2317935|P1|Overall Study|Enroll into other trial|2
719382|NCT00146328|2317933|P3|Overall Study|Patient decision to end|6
719383|NCT00146328|2317934|P2|Overall Study|Patient decision to end|1
719384|NCT00146328|2317935|P1|Overall Study|Patient decision to end|0
719385|NCT00146328|2317933|P3|Overall Study|Trial ended/site closed|19
719386|NCT00146328|2317934|P2|Overall Study|Trial ended/site closed|2
719387|NCT00146328|2317935|P1|Overall Study|Trial ended/site closed|8
719388|NCT00146328|2317933|P3|Overall Study|Virologic Failure/lack of efficacy|142
719389|NCT00146328|2317934|P2|Overall Study|Virologic Failure/lack of efficacy|72
719390|NCT00146328|2317935|P1|Overall Study|Virologic Failure/lack of efficacy|54
719391|NCT00146328|2317933|P3|Overall Study|Withdrawal by Subject|22
719392|NCT00146328|2317934|P2|Overall Study|Withdrawal by Subject|16
719393|NCT00146328|2317935|P1|Overall Study|Withdrawal by Subject|16
719394|NCT00146328|2317933|P3|Overall Study|Lost to Follow-up|7
719395|NCT00146328|2317934|P2|Overall Study|Lost to Follow-up|4
719396|NCT00146328|2317935|P1|Overall Study|Lost to Follow-up|7
719397|NCT00146328|2317933|P3|Overall Study|Protocol Violation|12
719398|NCT00146328|2317934|P2|Overall Study|Protocol Violation|6
719399|NCT00146328|2317935|P1|Overall Study|Protocol Violation|11
719400|NCT00146328|2317933|P3|Overall Study|Adverse Event|79
719401|NCT00146328|2317934|P2|Overall Study|Adverse Event|48
719402|NCT00146328|2317935|P1|Overall Study|Adverse Event|39
719403|NCT00152516|2318018|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
719404|NCT00152516|2318018|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
719405|NCT00152516|2318018|P1|Overall Study|Other: Moved Out Of State|1
719406|NCT00152516|2318018|P1|Overall Study|Other: Primary Care Physician's Decision|1
719407|NCT00152516|2318018|P1|Overall Study|Other: Non-Compliance|2
719408|NCT00152516|2318018|P1|Overall Study|Other: Parents Withdrew Consent|2
719409|NCT00152516|2318018|P1|Overall Study|Other: Given Commercial Drug in Error|2
719410|NCT00152516|2318018|P1|Overall Study|Other: Mother Refused To Cooperate|1
719411|NCT00152516|2318018|P1|Overall Study|Protocol Violation|3
719412|NCT00152516|2318018|P1|Overall Study|Withdrawal by Subject|8
719413|NCT00152516|2318018|P1|Overall Study|Lost to Follow-up|5
719414|NCT00152516|2318018|P1|Overall Study|Lack and Loss of Efficacy|30
719415|NCT00152516|2318018|P1|Overall Study|Adverse Event|18
890249|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
890250|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
890251|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
890252|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
890253|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
890254|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
890255|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
890256|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
890257|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
890258|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
890259|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
890260|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
890261|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
890262|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
890263|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
890264|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
890265|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
890266|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
890267|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
890268|NCT01054885|2825383|P7|24-week, Double-blind Treatment Period|Adverse Event|19
890269|NCT01054885|2825384|P6|24-week, Double-blind Treatment Period|Adverse Event|17
719446|NCT00153920|2318073|P1|Overall Study|Progressive Disease before Trt|1
719447|NCT00153920|2318073|P1|Overall Study|Withdrawal of Consent before Trt|1
719448|NCT00153920|2318073|P1|Overall Study|Non-Protocol Therapy|1
719449|NCT00153920|2318073|P1|Overall Study|Withdrawal by Subject|1
719450|NCT00153920|2318073|P1|Overall Study|Death|2
719451|NCT00153920|2318073|P1|Overall Study|Lack of Response|3
719452|NCT00153920|2318073|P1|Overall Study|Physician Decision|3
719453|NCT00153920|2318073|P1|Overall Study|Progressive Disease|9
719454|NCT00153920|2318073|P1|Overall Study|Adverse Event|9
719455|NCT00154063|2318090|P2|Overall Study|Not specified|3
719456|NCT00154063|2318091|P1|Overall Study|Not specified|3
719457|NCT00154063|2318090|P2|Overall Study|Withdrawal by Subject|9
719458|NCT00154063|2318091|P1|Overall Study|Withdrawal by Subject|4
719459|NCT00154063|2318090|P2|Overall Study|Investigator or Sponsor Request|1
719460|NCT00154063|2318091|P1|Overall Study|Investigator or Sponsor Request|0
719461|NCT00154063|2318090|P2|Overall Study|Protocol Violation|1
719462|NCT00154063|2318091|P1|Overall Study|Protocol Violation|1
719463|NCT00154063|2318090|P2|Overall Study|Adverse Event|8
719464|NCT00154063|2318091|P1|Overall Study|Adverse Event|4
719465|NCT00154102|2318149|P2|Overall Study|investigational study phase ongoing|2
719466|NCT00154102|2318150|P1|Overall Study|investigational study phase ongoing|7
719467|NCT00154284|2318186|P2|Overall Study|Protocol Violation|1
719468|NCT00154284|2318187|P1|Overall Study|Protocol Violation|0
719469|NCT00154284|2318186|P2|Overall Study|Lack of Efficacy|2
719470|NCT00154284|2318187|P1|Overall Study|Lack of Efficacy|1
719471|NCT00154284|2318186|P2|Overall Study|Abnormal laboratory value(s)|1
719472|NCT00154284|2318187|P1|Overall Study|Abnormal laboratory value(s)|0
719473|NCT00154284|2318186|P2|Overall Study|Adverse Event|9
719474|NCT00154284|2318187|P1|Overall Study|Adverse Event|6
719475|NCT00154297|2318201|P2|Overall Study|Lost to Follow-up|0
719476|NCT00154297|2318202|P1|Overall Study|Lost to Follow-up|3
719477|NCT00154297|2318201|P2|Overall Study|Withdrawal by Subject|5
719478|NCT00154297|2318202|P1|Overall Study|Withdrawal by Subject|0
719479|NCT00154297|2318201|P2|Overall Study|Death|2
719480|NCT00154297|2318202|P1|Overall Study|Death|5
719481|NCT00154310|2318220|P2|Overall Study|Death|1
719482|NCT00154310|2318221|P1|Overall Study|Death|0
719483|NCT00154310|2318220|P2|Overall Study|Administrative problems|1
719484|NCT00154310|2318221|P1|Overall Study|Administrative problems|0
719485|NCT00154310|2318220|P2|Overall Study|Lost to Follow-up|8
719486|NCT00154310|2318221|P1|Overall Study|Lost to Follow-up|0
719487|NCT00154310|2318220|P2|Overall Study|Withdrawal by Subject|3
719488|NCT00154310|2318221|P1|Overall Study|Withdrawal by Subject|9
719489|NCT00154310|2318220|P2|Overall Study|Protocol Violation|2
719490|NCT00154310|2318221|P1|Overall Study|Protocol Violation|4
719491|NCT00154310|2318220|P2|Overall Study|Lack of Efficacy|4
719492|NCT00154310|2318221|P1|Overall Study|Lack of Efficacy|5
719493|NCT00154310|2318220|P2|Overall Study|Adverse Event|9
719494|NCT00154310|2318221|P1|Overall Study|Adverse Event|19
719495|NCT00154375|2318237|P2|Overall Study|Suspected progression of disease|30
719496|NCT00154375|2318238|P1|Overall Study|Suspected progression of disease|44
719497|NCT00154375|2318237|P2|Overall Study|Protocol Violation|1
719498|NCT00154375|2318238|P1|Overall Study|Protocol Violation|0
719499|NCT00154375|2318237|P2|Overall Study|Abnormal laboratory value(s)|2
719500|NCT00154375|2318238|P1|Overall Study|Abnormal laboratory value(s)|0
719501|NCT00154375|2318237|P2|Overall Study|Lost to Follow-up|1
719502|NCT00154375|2318238|P1|Overall Study|Lost to Follow-up|2
719503|NCT00154375|2318237|P2|Overall Study|Study drug no longer required|3
719504|NCT00154375|2318238|P1|Overall Study|Study drug no longer required|5
719505|NCT00154375|2318237|P2|Overall Study|Death|13
719506|NCT00154375|2318238|P1|Overall Study|Death|5
719507|NCT00154375|2318237|P2|Overall Study|Withdrawal by Subject|10
719508|NCT00154375|2318238|P1|Overall Study|Withdrawal by Subject|14
719509|NCT00154375|2318237|P2|Overall Study|Adverse Event|20
719510|NCT00154375|2318238|P1|Overall Study|Adverse Event|18
719511|NCT00154375|2318237|P2|Overall Study|Unsatisfactory therapeutic effect|26
719512|NCT00154375|2318238|P1|Overall Study|Unsatisfactory therapeutic effect|25
719513|NCT00149630|2318264|P2|Overall Study|Adverse Event|0
719514|NCT00149630|2318265|P1|Overall Study|Adverse Event|2
719515|NCT00149630|2318264|P2|Overall Study|Treatment Programs|5
719516|NCT00149630|2318265|P1|Overall Study|Treatment Programs|4
719517|NCT00149630|2318264|P2|Overall Study|Incarceration|0
719518|NCT00149630|2318265|P1|Overall Study|Incarceration|2
719519|NCT00149747|2318311|P2|Overall Study|Withdrawal by Subject|3
719520|NCT00149747|2318312|P1|Overall Study|Withdrawal by Subject|3
719521|NCT00149747|2318311|P2|Overall Study|Death|0
719522|NCT00149747|2318312|P1|Overall Study|Death|1
719523|NCT00149825|2318336|P2|Overall Study|Other|0
719524|NCT00149825|2318337|P1|Overall Study|Other|1
719525|NCT00149825|2318336|P2|Overall Study|Not liking insomnia therapy|0
719526|NCT00149825|2318337|P1|Overall Study|Not liking insomnia therapy|1
719527|NCT00149825|2318336|P2|Overall Study|Time commitments|1
719528|NCT00149825|2318337|P1|Overall Study|Time commitments|2
719529|NCT00149825|2318336|P2|Overall Study|Intolerance to medication side effects|2
719530|NCT00149825|2318337|P1|Overall Study|Intolerance to medication side effects|1
719531|NCT00149890|2318347|P2|Overall Study|Graft Loss|1
719532|NCT00149890|2318348|P1|Overall Study|Graft Loss|2
719533|NCT00149890|2318347|P2|Overall Study|Lost to Follow-up|0
719534|NCT00149890|2318348|P1|Overall Study|Lost to Follow-up|1
719535|NCT00149890|2318347|P2|Overall Study|Protocol Violation|0
719536|NCT00149890|2318348|P1|Overall Study|Protocol Violation|1
719537|NCT00149890|2318347|P2|Overall Study|Lack of Efficacy|9
719538|NCT00149890|2318348|P1|Overall Study|Lack of Efficacy|8
719539|NCT00149890|2318347|P2|Overall Study|Adverse Event|8
719540|NCT00149890|2318348|P1|Overall Study|Adverse Event|1
719541|NCT00156065|2318373|P3|Overall Study|Unspecified|3
719542|NCT00156065|2318374|P2|Overall Study|Unspecified|9
719543|NCT00156065|2318375|P1|Overall Study|Unspecified|2
719544|NCT00156065|2318373|P3|Overall Study|Lost to Follow-up|1
719545|NCT00156065|2318374|P2|Overall Study|Lost to Follow-up|7
719546|NCT00156065|2318375|P1|Overall Study|Lost to Follow-up|5
719547|NCT00156065|2318373|P3|Overall Study|Withdrawal by Subject|16
719548|NCT00156065|2318374|P2|Overall Study|Withdrawal by Subject|26
719549|NCT00156065|2318375|P1|Overall Study|Withdrawal by Subject|13
719550|NCT00156065|2318373|P3|Overall Study|Lack of Efficacy|3
719551|NCT00156065|2318374|P2|Overall Study|Lack of Efficacy|9
719552|NCT00156065|2318375|P1|Overall Study|Lack of Efficacy|2
719553|NCT00156065|2318373|P3|Overall Study|Adverse Event|4
719554|NCT00156065|2318374|P2|Overall Study|Adverse Event|11
719555|NCT00156065|2318375|P1|Overall Study|Adverse Event|8
719556|NCT00156065|2318373|P3|Overall Study|Enrolled But Never Received Treatment|0
719557|NCT00156065|2318374|P2|Overall Study|Enrolled But Never Received Treatment|1
719558|NCT00156065|2318375|P1|Overall Study|Enrolled But Never Received Treatment|1
890270|NCT01054885|2825385|P5|24-week, Double-blind Treatment Period|Adverse Event|15
890271|NCT01054885|2825386|P4|24-week, Double-blind Treatment Period|Adverse Event|15
890272|NCT01054885|2825387|P3|24-week, Double-blind Treatment Period|Adverse Event|12
890273|NCT01054885|2825388|P2|24-week, Double-blind Treatment Period|Adverse Event|18
890274|NCT01054885|2825389|P1|24-week, Double-blind Treatment Period|Adverse Event|0
890275|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890276|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890277|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890278|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890279|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890280|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
890281|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
890282|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Adverse Event|0
890283|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Adverse Event|0
890284|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Adverse Event|0
890285|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Adverse Event|0
890286|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Adverse Event|0
890287|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Adverse Event|0
890288|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Adverse Event|7
890289|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
890290|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
890291|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
890292|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
890293|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
890294|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
719593|NCT00157196|2318529|P1|Overall Study|Ongoing at data cut-off|9
719594|NCT00157209|2318537|P2|Overall Study|Ongoing at data cut-off|0
719595|NCT00157209|2318538|P1|Overall Study|Ongoing at data cut-off|10
719596|NCT00157248|2318556|P4|Overall Study|site closures, subject moving|9
719597|NCT00157248|2318557|P3|Overall Study|site closures, subject moving|3
719598|NCT00157248|2318558|P2|Overall Study|site closures, subject moving|7
719599|NCT00157248|2318559|P1|Overall Study|site closures, subject moving|7
719600|NCT00157248|2318556|P4|Overall Study|Withdrawal by Subject|3
719601|NCT00157248|2318557|P3|Overall Study|Withdrawal by Subject|3
719602|NCT00157248|2318558|P2|Overall Study|Withdrawal by Subject|4
719603|NCT00157248|2318559|P1|Overall Study|Withdrawal by Subject|1
719604|NCT00157248|2318556|P4|Overall Study|Lost to Follow-up|0
719605|NCT00157248|2318557|P3|Overall Study|Lost to Follow-up|0
719606|NCT00157248|2318558|P2|Overall Study|Lost to Follow-up|1
719607|NCT00157248|2318559|P1|Overall Study|Lost to Follow-up|0
719608|NCT00157248|2318556|P4|Overall Study|Protocol Violation|2
719609|NCT00157248|2318557|P3|Overall Study|Protocol Violation|2
719610|NCT00157248|2318558|P2|Overall Study|Protocol Violation|0
719611|NCT00157248|2318559|P1|Overall Study|Protocol Violation|4
719612|NCT00157248|2318556|P4|Overall Study|Adverse Event|33
719613|NCT00157248|2318557|P3|Overall Study|Adverse Event|13
719614|NCT00157248|2318558|P2|Overall Study|Adverse Event|25
719615|NCT00157248|2318559|P1|Overall Study|Adverse Event|36
719616|NCT00157755|2318675|P6|Overall Study|Study completion|2
719617|NCT00157755|2318676|P5|Overall Study|Study completion|1
719618|NCT00157755|2318677|P4|Overall Study|Study completion|0
719619|NCT00157755|2318678|P3|Overall Study|Study completion|0
719620|NCT00157755|2318679|P2|Overall Study|Study completion|0
719621|NCT00157755|2318680|P1|Overall Study|Study completion|0
719622|NCT00157755|2318675|P6|Overall Study|Subject non-compliance|1
719623|NCT00157755|2318676|P5|Overall Study|Subject non-compliance|0
719624|NCT00157755|2318677|P4|Overall Study|Subject non-compliance|0
719625|NCT00157755|2318678|P3|Overall Study|Subject non-compliance|0
719626|NCT00157755|2318679|P2|Overall Study|Subject non-compliance|0
719627|NCT00157755|2318680|P1|Overall Study|Subject non-compliance|0
719628|NCT00157755|2318675|P6|Overall Study|Study site closure|0
719629|NCT00157755|2318676|P5|Overall Study|Study site closure|0
719630|NCT00157755|2318677|P4|Overall Study|Study site closure|0
719631|NCT00157755|2318678|P3|Overall Study|Study site closure|0
719632|NCT00157755|2318679|P2|Overall Study|Study site closure|1
719633|NCT00157755|2318680|P1|Overall Study|Study site closure|0
719634|NCT00157755|2318675|P6|Overall Study|Medical reason|0
719635|NCT00157755|2318676|P5|Overall Study|Medical reason|0
719636|NCT00157755|2318677|P4|Overall Study|Medical reason|1
719637|NCT00157755|2318678|P3|Overall Study|Medical reason|1
719638|NCT00157755|2318679|P2|Overall Study|Medical reason|0
719639|NCT00157755|2318680|P1|Overall Study|Medical reason|0
719640|NCT00157755|2318675|P6|Overall Study|Explant due to infection|0
719641|NCT00157755|2318676|P5|Overall Study|Explant due to infection|0
719642|NCT00157755|2318677|P4|Overall Study|Explant due to infection|0
719643|NCT00157755|2318678|P3|Overall Study|Explant due to infection|1
719644|NCT00157755|2318679|P2|Overall Study|Explant due to infection|0
719645|NCT00157755|2318680|P1|Overall Study|Explant due to infection|0
719646|NCT00157755|2318675|P6|Overall Study|Withdrawal by Subject|2
719647|NCT00157755|2318676|P5|Overall Study|Withdrawal by Subject|1
719648|NCT00157755|2318677|P4|Overall Study|Withdrawal by Subject|1
719649|NCT00157755|2318678|P3|Overall Study|Withdrawal by Subject|1
719650|NCT00157755|2318679|P2|Overall Study|Withdrawal by Subject|0
719651|NCT00157755|2318680|P1|Overall Study|Withdrawal by Subject|0
719652|NCT00157755|2318675|P6|Overall Study|Lost to Follow-up|0
719653|NCT00157755|2318676|P5|Overall Study|Lost to Follow-up|0
719654|NCT00157755|2318677|P4|Overall Study|Lost to Follow-up|0
719655|NCT00157755|2318678|P3|Overall Study|Lost to Follow-up|1
719656|NCT00157755|2318679|P2|Overall Study|Lost to Follow-up|0
719657|NCT00157755|2318680|P1|Overall Study|Lost to Follow-up|0
719658|NCT00157755|2318675|P6|Overall Study|Death|0
719659|NCT00157755|2318676|P5|Overall Study|Death|0
719660|NCT00157755|2318677|P4|Overall Study|Death|2
719661|NCT00157755|2318678|P3|Overall Study|Death|3
719662|NCT00157755|2318679|P2|Overall Study|Death|3
719663|NCT00157755|2318680|P1|Overall Study|Death|2
719664|NCT00157820|2318705|P3|2nd 8 Months|Premature cross-over|9
719665|NCT00157820|2318706|P2|2nd 8 Months|Premature cross-over|7
719666|NCT00157820|2318707|P1|2nd 8 Months|Premature cross-over|1
719667|NCT00157820|2318705|P3|2nd 8 Months|Lost to Follow-up|2
719668|NCT00157820|2318706|P2|2nd 8 Months|Lost to Follow-up|5
719669|NCT00157820|2318707|P1|2nd 8 Months|Lost to Follow-up|1
719670|NCT00157820|2318705|P3|2nd 8 Months|Death|3
719671|NCT00157820|2318706|P2|2nd 8 Months|Death|1
719672|NCT00157820|2318707|P1|2nd 8 Months|Death|3
719673|NCT00157820|2318705|P3|1st 8 Month|Premature cross-over|2
719674|NCT00157820|2318706|P2|1st 8 Month|Premature cross-over|2
719675|NCT00157820|2318707|P1|1st 8 Month|Premature cross-over|0
719676|NCT00157820|2318705|P3|1st 8 Month|Lost to Follow-up|1
719677|NCT00157820|2318706|P2|1st 8 Month|Lost to Follow-up|2
719678|NCT00157820|2318707|P1|1st 8 Month|Lost to Follow-up|1
719679|NCT00157820|2318705|P3|1st 8 Month|Death|3
719680|NCT00157820|2318706|P2|1st 8 Month|Death|8
719681|NCT00157820|2318707|P1|1st 8 Month|Death|7
719682|NCT00157820|2318705|P3|Randomized|Protocol Violation|2
719683|NCT00157820|2318706|P2|Randomized|Protocol Violation|1
719684|NCT00157820|2318707|P1|Randomized|Protocol Violation|2
719685|NCT00157820|2318705|P3|Randomized|Withdrawal by Subject|3
719686|NCT00157820|2318706|P2|Randomized|Withdrawal by Subject|2
719687|NCT00157820|2318707|P1|Randomized|Withdrawal by Subject|1
719688|NCT00157820|2318705|P3|Randomized|Physician Decision|3
719689|NCT00157820|2318706|P2|Randomized|Physician Decision|2
719690|NCT00157820|2318707|P1|Randomized|Physician Decision|4
719691|NCT00157950|2318720|P2|Overall Study|Death|0
719692|NCT00157950|2318721|P1|Overall Study|Death|1
719693|NCT00158054|2318737|P2|Overall Study|Unavailable for follow up|3
719694|NCT00158054|2318738|P1|Overall Study|Unavailable for follow up|7
719695|NCT00158054|2318737|P2|Overall Study|Refused to continue|0
719696|NCT00158054|2318738|P1|Overall Study|Refused to continue|3
719697|NCT00158184|2318752|P2|Overall Study|Adverse Event|1
719698|NCT00158184|2318753|P1|Overall Study|Adverse Event|1
719699|NCT00158184|2318752|P2|Overall Study|failed for follow unit/study rules|0
719700|NCT00158184|2318753|P1|Overall Study|failed for follow unit/study rules|2
719701|NCT00158184|2318752|P2|Overall Study|personal issues|1
719702|NCT00158184|2318753|P1|Overall Study|personal issues|3
719703|NCT00158262|2318812|P2|Overall Study|Lost to Follow-up|1
719704|NCT00158262|2318813|P1|Overall Study|Lost to Follow-up|1
719705|NCT00158600|2318830|P2|Overall Study|Withdrawal by Subject|2
719706|NCT00158600|2318831|P1|Overall Study|Withdrawal by Subject|2
719707|NCT00158600|2318830|P2|Overall Study|Death|0
719708|NCT00158600|2318831|P1|Overall Study|Death|1
719709|NCT00158600|2318830|P2|Overall Study|Adverse Event|1
719710|NCT00158600|2318831|P1|Overall Study|Adverse Event|2
719711|NCT00158600|2318830|P2|Overall Study|unable to commit time to study|1
719712|NCT00158600|2318831|P1|Overall Study|unable to commit time to study|0
719713|NCT00158756|2318863|P5|Overall Study|Serious adverse event|0
719714|NCT00158756|2318864|P4|Overall Study|Serious adverse event|0
719715|NCT00158756|2318865|P3|Overall Study|Serious adverse event|1
719716|NCT00158756|2318866|P2|Overall Study|Serious adverse event|0
719717|NCT00158756|2318867|P1|Overall Study|Serious adverse event|0
719718|NCT00158756|2318863|P5|Overall Study|Adverse Event|0
719719|NCT00158756|2318864|P4|Overall Study|Adverse Event|0
719720|NCT00158756|2318865|P3|Overall Study|Adverse Event|1
719721|NCT00158756|2318866|P2|Overall Study|Adverse Event|0
719722|NCT00158756|2318867|P1|Overall Study|Adverse Event|0
719723|NCT00158756|2318863|P5|Overall Study|Withdrawal by Subject|3
719724|NCT00158756|2318864|P4|Overall Study|Withdrawal by Subject|1
719725|NCT00158756|2318865|P3|Overall Study|Withdrawal by Subject|6
719726|NCT00158756|2318866|P2|Overall Study|Withdrawal by Subject|0
719727|NCT00158756|2318867|P1|Overall Study|Withdrawal by Subject|5
719728|NCT00159432|2318979|P1|Overall Study|Lack of Efficacy|8
719729|NCT00159432|2318979|P1|Overall Study|Death|1
719730|NCT00159432|2318979|P1|Overall Study|Adverse Event|1
719731|NCT00152763|2318988|P4|Overall Study|Lost to Follow-up|13
719732|NCT00152763|2318989|P3|Overall Study|Lost to Follow-up|2
719733|NCT00152763|2318990|P2|Overall Study|Lost to Follow-up|4
719734|NCT00152763|2318991|P1|Overall Study|Lost to Follow-up|6
719735|NCT00152763|2318988|P4|Overall Study|Death|1
719736|NCT00152763|2318989|P3|Overall Study|Death|2
719737|NCT00152763|2318990|P2|Overall Study|Death|1
719738|NCT00152763|2318991|P1|Overall Study|Death|4
719739|NCT00152971|2319110|P3|Treatment|not specified|10
719740|NCT00152971|2319111|P2|Treatment|not specified|11
719741|NCT00152971|2319112|P1|Treatment|not specified|9
719742|NCT00152971|2319110|P3|Treatment|Withdrawal by Subject|5
719743|NCT00152971|2319111|P2|Treatment|Withdrawal by Subject|4
719744|NCT00152971|2319112|P1|Treatment|Withdrawal by Subject|4
719745|NCT00152971|2319110|P3|Treatment|Lost to Follow-up|1
719746|NCT00152971|2319111|P2|Treatment|Lost to Follow-up|2
719747|NCT00152971|2319112|P1|Treatment|Lost to Follow-up|1
719748|NCT00152971|2319110|P3|Treatment|Protocol Violation|10
719749|NCT00152971|2319111|P2|Treatment|Protocol Violation|6
719750|NCT00152971|2319112|P1|Treatment|Protocol Violation|8
719751|NCT00152971|2319110|P3|Treatment|Adverse Event|54
719752|NCT00152971|2319111|P2|Treatment|Adverse Event|40
719753|NCT00152971|2319112|P1|Treatment|Adverse Event|49
719754|NCT00152971|2319110|P3|Overall Study|not specified|5
719755|NCT00152971|2319111|P2|Overall Study|not specified|5
719756|NCT00152971|2319112|P1|Overall Study|not specified|3
719757|NCT00152971|2319110|P3|Overall Study|Withdrawal by Subject|14
719758|NCT00152971|2319111|P2|Overall Study|Withdrawal by Subject|8
719759|NCT00152971|2319112|P1|Overall Study|Withdrawal by Subject|9
719760|NCT00152971|2319110|P3|Overall Study|Lost to Follow-up|13
719761|NCT00152971|2319111|P2|Overall Study|Lost to Follow-up|14
719762|NCT00152971|2319112|P1|Overall Study|Lost to Follow-up|17
719763|NCT00152971|2319110|P3|Overall Study|Protocol Violation|8
719764|NCT00152971|2319111|P2|Overall Study|Protocol Violation|11
719765|NCT00152971|2319112|P1|Overall Study|Protocol Violation|10
719766|NCT00152971|2319110|P3|Overall Study|Adverse Event|9
719767|NCT00152971|2319111|P2|Overall Study|Adverse Event|10
719768|NCT00152971|2319112|P1|Overall Study|Adverse Event|12
719769|NCT00153062|2319148|P4|Overall Study|Other|0
719770|NCT00153062|2319149|P3|Overall Study|Other|1
719771|NCT00153062|2319150|P2|Overall Study|Other|0
719772|NCT00153062|2319151|P1|Overall Study|Other|0
719773|NCT00153062|2319148|P4|Overall Study|No disposition data available|1
719774|NCT00153062|2319149|P3|Overall Study|No disposition data available|1
719775|NCT00153062|2319150|P2|Overall Study|No disposition data available|1
719776|NCT00153062|2319151|P1|Overall Study|No disposition data available|1
719777|NCT00153062|2319148|P4|Overall Study|Protocol Violation|1
719778|NCT00153062|2319149|P3|Overall Study|Protocol Violation|1
719779|NCT00153062|2319150|P2|Overall Study|Protocol Violation|2
719780|NCT00153062|2319151|P1|Overall Study|Protocol Violation|0
719781|NCT00153062|2319148|P4|Overall Study|Adverse Event|0
719782|NCT00153062|2319149|P3|Overall Study|Adverse Event|1
719783|NCT00153062|2319150|P2|Overall Study|Adverse Event|1
719784|NCT00153062|2319151|P1|Overall Study|Adverse Event|0
719785|NCT00153062|2319148|P4|Overall Study|Lost to Follow-up|16
719786|NCT00153062|2319149|P3|Overall Study|Lost to Follow-up|15
719787|NCT00153062|2319150|P2|Overall Study|Lost to Follow-up|20
719788|NCT00153062|2319151|P1|Overall Study|Lost to Follow-up|12
719789|NCT00153062|2319148|P4|Overall Study|Withdrawal by Subject|28
719790|NCT00153062|2319149|P3|Overall Study|Withdrawal by Subject|27
719791|NCT00153062|2319150|P2|Overall Study|Withdrawal by Subject|30
719792|NCT00153062|2319151|P1|Overall Study|Withdrawal by Subject|14
719793|NCT00153062|2319148|P4|Overall Study|Death|365
719794|NCT00153062|2319149|P3|Overall Study|Death|369
719795|NCT00153062|2319150|P2|Overall Study|Death|352
719796|NCT00153062|2319151|P1|Overall Study|Death|360
719797|NCT00153101|2319172|P5|Overall Study|Withdrawal by Subject|5
719798|NCT00153101|2319173|P4|Overall Study|Withdrawal by Subject|3
719799|NCT00153101|2319174|P3|Overall Study|Withdrawal by Subject|3
719800|NCT00153101|2319175|P2|Overall Study|Withdrawal by Subject|4
719801|NCT00153101|2319176|P1|Overall Study|Withdrawal by Subject|3
719802|NCT00153101|2319172|P5|Overall Study|Lost to Follow-up|5
719803|NCT00153101|2319173|P4|Overall Study|Lost to Follow-up|5
719804|NCT00153101|2319174|P3|Overall Study|Lost to Follow-up|12
719805|NCT00153101|2319175|P2|Overall Study|Lost to Follow-up|14
719806|NCT00153101|2319176|P1|Overall Study|Lost to Follow-up|14
719807|NCT00159783|2319313|P3|Overall Study|not specified|4
719808|NCT00159783|2319314|P2|Overall Study|not specified|2
719809|NCT00159783|2319315|P1|Overall Study|not specified|0
719810|NCT00159783|2319313|P3|Overall Study|Lost to Follow-up|11
719811|NCT00159783|2319314|P2|Overall Study|Lost to Follow-up|5
719812|NCT00159783|2319315|P1|Overall Study|Lost to Follow-up|6
719813|NCT00159783|2319313|P3|Overall Study|Withdrawal by Subject|12
719814|NCT00159783|2319314|P2|Overall Study|Withdrawal by Subject|11
719815|NCT00159783|2319315|P1|Overall Study|Withdrawal by Subject|7
719816|NCT00159783|2319313|P3|Overall Study|Lack of Efficacy|3
719817|NCT00159783|2319314|P2|Overall Study|Lack of Efficacy|2
719818|NCT00159783|2319315|P1|Overall Study|Lack of Efficacy|1
719819|NCT00159783|2319313|P3|Overall Study|Adverse Event|9
719820|NCT00159783|2319314|P2|Overall Study|Adverse Event|7
719821|NCT00159783|2319315|P1|Overall Study|Adverse Event|5
719822|NCT00159822|2319345|P1|Post-treatment Follow-up Period|Reason unspecified|1
719823|NCT00159822|2319345|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
719824|NCT00159822|2319345|P1|Post-treatment Follow-up Period|Death|1
719825|NCT00159822|2319345|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
719826|NCT00159822|2319345|P1|Voriconazole Treatment Period|Lost to Follow-up|2
719827|NCT00159822|2319345|P1|Voriconazole Treatment Period|Protocol Violation|2
719828|NCT00159822|2319345|P1|Voriconazole Treatment Period|Death|4
719829|NCT00159822|2319345|P1|Voriconazole Treatment Period|Adverse Event|9
719830|NCT00159822|2319345|P1|Voriconazole Treatment Period|Lack of Efficacy|3
719831|NCT00160524|2319360|P1|Overall Study|Other|20
719832|NCT00160524|2319360|P1|Overall Study|Lack of Efficacy and Other|1
719833|NCT00160524|2319360|P1|Overall Study|Lack of Efficacy|21
719834|NCT00160524|2319360|P1|Overall Study|Lost to Follow-up and Other|1
719835|NCT00160524|2319360|P1|Overall Study|Lost to Follow-up|13
719836|NCT00160524|2319360|P1|Overall Study|Physician Decision and Other|6
719837|NCT00160524|2319360|P1|Overall Study|Physician Decision|27
719838|NCT00160524|2319360|P1|Overall Study|Withdrawal by Subject and Other|17
719839|NCT00160524|2319360|P1|Overall Study|Withdrawal by Subject|141
719840|NCT00160524|2319360|P1|Overall Study|Protocol Violation and Other|2
719841|NCT00160524|2319360|P1|Overall Study|Protocol Violation|16
719842|NCT00160524|2319360|P1|Overall Study|Adverse Event and Other|94
719843|NCT00160524|2319360|P1|Overall Study|Adverse Event|119
719844|NCT00160563|2319374|P3|Overall Study|Missing reason|0
719845|NCT00160563|2319375|P2|Overall Study|Missing reason|1
719846|NCT00160563|2319376|P1|Overall Study|Missing reason|0
719847|NCT00160563|2319374|P3|Overall Study|Other (listed in the study report)|81
719848|NCT00160563|2319375|P2|Overall Study|Other (listed in the study report)|40
719849|NCT00160563|2319376|P1|Overall Study|Other (listed in the study report)|48
719850|NCT00160563|2319374|P3|Overall Study|Withdrawal by Subject|3
719851|NCT00160563|2319375|P2|Overall Study|Withdrawal by Subject|2
719852|NCT00160563|2319376|P1|Overall Study|Withdrawal by Subject|1
719853|NCT00160563|2319374|P3|Overall Study|Protocol Violation|3
719854|NCT00160563|2319375|P2|Overall Study|Protocol Violation|0
719855|NCT00160563|2319376|P1|Overall Study|Protocol Violation|0
719856|NCT00160563|2319374|P3|Overall Study|Lost to Follow-up|2
719857|NCT00160563|2319375|P2|Overall Study|Lost to Follow-up|1
719858|NCT00160563|2319376|P1|Overall Study|Lost to Follow-up|1
719859|NCT00160563|2319374|P3|Overall Study|Adverse Event|1
719860|NCT00160563|2319375|P2|Overall Study|Adverse Event|1
719861|NCT00160563|2319376|P1|Overall Study|Adverse Event|1
719862|NCT00160641|2319388|P1|Overall Study|Unspecified|9
719863|NCT00160641|2319388|P1|Overall Study|Protocol Violation|3
719864|NCT00160641|2319388|P1|Overall Study|Lack of Efficacy|12
719865|NCT00160641|2319388|P1|Overall Study|Lost to Follow-up|8
719866|NCT00160641|2319388|P1|Overall Study|Withdrawal by Subject|87
719867|NCT00160641|2319388|P1|Overall Study|Adverse Event|102
719868|NCT00160693|2319419|P1|Overall Study|Study terminated by sponsor|15
719869|NCT00160693|2319419|P1|Overall Study|Withdrawal by Subject|54
719870|NCT00160693|2319419|P1|Overall Study|Lost to Follow-up|15
719871|NCT00160693|2319419|P1|Overall Study|Protocol Violation|24
719872|NCT00160693|2319419|P1|Overall Study|Lack of Efficacy|30
719873|NCT00160693|2319419|P1|Overall Study|Adverse Event|97
719874|NCT00160706|2319436|P1|Overall Study|Other Reason|11
719875|NCT00160706|2319436|P1|Overall Study|Lack of Efficacy and Other|1
719876|NCT00160706|2319436|P1|Overall Study|Lack of Efficacy|42
719877|NCT00160706|2319436|P1|Overall Study|Lost to Follow-up and Other|1
719878|NCT00160706|2319436|P1|Overall Study|Lost to Follow-up|4
719879|NCT00160706|2319436|P1|Overall Study|Physician Decision and Other|3
719880|NCT00160706|2319436|P1|Overall Study|Physician Decision|10
719881|NCT00160706|2319436|P1|Overall Study|Withdrawal by Subject and Other|12
719882|NCT00160706|2319436|P1|Overall Study|Withdrawal by Subject|41
719883|NCT00160706|2319436|P1|Overall Study|Protocol Violation|3
719884|NCT00160706|2319436|P1|Overall Study|Adverse Event and Other Reason|105
719885|NCT00160706|2319436|P1|Overall Study|Adverse Event|53
719886|NCT00161213|2319448|P1|Overall Study|Evaluable for toxicity but not response|1
719887|NCT00161213|2319448|P1|Overall Study|Withdrawal by Subject|1
719888|NCT00161616|2319481|P2|Overall Study|Protocol deviation|0
719889|NCT00161616|2319482|P1|Overall Study|Protocol deviation|1
719890|NCT00161616|2319481|P2|Overall Study|Lost to Follow-up|13
719891|NCT00161616|2319482|P1|Overall Study|Lost to Follow-up|17
719892|NCT00161616|2319481|P2|Overall Study|Death|1
719893|NCT00161616|2319482|P1|Overall Study|Death|1
719894|NCT00161616|2319481|P2|Overall Study|Physician Decision|0
719895|NCT00161616|2319482|P1|Overall Study|Physician Decision|1
719896|NCT00161616|2319481|P2|Overall Study|Withdrawal by Subject|5
719897|NCT00161616|2319482|P1|Overall Study|Withdrawal by Subject|6
719898|NCT00162032|2319492|P2|Overall Study|Reason not specified|0
719899|NCT00162032|2319493|P1|Overall Study|Reason not specified|1
719900|NCT00162032|2319492|P2|Overall Study|Lost to Follow-up|2
719901|NCT00162032|2319493|P1|Overall Study|Lost to Follow-up|4
719902|NCT00162097|2319505|P4|Overall Study|Participant no longer met study criteria|1
719903|NCT00162097|2319506|P3|Overall Study|Participant no longer met study criteria|0
719904|NCT00162097|2319507|P2|Overall Study|Participant no longer met study criteria|0
719905|NCT00162097|2319508|P1|Overall Study|Participant no longer met study criteria|0
890295|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
890296|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890297|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890298|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890299|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890300|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890301|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
890302|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
890303|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Physician Decision|0
890304|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Physician Decision|0
890305|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Physician Decision|0
890306|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Physician Decision|0
890307|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Physician Decision|0
890308|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Physician Decision|0
890309|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Physician Decision|6
890310|NCT01054885|2825383|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890311|NCT01054885|2825384|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890312|NCT01054885|2825385|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890313|NCT01054885|2825386|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890314|NCT01054885|2825387|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890315|NCT01054885|2825388|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
890316|NCT01054885|2825389|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
890317|NCT01039675|2825440|P2|Overall Study|Physician Decision|1
890318|NCT01039675|2825441|P1|Overall Study|Physician Decision|0
890319|NCT01039675|2825440|P2|Overall Study|Lost to Follow-up|1
890320|NCT01039675|2825441|P1|Overall Study|Lost to Follow-up|0
890321|NCT01039675|2825440|P2|Overall Study|Withdrawal by Subject|1
890322|NCT01039675|2825441|P1|Overall Study|Withdrawal by Subject|0
890323|NCT01039675|2825440|P2|Overall Study|Lack of Efficacy|2
890324|NCT01039675|2825441|P1|Overall Study|Lack of Efficacy|0
890325|NCT01039675|2825440|P2|Overall Study|Adverse Event|2
890326|NCT01039675|2825441|P1|Overall Study|Adverse Event|0
890327|NCT01030965|2825464|P4|Overall Study|Withdrawal by Subject|2
890328|NCT01030965|2825465|P3|Overall Study|Withdrawal by Subject|0
890329|NCT01030965|2825466|P2|Overall Study|Withdrawal by Subject|1
890330|NCT01030965|2825467|P1|Overall Study|Withdrawal by Subject|0
890331|NCT01030965|2825464|P4|Overall Study|Protocol-defined Stopping Criteria|0
890332|NCT01030965|2825465|P3|Overall Study|Protocol-defined Stopping Criteria|1
890333|NCT01030965|2825466|P2|Overall Study|Protocol-defined Stopping Criteria|1
890334|NCT01030965|2825467|P1|Overall Study|Protocol-defined Stopping Criteria|0
890335|NCT01030965|2825464|P4|Overall Study|Adverse Event|1
890336|NCT01030965|2825465|P3|Overall Study|Adverse Event|2
890337|NCT01030965|2825466|P2|Overall Study|Adverse Event|1
890338|NCT01030965|2825467|P1|Overall Study|Adverse Event|0
890339|NCT01030965|2825464|P4|Overall Study|Protocol Violation|1
890340|NCT01030965|2825465|P3|Overall Study|Protocol Violation|1
890341|NCT01030965|2825466|P2|Overall Study|Protocol Violation|1
890342|NCT01030965|2825467|P1|Overall Study|Protocol Violation|1
890343|NCT01030965|2825464|P4|Overall Study|Lack of Efficacy|3
890344|NCT01030965|2825465|P3|Overall Study|Lack of Efficacy|0
890345|NCT01030965|2825466|P2|Overall Study|Lack of Efficacy|2
890346|NCT01030965|2825467|P1|Overall Study|Lack of Efficacy|3
890355|NCT01027702|2825508|P7|Overall Study|Death|0
890356|NCT01027702|2825509|P6|Overall Study|Death|0
890357|NCT01027702|2825510|P5|Overall Study|Death|0
890358|NCT01027702|2825511|P4|Overall Study|Death|0
890359|NCT01027702|2825512|P3|Overall Study|Death|1
890360|NCT01027702|2825513|P2|Overall Study|Death|0
890361|NCT01027702|2825514|P1|Overall Study|Death|0
890362|NCT01027702|2825508|P7|Overall Study|Received subsequent therapy|1
890363|NCT01027702|2825509|P6|Overall Study|Received subsequent therapy|0
890364|NCT01027702|2825510|P5|Overall Study|Received subsequent therapy|1
890365|NCT01027702|2825511|P4|Overall Study|Received subsequent therapy|4
890366|NCT01027702|2825512|P3|Overall Study|Received subsequent therapy|0
890367|NCT01027702|2825513|P2|Overall Study|Received subsequent therapy|2
890368|NCT01027702|2825514|P1|Overall Study|Received subsequent therapy|1
890369|NCT01009060|2825534|P2|Overall Study|Withdrawal by Subject|1
890370|NCT01009060|2825535|P1|Overall Study|Withdrawal by Subject|1
890371|NCT01009060|2825534|P2|Overall Study|Physician Decision|1
890372|NCT01009060|2825535|P1|Overall Study|Physician Decision|1
890373|NCT01009060|2825534|P2|Overall Study|Lost to Follow-up|0
890374|NCT01009060|2825535|P1|Overall Study|Lost to Follow-up|1
890375|NCT01009060|2825534|P2|Overall Study|Protocol Violation|1
890376|NCT01009060|2825535|P1|Overall Study|Protocol Violation|0
890377|NCT01009060|2825534|P2|Overall Study|Adverse Event|2
890378|NCT01009060|2825535|P1|Overall Study|Adverse Event|1
719994|NCT00162136|2319618|P1|Overall Study|Withdrawal by Subject|1
719995|NCT00162136|2319618|P1|Overall Study|Study Drug Toxicity|4
719996|NCT00162136|2319618|P1|Overall Study|Investigator Request|5
719997|NCT00162136|2319618|P1|Overall Study|Disease Progression/Relapse|23
719998|NCT00162136|2319618|P1|Overall Study|Death|1
719999|NCT00162136|2319618|P1|Overall Study|Adverse Event|1
720000|NCT00162266|2319645|P4|Open-Label Period|Other Reasons|15
720001|NCT00162266|2319646|P3|Open-Label Period|Other Reasons|0
720002|NCT00162266|2319647|P2|Open-Label Period|Other Reasons|0
720003|NCT00162266|2319648|P1|Open-Label Period|Other Reasons|0
720004|NCT00162266|2319645|P4|Open-Label Period|Administrative Reason By Sponsor|9
720005|NCT00162266|2319646|P3|Open-Label Period|Administrative Reason By Sponsor|0
720006|NCT00162266|2319647|P2|Open-Label Period|Administrative Reason By Sponsor|0
720007|NCT00162266|2319648|P1|Open-Label Period|Administrative Reason By Sponsor|0
720008|NCT00162266|2319645|P4|Open-Label Period|Withdrawal by Subject|31
720009|NCT00162266|2319646|P3|Open-Label Period|Withdrawal by Subject|0
720010|NCT00162266|2319647|P2|Open-Label Period|Withdrawal by Subject|0
720011|NCT00162266|2319648|P1|Open-Label Period|Withdrawal by Subject|0
720012|NCT00162266|2319645|P4|Open-Label Period|Lost to Follow-up|3
720013|NCT00162266|2319646|P3|Open-Label Period|Lost to Follow-up|0
720014|NCT00162266|2319647|P2|Open-Label Period|Lost to Follow-up|0
720015|NCT00162266|2319648|P1|Open-Label Period|Lost to Follow-up|0
720016|NCT00162266|2319645|P4|Open-Label Period|Lack of Efficacy|26
720017|NCT00162266|2319646|P3|Open-Label Period|Lack of Efficacy|0
720018|NCT00162266|2319647|P2|Open-Label Period|Lack of Efficacy|0
720019|NCT00162266|2319648|P1|Open-Label Period|Lack of Efficacy|0
720020|NCT00162266|2319645|P4|Open-Label Period|Adverse Event|46
720021|NCT00162266|2319646|P3|Open-Label Period|Adverse Event|0
720022|NCT00162266|2319647|P2|Open-Label Period|Adverse Event|0
720023|NCT00162266|2319648|P1|Open-Label Period|Adverse Event|0
720024|NCT00162266|2319645|P4|Open-Label Period|Death|7
720025|NCT00162266|2319646|P3|Open-Label Period|Death|0
720026|NCT00162266|2319647|P2|Open-Label Period|Death|0
720027|NCT00162266|2319648|P1|Open-Label Period|Death|0
720028|NCT00162266|2319645|P4|Double-Blind Period|Withdrawal by Subject|0
720029|NCT00162266|2319646|P3|Double-Blind Period|Withdrawal by Subject|6
720030|NCT00162266|2319647|P2|Double-Blind Period|Withdrawal by Subject|2
720031|NCT00162266|2319648|P1|Double-Blind Period|Withdrawal by Subject|5
720032|NCT00162266|2319645|P4|Double-Blind Period|Lack of Efficacy|0
720033|NCT00162266|2319646|P3|Double-Blind Period|Lack of Efficacy|30
720034|NCT00162266|2319647|P2|Double-Blind Period|Lack of Efficacy|17
720035|NCT00162266|2319648|P1|Double-Blind Period|Lack of Efficacy|13
720036|NCT00162266|2319645|P4|Double-Blind Period|Other Reason|0
720037|NCT00162266|2319646|P3|Double-Blind Period|Other Reason|1
720038|NCT00162266|2319647|P2|Double-Blind Period|Other Reason|0
720039|NCT00162266|2319648|P1|Double-Blind Period|Other Reason|1
720040|NCT00162266|2319645|P4|Double-Blind Period|Lost to Follow-up|0
720041|NCT00162266|2319646|P3|Double-Blind Period|Lost to Follow-up|0
720042|NCT00162266|2319647|P2|Double-Blind Period|Lost to Follow-up|2
720043|NCT00162266|2319648|P1|Double-Blind Period|Lost to Follow-up|1
720044|NCT00162266|2319645|P4|Double-Blind Period|Death|0
720045|NCT00162266|2319646|P3|Double-Blind Period|Death|0
720046|NCT00162266|2319647|P2|Double-Blind Period|Death|1
720047|NCT00162266|2319648|P1|Double-Blind Period|Death|0
720048|NCT00162266|2319645|P4|Double-Blind Period|Adverse Event|0
720049|NCT00162266|2319646|P3|Double-Blind Period|Adverse Event|11
720050|NCT00162266|2319647|P2|Double-Blind Period|Adverse Event|9
720051|NCT00162266|2319648|P1|Double-Blind Period|Adverse Event|5
720052|NCT00162370|2319843|P1|Efficacy Population|Lost to Follow-up|51
720053|NCT00162773|2319848|P1|Overall Study|P.I, Left institution. Study terminated|22
720054|NCT00156533|2319871|P4|Overall Study|Failed Screening|1
720055|NCT00156533|2319872|P3|Overall Study|Failed Screening|1
720056|NCT00156533|2319873|P2|Overall Study|Failed Screening|0
720057|NCT00156533|2319874|P1|Overall Study|Failed Screening|1
720058|NCT00156533|2319871|P4|Overall Study|Withdrawal by Subject|1
720059|NCT00156533|2319872|P3|Overall Study|Withdrawal by Subject|0
720060|NCT00156533|2319873|P2|Overall Study|Withdrawal by Subject|0
720061|NCT00156533|2319874|P1|Overall Study|Withdrawal by Subject|1
720062|NCT00156533|2319871|P4|Overall Study|Withdrawn - Medication Expiration|0
720063|NCT00156533|2319872|P3|Overall Study|Withdrawn - Medication Expiration|1
720064|NCT00156533|2319873|P2|Overall Study|Withdrawn - Medication Expiration|2
720065|NCT00156533|2319874|P1|Overall Study|Withdrawn - Medication Expiration|0
720066|NCT00156819|2319896|P3|Overall Study|Lost to Follow-up|3
720067|NCT00156819|2319897|P2|Overall Study|Lost to Follow-up|1
720068|NCT00156819|2319898|P1|Overall Study|Lost to Follow-up|1
720069|NCT00162942|2319908|P2|Overall Study|2 or more consecutive treatments missed|0
720070|NCT00162942|2319909|P1|Overall Study|2 or more consecutive treatments missed|1
720071|NCT00162942|2319908|P2|Overall Study|Flare During Active Treatment|3
720072|NCT00162942|2319909|P1|Overall Study|Flare During Active Treatment|7
720073|NCT00162942|2319908|P2|Overall Study|Lack of Efficacy|0
720074|NCT00162942|2319909|P1|Overall Study|Lack of Efficacy|1
720075|NCT00162942|2319908|P2|Overall Study|Alternate Therapy|2
720076|NCT00162942|2319909|P1|Overall Study|Alternate Therapy|6
720077|NCT00162942|2319908|P2|Overall Study|Enter Open-Label Study|35
720078|NCT00162942|2319909|P1|Overall Study|Enter Open-Label Study|76
720079|NCT00162942|2319908|P2|Overall Study|Physician Decision|0
720080|NCT00162942|2319909|P1|Overall Study|Physician Decision|1
720081|NCT00162942|2319908|P2|Overall Study|Withdrawal by Subject|6
720082|NCT00162942|2319909|P1|Overall Study|Withdrawal by Subject|3
720083|NCT00162942|2319908|P2|Overall Study|Death|0
720084|NCT00162942|2319909|P1|Overall Study|Death|1
720085|NCT00162942|2319908|P2|Overall Study|Adverse Event|6
720086|NCT00162942|2319909|P1|Overall Study|Adverse Event|10
720087|NCT00162981|2319959|P2|Overall Study|Physician Decision|0
720088|NCT00162981|2319960|P1|Overall Study|Physician Decision|1
720089|NCT00162981|2319959|P2|Overall Study|Withdrawal by Subject|1
720090|NCT00162981|2319960|P1|Overall Study|Withdrawal by Subject|1
720091|NCT00162981|2319959|P2|Overall Study|Adverse Event|5
720092|NCT00162981|2319960|P1|Overall Study|Adverse Event|2
720093|NCT00163020|2319976|P2|Overall Study|Lost to Follow-up|2
720094|NCT00163020|2319977|P1|Overall Study|Lost to Follow-up|0
720095|NCT00163657|2320018|P3|Overall Study|Other reason|3
720096|NCT00163657|2320019|P2|Overall Study|Other reason|1
720097|NCT00163657|2320020|P1|Overall Study|Other reason|0
720098|NCT00163657|2320018|P3|Overall Study|Lost to Follow-up|10
720099|NCT00163657|2320019|P2|Overall Study|Lost to Follow-up|3
720100|NCT00163657|2320020|P1|Overall Study|Lost to Follow-up|1
720101|NCT00163657|2320018|P3|Overall Study|Non Compliance|0
720102|NCT00163657|2320019|P2|Overall Study|Non Compliance|0
720103|NCT00163657|2320020|P1|Overall Study|Non Compliance|1
720104|NCT00163657|2320018|P3|Overall Study|Physician Decision|1
720105|NCT00163657|2320019|P2|Overall Study|Physician Decision|1
720106|NCT00163657|2320020|P1|Overall Study|Physician Decision|0
720107|NCT00163657|2320018|P3|Overall Study|Withdrawal by Subject|2
720108|NCT00163657|2320019|P2|Overall Study|Withdrawal by Subject|3
720109|NCT00163657|2320020|P1|Overall Study|Withdrawal by Subject|2
720110|NCT00163657|2320018|P3|Overall Study|graft loss|2
720111|NCT00163657|2320019|P2|Overall Study|graft loss|1
720112|NCT00163657|2320020|P1|Overall Study|graft loss|4
720113|NCT00163657|2320018|P3|Overall Study|Death|19
720114|NCT00163657|2320019|P2|Overall Study|Death|14
720115|NCT00163657|2320020|P1|Overall Study|Death|12
720116|NCT00165503|2320031|P1|Overall Study|Unresectable|3
720117|NCT00165503|2320031|P1|Overall Study|Lost to Follow-up|12
720118|NCT00165503|2320031|P1|Overall Study|Death|1
720119|NCT00165646|2320038|P3|Overall Study|Protocol Violation|0
720120|NCT00165646|2320039|P2|Overall Study|Protocol Violation|0
720121|NCT00165646|2320040|P1|Overall Study|Protocol Violation|1
720122|NCT00165646|2320038|P3|Overall Study|Physician Decision|2
720123|NCT00165646|2320039|P2|Overall Study|Physician Decision|0
720124|NCT00165646|2320040|P1|Overall Study|Physician Decision|2
720125|NCT00165646|2320038|P3|Overall Study|Withdrawal by Subject|1
720126|NCT00165646|2320039|P2|Overall Study|Withdrawal by Subject|2
720127|NCT00165646|2320040|P1|Overall Study|Withdrawal by Subject|0
720128|NCT00165646|2320038|P3|Overall Study|Lack of Efficacy|0
720129|NCT00165646|2320039|P2|Overall Study|Lack of Efficacy|2
720130|NCT00165646|2320040|P1|Overall Study|Lack of Efficacy|1
720131|NCT00165646|2320038|P3|Overall Study|Adverse Event|1
720132|NCT00165646|2320039|P2|Overall Study|Adverse Event|1
720133|NCT00165646|2320040|P1|Overall Study|Adverse Event|1
720134|NCT00165672|2320050|P2|Overall Study|Adverse Event|1
720135|NCT00165672|2320051|P1|Overall Study|Adverse Event|0
720136|NCT00165698|2320059|P2|Overall Study|Not Taken/Lost the medicine|2
720137|NCT00165698|2320060|P1|Overall Study|Not Taken/Lost the medicine|1
720138|NCT00165698|2320059|P2|Overall Study|Protocol Violation|0
720139|NCT00165698|2320060|P1|Overall Study|Protocol Violation|1
720140|NCT00165698|2320059|P2|Overall Study|Withdrawal by Subject|1
720141|NCT00165698|2320060|P1|Overall Study|Withdrawal by Subject|2
720142|NCT00165698|2320059|P2|Overall Study|Lost to Follow-up|2
720143|NCT00165698|2320060|P1|Overall Study|Lost to Follow-up|2
720144|NCT00165698|2320059|P2|Overall Study|Adverse Event|10
720145|NCT00165698|2320060|P1|Overall Study|Adverse Event|2
720146|NCT00165776|2320088|P4|Overall Study|Worsening of Cervical Dystonia|1
720147|NCT00165776|2320089|P3|Overall Study|Worsening of Cervical Dystonia|0
720148|NCT00165776|2320090|P2|Overall Study|Worsening of Cervical Dystonia|0
720149|NCT00165776|2320091|P1|Overall Study|Worsening of Cervical Dystonia|0
720150|NCT00165776|2320088|P4|Overall Study|Withdrawal by Subject|0
720151|NCT00165776|2320089|P3|Overall Study|Withdrawal by Subject|2
720152|NCT00165776|2320090|P2|Overall Study|Withdrawal by Subject|1
720153|NCT00165776|2320091|P1|Overall Study|Withdrawal by Subject|4
720154|NCT00165776|2320088|P4|Overall Study|Lack of Efficacy|1
720155|NCT00165776|2320089|P3|Overall Study|Lack of Efficacy|0
720156|NCT00165776|2320090|P2|Overall Study|Lack of Efficacy|0
720157|NCT00165776|2320091|P1|Overall Study|Lack of Efficacy|0
720158|NCT00165789|2320129|P4|Overall Study|Withdrawal by Subject|2
720159|NCT00165789|2320130|P3|Overall Study|Withdrawal by Subject|1
720160|NCT00165789|2320131|P2|Overall Study|Withdrawal by Subject|1
720161|NCT00165789|2320132|P1|Overall Study|Withdrawal by Subject|0
720162|NCT00165789|2320129|P4|Overall Study|Adverse Event|12
720163|NCT00165789|2320130|P3|Overall Study|Adverse Event|0
720164|NCT00165789|2320131|P2|Overall Study|Adverse Event|3
720165|NCT00165789|2320132|P1|Overall Study|Adverse Event|0
720166|NCT00165841|2320184|P2|Overall Study|Medication Noncompliance|1
720167|NCT00165841|2320185|P1|Overall Study|Medication Noncompliance|1
720168|NCT00165841|2320184|P2|Overall Study|Other|5
720169|NCT00165841|2320185|P1|Overall Study|Other|3
720170|NCT00165841|2320184|P2|Overall Study|Protocol Violation|8
720171|NCT00165841|2320185|P1|Overall Study|Protocol Violation|6
720172|NCT00165841|2320184|P2|Overall Study|Physician Decision|0
720173|NCT00165841|2320185|P1|Overall Study|Physician Decision|1
720174|NCT00165841|2320184|P2|Overall Study|Withdrawal by Subject|8
720175|NCT00165841|2320185|P1|Overall Study|Withdrawal by Subject|7
720176|NCT00165841|2320184|P2|Overall Study|Lost to Follow-up|4
720177|NCT00165841|2320185|P1|Overall Study|Lost to Follow-up|4
720178|NCT00165841|2320184|P2|Overall Study|Lack of Efficacy|33
720179|NCT00165841|2320185|P1|Overall Study|Lack of Efficacy|6
720180|NCT00165841|2320184|P2|Overall Study|Adverse Event|3
720181|NCT00165841|2320185|P1|Overall Study|Adverse Event|2
720182|NCT00165984|2320200|P1|Overall Study|Death|15
720183|NCT00159861|2320209|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
720184|NCT00159861|2320210|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
720185|NCT00159861|2320209|P2|Extension Study - up to 3 Years|Reason Unspecified|19
720186|NCT00159861|2320210|P1|Extension Study - up to 3 Years|Reason Unspecified|12
720187|NCT00159861|2320209|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
720188|NCT00159861|2320210|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
720189|NCT00159861|2320209|P2|Extension Study - up to 3 Years|Adverse Event|14
720190|NCT00159861|2320210|P1|Extension Study - up to 3 Years|Adverse Event|14
720191|NCT00159861|2320209|P2|Extension Study - up to 3 Years|Death|28
720192|NCT00159861|2320210|P1|Extension Study - up to 3 Years|Death|24
720193|NCT00159861|2320209|P2|Core Study - 16 Weeks|Randomized but not Treated|0
720194|NCT00159861|2320210|P1|Core Study - 16 Weeks|Randomized but not Treated|2
720195|NCT00159861|2320209|P2|Core Study - 16 Weeks|Subject Defaulted|0
720196|NCT00159861|2320210|P1|Core Study - 16 Weeks|Subject Defaulted|1
720197|NCT00159861|2320209|P2|Core Study - 16 Weeks|Reason Unspecified|3
720198|NCT00159861|2320210|P1|Core Study - 16 Weeks|Reason Unspecified|5
720199|NCT00159861|2320209|P2|Core Study - 16 Weeks|Lack of Efficacy|3
720200|NCT00159861|2320210|P1|Core Study - 16 Weeks|Lack of Efficacy|2
720201|NCT00159861|2320209|P2|Core Study - 16 Weeks|Adverse Event|6
720202|NCT00159861|2320210|P1|Core Study - 16 Weeks|Adverse Event|12
720203|NCT00159861|2320209|P2|Core Study - 16 Weeks|Death|0
720204|NCT00159861|2320210|P1|Core Study - 16 Weeks|Death|3
720205|NCT00159874|2320238|P7|Overall Study|Pregnancy|0
720206|NCT00159874|2320239|P6|Overall Study|Pregnancy|0
720207|NCT00159874|2320240|P5|Overall Study|Pregnancy|0
720208|NCT00159874|2320241|P4|Overall Study|Pregnancy|0
720209|NCT00159874|2320242|P3|Overall Study|Pregnancy|0
720210|NCT00159874|2320243|P2|Overall Study|Pregnancy|1
720211|NCT00159874|2320244|P1|Overall Study|Pregnancy|1
720212|NCT00159874|2320238|P7|Overall Study|Withdrawal by Subject|1
720213|NCT00159874|2320239|P6|Overall Study|Withdrawal by Subject|2
720214|NCT00159874|2320240|P5|Overall Study|Withdrawal by Subject|3
720215|NCT00159874|2320241|P4|Overall Study|Withdrawal by Subject|4
720216|NCT00159874|2320242|P3|Overall Study|Withdrawal by Subject|8
720217|NCT00159874|2320243|P2|Overall Study|Withdrawal by Subject|6
720218|NCT00159874|2320244|P1|Overall Study|Withdrawal by Subject|2
720219|NCT00159874|2320238|P7|Overall Study|Death|0
720220|NCT00159874|2320239|P6|Overall Study|Death|2
720221|NCT00159874|2320240|P5|Overall Study|Death|1
720222|NCT00159874|2320241|P4|Overall Study|Death|0
720223|NCT00159874|2320242|P3|Overall Study|Death|15
720224|NCT00159874|2320243|P2|Overall Study|Death|8
720225|NCT00159874|2320244|P1|Overall Study|Death|3
720226|NCT00159874|2320238|P7|Overall Study|Protocol Violation|0
720227|NCT00159874|2320239|P6|Overall Study|Protocol Violation|0
720228|NCT00159874|2320240|P5|Overall Study|Protocol Violation|0
720229|NCT00159874|2320241|P4|Overall Study|Protocol Violation|0
720230|NCT00159874|2320242|P3|Overall Study|Protocol Violation|2
720231|NCT00159874|2320243|P2|Overall Study|Protocol Violation|5
720232|NCT00159874|2320244|P1|Overall Study|Protocol Violation|0
720233|NCT00159874|2320238|P7|Overall Study|Not specified|3
720234|NCT00159874|2320239|P6|Overall Study|Not specified|1
720235|NCT00159874|2320240|P5|Overall Study|Not specified|2
720236|NCT00159874|2320241|P4|Overall Study|Not specified|0
720237|NCT00159874|2320242|P3|Overall Study|Not specified|8
720238|NCT00159874|2320243|P2|Overall Study|Not specified|8
720239|NCT00159874|2320244|P1|Overall Study|Not specified|8
720240|NCT00159874|2320238|P7|Overall Study|Lost to Follow-up|1
720241|NCT00159874|2320239|P6|Overall Study|Lost to Follow-up|2
720242|NCT00159874|2320240|P5|Overall Study|Lost to Follow-up|1
720243|NCT00159874|2320241|P4|Overall Study|Lost to Follow-up|0
720244|NCT00159874|2320242|P3|Overall Study|Lost to Follow-up|3
720245|NCT00159874|2320243|P2|Overall Study|Lost to Follow-up|0
720246|NCT00159874|2320244|P1|Overall Study|Lost to Follow-up|1
720247|NCT00159874|2320238|P7|Overall Study|Lack of Efficacy|0
720248|NCT00159874|2320239|P6|Overall Study|Lack of Efficacy|3
720249|NCT00159874|2320240|P5|Overall Study|Lack of Efficacy|0
720250|NCT00159874|2320241|P4|Overall Study|Lack of Efficacy|1
720251|NCT00159874|2320242|P3|Overall Study|Lack of Efficacy|1
720252|NCT00159874|2320243|P2|Overall Study|Lack of Efficacy|0
720253|NCT00159874|2320244|P1|Overall Study|Lack of Efficacy|2
720254|NCT00159874|2320238|P7|Overall Study|Does Not Meet Entrance Criteria|0
720255|NCT00159874|2320239|P6|Overall Study|Does Not Meet Entrance Criteria|0
720256|NCT00159874|2320240|P5|Overall Study|Does Not Meet Entrance Criteria|0
720257|NCT00159874|2320241|P4|Overall Study|Does Not Meet Entrance Criteria|0
720258|NCT00159874|2320242|P3|Overall Study|Does Not Meet Entrance Criteria|1
720259|NCT00159874|2320243|P2|Overall Study|Does Not Meet Entrance Criteria|0
720260|NCT00159874|2320244|P1|Overall Study|Does Not Meet Entrance Criteria|1
720261|NCT00159874|2320238|P7|Overall Study|Adverse Event|0
720262|NCT00159874|2320239|P6|Overall Study|Adverse Event|2
720263|NCT00159874|2320240|P5|Overall Study|Adverse Event|1
720264|NCT00159874|2320241|P4|Overall Study|Adverse Event|1
720265|NCT00159874|2320242|P3|Overall Study|Adverse Event|5
720266|NCT00159874|2320243|P2|Overall Study|Adverse Event|2
720267|NCT00159874|2320244|P1|Overall Study|Adverse Event|2
720268|NCT00159913|2320416|P4|Overall Study|Protocol Violation|0
720269|NCT00159913|2320417|P3|Overall Study|Protocol Violation|1
720270|NCT00159913|2320418|P2|Overall Study|Protocol Violation|0
720271|NCT00159913|2320419|P1|Overall Study|Protocol Violation|1
720272|NCT00159913|2320416|P4|Overall Study|Lost to Follow-up|1
720273|NCT00159913|2320417|P3|Overall Study|Lost to Follow-up|0
720274|NCT00159913|2320418|P2|Overall Study|Lost to Follow-up|0
720275|NCT00159913|2320419|P1|Overall Study|Lost to Follow-up|0
720276|NCT00159913|2320416|P4|Overall Study|Withdrawal by Subject|1
720277|NCT00159913|2320417|P3|Overall Study|Withdrawal by Subject|0
720278|NCT00159913|2320418|P2|Overall Study|Withdrawal by Subject|0
720279|NCT00159913|2320419|P1|Overall Study|Withdrawal by Subject|0
720280|NCT00159913|2320416|P4|Overall Study|Adverse Event|0
720281|NCT00159913|2320417|P3|Overall Study|Adverse Event|1
720282|NCT00159913|2320418|P2|Overall Study|Adverse Event|0
720283|NCT00159913|2320419|P1|Overall Study|Adverse Event|1
720284|NCT00160199|2320523|P2|Overall Study|Protocol Violation|8
720285|NCT00160199|2320524|P1|Overall Study|Protocol Violation|8
720286|NCT00160199|2320523|P2|Overall Study|Administrative|1
720287|NCT00160199|2320524|P1|Overall Study|Administrative|0
720288|NCT00160199|2320523|P2|Overall Study|Withdrawal by Subject|6
720289|NCT00160199|2320524|P1|Overall Study|Withdrawal by Subject|4
720290|NCT00160199|2320523|P2|Overall Study|Lost to Follow-up|7
720291|NCT00160199|2320524|P1|Overall Study|Lost to Follow-up|7
720292|NCT00160199|2320523|P2|Overall Study|Lack of Efficacy|1
720293|NCT00160199|2320524|P1|Overall Study|Lack of Efficacy|0
720294|NCT00160199|2320523|P2|Overall Study|Adverse Event|14
720295|NCT00160199|2320524|P1|Overall Study|Adverse Event|5
720296|NCT00160251|2320548|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
720297|NCT00160251|2320549|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720298|NCT00160251|2320550|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720299|NCT00160251|2320551|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720300|NCT00160251|2320552|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720301|NCT00160251|2320553|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720302|NCT00160251|2320554|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720303|NCT00160251|2320555|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
720304|NCT00160251|2320548|P8|Post-amendment 2|Lack of Efficacy|24
720305|NCT00160251|2320549|P7|Post-amendment 2|Lack of Efficacy|0
720306|NCT00160251|2320550|P6|Post-amendment 2|Lack of Efficacy|0
720307|NCT00160251|2320551|P5|Post-amendment 2|Lack of Efficacy|0
720308|NCT00160251|2320552|P4|Post-amendment 2|Lack of Efficacy|0
720309|NCT00160251|2320553|P3|Post-amendment 2|Lack of Efficacy|0
720310|NCT00160251|2320554|P2|Post-amendment 2|Lack of Efficacy|0
720311|NCT00160251|2320555|P1|Post-amendment 2|Lack of Efficacy|0
720312|NCT00160251|2320548|P8|Post-amendment 2|Adverse Event|20
720313|NCT00160251|2320549|P7|Post-amendment 2|Adverse Event|0
720314|NCT00160251|2320550|P6|Post-amendment 2|Adverse Event|0
720315|NCT00160251|2320551|P5|Post-amendment 2|Adverse Event|0
720316|NCT00160251|2320552|P4|Post-amendment 2|Adverse Event|0
720317|NCT00160251|2320553|P3|Post-amendment 2|Adverse Event|0
720318|NCT00160251|2320554|P2|Post-amendment 2|Adverse Event|0
720319|NCT00160251|2320555|P1|Post-amendment 2|Adverse Event|0
720320|NCT00160251|2320548|P8|Prior to Amendment 2|Completed Treatment Phase|0
720321|NCT00160251|2320549|P7|Prior to Amendment 2|Completed Treatment Phase|0
720322|NCT00160251|2320550|P6|Prior to Amendment 2|Completed Treatment Phase|23
720323|NCT00160251|2320551|P5|Prior to Amendment 2|Completed Treatment Phase|0
720324|NCT00160251|2320552|P4|Prior to Amendment 2|Completed Treatment Phase|0
720325|NCT00160251|2320553|P3|Prior to Amendment 2|Completed Treatment Phase|0
720326|NCT00160251|2320554|P2|Prior to Amendment 2|Completed Treatment Phase|0
720327|NCT00160251|2320555|P1|Prior to Amendment 2|Completed Treatment Phase|3
720328|NCT00160251|2320548|P8|Prior to Amendment 2|Noncompliance with protocol|0
720329|NCT00160251|2320549|P7|Prior to Amendment 2|Noncompliance with protocol|0
720330|NCT00160251|2320550|P6|Prior to Amendment 2|Noncompliance with protocol|0
720331|NCT00160251|2320551|P5|Prior to Amendment 2|Noncompliance with protocol|0
720332|NCT00160251|2320552|P4|Prior to Amendment 2|Noncompliance with protocol|0
720333|NCT00160251|2320553|P3|Prior to Amendment 2|Noncompliance with protocol|0
720334|NCT00160251|2320554|P2|Prior to Amendment 2|Noncompliance with protocol|0
720335|NCT00160251|2320555|P1|Prior to Amendment 2|Noncompliance with protocol|1
720336|NCT00160251|2320548|P8|Prior to Amendment 2|Withdrawal by Subject|0
720337|NCT00160251|2320549|P7|Prior to Amendment 2|Withdrawal by Subject|3
720338|NCT00160251|2320550|P6|Prior to Amendment 2|Withdrawal by Subject|3
720339|NCT00160251|2320551|P5|Prior to Amendment 2|Withdrawal by Subject|2
720340|NCT00160251|2320552|P4|Prior to Amendment 2|Withdrawal by Subject|4
720341|NCT00160251|2320553|P3|Prior to Amendment 2|Withdrawal by Subject|3
720342|NCT00160251|2320554|P2|Prior to Amendment 2|Withdrawal by Subject|1
720343|NCT00160251|2320555|P1|Prior to Amendment 2|Withdrawal by Subject|3
720344|NCT00160251|2320548|P8|Prior to Amendment 2|Lost to Follow-up|0
720345|NCT00160251|2320549|P7|Prior to Amendment 2|Lost to Follow-up|0
720346|NCT00160251|2320550|P6|Prior to Amendment 2|Lost to Follow-up|1
720347|NCT00160251|2320551|P5|Prior to Amendment 2|Lost to Follow-up|1
720348|NCT00160251|2320552|P4|Prior to Amendment 2|Lost to Follow-up|0
720349|NCT00160251|2320553|P3|Prior to Amendment 2|Lost to Follow-up|1
720350|NCT00160251|2320554|P2|Prior to Amendment 2|Lost to Follow-up|0
720351|NCT00160251|2320555|P1|Prior to Amendment 2|Lost to Follow-up|0
720352|NCT00160251|2320548|P8|Prior to Amendment 2|Lack of Efficacy|0
720353|NCT00160251|2320549|P7|Prior to Amendment 2|Lack of Efficacy|0
720354|NCT00160251|2320550|P6|Prior to Amendment 2|Lack of Efficacy|55
720355|NCT00160251|2320551|P5|Prior to Amendment 2|Lack of Efficacy|24
720356|NCT00160251|2320552|P4|Prior to Amendment 2|Lack of Efficacy|35
720357|NCT00160251|2320553|P3|Prior to Amendment 2|Lack of Efficacy|37
720358|NCT00160251|2320554|P2|Prior to Amendment 2|Lack of Efficacy|4
720359|NCT00160251|2320555|P1|Prior to Amendment 2|Lack of Efficacy|0
720360|NCT00160251|2320548|P8|Prior to Amendment 2|Adverse Event|0
720361|NCT00160251|2320549|P7|Prior to Amendment 2|Adverse Event|1
720362|NCT00160251|2320550|P6|Prior to Amendment 2|Adverse Event|1
720363|NCT00160251|2320551|P5|Prior to Amendment 2|Adverse Event|1
720364|NCT00160251|2320552|P4|Prior to Amendment 2|Adverse Event|1
720365|NCT00160251|2320553|P3|Prior to Amendment 2|Adverse Event|3
720366|NCT00160251|2320554|P2|Prior to Amendment 2|Adverse Event|1
720367|NCT00160251|2320555|P1|Prior to Amendment 2|Adverse Event|2
720368|NCT00166114|2320642|P2|Overall Study|Adverse Event|1
720369|NCT00166114|2320643|P1|Overall Study|Adverse Event|2
720370|NCT00166114|2320642|P2|Overall Study|Withdrawal by Subject|4
720371|NCT00166114|2320643|P1|Overall Study|Withdrawal by Subject|10
720372|NCT00166114|2320642|P2|Overall Study|Protocol Violation|1
720373|NCT00166114|2320643|P1|Overall Study|Protocol Violation|2
720374|NCT00166296|2320689|P2|Overall Study|Lost to Follow-up|2
720375|NCT00166296|2320690|P1|Overall Study|Lost to Follow-up|4
720376|NCT00166296|2320689|P2|Overall Study|Adverse Event|4
720377|NCT00166296|2320690|P1|Overall Study|Adverse Event|2
720378|NCT00166296|2320689|P2|Overall Study|Withdrawal by Subject|3
720379|NCT00166296|2320690|P1|Overall Study|Withdrawal by Subject|1
720380|NCT00167778|2320702|P1|Overall Study|Withdrawal by Subject|1
720381|NCT00168038|2320751|P1|Overall Study|Therapy failure|1
720382|NCT00168038|2320751|P1|Overall Study|Adverse Event|1
720383|NCT00168064|2320765|P2|Overall Study|Various|3
720384|NCT00168064|2320766|P1|Overall Study|Various|4
720385|NCT00168064|2320765|P2|Overall Study|Subject's Best interest|2
720386|NCT00168064|2320766|P1|Overall Study|Subject's Best interest|2
720387|NCT00168064|2320765|P2|Overall Study|Concurrent Illness|3
720388|NCT00168064|2320766|P1|Overall Study|Concurrent Illness|4
720389|NCT00168064|2320765|P2|Overall Study|Non-compliance|3
720390|NCT00168064|2320766|P1|Overall Study|Non-compliance|2
720391|NCT00168064|2320765|P2|Overall Study|Lost to Follow-up|3
720392|NCT00168064|2320766|P1|Overall Study|Lost to Follow-up|4
720393|NCT00168064|2320765|P2|Overall Study|Lack of Efficacy|4
720394|NCT00168064|2320766|P1|Overall Study|Lack of Efficacy|4
720395|NCT00168064|2320765|P2|Overall Study|Withdrawal by Subject|4
720396|NCT00168064|2320766|P1|Overall Study|Withdrawal by Subject|3
720397|NCT00168064|2320765|P2|Overall Study|Adverse Event|22
720398|NCT00168064|2320766|P1|Overall Study|Adverse Event|26
720399|NCT00168103|2320777|P4|Overall Study|Lost to Follow-up|0
720400|NCT00168103|2320778|P3|Overall Study|Lost to Follow-up|0
720401|NCT00168103|2320779|P2|Overall Study|Lost to Follow-up|3
720402|NCT00168103|2320780|P1|Overall Study|Lost to Follow-up|1
720403|NCT00168103|2320777|P4|Overall Study|Withdrawal by Subject|0
720404|NCT00168103|2320778|P3|Overall Study|Withdrawal by Subject|1
720405|NCT00168103|2320779|P2|Overall Study|Withdrawal by Subject|2
720406|NCT00168103|2320780|P1|Overall Study|Withdrawal by Subject|1
720407|NCT00168805|2320995|P3|Treatment|not specified|17
720408|NCT00168805|2320996|P2|Treatment|not specified|18
720409|NCT00168805|2320997|P1|Treatment|not specified|18
720410|NCT00168805|2320995|P3|Treatment|Withdrawal by Subject|8
720411|NCT00168805|2320996|P2|Treatment|Withdrawal by Subject|7
720412|NCT00168805|2320997|P1|Treatment|Withdrawal by Subject|3
720413|NCT00168805|2320995|P3|Treatment|Protocol Violation|5
720414|NCT00168805|2320996|P2|Treatment|Protocol Violation|5
720415|NCT00168805|2320997|P1|Treatment|Protocol Violation|3
720416|NCT00168805|2320995|P3|Treatment|Adverse Event|32
720417|NCT00168805|2320996|P2|Treatment|Adverse Event|26
720418|NCT00168805|2320997|P1|Treatment|Adverse Event|25
720419|NCT00168805|2320995|P3|Overall Study|not specified|22
720420|NCT00168805|2320996|P2|Overall Study|not specified|21
720421|NCT00168805|2320997|P1|Overall Study|not specified|24
720422|NCT00168805|2320995|P3|Overall Study|Withdrawal by Subject|21
720423|NCT00168805|2320996|P2|Overall Study|Withdrawal by Subject|18
720424|NCT00168805|2320997|P1|Overall Study|Withdrawal by Subject|16
720425|NCT00168805|2320995|P3|Overall Study|Lost to Follow-up|11
720426|NCT00168805|2320996|P2|Overall Study|Lost to Follow-up|17
720427|NCT00168805|2320997|P1|Overall Study|Lost to Follow-up|12
720428|NCT00168805|2320995|P3|Overall Study|Protocol Violation|8
720429|NCT00168805|2320996|P2|Overall Study|Protocol Violation|11
720430|NCT00168805|2320997|P1|Overall Study|Protocol Violation|12
720431|NCT00168805|2320995|P3|Overall Study|Adverse Event|16
720432|NCT00168805|2320996|P2|Overall Study|Adverse Event|11
720433|NCT00168805|2320997|P1|Overall Study|Adverse Event|7
720434|NCT00168818|2321041|P3|Treatment|not specified|31
720435|NCT00168818|2321042|P2|Treatment|not specified|29
720436|NCT00168818|2321043|P1|Treatment|not specified|23
720437|NCT00168818|2321041|P3|Treatment|Withdrawal by Subject|22
720438|NCT00168818|2321042|P2|Treatment|Withdrawal by Subject|20
720439|NCT00168818|2321043|P1|Treatment|Withdrawal by Subject|25
720440|NCT00168818|2321041|P3|Treatment|Lost to Follow-up|1
720441|NCT00168818|2321042|P2|Treatment|Lost to Follow-up|2
720442|NCT00168818|2321043|P1|Treatment|Lost to Follow-up|0
720443|NCT00168818|2321041|P3|Treatment|Protocol Violation|11
720444|NCT00168818|2321042|P2|Treatment|Protocol Violation|11
720445|NCT00168818|2321043|P1|Treatment|Protocol Violation|8
720446|NCT00168818|2321041|P3|Treatment|Adverse Event|68
720447|NCT00168818|2321042|P2|Treatment|Adverse Event|89
720448|NCT00168818|2321043|P1|Treatment|Adverse Event|77
720449|NCT00168818|2321041|P3|Overall Study|not specified|30
720450|NCT00168818|2321042|P2|Overall Study|not specified|24
720451|NCT00168818|2321043|P1|Overall Study|not specified|22
720452|NCT00168818|2321041|P3|Overall Study|Withdrawal by Subject|37
720453|NCT00168818|2321042|P2|Overall Study|Withdrawal by Subject|41
720454|NCT00168818|2321043|P1|Overall Study|Withdrawal by Subject|43
720455|NCT00168818|2321041|P3|Overall Study|Lost to Follow-up|15
720456|NCT00168818|2321042|P2|Overall Study|Lost to Follow-up|4
720457|NCT00168818|2321043|P1|Overall Study|Lost to Follow-up|13
720458|NCT00168818|2321041|P3|Overall Study|Protocol Violation|11
720459|NCT00168818|2321042|P2|Overall Study|Protocol Violation|11
720460|NCT00168818|2321043|P1|Overall Study|Protocol Violation|16
720461|NCT00168818|2321041|P3|Overall Study|Adverse Event|31
720462|NCT00168818|2321042|P2|Overall Study|Adverse Event|29
720463|NCT00168818|2321043|P1|Overall Study|Adverse Event|23
720464|NCT00168831|2321087|P3|Overall Study|Other|6
720465|NCT00168831|2321088|P2|Overall Study|Other|3
720466|NCT00168831|2321089|P1|Overall Study|Other|6
720467|NCT00168831|2321087|P3|Overall Study|Protocol Violation|11
720468|NCT00168831|2321088|P2|Overall Study|Protocol Violation|11
720469|NCT00168831|2321089|P1|Overall Study|Protocol Violation|6
720470|NCT00168831|2321087|P3|Overall Study|Withdrawal by Subject|19
720471|NCT00168831|2321088|P2|Overall Study|Withdrawal by Subject|14
720472|NCT00168831|2321089|P1|Overall Study|Withdrawal by Subject|7
720473|NCT00168831|2321087|P3|Overall Study|Lost to Follow-up|4
720474|NCT00168831|2321088|P2|Overall Study|Lost to Follow-up|6
720475|NCT00168831|2321089|P1|Overall Study|Lost to Follow-up|5
720476|NCT00168831|2321087|P3|Overall Study|Adverse Event|74
720477|NCT00168831|2321088|P2|Overall Study|Adverse Event|47
720478|NCT00168831|2321089|P1|Overall Study|Adverse Event|36
720479|NCT00168844|2321271|P3|Overall Study|Other|9
720480|NCT00168844|2321272|P2|Overall Study|Other|7
720481|NCT00168844|2321273|P1|Overall Study|Other|6
720482|NCT00168844|2321271|P3|Overall Study|Protocol Violation|4
720483|NCT00168844|2321272|P2|Overall Study|Protocol Violation|2
720484|NCT00168844|2321273|P1|Overall Study|Protocol Violation|2
720485|NCT00168844|2321271|P3|Overall Study|Withdrawal by Subject|19
720486|NCT00168844|2321272|P2|Overall Study|Withdrawal by Subject|9
720487|NCT00168844|2321273|P1|Overall Study|Withdrawal by Subject|12
720488|NCT00168844|2321271|P3|Overall Study|Lost to Follow-up|11
720489|NCT00168844|2321272|P2|Overall Study|Lost to Follow-up|5
720490|NCT00168844|2321273|P1|Overall Study|Lost to Follow-up|4
720491|NCT00168844|2321271|P3|Overall Study|Adverse Event|48
720492|NCT00168844|2321272|P2|Overall Study|Adverse Event|32
720493|NCT00168844|2321273|P1|Overall Study|Adverse Event|31
720494|NCT00169442|2321458|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
720495|NCT00169442|2321459|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
720496|NCT00169442|2321460|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
720497|NCT00169442|2321461|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
720498|NCT00169442|2321462|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
720499|NCT00169442|2321463|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
720500|NCT00169442|2321458|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
720501|NCT00169442|2321459|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
720502|NCT00169442|2321460|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
720503|NCT00169442|2321461|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
720504|NCT00169442|2321462|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
720505|NCT00169442|2321463|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
720506|NCT00169442|2321458|P6|Overall Study|Migrated/moved from study area|2
720507|NCT00169442|2321459|P5|Overall Study|Migrated/moved from study area|0
720508|NCT00169442|2321460|P4|Overall Study|Migrated/moved from study area|0
720509|NCT00169442|2321461|P3|Overall Study|Migrated/moved from study area|0
720510|NCT00169442|2321462|P2|Overall Study|Migrated/moved from study area|0
720511|NCT00169442|2321463|P1|Overall Study|Migrated/moved from study area|0
720512|NCT00169442|2321458|P6|Overall Study|Withdrawal by Subject|0
720513|NCT00169442|2321459|P5|Overall Study|Withdrawal by Subject|0
720514|NCT00169442|2321460|P4|Overall Study|Withdrawal by Subject|0
720515|NCT00169442|2321461|P3|Overall Study|Withdrawal by Subject|1
720516|NCT00169442|2321462|P2|Overall Study|Withdrawal by Subject|0
720517|NCT00169442|2321463|P1|Overall Study|Withdrawal by Subject|0
720518|NCT00163189|2321577|P1|Overall Study|Did not meet continuation criterion|16
720519|NCT00163189|2321577|P1|Overall Study|Withdrawal by Subject|11
720520|NCT00163189|2321577|P1|Overall Study|Study terminated by sponsor|11
720521|NCT00163189|2321577|P1|Overall Study|Lack of Efficacy|7
720522|NCT00163189|2321577|P1|Overall Study|Adverse Event|6
720523|NCT00163189|2321577|P1|Overall Study|Death|3
720524|NCT00163189|2321577|P1|Overall Study|Protocol Violation|2
720525|NCT00163189|2321577|P1|Overall Study|Lost to Follow-up|1
720526|NCT00163189|2321577|P1|Overall Study|Unspecified|6
720527|NCT00163215|2321599|P1|Overall Study|Unspecified|7
720528|NCT00163215|2321599|P1|Overall Study|Withdrawal by Subject|5
720529|NCT00163215|2321599|P1|Overall Study|Lack of Efficacy|3
720530|NCT00171704|2321700|P2|Overall Study|Protocol Violation|1
720531|NCT00171704|2321701|P1|Overall Study|Protocol Violation|0
720532|NCT00171704|2321700|P2|Overall Study|Withdrawal by Subject|3
720533|NCT00171704|2321701|P1|Overall Study|Withdrawal by Subject|1
720534|NCT00171704|2321700|P2|Overall Study|Death|2
720535|NCT00171704|2321701|P1|Overall Study|Death|2
720536|NCT00171704|2321700|P2|Overall Study|Administrative Problems|1
720537|NCT00171704|2321701|P1|Overall Study|Administrative Problems|2
720538|NCT00171704|2321700|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
720539|NCT00171704|2321701|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
720540|NCT00171704|2321700|P2|Overall Study|Disease Progression|9
720541|NCT00171704|2321701|P1|Overall Study|Disease Progression|14
720542|NCT00171704|2321700|P2|Overall Study|Adverse Event|33
720543|NCT00171704|2321701|P1|Overall Study|Adverse Event|24
720544|NCT00171834|2321728|P7|Overall Study|Treatment Duration Completed|0
720545|NCT00171834|2321729|P6|Overall Study|Treatment Duration Completed|1
720546|NCT00171834|2321730|P5|Overall Study|Treatment Duration Completed|2
720547|NCT00171834|2321731|P4|Overall Study|Treatment Duration Completed|0
720548|NCT00171834|2321732|P3|Overall Study|Treatment Duration Completed|1
720549|NCT00171834|2321733|P2|Overall Study|Treatment Duration Completed|0
720550|NCT00171834|2321734|P1|Overall Study|Treatment Duration Completed|0
720551|NCT00171834|2321728|P7|Overall Study|Disease Progression|3
720552|NCT00171834|2321729|P6|Overall Study|Disease Progression|18
720553|NCT00171834|2321730|P5|Overall Study|Disease Progression|2
720554|NCT00171834|2321731|P4|Overall Study|Disease Progression|9
720555|NCT00171834|2321732|P3|Overall Study|Disease Progression|8
720556|NCT00171834|2321733|P2|Overall Study|Disease Progression|8
720557|NCT00171834|2321734|P1|Overall Study|Disease Progression|4
720558|NCT00171834|2321728|P7|Overall Study|Death from study indication|0
720559|NCT00171834|2321729|P6|Overall Study|Death from study indication|0
720560|NCT00171834|2321730|P5|Overall Study|Death from study indication|1
720561|NCT00171834|2321731|P4|Overall Study|Death from study indication|0
720562|NCT00171834|2321732|P3|Overall Study|Death from study indication|0
720563|NCT00171834|2321733|P2|Overall Study|Death from study indication|1
720564|NCT00171834|2321734|P1|Overall Study|Death from study indication|0
720565|NCT00171834|2321728|P7|Overall Study|Withdrawal by Subject|0
720566|NCT00171834|2321729|P6|Overall Study|Withdrawal by Subject|1
720567|NCT00171834|2321730|P5|Overall Study|Withdrawal by Subject|1
720568|NCT00171834|2321731|P4|Overall Study|Withdrawal by Subject|1
720569|NCT00171834|2321732|P3|Overall Study|Withdrawal by Subject|0
720570|NCT00171834|2321733|P2|Overall Study|Withdrawal by Subject|2
720571|NCT00171834|2321734|P1|Overall Study|Withdrawal by Subject|0
720572|NCT00171834|2321728|P7|Overall Study|Adverse Event|1
720573|NCT00171834|2321729|P6|Overall Study|Adverse Event|15
720574|NCT00171834|2321730|P5|Overall Study|Adverse Event|2
720575|NCT00171834|2321731|P4|Overall Study|Adverse Event|2
720576|NCT00171834|2321732|P3|Overall Study|Adverse Event|3
720577|NCT00171834|2321733|P2|Overall Study|Adverse Event|1
720578|NCT00171834|2321734|P1|Overall Study|Adverse Event|2
720579|NCT00171873|2321774|P2|Overall Study|Switched to Octreotide|1
720580|NCT00171873|2321775|P1|Overall Study|Switched to Octreotide|0
720581|NCT00171873|2321774|P2|Overall Study|Adverse Event|0
720582|NCT00171873|2321775|P1|Overall Study|Adverse Event|5
720583|NCT00171873|2321774|P2|Overall Study|Withdrawal by Subject|2
720584|NCT00171873|2321775|P1|Overall Study|Withdrawal by Subject|4
720585|NCT00171925|2321783|P2|Overall Study|Death|2
720586|NCT00171925|2321784|P1|Overall Study|Death|1
720587|NCT00171925|2321783|P2|Overall Study|Administrative problems|11
720588|NCT00171925|2321784|P1|Overall Study|Administrative problems|10
720589|NCT00171925|2321783|P2|Overall Study|Lost to Follow-up|2
720590|NCT00171925|2321784|P1|Overall Study|Lost to Follow-up|2
720591|NCT00171925|2321783|P2|Overall Study|Withdrawal by Subject|9
720592|NCT00171925|2321784|P1|Overall Study|Withdrawal by Subject|6
720593|NCT00171925|2321783|P2|Overall Study|Protocol Violation|1
720594|NCT00171925|2321784|P1|Overall Study|Protocol Violation|1
720595|NCT00171925|2321783|P2|Overall Study|Adverse Event|6
720596|NCT00171925|2321784|P1|Overall Study|Adverse Event|10
720597|NCT00172042|2321796|P2|Overall Study|Death|42
720598|NCT00172042|2321797|P1|Overall Study|Death|42
720599|NCT00172042|2321796|P2|Overall Study|Administrative problems|10
720600|NCT00172042|2321797|P1|Overall Study|Administrative problems|13
720601|NCT00172042|2321796|P2|Overall Study|Lost to Follow-up|5
720602|NCT00172042|2321797|P1|Overall Study|Lost to Follow-up|3
720603|NCT00172042|2321796|P2|Overall Study|Withdrawal by Subject|25
720604|NCT00172042|2321797|P1|Overall Study|Withdrawal by Subject|37
720605|NCT00172042|2321796|P2|Overall Study|Protocol Violation|7
720606|NCT00172042|2321797|P1|Overall Study|Protocol Violation|8
720607|NCT00172042|2321796|P2|Overall Study|Patient no longer requires study drug|8
720608|NCT00172042|2321797|P1|Overall Study|Patient no longer requires study drug|10
720609|NCT00172042|2321796|P2|Overall Study|Unsatisfactory therapeutic effect|11
720610|NCT00172042|2321797|P1|Overall Study|Unsatisfactory therapeutic effect|13
720611|NCT00172042|2321796|P2|Overall Study|Abnormal test procedure(s)|3
720612|NCT00172042|2321797|P1|Overall Study|Abnormal test procedure(s)|0
720613|NCT00172042|2321796|P2|Overall Study|Abnormal laboratory value(s)|1
720614|NCT00172042|2321797|P1|Overall Study|Abnormal laboratory value(s)|5
720615|NCT00172042|2321796|P2|Overall Study|Adverse Event|13
720616|NCT00172042|2321797|P1|Overall Study|Adverse Event|27
720617|NCT00172185|2321821|P4|Overall Study|Withdrawal by Subject|0
720618|NCT00172185|2321822|P3|Overall Study|Withdrawal by Subject|1
720619|NCT00172185|2321823|P2|Overall Study|Withdrawal by Subject|0
720620|NCT00172185|2321824|P1|Overall Study|Withdrawal by Subject|0
720621|NCT00172185|2321821|P4|Overall Study|SPONSOR Decision|0
720622|NCT00172185|2321822|P3|Overall Study|SPONSOR Decision|0
720623|NCT00172185|2321823|P2|Overall Study|SPONSOR Decision|1
720624|NCT00172185|2321824|P1|Overall Study|SPONSOR Decision|0
720625|NCT00172185|2321821|P4|Overall Study|Physician Decision|0
720626|NCT00172185|2321822|P3|Overall Study|Physician Decision|1
720627|NCT00172185|2321823|P2|Overall Study|Physician Decision|0
720628|NCT00172185|2321824|P1|Overall Study|Physician Decision|0
720629|NCT00172185|2321821|P4|Overall Study|Adverse Event|4
720630|NCT00172185|2321822|P3|Overall Study|Adverse Event|3
720631|NCT00172185|2321823|P2|Overall Study|Adverse Event|1
720632|NCT00172185|2321824|P1|Overall Study|Adverse Event|0
720633|NCT00166504|2321849|P2|Overall Study|Withdrawal by Subject|0
720634|NCT00166504|2321850|P1|Overall Study|Withdrawal by Subject|1
720635|NCT00166504|2321849|P2|Overall Study|Lost to Follow-up|1
720636|NCT00166504|2321850|P1|Overall Study|Lost to Follow-up|1
720637|NCT00166504|2321849|P2|Overall Study|Adverse Event|3
720638|NCT00166504|2321850|P1|Overall Study|Adverse Event|3
720639|NCT00166517|2321858|P2|Overall Study|Withdrawal by Subject|1
720640|NCT00166517|2321859|P1|Overall Study|Withdrawal by Subject|0
720641|NCT00166517|2321858|P2|Overall Study|Protocol Violation|1
720642|NCT00166517|2321859|P1|Overall Study|Protocol Violation|4
720643|NCT00166517|2321858|P2|Overall Study|Lost to Follow-up|0
720644|NCT00166517|2321859|P1|Overall Study|Lost to Follow-up|1
720645|NCT00166712|2321869|P2|Overall Study|Physician Decision|2
720646|NCT00166712|2321870|P1|Overall Study|Physician Decision|0
720647|NCT00166712|2321869|P2|Overall Study|Withdrawal by Subject|2
720648|NCT00166712|2321870|P1|Overall Study|Withdrawal by Subject|1
720649|NCT00166712|2321869|P2|Overall Study|Adverse Event|0
720650|NCT00166712|2321870|P1|Overall Study|Adverse Event|1
720651|NCT00166712|2321869|P2|Overall Study|Death|1
720652|NCT00166712|2321870|P1|Overall Study|Death|0
720653|NCT00167245|2321927|P2|Overall Study|Drowsy|0
720654|NCT00167245|2321928|P1|Overall Study|Drowsy|1
720655|NCT00167245|2321927|P2|Overall Study|Incarcerated|2
720656|NCT00167245|2321928|P1|Overall Study|Incarcerated|3
720657|NCT00167245|2321927|P2|Overall Study|Withdrawal by Subject|8
720658|NCT00167245|2321928|P1|Overall Study|Withdrawal by Subject|5
720659|NCT00167245|2321927|P2|Overall Study|Lost to Follow-up|31
720660|NCT00167245|2321928|P1|Overall Study|Lost to Follow-up|20
720661|NCT00167310|2321938|P2|Overall Study|Withdrawal by Subject|7
720662|NCT00167310|2321939|P1|Overall Study|Withdrawal by Subject|3
720663|NCT00167310|2321938|P2|Overall Study|Protocol Violation|3
720664|NCT00167310|2321939|P1|Overall Study|Protocol Violation|5
720665|NCT00174187|2321981|P3|Period 2 (After 3 Years)|Unspecified|5
720666|NCT00174187|2321982|P2|Period 2 (After 3 Years)|Unspecified|0
720667|NCT00174187|2321983|P1|Period 2 (After 3 Years)|Unspecified|0
720668|NCT00174187|2321981|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
720669|NCT00174187|2321982|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
720670|NCT00174187|2321983|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
720671|NCT00174187|2321981|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
720672|NCT00174187|2321982|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
720673|NCT00174187|2321983|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
720674|NCT00174187|2321981|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
720675|NCT00174187|2321982|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
720676|NCT00174187|2321983|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
720677|NCT00174187|2321981|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
720678|NCT00174187|2321982|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
720679|NCT00174187|2321983|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
720680|NCT00174187|2321981|P3|Period 1 (up to 3 Years)|Unspecified|0
720681|NCT00174187|2321982|P2|Period 1 (up to 3 Years)|Unspecified|1
720682|NCT00174187|2321983|P1|Period 1 (up to 3 Years)|Unspecified|0
720683|NCT00174187|2321981|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
720684|NCT00174187|2321982|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
720685|NCT00174187|2321983|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
720686|NCT00174187|2321981|P3|Period 1 (up to 3 Years)|Non compliance|0
720687|NCT00174187|2321982|P2|Period 1 (up to 3 Years)|Non compliance|1
720688|NCT00174187|2321983|P1|Period 1 (up to 3 Years)|Non compliance|0
720689|NCT00174187|2321981|P3|Period 1 (up to 3 Years)|Serious adverse event|0
720690|NCT00174187|2321982|P2|Period 1 (up to 3 Years)|Serious adverse event|1
720691|NCT00174187|2321983|P1|Period 1 (up to 3 Years)|Serious adverse event|0
720692|NCT00174252|2322044|P1|Overall Study|Protocol Violation|2
720693|NCT00174265|2322079|P2|Overall Study|Other (Not specified)|10
720694|NCT00174265|2322080|P1|Overall Study|Other (Not specified)|16
720695|NCT00174265|2322079|P2|Overall Study|Lost to Follow-up|0
720696|NCT00174265|2322080|P1|Overall Study|Lost to Follow-up|1
720697|NCT00174265|2322079|P2|Overall Study|Withdrawal by Subject|5
720698|NCT00174265|2322080|P1|Overall Study|Withdrawal by Subject|3
720699|NCT00174265|2322079|P2|Overall Study|Lack of Efficacy|2
720700|NCT00174265|2322080|P1|Overall Study|Lack of Efficacy|2
720701|NCT00174265|2322079|P2|Overall Study|Adverse Event|4
720702|NCT00174265|2322080|P1|Overall Study|Adverse Event|7
720703|NCT00174291|2322090|P2|Overall Study|Withdrawal by Subject|3
720704|NCT00174291|2322091|P1|Overall Study|Withdrawal by Subject|3
720705|NCT00174291|2322090|P2|Overall Study|Study terminated by sponsor|0
720706|NCT00174291|2322091|P1|Overall Study|Study terminated by sponsor|1
720707|NCT00174291|2322090|P2|Overall Study|Protocol Violation|2
720708|NCT00174291|2322091|P1|Overall Study|Protocol Violation|0
720709|NCT00174291|2322090|P2|Overall Study|Lost to Follow-up|1
720710|NCT00174291|2322091|P1|Overall Study|Lost to Follow-up|1
720711|NCT00175877|2322119|P1|Overall Study|Withdrawal by subject & Other|1
720712|NCT00175877|2322119|P1|Overall Study|AE & Other|1
720713|NCT00175877|2322119|P1|Overall Study|Other Reason|20
720714|NCT00175877|2322119|P1|Overall Study|Protocol Violation|15
720715|NCT00175877|2322119|P1|Overall Study|Lack of Efficacy|26
720716|NCT00175877|2322119|P1|Overall Study|Lost to Follow-up|9
720717|NCT00175877|2322119|P1|Overall Study|Withdrawal by Subject|141
720718|NCT00175877|2322119|P1|Overall Study|Adverse Event|136
720719|NCT00176254|2322170|P1|Overall Study|Lost to Follow-up|1
720720|NCT00176462|2322193|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
720721|NCT00176462|2322194|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
720722|NCT00176462|2322193|P2|Intensive Continuation (8X8-week Cycles)|Death|0
720723|NCT00176462|2322194|P1|Intensive Continuation (8X8-week Cycles)|Death|1
720724|NCT00176462|2322193|P2|Consolidation (12 Weeks)|Not documented|1
720725|NCT00176462|2322194|P1|Consolidation (12 Weeks)|Not documented|0
720726|NCT00176462|2322193|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
720727|NCT00176462|2322194|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
720728|NCT00176462|2322193|P2|Consolidation (12 Weeks)|Adverse Event|1
720729|NCT00176462|2322194|P1|Consolidation (12 Weeks)|Adverse Event|0
720730|NCT00176462|2322193|P2|Consolidation (12 Weeks)|Patient moved to another state|1
720731|NCT00176462|2322194|P1|Consolidation (12 Weeks)|Patient moved to another state|0
720732|NCT00176462|2322193|P2|Induction (4 Weeks)|Lack of Efficacy|1
720733|NCT00176462|2322194|P1|Induction (4 Weeks)|Lack of Efficacy|0
720734|NCT00176462|2322193|P2|Induction (4 Weeks)|Death|2
720735|NCT00176462|2322194|P1|Induction (4 Weeks)|Death|1
720736|NCT00176462|2322193|P2|Induction (4 Weeks)|Withdrawal by Subject|2
720737|NCT00176462|2322194|P1|Induction (4 Weeks)|Withdrawal by Subject|0
720738|NCT00176488|2322201|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
720739|NCT00176605|2322213|P1|Overall Study|Withdrawal by Subject|2
720740|NCT00176644|2322223|P1|Overall Study|Withdrawal by Subject|1
720741|NCT00177164|2322386|P2|Overall Study|Pregnancy|1
720742|NCT00177164|2322387|P1|Overall Study|Pregnancy|0
720743|NCT00177164|2322386|P2|Overall Study|Lack of Efficacy|1
720744|NCT00177164|2322387|P1|Overall Study|Lack of Efficacy|2
720745|NCT00177164|2322386|P2|Overall Study|discharge from hospital|0
720746|NCT00177164|2322387|P1|Overall Study|discharge from hospital|1
720747|NCT00177164|2322386|P2|Overall Study|Adverse Event|0
720748|NCT00177164|2322387|P1|Overall Study|Adverse Event|1
720749|NCT00177164|2322386|P2|Overall Study|increase in alcohol and drug use|2
720750|NCT00177164|2322387|P1|Overall Study|increase in alcohol and drug use|1
720751|NCT00177164|2322386|P2|Overall Study|Lost to Follow-up|5
720752|NCT00177164|2322387|P1|Overall Study|Lost to Follow-up|4
720753|NCT00177164|2322386|P2|Overall Study|Protocol Violation|7
720754|NCT00177164|2322387|P1|Overall Study|Protocol Violation|0
720755|NCT00177216|2322402|P3|Overall Study|Withdrawal by Subject|1
720756|NCT00177216|2322403|P2|Overall Study|Withdrawal by Subject|3
720757|NCT00177216|2322404|P1|Overall Study|Withdrawal by Subject|6
720758|NCT00177294|2322425|P2|Overall Study|Withdrawal by Subject|5
720759|NCT00177294|2322426|P1|Overall Study|Withdrawal by Subject|7
720760|NCT00177307|2322432|P1|Overall Study|Withdrawal by Subject|1
720761|NCT00177671|2322441|P2|Overall Study|Physician Decision|8
720762|NCT00177671|2322442|P1|Overall Study|Physician Decision|12
720763|NCT00177671|2322441|P2|Overall Study|Adverse Event|0
720764|NCT00177671|2322442|P1|Overall Study|Adverse Event|6
720765|NCT00177671|2322441|P2|Overall Study|medical complications|0
720766|NCT00177671|2322442|P1|Overall Study|medical complications|2
720767|NCT00177671|2322441|P2|Overall Study|Withdrawal by Subject|6
720768|NCT00177671|2322442|P1|Overall Study|Withdrawal by Subject|5
720769|NCT00178126|2322490|P2|Overall Study|did not receive intervention|6
720770|NCT00178126|2322491|P1|Overall Study|did not receive intervention|4
720771|NCT00178126|2322490|P2|Overall Study|Lost to Follow-up|21
720772|NCT00178126|2322491|P1|Overall Study|Lost to Follow-up|21
720773|NCT00170846|2322535|P3|Overall Study|Reason Missing|0
720774|NCT00170846|2322536|P2|Overall Study|Reason Missing|1
720775|NCT00170846|2322537|P1|Overall Study|Reason Missing|0
720776|NCT00170846|2322535|P3|Overall Study|Death|3
720777|NCT00170846|2322536|P2|Overall Study|Death|3
720778|NCT00170846|2322537|P1|Overall Study|Death|0
720779|NCT00170846|2322535|P3|Overall Study|Lost to Follow-up|2
720780|NCT00170846|2322536|P2|Overall Study|Lost to Follow-up|3
720781|NCT00170846|2322537|P1|Overall Study|Lost to Follow-up|6
720782|NCT00170846|2322535|P3|Overall Study|Subject withdrew Informed Consent|8
720783|NCT00170846|2322536|P2|Overall Study|Subject withdrew Informed Consent|12
720784|NCT00170846|2322537|P1|Overall Study|Subject withdrew Informed Consent|5
720785|NCT00170950|2322553|P2|Overall Study|Termination Data Not Recorded|22
720786|NCT00170950|2322554|P1|Overall Study|Termination Data Not Recorded|17
720787|NCT00170950|2322553|P2|Overall Study|Missing|1
720788|NCT00170950|2322554|P1|Overall Study|Missing|2
720789|NCT00170950|2322553|P2|Overall Study|Lost to Follow-up|115
720790|NCT00170950|2322554|P1|Overall Study|Lost to Follow-up|134
720791|NCT00170950|2322553|P2|Overall Study|Withdrawal by Subject|498
720792|NCT00170950|2322554|P1|Overall Study|Withdrawal by Subject|496
720793|NCT00170950|2322553|P2|Overall Study|Death|274
720794|NCT00170950|2322554|P1|Overall Study|Death|236
720795|NCT00171054|2322566|P2|Overall Study|Condition no longer required study drug|1
720796|NCT00171054|2322567|P1|Overall Study|Condition no longer required study drug|0
720797|NCT00171054|2322566|P2|Overall Study|Adverse Event|8
720798|NCT00171054|2322567|P1|Overall Study|Adverse Event|8
720799|NCT00171054|2322566|P2|Overall Study|Lost to Follow-up|1
720800|NCT00171054|2322567|P1|Overall Study|Lost to Follow-up|0
720801|NCT00171054|2322566|P2|Overall Study|Patient withdrew consent|0
720802|NCT00171054|2322567|P1|Overall Study|Patient withdrew consent|1
720803|NCT00171054|2322566|P2|Overall Study|Protocol Violation|2
720804|NCT00171054|2322567|P1|Overall Study|Protocol Violation|1
720805|NCT00171210|2322599|P2|Overall Study|Stopped at end of extension 1|1
720806|NCT00171210|2322600|P1|Overall Study|Stopped at end of extension 1|0
720807|NCT00171210|2322599|P2|Overall Study|Stopped at end of core|32
720808|NCT00171210|2322600|P1|Overall Study|Stopped at end of core|0
720809|NCT00171210|2322599|P2|Overall Study|Death|3
720810|NCT00171210|2322600|P1|Overall Study|Death|2
720811|NCT00171210|2322599|P2|Overall Study|Administrative problems|1
720812|NCT00171210|2322600|P1|Overall Study|Administrative problems|1
720813|NCT00171210|2322599|P2|Overall Study|Lost to Follow-up|0
720814|NCT00171210|2322600|P1|Overall Study|Lost to Follow-up|1
720815|NCT00171210|2322599|P2|Overall Study|Withdrawal by Subject|30
720816|NCT00171210|2322600|P1|Overall Study|Withdrawal by Subject|32
720817|NCT00171210|2322599|P2|Overall Study|Protocol Violation|2
720818|NCT00171210|2322600|P1|Overall Study|Protocol Violation|0
720819|NCT00171210|2322599|P2|Overall Study|Unsatisfactory therapeutic effect|15
720820|NCT00171210|2322600|P1|Overall Study|Unsatisfactory therapeutic effect|11
720821|NCT00171210|2322599|P2|Overall Study|Abnormal test procedure result(s)|1
720822|NCT00171210|2322600|P1|Overall Study|Abnormal test procedure result(s)|0
720823|NCT00171210|2322599|P2|Overall Study|Abnormal laboratory value(s)|3
720824|NCT00171210|2322600|P1|Overall Study|Abnormal laboratory value(s)|6
720825|NCT00171210|2322599|P2|Overall Study|Adverse Event|27
720826|NCT00171210|2322600|P1|Overall Study|Adverse Event|16
720827|NCT00171301|2322630|P2|Overall Study|Withdrawal by Subject|1
720828|NCT00171301|2322631|P1|Overall Study|Withdrawal by Subject|0
720829|NCT00171301|2322630|P2|Overall Study|Protocol Violation|2
720830|NCT00171301|2322631|P1|Overall Study|Protocol Violation|0
720831|NCT00171301|2322630|P2|Overall Study|Lost to Follow-up|2
720832|NCT00171301|2322631|P1|Overall Study|Lost to Follow-up|6
720833|NCT00171301|2322630|P2|Overall Study|Adverse Event|2
720834|NCT00171301|2322631|P1|Overall Study|Adverse Event|1
720835|NCT00171301|2322630|P2|Overall Study|Death|2
720836|NCT00171301|2322631|P1|Overall Study|Death|1
720837|NCT00171314|2322644|P2|Overall Study|Death|1
720838|NCT00171314|2322645|P1|Overall Study|Death|2
720839|NCT00171314|2322644|P2|Overall Study|Lost to Follow-up|3
720840|NCT00171314|2322645|P1|Overall Study|Lost to Follow-up|1
720841|NCT00171314|2322644|P2|Overall Study|Administrative Problems|3
720842|NCT00171314|2322645|P1|Overall Study|Administrative Problems|4
720843|NCT00171314|2322644|P2|Overall Study|Protocol Violation|7
720844|NCT00171314|2322645|P1|Overall Study|Protocol Violation|3
720845|NCT00171314|2322644|P2|Overall Study|Abnormal Test Procedure Results|3
720846|NCT00171314|2322645|P1|Overall Study|Abnormal Test Procedure Results|9
720847|NCT00171314|2322644|P2|Overall Study|Withdrawal by Subject|6
720848|NCT00171314|2322645|P1|Overall Study|Withdrawal by Subject|9
720849|NCT00171314|2322644|P2|Overall Study|Lack of Efficacy|14
720850|NCT00171314|2322645|P1|Overall Study|Lack of Efficacy|19
720851|NCT00171314|2322644|P2|Overall Study|Adverse Event|41
720852|NCT00171314|2322645|P1|Overall Study|Adverse Event|44
720853|NCT00171340|2322661|P2|Overall Study|Death|6
720854|NCT00171340|2322662|P1|Overall Study|Death|6
720855|NCT00171340|2322661|P2|Overall Study|Administrative Problems|2
720856|NCT00171340|2322662|P1|Overall Study|Administrative Problems|5
720857|NCT00171340|2322661|P2|Overall Study|No Longer Required Study Drug|1
720858|NCT00171340|2322662|P1|Overall Study|No Longer Required Study Drug|1
720859|NCT00171340|2322661|P2|Overall Study|Abnormal Test Procedure Results|11
720860|NCT00171340|2322662|P1|Overall Study|Abnormal Test Procedure Results|6
720861|NCT00171340|2322661|P2|Overall Study|Abnormal Laboratory Results|0
720862|NCT00171340|2322662|P1|Overall Study|Abnormal Laboratory Results|2
720863|NCT00171340|2322661|P2|Overall Study|Lost to Follow-up|5
720864|NCT00171340|2322662|P1|Overall Study|Lost to Follow-up|0
720865|NCT00171340|2322661|P2|Overall Study|Withdrawal by Subject|19
720866|NCT00171340|2322662|P1|Overall Study|Withdrawal by Subject|22
720867|NCT00171340|2322661|P2|Overall Study|Protocol Violation|8
720868|NCT00171340|2322662|P1|Overall Study|Protocol Violation|7
720869|NCT00171340|2322661|P2|Overall Study|Lack of Efficacy|41
720870|NCT00171340|2322662|P1|Overall Study|Lack of Efficacy|29
720871|NCT00171340|2322661|P2|Overall Study|Adverse Event|42
720872|NCT00171340|2322662|P1|Overall Study|Adverse Event|46
720873|NCT00178256|2322676|P4|Overall Study|Cancer progression|1
720874|NCT00178256|2322677|P3|Overall Study|Cancer progression|0
720875|NCT00178256|2322678|P2|Overall Study|Cancer progression|0
720876|NCT00178256|2322679|P1|Overall Study|Cancer progression|2
720877|NCT00178256|2322676|P4|Overall Study|Death|1
720878|NCT00178256|2322677|P3|Overall Study|Death|0
720879|NCT00178256|2322678|P2|Overall Study|Death|1
720880|NCT00178256|2322679|P1|Overall Study|Death|0
720881|NCT00178256|2322676|P4|Overall Study|Adverse Event|0
720882|NCT00178256|2322677|P3|Overall Study|Adverse Event|0
720883|NCT00178256|2322678|P2|Overall Study|Adverse Event|0
720884|NCT00178256|2322679|P1|Overall Study|Adverse Event|2
720887|NCT00180479|2322731|P2|Overall Study|Informed consent not signed|1
720888|NCT00180479|2322732|P1|Overall Study|Informed consent not signed|0
720889|NCT00180479|2322731|P2|Overall Study|Withdrawal by Subject|3
720890|NCT00180479|2322732|P1|Overall Study|Withdrawal by Subject|3
720891|NCT00180479|2322731|P2|Overall Study|Lost to Follow-up|7
720892|NCT00180479|2322732|P1|Overall Study|Lost to Follow-up|9
720893|NCT00180479|2322731|P2|Overall Study|Death|2
720894|NCT00180479|2322732|P1|Overall Study|Death|4
720895|NCT00181155|2322853|P2|Overall Study|Withdrawal by Subject|0
720896|NCT00181155|2322854|P1|Overall Study|Withdrawal by Subject|1
720897|NCT00181155|2322853|P2|Overall Study|Physician Decision|0
720898|NCT00181155|2322854|P1|Overall Study|Physician Decision|1
720899|NCT00181766|2322883|P1|Overall Study|non-compliance|2
720900|NCT00181766|2322883|P1|Overall Study|Adverse Event|4
720901|NCT00181766|2322883|P1|Overall Study|Lost to Follow-up|6
720902|NCT00181844|2322888|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
720903|NCT00181844|2322888|P1|Exposed to Study Medication|Withdrawal by Subject|1
720904|NCT00181844|2322888|P1|Exposed to Study Medication|Non-compliance|2
720905|NCT00181844|2322888|P1|Exposed to Study Medication|Lack of Efficacy|2
720906|NCT00181844|2322888|P1|Exposed to Study Medication|Adverse Event|10
720907|NCT00181844|2322888|P1|Signed Consent|Did not meet entrance criteria|7
720908|NCT00181844|2322888|P1|Signed Consent|Withdrawal by Subject|5
720909|NCT00181883|2322892|P1|Overall Study|Lost to Follow-up|1
720910|NCT00181883|2322892|P1|Overall Study|Withdrawal by Subject|4
720911|NCT00181883|2322892|P1|Overall Study|Treatment Limiting AEs|3
720912|NCT00181883|2322892|P1|Overall Study|Lack of Efficacy|2
720913|NCT00182078|2322907|P2|Overall Study|Withdrawal by Subject|0
720914|NCT00182078|2322908|P1|Overall Study|Withdrawal by Subject|1
720915|NCT00182091|2322922|P4|Overall Study|Withdrawal by Subject|0
720916|NCT00182091|2322923|P3|Overall Study|Withdrawal by Subject|0
720917|NCT00182091|2322924|P2|Overall Study|Withdrawal by Subject|0
720918|NCT00182091|2322925|P1|Overall Study|Withdrawal by Subject|1
720919|NCT00182637|2322939|P1|Overall Study|Disease Progression|1
720920|NCT00182637|2322939|P1|Overall Study|Adverse Event|2
720921|NCT00182689|2322947|P2|Overall Study|Never received treatment|0
720922|NCT00182689|2322948|P1|Overall Study|Never received treatment|1
720923|NCT00182689|2322947|P2|Overall Study|Ineligible|4
720924|NCT00182689|2322948|P1|Overall Study|Ineligible|1
720925|NCT00182689|2322947|P2|Overall Study|not protocol specified|3
720926|NCT00182689|2322948|P1|Overall Study|not protocol specified|0
720927|NCT00182689|2322947|P2|Overall Study|Death|0
720928|NCT00182689|2322948|P1|Overall Study|Death|1
720929|NCT00182689|2322947|P2|Overall Study|Progression|29
720930|NCT00182689|2322948|P1|Overall Study|Progression|27
720931|NCT00182689|2322947|P2|Overall Study|Withdrawal by Subject|2
720932|NCT00182689|2322948|P1|Overall Study|Withdrawal by Subject|2
720933|NCT00182689|2322947|P2|Overall Study|Adverse Event|11
720934|NCT00182689|2322948|P1|Overall Study|Adverse Event|8
720935|NCT00174382|2322968|P1|Overall Study|Lost to Follow-up|1
720936|NCT00174382|2322968|P1|Overall Study|Subject felt pill not effective enough|1
720937|NCT00174382|2322968|P1|Overall Study|Arrived early for last visit in error|1
720938|NCT00174382|2322968|P1|Overall Study|Protocol Violation|3
720939|NCT00174382|2322968|P1|Overall Study|Withdrawal by Subject|6
720940|NCT00174382|2322968|P1|Overall Study|Adverse Event|19
720941|NCT00174382|2322968|P1|Overall Study|Death|2
720942|NCT00174447|2322985|P1|Overall Study|Administrative reason/Other|2
720943|NCT00174447|2322985|P1|Overall Study|Lack of Efficacy|1
720944|NCT00174447|2322985|P1|Overall Study|Protocol Violation|1
720945|NCT00174447|2322985|P1|Overall Study|Withdrawal by Subject|15
720946|NCT00174447|2322985|P1|Overall Study|Adverse Event|19
720947|NCT00174460|2322996|P2|Overall Study|Withdrawal by Subject|1
720948|NCT00174460|2322997|P1|Overall Study|Withdrawal by Subject|0
720949|NCT00174785|2323045|P2|Overall Study|Not pre-specified/Not coded|70
720950|NCT00174785|2323046|P1|Overall Study|Not pre-specified/Not coded|56
720951|NCT00174785|2323045|P2|Overall Study|Family request|8
720952|NCT00174785|2323046|P1|Overall Study|Family request|6
720953|NCT00174785|2323045|P2|Overall Study|Other prohibited medication|3
720954|NCT00174785|2323046|P1|Overall Study|Other prohibited medication|5
720955|NCT00174785|2323045|P2|Overall Study|Prohibited antiarrhythmic medication|88
720956|NCT00174785|2323046|P1|Overall Study|Prohibited antiarrhythmic medication|39
720957|NCT00174785|2323045|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
720958|NCT00174785|2323046|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
720959|NCT00174785|2323045|P2|Overall Study|Withdrawal by Subject|175
720960|NCT00174785|2323046|P1|Overall Study|Withdrawal by Subject|173
720961|NCT00174785|2323045|P2|Overall Study|Protocol Violation|14
720962|NCT00174785|2323046|P1|Overall Study|Protocol Violation|14
720963|NCT00174785|2323045|P2|Overall Study|Adverse Event|191
720964|NCT00174785|2323046|P1|Overall Study|Adverse Event|293
720965|NCT00174915|2323065|P5|Overall Study|Therapeutic Failure|3
720966|NCT00174915|2323066|P4|Overall Study|Therapeutic Failure|1
720967|NCT00174915|2323067|P3|Overall Study|Therapeutic Failure|2
720968|NCT00174915|2323068|P2|Overall Study|Therapeutic Failure|3
720969|NCT00174915|2323069|P1|Overall Study|Therapeutic Failure|6
720970|NCT00174915|2323065|P5|Overall Study|Protocol Violation|3
720971|NCT00174915|2323066|P4|Overall Study|Protocol Violation|6
720972|NCT00174915|2323067|P3|Overall Study|Protocol Violation|3
720973|NCT00174915|2323068|P2|Overall Study|Protocol Violation|3
720974|NCT00174915|2323069|P1|Overall Study|Protocol Violation|6
720975|NCT00174915|2323065|P5|Overall Study|Gout Flare|0
720976|NCT00174915|2323066|P4|Overall Study|Gout Flare|1
720977|NCT00174915|2323067|P3|Overall Study|Gout Flare|8
720978|NCT00174915|2323068|P2|Overall Study|Gout Flare|6
720979|NCT00174915|2323069|P1|Overall Study|Gout Flare|13
720980|NCT00174915|2323065|P5|Overall Study|Other|3
720981|NCT00174915|2323066|P4|Overall Study|Other|5
720982|NCT00174915|2323067|P3|Overall Study|Other|6
720983|NCT00174915|2323068|P2|Overall Study|Other|8
720984|NCT00174915|2323069|P1|Overall Study|Other|15
720985|NCT00174915|2323065|P5|Overall Study|Personal Reason(s)|9
720986|NCT00174915|2323066|P4|Overall Study|Personal Reason(s)|9
720987|NCT00174915|2323067|P3|Overall Study|Personal Reason(s)|9
720988|NCT00174915|2323068|P2|Overall Study|Personal Reason(s)|16
720989|NCT00174915|2323069|P1|Overall Study|Personal Reason(s)|16
720990|NCT00174915|2323065|P5|Overall Study|Adverse Event|5
720991|NCT00174915|2323066|P4|Overall Study|Adverse Event|18
720992|NCT00174915|2323067|P3|Overall Study|Adverse Event|11
720993|NCT00174915|2323068|P2|Overall Study|Adverse Event|16
720994|NCT00174915|2323069|P1|Overall Study|Adverse Event|18
720995|NCT00174915|2323065|P5|Overall Study|Lost to Follow-up|10
720996|NCT00174915|2323066|P4|Overall Study|Lost to Follow-up|17
720997|NCT00174915|2323067|P3|Overall Study|Lost to Follow-up|9
720998|NCT00174915|2323068|P2|Overall Study|Lost to Follow-up|17
720999|NCT00174915|2323069|P1|Overall Study|Lost to Follow-up|19
721000|NCT00174941|2323129|P4|Overall Study|Reason Not Specified|9
721001|NCT00174941|2323130|P3|Overall Study|Reason Not Specified|2
721002|NCT00174941|2323131|P2|Overall Study|Reason Not Specified|6
721003|NCT00174941|2323132|P1|Overall Study|Reason Not Specified|1
721004|NCT00174941|2323129|P4|Overall Study|Gout Flare|8
721005|NCT00174941|2323130|P3|Overall Study|Gout Flare|4
721006|NCT00174941|2323131|P2|Overall Study|Gout Flare|4
721007|NCT00174941|2323132|P1|Overall Study|Gout Flare|0
721008|NCT00174941|2323129|P4|Overall Study|Personal Reason(s)|22
721009|NCT00174941|2323130|P3|Overall Study|Personal Reason(s)|8
721010|NCT00174941|2323131|P2|Overall Study|Personal Reason(s)|14
721011|NCT00174941|2323132|P1|Overall Study|Personal Reason(s)|0
721012|NCT00174941|2323129|P4|Overall Study|Lost to Follow-up|5
721013|NCT00174941|2323130|P3|Overall Study|Lost to Follow-up|2
721014|NCT00174941|2323131|P2|Overall Study|Lost to Follow-up|3
721015|NCT00174941|2323132|P1|Overall Study|Lost to Follow-up|0
721016|NCT00174941|2323129|P4|Overall Study|Protocol Violation|1
721017|NCT00174941|2323130|P3|Overall Study|Protocol Violation|0
721018|NCT00174941|2323131|P2|Overall Study|Protocol Violation|1
721019|NCT00174941|2323132|P1|Overall Study|Protocol Violation|0
721020|NCT00174941|2323129|P4|Overall Study|Adverse Event|13
721021|NCT00174941|2323130|P3|Overall Study|Adverse Event|2
721022|NCT00174941|2323131|P2|Overall Study|Adverse Event|10
721023|NCT00174941|2323132|P1|Overall Study|Adverse Event|1
721024|NCT00174954|2323202|P1|Overall Study|Physician Decision|1
721025|NCT00174954|2323202|P1|Overall Study|No tophi found in MRI|1
721026|NCT00174954|2323202|P1|Overall Study|Adverse Event|2
721027|NCT00174967|2323211|P4|Overall Study|Not Specified|0
721028|NCT00174967|2323212|P3|Overall Study|Not Specified|0
721029|NCT00174967|2323213|P2|Overall Study|Not Specified|1
721030|NCT00174967|2323214|P1|Overall Study|Not Specified|0
721031|NCT00174967|2323211|P4|Overall Study|Gout Flare|1
721032|NCT00174967|2323212|P3|Overall Study|Gout Flare|0
721033|NCT00174967|2323213|P2|Overall Study|Gout Flare|0
721034|NCT00174967|2323214|P1|Overall Study|Gout Flare|0
721035|NCT00174967|2323211|P4|Overall Study|Adverse Event|1
721036|NCT00174967|2323212|P3|Overall Study|Adverse Event|2
721037|NCT00174967|2323213|P2|Overall Study|Adverse Event|2
721038|NCT00174967|2323214|P1|Overall Study|Adverse Event|1
721039|NCT00175019|2323268|P3|Overall Study|Reason Not Specified|11
721040|NCT00175019|2323269|P2|Overall Study|Reason Not Specified|34
721041|NCT00175019|2323270|P1|Overall Study|Reason Not Specified|40
721042|NCT00175019|2323268|P3|Overall Study|Gout Flare|0
721043|NCT00175019|2323269|P2|Overall Study|Gout Flare|3
721044|NCT00175019|2323270|P1|Overall Study|Gout Flare|2
721045|NCT00175019|2323268|P3|Overall Study|Therapeutic Failure|22
721046|NCT00175019|2323269|P2|Overall Study|Therapeutic Failure|38
721047|NCT00175019|2323270|P1|Overall Study|Therapeutic Failure|10
721048|NCT00175019|2323268|P3|Overall Study|Personal Reason(s)|8
721049|NCT00175019|2323269|P2|Overall Study|Personal Reason(s)|31
721050|NCT00175019|2323270|P1|Overall Study|Personal Reason(s)|39
721051|NCT00175019|2323268|P3|Overall Study|Did not continue under Amendment 4|2
721052|NCT00175019|2323269|P2|Overall Study|Did not continue under Amendment 4|1
721053|NCT00175019|2323270|P1|Overall Study|Did not continue under Amendment 4|1
721054|NCT00175019|2323268|P3|Overall Study|Lost to Follow-up|9
721055|NCT00175019|2323269|P2|Overall Study|Lost to Follow-up|39
721056|NCT00175019|2323270|P1|Overall Study|Lost to Follow-up|42
721057|NCT00175019|2323268|P3|Overall Study|Protocol Violation|3
721058|NCT00175019|2323269|P2|Overall Study|Protocol Violation|3
721059|NCT00175019|2323270|P1|Overall Study|Protocol Violation|6
721060|NCT00175019|2323268|P3|Overall Study|Adverse Event|2
721061|NCT00175019|2323269|P2|Overall Study|Adverse Event|22
721062|NCT00175019|2323270|P1|Overall Study|Adverse Event|54
721063|NCT00184002|2323372|P1|Overall Study|Withdrawal by Subject|4
721064|NCT00184002|2323372|P1|Overall Study|Physician Decision|1
721065|NCT00184002|2323372|P1|Overall Study|Death|3
721066|NCT00184002|2323372|P1|Overall Study|Adverse Event|9
721067|NCT00184028|2323377|P1|Overall Study|Non-compliance|2
721068|NCT00184028|2323377|P1|Overall Study|Withdrawal by Subject|1
721069|NCT00184028|2323377|P1|Overall Study|Adverse Event|2
721070|NCT00184028|2323377|P1|Overall Study|Lack of Efficacy|4
721071|NCT00184028|2323377|P1|Overall Study|Death|1
721072|NCT00184054|2323382|P1|Overall Study|Adverse Event|1
721073|NCT00184093|2323387|P1|Overall Study|Withdrawal by Subject|2
721074|NCT00184093|2323387|P1|Overall Study|Physician Decision|1
721075|NCT00184093|2323387|P1|Overall Study|Lost to Follow-up|3
721076|NCT00184093|2323387|P1|Overall Study|Adverse Event|3
721077|NCT00184600|2323436|P3|Overall Study|Unclassified|3
721078|NCT00184600|2323437|P2|Overall Study|Unclassified|5
721079|NCT00184600|2323438|P1|Overall Study|Unclassified|4
721080|NCT00184600|2323436|P3|Overall Study|Withdrawal by Subject|12
721081|NCT00184600|2323437|P2|Overall Study|Withdrawal by Subject|28
721082|NCT00184600|2323438|P1|Overall Study|Withdrawal by Subject|20
721083|NCT00184600|2323436|P3|Overall Study|Protocol Violation|3
721084|NCT00184600|2323437|P2|Overall Study|Protocol Violation|2
721085|NCT00184600|2323438|P1|Overall Study|Protocol Violation|2
721086|NCT00184600|2323436|P3|Overall Study|Lost to Follow-up|1
721087|NCT00184600|2323437|P2|Overall Study|Lost to Follow-up|6
721088|NCT00184600|2323438|P1|Overall Study|Lost to Follow-up|4
721089|NCT00184600|2323436|P3|Overall Study|Lack of Efficacy|3
721090|NCT00184600|2323437|P2|Overall Study|Lack of Efficacy|1
721091|NCT00184600|2323438|P1|Overall Study|Lack of Efficacy|3
721092|NCT00184600|2323436|P3|Overall Study|Death|7
721093|NCT00184600|2323437|P2|Overall Study|Death|9
721094|NCT00184600|2323438|P1|Overall Study|Death|3
721095|NCT00184600|2323436|P3|Overall Study|Adverse Event|5
721096|NCT00184600|2323437|P2|Overall Study|Adverse Event|0
721097|NCT00184600|2323438|P1|Overall Study|Adverse Event|9
721098|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
721099|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
721100|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
721101|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
721102|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
721103|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
721104|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
721105|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
721106|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
721107|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
721108|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
721109|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
721110|NCT00185211|2323535|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
721111|NCT00185211|2323536|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
721112|NCT00185211|2323535|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
721113|NCT00185211|2323536|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
721114|NCT00185211|2323535|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
721115|NCT00185211|2323536|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
721116|NCT00185211|2323535|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
721117|NCT00185211|2323536|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
721118|NCT00185211|2323535|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
721119|NCT00185211|2323536|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
721120|NCT00185211|2323535|P2|Placebo-controlled Study (92012)|Adverse Event|0
721121|NCT00185211|2323536|P1|Placebo-controlled Study (92012)|Adverse Event|8
721122|NCT00185380|2323564|P3|Overall Study|personal reason|1
721123|NCT00185380|2323565|P2|Overall Study|personal reason|1
721124|NCT00185380|2323566|P1|Overall Study|personal reason|6
721125|NCT00185380|2323564|P3|Overall Study|Could not attend visits|4
721126|NCT00185380|2323565|P2|Overall Study|Could not attend visits|0
721127|NCT00185380|2323566|P1|Overall Study|Could not attend visits|2
721128|NCT00185380|2323564|P3|Overall Study|No need for contraception|3
721129|NCT00185380|2323565|P2|Overall Study|No need for contraception|3
721130|NCT00185380|2323566|P1|Overall Study|No need for contraception|3
721131|NCT00185380|2323564|P3|Overall Study|Planned pregnancy|12
721132|NCT00185380|2323565|P2|Overall Study|Planned pregnancy|12
721133|NCT00185380|2323566|P1|Overall Study|Planned pregnancy|9
721134|NCT00185380|2323564|P3|Overall Study|Failed insertion|2
721135|NCT00185380|2323565|P2|Overall Study|Failed insertion|1
721136|NCT00185380|2323566|P1|Overall Study|Failed insertion|1
721137|NCT00185380|2323564|P3|Overall Study|Withdrawal by Subject|0
721138|NCT00185380|2323565|P2|Overall Study|Withdrawal by Subject|2
721139|NCT00185380|2323566|P1|Overall Study|Withdrawal by Subject|1
721140|NCT00185380|2323564|P3|Overall Study|Protocol Violation|1
721141|NCT00185380|2323565|P2|Overall Study|Protocol Violation|2
721142|NCT00185380|2323566|P1|Overall Study|Protocol Violation|2
721143|NCT00185380|2323564|P3|Overall Study|Pregnancy|0
721144|NCT00185380|2323565|P2|Overall Study|Pregnancy|4
721145|NCT00185380|2323566|P1|Overall Study|Pregnancy|1
721146|NCT00185380|2323564|P3|Overall Study|Lost to Follow-up|3
721147|NCT00185380|2323565|P2|Overall Study|Lost to Follow-up|4
721148|NCT00185380|2323566|P1|Overall Study|Lost to Follow-up|0
721149|NCT00185380|2323564|P3|Overall Study|Adverse Event|48
721150|NCT00185380|2323565|P2|Overall Study|Adverse Event|43
721151|NCT00185380|2323566|P1|Overall Study|Adverse Event|41
721152|NCT00185458|2323592|P1|HRT Phase|Withdrawal by Subject|3
721153|NCT00185458|2323592|P1|HRT Phase|Protocol Violation|2
721154|NCT00185458|2323592|P1|HRT Phase|Lost to Follow-up|4
721155|NCT00185458|2323592|P1|HRT Phase|Adverse Event|18
721156|NCT00185458|2323592|P1|Contraception Phase|Withdrawal by Subject|7
721157|NCT00185458|2323592|P1|Contraception Phase|Physician Decision|2
721158|NCT00185458|2323592|P1|Contraception Phase|Protocol Violation|2
721159|NCT00185458|2323592|P1|Contraception Phase|Lost to Follow-up|10
721160|NCT00185458|2323592|P1|Contraception Phase|Adverse Event|37
721161|NCT00185588|2323656|P4|Overall Study|Physician Decision|0
721162|NCT00185588|2323657|P3|Overall Study|Physician Decision|1
721163|NCT00185588|2323658|P2|Overall Study|Physician Decision|0
721164|NCT00185588|2323659|P1|Overall Study|Physician Decision|0
721165|NCT00185588|2323656|P4|Overall Study|Withdrawal by Subject|0
721166|NCT00185588|2323657|P3|Overall Study|Withdrawal by Subject|0
721167|NCT00185588|2323658|P2|Overall Study|Withdrawal by Subject|1
721168|NCT00185588|2323659|P1|Overall Study|Withdrawal by Subject|0
721169|NCT00185588|2323656|P4|Overall Study|Lost to Follow-up|2
721170|NCT00185588|2323657|P3|Overall Study|Lost to Follow-up|1
721171|NCT00185588|2323658|P2|Overall Study|Lost to Follow-up|0
721172|NCT00185588|2323659|P1|Overall Study|Lost to Follow-up|0
721173|NCT00185588|2323656|P4|Overall Study|Adverse Event|2
721174|NCT00185588|2323657|P3|Overall Study|Adverse Event|4
721175|NCT00185588|2323658|P2|Overall Study|Adverse Event|1
721176|NCT00185588|2323659|P1|Overall Study|Adverse Event|3
721177|NCT00185640|2323673|P1|Overall Study|Death|138
721178|NCT00185640|2323673|P1|Overall Study|Withdrawal by Subject|3
721179|NCT00185640|2323673|P1|Overall Study|Not Eligible|4
721180|NCT00185965|2323695|P2|Overall Study|Adverse Event|1
721181|NCT00185965|2323696|P1|Overall Study|Adverse Event|0
721182|NCT00186043|2323719|P2|Overall Study|Protocol Violation|1
721183|NCT00186043|2323720|P1|Overall Study|Protocol Violation|2
721184|NCT00186043|2323719|P2|Overall Study|Adverse Event|3
721185|NCT00186043|2323720|P1|Overall Study|Adverse Event|7
721186|NCT00186043|2323719|P2|Overall Study|Withdrawal by Subject|0
721187|NCT00186043|2323720|P1|Overall Study|Withdrawal by Subject|1
721188|NCT00186043|2323719|P2|Overall Study|Lost to Follow-up|6
721189|NCT00186043|2323720|P1|Overall Study|Lost to Follow-up|4
721190|NCT00186043|2323719|P2|Overall Study|Lack of Efficacy|3
721191|NCT00186043|2323720|P1|Overall Study|Lack of Efficacy|1
721192|NCT00186186|2323752|P1|Overall Study|Not reported as to reason|2
721193|NCT00186186|2323752|P1|Overall Study|Withdrawal by Subject|3
721194|NCT00186186|2323752|P1|Overall Study|Lack of Efficacy|3
721195|NCT00178633|2323757|P1|Overall Study|Lost to Follow-up|6
721196|NCT00178685|2323768|P3|Overall Study|Withdrawal by Subject|7
721197|NCT00178685|2323769|P2|Overall Study|Withdrawal by Subject|14
721198|NCT00178685|2323770|P1|Overall Study|Withdrawal by Subject|8
721199|NCT00178685|2323768|P3|Overall Study|Lost to Follow-up|183
721200|NCT00178685|2323769|P2|Overall Study|Lost to Follow-up|187
721201|NCT00178685|2323770|P1|Overall Study|Lost to Follow-up|100
721202|NCT00178685|2323768|P3|Overall Study|Death|6
721203|NCT00178685|2323769|P2|Overall Study|Death|3
721204|NCT00178685|2323770|P1|Overall Study|Death|3
721205|NCT00179309|2323811|P2|Treatment|Allergy|0
721206|NCT00179309|2323812|P1|Treatment|Allergy|1
721207|NCT00179309|2323811|P2|Treatment|Withdrawal by Subject|2
721208|NCT00179309|2323812|P1|Treatment|Withdrawal by Subject|1
721209|NCT00179309|2323811|P2|Treatment|Toxicity|3
721210|NCT00179309|2323812|P1|Treatment|Toxicity|2
721211|NCT00179413|2323822|P2|Overall Study|Withdrawal by Subject|95
721212|NCT00179413|2323823|P1|Overall Study|Withdrawal by Subject|87
721213|NCT00179413|2323822|P2|Overall Study|Adverse Event|20
721214|NCT00179413|2323823|P1|Overall Study|Adverse Event|38
721215|NCT00179517|2323849|P2|Overall Study|Withdrawal by Subject|1
721216|NCT00179517|2323850|P1|Overall Study|Withdrawal by Subject|2
721217|NCT00179621|2323875|P4|Open-Label Period|Unspecified|2
721218|NCT00179621|2323876|P3|Open-Label Period|Unspecified|1
721219|NCT00179621|2323877|P2|Open-Label Period|Unspecified|1
721220|NCT00179621|2323878|P1|Open-Label Period|Unspecified|0
721221|NCT00179621|2323875|P4|Open-Label Period|Death|2
721222|NCT00179621|2323876|P3|Open-Label Period|Death|1
721223|NCT00179621|2323877|P2|Open-Label Period|Death|0
721224|NCT00179621|2323878|P1|Open-Label Period|Death|0
721225|NCT00179621|2323875|P4|Open-Label Period|Withdrawal by Subject|2
721226|NCT00179621|2323876|P3|Open-Label Period|Withdrawal by Subject|2
721227|NCT00179621|2323877|P2|Open-Label Period|Withdrawal by Subject|2
721228|NCT00179621|2323878|P1|Open-Label Period|Withdrawal by Subject|0
721229|NCT00179621|2323875|P4|Open-Label Period|Adverse Event|6
721230|NCT00179621|2323876|P3|Open-Label Period|Adverse Event|5
721231|NCT00179621|2323877|P2|Open-Label Period|Adverse Event|6
721232|NCT00179621|2323878|P1|Open-Label Period|Adverse Event|0
721233|NCT00179621|2323875|P4|Open-Label Period|Lack of Therapeutic Effect|31
721234|NCT00179621|2323876|P3|Open-Label Period|Lack of Therapeutic Effect|19
721235|NCT00179621|2323877|P2|Open-Label Period|Lack of Therapeutic Effect|19
721236|NCT00179621|2323878|P1|Open-Label Period|Lack of Therapeutic Effect|0
721237|NCT00179621|2323875|P4|Double-Blind Period|Unspecified|0
721238|NCT00179621|2323876|P3|Double-Blind Period|Unspecified|2
721239|NCT00179621|2323877|P2|Double-Blind Period|Unspecified|2
721240|NCT00179621|2323878|P1|Double-Blind Period|Unspecified|0
721241|NCT00179621|2323875|P4|Double-Blind Period|Protocol Violation|0
721242|NCT00179621|2323876|P3|Double-Blind Period|Protocol Violation|0
721243|NCT00179621|2323877|P2|Double-Blind Period|Protocol Violation|0
721244|NCT00179621|2323878|P1|Double-Blind Period|Protocol Violation|1
721245|NCT00179621|2323875|P4|Double-Blind Period|Death|0
721246|NCT00179621|2323876|P3|Double-Blind Period|Death|2
721247|NCT00179621|2323877|P2|Double-Blind Period|Death|1
721248|NCT00179621|2323878|P1|Double-Blind Period|Death|0
721249|NCT00179621|2323875|P4|Double-Blind Period|Withdrawal by Subject|0
721250|NCT00179621|2323876|P3|Double-Blind Period|Withdrawal by Subject|3
721251|NCT00179621|2323877|P2|Double-Blind Period|Withdrawal by Subject|1
721252|NCT00179621|2323878|P1|Double-Blind Period|Withdrawal by Subject|2
721253|NCT00179621|2323875|P4|Double-Blind Period|Adverse Event|0
721254|NCT00179621|2323876|P3|Double-Blind Period|Adverse Event|4
721255|NCT00179621|2323877|P2|Double-Blind Period|Adverse Event|7
721256|NCT00179621|2323878|P1|Double-Blind Period|Adverse Event|2
721257|NCT00179621|2323875|P4|Double-Blind Period|Lack of Therapeutic Effect|0
721258|NCT00179621|2323876|P3|Double-Blind Period|Lack of Therapeutic Effect|19
721259|NCT00179621|2323877|P2|Double-Blind Period|Lack of Therapeutic Effect|35
721260|NCT00179621|2323878|P1|Double-Blind Period|Lack of Therapeutic Effect|59
721261|NCT00179647|2323929|P1|Overall Study|Not specified|960
721262|NCT00179647|2323929|P1|Overall Study|Death|94
721263|NCT00179647|2323929|P1|Overall Study|Lost to Follow-up|4
721264|NCT00179647|2323929|P1|Overall Study|Withdrawal by Subject|83
721265|NCT00179647|2323929|P1|Overall Study|Lack of Efficacy|478
721266|NCT00179647|2323929|P1|Overall Study|Adverse Event|294
721267|NCT00179660|2323933|P1|Overall Study|Other - Unspecified|9
721268|NCT00179660|2323933|P1|Overall Study|Death|3
721269|NCT00179660|2323933|P1|Overall Study|Lost to Follow-up|1
721270|NCT00179660|2323933|P1|Overall Study|Withdrawal by Subject|2
721271|NCT00179660|2323933|P1|Overall Study|Lack of therapeutic effect|28
721272|NCT00179660|2323933|P1|Overall Study|Adverse Event|7
721273|NCT00179673|2323942|P1|Overall Study|Other Observations and options|14
721274|NCT00179673|2323942|P1|Overall Study|Death|4
721275|NCT00179673|2323942|P1|Overall Study|Withdrawal by Subject|3
721276|NCT00179673|2323942|P1|Overall Study|Lack of Efficacy|15
721277|NCT00179673|2323942|P1|Overall Study|Adverse Event|7
721278|NCT00179959|2323952|P2|Overall Study|Withdrawal by Subject|2
721279|NCT00179959|2323953|P1|Overall Study|Withdrawal by Subject|3
721280|NCT00179959|2323952|P2|Overall Study|Lost to Follow-up|1
721281|NCT00179959|2323953|P1|Overall Study|Lost to Follow-up|3
721282|NCT00186485|2323965|P1|Overall Study|Lost to Follow-up|3
721283|NCT00186537|2323974|P3|Overall Study|ALT > 1.5 x ULN|0
721284|NCT00186537|2323975|P2|Overall Study|ALT > 1.5 x ULN|0
721285|NCT00186537|2323976|P1|Overall Study|ALT > 1.5 x ULN|3
721286|NCT00186537|2323974|P3|Overall Study|Withdrawal by Subject|3
721287|NCT00186537|2323975|P2|Overall Study|Withdrawal by Subject|0
721288|NCT00186537|2323976|P1|Overall Study|Withdrawal by Subject|4
721289|NCT00190671|2323992|P2|Overall Study|Withdrawal by Subject|2
721290|NCT00190671|2323993|P1|Overall Study|Withdrawal by Subject|0
721291|NCT00190671|2323992|P2|Overall Study|Protocol Violation|1
721292|NCT00190671|2323993|P1|Overall Study|Protocol Violation|0
721293|NCT00190671|2323992|P2|Overall Study|Death from Other Causes|2
721294|NCT00190671|2323993|P1|Overall Study|Death from Other Causes|0
721295|NCT00190671|2323992|P2|Overall Study|Death from Study-Drug Toxicity|2
721296|NCT00190671|2323993|P1|Overall Study|Death from Study-Drug Toxicity|0
721297|NCT00190671|2323992|P2|Overall Study|Clinical Relapse|1
721298|NCT00190671|2323993|P1|Overall Study|Clinical Relapse|0
721299|NCT00190671|2323992|P2|Overall Study|Adverse Event|2
721300|NCT00190671|2323993|P1|Overall Study|Adverse Event|3
721301|NCT00190671|2323992|P2|Overall Study|Death from Study Disease|1
721302|NCT00190671|2323993|P1|Overall Study|Death from Study Disease|1
721303|NCT00190671|2323992|P2|Overall Study|Lack of Efficacy|24
721304|NCT00190671|2323993|P1|Overall Study|Lack of Efficacy|19
721305|NCT00190671|2323992|P2|Overall Study|Satisfactory Response|7
721306|NCT00190671|2323993|P1|Overall Study|Satisfactory Response|4
721307|NCT00190684|2324011|P1|Overall Study|Study Period V Completed|1
721308|NCT00190684|2324011|P1|Overall Study|Study Period III Completed|103
721309|NCT00190684|2324011|P1|Overall Study|Protocol Violation|123
721310|NCT00190684|2324011|P1|Overall Study|Physician Decision|84
721311|NCT00190684|2324011|P1|Overall Study|Sponsor's decision|17
721312|NCT00190684|2324011|P1|Overall Study|Clinical relapse|67
721313|NCT00190684|2324011|P1|Overall Study|Patient Decision|432
721314|NCT00190684|2324011|P1|Overall Study|Patient moved|60
721315|NCT00190684|2324011|P1|Overall Study|Lost to Follow-up|232
721316|NCT00190684|2324011|P1|Overall Study|Lack of efficacy|204
721317|NCT00190684|2324011|P1|Overall Study|Satisfactory response|80
721318|NCT00190684|2324011|P1|Overall Study|Adverse Event|86
721319|NCT00190749|2324032|P2|Overall Study|Sponsor Decision|0
721320|NCT00190749|2324033|P1|Overall Study|Sponsor Decision|1
721321|NCT00190749|2324032|P2|Overall Study|Reason Not Specified|2
721322|NCT00190749|2324033|P1|Overall Study|Reason Not Specified|0
721323|NCT00190749|2324032|P2|Overall Study|Lack of Efficacy|3
721324|NCT00190749|2324033|P1|Overall Study|Lack of Efficacy|2
721325|NCT00190749|2324032|P2|Overall Study|Adverse Event|5
721326|NCT00190749|2324033|P1|Overall Study|Adverse Event|0
721327|NCT00190749|2324032|P2|Overall Study|Protocol Violation|4
721328|NCT00190749|2324033|P1|Overall Study|Protocol Violation|5
721329|NCT00190749|2324032|P2|Overall Study|Withdrawal by Subject|6
721330|NCT00190749|2324033|P1|Overall Study|Withdrawal by Subject|10
721331|NCT00190749|2324032|P2|Overall Study|Lost to Follow-up|11
721332|NCT00190749|2324033|P1|Overall Study|Lost to Follow-up|8
721333|NCT00190775|2324099|P2|Overall Study|Exclusion Criteria Met|3
721334|NCT00190775|2324100|P1|Overall Study|Exclusion Criteria Met|1
721335|NCT00190775|2324099|P2|Overall Study|Protocol Violation|1
721336|NCT00190775|2324100|P1|Overall Study|Protocol Violation|0
721337|NCT00190775|2324099|P2|Overall Study|Noncompliance|5
721338|NCT00190775|2324100|P1|Overall Study|Noncompliance|3
721339|NCT00190775|2324099|P2|Overall Study|Physician Decision|0
721340|NCT00190775|2324100|P1|Overall Study|Physician Decision|3
721341|NCT00190775|2324099|P2|Overall Study|Sponsor Decision|0
721342|NCT00190775|2324100|P1|Overall Study|Sponsor Decision|1
721343|NCT00190775|2324099|P2|Overall Study|Withdrawal by Subject|13
721344|NCT00190775|2324100|P1|Overall Study|Withdrawal by Subject|24
721345|NCT00190775|2324099|P2|Overall Study|Participant Moved|1
721346|NCT00190775|2324100|P1|Overall Study|Participant Moved|0
721347|NCT00190775|2324099|P2|Overall Study|Lost to Follow-up|23
721348|NCT00190775|2324100|P1|Overall Study|Lost to Follow-up|31
721349|NCT00190775|2324099|P2|Overall Study|Lack of Efficacy|32
721350|NCT00190775|2324100|P1|Overall Study|Lack of Efficacy|28
721351|NCT00190775|2324099|P2|Overall Study|Satisfactory Response|0
721352|NCT00190775|2324100|P1|Overall Study|Satisfactory Response|1
721353|NCT00190775|2324099|P2|Overall Study|Adverse Event|22
721354|NCT00190775|2324100|P1|Overall Study|Adverse Event|57
721355|NCT00190983|2324169|P1|Overall Study|Inevaluable (never treated)|2
721356|NCT00191100|2324178|P2|Overall Study|Reason Not Specified|1
721357|NCT00191100|2324179|P1|Overall Study|Reason Not Specified|0
721358|NCT00191100|2324178|P2|Overall Study|Death from Other Cause|0
721359|NCT00191100|2324179|P1|Overall Study|Death from Other Cause|1
721360|NCT00191100|2324178|P2|Overall Study|Protocol Violation|1
721361|NCT00191100|2324179|P1|Overall Study|Protocol Violation|1
721362|NCT00191100|2324178|P2|Overall Study|Death from Study Drug Toxicity|0
721363|NCT00191100|2324179|P1|Overall Study|Death from Study Drug Toxicity|2
721364|NCT00191100|2324178|P2|Overall Study|Physician Decision|1
721365|NCT00191100|2324179|P1|Overall Study|Physician Decision|3
721366|NCT00191100|2324178|P2|Overall Study|Lack of Efficacy, Stable Disease|0
721367|NCT00191100|2324179|P1|Overall Study|Lack of Efficacy, Stable Disease|1
721368|NCT00191100|2324178|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
721369|NCT00191100|2324179|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
721370|NCT00191100|2324178|P2|Overall Study|Clinical Relapse|1
721371|NCT00191100|2324179|P1|Overall Study|Clinical Relapse|2
721372|NCT00191100|2324178|P2|Overall Study|Protocol Entry Criteria Not Met|1
721373|NCT00191100|2324179|P1|Overall Study|Protocol Entry Criteria Not Met|2
721374|NCT00191100|2324178|P2|Overall Study|Withdrawal by Subject|3
721375|NCT00191100|2324179|P1|Overall Study|Withdrawal by Subject|9
721376|NCT00191100|2324178|P2|Overall Study|Patient Moved|1
721377|NCT00191100|2324179|P1|Overall Study|Patient Moved|0
721378|NCT00191100|2324178|P2|Overall Study|Lost to Follow-up|0
721379|NCT00191100|2324179|P1|Overall Study|Lost to Follow-up|2
721380|NCT00191100|2324178|P2|Overall Study|Adverse Event|1
721381|NCT00191100|2324179|P1|Overall Study|Adverse Event|18
721382|NCT00191113|2324197|P2|Core Study|Death|0
721383|NCT00191113|2324198|P1|Core Study|Death|1
721384|NCT00191113|2324197|P2|Core Study|Lack of Efficacy|2
721385|NCT00191113|2324198|P1|Core Study|Lack of Efficacy|0
721386|NCT00191113|2324197|P2|Core Study|Adverse Event|2
721387|NCT00191113|2324198|P1|Core Study|Adverse Event|0
721388|NCT00191113|2324197|P2|Core Study|Lost to Follow-up|0
721389|NCT00191113|2324198|P1|Core Study|Lost to Follow-up|3
721390|NCT00191113|2324197|P2|Core Study|Protocol Violation|2
721391|NCT00191113|2324198|P1|Core Study|Protocol Violation|6
721392|NCT00191113|2324197|P2|Core Study|Withdrawal by Subject|9
721393|NCT00191113|2324198|P1|Core Study|Withdrawal by Subject|25
721394|NCT00191139|2324240|P2|Overall Study|Other|2
721395|NCT00191139|2324241|P1|Overall Study|Other|1
721396|NCT00191139|2324240|P2|Overall Study|Disease Progression|1
721397|NCT00191139|2324241|P1|Overall Study|Disease Progression|0
721398|NCT00191139|2324240|P2|Overall Study|Withdrawal by Subject|3
721399|NCT00191139|2324241|P1|Overall Study|Withdrawal by Subject|0
721400|NCT00191139|2324240|P2|Overall Study|Death|0
721401|NCT00191139|2324241|P1|Overall Study|Death|2
721402|NCT00191139|2324240|P2|Overall Study|Adverse Event|6
721403|NCT00191139|2324241|P1|Overall Study|Adverse Event|2
721404|NCT00191152|2324257|P2|Crossover Treatment|Not Specified|3
721405|NCT00191152|2324258|P1|Crossover Treatment|Not Specified|4
721406|NCT00191152|2324257|P2|Crossover Treatment|Lost to Follow-up|1
721407|NCT00191152|2324258|P1|Crossover Treatment|Lost to Follow-up|2
721408|NCT00191152|2324257|P2|Crossover Treatment|Withdrawal by Subject|9
721409|NCT00191152|2324258|P1|Crossover Treatment|Withdrawal by Subject|6
721410|NCT00191152|2324257|P2|Crossover Treatment|Physician Decision|7
721411|NCT00191152|2324258|P1|Crossover Treatment|Physician Decision|7
721412|NCT00191152|2324257|P2|Crossover Treatment|Adverse Event|8
721413|NCT00191152|2324258|P1|Crossover Treatment|Adverse Event|8
721414|NCT00191152|2324257|P2|Initial Treatment|not specified|21
721415|NCT00191152|2324258|P1|Initial Treatment|not specified|18
721416|NCT00191152|2324257|P2|Initial Treatment|Lost to Follow-up|6
721417|NCT00191152|2324258|P1|Initial Treatment|Lost to Follow-up|0
721418|NCT00191152|2324257|P2|Initial Treatment|Withdrawal by Subject|28
721419|NCT00191152|2324258|P1|Initial Treatment|Withdrawal by Subject|40
721420|NCT00191152|2324257|P2|Initial Treatment|Physician Decision|31
721421|NCT00191152|2324258|P1|Initial Treatment|Physician Decision|40
721422|NCT00191152|2324257|P2|Initial Treatment|Adverse Event|67
721423|NCT00191152|2324258|P1|Initial Treatment|Adverse Event|43
721424|NCT00191165|2324290|P2|Overall Study|Participant Moved Away|1
721425|NCT00191165|2324291|P1|Overall Study|Participant Moved Away|0
721426|NCT00191165|2324290|P2|Overall Study|Protocol Violation|1
721427|NCT00191165|2324291|P1|Overall Study|Protocol Violation|0
721428|NCT00191165|2324290|P2|Overall Study|Adverse Event|0
721429|NCT00191165|2324291|P1|Overall Study|Adverse Event|2
721430|NCT00191191|2324303|P2|Overall Study|Good Clinical Practice Violation|1
721431|NCT00191191|2324304|P1|Overall Study|Good Clinical Practice Violation|0
721432|NCT00191191|2324303|P2|Overall Study|Physician Decision|2
721433|NCT00191191|2324304|P1|Overall Study|Physician Decision|3
721434|NCT00191191|2324303|P2|Overall Study|Lost to Follow-up|0
721435|NCT00191191|2324304|P1|Overall Study|Lost to Follow-up|1
721436|NCT00191191|2324303|P2|Overall Study|Family/Caregiver Decision|7
721437|NCT00191191|2324304|P1|Overall Study|Family/Caregiver Decision|5
721438|NCT00191191|2324303|P2|Overall Study|Toxicity After Dose Reduction|8
721439|NCT00191191|2324304|P1|Overall Study|Toxicity After Dose Reduction|7
721440|NCT00191191|2324303|P2|Overall Study|Progressive Disease|72
721441|NCT00191191|2324304|P1|Overall Study|Progressive Disease|84
721442|NCT00191191|2324303|P2|Overall Study|Adverse Event|21
721443|NCT00191191|2324304|P1|Overall Study|Adverse Event|11
721444|NCT00191191|2324303|P2|Overall Study|Treated with Another Systemic Agent|1
721445|NCT00191191|2324304|P1|Overall Study|Treated with Another Systemic Agent|1
721446|NCT00191191|2324303|P2|Overall Study|Entry Criteria Exclusion|0
721447|NCT00191191|2324304|P1|Overall Study|Entry Criteria Exclusion|2
721448|NCT00191269|2324320|P2|Overall Study|Physician Decision|3
721449|NCT00191269|2324321|P1|Overall Study|Physician Decision|0
721450|NCT00191269|2324320|P2|Overall Study|Pathologic Aggrevation|1
721451|NCT00191269|2324321|P1|Overall Study|Pathologic Aggrevation|0
721452|NCT00191269|2324320|P2|Overall Study|Withdrawal by Subject|1
721453|NCT00191269|2324321|P1|Overall Study|Withdrawal by Subject|0
721454|NCT00191269|2324320|P2|Overall Study|Lack of Efficacy|5
721455|NCT00191269|2324321|P1|Overall Study|Lack of Efficacy|1
721456|NCT00191269|2324320|P2|Overall Study|Progression of Disease|42
721457|NCT00191269|2324321|P1|Overall Study|Progression of Disease|4
721458|NCT00191269|2324320|P2|Overall Study|Adverse Event|4
721459|NCT00191269|2324321|P1|Overall Study|Adverse Event|1
721460|NCT00191269|2324320|P2|Overall Study|Protocol Violation|2
721461|NCT00191269|2324321|P1|Overall Study|Protocol Violation|0
721462|NCT00191282|2324337|P2|Overall Study|Lost to Follow-up|31
721463|NCT00191282|2324338|P1|Overall Study|Lost to Follow-up|24
721464|NCT00191282|2324337|P2|Overall Study|Sponsor's decision|2
721465|NCT00191282|2324338|P1|Overall Study|Sponsor's decision|2
721466|NCT00191282|2324337|P2|Overall Study|Severity of outcome|5
721467|NCT00191282|2324338|P1|Overall Study|Severity of outcome|2
721468|NCT00191282|2324337|P2|Overall Study|Protocol Violation|12
721469|NCT00191282|2324338|P1|Overall Study|Protocol Violation|9
721470|NCT00191282|2324337|P2|Overall Study|Protocol entry criteria not met|9
721471|NCT00191282|2324338|P1|Overall Study|Protocol entry criteria not met|14
721472|NCT00191282|2324337|P2|Overall Study|Physician Decision|15
721473|NCT00191282|2324338|P1|Overall Study|Physician Decision|18
721474|NCT00191282|2324337|P2|Overall Study|Withdrawal by Subject|44
721475|NCT00191282|2324338|P1|Overall Study|Withdrawal by Subject|59
721476|NCT00191282|2324337|P2|Overall Study|Patient moved|14
721477|NCT00191282|2324338|P1|Overall Study|Patient moved|11
721478|NCT00191282|2324337|P2|Overall Study|Noncompliance|17
721479|NCT00191282|2324338|P1|Overall Study|Noncompliance|14
721480|NCT00191282|2324337|P2|Overall Study|Lack of Efficacy|6
721481|NCT00191282|2324338|P1|Overall Study|Lack of Efficacy|11
721482|NCT00191282|2324337|P2|Overall Study|Death|51
721483|NCT00191282|2324338|P1|Overall Study|Death|51
721484|NCT00191282|2324337|P2|Overall Study|Adverse Event|6
721485|NCT00191282|2324338|P1|Overall Study|Adverse Event|5
721486|NCT00191308|2324396|P1|Overall Study|Adverse Event|1
721487|NCT00191334|2324404|P1|Overall Study|Withdrawal by Subject|4
721488|NCT00191334|2324404|P1|Overall Study|Physician Decision|1
721489|NCT00191334|2324404|P1|Overall Study|Disease Progression or Relapse|8
721490|NCT00191334|2324404|P1|Overall Study|Adverse Event|4
721491|NCT00191386|2324412|P1|Overall Study|Lack of Efficacy|15
721492|NCT00191386|2324412|P1|Overall Study|Physician Decision|11
721493|NCT00191386|2324412|P1|Overall Study|Withdrawal by Subject|96
721494|NCT00191386|2324412|P1|Overall Study|Protocol Violation|18
721495|NCT00191386|2324412|P1|Overall Study|Entry Criteria Exclusion|3
721496|NCT00191386|2324412|P1|Overall Study|Lost to Follow-up|1
721497|NCT00191386|2324412|P1|Overall Study|Adverse Event|16
721498|NCT00191451|2324422|P3|Overall Study|Reason Not Specified|3
721499|NCT00191451|2324423|P2|Overall Study|Reason Not Specified|1
721500|NCT00191451|2324424|P1|Overall Study|Reason Not Specified|2
721501|NCT00191451|2324422|P3|Overall Study|Ineligible|0
721502|NCT00191451|2324423|P2|Overall Study|Ineligible|1
721503|NCT00191451|2324424|P1|Overall Study|Ineligible|0
721504|NCT00191451|2324422|P3|Overall Study|Sponsor Decision|0
721505|NCT00191451|2324423|P2|Overall Study|Sponsor Decision|0
721506|NCT00191451|2324424|P1|Overall Study|Sponsor Decision|1
721507|NCT00191451|2324422|P3|Overall Study|Physician Decision|6
721508|NCT00191451|2324423|P2|Overall Study|Physician Decision|9
721509|NCT00191451|2324424|P1|Overall Study|Physician Decision|2
721510|NCT00191451|2324422|P3|Overall Study|Withdrawal by Subject|5
721511|NCT00191451|2324423|P2|Overall Study|Withdrawal by Subject|3
721512|NCT00191451|2324424|P1|Overall Study|Withdrawal by Subject|2
721513|NCT00191477|2324446|P2|Overall Study|Discontinued Prior to Instillation|14
721514|NCT00191477|2324447|P1|Overall Study|Discontinued Prior to Instillation|13
721515|NCT00191477|2324446|P2|Overall Study|Pathological Specimen Lost|0
721516|NCT00191477|2324447|P1|Overall Study|Pathological Specimen Lost|1
721517|NCT00191477|2324446|P2|Overall Study|Not Eligible|38
721518|NCT00191477|2324447|P1|Overall Study|Not Eligible|41
721519|NCT00191477|2324446|P2|Overall Study|Unspecified|0
721520|NCT00191477|2324447|P1|Overall Study|Unspecified|2
721521|NCT00191477|2324446|P2|Overall Study|Withdrawal by Subject|0
721522|NCT00191477|2324447|P1|Overall Study|Withdrawal by Subject|2
721523|NCT00191477|2324446|P2|Overall Study|Treatment Change|0
721524|NCT00191477|2324447|P1|Overall Study|Treatment Change|2
721525|NCT00191477|2324446|P2|Overall Study|Protocol Violation|1
721526|NCT00191477|2324447|P1|Overall Study|Protocol Violation|1
721527|NCT00191477|2324446|P2|Overall Study|Lost to Follow-up|21
721528|NCT00191477|2324447|P1|Overall Study|Lost to Follow-up|23
721529|NCT00191477|2324446|P2|Overall Study|Death, Other Cause|6
721530|NCT00191477|2324447|P1|Overall Study|Death, Other Cause|3
721531|NCT00191477|2324446|P2|Overall Study|Death, Study Disease|1
721532|NCT00191477|2324447|P1|Overall Study|Death, Study Disease|1
721533|NCT00191477|2324446|P2|Overall Study|Tumor Recurrence|48
721534|NCT00191477|2324447|P1|Overall Study|Tumor Recurrence|49
721535|NCT00191646|2324465|P2|Overall Study|Missing Data|11
721536|NCT00191646|2324466|P1|Overall Study|Missing Data|18
721537|NCT00191646|2324465|P2|Overall Study|Other|34
721538|NCT00191646|2324466|P1|Overall Study|Other|33
721539|NCT00191646|2324465|P2|Overall Study|Death|8
721540|NCT00191646|2324466|P1|Overall Study|Death|6
721541|NCT00191646|2324465|P2|Overall Study|Protocol Violation|7
721542|NCT00191646|2324466|P1|Overall Study|Protocol Violation|5
721543|NCT00191646|2324465|P2|Overall Study|Withdrawal by Subject|39
721544|NCT00191646|2324466|P1|Overall Study|Withdrawal by Subject|58
721545|NCT00191646|2324465|P2|Overall Study|Physician Decision|11
721546|NCT00191646|2324466|P1|Overall Study|Physician Decision|20
721547|NCT00191646|2324465|P2|Overall Study|Disease Progression|6
721548|NCT00191646|2324466|P1|Overall Study|Disease Progression|5
721549|NCT00191646|2324465|P2|Overall Study|Toxicity|37
721550|NCT00191646|2324466|P1|Overall Study|Toxicity|26
721551|NCT00191724|2324489|P5|Overall Study|Withdrawal by Subject|0
721552|NCT00191724|2324490|P4|Overall Study|Withdrawal by Subject|1
721553|NCT00191724|2324491|P3|Overall Study|Withdrawal by Subject|0
721554|NCT00191724|2324492|P2|Overall Study|Withdrawal by Subject|0
721555|NCT00191724|2324493|P1|Overall Study|Withdrawal by Subject|0
721556|NCT00191724|2324489|P5|Overall Study|Lost to Follow-up|3
721557|NCT00191724|2324490|P4|Overall Study|Lost to Follow-up|2
721558|NCT00191724|2324491|P3|Overall Study|Lost to Follow-up|0
721559|NCT00191724|2324492|P2|Overall Study|Lost to Follow-up|1
721560|NCT00191724|2324493|P1|Overall Study|Lost to Follow-up|1
721561|NCT00191724|2324489|P5|Overall Study|Adverse Event|0
721562|NCT00191724|2324490|P4|Overall Study|Adverse Event|0
721563|NCT00191724|2324491|P3|Overall Study|Adverse Event|1
721564|NCT00191724|2324492|P2|Overall Study|Adverse Event|0
721565|NCT00191724|2324493|P1|Overall Study|Adverse Event|0
721566|NCT00191789|2324520|P1|Overall Study|Death - Not Study-Drug Related|1
721567|NCT00191789|2324520|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
721568|NCT00191789|2324520|P1|Overall Study|Death - Possibly Study Drug Related|4
721569|NCT00191789|2324520|P1|Overall Study|Withdrawal by Subject|4
721570|NCT00191789|2324520|P1|Overall Study|Patient/Physician: Satisfactory Response|4
721571|NCT00191789|2324520|P1|Overall Study|Patient: Satisfactory Response|5
721572|NCT00191789|2324520|P1|Overall Study|Adverse Event|5
721573|NCT00191815|2324532|P1|Overall Study|Withdrawal by Subject|7
721574|NCT00191815|2324532|P1|Overall Study|Physician Decision|2
721575|NCT00191815|2324532|P1|Overall Study|Protocol Violation|3
721576|NCT00191815|2324532|P1|Overall Study|Death|2
721577|NCT00191815|2324532|P1|Overall Study|Disease progression or relapse|24
721578|NCT00191815|2324532|P1|Overall Study|Adverse Event|2
721579|NCT00191854|2324547|P3|Overall Study|Screen Failure|1
721580|NCT00191854|2324548|P2|Overall Study|Screen Failure|0
721581|NCT00191854|2324549|P1|Overall Study|Screen Failure|0
721582|NCT00191854|2324547|P3|Overall Study|Sponsor Decision|1
721583|NCT00191854|2324548|P2|Overall Study|Sponsor Decision|0
721584|NCT00191854|2324549|P1|Overall Study|Sponsor Decision|0
721585|NCT00191854|2324547|P3|Overall Study|Withdrawal by Subject|3
721586|NCT00191854|2324548|P2|Overall Study|Withdrawal by Subject|2
721587|NCT00191854|2324549|P1|Overall Study|Withdrawal by Subject|4
721588|NCT00191854|2324547|P3|Overall Study|Lost to Follow-up|5
721589|NCT00191854|2324548|P2|Overall Study|Lost to Follow-up|5
721590|NCT00191854|2324549|P1|Overall Study|Lost to Follow-up|7
721591|NCT00191854|2324547|P3|Overall Study|Death|29
721592|NCT00191854|2324548|P2|Overall Study|Death|23
721593|NCT00191854|2324549|P1|Overall Study|Death|26
721594|NCT00191906|2324573|P4|Study Period III|Lack of Efficacy|0
721595|NCT00191906|2324574|P3|Study Period III|Lack of Efficacy|0
721596|NCT00191906|2324575|P2|Study Period III|Lack of Efficacy|3
721597|NCT00191906|2324576|P1|Study Period III|Lack of Efficacy|3
721598|NCT00191906|2324573|P4|Study Period III|Parent/Caregiver Decision|0
721599|NCT00191906|2324574|P3|Study Period III|Parent/Caregiver Decision|0
721600|NCT00191906|2324575|P2|Study Period III|Parent/Caregiver Decision|0
721601|NCT00191906|2324576|P1|Study Period III|Parent/Caregiver Decision|1
721602|NCT00191906|2324573|P4|Study Period III|Lost to Follow-up|0
721603|NCT00191906|2324574|P3|Study Period III|Lost to Follow-up|0
721604|NCT00191906|2324575|P2|Study Period III|Lost to Follow-up|1
721605|NCT00191906|2324576|P1|Study Period III|Lost to Follow-up|0
721606|NCT00191906|2324573|P4|Study Period III|Adverse Event|0
721607|NCT00191906|2324574|P3|Study Period III|Adverse Event|0
721608|NCT00191906|2324575|P2|Study Period III|Adverse Event|0
721609|NCT00191906|2324576|P1|Study Period III|Adverse Event|1
721610|NCT00191906|2324573|P4|Study Period II|Entry Criteria Exclusion|0
721611|NCT00191906|2324574|P3|Study Period II|Entry Criteria Exclusion|1
721612|NCT00191906|2324575|P2|Study Period II|Entry Criteria Exclusion|0
721613|NCT00191906|2324576|P1|Study Period II|Entry Criteria Exclusion|0
721614|NCT00191906|2324573|P4|Study Period II|Parent/Caregiver Decision|0
721615|NCT00191906|2324574|P3|Study Period II|Parent/Caregiver Decision|0
721616|NCT00191906|2324575|P2|Study Period II|Parent/Caregiver Decision|1
721617|NCT00191906|2324576|P1|Study Period II|Parent/Caregiver Decision|0
721618|NCT00191906|2324573|P4|Study Period II|Withdrawal by Subject|0
721619|NCT00191906|2324574|P3|Study Period II|Withdrawal by Subject|0
721620|NCT00191906|2324575|P2|Study Period II|Withdrawal by Subject|3
721621|NCT00191906|2324576|P1|Study Period II|Withdrawal by Subject|0
721622|NCT00191906|2324573|P4|Study Period II|Adverse Event|0
721623|NCT00191906|2324574|P3|Study Period II|Adverse Event|0
721624|NCT00191906|2324575|P2|Study Period II|Adverse Event|1
721625|NCT00191906|2324576|P1|Study Period II|Adverse Event|0
721626|NCT00191945|2324618|P2|Double-Blind Acute Treatment|Physician Decision|2
721627|NCT00191945|2324619|P1|Double-Blind Acute Treatment|Physician Decision|0
721628|NCT00191945|2324618|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
721629|NCT00191945|2324619|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
721630|NCT00191945|2324618|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
721631|NCT00191945|2324619|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
721632|NCT00191945|2324618|P2|Double-Blind Acute Treatment|Parent's Decision|0
721633|NCT00191945|2324619|P1|Double-Blind Acute Treatment|Parent's Decision|3
721634|NCT00191984|2324651|P1|Overall Study|Physician Decision|4
721635|NCT00191984|2324651|P1|Overall Study|Withdrawal by Subject|7
721636|NCT00191984|2324651|P1|Overall Study|Entry Criteria Exclusion|1
721637|NCT00191984|2324651|P1|Overall Study|Death|2
721638|NCT00191984|2324651|P1|Overall Study|Adverse Event|4
721639|NCT00191984|2324651|P1|Overall Study|Disease Progression|21
721640|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Physician Decision|0
721641|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Physician Decision|9
721642|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
721643|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
721644|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Protocol Violation|0
721645|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Protocol Violation|1
721646|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
721647|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
721648|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
721649|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
721650|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
721651|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
721652|NCT00192023|2324661|P2|Period IV - Optional Open-Label|Adverse Event|0
721653|NCT00192023|2324662|P1|Period IV - Optional Open-Label|Adverse Event|6
721654|NCT00192023|2324661|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
721655|NCT00192023|2324662|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
721656|NCT00192023|2324661|P2|Period III - Double-Blind|Physician Decision|0
721657|NCT00192023|2324662|P1|Period III - Double-Blind|Physician Decision|2
721658|NCT00192023|2324661|P2|Period III - Double-Blind|Adverse Event|0
721659|NCT00192023|2324662|P1|Period III - Double-Blind|Adverse Event|3
721660|NCT00192036|2324684|P1|Overall Study|Unknown or Not Specified|5
721661|NCT00192036|2324684|P1|Overall Study|Death|1
721662|NCT00192036|2324684|P1|Overall Study|Clinical Disease Progression|1
721663|NCT00192036|2324684|P1|Overall Study|Objective Tumor Progression|4
721664|NCT00192036|2324684|P1|Overall Study|Patient/Physician Perception|1
721665|NCT00192036|2324684|P1|Overall Study|Adverse Event|6
721666|NCT00192036|2324684|P1|Overall Study|Protocol Violation|3
721667|NCT00192075|2324694|P2|Overall Study|Other|2
721668|NCT00192075|2324695|P1|Overall Study|Other|5
721669|NCT00192075|2324694|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
721670|NCT00192075|2324695|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
721671|NCT00192075|2324694|P2|Overall Study|Patient Non-Compliance|1
721672|NCT00192075|2324695|P1|Overall Study|Patient Non-Compliance|0
721673|NCT00192075|2324694|P2|Overall Study|Withdrawal by Subject|5
721674|NCT00192075|2324695|P1|Overall Study|Withdrawal by Subject|5
721675|NCT00192075|2324694|P2|Overall Study|Physician Decision|0
721676|NCT00192075|2324695|P1|Overall Study|Physician Decision|3
721677|NCT00192075|2324694|P2|Overall Study|Lack of Efficacy|0
721678|NCT00192075|2324695|P1|Overall Study|Lack of Efficacy|0
721679|NCT00192075|2324694|P2|Overall Study|Death|1
721680|NCT00192075|2324695|P1|Overall Study|Death|0
721681|NCT00192075|2324694|P2|Overall Study|Adverse Event|3
721682|NCT00192075|2324695|P1|Overall Study|Adverse Event|1
721683|NCT00192075|2324694|P2|Overall Study|Disease Progression|6
721684|NCT00192075|2324695|P1|Overall Study|Disease Progression|23
721685|NCT00183196|2324749|P3|Overall Study|Required more intensive care|2
721686|NCT00183196|2324750|P2|Overall Study|Required more intensive care|1
721687|NCT00183196|2324751|P1|Overall Study|Required more intensive care|0
721688|NCT00183196|2324749|P3|Overall Study|Legal event|1
721689|NCT00183196|2324750|P2|Overall Study|Legal event|1
721690|NCT00183196|2324751|P1|Overall Study|Legal event|1
721691|NCT00183196|2324749|P3|Overall Study|Adverse Event|2
721692|NCT00183196|2324750|P2|Overall Study|Adverse Event|2
721693|NCT00183196|2324751|P1|Overall Study|Adverse Event|1
721694|NCT00183196|2324749|P3|Overall Study|Withdrawal by Subject|13
721695|NCT00183196|2324750|P2|Overall Study|Withdrawal by Subject|11
721696|NCT00183196|2324751|P1|Overall Study|Withdrawal by Subject|18
721697|NCT00183248|2324761|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
721698|NCT00183248|2324762|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
721699|NCT00183248|2324761|P2|Overall Study|Lost to Follow-up|1
721700|NCT00183248|2324762|P1|Overall Study|Lost to Follow-up|0
721701|NCT00183274|2324780|P6|Phase 3: Double-Blind|Relapsed|2
721702|NCT00183274|2324781|P5|Phase 3: Double-Blind|Relapsed|11
721703|NCT00183274|2324782|P4|Phase 3: Double-Blind|Relapsed|1
721704|NCT00183274|2324783|P3|Phase 3: Double-Blind|Relapsed|0
721705|NCT00183274|2324784|P2|Phase 3: Double-Blind|Relapsed|0
721706|NCT00183274|2324785|P1|Phase 3: Double-Blind|Relapsed|0
721707|NCT00183274|2324780|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
721708|NCT00183274|2324781|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
721709|NCT00183274|2324782|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
721710|NCT00183274|2324783|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
721711|NCT00183274|2324784|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
721712|NCT00183274|2324785|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
721713|NCT00183274|2324780|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
721714|NCT00183274|2324781|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
721715|NCT00183274|2324782|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
721716|NCT00183274|2324783|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
721717|NCT00183274|2324784|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
721718|NCT00183274|2324785|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
721719|NCT00183274|2324780|P6|Phase 2: Double-Blind|Relapsed|0
721720|NCT00183274|2324781|P5|Phase 2: Double-Blind|Relapsed|0
721721|NCT00183274|2324782|P4|Phase 2: Double-Blind|Relapsed|0
721722|NCT00183274|2324783|P3|Phase 2: Double-Blind|Relapsed|29
721723|NCT00183274|2324784|P2|Phase 2: Double-Blind|Relapsed|8
721724|NCT00183274|2324785|P1|Phase 2: Double-Blind|Relapsed|0
721725|NCT00183274|2324780|P6|Phase 1: Open-Label|Other|0
721726|NCT00183274|2324781|P5|Phase 1: Open-Label|Other|0
721727|NCT00183274|2324782|P4|Phase 1: Open-Label|Other|0
721728|NCT00183274|2324783|P3|Phase 1: Open-Label|Other|0
721729|NCT00183274|2324784|P2|Phase 1: Open-Label|Other|0
721730|NCT00183274|2324785|P1|Phase 1: Open-Label|Other|9
721731|NCT00183274|2324780|P6|Phase 1: Open-Label|Lost to Follow-up|0
721732|NCT00183274|2324781|P5|Phase 1: Open-Label|Lost to Follow-up|0
721733|NCT00183274|2324782|P4|Phase 1: Open-Label|Lost to Follow-up|0
721734|NCT00183274|2324783|P3|Phase 1: Open-Label|Lost to Follow-up|0
721735|NCT00183274|2324784|P2|Phase 1: Open-Label|Lost to Follow-up|0
721736|NCT00183274|2324785|P1|Phase 1: Open-Label|Lost to Follow-up|33
721737|NCT00183274|2324780|P6|Phase 1: Open-Label|Withdrawal by Subject|0
721738|NCT00183274|2324781|P5|Phase 1: Open-Label|Withdrawal by Subject|0
721739|NCT00183274|2324782|P4|Phase 1: Open-Label|Withdrawal by Subject|0
721740|NCT00183274|2324783|P3|Phase 1: Open-Label|Withdrawal by Subject|0
721741|NCT00183274|2324784|P2|Phase 1: Open-Label|Withdrawal by Subject|0
721742|NCT00183274|2324785|P1|Phase 1: Open-Label|Withdrawal by Subject|13
721743|NCT00183274|2324780|P6|Phase 1: Open-Label|Protocol Violation|0
721744|NCT00183274|2324781|P5|Phase 1: Open-Label|Protocol Violation|0
721745|NCT00183274|2324782|P4|Phase 1: Open-Label|Protocol Violation|0
721746|NCT00183274|2324783|P3|Phase 1: Open-Label|Protocol Violation|0
721747|NCT00183274|2324784|P2|Phase 1: Open-Label|Protocol Violation|0
721748|NCT00183274|2324785|P1|Phase 1: Open-Label|Protocol Violation|11
721749|NCT00183274|2324780|P6|Phase 1: Open-Label|Lack of Efficacy|0
721750|NCT00183274|2324781|P5|Phase 1: Open-Label|Lack of Efficacy|0
721751|NCT00183274|2324782|P4|Phase 1: Open-Label|Lack of Efficacy|0
721752|NCT00183274|2324783|P3|Phase 1: Open-Label|Lack of Efficacy|0
721753|NCT00183274|2324784|P2|Phase 1: Open-Label|Lack of Efficacy|0
721754|NCT00183274|2324785|P1|Phase 1: Open-Label|Lack of Efficacy|13
721755|NCT00183274|2324780|P6|Phase 1: Open-Label|Adverse Event|0
721756|NCT00183274|2324781|P5|Phase 1: Open-Label|Adverse Event|0
721757|NCT00183274|2324782|P4|Phase 1: Open-Label|Adverse Event|0
721758|NCT00183274|2324783|P3|Phase 1: Open-Label|Adverse Event|0
721759|NCT00183274|2324784|P2|Phase 1: Open-Label|Adverse Event|0
721760|NCT00183274|2324785|P1|Phase 1: Open-Label|Adverse Event|31
721761|NCT00183430|2324817|P2|Overall Study|Withdrawal by Subject|0
721762|NCT00183430|2324818|P1|Overall Study|Withdrawal by Subject|1
721763|NCT00183430|2324817|P2|Overall Study|did not meet inclusion criteria|0
721764|NCT00183430|2324818|P1|Overall Study|did not meet inclusion criteria|1
721765|NCT00183430|2324817|P2|Overall Study|Lost to Follow-up|0
721766|NCT00183430|2324818|P1|Overall Study|Lost to Follow-up|3
721767|NCT00183430|2324817|P2|Overall Study|Adverse Event|0
721768|NCT00183430|2324818|P1|Overall Study|Adverse Event|1
721769|NCT00183625|2324892|P4|Overall Study|Withdrawal by Subject|14
721770|NCT00183625|2324893|P3|Overall Study|Withdrawal by Subject|19
721771|NCT00183625|2324894|P2|Overall Study|Withdrawal by Subject|18
721772|NCT00183625|2324895|P1|Overall Study|Withdrawal by Subject|18
721773|NCT00192296|2324925|P4|Overall Study|Withdrawal by Subject|0
721774|NCT00192296|2324926|P3|Overall Study|Withdrawal by Subject|0
721775|NCT00192296|2324927|P2|Overall Study|Withdrawal by Subject|1
721776|NCT00192296|2324928|P1|Overall Study|Withdrawal by Subject|0
721777|NCT00193050|2324993|P1|Adjuvant|Lack of Efficacy|2
721778|NCT00193050|2324993|P1|Adjuvant|Intercurrent Hospitalization|3
721779|NCT00193050|2324993|P1|Adjuvant|Physician Decision|5
721780|NCT00193050|2324993|P1|Neoadjuvant Treatment|Adverse Event|2
721781|NCT00193050|2324993|P1|Neoadjuvant Treatment|Physician Decision|2
721782|NCT00193050|2324993|P1|Neoadjuvant Treatment|Intercurrent Illness|3
721783|NCT00193050|2324993|P1|Neoadjuvant Treatment|Lack of Efficacy|2
721784|NCT00193063|2324997|P1|Overall Study|Adverse Event|1
721785|NCT00193063|2324997|P1|Overall Study|Lack of Efficacy|3
721786|NCT00193180|2325012|P1|Overall Study|Protocol Violation|1
721787|NCT00193180|2325012|P1|Overall Study|Adverse Event|8
721788|NCT00193180|2325012|P1|Overall Study|Lack of Efficacy|1
721789|NCT00193206|2325018|P1|Postoperative Therapy|Protocol Violation|1
721790|NCT00193206|2325018|P1|Postoperative Therapy|Lack of Efficacy|1
721791|NCT00193206|2325018|P1|Postoperative Therapy|Intercurrent Illness|2
721792|NCT00193206|2325018|P1|Postoperative Therapy|Physician Decision|3
721793|NCT00193206|2325018|P1|Postoperative Therapy|Withdrawal by Subject|7
721794|NCT00193206|2325018|P1|Preoperative Therapy|False Positive Pregnancy Test|1
721795|NCT00193206|2325018|P1|Preoperative Therapy|Withdrawal by Subject|2
721796|NCT00193206|2325018|P1|Preoperative Therapy|Adverse Event|2
721797|NCT00193206|2325018|P1|Preoperative Therapy|Lack of Efficacy|2
721798|NCT00193479|2325059|P1|Induction Chemotherapy|Disease Progression|1
721799|NCT00193479|2325059|P1|Induction Chemotherapy|Adverse Event|2
721800|NCT00193609|2325085|P1|Overall Study|Adverse Event|2
721801|NCT00193609|2325085|P1|Overall Study|Lack of Efficacy|2
721802|NCT00194012|2325092|P2|Open Label Extension (OLE)|Lack of Efficacy|0
721803|NCT00194012|2325093|P1|Open Label Extension (OLE)|Lack of Efficacy|1
721804|NCT00194012|2325092|P2|Open Label Extension (OLE)|Lost to Follow-up|5
721805|NCT00194012|2325093|P1|Open Label Extension (OLE)|Lost to Follow-up|3
721806|NCT00194012|2325092|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
721807|NCT00194012|2325093|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
721808|NCT00194012|2325092|P2|Open Label Extension (OLE)|Weight Gain|0
721809|NCT00194012|2325093|P1|Open Label Extension (OLE)|Weight Gain|1
721810|NCT00194012|2325092|P2|Randomized Phase|Oral/nasal twitching|1
721811|NCT00194012|2325093|P1|Randomized Phase|Oral/nasal twitching|0
721812|NCT00194012|2325092|P2|Randomized Phase|Emesis and enuresis|1
721813|NCT00194012|2325093|P1|Randomized Phase|Emesis and enuresis|0
721814|NCT00194012|2325092|P2|Randomized Phase|Participant reported having a rash|0
721815|NCT00194012|2325093|P1|Randomized Phase|Participant reported having a rash|1
721816|NCT00194012|2325092|P2|Randomized Phase|Adverse Event|1
721817|NCT00194012|2325093|P1|Randomized Phase|Adverse Event|2
721818|NCT00194012|2325092|P2|Randomized Phase|Withdrawal by Subject|3
721819|NCT00194012|2325093|P1|Randomized Phase|Withdrawal by Subject|3
721820|NCT00194012|2325092|P2|Randomized Phase|Study nonadherence|1
721821|NCT00194012|2325093|P1|Randomized Phase|Study nonadherence|2
721822|NCT00194012|2325092|P2|Randomized Phase|Lack of Efficacy|18
721823|NCT00194012|2325093|P1|Randomized Phase|Lack of Efficacy|8
721824|NCT00194025|2325129|P1|Overall Study|non-adherence with study medication|4
721825|NCT00194025|2325129|P1|Overall Study|Adverse Event|1
721826|NCT00194077|2325144|P2|Overall Study|Withdrawal by Subject|1
721827|NCT00194077|2325145|P1|Overall Study|Withdrawal by Subject|1
721828|NCT00194077|2325144|P2|Overall Study|Study nonadherence|0
721829|NCT00194077|2325145|P1|Overall Study|Study nonadherence|1
721830|NCT00194077|2325144|P2|Overall Study|Lack of Efficacy|29
721831|NCT00194077|2325145|P1|Overall Study|Lack of Efficacy|22
721842|NCT00194792|2325199|P1|Overall Study|Withdrawal by Subject|1
721843|NCT00187486|2325290|P1|Overall Study|Protocol Violation|1
721846|NCT00189202|2325370|P1|Overall Study|Physician Decision|5
721847|NCT00189306|2325379|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
721848|NCT00189306|2325379|P1|Long-Term Follow-up|Lost to Follow-up|9
721849|NCT00189306|2325379|P1|Long-Term Follow-up|Intercurrent disease|2
721850|NCT00189306|2325379|P1|Long-Term Follow-up|Withdrawal by Subject|1
721851|NCT00189306|2325379|P1|Long-Term Follow-up|Death|4
721852|NCT00189306|2325379|P1|Long-Term Follow-up|Adverse Event|2
721853|NCT00189306|2325379|P1|Posttreatment Period|Local skin reaction/sign|1
721854|NCT00189306|2325379|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
721855|NCT00189306|2325379|P1|Posttreatment Period|Protocol Violation|1
721856|NCT00189306|2325379|P1|Posttreatment Period|Target lesion excised|1
721857|NCT00189306|2325379|P1|Posttreatment Period|Noncompliance|1
721858|NCT00189306|2325379|P1|Posttreatment Period|Withdrawal by Subject|2
721859|NCT00189306|2325379|P1|Posttreatment Period|Death|1
721860|NCT00189306|2325379|P1|Treatment Period|Protocol Violation|1
721861|NCT00189306|2325379|P1|Treatment Period|Adverse Event|2
721862|NCT00189306|2325379|P1|Treatment Period|Withdrawal by Subject|2
721869|NCT00189462|2325418|P2|Overall Study|Lost to Follow-up|20
721870|NCT00189462|2325419|P1|Overall Study|Lost to Follow-up|18
721871|NCT00189462|2325418|P2|Overall Study|Lack of Efficacy|1
721872|NCT00189462|2325419|P1|Overall Study|Lack of Efficacy|5
721873|NCT00189488|2325436|P2|Overall Study|Other|0
721874|NCT00189488|2325437|P1|Overall Study|Other|1
721875|NCT00189488|2325436|P2|Overall Study|Death|8
721876|NCT00189488|2325437|P1|Overall Study|Death|5
721877|NCT00189488|2325436|P2|Overall Study|Administrative Decision|2
721878|NCT00189488|2325437|P1|Overall Study|Administrative Decision|0
721879|NCT00189488|2325436|P2|Overall Study|Disease progression|4
721880|NCT00189488|2325437|P1|Overall Study|Disease progression|2
721881|NCT00189488|2325436|P2|Overall Study|Withdrawal by Subject|6
721882|NCT00189488|2325437|P1|Overall Study|Withdrawal by Subject|2
721883|NCT00189488|2325436|P2|Overall Study|Adverse Event|1
721884|NCT00189488|2325437|P1|Overall Study|Adverse Event|2
721885|NCT00189488|2325436|P2|Overall Study|Protocol deviation|1
721886|NCT00189488|2325437|P1|Overall Study|Protocol deviation|2
721887|NCT00189488|2325436|P2|Overall Study|Ineligibility determined|0
721888|NCT00189488|2325437|P1|Overall Study|Ineligibility determined|1
721893|NCT00195260|2325478|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|3
721894|NCT00195260|2325479|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|4
721895|NCT00195260|2325480|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|6
721896|NCT00195260|2325481|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721897|NCT00195260|2325482|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721898|NCT00195260|2325483|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721899|NCT00195260|2325484|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721900|NCT00195260|2325485|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721901|NCT00195260|2325486|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721902|NCT00195260|2325487|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721903|NCT00195260|2325488|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
721904|NCT00195260|2325478|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
721905|NCT00195260|2325479|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
721906|NCT00195260|2325480|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
721907|NCT00195260|2325481|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721908|NCT00195260|2325482|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721909|NCT00195260|2325483|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721910|NCT00195260|2325484|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721911|NCT00195260|2325485|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721912|NCT00195260|2325486|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721913|NCT00195260|2325487|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721914|NCT00195260|2325488|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
721915|NCT00195260|2325478|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
721916|NCT00195260|2325479|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
721917|NCT00195260|2325480|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
721918|NCT00195260|2325481|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721919|NCT00195260|2325482|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721920|NCT00195260|2325483|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721921|NCT00195260|2325484|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721922|NCT00195260|2325485|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721923|NCT00195260|2325486|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721924|NCT00195260|2325487|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721925|NCT00195260|2325488|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
721926|NCT00195260|2325478|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
721927|NCT00195260|2325479|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
721928|NCT00195260|2325480|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
721929|NCT00195260|2325481|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721930|NCT00195260|2325482|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721931|NCT00195260|2325483|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721932|NCT00195260|2325484|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721933|NCT00195260|2325485|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721934|NCT00195260|2325486|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721935|NCT00195260|2325487|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721936|NCT00195260|2325488|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
721937|NCT00195260|2325478|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
721938|NCT00195260|2325479|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
721939|NCT00195260|2325480|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
721940|NCT00195260|2325481|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
721941|NCT00195260|2325482|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
721942|NCT00195260|2325483|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
721943|NCT00195260|2325484|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
721944|NCT00195260|2325485|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
721945|NCT00195260|2325486|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
721946|NCT00195260|2325487|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
721947|NCT00195260|2325488|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
721948|NCT00195260|2325478|P11|Part 1: Dose Escalation|Disease Progression|0
721949|NCT00195260|2325479|P10|Part 1: Dose Escalation|Disease Progression|0
721950|NCT00195260|2325480|P9|Part 1: Dose Escalation|Disease Progression|0
721951|NCT00195260|2325481|P8|Part 1: Dose Escalation|Disease Progression|4
721952|NCT00195260|2325482|P7|Part 1: Dose Escalation|Disease Progression|7
721953|NCT00195260|2325483|P6|Part 1: Dose Escalation|Disease Progression|6
721954|NCT00195260|2325484|P5|Part 1: Dose Escalation|Disease Progression|4
721955|NCT00195260|2325485|P4|Part 1: Dose Escalation|Disease Progression|6
721956|NCT00195260|2325486|P3|Part 1: Dose Escalation|Disease Progression|5
721957|NCT00195260|2325487|P2|Part 1: Dose Escalation|Disease Progression|2
721958|NCT00195260|2325488|P1|Part 1: Dose Escalation|Disease Progression|3
721959|NCT00195260|2325478|P11|Part 1: Dose Escalation|Death|0
721960|NCT00195260|2325479|P10|Part 1: Dose Escalation|Death|0
721961|NCT00195260|2325480|P9|Part 1: Dose Escalation|Death|0
721962|NCT00195260|2325481|P8|Part 1: Dose Escalation|Death|1
721963|NCT00195260|2325482|P7|Part 1: Dose Escalation|Death|0
721964|NCT00195260|2325483|P6|Part 1: Dose Escalation|Death|0
721965|NCT00195260|2325484|P5|Part 1: Dose Escalation|Death|0
721966|NCT00195260|2325485|P4|Part 1: Dose Escalation|Death|0
721967|NCT00195260|2325486|P3|Part 1: Dose Escalation|Death|0
721968|NCT00195260|2325487|P2|Part 1: Dose Escalation|Death|0
721969|NCT00195260|2325488|P1|Part 1: Dose Escalation|Death|0
721970|NCT00195260|2325478|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
721971|NCT00195260|2325479|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
721972|NCT00195260|2325480|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
721973|NCT00195260|2325481|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
721974|NCT00195260|2325482|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
721975|NCT00195260|2325483|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
721976|NCT00195260|2325484|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
721977|NCT00195260|2325485|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
721978|NCT00195260|2325486|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
721979|NCT00195260|2325487|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
721980|NCT00195260|2325488|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
721981|NCT00195260|2325478|P11|Part 1: Dose Escalation|Adverse Event|0
721982|NCT00195260|2325479|P10|Part 1: Dose Escalation|Adverse Event|0
721983|NCT00195260|2325480|P9|Part 1: Dose Escalation|Adverse Event|0
721984|NCT00195260|2325481|P8|Part 1: Dose Escalation|Adverse Event|0
721985|NCT00195260|2325482|P7|Part 1: Dose Escalation|Adverse Event|3
721986|NCT00195260|2325483|P6|Part 1: Dose Escalation|Adverse Event|0
721987|NCT00195260|2325484|P5|Part 1: Dose Escalation|Adverse Event|1
721988|NCT00195260|2325485|P4|Part 1: Dose Escalation|Adverse Event|1
721989|NCT00195260|2325486|P3|Part 1: Dose Escalation|Adverse Event|0
721990|NCT00195260|2325487|P2|Part 1: Dose Escalation|Adverse Event|1
721991|NCT00195260|2325488|P1|Part 1: Dose Escalation|Adverse Event|0
721992|NCT00195273|2325636|P2|Overall Study|Procedural complications|3
721993|NCT00195273|2325637|P1|Overall Study|Procedural complications|9
721994|NCT00195273|2325636|P2|Overall Study|Lack of Efficacy|1
721995|NCT00195273|2325637|P1|Overall Study|Lack of Efficacy|3
721996|NCT00195273|2325636|P2|Overall Study|Protocol deviation|1
721997|NCT00195273|2325637|P1|Overall Study|Protocol deviation|0
721998|NCT00195273|2325636|P2|Overall Study|Adverse Event|9
721999|NCT00195273|2325637|P1|Overall Study|Adverse Event|9
722000|NCT00195338|2325649|P1|Overall Study|Early closure of the site|4
722001|NCT00195338|2325649|P1|Overall Study|Lack of Efficacy|1
722002|NCT00195338|2325649|P1|Overall Study|Adverse Event|5
722003|NCT00195338|2325649|P1|Overall Study|Lost to Follow-up|2
722004|NCT00195351|2325659|P2|Overall Study|Lack of Efficacy|1
722005|NCT00195351|2325660|P1|Overall Study|Lack of Efficacy|0
722006|NCT00195351|2325659|P2|Overall Study|Death|1
722007|NCT00195351|2325660|P1|Overall Study|Death|3
722008|NCT00195351|2325659|P2|Overall Study|Protocol Deviation|2
722009|NCT00195351|2325660|P1|Overall Study|Protocol Deviation|3
722010|NCT00195351|2325659|P2|Overall Study|Withdrawal by Subject|3
722011|NCT00195351|2325660|P1|Overall Study|Withdrawal by Subject|6
722012|NCT00195351|2325659|P2|Overall Study|Lost to Follow-up|9
722013|NCT00195351|2325660|P1|Overall Study|Lost to Follow-up|9
722014|NCT00195429|2325678|P2|Overall Study|Lost to Follow-up|0
722015|NCT00195429|2325679|P1|Overall Study|Lost to Follow-up|1
722016|NCT00195429|2325678|P2|Overall Study|Lack of Efficacy|1
722017|NCT00195429|2325679|P1|Overall Study|Lack of Efficacy|2
722018|NCT00195429|2325678|P2|Overall Study|Adverse Event|4
722019|NCT00195429|2325679|P1|Overall Study|Adverse Event|2
722020|NCT00195442|2325687|P1|Overall Study|Other|14
722021|NCT00195442|2325687|P1|Overall Study|Poor cooperation|2
722022|NCT00195442|2325687|P1|Overall Study|No reason specified|4
722023|NCT00195442|2325687|P1|Overall Study|Death|7
722024|NCT00195442|2325687|P1|Overall Study|Intermittent product shortage|21
722025|NCT00195442|2325687|P1|Overall Study|Switch to other Factor VIII preparation|23
722026|NCT00195442|2325687|P1|Overall Study|Lost to Follow-up|27
722027|NCT00195442|2325687|P1|Overall Study|Less than expected therapeutic effect|38
722028|NCT00195494|2325706|P6|Year 2|System toxicity|0
722029|NCT00195494|2325707|P5|Year 2|System toxicity|0
722030|NCT00195494|2325708|P4|Year 2|System toxicity|1
722031|NCT00195494|2325709|P3|Year 2|System toxicity|0
722032|NCT00195494|2325710|P2|Year 2|System toxicity|0
722033|NCT00195494|2325711|P1|Year 2|System toxicity|0
722034|NCT00195494|2325706|P6|Year 2|Withdrawal by Subject|0
722035|NCT00195494|2325707|P5|Year 2|Withdrawal by Subject|0
722036|NCT00195494|2325708|P4|Year 2|Withdrawal by Subject|3
722037|NCT00195494|2325709|P3|Year 2|Withdrawal by Subject|4
722038|NCT00195494|2325710|P2|Year 2|Withdrawal by Subject|5
722039|NCT00195494|2325711|P1|Year 2|Withdrawal by Subject|1
722040|NCT00195494|2325706|P6|Year 2|Physician Decision|0
722041|NCT00195494|2325707|P5|Year 2|Physician Decision|0
722042|NCT00195494|2325708|P4|Year 2|Physician Decision|0
722043|NCT00195494|2325709|P3|Year 2|Physician Decision|0
722044|NCT00195494|2325710|P2|Year 2|Physician Decision|1
722045|NCT00195494|2325711|P1|Year 2|Physician Decision|1
722046|NCT00195494|2325706|P6|Year 2|Protocol deviation|0
722047|NCT00195494|2325707|P5|Year 2|Protocol deviation|0
722048|NCT00195494|2325708|P4|Year 2|Protocol deviation|0
722049|NCT00195494|2325709|P3|Year 2|Protocol deviation|0
722050|NCT00195494|2325710|P2|Year 2|Protocol deviation|1
722051|NCT00195494|2325711|P1|Year 2|Protocol deviation|0
722052|NCT00195494|2325706|P6|Year 2|Missed >4 consecutive doses|0
722053|NCT00195494|2325707|P5|Year 2|Missed >4 consecutive doses|0
722054|NCT00195494|2325708|P4|Year 2|Missed >4 consecutive doses|0
722055|NCT00195494|2325709|P3|Year 2|Missed >4 consecutive doses|1
722056|NCT00195494|2325710|P2|Year 2|Missed >4 consecutive doses|1
722057|NCT00195494|2325711|P1|Year 2|Missed >4 consecutive doses|1
722058|NCT00195494|2325706|P6|Year 2|Lost to Follow-up|0
722059|NCT00195494|2325707|P5|Year 2|Lost to Follow-up|0
722060|NCT00195494|2325708|P4|Year 2|Lost to Follow-up|1
722061|NCT00195494|2325709|P3|Year 2|Lost to Follow-up|1
722062|NCT00195494|2325710|P2|Year 2|Lost to Follow-up|0
722063|NCT00195494|2325711|P1|Year 2|Lost to Follow-up|0
722064|NCT00195494|2325706|P6|Year 2|Compliance|0
722065|NCT00195494|2325707|P5|Year 2|Compliance|0
722066|NCT00195494|2325708|P4|Year 2|Compliance|2
722067|NCT00195494|2325709|P3|Year 2|Compliance|0
722068|NCT00195494|2325710|P2|Year 2|Compliance|0
722069|NCT00195494|2325711|P1|Year 2|Compliance|1
722070|NCT00195494|2325706|P6|Year 2|Lack of Efficacy|0
722071|NCT00195494|2325707|P5|Year 2|Lack of Efficacy|0
722072|NCT00195494|2325708|P4|Year 2|Lack of Efficacy|7
722073|NCT00195494|2325709|P3|Year 2|Lack of Efficacy|7
722074|NCT00195494|2325710|P2|Year 2|Lack of Efficacy|1
722075|NCT00195494|2325711|P1|Year 2|Lack of Efficacy|0
722076|NCT00195494|2325706|P6|Year 2|Adverse Event|0
722077|NCT00195494|2325707|P5|Year 2|Adverse Event|0
722078|NCT00195494|2325708|P4|Year 2|Adverse Event|9
722079|NCT00195494|2325709|P3|Year 2|Adverse Event|5
722080|NCT00195494|2325710|P2|Year 2|Adverse Event|7
722081|NCT00195494|2325711|P1|Year 2|Adverse Event|3
722082|NCT00195494|2325706|P6|Year 1|Protocol Violation|1
722083|NCT00195494|2325707|P5|Year 1|Protocol Violation|1
722084|NCT00195494|2325708|P4|Year 1|Protocol Violation|0
722085|NCT00195494|2325709|P3|Year 1|Protocol Violation|0
722086|NCT00195494|2325710|P2|Year 1|Protocol Violation|0
722087|NCT00195494|2325711|P1|Year 1|Protocol Violation|0
722088|NCT00195494|2325706|P6|Year 1|Withdrawal by Subject|9
722089|NCT00195494|2325707|P5|Year 1|Withdrawal by Subject|8
722090|NCT00195494|2325708|P4|Year 1|Withdrawal by Subject|0
722091|NCT00195494|2325709|P3|Year 1|Withdrawal by Subject|0
722092|NCT00195494|2325710|P2|Year 1|Withdrawal by Subject|0
722093|NCT00195494|2325711|P1|Year 1|Withdrawal by Subject|0
722094|NCT00195494|2325706|P6|Year 1|Physician Decision|0
722095|NCT00195494|2325707|P5|Year 1|Physician Decision|1
722096|NCT00195494|2325708|P4|Year 1|Physician Decision|0
722097|NCT00195494|2325709|P3|Year 1|Physician Decision|0
722098|NCT00195494|2325710|P2|Year 1|Physician Decision|0
722099|NCT00195494|2325711|P1|Year 1|Physician Decision|0
722100|NCT00195494|2325706|P6|Year 1|Protocol deviation|3
722101|NCT00195494|2325707|P5|Year 1|Protocol deviation|2
722102|NCT00195494|2325708|P4|Year 1|Protocol deviation|0
722103|NCT00195494|2325709|P3|Year 1|Protocol deviation|0
722104|NCT00195494|2325710|P2|Year 1|Protocol deviation|0
722105|NCT00195494|2325711|P1|Year 1|Protocol deviation|0
722106|NCT00195494|2325706|P6|Year 1|Missed >4 consecutive doses|2
722107|NCT00195494|2325707|P5|Year 1|Missed >4 consecutive doses|3
722108|NCT00195494|2325708|P4|Year 1|Missed >4 consecutive doses|0
722109|NCT00195494|2325709|P3|Year 1|Missed >4 consecutive doses|0
722110|NCT00195494|2325710|P2|Year 1|Missed >4 consecutive doses|0
722111|NCT00195494|2325711|P1|Year 1|Missed >4 consecutive doses|0
722112|NCT00195494|2325706|P6|Year 1|Lost to Follow-up|0
722113|NCT00195494|2325707|P5|Year 1|Lost to Follow-up|1
722114|NCT00195494|2325708|P4|Year 1|Lost to Follow-up|0
722115|NCT00195494|2325709|P3|Year 1|Lost to Follow-up|0
722116|NCT00195494|2325710|P2|Year 1|Lost to Follow-up|0
722117|NCT00195494|2325711|P1|Year 1|Lost to Follow-up|0
722118|NCT00195494|2325706|P6|Year 1|Compliance|1
722119|NCT00195494|2325707|P5|Year 1|Compliance|5
722120|NCT00195494|2325708|P4|Year 1|Compliance|0
722121|NCT00195494|2325709|P3|Year 1|Compliance|0
722122|NCT00195494|2325710|P2|Year 1|Compliance|0
722123|NCT00195494|2325711|P1|Year 1|Compliance|0
722124|NCT00195494|2325706|P6|Year 1|Lack of Efficacy|9
722125|NCT00195494|2325707|P5|Year 1|Lack of Efficacy|24
722126|NCT00195494|2325708|P4|Year 1|Lack of Efficacy|0
722127|NCT00195494|2325709|P3|Year 1|Lack of Efficacy|0
722128|NCT00195494|2325710|P2|Year 1|Lack of Efficacy|0
722129|NCT00195494|2325711|P1|Year 1|Lack of Efficacy|0
722130|NCT00195494|2325706|P6|Year 1|System Toxicity|1
722131|NCT00195494|2325707|P5|Year 1|System Toxicity|0
722132|NCT00195494|2325708|P4|Year 1|System Toxicity|0
722133|NCT00195494|2325709|P3|Year 1|System Toxicity|0
722134|NCT00195494|2325710|P2|Year 1|System Toxicity|0
722135|NCT00195494|2325711|P1|Year 1|System Toxicity|0
722136|NCT00195494|2325706|P6|Year 1|Adverse Event|27
722137|NCT00195494|2325707|P5|Year 1|Adverse Event|34
722138|NCT00195494|2325708|P4|Year 1|Adverse Event|0
722139|NCT00195494|2325709|P3|Year 1|Adverse Event|0
722140|NCT00195494|2325710|P2|Year 1|Adverse Event|0
722141|NCT00195494|2325711|P1|Year 1|Adverse Event|0
722142|NCT00195507|2325731|P2|Overall Study|Protocol Deviation|3
722143|NCT00195507|2325732|P1|Overall Study|Protocol Deviation|6
722144|NCT00195507|2325731|P2|Overall Study|Withdrawal by Subject|23
722145|NCT00195507|2325732|P1|Overall Study|Withdrawal by Subject|16
722146|NCT00195507|2325731|P2|Overall Study|Lack of Efficacy|67
722147|NCT00195507|2325732|P1|Overall Study|Lack of Efficacy|40
722148|NCT00195507|2325731|P2|Overall Study|Protocol Violation|4
722149|NCT00195507|2325732|P1|Overall Study|Protocol Violation|5
722150|NCT00195507|2325731|P2|Overall Study|Lost to Follow-up|2
722151|NCT00195507|2325732|P1|Overall Study|Lost to Follow-up|3
722152|NCT00195507|2325731|P2|Overall Study|Physician Decision|2
722153|NCT00195507|2325732|P1|Overall Study|Physician Decision|1
722154|NCT00195507|2325731|P2|Overall Study|Failed to Return|3
722155|NCT00195507|2325732|P1|Overall Study|Failed to Return|4
722156|NCT00195507|2325731|P2|Overall Study|Death|1
722157|NCT00195507|2325732|P1|Overall Study|Death|0
722158|NCT00195507|2325731|P2|Overall Study|Adverse Event|13
722159|NCT00195507|2325732|P1|Overall Study|Adverse Event|24
722160|NCT00199381|2325744|P1|Overall Study|Study termination by Sponsor|323
722161|NCT00199381|2325744|P1|Overall Study|Not including due to early termination|37
722162|NCT00199381|2325744|P1|Overall Study|Lack of Efficacy|27
722163|NCT00199381|2325744|P1|Overall Study|Protocol Violation|6
722164|NCT00199381|2325744|P1|Overall Study|Adverse Event|73
722165|NCT00199381|2325744|P1|Overall Study|Withdrawal by Subject|38
722166|NCT00200057|2325757|P1|Overall Study|Death|1
722167|NCT00200057|2325757|P1|Overall Study|Infection|1
722168|NCT00200057|2325757|P1|Overall Study|Change in medical condition|1
722169|NCT00200057|2325757|P1|Overall Study|Withdrawal by Subject|1
722170|NCT00200057|2325757|P1|Overall Study|Exited due to terminal illness of PI|2
722171|NCT00200057|2325757|P1|Overall Study|Lack of Efficacy|3
722172|NCT00200356|2325797|P2|Overall Study|Nontreatment|0
722173|NCT00200356|2325798|P1|Overall Study|Nontreatment|1
722174|NCT00200356|2325797|P2|Overall Study|Protocol Violation|4
722175|NCT00200356|2325798|P1|Overall Study|Protocol Violation|4
722176|NCT00200356|2325797|P2|Overall Study|Lack of Efficacy|3
722177|NCT00200356|2325798|P1|Overall Study|Lack of Efficacy|3
722178|NCT00200967|2325835|P2|Run-out Period|Lost to Follow-up|0
722179|NCT00200967|2325836|P1|Run-out Period|Lost to Follow-up|1
722180|NCT00200967|2325835|P2|Second Treatment Period|Withdrawal by Subject|2
722181|NCT00200967|2325836|P1|Second Treatment Period|Withdrawal by Subject|1
722182|NCT00200967|2325835|P2|Wash-out Period|Lost to Follow-up|1
722183|NCT00200967|2325836|P1|Wash-out Period|Lost to Follow-up|0
722184|NCT00200967|2325835|P2|First Treatment Period|Pregnancy|0
722185|NCT00200967|2325836|P1|First Treatment Period|Pregnancy|1
722186|NCT00200967|2325835|P2|First Treatment Period|Withdrawal by Subject|1
722187|NCT00200967|2325836|P1|First Treatment Period|Withdrawal by Subject|5
722188|NCT00201006|2325867|P3|Overall Study|Adverse Event|1
722189|NCT00201006|2325868|P2|Overall Study|Adverse Event|0
722190|NCT00201006|2325869|P1|Overall Study|Adverse Event|1
722191|NCT00201006|2325867|P3|Overall Study|Withdrawal by Subject|3
722192|NCT00201006|2325868|P2|Overall Study|Withdrawal by Subject|2
722193|NCT00201006|2325869|P1|Overall Study|Withdrawal by Subject|7
722194|NCT00201201|2325898|P2|Overall Study|Withdrawal by Subject|5
722195|NCT00201201|2325899|P1|Overall Study|Withdrawal by Subject|5
722196|NCT00201201|2325898|P2|Overall Study|Death|2
722197|NCT00201201|2325899|P1|Overall Study|Death|0
722198|NCT00186888|2325964|P3|Overall Study|Relapse or progression of disease|0
722199|NCT00186888|2325965|P2|Overall Study|Relapse or progression of disease|2
722200|NCT00186888|2325966|P1|Overall Study|Relapse or progression of disease|4
722201|NCT00186888|2325964|P3|Overall Study|Toxicity|0
722202|NCT00186888|2325965|P2|Overall Study|Toxicity|1
722203|NCT00186888|2325966|P1|Overall Study|Toxicity|0
722204|NCT00186901|2326033|P3|Overall Study|Bone Mineral Density > 0|149
722205|NCT00186901|2326034|P2|Overall Study|Bone Mineral Density > 0|0
722206|NCT00186901|2326035|P1|Overall Study|Bone Mineral Density > 0|0
722207|NCT00186901|2326033|P3|Overall Study|Limited adherence to study requirements|0
722208|NCT00186901|2326034|P2|Overall Study|Limited adherence to study requirements|23
722209|NCT00186901|2326035|P1|Overall Study|Limited adherence to study requirements|20
722210|NCT00186901|2326033|P3|Overall Study|Open label|0
722211|NCT00186901|2326034|P2|Overall Study|Open label|2
722212|NCT00186901|2326035|P1|Overall Study|Open label|3
722213|NCT00186901|2326033|P3|Overall Study|Withdrawal by Subject|0
722214|NCT00186901|2326034|P2|Overall Study|Withdrawal by Subject|5
722215|NCT00186901|2326035|P1|Overall Study|Withdrawal by Subject|4
722216|NCT00186901|2326033|P3|Overall Study|ALL relapse or second malignancy|0
722217|NCT00186901|2326034|P2|Overall Study|ALL relapse or second malignancy|2
722218|NCT00186901|2326035|P1|Overall Study|ALL relapse or second malignancy|1
722219|NCT00186901|2326033|P3|Overall Study|Bone Mineral Density dropped > 5%|0
722220|NCT00186901|2326034|P2|Overall Study|Bone Mineral Density dropped > 5%|7
722221|NCT00186901|2326035|P1|Overall Study|Bone Mineral Density dropped > 5%|9
722222|NCT00186901|2326033|P3|Overall Study|Lost to Follow-up|0
722223|NCT00186901|2326034|P2|Overall Study|Lost to Follow-up|3
722224|NCT00186901|2326035|P1|Overall Study|Lost to Follow-up|6
722225|NCT00186901|2326033|P3|Overall Study|Pregnancy|0
722226|NCT00186901|2326034|P2|Overall Study|Pregnancy|3
722227|NCT00186901|2326035|P1|Overall Study|Pregnancy|6
722228|NCT00187096|2326075|P3|Overall Study|unacceptable toxicity|1
722229|NCT00187096|2326076|P2|Overall Study|unacceptable toxicity|0
722230|NCT00187096|2326077|P1|Overall Study|unacceptable toxicity|0
722231|NCT00187135|2326118|P6|Visit Three|Study Discontinued|6
722232|NCT00187135|2326119|P5|Visit Three|Study Discontinued|7
722233|NCT00187135|2326120|P4|Visit Three|Study Discontinued|7
722234|NCT00187135|2326121|P3|Visit Three|Study Discontinued|7
722235|NCT00187135|2326122|P2|Visit Three|Study Discontinued|6
722236|NCT00187135|2326123|P1|Visit Three|Study Discontinued|7
722237|NCT00187135|2326118|P6|Visit Three|Withdrawal by Subject|0
722238|NCT00187135|2326119|P5|Visit Three|Withdrawal by Subject|0
722239|NCT00187135|2326120|P4|Visit Three|Withdrawal by Subject|2
722240|NCT00187135|2326121|P3|Visit Three|Withdrawal by Subject|1
722241|NCT00187135|2326122|P2|Visit Three|Withdrawal by Subject|1
722242|NCT00187135|2326123|P1|Visit Three|Withdrawal by Subject|0
722243|NCT00187135|2326118|P6|Visit Three|Death|0
722244|NCT00187135|2326119|P5|Visit Three|Death|1
722245|NCT00187135|2326120|P4|Visit Three|Death|0
722246|NCT00187135|2326121|P3|Visit Three|Death|1
722247|NCT00187135|2326122|P2|Visit Three|Death|0
722248|NCT00187135|2326123|P1|Visit Three|Death|0
722249|NCT00187135|2326118|P6|Visit Two|Study Discontinued|6
722250|NCT00187135|2326119|P5|Visit Two|Study Discontinued|5
722251|NCT00187135|2326120|P4|Visit Two|Study Discontinued|7
722252|NCT00187135|2326121|P3|Visit Two|Study Discontinued|1
722253|NCT00187135|2326122|P2|Visit Two|Study Discontinued|2
722254|NCT00187135|2326123|P1|Visit Two|Study Discontinued|3
722255|NCT00187135|2326118|P6|Visit Two|Withdrawal by Subject|1
722256|NCT00187135|2326119|P5|Visit Two|Withdrawal by Subject|1
722257|NCT00187135|2326120|P4|Visit Two|Withdrawal by Subject|0
722258|NCT00187135|2326121|P3|Visit Two|Withdrawal by Subject|1
722259|NCT00187135|2326122|P2|Visit Two|Withdrawal by Subject|1
722260|NCT00187135|2326123|P1|Visit Two|Withdrawal by Subject|1
722261|NCT00187135|2326118|P6|Visit Two|Physician Decision|0
722262|NCT00187135|2326119|P5|Visit Two|Physician Decision|0
722263|NCT00187135|2326120|P4|Visit Two|Physician Decision|0
722264|NCT00187135|2326121|P3|Visit Two|Physician Decision|0
722265|NCT00187135|2326122|P2|Visit Two|Physician Decision|0
722266|NCT00187135|2326123|P1|Visit Two|Physician Decision|1
722267|NCT00187135|2326118|P6|Visit Two|Death|1
722268|NCT00187135|2326119|P5|Visit Two|Death|0
722269|NCT00187135|2326120|P4|Visit Two|Death|1
722270|NCT00187135|2326121|P3|Visit Two|Death|0
722271|NCT00187135|2326122|P2|Visit Two|Death|0
722272|NCT00187135|2326123|P1|Visit Two|Death|0
722273|NCT00187135|2326118|P6|Visit One|Physician Decision|1
722274|NCT00187135|2326119|P5|Visit One|Physician Decision|0
722275|NCT00187135|2326120|P4|Visit One|Physician Decision|0
722276|NCT00187135|2326121|P3|Visit One|Physician Decision|0
722277|NCT00187135|2326122|P2|Visit One|Physician Decision|1
722278|NCT00187135|2326123|P1|Visit One|Physician Decision|3
722279|NCT00187135|2326118|P6|Visit One|Withdrawal by Subject|1
722280|NCT00187135|2326119|P5|Visit One|Withdrawal by Subject|0
722281|NCT00187135|2326120|P4|Visit One|Withdrawal by Subject|0
722282|NCT00187135|2326121|P3|Visit One|Withdrawal by Subject|0
722283|NCT00187135|2326122|P2|Visit One|Withdrawal by Subject|0
722284|NCT00187135|2326123|P1|Visit One|Withdrawal by Subject|1
722285|NCT00192647|2326145|P2|Overall Study|Other/Administrative|3
722286|NCT00192647|2326146|P1|Overall Study|Other/Administrative|5
722287|NCT00192647|2326145|P2|Overall Study|Failure to Return|13
722288|NCT00192647|2326146|P1|Overall Study|Failure to Return|11
722289|NCT00192647|2326145|P2|Overall Study|Refused Treatment/Did not Cooperate|8
722290|NCT00192647|2326146|P1|Overall Study|Refused Treatment/Did not Cooperate|10
722291|NCT00192647|2326145|P2|Overall Study|Protocol Violation|1
722292|NCT00192647|2326146|P1|Overall Study|Protocol Violation|3
722293|NCT00192647|2326145|P2|Overall Study|Entry Criteria Violation|6
722294|NCT00192647|2326146|P1|Overall Study|Entry Criteria Violation|6
722295|NCT00192647|2326145|P2|Overall Study|Insufficient Therapeutic Response|83
722296|NCT00192647|2326146|P1|Overall Study|Insufficient Therapeutic Response|53
722297|NCT00192647|2326145|P2|Overall Study|Laboratory Test Abnormality|2
722298|NCT00192647|2326146|P1|Overall Study|Laboratory Test Abnormality|4
722299|NCT00192647|2326145|P2|Overall Study|Adverse Event|29
722300|NCT00192647|2326146|P1|Overall Study|Adverse Event|35
722301|NCT00192647|2326145|P2|Overall Study|Death|1
722302|NCT00192647|2326146|P1|Overall Study|Death|1
722303|NCT00201643|2326175|P2|Overall Study|Withdrawal by Subject|4
722304|NCT00201643|2326176|P1|Overall Study|Withdrawal by Subject|5
722305|NCT00203047|2326225|P2|Overall Study|Not specified|5
722306|NCT00203047|2326226|P1|Overall Study|Not specified|5
722307|NCT00203047|2326225|P2|Overall Study|Pregnancy|0
722308|NCT00203047|2326226|P1|Overall Study|Pregnancy|3
722309|NCT00203047|2326225|P2|Overall Study|Death|2
722310|NCT00203047|2326226|P1|Overall Study|Death|1
722311|NCT00203047|2326225|P2|Overall Study|Adverse Event|18
722312|NCT00203047|2326226|P1|Overall Study|Adverse Event|8
722313|NCT00203047|2326225|P2|Overall Study|Lost to Follow-up|5
722314|NCT00203047|2326226|P1|Overall Study|Lost to Follow-up|11
722315|NCT00203047|2326225|P2|Overall Study|Protocol Violation|0
722316|NCT00203047|2326226|P1|Overall Study|Protocol Violation|1
722317|NCT00203047|2326225|P2|Overall Study|Non-compliance|8
722318|NCT00203047|2326226|P1|Overall Study|Non-compliance|4
722319|NCT00203047|2326225|P2|Overall Study|Physician Decision|7
722320|NCT00203047|2326226|P1|Overall Study|Physician Decision|8
722321|NCT00203047|2326225|P2|Overall Study|Teva requested participant withdrawal|1
722322|NCT00203047|2326226|P1|Overall Study|Teva requested participant withdrawal|1
722323|NCT00203047|2326225|P2|Overall Study|Withdrawal by Subject|47
722324|NCT00203047|2326226|P1|Overall Study|Withdrawal by Subject|13
722325|NCT00203047|2326225|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
722326|NCT00203047|2326226|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
722327|NCT00203047|2326225|P2|Overall Study|Ongoing: in database - January 29, 2009|109
722328|NCT00203047|2326226|P1|Overall Study|Ongoing: in database - January 29, 2009|131
722329|NCT00203242|2326284|P1|Overall Study|Lost to Follow-up|1
722330|NCT00203268|2326288|P1|Early Treatment|Withdrawal by Subject|1
722331|NCT00203268|2326288|P1|Early Treatment|Lost to Follow-up|1
722332|NCT00203268|2326288|P1|Early Treatment|only treated one headache|2
722333|NCT00203294|2326296|P2|Overall Study|Withdrawal by Subject|13
722334|NCT00203294|2326297|P1|Overall Study|Withdrawal by Subject|8
722335|NCT00203307|2326305|P2|First Intervention|Adverse Event|0
722336|NCT00203307|2326306|P1|First Intervention|Adverse Event|2
722337|NCT00203411|2326312|P1|Follow-up|Progressive Disease|4
722338|NCT00203424|2326319|P1|Follow-up Period|Lost to Follow-up|1
722339|NCT00203424|2326319|P1|Follow-up Period|progressive disease|4
722340|NCT00203424|2326319|P1|Follow-up Period|Withdrawal by Subject|1
722341|NCT00203424|2326319|P1|Treatment Period|progressive disease|2
722342|NCT00203424|2326319|P1|Treatment Period|Adverse Event|5
722343|NCT00203424|2326319|P1|Treatment Period|Withdrawal by Subject|4
722344|NCT00203476|2326329|P3|Overall Study|Withdrawal by Subject|0
722345|NCT00203476|2326330|P2|Overall Study|Withdrawal by Subject|1
722346|NCT00203476|2326331|P1|Overall Study|Withdrawal by Subject|0
722347|NCT00203476|2326329|P3|Overall Study|Lost to Follow-up|0
722348|NCT00203476|2326330|P2|Overall Study|Lost to Follow-up|0
722349|NCT00203476|2326331|P1|Overall Study|Lost to Follow-up|1
722350|NCT00203502|2326348|P1|Overall Study|Death|1
722351|NCT00203892|2326359|P3|Overall Study|Death|0
722352|NCT00203892|2326360|P2|Overall Study|Death|0
722353|NCT00203892|2326361|P1|Overall Study|Death|1
722354|NCT00203892|2326359|P3|Overall Study|Physician Decision|0
722355|NCT00203892|2326360|P2|Overall Study|Physician Decision|2
722356|NCT00203892|2326361|P1|Overall Study|Physician Decision|1
722357|NCT00203996|2326395|P10|Overall Study|Scheduling issue|0
722358|NCT00203996|2326396|P9|Overall Study|Scheduling issue|0
722359|NCT00203996|2326397|P8|Overall Study|Scheduling issue|2
722360|NCT00203996|2326398|P7|Overall Study|Scheduling issue|0
722361|NCT00203996|2326399|P6|Overall Study|Scheduling issue|0
722362|NCT00203996|2326400|P5|Overall Study|Scheduling issue|0
722363|NCT00203996|2326401|P4|Overall Study|Scheduling issue|0
722364|NCT00203996|2326402|P3|Overall Study|Scheduling issue|0
722365|NCT00203996|2326403|P2|Overall Study|Scheduling issue|0
722366|NCT00203996|2326404|P1|Overall Study|Scheduling issue|0
722367|NCT00203996|2326395|P10|Overall Study|CPAP machine malfunction|0
722368|NCT00203996|2326396|P9|Overall Study|CPAP machine malfunction|0
722369|NCT00203996|2326397|P8|Overall Study|CPAP machine malfunction|0
722370|NCT00203996|2326398|P7|Overall Study|CPAP machine malfunction|0
722371|NCT00203996|2326399|P6|Overall Study|CPAP machine malfunction|0
722372|NCT00203996|2326400|P5|Overall Study|CPAP machine malfunction|0
722373|NCT00203996|2326401|P4|Overall Study|CPAP machine malfunction|1
722374|NCT00203996|2326402|P3|Overall Study|CPAP machine malfunction|0
722375|NCT00203996|2326403|P2|Overall Study|CPAP machine malfunction|0
722376|NCT00203996|2326404|P1|Overall Study|CPAP machine malfunction|0
722377|NCT00203996|2326395|P10|Overall Study|Physician Decision|1
722378|NCT00203996|2326396|P9|Overall Study|Physician Decision|0
722379|NCT00203996|2326397|P8|Overall Study|Physician Decision|0
722380|NCT00203996|2326398|P7|Overall Study|Physician Decision|0
722381|NCT00203996|2326399|P6|Overall Study|Physician Decision|0
722382|NCT00203996|2326400|P5|Overall Study|Physician Decision|0
722383|NCT00203996|2326401|P4|Overall Study|Physician Decision|2
722384|NCT00203996|2326402|P3|Overall Study|Physician Decision|0
722385|NCT00203996|2326403|P2|Overall Study|Physician Decision|0
722386|NCT00203996|2326404|P1|Overall Study|Physician Decision|0
722387|NCT00203996|2326395|P10|Overall Study|Protocol Violation|0
722388|NCT00203996|2326396|P9|Overall Study|Protocol Violation|0
722389|NCT00203996|2326397|P8|Overall Study|Protocol Violation|0
722390|NCT00203996|2326398|P7|Overall Study|Protocol Violation|0
722391|NCT00203996|2326399|P6|Overall Study|Protocol Violation|0
722392|NCT00203996|2326400|P5|Overall Study|Protocol Violation|1
722393|NCT00203996|2326401|P4|Overall Study|Protocol Violation|6
722394|NCT00203996|2326402|P3|Overall Study|Protocol Violation|0
722395|NCT00203996|2326403|P2|Overall Study|Protocol Violation|0
722396|NCT00203996|2326404|P1|Overall Study|Protocol Violation|0
722397|NCT00203996|2326395|P10|Overall Study|Lost to Follow-up|0
722398|NCT00203996|2326396|P9|Overall Study|Lost to Follow-up|0
722399|NCT00203996|2326397|P8|Overall Study|Lost to Follow-up|0
722400|NCT00203996|2326398|P7|Overall Study|Lost to Follow-up|0
722401|NCT00203996|2326399|P6|Overall Study|Lost to Follow-up|0
722402|NCT00203996|2326400|P5|Overall Study|Lost to Follow-up|0
722403|NCT00203996|2326401|P4|Overall Study|Lost to Follow-up|1
722404|NCT00203996|2326402|P3|Overall Study|Lost to Follow-up|0
722405|NCT00203996|2326403|P2|Overall Study|Lost to Follow-up|0
722406|NCT00203996|2326404|P1|Overall Study|Lost to Follow-up|0
722407|NCT00196326|2326485|P1|Overall Study|Not specified|22
722408|NCT00196326|2326485|P1|Overall Study|Lost to Follow-up|304
722409|NCT00196326|2326485|P1|Overall Study|Pregnancy|34
722410|NCT00196326|2326485|P1|Overall Study|Adverse Event|253
722411|NCT00196326|2326485|P1|Overall Study|Withdrawal by Subject|225
722412|NCT00196326|2326485|P1|Overall Study|Physician Decision|3
722413|NCT00196326|2326485|P1|Overall Study|Non-compliance with the protocol|81
722414|NCT00196326|2326485|P1|Overall Study|Did not meet protocol requirements|64
722415|NCT00196937|2326504|P3|Overall Study|Withdrawal by Subject|3
722416|NCT00196937|2326505|P2|Overall Study|Withdrawal by Subject|0
722417|NCT00196937|2326506|P1|Overall Study|Withdrawal by Subject|0
722418|NCT00196937|2326504|P3|Overall Study|Lost to Follow-up|3
722419|NCT00196937|2326505|P2|Overall Study|Lost to Follow-up|3
722420|NCT00196937|2326506|P1|Overall Study|Lost to Follow-up|4
722421|NCT00196937|2326504|P3|Overall Study|Subject did not come due to holidays|0
722422|NCT00196937|2326505|P2|Overall Study|Subject did not come due to holidays|1
722423|NCT00196937|2326506|P1|Overall Study|Subject did not come due to holidays|3
722424|NCT00196937|2326504|P3|Overall Study|Adverse Event|1
722425|NCT00196937|2326505|P2|Overall Study|Adverse Event|1
722426|NCT00196937|2326506|P1|Overall Study|Adverse Event|2
722427|NCT00196976|2326558|P14|Booster Study|Lost to Follow-up|0
722428|NCT00196976|2326559|P13|Booster Study|Lost to Follow-up|0
722429|NCT00196976|2326560|P12|Booster Study|Lost to Follow-up|2
722430|NCT00196976|2326561|P11|Booster Study|Lost to Follow-up|1
722431|NCT00196976|2326562|P10|Booster Study|Lost to Follow-up|0
722432|NCT00196976|2326563|P9|Booster Study|Lost to Follow-up|0
722433|NCT00196976|2326564|P8|Booster Study|Lost to Follow-up|0
722434|NCT00196976|2326565|P7|Booster Study|Lost to Follow-up|0
722435|NCT00196976|2326566|P6|Booster Study|Lost to Follow-up|0
722436|NCT00196976|2326567|P5|Booster Study|Lost to Follow-up|0
722437|NCT00196976|2326568|P4|Booster Study|Lost to Follow-up|0
722438|NCT00196976|2326569|P3|Booster Study|Lost to Follow-up|0
722439|NCT00196976|2326570|P2|Booster Study|Lost to Follow-up|0
722440|NCT00196976|2326571|P1|Booster Study|Lost to Follow-up|0
722441|NCT00196976|2326558|P14|Booster Study|Withdrawal by Subject|0
722442|NCT00196976|2326559|P13|Booster Study|Withdrawal by Subject|0
722443|NCT00196976|2326560|P12|Booster Study|Withdrawal by Subject|0
722444|NCT00196976|2326561|P11|Booster Study|Withdrawal by Subject|1
722445|NCT00196976|2326562|P10|Booster Study|Withdrawal by Subject|0
722446|NCT00196976|2326563|P9|Booster Study|Withdrawal by Subject|0
722447|NCT00196976|2326564|P8|Booster Study|Withdrawal by Subject|0
722448|NCT00196976|2326565|P7|Booster Study|Withdrawal by Subject|0
722449|NCT00196976|2326566|P6|Booster Study|Withdrawal by Subject|0
722450|NCT00196976|2326567|P5|Booster Study|Withdrawal by Subject|0
722451|NCT00196976|2326568|P4|Booster Study|Withdrawal by Subject|0
722452|NCT00196976|2326569|P3|Booster Study|Withdrawal by Subject|0
722453|NCT00196976|2326570|P2|Booster Study|Withdrawal by Subject|0
722454|NCT00196976|2326571|P1|Booster Study|Withdrawal by Subject|0
722455|NCT00196976|2326558|P14|Primary Study|Unspecified|0
722456|NCT00196976|2326559|P13|Primary Study|Unspecified|0
722457|NCT00196976|2326560|P12|Primary Study|Unspecified|0
722458|NCT00196976|2326561|P11|Primary Study|Unspecified|0
722459|NCT00196976|2326562|P10|Primary Study|Unspecified|0
722460|NCT00196976|2326563|P9|Primary Study|Unspecified|0
722461|NCT00196976|2326564|P8|Primary Study|Unspecified|0
722462|NCT00196976|2326565|P7|Primary Study|Unspecified|0
722463|NCT00196976|2326566|P6|Primary Study|Unspecified|0
722464|NCT00196976|2326567|P5|Primary Study|Unspecified|0
722465|NCT00196976|2326568|P4|Primary Study|Unspecified|0
722466|NCT00196976|2326569|P3|Primary Study|Unspecified|2
722467|NCT00196976|2326570|P2|Primary Study|Unspecified|0
722468|NCT00196976|2326571|P1|Primary Study|Unspecified|0
722469|NCT00196976|2326558|P14|Primary Study|Lost to Follow-up|0
722470|NCT00196976|2326559|P13|Primary Study|Lost to Follow-up|0
722471|NCT00196976|2326560|P12|Primary Study|Lost to Follow-up|0
722472|NCT00196976|2326561|P11|Primary Study|Lost to Follow-up|0
722473|NCT00196976|2326562|P10|Primary Study|Lost to Follow-up|0
722474|NCT00196976|2326563|P9|Primary Study|Lost to Follow-up|0
722475|NCT00196976|2326564|P8|Primary Study|Lost to Follow-up|2
722476|NCT00196976|2326565|P7|Primary Study|Lost to Follow-up|0
722477|NCT00196976|2326566|P6|Primary Study|Lost to Follow-up|1
722478|NCT00196976|2326567|P5|Primary Study|Lost to Follow-up|1
722479|NCT00196976|2326568|P4|Primary Study|Lost to Follow-up|0
722480|NCT00196976|2326569|P3|Primary Study|Lost to Follow-up|0
722481|NCT00196976|2326570|P2|Primary Study|Lost to Follow-up|0
722482|NCT00196976|2326571|P1|Primary Study|Lost to Follow-up|0
722483|NCT00196976|2326558|P14|Primary Study|Withdrawal by Subject|0
722484|NCT00196976|2326559|P13|Primary Study|Withdrawal by Subject|0
722485|NCT00196976|2326560|P12|Primary Study|Withdrawal by Subject|0
722486|NCT00196976|2326561|P11|Primary Study|Withdrawal by Subject|0
722487|NCT00196976|2326562|P10|Primary Study|Withdrawal by Subject|1
722488|NCT00196976|2326563|P9|Primary Study|Withdrawal by Subject|0
722489|NCT00196976|2326564|P8|Primary Study|Withdrawal by Subject|0
722490|NCT00196976|2326565|P7|Primary Study|Withdrawal by Subject|0
722491|NCT00196976|2326566|P6|Primary Study|Withdrawal by Subject|1
722492|NCT00196976|2326567|P5|Primary Study|Withdrawal by Subject|2
722493|NCT00196976|2326568|P4|Primary Study|Withdrawal by Subject|1
722494|NCT00196976|2326569|P3|Primary Study|Withdrawal by Subject|1
722495|NCT00196976|2326570|P2|Primary Study|Withdrawal by Subject|0
722496|NCT00196976|2326571|P1|Primary Study|Withdrawal by Subject|1
722497|NCT00196976|2326558|P14|Primary Study|Protocol Violation|0
722498|NCT00196976|2326559|P13|Primary Study|Protocol Violation|0
722499|NCT00196976|2326560|P12|Primary Study|Protocol Violation|0
722500|NCT00196976|2326561|P11|Primary Study|Protocol Violation|0
722501|NCT00196976|2326562|P10|Primary Study|Protocol Violation|0
722502|NCT00196976|2326563|P9|Primary Study|Protocol Violation|0
722503|NCT00196976|2326564|P8|Primary Study|Protocol Violation|0
722504|NCT00196976|2326565|P7|Primary Study|Protocol Violation|0
722505|NCT00196976|2326566|P6|Primary Study|Protocol Violation|0
722506|NCT00196976|2326567|P5|Primary Study|Protocol Violation|0
722507|NCT00196976|2326568|P4|Primary Study|Protocol Violation|0
722508|NCT00196976|2326569|P3|Primary Study|Protocol Violation|1
722509|NCT00196976|2326570|P2|Primary Study|Protocol Violation|1
722510|NCT00196976|2326571|P1|Primary Study|Protocol Violation|0
722511|NCT00196976|2326558|P14|Primary Study|Migrated from study area|0
722512|NCT00196976|2326559|P13|Primary Study|Migrated from study area|0
722513|NCT00196976|2326560|P12|Primary Study|Migrated from study area|0
722514|NCT00196976|2326561|P11|Primary Study|Migrated from study area|0
722515|NCT00196976|2326562|P10|Primary Study|Migrated from study area|0
722516|NCT00196976|2326563|P9|Primary Study|Migrated from study area|0
722517|NCT00196976|2326564|P8|Primary Study|Migrated from study area|1
722518|NCT00196976|2326565|P7|Primary Study|Migrated from study area|0
722519|NCT00196976|2326566|P6|Primary Study|Migrated from study area|0
722520|NCT00196976|2326567|P5|Primary Study|Migrated from study area|0
722521|NCT00196976|2326568|P4|Primary Study|Migrated from study area|0
722522|NCT00196976|2326569|P3|Primary Study|Migrated from study area|0
722523|NCT00196976|2326570|P2|Primary Study|Migrated from study area|0
722524|NCT00196976|2326571|P1|Primary Study|Migrated from study area|0
722525|NCT00197002|2326767|P3|Overall Study|Others|1
722526|NCT00197002|2326768|P2|Overall Study|Others|1
722527|NCT00197002|2326769|P1|Overall Study|Others|3
722528|NCT00197002|2326767|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
722529|NCT00197002|2326768|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
722530|NCT00197002|2326769|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
722531|NCT00197002|2326767|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
722532|NCT00197002|2326768|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
722533|NCT00197002|2326769|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
722534|NCT00197002|2326767|P3|Overall Study|Migrated/moved from study area|1
722535|NCT00197002|2326768|P2|Overall Study|Migrated/moved from study area|5
722536|NCT00197002|2326769|P1|Overall Study|Migrated/moved from study area|3
722537|NCT00197002|2326767|P3|Overall Study|Withdrawal by Subject|7
722538|NCT00197002|2326768|P2|Overall Study|Withdrawal by Subject|5
722539|NCT00197002|2326769|P1|Overall Study|Withdrawal by Subject|9
722540|NCT00197002|2326767|P3|Overall Study|Protocol Violation|2
722541|NCT00197002|2326768|P2|Overall Study|Protocol Violation|0
722542|NCT00197002|2326769|P1|Overall Study|Protocol Violation|1
722543|NCT00197002|2326767|P3|Overall Study|Adverse Event|0
722544|NCT00197002|2326768|P2|Overall Study|Adverse Event|1
722545|NCT00197002|2326769|P1|Overall Study|Adverse Event|0
722546|NCT00197015|2326809|P3|Overall Study|Other|2
722547|NCT00197015|2326810|P2|Overall Study|Other|3
722548|NCT00197015|2326811|P1|Overall Study|Other|2
722549|NCT00197015|2326809|P3|Overall Study|Lost to Follow-up|37
722550|NCT00197015|2326810|P2|Overall Study|Lost to Follow-up|46
722551|NCT00197015|2326811|P1|Overall Study|Lost to Follow-up|28
722552|NCT00197015|2326809|P3|Overall Study|Withdrawal by Subject|34
722553|NCT00197015|2326810|P2|Overall Study|Withdrawal by Subject|37
722554|NCT00197015|2326811|P1|Overall Study|Withdrawal by Subject|17
722555|NCT00197015|2326809|P3|Overall Study|Protocol Violation|3
722556|NCT00197015|2326810|P2|Overall Study|Protocol Violation|3
722557|NCT00197015|2326811|P1|Overall Study|Protocol Violation|0
722558|NCT00197015|2326809|P3|Overall Study|Adverse Event|1
722559|NCT00197015|2326810|P2|Overall Study|Adverse Event|0
722560|NCT00197015|2326811|P1|Overall Study|Adverse Event|3
722561|NCT00197028|2326869|P2|Overall Study|Unspecified|6
722562|NCT00197028|2326870|P1|Overall Study|Unspecified|3
722563|NCT00197028|2326869|P2|Overall Study|Lost to Follow-up|0
722564|NCT00197028|2326870|P1|Overall Study|Lost to Follow-up|1
722565|NCT00197028|2326869|P2|Overall Study|Withdrawal by Subject|12
722566|NCT00197028|2326870|P1|Overall Study|Withdrawal by Subject|8
722567|NCT00197028|2326869|P2|Overall Study|Protocol Violation|1
722568|NCT00197028|2326870|P1|Overall Study|Protocol Violation|2
722569|NCT00197028|2326869|P2|Overall Study|Adverse Event|2
722570|NCT00197028|2326870|P1|Overall Study|Adverse Event|2
722571|NCT00197106|2326912|P3|Overall Treatment Period|Withdrawal by Subject|2
722572|NCT00197106|2326913|P2|Overall Treatment Period|Withdrawal by Subject|0
722573|NCT00197106|2326914|P1|Overall Treatment Period|Withdrawal by Subject|0
722574|NCT00197106|2326912|P3|Overall Treatment Period|Protocol Violation|2
722575|NCT00197106|2326913|P2|Overall Treatment Period|Protocol Violation|0
722576|NCT00197106|2326914|P1|Overall Treatment Period|Protocol Violation|0
722577|NCT00197106|2326912|P3|Overall Treatment Period|Lost to Follow-up|2
722578|NCT00197106|2326913|P2|Overall Treatment Period|Lost to Follow-up|0
722579|NCT00197106|2326914|P1|Overall Treatment Period|Lost to Follow-up|0
722580|NCT00197106|2326912|P3|Overall Treatment Period|Lack of Efficacy|0
722581|NCT00197106|2326913|P2|Overall Treatment Period|Lack of Efficacy|1
722582|NCT00197106|2326914|P1|Overall Treatment Period|Lack of Efficacy|0
722583|NCT00197106|2326912|P3|4-Week Run-In Period|Did not meet entry criteria|0
722584|NCT00197106|2326913|P2|4-Week Run-In Period|Did not meet entry criteria|0
722585|NCT00197106|2326914|P1|4-Week Run-In Period|Did not meet entry criteria|99
722586|NCT00197236|2326989|P3|Overall Study|Returned out of specified time window|1
722587|NCT00197236|2326990|P2|Overall Study|Returned out of specified time window|0
722588|NCT00197236|2326991|P1|Overall Study|Returned out of specified time window|0
722589|NCT00197236|2326989|P3|Overall Study|Study drug/medication expiration|3
722590|NCT00197236|2326990|P2|Overall Study|Study drug/medication expiration|0
722591|NCT00197236|2326991|P1|Overall Study|Study drug/medication expiration|1
722592|NCT00197236|2326989|P3|Overall Study|Withdrawal by Subject|11
722593|NCT00197236|2326990|P2|Overall Study|Withdrawal by Subject|3
722594|NCT00197236|2326991|P1|Overall Study|Withdrawal by Subject|7
722595|NCT00197236|2326989|P3|Overall Study|Protocol Violation|1
722596|NCT00197236|2326990|P2|Overall Study|Protocol Violation|0
722597|NCT00197236|2326991|P1|Overall Study|Protocol Violation|0
722598|NCT00197236|2326989|P3|Overall Study|Lost to Follow-up|6
722599|NCT00197236|2326990|P2|Overall Study|Lost to Follow-up|14
722600|NCT00197236|2326991|P1|Overall Study|Lost to Follow-up|5
722601|NCT00197236|2326989|P3|Overall Study|Adverse Event|1
722602|NCT00197236|2326990|P2|Overall Study|Adverse Event|0
722603|NCT00197236|2326991|P1|Overall Study|Adverse Event|1
722604|NCT00197496|2327072|P2|Follow-up|Lost to Follow-up|1
722605|NCT00197496|2327073|P1|Follow-up|Lost to Follow-up|2
722606|NCT00197496|2327072|P2|Baseline to Discharge|Protocol Violation|1
722607|NCT00197496|2327073|P1|Baseline to Discharge|Protocol Violation|0
722608|NCT00197496|2327072|P2|Baseline to Discharge|Physician Decision|1
722609|NCT00197496|2327073|P1|Baseline to Discharge|Physician Decision|0
722610|NCT00197496|2327072|P2|Baseline to Discharge|MRSA|0
722611|NCT00197496|2327073|P1|Baseline to Discharge|MRSA|1
722612|NCT00197496|2327072|P2|Baseline to Discharge|not interested|0
722613|NCT00197496|2327073|P1|Baseline to Discharge|not interested|1
722614|NCT00198029|2327086|P1|Overall Study|Withdrawal by Subject|4
722615|NCT00198133|2327126|P2|Overall Study|Physician Decision|0
722616|NCT00198133|2327127|P1|Overall Study|Physician Decision|1
722617|NCT00198133|2327126|P2|Overall Study|Withdrawal by Subject|0
722618|NCT00198133|2327127|P1|Overall Study|Withdrawal by Subject|1
722619|NCT00198133|2327126|P2|Overall Study|Adverse Event|3
722620|NCT00198133|2327127|P1|Overall Study|Adverse Event|1
722621|NCT00198133|2327126|P2|Overall Study|Disease progression|5
722622|NCT00198133|2327127|P1|Overall Study|Disease progression|2
722623|NCT00198822|2327140|P3|Overall Study|Lost to Follow-up|21
722624|NCT00198822|2327141|P2|Overall Study|Lost to Follow-up|20
722625|NCT00198822|2327142|P1|Overall Study|Lost to Follow-up|14
722626|NCT00205712|2327188|P2|Overall Study|Lost to Follow-up|1
722627|NCT00205712|2327189|P1|Overall Study|Lost to Follow-up|0
722628|NCT00205777|2327203|P6|Study Extension II|Enrolled but not treated|131
722629|NCT00205777|2327204|P5|Study Extension II|Enrolled but not treated|0
722630|NCT00205777|2327205|P4|Study Extension II|Enrolled but not treated|71
722631|NCT00205777|2327206|P3|Study Extension II|Enrolled but not treated|0
722632|NCT00205777|2327207|P2|Study Extension II|Enrolled but not treated|0
722633|NCT00205777|2327208|P1|Study Extension II|Enrolled but not treated|0
722634|NCT00205777|2327203|P6|Study Extension II|Other Event|20
722635|NCT00205777|2327204|P5|Study Extension II|Other Event|0
722636|NCT00205777|2327205|P4|Study Extension II|Other Event|12
722637|NCT00205777|2327206|P3|Study Extension II|Other Event|0
722638|NCT00205777|2327207|P2|Study Extension II|Other Event|0
722639|NCT00205777|2327208|P1|Study Extension II|Other Event|0
722640|NCT00205777|2327203|P6|Study Extension II|Failed to return|26
722641|NCT00205777|2327204|P5|Study Extension II|Failed to return|0
722642|NCT00205777|2327205|P4|Study Extension II|Failed to return|14
722643|NCT00205777|2327206|P3|Study Extension II|Failed to return|0
722644|NCT00205777|2327207|P2|Study Extension II|Failed to return|0
722645|NCT00205777|2327208|P1|Study Extension II|Failed to return|0
722646|NCT00205777|2327203|P6|Study Extension II|Lack of Efficacy|1
722647|NCT00205777|2327204|P5|Study Extension II|Lack of Efficacy|0
722648|NCT00205777|2327205|P4|Study Extension II|Lack of Efficacy|0
722649|NCT00205777|2327206|P3|Study Extension II|Lack of Efficacy|0
722650|NCT00205777|2327207|P2|Study Extension II|Lack of Efficacy|0
722651|NCT00205777|2327208|P1|Study Extension II|Lack of Efficacy|0
722652|NCT00205777|2327203|P6|Study Extension II|Protocol Violation|10
722653|NCT00205777|2327204|P5|Study Extension II|Protocol Violation|0
722654|NCT00205777|2327205|P4|Study Extension II|Protocol Violation|1
722655|NCT00205777|2327206|P3|Study Extension II|Protocol Violation|0
722656|NCT00205777|2327207|P2|Study Extension II|Protocol Violation|0
722657|NCT00205777|2327208|P1|Study Extension II|Protocol Violation|0
722658|NCT00205777|2327203|P6|Study Extension II|Withdrawal by Subject|59
722659|NCT00205777|2327204|P5|Study Extension II|Withdrawal by Subject|0
722660|NCT00205777|2327205|P4|Study Extension II|Withdrawal by Subject|35
722661|NCT00205777|2327206|P3|Study Extension II|Withdrawal by Subject|0
722662|NCT00205777|2327207|P2|Study Extension II|Withdrawal by Subject|0
722663|NCT00205777|2327208|P1|Study Extension II|Withdrawal by Subject|0
722664|NCT00205777|2327203|P6|Study Extension II|Death|5
722665|NCT00205777|2327204|P5|Study Extension II|Death|0
722666|NCT00205777|2327205|P4|Study Extension II|Death|2
722667|NCT00205777|2327206|P3|Study Extension II|Death|0
722668|NCT00205777|2327207|P2|Study Extension II|Death|0
722669|NCT00205777|2327208|P1|Study Extension II|Death|0
722670|NCT00205777|2327203|P6|Study Extension II|Adverse Event|30
722671|NCT00205777|2327204|P5|Study Extension II|Adverse Event|0
722672|NCT00205777|2327205|P4|Study Extension II|Adverse Event|14
722673|NCT00205777|2327206|P3|Study Extension II|Adverse Event|0
722674|NCT00205777|2327207|P2|Study Extension II|Adverse Event|0
722675|NCT00205777|2327208|P1|Study Extension II|Adverse Event|0
722676|NCT00205777|2327203|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
722677|NCT00205777|2327204|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
722678|NCT00205777|2327205|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
722679|NCT00205777|2327206|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
722680|NCT00205777|2327207|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
722681|NCT00205777|2327208|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
722682|NCT00205777|2327203|P6|Study Extension I|Withdrawn as per protocol|0
722683|NCT00205777|2327204|P5|Study Extension I|Withdrawn as per protocol|0
722684|NCT00205777|2327205|P4|Study Extension I|Withdrawn as per protocol|0
722685|NCT00205777|2327206|P3|Study Extension I|Withdrawn as per protocol|1070
722686|NCT00205777|2327207|P2|Study Extension I|Withdrawn as per protocol|0
722687|NCT00205777|2327208|P1|Study Extension I|Withdrawn as per protocol|0
722688|NCT00205777|2327203|P6|Study Extension I|Other Event|0
722689|NCT00205777|2327204|P5|Study Extension I|Other Event|29
722690|NCT00205777|2327205|P4|Study Extension I|Other Event|34
722691|NCT00205777|2327206|P3|Study Extension I|Other Event|0
722692|NCT00205777|2327207|P2|Study Extension I|Other Event|0
722693|NCT00205777|2327208|P1|Study Extension I|Other Event|34
722694|NCT00205777|2327203|P6|Study Extension I|Failed to return|0
722695|NCT00205777|2327204|P5|Study Extension I|Failed to return|13
722696|NCT00205777|2327205|P4|Study Extension I|Failed to return|17
722697|NCT00205777|2327206|P3|Study Extension I|Failed to return|0
722698|NCT00205777|2327207|P2|Study Extension I|Failed to return|0
722699|NCT00205777|2327208|P1|Study Extension I|Failed to return|15
722700|NCT00205777|2327203|P6|Study Extension I|Lack of Efficacy|0
722701|NCT00205777|2327204|P5|Study Extension I|Lack of Efficacy|2
722702|NCT00205777|2327205|P4|Study Extension I|Lack of Efficacy|1
722703|NCT00205777|2327206|P3|Study Extension I|Lack of Efficacy|0
722704|NCT00205777|2327207|P2|Study Extension I|Lack of Efficacy|0
722705|NCT00205777|2327208|P1|Study Extension I|Lack of Efficacy|0
722706|NCT00205777|2327203|P6|Study Extension I|Protocol Violation|0
722707|NCT00205777|2327204|P5|Study Extension I|Protocol Violation|8
722708|NCT00205777|2327205|P4|Study Extension I|Protocol Violation|8
722709|NCT00205777|2327206|P3|Study Extension I|Protocol Violation|0
722710|NCT00205777|2327207|P2|Study Extension I|Protocol Violation|0
722711|NCT00205777|2327208|P1|Study Extension I|Protocol Violation|4
722712|NCT00205777|2327203|P6|Study Extension I|Withdrawal by Subject|0
722713|NCT00205777|2327204|P5|Study Extension I|Withdrawal by Subject|89
722714|NCT00205777|2327205|P4|Study Extension I|Withdrawal by Subject|106
722715|NCT00205777|2327206|P3|Study Extension I|Withdrawal by Subject|0
722716|NCT00205777|2327207|P2|Study Extension I|Withdrawal by Subject|0
722717|NCT00205777|2327208|P1|Study Extension I|Withdrawal by Subject|99
722718|NCT00205777|2327203|P6|Study Extension I|Death|0
722719|NCT00205777|2327204|P5|Study Extension I|Death|2
722720|NCT00205777|2327205|P4|Study Extension I|Death|1
722721|NCT00205777|2327206|P3|Study Extension I|Death|0
722722|NCT00205777|2327207|P2|Study Extension I|Death|0
722723|NCT00205777|2327208|P1|Study Extension I|Death|5
722724|NCT00205777|2327203|P6|Study Extension I|Adverse Event|0
722725|NCT00205777|2327204|P5|Study Extension I|Adverse Event|58
722726|NCT00205777|2327205|P4|Study Extension I|Adverse Event|61
722727|NCT00205777|2327206|P3|Study Extension I|Adverse Event|0
722728|NCT00205777|2327207|P2|Study Extension I|Adverse Event|0
722729|NCT00205777|2327208|P1|Study Extension I|Adverse Event|57
722730|NCT00205777|2327203|P6|Completed Core Study, Entered SE I|Other Event|0
722731|NCT00205777|2327204|P5|Completed Core Study, Entered SE I|Other Event|0
722732|NCT00205777|2327205|P4|Completed Core Study, Entered SE I|Other Event|50
722733|NCT00205777|2327206|P3|Completed Core Study, Entered SE I|Other Event|47
722734|NCT00205777|2327207|P2|Completed Core Study, Entered SE I|Other Event|46
722735|NCT00205777|2327208|P1|Completed Core Study, Entered SE I|Other Event|52
722736|NCT00205777|2327203|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
722737|NCT00205777|2327204|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
722738|NCT00205777|2327205|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
722739|NCT00205777|2327206|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
722740|NCT00205777|2327207|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
722741|NCT00205777|2327208|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
722742|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
722743|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
722744|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
722745|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
722746|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
722747|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
722748|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
722749|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
722750|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
722751|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
722752|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
722753|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
722754|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Protocol Violation|0
722755|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Protocol Violation|0
722756|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Protocol Violation|42
722757|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Protocol Violation|50
722758|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Protocol Violation|55
722759|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Protocol Violation|53
722760|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
722761|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
722762|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
722763|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
722764|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
722765|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
722766|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Other Event|0
722767|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Other Event|0
722768|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Other Event|58
722769|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Other Event|41
722770|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Other Event|52
722771|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Other Event|49
722772|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Failed to return|0
722773|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Failed to return|0
722774|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Failed to return|27
722775|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Failed to return|27
722776|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Failed to return|25
722777|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Failed to return|40
722778|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Death|0
722779|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Death|0
722780|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Death|7
722781|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Death|14
722782|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Death|7
722783|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Death|9
722784|NCT00205777|2327203|P6|Core Study (Up to 3 Years)|Adverse Event|0
722785|NCT00205777|2327204|P5|Core Study (Up to 3 Years)|Adverse Event|0
722786|NCT00205777|2327205|P4|Core Study (Up to 3 Years)|Adverse Event|232
722787|NCT00205777|2327206|P3|Core Study (Up to 3 Years)|Adverse Event|252
722788|NCT00205777|2327207|P2|Core Study (Up to 3 Years)|Adverse Event|267
722789|NCT00205777|2327208|P1|Core Study (Up to 3 Years)|Adverse Event|260
722790|NCT00205803|2327417|P2|Toddler Dose|Lost to Follow-up|3
722791|NCT00205803|2327418|P1|Toddler Dose|Lost to Follow-up|2
722792|NCT00205803|2327417|P2|After Infant Series|Unspecified|4
722793|NCT00205803|2327418|P1|After Infant Series|Unspecified|10
722794|NCT00205803|2327417|P2|After Infant Series|Withdrawal by Subject|4
722795|NCT00205803|2327418|P1|After Infant Series|Withdrawal by Subject|1
722796|NCT00205803|2327417|P2|After Infant Series|Physician Decision|2
722797|NCT00205803|2327418|P1|After Infant Series|Physician Decision|3
722798|NCT00205803|2327417|P2|After Infant Series|Lost to Follow-up|1
722799|NCT00205803|2327418|P1|After Infant Series|Lost to Follow-up|2
722800|NCT00205803|2327417|P2|After Infant Series|Protocol Violation|1
722801|NCT00205803|2327418|P1|After Infant Series|Protocol Violation|1
722802|NCT00205803|2327417|P2|After Infant Series|Adverse Event|1
722803|NCT00205803|2327418|P1|After Infant Series|Adverse Event|1
722804|NCT00205803|2327417|P2|Infant Series|Sponsor request|0
722805|NCT00205803|2327418|P1|Infant Series|Sponsor request|1
722806|NCT00205803|2327417|P2|Infant Series|Non-compliant|0
722807|NCT00205803|2327418|P1|Infant Series|Non-compliant|1
722808|NCT00205803|2327417|P2|Infant Series|Lost Kaiser coverage|1
722809|NCT00205803|2327418|P1|Infant Series|Lost Kaiser coverage|0
722810|NCT00205803|2327417|P2|Infant Series|Protocol Violation|0
722811|NCT00205803|2327418|P1|Infant Series|Protocol Violation|1
722812|NCT00205803|2327417|P2|Infant Series|Physician Decision|1
722813|NCT00205803|2327418|P1|Infant Series|Physician Decision|3
722814|NCT00205803|2327417|P2|Infant Series|Withdrawal by Subject|5
722815|NCT00205803|2327418|P1|Infant Series|Withdrawal by Subject|2
722816|NCT00205803|2327417|P2|Infant Series|Lost to Follow-up|4
722817|NCT00205803|2327418|P1|Infant Series|Lost to Follow-up|10
722818|NCT00205855|2327470|P1|Overall Study|Withdrawal by Subject|5
722819|NCT00205855|2327470|P1|Overall Study|Only received temporary implants|16
722820|NCT00205881|2327474|P1|Overall Study|Withdrawal by Subject|16
722821|NCT00206076|2327481|P2|Overall Study|Withdrawal by Subject|1
722822|NCT00206076|2327482|P1|Overall Study|Withdrawal by Subject|1
722823|NCT00206076|2327481|P2|Overall Study|Physician Decision|0
722824|NCT00206076|2327482|P1|Overall Study|Physician Decision|2
722825|NCT00206102|2327494|P2|Overall Study|None of those categories|36
722826|NCT00206102|2327495|P1|Overall Study|None of those categories|42
722827|NCT00206102|2327494|P2|Overall Study|Study-specific discontinuation criteria|17
722828|NCT00206102|2327495|P1|Overall Study|Study-specific discontinuation criteria|18
722829|NCT00206102|2327494|P2|Overall Study|Withdrawal by Subject|101
722830|NCT00206102|2327495|P1|Overall Study|Withdrawal by Subject|118
722831|NCT00206102|2327494|P2|Overall Study|Lost to Follow-up|66
722832|NCT00206102|2327495|P1|Overall Study|Lost to Follow-up|95
722833|NCT00206102|2327494|P2|Overall Study|Lack of therapeutic response|11
722834|NCT00206102|2327495|P1|Overall Study|Lack of therapeutic response|16
722835|NCT00206102|2327494|P2|Overall Study|Protocol Violation|2
722836|NCT00206102|2327495|P1|Overall Study|Protocol Violation|0
722837|NCT00206102|2327494|P2|Overall Study|Adverse Event|82
722838|NCT00206102|2327495|P1|Overall Study|Adverse Event|119
722839|NCT00206427|2327529|P1|Overall Study|Adverse Event|2
722840|NCT00206440|2327535|P2|Overall Study|Adverse Event|2
722841|NCT00206440|2327536|P1|Overall Study|Adverse Event|4
722842|NCT00206440|2327535|P2|Overall Study|Protocol Violation|2
722843|NCT00206440|2327536|P1|Overall Study|Protocol Violation|1
722844|NCT00206518|2327544|P2|Overall Study|Protocol Violation|1
722845|NCT00206518|2327545|P1|Overall Study|Protocol Violation|1
722846|NCT00206518|2327544|P2|Overall Study|Physician Decision|0
722847|NCT00206518|2327545|P1|Overall Study|Physician Decision|1
722848|NCT00206518|2327544|P2|Overall Study|Adverse Event|1
722849|NCT00206518|2327545|P1|Overall Study|Adverse Event|2
722850|NCT00206518|2327544|P2|Overall Study|Lack of Efficacy|4
722851|NCT00206518|2327545|P1|Overall Study|Lack of Efficacy|6
722852|NCT00206726|2327555|P1|Overall Study|Withdrawal by Subject|8
722853|NCT00206726|2327555|P1|Overall Study|Protocol Violation|1
722854|NCT00206726|2327555|P1|Overall Study|Death|4
722855|NCT00206726|2327555|P1|Overall Study|Adverse Event|17
722856|NCT00206726|2327555|P1|Overall Study|Bone marrow transplant|1
722857|NCT00206726|2327555|P1|Overall Study|Placed on new protocol|1
722858|NCT00206726|2327555|P1|Overall Study|Progressive disease or relapsed disease|18
722859|NCT00206726|2327555|P1|Overall Study|Delayed recovery of blood counts|1
722860|NCT00207090|2327564|P1|Overall Study|Physician Decision|1
722861|NCT00207090|2327564|P1|Overall Study|Disease progression/relapse|2
722862|NCT00207090|2327564|P1|Overall Study|Chest wall mass larger|1
722863|NCT00207090|2327564|P1|Overall Study|Study drug toxicity|3
722864|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
722865|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
722866|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
722867|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
722868|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Death|1
722869|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Death|0
722870|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Death|0
722871|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Death|0
722872|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
722873|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
722874|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
722875|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
722876|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
722877|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
722878|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
722879|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
722880|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
722881|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
722882|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
722883|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
722884|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
722885|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
722886|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
722887|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
722888|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
722889|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
722890|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
722891|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
722892|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
722893|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
722894|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
722895|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
722896|NCT00207142|2327596|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
722897|NCT00207142|2327597|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
722898|NCT00207142|2327598|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
722899|NCT00207142|2327599|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
722900|NCT00207142|2327596|P4|Induction Phase|Missing lab data|0
722901|NCT00207142|2327597|P3|Induction Phase|Missing lab data|0
722902|NCT00207142|2327598|P2|Induction Phase|Missing lab data|0
722903|NCT00207142|2327599|P1|Induction Phase|Missing lab data|1
722904|NCT00207142|2327596|P4|Induction Phase|Incarceration|0
722905|NCT00207142|2327597|P3|Induction Phase|Incarceration|0
722906|NCT00207142|2327598|P2|Induction Phase|Incarceration|0
722907|NCT00207142|2327599|P1|Induction Phase|Incarceration|1
722908|NCT00207142|2327596|P4|Induction Phase|Withdrawal by Subject|0
722909|NCT00207142|2327597|P3|Induction Phase|Withdrawal by Subject|0
722910|NCT00207142|2327598|P2|Induction Phase|Withdrawal by Subject|0
722911|NCT00207142|2327599|P1|Induction Phase|Withdrawal by Subject|4
722912|NCT00207142|2327596|P4|Induction Phase|Subject no longer meets study criteria|0
722913|NCT00207142|2327597|P3|Induction Phase|Subject no longer meets study criteria|0
722914|NCT00207142|2327598|P2|Induction Phase|Subject no longer meets study criteria|0
722915|NCT00207142|2327599|P1|Induction Phase|Subject no longer meets study criteria|3
722916|NCT00207142|2327596|P4|Induction Phase|Pregnancy|0
722917|NCT00207142|2327597|P3|Induction Phase|Pregnancy|0
722918|NCT00207142|2327598|P2|Induction Phase|Pregnancy|0
722919|NCT00207142|2327599|P1|Induction Phase|Pregnancy|1
722920|NCT00207142|2327596|P4|Induction Phase|Poor/noncompliance|0
722921|NCT00207142|2327597|P3|Induction Phase|Poor/noncompliance|0
722922|NCT00207142|2327598|P2|Induction Phase|Poor/noncompliance|0
722923|NCT00207142|2327599|P1|Induction Phase|Poor/noncompliance|2
722924|NCT00207142|2327596|P4|Induction Phase|Physician Decision|0
722925|NCT00207142|2327597|P3|Induction Phase|Physician Decision|0
722926|NCT00207142|2327598|P2|Induction Phase|Physician Decision|0
722927|NCT00207142|2327599|P1|Induction Phase|Physician Decision|2
722928|NCT00207142|2327596|P4|Induction Phase|Lost to Follow-up|0
722929|NCT00207142|2327597|P3|Induction Phase|Lost to Follow-up|0
722930|NCT00207142|2327598|P2|Induction Phase|Lost to Follow-up|0
722931|NCT00207142|2327599|P1|Induction Phase|Lost to Follow-up|5
722932|NCT00207142|2327596|P4|Induction Phase|Lack of Efficacy|0
722933|NCT00207142|2327597|P3|Induction Phase|Lack of Efficacy|0
722934|NCT00207142|2327598|P2|Induction Phase|Lack of Efficacy|0
722935|NCT00207142|2327599|P1|Induction Phase|Lack of Efficacy|1
722936|NCT00207142|2327596|P4|Induction Phase|Death|0
722937|NCT00207142|2327597|P3|Induction Phase|Death|0
722938|NCT00207142|2327598|P2|Induction Phase|Death|0
722939|NCT00207142|2327599|P1|Induction Phase|Death|1
722940|NCT00207142|2327596|P4|Induction Phase|Adverse Event|0
722941|NCT00207142|2327597|P3|Induction Phase|Adverse Event|0
722942|NCT00207142|2327598|P2|Induction Phase|Adverse Event|0
722943|NCT00207142|2327599|P1|Induction Phase|Adverse Event|9
722944|NCT00207714|2327641|P5|Overall Study|Unspecified|0
722945|NCT00207714|2327642|P4|Overall Study|Unspecified|1
722946|NCT00207714|2327643|P3|Overall Study|Unspecified|5
722947|NCT00207714|2327644|P2|Overall Study|Unspecified|2
722948|NCT00207714|2327645|P1|Overall Study|Unspecified|3
722949|NCT00207714|2327641|P5|Overall Study|Unsatisfactory therapeutic effect|4
722950|NCT00207714|2327642|P4|Overall Study|Unsatisfactory therapeutic effect|4
722951|NCT00207714|2327643|P3|Overall Study|Unsatisfactory therapeutic effect|1
722952|NCT00207714|2327644|P2|Overall Study|Unsatisfactory therapeutic effect|3
722953|NCT00207714|2327645|P1|Overall Study|Unsatisfactory therapeutic effect|5
722954|NCT00207714|2327641|P5|Overall Study|Adverse Event|1
722955|NCT00207714|2327642|P4|Overall Study|Adverse Event|3
722956|NCT00207714|2327643|P3|Overall Study|Adverse Event|4
722957|NCT00207714|2327644|P2|Overall Study|Adverse Event|2
722958|NCT00207714|2327645|P1|Overall Study|Adverse Event|6
722959|NCT00207727|2327669|P5|Overall Study|Not specified|33
722960|NCT00207727|2327670|P4|Overall Study|Not specified|37
722961|NCT00207727|2327671|P3|Overall Study|Not specified|41
722962|NCT00207727|2327672|P2|Overall Study|Not specified|41
722963|NCT00207727|2327673|P1|Overall Study|Not specified|38
722964|NCT00207727|2327669|P5|Overall Study|Lost to Follow-up|0
722965|NCT00207727|2327670|P4|Overall Study|Lost to Follow-up|0
722966|NCT00207727|2327671|P3|Overall Study|Lost to Follow-up|0
722967|NCT00207727|2327672|P2|Overall Study|Lost to Follow-up|1
722968|NCT00207727|2327673|P1|Overall Study|Lost to Follow-up|0
722969|NCT00207727|2327669|P5|Overall Study|Withdrawal by Subject|1
722970|NCT00207727|2327670|P4|Overall Study|Withdrawal by Subject|0
722971|NCT00207727|2327671|P3|Overall Study|Withdrawal by Subject|0
722972|NCT00207727|2327672|P2|Overall Study|Withdrawal by Subject|0
722973|NCT00207727|2327673|P1|Overall Study|Withdrawal by Subject|0
722974|NCT00207740|2327699|P4|Overall Study|Not Specified|5
722975|NCT00207740|2327700|P3|Overall Study|Not Specified|7
722976|NCT00207740|2327701|P2|Overall Study|Not Specified|10
722977|NCT00207740|2327702|P1|Overall Study|Not Specified|2
722978|NCT00207740|2327699|P4|Overall Study|Sponsor Directive|21
722979|NCT00207740|2327700|P3|Overall Study|Sponsor Directive|16
722980|NCT00207740|2327701|P2|Overall Study|Sponsor Directive|15
722981|NCT00207740|2327702|P1|Overall Study|Sponsor Directive|22
722982|NCT00207740|2327699|P4|Overall Study|Death|1
722983|NCT00207740|2327700|P3|Overall Study|Death|0
722984|NCT00207740|2327701|P2|Overall Study|Death|0
722985|NCT00207740|2327702|P1|Overall Study|Death|0
722986|NCT00207740|2327699|P4|Overall Study|Lost to Follow-up|1
722987|NCT00207740|2327700|P3|Overall Study|Lost to Follow-up|1
722988|NCT00207740|2327701|P2|Overall Study|Lost to Follow-up|2
722989|NCT00207740|2327702|P1|Overall Study|Lost to Follow-up|0
722990|NCT00207740|2327699|P4|Overall Study|Unsatisfactory therapeutic effect|4
722991|NCT00207740|2327700|P3|Overall Study|Unsatisfactory therapeutic effect|2
722992|NCT00207740|2327701|P2|Overall Study|Unsatisfactory therapeutic effect|0
722993|NCT00207740|2327702|P1|Overall Study|Unsatisfactory therapeutic effect|1
722994|NCT00207740|2327699|P4|Overall Study|Adverse Event|11
722995|NCT00207740|2327700|P3|Overall Study|Adverse Event|14
722996|NCT00207740|2327701|P2|Overall Study|Adverse Event|14
722997|NCT00207740|2327702|P1|Overall Study|Adverse Event|4
722998|NCT00195650|2327766|P1|Overall Study|Administrative reasons|83
722999|NCT00195650|2327766|P1|Overall Study|Protocol Violation|15
723000|NCT00195650|2327766|P1|Overall Study|Death|23
723001|NCT00195650|2327766|P1|Overall Study|Lost to Follow-up|44
723002|NCT00195650|2327766|P1|Overall Study|Withdrawal by Subject|67
723003|NCT00195650|2327766|P1|Overall Study|Lack of Efficacy|99
723004|NCT00195650|2327766|P1|Overall Study|Adverse Event|194
723005|NCT00195663|2327783|P3|Open-Label Extension Period|Administrative reasons|13
723006|NCT00195663|2327784|P2|Open-Label Extension Period|Administrative reasons|11
723007|NCT00195663|2327785|P1|Open-Label Extension Period|Administrative reasons|11
723008|NCT00195663|2327783|P3|Open-Label Extension Period|Lack of Efficacy|12
723009|NCT00195663|2327784|P2|Open-Label Extension Period|Lack of Efficacy|6
723010|NCT00195663|2327785|P1|Open-Label Extension Period|Lack of Efficacy|14
723011|NCT00195663|2327783|P3|Open-Label Extension Period|Withdrawal by Subject|22
723012|NCT00195663|2327784|P2|Open-Label Extension Period|Withdrawal by Subject|15
723013|NCT00195663|2327785|P1|Open-Label Extension Period|Withdrawal by Subject|16
723014|NCT00195663|2327783|P3|Open-Label Extension Period|Death|2
723015|NCT00195663|2327784|P2|Open-Label Extension Period|Death|2
723016|NCT00195663|2327785|P1|Open-Label Extension Period|Death|2
723017|NCT00195663|2327783|P3|Open-Label Extension Period|Protocol Violation|4
723018|NCT00195663|2327784|P2|Open-Label Extension Period|Protocol Violation|4
723019|NCT00195663|2327785|P1|Open-Label Extension Period|Protocol Violation|3
723020|NCT00195663|2327783|P3|Open-Label Extension Period|Recovery|2
723021|NCT00195663|2327784|P2|Open-Label Extension Period|Recovery|2
723022|NCT00195663|2327785|P1|Open-Label Extension Period|Recovery|0
723023|NCT00195663|2327783|P3|Open-Label Extension Period|Lost to Follow-up|6
723024|NCT00195663|2327784|P2|Open-Label Extension Period|Lost to Follow-up|2
723025|NCT00195663|2327785|P1|Open-Label Extension Period|Lost to Follow-up|9
723026|NCT00195663|2327783|P3|Open-Label Extension Period|Adverse Event|36
723027|NCT00195663|2327784|P2|Open-Label Extension Period|Adverse Event|32
723028|NCT00195663|2327785|P1|Open-Label Extension Period|Adverse Event|21
723029|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Administrative reasons|9
723030|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Administrative reasons|2
723031|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Administrative reasons|3
723032|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Recovery|1
723033|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Recovery|0
723034|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Recovery|1
723035|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
723036|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
723037|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
723038|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Protocol Violation|4
723039|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Protocol Violation|6
723040|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Protocol Violation|6
723041|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
723042|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
723043|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
723044|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
723045|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
723046|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
723047|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
723048|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
723049|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
723050|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Death|0
723051|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Death|2
723052|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Death|0
723053|NCT00195663|2327783|P3|2-year Double-blind Treatment Period|Adverse Event|32
723054|NCT00195663|2327784|P2|2-year Double-blind Treatment Period|Adverse Event|27
723055|NCT00195663|2327785|P1|2-year Double-blind Treatment Period|Adverse Event|21
723056|NCT00195676|2327879|P1|Period R - Retreatment 16 Weeks|Other reasons|6
723057|NCT00195676|2327879|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
723058|NCT00195676|2327879|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
723059|NCT00195676|2327879|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
723060|NCT00195676|2327879|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
723061|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
723062|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
723063|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
723064|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
723065|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
723066|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
723067|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Death|2
723068|NCT00195676|2327879|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
723069|NCT00195676|2327879|P1|Period O - Open-label Treatment|Other reasons|68
723070|NCT00195676|2327879|P1|Period O - Open-label Treatment|Administrative reasons|2
723071|NCT00195676|2327879|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
723072|NCT00195676|2327879|P1|Period O - Open-label Treatment|Protocol Violation|12
723073|NCT00195676|2327879|P1|Period O - Open-label Treatment|Lost to Follow-up|91
723074|NCT00195676|2327879|P1|Period O - Open-label Treatment|Lack of Efficacy|198
723075|NCT00195676|2327879|P1|Period O - Open-label Treatment|Death|6
723076|NCT00195676|2327879|P1|Period O - Open-label Treatment|Adverse Event|82
723077|NCT00195715|2327962|P1|Overall Study|Sponsor discretion - trial ended early|1
723078|NCT00195715|2327962|P1|Overall Study|Sponsor discontinued trial|1
723079|NCT00195715|2327962|P1|Overall Study|Colonic stricture|1
723080|NCT00195715|2327962|P1|Overall Study|Ineligible|1
723081|NCT00195715|2327962|P1|Overall Study|Increased infection rate|1
723082|NCT00195715|2327962|P1|Overall Study|Planned surgery|2
723083|NCT00195715|2327962|P1|Overall Study|Use of prohibited medication|2
723084|NCT00195715|2327962|P1|Overall Study|Subject wants to get pregnant|4
723085|NCT00195715|2327962|P1|Overall Study|Investigator's decision|2
723086|NCT00195715|2327962|P1|Overall Study|Administrative reasons|2
723087|NCT00195715|2327962|P1|Overall Study|Sponsor stopped study|1
723088|NCT00195715|2327962|P1|Overall Study|Loss of response/no improvement|3
723089|NCT00195715|2327962|P1|Overall Study|Subject choice|3
723090|NCT00195715|2327962|P1|Overall Study|Subject started commercial Humira|5
723091|NCT00195715|2327962|P1|Overall Study|Subject non-compliance|6
723092|NCT00195715|2327962|P1|Overall Study|Subject moved/relocated|7
723093|NCT00195715|2327962|P1|Overall Study|Investigative site closure|8
723094|NCT00195715|2327962|P1|Overall Study|Pregnancy|14
723095|NCT00195715|2327962|P1|Overall Study|Lack of Efficacy|93
723096|NCT00195715|2327962|P1|Overall Study|Protocol Violation|13
723097|NCT00195715|2327962|P1|Overall Study|Lost to Follow-up|27
723098|NCT00195715|2327962|P1|Overall Study|Withdrawal by Subject|58
723099|NCT00195715|2327962|P1|Overall Study|Adverse Event|122
723100|NCT00195819|2327990|P2|Open-label|Withdrawal by Subject|5
723101|NCT00195819|2327991|P1|Open-label|Withdrawal by Subject|0
723102|NCT00195819|2327990|P2|Open-label|Moved|1
723103|NCT00195819|2327991|P1|Open-label|Moved|0
723104|NCT00195819|2327990|P2|Open-label|Protocol Violation|2
723105|NCT00195819|2327991|P1|Open-label|Protocol Violation|0
723106|NCT00195819|2327990|P2|Open-label|Pregnancy|1
723107|NCT00195819|2327991|P1|Open-label|Pregnancy|0
723108|NCT00195819|2327990|P2|Open-label|Lack of Efficacy|2
723109|NCT00195819|2327991|P1|Open-label|Lack of Efficacy|0
723110|NCT00195819|2327990|P2|Open-label|Adverse Event|9
723111|NCT00195819|2327991|P1|Open-label|Adverse Event|0
723112|NCT00195819|2327990|P2|Double-Blind|Moved|0
723113|NCT00195819|2327991|P1|Double-Blind|Moved|1
723114|NCT00195819|2327990|P2|Double-Blind|Withdrawal by Subject|0
723115|NCT00195819|2327991|P1|Double-Blind|Withdrawal by Subject|1
723116|NCT00196105|2328044|P3|Overall Study|Lost to Follow-up|7
723117|NCT00196105|2328045|P2|Overall Study|Lost to Follow-up|5
723118|NCT00196105|2328046|P1|Overall Study|Lost to Follow-up|4
723119|NCT00196196|2328066|P1|Overall Study|Did not have required condition (hydroce|5
723120|NCT00196196|2328066|P1|Overall Study|Withdrawal by Subject|2
723121|NCT00196313|2328073|P2|Overall Study|Lost to Follow-up|2
723122|NCT00196313|2328074|P1|Overall Study|Lost to Follow-up|2
723123|NCT00196313|2328073|P2|Overall Study|Subject Pregnant|1
723124|NCT00196313|2328074|P1|Overall Study|Subject Pregnant|1
723125|NCT00196313|2328073|P2|Overall Study|Adverse Event|1
723126|NCT00196313|2328074|P1|Overall Study|Adverse Event|3
723127|NCT00196313|2328073|P2|Overall Study|Withdrawal by Subject|1
723128|NCT00196313|2328074|P1|Overall Study|Withdrawal by Subject|3
723129|NCT00196313|2328073|P2|Overall Study|Protocol Violation|3
723130|NCT00196313|2328074|P1|Overall Study|Protocol Violation|2
723131|NCT00201851|2328115|P3|Overall Study|Ineligible post enrollment|1
723132|NCT00201851|2328116|P2|Overall Study|Ineligible post enrollment|1
723133|NCT00201851|2328117|P1|Overall Study|Ineligible post enrollment|6
723134|NCT00201851|2328115|P3|Overall Study|Lost to Follow-up|0
723135|NCT00201851|2328116|P2|Overall Study|Lost to Follow-up|1
723136|NCT00201851|2328117|P1|Overall Study|Lost to Follow-up|2
723137|NCT00202839|2328165|P2|Overall Study|Lost to Follow-up|2
723138|NCT00202839|2328166|P1|Overall Study|Lost to Follow-up|3
723139|NCT00202839|2328165|P2|Overall Study|Protocol Violation|1
723140|NCT00202839|2328166|P1|Overall Study|Protocol Violation|2
723141|NCT00202839|2328165|P2|Overall Study|Withdrawal by Subject|2
723142|NCT00202839|2328166|P1|Overall Study|Withdrawal by Subject|6
723143|NCT00202839|2328165|P2|Overall Study|Physician Decision|0
723144|NCT00202839|2328166|P1|Overall Study|Physician Decision|12
723145|NCT00202839|2328165|P2|Overall Study|Adverse Event|5
723146|NCT00202839|2328166|P1|Overall Study|Adverse Event|1
723147|NCT00202878|2328176|P2|Overall Study|Withdrawal by Subject|808
723148|NCT00202878|2328177|P1|Overall Study|Withdrawal by Subject|795
723149|NCT00202878|2328176|P2|Overall Study|Site Closure|36
723150|NCT00202878|2328177|P1|Overall Study|Site Closure|39
723151|NCT00202878|2328176|P2|Overall Study|Lost to Follow-up|49
723152|NCT00202878|2328177|P1|Overall Study|Lost to Follow-up|44
723153|NCT00202878|2328176|P2|Overall Study|Only Vital Status Known|356
723154|NCT00202878|2328177|P1|Overall Study|Only Vital Status Known|357
723155|NCT00202878|2328176|P2|Overall Study|Death|968
723156|NCT00202878|2328177|P1|Overall Study|Death|964
723157|NCT00208325|2328193|P4|Overall Study|Mis-Randomized|0
723158|NCT00208325|2328194|P3|Overall Study|Mis-Randomized|0
723159|NCT00208325|2328195|P2|Overall Study|Mis-Randomized|20
723160|NCT00208325|2328196|P1|Overall Study|Mis-Randomized|17
723161|NCT00208325|2328193|P4|Overall Study|Other|0
723162|NCT00208325|2328194|P3|Overall Study|Other|1
723163|NCT00208325|2328195|P2|Overall Study|Other|1
723164|NCT00208325|2328196|P1|Overall Study|Other|2
723165|NCT00208325|2328193|P4|Overall Study|Does not wish to Continue in Study|2
723166|NCT00208325|2328194|P3|Overall Study|Does not wish to Continue in Study|3
723167|NCT00208325|2328195|P2|Overall Study|Does not wish to Continue in Study|8
723168|NCT00208325|2328196|P1|Overall Study|Does not wish to Continue in Study|5
723169|NCT00208325|2328193|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
723170|NCT00208325|2328194|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
723171|NCT00208325|2328195|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
723172|NCT00208325|2328196|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
723173|NCT00208325|2328193|P4|Overall Study|Lost to Follow-up|0
723174|NCT00208325|2328194|P3|Overall Study|Lost to Follow-up|2
723175|NCT00208325|2328195|P2|Overall Study|Lost to Follow-up|0
723176|NCT00208325|2328196|P1|Overall Study|Lost to Follow-up|1
723177|NCT00208325|2328193|P4|Overall Study|Revision|4
723178|NCT00208325|2328194|P3|Overall Study|Revision|0
723179|NCT00208325|2328195|P2|Overall Study|Revision|1
723180|NCT00208325|2328196|P1|Overall Study|Revision|4
723181|NCT00208325|2328193|P4|Overall Study|Withdrawal by Subject|0
723182|NCT00208325|2328194|P3|Overall Study|Withdrawal by Subject|0
723183|NCT00208325|2328195|P2|Overall Study|Withdrawal by Subject|1
723184|NCT00208325|2328196|P1|Overall Study|Withdrawal by Subject|0
723185|NCT00208325|2328193|P4|Overall Study|Death|5
723186|NCT00208325|2328194|P3|Overall Study|Death|7
723187|NCT00208325|2328195|P2|Overall Study|Death|19
723188|NCT00208325|2328196|P1|Overall Study|Death|18
723189|NCT00209560|2328335|P2|Overall Study|Lack of Efficacy|0
723190|NCT00209560|2328336|P1|Overall Study|Lack of Efficacy|1
723191|NCT00210470|2328344|P1|Overall Study|Subject did not continue to surgery|1
723192|NCT00210626|2328350|P2|Overall Study|Not Specified|5
723193|NCT00210626|2328351|P1|Overall Study|Not Specified|4
723194|NCT00210626|2328350|P2|Overall Study|Sponser Request|0
723195|NCT00210626|2328351|P1|Overall Study|Sponser Request|1
723196|NCT00210626|2328350|P2|Overall Study|Physician Decision|2
723197|NCT00210626|2328351|P1|Overall Study|Physician Decision|0
723198|NCT00210626|2328350|P2|Overall Study|Withdrawal by Subject|20
723199|NCT00210626|2328351|P1|Overall Study|Withdrawal by Subject|29
723200|NCT00210626|2328350|P2|Overall Study|Death|0
723201|NCT00210626|2328351|P1|Overall Study|Death|1
723202|NCT00210626|2328350|P2|Overall Study|Lost to Follow-up|11
723203|NCT00210626|2328351|P1|Overall Study|Lost to Follow-up|11
723204|NCT00210626|2328350|P2|Overall Study|Protocol Violation|5
723205|NCT00210626|2328351|P1|Overall Study|Protocol Violation|1
723206|NCT00210626|2328350|P2|Overall Study|Adverse Event|2
723207|NCT00210626|2328351|P1|Overall Study|Adverse Event|1
723208|NCT00210639|2328361|P2|Overall Study|Not specified|12
723209|NCT00210639|2328362|P1|Overall Study|Not specified|18
723210|NCT00210639|2328361|P2|Overall Study|Withdrawal by Subject|1
723211|NCT00210639|2328362|P1|Overall Study|Withdrawal by Subject|8
723212|NCT00210639|2328361|P2|Overall Study|Lost to Follow-up|29
723213|NCT00210639|2328362|P1|Overall Study|Lost to Follow-up|37
723215|NCT00211172|2328374|P2|Overall Study|Died or lost health plan eligibility|32
723216|NCT00211172|2328375|P1|Overall Study|Died or lost health plan eligibility|39
723271|NCT00211510|2328477|P2|Overall Study|Withdrawal by Subject|1
723272|NCT00211510|2328478|P1|Overall Study|Withdrawal by Subject|3
723273|NCT00211510|2328477|P2|Overall Study|Physician Decision|1
723274|NCT00211510|2328478|P1|Overall Study|Physician Decision|3
723275|NCT00211536|2328496|P2|Overall Study|Adverse Event|0
723276|NCT00211536|2328497|P1|Overall Study|Adverse Event|2
723277|NCT00211536|2328496|P2|Overall Study|Physician Decision|5
723278|NCT00211536|2328497|P1|Overall Study|Physician Decision|0
723279|NCT00211536|2328496|P2|Overall Study|Withdrawal by Subject|2
723280|NCT00211536|2328497|P1|Overall Study|Withdrawal by Subject|2
723281|NCT00211809|2328522|P1|Overall Study|side effects|2
723282|NCT00211809|2328522|P1|Overall Study|Pregnancy|1
723283|NCT00211809|2328522|P1|Overall Study|Lost to Follow-up|2
723284|NCT00211809|2328522|P1|Overall Study|Lack of Efficacy|1
723285|NCT00211887|2328539|P3|Overall Study|Side effects|5
723286|NCT00211887|2328540|P2|Overall Study|Side effects|13
723287|NCT00211887|2328541|P1|Overall Study|Side effects|19
723288|NCT00211887|2328539|P3|Overall Study|Other medical reason|7
723289|NCT00211887|2328540|P2|Overall Study|Other medical reason|11
723290|NCT00211887|2328541|P1|Overall Study|Other medical reason|15
723291|NCT00211887|2328539|P3|Overall Study|Non-medical reason|8
723292|NCT00211887|2328540|P2|Overall Study|Non-medical reason|14
723293|NCT00211887|2328541|P1|Overall Study|Non-medical reason|31
723294|NCT00211887|2328539|P3|Overall Study|Lost to Follow-up|9
723295|NCT00211887|2328540|P2|Overall Study|Lost to Follow-up|13
723296|NCT00211887|2328541|P1|Overall Study|Lost to Follow-up|28
723297|NCT00211887|2328539|P3|Overall Study|Death|1
723298|NCT00211887|2328540|P2|Overall Study|Death|1
723299|NCT00211887|2328541|P1|Overall Study|Death|1
723300|NCT00211887|2328539|P3|Overall Study|Adverse Event|6
723301|NCT00211887|2328540|P2|Overall Study|Adverse Event|4
723302|NCT00211887|2328541|P1|Overall Study|Adverse Event|8
723303|NCT00213135|2328582|P3|Overall Study|Unspecified|15
723304|NCT00213135|2328583|P2|Overall Study|Unspecified|12
723305|NCT00213135|2328584|P1|Overall Study|Unspecified|21
723306|NCT00213135|2328582|P3|Overall Study|Disease progression|21
723307|NCT00213135|2328583|P2|Overall Study|Disease progression|5
723308|NCT00213135|2328584|P1|Overall Study|Disease progression|4
723309|NCT00213135|2328582|P3|Overall Study|Death|2
723310|NCT00213135|2328583|P2|Overall Study|Death|1
723311|NCT00213135|2328584|P1|Overall Study|Death|1
723312|NCT00213135|2328582|P3|Overall Study|Protocol Violation|10
723313|NCT00213135|2328583|P2|Overall Study|Protocol Violation|4
723314|NCT00213135|2328584|P1|Overall Study|Protocol Violation|4
723315|NCT00213135|2328582|P3|Overall Study|Lost to Follow-up|4
723316|NCT00213135|2328583|P2|Overall Study|Lost to Follow-up|8
723317|NCT00213135|2328584|P1|Overall Study|Lost to Follow-up|11
723318|NCT00213135|2328582|P3|Overall Study|Adverse Event|5
723319|NCT00213135|2328583|P2|Overall Study|Adverse Event|5
723320|NCT00213135|2328584|P1|Overall Study|Adverse Event|9
723324|NCT00214201|2328610|P2|Overall Study|Death|2
723325|NCT00214201|2328611|P1|Overall Study|Death|0
723326|NCT00214201|2328610|P2|Overall Study|Withdrawal by Subject|0
723327|NCT00214201|2328611|P1|Overall Study|Withdrawal by Subject|2
723328|NCT00214383|2328623|P2|Overall Study|Lost to Follow-up|26
723329|NCT00214383|2328624|P1|Overall Study|Lost to Follow-up|16
723330|NCT00214461|2328638|P4|Overall Study|Withdrawal by Subject|0
723331|NCT00214461|2328639|P3|Overall Study|Withdrawal by Subject|1
723332|NCT00214461|2328640|P2|Overall Study|Withdrawal by Subject|0
723333|NCT00214461|2328641|P1|Overall Study|Withdrawal by Subject|0
723334|NCT00214461|2328638|P4|Overall Study|Adverse Event|1
723335|NCT00214461|2328639|P3|Overall Study|Adverse Event|1
723336|NCT00214461|2328640|P2|Overall Study|Adverse Event|0
723337|NCT00214461|2328641|P1|Overall Study|Adverse Event|0
723338|NCT00215137|2328754|P3|Randomization Period|Withdrawal by Subject|0
723339|NCT00215137|2328755|P2|Randomization Period|Withdrawal by Subject|1
723340|NCT00215137|2328756|P1|Randomization Period|Withdrawal by Subject|0
723341|NCT00215137|2328754|P3|Randomization Period|Lost to Follow-up|0
723342|NCT00215137|2328755|P2|Randomization Period|Lost to Follow-up|1
723343|NCT00215137|2328756|P1|Randomization Period|Lost to Follow-up|0
723344|NCT00215137|2328754|P3|Open Label Escitalopram|Lack of Efficacy|0
723345|NCT00215137|2328755|P2|Open Label Escitalopram|Lack of Efficacy|0
723346|NCT00215137|2328756|P1|Open Label Escitalopram|Lack of Efficacy|1
723347|NCT00215150|2328764|P1|Randomization Phase Placebo|Withdrawal by Subject|1
723348|NCT00215150|2328764|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
723349|NCT00215150|2328764|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
723350|NCT00215150|2328764|P1|Open Label Phase|Did not meet randomization criteria|9
723351|NCT00215150|2328764|P1|Open Label Phase|Did not complete a post base visit|13
723352|NCT00215150|2328764|P1|Open Label Phase|Withdrawal by Subject|1
723353|NCT00215150|2328764|P1|Open Label Phase|Lost to Follow-up|7
723354|NCT00208767|2328774|P2|Overall Study|Lost to Follow-up|3
723355|NCT00208767|2328775|P1|Overall Study|Lost to Follow-up|3
723356|NCT00208767|2328774|P2|Overall Study|Death|0
723357|NCT00208767|2328775|P1|Overall Study|Death|1
723358|NCT00208767|2328774|P2|Overall Study|Withdrawal by Subject|3
723359|NCT00208767|2328775|P1|Overall Study|Withdrawal by Subject|14
723360|NCT00208767|2328774|P2|Overall Study|Adverse Event|1
723361|NCT00208767|2328775|P1|Overall Study|Adverse Event|9
723362|NCT00209027|2328799|P2|Overall Study|study terminated|0
723363|NCT00209027|2328800|P1|Overall Study|study terminated|10
723364|NCT00209092|2328808|P2|Overall Study|Withdrawal by Subject|0
723365|NCT00209092|2328809|P1|Overall Study|Withdrawal by Subject|1
723366|NCT00209092|2328808|P2|Overall Study|Adverse Event|1
723367|NCT00209092|2328809|P1|Overall Study|Adverse Event|0
723368|NCT00209092|2328808|P2|Overall Study|Progression of disease|1
723369|NCT00209092|2328809|P1|Overall Study|Progression of disease|7
723370|NCT00209131|2328819|P2|Overall Study|Lack of personnel due to turnovers.|11
723371|NCT00209131|2328820|P1|Overall Study|Lack of personnel due to turnovers.|15
723372|NCT00209170|2328830|P2|Overall Study|Lack of Efficacy|1
723373|NCT00209170|2328831|P1|Overall Study|Lack of Efficacy|0
723374|NCT00209170|2328830|P2|Overall Study|Withdrawal by Subject|1
723375|NCT00209170|2328831|P1|Overall Study|Withdrawal by Subject|2
723376|NCT00209170|2328830|P2|Overall Study|Adverse Event|1
723377|NCT00209170|2328831|P1|Overall Study|Adverse Event|0
723378|NCT00209274|2328839|P2|Overall Study|Randomized not treated (RNT)|15
723379|NCT00209274|2328840|P1|Overall Study|Randomized not treated (RNT)|6
723380|NCT00209274|2328839|P2|Overall Study|Withdrawal by Subject|14
723381|NCT00209274|2328840|P1|Overall Study|Withdrawal by Subject|29
723382|NCT00209274|2328839|P2|Overall Study|Death|13
723383|NCT00209274|2328840|P1|Overall Study|Death|28
723384|NCT00209274|2328839|P2|Overall Study|Missed visit|3
723385|NCT00209274|2328840|P1|Overall Study|Missed visit|9
723386|NCT00209339|2329126|P1|At 5 Years Follow-up|Death|1
723387|NCT00209339|2329126|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
723388|NCT00209339|2329126|P1|At 5 Years Follow-up|Withdrawal by Subject|2
723389|NCT00209339|2329126|P1|At 4 Years Follow-up|Death|1
723390|NCT00209339|2329126|P1|At 4 Years Follow-up|Withdrawal by Subject|4
723391|NCT00209339|2329126|P1|At 3 Years Follow-up|Withdrawal by Subject|1
723392|NCT00209339|2329126|P1|At 24 Months Follow-up|Death|1
723393|NCT00209339|2329126|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
723394|NCT00209339|2329126|P1|At 24 Months Follow-up|Withdrawal by Subject|4
723395|NCT00209339|2329126|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
723396|NCT00209339|2329126|P1|At 12 Months Follow-up|Death|1
723397|NCT00209339|2329126|P1|At 12 Months Follow-up|Withdrawal by Subject|8
723398|NCT00215540|2329211|P3|Overall Study|Withdrew from study medication|0
723399|NCT00215540|2329212|P2|Overall Study|Withdrew from study medication|0
723400|NCT00215540|2329213|P1|Overall Study|Withdrew from study medication|1
723401|NCT00215657|2329299|P8|Overall Study|Not specified|1
723402|NCT00215657|2329300|P7|Overall Study|Not specified|6
723403|NCT00215657|2329301|P6|Overall Study|Not specified|4
723404|NCT00215657|2329302|P5|Overall Study|Not specified|5
723405|NCT00215657|2329303|P4|Overall Study|Not specified|3
723406|NCT00215657|2329304|P3|Overall Study|Not specified|2
723407|NCT00215657|2329305|P2|Overall Study|Not specified|1
723408|NCT00215657|2329306|P1|Overall Study|Not specified|3
723409|NCT00215657|2329299|P8|Overall Study|Insufficient testosterone response|7
723410|NCT00215657|2329300|P7|Overall Study|Insufficient testosterone response|4
723411|NCT00215657|2329301|P6|Overall Study|Insufficient testosterone response|12
723412|NCT00215657|2329302|P5|Overall Study|Insufficient testosterone response|8
723413|NCT00215657|2329303|P4|Overall Study|Insufficient testosterone response|12
723414|NCT00215657|2329304|P3|Overall Study|Insufficient testosterone response|1
723415|NCT00215657|2329305|P2|Overall Study|Insufficient testosterone response|4
723416|NCT00215657|2329306|P1|Overall Study|Insufficient testosterone response|5
723417|NCT00215657|2329299|P8|Overall Study|Insuff prostate specific antigen resp|2
723418|NCT00215657|2329300|P7|Overall Study|Insuff prostate specific antigen resp|3
723419|NCT00215657|2329301|P6|Overall Study|Insuff prostate specific antigen resp|2
723420|NCT00215657|2329302|P5|Overall Study|Insuff prostate specific antigen resp|1
723421|NCT00215657|2329303|P4|Overall Study|Insuff prostate specific antigen resp|2
723422|NCT00215657|2329304|P3|Overall Study|Insuff prostate specific antigen resp|2
723423|NCT00215657|2329305|P2|Overall Study|Insuff prostate specific antigen resp|2
723424|NCT00215657|2329306|P1|Overall Study|Insuff prostate specific antigen resp|3
723425|NCT00215657|2329299|P8|Overall Study|Withdrawal by Subject|3
723426|NCT00215657|2329300|P7|Overall Study|Withdrawal by Subject|10
723427|NCT00215657|2329301|P6|Overall Study|Withdrawal by Subject|1
723428|NCT00215657|2329302|P5|Overall Study|Withdrawal by Subject|6
723429|NCT00215657|2329303|P4|Overall Study|Withdrawal by Subject|1
723430|NCT00215657|2329304|P3|Overall Study|Withdrawal by Subject|3
723431|NCT00215657|2329305|P2|Overall Study|Withdrawal by Subject|3
723432|NCT00215657|2329306|P1|Overall Study|Withdrawal by Subject|6
723433|NCT00215657|2329299|P8|Overall Study|Adverse Event|3
723434|NCT00215657|2329300|P7|Overall Study|Adverse Event|0
723435|NCT00215657|2329301|P6|Overall Study|Adverse Event|1
723436|NCT00215657|2329302|P5|Overall Study|Adverse Event|3
723437|NCT00215657|2329303|P4|Overall Study|Adverse Event|0
723438|NCT00215657|2329304|P3|Overall Study|Adverse Event|3
723439|NCT00215657|2329305|P2|Overall Study|Adverse Event|1
723440|NCT00215657|2329306|P1|Overall Study|Adverse Event|5
723441|NCT00215683|2329335|P3|Overall Study|Intermittent therapy required|0
723442|NCT00215683|2329336|P2|Overall Study|Intermittent therapy required|1
723443|NCT00215683|2329337|P1|Overall Study|Intermittent therapy required|0
723444|NCT00215683|2329335|P3|Overall Study|No study drug available|0
723445|NCT00215683|2329336|P2|Overall Study|No study drug available|1
723446|NCT00215683|2329337|P1|Overall Study|No study drug available|0
723447|NCT00215683|2329335|P3|Overall Study|Difficult to attend visits|0
723448|NCT00215683|2329336|P2|Overall Study|Difficult to attend visits|1
723449|NCT00215683|2329337|P1|Overall Study|Difficult to attend visits|0
723450|NCT00215683|2329335|P3|Overall Study|Physician Decision|1
723451|NCT00215683|2329336|P2|Overall Study|Physician Decision|0
723452|NCT00215683|2329337|P1|Overall Study|Physician Decision|0
723453|NCT00215683|2329335|P3|Overall Study|Withdrawal by Subject|13
723454|NCT00215683|2329336|P2|Overall Study|Withdrawal by Subject|4
723455|NCT00215683|2329337|P1|Overall Study|Withdrawal by Subject|9
723456|NCT00215683|2329335|P3|Overall Study|Lost to Follow-up|1
723457|NCT00215683|2329336|P2|Overall Study|Lost to Follow-up|2
723458|NCT00215683|2329337|P1|Overall Study|Lost to Follow-up|0
723459|NCT00215683|2329335|P3|Overall Study|Lack of Efficacy|2
723460|NCT00215683|2329336|P2|Overall Study|Lack of Efficacy|1
723461|NCT00215683|2329337|P1|Overall Study|Lack of Efficacy|5
723462|NCT00215683|2329335|P3|Overall Study|Adverse Event|15
723463|NCT00215683|2329336|P2|Overall Study|Adverse Event|16
723464|NCT00215683|2329337|P1|Overall Study|Adverse Event|15
723465|NCT00216086|2329371|P1|Overall Study|Social Reasons|2
723466|NCT00216086|2329371|P1|Overall Study|Diagnosis of Metastatic Disease|1
723467|NCT00216086|2329371|P1|Overall Study|Protocol Violation|1
723468|NCT00216203|2329400|P1|Overall Study|Withdrawal by Subject|2
723469|NCT00216476|2329430|P3|Overall Study|Patient Moved|0
723470|NCT00216476|2329431|P2|Overall Study|Patient Moved|2
723471|NCT00216476|2329432|P1|Overall Study|Patient Moved|2
723472|NCT00216476|2329430|P3|Overall Study|Protocol Deviation|0
723473|NCT00216476|2329431|P2|Overall Study|Protocol Deviation|1
723474|NCT00216476|2329432|P1|Overall Study|Protocol Deviation|5
723475|NCT00216476|2329430|P3|Overall Study|Administrative Reasons|0
723476|NCT00216476|2329431|P2|Overall Study|Administrative Reasons|1
723477|NCT00216476|2329432|P1|Overall Study|Administrative Reasons|1
723478|NCT00216476|2329430|P3|Overall Study|Higher dose/Extra Medication Required|2
723479|NCT00216476|2329431|P2|Overall Study|Higher dose/Extra Medication Required|0
723480|NCT00216476|2329432|P1|Overall Study|Higher dose/Extra Medication Required|2
723481|NCT00216476|2329430|P3|Overall Study|Non-compliance|1
723482|NCT00216476|2329431|P2|Overall Study|Non-compliance|4
723483|NCT00216476|2329432|P1|Overall Study|Non-compliance|0
723484|NCT00216476|2329430|P3|Overall Study|No Further Need for Treatment|1
723485|NCT00216476|2329431|P2|Overall Study|No Further Need for Treatment|4
723486|NCT00216476|2329432|P1|Overall Study|No Further Need for Treatment|3
723487|NCT00216476|2329430|P3|Overall Study|Refuses Injection|0
723488|NCT00216476|2329431|P2|Overall Study|Refuses Injection|0
723489|NCT00216476|2329432|P1|Overall Study|Refuses Injection|11
723490|NCT00216476|2329430|P3|Overall Study|Other|1
723491|NCT00216476|2329431|P2|Overall Study|Other|0
723492|NCT00216476|2329432|P1|Overall Study|Other|0
723493|NCT00216476|2329430|P3|Overall Study|Pregnancy|1
723494|NCT00216476|2329431|P2|Overall Study|Pregnancy|1
723495|NCT00216476|2329432|P1|Overall Study|Pregnancy|0
723496|NCT00216476|2329430|P3|Overall Study|Death|0
723497|NCT00216476|2329431|P2|Overall Study|Death|0
723498|NCT00216476|2329432|P1|Overall Study|Death|2
723499|NCT00216476|2329430|P3|Overall Study|Lack of Efficacy|0
723500|NCT00216476|2329431|P2|Overall Study|Lack of Efficacy|3
723501|NCT00216476|2329432|P1|Overall Study|Lack of Efficacy|4
723502|NCT00216476|2329430|P3|Overall Study|Adverse Event|1
723503|NCT00216476|2329431|P2|Overall Study|Adverse Event|10
723504|NCT00216476|2329432|P1|Overall Study|Adverse Event|6
723505|NCT00216476|2329430|P3|Overall Study|Lost to Follow-up|1
723506|NCT00216476|2329431|P2|Overall Study|Lost to Follow-up|9
723507|NCT00216476|2329432|P1|Overall Study|Lost to Follow-up|10
723508|NCT00216476|2329430|P3|Overall Study|Withdrawal by Subject|9
723509|NCT00216476|2329431|P2|Overall Study|Withdrawal by Subject|72
723510|NCT00216476|2329432|P1|Overall Study|Withdrawal by Subject|59
723511|NCT00216671|2329451|P2|Overall Study|Insufficient Response Adverse Event|1
723512|NCT00216671|2329452|P1|Overall Study|Insufficient Response Adverse Event|2
723513|NCT00216671|2329451|P2|Overall Study|Ineligible, no efficacy data|2
723514|NCT00216671|2329452|P1|Overall Study|Ineligible, no efficacy data|2
723515|NCT00216671|2329451|P2|Overall Study|Patient Moved|1
723516|NCT00216671|2329452|P1|Overall Study|Patient Moved|0
723517|NCT00216671|2329451|P2|Overall Study|Investigator Illness|1
723518|NCT00216671|2329452|P1|Overall Study|Investigator Illness|0
723519|NCT00216671|2329451|P2|Overall Study|Relapse|0
723520|NCT00216671|2329452|P1|Overall Study|Relapse|1
723521|NCT00216671|2329451|P2|Overall Study|Protocol Violation|5
723522|NCT00216671|2329452|P1|Overall Study|Protocol Violation|3
723523|NCT00216671|2329451|P2|Overall Study|Physician Decision|1
723524|NCT00216671|2329452|P1|Overall Study|Physician Decision|1
723525|NCT00216671|2329451|P2|Overall Study|Ineligible|2
723526|NCT00216671|2329452|P1|Overall Study|Ineligible|0
723527|NCT00216671|2329451|P2|Overall Study|Non compliant|2
723528|NCT00216671|2329452|P1|Overall Study|Non compliant|2
723529|NCT00216671|2329451|P2|Overall Study|Lost to Follow-up|5
723530|NCT00216671|2329452|P1|Overall Study|Lost to Follow-up|3
723531|NCT00216671|2329451|P2|Overall Study|Insufficient Response|4
723532|NCT00216671|2329452|P1|Overall Study|Insufficient Response|9
723533|NCT00216671|2329451|P2|Overall Study|No Need to Continue Medication|1
723534|NCT00216671|2329452|P1|Overall Study|No Need to Continue Medication|1
723535|NCT00216671|2329451|P2|Overall Study|Refused Injections|13
723536|NCT00216671|2329452|P1|Overall Study|Refused Injections|3
723537|NCT00216671|2329451|P2|Overall Study|Withdrawal by Subject|2
723538|NCT00216671|2329452|P1|Overall Study|Withdrawal by Subject|4
723539|NCT00216671|2329451|P2|Overall Study|Pregnancy|1
723540|NCT00216671|2329452|P1|Overall Study|Pregnancy|0
723541|NCT00216671|2329451|P2|Overall Study|Adverse Event|9
723542|NCT00216671|2329452|P1|Overall Study|Adverse Event|4
723543|NCT00216736|2329470|P2|Overall Study|Lost to Follow-up|1
723544|NCT00216736|2329471|P1|Overall Study|Lost to Follow-up|1
723545|NCT00217022|2329485|P2|Overall Study|Withdrawal by Subject|1
723546|NCT00217022|2329486|P1|Overall Study|Withdrawal by Subject|1
723547|NCT00217087|2329496|P2|Overall Study|completed less than 12 months return|18
723548|NCT00217087|2329497|P1|Overall Study|completed less than 12 months return|10
723549|NCT00217087|2329496|P2|Overall Study|decided to have esophagectomy|2
723550|NCT00217087|2329497|P1|Overall Study|decided to have esophagectomy|1
723551|NCT00217425|2329515|P1|Overall Study|Other|4
723552|NCT00217425|2329515|P1|Overall Study|Other complicating disease|1
723553|NCT00217425|2329515|P1|Overall Study|Withdrawal by Subject|4
723554|NCT00217425|2329515|P1|Overall Study|Adverse Event|8
723555|NCT00217425|2329515|P1|Overall Study|Lack of Efficacy|13
723556|NCT00217425|2329515|P1|Overall Study|Patient ineligible|5
723557|NCT00217425|2329515|P1|Overall Study|Never started treatment|2
723558|NCT00217464|2329532|P1|Overall Study|not specified|2
723559|NCT00217464|2329532|P1|Overall Study|Progression|15
723560|NCT00217581|2329558|P1|Overall Study|Withdrawal by Subject|1
723561|NCT00217620|2329562|P1|Overall Study|Never received treatment|1
723562|NCT00217620|2329562|P1|Overall Study|Ineligible|13
723563|NCT00217620|2329562|P1|Overall Study|Not Protocol Specified|4
723564|NCT00217620|2329562|P1|Overall Study|Progression|31
723565|NCT00217620|2329562|P1|Overall Study|Adverse Event|2
723566|NCT00217672|2329573|P2|Follow-up|Lost to Follow-up|0
723567|NCT00217672|2329574|P1|Follow-up|Lost to Follow-up|1
723568|NCT00217672|2329573|P2|Follow-up|Withdrawal by Subject|0
723569|NCT00217672|2329574|P1|Follow-up|Withdrawal by Subject|4
723570|NCT00217672|2329573|P2|Treatment|secondary malignancy|0
723571|NCT00217672|2329574|P1|Treatment|secondary malignancy|1
723572|NCT00217672|2329573|P2|Treatment|Death|0
723573|NCT00217672|2329574|P1|Treatment|Death|2
723574|NCT00217672|2329573|P2|Treatment|insurance issues|1
723575|NCT00217672|2329574|P1|Treatment|insurance issues|1
723576|NCT00217672|2329573|P2|Treatment|Physician Decision|0
723577|NCT00217672|2329574|P1|Treatment|Physician Decision|6
723578|NCT00217672|2329573|P2|Treatment|reqd treatment not permitted by protocol|0
723579|NCT00217672|2329574|P1|Treatment|reqd treatment not permitted by protocol|6
723580|NCT00217672|2329573|P2|Treatment|Adverse Event|2
723581|NCT00217672|2329574|P1|Treatment|Adverse Event|18
723582|NCT00217672|2329573|P2|Treatment|disease progression|4
723583|NCT00217672|2329574|P1|Treatment|disease progression|33
723584|NCT00217672|2329573|P2|Allocation|Ineligible|0
723585|NCT00217672|2329574|P1|Allocation|Ineligible|2
723586|NCT00217971|2329591|P2|Overall Study|non compliant|0
723587|NCT00217971|2329592|P1|Overall Study|non compliant|1
723588|NCT00217971|2329591|P2|Overall Study|Withdrawal by Subject|12
723589|NCT00217971|2329592|P1|Overall Study|Withdrawal by Subject|7
723590|NCT00217971|2329591|P2|Overall Study|Physician Decision|1
723591|NCT00217971|2329592|P1|Overall Study|Physician Decision|0
723592|NCT00217971|2329591|P2|Overall Study|Lost to Follow-up|19
723593|NCT00217971|2329592|P1|Overall Study|Lost to Follow-up|15
723594|NCT00217971|2329591|P2|Overall Study|Adverse Event|1
723595|NCT00217971|2329592|P1|Overall Study|Adverse Event|1
723602|NCT00218543|2329770|P1|Overall Study|Adverse Event|2
723603|NCT00218543|2329770|P1|Overall Study|Physician Decision|3
723604|NCT00218543|2329770|P1|Overall Study|Withdrawal by Subject|1
723605|NCT00218543|2329770|P1|Overall Study|relocated|1
723606|NCT00218543|2329770|P1|Overall Study|Lost to Follow-up|8
723607|NCT00212355|2329790|P1|Overall Study|A change of address|1
723608|NCT00212355|2329790|P1|Overall Study|Withdrawal by Subject|1
723609|NCT00212355|2329790|P1|Overall Study|Adverse Event|1
723610|NCT00212758|2329794|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
723611|NCT00212758|2329795|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
723612|NCT00212758|2329794|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
723613|NCT00212758|2329795|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
723614|NCT00218634|2329803|P2|Overall Study|Lost to Follow-up|15
723615|NCT00218634|2329804|P1|Overall Study|Lost to Follow-up|8
723616|NCT00219141|2329827|P3|Overall Study|Condition no longer requires study drug|0
723617|NCT00219141|2329828|P2|Overall Study|Condition no longer requires study drug|0
723618|NCT00219141|2329829|P1|Overall Study|Condition no longer requires study drug|1
723619|NCT00219141|2329827|P3|Overall Study|Withdrawal by Subject|5
723620|NCT00219141|2329828|P2|Overall Study|Withdrawal by Subject|3
723621|NCT00219141|2329829|P1|Overall Study|Withdrawal by Subject|1
723622|NCT00219141|2329827|P3|Overall Study|Protocol Violation|1
723623|NCT00219141|2329828|P2|Overall Study|Protocol Violation|1
723624|NCT00219141|2329829|P1|Overall Study|Protocol Violation|3
723625|NCT00219141|2329827|P3|Overall Study|Lost to Follow-up|1
723626|NCT00219141|2329828|P2|Overall Study|Lost to Follow-up|4
723627|NCT00219141|2329829|P1|Overall Study|Lost to Follow-up|2
723628|NCT00219141|2329827|P3|Overall Study|Administrative problems|0
723629|NCT00219141|2329828|P2|Overall Study|Administrative problems|1
723630|NCT00219141|2329829|P1|Overall Study|Administrative problems|0
723631|NCT00219141|2329827|P3|Overall Study|Lack of Efficacy|0
723632|NCT00219141|2329828|P2|Overall Study|Lack of Efficacy|2
723633|NCT00219141|2329829|P1|Overall Study|Lack of Efficacy|3
723634|NCT00219141|2329827|P3|Overall Study|Adverse Event|5
723635|NCT00219141|2329828|P2|Overall Study|Adverse Event|10
723636|NCT00219141|2329829|P1|Overall Study|Adverse Event|4
723637|NCT00219284|2329875|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
723638|NCT00219284|2329876|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
723639|NCT00219284|2329875|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
723640|NCT00219284|2329876|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
723641|NCT00219284|2329875|P2|Extension Phase - 8 Weeks|Adverse Event|3
723642|NCT00219284|2329876|P1|Extension Phase - 8 Weeks|Adverse Event|2
723643|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
723644|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
723645|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
723646|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
723647|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
723648|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
723649|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
723650|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
723651|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
723652|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
723653|NCT00219284|2329875|P2|Treatment Phase - 16 Weeks|Adverse Event|24
723654|NCT00219284|2329876|P1|Treatment Phase - 16 Weeks|Adverse Event|26
723660|NCT00219544|2329902|P2|Single Blind Treatment Period|Withdrawal by Subject|0
723661|NCT00219544|2329903|P1|Single Blind Treatment Period|Withdrawal by Subject|1
723662|NCT00219544|2329902|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
723663|NCT00219544|2329903|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
723664|NCT00219544|2329902|P2|Single Blind Treatment Period|Lost to Follow-up|0
723665|NCT00219544|2329903|P1|Single Blind Treatment Period|Lost to Follow-up|2
723666|NCT00219544|2329902|P2|Single Blind Treatment Period|Protocol Violation|0
723667|NCT00219544|2329903|P1|Single Blind Treatment Period|Protocol Violation|4
723668|NCT00219544|2329902|P2|Single Blind Treatment Period|Adverse Event|0
723669|NCT00219544|2329903|P1|Single Blind Treatment Period|Adverse Event|9
723670|NCT00219544|2329902|P2|Single Blind Treatment Period|Lack of Efficacy|0
723671|NCT00219544|2329903|P1|Single Blind Treatment Period|Lack of Efficacy|5
723672|NCT00219557|2329944|P3|Phase 2|Treatment not received|3
723673|NCT00219557|2329945|P2|Phase 2|Treatment not received|1
723674|NCT00219557|2329946|P1|Phase 2|Treatment not received|0
723675|NCT00219557|2329944|P3|Phase 2|Withdrawal by Subject|5
723676|NCT00219557|2329945|P2|Phase 2|Withdrawal by Subject|9
723677|NCT00219557|2329946|P1|Phase 2|Withdrawal by Subject|0
723678|NCT00219557|2329944|P3|Phase 2|Unspecified|6
723679|NCT00219557|2329945|P2|Phase 2|Unspecified|8
723680|NCT00219557|2329946|P1|Phase 2|Unspecified|0
723681|NCT00219557|2329944|P3|Phase 2|Death|2
723682|NCT00219557|2329945|P2|Phase 2|Death|8
723683|NCT00219557|2329946|P1|Phase 2|Death|0
723684|NCT00219557|2329944|P3|Phase 2|Adverse Event|2
723685|NCT00219557|2329945|P2|Phase 2|Adverse Event|22
723686|NCT00219557|2329946|P1|Phase 2|Adverse Event|0
723687|NCT00219557|2329944|P3|Phase 2|Lack of Efficacy|15
723688|NCT00219557|2329945|P2|Phase 2|Lack of Efficacy|21
723689|NCT00219557|2329946|P1|Phase 2|Lack of Efficacy|0
723690|NCT00219557|2329944|P3|Phase 1|Started chemotherapy at other institute|0
723691|NCT00219557|2329945|P2|Phase 1|Started chemotherapy at other institute|0
723692|NCT00219557|2329946|P1|Phase 1|Started chemotherapy at other institute|1
723693|NCT00219557|2329944|P3|Phase 1|Withdrawal by Subject|0
723694|NCT00219557|2329945|P2|Phase 1|Withdrawal by Subject|0
723695|NCT00219557|2329946|P1|Phase 1|Withdrawal by Subject|1
723696|NCT00219557|2329944|P3|Phase 1|Adverse Event|0
723697|NCT00219557|2329945|P2|Phase 1|Adverse Event|0
723698|NCT00219557|2329946|P1|Phase 1|Adverse Event|2
723699|NCT00219557|2329944|P3|Phase 1|Lack of Efficacy|0
723700|NCT00219557|2329945|P2|Phase 1|Lack of Efficacy|0
723701|NCT00219557|2329946|P1|Phase 1|Lack of Efficacy|3
723702|NCT00220636|2329974|P1|Overall Study|Withdrawal by Subject|4
723703|NCT00220701|2329983|P2|Overall Study|Lost to Follow-up|4
723704|NCT00220701|2329984|P1|Overall Study|Lost to Follow-up|5
723705|NCT00220727|2330002|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
723706|NCT00220727|2330003|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
723707|NCT00220740|2330019|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
723708|NCT00220740|2330020|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
723709|NCT00220740|2330019|P2|Efficacy Period|Protocol Violation|0
723710|NCT00220740|2330020|P1|Efficacy Period|Protocol Violation|1
723711|NCT00220740|2330019|P2|Efficacy Period|Withdrawal by Subject|0
723712|NCT00220740|2330020|P1|Efficacy Period|Withdrawal by Subject|1
723713|NCT00220740|2330019|P2|Efficacy Period|Adverse Event|1
723714|NCT00220740|2330020|P1|Efficacy Period|Adverse Event|1
723715|NCT00220740|2330019|P2|Efficacy Period|Entered rescue treatment with placebo|0
723716|NCT00220740|2330020|P1|Efficacy Period|Entered rescue treatment with placebo|23
723717|NCT00220779|2330035|P3|Overall Study|Lack of Efficacy|1
723718|NCT00220779|2330036|P2|Overall Study|Lack of Efficacy|0
723719|NCT00220779|2330037|P1|Overall Study|Lack of Efficacy|3
723720|NCT00220779|2330035|P3|Overall Study|Pregnancy|2
723721|NCT00220779|2330036|P2|Overall Study|Pregnancy|0
723722|NCT00220779|2330037|P1|Overall Study|Pregnancy|0
723723|NCT00220779|2330035|P3|Overall Study|Too time consuming|0
723724|NCT00220779|2330036|P2|Overall Study|Too time consuming|0
723725|NCT00220779|2330037|P1|Overall Study|Too time consuming|1
723726|NCT00220779|2330035|P3|Overall Study|Non-compliance|0
723727|NCT00220779|2330036|P2|Overall Study|Non-compliance|0
723728|NCT00220779|2330037|P1|Overall Study|Non-compliance|1
723729|NCT00220779|2330035|P3|Overall Study|Withdrawal by Subject|1
723730|NCT00220779|2330036|P2|Overall Study|Withdrawal by Subject|4
723731|NCT00220779|2330037|P1|Overall Study|Withdrawal by Subject|1
723732|NCT00220779|2330035|P3|Overall Study|Adverse Event|0
723733|NCT00220779|2330036|P2|Overall Study|Adverse Event|0
723734|NCT00220779|2330037|P1|Overall Study|Adverse Event|1
723735|NCT00220805|2330047|P2|Overall Study|Develop. of choroidal neovascularization|8
723736|NCT00220805|2330048|P1|Overall Study|Develop. of choroidal neovascularization|3
723737|NCT00220805|2330047|P2|Overall Study|Lack of Efficacy|0
723738|NCT00220805|2330048|P1|Overall Study|Lack of Efficacy|1
723739|NCT00220805|2330047|P2|Overall Study|Withdrawal by Subject|0
723740|NCT00220805|2330048|P1|Overall Study|Withdrawal by Subject|3
723741|NCT00220805|2330047|P2|Overall Study|Adverse Event|3
723742|NCT00220805|2330048|P1|Overall Study|Adverse Event|1
723743|NCT00221195|2330085|P2|Overall Study|Lost to Follow-up|1
723744|NCT00221195|2330086|P1|Overall Study|Lost to Follow-up|0
723745|NCT00221195|2330085|P2|Overall Study|Death|1
723746|NCT00221195|2330086|P1|Overall Study|Death|1
723747|NCT00221195|2330085|P2|Overall Study|Withdrawal by Subject|1
723748|NCT00221195|2330086|P1|Overall Study|Withdrawal by Subject|4
723749|NCT00215943|2330119|P2|Overall Study|Other complications|1
723750|NCT00215943|2330120|P1|Overall Study|Other complications|3
723751|NCT00215943|2330119|P2|Overall Study|Other disease|1
723752|NCT00215943|2330120|P1|Overall Study|Other disease|0
723753|NCT00215943|2330119|P2|Overall Study|Adverse Event|6
723754|NCT00215943|2330120|P1|Overall Study|Adverse Event|3
723755|NCT00215943|2330119|P2|Overall Study|Alternate therapy|1
723756|NCT00215943|2330120|P1|Overall Study|Alternate therapy|0
723757|NCT00215943|2330119|P2|Overall Study|Disease Progression|5
723758|NCT00215943|2330120|P1|Overall Study|Disease Progression|3
723759|NCT00222105|2330132|P1|Overall Study|Death|2
723760|NCT00222105|2330132|P1|Overall Study|Treatment delays|2
723761|NCT00222105|2330132|P1|Overall Study|Adverse Event|8
723762|NCT00222105|2330132|P1|Overall Study|Withdrawal by Subject|1
723763|NCT00222105|2330132|P1|Overall Study|Removed due to wrong diagnosis|1
723764|NCT00222729|2330137|P1|Overall Study|Adverse Event|3
723765|NCT00223496|2330159|P1|Overall Study|Physician Decision|2
723766|NCT00223496|2330159|P1|Overall Study|Withdrawal by Subject|1
723767|NCT00223496|2330159|P1|Overall Study|Lack of Efficacy|6
723768|NCT00223496|2330159|P1|Overall Study|Lost to Follow-up|4
723769|NCT00223496|2330159|P1|Overall Study|screen failure|9
723774|NCT00223808|2330227|P3|Overall Study|<5 hrs therapy before discharge|5
723775|NCT00223808|2330228|P2|Overall Study|<5 hrs therapy before discharge|5
723776|NCT00223808|2330229|P1|Overall Study|<5 hrs therapy before discharge|3
723777|NCT00223977|2330260|P3|Overall Study|not specified|0
723778|NCT00223977|2330261|P2|Overall Study|not specified|0
723779|NCT00223977|2330262|P1|Overall Study|not specified|1
723780|NCT00223977|2330260|P3|Overall Study|Withdrawal by Subject|2
723781|NCT00223977|2330261|P2|Overall Study|Withdrawal by Subject|1
723782|NCT00223977|2330262|P1|Overall Study|Withdrawal by Subject|1
723783|NCT00223977|2330260|P3|Overall Study|Protocol Violation|1
723784|NCT00223977|2330261|P2|Overall Study|Protocol Violation|0
723785|NCT00223977|2330262|P1|Overall Study|Protocol Violation|0
723786|NCT00223977|2330260|P3|Overall Study|Adverse Event|0
723787|NCT00223977|2330261|P2|Overall Study|Adverse Event|10
723788|NCT00223977|2330262|P1|Overall Study|Adverse Event|7
723789|NCT00224003|2330282|P1|Overall Study|unk|3
723790|NCT00224003|2330282|P1|Overall Study|Withdrawal by Subject|1
723791|NCT00224003|2330282|P1|Overall Study|Protocol Violation|2
723792|NCT00224003|2330282|P1|Overall Study|Adverse Event|1
723793|NCT00224016|2330288|P2|Maintenance Period|Lost to Follow-up|1
723794|NCT00224016|2330289|P1|Maintenance Period|Lost to Follow-up|0
723795|NCT00224016|2330288|P2|Maintenance Period|Withdrawal by Subject|0
723796|NCT00224016|2330289|P1|Maintenance Period|Withdrawal by Subject|2
723797|NCT00224016|2330288|P2|Titration Period|Lost to Follow-up|0
723798|NCT00224016|2330289|P1|Titration Period|Lost to Follow-up|1
723799|NCT00224016|2330288|P2|Titration Period|Withdrawal by Subject|1
723800|NCT00224016|2330289|P1|Titration Period|Withdrawal by Subject|0
723801|NCT00224029|2330297|P1|Overall Study|Other|1
723802|NCT00224029|2330297|P1|Overall Study|Withdrawal by Subject|4
723803|NCT00224029|2330297|P1|Overall Study|Lost to Follow-up|1
723804|NCT00224042|2330303|P2|Overall Study|Not specified|0
723805|NCT00224042|2330304|P1|Overall Study|Not specified|2
723806|NCT00224042|2330303|P2|Overall Study|Did not meet lab incusion criteria|3
723807|NCT00224042|2330304|P1|Overall Study|Did not meet lab incusion criteria|2
723808|NCT00224042|2330303|P2|Overall Study|Physician Decision|1
723809|NCT00224042|2330304|P1|Overall Study|Physician Decision|0
723810|NCT00224042|2330303|P2|Overall Study|Protocol Violation|1
723811|NCT00224042|2330304|P1|Overall Study|Protocol Violation|0
723812|NCT00224042|2330303|P2|Overall Study|Adverse Event|1
723813|NCT00224042|2330304|P1|Overall Study|Adverse Event|2
723814|NCT00224055|2330318|P2|Overall Study|Not Specified|0
723815|NCT00224055|2330319|P1|Overall Study|Not Specified|1
723816|NCT00224055|2330318|P2|Overall Study|Withdrawal by Subject|2
723817|NCT00224055|2330319|P1|Overall Study|Withdrawal by Subject|0
723818|NCT00224055|2330318|P2|Overall Study|Inclusion Violation|6
723819|NCT00224055|2330319|P1|Overall Study|Inclusion Violation|3
723820|NCT00224055|2330318|P2|Overall Study|Protocol Violation|1
723821|NCT00224055|2330319|P1|Overall Study|Protocol Violation|1
723822|NCT00224055|2330318|P2|Overall Study|Lost to Follow-up|2
723823|NCT00224055|2330319|P1|Overall Study|Lost to Follow-up|1
723824|NCT00224055|2330318|P2|Overall Study|Adverse Event|3
723825|NCT00224055|2330319|P1|Overall Study|Adverse Event|9
723826|NCT00224107|2330329|P2|Overall Study|Not specified|1
723827|NCT00224107|2330330|P1|Overall Study|Not specified|1
723828|NCT00224107|2330329|P2|Overall Study|Physician Decision|0
723829|NCT00224107|2330330|P1|Overall Study|Physician Decision|1
723830|NCT00224107|2330329|P2|Overall Study|Lost to Follow-up|0
723831|NCT00224107|2330330|P1|Overall Study|Lost to Follow-up|4
723832|NCT00224107|2330329|P2|Overall Study|Lack of Efficacy|0
723833|NCT00224107|2330330|P1|Overall Study|Lack of Efficacy|2
723834|NCT00224107|2330329|P2|Overall Study|Withdrawal by Subject|4
723835|NCT00224107|2330330|P1|Overall Study|Withdrawal by Subject|1
723836|NCT00224107|2330329|P2|Overall Study|Protocol Violation|3
723837|NCT00224107|2330330|P1|Overall Study|Protocol Violation|2
723838|NCT00224107|2330329|P2|Overall Study|Adverse Event|6
723839|NCT00224107|2330330|P1|Overall Study|Adverse Event|20
723840|NCT00224120|2330340|P2|Overall Study|Not specified|5
723841|NCT00224120|2330341|P1|Overall Study|Not specified|4
723842|NCT00224120|2330340|P2|Overall Study|Lost to Follow-up|3
723843|NCT00224120|2330341|P1|Overall Study|Lost to Follow-up|2
723844|NCT00224120|2330340|P2|Overall Study|Lack of Efficacy|2
723845|NCT00224120|2330341|P1|Overall Study|Lack of Efficacy|0
723846|NCT00224120|2330340|P2|Overall Study|Withdrawal by Subject|10
723847|NCT00224120|2330341|P1|Overall Study|Withdrawal by Subject|5
723848|NCT00224120|2330340|P2|Overall Study|Protocol Violation|0
723849|NCT00224120|2330341|P1|Overall Study|Protocol Violation|1
723850|NCT00224120|2330340|P2|Overall Study|Adverse Event|4
723851|NCT00224120|2330341|P1|Overall Study|Adverse Event|10
723852|NCT00224133|2330349|P1|Overall Study|Not specified|14
723853|NCT00224133|2330349|P1|Overall Study|Physician Decision|1
723854|NCT00224133|2330349|P1|Overall Study|Lost to Follow-up|21
723855|NCT00224133|2330349|P1|Overall Study|Lack of Efficacy|58
723856|NCT00224133|2330349|P1|Overall Study|Withdrawal by Subject|33
723857|NCT00224133|2330349|P1|Overall Study|Protocol Violation|6
723858|NCT00224133|2330349|P1|Overall Study|Adverse Event|93
723859|NCT00224484|2330361|P3|Overall Study|Reaon not specified|2
723860|NCT00224484|2330362|P2|Overall Study|Reaon not specified|4
723861|NCT00224484|2330363|P1|Overall Study|Reaon not specified|5
723862|NCT00224484|2330361|P3|Overall Study|Lost to Follow-up|36
723863|NCT00224484|2330362|P2|Overall Study|Lost to Follow-up|28
723864|NCT00224484|2330363|P1|Overall Study|Lost to Follow-up|66
723865|NCT00224484|2330361|P3|Overall Study|Migrated/moved from study area|5
723866|NCT00224484|2330362|P2|Overall Study|Migrated/moved from study area|5
723867|NCT00224484|2330363|P1|Overall Study|Migrated/moved from study area|18
723868|NCT00224484|2330361|P3|Overall Study|Withdrawal by Subject|16
723869|NCT00224484|2330362|P2|Overall Study|Withdrawal by Subject|18
723870|NCT00224484|2330363|P1|Overall Study|Withdrawal by Subject|49
723871|NCT00224484|2330361|P3|Overall Study|Protocol Violation|0
723872|NCT00224484|2330362|P2|Overall Study|Protocol Violation|2
723873|NCT00224484|2330363|P1|Overall Study|Protocol Violation|2
723874|NCT00224484|2330361|P3|Overall Study|Non-Serious Adverse Event|3
723875|NCT00224484|2330362|P2|Overall Study|Non-Serious Adverse Event|7
723876|NCT00224484|2330363|P1|Overall Study|Non-Serious Adverse Event|5
723877|NCT00224484|2330361|P3|Overall Study|Serious Adverse Event|0
723878|NCT00224484|2330362|P2|Overall Study|Serious Adverse Event|1
723879|NCT00224484|2330363|P1|Overall Study|Serious Adverse Event|1
723880|NCT00224770|2330425|P3|Overall Study|Lost to Follow-up|0
723881|NCT00224770|2330426|P2|Overall Study|Lost to Follow-up|2
723882|NCT00224770|2330427|P1|Overall Study|Lost to Follow-up|4
723883|NCT00225212|2330459|P1|Overall Study|Intercurrent illness|1
723884|NCT00225212|2330459|P1|Overall Study|Adverse Event|2
723885|NCT00225212|2330459|P1|Overall Study|Death|1
723886|NCT00225212|2330459|P1|Overall Study|Disease progression|2
723887|NCT00225251|2330466|P2|Overall Study|Withdrawal by Subject|1
723888|NCT00225251|2330467|P1|Overall Study|Withdrawal by Subject|1
723889|NCT00225277|2330483|P2|Overall Study|Other|9
723890|NCT00225277|2330484|P1|Overall Study|Other|7
723891|NCT00225277|2330483|P2|Overall Study|Withdrawal by Subject|34
723892|NCT00225277|2330484|P1|Overall Study|Withdrawal by Subject|40
723893|NCT00225277|2330483|P2|Overall Study|Protocol Violation|3
723894|NCT00225277|2330484|P1|Overall Study|Protocol Violation|6
723895|NCT00225277|2330483|P2|Overall Study|Physician Decision|8
723896|NCT00225277|2330484|P1|Overall Study|Physician Decision|6
723897|NCT00225277|2330483|P2|Overall Study|Lost to Follow-up|6
723898|NCT00225277|2330484|P1|Overall Study|Lost to Follow-up|4
723899|NCT00225277|2330483|P2|Overall Study|Lack of Efficacy|1
723900|NCT00225277|2330484|P1|Overall Study|Lack of Efficacy|4
723901|NCT00225277|2330483|P2|Overall Study|Adverse Event|34
723902|NCT00225277|2330484|P1|Overall Study|Adverse Event|30
723903|NCT00226655|2330557|P1|Overall Study|Clinical deterioration|10
723904|NCT00226655|2330557|P1|Overall Study|Physician Decision|6
723905|NCT00226655|2330557|P1|Overall Study|Adverse Event|35
723906|NCT00226655|2330557|P1|Overall Study|Withdrawal by Subject|15
723907|NCT00226655|2330557|P1|Overall Study|Death|13
723908|NCT00226811|2330561|P1|Overall Study|Withdrawal by Subject|2
723909|NCT00226811|2330561|P1|Overall Study|Lack of Efficacy|55
723910|NCT00226811|2330561|P1|Overall Study|Adverse Event|11
723911|NCT00226811|2330561|P1|Overall Study|Death|8
723912|NCT00227266|2330580|P3|Overall Study|Excessive weight gain|2
723913|NCT00227266|2330581|P2|Overall Study|Excessive weight gain|0
723914|NCT00227266|2330582|P1|Overall Study|Excessive weight gain|0
723915|NCT00227266|2330580|P3|Overall Study|Protocol Violation|1
723916|NCT00227266|2330581|P2|Overall Study|Protocol Violation|0
723917|NCT00227266|2330582|P1|Overall Study|Protocol Violation|1
723918|NCT00227266|2330580|P3|Overall Study|Withdrawal by Subject|1
723919|NCT00227266|2330581|P2|Overall Study|Withdrawal by Subject|0
723920|NCT00227266|2330582|P1|Overall Study|Withdrawal by Subject|0
723921|NCT00227305|2330602|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
723922|NCT00227305|2330602|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
723923|NCT00227305|2330602|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
723924|NCT00227305|2330602|P1|Overall Study|Physician Decision|3
723925|NCT00227305|2330602|P1|Overall Study|Lack of Efficacy|7
723926|NCT00227305|2330602|P1|Overall Study|MOVED OUT OF AREA|3
723927|NCT00227305|2330602|P1|Overall Study|Study specific discontinuation|13
723928|NCT00227305|2330602|P1|Overall Study|Lost to Follow-up|33
723929|NCT00227305|2330602|P1|Overall Study|Withdrawal by Subject|42
723930|NCT00227305|2330602|P1|Overall Study|Adverse Event|40
723931|NCT00227344|2330618|P2|Overall Study|study terminated early|5
723932|NCT00227344|2330619|P1|Overall Study|study terminated early|12
723933|NCT00227370|2330641|P2|Overall Study|Other reasons|1
723934|NCT00227370|2330642|P1|Overall Study|Other reasons|2
723935|NCT00227370|2330641|P2|Overall Study|Physician Decision|6
723936|NCT00227370|2330642|P1|Overall Study|Physician Decision|9
723937|NCT00227370|2330641|P2|Overall Study|Adverse Event|11
723938|NCT00227370|2330642|P1|Overall Study|Adverse Event|6
723939|NCT00227370|2330641|P2|Overall Study|Death|4
723940|NCT00227370|2330642|P1|Overall Study|Death|3
723941|NCT00227370|2330641|P2|Overall Study|Withdrawal by Subject|2
723942|NCT00227370|2330642|P1|Overall Study|Withdrawal by Subject|1
723943|NCT00227539|2330660|P1|Overall Study|Protocol Violation|1
723944|NCT00227591|2330666|P1|Overall Study|Withdrawal by Subject|1
723945|NCT00227721|2330670|P1|Overall Study|On study, but never treated.|1
723946|NCT00227903|2330682|P2|Overall Study|Miscarriage|0
723947|NCT00227903|2330683|P1|Overall Study|Miscarriage|1
723948|NCT00227903|2330682|P2|Overall Study|Lost to Follow-up|3
723949|NCT00227903|2330683|P1|Overall Study|Lost to Follow-up|1
723950|NCT00227903|2330682|P2|Overall Study|Subject moved out of area|2
723951|NCT00227903|2330683|P1|Overall Study|Subject moved out of area|1
723952|NCT00227903|2330682|P2|Overall Study|Withdrawal by Subject|5
723953|NCT00227903|2330683|P1|Overall Study|Withdrawal by Subject|2
723954|NCT00228384|2330756|P2|Overall Study|Physician Decision|1
723955|NCT00228384|2330757|P1|Overall Study|Physician Decision|0
723956|NCT00228384|2330756|P2|Overall Study|Withdrawal by Subject|10
723957|NCT00228384|2330757|P1|Overall Study|Withdrawal by Subject|9
723958|NCT00228384|2330756|P2|Overall Study|Surgical Intervention (bypass)|5
723959|NCT00228384|2330757|P1|Overall Study|Surgical Intervention (bypass)|5
723960|NCT00228384|2330756|P2|Overall Study|Lost to Follow-up|10
723961|NCT00228384|2330757|P1|Overall Study|Lost to Follow-up|6
723962|NCT00228384|2330756|P2|Overall Study|Death|3
723963|NCT00228384|2330757|P1|Overall Study|Death|9
723964|NCT00228553|2330795|P1|Overall Study|Miscellaneous|46
723965|NCT00228553|2330795|P1|Overall Study|Pregnancy|2
723966|NCT00228553|2330795|P1|Overall Study|Withdrawal by Subject|115
723967|NCT00228553|2330795|P1|Overall Study|Protocol Violation|6
723968|NCT00228553|2330795|P1|Overall Study|Physician Decision|48
723969|NCT00228553|2330795|P1|Overall Study|Lost to Follow-up|67
723970|NCT00228553|2330795|P1|Overall Study|Lack of Efficacy|34
723971|NCT00228553|2330795|P1|Overall Study|Adverse Event|112
723972|NCT00228566|2330799|P1|Overall Study|Miscellaneous|1
723973|NCT00228566|2330799|P1|Overall Study|Withdrawal by Subject|4
723974|NCT00228566|2330799|P1|Overall Study|Physician Decision|5
723975|NCT00228566|2330799|P1|Overall Study|Lost to Follow-up|16
723976|NCT00228566|2330799|P1|Overall Study|Lack of Efficacy|14
723977|NCT00228566|2330799|P1|Overall Study|Adverse Event|31
723978|NCT00228813|2330803|P1|Overall Study|Death|4
723979|NCT00228917|2330813|P4|Overall Study|Migrated/moved from study area|0
723980|NCT00228917|2330814|P3|Overall Study|Migrated/moved from study area|0
723981|NCT00228917|2330815|P2|Overall Study|Migrated/moved from study area|3
723982|NCT00228917|2330816|P1|Overall Study|Migrated/moved from study area|0
723983|NCT00228917|2330813|P4|Overall Study|Lost to Follow-up|0
723984|NCT00228917|2330814|P3|Overall Study|Lost to Follow-up|0
723985|NCT00228917|2330815|P2|Overall Study|Lost to Follow-up|0
723986|NCT00228917|2330816|P1|Overall Study|Lost to Follow-up|1
723987|NCT00229203|2330852|P2|Overall Study|Withdrawal by Subject|4
723988|NCT00229203|2330853|P1|Overall Study|Withdrawal by Subject|1
723989|NCT00229203|2330852|P2|Overall Study|Other|3
723990|NCT00229203|2330853|P1|Overall Study|Other|3
723991|NCT00229203|2330852|P2|Overall Study|Death|2
723992|NCT00229203|2330853|P1|Overall Study|Death|4
723993|NCT00229203|2330852|P2|Overall Study|Toxicity|1
723994|NCT00229203|2330853|P1|Overall Study|Toxicity|6
723995|NCT00229203|2330852|P2|Overall Study|Progressive disease|9
723996|NCT00229203|2330853|P1|Overall Study|Progressive disease|18
723997|NCT00229658|2330871|P2|Overall Study|Withdrawal of consent|39
723998|NCT00229658|2330872|P1|Overall Study|Withdrawal of consent|46
723999|NCT00229658|2330871|P2|Overall Study|Serious Adverse Event|2
724000|NCT00229658|2330872|P1|Overall Study|Serious Adverse Event|2
724001|NCT00229658|2330871|P2|Overall Study|Lost to Follow-up|55
724002|NCT00229658|2330872|P1|Overall Study|Lost to Follow-up|82
724003|NCT00229658|2330871|P2|Overall Study|Other|60
724004|NCT00229658|2330872|P1|Overall Study|Other|80
724005|NCT00229658|2330871|P2|Overall Study|Investigator decision|10
724006|NCT00229658|2330872|P1|Overall Study|Investigator decision|13
724007|NCT00229658|2330871|P2|Overall Study|Administrative|1
724008|NCT00229658|2330872|P1|Overall Study|Administrative|2
724009|NCT00229723|2330907|P7|Maintenance Phase|Unspecified|1
724010|NCT00229723|2330908|P6|Maintenance Phase|Unspecified|3
724011|NCT00229723|2330909|P5|Maintenance Phase|Unspecified|3
724012|NCT00229723|2330910|P4|Maintenance Phase|Unspecified|2
724013|NCT00229723|2330911|P3|Maintenance Phase|Unspecified|1
724014|NCT00229723|2330912|P2|Maintenance Phase|Unspecified|4
724015|NCT00229723|2330913|P1|Maintenance Phase|Unspecified|5
724016|NCT00229723|2330907|P7|Maintenance Phase|Severe non-compliance|0
724017|NCT00229723|2330908|P6|Maintenance Phase|Severe non-compliance|0
724018|NCT00229723|2330909|P5|Maintenance Phase|Severe non-compliance|1
724019|NCT00229723|2330910|P4|Maintenance Phase|Severe non-compliance|0
724020|NCT00229723|2330911|P3|Maintenance Phase|Severe non-compliance|0
724021|NCT00229723|2330912|P2|Maintenance Phase|Severe non-compliance|1
724022|NCT00229723|2330913|P1|Maintenance Phase|Severe non-compliance|3
724023|NCT00229723|2330907|P7|Maintenance Phase|Informed consent withdrawn|0
724024|NCT00229723|2330908|P6|Maintenance Phase|Informed consent withdrawn|1
724025|NCT00229723|2330909|P5|Maintenance Phase|Informed consent withdrawn|1
724026|NCT00229723|2330910|P4|Maintenance Phase|Informed consent withdrawn|1
724027|NCT00229723|2330911|P3|Maintenance Phase|Informed consent withdrawn|0
724028|NCT00229723|2330912|P2|Maintenance Phase|Informed consent withdrawn|0
724029|NCT00229723|2330913|P1|Maintenance Phase|Informed consent withdrawn|1
724030|NCT00229723|2330907|P7|Maintenance Phase|Lost to Follow-up|1
724031|NCT00229723|2330908|P6|Maintenance Phase|Lost to Follow-up|0
724032|NCT00229723|2330909|P5|Maintenance Phase|Lost to Follow-up|0
724033|NCT00229723|2330910|P4|Maintenance Phase|Lost to Follow-up|2
724034|NCT00229723|2330911|P3|Maintenance Phase|Lost to Follow-up|2
724035|NCT00229723|2330912|P2|Maintenance Phase|Lost to Follow-up|1
724036|NCT00229723|2330913|P1|Maintenance Phase|Lost to Follow-up|0
724037|NCT00229723|2330907|P7|Maintenance Phase|Clinical progression|1
724038|NCT00229723|2330908|P6|Maintenance Phase|Clinical progression|1
724039|NCT00229723|2330909|P5|Maintenance Phase|Clinical progression|1
724040|NCT00229723|2330910|P4|Maintenance Phase|Clinical progression|2
724041|NCT00229723|2330911|P3|Maintenance Phase|Clinical progression|2
724042|NCT00229723|2330912|P2|Maintenance Phase|Clinical progression|1
724043|NCT00229723|2330913|P1|Maintenance Phase|Clinical progression|4
724044|NCT00229723|2330907|P7|Maintenance Phase|Objective disease progression|5
724045|NCT00229723|2330908|P6|Maintenance Phase|Objective disease progression|9
724046|NCT00229723|2330909|P5|Maintenance Phase|Objective disease progression|2
724047|NCT00229723|2330910|P4|Maintenance Phase|Objective disease progression|6
724048|NCT00229723|2330911|P3|Maintenance Phase|Objective disease progression|3
724049|NCT00229723|2330912|P2|Maintenance Phase|Objective disease progression|5
724050|NCT00229723|2330913|P1|Maintenance Phase|Objective disease progression|5
724051|NCT00229723|2330907|P7|Maintenance Phase|Adverse Event|2
724052|NCT00229723|2330908|P6|Maintenance Phase|Adverse Event|5
724053|NCT00229723|2330909|P5|Maintenance Phase|Adverse Event|7
724054|NCT00229723|2330910|P4|Maintenance Phase|Adverse Event|4
724055|NCT00229723|2330911|P3|Maintenance Phase|Adverse Event|1
724056|NCT00229723|2330912|P2|Maintenance Phase|Adverse Event|2
724057|NCT00229723|2330913|P1|Maintenance Phase|Adverse Event|7
724058|NCT00229723|2330907|P7|Concomitant Phase|Unspecified|0
724059|NCT00229723|2330908|P6|Concomitant Phase|Unspecified|2
724060|NCT00229723|2330909|P5|Concomitant Phase|Unspecified|0
724061|NCT00229723|2330910|P4|Concomitant Phase|Unspecified|1
724062|NCT00229723|2330911|P3|Concomitant Phase|Unspecified|1
724063|NCT00229723|2330912|P2|Concomitant Phase|Unspecified|0
724064|NCT00229723|2330913|P1|Concomitant Phase|Unspecified|3
724065|NCT00229723|2330907|P7|Concomitant Phase|Severe non-compliance|0
724066|NCT00229723|2330908|P6|Concomitant Phase|Severe non-compliance|0
724067|NCT00229723|2330909|P5|Concomitant Phase|Severe non-compliance|1
724068|NCT00229723|2330910|P4|Concomitant Phase|Severe non-compliance|0
724069|NCT00229723|2330911|P3|Concomitant Phase|Severe non-compliance|0
724070|NCT00229723|2330912|P2|Concomitant Phase|Severe non-compliance|1
724071|NCT00229723|2330913|P1|Concomitant Phase|Severe non-compliance|0
724072|NCT00229723|2330907|P7|Concomitant Phase|Informed consent withdrawn|0
724073|NCT00229723|2330908|P6|Concomitant Phase|Informed consent withdrawn|0
724074|NCT00229723|2330909|P5|Concomitant Phase|Informed consent withdrawn|0
724075|NCT00229723|2330910|P4|Concomitant Phase|Informed consent withdrawn|2
724076|NCT00229723|2330911|P3|Concomitant Phase|Informed consent withdrawn|0
724077|NCT00229723|2330912|P2|Concomitant Phase|Informed consent withdrawn|2
724078|NCT00229723|2330913|P1|Concomitant Phase|Informed consent withdrawn|3
724079|NCT00229723|2330907|P7|Concomitant Phase|Lost to Follow-up|0
724080|NCT00229723|2330908|P6|Concomitant Phase|Lost to Follow-up|0
724081|NCT00229723|2330909|P5|Concomitant Phase|Lost to Follow-up|1
724082|NCT00229723|2330910|P4|Concomitant Phase|Lost to Follow-up|0
724083|NCT00229723|2330911|P3|Concomitant Phase|Lost to Follow-up|0
724084|NCT00229723|2330912|P2|Concomitant Phase|Lost to Follow-up|0
724085|NCT00229723|2330913|P1|Concomitant Phase|Lost to Follow-up|0
724086|NCT00229723|2330907|P7|Concomitant Phase|Clinical progression|1
724087|NCT00229723|2330908|P6|Concomitant Phase|Clinical progression|0
724088|NCT00229723|2330909|P5|Concomitant Phase|Clinical progression|0
724089|NCT00229723|2330910|P4|Concomitant Phase|Clinical progression|0
724090|NCT00229723|2330911|P3|Concomitant Phase|Clinical progression|0
724091|NCT00229723|2330912|P2|Concomitant Phase|Clinical progression|0
724092|NCT00229723|2330913|P1|Concomitant Phase|Clinical progression|0
724093|NCT00229723|2330907|P7|Concomitant Phase|Objective disease progression|0
724094|NCT00229723|2330908|P6|Concomitant Phase|Objective disease progression|0
724095|NCT00229723|2330909|P5|Concomitant Phase|Objective disease progression|0
724096|NCT00229723|2330910|P4|Concomitant Phase|Objective disease progression|0
724097|NCT00229723|2330911|P3|Concomitant Phase|Objective disease progression|0
724098|NCT00229723|2330912|P2|Concomitant Phase|Objective disease progression|0
724099|NCT00229723|2330913|P1|Concomitant Phase|Objective disease progression|0
724100|NCT00229723|2330907|P7|Concomitant Phase|Adverse Event|2
724101|NCT00229723|2330908|P6|Concomitant Phase|Adverse Event|1
724102|NCT00229723|2330909|P5|Concomitant Phase|Adverse Event|0
724103|NCT00229723|2330910|P4|Concomitant Phase|Adverse Event|2
724104|NCT00229723|2330911|P3|Concomitant Phase|Adverse Event|5
724105|NCT00229723|2330912|P2|Concomitant Phase|Adverse Event|2
724106|NCT00229723|2330913|P1|Concomitant Phase|Adverse Event|4
724107|NCT00229931|2330966|P2|Overall Study|Lost to Follow-up|2
724108|NCT00229931|2330967|P1|Overall Study|Lost to Follow-up|3
724109|NCT00229931|2330966|P2|Overall Study|Death|0
724110|NCT00229931|2330967|P1|Overall Study|Death|1
724111|NCT00230048|2331025|P2|Overall Study|Lost to Follow-up|18
724112|NCT00230048|2331026|P1|Overall Study|Lost to Follow-up|13
724113|NCT00230178|2331073|P3|Overall Study|Various other reasons|4
724114|NCT00230178|2331074|P2|Overall Study|Various other reasons|2
724115|NCT00230178|2331075|P1|Overall Study|Various other reasons|3
724116|NCT00230178|2331073|P3|Overall Study|Withdrawal by Subject|1
724117|NCT00230178|2331074|P2|Overall Study|Withdrawal by Subject|0
724118|NCT00230178|2331075|P1|Overall Study|Withdrawal by Subject|0
724119|NCT00230178|2331073|P3|Overall Study|Adverse Event|2
724120|NCT00230178|2331074|P2|Overall Study|Adverse Event|5
724121|NCT00230178|2331075|P1|Overall Study|Adverse Event|1
724122|NCT00230282|2331089|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
724123|NCT00230282|2331089|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
724124|NCT00230282|2331089|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
724125|NCT00230282|2331089|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
724126|NCT00224874|2331124|P4|Overall Study|Withdrawal by Subject|0
724127|NCT00224874|2331125|P3|Overall Study|Withdrawal by Subject|1
724128|NCT00224874|2331126|P2|Overall Study|Withdrawal by Subject|0
724129|NCT00224874|2331127|P1|Overall Study|Withdrawal by Subject|0
724130|NCT00225147|2331202|P4|Open-label Phase|Withdrawal by Subject|6
724131|NCT00225147|2331203|P3|Open-label Phase|Withdrawal by Subject|0
724132|NCT00225147|2331204|P2|Open-label Phase|Withdrawal by Subject|0
724133|NCT00225147|2331205|P1|Open-label Phase|Withdrawal by Subject|0
724134|NCT00225147|2331202|P4|Open-label Phase|Lost to Follow-up|4
724135|NCT00225147|2331203|P3|Open-label Phase|Lost to Follow-up|0
724136|NCT00225147|2331204|P2|Open-label Phase|Lost to Follow-up|0
724137|NCT00225147|2331205|P1|Open-label Phase|Lost to Follow-up|0
724138|NCT00230971|2331221|P2|Baseline Participants|Reintervention|0
724139|NCT00230971|2331222|P1|Baseline Participants|Reintervention|1
724140|NCT00230971|2331221|P2|Baseline Participants|Failure to return|1
724141|NCT00230971|2331222|P1|Baseline Participants|Failure to return|1
724142|NCT00230971|2331221|P2|Baseline Participants|No bacteria observed|0
724143|NCT00230971|2331222|P1|Baseline Participants|No bacteria observed|1
724144|NCT00230971|2331221|P2|Baseline Participants|Adverse Event|0
724145|NCT00230971|2331222|P1|Baseline Participants|Adverse Event|1
724146|NCT00230971|2331221|P2|Baseline Participants|Withdrawal by Subject|1
724147|NCT00230971|2331222|P1|Baseline Participants|Withdrawal by Subject|7
724148|NCT00230971|2331221|P2|Baseline Participants|Death|5
724149|NCT00230971|2331222|P1|Baseline Participants|Death|6
724150|NCT00230971|2331221|P2|Baseline Participants|Lost to Follow-up|12
724151|NCT00230971|2331222|P1|Baseline Participants|Lost to Follow-up|5
724152|NCT00230971|2331221|P2|Randomization|No study drug administered|3
724153|NCT00230971|2331222|P1|Randomization|No study drug administered|3
724154|NCT00231062|2331234|P1|Overall Study|Physician Decision|6
724155|NCT00231114|2331242|P2|Post-Treatment Period|Withdrawal by Subject|0
724156|NCT00231114|2331243|P1|Post-Treatment Period|Withdrawal by Subject|1
724157|NCT00231114|2331242|P2|Post-Treatment Period|Physician Decision|0
724158|NCT00231114|2331243|P1|Post-Treatment Period|Physician Decision|1
724159|NCT00231114|2331242|P2|Post-Treatment Period|Lost to Follow-up|1
724160|NCT00231114|2331243|P1|Post-Treatment Period|Lost to Follow-up|6
724161|NCT00231114|2331242|P2|Treatment Period|Death: Motor Vehicle Accident|0
724162|NCT00231114|2331243|P1|Treatment Period|Death: Motor Vehicle Accident|1
724163|NCT00231114|2331242|P2|Randomized|Withdrawal by Subject|3
724164|NCT00231114|2331243|P1|Randomized|Withdrawal by Subject|6
724165|NCT00231179|2331292|P2|Overall Study|Withdrawal by Subject|3
724166|NCT00231179|2331293|P1|Overall Study|Withdrawal by Subject|3
724167|NCT00231179|2331292|P2|Overall Study|Lost to Follow-up|21
724168|NCT00231179|2331293|P1|Overall Study|Lost to Follow-up|21
724169|NCT00234494|2331307|P1|Overall Study|Protocol Violation|2
724170|NCT00235326|2331352|P2|Overall Study|Lost to Follow-up|1400
724171|NCT00235326|2331353|P1|Overall Study|Lost to Follow-up|746
724172|NCT00235391|2331363|P6|Overall Study|Death|0
724173|NCT00235391|2331364|P5|Overall Study|Death|0
724174|NCT00235391|2331365|P4|Overall Study|Death|4
724175|NCT00235391|2331366|P3|Overall Study|Death|1
724176|NCT00235391|2331367|P2|Overall Study|Death|0
724177|NCT00235391|2331368|P1|Overall Study|Death|0
724178|NCT00235391|2331363|P6|Overall Study|Administrative problems|0
724179|NCT00235391|2331364|P5|Overall Study|Administrative problems|0
724180|NCT00235391|2331365|P4|Overall Study|Administrative problems|1
724181|NCT00235391|2331366|P3|Overall Study|Administrative problems|0
724182|NCT00235391|2331367|P2|Overall Study|Administrative problems|0
724183|NCT00235391|2331368|P1|Overall Study|Administrative problems|0
724184|NCT00235391|2331363|P6|Overall Study|Lost to Follow-up|0
724185|NCT00235391|2331364|P5|Overall Study|Lost to Follow-up|0
724186|NCT00235391|2331365|P4|Overall Study|Lost to Follow-up|16
724187|NCT00235391|2331366|P3|Overall Study|Lost to Follow-up|3
724188|NCT00235391|2331367|P2|Overall Study|Lost to Follow-up|3
724189|NCT00235391|2331368|P1|Overall Study|Lost to Follow-up|0
724190|NCT00235391|2331363|P6|Overall Study|Withdrawal by Subject|0
724191|NCT00235391|2331364|P5|Overall Study|Withdrawal by Subject|5
724192|NCT00235391|2331365|P4|Overall Study|Withdrawal by Subject|61
724193|NCT00235391|2331366|P3|Overall Study|Withdrawal by Subject|3
724194|NCT00235391|2331367|P2|Overall Study|Withdrawal by Subject|3
724195|NCT00235391|2331368|P1|Overall Study|Withdrawal by Subject|2
724196|NCT00235391|2331363|P6|Overall Study|Protocol deviation|0
724197|NCT00235391|2331364|P5|Overall Study|Protocol deviation|0
724198|NCT00235391|2331365|P4|Overall Study|Protocol deviation|11
724199|NCT00235391|2331366|P3|Overall Study|Protocol deviation|1
724200|NCT00235391|2331367|P2|Overall Study|Protocol deviation|0
724201|NCT00235391|2331368|P1|Overall Study|Protocol deviation|0
724202|NCT00235391|2331363|P6|Overall Study|Condition no longer requires treatment|0
724203|NCT00235391|2331364|P5|Overall Study|Condition no longer requires treatment|1
724204|NCT00235391|2331365|P4|Overall Study|Condition no longer requires treatment|11
724205|NCT00235391|2331366|P3|Overall Study|Condition no longer requires treatment|0
724206|NCT00235391|2331367|P2|Overall Study|Condition no longer requires treatment|0
724207|NCT00235391|2331368|P1|Overall Study|Condition no longer requires treatment|3
724208|NCT00235391|2331363|P6|Overall Study|Unsatisfactory therapeutic effect|0
724209|NCT00235391|2331364|P5|Overall Study|Unsatisfactory therapeutic effect|0
724210|NCT00235391|2331365|P4|Overall Study|Unsatisfactory therapeutic effect|17
724211|NCT00235391|2331366|P3|Overall Study|Unsatisfactory therapeutic effect|2
724212|NCT00235391|2331367|P2|Overall Study|Unsatisfactory therapeutic effect|2
724213|NCT00235391|2331368|P1|Overall Study|Unsatisfactory therapeutic effect|0
724214|NCT00235391|2331363|P6|Overall Study|Abnormal laboratory value(s)|2
724215|NCT00235391|2331364|P5|Overall Study|Abnormal laboratory value(s)|1
724216|NCT00235391|2331365|P4|Overall Study|Abnormal laboratory value(s)|27
724217|NCT00235391|2331366|P3|Overall Study|Abnormal laboratory value(s)|4
724218|NCT00235391|2331367|P2|Overall Study|Abnormal laboratory value(s)|5
724219|NCT00235391|2331368|P1|Overall Study|Abnormal laboratory value(s)|3
724220|NCT00235391|2331363|P6|Overall Study|Adverse Event|2
724221|NCT00235391|2331364|P5|Overall Study|Adverse Event|5
724222|NCT00235391|2331365|P4|Overall Study|Adverse Event|72
724223|NCT00235391|2331366|P3|Overall Study|Adverse Event|10
724224|NCT00235391|2331367|P2|Overall Study|Adverse Event|5
724225|NCT00235391|2331368|P1|Overall Study|Adverse Event|4
724226|NCT00235443|2331389|P6|Overall Study|Other reasons for premature termination|6
724227|NCT00235443|2331390|P5|Overall Study|Other reasons for premature termination|3
724228|NCT00235443|2331391|P4|Overall Study|Other reasons for premature termination|7
724229|NCT00235443|2331392|P3|Overall Study|Other reasons for premature termination|6
724230|NCT00235443|2331393|P2|Overall Study|Other reasons for premature termination|6
724231|NCT00235443|2331394|P1|Overall Study|Other reasons for premature termination|1
724232|NCT00235443|2331389|P6|Overall Study|Unsatisfactory compliance|0
724233|NCT00235443|2331390|P5|Overall Study|Unsatisfactory compliance|1
724234|NCT00235443|2331391|P4|Overall Study|Unsatisfactory compliance|4
724235|NCT00235443|2331392|P3|Overall Study|Unsatisfactory compliance|3
724236|NCT00235443|2331393|P2|Overall Study|Unsatisfactory compliance|2
724237|NCT00235443|2331394|P1|Overall Study|Unsatisfactory compliance|0
724238|NCT00235443|2331389|P6|Overall Study|Lost to Follow-up|3
724239|NCT00235443|2331390|P5|Overall Study|Lost to Follow-up|4
724240|NCT00235443|2331391|P4|Overall Study|Lost to Follow-up|6
724241|NCT00235443|2331392|P3|Overall Study|Lost to Follow-up|6
724242|NCT00235443|2331393|P2|Overall Study|Lost to Follow-up|8
724243|NCT00235443|2331394|P1|Overall Study|Lost to Follow-up|0
724244|NCT00235443|2331389|P6|Overall Study|Withdrawal by Subject|12
724245|NCT00235443|2331390|P5|Overall Study|Withdrawal by Subject|10
724246|NCT00235443|2331391|P4|Overall Study|Withdrawal by Subject|24
724247|NCT00235443|2331392|P3|Overall Study|Withdrawal by Subject|25
724248|NCT00235443|2331393|P2|Overall Study|Withdrawal by Subject|9
724249|NCT00235443|2331394|P1|Overall Study|Withdrawal by Subject|3
724250|NCT00235443|2331389|P6|Overall Study|Lack of Efficacy|9
724251|NCT00235443|2331390|P5|Overall Study|Lack of Efficacy|2
724252|NCT00235443|2331391|P4|Overall Study|Lack of Efficacy|12
724253|NCT00235443|2331392|P3|Overall Study|Lack of Efficacy|5
724254|NCT00235443|2331393|P2|Overall Study|Lack of Efficacy|1
724255|NCT00235443|2331394|P1|Overall Study|Lack of Efficacy|0
724256|NCT00235443|2331389|P6|Overall Study|Adverse Event|15
724257|NCT00235443|2331390|P5|Overall Study|Adverse Event|10
724258|NCT00235443|2331391|P4|Overall Study|Adverse Event|44
724259|NCT00235443|2331392|P3|Overall Study|Adverse Event|17
724260|NCT00235443|2331393|P2|Overall Study|Adverse Event|12
724261|NCT00235443|2331394|P1|Overall Study|Adverse Event|4
724262|NCT00235716|2331556|P4|Overall Study|Physician Decision|3
724263|NCT00235716|2331557|P3|Overall Study|Physician Decision|1
724264|NCT00235716|2331558|P2|Overall Study|Physician Decision|1
724265|NCT00235716|2331559|P1|Overall Study|Physician Decision|0
724266|NCT00235716|2331556|P4|Overall Study|Adverse Event|0
724267|NCT00235716|2331557|P3|Overall Study|Adverse Event|1
724268|NCT00235716|2331558|P2|Overall Study|Adverse Event|1
724269|NCT00235716|2331559|P1|Overall Study|Adverse Event|1
724270|NCT00235716|2331556|P4|Overall Study|Lost to Follow-up|10
724271|NCT00235716|2331557|P3|Overall Study|Lost to Follow-up|14
724272|NCT00235716|2331558|P2|Overall Study|Lost to Follow-up|7
724273|NCT00235716|2331559|P1|Overall Study|Lost to Follow-up|12
724274|NCT00235716|2331556|P4|Overall Study|Withdrawal by Subject|18
724275|NCT00235716|2331557|P3|Overall Study|Withdrawal by Subject|17
724276|NCT00235716|2331558|P2|Overall Study|Withdrawal by Subject|19
724277|NCT00235716|2331559|P1|Overall Study|Withdrawal by Subject|23
724278|NCT00235716|2331556|P4|Overall Study|Death|31
724279|NCT00235716|2331557|P3|Overall Study|Death|32
724280|NCT00235716|2331558|P2|Overall Study|Death|39
724281|NCT00235716|2331559|P1|Overall Study|Death|26
724282|NCT00235755|2331596|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
724283|NCT00235755|2331597|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
724284|NCT00235755|2331598|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
724285|NCT00235755|2331596|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
724286|NCT00235755|2331597|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
724287|NCT00235755|2331598|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
724288|NCT00235755|2331596|P3|12-Week Maintenance Phase|Protocol Violation|2
724289|NCT00235755|2331597|P2|12-Week Maintenance Phase|Protocol Violation|4
724290|NCT00235755|2331598|P1|12-Week Maintenance Phase|Protocol Violation|0
724291|NCT00235755|2331596|P3|12-Week Maintenance Phase|Lack of Efficacy|0
724292|NCT00235755|2331597|P2|12-Week Maintenance Phase|Lack of Efficacy|0
724293|NCT00235755|2331598|P1|12-Week Maintenance Phase|Lack of Efficacy|5
724294|NCT00235755|2331596|P3|12-Week Maintenance Phase|Lost to Follow-up|0
724295|NCT00235755|2331597|P2|12-Week Maintenance Phase|Lost to Follow-up|3
724296|NCT00235755|2331598|P1|12-Week Maintenance Phase|Lost to Follow-up|2
724297|NCT00235755|2331596|P3|12-Week Maintenance Phase|Adverse Event|26
724298|NCT00235755|2331597|P2|12-Week Maintenance Phase|Adverse Event|12
724299|NCT00235755|2331598|P1|12-Week Maintenance Phase|Adverse Event|8
724300|NCT00235755|2331596|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
724301|NCT00235755|2331597|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
724302|NCT00235755|2331598|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
724303|NCT00235755|2331596|P3|4-Week Titration Phase|Randomization Occurred in Error|0
724304|NCT00235755|2331597|P2|4-Week Titration Phase|Randomization Occurred in Error|0
724305|NCT00235755|2331598|P1|4-Week Titration Phase|Randomization Occurred in Error|1
724306|NCT00235755|2331596|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
724307|NCT00235755|2331597|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
724308|NCT00235755|2331598|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
724309|NCT00235755|2331596|P3|4-Week Titration Phase|Withdrawal by Subject|3
724310|NCT00235755|2331597|P2|4-Week Titration Phase|Withdrawal by Subject|2
724311|NCT00235755|2331598|P1|4-Week Titration Phase|Withdrawal by Subject|1
724312|NCT00235755|2331596|P3|4-Week Titration Phase|Protocol Violation|1
724313|NCT00235755|2331597|P2|4-Week Titration Phase|Protocol Violation|2
724314|NCT00235755|2331598|P1|4-Week Titration Phase|Protocol Violation|2
724315|NCT00235755|2331596|P3|4-Week Titration Phase|Lost to Follow-up|1
724316|NCT00235755|2331597|P2|4-Week Titration Phase|Lost to Follow-up|1
724317|NCT00235755|2331598|P1|4-Week Titration Phase|Lost to Follow-up|0
724318|NCT00235755|2331596|P3|4-Week Titration Phase|Adverse Event|20
724319|NCT00235755|2331597|P2|4-Week Titration Phase|Adverse Event|14
724320|NCT00235755|2331598|P1|4-Week Titration Phase|Adverse Event|6
724321|NCT00235872|2331685|P1|Overall Study|Administrative reason|61
724322|NCT00235872|2331685|P1|Overall Study|Withdrawal by Subject|50
724323|NCT00235872|2331685|P1|Overall Study|Lost to Follow-up|1
724324|NCT00235872|2331685|P1|Overall Study|Death|1
724325|NCT00235872|2331685|P1|Overall Study|Adverse Event|34
724326|NCT00235989|2331704|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
724327|NCT00235989|2331705|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
724328|NCT00235989|2331706|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
724329|NCT00235989|2331707|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
724330|NCT00235989|2331708|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
724331|NCT00235989|2331709|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
724332|NCT00235989|2331704|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
724333|NCT00235989|2331705|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
724334|NCT00235989|2331706|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
724335|NCT00235989|2331707|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
724336|NCT00235989|2331708|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
724337|NCT00235989|2331709|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
724338|NCT00235989|2331704|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
724339|NCT00235989|2331705|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
724340|NCT00235989|2331706|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
724341|NCT00235989|2331707|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
724342|NCT00235989|2331708|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
724343|NCT00235989|2331709|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
724344|NCT00235989|2331704|P6|Extension Treatment Period (ET)|Adverse Event|0
724345|NCT00235989|2331705|P5|Extension Treatment Period (ET)|Adverse Event|0
724346|NCT00235989|2331706|P4|Extension Treatment Period (ET)|Adverse Event|0
724347|NCT00235989|2331707|P3|Extension Treatment Period (ET)|Adverse Event|2
724348|NCT00235989|2331708|P2|Extension Treatment Period (ET)|Adverse Event|0
724349|NCT00235989|2331709|P1|Extension Treatment Period (ET)|Adverse Event|3
724350|NCT00235989|2331704|P6|Core Treatment Period (CT)|Lost to Follow-up|2
724351|NCT00235989|2331705|P5|Core Treatment Period (CT)|Lost to Follow-up|0
724352|NCT00235989|2331706|P4|Core Treatment Period (CT)|Lost to Follow-up|0
724353|NCT00235989|2331707|P3|Core Treatment Period (CT)|Lost to Follow-up|0
724354|NCT00235989|2331708|P2|Core Treatment Period (CT)|Lost to Follow-up|0
724355|NCT00235989|2331709|P1|Core Treatment Period (CT)|Lost to Follow-up|0
724356|NCT00236080|2331728|P5|Overall Study|Miscellaneous|0
724357|NCT00236080|2331729|P4|Overall Study|Miscellaneous|0
724358|NCT00236080|2331730|P3|Overall Study|Miscellaneous|1
724359|NCT00236080|2331731|P2|Overall Study|Miscellaneous|0
724360|NCT00236080|2331732|P1|Overall Study|Miscellaneous|0
724361|NCT00236080|2331728|P5|Overall Study|Withdrawal by Subject|0
724362|NCT00236080|2331729|P4|Overall Study|Withdrawal by Subject|0
724363|NCT00236080|2331730|P3|Overall Study|Withdrawal by Subject|0
724364|NCT00236080|2331731|P2|Overall Study|Withdrawal by Subject|0
724365|NCT00236080|2331732|P1|Overall Study|Withdrawal by Subject|1
724366|NCT00236080|2331728|P5|Overall Study|Physician Decision|1
724367|NCT00236080|2331729|P4|Overall Study|Physician Decision|1
724368|NCT00236080|2331730|P3|Overall Study|Physician Decision|1
724369|NCT00236080|2331731|P2|Overall Study|Physician Decision|0
724370|NCT00236080|2331732|P1|Overall Study|Physician Decision|1
724371|NCT00236080|2331728|P5|Overall Study|Lost to Follow-up|0
724372|NCT00236080|2331729|P4|Overall Study|Lost to Follow-up|0
724373|NCT00236080|2331730|P3|Overall Study|Lost to Follow-up|0
724374|NCT00236080|2331731|P2|Overall Study|Lost to Follow-up|1
724375|NCT00236080|2331732|P1|Overall Study|Lost to Follow-up|0
724376|NCT00236080|2331728|P5|Overall Study|Adverse Event|0
724377|NCT00236080|2331729|P4|Overall Study|Adverse Event|1
724378|NCT00236080|2331730|P3|Overall Study|Adverse Event|3
724379|NCT00236080|2331731|P2|Overall Study|Adverse Event|0
724380|NCT00236080|2331732|P1|Overall Study|Adverse Event|0
724381|NCT00236184|2331751|P2|Overall Study|other|2
724382|NCT00236184|2331752|P1|Overall Study|other|1
724383|NCT00236184|2331751|P2|Overall Study|non-compliance with study drug|1
724384|NCT00236184|2331752|P1|Overall Study|non-compliance with study drug|2
724385|NCT00236184|2331751|P2|Overall Study|Protocol Violation|0
724386|NCT00236184|2331752|P1|Overall Study|Protocol Violation|3
724387|NCT00236184|2331751|P2|Overall Study|Withdrawal by Subject|0
724388|NCT00236184|2331752|P1|Overall Study|Withdrawal by Subject|3
724389|NCT00236184|2331751|P2|Overall Study|Physician Decision|1
724390|NCT00236184|2331752|P1|Overall Study|Physician Decision|1
724391|NCT00236184|2331751|P2|Overall Study|Lost to Follow-up|4
724392|NCT00236184|2331752|P1|Overall Study|Lost to Follow-up|3
724393|NCT00236184|2331751|P2|Overall Study|Lack of Efficacy|1
724394|NCT00236184|2331752|P1|Overall Study|Lack of Efficacy|0
724395|NCT00236184|2331751|P2|Overall Study|Adverse Event|2
724396|NCT00236184|2331752|P1|Overall Study|Adverse Event|5
724397|NCT00236197|2331760|P2|Overall Study|Other|2
724398|NCT00236197|2331761|P1|Overall Study|Other|0
724399|NCT00236197|2331760|P2|Overall Study|Medication non-compliance|2
724400|NCT00236197|2331761|P1|Overall Study|Medication non-compliance|1
724401|NCT00236197|2331760|P2|Overall Study|Protocol Violation|3
724402|NCT00236197|2331761|P1|Overall Study|Protocol Violation|0
724403|NCT00236197|2331760|P2|Overall Study|Lost to Follow-up|5
724404|NCT00236197|2331761|P1|Overall Study|Lost to Follow-up|1
724405|NCT00236197|2331760|P2|Overall Study|Withdrawal by Subject|2
724406|NCT00236197|2331761|P1|Overall Study|Withdrawal by Subject|3
724407|NCT00236899|2331771|P4|Overall Study|Lack of Efficacy|23
724408|NCT00236899|2331772|P3|Overall Study|Lack of Efficacy|25
724409|NCT00236899|2331773|P2|Overall Study|Lack of Efficacy|18
724410|NCT00236899|2331774|P1|Overall Study|Lack of Efficacy|18
724411|NCT00236899|2331771|P4|Overall Study|Satisfactory Response|1
724412|NCT00236899|2331772|P3|Overall Study|Satisfactory Response|0
724413|NCT00236899|2331773|P2|Overall Study|Satisfactory Response|0
724414|NCT00236899|2331774|P1|Overall Study|Satisfactory Response|2
724415|NCT00236899|2331771|P4|Overall Study|Physician Decision|6
724416|NCT00236899|2331772|P3|Overall Study|Physician Decision|7
724417|NCT00236899|2331773|P2|Overall Study|Physician Decision|8
724418|NCT00236899|2331774|P1|Overall Study|Physician Decision|7
724419|NCT00236899|2331771|P4|Overall Study|Withdrawal by Subject|2
724420|NCT00236899|2331772|P3|Overall Study|Withdrawal by Subject|5
724421|NCT00236899|2331773|P2|Overall Study|Withdrawal by Subject|4
724422|NCT00236899|2331774|P1|Overall Study|Withdrawal by Subject|6
724423|NCT00236899|2331771|P4|Overall Study|Protocol Violation|0
724424|NCT00236899|2331772|P3|Overall Study|Protocol Violation|0
724425|NCT00236899|2331773|P2|Overall Study|Protocol Violation|0
724426|NCT00236899|2331774|P1|Overall Study|Protocol Violation|1
724427|NCT00236899|2331771|P4|Overall Study|Entry Criteria Exclusion|0
724428|NCT00236899|2331772|P3|Overall Study|Entry Criteria Exclusion|1
724429|NCT00236899|2331773|P2|Overall Study|Entry Criteria Exclusion|1
724430|NCT00236899|2331774|P1|Overall Study|Entry Criteria Exclusion|0
724431|NCT00236899|2331771|P4|Overall Study|Lost to Follow-up|0
724432|NCT00236899|2331772|P3|Overall Study|Lost to Follow-up|0
724433|NCT00236899|2331773|P2|Overall Study|Lost to Follow-up|1
724434|NCT00236899|2331774|P1|Overall Study|Lost to Follow-up|0
724435|NCT00236899|2331771|P4|Overall Study|Death (Study Drug Toxicity)|0
724436|NCT00236899|2331772|P3|Overall Study|Death (Study Drug Toxicity)|0
724437|NCT00236899|2331773|P2|Overall Study|Death (Study Drug Toxicity)|0
724438|NCT00236899|2331774|P1|Overall Study|Death (Study Drug Toxicity)|1
724439|NCT00236899|2331771|P4|Overall Study|Death (Not Study Related)|0
724440|NCT00236899|2331772|P3|Overall Study|Death (Not Study Related)|0
724441|NCT00236899|2331773|P2|Overall Study|Death (Not Study Related)|0
724442|NCT00236899|2331774|P1|Overall Study|Death (Not Study Related)|2
724443|NCT00236899|2331771|P4|Overall Study|Death (Study Disease)|0
724444|NCT00236899|2331772|P3|Overall Study|Death (Study Disease)|0
724445|NCT00236899|2331773|P2|Overall Study|Death (Study Disease)|4
724446|NCT00236899|2331774|P1|Overall Study|Death (Study Disease)|1
724447|NCT00236899|2331771|P4|Overall Study|Adverse Event (Not Study Related)|7
724448|NCT00236899|2331772|P3|Overall Study|Adverse Event (Not Study Related)|4
724449|NCT00236899|2331773|P2|Overall Study|Adverse Event (Not Study Related)|3
724450|NCT00236899|2331774|P1|Overall Study|Adverse Event (Not Study Related)|3
724451|NCT00236899|2331771|P4|Overall Study|Adverse Event (Study Related)|1
724452|NCT00236899|2331772|P3|Overall Study|Adverse Event (Study Related)|2
724453|NCT00236899|2331773|P2|Overall Study|Adverse Event (Study Related)|1
724454|NCT00236899|2331774|P1|Overall Study|Adverse Event (Study Related)|1
724455|NCT00237042|2331860|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
724456|NCT00237042|2331861|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
724457|NCT00237042|2331862|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
724458|NCT00237042|2331860|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
724459|NCT00237042|2331861|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
724460|NCT00237042|2331862|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
724461|NCT00237042|2331860|P3|Treatment|Completed no treatment|21
724462|NCT00237042|2331861|P2|Treatment|Completed no treatment|5
724463|NCT00237042|2331862|P1|Treatment|Completed no treatment|5
724464|NCT00237042|2331860|P3|Treatment|Moved out of state|1
724465|NCT00237042|2331861|P2|Treatment|Moved out of state|1
724466|NCT00237042|2331862|P1|Treatment|Moved out of state|1
724467|NCT00237042|2331860|P3|Treatment|Became ineligible post-randomization|16
724468|NCT00237042|2331861|P2|Treatment|Became ineligible post-randomization|1
724469|NCT00237042|2331862|P1|Treatment|Became ineligible post-randomization|0
724470|NCT00237185|2331881|P2|Extension|Death|1
724471|NCT00237185|2331882|P1|Extension|Death|1
724472|NCT00237185|2331881|P2|Extension|Administrative problems|0
724473|NCT00237185|2331882|P1|Extension|Administrative problems|1
724474|NCT00237185|2331881|P2|Extension|Lost to Follow-up|0
724475|NCT00237185|2331882|P1|Extension|Lost to Follow-up|1
724476|NCT00237185|2331881|P2|Extension|Withdrawal by Subject|2
724477|NCT00237185|2331882|P1|Extension|Withdrawal by Subject|3
724478|NCT00237185|2331881|P2|Extension|Condition no longer required study drug|1
724479|NCT00237185|2331882|P1|Extension|Condition no longer required study drug|0
724480|NCT00237185|2331881|P2|Extension|Lack of Efficacy|14
724481|NCT00237185|2331882|P1|Extension|Lack of Efficacy|9
724482|NCT00237185|2331881|P2|Extension|Abnormal laboratory value|1
724483|NCT00237185|2331882|P1|Extension|Abnormal laboratory value|0
724484|NCT00237185|2331881|P2|Extension|Adverse Event|0
724485|NCT00237185|2331882|P1|Extension|Adverse Event|1
724486|NCT00237185|2331881|P2|Core|Determined ineligible post randomization|0
724487|NCT00237185|2331882|P1|Core|Determined ineligible post randomization|1
724488|NCT00237185|2331881|P2|Core|Death|0
724489|NCT00237185|2331882|P1|Core|Death|4
724490|NCT00237185|2331881|P2|Core|Administrative problems|1
724491|NCT00237185|2331882|P1|Core|Administrative problems|0
724492|NCT00237185|2331881|P2|Core|Withdrawal by Subject|4
724493|NCT00237185|2331882|P1|Core|Withdrawal by Subject|4
724494|NCT00237185|2331881|P2|Core|Protocol Violation|1
724495|NCT00237185|2331882|P1|Core|Protocol Violation|1
724496|NCT00237185|2331881|P2|Core|Lack of Efficacy|23
724497|NCT00237185|2331882|P1|Core|Lack of Efficacy|30
724498|NCT00237185|2331881|P2|Core|Abnormal test procedure results|0
724499|NCT00237185|2331882|P1|Core|Abnormal test procedure results|1
724500|NCT00237185|2331881|P2|Core|Abnormal laboratory value|4
724501|NCT00237185|2331882|P1|Core|Abnormal laboratory value|0
724502|NCT00237185|2331881|P2|Core|Adverse Event|4
724503|NCT00237185|2331882|P1|Core|Adverse Event|3
724504|NCT00237458|2331910|P1|Overall Study|Withdrawal by Subject|1
724505|NCT00237458|2331910|P1|Overall Study|Adverse Event|1
724506|NCT00237458|2331910|P1|Overall Study|Lack of Efficacy|1
724507|NCT00237692|2331940|P4|Overall Study|Withdrawal by Subject|4
724508|NCT00237692|2331941|P3|Overall Study|Withdrawal by Subject|10
724509|NCT00237692|2331942|P2|Overall Study|Withdrawal by Subject|6
724510|NCT00237692|2331943|P1|Overall Study|Withdrawal by Subject|4
724511|NCT00237692|2331940|P4|Overall Study|Excluded - did not meet criteria|9
724512|NCT00237692|2331941|P3|Overall Study|Excluded - did not meet criteria|5
724513|NCT00237692|2331942|P2|Overall Study|Excluded - did not meet criteria|3
724514|NCT00237692|2331943|P1|Overall Study|Excluded - did not meet criteria|4
724515|NCT00237692|2331940|P4|Overall Study|Death|3
724516|NCT00237692|2331941|P3|Overall Study|Death|2
724517|NCT00237692|2331942|P2|Overall Study|Death|2
724518|NCT00237692|2331943|P1|Overall Study|Death|1
724519|NCT00237692|2331940|P4|Overall Study|Lost to Follow-up|3
724520|NCT00237692|2331941|P3|Overall Study|Lost to Follow-up|5
724521|NCT00237692|2331942|P2|Overall Study|Lost to Follow-up|3
724522|NCT00237692|2331943|P1|Overall Study|Lost to Follow-up|9
724523|NCT00237744|2331987|P3|Overall Study|Withdrawal by Subject|0
724524|NCT00237744|2331988|P2|Overall Study|Withdrawal by Subject|1
724525|NCT00237744|2331989|P1|Overall Study|Withdrawal by Subject|3
724526|NCT00237796|2332015|P2|Overall Study|Baseline and one other ILSS required|5
724527|NCT00237796|2332016|P1|Overall Study|Baseline and one other ILSS required|10
724528|NCT00237809|2332038|P4|Overall Study|Lost to Follow-up|9
724529|NCT00237809|2332039|P3|Overall Study|Lost to Follow-up|9
724530|NCT00237809|2332040|P2|Overall Study|Lost to Follow-up|10
724531|NCT00237809|2332041|P1|Overall Study|Lost to Follow-up|11
724532|NCT00238121|2332086|P2|Overall Study|Adverse Event|1
724533|NCT00238121|2332087|P1|Overall Study|Adverse Event|2
724534|NCT00238121|2332086|P2|Overall Study|Withdrawal by Subject|1
724535|NCT00238121|2332087|P1|Overall Study|Withdrawal by Subject|1
724536|NCT00238238|2332101|P3|Overall Study|Withdrawal by Subject|0
724537|NCT00238238|2332102|P2|Overall Study|Withdrawal by Subject|3
724538|NCT00238238|2332103|P1|Overall Study|Withdrawal by Subject|0
724539|NCT00238264|2332114|P1|Overall Study|Ineligible|7
724540|NCT00238264|2332114|P1|Overall Study|Withdrawal by Subject|4
724541|NCT00238264|2332114|P1|Overall Study|Lost to Follow-up|18
724542|NCT00238264|2332114|P1|Overall Study|Death|7
724543|NCT00238303|2332127|P3|Overall Study|Adverse Event|3
724544|NCT00238303|2332128|P2|Overall Study|Adverse Event|1
724545|NCT00238303|2332129|P1|Overall Study|Adverse Event|0
724546|NCT00238303|2332127|P3|Overall Study|Poor tolerance of study treatment|1
724547|NCT00238303|2332128|P2|Overall Study|Poor tolerance of study treatment|0
724548|NCT00238303|2332129|P1|Overall Study|Poor tolerance of study treatment|1
724549|NCT00238303|2332127|P3|Overall Study|Other Medical Problems|2
724550|NCT00238303|2332128|P2|Overall Study|Other Medical Problems|0
724551|NCT00238303|2332129|P1|Overall Study|Other Medical Problems|2
724552|NCT00238303|2332127|P3|Overall Study|Death|1
724553|NCT00238303|2332128|P2|Overall Study|Death|0
724554|NCT00238303|2332129|P1|Overall Study|Death|1
724555|NCT00238303|2332127|P3|Overall Study|Withdrawal by Subject|2
724556|NCT00238303|2332128|P2|Overall Study|Withdrawal by Subject|1
724557|NCT00238303|2332129|P1|Overall Study|Withdrawal by Subject|11
724563|NCT00239005|2332176|P2|Overall Study|Lost to Follow-up|1
724564|NCT00239005|2332177|P1|Overall Study|Lost to Follow-up|0
724565|NCT00239005|2332176|P2|Overall Study|Subj. cond. no longer needs study drug|1
724566|NCT00239005|2332177|P1|Overall Study|Subj. cond. no longer needs study drug|0
724567|NCT00239005|2332176|P2|Overall Study|Protocol Violation|0
724568|NCT00239005|2332177|P1|Overall Study|Protocol Violation|1
724569|NCT00239005|2332176|P2|Overall Study|Unsatisfactory Therapeutic effect|0
724570|NCT00239005|2332177|P1|Overall Study|Unsatisfactory Therapeutic effect|2
724571|NCT00239005|2332176|P2|Overall Study|Withdrawal by Subject|4
724572|NCT00239005|2332177|P1|Overall Study|Withdrawal by Subject|3
724573|NCT00239005|2332176|P2|Overall Study|Adverse Event|6
724574|NCT00239005|2332177|P1|Overall Study|Adverse Event|6
724575|NCT00239226|2332191|P4|Overall Study|Lost to Follow-up|0
724576|NCT00239226|2332192|P3|Overall Study|Lost to Follow-up|1
724577|NCT00239226|2332193|P2|Overall Study|Lost to Follow-up|0
724578|NCT00239226|2332194|P1|Overall Study|Lost to Follow-up|1
724579|NCT00239226|2332191|P4|Overall Study|permAF during stabilization period|3
724580|NCT00239226|2332192|P3|Overall Study|permAF during stabilization period|0
724581|NCT00239226|2332193|P2|Overall Study|permAF during stabilization period|0
724582|NCT00239226|2332194|P1|Overall Study|permAF during stabilization period|0
724583|NCT00239356|2332206|P2|Overall Study|Drug available on market|2
724584|NCT00239356|2332207|P1|Overall Study|Drug available on market|11
724585|NCT00239356|2332206|P2|Overall Study|Administrative reason|1
724586|NCT00239356|2332207|P1|Overall Study|Administrative reason|0
724587|NCT00239356|2332206|P2|Overall Study|Pregnancy|0
724588|NCT00239356|2332207|P1|Overall Study|Pregnancy|1
724589|NCT00239356|2332206|P2|Overall Study|poor/non-compliance|0
724590|NCT00239356|2332207|P1|Overall Study|poor/non-compliance|2
724591|NCT00239356|2332206|P2|Overall Study|Lost to Follow-up|0
724592|NCT00239356|2332207|P1|Overall Study|Lost to Follow-up|3
724593|NCT00239356|2332206|P2|Overall Study|Withdrawal by Subject|6
724594|NCT00239356|2332207|P1|Overall Study|Withdrawal by Subject|15
724595|NCT00239356|2332206|P2|Overall Study|Adverse Event|0
724596|NCT00239356|2332207|P1|Overall Study|Adverse Event|6
724597|NCT00239356|2332206|P2|Overall Study|Lack of Efficacy|0
724598|NCT00239356|2332207|P1|Overall Study|Lack of Efficacy|1
724599|NCT00239681|2332264|P2|Overall Study|No information chacked on CaseReportForm|84
724600|NCT00239681|2332265|P1|Overall Study|No information chacked on CaseReportForm|90
724601|NCT00239681|2332264|P2|Overall Study|Physician Decision|17
724602|NCT00239681|2332265|P1|Overall Study|Physician Decision|13
724603|NCT00239681|2332264|P2|Overall Study|Protocol Violation|4
724604|NCT00239681|2332265|P1|Overall Study|Protocol Violation|4
724605|NCT00239681|2332264|P2|Overall Study|Lost to Follow-up|22
724606|NCT00239681|2332265|P1|Overall Study|Lost to Follow-up|28
724607|NCT00239681|2332264|P2|Overall Study|Withdrawal by Subject|489
724608|NCT00239681|2332265|P1|Overall Study|Withdrawal by Subject|458
724609|NCT00239681|2332264|P2|Overall Study|Adverse Event|99
724610|NCT00239681|2332265|P1|Overall Study|Adverse Event|100
724611|NCT00239720|2332283|P2|Overall Study|Lost to Follow-up|1
724612|NCT00239720|2332284|P1|Overall Study|Lost to Follow-up|0
724613|NCT00239720|2332283|P2|Overall Study|Adverse Event|0
724614|NCT00239720|2332284|P1|Overall Study|Adverse Event|1
724615|NCT00239837|2332297|P2|Overall Study|Lost to Follow-up|7
724616|NCT00239837|2332298|P1|Overall Study|Lost to Follow-up|3
724617|NCT00232141|2332320|P2|Overall Study|Withdrawal by Subject|3
724618|NCT00232141|2332321|P1|Overall Study|Withdrawal by Subject|5
724619|NCT00232141|2332320|P2|Overall Study|Other|10
724620|NCT00232141|2332321|P1|Overall Study|Other|8
724621|NCT00232141|2332320|P2|Overall Study|Lost to Follow-up|6
724622|NCT00232141|2332321|P1|Overall Study|Lost to Follow-up|9
724623|NCT00232141|2332320|P2|Overall Study|Lack of Efficacy|3
724624|NCT00232141|2332321|P1|Overall Study|Lack of Efficacy|0
724625|NCT00232141|2332320|P2|Overall Study|Adverse Event|4
724626|NCT00232141|2332321|P1|Overall Study|Adverse Event|9
724627|NCT00232180|2332391|P3|Open Label Phase|Randomized but not treated|1
724628|NCT00232180|2332392|P2|Open Label Phase|Randomized but not treated|0
724629|NCT00232180|2332393|P1|Open Label Phase|Randomized but not treated|0
724630|NCT00232180|2332391|P3|Open Label Phase|Laboratory abnormality|10
724631|NCT00232180|2332392|P2|Open Label Phase|Laboratory abnormality|0
724632|NCT00232180|2332393|P1|Open Label Phase|Laboratory abnormality|0
724633|NCT00232180|2332391|P3|Open Label Phase|Adverse Event|25
724634|NCT00232180|2332392|P2|Open Label Phase|Adverse Event|0
724635|NCT00232180|2332393|P1|Open Label Phase|Adverse Event|0
724636|NCT00232180|2332391|P3|Open Label Phase|Unspecified|16
724637|NCT00232180|2332392|P2|Open Label Phase|Unspecified|0
724638|NCT00232180|2332393|P1|Open Label Phase|Unspecified|0
724639|NCT00232180|2332391|P3|Open Label Phase|Withdrawal by Subject|37
724640|NCT00232180|2332392|P2|Open Label Phase|Withdrawal by Subject|0
724641|NCT00232180|2332393|P1|Open Label Phase|Withdrawal by Subject|0
724642|NCT00232180|2332391|P3|Open Label Phase|Study terminated by sponsor|3
724643|NCT00232180|2332392|P2|Open Label Phase|Study terminated by sponsor|0
724644|NCT00232180|2332393|P1|Open Label Phase|Study terminated by sponsor|0
724645|NCT00232180|2332391|P3|Open Label Phase|Protocol Violation|3
724646|NCT00232180|2332392|P2|Open Label Phase|Protocol Violation|0
724647|NCT00232180|2332393|P1|Open Label Phase|Protocol Violation|0
724648|NCT00232180|2332391|P3|Open Label Phase|Lost to Follow-up|5
724649|NCT00232180|2332392|P2|Open Label Phase|Lost to Follow-up|0
724650|NCT00232180|2332393|P1|Open Label Phase|Lost to Follow-up|0
724651|NCT00232180|2332391|P3|Open Label Phase|Death|48
724652|NCT00232180|2332392|P2|Open Label Phase|Death|0
724653|NCT00232180|2332393|P1|Open Label Phase|Death|0
724654|NCT00232180|2332391|P3|Double-blind (DB) Phase|Laboratory abnormality|0
724655|NCT00232180|2332392|P2|Double-blind (DB) Phase|Laboratory abnormality|7
724656|NCT00232180|2332393|P1|Double-blind (DB) Phase|Laboratory abnormality|6
724657|NCT00232180|2332391|P3|Double-blind (DB) Phase|Randomized but not treated|0
724658|NCT00232180|2332392|P2|Double-blind (DB) Phase|Randomized but not treated|4
724659|NCT00232180|2332393|P1|Double-blind (DB) Phase|Randomized but not treated|3
724660|NCT00232180|2332391|P3|Double-blind (DB) Phase|Unspecified|0
724661|NCT00232180|2332392|P2|Double-blind (DB) Phase|Unspecified|75
724662|NCT00232180|2332393|P1|Double-blind (DB) Phase|Unspecified|70
724663|NCT00232180|2332391|P3|Double-blind (DB) Phase|Adverse Event|0
724664|NCT00232180|2332392|P2|Double-blind (DB) Phase|Adverse Event|100
724665|NCT00232180|2332393|P1|Double-blind (DB) Phase|Adverse Event|83
724666|NCT00232180|2332391|P3|Double-blind (DB) Phase|Protocol Violation|0
724667|NCT00232180|2332392|P2|Double-blind (DB) Phase|Protocol Violation|21
724668|NCT00232180|2332393|P1|Double-blind (DB) Phase|Protocol Violation|28
724669|NCT00232180|2332391|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
724670|NCT00232180|2332392|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
724671|NCT00232180|2332393|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
724672|NCT00232180|2332391|P3|Double-blind (DB) Phase|Lost to Follow-up|0
724673|NCT00232180|2332392|P2|Double-blind (DB) Phase|Lost to Follow-up|28
724674|NCT00232180|2332393|P1|Double-blind (DB) Phase|Lost to Follow-up|34
724675|NCT00232180|2332391|P3|Double-blind (DB) Phase|Death|0
724676|NCT00232180|2332392|P2|Double-blind (DB) Phase|Death|222
724677|NCT00232180|2332393|P1|Double-blind (DB) Phase|Death|186
724678|NCT00232544|2332459|P2|Overall Study|Lost to Follow-up|15
724679|NCT00232544|2332460|P1|Overall Study|Lost to Follow-up|20
724680|NCT00232557|2332470|P2|Overall Study|Lost to Follow-up|5
724681|NCT00232557|2332471|P1|Overall Study|Lost to Follow-up|3
724682|NCT00232596|2332490|P2|12-Week Maintenance Phase|Other|3
724683|NCT00232596|2332491|P1|12-Week Maintenance Phase|Other|1
724684|NCT00232596|2332490|P2|12-Week Maintenance Phase|Protocol Violation|1
724685|NCT00232596|2332491|P1|12-Week Maintenance Phase|Protocol Violation|3
724686|NCT00232596|2332490|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
724687|NCT00232596|2332491|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
724688|NCT00232596|2332490|P2|12-Week Maintenance Phase|Adverse Event|22
724689|NCT00232596|2332491|P1|12-Week Maintenance Phase|Adverse Event|7
724690|NCT00232596|2332490|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
724691|NCT00232596|2332491|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
724692|NCT00232596|2332490|P2|6-Week Titration Phase|Other|3
724693|NCT00232596|2332491|P1|6-Week Titration Phase|Other|3
724694|NCT00232596|2332490|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
724695|NCT00232596|2332491|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
724696|NCT00232596|2332490|P2|6-Week Titration Phase|Protocol Violation|3
724697|NCT00232596|2332491|P1|6-Week Titration Phase|Protocol Violation|1
724698|NCT00232596|2332490|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
724699|NCT00232596|2332491|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
724700|NCT00232596|2332490|P2|6-Week Titration Phase|Failed to Return|1
724701|NCT00232596|2332491|P1|6-Week Titration Phase|Failed to Return|2
724702|NCT00232596|2332490|P2|6-Week Titration Phase|Adverse Event|19
724703|NCT00232596|2332491|P1|6-Week Titration Phase|Adverse Event|6
724704|NCT00233064|2332560|P2|Overall Study|Moved to Dom. Republic|0
724705|NCT00233064|2332561|P1|Overall Study|Moved to Dom. Republic|1
724706|NCT00233064|2332560|P2|Overall Study|Protocol Violation|0
724707|NCT00233064|2332561|P1|Overall Study|Protocol Violation|1
724708|NCT00233064|2332560|P2|Overall Study|Relocation|1
724709|NCT00233064|2332561|P1|Overall Study|Relocation|0
724710|NCT00233064|2332560|P2|Overall Study|Death|1
724711|NCT00233064|2332561|P1|Overall Study|Death|0
724712|NCT00233064|2332560|P2|Overall Study|Withdrawal by Subject|3
724713|NCT00233064|2332561|P1|Overall Study|Withdrawal by Subject|5
724714|NCT00233064|2332560|P2|Overall Study|Lost to Follow-up|7
724715|NCT00233064|2332561|P1|Overall Study|Lost to Follow-up|7
890444|NCT00984659|2825626|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
890445|NCT00984659|2825627|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
890446|NCT00984659|2825628|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
890447|NCT00984659|2825629|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
890448|NCT00984659|2825626|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
890449|NCT00984659|2825627|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
890450|NCT00984659|2825628|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
890451|NCT00984659|2825629|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
890452|NCT00984659|2825626|P4|6-week Double-blind Treatment Period|Protocol Violation|4
890453|NCT00984659|2825627|P3|6-week Double-blind Treatment Period|Protocol Violation|0
890454|NCT00984659|2825628|P2|6-week Double-blind Treatment Period|Protocol Violation|0
724728|NCT00233402|2332629|P2|Overall Study|Lost to follow up etc|21
724729|NCT00233402|2332630|P1|Overall Study|Lost to follow up etc|3
724730|NCT00233402|2332629|P2|Overall Study|No Ta/T1|94
724731|NCT00233402|2332630|P1|Overall Study|No Ta/T1|89
724732|NCT00233402|2332629|P2|Overall Study|No pathology data|9
724733|NCT00233402|2332630|P1|Overall Study|No pathology data|12
724734|NCT00233454|2332641|P1|Overall Study|Death|6
724735|NCT00233948|2332657|P6|Overall Study|Adverse Event|0
724736|NCT00233948|2332658|P5|Overall Study|Adverse Event|0
724737|NCT00233948|2332659|P4|Overall Study|Adverse Event|0
724738|NCT00233948|2332660|P3|Overall Study|Adverse Event|0
724739|NCT00233948|2332661|P2|Overall Study|Adverse Event|0
724740|NCT00233948|2332662|P1|Overall Study|Adverse Event|1
890455|NCT00984659|2825629|P1|6-week Double-blind Treatment Period|Protocol Violation|0
890456|NCT00984659|2825626|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
890457|NCT00984659|2825627|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
890458|NCT00984659|2825628|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
890459|NCT00984659|2825629|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
724747|NCT00234039|2332684|P1|Overall Study|No Protocol Treatment Received|2
724748|NCT00234039|2332684|P1|Overall Study|Ineligible|9
724749|NCT00234039|2332684|P1|Overall Study|Other - Not Protocol Specified|3
724750|NCT00234039|2332684|P1|Overall Study|Progression/relapse|34
724751|NCT00234039|2332684|P1|Overall Study|Adverse Event|2
724752|NCT00234065|2332693|P2|Overall Study|Not Classified|112
724753|NCT00234065|2332694|P1|Overall Study|Not Classified|111
724754|NCT00234065|2332693|P2|Overall Study|Physician Decision|22
724755|NCT00234065|2332694|P1|Overall Study|Physician Decision|23
724756|NCT00234065|2332693|P2|Overall Study|Withdrawal by Subject|56
724757|NCT00234065|2332694|P1|Overall Study|Withdrawal by Subject|73
724758|NCT00234065|2332693|P2|Overall Study|Adverse Event|166
724759|NCT00234065|2332694|P1|Overall Study|Adverse Event|268
724760|NCT00234104|2332743|P4|Overall Study|Physician Decision|2
724761|NCT00234104|2332744|P3|Overall Study|Physician Decision|2
724762|NCT00234104|2332745|P2|Overall Study|Physician Decision|1
724763|NCT00234104|2332746|P1|Overall Study|Physician Decision|0
724764|NCT00234104|2332743|P4|Overall Study|Protocol Violation|1
724765|NCT00234104|2332744|P3|Overall Study|Protocol Violation|0
724766|NCT00234104|2332745|P2|Overall Study|Protocol Violation|0
724767|NCT00234104|2332746|P1|Overall Study|Protocol Violation|0
724768|NCT00234104|2332743|P4|Overall Study|Adverse Event|5
724769|NCT00234104|2332744|P3|Overall Study|Adverse Event|3
724770|NCT00234104|2332745|P2|Overall Study|Adverse Event|0
724771|NCT00234104|2332746|P1|Overall Study|Adverse Event|4
724772|NCT00239928|2332791|P1|Overall Study|Withdrawal by Subject|2
724773|NCT00239928|2332791|P1|Overall Study|Not need to continue study|3
724774|NCT00239928|2332791|P1|Overall Study|Adverse Event|4
724775|NCT00239928|2332791|P1|Overall Study|Lack of Efficacy|1
724776|NCT00240071|2332801|P1|Overall Study|Withdrawal by Subject|3
724777|NCT00240097|2332805|P1|Part II|did not continue from Part I|23
724778|NCT00240097|2332805|P1|Part I|unevaluable|1
724779|NCT00240097|2332805|P1|Part I|histology|1
724780|NCT00240097|2332805|P1|Part I|Death|1
724781|NCT00240097|2332805|P1|Part I|Adverse Event|1
724782|NCT00240110|2332817|P2|Overall Study|Lost to Follow-up|7
724783|NCT00240110|2332818|P1|Overall Study|Lost to Follow-up|6
890460|NCT00984659|2825626|P4|6-week Double-blind Treatment Period|Adverse Event|7
890461|NCT00984659|2825627|P3|6-week Double-blind Treatment Period|Adverse Event|3
724788|NCT00242216|2332871|P2|Overall Study|no medicaiton dispensed|1
724789|NCT00242216|2332872|P1|Overall Study|no medicaiton dispensed|1
724790|NCT00242216|2332871|P2|Overall Study|Lack of Efficacy|2
724791|NCT00242216|2332872|P1|Overall Study|Lack of Efficacy|1
724792|NCT00242216|2332871|P2|Overall Study|Death|2
724793|NCT00242216|2332872|P1|Overall Study|Death|4
724794|NCT00242216|2332871|P2|Overall Study|Lost to Follow-up|17
724795|NCT00242216|2332872|P1|Overall Study|Lost to Follow-up|12
724796|NCT00242567|2332911|P2|Overall Study|Other|9
724797|NCT00242567|2332912|P1|Overall Study|Other|14
724798|NCT00242567|2332911|P2|Overall Study|Use of an inhibitor of bone resorption|2
724799|NCT00242567|2332912|P1|Overall Study|Use of an inhibitor of bone resorption|0
724800|NCT00242567|2332911|P2|Overall Study|Protocol Violation|12
724801|NCT00242567|2332912|P1|Overall Study|Protocol Violation|12
724802|NCT00242567|2332911|P2|Overall Study|Withdrawal by Subject|28
724803|NCT00242567|2332912|P1|Overall Study|Withdrawal by Subject|33
724804|NCT00242567|2332911|P2|Overall Study|Lost to Follow-up|19
724805|NCT00242567|2332912|P1|Overall Study|Lost to Follow-up|9
724806|NCT00242567|2332911|P2|Overall Study|Lack of Efficacy|2
724807|NCT00242567|2332912|P1|Overall Study|Lack of Efficacy|2
724808|NCT00242567|2332911|P2|Overall Study|Symptomatic deterioration|3
724809|NCT00242567|2332912|P1|Overall Study|Symptomatic deterioration|9
724810|NCT00242567|2332911|P2|Overall Study|Disease Progression|22
724811|NCT00242567|2332912|P1|Overall Study|Disease Progression|17
724812|NCT00242567|2332911|P2|Overall Study|Adverse Event|43
724813|NCT00242567|2332912|P1|Overall Study|Adverse Event|70
724814|NCT00242580|2332931|P3|Overall Study|Death|1
724815|NCT00242580|2332932|P2|Overall Study|Death|2
724816|NCT00242580|2332933|P1|Overall Study|Death|1
724817|NCT00242580|2332931|P3|Overall Study|Lost to Follow-up|0
724818|NCT00242580|2332932|P2|Overall Study|Lost to Follow-up|3
724819|NCT00242580|2332933|P1|Overall Study|Lost to Follow-up|0
724820|NCT00242580|2332931|P3|Overall Study|Subject withdrew consent|5
724821|NCT00242580|2332932|P2|Overall Study|Subject withdrew consent|2
724822|NCT00242580|2332933|P1|Overall Study|Subject withdrew consent|2
724823|NCT00242580|2332931|P3|Overall Study|Protocol Violation|1
724824|NCT00242580|2332932|P2|Overall Study|Protocol Violation|0
724825|NCT00242580|2332933|P1|Overall Study|Protocol Violation|0
724826|NCT00242580|2332931|P3|Overall Study|Unsatisfactory therapeutic effect|5
724827|NCT00242580|2332932|P2|Overall Study|Unsatisfactory therapeutic effect|5
724828|NCT00242580|2332933|P1|Overall Study|Unsatisfactory therapeutic effect|4
724829|NCT00242580|2332931|P3|Overall Study|Adverse Event|2
724830|NCT00242580|2332932|P2|Overall Study|Adverse Event|0
724831|NCT00242580|2332933|P1|Overall Study|Adverse Event|3
724832|NCT00242658|2332978|P2|Overall Study|Lost to Follow-up|19
724833|NCT00242658|2332979|P1|Overall Study|Lost to Follow-up|22
724834|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
724835|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
724836|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
724837|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
724838|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Protocol Violation|1
724839|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Protocol Violation|0
724840|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Protocol Violation|2
724841|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Protocol Violation|0
724842|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Unspecified|3
724843|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Unspecified|4
724844|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Unspecified|5
724845|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Unspecified|3
724846|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
724847|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
724848|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
724849|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
724850|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Death|1
724851|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Death|0
724852|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Death|0
724853|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Death|0
724854|NCT00242710|2332996|P4|Study Extension (up to Year 2)|Adverse Event|4
724855|NCT00242710|2332997|P3|Study Extension (up to Year 2)|Adverse Event|2
724856|NCT00242710|2332998|P2|Study Extension (up to Year 2)|Adverse Event|9
724857|NCT00242710|2332999|P1|Study Extension (up to Year 2)|Adverse Event|7
724858|NCT00242710|2332996|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
724859|NCT00242710|2332997|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
724860|NCT00242710|2332998|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
724861|NCT00242710|2332999|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
724862|NCT00242710|2332996|P4|Period Between Core Study and Extension|Protocol Violation|1
724863|NCT00242710|2332997|P3|Period Between Core Study and Extension|Protocol Violation|2
724864|NCT00242710|2332998|P2|Period Between Core Study and Extension|Protocol Violation|0
724865|NCT00242710|2332999|P1|Period Between Core Study and Extension|Protocol Violation|0
724866|NCT00242710|2332996|P4|Period Between Core Study and Extension|Extension not Available|7
724867|NCT00242710|2332997|P3|Period Between Core Study and Extension|Extension not Available|8
724868|NCT00242710|2332998|P2|Period Between Core Study and Extension|Extension not Available|21
724869|NCT00242710|2332999|P1|Period Between Core Study and Extension|Extension not Available|17
724870|NCT00242710|2332996|P4|Period Between Core Study and Extension|Unspecified|11
724871|NCT00242710|2332997|P3|Period Between Core Study and Extension|Unspecified|9
724872|NCT00242710|2332998|P2|Period Between Core Study and Extension|Unspecified|24
724873|NCT00242710|2332999|P1|Period Between Core Study and Extension|Unspecified|24
724874|NCT00242710|2332996|P4|Period Between Core Study and Extension|Physician Decision|0
724875|NCT00242710|2332997|P3|Period Between Core Study and Extension|Physician Decision|0
724876|NCT00242710|2332998|P2|Period Between Core Study and Extension|Physician Decision|1
724877|NCT00242710|2332999|P1|Period Between Core Study and Extension|Physician Decision|1
724878|NCT00242710|2332996|P4|Period Between Core Study and Extension|Adverse Event|2
724879|NCT00242710|2332997|P3|Period Between Core Study and Extension|Adverse Event|5
724880|NCT00242710|2332998|P2|Period Between Core Study and Extension|Adverse Event|3
724881|NCT00242710|2332999|P1|Period Between Core Study and Extension|Adverse Event|2
724882|NCT00242710|2332996|P4|Core Study (up to Year 1)|Randomized but not Treated|2
724883|NCT00242710|2332997|P3|Core Study (up to Year 1)|Randomized but not Treated|4
724884|NCT00242710|2332998|P2|Core Study (up to Year 1)|Randomized but not Treated|4
724885|NCT00242710|2332999|P1|Core Study (up to Year 1)|Randomized but not Treated|12
724886|NCT00242710|2332996|P4|Core Study (up to Year 1)|Lack of Efficacy|0
724887|NCT00242710|2332997|P3|Core Study (up to Year 1)|Lack of Efficacy|0
724888|NCT00242710|2332998|P2|Core Study (up to Year 1)|Lack of Efficacy|0
724889|NCT00242710|2332999|P1|Core Study (up to Year 1)|Lack of Efficacy|1
724890|NCT00242710|2332996|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
724891|NCT00242710|2332997|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
724892|NCT00242710|2332998|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
724893|NCT00242710|2332999|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
724894|NCT00242710|2332996|P4|Core Study (up to Year 1)|Protocol Violation|3
724895|NCT00242710|2332997|P3|Core Study (up to Year 1)|Protocol Violation|1
724896|NCT00242710|2332998|P2|Core Study (up to Year 1)|Protocol Violation|9
724897|NCT00242710|2332999|P1|Core Study (up to Year 1)|Protocol Violation|2
724898|NCT00242710|2332996|P4|Core Study (up to Year 1)|Unspecified|2
724899|NCT00242710|2332997|P3|Core Study (up to Year 1)|Unspecified|0
724900|NCT00242710|2332998|P2|Core Study (up to Year 1)|Unspecified|1
724901|NCT00242710|2332999|P1|Core Study (up to Year 1)|Unspecified|6
724902|NCT00242710|2332996|P4|Core Study (up to Year 1)|Lost to Follow-up|3
724903|NCT00242710|2332997|P3|Core Study (up to Year 1)|Lost to Follow-up|7
724904|NCT00242710|2332998|P2|Core Study (up to Year 1)|Lost to Follow-up|8
724905|NCT00242710|2332999|P1|Core Study (up to Year 1)|Lost to Follow-up|8
724906|NCT00242710|2332996|P4|Core Study (up to Year 1)|Physician Decision|1
724907|NCT00242710|2332997|P3|Core Study (up to Year 1)|Physician Decision|0
724908|NCT00242710|2332998|P2|Core Study (up to Year 1)|Physician Decision|1
724909|NCT00242710|2332999|P1|Core Study (up to Year 1)|Physician Decision|0
724910|NCT00242710|2332996|P4|Core Study (up to Year 1)|Death|0
724911|NCT00242710|2332997|P3|Core Study (up to Year 1)|Death|1
724912|NCT00242710|2332998|P2|Core Study (up to Year 1)|Death|0
724913|NCT00242710|2332999|P1|Core Study (up to Year 1)|Death|0
724914|NCT00242710|2332996|P4|Core Study (up to Year 1)|Adverse Event|14
724915|NCT00242710|2332997|P3|Core Study (up to Year 1)|Adverse Event|23
724916|NCT00242710|2332998|P2|Core Study (up to Year 1)|Adverse Event|25
724917|NCT00242710|2332999|P1|Core Study (up to Year 1)|Adverse Event|30
724918|NCT00243022|2333051|P2|Overall Study|Difficult Travel Distance|1
724919|NCT00243022|2333052|P1|Overall Study|Difficult Travel Distance|0
724920|NCT00243022|2333051|P2|Overall Study|Death|0
724921|NCT00243022|2333052|P1|Overall Study|Death|1
724922|NCT00243022|2333051|P2|Overall Study|Withdrawal by Subject|0
724923|NCT00243022|2333052|P1|Overall Study|Withdrawal by Subject|1
724924|NCT00243074|2333079|P1|Overall Study|Did not receive any treatment|1
724925|NCT00243074|2333079|P1|Overall Study|not protocol specified|1
724926|NCT00243074|2333079|P1|Overall Study|Death|2
724927|NCT00243074|2333079|P1|Overall Study|Lack of Efficacy|36
724928|NCT00243074|2333079|P1|Overall Study|Withdrawal by Subject|2
724929|NCT00243074|2333079|P1|Overall Study|Adverse Event|6
724930|NCT00243074|2333079|P1|Overall Study|Ineligible|6
724931|NCT00243269|2333105|P4|Overall Study|Lost to Follow-up|3
724932|NCT00243269|2333106|P3|Overall Study|Lost to Follow-up|1
724933|NCT00243269|2333107|P2|Overall Study|Lost to Follow-up|0
724934|NCT00243269|2333108|P1|Overall Study|Lost to Follow-up|1
724935|NCT00243269|2333105|P4|Overall Study|Protocol Violation|1
724936|NCT00243269|2333106|P3|Overall Study|Protocol Violation|0
724937|NCT00243269|2333107|P2|Overall Study|Protocol Violation|1
724938|NCT00243269|2333108|P1|Overall Study|Protocol Violation|2
724939|NCT00243347|2333122|P1|Overall Study|Condition worsened|7
724940|NCT00243347|2333122|P1|Overall Study|Withdrawal by Subject|5
724941|NCT00243347|2333122|P1|Overall Study|Death|1
724942|NCT00243347|2333122|P1|Overall Study|Adverse Event|2
724943|NCT00243347|2333122|P1|Overall Study|Lack of Efficacy|4
724968|NCT00243412|2333196|P2|Overall Study|not specified|1
724969|NCT00243412|2333197|P1|Overall Study|not specified|1
724970|NCT00243412|2333196|P2|Overall Study|Withdrawal by Subject|5
724971|NCT00243412|2333197|P1|Overall Study|Withdrawal by Subject|4
724972|NCT00243412|2333196|P2|Overall Study|Physician Decision|1
724973|NCT00243412|2333197|P1|Overall Study|Physician Decision|1
724974|NCT00243412|2333196|P2|Overall Study|Lost to Follow-up|1
724975|NCT00243412|2333197|P1|Overall Study|Lost to Follow-up|0
724976|NCT00243412|2333196|P2|Overall Study|Adverse Event|2
724977|NCT00243412|2333197|P1|Overall Study|Adverse Event|4
724978|NCT00243412|2333196|P2|Overall Study|Death|1
724979|NCT00243412|2333197|P1|Overall Study|Death|0
724980|NCT00243503|2333223|P1|Overall Study|Unspecified|1
724981|NCT00243503|2333223|P1|Overall Study|Death|1
724982|NCT00243503|2333223|P1|Overall Study|Lack of Efficacy|44
724983|NCT00243503|2333223|P1|Overall Study|Withdrawal by Subject|1
724984|NCT00243503|2333223|P1|Overall Study|Adverse Event|11
724985|NCT00243659|2333240|P2|Overall Study|Protocol Violation|2
724986|NCT00243659|2333241|P1|Overall Study|Protocol Violation|1
724987|NCT00243659|2333240|P2|Overall Study|Withdrawal by Subject|1
724988|NCT00243659|2333241|P1|Overall Study|Withdrawal by Subject|1
724989|NCT00243919|2333252|P3|Overall Study|Physician Decision|0
724990|NCT00243919|2333253|P2|Overall Study|Physician Decision|1
724991|NCT00243919|2333254|P1|Overall Study|Physician Decision|1
724992|NCT00243919|2333252|P3|Overall Study|Administrative Error|0
724993|NCT00243919|2333253|P2|Overall Study|Administrative Error|0
724994|NCT00243919|2333254|P1|Overall Study|Administrative Error|1
724995|NCT00243919|2333252|P3|Overall Study|Lost to Follow-up|3
724996|NCT00243919|2333253|P2|Overall Study|Lost to Follow-up|7
724997|NCT00243919|2333254|P1|Overall Study|Lost to Follow-up|6
724998|NCT00243919|2333252|P3|Overall Study|Withdrawal by Subject|2
724999|NCT00243919|2333253|P2|Overall Study|Withdrawal by Subject|6
725000|NCT00243919|2333254|P1|Overall Study|Withdrawal by Subject|6
725001|NCT00243919|2333252|P3|Overall Study|Death|6
725002|NCT00243919|2333253|P2|Overall Study|Death|4
725003|NCT00243919|2333254|P1|Overall Study|Death|3
725004|NCT00243932|2333298|P3|Stage 1: Dose Selection|Lost to Follow-up|0
725005|NCT00243932|2333299|P2|Stage 1: Dose Selection|Lost to Follow-up|0
725006|NCT00243932|2333300|P1|Stage 1: Dose Selection|Lost to Follow-up|2
725007|NCT00231465|2333357|P1|Overall Study|Did not have follow up CT scans|1
725008|NCT00231465|2333357|P1|Overall Study|Completed only one cycle|1
725009|NCT00231478|2333365|P2|Overall Study|Administrative|2
725010|NCT00231478|2333366|P1|Overall Study|Administrative|3
725011|NCT00231478|2333365|P2|Overall Study|Adverse Event|1
725012|NCT00231478|2333366|P1|Overall Study|Adverse Event|0
725013|NCT00231478|2333365|P2|Overall Study|Withdrawal by Subject|0
725014|NCT00231478|2333366|P1|Overall Study|Withdrawal by Subject|1
725015|NCT00231478|2333365|P2|Overall Study|Refused Treatment|1
725016|NCT00231478|2333366|P1|Overall Study|Refused Treatment|1
725017|NCT00231478|2333365|P2|Overall Study|Protocol Violation|2
725018|NCT00231478|2333366|P1|Overall Study|Protocol Violation|3
725019|NCT00231777|2333380|P2|Overall Study|Unspecified|2
725020|NCT00231777|2333381|P1|Overall Study|Unspecified|3
725021|NCT00231777|2333380|P2|Overall Study|Lost to Follow-up|0
725022|NCT00231777|2333381|P1|Overall Study|Lost to Follow-up|3
725023|NCT00231816|2333395|P2|Overall Study|Not Specified|1
725024|NCT00231816|2333396|P1|Overall Study|Not Specified|2
725025|NCT00231816|2333395|P2|Overall Study|Withdrawal by Subject|3
725026|NCT00231816|2333396|P1|Overall Study|Withdrawal by Subject|3
725027|NCT00231816|2333395|P2|Overall Study|Protocol Violation|3
725028|NCT00231816|2333396|P1|Overall Study|Protocol Violation|2
725029|NCT00231816|2333395|P2|Overall Study|Lost to Follow-up|5
725030|NCT00231816|2333396|P1|Overall Study|Lost to Follow-up|8
725031|NCT00231816|2333395|P2|Overall Study|Adverse Event|0
725032|NCT00231816|2333396|P1|Overall Study|Adverse Event|1
725033|NCT00244374|2333409|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
725034|NCT00244374|2333410|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
725035|NCT00244374|2333411|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
725036|NCT00244374|2333412|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
725037|NCT00244374|2333413|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
725038|NCT00244374|2333409|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
725039|NCT00244374|2333410|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
725040|NCT00244374|2333411|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
725041|NCT00244374|2333412|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
725042|NCT00244374|2333413|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
725043|NCT00244374|2333409|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
725044|NCT00244374|2333410|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
725045|NCT00244374|2333411|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
725046|NCT00244374|2333412|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
725047|NCT00244374|2333413|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
725048|NCT00244374|2333409|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
725049|NCT00244374|2333410|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
725050|NCT00244374|2333411|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
725051|NCT00244374|2333412|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
725052|NCT00244374|2333413|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
725053|NCT00244374|2333409|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
725054|NCT00244374|2333410|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
725055|NCT00244374|2333411|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
725056|NCT00244374|2333412|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
725057|NCT00244374|2333413|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
725058|NCT00244374|2333409|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
725059|NCT00244374|2333410|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
725060|NCT00244374|2333411|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
725061|NCT00244374|2333412|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
725062|NCT00244374|2333413|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
725063|NCT00244374|2333409|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
725064|NCT00244374|2333410|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
725065|NCT00244374|2333411|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
725066|NCT00244374|2333412|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
725067|NCT00244374|2333413|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
725068|NCT00244374|2333409|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
725069|NCT00244374|2333410|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
725070|NCT00244374|2333411|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
725071|NCT00244374|2333412|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
725072|NCT00244374|2333413|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
725073|NCT00244374|2333409|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
725074|NCT00244374|2333410|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
725075|NCT00244374|2333411|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
725076|NCT00244374|2333412|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
725077|NCT00244374|2333413|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
725078|NCT00244621|2333432|P3|Open-label Treatment Period|Moved abroad|1
725079|NCT00244621|2333433|P2|Open-label Treatment Period|Moved abroad|0
725080|NCT00244621|2333434|P1|Open-label Treatment Period|Moved abroad|0
725081|NCT00244621|2333432|P3|Open-label Treatment Period|Adverse Event|1
725082|NCT00244621|2333433|P2|Open-label Treatment Period|Adverse Event|0
725083|NCT00244621|2333434|P1|Open-label Treatment Period|Adverse Event|0
725084|NCT00244621|2333432|P3|Open-label Treatment Period|Withdrawal by Subject|0
725085|NCT00244621|2333433|P2|Open-label Treatment Period|Withdrawal by Subject|0
725086|NCT00244621|2333434|P1|Open-label Treatment Period|Withdrawal by Subject|1
725087|NCT00244621|2333432|P3|Open-label Treatment Period|Lost to Follow-up|0
725088|NCT00244621|2333433|P2|Open-label Treatment Period|Lost to Follow-up|1
725089|NCT00244621|2333434|P1|Open-label Treatment Period|Lost to Follow-up|0
725090|NCT00244621|2333432|P3|Double-blind Treatment Period|Multiple Reasons|1
725091|NCT00244621|2333433|P2|Double-blind Treatment Period|Multiple Reasons|1
725092|NCT00244621|2333434|P1|Double-blind Treatment Period|Multiple Reasons|2
725093|NCT00244621|2333432|P3|Double-blind Treatment Period|Lack of Efficacy|0
725094|NCT00244621|2333433|P2|Double-blind Treatment Period|Lack of Efficacy|1
725095|NCT00244621|2333434|P1|Double-blind Treatment Period|Lack of Efficacy|0
725096|NCT00244621|2333432|P3|Double-blind Treatment Period|Withdrawal by Subject|0
725097|NCT00244621|2333433|P2|Double-blind Treatment Period|Withdrawal by Subject|1
725098|NCT00244621|2333434|P1|Double-blind Treatment Period|Withdrawal by Subject|0
725099|NCT00244621|2333432|P3|Double-blind Treatment Period|Lost to Follow-up|1
725100|NCT00244621|2333433|P2|Double-blind Treatment Period|Lost to Follow-up|0
725101|NCT00244621|2333434|P1|Double-blind Treatment Period|Lost to Follow-up|0
725102|NCT00245102|2333457|P6|Overall Study|Clinical progression|0
725103|NCT00245102|2333458|P5|Overall Study|Clinical progression|0
725104|NCT00245102|2333459|P4|Overall Study|Clinical progression|0
725105|NCT00245102|2333460|P3|Overall Study|Clinical progression|0
725106|NCT00245102|2333461|P2|Overall Study|Clinical progression|0
725107|NCT00245102|2333462|P1|Overall Study|Clinical progression|1
725108|NCT00245102|2333457|P6|Overall Study|Participant needed surgery|0
725109|NCT00245102|2333458|P5|Overall Study|Participant needed surgery|0
725110|NCT00245102|2333459|P4|Overall Study|Participant needed surgery|0
725111|NCT00245102|2333460|P3|Overall Study|Participant needed surgery|1
725112|NCT00245102|2333461|P2|Overall Study|Participant needed surgery|0
725113|NCT00245102|2333462|P1|Overall Study|Participant needed surgery|0
725114|NCT00245102|2333457|P6|Overall Study|Decline in performance|2
725115|NCT00245102|2333458|P5|Overall Study|Decline in performance|0
725116|NCT00245102|2333459|P4|Overall Study|Decline in performance|1
725117|NCT00245102|2333460|P3|Overall Study|Decline in performance|0
725118|NCT00245102|2333461|P2|Overall Study|Decline in performance|2
725119|NCT00245102|2333462|P1|Overall Study|Decline in performance|0
725120|NCT00245102|2333457|P6|Overall Study|Adverse Event|2
725121|NCT00245102|2333458|P5|Overall Study|Adverse Event|0
725122|NCT00245102|2333459|P4|Overall Study|Adverse Event|1
725123|NCT00245102|2333460|P3|Overall Study|Adverse Event|5
725124|NCT00245102|2333461|P2|Overall Study|Adverse Event|2
725125|NCT00245102|2333462|P1|Overall Study|Adverse Event|4
725126|NCT00245102|2333457|P6|Overall Study|Death|0
725127|NCT00245102|2333458|P5|Overall Study|Death|0
725128|NCT00245102|2333459|P4|Overall Study|Death|1
725129|NCT00245102|2333460|P3|Overall Study|Death|0
725130|NCT00245102|2333461|P2|Overall Study|Death|0
725131|NCT00245102|2333462|P1|Overall Study|Death|0
725132|NCT00245102|2333457|P6|Overall Study|Protocol Violation|0
725133|NCT00245102|2333458|P5|Overall Study|Protocol Violation|0
725134|NCT00245102|2333459|P4|Overall Study|Protocol Violation|0
725135|NCT00245102|2333460|P3|Overall Study|Protocol Violation|0
725136|NCT00245102|2333461|P2|Overall Study|Protocol Violation|0
725137|NCT00245102|2333462|P1|Overall Study|Protocol Violation|1
725138|NCT00245102|2333457|P6|Overall Study|Not Treated|0
725139|NCT00245102|2333458|P5|Overall Study|Not Treated|0
725140|NCT00245102|2333459|P4|Overall Study|Not Treated|0
725141|NCT00245102|2333460|P3|Overall Study|Not Treated|1
725142|NCT00245102|2333461|P2|Overall Study|Not Treated|0
725143|NCT00245102|2333462|P1|Overall Study|Not Treated|1
725144|NCT00245466|2333502|P3|Overall Study|Administrative reasons|0
725145|NCT00245466|2333503|P2|Overall Study|Administrative reasons|1
725146|NCT00245466|2333504|P1|Overall Study|Administrative reasons|0
725147|NCT00245466|2333502|P3|Overall Study|Death|0
725148|NCT00245466|2333503|P2|Overall Study|Death|2
725149|NCT00245466|2333504|P1|Overall Study|Death|0
725150|NCT00245466|2333502|P3|Overall Study|Protocol Violation|2
725151|NCT00245466|2333503|P2|Overall Study|Protocol Violation|2
725152|NCT00245466|2333504|P1|Overall Study|Protocol Violation|1
725153|NCT00245466|2333502|P3|Overall Study|Disease progression|1
725154|NCT00245466|2333503|P2|Overall Study|Disease progression|3
725155|NCT00245466|2333504|P1|Overall Study|Disease progression|0
725156|NCT00245466|2333502|P3|Overall Study|Lost to Follow-up|0
725157|NCT00245466|2333503|P2|Overall Study|Lost to Follow-up|0
725158|NCT00245466|2333504|P1|Overall Study|Lost to Follow-up|3
725159|NCT00245466|2333502|P3|Overall Study|Withdrawal by Subject|1
725160|NCT00245466|2333503|P2|Overall Study|Withdrawal by Subject|2
725161|NCT00245466|2333504|P1|Overall Study|Withdrawal by Subject|2
725162|NCT00245466|2333502|P3|Overall Study|Insufficient PSA and testosterone suppr|3
725163|NCT00245466|2333503|P2|Overall Study|Insufficient PSA and testosterone suppr|0
725164|NCT00245466|2333504|P1|Overall Study|Insufficient PSA and testosterone suppr|0
725165|NCT00245466|2333502|P3|Overall Study|Insufficient testosterone suppr|21
725166|NCT00245466|2333503|P2|Overall Study|Insufficient testosterone suppr|12
725167|NCT00245466|2333504|P1|Overall Study|Insufficient testosterone suppr|12
725168|NCT00245466|2333502|P3|Overall Study|Low prostate specific antigen suppr|5
725169|NCT00245466|2333503|P2|Overall Study|Low prostate specific antigen suppr|14
725170|NCT00245466|2333504|P1|Overall Study|Low prostate specific antigen suppr|16
725171|NCT00245466|2333502|P3|Overall Study|Adverse Event|4
725172|NCT00245466|2333503|P2|Overall Study|Adverse Event|8
725173|NCT00245466|2333504|P1|Overall Study|Adverse Event|2
725174|NCT00245570|2333532|P6|Washout Between Periods III and IV|Adverse Event|0
725175|NCT00245570|2333533|P5|Washout Between Periods III and IV|Adverse Event|0
725176|NCT00245570|2333534|P4|Washout Between Periods III and IV|Adverse Event|0
725177|NCT00245570|2333535|P3|Washout Between Periods III and IV|Adverse Event|0
725178|NCT00245570|2333536|P2|Washout Between Periods III and IV|Adverse Event|1
725179|NCT00245570|2333537|P1|Washout Between Periods III and IV|Adverse Event|0
725180|NCT00245856|2333590|P2|Period Two|Withdrawal by Subject|1
725181|NCT00245856|2333591|P1|Period Two|Withdrawal by Subject|0
725182|NCT00245960|2333600|P2|Overall Study|Lack of Efficacy|6
725183|NCT00245960|2333601|P1|Overall Study|Lack of Efficacy|4
725184|NCT00245960|2333600|P2|Overall Study|Withdrawal by Subject|7
725185|NCT00245960|2333601|P1|Overall Study|Withdrawal by Subject|5
725186|NCT00245960|2333600|P2|Overall Study|Protocol Violation|3
725187|NCT00245960|2333601|P1|Overall Study|Protocol Violation|4
725188|NCT00245960|2333600|P2|Overall Study|Lost to Follow-up|2
725189|NCT00245960|2333601|P1|Overall Study|Lost to Follow-up|2
725190|NCT00245960|2333600|P2|Overall Study|Adverse Event|10
725191|NCT00245960|2333601|P1|Overall Study|Adverse Event|14
725192|NCT00246012|2333618|P9|Overall Study|Randomly assigned but not treated|0
725193|NCT00246012|2333619|P8|Overall Study|Randomly assigned but not treated|0
725194|NCT00246012|2333620|P7|Overall Study|Randomly assigned but not treated|1
725195|NCT00246012|2333621|P6|Overall Study|Randomly assigned but not treated|1
725196|NCT00246012|2333622|P5|Overall Study|Randomly assigned but not treated|0
725197|NCT00246012|2333623|P4|Overall Study|Randomly assigned but not treated|0
725198|NCT00246012|2333624|P3|Overall Study|Randomly assigned but not treated|0
725199|NCT00246012|2333625|P2|Overall Study|Randomly assigned but not treated|0
725200|NCT00246012|2333626|P1|Overall Study|Randomly assigned but not treated|0
725201|NCT00246012|2333618|P9|Overall Study|unspecified|0
725202|NCT00246012|2333619|P8|Overall Study|unspecified|1
725203|NCT00246012|2333620|P7|Overall Study|unspecified|0
725204|NCT00246012|2333621|P6|Overall Study|unspecified|0
725205|NCT00246012|2333622|P5|Overall Study|unspecified|0
725206|NCT00246012|2333623|P4|Overall Study|unspecified|0
725207|NCT00246012|2333624|P3|Overall Study|unspecified|0
725208|NCT00246012|2333625|P2|Overall Study|unspecified|0
725209|NCT00246012|2333626|P1|Overall Study|unspecified|0
725210|NCT00246012|2333618|P9|Overall Study|Disease progression|26
725211|NCT00246012|2333619|P8|Overall Study|Disease progression|27
725212|NCT00246012|2333620|P7|Overall Study|Disease progression|30
725213|NCT00246012|2333621|P6|Overall Study|Disease progression|25
725214|NCT00246012|2333622|P5|Overall Study|Disease progression|3
725215|NCT00246012|2333623|P4|Overall Study|Disease progression|3
725216|NCT00246012|2333624|P3|Overall Study|Disease progression|2
725217|NCT00246012|2333625|P2|Overall Study|Disease progression|1
725218|NCT00246012|2333626|P1|Overall Study|Disease progression|3
725219|NCT00246012|2333618|P9|Overall Study|Withdrawal by Subject|0
725220|NCT00246012|2333619|P8|Overall Study|Withdrawal by Subject|0
725221|NCT00246012|2333620|P7|Overall Study|Withdrawal by Subject|0
725222|NCT00246012|2333621|P6|Overall Study|Withdrawal by Subject|1
725223|NCT00246012|2333622|P5|Overall Study|Withdrawal by Subject|0
725224|NCT00246012|2333623|P4|Overall Study|Withdrawal by Subject|0
725225|NCT00246012|2333624|P3|Overall Study|Withdrawal by Subject|0
725226|NCT00246012|2333625|P2|Overall Study|Withdrawal by Subject|0
725227|NCT00246012|2333626|P1|Overall Study|Withdrawal by Subject|0
725228|NCT00246012|2333618|P9|Overall Study|Adverse Event|2
725229|NCT00246012|2333619|P8|Overall Study|Adverse Event|0
725230|NCT00246012|2333620|P7|Overall Study|Adverse Event|0
725231|NCT00246012|2333621|P6|Overall Study|Adverse Event|1
725232|NCT00246012|2333622|P5|Overall Study|Adverse Event|0
725233|NCT00246012|2333623|P4|Overall Study|Adverse Event|0
725234|NCT00246012|2333624|P3|Overall Study|Adverse Event|0
725235|NCT00246012|2333625|P2|Overall Study|Adverse Event|0
725236|NCT00246012|2333626|P1|Overall Study|Adverse Event|0
725237|NCT00246025|2333723|P4|Overall Study|unsuitable medical history was found|1
725238|NCT00246025|2333724|P3|Overall Study|unsuitable medical history was found|0
725239|NCT00246025|2333725|P2|Overall Study|unsuitable medical history was found|0
725240|NCT00246025|2333726|P1|Overall Study|unsuitable medical history was found|0
725241|NCT00246025|2333723|P4|Overall Study|Withdrawal by Subject|2
725242|NCT00246025|2333724|P3|Overall Study|Withdrawal by Subject|1
725243|NCT00246025|2333725|P2|Overall Study|Withdrawal by Subject|0
725244|NCT00246025|2333726|P1|Overall Study|Withdrawal by Subject|3
725245|NCT00246025|2333723|P4|Overall Study|Adverse Event|10
725246|NCT00246025|2333724|P3|Overall Study|Adverse Event|9
725247|NCT00246025|2333725|P2|Overall Study|Adverse Event|9
725248|NCT00246025|2333726|P1|Overall Study|Adverse Event|7
725249|NCT00246090|2333776|P1|Overall Study|Not Otherwise Specified|10
725250|NCT00246090|2333776|P1|Overall Study|Physician Decision|11
725251|NCT00246090|2333776|P1|Overall Study|Clinical Progression|30
725252|NCT00246090|2333776|P1|Overall Study|Progressive Disease|212
725253|NCT00246090|2333776|P1|Overall Study|Withdrawal by Subject|7
725254|NCT00246090|2333776|P1|Overall Study|Adverse Event|25
725255|NCT00246259|2333783|P2|Overall Study|randomly assigned, not eligible for ITT|6
725256|NCT00246259|2333784|P1|Overall Study|randomly assigned, not eligible for ITT|2
725257|NCT00246259|2333783|P2|Overall Study|Withdrawal by Subject|1
725258|NCT00246259|2333784|P1|Overall Study|Withdrawal by Subject|5
725259|NCT00246259|2333783|P2|Overall Study|Lost to Follow-up|4
725260|NCT00246259|2333784|P1|Overall Study|Lost to Follow-up|3
725261|NCT00246259|2333783|P2|Overall Study|Adverse Event|0
725262|NCT00246259|2333784|P1|Overall Study|Adverse Event|5
725263|NCT00246259|2333783|P2|Overall Study|Investigator withdrew participant|0
725264|NCT00246259|2333784|P1|Overall Study|Investigator withdrew participant|2
725265|NCT00246259|2333783|P2|Overall Study|Lack of Efficacy|2
725266|NCT00246259|2333784|P1|Overall Study|Lack of Efficacy|2
725267|NCT00246259|2333783|P2|Overall Study|Participant non-compliant|9
725268|NCT00246259|2333784|P1|Overall Study|Participant non-compliant|4
725269|NCT00246259|2333783|P2|Overall Study|Not stable by Week 18|1
725270|NCT00246259|2333784|P1|Overall Study|Not stable by Week 18|2
725271|NCT00246259|2333783|P2|Overall Study|Unspecified|3
725272|NCT00246259|2333784|P1|Overall Study|Unspecified|3
725273|NCT00246324|2333818|P1|Overall Study|Withdrawal by Subject|1
725274|NCT00246337|2333832|P9|Overall Study|Reported as completing trial in error|0
725275|NCT00246337|2333833|P8|Overall Study|Reported as completing trial in error|1
725276|NCT00246337|2333834|P7|Overall Study|Reported as completing trial in error|0
725277|NCT00246337|2333835|P6|Overall Study|Reported as completing trial in error|0
725278|NCT00246337|2333836|P5|Overall Study|Reported as completing trial in error|0
725279|NCT00246337|2333837|P4|Overall Study|Reported as completing trial in error|0
725280|NCT00246337|2333838|P3|Overall Study|Reported as completing trial in error|0
725281|NCT00246337|2333839|P2|Overall Study|Reported as completing trial in error|0
725282|NCT00246337|2333840|P1|Overall Study|Reported as completing trial in error|0
725283|NCT00246337|2333832|P9|Overall Study|Protocol Violator|0
725284|NCT00246337|2333833|P8|Overall Study|Protocol Violator|0
725285|NCT00246337|2333834|P7|Overall Study|Protocol Violator|0
725286|NCT00246337|2333835|P6|Overall Study|Protocol Violator|0
725287|NCT00246337|2333836|P5|Overall Study|Protocol Violator|0
725288|NCT00246337|2333837|P4|Overall Study|Protocol Violator|0
725289|NCT00246337|2333838|P3|Overall Study|Protocol Violator|0
725290|NCT00246337|2333839|P2|Overall Study|Protocol Violator|0
725291|NCT00246337|2333840|P1|Overall Study|Protocol Violator|1
725292|NCT00246337|2333832|P9|Overall Study|Overwhelmed|0
725293|NCT00246337|2333833|P8|Overall Study|Overwhelmed|0
725294|NCT00246337|2333834|P7|Overall Study|Overwhelmed|0
725295|NCT00246337|2333835|P6|Overall Study|Overwhelmed|1
725296|NCT00246337|2333836|P5|Overall Study|Overwhelmed|0
725297|NCT00246337|2333837|P4|Overall Study|Overwhelmed|0
725298|NCT00246337|2333838|P3|Overall Study|Overwhelmed|0
725299|NCT00246337|2333839|P2|Overall Study|Overwhelmed|0
725300|NCT00246337|2333840|P1|Overall Study|Overwhelmed|0
725301|NCT00246337|2333832|P9|Overall Study|Abnormal baseline lab values|4
725302|NCT00246337|2333833|P8|Overall Study|Abnormal baseline lab values|0
725303|NCT00246337|2333834|P7|Overall Study|Abnormal baseline lab values|2
725304|NCT00246337|2333835|P6|Overall Study|Abnormal baseline lab values|2
725305|NCT00246337|2333836|P5|Overall Study|Abnormal baseline lab values|0
725306|NCT00246337|2333837|P4|Overall Study|Abnormal baseline lab values|0
725307|NCT00246337|2333838|P3|Overall Study|Abnormal baseline lab values|2
725308|NCT00246337|2333839|P2|Overall Study|Abnormal baseline lab values|0
725309|NCT00246337|2333840|P1|Overall Study|Abnormal baseline lab values|7
725310|NCT00246337|2333832|P9|Overall Study|Site Terminated|2
725311|NCT00246337|2333833|P8|Overall Study|Site Terminated|6
725312|NCT00246337|2333834|P7|Overall Study|Site Terminated|1
725313|NCT00246337|2333835|P6|Overall Study|Site Terminated|7
725314|NCT00246337|2333836|P5|Overall Study|Site Terminated|0
725315|NCT00246337|2333837|P4|Overall Study|Site Terminated|0
725316|NCT00246337|2333838|P3|Overall Study|Site Terminated|0
725317|NCT00246337|2333839|P2|Overall Study|Site Terminated|0
725318|NCT00246337|2333840|P1|Overall Study|Site Terminated|10
725319|NCT00246337|2333832|P9|Overall Study|Lack of Qualifying Event|5
725320|NCT00246337|2333833|P8|Overall Study|Lack of Qualifying Event|2
725321|NCT00246337|2333834|P7|Overall Study|Lack of Qualifying Event|3
725322|NCT00246337|2333835|P6|Overall Study|Lack of Qualifying Event|3
725323|NCT00246337|2333836|P5|Overall Study|Lack of Qualifying Event|1
725324|NCT00246337|2333837|P4|Overall Study|Lack of Qualifying Event|1
725325|NCT00246337|2333838|P3|Overall Study|Lack of Qualifying Event|1
725326|NCT00246337|2333839|P2|Overall Study|Lack of Qualifying Event|2
725327|NCT00246337|2333840|P1|Overall Study|Lack of Qualifying Event|8
725328|NCT00246337|2333832|P9|Overall Study|Withdrawal by Subject|0
725329|NCT00246337|2333833|P8|Overall Study|Withdrawal by Subject|1
725330|NCT00246337|2333834|P7|Overall Study|Withdrawal by Subject|1
725331|NCT00246337|2333835|P6|Overall Study|Withdrawal by Subject|0
725332|NCT00246337|2333836|P5|Overall Study|Withdrawal by Subject|0
725333|NCT00246337|2333837|P4|Overall Study|Withdrawal by Subject|0
725334|NCT00246337|2333838|P3|Overall Study|Withdrawal by Subject|0
725335|NCT00246337|2333839|P2|Overall Study|Withdrawal by Subject|0
725336|NCT00246337|2333840|P1|Overall Study|Withdrawal by Subject|2
725337|NCT00246337|2333832|P9|Overall Study|Protocol Violation|0
725338|NCT00246337|2333833|P8|Overall Study|Protocol Violation|1
725339|NCT00246337|2333834|P7|Overall Study|Protocol Violation|1
725340|NCT00246337|2333835|P6|Overall Study|Protocol Violation|0
725341|NCT00246337|2333836|P5|Overall Study|Protocol Violation|1
725342|NCT00246337|2333837|P4|Overall Study|Protocol Violation|0
725343|NCT00246337|2333838|P3|Overall Study|Protocol Violation|0
725344|NCT00246337|2333839|P2|Overall Study|Protocol Violation|0
725345|NCT00246337|2333840|P1|Overall Study|Protocol Violation|1
725346|NCT00246337|2333832|P9|Overall Study|Lost to Follow-up|0
725347|NCT00246337|2333833|P8|Overall Study|Lost to Follow-up|2
725348|NCT00246337|2333834|P7|Overall Study|Lost to Follow-up|1
725349|NCT00246337|2333835|P6|Overall Study|Lost to Follow-up|2
725350|NCT00246337|2333836|P5|Overall Study|Lost to Follow-up|2
725351|NCT00246337|2333837|P4|Overall Study|Lost to Follow-up|0
725352|NCT00246337|2333838|P3|Overall Study|Lost to Follow-up|0
725353|NCT00246337|2333839|P2|Overall Study|Lost to Follow-up|0
725354|NCT00246337|2333840|P1|Overall Study|Lost to Follow-up|3
725355|NCT00246376|2333892|P5|Overall Study|Lost to Follow-up|13
725356|NCT00246376|2333893|P4|Overall Study|Lost to Follow-up|16
725357|NCT00246376|2333894|P3|Overall Study|Lost to Follow-up|11
725358|NCT00246376|2333895|P2|Overall Study|Lost to Follow-up|11
725359|NCT00246376|2333896|P1|Overall Study|Lost to Follow-up|2
725360|NCT00246376|2333892|P5|Overall Study|Adverse Event|1
725361|NCT00246376|2333893|P4|Overall Study|Adverse Event|3
725362|NCT00246376|2333894|P3|Overall Study|Adverse Event|1
725363|NCT00246376|2333895|P2|Overall Study|Adverse Event|3
725364|NCT00246376|2333896|P1|Overall Study|Adverse Event|2
725365|NCT00246376|2333892|P5|Overall Study|Dropped/withdrew during dietary run-in|3
725366|NCT00246376|2333893|P4|Overall Study|Dropped/withdrew during dietary run-in|7
725367|NCT00246376|2333894|P3|Overall Study|Dropped/withdrew during dietary run-in|4
725368|NCT00246376|2333895|P2|Overall Study|Dropped/withdrew during dietary run-in|5
725369|NCT00246376|2333896|P1|Overall Study|Dropped/withdrew during dietary run-in|11
725370|NCT00246571|2333949|P2|Overall Study|Crossover participants|74
725371|NCT00246571|2333950|P1|Overall Study|Crossover participants|0
725372|NCT00246571|2333949|P2|Overall Study|Laboratory abnormalities|0
725373|NCT00246571|2333950|P1|Overall Study|Laboratory abnormalities|1
725374|NCT00246571|2333949|P2|Overall Study|Did not meet entrance criteria|1
725375|NCT00246571|2333950|P1|Overall Study|Did not meet entrance criteria|2
725376|NCT00246571|2333949|P2|Overall Study|Sponsor|1
725377|NCT00246571|2333950|P1|Overall Study|Sponsor|0
725378|NCT00246571|2333949|P2|Overall Study|Death|3
725379|NCT00246571|2333950|P1|Overall Study|Death|17
725380|NCT00246571|2333949|P2|Overall Study|Lack of Efficacy|21
725381|NCT00246571|2333950|P1|Overall Study|Lack of Efficacy|84
725382|NCT00246571|2333949|P2|Overall Study|Withdrawal by Subject|3
725383|NCT00246571|2333950|P1|Overall Study|Withdrawal by Subject|2
725384|NCT00246571|2333949|P2|Overall Study|Protocol Violation|1
725385|NCT00246571|2333950|P1|Overall Study|Protocol Violation|0
725386|NCT00246571|2333949|P2|Overall Study|Adverse Event|0
725387|NCT00246571|2333950|P1|Overall Study|Adverse Event|7
725388|NCT00246753|2333988|P1|Overall Study|Unacceptable toxicity|2
725389|NCT00246753|2333988|P1|Overall Study|Adverse Event|2
725390|NCT00246753|2333988|P1|Overall Study|Physician Decision|2
725391|NCT00246753|2333988|P1|Overall Study|Withdrawal by Subject|2
725392|NCT00246805|2333996|P2|Phase 1|Lost to Follow-up|0
725393|NCT00246805|2333997|P1|Phase 1|Lost to Follow-up|1
725394|NCT00247273|2334005|P2|Overall Study|Did not take any study drug|0
725395|NCT00247273|2334006|P1|Overall Study|Did not take any study drug|2
725396|NCT00247273|2334005|P2|Overall Study|Withdrawal by Subject|47
725397|NCT00247273|2334006|P1|Overall Study|Withdrawal by Subject|46
725398|NCT00247273|2334005|P2|Overall Study|Lost to Follow-up|7
725399|NCT00247273|2334006|P1|Overall Study|Lost to Follow-up|7
725400|NCT00247273|2334005|P2|Overall Study|Physician Decision|3
725401|NCT00247273|2334006|P1|Overall Study|Physician Decision|6
725402|NCT00247273|2334005|P2|Overall Study|Adverse Event|80
725403|NCT00247273|2334006|P1|Overall Study|Adverse Event|85
725404|NCT00247416|2334079|P2|Overall Study|3 patients were found to be ineligible|2
725405|NCT00247416|2334080|P1|Overall Study|3 patients were found to be ineligible|1
725406|NCT00247611|2334094|P2|Baselined|Completed baseline only|8
725407|NCT00247611|2334095|P1|Baselined|Completed baseline only|9
725408|NCT00247611|2334094|P2|Baselined|Completed baseline, never placed on ARVs|5
725409|NCT00247611|2334095|P1|Baselined|Completed baseline, never placed on ARVs|8
725410|NCT00240331|2334113|P2|Overall Study|Option selected by investigator|2
725411|NCT00240331|2334114|P1|Overall Study|Option selected by investigator|1
725412|NCT00240331|2334113|P2|Overall Study|Withdrawal by Subject|132
725413|NCT00240331|2334114|P1|Overall Study|Withdrawal by Subject|125
725414|NCT00240994|2334261|P1|Overall Study|Graft failure|1
725415|NCT00240994|2334261|P1|Overall Study|Protocol Violation|1
725416|NCT00240994|2334261|P1|Overall Study|Lost to Follow-up|1
725417|NCT00241280|2334274|P2|Overall Study|Excessive Dryness|1
725418|NCT00241280|2334275|P1|Overall Study|Excessive Dryness|0
725419|NCT00241280|2334274|P2|Overall Study|Coating on Lens|0
725420|NCT00241280|2334275|P1|Overall Study|Coating on Lens|1
725421|NCT00241280|2334274|P2|Overall Study|History of Ocular Surgery|1
725422|NCT00241280|2334275|P1|Overall Study|History of Ocular Surgery|0
725423|NCT00241280|2334274|P2|Overall Study|Scheduling Conflict|2
725424|NCT00241280|2334275|P1|Overall Study|Scheduling Conflict|0
725425|NCT00241280|2334274|P2|Overall Study|Unacceptable Fit|1
725426|NCT00241280|2334275|P1|Overall Study|Unacceptable Fit|0
725427|NCT00241280|2334274|P2|Overall Study|Dispensed incorrect test article|2
725428|NCT00241280|2334275|P1|Overall Study|Dispensed incorrect test article|1
725429|NCT00241280|2334274|P2|Overall Study|Subject Ineligible/Dispensed|6
725430|NCT00241280|2334275|P1|Overall Study|Subject Ineligible/Dispensed|9
725431|NCT00241280|2334274|P2|Overall Study|Diabetic|0
725432|NCT00241280|2334275|P1|Overall Study|Diabetic|1
725433|NCT00241280|2334274|P2|Overall Study|Unsatisfactory Visual Response|1
725434|NCT00241280|2334275|P1|Overall Study|Unsatisfactory Visual Response|1
725435|NCT00241280|2334274|P2|Overall Study|Unsatisfactory Physiological Response|1
725436|NCT00241280|2334275|P1|Overall Study|Unsatisfactory Physiological Response|1
725437|NCT00241280|2334274|P2|Overall Study|Relocation|4
725438|NCT00241280|2334275|P1|Overall Study|Relocation|4
725439|NCT00241280|2334274|P2|Overall Study|Protocol Violation|10
725440|NCT00241280|2334275|P1|Overall Study|Protocol Violation|4
725441|NCT00241280|2334274|P2|Overall Study|Withdrawal by Subject|4
725442|NCT00241280|2334275|P1|Overall Study|Withdrawal by Subject|7
725443|NCT00241280|2334274|P2|Overall Study|Lost to Follow-up|8
725444|NCT00241280|2334275|P1|Overall Study|Lost to Follow-up|5
725445|NCT00241280|2334274|P2|Overall Study|Pregnancy|5
725446|NCT00241280|2334275|P1|Overall Study|Pregnancy|1
725447|NCT00241280|2334274|P2|Overall Study|Discomfort|16
725448|NCT00241280|2334275|P1|Overall Study|Discomfort|11
725449|NCT00241280|2334274|P2|Overall Study|Adverse Event|6
725450|NCT00241280|2334275|P1|Overall Study|Adverse Event|2
725451|NCT00241358|2334286|P3|Overall Study|Determined to be not ineligible|1
725452|NCT00241358|2334287|P2|Overall Study|Determined to be not ineligible|1
725453|NCT00241358|2334288|P1|Overall Study|Determined to be not ineligible|0
725454|NCT00241644|2334323|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
725455|NCT00241644|2334324|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
725456|NCT00241644|2334325|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
725457|NCT00241644|2334326|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
725458|NCT00241644|2334323|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
725459|NCT00241644|2334324|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
725460|NCT00241644|2334325|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
725461|NCT00241644|2334326|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
725462|NCT00241644|2334323|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
725463|NCT00241644|2334324|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
725464|NCT00241644|2334325|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
725465|NCT00241644|2334326|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
725466|NCT00241644|2334323|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
725467|NCT00241644|2334324|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
725468|NCT00241644|2334325|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
725469|NCT00241644|2334326|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
725470|NCT00241644|2334323|P4|Second Efficacy Period (Year 2)|Adverse Event|20
725471|NCT00241644|2334324|P3|Second Efficacy Period (Year 2)|Adverse Event|12
725472|NCT00241644|2334325|P2|Second Efficacy Period (Year 2)|Adverse Event|9
725473|NCT00241644|2334326|P1|Second Efficacy Period (Year 2)|Adverse Event|11
725474|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
725475|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
725476|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
725477|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
725478|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
725479|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
725480|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
725481|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
725482|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
725483|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
725484|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
725485|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
725486|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Non-compliance|3
725487|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Non-compliance|2
725488|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Non-compliance|1
725489|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Non-compliance|2
725490|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
725491|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
725492|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
725493|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
725494|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
725495|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
725496|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
725497|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
725498|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Protocol Violation|8
725499|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Protocol Violation|4
725500|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Protocol Violation|5
725501|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Protocol Violation|3
725502|NCT00241644|2334323|P4|First Efficacy Period (Year 1)|Adverse Event|91
725503|NCT00241644|2334324|P3|First Efficacy Period (Year 1)|Adverse Event|45
725504|NCT00241644|2334325|P2|First Efficacy Period (Year 1)|Adverse Event|45
725505|NCT00241644|2334326|P1|First Efficacy Period (Year 1)|Adverse Event|46
725506|NCT00247676|2334408|P1|Overall Study|Withdrawal by Subject|2
725507|NCT00247676|2334408|P1|Overall Study|Unspecified|3
725508|NCT00247676|2334408|P1|Overall Study|Lack of Efficacy|15
725509|NCT00247676|2334408|P1|Overall Study|Adverse Event|11
725510|NCT00247676|2334408|P1|Overall Study|Death|5
725511|NCT00247962|2334438|P2|Overall Study|Lack of Efficacy|2
725512|NCT00247962|2334439|P1|Overall Study|Lack of Efficacy|4
725513|NCT00247962|2334438|P2|Overall Study|Withdrawal by Subject|2
725514|NCT00247962|2334439|P1|Overall Study|Withdrawal by Subject|3
725515|NCT00247962|2334438|P2|Overall Study|Protocol Violation|1
725516|NCT00247962|2334439|P1|Overall Study|Protocol Violation|1
725517|NCT00247962|2334438|P2|Overall Study|Physician Decision|1
725518|NCT00247962|2334439|P1|Overall Study|Physician Decision|0
725519|NCT00247962|2334438|P2|Overall Study|Lost to Follow-up|1
725520|NCT00247962|2334439|P1|Overall Study|Lost to Follow-up|3
725521|NCT00247962|2334438|P2|Overall Study|Adverse Event|12
725522|NCT00247962|2334439|P1|Overall Study|Adverse Event|15
725523|NCT00249613|2334479|P2|12 Month Follow-up|Lost to Follow-up|8
725524|NCT00249613|2334480|P1|12 Month Follow-up|Lost to Follow-up|10
725525|NCT00249613|2334479|P2|12 Month Follow-up|Withdrawal by Subject|6
725526|NCT00249613|2334480|P1|12 Month Follow-up|Withdrawal by Subject|6
725527|NCT00249613|2334479|P2|12 Month Follow-up|Death|1
725528|NCT00249613|2334480|P1|12 Month Follow-up|Death|1
725529|NCT00249795|2334491|P2|Overall Study|Missing|1
725530|NCT00249795|2334492|P1|Overall Study|Missing|0
725531|NCT00249795|2334491|P2|Overall Study|Lost to Follow-up|2
725532|NCT00249795|2334492|P1|Overall Study|Lost to Follow-up|0
725533|NCT00249795|2334491|P2|Overall Study|Site not agree to continue after May08|1
725534|NCT00249795|2334492|P1|Overall Study|Site not agree to continue after May08|1
725535|NCT00249795|2334491|P2|Overall Study|Patient not wish to continue after May08|6
725536|NCT00249795|2334492|P1|Overall Study|Patient not wish to continue after May08|4
725537|NCT00249795|2334491|P2|Overall Study|Event related to cardiac condition|16
725538|NCT00249795|2334492|P1|Overall Study|Event related to cardiac condition|17
725539|NCT00249795|2334491|P2|Overall Study|Other contraindicated medication|1
725540|NCT00249795|2334492|P1|Overall Study|Other contraindicated medication|1
725541|NCT00249795|2334491|P2|Overall Study|Hypotension (non-symptomatic)|5
725542|NCT00249795|2334492|P1|Overall Study|Hypotension (non-symptomatic)|5
725543|NCT00249795|2334491|P2|Overall Study|Lightheadedness / dizziness|11
725544|NCT00249795|2334492|P1|Overall Study|Lightheadedness / dizziness|15
725545|NCT00249795|2334491|P2|Overall Study|Angiotensin II receptor blocker required|58
725546|NCT00249795|2334492|P1|Overall Study|Angiotensin II receptor blocker required|35
725547|NCT00249795|2334491|P2|Overall Study|Surgery / procedure|5
725548|NCT00249795|2334492|P1|Overall Study|Surgery / procedure|4
725549|NCT00249795|2334491|P2|Overall Study|Physician withdrew consent|63
725550|NCT00249795|2334492|P1|Overall Study|Physician withdrew consent|71
725551|NCT00249795|2334491|P2|Overall Study|Other adverse events (non-serious)|159
725552|NCT00249795|2334492|P1|Overall Study|Other adverse events (non-serious)|188
725553|NCT00249795|2334491|P2|Overall Study|Study drug intolerance|3
725554|NCT00249795|2334492|P1|Overall Study|Study drug intolerance|3
725555|NCT00249795|2334491|P2|Overall Study|Non-compliance|69
725556|NCT00249795|2334492|P1|Overall Study|Non-compliance|71
725557|NCT00249795|2334491|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
725558|NCT00249795|2334492|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
725559|NCT00249795|2334491|P2|Overall Study|Oral anticoagulant required|0
725560|NCT00249795|2334492|P1|Overall Study|Oral anticoagulant required|2
725561|NCT00249795|2334491|P2|Overall Study|Thromboembolic / outcome event|45
725562|NCT00249795|2334492|P1|Overall Study|Thromboembolic / outcome event|39
725563|NCT00249795|2334491|P2|Overall Study|Withdrawal by Subject|742
725564|NCT00249795|2334492|P1|Overall Study|Withdrawal by Subject|678
725565|NCT00249795|2334491|P2|Overall Study|Qualifying condition not present|29
725566|NCT00249795|2334492|P1|Overall Study|Qualifying condition not present|26
725567|NCT00249795|2334491|P2|Overall Study|Other Serious Adverse Event|93
725568|NCT00249795|2334492|P1|Overall Study|Other Serious Adverse Event|84
725569|NCT00249795|2334491|P2|Overall Study|Symptomatic hypotension|64
725570|NCT00249795|2334492|P1|Overall Study|Symptomatic hypotension|127
725571|NCT00249795|2334491|P2|Overall Study|Not treated|14
725572|NCT00249795|2334492|P1|Overall Study|Not treated|16
725573|NCT00249821|2334512|P2|Overall Study|Technical problem|1
725574|NCT00249821|2334513|P1|Overall Study|Technical problem|0
725575|NCT00249873|2334535|P2|Overall Study|Thromboembolic/outcome event|122
725576|NCT00249873|2334536|P1|Overall Study|Thromboembolic/outcome event|82
725577|NCT00249873|2334535|P2|Overall Study|Event related to cardiac condition|21
725578|NCT00249873|2334536|P1|Overall Study|Event related to cardiac condition|12
725579|NCT00249873|2334535|P2|Overall Study|Surgery/ procedure|9
725580|NCT00249873|2334536|P1|Overall Study|Surgery/ procedure|9
725581|NCT00249873|2334535|P2|Overall Study|Study drug intolerance|0
725582|NCT00249873|2334536|P1|Overall Study|Study drug intolerance|5
725583|NCT00249873|2334535|P2|Overall Study|Oral anticoagulant required|157
725584|NCT00249873|2334536|P1|Overall Study|Oral anticoagulant required|159
725585|NCT00249873|2334535|P2|Overall Study|Angiotensin II receptor blocker required|0
725586|NCT00249873|2334536|P1|Overall Study|Angiotensin II receptor blocker required|1
725587|NCT00249873|2334535|P2|Overall Study|Open label clopidogrel required|42
725588|NCT00249873|2334536|P1|Overall Study|Open label clopidogrel required|31
725589|NCT00249873|2334535|P2|Overall Study|Physician withdrew consent|60
725590|NCT00249873|2334536|P1|Overall Study|Physician withdrew consent|59
725591|NCT00249873|2334535|P2|Overall Study|Patient not wish to continue after May08|4
725592|NCT00249873|2334536|P1|Overall Study|Patient not wish to continue after May08|3
725593|NCT00249873|2334535|P2|Overall Study|Other contraindicated medication|0
725594|NCT00249873|2334536|P1|Overall Study|Other contraindicated medication|1
725595|NCT00249873|2334535|P2|Overall Study|Other non serious Adverse Event|108
725596|NCT00249873|2334536|P1|Overall Study|Other non serious Adverse Event|112
725597|NCT00249873|2334535|P2|Overall Study|Non-compliance|46
725598|NCT00249873|2334536|P1|Overall Study|Non-compliance|41
725599|NCT00249873|2334535|P2|Overall Study|Minor bleeding|37
725600|NCT00249873|2334536|P1|Overall Study|Minor bleeding|99
725601|NCT00249873|2334535|P2|Overall Study|Lost to Follow-up|7
725602|NCT00249873|2334536|P1|Overall Study|Lost to Follow-up|4
725603|NCT00249873|2334535|P2|Overall Study|Withdrawal by Subject|466
725604|NCT00249873|2334536|P1|Overall Study|Withdrawal by Subject|504
725605|NCT00249873|2334535|P2|Overall Study|Contraindication to oral anticoagulant|8
725606|NCT00249873|2334536|P1|Overall Study|Contraindication to oral anticoagulant|4
725607|NCT00249873|2334535|P2|Overall Study|Qualifying condition not present|23
725608|NCT00249873|2334536|P1|Overall Study|Qualifying condition not present|20
725609|NCT00249873|2334535|P2|Overall Study|Other Serious Adverse Event|97
725610|NCT00249873|2334536|P1|Overall Study|Other Serious Adverse Event|86
725611|NCT00249873|2334535|P2|Overall Study|Serious haemorrhagic Adverse Event|30
725612|NCT00249873|2334536|P1|Overall Study|Serious haemorrhagic Adverse Event|74
725613|NCT00249873|2334535|P2|Overall Study|Severe allergic reaction|1
725614|NCT00249873|2334536|P1|Overall Study|Severe allergic reaction|8
725615|NCT00249873|2334535|P2|Overall Study|Significant thrombocytopenia|8
725616|NCT00249873|2334536|P1|Overall Study|Significant thrombocytopenia|9
725617|NCT00249873|2334535|P2|Overall Study|Not treated|8
725618|NCT00249873|2334536|P1|Overall Study|Not treated|7
725619|NCT00250276|2334552|P4|Overall Study|Lost to Follow-up|8
725620|NCT00250276|2334553|P3|Overall Study|Lost to Follow-up|13
725621|NCT00250276|2334554|P2|Overall Study|Lost to Follow-up|18
725622|NCT00250276|2334555|P1|Overall Study|Lost to Follow-up|11
725623|NCT00250276|2334552|P4|Overall Study|Migrated/moved from study area|7
725624|NCT00250276|2334553|P3|Overall Study|Migrated/moved from study area|2
725625|NCT00250276|2334554|P2|Overall Study|Migrated/moved from study area|0
725626|NCT00250276|2334555|P1|Overall Study|Migrated/moved from study area|3
725627|NCT00250276|2334552|P4|Overall Study|Withdrawal by Subject|2
725628|NCT00250276|2334553|P3|Overall Study|Withdrawal by Subject|3
725629|NCT00250276|2334554|P2|Overall Study|Withdrawal by Subject|2
725630|NCT00250276|2334555|P1|Overall Study|Withdrawal by Subject|1
725631|NCT00250276|2334552|P4|Overall Study|Protocol Violation|0
725632|NCT00250276|2334553|P3|Overall Study|Protocol Violation|0
725633|NCT00250276|2334554|P2|Overall Study|Protocol Violation|1
725634|NCT00250276|2334555|P1|Overall Study|Protocol Violation|0
725635|NCT00250276|2334552|P4|Overall Study|Non-serious Adverse Event|2
725636|NCT00250276|2334553|P3|Overall Study|Non-serious Adverse Event|0
725637|NCT00250276|2334554|P2|Overall Study|Non-serious Adverse Event|0
725638|NCT00250276|2334555|P1|Overall Study|Non-serious Adverse Event|2
725639|NCT00250276|2334552|P4|Overall Study|Serious Adverse Event|0
725640|NCT00250276|2334553|P3|Overall Study|Serious Adverse Event|1
725641|NCT00250276|2334554|P2|Overall Study|Serious Adverse Event|0
725642|NCT00250276|2334555|P1|Overall Study|Serious Adverse Event|0
725643|NCT00250432|2334635|P2|Overall Study|Pt was considered untreatable|1
725644|NCT00250432|2334636|P1|Overall Study|Pt was considered untreatable|0
725645|NCT00250432|2334635|P2|Overall Study|Pt died out of posttherapy report period|5
725646|NCT00250432|2334636|P1|Overall Study|Pt died out of posttherapy report period|6
725647|NCT00250432|2334635|P2|Overall Study|Withdrawal by Subject|2
725648|NCT00250432|2334636|P1|Overall Study|Withdrawal by Subject|6
725649|NCT00250432|2334635|P2|Overall Study|Protocol Violation|3
725650|NCT00250432|2334636|P1|Overall Study|Protocol Violation|0
725651|NCT00250432|2334635|P2|Overall Study|Patient Moved|1
725652|NCT00250432|2334636|P1|Overall Study|Patient Moved|0
725653|NCT00250432|2334635|P2|Overall Study|Lost to Follow-up|5
725654|NCT00250432|2334636|P1|Overall Study|Lost to Follow-up|6
725655|NCT00250432|2334635|P2|Overall Study|Lack of Efficacy|1
725656|NCT00250432|2334636|P1|Overall Study|Lack of Efficacy|2
725657|NCT00250432|2334635|P2|Overall Study|Adverse Event|29
725658|NCT00250432|2334636|P1|Overall Study|Adverse Event|25
725659|NCT00250458|2334646|P2|Overall Study|Not Specified|0
725660|NCT00250458|2334647|P1|Overall Study|Not Specified|1
725661|NCT00250458|2334646|P2|Overall Study|Qualifying migraine but did not treat|3
725662|NCT00250458|2334647|P1|Overall Study|Qualifying migraine but did not treat|3
725663|NCT00250458|2334646|P2|Overall Study|Lack of Migraine Attack|9
725664|NCT00250458|2334647|P1|Overall Study|Lack of Migraine Attack|20
725665|NCT00250458|2334646|P2|Overall Study|Withdrawal by Subject|2
725666|NCT00250458|2334647|P1|Overall Study|Withdrawal by Subject|4
725667|NCT00250458|2334646|P2|Overall Study|Protocol Violation|1
725668|NCT00250458|2334647|P1|Overall Study|Protocol Violation|0
725669|NCT00250458|2334646|P2|Overall Study|Lost to Follow-up|2
725670|NCT00250458|2334647|P1|Overall Study|Lost to Follow-up|4
725671|NCT00250588|2334688|P3|Overall Study|Lost to Follow-up|13
725672|NCT00250588|2334689|P2|Overall Study|Lost to Follow-up|13
725673|NCT00250588|2334690|P1|Overall Study|Lost to Follow-up|6
725674|NCT00250588|2334688|P3|Overall Study|Withdrawal by Subject|0
725675|NCT00250588|2334689|P2|Overall Study|Withdrawal by Subject|6
725676|NCT00250588|2334690|P1|Overall Study|Withdrawal by Subject|3
725677|NCT00250679|2334707|P3|Overall Study|various single events: hip surgery,diary|1
725678|NCT00250679|2334708|P2|Overall Study|various single events: hip surgery,diary|1
725679|NCT00250679|2334709|P1|Overall Study|various single events: hip surgery,diary|3
725680|NCT00250679|2334707|P3|Overall Study|Non-compliance|0
725681|NCT00250679|2334708|P2|Overall Study|Non-compliance|1
725682|NCT00250679|2334709|P1|Overall Study|Non-compliance|1
725683|NCT00250679|2334707|P3|Overall Study|Moved|0
725684|NCT00250679|2334708|P2|Overall Study|Moved|1
725685|NCT00250679|2334709|P1|Overall Study|Moved|1
725686|NCT00250679|2334707|P3|Overall Study|Technical Holter issues|2
725687|NCT00250679|2334708|P2|Overall Study|Technical Holter issues|0
725688|NCT00250679|2334709|P1|Overall Study|Technical Holter issues|1
725689|NCT00250679|2334707|P3|Overall Study|Lack of Efficacy|3
725690|NCT00250679|2334708|P2|Overall Study|Lack of Efficacy|1
725691|NCT00250679|2334709|P1|Overall Study|Lack of Efficacy|0
725692|NCT00250679|2334707|P3|Overall Study|Does Not Meet Entry Criteria|2
725693|NCT00250679|2334708|P2|Overall Study|Does Not Meet Entry Criteria|4
725694|NCT00250679|2334709|P1|Overall Study|Does Not Meet Entry Criteria|1
725695|NCT00250679|2334707|P3|Overall Study|Lost to Follow-up|2
725696|NCT00250679|2334708|P2|Overall Study|Lost to Follow-up|4
725697|NCT00250679|2334709|P1|Overall Study|Lost to Follow-up|3
725698|NCT00250679|2334707|P3|Overall Study|Withdrawal by Subject|15
725699|NCT00250679|2334708|P2|Overall Study|Withdrawal by Subject|18
725700|NCT00250679|2334709|P1|Overall Study|Withdrawal by Subject|15
725701|NCT00250679|2334707|P3|Overall Study|Protocol Violation|3
725702|NCT00250679|2334708|P2|Overall Study|Protocol Violation|4
725703|NCT00250679|2334709|P1|Overall Study|Protocol Violation|2
725704|NCT00250679|2334707|P3|Overall Study|Adverse Event|16
725705|NCT00250679|2334708|P2|Overall Study|Adverse Event|15
725706|NCT00250679|2334709|P1|Overall Study|Adverse Event|12
725707|NCT00250705|2334807|P1|Overall Study|Lack of Efficacy|2
725708|NCT00250718|2334815|P1|Overall Study|Withdrawal by Subject|1
725709|NCT00250718|2334815|P1|Overall Study|Adverse Event|1
725710|NCT00250718|2334815|P1|Overall Study|Death|1
725711|NCT00250835|2334820|P1|Overall Study|Withdrawal by Subject|1
725712|NCT00251004|2334839|P3|Overall Study|Graft Loss|8
725713|NCT00251004|2334840|P2|Overall Study|Graft Loss|13
725714|NCT00251004|2334841|P1|Overall Study|Graft Loss|12
725715|NCT00251004|2334839|P3|Overall Study|Lost to Follow-up|1
725716|NCT00251004|2334840|P2|Overall Study|Lost to Follow-up|2
725717|NCT00251004|2334841|P1|Overall Study|Lost to Follow-up|1
725718|NCT00251004|2334839|P3|Overall Study|Death|8
725719|NCT00251004|2334840|P2|Overall Study|Death|10
725720|NCT00251004|2334841|P1|Overall Study|Death|9
725721|NCT00251004|2334839|P3|Overall Study|Withdrawal by Subject|14
725722|NCT00251004|2334840|P2|Overall Study|Withdrawal by Subject|16
725723|NCT00251004|2334841|P1|Overall Study|Withdrawal by Subject|23
725724|NCT00251316|2334890|P2|Overall Study|Physician Decision|3
725725|NCT00251316|2334891|P1|Overall Study|Physician Decision|2
725726|NCT00251589|2334901|P4|Overall Study|Discontinued due to progressive disease|1
725727|NCT00251589|2334902|P3|Overall Study|Discontinued due to progressive disease|0
725728|NCT00251589|2334903|P2|Overall Study|Discontinued due to progressive disease|1
725729|NCT00251589|2334904|P1|Overall Study|Discontinued due to progressive disease|9
725730|NCT00251589|2334901|P4|Overall Study|Withdrawal by Subject|0
725731|NCT00251589|2334902|P3|Overall Study|Withdrawal by Subject|0
725732|NCT00251589|2334903|P2|Overall Study|Withdrawal by Subject|1
725733|NCT00251589|2334904|P1|Overall Study|Withdrawal by Subject|1
725734|NCT00251589|2334901|P4|Overall Study|Adverse Event|1
725735|NCT00251589|2334902|P3|Overall Study|Adverse Event|2
725736|NCT00251589|2334903|P2|Overall Study|Adverse Event|1
725737|NCT00251589|2334904|P1|Overall Study|Adverse Event|5
725738|NCT00251641|2334941|P2|Overall Study|Switched Treatment|63
725739|NCT00251641|2334942|P1|Overall Study|Switched Treatment|9
725740|NCT00251641|2334941|P2|Overall Study|Did not Meet protocol Eligibility|1
725741|NCT00251641|2334942|P1|Overall Study|Did not Meet protocol Eligibility|2
725742|NCT00251641|2334941|P2|Overall Study|Protocol Violation|2
725743|NCT00251641|2334942|P1|Overall Study|Protocol Violation|10
725744|NCT00251641|2334941|P2|Overall Study|Withdrawal by Subject|8
725745|NCT00251641|2334942|P1|Overall Study|Withdrawal by Subject|6
725746|NCT00251641|2334941|P2|Overall Study|Lost to Follow-up|3
725747|NCT00251641|2334942|P1|Overall Study|Lost to Follow-up|3
725748|NCT00251641|2334941|P2|Overall Study|Progression of Disease|2
725749|NCT00251641|2334942|P1|Overall Study|Progression of Disease|0
725750|NCT00251641|2334941|P2|Overall Study|Lack of Efficacy|1
725751|NCT00251641|2334942|P1|Overall Study|Lack of Efficacy|2
725752|NCT00251641|2334941|P2|Overall Study|Adverse Event|8
725753|NCT00251641|2334942|P1|Overall Study|Adverse Event|80
725754|NCT00251693|2334959|P3|Overall Study|Abnormal laboratory findings|1
725755|NCT00251693|2334960|P2|Overall Study|Abnormal laboratory findings|0
725756|NCT00251693|2334961|P1|Overall Study|Abnormal laboratory findings|0
725757|NCT00251693|2334959|P3|Overall Study|Subject request/subject unavailable|0
725758|NCT00251693|2334960|P2|Overall Study|Subject request/subject unavailable|2
725759|NCT00251693|2334961|P1|Overall Study|Subject request/subject unavailable|1
725760|NCT00251693|2334959|P3|Overall Study|Possible Barrett's esophagus|2
725761|NCT00251693|2334960|P2|Overall Study|Possible Barrett's esophagus|5
725762|NCT00251693|2334961|P1|Overall Study|Possible Barrett's esophagus|3
725763|NCT00251693|2334959|P3|Overall Study|Noncompliant|2
725764|NCT00251693|2334960|P2|Overall Study|Noncompliant|0
725765|NCT00251693|2334961|P1|Overall Study|Noncompliant|0
725766|NCT00251693|2334959|P3|Overall Study|Inclusion/exclusion criteria not met|8
725767|NCT00251693|2334960|P2|Overall Study|Inclusion/exclusion criteria not met|3
725768|NCT00251693|2334961|P1|Overall Study|Inclusion/exclusion criteria not met|5
725769|NCT00251693|2334959|P3|Overall Study|Lack of Efficacy|0
725770|NCT00251693|2334960|P2|Overall Study|Lack of Efficacy|1
725771|NCT00251693|2334961|P1|Overall Study|Lack of Efficacy|0
725772|NCT00251693|2334959|P3|Overall Study|Withdrawal by Subject|14
725773|NCT00251693|2334960|P2|Overall Study|Withdrawal by Subject|17
725774|NCT00251693|2334961|P1|Overall Study|Withdrawal by Subject|11
725775|NCT00251693|2334959|P3|Overall Study|Lost to Follow-up|8
725776|NCT00251693|2334960|P2|Overall Study|Lost to Follow-up|7
725777|NCT00251693|2334961|P1|Overall Study|Lost to Follow-up|12
725778|NCT00251693|2334959|P3|Overall Study|Protocol Violation|2
725779|NCT00251693|2334960|P2|Overall Study|Protocol Violation|0
725780|NCT00251693|2334961|P1|Overall Study|Protocol Violation|2
725781|NCT00251693|2334959|P3|Overall Study|Adverse Event|9
725782|NCT00251693|2334960|P2|Overall Study|Adverse Event|9
725783|NCT00251693|2334961|P1|Overall Study|Adverse Event|17
725784|NCT00251719|2334987|P3|Overall Study|Barrett's esophagus|0
725785|NCT00251719|2334988|P2|Overall Study|Barrett's esophagus|2
725786|NCT00251719|2334989|P1|Overall Study|Barrett's esophagus|2
725787|NCT00251719|2334987|P3|Overall Study|Noncompliance|1
725788|NCT00251719|2334988|P2|Overall Study|Noncompliance|3
725789|NCT00251719|2334989|P1|Overall Study|Noncompliance|2
725790|NCT00251719|2334987|P3|Overall Study|Investigator decision|0
725791|NCT00251719|2334988|P2|Overall Study|Investigator decision|1
725792|NCT00251719|2334989|P1|Overall Study|Investigator decision|1
725793|NCT00251719|2334987|P3|Overall Study|Inclusion/exclusion criteria not met|2
725794|NCT00251719|2334988|P2|Overall Study|Inclusion/exclusion criteria not met|6
725795|NCT00251719|2334989|P1|Overall Study|Inclusion/exclusion criteria not met|12
725796|NCT00251719|2334987|P3|Overall Study|Lack of Efficacy|0
725797|NCT00251719|2334988|P2|Overall Study|Lack of Efficacy|1
725798|NCT00251719|2334989|P1|Overall Study|Lack of Efficacy|2
725799|NCT00251719|2334987|P3|Overall Study|Withdrawal by Subject|11
725800|NCT00251719|2334988|P2|Overall Study|Withdrawal by Subject|12
725801|NCT00251719|2334989|P1|Overall Study|Withdrawal by Subject|14
725802|NCT00251719|2334987|P3|Overall Study|Lost to Follow-up|8
725803|NCT00251719|2334988|P2|Overall Study|Lost to Follow-up|11
725804|NCT00251719|2334989|P1|Overall Study|Lost to Follow-up|5
725805|NCT00251719|2334987|P3|Overall Study|Protocol Violation|1
725806|NCT00251719|2334988|P2|Overall Study|Protocol Violation|1
725807|NCT00251719|2334989|P1|Overall Study|Protocol Violation|1
725808|NCT00251719|2334987|P3|Overall Study|Adverse Event|7
725809|NCT00251719|2334988|P2|Overall Study|Adverse Event|8
725810|NCT00251719|2334989|P1|Overall Study|Adverse Event|14
725811|NCT00251745|2335015|P3|Overall Study|Per Investigator Request|0
725812|NCT00251745|2335016|P2|Overall Study|Per Investigator Request|0
725813|NCT00251745|2335017|P1|Overall Study|Per Investigator Request|1
725814|NCT00251745|2335015|P3|Overall Study|Per Subject Request|1
725815|NCT00251745|2335016|P2|Overall Study|Per Subject Request|0
725816|NCT00251745|2335017|P1|Overall Study|Per Subject Request|0
725817|NCT00251745|2335015|P3|Overall Study|Pregnancy|0
725818|NCT00251745|2335016|P2|Overall Study|Pregnancy|1
725819|NCT00251745|2335017|P1|Overall Study|Pregnancy|0
725820|NCT00251745|2335015|P3|Overall Study|Noncompliant|2
725821|NCT00251745|2335016|P2|Overall Study|Noncompliant|2
725822|NCT00251745|2335017|P1|Overall Study|Noncompliant|0
725823|NCT00251745|2335015|P3|Overall Study|Lack of Efficacy|0
725824|NCT00251745|2335016|P2|Overall Study|Lack of Efficacy|0
725825|NCT00251745|2335017|P1|Overall Study|Lack of Efficacy|3
725826|NCT00251745|2335015|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
725827|NCT00251745|2335016|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
725828|NCT00251745|2335017|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
725829|NCT00251745|2335015|P3|Overall Study|Withdrawal by Subject|3
725830|NCT00251745|2335016|P2|Overall Study|Withdrawal by Subject|7
725831|NCT00251745|2335017|P1|Overall Study|Withdrawal by Subject|13
725832|NCT00251745|2335015|P3|Overall Study|Lost to Follow-up|5
725833|NCT00251745|2335016|P2|Overall Study|Lost to Follow-up|2
725834|NCT00251745|2335017|P1|Overall Study|Lost to Follow-up|4
725835|NCT00251745|2335015|P3|Overall Study|Adverse Event|11
725836|NCT00251745|2335016|P2|Overall Study|Adverse Event|9
725837|NCT00251745|2335017|P1|Overall Study|Adverse Event|7
725838|NCT00251758|2335037|P3|Overall Study|Per Investigator Request|0
725839|NCT00251758|2335038|P2|Overall Study|Per Investigator Request|0
725840|NCT00251758|2335039|P1|Overall Study|Per Investigator Request|1
725841|NCT00251758|2335037|P3|Overall Study|Per Subject Request|1
725842|NCT00251758|2335038|P2|Overall Study|Per Subject Request|0
725843|NCT00251758|2335039|P1|Overall Study|Per Subject Request|0
725844|NCT00251758|2335037|P3|Overall Study|Pregnancy|0
725845|NCT00251758|2335038|P2|Overall Study|Pregnancy|1
725846|NCT00251758|2335039|P1|Overall Study|Pregnancy|0
725847|NCT00251758|2335037|P3|Overall Study|Noncompliant|2
725848|NCT00251758|2335038|P2|Overall Study|Noncompliant|2
725849|NCT00251758|2335039|P1|Overall Study|Noncompliant|0
725850|NCT00251758|2335037|P3|Overall Study|Lack of Efficacy|0
725851|NCT00251758|2335038|P2|Overall Study|Lack of Efficacy|0
725852|NCT00251758|2335039|P1|Overall Study|Lack of Efficacy|3
725853|NCT00251758|2335037|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
725854|NCT00251758|2335038|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
725855|NCT00251758|2335039|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
725856|NCT00251758|2335037|P3|Overall Study|Withdrawal by Subject|3
725857|NCT00251758|2335038|P2|Overall Study|Withdrawal by Subject|7
725858|NCT00251758|2335039|P1|Overall Study|Withdrawal by Subject|13
725859|NCT00251758|2335037|P3|Overall Study|Lost to Follow-up|5
725860|NCT00251758|2335038|P2|Overall Study|Lost to Follow-up|2
725861|NCT00251758|2335039|P1|Overall Study|Lost to Follow-up|4
725862|NCT00251758|2335037|P3|Overall Study|Adverse Event|11
725863|NCT00251758|2335038|P2|Overall Study|Adverse Event|9
725864|NCT00251758|2335039|P1|Overall Study|Adverse Event|7
725865|NCT00251927|2335080|P2|Overall Study|Study procedure non-compliance|6
725866|NCT00251927|2335081|P1|Overall Study|Study procedure non-compliance|5
725867|NCT00251927|2335080|P2|Overall Study|Study-specific discont. achieved|2
725868|NCT00251927|2335081|P1|Overall Study|Study-specific discont. achieved|13
725869|NCT00251927|2335080|P2|Overall Study|Withdrawal by Subject|25
725870|NCT00251927|2335081|P1|Overall Study|Withdrawal by Subject|40
725871|NCT00251927|2335080|P2|Overall Study|Pregnancy|0
725872|NCT00251927|2335081|P1|Overall Study|Pregnancy|2
725873|NCT00251927|2335080|P2|Overall Study|Protocol Violation|2
725874|NCT00251927|2335081|P1|Overall Study|Protocol Violation|1
725875|NCT00251927|2335080|P2|Overall Study|Lost to Follow-up|8
725876|NCT00251927|2335081|P1|Overall Study|Lost to Follow-up|22
725877|NCT00251927|2335080|P2|Overall Study|Lack of Efficacy|16
725878|NCT00251927|2335081|P1|Overall Study|Lack of Efficacy|22
725879|NCT00251927|2335080|P2|Overall Study|Adverse Event|15
725880|NCT00251927|2335081|P1|Overall Study|Adverse Event|3
725881|NCT00244712|2335110|P2|Overall Study|Protocol Violation, disease progression|11
725882|NCT00244712|2335111|P1|Overall Study|Protocol Violation, disease progression|13
725883|NCT00244712|2335110|P2|Overall Study|Withdrawal by Subject|23
725884|NCT00244712|2335111|P1|Overall Study|Withdrawal by Subject|13
725885|NCT00244712|2335110|P2|Overall Study|Lost to Follow-up|52
725886|NCT00244712|2335111|P1|Overall Study|Lost to Follow-up|45
725887|NCT00244712|2335110|P2|Overall Study|Lack of Compliance|11
725888|NCT00244712|2335111|P1|Overall Study|Lack of Compliance|10
725889|NCT00244712|2335110|P2|Overall Study|Protocol-Defined Virologic Failure|6
725890|NCT00244712|2335111|P1|Overall Study|Protocol-Defined Virologic Failure|8
725891|NCT00244712|2335110|P2|Overall Study|Adverse Event|21
725892|NCT00244712|2335111|P1|Overall Study|Adverse Event|20
725893|NCT00244725|2335147|P4|Overall Study|Failed to follow-up|1
725894|NCT00244725|2335148|P3|Overall Study|Failed to follow-up|1
725895|NCT00244725|2335149|P2|Overall Study|Failed to follow-up|0
725896|NCT00244725|2335150|P1|Overall Study|Failed to follow-up|0
725897|NCT00244725|2335147|P4|Overall Study|Vomit|0
725898|NCT00244725|2335148|P3|Overall Study|Vomit|1
725899|NCT00244725|2335149|P2|Overall Study|Vomit|0
725900|NCT00244725|2335150|P1|Overall Study|Vomit|0
725901|NCT00244725|2335147|P4|Overall Study|Administrative reason|0
725902|NCT00244725|2335148|P3|Overall Study|Administrative reason|1
725903|NCT00244725|2335149|P2|Overall Study|Administrative reason|0
725904|NCT00244725|2335150|P1|Overall Study|Administrative reason|0
725905|NCT00244725|2335147|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
725906|NCT00244725|2335148|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
725907|NCT00244725|2335149|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
725908|NCT00244725|2335150|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
725909|NCT00244725|2335147|P4|Overall Study|Received prohibited medication|1
725910|NCT00244725|2335148|P3|Overall Study|Received prohibited medication|0
725911|NCT00244725|2335149|P2|Overall Study|Received prohibited medication|1
725912|NCT00244725|2335150|P1|Overall Study|Received prohibited medication|0
725913|NCT00244725|2335147|P4|Overall Study|Headache|0
725914|NCT00244725|2335148|P3|Overall Study|Headache|0
725915|NCT00244725|2335149|P2|Overall Study|Headache|1
725916|NCT00244725|2335150|P1|Overall Study|Headache|0
725917|NCT00244725|2335147|P4|Overall Study|Rehab Refused to allow participantion|0
725918|NCT00244725|2335148|P3|Overall Study|Rehab Refused to allow participantion|0
725919|NCT00244725|2335149|P2|Overall Study|Rehab Refused to allow participantion|1
725920|NCT00244725|2335150|P1|Overall Study|Rehab Refused to allow participantion|0
725921|NCT00244725|2335147|P4|Overall Study|Mediciation Error|0
725922|NCT00244725|2335148|P3|Overall Study|Mediciation Error|0
725923|NCT00244725|2335149|P2|Overall Study|Mediciation Error|1
725924|NCT00244725|2335150|P1|Overall Study|Mediciation Error|0
725925|NCT00244725|2335147|P4|Overall Study|Sponsor withdrew the participant|1
725926|NCT00244725|2335148|P3|Overall Study|Sponsor withdrew the participant|0
725927|NCT00244725|2335149|P2|Overall Study|Sponsor withdrew the participant|0
725928|NCT00244725|2335150|P1|Overall Study|Sponsor withdrew the participant|1
725929|NCT00244725|2335147|P4|Overall Study|Liver function test abnormality|1
725930|NCT00244725|2335148|P3|Overall Study|Liver function test abnormality|0
725931|NCT00244725|2335149|P2|Overall Study|Liver function test abnormality|0
725932|NCT00244725|2335150|P1|Overall Study|Liver function test abnormality|2
725933|NCT00244725|2335147|P4|Overall Study|Withdrwal by participant|1
725934|NCT00244725|2335148|P3|Overall Study|Withdrwal by participant|0
725935|NCT00244725|2335149|P2|Overall Study|Withdrwal by participant|0
725936|NCT00244725|2335150|P1|Overall Study|Withdrwal by participant|1
725937|NCT00244725|2335147|P4|Overall Study|Adverse Events|4
725938|NCT00244725|2335148|P3|Overall Study|Adverse Events|4
725939|NCT00244725|2335149|P2|Overall Study|Adverse Events|1
725940|NCT00244725|2335150|P1|Overall Study|Adverse Events|3
725941|NCT00244725|2335147|P4|Overall Study|Physician Decision|2
725942|NCT00244725|2335148|P3|Overall Study|Physician Decision|1
725943|NCT00244725|2335149|P2|Overall Study|Physician Decision|0
725944|NCT00244725|2335150|P1|Overall Study|Physician Decision|3
725945|NCT00244725|2335147|P4|Overall Study|Not meet treatment eligibility criteria|0
725946|NCT00244725|2335148|P3|Overall Study|Not meet treatment eligibility criteria|0
725947|NCT00244725|2335149|P2|Overall Study|Not meet treatment eligibility criteria|2
725948|NCT00244725|2335150|P1|Overall Study|Not meet treatment eligibility criteria|1
725949|NCT00244725|2335147|P4|Overall Study|Withdrawal by Subject|8
725950|NCT00244725|2335148|P3|Overall Study|Withdrawal by Subject|7
725951|NCT00244725|2335149|P2|Overall Study|Withdrawal by Subject|7
725952|NCT00244725|2335150|P1|Overall Study|Withdrawal by Subject|9
725953|NCT00244725|2335147|P4|Overall Study|Lost to Follow-up|2
725954|NCT00244725|2335148|P3|Overall Study|Lost to Follow-up|9
725955|NCT00244725|2335149|P2|Overall Study|Lost to Follow-up|4
725956|NCT00244725|2335150|P1|Overall Study|Lost to Follow-up|3
725957|NCT00244764|2335204|P1|Overall Study|Developed Secondary Malignancy|1
725958|NCT00244764|2335204|P1|Overall Study|Sponsor Terminated Study|2
725959|NCT00244764|2335204|P1|Overall Study|Primary Investigator Discretion|2
725960|NCT00244764|2335204|P1|Overall Study|Participant was Hospitalized until Death|1
725961|NCT00244764|2335204|P1|Overall Study|Declining Performance Status|1
725962|NCT00244764|2335204|P1|Overall Study|Off Study Medication for >21 Days|1
725963|NCT00244764|2335204|P1|Overall Study|Death|1
725964|NCT00244764|2335204|P1|Overall Study|Protocol Violation|2
725965|NCT00244764|2335204|P1|Overall Study|Disease Progression|13
725966|NCT00244764|2335204|P1|Overall Study|Withdrawal by Subject|12
725967|NCT00244764|2335204|P1|Overall Study|Lost to Follow-up|23
725968|NCT00244764|2335204|P1|Overall Study|Adverse Event|37
725969|NCT00244855|2335213|P2|Overall Study|Withdrawal by Subject|1
725970|NCT00244855|2335214|P1|Overall Study|Withdrawal by Subject|0
725971|NCT00244881|2335222|P1|Overall Study|Withdrawal by Subject|3
725972|NCT00244933|2335228|P1|Overall Study|Not response evaluable|2
725973|NCT00245011|2335240|P1|Overall Study|Lack of Efficacy|1
725975|NCT00245050|2335256|P2|Overall Study|Adverse Event|2
725976|NCT00245050|2335257|P1|Overall Study|Adverse Event|3
725977|NCT00245063|2335267|P2|Overall Study|Death|0
725978|NCT00245063|2335268|P1|Overall Study|Death|1
725979|NCT00245063|2335267|P2|Overall Study|Adverse Event|5
725980|NCT00245063|2335268|P1|Overall Study|Adverse Event|6
725981|NCT00251979|2335276|P2|Overall Study|Death|5
725982|NCT00251979|2335277|P1|Overall Study|Death|3
725983|NCT00251979|2335276|P2|Overall Study|Lost to Follow-up|6
725984|NCT00251979|2335277|P1|Overall Study|Lost to Follow-up|8
725985|NCT00251979|2335276|P2|Overall Study|Withdrawal by Subject|7
725986|NCT00251979|2335277|P1|Overall Study|Withdrawal by Subject|13
725987|NCT00251979|2335276|P2|Overall Study|Adverse Event|17
725988|NCT00251979|2335277|P1|Overall Study|Adverse Event|11
725989|NCT00251979|2335276|P2|Overall Study|Protocol Violation|5
725990|NCT00251979|2335277|P1|Overall Study|Protocol Violation|3
725991|NCT00252057|2335309|P2|Overall Study|Participant previously enrolled|1
725992|NCT00252057|2335310|P1|Overall Study|Participant previously enrolled|0
725993|NCT00252057|2335309|P2|Overall Study|Death|2
725994|NCT00252057|2335310|P1|Overall Study|Death|1
725995|NCT00252057|2335309|P2|Overall Study|Withdrawal by Subject|5
725996|NCT00252057|2335310|P1|Overall Study|Withdrawal by Subject|2
726000|NCT00252187|2335358|P2|Overall Study|Withdrawal by Subject|0
726001|NCT00252187|2335359|P1|Overall Study|Withdrawal by Subject|1
726002|NCT00252187|2335358|P2|Overall Study|Adverse Event|1
726003|NCT00252187|2335359|P1|Overall Study|Adverse Event|3
726004|NCT00252239|2335383|P4|Overall Study|Lost to Follow-up|0
726005|NCT00252239|2335384|P3|Overall Study|Lost to Follow-up|2
726006|NCT00252239|2335385|P2|Overall Study|Lost to Follow-up|0
726007|NCT00252239|2335386|P1|Overall Study|Lost to Follow-up|0
726008|NCT00252239|2335383|P4|Overall Study|Withdrawal by Subject|1
726009|NCT00252239|2335384|P3|Overall Study|Withdrawal by Subject|0
726010|NCT00252239|2335385|P2|Overall Study|Withdrawal by Subject|0
726011|NCT00252239|2335386|P1|Overall Study|Withdrawal by Subject|1
726012|NCT00253370|2335434|P1|Overall Study|Abdominal pain due to disease|1
726013|NCT00253370|2335434|P1|Overall Study|Protocol Violation|1
726014|NCT00253370|2335434|P1|Overall Study|Physician Decision|1
726015|NCT00253370|2335434|P1|Overall Study|Non-protocol therapy|1
726016|NCT00253370|2335434|P1|Overall Study|Withdrawal by Subject|6
726017|NCT00253370|2335434|P1|Overall Study|Death|2
726018|NCT00253370|2335434|P1|Overall Study|Disease progression|13
726019|NCT00253370|2335434|P1|Overall Study|Adverse Event|18
726020|NCT00253448|2335455|P1|Overall Study|Withdrawal by Subject|1
726021|NCT00253643|2335470|P4|Overall Study|Non-Compliance|2
726022|NCT00253643|2335471|P3|Overall Study|Non-Compliance|0
726023|NCT00253643|2335472|P2|Overall Study|Non-Compliance|0
726024|NCT00253643|2335473|P1|Overall Study|Non-Compliance|0
726025|NCT00253643|2335470|P4|Overall Study|Withdrawal by Subject|1
726026|NCT00253643|2335471|P3|Overall Study|Withdrawal by Subject|1
726027|NCT00253643|2335472|P2|Overall Study|Withdrawal by Subject|0
726028|NCT00253643|2335473|P1|Overall Study|Withdrawal by Subject|0
726029|NCT00253747|2335520|P2|Overall Study|Administrative Discharge (1), Other (2)|2
726030|NCT00253747|2335521|P1|Overall Study|Administrative Discharge (1), Other (2)|1
726031|NCT00253747|2335520|P2|Overall Study|Withdrawal by Subject|11
726032|NCT00253747|2335521|P1|Overall Study|Withdrawal by Subject|10
726033|NCT00253747|2335520|P2|Overall Study|Lost to Follow-up|14
726034|NCT00253747|2335521|P1|Overall Study|Lost to Follow-up|13
726035|NCT00254163|2335568|P2|Overall Study|Other|8
726036|NCT00254163|2335569|P1|Overall Study|Other|8
726037|NCT00254163|2335568|P2|Overall Study|Death|1
726038|NCT00254163|2335569|P1|Overall Study|Death|0
726039|NCT00254163|2335568|P2|Overall Study|Progressive disease|1
726040|NCT00254163|2335569|P1|Overall Study|Progressive disease|0
726041|NCT00254163|2335568|P2|Overall Study|Failed entry|3
726042|NCT00254163|2335569|P1|Overall Study|Failed entry|1
726043|NCT00254163|2335568|P2|Overall Study|Investigator request|3
726044|NCT00254163|2335569|P1|Overall Study|Investigator request|1
726045|NCT00254163|2335568|P2|Overall Study|Patient request/withdrew consent|4
726046|NCT00254163|2335569|P1|Overall Study|Patient request/withdrew consent|6
726047|NCT00254163|2335568|P2|Overall Study|Adverse Event|26
726048|NCT00254163|2335569|P1|Overall Study|Adverse Event|29
726049|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|not specified|1
726050|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|not specified|0
726051|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|not specified|0
726052|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|not specified|0
726053|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|not specified|0
726054|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|not specified|0
726055|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|not specified|0
726056|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
726057|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726058|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726059|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726060|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726061|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726062|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
726063|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
726064|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726065|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726066|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726067|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726068|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726069|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
726070|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
726071|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726072|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726073|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726074|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726075|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726076|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
726077|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
726078|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726079|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726080|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726081|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726082|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726083|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
726084|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Adverse Event|1
726085|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Adverse Event|0
726086|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Adverse Event|0
726087|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Adverse Event|0
726088|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Adverse Event|0
726089|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Adverse Event|0
726090|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Adverse Event|0
726091|NCT00254293|2335597|P7|LTE Open Label Fixed Dosing|Death|3
726092|NCT00254293|2335598|P6|LTE Open Label Fixed Dosing|Death|0
726093|NCT00254293|2335599|P5|LTE Open Label Fixed Dosing|Death|0
726094|NCT00254293|2335600|P4|LTE Open Label Fixed Dosing|Death|0
726095|NCT00254293|2335601|P3|LTE Open Label Fixed Dosing|Death|0
726096|NCT00254293|2335602|P2|LTE Open Label Fixed Dosing|Death|0
726097|NCT00254293|2335603|P1|LTE Open Label Fixed Dosing|Death|0
726098|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|not specified|0
726099|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|not specified|0
726100|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|not specified|0
726101|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|not specified|0
726102|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|not specified|2
726103|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|not specified|0
726104|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|not specified|0
726105|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726106|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726107|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726108|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726109|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
726110|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726111|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
726112|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726113|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726114|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726115|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726116|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
726117|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726118|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
726119|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726120|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726121|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726122|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726123|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
726124|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726125|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
726126|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
726127|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
726128|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
726129|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
726130|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
726131|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
726132|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
726133|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
726134|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
726135|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
726136|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
726137|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
726138|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
726139|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
726140|NCT00254293|2335597|P7|LTE Open Label Variable SC Dosing|Death|0
726141|NCT00254293|2335598|P6|LTE Open Label Variable SC Dosing|Death|0
726142|NCT00254293|2335599|P5|LTE Open Label Variable SC Dosing|Death|0
726143|NCT00254293|2335600|P4|LTE Open Label Variable SC Dosing|Death|0
726144|NCT00254293|2335601|P3|LTE Open Label Variable SC Dosing|Death|1
726145|NCT00254293|2335602|P2|LTE Open Label Variable SC Dosing|Death|0
726146|NCT00254293|2335603|P1|LTE Open Label Variable SC Dosing|Death|0
726147|NCT00254293|2335597|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726148|NCT00254293|2335598|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726149|NCT00254293|2335599|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726150|NCT00254293|2335600|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726151|NCT00254293|2335601|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
726152|NCT00254293|2335602|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726153|NCT00254293|2335603|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
726154|NCT00254293|2335597|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726155|NCT00254293|2335598|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726156|NCT00254293|2335599|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726157|NCT00254293|2335600|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726158|NCT00254293|2335601|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
726159|NCT00254293|2335602|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726160|NCT00254293|2335603|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
726161|NCT00254293|2335597|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
726162|NCT00254293|2335598|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
726163|NCT00254293|2335599|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
726164|NCT00254293|2335600|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
726165|NCT00254293|2335601|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
726166|NCT00254293|2335602|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
726167|NCT00254293|2335603|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
726168|NCT00254501|2335697|P2|Overall Study|Lost to Follow-up|1
726169|NCT00254501|2335698|P1|Overall Study|Lost to Follow-up|1
726170|NCT00254540|2335712|P2|Overall Study|Laboratory Test Abnormality|1
726171|NCT00254540|2335713|P1|Overall Study|Laboratory Test Abnormality|0
726172|NCT00254540|2335712|P2|Overall Study|Death|1
726173|NCT00254540|2335713|P1|Overall Study|Death|0
726174|NCT00254540|2335712|P2|Overall Study|Lack of Efficacy|13
726175|NCT00254540|2335713|P1|Overall Study|Lack of Efficacy|13
726176|NCT00254540|2335712|P2|Overall Study|Adverse Event|7
726177|NCT00254540|2335713|P1|Overall Study|Adverse Event|6
726178|NCT00254566|2335742|P2|Overall Study|Lost to Follow-up|2
726179|NCT00254566|2335743|P1|Overall Study|Lost to Follow-up|7
726180|NCT00254566|2335742|P2|Overall Study|Withdrawal by Subject|6
726181|NCT00254566|2335743|P1|Overall Study|Withdrawal by Subject|5
726182|NCT00254566|2335742|P2|Overall Study|Other|5
726183|NCT00254566|2335743|P1|Overall Study|Other|1
726184|NCT00254566|2335742|P2|Overall Study|Lack of Efficacy|9
726185|NCT00254566|2335743|P1|Overall Study|Lack of Efficacy|12
726186|NCT00254566|2335742|P2|Overall Study|Adverse Event|4
726187|NCT00254566|2335743|P1|Overall Study|Adverse Event|5
726188|NCT00254566|2335742|P2|Overall Study|Death|0
726189|NCT00254566|2335743|P1|Overall Study|Death|1
726190|NCT00254982|2335771|P2|Overall Study|Abnormal liver function tests|1
726191|NCT00254982|2335772|P1|Overall Study|Abnormal liver function tests|2
726192|NCT00254982|2335771|P2|Overall Study|Opportunistic infection|0
726193|NCT00254982|2335772|P1|Overall Study|Opportunistic infection|1
726194|NCT00254982|2335771|P2|Overall Study|Malignancy|2
726195|NCT00254982|2335772|P1|Overall Study|Malignancy|0
726196|NCT00254982|2335771|P2|Overall Study|Diagnosis of Tuberculosis|1
726197|NCT00254982|2335772|P1|Overall Study|Diagnosis of Tuberculosis|1
726198|NCT00254982|2335771|P2|Overall Study|Protocol deviation|1
726199|NCT00254982|2335772|P1|Overall Study|Protocol deviation|1
726200|NCT00254982|2335771|P2|Overall Study|Inclusion/exclusion criteria violation|2
726201|NCT00254982|2335772|P1|Overall Study|Inclusion/exclusion criteria violation|0
726202|NCT00254982|2335771|P2|Overall Study|Withdrawal by Subject|1
726203|NCT00254982|2335772|P1|Overall Study|Withdrawal by Subject|1
726204|NCT00254982|2335771|P2|Overall Study|Adverse Event|16
726205|NCT00254982|2335772|P1|Overall Study|Adverse Event|18
726206|NCT00254982|2335771|P2|Overall Study|Lost to Follow-up|3
726207|NCT00254982|2335772|P1|Overall Study|Lost to Follow-up|5
726208|NCT00254982|2335771|P2|Overall Study|Lack of Efficacy|3
726209|NCT00254982|2335772|P1|Overall Study|Lack of Efficacy|5
726210|NCT00254982|2335771|P2|Overall Study|Not specified|1
726211|NCT00254982|2335772|P1|Overall Study|Not specified|2
726212|NCT00255008|2335806|P4|Overall Study|Other|2
726213|NCT00255008|2335807|P3|Overall Study|Other|3
726214|NCT00255008|2335808|P2|Overall Study|Other|0
726215|NCT00255008|2335809|P1|Overall Study|Other|7
726216|NCT00255008|2335806|P4|Overall Study|Adverse lab experience|0
726217|NCT00255008|2335807|P3|Overall Study|Adverse lab experience|0
726218|NCT00255008|2335808|P2|Overall Study|Adverse lab experience|0
726219|NCT00255008|2335809|P1|Overall Study|Adverse lab experience|1
726220|NCT00255008|2335806|P4|Overall Study|Sponsor request|17
726221|NCT00255008|2335807|P3|Overall Study|Sponsor request|8
726222|NCT00255008|2335808|P2|Overall Study|Sponsor request|3
726223|NCT00255008|2335809|P1|Overall Study|Sponsor request|18
726224|NCT00255008|2335806|P4|Overall Study|Withdrew consent|0
726225|NCT00255008|2335807|P3|Overall Study|Withdrew consent|2
726226|NCT00255008|2335808|P2|Overall Study|Withdrew consent|0
726227|NCT00255008|2335809|P1|Overall Study|Withdrew consent|0
726228|NCT00255008|2335806|P4|Overall Study|Did not meet viral reduction criteria|1
726229|NCT00255008|2335807|P3|Overall Study|Did not meet viral reduction criteria|0
726230|NCT00255008|2335808|P2|Overall Study|Did not meet viral reduction criteria|5
726231|NCT00255008|2335809|P1|Overall Study|Did not meet viral reduction criteria|4
726232|NCT00255008|2335806|P4|Overall Study|Lost to Follow-up|2
726233|NCT00255008|2335807|P3|Overall Study|Lost to Follow-up|1
726234|NCT00255008|2335808|P2|Overall Study|Lost to Follow-up|0
726235|NCT00255008|2335809|P1|Overall Study|Lost to Follow-up|1
726236|NCT00255008|2335806|P4|Overall Study|Adverse Event|0
726237|NCT00255008|2335807|P3|Overall Study|Adverse Event|2
726238|NCT00255008|2335808|P2|Overall Study|Adverse Event|1
726239|NCT00255008|2335809|P1|Overall Study|Adverse Event|1
726240|NCT00255034|2335821|P2|Overall Study|Withdrawal by Subject|38
726241|NCT00255034|2335822|P1|Overall Study|Withdrawal by Subject|15
726242|NCT00255047|2335832|P4|Overall Study|Withdrawal by Subject|18
726243|NCT00255047|2335833|P3|Overall Study|Withdrawal by Subject|25
726244|NCT00255047|2335834|P2|Overall Study|Withdrawal by Subject|23
726245|NCT00255047|2335835|P1|Overall Study|Withdrawal by Subject|24
726246|NCT00255047|2335832|P4|Overall Study|Lost to Follow-up|6
726247|NCT00255047|2335833|P3|Overall Study|Lost to Follow-up|5
726248|NCT00255047|2335834|P2|Overall Study|Lost to Follow-up|8
726249|NCT00255047|2335835|P1|Overall Study|Lost to Follow-up|9
726250|NCT00255047|2335832|P4|Overall Study|Protocol Violation|20
726251|NCT00255047|2335833|P3|Overall Study|Protocol Violation|16
726252|NCT00255047|2335834|P2|Overall Study|Protocol Violation|13
726253|NCT00255047|2335835|P1|Overall Study|Protocol Violation|13
726254|NCT00255047|2335832|P4|Overall Study|Adverse Event|1
726255|NCT00255047|2335833|P3|Overall Study|Adverse Event|2
726256|NCT00255047|2335834|P2|Overall Study|Adverse Event|3
726257|NCT00255047|2335835|P1|Overall Study|Adverse Event|0
726258|NCT00255047|2335832|P4|Overall Study|Serious Adverse Events|1
726259|NCT00255047|2335833|P3|Overall Study|Serious Adverse Events|2
726260|NCT00255047|2335834|P2|Overall Study|Serious Adverse Events|1
726261|NCT00255047|2335835|P1|Overall Study|Serious Adverse Events|2
726262|NCT00255086|2335859|P2|Overall Study|Protocol Violation|1
726263|NCT00255086|2335860|P1|Overall Study|Protocol Violation|1
726264|NCT00255086|2335859|P2|Overall Study|Adverse Event|1
726265|NCT00255086|2335860|P1|Overall Study|Adverse Event|1
726266|NCT00255151|2335880|P3|Overall Study|Therapeutic Failure|3
726267|NCT00255151|2335881|P2|Overall Study|Therapeutic Failure|2
726268|NCT00255151|2335882|P1|Overall Study|Therapeutic Failure|11
726269|NCT00255151|2335880|P3|Overall Study|Esophageal Stricture|1
726270|NCT00255151|2335881|P2|Overall Study|Esophageal Stricture|0
726271|NCT00255151|2335882|P1|Overall Study|Esophageal Stricture|0
726272|NCT00255151|2335880|P3|Overall Study|Possible Barrett's Esophagus|8
726273|NCT00255151|2335881|P2|Overall Study|Possible Barrett's Esophagus|3
726274|NCT00255151|2335882|P1|Overall Study|Possible Barrett's Esophagus|1
726275|NCT00255151|2335880|P3|Overall Study|Relapse of Erosive Esophagitis|12
726276|NCT00255151|2335881|P2|Overall Study|Relapse of Erosive Esophagitis|16
726277|NCT00255151|2335882|P1|Overall Study|Relapse of Erosive Esophagitis|78
726278|NCT00255151|2335880|P3|Overall Study|Subject Request/Subject Unavailable|2
726279|NCT00255151|2335881|P2|Overall Study|Subject Request/Subject Unavailable|1
726280|NCT00255151|2335882|P1|Overall Study|Subject Request/Subject Unavailable|1
726281|NCT00255151|2335880|P3|Overall Study|Noncompliance|2
726282|NCT00255151|2335881|P2|Overall Study|Noncompliance|1
726283|NCT00255151|2335882|P1|Overall Study|Noncompliance|0
726284|NCT00255151|2335880|P3|Overall Study|Withdrawal by Subject|8
726285|NCT00255151|2335881|P2|Overall Study|Withdrawal by Subject|17
726286|NCT00255151|2335882|P1|Overall Study|Withdrawal by Subject|18
726287|NCT00255151|2335880|P3|Overall Study|Lost to Follow-up|4
726288|NCT00255151|2335881|P2|Overall Study|Lost to Follow-up|3
726289|NCT00255151|2335882|P1|Overall Study|Lost to Follow-up|4
726290|NCT00255151|2335880|P3|Overall Study|Adverse Event|9
726291|NCT00255151|2335881|P2|Overall Study|Adverse Event|6
726292|NCT00255151|2335882|P1|Overall Study|Adverse Event|10
726293|NCT00255164|2335908|P3|Overall Study|Therapeutic Failure|3
726294|NCT00255164|2335909|P2|Overall Study|Therapeutic Failure|2
726295|NCT00255164|2335910|P1|Overall Study|Therapeutic Failure|11
726296|NCT00255164|2335908|P3|Overall Study|Esophageal Stricture|1
726297|NCT00255164|2335909|P2|Overall Study|Esophageal Stricture|0
726298|NCT00255164|2335910|P1|Overall Study|Esophageal Stricture|0
726299|NCT00255164|2335908|P3|Overall Study|Possible Barrett's Esophagus|8
726300|NCT00255164|2335909|P2|Overall Study|Possible Barrett's Esophagus|3
726301|NCT00255164|2335910|P1|Overall Study|Possible Barrett's Esophagus|1
726302|NCT00255164|2335908|P3|Overall Study|Relapse of Erosive Esophagitis|12
726303|NCT00255164|2335909|P2|Overall Study|Relapse of Erosive Esophagitis|16
726304|NCT00255164|2335910|P1|Overall Study|Relapse of Erosive Esophagitis|78
726305|NCT00255164|2335908|P3|Overall Study|Subject Request/Subject Unavailable|2
726306|NCT00255164|2335909|P2|Overall Study|Subject Request/Subject Unavailable|1
726307|NCT00255164|2335910|P1|Overall Study|Subject Request/Subject Unavailable|1
726308|NCT00255164|2335908|P3|Overall Study|Noncompliance|2
726309|NCT00255164|2335909|P2|Overall Study|Noncompliance|1
726310|NCT00255164|2335910|P1|Overall Study|Noncompliance|0
726311|NCT00255164|2335908|P3|Overall Study|Withdrawal by Subject|8
726312|NCT00255164|2335909|P2|Overall Study|Withdrawal by Subject|17
726313|NCT00255164|2335910|P1|Overall Study|Withdrawal by Subject|18
726314|NCT00255164|2335908|P3|Overall Study|Lost to Follow-up|4
726315|NCT00255164|2335909|P2|Overall Study|Lost to Follow-up|3
726316|NCT00255164|2335910|P1|Overall Study|Lost to Follow-up|4
726317|NCT00255164|2335908|P3|Overall Study|Adverse Event|9
726318|NCT00255164|2335909|P2|Overall Study|Adverse Event|6
726319|NCT00255164|2335910|P1|Overall Study|Adverse Event|10
726320|NCT00255190|2335952|P2|Overall Study|Various|23
726321|NCT00255190|2335953|P1|Overall Study|Various|4
726322|NCT00255190|2335952|P2|Overall Study|Erosive esophagitis not healed|20
726323|NCT00255190|2335953|P1|Overall Study|Erosive esophagitis not healed|0
726324|NCT00255190|2335952|P2|Overall Study|Inclusion/Exclusion criteria not met|1
726325|NCT00255190|2335953|P1|Overall Study|Inclusion/Exclusion criteria not met|0
726326|NCT00255190|2335952|P2|Overall Study|Withdrew Consent|48
726327|NCT00255190|2335953|P1|Overall Study|Withdrew Consent|17
726328|NCT00255190|2335952|P2|Overall Study|Lost to Follow-up|27
726329|NCT00255190|2335953|P1|Overall Study|Lost to Follow-up|10
726330|NCT00255190|2335952|P2|Overall Study|Protocol Violation|2
726331|NCT00255190|2335953|P1|Overall Study|Protocol Violation|2
726332|NCT00255190|2335952|P2|Overall Study|Adverse Event|36
726333|NCT00255190|2335953|P1|Overall Study|Adverse Event|17
726334|NCT00248170|2336019|P2|Overall Study|Protocol deviation|19
726335|NCT00248170|2336020|P1|Overall Study|Protocol deviation|17
726336|NCT00248170|2336019|P2|Overall Study|Abnormal laboratory values|0
726337|NCT00248170|2336020|P1|Overall Study|Abnormal laboratory values|4
726338|NCT00248170|2336019|P2|Overall Study|Abnormal test procedure(s) result|61
726339|NCT00248170|2336020|P1|Overall Study|Abnormal test procedure(s) result|49
726340|NCT00248170|2336019|P2|Overall Study|Administrative problems|25
726341|NCT00248170|2336020|P1|Overall Study|Administrative problems|22
726342|NCT00248170|2336019|P2|Overall Study|Adverse Event|296
726343|NCT00248170|2336020|P1|Overall Study|Adverse Event|311
726344|NCT00248170|2336019|P2|Overall Study|Death|47
726345|NCT00248170|2336020|P1|Overall Study|Death|28
726346|NCT00248170|2336019|P2|Overall Study|Disease progression|216
726347|NCT00248170|2336020|P1|Overall Study|Disease progression|196
726348|NCT00248170|2336019|P2|Overall Study|Lost to Follow-up|35
726349|NCT00248170|2336020|P1|Overall Study|Lost to Follow-up|28
726350|NCT00248170|2336019|P2|Overall Study|Protocol Violation|30
726351|NCT00248170|2336020|P1|Overall Study|Protocol Violation|35
726352|NCT00248170|2336019|P2|Overall Study|Withdrawal by Subject|79
726353|NCT00248170|2336020|P1|Overall Study|Withdrawal by Subject|71
726354|NCT00248287|2336042|P2|Overall Study|Other|2
726355|NCT00248287|2336043|P1|Overall Study|Other|3
726356|NCT00248287|2336042|P2|Overall Study|Patient Request|3
726357|NCT00248287|2336043|P1|Overall Study|Patient Request|5
726358|NCT00248287|2336042|P2|Overall Study|Investigator Request|3
726359|NCT00248287|2336043|P1|Overall Study|Investigator Request|4
726360|NCT00248287|2336042|P2|Overall Study|Lost to Follow-up|1
726361|NCT00248287|2336043|P1|Overall Study|Lost to Follow-up|0
726362|NCT00248287|2336042|P2|Overall Study|Death|0
726363|NCT00248287|2336043|P1|Overall Study|Death|1
726364|NCT00248287|2336042|P2|Overall Study|Adverse Event|10
726365|NCT00248287|2336043|P1|Overall Study|Adverse Event|11
726366|NCT00248495|2336055|P1|Overall Study|Withdrawal by Subject|1
726367|NCT00248625|2336128|P2|Overall Study|Withdrawal by Subject|2
726368|NCT00248625|2336129|P1|Overall Study|Withdrawal by Subject|0
726369|NCT00248651|2336163|P3|Overall Study|Withdrawal by Subject|32
726370|NCT00248651|2336164|P2|Overall Study|Withdrawal by Subject|40
726371|NCT00248651|2336165|P1|Overall Study|Withdrawal by Subject|28
726372|NCT00248794|2336212|P3|Overall Study|Lost to Follow-up|3
726373|NCT00248794|2336213|P2|Overall Study|Lost to Follow-up|8
726374|NCT00248794|2336214|P1|Overall Study|Lost to Follow-up|6
726375|NCT00249002|2336251|P1|Overall Study|Unspecified|2
726376|NCT00249002|2336251|P1|Overall Study|Study cancellation|3
726377|NCT00249002|2336251|P1|Overall Study|Adverse Event|2
726378|NCT00249288|2336330|P2|Overall Study|Withdrawal by Subject|2
726379|NCT00249288|2336331|P1|Overall Study|Withdrawal by Subject|2
726380|NCT00249288|2336330|P2|Overall Study|Lost to Follow-up|3
726381|NCT00249288|2336331|P1|Overall Study|Lost to Follow-up|3
726382|NCT00255723|2336359|P2|Overall Study|Response Data Not Available|0
726383|NCT00255723|2336360|P1|Overall Study|Response Data Not Available|1
726384|NCT00255723|2336359|P2|Overall Study|Death|1
726385|NCT00255723|2336360|P1|Overall Study|Death|0
726386|NCT00255723|2336359|P2|Overall Study|Adverse Event|1
726387|NCT00255723|2336360|P1|Overall Study|Adverse Event|1
726388|NCT00258440|2336369|P3|Overall Study|Withdrawal by Subject|1
726389|NCT00258440|2336370|P2|Overall Study|Withdrawal by Subject|0
726390|NCT00258440|2336371|P1|Overall Study|Withdrawal by Subject|0
726391|NCT00258674|2336385|P3|Overall Study|Death|34
726392|NCT00258674|2336386|P2|Overall Study|Death|53
726393|NCT00258674|2336387|P1|Overall Study|Death|32
726394|NCT00258856|2336475|P4|Overall Study|Non-compliance|1
726395|NCT00258856|2336476|P3|Overall Study|Non-compliance|0
726396|NCT00258856|2336477|P2|Overall Study|Non-compliance|0
726397|NCT00258856|2336478|P1|Overall Study|Non-compliance|2
726398|NCT00258856|2336475|P4|Overall Study|Lost to Follow-up|0
726399|NCT00258856|2336476|P3|Overall Study|Lost to Follow-up|2
726400|NCT00258856|2336477|P2|Overall Study|Lost to Follow-up|0
726401|NCT00258856|2336478|P1|Overall Study|Lost to Follow-up|1
726402|NCT00258895|2336508|P2|Overall Study|Withdrawal by Subject|0
726403|NCT00258895|2336509|P1|Overall Study|Withdrawal by Subject|1
726404|NCT00258895|2336508|P2|Overall Study|Protocol Violation|2
726405|NCT00258895|2336509|P1|Overall Study|Protocol Violation|6
726406|NCT00258895|2336508|P2|Overall Study|Lost to Follow-up|1
726407|NCT00258895|2336509|P1|Overall Study|Lost to Follow-up|3
726408|NCT00259012|2336531|P2|Overall Study|Protocol Violation|1
726409|NCT00259012|2336532|P1|Overall Study|Protocol Violation|1
726410|NCT00259012|2336531|P2|Overall Study|Lost to Follow-up|1
726411|NCT00259012|2336532|P1|Overall Study|Lost to Follow-up|0
726412|NCT00259012|2336531|P2|Overall Study|Physician Decision|1
726413|NCT00259012|2336532|P1|Overall Study|Physician Decision|0
726414|NCT00259012|2336531|P2|Overall Study|Withdrawal by Subject|0
726415|NCT00259012|2336532|P1|Overall Study|Withdrawal by Subject|1
726416|NCT00259012|2336531|P2|Overall Study|Adverse Event|1
726417|NCT00259012|2336532|P1|Overall Study|Adverse Event|0
726418|NCT00259272|2336587|P4|Overall Study|Lost to Follow-up|1
726419|NCT00259272|2336588|P3|Overall Study|Lost to Follow-up|0
726420|NCT00259272|2336589|P2|Overall Study|Lost to Follow-up|0
726421|NCT00259272|2336590|P1|Overall Study|Lost to Follow-up|1
726422|NCT00259272|2336587|P4|Overall Study|Withdrawal by Subject|7
726423|NCT00259272|2336588|P3|Overall Study|Withdrawal by Subject|2
726424|NCT00259272|2336589|P2|Overall Study|Withdrawal by Subject|2
726425|NCT00259272|2336590|P1|Overall Study|Withdrawal by Subject|4
726426|NCT00259272|2336587|P4|Overall Study|Sponsor Decision|0
726427|NCT00259272|2336588|P3|Overall Study|Sponsor Decision|0
726428|NCT00259272|2336589|P2|Overall Study|Sponsor Decision|1
726429|NCT00259272|2336590|P1|Overall Study|Sponsor Decision|0
726430|NCT00259272|2336587|P4|Overall Study|Protocol Violation|1
726431|NCT00259272|2336588|P3|Overall Study|Protocol Violation|0
726432|NCT00259272|2336589|P2|Overall Study|Protocol Violation|0
726433|NCT00259272|2336590|P1|Overall Study|Protocol Violation|2
726434|NCT00259272|2336587|P4|Overall Study|Physician Decision|3
726435|NCT00259272|2336588|P3|Overall Study|Physician Decision|1
726436|NCT00259272|2336589|P2|Overall Study|Physician Decision|2
726437|NCT00259272|2336590|P1|Overall Study|Physician Decision|1
726438|NCT00259272|2336587|P4|Overall Study|Lack of Efficacy|6
726439|NCT00259272|2336588|P3|Overall Study|Lack of Efficacy|2
726440|NCT00259272|2336589|P2|Overall Study|Lack of Efficacy|1
726441|NCT00259272|2336590|P1|Overall Study|Lack of Efficacy|5
726442|NCT00259272|2336587|P4|Overall Study|Adverse Event|3
726443|NCT00259272|2336588|P3|Overall Study|Adverse Event|0
726444|NCT00259272|2336589|P2|Overall Study|Adverse Event|1
726445|NCT00259272|2336590|P1|Overall Study|Adverse Event|2
726446|NCT00259298|2336671|P1|Overall Study|Physician Decision|2
726447|NCT00259298|2336671|P1|Overall Study|Withdrawal by Subject|1
726448|NCT00259610|2336683|P4|Overall Study|Serious Adverse Event|2
726449|NCT00259610|2336684|P3|Overall Study|Serious Adverse Event|2
726450|NCT00259610|2336685|P2|Overall Study|Serious Adverse Event|2
726451|NCT00259610|2336686|P1|Overall Study|Serious Adverse Event|8
726452|NCT00259610|2336683|P4|Overall Study|Adverse Event|2
726453|NCT00259610|2336684|P3|Overall Study|Adverse Event|5
726454|NCT00259610|2336685|P2|Overall Study|Adverse Event|4
726455|NCT00259610|2336686|P1|Overall Study|Adverse Event|3
726456|NCT00259610|2336683|P4|Overall Study|non medical reason|3
726457|NCT00259610|2336684|P3|Overall Study|non medical reason|10
726458|NCT00259610|2336685|P2|Overall Study|non medical reason|2
726459|NCT00259610|2336686|P1|Overall Study|non medical reason|6
726460|NCT00259610|2336683|P4|Overall Study|Death|0
726461|NCT00259610|2336684|P3|Overall Study|Death|2
726462|NCT00259610|2336685|P2|Overall Study|Death|1
726463|NCT00259610|2336686|P1|Overall Study|Death|1
726464|NCT00259610|2336683|P4|Overall Study|Physician Decision|2
726465|NCT00259610|2336684|P3|Overall Study|Physician Decision|7
726466|NCT00259610|2336685|P2|Overall Study|Physician Decision|4
726467|NCT00259610|2336686|P1|Overall Study|Physician Decision|6
726468|NCT00259610|2336683|P4|Overall Study|Lost to Follow-up|15
726469|NCT00259610|2336684|P3|Overall Study|Lost to Follow-up|18
726470|NCT00259610|2336685|P2|Overall Study|Lost to Follow-up|8
726471|NCT00259610|2336686|P1|Overall Study|Lost to Follow-up|19
726472|NCT00259610|2336683|P4|Overall Study|Withdrawal by Subject|19
726473|NCT00259610|2336684|P3|Overall Study|Withdrawal by Subject|29
726474|NCT00259610|2336685|P2|Overall Study|Withdrawal by Subject|25
726475|NCT00259610|2336686|P1|Overall Study|Withdrawal by Subject|33
726476|NCT00259649|2336700|P1|Overall Study|irregular menses|3
726477|NCT00259649|2336700|P1|Overall Study|Lost to Follow-up|7
726478|NCT00259740|2336706|P2|Overall Study|Requirement for alternative therapy|4
726479|NCT00259740|2336707|P1|Overall Study|Requirement for alternative therapy|0
726480|NCT00259740|2336706|P2|Overall Study|Other|0
726481|NCT00259740|2336707|P1|Overall Study|Other|3
726482|NCT00259740|2336706|P2|Overall Study|Ongoing|3
726483|NCT00259740|2336707|P1|Overall Study|Ongoing|17
726484|NCT00259740|2336706|P2|Overall Study|Disease progression|36
726485|NCT00259740|2336707|P1|Overall Study|Disease progression|19
726486|NCT00259740|2336706|P2|Overall Study|Death|1
726487|NCT00259740|2336707|P1|Overall Study|Death|1
726488|NCT00259740|2336706|P2|Overall Study|Withdrawal by Subject|6
726489|NCT00259740|2336707|P1|Overall Study|Withdrawal by Subject|2
726490|NCT00259740|2336706|P2|Overall Study|Adverse Event|2
726491|NCT00259740|2336707|P1|Overall Study|Adverse Event|0
726492|NCT00259740|2336706|P2|Overall Study|Physician Decision|1
726493|NCT00259740|2336707|P1|Overall Study|Physician Decision|1
726494|NCT00259857|2336719|P2|24 Months Treatment|Lost to Follow-up|3
726495|NCT00259857|2336720|P1|24 Months Treatment|Lost to Follow-up|0
726496|NCT00259857|2336719|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
726497|NCT00259857|2336720|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
726498|NCT00260065|2336736|P1|Overall Study|Medication Noncompliance|1
726499|NCT00260065|2336736|P1|Overall Study|Not otherwise specified|8
726500|NCT00260065|2336736|P1|Overall Study|Physician Decision|19
726501|NCT00260065|2336736|P1|Overall Study|Withdrawal by Subject|13
726502|NCT00260065|2336736|P1|Overall Study|Death|13
726503|NCT00260065|2336736|P1|Overall Study|Adverse Event|17
726504|NCT00260065|2336736|P1|Overall Study|Progressive Disease|22
726505|NCT00260208|2336758|P2|Overall Study|Missing|16
726506|NCT00260208|2336759|P1|Overall Study|Missing|18
726507|NCT00260208|2336758|P2|Overall Study|Death|10
726508|NCT00260208|2336759|P1|Overall Study|Death|12
726509|NCT00260208|2336758|P2|Overall Study|Lost to Follow-up|1
726510|NCT00260208|2336759|P1|Overall Study|Lost to Follow-up|6
726511|NCT00260208|2336758|P2|Overall Study|Subject withdrew consent|7
726512|NCT00260208|2336759|P1|Overall Study|Subject withdrew consent|11
726513|NCT00260429|2336789|P2|Overall Study|scheduled hand surgery|0
726514|NCT00260429|2336790|P1|Overall Study|scheduled hand surgery|1
726515|NCT00260429|2336789|P2|Overall Study|failure to follow appointments|0
726516|NCT00260429|2336790|P1|Overall Study|failure to follow appointments|1
726517|NCT00260533|2336798|P2|Overall Study|Not Known|3
726518|NCT00260533|2336799|P1|Overall Study|Not Known|3
726519|NCT00260832|2336826|P2|Overall Study|Protocol Violation|1
726520|NCT00260832|2336827|P1|Overall Study|Protocol Violation|3
726521|NCT00260832|2336826|P2|Overall Study|Not Specified|7
726522|NCT00260832|2336827|P1|Overall Study|Not Specified|10
726523|NCT00260832|2336826|P2|Overall Study|Death|62
726524|NCT00260832|2336827|P1|Overall Study|Death|43
726525|NCT00260832|2336826|P2|Overall Study|Physician Decision|9
726526|NCT00260832|2336827|P1|Overall Study|Physician Decision|15
726527|NCT00260832|2336826|P2|Overall Study|Withdrawal by Subject|17
726528|NCT00260832|2336827|P1|Overall Study|Withdrawal by Subject|15
726529|NCT00260832|2336826|P2|Overall Study|Progression|96
726530|NCT00260832|2336827|P1|Overall Study|Progression|116
726531|NCT00260832|2336826|P2|Overall Study|Adverse Event|19
726532|NCT00260832|2336827|P1|Overall Study|Adverse Event|26
726533|NCT00252499|2336841|P3|Overall Study|Lost to Follow-up|0
726534|NCT00252499|2336842|P2|Overall Study|Lost to Follow-up|0
726535|NCT00252499|2336843|P1|Overall Study|Lost to Follow-up|1
726536|NCT00252564|2336883|P2|Overall Study|Withdrawal by Subject|2
726537|NCT00252564|2336884|P1|Overall Study|Withdrawal by Subject|0
726538|NCT00252564|2336883|P2|Overall Study|Patient Request|5
726539|NCT00252564|2336884|P1|Overall Study|Patient Request|4
726540|NCT00252564|2336883|P2|Overall Study|Lost to Follow-up|0
726541|NCT00252564|2336884|P1|Overall Study|Lost to Follow-up|1
726542|NCT00252564|2336883|P2|Overall Study|Physician Decision|0
726543|NCT00252564|2336884|P1|Overall Study|Physician Decision|1
726544|NCT00252564|2336883|P2|Overall Study|Protocol Violation|0
726545|NCT00252564|2336884|P1|Overall Study|Protocol Violation|0
726546|NCT00252564|2336883|P2|Overall Study|Death|3
726547|NCT00252564|2336884|P1|Overall Study|Death|0
726548|NCT00252564|2336883|P2|Overall Study|Disease Progression|20
726549|NCT00252564|2336884|P1|Overall Study|Disease Progression|14
726550|NCT00252564|2336883|P2|Overall Study|Unrelated Complication|1
726551|NCT00252564|2336884|P1|Overall Study|Unrelated Complication|2
726552|NCT00252564|2336883|P2|Overall Study|Adverse Event|13
726553|NCT00252564|2336884|P1|Overall Study|Adverse Event|17
726554|NCT00252694|2336932|P2|Overall Study|Patient Moving|16
726555|NCT00252694|2336933|P1|Overall Study|Patient Moving|17
726556|NCT00252694|2336932|P2|Overall Study|Mostly Lost to Follow Up|13
726557|NCT00252694|2336933|P1|Overall Study|Mostly Lost to Follow Up|8
726558|NCT00252694|2336932|P2|Overall Study|Death|34
726559|NCT00252694|2336933|P1|Overall Study|Death|36
726560|NCT00252694|2336932|P2|Overall Study|Withdrawal by Subject|91
726561|NCT00252694|2336933|P1|Overall Study|Withdrawal by Subject|83
726562|NCT00252720|2336947|P2|Overall Study|Mainly patients lost to follow-up|18
726563|NCT00252720|2336948|P1|Overall Study|Mainly patients lost to follow-up|7
726564|NCT00252720|2336947|P2|Overall Study|Moving|42
726565|NCT00252720|2336948|P1|Overall Study|Moving|23
726566|NCT00252720|2336947|P2|Overall Study|Death|8
726567|NCT00252720|2336948|P1|Overall Study|Death|7
726568|NCT00252720|2336947|P2|Overall Study|Withdrawal by Subject|97
726569|NCT00252720|2336948|P1|Overall Study|Withdrawal by Subject|95
726570|NCT00252733|2336962|P2|Overall Study|Multiple Reasons|14
726571|NCT00252733|2336963|P1|Overall Study|Multiple Reasons|14
726572|NCT00252733|2336962|P2|Overall Study|Lost to Follow-up|6
726573|NCT00252733|2336963|P1|Overall Study|Lost to Follow-up|12
726574|NCT00252733|2336962|P2|Overall Study|Death|5
726575|NCT00252733|2336963|P1|Overall Study|Death|7
726576|NCT00252733|2336962|P2|Overall Study|Withdrawal by Subject|67
726577|NCT00252733|2336963|P1|Overall Study|Withdrawal by Subject|73
726578|NCT00263887|2336984|P2|Overall Study|Lack of Efficacy|1
726579|NCT00263887|2336985|P1|Overall Study|Lack of Efficacy|0
726580|NCT00263887|2336984|P2|Overall Study|Disease progression|1
726581|NCT00263887|2336985|P1|Overall Study|Disease progression|0
726582|NCT00263887|2336984|P2|Overall Study|Adverse Event|2
726583|NCT00263887|2336985|P1|Overall Study|Adverse Event|0
726584|NCT00263887|2336984|P2|Overall Study|Too ill to attend visit|0
726585|NCT00263887|2336985|P1|Overall Study|Too ill to attend visit|1
726586|NCT00263887|2336984|P2|Overall Study|Lung transplantation|2
726587|NCT00263887|2336985|P1|Overall Study|Lung transplantation|1
726588|NCT00263887|2336984|P2|Overall Study|Withdrawal by Subject|1
726589|NCT00263887|2336985|P1|Overall Study|Withdrawal by Subject|1
726590|NCT00264004|2336995|P4|Overall Study|Not treated|2
726591|NCT00264004|2336996|P3|Overall Study|Not treated|2
726592|NCT00264004|2336997|P2|Overall Study|Not treated|0
726593|NCT00264004|2336998|P1|Overall Study|Not treated|3
726594|NCT00264004|2336995|P4|Overall Study|Cond. under inv. worsened|4
726595|NCT00264004|2336996|P3|Overall Study|Cond. under inv. worsened|3
726596|NCT00264004|2336997|P2|Overall Study|Cond. under inv. worsened|5
726597|NCT00264004|2336998|P1|Overall Study|Cond. under inv. worsened|9
726598|NCT00264004|2336995|P4|Overall Study|Development study specific disc. crit.|0
726599|NCT00264004|2336996|P3|Overall Study|Development study specific disc. crit.|1
726600|NCT00264004|2336997|P2|Overall Study|Development study specific disc. crit.|0
726601|NCT00264004|2336998|P1|Overall Study|Development study specific disc. crit.|1
726602|NCT00264004|2336995|P4|Overall Study|Not specified|3
726603|NCT00264004|2336996|P3|Overall Study|Not specified|0
726604|NCT00264004|2336997|P2|Overall Study|Not specified|2
726605|NCT00264004|2336998|P1|Overall Study|Not specified|2
726606|NCT00264004|2336995|P4|Overall Study|Withdrawal by Subject|2
726607|NCT00264004|2336996|P3|Overall Study|Withdrawal by Subject|2
726608|NCT00264004|2336997|P2|Overall Study|Withdrawal by Subject|1
726609|NCT00264004|2336998|P1|Overall Study|Withdrawal by Subject|0
726610|NCT00264004|2336995|P4|Overall Study|Adverse Event|4
726611|NCT00264004|2336996|P3|Overall Study|Adverse Event|6
726612|NCT00264004|2336997|P2|Overall Study|Adverse Event|3
726613|NCT00264004|2336998|P1|Overall Study|Adverse Event|2
726614|NCT00264147|2337029|P6|Treatment II Period|Pre-scheduled total hip replacement|1
726615|NCT00264147|2337030|P5|Treatment II Period|Pre-scheduled total hip replacement|0
726616|NCT00264147|2337031|P4|Treatment II Period|Pre-scheduled total hip replacement|0
726617|NCT00264147|2337032|P3|Treatment II Period|Pre-scheduled total hip replacement|0
726618|NCT00264147|2337033|P2|Treatment II Period|Pre-scheduled total hip replacement|0
726619|NCT00264147|2337034|P1|Treatment II Period|Pre-scheduled total hip replacement|0
726620|NCT00264147|2337029|P6|Treatment II Period|Withdrawal by Subject|2
726621|NCT00264147|2337030|P5|Treatment II Period|Withdrawal by Subject|3
726622|NCT00264147|2337031|P4|Treatment II Period|Withdrawal by Subject|0
726623|NCT00264147|2337032|P3|Treatment II Period|Withdrawal by Subject|0
726624|NCT00264147|2337033|P2|Treatment II Period|Withdrawal by Subject|0
726625|NCT00264147|2337034|P1|Treatment II Period|Withdrawal by Subject|0
726626|NCT00264147|2337029|P6|Treatment II Period|Lost to Follow-up|1
726627|NCT00264147|2337030|P5|Treatment II Period|Lost to Follow-up|1
726628|NCT00264147|2337031|P4|Treatment II Period|Lost to Follow-up|0
726629|NCT00264147|2337032|P3|Treatment II Period|Lost to Follow-up|0
726630|NCT00264147|2337033|P2|Treatment II Period|Lost to Follow-up|0
726631|NCT00264147|2337034|P1|Treatment II Period|Lost to Follow-up|0
726632|NCT00264147|2337029|P6|Treatment II Period|Lack of Efficacy|19
726633|NCT00264147|2337030|P5|Treatment II Period|Lack of Efficacy|20
726634|NCT00264147|2337031|P4|Treatment II Period|Lack of Efficacy|0
726635|NCT00264147|2337032|P3|Treatment II Period|Lack of Efficacy|0
726636|NCT00264147|2337033|P2|Treatment II Period|Lack of Efficacy|0
726637|NCT00264147|2337034|P1|Treatment II Period|Lack of Efficacy|0
726638|NCT00264147|2337029|P6|Treatment II Period|Laboratory Adverse Event|1
726639|NCT00264147|2337030|P5|Treatment II Period|Laboratory Adverse Event|0
726640|NCT00264147|2337031|P4|Treatment II Period|Laboratory Adverse Event|0
726641|NCT00264147|2337032|P3|Treatment II Period|Laboratory Adverse Event|0
726642|NCT00264147|2337033|P2|Treatment II Period|Laboratory Adverse Event|0
726643|NCT00264147|2337034|P1|Treatment II Period|Laboratory Adverse Event|0
726644|NCT00264147|2337029|P6|Treatment II Period|Adverse Event|9
726645|NCT00264147|2337030|P5|Treatment II Period|Adverse Event|9
726646|NCT00264147|2337031|P4|Treatment II Period|Adverse Event|0
726647|NCT00264147|2337032|P3|Treatment II Period|Adverse Event|0
726648|NCT00264147|2337033|P2|Treatment II Period|Adverse Event|0
726649|NCT00264147|2337034|P1|Treatment II Period|Adverse Event|0
726650|NCT00264147|2337029|P6|Treatment I Period|Reassigned to Treatment II Period|0
726651|NCT00264147|2337030|P5|Treatment I Period|Reassigned to Treatment II Period|45
726652|NCT00264147|2337031|P4|Treatment I Period|Reassigned to Treatment II Period|63
726653|NCT00264147|2337032|P3|Treatment I Period|Reassigned to Treatment II Period|65
726654|NCT00264147|2337033|P2|Treatment I Period|Reassigned to Treatment II Period|72
726655|NCT00264147|2337034|P1|Treatment I Period|Reassigned to Treatment II Period|84
726656|NCT00264147|2337029|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
726657|NCT00264147|2337030|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
726658|NCT00264147|2337031|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
726659|NCT00264147|2337032|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
726660|NCT00264147|2337033|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
726661|NCT00264147|2337034|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
726662|NCT00264147|2337029|P6|Treatment I Period|Patient out of town for an extended time|0
726663|NCT00264147|2337030|P5|Treatment I Period|Patient out of town for an extended time|0
726664|NCT00264147|2337031|P4|Treatment I Period|Patient out of town for an extended time|0
726665|NCT00264147|2337032|P3|Treatment I Period|Patient out of town for an extended time|0
726666|NCT00264147|2337033|P2|Treatment I Period|Patient out of town for an extended time|1
726667|NCT00264147|2337034|P1|Treatment I Period|Patient out of town for an extended time|0
726668|NCT00264147|2337029|P6|Treatment I Period|Withdrawal by Subject|0
726669|NCT00264147|2337030|P5|Treatment I Period|Withdrawal by Subject|2
726670|NCT00264147|2337031|P4|Treatment I Period|Withdrawal by Subject|2
726671|NCT00264147|2337032|P3|Treatment I Period|Withdrawal by Subject|0
726672|NCT00264147|2337033|P2|Treatment I Period|Withdrawal by Subject|0
726673|NCT00264147|2337034|P1|Treatment I Period|Withdrawal by Subject|2
726674|NCT00264147|2337029|P6|Treatment I Period|Protocol Violation|0
726675|NCT00264147|2337030|P5|Treatment I Period|Protocol Violation|0
726676|NCT00264147|2337031|P4|Treatment I Period|Protocol Violation|0
726677|NCT00264147|2337032|P3|Treatment I Period|Protocol Violation|0
726678|NCT00264147|2337033|P2|Treatment I Period|Protocol Violation|2
726679|NCT00264147|2337034|P1|Treatment I Period|Protocol Violation|2
726680|NCT00264147|2337029|P6|Treatment I Period|Lost to Follow-up|0
726681|NCT00264147|2337030|P5|Treatment I Period|Lost to Follow-up|1
726682|NCT00264147|2337031|P4|Treatment I Period|Lost to Follow-up|1
726683|NCT00264147|2337032|P3|Treatment I Period|Lost to Follow-up|0
726684|NCT00264147|2337033|P2|Treatment I Period|Lost to Follow-up|0
726685|NCT00264147|2337034|P1|Treatment I Period|Lost to Follow-up|1
726686|NCT00264147|2337029|P6|Treatment I Period|Lack of Efficacy|0
726687|NCT00264147|2337030|P5|Treatment I Period|Lack of Efficacy|1
726688|NCT00264147|2337031|P4|Treatment I Period|Lack of Efficacy|0
726689|NCT00264147|2337032|P3|Treatment I Period|Lack of Efficacy|8
726690|NCT00264147|2337033|P2|Treatment I Period|Lack of Efficacy|2
726691|NCT00264147|2337034|P1|Treatment I Period|Lack of Efficacy|6
726692|NCT00264147|2337029|P6|Treatment I Period|Laboratory Adverse Event|0
726693|NCT00264147|2337030|P5|Treatment I Period|Laboratory Adverse Event|0
726694|NCT00264147|2337031|P4|Treatment I Period|Laboratory Adverse Event|1
726695|NCT00264147|2337032|P3|Treatment I Period|Laboratory Adverse Event|0
726696|NCT00264147|2337033|P2|Treatment I Period|Laboratory Adverse Event|0
726697|NCT00264147|2337034|P1|Treatment I Period|Laboratory Adverse Event|0
726698|NCT00264147|2337029|P6|Treatment I Period|Adverse Event|0
726699|NCT00264147|2337030|P5|Treatment I Period|Adverse Event|7
726700|NCT00264147|2337031|P4|Treatment I Period|Adverse Event|5
726701|NCT00264147|2337032|P3|Treatment I Period|Adverse Event|3
726702|NCT00264147|2337033|P2|Treatment I Period|Adverse Event|6
726703|NCT00264147|2337034|P1|Treatment I Period|Adverse Event|3
726704|NCT00264238|2337073|P1|Overall Study|Protocol Violation|1
726705|NCT00264290|2337082|P2|Intervention (8 Weeks)|Adverse Event|0
726706|NCT00264290|2337083|P1|Intervention (8 Weeks)|Adverse Event|1
726707|NCT00264303|2337091|P2|Overall Study|Various reasons listed in study report|7
726708|NCT00264303|2337092|P1|Overall Study|Various reasons listed in study report|6
726709|NCT00264303|2337091|P2|Overall Study|Withdrawal by Subject|3
726710|NCT00264303|2337092|P1|Overall Study|Withdrawal by Subject|2
726711|NCT00264303|2337091|P2|Overall Study|Lost to Follow-up|3
726712|NCT00264303|2337092|P1|Overall Study|Lost to Follow-up|3
726713|NCT00264303|2337091|P2|Overall Study|Lack of Efficacy|13
726714|NCT00264303|2337092|P1|Overall Study|Lack of Efficacy|10
726715|NCT00264303|2337091|P2|Overall Study|Adverse Event|3
726716|NCT00264303|2337092|P1|Overall Study|Adverse Event|4
726717|NCT00264498|2337125|P2|Crossover Treatment|Withdrawal by Subject|0
726718|NCT00264498|2337126|P1|Crossover Treatment|Withdrawal by Subject|1
726719|NCT00264498|2337125|P2|Crossover Treatment|Study closure|1
726720|NCT00264498|2337126|P1|Crossover Treatment|Study closure|0
726721|NCT00264498|2337125|P2|Crossover Treatment|Objective disease progression|5
726722|NCT00264498|2337126|P1|Crossover Treatment|Objective disease progression|4
726723|NCT00264498|2337125|P2|Crossover Treatment|Death|3
726724|NCT00264498|2337126|P1|Crossover Treatment|Death|1
726725|NCT00264498|2337125|P2|Randomized Treatment|Protocol Violation|0
726726|NCT00264498|2337126|P1|Randomized Treatment|Protocol Violation|1
726727|NCT00264498|2337125|P2|Randomized Treatment|Study Closure|0
726728|NCT00264498|2337126|P1|Randomized Treatment|Study Closure|1
726729|NCT00264498|2337125|P2|Randomized Treatment|Incorrectly randomized|0
726730|NCT00264498|2337126|P1|Randomized Treatment|Incorrectly randomized|1
726731|NCT00264498|2337125|P2|Randomized Treatment|Physician Decision|0
726732|NCT00264498|2337126|P1|Randomized Treatment|Physician Decision|1
726733|NCT00264498|2337125|P2|Randomized Treatment|Objective disease Progression|14
726734|NCT00264498|2337126|P1|Randomized Treatment|Objective disease Progression|13
726735|NCT00264498|2337125|P2|Randomized Treatment|Withdrawal by Subject|1
726736|NCT00264498|2337126|P1|Randomized Treatment|Withdrawal by Subject|0
726737|NCT00264498|2337125|P2|Randomized Treatment|Death|3
726738|NCT00264498|2337126|P1|Randomized Treatment|Death|0
726739|NCT00264537|2337136|P4|Overall Study|Not treated|0
726740|NCT00264537|2337137|P3|Overall Study|Not treated|1
726741|NCT00264537|2337138|P2|Overall Study|Not treated|2
726742|NCT00264537|2337139|P1|Overall Study|Not treated|0
726743|NCT00264537|2337136|P4|Overall Study|Not specified|11
726744|NCT00264537|2337137|P3|Overall Study|Not specified|10
726745|NCT00264537|2337138|P2|Overall Study|Not specified|11
726746|NCT00264537|2337139|P1|Overall Study|Not specified|21
726747|NCT00264537|2337136|P4|Overall Study|Unsatisfactory therapeutic effect|7
726748|NCT00264537|2337137|P3|Overall Study|Unsatisfactory therapeutic effect|5
726749|NCT00264537|2337138|P2|Overall Study|Unsatisfactory therapeutic effect|6
726750|NCT00264537|2337139|P1|Overall Study|Unsatisfactory therapeutic effect|5
726751|NCT00264537|2337136|P4|Overall Study|Adverse Event|34
726752|NCT00264537|2337137|P3|Overall Study|Adverse Event|24
726753|NCT00264537|2337138|P2|Overall Study|Adverse Event|32
726754|NCT00264537|2337139|P1|Overall Study|Adverse Event|21
726755|NCT00264537|2337136|P4|Overall Study|Lost to Follow-up|6
726756|NCT00264537|2337137|P3|Overall Study|Lost to Follow-up|7
726757|NCT00264537|2337138|P2|Overall Study|Lost to Follow-up|4
726758|NCT00264537|2337139|P1|Overall Study|Lost to Follow-up|3
726759|NCT00264537|2337136|P4|Overall Study|Death|2
726760|NCT00264537|2337137|P3|Overall Study|Death|3
726761|NCT00264537|2337138|P2|Overall Study|Death|3
726762|NCT00264537|2337139|P1|Overall Study|Death|0
726763|NCT00264550|2337173|P4|Overall Study|Not specified|9
726764|NCT00264550|2337174|P3|Overall Study|Not specified|3
726765|NCT00264550|2337175|P2|Overall Study|Not specified|7
726766|NCT00264550|2337176|P1|Overall Study|Not specified|13
726767|NCT00264550|2337173|P4|Overall Study|Discontinued oral study agent|0
726768|NCT00264550|2337174|P3|Overall Study|Discontinued oral study agent|0
726769|NCT00264550|2337175|P2|Overall Study|Discontinued oral study agent|1
726770|NCT00264550|2337176|P1|Overall Study|Discontinued oral study agent|0
726771|NCT00264550|2337173|P4|Overall Study|Unsatisfactory therapeutic effect|6
726772|NCT00264550|2337174|P3|Overall Study|Unsatisfactory therapeutic effect|4
726773|NCT00264550|2337175|P2|Overall Study|Unsatisfactory therapeutic effect|11
726774|NCT00264550|2337176|P1|Overall Study|Unsatisfactory therapeutic effect|4
726775|NCT00264550|2337173|P4|Overall Study|Adverse Event|14
726776|NCT00264550|2337174|P3|Overall Study|Adverse Event|9
726777|NCT00264550|2337175|P2|Overall Study|Adverse Event|18
726778|NCT00264550|2337176|P1|Overall Study|Adverse Event|23
726779|NCT00264550|2337173|P4|Overall Study|Lost to Follow-up|1
726780|NCT00264550|2337174|P3|Overall Study|Lost to Follow-up|1
726781|NCT00264550|2337175|P2|Overall Study|Lost to Follow-up|1
726782|NCT00264550|2337176|P1|Overall Study|Lost to Follow-up|3
726783|NCT00264550|2337173|P4|Overall Study|Death|0
726784|NCT00264550|2337174|P3|Overall Study|Death|0
726785|NCT00264550|2337175|P2|Overall Study|Death|3
726786|NCT00264550|2337176|P1|Overall Study|Death|0
726787|NCT00264576|2337213|P2|Overall Study|Lost to Follow-up|1
726788|NCT00264576|2337214|P1|Overall Study|Lost to Follow-up|1
726789|NCT00264797|2337244|P2|Overall Study|Other|4
726790|NCT00264797|2337245|P1|Overall Study|Other|3
726791|NCT00264797|2337244|P2|Overall Study|Feels treatment not necessary, not worki|1
726792|NCT00264797|2337245|P1|Overall Study|Feels treatment not necessary, not worki|0
726793|NCT00264797|2337244|P2|Overall Study|Pressure/advice from Outsiders|1
726794|NCT00264797|2337245|P1|Overall Study|Pressure/advice from Outsiders|1
726795|NCT00264797|2337244|P2|Overall Study|Incarceration|5
726796|NCT00264797|2337245|P1|Overall Study|Incarceration|4
726797|NCT00264797|2337244|P2|Overall Study|Practical Problems|3
726798|NCT00264797|2337245|P1|Overall Study|Practical Problems|2
726799|NCT00264797|2337244|P2|Overall Study|Moved from area|1
726800|NCT00264797|2337245|P1|Overall Study|Moved from area|3
726801|NCT00264797|2337244|P2|Overall Study|Lost to Follow-up|17
726802|NCT00264797|2337245|P1|Overall Study|Lost to Follow-up|9
726803|NCT00264797|2337244|P2|Overall Study|Withdrawal by Subject|11
726804|NCT00264797|2337245|P1|Overall Study|Withdrawal by Subject|11
726805|NCT00264810|2337259|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
726806|NCT00264810|2337260|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
726807|NCT00264810|2337259|P2|Open Label Evaluation Period|Death|2
726808|NCT00264810|2337260|P1|Open Label Evaluation Period|Death|3
726809|NCT00264810|2337259|P2|Open Label Evaluation Period|Explant due to infection|1
726810|NCT00264810|2337260|P1|Open Label Evaluation Period|Explant due to infection|1
726811|NCT00264810|2337259|P2|Blinded Evaluation Period|Explant due to infection|1
726812|NCT00264810|2337260|P1|Blinded Evaluation Period|Explant due to infection|1
726813|NCT00264810|2337259|P2|Stimulation Optimization Period|Death|1
726814|NCT00264810|2337260|P1|Stimulation Optimization Period|Death|0
726815|NCT00264810|2337259|P2|Stimulation Optimization Period|Withdrawal by Subject|0
726816|NCT00264810|2337260|P1|Stimulation Optimization Period|Withdrawal by Subject|1
726817|NCT00264810|2337259|P2|Baseline|Other|1
726818|NCT00264810|2337260|P1|Baseline|Other|0
726819|NCT00264810|2337259|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
726820|NCT00264810|2337260|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
726821|NCT00264810|2337259|P2|Baseline|Insufficient Seizure Frequency|2
726822|NCT00264810|2337260|P1|Baseline|Insufficient Seizure Frequency|2
726823|NCT00264810|2337259|P2|Baseline|Subject Compliance Failure|3
726824|NCT00264810|2337260|P1|Baseline|Subject Compliance Failure|3
726825|NCT00264810|2337259|P2|Baseline|Physician Decision|8
726826|NCT00264810|2337260|P1|Baseline|Physician Decision|7
726827|NCT00264810|2337259|P2|Baseline|Withdrawal by Subject|10
726828|NCT00264810|2337260|P1|Baseline|Withdrawal by Subject|10
726829|NCT00264849|2337270|P2|Overall Study|Administrative Problems|0
726830|NCT00264849|2337271|P1|Overall Study|Administrative Problems|2
726831|NCT00264849|2337270|P2|Overall Study|Death|1
726832|NCT00264849|2337271|P1|Overall Study|Death|0
726833|NCT00264849|2337270|P2|Overall Study|Lost to Follow-up|2
726834|NCT00264849|2337271|P1|Overall Study|Lost to Follow-up|0
726835|NCT00264849|2337270|P2|Overall Study|Lack of Efficacy|6
726836|NCT00264849|2337271|P1|Overall Study|Lack of Efficacy|1
726837|NCT00264849|2337270|P2|Overall Study|Protocol Violation|3
726838|NCT00264849|2337271|P1|Overall Study|Protocol Violation|5
726839|NCT00264849|2337270|P2|Overall Study|Withdrawal by Subject|11
726840|NCT00264849|2337271|P1|Overall Study|Withdrawal by Subject|7
726841|NCT00264849|2337270|P2|Overall Study|Adverse Event|2
726842|NCT00264849|2337271|P1|Overall Study|Adverse Event|7
726843|NCT00264875|2337305|P1|Overall Study|Withdrawal by Subject|7
726844|NCT00264875|2337305|P1|Overall Study|Protocol Violation|11
726845|NCT00264875|2337305|P1|Overall Study|Lost to Follow-up|6
726846|NCT00264875|2337305|P1|Overall Study|Adverse Event|6
726847|NCT00265083|2337312|P3|Overall Study|Not specified|9
726848|NCT00265083|2337313|P2|Overall Study|Not specified|12
726849|NCT00265083|2337314|P1|Overall Study|Not specified|1
726850|NCT00265083|2337312|P3|Overall Study|Unsatisfactory therapeutic effect|14
726851|NCT00265083|2337313|P2|Overall Study|Unsatisfactory therapeutic effect|13
726852|NCT00265083|2337314|P1|Overall Study|Unsatisfactory therapeutic effect|8
726853|NCT00265083|2337312|P3|Overall Study|Lost to Follow-up|4
726854|NCT00265083|2337313|P2|Overall Study|Lost to Follow-up|4
726855|NCT00265083|2337314|P1|Overall Study|Lost to Follow-up|3
726856|NCT00265083|2337312|P3|Overall Study|Adverse Event|15
726857|NCT00265083|2337313|P2|Overall Study|Adverse Event|13
726858|NCT00265083|2337314|P1|Overall Study|Adverse Event|5
726859|NCT00265096|2337338|P3|Overall Study|Not Specified|10
726860|NCT00265096|2337339|P2|Overall Study|Not Specified|19
726861|NCT00265096|2337340|P1|Overall Study|Not Specified|11
726862|NCT00265096|2337338|P3|Overall Study|Unsatisfactory therapeutic effect|6
726863|NCT00265096|2337339|P2|Overall Study|Unsatisfactory therapeutic effect|8
726864|NCT00265096|2337340|P1|Overall Study|Unsatisfactory therapeutic effect|9
726865|NCT00265096|2337338|P3|Overall Study|Death|2
726866|NCT00265096|2337339|P2|Overall Study|Death|1
726867|NCT00265096|2337340|P1|Overall Study|Death|0
726868|NCT00265096|2337338|P3|Overall Study|Lost to Follow-up|3
726869|NCT00265096|2337339|P2|Overall Study|Lost to Follow-up|5
726870|NCT00265096|2337340|P1|Overall Study|Lost to Follow-up|2
726871|NCT00265096|2337338|P3|Overall Study|Adverse Event|18
726872|NCT00265096|2337339|P2|Overall Study|Adverse Event|18
726873|NCT00265096|2337340|P1|Overall Study|Adverse Event|14
726874|NCT00265109|2337369|P1|Overall Study|Adverse Event|1
726875|NCT00265109|2337369|P1|Overall Study|Withdrawal by Subject|5
726876|NCT00265122|2337379|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
726877|NCT00265122|2337380|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
726878|NCT00265122|2337381|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
726879|NCT00265122|2337382|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
726880|NCT00265122|2337383|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
726881|NCT00265122|2337384|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
726882|NCT00265122|2337379|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
726883|NCT00265122|2337380|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
726884|NCT00265122|2337381|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
726885|NCT00265122|2337382|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
726886|NCT00265122|2337383|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
726887|NCT00265122|2337384|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
726888|NCT00265122|2337379|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
726889|NCT00265122|2337380|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
726890|NCT00265122|2337381|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
726891|NCT00265122|2337382|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
726892|NCT00265122|2337383|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
726893|NCT00265122|2337384|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
726894|NCT00265122|2337379|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
726895|NCT00265122|2337380|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
726896|NCT00265122|2337381|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
726897|NCT00265122|2337382|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
726898|NCT00265122|2337383|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
726899|NCT00265122|2337384|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
726900|NCT00265122|2337379|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
726901|NCT00265122|2337380|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
726902|NCT00265122|2337381|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
726903|NCT00265122|2337382|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
726904|NCT00265122|2337383|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
726905|NCT00265122|2337384|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
726906|NCT00265122|2337379|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
726907|NCT00265122|2337380|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
726908|NCT00265122|2337381|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
726909|NCT00265122|2337382|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
726910|NCT00265122|2337383|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
726911|NCT00265122|2337384|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
726912|NCT00265239|2337412|P2|Overall Study|Adverse Event|1
726913|NCT00265239|2337413|P1|Overall Study|Adverse Event|2
726914|NCT00265317|2337429|P4|Phase 2|Unspecified|1
726915|NCT00265317|2337430|P3|Phase 2|Unspecified|1
726916|NCT00265317|2337431|P2|Phase 2|Unspecified|0
726917|NCT00265317|2337432|P1|Phase 2|Unspecified|0
726918|NCT00265317|2337429|P4|Phase 2|Study terminated by sponsor|0
726919|NCT00265317|2337430|P3|Phase 2|Study terminated by sponsor|1
726920|NCT00265317|2337431|P2|Phase 2|Study terminated by sponsor|0
726921|NCT00265317|2337432|P1|Phase 2|Study terminated by sponsor|0
726922|NCT00265317|2337429|P4|Phase 2|Withdrawal/other than adverse event|1
726923|NCT00265317|2337430|P3|Phase 2|Withdrawal/other than adverse event|2
726924|NCT00265317|2337431|P2|Phase 2|Withdrawal/other than adverse event|0
726925|NCT00265317|2337432|P1|Phase 2|Withdrawal/other than adverse event|0
726926|NCT00265317|2337429|P4|Phase 2|Lost to Follow-up|1
726927|NCT00265317|2337430|P3|Phase 2|Lost to Follow-up|0
726928|NCT00265317|2337431|P2|Phase 2|Lost to Follow-up|0
726929|NCT00265317|2337432|P1|Phase 2|Lost to Follow-up|0
726930|NCT00265317|2337429|P4|Phase 2|Protocol Violation|4
726931|NCT00265317|2337430|P3|Phase 2|Protocol Violation|1
726932|NCT00265317|2337431|P2|Phase 2|Protocol Violation|0
726933|NCT00265317|2337432|P1|Phase 2|Protocol Violation|0
726934|NCT00265317|2337429|P4|Phase 2|Death|15
726935|NCT00265317|2337430|P3|Phase 2|Death|12
726936|NCT00265317|2337431|P2|Phase 2|Death|0
726937|NCT00265317|2337432|P1|Phase 2|Death|0
726938|NCT00265317|2337429|P4|Phase 2|Adverse Event|5
726939|NCT00265317|2337430|P3|Phase 2|Adverse Event|7
726940|NCT00265317|2337431|P2|Phase 2|Adverse Event|0
726941|NCT00265317|2337432|P1|Phase 2|Adverse Event|0
726942|NCT00265317|2337429|P4|Phase 2|Global deterioration of health status|0
726943|NCT00265317|2337430|P3|Phase 2|Global deterioration of health status|3
726944|NCT00265317|2337431|P2|Phase 2|Global deterioration of health status|0
726945|NCT00265317|2337432|P1|Phase 2|Global deterioration of health status|0
726946|NCT00265317|2337429|P4|Phase 2|Objective progression or relapse|38
726947|NCT00265317|2337430|P3|Phase 2|Objective progression or relapse|37
726948|NCT00265317|2337431|P2|Phase 2|Objective progression or relapse|0
726949|NCT00265317|2337432|P1|Phase 2|Objective progression or relapse|0
726950|NCT00265317|2337429|P4|Lead-In|Withdrawal/other than adverse event|0
726951|NCT00265317|2337430|P3|Lead-In|Withdrawal/other than adverse event|0
726952|NCT00265317|2337431|P2|Lead-In|Withdrawal/other than adverse event|0
726953|NCT00265317|2337432|P1|Lead-In|Withdrawal/other than adverse event|1
726954|NCT00265317|2337429|P4|Lead-In|Death|0
726955|NCT00265317|2337430|P3|Lead-In|Death|0
726956|NCT00265317|2337431|P2|Lead-In|Death|5
726957|NCT00265317|2337432|P1|Lead-In|Death|3
726958|NCT00265317|2337429|P4|Lead-In|Adverse Event|0
726959|NCT00265317|2337430|P3|Lead-In|Adverse Event|0
726960|NCT00265317|2337431|P2|Lead-In|Adverse Event|1
726961|NCT00265317|2337432|P1|Lead-In|Adverse Event|2
726962|NCT00265317|2337429|P4|Lead-In|Objective progression or relapse|0
726963|NCT00265317|2337430|P3|Lead-In|Objective progression or relapse|0
726964|NCT00265317|2337431|P2|Lead-In|Objective progression or relapse|11
726965|NCT00265317|2337432|P1|Lead-In|Objective progression or relapse|6
726966|NCT00265330|2337545|P1|Overall Study|Protocol Violation|1
726967|NCT00265330|2337545|P1|Overall Study|Withdrew Consent|1
726968|NCT00265330|2337545|P1|Overall Study|Principal Investigators Request|1
726969|NCT00265330|2337545|P1|Overall Study|Site Closed by Sponsor|1
726970|NCT00265330|2337545|P1|Overall Study|Discharged from Unit for Long Term Care|1
726971|NCT00265330|2337545|P1|Overall Study|Began Taking Formulary Geodon|1
726972|NCT00265330|2337545|P1|Overall Study|Family Scheduling Conflicts|1
726973|NCT00265330|2337545|P1|Overall Study|Lack of Efficacy|4
726974|NCT00265330|2337545|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
726975|NCT00265330|2337545|P1|Overall Study|Withdrawal by Subject|34
726976|NCT00265330|2337545|P1|Overall Study|Lost to Follow-up|8
726977|NCT00265330|2337545|P1|Overall Study|Adverse Event|41
726978|NCT00265343|2337569|P2|Overall Study|Other|3
726979|NCT00265343|2337570|P1|Overall Study|Other|8
726980|NCT00265343|2337569|P2|Overall Study|Withdrawal by Subject|9
726981|NCT00265343|2337570|P1|Overall Study|Withdrawal by Subject|3
726982|NCT00265343|2337569|P2|Overall Study|Adverse Event|7
726983|NCT00265343|2337570|P1|Overall Study|Adverse Event|10
726984|NCT00265382|2337578|P1|Overall Study|Death|1
726985|NCT00265382|2337578|P1|Overall Study|Study terminated by sponsor|94
726986|NCT00265382|2337578|P1|Overall Study|Withdrawal by Subject|13
726987|NCT00265382|2337578|P1|Overall Study|Miscellaneous|6
726988|NCT00265382|2337578|P1|Overall Study|Lack of Efficacy|6
726989|NCT00265382|2337578|P1|Overall Study|Lost to Follow-up|3
726990|NCT00265382|2337578|P1|Overall Study|Laboratory Abnormality|1
726991|NCT00265382|2337578|P1|Overall Study|Adverse Event|21
726992|NCT00265395|2337598|P2|Overall Study|Administrative|1
726993|NCT00265395|2337599|P1|Overall Study|Administrative|0
726994|NCT00265395|2337598|P2|Overall Study|Lack of Efficacy|1
726995|NCT00265395|2337599|P1|Overall Study|Lack of Efficacy|0
726996|NCT00265395|2337598|P2|Overall Study|Protocol Violation|2
726997|NCT00265395|2337599|P1|Overall Study|Protocol Violation|2
726998|NCT00265395|2337598|P2|Overall Study|Withdrawal by Subject|6
726999|NCT00265395|2337599|P1|Overall Study|Withdrawal by Subject|1
727000|NCT00265395|2337598|P2|Overall Study|Lost to Follow-up|1
727001|NCT00265395|2337599|P1|Overall Study|Lost to Follow-up|2
727002|NCT00265395|2337598|P2|Overall Study|Adverse Event|6
727003|NCT00265395|2337599|P1|Overall Study|Adverse Event|3
727004|NCT00265759|2337646|P4|Overall Study|Discontinued due to intolerability|1
727005|NCT00265759|2337647|P3|Overall Study|Discontinued due to intolerability|0
727006|NCT00265759|2337648|P2|Overall Study|Discontinued due to intolerability|0
727007|NCT00265759|2337649|P1|Overall Study|Discontinued due to intolerability|0
727008|NCT00265759|2337646|P4|Overall Study|Bilateral disease|2
727009|NCT00265759|2337647|P3|Overall Study|Bilateral disease|0
727010|NCT00265759|2337648|P2|Overall Study|Bilateral disease|0
727011|NCT00265759|2337649|P1|Overall Study|Bilateral disease|0
727012|NCT00265759|2337646|P4|Overall Study|Ineligible|1
727013|NCT00265759|2337647|P3|Overall Study|Ineligible|0
727014|NCT00265759|2337648|P2|Overall Study|Ineligible|0
727015|NCT00265759|2337649|P1|Overall Study|Ineligible|0
727016|NCT00265759|2337646|P4|Overall Study|Cancel|3
727017|NCT00265759|2337647|P3|Overall Study|Cancel|0
727018|NCT00265759|2337648|P2|Overall Study|Cancel|0
727019|NCT00265759|2337649|P1|Overall Study|Cancel|0
727020|NCT00265759|2337646|P4|Overall Study|Withdrawal by Subject|2
727021|NCT00265759|2337647|P3|Overall Study|Withdrawal by Subject|2
727022|NCT00265759|2337648|P2|Overall Study|Withdrawal by Subject|1
727023|NCT00265759|2337649|P1|Overall Study|Withdrawal by Subject|0
727024|NCT00265785|2337678|P1|Overall Study|Did not receive protocol treatment|2
727025|NCT00265785|2337678|P1|Overall Study|Ineligible|1
727026|NCT00265785|2337678|P1|Overall Study|Not protocol specified|2
727027|NCT00265785|2337678|P1|Overall Study|Progression/Relapse|15
727028|NCT00265785|2337678|P1|Overall Study|Withdrawal by Subject|3
727029|NCT00265785|2337678|P1|Overall Study|Adverse Event|4
727030|NCT00265889|2337706|P1|Overall Study|Insurance denied the request|3
727031|NCT00265889|2337706|P1|Overall Study|Protocol Violation|1
727032|NCT00265889|2337706|P1|Overall Study|Physician Decision|1
727033|NCT00266032|2337715|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
727034|NCT00266032|2337716|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
727035|NCT00266032|2337717|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
727036|NCT00266032|2337715|P3|Open-label Safety Extension|Withdrawal by Subject|12
727037|NCT00266032|2337716|P2|Open-label Safety Extension|Withdrawal by Subject|3
727038|NCT00266032|2337717|P1|Open-label Safety Extension|Withdrawal by Subject|19
727039|NCT00266032|2337715|P3|Open-label Safety Extension|Protocol Violation|2
727040|NCT00266032|2337716|P2|Open-label Safety Extension|Protocol Violation|3
727041|NCT00266032|2337717|P1|Open-label Safety Extension|Protocol Violation|1
727042|NCT00266032|2337715|P3|Open-label Safety Extension|Pregnancy|2
727043|NCT00266032|2337716|P2|Open-label Safety Extension|Pregnancy|1
727044|NCT00266032|2337717|P1|Open-label Safety Extension|Pregnancy|4
727045|NCT00266032|2337715|P3|Open-label Safety Extension|Lost to Follow-up|4
727046|NCT00266032|2337716|P2|Open-label Safety Extension|Lost to Follow-up|5
727047|NCT00266032|2337717|P1|Open-label Safety Extension|Lost to Follow-up|2
727048|NCT00266032|2337715|P3|Open-label Safety Extension|Adverse Event|4
727049|NCT00266032|2337716|P2|Open-label Safety Extension|Adverse Event|0
727050|NCT00266032|2337717|P1|Open-label Safety Extension|Adverse Event|5
727051|NCT00266032|2337715|P3|Treatment|patient moved/wish for pregnancy/no need|8
727052|NCT00266032|2337716|P2|Treatment|patient moved/wish for pregnancy/no need|5
727053|NCT00266032|2337717|P1|Treatment|patient moved/wish for pregnancy/no need|13
727054|NCT00266032|2337715|P3|Treatment|Withdrawal by Subject|12
727055|NCT00266032|2337716|P2|Treatment|Withdrawal by Subject|13
727056|NCT00266032|2337717|P1|Treatment|Withdrawal by Subject|28
727057|NCT00266032|2337715|P3|Treatment|Protocol Violation|13
727058|NCT00266032|2337716|P2|Treatment|Protocol Violation|14
727059|NCT00266032|2337717|P1|Treatment|Protocol Violation|6
727060|NCT00266032|2337715|P3|Treatment|Pregnancy|2
727061|NCT00266032|2337716|P2|Treatment|Pregnancy|2
727062|NCT00266032|2337717|P1|Treatment|Pregnancy|3
727063|NCT00266032|2337715|P3|Treatment|Lost to Follow-up|2
727064|NCT00266032|2337716|P2|Treatment|Lost to Follow-up|4
727065|NCT00266032|2337717|P1|Treatment|Lost to Follow-up|19
727066|NCT00266032|2337715|P3|Treatment|Adverse Event|10
727067|NCT00266032|2337716|P2|Treatment|Adverse Event|26
727068|NCT00266032|2337717|P1|Treatment|Adverse Event|42
727069|NCT00266227|2337751|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
727070|NCT00266227|2337752|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
727071|NCT00266227|2337753|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
727072|NCT00266227|2337751|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
727073|NCT00266227|2337752|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
727074|NCT00266227|2337753|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
727075|NCT00266227|2337751|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
727076|NCT00266227|2337752|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
727077|NCT00266227|2337753|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
727078|NCT00266227|2337751|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
727079|NCT00266227|2337752|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
727080|NCT00266227|2337753|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
727081|NCT00266227|2337751|P3|Retreatment: Week 48 to Week 72|Death|0
727082|NCT00266227|2337752|P2|Retreatment: Week 48 to Week 72|Death|1
727083|NCT00266227|2337753|P1|Retreatment: Week 48 to Week 72|Death|1
727084|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Pregnancy|0
727085|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Pregnancy|0
727086|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Pregnancy|1
727087|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
727088|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
727089|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
727090|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
727091|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
727092|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
727093|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
727094|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
727095|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
727096|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Adverse Event|0
727097|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Adverse Event|7
727098|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Adverse Event|7
727099|NCT00266227|2337751|P3|Retreatment: Up to Week 48|Death|0
727100|NCT00266227|2337752|P2|Retreatment: Up to Week 48|Death|0
727101|NCT00266227|2337753|P1|Retreatment: Up to Week 48|Death|1
727102|NCT00266227|2337751|P3|Initial Treatment|Pregnancy|1
727103|NCT00266227|2337752|P2|Initial Treatment|Pregnancy|0
727104|NCT00266227|2337753|P1|Initial Treatment|Pregnancy|0
727105|NCT00266227|2337751|P3|Initial Treatment|Physician decision to withdraw|12
727106|NCT00266227|2337752|P2|Initial Treatment|Physician decision to withdraw|0
727107|NCT00266227|2337753|P1|Initial Treatment|Physician decision to withdraw|0
727108|NCT00266227|2337751|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
727109|NCT00266227|2337752|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
727110|NCT00266227|2337753|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
727111|NCT00266227|2337751|P3|Initial Treatment|Lost to Follow-up|6
727112|NCT00266227|2337752|P2|Initial Treatment|Lost to Follow-up|0
727113|NCT00266227|2337753|P1|Initial Treatment|Lost to Follow-up|0
727114|NCT00266227|2337751|P3|Initial Treatment|Adverse Event|13
727115|NCT00266227|2337752|P2|Initial Treatment|Adverse Event|0
727116|NCT00266227|2337753|P1|Initial Treatment|Adverse Event|0
727117|NCT00256204|2337827|P4|Overall Study|Need for additional prohibited treatment|25
727118|NCT00256204|2337828|P3|Overall Study|Need for additional prohibited treatment|27
727119|NCT00256204|2337829|P2|Overall Study|Need for additional prohibited treatment|28
727120|NCT00256204|2337830|P1|Overall Study|Need for additional prohibited treatment|38
727121|NCT00256204|2337827|P4|Overall Study|Withdrawal by Subject|5
727122|NCT00256204|2337828|P3|Overall Study|Withdrawal by Subject|7
727123|NCT00256204|2337829|P2|Overall Study|Withdrawal by Subject|6
727124|NCT00256204|2337830|P1|Overall Study|Withdrawal by Subject|17
727125|NCT00256204|2337827|P4|Overall Study|Physician Decision|2
727126|NCT00256204|2337828|P3|Overall Study|Physician Decision|1
727127|NCT00256204|2337829|P2|Overall Study|Physician Decision|0
727128|NCT00256204|2337830|P1|Overall Study|Physician Decision|0
727129|NCT00256204|2337827|P4|Overall Study|Protocol Violation|1
727130|NCT00256204|2337828|P3|Overall Study|Protocol Violation|2
727131|NCT00256204|2337829|P2|Overall Study|Protocol Violation|0
727132|NCT00256204|2337830|P1|Overall Study|Protocol Violation|1
727133|NCT00256204|2337827|P4|Overall Study|Lost to Follow-up|2
727134|NCT00256204|2337828|P3|Overall Study|Lost to Follow-up|1
727135|NCT00256204|2337829|P2|Overall Study|Lost to Follow-up|1
727136|NCT00256204|2337830|P1|Overall Study|Lost to Follow-up|1
727137|NCT00256204|2337827|P4|Overall Study|Death|0
727138|NCT00256204|2337828|P3|Overall Study|Death|0
727139|NCT00256204|2337829|P2|Overall Study|Death|1
727140|NCT00256204|2337830|P1|Overall Study|Death|0
727141|NCT00256204|2337827|P4|Overall Study|Adverse Event|14
727142|NCT00256204|2337828|P3|Overall Study|Adverse Event|16
727143|NCT00256204|2337829|P2|Overall Study|Adverse Event|14
727144|NCT00256204|2337830|P1|Overall Study|Adverse Event|10
727145|NCT00256243|2337843|P1|Overall Study|Not treated|1
727146|NCT00256243|2337843|P1|Overall Study|Death|7
727147|NCT00256243|2337843|P1|Overall Study|Lost to Follow-up|2
727148|NCT00256295|2337848|P1|Overall Study|Death|1
727149|NCT00256295|2337848|P1|Overall Study|Withdrawal by Subject|3
727150|NCT00256698|2337856|P2|Overall Study|Prematurely Discontinued|0
727151|NCT00256698|2337857|P1|Overall Study|Prematurely Discontinued|1
727152|NCT00256698|2337856|P2|Overall Study|withdrawn due to osteoporosis|0
727153|NCT00256698|2337857|P1|Overall Study|withdrawn due to osteoporosis|1
727154|NCT00256698|2337856|P2|Overall Study|still ongoing at data cut-off|46
727155|NCT00256698|2337857|P1|Overall Study|still ongoing at data cut-off|41
727156|NCT00256698|2337856|P2|Overall Study|disease progression|105
727157|NCT00256698|2337857|P1|Overall Study|disease progression|97
727158|NCT00256698|2337856|P2|Overall Study|Lost to Follow-up|3
727159|NCT00256698|2337857|P1|Overall Study|Lost to Follow-up|1
727160|NCT00256698|2337856|P2|Overall Study|Protocol Violation|5
727161|NCT00256698|2337857|P1|Overall Study|Protocol Violation|6
727162|NCT00256698|2337856|P2|Overall Study|Adverse Event|6
727163|NCT00256698|2337857|P1|Overall Study|Adverse Event|13
727164|NCT00256698|2337856|P2|Overall Study|Withdrawal by Subject|7
727165|NCT00256698|2337857|P1|Overall Study|Withdrawal by Subject|7
727166|NCT00256724|2337877|P2|Overall Study|Protocol Violation|3
727167|NCT00256724|2337878|P1|Overall Study|Protocol Violation|3
727168|NCT00256724|2337877|P2|Overall Study|Physician Decision|5
727169|NCT00256724|2337878|P1|Overall Study|Physician Decision|2
890462|NCT00984659|2825628|P2|6-week Double-blind Treatment Period|Adverse Event|3
890463|NCT00984659|2825629|P1|6-week Double-blind Treatment Period|Adverse Event|0
890464|NCT00984659|2825626|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
890465|NCT00984659|2825627|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
890466|NCT00984659|2825628|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
890467|NCT00984659|2825629|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
890468|NCT00984659|2825626|P4|2-week Run-in Period|Withdrawal by Subject|0
890469|NCT00984659|2825627|P3|2-week Run-in Period|Withdrawal by Subject|0
890470|NCT00984659|2825628|P2|2-week Run-in Period|Withdrawal by Subject|0
890471|NCT00984659|2825629|P1|2-week Run-in Period|Withdrawal by Subject|10
890472|NCT00984659|2825626|P4|2-week Run-in Period|Physician Decision|0
890473|NCT00984659|2825627|P3|2-week Run-in Period|Physician Decision|0
890474|NCT00984659|2825628|P2|2-week Run-in Period|Physician Decision|0
890475|NCT00984659|2825629|P1|2-week Run-in Period|Physician Decision|10
890476|NCT00984659|2825626|P4|2-week Run-in Period|Lost to Follow-up|0
890477|NCT00984659|2825627|P3|2-week Run-in Period|Lost to Follow-up|0
890478|NCT00984659|2825628|P2|2-week Run-in Period|Lost to Follow-up|0
890479|NCT00984659|2825629|P1|2-week Run-in Period|Lost to Follow-up|3
890480|NCT00984659|2825626|P4|2-week Run-in Period|Study Closed/Terminated|0
890481|NCT00984659|2825627|P3|2-week Run-in Period|Study Closed/Terminated|0
890482|NCT00984659|2825628|P2|2-week Run-in Period|Study Closed/Terminated|0
890483|NCT00984659|2825629|P1|2-week Run-in Period|Study Closed/Terminated|2
890484|NCT00984659|2825626|P4|2-week Run-in Period|Protocol Violation|0
890485|NCT00984659|2825627|P3|2-week Run-in Period|Protocol Violation|0
890486|NCT00984659|2825628|P2|2-week Run-in Period|Protocol Violation|0
890487|NCT00984659|2825629|P1|2-week Run-in Period|Protocol Violation|5
890488|NCT00984659|2825626|P4|2-week Run-in Period|Adverse Event|0
890489|NCT00984659|2825627|P3|2-week Run-in Period|Adverse Event|0
890490|NCT00984659|2825628|P2|2-week Run-in Period|Adverse Event|0
890491|NCT00984659|2825629|P1|2-week Run-in Period|Adverse Event|8
890492|NCT00968864|2825676|P1|Overall Study|Protocol exception/ not evaluable|1
890497|NCT00950807|2825715|P10|Treatment Period 3|Adverse Event|0
890498|NCT00950807|2825716|P9|Treatment Period 3|Adverse Event|0
890499|NCT00950807|2825717|P8|Treatment Period 3|Adverse Event|0
890500|NCT00950807|2825718|P7|Treatment Period 3|Adverse Event|1
890501|NCT00950807|2825719|P6|Treatment Period 3|Adverse Event|0
890502|NCT00950807|2825720|P5|Treatment Period 3|Adverse Event|0
890503|NCT00950807|2825721|P4|Treatment Period 3|Adverse Event|0
890504|NCT00950807|2825722|P3|Treatment Period 3|Adverse Event|0
890505|NCT00950807|2825723|P2|Treatment Period 3|Adverse Event|0
890506|NCT00950807|2825724|P1|Treatment Period 3|Adverse Event|0
890507|NCT00950807|2825715|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
890508|NCT00950807|2825716|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
890509|NCT00950807|2825717|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
890510|NCT00950807|2825718|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
890511|NCT00950807|2825719|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
890512|NCT00950807|2825720|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
890513|NCT00950807|2825721|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
890514|NCT00950807|2825722|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
890515|NCT00950807|2825723|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
890516|NCT00950807|2825724|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
890517|NCT00950807|2825715|P10|Treatment Period 3|Withdrawal by Subject|1
890518|NCT00950807|2825716|P9|Treatment Period 3|Withdrawal by Subject|0
890519|NCT00950807|2825717|P8|Treatment Period 3|Withdrawal by Subject|0
890520|NCT00950807|2825718|P7|Treatment Period 3|Withdrawal by Subject|0
890521|NCT00950807|2825719|P6|Treatment Period 3|Withdrawal by Subject|0
890522|NCT00950807|2825720|P5|Treatment Period 3|Withdrawal by Subject|0
890523|NCT00950807|2825721|P4|Treatment Period 3|Withdrawal by Subject|0
890524|NCT00950807|2825722|P3|Treatment Period 3|Withdrawal by Subject|0
890525|NCT00950807|2825723|P2|Treatment Period 3|Withdrawal by Subject|0
890526|NCT00950807|2825724|P1|Treatment Period 3|Withdrawal by Subject|0
890527|NCT00950807|2825715|P10|Washout Period 2|Adverse Event|0
890528|NCT00950807|2825716|P9|Washout Period 2|Adverse Event|0
890529|NCT00950807|2825717|P8|Washout Period 2|Adverse Event|0
890530|NCT00950807|2825718|P7|Washout Period 2|Adverse Event|0
890531|NCT00950807|2825719|P6|Washout Period 2|Adverse Event|0
890532|NCT00950807|2825720|P5|Washout Period 2|Adverse Event|0
890533|NCT00950807|2825721|P4|Washout Period 2|Adverse Event|1
890534|NCT00950807|2825722|P3|Washout Period 2|Adverse Event|0
890535|NCT00950807|2825723|P2|Washout Period 2|Adverse Event|0
890536|NCT00950807|2825724|P1|Washout Period 2|Adverse Event|3
890537|NCT00950807|2825715|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
890538|NCT00950807|2825716|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
890539|NCT00950807|2825717|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
890540|NCT00950807|2825718|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
890541|NCT00950807|2825719|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
890542|NCT00950807|2825720|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
890543|NCT00950807|2825721|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
890544|NCT00950807|2825722|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
890545|NCT00950807|2825723|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
890546|NCT00950807|2825724|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
890547|NCT00950807|2825715|P10|Washout Period 2|Lack of Efficacy|0
890548|NCT00950807|2825716|P9|Washout Period 2|Lack of Efficacy|0
890549|NCT00950807|2825717|P8|Washout Period 2|Lack of Efficacy|0
890550|NCT00950807|2825718|P7|Washout Period 2|Lack of Efficacy|0
890551|NCT00950807|2825719|P6|Washout Period 2|Lack of Efficacy|0
890552|NCT00950807|2825720|P5|Washout Period 2|Lack of Efficacy|0
890553|NCT00950807|2825721|P4|Washout Period 2|Lack of Efficacy|0
890554|NCT00950807|2825722|P3|Washout Period 2|Lack of Efficacy|0
890555|NCT00950807|2825723|P2|Washout Period 2|Lack of Efficacy|0
890556|NCT00950807|2825724|P1|Washout Period 2|Lack of Efficacy|1
890557|NCT00950807|2825715|P10|Treatment Period 2|Adverse Event|0
890558|NCT00950807|2825716|P9|Treatment Period 2|Adverse Event|0
890559|NCT00950807|2825717|P8|Treatment Period 2|Adverse Event|1
890560|NCT00950807|2825718|P7|Treatment Period 2|Adverse Event|0
727263|NCT00256997|2338037|P2|Overall Study|Investigator Withdrew Participant|1
727264|NCT00256997|2338038|P1|Overall Study|Investigator Withdrew Participant|2
727265|NCT00256997|2338037|P2|Overall Study|Participant Non-compliant|6
727266|NCT00256997|2338038|P1|Overall Study|Participant Non-compliant|3
727267|NCT00256997|2338037|P2|Overall Study|End of Study (As Per Sponsor)|24
727268|NCT00256997|2338038|P1|Overall Study|End of Study (As Per Sponsor)|12
727269|NCT00256997|2338037|P2|Overall Study|Unspecified|8
727270|NCT00256997|2338038|P1|Overall Study|Unspecified|5
727271|NCT00256997|2338037|P2|Overall Study|Started but not treated|0
727272|NCT00256997|2338038|P1|Overall Study|Started but not treated|2
727273|NCT00256997|2338037|P2|Overall Study|Withdrawal by Subject|3
727274|NCT00256997|2338038|P1|Overall Study|Withdrawal by Subject|13
727275|NCT00256997|2338037|P2|Overall Study|Lost to Follow-up|5
727276|NCT00256997|2338038|P1|Overall Study|Lost to Follow-up|3
727277|NCT00256997|2338037|P2|Overall Study|Adverse Event|0
727278|NCT00256997|2338038|P1|Overall Study|Adverse Event|4
727279|NCT00256997|2338037|P2|Overall Study|Death|0
727280|NCT00256997|2338038|P1|Overall Study|Death|2
727281|NCT00256997|2338037|P2|Overall Study|Lack of Efficacy|4
727282|NCT00256997|2338038|P1|Overall Study|Lack of Efficacy|1
727283|NCT00256997|2338037|P2|Overall Study|Protocol Violation|4
727284|NCT00256997|2338038|P1|Overall Study|Protocol Violation|1
727285|NCT00257010|2338062|P1|Overall Study|no headache reported|9
727286|NCT00257010|2338062|P1|Overall Study|various|11
727287|NCT00257010|2338062|P1|Overall Study|Adverse Event|10
727288|NCT00257010|2338062|P1|Overall Study|Withdrawal by Subject|34
727289|NCT00257010|2338062|P1|Overall Study|Lost to Follow-up|53
727290|NCT00257010|2338062|P1|Overall Study|Lack of Efficacy|11
727291|NCT00257166|2338073|P2|Overall Study|Randomized, but not treated|0
727292|NCT00257166|2338074|P1|Overall Study|Randomized, but not treated|1
727293|NCT00257166|2338073|P2|Overall Study|Unspecified|21
727294|NCT00257166|2338074|P1|Overall Study|Unspecified|16
727295|NCT00257166|2338073|P2|Overall Study|Withdrawal by Subject|2
727296|NCT00257166|2338074|P1|Overall Study|Withdrawal by Subject|9
727297|NCT00257166|2338073|P2|Overall Study|Lost to Follow-up|1
727298|NCT00257166|2338074|P1|Overall Study|Lost to Follow-up|8
727299|NCT00257166|2338073|P2|Overall Study|Laboratory abnormality|0
727300|NCT00257166|2338074|P1|Overall Study|Laboratory abnormality|1
727301|NCT00257166|2338073|P2|Overall Study|Adverse Event|13
727302|NCT00257166|2338074|P1|Overall Study|Adverse Event|18
727303|NCT00257192|2338088|P2|Overall Study|Miscellaneous|4
727304|NCT00257192|2338089|P1|Overall Study|Miscellaneous|0
727305|NCT00257192|2338088|P2|Overall Study|Study terminated by sponsor|0
890561|NCT00950807|2825719|P6|Treatment Period 2|Adverse Event|1
890562|NCT00950807|2825720|P5|Treatment Period 2|Adverse Event|0
890563|NCT00950807|2825721|P4|Treatment Period 2|Adverse Event|1
890564|NCT00950807|2825722|P3|Treatment Period 2|Adverse Event|0
727306|NCT00257192|2338089|P1|Overall Study|Study terminated by sponsor|1
727307|NCT00257192|2338088|P2|Overall Study|Randomized but not treated|1
727308|NCT00257192|2338089|P1|Overall Study|Randomized but not treated|0
727309|NCT00257192|2338088|P2|Overall Study|Withdrawal by Subject|2
727310|NCT00257192|2338089|P1|Overall Study|Withdrawal by Subject|14
727311|NCT00257192|2338088|P2|Overall Study|Insufficient clinical response|18
727312|NCT00257192|2338089|P1|Overall Study|Insufficient clinical response|18
727313|NCT00257192|2338088|P2|Overall Study|Lost to Follow-up|3
727314|NCT00257192|2338089|P1|Overall Study|Lost to Follow-up|3
727315|NCT00257192|2338088|P2|Overall Study|Laboratory abnormality|1
727316|NCT00257192|2338089|P1|Overall Study|Laboratory abnormality|1
727317|NCT00257192|2338088|P2|Overall Study|Adverse Event|10
727318|NCT00257192|2338089|P1|Overall Study|Adverse Event|21
727319|NCT00257556|2338149|P2|Overall Study|other reason|6
727320|NCT00257556|2338150|P1|Overall Study|other reason|4
727321|NCT00257556|2338149|P2|Overall Study|Did not meet hCG criterion|0
727322|NCT00257556|2338150|P1|Overall Study|Did not meet hCG criterion|3
727323|NCT00257556|2338149|P2|Overall Study|Physician Decision|0
727324|NCT00257556|2338150|P1|Overall Study|Physician Decision|6
727325|NCT00257556|2338149|P2|Overall Study|Adverse Event|4
727326|NCT00257556|2338150|P1|Overall Study|Adverse Event|1
727327|NCT00257608|2338178|P3|Post Chemotherapy Phase|Not treated|7
727328|NCT00257608|2338179|P2|Post Chemotherapy Phase|Not treated|4
727329|NCT00257608|2338180|P1|Post Chemotherapy Phase|Not treated|0
727330|NCT00257608|2338178|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
727331|NCT00257608|2338179|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
727332|NCT00257608|2338180|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
727333|NCT00257608|2338178|P3|Post Chemotherapy Phase|Physician Decision|11
727334|NCT00257608|2338179|P2|Post Chemotherapy Phase|Physician Decision|8
727335|NCT00257608|2338180|P1|Post Chemotherapy Phase|Physician Decision|0
727336|NCT00257608|2338178|P3|Post Chemotherapy Phase|Lost to Follow-up|1
727337|NCT00257608|2338179|P2|Post Chemotherapy Phase|Lost to Follow-up|0
727338|NCT00257608|2338180|P1|Post Chemotherapy Phase|Lost to Follow-up|0
727339|NCT00257608|2338178|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
727340|NCT00257608|2338179|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
727341|NCT00257608|2338180|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
727342|NCT00257608|2338178|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
727343|NCT00257608|2338179|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
727344|NCT00257608|2338180|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
727345|NCT00257608|2338178|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
727346|NCT00257608|2338179|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
727347|NCT00257608|2338180|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
727348|NCT00257608|2338178|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
727349|NCT00257608|2338179|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
727350|NCT00257608|2338180|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
727351|NCT00257608|2338178|P3|Post Chemotherapy Phase|Disease progression|168
727352|NCT00257608|2338179|P2|Post Chemotherapy Phase|Disease progression|204
727353|NCT00257608|2338180|P1|Post Chemotherapy Phase|Disease progression|0
727354|NCT00257608|2338178|P3|Post Chemotherapy Phase|Adverse Event|38
727355|NCT00257608|2338179|P2|Post Chemotherapy Phase|Adverse Event|34
727356|NCT00257608|2338180|P1|Post Chemotherapy Phase|Adverse Event|0
727357|NCT00257608|2338178|P3|Chemotherapy Phase|Physician Decision|0
727358|NCT00257608|2338179|P2|Chemotherapy Phase|Physician Decision|0
727359|NCT00257608|2338180|P1|Chemotherapy Phase|Physician Decision|28
727360|NCT00257608|2338178|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
727361|NCT00257608|2338179|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
727362|NCT00257608|2338180|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
727363|NCT00257608|2338178|P3|Chemotherapy Phase|Patient's decision to discontinue|0
727364|NCT00257608|2338179|P2|Chemotherapy Phase|Patient's decision to discontinue|0
727365|NCT00257608|2338180|P1|Chemotherapy Phase|Patient's decision to discontinue|35
727366|NCT00257608|2338178|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
727367|NCT00257608|2338179|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
727368|NCT00257608|2338180|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
727369|NCT00257608|2338178|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
727370|NCT00257608|2338179|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
727371|NCT00257608|2338180|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
727372|NCT00257608|2338178|P3|Chemotherapy Phase|Disease progression|0
727373|NCT00257608|2338179|P2|Chemotherapy Phase|Disease progression|0
727374|NCT00257608|2338180|P1|Chemotherapy Phase|Disease progression|139
727375|NCT00257608|2338178|P3|Chemotherapy Phase|Adverse Event|0
727376|NCT00257608|2338179|P2|Chemotherapy Phase|Adverse Event|0
727377|NCT00257608|2338180|P1|Chemotherapy Phase|Adverse Event|138
727378|NCT00257660|2338206|P2|Overall Study|No longer wanted to do blood draws|0
727379|NCT00257660|2338207|P1|Overall Study|No longer wanted to do blood draws|1
727380|NCT00257660|2338206|P2|Overall Study|PI & Subject Schedule Conflicts|0
727381|NCT00257660|2338207|P1|Overall Study|PI & Subject Schedule Conflicts|1
727382|NCT00257660|2338206|P2|Overall Study|Lost to Follow-up|0
727383|NCT00257660|2338207|P1|Overall Study|Lost to Follow-up|1
727384|NCT00257660|2338206|P2|Overall Study|Withdrawal by Subject|0
727385|NCT00257660|2338207|P1|Overall Study|Withdrawal by Subject|2
727386|NCT00257660|2338206|P2|Overall Study|Lack of Efficacy|23
727387|NCT00257660|2338207|P1|Overall Study|Lack of Efficacy|5
727388|NCT00257920|2338283|P2|Period: Second Intervention|Other|1
727389|NCT00257920|2338284|P1|Period: Second Intervention|Other|2
727390|NCT00257920|2338283|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
727391|NCT00257920|2338284|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
727392|NCT00258154|2338308|P2|Overall Study|Patient Moved|1
727393|NCT00258154|2338309|P1|Overall Study|Patient Moved|3
727394|NCT00258154|2338308|P2|Overall Study|Withdrawal by Subject|4
727395|NCT00258154|2338309|P1|Overall Study|Withdrawal by Subject|3
727396|NCT00258154|2338308|P2|Overall Study|Protocol Violation|1
727397|NCT00258154|2338309|P1|Overall Study|Protocol Violation|2
727398|NCT00258154|2338308|P2|Overall Study|Lost to Follow-up|1
727399|NCT00258154|2338309|P1|Overall Study|Lost to Follow-up|0
727400|NCT00258154|2338308|P2|Overall Study|Adverse Event|0
727401|NCT00258154|2338309|P1|Overall Study|Adverse Event|1
727402|NCT00266409|2338401|P4|Overall Study|unspecified|0
727403|NCT00266409|2338402|P3|Overall Study|unspecified|2
727404|NCT00266409|2338403|P2|Overall Study|unspecified|4
727405|NCT00266409|2338404|P1|Overall Study|unspecified|7
727406|NCT00266409|2338401|P4|Overall Study|Protocol Violation|2
727407|NCT00266409|2338402|P3|Overall Study|Protocol Violation|4
727408|NCT00266409|2338403|P2|Overall Study|Protocol Violation|3
727409|NCT00266409|2338404|P1|Overall Study|Protocol Violation|5
727410|NCT00266409|2338401|P4|Overall Study|Withdrawal by Subject|9
727411|NCT00266409|2338402|P3|Overall Study|Withdrawal by Subject|3
727412|NCT00266409|2338403|P2|Overall Study|Withdrawal by Subject|10
727413|NCT00266409|2338404|P1|Overall Study|Withdrawal by Subject|6
727414|NCT00266409|2338401|P4|Overall Study|Lost to Follow-up|8
727415|NCT00266409|2338402|P3|Overall Study|Lost to Follow-up|6
727416|NCT00266409|2338403|P2|Overall Study|Lost to Follow-up|21
727417|NCT00266409|2338404|P1|Overall Study|Lost to Follow-up|18
727418|NCT00266409|2338401|P4|Overall Study|Adverse Event|1
727419|NCT00266409|2338402|P3|Overall Study|Adverse Event|1
727420|NCT00266409|2338403|P2|Overall Study|Adverse Event|2
727421|NCT00266409|2338404|P1|Overall Study|Adverse Event|7
727422|NCT00266409|2338401|P4|Overall Study|Lack of Efficacy|2
727423|NCT00266409|2338402|P3|Overall Study|Lack of Efficacy|1
727424|NCT00266409|2338403|P2|Overall Study|Lack of Efficacy|6
727425|NCT00266409|2338404|P1|Overall Study|Lack of Efficacy|2
727426|NCT00266630|2338688|P2|Overall Study|Not Specified|11
727427|NCT00266630|2338689|P1|Overall Study|Not Specified|19
727428|NCT00266630|2338688|P2|Overall Study|Lost to Follow-up|0
727429|NCT00266630|2338689|P1|Overall Study|Lost to Follow-up|1
727430|NCT00266630|2338688|P2|Overall Study|Withdrawal by Subject|2
727431|NCT00266630|2338689|P1|Overall Study|Withdrawal by Subject|10
727432|NCT00266630|2338688|P2|Overall Study|Physician Decision|2
727433|NCT00266630|2338689|P1|Overall Study|Physician Decision|1
727434|NCT00266630|2338688|P2|Overall Study|Protocol Violation|3
727435|NCT00266630|2338689|P1|Overall Study|Protocol Violation|1
727436|NCT00266630|2338688|P2|Overall Study|Entry Criteria not met|0
727437|NCT00266630|2338689|P1|Overall Study|Entry Criteria not met|1
727438|NCT00266630|2338688|P2|Overall Study|Lack of Efficacy|4
727439|NCT00266630|2338689|P1|Overall Study|Lack of Efficacy|1
727440|NCT00266630|2338688|P2|Overall Study|Adverse Event|6
727441|NCT00266630|2338689|P1|Overall Study|Adverse Event|8
727442|NCT00267748|2338750|P3|Randomized Period|randomized but not treated|3
727443|NCT00267748|2338751|P2|Randomized Period|randomized but not treated|0
727444|NCT00267748|2338752|P1|Randomized Period|randomized but not treated|0
727445|NCT00267748|2338750|P3|Randomized Period|Unspecified|6
727446|NCT00267748|2338751|P2|Randomized Period|Unspecified|9
727447|NCT00267748|2338752|P1|Randomized Period|Unspecified|0
727448|NCT00267748|2338750|P3|Randomized Period|Withdrawal by Subject|2
727449|NCT00267748|2338751|P2|Randomized Period|Withdrawal by Subject|9
727450|NCT00267748|2338752|P1|Randomized Period|Withdrawal by Subject|0
727451|NCT00267748|2338750|P3|Randomized Period|Objective progression or relapse|86
727452|NCT00267748|2338751|P2|Randomized Period|Objective progression or relapse|77
727453|NCT00267748|2338752|P1|Randomized Period|Objective progression or relapse|0
727454|NCT00267748|2338750|P3|Randomized Period|Lost to Follow-up|0
727455|NCT00267748|2338751|P2|Randomized Period|Lost to Follow-up|1
727456|NCT00267748|2338752|P1|Randomized Period|Lost to Follow-up|0
727457|NCT00267748|2338750|P3|Randomized Period|Global deterioration of health status|7
727458|NCT00267748|2338751|P2|Randomized Period|Global deterioration of health status|6
727459|NCT00267748|2338752|P1|Randomized Period|Global deterioration of health status|0
727460|NCT00267748|2338750|P3|Randomized Period|Adverse Event|25
727461|NCT00267748|2338751|P2|Randomized Period|Adverse Event|23
727462|NCT00267748|2338752|P1|Randomized Period|Adverse Event|0
727463|NCT00267748|2338750|P3|Randomized Period|Death|3
727464|NCT00267748|2338751|P2|Randomized Period|Death|2
727465|NCT00267748|2338752|P1|Randomized Period|Death|0
727466|NCT00267748|2338750|P3|Non-randomized Period|Unspecified|0
727467|NCT00267748|2338751|P2|Non-randomized Period|Unspecified|0
727468|NCT00267748|2338752|P1|Non-randomized Period|Unspecified|3
727469|NCT00267748|2338750|P3|Non-randomized Period|Participant not willing to participate|0
727470|NCT00267748|2338751|P2|Non-randomized Period|Participant not willing to participate|0
727471|NCT00267748|2338752|P1|Non-randomized Period|Participant not willing to participate|1
727472|NCT00267748|2338750|P3|Non-randomized Period|Death|0
727473|NCT00267748|2338751|P2|Non-randomized Period|Death|0
727474|NCT00267748|2338752|P1|Non-randomized Period|Death|1
727475|NCT00267748|2338750|P3|Non-randomized Period|Adverse Event|0
727476|NCT00267748|2338751|P2|Non-randomized Period|Adverse Event|0
727477|NCT00267748|2338752|P1|Non-randomized Period|Adverse Event|8
727478|NCT00267748|2338750|P3|Non-randomized Period|Progressive disease|0
727479|NCT00267748|2338751|P2|Non-randomized Period|Progressive disease|0
727480|NCT00267748|2338752|P1|Non-randomized Period|Progressive disease|10
727481|NCT00267956|2338780|P4|After Controlled Period|Withdrew consent|0
727482|NCT00267956|2338781|P3|After Controlled Period|Withdrew consent|1
727483|NCT00267956|2338782|P2|After Controlled Period|Withdrew consent|0
727484|NCT00267956|2338783|P1|After Controlled Period|Withdrew consent|0
727485|NCT00267956|2338780|P4|After Controlled Period|Lost to Follow-up|0
727486|NCT00267956|2338781|P3|After Controlled Period|Lost to Follow-up|1
727487|NCT00267956|2338782|P2|After Controlled Period|Lost to Follow-up|0
727488|NCT00267956|2338783|P1|After Controlled Period|Lost to Follow-up|0
727489|NCT00267956|2338780|P4|After Controlled Period|Lack of Efficacy|1
727490|NCT00267956|2338781|P3|After Controlled Period|Lack of Efficacy|1
727491|NCT00267956|2338782|P2|After Controlled Period|Lack of Efficacy|0
727492|NCT00267956|2338783|P1|After Controlled Period|Lack of Efficacy|0
727493|NCT00267956|2338780|P4|After Controlled Period|Adverse Event|1
727494|NCT00267956|2338781|P3|After Controlled Period|Adverse Event|2
727495|NCT00267956|2338782|P2|After Controlled Period|Adverse Event|0
727496|NCT00267956|2338783|P1|After Controlled Period|Adverse Event|0
727497|NCT00267956|2338780|P4|Controlled Period|Withdrew consent|0
727498|NCT00267956|2338781|P3|Controlled Period|Withdrew consent|0
727499|NCT00267956|2338782|P2|Controlled Period|Withdrew consent|1
727500|NCT00267956|2338783|P1|Controlled Period|Withdrew consent|3
727501|NCT00267956|2338780|P4|Controlled Period|Lost to Follow-up|0
727502|NCT00267956|2338781|P3|Controlled Period|Lost to Follow-up|0
727503|NCT00267956|2338782|P2|Controlled Period|Lost to Follow-up|0
727504|NCT00267956|2338783|P1|Controlled Period|Lost to Follow-up|2
727505|NCT00267956|2338780|P4|Controlled Period|Lack of Efficacy|0
727506|NCT00267956|2338781|P3|Controlled Period|Lack of Efficacy|0
727507|NCT00267956|2338782|P2|Controlled Period|Lack of Efficacy|2
727508|NCT00267956|2338783|P1|Controlled Period|Lack of Efficacy|4
727509|NCT00267956|2338780|P4|Controlled Period|Adverse Event|0
727510|NCT00267956|2338781|P3|Controlled Period|Adverse Event|0
727511|NCT00267956|2338782|P2|Controlled Period|Adverse Event|1
727512|NCT00267956|2338783|P1|Controlled Period|Adverse Event|4
727513|NCT00267969|2338804|P7|After Controlled Period|Not specified|25
727514|NCT00267969|2338805|P6|After Controlled Period|Not specified|22
727515|NCT00267969|2338806|P5|After Controlled Period|Not specified|11
727516|NCT00267969|2338807|P4|After Controlled Period|Not specified|13
727517|NCT00267969|2338808|P3|After Controlled Period|Not specified|0
727518|NCT00267969|2338809|P2|After Controlled Period|Not specified|0
727519|NCT00267969|2338810|P1|After Controlled Period|Not specified|0
727520|NCT00267969|2338804|P7|After Controlled Period|Lost to Follow-up|10
727521|NCT00267969|2338805|P6|After Controlled Period|Lost to Follow-up|9
727522|NCT00267969|2338806|P5|After Controlled Period|Lost to Follow-up|8
727523|NCT00267969|2338807|P4|After Controlled Period|Lost to Follow-up|5
727524|NCT00267969|2338808|P3|After Controlled Period|Lost to Follow-up|0
727525|NCT00267969|2338809|P2|After Controlled Period|Lost to Follow-up|0
727526|NCT00267969|2338810|P1|After Controlled Period|Lost to Follow-up|0
727527|NCT00267969|2338804|P7|After Controlled Period|Lack of Efficacy|15
727528|NCT00267969|2338805|P6|After Controlled Period|Lack of Efficacy|28
727529|NCT00267969|2338806|P5|After Controlled Period|Lack of Efficacy|6
727530|NCT00267969|2338807|P4|After Controlled Period|Lack of Efficacy|10
727531|NCT00267969|2338808|P3|After Controlled Period|Lack of Efficacy|0
727532|NCT00267969|2338809|P2|After Controlled Period|Lack of Efficacy|0
727533|NCT00267969|2338810|P1|After Controlled Period|Lack of Efficacy|0
727534|NCT00267969|2338804|P7|After Controlled Period|Death|1
727535|NCT00267969|2338805|P6|After Controlled Period|Death|0
727536|NCT00267969|2338806|P5|After Controlled Period|Death|2
727537|NCT00267969|2338807|P4|After Controlled Period|Death|1
727538|NCT00267969|2338808|P3|After Controlled Period|Death|0
727539|NCT00267969|2338809|P2|After Controlled Period|Death|0
727540|NCT00267969|2338810|P1|After Controlled Period|Death|0
727541|NCT00267969|2338804|P7|After Controlled Period|Adverse Event|21
727542|NCT00267969|2338805|P6|After Controlled Period|Adverse Event|23
727543|NCT00267969|2338806|P5|After Controlled Period|Adverse Event|8
727544|NCT00267969|2338807|P4|After Controlled Period|Adverse Event|7
727545|NCT00267969|2338808|P3|After Controlled Period|Adverse Event|0
727546|NCT00267969|2338809|P2|After Controlled Period|Adverse Event|0
727547|NCT00267969|2338810|P1|After Controlled Period|Adverse Event|0
727548|NCT00267969|2338804|P7|Controlled Period|Not specified|0
727549|NCT00267969|2338805|P6|Controlled Period|Not specified|0
727550|NCT00267969|2338806|P5|Controlled Period|Not specified|0
727551|NCT00267969|2338807|P4|Controlled Period|Not specified|0
727552|NCT00267969|2338808|P3|Controlled Period|Not specified|6
727553|NCT00267969|2338809|P2|Controlled Period|Not specified|1
727554|NCT00267969|2338810|P1|Controlled Period|Not specified|2
727555|NCT00267969|2338804|P7|Controlled Period|Randomized but not treated|0
727556|NCT00267969|2338805|P6|Controlled Period|Randomized but not treated|0
727557|NCT00267969|2338806|P5|Controlled Period|Randomized but not treated|0
727558|NCT00267969|2338807|P4|Controlled Period|Randomized but not treated|0
727559|NCT00267969|2338808|P3|Controlled Period|Randomized but not treated|1
727560|NCT00267969|2338809|P2|Controlled Period|Randomized but not treated|0
727561|NCT00267969|2338810|P1|Controlled Period|Randomized but not treated|0
727562|NCT00267969|2338804|P7|Controlled Period|Lost to Follow-up|0
727563|NCT00267969|2338805|P6|Controlled Period|Lost to Follow-up|0
727564|NCT00267969|2338806|P5|Controlled Period|Lost to Follow-up|0
727565|NCT00267969|2338807|P4|Controlled Period|Lost to Follow-up|0
727566|NCT00267969|2338808|P3|Controlled Period|Lost to Follow-up|1
727567|NCT00267969|2338809|P2|Controlled Period|Lost to Follow-up|0
727568|NCT00267969|2338810|P1|Controlled Period|Lost to Follow-up|1
727569|NCT00267969|2338804|P7|Controlled Period|Lack of Efficacy|0
727570|NCT00267969|2338805|P6|Controlled Period|Lack of Efficacy|0
727571|NCT00267969|2338806|P5|Controlled Period|Lack of Efficacy|0
727572|NCT00267969|2338807|P4|Controlled Period|Lack of Efficacy|0
727573|NCT00267969|2338808|P3|Controlled Period|Lack of Efficacy|1
727574|NCT00267969|2338809|P2|Controlled Period|Lack of Efficacy|0
727575|NCT00267969|2338810|P1|Controlled Period|Lack of Efficacy|3
727576|NCT00267969|2338804|P7|Controlled Period|Adverse Event|0
727577|NCT00267969|2338805|P6|Controlled Period|Adverse Event|0
727578|NCT00267969|2338806|P5|Controlled Period|Adverse Event|0
727579|NCT00267969|2338807|P4|Controlled Period|Adverse Event|0
727580|NCT00267969|2338808|P3|Controlled Period|Adverse Event|2
727581|NCT00267969|2338809|P2|Controlled Period|Adverse Event|0
727582|NCT00267969|2338810|P1|Controlled Period|Adverse Event|6
727583|NCT00268203|2338834|P1|Overall Study|Completed 2 Years of Follow-up|62
727584|NCT00268203|2338834|P1|Overall Study|Reason Not Specified|34
727585|NCT00268203|2338834|P1|Overall Study|Death|84
727586|NCT00268203|2338834|P1|Overall Study|Progressive Disease|359
727587|NCT00268203|2338834|P1|Overall Study|Received Other NHL Therapy|7
727588|NCT00268203|2338834|P1|Overall Study|Withdrawal by Subject|9
727589|NCT00268203|2338834|P1|Overall Study|Lost to Follow-up|92
727590|NCT00268242|2338845|P1|Overall Study|Death|1
727591|NCT00268346|2338856|P2|Overall Study|Withdrawal by Subject|1
727592|NCT00268346|2338857|P1|Overall Study|Withdrawal by Subject|0
727593|NCT00268346|2338856|P2|Overall Study|Death|1
727594|NCT00268346|2338857|P1|Overall Study|Death|0
727595|NCT00268346|2338856|P2|Overall Study|Adverse Event|1
727596|NCT00268346|2338857|P1|Overall Study|Adverse Event|0
727597|NCT00268437|2338863|P1|Overall Study|Ineligible|1
727598|NCT00268463|2338870|P2|Overall Study|study terminated due to low accrual|12
727599|NCT00268463|2338871|P1|Overall Study|study terminated due to low accrual|10
727600|NCT00268892|2338886|P3|Overall Study|Trial Site Closed|2
727601|NCT00268892|2338887|P2|Overall Study|Trial Site Closed|2
727602|NCT00268892|2338888|P1|Overall Study|Trial Site Closed|4
727603|NCT00268892|2338886|P3|Overall Study|Disease Progression|0
727604|NCT00268892|2338887|P2|Overall Study|Disease Progression|1
727605|NCT00268892|2338888|P1|Overall Study|Disease Progression|1
727606|NCT00268892|2338886|P3|Overall Study|Protocol Violation|0
727607|NCT00268892|2338887|P2|Overall Study|Protocol Violation|1
727608|NCT00268892|2338888|P1|Overall Study|Protocol Violation|0
727609|NCT00268892|2338886|P3|Overall Study|Lost to Follow-up|4
727610|NCT00268892|2338887|P2|Overall Study|Lost to Follow-up|2
727611|NCT00268892|2338888|P1|Overall Study|Lost to Follow-up|5
727612|NCT00268892|2338886|P3|Overall Study|Physician Decision|0
727613|NCT00268892|2338887|P2|Overall Study|Physician Decision|1
727614|NCT00268892|2338888|P1|Overall Study|Physician Decision|0
727615|NCT00268892|2338886|P3|Overall Study|Withdrawal by Subject|13
727616|NCT00268892|2338887|P2|Overall Study|Withdrawal by Subject|15
727617|NCT00268892|2338888|P1|Overall Study|Withdrawal by Subject|14
727618|NCT00268892|2338886|P3|Overall Study|Lack of Efficacy|0
727619|NCT00268892|2338887|P2|Overall Study|Lack of Efficacy|3
727620|NCT00268892|2338888|P1|Overall Study|Lack of Efficacy|1
727621|NCT00268892|2338886|P3|Overall Study|Adverse Event|20
727622|NCT00268892|2338887|P2|Overall Study|Adverse Event|17
727623|NCT00268892|2338888|P1|Overall Study|Adverse Event|14
727624|NCT00268905|2338902|P3|Overall Study|Clinical Progression|1
727625|NCT00268905|2338903|P2|Overall Study|Clinical Progression|4
727626|NCT00268905|2338904|P1|Overall Study|Clinical Progression|9
727627|NCT00268905|2338902|P3|Overall Study|Physician Decision|1
727628|NCT00268905|2338903|P2|Overall Study|Physician Decision|0
727629|NCT00268905|2338904|P1|Overall Study|Physician Decision|3
727630|NCT00268905|2338902|P3|Overall Study|Progressive Disease|3
727631|NCT00268905|2338903|P2|Overall Study|Progressive Disease|4
727632|NCT00268905|2338904|P1|Overall Study|Progressive Disease|28
727633|NCT00268905|2338902|P3|Overall Study|Withdrawal by Subject|3
727634|NCT00268905|2338903|P2|Overall Study|Withdrawal by Subject|0
727635|NCT00268905|2338904|P1|Overall Study|Withdrawal by Subject|0
727636|NCT00268905|2338902|P3|Overall Study|Lost to Follow-up|0
727637|NCT00268905|2338903|P2|Overall Study|Lost to Follow-up|1
727638|NCT00268905|2338904|P1|Overall Study|Lost to Follow-up|0
727639|NCT00268905|2338902|P3|Overall Study|Adverse Event|4
727640|NCT00268905|2338903|P2|Overall Study|Adverse Event|0
727641|NCT00268905|2338904|P1|Overall Study|Adverse Event|3
727642|NCT00268983|2338920|P2|Overall Study|Death|0
727643|NCT00268983|2338921|P1|Overall Study|Death|3
727644|NCT00269113|2338963|P2|Overall Study|Not specified|2
727645|NCT00269113|2338964|P1|Overall Study|Not specified|0
727646|NCT00269113|2338963|P2|Overall Study|Protocol Violation|5
727647|NCT00269113|2338964|P1|Overall Study|Protocol Violation|15
727648|NCT00269113|2338963|P2|Overall Study|Lost to Follow-up|1
727649|NCT00269113|2338964|P1|Overall Study|Lost to Follow-up|2
727650|NCT00269113|2338963|P2|Overall Study|Death|2
727651|NCT00269113|2338964|P1|Overall Study|Death|6
727652|NCT00269113|2338963|P2|Overall Study|Withdrawal by Subject|2
727653|NCT00269113|2338964|P1|Overall Study|Withdrawal by Subject|0
727654|NCT00269113|2338963|P2|Overall Study|Early Improvement|0
727655|NCT00269113|2338964|P1|Overall Study|Early Improvement|2
727656|NCT00269113|2338963|P2|Overall Study|Lack of Efficacy|18
727657|NCT00269113|2338964|P1|Overall Study|Lack of Efficacy|35
727658|NCT00269113|2338963|P2|Overall Study|Adverse Event|7
727659|NCT00269113|2338964|P1|Overall Study|Adverse Event|14
727660|NCT00269152|2338984|P2|Overall Study|Protocol Violation|1
727661|NCT00269152|2338985|P1|Overall Study|Protocol Violation|0
727662|NCT00269152|2338984|P2|Overall Study|Physician Decision|3
727663|NCT00269152|2338985|P1|Overall Study|Physician Decision|2
727664|NCT00269152|2338984|P2|Overall Study|Withdrawal by Subject|3
727665|NCT00269152|2338985|P1|Overall Study|Withdrawal by Subject|7
727666|NCT00269152|2338984|P2|Overall Study|Adverse Event|3
727667|NCT00269152|2338985|P1|Overall Study|Adverse Event|9
727668|NCT00269477|2339003|P4|Overall Study|Missed post-vaccination blood draw|0
727669|NCT00269477|2339004|P3|Overall Study|Missed post-vaccination blood draw|0
727670|NCT00269477|2339005|P2|Overall Study|Missed post-vaccination blood draw|1
727671|NCT00269477|2339006|P1|Overall Study|Missed post-vaccination blood draw|0
727672|NCT00269477|2339003|P4|Overall Study|Protocol Violation|0
727673|NCT00269477|2339004|P3|Overall Study|Protocol Violation|1
727674|NCT00269477|2339005|P2|Overall Study|Protocol Violation|5
727675|NCT00269477|2339006|P1|Overall Study|Protocol Violation|5
727676|NCT00269633|2339022|P2|Overall Study|Withdrawal by Subject|0
727677|NCT00269633|2339023|P1|Overall Study|Withdrawal by Subject|1
727678|NCT00269919|2339029|P1|Overall Study|Started but not treated|1
727679|NCT00269919|2339029|P1|Overall Study|Unspecified|26
727680|NCT00270205|2339050|P4|Overall Study|Lost to Follow-up|1
727681|NCT00270205|2339051|P3|Overall Study|Lost to Follow-up|0
727682|NCT00270205|2339052|P2|Overall Study|Lost to Follow-up|0
727683|NCT00270205|2339053|P1|Overall Study|Lost to Follow-up|1
727684|NCT00270231|2339163|P2|Second Intervention|Lost to Follow-up|1
727685|NCT00270231|2339164|P1|Second Intervention|Lost to Follow-up|0
727686|NCT00270231|2339163|P2|Washout Period|Lost to Follow-up|0
727687|NCT00270231|2339164|P1|Washout Period|Lost to Follow-up|1
727688|NCT00270231|2339163|P2|First Intervention|Lost to Follow-up|1
727689|NCT00270231|2339164|P1|First Intervention|Lost to Follow-up|1
727690|NCT00255840|2339172|P2|Overall Study|Discontinued intervention|56
727691|NCT00255840|2339173|P1|Overall Study|Discontinued intervention|53
727692|NCT00255840|2339172|P2|Overall Study|Lost to Follow-up|14
727693|NCT00255840|2339173|P1|Overall Study|Lost to Follow-up|10
727694|NCT00261443|2339181|P3|4: Extension Phase|Lost to Follow-up|0
727695|NCT00261443|2339182|P2|4: Extension Phase|Lost to Follow-up|1
727696|NCT00261443|2339183|P1|4: Extension Phase|Lost to Follow-up|0
727697|NCT00261443|2339181|P3|4: Extension Phase|Withdrawal by Subject|2
727698|NCT00261443|2339182|P2|4: Extension Phase|Withdrawal by Subject|1
727699|NCT00261443|2339183|P1|4: Extension Phase|Withdrawal by Subject|0
727700|NCT00261443|2339181|P3|4: Extension Phase|Adverse Event|0
727701|NCT00261443|2339182|P2|4: Extension Phase|Adverse Event|1
727702|NCT00261443|2339183|P1|4: Extension Phase|Adverse Event|0
727703|NCT00261443|2339181|P3|3: Assessment of Relapse|Other Reasons|3
727704|NCT00261443|2339182|P2|3: Assessment of Relapse|Other Reasons|4
727705|NCT00261443|2339183|P1|3: Assessment of Relapse|Other Reasons|0
727706|NCT00261443|2339181|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
727707|NCT00261443|2339182|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
727708|NCT00261443|2339183|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
727709|NCT00261443|2339181|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
727710|NCT00261443|2339182|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
727711|NCT00261443|2339183|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
727712|NCT00261443|2339181|P3|3: Assessment of Relapse|Pregnancy|1
727713|NCT00261443|2339182|P2|3: Assessment of Relapse|Pregnancy|2
727714|NCT00261443|2339183|P1|3: Assessment of Relapse|Pregnancy|0
727715|NCT00261443|2339181|P3|3: Assessment of Relapse|Poor/Noncompliance|3
727716|NCT00261443|2339182|P2|3: Assessment of Relapse|Poor/Noncompliance|5
727717|NCT00261443|2339183|P1|3: Assessment of Relapse|Poor/Noncompliance|0
727718|NCT00261443|2339181|P3|3: Assessment of Relapse|Lost to Follow-up|6
727719|NCT00261443|2339182|P2|3: Assessment of Relapse|Lost to Follow-up|7
727720|NCT00261443|2339183|P1|3: Assessment of Relapse|Lost to Follow-up|0
727721|NCT00261443|2339181|P3|3: Assessment of Relapse|Death|1
727722|NCT00261443|2339182|P2|3: Assessment of Relapse|Death|0
727723|NCT00261443|2339183|P1|3: Assessment of Relapse|Death|0
727724|NCT00261443|2339181|P3|3: Assessment of Relapse|Withdrawal by Subject|15
727725|NCT00261443|2339182|P2|3: Assessment of Relapse|Withdrawal by Subject|14
727726|NCT00261443|2339183|P1|3: Assessment of Relapse|Withdrawal by Subject|0
727727|NCT00261443|2339181|P3|3: Assessment of Relapse|Adverse Event|19
727728|NCT00261443|2339182|P2|3: Assessment of Relapse|Adverse Event|15
727729|NCT00261443|2339183|P1|3: Assessment of Relapse|Adverse Event|0
727730|NCT00261443|2339181|P3|3: Assessment of Relapse|Lack of Efficacy|14
727731|NCT00261443|2339182|P2|3: Assessment of Relapse|Lack of Efficacy|31
727732|NCT00261443|2339183|P1|3: Assessment of Relapse|Lack of Efficacy|0
727733|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Other Reasons|0
727734|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Other Reasons|0
727735|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Other Reasons|13
727736|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
727737|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
727738|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
727739|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
727740|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
727741|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
727742|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Pregnancy|0
727743|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Pregnancy|0
727744|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Pregnancy|1
727745|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
727746|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
727747|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
727748|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
727749|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
727750|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
727751|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
727752|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
727753|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
727754|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Adverse Event|0
727755|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Adverse Event|0
727756|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Adverse Event|93
727757|NCT00261443|2339181|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
727758|NCT00261443|2339182|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
727759|NCT00261443|2339183|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
727760|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
727761|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
727762|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
727763|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
727764|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
727765|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
727766|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
727767|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
727768|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
727769|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
727770|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
727771|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
727772|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
727773|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
727774|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
727775|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
727776|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
727777|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
727778|NCT00261443|2339181|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
727779|NCT00261443|2339182|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
727780|NCT00261443|2339183|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
727781|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
727782|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
727783|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
727784|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
727785|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
727786|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
727787|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
727788|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
727789|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
727790|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
727791|NCT00261495|2339440|P2|Extension Phase (Weeks 24 to 52)|Other|2
727792|NCT00261495|2339441|P1|Extension Phase (Weeks 24 to 52)|Other|4
727793|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
727794|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
727795|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
727796|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
727797|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
727798|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
727799|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
727800|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
727801|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
727802|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
727803|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
727804|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
727805|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
727806|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
727807|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
727808|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
727809|NCT00261495|2339440|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
727810|NCT00261495|2339441|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
727811|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
727812|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
727813|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
727814|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
727815|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
727816|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
727817|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
727818|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
727819|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
727820|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
727821|NCT00261495|2339440|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
727822|NCT00261495|2339441|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
727823|NCT00261716|2339605|P2|Overall Study|Lost to Follow-up|2
727824|NCT00261716|2339606|P1|Overall Study|Lost to Follow-up|0
727825|NCT00261716|2339605|P2|Overall Study|Withdrawal by Subject|8
727826|NCT00261716|2339606|P1|Overall Study|Withdrawal by Subject|6
727827|NCT00261833|2339626|P2|Overall Study|Not interested in being participant|1
727828|NCT00261833|2339627|P1|Overall Study|Not interested in being participant|0
727829|NCT00261833|2339626|P2|Overall Study|Missing reason|0
727830|NCT00261833|2339627|P1|Overall Study|Missing reason|1
727831|NCT00261833|2339626|P2|Overall Study|Lung transplantation|1
727832|NCT00261833|2339627|P1|Overall Study|Lung transplantation|1
727833|NCT00261833|2339626|P2|Overall Study|Suspicion of pulmonary cancer|1
727834|NCT00261833|2339627|P1|Overall Study|Suspicion of pulmonary cancer|0
727835|NCT00261833|2339626|P2|Overall Study|Protocol Violation|1
727836|NCT00261833|2339627|P1|Overall Study|Protocol Violation|0
727837|NCT00261833|2339626|P2|Overall Study|Withdrawal by Subject|7
727838|NCT00261833|2339627|P1|Overall Study|Withdrawal by Subject|5
727839|NCT00261833|2339626|P2|Overall Study|Adverse Event|4
727840|NCT00261833|2339627|P1|Overall Study|Adverse Event|1
727841|NCT00261833|2339626|P2|Overall Study|Death|3
727842|NCT00261833|2339627|P1|Overall Study|Death|1
727843|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Extension study|1
727844|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Extension study|1
727845|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Extension study|9
727846|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Extension study|5
727847|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Extension study|9
727848|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Extension study|4
727849|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Extension study|0
727850|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Extension study|27
727851|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Extension study|61
727852|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Extension study|0
727853|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Extension study|0
727854|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Extension study|0
727855|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Death|22
727856|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Death|44
727857|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Death|30
727858|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Death|3
727859|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Death|12
727860|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Death|10
727861|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Death|1
727862|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Death|7
727863|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Death|37
727864|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Death|0
727865|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Death|0
727866|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Death|0
727867|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Unspecified|0
727868|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Unspecified|0
727869|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Unspecified|4
727870|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Unspecified|4
727871|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Unspecified|5
727872|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Unspecified|1
727873|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Unspecified|0
727874|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Unspecified|4
727875|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Unspecified|15
727876|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Unspecified|0
727877|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Unspecified|0
727878|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Unspecified|0
727879|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727880|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
727881|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
727882|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
727883|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727884|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
727885|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727886|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
727887|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
727888|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727889|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727890|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
727891|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727892|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727893|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
727894|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727895|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
727896|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
727897|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
727898|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
727899|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
727900|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727901|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727902|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
727903|NCT00261846|2339668|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727904|NCT00261846|2339669|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727905|NCT00261846|2339670|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727906|NCT00261846|2339671|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
727907|NCT00261846|2339672|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727908|NCT00261846|2339673|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727909|NCT00261846|2339674|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727910|NCT00261846|2339675|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727911|NCT00261846|2339676|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
727912|NCT00261846|2339677|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727913|NCT00261846|2339678|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727914|NCT00261846|2339679|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
727915|NCT00261846|2339668|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727916|NCT00261846|2339669|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727917|NCT00261846|2339670|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727918|NCT00261846|2339671|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727919|NCT00261846|2339672|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727920|NCT00261846|2339673|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727921|NCT00261846|2339674|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727922|NCT00261846|2339675|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727923|NCT00261846|2339676|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
727924|NCT00261846|2339677|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
727925|NCT00261846|2339678|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
727926|NCT00261846|2339679|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
727927|NCT00261950|2339936|P1|Overall Study|Protocol specified Criteria|11
727928|NCT00261950|2339936|P1|Overall Study|Physician Decision|1
727929|NCT00261950|2339936|P1|Overall Study|not specified|1
727930|NCT00261950|2339936|P1|Overall Study|Withdrawal by Subject|5
727931|NCT00261950|2339936|P1|Overall Study|Death|6
727932|NCT00261950|2339936|P1|Overall Study|Lost to Follow-up|2
727933|NCT00262002|2339959|P7|Overall Study|Unable to classify|2
727934|NCT00262002|2339960|P6|Overall Study|Unable to classify|0
727935|NCT00262002|2339961|P5|Overall Study|Unable to classify|0
727936|NCT00262002|2339962|P4|Overall Study|Unable to classify|0
727937|NCT00262002|2339963|P3|Overall Study|Unable to classify|0
727938|NCT00262002|2339964|P2|Overall Study|Unable to classify|0
727939|NCT00262002|2339965|P1|Overall Study|Unable to classify|0
727940|NCT00262002|2339959|P7|Overall Study|Protocol Violation|2
727941|NCT00262002|2339960|P6|Overall Study|Protocol Violation|3
727942|NCT00262002|2339961|P5|Overall Study|Protocol Violation|5
727943|NCT00262002|2339962|P4|Overall Study|Protocol Violation|2
727944|NCT00262002|2339963|P3|Overall Study|Protocol Violation|0
727945|NCT00262002|2339964|P2|Overall Study|Protocol Violation|2
727946|NCT00262002|2339965|P1|Overall Study|Protocol Violation|3
727947|NCT00262002|2339959|P7|Overall Study|Inapropriate enrollment|0
727948|NCT00262002|2339960|P6|Overall Study|Inapropriate enrollment|0
727949|NCT00262002|2339961|P5|Overall Study|Inapropriate enrollment|0
727950|NCT00262002|2339962|P4|Overall Study|Inapropriate enrollment|0
727951|NCT00262002|2339963|P3|Overall Study|Inapropriate enrollment|0
727952|NCT00262002|2339964|P2|Overall Study|Inapropriate enrollment|1
727953|NCT00262002|2339965|P1|Overall Study|Inapropriate enrollment|0
727954|NCT00262002|2339959|P7|Overall Study|Lost to Follow-up|0
727955|NCT00262002|2339960|P6|Overall Study|Lost to Follow-up|1
727956|NCT00262002|2339961|P5|Overall Study|Lost to Follow-up|0
727957|NCT00262002|2339962|P4|Overall Study|Lost to Follow-up|2
727958|NCT00262002|2339963|P3|Overall Study|Lost to Follow-up|0
727959|NCT00262002|2339964|P2|Overall Study|Lost to Follow-up|0
727960|NCT00262002|2339965|P1|Overall Study|Lost to Follow-up|2
727961|NCT00262002|2339959|P7|Overall Study|Withdrawal by Subject|2
727962|NCT00262002|2339960|P6|Overall Study|Withdrawal by Subject|2
727963|NCT00262002|2339961|P5|Overall Study|Withdrawal by Subject|2
727964|NCT00262002|2339962|P4|Overall Study|Withdrawal by Subject|1
727965|NCT00262002|2339963|P3|Overall Study|Withdrawal by Subject|0
727966|NCT00262002|2339964|P2|Overall Study|Withdrawal by Subject|2
727967|NCT00262002|2339965|P1|Overall Study|Withdrawal by Subject|4
727968|NCT00262002|2339959|P7|Overall Study|Adverse Event|0
727969|NCT00262002|2339960|P6|Overall Study|Adverse Event|1
727970|NCT00262002|2339961|P5|Overall Study|Adverse Event|0
727971|NCT00262002|2339962|P4|Overall Study|Adverse Event|0
727972|NCT00262002|2339963|P3|Overall Study|Adverse Event|0
727973|NCT00262002|2339964|P2|Overall Study|Adverse Event|1
727974|NCT00262002|2339965|P1|Overall Study|Adverse Event|2
727975|NCT00262028|2340067|P9|Overall Study|Unable to classify|1
727976|NCT00262028|2340068|P8|Overall Study|Unable to classify|0
727977|NCT00262028|2340069|P7|Overall Study|Unable to classify|0
727978|NCT00262028|2340070|P6|Overall Study|Unable to classify|0
727979|NCT00262028|2340071|P5|Overall Study|Unable to classify|0
727980|NCT00262028|2340072|P4|Overall Study|Unable to classify|0
727981|NCT00262028|2340073|P3|Overall Study|Unable to classify|0
727982|NCT00262028|2340074|P2|Overall Study|Unable to classify|3
727983|NCT00262028|2340075|P1|Overall Study|Unable to classify|0
727984|NCT00262028|2340067|P9|Overall Study|Protocol Violation|0
727985|NCT00262028|2340068|P8|Overall Study|Protocol Violation|0
727986|NCT00262028|2340069|P7|Overall Study|Protocol Violation|0
727987|NCT00262028|2340070|P6|Overall Study|Protocol Violation|0
727988|NCT00262028|2340071|P5|Overall Study|Protocol Violation|0
727989|NCT00262028|2340072|P4|Overall Study|Protocol Violation|1
727990|NCT00262028|2340073|P3|Overall Study|Protocol Violation|0
727991|NCT00262028|2340074|P2|Overall Study|Protocol Violation|0
727992|NCT00262028|2340075|P1|Overall Study|Protocol Violation|0
727993|NCT00262028|2340067|P9|Overall Study|Administrative Reason|10
727994|NCT00262028|2340068|P8|Overall Study|Administrative Reason|6
727995|NCT00262028|2340069|P7|Overall Study|Administrative Reason|4
727996|NCT00262028|2340070|P6|Overall Study|Administrative Reason|7
727997|NCT00262028|2340071|P5|Overall Study|Administrative Reason|6
727998|NCT00262028|2340072|P4|Overall Study|Administrative Reason|12
727999|NCT00262028|2340073|P3|Overall Study|Administrative Reason|9
728000|NCT00262028|2340074|P2|Overall Study|Administrative Reason|14
728001|NCT00262028|2340075|P1|Overall Study|Administrative Reason|11
728002|NCT00262028|2340067|P9|Overall Study|Lost to Follow-up|6
728003|NCT00262028|2340068|P8|Overall Study|Lost to Follow-up|5
728004|NCT00262028|2340069|P7|Overall Study|Lost to Follow-up|3
728005|NCT00262028|2340070|P6|Overall Study|Lost to Follow-up|3
728006|NCT00262028|2340071|P5|Overall Study|Lost to Follow-up|4
728007|NCT00262028|2340072|P4|Overall Study|Lost to Follow-up|5
728008|NCT00262028|2340073|P3|Overall Study|Lost to Follow-up|5
728009|NCT00262028|2340074|P2|Overall Study|Lost to Follow-up|7
728010|NCT00262028|2340075|P1|Overall Study|Lost to Follow-up|7
728011|NCT00262028|2340067|P9|Overall Study|Withdrawal by Subject|2
728012|NCT00262028|2340068|P8|Overall Study|Withdrawal by Subject|7
728013|NCT00262028|2340069|P7|Overall Study|Withdrawal by Subject|5
728014|NCT00262028|2340070|P6|Overall Study|Withdrawal by Subject|3
728015|NCT00262028|2340071|P5|Overall Study|Withdrawal by Subject|2
728016|NCT00262028|2340072|P4|Overall Study|Withdrawal by Subject|5
728017|NCT00262028|2340073|P3|Overall Study|Withdrawal by Subject|6
728018|NCT00262028|2340074|P2|Overall Study|Withdrawal by Subject|3
728019|NCT00262028|2340075|P1|Overall Study|Withdrawal by Subject|6
728020|NCT00262041|2340134|P3|Overall Study|Unable to classify|0
728021|NCT00262041|2340135|P2|Overall Study|Unable to classify|0
728022|NCT00262041|2340136|P1|Overall Study|Unable to classify|1
728023|NCT00262041|2340134|P3|Overall Study|Lost to Follow-up|5
728024|NCT00262041|2340135|P2|Overall Study|Lost to Follow-up|1
728025|NCT00262041|2340136|P1|Overall Study|Lost to Follow-up|1
728026|NCT00262041|2340134|P3|Overall Study|Withdrawal by Subject|1
728027|NCT00262041|2340135|P2|Overall Study|Withdrawal by Subject|3
728028|NCT00262041|2340136|P1|Overall Study|Withdrawal by Subject|0
728029|NCT00262067|2340160|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
728030|NCT00262067|2340161|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
728031|NCT00262067|2340162|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
728032|NCT00262067|2340163|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
728033|NCT00262067|2340160|P4|Overall Study|Sponsor's Decision to Terminate Study|0
728034|NCT00262067|2340161|P3|Overall Study|Sponsor's Decision to Terminate Study|0
728035|NCT00262067|2340162|P2|Overall Study|Sponsor's Decision to Terminate Study|0
728036|NCT00262067|2340163|P1|Overall Study|Sponsor's Decision to Terminate Study|1
728037|NCT00262067|2340160|P4|Overall Study|Lost to Follow-up|5
728038|NCT00262067|2340161|P3|Overall Study|Lost to Follow-up|7
728039|NCT00262067|2340162|P2|Overall Study|Lost to Follow-up|4
728040|NCT00262067|2340163|P1|Overall Study|Lost to Follow-up|5
728041|NCT00262067|2340160|P4|Overall Study|Death|99
728042|NCT00262067|2340161|P3|Overall Study|Death|186
728043|NCT00262067|2340162|P2|Overall Study|Death|89
728044|NCT00262067|2340163|P1|Overall Study|Death|190
728045|NCT00262080|2340196|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
728046|NCT00262080|2340197|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
728047|NCT00262080|2340198|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
728048|NCT00262080|2340196|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
728049|NCT00262080|2340197|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
728050|NCT00262080|2340198|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
728051|NCT00262080|2340196|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
728052|NCT00262080|2340197|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
728053|NCT00262080|2340198|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
728054|NCT00262080|2340196|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
728055|NCT00262080|2340197|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
728056|NCT00262080|2340198|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
728057|NCT00262080|2340196|P3|Repeat Dose Treatment Period|Adverse Event|0
728058|NCT00262080|2340197|P2|Repeat Dose Treatment Period|Adverse Event|0
728059|NCT00262080|2340198|P1|Repeat Dose Treatment Period|Adverse Event|1
728060|NCT00262080|2340196|P3|Double Blind Treatment Period|Lost to Follow-up|0
728061|NCT00262080|2340197|P2|Double Blind Treatment Period|Lost to Follow-up|0
728062|NCT00262080|2340198|P1|Double Blind Treatment Period|Lost to Follow-up|1
728063|NCT00262119|2340217|P3|Overall Study|Death|16
728064|NCT00262119|2340218|P2|Overall Study|Death|19
728065|NCT00262119|2340219|P1|Overall Study|Death|20
728066|NCT00262119|2340217|P3|Overall Study|Lost to Follow-up|42
728067|NCT00262119|2340218|P2|Overall Study|Lost to Follow-up|51
728068|NCT00262119|2340219|P1|Overall Study|Lost to Follow-up|38
728079|NCT00262301|2340250|P3|Double-blind Phase|"worsening of HAE symptoms"|0
728080|NCT00262301|2340251|P2|Double-blind Phase|"worsening of HAE symptoms"|1
728081|NCT00262301|2340252|P1|Double-blind Phase|"worsening of HAE symptoms"|0
728082|NCT00262301|2340250|P3|Double-blind Phase|Lost to Follow-up|0
728083|NCT00262301|2340251|P2|Double-blind Phase|Lost to Follow-up|0
728084|NCT00262301|2340252|P1|Double-blind Phase|Lost to Follow-up|1
728085|NCT00262314|2340263|P1|Overall Study|Administrative withdrawal|30
728086|NCT00262314|2340263|P1|Overall Study|Lost to Follow-up|70
728087|NCT00262314|2340263|P1|Overall Study|Not specified|95
728088|NCT00262314|2340263|P1|Overall Study|Patient's decision|92
728089|NCT00262314|2340263|P1|Overall Study|Death|12
728090|NCT00262314|2340263|P1|Overall Study|Changing physicians|38
728091|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
728092|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
728093|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
728094|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
728095|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Virologic failure|0
728096|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Virologic failure|8
728097|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Virologic failure|0
728098|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Virologic failure|5
728099|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Death|0
728100|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Death|2
728101|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Death|0
728102|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Death|2
728103|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Noncompliance|0
728104|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Noncompliance|11
728105|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Noncompliance|0
728106|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Noncompliance|6
728107|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
728108|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
728109|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
728110|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
728111|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
728112|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
728113|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
728114|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
728115|NCT00262522|2340291|P4|Study Start Through 96 Weeks|Adverse Event|0
728116|NCT00262522|2340292|P3|Study Start Through 96 Weeks|Adverse Event|16
728117|NCT00262522|2340293|P2|Study Start Through 96 Weeks|Adverse Event|0
728118|NCT00262522|2340294|P1|Study Start Through 96 Weeks|Adverse Event|20
728119|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
728120|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
728121|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
728122|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
728123|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Virologic failure|0
728124|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Virologic failure|4
728125|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Virologic failure|0
728126|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Virologic failure|2
728127|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Death|0
728128|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Death|1
728129|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Death|0
728130|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Death|2
728131|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Noncompliance|0
728132|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Noncompliance|8
728133|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Noncompliance|0
728134|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Noncompliance|3
728135|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
728136|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
728137|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
728138|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
728139|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
728140|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
728141|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
728142|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
728143|NCT00262522|2340291|P4|Study Start Through 48 Weeks|Adverse Event|0
728144|NCT00262522|2340292|P3|Study Start Through 48 Weeks|Adverse Event|10
728145|NCT00262522|2340293|P2|Study Start Through 48 Weeks|Adverse Event|0
728146|NCT00262522|2340294|P1|Study Start Through 48 Weeks|Adverse Event|16
728147|NCT00262522|2340291|P4|Study Start Through 8 Weeks|Death|0
728148|NCT00262522|2340292|P3|Study Start Through 8 Weeks|Death|0
728149|NCT00262522|2340293|P2|Study Start Through 8 Weeks|Death|0
728150|NCT00262522|2340294|P1|Study Start Through 8 Weeks|Death|1
728151|NCT00262522|2340291|P4|Study Start Through 8 Weeks|Noncompliance|2
728152|NCT00262522|2340292|P3|Study Start Through 8 Weeks|Noncompliance|2
728153|NCT00262522|2340293|P2|Study Start Through 8 Weeks|Noncompliance|0
728154|NCT00262522|2340294|P1|Study Start Through 8 Weeks|Noncompliance|0
728155|NCT00262522|2340291|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
728156|NCT00262522|2340292|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
728157|NCT00262522|2340293|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
728158|NCT00262522|2340294|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
728159|NCT00262522|2340291|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
728160|NCT00262522|2340292|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
728161|NCT00262522|2340293|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
728162|NCT00262522|2340294|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
728163|NCT00262522|2340291|P4|Study Start Through 8 Weeks|Adverse Event|1
728164|NCT00262522|2340292|P3|Study Start Through 8 Weeks|Adverse Event|3
728165|NCT00262522|2340293|P2|Study Start Through 8 Weeks|Adverse Event|2
728166|NCT00262522|2340294|P1|Study Start Through 8 Weeks|Adverse Event|1
728167|NCT00262600|2340317|P3|Overall Study|Not Specified|62
728168|NCT00262600|2340318|P2|Overall Study|Not Specified|59
728169|NCT00262600|2340319|P1|Overall Study|Not Specified|58
728170|NCT00262600|2340317|P3|Overall Study|Not Treated|24
728171|NCT00262600|2340318|P2|Overall Study|Not Treated|17
728172|NCT00262600|2340319|P1|Overall Study|Not Treated|32
728173|NCT00262600|2340317|P3|Overall Study|Withdrawal by Subject|139
728174|NCT00262600|2340318|P2|Overall Study|Withdrawal by Subject|145
728175|NCT00262600|2340319|P1|Overall Study|Withdrawal by Subject|128
728176|NCT00262600|2340317|P3|Overall Study|Lost to Follow-up|41
728177|NCT00262600|2340318|P2|Overall Study|Lost to Follow-up|31
728178|NCT00262600|2340319|P1|Overall Study|Lost to Follow-up|17
728179|NCT00262743|2340369|P2|Overall Study|Disease progression|3
728180|NCT00262743|2340370|P1|Overall Study|Disease progression|0
728181|NCT00262743|2340369|P2|Overall Study|Adverse Event|9
728182|NCT00262743|2340370|P1|Overall Study|Adverse Event|0
728183|NCT00262821|2340379|P2|Overall Study|Inevaluable - inadequate data|4
728184|NCT00262821|2340380|P1|Overall Study|Inevaluable - inadequate data|0
728185|NCT00262821|2340379|P2|Overall Study|Ineligible - required test not done|4
728186|NCT00262821|2340380|P1|Overall Study|Ineligible - required test not done|1
728187|NCT00262821|2340379|P2|Overall Study|Ineligible - elevated creatinine|2
728188|NCT00262821|2340380|P1|Overall Study|Ineligible - elevated creatinine|0
728189|NCT00262821|2340379|P2|Overall Study|Ineligible - inadequate pathology|3
728190|NCT00262821|2340380|P1|Overall Study|Ineligible - inadequate pathology|1
728191|NCT00262821|2340379|P2|Overall Study|Ineligible - wrong primary|1
728192|NCT00262821|2340380|P1|Overall Study|Ineligible - wrong primary|0
728193|NCT00262821|2340379|P2|Overall Study|Ineligible - wrong cell type|2
728194|NCT00262821|2340380|P1|Overall Study|Ineligible - wrong cell type|2
728195|NCT00262821|2340379|P2|Overall Study|Ineligible - wrong stage|3
728196|NCT00262821|2340380|P1|Overall Study|Ineligible - wrong stage|0
728197|NCT00262834|2340392|P2|Overall Study|Surgery delayed/tissue not collected|4
728198|NCT00262834|2340393|P1|Overall Study|Surgery delayed/tissue not collected|1
728220|NCT00262860|2340420|P1|Overall Study|Adverse Event|2
728221|NCT00262873|2340426|P1|Overall Study|Withdrawal by Subject|5
728222|NCT00262873|2340426|P1|Overall Study|Adverse Event|3
728223|NCT00262925|2340437|P1|Overall Study|Other|1
728224|NCT00262925|2340437|P1|Overall Study|alternative therapy|1
728225|NCT00262925|2340437|P1|Overall Study|Death|2
728226|NCT00262925|2340437|P1|Overall Study|Adverse Event|4
728227|NCT00262925|2340437|P1|Overall Study|Lack of Efficacy|3
728228|NCT00262951|2340443|P1|Overall Study|Off treatment for other disease|1
728229|NCT00262951|2340443|P1|Overall Study|Alternative treatment|3
728230|NCT00262951|2340443|P1|Overall Study|Withdrawal by Subject|1
728231|NCT00262951|2340443|P1|Overall Study|Death|1
728232|NCT00262951|2340443|P1|Overall Study|Adverse Event|7
728233|NCT00262951|2340443|P1|Overall Study|Progressive disease/relapse|3
728234|NCT00263211|2340485|P2|Overall Study|Disease Progression|1
728235|NCT00263211|2340486|P1|Overall Study|Disease Progression|0
728236|NCT00263211|2340485|P2|Overall Study|Protocol Violation|0
728237|NCT00263211|2340486|P1|Overall Study|Protocol Violation|1
728238|NCT00263211|2340485|P2|Overall Study|Withdrawal by Subject|0
728239|NCT00263211|2340486|P1|Overall Study|Withdrawal by Subject|3
728240|NCT00263211|2340485|P2|Overall Study|Death|0
728241|NCT00263211|2340486|P1|Overall Study|Death|1
728242|NCT00263328|2340505|P3|Overall Study|Adverse Event|4
728243|NCT00263328|2340506|P2|Overall Study|Adverse Event|1
728244|NCT00263328|2340507|P1|Overall Study|Adverse Event|1
728245|NCT00263328|2340505|P3|Overall Study|Not specified|1
728246|NCT00263328|2340506|P2|Overall Study|Not specified|0
728247|NCT00263328|2340507|P1|Overall Study|Not specified|3
728248|NCT00263328|2340505|P3|Overall Study|Withdrawal by Subject|1
728249|NCT00263328|2340506|P2|Overall Study|Withdrawal by Subject|0
728250|NCT00263328|2340507|P1|Overall Study|Withdrawal by Subject|3
728251|NCT00263328|2340505|P3|Overall Study|Lost to Follow-up|0
728252|NCT00263328|2340506|P2|Overall Study|Lost to Follow-up|1
728253|NCT00263328|2340507|P1|Overall Study|Lost to Follow-up|1
728254|NCT00263328|2340505|P3|Overall Study|Death|1
728255|NCT00263328|2340506|P2|Overall Study|Death|0
728256|NCT00263328|2340507|P1|Overall Study|Death|0
728257|NCT00263666|2340665|P2|Overall Study|Withdrawal by Subject|1
728258|NCT00263666|2340666|P1|Overall Study|Withdrawal by Subject|0
728259|NCT00263666|2340665|P2|Overall Study|Lost to Follow-up|2
728260|NCT00263666|2340666|P1|Overall Study|Lost to Follow-up|1
728261|NCT00263666|2340665|P2|Overall Study|Adverse Event|8
728262|NCT00263666|2340666|P1|Overall Study|Adverse Event|6
728263|NCT00263757|2340719|P2|Overall Study|Adverse Event|3
728264|NCT00263757|2340720|P1|Overall Study|Adverse Event|3
728265|NCT00263757|2340719|P2|Overall Study|Screen failure|1
728266|NCT00263757|2340720|P1|Overall Study|Screen failure|0
728267|NCT00263757|2340719|P2|Overall Study|Withdrawal by Subject|4
728268|NCT00263757|2340720|P1|Overall Study|Withdrawal by Subject|5
728269|NCT00270257|2340732|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
728270|NCT00270257|2340733|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
728271|NCT00271544|2340835|P1|Overall Study|Implant not attempted|4
728272|NCT00271544|2340835|P1|Overall Study|Model 4196 lead not attempted|9
728273|NCT00271544|2340835|P1|Overall Study|Subjects did not receive a 4196 lead|7
728274|NCT00271596|2340869|P2|Overall Study|Withdrawal by Subject|1
728275|NCT00271596|2340870|P1|Overall Study|Withdrawal by Subject|0
728276|NCT00271596|2340869|P2|Overall Study|Protocol Violation|0
728277|NCT00271596|2340870|P1|Overall Study|Protocol Violation|1
728278|NCT00271609|2340896|P2|Overall Study|Withdrawal by Subject|0
728279|NCT00271609|2340897|P1|Overall Study|Withdrawal by Subject|2
728280|NCT00271609|2340896|P2|Overall Study|Adverse Event|3
728281|NCT00271609|2340897|P1|Overall Study|Adverse Event|11
728282|NCT00271817|2340921|P3|Part 2|LDL < 50 mg/dL|4
728283|NCT00271817|2340922|P2|Part 2|LDL < 50 mg/dL|3
728284|NCT00271817|2340923|P1|Part 2|LDL < 50 mg/dL|0
728285|NCT00271817|2340921|P3|Part 2|Withdrawal by Subject|13
728286|NCT00271817|2340922|P2|Part 2|Withdrawal by Subject|2
728287|NCT00271817|2340923|P1|Part 2|Withdrawal by Subject|0
728288|NCT00271817|2340921|P3|Part 2|Patient Moved|5
728289|NCT00271817|2340922|P2|Part 2|Patient Moved|0
728290|NCT00271817|2340923|P1|Part 2|Patient Moved|0
728291|NCT00271817|2340921|P3|Part 2|Protocol Violation|5
728292|NCT00271817|2340922|P2|Part 2|Protocol Violation|3
728293|NCT00271817|2340923|P1|Part 2|Protocol Violation|0
728294|NCT00271817|2340921|P3|Part 2|Lost to Follow-up|18
728295|NCT00271817|2340922|P2|Part 2|Lost to Follow-up|6
728296|NCT00271817|2340923|P1|Part 2|Lost to Follow-up|0
728297|NCT00271817|2340921|P3|Part 2|Lack of Efficacy|6
728298|NCT00271817|2340922|P2|Part 2|Lack of Efficacy|1
728299|NCT00271817|2340923|P1|Part 2|Lack of Efficacy|0
728300|NCT00271817|2340921|P3|Part 2|Adverse Event|33
728301|NCT00271817|2340922|P2|Part 2|Adverse Event|17
728302|NCT00271817|2340923|P1|Part 2|Adverse Event|0
728303|NCT00271817|2340921|P3|Part 1|LDL < 50 mg/dL|48
728304|NCT00271817|2340922|P2|Part 1|LDL < 50 mg/dL|4
728305|NCT00271817|2340923|P1|Part 1|LDL < 50 mg/dL|1
728306|NCT00271817|2340921|P3|Part 1|Withdrawal by Subject|45
728307|NCT00271817|2340922|P2|Part 1|Withdrawal by Subject|17
728308|NCT00271817|2340923|P1|Part 1|Withdrawal by Subject|23
728309|NCT00271817|2340921|P3|Part 1|Patient Moved|5
728310|NCT00271817|2340922|P2|Part 1|Patient Moved|1
728311|NCT00271817|2340923|P1|Part 1|Patient Moved|3
728312|NCT00271817|2340921|P3|Part 1|Protocol Violation|7
728313|NCT00271817|2340922|P2|Part 1|Protocol Violation|4
728314|NCT00271817|2340923|P1|Part 1|Protocol Violation|5
728315|NCT00271817|2340921|P3|Part 1|Lost to Follow-up|24
728316|NCT00271817|2340922|P2|Part 1|Lost to Follow-up|8
728317|NCT00271817|2340923|P1|Part 1|Lost to Follow-up|6
728318|NCT00271817|2340921|P3|Part 1|Adverse Event|156
728319|NCT00271817|2340922|P2|Part 1|Adverse Event|25
728320|NCT00271817|2340923|P1|Part 1|Adverse Event|68
728321|NCT00271856|2340952|P2|Overall Study|Lost to Follow-up|11
728322|NCT00271856|2340953|P1|Overall Study|Lost to Follow-up|10
728323|NCT00271856|2340952|P2|Overall Study|Withdrawal by Subject|7
728324|NCT00271856|2340953|P1|Overall Study|Withdrawal by Subject|1
728325|NCT00271947|2340969|P1|Overall Study|Lost to Follow-up|1
728327|NCT00272779|2341042|P2|Baseline Through Week 96|Continuing on treatment|38
728328|NCT00272779|2341043|P1|Baseline Through Week 96|Continuing on treatment|61
728329|NCT00272779|2341042|P2|Baseline Through Week 96|Never treated|3
728330|NCT00272779|2341043|P1|Baseline Through Week 96|Never treated|2
728331|NCT00272779|2341042|P2|Baseline Through Week 96|Pregnancy at Week 96|0
728332|NCT00272779|2341043|P1|Baseline Through Week 96|Pregnancy at Week 96|1
728333|NCT00272779|2341042|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
728334|NCT00272779|2341043|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
728335|NCT00272779|2341042|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
728336|NCT00272779|2341043|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
728337|NCT00272779|2341042|P2|Baseline Through Week 96|Changed address before Week 96|1
728338|NCT00272779|2341043|P1|Baseline Through Week 96|Changed address before Week 96|0
728339|NCT00272779|2341042|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
728340|NCT00272779|2341043|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
728341|NCT00272779|2341042|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
728342|NCT00272779|2341043|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
728343|NCT00272779|2341042|P2|Baseline Through Week 96|Pregnancy before Week 96|7
728344|NCT00272779|2341043|P1|Baseline Through Week 96|Pregnancy before Week 96|5
728345|NCT00272779|2341042|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
728346|NCT00272779|2341043|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
728347|NCT00272779|2341042|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
728348|NCT00272779|2341043|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
728349|NCT00272779|2341042|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
728350|NCT00272779|2341043|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
728351|NCT00272779|2341042|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
728352|NCT00272779|2341043|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
728353|NCT00272779|2341042|P2|Baseline Through Week 96|Death before Week 96|5
728354|NCT00272779|2341043|P1|Baseline Through Week 96|Death before Week 96|6
728355|NCT00272779|2341042|P2|Baseline Through Week 96|Adverse event before Week 96|22
728356|NCT00272779|2341043|P1|Baseline Through Week 96|Adverse event before Week 96|13
728357|NCT00272779|2341042|P2|Baseline Through Week 48|Never treated|3
728358|NCT00272779|2341043|P1|Baseline Through Week 48|Never treated|2
728359|NCT00272779|2341042|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
728360|NCT00272779|2341043|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
728361|NCT00272779|2341042|P2|Baseline Through Week 48|Continuing treatment|368
728362|NCT00272779|2341043|P1|Baseline Through Week 48|Continuing treatment|385
728363|NCT00272779|2341042|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
728364|NCT00272779|2341043|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
728365|NCT00272779|2341042|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
728366|NCT00272779|2341043|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
728367|NCT00272779|2341042|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
728368|NCT00272779|2341043|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
728369|NCT00272779|2341042|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
728370|NCT00272779|2341043|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
728371|NCT00272779|2341042|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
728372|NCT00272779|2341043|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
728373|NCT00272779|2341042|P2|Baseline Through Week 48|Death on/after Week 48|1
728374|NCT00272779|2341043|P1|Baseline Through Week 48|Death on/after Week 48|1
728375|NCT00272779|2341042|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
728376|NCT00272779|2341043|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
728377|NCT00272779|2341042|P2|Baseline Through Week 48|Chose different site before wk 48|1
728378|NCT00272779|2341043|P1|Baseline Through Week 48|Chose different site before wk 48|0
728379|NCT00272779|2341042|P2|Baseline Through Week 48|Participant's decision before wk 48|1
728380|NCT00272779|2341043|P1|Baseline Through Week 48|Participant's decision before wk 48|0
728381|NCT00272779|2341042|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
728382|NCT00272779|2341043|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
728383|NCT00272779|2341042|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
728384|NCT00272779|2341043|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
728385|NCT00272779|2341042|P2|Baseline Through Week 48|Pregnancy before Week 48|2
728386|NCT00272779|2341043|P1|Baseline Through Week 48|Pregnancy before Week 48|2
728387|NCT00272779|2341042|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
728388|NCT00272779|2341043|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
728389|NCT00272779|2341042|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
728390|NCT00272779|2341043|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
728391|NCT00272779|2341042|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
728392|NCT00272779|2341043|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
728393|NCT00272779|2341042|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
728394|NCT00272779|2341043|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
728395|NCT00272779|2341042|P2|Baseline Through Week 48|Death before Week 48|4
728396|NCT00272779|2341043|P1|Baseline Through Week 48|Death before Week 48|4
728397|NCT00272779|2341042|P2|Baseline Through Week 48|Adverse event before Week 48|14
728398|NCT00272779|2341043|P1|Baseline Through Week 48|Adverse event before Week 48|10
728399|NCT00272792|2341224|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
728400|NCT00272792|2341225|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
728401|NCT00272792|2341224|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
728402|NCT00272792|2341225|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
728403|NCT00272792|2341224|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
728404|NCT00272792|2341225|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
728405|NCT00272792|2341224|P2|Part 1: Responsiveness|Lost to Follow-up|0
728406|NCT00272792|2341225|P1|Part 1: Responsiveness|Lost to Follow-up|1
728407|NCT00272961|2341238|P5|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
728408|NCT00272961|2341239|P4|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
728409|NCT00272961|2341240|P3|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
728410|NCT00272961|2341241|P2|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
728411|NCT00272961|2341242|P1|Treatment Phase: Week 3 Up to Week 12|Unspecified|1
728412|NCT00272961|2341238|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
728413|NCT00272961|2341239|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
728414|NCT00272961|2341240|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
728415|NCT00272961|2341241|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
728416|NCT00272961|2341242|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
728417|NCT00272961|2341238|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
728418|NCT00272961|2341239|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
728419|NCT00272961|2341240|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
728420|NCT00272961|2341241|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
728421|NCT00272961|2341242|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
728422|NCT00272961|2341238|P5|Placebo Run-in Phase: Up to Week 2|Unspecified|0
728423|NCT00272961|2341239|P4|Placebo Run-in Phase: Up to Week 2|Unspecified|0
728424|NCT00272961|2341240|P3|Placebo Run-in Phase: Up to Week 2|Unspecified|0
728425|NCT00272961|2341241|P2|Placebo Run-in Phase: Up to Week 2|Unspecified|0
728426|NCT00272961|2341242|P1|Placebo Run-in Phase: Up to Week 2|Unspecified|2
728427|NCT00272961|2341238|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
728428|NCT00272961|2341239|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
728429|NCT00272961|2341240|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
728430|NCT00272961|2341241|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
728431|NCT00272961|2341242|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
728432|NCT00272961|2341238|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
728433|NCT00272961|2341239|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
728434|NCT00272961|2341240|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
728435|NCT00272961|2341241|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
728436|NCT00272961|2341242|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
728437|NCT00272961|2341238|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
728438|NCT00272961|2341239|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
728439|NCT00272961|2341240|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
728440|NCT00272961|2341241|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
728441|NCT00272961|2341242|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
728442|NCT00272961|2341238|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
728443|NCT00272961|2341239|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
728444|NCT00272961|2341240|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
728445|NCT00272961|2341241|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
728446|NCT00272961|2341242|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
728447|NCT00272987|2341302|P3|Overall Study|Ongoing|15
728448|NCT00272987|2341303|P2|Overall Study|Ongoing|14
728449|NCT00272987|2341304|P1|Overall Study|Ongoing|20
728450|NCT00272987|2341302|P3|Overall Study|Missed >3 Visits|1
728451|NCT00272987|2341303|P2|Overall Study|Missed >3 Visits|0
728452|NCT00272987|2341304|P1|Overall Study|Missed >3 Visits|0
728453|NCT00272987|2341302|P3|Overall Study|Withdrawal by Subject|3
728454|NCT00272987|2341303|P2|Overall Study|Withdrawal by Subject|0
728455|NCT00272987|2341304|P1|Overall Study|Withdrawal by Subject|0
728456|NCT00272987|2341302|P3|Overall Study|Adverse Event|0
728457|NCT00272987|2341303|P2|Overall Study|Adverse Event|0
728458|NCT00272987|2341304|P1|Overall Study|Adverse Event|1
728459|NCT00273052|2341365|P2|Overall Study|Worsening serum lipid levels|2
728460|NCT00273052|2341366|P1|Overall Study|Worsening serum lipid levels|0
728461|NCT00273052|2341365|P2|Overall Study|Not specified|0
728462|NCT00273052|2341366|P1|Overall Study|Not specified|2
728463|NCT00273052|2341365|P2|Overall Study|Non-Compliance|1
728464|NCT00273052|2341366|P1|Overall Study|Non-Compliance|3
728465|NCT00273052|2341365|P2|Overall Study|Lack of Efficacy|4
728466|NCT00273052|2341366|P1|Overall Study|Lack of Efficacy|6
728467|NCT00273052|2341365|P2|Overall Study|Lost to Follow-up|25
728468|NCT00273052|2341366|P1|Overall Study|Lost to Follow-up|7
728469|NCT00273052|2341365|P2|Overall Study|Protocol Violation|18
728470|NCT00273052|2341366|P1|Overall Study|Protocol Violation|14
728471|NCT00273052|2341365|P2|Overall Study|Adverse Event|19
728472|NCT00273052|2341366|P1|Overall Study|Adverse Event|21
728473|NCT00273052|2341365|P2|Overall Study|Withdrawal by Subject|19
728474|NCT00273052|2341366|P1|Overall Study|Withdrawal by Subject|16
728475|NCT00273182|2341398|P1|Overall Study|Site exit, system change, 36 m FU missed|36
728476|NCT00273182|2341398|P1|Overall Study|Device/System Explant|154
728477|NCT00273182|2341398|P1|Overall Study|Withdrawal by Subject|257
728478|NCT00273182|2341398|P1|Overall Study|Lost to Follow-up|88
728479|NCT00273182|2341398|P1|Overall Study|Death|450
728480|NCT00266656|2341408|P2|Overall Study|Parent/Caregiver Decision|2
728481|NCT00266656|2341409|P1|Overall Study|Parent/Caregiver Decision|1
728482|NCT00266656|2341408|P2|Overall Study|Did Not Reach Final Height|8
728483|NCT00266656|2341409|P1|Overall Study|Did Not Reach Final Height|4
728484|NCT00266656|2341408|P2|Overall Study|Withdrawal by Subject|2
728485|NCT00266656|2341409|P1|Overall Study|Withdrawal by Subject|4
728486|NCT00266656|2341408|P2|Overall Study|Lost to Follow-up|1
728487|NCT00266656|2341409|P1|Overall Study|Lost to Follow-up|4
728488|NCT00266656|2341408|P2|Overall Study|Death|0
728489|NCT00266656|2341409|P1|Overall Study|Death|1
728490|NCT00266695|2341431|P1|Overall Study|Withdrawal by Subject|15
728491|NCT00266695|2341431|P1|Overall Study|Lost to Follow-up|3
728492|NCT00266695|2341431|P1|Overall Study|Physician Decision|1
728493|NCT00266695|2341431|P1|Overall Study|Death|9
728494|NCT00266695|2341431|P1|Overall Study|Adverse Event|1
728495|NCT00266812|2341460|P2|Overall Study|Discontinued before starting study drug|0
728496|NCT00266812|2341461|P1|Overall Study|Discontinued before starting study drug|4
728497|NCT00266812|2341460|P2|Overall Study|Withdrawal by Subject|2
728498|NCT00266812|2341461|P1|Overall Study|Withdrawal by Subject|0
728499|NCT00266812|2341460|P2|Overall Study|Protocol Violation|1
728500|NCT00266812|2341461|P1|Overall Study|Protocol Violation|0
728501|NCT00266812|2341460|P2|Overall Study|Adverse Event|1
728502|NCT00266812|2341461|P1|Overall Study|Adverse Event|3
728503|NCT00266812|2341460|P2|Overall Study|Death|4
728504|NCT00266812|2341461|P1|Overall Study|Death|5
728505|NCT00266812|2341460|P2|Overall Study|Disease Progression|3
728506|NCT00266812|2341461|P1|Overall Study|Disease Progression|9
728507|NCT00266825|2341469|P2|Completed Follow-Up|Withdrawal by Subject|5
728508|NCT00266825|2341470|P1|Completed Follow-Up|Withdrawal by Subject|11
728509|NCT00266825|2341469|P2|Completed Follow-Up|Lost to Follow-up|19
728510|NCT00266825|2341470|P1|Completed Follow-Up|Lost to Follow-up|14
890565|NCT00950807|2825723|P2|Treatment Period 2|Adverse Event|1
890566|NCT00950807|2825724|P1|Treatment Period 2|Adverse Event|0
890567|NCT00950807|2825715|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
890568|NCT00950807|2825716|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
728515|NCT00267007|2341506|P2|Overall Study|Adverse Event|0
728516|NCT00267007|2341507|P1|Overall Study|Adverse Event|1
728517|NCT00267007|2341506|P2|Overall Study|Non-compliance|1
728518|NCT00267007|2341507|P1|Overall Study|Non-compliance|0
728519|NCT00267007|2341506|P2|Overall Study|Lost to Follow-up|0
728520|NCT00267007|2341507|P1|Overall Study|Lost to Follow-up|1
728521|NCT00267007|2341506|P2|Overall Study|Withdrawal by Subject|0
728522|NCT00267007|2341507|P1|Overall Study|Withdrawal by Subject|6
728523|NCT00267046|2341517|P2|Overall Study|Radiation|1
728524|NCT00267046|2341518|P1|Overall Study|Radiation|0
728525|NCT00267046|2341517|P2|Overall Study|Withdrawal by Subject|0
728526|NCT00267046|2341518|P1|Overall Study|Withdrawal by Subject|1
728527|NCT00267046|2341517|P2|Overall Study|Surgery|1
728528|NCT00267046|2341518|P1|Overall Study|Surgery|3
728529|NCT00267046|2341517|P2|Overall Study|Open-label palifermin|7
728530|NCT00267046|2341518|P1|Overall Study|Open-label palifermin|2
728531|NCT00267046|2341517|P2|Overall Study|Chemotoxicity|0
728532|NCT00267046|2341518|P1|Overall Study|Chemotoxicity|2
728533|NCT00267046|2341517|P2|Overall Study|Disease progression|2
728534|NCT00267046|2341518|P1|Overall Study|Disease progression|4
728535|NCT00267098|2341542|P8|Overall Study|Sponsor withdrew subject|0
728536|NCT00267098|2341543|P7|Overall Study|Sponsor withdrew subject|0
728537|NCT00267098|2341544|P6|Overall Study|Sponsor withdrew subject|0
728538|NCT00267098|2341545|P5|Overall Study|Sponsor withdrew subject|0
728539|NCT00267098|2341546|P4|Overall Study|Sponsor withdrew subject|1
728540|NCT00267098|2341547|P3|Overall Study|Sponsor withdrew subject|0
728541|NCT00267098|2341548|P2|Overall Study|Sponsor withdrew subject|0
728542|NCT00267098|2341549|P1|Overall Study|Sponsor withdrew subject|0
728543|NCT00267098|2341542|P8|Overall Study|Subject listed for heart transplant|0
728544|NCT00267098|2341543|P7|Overall Study|Subject listed for heart transplant|1
728545|NCT00267098|2341544|P6|Overall Study|Subject listed for heart transplant|0
728546|NCT00267098|2341545|P5|Overall Study|Subject listed for heart transplant|0
728547|NCT00267098|2341546|P4|Overall Study|Subject listed for heart transplant|0
728548|NCT00267098|2341547|P3|Overall Study|Subject listed for heart transplant|0
728549|NCT00267098|2341548|P2|Overall Study|Subject listed for heart transplant|0
728550|NCT00267098|2341549|P1|Overall Study|Subject listed for heart transplant|0
728551|NCT00267098|2341542|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
728552|NCT00267098|2341543|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
728553|NCT00267098|2341544|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
728554|NCT00267098|2341545|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
728555|NCT00267098|2341546|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
728556|NCT00267098|2341547|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
728557|NCT00267098|2341548|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
728558|NCT00267098|2341549|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
728559|NCT00267098|2341542|P8|Overall Study|Explanted Medtronic device|0
728560|NCT00267098|2341543|P7|Overall Study|Explanted Medtronic device|0
728561|NCT00267098|2341544|P6|Overall Study|Explanted Medtronic device|0
728562|NCT00267098|2341545|P5|Overall Study|Explanted Medtronic device|0
728563|NCT00267098|2341546|P4|Overall Study|Explanted Medtronic device|1
728564|NCT00267098|2341547|P3|Overall Study|Explanted Medtronic device|0
728565|NCT00267098|2341548|P2|Overall Study|Explanted Medtronic device|0
728566|NCT00267098|2341549|P1|Overall Study|Explanted Medtronic device|0
728567|NCT00267098|2341542|P8|Overall Study|Site closure|0
728568|NCT00267098|2341543|P7|Overall Study|Site closure|1
728569|NCT00267098|2341544|P6|Overall Study|Site closure|1
728570|NCT00267098|2341545|P5|Overall Study|Site closure|0
728571|NCT00267098|2341546|P4|Overall Study|Site closure|1
728572|NCT00267098|2341547|P3|Overall Study|Site closure|0
728573|NCT00267098|2341548|P2|Overall Study|Site closure|0
728574|NCT00267098|2341549|P1|Overall Study|Site closure|0
728575|NCT00267098|2341542|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728576|NCT00267098|2341543|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728577|NCT00267098|2341544|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728578|NCT00267098|2341545|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728579|NCT00267098|2341546|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728580|NCT00267098|2341547|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728581|NCT00267098|2341548|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
728582|NCT00267098|2341549|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
728583|NCT00267098|2341542|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728584|NCT00267098|2341543|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728585|NCT00267098|2341544|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728586|NCT00267098|2341545|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
728587|NCT00267098|2341546|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728588|NCT00267098|2341547|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728589|NCT00267098|2341548|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
728590|NCT00267098|2341549|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
728591|NCT00267098|2341542|P8|Overall Study|Physician Decision|0
728592|NCT00267098|2341543|P7|Overall Study|Physician Decision|3
728593|NCT00267098|2341544|P6|Overall Study|Physician Decision|4
728594|NCT00267098|2341545|P5|Overall Study|Physician Decision|5
728595|NCT00267098|2341546|P4|Overall Study|Physician Decision|11
728596|NCT00267098|2341547|P3|Overall Study|Physician Decision|7
728597|NCT00267098|2341548|P2|Overall Study|Physician Decision|0
728598|NCT00267098|2341549|P1|Overall Study|Physician Decision|5
728599|NCT00267098|2341542|P8|Overall Study|Withdrawal by Subject|5
728600|NCT00267098|2341543|P7|Overall Study|Withdrawal by Subject|12
728601|NCT00267098|2341544|P6|Overall Study|Withdrawal by Subject|9
728602|NCT00267098|2341545|P5|Overall Study|Withdrawal by Subject|12
728603|NCT00267098|2341546|P4|Overall Study|Withdrawal by Subject|21
728604|NCT00267098|2341547|P3|Overall Study|Withdrawal by Subject|24
728605|NCT00267098|2341548|P2|Overall Study|Withdrawal by Subject|0
728606|NCT00267098|2341549|P1|Overall Study|Withdrawal by Subject|8
728607|NCT00267098|2341542|P8|Overall Study|Lost to Follow-up|1
728608|NCT00267098|2341543|P7|Overall Study|Lost to Follow-up|1
728609|NCT00267098|2341544|P6|Overall Study|Lost to Follow-up|3
728610|NCT00267098|2341545|P5|Overall Study|Lost to Follow-up|2
728611|NCT00267098|2341546|P4|Overall Study|Lost to Follow-up|5
728612|NCT00267098|2341547|P3|Overall Study|Lost to Follow-up|6
728613|NCT00267098|2341548|P2|Overall Study|Lost to Follow-up|0
728614|NCT00267098|2341549|P1|Overall Study|Lost to Follow-up|0
728615|NCT00267098|2341542|P8|Overall Study|Death|9
728616|NCT00267098|2341543|P7|Overall Study|Death|28
728617|NCT00267098|2341544|P6|Overall Study|Death|23
728618|NCT00267098|2341545|P5|Overall Study|Death|14
728619|NCT00267098|2341546|P4|Overall Study|Death|66
728620|NCT00267098|2341547|P3|Overall Study|Death|57
728621|NCT00267098|2341548|P2|Overall Study|Death|0
728622|NCT00267098|2341549|P1|Overall Study|Death|0
728623|NCT00267150|2341693|P1|Overall Study|Adverse Event|1
728624|NCT00267189|2341700|P2|Overall Study|Missing|0
728625|NCT00267189|2341701|P1|Overall Study|Missing|3
728626|NCT00267189|2341700|P2|Overall Study|Death|0
728627|NCT00267189|2341701|P1|Overall Study|Death|1
728628|NCT00267189|2341700|P2|Overall Study|Patient withdrew consent|1
728629|NCT00267189|2341701|P1|Overall Study|Patient withdrew consent|1
728630|NCT00267202|2341713|P2|Overall Study|Lost to Follow-up|0
728631|NCT00267202|2341714|P1|Overall Study|Lost to Follow-up|3
728632|NCT00267202|2341713|P2|Overall Study|Administrative problems|1
728633|NCT00267202|2341714|P1|Overall Study|Administrative problems|2
728634|NCT00267202|2341713|P2|Overall Study|Protocol Violation|3
728635|NCT00267202|2341714|P1|Overall Study|Protocol Violation|2
728636|NCT00267202|2341713|P2|Overall Study|Adverse Event|7
728637|NCT00267202|2341714|P1|Overall Study|Adverse Event|13
728638|NCT00267202|2341713|P2|Overall Study|Withdrawal by Subject|15
728639|NCT00267202|2341714|P1|Overall Study|Withdrawal by Subject|12
728640|NCT00267202|2341713|P2|Overall Study|Unsatisfactory therapeutic effect|8
728641|NCT00267202|2341714|P1|Overall Study|Unsatisfactory therapeutic effect|21
728642|NCT00267488|2341746|P1|Overall Study|Other (Disease Progression)|1
728643|NCT00267488|2341746|P1|Overall Study|Protocol Violation|1
728644|NCT00267488|2341746|P1|Overall Study|Sponsor Terminated Study|9
728645|NCT00273858|2341825|P1|Overall Study|Adverse Event|81
728646|NCT00273858|2341825|P1|Overall Study|Withdrawal by Subject|21
728647|NCT00273858|2341825|P1|Overall Study|Lost to Follow-up|101
728648|NCT00273858|2341825|P1|Overall Study|Not completed 24 month observation time|334
728649|NCT00275821|2341868|P3|Overall Study|Protocol Violation|0
728650|NCT00275821|2341869|P2|Overall Study|Protocol Violation|1
728651|NCT00275821|2341870|P1|Overall Study|Protocol Violation|5
728652|NCT00275821|2341868|P3|Overall Study|Lack of Efficacy|0
728653|NCT00275821|2341869|P2|Overall Study|Lack of Efficacy|1
728654|NCT00275821|2341870|P1|Overall Study|Lack of Efficacy|2
728655|NCT00275821|2341868|P3|Overall Study|Death|1
728656|NCT00275821|2341869|P2|Overall Study|Death|2
728657|NCT00275821|2341870|P1|Overall Study|Death|0
728658|NCT00275821|2341868|P3|Overall Study|Lost to Follow-up|1
728659|NCT00275821|2341869|P2|Overall Study|Lost to Follow-up|1
728660|NCT00275821|2341870|P1|Overall Study|Lost to Follow-up|0
728661|NCT00275821|2341868|P3|Overall Study|Withdrawal by Subject|1
728662|NCT00275821|2341869|P2|Overall Study|Withdrawal by Subject|2
728663|NCT00275821|2341870|P1|Overall Study|Withdrawal by Subject|0
728664|NCT00275821|2341868|P3|Overall Study|Administrative problems|4
728665|NCT00275821|2341869|P2|Overall Study|Administrative problems|4
728666|NCT00275821|2341870|P1|Overall Study|Administrative problems|3
728667|NCT00275821|2341868|P3|Overall Study|Adverse Event|5
728668|NCT00275821|2341869|P2|Overall Study|Adverse Event|12
728669|NCT00275821|2341870|P1|Overall Study|Adverse Event|4
728670|NCT00276016|2341927|P6|Intervention 1|Withdrawal by Subject|0
728671|NCT00276016|2341928|P5|Intervention 1|Withdrawal by Subject|0
728672|NCT00276016|2341929|P4|Intervention 1|Withdrawal by Subject|0
728673|NCT00276016|2341930|P3|Intervention 1|Withdrawal by Subject|0
728674|NCT00276016|2341931|P2|Intervention 1|Withdrawal by Subject|1
728675|NCT00276016|2341932|P1|Intervention 1|Withdrawal by Subject|0
728676|NCT00276094|2341944|P3|Overall Study|Other-Study medication lost|1
728677|NCT00276094|2341945|P2|Overall Study|Other-Study medication lost|0
728678|NCT00276094|2341946|P1|Overall Study|Other-Study medication lost|0
728679|NCT00276094|2341944|P3|Overall Study|Other-Relocation|0
728680|NCT00276094|2341945|P2|Overall Study|Other-Relocation|1
728681|NCT00276094|2341946|P1|Overall Study|Other-Relocation|0
728682|NCT00276094|2341944|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
728683|NCT00276094|2341945|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
728684|NCT00276094|2341946|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
728685|NCT00276094|2341944|P3|Overall Study|Other-Refused follow-up visit|0
728686|NCT00276094|2341945|P2|Overall Study|Other-Refused follow-up visit|0
728687|NCT00276094|2341946|P1|Overall Study|Other-Refused follow-up visit|1
728688|NCT00276094|2341944|P3|Overall Study|Other-Lack of efficacy|0
728689|NCT00276094|2341945|P2|Overall Study|Other-Lack of efficacy|0
728690|NCT00276094|2341946|P1|Overall Study|Other-Lack of efficacy|1
728691|NCT00276094|2341944|P3|Overall Study|Other-Scheduled gastroplasty|0
728692|NCT00276094|2341945|P2|Overall Study|Other-Scheduled gastroplasty|0
728693|NCT00276094|2341946|P1|Overall Study|Other-Scheduled gastroplasty|1
728694|NCT00276094|2341944|P3|Overall Study|Other-Subject moved out of country|0
728695|NCT00276094|2341945|P2|Overall Study|Other-Subject moved out of country|0
728696|NCT00276094|2341946|P1|Overall Study|Other-Subject moved out of country|1
728697|NCT00276094|2341944|P3|Overall Study|Lost to Follow-up|4
728698|NCT00276094|2341945|P2|Overall Study|Lost to Follow-up|6
728699|NCT00276094|2341946|P1|Overall Study|Lost to Follow-up|8
728700|NCT00276094|2341944|P3|Overall Study|Protocol Violation|10
728701|NCT00276094|2341945|P2|Overall Study|Protocol Violation|7
728702|NCT00276094|2341946|P1|Overall Study|Protocol Violation|16
728703|NCT00276094|2341944|P3|Overall Study|Withdrawal by Subject|12
728704|NCT00276094|2341945|P2|Overall Study|Withdrawal by Subject|14
728705|NCT00276094|2341946|P1|Overall Study|Withdrawal by Subject|14
728706|NCT00276094|2341944|P3|Overall Study|Adverse Event|11
728707|NCT00276094|2341945|P2|Overall Study|Adverse Event|13
728708|NCT00276094|2341946|P1|Overall Study|Adverse Event|15
728709|NCT00276159|2341993|P1|Overall Study|Did not receive all 24 doses of 852A|6
728710|NCT00276419|2342070|P2|First Intervention|Withdrawal by Subject|2
728711|NCT00276419|2342071|P1|First Intervention|Withdrawal by Subject|0
728712|NCT00276419|2342070|P2|First Intervention|Adverse Event|0
728713|NCT00276419|2342071|P1|First Intervention|Adverse Event|1
728714|NCT00276458|2342083|P2|Overall Study|Protocol Violation|3
728715|NCT00276458|2342084|P1|Overall Study|Protocol Violation|4
728716|NCT00276458|2342083|P2|Overall Study|Lost to Follow-up|2
728717|NCT00276458|2342084|P1|Overall Study|Lost to Follow-up|2
728718|NCT00276458|2342083|P2|Overall Study|Adverse Event|2
728719|NCT00276458|2342084|P1|Overall Study|Adverse Event|0
728720|NCT00276484|2342118|P2|Overall Study|Could not take time off work|1
728721|NCT00276484|2342119|P1|Overall Study|Could not take time off work|0
728722|NCT00276484|2342118|P2|Overall Study|Withdrawal by Subject|3
728723|NCT00276484|2342119|P1|Overall Study|Withdrawal by Subject|4
728724|NCT00276484|2342118|P2|Overall Study|Protocol Violation|1
728725|NCT00276484|2342119|P1|Overall Study|Protocol Violation|0
728726|NCT00276484|2342118|P2|Overall Study|Lost to Follow-up|1
728727|NCT00276484|2342119|P1|Overall Study|Lost to Follow-up|1
728728|NCT00276484|2342118|P2|Overall Study|Adverse Event|7
728729|NCT00276484|2342119|P1|Overall Study|Adverse Event|4
728730|NCT00276614|2342154|P1|Overall Study|Progression of disease under study|3
728731|NCT00277095|2342163|P1|Overall Study|Physician Decision|1
728732|NCT00277095|2342163|P1|Overall Study|Missed Follow-up|9
728733|NCT00277095|2342163|P1|Overall Study|Lost to Follow-up|2
728734|NCT00277095|2342163|P1|Overall Study|Explanted|7
728735|NCT00277095|2342163|P1|Overall Study|Death|2
728736|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
728737|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
728738|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
728739|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
728740|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
728741|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
728742|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
728743|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
728744|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
728745|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
728746|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
728747|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
728748|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
728749|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
728750|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
728751|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
728752|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
728753|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
728754|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
728755|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
728756|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
728757|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
728758|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
728759|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
728760|NCT00277212|2342167|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
728761|NCT00277212|2342168|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
728762|NCT00277212|2342169|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
728763|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
728764|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
728765|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
728766|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
728767|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
728768|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
728769|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
728770|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
728771|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
728772|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
728773|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
728774|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
728775|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
728776|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
728777|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
728778|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
728779|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
728780|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
728781|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
728782|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
728783|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
728784|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
728785|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
728786|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
728787|NCT00277212|2342167|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
728788|NCT00277212|2342168|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
728789|NCT00277212|2342169|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
728790|NCT00277355|2342209|P2|Overall Study|Physician Decision|0
728791|NCT00277355|2342210|P1|Overall Study|Physician Decision|1
728792|NCT00277355|2342209|P2|Overall Study|Death|0
728793|NCT00277355|2342210|P1|Overall Study|Death|3
728794|NCT00277355|2342209|P2|Overall Study|Adverse Event|0
728795|NCT00277355|2342210|P1|Overall Study|Adverse Event|5
728796|NCT00277355|2342209|P2|Overall Study|Lost to Follow-up|2
728797|NCT00277355|2342210|P1|Overall Study|Lost to Follow-up|2
728798|NCT00277355|2342209|P2|Overall Study|Withdrawal by Subject|3
728799|NCT00277355|2342210|P1|Overall Study|Withdrawal by Subject|3
728802|NCT00270894|2342331|P1|Overall Study|Withdrawal by Subject|1
728803|NCT00270894|2342331|P1|Overall Study|Adverse Event|1
728804|NCT00270998|2342344|P3|12 Month Follow-up|Received/desired alternate treatment|1
728805|NCT00270998|2342345|P2|12 Month Follow-up|Received/desired alternate treatment|4
728806|NCT00270998|2342346|P1|12 Month Follow-up|Received/desired alternate treatment|1
728807|NCT00270998|2342344|P3|12 Month Follow-up|Personal/family health|1
728808|NCT00270998|2342345|P2|12 Month Follow-up|Personal/family health|5
728809|NCT00270998|2342346|P1|12 Month Follow-up|Personal/family health|0
728810|NCT00270998|2342344|P3|12 Month Follow-up|Pessary did not fit|0
728811|NCT00270998|2342345|P2|12 Month Follow-up|Pessary did not fit|0
728812|NCT00270998|2342346|P1|12 Month Follow-up|Pessary did not fit|1
728813|NCT00270998|2342344|P3|12 Month Follow-up|Withdrawal by Subject|16
728814|NCT00270998|2342345|P2|12 Month Follow-up|Withdrawal by Subject|12
728815|NCT00270998|2342346|P1|12 Month Follow-up|Withdrawal by Subject|7
728816|NCT00270998|2342344|P3|12 Month Follow-up|Lack of Efficacy|3
728817|NCT00270998|2342345|P2|12 Month Follow-up|Lack of Efficacy|4
728818|NCT00270998|2342346|P1|12 Month Follow-up|Lack of Efficacy|5
728819|NCT00270998|2342344|P3|3 Month Follow-up|Received/desired alternate treatment|2
728820|NCT00270998|2342345|P2|3 Month Follow-up|Received/desired alternate treatment|5
728821|NCT00270998|2342346|P1|3 Month Follow-up|Received/desired alternate treatment|13
728822|NCT00270998|2342344|P3|3 Month Follow-up|Personal/family health|0
728823|NCT00270998|2342345|P2|3 Month Follow-up|Personal/family health|1
728824|NCT00270998|2342346|P1|3 Month Follow-up|Personal/family health|1
728825|NCT00270998|2342344|P3|3 Month Follow-up|Pessary did not fit|0
728826|NCT00270998|2342345|P2|3 Month Follow-up|Pessary did not fit|0
728827|NCT00270998|2342346|P1|3 Month Follow-up|Pessary did not fit|12
728828|NCT00270998|2342344|P3|3 Month Follow-up|Withdrawal by Subject|15
728829|NCT00270998|2342345|P2|3 Month Follow-up|Withdrawal by Subject|14
728830|NCT00270998|2342346|P1|3 Month Follow-up|Withdrawal by Subject|11
728831|NCT00270998|2342344|P3|3 Month Follow-up|Lack of Efficacy|1
728832|NCT00270998|2342345|P2|3 Month Follow-up|Lack of Efficacy|2
728833|NCT00270998|2342346|P1|3 Month Follow-up|Lack of Efficacy|1
728834|NCT00270998|2342344|P3|3 Month Follow-up|Adverse Event|0
728835|NCT00270998|2342345|P2|3 Month Follow-up|Adverse Event|0
728836|NCT00270998|2342346|P1|3 Month Follow-up|Adverse Event|1
728837|NCT00271024|2342384|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
728838|NCT00271024|2342385|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
728839|NCT00271024|2342386|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
728840|NCT00271024|2342387|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
728841|NCT00271024|2342384|P4|Overall Study|Unpleasant Reaction To Tablet|2
728842|NCT00271024|2342385|P3|Overall Study|Unpleasant Reaction To Tablet|4
728843|NCT00271024|2342386|P2|Overall Study|Unpleasant Reaction To Tablet|3
728844|NCT00271024|2342387|P1|Overall Study|Unpleasant Reaction To Tablet|1
728845|NCT00271024|2342384|P4|Overall Study|Protocol Violation|11
728846|NCT00271024|2342385|P3|Overall Study|Protocol Violation|5
728847|NCT00271024|2342386|P2|Overall Study|Protocol Violation|6
728848|NCT00271024|2342387|P1|Overall Study|Protocol Violation|1
728849|NCT00271024|2342384|P4|Overall Study|Unknown/Unspecified|4
728850|NCT00271024|2342385|P3|Overall Study|Unknown/Unspecified|8
728851|NCT00271024|2342386|P2|Overall Study|Unknown/Unspecified|11
728852|NCT00271024|2342387|P1|Overall Study|Unknown/Unspecified|11
728853|NCT00271024|2342384|P4|Overall Study|Lost Interest|3
728854|NCT00271024|2342385|P3|Overall Study|Lost Interest|2
728855|NCT00271024|2342386|P2|Overall Study|Lost Interest|4
728856|NCT00271024|2342387|P1|Overall Study|Lost Interest|3
728857|NCT00278473|2342443|P2|Overall Study|drop out|3
728858|NCT00278473|2342444|P1|Overall Study|drop out|4
728859|NCT00281957|2342540|P2|Overall Study|Refusal unrelated to adverse events|1
728860|NCT00281957|2342541|P1|Overall Study|Refusal unrelated to adverse events|0
728861|NCT00281957|2342540|P2|Overall Study|Did not start treatment|1
728862|NCT00281957|2342541|P1|Overall Study|Did not start treatment|3
728863|NCT00281957|2342540|P2|Overall Study|Not eligible|2
728864|NCT00281957|2342541|P1|Overall Study|Not eligible|1
728865|NCT00281957|2342540|P2|Overall Study|Not protocol specified|1
728866|NCT00281957|2342541|P1|Overall Study|Not protocol specified|8
728867|NCT00281957|2342540|P2|Overall Study|Progression/relapse|35
728868|NCT00281957|2342541|P1|Overall Study|Progression/relapse|47
728869|NCT00281957|2342540|P2|Overall Study|Death|0
728870|NCT00281957|2342541|P1|Overall Study|Death|1
728871|NCT00281957|2342540|P2|Overall Study|Adverse Event|2
728872|NCT00281957|2342541|P1|Overall Study|Adverse Event|7
728873|NCT00282048|2342553|P1|Overall Study|Ongoing|1
728874|NCT00282048|2342553|P1|Overall Study|Unspecified|8
728875|NCT00282048|2342553|P1|Overall Study|Withdrawal by Subject|1
728876|NCT00282048|2342553|P1|Overall Study|Adverse Event|22
728877|NCT00282048|2342553|P1|Overall Study|Lack of Efficacy|30
728878|NCT00282087|2342565|P1|Overall Study|Death|1
728879|NCT00282113|2342581|P3|Overall Study|Removed at parents request|0
728880|NCT00282113|2342582|P2|Overall Study|Removed at parents request|0
728881|NCT00282113|2342583|P1|Overall Study|Removed at parents request|1
728882|NCT00282152|2342599|P2|Overall Study|Withdrawal by Subject|0
728883|NCT00282152|2342600|P1|Overall Study|Withdrawal by Subject|1
728884|NCT00282243|2342618|P1|Extension Treatment Period|Physician Decision|1
728885|NCT00282243|2342618|P1|Extension Treatment Period|Non-compliance|2
728886|NCT00282243|2342618|P1|Extension Treatment Period|Withdrawal by Subject|4
728887|NCT00282243|2342618|P1|Extension Treatment Period|Adverse Event|15
728888|NCT00282243|2342618|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
728889|NCT00282243|2342618|P1|Pharmacokinetic Treatment Period|Adverse Event|3
728890|NCT00282256|2342642|P1|Extension Treatment Period|Adverse Event|2
728891|NCT00282256|2342642|P1|Pharmacokinetic Treatment Period|Poor venous access|1
728892|NCT00282295|2342672|P3|Overall Study|Unspecified|0
728893|NCT00282295|2342673|P2|Overall Study|Unspecified|1
728894|NCT00282295|2342674|P1|Overall Study|Unspecified|0
728895|NCT00282295|2342672|P3|Overall Study|Lost to Follow-up|2
728896|NCT00282295|2342673|P2|Overall Study|Lost to Follow-up|7
728897|NCT00282295|2342674|P1|Overall Study|Lost to Follow-up|1
728898|NCT00282295|2342672|P3|Overall Study|Withdrawal by Subject|4
728899|NCT00282295|2342673|P2|Overall Study|Withdrawal by Subject|6
728900|NCT00282295|2342674|P1|Overall Study|Withdrawal by Subject|2
728901|NCT00282295|2342672|P3|Overall Study|Protocol Violation|1
728902|NCT00282295|2342673|P2|Overall Study|Protocol Violation|2
728903|NCT00282295|2342674|P1|Overall Study|Protocol Violation|0
728904|NCT00282295|2342672|P3|Overall Study|Serious Adverse Events|1
728905|NCT00282295|2342673|P2|Overall Study|Serious Adverse Events|0
728906|NCT00282295|2342674|P1|Overall Study|Serious Adverse Events|0
728907|NCT00282295|2342672|P3|Overall Study|Adverse Event|0
728908|NCT00282295|2342673|P2|Overall Study|Adverse Event|1
728909|NCT00282295|2342674|P1|Overall Study|Adverse Event|0
728910|NCT00282308|2342725|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
728911|NCT00282308|2342726|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
728912|NCT00282308|2342727|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
728913|NCT00282308|2342725|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
728914|NCT00282308|2342726|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
728915|NCT00282308|2342727|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
728916|NCT00282308|2342725|P3|Safety Follow-up Period|Lost to Follow-up|5
728917|NCT00282308|2342726|P2|Safety Follow-up Period|Lost to Follow-up|0
728918|NCT00282308|2342727|P1|Safety Follow-up Period|Lost to Follow-up|0
728919|NCT00282308|2342725|P3|Safety Follow-up Period|Adverse Event|1
728920|NCT00282308|2342726|P2|Safety Follow-up Period|Adverse Event|0
728921|NCT00282308|2342727|P1|Safety Follow-up Period|Adverse Event|0
728922|NCT00282308|2342725|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
728923|NCT00282308|2342726|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
728924|NCT00282308|2342727|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
728925|NCT00282308|2342725|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
728926|NCT00282308|2342726|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
728927|NCT00282308|2342727|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
728928|NCT00282308|2342725|P3|Optional Extension Re-treatment Period|Adverse Event|4
728929|NCT00282308|2342726|P2|Optional Extension Re-treatment Period|Adverse Event|0
728930|NCT00282308|2342727|P1|Optional Extension Re-treatment Period|Adverse Event|0
728931|NCT00282308|2342725|P3|Treatment Period|Not Treated with Study Drug|0
728932|NCT00282308|2342726|P2|Treatment Period|Not Treated with Study Drug|0
728933|NCT00282308|2342727|P1|Treatment Period|Not Treated with Study Drug|1
728934|NCT00282308|2342725|P3|Treatment Period|Adverse Event|0
728935|NCT00282308|2342726|P2|Treatment Period|Adverse Event|2
728936|NCT00282308|2342727|P1|Treatment Period|Adverse Event|0
728937|NCT00282308|2342725|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
728938|NCT00282308|2342726|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
728939|NCT00282308|2342727|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
728940|NCT00282308|2342725|P3|Treatment Period|Lost to Follow-up|0
728941|NCT00282308|2342726|P2|Treatment Period|Lost to Follow-up|0
728942|NCT00282308|2342727|P1|Treatment Period|Lost to Follow-up|1
728943|NCT00282334|2342756|P2|Overall Study|Withdrawal by Subject|5
728944|NCT00282334|2342757|P1|Overall Study|Withdrawal by Subject|8
728945|NCT00282347|2342765|P2|B Cell Follow-up Period|Reason Not Specified|0
728946|NCT00282347|2342766|P1|B Cell Follow-up Period|Reason Not Specified|2
728947|NCT00282347|2342765|P2|B Cell Follow-up Period|Physician Decision|0
728948|NCT00282347|2342766|P1|B Cell Follow-up Period|Physician Decision|1
728949|NCT00282347|2342765|P2|B Cell Follow-up Period|Withdrawal by Subject|0
728950|NCT00282347|2342766|P1|B Cell Follow-up Period|Withdrawal by Subject|2
728951|NCT00282347|2342765|P2|Safety Follow-up Period|Protocol Deviation|2
728952|NCT00282347|2342766|P1|Safety Follow-up Period|Protocol Deviation|0
728953|NCT00282347|2342765|P2|Safety Follow-up Period|Physician Decision|1
728954|NCT00282347|2342766|P1|Safety Follow-up Period|Physician Decision|1
728955|NCT00282347|2342765|P2|Safety Follow-up Period|Withdrawal by Subject|1
728956|NCT00282347|2342766|P1|Safety Follow-up Period|Withdrawal by Subject|2
728957|NCT00282347|2342765|P2|Safety Follow-up Period|Lost to Follow-up|2
728958|NCT00282347|2342766|P1|Safety Follow-up Period|Lost to Follow-up|0
728959|NCT00282347|2342765|P2|Treatment Period|Physician Decision|1
728960|NCT00282347|2342766|P1|Treatment Period|Physician Decision|0
728961|NCT00282347|2342765|P2|Treatment Period|Withdrawal by Subject|3
728962|NCT00282347|2342766|P1|Treatment Period|Withdrawal by Subject|1
728963|NCT00282347|2342765|P2|Treatment Period|Lost to Follow-up|5
728964|NCT00282347|2342766|P1|Treatment Period|Lost to Follow-up|2
728965|NCT00282347|2342765|P2|Treatment Period|Death|0
728966|NCT00282347|2342766|P1|Treatment Period|Death|2
728967|NCT00282438|2342792|P2|Overall Study|Death|1
728968|NCT00282438|2342793|P1|Overall Study|Death|0
728969|NCT00282438|2342792|P2|Overall Study|Lack of Efficacy|0
728970|NCT00282438|2342793|P1|Overall Study|Lack of Efficacy|1
728971|NCT00282464|2342801|P2|Overall Study|dropped due to missed visits|1
728972|NCT00282464|2342802|P1|Overall Study|dropped due to missed visits|0
728973|NCT00282464|2342801|P2|Overall Study|dispensed wrong kit|1
728974|NCT00282464|2342802|P1|Overall Study|dispensed wrong kit|0
728975|NCT00282464|2342801|P2|Overall Study|family crisis|1
728976|NCT00282464|2342802|P1|Overall Study|family crisis|0
728977|NCT00282464|2342801|P2|Overall Study|patient incarcerated|1
728978|NCT00282464|2342802|P1|Overall Study|patient incarcerated|0
728979|NCT00282464|2342801|P2|Overall Study|patient no show|1
728980|NCT00282464|2342802|P1|Overall Study|patient no show|0
728981|NCT00282464|2342801|P2|Overall Study|patient non-compliant|0
728982|NCT00282464|2342802|P1|Overall Study|patient non-compliant|3
728983|NCT00282464|2342801|P2|Overall Study|Patient moved|0
728984|NCT00282464|2342802|P1|Overall Study|Patient moved|1
728985|NCT00282464|2342801|P2|Overall Study|Protocol Violation|7
728986|NCT00282464|2342802|P1|Overall Study|Protocol Violation|0
728987|NCT00282464|2342801|P2|Overall Study|laboratory abnormality|2
728988|NCT00282464|2342802|P1|Overall Study|laboratory abnormality|1
728989|NCT00282464|2342801|P2|Overall Study|Withdrawal by Subject|10
728990|NCT00282464|2342802|P1|Overall Study|Withdrawal by Subject|24
728991|NCT00282464|2342801|P2|Overall Study|Lost to Follow-up|10
728992|NCT00282464|2342802|P1|Overall Study|Lost to Follow-up|10
728993|NCT00282464|2342801|P2|Overall Study|Lack of Efficacy|8
728994|NCT00282464|2342802|P1|Overall Study|Lack of Efficacy|8
728995|NCT00282464|2342801|P2|Overall Study|Adverse Event|20
728996|NCT00282464|2342802|P1|Overall Study|Adverse Event|26
728997|NCT00282568|2342850|P1|Extended Treatment Period|Lost to Follow-up|2
728998|NCT00282568|2342850|P1|Extended Treatment Period|Physician Decision|1
728999|NCT00282568|2342850|P1|Extended Treatment Period|Non-compliance|4
729000|NCT00282568|2342850|P1|Extended Treatment Period|Adverse Event|17
729001|NCT00282568|2342850|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
729002|NCT00282568|2342850|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
729003|NCT00282867|2342958|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
729004|NCT00282867|2342959|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
729005|NCT00282867|2342960|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
729006|NCT00282919|2342974|P1|Overall Study|Asymptomatic Parasitemia|2
729007|NCT00282919|2342974|P1|Overall Study|Withdrawal by Subject|1
729008|NCT00282919|2342974|P1|Overall Study|Lack of Efficacy|4
729009|NCT00282984|2343001|P2|Overall Study|Protocol Violation|0
729010|NCT00282984|2343002|P1|Overall Study|Protocol Violation|2
729011|NCT00282984|2343001|P2|Overall Study|in prison|1
729012|NCT00282984|2343002|P1|Overall Study|in prison|0
729013|NCT00282984|2343001|P2|Overall Study|lack of motivation|0
729014|NCT00282984|2343002|P1|Overall Study|lack of motivation|1
729015|NCT00282984|2343001|P2|Overall Study|Participant used antipsychosis meds|1
729016|NCT00282984|2343002|P1|Overall Study|Participant used antipsychosis meds|0
729017|NCT00282984|2343001|P2|Overall Study|Participant only allowed phone follow-up|1
729018|NCT00282984|2343002|P1|Overall Study|Participant only allowed phone follow-up|0
729019|NCT00282984|2343001|P2|Overall Study|Participant stopped study medication|2
729020|NCT00282984|2343002|P1|Overall Study|Participant stopped study medication|2
729021|NCT00282984|2343001|P2|Overall Study|Withdrawal by Participant|34
729022|NCT00282984|2343002|P1|Overall Study|Withdrawal by Participant|22
729023|NCT00282984|2343001|P2|Overall Study|Lost to Follow-up|10
729024|NCT00282984|2343002|P1|Overall Study|Lost to Follow-up|14
729025|NCT00282984|2343001|P2|Overall Study|Lack of Efficacy|2
729026|NCT00282984|2343002|P1|Overall Study|Lack of Efficacy|0
729027|NCT00282984|2343001|P2|Overall Study|Adverse Event|5
729028|NCT00282984|2343002|P1|Overall Study|Adverse Event|8
729029|NCT00282984|2343001|P2|Overall Study|Death|5
729030|NCT00282984|2343002|P1|Overall Study|Death|2
729031|NCT00283049|2343029|P3|Overall Study|No longer requires study treatment|1
729032|NCT00283049|2343030|P2|Overall Study|No longer requires study treatment|0
729033|NCT00283049|2343031|P1|Overall Study|No longer requires study treatment|0
729034|NCT00283049|2343029|P3|Overall Study|Discontinuation of Study|20
729035|NCT00283049|2343030|P2|Overall Study|Discontinuation of Study|16
729036|NCT00283049|2343031|P1|Overall Study|Discontinuation of Study|18
729037|NCT00283049|2343029|P3|Overall Study|Withdrawal by Subject|19
729038|NCT00283049|2343030|P2|Overall Study|Withdrawal by Subject|24
729039|NCT00283049|2343031|P1|Overall Study|Withdrawal by Subject|26
729040|NCT00283049|2343029|P3|Overall Study|Lost to Follow-up|5
729041|NCT00283049|2343030|P2|Overall Study|Lost to Follow-up|2
729042|NCT00283049|2343031|P1|Overall Study|Lost to Follow-up|4
729043|NCT00283049|2343029|P3|Overall Study|Lack of Efficacy|1
729044|NCT00283049|2343030|P2|Overall Study|Lack of Efficacy|1
729045|NCT00283049|2343031|P1|Overall Study|Lack of Efficacy|0
729046|NCT00283049|2343029|P3|Overall Study|Death|1
729047|NCT00283049|2343030|P2|Overall Study|Death|1
729048|NCT00283049|2343031|P1|Overall Study|Death|1
729049|NCT00283049|2343029|P3|Overall Study|Protocol Violation|3
729050|NCT00283049|2343030|P2|Overall Study|Protocol Violation|0
729051|NCT00283049|2343031|P1|Overall Study|Protocol Violation|3
729052|NCT00283049|2343029|P3|Overall Study|Adverse Event|4
729053|NCT00283049|2343030|P2|Overall Study|Adverse Event|1
729054|NCT00283049|2343031|P1|Overall Study|Adverse Event|6
729055|NCT00283062|2343061|P4|Overall Study|chemotherapy not completed (cycle 6)|0
729056|NCT00283062|2343062|P3|Overall Study|chemotherapy not completed (cycle 6)|0
729057|NCT00283062|2343063|P2|Overall Study|chemotherapy not completed (cycle 6)|0
729058|NCT00283062|2343064|P1|Overall Study|chemotherapy not completed (cycle 6)|1
729059|NCT00283062|2343061|P4|Overall Study|Undefined|4
729060|NCT00283062|2343062|P3|Overall Study|Undefined|1
729061|NCT00283062|2343063|P2|Overall Study|Undefined|1
729062|NCT00283062|2343064|P1|Overall Study|Undefined|0
729063|NCT00283062|2343061|P4|Overall Study|Participant did not wish to continue|0
729064|NCT00283062|2343062|P3|Overall Study|Participant did not wish to continue|1
729065|NCT00283062|2343063|P2|Overall Study|Participant did not wish to continue|2
729066|NCT00283062|2343064|P1|Overall Study|Participant did not wish to continue|3
729067|NCT00283062|2343061|P4|Overall Study|Progressive disease|0
729068|NCT00283062|2343062|P3|Overall Study|Progressive disease|1
729069|NCT00283062|2343063|P2|Overall Study|Progressive disease|0
729070|NCT00283062|2343064|P1|Overall Study|Progressive disease|0
729071|NCT00283062|2343061|P4|Overall Study|Lost to Follow-up|0
729072|NCT00283062|2343062|P3|Overall Study|Lost to Follow-up|1
729073|NCT00283062|2343063|P2|Overall Study|Lost to Follow-up|0
729074|NCT00283062|2343064|P1|Overall Study|Lost to Follow-up|1
729075|NCT00283062|2343061|P4|Overall Study|Adverse Event|0
729076|NCT00283062|2343062|P3|Overall Study|Adverse Event|1
729077|NCT00283062|2343063|P2|Overall Study|Adverse Event|0
729078|NCT00283062|2343064|P1|Overall Study|Adverse Event|2
729079|NCT00283062|2343061|P4|Overall Study|Did not receive any study medication|45
729080|NCT00283062|2343062|P3|Overall Study|Did not receive any study medication|36
729081|NCT00283062|2343063|P2|Overall Study|Did not receive any study medication|4
729082|NCT00283062|2343064|P1|Overall Study|Did not receive any study medication|5
729083|NCT00283244|2343109|P3|Overall Study|Clinical deterioration|3
729084|NCT00283244|2343110|P2|Overall Study|Clinical deterioration|3
729085|NCT00283244|2343111|P1|Overall Study|Clinical deterioration|1
729086|NCT00283244|2343109|P3|Overall Study|Medical illness (other complicating dz)|6
729087|NCT00283244|2343110|P2|Overall Study|Medical illness (other complicating dz)|3
729088|NCT00283244|2343111|P1|Overall Study|Medical illness (other complicating dz)|4
729089|NCT00283244|2343109|P3|Overall Study|Physician Decision|1
729090|NCT00283244|2343110|P2|Overall Study|Physician Decision|0
729091|NCT00283244|2343111|P1|Overall Study|Physician Decision|0
729092|NCT00283244|2343109|P3|Overall Study|Withdrawal by Subject|2
729093|NCT00283244|2343110|P2|Overall Study|Withdrawal by Subject|2
729094|NCT00283244|2343111|P1|Overall Study|Withdrawal by Subject|1
729095|NCT00283244|2343109|P3|Overall Study|Lack of Efficacy|26
729096|NCT00283244|2343110|P2|Overall Study|Lack of Efficacy|32
729097|NCT00283244|2343111|P1|Overall Study|Lack of Efficacy|8
729098|NCT00283244|2343109|P3|Overall Study|Death|2
729099|NCT00283244|2343110|P2|Overall Study|Death|3
729100|NCT00283244|2343111|P1|Overall Study|Death|4
729101|NCT00283244|2343109|P3|Overall Study|Adverse Event|11
729102|NCT00283244|2343110|P2|Overall Study|Adverse Event|8
729103|NCT00283244|2343111|P1|Overall Study|Adverse Event|0
729104|NCT00283296|2343131|P1|Overall Study|in-home trial not completed|5
729105|NCT00283387|2343137|P2|First Intervention|Withdrawal by Subject|1
729106|NCT00283387|2343138|P1|First Intervention|Withdrawal by Subject|0
729107|NCT00283387|2343137|P2|First Intervention|Subject non-compliant|1
729108|NCT00283387|2343138|P1|First Intervention|Subject non-compliant|1
729109|NCT00283400|2343148|P4|Overall Study|Death|0
729110|NCT00283400|2343149|P3|Overall Study|Death|1
729111|NCT00283400|2343150|P2|Overall Study|Death|0
729112|NCT00283400|2343151|P1|Overall Study|Death|1
729113|NCT00283400|2343148|P4|Overall Study|Withdrawal by Subject|0
729114|NCT00283400|2343149|P3|Overall Study|Withdrawal by Subject|0
729115|NCT00283400|2343150|P2|Overall Study|Withdrawal by Subject|1
729116|NCT00283400|2343151|P1|Overall Study|Withdrawal by Subject|1
729117|NCT00283439|2343173|P4|Overall Study|Not specified|0
729118|NCT00283439|2343174|P3|Overall Study|Not specified|0
729119|NCT00283439|2343175|P2|Overall Study|Not specified|0
729120|NCT00283439|2343176|P1|Overall Study|Not specified|1
729121|NCT00283439|2343173|P4|Overall Study|Treatment discontinued|3
729122|NCT00283439|2343174|P3|Overall Study|Treatment discontinued|1
729123|NCT00283439|2343175|P2|Overall Study|Treatment discontinued|2
729124|NCT00283439|2343176|P1|Overall Study|Treatment discontinued|0
729125|NCT00283439|2343173|P4|Overall Study|Stem cell transplant|3
729126|NCT00283439|2343174|P3|Overall Study|Stem cell transplant|4
729127|NCT00283439|2343175|P2|Overall Study|Stem cell transplant|6
729128|NCT00283439|2343176|P1|Overall Study|Stem cell transplant|6
729129|NCT00283439|2343173|P4|Overall Study|Requirement for alternative therapy|2
729130|NCT00283439|2343174|P3|Overall Study|Requirement for alternative therapy|5
729131|NCT00283439|2343175|P2|Overall Study|Requirement for alternative therapy|2
729132|NCT00283439|2343176|P1|Overall Study|Requirement for alternative therapy|1
729133|NCT00283439|2343173|P4|Overall Study|Disease progression|0
729134|NCT00283439|2343174|P3|Overall Study|Disease progression|0
729135|NCT00283439|2343175|P2|Overall Study|Disease progression|1
729136|NCT00283439|2343176|P1|Overall Study|Disease progression|0
729137|NCT00283439|2343173|P4|Overall Study|Death|0
729138|NCT00283439|2343174|P3|Overall Study|Death|1
729139|NCT00283439|2343175|P2|Overall Study|Death|0
729140|NCT00283439|2343176|P1|Overall Study|Death|0
729141|NCT00283439|2343173|P4|Overall Study|Adverse Event|1
729142|NCT00283439|2343174|P3|Overall Study|Adverse Event|0
729143|NCT00283439|2343175|P2|Overall Study|Adverse Event|0
729144|NCT00283439|2343176|P1|Overall Study|Adverse Event|0
729145|NCT00283595|2343200|P2|Overall Study|Withdrawal by Subject|2
729146|NCT00283595|2343201|P1|Overall Study|Withdrawal by Subject|1
729147|NCT00283686|2343213|P4|Overall Study|Less than full participation|12
729148|NCT00283686|2343214|P3|Overall Study|Less than full participation|6
729149|NCT00283686|2343215|P2|Overall Study|Less than full participation|9
729150|NCT00283686|2343216|P1|Overall Study|Less than full participation|7
729151|NCT00283686|2343213|P4|Overall Study|Lost to Follow-up|20
729152|NCT00283686|2343214|P3|Overall Study|Lost to Follow-up|26
729153|NCT00283686|2343215|P2|Overall Study|Lost to Follow-up|31
729154|NCT00283686|2343216|P1|Overall Study|Lost to Follow-up|21
729155|NCT00283686|2343213|P4|Overall Study|Death|0
729156|NCT00283686|2343214|P3|Overall Study|Death|1
729157|NCT00283686|2343215|P2|Overall Study|Death|1
729158|NCT00283686|2343216|P1|Overall Study|Death|1
729161|NCT00283842|2343315|P5|Overall Study|Lost to Follow-up|1
729162|NCT00283842|2343316|P4|Overall Study|Lost to Follow-up|1
729163|NCT00283842|2343317|P3|Overall Study|Lost to Follow-up|4
729164|NCT00283842|2343318|P2|Overall Study|Lost to Follow-up|2
729165|NCT00283842|2343319|P1|Overall Study|Lost to Follow-up|0
729166|NCT00283842|2343315|P5|Overall Study|Lack of Efficacy|3
729167|NCT00283842|2343316|P4|Overall Study|Lack of Efficacy|0
729168|NCT00283842|2343317|P3|Overall Study|Lack of Efficacy|1
729169|NCT00283842|2343318|P2|Overall Study|Lack of Efficacy|3
729170|NCT00283842|2343319|P1|Overall Study|Lack of Efficacy|1
729171|NCT00283842|2343315|P5|Overall Study|Withdrawal by Subject|4
729172|NCT00283842|2343316|P4|Overall Study|Withdrawal by Subject|5
729173|NCT00283842|2343317|P3|Overall Study|Withdrawal by Subject|1
729174|NCT00283842|2343318|P2|Overall Study|Withdrawal by Subject|1
729175|NCT00283842|2343319|P1|Overall Study|Withdrawal by Subject|2
729176|NCT00283842|2343315|P5|Overall Study|Protocol deviation|2
729177|NCT00283842|2343316|P4|Overall Study|Protocol deviation|0
729178|NCT00283842|2343317|P3|Overall Study|Protocol deviation|0
729179|NCT00283842|2343318|P2|Overall Study|Protocol deviation|0
729180|NCT00283842|2343319|P1|Overall Study|Protocol deviation|0
729181|NCT00283842|2343315|P5|Overall Study|Protocol Violation|0
729182|NCT00283842|2343316|P4|Overall Study|Protocol Violation|0
729183|NCT00283842|2343317|P3|Overall Study|Protocol Violation|4
729184|NCT00283842|2343318|P2|Overall Study|Protocol Violation|5
729185|NCT00283842|2343319|P1|Overall Study|Protocol Violation|1
729186|NCT00283842|2343315|P5|Overall Study|Adverse Event|5
729187|NCT00283842|2343316|P4|Overall Study|Adverse Event|21
729188|NCT00283842|2343317|P3|Overall Study|Adverse Event|21
729189|NCT00283842|2343318|P2|Overall Study|Adverse Event|7
729190|NCT00283842|2343319|P1|Overall Study|Adverse Event|8
729191|NCT00283868|2343338|P2|Overall Study|Lost to Follow-up|8
729192|NCT00283868|2343339|P1|Overall Study|Lost to Follow-up|7
729193|NCT00284050|2343354|P3|Overall Study|Death|0
729194|NCT00284050|2343355|P2|Overall Study|Death|0
729195|NCT00284050|2343356|P1|Overall Study|Death|1
729196|NCT00284050|2343354|P3|Overall Study|Lost to Follow-up|1
729197|NCT00284050|2343355|P2|Overall Study|Lost to Follow-up|0
729198|NCT00284050|2343356|P1|Overall Study|Lost to Follow-up|1
729199|NCT00284050|2343354|P3|Overall Study|Withdrawal by Subject|2
729200|NCT00284050|2343355|P2|Overall Study|Withdrawal by Subject|2
729201|NCT00284050|2343356|P1|Overall Study|Withdrawal by Subject|2
729202|NCT00284050|2343354|P3|Overall Study|Protocol Violation|2
729203|NCT00284050|2343355|P2|Overall Study|Protocol Violation|1
729204|NCT00284050|2343356|P1|Overall Study|Protocol Violation|0
729205|NCT00284050|2343354|P3|Overall Study|Lack of Efficacy|3
729206|NCT00284050|2343355|P2|Overall Study|Lack of Efficacy|1
729207|NCT00284050|2343356|P1|Overall Study|Lack of Efficacy|0
729208|NCT00284050|2343354|P3|Overall Study|Adverse Event|1
729209|NCT00284050|2343355|P2|Overall Study|Adverse Event|1
729210|NCT00284050|2343356|P1|Overall Study|Adverse Event|1
729211|NCT00284089|2343374|P4|Extension Phase|Withdrawal by Subject|3
729212|NCT00284089|2343375|P3|Extension Phase|Withdrawal by Subject|1
729213|NCT00284089|2343376|P2|Extension Phase|Withdrawal by Subject|0
729214|NCT00284089|2343377|P1|Extension Phase|Withdrawal by Subject|0
729215|NCT00284089|2343374|P4|Extension Phase|Protocol Violation|0
729216|NCT00284089|2343375|P3|Extension Phase|Protocol Violation|1
729217|NCT00284089|2343376|P2|Extension Phase|Protocol Violation|0
729218|NCT00284089|2343377|P1|Extension Phase|Protocol Violation|0
729219|NCT00284089|2343374|P4|Extension Phase|condition no longer requires study drug|7
729220|NCT00284089|2343375|P3|Extension Phase|condition no longer requires study drug|2
729221|NCT00284089|2343376|P2|Extension Phase|condition no longer requires study drug|0
729222|NCT00284089|2343377|P1|Extension Phase|condition no longer requires study drug|2
729223|NCT00284089|2343374|P4|Extension Phase|Adverse Event|2
729224|NCT00284089|2343375|P3|Extension Phase|Adverse Event|2
729225|NCT00284089|2343376|P2|Extension Phase|Adverse Event|0
729226|NCT00284089|2343377|P1|Extension Phase|Adverse Event|0
729227|NCT00284089|2343374|P4|Multiple Dose Phase|Death|1
729228|NCT00284089|2343375|P3|Multiple Dose Phase|Death|1
729229|NCT00284089|2343376|P2|Multiple Dose Phase|Death|0
729230|NCT00284089|2343377|P1|Multiple Dose Phase|Death|0
729231|NCT00284089|2343374|P4|Multiple Dose Phase|Withdrawal by Subject|2
729232|NCT00284089|2343375|P3|Multiple Dose Phase|Withdrawal by Subject|1
729233|NCT00284089|2343376|P2|Multiple Dose Phase|Withdrawal by Subject|0
729234|NCT00284089|2343377|P1|Multiple Dose Phase|Withdrawal by Subject|0
729235|NCT00284089|2343374|P4|Multiple Dose Phase|Protocol Violation|0
729236|NCT00284089|2343375|P3|Multiple Dose Phase|Protocol Violation|1
729237|NCT00284089|2343376|P2|Multiple Dose Phase|Protocol Violation|0
729238|NCT00284089|2343377|P1|Multiple Dose Phase|Protocol Violation|0
729239|NCT00284089|2343374|P4|Multiple Dose Phase|Adverse Event|1
729240|NCT00284089|2343375|P3|Multiple Dose Phase|Adverse Event|1
729241|NCT00284089|2343376|P2|Multiple Dose Phase|Adverse Event|0
729242|NCT00284089|2343377|P1|Multiple Dose Phase|Adverse Event|1
729243|NCT00284141|2343403|P1|Overall Study|Ongoing treatment|2
729244|NCT00284141|2343403|P1|Overall Study|Did not take study medication|2
729245|NCT00284141|2343403|P1|Overall Study|Pneumonia|1
729246|NCT00284141|2343403|P1|Overall Study|General decline|1
729247|NCT00284141|2343403|P1|Overall Study|Clinical deterioration / death|2
729248|NCT00284141|2343403|P1|Overall Study|Symptomatic / Clinical Progression|11
729249|NCT00284141|2343403|P1|Overall Study|Participant's request|9
729250|NCT00284141|2343403|P1|Overall Study|Adverse Event|19
729251|NCT00284141|2343403|P1|Overall Study|Disease Progression / Lack of efficacy|51
729252|NCT00274261|2343440|P2|Overall Study|Lost to Follow-up|75
729253|NCT00274261|2343441|P1|Overall Study|Lost to Follow-up|106
729254|NCT00274261|2343440|P2|Overall Study|Protocol Violation|42
729255|NCT00274261|2343441|P1|Overall Study|Protocol Violation|71
729256|NCT00274261|2343440|P2|Overall Study|Withdrawal by Subject|126
729257|NCT00274261|2343441|P1|Overall Study|Withdrawal by Subject|179
729258|NCT00274261|2343440|P2|Overall Study|Pregnancy|83
729259|NCT00274261|2343441|P1|Overall Study|Pregnancy|114
729260|NCT00274261|2343440|P2|Overall Study|Adverse Event|11
729261|NCT00274261|2343441|P1|Overall Study|Adverse Event|19
729264|NCT00274456|2343455|P4|Overall Study|Withdrawal by Subject|13
729265|NCT00274456|2343456|P3|Overall Study|Withdrawal by Subject|9
729266|NCT00274456|2343457|P2|Overall Study|Withdrawal by Subject|13
729267|NCT00274456|2343458|P1|Overall Study|Withdrawal by Subject|18
729268|NCT00274456|2343455|P4|Overall Study|Lost to Follow-up|0
729269|NCT00274456|2343456|P3|Overall Study|Lost to Follow-up|1
729270|NCT00274456|2343457|P2|Overall Study|Lost to Follow-up|0
729271|NCT00274456|2343458|P1|Overall Study|Lost to Follow-up|0
729272|NCT00274456|2343455|P4|Overall Study|Physician Decision|13
729273|NCT00274456|2343456|P3|Overall Study|Physician Decision|6
729274|NCT00274456|2343457|P2|Overall Study|Physician Decision|5
729275|NCT00274456|2343458|P1|Overall Study|Physician Decision|7
729276|NCT00274456|2343455|P4|Overall Study|Adverse Event|2
729277|NCT00274456|2343456|P3|Overall Study|Adverse Event|2
729278|NCT00274456|2343457|P2|Overall Study|Adverse Event|1
729279|NCT00274456|2343458|P1|Overall Study|Adverse Event|0
729280|NCT00274456|2343455|P4|Overall Study|Unacceptable toxicity|16
729281|NCT00274456|2343456|P3|Overall Study|Unacceptable toxicity|12
729282|NCT00274456|2343457|P2|Overall Study|Unacceptable toxicity|5
729283|NCT00274456|2343458|P1|Overall Study|Unacceptable toxicity|10
729284|NCT00274456|2343455|P4|Overall Study|Still on treatment|1
729285|NCT00274456|2343456|P3|Overall Study|Still on treatment|5
729286|NCT00274456|2343457|P2|Overall Study|Still on treatment|3
729287|NCT00274456|2343458|P1|Overall Study|Still on treatment|2
729288|NCT00274469|2343502|P2|Overall Study|Reasons not specified|8
729289|NCT00274469|2343503|P1|Overall Study|Reasons not specified|5
729290|NCT00274469|2343502|P2|Overall Study|Withdrawal by Subject|0
729291|NCT00274469|2343503|P1|Overall Study|Withdrawal by Subject|2
729292|NCT00274469|2343502|P2|Overall Study|Condition under investigation worsened|38
729293|NCT00274469|2343503|P1|Overall Study|Condition under investigation worsened|28
729294|NCT00274469|2343502|P2|Overall Study|Adverse Event|3
729295|NCT00274469|2343503|P1|Overall Study|Adverse Event|2
729296|NCT00274469|2343502|P2|Overall Study|Death|1
729297|NCT00274469|2343503|P1|Overall Study|Death|1
729298|NCT00274625|2343519|P2|Overall Study|Excluded from analysis|8
729299|NCT00274625|2343520|P1|Overall Study|Excluded from analysis|14
729300|NCT00274625|2343519|P2|Overall Study|Lost to Follow-up|54
729301|NCT00274625|2343520|P1|Overall Study|Lost to Follow-up|46
729302|NCT00274651|2343528|P2|Overall Study|Physician Decision|7
729303|NCT00274651|2343529|P1|Overall Study|Physician Decision|8
729304|NCT00274651|2343528|P2|Overall Study|Withdrawal by Subject|1
729305|NCT00274651|2343529|P1|Overall Study|Withdrawal by Subject|0
729306|NCT00274651|2343528|P2|Overall Study|Death|3
729307|NCT00274651|2343529|P1|Overall Study|Death|1
729308|NCT00274651|2343528|P2|Overall Study|Lack of Efficacy|6
729309|NCT00274651|2343529|P1|Overall Study|Lack of Efficacy|13
729310|NCT00274651|2343528|P2|Overall Study|Adverse Event|3
729311|NCT00274651|2343529|P1|Overall Study|Adverse Event|6
729312|NCT00274716|2343548|P6|Phase B|Lost to Follow-up|0
729313|NCT00274716|2343549|P5|Phase B|Lost to Follow-up|0
729314|NCT00274716|2343550|P4|Phase B|Lost to Follow-up|0
729315|NCT00274716|2343551|P3|Phase B|Lost to Follow-up|0
729316|NCT00274716|2343552|P2|Phase B|Lost to Follow-up|1
729317|NCT00274716|2343553|P1|Phase B|Lost to Follow-up|0
729318|NCT00274716|2343548|P6|Phase B|Other non-reported reason|0
729319|NCT00274716|2343549|P5|Phase B|Other non-reported reason|0
729320|NCT00274716|2343550|P4|Phase B|Other non-reported reason|1
729321|NCT00274716|2343551|P3|Phase B|Other non-reported reason|1
729322|NCT00274716|2343552|P2|Phase B|Other non-reported reason|0
729323|NCT00274716|2343553|P1|Phase B|Other non-reported reason|0
729324|NCT00274716|2343548|P6|Phase B|Participant moved|0
729325|NCT00274716|2343549|P5|Phase B|Participant moved|0
729326|NCT00274716|2343550|P4|Phase B|Participant moved|0
729327|NCT00274716|2343551|P3|Phase B|Participant moved|0
729328|NCT00274716|2343552|P2|Phase B|Participant moved|0
729329|NCT00274716|2343553|P1|Phase B|Participant moved|1
729330|NCT00274716|2343548|P6|Phase B|Withdrawal by Subject|0
729331|NCT00274716|2343549|P5|Phase B|Withdrawal by Subject|0
729332|NCT00274716|2343550|P4|Phase B|Withdrawal by Subject|0
729333|NCT00274716|2343551|P3|Phase B|Withdrawal by Subject|0
729334|NCT00274716|2343552|P2|Phase B|Withdrawal by Subject|1
729335|NCT00274716|2343553|P1|Phase B|Withdrawal by Subject|0
729336|NCT00274716|2343548|P6|Phase B|Protocol Violation|0
729337|NCT00274716|2343549|P5|Phase B|Protocol Violation|0
729338|NCT00274716|2343550|P4|Phase B|Protocol Violation|0
729339|NCT00274716|2343551|P3|Phase B|Protocol Violation|0
729340|NCT00274716|2343552|P2|Phase B|Protocol Violation|2
729341|NCT00274716|2343553|P1|Phase B|Protocol Violation|0
729342|NCT00274716|2343548|P6|Phase B|Adverse Event|1
729343|NCT00274716|2343549|P5|Phase B|Adverse Event|0
729344|NCT00274716|2343550|P4|Phase B|Adverse Event|0
729345|NCT00274716|2343551|P3|Phase B|Adverse Event|2
729346|NCT00274716|2343552|P2|Phase B|Adverse Event|0
729347|NCT00274716|2343553|P1|Phase B|Adverse Event|0
729348|NCT00274716|2343548|P6|Phase A|Completed but did not enter Phase B|1
729349|NCT00274716|2343549|P5|Phase A|Completed but did not enter Phase B|1
729350|NCT00274716|2343550|P4|Phase A|Completed but did not enter Phase B|2
729351|NCT00274716|2343551|P3|Phase A|Completed but did not enter Phase B|2
729352|NCT00274716|2343552|P2|Phase A|Completed but did not enter Phase B|2
729353|NCT00274716|2343553|P1|Phase A|Completed but did not enter Phase B|1
729354|NCT00274716|2343548|P6|Phase A|Adverse Event|0
729355|NCT00274716|2343549|P5|Phase A|Adverse Event|2
729356|NCT00274716|2343550|P4|Phase A|Adverse Event|0
729357|NCT00274716|2343551|P3|Phase A|Adverse Event|3
729358|NCT00274716|2343552|P2|Phase A|Adverse Event|3
729359|NCT00274716|2343553|P1|Phase A|Adverse Event|2
729360|NCT00274716|2343548|P6|Phase A|Withdrawal by Subject|1
729361|NCT00274716|2343549|P5|Phase A|Withdrawal by Subject|0
729362|NCT00274716|2343550|P4|Phase A|Withdrawal by Subject|3
729363|NCT00274716|2343551|P3|Phase A|Withdrawal by Subject|1
729364|NCT00274716|2343552|P2|Phase A|Withdrawal by Subject|2
729365|NCT00274716|2343553|P1|Phase A|Withdrawal by Subject|2
729366|NCT00274716|2343548|P6|Phase A|Met criteria for discontinuation|0
729367|NCT00274716|2343549|P5|Phase A|Met criteria for discontinuation|0
729368|NCT00274716|2343550|P4|Phase A|Met criteria for discontinuation|0
729369|NCT00274716|2343551|P3|Phase A|Met criteria for discontinuation|0
729370|NCT00274716|2343552|P2|Phase A|Met criteria for discontinuation|1
729371|NCT00274716|2343553|P1|Phase A|Met criteria for discontinuation|1
729372|NCT00274716|2343548|P6|Phase A|Protocol Violation|0
729373|NCT00274716|2343549|P5|Phase A|Protocol Violation|0
729374|NCT00274716|2343550|P4|Phase A|Protocol Violation|1
729375|NCT00274716|2343551|P3|Phase A|Protocol Violation|0
729376|NCT00274716|2343552|P2|Phase A|Protocol Violation|0
729377|NCT00274716|2343553|P1|Phase A|Protocol Violation|1
729378|NCT00274716|2343548|P6|Phase A|Site Terminated|0
729379|NCT00274716|2343549|P5|Phase A|Site Terminated|0
729380|NCT00274716|2343550|P4|Phase A|Site Terminated|1
729381|NCT00274716|2343551|P3|Phase A|Site Terminated|0
729382|NCT00274716|2343552|P2|Phase A|Site Terminated|0
729383|NCT00274716|2343553|P1|Phase A|Site Terminated|0
729384|NCT00274716|2343548|P6|Phase A|Participant moved|1
729385|NCT00274716|2343549|P5|Phase A|Participant moved|0
729386|NCT00274716|2343550|P4|Phase A|Participant moved|0
729387|NCT00274716|2343551|P3|Phase A|Participant moved|1
729388|NCT00274716|2343552|P2|Phase A|Participant moved|0
729389|NCT00274716|2343553|P1|Phase A|Participant moved|0
729390|NCT00274716|2343548|P6|Phase A|Other non-reported reason|1
729391|NCT00274716|2343549|P5|Phase A|Other non-reported reason|0
729392|NCT00274716|2343550|P4|Phase A|Other non-reported reason|2
729393|NCT00274716|2343551|P3|Phase A|Other non-reported reason|1
729394|NCT00274716|2343552|P2|Phase A|Other non-reported reason|2
729395|NCT00274716|2343553|P1|Phase A|Other non-reported reason|4
729396|NCT00274742|2343619|P6|Overall Study|Other|0
729397|NCT00274742|2343620|P5|Overall Study|Other|2
729398|NCT00274742|2343621|P4|Overall Study|Other|0
729399|NCT00274742|2343622|P3|Overall Study|Other|0
729400|NCT00274742|2343623|P2|Overall Study|Other|3
729401|NCT00274742|2343624|P1|Overall Study|Other|0
729402|NCT00274742|2343619|P6|Overall Study|Disease Progression|0
729403|NCT00274742|2343620|P5|Overall Study|Disease Progression|1
729404|NCT00274742|2343621|P4|Overall Study|Disease Progression|0
729405|NCT00274742|2343622|P3|Overall Study|Disease Progression|1
729406|NCT00274742|2343623|P2|Overall Study|Disease Progression|1
729407|NCT00274742|2343624|P1|Overall Study|Disease Progression|0
729408|NCT00274742|2343619|P6|Overall Study|End of Study|0
729409|NCT00274742|2343620|P5|Overall Study|End of Study|0
729410|NCT00274742|2343621|P4|Overall Study|End of Study|1
729411|NCT00274742|2343622|P3|Overall Study|End of Study|0
729412|NCT00274742|2343623|P2|Overall Study|End of Study|0
729413|NCT00274742|2343624|P1|Overall Study|End of Study|0
729414|NCT00274742|2343619|P6|Overall Study|Lost to Follow-up|0
729415|NCT00274742|2343620|P5|Overall Study|Lost to Follow-up|1
729416|NCT00274742|2343621|P4|Overall Study|Lost to Follow-up|0
729417|NCT00274742|2343622|P3|Overall Study|Lost to Follow-up|0
729418|NCT00274742|2343623|P2|Overall Study|Lost to Follow-up|0
729419|NCT00274742|2343624|P1|Overall Study|Lost to Follow-up|0
729420|NCT00274742|2343619|P6|Overall Study|Adverse Event|3
729421|NCT00274742|2343620|P5|Overall Study|Adverse Event|12
729422|NCT00274742|2343621|P4|Overall Study|Adverse Event|4
729423|NCT00274742|2343622|P3|Overall Study|Adverse Event|1
729424|NCT00274742|2343623|P2|Overall Study|Adverse Event|4
729425|NCT00274742|2343624|P1|Overall Study|Adverse Event|0
729426|NCT00274846|2343666|P1|Overall Study|Did not receive adequate NK cells|1
729466|NCT00274937|2343688|P1|Overall Study|Progressive Disease|4
729467|NCT00274937|2343688|P1|Overall Study|Withdrawal by Subject|6
729468|NCT00274937|2343688|P1|Overall Study|Physician Decision|10
729469|NCT00275002|2343697|P2|Overall Study|Adverse Event|1
729470|NCT00275002|2343698|P1|Overall Study|Adverse Event|0
729471|NCT00275002|2343697|P2|Overall Study|Disease progression|15
729472|NCT00275002|2343698|P1|Overall Study|Disease progression|21
729473|NCT00275002|2343697|P2|Overall Study|Death|0
729474|NCT00275002|2343698|P1|Overall Study|Death|1
729475|NCT00275028|2343706|P1|Overall Study|Physician Decision|2
729476|NCT00275028|2343706|P1|Overall Study|Progressive Disease|30
729477|NCT00275028|2343706|P1|Overall Study|Adverse Event|9
729478|NCT00275028|2343706|P1|Overall Study|Withdrawal by Subject|5
729479|NCT00275028|2343706|P1|Overall Study|Withdrew consent before treatment began|1
729480|NCT00275262|2343713|P2|Overall Study|Started Chemotherapy|0
729481|NCT00275262|2343714|P1|Overall Study|Started Chemotherapy|1
729482|NCT00275262|2343713|P2|Overall Study|Death|0
729483|NCT00275262|2343714|P1|Overall Study|Death|1
729484|NCT00275262|2343713|P2|Overall Study|Protocol Violation|2
729485|NCT00275262|2343714|P1|Overall Study|Protocol Violation|0
729486|NCT00275262|2343713|P2|Overall Study|Lost to Follow-up|2
729487|NCT00275262|2343714|P1|Overall Study|Lost to Follow-up|0
729488|NCT00275262|2343713|P2|Overall Study|Disease progression|5
729489|NCT00275262|2343714|P1|Overall Study|Disease progression|2
729490|NCT00275262|2343713|P2|Overall Study|Adverse Event|0
729491|NCT00275262|2343714|P1|Overall Study|Adverse Event|2
729492|NCT00275301|2343741|P1|Overall Study|Adverse Event|5
729493|NCT00275340|2343747|P2|Overall Study|Lost to Follow-up|4
729494|NCT00275340|2343748|P1|Overall Study|Lost to Follow-up|2
729495|NCT00275561|2343765|P2|Overall Study|Family Issues|2
729496|NCT00275561|2343766|P1|Overall Study|Family Issues|0
729497|NCT00275561|2343765|P2|Overall Study|Scheduling|2
729498|NCT00275561|2343766|P1|Overall Study|Scheduling|1
729499|NCT00275561|2343765|P2|Overall Study|Travel|1
729500|NCT00275561|2343766|P1|Overall Study|Travel|1
729501|NCT00275561|2343765|P2|Overall Study|Withdrawal by Subject|1
729502|NCT00275561|2343766|P1|Overall Study|Withdrawal by Subject|0
729503|NCT00285207|2343834|P2|Overall Study|non-compliance|1
729504|NCT00285207|2343835|P1|Overall Study|non-compliance|0
729505|NCT00285207|2343834|P2|Overall Study|Pregnancy|1
729506|NCT00285207|2343835|P1|Overall Study|Pregnancy|1
729507|NCT00285207|2343834|P2|Overall Study|Withdrawal by Subject|2
729508|NCT00285207|2343835|P1|Overall Study|Withdrawal by Subject|5
729509|NCT00285207|2343834|P2|Overall Study|Lost to Follow-up|2
729510|NCT00285207|2343835|P1|Overall Study|Lost to Follow-up|3
729517|NCT00285649|2343877|P3|Overall Study|Withdrawal by Subject|2
729518|NCT00285649|2343878|P2|Overall Study|Withdrawal by Subject|2
729519|NCT00285649|2343879|P1|Overall Study|Withdrawal by Subject|3
729520|NCT00285649|2343877|P3|Overall Study|Lost to Follow-up|4
729521|NCT00285649|2343878|P2|Overall Study|Lost to Follow-up|4
729522|NCT00285649|2343879|P1|Overall Study|Lost to Follow-up|6
729523|NCT00285818|2343898|P2|Overall Study|Lost to Follow-up|0
729524|NCT00285818|2343899|P1|Overall Study|Lost to Follow-up|1
729525|NCT00285818|2343898|P2|Overall Study|Withdrawal by Subject|2
729526|NCT00285818|2343899|P1|Overall Study|Withdrawal by Subject|3
729527|NCT00285857|2343905|P1|Overall Study|Adverse Event|1
729528|NCT00285857|2343905|P1|Overall Study|Inadequate initial breast cytology|1
729529|NCT00285857|2343905|P1|Overall Study|Withdrawal by Subject|2
729530|NCT00286091|2343929|P2|Open-label Treatment Phase|Missing End of Study Information|1
729531|NCT00286091|2343930|P1|Open-label Treatment Phase|Missing End of Study Information|0
729532|NCT00286091|2343929|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
729533|NCT00286091|2343930|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
729534|NCT00286091|2343929|P2|Open-label Treatment Phase|Lost to Follow-up|1
729535|NCT00286091|2343930|P1|Open-label Treatment Phase|Lost to Follow-up|0
729536|NCT00286091|2343929|P2|Open-label Treatment Phase|Noncompliance|1
729537|NCT00286091|2343930|P1|Open-label Treatment Phase|Noncompliance|3
729538|NCT00286091|2343929|P2|Open-label Treatment Phase|Disease Progression|3
729539|NCT00286091|2343930|P1|Open-label Treatment Phase|Disease Progression|9
729540|NCT00286091|2343929|P2|Open-label Treatment Phase|Death|7
729541|NCT00286091|2343930|P1|Open-label Treatment Phase|Death|10
729542|NCT00286091|2343929|P2|Open-label Treatment Phase|Withdrawal by Subject|10
729543|NCT00286091|2343930|P1|Open-label Treatment Phase|Withdrawal by Subject|14
729544|NCT00286091|2343929|P2|Open-label Treatment Phase|Other|11
729545|NCT00286091|2343930|P1|Open-label Treatment Phase|Other|11
729546|NCT00286091|2343929|P2|Open-label Treatment Phase|Adverse Event|16
729547|NCT00286091|2343930|P1|Open-label Treatment Phase|Adverse Event|5
729548|NCT00286091|2343929|P2|Open-label Treatment Phase|Physician Decision|21
729549|NCT00286091|2343930|P1|Open-label Treatment Phase|Physician Decision|24
729550|NCT00286091|2343929|P2|Double-blind Treatment Phase|Ineligibility Determined|2
729551|NCT00286091|2343930|P1|Double-blind Treatment Phase|Ineligibility Determined|1
729552|NCT00286091|2343929|P2|Double-blind Treatment Phase|Protocol Deviation|3
729553|NCT00286091|2343930|P1|Double-blind Treatment Phase|Protocol Deviation|1
729554|NCT00286091|2343929|P2|Double-blind Treatment Phase|Lost to Follow-up|4
729555|NCT00286091|2343930|P1|Double-blind Treatment Phase|Lost to Follow-up|11
729556|NCT00286091|2343929|P2|Double-blind Treatment Phase|Noncompliance|8
729557|NCT00286091|2343930|P1|Double-blind Treatment Phase|Noncompliance|8
729558|NCT00286091|2343929|P2|Double-blind Treatment Phase|Administrative Decision|21
729559|NCT00286091|2343930|P1|Double-blind Treatment Phase|Administrative Decision|20
729560|NCT00286091|2343929|P2|Double-blind Treatment Phase|Other|33
729561|NCT00286091|2343930|P1|Double-blind Treatment Phase|Other|25
729562|NCT00286091|2343929|P2|Double-blind Treatment Phase|Disease Progression|35
729563|NCT00286091|2343930|P1|Double-blind Treatment Phase|Disease Progression|22
729564|NCT00286091|2343929|P2|Double-blind Treatment Phase|Adverse Event|40
729565|NCT00286091|2343930|P1|Double-blind Treatment Phase|Adverse Event|28
729566|NCT00286091|2343929|P2|Double-blind Treatment Phase|Death|65
729567|NCT00286091|2343930|P1|Double-blind Treatment Phase|Death|58
729568|NCT00286091|2343929|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
729569|NCT00286091|2343930|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
729570|NCT00286091|2343929|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
729571|NCT00286091|2343930|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
729572|NCT00286156|2343945|P3|Overall Study|AE: pneumonia|0
729573|NCT00286156|2343946|P2|Overall Study|AE: pneumonia|0
729574|NCT00286156|2343947|P1|Overall Study|AE: pneumonia|1
729575|NCT00286156|2343945|P3|Overall Study|AE: nephrotic-range proteinuruia|0
729576|NCT00286156|2343946|P2|Overall Study|AE: nephrotic-range proteinuruia|0
729577|NCT00286156|2343947|P1|Overall Study|AE: nephrotic-range proteinuruia|1
729578|NCT00286156|2343945|P3|Overall Study|AE: pulmonary embolus|0
729579|NCT00286156|2343946|P2|Overall Study|AE: pulmonary embolus|1
729580|NCT00286156|2343947|P1|Overall Study|AE: pulmonary embolus|0
729581|NCT00286156|2343945|P3|Overall Study|Missed 12 month visit|1
729582|NCT00286156|2343946|P2|Overall Study|Missed 12 month visit|0
729583|NCT00286156|2343947|P1|Overall Study|Missed 12 month visit|0
729584|NCT00286221|2343971|P4|Overall Study|Unrecognized exclusion criteria met|0
729585|NCT00286221|2343972|P3|Overall Study|Unrecognized exclusion criteria met|0
729586|NCT00286221|2343973|P2|Overall Study|Unrecognized exclusion criteria met|1
729587|NCT00286221|2343974|P1|Overall Study|Unrecognized exclusion criteria met|0
729588|NCT00286221|2343971|P4|Overall Study|Inability to trigger PCA|0
729589|NCT00286221|2343972|P3|Overall Study|Inability to trigger PCA|0
729590|NCT00286221|2343973|P2|Overall Study|Inability to trigger PCA|0
729591|NCT00286221|2343974|P1|Overall Study|Inability to trigger PCA|2
729592|NCT00286221|2343971|P4|Overall Study|Unanticipated Neurosurgical Complication|2
729593|NCT00286221|2343972|P3|Overall Study|Unanticipated Neurosurgical Complication|3
729594|NCT00286221|2343973|P2|Overall Study|Unanticipated Neurosurgical Complication|3
729595|NCT00286221|2343974|P1|Overall Study|Unanticipated Neurosurgical Complication|6
729596|NCT00286221|2343971|P4|Overall Study|Protocol Violation|4
729597|NCT00286221|2343972|P3|Overall Study|Protocol Violation|6
729598|NCT00286221|2343973|P2|Overall Study|Protocol Violation|1
729599|NCT00286221|2343974|P1|Overall Study|Protocol Violation|2
729600|NCT00286429|2343999|P3|Overall Study|Administrative Decision|0
729601|NCT00286429|2344000|P2|Overall Study|Administrative Decision|1
729602|NCT00286429|2344001|P1|Overall Study|Administrative Decision|0
729603|NCT00286429|2343999|P3|Overall Study|Administrative Error|1
729604|NCT00286429|2344000|P2|Overall Study|Administrative Error|1
729605|NCT00286429|2344001|P1|Overall Study|Administrative Error|1
729606|NCT00286429|2343999|P3|Overall Study|Withdrawal by Subject|6
729607|NCT00286429|2344000|P2|Overall Study|Withdrawal by Subject|2
729608|NCT00286429|2344001|P1|Overall Study|Withdrawal by Subject|3
729609|NCT00286429|2343999|P3|Overall Study|Protocol Violation|4
729610|NCT00286429|2344000|P2|Overall Study|Protocol Violation|5
729611|NCT00286429|2344001|P1|Overall Study|Protocol Violation|3
729612|NCT00286429|2343999|P3|Overall Study|Physician Decision|7
729613|NCT00286429|2344000|P2|Overall Study|Physician Decision|7
729614|NCT00286429|2344001|P1|Overall Study|Physician Decision|10
729615|NCT00286429|2343999|P3|Overall Study|Lost to Follow-up|3
729616|NCT00286429|2344000|P2|Overall Study|Lost to Follow-up|4
729617|NCT00286429|2344001|P1|Overall Study|Lost to Follow-up|2
729618|NCT00286429|2343999|P3|Overall Study|Lack of Efficacy|25
729619|NCT00286429|2344000|P2|Overall Study|Lack of Efficacy|27
729620|NCT00286429|2344001|P1|Overall Study|Lack of Efficacy|52
729621|NCT00286429|2343999|P3|Overall Study|Adverse Event|6
729622|NCT00286429|2344000|P2|Overall Study|Adverse Event|1
729623|NCT00286429|2344001|P1|Overall Study|Adverse Event|4
729624|NCT00286442|2344108|P3|Overall Study|Withdrawal by Subject|2
729625|NCT00286442|2344109|P2|Overall Study|Withdrawal by Subject|14
729626|NCT00286442|2344110|P1|Overall Study|Withdrawal by Subject|2
729627|NCT00286442|2344108|P3|Overall Study|Administrative Error|0
729628|NCT00286442|2344109|P2|Overall Study|Administrative Error|1
729629|NCT00286442|2344110|P1|Overall Study|Administrative Error|1
729630|NCT00286442|2344108|P3|Overall Study|Physician Decision|1
729631|NCT00286442|2344109|P2|Overall Study|Physician Decision|1
729632|NCT00286442|2344110|P1|Overall Study|Physician Decision|1
729633|NCT00286442|2344108|P3|Overall Study|Lost to Follow-up|1
729634|NCT00286442|2344109|P2|Overall Study|Lost to Follow-up|2
729635|NCT00286442|2344110|P1|Overall Study|Lost to Follow-up|5
729636|NCT00286442|2344108|P3|Overall Study|Protocol Violation|2
729637|NCT00286442|2344109|P2|Overall Study|Protocol Violation|4
729638|NCT00286442|2344110|P1|Overall Study|Protocol Violation|2
729639|NCT00286442|2344108|P3|Overall Study|Adverse Event|1
729640|NCT00286442|2344109|P2|Overall Study|Adverse Event|6
729641|NCT00286442|2344110|P1|Overall Study|Adverse Event|7
729642|NCT00286442|2344108|P3|Overall Study|Hyperglycemic Rescue|25
729643|NCT00286442|2344109|P2|Overall Study|Hyperglycemic Rescue|17
729644|NCT00286442|2344110|P1|Overall Study|Hyperglycemic Rescue|19
729645|NCT00286455|2344271|P3|Overall Study|Withdrawal by Subject|7
729646|NCT00286455|2344272|P2|Overall Study|Withdrawal by Subject|8
729647|NCT00286455|2344273|P1|Overall Study|Withdrawal by Subject|0
729648|NCT00286455|2344271|P3|Overall Study|Participant Non-compliance|0
729649|NCT00286455|2344272|P2|Overall Study|Participant Non-compliance|0
729650|NCT00286455|2344273|P1|Overall Study|Participant Non-compliance|1
729651|NCT00286455|2344271|P3|Overall Study|Protocol Violation|0
729652|NCT00286455|2344272|P2|Overall Study|Protocol Violation|1
729653|NCT00286455|2344273|P1|Overall Study|Protocol Violation|1
729654|NCT00286455|2344271|P3|Overall Study|Physician Decision|2
729655|NCT00286455|2344272|P2|Overall Study|Physician Decision|0
729656|NCT00286455|2344273|P1|Overall Study|Physician Decision|3
729657|NCT00286455|2344271|P3|Overall Study|Lost to Follow-up|3
729658|NCT00286455|2344272|P2|Overall Study|Lost to Follow-up|3
729659|NCT00286455|2344273|P1|Overall Study|Lost to Follow-up|0
729660|NCT00286455|2344271|P3|Overall Study|Adverse Event|2
729661|NCT00286455|2344272|P2|Overall Study|Adverse Event|3
729662|NCT00286455|2344273|P1|Overall Study|Adverse Event|1
729663|NCT00286455|2344271|P3|Overall Study|Hyperglycemia rescue|10
729664|NCT00286455|2344272|P2|Overall Study|Hyperglycemia rescue|13
729665|NCT00286455|2344273|P1|Overall Study|Hyperglycemia rescue|19
729666|NCT00286468|2344452|P3|Overall Study|Physician Decision|1
729667|NCT00286468|2344453|P2|Overall Study|Physician Decision|2
729668|NCT00286468|2344454|P1|Overall Study|Physician Decision|3
729669|NCT00286468|2344452|P3|Overall Study|Withdrawal by Subject|11
729670|NCT00286468|2344453|P2|Overall Study|Withdrawal by Subject|8
729671|NCT00286468|2344454|P1|Overall Study|Withdrawal by Subject|3
729672|NCT00286468|2344452|P3|Overall Study|Lost to Follow-up|2
729673|NCT00286468|2344453|P2|Overall Study|Lost to Follow-up|1
729674|NCT00286468|2344454|P1|Overall Study|Lost to Follow-up|1
729675|NCT00286468|2344452|P3|Overall Study|Protocol Violation|1
729676|NCT00286468|2344453|P2|Overall Study|Protocol Violation|3
729677|NCT00286468|2344454|P1|Overall Study|Protocol Violation|0
729678|NCT00286468|2344452|P3|Overall Study|Adverse Event|4
729679|NCT00286468|2344453|P2|Overall Study|Adverse Event|6
729680|NCT00286468|2344454|P1|Overall Study|Adverse Event|2
729681|NCT00286468|2344452|P3|Overall Study|Hyperglycemic Rescue|31
729682|NCT00286468|2344453|P2|Overall Study|Hyperglycemic Rescue|30
729683|NCT00286468|2344454|P1|Overall Study|Hyperglycemic Rescue|28
729684|NCT00286494|2344615|P3|Overall Study|Protocol Violation|2
729685|NCT00286494|2344616|P2|Overall Study|Protocol Violation|1
729686|NCT00286494|2344617|P1|Overall Study|Protocol Violation|1
729687|NCT00286494|2344615|P3|Overall Study|Lost to Follow-up|3
729688|NCT00286494|2344616|P2|Overall Study|Lost to Follow-up|1
729689|NCT00286494|2344617|P1|Overall Study|Lost to Follow-up|3
729690|NCT00286494|2344615|P3|Overall Study|Physician Decision|1
729691|NCT00286494|2344616|P2|Overall Study|Physician Decision|5
729692|NCT00286494|2344617|P1|Overall Study|Physician Decision|5
729693|NCT00286494|2344615|P3|Overall Study|Adverse Event|6
729694|NCT00286494|2344616|P2|Overall Study|Adverse Event|8
729695|NCT00286494|2344617|P1|Overall Study|Adverse Event|3
729696|NCT00286494|2344615|P3|Overall Study|Withdrawal by Subject|9
729697|NCT00286494|2344616|P2|Overall Study|Withdrawal by Subject|10
729698|NCT00286494|2344617|P1|Overall Study|Withdrawal by Subject|2
729699|NCT00286494|2344615|P3|Overall Study|Hyperglycemic rescue|18
729700|NCT00286494|2344616|P2|Overall Study|Hyperglycemic rescue|19
729701|NCT00286494|2344617|P1|Overall Study|Hyperglycemic rescue|12
729702|NCT00286754|2344798|P3|Overall Study|Moved out of state|1
729703|NCT00286754|2344799|P2|Overall Study|Moved out of state|0
729704|NCT00286754|2344800|P1|Overall Study|Moved out of state|0
729705|NCT00286754|2344798|P3|Overall Study|Lost to Follow-up|6
729706|NCT00286754|2344799|P2|Overall Study|Lost to Follow-up|14
729707|NCT00286754|2344800|P1|Overall Study|Lost to Follow-up|12
729708|NCT00286754|2344798|P3|Overall Study|Withdrawal by Subject|0
729709|NCT00286754|2344799|P2|Overall Study|Withdrawal by Subject|2
729710|NCT00286754|2344800|P1|Overall Study|Withdrawal by Subject|6
729711|NCT00286754|2344798|P3|Overall Study|Adverse Event|3
729712|NCT00286754|2344799|P2|Overall Study|Adverse Event|2
729713|NCT00286754|2344800|P1|Overall Study|Adverse Event|2
729714|NCT00287079|2344849|P2|Overall Study|Unspecified|0
729715|NCT00287079|2344850|P1|Overall Study|Unspecified|3
729716|NCT00287079|2344849|P2|Overall Study|Protocol Violation|0
729717|NCT00287079|2344850|P1|Overall Study|Protocol Violation|1
729718|NCT00287079|2344849|P2|Overall Study|Adverse Event|0
729719|NCT00287079|2344850|P1|Overall Study|Adverse Event|5
729720|NCT00287079|2344849|P2|Overall Study|Non-qualifying relapse|0
729721|NCT00287079|2344850|P1|Overall Study|Non-qualifying relapse|1
729722|NCT00287079|2344849|P2|Overall Study|Qualifying relapse|1
729723|NCT00287079|2344850|P1|Overall Study|Qualifying relapse|12
890569|NCT00950807|2825717|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
729725|NCT00287586|2344882|P2|Overall Study|Recurrent Melanoma|1
729726|NCT00287586|2344883|P1|Overall Study|Recurrent Melanoma|0
729727|NCT00287586|2344882|P2|Overall Study|Itchy Swollen Eyes|1
729728|NCT00287586|2344883|P1|Overall Study|Itchy Swollen Eyes|0
729729|NCT00287586|2344882|P2|Overall Study|Bradycardia|1
729730|NCT00287586|2344883|P1|Overall Study|Bradycardia|0
729731|NCT00287586|2344882|P2|Overall Study|Mood Swings and Irritability|1
729732|NCT00287586|2344883|P1|Overall Study|Mood Swings and Irritability|0
729733|NCT00287586|2344882|P2|Overall Study|Mastodynia and Gynecomastia|1
729734|NCT00287586|2344883|P1|Overall Study|Mastodynia and Gynecomastia|0
729735|NCT00287586|2344882|P2|Overall Study|Retroperitoneal Cancer|1
729736|NCT00287586|2344883|P1|Overall Study|Retroperitoneal Cancer|0
729737|NCT00287586|2344882|P2|Overall Study|Elevated IPSS Score|1
729738|NCT00287586|2344883|P1|Overall Study|Elevated IPSS Score|0
729739|NCT00287586|2344882|P2|Overall Study|Lung Cancer|2
729740|NCT00287586|2344883|P1|Overall Study|Lung Cancer|0
729741|NCT00287586|2344882|P2|Overall Study|Major Depression|2
729742|NCT00287586|2344883|P1|Overall Study|Major Depression|0
729743|NCT00287586|2344882|P2|Overall Study|Enrolled in Another Study|0
729744|NCT00287586|2344883|P1|Overall Study|Enrolled in Another Study|1
729745|NCT00287586|2344882|P2|Overall Study|Nonadherence|1
729746|NCT00287586|2344883|P1|Overall Study|Nonadherence|1
729747|NCT00287586|2344882|P2|Overall Study|Inappropriate Behaviour with Staff|0
729748|NCT00287586|2344883|P1|Overall Study|Inappropriate Behaviour with Staff|1
729749|NCT00287586|2344882|P2|Overall Study|Shoulder Pain|0
729750|NCT00287586|2344883|P1|Overall Study|Shoulder Pain|1
729751|NCT00287586|2344882|P2|Overall Study|Sleep Apnea|0
729752|NCT00287586|2344883|P1|Overall Study|Sleep Apnea|1
729753|NCT00287586|2344882|P2|Overall Study|Pancreatic Cancer|3
729754|NCT00287586|2344883|P1|Overall Study|Pancreatic Cancer|1
729755|NCT00287586|2344882|P2|Overall Study|Cognitive Impairment|0
729756|NCT00287586|2344883|P1|Overall Study|Cognitive Impairment|1
729757|NCT00287586|2344882|P2|Overall Study|Lower Urinary Tract Symptoms|0
729758|NCT00287586|2344883|P1|Overall Study|Lower Urinary Tract Symptoms|1
729759|NCT00287586|2344882|P2|Overall Study|Myocardial Infarction|0
729760|NCT00287586|2344883|P1|Overall Study|Myocardial Infarction|1
729761|NCT00287586|2344882|P2|Overall Study|Stroke|0
729762|NCT00287586|2344883|P1|Overall Study|Stroke|2
729763|NCT00287586|2344882|P2|Overall Study|Elevated Prostate Specific Antigen|0
729764|NCT00287586|2344883|P1|Overall Study|Elevated Prostate Specific Antigen|2
729765|NCT00287586|2344882|P2|Overall Study|Rash|0
729766|NCT00287586|2344883|P1|Overall Study|Rash|3
729767|NCT00287586|2344882|P2|Overall Study|Elevated Hematocrit|0
729768|NCT00287586|2344883|P1|Overall Study|Elevated Hematocrit|3
729769|NCT00287586|2344882|P2|Overall Study|Death|3
729770|NCT00287586|2344883|P1|Overall Study|Death|2
729771|NCT00287586|2344882|P2|Overall Study|Lost to Follow-up|4
729772|NCT00287586|2344883|P1|Overall Study|Lost to Follow-up|5
729773|NCT00287586|2344882|P2|Overall Study|Withdrew Consent|30
729774|NCT00287586|2344883|P1|Overall Study|Withdrew Consent|19
729775|NCT00279708|2344938|P2|Overall Study|Adverse Event|1
729776|NCT00279708|2344939|P1|Overall Study|Adverse Event|1
729777|NCT00279708|2344938|P2|Overall Study|Withdrawal by Subject|3
729778|NCT00279708|2344939|P1|Overall Study|Withdrawal by Subject|2
729779|NCT00279916|2344947|P2|Overall Study|Lost to Follow-up|2
729780|NCT00279916|2344948|P1|Overall Study|Lost to Follow-up|3
729781|NCT00279916|2344947|P2|Overall Study|Withdrawal by Subject|3
729782|NCT00279916|2344948|P1|Overall Study|Withdrawal by Subject|4
729783|NCT00280059|2344986|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
729784|NCT00280059|2344987|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
729785|NCT00280059|2344986|P2|Efficacy Assessment Phase|Unspecified|8
729786|NCT00280059|2344987|P1|Efficacy Assessment Phase|Unspecified|7
729787|NCT00280059|2344986|P2|Efficacy Assessment Phase|Lost to Follow-up|13
729788|NCT00280059|2344987|P1|Efficacy Assessment Phase|Lost to Follow-up|6
729789|NCT00280059|2344986|P2|Efficacy Assessment Phase|Lack of Efficacy|3
729790|NCT00280059|2344987|P1|Efficacy Assessment Phase|Lack of Efficacy|19
729791|NCT00280059|2344986|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
729792|NCT00280059|2344987|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
729793|NCT00280059|2344986|P2|Efficacy Assessment Phase|Adverse Event|31
729794|NCT00280059|2344987|P1|Efficacy Assessment Phase|Adverse Event|33
729795|NCT00280059|2344986|P2|Efficacy Assessment Phase|Death|0
729796|NCT00280059|2344987|P1|Efficacy Assessment Phase|Death|2
729797|NCT00280150|2345037|P4|Overall Study|Declining Performance Status|1
729798|NCT00280150|2345038|P3|Overall Study|Declining Performance Status|0
729799|NCT00280150|2345039|P2|Overall Study|Declining Performance Status|0
729800|NCT00280150|2345040|P1|Overall Study|Declining Performance Status|0
729801|NCT00280150|2345037|P4|Overall Study|Did not get consolidation therapy|0
729802|NCT00280150|2345038|P3|Overall Study|Did not get consolidation therapy|3
729803|NCT00280150|2345039|P2|Overall Study|Did not get consolidation therapy|0
729804|NCT00280150|2345040|P1|Overall Study|Did not get consolidation therapy|3
729805|NCT00280150|2345037|P4|Overall Study|Withdrawal by Subject|1
729806|NCT00280150|2345038|P3|Overall Study|Withdrawal by Subject|0
729807|NCT00280150|2345039|P2|Overall Study|Withdrawal by Subject|0
729808|NCT00280150|2345040|P1|Overall Study|Withdrawal by Subject|0
729809|NCT00280150|2345037|P4|Overall Study|Protocol Violation|1
729810|NCT00280150|2345038|P3|Overall Study|Protocol Violation|0
729811|NCT00280150|2345039|P2|Overall Study|Protocol Violation|0
729812|NCT00280150|2345040|P1|Overall Study|Protocol Violation|0
729813|NCT00280150|2345037|P4|Overall Study|Physician Decision|1
729814|NCT00280150|2345038|P3|Overall Study|Physician Decision|0
729815|NCT00280150|2345039|P2|Overall Study|Physician Decision|0
729816|NCT00280150|2345040|P1|Overall Study|Physician Decision|0
729817|NCT00280150|2345037|P4|Overall Study|Lack of Efficacy|3
729818|NCT00280150|2345038|P3|Overall Study|Lack of Efficacy|0
729819|NCT00280150|2345039|P2|Overall Study|Lack of Efficacy|0
729820|NCT00280150|2345040|P1|Overall Study|Lack of Efficacy|0
729821|NCT00280150|2345037|P4|Overall Study|Adverse Event|3
729822|NCT00280150|2345038|P3|Overall Study|Adverse Event|2
729823|NCT00280150|2345039|P2|Overall Study|Adverse Event|1
729824|NCT00280150|2345040|P1|Overall Study|Adverse Event|0
729825|NCT00280293|2345062|P2|Overall Study|Adverse Event|1
729826|NCT00280293|2345063|P1|Overall Study|Adverse Event|0
729827|NCT00280293|2345062|P2|Overall Study|Incarceration/Legal Reasons|1
729828|NCT00280293|2345063|P1|Overall Study|Incarceration/Legal Reasons|1
729829|NCT00280293|2345062|P2|Overall Study|Withdrawal by Subject|5
729830|NCT00280293|2345063|P1|Overall Study|Withdrawal by Subject|3
729831|NCT00280293|2345062|P2|Overall Study|Lost to Follow-up|12
729832|NCT00280293|2345063|P1|Overall Study|Lost to Follow-up|14
729833|NCT00280293|2345062|P2|Overall Study|Physician Decision|4
729834|NCT00280293|2345063|P1|Overall Study|Physician Decision|5
729835|NCT00280293|2345062|P2|Overall Study|Protocol Violation|0
729836|NCT00280293|2345063|P1|Overall Study|Protocol Violation|3
729837|NCT00280397|2345132|P1|Overall Study|Adverse Event|1
729838|NCT00280566|2345141|P3|Period 2 Double Blind|miscellaneous|5
729839|NCT00280566|2345142|P2|Period 2 Double Blind|miscellaneous|10
729840|NCT00280566|2345143|P1|Period 2 Double Blind|miscellaneous|0
729841|NCT00280566|2345141|P3|Period 2 Double Blind|Withdrawal by Subject|9
729842|NCT00280566|2345142|P2|Period 2 Double Blind|Withdrawal by Subject|9
729843|NCT00280566|2345143|P1|Period 2 Double Blind|Withdrawal by Subject|0
729844|NCT00280566|2345141|P3|Period 2 Double Blind|Lost to Follow-up|6
729845|NCT00280566|2345142|P2|Period 2 Double Blind|Lost to Follow-up|3
729846|NCT00280566|2345143|P1|Period 2 Double Blind|Lost to Follow-up|0
729847|NCT00280566|2345141|P3|Period 2 Double Blind|Adverse Event|15
729848|NCT00280566|2345142|P2|Period 2 Double Blind|Adverse Event|11
729849|NCT00280566|2345143|P1|Period 2 Double Blind|Adverse Event|0
729850|NCT00280566|2345141|P3|Period 2 Double Blind|Laboratory Abnormality|0
729851|NCT00280566|2345142|P2|Period 2 Double Blind|Laboratory Abnormality|1
729852|NCT00280566|2345143|P1|Period 2 Double Blind|Laboratory Abnormality|0
729853|NCT00280566|2345141|P3|Period 2 Double Blind|Lack of Efficacy|22
729854|NCT00280566|2345142|P2|Period 2 Double Blind|Lack of Efficacy|9
729855|NCT00280566|2345143|P1|Period 2 Double Blind|Lack of Efficacy|0
729856|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
729857|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
729858|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
729859|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
729860|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
729861|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
729862|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
729863|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
729864|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
729865|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
729866|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
729867|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
729868|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
729869|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
729870|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
729871|NCT00280566|2345141|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
729872|NCT00280566|2345142|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
729873|NCT00280566|2345143|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
729874|NCT00280683|2345170|P2|Overall Study|Adverse Event|1
729875|NCT00280683|2345171|P1|Overall Study|Adverse Event|1
729876|NCT00280683|2345170|P2|Overall Study|Withdrawal by Subject|2
729877|NCT00280683|2345171|P1|Overall Study|Withdrawal by Subject|1
729878|NCT00280735|2345179|P1|Overall Study|Intercurrent Illness|2
729879|NCT00280735|2345179|P1|Overall Study|Withdrawal by Subject|8
729880|NCT00280735|2345179|P1|Overall Study|Lack of Efficacy|3
729881|NCT00280735|2345179|P1|Overall Study|Adverse Event|5
729882|NCT00280748|2345189|P1|Overall Study|Extra-cranial disease progression|1
729883|NCT00280748|2345189|P1|Overall Study|Decline in performance|3
729884|NCT00280917|2345216|P4|Overall Study|Noncompliance|0
729885|NCT00280917|2345217|P3|Overall Study|Noncompliance|2
729886|NCT00280917|2345218|P2|Overall Study|Noncompliance|1
729887|NCT00280917|2345219|P1|Overall Study|Noncompliance|0
729888|NCT00280917|2345216|P4|Overall Study|Withdrawal by Subject|1
729889|NCT00280917|2345217|P3|Overall Study|Withdrawal by Subject|0
729890|NCT00280917|2345218|P2|Overall Study|Withdrawal by Subject|2
729891|NCT00280917|2345219|P1|Overall Study|Withdrawal by Subject|0
729892|NCT00280917|2345216|P4|Overall Study|Change Therapy|0
729893|NCT00280917|2345217|P3|Overall Study|Change Therapy|0
729894|NCT00280917|2345218|P2|Overall Study|Change Therapy|2
729895|NCT00280917|2345219|P1|Overall Study|Change Therapy|1
729896|NCT00280917|2345216|P4|Overall Study|Adverse Event|1
729897|NCT00280917|2345217|P3|Overall Study|Adverse Event|4
729898|NCT00280917|2345218|P2|Overall Study|Adverse Event|1
729899|NCT00280917|2345219|P1|Overall Study|Adverse Event|1
729900|NCT00281099|2345235|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
729901|NCT00281099|2345236|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
729902|NCT00281099|2345235|P2|Overall Study|Physician Decision|72
729903|NCT00281099|2345236|P1|Overall Study|Physician Decision|79
729904|NCT00281099|2345235|P2|Overall Study|Withdrawal by Subject|70
729905|NCT00281099|2345236|P1|Overall Study|Withdrawal by Subject|65
729906|NCT00281099|2345235|P2|Overall Study|Lost to Follow-up|19
729907|NCT00281099|2345236|P1|Overall Study|Lost to Follow-up|10
729908|NCT00281099|2345235|P2|Overall Study|Death|57
729909|NCT00281099|2345236|P1|Overall Study|Death|46
729910|NCT00281320|2345279|P2|Overall Study|Not specified|1
729911|NCT00281320|2345280|P1|Overall Study|Not specified|3
729912|NCT00281320|2345279|P2|Overall Study|Lost to Follow-up|2
729913|NCT00281320|2345280|P1|Overall Study|Lost to Follow-up|1
729914|NCT00281320|2345279|P2|Overall Study|Withdrawal by Subject|6
729915|NCT00281320|2345280|P1|Overall Study|Withdrawal by Subject|5
729916|NCT00281320|2345279|P2|Overall Study|Lack of Efficacy|3
729917|NCT00281320|2345280|P1|Overall Study|Lack of Efficacy|4
729918|NCT00281320|2345279|P2|Overall Study|Adverse Event|9
729919|NCT00281320|2345280|P1|Overall Study|Adverse Event|12
729920|NCT00281528|2345308|P3|Overall Study|Unspecified|5
729921|NCT00281528|2345309|P2|Overall Study|Unspecified|3
729922|NCT00281528|2345310|P1|Overall Study|Unspecified|6
729923|NCT00281528|2345308|P3|Overall Study|Withdrawal by Subject|7
729924|NCT00281528|2345309|P2|Overall Study|Withdrawal by Subject|5
729925|NCT00281528|2345310|P1|Overall Study|Withdrawal by Subject|5
729926|NCT00281528|2345308|P3|Overall Study|Protocol Violation|1
729927|NCT00281528|2345309|P2|Overall Study|Protocol Violation|0
729928|NCT00281528|2345310|P1|Overall Study|Protocol Violation|1
729929|NCT00281528|2345308|P3|Overall Study|Physician Decision|5
729930|NCT00281528|2345309|P2|Overall Study|Physician Decision|4
729931|NCT00281528|2345310|P1|Overall Study|Physician Decision|11
729932|NCT00281528|2345308|P3|Overall Study|Adverse Event-unrelated to treatment|2
729933|NCT00281528|2345309|P2|Overall Study|Adverse Event-unrelated to treatment|0
729934|NCT00281528|2345310|P1|Overall Study|Adverse Event-unrelated to treatment|3
729935|NCT00281528|2345308|P3|Overall Study|Unacceptable Toxicity-related to trt|32
729936|NCT00281528|2345309|P2|Overall Study|Unacceptable Toxicity-related to trt|24
729937|NCT00281528|2345310|P1|Overall Study|Unacceptable Toxicity-related to trt|21
729938|NCT00281528|2345308|P3|Overall Study|Progressive Disease|27
729939|NCT00281528|2345309|P2|Overall Study|Progressive Disease|18
729940|NCT00281528|2345310|P1|Overall Study|Progressive Disease|28
729941|NCT00281580|2345370|P16|Overall Study|Randomised in error; pregnancy; moving|2
729942|NCT00281580|2345371|P15|Overall Study|Randomised in error; pregnancy; moving|1
729943|NCT00281580|2345372|P14|Overall Study|Randomised in error; pregnancy; moving|0
729944|NCT00281580|2345373|P13|Overall Study|Randomised in error; pregnancy; moving|2
729945|NCT00281580|2345374|P12|Overall Study|Randomised in error; pregnancy; moving|1
729946|NCT00281580|2345375|P11|Overall Study|Randomised in error; pregnancy; moving|1
729947|NCT00281580|2345376|P10|Overall Study|Randomised in error; pregnancy; moving|1
729948|NCT00281580|2345377|P9|Overall Study|Randomised in error; pregnancy; moving|2
729949|NCT00281580|2345378|P8|Overall Study|Randomised in error; pregnancy; moving|0
729950|NCT00281580|2345379|P7|Overall Study|Randomised in error; pregnancy; moving|1
729951|NCT00281580|2345380|P6|Overall Study|Randomised in error; pregnancy; moving|0
729952|NCT00281580|2345381|P5|Overall Study|Randomised in error; pregnancy; moving|0
729953|NCT00281580|2345382|P4|Overall Study|Randomised in error; pregnancy; moving|2
729954|NCT00281580|2345383|P3|Overall Study|Randomised in error; pregnancy; moving|0
729955|NCT00281580|2345384|P2|Overall Study|Randomised in error; pregnancy; moving|0
729956|NCT00281580|2345385|P1|Overall Study|Randomised in error; pregnancy; moving|0
729957|NCT00281580|2345370|P16|Overall Study|Lost to Follow-up|0
729958|NCT00281580|2345371|P15|Overall Study|Lost to Follow-up|0
729959|NCT00281580|2345372|P14|Overall Study|Lost to Follow-up|0
729960|NCT00281580|2345373|P13|Overall Study|Lost to Follow-up|1
729961|NCT00281580|2345374|P12|Overall Study|Lost to Follow-up|0
729962|NCT00281580|2345375|P11|Overall Study|Lost to Follow-up|1
729963|NCT00281580|2345376|P10|Overall Study|Lost to Follow-up|1
729964|NCT00281580|2345377|P9|Overall Study|Lost to Follow-up|2
729965|NCT00281580|2345378|P8|Overall Study|Lost to Follow-up|1
729966|NCT00281580|2345379|P7|Overall Study|Lost to Follow-up|0
729967|NCT00281580|2345380|P6|Overall Study|Lost to Follow-up|1
729968|NCT00281580|2345381|P5|Overall Study|Lost to Follow-up|0
729969|NCT00281580|2345382|P4|Overall Study|Lost to Follow-up|3
729970|NCT00281580|2345383|P3|Overall Study|Lost to Follow-up|0
729971|NCT00281580|2345384|P2|Overall Study|Lost to Follow-up|0
729972|NCT00281580|2345385|P1|Overall Study|Lost to Follow-up|0
729973|NCT00281580|2345370|P16|Overall Study|Lack of Efficacy|0
729974|NCT00281580|2345371|P15|Overall Study|Lack of Efficacy|1
729975|NCT00281580|2345372|P14|Overall Study|Lack of Efficacy|2
729976|NCT00281580|2345373|P13|Overall Study|Lack of Efficacy|0
729977|NCT00281580|2345374|P12|Overall Study|Lack of Efficacy|1
729978|NCT00281580|2345375|P11|Overall Study|Lack of Efficacy|0
729979|NCT00281580|2345376|P10|Overall Study|Lack of Efficacy|0
729980|NCT00281580|2345377|P9|Overall Study|Lack of Efficacy|0
729981|NCT00281580|2345378|P8|Overall Study|Lack of Efficacy|0
729982|NCT00281580|2345379|P7|Overall Study|Lack of Efficacy|0
729983|NCT00281580|2345380|P6|Overall Study|Lack of Efficacy|0
729984|NCT00281580|2345381|P5|Overall Study|Lack of Efficacy|2
729985|NCT00281580|2345382|P4|Overall Study|Lack of Efficacy|6
729986|NCT00281580|2345383|P3|Overall Study|Lack of Efficacy|1
729987|NCT00281580|2345384|P2|Overall Study|Lack of Efficacy|1
729988|NCT00281580|2345385|P1|Overall Study|Lack of Efficacy|2
729989|NCT00281580|2345370|P16|Overall Study|Withdrawal by Subject|5
729990|NCT00281580|2345371|P15|Overall Study|Withdrawal by Subject|1
729991|NCT00281580|2345372|P14|Overall Study|Withdrawal by Subject|2
729992|NCT00281580|2345373|P13|Overall Study|Withdrawal by Subject|2
729993|NCT00281580|2345374|P12|Overall Study|Withdrawal by Subject|1
729994|NCT00281580|2345375|P11|Overall Study|Withdrawal by Subject|1
729995|NCT00281580|2345376|P10|Overall Study|Withdrawal by Subject|4
729996|NCT00281580|2345377|P9|Overall Study|Withdrawal by Subject|1
729997|NCT00281580|2345378|P8|Overall Study|Withdrawal by Subject|0
729998|NCT00281580|2345379|P7|Overall Study|Withdrawal by Subject|2
729999|NCT00281580|2345380|P6|Overall Study|Withdrawal by Subject|2
730000|NCT00281580|2345381|P5|Overall Study|Withdrawal by Subject|1
730001|NCT00281580|2345382|P4|Overall Study|Withdrawal by Subject|1
730002|NCT00281580|2345383|P3|Overall Study|Withdrawal by Subject|1
730003|NCT00281580|2345384|P2|Overall Study|Withdrawal by Subject|0
730004|NCT00281580|2345385|P1|Overall Study|Withdrawal by Subject|3
730005|NCT00281580|2345370|P16|Overall Study|Protocol Violation|3
730006|NCT00281580|2345371|P15|Overall Study|Protocol Violation|1
730007|NCT00281580|2345372|P14|Overall Study|Protocol Violation|1
730008|NCT00281580|2345373|P13|Overall Study|Protocol Violation|0
730009|NCT00281580|2345374|P12|Overall Study|Protocol Violation|2
730010|NCT00281580|2345375|P11|Overall Study|Protocol Violation|1
730011|NCT00281580|2345376|P10|Overall Study|Protocol Violation|0
730012|NCT00281580|2345377|P9|Overall Study|Protocol Violation|2
730013|NCT00281580|2345378|P8|Overall Study|Protocol Violation|0
730014|NCT00281580|2345379|P7|Overall Study|Protocol Violation|1
730015|NCT00281580|2345380|P6|Overall Study|Protocol Violation|0
730016|NCT00281580|2345381|P5|Overall Study|Protocol Violation|0
730017|NCT00281580|2345382|P4|Overall Study|Protocol Violation|1
730018|NCT00281580|2345383|P3|Overall Study|Protocol Violation|1
730019|NCT00281580|2345384|P2|Overall Study|Protocol Violation|0
730020|NCT00281580|2345385|P1|Overall Study|Protocol Violation|0
730021|NCT00281580|2345370|P16|Overall Study|Adverse Event|3
730022|NCT00281580|2345371|P15|Overall Study|Adverse Event|3
730023|NCT00281580|2345372|P14|Overall Study|Adverse Event|2
730024|NCT00281580|2345373|P13|Overall Study|Adverse Event|8
730025|NCT00281580|2345374|P12|Overall Study|Adverse Event|5
730026|NCT00281580|2345375|P11|Overall Study|Adverse Event|0
730027|NCT00281580|2345376|P10|Overall Study|Adverse Event|6
730028|NCT00281580|2345377|P9|Overall Study|Adverse Event|1
730029|NCT00281580|2345378|P8|Overall Study|Adverse Event|0
730030|NCT00281580|2345379|P7|Overall Study|Adverse Event|1
730031|NCT00281580|2345380|P6|Overall Study|Adverse Event|0
730032|NCT00281580|2345381|P5|Overall Study|Adverse Event|1
730033|NCT00281580|2345382|P4|Overall Study|Adverse Event|4
730034|NCT00281580|2345383|P3|Overall Study|Adverse Event|2
730035|NCT00281580|2345384|P2|Overall Study|Adverse Event|0
730036|NCT00281580|2345385|P1|Overall Study|Adverse Event|2
730037|NCT00281632|2345729|P1|Overall Study|Ongoing|3
730038|NCT00281632|2345729|P1|Overall Study|Physician Decision|1
730039|NCT00281632|2345729|P1|Overall Study|Death|1
730040|NCT00281632|2345729|P1|Overall Study|Disease Progression|22
730041|NCT00281632|2345729|P1|Overall Study|Withdrawal by Subject|2
730042|NCT00281632|2345729|P1|Overall Study|Adverse Event|7
730043|NCT00281658|2345757|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
730044|NCT00281658|2345758|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
730045|NCT00281658|2345759|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
730046|NCT00281658|2345757|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
730047|NCT00281658|2345758|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
730048|NCT00281658|2345759|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
730049|NCT00281658|2345757|P3|Open-label Monotherapy Extension Phase|Death|97
730050|NCT00281658|2345758|P2|Open-label Monotherapy Extension Phase|Death|0
730051|NCT00281658|2345759|P1|Open-label Monotherapy Extension Phase|Death|0
730052|NCT00281658|2345757|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
730053|NCT00281658|2345758|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
730054|NCT00281658|2345759|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
730055|NCT00281658|2345757|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
730056|NCT00281658|2345758|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
730057|NCT00281658|2345759|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
730058|NCT00281658|2345757|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
730059|NCT00281658|2345758|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
730060|NCT00281658|2345759|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
730061|NCT00281658|2345757|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
730062|NCT00281658|2345758|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
730063|NCT00281658|2345759|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
730064|NCT00281658|2345757|P3|Double-blind, Randomized Phase|Death|0
730065|NCT00281658|2345758|P2|Double-blind, Randomized Phase|Death|46
730066|NCT00281658|2345759|P1|Double-blind, Randomized Phase|Death|120
730067|NCT00281697|2345778|P2|Overall Study|Did not receive study drug|2
730068|NCT00281697|2345779|P1|Overall Study|Did not receive study drug|3
730069|NCT00281697|2345778|P2|Overall Study|Subject/guardian's decision to withdraw|6
730070|NCT00281697|2345779|P1|Overall Study|Subject/guardian's decision to withdraw|33
730071|NCT00281697|2345778|P2|Overall Study|Physician's decision to withdraw|12
730072|NCT00281697|2345779|P1|Overall Study|Physician's decision to withdraw|15
730073|NCT00281697|2345778|P2|Overall Study|Not specified|6
730074|NCT00281697|2345779|P1|Overall Study|Not specified|5
730075|NCT00281697|2345778|P2|Overall Study|Disease progression|149
730076|NCT00281697|2345779|P1|Overall Study|Disease progression|279
730077|NCT00281697|2345778|P2|Overall Study|Death|3
730078|NCT00281697|2345779|P1|Overall Study|Death|8
730079|NCT00281697|2345778|P2|Overall Study|Adverse Event|15
730080|NCT00281697|2345779|P1|Overall Study|Adverse Event|54
730081|NCT00281697|2345778|P2|Overall Study|> 60 days since last dose of study drug|4
730082|NCT00281697|2345779|P1|Overall Study|> 60 days since last dose of study drug|4
730083|NCT00281840|2345804|P1|Overall Study|Complicating Disease|1
730084|NCT00281840|2345804|P1|Overall Study|exceed maximum delay in treatment|1
730085|NCT00281840|2345804|P1|Overall Study|Disease Progression|2
730086|NCT00281840|2345804|P1|Overall Study|Withdrawal by Subject|3
730087|NCT00281840|2345804|P1|Overall Study|Physician Decision|6
730088|NCT00281840|2345804|P1|Overall Study|Adverse Event|12
730089|NCT00288509|2345871|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
730090|NCT00288509|2345871|P1|Treatment Cycle 4|Physician Decision|4
730091|NCT00288509|2345871|P1|Treatment Cycle 4|Withdrawal by Subject|3
730092|NCT00288509|2345871|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
730093|NCT00288509|2345871|P1|Treatment Cycle 3|Lost to Follow-up|2
730094|NCT00288509|2345871|P1|Treatment Cycle 3|Withdrawal by Subject|1
730095|NCT00288509|2345871|P1|Treatment Cycle 3|Lack of Efficacy|1
730096|NCT00288509|2345871|P1|Treatment Cycle 2|Withdrawal by Subject|2
730097|NCT00288509|2345871|P1|Treatment Cycle 2|Lack of Efficacy|1
730098|NCT00288509|2345871|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
730099|NCT00288509|2345871|P1|Treatment Cycle 1|Lost to Follow-up|2
730100|NCT00288509|2345871|P1|Treatment Cycle 1|Withdrawal by Subject|1
730101|NCT00288509|2345871|P1|Treatment Cycle 1|Lack of Efficacy|1
730102|NCT00288509|2345871|P1|Treatment Cycle 1|Adverse Event|1
730103|NCT00288587|2345889|P2|Overall Study|Severe Aortic Stenosis|0
730104|NCT00288587|2345890|P1|Overall Study|Severe Aortic Stenosis|1
730105|NCT00288587|2345889|P2|Overall Study|Physician Decision|2
730106|NCT00288587|2345890|P1|Overall Study|Physician Decision|0
730107|NCT00288587|2345889|P2|Overall Study|Adverse Event|1
730108|NCT00288587|2345890|P1|Overall Study|Adverse Event|0
730109|NCT00288587|2345889|P2|Overall Study|Transplant|3
730110|NCT00288587|2345890|P1|Overall Study|Transplant|0
730111|NCT00288587|2345889|P2|Overall Study|Death|4
730112|NCT00288587|2345890|P1|Overall Study|Death|4
730113|NCT00288626|2345913|P1|Overall Study|Withdrawal by Subject|4
730114|NCT00288626|2345913|P1|Overall Study|Death|3
730115|NCT00288639|2345936|P1|Overall Study|Other|1
730116|NCT00288639|2345936|P1|Overall Study|Withdrawal by Subject|2
730117|NCT00288639|2345936|P1|Overall Study|Lack of Efficacy|4
730118|NCT00288639|2345936|P1|Overall Study|Adverse Event|5
730119|NCT00288704|2345956|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
730120|NCT00288704|2345957|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
730121|NCT00288704|2345958|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
730122|NCT00288704|2345956|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
730123|NCT00288704|2345957|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
730124|NCT00288704|2345958|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
730125|NCT00288704|2345956|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
730126|NCT00288704|2345957|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
730127|NCT00288704|2345958|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
730128|NCT00288704|2345956|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
730129|NCT00288704|2345957|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
730130|NCT00288704|2345958|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
730131|NCT00288704|2345956|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
730132|NCT00288704|2345957|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
730133|NCT00288704|2345958|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
730134|NCT00288704|2345956|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
730135|NCT00288704|2345957|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
730136|NCT00288704|2345958|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
730137|NCT00288704|2345956|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
730138|NCT00288704|2345957|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
730139|NCT00288704|2345958|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
730140|NCT00288860|2345987|P2|Overall Study|Lost to Follow-up|71
730141|NCT00288860|2345988|P1|Overall Study|Lost to Follow-up|74
730142|NCT00288860|2345987|P2|Overall Study|Withdrawal by Subject|15
730143|NCT00288860|2345988|P1|Overall Study|Withdrawal by Subject|20
730144|NCT00288860|2345987|P2|Overall Study|Death|3
730145|NCT00288860|2345988|P1|Overall Study|Death|4
730146|NCT00288860|2345987|P2|Overall Study|Did not complete intake|8
730147|NCT00288860|2345988|P1|Overall Study|Did not complete intake|4
730148|NCT00288912|2346022|P3|Overall Study|Withdrawal by Subject|12
730149|NCT00288912|2346023|P2|Overall Study|Withdrawal by Subject|5
730150|NCT00288912|2346024|P1|Overall Study|Withdrawal by Subject|4
730151|NCT00288912|2346022|P3|Overall Study|Lost to Follow-up|9
730152|NCT00288912|2346023|P2|Overall Study|Lost to Follow-up|6
730153|NCT00288912|2346024|P1|Overall Study|Lost to Follow-up|9
730154|NCT00288912|2346022|P3|Overall Study|Developed exclusion criterion|7
730155|NCT00288912|2346023|P2|Overall Study|Developed exclusion criterion|6
730156|NCT00288912|2346024|P1|Overall Study|Developed exclusion criterion|4
730157|NCT00289016|2346041|P1|Overall Study|Other|1
730158|NCT00289016|2346041|P1|Overall Study|Adverse Event|1
730159|NCT00289016|2346041|P1|Overall Study|Withdrawal by Subject|2
730160|NCT00289016|2346041|P1|Overall Study|Unrelated Medical Condition or Accident|2
730161|NCT00289016|2346041|P1|Overall Study|Death|2
730162|NCT00289016|2346041|P1|Overall Study|Disease Progression|29
730163|NCT00289133|2346086|P2|Overall Study|Lost to Follow-up|115
730164|NCT00289133|2346087|P1|Overall Study|Lost to Follow-up|92
730165|NCT00289133|2346086|P2|Overall Study|Revision|6
730166|NCT00289133|2346087|P1|Overall Study|Revision|8
730167|NCT00289133|2346086|P2|Overall Study|Physician Decision|45
730168|NCT00289133|2346087|P1|Overall Study|Physician Decision|41
730169|NCT00289133|2346086|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
730170|NCT00289133|2346087|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
730171|NCT00289133|2346086|P2|Overall Study|Death|10
730172|NCT00289133|2346087|P1|Overall Study|Death|5
730173|NCT00289133|2346086|P2|Overall Study|Withdrawal by Subject|10
730174|NCT00289133|2346087|P1|Overall Study|Withdrawal by Subject|9
730175|NCT00289133|2346086|P2|Overall Study|Protocol Violation|38
730176|NCT00289133|2346087|P1|Overall Study|Protocol Violation|32
730177|NCT00289133|2346086|P2|Overall Study|Non-study device implanted|0
730178|NCT00289133|2346087|P1|Overall Study|Non-study device implanted|12
730179|NCT00289185|2346111|P2|Overall Study|Death|1
730180|NCT00289185|2346112|P1|Overall Study|Death|1
730181|NCT00289185|2346111|P2|Overall Study|Lost to Follow-up|17
730182|NCT00289185|2346112|P1|Overall Study|Lost to Follow-up|23
730183|NCT00289185|2346111|P2|Overall Study|Withdrawal by Subject|8
730184|NCT00289185|2346112|P1|Overall Study|Withdrawal by Subject|4
730185|NCT00289276|2346180|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
730186|NCT00289276|2346181|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
730187|NCT00289276|2346180|P2|Second Part of FAST Study (Expansion)|Death|2
730188|NCT00289276|2346181|P1|Second Part of FAST Study (Expansion)|Death|0
730189|NCT00289289|2346196|P3|Overall Study|Other Exit Reason|12
730190|NCT00289289|2346197|P2|Overall Study|Other Exit Reason|4
730191|NCT00289289|2346198|P1|Overall Study|Other Exit Reason|6
730192|NCT00289289|2346196|P3|Overall Study|Did not meet inclusion/exclusion|6
730193|NCT00289289|2346197|P2|Overall Study|Did not meet inclusion/exclusion|0
730194|NCT00289289|2346198|P1|Overall Study|Did not meet inclusion/exclusion|0
730195|NCT00289289|2346196|P3|Overall Study|Non-study device implanted|3
730196|NCT00289289|2346197|P2|Overall Study|Non-study device implanted|1
730197|NCT00289289|2346198|P1|Overall Study|Non-study device implanted|2
730198|NCT00289289|2346196|P3|Overall Study|Physician Decision|6
730199|NCT00289289|2346197|P2|Overall Study|Physician Decision|0
730200|NCT00289289|2346198|P1|Overall Study|Physician Decision|1
730201|NCT00289289|2346196|P3|Overall Study|No implant attempted|1
730202|NCT00289289|2346197|P2|Overall Study|No implant attempted|0
730203|NCT00289289|2346198|P1|Overall Study|No implant attempted|0
730204|NCT00289289|2346196|P3|Overall Study|Death|5
730205|NCT00289289|2346197|P2|Overall Study|Death|2
730206|NCT00289289|2346198|P1|Overall Study|Death|4
730207|NCT00289289|2346196|P3|Overall Study|Lost to Follow-up|1
730208|NCT00289289|2346197|P2|Overall Study|Lost to Follow-up|0
730209|NCT00289289|2346198|P1|Overall Study|Lost to Follow-up|1
730210|NCT00289289|2346196|P3|Overall Study|Withdrawal by Subject|15
730211|NCT00289289|2346197|P2|Overall Study|Withdrawal by Subject|3
730212|NCT00289289|2346198|P1|Overall Study|Withdrawal by Subject|5
730213|NCT00289458|2346227|P3|Overall Study|Withdrawal by Subject|4
730214|NCT00289458|2346228|P2|Overall Study|Withdrawal by Subject|2
730215|NCT00289458|2346229|P1|Overall Study|Withdrawal by Subject|2
730216|NCT00289458|2346227|P3|Overall Study|Physician Decision|2
730217|NCT00289458|2346228|P2|Overall Study|Physician Decision|4
730218|NCT00289458|2346229|P1|Overall Study|Physician Decision|3
730219|NCT00289458|2346227|P3|Overall Study|Death|0
730220|NCT00289458|2346228|P2|Overall Study|Death|0
730221|NCT00289458|2346229|P1|Overall Study|Death|1
890570|NCT00950807|2825718|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
890571|NCT00950807|2825719|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
730225|NCT00289770|2346340|P1|Year 15|Withdrawal by Subject|1
730226|NCT00289783|2346354|P2|Fourth Dose Phase|Unspecified|10
730227|NCT00289783|2346355|P1|Fourth Dose Phase|Unspecified|22
730228|NCT00289783|2346354|P2|Fourth Dose Phase|Migration from the study area|1
730229|NCT00289783|2346355|P1|Fourth Dose Phase|Migration from the study area|1
730230|NCT00289783|2346354|P2|Fourth Dose Phase|Lost to Follow-up|12
730231|NCT00289783|2346355|P1|Fourth Dose Phase|Lost to Follow-up|53
730232|NCT00289783|2346354|P2|Fourth Dose Phase|Withdrawal by Subject|1
730233|NCT00289783|2346355|P1|Fourth Dose Phase|Withdrawal by Subject|10
730234|NCT00289783|2346354|P2|Fourth Dose Phase|Adverse Event|0
730235|NCT00289783|2346355|P1|Fourth Dose Phase|Adverse Event|1
730236|NCT00289783|2346354|P2|Primary Phase|Unspecified|12
730237|NCT00289783|2346355|P1|Primary Phase|Unspecified|32
730238|NCT00289783|2346354|P2|Primary Phase|Migration from the study area|10
730239|NCT00289783|2346355|P1|Primary Phase|Migration from the study area|26
730240|NCT00289783|2346354|P2|Primary Phase|Lost to Follow-up|14
730241|NCT00289783|2346355|P1|Primary Phase|Lost to Follow-up|60
730242|NCT00289783|2346354|P2|Primary Phase|Withdrawal by Subject|40
730243|NCT00289783|2346355|P1|Primary Phase|Withdrawal by Subject|93
730244|NCT00289783|2346354|P2|Primary Phase|Protocol Violation|6
730245|NCT00289783|2346355|P1|Primary Phase|Protocol Violation|27
730246|NCT00289783|2346354|P2|Primary Phase|Adverse Event|1
730247|NCT00289783|2346355|P1|Primary Phase|Adverse Event|10
730248|NCT00289848|2346535|P2|Overall Study|Open-Label AHA Treatment Requested|1
730249|NCT00289848|2346536|P1|Overall Study|Open-Label AHA Treatment Requested|0
730250|NCT00289848|2346535|P2|Overall Study|Patient Moved|2
730251|NCT00289848|2346536|P1|Overall Study|Patient Moved|6
730252|NCT00289848|2346535|P2|Overall Study|Withdrawal by Subject|11
730253|NCT00289848|2346536|P1|Overall Study|Withdrawal by Subject|5
730254|NCT00289848|2346535|P2|Overall Study|Protocol Violation|2
730255|NCT00289848|2346536|P1|Overall Study|Protocol Violation|5
730256|NCT00289848|2346535|P2|Overall Study|Lost to Follow-up|1
730257|NCT00289848|2346536|P1|Overall Study|Lost to Follow-up|3
730258|NCT00289848|2346535|P2|Overall Study|Lack of Efficacy|24
730259|NCT00289848|2346536|P1|Overall Study|Lack of Efficacy|20
730260|NCT00289848|2346535|P2|Overall Study|Death|0
730261|NCT00289848|2346536|P1|Overall Study|Death|1
730262|NCT00289848|2346535|P2|Overall Study|Adverse Event|4
730263|NCT00289848|2346536|P1|Overall Study|Adverse Event|6
730264|NCT00289874|2346548|P2|Overall Study|Did not meet eligibility|0
730265|NCT00289874|2346549|P1|Overall Study|Did not meet eligibility|1
730266|NCT00289874|2346548|P2|Overall Study|Protocol Violation|2
730267|NCT00289874|2346549|P1|Overall Study|Protocol Violation|3
730268|NCT00289874|2346548|P2|Overall Study|Lost to Follow-up|1
730269|NCT00289874|2346549|P1|Overall Study|Lost to Follow-up|1
730270|NCT00289874|2346548|P2|Overall Study|Adverse Event|5
730271|NCT00289874|2346549|P1|Overall Study|Adverse Event|1
730272|NCT00289887|2346559|P2|Overall Study|Unspecified|3
730273|NCT00289887|2346560|P1|Overall Study|Unspecified|7
730274|NCT00289887|2346559|P2|Overall Study|Withdrawal by Subject|8
730275|NCT00289887|2346560|P1|Overall Study|Withdrawal by Subject|3
730276|NCT00289887|2346559|P2|Overall Study|Protocol Violation|1
730277|NCT00289887|2346560|P1|Overall Study|Protocol Violation|3
730278|NCT00289887|2346559|P2|Overall Study|Lost to Follow-up|3
730279|NCT00289887|2346560|P1|Overall Study|Lost to Follow-up|3
730280|NCT00289887|2346559|P2|Overall Study|Lack of Efficacy|11
730281|NCT00289887|2346560|P1|Overall Study|Lack of Efficacy|3
730282|NCT00289887|2346559|P2|Overall Study|Adverse Event|3
730283|NCT00289887|2346560|P1|Overall Study|Adverse Event|3
730284|NCT00289900|2346582|P6|Overall Study|Not treated|0
730285|NCT00289900|2346583|P5|Overall Study|Not treated|0
730286|NCT00289900|2346584|P4|Overall Study|Not treated|0
730287|NCT00289900|2346585|P3|Overall Study|Not treated|0
730288|NCT00289900|2346586|P2|Overall Study|Not treated|1
730289|NCT00289900|2346587|P1|Overall Study|Not treated|0
730290|NCT00289900|2346582|P6|Overall Study|site terminated|0
730291|NCT00289900|2346583|P5|Overall Study|site terminated|0
730292|NCT00289900|2346584|P4|Overall Study|site terminated|0
730293|NCT00289900|2346585|P3|Overall Study|site terminated|1
730294|NCT00289900|2346586|P2|Overall Study|site terminated|0
730295|NCT00289900|2346587|P1|Overall Study|site terminated|1
730296|NCT00289900|2346582|P6|Overall Study|Protocol Violation|4
730297|NCT00289900|2346583|P5|Overall Study|Protocol Violation|7
730298|NCT00289900|2346584|P4|Overall Study|Protocol Violation|6
730299|NCT00289900|2346585|P3|Overall Study|Protocol Violation|2
730300|NCT00289900|2346586|P2|Overall Study|Protocol Violation|9
730301|NCT00289900|2346587|P1|Overall Study|Protocol Violation|3
730302|NCT00289900|2346582|P6|Overall Study|Withdrawal by Subject|11
730303|NCT00289900|2346583|P5|Overall Study|Withdrawal by Subject|12
730304|NCT00289900|2346584|P4|Overall Study|Withdrawal by Subject|18
730305|NCT00289900|2346585|P3|Overall Study|Withdrawal by Subject|8
730306|NCT00289900|2346586|P2|Overall Study|Withdrawal by Subject|21
730307|NCT00289900|2346587|P1|Overall Study|Withdrawal by Subject|10
730308|NCT00289900|2346582|P6|Overall Study|Participant moved|1
730309|NCT00289900|2346583|P5|Overall Study|Participant moved|1
730310|NCT00289900|2346584|P4|Overall Study|Participant moved|1
730311|NCT00289900|2346585|P3|Overall Study|Participant moved|0
730312|NCT00289900|2346586|P2|Overall Study|Participant moved|0
730313|NCT00289900|2346587|P1|Overall Study|Participant moved|1
730314|NCT00289900|2346582|P6|Overall Study|Other|0
730315|NCT00289900|2346583|P5|Overall Study|Other|1
730316|NCT00289900|2346584|P4|Overall Study|Other|5
730317|NCT00289900|2346585|P3|Overall Study|Other|0
730318|NCT00289900|2346586|P2|Overall Study|Other|0
730319|NCT00289900|2346587|P1|Overall Study|Other|0
730320|NCT00289900|2346582|P6|Overall Study|Participant had flushing|4
730321|NCT00289900|2346583|P5|Overall Study|Participant had flushing|0
730322|NCT00289900|2346584|P4|Overall Study|Participant had flushing|2
730323|NCT00289900|2346585|P3|Overall Study|Participant had flushing|1
730324|NCT00289900|2346586|P2|Overall Study|Participant had flushing|42
730325|NCT00289900|2346587|P1|Overall Study|Participant had flushing|18
730326|NCT00289900|2346582|P6|Overall Study|Lost to Follow-up|8
730327|NCT00289900|2346583|P5|Overall Study|Lost to Follow-up|4
730328|NCT00289900|2346584|P4|Overall Study|Lost to Follow-up|8
730329|NCT00289900|2346585|P3|Overall Study|Lost to Follow-up|8
730330|NCT00289900|2346586|P2|Overall Study|Lost to Follow-up|7
730331|NCT00289900|2346587|P1|Overall Study|Lost to Follow-up|7
730332|NCT00289900|2346582|P6|Overall Study|Adverse Event|33
730333|NCT00289900|2346583|P5|Overall Study|Adverse Event|20
730334|NCT00289900|2346584|P4|Overall Study|Adverse Event|19
730335|NCT00289900|2346585|P3|Overall Study|Adverse Event|13
730336|NCT00289900|2346586|P2|Overall Study|Adverse Event|40
730337|NCT00289900|2346587|P1|Overall Study|Adverse Event|28
730338|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
730339|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
730340|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
730341|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
730342|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
730343|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
730344|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
730345|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
730346|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
730347|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
730348|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
730349|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
730350|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
730351|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
730352|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
730353|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
730354|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
730355|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
730356|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
730357|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
730358|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
730359|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
730360|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
730361|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
730362|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
730363|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730364|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
730365|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730366|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730367|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730368|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
730369|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
730370|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
730371|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
730372|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
730373|NCT00289913|2346694|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730374|NCT00289913|2346695|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730375|NCT00289913|2346696|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730376|NCT00289913|2346697|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
730377|NCT00289913|2346698|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730378|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
730379|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
730380|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
730381|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
730382|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
730383|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
730384|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
730385|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
730386|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
730387|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
730388|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
730389|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
730390|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
730391|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
730392|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
730393|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
730394|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
730395|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
730396|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
730397|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
730398|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
730399|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
730400|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
730401|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
730402|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
730403|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
730404|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
730405|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
730406|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
730407|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
730408|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
730409|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
730410|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
730411|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
730412|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
730413|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
730414|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
730415|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
730416|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
730417|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
730418|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
730419|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
730420|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
730421|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
730422|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
730423|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
730424|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
730425|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
730426|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
730427|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
730428|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730429|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730430|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
730431|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
730432|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
730433|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
730434|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
730435|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
730436|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
730437|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
730438|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
730439|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
730440|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
730441|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
730442|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
730443|NCT00289913|2346694|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730444|NCT00289913|2346695|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730445|NCT00289913|2346696|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
730446|NCT00289913|2346697|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730447|NCT00289913|2346698|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730448|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
730449|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
730450|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
730451|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
730452|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
730453|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
730454|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
730455|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
730456|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
730457|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
730458|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
730459|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
730460|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
730461|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
730462|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
730463|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
730464|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
730465|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
730466|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
730467|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
730468|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
730469|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
730470|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
730471|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
730472|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
730473|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
730474|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
730475|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
730476|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
730477|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
730478|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
730479|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
730480|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
730481|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
730482|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
730483|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
730484|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
730485|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
730486|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
730487|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
730488|NCT00289913|2346694|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730489|NCT00289913|2346695|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730490|NCT00289913|2346696|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730491|NCT00289913|2346697|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
730492|NCT00289913|2346698|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
730493|NCT00289978|2346726|P3|Overall Study|Death|2
730494|NCT00289978|2346727|P2|Overall Study|Death|0
730495|NCT00289978|2346728|P1|Overall Study|Death|1
730496|NCT00289978|2346726|P3|Overall Study|Abnormal test procedure result(s)|1
730497|NCT00289978|2346727|P2|Overall Study|Abnormal test procedure result(s)|1
730498|NCT00289978|2346728|P1|Overall Study|Abnormal test procedure result(s)|2
730499|NCT00289978|2346726|P3|Overall Study|Protocol Violation|4
730500|NCT00289978|2346727|P2|Overall Study|Protocol Violation|5
730501|NCT00289978|2346728|P1|Overall Study|Protocol Violation|5
730502|NCT00289978|2346726|P3|Overall Study|Lost to Follow-up|7
730503|NCT00289978|2346727|P2|Overall Study|Lost to Follow-up|5
730504|NCT00289978|2346728|P1|Overall Study|Lost to Follow-up|3
730505|NCT00289978|2346726|P3|Overall Study|Abnormal laboratory value(s)|1
730506|NCT00289978|2346727|P2|Overall Study|Abnormal laboratory value(s)|9
730507|NCT00289978|2346728|P1|Overall Study|Abnormal laboratory value(s)|20
730508|NCT00289978|2346726|P3|Overall Study|Lack of Efficacy|25
730509|NCT00289978|2346727|P2|Overall Study|Lack of Efficacy|6
730510|NCT00289978|2346728|P1|Overall Study|Lack of Efficacy|13
730511|NCT00289978|2346726|P3|Overall Study|Adverse Event|18
730512|NCT00289978|2346727|P2|Overall Study|Adverse Event|13
730513|NCT00289978|2346728|P1|Overall Study|Adverse Event|22
730514|NCT00289978|2346726|P3|Overall Study|Withdrawal by Subject|28
730515|NCT00289978|2346727|P2|Overall Study|Withdrawal by Subject|17
730516|NCT00289978|2346728|P1|Overall Study|Withdrawal by Subject|31
730517|NCT00289991|2346744|P2|Overall Study|Unspecified|14
730518|NCT00289991|2346745|P1|Overall Study|Unspecified|5
730519|NCT00289991|2346744|P2|Overall Study|Withdrawal by Subject|12
730520|NCT00289991|2346745|P1|Overall Study|Withdrawal by Subject|2
730521|NCT00289991|2346744|P2|Overall Study|Lost to Follow-up|1
730522|NCT00289991|2346745|P1|Overall Study|Lost to Follow-up|0
730523|NCT00289991|2346744|P2|Overall Study|Fungal breakthrough infection|1
730524|NCT00289991|2346745|P1|Overall Study|Fungal breakthrough infection|0
730525|NCT00289991|2346744|P2|Overall Study|Failure of prophylaxis|1
730526|NCT00289991|2346745|P1|Overall Study|Failure of prophylaxis|1
730527|NCT00289991|2346744|P2|Overall Study|Adverse Event|13
730528|NCT00289991|2346745|P1|Overall Study|Adverse Event|15
730529|NCT00289991|2346744|P2|Overall Study|Death|38
730530|NCT00289991|2346745|P1|Overall Study|Death|35
730531|NCT00290186|2346780|P2|Overall Study|Withdrawal by Subject|1
730532|NCT00290186|2346781|P1|Overall Study|Withdrawal by Subject|0
730533|NCT00290186|2346780|P2|Overall Study|Study was terminated prior to 3-month te|1
730534|NCT00290186|2346781|P1|Overall Study|Study was terminated prior to 3-month te|1
730535|NCT00290186|2346780|P2|Overall Study|Lost to Follow-up|2
730536|NCT00290186|2346781|P1|Overall Study|Lost to Follow-up|3
730537|NCT00290186|2346780|P2|Overall Study|Adverse Event|1
730538|NCT00290186|2346781|P1|Overall Study|Adverse Event|1
730539|NCT00290238|2346836|P2|Overall Study|Withdrawal by Subject|13
730540|NCT00290238|2346837|P1|Overall Study|Withdrawal by Subject|15
730541|NCT00290238|2346836|P2|Overall Study|Lost to Follow-up|1
730542|NCT00290238|2346837|P1|Overall Study|Lost to Follow-up|0
730543|NCT00290238|2346836|P2|Overall Study|Study terminated|27
730544|NCT00290238|2346837|P1|Overall Study|Study terminated|27
730545|NCT00290251|2346845|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
730546|NCT00290251|2346846|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
730547|NCT00290251|2346847|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
730548|NCT00290251|2346845|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
730549|NCT00290251|2346846|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
730550|NCT00290251|2346847|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
730551|NCT00290251|2346845|P3|Treatment 1 (Months 1 - 3)|headache|0
730552|NCT00290251|2346846|P2|Treatment 1 (Months 1 - 3)|headache|1
730553|NCT00290251|2346847|P1|Treatment 1 (Months 1 - 3)|headache|0
730554|NCT00290251|2346845|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
730555|NCT00290251|2346846|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
730556|NCT00290251|2346847|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
730557|NCT00290290|2346859|P2|Overall Study|Underwent clean surgical procedure|12
730558|NCT00290290|2346860|P1|Overall Study|Underwent clean surgical procedure|13
730559|NCT00290290|2346859|P2|Overall Study|Withdrawal by Subject|2
730560|NCT00290290|2346860|P1|Overall Study|Withdrawal by Subject|2
730561|NCT00290290|2346859|P2|Overall Study|Death|4
730562|NCT00290290|2346860|P1|Overall Study|Death|3
730563|NCT00290732|2346943|P5|Overall Study|Inability to instill drug intraductally.|0
730564|NCT00290732|2346944|P4|Overall Study|Inability to instill drug intraductally.|0
730565|NCT00290732|2346945|P3|Overall Study|Inability to instill drug intraductally.|1
730566|NCT00290732|2346946|P2|Overall Study|Inability to instill drug intraductally.|1
730567|NCT00290732|2346947|P1|Overall Study|Inability to instill drug intraductally.|0
730568|NCT00290758|2346967|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
730569|NCT00290758|2346968|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
730570|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
730571|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
730572|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
730573|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
730574|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
730575|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
730576|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
730577|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
730578|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
730579|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
730580|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
730581|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
730582|NCT00290758|2346967|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
730583|NCT00290758|2346968|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
730584|NCT00278889|2347008|P3|Overall Study|Death|17
730585|NCT00278889|2347009|P2|Overall Study|Death|21
730586|NCT00278889|2347010|P1|Overall Study|Death|24
730587|NCT00278889|2347008|P3|Overall Study|Lost to Follow-up|0
730588|NCT00278889|2347009|P2|Overall Study|Lost to Follow-up|1
730589|NCT00278889|2347010|P1|Overall Study|Lost to Follow-up|1
730590|NCT00278889|2347008|P3|Overall Study|Withdrawal by Subject|3
730591|NCT00278889|2347009|P2|Overall Study|Withdrawal by Subject|5
730592|NCT00278889|2347010|P1|Overall Study|Withdrawal by Subject|0
730594|NCT00278954|2347069|P1|Overall Study|Withdrawal by Subject|1
730595|NCT00278954|2347069|P1|Overall Study|Lost to Follow-up|1
730596|NCT00278954|2347069|P1|Overall Study|Adverse Event|3
730597|NCT00278993|2347077|P1|Overall Study|Not Otherwise Specified|4
730598|NCT00278993|2347077|P1|Overall Study|Physician Decision|9
730599|NCT00278993|2347077|P1|Overall Study|Progressive Disease|65
730600|NCT00278993|2347077|P1|Overall Study|Withdrawal by Subject|5
730601|NCT00278993|2347077|P1|Overall Study|Adverse Event|24
730602|NCT00279201|2347087|P6|Intensification Addendum|Death|0
730603|NCT00279201|2347088|P5|Intensification Addendum|Death|1
730604|NCT00279201|2347089|P4|Intensification Addendum|Death|0
730605|NCT00279201|2347090|P3|Intensification Addendum|Death|0
730606|NCT00279201|2347091|P2|Intensification Addendum|Death|0
730607|NCT00279201|2347092|P1|Intensification Addendum|Death|0
730608|NCT00279201|2347087|P6|Intensification Addendum|Lack of Efficacy|0
730609|NCT00279201|2347088|P5|Intensification Addendum|Lack of Efficacy|1
730610|NCT00279201|2347089|P4|Intensification Addendum|Lack of Efficacy|1
730611|NCT00279201|2347090|P3|Intensification Addendum|Lack of Efficacy|0
730612|NCT00279201|2347091|P2|Intensification Addendum|Lack of Efficacy|0
730613|NCT00279201|2347092|P1|Intensification Addendum|Lack of Efficacy|0
730614|NCT00279201|2347087|P6|Intensification Addendum|Entry Criteria Exclusion|0
730615|NCT00279201|2347088|P5|Intensification Addendum|Entry Criteria Exclusion|0
730616|NCT00279201|2347089|P4|Intensification Addendum|Entry Criteria Exclusion|0
730617|NCT00279201|2347090|P3|Intensification Addendum|Entry Criteria Exclusion|1
730618|NCT00279201|2347091|P2|Intensification Addendum|Entry Criteria Exclusion|0
730619|NCT00279201|2347092|P1|Intensification Addendum|Entry Criteria Exclusion|0
730620|NCT00279201|2347087|P6|Intensification Addendum|Sponsor Decision|1
730621|NCT00279201|2347088|P5|Intensification Addendum|Sponsor Decision|1
730622|NCT00279201|2347089|P4|Intensification Addendum|Sponsor Decision|0
730623|NCT00279201|2347090|P3|Intensification Addendum|Sponsor Decision|0
730624|NCT00279201|2347091|P2|Intensification Addendum|Sponsor Decision|0
730625|NCT00279201|2347092|P1|Intensification Addendum|Sponsor Decision|0
730626|NCT00279201|2347087|P6|Intensification Addendum|Physician Decision|2
730627|NCT00279201|2347088|P5|Intensification Addendum|Physician Decision|3
730628|NCT00279201|2347089|P4|Intensification Addendum|Physician Decision|1
730629|NCT00279201|2347090|P3|Intensification Addendum|Physician Decision|4
730630|NCT00279201|2347091|P2|Intensification Addendum|Physician Decision|0
730631|NCT00279201|2347092|P1|Intensification Addendum|Physician Decision|0
730632|NCT00279201|2347087|P6|Intensification Addendum|Adverse Event|3
730633|NCT00279201|2347088|P5|Intensification Addendum|Adverse Event|1
730634|NCT00279201|2347089|P4|Intensification Addendum|Adverse Event|4
730635|NCT00279201|2347090|P3|Intensification Addendum|Adverse Event|0
730636|NCT00279201|2347091|P2|Intensification Addendum|Adverse Event|0
730637|NCT00279201|2347092|P1|Intensification Addendum|Adverse Event|0
730638|NCT00279201|2347087|P6|Intensification Addendum|Protocol Violation|6
730639|NCT00279201|2347088|P5|Intensification Addendum|Protocol Violation|6
730640|NCT00279201|2347089|P4|Intensification Addendum|Protocol Violation|2
730641|NCT00279201|2347090|P3|Intensification Addendum|Protocol Violation|2
730642|NCT00279201|2347091|P2|Intensification Addendum|Protocol Violation|0
730643|NCT00279201|2347092|P1|Intensification Addendum|Protocol Violation|0
730644|NCT00279201|2347087|P6|Intensification Addendum|Lost to Follow-up|7
730645|NCT00279201|2347088|P5|Intensification Addendum|Lost to Follow-up|7
730646|NCT00279201|2347089|P4|Intensification Addendum|Lost to Follow-up|6
730647|NCT00279201|2347090|P3|Intensification Addendum|Lost to Follow-up|4
730648|NCT00279201|2347091|P2|Intensification Addendum|Lost to Follow-up|0
730649|NCT00279201|2347092|P1|Intensification Addendum|Lost to Follow-up|0
730650|NCT00279201|2347087|P6|Intensification Addendum|Withdrawal by Subject|18
730651|NCT00279201|2347088|P5|Intensification Addendum|Withdrawal by Subject|9
730652|NCT00279201|2347089|P4|Intensification Addendum|Withdrawal by Subject|14
730653|NCT00279201|2347090|P3|Intensification Addendum|Withdrawal by Subject|12
730654|NCT00279201|2347091|P2|Intensification Addendum|Withdrawal by Subject|0
730655|NCT00279201|2347092|P1|Intensification Addendum|Withdrawal by Subject|0
730656|NCT00279201|2347087|P6|Maintenance|HbA1c>7.5%|0
730657|NCT00279201|2347088|P5|Maintenance|HbA1c>7.5%|0
730658|NCT00279201|2347089|P4|Maintenance|HbA1c>7.5%|0
730659|NCT00279201|2347090|P3|Maintenance|HbA1c>7.5%|0
730660|NCT00279201|2347091|P2|Maintenance|HbA1c>7.5%|126
730661|NCT00279201|2347092|P1|Maintenance|HbA1c>7.5%|123
730662|NCT00279201|2347087|P6|Maintenance|Sponsor Decision|0
730663|NCT00279201|2347088|P5|Maintenance|Sponsor Decision|0
730664|NCT00279201|2347089|P4|Maintenance|Sponsor Decision|0
730665|NCT00279201|2347090|P3|Maintenance|Sponsor Decision|0
730666|NCT00279201|2347091|P2|Maintenance|Sponsor Decision|0
730667|NCT00279201|2347092|P1|Maintenance|Sponsor Decision|4
730668|NCT00279201|2347087|P6|Maintenance|Physician Decision|0
730669|NCT00279201|2347088|P5|Maintenance|Physician Decision|0
730670|NCT00279201|2347089|P4|Maintenance|Physician Decision|0
730671|NCT00279201|2347090|P3|Maintenance|Physician Decision|0
730672|NCT00279201|2347091|P2|Maintenance|Physician Decision|9
730673|NCT00279201|2347092|P1|Maintenance|Physician Decision|9
730674|NCT00279201|2347087|P6|Maintenance|Withdrawal by Subject|0
730675|NCT00279201|2347088|P5|Maintenance|Withdrawal by Subject|0
730676|NCT00279201|2347089|P4|Maintenance|Withdrawal by Subject|0
730677|NCT00279201|2347090|P3|Maintenance|Withdrawal by Subject|0
730678|NCT00279201|2347091|P2|Maintenance|Withdrawal by Subject|18
730679|NCT00279201|2347092|P1|Maintenance|Withdrawal by Subject|18
730680|NCT00279201|2347087|P6|Maintenance|Protocol Violation|0
730681|NCT00279201|2347088|P5|Maintenance|Protocol Violation|0
730682|NCT00279201|2347089|P4|Maintenance|Protocol Violation|0
730683|NCT00279201|2347090|P3|Maintenance|Protocol Violation|0
730684|NCT00279201|2347091|P2|Maintenance|Protocol Violation|24
730685|NCT00279201|2347092|P1|Maintenance|Protocol Violation|16
730686|NCT00279201|2347087|P6|Maintenance|Entry Criteria Exclusion|0
730687|NCT00279201|2347088|P5|Maintenance|Entry Criteria Exclusion|0
730688|NCT00279201|2347089|P4|Maintenance|Entry Criteria Exclusion|0
730689|NCT00279201|2347090|P3|Maintenance|Entry Criteria Exclusion|0
730690|NCT00279201|2347091|P2|Maintenance|Entry Criteria Exclusion|4
730691|NCT00279201|2347092|P1|Maintenance|Entry Criteria Exclusion|1
730692|NCT00279201|2347087|P6|Maintenance|Lost to Follow-up|0
730693|NCT00279201|2347088|P5|Maintenance|Lost to Follow-up|0
730694|NCT00279201|2347089|P4|Maintenance|Lost to Follow-up|0
730695|NCT00279201|2347090|P3|Maintenance|Lost to Follow-up|0
730696|NCT00279201|2347091|P2|Maintenance|Lost to Follow-up|13
730697|NCT00279201|2347092|P1|Maintenance|Lost to Follow-up|17
730698|NCT00279201|2347087|P6|Maintenance|Death|0
730699|NCT00279201|2347088|P5|Maintenance|Death|0
730700|NCT00279201|2347089|P4|Maintenance|Death|0
730701|NCT00279201|2347090|P3|Maintenance|Death|0
730702|NCT00279201|2347091|P2|Maintenance|Death|4
730703|NCT00279201|2347092|P1|Maintenance|Death|4
730704|NCT00279201|2347087|P6|Maintenance|Adverse Event|0
730705|NCT00279201|2347088|P5|Maintenance|Adverse Event|0
730706|NCT00279201|2347089|P4|Maintenance|Adverse Event|0
730707|NCT00279201|2347090|P3|Maintenance|Adverse Event|0
730708|NCT00279201|2347091|P2|Maintenance|Adverse Event|4
730709|NCT00279201|2347092|P1|Maintenance|Adverse Event|4
730710|NCT00279201|2347087|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
730711|NCT00279201|2347088|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
730712|NCT00279201|2347089|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
730713|NCT00279201|2347090|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
730714|NCT00279201|2347091|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
730715|NCT00279201|2347092|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
730716|NCT00279201|2347087|P6|Maintenance|Lack of Efficacy|0
730717|NCT00279201|2347088|P5|Maintenance|Lack of Efficacy|0
730718|NCT00279201|2347089|P4|Maintenance|Lack of Efficacy|0
730719|NCT00279201|2347090|P3|Maintenance|Lack of Efficacy|0
730720|NCT00279201|2347091|P2|Maintenance|Lack of Efficacy|30
730721|NCT00279201|2347092|P1|Maintenance|Lack of Efficacy|32
730722|NCT00279201|2347087|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
730723|NCT00279201|2347088|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
730724|NCT00279201|2347089|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
730725|NCT00279201|2347090|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
730726|NCT00279201|2347091|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
730727|NCT00279201|2347092|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
730728|NCT00279201|2347087|P6|Initiation|Sponsor Decision|0
730729|NCT00279201|2347088|P5|Initiation|Sponsor Decision|0
730730|NCT00279201|2347089|P4|Initiation|Sponsor Decision|0
730731|NCT00279201|2347090|P3|Initiation|Sponsor Decision|0
730732|NCT00279201|2347091|P2|Initiation|Sponsor Decision|5
730733|NCT00279201|2347092|P1|Initiation|Sponsor Decision|13
730734|NCT00279201|2347087|P6|Initiation|Physician Decision|0
730735|NCT00279201|2347088|P5|Initiation|Physician Decision|0
730736|NCT00279201|2347089|P4|Initiation|Physician Decision|0
730737|NCT00279201|2347090|P3|Initiation|Physician Decision|0
730738|NCT00279201|2347091|P2|Initiation|Physician Decision|18
730739|NCT00279201|2347092|P1|Initiation|Physician Decision|15
730740|NCT00279201|2347087|P6|Initiation|Withdrawal by Subject|0
730741|NCT00279201|2347088|P5|Initiation|Withdrawal by Subject|0
730742|NCT00279201|2347089|P4|Initiation|Withdrawal by Subject|0
730743|NCT00279201|2347090|P3|Initiation|Withdrawal by Subject|0
730744|NCT00279201|2347091|P2|Initiation|Withdrawal by Subject|41
730745|NCT00279201|2347092|P1|Initiation|Withdrawal by Subject|35
730746|NCT00279201|2347087|P6|Initiation|Protocol Violation|0
730747|NCT00279201|2347088|P5|Initiation|Protocol Violation|0
730748|NCT00279201|2347089|P4|Initiation|Protocol Violation|0
730749|NCT00279201|2347090|P3|Initiation|Protocol Violation|0
730750|NCT00279201|2347091|P2|Initiation|Protocol Violation|10
730751|NCT00279201|2347092|P1|Initiation|Protocol Violation|9
730752|NCT00279201|2347087|P6|Initiation|Entry Criteria Exclusion|0
730753|NCT00279201|2347088|P5|Initiation|Entry Criteria Exclusion|0
730754|NCT00279201|2347089|P4|Initiation|Entry Criteria Exclusion|0
730755|NCT00279201|2347090|P3|Initiation|Entry Criteria Exclusion|0
730756|NCT00279201|2347091|P2|Initiation|Entry Criteria Exclusion|9
730757|NCT00279201|2347092|P1|Initiation|Entry Criteria Exclusion|7
730758|NCT00279201|2347087|P6|Initiation|Lost to Follow-up|0
730759|NCT00279201|2347088|P5|Initiation|Lost to Follow-up|0
730760|NCT00279201|2347089|P4|Initiation|Lost to Follow-up|0
730761|NCT00279201|2347090|P3|Initiation|Lost to Follow-up|0
730762|NCT00279201|2347091|P2|Initiation|Lost to Follow-up|41
730763|NCT00279201|2347092|P1|Initiation|Lost to Follow-up|42
730764|NCT00279201|2347087|P6|Initiation|Adverse Event|0
730765|NCT00279201|2347088|P5|Initiation|Adverse Event|0
730766|NCT00279201|2347089|P4|Initiation|Adverse Event|0
730767|NCT00279201|2347090|P3|Initiation|Adverse Event|0
730768|NCT00279201|2347091|P2|Initiation|Adverse Event|15
730769|NCT00279201|2347092|P1|Initiation|Adverse Event|6
730770|NCT00279201|2347087|P6|Initiation|Death|0
730771|NCT00279201|2347088|P5|Initiation|Death|0
730772|NCT00279201|2347089|P4|Initiation|Death|0
730773|NCT00279201|2347090|P3|Initiation|Death|0
730774|NCT00279201|2347091|P2|Initiation|Death|5
730775|NCT00279201|2347092|P1|Initiation|Death|1
730776|NCT00279214|2347238|P2|Overall Study|Physician Decision|2
730777|NCT00279214|2347239|P1|Overall Study|Physician Decision|3
730778|NCT00279305|2347269|P2|Overall Study|FDA Safety Alert|1
730779|NCT00279305|2347270|P1|Overall Study|FDA Safety Alert|4
730780|NCT00279305|2347269|P2|Overall Study|Dificulting establishing IV|0
730781|NCT00279305|2347270|P1|Overall Study|Dificulting establishing IV|1
730782|NCT00279305|2347269|P2|Overall Study|Withdrawal by Subject|0
730783|NCT00279305|2347270|P1|Overall Study|Withdrawal by Subject|2
730784|NCT00279305|2347269|P2|Overall Study|Pregnancy|0
730785|NCT00279305|2347270|P1|Overall Study|Pregnancy|1
730786|NCT00284856|2347292|P3|Overall Study|Unspecified|4
730787|NCT00284856|2347293|P2|Overall Study|Unspecified|5
730788|NCT00284856|2347294|P1|Overall Study|Unspecified|4
730789|NCT00284856|2347292|P3|Overall Study|Withdrawal by Subject|18
730790|NCT00284856|2347293|P2|Overall Study|Withdrawal by Subject|16
730791|NCT00284856|2347294|P1|Overall Study|Withdrawal by Subject|12
730792|NCT00284856|2347292|P3|Overall Study|Protocol Violation|5
730793|NCT00284856|2347293|P2|Overall Study|Protocol Violation|4
730794|NCT00284856|2347294|P1|Overall Study|Protocol Violation|5
730795|NCT00284856|2347292|P3|Overall Study|Lost to Follow-up|22
730796|NCT00284856|2347293|P2|Overall Study|Lost to Follow-up|21
730797|NCT00284856|2347294|P1|Overall Study|Lost to Follow-up|25
730798|NCT00284856|2347292|P3|Overall Study|Lack of Efficacy|8
730799|NCT00284856|2347293|P2|Overall Study|Lack of Efficacy|1
730800|NCT00284856|2347294|P1|Overall Study|Lack of Efficacy|2
730801|NCT00284856|2347292|P3|Overall Study|Adverse Event|3
730802|NCT00284856|2347293|P2|Overall Study|Adverse Event|3
730803|NCT00284856|2347294|P1|Overall Study|Adverse Event|3
730804|NCT00284934|2347310|P2|Overall Study|Other reasons|1
730805|NCT00284934|2347311|P1|Overall Study|Other reasons|3
730806|NCT00284934|2347310|P2|Overall Study|Adverse Event|2
730807|NCT00284934|2347311|P1|Overall Study|Adverse Event|1
730808|NCT00285012|2347325|P2|Received Study Tx|Other|5
730809|NCT00285012|2347326|P1|Received Study Tx|Other|5
730810|NCT00285012|2347325|P2|Received Study Tx|Withdrawal by Subject|43
730811|NCT00285012|2347326|P1|Received Study Tx|Withdrawal by Subject|31
730812|NCT00285012|2347325|P2|Received Study Tx|Lost to Follow-up|31
730813|NCT00285012|2347326|P1|Received Study Tx|Lost to Follow-up|29
730814|NCT00285012|2347325|P2|Received Study Tx|Lack of Efficacy|3
730815|NCT00285012|2347326|P1|Received Study Tx|Lack of Efficacy|0
730816|NCT00285012|2347325|P2|Received Study Tx|Adverse Event|11
730817|NCT00285012|2347326|P1|Received Study Tx|Adverse Event|5
730818|NCT00285012|2347325|P2|Received Study Tx|Death|1
730819|NCT00285012|2347326|P1|Received Study Tx|Death|2
730820|NCT00285012|2347325|P2|Assigned to Study Treatment (Tx)|Other|3
730821|NCT00285012|2347326|P1|Assigned to Study Treatment (Tx)|Other|2
730822|NCT00290771|2347352|P2|Overall Study|Lost to Follow-up|1
730823|NCT00290771|2347353|P1|Overall Study|Lost to Follow-up|0
730824|NCT00290771|2347352|P2|Overall Study|Protocol Violation|0
730825|NCT00290771|2347353|P1|Overall Study|Protocol Violation|2
730826|NCT00290771|2347352|P2|Overall Study|Administrative problems|1
730827|NCT00290771|2347353|P1|Overall Study|Administrative problems|2
730828|NCT00290771|2347352|P2|Overall Study|Withdrawal by Subject|6
730829|NCT00290771|2347353|P1|Overall Study|Withdrawal by Subject|5
730830|NCT00290771|2347352|P2|Overall Study|Adverse Event|6
730831|NCT00290771|2347353|P1|Overall Study|Adverse Event|12
730832|NCT00290771|2347352|P2|Overall Study|Death|10
730833|NCT00290771|2347353|P1|Overall Study|Death|11
730834|NCT00290771|2347352|P2|Overall Study|Disease progression|73
730835|NCT00290771|2347353|P1|Overall Study|Disease progression|95
730836|NCT00290888|2347384|P2|Overall Study|Physician Decision|1
730837|NCT00290888|2347385|P1|Overall Study|Physician Decision|3
730853|NCT00294554|2347438|P2|Overall Study|Physician Decision|1
730854|NCT00294554|2347439|P1|Overall Study|Physician Decision|0
730855|NCT00294554|2347438|P2|Overall Study|Lack of Efficacy|1
730856|NCT00294554|2347439|P1|Overall Study|Lack of Efficacy|0
730857|NCT00294645|2347449|P2|Overall Study|Other|10
730858|NCT00294645|2347450|P1|Overall Study|Other|4
730859|NCT00294645|2347449|P2|Overall Study|Physician Decision|20
730860|NCT00294645|2347450|P1|Overall Study|Physician Decision|15
730861|NCT00294645|2347449|P2|Overall Study|Withdrawal by Subject|34
730862|NCT00294645|2347450|P1|Overall Study|Withdrawal by Subject|18
730863|NCT00294645|2347449|P2|Overall Study|Lost to Follow-up|10
730864|NCT00294645|2347450|P1|Overall Study|Lost to Follow-up|1
730865|NCT00294645|2347449|P2|Overall Study|Death|18
730866|NCT00294645|2347450|P1|Overall Study|Death|10
730867|NCT00294658|2347484|P2|Overall Study|Patient and family were not satisfied|1
730868|NCT00294658|2347485|P1|Overall Study|Patient and family were not satisfied|0
730869|NCT00294658|2347484|P2|Overall Study|Found to have invasive thymoma|0
730870|NCT00294658|2347485|P1|Overall Study|Found to have invasive thymoma|1
730871|NCT00294658|2347484|P2|Overall Study|Withdrawal by Subject|4
730872|NCT00294658|2347485|P1|Overall Study|Withdrawal by Subject|0
730873|NCT00294658|2347484|P2|Overall Study|Pregnancy|1
730874|NCT00294658|2347485|P1|Overall Study|Pregnancy|0
730875|NCT00294658|2347484|P2|Overall Study|Physician Decision|2
730876|NCT00294658|2347485|P1|Overall Study|Physician Decision|1
730877|NCT00294658|2347484|P2|Overall Study|Lost to Follow-up|0
730878|NCT00294658|2347485|P1|Overall Study|Lost to Follow-up|4
730879|NCT00294658|2347484|P2|Overall Study|Death|1
730880|NCT00294658|2347485|P1|Overall Study|Death|0
730881|NCT00294671|2347549|P2|Overall Study|Death|1
730882|NCT00294671|2347550|P1|Overall Study|Death|0
730883|NCT00294671|2347549|P2|Overall Study|Non-compliance|0
730884|NCT00294671|2347550|P1|Overall Study|Non-compliance|1
730885|NCT00294671|2347549|P2|Overall Study|Lost to Follow-up|3
730886|NCT00294671|2347550|P1|Overall Study|Lost to Follow-up|1
730887|NCT00294671|2347549|P2|Overall Study|Non-drug related AE|2
730888|NCT00294671|2347550|P1|Overall Study|Non-drug related AE|3
730889|NCT00294671|2347549|P2|Overall Study|Drug related adverse event (AE)|2
730890|NCT00294671|2347550|P1|Overall Study|Drug related adverse event (AE)|4
730891|NCT00294671|2347549|P2|Overall Study|Liver transplant|9
730892|NCT00294671|2347550|P1|Overall Study|Liver transplant|7
730893|NCT00294671|2347549|P2|Overall Study|Lack of Efficacy|23
730894|NCT00294671|2347550|P1|Overall Study|Lack of Efficacy|11
730895|NCT00294684|2347566|P2|Overall Study|Lost to Follow-up|8
730896|NCT00294684|2347567|P1|Overall Study|Lost to Follow-up|5
730897|NCT00294723|2347608|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
730898|NCT00294723|2347609|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
730899|NCT00294723|2347610|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
730900|NCT00294723|2347608|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
730901|NCT00294723|2347609|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
730902|NCT00294723|2347610|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
730903|NCT00294723|2347608|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
730987|NCT00295750|2347806|P1|Overall Study|Withdrawal by Subject|9
730904|NCT00294723|2347609|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
730905|NCT00294723|2347610|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
730906|NCT00294723|2347608|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
730907|NCT00294723|2347609|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
730908|NCT00294723|2347610|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
730909|NCT00294723|2347608|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
730910|NCT00294723|2347609|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
730911|NCT00294723|2347610|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
730912|NCT00294723|2347608|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
730913|NCT00294723|2347609|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
730914|NCT00294723|2347610|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
730915|NCT00294723|2347608|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
730916|NCT00294723|2347609|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
730917|NCT00294723|2347610|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
730918|NCT00294723|2347608|P3|Open-Label Extension 52 Weeks|Adverse Event|2
730919|NCT00294723|2347609|P2|Open-Label Extension 52 Weeks|Adverse Event|5
730920|NCT00294723|2347610|P1|Open-Label Extension 52 Weeks|Adverse Event|5
730921|NCT00294723|2347608|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
730922|NCT00294723|2347609|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
730923|NCT00294723|2347610|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
730924|NCT00294723|2347608|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
730925|NCT00294723|2347609|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
730926|NCT00294723|2347610|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
730927|NCT00294723|2347608|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
730928|NCT00294723|2347609|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
730929|NCT00294723|2347610|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
730930|NCT00294723|2347608|P3|Double-Blind Period 52 Weeks|Adverse Event|15
730931|NCT00294723|2347609|P2|Double-Blind Period 52 Weeks|Adverse Event|25
730932|NCT00294723|2347610|P1|Double-Blind Period 52 Weeks|Adverse Event|18
730933|NCT00294762|2347671|P2|Overall Study|Did not receive study treatment|3
730934|NCT00294762|2347672|P1|Overall Study|Did not receive study treatment|3
730935|NCT00295490|2347732|P4|Overall Study|Other|1
730936|NCT00295490|2347733|P3|Overall Study|Other|0
730937|NCT00295490|2347734|P2|Overall Study|Other|2
730938|NCT00295490|2347735|P1|Overall Study|Other|0
730939|NCT00295490|2347732|P4|Overall Study|Adverse Event|0
730940|NCT00295490|2347733|P3|Overall Study|Adverse Event|0
730941|NCT00295490|2347734|P2|Overall Study|Adverse Event|0
730942|NCT00295490|2347735|P1|Overall Study|Adverse Event|1
730943|NCT00295490|2347732|P4|Overall Study|Lost to Follow-up|0
730944|NCT00295490|2347733|P3|Overall Study|Lost to Follow-up|1
730945|NCT00295490|2347734|P2|Overall Study|Lost to Follow-up|0
730946|NCT00295490|2347735|P1|Overall Study|Lost to Follow-up|0
730947|NCT00295490|2347732|P4|Overall Study|Withdrawal by Subject|1
730948|NCT00295490|2347733|P3|Overall Study|Withdrawal by Subject|0
730949|NCT00295490|2347734|P2|Overall Study|Withdrawal by Subject|2
730950|NCT00295490|2347735|P1|Overall Study|Withdrawal by Subject|0
730951|NCT00295490|2347732|P4|Overall Study|Protocol Violation|3
730952|NCT00295490|2347733|P3|Overall Study|Protocol Violation|3
730953|NCT00295490|2347734|P2|Overall Study|Protocol Violation|0
730954|NCT00295490|2347735|P1|Overall Study|Protocol Violation|0
730955|NCT00295633|2347782|P3|Overall Study|Administrative reason by sponsor|1
730956|NCT00295633|2347783|P2|Overall Study|Administrative reason by sponsor|0
730957|NCT00295633|2347784|P1|Overall Study|Administrative reason by sponsor|0
730958|NCT00295633|2347782|P3|Overall Study|Death|0
730959|NCT00295633|2347783|P2|Overall Study|Death|1
730960|NCT00295633|2347784|P1|Overall Study|Death|1
730961|NCT00295633|2347782|P3|Overall Study|Subject No Longer Meets Study Criteria|3
730962|NCT00295633|2347783|P2|Overall Study|Subject No Longer Meets Study Criteria|3
730963|NCT00295633|2347784|P1|Overall Study|Subject No Longer Meets Study Criteria|0
730964|NCT00295633|2347782|P3|Overall Study|Poor/Noncompliance|6
730965|NCT00295633|2347783|P2|Overall Study|Poor/Noncompliance|2
730966|NCT00295633|2347784|P1|Overall Study|Poor/Noncompliance|2
730967|NCT00295633|2347782|P3|Overall Study|Physician Decision|8
730968|NCT00295633|2347783|P2|Overall Study|Physician Decision|10
730969|NCT00295633|2347784|P1|Overall Study|Physician Decision|9
730970|NCT00295633|2347782|P3|Overall Study|Lost to Follow-up|7
730971|NCT00295633|2347783|P2|Overall Study|Lost to Follow-up|11
730972|NCT00295633|2347784|P1|Overall Study|Lost to Follow-up|6
730973|NCT00295633|2347782|P3|Overall Study|Adverse Event|9
730974|NCT00295633|2347783|P2|Overall Study|Adverse Event|17
730975|NCT00295633|2347784|P1|Overall Study|Adverse Event|9
730976|NCT00295633|2347782|P3|Overall Study|Withdrawal of consent by subject|26
730977|NCT00295633|2347783|P2|Overall Study|Withdrawal of consent by subject|16
730978|NCT00295633|2347784|P1|Overall Study|Withdrawal of consent by subject|16
730979|NCT00295633|2347782|P3|Overall Study|Lack of Efficacy|16
730980|NCT00295633|2347783|P2|Overall Study|Lack of Efficacy|7
730981|NCT00295633|2347784|P1|Overall Study|Lack of Efficacy|19
730982|NCT00295750|2347804|P3|Overall Study|Protocol Violation|2
730983|NCT00295750|2347805|P2|Overall Study|Protocol Violation|4
730984|NCT00295750|2347806|P1|Overall Study|Protocol Violation|2
730985|NCT00295750|2347804|P3|Overall Study|Withdrawal by Subject|7
730986|NCT00295750|2347805|P2|Overall Study|Withdrawal by Subject|4
730988|NCT00295750|2347804|P3|Overall Study|Randomized but never received trial drug|3
730989|NCT00295750|2347805|P2|Overall Study|Randomized but never received trial drug|3
730990|NCT00295750|2347806|P1|Overall Study|Randomized but never received trial drug|4
730991|NCT00295750|2347804|P3|Overall Study|Personal reasons|0
730992|NCT00295750|2347805|P2|Overall Study|Personal reasons|1
730993|NCT00295750|2347806|P1|Overall Study|Personal reasons|0
730994|NCT00295750|2347804|P3|Overall Study|Disease progression|0
730995|NCT00295750|2347805|P2|Overall Study|Disease progression|1
730996|NCT00295750|2347806|P1|Overall Study|Disease progression|2
730997|NCT00295750|2347804|P3|Overall Study|Trial drug errors|0
730998|NCT00295750|2347805|P2|Overall Study|Trial drug errors|1
730999|NCT00295750|2347806|P1|Overall Study|Trial drug errors|1
731000|NCT00295750|2347804|P3|Overall Study|Administrative errors|5
731001|NCT00295750|2347805|P2|Overall Study|Administrative errors|4
731002|NCT00295750|2347806|P1|Overall Study|Administrative errors|2
731003|NCT00295750|2347804|P3|Overall Study|Taking prohibited therapy|2
731004|NCT00295750|2347805|P2|Overall Study|Taking prohibited therapy|3
731005|NCT00295750|2347806|P1|Overall Study|Taking prohibited therapy|2
731006|NCT00295750|2347804|P3|Overall Study|Lost to Follow-up|1
731007|NCT00295750|2347805|P2|Overall Study|Lost to Follow-up|4
731008|NCT00295750|2347806|P1|Overall Study|Lost to Follow-up|1
731009|NCT00295750|2347804|P3|Overall Study|Lack of Efficacy|0
731010|NCT00295750|2347805|P2|Overall Study|Lack of Efficacy|1
731011|NCT00295750|2347806|P1|Overall Study|Lack of Efficacy|1
731012|NCT00295750|2347804|P3|Overall Study|Adverse Event|12
731013|NCT00295750|2347805|P2|Overall Study|Adverse Event|15
731014|NCT00295750|2347806|P1|Overall Study|Adverse Event|19
731015|NCT00295854|2347841|P3|Overall Study|not specified|1
731016|NCT00295854|2347842|P2|Overall Study|not specified|5
731017|NCT00295854|2347843|P1|Overall Study|not specified|3
731018|NCT00295854|2347841|P3|Overall Study|required a prohibited medication|0
731019|NCT00295854|2347842|P2|Overall Study|required a prohibited medication|0
731020|NCT00295854|2347843|P1|Overall Study|required a prohibited medication|1
731021|NCT00295854|2347841|P3|Overall Study|did not continue to meet criteria|2
731022|NCT00295854|2347842|P2|Overall Study|did not continue to meet criteria|1
731023|NCT00295854|2347843|P1|Overall Study|did not continue to meet criteria|1
731024|NCT00295854|2347841|P3|Overall Study|Withdrawal by Subject|4
731025|NCT00295854|2347842|P2|Overall Study|Withdrawal by Subject|7
731026|NCT00295854|2347843|P1|Overall Study|Withdrawal by Subject|3
731027|NCT00295854|2347841|P3|Overall Study|Lost to Follow-up|1
731028|NCT00295854|2347842|P2|Overall Study|Lost to Follow-up|0
731029|NCT00295854|2347843|P1|Overall Study|Lost to Follow-up|2
731030|NCT00295854|2347841|P3|Overall Study|Protocol Violation|1
731031|NCT00295854|2347842|P2|Overall Study|Protocol Violation|1
731032|NCT00295854|2347843|P1|Overall Study|Protocol Violation|1
731033|NCT00295854|2347841|P3|Overall Study|Adverse Event|6
731034|NCT00295854|2347842|P2|Overall Study|Adverse Event|7
731035|NCT00295854|2347843|P1|Overall Study|Adverse Event|7
731036|NCT00295880|2347854|P1|Overall Study|Unit randomization did not occur|1
731037|NCT00295880|2347854|P1|Overall Study|IBMI unit could not be volume reduced|1
731038|NCT00296036|2347867|P6|Overall Study|Protocol Violation|3
731039|NCT00296036|2347868|P5|Overall Study|Protocol Violation|0
731040|NCT00296036|2347869|P4|Overall Study|Protocol Violation|0
731041|NCT00296036|2347870|P3|Overall Study|Protocol Violation|0
731042|NCT00296036|2347871|P2|Overall Study|Protocol Violation|0
731043|NCT00296036|2347872|P1|Overall Study|Protocol Violation|0
731044|NCT00296036|2347867|P6|Overall Study|Withdrawal by Subject|1
731045|NCT00296036|2347868|P5|Overall Study|Withdrawal by Subject|2
731046|NCT00296036|2347869|P4|Overall Study|Withdrawal by Subject|1
731047|NCT00296036|2347870|P3|Overall Study|Withdrawal by Subject|2
731048|NCT00296036|2347871|P2|Overall Study|Withdrawal by Subject|0
731049|NCT00296036|2347872|P1|Overall Study|Withdrawal by Subject|1
731050|NCT00296244|2347946|P2|Overall Study|Underwent retransplant|1
731051|NCT00296244|2347947|P1|Overall Study|Underwent retransplant|0
731052|NCT00296335|2347993|P2|Overall Study|Physician Decision|11
731053|NCT00296335|2347994|P1|Overall Study|Physician Decision|3
731054|NCT00296335|2347993|P2|Overall Study|Lost to Follow-up|33
731055|NCT00296335|2347994|P1|Overall Study|Lost to Follow-up|7
731056|NCT00296335|2347993|P2|Overall Study|Adverse Event|27
731057|NCT00296335|2347994|P1|Overall Study|Adverse Event|17
731058|NCT00296335|2347993|P2|Overall Study|Recurrence|51
731059|NCT00296335|2347994|P1|Overall Study|Recurrence|3
731060|NCT00296374|2348007|P3|Overall Study|Not specified|1
731061|NCT00296374|2348008|P2|Overall Study|Not specified|0
731062|NCT00296374|2348009|P1|Overall Study|Not specified|0
731063|NCT00296374|2348007|P3|Overall Study|Pregnancy|2
731064|NCT00296374|2348008|P2|Overall Study|Pregnancy|0
731065|NCT00296374|2348009|P1|Overall Study|Pregnancy|0
731066|NCT00296374|2348007|P3|Overall Study|Nephrologist introduced ACE|0
731067|NCT00296374|2348008|P2|Overall Study|Nephrologist introduced ACE|1
731068|NCT00296374|2348009|P1|Overall Study|Nephrologist introduced ACE|0
731069|NCT00296374|2348007|P3|Overall Study|Stopped drug before end of study visit|0
731070|NCT00296374|2348008|P2|Overall Study|Stopped drug before end of study visit|1
731071|NCT00296374|2348009|P1|Overall Study|Stopped drug before end of study visit|0
731072|NCT00296374|2348007|P3|Overall Study|Relocated to another state|0
731073|NCT00296374|2348008|P2|Overall Study|Relocated to another state|0
731074|NCT00296374|2348009|P1|Overall Study|Relocated to another state|1
731075|NCT00296374|2348007|P3|Overall Study|Lost to Follow-up|1
731076|NCT00296374|2348008|P2|Overall Study|Lost to Follow-up|1
731077|NCT00296374|2348009|P1|Overall Study|Lost to Follow-up|3
731078|NCT00296374|2348007|P3|Overall Study|Protocol Violation|3
731079|NCT00296374|2348008|P2|Overall Study|Protocol Violation|2
731080|NCT00296374|2348009|P1|Overall Study|Protocol Violation|1
731081|NCT00296374|2348007|P3|Overall Study|Incorrect enrollment|4
731082|NCT00296374|2348008|P2|Overall Study|Incorrect enrollment|3
731083|NCT00296374|2348009|P1|Overall Study|Incorrect enrollment|3
731084|NCT00296374|2348007|P3|Overall Study|Withdrawal by Subject|11
731085|NCT00296374|2348008|P2|Overall Study|Withdrawal by Subject|5
731086|NCT00296374|2348009|P1|Overall Study|Withdrawal by Subject|3
731087|NCT00296374|2348007|P3|Overall Study|Adverse Event|7
731088|NCT00296374|2348008|P2|Overall Study|Adverse Event|10
731089|NCT00296374|2348009|P1|Overall Study|Adverse Event|14
731090|NCT00296400|2348233|P3|Overall Study|Pregnancy|0
731091|NCT00296400|2348234|P2|Overall Study|Pregnancy|2
731092|NCT00296400|2348235|P1|Overall Study|Pregnancy|1
731093|NCT00296400|2348233|P3|Overall Study|Visit 10 was performed earlier|0
731094|NCT00296400|2348234|P2|Overall Study|Visit 10 was performed earlier|1
731095|NCT00296400|2348235|P1|Overall Study|Visit 10 was performed earlier|0
731096|NCT00296400|2348233|P3|Overall Study|Study specific discontinuation criteria|1
731097|NCT00296400|2348234|P2|Overall Study|Study specific discontinuation criteria|0
731098|NCT00296400|2348235|P1|Overall Study|Study specific discontinuation criteria|0
731099|NCT00296400|2348233|P3|Overall Study|Lost to Follow-up|2
731100|NCT00296400|2348234|P2|Overall Study|Lost to Follow-up|1
731101|NCT00296400|2348235|P1|Overall Study|Lost to Follow-up|1
731102|NCT00296400|2348233|P3|Overall Study|Protocol Violation|1
731103|NCT00296400|2348234|P2|Overall Study|Protocol Violation|1
731104|NCT00296400|2348235|P1|Overall Study|Protocol Violation|1
731105|NCT00296400|2348233|P3|Overall Study|Incorrect enrollment|0
731106|NCT00296400|2348234|P2|Overall Study|Incorrect enrollment|0
731107|NCT00296400|2348235|P1|Overall Study|Incorrect enrollment|2
731108|NCT00296400|2348233|P3|Overall Study|Withdrawal by Subject|2
731109|NCT00296400|2348234|P2|Overall Study|Withdrawal by Subject|6
731110|NCT00296400|2348235|P1|Overall Study|Withdrawal by Subject|5
731111|NCT00296400|2348233|P3|Overall Study|Adverse Event|7
731112|NCT00296400|2348234|P2|Overall Study|Adverse Event|7
731113|NCT00296400|2348235|P1|Overall Study|Adverse Event|7
731114|NCT00296491|2348460|P4|Overall Study|Lost to Follow-up|0
731115|NCT00296491|2348461|P3|Overall Study|Lost to Follow-up|2
731116|NCT00296491|2348462|P2|Overall Study|Lost to Follow-up|2
731117|NCT00296491|2348463|P1|Overall Study|Lost to Follow-up|0
731118|NCT00296491|2348460|P4|Overall Study|Non-Compliance|14
731119|NCT00296491|2348461|P3|Overall Study|Non-Compliance|10
731120|NCT00296491|2348462|P2|Overall Study|Non-Compliance|13
731121|NCT00296491|2348463|P1|Overall Study|Non-Compliance|12
731122|NCT00296491|2348460|P4|Overall Study|Withdrawal by Subject|2
731123|NCT00296491|2348461|P3|Overall Study|Withdrawal by Subject|3
731124|NCT00296491|2348462|P2|Overall Study|Withdrawal by Subject|3
731125|NCT00296491|2348463|P1|Overall Study|Withdrawal by Subject|7
731126|NCT00296491|2348460|P4|Overall Study|Withdrawn due to Asthma|4
731127|NCT00296491|2348461|P3|Overall Study|Withdrawn due to Asthma|0
731128|NCT00296491|2348462|P2|Overall Study|Withdrawn due to Asthma|0
731129|NCT00296491|2348463|P1|Overall Study|Withdrawn due to Asthma|0
731130|NCT00296491|2348460|P4|Overall Study|Adverse Event|4
731131|NCT00296491|2348461|P3|Overall Study|Adverse Event|1
731132|NCT00296491|2348462|P2|Overall Study|Adverse Event|3
731133|NCT00296491|2348463|P1|Overall Study|Adverse Event|1
731134|NCT00296491|2348460|P4|Overall Study|Protocol Violation|3
731135|NCT00296491|2348461|P3|Overall Study|Protocol Violation|2
731136|NCT00296491|2348462|P2|Overall Study|Protocol Violation|6
731137|NCT00296491|2348463|P1|Overall Study|Protocol Violation|4
731138|NCT00296491|2348460|P4|Overall Study|Low Pollen Counts|16
731139|NCT00296491|2348461|P3|Overall Study|Low Pollen Counts|25
731140|NCT00296491|2348462|P2|Overall Study|Low Pollen Counts|26
731141|NCT00296491|2348463|P1|Overall Study|Low Pollen Counts|18
731142|NCT00296504|2348497|P9|Final Analysis|Poor Adherence|1
731143|NCT00296504|2348498|P8|Final Analysis|Poor Adherence|0
731144|NCT00296504|2348499|P7|Final Analysis|Poor Adherence|0
731145|NCT00296504|2348500|P6|Final Analysis|Poor Adherence|0
731146|NCT00296504|2348501|P5|Final Analysis|Poor Adherence|0
731147|NCT00296504|2348502|P4|Final Analysis|Poor Adherence|0
731148|NCT00296504|2348503|P3|Final Analysis|Poor Adherence|0
731149|NCT00296504|2348504|P2|Final Analysis|Poor Adherence|0
731150|NCT00296504|2348505|P1|Final Analysis|Poor Adherence|0
731151|NCT00296504|2348497|P9|Final Analysis|Participant Moved to Another Country|1
731152|NCT00296504|2348498|P8|Final Analysis|Participant Moved to Another Country|0
731153|NCT00296504|2348499|P7|Final Analysis|Participant Moved to Another Country|0
731154|NCT00296504|2348500|P6|Final Analysis|Participant Moved to Another Country|0
731155|NCT00296504|2348501|P5|Final Analysis|Participant Moved to Another Country|0
731156|NCT00296504|2348502|P4|Final Analysis|Participant Moved to Another Country|0
731157|NCT00296504|2348503|P3|Final Analysis|Participant Moved to Another Country|0
731158|NCT00296504|2348504|P2|Final Analysis|Participant Moved to Another Country|0
731159|NCT00296504|2348505|P1|Final Analysis|Participant Moved to Another Country|0
731160|NCT00296504|2348497|P9|Final Analysis|Tuberculosis|1
731161|NCT00296504|2348498|P8|Final Analysis|Tuberculosis|0
731162|NCT00296504|2348499|P7|Final Analysis|Tuberculosis|0
731163|NCT00296504|2348500|P6|Final Analysis|Tuberculosis|0
731164|NCT00296504|2348501|P5|Final Analysis|Tuberculosis|0
731165|NCT00296504|2348502|P4|Final Analysis|Tuberculosis|0
731166|NCT00296504|2348503|P3|Final Analysis|Tuberculosis|0
731167|NCT00296504|2348504|P2|Final Analysis|Tuberculosis|0
731168|NCT00296504|2348505|P1|Final Analysis|Tuberculosis|0
731169|NCT00296504|2348497|P9|Final Analysis|Pregnancy|4
731170|NCT00296504|2348498|P8|Final Analysis|Pregnancy|0
731171|NCT00296504|2348499|P7|Final Analysis|Pregnancy|0
731172|NCT00296504|2348500|P6|Final Analysis|Pregnancy|0
731173|NCT00296504|2348501|P5|Final Analysis|Pregnancy|0
731174|NCT00296504|2348502|P4|Final Analysis|Pregnancy|0
731175|NCT00296504|2348503|P3|Final Analysis|Pregnancy|0
731176|NCT00296504|2348504|P2|Final Analysis|Pregnancy|0
731177|NCT00296504|2348505|P1|Final Analysis|Pregnancy|0
731178|NCT00296504|2348497|P9|Final Analysis|Adverse Event|2
731179|NCT00296504|2348498|P8|Final Analysis|Adverse Event|0
731180|NCT00296504|2348499|P7|Final Analysis|Adverse Event|0
731181|NCT00296504|2348500|P6|Final Analysis|Adverse Event|0
731182|NCT00296504|2348501|P5|Final Analysis|Adverse Event|0
731183|NCT00296504|2348502|P4|Final Analysis|Adverse Event|0
731184|NCT00296504|2348503|P3|Final Analysis|Adverse Event|0
731185|NCT00296504|2348504|P2|Final Analysis|Adverse Event|0
731186|NCT00296504|2348505|P1|Final Analysis|Adverse Event|0
731187|NCT00296504|2348497|P9|Final Analysis|Insufficient Viral Load Response|6
731188|NCT00296504|2348498|P8|Final Analysis|Insufficient Viral Load Response|0
731189|NCT00296504|2348499|P7|Final Analysis|Insufficient Viral Load Response|0
731190|NCT00296504|2348500|P6|Final Analysis|Insufficient Viral Load Response|0
731191|NCT00296504|2348501|P5|Final Analysis|Insufficient Viral Load Response|0
731192|NCT00296504|2348502|P4|Final Analysis|Insufficient Viral Load Response|0
731193|NCT00296504|2348503|P3|Final Analysis|Insufficient Viral Load Response|0
731194|NCT00296504|2348504|P2|Final Analysis|Insufficient Viral Load Response|0
731195|NCT00296504|2348505|P1|Final Analysis|Insufficient Viral Load Response|0
731196|NCT00296504|2348497|P9|Final Analysis|Lost to Follow-up|5
731197|NCT00296504|2348498|P8|Final Analysis|Lost to Follow-up|0
731198|NCT00296504|2348499|P7|Final Analysis|Lost to Follow-up|0
731199|NCT00296504|2348500|P6|Final Analysis|Lost to Follow-up|0
731200|NCT00296504|2348501|P5|Final Analysis|Lost to Follow-up|0
731201|NCT00296504|2348502|P4|Final Analysis|Lost to Follow-up|0
731202|NCT00296504|2348503|P3|Final Analysis|Lost to Follow-up|0
731203|NCT00296504|2348504|P2|Final Analysis|Lost to Follow-up|0
731204|NCT00296504|2348505|P1|Final Analysis|Lost to Follow-up|0
731205|NCT00296504|2348497|P9|Final Analysis|Withdrawal by Subject|1
731206|NCT00296504|2348498|P8|Final Analysis|Withdrawal by Subject|0
731207|NCT00296504|2348499|P7|Final Analysis|Withdrawal by Subject|0
731208|NCT00296504|2348500|P6|Final Analysis|Withdrawal by Subject|0
731209|NCT00296504|2348501|P5|Final Analysis|Withdrawal by Subject|0
731210|NCT00296504|2348502|P4|Final Analysis|Withdrawal by Subject|0
731211|NCT00296504|2348503|P3|Final Analysis|Withdrawal by Subject|0
731212|NCT00296504|2348504|P2|Final Analysis|Withdrawal by Subject|0
731213|NCT00296504|2348505|P1|Final Analysis|Withdrawal by Subject|0
731214|NCT00296504|2348497|P9|Interim Analysis|Ongoing|0
731215|NCT00296504|2348498|P8|Interim Analysis|Ongoing|1
731216|NCT00296504|2348499|P7|Interim Analysis|Ongoing|30
731217|NCT00296504|2348500|P6|Interim Analysis|Ongoing|0
731218|NCT00296504|2348501|P5|Interim Analysis|Ongoing|0
731219|NCT00296504|2348502|P4|Interim Analysis|Ongoing|22
731220|NCT00296504|2348503|P3|Interim Analysis|Ongoing|16
731221|NCT00296504|2348504|P2|Interim Analysis|Ongoing|12
731222|NCT00296504|2348505|P1|Interim Analysis|Ongoing|32
731223|NCT00296504|2348497|P9|Interim Analysis|Participant Needed Interferon|0
731224|NCT00296504|2348498|P8|Interim Analysis|Participant Needed Interferon|1
731225|NCT00296504|2348499|P7|Interim Analysis|Participant Needed Interferon|0
731226|NCT00296504|2348500|P6|Interim Analysis|Participant Needed Interferon|0
731227|NCT00296504|2348501|P5|Interim Analysis|Participant Needed Interferon|0
731228|NCT00296504|2348502|P4|Interim Analysis|Participant Needed Interferon|0
731229|NCT00296504|2348503|P3|Interim Analysis|Participant Needed Interferon|0
731230|NCT00296504|2348504|P2|Interim Analysis|Participant Needed Interferon|0
731231|NCT00296504|2348505|P1|Interim Analysis|Participant Needed Interferon|0
731232|NCT00296504|2348497|P9|Interim Analysis|Study Ended|0
731233|NCT00296504|2348498|P8|Interim Analysis|Study Ended|0
731234|NCT00296504|2348499|P7|Interim Analysis|Study Ended|1
731235|NCT00296504|2348500|P6|Interim Analysis|Study Ended|0
731236|NCT00296504|2348501|P5|Interim Analysis|Study Ended|0
731237|NCT00296504|2348502|P4|Interim Analysis|Study Ended|0
731238|NCT00296504|2348503|P3|Interim Analysis|Study Ended|0
731239|NCT00296504|2348504|P2|Interim Analysis|Study Ended|0
731240|NCT00296504|2348505|P1|Interim Analysis|Study Ended|0
731241|NCT00296504|2348497|P9|Interim Analysis|Participant Stopped HIV Medications|0
731242|NCT00296504|2348498|P8|Interim Analysis|Participant Stopped HIV Medications|0
731243|NCT00296504|2348499|P7|Interim Analysis|Participant Stopped HIV Medications|1
731244|NCT00296504|2348500|P6|Interim Analysis|Participant Stopped HIV Medications|0
731245|NCT00296504|2348501|P5|Interim Analysis|Participant Stopped HIV Medications|0
731246|NCT00296504|2348502|P4|Interim Analysis|Participant Stopped HIV Medications|0
731247|NCT00296504|2348503|P3|Interim Analysis|Participant Stopped HIV Medications|0
731248|NCT00296504|2348504|P2|Interim Analysis|Participant Stopped HIV Medications|0
731249|NCT00296504|2348505|P1|Interim Analysis|Participant Stopped HIV Medications|0
731250|NCT00296504|2348497|P9|Interim Analysis|Physician and Participant Decision|0
731251|NCT00296504|2348498|P8|Interim Analysis|Physician and Participant Decision|0
731252|NCT00296504|2348499|P7|Interim Analysis|Physician and Participant Decision|0
731253|NCT00296504|2348500|P6|Interim Analysis|Physician and Participant Decision|1
731254|NCT00296504|2348501|P5|Interim Analysis|Physician and Participant Decision|0
731255|NCT00296504|2348502|P4|Interim Analysis|Physician and Participant Decision|0
731256|NCT00296504|2348503|P3|Interim Analysis|Physician and Participant Decision|0
731257|NCT00296504|2348504|P2|Interim Analysis|Physician and Participant Decision|0
731258|NCT00296504|2348505|P1|Interim Analysis|Physician and Participant Decision|0
731259|NCT00296504|2348497|P9|Interim Analysis|Participant Stopped|0
731260|NCT00296504|2348498|P8|Interim Analysis|Participant Stopped|0
731261|NCT00296504|2348499|P7|Interim Analysis|Participant Stopped|0
731262|NCT00296504|2348500|P6|Interim Analysis|Participant Stopped|0
731263|NCT00296504|2348501|P5|Interim Analysis|Participant Stopped|1
731264|NCT00296504|2348502|P4|Interim Analysis|Participant Stopped|0
731265|NCT00296504|2348503|P3|Interim Analysis|Participant Stopped|0
731266|NCT00296504|2348504|P2|Interim Analysis|Participant Stopped|0
731267|NCT00296504|2348505|P1|Interim Analysis|Participant Stopped|0
731268|NCT00296504|2348497|P9|Interim Analysis|Inclusion in Other Protocol|0
731269|NCT00296504|2348498|P8|Interim Analysis|Inclusion in Other Protocol|0
731270|NCT00296504|2348499|P7|Interim Analysis|Inclusion in Other Protocol|0
731271|NCT00296504|2348500|P6|Interim Analysis|Inclusion in Other Protocol|0
731272|NCT00296504|2348501|P5|Interim Analysis|Inclusion in Other Protocol|0
731273|NCT00296504|2348502|P4|Interim Analysis|Inclusion in Other Protocol|1
731274|NCT00296504|2348503|P3|Interim Analysis|Inclusion in Other Protocol|0
731275|NCT00296504|2348504|P2|Interim Analysis|Inclusion in Other Protocol|0
731276|NCT00296504|2348505|P1|Interim Analysis|Inclusion in Other Protocol|0
731277|NCT00296504|2348497|P9|Interim Analysis|Missed Schedule Date|0
731278|NCT00296504|2348498|P8|Interim Analysis|Missed Schedule Date|0
731279|NCT00296504|2348499|P7|Interim Analysis|Missed Schedule Date|0
731280|NCT00296504|2348500|P6|Interim Analysis|Missed Schedule Date|0
731281|NCT00296504|2348501|P5|Interim Analysis|Missed Schedule Date|0
731282|NCT00296504|2348502|P4|Interim Analysis|Missed Schedule Date|0
731283|NCT00296504|2348503|P3|Interim Analysis|Missed Schedule Date|0
731284|NCT00296504|2348504|P2|Interim Analysis|Missed Schedule Date|0
731285|NCT00296504|2348505|P1|Interim Analysis|Missed Schedule Date|1
731286|NCT00296504|2348497|P9|Interim Analysis|Lack of Personnel at Site|0
731287|NCT00296504|2348498|P8|Interim Analysis|Lack of Personnel at Site|0
731288|NCT00296504|2348499|P7|Interim Analysis|Lack of Personnel at Site|0
731289|NCT00296504|2348500|P6|Interim Analysis|Lack of Personnel at Site|0
731290|NCT00296504|2348501|P5|Interim Analysis|Lack of Personnel at Site|0
731291|NCT00296504|2348502|P4|Interim Analysis|Lack of Personnel at Site|0
731292|NCT00296504|2348503|P3|Interim Analysis|Lack of Personnel at Site|0
731293|NCT00296504|2348504|P2|Interim Analysis|Lack of Personnel at Site|0
731294|NCT00296504|2348505|P1|Interim Analysis|Lack of Personnel at Site|1
731295|NCT00296504|2348497|P9|Interim Analysis|Site Closing|0
731296|NCT00296504|2348498|P8|Interim Analysis|Site Closing|0
731297|NCT00296504|2348499|P7|Interim Analysis|Site Closing|2
731298|NCT00296504|2348500|P6|Interim Analysis|Site Closing|1
731299|NCT00296504|2348501|P5|Interim Analysis|Site Closing|0
731300|NCT00296504|2348502|P4|Interim Analysis|Site Closing|0
731301|NCT00296504|2348503|P3|Interim Analysis|Site Closing|0
731302|NCT00296504|2348504|P2|Interim Analysis|Site Closing|0
731303|NCT00296504|2348505|P1|Interim Analysis|Site Closing|1
731304|NCT00296504|2348497|P9|Interim Analysis|Non-adherence|0
731305|NCT00296504|2348498|P8|Interim Analysis|Non-adherence|1
731306|NCT00296504|2348499|P7|Interim Analysis|Non-adherence|0
731307|NCT00296504|2348500|P6|Interim Analysis|Non-adherence|0
731308|NCT00296504|2348501|P5|Interim Analysis|Non-adherence|1
731309|NCT00296504|2348502|P4|Interim Analysis|Non-adherence|0
731310|NCT00296504|2348503|P3|Interim Analysis|Non-adherence|0
731311|NCT00296504|2348504|P2|Interim Analysis|Non-adherence|0
731312|NCT00296504|2348505|P1|Interim Analysis|Non-adherence|2
731313|NCT00296504|2348497|P9|Interim Analysis|Principle Investigator Terminated Study|0
731314|NCT00296504|2348498|P8|Interim Analysis|Principle Investigator Terminated Study|0
731315|NCT00296504|2348499|P7|Interim Analysis|Principle Investigator Terminated Study|0
731316|NCT00296504|2348500|P6|Interim Analysis|Principle Investigator Terminated Study|0
731317|NCT00296504|2348501|P5|Interim Analysis|Principle Investigator Terminated Study|0
731318|NCT00296504|2348502|P4|Interim Analysis|Principle Investigator Terminated Study|0
731319|NCT00296504|2348503|P3|Interim Analysis|Principle Investigator Terminated Study|1
731320|NCT00296504|2348504|P2|Interim Analysis|Principle Investigator Terminated Study|0
731321|NCT00296504|2348505|P1|Interim Analysis|Principle Investigator Terminated Study|0
731322|NCT00296504|2348497|P9|Interim Analysis|Principle Investigator Discretion|0
731323|NCT00296504|2348498|P8|Interim Analysis|Principle Investigator Discretion|0
731324|NCT00296504|2348499|P7|Interim Analysis|Principle Investigator Discretion|0
731325|NCT00296504|2348500|P6|Interim Analysis|Principle Investigator Discretion|0
731326|NCT00296504|2348501|P5|Interim Analysis|Principle Investigator Discretion|0
731327|NCT00296504|2348502|P4|Interim Analysis|Principle Investigator Discretion|1
731328|NCT00296504|2348503|P3|Interim Analysis|Principle Investigator Discretion|1
731410|NCT00296504|2348504|P2|Interim Analysis|Death|0
731329|NCT00296504|2348504|P2|Interim Analysis|Principle Investigator Discretion|0
731330|NCT00296504|2348505|P1|Interim Analysis|Principle Investigator Discretion|2
731331|NCT00296504|2348497|P9|Interim Analysis|Physician Decision|0
731332|NCT00296504|2348498|P8|Interim Analysis|Physician Decision|0
731333|NCT00296504|2348499|P7|Interim Analysis|Physician Decision|0
731334|NCT00296504|2348500|P6|Interim Analysis|Physician Decision|0
731335|NCT00296504|2348501|P5|Interim Analysis|Physician Decision|0
731336|NCT00296504|2348502|P4|Interim Analysis|Physician Decision|0
731337|NCT00296504|2348503|P3|Interim Analysis|Physician Decision|1
731338|NCT00296504|2348504|P2|Interim Analysis|Physician Decision|0
731339|NCT00296504|2348505|P1|Interim Analysis|Physician Decision|0
731340|NCT00296504|2348497|P9|Interim Analysis|Resistance to FPV|0
731341|NCT00296504|2348498|P8|Interim Analysis|Resistance to FPV|0
731342|NCT00296504|2348499|P7|Interim Analysis|Resistance to FPV|0
731343|NCT00296504|2348500|P6|Interim Analysis|Resistance to FPV|0
731344|NCT00296504|2348501|P5|Interim Analysis|Resistance to FPV|0
731345|NCT00296504|2348502|P4|Interim Analysis|Resistance to FPV|0
731346|NCT00296504|2348503|P3|Interim Analysis|Resistance to FPV|1
731347|NCT00296504|2348504|P2|Interim Analysis|Resistance to FPV|0
731348|NCT00296504|2348505|P1|Interim Analysis|Resistance to FPV|0
731349|NCT00296504|2348497|P9|Interim Analysis|Participant Was Incarcerated|0
731350|NCT00296504|2348498|P8|Interim Analysis|Participant Was Incarcerated|0
731351|NCT00296504|2348499|P7|Interim Analysis|Participant Was Incarcerated|0
731352|NCT00296504|2348500|P6|Interim Analysis|Participant Was Incarcerated|0
731353|NCT00296504|2348501|P5|Interim Analysis|Participant Was Incarcerated|0
731354|NCT00296504|2348502|P4|Interim Analysis|Participant Was Incarcerated|0
731355|NCT00296504|2348503|P3|Interim Analysis|Participant Was Incarcerated|1
731356|NCT00296504|2348504|P2|Interim Analysis|Participant Was Incarcerated|0
731357|NCT00296504|2348505|P1|Interim Analysis|Participant Was Incarcerated|2
731358|NCT00296504|2348497|P9|Interim Analysis|Participant Moved|0
731359|NCT00296504|2348498|P8|Interim Analysis|Participant Moved|0
731360|NCT00296504|2348499|P7|Interim Analysis|Participant Moved|1
731361|NCT00296504|2348500|P6|Interim Analysis|Participant Moved|1
731362|NCT00296504|2348501|P5|Interim Analysis|Participant Moved|0
731363|NCT00296504|2348502|P4|Interim Analysis|Participant Moved|0
731364|NCT00296504|2348503|P3|Interim Analysis|Participant Moved|1
731365|NCT00296504|2348504|P2|Interim Analysis|Participant Moved|0
731366|NCT00296504|2348505|P1|Interim Analysis|Participant Moved|1
731367|NCT00296504|2348497|P9|Interim Analysis|Participant Had Problems with Alcohol|0
731368|NCT00296504|2348498|P8|Interim Analysis|Participant Had Problems with Alcohol|0
731369|NCT00296504|2348499|P7|Interim Analysis|Participant Had Problems with Alcohol|0
731370|NCT00296504|2348500|P6|Interim Analysis|Participant Had Problems with Alcohol|0
731371|NCT00296504|2348501|P5|Interim Analysis|Participant Had Problems with Alcohol|0
731372|NCT00296504|2348502|P4|Interim Analysis|Participant Had Problems with Alcohol|0
731373|NCT00296504|2348503|P3|Interim Analysis|Participant Had Problems with Alcohol|1
731374|NCT00296504|2348504|P2|Interim Analysis|Participant Had Problems with Alcohol|0
731375|NCT00296504|2348505|P1|Interim Analysis|Participant Had Problems with Alcohol|0
731376|NCT00296504|2348497|P9|Interim Analysis|To Simplify Treatment|0
731377|NCT00296504|2348498|P8|Interim Analysis|To Simplify Treatment|0
731378|NCT00296504|2348499|P7|Interim Analysis|To Simplify Treatment|2
731379|NCT00296504|2348500|P6|Interim Analysis|To Simplify Treatment|0
731380|NCT00296504|2348501|P5|Interim Analysis|To Simplify Treatment|0
731381|NCT00296504|2348502|P4|Interim Analysis|To Simplify Treatment|0
731382|NCT00296504|2348503|P3|Interim Analysis|To Simplify Treatment|1
731383|NCT00296504|2348504|P2|Interim Analysis|To Simplify Treatment|0
731384|NCT00296504|2348505|P1|Interim Analysis|To Simplify Treatment|0
731385|NCT00296504|2348497|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
731386|NCT00296504|2348498|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
731387|NCT00296504|2348499|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
731388|NCT00296504|2348500|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
731389|NCT00296504|2348501|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
731390|NCT00296504|2348502|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
731391|NCT00296504|2348503|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
731392|NCT00296504|2348504|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
731393|NCT00296504|2348505|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
731394|NCT00296504|2348497|P9|Interim Analysis|Participant Non-compliant|0
731395|NCT00296504|2348498|P8|Interim Analysis|Participant Non-compliant|2
731396|NCT00296504|2348499|P7|Interim Analysis|Participant Non-compliant|6
731397|NCT00296504|2348500|P6|Interim Analysis|Participant Non-compliant|3
731398|NCT00296504|2348501|P5|Interim Analysis|Participant Non-compliant|1
731399|NCT00296504|2348502|P4|Interim Analysis|Participant Non-compliant|1
731400|NCT00296504|2348503|P3|Interim Analysis|Participant Non-compliant|2
731401|NCT00296504|2348504|P2|Interim Analysis|Participant Non-compliant|1
731402|NCT00296504|2348505|P1|Interim Analysis|Participant Non-compliant|0
731403|NCT00296504|2348497|P9|Interim Analysis|Death|0
731404|NCT00296504|2348498|P8|Interim Analysis|Death|0
731405|NCT00296504|2348499|P7|Interim Analysis|Death|0
731406|NCT00296504|2348500|P6|Interim Analysis|Death|0
731407|NCT00296504|2348501|P5|Interim Analysis|Death|0
731408|NCT00296504|2348502|P4|Interim Analysis|Death|0
731409|NCT00296504|2348503|P3|Interim Analysis|Death|3
731411|NCT00296504|2348505|P1|Interim Analysis|Death|1
731412|NCT00296504|2348497|P9|Interim Analysis|Pregnancy|0
731413|NCT00296504|2348498|P8|Interim Analysis|Pregnancy|1
731414|NCT00296504|2348499|P7|Interim Analysis|Pregnancy|1
731415|NCT00296504|2348500|P6|Interim Analysis|Pregnancy|1
731416|NCT00296504|2348501|P5|Interim Analysis|Pregnancy|0
731417|NCT00296504|2348502|P4|Interim Analysis|Pregnancy|2
731418|NCT00296504|2348503|P3|Interim Analysis|Pregnancy|4
731419|NCT00296504|2348504|P2|Interim Analysis|Pregnancy|1
731420|NCT00296504|2348505|P1|Interim Analysis|Pregnancy|4
731421|NCT00296504|2348497|P9|Interim Analysis|Switched to Commercially Available Drug|0
731422|NCT00296504|2348498|P8|Interim Analysis|Switched to Commercially Available Drug|4
731423|NCT00296504|2348499|P7|Interim Analysis|Switched to Commercially Available Drug|3
731424|NCT00296504|2348500|P6|Interim Analysis|Switched to Commercially Available Drug|5
731425|NCT00296504|2348501|P5|Interim Analysis|Switched to Commercially Available Drug|0
731426|NCT00296504|2348502|P4|Interim Analysis|Switched to Commercially Available Drug|1
731427|NCT00296504|2348503|P3|Interim Analysis|Switched to Commercially Available Drug|4
731428|NCT00296504|2348504|P2|Interim Analysis|Switched to Commercially Available Drug|0
731429|NCT00296504|2348505|P1|Interim Analysis|Switched to Commercially Available Drug|2
731430|NCT00296504|2348497|P9|Interim Analysis|Insufficient CD4 Response|0
731431|NCT00296504|2348498|P8|Interim Analysis|Insufficient CD4 Response|0
731432|NCT00296504|2348499|P7|Interim Analysis|Insufficient CD4 Response|0
731433|NCT00296504|2348500|P6|Interim Analysis|Insufficient CD4 Response|1
731434|NCT00296504|2348501|P5|Interim Analysis|Insufficient CD4 Response|1
731435|NCT00296504|2348502|P4|Interim Analysis|Insufficient CD4 Response|0
731436|NCT00296504|2348503|P3|Interim Analysis|Insufficient CD4 Response|0
731437|NCT00296504|2348504|P2|Interim Analysis|Insufficient CD4 Response|0
731438|NCT00296504|2348505|P1|Interim Analysis|Insufficient CD4 Response|0
731439|NCT00296504|2348497|P9|Interim Analysis|Protocol Violation|0
731440|NCT00296504|2348498|P8|Interim Analysis|Protocol Violation|1
731441|NCT00296504|2348499|P7|Interim Analysis|Protocol Violation|0
731442|NCT00296504|2348500|P6|Interim Analysis|Protocol Violation|0
731443|NCT00296504|2348501|P5|Interim Analysis|Protocol Violation|1
731444|NCT00296504|2348502|P4|Interim Analysis|Protocol Violation|0
731445|NCT00296504|2348503|P3|Interim Analysis|Protocol Violation|2
731446|NCT00296504|2348504|P2|Interim Analysis|Protocol Violation|0
731447|NCT00296504|2348505|P1|Interim Analysis|Protocol Violation|0
731448|NCT00296504|2348497|P9|Interim Analysis|Adverse Event|0
731449|NCT00296504|2348498|P8|Interim Analysis|Adverse Event|5
731450|NCT00296504|2348499|P7|Interim Analysis|Adverse Event|4
731451|NCT00296504|2348500|P6|Interim Analysis|Adverse Event|3
731452|NCT00296504|2348501|P5|Interim Analysis|Adverse Event|6
731453|NCT00296504|2348502|P4|Interim Analysis|Adverse Event|4
731454|NCT00296504|2348503|P3|Interim Analysis|Adverse Event|13
731455|NCT00296504|2348504|P2|Interim Analysis|Adverse Event|0
731456|NCT00296504|2348505|P1|Interim Analysis|Adverse Event|0
731457|NCT00296504|2348497|P9|Interim Analysis|Insufficient Viral Load Response|0
731458|NCT00296504|2348498|P8|Interim Analysis|Insufficient Viral Load Response|24
731459|NCT00296504|2348499|P7|Interim Analysis|Insufficient Viral Load Response|2
731460|NCT00296504|2348500|P6|Interim Analysis|Insufficient Viral Load Response|9
731461|NCT00296504|2348501|P5|Interim Analysis|Insufficient Viral Load Response|7
731462|NCT00296504|2348502|P4|Interim Analysis|Insufficient Viral Load Response|2
731463|NCT00296504|2348503|P3|Interim Analysis|Insufficient Viral Load Response|12
731464|NCT00296504|2348504|P2|Interim Analysis|Insufficient Viral Load Response|1
731465|NCT00296504|2348505|P1|Interim Analysis|Insufficient Viral Load Response|5
731466|NCT00296504|2348497|P9|Interim Analysis|Clinical Progression|0
731467|NCT00296504|2348498|P8|Interim Analysis|Clinical Progression|2
731468|NCT00296504|2348499|P7|Interim Analysis|Clinical Progression|1
731469|NCT00296504|2348500|P6|Interim Analysis|Clinical Progression|2
731470|NCT00296504|2348501|P5|Interim Analysis|Clinical Progression|0
731471|NCT00296504|2348502|P4|Interim Analysis|Clinical Progression|1
731472|NCT00296504|2348503|P3|Interim Analysis|Clinical Progression|1
731473|NCT00296504|2348504|P2|Interim Analysis|Clinical Progression|0
731474|NCT00296504|2348505|P1|Interim Analysis|Clinical Progression|1
731475|NCT00296504|2348497|P9|Interim Analysis|Lost to Follow-up|0
731476|NCT00296504|2348498|P8|Interim Analysis|Lost to Follow-up|4
731477|NCT00296504|2348499|P7|Interim Analysis|Lost to Follow-up|11
731478|NCT00296504|2348500|P6|Interim Analysis|Lost to Follow-up|4
731479|NCT00296504|2348501|P5|Interim Analysis|Lost to Follow-up|14
731480|NCT00296504|2348502|P4|Interim Analysis|Lost to Follow-up|8
731481|NCT00296504|2348503|P3|Interim Analysis|Lost to Follow-up|26
731482|NCT00296504|2348504|P2|Interim Analysis|Lost to Follow-up|3
731483|NCT00296504|2348505|P1|Interim Analysis|Lost to Follow-up|13
731484|NCT00296504|2348497|P9|Interim Analysis|Withdrawal by Subject|0
731485|NCT00296504|2348498|P8|Interim Analysis|Withdrawal by Subject|3
731486|NCT00296504|2348499|P7|Interim Analysis|Withdrawal by Subject|9
731487|NCT00296504|2348500|P6|Interim Analysis|Withdrawal by Subject|5
731488|NCT00296504|2348501|P5|Interim Analysis|Withdrawal by Subject|5
731489|NCT00296504|2348502|P4|Interim Analysis|Withdrawal by Subject|0
731490|NCT00296504|2348503|P3|Interim Analysis|Withdrawal by Subject|12
731491|NCT00296504|2348504|P2|Interim Analysis|Withdrawal by Subject|0
731492|NCT00296504|2348505|P1|Interim Analysis|Withdrawal by Subject|8
731493|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Not specified|2
731494|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Not specified|0
731495|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
731496|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
731497|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
731498|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
731499|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
731500|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
731501|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
731502|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
731503|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
731504|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
731505|NCT00296517|2348596|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
731506|NCT00296517|2348597|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
731507|NCT00296517|2348596|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
731508|NCT00296517|2348597|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
731509|NCT00296517|2348596|P2|Dose Level 2 - Week 2|Adverse Event|5
731510|NCT00296517|2348597|P1|Dose Level 2 - Week 2|Adverse Event|1
731511|NCT00296647|2348630|P5|Overall Study|Withdrawal by Subject|19
731512|NCT00296647|2348631|P4|Overall Study|Withdrawal by Subject|16
731513|NCT00296647|2348632|P3|Overall Study|Withdrawal by Subject|32
731514|NCT00296647|2348633|P2|Overall Study|Withdrawal by Subject|27
731515|NCT00296647|2348634|P1|Overall Study|Withdrawal by Subject|28
731516|NCT00296647|2348630|P5|Overall Study|Death|1
731517|NCT00296647|2348631|P4|Overall Study|Death|1
731518|NCT00296647|2348632|P3|Overall Study|Death|2
731519|NCT00296647|2348633|P2|Overall Study|Death|1
731520|NCT00296647|2348634|P1|Overall Study|Death|4
731521|NCT00296816|2348648|P1|Overall Study|ineligibility due to radiation treatment|1
731522|NCT00296816|2348648|P1|Overall Study|Proteinuria|1
731523|NCT00296816|2348648|P1|Overall Study|Neuropathy/patient preference|1
731524|NCT00296816|2348648|P1|Overall Study|Urine protein/creatinine ratio delay|1
731525|NCT00296816|2348648|P1|Overall Study|Noncompliance/decision to discontinue|1
731526|NCT00296816|2348648|P1|Overall Study|Relocation to Florida|1
731527|NCT00296816|2348648|P1|Overall Study|Poor performance status|1
731528|NCT00296816|2348648|P1|Overall Study|Progression based on CA-125 (biomarker)|2
731529|NCT00296816|2348648|P1|Overall Study|Missing for end of treatment|4
731530|NCT00296816|2348648|P1|Overall Study|Non-compliance|1
731531|NCT00296816|2348648|P1|Overall Study|Investigator/Participant request|5
731532|NCT00296816|2348648|P1|Overall Study|Adverse Event|18
731533|NCT00296816|2348648|P1|Overall Study|Disease Progression|37
731534|NCT00297037|2348662|P2|Overall Study|Withdrawal by Subject|0
731535|NCT00297037|2348663|P1|Overall Study|Withdrawal by Subject|2
731536|NCT00288054|2348673|P1|Overall Study|Not protocol specified|2
731537|NCT00288054|2348673|P1|Overall Study|Withdrawal by Subject|1
731538|NCT00288054|2348673|P1|Overall Study|Adverse Event|3
731539|NCT00288054|2348673|P1|Overall Study|Lack of Efficacy|16
731540|NCT00288054|2348673|P1|Overall Study|Protocol Violation|2
731541|NCT00288080|2348689|P2|Overall Study|Protocol Violation|20
731542|NCT00288080|2348690|P1|Overall Study|Protocol Violation|25
731543|NCT00288080|2348689|P2|Overall Study|Withdrawal by Subject|3
731544|NCT00288080|2348690|P1|Overall Study|Withdrawal by Subject|1
731545|NCT00297167|2348744|P3|Second Double-blind Intervention Period|Protocol Violation|0
731546|NCT00297167|2348745|P2|Second Double-blind Intervention Period|Protocol Violation|0
731547|NCT00297167|2348746|P1|Second Double-blind Intervention Period|Protocol Violation|1
731548|NCT00297167|2348744|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
731549|NCT00297167|2348745|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
731550|NCT00297167|2348746|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
731551|NCT00297232|2348770|P1|Overall Study|Other|1
731552|NCT00297232|2348770|P1|Overall Study|No data available after Week 264|161
731553|NCT00297232|2348770|P1|Overall Study|Did Not Enroll to Week 480|17
731554|NCT00297232|2348770|P1|Overall Study|Did Not Enroll to Week 264|34
731555|NCT00297232|2348770|P1|Overall Study|Investigator Withdrew From Program|19
731556|NCT00297232|2348770|P1|Overall Study|Persistently Positive Antibodies|11
731557|NCT00297232|2348770|P1|Overall Study|Subject Withdrew Consent|37
731558|NCT00297232|2348770|P1|Overall Study|Subject Relocated|7
731559|NCT00297232|2348770|P1|Overall Study|Sponsor Decision|34
731560|NCT00297232|2348770|P1|Overall Study|Miscellaneous|5
731561|NCT00297232|2348770|P1|Overall Study|Anti-JCV Antibody Positive|13
731562|NCT00297232|2348770|P1|Overall Study|Fear of PML|10
731563|NCT00297232|2348770|P1|Overall Study|Disease Progression|8
731564|NCT00297232|2348770|P1|Overall Study|Switched to Commercial Tysabri|22
731565|NCT00297232|2348770|P1|Overall Study|Anti-natalizumab Positive|8
731566|NCT00297232|2348770|P1|Overall Study|Death|9
731567|NCT00297232|2348770|P1|Overall Study|Subject was Noncompliant|9
731568|NCT00297232|2348770|P1|Overall Study|Voluntary Withdrawal|120
731569|NCT00297232|2348770|P1|Overall Study|Adverse Event|63
731570|NCT00297232|2348770|P1|Overall Study|Lost to Follow-up|10
731571|NCT00297232|2348770|P1|Overall Study|Lack of Efficacy|7
731572|NCT00297258|2348776|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
731573|NCT00297258|2348776|P1|Overall Study|Switch to Commercial Treatment|1
731574|NCT00297258|2348776|P1|Overall Study|Surgery Performed on Target Lesion|1
731575|NCT00297258|2348776|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
731576|NCT00297258|2348776|P1|Overall Study|Deteriorization of General Condition|1
731577|NCT00297258|2348776|P1|Overall Study|Intercurrent Death|2
731578|NCT00297258|2348776|P1|Overall Study|Intercurrent Illness|3
731579|NCT00297258|2348776|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
731580|NCT00297258|2348776|P1|Overall Study|Toxicity (or Toxic Death)|10
731581|NCT00297258|2348776|P1|Overall Study|Disease Progression, Relapse, Death|120
731582|NCT00298272|2348818|P2|Safety Follow-up Phase|Administrative/Other Reason|1
731583|NCT00298272|2348819|P1|Safety Follow-up Phase|Administrative/Other Reason|1
731584|NCT00298272|2348818|P2|Safety Follow-up Phase|Withdrawal by Subject|2
731585|NCT00298272|2348819|P1|Safety Follow-up Phase|Withdrawal by Subject|2
731586|NCT00298272|2348818|P2|Safety Follow-up Phase|Failure to Return|1
731587|NCT00298272|2348819|P1|Safety Follow-up Phase|Failure to Return|1
731588|NCT00298272|2348818|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
731589|NCT00298272|2348819|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
731590|NCT00298272|2348818|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
731591|NCT00298272|2348819|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
731592|NCT00298272|2348818|P2|Open Label Retreatment Phase|Protocol Violation|1
731593|NCT00298272|2348819|P1|Open Label Retreatment Phase|Protocol Violation|2
731594|NCT00298272|2348818|P2|Open Label Retreatment Phase|Failure to Return|0
731595|NCT00298272|2348819|P1|Open Label Retreatment Phase|Failure to Return|1
731596|NCT00298272|2348818|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
731597|NCT00298272|2348819|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
731598|NCT00298272|2348818|P2|Open Label Retreatment Phase|Adverse Event|2
731599|NCT00298272|2348819|P1|Open Label Retreatment Phase|Adverse Event|1
731600|NCT00298272|2348818|P2|Double-blind Phase|Withdrawal by Subject|0
731601|NCT00298272|2348819|P1|Double-blind Phase|Withdrawal by Subject|2
731602|NCT00298272|2348818|P2|Double-blind Phase|Protocol Violation|0
731603|NCT00298272|2348819|P1|Double-blind Phase|Protocol Violation|2
731604|NCT00298272|2348818|P2|Double-blind Phase|Failure to Return|0
731605|NCT00298272|2348819|P1|Double-blind Phase|Failure to Return|2
731606|NCT00298272|2348818|P2|Double-blind Phase|Adverse Event|0
731607|NCT00298272|2348819|P1|Double-blind Phase|Adverse Event|2
731608|NCT00298363|2348843|P3|Overall Study|Lack of Efficacy|0
731609|NCT00298363|2348844|P2|Overall Study|Lack of Efficacy|3
731610|NCT00298363|2348845|P1|Overall Study|Lack of Efficacy|2
731611|NCT00298363|2348843|P3|Overall Study|Adverse Event|2
731612|NCT00298363|2348844|P2|Overall Study|Adverse Event|2
731613|NCT00298363|2348845|P1|Overall Study|Adverse Event|5
731614|NCT00298363|2348843|P3|Overall Study|Withdrawal by Subject|3
731615|NCT00298363|2348844|P2|Overall Study|Withdrawal by Subject|1
731616|NCT00298363|2348845|P1|Overall Study|Withdrawal by Subject|5
731617|NCT00298363|2348843|P3|Overall Study|Protocol Violation|0
731618|NCT00298363|2348844|P2|Overall Study|Protocol Violation|1
731619|NCT00298363|2348845|P1|Overall Study|Protocol Violation|1
731620|NCT00298363|2348843|P3|Overall Study|Physician Decision|0
731621|NCT00298363|2348844|P2|Overall Study|Physician Decision|1
731622|NCT00298363|2348845|P1|Overall Study|Physician Decision|4
731623|NCT00298363|2348843|P3|Overall Study|Lost to Follow-up|1
731624|NCT00298363|2348844|P2|Overall Study|Lost to Follow-up|0
731625|NCT00298363|2348845|P1|Overall Study|Lost to Follow-up|0
731626|NCT00298740|2349048|P1|Overall Study|Withdrawal by Subject|3
731627|NCT00298740|2349048|P1|Overall Study|Lack of Efficacy|6
731628|NCT00298766|2349052|P1|Overall Study|Other|4
731629|NCT00298766|2349052|P1|Overall Study|Subjects overall condition deterioration|4
731630|NCT00298766|2349052|P1|Overall Study|Deterioration in KPS and organ function|1
731631|NCT00298766|2349052|P1|Overall Study|Progression of amyloid markers|4
731632|NCT00298766|2349052|P1|Overall Study|Treatment ongoing|4
731633|NCT00298766|2349052|P1|Overall Study|Withdrawal by Subject|9
731634|NCT00298766|2349052|P1|Overall Study|Death|2
731635|NCT00298766|2349052|P1|Overall Study|Adverse Event|18
731636|NCT00299104|2349079|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
731637|NCT00299104|2349080|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
731638|NCT00299104|2349081|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
731639|NCT00299104|2349079|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
731640|NCT00299104|2349080|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
731641|NCT00299104|2349081|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
731642|NCT00299104|2349079|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
731643|NCT00299104|2349080|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
731644|NCT00299104|2349081|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
731645|NCT00299104|2349079|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
731646|NCT00299104|2349080|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
731647|NCT00299104|2349081|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
731648|NCT00299104|2349079|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
731649|NCT00299104|2349080|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
731650|NCT00299104|2349081|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
731651|NCT00299104|2349079|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
731652|NCT00299104|2349080|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
731653|NCT00299104|2349081|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
731654|NCT00299104|2349079|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
731655|NCT00299104|2349080|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
731656|NCT00299104|2349081|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
731657|NCT00299104|2349079|P3|Safety Follow-Up (SFU) Period|Death|1
731658|NCT00299104|2349080|P2|Safety Follow-Up (SFU) Period|Death|2
731659|NCT00299104|2349081|P1|Safety Follow-Up (SFU) Period|Death|3
731660|NCT00299104|2349079|P3|Treatment Period|Administrative reasons|137
731661|NCT00299104|2349080|P2|Treatment Period|Administrative reasons|120
731662|NCT00299104|2349081|P1|Treatment Period|Administrative reasons|106
731663|NCT00299104|2349079|P3|Treatment Period|Withdrew consent|9
731664|NCT00299104|2349080|P2|Treatment Period|Withdrew consent|19
731665|NCT00299104|2349081|P1|Treatment Period|Withdrew consent|14
731666|NCT00299104|2349079|P3|Treatment Period|Refused treatment|2
731667|NCT00299104|2349080|P2|Treatment Period|Refused treatment|2
731668|NCT00299104|2349081|P1|Treatment Period|Refused treatment|9
731669|NCT00299104|2349079|P3|Treatment Period|Protocol Violation|0
731670|NCT00299104|2349080|P2|Treatment Period|Protocol Violation|1
731671|NCT00299104|2349081|P1|Treatment Period|Protocol Violation|1
731672|NCT00299104|2349079|P3|Treatment Period|Violation of selection criteria|0
731673|NCT00299104|2349080|P2|Treatment Period|Violation of selection criteria|2
731674|NCT00299104|2349081|P1|Treatment Period|Violation of selection criteria|1
731675|NCT00299104|2349079|P3|Treatment Period|Failure to return|8
731676|NCT00299104|2349080|P2|Treatment Period|Failure to return|8
731677|NCT00299104|2349081|P1|Treatment Period|Failure to return|9
731678|NCT00299104|2349079|P3|Treatment Period|Insufficient therapeutic response|8
731679|NCT00299104|2349080|P2|Treatment Period|Insufficient therapeutic response|13
731680|NCT00299104|2349081|P1|Treatment Period|Insufficient therapeutic response|34
731681|NCT00299104|2349079|P3|Treatment Period|Death|1
731682|NCT00299104|2349080|P2|Treatment Period|Death|1
731683|NCT00299104|2349081|P1|Treatment Period|Death|1
731684|NCT00299104|2349079|P3|Treatment Period|Adverse Event|7
731685|NCT00299104|2349080|P2|Treatment Period|Adverse Event|9
731686|NCT00299104|2349081|P1|Treatment Period|Adverse Event|14
731687|NCT00299130|2349179|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
731688|NCT00299130|2349180|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
731689|NCT00299130|2349181|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
731690|NCT00299130|2349179|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
731691|NCT00299130|2349180|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
731692|NCT00299130|2349181|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
731693|NCT00299130|2349179|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
731694|NCT00299130|2349180|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
731695|NCT00299130|2349181|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
731696|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
731697|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
731698|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
731699|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
731700|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
731701|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
731702|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
731703|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
731704|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
731705|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
731706|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
731707|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
731708|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
731709|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
731710|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
731711|NCT00299130|2349179|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
731712|NCT00299130|2349180|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
731713|NCT00299130|2349181|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
731714|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
731715|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
731716|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
731717|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
731718|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
731719|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
731720|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Failure to Return|6
731721|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Failure to Return|6
731722|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Failure to Return|4
731723|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
731724|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
731725|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
731726|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
731727|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
731728|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
731729|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
731730|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
731731|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
731732|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Death|1
731733|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Death|3
731734|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Death|1
731735|NCT00299130|2349179|P3|Treatment Period (up to 5 Years)|Adverse Event|13
731736|NCT00299130|2349180|P2|Treatment Period (up to 5 Years)|Adverse Event|8
731737|NCT00299130|2349181|P1|Treatment Period (up to 5 Years)|Adverse Event|13
731738|NCT00299156|2349286|P3|Period 2 (Randomized)|Screen Failure|0
731739|NCT00299156|2349287|P2|Period 2 (Randomized)|Screen Failure|1
731740|NCT00299156|2349288|P1|Period 2 (Randomized)|Screen Failure|0
731741|NCT00299546|2349322|P3|Overall Study|Not treated|1
731742|NCT00299546|2349323|P2|Overall Study|Not treated|1
731743|NCT00299546|2349324|P1|Overall Study|Not treated|0
731744|NCT00299546|2349322|P3|Overall Study|Not specified|19
731745|NCT00299546|2349323|P2|Overall Study|Not specified|26
731746|NCT00299546|2349324|P1|Overall Study|Not specified|24
731747|NCT00299546|2349322|P3|Overall Study|Unsatisfactory therapeutic effect|34
731748|NCT00299546|2349323|P2|Overall Study|Unsatisfactory therapeutic effect|39
731749|NCT00299546|2349324|P1|Overall Study|Unsatisfactory therapeutic effect|34
731750|NCT00299546|2349322|P3|Overall Study|Adverse Event|27
731751|NCT00299546|2349323|P2|Overall Study|Adverse Event|22
731752|NCT00299546|2349324|P1|Overall Study|Adverse Event|37
731753|NCT00299546|2349322|P3|Overall Study|Lost to Follow-up|5
731754|NCT00299546|2349323|P2|Overall Study|Lost to Follow-up|2
731755|NCT00299546|2349324|P1|Overall Study|Lost to Follow-up|2
731756|NCT00299546|2349322|P3|Overall Study|Death|0
731757|NCT00299546|2349323|P2|Overall Study|Death|2
731758|NCT00299546|2349324|P1|Overall Study|Death|3
731759|NCT00299702|2349355|P2|Overall Study|Admin issues, sponsor decision, etc.|9
731760|NCT00299702|2349356|P1|Overall Study|Admin issues, sponsor decision, etc.|5
731761|NCT00299702|2349355|P2|Overall Study|Insufficient Response|3
731762|NCT00299702|2349356|P1|Overall Study|Insufficient Response|4
731763|NCT00299702|2349355|P2|Overall Study|Pregnancy|1
731764|NCT00299702|2349356|P1|Overall Study|Pregnancy|0
731765|NCT00299702|2349355|P2|Overall Study|Withdrawal by Subject|23
731766|NCT00299702|2349356|P1|Overall Study|Withdrawal by Subject|25
731767|NCT00299702|2349355|P2|Overall Study|Lost to Follow-up|10
731768|NCT00299702|2349356|P1|Overall Study|Lost to Follow-up|18
731769|NCT00299702|2349355|P2|Overall Study|Adverse Event|4
731770|NCT00299702|2349356|P1|Overall Study|Adverse Event|0
731771|NCT00299702|2349355|P2|Overall Study|Death|0
731772|NCT00299702|2349356|P1|Overall Study|Death|1
731773|NCT00299975|2349372|P3|Overall Study|Physician Decision|1
731774|NCT00299975|2349373|P2|Overall Study|Physician Decision|0
731775|NCT00299975|2349374|P1|Overall Study|Physician Decision|0
731776|NCT00299975|2349372|P3|Overall Study|Withdrawal by Subject|3
731777|NCT00299975|2349373|P2|Overall Study|Withdrawal by Subject|1
731778|NCT00299975|2349374|P1|Overall Study|Withdrawal by Subject|0
731779|NCT00299975|2349372|P3|Overall Study|Lost to Follow-up|0
731780|NCT00299975|2349373|P2|Overall Study|Lost to Follow-up|0
731781|NCT00299975|2349374|P1|Overall Study|Lost to Follow-up|1
731782|NCT00299975|2349372|P3|Overall Study|Lack of Efficacy|1
731783|NCT00299975|2349373|P2|Overall Study|Lack of Efficacy|0
731784|NCT00299975|2349374|P1|Overall Study|Lack of Efficacy|1
731785|NCT00299975|2349372|P3|Overall Study|Pregnancy|1
731786|NCT00299975|2349373|P2|Overall Study|Pregnancy|0
731787|NCT00299975|2349374|P1|Overall Study|Pregnancy|0
731788|NCT00299975|2349372|P3|Overall Study|Adverse Event|2
731789|NCT00299975|2349373|P2|Overall Study|Adverse Event|0
731790|NCT00299975|2349374|P1|Overall Study|Adverse Event|1
731791|NCT00300274|2349448|P3|Overall Study|Re-transplant|1
731792|NCT00300274|2349449|P2|Overall Study|Re-transplant|0
731793|NCT00300274|2349450|P1|Overall Study|Re-transplant|0
731794|NCT00300274|2349448|P3|Overall Study|Death|25
731795|NCT00300274|2349449|P2|Overall Study|Death|20
731796|NCT00300274|2349450|P1|Overall Study|Death|31
731797|NCT00300274|2349448|P3|Overall Study|Lost to Follow-up|5
731798|NCT00300274|2349449|P2|Overall Study|Lost to Follow-up|4
731799|NCT00300274|2349450|P1|Overall Study|Lost to Follow-up|3
731800|NCT00300274|2349448|P3|Overall Study|Withdrawal by Subject|14
731801|NCT00300274|2349449|P2|Overall Study|Withdrawal by Subject|3
731802|NCT00300274|2349450|P1|Overall Study|Withdrawal by Subject|12
731803|NCT00300365|2349487|P2|Overall Study|Adverse Event|2
731804|NCT00300365|2349488|P1|Overall Study|Adverse Event|0
731805|NCT00300365|2349487|P2|Overall Study|Withdrawal by Subject|0
731806|NCT00300365|2349488|P1|Overall Study|Withdrawal by Subject|1
731807|NCT00300365|2349487|P2|Overall Study|Physician Decision|0
731808|NCT00300365|2349488|P1|Overall Study|Physician Decision|2
731809|NCT00300365|2349487|P2|Overall Study|Lost to Follow-up|0
731810|NCT00300365|2349488|P1|Overall Study|Lost to Follow-up|1
731811|NCT00300495|2349734|P2|Overall Study|Protocol Violation|1
731812|NCT00300495|2349735|P1|Overall Study|Protocol Violation|4
731813|NCT00291187|2349773|P4|Overall Study|Protocol Violation- No Drug Administered|0
731814|NCT00291187|2349774|P3|Overall Study|Protocol Violation- No Drug Administered|1
731815|NCT00291187|2349775|P2|Overall Study|Protocol Violation- No Drug Administered|0
731816|NCT00291187|2349776|P1|Overall Study|Protocol Violation- No Drug Administered|0
731817|NCT00291330|2349816|P2|Overall Study|Other|1
731818|NCT00291330|2349817|P1|Overall Study|Other|3
731819|NCT00291330|2349816|P2|Overall Study|Withdrawal by Subject|25
731820|NCT00291330|2349817|P1|Overall Study|Withdrawal by Subject|22
731821|NCT00291330|2349816|P2|Overall Study|Lost to Follow-up|11
731822|NCT00291330|2349817|P1|Overall Study|Lost to Follow-up|16
731823|NCT00291330|2349816|P2|Overall Study|Protocol Violation|20
731824|NCT00291330|2349817|P1|Overall Study|Protocol Violation|13
731825|NCT00291330|2349816|P2|Overall Study|Adverse Event|40
731826|NCT00291330|2349817|P1|Overall Study|Adverse Event|47
731827|NCT00292188|2349891|P3|Double-Blind|Laboratory Abnormality|1
731828|NCT00292188|2349892|P2|Double-Blind|Laboratory Abnormality|0
731829|NCT00292188|2349893|P1|Double-Blind|Laboratory Abnormality|0
731830|NCT00292188|2349891|P3|Double-Blind|Withdrawal by Subject|3
731831|NCT00292188|2349892|P2|Double-Blind|Withdrawal by Subject|0
731832|NCT00292188|2349893|P1|Double-Blind|Withdrawal by Subject|0
731833|NCT00292188|2349891|P3|Double-Blind|Other|4
731834|NCT00292188|2349892|P2|Double-Blind|Other|3
731835|NCT00292188|2349893|P1|Double-Blind|Other|0
731836|NCT00292188|2349891|P3|Double-Blind|Lost to Follow-up|0
731837|NCT00292188|2349892|P2|Double-Blind|Lost to Follow-up|1
731838|NCT00292188|2349893|P1|Double-Blind|Lost to Follow-up|0
731839|NCT00292188|2349891|P3|Double-Blind|Lack of Efficacy|12
731840|NCT00292188|2349892|P2|Double-Blind|Lack of Efficacy|2
731841|NCT00292188|2349893|P1|Double-Blind|Lack of Efficacy|0
731842|NCT00292188|2349891|P3|Double-Blind|Adverse Event|9
731843|NCT00292188|2349892|P2|Double-Blind|Adverse Event|25
731844|NCT00292188|2349893|P1|Double-Blind|Adverse Event|0
731845|NCT00292188|2349891|P3|Single-Blind|Did not receive treatment|0
731846|NCT00292188|2349892|P2|Single-Blind|Did not receive treatment|0
731847|NCT00292188|2349893|P1|Single-Blind|Did not receive treatment|1
731848|NCT00292188|2349891|P3|Single-Blind|Withdrawal by Subject|0
731849|NCT00292188|2349892|P2|Single-Blind|Withdrawal by Subject|0
731850|NCT00292188|2349893|P1|Single-Blind|Withdrawal by Subject|12
731851|NCT00292188|2349891|P3|Single-Blind|Other|0
731852|NCT00292188|2349892|P2|Single-Blind|Other|0
731853|NCT00292188|2349893|P1|Single-Blind|Other|77
731854|NCT00292188|2349891|P3|Single-Blind|Lost to Follow-up|0
731855|NCT00292188|2349892|P2|Single-Blind|Lost to Follow-up|0
731856|NCT00292188|2349893|P1|Single-Blind|Lost to Follow-up|3
731857|NCT00292188|2349891|P3|Single-Blind|Laboratory Abnormality|0
731858|NCT00292188|2349892|P2|Single-Blind|Laboratory Abnormality|0
731859|NCT00292188|2349893|P1|Single-Blind|Laboratory Abnormality|5
731860|NCT00292188|2349891|P3|Single-Blind|Lack of Efficacy|0
731861|NCT00292188|2349892|P2|Single-Blind|Lack of Efficacy|0
731862|NCT00292188|2349893|P1|Single-Blind|Lack of Efficacy|2
731863|NCT00292188|2349891|P3|Single-Blind|Adverse Event|0
731864|NCT00292188|2349892|P2|Single-Blind|Adverse Event|0
731865|NCT00292188|2349893|P1|Single-Blind|Adverse Event|14
731866|NCT00292227|2349954|P3|Patch Period|Withdrawal by Subject|1
731867|NCT00292227|2349955|P2|Patch Period|Withdrawal by Subject|0
731868|NCT00292227|2349956|P1|Patch Period|Withdrawal by Subject|0
731869|NCT00292227|2349954|P3|Patch Period|Adverse Event|2
731870|NCT00292227|2349955|P2|Patch Period|Adverse Event|0
731871|NCT00292227|2349956|P1|Patch Period|Adverse Event|1
731872|NCT00292318|2350038|P2|Overall Study|Study terminated by officials|1
731873|NCT00292318|2350039|P1|Overall Study|Study terminated by officials|2
731874|NCT00292370|2350050|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
731875|NCT00292370|2350051|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
731876|NCT00292370|2350052|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
731877|NCT00292370|2350050|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
731878|NCT00292370|2350051|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
731879|NCT00292370|2350052|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
731880|NCT00292370|2350050|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
731881|NCT00292370|2350051|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
731882|NCT00292370|2350052|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
731883|NCT00292370|2350050|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
731884|NCT00292370|2350051|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
731885|NCT00292370|2350052|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
731886|NCT00292370|2350050|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
731887|NCT00292370|2350051|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
731888|NCT00292370|2350052|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
731889|NCT00292370|2350050|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
731890|NCT00292370|2350051|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
731891|NCT00292370|2350052|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
731892|NCT00292461|2350061|P2|Overall Study|Lost to Follow-up|0
731893|NCT00292461|2350062|P1|Overall Study|Lost to Follow-up|1
731894|NCT00292461|2350061|P2|Overall Study|Protocol Violation|3
731895|NCT00292461|2350062|P1|Overall Study|Protocol Violation|4
731896|NCT00292461|2350061|P2|Overall Study|Withdrawal by Subject|1
731897|NCT00292461|2350062|P1|Overall Study|Withdrawal by Subject|0
731898|NCT00292461|2350061|P2|Overall Study|Lack of Efficacy|0
731899|NCT00292461|2350062|P1|Overall Study|Lack of Efficacy|1
731900|NCT00292461|2350061|P2|Overall Study|Adverse Event|2
731901|NCT00292461|2350062|P1|Overall Study|Adverse Event|4
731902|NCT00292981|2350087|P1|Overall Study|Not specified|3
731903|NCT00292981|2350087|P1|Overall Study|Withdrawal by Subject|22
731904|NCT00292981|2350087|P1|Overall Study|Lost to Follow-up|13
731905|NCT00292981|2350087|P1|Overall Study|Adverse Event|1
731906|NCT00293020|2350094|P1|Overall Study|No dose taken|1
731907|NCT00293020|2350094|P1|Overall Study|Other Reason|22
731908|NCT00293020|2350094|P1|Overall Study|Physician Decision|21
731909|NCT00293020|2350094|P1|Overall Study|Protocol Violation|6
731910|NCT00293020|2350094|P1|Overall Study|Lost to Follow-up|4
731911|NCT00293020|2350094|P1|Overall Study|Lack of Efficacy|12
731912|NCT00293020|2350094|P1|Overall Study|Death|32
731913|NCT00293020|2350094|P1|Overall Study|Adverse Event|30
731914|NCT00293020|2350094|P1|Overall Study|Withdrawal by Subject|34
731915|NCT00293059|2350100|P2|Overall Study|missing|5
731916|NCT00293059|2350101|P1|Overall Study|missing|3
731917|NCT00293059|2350100|P2|Overall Study|Noncompliant - sanitary pads collection|1
731918|NCT00293059|2350101|P1|Overall Study|Noncompliant - sanitary pads collection|0
731919|NCT00293059|2350100|P2|Overall Study|Participant stopped study drug|0
731920|NCT00293059|2350101|P1|Overall Study|Participant stopped study drug|1
731921|NCT00293059|2350100|P2|Overall Study|Participant moved out of state|0
731922|NCT00293059|2350101|P1|Overall Study|Participant moved out of state|1
731923|NCT00293059|2350100|P2|Overall Study|Withdrawal by Subject|5
731924|NCT00293059|2350101|P1|Overall Study|Withdrawal by Subject|11
731925|NCT00293059|2350100|P2|Overall Study|Protocol Violation|0
731926|NCT00293059|2350101|P1|Overall Study|Protocol Violation|2
731927|NCT00293059|2350100|P2|Overall Study|Pregnancy|1
731928|NCT00293059|2350101|P1|Overall Study|Pregnancy|1
731929|NCT00293059|2350100|P2|Overall Study|Lost to Follow-up|3
731930|NCT00293059|2350101|P1|Overall Study|Lost to Follow-up|2
731931|NCT00293059|2350100|P2|Overall Study|Lack of Efficacy|0
731932|NCT00293059|2350101|P1|Overall Study|Lack of Efficacy|2
731933|NCT00293059|2350100|P2|Overall Study|Adverse Event|4
731934|NCT00293059|2350101|P1|Overall Study|Adverse Event|12
731935|NCT00293241|2350215|P2|Overall Study|Withdrawal by Subject|8
731936|NCT00293241|2350216|P1|Overall Study|Withdrawal by Subject|4
731937|NCT00293241|2350215|P2|Overall Study|Physician Decision|17
731938|NCT00293241|2350216|P1|Overall Study|Physician Decision|23
731939|NCT00293241|2350215|P2|Overall Study|Lost to Follow-up|16
731940|NCT00293241|2350216|P1|Overall Study|Lost to Follow-up|9
731941|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
731942|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
731943|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
731944|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
731945|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
731946|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
731947|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
731948|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
731949|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
731950|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
731951|NCT00293254|2350260|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
731952|NCT00293254|2350261|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
731953|NCT00293254|2350260|P2|Extension - Open-Label Week 157-240|Other Reason|0
731954|NCT00293254|2350261|P1|Extension - Open-Label Week 157-240|Other Reason|4
731955|NCT00293254|2350260|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
731956|NCT00293254|2350261|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
731957|NCT00293254|2350260|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
731958|NCT00293254|2350261|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
731959|NCT00293254|2350260|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
731960|NCT00293254|2350261|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
731961|NCT00293254|2350260|P2|Extension - Open-Label Week 157-240|Adverse Event|1
731962|NCT00293254|2350261|P1|Extension - Open-Label Week 157-240|Adverse Event|2
731963|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
731964|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
731965|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Other Reason|2
731966|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Other Reason|10
731967|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
731968|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
731969|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
731970|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
731971|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
731972|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
731973|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
731974|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
731975|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Death|1
731976|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Death|4
731977|NCT00293254|2350260|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
731978|NCT00293254|2350261|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
731979|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
731980|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
731981|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
731982|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
731983|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
731984|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
731985|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
732058|NCT00293384|2350369|P1|Overall Study|Missed dosage/study drug|1
731986|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
731987|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
731988|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
731989|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Death|2
731990|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Death|5
731991|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
731992|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
731993|NCT00293254|2350260|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
731994|NCT00293254|2350261|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
731995|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
731996|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
731997|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
731998|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
731999|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
732000|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
732001|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
732002|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
732003|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
732004|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
732005|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
732006|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
732007|NCT00293267|2350301|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
732008|NCT00293267|2350302|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
732009|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Other Reason|1
732010|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Other Reason|3
732011|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
732012|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
732013|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
732014|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
732015|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
732016|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
732017|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
732018|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
732019|NCT00293267|2350301|P2|Extension - Open-Label Week 157-240|Adverse Event|0
732020|NCT00293267|2350302|P1|Extension - Open-Label Week 157-240|Adverse Event|5
732021|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
732022|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
732023|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Other Reason|0
732024|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Other Reason|7
732025|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
732026|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
732027|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Death|0
732028|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Death|3
732029|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
732030|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
732031|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
732032|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
732033|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
732034|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
732035|NCT00293267|2350301|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
732036|NCT00293267|2350302|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
732037|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
732038|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
732039|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
732040|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
732041|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
732042|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
732043|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
732044|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
732045|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Death|3
732046|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Death|3
732047|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
732048|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
732049|NCT00293267|2350301|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
732050|NCT00293267|2350302|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
732051|NCT00293293|2350342|P2|Overall Study|Patient discontinued chemotherapy|1
732052|NCT00293293|2350343|P1|Overall Study|Patient discontinued chemotherapy|0
732053|NCT00293293|2350342|P2|Overall Study|"Patient too anxious to complete trial"|0
732054|NCT00293293|2350343|P1|Overall Study|"Patient too anxious to complete trial"|1
732055|NCT00293293|2350342|P2|Overall Study|Withdrawal by Subject|1
732056|NCT00293293|2350343|P1|Overall Study|Withdrawal by Subject|1
732057|NCT00293384|2350369|P1|Overall Study|Ineligible|2
732059|NCT00293384|2350369|P1|Overall Study|Non-compliance|2
732060|NCT00293462|2350379|P3|Overall Study|Physician Decision|0
732061|NCT00293462|2350380|P2|Overall Study|Physician Decision|1
732062|NCT00293462|2350381|P1|Overall Study|Physician Decision|0
732063|NCT00293462|2350379|P3|Overall Study|Low radiation dose in oral cavity|0
732064|NCT00293462|2350380|P2|Overall Study|Low radiation dose in oral cavity|1
732065|NCT00293462|2350381|P1|Overall Study|Low radiation dose in oral cavity|0
732066|NCT00293462|2350379|P3|Overall Study|Possible Tracheostomy leakage|0
732067|NCT00293462|2350380|P2|Overall Study|Possible Tracheostomy leakage|1
732068|NCT00293462|2350381|P1|Overall Study|Possible Tracheostomy leakage|0
732069|NCT00293462|2350379|P3|Overall Study|Ischemic stroke after chemotherapy|1
732070|NCT00293462|2350380|P2|Overall Study|Ischemic stroke after chemotherapy|0
732071|NCT00293462|2350381|P1|Overall Study|Ischemic stroke after chemotherapy|0
732072|NCT00293462|2350379|P3|Overall Study|Blood clot after chemotherapy|1
732073|NCT00293462|2350380|P2|Overall Study|Blood clot after chemotherapy|0
732074|NCT00293462|2350381|P1|Overall Study|Blood clot after chemotherapy|0
732075|NCT00293462|2350379|P3|Overall Study|Went back to his home country|1
732076|NCT00293462|2350380|P2|Overall Study|Went back to his home country|0
732077|NCT00293462|2350381|P1|Overall Study|Went back to his home country|0
732078|NCT00293462|2350379|P3|Overall Study|No Show|1
732079|NCT00293462|2350380|P2|Overall Study|No Show|0
732080|NCT00293462|2350381|P1|Overall Study|No Show|0
732081|NCT00293462|2350379|P3|Overall Study|Refuse Radiation Treatment|0
732082|NCT00293462|2350380|P2|Overall Study|Refuse Radiation Treatment|0
732083|NCT00293462|2350381|P1|Overall Study|Refuse Radiation Treatment|1
732084|NCT00293462|2350379|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
732085|NCT00293462|2350380|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
732086|NCT00293462|2350381|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
732087|NCT00293462|2350379|P3|Overall Study|Change Treatment Regimen (ineligible)|0
732088|NCT00293462|2350380|P2|Overall Study|Change Treatment Regimen (ineligible)|0
732089|NCT00293462|2350381|P1|Overall Study|Change Treatment Regimen (ineligible)|1
732090|NCT00293462|2350379|P3|Overall Study|Lost to Follow-up|0
732091|NCT00293462|2350380|P2|Overall Study|Lost to Follow-up|1
732092|NCT00293462|2350381|P1|Overall Study|Lost to Follow-up|0
732093|NCT00293462|2350379|P3|Overall Study|Death|0
732094|NCT00293462|2350380|P2|Overall Study|Death|0
732095|NCT00293462|2350381|P1|Overall Study|Death|1
732096|NCT00293462|2350379|P3|Overall Study|Withdrawal by Subject|6
732097|NCT00293462|2350380|P2|Overall Study|Withdrawal by Subject|3
732098|NCT00293462|2350381|P1|Overall Study|Withdrawal by Subject|4
732099|NCT00293579|2350409|P1|Overall Study|Withdrawal by Subject|1
732100|NCT00293709|2350416|P1|Overall Study|Unspecified|47
732101|NCT00293722|2350430|P1|Overall Study|Unspecified|427
732102|NCT00293813|2350447|P3|Overall Study|Noncompliance|0
732103|NCT00293813|2350448|P2|Overall Study|Noncompliance|1
732104|NCT00293813|2350449|P1|Overall Study|Noncompliance|0
732105|NCT00293813|2350447|P3|Overall Study|Lost to Follow-up|3
732106|NCT00293813|2350448|P2|Overall Study|Lost to Follow-up|2
732107|NCT00293813|2350449|P1|Overall Study|Lost to Follow-up|3
732108|NCT00293813|2350447|P3|Overall Study|Withdrawal by Subject|4
732109|NCT00293813|2350448|P2|Overall Study|Withdrawal by Subject|4
732110|NCT00293813|2350449|P1|Overall Study|Withdrawal by Subject|7
732111|NCT00293813|2350447|P3|Overall Study|Adverse Event|1
732112|NCT00293813|2350448|P2|Overall Study|Adverse Event|1
732113|NCT00293813|2350449|P1|Overall Study|Adverse Event|3
732114|NCT00293813|2350447|P3|Overall Study|Physician Decision|0
732115|NCT00293813|2350448|P2|Overall Study|Physician Decision|1
732116|NCT00293813|2350449|P1|Overall Study|Physician Decision|0
732117|NCT00294047|2350462|P2|Month 84|No consent for Month 84 Follow-up|754
732118|NCT00294047|2350463|P1|Month 84|No consent for Month 84 Follow-up|731
732119|NCT00294047|2350462|P2|Month 84|Visit missed|1
732120|NCT00294047|2350463|P1|Month 84|Visit missed|0
732121|NCT00294047|2350462|P2|Month 84|Under investigation locally|0
732122|NCT00294047|2350463|P1|Month 84|Under investigation locally|1
732123|NCT00294047|2350462|P2|Month 84|Unable to reach study site|0
732124|NCT00294047|2350463|P1|Month 84|Unable to reach study site|1
732125|NCT00294047|2350462|P2|Month 84|Transport reimbursement delayed|1
732126|NCT00294047|2350463|P1|Month 84|Transport reimbursement delayed|0
732127|NCT00294047|2350462|P2|Month 84|Subject does not want male physician|0
732128|NCT00294047|2350463|P1|Month 84|Subject does not want male physician|1
732129|NCT00294047|2350462|P2|Month 84|Personal reason|4
732130|NCT00294047|2350463|P1|Month 84|Personal reason|2
732131|NCT00294047|2350462|P2|Month 84|Lack of time|1
732132|NCT00294047|2350463|P1|Month 84|Lack of time|3
732133|NCT00294047|2350462|P2|Month 84|Family problems|2
732134|NCT00294047|2350463|P1|Month 84|Family problems|2
732135|NCT00294047|2350462|P2|Month 84|Center closed, subject did not transfer|0
732136|NCT00294047|2350463|P1|Month 84|Center closed, subject did not transfer|1
732137|NCT00294047|2350462|P2|Month 84|Work related reasons|2
732138|NCT00294047|2350463|P1|Month 84|Work related reasons|4
732139|NCT00294047|2350462|P2|Month 84|Absent Cervix|0
732140|NCT00294047|2350463|P1|Month 84|Absent Cervix|2
732141|NCT00294047|2350462|P2|Month 84|Lost to Follow-up|190
732142|NCT00294047|2350463|P1|Month 84|Lost to Follow-up|187
732143|NCT00294047|2350462|P2|Month 84|Withdrawal by Subject|31
732144|NCT00294047|2350463|P1|Month 84|Withdrawal by Subject|33
732145|NCT00294047|2350462|P2|Month 84|Protocol Violation|1
732146|NCT00294047|2350463|P1|Month 84|Protocol Violation|1
732147|NCT00294047|2350462|P2|Month 84|Adverse Event|2
732148|NCT00294047|2350463|P1|Month 84|Adverse Event|4
732149|NCT00294047|2350462|P2|Month 48|Unspecified|14
732150|NCT00294047|2350463|P1|Month 48|Unspecified|10
732151|NCT00294047|2350462|P2|Month 48|Lost to Follow-up|287
732152|NCT00294047|2350463|P1|Month 48|Lost to Follow-up|272
732153|NCT00294047|2350462|P2|Month 48|Withdrawal by Subject|115
732154|NCT00294047|2350463|P1|Month 48|Withdrawal by Subject|111
732155|NCT00294047|2350462|P2|Month 48|Protocol Violation|4
732156|NCT00294047|2350463|P1|Month 48|Protocol Violation|4
732157|NCT00294047|2350462|P2|Month 48|Adverse Event|13
732158|NCT00294047|2350463|P1|Month 48|Adverse Event|28
732159|NCT00294060|2350565|P1|Overall Study|Device explanted/not replaced|23
732160|NCT00294060|2350565|P1|Overall Study|Medical condition|3
732161|NCT00294060|2350565|P1|Overall Study|Physician Decision|797
732162|NCT00294060|2350565|P1|Overall Study|Withdrawal by Subject|11
732163|NCT00294060|2350565|P1|Overall Study|Lost to Follow-up|55
732164|NCT00294060|2350565|P1|Overall Study|Other|59
732165|NCT00294060|2350565|P1|Overall Study|Death|225
732166|NCT00294398|2350573|P2|Overall Study|Lost to Follow-up|26
732167|NCT00294398|2350574|P1|Overall Study|Lost to Follow-up|21
732168|NCT00300755|2350610|P3|Overall Study|Protocol Violation|1
732169|NCT00300755|2350611|P2|Overall Study|Protocol Violation|0
732170|NCT00300755|2350612|P1|Overall Study|Protocol Violation|0
732171|NCT00300755|2350610|P3|Overall Study|Withdrawal by Subject|0
732172|NCT00300755|2350611|P2|Overall Study|Withdrawal by Subject|2
732173|NCT00300755|2350612|P1|Overall Study|Withdrawal by Subject|0
732174|NCT00300755|2350610|P3|Overall Study|Adverse Event|1
732175|NCT00300755|2350611|P2|Overall Study|Adverse Event|2
732176|NCT00300755|2350612|P1|Overall Study|Adverse Event|1
732177|NCT00300781|2350631|P2|Overall Study|Lost to Follow-up|1
732178|NCT00300781|2350632|P1|Overall Study|Lost to Follow-up|0
732179|NCT00300781|2350631|P2|Overall Study|Symptomatic Deterioration|0
732180|NCT00300781|2350632|P1|Overall Study|Symptomatic Deterioration|1
732181|NCT00300781|2350631|P2|Overall Study|Not Recorded|1
732182|NCT00300781|2350632|P1|Overall Study|Not Recorded|0
732183|NCT00300781|2350631|P2|Overall Study|Physician Decision|0
732184|NCT00300781|2350632|P1|Overall Study|Physician Decision|1
732185|NCT00300781|2350631|P2|Overall Study|Withdrawal by Subject|2
732186|NCT00300781|2350632|P1|Overall Study|Withdrawal by Subject|1
732187|NCT00300781|2350631|P2|Overall Study|Adverse Event|6
732188|NCT00300781|2350632|P1|Overall Study|Adverse Event|5
732189|NCT00300781|2350631|P2|Overall Study|Disease Progression|52
732190|NCT00300781|2350632|P1|Overall Study|Disease Progression|55
732191|NCT00300885|2350646|P2|Follow-up|Withdrawal by Subject|25
732192|NCT00300885|2350647|P1|Follow-up|Withdrawal by Subject|26
732193|NCT00300885|2350646|P2|Follow-up|Lost to Follow-up|7
732194|NCT00300885|2350647|P1|Follow-up|Lost to Follow-up|11
732195|NCT00300885|2350646|P2|Follow-up|Death|163
732196|NCT00300885|2350647|P1|Follow-up|Death|141
732197|NCT00300885|2350646|P2|Treatment|Non-compliant with study medication|4
732198|NCT00300885|2350647|P1|Treatment|Non-compliant with study medication|3
732199|NCT00300885|2350646|P2|Treatment|Random code broken (subject died)|1
732200|NCT00300885|2350647|P1|Treatment|Random code broken (subject died)|0
732201|NCT00300885|2350646|P2|Treatment|Disease progression|238
732202|NCT00300885|2350647|P1|Treatment|Disease progression|171
732203|NCT00300885|2350646|P2|Treatment|Withdrawal by Subject|23
732204|NCT00300885|2350647|P1|Treatment|Withdrawal by Subject|26
732205|NCT00300885|2350646|P2|Treatment|Protocol Violation|11
732206|NCT00300885|2350647|P1|Treatment|Protocol Violation|11
732207|NCT00300885|2350646|P2|Treatment|Physician Decision|5
732208|NCT00300885|2350647|P1|Treatment|Physician Decision|4
732209|NCT00300885|2350646|P2|Treatment|Lost to Follow-up|2
732210|NCT00300885|2350647|P1|Treatment|Lost to Follow-up|3
732211|NCT00300885|2350646|P2|Treatment|Lack of Efficacy|1
732212|NCT00300885|2350647|P1|Treatment|Lack of Efficacy|1
732213|NCT00300885|2350646|P2|Treatment|Death|7
732214|NCT00300885|2350647|P1|Treatment|Death|20
732215|NCT00300885|2350646|P2|Treatment|Adverse Event|82
732216|NCT00300885|2350647|P1|Treatment|Adverse Event|134
732217|NCT00304278|2350696|P1|Overall Study|PT had medical condition preventing TX|1
732218|NCT00304278|2350696|P1|Overall Study|lack of insurance coverage for chemoRT|1
732219|NCT00304915|2350723|P2|Overall Study|Withdrawal by Subject|0
732220|NCT00304915|2350724|P1|Overall Study|Withdrawal by Subject|3
732221|NCT00304915|2350723|P2|Overall Study|Death|5
732222|NCT00304915|2350724|P1|Overall Study|Death|4
732223|NCT00304915|2350723|P2|Overall Study|Lost to Follow-up|11
732224|NCT00304915|2350724|P1|Overall Study|Lost to Follow-up|11
732225|NCT00304954|2350734|P4|Overall Study|Adverse Event|0
732226|NCT00304954|2350735|P3|Overall Study|Adverse Event|0
732227|NCT00304954|2350736|P2|Overall Study|Adverse Event|0
732228|NCT00304954|2350737|P1|Overall Study|Adverse Event|1
732229|NCT00304954|2350734|P4|Overall Study|Withdrawal by Subject|0
732230|NCT00304954|2350735|P3|Overall Study|Withdrawal by Subject|1
732231|NCT00304954|2350736|P2|Overall Study|Withdrawal by Subject|0
732232|NCT00304954|2350737|P1|Overall Study|Withdrawal by Subject|0
732233|NCT00305227|2350798|P2|Overall Study|Lost to Follow-up|6
732234|NCT00305227|2350799|P1|Overall Study|Lost to Follow-up|7
732235|NCT00305253|2350807|P2|Overall Study|Withdrawal by Subject|1
732236|NCT00305253|2350808|P1|Overall Study|Withdrawal by Subject|0
732237|NCT00305448|2350825|P3|Overall Study|Tumor Marker Elevation|1
732238|NCT00305448|2350826|P2|Overall Study|Tumor Marker Elevation|0
732239|NCT00305448|2350827|P1|Overall Study|Tumor Marker Elevation|0
732240|NCT00305448|2350825|P3|Overall Study|Subjective Disease Progression|2
732241|NCT00305448|2350826|P2|Overall Study|Subjective Disease Progression|2
732242|NCT00305448|2350827|P1|Overall Study|Subjective Disease Progression|1
732243|NCT00305448|2350825|P3|Overall Study|Disease Progression|28
732244|NCT00305448|2350826|P2|Overall Study|Disease Progression|31
732245|NCT00305448|2350827|P1|Overall Study|Disease Progression|27
732246|NCT00305448|2350825|P3|Overall Study|Adverse Event|1
732247|NCT00305448|2350826|P2|Overall Study|Adverse Event|0
732248|NCT00305448|2350827|P1|Overall Study|Adverse Event|1
732249|NCT00305448|2350825|P3|Overall Study|Withdrawal by Subject|1
732250|NCT00305448|2350826|P2|Overall Study|Withdrawal by Subject|0
732251|NCT00305448|2350827|P1|Overall Study|Withdrawal by Subject|2
732252|NCT00305448|2350825|P3|Overall Study|Protocol Violation|0
732253|NCT00305448|2350826|P2|Overall Study|Protocol Violation|1
732254|NCT00305448|2350827|P1|Overall Study|Protocol Violation|0
732255|NCT00305604|2350974|P2|Overall Study|Patient moved|0
732256|NCT00305604|2350975|P1|Overall Study|Patient moved|1
732257|NCT00305604|2350974|P2|Overall Study|Withdrawal by Subject|21
732258|NCT00305604|2350975|P1|Overall Study|Withdrawal by Subject|12
732259|NCT00305604|2350974|P2|Overall Study|Protocol Violation|1
732260|NCT00305604|2350975|P1|Overall Study|Protocol Violation|2
732261|NCT00305604|2350974|P2|Overall Study|Lost to Follow-up|4
732262|NCT00305604|2350975|P1|Overall Study|Lost to Follow-up|0
732263|NCT00305604|2350974|P2|Overall Study|Lack of Efficacy|18
732264|NCT00305604|2350975|P1|Overall Study|Lack of Efficacy|11
732265|NCT00305604|2350974|P2|Overall Study|Adverse Event|3
732266|NCT00305604|2350975|P1|Overall Study|Adverse Event|6
732267|NCT00305773|2351004|P2|Overall Study|All other reasons|2
732268|NCT00305773|2351005|P1|Overall Study|All other reasons|3
732269|NCT00305773|2351004|P2|Overall Study|Disease Progression|3
732270|NCT00305773|2351005|P1|Overall Study|Disease Progression|1
732271|NCT00305773|2351004|P2|Overall Study|Withdrawal by Subject|4
732272|NCT00305773|2351005|P1|Overall Study|Withdrawal by Subject|1
732273|NCT00305773|2351004|P2|Overall Study|Physician Decision|1
732274|NCT00305773|2351005|P1|Overall Study|Physician Decision|1
732275|NCT00305773|2351004|P2|Overall Study|Alternative Treatment|4
732276|NCT00305773|2351005|P1|Overall Study|Alternative Treatment|4
732277|NCT00305773|2351004|P2|Overall Study|Adverse Event|2
732278|NCT00305773|2351005|P1|Overall Study|Adverse Event|1
732279|NCT00305773|2351004|P2|Overall Study|Death|2
732280|NCT00305773|2351005|P1|Overall Study|Death|3
732285|NCT00305877|2351038|P2|Overall Study|Transportation issue with daily RT|1
732286|NCT00305877|2351039|P1|Overall Study|Transportation issue with daily RT|0
732287|NCT00305877|2351038|P2|Overall Study|Ineligible|1
732288|NCT00305877|2351039|P1|Overall Study|Ineligible|2
732289|NCT00305877|2351038|P2|Overall Study|Never start treatment|5
732290|NCT00305877|2351039|P1|Overall Study|Never start treatment|2
732291|NCT00305877|2351038|P2|Overall Study|Physician Decision|1
732292|NCT00305877|2351039|P1|Overall Study|Physician Decision|1
732293|NCT00305877|2351038|P2|Overall Study|Withdrawal by Subject|2
732294|NCT00305877|2351039|P1|Overall Study|Withdrawal by Subject|4
732295|NCT00305877|2351038|P2|Overall Study|Death|1
732296|NCT00305877|2351039|P1|Overall Study|Death|0
732297|NCT00305877|2351038|P2|Overall Study|Adverse Event|14
732298|NCT00305877|2351039|P1|Overall Study|Adverse Event|9
732299|NCT00305877|2351038|P2|Overall Study|Lack of Efficacy|9
732300|NCT00305877|2351039|P1|Overall Study|Lack of Efficacy|6
732301|NCT00306189|2351068|P4|Overall Study|Other|0
732302|NCT00306189|2351069|P3|Overall Study|Other|0
732303|NCT00306189|2351070|P2|Overall Study|Other|0
732304|NCT00306189|2351071|P1|Overall Study|Other|1
732305|NCT00306189|2351068|P4|Overall Study|Ineligibility determined|1
732306|NCT00306189|2351069|P3|Overall Study|Ineligibility determined|1
732307|NCT00306189|2351070|P2|Overall Study|Ineligibility determined|1
732308|NCT00306189|2351071|P1|Overall Study|Ineligibility determined|1
732309|NCT00306189|2351068|P4|Overall Study|Withdrawal by Subject|1
732310|NCT00306189|2351069|P3|Overall Study|Withdrawal by Subject|8
732311|NCT00306189|2351070|P2|Overall Study|Withdrawal by Subject|2
732312|NCT00306189|2351071|P1|Overall Study|Withdrawal by Subject|4
732313|NCT00306189|2351068|P4|Overall Study|Adverse Event|2
732314|NCT00306189|2351069|P3|Overall Study|Adverse Event|2
732315|NCT00306189|2351070|P2|Overall Study|Adverse Event|3
732316|NCT00306189|2351071|P1|Overall Study|Adverse Event|3
732317|NCT00306189|2351068|P4|Overall Study|Physician Decision|1
732318|NCT00306189|2351069|P3|Overall Study|Physician Decision|0
732319|NCT00306189|2351070|P2|Overall Study|Physician Decision|0
732320|NCT00306189|2351071|P1|Overall Study|Physician Decision|0
732321|NCT00306202|2351084|P3|Overall Study|Still on treatment|0
732322|NCT00306202|2351085|P2|Overall Study|Still on treatment|1
732323|NCT00306202|2351086|P1|Overall Study|Still on treatment|6
732324|NCT00306384|2351245|P3|Overall Study|Site closure|0
732325|NCT00306384|2351246|P2|Overall Study|Site closure|0
732326|NCT00306384|2351247|P1|Overall Study|Site closure|2
732327|NCT00306384|2351245|P3|Overall Study|Other|32
732328|NCT00306384|2351246|P2|Overall Study|Other|70
732329|NCT00306384|2351247|P1|Overall Study|Other|80
732330|NCT00306384|2351245|P3|Overall Study|Investigator discretion|21
732331|NCT00306384|2351246|P2|Overall Study|Investigator discretion|31
732332|NCT00306384|2351247|P1|Overall Study|Investigator discretion|28
732333|NCT00306384|2351245|P3|Overall Study|Lack of Efficacy|38
732334|NCT00306384|2351246|P2|Overall Study|Lack of Efficacy|40
732335|NCT00306384|2351247|P1|Overall Study|Lack of Efficacy|26
732336|NCT00306384|2351245|P3|Overall Study|Pregnancy|1
732337|NCT00306384|2351246|P2|Overall Study|Pregnancy|1
732338|NCT00306384|2351247|P1|Overall Study|Pregnancy|3
732339|NCT00306384|2351245|P3|Overall Study|Study termination|1
732340|NCT00306384|2351246|P2|Overall Study|Study termination|0
732341|NCT00306384|2351247|P1|Overall Study|Study termination|1
732342|NCT00306384|2351245|P3|Overall Study|Voluntary withdrawal|91
732343|NCT00306384|2351246|P2|Overall Study|Voluntary withdrawal|187
732344|NCT00306384|2351247|P1|Overall Study|Voluntary withdrawal|199
732345|NCT00306384|2351245|P3|Overall Study|Lost to Follow-up|35
732346|NCT00306384|2351246|P2|Overall Study|Lost to Follow-up|41
732347|NCT00306384|2351247|P1|Overall Study|Lost to Follow-up|57
732348|NCT00306384|2351245|P3|Overall Study|Major protocol deviation|18
732349|NCT00306384|2351246|P2|Overall Study|Major protocol deviation|51
732350|NCT00306384|2351247|P1|Overall Study|Major protocol deviation|43
732351|NCT00306384|2351245|P3|Overall Study|Adverse Event|40
732352|NCT00306384|2351246|P2|Overall Study|Adverse Event|87
732353|NCT00306384|2351247|P1|Overall Study|Adverse Event|103
732354|NCT00306527|2351295|P4|Overall Study|Death|2
732355|NCT00306527|2351296|P3|Overall Study|Death|1
732356|NCT00306527|2351297|P2|Overall Study|Death|0
732357|NCT00306527|2351298|P1|Overall Study|Death|1
732358|NCT00306527|2351295|P4|Overall Study|Adverse Event|1
732359|NCT00306527|2351296|P3|Overall Study|Adverse Event|1
732360|NCT00306527|2351297|P2|Overall Study|Adverse Event|0
732361|NCT00306527|2351298|P1|Overall Study|Adverse Event|0
732362|NCT00306527|2351295|P4|Overall Study|Withdrawal by Subject|3
732363|NCT00306527|2351296|P3|Overall Study|Withdrawal by Subject|0
732364|NCT00306527|2351297|P2|Overall Study|Withdrawal by Subject|3
732365|NCT00306527|2351298|P1|Overall Study|Withdrawal by Subject|2
732366|NCT00306527|2351295|P4|Overall Study|Lost to Follow-up|0
732367|NCT00306527|2351296|P3|Overall Study|Lost to Follow-up|3
732368|NCT00306527|2351297|P2|Overall Study|Lost to Follow-up|4
732369|NCT00306527|2351298|P1|Overall Study|Lost to Follow-up|3
732370|NCT00306592|2351352|P2|Overall Study|48-week Treatment Period Ongoing|20
732371|NCT00306592|2351353|P1|Overall Study|48-week Treatment Period Ongoing|0
732372|NCT00306592|2351352|P2|Overall Study|Other|2
732373|NCT00306592|2351353|P1|Overall Study|Other|1
732374|NCT00306592|2351352|P2|Overall Study|Not Specified|10
732375|NCT00306592|2351353|P1|Overall Study|Not Specified|5
732376|NCT00306592|2351352|P2|Overall Study|Voluntary|6
732377|NCT00306592|2351353|P1|Overall Study|Voluntary|10
732378|NCT00306592|2351352|P2|Overall Study|Persistent Antibodies|3
732379|NCT00306592|2351353|P1|Overall Study|Persistent Antibodies|6
732380|NCT00306592|2351352|P2|Overall Study|Noncompliance|2
732381|NCT00306592|2351353|P1|Overall Study|Noncompliance|0
732382|NCT00306592|2351352|P2|Overall Study|Lost to Follow-up|0
732383|NCT00306592|2351353|P1|Overall Study|Lost to Follow-up|1
732384|NCT00306592|2351352|P2|Overall Study|Adverse Event|15
732385|NCT00306592|2351353|P1|Overall Study|Adverse Event|8
732386|NCT00306670|2351361|P2|Overall Study|patients recruited; Genentech, the st|2
732387|NCT00306670|2351362|P1|Overall Study|patients recruited; Genentech, the st|0
732388|NCT00291551|2351368|P1|Overall Study|Withdrawal by Subject|6
732389|NCT00291551|2351368|P1|Overall Study|Death|7
732390|NCT00291577|2351383|P1|Overall Study|Lack of Efficacy|14
732391|NCT00291577|2351383|P1|Overall Study|Withdrawal by Subject|2
732392|NCT00291577|2351383|P1|Overall Study|Other|4
732393|NCT00291577|2351383|P1|Overall Study|Adverse Event|1
732394|NCT00297427|2351438|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
732395|NCT00297427|2351439|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
732396|NCT00297427|2351438|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
732397|NCT00297427|2351439|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
732398|NCT00297427|2351438|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
732399|NCT00297427|2351439|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
732400|NCT00297427|2351438|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
732401|NCT00297427|2351439|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
732402|NCT00297427|2351438|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
732403|NCT00297427|2351439|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
732404|NCT00297427|2351438|P2|Phase 1: Initial Intervention|Death|1
732405|NCT00297427|2351439|P1|Phase 1: Initial Intervention|Death|0
732406|NCT00297427|2351438|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
732407|NCT00297427|2351439|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
732408|NCT00297427|2351438|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
732409|NCT00297427|2351439|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
732410|NCT00297492|2351483|P3|6 Month Follow-up|Lost to Follow-up|27
732411|NCT00297492|2351484|P2|6 Month Follow-up|Lost to Follow-up|49
732412|NCT00297492|2351485|P1|6 Month Follow-up|Lost to Follow-up|63
732413|NCT00297492|2351483|P3|Set Quit Date|Lost to Follow-up|5
732414|NCT00297492|2351484|P2|Set Quit Date|Lost to Follow-up|13
732415|NCT00297492|2351485|P1|Set Quit Date|Lost to Follow-up|7
732416|NCT00297648|2351497|P1|Overall Study|Other: Incompliance|1
732417|NCT00297648|2351497|P1|Overall Study|Withdrawal by Subject|3
732418|NCT00297648|2351497|P1|Overall Study|Lost to Follow-up|1
732419|NCT00297648|2351497|P1|Overall Study|Lack of Efficacy|18
732420|NCT00297648|2351497|P1|Overall Study|Adverse Event|13
732421|NCT00297778|2351538|P2|Overall Study|Other|1
732422|NCT00297778|2351539|P1|Overall Study|Other|0
732423|NCT00297778|2351538|P2|Overall Study|Non-compliant with trial protocol|3
732424|NCT00297778|2351539|P1|Overall Study|Non-compliant with trial protocol|0
732425|NCT00297778|2351538|P2|Overall Study|Lack of Efficacy|1
732426|NCT00297778|2351539|P1|Overall Study|Lack of Efficacy|2
732427|NCT00297778|2351538|P2|Overall Study|Withdrawal by Subject|5
732428|NCT00297778|2351539|P1|Overall Study|Withdrawal by Subject|1
732429|NCT00297778|2351538|P2|Overall Study|Adverse Event|10
732430|NCT00297778|2351539|P1|Overall Study|Adverse Event|16
732431|NCT00297830|2351576|P3|12 Month Visit|Withdrawal by Subject|0
732432|NCT00297830|2351577|P2|12 Month Visit|Withdrawal by Subject|3
732433|NCT00297830|2351578|P1|12 Month Visit|Withdrawal by Subject|0
732434|NCT00297830|2351576|P3|12 Month Visit|Adverse Event|0
732435|NCT00297830|2351577|P2|12 Month Visit|Adverse Event|3
732436|NCT00297830|2351578|P1|12 Month Visit|Adverse Event|0
732437|NCT00297830|2351576|P3|12 Month Visit|Lost to Follow-up|0
732438|NCT00297830|2351577|P2|12 Month Visit|Lost to Follow-up|0
732439|NCT00297830|2351578|P1|12 Month Visit|Lost to Follow-up|1
732440|NCT00297830|2351576|P3|6 Month Visit|Adverse Event|0
732441|NCT00297830|2351577|P2|6 Month Visit|Adverse Event|1
732442|NCT00297830|2351578|P1|6 Month Visit|Adverse Event|0
732443|NCT00297830|2351576|P3|6 Month Visit|Withdrawal by Subject|1
732444|NCT00297830|2351577|P2|6 Month Visit|Withdrawal by Subject|1
732445|NCT00297830|2351578|P1|6 Month Visit|Withdrawal by Subject|2
732446|NCT00297830|2351576|P3|6 Month Visit|Death|2
732447|NCT00297830|2351577|P2|6 Month Visit|Death|0
732448|NCT00297830|2351578|P1|6 Month Visit|Death|1
732449|NCT00306787|2351617|P2|Overall Study|Abnormal laboratory value(s)|0
732450|NCT00306787|2351618|P1|Overall Study|Abnormal laboratory value(s)|1
732451|NCT00306787|2351617|P2|Overall Study|Administrative problems|0
732452|NCT00306787|2351618|P1|Overall Study|Administrative problems|4
732453|NCT00306787|2351617|P2|Overall Study|Lost to Follow-up|6
732454|NCT00306787|2351618|P1|Overall Study|Lost to Follow-up|9
732455|NCT00306787|2351617|P2|Overall Study|Withdrawal by Subject|9
732456|NCT00306787|2351618|P1|Overall Study|Withdrawal by Subject|2
732457|NCT00306787|2351617|P2|Overall Study|Protocol Violation|10
732458|NCT00306787|2351618|P1|Overall Study|Protocol Violation|8
732459|NCT00306787|2351617|P2|Overall Study|Lack of Efficacy|0
732460|NCT00306787|2351618|P1|Overall Study|Lack of Efficacy|1
732461|NCT00306787|2351617|P2|Overall Study|Adverse Event|1
732462|NCT00306787|2351618|P1|Overall Study|Adverse Event|1
732463|NCT00306787|2351617|P2|Overall Study|Discontinued without taking study drug|215
732464|NCT00306787|2351618|P1|Overall Study|Discontinued without taking study drug|208
732465|NCT00306852|2351636|P2|Overall Study|Lost to Follow-up|24
732466|NCT00306852|2351637|P1|Overall Study|Lost to Follow-up|15
732467|NCT00306852|2351636|P2|Overall Study|Death|14
732468|NCT00306852|2351637|P1|Overall Study|Death|14
732469|NCT00306891|2351657|P4|Part B|Development of study specific disc crit.|1
732470|NCT00306891|2351658|P3|Part B|Development of study specific disc crit.|0
732471|NCT00306891|2351659|P2|Part B|Development of study specific disc crit.|0
732472|NCT00306891|2351660|P1|Part B|Development of study specific disc crit.|0
732473|NCT00306891|2351657|P4|Part B|Condition under investigation worsened|8
732474|NCT00306891|2351658|P3|Part B|Condition under investigation worsened|2
732475|NCT00306891|2351659|P2|Part B|Condition under investigation worsened|0
732476|NCT00306891|2351660|P1|Part B|Condition under investigation worsened|0
732477|NCT00306891|2351657|P4|Part B|Withdrawal by Subject|1
732478|NCT00306891|2351658|P3|Part B|Withdrawal by Subject|3
732479|NCT00306891|2351659|P2|Part B|Withdrawal by Subject|0
732480|NCT00306891|2351660|P1|Part B|Withdrawal by Subject|0
732481|NCT00306891|2351657|P4|Part B|Adverse Event|5
732482|NCT00306891|2351658|P3|Part B|Adverse Event|5
732483|NCT00306891|2351659|P2|Part B|Adverse Event|0
732484|NCT00306891|2351660|P1|Part B|Adverse Event|0
732485|NCT00306891|2351657|P4|Part B|Death|2
732486|NCT00306891|2351658|P3|Part B|Death|1
732487|NCT00306891|2351659|P2|Part B|Death|0
732488|NCT00306891|2351660|P1|Part B|Death|0
732489|NCT00306891|2351657|P4|Part A|QTC interval outwith elig. criteria|0
732490|NCT00306891|2351658|P3|Part A|QTC interval outwith elig. criteria|0
732491|NCT00306891|2351659|P2|Part A|QTC interval outwith elig. criteria|0
732492|NCT00306891|2351660|P1|Part A|QTC interval outwith elig. criteria|1
732493|NCT00306891|2351657|P4|Part A|Suspicion of second malignancy|0
732494|NCT00306891|2351658|P3|Part A|Suspicion of second malignancy|0
732495|NCT00306891|2351659|P2|Part A|Suspicion of second malignancy|1
732496|NCT00306891|2351660|P1|Part A|Suspicion of second malignancy|0
732497|NCT00306891|2351657|P4|Part A|Reaccumul. of ascites following drainage|0
732498|NCT00306891|2351658|P3|Part A|Reaccumul. of ascites following drainage|0
732499|NCT00306891|2351659|P2|Part A|Reaccumul. of ascites following drainage|1
732500|NCT00306891|2351660|P1|Part A|Reaccumul. of ascites following drainage|0
732501|NCT00306891|2351657|P4|Part A|Partial bowel obstruction|0
732502|NCT00306891|2351658|P3|Part A|Partial bowel obstruction|0
732503|NCT00306891|2351659|P2|Part A|Partial bowel obstruction|0
732504|NCT00306891|2351660|P1|Part A|Partial bowel obstruction|1
732505|NCT00306891|2351657|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
732506|NCT00306891|2351658|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
732507|NCT00306891|2351659|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
732508|NCT00306891|2351660|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
732509|NCT00306891|2351657|P4|Part A|Condition under investigation worsened|0
732510|NCT00306891|2351658|P3|Part A|Condition under investigation worsened|0
732511|NCT00306891|2351659|P2|Part A|Condition under investigation worsened|2
732512|NCT00306891|2351660|P1|Part A|Condition under investigation worsened|2
732513|NCT00306891|2351657|P4|Part A|Withdrawal by Subject|0
732514|NCT00306891|2351658|P3|Part A|Withdrawal by Subject|0
732515|NCT00306891|2351659|P2|Part A|Withdrawal by Subject|1
732516|NCT00306891|2351660|P1|Part A|Withdrawal by Subject|1
732517|NCT00311155|2351690|P1|Overall Study|Did not meet entry criteria|55
732518|NCT00311155|2351690|P1|Overall Study|Withdrawal by Subject|17
732519|NCT00311155|2351690|P1|Overall Study|Adverse Event|21
732520|NCT00311181|2351699|P1|Overall Study|Final DFTs were not obtained|96
732521|NCT00311311|2351707|P2|Overall Study|Lack of ancillary assistance|1
732522|NCT00311311|2351708|P1|Overall Study|Lack of ancillary assistance|0
732523|NCT00311311|2351707|P2|Overall Study|Death|0
732524|NCT00311311|2351708|P1|Overall Study|Death|1
732525|NCT00311311|2351707|P2|Overall Study|Study Termination by Sponsor|4
732526|NCT00311311|2351708|P1|Overall Study|Study Termination by Sponsor|3
732527|NCT00311311|2351707|P2|Overall Study|Noncompliance|1
732528|NCT00311311|2351708|P1|Overall Study|Noncompliance|0
732529|NCT00311311|2351707|P2|Overall Study|Withdrawal by Subject|1
732530|NCT00311311|2351708|P1|Overall Study|Withdrawal by Subject|1
732531|NCT00311311|2351707|P2|Overall Study|Adverse Event|2
732532|NCT00311311|2351708|P1|Overall Study|Adverse Event|3
732533|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
732534|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
732535|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
732536|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
732537|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
732538|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
732539|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
732540|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
732541|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
732542|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
732543|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
732544|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
732545|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
732546|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
732547|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
732548|NCT00311363|2351761|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
732549|NCT00311363|2351762|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
732550|NCT00311363|2351763|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
732551|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Death|0
732552|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Death|0
732553|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Death|1
732554|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
732555|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
732556|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
732557|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
732558|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
732559|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
732560|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
732561|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
732562|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
732563|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
732564|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
732565|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
732566|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
732567|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
732568|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
732569|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
732570|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
732571|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
732572|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
732573|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
732574|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
732575|NCT00311363|2351761|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
732576|NCT00311363|2351762|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
732577|NCT00311363|2351763|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
732578|NCT00311402|2351845|P2|Overall Study|IRB's rejection etc.|3
732579|NCT00311402|2351846|P1|Overall Study|IRB's rejection etc.|10
732580|NCT00311402|2351845|P2|Overall Study|Protocol Violation|6
732581|NCT00311402|2351846|P1|Overall Study|Protocol Violation|7
732582|NCT00311402|2351845|P2|Overall Study|Lack of Efficacy|42
732583|NCT00311402|2351846|P1|Overall Study|Lack of Efficacy|58
732584|NCT00311402|2351845|P2|Overall Study|Withdrawal by Subject|18
732585|NCT00311402|2351846|P1|Overall Study|Withdrawal by Subject|17
732586|NCT00311402|2351845|P2|Overall Study|Lost to Follow-up|3
732587|NCT00311402|2351846|P1|Overall Study|Lost to Follow-up|0
732588|NCT00311402|2351845|P2|Overall Study|Adverse Event|105
732589|NCT00311402|2351846|P1|Overall Study|Adverse Event|118
732590|NCT00311584|2351872|P2|Overall Study|ineligible|2
732591|NCT00311584|2351873|P1|Overall Study|ineligible|2
732592|NCT00311584|2351872|P2|Overall Study|Withdrawal by Subject|1
732593|NCT00311584|2351873|P1|Overall Study|Withdrawal by Subject|1
732594|NCT00311584|2351872|P2|Overall Study|Physician Decision|5
732595|NCT00311584|2351873|P1|Overall Study|Physician Decision|4
732596|NCT00311584|2351872|P2|Overall Study|Lack of Efficacy|15
732597|NCT00311584|2351873|P1|Overall Study|Lack of Efficacy|12
732598|NCT00311584|2351872|P2|Overall Study|Death|0
732599|NCT00311584|2351873|P1|Overall Study|Death|1
732600|NCT00312195|2351892|P2|Overall Study|Protocol Violation|0
732601|NCT00312195|2351893|P1|Overall Study|Protocol Violation|1
732602|NCT00312195|2351892|P2|Overall Study|Lost to Follow-up|0
732603|NCT00312195|2351893|P1|Overall Study|Lost to Follow-up|1
732604|NCT00312195|2351892|P2|Overall Study|Adverse Event|6
732605|NCT00312195|2351893|P1|Overall Study|Adverse Event|4
732606|NCT00312208|2351909|P2|Overall Study|Not specified|7
732607|NCT00312208|2351910|P1|Overall Study|Not specified|5
732608|NCT00312208|2351909|P2|Overall Study|Withdrawal by Subject|42
732609|NCT00312208|2351910|P1|Overall Study|Withdrawal by Subject|53
732610|NCT00312208|2351909|P2|Overall Study|Lost to Follow-up|5
732611|NCT00312208|2351910|P1|Overall Study|Lost to Follow-up|3
732612|NCT00312208|2351909|P2|Overall Study|Lack of Efficacy|4
732613|NCT00312208|2351910|P1|Overall Study|Lack of Efficacy|7
732614|NCT00312208|2351909|P2|Overall Study|Death|1
732615|NCT00312208|2351910|P1|Overall Study|Death|2
732616|NCT00312208|2351909|P2|Overall Study|Protocol Violation|3
732617|NCT00312208|2351910|P1|Overall Study|Protocol Violation|5
732618|NCT00312208|2351909|P2|Overall Study|Adverse Event|61
732619|NCT00312208|2351910|P1|Overall Study|Adverse Event|97
732620|NCT00312221|2351921|P4|Double-blind Phase|Lack of Efficacy|10
732621|NCT00312221|2351922|P3|Double-blind Phase|Lack of Efficacy|6
732622|NCT00312221|2351923|P2|Double-blind Phase|Lack of Efficacy|17
732623|NCT00312221|2351924|P1|Double-blind Phase|Lack of Efficacy|0
732624|NCT00312221|2351921|P4|Double-blind Phase|Administrative|33
732625|NCT00312221|2351922|P3|Double-blind Phase|Administrative|37
732626|NCT00312221|2351923|P2|Double-blind Phase|Administrative|26
732627|NCT00312221|2351924|P1|Double-blind Phase|Administrative|0
732628|NCT00312221|2351921|P4|Double-blind Phase|Lost to Follow-up|2
732629|NCT00312221|2351922|P3|Double-blind Phase|Lost to Follow-up|2
732630|NCT00312221|2351923|P2|Double-blind Phase|Lost to Follow-up|0
732631|NCT00312221|2351924|P1|Double-blind Phase|Lost to Follow-up|0
732632|NCT00312221|2351921|P4|Double-blind Phase|Adverse Event|18
732633|NCT00312221|2351922|P3|Double-blind Phase|Adverse Event|19
732634|NCT00312221|2351923|P2|Double-blind Phase|Adverse Event|10
732635|NCT00312221|2351924|P1|Double-blind Phase|Adverse Event|0
732636|NCT00312221|2351921|P4|Double-blind Phase|Withdrawal by Subject|7
732637|NCT00312221|2351922|P3|Double-blind Phase|Withdrawal by Subject|8
732638|NCT00312221|2351923|P2|Double-blind Phase|Withdrawal by Subject|6
732639|NCT00312221|2351924|P1|Double-blind Phase|Withdrawal by Subject|0
732640|NCT00312221|2351921|P4|Open-label Run-in Period|Did not qualify|0
732641|NCT00312221|2351922|P3|Open-label Run-in Period|Did not qualify|0
732642|NCT00312221|2351923|P2|Open-label Run-in Period|Did not qualify|0
732643|NCT00312221|2351924|P1|Open-label Run-in Period|Did not qualify|5
732644|NCT00312221|2351921|P4|Open-label Run-in Period|Lack of Efficacy|0
732645|NCT00312221|2351922|P3|Open-label Run-in Period|Lack of Efficacy|0
732646|NCT00312221|2351923|P2|Open-label Run-in Period|Lack of Efficacy|0
732647|NCT00312221|2351924|P1|Open-label Run-in Period|Lack of Efficacy|102
732648|NCT00312221|2351921|P4|Open-label Run-in Period|Administrative|0
732649|NCT00312221|2351922|P3|Open-label Run-in Period|Administrative|0
732650|NCT00312221|2351923|P2|Open-label Run-in Period|Administrative|0
732651|NCT00312221|2351924|P1|Open-label Run-in Period|Administrative|42
732652|NCT00312221|2351921|P4|Open-label Run-in Period|Lost to Follow-up|0
732653|NCT00312221|2351922|P3|Open-label Run-in Period|Lost to Follow-up|0
732654|NCT00312221|2351923|P2|Open-label Run-in Period|Lost to Follow-up|0
732655|NCT00312221|2351924|P1|Open-label Run-in Period|Lost to Follow-up|5
732656|NCT00312221|2351921|P4|Open-label Run-in Period|Adverse Event|0
732657|NCT00312221|2351922|P3|Open-label Run-in Period|Adverse Event|0
732658|NCT00312221|2351923|P2|Open-label Run-in Period|Adverse Event|0
732659|NCT00312221|2351924|P1|Open-label Run-in Period|Adverse Event|74
732660|NCT00312221|2351921|P4|Open-label Run-in Period|Withdrawal by Subject|0
732661|NCT00312221|2351922|P3|Open-label Run-in Period|Withdrawal by Subject|0
732662|NCT00312221|2351923|P2|Open-label Run-in Period|Withdrawal by Subject|0
732663|NCT00312221|2351924|P1|Open-label Run-in Period|Withdrawal by Subject|6
732664|NCT00312338|2351944|P2|Overall Study|Subsequent infection|0
732665|NCT00312338|2351945|P1|Overall Study|Subsequent infection|2
732666|NCT00312338|2351944|P2|Overall Study|Withdrawal by Subject|0
732667|NCT00312338|2351945|P1|Overall Study|Withdrawal by Subject|4
732668|NCT00312338|2351944|P2|Overall Study|Lost to Follow-up|1
732669|NCT00312338|2351945|P1|Overall Study|Lost to Follow-up|9
732670|NCT00312338|2351944|P2|Overall Study|Adverse Event|2
732671|NCT00312338|2351945|P1|Overall Study|Adverse Event|7
732672|NCT00312377|2351957|P2|Overall Study|Site ended participation in study|0
732673|NCT00312377|2351958|P1|Overall Study|Site ended participation in study|1
732674|NCT00312377|2351957|P2|Overall Study|Discontinue treatment survival follow up|200
732675|NCT00312377|2351958|P1|Overall Study|Discontinue treatment survival follow up|202
732676|NCT00312377|2351957|P2|Overall Study|Randomised but never received treatment|6
732677|NCT00312377|2351958|P1|Overall Study|Randomised but never received treatment|6
732678|NCT00312377|2351957|P2|Overall Study|Non-compliance|2
732679|NCT00312377|2351958|P1|Overall Study|Non-compliance|0
732680|NCT00312377|2351957|P2|Overall Study|Lost to Follow-up|12
732681|NCT00312377|2351958|P1|Overall Study|Lost to Follow-up|9
732682|NCT00312377|2351957|P2|Overall Study|Withdrawal by Subject|30
732683|NCT00312377|2351958|P1|Overall Study|Withdrawal by Subject|23
732684|NCT00312377|2351957|P2|Overall Study|Death|418
732685|NCT00312377|2351958|P1|Overall Study|Death|403
732686|NCT00312494|2351983|P3|Overall Study|Unspecified|1
732687|NCT00312494|2351984|P2|Overall Study|Unspecified|10
732688|NCT00312494|2351985|P1|Overall Study|Unspecified|10
732689|NCT00312494|2351983|P3|Overall Study|Withdrawal by Subject|10
732690|NCT00312494|2351984|P2|Overall Study|Withdrawal by Subject|9
732691|NCT00312494|2351985|P1|Overall Study|Withdrawal by Subject|6
732692|NCT00312494|2351983|P3|Overall Study|Lost to Follow-up|8
732693|NCT00312494|2351984|P2|Overall Study|Lost to Follow-up|8
732694|NCT00312494|2351985|P1|Overall Study|Lost to Follow-up|8
732695|NCT00312494|2351983|P3|Overall Study|Laboratory abnormality|0
732696|NCT00312494|2351984|P2|Overall Study|Laboratory abnormality|0
732697|NCT00312494|2351985|P1|Overall Study|Laboratory abnormality|1
732698|NCT00312494|2351983|P3|Overall Study|Lack of Efficacy|8
732699|NCT00312494|2351984|P2|Overall Study|Lack of Efficacy|6
732700|NCT00312494|2351985|P1|Overall Study|Lack of Efficacy|4
732701|NCT00312494|2351983|P3|Overall Study|Adverse Event|11
732702|NCT00312494|2351984|P2|Overall Study|Adverse Event|15
732703|NCT00312494|2351985|P1|Overall Study|Adverse Event|33
732704|NCT00312494|2351983|P3|Overall Study|Randomized; not treated with study drug|5
732705|NCT00312494|2351984|P2|Overall Study|Randomized; not treated with study drug|10
732706|NCT00312494|2351985|P1|Overall Study|Randomized; not treated with study drug|9
732707|NCT00312572|2352019|P2|Overall Study|Lack of Efficacy|2
732708|NCT00312572|2352020|P1|Overall Study|Lack of Efficacy|1
732709|NCT00312572|2352019|P2|Overall Study|Administrative|2
732710|NCT00312572|2352020|P1|Overall Study|Administrative|4
732711|NCT00312572|2352019|P2|Overall Study|Lost to Follow-up|1
732712|NCT00312572|2352020|P1|Overall Study|Lost to Follow-up|1
732713|NCT00312572|2352019|P2|Overall Study|Adverse Event|16
732714|NCT00312572|2352020|P1|Overall Study|Adverse Event|10
732715|NCT00312728|2352028|P1|Overall Study|Other|1
732716|NCT00312728|2352028|P1|Overall Study|Other|10
732717|NCT00312728|2352028|P1|Overall Study|Protocol Violation|2
732718|NCT00312728|2352028|P1|Overall Study|Required non-protocol cancer treatment|2
732719|NCT00312728|2352028|P1|Overall Study|Withdrawal by Subject|10
732720|NCT00312728|2352028|P1|Overall Study|Adverse Event|32
732721|NCT00312728|2352028|P1|Overall Study|Progressive disease|53
732722|NCT00312845|2352039|P2|Overall Study|Other|5
732723|NCT00312845|2352040|P1|Overall Study|Other|6
732724|NCT00312845|2352039|P2|Overall Study|Lost to Follow-up|0
732725|NCT00312845|2352040|P1|Overall Study|Lost to Follow-up|2
732726|NCT00312845|2352039|P2|Overall Study|Disease Progression|77
732727|NCT00312845|2352040|P1|Overall Study|Disease Progression|56
732728|NCT00312845|2352039|P2|Overall Study|Withdrawal by Subject|6
732729|NCT00312845|2352040|P1|Overall Study|Withdrawal by Subject|14
732730|NCT00312845|2352039|P2|Overall Study|Death|2
732731|NCT00312845|2352040|P1|Overall Study|Death|2
732732|NCT00312845|2352039|P2|Overall Study|Adverse Event|5
732733|NCT00312845|2352040|P1|Overall Study|Adverse Event|19
732734|NCT00312858|2352050|P2|Overall Study|Unspecified|12
732735|NCT00312858|2352051|P1|Overall Study|Unspecified|9
732736|NCT00312858|2352050|P2|Overall Study|Participant Moved|10
732737|NCT00312858|2352051|P1|Overall Study|Participant Moved|11
732738|NCT00312858|2352050|P2|Overall Study|Withdraw by Participant|20
732739|NCT00312858|2352051|P1|Overall Study|Withdraw by Participant|20
732740|NCT00312858|2352050|P2|Overall Study|Protocol Violation|8
732741|NCT00312858|2352051|P1|Overall Study|Protocol Violation|3
732742|NCT00312858|2352050|P2|Overall Study|Lost to Follow-up|42
732743|NCT00312858|2352051|P1|Overall Study|Lost to Follow-up|25
732744|NCT00312858|2352050|P2|Overall Study|Adverse Event|1
732745|NCT00312858|2352051|P1|Overall Study|Adverse Event|0
732746|NCT00313014|2352132|P3|Overall Study|Lack of Efficacy|16
732747|NCT00313014|2352133|P2|Overall Study|Lack of Efficacy|25
732748|NCT00313014|2352134|P1|Overall Study|Lack of Efficacy|52
732749|NCT00313014|2352132|P3|Overall Study|Administrative|14
732750|NCT00313014|2352133|P2|Overall Study|Administrative|6
732751|NCT00313014|2352134|P1|Overall Study|Administrative|9
732752|NCT00313014|2352132|P3|Overall Study|Lost to Follow-up|10
732753|NCT00313014|2352133|P2|Overall Study|Lost to Follow-up|6
732754|NCT00313014|2352134|P1|Overall Study|Lost to Follow-up|7
732755|NCT00313014|2352132|P3|Overall Study|Adverse Event|16
732756|NCT00313014|2352133|P2|Overall Study|Adverse Event|29
732757|NCT00313014|2352134|P1|Overall Study|Adverse Event|14
732758|NCT00313014|2352132|P3|Overall Study|Withdrawal by Subject|5
732759|NCT00313014|2352133|P2|Overall Study|Withdrawal by Subject|7
732760|NCT00313014|2352134|P1|Overall Study|Withdrawal by Subject|11
732772|NCT00313170|2352239|P3|Overall Study|brain mets. after randomisation|1
732773|NCT00313170|2352240|P2|Overall Study|brain mets. after randomisation|0
732774|NCT00313170|2352241|P1|Overall Study|brain mets. after randomisation|0
732775|NCT00313170|2352239|P3|Overall Study|dosing error|1
732776|NCT00313170|2352240|P2|Overall Study|dosing error|0
732777|NCT00313170|2352241|P1|Overall Study|dosing error|0
732778|NCT00313170|2352239|P3|Overall Study|Clinical progression|0
732779|NCT00313170|2352240|P2|Overall Study|Clinical progression|0
732780|NCT00313170|2352241|P1|Overall Study|Clinical progression|1
732781|NCT00313170|2352239|P3|Overall Study|Lost to Follow-up|1
732782|NCT00313170|2352240|P2|Overall Study|Lost to Follow-up|0
732783|NCT00313170|2352241|P1|Overall Study|Lost to Follow-up|0
732784|NCT00313170|2352239|P3|Overall Study|Incorrect enrollment|1
732785|NCT00313170|2352240|P2|Overall Study|Incorrect enrollment|2
732786|NCT00313170|2352241|P1|Overall Study|Incorrect enrollment|0
732787|NCT00313170|2352239|P3|Overall Study|Withdrawal by Subject|1
732788|NCT00313170|2352240|P2|Overall Study|Withdrawal by Subject|1
732789|NCT00313170|2352241|P1|Overall Study|Withdrawal by Subject|1
732790|NCT00313170|2352239|P3|Overall Study|Disease progression|27
732791|NCT00313170|2352240|P2|Overall Study|Disease progression|26
732792|NCT00313170|2352241|P1|Overall Study|Disease progression|31
732793|NCT00313170|2352239|P3|Overall Study|Adverse Event|0
732794|NCT00313170|2352240|P2|Overall Study|Adverse Event|2
732795|NCT00313170|2352241|P1|Overall Study|Adverse Event|2
732796|NCT00313170|2352239|P3|Overall Study|Death|0
732797|NCT00313170|2352240|P2|Overall Study|Death|4
732798|NCT00313170|2352241|P1|Overall Study|Death|1
732799|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
732800|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
732801|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
732802|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
732803|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
732804|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
732805|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
732806|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
732807|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
732808|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
732809|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase B|Death|0
732810|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase B|Death|0
732811|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase B|Death|0
732812|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase B|Death|0
732813|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase B|Death|1
732814|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
732815|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
732816|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
732817|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
732818|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
732819|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase A|Death|0
732820|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase A|Death|0
732821|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase A|Death|0
732822|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase A|Death|1
732823|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase A|Death|0
732824|NCT00313300|2352279|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
732825|NCT00313300|2352280|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
732826|NCT00313300|2352281|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
732827|NCT00313300|2352282|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
732828|NCT00313300|2352283|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
732829|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|non-specified|0
732830|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|non-specified|0
732831|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|non-specified|0
732832|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|non-specified|0
732833|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|non-specified|1
732834|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
732835|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
732836|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
732837|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
732838|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
732839|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
732840|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
732841|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
732842|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
732843|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
732844|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
732845|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
732846|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
732847|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
732848|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
732849|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
732850|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
732851|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
732852|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
732853|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
732854|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|Death|1
732855|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|Death|0
732856|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|Death|1
732857|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|Death|3
732858|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|Death|5
732859|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
732860|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
732861|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
732862|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
732863|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
732864|NCT00313300|2352279|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
732865|NCT00313300|2352280|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
732866|NCT00313300|2352281|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
732867|NCT00313300|2352282|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
732868|NCT00313300|2352283|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
732869|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
732870|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
732871|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
732872|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
732873|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
732874|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
732875|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
732876|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
732877|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
732878|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
732879|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
732880|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
732881|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
732882|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
732883|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
732884|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
732885|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
732886|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
732887|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
732888|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
732889|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Death|0
732890|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Death|0
732891|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Death|0
732892|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Death|4
732893|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Death|3
732894|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
732895|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
732896|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
732897|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
732898|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
732899|NCT00313300|2352279|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
732900|NCT00313300|2352280|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
732901|NCT00313300|2352281|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
732902|NCT00313300|2352282|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
732903|NCT00313300|2352283|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
732904|NCT00313313|2352336|P3|Overall Study|Subject No Longer Meets Study Criteria|2
732905|NCT00313313|2352337|P2|Overall Study|Subject No Longer Meets Study Criteria|3
732906|NCT00313313|2352338|P1|Overall Study|Subject No Longer Meets Study Criteria|0
732907|NCT00313313|2352336|P3|Overall Study|Death|2
732908|NCT00313313|2352337|P2|Overall Study|Death|0
732909|NCT00313313|2352338|P1|Overall Study|Death|0
732910|NCT00313313|2352336|P3|Overall Study|Pregnancy|0
732911|NCT00313313|2352337|P2|Overall Study|Pregnancy|2
732912|NCT00313313|2352338|P1|Overall Study|Pregnancy|1
732913|NCT00313313|2352336|P3|Overall Study|Poor/Noncompliance|2
732914|NCT00313313|2352337|P2|Overall Study|Poor/Noncompliance|6
732915|NCT00313313|2352338|P1|Overall Study|Poor/Noncompliance|3
732916|NCT00313313|2352336|P3|Overall Study|Physician Decision|4
732917|NCT00313313|2352337|P2|Overall Study|Physician Decision|6
732918|NCT00313313|2352338|P1|Overall Study|Physician Decision|2
732919|NCT00313313|2352336|P3|Overall Study|Adverse Event|12
732920|NCT00313313|2352337|P2|Overall Study|Adverse Event|16
732921|NCT00313313|2352338|P1|Overall Study|Adverse Event|15
732922|NCT00313313|2352336|P3|Overall Study|Lost to Follow-up|9
732923|NCT00313313|2352337|P2|Overall Study|Lost to Follow-up|7
732924|NCT00313313|2352338|P1|Overall Study|Lost to Follow-up|10
732925|NCT00313313|2352336|P3|Overall Study|Withdrawal of consent by subject|31
732926|NCT00313313|2352337|P2|Overall Study|Withdrawal of consent by subject|17
732927|NCT00313313|2352338|P1|Overall Study|Withdrawal of consent by subject|18
732928|NCT00313313|2352336|P3|Overall Study|Lack of Efficacy|20
732929|NCT00313313|2352337|P2|Overall Study|Lack of Efficacy|9
732930|NCT00313313|2352338|P1|Overall Study|Lack of Efficacy|14
732934|NCT00301821|2352368|P1|Overall Study|Cancel|1
732935|NCT00301821|2352368|P1|Overall Study|Ineligible|25
732936|NCT00301834|2352375|P1|Overall Study|Death|1
732940|NCT00302003|2352395|P1|Overall Study|Protocol Violation|1
732941|NCT00302003|2352395|P1|Overall Study|Ineligible|9
732942|NCT00302003|2352395|P1|Overall Study|Withdrawal by Subject|5
732943|NCT00302003|2352395|P1|Overall Study|Physician Decision|2
732944|NCT00302003|2352395|P1|Overall Study|Lost to Follow-up|1
732945|NCT00302003|2352395|P1|Overall Study|Lack of Efficacy|62
732946|NCT00302081|2352454|P3|Overall Study|Other|5
732947|NCT00302081|2352455|P2|Overall Study|Other|6
732948|NCT00302081|2352456|P1|Overall Study|Other|13
732949|NCT00302081|2352454|P3|Overall Study|Death|0
732950|NCT00302081|2352455|P2|Overall Study|Death|1
732951|NCT00302081|2352456|P1|Overall Study|Death|2
732952|NCT00302081|2352454|P3|Overall Study|Lack of Efficacy|5
732953|NCT00302081|2352455|P2|Overall Study|Lack of Efficacy|0
732954|NCT00302081|2352456|P1|Overall Study|Lack of Efficacy|1
732955|NCT00302081|2352454|P3|Overall Study|Protocol Violation|2
732956|NCT00302081|2352455|P2|Overall Study|Protocol Violation|1
732957|NCT00302081|2352456|P1|Overall Study|Protocol Violation|5
732958|NCT00302081|2352454|P3|Overall Study|Withdrawal by Subject|8
732959|NCT00302081|2352455|P2|Overall Study|Withdrawal by Subject|12
732960|NCT00302081|2352456|P1|Overall Study|Withdrawal by Subject|8
732961|NCT00302081|2352454|P3|Overall Study|Lost to Follow-up|28
732962|NCT00302081|2352455|P2|Overall Study|Lost to Follow-up|18
732963|NCT00302081|2352456|P1|Overall Study|Lost to Follow-up|21
732964|NCT00302081|2352454|P3|Overall Study|Adverse Event|4
732965|NCT00302081|2352455|P2|Overall Study|Adverse Event|5
732966|NCT00302081|2352456|P1|Overall Study|Adverse Event|6
732967|NCT00302107|2352466|P2|Overall Study|Adverse Event|0
732968|NCT00302107|2352467|P1|Overall Study|Adverse Event|1
732969|NCT00302107|2352466|P2|Overall Study|Withdrawal by Subject|3
732970|NCT00302107|2352467|P1|Overall Study|Withdrawal by Subject|0
732971|NCT00302107|2352466|P2|Overall Study|Relocation|1
732972|NCT00302107|2352467|P1|Overall Study|Relocation|0
732973|NCT00302107|2352466|P2|Overall Study|Protocol Violation|0
732974|NCT00302107|2352467|P1|Overall Study|Protocol Violation|1
732975|NCT00302107|2352466|P2|Overall Study|Lost to Follow-up|5
732976|NCT00302107|2352467|P1|Overall Study|Lost to Follow-up|6
732977|NCT00302159|2352484|P1|Overall Study|pt started Avastin|1
732978|NCT00302159|2352484|P1|Overall Study|pt declined before treatment started|1
732979|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
732980|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
732981|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
732982|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
732983|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
732984|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
732985|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
732986|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
732987|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
732988|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
732989|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
732990|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
732991|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
732992|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
732993|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
732994|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Death|1
732995|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Death|1
732996|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Death|0
732997|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Death|0
732998|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Death|0
732999|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Disease progression|2
733000|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Disease progression|1
733001|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Disease progression|0
733002|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Disease progression|0
733003|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Disease progression|0
733004|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
733005|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
733006|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
733007|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
733008|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
733009|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Adverse Event|0
733010|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Adverse Event|1
733011|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Adverse Event|0
733012|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Adverse Event|0
733013|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Adverse Event|0
733014|NCT00302211|2352496|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
733015|NCT00302211|2352497|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
733016|NCT00302211|2352498|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
733017|NCT00302211|2352499|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
733018|NCT00302211|2352500|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
733019|NCT00302211|2352496|P5|Double Blind Period (New Patients)|Disease progression|0
733020|NCT00302211|2352497|P4|Double Blind Period (New Patients)|Disease progression|0
733021|NCT00302211|2352498|P3|Double Blind Period (New Patients)|Disease progression|1
733022|NCT00302211|2352499|P2|Double Blind Period (New Patients)|Disease progression|1
733023|NCT00302211|2352500|P1|Double Blind Period (New Patients)|Disease progression|0
733024|NCT00302211|2352496|P5|Double Blind Period (New Patients)|Investigator's judgement|0
733025|NCT00302211|2352497|P4|Double Blind Period (New Patients)|Investigator's judgement|0
733026|NCT00302211|2352498|P3|Double Blind Period (New Patients)|Investigator's judgement|0
733027|NCT00302211|2352499|P2|Double Blind Period (New Patients)|Investigator's judgement|0
733028|NCT00302211|2352500|P1|Double Blind Period (New Patients)|Investigator's judgement|1
733029|NCT00302211|2352496|P5|Double Blind Period (New Patients)|Adverse Event|0
733030|NCT00302211|2352497|P4|Double Blind Period (New Patients)|Adverse Event|0
733031|NCT00302211|2352498|P3|Double Blind Period (New Patients)|Adverse Event|3
733032|NCT00302211|2352499|P2|Double Blind Period (New Patients)|Adverse Event|0
733033|NCT00302211|2352500|P1|Double Blind Period (New Patients)|Adverse Event|0
733034|NCT00302211|2352496|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
733035|NCT00302211|2352497|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
733036|NCT00302211|2352498|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
733037|NCT00302211|2352499|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
733038|NCT00302211|2352500|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
733039|NCT00302328|2352515|P3|Overall Study|Physician Decision|0
733040|NCT00302328|2352516|P2|Overall Study|Physician Decision|1
733041|NCT00302328|2352517|P1|Overall Study|Physician Decision|0
733042|NCT00302458|2352531|P1|Overall Study|Withdrawal by Subject|1
733043|NCT00302458|2352531|P1|Overall Study|Ineligible after screening|1
733044|NCT00302458|2352531|P1|Overall Study|Lost to Follow-up|1
733045|NCT00302718|2352543|P4|Overall Study|Participant left primary care setting|1
733046|NCT00302718|2352544|P3|Overall Study|Participant left primary care setting|2
733047|NCT00302718|2352545|P2|Overall Study|Participant left primary care setting|0
733048|NCT00302718|2352546|P1|Overall Study|Participant left primary care setting|0
733049|NCT00302718|2352543|P4|Overall Study|Withdrawal by Subject|0
733050|NCT00302718|2352544|P3|Overall Study|Withdrawal by Subject|0
733051|NCT00302718|2352545|P2|Overall Study|Withdrawal by Subject|1
733052|NCT00302718|2352546|P1|Overall Study|Withdrawal by Subject|0
733053|NCT00302718|2352543|P4|Overall Study|Participant left the hospital|1
733054|NCT00302718|2352544|P3|Overall Study|Participant left the hospital|0
733055|NCT00302718|2352545|P2|Overall Study|Participant left the hospital|0
733056|NCT00302718|2352546|P1|Overall Study|Participant left the hospital|1
733057|NCT00302952|2352592|P2|Overall Study|Elevated SGOT (AST) lab value|1
733058|NCT00302952|2352593|P1|Overall Study|Elevated SGOT (AST) lab value|0
733059|NCT00302952|2352592|P2|Overall Study|Withdrawal by Subject|3
733060|NCT00302952|2352593|P1|Overall Study|Withdrawal by Subject|2
733061|NCT00302952|2352592|P2|Overall Study|Physician Decision|1
733062|NCT00302952|2352593|P1|Overall Study|Physician Decision|1
733063|NCT00303069|2352631|P4|Overall Study|Recruitment into Army Reserves|0
733064|NCT00303069|2352632|P3|Overall Study|Recruitment into Army Reserves|1
733065|NCT00303069|2352633|P2|Overall Study|Recruitment into Army Reserves|0
733066|NCT00303069|2352634|P1|Overall Study|Recruitment into Army Reserves|0
733067|NCT00303069|2352631|P4|Overall Study|subject moved|0
733068|NCT00303069|2352632|P3|Overall Study|subject moved|0
733069|NCT00303069|2352633|P2|Overall Study|subject moved|0
733070|NCT00303069|2352634|P1|Overall Study|subject moved|1
733071|NCT00303069|2352631|P4|Overall Study|Lost to Follow-up|2
733072|NCT00303069|2352632|P3|Overall Study|Lost to Follow-up|0
733073|NCT00303069|2352633|P2|Overall Study|Lost to Follow-up|0
733074|NCT00303069|2352634|P1|Overall Study|Lost to Follow-up|1
733075|NCT00303108|2352655|P3|Overall Study|ineligible|0
733076|NCT00303108|2352656|P2|Overall Study|ineligible|1
733077|NCT00303108|2352657|P1|Overall Study|ineligible|2
733078|NCT00303108|2352655|P3|Overall Study|Failed Entry|1
733079|NCT00303108|2352656|P2|Overall Study|Failed Entry|0
733080|NCT00303108|2352657|P1|Overall Study|Failed Entry|1
733081|NCT00303108|2352655|P3|Overall Study|Patient Request|8
733082|NCT00303108|2352656|P2|Overall Study|Patient Request|2
733083|NCT00303108|2352657|P1|Overall Study|Patient Request|4
733084|NCT00303108|2352655|P3|Overall Study|Adverse Event|7
733085|NCT00303108|2352656|P2|Overall Study|Adverse Event|6
733086|NCT00303108|2352657|P1|Overall Study|Adverse Event|5
733087|NCT00303186|2352673|P1|Overall Study|Unspecified|52
733088|NCT00303316|2352706|P2|Overall Study|Withdrawal by Subject|2
733089|NCT00303316|2352707|P1|Overall Study|Withdrawal by Subject|1
733090|NCT00303316|2352706|P2|Overall Study|Lost to Follow-up|1
733091|NCT00303316|2352707|P1|Overall Study|Lost to Follow-up|0
733092|NCT00303316|2352706|P2|Overall Study|Protocol Violation|0
733093|NCT00303316|2352707|P1|Overall Study|Protocol Violation|1
733094|NCT00303329|2352721|P2|Overall Study|Stopped at end of extension 1|0
733095|NCT00303329|2352722|P1|Overall Study|Stopped at end of extension 1|1
733096|NCT00303329|2352721|P2|Overall Study|Stopped at end of core|9
733097|NCT00303329|2352722|P1|Overall Study|Stopped at end of core|3
733098|NCT00303329|2352721|P2|Overall Study|Death|12
733099|NCT00303329|2352722|P1|Overall Study|Death|2
733100|NCT00303329|2352721|P2|Overall Study|Administrative problems|0
733101|NCT00303329|2352722|P1|Overall Study|Administrative problems|1
733102|NCT00303329|2352721|P2|Overall Study|Lost to Follow-up|1
733103|NCT00303329|2352722|P1|Overall Study|Lost to Follow-up|0
733104|NCT00303329|2352721|P2|Overall Study|Withdrawal by Subject|15
733105|NCT00303329|2352722|P1|Overall Study|Withdrawal by Subject|9
733106|NCT00303329|2352721|P2|Overall Study|Protocol Violation|0
733107|NCT00303329|2352722|P1|Overall Study|Protocol Violation|3
733108|NCT00303329|2352721|P2|Overall Study|Condition no longer requires study drug|8
733109|NCT00303329|2352722|P1|Overall Study|Condition no longer requires study drug|0
733110|NCT00303329|2352721|P2|Overall Study|Unsatisfactory therapeutic effect|2
733111|NCT00303329|2352722|P1|Overall Study|Unsatisfactory therapeutic effect|9
733112|NCT00303329|2352721|P2|Overall Study|Abnormal Laboratory Values|1
733113|NCT00303329|2352722|P1|Overall Study|Abnormal Laboratory Values|0
733114|NCT00303329|2352721|P2|Overall Study|Adverse Event|14
733115|NCT00303329|2352722|P1|Overall Study|Adverse Event|7
733116|NCT00303446|2352736|P2|Overall Study|Physician Decision|1
733117|NCT00303446|2352737|P1|Overall Study|Physician Decision|0
733118|NCT00303446|2352736|P2|Overall Study|Death|1
733119|NCT00303446|2352737|P1|Overall Study|Death|0
733120|NCT00303446|2352736|P2|Overall Study|Withdrawal by Subject|2
733121|NCT00303446|2352737|P1|Overall Study|Withdrawal by Subject|2
733122|NCT00303459|2352773|P2|Overall Study|Lung transplantation|1
733123|NCT00303459|2352774|P1|Overall Study|Lung transplantation|1
733124|NCT00303459|2352773|P2|Overall Study|Decision by the investigator|7
733125|NCT00303459|2352774|P1|Overall Study|Decision by the investigator|5
733126|NCT00303459|2352773|P2|Overall Study|Administrative reason|7
733127|NCT00303459|2352774|P1|Overall Study|Administrative reason|7
733128|NCT00303459|2352773|P2|Overall Study|Lost to Follow-up|4
733129|NCT00303459|2352774|P1|Overall Study|Lost to Follow-up|5
733130|NCT00303459|2352773|P2|Overall Study|Withdrawal of consent|26
733131|NCT00303459|2352774|P1|Overall Study|Withdrawal of consent|32
733132|NCT00303459|2352773|P2|Overall Study|Death|44
733133|NCT00303459|2352774|P1|Overall Study|Death|33
733134|NCT00303472|2352805|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
733135|NCT00303472|2352806|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
733136|NCT00303472|2352807|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
733137|NCT00303472|2352808|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
733138|NCT00303472|2352809|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
733139|NCT00303472|2352810|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
733140|NCT00303472|2352811|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
733141|NCT00303472|2352805|P7|Treatment Extension (Optional)|Not specified|0
733142|NCT00303472|2352806|P6|Treatment Extension (Optional)|Not specified|0
733143|NCT00303472|2352807|P5|Treatment Extension (Optional)|Not specified|1
733144|NCT00303472|2352808|P4|Treatment Extension (Optional)|Not specified|2
733145|NCT00303472|2352809|P3|Treatment Extension (Optional)|Not specified|4
733146|NCT00303472|2352810|P2|Treatment Extension (Optional)|Not specified|2
733147|NCT00303472|2352811|P1|Treatment Extension (Optional)|Not specified|0
733148|NCT00303472|2352805|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
733149|NCT00303472|2352806|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
733150|NCT00303472|2352807|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
733151|NCT00303472|2352808|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
733152|NCT00303472|2352809|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
733153|NCT00303472|2352810|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
733154|NCT00303472|2352811|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
733155|NCT00303472|2352805|P7|Treatment Extension (Optional)|Physician Decision|0
733156|NCT00303472|2352806|P6|Treatment Extension (Optional)|Physician Decision|0
733157|NCT00303472|2352807|P5|Treatment Extension (Optional)|Physician Decision|2
733158|NCT00303472|2352808|P4|Treatment Extension (Optional)|Physician Decision|3
733159|NCT00303472|2352809|P3|Treatment Extension (Optional)|Physician Decision|2
733160|NCT00303472|2352810|P2|Treatment Extension (Optional)|Physician Decision|4
733161|NCT00303472|2352811|P1|Treatment Extension (Optional)|Physician Decision|0
733162|NCT00303472|2352805|P7|Treatment Extension (Optional)|Lost to Follow-up|0
733163|NCT00303472|2352806|P6|Treatment Extension (Optional)|Lost to Follow-up|0
733164|NCT00303472|2352807|P5|Treatment Extension (Optional)|Lost to Follow-up|0
733165|NCT00303472|2352808|P4|Treatment Extension (Optional)|Lost to Follow-up|1
733166|NCT00303472|2352809|P3|Treatment Extension (Optional)|Lost to Follow-up|0
733167|NCT00303472|2352810|P2|Treatment Extension (Optional)|Lost to Follow-up|0
733168|NCT00303472|2352811|P1|Treatment Extension (Optional)|Lost to Follow-up|0
733169|NCT00303472|2352805|P7|Treatment Extension (Optional)|Death|0
733170|NCT00303472|2352806|P6|Treatment Extension (Optional)|Death|0
733171|NCT00303472|2352807|P5|Treatment Extension (Optional)|Death|0
733172|NCT00303472|2352808|P4|Treatment Extension (Optional)|Death|0
733173|NCT00303472|2352809|P3|Treatment Extension (Optional)|Death|1
733174|NCT00303472|2352810|P2|Treatment Extension (Optional)|Death|0
733175|NCT00303472|2352811|P1|Treatment Extension (Optional)|Death|2
733176|NCT00303472|2352805|P7|Treatment Extension (Optional)|Adverse Event|0
733177|NCT00303472|2352806|P6|Treatment Extension (Optional)|Adverse Event|0
733178|NCT00303472|2352807|P5|Treatment Extension (Optional)|Adverse Event|0
733179|NCT00303472|2352808|P4|Treatment Extension (Optional)|Adverse Event|0
733180|NCT00303472|2352809|P3|Treatment Extension (Optional)|Adverse Event|1
733181|NCT00303472|2352810|P2|Treatment Extension (Optional)|Adverse Event|0
733182|NCT00303472|2352811|P1|Treatment Extension (Optional)|Adverse Event|1
733183|NCT00303472|2352805|P7|Treatment Period|Disease Progression (to AML)|0
733184|NCT00303472|2352806|P6|Treatment Period|Disease Progression (to AML)|0
733185|NCT00303472|2352807|P5|Treatment Period|Disease Progression (to AML)|1
733186|NCT00303472|2352808|P4|Treatment Period|Disease Progression (to AML)|0
733187|NCT00303472|2352809|P3|Treatment Period|Disease Progression (to AML)|0
733188|NCT00303472|2352810|P2|Treatment Period|Disease Progression (to AML)|0
733189|NCT00303472|2352811|P1|Treatment Period|Disease Progression (to AML)|0
733190|NCT00303472|2352805|P7|Treatment Period|Not specified|1
733191|NCT00303472|2352806|P6|Treatment Period|Not specified|0
733192|NCT00303472|2352807|P5|Treatment Period|Not specified|1
733193|NCT00303472|2352808|P4|Treatment Period|Not specified|0
733194|NCT00303472|2352809|P3|Treatment Period|Not specified|0
733195|NCT00303472|2352810|P2|Treatment Period|Not specified|0
733196|NCT00303472|2352811|P1|Treatment Period|Not specified|0
733197|NCT00303472|2352805|P7|Treatment Period|Withdrawal by Subject|0
733198|NCT00303472|2352806|P6|Treatment Period|Withdrawal by Subject|1
733199|NCT00303472|2352807|P5|Treatment Period|Withdrawal by Subject|0
733200|NCT00303472|2352808|P4|Treatment Period|Withdrawal by Subject|1
733201|NCT00303472|2352809|P3|Treatment Period|Withdrawal by Subject|0
733202|NCT00303472|2352810|P2|Treatment Period|Withdrawal by Subject|0
733203|NCT00303472|2352811|P1|Treatment Period|Withdrawal by Subject|0
733204|NCT00303472|2352805|P7|Treatment Period|Death|1
733205|NCT00303472|2352806|P6|Treatment Period|Death|0
733206|NCT00303472|2352807|P5|Treatment Period|Death|0
733207|NCT00303472|2352808|P4|Treatment Period|Death|1
733208|NCT00303472|2352809|P3|Treatment Period|Death|0
733209|NCT00303472|2352810|P2|Treatment Period|Death|0
733210|NCT00303472|2352811|P1|Treatment Period|Death|0
733211|NCT00303472|2352805|P7|Treatment Period|Adverse Event|0
733212|NCT00303472|2352806|P6|Treatment Period|Adverse Event|0
733213|NCT00303472|2352807|P5|Treatment Period|Adverse Event|1
733214|NCT00303472|2352808|P4|Treatment Period|Adverse Event|0
733215|NCT00303472|2352809|P3|Treatment Period|Adverse Event|0
733216|NCT00303472|2352810|P2|Treatment Period|Adverse Event|0
733217|NCT00303472|2352811|P1|Treatment Period|Adverse Event|0
733218|NCT00303485|2352871|P2|Overall Study|Withdrawal by Subject|0
733219|NCT00303485|2352872|P1|Overall Study|Withdrawal by Subject|1
733220|NCT00303485|2352871|P2|Overall Study|Failure to return|1
733221|NCT00303485|2352872|P1|Overall Study|Failure to return|0
733222|NCT00303485|2352871|P2|Overall Study|Adverse Event/Intercurrent Illness|1
733223|NCT00303485|2352872|P1|Overall Study|Adverse Event/Intercurrent Illness|0
733224|NCT00303602|2352902|P2|Overall Study|Protocol Violation|0
733225|NCT00303602|2352903|P1|Overall Study|Protocol Violation|1
733226|NCT00303602|2352902|P2|Overall Study|Noncompliance|2
733227|NCT00303602|2352903|P1|Overall Study|Noncompliance|2
733228|NCT00303602|2352902|P2|Overall Study|Physician Decision|1
733229|NCT00303602|2352903|P1|Overall Study|Physician Decision|2
733230|NCT00303602|2352902|P2|Overall Study|Protocol entry criteria not met|2
733231|NCT00303602|2352903|P1|Overall Study|Protocol entry criteria not met|2
733232|NCT00303602|2352902|P2|Overall Study|Lost to Follow-up|2
733233|NCT00303602|2352903|P1|Overall Study|Lost to Follow-up|5
733234|NCT00303602|2352902|P2|Overall Study|Withdrawal by Subject|6
733235|NCT00303602|2352903|P1|Overall Study|Withdrawal by Subject|5
733236|NCT00303602|2352902|P2|Overall Study|Adverse Event|2
733237|NCT00303602|2352903|P1|Overall Study|Adverse Event|2
733238|NCT00303628|2352945|P2|Overall Study|Other|9
733239|NCT00303628|2352946|P1|Overall Study|Other|8
733240|NCT00303628|2352945|P2|Overall Study|Not start protocol therapy|5
733241|NCT00303628|2352946|P1|Overall Study|Not start protocol therapy|3
733242|NCT00303628|2352945|P2|Overall Study|Other complicating disease|1
733243|NCT00303628|2352946|P1|Overall Study|Other complicating disease|0
733244|NCT00303628|2352945|P2|Overall Study|Alternative therapy|0
733245|NCT00303628|2352946|P1|Overall Study|Alternative therapy|2
733246|NCT00303628|2352945|P2|Overall Study|Withdrawal by Subject|20
733247|NCT00303628|2352946|P1|Overall Study|Withdrawal by Subject|11
733248|NCT00303628|2352945|P2|Overall Study|Death|1
733249|NCT00303628|2352946|P1|Overall Study|Death|0
733250|NCT00303628|2352945|P2|Overall Study|Adverse Event|36
733251|NCT00303628|2352946|P1|Overall Study|Adverse Event|26
733252|NCT00303628|2352945|P2|Overall Study|Disease progression|1
733253|NCT00303628|2352946|P1|Overall Study|Disease progression|0
733254|NCT00303667|2352964|P2|Overall Study|Death|4
733255|NCT00303667|2352965|P1|Overall Study|Death|0
733256|NCT00303953|2353014|P1|Overall Study|Physician Decision|1
733257|NCT00303953|2353014|P1|Overall Study|Lack of Efficacy|12
733258|NCT00303953|2353014|P1|Overall Study|Adverse Event|4
733259|NCT00303953|2353014|P1|Overall Study|Death|1
733260|NCT00303953|2353014|P1|Overall Study|Ineligible|1
733261|NCT00304031|2353047|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
733262|NCT00304031|2353048|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
733263|NCT00304031|2353049|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
733264|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
733265|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
733266|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
733267|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
733268|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
733269|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
733270|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
733271|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
733272|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
733273|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
733274|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
733275|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
733276|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Death|0
733277|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Death|0
733278|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Death|18
733279|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
733280|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
733281|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
733282|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
733283|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
733284|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
733285|NCT00304031|2353047|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
733286|NCT00304031|2353048|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
733287|NCT00304031|2353049|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
733288|NCT00304031|2353047|P3|Registration|Ineligible|0
733289|NCT00304031|2353048|P2|Registration|Ineligible|0
733290|NCT00304031|2353049|P1|Registration|Ineligible|48
733291|NCT00304070|2353059|P3|Overall Study|Progressive Disease|4
733292|NCT00304070|2353060|P2|Overall Study|Progressive Disease|7
733293|NCT00304070|2353061|P1|Overall Study|Progressive Disease|3
733294|NCT00304070|2353059|P3|Overall Study|Withdrawal by Subject|1
733295|NCT00304070|2353060|P2|Overall Study|Withdrawal by Subject|0
733296|NCT00304070|2353061|P1|Overall Study|Withdrawal by Subject|0
733297|NCT00304070|2353059|P3|Overall Study|Physician Decision|3
733298|NCT00304070|2353060|P2|Overall Study|Physician Decision|0
733299|NCT00304070|2353061|P1|Overall Study|Physician Decision|0
733300|NCT00304070|2353059|P3|Overall Study|Lost to Follow-up|1
733301|NCT00304070|2353060|P2|Overall Study|Lost to Follow-up|0
733302|NCT00304070|2353061|P1|Overall Study|Lost to Follow-up|0
733303|NCT00304070|2353059|P3|Overall Study|Death|3
733304|NCT00304070|2353060|P2|Overall Study|Death|0
733305|NCT00304070|2353061|P1|Overall Study|Death|0
733306|NCT00313586|2353096|P4|Overall Study|Death before starting treatment|0
733307|NCT00313586|2353097|P3|Overall Study|Death before starting treatment|0
733308|NCT00313586|2353098|P2|Overall Study|Death before starting treatment|0
733309|NCT00313586|2353099|P1|Overall Study|Death before starting treatment|1
733310|NCT00313586|2353096|P4|Overall Study|Moved|0
733311|NCT00313586|2353097|P3|Overall Study|Moved|0
733312|NCT00313586|2353098|P2|Overall Study|Moved|1
733313|NCT00313586|2353099|P1|Overall Study|Moved|0
733314|NCT00313586|2353096|P4|Overall Study|Lost insurance|0
733315|NCT00313586|2353097|P3|Overall Study|Lost insurance|0
733316|NCT00313586|2353098|P2|Overall Study|Lost insurance|1
733317|NCT00313586|2353099|P1|Overall Study|Lost insurance|0
733318|NCT00313586|2353096|P4|Overall Study|Absolute neutrophil count not recovered|0
733319|NCT00313586|2353097|P3|Overall Study|Absolute neutrophil count not recovered|0
733320|NCT00313586|2353098|P2|Overall Study|Absolute neutrophil count not recovered|1
733321|NCT00313586|2353099|P1|Overall Study|Absolute neutrophil count not recovered|2
733322|NCT00313586|2353096|P4|Overall Study|Physician Decision|0
733323|NCT00313586|2353097|P3|Overall Study|Physician Decision|0
733324|NCT00313586|2353098|P2|Overall Study|Physician Decision|1
733325|NCT00313586|2353099|P1|Overall Study|Physician Decision|2
733326|NCT00313586|2353096|P4|Overall Study|Did not achieve HI-major/better response|1
733327|NCT00313586|2353097|P3|Overall Study|Did not achieve HI-major/better response|2
733328|NCT00313586|2353098|P2|Overall Study|Did not achieve HI-major/better response|7
733329|NCT00313586|2353099|P1|Overall Study|Did not achieve HI-major/better response|10
733330|NCT00313586|2353096|P4|Overall Study|Other complicating disease|0
733331|NCT00313586|2353097|P3|Overall Study|Other complicating disease|0
733332|NCT00313586|2353098|P2|Overall Study|Other complicating disease|2
733333|NCT00313586|2353099|P1|Overall Study|Other complicating disease|2
733334|NCT00313586|2353096|P4|Overall Study|Alternative therapy|0
733335|NCT00313586|2353097|P3|Overall Study|Alternative therapy|2
733336|NCT00313586|2353098|P2|Overall Study|Alternative therapy|6
733337|NCT00313586|2353099|P1|Overall Study|Alternative therapy|3
733338|NCT00313586|2353096|P4|Overall Study|Withdrawal by Subject|2
733339|NCT00313586|2353097|P3|Overall Study|Withdrawal by Subject|6
733340|NCT00313586|2353098|P2|Overall Study|Withdrawal by Subject|6
733341|NCT00313586|2353099|P1|Overall Study|Withdrawal by Subject|13
733342|NCT00313586|2353096|P4|Overall Study|Death|7
733343|NCT00313586|2353097|P3|Overall Study|Death|1
733344|NCT00313586|2353098|P2|Overall Study|Death|8
733345|NCT00313586|2353099|P1|Overall Study|Death|11
733346|NCT00313586|2353096|P4|Overall Study|Adverse Event|10
733347|NCT00313586|2353097|P3|Overall Study|Adverse Event|3
733348|NCT00313586|2353098|P2|Overall Study|Adverse Event|18
733349|NCT00313586|2353099|P1|Overall Study|Adverse Event|12
733350|NCT00313586|2353096|P4|Overall Study|Disease progression|3
733351|NCT00313586|2353097|P3|Overall Study|Disease progression|10
733352|NCT00313586|2353098|P2|Overall Study|Disease progression|19
733353|NCT00313586|2353099|P1|Overall Study|Disease progression|14
733354|NCT00313612|2353109|P2|Overall Study|Patient never received treatment|1
733355|NCT00313612|2353110|P1|Overall Study|Patient never received treatment|0
733356|NCT00313703|2353122|P4|Overall Study|Lost to Follow-up|12
733357|NCT00313703|2353123|P3|Overall Study|Lost to Follow-up|5
733358|NCT00313703|2353124|P2|Overall Study|Lost to Follow-up|2
733359|NCT00313703|2353125|P1|Overall Study|Lost to Follow-up|11
733360|NCT00313716|2353145|P6|Overall Study|Withdrawal by Subject|0
733361|NCT00313716|2353146|P5|Overall Study|Withdrawal by Subject|1
733362|NCT00313716|2353147|P4|Overall Study|Withdrawal by Subject|0
733363|NCT00313716|2353148|P3|Overall Study|Withdrawal by Subject|1
733364|NCT00313716|2353149|P2|Overall Study|Withdrawal by Subject|1
733365|NCT00313716|2353150|P1|Overall Study|Withdrawal by Subject|0
733366|NCT00313716|2353145|P6|Overall Study|Lost to Follow-up|4
733367|NCT00313716|2353146|P5|Overall Study|Lost to Follow-up|0
733368|NCT00313716|2353147|P4|Overall Study|Lost to Follow-up|1
733369|NCT00313716|2353148|P3|Overall Study|Lost to Follow-up|2
733370|NCT00313716|2353149|P2|Overall Study|Lost to Follow-up|5
733371|NCT00313716|2353150|P1|Overall Study|Lost to Follow-up|2
733372|NCT00313716|2353145|P6|Overall Study|Death|9
733373|NCT00313716|2353146|P5|Overall Study|Death|5
733374|NCT00313716|2353147|P4|Overall Study|Death|3
733375|NCT00313716|2353148|P3|Overall Study|Death|9
733376|NCT00313716|2353149|P2|Overall Study|Death|2
733377|NCT00313716|2353150|P1|Overall Study|Death|3
733378|NCT00316888|2353181|P2|Overall Study|Not start protocol therapy|1
733379|NCT00316888|2353182|P1|Overall Study|Not start protocol therapy|0
733380|NCT00316888|2353181|P2|Overall Study|Withdrawal by Subject|2
733381|NCT00316888|2353182|P1|Overall Study|Withdrawal by Subject|2
733382|NCT00316888|2353181|P2|Overall Study|Adverse Event|5
733383|NCT00316888|2353182|P1|Overall Study|Adverse Event|4
733384|NCT00316914|2353198|P2|Overall Study|Missing end of treatment documentation|15
733385|NCT00316914|2353199|P1|Overall Study|Missing end of treatment documentation|14
733386|NCT00316914|2353198|P2|Overall Study|Other Problems|11
733387|NCT00316914|2353199|P1|Overall Study|Other Problems|6
733388|NCT00316914|2353198|P2|Overall Study|Adverse Event|7
733389|NCT00316914|2353199|P1|Overall Study|Adverse Event|8
733390|NCT00316914|2353198|P2|Overall Study|Withdrawal by Subject|3
733391|NCT00316914|2353199|P1|Overall Study|Withdrawal by Subject|5
733392|NCT00317044|2353230|P3|Overall Study|Multiple Reasons|6
733393|NCT00317044|2353231|P2|Overall Study|Multiple Reasons|2
733394|NCT00317044|2353232|P1|Overall Study|Multiple Reasons|6
733395|NCT00317044|2353230|P3|Overall Study|Lost to Follow-up|3
733396|NCT00317044|2353231|P2|Overall Study|Lost to Follow-up|2
733397|NCT00317044|2353232|P1|Overall Study|Lost to Follow-up|0
733398|NCT00317044|2353230|P3|Overall Study|Withdrawal by Subject|12
733399|NCT00317044|2353231|P2|Overall Study|Withdrawal by Subject|7
733400|NCT00317044|2353232|P1|Overall Study|Withdrawal by Subject|10
733401|NCT00317044|2353230|P3|Overall Study|Adverse Event|4
733402|NCT00317044|2353231|P2|Overall Study|Adverse Event|7
733403|NCT00317044|2353232|P1|Overall Study|Adverse Event|4
733404|NCT00317044|2353230|P3|Overall Study|Protocol Violation|20
733405|NCT00317044|2353231|P2|Overall Study|Protocol Violation|22
733406|NCT00317044|2353232|P1|Overall Study|Protocol Violation|28
733407|NCT00317109|2353278|P2|Overall Study|Migated/moved from study area|0
733408|NCT00317109|2353279|P1|Overall Study|Migated/moved from study area|1
733409|NCT00317109|2353278|P2|Overall Study|Withdrawal by Subject|0
733410|NCT00317109|2353279|P1|Overall Study|Withdrawal by Subject|2
733411|NCT00317473|2353332|P6|Overall Study|Other|0
733412|NCT00317473|2353333|P5|Overall Study|Other|0
733413|NCT00317473|2353334|P4|Overall Study|Other|0
733414|NCT00317473|2353335|P3|Overall Study|Other|0
733415|NCT00317473|2353336|P2|Overall Study|Other|2
733416|NCT00317473|2353337|P1|Overall Study|Other|0
733417|NCT00317473|2353332|P6|Overall Study|Death|0
733418|NCT00317473|2353333|P5|Overall Study|Death|0
733419|NCT00317473|2353334|P4|Overall Study|Death|0
733420|NCT00317473|2353335|P3|Overall Study|Death|0
733421|NCT00317473|2353336|P2|Overall Study|Death|0
733422|NCT00317473|2353337|P1|Overall Study|Death|1
733423|NCT00317473|2353332|P6|Overall Study|Relocation|2
733424|NCT00317473|2353333|P5|Overall Study|Relocation|5
733425|NCT00317473|2353334|P4|Overall Study|Relocation|1
733426|NCT00317473|2353335|P3|Overall Study|Relocation|1
733427|NCT00317473|2353336|P2|Overall Study|Relocation|0
733428|NCT00317473|2353337|P1|Overall Study|Relocation|1
733429|NCT00317473|2353332|P6|Overall Study|Withdrawal by Subject|1
733430|NCT00317473|2353333|P5|Overall Study|Withdrawal by Subject|3
733431|NCT00317473|2353334|P4|Overall Study|Withdrawal by Subject|1
733432|NCT00317473|2353335|P3|Overall Study|Withdrawal by Subject|2
733433|NCT00317473|2353336|P2|Overall Study|Withdrawal by Subject|1
733434|NCT00317473|2353337|P1|Overall Study|Withdrawal by Subject|2
733435|NCT00317642|2353363|P2|Overall Study|AML Not Centrally Confirmed|5
733436|NCT00317642|2353364|P1|Overall Study|AML Not Centrally Confirmed|1
733437|NCT00317642|2353363|P2|Overall Study|Referred For Transplantation|0
733438|NCT00317642|2353364|P1|Overall Study|Referred For Transplantation|1
733439|NCT00317642|2353363|P2|Overall Study|Withdrawal by Subject|1
733440|NCT00317642|2353364|P1|Overall Study|Withdrawal by Subject|0
733441|NCT00317642|2353363|P2|Overall Study|Not Continue to Consolidation|0
733442|NCT00317642|2353364|P1|Overall Study|Not Continue to Consolidation|2
733443|NCT00317642|2353363|P2|Overall Study|Death|7
733444|NCT00317642|2353364|P1|Overall Study|Death|14
733445|NCT00317642|2353363|P2|Overall Study|Disease Recurrence|2
733446|NCT00317642|2353364|P1|Overall Study|Disease Recurrence|1
733447|NCT00317642|2353363|P2|Overall Study|Treatment Failure|102
733448|NCT00317642|2353364|P1|Overall Study|Treatment Failure|56
733449|NCT00317642|2353363|P2|Overall Study|Adverse Event|5
733450|NCT00317642|2353364|P1|Overall Study|Adverse Event|17
733451|NCT00317642|2353363|P2|Overall Study|Participant declined treatment|3
733452|NCT00317642|2353364|P1|Overall Study|Participant declined treatment|14
733453|NCT00317642|2353363|P2|Overall Study|Physician Decision|7
733454|NCT00317642|2353364|P1|Overall Study|Physician Decision|15
733455|NCT00317642|2353363|P2|Overall Study|Not Received Either Study Drug|3
733456|NCT00317642|2353364|P1|Overall Study|Not Received Either Study Drug|1
733457|NCT00318370|2353504|P3|Period 3|Other|3
733458|NCT00318370|2353505|P2|Period 3|Other|0
733459|NCT00318370|2353506|P1|Period 3|Other|0
733460|NCT00318370|2353504|P3|Period 3|Withdrawal by Subject|3
733461|NCT00318370|2353505|P2|Period 3|Withdrawal by Subject|0
733462|NCT00318370|2353506|P1|Period 3|Withdrawal by Subject|0
733463|NCT00318370|2353504|P3|Period 3|Physician Decision|1
733464|NCT00318370|2353505|P2|Period 3|Physician Decision|0
733465|NCT00318370|2353506|P1|Period 3|Physician Decision|0
733466|NCT00318370|2353504|P3|Period 3|Death|1
733467|NCT00318370|2353505|P2|Period 3|Death|0
733468|NCT00318370|2353506|P1|Period 3|Death|0
733469|NCT00318370|2353504|P3|Period 3|Lack of Efficacy|24
733470|NCT00318370|2353505|P2|Period 3|Lack of Efficacy|0
733471|NCT00318370|2353506|P1|Period 3|Lack of Efficacy|0
733472|NCT00318370|2353504|P3|Period 3|Adverse Event|1
733473|NCT00318370|2353505|P2|Period 3|Adverse Event|0
733474|NCT00318370|2353506|P1|Period 3|Adverse Event|0
733475|NCT00318370|2353504|P3|Period 2|Other|0
733476|NCT00318370|2353505|P2|Period 2|Other|1
733477|NCT00318370|2353506|P1|Period 2|Other|0
733478|NCT00318370|2353504|P3|Period 2|Withdrawal by Subject|0
733479|NCT00318370|2353505|P2|Period 2|Withdrawal by Subject|1
733480|NCT00318370|2353506|P1|Period 2|Withdrawal by Subject|0
733481|NCT00318370|2353504|P3|Period 2|Physician Decision|0
733482|NCT00318370|2353505|P2|Period 2|Physician Decision|1
733483|NCT00318370|2353506|P1|Period 2|Physician Decision|0
733484|NCT00318370|2353504|P3|Period 2|Lack of Efficacy|0
733485|NCT00318370|2353505|P2|Period 2|Lack of Efficacy|5
733486|NCT00318370|2353506|P1|Period 2|Lack of Efficacy|0
733487|NCT00318370|2353504|P3|Period 2|Adverse Event|0
733488|NCT00318370|2353505|P2|Period 2|Adverse Event|3
733489|NCT00318370|2353506|P1|Period 2|Adverse Event|0
733490|NCT00318370|2353504|P3|Period 1|Withdrawal by Subject|0
733491|NCT00318370|2353505|P2|Period 1|Withdrawal by Subject|0
733492|NCT00318370|2353506|P1|Period 1|Withdrawal by Subject|1
733493|NCT00318370|2353504|P3|Period 1|Physician Decision|0
733494|NCT00318370|2353505|P2|Period 1|Physician Decision|0
733495|NCT00318370|2353506|P1|Period 1|Physician Decision|1
733496|NCT00318370|2353504|P3|Period 1|Lack of Efficacy|0
733497|NCT00318370|2353505|P2|Period 1|Lack of Efficacy|0
733498|NCT00318370|2353506|P1|Period 1|Lack of Efficacy|5
733499|NCT00318461|2353543|P5|Open-Label Extension, 18 Months|Protocol Violation|6
733500|NCT00318461|2353544|P4|Open-Label Extension, 18 Months|Protocol Violation|4
733501|NCT00318461|2353545|P3|Open-Label Extension, 18 Months|Protocol Violation|3
733502|NCT00318461|2353546|P2|Open-Label Extension, 18 Months|Protocol Violation|5
733503|NCT00318461|2353547|P1|Open-Label Extension, 18 Months|Protocol Violation|7
733504|NCT00318461|2353543|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
733505|NCT00318461|2353544|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
733506|NCT00318461|2353545|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
733507|NCT00318461|2353546|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
733508|NCT00318461|2353547|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
733509|NCT00318461|2353543|P5|Open-Label Extension, 18 Months|Adverse Event|6
733510|NCT00318461|2353544|P4|Open-Label Extension, 18 Months|Adverse Event|1
733511|NCT00318461|2353545|P3|Open-Label Extension, 18 Months|Adverse Event|6
733512|NCT00318461|2353546|P2|Open-Label Extension, 18 Months|Adverse Event|8
733513|NCT00318461|2353547|P1|Open-Label Extension, 18 Months|Adverse Event|11
733514|NCT00318461|2353543|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
733515|NCT00318461|2353544|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
733516|NCT00318461|2353545|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
733517|NCT00318461|2353546|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
733518|NCT00318461|2353547|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
733519|NCT00318461|2353543|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
733520|NCT00318461|2353544|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
733521|NCT00318461|2353545|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
733522|NCT00318461|2353546|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
733523|NCT00318461|2353547|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
733524|NCT00318461|2353543|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
733525|NCT00318461|2353544|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
733526|NCT00318461|2353545|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
733527|NCT00318461|2353546|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
733528|NCT00318461|2353547|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
733529|NCT00318461|2353543|P5|Double-Blind, 6 Months|Hyperglicaemia|0
733530|NCT00318461|2353544|P4|Double-Blind, 6 Months|Hyperglicaemia|1
733531|NCT00318461|2353545|P3|Double-Blind, 6 Months|Hyperglicaemia|0
733532|NCT00318461|2353546|P2|Double-Blind, 6 Months|Hyperglicaemia|0
733533|NCT00318461|2353547|P1|Double-Blind, 6 Months|Hyperglicaemia|0
733534|NCT00318461|2353543|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
733535|NCT00318461|2353544|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
733536|NCT00318461|2353545|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
733537|NCT00318461|2353546|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
733538|NCT00318461|2353547|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
733539|NCT00318461|2353543|P5|Double-Blind, 6 Months|Lack of time|0
733540|NCT00318461|2353544|P4|Double-Blind, 6 Months|Lack of time|0
733541|NCT00318461|2353545|P3|Double-Blind, 6 Months|Lack of time|0
733542|NCT00318461|2353546|P2|Double-Blind, 6 Months|Lack of time|0
733543|NCT00318461|2353547|P1|Double-Blind, 6 Months|Lack of time|1
733544|NCT00318461|2353543|P5|Double-Blind, 6 Months|Investigator decision|1
733545|NCT00318461|2353544|P4|Double-Blind, 6 Months|Investigator decision|0
733546|NCT00318461|2353545|P3|Double-Blind, 6 Months|Investigator decision|0
733547|NCT00318461|2353546|P2|Double-Blind, 6 Months|Investigator decision|0
733548|NCT00318461|2353547|P1|Double-Blind, 6 Months|Investigator decision|0
733549|NCT00318461|2353543|P5|Double-Blind, 6 Months|Work commitment|1
733550|NCT00318461|2353544|P4|Double-Blind, 6 Months|Work commitment|0
733551|NCT00318461|2353545|P3|Double-Blind, 6 Months|Work commitment|0
733552|NCT00318461|2353546|P2|Double-Blind, 6 Months|Work commitment|0
733553|NCT00318461|2353547|P1|Double-Blind, 6 Months|Work commitment|0
733554|NCT00318461|2353543|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
733555|NCT00318461|2353544|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
733556|NCT00318461|2353545|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
733557|NCT00318461|2353546|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
733558|NCT00318461|2353547|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
733559|NCT00318461|2353543|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
733560|NCT00318461|2353544|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
733561|NCT00318461|2353545|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
733562|NCT00318461|2353546|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
733563|NCT00318461|2353547|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
733564|NCT00318461|2353543|P5|Double-Blind, 6 Months|Move|0
733565|NCT00318461|2353544|P4|Double-Blind, 6 Months|Move|0
733566|NCT00318461|2353545|P3|Double-Blind, 6 Months|Move|0
733567|NCT00318461|2353546|P2|Double-Blind, 6 Months|Move|1
733568|NCT00318461|2353547|P1|Double-Blind, 6 Months|Move|0
733569|NCT00318461|2353543|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
733570|NCT00318461|2353544|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
733571|NCT00318461|2353545|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
733572|NCT00318461|2353546|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
733573|NCT00318461|2353547|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
733574|NCT00318461|2353543|P5|Double-Blind, 6 Months|Consent withdrawn|4
733575|NCT00318461|2353544|P4|Double-Blind, 6 Months|Consent withdrawn|10
733576|NCT00318461|2353545|P3|Double-Blind, 6 Months|Consent withdrawn|4
733577|NCT00318461|2353546|P2|Double-Blind, 6 Months|Consent withdrawn|3
733578|NCT00318461|2353547|P1|Double-Blind, 6 Months|Consent withdrawn|0
733579|NCT00318461|2353543|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
733580|NCT00318461|2353544|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
733581|NCT00318461|2353545|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
733582|NCT00318461|2353546|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
733583|NCT00318461|2353547|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
733584|NCT00318461|2353543|P5|Double-Blind, 6 Months|Lost to follow up|0
733585|NCT00318461|2353544|P4|Double-Blind, 6 Months|Lost to follow up|0
733586|NCT00318461|2353545|P3|Double-Blind, 6 Months|Lost to follow up|0
733587|NCT00318461|2353546|P2|Double-Blind, 6 Months|Lost to follow up|1
733588|NCT00318461|2353547|P1|Double-Blind, 6 Months|Lost to follow up|0
733589|NCT00318461|2353543|P5|Double-Blind, 6 Months|Protocol Violation|5
733590|NCT00318461|2353544|P4|Double-Blind, 6 Months|Protocol Violation|4
733591|NCT00318461|2353545|P3|Double-Blind, 6 Months|Protocol Violation|4
733592|NCT00318461|2353546|P2|Double-Blind, 6 Months|Protocol Violation|4
733593|NCT00318461|2353547|P1|Double-Blind, 6 Months|Protocol Violation|2
733594|NCT00318461|2353543|P5|Double-Blind, 6 Months|Lack of Efficacy|9
733595|NCT00318461|2353544|P4|Double-Blind, 6 Months|Lack of Efficacy|29
733596|NCT00318461|2353545|P3|Double-Blind, 6 Months|Lack of Efficacy|13
733597|NCT00318461|2353546|P2|Double-Blind, 6 Months|Lack of Efficacy|8
733598|NCT00318461|2353547|P1|Double-Blind, 6 Months|Lack of Efficacy|19
733599|NCT00318461|2353543|P5|Double-Blind, 6 Months|Adverse Event|8
733600|NCT00318461|2353544|P4|Double-Blind, 6 Months|Adverse Event|2
733601|NCT00318461|2353545|P3|Double-Blind, 6 Months|Adverse Event|29
733602|NCT00318461|2353546|P2|Double-Blind, 6 Months|Adverse Event|23
733603|NCT00318461|2353547|P1|Double-Blind, 6 Months|Adverse Event|11
733604|NCT00318474|2353626|P2|Overall Study|Trial terminated|7
733605|NCT00318474|2353627|P1|Overall Study|Trial terminated|10
733606|NCT00318474|2353626|P2|Overall Study|Post-therapy hyperflycemia|1
733607|NCT00318474|2353627|P1|Overall Study|Post-therapy hyperflycemia|0
733608|NCT00318474|2353626|P2|Overall Study|Fall in GFR|3
733609|NCT00318474|2353627|P1|Overall Study|Fall in GFR|3
733610|NCT00318474|2353626|P2|Overall Study|Withdrawal by Subject|2
733611|NCT00318474|2353627|P1|Overall Study|Withdrawal by Subject|3
733612|NCT00318474|2353626|P2|Overall Study|Protocol Violation|0
733613|NCT00318474|2353627|P1|Overall Study|Protocol Violation|1
733614|NCT00318474|2353626|P2|Overall Study|Pregnancy|2
733615|NCT00318474|2353627|P1|Overall Study|Pregnancy|0
733616|NCT00318474|2353626|P2|Overall Study|Lost to Follow-up|1
733617|NCT00318474|2353627|P1|Overall Study|Lost to Follow-up|0
733618|NCT00318474|2353626|P2|Overall Study|Adverse Event|1
733619|NCT00318474|2353627|P1|Overall Study|Adverse Event|1
733620|NCT00318565|2353633|P1|Overall Study|Excluded per protocol|24
733621|NCT00318656|2353661|P2|Overall Study|Did not receive any treatment|1
733622|NCT00318656|2353662|P1|Overall Study|Did not receive any treatment|0
733623|NCT00318656|2353661|P2|Overall Study|Took Avandamet instead of Glim/Met|1
733624|NCT00318656|2353662|P1|Overall Study|Took Avandamet instead of Glim/Met|0
733625|NCT00319020|2353726|P2|Overall Study|Adverse Event|1
733626|NCT00319020|2353727|P1|Overall Study|Adverse Event|0
733627|NCT00319020|2353726|P2|Overall Study|Treatment failure|1
733628|NCT00319020|2353727|P1|Overall Study|Treatment failure|0
733629|NCT00319020|2353726|P2|Overall Study|Transplant|1
733630|NCT00319020|2353727|P1|Overall Study|Transplant|0
733631|NCT00319020|2353726|P2|Overall Study|Disease progression|2
733632|NCT00319020|2353727|P1|Overall Study|Disease progression|0
733633|NCT00319020|2353726|P2|Overall Study|Administrative reason|5
733634|NCT00319020|2353727|P1|Overall Study|Administrative reason|0
733635|NCT00319020|2353726|P2|Overall Study|F-1 completed but not enrolled in F-2|0
733636|NCT00319020|2353727|P1|Overall Study|F-1 completed but not enrolled in F-2|1
733637|NCT00319020|2353726|P2|Overall Study|Withdrawal by Subject|1
733638|NCT00319020|2353727|P1|Overall Study|Withdrawal by Subject|4
733639|NCT00319020|2353726|P2|Overall Study|Death|2
733640|NCT00319020|2353727|P1|Overall Study|Death|2
733641|NCT00319046|2353756|P1|Overall Study|administrative reason|1
733642|NCT00319046|2353756|P1|Overall Study|withdrawal of subject's consent|7
733643|NCT00319098|2353767|P2|Overall Study|Protocol Violation|1
733644|NCT00319098|2353768|P1|Overall Study|Protocol Violation|3
733645|NCT00319098|2353767|P2|Overall Study|Others|8
733646|NCT00319098|2353768|P1|Overall Study|Others|33
733647|NCT00319098|2353767|P2|Overall Study|Lost to Follow-up|13
733648|NCT00319098|2353768|P1|Overall Study|Lost to Follow-up|37
733649|NCT00319098|2353767|P2|Overall Study|Migrated/moved from study area|1
733650|NCT00319098|2353768|P1|Overall Study|Migrated/moved from study area|2
733651|NCT00319098|2353767|P2|Overall Study|Withdrawal by Subject|8
733652|NCT00319098|2353768|P1|Overall Study|Withdrawal by Subject|37
733653|NCT00319098|2353767|P2|Overall Study|Adverse Event|1
733654|NCT00319098|2353768|P1|Overall Study|Adverse Event|20
733655|NCT00319098|2353767|P2|Overall Study|Serious adverse event|0
733656|NCT00319098|2353768|P1|Overall Study|Serious adverse event|3
733657|NCT00319111|2353826|P1|Overall Study|Treatment failure|1
733658|NCT00319111|2353826|P1|Overall Study|Administrative|2
733659|NCT00319111|2353826|P1|Overall Study|Lack of clinical improvement|4
733660|NCT00319111|2353826|P1|Overall Study|Death|9
733661|NCT00319111|2353826|P1|Overall Study|Withdrawal of consent|11
733662|NCT00319111|2353826|P1|Overall Study|Adverse Event|20
733663|NCT00319254|2353836|P1|Overall Study|Enrolled, Not Treated|2
733664|NCT00319254|2353836|P1|Overall Study|Lost to Follow-up|2
733665|NCT00319254|2353836|P1|Overall Study|Death|46
733666|NCT00319254|2353836|P1|Overall Study|Withdrawal by Subject|4
733667|NCT00301080|2353849|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
733668|NCT00301080|2353850|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
733669|NCT00301080|2353851|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
733670|NCT00301080|2353852|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
733671|NCT00301080|2353853|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
733672|NCT00301262|2353884|P2|Open Label Phase (OL)|Other|0
733673|NCT00301262|2353885|P1|Open Label Phase (OL)|Other|2
733674|NCT00301262|2353884|P2|Open Label Phase (OL)|Lost to Follow-up|2
733675|NCT00301262|2353885|P1|Open Label Phase (OL)|Lost to Follow-up|1
733676|NCT00301262|2353884|P2|Open Label Phase (OL)|Adverse Event|0
733677|NCT00301262|2353885|P1|Open Label Phase (OL)|Adverse Event|1
733678|NCT00301262|2353884|P2|Double Blind Phase (DB)|Other|4
733679|NCT00301262|2353885|P1|Double Blind Phase (DB)|Other|1
733680|NCT00301262|2353884|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
733681|NCT00301262|2353885|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
733682|NCT00301262|2353884|P2|Double Blind Phase (DB)|Lost to Follow-up|3
733683|NCT00301262|2353885|P1|Double Blind Phase (DB)|Lost to Follow-up|3
733684|NCT00301262|2353884|P2|Double Blind Phase (DB)|Lack of Efficacy|1
733685|NCT00301262|2353885|P1|Double Blind Phase (DB)|Lack of Efficacy|0
733686|NCT00301262|2353884|P2|Double Blind Phase (DB)|Adverse Event|0
733687|NCT00301262|2353885|P1|Double Blind Phase (DB)|Adverse Event|1
733688|NCT00301366|2354043|P1|Overall Study|Adverse Event|1
733689|NCT00307034|2354055|P2|Overall Study|Lost to Follow-up|3
733690|NCT00307034|2354056|P1|Overall Study|Lost to Follow-up|0
733691|NCT00307034|2354055|P2|Overall Study|Withdrawal by Subject|2
733692|NCT00307034|2354056|P1|Overall Study|Withdrawal by Subject|1
733693|NCT00307034|2354055|P2|Overall Study|Adverse Event|2
733694|NCT00307034|2354056|P1|Overall Study|Adverse Event|1
733695|NCT00307047|2354096|P2|Overall Study|All death, all MI, all Revascularization|16
733696|NCT00307047|2354097|P1|Overall Study|All death, all MI, all Revascularization|27
733697|NCT00307047|2354096|P2|Overall Study|Lost to follow-up for other reasons|1
733698|NCT00307047|2354097|P1|Overall Study|Lost to follow-up for other reasons|0
733699|NCT00307047|2354096|P2|Overall Study|Physician Decision|2
733700|NCT00307047|2354097|P1|Overall Study|Physician Decision|1
733701|NCT00307047|2354096|P2|Overall Study|Withdrawal by Subject|6
733702|NCT00307047|2354097|P1|Overall Study|Withdrawal by Subject|6
733703|NCT00307047|2354096|P2|Overall Study|Lost to Follow-up|24
733704|NCT00307047|2354097|P1|Overall Study|Lost to Follow-up|35
733705|NCT00307086|2354233|P1|Overall Study|ineligible|5
733706|NCT00307125|2354239|P3|Pilot Phase|Withdrawal by Subject|1
733707|NCT00307125|2354240|P2|Pilot Phase|Withdrawal by Subject|1
733708|NCT00307125|2354241|P1|Pilot Phase|Withdrawal by Subject|0
733709|NCT00307125|2354239|P3|Pilot Phase|Lost to Follow-up|0
733710|NCT00307125|2354240|P2|Pilot Phase|Lost to Follow-up|1
733711|NCT00307125|2354241|P1|Pilot Phase|Lost to Follow-up|0
733712|NCT00307125|2354239|P3|Screening Phase|Coronary artery bypass|0
733713|NCT00307125|2354240|P2|Screening Phase|Coronary artery bypass|0
733714|NCT00307125|2354241|P1|Screening Phase|Coronary artery bypass|1
733715|NCT00307125|2354239|P3|Screening Phase|AMR and treated with rituximab|0
733716|NCT00307125|2354240|P2|Screening Phase|AMR and treated with rituximab|0
733717|NCT00307125|2354241|P1|Screening Phase|AMR and treated with rituximab|1
733718|NCT00307125|2354239|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
733719|NCT00307125|2354240|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
733720|NCT00307125|2354241|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
733721|NCT00307125|2354239|P3|Screening Phase|Screen Error|0
733722|NCT00307125|2354240|P2|Screening Phase|Screen Error|0
733723|NCT00307125|2354241|P1|Screening Phase|Screen Error|1
733724|NCT00307125|2354239|P3|Screening Phase|Ineligible|0
733725|NCT00307125|2354240|P2|Screening Phase|Ineligible|0
733726|NCT00307125|2354241|P1|Screening Phase|Ineligible|1
733727|NCT00307125|2354239|P3|Screening Phase|PAK|0
733728|NCT00307125|2354240|P2|Screening Phase|PAK|0
733729|NCT00307125|2354241|P1|Screening Phase|PAK|1
733730|NCT00307125|2354239|P3|Screening Phase|Malignancy|0
733731|NCT00307125|2354240|P2|Screening Phase|Malignancy|0
733732|NCT00307125|2354241|P1|Screening Phase|Malignancy|1
733733|NCT00307125|2354239|P3|Screening Phase|Metastatic colon cancer|0
733734|NCT00307125|2354240|P2|Screening Phase|Metastatic colon cancer|0
733735|NCT00307125|2354241|P1|Screening Phase|Metastatic colon cancer|1
733736|NCT00307125|2354239|P3|Screening Phase|Developed acute leukemia|0
733737|NCT00307125|2354240|P2|Screening Phase|Developed acute leukemia|0
733738|NCT00307125|2354241|P1|Screening Phase|Developed acute leukemia|1
733739|NCT00307125|2354239|P3|Screening Phase|Try to get pregnant|0
733740|NCT00307125|2354240|P2|Screening Phase|Try to get pregnant|0
733741|NCT00307125|2354241|P1|Screening Phase|Try to get pregnant|1
733742|NCT00307125|2354239|P3|Screening Phase|Ineligible for pilot|0
733743|NCT00307125|2354240|P2|Screening Phase|Ineligible for pilot|0
733744|NCT00307125|2354241|P1|Screening Phase|Ineligible for pilot|4
733745|NCT00307125|2354239|P3|Screening Phase|Received Pancreas Transplant|0
733746|NCT00307125|2354240|P2|Screening Phase|Received Pancreas Transplant|0
733747|NCT00307125|2354241|P1|Screening Phase|Received Pancreas Transplant|8
733748|NCT00307125|2354239|P3|Screening Phase|Moved or transferred facilities|0
733749|NCT00307125|2354240|P2|Screening Phase|Moved or transferred facilities|0
733750|NCT00307125|2354241|P1|Screening Phase|Moved or transferred facilities|34
733751|NCT00307125|2354239|P3|Screening Phase|Scheduling issues/Non-compliance|0
733752|NCT00307125|2354240|P2|Screening Phase|Scheduling issues/Non-compliance|0
733753|NCT00307125|2354241|P1|Screening Phase|Scheduling issues/Non-compliance|55
733754|NCT00307125|2354239|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
733755|NCT00307125|2354240|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
733756|NCT00307125|2354241|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
733757|NCT00307125|2354239|P3|Screening Phase|Graft Failure|0
733758|NCT00307125|2354240|P2|Screening Phase|Graft Failure|0
733759|NCT00307125|2354241|P1|Screening Phase|Graft Failure|8
733760|NCT00307125|2354239|P3|Screening Phase|Graft Loss|0
733761|NCT00307125|2354240|P2|Screening Phase|Graft Loss|0
733762|NCT00307125|2354241|P1|Screening Phase|Graft Loss|3
733763|NCT00307125|2354239|P3|Screening Phase|Study Terminated|0
733764|NCT00307125|2354240|P2|Screening Phase|Study Terminated|0
733765|NCT00307125|2354241|P1|Screening Phase|Study Terminated|17
733766|NCT00307125|2354239|P3|Screening Phase|Sponsor Decision|0
733767|NCT00307125|2354240|P2|Screening Phase|Sponsor Decision|0
733768|NCT00307125|2354241|P1|Screening Phase|Sponsor Decision|4
733769|NCT00307125|2354239|P3|Screening Phase|Physician Decision|0
733770|NCT00307125|2354240|P2|Screening Phase|Physician Decision|0
733771|NCT00307125|2354241|P1|Screening Phase|Physician Decision|26
733772|NCT00307125|2354239|P3|Screening Phase|Withdrawal by Subject|0
733773|NCT00307125|2354240|P2|Screening Phase|Withdrawal by Subject|0
733774|NCT00307125|2354241|P1|Screening Phase|Withdrawal by Subject|77
733775|NCT00307125|2354239|P3|Screening Phase|Death|0
733776|NCT00307125|2354240|P2|Screening Phase|Death|0
733777|NCT00307125|2354241|P1|Screening Phase|Death|10
733778|NCT00307125|2354239|P3|Screening Phase|Lost to Follow-up|0
733779|NCT00307125|2354240|P2|Screening Phase|Lost to Follow-up|0
733780|NCT00307125|2354241|P1|Screening Phase|Lost to Follow-up|87
733781|NCT00307125|2354239|P3|Screening Phase|Protocol Violation|0
733782|NCT00307125|2354240|P2|Screening Phase|Protocol Violation|0
733783|NCT00307125|2354241|P1|Screening Phase|Protocol Violation|27
733784|NCT00307125|2354239|P3|Screening Phase|Adverse Event|0
733785|NCT00307125|2354240|P2|Screening Phase|Adverse Event|0
733786|NCT00307125|2354241|P1|Screening Phase|Adverse Event|1
733787|NCT00307151|2354267|P4|Overall Study|Clinic unable to contact subject|1
733788|NCT00307151|2354268|P3|Overall Study|Clinic unable to contact subject|1
733789|NCT00307151|2354269|P2|Overall Study|Clinic unable to contact subject|3
733790|NCT00307151|2354270|P1|Overall Study|Clinic unable to contact subject|3
733791|NCT00307151|2354267|P4|Overall Study|Not willing to adhere to study reqs|2
733792|NCT00307151|2354268|P3|Overall Study|Not willing to adhere to study reqs|2
733793|NCT00307151|2354269|P2|Overall Study|Not willing to adhere to study reqs|0
733794|NCT00307151|2354270|P1|Overall Study|Not willing to adhere to study reqs|2
733795|NCT00307151|2354267|P4|Overall Study|Withdrew consent|3
733796|NCT00307151|2354268|P3|Overall Study|Withdrew consent|1
733797|NCT00307151|2354269|P2|Overall Study|Withdrew consent|1
733798|NCT00307151|2354270|P1|Overall Study|Withdrew consent|0
733799|NCT00307151|2354267|P4|Overall Study|Subject unable to get to clinic|2
733800|NCT00307151|2354268|P3|Overall Study|Subject unable to get to clinic|6
733801|NCT00307151|2354269|P2|Overall Study|Subject unable to get to clinic|0
733802|NCT00307151|2354270|P1|Overall Study|Subject unable to get to clinic|1
733803|NCT00307151|2354267|P4|Overall Study|Severe debilitation, unable to continue|0
733804|NCT00307151|2354268|P3|Overall Study|Severe debilitation, unable to continue|0
733805|NCT00307151|2354269|P2|Overall Study|Severe debilitation, unable to continue|0
733806|NCT00307151|2354270|P1|Overall Study|Severe debilitation, unable to continue|1
733807|NCT00307151|2354267|P4|Overall Study|Death|3
733808|NCT00307151|2354268|P3|Overall Study|Death|10
733809|NCT00307151|2354269|P2|Overall Study|Death|3
733810|NCT00307151|2354270|P1|Overall Study|Death|4
733811|NCT00307164|2354314|P2|Overall Study|Lost to Follow-up|1
733812|NCT00307164|2354315|P1|Overall Study|Lost to Follow-up|6
733813|NCT00307164|2354314|P2|Overall Study|Not compliant with requirements|4
733814|NCT00307164|2354315|P1|Overall Study|Not compliant with requirements|4
733815|NCT00307164|2354314|P2|Overall Study|Withdrawal by Subject|8
733816|NCT00307164|2354315|P1|Overall Study|Withdrawal by Subject|1
733817|NCT00307164|2354314|P2|Overall Study|Subject/parent not able to get to clinic|1
733818|NCT00307164|2354315|P1|Overall Study|Subject/parent not able to get to clinic|2
733819|NCT00307164|2354314|P2|Overall Study|Severe debilitation, unable to continue|0
733820|NCT00307164|2354315|P1|Overall Study|Severe debilitation, unable to continue|1
733821|NCT00307164|2354314|P2|Overall Study|Death|0
733822|NCT00307164|2354315|P1|Overall Study|Death|1
733823|NCT00308555|2354362|P2|Overall Study|Physician Decision|0
733824|NCT00308555|2354363|P1|Overall Study|Physician Decision|2
733825|NCT00308555|2354362|P2|Overall Study|Withdrawal by Subject|0
733826|NCT00308555|2354363|P1|Overall Study|Withdrawal by Subject|1
733827|NCT00308581|2354369|P3|Randomized Maintenance Phase|Unknown reason|0
733828|NCT00308581|2354370|P2|Randomized Maintenance Phase|Unknown reason|0
733829|NCT00308581|2354371|P1|Randomized Maintenance Phase|Unknown reason|3
733830|NCT00308581|2354369|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
733831|NCT00308581|2354370|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
733832|NCT00308581|2354371|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
733833|NCT00308581|2354369|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
733834|NCT00308581|2354370|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
733835|NCT00308581|2354371|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
733836|NCT00308581|2354369|P3|Randomized Maintenance Phase|Lost to Follow-up|0
733837|NCT00308581|2354370|P2|Randomized Maintenance Phase|Lost to Follow-up|2
733838|NCT00308581|2354371|P1|Randomized Maintenance Phase|Lost to Follow-up|0
733839|NCT00308581|2354369|P3|Randomized Maintenance Phase|Lack of Efficacy|0
733840|NCT00308581|2354370|P2|Randomized Maintenance Phase|Lack of Efficacy|21
733841|NCT00308581|2354371|P1|Randomized Maintenance Phase|Lack of Efficacy|9
733842|NCT00308581|2354369|P3|Randomized Maintenance Phase|Adverse Event|0
733843|NCT00308581|2354370|P2|Randomized Maintenance Phase|Adverse Event|17
733844|NCT00308581|2354371|P1|Randomized Maintenance Phase|Adverse Event|10
733845|NCT00308581|2354369|P3|Induction Phase|Unknown reason|3
733846|NCT00308581|2354370|P2|Induction Phase|Unknown reason|0
733847|NCT00308581|2354371|P1|Induction Phase|Unknown reason|0
733848|NCT00308581|2354369|P3|Induction Phase|Withdrawal by Subject|5
733849|NCT00308581|2354370|P2|Induction Phase|Withdrawal by Subject|0
733850|NCT00308581|2354371|P1|Induction Phase|Withdrawal by Subject|0
733851|NCT00308581|2354369|P3|Induction Phase|Lack of Efficacy|121
733852|NCT00308581|2354370|P2|Induction Phase|Lack of Efficacy|0
733853|NCT00308581|2354371|P1|Induction Phase|Lack of Efficacy|0
733854|NCT00308581|2354369|P3|Induction Phase|Adverse Event|37
733855|NCT00308581|2354370|P2|Induction Phase|Adverse Event|0
733856|NCT00308581|2354371|P1|Induction Phase|Adverse Event|0
733857|NCT00308620|2354498|P3|Overall Study|Lost to Follow-up|1
733858|NCT00308620|2354499|P2|Overall Study|Lost to Follow-up|0
733859|NCT00308620|2354500|P1|Overall Study|Lost to Follow-up|0
733860|NCT00308620|2354498|P3|Overall Study|Death|0
733861|NCT00308620|2354499|P2|Overall Study|Death|1
733862|NCT00308620|2354500|P1|Overall Study|Death|1
733863|NCT00308711|2354512|P3|Overall Study|Subject incarcerated, data not allowed|1
733864|NCT00308711|2354513|P2|Overall Study|Subject incarcerated, data not allowed|0
733865|NCT00308711|2354514|P1|Overall Study|Subject incarcerated, data not allowed|0
733866|NCT00308711|2354512|P3|Overall Study|Baby not born within 7 days of treatment|2
733867|NCT00308711|2354513|P2|Overall Study|Baby not born within 7 days of treatment|2
733868|NCT00308711|2354514|P1|Overall Study|Baby not born within 7 days of treatment|1
733869|NCT00308711|2354512|P3|Overall Study|Lost to Follow-up|0
733870|NCT00308711|2354513|P2|Overall Study|Lost to Follow-up|1
733871|NCT00308711|2354514|P1|Overall Study|Lost to Follow-up|0
733872|NCT00308711|2354512|P3|Overall Study|Protocol Violation|1
733873|NCT00308711|2354513|P2|Overall Study|Protocol Violation|1
733874|NCT00308711|2354514|P1|Overall Study|Protocol Violation|0
733875|NCT00308711|2354512|P3|Overall Study|Withdrawal by Subject|1
733876|NCT00308711|2354513|P2|Overall Study|Withdrawal by Subject|0
733877|NCT00308711|2354514|P1|Overall Study|Withdrawal by Subject|1
733878|NCT00308737|2354549|P3|Overall Study|Various|8
733879|NCT00308737|2354550|P2|Overall Study|Various|20
733880|NCT00308737|2354551|P1|Overall Study|Various|32
733881|NCT00308737|2354549|P3|Overall Study|Withdrawal by Subject|18
733882|NCT00308737|2354550|P2|Overall Study|Withdrawal by Subject|166
733883|NCT00308737|2354551|P1|Overall Study|Withdrawal by Subject|218
733884|NCT00308737|2354549|P3|Overall Study|Protocol Violation|5
733885|NCT00308737|2354550|P2|Overall Study|Protocol Violation|9
733886|NCT00308737|2354551|P1|Overall Study|Protocol Violation|34
733887|NCT00308737|2354549|P3|Overall Study|Physician Decision|1
733888|NCT00308737|2354550|P2|Overall Study|Physician Decision|2
733889|NCT00308737|2354551|P1|Overall Study|Physician Decision|15
733890|NCT00308737|2354549|P3|Overall Study|Lost to Follow-up|5
733891|NCT00308737|2354550|P2|Overall Study|Lost to Follow-up|80
733892|NCT00308737|2354551|P1|Overall Study|Lost to Follow-up|56
733893|NCT00308737|2354549|P3|Overall Study|Death|0
733894|NCT00308737|2354550|P2|Overall Study|Death|3
733895|NCT00308737|2354551|P1|Overall Study|Death|4
733896|NCT00308737|2354549|P3|Overall Study|Adverse Event|0
733897|NCT00308737|2354550|P2|Overall Study|Adverse Event|9
733898|NCT00308737|2354551|P1|Overall Study|Adverse Event|104
733899|NCT00308997|2354590|P2|Overall Study|Unable to tolerate intervention|0
733900|NCT00308997|2354591|P1|Overall Study|Unable to tolerate intervention|1
733901|NCT00308997|2354590|P2|Overall Study|Subject feigned clinical data|1
733902|NCT00308997|2354591|P1|Overall Study|Subject feigned clinical data|0
733903|NCT00309244|2354609|P2|Overall Study|Death|1
733904|NCT00309244|2354610|P1|Overall Study|Death|4
733905|NCT00309244|2354609|P2|Overall Study|Randomized but not dosed|12
733906|NCT00309244|2354610|P1|Overall Study|Randomized but not dosed|11
733907|NCT00309244|2354609|P2|Overall Study|Various|7
733908|NCT00309244|2354610|P1|Overall Study|Various|7
733909|NCT00309244|2354609|P2|Overall Study|Withdrawal by Subject|32
733910|NCT00309244|2354610|P1|Overall Study|Withdrawal by Subject|50
733911|NCT00309244|2354609|P2|Overall Study|Protocol Violation|3
733912|NCT00309244|2354610|P1|Overall Study|Protocol Violation|6
733913|NCT00309244|2354609|P2|Overall Study|Physician Decision|8
733914|NCT00309244|2354610|P1|Overall Study|Physician Decision|5
733915|NCT00309244|2354609|P2|Overall Study|Lost to Follow-up|22
733916|NCT00309244|2354610|P1|Overall Study|Lost to Follow-up|6
733917|NCT00309244|2354609|P2|Overall Study|Adverse Event|12
733918|NCT00309244|2354610|P1|Overall Study|Adverse Event|29
733919|NCT00309387|2354632|P2|Overall Study|Lost to Follow-up|86
733920|NCT00309387|2354633|P1|Overall Study|Lost to Follow-up|70
733921|NCT00309387|2354632|P2|Overall Study|Death|73
733922|NCT00309387|2354633|P1|Overall Study|Death|72
733923|NCT00309452|2354651|P2|Overall Study|Withdrawal by Subject|0
733924|NCT00309452|2354652|P1|Overall Study|Withdrawal by Subject|3
733925|NCT00309608|2354708|P5|Overall Study|Other incl. Lack of efficacy|0
733926|NCT00309608|2354709|P4|Overall Study|Other incl. Lack of efficacy|4
733927|NCT00309608|2354710|P3|Overall Study|Other incl. Lack of efficacy|3
733928|NCT00309608|2354711|P2|Overall Study|Other incl. Lack of efficacy|4
733929|NCT00309608|2354712|P1|Overall Study|Other incl. Lack of efficacy|10
733930|NCT00309608|2354708|P5|Overall Study|Withdrawal by Subject|0
733931|NCT00309608|2354709|P4|Overall Study|Withdrawal by Subject|0
733932|NCT00309608|2354710|P3|Overall Study|Withdrawal by Subject|2
733933|NCT00309608|2354711|P2|Overall Study|Withdrawal by Subject|4
733934|NCT00309608|2354712|P1|Overall Study|Withdrawal by Subject|1
733935|NCT00309608|2354708|P5|Overall Study|Lost to Follow-up|1
733936|NCT00309608|2354709|P4|Overall Study|Lost to Follow-up|0
733937|NCT00309608|2354710|P3|Overall Study|Lost to Follow-up|2
733938|NCT00309608|2354711|P2|Overall Study|Lost to Follow-up|0
733939|NCT00309608|2354712|P1|Overall Study|Lost to Follow-up|0
733940|NCT00309608|2354708|P5|Overall Study|Protocol Violation|0
733941|NCT00309608|2354709|P4|Overall Study|Protocol Violation|0
733942|NCT00309608|2354710|P3|Overall Study|Protocol Violation|0
733943|NCT00309608|2354711|P2|Overall Study|Protocol Violation|0
733944|NCT00309608|2354712|P1|Overall Study|Protocol Violation|2
733945|NCT00309608|2354708|P5|Overall Study|Adverse Event|3
733946|NCT00309608|2354709|P4|Overall Study|Adverse Event|2
733947|NCT00309608|2354710|P3|Overall Study|Adverse Event|3
733948|NCT00309608|2354711|P2|Overall Study|Adverse Event|5
733949|NCT00309608|2354712|P1|Overall Study|Adverse Event|1
733950|NCT00309777|2354759|P4|Overall Study|Death|0
733951|NCT00309777|2354760|P3|Overall Study|Death|0
733952|NCT00309777|2354761|P2|Overall Study|Death|1
733953|NCT00309777|2354762|P1|Overall Study|Death|0
733954|NCT00309777|2354759|P4|Overall Study|Lost to Follow-up|0
733955|NCT00309777|2354760|P3|Overall Study|Lost to Follow-up|1
733956|NCT00309777|2354761|P2|Overall Study|Lost to Follow-up|0
733957|NCT00309777|2354762|P1|Overall Study|Lost to Follow-up|0
733958|NCT00309777|2354759|P4|Overall Study|Withdrawal by Subject|2
733959|NCT00309777|2354760|P3|Overall Study|Withdrawal by Subject|7
733960|NCT00309777|2354761|P2|Overall Study|Withdrawal by Subject|5
733961|NCT00309777|2354762|P1|Overall Study|Withdrawal by Subject|6
733962|NCT00309777|2354759|P4|Overall Study|Protocol Violation|1
733963|NCT00309777|2354760|P3|Overall Study|Protocol Violation|3
733964|NCT00309777|2354761|P2|Overall Study|Protocol Violation|1
733965|NCT00309777|2354762|P1|Overall Study|Protocol Violation|4
733966|NCT00309777|2354759|P4|Overall Study|Adverse Event|1
733967|NCT00309777|2354760|P3|Overall Study|Adverse Event|8
733968|NCT00309777|2354761|P2|Overall Study|Adverse Event|2
733969|NCT00309777|2354762|P1|Overall Study|Adverse Event|13
733970|NCT00309907|2354776|P1|Overall Study|Major infectious event|4
733971|NCT00309907|2354776|P1|Overall Study|Ineligible|11
733972|NCT00309907|2354776|P1|Overall Study|Physician Decision|1
733973|NCT00309907|2354776|P1|Overall Study|Death|4
733974|NCT00309946|2354785|P1|Overall Study|Withdrawal by Subject|1
733975|NCT00309985|2354793|P2|Overall Study|Chemotherapy discontinued only|0
733976|NCT00309985|2354794|P1|Overall Study|Chemotherapy discontinued only|1
733977|NCT00309985|2354793|P2|Overall Study|Non-compliance|0
733978|NCT00309985|2354794|P1|Overall Study|Non-compliance|1
733979|NCT00309985|2354793|P2|Overall Study|Complicating disease|0
733980|NCT00309985|2354794|P1|Overall Study|Complicating disease|1
733981|NCT00309985|2354793|P2|Overall Study|Never started treatment|0
733982|NCT00309985|2354794|P1|Overall Study|Never started treatment|7
733983|NCT00309985|2354793|P2|Overall Study|Physician Decision|0
733984|NCT00309985|2354794|P1|Overall Study|Physician Decision|3
733985|NCT00309985|2354793|P2|Overall Study|Withdrawal by Subject|1
733986|NCT00309985|2354794|P1|Overall Study|Withdrawal by Subject|5
733987|NCT00309985|2354793|P2|Overall Study|Death|0
733988|NCT00309985|2354794|P1|Overall Study|Death|2
733989|NCT00309985|2354793|P2|Overall Study|Adverse Event|0
733990|NCT00309985|2354794|P1|Overall Study|Adverse Event|30
733991|NCT00309985|2354793|P2|Overall Study|Disease progression|0
733992|NCT00309985|2354794|P1|Overall Study|Disease progression|12
733993|NCT00310375|2354856|P2|Overall Study|Request of Ethics Committee|1
733994|NCT00310375|2354857|P1|Overall Study|Request of Ethics Committee|0
733995|NCT00310375|2354856|P2|Overall Study|Par. switched to commercial product|1
733996|NCT00310375|2354857|P1|Overall Study|Par. switched to commercial product|0
733997|NCT00310375|2354856|P2|Overall Study|Missed study drug for 2 months|0
733998|NCT00310375|2354857|P1|Overall Study|Missed study drug for 2 months|1
733999|NCT00310375|2354856|P2|Overall Study|Site closure|0
734000|NCT00310375|2354857|P1|Overall Study|Site closure|3
734001|NCT00310375|2354856|P2|Overall Study|Missed study drug >5 days|0
734002|NCT00310375|2354857|P1|Overall Study|Missed study drug >5 days|1
734003|NCT00310375|2354856|P2|Overall Study|Going for temporal lobectomy|0
734004|NCT00310375|2354857|P1|Overall Study|Going for temporal lobectomy|1
734005|NCT00310375|2354856|P2|Overall Study|Participant request unrelated to study|2
734006|NCT00310375|2354857|P1|Overall Study|Participant request unrelated to study|1
734007|NCT00310375|2354856|P2|Overall Study|Failed to return|3
734008|NCT00310375|2354857|P1|Overall Study|Failed to return|1
734009|NCT00310375|2354856|P2|Overall Study|Request of the sponsor|2
734010|NCT00310375|2354857|P1|Overall Study|Request of the sponsor|2
734011|NCT00310375|2354856|P2|Overall Study|Physician Decision|3
734012|NCT00310375|2354857|P1|Overall Study|Physician Decision|5
734013|NCT00310375|2354856|P2|Overall Study|Transaminase >5 upper limit of normal|1
734014|NCT00310375|2354857|P1|Overall Study|Transaminase >5 upper limit of normal|2
734015|NCT00310375|2354856|P2|Overall Study|Change in Par medical condition|0
734016|NCT00310375|2354857|P1|Overall Study|Change in Par medical condition|2
734017|NCT00310375|2354856|P2|Overall Study|Protocol Violation|5
734018|NCT00310375|2354857|P1|Overall Study|Protocol Violation|8
734019|NCT00310375|2354856|P2|Overall Study|Withdrawal by Subject|7
734020|NCT00310375|2354857|P1|Overall Study|Withdrawal by Subject|10
734021|NCT00310375|2354856|P2|Overall Study|Pregnancy|2
734022|NCT00310375|2354857|P1|Overall Study|Pregnancy|2
734023|NCT00310375|2354856|P2|Overall Study|Lack of Efficacy|19
734024|NCT00310375|2354857|P1|Overall Study|Lack of Efficacy|24
734025|NCT00310375|2354856|P2|Overall Study|Adverse Event|22
734026|NCT00310375|2354857|P1|Overall Study|Adverse Event|28
734027|NCT00310440|2354929|P2|Overall Study|Missed 12 Month Visit|4
734028|NCT00310440|2354930|P1|Overall Study|Missed 12 Month Visit|7
734029|NCT00310440|2354929|P2|Overall Study|Withdrawal by Subject|1
734030|NCT00310440|2354930|P1|Overall Study|Withdrawal by Subject|2
734031|NCT00310440|2354929|P2|Overall Study|Lost to Follow-up|8
734032|NCT00310440|2354930|P1|Overall Study|Lost to Follow-up|17
734033|NCT00310804|2354980|P2|Overall Study|Withdrawal by Subject|0
734034|NCT00310804|2354981|P1|Overall Study|Withdrawal by Subject|3
734035|NCT00310804|2354980|P2|Overall Study|Lost to Follow-up|0
734036|NCT00310804|2354981|P1|Overall Study|Lost to Follow-up|2
734037|NCT00310817|2355018|P4|Overall Study|Unable to classify|0
734038|NCT00310817|2355019|P3|Overall Study|Unable to classify|0
734039|NCT00310817|2355020|P2|Overall Study|Unable to classify|1
734040|NCT00310817|2355021|P1|Overall Study|Unable to classify|3
734041|NCT00310817|2355018|P4|Overall Study|Protocol Violation|1
734042|NCT00310817|2355019|P3|Overall Study|Protocol Violation|1
734043|NCT00310817|2355020|P2|Overall Study|Protocol Violation|1
734044|NCT00310817|2355021|P1|Overall Study|Protocol Violation|1
734045|NCT00310817|2355018|P4|Overall Study|Inappropriate Enrollment|0
734046|NCT00310817|2355019|P3|Overall Study|Inappropriate Enrollment|1
734047|NCT00310817|2355020|P2|Overall Study|Inappropriate Enrollment|0
734048|NCT00310817|2355021|P1|Overall Study|Inappropriate Enrollment|1
734049|NCT00310817|2355018|P4|Overall Study|Lost to Follow-up|0
734050|NCT00310817|2355019|P3|Overall Study|Lost to Follow-up|0
734051|NCT00310817|2355020|P2|Overall Study|Lost to Follow-up|1
734052|NCT00310817|2355021|P1|Overall Study|Lost to Follow-up|2
734053|NCT00310817|2355018|P4|Overall Study|Withdrawal by Subject|7
734054|NCT00310817|2355019|P3|Overall Study|Withdrawal by Subject|6
734055|NCT00310817|2355020|P2|Overall Study|Withdrawal by Subject|4
734056|NCT00310817|2355021|P1|Overall Study|Withdrawal by Subject|1
734057|NCT00310817|2355018|P4|Overall Study|AE or Death|0
734058|NCT00310817|2355019|P3|Overall Study|AE or Death|0
734059|NCT00310817|2355020|P2|Overall Study|AE or Death|1
734060|NCT00310817|2355021|P1|Overall Study|AE or Death|3
734061|NCT00310856|2355110|P3|Overall Study|Unable to classify|0
734062|NCT00310856|2355111|P2|Overall Study|Unable to classify|0
734063|NCT00310856|2355112|P1|Overall Study|Unable to classify|1
734064|NCT00310856|2355110|P3|Overall Study|Inappropriate enrollment|0
734065|NCT00310856|2355111|P2|Overall Study|Inappropriate enrollment|1
734066|NCT00310856|2355112|P1|Overall Study|Inappropriate enrollment|1
734067|NCT00310856|2355110|P3|Overall Study|Lost to Follow-up|6
734068|NCT00310856|2355111|P2|Overall Study|Lost to Follow-up|2
734069|NCT00310856|2355112|P1|Overall Study|Lost to Follow-up|1
734070|NCT00310856|2355110|P3|Overall Study|Withdrawal by Subject|2
734071|NCT00310856|2355111|P2|Overall Study|Withdrawal by Subject|2
734072|NCT00310856|2355112|P1|Overall Study|Withdrawal by Subject|2
734073|NCT00319436|2355134|P2|Overall Study|Withdrawal by Subject|7
734074|NCT00319436|2355135|P1|Overall Study|Withdrawal by Subject|6
734075|NCT00319449|2355155|P2|Overall Study|Noncompliance with the protocol|0
734076|NCT00319449|2355156|P1|Overall Study|Noncompliance with the protocol|1
734077|NCT00319449|2355155|P2|Overall Study|Subject did not wish to continue|0
734078|NCT00319449|2355156|P1|Overall Study|Subject did not wish to continue|1
734079|NCT00319501|2355168|P2|Open-label Extension Period|Withdrawal by Subject|0
734080|NCT00319501|2355169|P1|Open-label Extension Period|Withdrawal by Subject|2
734081|NCT00319501|2355168|P2|Open-label Extension Period|Sponsor request|0
734082|NCT00319501|2355169|P1|Open-label Extension Period|Sponsor request|26
734083|NCT00319501|2355168|P2|Open-label Extension Period|Principal investigator decision|0
734084|NCT00319501|2355169|P1|Open-label Extension Period|Principal investigator decision|2
734085|NCT00319501|2355168|P2|Open-label Extension Period|Not specified|0
734086|NCT00319501|2355169|P1|Open-label Extension Period|Not specified|1
734087|NCT00319501|2355168|P2|Open-label Extension Period|Did not receive treatment|0
734088|NCT00319501|2355169|P1|Open-label Extension Period|Did not receive treatment|18
734089|NCT00319501|2355168|P2|Open-label Extension Period|Adverse Event|0
734090|NCT00319501|2355169|P1|Open-label Extension Period|Adverse Event|2
734091|NCT00319501|2355168|P2|Open-label Period|Not specified|0
734092|NCT00319501|2355169|P1|Open-label Period|Not specified|11
734093|NCT00319501|2355168|P2|Open-label Period|Did not receive treatment|0
734094|NCT00319501|2355169|P1|Open-label Period|Did not receive treatment|33
734095|NCT00319501|2355168|P2|Open-label Period|Lost to Follow-up|0
734096|NCT00319501|2355169|P1|Open-label Period|Lost to Follow-up|5
734097|NCT00319501|2355168|P2|Open-label Period|Sponsor request|0
734098|NCT00319501|2355169|P1|Open-label Period|Sponsor request|12
734099|NCT00319501|2355168|P2|Open-label Period|Principal Investigator decision|0
734100|NCT00319501|2355169|P1|Open-label Period|Principal Investigator decision|6
734101|NCT00319501|2355168|P2|Open-label Period|Withdrawal by Subject|0
734102|NCT00319501|2355169|P1|Open-label Period|Withdrawal by Subject|38
734103|NCT00319501|2355168|P2|Open-label Period|Protocol Violation|0
734104|NCT00319501|2355169|P1|Open-label Period|Protocol Violation|6
734105|NCT00319501|2355168|P2|Open-label Period|Adverse Event|0
734106|NCT00319501|2355169|P1|Open-label Period|Adverse Event|5
734107|NCT00319501|2355168|P2|Double-blind Period|Did not receive treatment|29
734108|NCT00319501|2355169|P1|Double-blind Period|Did not receive treatment|42
734109|NCT00319501|2355168|P2|Double-blind Period|Sponsor Request|0
734110|NCT00319501|2355169|P1|Double-blind Period|Sponsor Request|1
734111|NCT00319501|2355168|P2|Double-blind Period|Withdrawal by Subject|3
734112|NCT00319501|2355169|P1|Double-blind Period|Withdrawal by Subject|0
734113|NCT00319553|2355195|P2|Overall Study|Withdrawal by Subject|1
734114|NCT00319553|2355196|P1|Overall Study|Withdrawal by Subject|1
734115|NCT00319553|2355195|P2|Overall Study|Lost to Follow-up|1
734116|NCT00319553|2355196|P1|Overall Study|Lost to Follow-up|2
734117|NCT00319553|2355195|P2|Overall Study|Protocol Violation|2
734118|NCT00319553|2355196|P1|Overall Study|Protocol Violation|1
734119|NCT00319592|2355210|P2|Overall Study|Physician Decision|1
734120|NCT00319592|2355211|P1|Overall Study|Physician Decision|0
734121|NCT00319592|2355210|P2|Overall Study|Protocol Violation|0
734122|NCT00319592|2355211|P1|Overall Study|Protocol Violation|1
734123|NCT00321672|2355240|P4|Overall Study|Extensive travel required for new job|0
734124|NCT00321672|2355241|P3|Overall Study|Extensive travel required for new job|0
734125|NCT00321672|2355242|P2|Overall Study|Extensive travel required for new job|1
734126|NCT00321672|2355243|P1|Overall Study|Extensive travel required for new job|0
734127|NCT00321672|2355240|P4|Overall Study|Diagnosis of testicular cancer|0
734128|NCT00321672|2355241|P3|Overall Study|Diagnosis of testicular cancer|0
734129|NCT00321672|2355242|P2|Overall Study|Diagnosis of testicular cancer|1
734130|NCT00321672|2355243|P1|Overall Study|Diagnosis of testicular cancer|0
734131|NCT00321672|2355240|P4|Overall Study|Protocol Violation|0
734132|NCT00321672|2355241|P3|Overall Study|Protocol Violation|1
734133|NCT00321672|2355242|P2|Overall Study|Protocol Violation|0
734134|NCT00321672|2355243|P1|Overall Study|Protocol Violation|0
734135|NCT00321672|2355240|P4|Overall Study|Moved out of state|0
734136|NCT00321672|2355241|P3|Overall Study|Moved out of state|1
734137|NCT00321672|2355242|P2|Overall Study|Moved out of state|1
734138|NCT00321672|2355243|P1|Overall Study|Moved out of state|0
734139|NCT00321672|2355240|P4|Overall Study|Incarcerated|0
734140|NCT00321672|2355241|P3|Overall Study|Incarcerated|2
734141|NCT00321672|2355242|P2|Overall Study|Incarcerated|0
734142|NCT00321672|2355243|P1|Overall Study|Incarcerated|0
734143|NCT00321672|2355240|P4|Overall Study|Too far to travel for visits|0
734144|NCT00321672|2355241|P3|Overall Study|Too far to travel for visits|0
734145|NCT00321672|2355242|P2|Overall Study|Too far to travel for visits|0
734146|NCT00321672|2355243|P1|Overall Study|Too far to travel for visits|1
734147|NCT00321672|2355240|P4|Overall Study|Death|0
734148|NCT00321672|2355241|P3|Overall Study|Death|0
734149|NCT00321672|2355242|P2|Overall Study|Death|0
734150|NCT00321672|2355243|P1|Overall Study|Death|1
734151|NCT00321672|2355240|P4|Overall Study|Lost to Follow-up|2
734152|NCT00321672|2355241|P3|Overall Study|Lost to Follow-up|4
734153|NCT00321672|2355242|P2|Overall Study|Lost to Follow-up|0
734154|NCT00321672|2355243|P1|Overall Study|Lost to Follow-up|2
734155|NCT00321672|2355240|P4|Overall Study|Lack of Efficacy|0
734156|NCT00321672|2355241|P3|Overall Study|Lack of Efficacy|0
734157|NCT00321672|2355242|P2|Overall Study|Lack of Efficacy|1
734158|NCT00321672|2355243|P1|Overall Study|Lack of Efficacy|1
734159|NCT00321672|2355240|P4|Overall Study|Adverse Event|0
734160|NCT00321672|2355241|P3|Overall Study|Adverse Event|0
734161|NCT00321672|2355242|P2|Overall Study|Adverse Event|1
734162|NCT00321672|2355243|P1|Overall Study|Adverse Event|1
734163|NCT00321672|2355240|P4|Overall Study|Noncompliance|0
734164|NCT00321672|2355241|P3|Overall Study|Noncompliance|1
734165|NCT00321672|2355242|P2|Overall Study|Noncompliance|2
734166|NCT00321672|2355243|P1|Overall Study|Noncompliance|1
734167|NCT00321672|2355240|P4|Overall Study|Withdrawal by Subject|0
734168|NCT00321672|2355241|P3|Overall Study|Withdrawal by Subject|2
734169|NCT00321672|2355242|P2|Overall Study|Withdrawal by Subject|1
734170|NCT00321672|2355243|P1|Overall Study|Withdrawal by Subject|5
890572|NCT00950807|2825720|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
890573|NCT00950807|2825721|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
890574|NCT00950807|2825722|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
890575|NCT00950807|2825723|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
890576|NCT00950807|2825724|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
890577|NCT00950807|2825715|P10|Treatment Period 2|Withdrawal by Subject|0
734179|NCT00321711|2355305|P5|Part B|Death|1
734180|NCT00321711|2355306|P4|Part B|Death|2
734181|NCT00321711|2355307|P3|Part B|Death|0
734182|NCT00321711|2355308|P2|Part B|Death|0
734183|NCT00321711|2355309|P1|Part B|Death|0
734184|NCT00321711|2355305|P5|Part B|Physician Decision|2
734185|NCT00321711|2355306|P4|Part B|Physician Decision|1
734186|NCT00321711|2355307|P3|Part B|Physician Decision|0
734187|NCT00321711|2355308|P2|Part B|Physician Decision|0
734188|NCT00321711|2355309|P1|Part B|Physician Decision|0
734189|NCT00321711|2355305|P5|Part B|Disease progression|0
734190|NCT00321711|2355306|P4|Part B|Disease progression|1
734191|NCT00321711|2355307|P3|Part B|Disease progression|0
734192|NCT00321711|2355308|P2|Part B|Disease progression|0
734193|NCT00321711|2355309|P1|Part B|Disease progression|0
734194|NCT00321711|2355305|P5|Part B|Adverse Event|1
734195|NCT00321711|2355306|P4|Part B|Adverse Event|2
734196|NCT00321711|2355307|P3|Part B|Adverse Event|0
734197|NCT00321711|2355308|P2|Part B|Adverse Event|0
734198|NCT00321711|2355309|P1|Part B|Adverse Event|0
734199|NCT00321711|2355305|P5|Part B|Noncompliance|1
734200|NCT00321711|2355306|P4|Part B|Noncompliance|0
734201|NCT00321711|2355307|P3|Part B|Noncompliance|0
734202|NCT00321711|2355308|P2|Part B|Noncompliance|0
734203|NCT00321711|2355309|P1|Part B|Noncompliance|0
734204|NCT00321711|2355305|P5|Part A|Protocol deviation|0
734205|NCT00321711|2355306|P4|Part A|Protocol deviation|0
734206|NCT00321711|2355307|P3|Part A|Protocol deviation|1
734207|NCT00321711|2355308|P2|Part A|Protocol deviation|0
734208|NCT00321711|2355309|P1|Part A|Protocol deviation|0
734209|NCT00321711|2355305|P5|Part A|Other|0
734210|NCT00321711|2355306|P4|Part A|Other|0
734211|NCT00321711|2355307|P3|Part A|Other|3
734212|NCT00321711|2355308|P2|Part A|Other|2
734213|NCT00321711|2355309|P1|Part A|Other|1
734214|NCT00321711|2355305|P5|Part A|Physician Decision|0
734215|NCT00321711|2355306|P4|Part A|Physician Decision|0
734216|NCT00321711|2355307|P3|Part A|Physician Decision|3
734217|NCT00321711|2355308|P2|Part A|Physician Decision|1
734218|NCT00321711|2355309|P1|Part A|Physician Decision|0
734219|NCT00321711|2355305|P5|Part A|Requirement for alternative therapy|0
734220|NCT00321711|2355306|P4|Part A|Requirement for alternative therapy|0
734221|NCT00321711|2355307|P3|Part A|Requirement for alternative therapy|1
734222|NCT00321711|2355308|P2|Part A|Requirement for alternative therapy|2
734223|NCT00321711|2355309|P1|Part A|Requirement for alternative therapy|0
734224|NCT00321711|2355305|P5|Part A|Disease progression|0
734225|NCT00321711|2355306|P4|Part A|Disease progression|0
734226|NCT00321711|2355307|P3|Part A|Disease progression|0
734227|NCT00321711|2355308|P2|Part A|Disease progression|1
734228|NCT00321711|2355309|P1|Part A|Disease progression|0
734229|NCT00321711|2355305|P5|Part A|Withdrawal by Subject|0
734230|NCT00321711|2355306|P4|Part A|Withdrawal by Subject|0
734231|NCT00321711|2355307|P3|Part A|Withdrawal by Subject|1
734232|NCT00321711|2355308|P2|Part A|Withdrawal by Subject|1
734233|NCT00321711|2355309|P1|Part A|Withdrawal by Subject|1
734234|NCT00321711|2355305|P5|Part A|Adverse Event|0
734235|NCT00321711|2355306|P4|Part A|Adverse Event|0
734236|NCT00321711|2355307|P3|Part A|Adverse Event|2
734237|NCT00321711|2355308|P2|Part A|Adverse Event|3
734238|NCT00321711|2355309|P1|Part A|Adverse Event|3
734239|NCT00321737|2355339|P3|Overall Study|Subject Request/ Subject Unavailable|2
734240|NCT00321737|2355340|P2|Overall Study|Subject Request/ Subject Unavailable|0
734241|NCT00321737|2355341|P1|Overall Study|Subject Request/ Subject Unavailable|0
734242|NCT00321737|2355339|P3|Overall Study|Noncompliance|0
734243|NCT00321737|2355340|P2|Overall Study|Noncompliance|0
734244|NCT00321737|2355341|P1|Overall Study|Noncompliance|2
734245|NCT00321737|2355339|P3|Overall Study|Pregnancy|0
734246|NCT00321737|2355340|P2|Overall Study|Pregnancy|2
734247|NCT00321737|2355341|P1|Overall Study|Pregnancy|0
734248|NCT00321737|2355339|P3|Overall Study|Therapeutic Failure|2
734249|NCT00321737|2355340|P2|Overall Study|Therapeutic Failure|0
734250|NCT00321737|2355341|P1|Overall Study|Therapeutic Failure|6
734251|NCT00321737|2355339|P3|Overall Study|Possible Barrett's Esophagus|1
734252|NCT00321737|2355340|P2|Overall Study|Possible Barrett's Esophagus|1
734253|NCT00321737|2355341|P1|Overall Study|Possible Barrett's Esophagus|2
734254|NCT00321737|2355339|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
734255|NCT00321737|2355340|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
734256|NCT00321737|2355341|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
734257|NCT00321737|2355339|P3|Overall Study|Protocol Violation|1
734258|NCT00321737|2355340|P2|Overall Study|Protocol Violation|0
734259|NCT00321737|2355341|P1|Overall Study|Protocol Violation|0
734260|NCT00321737|2355339|P3|Overall Study|Withdrawal by Subject|17
734261|NCT00321737|2355340|P2|Overall Study|Withdrawal by Subject|12
734262|NCT00321737|2355341|P1|Overall Study|Withdrawal by Subject|19
734263|NCT00321737|2355339|P3|Overall Study|Lost to Follow-up|6
734264|NCT00321737|2355340|P2|Overall Study|Lost to Follow-up|5
734265|NCT00321737|2355341|P1|Overall Study|Lost to Follow-up|5
734266|NCT00321737|2355339|P3|Overall Study|Adverse Event|6
734267|NCT00321737|2355340|P2|Overall Study|Adverse Event|3
734268|NCT00321737|2355341|P1|Overall Study|Adverse Event|11
734269|NCT00321737|2355339|P3|Overall Study|Relapse of Erosive Esophagitis|19
734270|NCT00321737|2355340|P2|Overall Study|Relapse of Erosive Esophagitis|25
734271|NCT00321737|2355341|P1|Overall Study|Relapse of Erosive Esophagitis|76
734272|NCT00321763|2355368|P4|Overall Study|Lost to Follow-up|4
734273|NCT00321763|2355369|P3|Overall Study|Lost to Follow-up|5
734274|NCT00321763|2355370|P2|Overall Study|Lost to Follow-up|1
734275|NCT00321763|2355371|P1|Overall Study|Lost to Follow-up|3
734276|NCT00321763|2355368|P4|Overall Study|Withdrawal by Subject|0
734277|NCT00321763|2355369|P3|Overall Study|Withdrawal by Subject|1
734278|NCT00321763|2355370|P2|Overall Study|Withdrawal by Subject|0
734279|NCT00321763|2355371|P1|Overall Study|Withdrawal by Subject|2
734280|NCT00321763|2355368|P4|Overall Study|Adverse Event|1
734281|NCT00321763|2355369|P3|Overall Study|Adverse Event|0
734282|NCT00321763|2355370|P2|Overall Study|Adverse Event|1
734283|NCT00321763|2355371|P1|Overall Study|Adverse Event|1
734284|NCT00321789|2355430|P2|Overall Study|Protocol Violation|3
734285|NCT00321789|2355431|P1|Overall Study|Protocol Violation|5
734286|NCT00321789|2355430|P2|Overall Study|Withdrawal by Subject|6
734287|NCT00321789|2355431|P1|Overall Study|Withdrawal by Subject|6
734288|NCT00321789|2355430|P2|Overall Study|Lost to Follow-up|7
734289|NCT00321789|2355431|P1|Overall Study|Lost to Follow-up|4
734290|NCT00321828|2355459|P1|Overall Study|No follow up data|1
734291|NCT00321828|2355459|P1|Overall Study|Ineligible|3
734292|NCT00321854|2355465|P2|Overall Study|Other|1
734293|NCT00321854|2355466|P1|Overall Study|Other|1
734294|NCT00321854|2355465|P2|Overall Study|Withdrawal by Subject|17
734295|NCT00321854|2355466|P1|Overall Study|Withdrawal by Subject|6
734296|NCT00321854|2355465|P2|Overall Study|Lost to Follow-up|2
734297|NCT00321854|2355466|P1|Overall Study|Lost to Follow-up|0
734298|NCT00321854|2355465|P2|Overall Study|Protocol Violation|5
734299|NCT00321854|2355466|P1|Overall Study|Protocol Violation|6
734300|NCT00321854|2355465|P2|Overall Study|Lack of Efficacy|14
734301|NCT00321854|2355466|P1|Overall Study|Lack of Efficacy|9
734302|NCT00321854|2355465|P2|Overall Study|Adverse Event|43
734303|NCT00321854|2355466|P1|Overall Study|Adverse Event|41
734304|NCT00321893|2355586|P2|Overall Study|Adverse Event|3
734305|NCT00321893|2355587|P1|Overall Study|Adverse Event|6
734306|NCT00321893|2355586|P2|Overall Study|Lost to Follow-up|1
734307|NCT00321893|2355587|P1|Overall Study|Lost to Follow-up|2
734308|NCT00321893|2355586|P2|Overall Study|Non-Compliance/Refusal|10
734309|NCT00321893|2355587|P1|Overall Study|Non-Compliance/Refusal|16
734310|NCT00321906|2355601|P2|Overall Study|Withdrawal by Subject|4
734311|NCT00321906|2355602|P1|Overall Study|Withdrawal by Subject|0
734312|NCT00321906|2355601|P2|Overall Study|Lost to Follow-up|2
734313|NCT00321906|2355602|P1|Overall Study|Lost to Follow-up|1
734314|NCT00321906|2355601|P2|Overall Study|Death|6
734315|NCT00321906|2355602|P1|Overall Study|Death|9
734316|NCT00321906|2355601|P2|Overall Study|Adverse Event|44
734317|NCT00321906|2355602|P1|Overall Study|Adverse Event|36
734318|NCT00321919|2355624|P2|Overall Study|Other withdrawal reason|6
734319|NCT00321919|2355625|P1|Overall Study|Other withdrawal reason|7
734320|NCT00321919|2355624|P2|Overall Study|Failure to Return|1
734321|NCT00321919|2355625|P1|Overall Study|Failure to Return|3
734322|NCT00321919|2355624|P2|Overall Study|Other Protocol Violation|3
734323|NCT00321919|2355625|P1|Overall Study|Other Protocol Violation|2
734324|NCT00321919|2355624|P2|Overall Study|Refused Treatment|14
734325|NCT00321919|2355625|P1|Overall Study|Refused Treatment|23
734326|NCT00321919|2355624|P2|Overall Study|Violation of Selection Criteria at Entry|1
734327|NCT00321919|2355625|P1|Overall Study|Violation of Selection Criteria at Entry|1
734328|NCT00321919|2355624|P2|Overall Study|Insufficient Therapeutic Response|0
734329|NCT00321919|2355625|P1|Overall Study|Insufficient Therapeutic Response|1
734330|NCT00321919|2355624|P2|Overall Study|Death|17
734331|NCT00321919|2355625|P1|Overall Study|Death|21
734332|NCT00321919|2355624|P2|Overall Study|Adverse Event|10
734333|NCT00321919|2355625|P1|Overall Study|Adverse Event|17
734334|NCT00321932|2355667|P2|Overall Study|Missing data|1
734335|NCT00321932|2355668|P1|Overall Study|Missing data|2
734336|NCT00321932|2355667|P2|Overall Study|Early relapse|8
734337|NCT00321932|2355668|P1|Overall Study|Early relapse|2
734338|NCT00321932|2355667|P2|Overall Study|Withdrawal by Subject|6
734339|NCT00321932|2355668|P1|Overall Study|Withdrawal by Subject|3
734340|NCT00321932|2355667|P2|Overall Study|Death|6
734341|NCT00321932|2355668|P1|Overall Study|Death|3
734342|NCT00321984|2355693|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
734343|NCT00321984|2355694|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
734344|NCT00321984|2355695|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
734345|NCT00321984|2355693|P3|Overall Study|Per Investigator Request|0
734346|NCT00321984|2355694|P2|Overall Study|Per Investigator Request|0
734347|NCT00321984|2355695|P1|Overall Study|Per Investigator Request|1
734348|NCT00321984|2355693|P3|Overall Study|Per Subject Request|0
734349|NCT00321984|2355694|P2|Overall Study|Per Subject Request|0
734350|NCT00321984|2355695|P1|Overall Study|Per Subject Request|1
734351|NCT00321984|2355693|P3|Overall Study|Pregnancy|0
734352|NCT00321984|2355694|P2|Overall Study|Pregnancy|1
734353|NCT00321984|2355695|P1|Overall Study|Pregnancy|0
734354|NCT00321984|2355693|P3|Overall Study|Noncompliant|2
734355|NCT00321984|2355694|P2|Overall Study|Noncompliant|0
734356|NCT00321984|2355695|P1|Overall Study|Noncompliant|0
734357|NCT00321984|2355693|P3|Overall Study|Lack of Efficacy|3
734358|NCT00321984|2355694|P2|Overall Study|Lack of Efficacy|1
734359|NCT00321984|2355695|P1|Overall Study|Lack of Efficacy|3
734360|NCT00321984|2355693|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
734361|NCT00321984|2355694|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
734362|NCT00321984|2355695|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
734363|NCT00321984|2355693|P3|Overall Study|Withdrawal by Subject|5
734364|NCT00321984|2355694|P2|Overall Study|Withdrawal by Subject|6
734365|NCT00321984|2355695|P1|Overall Study|Withdrawal by Subject|8
734366|NCT00321984|2355693|P3|Overall Study|Lost to Follow-up|2
734367|NCT00321984|2355694|P2|Overall Study|Lost to Follow-up|4
734368|NCT00321984|2355695|P1|Overall Study|Lost to Follow-up|2
734369|NCT00321984|2355693|P3|Overall Study|Protocol Violation|1
734370|NCT00321984|2355694|P2|Overall Study|Protocol Violation|1
734371|NCT00321984|2355695|P1|Overall Study|Protocol Violation|0
734372|NCT00321984|2355693|P3|Overall Study|Adverse Event|8
734373|NCT00321984|2355694|P2|Overall Study|Adverse Event|6
734374|NCT00321984|2355695|P1|Overall Study|Adverse Event|9
734375|NCT00322049|2355716|P4|Overall Study|Infected with Dengue during study|0
734376|NCT00322049|2355717|P3|Overall Study|Infected with Dengue during study|0
734377|NCT00322049|2355718|P2|Overall Study|Infected with Dengue during study|1
734378|NCT00322049|2355719|P1|Overall Study|Infected with Dengue during study|0
734379|NCT00322049|2355716|P4|Overall Study|Moved out of area|1
734380|NCT00322049|2355717|P3|Overall Study|Moved out of area|0
734381|NCT00322049|2355718|P2|Overall Study|Moved out of area|0
734382|NCT00322049|2355719|P1|Overall Study|Moved out of area|0
734383|NCT00322153|2355770|P2|Overall Study|Withdrawn for other reasons|4
734384|NCT00322153|2355771|P1|Overall Study|Withdrawn for other reasons|5
734385|NCT00322153|2355770|P2|Overall Study|Lost to Follow-up|4
734386|NCT00322153|2355771|P1|Overall Study|Lost to Follow-up|5
734387|NCT00322153|2355770|P2|Overall Study|Lack of Efficacy|3
734388|NCT00322153|2355771|P1|Overall Study|Lack of Efficacy|8
734389|NCT00322153|2355770|P2|Overall Study|Withdrawal by Subject|10
734390|NCT00322153|2355771|P1|Overall Study|Withdrawal by Subject|18
734391|NCT00322153|2355770|P2|Overall Study|Protocol Violation|14
734392|NCT00322153|2355771|P1|Overall Study|Protocol Violation|6
734393|NCT00322153|2355770|P2|Overall Study|Adverse Event|34
734394|NCT00322153|2355771|P1|Overall Study|Adverse Event|21
734395|NCT00322348|2355856|P2|Overall Study|Reasons not specified|1
734396|NCT00322348|2355857|P1|Overall Study|Reasons not specified|5
734397|NCT00322348|2355856|P2|Overall Study|Disease Progression|25
734398|NCT00322348|2355857|P1|Overall Study|Disease Progression|30
734399|NCT00322348|2355856|P2|Overall Study|Death|2
734400|NCT00322348|2355857|P1|Overall Study|Death|0
734401|NCT00322348|2355856|P2|Overall Study|Lost to Follow-up|0
734402|NCT00322348|2355857|P1|Overall Study|Lost to Follow-up|1
734403|NCT00322348|2355856|P2|Overall Study|Withdrawal by Subject|4
734404|NCT00322348|2355857|P1|Overall Study|Withdrawal by Subject|1
734405|NCT00322348|2355856|P2|Overall Study|Adverse Event|1
734406|NCT00322348|2355857|P1|Overall Study|Adverse Event|0
734407|NCT00322374|2355876|P4|Second Escalation|Study Drug Toxicity|0
734408|NCT00322374|2355877|P3|Second Escalation|Study Drug Toxicity|1
734409|NCT00322374|2355878|P2|Second Escalation|Study Drug Toxicity|0
734410|NCT00322374|2355879|P1|Second Escalation|Study Drug Toxicity|0
734411|NCT00322374|2355876|P4|Second Escalation|Physician Decision|0
734412|NCT00322374|2355877|P3|Second Escalation|Physician Decision|5
734413|NCT00322374|2355878|P2|Second Escalation|Physician Decision|0
734414|NCT00322374|2355879|P1|Second Escalation|Physician Decision|0
734415|NCT00322374|2355876|P4|First Escalation|Participant Request|0
734416|NCT00322374|2355877|P3|First Escalation|Participant Request|0
734417|NCT00322374|2355878|P2|First Escalation|Participant Request|1
734418|NCT00322374|2355879|P1|First Escalation|Participant Request|0
734419|NCT00322374|2355876|P4|First Escalation|Study Drug Toxicity|0
734420|NCT00322374|2355877|P3|First Escalation|Study Drug Toxicity|0
734421|NCT00322374|2355878|P2|First Escalation|Study Drug Toxicity|11
734422|NCT00322374|2355879|P1|First Escalation|Study Drug Toxicity|0
734423|NCT00322374|2355876|P4|First Escalation|Physician Decision|0
734424|NCT00322374|2355877|P3|First Escalation|Physician Decision|0
734425|NCT00322374|2355878|P2|First Escalation|Physician Decision|12
734426|NCT00322374|2355879|P1|First Escalation|Physician Decision|0
734427|NCT00322374|2355876|P4|First Escalation|Documented Disease Progression|0
734428|NCT00322374|2355877|P3|First Escalation|Documented Disease Progression|0
734429|NCT00322374|2355878|P2|First Escalation|Documented Disease Progression|6
734430|NCT00322374|2355879|P1|First Escalation|Documented Disease Progression|0
734431|NCT00322374|2355876|P4|Starting Dose|Study Drug Toxicity|0
734432|NCT00322374|2355877|P3|Starting Dose|Study Drug Toxicity|0
734433|NCT00322374|2355878|P2|Starting Dose|Study Drug Toxicity|0
734434|NCT00322374|2355879|P1|Starting Dose|Study Drug Toxicity|4
734435|NCT00322374|2355876|P4|Starting Dose|Physician Decision|0
734436|NCT00322374|2355877|P3|Starting Dose|Physician Decision|0
734437|NCT00322374|2355878|P2|Starting Dose|Physician Decision|0
734438|NCT00322374|2355879|P1|Starting Dose|Physician Decision|2
734439|NCT00322387|2355929|P2|Follow-up Period|Death|0
734440|NCT00322387|2355930|P1|Follow-up Period|Death|1
734441|NCT00322387|2355929|P2|Follow-up Period|Final assessment not done|3
734442|NCT00322387|2355930|P1|Follow-up Period|Final assessment not done|1
734443|NCT00322387|2355929|P2|Treatment Period|Adverse Event|1
734444|NCT00322387|2355930|P1|Treatment Period|Adverse Event|0
734445|NCT00322452|2355976|P2|Overall Study|Death|227
734446|NCT00322452|2355977|P1|Overall Study|Death|223
734447|NCT00322452|2355976|P2|Overall Study|Withdrawal by Subject|46
734448|NCT00322452|2355977|P1|Overall Study|Withdrawal by Subject|19
734449|NCT00322452|2355976|P2|Overall Study|Lost to Follow-up|2
734450|NCT00322452|2355977|P1|Overall Study|Lost to Follow-up|5
734451|NCT00322452|2355976|P2|Overall Study|Eligibility criteria not fulfilled|1
734452|NCT00322452|2355977|P1|Overall Study|Eligibility criteria not fulfilled|0
734453|NCT00322491|2356081|P2|Overall Study|Death|2
734454|NCT00322491|2356082|P1|Overall Study|Death|1
734455|NCT00322491|2356081|P2|Overall Study|Adverse Event|0
734456|NCT00322491|2356082|P1|Overall Study|Adverse Event|1
734457|NCT00322556|2356104|P1|Overall Study|Other Reason|7
734458|NCT00322556|2356104|P1|Overall Study|Lost to Follow-up|3
734459|NCT00322556|2356104|P1|Overall Study|Withdrawal by Subject|1
734460|NCT00322556|2356104|P1|Overall Study|Adverse Event|1
734461|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
734462|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
734463|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
734464|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Death|0
734465|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Death|1
734466|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Death|0
734467|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
734468|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
734469|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
734470|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
734471|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
734472|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
734473|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
734474|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
734475|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
734476|NCT00322621|2356118|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
734477|NCT00322621|2356119|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
734478|NCT00322621|2356120|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
734479|NCT00322621|2356118|P3|Period II - Acute Therapy Phase|Physician Decision|0
734480|NCT00322621|2356119|P2|Period II - Acute Therapy Phase|Physician Decision|0
734481|NCT00322621|2356120|P1|Period II - Acute Therapy Phase|Physician Decision|1
734482|NCT00322621|2356118|P3|Period II - Acute Therapy Phase|Protocol Violation|0
734483|NCT00322621|2356119|P2|Period II - Acute Therapy Phase|Protocol Violation|0
734484|NCT00322621|2356120|P1|Period II - Acute Therapy Phase|Protocol Violation|2
734485|NCT00322621|2356118|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
734486|NCT00322621|2356119|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
734487|NCT00322621|2356120|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
734488|NCT00322621|2356118|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
734489|NCT00322621|2356119|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
734490|NCT00322621|2356120|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
734491|NCT00322621|2356118|P3|Period II - Acute Therapy Phase|Adverse Event|0
734492|NCT00322621|2356119|P2|Period II - Acute Therapy Phase|Adverse Event|0
734493|NCT00322621|2356120|P1|Period II - Acute Therapy Phase|Adverse Event|20
734494|NCT00322712|2356172|P1|Overall Study|treated with bevacizumab not cetuximab|1
734495|NCT00322842|2356191|P2|Overall Study|Death|0
734496|NCT00322842|2356192|P1|Overall Study|Death|1
734497|NCT00322842|2356191|P2|Overall Study|Refused transplant|0
734498|NCT00322842|2356192|P1|Overall Study|Refused transplant|1
734499|NCT00322842|2356191|P2|Overall Study|Lost to Follow-up|1
734500|NCT00322842|2356192|P1|Overall Study|Lost to Follow-up|0
734501|NCT00322842|2356191|P2|Overall Study|Withdrawal by Subject|1
734502|NCT00322842|2356192|P1|Overall Study|Withdrawal by Subject|0
734503|NCT00322881|2356221|P1|Overall Study|Disease Progression|2
734504|NCT00322881|2356221|P1|Overall Study|Adverse Event|1
734505|NCT00322881|2356221|P1|Overall Study|Death|2
734506|NCT00323115|2356232|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
734507|NCT00323115|2356232|P1|Vaccine Administration|Adverse Event|1
734508|NCT00323258|2356250|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
734509|NCT00323258|2356251|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
734510|NCT00323258|2356250|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
734511|NCT00323258|2356251|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
734512|NCT00323258|2356250|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
734513|NCT00323258|2356251|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
734514|NCT00323258|2356250|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
734515|NCT00323258|2356251|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
734516|NCT00323258|2356250|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
734517|NCT00323258|2356251|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
734518|NCT00323258|2356250|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
734519|NCT00323258|2356251|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
734520|NCT00323258|2356250|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
734521|NCT00323258|2356251|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
734522|NCT00323297|2356289|P2|Part B (Open-label)|Protocol Violation|1
734523|NCT00323297|2356290|P1|Part B (Open-label)|Protocol Violation|0
734524|NCT00323297|2356289|P2|Part B (Open-label)|Adverse Event|5
734525|NCT00323297|2356290|P1|Part B (Open-label)|Adverse Event|5
734526|NCT00323297|2356289|P2|Part B (Open-label)|Lack of Efficacy|1
734527|NCT00323297|2356290|P1|Part B (Open-label)|Lack of Efficacy|3
734528|NCT00323297|2356289|P2|Part B (Open-label)|Withdrawal by Subject|3
734529|NCT00323297|2356290|P1|Part B (Open-label)|Withdrawal by Subject|1
734530|NCT00323297|2356289|P2|Part B (Open-label)|Reason unspecified|1
734531|NCT00323297|2356290|P1|Part B (Open-label)|Reason unspecified|0
734532|NCT00323297|2356289|P2|Part B (Open-label)|Death|1
734533|NCT00323297|2356290|P1|Part B (Open-label)|Death|0
734534|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Related adverse event|2
734535|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Related adverse event|2
734536|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
734537|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
734538|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
734539|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
734540|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Protocol Violation|3
734541|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Protocol Violation|1
734542|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Death|1
734543|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Death|0
734544|NCT00323297|2356289|P2|Part A (Double Blind Randomized)|Reason unspecified|1
734545|NCT00323297|2356290|P1|Part A (Double Blind Randomized)|Reason unspecified|0
734546|NCT00323310|2356306|P1|Overall Study|did not complete the 24-hr f-up visit|1
734547|NCT00323310|2356306|P1|Overall Study|a parent refused blood draw|1
734548|NCT00323310|2356306|P1|Overall Study|Withdrawal by Subject|1
734549|NCT00323479|2356338|P1|Overall Study|house moving|1
734550|NCT00323479|2356338|P1|Overall Study|Protocol Violation|3
734551|NCT00323479|2356338|P1|Overall Study|Withdrawal by Subject|2
734552|NCT00323479|2356338|P1|Overall Study|Adverse Event|2
734553|NCT00323492|2356349|P3|Study Phase 2|Protocol Violation|0
734554|NCT00323492|2356350|P2|Study Phase 2|Protocol Violation|0
734555|NCT00323492|2356351|P1|Study Phase 2|Protocol Violation|1
734556|NCT00323492|2356349|P3|Study Phase 2|Noncompliance with study schedule|1
734557|NCT00323492|2356350|P2|Study Phase 2|Noncompliance with study schedule|0
734558|NCT00323492|2356351|P1|Study Phase 2|Noncompliance with study schedule|0
734559|NCT00323492|2356349|P3|Study Phase 2|Withdrawal by Subject|0
734560|NCT00323492|2356350|P2|Study Phase 2|Withdrawal by Subject|1
734561|NCT00323492|2356351|P1|Study Phase 2|Withdrawal by Subject|0
734562|NCT00323492|2356349|P3|Study Phase 2|Lost to Follow-up|0
734563|NCT00323492|2356350|P2|Study Phase 2|Lost to Follow-up|0
734564|NCT00323492|2356351|P1|Study Phase 2|Lost to Follow-up|1
734565|NCT00323492|2356349|P3|Study Phase 2|Physician Decision|0
734566|NCT00323492|2356350|P2|Study Phase 2|Physician Decision|0
734567|NCT00323492|2356351|P1|Study Phase 2|Physician Decision|1
734568|NCT00323492|2356349|P3|Study Phase 2|Adverse Event|0
734569|NCT00323492|2356350|P2|Study Phase 2|Adverse Event|0
734570|NCT00323492|2356351|P1|Study Phase 2|Adverse Event|1
734571|NCT00323492|2356349|P3|Study Phase 1|Adverse Event|0
734572|NCT00323492|2356350|P2|Study Phase 1|Adverse Event|0
734573|NCT00323492|2356351|P1|Study Phase 1|Adverse Event|2
734574|NCT00323557|2356384|P2|Overall Study|Physician Decision|0
734575|NCT00323557|2356385|P1|Overall Study|Physician Decision|1
734576|NCT00323609|2356394|P4|Overall Study|Other reason|9
734577|NCT00323609|2356395|P3|Overall Study|Other reason|4
734578|NCT00323609|2356396|P2|Overall Study|Other reason|8
734579|NCT00323609|2356397|P1|Overall Study|Other reason|11
734580|NCT00323609|2356394|P4|Overall Study|Logistical withdrawal|1
734581|NCT00323609|2356395|P3|Overall Study|Logistical withdrawal|0
734582|NCT00323609|2356396|P2|Overall Study|Logistical withdrawal|5
734583|NCT00323609|2356397|P1|Overall Study|Logistical withdrawal|9
734584|NCT00323609|2356394|P4|Overall Study|Unrelenting or severe back pain|0
734585|NCT00323609|2356395|P3|Overall Study|Unrelenting or severe back pain|0
734586|NCT00323609|2356396|P2|Overall Study|Unrelenting or severe back pain|1
734587|NCT00323609|2356397|P1|Overall Study|Unrelenting or severe back pain|1
734588|NCT00323609|2356394|P4|Overall Study|Sponsor discontinued trial|0
734589|NCT00323609|2356395|P3|Overall Study|Sponsor discontinued trial|0
734590|NCT00323609|2356396|P2|Overall Study|Sponsor discontinued trial|29
734591|NCT00323609|2356397|P1|Overall Study|Sponsor discontinued trial|29
734592|NCT00323609|2356394|P4|Overall Study|Other non-VCF-related medical condition|0
734593|NCT00323609|2356395|P3|Overall Study|Other non-VCF-related medical condition|0
734594|NCT00323609|2356396|P2|Overall Study|Other non-VCF-related medical condition|2
734595|NCT00323609|2356397|P1|Overall Study|Other non-VCF-related medical condition|3
734596|NCT00323609|2356394|P4|Overall Study|Withdrawal by Subject|4
734597|NCT00323609|2356395|P3|Overall Study|Withdrawal by Subject|4
734598|NCT00323609|2356396|P2|Overall Study|Withdrawal by Subject|23
734599|NCT00323609|2356397|P1|Overall Study|Withdrawal by Subject|11
734600|NCT00323609|2356394|P4|Overall Study|Physician Decision|1
734601|NCT00323609|2356395|P3|Overall Study|Physician Decision|0
734602|NCT00323609|2356396|P2|Overall Study|Physician Decision|0
734603|NCT00323609|2356397|P1|Overall Study|Physician Decision|2
734604|NCT00323609|2356394|P4|Overall Study|Lost to Follow-up|0
734605|NCT00323609|2356395|P3|Overall Study|Lost to Follow-up|0
734606|NCT00323609|2356396|P2|Overall Study|Lost to Follow-up|10
734607|NCT00323609|2356397|P1|Overall Study|Lost to Follow-up|9
734608|NCT00323609|2356394|P4|Overall Study|Death|0
734609|NCT00323609|2356395|P3|Overall Study|Death|0
734610|NCT00323609|2356396|P2|Overall Study|Death|21
734611|NCT00323609|2356397|P1|Overall Study|Death|16
734612|NCT00323622|2356439|P8|Overall Study|Death|2
734613|NCT00323622|2356440|P7|Overall Study|Death|0
734614|NCT00323622|2356441|P6|Overall Study|Death|0
734615|NCT00323622|2356442|P5|Overall Study|Death|7
734616|NCT00323622|2356443|P4|Overall Study|Death|0
734617|NCT00323622|2356444|P3|Overall Study|Death|0
734618|NCT00323622|2356445|P2|Overall Study|Death|1
734619|NCT00323622|2356446|P1|Overall Study|Death|1
734620|NCT00323622|2356439|P8|Overall Study|Unspecified|13
734621|NCT00323622|2356440|P7|Overall Study|Unspecified|5
734622|NCT00323622|2356441|P6|Overall Study|Unspecified|74
734623|NCT00323622|2356442|P5|Overall Study|Unspecified|32
734624|NCT00323622|2356443|P4|Overall Study|Unspecified|12
734625|NCT00323622|2356444|P3|Overall Study|Unspecified|4
734626|NCT00323622|2356445|P2|Overall Study|Unspecified|91
734627|NCT00323622|2356446|P1|Overall Study|Unspecified|30
734628|NCT00323869|2356510|P1|Overall Study|Death|1
734629|NCT00323882|2356527|P5|Overall Study|Not Specified|1
734630|NCT00323882|2356528|P4|Overall Study|Not Specified|1
734631|NCT00323882|2356529|P3|Overall Study|Not Specified|0
734632|NCT00323882|2356530|P2|Overall Study|Not Specified|0
734633|NCT00323882|2356531|P1|Overall Study|Not Specified|0
734634|NCT00323882|2356527|P5|Overall Study|Lost to Follow-up|1
734635|NCT00323882|2356528|P4|Overall Study|Lost to Follow-up|0
734636|NCT00323882|2356529|P3|Overall Study|Lost to Follow-up|1
734637|NCT00323882|2356530|P2|Overall Study|Lost to Follow-up|0
734638|NCT00323882|2356531|P1|Overall Study|Lost to Follow-up|0
734639|NCT00323882|2356527|P5|Overall Study|Death|5
734640|NCT00323882|2356528|P4|Overall Study|Death|0
734641|NCT00323882|2356529|P3|Overall Study|Death|1
734642|NCT00323882|2356530|P2|Overall Study|Death|1
734643|NCT00323882|2356531|P1|Overall Study|Death|0
734644|NCT00323882|2356527|P5|Overall Study|Disease Progression|22
734645|NCT00323882|2356528|P4|Overall Study|Disease Progression|5
734646|NCT00323882|2356529|P3|Overall Study|Disease Progression|10
734647|NCT00323882|2356530|P2|Overall Study|Disease Progression|4
734648|NCT00323882|2356531|P1|Overall Study|Disease Progression|6
734649|NCT00323882|2356527|P5|Overall Study|Adverse Event|3
734650|NCT00323882|2356528|P4|Overall Study|Adverse Event|1
734651|NCT00323882|2356529|P3|Overall Study|Adverse Event|1
734652|NCT00323882|2356530|P2|Overall Study|Adverse Event|1
734653|NCT00323882|2356531|P1|Overall Study|Adverse Event|2
734654|NCT00324038|2356604|P2|Overall Study|Other|13
734655|NCT00324038|2356605|P1|Overall Study|Other|6
734656|NCT00324038|2356604|P2|Overall Study|Lost to Follow-up|2
734657|NCT00324038|2356605|P1|Overall Study|Lost to Follow-up|0
734658|NCT00324038|2356604|P2|Overall Study|Lack of Efficacy|13
734659|NCT00324038|2356605|P1|Overall Study|Lack of Efficacy|5
734660|NCT00324038|2356604|P2|Overall Study|Adverse Event|23
734661|NCT00324038|2356605|P1|Overall Study|Adverse Event|38
734662|NCT00324116|2356611|P1|Overall Study|Other|5
734663|NCT00324116|2356611|P1|Overall Study|Withdrawal by Subject|5
734664|NCT00324116|2356611|P1|Overall Study|Lack of Efficacy|17
734665|NCT00324116|2356611|P1|Overall Study|Adverse Event|5
890578|NCT00950807|2825716|P9|Treatment Period 2|Withdrawal by Subject|0
890579|NCT00950807|2825717|P8|Treatment Period 2|Withdrawal by Subject|2
890580|NCT00950807|2825718|P7|Treatment Period 2|Withdrawal by Subject|1
890581|NCT00950807|2825719|P6|Treatment Period 2|Withdrawal by Subject|0
890582|NCT00950807|2825720|P5|Treatment Period 2|Withdrawal by Subject|0
890583|NCT00950807|2825721|P4|Treatment Period 2|Withdrawal by Subject|0
890584|NCT00950807|2825722|P3|Treatment Period 2|Withdrawal by Subject|0
890585|NCT00950807|2825723|P2|Treatment Period 2|Withdrawal by Subject|0
890586|NCT00950807|2825724|P1|Treatment Period 2|Withdrawal by Subject|0
890587|NCT00950807|2825715|P10|Treatment Period 2|Lack of Efficacy|0
890588|NCT00950807|2825716|P9|Treatment Period 2|Lack of Efficacy|0
890589|NCT00950807|2825717|P8|Treatment Period 2|Lack of Efficacy|0
890590|NCT00950807|2825718|P7|Treatment Period 2|Lack of Efficacy|0
890591|NCT00950807|2825719|P6|Treatment Period 2|Lack of Efficacy|0
890592|NCT00950807|2825720|P5|Treatment Period 2|Lack of Efficacy|0
890593|NCT00950807|2825721|P4|Treatment Period 2|Lack of Efficacy|0
890594|NCT00950807|2825722|P3|Treatment Period 2|Lack of Efficacy|0
890595|NCT00950807|2825723|P2|Treatment Period 2|Lack of Efficacy|0
890596|NCT00950807|2825724|P1|Treatment Period 2|Lack of Efficacy|1
890597|NCT00950807|2825715|P10|Washout Period 1|Adverse Event|0
890598|NCT00950807|2825716|P9|Washout Period 1|Adverse Event|0
890599|NCT00950807|2825717|P8|Washout Period 1|Adverse Event|0
890600|NCT00950807|2825718|P7|Washout Period 1|Adverse Event|0
890601|NCT00950807|2825719|P6|Washout Period 1|Adverse Event|0
890602|NCT00950807|2825720|P5|Washout Period 1|Adverse Event|1
890603|NCT00950807|2825721|P4|Washout Period 1|Adverse Event|1
890604|NCT00950807|2825722|P3|Washout Period 1|Adverse Event|0
890605|NCT00950807|2825723|P2|Washout Period 1|Adverse Event|0
890606|NCT00950807|2825724|P1|Washout Period 1|Adverse Event|2
890607|NCT00950807|2825715|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
734696|NCT00324168|2356656|P2|Overall Study|Patient did not visit in f/u window|9
734697|NCT00324168|2356657|P1|Overall Study|Patient did not visit in f/u window|6
734698|NCT00324168|2356656|P2|Overall Study|Death|3
734699|NCT00324168|2356657|P1|Overall Study|Death|3
734700|NCT00324168|2356656|P2|Overall Study|Lost to Follow-up|18
734701|NCT00324168|2356657|P1|Overall Study|Lost to Follow-up|19
734702|NCT00307333|2356689|P2|Overall Study|Lost to Follow-up|3
890608|NCT00950807|2825716|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
890609|NCT00950807|2825717|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
890610|NCT00950807|2825718|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
890611|NCT00950807|2825719|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
890612|NCT00950807|2825720|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
890613|NCT00950807|2825721|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
734703|NCT00307333|2356690|P1|Overall Study|Lost to Follow-up|11
734704|NCT00307437|2356705|P7|After Controlled Period|Unspecified|28
734705|NCT00307437|2356706|P6|After Controlled Period|Unspecified|40
734706|NCT00307437|2356707|P5|After Controlled Period|Unspecified|9
734707|NCT00307437|2356708|P4|After Controlled Period|Unspecified|15
734708|NCT00307437|2356709|P3|After Controlled Period|Unspecified|0
734709|NCT00307437|2356710|P2|After Controlled Period|Unspecified|0
734710|NCT00307437|2356711|P1|After Controlled Period|Unspecified|0
734711|NCT00307437|2356705|P7|After Controlled Period|Lost to Follow-up|18
734712|NCT00307437|2356706|P6|After Controlled Period|Lost to Follow-up|13
734713|NCT00307437|2356707|P5|After Controlled Period|Lost to Follow-up|12
734714|NCT00307437|2356708|P4|After Controlled Period|Lost to Follow-up|7
734715|NCT00307437|2356709|P3|After Controlled Period|Lost to Follow-up|0
734716|NCT00307437|2356710|P2|After Controlled Period|Lost to Follow-up|0
734717|NCT00307437|2356711|P1|After Controlled Period|Lost to Follow-up|0
734718|NCT00307437|2356705|P7|After Controlled Period|Lack of Efficacy|24
734719|NCT00307437|2356706|P6|After Controlled Period|Lack of Efficacy|37
734720|NCT00307437|2356707|P5|After Controlled Period|Lack of Efficacy|17
734721|NCT00307437|2356708|P4|After Controlled Period|Lack of Efficacy|15
734722|NCT00307437|2356709|P3|After Controlled Period|Lack of Efficacy|0
734723|NCT00307437|2356710|P2|After Controlled Period|Lack of Efficacy|0
734724|NCT00307437|2356711|P1|After Controlled Period|Lack of Efficacy|0
734725|NCT00307437|2356705|P7|After Controlled Period|Death|3
734726|NCT00307437|2356706|P6|After Controlled Period|Death|1
734727|NCT00307437|2356707|P5|After Controlled Period|Death|1
734728|NCT00307437|2356708|P4|After Controlled Period|Death|3
734729|NCT00307437|2356709|P3|After Controlled Period|Death|0
734730|NCT00307437|2356710|P2|After Controlled Period|Death|0
734731|NCT00307437|2356711|P1|After Controlled Period|Death|0
734732|NCT00307437|2356705|P7|After Controlled Period|Adverse Event|40
734733|NCT00307437|2356706|P6|After Controlled Period|Adverse Event|31
734734|NCT00307437|2356707|P5|After Controlled Period|Adverse Event|16
734735|NCT00307437|2356708|P4|After Controlled Period|Adverse Event|18
734736|NCT00307437|2356709|P3|After Controlled Period|Adverse Event|0
734737|NCT00307437|2356710|P2|After Controlled Period|Adverse Event|0
734738|NCT00307437|2356711|P1|After Controlled Period|Adverse Event|0
734739|NCT00307437|2356705|P7|Controlled Period|Unspecified|0
734740|NCT00307437|2356706|P6|Controlled Period|Unspecified|0
734741|NCT00307437|2356707|P5|Controlled Period|Unspecified|0
734742|NCT00307437|2356708|P4|Controlled Period|Unspecified|0
734743|NCT00307437|2356709|P3|Controlled Period|Unspecified|3
734744|NCT00307437|2356710|P2|Controlled Period|Unspecified|1
734745|NCT00307437|2356711|P1|Controlled Period|Unspecified|5
734746|NCT00307437|2356705|P7|Controlled Period|Lost to Follow-up|0
734747|NCT00307437|2356706|P6|Controlled Period|Lost to Follow-up|0
734748|NCT00307437|2356707|P5|Controlled Period|Lost to Follow-up|0
734749|NCT00307437|2356708|P4|Controlled Period|Lost to Follow-up|0
734750|NCT00307437|2356709|P3|Controlled Period|Lost to Follow-up|0
734751|NCT00307437|2356710|P2|Controlled Period|Lost to Follow-up|3
734752|NCT00307437|2356711|P1|Controlled Period|Lost to Follow-up|2
734753|NCT00307437|2356705|P7|Controlled Period|Lack of Efficacy|0
734754|NCT00307437|2356706|P6|Controlled Period|Lack of Efficacy|0
734755|NCT00307437|2356707|P5|Controlled Period|Lack of Efficacy|0
734756|NCT00307437|2356708|P4|Controlled Period|Lack of Efficacy|0
734757|NCT00307437|2356709|P3|Controlled Period|Lack of Efficacy|0
734758|NCT00307437|2356710|P2|Controlled Period|Lack of Efficacy|0
734759|NCT00307437|2356711|P1|Controlled Period|Lack of Efficacy|2
734760|NCT00307437|2356705|P7|Controlled Period|Death|0
734761|NCT00307437|2356706|P6|Controlled Period|Death|0
734762|NCT00307437|2356707|P5|Controlled Period|Death|0
734763|NCT00307437|2356708|P4|Controlled Period|Death|0
734764|NCT00307437|2356709|P3|Controlled Period|Death|1
734765|NCT00307437|2356710|P2|Controlled Period|Death|0
734766|NCT00307437|2356711|P1|Controlled Period|Death|0
734767|NCT00307437|2356705|P7|Controlled Period|Adverse Event|0
734768|NCT00307437|2356706|P6|Controlled Period|Adverse Event|0
734769|NCT00307437|2356707|P5|Controlled Period|Adverse Event|0
734770|NCT00307437|2356708|P4|Controlled Period|Adverse Event|0
734771|NCT00307437|2356709|P3|Controlled Period|Adverse Event|5
734772|NCT00307437|2356710|P2|Controlled Period|Adverse Event|2
734773|NCT00307437|2356711|P1|Controlled Period|Adverse Event|7
734774|NCT00307489|2356737|P2|Week 48 Through Week 168|Seroconversion|0
734775|NCT00307489|2356738|P1|Week 48 Through Week 168|Seroconversion|1
734776|NCT00307489|2356737|P2|Week 48 Through Week 168|Lost to Follow-up|1
734777|NCT00307489|2356738|P1|Week 48 Through Week 168|Lost to Follow-up|0
734778|NCT00307489|2356737|P2|Week 48 Through Week 168|Death|1
734779|NCT00307489|2356738|P1|Week 48 Through Week 168|Death|0
734780|NCT00307489|2356737|P2|Week 48 Through Week 168|Lack of Efficacy|2
734781|NCT00307489|2356738|P1|Week 48 Through Week 168|Lack of Efficacy|2
734782|NCT00307489|2356737|P2|Week 48 Through Week 168|Withdrawal by Subject|2
734783|NCT00307489|2356738|P1|Week 48 Through Week 168|Withdrawal by Subject|1
734784|NCT00307489|2356737|P2|Week 48 Through Week 168|Physician Decision|0
734785|NCT00307489|2356738|P1|Week 48 Through Week 168|Physician Decision|1
734786|NCT00307489|2356737|P2|Week 48 Through Week 168|Adverse Event|0
734787|NCT00307489|2356738|P1|Week 48 Through Week 168|Adverse Event|1
734788|NCT00307489|2356737|P2|Baseline Through Week 48|Withdrawal by Subject|1
734789|NCT00307489|2356738|P1|Baseline Through Week 48|Withdrawal by Subject|0
734790|NCT00307489|2356737|P2|Baseline Through Week 48|Physician Decision|0
734791|NCT00307489|2356738|P1|Baseline Through Week 48|Physician Decision|1
734792|NCT00307489|2356737|P2|Baseline Through Week 48|Lost to Follow-up|1
734793|NCT00307489|2356738|P1|Baseline Through Week 48|Lost to Follow-up|0
734794|NCT00307684|2356780|P3|Double Blind Phase|Lack of Efficacy|0
734795|NCT00307684|2356781|P2|Double Blind Phase|Lack of Efficacy|5
734796|NCT00307684|2356782|P1|Double Blind Phase|Lack of Efficacy|2
734797|NCT00307684|2356780|P3|Open Label Phase|other|6
734798|NCT00307684|2356781|P2|Open Label Phase|other|0
734799|NCT00307684|2356782|P1|Open Label Phase|other|0
734800|NCT00307684|2356780|P3|Open Label Phase|non compliance|5
734801|NCT00307684|2356781|P2|Open Label Phase|non compliance|0
734802|NCT00307684|2356782|P1|Open Label Phase|non compliance|0
734803|NCT00307684|2356780|P3|Open Label Phase|Lost to Follow-up|11
734804|NCT00307684|2356781|P2|Open Label Phase|Lost to Follow-up|0
734805|NCT00307684|2356782|P1|Open Label Phase|Lost to Follow-up|0
734806|NCT00307684|2356780|P3|Open Label Phase|Withdrawal by Subject|15
734807|NCT00307684|2356781|P2|Open Label Phase|Withdrawal by Subject|0
734808|NCT00307684|2356782|P1|Open Label Phase|Withdrawal by Subject|0
734809|NCT00307684|2356780|P3|Open Label Phase|Adverse Event|16
734810|NCT00307684|2356781|P2|Open Label Phase|Adverse Event|0
734811|NCT00307684|2356782|P1|Open Label Phase|Adverse Event|0
734812|NCT00307684|2356780|P3|Open Label Phase|Lack of Efficacy|3
734813|NCT00307684|2356781|P2|Open Label Phase|Lack of Efficacy|0
734814|NCT00307684|2356782|P1|Open Label Phase|Lack of Efficacy|0
734815|NCT00307736|2356808|P4|Overall Study|Withdrawal by Subject|0
734816|NCT00307736|2356809|P3|Overall Study|Withdrawal by Subject|2
734817|NCT00307736|2356810|P2|Overall Study|Withdrawal by Subject|0
734818|NCT00307736|2356811|P1|Overall Study|Withdrawal by Subject|0
734819|NCT00307736|2356808|P4|Overall Study|Adverse Event|3
734820|NCT00307736|2356809|P3|Overall Study|Adverse Event|1
734821|NCT00307736|2356810|P2|Overall Study|Adverse Event|0
734822|NCT00307736|2356811|P1|Overall Study|Adverse Event|0
734823|NCT00307801|2356824|P2|Overall Study|Pregnancy|1
734824|NCT00307801|2356825|P1|Overall Study|Pregnancy|0
734825|NCT00307801|2356824|P2|Overall Study|No reason specified|0
734826|NCT00307801|2356825|P1|Overall Study|No reason specified|2
734827|NCT00307801|2356824|P2|Overall Study|Protocol Violation|2
734828|NCT00307801|2356825|P1|Overall Study|Protocol Violation|3
734829|NCT00307801|2356824|P2|Overall Study|Frustration with e-diary|0
734830|NCT00307801|2356825|P1|Overall Study|Frustration with e-diary|1
734831|NCT00307801|2356824|P2|Overall Study|Lost to Follow-up, moved abroad|1
734832|NCT00307801|2356825|P1|Overall Study|Lost to Follow-up, moved abroad|1
734833|NCT00307801|2356824|P2|Overall Study|Lack of Efficacy|2
734834|NCT00307801|2356825|P1|Overall Study|Lack of Efficacy|0
734835|NCT00307801|2356824|P2|Overall Study|Wrong Randomization|0
734836|NCT00307801|2356825|P1|Overall Study|Wrong Randomization|1
734837|NCT00307801|2356824|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
734838|NCT00307801|2356825|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
734839|NCT00307801|2356824|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
734840|NCT00307801|2356825|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
734841|NCT00307801|2356824|P2|Overall Study|Non-compliance, not taken all tablets|2
734842|NCT00307801|2356825|P1|Overall Study|Non-compliance, not taken all tablets|1
734843|NCT00307801|2356824|P2|Overall Study|Withdrawal by Subject|4
734844|NCT00307801|2356825|P1|Overall Study|Withdrawal by Subject|9
734845|NCT00307801|2356824|P2|Overall Study|Adverse Event|4
734846|NCT00307801|2356825|P1|Overall Study|Adverse Event|12
734847|NCT00307931|2356937|P1|Overall Study|Adverse Event|1
734848|NCT00314574|2356954|P2|Overall Study|Data unknown at database lock|1
734849|NCT00314574|2356955|P1|Overall Study|Data unknown at database lock|0
734850|NCT00314574|2356954|P2|Overall Study|Pregnancy|4
734851|NCT00314574|2356955|P1|Overall Study|Pregnancy|6
734852|NCT00314574|2356954|P2|Overall Study|Physician Decision|15
734853|NCT00314574|2356955|P1|Overall Study|Physician Decision|22
734854|NCT00314574|2356954|P2|Overall Study|Withdrawal by Subject|22
734855|NCT00314574|2356955|P1|Overall Study|Withdrawal by Subject|33
734856|NCT00314574|2356954|P2|Overall Study|Lost to Follow-up|25
734857|NCT00314574|2356955|P1|Overall Study|Lost to Follow-up|19
734858|NCT00314574|2356954|P2|Overall Study|Adverse Event|16
734859|NCT00314574|2356955|P1|Overall Study|Adverse Event|11
734860|NCT00314574|2356954|P2|Overall Study|Death|0
734861|NCT00314574|2356955|P1|Overall Study|Death|3
734862|NCT00314808|2356969|P1|Overall Study|Withdrawal by Subject/PI without AE|4
734863|NCT00314808|2356969|P1|Overall Study|Disease Progression without AE|4
734864|NCT00314951|2356979|P2|Follow-up|mITT failure|34
734865|NCT00314951|2356980|P1|Follow-up|mITT failure|44
734866|NCT00314951|2356979|P2|Treatment|Didn't meet criteria for mITT population|11
734867|NCT00314951|2356980|P1|Treatment|Didn't meet criteria for mITT population|16
734868|NCT00315055|2356992|P2|Overall Study|Lost to Follow-up|1
734869|NCT00315055|2356993|P1|Overall Study|Lost to Follow-up|1
734870|NCT00315055|2356992|P2|Overall Study|Protocol Violation|4
734871|NCT00315055|2356993|P1|Overall Study|Protocol Violation|2
734872|NCT00315445|2357229|P3|Overall Study|Other|0
734873|NCT00315445|2357230|P2|Overall Study|Other|3
734874|NCT00315445|2357231|P1|Overall Study|Other|1
734875|NCT00315445|2357229|P3|Overall Study|Protocol Violation|1
734876|NCT00315445|2357230|P2|Overall Study|Protocol Violation|0
734877|NCT00315445|2357231|P1|Overall Study|Protocol Violation|2
734878|NCT00315445|2357229|P3|Overall Study|Lost to Follow-up|1
734879|NCT00315445|2357230|P2|Overall Study|Lost to Follow-up|0
734880|NCT00315445|2357231|P1|Overall Study|Lost to Follow-up|1
734881|NCT00315445|2357229|P3|Overall Study|Lack of Efficacy|7
734882|NCT00315445|2357230|P2|Overall Study|Lack of Efficacy|1
734883|NCT00315445|2357231|P1|Overall Study|Lack of Efficacy|16
734884|NCT00315445|2357229|P3|Overall Study|Adverse Event|15
734885|NCT00315445|2357230|P2|Overall Study|Adverse Event|12
734886|NCT00315445|2357231|P1|Overall Study|Adverse Event|7
734887|NCT00315458|2357304|P4|Overall Study|Did not qualify|0
734888|NCT00315458|2357305|P3|Overall Study|Did not qualify|1
734889|NCT00315458|2357306|P2|Overall Study|Did not qualify|0
734890|NCT00315458|2357307|P1|Overall Study|Did not qualify|0
734891|NCT00315458|2357304|P4|Overall Study|Lack of Efficacy|1
734892|NCT00315458|2357305|P3|Overall Study|Lack of Efficacy|20
734893|NCT00315458|2357306|P2|Overall Study|Lack of Efficacy|0
734894|NCT00315458|2357307|P1|Overall Study|Lack of Efficacy|0
734895|NCT00315458|2357304|P4|Overall Study|Withdrawal by Subject|2
734896|NCT00315458|2357305|P3|Overall Study|Withdrawal by Subject|0
734897|NCT00315458|2357306|P2|Overall Study|Withdrawal by Subject|3
734898|NCT00315458|2357307|P1|Overall Study|Withdrawal by Subject|0
734899|NCT00315458|2357304|P4|Overall Study|Lost to Follow-up|2
734900|NCT00315458|2357305|P3|Overall Study|Lost to Follow-up|0
734901|NCT00315458|2357306|P2|Overall Study|Lost to Follow-up|2
734902|NCT00315458|2357307|P1|Overall Study|Lost to Follow-up|1
734903|NCT00315458|2357304|P4|Overall Study|Adverse Event|3
734904|NCT00315458|2357305|P3|Overall Study|Adverse Event|23
734905|NCT00315458|2357306|P2|Overall Study|Adverse Event|4
734906|NCT00315458|2357307|P1|Overall Study|Adverse Event|2
734907|NCT00315458|2357304|P4|Overall Study|Administrative|21
734908|NCT00315458|2357305|P3|Overall Study|Administrative|8
734909|NCT00315458|2357306|P2|Overall Study|Administrative|3
734910|NCT00315458|2357307|P1|Overall Study|Administrative|0
734911|NCT00315705|2357341|P1|Phase 2|Death|7
734912|NCT00315705|2357341|P1|Phase 2|Unspecified|1
734913|NCT00315705|2357341|P1|Phase 2|Scheduled for transplant|8
734914|NCT00315705|2357341|P1|Phase 2|Disease relapse|1
734915|NCT00315705|2357341|P1|Phase 2|Failure to achieve response|3
734916|NCT00315705|2357341|P1|Phase 2|Adverse Event|1
734917|NCT00315705|2357341|P1|Phase 2|Physician Decision|4
734918|NCT00315705|2357341|P1|Phase 1|Death|3
734919|NCT00315705|2357341|P1|Phase 1|Scheduled for transplant|9
734920|NCT00315705|2357341|P1|Phase 1|Disease relapse|4
734921|NCT00315705|2357341|P1|Phase 1|Failure to achieve response|8
734922|NCT00315705|2357341|P1|Phase 1|Refused further treatment|1
734923|NCT00315731|2357378|P1|Overall Study|Death|5
734924|NCT00315731|2357378|P1|Overall Study|Lost to Follow-up|1
734925|NCT00316004|2357425|P3|Overall Study|Subject was not given study fluid.|21
734926|NCT00316004|2357426|P2|Overall Study|Subject was not given study fluid.|14
734927|NCT00316004|2357427|P1|Overall Study|Subject was not given study fluid.|14
734928|NCT00316017|2357483|P3|Overall Study|Protocol Violation|19
734929|NCT00316017|2357484|P2|Overall Study|Protocol Violation|13
734930|NCT00316017|2357485|P1|Overall Study|Protocol Violation|11
734931|NCT00316082|2357561|P5|Overall Study|Administrative reason by sponsor|0
734932|NCT00316082|2357562|P4|Overall Study|Administrative reason by sponsor|0
734933|NCT00316082|2357563|P3|Overall Study|Administrative reason by sponsor|1
734934|NCT00316082|2357564|P2|Overall Study|Administrative reason by sponsor|0
734935|NCT00316082|2357565|P1|Overall Study|Administrative reason by sponsor|0
734936|NCT00316082|2357561|P5|Overall Study|Death|0
734937|NCT00316082|2357562|P4|Overall Study|Death|0
734938|NCT00316082|2357563|P3|Overall Study|Death|1
734939|NCT00316082|2357564|P2|Overall Study|Death|0
734940|NCT00316082|2357565|P1|Overall Study|Death|0
734941|NCT00316082|2357561|P5|Overall Study|Physician Decision|1
734942|NCT00316082|2357562|P4|Overall Study|Physician Decision|1
734943|NCT00316082|2357563|P3|Overall Study|Physician Decision|2
734944|NCT00316082|2357564|P2|Overall Study|Physician Decision|1
734945|NCT00316082|2357565|P1|Overall Study|Physician Decision|1
734946|NCT00316082|2357561|P5|Overall Study|Subject no longer meets study criteria|1
734947|NCT00316082|2357562|P4|Overall Study|Subject no longer meets study criteria|2
734948|NCT00316082|2357563|P3|Overall Study|Subject no longer meets study criteria|2
734949|NCT00316082|2357564|P2|Overall Study|Subject no longer meets study criteria|1
734950|NCT00316082|2357565|P1|Overall Study|Subject no longer meets study criteria|3
734951|NCT00316082|2357561|P5|Overall Study|Adverse Event|3
734952|NCT00316082|2357562|P4|Overall Study|Adverse Event|1
734953|NCT00316082|2357563|P3|Overall Study|Adverse Event|5
734954|NCT00316082|2357564|P2|Overall Study|Adverse Event|2
734955|NCT00316082|2357565|P1|Overall Study|Adverse Event|4
734956|NCT00316082|2357561|P5|Overall Study|Poor/noncompliance|4
734957|NCT00316082|2357562|P4|Overall Study|Poor/noncompliance|1
734958|NCT00316082|2357563|P3|Overall Study|Poor/noncompliance|4
734959|NCT00316082|2357564|P2|Overall Study|Poor/noncompliance|1
734960|NCT00316082|2357565|P1|Overall Study|Poor/noncompliance|6
734961|NCT00316082|2357561|P5|Overall Study|Lost to Follow-up|6
734962|NCT00316082|2357562|P4|Overall Study|Lost to Follow-up|8
734963|NCT00316082|2357563|P3|Overall Study|Lost to Follow-up|7
734964|NCT00316082|2357564|P2|Overall Study|Lost to Follow-up|6
734965|NCT00316082|2357565|P1|Overall Study|Lost to Follow-up|7
734966|NCT00316082|2357561|P5|Overall Study|Withdrawal of Consent by Subject|5
734967|NCT00316082|2357562|P4|Overall Study|Withdrawal of Consent by Subject|9
734968|NCT00316082|2357563|P3|Overall Study|Withdrawal of Consent by Subject|2
734969|NCT00316082|2357564|P2|Overall Study|Withdrawal of Consent by Subject|8
734970|NCT00316082|2357565|P1|Overall Study|Withdrawal of Consent by Subject|10
734971|NCT00316082|2357561|P5|Overall Study|Lack of Efficacy|6
734972|NCT00316082|2357562|P4|Overall Study|Lack of Efficacy|4
734973|NCT00316082|2357563|P3|Overall Study|Lack of Efficacy|3
734974|NCT00316082|2357564|P2|Overall Study|Lack of Efficacy|3
734975|NCT00316082|2357565|P1|Overall Study|Lack of Efficacy|2
734976|NCT00316121|2357595|P2|Overall Study|Subject did not have 24 month visit|0
734977|NCT00316121|2357596|P1|Overall Study|Subject did not have 24 month visit|1
734978|NCT00316121|2357595|P2|Overall Study|Subject no show for visit x 3|0
734979|NCT00316121|2357596|P1|Overall Study|Subject no show for visit x 3|1
734980|NCT00316121|2357595|P2|Overall Study|Subject refused to return|0
734981|NCT00316121|2357596|P1|Overall Study|Subject refused to return|1
734982|NCT00316121|2357595|P2|Overall Study|Subject relocated|1
734983|NCT00316121|2357596|P1|Overall Study|Subject relocated|1
734984|NCT00316121|2357595|P2|Overall Study|Reason is missing|0
734985|NCT00316121|2357596|P1|Overall Study|Reason is missing|1
734986|NCT00316121|2357595|P2|Overall Study|Withdrawal by Subject|0
734987|NCT00316121|2357596|P1|Overall Study|Withdrawal by Subject|2
734988|NCT00316121|2357595|P2|Overall Study|Lost to Follow-up|8
734989|NCT00316121|2357596|P1|Overall Study|Lost to Follow-up|14
734990|NCT00316121|2357595|P2|Overall Study|Death|0
734991|NCT00316121|2357596|P1|Overall Study|Death|1
734992|NCT00316173|2357604|P2|Treatment Phase|Study Follow-up Stopped|34
734993|NCT00316173|2357605|P1|Treatment Phase|Study Follow-up Stopped|0
734994|NCT00316173|2357604|P2|Treatment Phase|Withdrawal by Subject|1
734995|NCT00316173|2357605|P1|Treatment Phase|Withdrawal by Subject|0
734996|NCT00316173|2357604|P2|Treatment Phase|Lost to Follow-up|3
734997|NCT00316173|2357605|P1|Treatment Phase|Lost to Follow-up|0
734998|NCT00316173|2357604|P2|Treatment Phase|Lack of Efficacy|3
734999|NCT00316173|2357605|P1|Treatment Phase|Lack of Efficacy|0
735000|NCT00316173|2357604|P2|Treatment Phase|Adverse Event|1
735001|NCT00316173|2357605|P1|Treatment Phase|Adverse Event|0
735002|NCT00316173|2357604|P2|Run-in Phase|Study Follow-up Stopped|0
735003|NCT00316173|2357605|P1|Run-in Phase|Study Follow-up Stopped|5
735004|NCT00316173|2357604|P2|Run-in Phase|Protocol Violation|0
735005|NCT00316173|2357605|P1|Run-in Phase|Protocol Violation|1
735006|NCT00316173|2357604|P2|Run-in Phase|Adverse Event|0
735007|NCT00316173|2357605|P1|Run-in Phase|Adverse Event|1
735008|NCT00316186|2357616|P1|Overall Study|Other|1
735009|NCT00316186|2357616|P1|Overall Study|Lost to Follow-up|1
735010|NCT00316186|2357616|P1|Overall Study|Disease Progression|4
735011|NCT00316186|2357616|P1|Overall Study|Adverse Event|6
735012|NCT00316199|2357628|P1|Overall Study|Lost to Follow-up|2
735013|NCT00316199|2357628|P1|Overall Study|Death|8
735014|NCT00316199|2357628|P1|Overall Study|Adverse Event|2
735015|NCT00316225|2357636|P1|Overall Study|Death|2
735016|NCT00316225|2357636|P1|Overall Study|Withdrawal by Subject|3
735017|NCT00316225|2357636|P1|Overall Study|Progressive Disease|15
735018|NCT00316225|2357636|P1|Overall Study|Physician Decision|3
735019|NCT00316225|2357636|P1|Overall Study|Adverse Event|2
735020|NCT00316264|2357648|P3|Overall Study|not specified|0
735021|NCT00316264|2357649|P2|Overall Study|not specified|1
735022|NCT00316264|2357650|P1|Overall Study|not specified|1
735023|NCT00316264|2357648|P3|Overall Study|Death|0
735024|NCT00316264|2357649|P2|Overall Study|Death|0
735025|NCT00316264|2357650|P1|Overall Study|Death|2
735026|NCT00316264|2357648|P3|Overall Study|Withdrawal of Consent|6
735027|NCT00316264|2357649|P2|Overall Study|Withdrawal of Consent|5
735028|NCT00316264|2357650|P1|Overall Study|Withdrawal of Consent|3
735029|NCT00316264|2357648|P3|Overall Study|Lost to Follow-up|0
735030|NCT00316264|2357649|P2|Overall Study|Lost to Follow-up|1
735031|NCT00316264|2357650|P1|Overall Study|Lost to Follow-up|0
735032|NCT00316277|2357720|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
735033|NCT00316277|2357721|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
735034|NCT00316277|2357720|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
735035|NCT00316277|2357721|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
735036|NCT00316277|2357720|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
735037|NCT00316277|2357721|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
735038|NCT00316277|2357720|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
735039|NCT00316277|2357721|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
735040|NCT00316277|2357720|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
735041|NCT00316277|2357721|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
735042|NCT00316303|2357741|P2|Overall Study|Lost to Follow-up|16
735043|NCT00316303|2357742|P1|Overall Study|Lost to Follow-up|11
735044|NCT00316693|2357769|P2|Overall Study|Other|44
735045|NCT00316693|2357770|P1|Overall Study|Other|38
735046|NCT00316693|2357769|P2|Overall Study|Lost to Follow-up|34
735047|NCT00316693|2357770|P1|Overall Study|Lost to Follow-up|26
735048|NCT00316693|2357769|P2|Overall Study|Withdrawal by Subject|6
735049|NCT00316693|2357770|P1|Overall Study|Withdrawal by Subject|6
735050|NCT00316693|2357769|P2|Overall Study|Protocol Violation|0
735051|NCT00316693|2357770|P1|Overall Study|Protocol Violation|1
735052|NCT00316693|2357769|P2|Overall Study|Adverse Event|1
735053|NCT00316693|2357770|P1|Overall Study|Adverse Event|6
735054|NCT00316706|2357812|P2|Overall Study|Lost to Follow-up|48
735055|NCT00316706|2357813|P1|Overall Study|Lost to Follow-up|38
735056|NCT00316719|2357829|P2|Overall Study|Consent withdrawn|0
735057|NCT00316719|2357830|P1|Overall Study|Consent withdrawn|2
735058|NCT00316719|2357829|P2|Overall Study|Adverse Event|6
735059|NCT00316719|2357830|P1|Overall Study|Adverse Event|0
735060|NCT00324233|2357856|P2|Second Period|Protocol Violation|6
735061|NCT00324233|2357857|P1|Second Period|Protocol Violation|4
735062|NCT00324233|2357856|P2|Second Period|unable to insert catheter|1
735063|NCT00324233|2357857|P1|Second Period|unable to insert catheter|1
735064|NCT00324233|2357856|P2|First Period|unable to insert catheter|0
735065|NCT00324233|2357857|P1|First Period|unable to insert catheter|1
735066|NCT00325468|2357957|P5|Overall Study|site closure etc|1
735067|NCT00325468|2357958|P4|Overall Study|site closure etc|8
735068|NCT00325468|2357959|P3|Overall Study|site closure etc|1
735069|NCT00325468|2357960|P2|Overall Study|site closure etc|2
735070|NCT00325468|2357961|P1|Overall Study|site closure etc|4
735071|NCT00325468|2357957|P5|Overall Study|Withdrawal by Subject|4
735072|NCT00325468|2357958|P4|Overall Study|Withdrawal by Subject|14
735073|NCT00325468|2357959|P3|Overall Study|Withdrawal by Subject|0
735074|NCT00325468|2357960|P2|Overall Study|Withdrawal by Subject|1
735075|NCT00325468|2357961|P1|Overall Study|Withdrawal by Subject|3
735076|NCT00325468|2357957|P5|Overall Study|Physician Decision|0
735077|NCT00325468|2357958|P4|Overall Study|Physician Decision|1
735078|NCT00325468|2357959|P3|Overall Study|Physician Decision|0
735079|NCT00325468|2357960|P2|Overall Study|Physician Decision|1
735080|NCT00325468|2357961|P1|Overall Study|Physician Decision|1
735081|NCT00325468|2357957|P5|Overall Study|Lost to Follow-up|2
735082|NCT00325468|2357958|P4|Overall Study|Lost to Follow-up|2
735083|NCT00325468|2357959|P3|Overall Study|Lost to Follow-up|1
735084|NCT00325468|2357960|P2|Overall Study|Lost to Follow-up|0
735085|NCT00325468|2357961|P1|Overall Study|Lost to Follow-up|0
735086|NCT00325468|2357957|P5|Overall Study|Death|0
735087|NCT00325468|2357958|P4|Overall Study|Death|4
735088|NCT00325468|2357959|P3|Overall Study|Death|2
735089|NCT00325468|2357960|P2|Overall Study|Death|0
735090|NCT00325468|2357961|P1|Overall Study|Death|2
735091|NCT00325468|2357957|P5|Overall Study|Adverse Event|1
735092|NCT00325468|2357958|P4|Overall Study|Adverse Event|5
735093|NCT00325468|2357959|P3|Overall Study|Adverse Event|0
735094|NCT00325468|2357960|P2|Overall Study|Adverse Event|1
735095|NCT00325468|2357961|P1|Overall Study|Adverse Event|1
735096|NCT00325754|2358009|P2|Overall Study|Adverse Event|1
735097|NCT00325754|2358010|P1|Overall Study|Adverse Event|4
890614|NCT00950807|2825722|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
890615|NCT00950807|2825723|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
890616|NCT00950807|2825724|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
890617|NCT00950807|2825715|P10|Washout Period 1|Withdrawal by Subject|0
890618|NCT00950807|2825716|P9|Washout Period 1|Withdrawal by Subject|1
890619|NCT00950807|2825717|P8|Washout Period 1|Withdrawal by Subject|0
735104|NCT00325897|2358054|P2|Overall Study|Lost to Follow-up|13
735105|NCT00325897|2358055|P1|Overall Study|Lost to Follow-up|12
735106|NCT00326001|2358075|P2|Overall Study|Physician Decision|3
735107|NCT00326001|2358076|P1|Overall Study|Physician Decision|3
735108|NCT00326001|2358075|P2|Overall Study|Adverse Event|5
735109|NCT00326001|2358076|P1|Overall Study|Adverse Event|4
735110|NCT00326118|2358090|P2|Active Phase|Withdrawal by Subject|1
735111|NCT00326118|2358091|P1|Active Phase|Withdrawal by Subject|4
735112|NCT00326183|2358131|P2|Overall Study|Adverse Event|0
735113|NCT00326183|2358132|P1|Overall Study|Adverse Event|1
735114|NCT00326183|2358131|P2|Overall Study|Unspecified|13
735115|NCT00326183|2358132|P1|Overall Study|Unspecified|47
735116|NCT00326183|2358131|P2|Overall Study|Subject Moved|4
735117|NCT00326183|2358132|P1|Overall Study|Subject Moved|7
735118|NCT00326183|2358131|P2|Overall Study|Withdrawal by Subject|7
735119|NCT00326183|2358132|P1|Overall Study|Withdrawal by Subject|35
735120|NCT00326183|2358131|P2|Overall Study|Protocol Violation|3
735121|NCT00326183|2358132|P1|Overall Study|Protocol Violation|6
735122|NCT00326183|2358131|P2|Overall Study|Lost to Follow-up|56
735123|NCT00326183|2358132|P1|Overall Study|Lost to Follow-up|104
890620|NCT00950807|2825718|P7|Washout Period 1|Withdrawal by Subject|0
890621|NCT00950807|2825719|P6|Washout Period 1|Withdrawal by Subject|0
890622|NCT00950807|2825720|P5|Washout Period 1|Withdrawal by Subject|0
890623|NCT00950807|2825721|P4|Washout Period 1|Withdrawal by Subject|0
890624|NCT00950807|2825722|P3|Washout Period 1|Withdrawal by Subject|0
890625|NCT00950807|2825723|P2|Washout Period 1|Withdrawal by Subject|0
890626|NCT00950807|2825724|P1|Washout Period 1|Withdrawal by Subject|0
890627|NCT00950807|2825715|P10|Washout Period 1|Lack of Efficacy|0
890628|NCT00950807|2825716|P9|Washout Period 1|Lack of Efficacy|0
890629|NCT00950807|2825717|P8|Washout Period 1|Lack of Efficacy|0
735136|NCT00326495|2358188|P1|Overall Study|Subject off study before assessment|1
735137|NCT00326495|2358188|P1|Overall Study|Refused further treatment|2
735138|NCT00326495|2358188|P1|Overall Study|Disease progression before treatment|1
735139|NCT00326495|2358188|P1|Overall Study|Switched to alternative treatment|1
735140|NCT00326599|2358197|P4|Overall Study|Other Unspecified Reason|1
735141|NCT00326599|2358198|P3|Overall Study|Other Unspecified Reason|2
735142|NCT00326599|2358199|P2|Overall Study|Other Unspecified Reason|0
735143|NCT00326599|2358200|P1|Overall Study|Other Unspecified Reason|0
735144|NCT00326599|2358197|P4|Overall Study|Death|2
735145|NCT00326599|2358198|P3|Overall Study|Death|1
735146|NCT00326599|2358199|P2|Overall Study|Death|0
735147|NCT00326599|2358200|P1|Overall Study|Death|0
735148|NCT00326599|2358197|P4|Overall Study|Alternate Treatment|0
735149|NCT00326599|2358198|P3|Overall Study|Alternate Treatment|0
735150|NCT00326599|2358199|P2|Overall Study|Alternate Treatment|0
735151|NCT00326599|2358200|P1|Overall Study|Alternate Treatment|1
735152|NCT00326599|2358197|P4|Overall Study|Disease Progression|11
735153|NCT00326599|2358198|P3|Overall Study|Disease Progression|13
735154|NCT00326599|2358199|P2|Overall Study|Disease Progression|1
735155|NCT00326599|2358200|P1|Overall Study|Disease Progression|3
735156|NCT00326599|2358197|P4|Overall Study|Adverse Event|3
735157|NCT00326599|2358198|P3|Overall Study|Adverse Event|32
735158|NCT00326599|2358199|P2|Overall Study|Adverse Event|0
735159|NCT00326599|2358200|P1|Overall Study|Adverse Event|1
735160|NCT00326599|2358197|P4|Overall Study|Withdrawal by Subject|2
735161|NCT00326599|2358198|P3|Overall Study|Withdrawal by Subject|5
735162|NCT00326599|2358199|P2|Overall Study|Withdrawal by Subject|0
735163|NCT00326599|2358200|P1|Overall Study|Withdrawal by Subject|1
735164|NCT00326612|2358221|P2|Overall Study|They did not have a seizure requiring tx|137
735165|NCT00326612|2358222|P1|Overall Study|They did not have a seizure requiring tx|129
735166|NCT00326716|2358242|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
735167|NCT00326716|2358243|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
735168|NCT00326716|2358244|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
735169|NCT00326716|2358245|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
735170|NCT00326885|2358335|P1|Overall Study|Hospice withdrew consent|2
735171|NCT00326885|2358335|P1|Overall Study|Physician Decision|1
735172|NCT00326885|2358335|P1|Overall Study|Withdrawal by Subject|3
735173|NCT00326885|2358335|P1|Overall Study|Adverse Event|1
735174|NCT00326898|2358347|P3|Overall Study|Other/Missing/Unknown|32
735175|NCT00326898|2358348|P2|Overall Study|Other/Missing/Unknown|28
735176|NCT00326898|2358349|P1|Overall Study|Other/Missing/Unknown|33
735177|NCT00326898|2358347|P3|Overall Study|Other complicating disease|4
735178|NCT00326898|2358348|P2|Overall Study|Other complicating disease|5
735179|NCT00326898|2358349|P1|Overall Study|Other complicating disease|5
735180|NCT00326898|2358347|P3|Overall Study|Alternative therapy|0
735181|NCT00326898|2358348|P2|Overall Study|Alternative therapy|0
735182|NCT00326898|2358349|P1|Overall Study|Alternative therapy|1
735183|NCT00326898|2358347|P3|Overall Study|Withdrawal by Subject|32
735184|NCT00326898|2358348|P2|Overall Study|Withdrawal by Subject|128
735185|NCT00326898|2358349|P1|Overall Study|Withdrawal by Subject|134
735186|NCT00326898|2358347|P3|Overall Study|Death|0
735187|NCT00326898|2358348|P2|Overall Study|Death|0
735188|NCT00326898|2358349|P1|Overall Study|Death|2
735189|NCT00326898|2358347|P3|Overall Study|Adverse Event|33
735190|NCT00326898|2358348|P2|Overall Study|Adverse Event|128
735191|NCT00326898|2358349|P1|Overall Study|Adverse Event|124
735192|NCT00326898|2358347|P3|Overall Study|Disease progression|102
735193|NCT00326898|2358348|P2|Overall Study|Disease progression|54
735194|NCT00326898|2358349|P1|Overall Study|Disease progression|52
735195|NCT00326911|2358368|P2|Overall Study|Withdrawal by subject prior to treatment|1
735196|NCT00326911|2358369|P1|Overall Study|Withdrawal by subject prior to treatment|0
735197|NCT00326911|2358368|P2|Overall Study|Physician decision prior to treatment|0
735198|NCT00326911|2358369|P1|Overall Study|Physician decision prior to treatment|1
735199|NCT00326911|2358368|P2|Overall Study|Hospitalization prior to treatment|1
735200|NCT00326911|2358369|P1|Overall Study|Hospitalization prior to treatment|0
735201|NCT00326950|2358419|P1|Overall Study|Progressive Disease|1
735202|NCT00326963|2358424|P1|Overall Study|Administrative / other|1
735203|NCT00326963|2358424|P1|Overall Study|Other protocol violation|1
735204|NCT00326963|2358424|P1|Overall Study|Violation of selection criteria at entry|2
735205|NCT00326963|2358424|P1|Overall Study|Refused treatment / did not cooperate|5
735206|NCT00326963|2358424|P1|Overall Study|Withdrawal by Subject|10
735207|NCT00326963|2358424|P1|Overall Study|Failure to return|10
735208|NCT00326963|2358424|P1|Overall Study|Death|1
735209|NCT00326963|2358424|P1|Overall Study|Injection site reaction|1
735210|NCT00326963|2358424|P1|Overall Study|Adverse Event|2
735211|NCT00327015|2358448|P4|Overall Study|Administrative Reason by Sponsor|1
735212|NCT00327015|2358449|P3|Overall Study|Administrative Reason by Sponsor|2
735213|NCT00327015|2358450|P2|Overall Study|Administrative Reason by Sponsor|2
735214|NCT00327015|2358451|P1|Overall Study|Administrative Reason by Sponsor|1
735215|NCT00327015|2358448|P4|Overall Study|Pregnancy|1
735216|NCT00327015|2358449|P3|Overall Study|Pregnancy|1
735217|NCT00327015|2358450|P2|Overall Study|Pregnancy|2
735218|NCT00327015|2358451|P1|Overall Study|Pregnancy|0
735219|NCT00327015|2358448|P4|Overall Study|Death|3
735220|NCT00327015|2358449|P3|Overall Study|Death|2
735221|NCT00327015|2358450|P2|Overall Study|Death|2
735222|NCT00327015|2358451|P1|Overall Study|Death|1
735223|NCT00327015|2358448|P4|Overall Study|Physician Decision|2
735224|NCT00327015|2358449|P3|Overall Study|Physician Decision|3
735225|NCT00327015|2358450|P2|Overall Study|Physician Decision|1
735226|NCT00327015|2358451|P1|Overall Study|Physician Decision|0
735227|NCT00327015|2358448|P4|Overall Study|Poor/Noncompliance|5
735228|NCT00327015|2358449|P3|Overall Study|Poor/Noncompliance|4
735229|NCT00327015|2358450|P2|Overall Study|Poor/Noncompliance|8
735230|NCT00327015|2358451|P1|Overall Study|Poor/Noncompliance|11
735231|NCT00327015|2358448|P4|Overall Study|Subject no longer meets study criteria|7
735232|NCT00327015|2358449|P3|Overall Study|Subject no longer meets study criteria|8
735233|NCT00327015|2358450|P2|Overall Study|Subject no longer meets study criteria|2
735234|NCT00327015|2358451|P1|Overall Study|Subject no longer meets study criteria|4
735235|NCT00327015|2358448|P4|Overall Study|Adverse Event|14
735236|NCT00327015|2358449|P3|Overall Study|Adverse Event|14
735237|NCT00327015|2358450|P2|Overall Study|Adverse Event|10
735238|NCT00327015|2358451|P1|Overall Study|Adverse Event|14
735239|NCT00327015|2358448|P4|Overall Study|Lost to Follow-up|22
735240|NCT00327015|2358449|P3|Overall Study|Lost to Follow-up|29
735241|NCT00327015|2358450|P2|Overall Study|Lost to Follow-up|23
735242|NCT00327015|2358451|P1|Overall Study|Lost to Follow-up|22
735243|NCT00327015|2358448|P4|Overall Study|Withdrawal of Consent by Subject|25
735244|NCT00327015|2358449|P3|Overall Study|Withdrawal of Consent by Subject|28
735245|NCT00327015|2358450|P2|Overall Study|Withdrawal of Consent by Subject|24
735246|NCT00327015|2358451|P1|Overall Study|Withdrawal of Consent by Subject|20
735247|NCT00327015|2358448|P4|Overall Study|Lack of Efficacy|29
735248|NCT00327015|2358449|P3|Overall Study|Lack of Efficacy|35
735249|NCT00327015|2358450|P2|Overall Study|Lack of Efficacy|18
735250|NCT00327015|2358451|P1|Overall Study|Lack of Efficacy|18
735251|NCT00327171|2358495|P2|Overall Study|Unspecified|0
735252|NCT00327171|2358496|P1|Overall Study|Unspecified|1
735253|NCT00327171|2358495|P2|Overall Study|Undisclosed history of ischemia|1
735254|NCT00327171|2358496|P1|Overall Study|Undisclosed history of ischemia|0
735255|NCT00327171|2358495|P2|Overall Study|Clinical progression|8
735256|NCT00327171|2358496|P1|Overall Study|Clinical progression|12
735257|NCT00327171|2358495|P2|Overall Study|Investigator/participant request|8
735258|NCT00327171|2358496|P1|Overall Study|Investigator/participant request|1
735259|NCT00327171|2358495|P2|Overall Study|Disease progression/lack of efficacy|69
735260|NCT00327171|2358496|P1|Overall Study|Disease progression/lack of efficacy|68
735261|NCT00327171|2358495|P2|Overall Study|Adverse Event|23
735262|NCT00327171|2358496|P1|Overall Study|Adverse Event|23
735263|NCT00327171|2358495|P2|Overall Study|Did not receive study medication|0
735264|NCT00327171|2358496|P1|Overall Study|Did not receive study medication|3
735265|NCT00327340|2358526|P2|Overall Study|Adverse Event|3
735266|NCT00327340|2358527|P1|Overall Study|Adverse Event|3
735267|NCT00327340|2358526|P2|Overall Study|Symptomatic Disease|2
735268|NCT00327340|2358527|P1|Overall Study|Symptomatic Disease|0
735269|NCT00327340|2358526|P2|Overall Study|Disease Progression|19
735270|NCT00327340|2358527|P1|Overall Study|Disease Progression|10
735271|NCT00327340|2358526|P2|Overall Study|Physician Decision|1
735272|NCT00327340|2358527|P1|Overall Study|Physician Decision|1
735273|NCT00327340|2358526|P2|Overall Study|Withdrawal by Subject|5
735274|NCT00327340|2358527|P1|Overall Study|Withdrawal by Subject|1
735275|NCT00327444|2358545|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
735276|NCT00327444|2358546|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
735277|NCT00327444|2358545|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
735278|NCT00327444|2358546|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
735279|NCT00327444|2358545|P2|Open Label Treatment (OL) Period|Adverse Event|2
735280|NCT00327444|2358546|P1|Open Label Treatment (OL) Period|Adverse Event|2
735281|NCT00327444|2358545|P2|Open Label Treatment (OL) Period|Disease progression|7
735282|NCT00327444|2358546|P1|Open Label Treatment (OL) Period|Disease progression|8
735283|NCT00327444|2358545|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
735284|NCT00327444|2358546|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
735285|NCT00327444|2358545|P2|Double Blind Treatment (DB) Period|Subject request|1
735286|NCT00327444|2358546|P1|Double Blind Treatment (DB) Period|Subject request|0
735287|NCT00327444|2358545|P2|Double Blind Treatment (DB) Period|Adverse Event|5
735288|NCT00327444|2358546|P1|Double Blind Treatment (DB) Period|Adverse Event|5
735289|NCT00327444|2358545|P2|Double Blind Treatment (DB) Period|Disease progression|13
735290|NCT00327444|2358546|P1|Double Blind Treatment (DB) Period|Disease progression|10
735291|NCT00327470|2358560|P2|Overall Study|Death|4
735292|NCT00327470|2358561|P1|Overall Study|Death|1
735293|NCT00327470|2358560|P2|Overall Study|Withdrawal by Subject|12
735294|NCT00327470|2358561|P1|Overall Study|Withdrawal by Subject|6
735295|NCT00327470|2358560|P2|Overall Study|Lost to Follow-up|3
735296|NCT00327470|2358561|P1|Overall Study|Lost to Follow-up|1
735297|NCT00327470|2358560|P2|Overall Study|Other|9
735298|NCT00327470|2358561|P1|Overall Study|Other|5
735299|NCT00327470|2358560|P2|Overall Study|Lack of Efficacy|19
735300|NCT00327470|2358561|P1|Overall Study|Lack of Efficacy|7
735301|NCT00327470|2358560|P2|Overall Study|Adverse Event|14
735302|NCT00327470|2358561|P1|Overall Study|Adverse Event|9
735303|NCT00327470|2358560|P2|Overall Study|Randomized, but not treated|2
735304|NCT00327470|2358561|P1|Overall Study|Randomized, but not treated|0
735305|NCT00327717|2358581|P2|Overall Study|Withdrawal by Subject|7
735306|NCT00327717|2358582|P1|Overall Study|Withdrawal by Subject|3
735307|NCT00327717|2358581|P2|Overall Study|Lack of Efficacy|1
735308|NCT00327717|2358582|P1|Overall Study|Lack of Efficacy|0
735309|NCT00327717|2358581|P2|Overall Study|Adverse Event|6
735310|NCT00327717|2358582|P1|Overall Study|Adverse Event|6
735311|NCT00313846|2358608|P2|Overall Study|Administrative|3
735312|NCT00313846|2358609|P1|Overall Study|Administrative|2
735313|NCT00313846|2358608|P2|Overall Study|Adverse Event|8
735314|NCT00313846|2358609|P1|Overall Study|Adverse Event|1
735315|NCT00313846|2358608|P2|Overall Study|Withdrawal by Subject|0
735316|NCT00313846|2358609|P1|Overall Study|Withdrawal by Subject|2
735317|NCT00313911|2358620|P2|Overall Study|Did not meet age criteria|1
735318|NCT00313911|2358621|P1|Overall Study|Did not meet age criteria|1
735319|NCT00313911|2358620|P2|Overall Study|Withdrawal by Subject|12
735320|NCT00313911|2358621|P1|Overall Study|Withdrawal by Subject|39
735321|NCT00313911|2358620|P2|Overall Study|Lost to Follow-up|14
735322|NCT00313911|2358621|P1|Overall Study|Lost to Follow-up|27
735323|NCT00313911|2358620|P2|Overall Study|Protocol Violation|10
735324|NCT00313911|2358621|P1|Overall Study|Protocol Violation|19
735325|NCT00313911|2358620|P2|Overall Study|Adverse Event|3
735326|NCT00313911|2358621|P1|Overall Study|Adverse Event|2
735327|NCT00313911|2358620|P2|Overall Study|Serious adverse event|1
735328|NCT00313911|2358621|P1|Overall Study|Serious adverse event|6
735329|NCT00314132|2358646|P2|Overall Study|Physician Decision|0
735330|NCT00314132|2358647|P1|Overall Study|Physician Decision|1
735331|NCT00314132|2358646|P2|Overall Study|Adverse Event|0
735332|NCT00314132|2358647|P1|Overall Study|Adverse Event|1
735333|NCT00314132|2358646|P2|Overall Study|Withdrawal by Subject|5
735334|NCT00314132|2358647|P1|Overall Study|Withdrawal by Subject|3
735335|NCT00314132|2358646|P2|Overall Study|Lost to Follow-up|13
735336|NCT00314132|2358647|P1|Overall Study|Lost to Follow-up|3
735337|NCT00314145|2358657|P2|Overall Study|Sponsor Decision|0
735338|NCT00314145|2358658|P1|Overall Study|Sponsor Decision|2
735339|NCT00314145|2358657|P2|Overall Study|Protocol Violation|0
735340|NCT00314145|2358658|P1|Overall Study|Protocol Violation|3
735341|NCT00314145|2358657|P2|Overall Study|Adverse Event|3
735342|NCT00314145|2358658|P1|Overall Study|Adverse Event|0
735343|NCT00314145|2358657|P2|Overall Study|Physician Decision|4
735344|NCT00314145|2358658|P1|Overall Study|Physician Decision|3
735345|NCT00314145|2358657|P2|Overall Study|Lost to Follow-up|12
735346|NCT00314145|2358658|P1|Overall Study|Lost to Follow-up|5
735347|NCT00314145|2358657|P2|Overall Study|Withdrawal by Subject|10
735348|NCT00314145|2358658|P1|Overall Study|Withdrawal by Subject|8
735349|NCT00314249|2358687|P2|Overall Study|Non-Compliant|6
735350|NCT00314249|2358688|P1|Overall Study|Non-Compliant|5
735351|NCT00314249|2358687|P2|Overall Study|Withdrawn for other reasons|1
735352|NCT00314249|2358688|P1|Overall Study|Withdrawn for other reasons|4
735353|NCT00314249|2358687|P2|Overall Study|Physician Decision|1
735354|NCT00314249|2358688|P1|Overall Study|Physician Decision|1
735355|NCT00314249|2358687|P2|Overall Study|Lost to Follow-up|9
735356|NCT00314249|2358688|P1|Overall Study|Lost to Follow-up|15
735357|NCT00314249|2358687|P2|Overall Study|Withdrawal by Subject|28
735358|NCT00314249|2358688|P1|Overall Study|Withdrawal by Subject|21
735359|NCT00314249|2358687|P2|Overall Study|Lack of Efficacy|24
735360|NCT00314249|2358688|P1|Overall Study|Lack of Efficacy|33
735361|NCT00314249|2358687|P2|Overall Study|Adverse Event|94
735362|NCT00314249|2358688|P1|Overall Study|Adverse Event|73
735363|NCT00314262|2358704|P1|Overall Study|Physician Decision|1
735364|NCT00314262|2358704|P1|Overall Study|Withdrawal by Subject|2
735365|NCT00314262|2358704|P1|Overall Study|Adverse Event|2
735367|NCT00314340|2358714|P1|Overall Study|lost interest|1
735368|NCT00314366|2358731|P2|Overall Study|not treated due to patient medical condi|0
735369|NCT00314366|2358732|P1|Overall Study|not treated due to patient medical condi|1
735370|NCT00319696|2358760|P1|Overall Study|Lost to Follow-up|3
735371|NCT00319696|2358760|P1|Overall Study|administrative|7
735372|NCT00319696|2358760|P1|Overall Study|withdrawal of consent|14
735373|NCT00319696|2358760|P1|Overall Study|Adverse Event|36
735374|NCT00319735|2358784|P1|Overall Study|Death|2
735375|NCT00319982|2358809|P2|Overall Study|Withdrawal by Subject|0
735376|NCT00319982|2358810|P1|Overall Study|Withdrawal by Subject|1
735377|NCT00320112|2358830|P2|Overall Study|Death|1
735378|NCT00320112|2358831|P1|Overall Study|Death|2
735379|NCT00320112|2358830|P2|Overall Study|Withdrawal by Subject|0
735380|NCT00320112|2358831|P1|Overall Study|Withdrawal by Subject|3
735381|NCT00320112|2358830|P2|Overall Study|Lost to Follow-up|4
735382|NCT00320112|2358831|P1|Overall Study|Lost to Follow-up|3
735383|NCT00320190|2358845|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
735384|NCT00320190|2358846|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
735385|NCT00320190|2358845|P2|Long-term (12-month) Extension|Lack of major molecular response|2
735386|NCT00320190|2358846|P1|Long-term (12-month) Extension|Lack of major molecular response|1
735387|NCT00320190|2358845|P2|Long-term (12-month) Extension|Sponsor terminated study|0
735388|NCT00320190|2358846|P1|Long-term (12-month) Extension|Sponsor terminated study|7
735389|NCT00320190|2358845|P2|First 12 Months|Withdrawal by Subject|1
735390|NCT00320190|2358846|P1|First 12 Months|Withdrawal by Subject|0
735391|NCT00320190|2358845|P2|First 12 Months|Study drug toxicity|1
735392|NCT00320190|2358846|P1|First 12 Months|Study drug toxicity|0
735393|NCT00320190|2358845|P2|First 12 Months|Investigator request|1
735394|NCT00320190|2358846|P1|First 12 Months|Investigator request|0
735395|NCT00320190|2358845|P2|First 12 Months|Adverse event unrelated to study drug|0
735396|NCT00320190|2358846|P1|First 12 Months|Adverse event unrelated to study drug|1
735397|NCT00320190|2358845|P2|First 12 Months|Enrollment failure|1
735398|NCT00320190|2358846|P1|First 12 Months|Enrollment failure|0
735399|NCT00320190|2358845|P2|First 12 Months|Lost to Follow-up|1
735400|NCT00320190|2358846|P1|First 12 Months|Lost to Follow-up|0
735401|NCT00320190|2358845|P2|First 12 Months|Sponsor terminated study|2
735402|NCT00320190|2358846|P1|First 12 Months|Sponsor terminated study|2
735403|NCT00320190|2358845|P2|First 12 Months|Completed but did not enter extension|3
735404|NCT00320190|2358846|P1|First 12 Months|Completed but did not enter extension|5
735405|NCT00320216|2358869|P5|Overall Study|Other|3
735406|NCT00320216|2358870|P4|Overall Study|Other|1
735407|NCT00320216|2358871|P3|Overall Study|Other|5
735408|NCT00320216|2358872|P2|Overall Study|Other|2
735409|NCT00320216|2358873|P1|Overall Study|Other|7
735410|NCT00320216|2358869|P5|Overall Study|Lost to Follow-up|0
735411|NCT00320216|2358870|P4|Overall Study|Lost to Follow-up|0
735412|NCT00320216|2358871|P3|Overall Study|Lost to Follow-up|0
735413|NCT00320216|2358872|P2|Overall Study|Lost to Follow-up|0
735414|NCT00320216|2358873|P1|Overall Study|Lost to Follow-up|3
735415|NCT00320216|2358869|P5|Overall Study|Lack of Efficacy|1
735416|NCT00320216|2358870|P4|Overall Study|Lack of Efficacy|0
735417|NCT00320216|2358871|P3|Overall Study|Lack of Efficacy|1
735418|NCT00320216|2358872|P2|Overall Study|Lack of Efficacy|2
735419|NCT00320216|2358873|P1|Overall Study|Lack of Efficacy|6
735420|NCT00320216|2358869|P5|Overall Study|Adverse Event|2
735421|NCT00320216|2358870|P4|Overall Study|Adverse Event|2
735422|NCT00320216|2358871|P3|Overall Study|Adverse Event|0
735423|NCT00320216|2358872|P2|Overall Study|Adverse Event|6
735424|NCT00320216|2358873|P1|Overall Study|Adverse Event|0
735425|NCT00320255|2358919|P6|Overall Study|Not specified|0
735426|NCT00320255|2358920|P5|Overall Study|Not specified|0
735427|NCT00320255|2358921|P4|Overall Study|Not specified|0
735428|NCT00320255|2358922|P3|Overall Study|Not specified|1
735429|NCT00320255|2358923|P2|Overall Study|Not specified|2
735430|NCT00320255|2358924|P1|Overall Study|Not specified|3
735431|NCT00320255|2358919|P6|Overall Study|No longer meets study criteria|0
735432|NCT00320255|2358920|P5|Overall Study|No longer meets study criteria|0
735433|NCT00320255|2358921|P4|Overall Study|No longer meets study criteria|1
735434|NCT00320255|2358922|P3|Overall Study|No longer meets study criteria|0
735435|NCT00320255|2358923|P2|Overall Study|No longer meets study criteria|0
735436|NCT00320255|2358924|P1|Overall Study|No longer meets study criteria|0
735437|NCT00320255|2358919|P6|Overall Study|Poor compliance/noncompliance|0
735438|NCT00320255|2358920|P5|Overall Study|Poor compliance/noncompliance|0
735439|NCT00320255|2358921|P4|Overall Study|Poor compliance/noncompliance|1
735440|NCT00320255|2358922|P3|Overall Study|Poor compliance/noncompliance|0
735441|NCT00320255|2358923|P2|Overall Study|Poor compliance/noncompliance|1
735442|NCT00320255|2358924|P1|Overall Study|Poor compliance/noncompliance|1
735443|NCT00320255|2358919|P6|Overall Study|Withdrawal by Subject|0
735444|NCT00320255|2358920|P5|Overall Study|Withdrawal by Subject|0
735445|NCT00320255|2358921|P4|Overall Study|Withdrawal by Subject|4
735446|NCT00320255|2358922|P3|Overall Study|Withdrawal by Subject|2
735447|NCT00320255|2358923|P2|Overall Study|Withdrawal by Subject|2
735448|NCT00320255|2358924|P1|Overall Study|Withdrawal by Subject|1
735449|NCT00320255|2358919|P6|Overall Study|Adverse Event|0
735450|NCT00320255|2358920|P5|Overall Study|Adverse Event|0
735451|NCT00320255|2358921|P4|Overall Study|Adverse Event|2
735452|NCT00320255|2358922|P3|Overall Study|Adverse Event|3
735453|NCT00320255|2358923|P2|Overall Study|Adverse Event|2
735454|NCT00320255|2358924|P1|Overall Study|Adverse Event|5
735455|NCT00320255|2358919|P6|Overall Study|Lack of Efficacy|0
735456|NCT00320255|2358920|P5|Overall Study|Lack of Efficacy|0
735457|NCT00320255|2358921|P4|Overall Study|Lack of Efficacy|0
735458|NCT00320255|2358922|P3|Overall Study|Lack of Efficacy|0
735459|NCT00320255|2358923|P2|Overall Study|Lack of Efficacy|0
735460|NCT00320255|2358924|P1|Overall Study|Lack of Efficacy|1
735461|NCT00320372|2359016|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
735462|NCT00320372|2359017|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
735463|NCT00320372|2359016|P2|Overall Study|Did not Meet (I/E)|1
735464|NCT00320372|2359017|P1|Overall Study|Did not Meet (I/E)|3
735465|NCT00320372|2359016|P2|Overall Study|Non-Compliance|39
735466|NCT00320372|2359017|P1|Overall Study|Non-Compliance|40
735467|NCT00320372|2359016|P2|Overall Study|Withdrawal by Subject|37
735468|NCT00320372|2359017|P1|Overall Study|Withdrawal by Subject|55
735469|NCT00320372|2359016|P2|Overall Study|Death|8
735470|NCT00320372|2359017|P1|Overall Study|Death|7
735471|NCT00320372|2359016|P2|Overall Study|Physician Decision|7
735472|NCT00320372|2359017|P1|Overall Study|Physician Decision|4
735473|NCT00320385|2359044|P2|Overall Study|Adverse Event|1
735474|NCT00320385|2359045|P1|Overall Study|Adverse Event|0
735475|NCT00320385|2359044|P2|Overall Study|Withdrew Consent|0
735476|NCT00320385|2359045|P1|Overall Study|Withdrew Consent|1
735477|NCT00320385|2359044|P2|Overall Study|Serious Adverse Event|0
735478|NCT00320385|2359045|P1|Overall Study|Serious Adverse Event|1
735479|NCT00320385|2359044|P2|Overall Study|Death|2
735480|NCT00320385|2359045|P1|Overall Study|Death|1
735481|NCT00320385|2359044|P2|Overall Study|Investigator Decision|1
735482|NCT00320385|2359045|P1|Overall Study|Investigator Decision|0
735483|NCT00320385|2359044|P2|Overall Study|Sponsor Terminated Study|1
735484|NCT00320385|2359045|P1|Overall Study|Sponsor Terminated Study|2
735485|NCT00320385|2359044|P2|Overall Study|Withdrawal by Subject|7
735486|NCT00320385|2359045|P1|Overall Study|Withdrawal by Subject|6
735487|NCT00320385|2359044|P2|Overall Study|Lost to Follow-up|10
735488|NCT00320385|2359045|P1|Overall Study|Lost to Follow-up|7
735489|NCT00320411|2359065|P1|Overall Study|No investigational product admin.|4
735490|NCT00320489|2359088|P2|Overall Study|Withdrawal by Subject|41
735491|NCT00320489|2359089|P1|Overall Study|Withdrawal by Subject|39
735492|NCT00320489|2359088|P2|Overall Study|Sponsor Decision|3
735493|NCT00320489|2359089|P1|Overall Study|Sponsor Decision|3
735494|NCT00320489|2359088|P2|Overall Study|Protocol Violation|4
735495|NCT00320489|2359089|P1|Overall Study|Protocol Violation|4
735496|NCT00320489|2359088|P2|Overall Study|Physician Decision|8
735497|NCT00320489|2359089|P1|Overall Study|Physician Decision|8
735498|NCT00320489|2359088|P2|Overall Study|Lost to Follow-up|22
735499|NCT00320489|2359089|P1|Overall Study|Lost to Follow-up|21
735500|NCT00320489|2359088|P2|Overall Study|Lack of Efficacy|7
735501|NCT00320489|2359089|P1|Overall Study|Lack of Efficacy|16
735502|NCT00320489|2359088|P2|Overall Study|Entry Criteria Exclusion|4
735503|NCT00320489|2359089|P1|Overall Study|Entry Criteria Exclusion|2
735504|NCT00320489|2359088|P2|Overall Study|Death|2
735505|NCT00320489|2359089|P1|Overall Study|Death|0
735506|NCT00320489|2359088|P2|Overall Study|Clinical Relapse|20
735507|NCT00320489|2359089|P1|Overall Study|Clinical Relapse|26
735508|NCT00320489|2359088|P2|Overall Study|Adverse Event|25
735509|NCT00320489|2359089|P1|Overall Study|Adverse Event|26
735510|NCT00320515|2359145|P1|Overall Study|Withdrawal by Subject|8
735511|NCT00320515|2359145|P1|Overall Study|Physician Decision|2
735512|NCT00320515|2359145|P1|Overall Study|Lost to Follow-up|6
735513|NCT00320515|2359145|P1|Overall Study|Death|33
735514|NCT00320528|2359155|P3|Study Period III|Atomoxetine Commercially Available|90
735515|NCT00320528|2359156|P2|Study Period III|Atomoxetine Commercially Available|25
735516|NCT00320528|2359157|P1|Study Period III|Atomoxetine Commercially Available|68
735517|NCT00320528|2359155|P3|Study Period III|Sponsor Decision|1
735518|NCT00320528|2359156|P2|Study Period III|Sponsor Decision|0
735519|NCT00320528|2359157|P1|Study Period III|Sponsor Decision|0
735520|NCT00320528|2359155|P3|Study Period III|Physician Decision|2
735521|NCT00320528|2359156|P2|Study Period III|Physician Decision|1
735522|NCT00320528|2359157|P1|Study Period III|Physician Decision|0
735523|NCT00320528|2359155|P3|Study Period III|Protocol Violation|0
735524|NCT00320528|2359156|P2|Study Period III|Protocol Violation|1
735525|NCT00320528|2359157|P1|Study Period III|Protocol Violation|0
735526|NCT00320528|2359155|P3|Study Period III|Parent/Caregiver Decision|11
735527|NCT00320528|2359156|P2|Study Period III|Parent/Caregiver Decision|3
735528|NCT00320528|2359157|P1|Study Period III|Parent/Caregiver Decision|14
735529|NCT00320528|2359155|P3|Study Period III|Lack of Efficacy|0
735530|NCT00320528|2359156|P2|Study Period III|Lack of Efficacy|0
735531|NCT00320528|2359157|P1|Study Period III|Lack of Efficacy|2
735532|NCT00320528|2359155|P3|Study Period III|Withdrawal by Subject|2
735533|NCT00320528|2359156|P2|Study Period III|Withdrawal by Subject|1
735534|NCT00320528|2359157|P1|Study Period III|Withdrawal by Subject|1
735535|NCT00320528|2359155|P3|Study Period III|Lost to Follow-up|0
735536|NCT00320528|2359156|P2|Study Period III|Lost to Follow-up|0
735537|NCT00320528|2359157|P1|Study Period III|Lost to Follow-up|1
735538|NCT00320528|2359155|P3|Study Period III|Adverse Event|0
735539|NCT00320528|2359156|P2|Study Period III|Adverse Event|0
735540|NCT00320528|2359157|P1|Study Period III|Adverse Event|1
735541|NCT00320528|2359155|P3|Study Period II|Entry Criteria Exclusion|2
735542|NCT00320528|2359156|P2|Study Period II|Entry Criteria Exclusion|2
735543|NCT00320528|2359157|P1|Study Period II|Entry Criteria Exclusion|0
735544|NCT00320528|2359155|P3|Study Period II|Withdrawal by Subject|1
735545|NCT00320528|2359156|P2|Study Period II|Withdrawal by Subject|1
735546|NCT00320528|2359157|P1|Study Period II|Withdrawal by Subject|0
735547|NCT00320528|2359155|P3|Study Period II|Parent/Caregiver Decision|11
735548|NCT00320528|2359156|P2|Study Period II|Parent/Caregiver Decision|3
735549|NCT00320528|2359157|P1|Study Period II|Parent/Caregiver Decision|8
735550|NCT00320528|2359155|P3|Study Period II|Adverse Event|8
735551|NCT00320528|2359156|P2|Study Period II|Adverse Event|4
735552|NCT00320528|2359157|P1|Study Period II|Adverse Event|3
735553|NCT00320541|2359194|P2|Overall Study|Protocol Entry Criterion Not Met|0
735554|NCT00320541|2359195|P1|Overall Study|Protocol Entry Criterion Not Met|1
735555|NCT00320541|2359194|P2|Overall Study|Death due to Adverse Event(s)|0
735556|NCT00320541|2359195|P1|Overall Study|Death due to Adverse Event(s)|1
735557|NCT00320541|2359194|P2|Overall Study|Death due to Study Disease|3
735558|NCT00320541|2359195|P1|Overall Study|Death due to Study Disease|1
735559|NCT00320541|2359194|P2|Overall Study|Sponsor Decision|1
735560|NCT00320541|2359195|P1|Overall Study|Sponsor Decision|2
735561|NCT00320541|2359194|P2|Overall Study|Other|4
735562|NCT00320541|2359195|P1|Overall Study|Other|3
735563|NCT00320541|2359194|P2|Overall Study|Physician Decision|13
735564|NCT00320541|2359195|P1|Overall Study|Physician Decision|9
735565|NCT00320541|2359194|P2|Overall Study|Withdrawal by Subject|16
735566|NCT00320541|2359195|P1|Overall Study|Withdrawal by Subject|12
735567|NCT00320541|2359194|P2|Overall Study|Protocol Violation|1
735568|NCT00320541|2359195|P1|Overall Study|Protocol Violation|0
735569|NCT00320541|2359194|P2|Overall Study|Adverse Event|19
735570|NCT00320541|2359195|P1|Overall Study|Adverse Event|21
735571|NCT00320593|2359221|P2|Overall Study|Withdrawal by clinical center|0
735572|NCT00320593|2359222|P1|Overall Study|Withdrawal by clinical center|1
735573|NCT00320593|2359221|P2|Overall Study|Withdrawal by Subject|1
735574|NCT00320593|2359222|P1|Overall Study|Withdrawal by Subject|2
735575|NCT00320593|2359221|P2|Overall Study|Moved to another state|0
735576|NCT00320593|2359222|P1|Overall Study|Moved to another state|1
735577|NCT00320593|2359221|P2|Overall Study|Lost to Follow-up|0
735578|NCT00320593|2359222|P1|Overall Study|Lost to Follow-up|3
735579|NCT00320606|2359244|P1|Overall Study|Ongoing in study|12
735580|NCT00320606|2359244|P1|Overall Study|Protocol Violation|1
735581|NCT00320606|2359244|P1|Overall Study|Adverse Event|1
735582|NCT00320710|2359260|P3|Overall Study|Lost to Follow-up|0
735583|NCT00320710|2359261|P2|Overall Study|Lost to Follow-up|0
735584|NCT00320710|2359262|P1|Overall Study|Lost to Follow-up|1
735585|NCT00320710|2359260|P3|Overall Study|Adverse Event|1
735586|NCT00320710|2359261|P2|Overall Study|Adverse Event|14
735587|NCT00320710|2359262|P1|Overall Study|Adverse Event|18
735588|NCT00320710|2359260|P3|Overall Study|Abnormal laboratory value(s)|0
735589|NCT00320710|2359261|P2|Overall Study|Abnormal laboratory value(s)|3
735590|NCT00320710|2359262|P1|Overall Study|Abnormal laboratory value(s)|12
735591|NCT00320710|2359260|P3|Overall Study|Abnormal test procedure result(s)|0
735592|NCT00320710|2359261|P2|Overall Study|Abnormal test procedure result(s)|0
735593|NCT00320710|2359262|P1|Overall Study|Abnormal test procedure result(s)|2
735594|NCT00320710|2359260|P3|Overall Study|Protocol Violation|0
735595|NCT00320710|2359261|P2|Overall Study|Protocol Violation|5
735596|NCT00320710|2359262|P1|Overall Study|Protocol Violation|6
735597|NCT00320710|2359260|P3|Overall Study|Withdrawal by Subject|1
735598|NCT00320710|2359261|P2|Overall Study|Withdrawal by Subject|26
735599|NCT00320710|2359262|P1|Overall Study|Withdrawal by Subject|20
735600|NCT00320710|2359260|P3|Overall Study|Administrative problems|0
735601|NCT00320710|2359261|P2|Overall Study|Administrative problems|2
735602|NCT00320710|2359262|P1|Overall Study|Administrative problems|1
735603|NCT00320710|2359260|P3|Overall Study|Death|1
735604|NCT00320710|2359261|P2|Overall Study|Death|7
735605|NCT00320710|2359262|P1|Overall Study|Death|10
735606|NCT00320710|2359260|P3|Overall Study|Disease progression|2
735607|NCT00320710|2359261|P2|Overall Study|Disease progression|19
735608|NCT00320710|2359262|P1|Overall Study|Disease progression|24
735609|NCT00320788|2359296|P5|Overall Study|Withdrawal by Subject|1
735610|NCT00320788|2359297|P4|Overall Study|Withdrawal by Subject|3
735611|NCT00320788|2359298|P3|Overall Study|Withdrawal by Subject|0
735612|NCT00320788|2359299|P2|Overall Study|Withdrawal by Subject|0
735613|NCT00320788|2359300|P1|Overall Study|Withdrawal by Subject|3
735614|NCT00320788|2359296|P5|Overall Study|Protocol Violation|1
735615|NCT00320788|2359297|P4|Overall Study|Protocol Violation|0
735616|NCT00320788|2359298|P3|Overall Study|Protocol Violation|0
735617|NCT00320788|2359299|P2|Overall Study|Protocol Violation|0
735618|NCT00320788|2359300|P1|Overall Study|Protocol Violation|0
735619|NCT00320788|2359296|P5|Overall Study|Physician Decision|0
735620|NCT00320788|2359297|P4|Overall Study|Physician Decision|0
735621|NCT00320788|2359298|P3|Overall Study|Physician Decision|0
735622|NCT00320788|2359299|P2|Overall Study|Physician Decision|1
735623|NCT00320788|2359300|P1|Overall Study|Physician Decision|1
735624|NCT00320788|2359296|P5|Overall Study|Other|1
735625|NCT00320788|2359297|P4|Overall Study|Other|1
735626|NCT00320788|2359298|P3|Overall Study|Other|1
735627|NCT00320788|2359299|P2|Overall Study|Other|2
735628|NCT00320788|2359300|P1|Overall Study|Other|1
735629|NCT00320788|2359296|P5|Overall Study|Decision by the Sponsor|1
735630|NCT00320788|2359297|P4|Overall Study|Decision by the Sponsor|0
735631|NCT00320788|2359298|P3|Overall Study|Decision by the Sponsor|0
735632|NCT00320788|2359299|P2|Overall Study|Decision by the Sponsor|1
735633|NCT00320788|2359300|P1|Overall Study|Decision by the Sponsor|1
735634|NCT00320788|2359296|P5|Overall Study|Lost to Follow-up|0
735635|NCT00320788|2359297|P4|Overall Study|Lost to Follow-up|0
735636|NCT00320788|2359298|P3|Overall Study|Lost to Follow-up|1
735637|NCT00320788|2359299|P2|Overall Study|Lost to Follow-up|2
735638|NCT00320788|2359300|P1|Overall Study|Lost to Follow-up|0
735639|NCT00320788|2359296|P5|Overall Study|Death|1
735640|NCT00320788|2359297|P4|Overall Study|Death|0
735641|NCT00320788|2359298|P3|Overall Study|Death|1
735642|NCT00320788|2359299|P2|Overall Study|Death|0
735643|NCT00320788|2359300|P1|Overall Study|Death|0
735644|NCT00320788|2359296|P5|Overall Study|Adverse Event|0
735645|NCT00320788|2359297|P4|Overall Study|Adverse Event|1
735646|NCT00320788|2359298|P3|Overall Study|Adverse Event|0
735647|NCT00320788|2359299|P2|Overall Study|Adverse Event|0
735648|NCT00320788|2359300|P1|Overall Study|Adverse Event|0
735649|NCT00320801|2359345|P4|Extension Phase|Lost to Follow-up|3
735650|NCT00320801|2359346|P3|Extension Phase|Lost to Follow-up|0
735651|NCT00320801|2359347|P2|Extension Phase|Lost to Follow-up|0
735652|NCT00320801|2359348|P1|Extension Phase|Lost to Follow-up|0
735653|NCT00320801|2359345|P4|Extension Phase|Lack of Efficacy|2
735654|NCT00320801|2359346|P3|Extension Phase|Lack of Efficacy|0
735655|NCT00320801|2359347|P2|Extension Phase|Lack of Efficacy|0
735656|NCT00320801|2359348|P1|Extension Phase|Lack of Efficacy|0
735657|NCT00320801|2359345|P4|Extension Phase|Administrative|29
735658|NCT00320801|2359346|P3|Extension Phase|Administrative|0
735659|NCT00320801|2359347|P2|Extension Phase|Administrative|0
735660|NCT00320801|2359348|P1|Extension Phase|Administrative|0
735661|NCT00320801|2359345|P4|Extension Phase|Adverse Event|8
735662|NCT00320801|2359346|P3|Extension Phase|Adverse Event|0
735663|NCT00320801|2359347|P2|Extension Phase|Adverse Event|0
735664|NCT00320801|2359348|P1|Extension Phase|Adverse Event|0
735665|NCT00320801|2359345|P4|Extension Phase|Withdrawal by Subject|6
735666|NCT00320801|2359346|P3|Extension Phase|Withdrawal by Subject|0
735667|NCT00320801|2359347|P2|Extension Phase|Withdrawal by Subject|0
735668|NCT00320801|2359348|P1|Extension Phase|Withdrawal by Subject|0
735669|NCT00320801|2359345|P4|Double-blind Phase|Lack of Efficacy|0
735670|NCT00320801|2359346|P3|Double-blind Phase|Lack of Efficacy|1
735671|NCT00320801|2359347|P2|Double-blind Phase|Lack of Efficacy|9
735672|NCT00320801|2359348|P1|Double-blind Phase|Lack of Efficacy|0
735673|NCT00320801|2359345|P4|Double-blind Phase|Administrative|0
735674|NCT00320801|2359346|P3|Double-blind Phase|Administrative|4
735675|NCT00320801|2359347|P2|Double-blind Phase|Administrative|0
735676|NCT00320801|2359348|P1|Double-blind Phase|Administrative|0
735677|NCT00320801|2359345|P4|Double-blind Phase|Adverse Event|0
735678|NCT00320801|2359346|P3|Double-blind Phase|Adverse Event|8
735679|NCT00320801|2359347|P2|Double-blind Phase|Adverse Event|2
735680|NCT00320801|2359348|P1|Double-blind Phase|Adverse Event|0
735681|NCT00320801|2359345|P4|Double-blind Phase|Withdrawal by Subject|0
735682|NCT00320801|2359346|P3|Double-blind Phase|Withdrawal by Subject|1
735683|NCT00320801|2359347|P2|Double-blind Phase|Withdrawal by Subject|0
735684|NCT00320801|2359348|P1|Double-blind Phase|Withdrawal by Subject|0
735685|NCT00320801|2359345|P4|Open-label Run-in Period|Did not qualify|0
735686|NCT00320801|2359346|P3|Open-label Run-in Period|Did not qualify|0
735687|NCT00320801|2359347|P2|Open-label Run-in Period|Did not qualify|0
735688|NCT00320801|2359348|P1|Open-label Run-in Period|Did not qualify|1
735689|NCT00320801|2359345|P4|Open-label Run-in Period|Lost to Follow-up|0
735690|NCT00320801|2359346|P3|Open-label Run-in Period|Lost to Follow-up|0
735691|NCT00320801|2359347|P2|Open-label Run-in Period|Lost to Follow-up|0
735692|NCT00320801|2359348|P1|Open-label Run-in Period|Lost to Follow-up|2
735693|NCT00320801|2359345|P4|Open-label Run-in Period|Lack of Efficacy|0
735694|NCT00320801|2359346|P3|Open-label Run-in Period|Lack of Efficacy|0
735695|NCT00320801|2359347|P2|Open-label Run-in Period|Lack of Efficacy|0
735696|NCT00320801|2359348|P1|Open-label Run-in Period|Lack of Efficacy|44
735697|NCT00320801|2359345|P4|Open-label Run-in Period|Administrative|0
735698|NCT00320801|2359346|P3|Open-label Run-in Period|Administrative|0
735699|NCT00320801|2359347|P2|Open-label Run-in Period|Administrative|0
735700|NCT00320801|2359348|P1|Open-label Run-in Period|Administrative|10
735701|NCT00320801|2359345|P4|Open-label Run-in Period|Adverse Event|0
735702|NCT00320801|2359346|P3|Open-label Run-in Period|Adverse Event|0
735703|NCT00320801|2359347|P2|Open-label Run-in Period|Adverse Event|0
735704|NCT00320801|2359348|P1|Open-label Run-in Period|Adverse Event|33
735705|NCT00320801|2359345|P4|Open-label Run-in Period|Withdrawal by Subject|0
735706|NCT00320801|2359346|P3|Open-label Run-in Period|Withdrawal by Subject|0
735707|NCT00320801|2359347|P2|Open-label Run-in Period|Withdrawal by Subject|0
735708|NCT00320801|2359348|P1|Open-label Run-in Period|Withdrawal by Subject|2
735709|NCT00321373|2359376|P3|Overall Study|Unspecified|1
735710|NCT00321373|2359377|P2|Overall Study|Unspecified|0
735711|NCT00321373|2359378|P1|Overall Study|Unspecified|0
735712|NCT00321373|2359376|P3|Overall Study|Withdrawal by Subject|0
735713|NCT00321373|2359377|P2|Overall Study|Withdrawal by Subject|0
735714|NCT00321373|2359378|P1|Overall Study|Withdrawal by Subject|1
735715|NCT00321373|2359376|P3|Overall Study|Lost to Follow-up|1
735716|NCT00321373|2359377|P2|Overall Study|Lost to Follow-up|0
735717|NCT00321373|2359378|P1|Overall Study|Lost to Follow-up|1
735718|NCT00321373|2359376|P3|Overall Study|Adverse Event|1
735719|NCT00321373|2359377|P2|Overall Study|Adverse Event|0
735720|NCT00321373|2359378|P1|Overall Study|Adverse Event|0
735721|NCT00321464|2359403|P2|Overall Study|Other|18
735722|NCT00321464|2359404|P1|Overall Study|Other|21
735723|NCT00321464|2359403|P2|Overall Study|Ineligibility determined|1
735724|NCT00321464|2359404|P1|Overall Study|Ineligibility determined|2
735725|NCT00321464|2359403|P2|Overall Study|Protocol deviation|2
735726|NCT00321464|2359404|P1|Overall Study|Protocol deviation|0
735727|NCT00321464|2359403|P2|Overall Study|Lost to Follow-up|8
735728|NCT00321464|2359404|P1|Overall Study|Lost to Follow-up|7
735729|NCT00321464|2359403|P2|Overall Study|Noncompliance|10
735730|NCT00321464|2359404|P1|Overall Study|Noncompliance|4
735731|NCT00321464|2359403|P2|Overall Study|Physician Decision|14
735732|NCT00321464|2359404|P1|Overall Study|Physician Decision|15
735733|NCT00321464|2359403|P2|Overall Study|Adverse Event|28
735734|NCT00321464|2359404|P1|Overall Study|Adverse Event|43
735735|NCT00321464|2359403|P2|Overall Study|Participant request|61
735736|NCT00321464|2359404|P1|Overall Study|Participant request|57
735737|NCT00321464|2359403|P2|Overall Study|Withdrawal by Subject|118
735738|NCT00321464|2359404|P1|Overall Study|Withdrawal by Subject|117
735739|NCT00321464|2359403|P2|Overall Study|Disease progression|124
735740|NCT00321464|2359404|P1|Overall Study|Disease progression|124
735741|NCT00321464|2359403|P2|Overall Study|Death|174
735742|NCT00321464|2359404|P1|Overall Study|Death|169
735743|NCT00321620|2359434|P2|Overall Study|Other|33
735744|NCT00321620|2359435|P1|Overall Study|Other|42
735745|NCT00321620|2359434|P2|Overall Study|Participant request|52
735746|NCT00321620|2359435|P1|Overall Study|Participant request|75
735747|NCT00321620|2359434|P2|Overall Study|Ineligibility determined|3
735748|NCT00321620|2359435|P1|Overall Study|Ineligibility determined|2
735749|NCT00321620|2359434|P2|Overall Study|Protocol deviation|3
735750|NCT00321620|2359435|P1|Overall Study|Protocol deviation|4
735751|NCT00321620|2359434|P2|Overall Study|Noncompliance|7
735752|NCT00321620|2359435|P1|Overall Study|Noncompliance|14
735753|NCT00321620|2359434|P2|Overall Study|Physician Decision|1
735754|NCT00321620|2359435|P1|Overall Study|Physician Decision|4
735755|NCT00321620|2359434|P2|Overall Study|Lost to Follow-up|9
735756|NCT00321620|2359435|P1|Overall Study|Lost to Follow-up|13
735757|NCT00321620|2359434|P2|Overall Study|Adverse Event|56
735758|NCT00321620|2359435|P1|Overall Study|Adverse Event|43
735759|NCT00321620|2359434|P2|Overall Study|Disease progression|117
735760|NCT00321620|2359435|P1|Overall Study|Disease progression|113
735761|NCT00321620|2359434|P2|Overall Study|Withdrawal by Subject|147
735762|NCT00321620|2359435|P1|Overall Study|Withdrawal by Subject|164
735763|NCT00321620|2359434|P2|Overall Study|Death|294
735764|NCT00321620|2359435|P1|Overall Study|Death|269
735765|NCT00321646|2359445|P1|Neoadjuvant Chemotherapy|Disease progression|1
735766|NCT00321646|2359445|P1|Neoadjuvant Chemotherapy|Adverse Event|2
735767|NCT00321646|2359445|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
735768|NCT00328094|2359476|P2|Overall Study|Physician Decision|3
735769|NCT00328094|2359477|P1|Overall Study|Physician Decision|3
735770|NCT00328172|2359490|P5|Overall Study|Other reason (not specified)|0
735771|NCT00328172|2359491|P4|Overall Study|Other reason (not specified)|0
735772|NCT00328172|2359492|P3|Overall Study|Other reason (not specified)|1
735773|NCT00328172|2359493|P2|Overall Study|Other reason (not specified)|0
735774|NCT00328172|2359494|P1|Overall Study|Other reason (not specified)|3
735775|NCT00328172|2359490|P5|Overall Study|Lack of Efficacy|3
735776|NCT00328172|2359491|P4|Overall Study|Lack of Efficacy|4
735777|NCT00328172|2359492|P3|Overall Study|Lack of Efficacy|4
735778|NCT00328172|2359493|P2|Overall Study|Lack of Efficacy|9
735779|NCT00328172|2359494|P1|Overall Study|Lack of Efficacy|14
735780|NCT00328172|2359490|P5|Overall Study|Withdrawal by Subject|0
735781|NCT00328172|2359491|P4|Overall Study|Withdrawal by Subject|6
735782|NCT00328172|2359492|P3|Overall Study|Withdrawal by Subject|1
735783|NCT00328172|2359493|P2|Overall Study|Withdrawal by Subject|1
735784|NCT00328172|2359494|P1|Overall Study|Withdrawal by Subject|1
735785|NCT00328172|2359490|P5|Overall Study|Lost to Follow-up|1
735786|NCT00328172|2359491|P4|Overall Study|Lost to Follow-up|1
735787|NCT00328172|2359492|P3|Overall Study|Lost to Follow-up|2
735788|NCT00328172|2359493|P2|Overall Study|Lost to Follow-up|1
735789|NCT00328172|2359494|P1|Overall Study|Lost to Follow-up|1
735790|NCT00328172|2359490|P5|Overall Study|Protocol Violation|0
735791|NCT00328172|2359491|P4|Overall Study|Protocol Violation|0
735792|NCT00328172|2359492|P3|Overall Study|Protocol Violation|1
735793|NCT00328172|2359493|P2|Overall Study|Protocol Violation|1
735794|NCT00328172|2359494|P1|Overall Study|Protocol Violation|0
735795|NCT00328172|2359490|P5|Overall Study|Adverse Event|1
735796|NCT00328172|2359491|P4|Overall Study|Adverse Event|2
735797|NCT00328172|2359492|P3|Overall Study|Adverse Event|1
735798|NCT00328172|2359493|P2|Overall Study|Adverse Event|2
735799|NCT00328172|2359494|P1|Overall Study|Adverse Event|3
735800|NCT00328198|2359516|P1|Follow-up|Death|31
735801|NCT00328198|2359516|P1|Follow-up|Lost to Follow-up|4
735802|NCT00328198|2359516|P1|Treatment|Confirmed complete response, MRD -|3
735803|NCT00328198|2359516|P1|Treatment|Non-compliance|1
735804|NCT00328198|2359516|P1|Treatment|Evidence of disease progression|2
735805|NCT00328198|2359516|P1|Treatment|Withdrawal by Subject|5
735806|NCT00328198|2359516|P1|Treatment|Physician Decision|5
735807|NCT00328198|2359516|P1|Treatment|Death|1
735808|NCT00328198|2359516|P1|Treatment|Adverse Event|21
735812|NCT00328926|2359560|P3|Overall Study|Lack of ovarian response|0
735813|NCT00328926|2359561|P2|Overall Study|Lack of ovarian response|1
735814|NCT00328926|2359562|P1|Overall Study|Lack of ovarian response|0
735815|NCT00328926|2359560|P3|Overall Study|In vitro fertilization treatment|1
735816|NCT00328926|2359561|P2|Overall Study|In vitro fertilization treatment|0
735817|NCT00328926|2359562|P1|Overall Study|In vitro fertilization treatment|0
735818|NCT00328926|2359560|P3|Overall Study|Death|1
735819|NCT00328926|2359561|P2|Overall Study|Death|0
735820|NCT00328926|2359562|P1|Overall Study|Death|0
735821|NCT00328926|2359560|P3|Overall Study|Lost to Follow-up|0
735822|NCT00328926|2359561|P2|Overall Study|Lost to Follow-up|1
735823|NCT00328926|2359562|P1|Overall Study|Lost to Follow-up|0
735824|NCT00328926|2359560|P3|Overall Study|Pregnancy|0
735825|NCT00328926|2359561|P2|Overall Study|Pregnancy|1
735826|NCT00328926|2359562|P1|Overall Study|Pregnancy|2
735827|NCT00329030|2359578|P2|Overall Study|Ineligible Pathology|1
735828|NCT00329030|2359579|P1|Overall Study|Ineligible Pathology|1
735829|NCT00329030|2359578|P2|Overall Study|Progressive Disease|2
735830|NCT00329030|2359579|P1|Overall Study|Progressive Disease|6
735831|NCT00329030|2359578|P2|Overall Study|Withdrawal by Subject|3
735832|NCT00329030|2359579|P1|Overall Study|Withdrawal by Subject|1
735833|NCT00329108|2359609|P2|Overall Study|Protocol Violation|2
735834|NCT00329108|2359610|P1|Overall Study|Protocol Violation|0
735835|NCT00329108|2359609|P2|Overall Study|withdrew patient after SAE resolved|0
735836|NCT00329108|2359610|P1|Overall Study|withdrew patient after SAE resolved|1
735837|NCT00329108|2359609|P2|Overall Study|study terminated by sponsor|0
735838|NCT00329108|2359610|P1|Overall Study|study terminated by sponsor|1
735839|NCT00329108|2359609|P2|Overall Study|Subject no longer willing to participate|2
735840|NCT00329108|2359610|P1|Overall Study|Subject no longer willing to participate|2
735841|NCT00329108|2359609|P2|Overall Study|symptomatic deterioration|1
735842|NCT00329108|2359610|P1|Overall Study|symptomatic deterioration|1
735843|NCT00329108|2359609|P2|Overall Study|Withdrawal by Subject|2
735844|NCT00329108|2359610|P1|Overall Study|Withdrawal by Subject|0
735845|NCT00329108|2359609|P2|Overall Study|Lack of Efficacy|3
735846|NCT00329108|2359610|P1|Overall Study|Lack of Efficacy|3
735847|NCT00329108|2359609|P2|Overall Study|Adverse Event|2
735848|NCT00329108|2359610|P1|Overall Study|Adverse Event|2
735849|NCT00329160|2359616|P1|Overall Study|Incomplete IVUS|45
735850|NCT00329160|2359616|P1|Overall Study|Did not Receive Study Drug|1
735851|NCT00329160|2359616|P1|Overall Study|Protocol Violation|2
735852|NCT00329160|2359616|P1|Overall Study|Withdrawal by Subject|13
735853|NCT00329160|2359616|P1|Overall Study|Adverse Event|27
735854|NCT00329238|2359625|P2|Overall Study|Other reason (not specified)|54
735855|NCT00329238|2359626|P1|Overall Study|Other reason (not specified)|40
735856|NCT00329238|2359625|P2|Overall Study|Withdrawal by Subject|58
735857|NCT00329238|2359626|P1|Overall Study|Withdrawal by Subject|64
735858|NCT00329238|2359625|P2|Overall Study|Lost to Follow-up|6
735859|NCT00329238|2359626|P1|Overall Study|Lost to Follow-up|2
735860|NCT00329238|2359625|P2|Overall Study|Protocol Violation|34
735861|NCT00329238|2359626|P1|Overall Study|Protocol Violation|23
735862|NCT00329238|2359625|P2|Overall Study|Adverse Event|129
735863|NCT00329238|2359626|P1|Overall Study|Adverse Event|147
735864|NCT00329407|2359662|P1|Overall Study|Withdrawal by Subject|1
735865|NCT00329420|2359670|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
735866|NCT00329420|2359671|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
735867|NCT00329420|2359672|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
735868|NCT00329420|2359670|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
735869|NCT00329420|2359671|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
735870|NCT00329420|2359672|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
735871|NCT00329420|2359670|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
735872|NCT00329420|2359671|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
735873|NCT00329420|2359672|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
735874|NCT00329420|2359670|P3|Re-induction Phase|Did not respond to re-induction|7
735875|NCT00329420|2359671|P2|Re-induction Phase|Did not respond to re-induction|5
735876|NCT00329420|2359672|P1|Re-induction Phase|Did not respond to re-induction|6
735877|NCT00329420|2359670|P3|Re-induction Phase|Withdrawal of Consent|1
735878|NCT00329420|2359671|P2|Re-induction Phase|Withdrawal of Consent|0
735879|NCT00329420|2359672|P1|Re-induction Phase|Withdrawal of Consent|0
735880|NCT00329420|2359670|P3|Re-induction Phase|Lack of Efficacy|0
735881|NCT00329420|2359671|P2|Re-induction Phase|Lack of Efficacy|1
735882|NCT00329420|2359672|P1|Re-induction Phase|Lack of Efficacy|0
735883|NCT00329550|2360069|P3|Overall Study|Due to Relocation|1
735884|NCT00329550|2360070|P2|Overall Study|Due to Relocation|0
735885|NCT00329550|2360071|P1|Overall Study|Due to Relocation|0
735886|NCT00329550|2360069|P3|Overall Study|Withdrawal of Consent|1
735887|NCT00329550|2360070|P2|Overall Study|Withdrawal of Consent|0
735888|NCT00329550|2360071|P1|Overall Study|Withdrawal of Consent|1
735889|NCT00329550|2360069|P3|Overall Study|Adverse Event|2
735890|NCT00329550|2360070|P2|Overall Study|Adverse Event|4
735891|NCT00329550|2360071|P1|Overall Study|Adverse Event|3
735892|NCT00329602|2360320|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
735893|NCT00329602|2360321|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
735894|NCT00329602|2360322|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
735895|NCT00329602|2360320|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
735896|NCT00329602|2360321|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
735897|NCT00329602|2360322|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
735898|NCT00329602|2360320|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
735899|NCT00329602|2360321|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
735900|NCT00329602|2360322|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
735901|NCT00329602|2360320|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
735902|NCT00329602|2360321|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
735903|NCT00329602|2360322|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
735904|NCT00329602|2360320|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
735905|NCT00329602|2360321|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
735906|NCT00329602|2360322|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
735907|NCT00329602|2360320|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
735908|NCT00329602|2360321|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
735909|NCT00329602|2360322|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
735910|NCT00329641|2360357|P1|Overall Study|Other reason, not protocol specified|1
735911|NCT00329641|2360357|P1|Overall Study|Adverse Event|3
735912|NCT00329641|2360357|P1|Overall Study|Not eligible|1
735913|NCT00329641|2360357|P1|Overall Study|Did not start treatment|1
735914|NCT00329719|2360368|P4|Overall Study|Lost to Follow-up|1
735915|NCT00329719|2360369|P3|Overall Study|Lost to Follow-up|0
735916|NCT00329719|2360370|P2|Overall Study|Lost to Follow-up|0
735917|NCT00329719|2360371|P1|Overall Study|Lost to Follow-up|0
735918|NCT00329745|2360403|P2|Overall Study|Lost to Follow-up|101
735919|NCT00329745|2360404|P1|Overall Study|Lost to Follow-up|86
735920|NCT00329745|2360403|P2|Overall Study|Withdrawal by Subject|1
735921|NCT00329745|2360404|P1|Overall Study|Withdrawal by Subject|0
735922|NCT00329745|2360403|P2|Overall Study|Protocol Violation|0
735923|NCT00329745|2360404|P1|Overall Study|Protocol Violation|1
735924|NCT00329784|2360420|P4|Overall Study|Unspecified|0
735925|NCT00329784|2360421|P3|Overall Study|Unspecified|0
735926|NCT00329784|2360422|P2|Overall Study|Unspecified|2
735927|NCT00329784|2360423|P1|Overall Study|Unspecified|1
735928|NCT00329784|2360420|P4|Overall Study|Withdrawal by Subject|0
735929|NCT00329784|2360421|P3|Overall Study|Withdrawal by Subject|0
735930|NCT00329784|2360422|P2|Overall Study|Withdrawal by Subject|2
735931|NCT00329784|2360423|P1|Overall Study|Withdrawal by Subject|4
735932|NCT00329784|2360420|P4|Overall Study|Lost to Follow-up|0
735933|NCT00329784|2360421|P3|Overall Study|Lost to Follow-up|0
735934|NCT00329784|2360422|P2|Overall Study|Lost to Follow-up|1
735935|NCT00329784|2360423|P1|Overall Study|Lost to Follow-up|0
735936|NCT00329849|2360451|P2|Overall Study|Withdrawal by Subject|4
735937|NCT00329849|2360452|P1|Overall Study|Withdrawal by Subject|6
735938|NCT00329901|2360475|P3|Overall Study|Unable to classify|0
735939|NCT00329901|2360476|P2|Overall Study|Unable to classify|2
735940|NCT00329901|2360477|P1|Overall Study|Unable to classify|2
735941|NCT00329901|2360475|P3|Overall Study|Protocol Violation|1
735942|NCT00329901|2360476|P2|Overall Study|Protocol Violation|0
735943|NCT00329901|2360477|P1|Overall Study|Protocol Violation|1
735944|NCT00329901|2360475|P3|Overall Study|Lost to Follow-up|1
735945|NCT00329901|2360476|P2|Overall Study|Lost to Follow-up|0
735946|NCT00329901|2360477|P1|Overall Study|Lost to Follow-up|2
735947|NCT00329901|2360475|P3|Overall Study|Withdrawal by Subject|2
735948|NCT00329901|2360476|P2|Overall Study|Withdrawal by Subject|3
735949|NCT00329901|2360477|P1|Overall Study|Withdrawal by Subject|4
735950|NCT00330174|2360516|P2|Overall Study|Miscellaneous reasons|1
735951|NCT00330174|2360517|P1|Overall Study|Miscellaneous reasons|7
735952|NCT00330174|2360516|P2|Overall Study|Excessive missed visits|8
735953|NCT00330174|2360517|P1|Overall Study|Excessive missed visits|3
735954|NCT00330174|2360516|P2|Overall Study|Clinical deterioration|2
735955|NCT00330174|2360517|P1|Overall Study|Clinical deterioration|1
735956|NCT00330174|2360516|P2|Overall Study|Lost to Follow-up|1
735957|NCT00330174|2360517|P1|Overall Study|Lost to Follow-up|4
735958|NCT00330174|2360516|P2|Overall Study|Withdrawal by Subject|7
735959|NCT00330174|2360517|P1|Overall Study|Withdrawal by Subject|7
735960|NCT00330343|2360529|P1|Overall Study|Lost to Follow-up|5
735961|NCT00330460|2360564|P2|Overall Study|Other|0
735962|NCT00330460|2360565|P1|Overall Study|Other|1
735963|NCT00330460|2360564|P2|Overall Study|Noncompliance|1
735964|NCT00330460|2360565|P1|Overall Study|Noncompliance|2
735965|NCT00330460|2360564|P2|Overall Study|Lost to Follow-up|3
735966|NCT00330460|2360565|P1|Overall Study|Lost to Follow-up|8
735967|NCT00330460|2360564|P2|Overall Study|Ineligibility determined|3
735968|NCT00330460|2360565|P1|Overall Study|Ineligibility determined|1
735969|NCT00330460|2360564|P2|Overall Study|Death|1
735970|NCT00330460|2360565|P1|Overall Study|Death|1
735971|NCT00330460|2360564|P2|Overall Study|Withdrawal by Subject|17
735972|NCT00330460|2360565|P1|Overall Study|Withdrawal by Subject|18
735973|NCT00330460|2360564|P2|Overall Study|Adverse Event|8
735974|NCT00330460|2360565|P1|Overall Study|Adverse Event|10
735975|NCT00330460|2360564|P2|Overall Study|Physician Decision|0
735976|NCT00330460|2360565|P1|Overall Study|Physician Decision|1
735977|NCT00330616|2360584|P1|Overall Study|Not specified|1
735978|NCT00330616|2360584|P1|Overall Study|Withdrawal by Subject|4
735979|NCT00330616|2360584|P1|Overall Study|Lost to Follow-up|2
735980|NCT00330616|2360584|P1|Overall Study|Lack of Efficacy|1
735981|NCT00330616|2360584|P1|Overall Study|Adverse Event|13
735982|NCT00330668|2360603|P1|Overall Study|Patient started Lupron|1
735983|NCT00330668|2360603|P1|Overall Study|Use of exclusionary medication|1
735984|NCT00330668|2360603|P1|Overall Study|Lack of Efficacy|1
735985|NCT00330668|2360603|P1|Overall Study|Sponsor's decision|76
735986|NCT00330668|2360603|P1|Overall Study|Withdrawal by Subject|20
735987|NCT00330668|2360603|P1|Overall Study|Non-Compliance|5
735988|NCT00330668|2360603|P1|Overall Study|Lost to Follow-up|9
735989|NCT00330668|2360603|P1|Overall Study|Adverse Event|1
735990|NCT00330681|2360612|P2|Overall Study|Tracheotomy due to worsening of ALS|2
735991|NCT00330681|2360613|P1|Overall Study|Tracheotomy due to worsening of ALS|1
735992|NCT00330681|2360612|P2|Overall Study|Withdrawal by Subject|5
735993|NCT00330681|2360613|P1|Overall Study|Withdrawal by Subject|5
735994|NCT00330681|2360612|P2|Overall Study|Protocol Violation|1
735995|NCT00330681|2360613|P1|Overall Study|Protocol Violation|0
735996|NCT00330681|2360612|P2|Overall Study|Adverse Event|6
735997|NCT00330681|2360613|P1|Overall Study|Adverse Event|3
735998|NCT00330759|2360646|P2|Overall Study|Other|44
735999|NCT00330759|2360647|P1|Overall Study|Other|36
736000|NCT00330759|2360646|P2|Overall Study|Ineligibility determined|1
736001|NCT00330759|2360647|P1|Overall Study|Ineligibility determined|2
736002|NCT00330759|2360646|P2|Overall Study|Protocol deviation|2
736003|NCT00330759|2360647|P1|Overall Study|Protocol deviation|0
736004|NCT00330759|2360646|P2|Overall Study|Physician Decision|2
736005|NCT00330759|2360647|P1|Overall Study|Physician Decision|1
736006|NCT00330759|2360646|P2|Overall Study|Noncompliance|17
736007|NCT00330759|2360647|P1|Overall Study|Noncompliance|15
736008|NCT00330759|2360646|P2|Overall Study|Lost to Follow-up|22
736009|NCT00330759|2360647|P1|Overall Study|Lost to Follow-up|16
736010|NCT00330759|2360646|P2|Overall Study|Participant request|22
736011|NCT00330759|2360647|P1|Overall Study|Participant request|31
736012|NCT00330759|2360646|P2|Overall Study|Adverse Event|36
736013|NCT00330759|2360647|P1|Overall Study|Adverse Event|48
736014|NCT00330759|2360646|P2|Overall Study|Withdrawal by Subject|124
736015|NCT00330759|2360647|P1|Overall Study|Withdrawal by Subject|143
736016|NCT00330759|2360646|P2|Overall Study|Disease progression|126
736017|NCT00330759|2360647|P1|Overall Study|Disease progression|104
736018|NCT00330759|2360646|P2|Overall Study|Death|310
736019|NCT00330759|2360647|P1|Overall Study|Death|316
736020|NCT00330928|2360673|P1|Overall Study|IVUS could not be performed.|1
736021|NCT00330928|2360673|P1|Overall Study|Death|1
736022|NCT00330928|2360673|P1|Overall Study|Physician Decision|9
736023|NCT00330928|2360673|P1|Overall Study|Lost to Follow-up|6
736024|NCT00330967|2360680|P2|Overall Study|Physician Decision|9
736025|NCT00330967|2360681|P1|Overall Study|Physician Decision|0
736026|NCT00330967|2360680|P2|Overall Study|Withdrawal by Subject|5
736027|NCT00330967|2360681|P1|Overall Study|Withdrawal by Subject|0
736028|NCT00331006|2360692|P1|Follow-Up Phase II|Lost to Follow-up|3
736029|NCT00331006|2360692|P1|Follow-Up Phase I|Lost to Follow-up|1
736030|NCT00331006|2360692|P1|Treatment Phase|Withdrawal by Subject|1
736031|NCT00331006|2360692|P1|Screening Phase|Ineligible for treatment phase|4
736032|NCT00331006|2360692|P1|Screening Phase|Lost to Follow-up|1
736033|NCT00331006|2360692|P1|Screening Phase|enrollment halted|1
736034|NCT00331006|2360692|P1|Screening Phase|Withdrawal by Subject|1
736035|NCT00308074|2360713|P1|Overall Study|Withdrawal by Subject|1
736036|NCT00308087|2360722|P2|Overall Study|Not Specified|3
736037|NCT00308087|2360723|P1|Overall Study|Not Specified|4
736038|NCT00308087|2360722|P2|Overall Study|Withdrawal by Subject|1
736039|NCT00308087|2360723|P1|Overall Study|Withdrawal by Subject|2
736040|NCT00308087|2360722|P2|Overall Study|Study Closure|12
736041|NCT00308087|2360723|P1|Overall Study|Study Closure|11
736042|NCT00308087|2360722|P2|Overall Study|Progressive Disease|21
736043|NCT00308087|2360723|P1|Overall Study|Progressive Disease|19
736044|NCT00308113|2360743|P4|Overall Study|Protocol closure|1
736045|NCT00308113|2360744|P3|Overall Study|Protocol closure|0
736046|NCT00308113|2360745|P2|Overall Study|Protocol closure|0
736047|NCT00308113|2360746|P1|Overall Study|Protocol closure|0
736048|NCT00308139|2360766|P2|Overall Study|Other|0
736049|NCT00308139|2360767|P1|Overall Study|Other|1
736050|NCT00308139|2360766|P2|Overall Study|Administrative|4
736051|NCT00308139|2360767|P1|Overall Study|Administrative|1
736052|NCT00308139|2360766|P2|Overall Study|Loss of Glucose Control|7
736053|NCT00308139|2360767|P1|Overall Study|Loss of Glucose Control|5
736054|NCT00308139|2360766|P2|Overall Study|Investigator Decision|10
736055|NCT00308139|2360767|P1|Overall Study|Investigator Decision|11
736056|NCT00308139|2360766|P2|Overall Study|Withdrawal of Consent|42
736057|NCT00308139|2360767|P1|Overall Study|Withdrawal of Consent|40
736058|NCT00308139|2360766|P2|Overall Study|Protocol Violation|2
736059|NCT00308139|2360767|P1|Overall Study|Protocol Violation|3
736060|NCT00308139|2360766|P2|Overall Study|Lost to Follow-up|8
736061|NCT00308139|2360767|P1|Overall Study|Lost to Follow-up|13
736062|NCT00308139|2360766|P2|Overall Study|Adverse Event|14
736063|NCT00308139|2360767|P1|Overall Study|Adverse Event|20
736064|NCT00308308|2360852|P2|Overall Study|Other|0
736065|NCT00308308|2360853|P1|Overall Study|Other|1
736066|NCT00308308|2360852|P2|Overall Study|Randomized but not dosed|16
736067|NCT00308308|2360853|P1|Overall Study|Randomized but not dosed|8
736068|NCT00308308|2360852|P2|Overall Study|Various|5
736069|NCT00308308|2360853|P1|Overall Study|Various|7
736070|NCT00308308|2360852|P2|Overall Study|Withdrawal by Subject|19
736071|NCT00308308|2360853|P1|Overall Study|Withdrawal by Subject|47
736072|NCT00308308|2360852|P2|Overall Study|Protocol Violation|14
736073|NCT00308308|2360853|P1|Overall Study|Protocol Violation|3
736074|NCT00308308|2360852|P2|Overall Study|Physician Decision|7
736075|NCT00308308|2360853|P1|Overall Study|Physician Decision|15
736076|NCT00308308|2360852|P2|Overall Study|Lost to Follow-up|5
736077|NCT00308308|2360853|P1|Overall Study|Lost to Follow-up|5
736078|NCT00308308|2360852|P2|Overall Study|Adverse Event|2
736079|NCT00308308|2360853|P1|Overall Study|Adverse Event|17
736080|NCT00313781|2360875|P3|After Crossover|Unspecified|18
736081|NCT00313781|2360876|P2|After Crossover|Unspecified|0
736082|NCT00313781|2360877|P1|After Crossover|Unspecified|0
736083|NCT00313781|2360875|P3|After Crossover|Withdrawal by Subject|3
736084|NCT00313781|2360876|P2|After Crossover|Withdrawal by Subject|0
736085|NCT00313781|2360877|P1|After Crossover|Withdrawal by Subject|0
736086|NCT00313781|2360875|P3|After Crossover|Death|6
736087|NCT00313781|2360876|P2|After Crossover|Death|0
736088|NCT00313781|2360877|P1|After Crossover|Death|0
736089|NCT00313781|2360875|P3|Before Crossover|Randomized, not treated|0
736090|NCT00313781|2360876|P2|Before Crossover|Randomized, not treated|0
736091|NCT00313781|2360877|P1|Before Crossover|Randomized, not treated|5
736092|NCT00313781|2360875|P3|Before Crossover|Crossover|0
736093|NCT00313781|2360876|P2|Before Crossover|Crossover|37
736094|NCT00313781|2360877|P1|Before Crossover|Crossover|0
736095|NCT00313781|2360875|P3|Before Crossover|Unspecified|0
736096|NCT00313781|2360876|P2|Before Crossover|Unspecified|30
736097|NCT00313781|2360877|P1|Before Crossover|Unspecified|45
736098|NCT00313781|2360875|P3|Before Crossover|Withdrawal by Subject|0
736099|NCT00313781|2360876|P2|Before Crossover|Withdrawal by Subject|1
736100|NCT00313781|2360877|P1|Before Crossover|Withdrawal by Subject|3
736101|NCT00313781|2360875|P3|Before Crossover|Lost to Follow-up|0
736102|NCT00313781|2360876|P2|Before Crossover|Lost to Follow-up|3
736103|NCT00313781|2360877|P1|Before Crossover|Lost to Follow-up|0
736104|NCT00313781|2360875|P3|Before Crossover|Death|0
736105|NCT00313781|2360876|P2|Before Crossover|Death|8
736106|NCT00313781|2360877|P1|Before Crossover|Death|22
736107|NCT00313820|2360913|P2|Pregabalin or Placebo Treatment Period|Other|3
736108|NCT00313820|2360914|P1|Pregabalin or Placebo Treatment Period|Other|2
736109|NCT00313820|2360913|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
736110|NCT00313820|2360914|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
736111|NCT00313820|2360913|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
736112|NCT00313820|2360914|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
736113|NCT00313820|2360913|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
736114|NCT00313820|2360914|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
736115|NCT00313820|2360913|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
736116|NCT00313820|2360914|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
736117|NCT00313820|2360913|P2|Assigned to Treatment|Other|0
736118|NCT00313820|2360914|P1|Assigned to Treatment|Other|1
736119|NCT00324649|2360952|P2|Overall Study|Noncompliance|0
736120|NCT00324649|2360953|P1|Overall Study|Noncompliance|1
736121|NCT00324649|2360952|P2|Overall Study|Withdrawal by Subject|1
736122|NCT00324649|2360953|P1|Overall Study|Withdrawal by Subject|0
736123|NCT00324649|2360952|P2|Overall Study|Adverse Event|4
736124|NCT00324649|2360953|P1|Overall Study|Adverse Event|1
736125|NCT00324675|2360995|P2|Overall Study|Adverse Event|0
736126|NCT00324675|2360996|P1|Overall Study|Adverse Event|1
736127|NCT00324740|2361013|P3|Overall Study|Withdrawal by Subject|1
736128|NCT00324740|2361014|P2|Overall Study|Withdrawal by Subject|0
736129|NCT00324740|2361015|P1|Overall Study|Withdrawal by Subject|1
736130|NCT00324961|2361054|P1|Overall Study|Other|2
736131|NCT00324961|2361054|P1|Overall Study|Protocol Violation|3
736132|NCT00324961|2361054|P1|Overall Study|Lost to Follow-up|22
736133|NCT00324961|2361054|P1|Overall Study|Consent Withdrawn|11
736134|NCT00324961|2361054|P1|Overall Study|Adverse Event|5
736135|NCT00324987|2361069|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
736136|NCT00324987|2361070|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
736137|NCT00324987|2361069|P2|Overall Study|Progression|1
736138|NCT00324987|2361070|P1|Overall Study|Progression|1
736139|NCT00324987|2361069|P2|Overall Study|Withdrawal by Subject|1
736140|NCT00324987|2361070|P1|Overall Study|Withdrawal by Subject|1
736141|NCT00324987|2361069|P2|Overall Study|Adverse Event|1
736142|NCT00324987|2361070|P1|Overall Study|Adverse Event|2
736143|NCT00325039|2361086|P2|Overall Study|Lost to Follow-up|14
736144|NCT00325039|2361087|P1|Overall Study|Lost to Follow-up|18
736145|NCT00325130|2361118|P2|Overall Study|Patient Discontinued for Other|0
736146|NCT00325130|2361119|P1|Overall Study|Patient Discontinued for Other|1
736147|NCT00325130|2361118|P2|Overall Study|Moved|1
736148|NCT00325130|2361119|P1|Overall Study|Moved|0
736149|NCT00325130|2361118|P2|Overall Study|Protocol Deviation|1
736150|NCT00325130|2361119|P1|Overall Study|Protocol Deviation|0
736151|NCT00325130|2361118|P2|Overall Study|Withdrawal by Subject|14
736152|NCT00325130|2361119|P1|Overall Study|Withdrawal by Subject|12
736153|NCT00325130|2361118|P2|Overall Study|Lost to Follow-up|14
736154|NCT00325130|2361119|P1|Overall Study|Lost to Follow-up|6
736155|NCT00325143|2361159|P1|Overall Study|Withdrawal by Subject|8
736156|NCT00325143|2361159|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
736157|NCT00325143|2361159|P1|Overall Study|Migrated/moved from study area|1
736158|NCT00325143|2361159|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
736159|NCT00325156|2361166|P1|Overall Study|Withdrawal by Subject|31
736160|NCT00325156|2361166|P1|Overall Study|Unspecified|1
736161|NCT00325156|2361166|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
736162|NCT00325156|2361166|P1|Overall Study|Adverse event, non-fatal|3
736163|NCT00325156|2361166|P1|Overall Study|Migrated/moved from study area|12
736164|NCT00325156|2361166|P1|Overall Study|Lost to follow-up (complete vaccination)|41
736165|NCT00325156|2361166|P1|Overall Study|Protocol Violation|8
736166|NCT00325195|2361176|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
736167|NCT00325195|2361177|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
736168|NCT00325195|2361178|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
736169|NCT00325195|2361176|P3|Received Intervention: ITT Population|Lost to Follow-up|2
736170|NCT00325195|2361177|P2|Received Intervention: ITT Population|Lost to Follow-up|0
736171|NCT00325195|2361178|P1|Received Intervention: ITT Population|Lost to Follow-up|0
736172|NCT00325195|2361176|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
736173|NCT00325195|2361177|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
736174|NCT00325195|2361178|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
736175|NCT00325195|2361176|P3|Received Intervention: ITT Population|Death|0
736176|NCT00325195|2361177|P2|Received Intervention: ITT Population|Death|1
736177|NCT00325195|2361178|P1|Received Intervention: ITT Population|Death|3
736178|NCT00325195|2361176|P3|Received Intervention: ITT Population|Adverse Event|1
736179|NCT00325195|2361177|P2|Received Intervention: ITT Population|Adverse Event|17
736180|NCT00325195|2361178|P1|Received Intervention: ITT Population|Adverse Event|15
736181|NCT00325195|2361176|P3|Randomized|Not dosed|3
736182|NCT00325195|2361177|P2|Randomized|Not dosed|5
736183|NCT00325195|2361178|P1|Randomized|Not dosed|5
736184|NCT00325234|2361203|P2|Overall Study|Progressive Disease|37
736185|NCT00325234|2361204|P1|Overall Study|Progressive Disease|34
736186|NCT00325234|2361203|P2|Overall Study|Physician Decision|12
736187|NCT00325234|2361204|P1|Overall Study|Physician Decision|17
736188|NCT00325234|2361203|P2|Overall Study|Subject Decision|8
736189|NCT00325234|2361204|P1|Overall Study|Subject Decision|6
736190|NCT00325234|2361203|P2|Overall Study|Entry Criteria Not Met|2
736191|NCT00325234|2361204|P1|Overall Study|Entry Criteria Not Met|1
736192|NCT00325234|2361203|P2|Overall Study|Death due to Study Disease|0
736193|NCT00325234|2361204|P1|Overall Study|Death due to Study Disease|1
736194|NCT00325234|2361203|P2|Overall Study|Adverse Event|7
736195|NCT00325234|2361204|P1|Overall Study|Adverse Event|10
736196|NCT00325416|2361261|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
736197|NCT00325416|2361262|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
736198|NCT00325416|2361261|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
736199|NCT00325416|2361262|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
736200|NCT00325416|2361261|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
736201|NCT00325416|2361262|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
736202|NCT00325416|2361261|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
736203|NCT00325416|2361262|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
736204|NCT00325416|2361261|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
736205|NCT00325416|2361262|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
736206|NCT00325416|2361261|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
736207|NCT00325416|2361262|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
890630|NCT00950807|2825718|P7|Washout Period 1|Lack of Efficacy|1
736209|NCT00331422|2361329|P1|Overall Study|Did not receive entire study regimen|5
736210|NCT00331552|2361340|P2|Period 3: Phase II|Severe Nausea|0
736211|NCT00331552|2361341|P1|Period 3: Phase II|Severe Nausea|1
736212|NCT00331552|2361340|P2|Period 3: Phase II|Neurological Symptoms|0
736213|NCT00331552|2361341|P1|Period 3: Phase II|Neurological Symptoms|1
736214|NCT00332839|2361357|P2|Follow-up (Months 12 - 60)|Death|1
736215|NCT00332839|2361358|P1|Follow-up (Months 12 - 60)|Death|1
736216|NCT00332839|2361357|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
736217|NCT00332839|2361358|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
736218|NCT00332839|2361357|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
736219|NCT00332839|2361358|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
736220|NCT00332839|2361357|P2|Core (Months 0 - 12)|Adverse Event|15
736221|NCT00332839|2361358|P1|Core (Months 0 - 12)|Adverse Event|5
736222|NCT00332839|2361357|P2|Core (Months 0 - 12)|Protocol deviation|1
736223|NCT00332839|2361358|P1|Core (Months 0 - 12)|Protocol deviation|1
736224|NCT00332839|2361357|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
736225|NCT00332839|2361358|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
736226|NCT00332839|2361357|P2|Core (Months 0 - 12)|Administrative problems|1
736227|NCT00332839|2361358|P1|Core (Months 0 - 12)|Administrative problems|1
736228|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Death|0
736229|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Death|1
736230|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Death|0
736231|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
736232|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
736233|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
736234|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
736235|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
736236|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
736237|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
736238|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
736239|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
736240|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
736241|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
736242|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
736243|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
736244|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
736245|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
736246|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
736247|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
736248|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
736249|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
736250|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
736251|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
736252|NCT00333138|2361379|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
736253|NCT00333138|2361380|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
736254|NCT00333138|2361381|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
736255|NCT00333138|2361379|P3|Core Study (6 Months)|Laboratory abnormality|1
736256|NCT00333138|2361380|P2|Core Study (6 Months)|Laboratory abnormality|0
736257|NCT00333138|2361381|P1|Core Study (6 Months)|Laboratory abnormality|0
736258|NCT00333138|2361379|P3|Core Study (6 Months)|Protocol Violation|1
736259|NCT00333138|2361380|P2|Core Study (6 Months)|Protocol Violation|0
736260|NCT00333138|2361381|P1|Core Study (6 Months)|Protocol Violation|1
736261|NCT00333138|2361379|P3|Core Study (6 Months)|Lack of Efficacy|0
736262|NCT00333138|2361380|P2|Core Study (6 Months)|Lack of Efficacy|0
736263|NCT00333138|2361381|P1|Core Study (6 Months)|Lack of Efficacy|1
736264|NCT00333138|2361379|P3|Core Study (6 Months)|Withdrawal by Subject|2
736265|NCT00333138|2361380|P2|Core Study (6 Months)|Withdrawal by Subject|1
736266|NCT00333138|2361381|P1|Core Study (6 Months)|Withdrawal by Subject|1
736267|NCT00333138|2361379|P3|Core Study (6 Months)|Adverse Event|8
736268|NCT00333138|2361380|P2|Core Study (6 Months)|Adverse Event|5
736269|NCT00333138|2361381|P1|Core Study (6 Months)|Adverse Event|4
736270|NCT00333229|2361420|P2|Overall Study|Lack of Efficacy|1
736271|NCT00333229|2361421|P1|Overall Study|Lack of Efficacy|0
736272|NCT00333359|2361437|P2|Overall Study|Withdrew before Receiving One Dose|6
736273|NCT00333359|2361438|P1|Overall Study|Withdrew before Receiving One Dose|2
736274|NCT00333359|2361437|P2|Overall Study|Treatment Failure|8
736275|NCT00333359|2361438|P1|Overall Study|Treatment Failure|3
736276|NCT00333359|2361437|P2|Overall Study|Termination or Withdrawal by Sponsor|1
736277|NCT00333359|2361438|P1|Overall Study|Termination or Withdrawal by Sponsor|1
736278|NCT00333359|2361437|P2|Overall Study|Lost to Follow-up|25
736279|NCT00333359|2361438|P1|Overall Study|Lost to Follow-up|15
736280|NCT00333359|2361437|P2|Overall Study|Protocol Non-compliance|8
736281|NCT00333359|2361438|P1|Overall Study|Protocol Non-compliance|2
736282|NCT00333359|2361437|P2|Overall Study|Physician Decision|2
736283|NCT00333359|2361438|P1|Overall Study|Physician Decision|2
736284|NCT00333359|2361437|P2|Overall Study|Withdrawal by Subject|37
736285|NCT00333359|2361438|P1|Overall Study|Withdrawal by Subject|19
736286|NCT00333359|2361437|P2|Overall Study|Adverse Event|35
736287|NCT00333359|2361438|P1|Overall Study|Adverse Event|29
736288|NCT00333619|2361489|P2|Overall Study|Lost to Follow-up|3
736289|NCT00333619|2361490|P1|Overall Study|Lost to Follow-up|3
736290|NCT00333619|2361489|P2|Overall Study|Withdrawal by Subject|1
736291|NCT00333619|2361490|P1|Overall Study|Withdrawal by Subject|6
736292|NCT00333619|2361489|P2|Overall Study|Death|6
736293|NCT00333619|2361490|P1|Overall Study|Death|12
736294|NCT00333775|2361518|P3|Overall Study|Lost to Follow-up|8
736295|NCT00333775|2361519|P2|Overall Study|Lost to Follow-up|7
736296|NCT00333775|2361520|P1|Overall Study|Lost to Follow-up|10
736297|NCT00333775|2361518|P3|Overall Study|In Follow−up When Study Stopped|96
736298|NCT00333775|2361519|P2|Overall Study|In Follow−up When Study Stopped|92
736299|NCT00333775|2361520|P1|Overall Study|In Follow−up When Study Stopped|87
736300|NCT00333775|2361518|P3|Overall Study|Death|143
736301|NCT00333775|2361519|P2|Overall Study|Death|149
736302|NCT00333775|2361520|P1|Overall Study|Death|144
736303|NCT00333788|2361540|P1|Overall Study|Other: Signed consent for another study|1
736304|NCT00333788|2361540|P1|Overall Study|Other: Physician decision|1
736305|NCT00333788|2361540|P1|Overall Study|Other: Medical monitor decision|1
736306|NCT00333788|2361540|P1|Overall Study|Other: Subject in need of an Entocort|1
736307|NCT00333788|2361540|P1|Overall Study|Other: Sponsor decision|1
736308|NCT00333788|2361540|P1|Overall Study|Other: Quality of life concern|1
736309|NCT00333788|2361540|P1|Overall Study|Other: Investigator decision|1
736310|NCT00333788|2361540|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
736311|NCT00333788|2361540|P1|Overall Study|Other: Moved|2
736312|NCT00333788|2361540|P1|Overall Study|Other: Non-compliance|2
736313|NCT00333788|2361540|P1|Overall Study|Withdrawal by Subject|24
736314|NCT00333788|2361540|P1|Overall Study|Lost to Follow-up|2
736315|NCT00333788|2361540|P1|Overall Study|Lack of Efficacy|80
736316|NCT00333788|2361540|P1|Overall Study|Adverse Event|44
736317|NCT00333801|2361569|P2|Overall Study|Withdrawal by Subject|1
736318|NCT00333801|2361570|P1|Overall Study|Withdrawal by Subject|0
736319|NCT00333801|2361569|P2|Overall Study|Incarcerated|2
736320|NCT00333801|2361570|P1|Overall Study|Incarcerated|1
736321|NCT00333801|2361569|P2|Overall Study|Lost to Follow-up|0
736322|NCT00333801|2361570|P1|Overall Study|Lost to Follow-up|2
736323|NCT00333801|2361569|P2|Overall Study|Moved to another state|3
736324|NCT00333801|2361570|P1|Overall Study|Moved to another state|5
736325|NCT00333840|2361609|P4|Second-line Treatment Period|Death|9
736326|NCT00333840|2361610|P3|Second-line Treatment Period|Death|0
736327|NCT00333840|2361611|P2|Second-line Treatment Period|Death|0
736328|NCT00333840|2361612|P1|Second-line Treatment Period|Death|0
736329|NCT00333840|2361609|P4|Second-line Treatment Period|Administrative problems|7
736330|NCT00333840|2361610|P3|Second-line Treatment Period|Administrative problems|0
736331|NCT00333840|2361611|P2|Second-line Treatment Period|Administrative problems|0
736332|NCT00333840|2361612|P1|Second-line Treatment Period|Administrative problems|0
736333|NCT00333840|2361609|P4|Second-line Treatment Period|Lost to Follow-up|6
736334|NCT00333840|2361610|P3|Second-line Treatment Period|Lost to Follow-up|0
736335|NCT00333840|2361611|P2|Second-line Treatment Period|Lost to Follow-up|0
736336|NCT00333840|2361612|P1|Second-line Treatment Period|Lost to Follow-up|0
736337|NCT00333840|2361609|P4|Second-line Treatment Period|Subject withdrew consent|34
736338|NCT00333840|2361610|P3|Second-line Treatment Period|Subject withdrew consent|0
736339|NCT00333840|2361611|P2|Second-line Treatment Period|Subject withdrew consent|0
736340|NCT00333840|2361612|P1|Second-line Treatment Period|Subject withdrew consent|0
736341|NCT00333840|2361609|P4|Second-line Treatment Period|Protocol Violation|10
736342|NCT00333840|2361610|P3|Second-line Treatment Period|Protocol Violation|1
736343|NCT00333840|2361611|P2|Second-line Treatment Period|Protocol Violation|0
736344|NCT00333840|2361612|P1|Second-line Treatment Period|Protocol Violation|0
736345|NCT00333840|2361609|P4|Second-line Treatment Period|No longer required study drug|14
736346|NCT00333840|2361610|P3|Second-line Treatment Period|No longer required study drug|1
736347|NCT00333840|2361611|P2|Second-line Treatment Period|No longer required study drug|0
736348|NCT00333840|2361612|P1|Second-line Treatment Period|No longer required study drug|0
736349|NCT00333840|2361609|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
736350|NCT00333840|2361610|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
736351|NCT00333840|2361611|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
736352|NCT00333840|2361612|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
736353|NCT00333840|2361609|P4|Second-line Treatment Period|Abnormal procedure|1
736354|NCT00333840|2361610|P3|Second-line Treatment Period|Abnormal procedure|0
736355|NCT00333840|2361611|P2|Second-line Treatment Period|Abnormal procedure|0
736356|NCT00333840|2361612|P1|Second-line Treatment Period|Abnormal procedure|0
736357|NCT00333840|2361609|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
736358|NCT00333840|2361610|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
736359|NCT00333840|2361611|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
736360|NCT00333840|2361612|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
736361|NCT00333840|2361609|P4|Second-line Treatment Period|Adverse Event|34
736362|NCT00333840|2361610|P3|Second-line Treatment Period|Adverse Event|3
736363|NCT00333840|2361611|P2|Second-line Treatment Period|Adverse Event|0
736364|NCT00333840|2361612|P1|Second-line Treatment Period|Adverse Event|0
736365|NCT00333840|2361609|P4|First-line Treatment Period|Crossed over to other treatment arm|0
736366|NCT00333840|2361610|P3|First-line Treatment Period|Crossed over to other treatment arm|0
736367|NCT00333840|2361611|P2|First-line Treatment Period|Crossed over to other treatment arm|363
736368|NCT00333840|2361612|P1|First-line Treatment Period|Crossed over to other treatment arm|14
736369|NCT00333840|2361609|P4|First-line Treatment Period|Death|0
736370|NCT00333840|2361610|P3|First-line Treatment Period|Death|0
736371|NCT00333840|2361611|P2|First-line Treatment Period|Death|2
736372|NCT00333840|2361612|P1|First-line Treatment Period|Death|19
736373|NCT00333840|2361609|P4|First-line Treatment Period|Administrative problems|0
736374|NCT00333840|2361610|P3|First-line Treatment Period|Administrative problems|0
736375|NCT00333840|2361611|P2|First-line Treatment Period|Administrative problems|6
736376|NCT00333840|2361612|P1|First-line Treatment Period|Administrative problems|12
736377|NCT00333840|2361609|P4|First-line Treatment Period|Lost to Follow-up|0
736378|NCT00333840|2361610|P3|First-line Treatment Period|Lost to Follow-up|0
736379|NCT00333840|2361611|P2|First-line Treatment Period|Lost to Follow-up|6
736380|NCT00333840|2361612|P1|First-line Treatment Period|Lost to Follow-up|15
736381|NCT00333840|2361609|P4|First-line Treatment Period|Subject withdrew consent|0
736382|NCT00333840|2361610|P3|First-line Treatment Period|Subject withdrew consent|0
736383|NCT00333840|2361611|P2|First-line Treatment Period|Subject withdrew consent|77
736384|NCT00333840|2361612|P1|First-line Treatment Period|Subject withdrew consent|57
736385|NCT00333840|2361609|P4|First-line Treatment Period|Protocol Violation|0
736386|NCT00333840|2361610|P3|First-line Treatment Period|Protocol Violation|0
736387|NCT00333840|2361611|P2|First-line Treatment Period|Protocol Violation|17
736388|NCT00333840|2361612|P1|First-line Treatment Period|Protocol Violation|17
736389|NCT00333840|2361609|P4|First-line Treatment Period|No longer required study drug|0
736390|NCT00333840|2361610|P3|First-line Treatment Period|No longer required study drug|0
736391|NCT00333840|2361611|P2|First-line Treatment Period|No longer required study drug|8
736392|NCT00333840|2361612|P1|First-line Treatment Period|No longer required study drug|21
736393|NCT00333840|2361609|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
736394|NCT00333840|2361610|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
736395|NCT00333840|2361611|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
736396|NCT00333840|2361612|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
736397|NCT00333840|2361609|P4|First-line Treatment Period|Abnormal procedure|0
736398|NCT00333840|2361610|P3|First-line Treatment Period|Abnormal procedure|0
736399|NCT00333840|2361611|P2|First-line Treatment Period|Abnormal procedure|0
736400|NCT00333840|2361612|P1|First-line Treatment Period|Abnormal procedure|2
736401|NCT00333840|2361609|P4|First-line Treatment Period|Abnormal laboratory values|0
736402|NCT00333840|2361610|P3|First-line Treatment Period|Abnormal laboratory values|0
736403|NCT00333840|2361611|P2|First-line Treatment Period|Abnormal laboratory values|1
736404|NCT00333840|2361612|P1|First-line Treatment Period|Abnormal laboratory values|3
736405|NCT00333840|2361609|P4|First-line Treatment Period|Adverse Event|0
736406|NCT00333840|2361610|P3|First-line Treatment Period|Adverse Event|0
736407|NCT00333840|2361611|P2|First-line Treatment Period|Adverse Event|37
736408|NCT00333840|2361612|P1|First-line Treatment Period|Adverse Event|38
736409|NCT00333866|2361641|P4|Overall Study|Randomized but not Treated|1
736410|NCT00333866|2361642|P3|Overall Study|Randomized but not Treated|2
736411|NCT00333866|2361643|P2|Overall Study|Randomized but not Treated|3
736412|NCT00333866|2361644|P1|Overall Study|Randomized but not Treated|5
736413|NCT00333866|2361641|P4|Overall Study|Withdrawal by Subject|9
736414|NCT00333866|2361642|P3|Overall Study|Withdrawal by Subject|4
736415|NCT00333866|2361643|P2|Overall Study|Withdrawal by Subject|14
736416|NCT00333866|2361644|P1|Overall Study|Withdrawal by Subject|8
736417|NCT00333866|2361641|P4|Overall Study|Lost to Follow-up|2
736418|NCT00333866|2361642|P3|Overall Study|Lost to Follow-up|2
736419|NCT00333866|2361643|P2|Overall Study|Lost to Follow-up|2
736420|NCT00333866|2361644|P1|Overall Study|Lost to Follow-up|1
736421|NCT00333866|2361641|P4|Overall Study|Lack of Efficacy|5
736422|NCT00333866|2361642|P3|Overall Study|Lack of Efficacy|3
736423|NCT00333866|2361643|P2|Overall Study|Lack of Efficacy|6
736424|NCT00333866|2361644|P1|Overall Study|Lack of Efficacy|8
736425|NCT00333866|2361641|P4|Overall Study|Unspecified|2
736426|NCT00333866|2361642|P3|Overall Study|Unspecified|2
736427|NCT00333866|2361643|P2|Overall Study|Unspecified|2
736428|NCT00333866|2361644|P1|Overall Study|Unspecified|3
736429|NCT00333866|2361641|P4|Overall Study|Adverse Event|47
736430|NCT00333866|2361642|P3|Overall Study|Adverse Event|38
736431|NCT00333866|2361643|P2|Overall Study|Adverse Event|37
736432|NCT00333866|2361644|P1|Overall Study|Adverse Event|23
736433|NCT00333970|2361709|P2|Overall Study|Withdrawal by Subject|7
736434|NCT00333970|2361710|P1|Overall Study|Withdrawal by Subject|13
736435|NCT00333983|2361719|P3|Overall Study|Withdrawal by Subject|1
736436|NCT00333983|2361720|P2|Overall Study|Withdrawal by Subject|3
736437|NCT00333983|2361721|P1|Overall Study|Withdrawal by Subject|0
736438|NCT00333983|2361719|P3|Overall Study|Adverse Event|1
736439|NCT00333983|2361720|P2|Overall Study|Adverse Event|1
736440|NCT00333983|2361721|P1|Overall Study|Adverse Event|1
736441|NCT00333983|2361719|P3|Overall Study|Lost to Follow-up|0
736442|NCT00333983|2361720|P2|Overall Study|Lost to Follow-up|1
736443|NCT00333983|2361721|P1|Overall Study|Lost to Follow-up|2
736444|NCT00334113|2361745|P2|Overall Study|Withdrawal by Subject|1
736445|NCT00334113|2361746|P1|Overall Study|Withdrawal by Subject|0
736446|NCT00334113|2361745|P2|Overall Study|Lost to Follow-up|2
736447|NCT00334113|2361746|P1|Overall Study|Lost to Follow-up|2
736448|NCT00334282|2361760|P2|Overall Study|Death|100
736449|NCT00334282|2361761|P1|Overall Study|Death|194
736450|NCT00334282|2361760|P2|Overall Study|Withdrawal by Subject|3
736451|NCT00334282|2361761|P1|Overall Study|Withdrawal by Subject|17
736452|NCT00334282|2361760|P2|Overall Study|Lost to Follow-up|5
736453|NCT00334282|2361761|P1|Overall Study|Lost to Follow-up|11
736454|NCT00334295|2361784|P1|Overall Study|Patients received fewer than 3 injection|5
736455|NCT00334542|2361792|P1|Overall Study|New cancer diagnosis|1
736456|NCT00334542|2361792|P1|Overall Study|Withdrawal by Subject|1
736457|NCT00334542|2361792|P1|Overall Study|Adverse Event|3
736458|NCT00334802|2361812|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
736459|NCT00334802|2361813|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
736460|NCT00334802|2361812|P2|Overall Study|Adverse Event|3
736461|NCT00334802|2361813|P1|Overall Study|Adverse Event|0
736462|NCT00334802|2361812|P2|Overall Study|Withdrawal by Subject|4
736463|NCT00334802|2361813|P1|Overall Study|Withdrawal by Subject|0
736464|NCT00334802|2361812|P2|Overall Study|Physician Decision|0
736465|NCT00334802|2361813|P1|Overall Study|Physician Decision|1
736466|NCT00334802|2361812|P2|Overall Study|Patient Condition Aggrevated|0
736467|NCT00334802|2361813|P1|Overall Study|Patient Condition Aggrevated|1
736468|NCT00334802|2361812|P2|Overall Study|Lack of Efficacy|3
736469|NCT00334802|2361813|P1|Overall Study|Lack of Efficacy|1
736470|NCT00334802|2361812|P2|Overall Study|Toxicity|5
736471|NCT00334802|2361813|P1|Overall Study|Toxicity|1
736472|NCT00334802|2361812|P2|Overall Study|Progressive Disease|24
736473|NCT00334802|2361813|P1|Overall Study|Progressive Disease|2
736474|NCT00334815|2361832|P2|Overall Study|Physician Decision|4
736475|NCT00334815|2361833|P1|Overall Study|Physician Decision|2
736476|NCT00334815|2361832|P2|Overall Study|patient refused treatment|1
736477|NCT00334815|2361833|P1|Overall Study|patient refused treatment|0
736478|NCT00334815|2361832|P2|Overall Study|ineligible|1
736479|NCT00334815|2361833|P1|Overall Study|ineligible|1
736480|NCT00334815|2361832|P2|Overall Study|Progression|0
736481|NCT00334815|2361833|P1|Overall Study|Progression|1
736482|NCT00334815|2361832|P2|Overall Study|Death|2
736483|NCT00334815|2361833|P1|Overall Study|Death|0
736484|NCT00334815|2361832|P2|Overall Study|Adverse Event|2
736485|NCT00334815|2361833|P1|Overall Study|Adverse Event|3
736488|NCT00334958|2361856|P2|Overall Study|Not specified|2
736489|NCT00334958|2361857|P1|Overall Study|Not specified|1
736490|NCT00334958|2361856|P2|Overall Study|Adverse Event|12
736491|NCT00334958|2361857|P1|Overall Study|Adverse Event|27
736492|NCT00334958|2361856|P2|Overall Study|Withdrawal by Subject|4
736493|NCT00334958|2361857|P1|Overall Study|Withdrawal by Subject|7
736494|NCT00334958|2361856|P2|Overall Study|Request of the investigator or sponsor|1
736495|NCT00334958|2361857|P1|Overall Study|Request of the investigator or sponsor|0
736496|NCT00334958|2361856|P2|Overall Study|Protocol Violation|2
736497|NCT00334958|2361857|P1|Overall Study|Protocol Violation|2
736498|NCT00334958|2361856|P2|Overall Study|Medication Noncompliance|3
736499|NCT00334958|2361857|P1|Overall Study|Medication Noncompliance|0
736500|NCT00335140|2361869|P1|Overall Study|Ineligible|1
736501|NCT00335153|2361873|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
736502|NCT00335153|2361873|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
736503|NCT00335153|2361873|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
736504|NCT00335153|2361873|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
736505|NCT00335153|2361873|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
736506|NCT00335153|2361873|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
736507|NCT00335153|2361873|P1|Nasojejunal (NJ) Test Period|Administrative|1
736508|NCT00335153|2361873|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
736509|NCT00335153|2361873|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
736510|NCT00335153|2361873|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
736511|NCT00328510|2361912|P2|Overall Study|Treatment changed to a single fraction|1
736512|NCT00328510|2361913|P1|Overall Study|Treatment changed to a single fraction|1
736513|NCT00328510|2361912|P2|Overall Study|Severe kyphosis, could not use mask|1
736514|NCT00328510|2361913|P1|Overall Study|Severe kyphosis, could not use mask|0
736515|NCT00328510|2361912|P2|Overall Study|Withdrawal by Subject|2
736516|NCT00328510|2361913|P1|Overall Study|Withdrawal by Subject|4
736517|NCT00328510|2361912|P2|Overall Study|Dentition problems, could not use frame|0
736518|NCT00328510|2361913|P1|Overall Study|Dentition problems, could not use frame|1
736519|NCT00328510|2361912|P2|Overall Study|Gag disorder, could not use frame|0
736520|NCT00328510|2361913|P1|Overall Study|Gag disorder, could not use frame|4
736521|NCT00328562|2361919|P1|Overall Study|Disease progression|1
736522|NCT00328627|2361958|P12|Overall Study|Other|0
736523|NCT00328627|2361959|P11|Overall Study|Other|1
736524|NCT00328627|2361960|P10|Overall Study|Other|1
736525|NCT00328627|2361961|P9|Overall Study|Other|0
736526|NCT00328627|2361962|P8|Overall Study|Other|0
736527|NCT00328627|2361963|P7|Overall Study|Other|1
736528|NCT00328627|2361964|P6|Overall Study|Other|0
736529|NCT00328627|2361965|P5|Overall Study|Other|0
736530|NCT00328627|2361966|P4|Overall Study|Other|1
736531|NCT00328627|2361967|P3|Overall Study|Other|0
736532|NCT00328627|2361968|P2|Overall Study|Other|0
736533|NCT00328627|2361969|P1|Overall Study|Other|0
736534|NCT00328627|2361958|P12|Overall Study|Physician Decision|0
736535|NCT00328627|2361959|P11|Overall Study|Physician Decision|1
736536|NCT00328627|2361960|P10|Overall Study|Physician Decision|2
736537|NCT00328627|2361961|P9|Overall Study|Physician Decision|3
736538|NCT00328627|2361962|P8|Overall Study|Physician Decision|0
736539|NCT00328627|2361963|P7|Overall Study|Physician Decision|1
736540|NCT00328627|2361964|P6|Overall Study|Physician Decision|1
736541|NCT00328627|2361965|P5|Overall Study|Physician Decision|1
736542|NCT00328627|2361966|P4|Overall Study|Physician Decision|2
736543|NCT00328627|2361967|P3|Overall Study|Physician Decision|1
736544|NCT00328627|2361968|P2|Overall Study|Physician Decision|3
736545|NCT00328627|2361969|P1|Overall Study|Physician Decision|4
736546|NCT00328627|2361958|P12|Overall Study|Pregnancy|0
736547|NCT00328627|2361959|P11|Overall Study|Pregnancy|0
736548|NCT00328627|2361960|P10|Overall Study|Pregnancy|0
736549|NCT00328627|2361961|P9|Overall Study|Pregnancy|0
736550|NCT00328627|2361962|P8|Overall Study|Pregnancy|0
736551|NCT00328627|2361963|P7|Overall Study|Pregnancy|0
736552|NCT00328627|2361964|P6|Overall Study|Pregnancy|0
736553|NCT00328627|2361965|P5|Overall Study|Pregnancy|0
736554|NCT00328627|2361966|P4|Overall Study|Pregnancy|0
736555|NCT00328627|2361967|P3|Overall Study|Pregnancy|0
736556|NCT00328627|2361968|P2|Overall Study|Pregnancy|1
736557|NCT00328627|2361969|P1|Overall Study|Pregnancy|0
736558|NCT00328627|2361958|P12|Overall Study|Withdrawal by Subject|7
736559|NCT00328627|2361959|P11|Overall Study|Withdrawal by Subject|2
736560|NCT00328627|2361960|P10|Overall Study|Withdrawal by Subject|5
736561|NCT00328627|2361961|P9|Overall Study|Withdrawal by Subject|4
736562|NCT00328627|2361962|P8|Overall Study|Withdrawal by Subject|4
736563|NCT00328627|2361963|P7|Overall Study|Withdrawal by Subject|4
736564|NCT00328627|2361964|P6|Overall Study|Withdrawal by Subject|5
736565|NCT00328627|2361965|P5|Overall Study|Withdrawal by Subject|2
736566|NCT00328627|2361966|P4|Overall Study|Withdrawal by Subject|6
736567|NCT00328627|2361967|P3|Overall Study|Withdrawal by Subject|5
736568|NCT00328627|2361968|P2|Overall Study|Withdrawal by Subject|4
736569|NCT00328627|2361969|P1|Overall Study|Withdrawal by Subject|5
736570|NCT00328627|2361958|P12|Overall Study|Lost to Follow-up|1
736571|NCT00328627|2361959|P11|Overall Study|Lost to Follow-up|0
736572|NCT00328627|2361960|P10|Overall Study|Lost to Follow-up|2
736573|NCT00328627|2361961|P9|Overall Study|Lost to Follow-up|3
736574|NCT00328627|2361962|P8|Overall Study|Lost to Follow-up|0
736575|NCT00328627|2361963|P7|Overall Study|Lost to Follow-up|3
736576|NCT00328627|2361964|P6|Overall Study|Lost to Follow-up|2
736577|NCT00328627|2361965|P5|Overall Study|Lost to Follow-up|0
736578|NCT00328627|2361966|P4|Overall Study|Lost to Follow-up|4
736579|NCT00328627|2361967|P3|Overall Study|Lost to Follow-up|2
736580|NCT00328627|2361968|P2|Overall Study|Lost to Follow-up|2
736581|NCT00328627|2361969|P1|Overall Study|Lost to Follow-up|4
736582|NCT00328627|2361958|P12|Overall Study|Protocol Violation|2
736583|NCT00328627|2361959|P11|Overall Study|Protocol Violation|6
736584|NCT00328627|2361960|P10|Overall Study|Protocol Violation|4
736585|NCT00328627|2361961|P9|Overall Study|Protocol Violation|1
736586|NCT00328627|2361962|P8|Overall Study|Protocol Violation|2
736587|NCT00328627|2361963|P7|Overall Study|Protocol Violation|6
736588|NCT00328627|2361964|P6|Overall Study|Protocol Violation|5
736589|NCT00328627|2361965|P5|Overall Study|Protocol Violation|5
736590|NCT00328627|2361966|P4|Overall Study|Protocol Violation|8
736591|NCT00328627|2361967|P3|Overall Study|Protocol Violation|2
736592|NCT00328627|2361968|P2|Overall Study|Protocol Violation|2
736593|NCT00328627|2361969|P1|Overall Study|Protocol Violation|2
736594|NCT00328627|2361958|P12|Overall Study|Adverse Event|4
736595|NCT00328627|2361959|P11|Overall Study|Adverse Event|5
736596|NCT00328627|2361960|P10|Overall Study|Adverse Event|7
736597|NCT00328627|2361961|P9|Overall Study|Adverse Event|0
736598|NCT00328627|2361962|P8|Overall Study|Adverse Event|2
736599|NCT00328627|2361963|P7|Overall Study|Adverse Event|1
736600|NCT00328627|2361964|P6|Overall Study|Adverse Event|2
736601|NCT00328627|2361965|P5|Overall Study|Adverse Event|1
736602|NCT00328627|2361966|P4|Overall Study|Adverse Event|3
736603|NCT00328627|2361967|P3|Overall Study|Adverse Event|2
736604|NCT00328627|2361968|P2|Overall Study|Adverse Event|1
736605|NCT00328627|2361969|P1|Overall Study|Adverse Event|3
736606|NCT00328627|2361958|P12|Overall Study|Hyperglycemic Rescue|2
736607|NCT00328627|2361959|P11|Overall Study|Hyperglycemic Rescue|3
736608|NCT00328627|2361960|P10|Overall Study|Hyperglycemic Rescue|11
736609|NCT00328627|2361961|P9|Overall Study|Hyperglycemic Rescue|6
736610|NCT00328627|2361962|P8|Overall Study|Hyperglycemic Rescue|6
736611|NCT00328627|2361963|P7|Overall Study|Hyperglycemic Rescue|19
736612|NCT00328627|2361964|P6|Overall Study|Hyperglycemic Rescue|5
736613|NCT00328627|2361965|P5|Overall Study|Hyperglycemic Rescue|6
736614|NCT00328627|2361966|P4|Overall Study|Hyperglycemic Rescue|13
736615|NCT00328627|2361967|P3|Overall Study|Hyperglycemic Rescue|16
736616|NCT00328627|2361968|P2|Overall Study|Hyperglycemic Rescue|18
736617|NCT00328627|2361969|P1|Overall Study|Hyperglycemic Rescue|41
736618|NCT00335322|2363526|P3|Overall Study|Randomised but withdrew prior to ART sta|2
736619|NCT00335322|2363527|P2|Overall Study|Randomised but withdrew prior to ART sta|2
736620|NCT00335322|2363528|P1|Overall Study|Randomised but withdrew prior to ART sta|1
736621|NCT00335452|2363540|P4|Overall Study|Lost to Follow-up|2
736622|NCT00335452|2363541|P3|Overall Study|Lost to Follow-up|1
736623|NCT00335452|2363542|P2|Overall Study|Lost to Follow-up|3
736624|NCT00335452|2363543|P1|Overall Study|Lost to Follow-up|2
736625|NCT00335452|2363540|P4|Overall Study|Death|129
736626|NCT00335452|2363541|P3|Overall Study|Death|158
736627|NCT00335452|2363542|P2|Overall Study|Death|144
736628|NCT00335452|2363543|P1|Overall Study|Death|156
736629|NCT00335556|2363608|P6|Overall Study|Refusal of further protocol therapy|0
736630|NCT00335556|2363609|P5|Overall Study|Refusal of further protocol therapy|0
736631|NCT00335556|2363610|P4|Overall Study|Refusal of further protocol therapy|1
736632|NCT00335556|2363611|P3|Overall Study|Refusal of further protocol therapy|0
736633|NCT00335556|2363612|P2|Overall Study|Refusal of further protocol therapy|4
736634|NCT00335556|2363613|P1|Overall Study|Refusal of further protocol therapy|0
736635|NCT00335556|2363608|P6|Overall Study|Ineligible|0
736636|NCT00335556|2363609|P5|Overall Study|Ineligible|0
736637|NCT00335556|2363610|P4|Overall Study|Ineligible|0
736638|NCT00335556|2363611|P3|Overall Study|Ineligible|0
736639|NCT00335556|2363612|P2|Overall Study|Ineligible|0
736640|NCT00335556|2363613|P1|Overall Study|Ineligible|2
736641|NCT00335556|2363608|P6|Overall Study|Physician Decision|0
736642|NCT00335556|2363609|P5|Overall Study|Physician Decision|0
736643|NCT00335556|2363610|P4|Overall Study|Physician Decision|1
736644|NCT00335556|2363611|P3|Overall Study|Physician Decision|2
736645|NCT00335556|2363612|P2|Overall Study|Physician Decision|6
736646|NCT00335556|2363613|P1|Overall Study|Physician Decision|0
736647|NCT00335556|2363608|P6|Overall Study|Lack of Efficacy|1
736648|NCT00335556|2363609|P5|Overall Study|Lack of Efficacy|0
736649|NCT00335556|2363610|P4|Overall Study|Lack of Efficacy|3
736650|NCT00335556|2363611|P3|Overall Study|Lack of Efficacy|3
736651|NCT00335556|2363612|P2|Overall Study|Lack of Efficacy|19
736652|NCT00335556|2363613|P1|Overall Study|Lack of Efficacy|0
736653|NCT00335556|2363608|P6|Overall Study|Death|0
736654|NCT00335556|2363609|P5|Overall Study|Death|1
736655|NCT00335556|2363610|P4|Overall Study|Death|0
736656|NCT00335556|2363611|P3|Overall Study|Death|0
736657|NCT00335556|2363612|P2|Overall Study|Death|5
736658|NCT00335556|2363613|P1|Overall Study|Death|0
736659|NCT00335777|2363645|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
736660|NCT00335777|2363645|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
736661|NCT00335777|2363645|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
736662|NCT00335777|2363645|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
736663|NCT00335777|2363645|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
736664|NCT00335829|2363650|P1|Overall Study|Adverse Event|1
736665|NCT00335829|2363650|P1|Overall Study|Lost to Follow-up|1
736666|NCT00335829|2363650|P1|Overall Study|Withdrawal by Subject|1
736667|NCT00335959|2363664|P1|Overall Study|Ineligible|1
736668|NCT00335959|2363664|P1|Overall Study|Adverse Event|2
736669|NCT00335972|2363671|P2|Overall Study|not given treatments|3
736670|NCT00335972|2363672|P1|Overall Study|not given treatments|0
736671|NCT00336284|2363688|P2|Overall Study|Withdrawal by Physician or Subject|64
736672|NCT00336284|2363689|P1|Overall Study|Withdrawal by Physician or Subject|102
736673|NCT00336284|2363688|P2|Overall Study|Lost to Follow-up|61
736674|NCT00336284|2363689|P1|Overall Study|Lost to Follow-up|82
736675|NCT00336284|2363688|P2|Overall Study|Death|26
736676|NCT00336284|2363689|P1|Overall Study|Death|52
736677|NCT00336479|2363769|P4|Overall Study|Virologic Stopping Rule|0
736678|NCT00336479|2363770|P3|Overall Study|Virologic Stopping Rule|0
736679|NCT00336479|2363771|P2|Overall Study|Virologic Stopping Rule|0
736680|NCT00336479|2363772|P1|Overall Study|Virologic Stopping Rule|20
736681|NCT00336479|2363769|P4|Overall Study|Unspecified|0
736682|NCT00336479|2363770|P3|Overall Study|Unspecified|1
736683|NCT00336479|2363771|P2|Overall Study|Unspecified|0
736684|NCT00336479|2363772|P1|Overall Study|Unspecified|0
736685|NCT00336479|2363769|P4|Overall Study|Withdrawal by Subject|0
736686|NCT00336479|2363770|P3|Overall Study|Withdrawal by Subject|3
736687|NCT00336479|2363771|P2|Overall Study|Withdrawal by Subject|2
736688|NCT00336479|2363772|P1|Overall Study|Withdrawal by Subject|3
736689|NCT00336479|2363769|P4|Overall Study|Lost to Follow-up|0
736690|NCT00336479|2363770|P3|Overall Study|Lost to Follow-up|0
736691|NCT00336479|2363771|P2|Overall Study|Lost to Follow-up|2
736692|NCT00336479|2363772|P1|Overall Study|Lost to Follow-up|3
736693|NCT00336479|2363769|P4|Overall Study|Physician Decision|0
736694|NCT00336479|2363770|P3|Overall Study|Physician Decision|1
736695|NCT00336479|2363771|P2|Overall Study|Physician Decision|3
736696|NCT00336479|2363772|P1|Overall Study|Physician Decision|2
736697|NCT00336479|2363769|P4|Overall Study|Noncompliant|0
736698|NCT00336479|2363770|P3|Overall Study|Noncompliant|3
736699|NCT00336479|2363771|P2|Overall Study|Noncompliant|7
736700|NCT00336479|2363772|P1|Overall Study|Noncompliant|1
736701|NCT00336479|2363769|P4|Overall Study|Adverse Event|4
736702|NCT00336479|2363770|P3|Overall Study|Adverse Event|18
736703|NCT00336479|2363771|P2|Overall Study|Adverse Event|11
736704|NCT00336479|2363772|P1|Overall Study|Adverse Event|8
736705|NCT00336492|2363798|P3|Overall Study|Other|1
736706|NCT00336492|2363799|P2|Overall Study|Other|0
736707|NCT00336492|2363800|P1|Overall Study|Other|5
736708|NCT00336492|2363798|P3|Overall Study|Lack of Efficacy|4
736709|NCT00336492|2363799|P2|Overall Study|Lack of Efficacy|1
736710|NCT00336492|2363800|P1|Overall Study|Lack of Efficacy|6
736711|NCT00336492|2363798|P3|Overall Study|Adverse Event|6
736712|NCT00336492|2363799|P2|Overall Study|Adverse Event|3
736713|NCT00336492|2363800|P1|Overall Study|Adverse Event|4
736714|NCT00336505|2363810|P2|Overall Study|Other|7
736715|NCT00336505|2363811|P1|Overall Study|Other|7
736716|NCT00336505|2363810|P2|Overall Study|Withdrawal by Subject|3
736717|NCT00336505|2363811|P1|Overall Study|Withdrawal by Subject|5
736718|NCT00336505|2363810|P2|Overall Study|Lost to Follow-up|4
736719|NCT00336505|2363811|P1|Overall Study|Lost to Follow-up|7
736720|NCT00336505|2363810|P2|Overall Study|Lack of Efficacy|4
736721|NCT00336505|2363811|P1|Overall Study|Lack of Efficacy|8
736722|NCT00336505|2363810|P2|Overall Study|Adverse Event|9
736723|NCT00336505|2363811|P1|Overall Study|Adverse Event|10
736724|NCT00336544|2363825|P2|Overall Study|Other|5
736725|NCT00336544|2363826|P1|Overall Study|Other|3
736726|NCT00336544|2363825|P2|Overall Study|Withdrawal by Subject|3
736727|NCT00336544|2363826|P1|Overall Study|Withdrawal by Subject|4
736728|NCT00336544|2363825|P2|Overall Study|Adverse Event|9
736729|NCT00336544|2363826|P1|Overall Study|Adverse Event|4
736730|NCT00336544|2363825|P2|Overall Study|Lack of Efficacy|5
736731|NCT00336544|2363826|P1|Overall Study|Lack of Efficacy|8
736732|NCT00336583|2363838|P1|Overall Study|Death|1
736733|NCT00336583|2363838|P1|Overall Study|Lost to Follow-up|1
736734|NCT00336856|2363885|P1|Overall Study|Found ineligible at time of analysis|1
736735|NCT00336856|2363885|P1|Overall Study|Withdrawal by Subject|3
736736|NCT00336895|2363891|P1|Overall Study|screen failed|1
736737|NCT00336895|2363891|P1|Overall Study|Physician Decision|1
736738|NCT00336895|2363891|P1|Overall Study|nausea and upset stomach|1
736739|NCT00336895|2363891|P1|Overall Study|diarrhea|1
736740|NCT00337077|2363906|P3|Overall Study|Ineligible|1
736741|NCT00337077|2363907|P2|Overall Study|Ineligible|1
736742|NCT00337077|2363908|P1|Overall Study|Ineligible|1
736743|NCT00337077|2363906|P3|Overall Study|Never started treatment|0
736744|NCT00337077|2363907|P2|Overall Study|Never started treatment|1
736745|NCT00337077|2363908|P1|Overall Study|Never started treatment|1
736746|NCT00337077|2363906|P3|Overall Study|Physician Decision|2
736747|NCT00337077|2363907|P2|Overall Study|Physician Decision|4
736748|NCT00337077|2363908|P1|Overall Study|Physician Decision|1
736749|NCT00337077|2363906|P3|Overall Study|Alternative therapy|0
736750|NCT00337077|2363907|P2|Overall Study|Alternative therapy|0
736751|NCT00337077|2363908|P1|Overall Study|Alternative therapy|1
736752|NCT00337077|2363906|P3|Overall Study|Withdrawal by Subject|2
736753|NCT00337077|2363907|P2|Overall Study|Withdrawal by Subject|2
736754|NCT00337077|2363908|P1|Overall Study|Withdrawal by Subject|7
736755|NCT00337077|2363906|P3|Overall Study|Death|0
736756|NCT00337077|2363907|P2|Overall Study|Death|1
736757|NCT00337077|2363908|P1|Overall Study|Death|0
736758|NCT00337077|2363906|P3|Overall Study|Adverse Event|1
736759|NCT00337077|2363907|P2|Overall Study|Adverse Event|7
736760|NCT00337077|2363908|P1|Overall Study|Adverse Event|7
736761|NCT00337077|2363906|P3|Overall Study|Progressive disease|19
736762|NCT00337077|2363907|P2|Overall Study|Progressive disease|37
736763|NCT00337077|2363908|P1|Overall Study|Progressive disease|25
736764|NCT00337103|2363919|P2|Overall Study|Death|0
736765|NCT00337103|2363920|P1|Overall Study|Death|1
736766|NCT00337103|2363919|P2|Overall Study|Lost to Follow-up|2
736767|NCT00337103|2363920|P1|Overall Study|Lost to Follow-up|1
736768|NCT00337103|2363919|P2|Overall Study|Entry Criteria Not Met|1
736769|NCT00337103|2363920|P1|Overall Study|Entry Criteria Not Met|4
736770|NCT00337103|2363919|P2|Overall Study|Not specified|6
736771|NCT00337103|2363920|P1|Overall Study|Not specified|5
736772|NCT00337103|2363919|P2|Overall Study|Withdrawal by Subject|5
736773|NCT00337103|2363920|P1|Overall Study|Withdrawal by Subject|8
736774|NCT00337103|2363919|P2|Overall Study|Physician Decision|14
736775|NCT00337103|2363920|P1|Overall Study|Physician Decision|15
736776|NCT00337103|2363919|P2|Overall Study|Clinical Progression|24
736777|NCT00337103|2363920|P1|Overall Study|Clinical Progression|27
736778|NCT00337103|2363919|P2|Overall Study|Subject Choice|27
736779|NCT00337103|2363920|P1|Overall Study|Subject Choice|34
736780|NCT00337103|2363919|P2|Overall Study|Adverse Event|59
736781|NCT00337103|2363920|P1|Overall Study|Adverse Event|45
736782|NCT00337103|2363919|P2|Overall Study|Progressive Disease|405
736783|NCT00337103|2363920|P1|Overall Study|Progressive Disease|409
736784|NCT00337129|2363928|P1|Overall Study|not protocol specified|1
736785|NCT00337129|2363928|P1|Overall Study|Death|2
736786|NCT00337129|2363928|P1|Overall Study|Lack of Efficacy|32
736787|NCT00337129|2363928|P1|Overall Study|Withdrawal by Subject|1
736788|NCT00337129|2363928|P1|Overall Study|Adverse Event|4
736789|NCT00337168|2363935|P1|Overall Study|Did not start therapy|1
736790|NCT00337168|2363935|P1|Overall Study|Not protocol specified|2
736791|NCT00337168|2363935|P1|Overall Study|Death|5
736792|NCT00337194|2363944|P2|Overall Study|Subsequent non-protocol therapy|1
736793|NCT00337194|2363945|P1|Overall Study|Subsequent non-protocol therapy|3
736794|NCT00337194|2363944|P2|Overall Study|Disease progression|2
736795|NCT00337194|2363945|P1|Overall Study|Disease progression|1
736796|NCT00337194|2363944|P2|Overall Study|Withdrawal by Subject|0
736797|NCT00337194|2363945|P1|Overall Study|Withdrawal by Subject|1
736798|NCT00337194|2363944|P2|Overall Study|Death|0
736799|NCT00337194|2363945|P1|Overall Study|Death|2
736800|NCT00337194|2363944|P2|Overall Study|Adverse Event|1
736801|NCT00337194|2363945|P1|Overall Study|Adverse Event|5
736802|NCT00337207|2363960|P1|Overall Study|Withdrawal by Subject|3
736803|NCT00337272|2363966|P2|Withdrawal Period|Non-compliance|1
736804|NCT00337272|2363967|P1|Withdrawal Period|Non-compliance|0
736805|NCT00337272|2363966|P2|Treatment Period|Withdrawal by Subject|1
736806|NCT00337272|2363967|P1|Treatment Period|Withdrawal by Subject|0
736807|NCT00337272|2363966|P2|Treatment Period|Non-compliance|1
736808|NCT00337272|2363967|P1|Treatment Period|Non-compliance|1
736809|NCT00337272|2363966|P2|Screening Period (Pre-randomization)|Screen failure|0
736810|NCT00337272|2363967|P1|Screening Period (Pre-randomization)|Screen failure|3
736811|NCT00337272|2363966|P2|Screening Period (Pre-randomization)|Non-compliance|0
736812|NCT00337272|2363967|P1|Screening Period (Pre-randomization)|Non-compliance|1
736813|NCT00337272|2363966|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
736814|NCT00337272|2363967|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
736815|NCT00337285|2363987|P1|Overall Study|Lack of protocol compliance|7
736816|NCT00337285|2363987|P1|Overall Study|Physician Decision|1
736817|NCT00337285|2363987|P1|Overall Study|Death|1
736818|NCT00337285|2363987|P1|Overall Study|Lack of Efficacy|11
736819|NCT00337285|2363987|P1|Overall Study|Protocol Violation|27
736820|NCT00337285|2363987|P1|Overall Study|Adverse Event|28
736821|NCT00337285|2363987|P1|Overall Study|Lost to Follow-up|41
736822|NCT00337285|2363987|P1|Overall Study|Withdrawal by Subject|42
736823|NCT00337428|2364008|P2|Overall Study|Anorexia|0
736824|NCT00337428|2364009|P1|Overall Study|Anorexia|1
736825|NCT00337428|2364008|P2|Overall Study|Unwilling to Continue|0
736826|NCT00337428|2364009|P1|Overall Study|Unwilling to Continue|1
736827|NCT00337428|2364008|P2|Overall Study|Lack of Time|1
736828|NCT00337428|2364009|P1|Overall Study|Lack of Time|1
736829|NCT00337428|2364008|P2|Overall Study|Withdrawal by Subject|2
736830|NCT00337428|2364009|P1|Overall Study|Withdrawal by Subject|1
736831|NCT00337467|2364047|P1|Overall Study|Subject No Longer Met Study Criteria|2
736832|NCT00337467|2364047|P1|Overall Study|Lost to Follow-up|2
736833|NCT00337467|2364047|P1|Overall Study|Pregnancy|1
736834|NCT00337467|2364047|P1|Overall Study|Subject Withdrew Consent|2
736835|NCT00337467|2364047|P1|Overall Study|Adverse Event|3
736836|NCT00337571|2364068|P4|Overall Study|High Potassium level|1
736837|NCT00337571|2364069|P3|Overall Study|High Potassium level|0
736838|NCT00337571|2364070|P2|Overall Study|High Potassium level|0
736839|NCT00337571|2364071|P1|Overall Study|High Potassium level|0
736840|NCT00337571|2364068|P4|Overall Study|No longer met study criteria|0
736841|NCT00337571|2364069|P3|Overall Study|No longer met study criteria|0
736842|NCT00337571|2364070|P2|Overall Study|No longer met study criteria|0
736843|NCT00337571|2364071|P1|Overall Study|No longer met study criteria|1
736844|NCT00337571|2364068|P4|Overall Study|Poor/noncompliance|1
736845|NCT00337571|2364069|P3|Overall Study|Poor/noncompliance|1
736846|NCT00337571|2364070|P2|Overall Study|Poor/noncompliance|1
736847|NCT00337571|2364071|P1|Overall Study|Poor/noncompliance|1
736848|NCT00337571|2364068|P4|Overall Study|Lost to Follow-up|1
736849|NCT00337571|2364069|P3|Overall Study|Lost to Follow-up|0
736850|NCT00337571|2364070|P2|Overall Study|Lost to Follow-up|1
736851|NCT00337571|2364071|P1|Overall Study|Lost to Follow-up|3
736852|NCT00337571|2364068|P4|Overall Study|Withdrawal by Subject|0
736853|NCT00337571|2364069|P3|Overall Study|Withdrawal by Subject|1
736854|NCT00337571|2364070|P2|Overall Study|Withdrawal by Subject|2
736855|NCT00337571|2364071|P1|Overall Study|Withdrawal by Subject|2
736856|NCT00337571|2364068|P4|Overall Study|Adverse Event|4
736857|NCT00337571|2364069|P3|Overall Study|Adverse Event|8
736858|NCT00337571|2364070|P2|Overall Study|Adverse Event|5
736859|NCT00337571|2364071|P1|Overall Study|Adverse Event|4
736860|NCT00337571|2364068|P4|Overall Study|Lack of Efficacy|0
736861|NCT00337571|2364069|P3|Overall Study|Lack of Efficacy|0
736862|NCT00337571|2364070|P2|Overall Study|Lack of Efficacy|0
736863|NCT00337571|2364071|P1|Overall Study|Lack of Efficacy|3
736864|NCT00337610|2364111|P2|Overall Study|Withdrawal by Subject|5
736865|NCT00337610|2364112|P1|Overall Study|Withdrawal by Subject|6
736866|NCT00337610|2364111|P2|Overall Study|Lost to Follow-up|3
736867|NCT00337610|2364112|P1|Overall Study|Lost to Follow-up|3
736868|NCT00337610|2364111|P2|Overall Study|Lack of Efficacy|3
736869|NCT00337610|2364112|P1|Overall Study|Lack of Efficacy|6
736870|NCT00337610|2364111|P2|Overall Study|Death|1
736871|NCT00337610|2364112|P1|Overall Study|Death|0
736872|NCT00337610|2364111|P2|Overall Study|Adverse Event|2
736873|NCT00337610|2364112|P1|Overall Study|Adverse Event|2
736874|NCT00337662|2364127|P4|Study Period III|Clinical Relapse|0
736875|NCT00337662|2364128|P3|Study Period III|Clinical Relapse|0
736876|NCT00337662|2364129|P2|Study Period III|Clinical Relapse|0
736877|NCT00337662|2364130|P1|Study Period III|Clinical Relapse|1
736878|NCT00337662|2364127|P4|Study Period III|Sponsor Decision|0
736879|NCT00337662|2364128|P3|Study Period III|Sponsor Decision|1
736880|NCT00337662|2364129|P2|Study Period III|Sponsor Decision|0
736881|NCT00337662|2364130|P1|Study Period III|Sponsor Decision|1
736882|NCT00337662|2364127|P4|Study Period III|Parent/Caregiver Decision|0
736883|NCT00337662|2364128|P3|Study Period III|Parent/Caregiver Decision|2
736884|NCT00337662|2364129|P2|Study Period III|Parent/Caregiver Decision|0
736885|NCT00337662|2364130|P1|Study Period III|Parent/Caregiver Decision|0
736886|NCT00337662|2364127|P4|Study Period III|Lack of Efficacy|0
736887|NCT00337662|2364128|P3|Study Period III|Lack of Efficacy|2
736888|NCT00337662|2364129|P2|Study Period III|Lack of Efficacy|4
736889|NCT00337662|2364130|P1|Study Period III|Lack of Efficacy|4
736890|NCT00337662|2364127|P4|Study Period III|Entry Criteria Not Met|0
736891|NCT00337662|2364128|P3|Study Period III|Entry Criteria Not Met|3
736892|NCT00337662|2364129|P2|Study Period III|Entry Criteria Not Met|1
736893|NCT00337662|2364130|P1|Study Period III|Entry Criteria Not Met|4
736894|NCT00337662|2364127|P4|Study Period III|Physician Decision|0
736895|NCT00337662|2364128|P3|Study Period III|Physician Decision|0
736896|NCT00337662|2364129|P2|Study Period III|Physician Decision|5
736897|NCT00337662|2364130|P1|Study Period III|Physician Decision|6
736898|NCT00337662|2364127|P4|Study Period III|Protocol Violation|0
736899|NCT00337662|2364128|P3|Study Period III|Protocol Violation|2
736900|NCT00337662|2364129|P2|Study Period III|Protocol Violation|8
736901|NCT00337662|2364130|P1|Study Period III|Protocol Violation|3
736902|NCT00337662|2364127|P4|Study Period III|Adverse Event|0
736903|NCT00337662|2364128|P3|Study Period III|Adverse Event|8
736904|NCT00337662|2364129|P2|Study Period III|Adverse Event|10
736905|NCT00337662|2364130|P1|Study Period III|Adverse Event|9
736906|NCT00337662|2364127|P4|Study Period III|Withdrawal by Subject|0
736907|NCT00337662|2364128|P3|Study Period III|Withdrawal by Subject|12
736908|NCT00337662|2364129|P2|Study Period III|Withdrawal by Subject|14
736909|NCT00337662|2364130|P1|Study Period III|Withdrawal by Subject|18
736910|NCT00337662|2364127|P4|Study Period III|Lost to Follow-up|0
736911|NCT00337662|2364128|P3|Study Period III|Lost to Follow-up|14
736912|NCT00337662|2364129|P2|Study Period III|Lost to Follow-up|16
736913|NCT00337662|2364130|P1|Study Period III|Lost to Follow-up|14
736914|NCT00337662|2364127|P4|Study Period II|Parent/Caregiver Decision|1
736915|NCT00337662|2364128|P3|Study Period II|Parent/Caregiver Decision|0
736916|NCT00337662|2364129|P2|Study Period II|Parent/Caregiver Decision|0
736917|NCT00337662|2364130|P1|Study Period II|Parent/Caregiver Decision|0
736918|NCT00337662|2364127|P4|Study Period II|Sponsor Decision|2
736919|NCT00337662|2364128|P3|Study Period II|Sponsor Decision|0
736920|NCT00337662|2364129|P2|Study Period II|Sponsor Decision|0
736921|NCT00337662|2364130|P1|Study Period II|Sponsor Decision|0
736922|NCT00337662|2364127|P4|Study Period II|Lack of Efficacy|7
736923|NCT00337662|2364128|P3|Study Period II|Lack of Efficacy|0
736924|NCT00337662|2364129|P2|Study Period II|Lack of Efficacy|0
736925|NCT00337662|2364130|P1|Study Period II|Lack of Efficacy|0
736926|NCT00337662|2364127|P4|Study Period II|Protocol Violation|6
736927|NCT00337662|2364128|P3|Study Period II|Protocol Violation|0
736928|NCT00337662|2364129|P2|Study Period II|Protocol Violation|0
736929|NCT00337662|2364130|P1|Study Period II|Protocol Violation|0
736930|NCT00337662|2364127|P4|Study Period II|Entry Criteria Not Met|6
736931|NCT00337662|2364128|P3|Study Period II|Entry Criteria Not Met|0
736932|NCT00337662|2364129|P2|Study Period II|Entry Criteria Not Met|0
736933|NCT00337662|2364130|P1|Study Period II|Entry Criteria Not Met|0
736934|NCT00337662|2364127|P4|Study Period II|Physician Decision|13
736935|NCT00337662|2364128|P3|Study Period II|Physician Decision|0
736936|NCT00337662|2364129|P2|Study Period II|Physician Decision|0
736937|NCT00337662|2364130|P1|Study Period II|Physician Decision|0
736938|NCT00337662|2364127|P4|Study Period II|Adverse Event|16
736939|NCT00337662|2364128|P3|Study Period II|Adverse Event|0
736940|NCT00337662|2364129|P2|Study Period II|Adverse Event|0
736941|NCT00337662|2364130|P1|Study Period II|Adverse Event|0
736942|NCT00337662|2364127|P4|Study Period II|Withdrawal by Subject|20
736943|NCT00337662|2364128|P3|Study Period II|Withdrawal by Subject|0
736944|NCT00337662|2364129|P2|Study Period II|Withdrawal by Subject|0
736945|NCT00337662|2364130|P1|Study Period II|Withdrawal by Subject|0
736946|NCT00337662|2364127|P4|Study Period II|Lost to Follow-up|35
736947|NCT00337662|2364128|P3|Study Period II|Lost to Follow-up|0
736948|NCT00337662|2364129|P2|Study Period II|Lost to Follow-up|0
736949|NCT00337662|2364130|P1|Study Period II|Lost to Follow-up|0
736950|NCT00337675|2364185|P3|Overall Study|Trial Terminated|2
736951|NCT00337675|2364186|P2|Overall Study|Trial Terminated|0
736952|NCT00337675|2364187|P1|Overall Study|Trial Terminated|0
736953|NCT00337675|2364185|P3|Overall Study|Progressive Disease|0
736954|NCT00337675|2364186|P2|Overall Study|Progressive Disease|2
736955|NCT00337675|2364187|P1|Overall Study|Progressive Disease|0
736956|NCT00337675|2364185|P3|Overall Study|Withdrawal by Subject|19
736957|NCT00337675|2364186|P2|Overall Study|Withdrawal by Subject|25
736958|NCT00337675|2364187|P1|Overall Study|Withdrawal by Subject|25
736959|NCT00337675|2364185|P3|Overall Study|Protocol Violation|19
736960|NCT00337675|2364186|P2|Overall Study|Protocol Violation|24
736961|NCT00337675|2364187|P1|Overall Study|Protocol Violation|21
736962|NCT00337675|2364185|P3|Overall Study|Physician Decision|14
736963|NCT00337675|2364186|P2|Overall Study|Physician Decision|17
736964|NCT00337675|2364187|P1|Overall Study|Physician Decision|9
736965|NCT00337675|2364185|P3|Overall Study|Lost to Follow-up|17
736966|NCT00337675|2364186|P2|Overall Study|Lost to Follow-up|19
736967|NCT00337675|2364187|P1|Overall Study|Lost to Follow-up|22
736968|NCT00337675|2364185|P3|Overall Study|Lack of Efficacy|9
736969|NCT00337675|2364186|P2|Overall Study|Lack of Efficacy|7
736970|NCT00337675|2364187|P1|Overall Study|Lack of Efficacy|10
736971|NCT00337675|2364185|P3|Overall Study|Adverse Event|19
736972|NCT00337675|2364186|P2|Overall Study|Adverse Event|9
736973|NCT00337675|2364187|P1|Overall Study|Adverse Event|10
736974|NCT00337727|2364203|P2|Overall Study|Withdrawal by Subject|5
736975|NCT00337727|2364204|P1|Overall Study|Withdrawal by Subject|3
736976|NCT00337727|2364203|P2|Overall Study|Protocol Violation|0
736977|NCT00337727|2364204|P1|Overall Study|Protocol Violation|4
736978|NCT00337727|2364203|P2|Overall Study|Physician Decision|0
736979|NCT00337727|2364204|P1|Overall Study|Physician Decision|1
736980|NCT00337727|2364203|P2|Overall Study|Lost to Follow-up|4
736981|NCT00337727|2364204|P1|Overall Study|Lost to Follow-up|5
736982|NCT00337727|2364203|P2|Overall Study|Adverse Event|3
736983|NCT00337727|2364204|P1|Overall Study|Adverse Event|5
736984|NCT00337779|2364214|P2|Overall Study|Death|1
736985|NCT00337779|2364215|P1|Overall Study|Death|0
736986|NCT00337779|2364214|P2|Overall Study|Pregnancy|2
736987|NCT00337779|2364215|P1|Overall Study|Pregnancy|3
736988|NCT00337779|2364214|P2|Overall Study|Adverse Event|51
736989|NCT00337779|2364215|P1|Overall Study|Adverse Event|28
736990|NCT00337779|2364214|P2|Overall Study|Lost to Follow-up|5
736991|NCT00337779|2364215|P1|Overall Study|Lost to Follow-up|6
736992|NCT00337779|2364214|P2|Overall Study|Protocol Violation|1
736993|NCT00337779|2364215|P1|Overall Study|Protocol Violation|1
736994|NCT00337779|2364214|P2|Overall Study|Physician Decision|6
736995|NCT00337779|2364215|P1|Overall Study|Physician Decision|3
736996|NCT00337779|2364214|P2|Overall Study|Sponsor decision|1
736997|NCT00337779|2364215|P1|Overall Study|Sponsor decision|1
736998|NCT00337779|2364214|P2|Overall Study|Withdrawal by Subject|12
736999|NCT00337779|2364215|P1|Overall Study|Withdrawal by Subject|10
737000|NCT00337818|2364228|P3|Overall Study|Lost to Follow-up|107
737001|NCT00337818|2364229|P2|Overall Study|Lost to Follow-up|91
737002|NCT00337818|2364230|P1|Overall Study|Lost to Follow-up|289
737003|NCT00337935|2364252|P2|Overall Study|Lack of Efficacy|1
737004|NCT00337935|2364253|P1|Overall Study|Lack of Efficacy|0
737005|NCT00337935|2364252|P2|Overall Study|Other|1
737006|NCT00337935|2364253|P1|Overall Study|Other|0
737007|NCT00337935|2364252|P2|Overall Study|Withdrawal by Subject|7
737008|NCT00337935|2364253|P1|Overall Study|Withdrawal by Subject|1
737009|NCT00337935|2364252|P2|Overall Study|Protocol Violation|3
737010|NCT00337935|2364253|P1|Overall Study|Protocol Violation|4
737011|NCT00337935|2364252|P2|Overall Study|Lost to Follow-up|1
737012|NCT00337935|2364253|P1|Overall Study|Lost to Follow-up|0
737013|NCT00337935|2364252|P2|Overall Study|Physician Decision|1
737014|NCT00337935|2364253|P1|Overall Study|Physician Decision|1
737015|NCT00337935|2364252|P2|Overall Study|Death|8
737016|NCT00337935|2364253|P1|Overall Study|Death|2
737017|NCT00337935|2364252|P2|Overall Study|Adverse Event|5
737018|NCT00337935|2364253|P1|Overall Study|Adverse Event|2
737019|NCT00338104|2364276|P3|Overall Study|Protocol Violation|3
737020|NCT00338104|2364277|P2|Overall Study|Protocol Violation|1
737021|NCT00338104|2364278|P1|Overall Study|Protocol Violation|2
737022|NCT00331682|2364289|P1|Overall Study|Adverse Event|1
737023|NCT00331760|2364297|P2|Overall Study|Ineligible / no protocol treatment|8
737024|NCT00331760|2364298|P1|Overall Study|Ineligible / no protocol treatment|15
737025|NCT00331773|2364306|P2|Overall Study|Protocol Violation|3
737026|NCT00331773|2364307|P1|Overall Study|Protocol Violation|10
737027|NCT00331773|2364306|P2|Overall Study|Withdrawal by Subject|4
737028|NCT00331773|2364307|P1|Overall Study|Withdrawal by Subject|6
737029|NCT00331799|2364333|P1|Overall Study|Sedation|1
737030|NCT00331799|2364333|P1|Overall Study|Withdrawal by Subject|2
737031|NCT00331864|2364339|P2|Overall Study|Death|0
737032|NCT00331864|2364340|P1|Overall Study|Death|6
737033|NCT00331864|2364339|P2|Overall Study|Administrative Problems|0
737034|NCT00331864|2364340|P1|Overall Study|Administrative Problems|1
737035|NCT00331864|2364339|P2|Overall Study|Lost to Follow-up|3
737036|NCT00331864|2364340|P1|Overall Study|Lost to Follow-up|4
737037|NCT00331864|2364339|P2|Overall Study|Withdrawal by Subject|0
737038|NCT00331864|2364340|P1|Overall Study|Withdrawal by Subject|10
737039|NCT00331864|2364339|P2|Overall Study|Protocol Violation|0
737040|NCT00331864|2364340|P1|Overall Study|Protocol Violation|3
737041|NCT00331864|2364339|P2|Overall Study|Lack of Efficacy|0
737042|NCT00331864|2364340|P1|Overall Study|Lack of Efficacy|4
737043|NCT00331864|2364339|P2|Overall Study|Adverse Event|1
737044|NCT00331864|2364340|P1|Overall Study|Adverse Event|30
737045|NCT00332189|2364394|P1|Overall Study|Moved out of country|2
737046|NCT00332189|2364394|P1|Overall Study|Lack of Efficacy|4
737047|NCT00332189|2364394|P1|Overall Study|Withdrawal by Subject|9
737048|NCT00332189|2364394|P1|Overall Study|Uncooperative/Noncompliant|3
737049|NCT00332189|2364394|P1|Overall Study|Adverse Event|3
737050|NCT00332241|2364401|P2|Overall Study|Lost to Follow-up|1
737051|NCT00332241|2364402|P1|Overall Study|Lost to Follow-up|4
737052|NCT00332241|2364401|P2|Overall Study|Withdrawal by Subject|1
737053|NCT00332241|2364402|P1|Overall Study|Withdrawal by Subject|2
737054|NCT00332241|2364401|P2|Overall Study|Adverse Event|5
737055|NCT00332241|2364402|P1|Overall Study|Adverse Event|3
737056|NCT00332241|2364401|P2|Overall Study|Lack of Efficacy|1
737057|NCT00332241|2364402|P1|Overall Study|Lack of Efficacy|6
737058|NCT00332332|2364422|P1|Overall Study|Did not receive study treatment|16
737059|NCT00332332|2364422|P1|Overall Study|Not specified|18
737060|NCT00332332|2364422|P1|Overall Study|Disease progression|2
737061|NCT00332332|2364422|P1|Overall Study|Noncompliance|2
737062|NCT00332332|2364422|P1|Overall Study|Protocol deviation|4
737063|NCT00332332|2364422|P1|Overall Study|Lost to Follow-up|3
737064|NCT00332332|2364422|P1|Overall Study|Physician Decision|1
737065|NCT00332332|2364422|P1|Overall Study|Withdrawal by Subject|8
737066|NCT00332332|2364422|P1|Overall Study|Death|1
737067|NCT00332332|2364422|P1|Overall Study|Adverse Event|13
737068|NCT00332462|2364429|P1|Overall Study|Graft Loss|2
737069|NCT00332462|2364429|P1|Overall Study|Death|3
737070|NCT00332462|2364429|P1|Overall Study|no longer requires study drug|1
737071|NCT00332462|2364429|P1|Overall Study|Unsatisfactory therapeutic effect|4
737072|NCT00332462|2364429|P1|Overall Study|Abnormal Lab Value|1
737073|NCT00332462|2364429|P1|Overall Study|Adverse Event|5
737074|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
737075|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
737076|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
737077|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
737078|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
737079|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
737080|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
737081|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
737082|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
737083|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
737084|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
737085|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
737086|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
737087|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
737088|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
737089|NCT00332488|2364439|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
737090|NCT00332488|2364440|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
737091|NCT00332488|2364441|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
737092|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
737093|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
737094|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
737095|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
737096|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
737097|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
737098|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
737099|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
737100|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
737101|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
737102|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
737103|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
737104|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
737105|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
737106|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
737107|NCT00332488|2364439|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
737108|NCT00332488|2364440|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
737109|NCT00332488|2364441|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
737110|NCT00332696|2364502|P2|Overall Study|Withdrawal by Subject|0
737111|NCT00332696|2364503|P1|Overall Study|Withdrawal by Subject|1
737112|NCT00332696|2364502|P2|Overall Study|Lost to Follow-up|1
737113|NCT00332696|2364503|P1|Overall Study|Lost to Follow-up|0
737114|NCT00332696|2364502|P2|Overall Study|Condition does not justify treatment|2
737115|NCT00332696|2364503|P1|Overall Study|Condition does not justify treatment|0
737116|NCT00332696|2364502|P2|Overall Study|Adverse Event|2
737117|NCT00332696|2364503|P1|Overall Study|Adverse Event|1
737118|NCT00332696|2364502|P2|Overall Study|Insufficient therapeutic effect|11
737119|NCT00332696|2364503|P1|Overall Study|Insufficient therapeutic effect|4
737120|NCT00332696|2364502|P2|Overall Study|Death|14
737121|NCT00332696|2364503|P1|Overall Study|Death|24
737122|NCT00332709|2364531|P2|Overall Study|Abnormal test procedure result|0
737123|NCT00332709|2364532|P1|Overall Study|Abnormal test procedure result|1
737124|NCT00332709|2364531|P2|Overall Study|Administrative Problems|3
737125|NCT00332709|2364532|P1|Overall Study|Administrative Problems|0
737126|NCT00332709|2364531|P2|Overall Study|Lost to Follow-up|0
737127|NCT00332709|2364532|P1|Overall Study|Lost to Follow-up|2
737128|NCT00332709|2364531|P2|Overall Study|Withdrawal by Subject|3
737129|NCT00332709|2364532|P1|Overall Study|Withdrawal by Subject|2
737130|NCT00332709|2364531|P2|Overall Study|Adverse Event|14
737131|NCT00332709|2364532|P1|Overall Study|Adverse Event|11
737132|NCT00338286|2364567|P2|Overall Study|undefined|4
737133|NCT00338286|2364568|P1|Overall Study|undefined|3
737134|NCT00338286|2364567|P2|Overall Study|ongoing|272
737135|NCT00338286|2364568|P1|Overall Study|ongoing|297
737136|NCT00338286|2364567|P2|Overall Study|Lost to Follow-up|50
737137|NCT00338286|2364568|P1|Overall Study|Lost to Follow-up|53
737138|NCT00338286|2364567|P2|Overall Study|Withdrawal by Subject|44
737139|NCT00338286|2364568|P1|Overall Study|Withdrawal by Subject|40
737140|NCT00338455|2364584|P2|Overall Study|Physician Decision|0
737141|NCT00338455|2364585|P1|Overall Study|Physician Decision|1
737142|NCT00338455|2364584|P2|Overall Study|Death|1
737143|NCT00338455|2364585|P1|Overall Study|Death|2
737144|NCT00342628|2364665|P3|Overall Study|moved residence|1
737145|NCT00342628|2364666|P2|Overall Study|moved residence|1
737146|NCT00342628|2364667|P1|Overall Study|moved residence|0
737147|NCT00342628|2364665|P3|Overall Study|Death|0
737148|NCT00342628|2364666|P2|Overall Study|Death|1
737149|NCT00342628|2364667|P1|Overall Study|Death|1
737150|NCT00342628|2364665|P3|Overall Study|Withdrawal by Subject|18
737151|NCT00342628|2364666|P2|Overall Study|Withdrawal by Subject|19
737152|NCT00342628|2364667|P1|Overall Study|Withdrawal by Subject|19
737153|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
737154|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
737155|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Sponsor Decision|5
737156|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Sponsor Decision|8
737157|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Protocol Violation|3
737158|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Protocol Violation|3
737159|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Physician Decision|7
737160|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Physician Decision|4
737161|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
737162|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
737163|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
737164|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
737165|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
737166|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
737167|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Death|5
737168|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Death|4
737169|NCT00343252|2364702|P2|18 Months (All Treated Participants)|Adverse Event|23
737170|NCT00343252|2364703|P1|18 Months (All Treated Participants)|Adverse Event|31
737171|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
737172|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
737173|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Sponsor Decision|6
737174|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Sponsor Decision|9
737175|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Protocol Violation|2
737176|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Protocol Violation|3
737177|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Physician Decision|5
737178|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Physician Decision|4
737179|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
737180|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
737181|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
737182|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
737183|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
737184|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
737185|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Death|3
737186|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Death|3
737187|NCT00343252|2364702|P2|12 Months (All Treated Participants)|Adverse Event|20
737188|NCT00343252|2364703|P1|12 Months (All Treated Participants)|Adverse Event|22
737189|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
737190|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
737191|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Sponsor Decision|4
737192|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Sponsor Decision|7
737193|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Protocol Violation|2
737194|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Protocol Violation|2
737195|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Physician Decision|3
737196|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Physician Decision|1
737197|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
737198|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
737199|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
737200|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
737201|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
737202|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
737203|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Death|2
737204|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Death|0
737205|NCT00343252|2364702|P2|6 Months (All Treated Participants)|Adverse Event|11
737206|NCT00343252|2364703|P1|6 Months (All Treated Participants)|Adverse Event|17
737207|NCT00343291|2364751|P2|Overall Study|Other|5
737208|NCT00343291|2364752|P1|Overall Study|Other|8
737209|NCT00343291|2364751|P2|Overall Study|Withdrawal by Subject|2
737210|NCT00343291|2364752|P1|Overall Study|Withdrawal by Subject|0
737211|NCT00343291|2364751|P2|Overall Study|Progressive disease|34
737212|NCT00343291|2364752|P1|Overall Study|Progressive disease|33
737213|NCT00343291|2364751|P2|Overall Study|Death|2
737214|NCT00343291|2364752|P1|Overall Study|Death|3
737215|NCT00343291|2364751|P2|Overall Study|Adverse Event|13
737216|NCT00343291|2364752|P1|Overall Study|Adverse Event|13
737217|NCT00343382|2364769|P3|Overall Study|Other Reason Not Specified|4
737218|NCT00343382|2364770|P2|Overall Study|Other Reason Not Specified|2
737219|NCT00343382|2364771|P1|Overall Study|Other Reason Not Specified|1
737220|NCT00343382|2364769|P3|Overall Study|Withdrawal by Subject|6
737221|NCT00343382|2364770|P2|Overall Study|Withdrawal by Subject|2
737222|NCT00343382|2364771|P1|Overall Study|Withdrawal by Subject|1
737223|NCT00343382|2364769|P3|Overall Study|Adverse Event|7
737224|NCT00343382|2364770|P2|Overall Study|Adverse Event|10
737225|NCT00343382|2364771|P1|Overall Study|Adverse Event|2
737226|NCT00343512|2364867|P1|Overall Study|Withdrawal by Subject|2
737227|NCT00343889|2364942|P2|Overall Study|Protocol Violation|0
737228|NCT00343889|2364943|P1|Overall Study|Protocol Violation|1
737229|NCT00343889|2364942|P2|Overall Study|Withdrawal by Subject|1
737230|NCT00343889|2364943|P1|Overall Study|Withdrawal by Subject|0
737231|NCT00343889|2364942|P2|Overall Study|Lost to Follow-up|0
737232|NCT00343889|2364943|P1|Overall Study|Lost to Follow-up|2
737233|NCT00343915|2364961|P2|Primary Study|Unspecified|0
737234|NCT00343915|2364962|P1|Primary Study|Unspecified|1
737235|NCT00343915|2364961|P2|Primary Study|Lost to Follow-up|3
737236|NCT00343915|2364962|P1|Primary Study|Lost to Follow-up|2
737237|NCT00343915|2364961|P2|Primary Study|Withdrawal by Subject|0
737238|NCT00343915|2364962|P1|Primary Study|Withdrawal by Subject|1
737239|NCT00344487|2364986|P1|Overall Study|immunologic failure|1
737240|NCT00344500|2364992|P3|Overall Study|Not Noted|0
737241|NCT00344500|2364993|P2|Overall Study|Not Noted|3
737242|NCT00344500|2364994|P1|Overall Study|Not Noted|1
737243|NCT00344500|2364992|P3|Overall Study|Protocol Violation|1
737244|NCT00344500|2364993|P2|Overall Study|Protocol Violation|7
737245|NCT00344500|2364994|P1|Overall Study|Protocol Violation|4
737246|NCT00344500|2364992|P3|Overall Study|Withdrawal by Subject|0
737247|NCT00344500|2364993|P2|Overall Study|Withdrawal by Subject|10
737248|NCT00344500|2364994|P1|Overall Study|Withdrawal by Subject|7
737249|NCT00344500|2364992|P3|Overall Study|Lost to Follow-up|1
737250|NCT00344500|2364993|P2|Overall Study|Lost to Follow-up|13
737251|NCT00344500|2364994|P1|Overall Study|Lost to Follow-up|5
737252|NCT00344500|2364992|P3|Overall Study|Adverse Event|0
737253|NCT00344500|2364993|P2|Overall Study|Adverse Event|2
737254|NCT00344500|2364994|P1|Overall Study|Adverse Event|6
737255|NCT00344773|2365020|P1|Overall Study|Not Eligible for the study|2
737256|NCT00344773|2365020|P1|Overall Study|Withdrawal by Subject|1
737257|NCT00344773|2365020|P1|Overall Study|Objective Disease Progression|16
737258|NCT00344773|2365020|P1|Overall Study|Adverse Event|2
737259|NCT00344968|2365029|P3|Overall Study|Other|0
737260|NCT00344968|2365030|P2|Overall Study|Other|1
737261|NCT00344968|2365031|P1|Overall Study|Other|0
737262|NCT00344968|2365029|P3|Overall Study|Death|31
737263|NCT00344968|2365030|P2|Overall Study|Death|27
737264|NCT00344968|2365031|P1|Overall Study|Death|11
737265|NCT00344968|2365029|P3|Overall Study|Lost to Follow-up|37
737266|NCT00344968|2365030|P2|Overall Study|Lost to Follow-up|37
737267|NCT00344968|2365031|P1|Overall Study|Lost to Follow-up|24
737268|NCT00344968|2365029|P3|Overall Study|Withdrawal by Subject|27
737269|NCT00344968|2365030|P2|Overall Study|Withdrawal by Subject|31
737270|NCT00344968|2365031|P1|Overall Study|Withdrawal by Subject|14
737271|NCT00344968|2365029|P3|Overall Study|Protocol Violation|5
737272|NCT00344968|2365030|P2|Overall Study|Protocol Violation|2
737273|NCT00344968|2365031|P1|Overall Study|Protocol Violation|2
737274|NCT00344968|2365029|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
737275|NCT00344968|2365030|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
737276|NCT00344968|2365031|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
737277|NCT00344968|2365029|P3|Overall Study|Adverse Event|15
737278|NCT00344968|2365030|P2|Overall Study|Adverse Event|4
737279|NCT00344968|2365031|P1|Overall Study|Adverse Event|5
737280|NCT00345046|2365064|P3|Overall Study|Protocol Violation|2
737281|NCT00345046|2365065|P2|Overall Study|Protocol Violation|1
737282|NCT00345046|2365066|P1|Overall Study|Protocol Violation|1
737283|NCT00345293|2365110|P2|Overall Study|Withdrawal by Subject|0
737284|NCT00345293|2365111|P1|Overall Study|Withdrawal by Subject|1
737285|NCT00345293|2365110|P2|Overall Study|Unable to access line for sample|0
737286|NCT00345293|2365111|P1|Overall Study|Unable to access line for sample|1
737288|NCT00345540|2365156|P1|Overall Study|Withdrawal by Subject|1
737289|NCT00345579|2365164|P2|Overall Study|Unspecified|1
737290|NCT00345579|2365165|P1|Overall Study|Unspecified|9
737291|NCT00345579|2365164|P2|Overall Study|Lost to Follow-up|36
737292|NCT00345579|2365165|P1|Overall Study|Lost to Follow-up|82
737293|NCT00345579|2365164|P2|Overall Study|Withdrawal by Subject|17
737294|NCT00345579|2365165|P1|Overall Study|Withdrawal by Subject|50
737295|NCT00345579|2365164|P2|Overall Study|Protocol Violation|5
737296|NCT00345579|2365165|P1|Overall Study|Protocol Violation|14
737297|NCT00345579|2365164|P2|Overall Study|Adverse Event|6
737298|NCT00345579|2365165|P1|Overall Study|Adverse Event|9
737299|NCT00345592|2365187|P2|Overall Study|Withdrawal by Subject|8
737300|NCT00345592|2365188|P1|Overall Study|Withdrawal by Subject|11
737301|NCT00345592|2365187|P2|Overall Study|Death|16
737302|NCT00345592|2365188|P1|Overall Study|Death|14
737303|NCT00345605|2365194|P2|Arm 2, Opposite Treatment|Adverse Event|0
737304|NCT00345605|2365195|P1|Arm 2, Opposite Treatment|Adverse Event|1
737305|NCT00345605|2365194|P2|Arm 1|Adverse Event|1
737306|NCT00345605|2365195|P1|Arm 1|Adverse Event|0
737307|NCT00345631|2365216|P3|Overall Study|Other reasons|1
737308|NCT00345631|2365217|P2|Overall Study|Other reasons|0
737309|NCT00345631|2365218|P1|Overall Study|Other reasons|0
737310|NCT00345631|2365216|P3|Overall Study|Lost to Follow-up|4
737311|NCT00345631|2365217|P2|Overall Study|Lost to Follow-up|7
737312|NCT00345631|2365218|P1|Overall Study|Lost to Follow-up|3
737313|NCT00345631|2365216|P3|Overall Study|Adverse Event|0
737314|NCT00345631|2365217|P2|Overall Study|Adverse Event|1
737315|NCT00345631|2365218|P1|Overall Study|Adverse Event|0
737316|NCT00345631|2365216|P3|Overall Study|Withdrawal by Subject|1
737317|NCT00345631|2365217|P2|Overall Study|Withdrawal by Subject|0
737318|NCT00345631|2365218|P1|Overall Study|Withdrawal by Subject|1
737319|NCT00345683|2365252|P2|Overall Study|Unspecified|2
737320|NCT00345683|2365253|P1|Overall Study|Unspecified|6
737321|NCT00345683|2365252|P2|Overall Study|Lost to Follow-up|7
737322|NCT00345683|2365253|P1|Overall Study|Lost to Follow-up|19
737323|NCT00345839|2365275|P2|Overall Study|Lost to Follow-up|61
737324|NCT00345839|2365276|P1|Overall Study|Lost to Follow-up|58
737325|NCT00345839|2365275|P2|Overall Study|Withdrawal by Subject|98
737326|NCT00345839|2365276|P1|Overall Study|Withdrawal by Subject|91
737327|NCT00345878|2365302|P2|Overall Study|Other|0
737328|NCT00345878|2365303|P1|Overall Study|Other|1
737329|NCT00345878|2365302|P2|Overall Study|Lost to Follow-up|1
737330|NCT00345878|2365303|P1|Overall Study|Lost to Follow-up|2
737331|NCT00345878|2365302|P2|Overall Study|Adverse Event|0
737332|NCT00345878|2365303|P1|Overall Study|Adverse Event|1
737333|NCT00346034|2365319|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
737334|NCT00346034|2365319|P1|Overall Study|Patient Stopped Taking Study Drug|1
737335|NCT00346034|2365319|P1|Overall Study|Withdrawal by Subject|13
737336|NCT00346034|2365319|P1|Overall Study|Lack of Efficacy|8
737337|NCT00346034|2365319|P1|Overall Study|Adverse Event|34
737338|NCT00346151|2365324|P1|Overall Study|Withdrawal by Subject|3
737339|NCT00346164|2365346|P4|Overall Study|Inability to start week 16 tx on time|11
737340|NCT00346164|2365347|P3|Overall Study|Inability to start week 16 tx on time|0
737341|NCT00346164|2365348|P2|Overall Study|Inability to start week 16 tx on time|0
737342|NCT00346164|2365349|P1|Overall Study|Inability to start week 16 tx on time|0
737343|NCT00346164|2365346|P4|Overall Study|Refusal of further protocol therapy|15
737344|NCT00346164|2365347|P3|Overall Study|Refusal of further protocol therapy|3
737345|NCT00346164|2365348|P2|Overall Study|Refusal of further protocol therapy|1
737346|NCT00346164|2365349|P1|Overall Study|Refusal of further protocol therapy|0
737347|NCT00346164|2365346|P4|Overall Study|Ineligible|23
737348|NCT00346164|2365347|P3|Overall Study|Ineligible|2
737349|NCT00346164|2365348|P2|Overall Study|Ineligible|2
737350|NCT00346164|2365349|P1|Overall Study|Ineligible|11
737351|NCT00346164|2365346|P4|Overall Study|Withdrawal by Subject|0
737352|NCT00346164|2365347|P3|Overall Study|Withdrawal by Subject|2
737353|NCT00346164|2365348|P2|Overall Study|Withdrawal by Subject|0
737354|NCT00346164|2365349|P1|Overall Study|Withdrawal by Subject|0
737355|NCT00346164|2365346|P4|Overall Study|Protocol Violation|4
737356|NCT00346164|2365347|P3|Overall Study|Protocol Violation|10
737357|NCT00346164|2365348|P2|Overall Study|Protocol Violation|2
737358|NCT00346164|2365349|P1|Overall Study|Protocol Violation|6
737359|NCT00346164|2365346|P4|Overall Study|Physician Decision|27
737360|NCT00346164|2365347|P3|Overall Study|Physician Decision|2
737361|NCT00346164|2365348|P2|Overall Study|Physician Decision|1
737362|NCT00346164|2365349|P1|Overall Study|Physician Decision|0
737363|NCT00346164|2365346|P4|Overall Study|Lack of Efficacy|25
737364|NCT00346164|2365347|P3|Overall Study|Lack of Efficacy|7
737365|NCT00346164|2365348|P2|Overall Study|Lack of Efficacy|1
737366|NCT00346164|2365349|P1|Overall Study|Lack of Efficacy|0
737367|NCT00346164|2365346|P4|Overall Study|Adverse Event|1
737368|NCT00346164|2365347|P3|Overall Study|Adverse Event|0
737369|NCT00346164|2365348|P2|Overall Study|Adverse Event|0
737370|NCT00346164|2365349|P1|Overall Study|Adverse Event|0
737371|NCT00346216|2365387|P3|Overall Study|Missing Subject Summary Status|62
737372|NCT00346216|2365388|P2|Overall Study|Missing Subject Summary Status|61
737373|NCT00346216|2365389|P1|Overall Study|Missing Subject Summary Status|62
737374|NCT00346216|2365387|P3|Overall Study|Study terminated by sponsor|8
737375|NCT00346216|2365388|P2|Overall Study|Study terminated by sponsor|4
737376|NCT00346216|2365389|P1|Overall Study|Study terminated by sponsor|11
737377|NCT00346216|2365387|P3|Overall Study|Death|228
737378|NCT00346216|2365388|P2|Overall Study|Death|192
737379|NCT00346216|2365389|P1|Overall Study|Death|189
737380|NCT00346216|2365387|P3|Overall Study|Does not meet entrance criteria|8
737381|NCT00346216|2365388|P2|Overall Study|Does not meet entrance criteria|10
737382|NCT00346216|2365389|P1|Overall Study|Does not meet entrance criteria|13
737383|NCT00346216|2365387|P3|Overall Study|Physician Decision|59
737384|NCT00346216|2365388|P2|Overall Study|Physician Decision|76
737385|NCT00346216|2365389|P1|Overall Study|Physician Decision|80
737386|NCT00346216|2365387|P3|Overall Study|Lost to Follow-up|542
737387|NCT00346216|2365388|P2|Overall Study|Lost to Follow-up|588
737388|NCT00346216|2365389|P1|Overall Study|Lost to Follow-up|611
737389|NCT00346216|2365387|P3|Overall Study|Withdrawal by Subject|651
737390|NCT00346216|2365388|P2|Overall Study|Withdrawal by Subject|692
737391|NCT00346216|2365389|P1|Overall Study|Withdrawal by Subject|661
737392|NCT00346216|2365387|P3|Overall Study|No longer willing to participate|585
737393|NCT00346216|2365388|P2|Overall Study|No longer willing to participate|606
737394|NCT00346216|2365389|P1|Overall Study|No longer willing to participate|600
737395|NCT00346216|2365387|P3|Overall Study|Not specified|205
737396|NCT00346216|2365388|P2|Overall Study|Not specified|231
737397|NCT00346216|2365389|P1|Overall Study|Not specified|181
737398|NCT00346268|2365408|P2|Overall Study|Participant refused|3
737399|NCT00346268|2365409|P1|Overall Study|Participant refused|0
737400|NCT00346268|2365408|P2|Overall Study|Protocol Violation|0
737401|NCT00346268|2365409|P1|Overall Study|Protocol Violation|1
737402|NCT00346268|2365408|P2|Overall Study|Adverse Event|0
737403|NCT00346268|2365409|P1|Overall Study|Adverse Event|1
737404|NCT00346333|2365443|P2|Overall Study|unwilling or unable to continue|8
737405|NCT00346333|2365444|P1|Overall Study|unwilling or unable to continue|4
737406|NCT00346333|2365443|P2|Overall Study|Death|0
737407|NCT00346333|2365444|P1|Overall Study|Death|1
737408|NCT00346398|2365460|P2|Overall Study|Withdrawal by Subject|2
737409|NCT00346398|2365461|P1|Overall Study|Withdrawal by Subject|0
737410|NCT00346398|2365460|P2|Overall Study|Lost to Follow-up|0
737411|NCT00346398|2365461|P1|Overall Study|Lost to Follow-up|3
737412|NCT00346632|2365478|P10|Overall Study|Not Stated|1
737413|NCT00346632|2365479|P9|Overall Study|Not Stated|2
737414|NCT00346632|2365480|P8|Overall Study|Not Stated|2
737415|NCT00346632|2365481|P7|Overall Study|Not Stated|0
737416|NCT00346632|2365482|P6|Overall Study|Not Stated|0
737417|NCT00346632|2365483|P5|Overall Study|Not Stated|0
737418|NCT00346632|2365484|P4|Overall Study|Not Stated|0
737419|NCT00346632|2365485|P3|Overall Study|Not Stated|0
737420|NCT00346632|2365486|P2|Overall Study|Not Stated|1
737421|NCT00346632|2365487|P1|Overall Study|Not Stated|1
737422|NCT00346632|2365478|P10|Overall Study|Switched to alternative treatment|0
737423|NCT00346632|2365479|P9|Overall Study|Switched to alternative treatment|0
737424|NCT00346632|2365480|P8|Overall Study|Switched to alternative treatment|0
737425|NCT00346632|2365481|P7|Overall Study|Switched to alternative treatment|0
737426|NCT00346632|2365482|P6|Overall Study|Switched to alternative treatment|0
737427|NCT00346632|2365483|P5|Overall Study|Switched to alternative treatment|0
737428|NCT00346632|2365484|P4|Overall Study|Switched to alternative treatment|0
737429|NCT00346632|2365485|P3|Overall Study|Switched to alternative treatment|1
737430|NCT00346632|2365486|P2|Overall Study|Switched to alternative treatment|0
737431|NCT00346632|2365487|P1|Overall Study|Switched to alternative treatment|0
737432|NCT00346632|2365478|P10|Overall Study|Withdrawal by Subject|0
737433|NCT00346632|2365479|P9|Overall Study|Withdrawal by Subject|0
737434|NCT00346632|2365480|P8|Overall Study|Withdrawal by Subject|0
737435|NCT00346632|2365481|P7|Overall Study|Withdrawal by Subject|1
737436|NCT00346632|2365482|P6|Overall Study|Withdrawal by Subject|0
737437|NCT00346632|2365483|P5|Overall Study|Withdrawal by Subject|0
737438|NCT00346632|2365484|P4|Overall Study|Withdrawal by Subject|0
737439|NCT00346632|2365485|P3|Overall Study|Withdrawal by Subject|0
737440|NCT00346632|2365486|P2|Overall Study|Withdrawal by Subject|0
737441|NCT00346632|2365487|P1|Overall Study|Withdrawal by Subject|0
737442|NCT00346632|2365478|P10|Overall Study|Protocol Violation|0
737443|NCT00346632|2365479|P9|Overall Study|Protocol Violation|0
737444|NCT00346632|2365480|P8|Overall Study|Protocol Violation|0
737445|NCT00346632|2365481|P7|Overall Study|Protocol Violation|1
737446|NCT00346632|2365482|P6|Overall Study|Protocol Violation|0
737447|NCT00346632|2365483|P5|Overall Study|Protocol Violation|0
737448|NCT00346632|2365484|P4|Overall Study|Protocol Violation|0
737449|NCT00346632|2365485|P3|Overall Study|Protocol Violation|0
737450|NCT00346632|2365486|P2|Overall Study|Protocol Violation|0
737451|NCT00346632|2365487|P1|Overall Study|Protocol Violation|0
737452|NCT00346632|2365478|P10|Overall Study|Death|0
737453|NCT00346632|2365479|P9|Overall Study|Death|0
737454|NCT00346632|2365480|P8|Overall Study|Death|0
737455|NCT00346632|2365481|P7|Overall Study|Death|0
737456|NCT00346632|2365482|P6|Overall Study|Death|0
737457|NCT00346632|2365483|P5|Overall Study|Death|0
737458|NCT00346632|2365484|P4|Overall Study|Death|0
737459|NCT00346632|2365485|P3|Overall Study|Death|1
737460|NCT00346632|2365486|P2|Overall Study|Death|0
737461|NCT00346632|2365487|P1|Overall Study|Death|0
737462|NCT00346632|2365478|P10|Overall Study|Adverse Event|0
737463|NCT00346632|2365479|P9|Overall Study|Adverse Event|0
737464|NCT00346632|2365480|P8|Overall Study|Adverse Event|0
737465|NCT00346632|2365481|P7|Overall Study|Adverse Event|1
737466|NCT00346632|2365482|P6|Overall Study|Adverse Event|1
737467|NCT00346632|2365483|P5|Overall Study|Adverse Event|1
737468|NCT00346632|2365484|P4|Overall Study|Adverse Event|0
737469|NCT00346632|2365485|P3|Overall Study|Adverse Event|0
737470|NCT00346632|2365486|P2|Overall Study|Adverse Event|0
737471|NCT00346632|2365487|P1|Overall Study|Adverse Event|0
737472|NCT00346632|2365478|P10|Overall Study|Progressive Disease|2
737473|NCT00346632|2365479|P9|Overall Study|Progressive Disease|2
737474|NCT00346632|2365480|P8|Overall Study|Progressive Disease|2
737475|NCT00346632|2365481|P7|Overall Study|Progressive Disease|2
737476|NCT00346632|2365482|P6|Overall Study|Progressive Disease|1
737477|NCT00346632|2365483|P5|Overall Study|Progressive Disease|3
737478|NCT00346632|2365484|P4|Overall Study|Progressive Disease|3
737479|NCT00346632|2365485|P3|Overall Study|Progressive Disease|4
737480|NCT00346632|2365486|P2|Overall Study|Progressive Disease|2
737481|NCT00346632|2365487|P1|Overall Study|Progressive Disease|2
737482|NCT00346697|2365632|P2|Overall Study|Lost to Follow-up|1
737483|NCT00346697|2365633|P1|Overall Study|Lost to Follow-up|0
737484|NCT00338741|2365673|P2|Overall Study|Lost to Follow-up|0
737485|NCT00338741|2365674|P1|Overall Study|Lost to Follow-up|2
737486|NCT00338806|2365684|P2|Follow-up|Lost to Follow-up|3
737487|NCT00338806|2365685|P1|Follow-up|Lost to Follow-up|1
737488|NCT00338806|2365684|P2|Acute Phase|Withdrawal by Subject|1
737489|NCT00338806|2365685|P1|Acute Phase|Withdrawal by Subject|0
737490|NCT00338884|2365745|P1|Overall Study|Randomized But Did Not Receive Treatment|1
737491|NCT00338884|2365745|P1|Overall Study|Lost to Follow-up|1
737492|NCT00338884|2365745|P1|Overall Study|Withdrawal by Subject|3
737493|NCT00338884|2365745|P1|Overall Study|Global Deterioration of Health Status|3
737494|NCT00338884|2365745|P1|Overall Study|Unspecified|4
737495|NCT00338884|2365745|P1|Overall Study|Death|8
737496|NCT00338884|2365745|P1|Overall Study|Adverse Event|14
737497|NCT00338884|2365745|P1|Overall Study|Objective Disease Progression or Relapse|44
737498|NCT00338962|2365781|P4|Overall Study|Poor Compliance|0
737499|NCT00338962|2365782|P3|Overall Study|Poor Compliance|2
737500|NCT00338962|2365783|P2|Overall Study|Poor Compliance|0
737501|NCT00338962|2365784|P1|Overall Study|Poor Compliance|0
737502|NCT00338962|2365781|P4|Overall Study|Adverse Event|0
737503|NCT00338962|2365782|P3|Overall Study|Adverse Event|2
737504|NCT00338962|2365783|P2|Overall Study|Adverse Event|0
737505|NCT00338962|2365784|P1|Overall Study|Adverse Event|0
737506|NCT00338962|2365781|P4|Overall Study|Moved|0
737507|NCT00338962|2365782|P3|Overall Study|Moved|0
737508|NCT00338962|2365783|P2|Overall Study|Moved|1
737509|NCT00338962|2365784|P1|Overall Study|Moved|0
737510|NCT00338962|2365781|P4|Overall Study|Time Constraint|0
737511|NCT00338962|2365782|P3|Overall Study|Time Constraint|0
737512|NCT00338962|2365783|P2|Overall Study|Time Constraint|0
737513|NCT00338962|2365784|P1|Overall Study|Time Constraint|2
737514|NCT00338962|2365781|P4|Overall Study|No Transportation|0
737515|NCT00338962|2365782|P3|Overall Study|No Transportation|0
737516|NCT00338962|2365783|P2|Overall Study|No Transportation|0
737517|NCT00338962|2365784|P1|Overall Study|No Transportation|2
737518|NCT00338962|2365781|P4|Overall Study|Withdrawal by Subject|0
737519|NCT00338962|2365782|P3|Overall Study|Withdrawal by Subject|0
737520|NCT00338962|2365783|P2|Overall Study|Withdrawal by Subject|0
737521|NCT00338962|2365784|P1|Overall Study|Withdrawal by Subject|1
737522|NCT00338962|2365781|P4|Overall Study|Lost to Follow-up|3
737523|NCT00338962|2365782|P3|Overall Study|Lost to Follow-up|2
737524|NCT00338962|2365783|P2|Overall Study|Lost to Follow-up|3
737525|NCT00338962|2365784|P1|Overall Study|Lost to Follow-up|3
737526|NCT00339040|2365813|P2|Stage II|Site closing|0
737527|NCT00339040|2365814|P1|Stage II|Site closing|2
737528|NCT00339040|2365813|P2|Stage II|Not able to attend clinic|0
737529|NCT00339040|2365814|P1|Stage II|Not able to attend clinic|1
737530|NCT00339040|2365813|P2|Stage II|Protocol Violation|0
737531|NCT00339040|2365814|P1|Stage II|Protocol Violation|3
737532|NCT00339040|2365813|P2|Stage II|Withdrawal by Subject|2
737533|NCT00339040|2365814|P1|Stage II|Withdrawal by Subject|1
737534|NCT00339040|2365813|P2|Stage II|Lost to Follow-up|0
737535|NCT00339040|2365814|P1|Stage II|Lost to Follow-up|3
737536|NCT00339040|2365813|P2|Stage I|Protocol Violation|1
737537|NCT00339040|2365814|P1|Stage I|Protocol Violation|1
737538|NCT00339040|2365813|P2|Stage I|Not able to attend clinic|0
737539|NCT00339040|2365814|P1|Stage I|Not able to attend clinic|1
737540|NCT00339144|2365856|P3|Overall Study|Participant's request to discontinuation|1
737541|NCT00339144|2365857|P2|Overall Study|Participant's request to discontinuation|0
737542|NCT00339144|2365858|P1|Overall Study|Participant's request to discontinuation|1
737543|NCT00339144|2365856|P3|Overall Study|Study drug toxicity|1
737544|NCT00339144|2365857|P2|Overall Study|Study drug toxicity|1
737545|NCT00339144|2365858|P1|Overall Study|Study drug toxicity|3
737546|NCT00339144|2365856|P3|Overall Study|Disease progression|2
737547|NCT00339144|2365857|P2|Overall Study|Disease progression|2
737548|NCT00339144|2365858|P1|Overall Study|Disease progression|5
737549|NCT00339183|2365942|P2|Overall Study|Ongoing|13
737550|NCT00339183|2365943|P1|Overall Study|Ongoing|20
737551|NCT00339183|2365942|P2|Overall Study|Other|40
737552|NCT00339183|2365943|P1|Overall Study|Other|46
737553|NCT00339183|2365942|P2|Overall Study|Missing reason|1
737554|NCT00339183|2365943|P1|Overall Study|Missing reason|3
737555|NCT00339183|2365942|P2|Overall Study|Protocol-specified criteria|8
737556|NCT00339183|2365943|P1|Overall Study|Protocol-specified criteria|12
737557|NCT00339183|2365942|P2|Overall Study|Lost to Follow-up|17
737558|NCT00339183|2365943|P1|Overall Study|Lost to Follow-up|17
737559|NCT00339183|2365942|P2|Overall Study|Physician Decision|4
737560|NCT00339183|2365943|P1|Overall Study|Physician Decision|2
737561|NCT00339183|2365942|P2|Overall Study|Withdrawal by Subject|19
737562|NCT00339183|2365943|P1|Overall Study|Withdrawal by Subject|16
737563|NCT00339183|2365942|P2|Overall Study|Adverse Event|3
737564|NCT00339183|2365943|P1|Overall Study|Adverse Event|5
737565|NCT00339833|2365971|P2|Overall Study|Error in data records|0
737566|NCT00339833|2365972|P1|Overall Study|Error in data records|1
737567|NCT00339833|2365971|P2|Overall Study|anaemia or excess drop in glycaemia|0
737568|NCT00339833|2365972|P1|Overall Study|anaemia or excess drop in glycaemia|2
737569|NCT00339833|2365971|P2|Overall Study|Poor venous access|2
737570|NCT00339833|2365972|P1|Overall Study|Poor venous access|2
737571|NCT00339833|2365971|P2|Overall Study|minor infection|1
737572|NCT00339833|2365972|P1|Overall Study|minor infection|0
737573|NCT00339833|2365971|P2|Overall Study|Chest pain|1
737574|NCT00339833|2365972|P1|Overall Study|Chest pain|0
737575|NCT00339833|2365971|P2|Overall Study|indigestion|1
737576|NCT00339833|2365972|P1|Overall Study|indigestion|0
737577|NCT00339833|2365971|P2|Overall Study|toothache|1
737578|NCT00339833|2365972|P1|Overall Study|toothache|0
737579|NCT00339833|2365971|P2|Overall Study|Withdrawal by Subject|2
737580|NCT00339833|2365972|P1|Overall Study|Withdrawal by Subject|1
737581|NCT00340678|2365997|P4|Overall Study|Lost to Follow-up|0
737582|NCT00340678|2365998|P3|Overall Study|Lost to Follow-up|0
737583|NCT00340678|2365999|P2|Overall Study|Lost to Follow-up|0
737584|NCT00340678|2366000|P1|Overall Study|Lost to Follow-up|1
737585|NCT00340704|2366021|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
737586|NCT00340704|2366022|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
737587|NCT00340704|2366023|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
737588|NCT00340704|2366024|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
737589|NCT00340704|2366025|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
737590|NCT00340704|2366026|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
737591|NCT00340704|2366027|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
737592|NCT00340704|2366028|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
737593|NCT00340704|2366029|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
737594|NCT00340704|2366021|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737595|NCT00340704|2366022|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737596|NCT00340704|2366023|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737597|NCT00340704|2366024|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
737598|NCT00340704|2366025|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
737599|NCT00340704|2366026|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737600|NCT00340704|2366027|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737601|NCT00340704|2366028|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737602|NCT00340704|2366029|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
737603|NCT00340704|2366021|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737604|NCT00340704|2366022|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737605|NCT00340704|2366023|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737606|NCT00340704|2366024|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
737607|NCT00340704|2366025|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737608|NCT00340704|2366026|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737609|NCT00340704|2366027|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737610|NCT00340704|2366028|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737611|NCT00340704|2366029|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
737612|NCT00340704|2366021|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
737613|NCT00340704|2366022|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
737614|NCT00340704|2366023|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
737615|NCT00340704|2366024|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
737616|NCT00340704|2366025|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
737617|NCT00340704|2366026|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
737618|NCT00340704|2366027|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
737619|NCT00340704|2366028|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
737620|NCT00340704|2366029|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
737621|NCT00340704|2366021|P9|PK Study|Not treated|0
737622|NCT00340704|2366022|P8|PK Study|Not treated|0
737623|NCT00340704|2366023|P7|PK Study|Not treated|0
737624|NCT00340704|2366024|P6|PK Study|Not treated|0
737625|NCT00340704|2366025|P5|PK Study|Not treated|0
737626|NCT00340704|2366026|P4|PK Study|Not treated|0
737627|NCT00340704|2366027|P3|PK Study|Not treated|1
737628|NCT00340704|2366028|P2|PK Study|Not treated|0
737629|NCT00340704|2366029|P1|PK Study|Not treated|0
737630|NCT00340704|2366021|P9|PK Study|Adverse Event|0
737631|NCT00340704|2366022|P8|PK Study|Adverse Event|0
737632|NCT00340704|2366023|P7|PK Study|Adverse Event|0
737633|NCT00340704|2366024|P6|PK Study|Adverse Event|0
737634|NCT00340704|2366025|P5|PK Study|Adverse Event|0
737635|NCT00340704|2366026|P4|PK Study|Adverse Event|0
737636|NCT00340704|2366027|P3|PK Study|Adverse Event|0
737637|NCT00340704|2366028|P2|PK Study|Adverse Event|1
737638|NCT00340704|2366029|P1|PK Study|Adverse Event|0
737639|NCT00340834|2366136|P5|Extension Phase of Study|Death|1
737640|NCT00340834|2366137|P4|Extension Phase of Study|Death|0
737641|NCT00340834|2366138|P3|Extension Phase of Study|Death|0
737642|NCT00340834|2366139|P2|Extension Phase of Study|Death|0
737643|NCT00340834|2366140|P1|Extension Phase of Study|Death|0
737644|NCT00340834|2366136|P5|Extension Phase of Study|Protocol Violation|0
737645|NCT00340834|2366137|P4|Extension Phase of Study|Protocol Violation|0
737646|NCT00340834|2366138|P3|Extension Phase of Study|Protocol Violation|0
737647|NCT00340834|2366139|P2|Extension Phase of Study|Protocol Violation|0
737648|NCT00340834|2366140|P1|Extension Phase of Study|Protocol Violation|3
737649|NCT00340834|2366136|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
737650|NCT00340834|2366137|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
737651|NCT00340834|2366138|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
737652|NCT00340834|2366139|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
737653|NCT00340834|2366140|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
737654|NCT00340834|2366136|P5|Extension Phase of Study|Administrative problems|1
737655|NCT00340834|2366137|P4|Extension Phase of Study|Administrative problems|1
737656|NCT00340834|2366138|P3|Extension Phase of Study|Administrative problems|0
737657|NCT00340834|2366139|P2|Extension Phase of Study|Administrative problems|0
737658|NCT00340834|2366140|P1|Extension Phase of Study|Administrative problems|3
737659|NCT00340834|2366136|P5|Extension Phase of Study|Subject no longer requires study drug|2
737660|NCT00340834|2366137|P4|Extension Phase of Study|Subject no longer requires study drug|0
737661|NCT00340834|2366138|P3|Extension Phase of Study|Subject no longer requires study drug|0
737662|NCT00340834|2366139|P2|Extension Phase of Study|Subject no longer requires study drug|0
737663|NCT00340834|2366140|P1|Extension Phase of Study|Subject no longer requires study drug|4
737664|NCT00340834|2366136|P5|Extension Phase of Study|Lost to Follow-up|3
737665|NCT00340834|2366137|P4|Extension Phase of Study|Lost to Follow-up|2
737666|NCT00340834|2366138|P3|Extension Phase of Study|Lost to Follow-up|0
737667|NCT00340834|2366139|P2|Extension Phase of Study|Lost to Follow-up|1
737668|NCT00340834|2366140|P1|Extension Phase of Study|Lost to Follow-up|1
737669|NCT00340834|2366136|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
737670|NCT00340834|2366137|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
737671|NCT00340834|2366138|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
737672|NCT00340834|2366139|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
737673|NCT00340834|2366140|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
737674|NCT00340834|2366136|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
737675|NCT00340834|2366137|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
737676|NCT00340834|2366138|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
737677|NCT00340834|2366139|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
737678|NCT00340834|2366140|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
737679|NCT00340834|2366136|P5|Extension Phase of Study|Adverse Event|7
737680|NCT00340834|2366137|P4|Extension Phase of Study|Adverse Event|19
737681|NCT00340834|2366138|P3|Extension Phase of Study|Adverse Event|0
737682|NCT00340834|2366139|P2|Extension Phase of Study|Adverse Event|22
737683|NCT00340834|2366140|P1|Extension Phase of Study|Adverse Event|21
737684|NCT00340834|2366136|P5|Extension Phase of Study|Subject withdrew consent|15
737685|NCT00340834|2366137|P4|Extension Phase of Study|Subject withdrew consent|12
737686|NCT00340834|2366138|P3|Extension Phase of Study|Subject withdrew consent|0
737687|NCT00340834|2366139|P2|Extension Phase of Study|Subject withdrew consent|31
737688|NCT00340834|2366140|P1|Extension Phase of Study|Subject withdrew consent|26
737689|NCT00340834|2366136|P5|Extension Phase of Study|Subject did not receive study drug|0
737690|NCT00340834|2366137|P4|Extension Phase of Study|Subject did not receive study drug|2
737691|NCT00340834|2366138|P3|Extension Phase of Study|Subject did not receive study drug|0
737692|NCT00340834|2366139|P2|Extension Phase of Study|Subject did not receive study drug|1
737693|NCT00340834|2366140|P1|Extension Phase of Study|Subject did not receive study drug|0
737694|NCT00340834|2366136|P5|Core Phase of Study|Protocol Violation|0
737695|NCT00340834|2366137|P4|Core Phase of Study|Protocol Violation|0
737696|NCT00340834|2366138|P3|Core Phase of Study|Protocol Violation|2
737697|NCT00340834|2366139|P2|Core Phase of Study|Protocol Violation|0
737698|NCT00340834|2366140|P1|Core Phase of Study|Protocol Violation|0
737699|NCT00340834|2366136|P5|Core Phase of Study|Death|0
737700|NCT00340834|2366137|P4|Core Phase of Study|Death|0
737701|NCT00340834|2366138|P3|Core Phase of Study|Death|0
737702|NCT00340834|2366139|P2|Core Phase of Study|Death|0
737703|NCT00340834|2366140|P1|Core Phase of Study|Death|2
737704|NCT00340834|2366136|P5|Core Phase of Study|Lost to Follow-up|0
737705|NCT00340834|2366137|P4|Core Phase of Study|Lost to Follow-up|0
737706|NCT00340834|2366138|P3|Core Phase of Study|Lost to Follow-up|4
737707|NCT00340834|2366139|P2|Core Phase of Study|Lost to Follow-up|1
737708|NCT00340834|2366140|P1|Core Phase of Study|Lost to Follow-up|1
737709|NCT00340834|2366136|P5|Core Phase of Study|Abnormal test procedure result(s)|0
737710|NCT00340834|2366137|P4|Core Phase of Study|Abnormal test procedure result(s)|0
737711|NCT00340834|2366138|P3|Core Phase of Study|Abnormal test procedure result(s)|3
737712|NCT00340834|2366139|P2|Core Phase of Study|Abnormal test procedure result(s)|3
737713|NCT00340834|2366140|P1|Core Phase of Study|Abnormal test procedure result(s)|4
737714|NCT00340834|2366136|P5|Core Phase of Study|Abnormal laboratory value(s)|0
737715|NCT00340834|2366137|P4|Core Phase of Study|Abnormal laboratory value(s)|0
737716|NCT00340834|2366138|P3|Core Phase of Study|Abnormal laboratory value(s)|1
737717|NCT00340834|2366139|P2|Core Phase of Study|Abnormal laboratory value(s)|6
737718|NCT00340834|2366140|P1|Core Phase of Study|Abnormal laboratory value(s)|4
737719|NCT00340834|2366136|P5|Core Phase of Study|Lack of Efficacy|0
737720|NCT00340834|2366137|P4|Core Phase of Study|Lack of Efficacy|0
737721|NCT00340834|2366138|P3|Core Phase of Study|Lack of Efficacy|7
737722|NCT00340834|2366139|P2|Core Phase of Study|Lack of Efficacy|3
737723|NCT00340834|2366140|P1|Core Phase of Study|Lack of Efficacy|3
737724|NCT00340834|2366136|P5|Core Phase of Study|Administrative Problems|0
737725|NCT00340834|2366137|P4|Core Phase of Study|Administrative Problems|0
737726|NCT00340834|2366138|P3|Core Phase of Study|Administrative Problems|7
737727|NCT00340834|2366139|P2|Core Phase of Study|Administrative Problems|2
737728|NCT00340834|2366140|P1|Core Phase of Study|Administrative Problems|6
737729|NCT00340834|2366136|P5|Core Phase of Study|Withdrawal by Subject|0
737730|NCT00340834|2366137|P4|Core Phase of Study|Withdrawal by Subject|0
737731|NCT00340834|2366138|P3|Core Phase of Study|Withdrawal by Subject|16
737732|NCT00340834|2366139|P2|Core Phase of Study|Withdrawal by Subject|9
737733|NCT00340834|2366140|P1|Core Phase of Study|Withdrawal by Subject|11
737734|NCT00340834|2366136|P5|Core Phase of Study|Adverse Event|0
737735|NCT00340834|2366137|P4|Core Phase of Study|Adverse Event|0
737736|NCT00340834|2366138|P3|Core Phase of Study|Adverse Event|9
737737|NCT00340834|2366139|P2|Core Phase of Study|Adverse Event|9
737738|NCT00340834|2366140|P1|Core Phase of Study|Adverse Event|26
737739|NCT00347009|2366165|P1|Overall Study|Serious Adverse Event|1
737740|NCT00347009|2366165|P1|Overall Study|Increased ALT/HBV DNA|1
737741|NCT00347009|2366165|P1|Overall Study|Insufficient Viral Suppression|3
737742|NCT00347009|2366165|P1|Overall Study|Adverse Laboratory Experience|1
737743|NCT00347009|2366165|P1|Overall Study|Protocol Violation|2
737744|NCT00347009|2366165|P1|Overall Study|Lost to Follow-up|4
737745|NCT00347009|2366165|P1|Overall Study|Physician Decision|5
737746|NCT00347009|2366165|P1|Overall Study|Withdrawal by Subject|3
737747|NCT00347009|2366165|P1|Overall Study|Adverse Event|6
737748|NCT00347009|2366165|P1|Overall Study|Death|1
737749|NCT00347269|2366193|P2|Overall Study|Death|3
737750|NCT00347269|2366194|P1|Overall Study|Death|2
737751|NCT00347269|2366193|P2|Overall Study|Withdrawal by Subject|38
737752|NCT00347269|2366194|P1|Overall Study|Withdrawal by Subject|18
737753|NCT00347269|2366193|P2|Overall Study|Lost to Follow-up|65
737754|NCT00347269|2366194|P1|Overall Study|Lost to Follow-up|74
890631|NCT00950807|2825719|P6|Washout Period 1|Lack of Efficacy|0
737756|NCT00348673|2366217|P9|Stage 1|Randomized but not Treated|0
737757|NCT00348673|2366218|P8|Stage 1|Randomized but not Treated|0
737758|NCT00348673|2366219|P7|Stage 1|Randomized but not Treated|0
737759|NCT00348673|2366220|P6|Stage 1|Randomized but not Treated|0
737760|NCT00348673|2366221|P5|Stage 1|Randomized but not Treated|0
737761|NCT00348673|2366222|P4|Stage 1|Randomized but not Treated|0
737762|NCT00348673|2366223|P3|Stage 1|Randomized but not Treated|1
737763|NCT00348673|2366224|P2|Stage 1|Randomized but not Treated|0
737764|NCT00348673|2366225|P1|Stage 1|Randomized but not Treated|0
737765|NCT00348686|2366272|P1|Overall Study|Multiple Reasons|8
737766|NCT00348686|2366272|P1|Overall Study|Lost to Follow-up|2
737767|NCT00348686|2366272|P1|Overall Study|Protocol Violation|6
737768|NCT00348686|2366272|P1|Overall Study|Adverse Event|5
737769|NCT00348686|2366272|P1|Overall Study|Withdrawal by Subject|45
737770|NCT00348790|2366281|P1|Completed Treatment|Unable to travel to study site|1
737771|NCT00348790|2366281|P1|Completed Treatment|Required surgery|2
737772|NCT00348790|2366281|P1|Completed Treatment|Adverse Event|4
737773|NCT00348790|2366281|P1|Completed Treatment|Disease progression|14
737774|NCT00348790|2366281|P1|Completed Treatment|Withdrawal by Subject|4
890632|NCT00950807|2825720|P5|Washout Period 1|Lack of Efficacy|0
737776|NCT00348881|2366293|P2|Overall Study|Serious Adverse Event|2
737777|NCT00348881|2366294|P1|Overall Study|Serious Adverse Event|0
737778|NCT00348881|2366293|P2|Overall Study|Adverse Event|0
737779|NCT00348881|2366294|P1|Overall Study|Adverse Event|2
737780|NCT00348881|2366293|P2|Overall Study|Withdrawal by Subject|4
737781|NCT00348881|2366294|P1|Overall Study|Withdrawal by Subject|3
737782|NCT00348881|2366293|P2|Overall Study|Lost to Follow-up|6
737783|NCT00348881|2366294|P1|Overall Study|Lost to Follow-up|12
737784|NCT00348933|2366306|P1|Overall Study|Adverse Event|7
737785|NCT00348933|2366306|P1|Overall Study|Protocol Violation|2
737786|NCT00348933|2366306|P1|Overall Study|Lost to Follow-up|6
737787|NCT00348933|2366306|P1|Overall Study|Withdrawal by Subject|10
737788|NCT00349349|2366340|P3|Overall Study|New Malignancy (Bladder Cancer)|0
737789|NCT00349349|2366341|P2|Overall Study|New Malignancy (Bladder Cancer)|1
737790|NCT00349349|2366342|P1|Overall Study|New Malignancy (Bladder Cancer)|0
737791|NCT00349349|2366340|P3|Overall Study|No Response|0
737792|NCT00349349|2366341|P2|Overall Study|No Response|3
737793|NCT00349349|2366342|P1|Overall Study|No Response|0
737794|NCT00349349|2366340|P3|Overall Study|Physician Decision|1
737795|NCT00349349|2366341|P2|Overall Study|Physician Decision|2
737796|NCT00349349|2366342|P1|Overall Study|Physician Decision|1
737797|NCT00349349|2366340|P3|Overall Study|Participant Reduced General Condition|0
737798|NCT00349349|2366341|P2|Overall Study|Participant Reduced General Condition|1
737799|NCT00349349|2366342|P1|Overall Study|Participant Reduced General Condition|0
737800|NCT00349349|2366340|P3|Overall Study|Other Treatment Selected|0
737801|NCT00349349|2366341|P2|Overall Study|Other Treatment Selected|0
737802|NCT00349349|2366342|P1|Overall Study|Other Treatment Selected|2
737803|NCT00349349|2366340|P3|Overall Study|Death|1
737804|NCT00349349|2366341|P2|Overall Study|Death|10
737805|NCT00349349|2366342|P1|Overall Study|Death|13
737806|NCT00349349|2366340|P3|Overall Study|Withdrawn due to Disease Progression|1
737807|NCT00349349|2366341|P2|Overall Study|Withdrawn due to Disease Progression|37
737808|NCT00349349|2366342|P1|Overall Study|Withdrawn due to Disease Progression|27
737809|NCT00349349|2366340|P3|Overall Study|Withdrawal by Subject|1
737810|NCT00349349|2366341|P2|Overall Study|Withdrawal by Subject|2
737811|NCT00349349|2366342|P1|Overall Study|Withdrawal by Subject|5
737812|NCT00349349|2366340|P3|Overall Study|Adverse Event|2
737813|NCT00349349|2366341|P2|Overall Study|Adverse Event|6
737814|NCT00349349|2366342|P1|Overall Study|Adverse Event|5
737815|NCT00349622|2366426|P2|Overall Study|Withdrawal by Subject|9
737816|NCT00349622|2366427|P1|Overall Study|Withdrawal by Subject|5
737817|NCT00349622|2366426|P2|Overall Study|Lost to Follow-up|1
737818|NCT00349622|2366427|P1|Overall Study|Lost to Follow-up|5
737819|NCT00349622|2366426|P2|Overall Study|Death|86
737820|NCT00349622|2366427|P1|Overall Study|Death|168
737821|NCT00349752|2366470|P2|Overall Study|Other:History of squamous cell carcinoma|0
737822|NCT00349752|2366471|P1|Overall Study|Other:History of squamous cell carcinoma|1
737823|NCT00349752|2366470|P2|Overall Study|Other: Inadvertently unblinded|0
737824|NCT00349752|2366471|P1|Overall Study|Other: Inadvertently unblinded|1
737825|NCT00349752|2366470|P2|Overall Study|Other: Ineligible|0
737826|NCT00349752|2366471|P1|Overall Study|Other: Ineligible|1
737827|NCT00349752|2366470|P2|Overall Study|Other: Patient's steroid use|0
737828|NCT00349752|2366471|P1|Overall Study|Other: Patient's steroid use|1
737829|NCT00349752|2366470|P2|Overall Study|Other: Patient stopped steroids|1
737830|NCT00349752|2366471|P1|Overall Study|Other: Patient stopped steroids|0
737831|NCT00349752|2366470|P2|Overall Study|Other: Non compliance|1
737832|NCT00349752|2366471|P1|Overall Study|Other: Non compliance|0
737833|NCT00349752|2366470|P2|Overall Study|Other: Required exclusionary medication|1
737834|NCT00349752|2366471|P1|Overall Study|Other: Required exclusionary medication|0
737835|NCT00349752|2366470|P2|Overall Study|Personal reasons|5
737836|NCT00349752|2366471|P1|Overall Study|Personal reasons|6
737837|NCT00349752|2366470|P2|Overall Study|Lost to Follow-up|2
737838|NCT00349752|2366471|P1|Overall Study|Lost to Follow-up|4
737839|NCT00349752|2366470|P2|Overall Study|Lack of Efficacy|42
737840|NCT00349752|2366471|P1|Overall Study|Lack of Efficacy|37
737841|NCT00349752|2366470|P2|Overall Study|Adverse Event|12
737842|NCT00349752|2366471|P1|Overall Study|Adverse Event|8
737843|NCT00349908|2366499|P2|Overall Study|Withdrawal by Subject|4
737844|NCT00349908|2366500|P1|Overall Study|Withdrawal by Subject|0
890633|NCT00950807|2825721|P4|Washout Period 1|Lack of Efficacy|0
890634|NCT00950807|2825722|P3|Washout Period 1|Lack of Efficacy|0
890635|NCT00950807|2825723|P2|Washout Period 1|Lack of Efficacy|0
890636|NCT00950807|2825724|P1|Washout Period 1|Lack of Efficacy|0
890637|NCT00950807|2825715|P10|Treatment Period 1|Adverse Event|0
890638|NCT00950807|2825716|P9|Treatment Period 1|Adverse Event|0
890639|NCT00950807|2825717|P8|Treatment Period 1|Adverse Event|0
890640|NCT00950807|2825718|P7|Treatment Period 1|Adverse Event|0
737853|NCT00350207|2366553|P3|Overall Study|Other|1
737854|NCT00350207|2366554|P2|Overall Study|Other|3
737855|NCT00350207|2366555|P1|Overall Study|Other|1
737856|NCT00350207|2366553|P3|Overall Study|Withdrawal by Subject|1
737857|NCT00350207|2366554|P2|Overall Study|Withdrawal by Subject|1
737858|NCT00350207|2366555|P1|Overall Study|Withdrawal by Subject|0
737859|NCT00350207|2366553|P3|Overall Study|Lost to Follow-up|1
737860|NCT00350207|2366554|P2|Overall Study|Lost to Follow-up|0
737861|NCT00350207|2366555|P1|Overall Study|Lost to Follow-up|1
737862|NCT00350207|2366553|P3|Overall Study|Lack of Efficacy|2
737863|NCT00350207|2366554|P2|Overall Study|Lack of Efficacy|0
737864|NCT00350207|2366555|P1|Overall Study|Lack of Efficacy|1
737865|NCT00350207|2366553|P3|Overall Study|Adverse Event|2
737866|NCT00350207|2366554|P2|Overall Study|Adverse Event|2
737867|NCT00350207|2366555|P1|Overall Study|Adverse Event|5
737868|NCT00350272|2366762|P2|Open-Label 84 Week Treatment|Sponsor decision|1
737869|NCT00350272|2366763|P1|Open-Label 84 Week Treatment|Sponsor decision|2
737870|NCT00350272|2366762|P2|Open-Label 84 Week Treatment|Physician Decision|2
737871|NCT00350272|2366763|P1|Open-Label 84 Week Treatment|Physician Decision|1
737872|NCT00350272|2366762|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
737873|NCT00350272|2366763|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
737874|NCT00350272|2366762|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
737875|NCT00350272|2366763|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
737876|NCT00350272|2366762|P2|Open-Label 84 Week Treatment|Adverse Event|1
737877|NCT00350272|2366763|P1|Open-Label 84 Week Treatment|Adverse Event|2
737878|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Sponsor decision|1
737879|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Sponsor decision|0
737880|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Physician Decision|1
737881|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Physician Decision|2
737882|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
737883|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
737884|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
737885|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
737886|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Death|0
737887|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Death|1
737888|NCT00350272|2366762|P2|Blinded 12 Week Treatment|Adverse Event|0
737889|NCT00350272|2366763|P1|Blinded 12 Week Treatment|Adverse Event|1
737890|NCT00350402|2366777|P2|Overall Study|Lost to Follow-up|1
737891|NCT00350402|2366778|P1|Overall Study|Lost to Follow-up|1
737892|NCT00350519|2366792|P2|Overall Study|Withdrawal by Subject|2
737893|NCT00350519|2366793|P1|Overall Study|Withdrawal by Subject|3
737894|NCT00350519|2366792|P2|Overall Study|Protocol Violation|2
737895|NCT00350519|2366793|P1|Overall Study|Protocol Violation|1
737896|NCT00350519|2366792|P2|Overall Study|Physician Decision|1
737897|NCT00350519|2366793|P1|Overall Study|Physician Decision|0
737898|NCT00350519|2366792|P2|Overall Study|Death|1
737899|NCT00350519|2366793|P1|Overall Study|Death|0
737900|NCT00350623|2366817|P3|Overall Study|patient traveling outside the country|1
737901|NCT00350623|2366818|P2|Overall Study|patient traveling outside the country|0
737902|NCT00350623|2366819|P1|Overall Study|patient traveling outside the country|0
737903|NCT00350623|2366817|P3|Overall Study|Withdrawal by Subject|1
737904|NCT00350623|2366818|P2|Overall Study|Withdrawal by Subject|1
737905|NCT00350623|2366819|P1|Overall Study|Withdrawal by Subject|0
737906|NCT00350623|2366817|P3|Overall Study|Lost to Follow-up|4
737907|NCT00350623|2366818|P2|Overall Study|Lost to Follow-up|3
737908|NCT00350623|2366819|P1|Overall Study|Lost to Follow-up|8
737909|NCT00350636|2366829|P2|Overall Study|Other|2
737910|NCT00350636|2366830|P1|Overall Study|Other|1
737911|NCT00350636|2366829|P2|Overall Study|Physician Decision|2
737912|NCT00350636|2366830|P1|Overall Study|Physician Decision|0
737913|NCT00350636|2366829|P2|Overall Study|Lost to Follow-up|8
737914|NCT00350636|2366830|P1|Overall Study|Lost to Follow-up|9
737915|NCT00350636|2366829|P2|Overall Study|Withdrawal by Subject|17
737916|NCT00350636|2366830|P1|Overall Study|Withdrawal by Subject|13
737917|NCT00350636|2366829|P2|Overall Study|Protocol Violation|3
737918|NCT00350636|2366830|P1|Overall Study|Protocol Violation|1
737919|NCT00350636|2366829|P2|Overall Study|Adverse Event|13
737920|NCT00350636|2366830|P1|Overall Study|Adverse Event|19
737921|NCT00350727|2366849|P3|Phase II|Enrolled in Rollover Study|1
737922|NCT00350727|2366850|P2|Phase II|Enrolled in Rollover Study|0
737923|NCT00350727|2366851|P1|Phase II|Enrolled in Rollover Study|0
737924|NCT00350727|2366849|P3|Phase II|Sponsor Terminated Study|1
737925|NCT00350727|2366850|P2|Phase II|Sponsor Terminated Study|0
737926|NCT00350727|2366851|P1|Phase II|Sponsor Terminated Study|0
737927|NCT00350727|2366849|P3|Phase II|Death|2
737928|NCT00350727|2366850|P2|Phase II|Death|0
737929|NCT00350727|2366851|P1|Phase II|Death|0
737930|NCT00350727|2366849|P3|Phase II|Adverse Event|1
737931|NCT00350727|2366850|P2|Phase II|Adverse Event|1
737932|NCT00350727|2366851|P1|Phase II|Adverse Event|0
737933|NCT00350727|2366849|P3|Phase II|Withdrawal by Subject|1
737934|NCT00350727|2366850|P2|Phase II|Withdrawal by Subject|2
737935|NCT00350727|2366851|P1|Phase II|Withdrawal by Subject|0
737936|NCT00350727|2366849|P3|Phase II|Clinical Deterioration|0
737937|NCT00350727|2366850|P2|Phase II|Clinical Deterioration|1
737938|NCT00350727|2366851|P1|Phase II|Clinical Deterioration|0
737939|NCT00350727|2366849|P3|Phase II|Disease Progression|16
737940|NCT00350727|2366850|P2|Phase II|Disease Progression|15
737941|NCT00350727|2366851|P1|Phase II|Disease Progression|0
737942|NCT00350727|2366849|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
737943|NCT00350727|2366850|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
737944|NCT00350727|2366851|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
737945|NCT00350727|2366849|P3|Phase I: Dose Escalation|Physician Decision|0
737946|NCT00350727|2366850|P2|Phase I: Dose Escalation|Physician Decision|0
737947|NCT00350727|2366851|P1|Phase I: Dose Escalation|Physician Decision|1
737948|NCT00350727|2366849|P3|Phase I: Dose Escalation|Death|0
737949|NCT00350727|2366850|P2|Phase I: Dose Escalation|Death|0
737950|NCT00350727|2366851|P1|Phase I: Dose Escalation|Death|1
737951|NCT00350727|2366849|P3|Phase I: Dose Escalation|Lack of Efficacy|0
737952|NCT00350727|2366850|P2|Phase I: Dose Escalation|Lack of Efficacy|0
737953|NCT00350727|2366851|P1|Phase I: Dose Escalation|Lack of Efficacy|25
737954|NCT00350727|2366849|P3|Phase I: Dose Escalation|Adverse Event|0
737955|NCT00350727|2366850|P2|Phase I: Dose Escalation|Adverse Event|0
737956|NCT00350727|2366851|P1|Phase I: Dose Escalation|Adverse Event|4
737957|NCT00350779|2366995|P2|Overall Study|Non-compliance with study procedures|1
737958|NCT00350779|2366996|P1|Overall Study|Non-compliance with study procedures|0
737959|NCT00350779|2366995|P2|Overall Study|Patient Moved|1
737960|NCT00350779|2366996|P1|Overall Study|Patient Moved|2
737961|NCT00350779|2366995|P2|Overall Study|Withdrawal by Subject|8
737962|NCT00350779|2366996|P1|Overall Study|Withdrawal by Subject|9
737963|NCT00350779|2366995|P2|Overall Study|Protocol Violation|1
737964|NCT00350779|2366996|P1|Overall Study|Protocol Violation|3
737965|NCT00350779|2366995|P2|Overall Study|Physician Decision|4
737966|NCT00350779|2366996|P1|Overall Study|Physician Decision|2
737967|NCT00350779|2366995|P2|Overall Study|Lost to Follow-up|0
737968|NCT00350779|2366996|P1|Overall Study|Lost to Follow-up|2
737969|NCT00350779|2366995|P2|Overall Study|Lack of Efficacy|4
737970|NCT00350779|2366996|P1|Overall Study|Lack of Efficacy|0
737971|NCT00350779|2366995|P2|Overall Study|Adverse Event|2
737972|NCT00350779|2366996|P1|Overall Study|Adverse Event|4
737973|NCT00350792|2367014|P1|Overall Study|Lack of Efficacy|11
737974|NCT00350792|2367014|P1|Overall Study|Physician Decision|2
737975|NCT00350792|2367014|P1|Overall Study|Withdrawal by Subject|4
737976|NCT00350792|2367014|P1|Overall Study|Protocol Violation|1
737977|NCT00350792|2367014|P1|Overall Study|Death Not Study Drug Related|2
737978|NCT00350792|2367014|P1|Overall Study|Death from Study Drug Toxicity|1
737979|NCT00350792|2367014|P1|Overall Study|Death from Study Disease|1
737980|NCT00350792|2367014|P1|Overall Study|Adverse Event|11
737981|NCT00350844|2367022|P1|Overall Study|Lost to Follow-up|1
737982|NCT00350870|2367030|P4|Overall Study|Physician Decision|1
737983|NCT00350870|2367031|P3|Overall Study|Physician Decision|1
737984|NCT00350870|2367032|P2|Overall Study|Physician Decision|0
737985|NCT00350870|2367033|P1|Overall Study|Physician Decision|1
737986|NCT00350870|2367030|P4|Overall Study|Withdrawal by Subject|14
737987|NCT00350870|2367031|P3|Overall Study|Withdrawal by Subject|15
737988|NCT00350870|2367032|P2|Overall Study|Withdrawal by Subject|17
737989|NCT00350870|2367033|P1|Overall Study|Withdrawal by Subject|21
737990|NCT00344019|2367057|P3|Overall Study|did not meet final inclusion criteria|74
737991|NCT00344019|2367058|P2|Overall Study|did not meet final inclusion criteria|0
737992|NCT00344019|2367059|P1|Overall Study|did not meet final inclusion criteria|0
737993|NCT00344032|2367068|P2|Overall Study|Physician Decision|1
737994|NCT00344032|2367069|P1|Overall Study|Physician Decision|4
737995|NCT00344032|2367068|P2|Overall Study|Lost to Follow-up|6
737996|NCT00344032|2367069|P1|Overall Study|Lost to Follow-up|4
737997|NCT00344032|2367068|P2|Overall Study|Withdrawal by Subject|2
737998|NCT00344032|2367069|P1|Overall Study|Withdrawal by Subject|6
737999|NCT00344032|2367068|P2|Overall Study|Adverse Event|1
738000|NCT00344032|2367069|P1|Overall Study|Adverse Event|0
738001|NCT00344305|2367100|P2|Overall Study|Participant was not contacted in window|1
738002|NCT00344305|2367101|P1|Overall Study|Participant was not contacted in window|0
738003|NCT00344305|2367100|P2|Overall Study|Lost to Follow-up|0
738004|NCT00344305|2367101|P1|Overall Study|Lost to Follow-up|2
738005|NCT00344448|2367149|P2|Open Label|Study terminated|0
738006|NCT00344448|2367150|P1|Open Label|Study terminated|1
738007|NCT00344448|2367149|P2|Open Label|Withdrawal by Subject|1
738008|NCT00344448|2367150|P1|Open Label|Withdrawal by Subject|1
738009|NCT00344448|2367149|P2|Double Blind, Placebo Controlled|Study terminated|0
738010|NCT00344448|2367150|P1|Double Blind, Placebo Controlled|Study terminated|1
738011|NCT00344448|2367149|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
738012|NCT00344448|2367150|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
738013|NCT00344448|2367149|P2|Screening|Withdrawal by Subject|1
738014|NCT00344448|2367150|P1|Screening|Withdrawal by Subject|0
738015|NCT00351273|2367168|P3|Overall Study|Lost to Follow-up|5
738016|NCT00351273|2367169|P2|Overall Study|Lost to Follow-up|2
738017|NCT00351273|2367170|P1|Overall Study|Lost to Follow-up|1
738018|NCT00351468|2367195|P1|Overall Study|Protocol Violation|3
738019|NCT00351468|2367195|P1|Overall Study|Lost to Follow-up|4
738020|NCT00351468|2367195|P1|Overall Study|Non-compliance|8
738021|NCT00351468|2367195|P1|Overall Study|Lack of Efficacy|32
738022|NCT00351468|2367195|P1|Overall Study|Various -follow up w clinical team|39
738023|NCT00351468|2367195|P1|Overall Study|Withdrawal by Subject|39
738024|NCT00351468|2367195|P1|Overall Study|Adverse Event|42
738025|NCT00351533|2367212|P2|Overall Study|Withdrawal by Subject|1
738026|NCT00351533|2367213|P1|Overall Study|Withdrawal by Subject|0
738027|NCT00351533|2367212|P2|Overall Study|Physician Decision|1
738028|NCT00351533|2367213|P1|Overall Study|Physician Decision|0
738029|NCT00351533|2367212|P2|Overall Study|Lost to Follow-up|3
738030|NCT00351533|2367213|P1|Overall Study|Lost to Follow-up|1
738031|NCT00351533|2367212|P2|Overall Study|Extubated before first BAL|0
738032|NCT00351533|2367213|P1|Overall Study|Extubated before first BAL|1
738033|NCT00351819|2367296|P2|Overall Study|Enrolled in another trial|1
738034|NCT00351819|2367297|P1|Overall Study|Enrolled in another trial|0
738035|NCT00351819|2367296|P2|Overall Study|Incarcerated|1
738036|NCT00351819|2367297|P1|Overall Study|Incarcerated|0
738037|NCT00351819|2367296|P2|Overall Study|Non-compliance|1
738038|NCT00351819|2367297|P1|Overall Study|Non-compliance|0
738039|NCT00351819|2367296|P2|Overall Study|Unprofessional behavior|0
738040|NCT00351819|2367297|P1|Overall Study|Unprofessional behavior|1
738041|NCT00351819|2367296|P2|Overall Study|Traumatic ankle fracture|0
738042|NCT00351819|2367297|P1|Overall Study|Traumatic ankle fracture|1
738043|NCT00351819|2367296|P2|Overall Study|Elevated PSA|1
738044|NCT00351819|2367297|P1|Overall Study|Elevated PSA|1
738045|NCT00351819|2367296|P2|Overall Study|Withdrawal by Subject|4
738046|NCT00351819|2367297|P1|Overall Study|Withdrawal by Subject|0
738047|NCT00351819|2367296|P2|Overall Study|Lost to Follow-up|4
738048|NCT00351819|2367297|P1|Overall Study|Lost to Follow-up|4
738050|NCT00352053|2367633|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
738051|NCT00352053|2367634|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
738052|NCT00352053|2367633|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
738053|NCT00352053|2367634|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
738054|NCT00352053|2367633|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
738055|NCT00352053|2367634|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
738056|NCT00352053|2367633|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
738057|NCT00352053|2367634|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
738058|NCT00352053|2367633|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
738059|NCT00352053|2367634|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
738060|NCT00352053|2367633|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
738061|NCT00352053|2367634|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
738062|NCT00352053|2367633|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
738063|NCT00352053|2367634|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
738064|NCT00352053|2367633|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
738065|NCT00352053|2367634|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
738066|NCT00352053|2367633|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
738067|NCT00352053|2367634|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
738068|NCT00352053|2367633|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
738069|NCT00352053|2367634|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
738070|NCT00352053|2367633|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
738071|NCT00352053|2367634|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
738072|NCT00352053|2367633|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
738073|NCT00352053|2367634|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
738074|NCT00352053|2367633|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
738075|NCT00352053|2367634|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
738076|NCT00352105|2367801|P1|Overall Study|Protocol Violation|2
738077|NCT00352105|2367801|P1|Overall Study|Adverse Event|19
738078|NCT00352105|2367801|P1|Overall Study|Lack of Efficacy|9
738079|NCT00352105|2367801|P1|Overall Study|Withdrawal by Subject|5
738080|NCT00352105|2367801|P1|Overall Study|Death|5
738081|NCT00352118|2367810|P1|Overall Study|Physician Decision|4
738082|NCT00352365|2367820|P1|Maintenance Therapy|Not eligible|4
738083|NCT00352365|2367820|P1|Maintenance Therapy|Not protocol specified|3
738084|NCT00352365|2367820|P1|Maintenance Therapy|Death|2
738085|NCT00352365|2367820|P1|Maintenance Therapy|Progression/Relapse|3
738086|NCT00352365|2367820|P1|Induction Therapy|Death before starting protocol therapy|1
738087|NCT00352365|2367820|P1|Induction Therapy|Not eligible|3
738088|NCT00352365|2367820|P1|Induction Therapy|Not protocol specified|1
738089|NCT00352365|2367820|P1|Induction Therapy|Death|7
738090|NCT00352365|2367820|P1|Induction Therapy|Progression/Relapse|8
738091|NCT00352365|2367820|P1|Induction Therapy|Adverse Event|7
738092|NCT00352417|2367832|P2|Overall Study|Schedule Change|1
738093|NCT00352417|2367833|P1|Overall Study|Schedule Change|2
738094|NCT00352417|2367832|P2|Overall Study|Lost to Follow-up|0
738095|NCT00352417|2367833|P1|Overall Study|Lost to Follow-up|1
738096|NCT00352417|2367832|P2|Overall Study|Withdrawal by Subject|2
738097|NCT00352417|2367833|P1|Overall Study|Withdrawal by Subject|1
738098|NCT00352417|2367832|P2|Overall Study|Protocol Violation|2
738099|NCT00352417|2367833|P1|Overall Study|Protocol Violation|0
738100|NCT00352417|2367832|P2|Overall Study|Adverse Event|0
738101|NCT00352417|2367833|P1|Overall Study|Adverse Event|1
738102|NCT00352534|2367849|P7|Final Risk Group Assignment|Death|0
738103|NCT00352534|2367850|P6|Final Risk Group Assignment|Death|2
738104|NCT00352534|2367851|P5|Final Risk Group Assignment|Death|0
738105|NCT00352534|2367852|P4|Final Risk Group Assignment|Death|0
738106|NCT00352534|2367853|P3|Final Risk Group Assignment|Death|0
738107|NCT00352534|2367854|P2|Final Risk Group Assignment|Death|0
738108|NCT00352534|2367855|P1|Final Risk Group Assignment|Death|0
738109|NCT00352534|2367849|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
738110|NCT00352534|2367850|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738111|NCT00352534|2367851|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738112|NCT00352534|2367852|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738113|NCT00352534|2367853|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738114|NCT00352534|2367854|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738115|NCT00352534|2367855|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
738116|NCT00352534|2367849|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
738117|NCT00352534|2367850|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
738118|NCT00352534|2367851|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
738119|NCT00352534|2367852|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
738120|NCT00352534|2367853|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
738121|NCT00352534|2367854|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
738122|NCT00352534|2367855|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
738123|NCT00352534|2367849|P7|Final Risk Group Assignment|Ineligible|0
738124|NCT00352534|2367850|P6|Final Risk Group Assignment|Ineligible|13
738125|NCT00352534|2367851|P5|Final Risk Group Assignment|Ineligible|0
738126|NCT00352534|2367852|P4|Final Risk Group Assignment|Ineligible|1
738127|NCT00352534|2367853|P3|Final Risk Group Assignment|Ineligible|3
738128|NCT00352534|2367854|P2|Final Risk Group Assignment|Ineligible|0
738129|NCT00352534|2367855|P1|Final Risk Group Assignment|Ineligible|0
738130|NCT00352534|2367849|P7|Final Risk Group Assignment|Withdrawal by Subject|0
738131|NCT00352534|2367850|P6|Final Risk Group Assignment|Withdrawal by Subject|3
738218|NCT00347360|2368140|P1|Overall Study|Visits conflicted with new job|0
738132|NCT00352534|2367851|P5|Final Risk Group Assignment|Withdrawal by Subject|0
738133|NCT00352534|2367852|P4|Final Risk Group Assignment|Withdrawal by Subject|0
738134|NCT00352534|2367853|P3|Final Risk Group Assignment|Withdrawal by Subject|0
738135|NCT00352534|2367854|P2|Final Risk Group Assignment|Withdrawal by Subject|0
738136|NCT00352534|2367855|P1|Final Risk Group Assignment|Withdrawal by Subject|0
738137|NCT00352534|2367849|P7|Final Risk Group Assignment|Physician Decision|0
738138|NCT00352534|2367850|P6|Final Risk Group Assignment|Physician Decision|8
738139|NCT00352534|2367851|P5|Final Risk Group Assignment|Physician Decision|0
738140|NCT00352534|2367852|P4|Final Risk Group Assignment|Physician Decision|0
738141|NCT00352534|2367853|P3|Final Risk Group Assignment|Physician Decision|0
738142|NCT00352534|2367854|P2|Final Risk Group Assignment|Physician Decision|0
738143|NCT00352534|2367855|P1|Final Risk Group Assignment|Physician Decision|0
738144|NCT00352534|2367849|P7|Final Risk Group Assignment|Lack of Efficacy|0
738145|NCT00352534|2367850|P6|Final Risk Group Assignment|Lack of Efficacy|19
738146|NCT00352534|2367851|P5|Final Risk Group Assignment|Lack of Efficacy|1
738147|NCT00352534|2367852|P4|Final Risk Group Assignment|Lack of Efficacy|2
738148|NCT00352534|2367853|P3|Final Risk Group Assignment|Lack of Efficacy|0
738149|NCT00352534|2367854|P2|Final Risk Group Assignment|Lack of Efficacy|0
738150|NCT00352534|2367855|P1|Final Risk Group Assignment|Lack of Efficacy|0
738151|NCT00352534|2367849|P7|Initial Staging|Ineligible|0
738152|NCT00352534|2367850|P6|Initial Staging|Ineligible|0
738153|NCT00352534|2367851|P5|Initial Staging|Ineligible|0
738154|NCT00352534|2367852|P4|Initial Staging|Ineligible|0
738155|NCT00352534|2367853|P3|Initial Staging|Ineligible|0
738156|NCT00352534|2367854|P2|Initial Staging|Ineligible|9
738157|NCT00352534|2367855|P1|Initial Staging|Ineligible|8
738158|NCT00352664|2367881|P2|Overall Study|Withdrawal by Subject|0
738159|NCT00352664|2367882|P1|Overall Study|Withdrawal by Subject|7
738160|NCT00352690|2367890|P2|Overall Study|Determined to be ineligible|0
738161|NCT00352690|2367891|P1|Overall Study|Determined to be ineligible|2
738162|NCT00352755|2367909|P1|Overall Study|Adverse Event|1
738163|NCT00352755|2367909|P1|Overall Study|Physician Decision|1
738164|NCT00352846|2367924|P2|Overall Study|Death|1
738165|NCT00352846|2367925|P1|Overall Study|Death|0
738166|NCT00352846|2367924|P2|Overall Study|Non-compliance|0
738167|NCT00352846|2367925|P1|Overall Study|Non-compliance|2
738168|NCT00352846|2367924|P2|Overall Study|Ineligible|2
738169|NCT00352846|2367925|P1|Overall Study|Ineligible|3
738170|NCT00352846|2367924|P2|Overall Study|Withdrawal by Subject|8
738171|NCT00352846|2367925|P1|Overall Study|Withdrawal by Subject|3
738172|NCT00352846|2367924|P2|Overall Study|Disease progression|2
738173|NCT00352846|2367925|P1|Overall Study|Disease progression|0
738174|NCT00353262|2367962|P1|Overall Study|Break from Chemotherapy|1
738175|NCT00353262|2367962|P1|Overall Study|Surgery|4
738176|NCT00353262|2367962|P1|Overall Study|Progression|1
738177|NCT00353262|2367962|P1|Overall Study|Insufficient Therapeutic Response|13
738178|NCT00353262|2367962|P1|Overall Study|Withdrawal by Subject|2
738179|NCT00353262|2367962|P1|Overall Study|Adverse Event|8
738180|NCT00353366|2367993|P1|Overall Study|Unspecified|135
738181|NCT00353366|2367993|P1|Overall Study|Adverse Event|8
738182|NCT00353496|2368040|P2|Overall Study|Not otherwise specified|2
738183|NCT00353496|2368041|P1|Overall Study|Not otherwise specified|4
738184|NCT00353496|2368040|P2|Overall Study|Physician Decision|9
738185|NCT00353496|2368041|P1|Overall Study|Physician Decision|6
738186|NCT00353496|2368040|P2|Overall Study|Withdrawal by Subject|4
738187|NCT00353496|2368041|P1|Overall Study|Withdrawal by Subject|3
738188|NCT00353496|2368040|P2|Overall Study|Protocol Violation|2
738189|NCT00353496|2368041|P1|Overall Study|Protocol Violation|2
738190|NCT00353496|2368040|P2|Overall Study|Adverse Event|0
738191|NCT00353496|2368041|P1|Overall Study|Adverse Event|1
738192|NCT00353704|2368083|P2|Overall Study|Protocol Violation|1
738193|NCT00353704|2368084|P1|Overall Study|Protocol Violation|3
738194|NCT00353873|2368098|P2|Overall Study|Withdrawal by Subject|1
738195|NCT00353873|2368099|P1|Overall Study|Withdrawal by Subject|1
738196|NCT00353873|2368098|P2|Overall Study|Physician Decision|0
738197|NCT00353873|2368099|P1|Overall Study|Physician Decision|2
738198|NCT00353873|2368098|P2|Overall Study|Adverse Event|0
738199|NCT00353873|2368099|P1|Overall Study|Adverse Event|1
738200|NCT00353873|2368098|P2|Overall Study|Exacerbation|0
738201|NCT00353873|2368099|P1|Overall Study|Exacerbation|1
738202|NCT00353873|2368098|P2|Overall Study|Protocol Violation|2
738203|NCT00353873|2368099|P1|Overall Study|Protocol Violation|1
738204|NCT00347360|2368126|P15|Overall Study|Visits conflicted with new job|0
738205|NCT00347360|2368127|P14|Overall Study|Visits conflicted with new job|0
738206|NCT00347360|2368128|P13|Overall Study|Visits conflicted with new job|0
738207|NCT00347360|2368129|P12|Overall Study|Visits conflicted with new job|0
738208|NCT00347360|2368130|P11|Overall Study|Visits conflicted with new job|0
738209|NCT00347360|2368131|P10|Overall Study|Visits conflicted with new job|0
738210|NCT00347360|2368132|P9|Overall Study|Visits conflicted with new job|0
738211|NCT00347360|2368133|P8|Overall Study|Visits conflicted with new job|0
738212|NCT00347360|2368134|P7|Overall Study|Visits conflicted with new job|1
738213|NCT00347360|2368135|P6|Overall Study|Visits conflicted with new job|0
738214|NCT00347360|2368136|P5|Overall Study|Visits conflicted with new job|0
738215|NCT00347360|2368137|P4|Overall Study|Visits conflicted with new job|0
738216|NCT00347360|2368138|P3|Overall Study|Visits conflicted with new job|0
738217|NCT00347360|2368139|P2|Overall Study|Visits conflicted with new job|0
738219|NCT00347360|2368126|P15|Overall Study|Subject refuse to sign updated consent|1
738220|NCT00347360|2368127|P14|Overall Study|Subject refuse to sign updated consent|0
738221|NCT00347360|2368128|P13|Overall Study|Subject refuse to sign updated consent|0
738222|NCT00347360|2368129|P12|Overall Study|Subject refuse to sign updated consent|0
738223|NCT00347360|2368130|P11|Overall Study|Subject refuse to sign updated consent|0
738224|NCT00347360|2368131|P10|Overall Study|Subject refuse to sign updated consent|0
738225|NCT00347360|2368132|P9|Overall Study|Subject refuse to sign updated consent|0
738226|NCT00347360|2368133|P8|Overall Study|Subject refuse to sign updated consent|0
738227|NCT00347360|2368134|P7|Overall Study|Subject refuse to sign updated consent|0
738228|NCT00347360|2368135|P6|Overall Study|Subject refuse to sign updated consent|0
738229|NCT00347360|2368136|P5|Overall Study|Subject refuse to sign updated consent|0
738230|NCT00347360|2368137|P4|Overall Study|Subject refuse to sign updated consent|0
738231|NCT00347360|2368138|P3|Overall Study|Subject refuse to sign updated consent|0
738232|NCT00347360|2368139|P2|Overall Study|Subject refuse to sign updated consent|0
738233|NCT00347360|2368140|P1|Overall Study|Subject refuse to sign updated consent|0
738234|NCT00347360|2368126|P15|Overall Study|Subject left town, ran out of study drug|0
738235|NCT00347360|2368127|P14|Overall Study|Subject left town, ran out of study drug|1
738236|NCT00347360|2368128|P13|Overall Study|Subject left town, ran out of study drug|0
738237|NCT00347360|2368129|P12|Overall Study|Subject left town, ran out of study drug|0
738238|NCT00347360|2368130|P11|Overall Study|Subject left town, ran out of study drug|0
738239|NCT00347360|2368131|P10|Overall Study|Subject left town, ran out of study drug|0
738240|NCT00347360|2368132|P9|Overall Study|Subject left town, ran out of study drug|0
738241|NCT00347360|2368133|P8|Overall Study|Subject left town, ran out of study drug|0
738242|NCT00347360|2368134|P7|Overall Study|Subject left town, ran out of study drug|0
738243|NCT00347360|2368135|P6|Overall Study|Subject left town, ran out of study drug|0
738244|NCT00347360|2368136|P5|Overall Study|Subject left town, ran out of study drug|0
738245|NCT00347360|2368137|P4|Overall Study|Subject left town, ran out of study drug|0
738246|NCT00347360|2368138|P3|Overall Study|Subject left town, ran out of study drug|0
738247|NCT00347360|2368139|P2|Overall Study|Subject left town, ran out of study drug|0
738248|NCT00347360|2368140|P1|Overall Study|Subject left town, ran out of study drug|0
738249|NCT00347360|2368126|P15|Overall Study|Prolonged duration between visits|0
738250|NCT00347360|2368127|P14|Overall Study|Prolonged duration between visits|0
738251|NCT00347360|2368128|P13|Overall Study|Prolonged duration between visits|1
738252|NCT00347360|2368129|P12|Overall Study|Prolonged duration between visits|0
738253|NCT00347360|2368130|P11|Overall Study|Prolonged duration between visits|0
738254|NCT00347360|2368131|P10|Overall Study|Prolonged duration between visits|0
738255|NCT00347360|2368132|P9|Overall Study|Prolonged duration between visits|0
738256|NCT00347360|2368133|P8|Overall Study|Prolonged duration between visits|0
738257|NCT00347360|2368134|P7|Overall Study|Prolonged duration between visits|0
738258|NCT00347360|2368135|P6|Overall Study|Prolonged duration between visits|0
738259|NCT00347360|2368136|P5|Overall Study|Prolonged duration between visits|0
738260|NCT00347360|2368137|P4|Overall Study|Prolonged duration between visits|0
738261|NCT00347360|2368138|P3|Overall Study|Prolonged duration between visits|0
738262|NCT00347360|2368139|P2|Overall Study|Prolonged duration between visits|0
738263|NCT00347360|2368140|P1|Overall Study|Prolonged duration between visits|0
738264|NCT00347360|2368126|P15|Overall Study|Failed inclusion criteria #4|0
738265|NCT00347360|2368127|P14|Overall Study|Failed inclusion criteria #4|0
738266|NCT00347360|2368128|P13|Overall Study|Failed inclusion criteria #4|0
738267|NCT00347360|2368129|P12|Overall Study|Failed inclusion criteria #4|1
738268|NCT00347360|2368130|P11|Overall Study|Failed inclusion criteria #4|0
738269|NCT00347360|2368131|P10|Overall Study|Failed inclusion criteria #4|0
738270|NCT00347360|2368132|P9|Overall Study|Failed inclusion criteria #4|0
738271|NCT00347360|2368133|P8|Overall Study|Failed inclusion criteria #4|0
738272|NCT00347360|2368134|P7|Overall Study|Failed inclusion criteria #4|0
738273|NCT00347360|2368135|P6|Overall Study|Failed inclusion criteria #4|0
738274|NCT00347360|2368136|P5|Overall Study|Failed inclusion criteria #4|0
738275|NCT00347360|2368137|P4|Overall Study|Failed inclusion criteria #4|0
738276|NCT00347360|2368138|P3|Overall Study|Failed inclusion criteria #4|0
738277|NCT00347360|2368139|P2|Overall Study|Failed inclusion criteria #4|0
738278|NCT00347360|2368140|P1|Overall Study|Failed inclusion criteria #4|0
738279|NCT00347360|2368126|P15|Overall Study|Randomized in error|0
738280|NCT00347360|2368127|P14|Overall Study|Randomized in error|0
738281|NCT00347360|2368128|P13|Overall Study|Randomized in error|0
738282|NCT00347360|2368129|P12|Overall Study|Randomized in error|1
738283|NCT00347360|2368130|P11|Overall Study|Randomized in error|0
738284|NCT00347360|2368131|P10|Overall Study|Randomized in error|0
738285|NCT00347360|2368132|P9|Overall Study|Randomized in error|0
738286|NCT00347360|2368133|P8|Overall Study|Randomized in error|0
738287|NCT00347360|2368134|P7|Overall Study|Randomized in error|0
738288|NCT00347360|2368135|P6|Overall Study|Randomized in error|0
738289|NCT00347360|2368136|P5|Overall Study|Randomized in error|0
738290|NCT00347360|2368137|P4|Overall Study|Randomized in error|0
738291|NCT00347360|2368138|P3|Overall Study|Randomized in error|0
738292|NCT00347360|2368139|P2|Overall Study|Randomized in error|0
738293|NCT00347360|2368140|P1|Overall Study|Randomized in error|0
738294|NCT00347360|2368126|P15|Overall Study|Did not meet criteria before ABPM|0
738295|NCT00347360|2368127|P14|Overall Study|Did not meet criteria before ABPM|0
738296|NCT00347360|2368128|P13|Overall Study|Did not meet criteria before ABPM|0
738297|NCT00347360|2368129|P12|Overall Study|Did not meet criteria before ABPM|0
738298|NCT00347360|2368130|P11|Overall Study|Did not meet criteria before ABPM|1
738299|NCT00347360|2368131|P10|Overall Study|Did not meet criteria before ABPM|0
738300|NCT00347360|2368132|P9|Overall Study|Did not meet criteria before ABPM|0
738301|NCT00347360|2368133|P8|Overall Study|Did not meet criteria before ABPM|0
738302|NCT00347360|2368134|P7|Overall Study|Did not meet criteria before ABPM|0
738303|NCT00347360|2368135|P6|Overall Study|Did not meet criteria before ABPM|0
738304|NCT00347360|2368136|P5|Overall Study|Did not meet criteria before ABPM|0
738305|NCT00347360|2368137|P4|Overall Study|Did not meet criteria before ABPM|0
738306|NCT00347360|2368138|P3|Overall Study|Did not meet criteria before ABPM|0
738307|NCT00347360|2368139|P2|Overall Study|Did not meet criteria before ABPM|0
738308|NCT00347360|2368140|P1|Overall Study|Did not meet criteria before ABPM|0
738309|NCT00347360|2368126|P15|Overall Study|PI recommended early withdrawal|0
738310|NCT00347360|2368127|P14|Overall Study|PI recommended early withdrawal|0
738311|NCT00347360|2368128|P13|Overall Study|PI recommended early withdrawal|0
738312|NCT00347360|2368129|P12|Overall Study|PI recommended early withdrawal|0
738313|NCT00347360|2368130|P11|Overall Study|PI recommended early withdrawal|0
738314|NCT00347360|2368131|P10|Overall Study|PI recommended early withdrawal|1
738315|NCT00347360|2368132|P9|Overall Study|PI recommended early withdrawal|0
738316|NCT00347360|2368133|P8|Overall Study|PI recommended early withdrawal|0
738317|NCT00347360|2368134|P7|Overall Study|PI recommended early withdrawal|0
738318|NCT00347360|2368135|P6|Overall Study|PI recommended early withdrawal|0
738319|NCT00347360|2368136|P5|Overall Study|PI recommended early withdrawal|0
738320|NCT00347360|2368137|P4|Overall Study|PI recommended early withdrawal|0
738321|NCT00347360|2368138|P3|Overall Study|PI recommended early withdrawal|0
738322|NCT00347360|2368139|P2|Overall Study|PI recommended early withdrawal|0
738323|NCT00347360|2368140|P1|Overall Study|PI recommended early withdrawal|0
738324|NCT00347360|2368126|P15|Overall Study|Abnormal lab values|0
738325|NCT00347360|2368127|P14|Overall Study|Abnormal lab values|0
738326|NCT00347360|2368128|P13|Overall Study|Abnormal lab values|0
738327|NCT00347360|2368129|P12|Overall Study|Abnormal lab values|0
738328|NCT00347360|2368130|P11|Overall Study|Abnormal lab values|0
738329|NCT00347360|2368131|P10|Overall Study|Abnormal lab values|0
738330|NCT00347360|2368132|P9|Overall Study|Abnormal lab values|0
738331|NCT00347360|2368133|P8|Overall Study|Abnormal lab values|0
738332|NCT00347360|2368134|P7|Overall Study|Abnormal lab values|1
738333|NCT00347360|2368135|P6|Overall Study|Abnormal lab values|0
738334|NCT00347360|2368136|P5|Overall Study|Abnormal lab values|0
738335|NCT00347360|2368137|P4|Overall Study|Abnormal lab values|0
738336|NCT00347360|2368138|P3|Overall Study|Abnormal lab values|0
738337|NCT00347360|2368139|P2|Overall Study|Abnormal lab values|0
738338|NCT00347360|2368140|P1|Overall Study|Abnormal lab values|0
738339|NCT00347360|2368126|P15|Overall Study|Subject did not meet end of study ABPM|0
738340|NCT00347360|2368127|P14|Overall Study|Subject did not meet end of study ABPM|1
738341|NCT00347360|2368128|P13|Overall Study|Subject did not meet end of study ABPM|1
738342|NCT00347360|2368129|P12|Overall Study|Subject did not meet end of study ABPM|0
738343|NCT00347360|2368130|P11|Overall Study|Subject did not meet end of study ABPM|1
738344|NCT00347360|2368131|P10|Overall Study|Subject did not meet end of study ABPM|0
738345|NCT00347360|2368132|P9|Overall Study|Subject did not meet end of study ABPM|0
738346|NCT00347360|2368133|P8|Overall Study|Subject did not meet end of study ABPM|0
738347|NCT00347360|2368134|P7|Overall Study|Subject did not meet end of study ABPM|1
738348|NCT00347360|2368135|P6|Overall Study|Subject did not meet end of study ABPM|0
738349|NCT00347360|2368136|P5|Overall Study|Subject did not meet end of study ABPM|0
738350|NCT00347360|2368137|P4|Overall Study|Subject did not meet end of study ABPM|0
738351|NCT00347360|2368138|P3|Overall Study|Subject did not meet end of study ABPM|0
738352|NCT00347360|2368139|P2|Overall Study|Subject did not meet end of study ABPM|0
738353|NCT00347360|2368140|P1|Overall Study|Subject did not meet end of study ABPM|0
738354|NCT00347360|2368126|P15|Overall Study|P.I. recommended due to blood pressure|0
738355|NCT00347360|2368127|P14|Overall Study|P.I. recommended due to blood pressure|0
738356|NCT00347360|2368128|P13|Overall Study|P.I. recommended due to blood pressure|0
738357|NCT00347360|2368129|P12|Overall Study|P.I. recommended due to blood pressure|0
738358|NCT00347360|2368130|P11|Overall Study|P.I. recommended due to blood pressure|0
738359|NCT00347360|2368131|P10|Overall Study|P.I. recommended due to blood pressure|0
738360|NCT00347360|2368132|P9|Overall Study|P.I. recommended due to blood pressure|0
738361|NCT00347360|2368133|P8|Overall Study|P.I. recommended due to blood pressure|0
738362|NCT00347360|2368134|P7|Overall Study|P.I. recommended due to blood pressure|0
738363|NCT00347360|2368135|P6|Overall Study|P.I. recommended due to blood pressure|0
738364|NCT00347360|2368136|P5|Overall Study|P.I. recommended due to blood pressure|1
738365|NCT00347360|2368137|P4|Overall Study|P.I. recommended due to blood pressure|0
738366|NCT00347360|2368138|P3|Overall Study|P.I. recommended due to blood pressure|0
738367|NCT00347360|2368139|P2|Overall Study|P.I. recommended due to blood pressure|0
738368|NCT00347360|2368140|P1|Overall Study|P.I. recommended due to blood pressure|0
738369|NCT00347360|2368126|P15|Overall Study|Per sponsors instruction|0
738370|NCT00347360|2368127|P14|Overall Study|Per sponsors instruction|0
738371|NCT00347360|2368128|P13|Overall Study|Per sponsors instruction|0
738372|NCT00347360|2368129|P12|Overall Study|Per sponsors instruction|0
738373|NCT00347360|2368130|P11|Overall Study|Per sponsors instruction|0
738374|NCT00347360|2368131|P10|Overall Study|Per sponsors instruction|0
738375|NCT00347360|2368132|P9|Overall Study|Per sponsors instruction|0
738376|NCT00347360|2368133|P8|Overall Study|Per sponsors instruction|0
738377|NCT00347360|2368134|P7|Overall Study|Per sponsors instruction|0
738378|NCT00347360|2368135|P6|Overall Study|Per sponsors instruction|0
738379|NCT00347360|2368136|P5|Overall Study|Per sponsors instruction|0
738380|NCT00347360|2368137|P4|Overall Study|Per sponsors instruction|0
738381|NCT00347360|2368138|P3|Overall Study|Per sponsors instruction|0
738382|NCT00347360|2368139|P2|Overall Study|Per sponsors instruction|1
738383|NCT00347360|2368140|P1|Overall Study|Per sponsors instruction|0
738384|NCT00347360|2368126|P15|Overall Study|Reason not listed/blank|0
738385|NCT00347360|2368127|P14|Overall Study|Reason not listed/blank|1
738386|NCT00347360|2368128|P13|Overall Study|Reason not listed/blank|0
738387|NCT00347360|2368129|P12|Overall Study|Reason not listed/blank|0
738388|NCT00347360|2368130|P11|Overall Study|Reason not listed/blank|0
738389|NCT00347360|2368131|P10|Overall Study|Reason not listed/blank|0
738390|NCT00347360|2368132|P9|Overall Study|Reason not listed/blank|0
738391|NCT00347360|2368133|P8|Overall Study|Reason not listed/blank|0
738392|NCT00347360|2368134|P7|Overall Study|Reason not listed/blank|1
738393|NCT00347360|2368135|P6|Overall Study|Reason not listed/blank|0
738394|NCT00347360|2368136|P5|Overall Study|Reason not listed/blank|0
738395|NCT00347360|2368137|P4|Overall Study|Reason not listed/blank|0
738396|NCT00347360|2368138|P3|Overall Study|Reason not listed/blank|0
738397|NCT00347360|2368139|P2|Overall Study|Reason not listed/blank|0
738398|NCT00347360|2368140|P1|Overall Study|Reason not listed/blank|1
738399|NCT00347360|2368126|P15|Overall Study|Lack of Efficacy|0
738400|NCT00347360|2368127|P14|Overall Study|Lack of Efficacy|0
738401|NCT00347360|2368128|P13|Overall Study|Lack of Efficacy|0
738402|NCT00347360|2368129|P12|Overall Study|Lack of Efficacy|0
738403|NCT00347360|2368130|P11|Overall Study|Lack of Efficacy|0
738404|NCT00347360|2368131|P10|Overall Study|Lack of Efficacy|0
738405|NCT00347360|2368132|P9|Overall Study|Lack of Efficacy|1
738406|NCT00347360|2368133|P8|Overall Study|Lack of Efficacy|1
738407|NCT00347360|2368134|P7|Overall Study|Lack of Efficacy|0
738408|NCT00347360|2368135|P6|Overall Study|Lack of Efficacy|1
738409|NCT00347360|2368136|P5|Overall Study|Lack of Efficacy|0
738410|NCT00347360|2368137|P4|Overall Study|Lack of Efficacy|1
738411|NCT00347360|2368138|P3|Overall Study|Lack of Efficacy|3
738412|NCT00347360|2368139|P2|Overall Study|Lack of Efficacy|1
738413|NCT00347360|2368140|P1|Overall Study|Lack of Efficacy|1
738414|NCT00347360|2368126|P15|Overall Study|Withdrawal by Subject|1
738415|NCT00347360|2368127|P14|Overall Study|Withdrawal by Subject|2
738416|NCT00347360|2368128|P13|Overall Study|Withdrawal by Subject|4
738417|NCT00347360|2368129|P12|Overall Study|Withdrawal by Subject|3
738418|NCT00347360|2368130|P11|Overall Study|Withdrawal by Subject|0
738419|NCT00347360|2368131|P10|Overall Study|Withdrawal by Subject|1
738420|NCT00347360|2368132|P9|Overall Study|Withdrawal by Subject|1
738421|NCT00347360|2368133|P8|Overall Study|Withdrawal by Subject|1
738422|NCT00347360|2368134|P7|Overall Study|Withdrawal by Subject|1
738423|NCT00347360|2368135|P6|Overall Study|Withdrawal by Subject|2
738424|NCT00347360|2368136|P5|Overall Study|Withdrawal by Subject|1
738425|NCT00347360|2368137|P4|Overall Study|Withdrawal by Subject|4
738426|NCT00347360|2368138|P3|Overall Study|Withdrawal by Subject|2
738427|NCT00347360|2368139|P2|Overall Study|Withdrawal by Subject|1
738428|NCT00347360|2368140|P1|Overall Study|Withdrawal by Subject|0
738429|NCT00347360|2368126|P15|Overall Study|Protocol Violation|0
738430|NCT00347360|2368127|P14|Overall Study|Protocol Violation|1
738431|NCT00347360|2368128|P13|Overall Study|Protocol Violation|0
738432|NCT00347360|2368129|P12|Overall Study|Protocol Violation|0
738433|NCT00347360|2368130|P11|Overall Study|Protocol Violation|0
738434|NCT00347360|2368131|P10|Overall Study|Protocol Violation|2
738435|NCT00347360|2368132|P9|Overall Study|Protocol Violation|1
738436|NCT00347360|2368133|P8|Overall Study|Protocol Violation|0
738437|NCT00347360|2368134|P7|Overall Study|Protocol Violation|0
738438|NCT00347360|2368135|P6|Overall Study|Protocol Violation|2
738439|NCT00347360|2368136|P5|Overall Study|Protocol Violation|1
738440|NCT00347360|2368137|P4|Overall Study|Protocol Violation|2
738441|NCT00347360|2368138|P3|Overall Study|Protocol Violation|1
738442|NCT00347360|2368139|P2|Overall Study|Protocol Violation|3
738443|NCT00347360|2368140|P1|Overall Study|Protocol Violation|2
738444|NCT00347360|2368126|P15|Overall Study|Lost to Follow-up|0
738445|NCT00347360|2368127|P14|Overall Study|Lost to Follow-up|0
738446|NCT00347360|2368128|P13|Overall Study|Lost to Follow-up|1
738447|NCT00347360|2368129|P12|Overall Study|Lost to Follow-up|0
738448|NCT00347360|2368130|P11|Overall Study|Lost to Follow-up|0
738449|NCT00347360|2368131|P10|Overall Study|Lost to Follow-up|2
738450|NCT00347360|2368132|P9|Overall Study|Lost to Follow-up|1
738451|NCT00347360|2368133|P8|Overall Study|Lost to Follow-up|1
738452|NCT00347360|2368134|P7|Overall Study|Lost to Follow-up|0
738453|NCT00347360|2368135|P6|Overall Study|Lost to Follow-up|1
738454|NCT00347360|2368136|P5|Overall Study|Lost to Follow-up|1
738455|NCT00347360|2368137|P4|Overall Study|Lost to Follow-up|2
738456|NCT00347360|2368138|P3|Overall Study|Lost to Follow-up|0
738457|NCT00347360|2368139|P2|Overall Study|Lost to Follow-up|0
738458|NCT00347360|2368140|P1|Overall Study|Lost to Follow-up|0
738459|NCT00347360|2368126|P15|Overall Study|Adverse Event|2
738460|NCT00347360|2368127|P14|Overall Study|Adverse Event|2
738461|NCT00347360|2368128|P13|Overall Study|Adverse Event|3
738462|NCT00347360|2368129|P12|Overall Study|Adverse Event|1
738463|NCT00347360|2368130|P11|Overall Study|Adverse Event|3
738464|NCT00347360|2368131|P10|Overall Study|Adverse Event|3
738465|NCT00347360|2368132|P9|Overall Study|Adverse Event|2
738466|NCT00347360|2368133|P8|Overall Study|Adverse Event|0
738467|NCT00347360|2368134|P7|Overall Study|Adverse Event|2
738468|NCT00347360|2368135|P6|Overall Study|Adverse Event|2
738469|NCT00347360|2368136|P5|Overall Study|Adverse Event|1
738470|NCT00347360|2368137|P4|Overall Study|Adverse Event|4
738471|NCT00347360|2368138|P3|Overall Study|Adverse Event|0
738472|NCT00347360|2368139|P2|Overall Study|Adverse Event|2
738473|NCT00347360|2368140|P1|Overall Study|Adverse Event|1
738474|NCT00347438|2368322|P1|Overall Study|Physician Decision|1
738475|NCT00347438|2368322|P1|Overall Study|Withdrawal by Subject|1
738476|NCT00347776|2368332|P3|12 Month Follow-up|Reached endpoint|9
738477|NCT00347776|2368333|P2|12 Month Follow-up|Reached endpoint|6
738478|NCT00347776|2368334|P1|12 Month Follow-up|Reached endpoint|13
738479|NCT00347776|2368332|P3|12 Month Follow-up|Death|4
738480|NCT00347776|2368333|P2|12 Month Follow-up|Death|4
738481|NCT00347776|2368334|P1|12 Month Follow-up|Death|3
738482|NCT00347776|2368332|P3|12 Month Follow-up|Lost to Follow-up|6
738483|NCT00347776|2368333|P2|12 Month Follow-up|Lost to Follow-up|6
738484|NCT00347776|2368334|P1|12 Month Follow-up|Lost to Follow-up|7
738485|NCT00347776|2368332|P3|6 Month Follow-up|reached endpont|15
738486|NCT00347776|2368333|P2|6 Month Follow-up|reached endpont|12
738487|NCT00347776|2368334|P1|6 Month Follow-up|reached endpont|20
738488|NCT00347776|2368332|P3|6 Month Follow-up|Death|3
738489|NCT00347776|2368333|P2|6 Month Follow-up|Death|1
738490|NCT00347776|2368334|P1|6 Month Follow-up|Death|2
738491|NCT00347776|2368332|P3|1.5 Month Follow-up|reached the endpoint|12
738492|NCT00347776|2368333|P2|1.5 Month Follow-up|reached the endpoint|8
738493|NCT00347776|2368334|P1|1.5 Month Follow-up|reached the endpoint|12
738494|NCT00347776|2368332|P3|1.5 Month Follow-up|Death|0
738495|NCT00347776|2368333|P2|1.5 Month Follow-up|Death|0
738496|NCT00347776|2368334|P1|1.5 Month Follow-up|Death|2
738497|NCT00347919|2368349|P3|Overall Study|Missing|2
738498|NCT00347919|2368350|P2|Overall Study|Missing|1
738499|NCT00347919|2368351|P1|Overall Study|Missing|2
738500|NCT00347919|2368349|P3|Overall Study|Par. Started Other Treatment|1
738501|NCT00347919|2368350|P2|Overall Study|Par. Started Other Treatment|1
738502|NCT00347919|2368351|P1|Overall Study|Par. Started Other Treatment|1
738503|NCT00347919|2368349|P3|Overall Study|Death|19
738504|NCT00347919|2368350|P2|Overall Study|Death|42
738505|NCT00347919|2368351|P1|Overall Study|Death|35
738506|NCT00347919|2368349|P3|Overall Study|Sponsor terminated study|16
738507|NCT00347919|2368350|P2|Overall Study|Sponsor terminated study|10
738508|NCT00347919|2368351|P1|Overall Study|Sponsor terminated study|15
738509|NCT00347919|2368349|P3|Overall Study|Physician Decision|0
738510|NCT00347919|2368350|P2|Overall Study|Physician Decision|1
738511|NCT00347919|2368351|P1|Overall Study|Physician Decision|1
738512|NCT00347919|2368349|P3|Overall Study|Withdrawal by Subject|0
738513|NCT00347919|2368350|P2|Overall Study|Withdrawal by Subject|8
738514|NCT00347919|2368351|P1|Overall Study|Withdrawal by Subject|6
738515|NCT00347919|2368349|P3|Overall Study|Lost to Follow-up|0
738516|NCT00347919|2368350|P2|Overall Study|Lost to Follow-up|13
738517|NCT00347919|2368351|P1|Overall Study|Lost to Follow-up|11
738518|NCT00347932|2368373|P2|Overall Study|Did not meet inclusion criteria|8
738519|NCT00347932|2368374|P1|Overall Study|Did not meet inclusion criteria|4
738520|NCT00347932|2368373|P2|Overall Study|Withdrawal by Subject|16
738521|NCT00347932|2368374|P1|Overall Study|Withdrawal by Subject|10
738522|NCT00347932|2368373|P2|Overall Study|Lost to Follow-up|9
738523|NCT00347932|2368374|P1|Overall Study|Lost to Follow-up|10
738524|NCT00347932|2368373|P2|Overall Study|Lack of Efficacy|14
738525|NCT00347932|2368374|P1|Overall Study|Lack of Efficacy|3
738526|NCT00347932|2368373|P2|Overall Study|Adverse Event|5
738527|NCT00347932|2368374|P1|Overall Study|Adverse Event|4
738528|NCT00347958|2368386|P1|Overall Study|Withdrawal by Subject|1
738529|NCT00347958|2368386|P1|Overall Study|Protocol Violation|2
738530|NCT00347958|2368386|P1|Overall Study|Adverse Event|1
738531|NCT00348140|2368396|P3|Overall Study|Memory declined|1
738532|NCT00348140|2368397|P2|Overall Study|Memory declined|0
738533|NCT00348140|2368398|P1|Overall Study|Memory declined|0
738534|NCT00348140|2368396|P3|Overall Study|Exclusion criteria met|1
738535|NCT00348140|2368397|P2|Overall Study|Exclusion criteria met|0
738536|NCT00348140|2368398|P1|Overall Study|Exclusion criteria met|0
738537|NCT00348140|2368396|P3|Overall Study|Participant died|0
738538|NCT00348140|2368397|P2|Overall Study|Participant died|1
738539|NCT00348140|2368398|P1|Overall Study|Participant died|0
738540|NCT00348140|2368396|P3|Overall Study|Abnormal ECG|3
738541|NCT00348140|2368397|P2|Overall Study|Abnormal ECG|1
738542|NCT00348140|2368398|P1|Overall Study|Abnormal ECG|0
738543|NCT00348140|2368396|P3|Overall Study|Serious adverse event|0
738544|NCT00348140|2368397|P2|Overall Study|Serious adverse event|1
738545|NCT00348140|2368398|P1|Overall Study|Serious adverse event|0
738546|NCT00348140|2368396|P3|Overall Study|Increased risk of cardiac infarction|0
738547|NCT00348140|2368397|P2|Overall Study|Increased risk of cardiac infarction|1
738548|NCT00348140|2368398|P1|Overall Study|Increased risk of cardiac infarction|0
738549|NCT00348140|2368396|P3|Overall Study|Disease progression|5
738550|NCT00348140|2368397|P2|Overall Study|Disease progression|2
738551|NCT00348140|2368398|P1|Overall Study|Disease progression|1
738552|NCT00348140|2368396|P3|Overall Study|Use of prohibited drug|2
738553|NCT00348140|2368397|P2|Overall Study|Use of prohibited drug|0
738554|NCT00348140|2368398|P1|Overall Study|Use of prohibited drug|1
738555|NCT00348140|2368396|P3|Overall Study|Decided to discontinue on their own|1
738556|NCT00348140|2368397|P2|Overall Study|Decided to discontinue on their own|4
738557|NCT00348140|2368398|P1|Overall Study|Decided to discontinue on their own|1
738558|NCT00348140|2368396|P3|Overall Study|Investigator decided to discontinue|4
738559|NCT00348140|2368397|P2|Overall Study|Investigator decided to discontinue|1
738560|NCT00348140|2368398|P1|Overall Study|Investigator decided to discontinue|4
738561|NCT00348140|2368396|P3|Overall Study|Screen failure|0
738562|NCT00348140|2368397|P2|Overall Study|Screen failure|0
738563|NCT00348140|2368398|P1|Overall Study|Screen failure|1
738564|NCT00348140|2368396|P3|Overall Study|Participant unwell|0
738565|NCT00348140|2368397|P2|Overall Study|Participant unwell|0
738566|NCT00348140|2368398|P1|Overall Study|Participant unwell|1
738567|NCT00348140|2368396|P3|Overall Study|Unmet inclusion-exclusion criteria|1
738568|NCT00348140|2368397|P2|Overall Study|Unmet inclusion-exclusion criteria|0
738569|NCT00348140|2368398|P1|Overall Study|Unmet inclusion-exclusion criteria|1
738570|NCT00348140|2368396|P3|Overall Study|Administration related|1
738571|NCT00348140|2368397|P2|Overall Study|Administration related|1
738572|NCT00348140|2368398|P1|Overall Study|Administration related|3
738573|NCT00348140|2368396|P3|Overall Study|Efficacy related|0
738574|NCT00348140|2368397|P2|Overall Study|Efficacy related|1
738575|NCT00348140|2368398|P1|Overall Study|Efficacy related|1
738576|NCT00348140|2368396|P3|Overall Study|Participant hospitalised|0
738577|NCT00348140|2368397|P2|Overall Study|Participant hospitalised|0
738578|NCT00348140|2368398|P1|Overall Study|Participant hospitalised|3
738579|NCT00348140|2368396|P3|Overall Study|Caregiver related|3
738580|NCT00348140|2368397|P2|Overall Study|Caregiver related|7
738581|NCT00348140|2368398|P1|Overall Study|Caregiver related|4
738582|NCT00348140|2368396|P3|Overall Study|Conditional medication increased dose|0
738583|NCT00348140|2368397|P2|Overall Study|Conditional medication increased dose|0
738584|NCT00348140|2368398|P1|Overall Study|Conditional medication increased dose|1
738585|NCT00348140|2368396|P3|Overall Study|Participant at risk due to study drug|0
738586|NCT00348140|2368397|P2|Overall Study|Participant at risk due to study drug|0
738587|NCT00348140|2368398|P1|Overall Study|Participant at risk due to study drug|2
738588|NCT00348140|2368396|P3|Overall Study|Non-compliance|5
738589|NCT00348140|2368397|P2|Overall Study|Non-compliance|13
738590|NCT00348140|2368398|P1|Overall Study|Non-compliance|8
738591|NCT00348140|2368396|P3|Overall Study|Withdrawal by Subject|40
738592|NCT00348140|2368397|P2|Overall Study|Withdrawal by Subject|40
738593|NCT00348140|2368398|P1|Overall Study|Withdrawal by Subject|32
738594|NCT00348140|2368396|P3|Overall Study|Protocol Violation|14
738595|NCT00348140|2368397|P2|Overall Study|Protocol Violation|13
738596|NCT00348140|2368398|P1|Overall Study|Protocol Violation|12
738597|NCT00348140|2368396|P3|Overall Study|Lost to Follow-up|4
738598|NCT00348140|2368397|P2|Overall Study|Lost to Follow-up|4
738599|NCT00348140|2368398|P1|Overall Study|Lost to Follow-up|4
738600|NCT00348140|2368396|P3|Overall Study|Adverse Event|78
738601|NCT00348140|2368397|P2|Overall Study|Adverse Event|49
738602|NCT00348140|2368398|P1|Overall Study|Adverse Event|46
738603|NCT00348283|2368498|P2|Open Label|Sponsor decision|1
738604|NCT00348283|2368499|P1|Open Label|Sponsor decision|0
738605|NCT00348283|2368498|P2|Open Label|Pregnancy|1
738606|NCT00348283|2368499|P1|Open Label|Pregnancy|0
738607|NCT00348283|2368498|P2|Open Label|Subject moved to the United States|1
738608|NCT00348283|2368499|P1|Open Label|Subject moved to the United States|0
738609|NCT00348283|2368498|P2|Open Label|Administrative reasons|5
738610|NCT00348283|2368499|P1|Open Label|Administrative reasons|0
738611|NCT00348283|2368498|P2|Open Label|Lack of Efficacy|13
738612|NCT00348283|2368499|P1|Open Label|Lack of Efficacy|0
738613|NCT00348283|2368498|P2|Open Label|Lost to Follow-up|1
738614|NCT00348283|2368499|P1|Open Label|Lost to Follow-up|0
738615|NCT00348283|2368498|P2|Open Label|Withdrawal by Subject|4
738616|NCT00348283|2368499|P1|Open Label|Withdrawal by Subject|0
738617|NCT00348283|2368498|P2|Open Label|Adverse Event|8
738618|NCT00348283|2368499|P1|Open Label|Adverse Event|0
738619|NCT00348283|2368498|P2|Double Blind|Pregnancy|1
738620|NCT00348283|2368499|P1|Double Blind|Pregnancy|0
738621|NCT00348283|2368498|P2|Double Blind|Lack of Efficacy|2
738622|NCT00348283|2368499|P1|Double Blind|Lack of Efficacy|2
738623|NCT00348283|2368498|P2|Double Blind|Protocol Violation|1
738624|NCT00348283|2368499|P1|Double Blind|Protocol Violation|0
738625|NCT00348283|2368498|P2|Double Blind|Withdrawal by Subject|1
738626|NCT00348283|2368499|P1|Double Blind|Withdrawal by Subject|1
738627|NCT00348283|2368498|P2|Double Blind|Adverse Event|5
738628|NCT00348283|2368499|P1|Double Blind|Adverse Event|2
738629|NCT00348283|2368498|P2|Induction|Protocol Violation|4
738630|NCT00348283|2368499|P1|Induction|Protocol Violation|0
738631|NCT00348283|2368498|P2|Induction|Adverse Event|2
738632|NCT00348283|2368499|P1|Induction|Adverse Event|0
738633|NCT00348348|2368517|P2|Overall Study|Adverse event probably related to study|0
738634|NCT00348348|2368518|P1|Overall Study|Adverse event probably related to study|1
738635|NCT00348348|2368517|P2|Overall Study|Worsening of BC - Unlikely related|2
738636|NCT00348348|2368518|P1|Overall Study|Worsening of BC - Unlikely related|1
738637|NCT00348348|2368517|P2|Overall Study|Worsening of BC - Unrelated to study|3
738638|NCT00348348|2368518|P1|Overall Study|Worsening of BC - Unrelated to study|0
738639|NCT00348348|2368517|P2|Overall Study|Dissallowed Meds - possibly releated|1
738640|NCT00348348|2368518|P1|Overall Study|Dissallowed Meds - possibly releated|1
738641|NCT00348348|2368517|P2|Overall Study|Dissallowed Meds - unlikley related|1
738642|NCT00348348|2368518|P1|Overall Study|Dissallowed Meds - unlikley related|1
738643|NCT00348348|2368517|P2|Overall Study|Dissallowed Meds - unrelated to study|3
738644|NCT00348348|2368518|P1|Overall Study|Dissallowed Meds - unrelated to study|1
738645|NCT00348348|2368517|P2|Overall Study|Not specified|4
738646|NCT00348348|2368518|P1|Overall Study|Not specified|7
738647|NCT00348348|2368517|P2|Overall Study|Withdrawal by Subject|1
738648|NCT00348348|2368518|P1|Overall Study|Withdrawal by Subject|4
738649|NCT00348348|2368517|P2|Overall Study|Lost to Follow-up|10
738650|NCT00348348|2368518|P1|Overall Study|Lost to Follow-up|8
738651|NCT00348348|2368517|P2|Overall Study|Lack of Efficacy|1
738652|NCT00348348|2368518|P1|Overall Study|Lack of Efficacy|1
738653|NCT00348348|2368517|P2|Overall Study|Adverse event - unrelated to study drug|1
738654|NCT00348348|2368518|P1|Overall Study|Adverse event - unrelated to study drug|0
738655|NCT00348374|2368532|P2|Overall Study|randomized but did not receive treatment|7
738656|NCT00348374|2368533|P1|Overall Study|randomized but did not receive treatment|0
738657|NCT00348374|2368532|P2|Overall Study|ongoing at date of cutoff|1
738658|NCT00348374|2368533|P1|Overall Study|ongoing at date of cutoff|1
738659|NCT00348374|2368532|P2|Overall Study|Other|12
738660|NCT00348374|2368533|P1|Overall Study|Other|11
738661|NCT00348374|2368532|P2|Overall Study|Withdrawal by Subject|5
738662|NCT00348374|2368533|P1|Overall Study|Withdrawal by Subject|5
738663|NCT00348374|2368532|P2|Overall Study|Lost to Follow-up|3
738664|NCT00348374|2368533|P1|Overall Study|Lost to Follow-up|1
738665|NCT00348374|2368532|P2|Overall Study|Adverse Event|4
738666|NCT00348374|2368533|P1|Overall Study|Adverse Event|1
738667|NCT00354029|2368584|P2|Overall Study|Protocol Violation|2
738668|NCT00354029|2368585|P1|Overall Study|Protocol Violation|4
738669|NCT00354107|2368591|P1|Overall Study|Withdrawal by Subject|1
738670|NCT00354107|2368591|P1|Overall Study|Physician Decision|2
738671|NCT00354107|2368591|P1|Overall Study|Adverse Event|2
738672|NCT00354159|2368597|P2|Long-term Follow-up|Study Closed|34
738673|NCT00354159|2368598|P1|Long-term Follow-up|Study Closed|29
738674|NCT00354159|2368597|P2|Long-term Follow-up|Death|11
738675|NCT00354159|2368598|P1|Long-term Follow-up|Death|14
738676|NCT00354159|2368597|P2|Long-term Follow-up|Lost to Follow-up|0
738677|NCT00354159|2368598|P1|Long-term Follow-up|Lost to Follow-up|1
738678|NCT00354159|2368597|P2|Long-term Follow-up|Physician Decision|122
738679|NCT00354159|2368598|P1|Long-term Follow-up|Physician Decision|127
738680|NCT00354159|2368597|P2|Long-term Follow-up|Withdrawal by Subject|9
738681|NCT00354159|2368598|P1|Long-term Follow-up|Withdrawal by Subject|9
738682|NCT00354159|2368597|P2|Randomized Study Period|Death|9
738683|NCT00354159|2368598|P1|Randomized Study Period|Death|7
738684|NCT00354159|2368597|P2|Randomized Study Period|Lost to Follow-up|0
738685|NCT00354159|2368598|P1|Randomized Study Period|Lost to Follow-up|4
738686|NCT00354159|2368597|P2|Randomized Study Period|Physician Decision|10
738687|NCT00354159|2368598|P1|Randomized Study Period|Physician Decision|6
738688|NCT00354159|2368597|P2|Randomized Study Period|Withdrawal by Subject|3
738689|NCT00354159|2368598|P1|Randomized Study Period|Withdrawal by Subject|5
890641|NCT00950807|2825719|P6|Treatment Period 1|Adverse Event|1
738691|NCT00354341|2368661|P2|Overall Study|Unspecified|2
738692|NCT00354341|2368662|P1|Overall Study|Unspecified|1
738693|NCT00354341|2368661|P2|Overall Study|Failure to return|1
738694|NCT00354341|2368662|P1|Overall Study|Failure to return|0
738695|NCT00354341|2368661|P2|Overall Study|Refused treatment|2
738696|NCT00354341|2368662|P1|Overall Study|Refused treatment|1
738697|NCT00354341|2368661|P2|Overall Study|Death|2
738698|NCT00354341|2368662|P1|Overall Study|Death|0
738699|NCT00354341|2368661|P2|Overall Study|Adverse Event|0
738700|NCT00354341|2368662|P1|Overall Study|Adverse Event|1
738701|NCT00354432|2368682|P4|Overall Study|Off/Toxicity|5
738702|NCT00354432|2368683|P3|Overall Study|Off/Toxicity|5
738703|NCT00354432|2368684|P2|Overall Study|Off/Toxicity|7
738704|NCT00354432|2368685|P1|Overall Study|Off/Toxicity|3
738705|NCT00354432|2368682|P4|Overall Study|Adverse Event|5
738706|NCT00354432|2368683|P3|Overall Study|Adverse Event|5
738707|NCT00354432|2368684|P2|Overall Study|Adverse Event|1
738708|NCT00354432|2368685|P1|Overall Study|Adverse Event|3
738709|NCT00354601|2368708|P1|Overall Study|progression|1
738710|NCT00354601|2368708|P1|Overall Study|Protocol Violation|1
738711|NCT00354614|2368715|P1|Overall Study|Lack of Efficacy|28
738712|NCT00354679|2368724|P1|Overall Study|Patient Not Treated|1
738713|NCT00354744|2368728|P1|Overall Study|Withdrawal by Subject|14
738714|NCT00354744|2368728|P1|Overall Study|Physician Decision|11
738715|NCT00354744|2368728|P1|Overall Study|Lost to Follow-up|2
738716|NCT00354744|2368728|P1|Overall Study|Lack of Efficacy|11
738717|NCT00354744|2368728|P1|Overall Study|Death|2
738718|NCT00354744|2368728|P1|Overall Study|Adverse Event|2
738719|NCT00354835|2368744|P2|Overall Study|Refusal of further therapy|8
738720|NCT00354835|2368745|P1|Overall Study|Refusal of further therapy|3
738721|NCT00354835|2368744|P2|Overall Study|Adverse Event|0
738722|NCT00354835|2368745|P1|Overall Study|Adverse Event|6
738723|NCT00354835|2368744|P2|Overall Study|Disease progression or relapse|22
738724|NCT00354835|2368745|P1|Overall Study|Disease progression or relapse|15
738725|NCT00354835|2368744|P2|Overall Study|Ineligible|16
738726|NCT00354835|2368745|P1|Overall Study|Ineligible|17
738727|NCT00354835|2368744|P2|Overall Study|Withdrawal by Subject|1
738728|NCT00354835|2368745|P1|Overall Study|Withdrawal by Subject|2
738729|NCT00354835|2368744|P2|Overall Study|Physician Decision|13
738730|NCT00354835|2368745|P1|Overall Study|Physician Decision|8
738731|NCT00354835|2368744|P2|Overall Study|Death|1
738732|NCT00354835|2368745|P1|Overall Study|Death|1
738733|NCT00355030|2368792|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
738734|NCT00355030|2368793|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
738735|NCT00355030|2368792|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
738736|NCT00355030|2368793|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
738737|NCT00355030|2368792|P2|Study Period 1 Treatment|Other|6
738738|NCT00355030|2368793|P1|Study Period 1 Treatment|Other|2
738739|NCT00355030|2368792|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
738740|NCT00355030|2368793|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
738741|NCT00355030|2368792|P2|Study Period 1 Treatment|Sponsor Decision|32
738742|NCT00355030|2368793|P1|Study Period 1 Treatment|Sponsor Decision|34
738743|NCT00355030|2368792|P2|Study Period 1 Treatment|Physician Decision|1
738744|NCT00355030|2368793|P1|Study Period 1 Treatment|Physician Decision|0
738745|NCT00355030|2368792|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
738746|NCT00355030|2368793|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
738747|NCT00355030|2368792|P2|Study Period 1 Treatment|Withdrawal by Subject|1
738748|NCT00355030|2368793|P1|Study Period 1 Treatment|Withdrawal by Subject|4
738749|NCT00355030|2368792|P2|Study Period 1 Treatment|Lost to Follow-up|0
738750|NCT00355030|2368793|P1|Study Period 1 Treatment|Lost to Follow-up|3
738751|NCT00355030|2368792|P2|Study Period 1 Treatment|Adverse Event|1
738752|NCT00355030|2368793|P1|Study Period 1 Treatment|Adverse Event|1
738753|NCT00355082|2368817|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
738754|NCT00355082|2368818|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
738755|NCT00355082|2368819|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
738756|NCT00355082|2368817|P3|Continuation Phase|Scheduling Error|0
738757|NCT00355082|2368818|P2|Continuation Phase|Scheduling Error|0
738758|NCT00355082|2368819|P1|Continuation Phase|Scheduling Error|1
738759|NCT00355082|2368817|P3|Continuation Phase|Site Closed by Sponsor|0
738760|NCT00355082|2368818|P2|Continuation Phase|Site Closed by Sponsor|0
738761|NCT00355082|2368819|P1|Continuation Phase|Site Closed by Sponsor|8
738762|NCT00355082|2368817|P3|Continuation Phase|Lack of Efficacy|0
738763|NCT00355082|2368818|P2|Continuation Phase|Lack of Efficacy|0
738764|NCT00355082|2368819|P1|Continuation Phase|Lack of Efficacy|5
738765|NCT00355082|2368817|P3|Continuation Phase|Withdrawal by Subject|0
738766|NCT00355082|2368818|P2|Continuation Phase|Withdrawal by Subject|0
738767|NCT00355082|2368819|P1|Continuation Phase|Withdrawal by Subject|4
738768|NCT00355082|2368817|P3|Continuation Phase|Protocol Violation|1
738769|NCT00355082|2368818|P2|Continuation Phase|Protocol Violation|0
738770|NCT00355082|2368819|P1|Continuation Phase|Protocol Violation|1
738771|NCT00355082|2368817|P3|Continuation Phase|Lost to Follow-up|1
738772|NCT00355082|2368818|P2|Continuation Phase|Lost to Follow-up|0
738773|NCT00355082|2368819|P1|Continuation Phase|Lost to Follow-up|2
738774|NCT00355082|2368817|P3|Continuation Phase|Adverse Event|1
738775|NCT00355082|2368818|P2|Continuation Phase|Adverse Event|0
738776|NCT00355082|2368819|P1|Continuation Phase|Adverse Event|2
738777|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
738778|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
738779|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
738780|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
738781|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
738782|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
738783|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
738784|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
738785|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
738786|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
738787|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
738788|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
738789|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
738790|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
738791|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
738792|NCT00355082|2368817|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
738793|NCT00355082|2368818|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
738794|NCT00355082|2368819|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
890642|NCT00950807|2825720|P5|Treatment Period 1|Adverse Event|0
890643|NCT00950807|2825721|P4|Treatment Period 1|Adverse Event|0
890644|NCT00950807|2825722|P3|Treatment Period 1|Adverse Event|0
890645|NCT00950807|2825723|P2|Treatment Period 1|Adverse Event|0
890646|NCT00950807|2825724|P1|Treatment Period 1|Adverse Event|0
890647|NCT00950807|2825715|P10|Treatment Period 1|Withdrawal by Subject|0
890648|NCT00950807|2825716|P9|Treatment Period 1|Withdrawal by Subject|1
890649|NCT00950807|2825717|P8|Treatment Period 1|Withdrawal by Subject|0
890650|NCT00950807|2825718|P7|Treatment Period 1|Withdrawal by Subject|0
890651|NCT00950807|2825719|P6|Treatment Period 1|Withdrawal by Subject|0
890652|NCT00950807|2825720|P5|Treatment Period 1|Withdrawal by Subject|1
890653|NCT00950807|2825721|P4|Treatment Period 1|Withdrawal by Subject|0
890654|NCT00950807|2825722|P3|Treatment Period 1|Withdrawal by Subject|0
890655|NCT00950807|2825723|P2|Treatment Period 1|Withdrawal by Subject|0
890656|NCT00950807|2825724|P1|Treatment Period 1|Withdrawal by Subject|1
890657|NCT00950807|2825715|P10|Treatment Period 1|Lost to Follow-up|0
890658|NCT00950807|2825716|P9|Treatment Period 1|Lost to Follow-up|0
738813|NCT00355134|2368878|P5|Extension Phase|Protocol Violation|0
738814|NCT00355134|2368879|P4|Extension Phase|Protocol Violation|1
738815|NCT00355134|2368880|P3|Extension Phase|Protocol Violation|0
738816|NCT00355134|2368881|P2|Extension Phase|Protocol Violation|0
738817|NCT00355134|2368882|P1|Extension Phase|Protocol Violation|0
738818|NCT00355134|2368878|P5|Extension Phase|Abnormal test procedure result(s)|1
738819|NCT00355134|2368879|P4|Extension Phase|Abnormal test procedure result(s)|0
738820|NCT00355134|2368880|P3|Extension Phase|Abnormal test procedure result(s)|0
738821|NCT00355134|2368881|P2|Extension Phase|Abnormal test procedure result(s)|1
738822|NCT00355134|2368882|P1|Extension Phase|Abnormal test procedure result(s)|0
738823|NCT00355134|2368878|P5|Extension Phase|Unsatisfactory therapeutic effect|1
738824|NCT00355134|2368879|P4|Extension Phase|Unsatisfactory therapeutic effect|0
738825|NCT00355134|2368880|P3|Extension Phase|Unsatisfactory therapeutic effect|0
738826|NCT00355134|2368881|P2|Extension Phase|Unsatisfactory therapeutic effect|4
738827|NCT00355134|2368882|P1|Extension Phase|Unsatisfactory therapeutic effect|3
738828|NCT00355134|2368878|P5|Extension Phase|Administrative problems|1
738829|NCT00355134|2368879|P4|Extension Phase|Administrative problems|1
738830|NCT00355134|2368880|P3|Extension Phase|Administrative problems|0
738831|NCT00355134|2368881|P2|Extension Phase|Administrative problems|4
738832|NCT00355134|2368882|P1|Extension Phase|Administrative problems|2
738833|NCT00355134|2368878|P5|Extension Phase|Abnormal laboratory value(s)|2
738834|NCT00355134|2368879|P4|Extension Phase|Abnormal laboratory value(s)|2
738835|NCT00355134|2368880|P3|Extension Phase|Abnormal laboratory value(s)|0
738836|NCT00355134|2368881|P2|Extension Phase|Abnormal laboratory value(s)|2
738837|NCT00355134|2368882|P1|Extension Phase|Abnormal laboratory value(s)|4
738838|NCT00355134|2368878|P5|Extension Phase|Lost to Follow-up|4
738839|NCT00355134|2368879|P4|Extension Phase|Lost to Follow-up|2
738840|NCT00355134|2368880|P3|Extension Phase|Lost to Follow-up|0
738841|NCT00355134|2368881|P2|Extension Phase|Lost to Follow-up|6
738842|NCT00355134|2368882|P1|Extension Phase|Lost to Follow-up|2
738843|NCT00355134|2368878|P5|Extension Phase|Adverse Event|5
738844|NCT00355134|2368879|P4|Extension Phase|Adverse Event|3
738845|NCT00355134|2368880|P3|Extension Phase|Adverse Event|0
738846|NCT00355134|2368881|P2|Extension Phase|Adverse Event|9
738847|NCT00355134|2368882|P1|Extension Phase|Adverse Event|13
738848|NCT00355134|2368878|P5|Extension Phase|Withdrawal by Subject|5
738849|NCT00355134|2368879|P4|Extension Phase|Withdrawal by Subject|7
738850|NCT00355134|2368880|P3|Extension Phase|Withdrawal by Subject|0
738851|NCT00355134|2368881|P2|Extension Phase|Withdrawal by Subject|11
738852|NCT00355134|2368882|P1|Extension Phase|Withdrawal by Subject|7
738853|NCT00355134|2368878|P5|Core Phase|Condition no longer requires study drug|0
738854|NCT00355134|2368879|P4|Core Phase|Condition no longer requires study drug|0
738855|NCT00355134|2368880|P3|Core Phase|Condition no longer requires study drug|1
738856|NCT00355134|2368881|P2|Core Phase|Condition no longer requires study drug|0
738857|NCT00355134|2368882|P1|Core Phase|Condition no longer requires study drug|1
738858|NCT00355134|2368878|P5|Core Phase|Abnormal test procedure result(s)|0
738859|NCT00355134|2368879|P4|Core Phase|Abnormal test procedure result(s)|0
738860|NCT00355134|2368880|P3|Core Phase|Abnormal test procedure result(s)|1
738861|NCT00355134|2368881|P2|Core Phase|Abnormal test procedure result(s)|2
738862|NCT00355134|2368882|P1|Core Phase|Abnormal test procedure result(s)|1
738863|NCT00355134|2368878|P5|Core Phase|Protocol Violation|0
738864|NCT00355134|2368879|P4|Core Phase|Protocol Violation|0
738865|NCT00355134|2368880|P3|Core Phase|Protocol Violation|2
738866|NCT00355134|2368881|P2|Core Phase|Protocol Violation|2
738867|NCT00355134|2368882|P1|Core Phase|Protocol Violation|3
738868|NCT00355134|2368878|P5|Core Phase|Administrative problems|0
738869|NCT00355134|2368879|P4|Core Phase|Administrative problems|0
738870|NCT00355134|2368880|P3|Core Phase|Administrative problems|5
738871|NCT00355134|2368881|P2|Core Phase|Administrative problems|3
738872|NCT00355134|2368882|P1|Core Phase|Administrative problems|5
738873|NCT00355134|2368878|P5|Core Phase|Unsatisfactory therapeutic effect|0
738874|NCT00355134|2368879|P4|Core Phase|Unsatisfactory therapeutic effect|0
738875|NCT00355134|2368880|P3|Core Phase|Unsatisfactory therapeutic effect|17
738876|NCT00355134|2368881|P2|Core Phase|Unsatisfactory therapeutic effect|6
738877|NCT00355134|2368882|P1|Core Phase|Unsatisfactory therapeutic effect|10
738878|NCT00355134|2368878|P5|Core Phase|Abnormal laboratory value(s)|0
738879|NCT00355134|2368879|P4|Core Phase|Abnormal laboratory value(s)|0
738880|NCT00355134|2368880|P3|Core Phase|Abnormal laboratory value(s)|2
738881|NCT00355134|2368881|P2|Core Phase|Abnormal laboratory value(s)|14
738882|NCT00355134|2368882|P1|Core Phase|Abnormal laboratory value(s)|19
738883|NCT00355134|2368878|P5|Core Phase|Lost to Follow-up|0
738884|NCT00355134|2368879|P4|Core Phase|Lost to Follow-up|0
738885|NCT00355134|2368880|P3|Core Phase|Lost to Follow-up|21
738886|NCT00355134|2368881|P2|Core Phase|Lost to Follow-up|13
738887|NCT00355134|2368882|P1|Core Phase|Lost to Follow-up|17
738888|NCT00355134|2368878|P5|Core Phase|Adverse Event|0
738889|NCT00355134|2368879|P4|Core Phase|Adverse Event|0
738890|NCT00355134|2368880|P3|Core Phase|Adverse Event|16
738891|NCT00355134|2368881|P2|Core Phase|Adverse Event|22
738892|NCT00355134|2368882|P1|Core Phase|Adverse Event|28
738893|NCT00355134|2368878|P5|Core Phase|Withdrawal by Subject|0
738894|NCT00355134|2368879|P4|Core Phase|Withdrawal by Subject|0
738895|NCT00355134|2368880|P3|Core Phase|Withdrawal by Subject|35
738896|NCT00355134|2368881|P2|Core Phase|Withdrawal by Subject|24
738897|NCT00355134|2368882|P1|Core Phase|Withdrawal by Subject|35
738898|NCT00355147|2368924|P2|Overall Study|Withdrawal by Subject|12
738899|NCT00355147|2368925|P1|Overall Study|Withdrawal by Subject|8
738900|NCT00355147|2368924|P2|Overall Study|Lost to Follow-up|8
738901|NCT00355147|2368925|P1|Overall Study|Lost to Follow-up|10
738902|NCT00355368|2368958|P2|Overall Study|cardiac arrest prior to intubation|2
738903|NCT00355368|2368959|P1|Overall Study|cardiac arrest prior to intubation|2
738904|NCT00355368|2368958|P2|Overall Study|Protocol Violation|7
738905|NCT00355368|2368959|P1|Overall Study|Protocol Violation|8
738906|NCT00355472|2368990|P1|Overall Study|Physician Decision|1
738907|NCT00355615|2369019|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
738908|NCT00355615|2369020|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
738909|NCT00355615|2369021|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
738910|NCT00355615|2369022|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
738911|NCT00355615|2369023|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
738912|NCT00355615|2369019|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
738913|NCT00355615|2369020|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
738914|NCT00355615|2369021|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
738915|NCT00355615|2369022|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
738916|NCT00355615|2369023|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
738917|NCT00355615|2369019|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
738918|NCT00355615|2369020|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
738919|NCT00355615|2369021|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
738920|NCT00355615|2369022|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
738921|NCT00355615|2369023|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
738922|NCT00355615|2369019|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
738923|NCT00355615|2369020|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
738924|NCT00355615|2369021|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
738925|NCT00355615|2369022|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
738926|NCT00355615|2369023|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
738927|NCT00355615|2369019|P5|Randomized Double Blind Period|Protocol Violation|0
738928|NCT00355615|2369020|P4|Randomized Double Blind Period|Protocol Violation|1
738929|NCT00355615|2369021|P3|Randomized Double Blind Period|Protocol Violation|1
738930|NCT00355615|2369022|P2|Randomized Double Blind Period|Protocol Violation|0
738931|NCT00355615|2369023|P1|Randomized Double Blind Period|Protocol Violation|0
738932|NCT00355615|2369019|P5|Randomized Double Blind Period|Adverse Event|0
738933|NCT00355615|2369020|P4|Randomized Double Blind Period|Adverse Event|0
738934|NCT00355615|2369021|P3|Randomized Double Blind Period|Adverse Event|0
738935|NCT00355615|2369022|P2|Randomized Double Blind Period|Adverse Event|0
738936|NCT00355615|2369023|P1|Randomized Double Blind Period|Adverse Event|1
738937|NCT00355784|2369098|P3|Overall Study|Withdrawal by Subject|2
738938|NCT00355784|2369099|P2|Overall Study|Withdrawal by Subject|0
738939|NCT00355784|2369100|P1|Overall Study|Withdrawal by Subject|0
738940|NCT00356122|2369197|P1|FOLLOW-UP|Other|2
738941|NCT00356122|2369197|P1|FOLLOW-UP|Lost to Follow-up|2
738942|NCT00356122|2369197|P1|FOLLOW-UP|Death|37
738943|NCT00356122|2369197|P1|TREATMENT|Did not receive study medication|1
738944|NCT00356122|2369197|P1|TREATMENT|Other|4
738945|NCT00356122|2369197|P1|TREATMENT|Subject's request|4
738946|NCT00356122|2369197|P1|TREATMENT|Adverse Event|10
738947|NCT00356122|2369197|P1|TREATMENT|Lack of Efficacy|26
738948|NCT00356135|2369208|P3|Overall Study|Subject non-compliance|3
738949|NCT00356135|2369209|P2|Overall Study|Subject non-compliance|1
738950|NCT00356135|2369210|P1|Overall Study|Subject non-compliance|1
738951|NCT00356135|2369208|P3|Overall Study|Physician Decision|1
738952|NCT00356135|2369209|P2|Overall Study|Physician Decision|1
738953|NCT00356135|2369210|P1|Overall Study|Physician Decision|1
738954|NCT00356135|2369208|P3|Overall Study|Lost to Follow-up|1
738955|NCT00356135|2369209|P2|Overall Study|Lost to Follow-up|0
738956|NCT00356135|2369210|P1|Overall Study|Lost to Follow-up|0
738957|NCT00356135|2369208|P3|Overall Study|Adverse Event|0
738958|NCT00356135|2369209|P2|Overall Study|Adverse Event|0
738959|NCT00356135|2369210|P1|Overall Study|Adverse Event|1
738960|NCT00356135|2369208|P3|Overall Study|Protocol Violation|0
738961|NCT00356135|2369209|P2|Overall Study|Protocol Violation|0
738962|NCT00356135|2369210|P1|Overall Study|Protocol Violation|1
738963|NCT00356148|2369234|P2|Overall Study|Reoperation within 30 days|1
738964|NCT00356148|2369235|P1|Overall Study|Reoperation within 30 days|2
738965|NCT00356200|2369245|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
738966|NCT00356200|2369246|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
738967|NCT00356200|2369245|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
738968|NCT00356200|2369246|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
738969|NCT00356278|2369261|P3|Overall Study|Withdrawal by Subject|19
738970|NCT00356278|2369262|P2|Overall Study|Withdrawal by Subject|15
738971|NCT00356278|2369263|P1|Overall Study|Withdrawal by Subject|25
738972|NCT00356408|2369313|P1|Overall Study|Other: Subject chose commerical dosing|1
738973|NCT00356408|2369313|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
738974|NCT00356408|2369313|P1|Overall Study|Other: Azathioprine stopped|1
738975|NCT00356408|2369313|P1|Overall Study|Other: Sponsor request|1
738976|NCT00356408|2369313|P1|Overall Study|Other: Principal investigator discretion|3
738977|NCT00356408|2369313|P1|Overall Study|Withdrawal by Subject|6
738978|NCT00356408|2369313|P1|Overall Study|Lost to Follow-up|2
738979|NCT00356408|2369313|P1|Overall Study|Lack of Efficacy|36
738980|NCT00356408|2369313|P1|Overall Study|Adverse Event|9
738981|NCT00356421|2369330|P2|Overall Study|Not related to study drug|3
738982|NCT00356421|2369331|P1|Overall Study|Not related to study drug|5
738983|NCT00356421|2369330|P2|Overall Study|Related to study drug|12
738984|NCT00356421|2369331|P1|Overall Study|Related to study drug|15
738985|NCT00356421|2369330|P2|Overall Study|Withdrawal by Subject|2
738986|NCT00356421|2369331|P1|Overall Study|Withdrawal by Subject|9
738987|NCT00356421|2369330|P2|Overall Study|Lack of Efficacy|0
738988|NCT00356421|2369331|P1|Overall Study|Lack of Efficacy|3
738989|NCT00356525|2369384|P4|Overall Study|Sponsor Decision|1
738990|NCT00356525|2369385|P3|Overall Study|Sponsor Decision|0
738991|NCT00356525|2369386|P2|Overall Study|Sponsor Decision|0
738992|NCT00356525|2369387|P1|Overall Study|Sponsor Decision|0
738993|NCT00356525|2369384|P4|Overall Study|Death|1
738994|NCT00356525|2369385|P3|Overall Study|Death|0
738995|NCT00356525|2369386|P2|Overall Study|Death|0
738996|NCT00356525|2369387|P1|Overall Study|Death|0
738997|NCT00356525|2369384|P4|Overall Study|Withdrawal by Subject|3
738998|NCT00356525|2369385|P3|Overall Study|Withdrawal by Subject|0
738999|NCT00356525|2369386|P2|Overall Study|Withdrawal by Subject|1
739000|NCT00356525|2369387|P1|Overall Study|Withdrawal by Subject|1
739001|NCT00356525|2369384|P4|Overall Study|Protocol Entry Criteria Not Met|0
739002|NCT00356525|2369385|P3|Overall Study|Protocol Entry Criteria Not Met|0
739003|NCT00356525|2369386|P2|Overall Study|Protocol Entry Criteria Not Met|0
739004|NCT00356525|2369387|P1|Overall Study|Protocol Entry Criteria Not Met|1
739005|NCT00356525|2369384|P4|Overall Study|Physician Decision|1
739006|NCT00356525|2369385|P3|Overall Study|Physician Decision|2
739007|NCT00356525|2369386|P2|Overall Study|Physician Decision|2
739008|NCT00356525|2369387|P1|Overall Study|Physician Decision|2
739009|NCT00356525|2369384|P4|Overall Study|Lost to Follow-up|0
739010|NCT00356525|2369385|P3|Overall Study|Lost to Follow-up|0
739011|NCT00356525|2369386|P2|Overall Study|Lost to Follow-up|0
739012|NCT00356525|2369387|P1|Overall Study|Lost to Follow-up|1
739013|NCT00356525|2369384|P4|Overall Study|Adverse Event|1
739014|NCT00356525|2369385|P3|Overall Study|Adverse Event|1
739015|NCT00356525|2369386|P2|Overall Study|Adverse Event|3
739016|NCT00356525|2369387|P1|Overall Study|Adverse Event|1
739017|NCT00356525|2369384|P4|Overall Study|Progressive Disease|2
739018|NCT00356525|2369385|P3|Overall Study|Progressive Disease|4
739019|NCT00356525|2369386|P2|Overall Study|Progressive Disease|5
739020|NCT00356525|2369387|P1|Overall Study|Progressive Disease|8
739021|NCT00356590|2369413|P1|Overall Study|Other|52
739022|NCT00356590|2369413|P1|Overall Study|Response status|28
739023|NCT00356590|2369413|P1|Overall Study|Protocol issues|6
739024|NCT00356590|2369413|P1|Overall Study|Completed month 12 only|2
739025|NCT00356590|2369413|P1|Overall Study|Withdrawal by Subject|41
739026|NCT00356590|2369413|P1|Overall Study|Physician Decision|46
739027|NCT00356590|2369413|P1|Overall Study|Lost to Follow-up|35
739028|NCT00356590|2369413|P1|Overall Study|Death|10
739029|NCT00356590|2369413|P1|Overall Study|Adverse Event|54
739030|NCT00356811|2369445|P1|Overall Study|Site Closed during Follow-up|2
739031|NCT00356811|2369445|P1|Overall Study|Study Is Terminating|3
739032|NCT00356811|2369445|P1|Overall Study|Participant Could Not Make a Checkup|1
739033|NCT00356811|2369445|P1|Overall Study|Withdrawal by Subject|6
739034|NCT00356811|2369445|P1|Overall Study|Lost to Follow-up|2
739035|NCT00356811|2369445|P1|Overall Study|Death|35
739040|NCT00356889|2369487|P1|Overall Study|Adverse Event|1
739041|NCT00356889|2369487|P1|Overall Study|Protocol Violation|2
739042|NCT00351351|2369496|P2|Overall Study|surgical access pbs; device issues|4
739043|NCT00351351|2369497|P1|Overall Study|surgical access pbs; device issues|9
739044|NCT00351377|2369503|P1|Overall Study|Unsatisfactory therapeutic effect|1
739045|NCT00351377|2369503|P1|Overall Study|Death|1
739046|NCT00351377|2369503|P1|Overall Study|Adverse Event|5
739047|NCT00356915|2369527|P3|Overall Study|Miscellaneous reasons|3
739048|NCT00356915|2369528|P2|Overall Study|Miscellaneous reasons|8
739049|NCT00356915|2369529|P1|Overall Study|Miscellaneous reasons|11
739050|NCT00356915|2369527|P3|Overall Study|Adverse Event|8
739051|NCT00356915|2369528|P2|Overall Study|Adverse Event|31
739052|NCT00356915|2369529|P1|Overall Study|Adverse Event|21
739053|NCT00356915|2369527|P3|Overall Study|Physician Decision|0
739054|NCT00356915|2369528|P2|Overall Study|Physician Decision|2
739055|NCT00356915|2369529|P1|Overall Study|Physician Decision|0
739056|NCT00356915|2369527|P3|Overall Study|Administrative Decision|1
739057|NCT00356915|2369528|P2|Overall Study|Administrative Decision|0
739058|NCT00356915|2369529|P1|Overall Study|Administrative Decision|0
739059|NCT00356915|2369527|P3|Overall Study|Lost to Follow-up|14
739060|NCT00356915|2369528|P2|Overall Study|Lost to Follow-up|34
739061|NCT00356915|2369529|P1|Overall Study|Lost to Follow-up|27
739062|NCT00356915|2369527|P3|Overall Study|Lack of Efficacy|3
739063|NCT00356915|2369528|P2|Overall Study|Lack of Efficacy|0
739064|NCT00356915|2369529|P1|Overall Study|Lack of Efficacy|0
739065|NCT00356915|2369527|P3|Overall Study|Withdrawal by Subject|10
739066|NCT00356915|2369528|P2|Overall Study|Withdrawal by Subject|14
739067|NCT00356915|2369529|P1|Overall Study|Withdrawal by Subject|14
739068|NCT00356915|2369527|P3|Overall Study|Protocol Violation|2
739069|NCT00356915|2369528|P2|Overall Study|Protocol Violation|3
739070|NCT00356915|2369529|P1|Overall Study|Protocol Violation|2
739071|NCT00356915|2369527|P3|Overall Study|Non compliance|1
739072|NCT00356915|2369528|P2|Overall Study|Non compliance|2
739073|NCT00356915|2369529|P1|Overall Study|Non compliance|1
739074|NCT00357006|2369549|P3|Overall Study|Withdrawal by Subject|2
739075|NCT00357006|2369550|P2|Overall Study|Withdrawal by Subject|3
739076|NCT00357006|2369551|P1|Overall Study|Withdrawal by Subject|1
739077|NCT00357006|2369549|P3|Overall Study|Lost to Follow-up|1
739078|NCT00357006|2369550|P2|Overall Study|Lost to Follow-up|2
739079|NCT00357006|2369551|P1|Overall Study|Lost to Follow-up|1
739080|NCT00357097|2369566|P2|Overall Study|Increase of RLS Symptoms|1
739081|NCT00357097|2369567|P1|Overall Study|Increase of RLS Symptoms|0
739082|NCT00357097|2369566|P2|Overall Study|Other|1
739083|NCT00357097|2369567|P1|Overall Study|Other|1
739084|NCT00357097|2369566|P2|Overall Study|Met Exclusion Criteria|1
739085|NCT00357097|2369567|P1|Overall Study|Met Exclusion Criteria|3
739086|NCT00357097|2369566|P2|Overall Study|Lack of Efficacy|8
739087|NCT00357097|2369567|P1|Overall Study|Lack of Efficacy|2
739088|NCT00357097|2369566|P2|Overall Study|Non-compliance|2
739089|NCT00357097|2369567|P1|Overall Study|Non-compliance|1
739090|NCT00357097|2369566|P2|Overall Study|Withdrawal by Subject|7
739091|NCT00357097|2369567|P1|Overall Study|Withdrawal by Subject|8
739092|NCT00357097|2369566|P2|Overall Study|Adverse Event|6
739093|NCT00357097|2369567|P1|Overall Study|Adverse Event|34
739094|NCT00357097|2369566|P2|Overall Study|Did not meet inclusion criteria|3
739095|NCT00357097|2369567|P1|Overall Study|Did not meet inclusion criteria|5
739096|NCT00357110|2369613|P2|Overall Study|Early study termination|5
739097|NCT00357110|2369614|P1|Overall Study|Early study termination|5
739098|NCT00358644|2369628|P1|Overall Study|Patient not eligible for study|1
739099|NCT00358644|2369628|P1|Overall Study|Physician Decision|6
739100|NCT00358644|2369628|P1|Overall Study|Withdrawal by Subject|4
739101|NCT00358644|2369628|P1|Overall Study|Death|11
739102|NCT00358644|2369628|P1|Overall Study|Adverse Event|7
739103|NCT00358644|2369628|P1|Overall Study|Progressive Disease|21
739104|NCT00358670|2369634|P2|Overall Study|Administrative|125
739105|NCT00358670|2369635|P1|Overall Study|Administrative|153
739106|NCT00358670|2369634|P2|Overall Study|Did Not Meet Protocol Eligibility|3
739107|NCT00358670|2369635|P1|Overall Study|Did Not Meet Protocol Eligibility|0
739108|NCT00358670|2369634|P2|Overall Study|Protocol Defined Clinical Event|1
739109|NCT00358670|2369635|P1|Overall Study|Protocol Defined Clinical Event|0
739110|NCT00358670|2369634|P2|Overall Study|Withdrawal by Subject|24
739111|NCT00358670|2369635|P1|Overall Study|Withdrawal by Subject|13
739112|NCT00358670|2369634|P2|Overall Study|Lost to Follow-up|5
739113|NCT00358670|2369635|P1|Overall Study|Lost to Follow-up|4
739114|NCT00358670|2369634|P2|Overall Study|Protocol Violation|9
739115|NCT00358670|2369635|P1|Overall Study|Protocol Violation|6
739116|NCT00358670|2369634|P2|Overall Study|Lack of Efficacy|23
739117|NCT00358670|2369635|P1|Overall Study|Lack of Efficacy|20
739118|NCT00358670|2369634|P2|Overall Study|Adverse Event|29
739119|NCT00358670|2369635|P1|Overall Study|Adverse Event|26
739120|NCT00358826|2369684|P8|MDCT Substudy|Withdrawal by Subject|0
739121|NCT00358826|2369685|P7|MDCT Substudy|Withdrawal by Subject|0
739122|NCT00358826|2369686|P6|MDCT Substudy|Withdrawal by Subject|1
739123|NCT00358826|2369687|P5|MDCT Substudy|Withdrawal by Subject|0
739124|NCT00358826|2369688|P4|MDCT Substudy|Withdrawal by Subject|0
739125|NCT00358826|2369689|P3|MDCT Substudy|Withdrawal by Subject|0
739126|NCT00358826|2369690|P2|MDCT Substudy|Withdrawal by Subject|0
739127|NCT00358826|2369691|P1|MDCT Substudy|Withdrawal by Subject|0
739128|NCT00358826|2369684|P8|MDCT Substudy|Lost to Follow-up|0
739129|NCT00358826|2369685|P7|MDCT Substudy|Lost to Follow-up|0
739130|NCT00358826|2369686|P6|MDCT Substudy|Lost to Follow-up|1
739131|NCT00358826|2369687|P5|MDCT Substudy|Lost to Follow-up|0
739132|NCT00358826|2369688|P4|MDCT Substudy|Lost to Follow-up|0
739133|NCT00358826|2369689|P3|MDCT Substudy|Lost to Follow-up|0
739134|NCT00358826|2369690|P2|MDCT Substudy|Lost to Follow-up|0
739135|NCT00358826|2369691|P1|MDCT Substudy|Lost to Follow-up|0
739136|NCT00358826|2369684|P8|MDCT Substudy|Adverse Event|0
739137|NCT00358826|2369685|P7|MDCT Substudy|Adverse Event|0
739138|NCT00358826|2369686|P6|MDCT Substudy|Adverse Event|0
739139|NCT00358826|2369687|P5|MDCT Substudy|Adverse Event|1
739140|NCT00358826|2369688|P4|MDCT Substudy|Adverse Event|0
739141|NCT00358826|2369689|P3|MDCT Substudy|Adverse Event|0
739142|NCT00358826|2369690|P2|MDCT Substudy|Adverse Event|0
739143|NCT00358826|2369691|P1|MDCT Substudy|Adverse Event|0
739144|NCT00358826|2369684|P8|Core Study|Physician Decision|0
739145|NCT00358826|2369685|P7|Core Study|Physician Decision|0
739146|NCT00358826|2369686|P6|Core Study|Physician Decision|0
739147|NCT00358826|2369687|P5|Core Study|Physician Decision|0
739148|NCT00358826|2369688|P4|Core Study|Physician Decision|0
739149|NCT00358826|2369689|P3|Core Study|Physician Decision|1
739150|NCT00358826|2369690|P2|Core Study|Physician Decision|0
739151|NCT00358826|2369691|P1|Core Study|Physician Decision|0
739152|NCT00358826|2369684|P8|Core Study|Lost to Follow-up|0
739153|NCT00358826|2369685|P7|Core Study|Lost to Follow-up|0
739154|NCT00358826|2369686|P6|Core Study|Lost to Follow-up|0
739155|NCT00358826|2369687|P5|Core Study|Lost to Follow-up|0
739156|NCT00358826|2369688|P4|Core Study|Lost to Follow-up|1
739157|NCT00358826|2369689|P3|Core Study|Lost to Follow-up|0
739158|NCT00358826|2369690|P2|Core Study|Lost to Follow-up|0
739159|NCT00358826|2369691|P1|Core Study|Lost to Follow-up|0
739160|NCT00358826|2369684|P8|Core Study|Withdrawal by Subject|0
739161|NCT00358826|2369685|P7|Core Study|Withdrawal by Subject|0
739162|NCT00358826|2369686|P6|Core Study|Withdrawal by Subject|0
739163|NCT00358826|2369687|P5|Core Study|Withdrawal by Subject|0
739164|NCT00358826|2369688|P4|Core Study|Withdrawal by Subject|0
739165|NCT00358826|2369689|P3|Core Study|Withdrawal by Subject|0
739166|NCT00358826|2369690|P2|Core Study|Withdrawal by Subject|2
739167|NCT00358826|2369691|P1|Core Study|Withdrawal by Subject|2
739168|NCT00358826|2369684|P8|Core Study|Adverse Event|0
739169|NCT00358826|2369685|P7|Core Study|Adverse Event|0
739170|NCT00358826|2369686|P6|Core Study|Adverse Event|0
739171|NCT00358826|2369687|P5|Core Study|Adverse Event|0
739172|NCT00358826|2369688|P4|Core Study|Adverse Event|1
739173|NCT00358826|2369689|P3|Core Study|Adverse Event|1
739174|NCT00358826|2369690|P2|Core Study|Adverse Event|3
739175|NCT00358826|2369691|P1|Core Study|Adverse Event|1
739176|NCT00358917|2369727|P2|Overall Study|Unable to Continue Participation|2
739177|NCT00358917|2369728|P1|Overall Study|Unable to Continue Participation|2
739178|NCT00358917|2369727|P2|Overall Study|Virologic failure|8
739179|NCT00358917|2369728|P1|Overall Study|Virologic failure|11
739180|NCT00358917|2369727|P2|Overall Study|Death|3
739181|NCT00358917|2369728|P1|Overall Study|Death|2
739182|NCT00358917|2369727|P2|Overall Study|Noncompliance|11
739183|NCT00358917|2369728|P1|Overall Study|Noncompliance|12
739184|NCT00358917|2369727|P2|Overall Study|Lost to Follow-up|17
739185|NCT00358917|2369728|P1|Overall Study|Lost to Follow-up|20
739186|NCT00358917|2369727|P2|Overall Study|Withdrawal by Subject|7
739187|NCT00358917|2369728|P1|Overall Study|Withdrawal by Subject|5
739188|NCT00358917|2369727|P2|Overall Study|Adverse Event|21
739189|NCT00358917|2369728|P1|Overall Study|Adverse Event|14
739190|NCT00358956|2369742|P1|Overall Study|Withdrawal by Subject|1
739191|NCT00358956|2369742|P1|Overall Study|condition under investigation worsened|4
739192|NCT00358956|2369742|P1|Overall Study|Adverse Event|3
739193|NCT00359021|2369754|P2|Overall Study|Pregnancy|0
739194|NCT00359021|2369755|P1|Overall Study|Pregnancy|1
739195|NCT00359021|2369754|P2|Overall Study|Not specified|1
739196|NCT00359021|2369755|P1|Overall Study|Not specified|4
739197|NCT00359021|2369754|P2|Overall Study|Lost to Follow-up|0
739198|NCT00359021|2369755|P1|Overall Study|Lost to Follow-up|1
739199|NCT00359021|2369754|P2|Overall Study|Withdrawal by Subject|9
739200|NCT00359021|2369755|P1|Overall Study|Withdrawal by Subject|2
739201|NCT00359021|2369754|P2|Overall Study|Subject Reached A Virologic Endpoint|32
739202|NCT00359021|2369755|P1|Overall Study|Subject Reached A Virologic Endpoint|45
739203|NCT00359021|2369754|P2|Overall Study|Subject Ineligible To Continue The Trial|0
739204|NCT00359021|2369755|P1|Overall Study|Subject Ineligible To Continue The Trial|1
739205|NCT00359021|2369754|P2|Overall Study|Subject Non-Compliant|2
739206|NCT00359021|2369755|P1|Overall Study|Subject Non-Compliant|1
739207|NCT00359021|2369754|P2|Overall Study|Adverse Event|8
739208|NCT00359021|2369755|P1|Overall Study|Adverse Event|26
739209|NCT00359281|2369807|P9|Overall Study|Withdrawal by Subject|0
739210|NCT00359281|2369808|P8|Overall Study|Withdrawal by Subject|0
739211|NCT00359281|2369809|P7|Overall Study|Withdrawal by Subject|1
739212|NCT00359281|2369810|P6|Overall Study|Withdrawal by Subject|0
739213|NCT00359281|2369811|P5|Overall Study|Withdrawal by Subject|0
739214|NCT00359281|2369812|P4|Overall Study|Withdrawal by Subject|0
739215|NCT00359281|2369813|P3|Overall Study|Withdrawal by Subject|0
739216|NCT00359281|2369814|P2|Overall Study|Withdrawal by Subject|0
739217|NCT00359281|2369815|P1|Overall Study|Withdrawal by Subject|0
739218|NCT00359281|2369807|P9|Overall Study|Adverse Event|0
739219|NCT00359281|2369808|P8|Overall Study|Adverse Event|0
739220|NCT00359281|2369809|P7|Overall Study|Adverse Event|1
739221|NCT00359281|2369810|P6|Overall Study|Adverse Event|0
739222|NCT00359281|2369811|P5|Overall Study|Adverse Event|0
739223|NCT00359281|2369812|P4|Overall Study|Adverse Event|0
739224|NCT00359281|2369813|P3|Overall Study|Adverse Event|0
739225|NCT00359281|2369814|P2|Overall Study|Adverse Event|0
739226|NCT00359281|2369815|P1|Overall Study|Adverse Event|1
739227|NCT00359424|2369847|P2|Overall Study|follow up not conducted|0
739228|NCT00359424|2369848|P1|Overall Study|follow up not conducted|2
739229|NCT00359424|2369847|P2|Overall Study|Withdrawal by Subject|2
739230|NCT00359424|2369848|P1|Overall Study|Withdrawal by Subject|10
739231|NCT00359424|2369847|P2|Overall Study|Lost to Follow-up|7
739232|NCT00359424|2369848|P1|Overall Study|Lost to Follow-up|19
739233|NCT00359424|2369847|P2|Overall Study|Death|58
739234|NCT00359424|2369848|P1|Overall Study|Death|99
739235|NCT00359619|2369885|P7|Overall Study|Lost to Follow-up|0
739236|NCT00359619|2369886|P6|Overall Study|Lost to Follow-up|5
739237|NCT00359619|2369887|P5|Overall Study|Lost to Follow-up|1
739238|NCT00359619|2369888|P4|Overall Study|Lost to Follow-up|1
739239|NCT00359619|2369889|P3|Overall Study|Lost to Follow-up|2
739240|NCT00359619|2369890|P2|Overall Study|Lost to Follow-up|4
739241|NCT00359619|2369891|P1|Overall Study|Lost to Follow-up|4
739242|NCT00359619|2369885|P7|Overall Study|Unspecified|0
739243|NCT00359619|2369886|P6|Overall Study|Unspecified|0
739244|NCT00359619|2369887|P5|Overall Study|Unspecified|0
739245|NCT00359619|2369888|P4|Overall Study|Unspecified|0
739246|NCT00359619|2369889|P3|Overall Study|Unspecified|0
739247|NCT00359619|2369890|P2|Overall Study|Unspecified|0
739248|NCT00359619|2369891|P1|Overall Study|Unspecified|1
739249|NCT00359619|2369885|P7|Overall Study|Withdrawal by Subject|3
739250|NCT00359619|2369886|P6|Overall Study|Withdrawal by Subject|0
739251|NCT00359619|2369887|P5|Overall Study|Withdrawal by Subject|2
739252|NCT00359619|2369888|P4|Overall Study|Withdrawal by Subject|2
739253|NCT00359619|2369889|P3|Overall Study|Withdrawal by Subject|4
739254|NCT00359619|2369890|P2|Overall Study|Withdrawal by Subject|1
739255|NCT00359619|2369891|P1|Overall Study|Withdrawal by Subject|3
739256|NCT00359619|2369885|P7|Overall Study|Adverse Event|1
739257|NCT00359619|2369886|P6|Overall Study|Adverse Event|0
739258|NCT00359619|2369887|P5|Overall Study|Adverse Event|0
739259|NCT00359619|2369888|P4|Overall Study|Adverse Event|0
739260|NCT00359619|2369889|P3|Overall Study|Adverse Event|1
739261|NCT00359619|2369890|P2|Overall Study|Adverse Event|0
739262|NCT00359619|2369891|P1|Overall Study|Adverse Event|0
739263|NCT00359632|2370021|P2|Overall Study|Non-compliance with visit schedule|0
739264|NCT00359632|2370022|P1|Overall Study|Non-compliance with visit schedule|1
739265|NCT00359632|2370021|P2|Overall Study|Adverse Event|0
739266|NCT00359632|2370022|P1|Overall Study|Adverse Event|1
739267|NCT00359632|2370021|P2|Overall Study|Death|0
739268|NCT00359632|2370022|P1|Overall Study|Death|2
739269|NCT00359762|2370042|P5|Period III|Subject Decision|0
739270|NCT00359762|2370043|P4|Period III|Subject Decision|20
739271|NCT00359762|2370044|P3|Period III|Subject Decision|8
739272|NCT00359762|2370045|P2|Period III|Subject Decision|7
739273|NCT00359762|2370046|P1|Period III|Subject Decision|0
739274|NCT00359762|2370042|P5|Period III|Entry Criteria Not Met|0
739275|NCT00359762|2370043|P4|Period III|Entry Criteria Not Met|1
739276|NCT00359762|2370044|P3|Period III|Entry Criteria Not Met|0
739277|NCT00359762|2370045|P2|Period III|Entry Criteria Not Met|1
739278|NCT00359762|2370046|P1|Period III|Entry Criteria Not Met|0
739279|NCT00359762|2370042|P5|Period III|Lost to follow up|0
739280|NCT00359762|2370043|P4|Period III|Lost to follow up|2
739281|NCT00359762|2370044|P3|Period III|Lost to follow up|1
739282|NCT00359762|2370045|P2|Period III|Lost to follow up|1
739283|NCT00359762|2370046|P1|Period III|Lost to follow up|0
739284|NCT00359762|2370042|P5|Period III|Lack of Efficacy|0
739285|NCT00359762|2370043|P4|Period III|Lack of Efficacy|9
739286|NCT00359762|2370044|P3|Period III|Lack of Efficacy|5
739287|NCT00359762|2370045|P2|Period III|Lack of Efficacy|7
739288|NCT00359762|2370046|P1|Period III|Lack of Efficacy|0
739289|NCT00359762|2370042|P5|Period III|Physician Decision|0
739290|NCT00359762|2370043|P4|Period III|Physician Decision|15
739291|NCT00359762|2370044|P3|Period III|Physician Decision|9
739292|NCT00359762|2370045|P2|Period III|Physician Decision|5
739293|NCT00359762|2370046|P1|Period III|Physician Decision|0
739294|NCT00359762|2370042|P5|Period III|Adverse Event|0
739295|NCT00359762|2370043|P4|Period III|Adverse Event|10
739296|NCT00359762|2370044|P3|Period III|Adverse Event|4
739297|NCT00359762|2370045|P2|Period III|Adverse Event|3
739298|NCT00359762|2370046|P1|Period III|Adverse Event|0
739299|NCT00359762|2370042|P5|Period III|Protocol Violation|0
739300|NCT00359762|2370043|P4|Period III|Protocol Violation|8
739301|NCT00359762|2370044|P3|Period III|Protocol Violation|3
739302|NCT00359762|2370045|P2|Period III|Protocol Violation|5
739303|NCT00359762|2370046|P1|Period III|Protocol Violation|0
739304|NCT00359762|2370042|P5|Period II|Subject Decision|70
739305|NCT00359762|2370043|P4|Period II|Subject Decision|0
739306|NCT00359762|2370044|P3|Period II|Subject Decision|0
739307|NCT00359762|2370045|P2|Period II|Subject Decision|0
739308|NCT00359762|2370046|P1|Period II|Subject Decision|50
739309|NCT00359762|2370042|P5|Period II|Entry Criteria Not Met|4
739310|NCT00359762|2370043|P4|Period II|Entry Criteria Not Met|0
739311|NCT00359762|2370044|P3|Period II|Entry Criteria Not Met|0
739312|NCT00359762|2370045|P2|Period II|Entry Criteria Not Met|0
739313|NCT00359762|2370046|P1|Period II|Entry Criteria Not Met|8
739314|NCT00359762|2370042|P5|Period II|Lost to follow up|5
739315|NCT00359762|2370043|P4|Period II|Lost to follow up|0
739316|NCT00359762|2370044|P3|Period II|Lost to follow up|0
739317|NCT00359762|2370045|P2|Period II|Lost to follow up|0
739318|NCT00359762|2370046|P1|Period II|Lost to follow up|5
739319|NCT00359762|2370042|P5|Period II|Lack of Efficacy|8
739320|NCT00359762|2370043|P4|Period II|Lack of Efficacy|0
739321|NCT00359762|2370044|P3|Period II|Lack of Efficacy|0
739322|NCT00359762|2370045|P2|Period II|Lack of Efficacy|0
739323|NCT00359762|2370046|P1|Period II|Lack of Efficacy|11
739324|NCT00359762|2370042|P5|Period II|Death|4
739325|NCT00359762|2370043|P4|Period II|Death|0
739326|NCT00359762|2370044|P3|Period II|Death|0
739327|NCT00359762|2370045|P2|Period II|Death|0
739328|NCT00359762|2370046|P1|Period II|Death|2
739329|NCT00359762|2370042|P5|Period II|Physician Decision|23
739330|NCT00359762|2370043|P4|Period II|Physician Decision|0
739331|NCT00359762|2370044|P3|Period II|Physician Decision|0
739332|NCT00359762|2370045|P2|Period II|Physician Decision|0
739333|NCT00359762|2370046|P1|Period II|Physician Decision|17
739334|NCT00359762|2370042|P5|Period II|Protocol Violation|11
739335|NCT00359762|2370043|P4|Period II|Protocol Violation|0
739336|NCT00359762|2370044|P3|Period II|Protocol Violation|0
739337|NCT00359762|2370045|P2|Period II|Protocol Violation|0
739338|NCT00359762|2370046|P1|Period II|Protocol Violation|18
739339|NCT00359762|2370042|P5|Period II|Adverse Event|49
739340|NCT00359762|2370043|P4|Period II|Adverse Event|0
739341|NCT00359762|2370044|P3|Period II|Adverse Event|0
739342|NCT00359762|2370045|P2|Period II|Adverse Event|0
739343|NCT00359762|2370046|P1|Period II|Adverse Event|17
739344|NCT00359788|2370109|P2|Overall Study|Protocol Violation|2
739345|NCT00359788|2370110|P1|Overall Study|Protocol Violation|4
739346|NCT00359788|2370109|P2|Overall Study|Withdrawal by Subject|1
739347|NCT00359788|2370110|P1|Overall Study|Withdrawal by Subject|4
739348|NCT00359788|2370109|P2|Overall Study|Lost to Follow-up|2
739349|NCT00359788|2370110|P1|Overall Study|Lost to Follow-up|3
739350|NCT00359788|2370109|P2|Overall Study|Lack of Efficacy|2
739351|NCT00359788|2370110|P1|Overall Study|Lack of Efficacy|1
739352|NCT00359788|2370109|P2|Overall Study|Adverse Event|10
739353|NCT00359788|2370110|P1|Overall Study|Adverse Event|11
739354|NCT00359801|2370344|P2|Overall Study|Sponsor Decision|16
739355|NCT00359801|2370345|P1|Overall Study|Sponsor Decision|17
739356|NCT00359801|2370344|P2|Overall Study|Final Status Unknown: missing data|4
739357|NCT00359801|2370345|P1|Overall Study|Final Status Unknown: missing data|7
739358|NCT00359801|2370344|P2|Overall Study|Unspecified|46
739359|NCT00359801|2370345|P1|Overall Study|Unspecified|66
739360|NCT00359801|2370344|P2|Overall Study|Withdrawal by Subject|96
739361|NCT00359801|2370345|P1|Overall Study|Withdrawal by Subject|143
739362|NCT00359801|2370344|P2|Overall Study|Lost to Follow-up|58
739363|NCT00359801|2370345|P1|Overall Study|Lost to Follow-up|72
739364|NCT00360269|2370503|P2|Overall Study|Withdrawal by Subject|1
739365|NCT00360269|2370504|P1|Overall Study|Withdrawal by Subject|1
739366|NCT00360269|2370503|P2|Overall Study|Adverse Event|0
739367|NCT00360269|2370504|P1|Overall Study|Adverse Event|1
739368|NCT00360269|2370503|P2|Overall Study|Physician Decision|2
739369|NCT00360269|2370504|P1|Overall Study|Physician Decision|1
739370|NCT00360269|2370503|P2|Overall Study|Lost to Follow-up|9
739371|NCT00360269|2370504|P1|Overall Study|Lost to Follow-up|7
739372|NCT00360282|2370518|P4|Second Intervention|Adverse Event|0
739373|NCT00360282|2370519|P3|Second Intervention|Adverse Event|0
739374|NCT00360282|2370520|P2|Second Intervention|Adverse Event|1
739375|NCT00360282|2370521|P1|Second Intervention|Adverse Event|0
739376|NCT00360282|2370518|P4|Washout 1-3 Weeks|Lost to Follow-up|0
739377|NCT00360282|2370519|P3|Washout 1-3 Weeks|Lost to Follow-up|1
739378|NCT00360282|2370520|P2|Washout 1-3 Weeks|Lost to Follow-up|0
739379|NCT00360282|2370521|P1|Washout 1-3 Weeks|Lost to Follow-up|0
739380|NCT00360308|2370534|P3|Overall Study|Study termination by sponsor|44
739381|NCT00360308|2370535|P2|Overall Study|Study termination by sponsor|55
739382|NCT00360308|2370536|P1|Overall Study|Study termination by sponsor|43
739383|NCT00360308|2370534|P3|Overall Study|Not Specified|1
739384|NCT00360308|2370535|P2|Overall Study|Not Specified|1
739385|NCT00360308|2370536|P1|Overall Study|Not Specified|2
739386|NCT00360308|2370534|P3|Overall Study|Lack of Efficacy|2
739387|NCT00360308|2370535|P2|Overall Study|Lack of Efficacy|0
739388|NCT00360308|2370536|P1|Overall Study|Lack of Efficacy|3
739389|NCT00360308|2370534|P3|Overall Study|Withdrawal by Subject|14
739390|NCT00360308|2370535|P2|Overall Study|Withdrawal by Subject|7
739391|NCT00360308|2370536|P1|Overall Study|Withdrawal by Subject|11
739392|NCT00360308|2370534|P3|Overall Study|Protocol Violation|2
739393|NCT00360308|2370535|P2|Overall Study|Protocol Violation|1
739394|NCT00360308|2370536|P1|Overall Study|Protocol Violation|2
739395|NCT00360308|2370534|P3|Overall Study|Abnormal Laboratory Value(s)|0
739396|NCT00360308|2370535|P2|Overall Study|Abnormal Laboratory Value(s)|1
739397|NCT00360308|2370536|P1|Overall Study|Abnormal Laboratory Value(s)|0
739398|NCT00360308|2370534|P3|Overall Study|Adverse Event|25
739399|NCT00360308|2370535|P2|Overall Study|Adverse Event|14
739400|NCT00360308|2370536|P1|Overall Study|Adverse Event|15
739401|NCT00360334|2370555|P2|Overall Study|Subject decision|2
739402|NCT00360334|2370556|P1|Overall Study|Subject decision|8
739403|NCT00360334|2370555|P2|Overall Study|Entry criterion not met|2
739404|NCT00360334|2370556|P1|Overall Study|Entry criterion not met|1
739405|NCT00360334|2370555|P2|Overall Study|Lack of Efficacy|1
739406|NCT00360334|2370556|P1|Overall Study|Lack of Efficacy|0
739407|NCT00360334|2370555|P2|Overall Study|Physician Decision|3
739408|NCT00360334|2370556|P1|Overall Study|Physician Decision|2
739409|NCT00360334|2370555|P2|Overall Study|Protocol Violation|1
739410|NCT00360334|2370556|P1|Overall Study|Protocol Violation|1
739411|NCT00360334|2370555|P2|Overall Study|Adverse Event|4
739412|NCT00360334|2370556|P1|Overall Study|Adverse Event|7
739413|NCT00360412|2370651|P2|Overall Study|Study termination by Sponsor|469
739414|NCT00360412|2370652|P1|Overall Study|Study termination by Sponsor|214
739415|NCT00360412|2370651|P2|Overall Study|Not specified|6
739416|NCT00360412|2370652|P1|Overall Study|Not specified|5
739417|NCT00360412|2370651|P2|Overall Study|Physician Decision|4
739418|NCT00360412|2370652|P1|Overall Study|Physician Decision|2
739419|NCT00360412|2370651|P2|Overall Study|Lack of therapeutic efficacy|61
739420|NCT00360412|2370652|P1|Overall Study|Lack of therapeutic efficacy|46
739421|NCT00360412|2370651|P2|Overall Study|Patient withdrew consent|52
739422|NCT00360412|2370652|P1|Overall Study|Patient withdrew consent|27
739423|NCT00360412|2370651|P2|Overall Study|Protocol Violation|5
739424|NCT00360412|2370652|P1|Overall Study|Protocol Violation|2
739425|NCT00360412|2370651|P2|Overall Study|Adverse Event|65
739426|NCT00360412|2370652|P1|Overall Study|Adverse Event|37
739427|NCT00360490|2370666|P2|Overall Study|Withdrawal by Subject|3
739428|NCT00360490|2370667|P1|Overall Study|Withdrawal by Subject|1
739429|NCT00360490|2370666|P2|Overall Study|Protocol Violation|4
739430|NCT00360490|2370667|P1|Overall Study|Protocol Violation|0
739431|NCT00360490|2370666|P2|Overall Study|Physician Decision|1
739432|NCT00360490|2370667|P1|Overall Study|Physician Decision|2
739433|NCT00360490|2370666|P2|Overall Study|Lost to Follow-up|1
739434|NCT00360490|2370667|P1|Overall Study|Lost to Follow-up|2
739435|NCT00360490|2370666|P2|Overall Study|Adverse Event|2
739436|NCT00360490|2370667|P1|Overall Study|Adverse Event|4
739437|NCT00360529|2370703|P3|Overall Study|Reason discontinued not explained above|11
739438|NCT00360529|2370704|P2|Overall Study|Reason discontinued not explained above|9
739439|NCT00360529|2370705|P1|Overall Study|Reason discontinued not explained above|4
739440|NCT00360529|2370703|P3|Overall Study|Lack of Efficacy|5
739441|NCT00360529|2370704|P2|Overall Study|Lack of Efficacy|6
739442|NCT00360529|2370705|P1|Overall Study|Lack of Efficacy|8
739443|NCT00360529|2370703|P3|Overall Study|Withdrawal by Subject|18
739444|NCT00360529|2370704|P2|Overall Study|Withdrawal by Subject|14
739445|NCT00360529|2370705|P1|Overall Study|Withdrawal by Subject|22
739446|NCT00360529|2370703|P3|Overall Study|Lost to Follow-up|13
739447|NCT00360529|2370704|P2|Overall Study|Lost to Follow-up|10
739448|NCT00360529|2370705|P1|Overall Study|Lost to Follow-up|14
739449|NCT00360529|2370703|P3|Overall Study|Protocol Violation|11
739450|NCT00360529|2370704|P2|Overall Study|Protocol Violation|3
739451|NCT00360529|2370705|P1|Overall Study|Protocol Violation|3
739452|NCT00360529|2370703|P3|Overall Study|Adverse Event|33
739453|NCT00360529|2370704|P2|Overall Study|Adverse Event|23
739454|NCT00360529|2370705|P1|Overall Study|Adverse Event|10
739455|NCT00360568|2370754|P2|Overall Study|Withdrawal by Subject|3
739456|NCT00360568|2370755|P1|Overall Study|Withdrawal by Subject|0
739457|NCT00360568|2370754|P2|Overall Study|Lack of Efficacy|0
739458|NCT00360568|2370755|P1|Overall Study|Lack of Efficacy|1
739459|NCT00360568|2370754|P2|Overall Study|Adverse Event|2
739460|NCT00360568|2370755|P1|Overall Study|Adverse Event|1
739461|NCT00360698|2370881|P2|Treatment Period|Early termination by error|1
739462|NCT00360698|2370882|P1|Treatment Period|Early termination by error|0
739463|NCT00360698|2370881|P2|Treatment Period|Non compliance with treatment procedure|0
739464|NCT00360698|2370882|P1|Treatment Period|Non compliance with treatment procedure|1
739465|NCT00360698|2370881|P2|Run-In|Need of insulin with meals|1
739466|NCT00360698|2370882|P1|Run-In|Need of insulin with meals|0
739467|NCT00360698|2370881|P2|Run-In|Patient personal reasons|2
739468|NCT00360698|2370882|P1|Run-In|Patient personal reasons|0
739469|NCT00360698|2370881|P2|Run-In|Patient did not meet inclusion criteria|1
739470|NCT00360698|2370882|P1|Run-In|Patient did not meet inclusion criteria|0
739471|NCT00360698|2370881|P2|Run-In|Sponsor request|2
739472|NCT00360698|2370882|P1|Run-In|Sponsor request|0
739473|NCT00360698|2370881|P2|Run-In|Non compliance with treatment procedure|1
739474|NCT00360698|2370882|P1|Run-In|Non compliance with treatment procedure|0
739475|NCT00360698|2370881|P2|Run-In|Withdrawal by Subject|2
739476|NCT00360698|2370882|P1|Run-In|Withdrawal by Subject|0
739477|NCT00360698|2370881|P2|Run-In|Physician Decision|1
739478|NCT00360698|2370882|P1|Run-In|Physician Decision|0
739482|NCT00361231|2370974|P1|Overall Study|Adverse Event|6
739483|NCT00361231|2370974|P1|Overall Study|Withdrawal by Subject|4
739484|NCT00361231|2370974|P1|Overall Study|Radiographic disease progression|16
739485|NCT00361231|2370974|P1|Overall Study|Symptomatic deterioration|5
739486|NCT00361231|2370974|P1|Overall Study|Physician Decision|3
739519|NCT00361283|2371059|P1|Overall Study|Lost to Follow-up|27
739520|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
739521|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
739522|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
739523|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
739524|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
739525|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
739526|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
739527|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Not specified|2
739528|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Not specified|1
739529|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Not specified|0
739530|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Not specified|1
739531|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Not specified|0
739532|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Not specified|0
739533|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Not specified|1
739534|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
739535|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
739536|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
739537|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
739538|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
739539|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
739540|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
739541|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Death|1
739542|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Death|0
739543|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Death|0
739544|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Death|0
739545|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Death|0
739546|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Death|0
739547|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Death|0
739548|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
739549|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
739550|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
739551|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
739552|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
739553|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
739554|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
739555|NCT00361335|2371068|P7|SC Period: Week E0 to Week E24|Adverse Event|2
739556|NCT00361335|2371069|P6|SC Period: Week E0 to Week E24|Adverse Event|0
739557|NCT00361335|2371070|P5|SC Period: Week E0 to Week E24|Adverse Event|0
739558|NCT00361335|2371071|P4|SC Period: Week E0 to Week E24|Adverse Event|2
739559|NCT00361335|2371072|P3|SC Period: Week E0 to Week E24|Adverse Event|1
739560|NCT00361335|2371073|P2|SC Period: Week E0 to Week E24|Adverse Event|2
739561|NCT00361335|2371074|P1|SC Period: Week E0 to Week E24|Adverse Event|0
739562|NCT00361335|2371068|P7|IV Period: Baseline to E0|Lack of Efficacy|0
739563|NCT00361335|2371069|P6|IV Period: Baseline to E0|Lack of Efficacy|0
739564|NCT00361335|2371070|P5|IV Period: Baseline to E0|Lack of Efficacy|8
739565|NCT00361335|2371071|P4|IV Period: Baseline to E0|Lack of Efficacy|7
739566|NCT00361335|2371072|P3|IV Period: Baseline to E0|Lack of Efficacy|3
739567|NCT00361335|2371073|P2|IV Period: Baseline to E0|Lack of Efficacy|9
739568|NCT00361335|2371074|P1|IV Period: Baseline to E0|Lack of Efficacy|5
739569|NCT00361335|2371068|P7|IV Period: Baseline to E0|Not specified|0
739570|NCT00361335|2371069|P6|IV Period: Baseline to E0|Not specified|0
739571|NCT00361335|2371070|P5|IV Period: Baseline to E0|Not specified|2
739572|NCT00361335|2371071|P4|IV Period: Baseline to E0|Not specified|3
739573|NCT00361335|2371072|P3|IV Period: Baseline to E0|Not specified|9
739574|NCT00361335|2371073|P2|IV Period: Baseline to E0|Not specified|9
739575|NCT00361335|2371074|P1|IV Period: Baseline to E0|Not specified|2
739576|NCT00361335|2371068|P7|IV Period: Baseline to E0|Worsening of RA|0
739577|NCT00361335|2371069|P6|IV Period: Baseline to E0|Worsening of RA|0
739578|NCT00361335|2371070|P5|IV Period: Baseline to E0|Worsening of RA|2
739579|NCT00361335|2371071|P4|IV Period: Baseline to E0|Worsening of RA|4
739580|NCT00361335|2371072|P3|IV Period: Baseline to E0|Worsening of RA|1
739581|NCT00361335|2371073|P2|IV Period: Baseline to E0|Worsening of RA|5
739582|NCT00361335|2371074|P1|IV Period: Baseline to E0|Worsening of RA|0
739583|NCT00361335|2371068|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
739584|NCT00361335|2371069|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
739585|NCT00361335|2371070|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
739586|NCT00361335|2371071|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
739587|NCT00361335|2371072|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
739588|NCT00361335|2371073|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
739589|NCT00361335|2371074|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
739590|NCT00361335|2371068|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
739591|NCT00361335|2371069|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
739592|NCT00361335|2371070|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
739593|NCT00361335|2371071|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
739594|NCT00361335|2371072|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
739595|NCT00361335|2371073|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
739596|NCT00361335|2371074|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
739597|NCT00361335|2371068|P7|IV Period: Baseline to E0|Death|0
739598|NCT00361335|2371069|P6|IV Period: Baseline to E0|Death|0
739599|NCT00361335|2371070|P5|IV Period: Baseline to E0|Death|0
739600|NCT00361335|2371071|P4|IV Period: Baseline to E0|Death|1
739601|NCT00361335|2371072|P3|IV Period: Baseline to E0|Death|1
739602|NCT00361335|2371073|P2|IV Period: Baseline to E0|Death|1
739603|NCT00361335|2371074|P1|IV Period: Baseline to E0|Death|1
739604|NCT00361335|2371068|P7|IV Period: Baseline to E0|Lost to Follow-up|0
739605|NCT00361335|2371069|P6|IV Period: Baseline to E0|Lost to Follow-up|0
739606|NCT00361335|2371070|P5|IV Period: Baseline to E0|Lost to Follow-up|2
739607|NCT00361335|2371071|P4|IV Period: Baseline to E0|Lost to Follow-up|2
739608|NCT00361335|2371072|P3|IV Period: Baseline to E0|Lost to Follow-up|0
739609|NCT00361335|2371073|P2|IV Period: Baseline to E0|Lost to Follow-up|0
739610|NCT00361335|2371074|P1|IV Period: Baseline to E0|Lost to Follow-up|1
739611|NCT00361335|2371068|P7|IV Period: Baseline to E0|Adverse Event|0
739612|NCT00361335|2371069|P6|IV Period: Baseline to E0|Adverse Event|0
739613|NCT00361335|2371070|P5|IV Period: Baseline to E0|Adverse Event|8
739614|NCT00361335|2371071|P4|IV Period: Baseline to E0|Adverse Event|9
739615|NCT00361335|2371072|P3|IV Period: Baseline to E0|Adverse Event|5
739616|NCT00361335|2371073|P2|IV Period: Baseline to E0|Adverse Event|4
739617|NCT00361335|2371074|P1|IV Period: Baseline to E0|Adverse Event|9
739618|NCT00361504|2371148|P2|Overall Study|All other|3
739619|NCT00361504|2371149|P1|Overall Study|All other|28
739620|NCT00361504|2371148|P2|Overall Study|Study medication non compliant|15
739621|NCT00361504|2371149|P1|Overall Study|Study medication non compliant|42
739622|NCT00361504|2371148|P2|Overall Study|Resolution of Pain|0
739623|NCT00361504|2371149|P1|Overall Study|Resolution of Pain|2
739624|NCT00361504|2371148|P2|Overall Study|Lack of Efficacy|7
739625|NCT00361504|2371149|P1|Overall Study|Lack of Efficacy|72
739626|NCT00361504|2371148|P2|Overall Study|Adverse Event|82
739627|NCT00361504|2371149|P1|Overall Study|Adverse Event|203
739628|NCT00361504|2371148|P2|Overall Study|Lost to Follow-up|7
739629|NCT00361504|2371149|P1|Overall Study|Lost to Follow-up|40
739630|NCT00361504|2371148|P2|Overall Study|Withdrawal by Subject|31
739631|NCT00361504|2371149|P1|Overall Study|Withdrawal by Subject|94
739632|NCT00363415|2371159|P2|Overall Study|Protocol Violation|4
739633|NCT00363415|2371160|P1|Overall Study|Protocol Violation|1
739634|NCT00363415|2371159|P2|Overall Study|Lost to Follow-up|3
739635|NCT00363415|2371160|P1|Overall Study|Lost to Follow-up|3
739636|NCT00363415|2371159|P2|Overall Study|Withdrawal by Subject|15
739637|NCT00363415|2371160|P1|Overall Study|Withdrawal by Subject|9
739638|NCT00363415|2371159|P2|Overall Study|Entry Criteria Not Met|10
739639|NCT00363415|2371160|P1|Overall Study|Entry Criteria Not Met|11
739640|NCT00363415|2371159|P2|Overall Study|Physician Decision|35
739641|NCT00363415|2371160|P1|Overall Study|Physician Decision|18
739642|NCT00363415|2371159|P2|Overall Study|Adverse Event|15
739643|NCT00363415|2371160|P1|Overall Study|Adverse Event|24
739644|NCT00363415|2371159|P2|Overall Study|Death|29
739645|NCT00363415|2371160|P1|Overall Study|Death|32
739646|NCT00363415|2371159|P2|Overall Study|Sponsor Decision|31
739647|NCT00363415|2371160|P1|Overall Study|Sponsor Decision|67
739648|NCT00363415|2371159|P2|Overall Study|Progressive Disease|107
739649|NCT00363415|2371160|P1|Overall Study|Progressive Disease|196
739650|NCT00363467|2371176|P1|Overall Study|Physician Decision|1
739651|NCT00363545|2371186|P2|Overall Study|Others|0
739652|NCT00363545|2371187|P1|Overall Study|Others|1
739653|NCT00363545|2371186|P2|Overall Study|Lost to follow-up (complete vaccination)|17
739654|NCT00363545|2371187|P1|Overall Study|Lost to follow-up (complete vaccination)|14
739655|NCT00363545|2371186|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
739656|NCT00363545|2371187|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
739657|NCT00363545|2371186|P2|Overall Study|Migrated/moved from study area|6
739658|NCT00363545|2371187|P1|Overall Study|Migrated/moved from study area|3
739659|NCT00363545|2371186|P2|Overall Study|Withdrawal by Subject|15
739660|NCT00363545|2371187|P1|Overall Study|Withdrawal by Subject|12
739661|NCT00363545|2371186|P2|Overall Study|Serious Adverse Event|1
739662|NCT00363545|2371187|P1|Overall Study|Serious Adverse Event|0
739663|NCT00363896|2371241|P2|Overall Study|Other|2
739664|NCT00363896|2371242|P1|Overall Study|Other|1
739665|NCT00363896|2371241|P2|Overall Study|Non-fulfilment of entry criteria|0
739666|NCT00363896|2371242|P1|Overall Study|Non-fulfilment of entry criteria|1
739667|NCT00363896|2371241|P2|Overall Study|Lost to Follow-up|0
739668|NCT00363896|2371242|P1|Overall Study|Lost to Follow-up|3
739669|NCT00363896|2371241|P2|Overall Study|Protocol Violation|1
739670|NCT00363896|2371242|P1|Overall Study|Protocol Violation|6
739671|NCT00363896|2371241|P2|Overall Study|Lack of Efficacy|8
739672|NCT00363896|2371242|P1|Overall Study|Lack of Efficacy|12
739673|NCT00363896|2371241|P2|Overall Study|COPD exacerbation|7
739674|NCT00363896|2371242|P1|Overall Study|COPD exacerbation|13
739675|NCT00363896|2371241|P2|Overall Study|Adverse Event|13
739676|NCT00363896|2371242|P1|Overall Study|Adverse Event|24
739677|NCT00363896|2371241|P2|Overall Study|Withdrawal by Subject|16
739678|NCT00363896|2371242|P1|Overall Study|Withdrawal by Subject|29
739679|NCT00364013|2371256|P2|Overall Study|Ongoing|13
739680|NCT00364013|2371257|P1|Overall Study|Ongoing|20
739681|NCT00364013|2371256|P2|Overall Study|Other|47
739682|NCT00364013|2371257|P1|Overall Study|Other|41
739683|NCT00364013|2371256|P2|Overall Study|Protocol-specified criteria|6
739684|NCT00364013|2371257|P1|Overall Study|Protocol-specified criteria|6
739685|NCT00364013|2371256|P2|Overall Study|Lost to Follow-up|3
739686|NCT00364013|2371257|P1|Overall Study|Lost to Follow-up|10
739687|NCT00364013|2371256|P2|Overall Study|Physician Decision|3
739688|NCT00364013|2371257|P1|Overall Study|Physician Decision|3
739689|NCT00364013|2371256|P2|Overall Study|Withdrawal by Subject|18
739690|NCT00364013|2371257|P1|Overall Study|Withdrawal by Subject|13
739691|NCT00364013|2371256|P2|Overall Study|Adverse Event|3
739692|NCT00364013|2371257|P1|Overall Study|Adverse Event|4
739693|NCT00364013|2371256|P2|Overall Study|Ineligibility determined|2
739694|NCT00364013|2371257|P1|Overall Study|Ineligibility determined|4
739695|NCT00364130|2371285|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
739696|NCT00364130|2371286|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
739697|NCT00364130|2371285|P2|Intervention Period|Withdrawal by Subject|5
739698|NCT00364130|2371286|P1|Intervention Period|Withdrawal by Subject|4
739699|NCT00364130|2371285|P2|Intervention Period|Pregnancy|0
739700|NCT00364130|2371286|P1|Intervention Period|Pregnancy|1
739701|NCT00364130|2371285|P2|Intervention Period|Lost to Follow-up|3
739702|NCT00364130|2371286|P1|Intervention Period|Lost to Follow-up|4
739703|NCT00364156|2371308|P2|Overall Study|Protocol Violation|1
739704|NCT00364156|2371309|P1|Overall Study|Protocol Violation|6
739705|NCT00364156|2371308|P2|Overall Study|Withdrawal by Subject|80
739706|NCT00364156|2371309|P1|Overall Study|Withdrawal by Subject|73
739707|NCT00364182|2371318|P3|Third Intervention|Lost to Follow-up|1
739708|NCT00364182|2371319|P2|Third Intervention|Lost to Follow-up|0
739709|NCT00364182|2371320|P1|Third Intervention|Lost to Follow-up|0
739710|NCT00364182|2371318|P3|Third Intervention|non-compliance|0
739711|NCT00364182|2371319|P2|Third Intervention|non-compliance|1
739712|NCT00364182|2371320|P1|Third Intervention|non-compliance|0
739713|NCT00364182|2371318|P3|Second Intervention|Adverse Event|1
739714|NCT00364182|2371319|P2|Second Intervention|Adverse Event|0
739715|NCT00364182|2371320|P1|Second Intervention|Adverse Event|0
739716|NCT00364182|2371318|P3|Second Intervention|Protocol Violation|0
739717|NCT00364182|2371319|P2|Second Intervention|Protocol Violation|1
739718|NCT00364182|2371320|P1|Second Intervention|Protocol Violation|0
739719|NCT00364182|2371318|P3|Second Intervention|non-compliance|1
739720|NCT00364182|2371319|P2|Second Intervention|non-compliance|1
739721|NCT00364182|2371320|P1|Second Intervention|non-compliance|0
739722|NCT00364182|2371318|P3|First Intervention|Withdrawal by Subject|0
739723|NCT00364182|2371319|P2|First Intervention|Withdrawal by Subject|0
739724|NCT00364182|2371320|P1|First Intervention|Withdrawal by Subject|2
739725|NCT00364182|2371318|P3|First Intervention|Secondary prophylaxis|0
739726|NCT00364182|2371319|P2|First Intervention|Secondary prophylaxis|0
739727|NCT00364182|2371320|P1|First Intervention|Secondary prophylaxis|1
739728|NCT00364351|2371358|P2|Overall Study|Randomised treatment not started|3
739729|NCT00364351|2371359|P1|Overall Study|Randomised treatment not started|0
739730|NCT00364351|2371358|P2|Overall Study|Patient could not travel to site|1
739731|NCT00364351|2371359|P1|Overall Study|Patient could not travel to site|0
739732|NCT00364351|2371358|P2|Overall Study|Investigator error|2
739733|NCT00364351|2371359|P1|Overall Study|Investigator error|0
739734|NCT00364351|2371358|P2|Overall Study|Poor treatment compliance|3
739735|NCT00364351|2371359|P1|Overall Study|Poor treatment compliance|0
739736|NCT00364351|2371358|P2|Overall Study|Sponsor decision|0
739737|NCT00364351|2371359|P1|Overall Study|Sponsor decision|1
739738|NCT00364351|2371358|P2|Overall Study|Incorrect enrollment|1
739739|NCT00364351|2371359|P1|Overall Study|Incorrect enrollment|1
739740|NCT00364351|2371358|P2|Overall Study|Withdrawal by Subject|29
739741|NCT00364351|2371359|P1|Overall Study|Withdrawal by Subject|30
739742|NCT00364351|2371358|P2|Overall Study|Lost to Follow-up|1
739743|NCT00364351|2371359|P1|Overall Study|Lost to Follow-up|1
739744|NCT00364351|2371358|P2|Overall Study|Prohibited concomitant medication|2
739745|NCT00364351|2371359|P1|Overall Study|Prohibited concomitant medication|0
739746|NCT00364351|2371358|P2|Overall Study|Condition under investigation worsened|497
739747|NCT00364351|2371359|P1|Overall Study|Condition under investigation worsened|469
739748|NCT00364351|2371358|P2|Overall Study|Adverse Event|44
739749|NCT00364351|2371359|P1|Overall Study|Adverse Event|90
739750|NCT00364533|2371391|P5|Overall Study|Protocol Violation|0
739751|NCT00364533|2371392|P4|Overall Study|Protocol Violation|0
739752|NCT00364533|2371393|P3|Overall Study|Protocol Violation|0
739753|NCT00364533|2371394|P2|Overall Study|Protocol Violation|1
739754|NCT00364533|2371395|P1|Overall Study|Protocol Violation|1
739755|NCT00364533|2371391|P5|Overall Study|Non-compliance|0
739756|NCT00364533|2371392|P4|Overall Study|Non-compliance|0
739757|NCT00364533|2371393|P3|Overall Study|Non-compliance|0
739758|NCT00364533|2371394|P2|Overall Study|Non-compliance|0
739759|NCT00364533|2371395|P1|Overall Study|Non-compliance|1
739760|NCT00364533|2371391|P5|Overall Study|Variations in drug compliance|0
739761|NCT00364533|2371392|P4|Overall Study|Variations in drug compliance|0
739762|NCT00364533|2371393|P3|Overall Study|Variations in drug compliance|1
739763|NCT00364533|2371394|P2|Overall Study|Variations in drug compliance|1
739764|NCT00364533|2371395|P1|Overall Study|Variations in drug compliance|2
739765|NCT00364533|2371391|P5|Overall Study|Subject discharged from hospital|1
739766|NCT00364533|2371392|P4|Overall Study|Subject discharged from hospital|3
739767|NCT00364533|2371393|P3|Overall Study|Subject discharged from hospital|2
739768|NCT00364533|2371394|P2|Overall Study|Subject discharged from hospital|1
739769|NCT00364533|2371395|P1|Overall Study|Subject discharged from hospital|4
739770|NCT00364533|2371391|P5|Overall Study|Lack of Efficacy|42
739771|NCT00364533|2371392|P4|Overall Study|Lack of Efficacy|17
739772|NCT00364533|2371393|P3|Overall Study|Lack of Efficacy|21
739773|NCT00364533|2371394|P2|Overall Study|Lack of Efficacy|22
739774|NCT00364533|2371395|P1|Overall Study|Lack of Efficacy|22
739775|NCT00364533|2371391|P5|Overall Study|Withdrawal by Subject|6
739776|NCT00364533|2371392|P4|Overall Study|Withdrawal by Subject|6
739777|NCT00364533|2371393|P3|Overall Study|Withdrawal by Subject|6
739778|NCT00364533|2371394|P2|Overall Study|Withdrawal by Subject|8
739779|NCT00364533|2371395|P1|Overall Study|Withdrawal by Subject|4
739780|NCT00364533|2371391|P5|Overall Study|Adverse Event|2
739781|NCT00364533|2371392|P4|Overall Study|Adverse Event|5
739782|NCT00364533|2371393|P3|Overall Study|Adverse Event|15
739783|NCT00364533|2371394|P2|Overall Study|Adverse Event|7
739784|NCT00364533|2371395|P1|Overall Study|Adverse Event|8
739785|NCT00364611|2371419|P2|Overall Study|Receiving Liver Ablation|1
739786|NCT00364611|2371420|P1|Overall Study|Receiving Liver Ablation|0
739787|NCT00364611|2371419|P2|Overall Study|Presumed CR on Study|1
739788|NCT00364611|2371420|P1|Overall Study|Presumed CR on Study|0
739789|NCT00364611|2371419|P2|Overall Study|Found Ineligible|0
739790|NCT00364611|2371420|P1|Overall Study|Found Ineligible|1
739791|NCT00364611|2371419|P2|Overall Study|Investigator decision|2
739792|NCT00364611|2371420|P1|Overall Study|Investigator decision|2
739793|NCT00364611|2371419|P2|Overall Study|Disease Progression|8
739794|NCT00364611|2371420|P1|Overall Study|Disease Progression|38
739795|NCT00364611|2371419|P2|Overall Study|Participant's Request|4
739796|NCT00364611|2371420|P1|Overall Study|Participant's Request|3
739797|NCT00364611|2371419|P2|Overall Study|Adverse Event|4
739798|NCT00364611|2371420|P1|Overall Study|Adverse Event|7
739799|NCT00364611|2371419|P2|Overall Study|Did not receive study medication|1
739800|NCT00364611|2371420|P1|Overall Study|Did not receive study medication|0
739801|NCT00364793|2371442|P4|Overall Study|Withdrawal by Subject|0
739802|NCT00364793|2371443|P3|Overall Study|Withdrawal by Subject|0
739803|NCT00364793|2371444|P2|Overall Study|Withdrawal by Subject|1
739804|NCT00364793|2371445|P1|Overall Study|Withdrawal by Subject|0
739805|NCT00364793|2371442|P4|Overall Study|No longer meets criteria|1
739806|NCT00364793|2371443|P3|Overall Study|No longer meets criteria|0
739807|NCT00364793|2371444|P2|Overall Study|No longer meets criteria|0
739808|NCT00364793|2371445|P1|Overall Study|No longer meets criteria|0
739809|NCT00364793|2371442|P4|Overall Study|Poor or non-compliance|1
739810|NCT00364793|2371443|P3|Overall Study|Poor or non-compliance|0
739811|NCT00364793|2371444|P2|Overall Study|Poor or non-compliance|1
739812|NCT00364793|2371445|P1|Overall Study|Poor or non-compliance|1
739813|NCT00364793|2371442|P4|Overall Study|Lost to Follow-up|0
739814|NCT00364793|2371443|P3|Overall Study|Lost to Follow-up|2
739815|NCT00364793|2371444|P2|Overall Study|Lost to Follow-up|0
739816|NCT00364793|2371445|P1|Overall Study|Lost to Follow-up|1
739817|NCT00364793|2371442|P4|Overall Study|Lack of Efficacy|1
739818|NCT00364793|2371443|P3|Overall Study|Lack of Efficacy|1
739819|NCT00364793|2371444|P2|Overall Study|Lack of Efficacy|3
739820|NCT00364793|2371445|P1|Overall Study|Lack of Efficacy|3
739821|NCT00364793|2371442|P4|Overall Study|Death|0
739822|NCT00364793|2371443|P3|Overall Study|Death|1
739823|NCT00364793|2371444|P2|Overall Study|Death|0
739824|NCT00364793|2371445|P1|Overall Study|Death|1
739825|NCT00364793|2371442|P4|Overall Study|Adverse Event|0
739826|NCT00364793|2371443|P3|Overall Study|Adverse Event|0
739827|NCT00364793|2371444|P2|Overall Study|Adverse Event|0
739828|NCT00364793|2371445|P1|Overall Study|Adverse Event|2
739829|NCT00364832|2371596|P12|Extension Year 2|Early Withdrawals|3
739830|NCT00364832|2371597|P11|Extension Year 2|Early Withdrawals|5
739831|NCT00364832|2371598|P10|Extension Year 2|Early Withdrawals|5
739832|NCT00364832|2371599|P9|Extension Year 2|Early Withdrawals|0
739833|NCT00364832|2371600|P8|Extension Year 2|Early Withdrawals|0
739834|NCT00364832|2371601|P7|Extension Year 2|Early Withdrawals|0
739835|NCT00364832|2371602|P6|Extension Year 2|Early Withdrawals|0
739836|NCT00364832|2371603|P5|Extension Year 2|Early Withdrawals|0
739837|NCT00364832|2371604|P4|Extension Year 2|Early Withdrawals|0
739838|NCT00364832|2371605|P3|Extension Year 2|Early Withdrawals|0
739839|NCT00364832|2371606|P2|Extension Year 2|Early Withdrawals|0
739840|NCT00364832|2371607|P1|Extension Year 2|Early Withdrawals|0
739841|NCT00364832|2371596|P12|Extension Year 1|Early Withdrawals|10
739842|NCT00364832|2371597|P11|Extension Year 1|Early Withdrawals|2
739843|NCT00364832|2371598|P10|Extension Year 1|Early Withdrawals|4
739844|NCT00364832|2371599|P9|Extension Year 1|Early Withdrawals|0
739845|NCT00364832|2371600|P8|Extension Year 1|Early Withdrawals|0
739846|NCT00364832|2371601|P7|Extension Year 1|Early Withdrawals|0
739847|NCT00364832|2371602|P6|Extension Year 1|Early Withdrawals|0
739848|NCT00364832|2371603|P5|Extension Year 1|Early Withdrawals|0
739849|NCT00364832|2371604|P4|Extension Year 1|Early Withdrawals|0
739850|NCT00364832|2371605|P3|Extension Year 1|Early Withdrawals|0
739851|NCT00364832|2371606|P2|Extension Year 1|Early Withdrawals|0
739852|NCT00364832|2371607|P1|Extension Year 1|Early Withdrawals|0
739853|NCT00364832|2371596|P12|Core Period|Early Withdrawals|0
739854|NCT00364832|2371597|P11|Core Period|Early Withdrawals|0
739855|NCT00364832|2371598|P10|Core Period|Early Withdrawals|0
739856|NCT00364832|2371599|P9|Core Period|Early Withdrawals|0
739857|NCT00364832|2371600|P8|Core Period|Early Withdrawals|1
739858|NCT00364832|2371601|P7|Core Period|Early Withdrawals|4
739859|NCT00364832|2371602|P6|Core Period|Early Withdrawals|0
739860|NCT00364832|2371603|P5|Core Period|Early Withdrawals|0
739861|NCT00364832|2371604|P4|Core Period|Early Withdrawals|1
739862|NCT00364832|2371605|P3|Core Period|Early Withdrawals|1
739863|NCT00364832|2371606|P2|Core Period|Early Withdrawals|2
739864|NCT00364832|2371607|P1|Core Period|Early Withdrawals|2
739865|NCT00364845|2371662|P2|Overall Study|Death|1
739866|NCT00364845|2371663|P1|Overall Study|Death|0
739867|NCT00364845|2371662|P2|Overall Study|Lost to Follow-up|1
739868|NCT00364845|2371663|P1|Overall Study|Lost to Follow-up|0
739869|NCT00364845|2371662|P2|Overall Study|Physician Decision|8
739870|NCT00364845|2371663|P1|Overall Study|Physician Decision|8
739871|NCT00364845|2371662|P2|Overall Study|Withdrawal by Subject|1
739872|NCT00364845|2371663|P1|Overall Study|Withdrawal by Subject|2
739873|NCT00364845|2371662|P2|Overall Study|Adverse Event|0
739874|NCT00364845|2371663|P1|Overall Study|Adverse Event|1
739875|NCT00364858|2371677|P2|Overall Study|Clinical baseline issue|1
739876|NCT00364858|2371678|P1|Overall Study|Clinical baseline issue|0
739877|NCT00364858|2371677|P2|Overall Study|Return to Q2 regimen|1
739878|NCT00364858|2371678|P1|Overall Study|Return to Q2 regimen|0
739879|NCT00364858|2371677|P2|Overall Study|Non-compliant|0
739880|NCT00364858|2371678|P1|Overall Study|Non-compliant|1
739881|NCT00364858|2371677|P2|Overall Study|Discontinuation at baseline|0
739882|NCT00364858|2371678|P1|Overall Study|Discontinuation at baseline|1
739883|NCT00364858|2371677|P2|Overall Study|Clinical failure|13
739884|NCT00364858|2371678|P1|Overall Study|Clinical failure|2
739885|NCT00364858|2371677|P2|Overall Study|Pregnancy|1
739886|NCT00364858|2371678|P1|Overall Study|Pregnancy|1
739887|NCT00364858|2371677|P2|Overall Study|Withdrawal by Subject|1
739888|NCT00364858|2371678|P1|Overall Study|Withdrawal by Subject|1
739889|NCT00364858|2371677|P2|Overall Study|Adverse Event|5
739890|NCT00364858|2371678|P1|Overall Study|Adverse Event|1
739891|NCT00364923|2371691|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
739892|NCT00364923|2371691|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
739893|NCT00365105|2371727|P2|Overall Study|Lost to Follow-up|0
739894|NCT00365105|2371728|P1|Overall Study|Lost to Follow-up|1
739895|NCT00365105|2371727|P2|Overall Study|Withdrawal by Subject|1
739896|NCT00365105|2371728|P1|Overall Study|Withdrawal by Subject|1
739897|NCT00365105|2371727|P2|Overall Study|Protocol Violation|3
739898|NCT00365105|2371728|P1|Overall Study|Protocol Violation|4
739899|NCT00365300|2371788|P2|Double-blind Phase|Lack of Efficacy|6
739900|NCT00365300|2371789|P1|Double-blind Phase|Lack of Efficacy|6
739901|NCT00365300|2371788|P2|Double-blind Phase|Protocol Violation|1
739902|NCT00365300|2371789|P1|Double-blind Phase|Protocol Violation|3
739903|NCT00365300|2371788|P2|Double-blind Phase|Withdrawal by Subject|1
739904|NCT00365300|2371789|P1|Double-blind Phase|Withdrawal by Subject|0
739905|NCT00365300|2371788|P2|Double-blind Phase|Noncompliance|1
739906|NCT00365300|2371789|P1|Double-blind Phase|Noncompliance|1
739907|NCT00365300|2371788|P2|Double-blind Phase|Failed to return|0
739908|NCT00365300|2371789|P1|Double-blind Phase|Failed to return|1
739909|NCT00365300|2371788|P2|Open-label Phase|Patient skipped open label phase|0
739910|NCT00365300|2371789|P1|Open-label Phase|Patient skipped open label phase|1
739911|NCT00365300|2371788|P2|Open-label Phase|Lack of Efficacy|0
739912|NCT00365300|2371789|P1|Open-label Phase|Lack of Efficacy|1
739913|NCT00365300|2371788|P2|Open-label Phase|Protocol Violation|0
739914|NCT00365300|2371789|P1|Open-label Phase|Protocol Violation|1
739915|NCT00365300|2371788|P2|Open-label Phase|Parent/Legal Guardian Request|0
739916|NCT00365300|2371789|P1|Open-label Phase|Parent/Legal Guardian Request|4
739917|NCT00365300|2371788|P2|Open-label Phase|Noncompliance|0
739918|NCT00365300|2371789|P1|Open-label Phase|Noncompliance|9
739919|NCT00365300|2371788|P2|Open-label Phase|Physician Decision|0
739920|NCT00365300|2371789|P1|Open-label Phase|Physician Decision|1
739921|NCT00365300|2371788|P2|Open-label Phase|Failed to Return|0
739922|NCT00365300|2371789|P1|Open-label Phase|Failed to Return|1
739923|NCT00365300|2371788|P2|Open-label Phase|Adverse Event|0
739924|NCT00365300|2371789|P1|Open-label Phase|Adverse Event|4
739925|NCT00365352|2371801|P3|Overall Study|Withdrawal of Participant by Sponsor|0
739926|NCT00365352|2371802|P2|Overall Study|Withdrawal of Participant by Sponsor|0
739927|NCT00365352|2371803|P1|Overall Study|Withdrawal of Participant by Sponsor|1
739928|NCT00365352|2371801|P3|Overall Study|Lost to Follow-up|0
739929|NCT00365352|2371802|P2|Overall Study|Lost to Follow-up|1
739930|NCT00365352|2371803|P1|Overall Study|Lost to Follow-up|1
739931|NCT00365352|2371801|P3|Overall Study|Non-Compliance (after Randomization)|1
739932|NCT00365352|2371802|P2|Overall Study|Non-Compliance (after Randomization)|0
739933|NCT00365352|2371803|P1|Overall Study|Non-Compliance (after Randomization)|1
739934|NCT00365352|2371801|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
739935|NCT00365352|2371802|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
739936|NCT00365352|2371803|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
739937|NCT00365352|2371801|P3|Overall Study|Lack of Efficacy|0
739938|NCT00365352|2371802|P2|Overall Study|Lack of Efficacy|0
739939|NCT00365352|2371803|P1|Overall Study|Lack of Efficacy|3
739940|NCT00365352|2371801|P3|Overall Study|Participant Withdrew Consent|4
739941|NCT00365352|2371802|P2|Overall Study|Participant Withdrew Consent|3
739942|NCT00365352|2371803|P1|Overall Study|Participant Withdrew Consent|8
739943|NCT00365352|2371801|P3|Overall Study|Adverse Event|8
739944|NCT00365352|2371802|P2|Overall Study|Adverse Event|7
739945|NCT00365352|2371803|P1|Overall Study|Adverse Event|6
739946|NCT00365365|2371888|P3|Overall Study|Patient/physician decision|1
739947|NCT00365365|2371889|P2|Overall Study|Patient/physician decision|0
739948|NCT00365365|2371890|P1|Overall Study|Patient/physician decision|0
739949|NCT00365365|2371888|P3|Overall Study|Second malignancy|0
739950|NCT00365365|2371889|P2|Overall Study|Second malignancy|1
739951|NCT00365365|2371890|P1|Overall Study|Second malignancy|0
739952|NCT00365365|2371888|P3|Overall Study|Withdrew consent|0
739953|NCT00365365|2371889|P2|Overall Study|Withdrew consent|1
739954|NCT00365365|2371890|P1|Overall Study|Withdrew consent|1
739955|NCT00365365|2371888|P3|Overall Study|New cancer|0
739956|NCT00365365|2371889|P2|Overall Study|New cancer|0
739957|NCT00365365|2371890|P1|Overall Study|New cancer|1
739958|NCT00365365|2371888|P3|Overall Study|Moved|0
739959|NCT00365365|2371889|P2|Overall Study|Moved|0
739960|NCT00365365|2371890|P1|Overall Study|Moved|2
739961|NCT00365365|2371888|P3|Overall Study|Adverse Event|3
739962|NCT00365365|2371889|P2|Overall Study|Adverse Event|6
739963|NCT00365365|2371890|P1|Overall Study|Adverse Event|6
739964|NCT00365365|2371888|P3|Overall Study|Disease progression/relapse|7
739965|NCT00365365|2371889|P2|Overall Study|Disease progression/relapse|6
739966|NCT00365365|2371890|P1|Overall Study|Disease progression/relapse|9
739967|NCT00365365|2371888|P3|Overall Study|Subject's request|1
739968|NCT00365365|2371889|P2|Overall Study|Subject's request|13
739969|NCT00365365|2371890|P1|Overall Study|Subject's request|11
739970|NCT00365365|2371888|P3|Overall Study|Death|0
739971|NCT00365365|2371889|P2|Overall Study|Death|3
739972|NCT00365365|2371890|P1|Overall Study|Death|1
739973|NCT00365365|2371888|P3|Overall Study|Lost to Follow-up|3
739974|NCT00365365|2371889|P2|Overall Study|Lost to Follow-up|3
739975|NCT00365365|2371890|P1|Overall Study|Lost to Follow-up|3
739976|NCT00365365|2371888|P3|Overall Study|Poor compliance to protocol|0
739977|NCT00365365|2371889|P2|Overall Study|Poor compliance to protocol|1
739978|NCT00365365|2371890|P1|Overall Study|Poor compliance to protocol|0
739979|NCT00365365|2371888|P3|Overall Study|Randomized but not treated|0
739980|NCT00365365|2371889|P2|Overall Study|Randomized but not treated|2
739981|NCT00365365|2371890|P1|Overall Study|Randomized but not treated|0
739982|NCT00365378|2371906|P3|Extension|Unspecified|31
739983|NCT00365378|2371907|P2|Extension|Unspecified|0
739984|NCT00365378|2371908|P1|Extension|Unspecified|0
739985|NCT00365378|2371906|P3|Extension|Withdrawal by Subject|98
739986|NCT00365378|2371907|P2|Extension|Withdrawal by Subject|0
739987|NCT00365378|2371908|P1|Extension|Withdrawal by Subject|0
739988|NCT00365378|2371906|P3|Extension|Protocol Violation|2
739989|NCT00365378|2371907|P2|Extension|Protocol Violation|0
739990|NCT00365378|2371908|P1|Extension|Protocol Violation|0
739991|NCT00365378|2371906|P3|Extension|Lost to Follow-up|57
739992|NCT00365378|2371907|P2|Extension|Lost to Follow-up|0
739993|NCT00365378|2371908|P1|Extension|Lost to Follow-up|0
739994|NCT00365378|2371906|P3|Extension|Moved|8
739995|NCT00365378|2371907|P2|Extension|Moved|0
739996|NCT00365378|2371908|P1|Extension|Moved|0
739997|NCT00365378|2371906|P3|Extension|Adverse Event|1
739998|NCT00365378|2371907|P2|Extension|Adverse Event|0
739999|NCT00365378|2371908|P1|Extension|Adverse Event|0
740000|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Unspecified|0
740001|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Unspecified|21
740002|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Unspecified|11
740003|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
740004|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
740005|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
740006|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
740007|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
740008|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
740009|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
740010|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
740011|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
740012|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
740013|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
740014|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
740015|NCT00365378|2371906|P3|Follow-up (Month 7 Though Month 48)|Moved|0
740016|NCT00365378|2371907|P2|Follow-up (Month 7 Though Month 48)|Moved|5
740017|NCT00365378|2371908|P1|Follow-up (Month 7 Though Month 48)|Moved|6
740018|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Unspecified|0
740019|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Unspecified|9
740020|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Unspecified|17
740021|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
740022|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
740023|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
740024|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
740025|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
740026|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
740027|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
740028|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
740029|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
740030|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
740031|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
740032|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
740033|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
740034|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
740035|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
740036|NCT00365378|2371906|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
740037|NCT00365378|2371907|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
740038|NCT00365378|2371908|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
740039|NCT00365456|2371933|P2|Trial Period III (12 Months)|Other|1
740040|NCT00365456|2371934|P1|Trial Period III (12 Months)|Other|1
740041|NCT00365456|2371933|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
740042|NCT00365456|2371934|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
740043|NCT00365456|2371933|P2|Trial Period III (12 Months)|Adverse Event|3
740044|NCT00365456|2371934|P1|Trial Period III (12 Months)|Adverse Event|13
740045|NCT00365456|2371933|P2|Trial Period II (12 Months)|Other|1
740046|NCT00365456|2371934|P1|Trial Period II (12 Months)|Other|0
740047|NCT00365456|2371933|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
740048|NCT00365456|2371934|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
740049|NCT00365456|2371933|P2|Trial Period II (12 Months)|Non-compliance|2
740050|NCT00365456|2371934|P1|Trial Period II (12 Months)|Non-compliance|0
740051|NCT00365456|2371933|P2|Trial Period II (12 Months)|Adverse Event|6
740052|NCT00365456|2371934|P1|Trial Period II (12 Months)|Adverse Event|0
740053|NCT00365456|2371933|P2|Trial Period I (12 Months)|Other|0
740054|NCT00365456|2371934|P1|Trial Period I (12 Months)|Other|11
740055|NCT00365456|2371933|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
740056|NCT00365456|2371934|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
740057|NCT00365456|2371933|P2|Trial Period I (12 Months)|Non-compliance|0
740058|NCT00365456|2371934|P1|Trial Period I (12 Months)|Non-compliance|3
740059|NCT00365456|2371933|P2|Trial Period I (12 Months)|Adverse Event|0
740060|NCT00365456|2371934|P1|Trial Period I (12 Months)|Adverse Event|84
740061|NCT00365508|2371942|P2|Overall Study|Lost to Follow-up|154
740062|NCT00365508|2371943|P1|Overall Study|Lost to Follow-up|139
740063|NCT00365547|2371951|P1|Overall Study|Withdrawal by Subject|1
740064|NCT00365547|2371951|P1|Overall Study|Screen failure|1
740065|NCT00365547|2371951|P1|Overall Study|Insurance did not cover Avastin|1
740066|NCT00365716|2371970|P7|Extension 2|Withdrawal by Subject|5
740067|NCT00365716|2371971|P6|Extension 2|Withdrawal by Subject|0
740068|NCT00365716|2371972|P5|Extension 2|Withdrawal by Subject|0
740069|NCT00365716|2371973|P4|Extension 2|Withdrawal by Subject|0
740070|NCT00365716|2371974|P3|Extension 2|Withdrawal by Subject|0
740071|NCT00365716|2371975|P2|Extension 2|Withdrawal by Subject|0
740072|NCT00365716|2371976|P1|Extension 2|Withdrawal by Subject|0
740073|NCT00365716|2371970|P7|Extension 2|Unspecified|3
740074|NCT00365716|2371971|P6|Extension 2|Unspecified|0
740075|NCT00365716|2371972|P5|Extension 2|Unspecified|0
740076|NCT00365716|2371973|P4|Extension 2|Unspecified|0
740077|NCT00365716|2371974|P3|Extension 2|Unspecified|0
740078|NCT00365716|2371975|P2|Extension 2|Unspecified|0
740079|NCT00365716|2371976|P1|Extension 2|Unspecified|0
740080|NCT00365716|2371970|P7|Extension 2|Lost to Follow-up|2
740081|NCT00365716|2371971|P6|Extension 2|Lost to Follow-up|0
740082|NCT00365716|2371972|P5|Extension 2|Lost to Follow-up|0
740083|NCT00365716|2371973|P4|Extension 2|Lost to Follow-up|0
740084|NCT00365716|2371974|P3|Extension 2|Lost to Follow-up|0
740085|NCT00365716|2371975|P2|Extension 2|Lost to Follow-up|0
740086|NCT00365716|2371976|P1|Extension 2|Lost to Follow-up|0
740087|NCT00365716|2371970|P7|Extension 1|Protocol Violation|0
740088|NCT00365716|2371971|P6|Extension 1|Protocol Violation|1
740089|NCT00365716|2371972|P5|Extension 1|Protocol Violation|0
740090|NCT00365716|2371973|P4|Extension 1|Protocol Violation|0
740091|NCT00365716|2371974|P3|Extension 1|Protocol Violation|0
740092|NCT00365716|2371975|P2|Extension 1|Protocol Violation|0
740093|NCT00365716|2371976|P1|Extension 1|Protocol Violation|0
740094|NCT00365716|2371970|P7|Extension 1|Pregnancy|0
740095|NCT00365716|2371971|P6|Extension 1|Pregnancy|4
740096|NCT00365716|2371972|P5|Extension 1|Pregnancy|0
740097|NCT00365716|2371973|P4|Extension 1|Pregnancy|0
740098|NCT00365716|2371974|P3|Extension 1|Pregnancy|0
740099|NCT00365716|2371975|P2|Extension 1|Pregnancy|0
740100|NCT00365716|2371976|P1|Extension 1|Pregnancy|0
740101|NCT00365716|2371970|P7|Extension 1|Withdrawal by Subject|0
740102|NCT00365716|2371971|P6|Extension 1|Withdrawal by Subject|3
740103|NCT00365716|2371972|P5|Extension 1|Withdrawal by Subject|0
740104|NCT00365716|2371973|P4|Extension 1|Withdrawal by Subject|0
740105|NCT00365716|2371974|P3|Extension 1|Withdrawal by Subject|0
740106|NCT00365716|2371975|P2|Extension 1|Withdrawal by Subject|0
740107|NCT00365716|2371976|P1|Extension 1|Withdrawal by Subject|0
740108|NCT00365716|2371970|P7|Extension 1|Moved|0
740109|NCT00365716|2371971|P6|Extension 1|Moved|4
740110|NCT00365716|2371972|P5|Extension 1|Moved|0
740111|NCT00365716|2371973|P4|Extension 1|Moved|0
740112|NCT00365716|2371974|P3|Extension 1|Moved|0
740113|NCT00365716|2371975|P2|Extension 1|Moved|0
740114|NCT00365716|2371976|P1|Extension 1|Moved|0
740115|NCT00365716|2371970|P7|Extension 1|Unspecified|0
740116|NCT00365716|2371971|P6|Extension 1|Unspecified|9
740117|NCT00365716|2371972|P5|Extension 1|Unspecified|0
740118|NCT00365716|2371973|P4|Extension 1|Unspecified|0
740119|NCT00365716|2371974|P3|Extension 1|Unspecified|0
740120|NCT00365716|2371975|P2|Extension 1|Unspecified|0
740121|NCT00365716|2371976|P1|Extension 1|Unspecified|0
740122|NCT00365716|2371970|P7|Extension 1|Lost to Follow-up|0
740123|NCT00365716|2371971|P6|Extension 1|Lost to Follow-up|1
740124|NCT00365716|2371972|P5|Extension 1|Lost to Follow-up|0
740125|NCT00365716|2371973|P4|Extension 1|Lost to Follow-up|0
740126|NCT00365716|2371974|P3|Extension 1|Lost to Follow-up|0
740127|NCT00365716|2371975|P2|Extension 1|Lost to Follow-up|0
740128|NCT00365716|2371976|P1|Extension 1|Lost to Follow-up|0
740129|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
740130|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
740131|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
740132|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
740133|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
740134|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
740135|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
740136|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
740137|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
740138|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
740139|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
740140|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
740141|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
740142|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
740143|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
740144|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
740145|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|1
740146|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
740147|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
740148|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
740149|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|2
740150|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
740151|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
740152|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
740153|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
740154|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
740155|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
740156|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
740157|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
740158|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
740159|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
740160|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
740161|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
740162|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
740163|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
740164|NCT00365716|2371970|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
740165|NCT00365716|2371971|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
740166|NCT00365716|2371972|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
740167|NCT00365716|2371973|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
740168|NCT00365716|2371974|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
740169|NCT00365716|2371975|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
740170|NCT00365716|2371976|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
740171|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
740172|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
740173|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
740174|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
740175|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
740176|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
740177|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
740178|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
740179|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
740180|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
740181|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
740182|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
740183|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
740184|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
740185|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
740186|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
740187|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
740188|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
740189|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
740190|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
740191|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
740192|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Unspecified|0
740193|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Unspecified|0
740194|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Unspecified|0
740195|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Unspecified|0
740196|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Unspecified|0
740197|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Unspecified|1
740198|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Unspecified|0
740199|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
740200|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
740201|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
740202|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
740203|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
740204|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
740205|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
740206|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
740207|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
740208|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
740209|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
740210|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
740211|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
740212|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
740213|NCT00365716|2371970|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
740214|NCT00365716|2371971|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
740215|NCT00365716|2371972|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
740216|NCT00365716|2371973|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
740217|NCT00365716|2371974|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
740218|NCT00365716|2371975|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
740219|NCT00365716|2371976|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
740220|NCT00365846|2372002|P1|Overall Study|Lost to Follow-up|1
740221|NCT00357370|2372137|P3|Cohort 2|Withdrawal by Subject|0
740222|NCT00357370|2372138|P2|Cohort 2|Withdrawal by Subject|2
740223|NCT00357370|2372139|P1|Cohort 2|Withdrawal by Subject|0
740224|NCT00357370|2372137|P3|Cohort 2|non-compliance, not met criteria, etc|0
740225|NCT00357370|2372138|P2|Cohort 2|non-compliance, not met criteria, etc|1
740226|NCT00357370|2372139|P1|Cohort 2|non-compliance, not met criteria, etc|1
740227|NCT00357370|2372137|P3|Cohort 2|Lost to Follow-up|0
740228|NCT00357370|2372138|P2|Cohort 2|Lost to Follow-up|1
740229|NCT00357370|2372139|P1|Cohort 2|Lost to Follow-up|0
740230|NCT00357370|2372137|P3|Cohort 2|Adverse Event|1
740231|NCT00357370|2372138|P2|Cohort 2|Adverse Event|1
740232|NCT00357370|2372139|P1|Cohort 2|Adverse Event|1
740233|NCT00357370|2372137|P3|Cohort 2|Lack of Efficacy|1
740234|NCT00357370|2372138|P2|Cohort 2|Lack of Efficacy|2
740235|NCT00357370|2372139|P1|Cohort 2|Lack of Efficacy|0
740236|NCT00357396|2372164|P2|Overall Study|Adverse Event|0
740237|NCT00357396|2372165|P1|Overall Study|Adverse Event|1
740238|NCT00357500|2372170|P1|Overall Study|Not Started Protocol Therapy|4
740239|NCT00357500|2372170|P1|Overall Study|Progressive Disease|65
740240|NCT00357500|2372170|P1|Overall Study|Withdrawal by Subject|5
740241|NCT00357500|2372170|P1|Overall Study|Adverse Event|3
740242|NCT00357552|2372177|P1|Weeks 24 to 104|Not able to get to clinic|2
740243|NCT00357552|2372177|P1|Weeks 24 to 104|Death|3
740244|NCT00357552|2372177|P1|Weeks 0 to 24|Death|1
740245|NCT00357552|2372177|P1|Screening|Did not meet eligibility criteria|84
890659|NCT00950807|2825717|P8|Treatment Period 1|Lost to Follow-up|0
890660|NCT00950807|2825718|P7|Treatment Period 1|Lost to Follow-up|0
740248|NCT00357760|2372257|P2|Overall Study|To receive hospice care|1
740249|NCT00357760|2372258|P1|Overall Study|To receive hospice care|0
740250|NCT00357760|2372257|P2|Overall Study|Protocol Violation|1
740251|NCT00357760|2372258|P1|Overall Study|Protocol Violation|0
740252|NCT00357760|2372257|P2|Overall Study|Physician Decision|1
740253|NCT00357760|2372258|P1|Overall Study|Physician Decision|2
740254|NCT00357760|2372257|P2|Overall Study|Ineligible|2
740255|NCT00357760|2372258|P1|Overall Study|Ineligible|0
740256|NCT00357760|2372257|P2|Overall Study|Never started treatment|1
740257|NCT00357760|2372258|P1|Overall Study|Never started treatment|2
740258|NCT00357760|2372257|P2|Overall Study|Withdrawal by Subject|2
740259|NCT00357760|2372258|P1|Overall Study|Withdrawal by Subject|0
740260|NCT00357760|2372257|P2|Overall Study|Alternative therapy|0
740261|NCT00357760|2372258|P1|Overall Study|Alternative therapy|1
740262|NCT00357760|2372257|P2|Overall Study|Death|3
740263|NCT00357760|2372258|P1|Overall Study|Death|0
740264|NCT00357760|2372257|P2|Overall Study|Adverse Event|7
740265|NCT00357760|2372258|P1|Overall Study|Adverse Event|10
740266|NCT00357760|2372257|P2|Overall Study|Disease progression|17
740267|NCT00357760|2372258|P1|Overall Study|Disease progression|44
740268|NCT00357877|2372270|P2|Overall Study|Other|2
740269|NCT00357877|2372271|P1|Overall Study|Other|0
740270|NCT00357877|2372270|P2|Overall Study|Administrative withdrawal|1
740271|NCT00357877|2372271|P1|Overall Study|Administrative withdrawal|1
740272|NCT00357877|2372270|P2|Overall Study|Withdrawal by Subject|3
740273|NCT00357877|2372271|P1|Overall Study|Withdrawal by Subject|3
740274|NCT00357877|2372270|P2|Overall Study|Lost to Follow-up|23
740275|NCT00357877|2372271|P1|Overall Study|Lost to Follow-up|20
740276|NCT00357877|2372270|P2|Overall Study|Death|1
740277|NCT00357877|2372271|P1|Overall Study|Death|2
740278|NCT00357903|2372285|P2|Overall Study|Other|10
740279|NCT00357903|2372286|P1|Overall Study|Other|49
740280|NCT00357903|2372285|P2|Overall Study|Response status|9
740281|NCT00357903|2372286|P1|Overall Study|Response status|61
740282|NCT00357903|2372285|P2|Overall Study|Protocol issues|3
740283|NCT00357903|2372286|P1|Overall Study|Protocol issues|14
740284|NCT00357903|2372285|P2|Overall Study|Completed month 12 only|1
740285|NCT00357903|2372286|P1|Overall Study|Completed month 12 only|0
740286|NCT00357903|2372285|P2|Overall Study|Withdrawal by Subject|7
740287|NCT00357903|2372286|P1|Overall Study|Withdrawal by Subject|57
740288|NCT00357903|2372285|P2|Overall Study|Physician Decision|5
740289|NCT00357903|2372286|P1|Overall Study|Physician Decision|39
740290|NCT00357903|2372285|P2|Overall Study|Lost to Follow-up|4
740291|NCT00357903|2372286|P1|Overall Study|Lost to Follow-up|23
740292|NCT00357903|2372285|P2|Overall Study|Death|0
740293|NCT00357903|2372286|P1|Overall Study|Death|33
740294|NCT00357903|2372285|P2|Overall Study|Adverse Event|4
740295|NCT00357903|2372286|P1|Overall Study|Adverse Event|87
740296|NCT00357968|2372335|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
740297|NCT00357968|2372336|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
740298|NCT00357968|2372335|P2|First Maintenance Dose Phase|Not a PCI patient|42
740299|NCT00357968|2372336|P1|First Maintenance Dose Phase|Not a PCI patient|47
740300|NCT00357994|2372380|P2|Overall Study|Protocol Violation|0
740301|NCT00357994|2372381|P1|Overall Study|Protocol Violation|1
740302|NCT00357994|2372380|P2|Overall Study|Lack of Efficacy|1
740303|NCT00357994|2372381|P1|Overall Study|Lack of Efficacy|0
740304|NCT00357994|2372380|P2|Overall Study|Adverse Event|2
740305|NCT00357994|2372381|P1|Overall Study|Adverse Event|1
740306|NCT00358150|2372438|P1|Overall Study|Undefined|3
740307|NCT00358150|2372438|P1|Overall Study|Withdrawal by Subject|1
740308|NCT00358150|2372438|P1|Overall Study|Adverse Event|3
740309|NCT00358215|2372462|P2|Overall Study|Did not receive investigational product|3
740310|NCT00358215|2372463|P1|Overall Study|Did not receive investigational product|2
740311|NCT00358215|2372462|P2|Overall Study|Other|14
740312|NCT00358215|2372463|P1|Overall Study|Other|21
740313|NCT00358215|2372462|P2|Overall Study|Pregnancy|0
740314|NCT00358215|2372463|P1|Overall Study|Pregnancy|1
740315|NCT00358215|2372462|P2|Overall Study|Protocol Violation|59
740316|NCT00358215|2372463|P1|Overall Study|Protocol Violation|64
740317|NCT00358215|2372462|P2|Overall Study|Death|281
740318|NCT00358215|2372463|P1|Overall Study|Death|265
740319|NCT00358215|2372462|P2|Overall Study|Lost to Follow-up|22
740320|NCT00358215|2372463|P1|Overall Study|Lost to Follow-up|16
740321|NCT00358215|2372462|P2|Overall Study|Physician Decision|39
740322|NCT00358215|2372463|P1|Overall Study|Physician Decision|47
740323|NCT00358215|2372462|P2|Overall Study|Participant request|64
740324|NCT00358215|2372463|P1|Overall Study|Participant request|65
740325|NCT00358215|2372462|P2|Overall Study|Withdrawal by Subject|102
740326|NCT00358215|2372463|P1|Overall Study|Withdrawal by Subject|111
740327|NCT00358215|2372462|P2|Overall Study|Adverse Event|65
740328|NCT00358215|2372463|P1|Overall Study|Adverse Event|83
740329|NCT00358215|2372462|P2|Overall Study|Ineligibility determined|3
740330|NCT00358215|2372463|P1|Overall Study|Ineligibility determined|4
740331|NCT00358436|2372536|P2|Overall Study|Other|1
740332|NCT00358436|2372537|P1|Overall Study|Other|6
740333|NCT00358436|2372536|P2|Overall Study|COPD exacerbation|10
740334|NCT00358436|2372537|P1|Overall Study|COPD exacerbation|22
740335|NCT00358436|2372536|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
740336|NCT00358436|2372537|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
740337|NCT00358436|2372536|P2|Overall Study|Withdrawal by Subject|17
740338|NCT00358436|2372537|P1|Overall Study|Withdrawal by Subject|40
740339|NCT00358436|2372536|P2|Overall Study|Protocol Violation|3
740340|NCT00358436|2372537|P1|Overall Study|Protocol Violation|8
740341|NCT00358436|2372536|P2|Overall Study|Lost to Follow-up|6
740342|NCT00358436|2372537|P1|Overall Study|Lost to Follow-up|11
740343|NCT00358436|2372536|P2|Overall Study|Lack of Efficacy|36
740344|NCT00358436|2372537|P1|Overall Study|Lack of Efficacy|34
740345|NCT00358436|2372536|P2|Overall Study|Adverse Event|13
740346|NCT00358436|2372537|P1|Overall Study|Adverse Event|29
740347|NCT00358449|2372552|P3|Overall Study|Steriod Inhaler was Increased|1
740348|NCT00358449|2372553|P2|Overall Study|Steriod Inhaler was Increased|0
740349|NCT00358449|2372554|P1|Overall Study|Steriod Inhaler was Increased|0
740350|NCT00358449|2372552|P3|Overall Study|Lack of Efficacy|0
740351|NCT00358449|2372553|P2|Overall Study|Lack of Efficacy|1
740352|NCT00358449|2372554|P1|Overall Study|Lack of Efficacy|0
740353|NCT00358449|2372552|P3|Overall Study|Withdrawal by Subject|0
740354|NCT00358449|2372553|P2|Overall Study|Withdrawal by Subject|0
740355|NCT00358449|2372554|P1|Overall Study|Withdrawal by Subject|2
740356|NCT00358449|2372552|P3|Overall Study|Lost to Follow-up|0
740357|NCT00358449|2372553|P2|Overall Study|Lost to Follow-up|0
740358|NCT00358449|2372554|P1|Overall Study|Lost to Follow-up|1
740359|NCT00358449|2372552|P3|Overall Study|Adverse Event|1
740360|NCT00358449|2372553|P2|Overall Study|Adverse Event|0
740361|NCT00358449|2372554|P1|Overall Study|Adverse Event|1
740362|NCT00358527|2372684|P2|Overall Study|Administrative|1
740363|NCT00358527|2372685|P1|Overall Study|Administrative|2
740364|NCT00358527|2372684|P2|Overall Study|Non-compliance with protocol|1
740365|NCT00358527|2372685|P1|Overall Study|Non-compliance with protocol|6
740366|NCT00358527|2372684|P2|Overall Study|Withdrawal by Subject|1
740367|NCT00358527|2372685|P1|Overall Study|Withdrawal by Subject|1
740368|NCT00358527|2372684|P2|Overall Study|Adverse Event|0
740369|NCT00358527|2372685|P1|Overall Study|Adverse Event|4
740370|NCT00365976|2372712|P2|Overall Study|Withdrawal by Subject|5
740371|NCT00365976|2372713|P1|Overall Study|Withdrawal by Subject|1
740372|NCT00366249|2372761|P2|Overall Study|Most due to osteomylitis status|20
740373|NCT00366249|2372762|P1|Overall Study|Most due to osteomylitis status|31
740374|NCT00366249|2372761|P2|Overall Study|Lack of Efficacy|21
740375|NCT00366249|2372762|P1|Overall Study|Lack of Efficacy|21
740376|NCT00366249|2372761|P2|Overall Study|Withdrawal by Subject|4
740377|NCT00366249|2372762|P1|Overall Study|Withdrawal by Subject|18
740378|NCT00366249|2372761|P2|Overall Study|Protocol Violation|2
740379|NCT00366249|2372762|P1|Overall Study|Protocol Violation|1
740380|NCT00366249|2372761|P2|Overall Study|Lost to Follow-up|0
740381|NCT00366249|2372762|P1|Overall Study|Lost to Follow-up|2
740382|NCT00366249|2372761|P2|Overall Study|Physician Decision|2
740383|NCT00366249|2372762|P1|Overall Study|Physician Decision|5
740384|NCT00366249|2372761|P2|Overall Study|Death|1
740385|NCT00366249|2372762|P1|Overall Study|Death|0
740386|NCT00366249|2372761|P2|Overall Study|Adverse Event|28
740387|NCT00366249|2372762|P1|Overall Study|Adverse Event|53
740388|NCT00371839|2372783|P3|Overall Study|Lost to Follow-up|2
740389|NCT00371839|2372784|P2|Overall Study|Lost to Follow-up|3
740390|NCT00371839|2372785|P1|Overall Study|Lost to Follow-up|6
740391|NCT00371839|2372783|P3|Overall Study|Withdrawal by Subject|0
740392|NCT00371839|2372784|P2|Overall Study|Withdrawal by Subject|4
740393|NCT00371839|2372785|P1|Overall Study|Withdrawal by Subject|7
740394|NCT00371839|2372783|P3|Overall Study|Death|0
740395|NCT00371839|2372784|P2|Overall Study|Death|0
740396|NCT00371839|2372785|P1|Overall Study|Death|4
740397|NCT00371865|2372793|P2|Overall Study|Withdrawal by Subject|10
740398|NCT00371865|2372794|P1|Overall Study|Withdrawal by Subject|12
740399|NCT00371865|2372793|P2|Overall Study|Protocol Violation|2
740400|NCT00371865|2372794|P1|Overall Study|Protocol Violation|3
740401|NCT00371865|2372793|P2|Overall Study|Lack of Efficacy|2
740402|NCT00371865|2372794|P1|Overall Study|Lack of Efficacy|0
740403|NCT00372060|2372810|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
740404|NCT00372060|2372811|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
740405|NCT00372060|2372810|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
740406|NCT00372060|2372811|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
740407|NCT00372060|2372810|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
740408|NCT00372060|2372811|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
740409|NCT00372060|2372810|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
740410|NCT00372060|2372811|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
740411|NCT00372060|2372810|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
740412|NCT00372060|2372811|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
740413|NCT00372060|2372810|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
740414|NCT00372060|2372811|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
740415|NCT00372190|2372826|P2|Overall Study|Lost to Follow-up|1
740416|NCT00372190|2372827|P1|Overall Study|Lost to Follow-up|3
740417|NCT00372385|2372843|P4|Overall Study|Virologic Stopping Rule|0
740418|NCT00372385|2372844|P3|Overall Study|Virologic Stopping Rule|0
740419|NCT00372385|2372845|P2|Overall Study|Virologic Stopping Rule|0
740420|NCT00372385|2372846|P1|Overall Study|Virologic Stopping Rule|17
740421|NCT00372385|2372843|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
740422|NCT00372385|2372844|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
740423|NCT00372385|2372845|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
740424|NCT00372385|2372846|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
740425|NCT00372385|2372843|P4|Overall Study|No Response|0
740426|NCT00372385|2372844|P3|Overall Study|No Response|0
740427|NCT00372385|2372845|P2|Overall Study|No Response|1
740428|NCT00372385|2372846|P1|Overall Study|No Response|1
740429|NCT00372385|2372843|P4|Overall Study|Refusal of Treatment|0
740430|NCT00372385|2372844|P3|Overall Study|Refusal of Treatment|0
740431|NCT00372385|2372845|P2|Overall Study|Refusal of Treatment|6
740432|NCT00372385|2372846|P1|Overall Study|Refusal of Treatment|3
740433|NCT00372385|2372843|P4|Overall Study|Withdrawal by Subject|0
740434|NCT00372385|2372844|P3|Overall Study|Withdrawal by Subject|0
740435|NCT00372385|2372845|P2|Overall Study|Withdrawal by Subject|1
740436|NCT00372385|2372846|P1|Overall Study|Withdrawal by Subject|2
740437|NCT00372385|2372843|P4|Overall Study|Lost to Follow-up|0
740438|NCT00372385|2372844|P3|Overall Study|Lost to Follow-up|0
740439|NCT00372385|2372845|P2|Overall Study|Lost to Follow-up|0
740440|NCT00372385|2372846|P1|Overall Study|Lost to Follow-up|2
740441|NCT00372385|2372843|P4|Overall Study|Physician Decision|0
740442|NCT00372385|2372844|P3|Overall Study|Physician Decision|0
740443|NCT00372385|2372845|P2|Overall Study|Physician Decision|0
740444|NCT00372385|2372846|P1|Overall Study|Physician Decision|1
740445|NCT00372385|2372843|P4|Overall Study|Noncompliance|1
740446|NCT00372385|2372844|P3|Overall Study|Noncompliance|1
740447|NCT00372385|2372845|P2|Overall Study|Noncompliance|1
740448|NCT00372385|2372846|P1|Overall Study|Noncompliance|0
740449|NCT00372385|2372843|P4|Overall Study|Adverse Event|7
740450|NCT00372385|2372844|P3|Overall Study|Adverse Event|9
740451|NCT00372385|2372845|P2|Overall Study|Adverse Event|11
740452|NCT00372385|2372846|P1|Overall Study|Adverse Event|6
740453|NCT00372411|2372876|P3|Overall Study|Adverse Event|0
740454|NCT00372411|2372877|P2|Overall Study|Adverse Event|1
740455|NCT00372411|2372878|P1|Overall Study|Adverse Event|1
740456|NCT00372411|2372876|P3|Overall Study|Lost to Follow-up|1
740457|NCT00372411|2372877|P2|Overall Study|Lost to Follow-up|1
740458|NCT00372411|2372878|P1|Overall Study|Lost to Follow-up|1
740459|NCT00372411|2372876|P3|Overall Study|Death|1
740460|NCT00372411|2372877|P2|Overall Study|Death|2
740461|NCT00372411|2372878|P1|Overall Study|Death|0
740462|NCT00372411|2372876|P3|Overall Study|Withdrawal by Subject|1
740463|NCT00372411|2372877|P2|Overall Study|Withdrawal by Subject|4
740464|NCT00372411|2372878|P1|Overall Study|Withdrawal by Subject|3
740465|NCT00372424|2372898|P1|Overall Study|Enrolled, Not Treated|1
740466|NCT00372424|2372898|P1|Overall Study|Unspecified|7
740467|NCT00372424|2372898|P1|Overall Study|Objective Progression or Relapse|14
740468|NCT00372424|2372898|P1|Overall Study|Death|1
740469|NCT00372424|2372898|P1|Overall Study|Withdrawal by Subject|1
740470|NCT00372424|2372898|P1|Overall Study|Adverse Event|2
740471|NCT00372489|2372909|P1|Overall Study|Sponsor Decision to Terminate Study|41
740472|NCT00372489|2372909|P1|Overall Study|Renal transplant|6
740473|NCT00372489|2372909|P1|Overall Study|Patient Relocation|2
740474|NCT00372489|2372909|P1|Overall Study|Withdrawal by Subject|5
740475|NCT00372489|2372909|P1|Overall Study|Physician Decision|3
740476|NCT00372489|2372909|P1|Overall Study|Lost to Follow-up|3
740477|NCT00372489|2372909|P1|Overall Study|Lack of Efficacy|1
740478|NCT00372489|2372909|P1|Overall Study|Adverse Event|18
740479|NCT00372528|2372913|P1|Overall Study|Unspecified|1
740480|NCT00372528|2372913|P1|Overall Study|Study Terminated by Sponsor|18
740481|NCT00372528|2372913|P1|Overall Study|Adverse Event|1
740482|NCT00372528|2372913|P1|Overall Study|Lack of Efficacy|1
740483|NCT00372567|2372921|P3|Phase 3 Study|study terminated by sponsor|5
740484|NCT00372567|2372922|P2|Phase 3 Study|study terminated by sponsor|8
740485|NCT00372567|2372923|P1|Phase 3 Study|study terminated by sponsor|13
740486|NCT00372567|2372921|P3|Phase 3 Study|not specified|1
740487|NCT00372567|2372922|P2|Phase 3 Study|not specified|2
740488|NCT00372567|2372923|P1|Phase 3 Study|not specified|2
740489|NCT00372567|2372921|P3|Phase 3 Study|Global deterioration of health status|0
740490|NCT00372567|2372922|P2|Phase 3 Study|Global deterioration of health status|1
740491|NCT00372567|2372923|P1|Phase 3 Study|Global deterioration of health status|0
740492|NCT00372567|2372921|P3|Phase 3 Study|Objective progression or relapse|4
740493|NCT00372567|2372922|P2|Phase 3 Study|Objective progression or relapse|13
740494|NCT00372567|2372923|P1|Phase 3 Study|Objective progression or relapse|10
740495|NCT00372567|2372921|P3|Phase 3 Study|Protocol Violation|1
740496|NCT00372567|2372922|P2|Phase 3 Study|Protocol Violation|0
740497|NCT00372567|2372923|P1|Phase 3 Study|Protocol Violation|0
740498|NCT00372567|2372921|P3|Phase 3 Study|Death|0
740499|NCT00372567|2372922|P2|Phase 3 Study|Death|1
740500|NCT00372567|2372923|P1|Phase 3 Study|Death|1
740501|NCT00372567|2372921|P3|Phase 3 Study|Adverse Event|1
740502|NCT00372567|2372922|P2|Phase 3 Study|Adverse Event|1
740503|NCT00372567|2372923|P1|Phase 3 Study|Adverse Event|5
740504|NCT00372593|2372954|P3|Overall Study|Ineligible|1
740505|NCT00372593|2372955|P2|Overall Study|Ineligible|21
740506|NCT00372593|2372956|P1|Overall Study|Ineligible|20
740507|NCT00372593|2372954|P3|Overall Study|Physician Decision|0
740508|NCT00372593|2372955|P2|Overall Study|Physician Decision|41
740509|NCT00372593|2372956|P1|Overall Study|Physician Decision|42
740510|NCT00372593|2372954|P3|Overall Study|Lost to Follow-up|0
740511|NCT00372593|2372955|P2|Overall Study|Lost to Follow-up|0
740512|NCT00372593|2372956|P1|Overall Study|Lost to Follow-up|1
740513|NCT00372593|2372954|P3|Overall Study|Lack of Efficacy|2
740514|NCT00372593|2372955|P2|Overall Study|Lack of Efficacy|71
740515|NCT00372593|2372956|P1|Overall Study|Lack of Efficacy|82
740516|NCT00372593|2372954|P3|Overall Study|Death|1
740517|NCT00372593|2372955|P2|Overall Study|Death|20
740518|NCT00372593|2372956|P1|Overall Study|Death|16
740519|NCT00372593|2372954|P3|Overall Study|Adverse Event|0
740520|NCT00372593|2372955|P2|Overall Study|Adverse Event|45
740521|NCT00372593|2372956|P1|Overall Study|Adverse Event|43
740522|NCT00372619|2372989|P7|Overall Study|Inevaluable|0
740523|NCT00372619|2372990|P6|Overall Study|Inevaluable|1
740524|NCT00372619|2372991|P5|Overall Study|Inevaluable|0
740525|NCT00372619|2372992|P4|Overall Study|Inevaluable|0
740526|NCT00372619|2372993|P3|Overall Study|Inevaluable|0
740527|NCT00372619|2372994|P2|Overall Study|Inevaluable|0
740528|NCT00372619|2372995|P1|Overall Study|Inevaluable|0
740529|NCT00372619|2372989|P7|Overall Study|Ineligible|0
740530|NCT00372619|2372990|P6|Overall Study|Ineligible|2
740531|NCT00372619|2372991|P5|Overall Study|Ineligible|0
740532|NCT00372619|2372992|P4|Overall Study|Ineligible|0
740533|NCT00372619|2372993|P3|Overall Study|Ineligible|0
740534|NCT00372619|2372994|P2|Overall Study|Ineligible|0
740535|NCT00372619|2372995|P1|Overall Study|Ineligible|0
740536|NCT00372697|2373027|P2|Overall Study|Protocol Violation|1
740537|NCT00372697|2373028|P1|Overall Study|Protocol Violation|1
740538|NCT00372775|2373046|P1|Overall Study|Not Treated|2
740539|NCT00372775|2373046|P1|Overall Study|Not specified|1
740540|NCT00372775|2373046|P1|Overall Study|Withdrawal by Subject|1
740541|NCT00372775|2373046|P1|Overall Study|Global deterioration of health status|6
740542|NCT00372775|2373046|P1|Overall Study|Objective progression or relapse|30
740543|NCT00372775|2373046|P1|Overall Study|Death|15
740544|NCT00372775|2373046|P1|Overall Study|Adverse Event|8
740545|NCT00372996|2373077|P4|Overall Study|Not specified|7
740546|NCT00372996|2373078|P3|Overall Study|Not specified|7
740547|NCT00372996|2373079|P2|Overall Study|Not specified|2
740548|NCT00372996|2373080|P1|Overall Study|Not specified|10
740549|NCT00372996|2373077|P4|Overall Study|Study Terminated by Sponsor|0
740550|NCT00372996|2373078|P3|Overall Study|Study Terminated by Sponsor|4
740551|NCT00372996|2373079|P2|Overall Study|Study Terminated by Sponsor|0
740552|NCT00372996|2373080|P1|Overall Study|Study Terminated by Sponsor|4
740553|NCT00372996|2373077|P4|Overall Study|Withdrawal by Subject|5
740554|NCT00372996|2373078|P3|Overall Study|Withdrawal by Subject|9
740555|NCT00372996|2373079|P2|Overall Study|Withdrawal by Subject|6
740556|NCT00372996|2373080|P1|Overall Study|Withdrawal by Subject|12
740557|NCT00372996|2373077|P4|Overall Study|Lost to Follow-up|1
740558|NCT00372996|2373078|P3|Overall Study|Lost to Follow-up|0
740559|NCT00372996|2373079|P2|Overall Study|Lost to Follow-up|2
740560|NCT00372996|2373080|P1|Overall Study|Lost to Follow-up|0
740561|NCT00372996|2373077|P4|Overall Study|Death|7
740562|NCT00372996|2373078|P3|Overall Study|Death|8
740563|NCT00372996|2373079|P2|Overall Study|Death|4
740564|NCT00372996|2373080|P1|Overall Study|Death|11
740565|NCT00373113|2373106|P2|Overall Study|Withdrawal by Subject|15
740566|NCT00373113|2373107|P1|Overall Study|Withdrawal by Subject|10
740567|NCT00373113|2373106|P2|Overall Study|Protocol Violation|1
740568|NCT00373113|2373107|P1|Overall Study|Protocol Violation|5
740569|NCT00373113|2373106|P2|Overall Study|Unspecified|17
740570|NCT00373113|2373107|P1|Overall Study|Unspecified|14
740571|NCT00373113|2373106|P2|Overall Study|Objective progression or relapse|169
740572|NCT00373113|2373107|P1|Overall Study|Objective progression or relapse|150
740573|NCT00373113|2373106|P2|Overall Study|Lost to Follow-up|3
740574|NCT00373113|2373107|P1|Overall Study|Lost to Follow-up|1
740575|NCT00373113|2373106|P2|Overall Study|Global deterioration of health status|7
740576|NCT00373113|2373107|P1|Overall Study|Global deterioration of health status|10
740577|NCT00373113|2373106|P2|Overall Study|Study terminated by sponsor|1
740578|NCT00373113|2373107|P1|Overall Study|Study terminated by sponsor|9
740579|NCT00373113|2373106|P2|Overall Study|Adverse Event|24
740580|NCT00373113|2373107|P1|Overall Study|Adverse Event|38
740581|NCT00373113|2373106|P2|Overall Study|Death|7
740582|NCT00373113|2373107|P1|Overall Study|Death|1
740583|NCT00373256|2373129|P2|Overall Study|Study Terminated by Sponsor|13
740584|NCT00373256|2373130|P1|Overall Study|Study Terminated by Sponsor|41
740585|NCT00373256|2373129|P2|Overall Study|Protocol Violation|2
740586|NCT00373256|2373130|P1|Overall Study|Protocol Violation|0
740587|NCT00373256|2373129|P2|Overall Study|Unspecified|107
740588|NCT00373256|2373130|P1|Overall Study|Unspecified|73
740589|NCT00373256|2373129|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
740590|NCT00373256|2373130|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
740591|NCT00373256|2373129|P2|Overall Study|Objective Progression or Relapse|104
740592|NCT00373256|2373130|P1|Overall Study|Objective Progression or Relapse|111
740593|NCT00373256|2373129|P2|Overall Study|Death|8
740594|NCT00373256|2373130|P1|Overall Study|Death|9
740595|NCT00373256|2373129|P2|Overall Study|Lost to Follow-up|1
740596|NCT00373256|2373130|P1|Overall Study|Lost to Follow-up|2
740597|NCT00373256|2373129|P2|Overall Study|Adverse Event (AE)|5
740598|NCT00373256|2373130|P1|Overall Study|Adverse Event (AE)|1
740599|NCT00373295|2373165|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
740600|NCT00373295|2373166|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
740601|NCT00373295|2373167|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
740602|NCT00373295|2373168|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
740603|NCT00373295|2373169|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
740604|NCT00373295|2373170|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
740605|NCT00373425|2373230|P5|Overall Study|Death|0
740606|NCT00373425|2373231|P4|Overall Study|Death|1
740607|NCT00373425|2373232|P3|Overall Study|Death|3
740608|NCT00373425|2373233|P2|Overall Study|Death|0
740609|NCT00373425|2373234|P1|Overall Study|Death|7
740610|NCT00373425|2373230|P5|Overall Study|Medical/ethical/noncompliance reason|5
740611|NCT00373425|2373231|P4|Overall Study|Medical/ethical/noncompliance reason|2
740612|NCT00373425|2373232|P3|Overall Study|Medical/ethical/noncompliance reason|10
740613|NCT00373425|2373233|P2|Overall Study|Medical/ethical/noncompliance reason|9
740614|NCT00373425|2373234|P1|Overall Study|Medical/ethical/noncompliance reason|21
740615|NCT00373425|2373230|P5|Overall Study|Patient request|7
740616|NCT00373425|2373231|P4|Overall Study|Patient request|6
740617|NCT00373425|2373232|P3|Overall Study|Patient request|43
740618|NCT00373425|2373233|P2|Overall Study|Patient request|18
740619|NCT00373425|2373234|P1|Overall Study|Patient request|35
740620|NCT00373425|2373230|P5|Overall Study|Adverse Event|34
740621|NCT00373425|2373231|P4|Overall Study|Adverse Event|0
740622|NCT00373425|2373232|P3|Overall Study|Adverse Event|59
740623|NCT00373425|2373233|P2|Overall Study|Adverse Event|22
740624|NCT00373425|2373234|P1|Overall Study|Adverse Event|191
740625|NCT00373425|2373230|P5|Overall Study|Relapse of NSCLC|26
740626|NCT00373425|2373231|P4|Overall Study|Relapse of NSCLC|2
740627|NCT00373425|2373232|P3|Overall Study|Relapse of NSCLC|19
740628|NCT00373425|2373233|P2|Overall Study|Relapse of NSCLC|104
740629|NCT00373425|2373234|P1|Overall Study|Relapse of NSCLC|116
740630|NCT00373490|2373261|P2|Overall Study|Withdrawal by Subject|1
740631|NCT00373490|2373262|P1|Overall Study|Withdrawal by Subject|0
740632|NCT00373490|2373261|P2|Overall Study|Lack of Efficacy|4
740633|NCT00373490|2373262|P1|Overall Study|Lack of Efficacy|9
740634|NCT00373490|2373261|P2|Overall Study|Adverse Event|1
740635|NCT00373490|2373262|P1|Overall Study|Adverse Event|0
740636|NCT00373529|2373280|P1|Overall Study|Consent violation|1
740637|NCT00373529|2373280|P1|Overall Study|Failed independent confirmation of AML|3
740638|NCT00373529|2373280|P1|Overall Study|Not specified|8
740639|NCT00373529|2373280|P1|Overall Study|Need for treatment prohibited by study|1
740640|NCT00373529|2373280|P1|Overall Study|Death|16
740641|NCT00373529|2373280|P1|Overall Study|Disease recurrence|10
740642|NCT00373529|2373280|P1|Overall Study|Treatment failure|36
740643|NCT00373529|2373280|P1|Overall Study|Adverse Event|7
740644|NCT00373529|2373280|P1|Overall Study|Withdrawal by Subject|7
740645|NCT00373529|2373280|P1|Overall Study|Physician Decision|19
740646|NCT00373685|2373292|P2|Overall Study|Randomized, not treated|77
740647|NCT00373685|2373293|P1|Overall Study|Randomized, not treated|51
740648|NCT00373685|2373292|P2|Overall Study|Final Status Unknown|4
740649|NCT00373685|2373293|P1|Overall Study|Final Status Unknown|12
740650|NCT00373685|2373292|P2|Overall Study|Protocol Violation|182
740651|NCT00373685|2373293|P1|Overall Study|Protocol Violation|191
740652|NCT00373685|2373292|P2|Overall Study|Unspecified|146
740653|NCT00373685|2373293|P1|Overall Study|Unspecified|149
740654|NCT00373685|2373292|P2|Overall Study|No longer willing to participate|352
740655|NCT00373685|2373293|P1|Overall Study|No longer willing to participate|337
740656|NCT00373685|2373292|P2|Overall Study|Lost to follow up|103
740657|NCT00373685|2373293|P1|Overall Study|Lost to follow up|83
740658|NCT00373685|2373292|P2|Overall Study|Did not meet entrance criteria|184
740659|NCT00373685|2373293|P1|Overall Study|Did not meet entrance criteria|167
740660|NCT00373685|2373292|P2|Overall Study|Insufficient clinical response|119
740661|NCT00373685|2373293|P1|Overall Study|Insufficient clinical response|169
740662|NCT00373685|2373292|P2|Overall Study|Adverse Event|253
740663|NCT00373685|2373293|P1|Overall Study|Adverse Event|278
740664|NCT00373685|2373292|P2|Overall Study|Death|1
740665|NCT00373685|2373293|P1|Overall Study|Death|2
740666|NCT00373880|2373342|P1|Overall Study|Protocol Violation|14
740667|NCT00373880|2373342|P1|Overall Study|Arrested|1
740668|NCT00373880|2373342|P1|Overall Study|Physician Decision|3
740669|NCT00373958|2373372|P2|Toddler Dose|Withdrawn after infant series|25
740670|NCT00373958|2373373|P1|Toddler Dose|Withdrawn after infant series|22
740671|NCT00373958|2373372|P2|Toddler Dose|Protocol Violation|1
740672|NCT00373958|2373373|P1|Toddler Dose|Protocol Violation|0
740673|NCT00373958|2373372|P2|Toddler Dose|Failed to return|2
740674|NCT00373958|2373373|P1|Toddler Dose|Failed to return|1
740675|NCT00373958|2373372|P2|Toddler Dose|Withdrawal by Subject|2
740676|NCT00373958|2373373|P1|Toddler Dose|Withdrawal by Subject|2
740677|NCT00373958|2373372|P2|Toddler Dose|Lost to Follow-up|8
740678|NCT00373958|2373373|P1|Toddler Dose|Lost to Follow-up|5
740679|NCT00373958|2373372|P2|Infant Series|Physician Decision|1
740680|NCT00373958|2373373|P1|Infant Series|Physician Decision|1
740681|NCT00373958|2373372|P2|Infant Series|Adverse Event|1
740682|NCT00373958|2373373|P1|Infant Series|Adverse Event|3
740683|NCT00373958|2373372|P2|Infant Series|Consent was not received|0
740684|NCT00373958|2373373|P1|Infant Series|Consent was not received|1
740685|NCT00373958|2373372|P2|Infant Series|Child relocated|0
740686|NCT00373958|2373373|P1|Infant Series|Child relocated|1
740687|NCT00373958|2373372|P2|Infant Series|Lost Kaiser coverage|0
740688|NCT00373958|2373373|P1|Infant Series|Lost Kaiser coverage|4
740689|NCT00373958|2373372|P2|Infant Series|Protocol Violation|7
740690|NCT00373958|2373373|P1|Infant Series|Protocol Violation|3
740691|NCT00373958|2373372|P2|Infant Series|Lost to Follow-up|5
740692|NCT00373958|2373373|P1|Infant Series|Lost to Follow-up|6
740693|NCT00373958|2373372|P2|Infant Series|Failed to return|13
740694|NCT00373958|2373373|P1|Infant Series|Failed to return|8
740695|NCT00373958|2373372|P2|Infant Series|Withdrawal by Subject|15
740696|NCT00373958|2373373|P1|Infant Series|Withdrawal by Subject|13
740697|NCT00374127|2373434|P1|Overall Study|Pregnancy|1
740698|NCT00374127|2373434|P1|Overall Study|Protocol Violation|5
740699|NCT00374127|2373434|P1|Overall Study|Blood could not be drawn.|2
740700|NCT00374127|2373434|P1|Overall Study|Did not inhale during smoking procedure.|3
890661|NCT00950807|2825719|P6|Treatment Period 1|Lost to Follow-up|0
740703|NCT00374322|2373529|P2|Overall Study|Did Not Receive Study Medication|6
740704|NCT00374322|2373530|P1|Overall Study|Did Not Receive Study Medication|8
740705|NCT00374322|2373529|P2|Overall Study|Withdrew Consent During Follow-up|5
740706|NCT00374322|2373530|P1|Overall Study|Withdrew Consent During Follow-up|0
740707|NCT00374322|2373529|P2|Overall Study|Noncompliance with Study Requirements|1
740708|NCT00374322|2373530|P1|Overall Study|Noncompliance with Study Requirements|0
740709|NCT00374322|2373529|P2|Overall Study|Started Another Chemotherapy Regimen|1
740710|NCT00374322|2373530|P1|Overall Study|Started Another Chemotherapy Regimen|0
740711|NCT00374322|2373529|P2|Overall Study|Participant Changed Physician|0
740712|NCT00374322|2373530|P1|Overall Study|Participant Changed Physician|1
740713|NCT00374322|2373529|P2|Overall Study|Site Closed|2
740714|NCT00374322|2373530|P1|Overall Study|Site Closed|2
740715|NCT00374322|2373529|P2|Overall Study|Severe Toxicity|0
740716|NCT00374322|2373530|P1|Overall Study|Severe Toxicity|1
740717|NCT00374322|2373529|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
740718|NCT00374322|2373530|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
740719|NCT00374322|2373529|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
740720|NCT00374322|2373530|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
740721|NCT00374322|2373529|P2|Overall Study|Sponsor Decision|3
740722|NCT00374322|2373530|P1|Overall Study|Sponsor Decision|2
740723|NCT00374322|2373529|P2|Overall Study|Par. Consented to Survival FU Only|1
740724|NCT00374322|2373530|P1|Overall Study|Par. Consented to Survival FU Only|3
740725|NCT00374322|2373529|P2|Overall Study|Physician Decision|32
740726|NCT00374322|2373530|P1|Overall Study|Physician Decision|36
740727|NCT00374322|2373529|P2|Overall Study|Sponsor Terminated Study|990
740728|NCT00374322|2373530|P1|Overall Study|Sponsor Terminated Study|866
740729|NCT00374322|2373529|P2|Overall Study|Withdrawal by Subject|167
740730|NCT00374322|2373530|P1|Overall Study|Withdrawal by Subject|235
740731|NCT00374322|2373529|P2|Overall Study|Protocol Violation|3
740732|NCT00374322|2373530|P1|Overall Study|Protocol Violation|8
740733|NCT00374322|2373529|P2|Overall Study|Lost to Follow-up|90
740734|NCT00374322|2373530|P1|Overall Study|Lost to Follow-up|92
740735|NCT00361569|2373575|P4|Overall Study|Not specified by investigator|1
740736|NCT00361569|2373576|P3|Overall Study|Not specified by investigator|0
740737|NCT00361569|2373577|P2|Overall Study|Not specified by investigator|0
740738|NCT00361569|2373578|P1|Overall Study|Not specified by investigator|2
740739|NCT00361569|2373575|P4|Overall Study|Lost to Follow-up|2
740740|NCT00361569|2373576|P3|Overall Study|Lost to Follow-up|3
740741|NCT00361569|2373577|P2|Overall Study|Lost to Follow-up|3
740742|NCT00361569|2373578|P1|Overall Study|Lost to Follow-up|2
740743|NCT00361569|2373575|P4|Overall Study|Adverse Event|2
740744|NCT00361569|2373576|P3|Overall Study|Adverse Event|2
740745|NCT00361569|2373577|P2|Overall Study|Adverse Event|5
740746|NCT00361569|2373578|P1|Overall Study|Adverse Event|3
740747|NCT00361569|2373575|P4|Overall Study|Withdrawal by Subject|14
740748|NCT00361569|2373576|P3|Overall Study|Withdrawal by Subject|9
740749|NCT00361569|2373577|P2|Overall Study|Withdrawal by Subject|1
740750|NCT00361569|2373578|P1|Overall Study|Withdrawal by Subject|2
740751|NCT00361569|2373575|P4|Overall Study|Protocol Violation|2
740752|NCT00361569|2373576|P3|Overall Study|Protocol Violation|4
740753|NCT00361569|2373577|P2|Overall Study|Protocol Violation|2
740754|NCT00361569|2373578|P1|Overall Study|Protocol Violation|3
740755|NCT00361634|2373607|P1|Overall Study|Withdrawal by Subject|1
740756|NCT00361634|2373607|P1|Overall Study|Lost to Follow-up|1
740757|NCT00362115|2373643|P7|Overall Study|Other|0
740758|NCT00362115|2373644|P6|Overall Study|Other|1
740759|NCT00362115|2373645|P5|Overall Study|Other|0
740760|NCT00362115|2373646|P4|Overall Study|Other|1
740761|NCT00362115|2373647|P3|Overall Study|Other|0
740762|NCT00362115|2373648|P2|Overall Study|Other|1
740763|NCT00362115|2373649|P1|Overall Study|Other|0
740764|NCT00362115|2373643|P7|Overall Study|Physician Decision|3
740765|NCT00362115|2373644|P6|Overall Study|Physician Decision|0
740766|NCT00362115|2373645|P5|Overall Study|Physician Decision|0
740767|NCT00362115|2373646|P4|Overall Study|Physician Decision|0
740768|NCT00362115|2373647|P3|Overall Study|Physician Decision|0
740769|NCT00362115|2373648|P2|Overall Study|Physician Decision|0
740770|NCT00362115|2373649|P1|Overall Study|Physician Decision|0
740771|NCT00362115|2373643|P7|Overall Study|Lack of Efficacy|3
740772|NCT00362115|2373644|P6|Overall Study|Lack of Efficacy|0
740773|NCT00362115|2373645|P5|Overall Study|Lack of Efficacy|2
740774|NCT00362115|2373646|P4|Overall Study|Lack of Efficacy|2
740775|NCT00362115|2373647|P3|Overall Study|Lack of Efficacy|5
740776|NCT00362115|2373648|P2|Overall Study|Lack of Efficacy|0
740777|NCT00362115|2373649|P1|Overall Study|Lack of Efficacy|1
740778|NCT00362115|2373643|P7|Overall Study|Withdrawal by Subject|4
740779|NCT00362115|2373644|P6|Overall Study|Withdrawal by Subject|3
740780|NCT00362115|2373645|P5|Overall Study|Withdrawal by Subject|1
740781|NCT00362115|2373646|P4|Overall Study|Withdrawal by Subject|0
740782|NCT00362115|2373647|P3|Overall Study|Withdrawal by Subject|1
740783|NCT00362115|2373648|P2|Overall Study|Withdrawal by Subject|3
740784|NCT00362115|2373649|P1|Overall Study|Withdrawal by Subject|1
740785|NCT00362115|2373643|P7|Overall Study|Lost to Follow-up|1
740786|NCT00362115|2373644|P6|Overall Study|Lost to Follow-up|0
740787|NCT00362115|2373645|P5|Overall Study|Lost to Follow-up|2
740788|NCT00362115|2373646|P4|Overall Study|Lost to Follow-up|0
740789|NCT00362115|2373647|P3|Overall Study|Lost to Follow-up|0
740790|NCT00362115|2373648|P2|Overall Study|Lost to Follow-up|1
740791|NCT00362115|2373649|P1|Overall Study|Lost to Follow-up|0
740792|NCT00362115|2373643|P7|Overall Study|Protocol Violation|0
740793|NCT00362115|2373644|P6|Overall Study|Protocol Violation|1
740794|NCT00362115|2373645|P5|Overall Study|Protocol Violation|0
740795|NCT00362115|2373646|P4|Overall Study|Protocol Violation|0
740796|NCT00362115|2373647|P3|Overall Study|Protocol Violation|0
740797|NCT00362115|2373648|P2|Overall Study|Protocol Violation|0
740798|NCT00362115|2373649|P1|Overall Study|Protocol Violation|0
740799|NCT00362115|2373643|P7|Overall Study|Adverse Event|1
740800|NCT00362115|2373644|P6|Overall Study|Adverse Event|2
740801|NCT00362115|2373645|P5|Overall Study|Adverse Event|2
740802|NCT00362115|2373646|P4|Overall Study|Adverse Event|1
740803|NCT00362115|2373647|P3|Overall Study|Adverse Event|1
740804|NCT00362115|2373648|P2|Overall Study|Adverse Event|1
740805|NCT00362115|2373649|P1|Overall Study|Adverse Event|0
740806|NCT00362180|2373811|P9|Treated Period|Adverse Event|0
740807|NCT00362180|2373812|P8|Treated Period|Adverse Event|1
740808|NCT00362180|2373813|P7|Treated Period|Adverse Event|0
740809|NCT00362180|2373814|P6|Treated Period|Adverse Event|1
740810|NCT00362180|2373815|P5|Treated Period|Adverse Event|0
740811|NCT00362180|2373816|P4|Treated Period|Adverse Event|0
740812|NCT00362180|2373817|P3|Treated Period|Adverse Event|0
740813|NCT00362180|2373818|P2|Treated Period|Adverse Event|0
740814|NCT00362180|2373819|P1|Treated Period|Adverse Event|0
740815|NCT00362180|2373811|P9|Treated Period|Withdrawal by Subject|0
740816|NCT00362180|2373812|P8|Treated Period|Withdrawal by Subject|0
740817|NCT00362180|2373813|P7|Treated Period|Withdrawal by Subject|0
740818|NCT00362180|2373814|P6|Treated Period|Withdrawal by Subject|0
740819|NCT00362180|2373815|P5|Treated Period|Withdrawal by Subject|0
740820|NCT00362180|2373816|P4|Treated Period|Withdrawal by Subject|0
740821|NCT00362180|2373817|P3|Treated Period|Withdrawal by Subject|0
740822|NCT00362180|2373818|P2|Treated Period|Withdrawal by Subject|0
740823|NCT00362180|2373819|P1|Treated Period|Withdrawal by Subject|1
740824|NCT00362232|2373882|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
740825|NCT00362232|2373883|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
740826|NCT00362232|2373882|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
740827|NCT00362232|2373883|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
740828|NCT00362232|2373882|P2|Follow-up (30 (+ 5) Days)|Death|1
740829|NCT00362232|2373883|P1|Follow-up (30 (+ 5) Days)|Death|1
740830|NCT00362232|2373882|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
740831|NCT00362232|2373883|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
740832|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
740833|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
740834|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
740835|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
740836|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
740837|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
740838|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
740839|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
740840|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
740841|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
740842|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
740843|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
740844|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
740845|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
740846|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Death|3
740847|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Death|1
740848|NCT00362232|2373882|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
740849|NCT00362232|2373883|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
740850|NCT00362297|2373921|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
740851|NCT00362297|2373922|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
740852|NCT00362336|2373931|P3|Overall Study|Withdrawal by Subject|1
740853|NCT00362336|2373932|P2|Overall Study|Withdrawal by Subject|3
740854|NCT00362336|2373933|P1|Overall Study|Withdrawal by Subject|3
740855|NCT00362336|2373931|P3|Overall Study|Lost to Follow-up|0
740856|NCT00362336|2373932|P2|Overall Study|Lost to Follow-up|4
740857|NCT00362336|2373933|P1|Overall Study|Lost to Follow-up|6
740858|NCT00362336|2373931|P3|Overall Study|Protocol Violation|1
740859|NCT00362336|2373932|P2|Overall Study|Protocol Violation|0
740860|NCT00362336|2373933|P1|Overall Study|Protocol Violation|0
740861|NCT00362336|2373931|P3|Overall Study|Serious Adverse Event|1
740862|NCT00362336|2373932|P2|Overall Study|Serious Adverse Event|0
740863|NCT00362336|2373933|P1|Overall Study|Serious Adverse Event|1
740864|NCT00362375|2373961|P2|Overall Study|Lost to Follow-up|35
740865|NCT00362375|2373962|P1|Overall Study|Lost to Follow-up|40
740866|NCT00362414|2373986|P1|Overall Study|Adverse Event|1
740867|NCT00362414|2373986|P1|Overall Study|Death|2
740868|NCT00362609|2374074|P2|Overall Study|Protocol Violation|1
740869|NCT00362609|2374075|P1|Overall Study|Protocol Violation|0
740870|NCT00362609|2374074|P2|Overall Study|Withdrawal by Subject|1
740871|NCT00362609|2374075|P1|Overall Study|Withdrawal by Subject|0
740872|NCT00362648|2374091|P4|Overall Study|Withdrawal by Subject|6
740873|NCT00362648|2374092|P3|Overall Study|Withdrawal by Subject|2
740874|NCT00362648|2374093|P2|Overall Study|Withdrawal by Subject|42
740875|NCT00362648|2374094|P1|Overall Study|Withdrawal by Subject|48
740876|NCT00362648|2374091|P4|Overall Study|Protocol Violation|2
740877|NCT00362648|2374092|P3|Overall Study|Protocol Violation|2
740878|NCT00362648|2374093|P2|Overall Study|Protocol Violation|2
740879|NCT00362648|2374094|P1|Overall Study|Protocol Violation|4
740880|NCT00362648|2374091|P4|Overall Study|Lost to Follow-up|3
740881|NCT00362648|2374092|P3|Overall Study|Lost to Follow-up|4
740882|NCT00362648|2374093|P2|Overall Study|Lost to Follow-up|69
740883|NCT00362648|2374094|P1|Overall Study|Lost to Follow-up|62
740884|NCT00362648|2374091|P4|Overall Study|Adverse Event|0
740885|NCT00362648|2374092|P3|Overall Study|Adverse Event|1
740886|NCT00362648|2374093|P2|Overall Study|Adverse Event|21
740887|NCT00362648|2374094|P1|Overall Study|Adverse Event|12
740888|NCT00363051|2374138|P2|Overall Study|Death|2
740889|NCT00363051|2374139|P1|Overall Study|Death|3
740890|NCT00363051|2374138|P2|Overall Study|Protocol Violation|2
740891|NCT00363051|2374139|P1|Overall Study|Protocol Violation|0
740892|NCT00363051|2374138|P2|Overall Study|Lost to Follow-up|1
740893|NCT00363051|2374139|P1|Overall Study|Lost to Follow-up|0
740894|NCT00363051|2374138|P2|Overall Study|Withdrawal by Subject|3
740895|NCT00363051|2374139|P1|Overall Study|Withdrawal by Subject|11
740896|NCT00363051|2374138|P2|Overall Study|New Cancer Therapy|1
740897|NCT00363051|2374139|P1|Overall Study|New Cancer Therapy|2
740898|NCT00363051|2374138|P2|Overall Study|Adverse Event|12
740899|NCT00363051|2374139|P1|Overall Study|Adverse Event|21
740900|NCT00363051|2374138|P2|Overall Study|Adminstrative problems|1
740901|NCT00363051|2374139|P1|Overall Study|Adminstrative problems|1
740902|NCT00363129|2374185|P2|Overall Study|Other Reasons|3
740903|NCT00363129|2374186|P1|Overall Study|Other Reasons|6
740904|NCT00363129|2374185|P2|Overall Study|Death|1
740905|NCT00363129|2374186|P1|Overall Study|Death|0
740906|NCT00363129|2374185|P2|Overall Study|Other Medical Problems|4
740907|NCT00363129|2374186|P1|Overall Study|Other Medical Problems|2
740908|NCT00363129|2374185|P2|Overall Study|Alternate Treatment|4
740909|NCT00363129|2374186|P1|Overall Study|Alternate Treatment|2
740910|NCT00363129|2374185|P2|Overall Study|Adverse Event|3
740911|NCT00363129|2374186|P1|Overall Study|Adverse Event|8
740912|NCT00363129|2374185|P2|Overall Study|Withdrawal by Subject|18
740913|NCT00363129|2374186|P1|Overall Study|Withdrawal by Subject|11
740914|NCT00363142|2374202|P2|Overall Study|Withdrawal by Subject|1
740915|NCT00363142|2374203|P1|Overall Study|Withdrawal by Subject|3
740916|NCT00363142|2374202|P2|Overall Study|Non-compliance|1
740917|NCT00363142|2374203|P1|Overall Study|Non-compliance|1
740918|NCT00363142|2374202|P2|Overall Study|Lost to Follow-up|0
740919|NCT00363142|2374203|P1|Overall Study|Lost to Follow-up|1
740920|NCT00363142|2374202|P2|Overall Study|Lack of Efficacy|1
740921|NCT00363142|2374203|P1|Overall Study|Lack of Efficacy|0
740922|NCT00363142|2374202|P2|Overall Study|Adverse Event|0
740923|NCT00363142|2374203|P1|Overall Study|Adverse Event|2
740924|NCT00363246|2374241|P1|Overall Study|Eligibility changed due to Hospice move|5
740925|NCT00363246|2374241|P1|Overall Study|Subject expressed security concerns|2
740926|NCT00363246|2374241|P1|Overall Study|Stopped using wheelchair|11
740927|NCT00363246|2374241|P1|Overall Study|Bad health|6
740928|NCT00363246|2374241|P1|Overall Study|Lost to Follow-up|14
740929|NCT00363246|2374241|P1|Overall Study|Withdrawal by Subject|19
740930|NCT00363246|2374241|P1|Overall Study|Death|40
740931|NCT00363298|2374248|P2|4-week Study Continuation Phase|Lack of Efficacy|0
740932|NCT00363298|2374249|P1|4-week Study Continuation Phase|Lack of Efficacy|1
740933|NCT00363298|2374248|P2|First Study Week|Lack of Efficacy|5
740934|NCT00363298|2374249|P1|First Study Week|Lack of Efficacy|6
740935|NCT00363311|2374259|P2|Overall Study|Participant Moved to Louisiana|1
740936|NCT00363311|2374260|P1|Overall Study|Participant Moved to Louisiana|0
740937|NCT00363311|2374259|P2|Overall Study|Withdrawn per Instructions of Monitor|1
740938|NCT00363311|2374260|P1|Overall Study|Withdrawn per Instructions of Monitor|0
740939|NCT00363311|2374259|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
740940|NCT00363311|2374260|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
740941|NCT00363311|2374259|P2|Overall Study|Participant Moved to Another Country|0
740942|NCT00363311|2374260|P1|Overall Study|Participant Moved to Another Country|1
740943|NCT00363311|2374259|P2|Overall Study|Participant Opted for Treatment|0
740944|NCT00363311|2374260|P1|Overall Study|Participant Opted for Treatment|1
740945|NCT00363311|2374259|P2|Overall Study|Prostate Volume/PSA Doubled|0
740946|NCT00363311|2374260|P1|Overall Study|Prostate Volume/PSA Doubled|1
740947|NCT00363311|2374259|P2|Overall Study|Participant Refused Biopsy|0
740948|NCT00363311|2374260|P1|Overall Study|Participant Refused Biopsy|1
740949|NCT00363311|2374259|P2|Overall Study|Non-Compliance|1
740950|NCT00363311|2374260|P1|Overall Study|Non-Compliance|1
740951|NCT00363311|2374259|P2|Overall Study|Disease Progression|26
740952|NCT00363311|2374260|P1|Overall Study|Disease Progression|46
740953|NCT00363311|2374259|P2|Overall Study|Sponsor Terminated Study|2
740954|NCT00363311|2374260|P1|Overall Study|Sponsor Terminated Study|2
740955|NCT00363311|2374259|P2|Overall Study|Physician Decision|1
740956|NCT00363311|2374260|P1|Overall Study|Physician Decision|1
740957|NCT00363311|2374259|P2|Overall Study|Withdrawal by Subject|6
740958|NCT00363311|2374260|P1|Overall Study|Withdrawal by Subject|12
740959|NCT00363311|2374259|P2|Overall Study|Protocol Violation|2
740960|NCT00363311|2374260|P1|Overall Study|Protocol Violation|1
740961|NCT00363311|2374259|P2|Overall Study|Lost to Follow-up|0
740962|NCT00363311|2374260|P1|Overall Study|Lost to Follow-up|3
740963|NCT00363311|2374259|P2|Overall Study|Adverse Event|4
740964|NCT00363311|2374260|P1|Overall Study|Adverse Event|6
890662|NCT00950807|2825720|P5|Treatment Period 1|Lost to Follow-up|0
890663|NCT00950807|2825721|P4|Treatment Period 1|Lost to Follow-up|0
890664|NCT00950807|2825722|P3|Treatment Period 1|Lost to Follow-up|1
890665|NCT00950807|2825723|P2|Treatment Period 1|Lost to Follow-up|0
890666|NCT00950807|2825724|P1|Treatment Period 1|Lost to Follow-up|0
890667|NCT00950807|2825715|P10|Treatment Period 1|Protocol Violation|0
890668|NCT00950807|2825716|P9|Treatment Period 1|Protocol Violation|0
890669|NCT00950807|2825717|P8|Treatment Period 1|Protocol Violation|0
890670|NCT00950807|2825718|P7|Treatment Period 1|Protocol Violation|0
890671|NCT00950807|2825719|P6|Treatment Period 1|Protocol Violation|0
890672|NCT00950807|2825720|P5|Treatment Period 1|Protocol Violation|0
890673|NCT00950807|2825721|P4|Treatment Period 1|Protocol Violation|0
890674|NCT00950807|2825722|P3|Treatment Period 1|Protocol Violation|0
890675|NCT00950807|2825723|P2|Treatment Period 1|Protocol Violation|0
890676|NCT00950807|2825724|P1|Treatment Period 1|Protocol Violation|1
890677|NCT00950807|2825715|P10|Treatment Period 1|Lack of Efficacy|0
890678|NCT00950807|2825716|P9|Treatment Period 1|Lack of Efficacy|0
890679|NCT00950807|2825717|P8|Treatment Period 1|Lack of Efficacy|0
890680|NCT00950807|2825718|P7|Treatment Period 1|Lack of Efficacy|0
890681|NCT00950807|2825719|P6|Treatment Period 1|Lack of Efficacy|1
890682|NCT00950807|2825720|P5|Treatment Period 1|Lack of Efficacy|0
890683|NCT00950807|2825721|P4|Treatment Period 1|Lack of Efficacy|0
890684|NCT00950807|2825722|P3|Treatment Period 1|Lack of Efficacy|0
890685|NCT00950807|2825723|P2|Treatment Period 1|Lack of Efficacy|0
890686|NCT00950807|2825724|P1|Treatment Period 1|Lack of Efficacy|1
890687|NCT00945243|2825766|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
890688|NCT00945815|2825772|P1|Overall Study|Did not begin protocol therapy|1
890689|NCT00945815|2825772|P1|Overall Study|Ineligible|3
890690|NCT00945815|2825772|P1|Overall Study|Not protocol specified|1
890691|NCT00945815|2825772|P1|Overall Study|Death|3
890692|NCT00937560|2825777|P1|Maintenance Treatment|According to protocol|1
890693|NCT00937560|2825777|P1|Maintenance Treatment|Withdraw consent|5
890694|NCT00937560|2825777|P1|Maintenance Treatment|Death|12
890695|NCT00937560|2825777|P1|Initial Treatment|No end of study page|10
890696|NCT00937560|2825777|P1|Initial Treatment|Lost to Follow-up|1
890697|NCT00937560|2825777|P1|Initial Treatment|Adverse Event|1
741001|NCT00375427|2374406|P2|Overall Study|Death|10
741002|NCT00375427|2374407|P1|Overall Study|Death|11
741003|NCT00375427|2374406|P2|Overall Study|Administrative reasons|1
741004|NCT00375427|2374407|P1|Overall Study|Administrative reasons|0
741005|NCT00375427|2374406|P2|Overall Study|Lost to Follow-up|1
741006|NCT00375427|2374407|P1|Overall Study|Lost to Follow-up|1
741007|NCT00375427|2374406|P2|Overall Study|Withdrawal by Subject|13
741008|NCT00375427|2374407|P1|Overall Study|Withdrawal by Subject|9
741009|NCT00375427|2374406|P2|Overall Study|Protocol Violation|8
741010|NCT00375427|2374407|P1|Overall Study|Protocol Violation|10
741011|NCT00375427|2374406|P2|Overall Study|Patient no longer requires study drug|7
741012|NCT00375427|2374407|P1|Overall Study|Patient no longer requires study drug|3
741013|NCT00375427|2374406|P2|Overall Study|Unsatisfactory therapeutic effect|4
741014|NCT00375427|2374407|P1|Overall Study|Unsatisfactory therapeutic effect|4
741015|NCT00375427|2374406|P2|Overall Study|Abnormal laboratory value(s)|2
741016|NCT00375427|2374407|P1|Overall Study|Abnormal laboratory value(s)|1
741017|NCT00375427|2374406|P2|Overall Study|Abnormal test procedure result(s)|1
741018|NCT00375427|2374407|P1|Overall Study|Abnormal test procedure result(s)|0
741019|NCT00375427|2374406|P2|Overall Study|Adverse Event|27
741020|NCT00375427|2374407|P1|Overall Study|Adverse Event|21
741021|NCT00375492|2374431|P2|Overall Study|Withdrawal by Subject|6
741022|NCT00375492|2374432|P1|Overall Study|Withdrawal by Subject|6
741023|NCT00375492|2374431|P2|Overall Study|Sponsor Decision|1
741024|NCT00375492|2374432|P1|Overall Study|Sponsor Decision|0
741025|NCT00375492|2374431|P2|Overall Study|Protocol Violation|3
741026|NCT00375492|2374432|P1|Overall Study|Protocol Violation|6
741027|NCT00375492|2374431|P2|Overall Study|Physician Decision|4
741028|NCT00375492|2374432|P1|Overall Study|Physician Decision|0
741029|NCT00375492|2374431|P2|Overall Study|Lost to Follow-up|5
741030|NCT00375492|2374432|P1|Overall Study|Lost to Follow-up|10
741031|NCT00375492|2374431|P2|Overall Study|Loss of Glucose Control|1
741032|NCT00375492|2374432|P1|Overall Study|Loss of Glucose Control|0
741033|NCT00375492|2374431|P2|Overall Study|Entry Criteria Not Met|1
741034|NCT00375492|2374432|P1|Overall Study|Entry Criteria Not Met|0
741035|NCT00375492|2374431|P2|Overall Study|Adverse Event|5
741036|NCT00375492|2374432|P1|Overall Study|Adverse Event|4
741037|NCT00375505|2374462|P2|Overall Study|Adverse Event|2
741038|NCT00375505|2374463|P1|Overall Study|Adverse Event|1
741039|NCT00375518|2374507|P2|Overall Study|Death|1
741040|NCT00375518|2374508|P1|Overall Study|Death|0
741041|NCT00375518|2374507|P2|Overall Study|Patient Not Treated|6
741042|NCT00375518|2374508|P1|Overall Study|Patient Not Treated|6
741043|NCT00375518|2374507|P2|Overall Study|Withdrawal by Subject|10
741044|NCT00375518|2374508|P1|Overall Study|Withdrawal by Subject|2
741045|NCT00375674|2374516|P2|Overall Study|Lost to Follow-up|12
741046|NCT00375674|2374517|P1|Overall Study|Lost to Follow-up|14
741047|NCT00375674|2374516|P2|Overall Study|Subject refused further follow-up|23
741048|NCT00375674|2374517|P1|Overall Study|Subject refused further follow-up|24
741049|NCT00375674|2374516|P2|Overall Study|Death|64
741050|NCT00375674|2374517|P1|Overall Study|Death|61
741051|NCT00375674|2374516|P2|Overall Study|Not specified|16
741052|NCT00375674|2374517|P1|Overall Study|Not specified|24
890698|NCT00937560|2825777|P1|Initial Treatment|Withdraw consent|3
890699|NCT00937560|2825777|P1|Initial Treatment|Death|6
890700|NCT00915018|2825787|P2|Overall Study|By Sponsor due to Protocol Amendment|105
890701|NCT00915018|2825788|P1|Overall Study|By Sponsor due to Protocol Amendment|92
890702|NCT00915018|2825787|P2|Overall Study|Withdrawal by Subject|27
890703|NCT00915018|2825788|P1|Overall Study|Withdrawal by Subject|38
890704|NCT00915018|2825787|P2|Overall Study|Lost to Follow-up|5
890705|NCT00915018|2825788|P1|Overall Study|Lost to Follow-up|10
890706|NCT00915018|2825787|P2|Overall Study|Death|70
890707|NCT00915018|2825788|P1|Overall Study|Death|75
741065|NCT00375934|2374577|P2|Overall Study|Physician Decision|1
741066|NCT00375934|2374578|P1|Overall Study|Physician Decision|0
741067|NCT00375934|2374577|P2|Overall Study|Lack of Efficacy|2
741068|NCT00375934|2374578|P1|Overall Study|Lack of Efficacy|0
741069|NCT00375934|2374577|P2|Overall Study|Withdrawal by Subject|2
741070|NCT00375934|2374578|P1|Overall Study|Withdrawal by Subject|2
741071|NCT00375934|2374577|P2|Overall Study|Adverse Event|1
741072|NCT00375934|2374578|P1|Overall Study|Adverse Event|1
741073|NCT00376168|2374631|P2|Overall Study|Pregnancy|0
741074|NCT00376168|2374632|P1|Overall Study|Pregnancy|1
741075|NCT00376168|2374631|P2|Overall Study|Adverse Event|1
741076|NCT00376168|2374632|P1|Overall Study|Adverse Event|1
741077|NCT00376220|2374648|P2|Overall Study|Withdrawal by Subject|2
741078|NCT00376220|2374649|P1|Overall Study|Withdrawal by Subject|3
741079|NCT00376220|2374648|P2|Overall Study|Lost to Follow-up|10
741080|NCT00376220|2374649|P1|Overall Study|Lost to Follow-up|7
741081|NCT00376259|2374657|P2|Overall Study|Patient request|0
741082|NCT00376259|2374658|P1|Overall Study|Patient request|1
741083|NCT00376259|2374657|P2|Overall Study|Sponsor request - study termination|21
741084|NCT00376259|2374658|P1|Overall Study|Sponsor request - study termination|21
741085|NCT00376506|2374685|P2|Overall Study|Death|2
741086|NCT00376506|2374686|P1|Overall Study|Death|0
741087|NCT00376532|2374704|P2|Overall Study|Lack sufficient blood sample|6
741088|NCT00376532|2374705|P1|Overall Study|Lack sufficient blood sample|6
741089|NCT00376675|2374740|P2|Overall Study|Other Reason|7
741090|NCT00376675|2374741|P1|Overall Study|Other Reason|1
741091|NCT00376675|2374740|P2|Overall Study|Adverse Event|5
741092|NCT00376675|2374741|P1|Overall Study|Adverse Event|10
741093|NCT00376675|2374740|P2|Overall Study|Withdrawal by Subject|2
741094|NCT00376675|2374741|P1|Overall Study|Withdrawal by Subject|9
741113|NCT00377156|2374836|P2|Overall Study|Other|2
741114|NCT00377156|2374837|P1|Overall Study|Other|5
741115|NCT00377156|2374836|P2|Overall Study|Disability or language problem|1
741116|NCT00377156|2374837|P1|Overall Study|Disability or language problem|0
741117|NCT00377156|2374836|P2|Overall Study|Ineligible|1
741118|NCT00377156|2374837|P1|Overall Study|Ineligible|0
741119|NCT00377156|2374836|P2|Overall Study|Refused testing|1
741120|NCT00377156|2374837|P1|Overall Study|Refused testing|0
741121|NCT00377156|2374836|P2|Overall Study|Cancellation|0
741122|NCT00377156|2374837|P1|Overall Study|Cancellation|1
741123|NCT00377156|2374836|P2|Overall Study|Had follow-up <90 d|6
741124|NCT00377156|2374837|P1|Overall Study|Had follow-up <90 d|3
741125|NCT00377156|2374836|P2|Overall Study|Withdrawal by Subject|24
741126|NCT00377156|2374837|P1|Overall Study|Withdrawal by Subject|16
741127|NCT00377156|2374836|P2|Overall Study|Death|19
741128|NCT00377156|2374837|P1|Overall Study|Death|23
741129|NCT00377234|2374853|P2|Overall Study|Not assigned|2
741130|NCT00377234|2374854|P1|Overall Study|Not assigned|3
741131|NCT00377234|2374853|P2|Overall Study|Administrative|1
741132|NCT00377234|2374854|P1|Overall Study|Administrative|2
741133|NCT00377234|2374853|P2|Overall Study|Lost to Follow-up|2
741134|NCT00377234|2374854|P1|Overall Study|Lost to Follow-up|4
741135|NCT00377234|2374853|P2|Overall Study|Withdrawal by Subject|9
741136|NCT00377234|2374854|P1|Overall Study|Withdrawal by Subject|11
741137|NCT00377234|2374853|P2|Overall Study|Adverse Event|17
741138|NCT00377234|2374854|P1|Overall Study|Adverse Event|14
741139|NCT00377260|2374872|P2|Overall Study|Withdrawal by Subject|4
741140|NCT00377260|2374873|P1|Overall Study|Withdrawal by Subject|2
741141|NCT00377260|2374872|P2|Overall Study|Lost to Follow-up|1
741142|NCT00377260|2374873|P1|Overall Study|Lost to Follow-up|0
741143|NCT00377299|2374927|P2|Overall Study|Withdrawal by Subject|4
741144|NCT00377299|2374928|P1|Overall Study|Withdrawal by Subject|5
741145|NCT00377299|2374927|P2|Overall Study|Adverse Event|1
741146|NCT00377299|2374928|P1|Overall Study|Adverse Event|0
741147|NCT00377299|2374927|P2|Overall Study|Lost to Follow-up|19
741148|NCT00377299|2374928|P1|Overall Study|Lost to Follow-up|14
741149|NCT00377312|2374944|P2|Overall Study|Adverse Event|1
741150|NCT00377312|2374945|P1|Overall Study|Adverse Event|1
741151|NCT00377364|2374977|P2|Overall Study|Withdrawal by Subject|0
741152|NCT00377364|2374978|P1|Overall Study|Withdrawal by Subject|1
741153|NCT00377364|2374977|P2|Overall Study|Lost to Follow-up|0
741154|NCT00377364|2374978|P1|Overall Study|Lost to Follow-up|1
741155|NCT00377403|2375004|P2|Overall Study|Unable to contact for telephone intervie|7
741156|NCT00377403|2375005|P1|Overall Study|Unable to contact for telephone intervie|4
741157|NCT00377429|2375011|P1|Overall Study|Patient non-compliance|1
741158|NCT00377429|2375011|P1|Overall Study|Physician Decision|1
741159|NCT00377429|2375011|P1|Overall Study|Adverse Event|8
741160|NCT00377429|2375011|P1|Overall Study|Withdrawal by Subject|5
741161|NCT00377455|2375020|P1|Overall Study|Withdrawal by Subject|1
741162|NCT00377520|2375024|P1|Overall Study|Ineligible (Prior radiation)|1
741163|NCT00369317|2375070|P1|Overall Study|Ineligible|1
741164|NCT00369317|2375070|P1|Overall Study|Withdrawal by Subject|8
741165|NCT00369317|2375070|P1|Overall Study|Physician Decision|2
741166|NCT00369317|2375070|P1|Overall Study|Lack of Efficacy|5
741167|NCT00369317|2375070|P1|Overall Study|Death|1
741168|NCT00369317|2375070|P1|Overall Study|Adverse Event|3
741169|NCT00369343|2375086|P2|Open-label Phase|did not take study drug|2
741170|NCT00369343|2375087|P1|Open-label Phase|did not take study drug|1
741171|NCT00369343|2375086|P2|Open-label Phase|Lack of continuance tolerability|4
741172|NCT00369343|2375087|P1|Open-label Phase|Lack of continuance tolerability|3
741173|NCT00369343|2375086|P2|Open-label Phase|Lack of Efficacy|3
741174|NCT00369343|2375087|P1|Open-label Phase|Lack of Efficacy|4
741175|NCT00369343|2375086|P2|Open-label Phase|Withdrawal by Subject|6
741176|NCT00369343|2375087|P1|Open-label Phase|Withdrawal by Subject|15
741177|NCT00369343|2375086|P2|Open-label Phase|Protocol Violation|3
741178|NCT00369343|2375087|P1|Open-label Phase|Protocol Violation|1
741179|NCT00369343|2375086|P2|Open-label Phase|inadvertently reported study completers|2
741180|NCT00369343|2375087|P1|Open-label Phase|inadvertently reported study completers|3
741181|NCT00369343|2375086|P2|Open-label Phase|Lost to Follow-up|3
741182|NCT00369343|2375087|P1|Open-label Phase|Lost to Follow-up|5
741183|NCT00369343|2375086|P2|Open-label Phase|Physician Decision|0
741184|NCT00369343|2375087|P1|Open-label Phase|Physician Decision|2
741185|NCT00369343|2375086|P2|Open-label Phase|Failed to return|0
741186|NCT00369343|2375087|P1|Open-label Phase|Failed to return|4
741187|NCT00369343|2375086|P2|Open-label Phase|Adverse Event|7
741188|NCT00369343|2375087|P1|Open-label Phase|Adverse Event|19
741189|NCT00369343|2375086|P2|Double-blind Phase|Protocol deviation|0
741190|NCT00369343|2375087|P1|Double-blind Phase|Protocol deviation|4
741191|NCT00369343|2375086|P2|Double-blind Phase|Lack of Efficacy|4
741192|NCT00369343|2375087|P1|Double-blind Phase|Lack of Efficacy|0
741193|NCT00369343|2375086|P2|Double-blind Phase|Withdrawal by Subject|6
741194|NCT00369343|2375087|P1|Double-blind Phase|Withdrawal by Subject|8
741195|NCT00369343|2375086|P2|Double-blind Phase|Protocol Violation|0
741196|NCT00369343|2375087|P1|Double-blind Phase|Protocol Violation|2
741197|NCT00369343|2375086|P2|Double-blind Phase|Lost to Follow-up|2
741198|NCT00369343|2375087|P1|Double-blind Phase|Lost to Follow-up|9
741199|NCT00369343|2375086|P2|Double-blind Phase|Failed to return|0
741200|NCT00369343|2375087|P1|Double-blind Phase|Failed to return|2
741201|NCT00369343|2375086|P2|Double-blind Phase|Adverse Event|4
741202|NCT00369343|2375087|P1|Double-blind Phase|Adverse Event|19
741203|NCT00369382|2375122|P2|Overall Study|Unspecified|0
741204|NCT00369382|2375123|P1|Overall Study|Unspecified|1
741205|NCT00369382|2375122|P2|Overall Study|Randomized, not treated|0
741206|NCT00369382|2375123|P1|Overall Study|Randomized, not treated|2
741207|NCT00369382|2375122|P2|Overall Study|Withdrawal by Subject|0
741208|NCT00369382|2375123|P1|Overall Study|Withdrawal by Subject|5
741209|NCT00369382|2375122|P2|Overall Study|Physician Decision|1
741210|NCT00369382|2375123|P1|Overall Study|Physician Decision|2
741211|NCT00369382|2375122|P2|Overall Study|Death|2
741212|NCT00369382|2375123|P1|Overall Study|Death|0
741213|NCT00369486|2375159|P5|34-Week Visit|Dropped|3
741214|NCT00369486|2375160|P4|34-Week Visit|Dropped|3
741215|NCT00369486|2375161|P3|34-Week Visit|Dropped|1
741216|NCT00369486|2375162|P2|34-Week Visit|Dropped|1
741217|NCT00369486|2375163|P1|34-Week Visit|Dropped|0
741218|NCT00369486|2375159|P5|17-Week Visit|Missed visit|1
741219|NCT00369486|2375160|P4|17-Week Visit|Missed visit|1
741220|NCT00369486|2375161|P3|17-Week Visit|Missed visit|1
741221|NCT00369486|2375162|P2|17-Week Visit|Missed visit|0
741222|NCT00369486|2375163|P1|17-Week Visit|Missed visit|0
741223|NCT00369486|2375159|P5|8-Week Visit|Dropped|0
741224|NCT00369486|2375160|P4|8-Week Visit|Dropped|1
741225|NCT00369486|2375161|P3|8-Week Visit|Dropped|0
741226|NCT00369486|2375162|P2|8-Week Visit|Dropped|0
741227|NCT00369486|2375163|P1|8-Week Visit|Dropped|0
741228|NCT00369486|2375159|P5|8-Week Visit|Missed visit|1
741229|NCT00369486|2375160|P4|8-Week Visit|Missed visit|0
741230|NCT00369486|2375161|P3|8-Week Visit|Missed visit|0
741231|NCT00369486|2375162|P2|8-Week Visit|Missed visit|1
741232|NCT00369486|2375163|P1|8-Week Visit|Missed visit|0
741233|NCT00369486|2375159|P5|4-Week Visit|Dropped|0
741234|NCT00369486|2375160|P4|4-Week Visit|Dropped|0
741235|NCT00369486|2375161|P3|4-Week Visit|Dropped|1
741236|NCT00369486|2375162|P2|4-Week Visit|Dropped|0
741237|NCT00369486|2375163|P1|4-Week Visit|Dropped|0
741238|NCT00369486|2375159|P5|4-Week Visit|Missed visit|1
741239|NCT00369486|2375160|P4|4-Week Visit|Missed visit|2
741240|NCT00369486|2375161|P3|4-Week Visit|Missed visit|0
741241|NCT00369486|2375162|P2|4-Week Visit|Missed visit|2
741242|NCT00369486|2375163|P1|4-Week Visit|Missed visit|2
741243|NCT00369655|2375233|P1|Overall Study|Refusal of further treatment|2
741244|NCT00369668|2375245|P3|Overall Study|Lack of Efficacy|7
741245|NCT00369668|2375246|P2|Overall Study|Lack of Efficacy|5
741246|NCT00369668|2375247|P1|Overall Study|Lack of Efficacy|4
741247|NCT00369681|2375261|P1|Overall Study|Inevaluable|1
741248|NCT00369785|2375282|P2|Overall Study|Multiple reasons|5
741249|NCT00369785|2375283|P1|Overall Study|Multiple reasons|6
741250|NCT00369785|2375282|P2|Overall Study|Progression|4
741251|NCT00369785|2375283|P1|Overall Study|Progression|4
741252|NCT00369785|2375282|P2|Overall Study|Never started|2
741253|NCT00369785|2375283|P1|Overall Study|Never started|0
741254|NCT00369785|2375282|P2|Overall Study|Toxicity|4
741255|NCT00369785|2375283|P1|Overall Study|Toxicity|6
741256|NCT00369785|2375282|P2|Overall Study|Withdrawal by Subject|6
741257|NCT00369785|2375283|P1|Overall Study|Withdrawal by Subject|7
741258|NCT00369785|2375282|P2|Overall Study|Death|2
741259|NCT00369785|2375283|P1|Overall Study|Death|1
741260|NCT00369785|2375282|P2|Overall Study|Physician Decision|2
741261|NCT00369785|2375283|P1|Overall Study|Physician Decision|3
741262|NCT00369824|2375297|P6|Overall Study|Other|3
741263|NCT00369824|2375298|P5|Overall Study|Other|1
741264|NCT00369824|2375299|P4|Overall Study|Other|2
741265|NCT00369824|2375300|P3|Overall Study|Other|0
741266|NCT00369824|2375301|P2|Overall Study|Other|0
741267|NCT00369824|2375302|P1|Overall Study|Other|0
741268|NCT00369824|2375297|P6|Overall Study|Lost to Follow-up|6
741269|NCT00369824|2375298|P5|Overall Study|Lost to Follow-up|9
741270|NCT00369824|2375299|P4|Overall Study|Lost to Follow-up|8
741271|NCT00369824|2375300|P3|Overall Study|Lost to Follow-up|7
741272|NCT00369824|2375301|P2|Overall Study|Lost to Follow-up|11
741273|NCT00369824|2375302|P1|Overall Study|Lost to Follow-up|6
741274|NCT00369824|2375297|P6|Overall Study|Withdrawal by Subject|2
741275|NCT00369824|2375298|P5|Overall Study|Withdrawal by Subject|6
741276|NCT00369824|2375299|P4|Overall Study|Withdrawal by Subject|4
741277|NCT00369824|2375300|P3|Overall Study|Withdrawal by Subject|5
741278|NCT00369824|2375301|P2|Overall Study|Withdrawal by Subject|5
741279|NCT00369824|2375302|P1|Overall Study|Withdrawal by Subject|9
741280|NCT00369824|2375297|P6|Overall Study|Protocol Violation|0
741281|NCT00369824|2375298|P5|Overall Study|Protocol Violation|1
741282|NCT00369824|2375299|P4|Overall Study|Protocol Violation|1
741283|NCT00369824|2375300|P3|Overall Study|Protocol Violation|0
741284|NCT00369824|2375301|P2|Overall Study|Protocol Violation|1
741285|NCT00369824|2375302|P1|Overall Study|Protocol Violation|0
741286|NCT00369824|2375297|P6|Overall Study|Adverse Event|0
741287|NCT00369824|2375298|P5|Overall Study|Adverse Event|1
741288|NCT00369824|2375299|P4|Overall Study|Adverse Event|0
741289|NCT00369824|2375300|P3|Overall Study|Adverse Event|0
741290|NCT00369824|2375301|P2|Overall Study|Adverse Event|2
741291|NCT00369824|2375302|P1|Overall Study|Adverse Event|0
741292|NCT00369915|2375402|P2|Overall Study|W/drawl by investigators|1
741293|NCT00369915|2375403|P1|Overall Study|W/drawl by investigators|0
741294|NCT00369915|2375402|P2|Overall Study|Withdrawal by Subject|1
741295|NCT00369915|2375403|P1|Overall Study|Withdrawal by Subject|4
741296|NCT00369915|2375402|P2|Overall Study|expected side effects|1
741297|NCT00369915|2375403|P1|Overall Study|expected side effects|2
741298|NCT00369941|2375426|P2|Overall Study|Miscellaneous|3
741299|NCT00369941|2375427|P1|Overall Study|Miscellaneous|3
741300|NCT00369941|2375426|P2|Overall Study|Study Site Terminated|0
741301|NCT00369941|2375427|P1|Overall Study|Study Site Terminated|2
741302|NCT00369941|2375426|P2|Overall Study|Employment Interfered with Study Visits|0
741303|NCT00369941|2375427|P1|Overall Study|Employment Interfered with Study Visits|1
741304|NCT00369941|2375426|P2|Overall Study|Treatment with Prohibited Medication|1
741305|NCT00369941|2375427|P1|Overall Study|Treatment with Prohibited Medication|3
741306|NCT00369941|2375426|P2|Overall Study|Moved|5
741307|NCT00369941|2375427|P1|Overall Study|Moved|11
741308|NCT00369941|2375426|P2|Overall Study|Completed, Did Not Enter Extension|6
741309|NCT00369941|2375427|P1|Overall Study|Completed, Did Not Enter Extension|5
741310|NCT00369941|2375426|P2|Overall Study|Pregnancy|2
741311|NCT00369941|2375427|P1|Overall Study|Pregnancy|4
741312|NCT00369941|2375426|P2|Overall Study|Withdrawal by Subject|18
741313|NCT00369941|2375427|P1|Overall Study|Withdrawal by Subject|5
741314|NCT00369941|2375426|P2|Overall Study|Protocol Violation|3
741315|NCT00369941|2375427|P1|Overall Study|Protocol Violation|5
741316|NCT00369941|2375426|P2|Overall Study|Lost to Follow-up|22
741317|NCT00369941|2375427|P1|Overall Study|Lost to Follow-up|12
741318|NCT00369941|2375426|P2|Overall Study|Lack of Efficacy|10
741319|NCT00369941|2375427|P1|Overall Study|Lack of Efficacy|6
741320|NCT00369941|2375426|P2|Overall Study|Adverse Event|28
741321|NCT00369941|2375427|P1|Overall Study|Adverse Event|14
741322|NCT00369941|2375426|P2|Overall Study|Never Treated|2
741323|NCT00369941|2375427|P1|Overall Study|Never Treated|1
741324|NCT00369967|2375579|P2|Overall Study|Lost to Follow-up|12
741325|NCT00369967|2375580|P1|Overall Study|Lost to Follow-up|23
741326|NCT00370032|2375598|P2|Follow-up Period|Withdrawal by Subject|0
741327|NCT00370032|2375599|P1|Follow-up Period|Withdrawal by Subject|1
741328|NCT00370032|2375598|P2|Washout Period|Adverse Event|0
741329|NCT00370032|2375599|P1|Washout Period|Adverse Event|1
741330|NCT00370032|2375598|P2|Washout Period|Lost to Follow-up|1
741331|NCT00370032|2375599|P1|Washout Period|Lost to Follow-up|0
741332|NCT00370032|2375598|P2|Washout Period|Withdrawal by Subject|1
741333|NCT00370032|2375599|P1|Washout Period|Withdrawal by Subject|0
741334|NCT00370032|2375598|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
741335|NCT00370032|2375599|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
741336|NCT00370071|2375617|P1|Overall Study|Withdrawal by Subject|2
741337|NCT00370149|2375634|P2|Overall Study|Antibiotic coated dressing placed|1
741338|NCT00370149|2375635|P1|Overall Study|Antibiotic coated dressing placed|0
741339|NCT00370149|2375634|P2|Overall Study|Pre-existing infection|1
741340|NCT00370149|2375635|P1|Overall Study|Pre-existing infection|0
741341|NCT00370149|2375634|P2|Overall Study|Catheter inserted in wrong vessel-|1
741342|NCT00370149|2375635|P1|Overall Study|Catheter inserted in wrong vessel-|2
741343|NCT00370149|2375634|P2|Overall Study|Protocol Violation|0
741344|NCT00370149|2375635|P1|Overall Study|Protocol Violation|1
741345|NCT00370149|2375634|P2|Overall Study|Physician Decision|16
741346|NCT00370149|2375635|P1|Overall Study|Physician Decision|16
741347|NCT00370292|2375647|P1|Overall Study|Physician Decision|2
741348|NCT00370292|2375647|P1|Overall Study|Adverse Event|7
741349|NCT00370292|2375647|P1|Overall Study|Disease Progression|4
741350|NCT00370331|2375660|P2|Overall Study|Protocol Violation|1
741351|NCT00370331|2375661|P1|Overall Study|Protocol Violation|1
741352|NCT00370331|2375660|P2|Overall Study|Non-compliance|1
741353|NCT00370331|2375661|P1|Overall Study|Non-compliance|0
741354|NCT00370331|2375660|P2|Overall Study|Lack of Efficacy|1
741355|NCT00370331|2375661|P1|Overall Study|Lack of Efficacy|0
741356|NCT00370331|2375660|P2|Overall Study|Lost to Follow-up|3
741357|NCT00370331|2375661|P1|Overall Study|Lost to Follow-up|0
741358|NCT00370331|2375660|P2|Overall Study|Withdrawal by Subject|4
741359|NCT00370331|2375661|P1|Overall Study|Withdrawal by Subject|2
741360|NCT00370331|2375660|P2|Overall Study|Adverse Event|13
741361|NCT00370331|2375661|P1|Overall Study|Adverse Event|4
741362|NCT00370552|2375688|P3|Overall Study|Planned radiation for palliation|0
741363|NCT00370552|2375689|P2|Overall Study|Planned radiation for palliation|1
741364|NCT00370552|2375690|P1|Overall Study|Planned radiation for palliation|0
741365|NCT00370552|2375688|P3|Overall Study|High risk of allergic reaction|0
741366|NCT00370552|2375689|P2|Overall Study|High risk of allergic reaction|1
741367|NCT00370552|2375690|P1|Overall Study|High risk of allergic reaction|0
741368|NCT00370552|2375688|P3|Overall Study|Investigator decision|0
741369|NCT00370552|2375689|P2|Overall Study|Investigator decision|1
741370|NCT00370552|2375690|P1|Overall Study|Investigator decision|2
741371|NCT00370552|2375688|P3|Overall Study|Physician Decision|0
741372|NCT00370552|2375689|P2|Overall Study|Physician Decision|1
741373|NCT00370552|2375690|P1|Overall Study|Physician Decision|1
741374|NCT00370552|2375688|P3|Overall Study|Never treated|0
741375|NCT00370552|2375689|P2|Overall Study|Never treated|0
741376|NCT00370552|2375690|P1|Overall Study|Never treated|1
741377|NCT00370552|2375688|P3|Overall Study|Still on treatment|2
741378|NCT00370552|2375689|P2|Overall Study|Still on treatment|3
741379|NCT00370552|2375690|P1|Overall Study|Still on treatment|1
741380|NCT00370552|2375688|P3|Overall Study|Withdrawal by Subject|1
741381|NCT00370552|2375689|P2|Overall Study|Withdrawal by Subject|0
741382|NCT00370552|2375690|P1|Overall Study|Withdrawal by Subject|2
741383|NCT00370552|2375688|P3|Overall Study|Study drug toxicity|6
741384|NCT00370552|2375689|P2|Overall Study|Study drug toxicity|8
741385|NCT00370552|2375690|P1|Overall Study|Study drug toxicity|11
741386|NCT00370552|2375688|P3|Overall Study|Poor or noncompliance|1
741387|NCT00370552|2375689|P2|Overall Study|Poor or noncompliance|0
741388|NCT00370552|2375690|P1|Overall Study|Poor or noncompliance|0
741389|NCT00370552|2375688|P3|Overall Study|Maximum clinical benefit|5
741390|NCT00370552|2375689|P2|Overall Study|Maximum clinical benefit|5
741391|NCT00370552|2375690|P1|Overall Study|Maximum clinical benefit|3
741392|NCT00370552|2375688|P3|Overall Study|Disease progression|15
741393|NCT00370552|2375689|P2|Overall Study|Disease progression|23
741394|NCT00370552|2375690|P1|Overall Study|Disease progression|23
741395|NCT00370552|2375688|P3|Overall Study|Adverse Event|2
741396|NCT00370552|2375689|P2|Overall Study|Adverse Event|2
741397|NCT00370552|2375690|P1|Overall Study|Adverse Event|2
741398|NCT00370682|2375731|P3|Overall Study|Lost to Follow-up|1
741399|NCT00370682|2375732|P2|Overall Study|Lost to Follow-up|1
741400|NCT00370682|2375733|P1|Overall Study|Lost to Follow-up|0
741401|NCT00370682|2375731|P3|Overall Study|Moved from area|0
741402|NCT00370682|2375732|P2|Overall Study|Moved from area|2
741403|NCT00370682|2375733|P1|Overall Study|Moved from area|0
741404|NCT00371137|2375807|P3|Overall Study|Protocol Violation|1
741405|NCT00371137|2375808|P2|Overall Study|Protocol Violation|1
741406|NCT00371137|2375809|P1|Overall Study|Protocol Violation|2
741407|NCT00371137|2375807|P3|Overall Study|Physician Decision|1
741408|NCT00371137|2375808|P2|Overall Study|Physician Decision|1
741409|NCT00371137|2375809|P1|Overall Study|Physician Decision|1
741410|NCT00371137|2375807|P3|Overall Study|Sponsor Decision|2
741411|NCT00371137|2375808|P2|Overall Study|Sponsor Decision|1
741412|NCT00371137|2375809|P1|Overall Study|Sponsor Decision|2
741413|NCT00371137|2375807|P3|Overall Study|Lack of Efficacy|13
741414|NCT00371137|2375808|P2|Overall Study|Lack of Efficacy|12
741415|NCT00371137|2375809|P1|Overall Study|Lack of Efficacy|30
741416|NCT00371137|2375807|P3|Overall Study|Lost to Follow-up|5
741417|NCT00371137|2375808|P2|Overall Study|Lost to Follow-up|3
741418|NCT00371137|2375809|P1|Overall Study|Lost to Follow-up|6
741419|NCT00371137|2375807|P3|Overall Study|Withdrawal by Subject|15
741420|NCT00371137|2375808|P2|Overall Study|Withdrawal by Subject|10
741421|NCT00371137|2375809|P1|Overall Study|Withdrawal by Subject|11
741422|NCT00371137|2375807|P3|Overall Study|Adverse Event|42
741423|NCT00371137|2375808|P2|Overall Study|Adverse Event|35
741424|NCT00371137|2375809|P1|Overall Study|Adverse Event|20
741425|NCT00371150|2375819|P2|Overall Study|Lost to Follow-up|2
741426|NCT00371150|2375820|P1|Overall Study|Lost to Follow-up|3
741427|NCT00371254|2375885|P2|Overall Study|Withdrawal by Subject|1
741428|NCT00371254|2375886|P1|Overall Study|Withdrawal by Subject|0
741429|NCT00371254|2375885|P2|Overall Study|Lost to Follow-up|1
741430|NCT00371254|2375886|P1|Overall Study|Lost to Follow-up|0
741431|NCT00371254|2375885|P2|Overall Study|Adverse event unrelated to study drug|1
741432|NCT00371254|2375886|P1|Overall Study|Adverse event unrelated to study drug|0
741433|NCT00371254|2375885|P2|Overall Study|Investigator Decision|0
741434|NCT00371254|2375886|P1|Overall Study|Investigator Decision|2
741435|NCT00371254|2375885|P2|Overall Study|Subject request|0
741436|NCT00371254|2375886|P1|Overall Study|Subject request|5
741437|NCT00371254|2375885|P2|Overall Study|Study drug toxicity|5
741438|NCT00371254|2375886|P1|Overall Study|Study drug toxicity|3
741439|NCT00371254|2375885|P2|Overall Study|Disease progression|13
741440|NCT00371254|2375886|P1|Overall Study|Disease progression|13
741441|NCT00371345|2375980|P2|Overall Study|Participant Withdrew Consent|1
741442|NCT00371345|2375981|P1|Overall Study|Participant Withdrew Consent|0
741443|NCT00371345|2375980|P2|Overall Study|Participant Request|1
741444|NCT00371345|2375981|P1|Overall Study|Participant Request|1
741445|NCT00371345|2375980|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
741446|NCT00371345|2375981|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
741447|NCT00371345|2375980|P2|Overall Study|Study Drug Toxicity|7
741448|NCT00371345|2375981|P1|Overall Study|Study Drug Toxicity|1
741449|NCT00371345|2375980|P2|Overall Study|Disease Progression|35
741450|NCT00371345|2375981|P1|Overall Study|Disease Progression|21
741451|NCT00371397|2376038|P12|Session 1|Withdrawal by Subject|0
741452|NCT00371397|2376039|P11|Session 1|Withdrawal by Subject|0
741453|NCT00371397|2376040|P10|Session 1|Withdrawal by Subject|0
741454|NCT00371397|2376041|P9|Session 1|Withdrawal by Subject|0
741455|NCT00371397|2376042|P8|Session 1|Withdrawal by Subject|1
741456|NCT00371397|2376043|P7|Session 1|Withdrawal by Subject|0
741457|NCT00371397|2376044|P6|Session 1|Withdrawal by Subject|0
741458|NCT00371397|2376045|P5|Session 1|Withdrawal by Subject|0
741459|NCT00371397|2376046|P4|Session 1|Withdrawal by Subject|0
741460|NCT00371397|2376047|P3|Session 1|Withdrawal by Subject|0
741461|NCT00371397|2376048|P2|Session 1|Withdrawal by Subject|0
741462|NCT00371397|2376049|P1|Session 1|Withdrawal by Subject|1
741463|NCT00371462|2376075|P2|Overall Study|Other|8
741464|NCT00371462|2376076|P1|Overall Study|Other|7
741465|NCT00371462|2376075|P2|Overall Study|Withdrawal by Subject|0
741466|NCT00371462|2376076|P1|Overall Study|Withdrawal by Subject|1
741467|NCT00371566|2376097|P2|Follow Up Phase|Lost to Follow-up|0
741468|NCT00371566|2376098|P1|Follow Up Phase|Lost to Follow-up|1
741469|NCT00371566|2376097|P2|Follow Up Phase|Physician Decision|1
741470|NCT00371566|2376098|P1|Follow Up Phase|Physician Decision|1
741471|NCT00371566|2376097|P2|Follow Up Phase|Withdrawal by Subject|1
741472|NCT00371566|2376098|P1|Follow Up Phase|Withdrawal by Subject|0
741473|NCT00371566|2376097|P2|Follow Up Phase|Disease progression|0
741474|NCT00371566|2376098|P1|Follow Up Phase|Disease progression|1
741475|NCT00371566|2376097|P2|Follow Up Phase|Death|5
741476|NCT00371566|2376098|P1|Follow Up Phase|Death|0
741477|NCT00371566|2376097|P2|Chemoradiation Phase|Death|0
741478|NCT00371566|2376098|P1|Chemoradiation Phase|Death|2
741479|NCT00371566|2376097|P2|Chemoradiation Phase|Progressive Disease|1
741480|NCT00371566|2376098|P1|Chemoradiation Phase|Progressive Disease|1
741481|NCT00371566|2376097|P2|Chemoradiation Phase|Non compliant|1
741482|NCT00371566|2376098|P1|Chemoradiation Phase|Non compliant|0
741483|NCT00371566|2376097|P2|Chemoradiation Phase|Withdrawal by Subject|1
741484|NCT00371566|2376098|P1|Chemoradiation Phase|Withdrawal by Subject|0
741485|NCT00371566|2376097|P2|Chemoradiation Phase|Physician Decision|0
741486|NCT00371566|2376098|P1|Chemoradiation Phase|Physician Decision|2
741487|NCT00371566|2376097|P2|Treatment Phase|Protocol Violation|1
741488|NCT00371566|2376098|P1|Treatment Phase|Protocol Violation|0
741489|NCT00371566|2376097|P2|Treatment Phase|Adverse Event|1
741490|NCT00371566|2376098|P1|Treatment Phase|Adverse Event|0
741491|NCT00371566|2376097|P2|Treatment Phase|Withdrawal by Subject|1
741492|NCT00371566|2376098|P1|Treatment Phase|Withdrawal by Subject|0
741493|NCT00371683|2376184|P2|Follow-Up Period - Randomized Patients|non-specified|12
741494|NCT00371683|2376185|P1|Follow-Up Period - Randomized Patients|non-specified|6
741495|NCT00371683|2376184|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
741496|NCT00371683|2376185|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
741497|NCT00371683|2376184|P2|Follow-Up Period - Randomized Patients|Death|2
741498|NCT00371683|2376185|P1|Follow-Up Period - Randomized Patients|Death|0
741499|NCT00371683|2376184|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
741500|NCT00371683|2376185|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
741501|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|non-specified|8
741502|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|non-specified|9
741503|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
741504|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
741505|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
741506|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
741507|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
741508|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
741509|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
741510|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
741511|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
741512|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
741513|NCT00371683|2376184|P2|DB Treatment Period-Randomized Patients|Death|1
741514|NCT00371683|2376185|P1|DB Treatment Period-Randomized Patients|Death|1
741515|NCT00371761|2376239|P2|Overall Study|Study termination|3
741516|NCT00371761|2376240|P1|Overall Study|Study termination|4
741517|NCT00371761|2376239|P2|Overall Study|Investigator Judgment|3
741518|NCT00371761|2376240|P1|Overall Study|Investigator Judgment|2
741519|NCT00371761|2376239|P2|Overall Study|Withdrawal by Subject|3
741520|NCT00371761|2376240|P1|Overall Study|Withdrawal by Subject|1
741521|NCT00371761|2376239|P2|Overall Study|Adverse Event|1
741522|NCT00371761|2376240|P1|Overall Study|Adverse Event|1
741523|NCT00371787|2376248|P2|Overall Study|Withdrawal by Subject|1
741524|NCT00371787|2376249|P1|Overall Study|Withdrawal by Subject|3
741525|NCT00371826|2376264|P3|Extension Phase (24 Months)|Administrative problems|2
741526|NCT00371826|2376265|P2|Extension Phase (24 Months)|Administrative problems|0
741527|NCT00371826|2376266|P1|Extension Phase (24 Months)|Administrative problems|0
741528|NCT00371826|2376264|P3|Extension Phase (24 Months)|Subject withdrew consent|0
741529|NCT00371826|2376265|P2|Extension Phase (24 Months)|Subject withdrew consent|2
741530|NCT00371826|2376266|P1|Extension Phase (24 Months)|Subject withdrew consent|1
741531|NCT00371826|2376264|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
741532|NCT00371826|2376265|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
741533|NCT00371826|2376266|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
741534|NCT00371826|2376264|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
741535|NCT00371826|2376265|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
741536|NCT00371826|2376266|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
741537|NCT00371826|2376264|P3|Extension Phase (24 Months)|Adverse Event|0
741538|NCT00371826|2376265|P2|Extension Phase (24 Months)|Adverse Event|5
741539|NCT00371826|2376266|P1|Extension Phase (24 Months)|Adverse Event|4
741540|NCT00371826|2376264|P3|Core Phase (12 Months)|Graft Loss|0
741541|NCT00371826|2376265|P2|Core Phase (12 Months)|Graft Loss|1
741542|NCT00371826|2376266|P1|Core Phase (12 Months)|Graft Loss|0
741543|NCT00371826|2376264|P3|Core Phase (12 Months)|Administrative problems|8
741544|NCT00371826|2376265|P2|Core Phase (12 Months)|Administrative problems|0
741545|NCT00371826|2376266|P1|Core Phase (12 Months)|Administrative problems|1
741546|NCT00371826|2376264|P3|Core Phase (12 Months)|Subject withdrew consent|3
741547|NCT00371826|2376265|P2|Core Phase (12 Months)|Subject withdrew consent|0
741548|NCT00371826|2376266|P1|Core Phase (12 Months)|Subject withdrew consent|0
741549|NCT00371826|2376264|P3|Core Phase (12 Months)|Protocol Violation|1
741550|NCT00371826|2376265|P2|Core Phase (12 Months)|Protocol Violation|0
741551|NCT00371826|2376266|P1|Core Phase (12 Months)|Protocol Violation|1
741552|NCT00371826|2376264|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
741553|NCT00371826|2376265|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
741554|NCT00371826|2376266|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
741555|NCT00371826|2376264|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
741556|NCT00371826|2376265|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
741557|NCT00371826|2376266|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
741558|NCT00371826|2376264|P3|Core Phase (12 Months)|Adverse Event|9
741559|NCT00371826|2376265|P2|Core Phase (12 Months)|Adverse Event|4
741560|NCT00371826|2376266|P1|Core Phase (12 Months)|Adverse Event|15
741561|NCT00377637|2376392|P4|Maintenance Phase|Death|1
741562|NCT00377637|2376393|P3|Maintenance Phase|Death|0
741563|NCT00377637|2376394|P2|Maintenance Phase|Death|0
741564|NCT00377637|2376395|P1|Maintenance Phase|Death|0
741565|NCT00377637|2376392|P4|Maintenance Phase|Study medication stopped > 14 days|1
741566|NCT00377637|2376393|P3|Maintenance Phase|Study medication stopped > 14 days|0
741567|NCT00377637|2376394|P2|Maintenance Phase|Study medication stopped > 14 days|0
741568|NCT00377637|2376395|P1|Maintenance Phase|Study medication stopped > 14 days|0
741569|NCT00377637|2376392|P4|Maintenance Phase|Non-compliance|1
741570|NCT00377637|2376393|P3|Maintenance Phase|Non-compliance|1
741571|NCT00377637|2376394|P2|Maintenance Phase|Non-compliance|0
741572|NCT00377637|2376395|P1|Maintenance Phase|Non-compliance|0
741573|NCT00377637|2376392|P4|Maintenance Phase|Sponsor decision|3
741574|NCT00377637|2376393|P3|Maintenance Phase|Sponsor decision|2
741575|NCT00377637|2376394|P2|Maintenance Phase|Sponsor decision|0
741576|NCT00377637|2376395|P1|Maintenance Phase|Sponsor decision|0
741577|NCT00377637|2376392|P4|Maintenance Phase|Withdrawal by Subject|3
741578|NCT00377637|2376393|P3|Maintenance Phase|Withdrawal by Subject|3
741579|NCT00377637|2376394|P2|Maintenance Phase|Withdrawal by Subject|0
741580|NCT00377637|2376395|P1|Maintenance Phase|Withdrawal by Subject|0
741581|NCT00377637|2376392|P4|Maintenance Phase|Lost to Follow-up|1
741582|NCT00377637|2376393|P3|Maintenance Phase|Lost to Follow-up|3
741583|NCT00377637|2376394|P2|Maintenance Phase|Lost to Follow-up|0
741584|NCT00377637|2376395|P1|Maintenance Phase|Lost to Follow-up|0
741585|NCT00377637|2376392|P4|Maintenance Phase|Physician Decision|4
741586|NCT00377637|2376393|P3|Maintenance Phase|Physician Decision|5
741587|NCT00377637|2376394|P2|Maintenance Phase|Physician Decision|0
741588|NCT00377637|2376395|P1|Maintenance Phase|Physician Decision|0
741589|NCT00377637|2376392|P4|Maintenance Phase|Adverse Event|43
741590|NCT00377637|2376393|P3|Maintenance Phase|Adverse Event|29
741591|NCT00377637|2376394|P2|Maintenance Phase|Adverse Event|0
741592|NCT00377637|2376395|P1|Maintenance Phase|Adverse Event|0
741593|NCT00377637|2376392|P4|Induction Phase|Reason for withdrawal is not noted|0
741594|NCT00377637|2376393|P3|Induction Phase|Reason for withdrawal is not noted|0
741595|NCT00377637|2376394|P2|Induction Phase|Reason for withdrawal is not noted|0
741596|NCT00377637|2376395|P1|Induction Phase|Reason for withdrawal is not noted|2
741597|NCT00377637|2376392|P4|Induction Phase|Non-Compliance|0
741598|NCT00377637|2376393|P3|Induction Phase|Non-Compliance|0
741599|NCT00377637|2376394|P2|Induction Phase|Non-Compliance|0
741600|NCT00377637|2376395|P1|Induction Phase|Non-Compliance|1
741601|NCT00377637|2376392|P4|Induction Phase|Sponsor decision|0
741602|NCT00377637|2376393|P3|Induction Phase|Sponsor decision|0
741603|NCT00377637|2376394|P2|Induction Phase|Sponsor decision|2
741604|NCT00377637|2376395|P1|Induction Phase|Sponsor decision|1
741605|NCT00377637|2376392|P4|Induction Phase|Physician Decision|0
741606|NCT00377637|2376393|P3|Induction Phase|Physician Decision|0
741607|NCT00377637|2376394|P2|Induction Phase|Physician Decision|1
741608|NCT00377637|2376395|P1|Induction Phase|Physician Decision|3
741609|NCT00377637|2376392|P4|Induction Phase|Withdrawal by Subject|0
741610|NCT00377637|2376393|P3|Induction Phase|Withdrawal by Subject|0
741611|NCT00377637|2376394|P2|Induction Phase|Withdrawal by Subject|6
741612|NCT00377637|2376395|P1|Induction Phase|Withdrawal by Subject|5
741613|NCT00377637|2376392|P4|Induction Phase|Death|0
741614|NCT00377637|2376393|P3|Induction Phase|Death|0
741615|NCT00377637|2376394|P2|Induction Phase|Death|3
741616|NCT00377637|2376395|P1|Induction Phase|Death|1
741617|NCT00377637|2376392|P4|Induction Phase|Lost to Follow-up|0
741618|NCT00377637|2376393|P3|Induction Phase|Lost to Follow-up|0
741619|NCT00377637|2376394|P2|Induction Phase|Lost to Follow-up|1
741620|NCT00377637|2376395|P1|Induction Phase|Lost to Follow-up|2
741621|NCT00377637|2376392|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
741622|NCT00377637|2376393|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
741623|NCT00377637|2376394|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
741624|NCT00377637|2376395|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
741625|NCT00377637|2376392|P4|Induction Phase|Deterioration/serum creatinine|0
741626|NCT00377637|2376393|P3|Induction Phase|Deterioration/serum creatinine|0
741627|NCT00377637|2376394|P2|Induction Phase|Deterioration/serum creatinine|0
741628|NCT00377637|2376395|P1|Induction Phase|Deterioration/serum creatinine|2
741629|NCT00377637|2376392|P4|Induction Phase|Adverse Event|0
741630|NCT00377637|2376393|P3|Induction Phase|Adverse Event|0
741631|NCT00377637|2376394|P2|Induction Phase|Adverse Event|21
741632|NCT00377637|2376395|P1|Induction Phase|Adverse Event|12
741633|NCT00377676|2376431|P2|Overall Study|not specified|58
741634|NCT00377676|2376432|P1|Overall Study|not specified|118
741635|NCT00377676|2376431|P2|Overall Study|Lost to Follow-up|56
741636|NCT00377676|2376432|P1|Overall Study|Lost to Follow-up|120
741637|NCT00377676|2376431|P2|Overall Study|Withdrawal by Subject|72
741638|NCT00377676|2376432|P1|Overall Study|Withdrawal by Subject|187
741639|NCT00377676|2376431|P2|Overall Study|Death|2
741640|NCT00377676|2376432|P1|Overall Study|Death|5
741641|NCT00377676|2376431|P2|Overall Study|Protocol Violation|27
741642|NCT00377676|2376432|P1|Overall Study|Protocol Violation|33
741643|NCT00377676|2376431|P2|Overall Study|Adverse Event|107
741644|NCT00377676|2376432|P1|Overall Study|Adverse Event|498
741645|NCT00377819|2376463|P2|Overall Study|Protocol Violation|1
741646|NCT00377819|2376464|P1|Overall Study|Protocol Violation|1
741647|NCT00377819|2376463|P2|Overall Study|Lost to Follow-up|1
741648|NCT00377819|2376464|P1|Overall Study|Lost to Follow-up|0
741649|NCT00377819|2376463|P2|Overall Study|Death|1
741650|NCT00377819|2376464|P1|Overall Study|Death|0
741651|NCT00377819|2376463|P2|Overall Study|Withdrawal by Subject|4
741652|NCT00377819|2376464|P1|Overall Study|Withdrawal by Subject|10
741653|NCT00377819|2376463|P2|Overall Study|Adverse Event|3
741654|NCT00377819|2376464|P1|Overall Study|Adverse Event|2
741655|NCT00377858|2376499|P2|Overall Study|Death|3
741656|NCT00377858|2376500|P1|Overall Study|Death|0
741657|NCT00377858|2376499|P2|Overall Study|Sponsor Decision|2
741658|NCT00377858|2376500|P1|Overall Study|Sponsor Decision|1
741659|NCT00377858|2376499|P2|Overall Study|Entry Criteria Not Met|0
741660|NCT00377858|2376500|P1|Overall Study|Entry Criteria Not Met|2
741661|NCT00377858|2376499|P2|Overall Study|Adverse Event|1
741662|NCT00377858|2376500|P1|Overall Study|Adverse Event|2
741663|NCT00377858|2376499|P2|Overall Study|Protocol Violation|4
741664|NCT00377858|2376500|P1|Overall Study|Protocol Violation|3
741665|NCT00377858|2376499|P2|Overall Study|Physician Decision|5
741666|NCT00377858|2376500|P1|Overall Study|Physician Decision|5
741667|NCT00377858|2376499|P2|Overall Study|Lost to Follow-up|1
741668|NCT00377858|2376500|P1|Overall Study|Lost to Follow-up|6
741669|NCT00377858|2376499|P2|Overall Study|Withdrawal by Subject|11
741670|NCT00377858|2376500|P1|Overall Study|Withdrawal by Subject|12
741671|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
741672|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
741673|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
741674|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
741675|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
741676|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
741677|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Administrative problems|0
741678|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Administrative problems|1
741679|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Death|2
741680|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Death|1
741681|NCT00378014|2376530|P2|Extension (Month 12 to Month 59)|Adverse Event|7
741682|NCT00378014|2376531|P1|Extension (Month 12 to Month 59)|Adverse Event|8
741683|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
741684|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
741685|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Protocol deviation|1
741686|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Protocol deviation|0
741687|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
741688|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
741689|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
741690|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
741691|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Administrative Problems|2
741692|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Administrative Problems|2
741693|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Death|3
741694|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Death|5
741695|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Graft loss|2
741696|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Graft loss|1
741697|NCT00378014|2376530|P2|Core (Randomization to Month 11)|Adverse Event|0
741698|NCT00378014|2376531|P1|Core (Randomization to Month 11)|Adverse Event|1
741699|NCT00378079|2376558|P3|Overall Study|Lost to Follow-up|0
741700|NCT00378079|2376559|P2|Overall Study|Lost to Follow-up|1
741701|NCT00378079|2376560|P1|Overall Study|Lost to Follow-up|6
741702|NCT00378105|2376582|P2|Overall Study|necessity to increase lenalidomide dose|1
741703|NCT00378105|2376583|P1|Overall Study|necessity to increase lenalidomide dose|0
741704|NCT00378105|2376582|P2|Overall Study|Going non-protocol therapy|1
741705|NCT00378105|2376583|P1|Overall Study|Going non-protocol therapy|0
741706|NCT00378105|2376582|P2|Overall Study|Physician Decision|2
741707|NCT00378105|2376583|P1|Overall Study|Physician Decision|0
741708|NCT00378105|2376582|P2|Overall Study|remain on study|11
741709|NCT00378105|2376583|P1|Overall Study|remain on study|3
741710|NCT00378105|2376582|P2|Overall Study|Progressive disease|3
741711|NCT00378105|2376583|P1|Overall Study|Progressive disease|3
741712|NCT00378105|2376582|P2|Overall Study|Going to transplant|8
741713|NCT00378105|2376583|P1|Overall Study|Going to transplant|7
741714|NCT00378105|2376582|P2|Overall Study|Death|0
741715|NCT00378105|2376583|P1|Overall Study|Death|1
741716|NCT00378105|2376582|P2|Overall Study|Withdrawal by Subject|3
741717|NCT00378105|2376583|P1|Overall Study|Withdrawal by Subject|3
741718|NCT00378105|2376582|P2|Overall Study|Adverse Event|1
741719|NCT00378105|2376583|P1|Overall Study|Adverse Event|3
741720|NCT00378209|2376592|P1|Overall Study|Treatment delay|1
741721|NCT00378209|2376592|P1|Overall Study|Death|1
741722|NCT00378209|2376592|P1|Overall Study|Physician Decision|3
741723|NCT00378209|2376592|P1|Overall Study|Initiation of non-protocol therapy|3
741724|NCT00378209|2376592|P1|Overall Study|Adverse Event|3
741725|NCT00378209|2376592|P1|Overall Study|Progressive disease|11
741726|NCT00378378|2376638|P3|Overall Study|Non-compliance with protocol|1
741727|NCT00378378|2376639|P2|Overall Study|Non-compliance with protocol|0
741728|NCT00378378|2376640|P1|Overall Study|Non-compliance with protocol|0
741729|NCT00378378|2376638|P3|Overall Study|Treatment Failure|1
741730|NCT00378378|2376639|P2|Overall Study|Treatment Failure|0
741731|NCT00378378|2376640|P1|Overall Study|Treatment Failure|0
741732|NCT00378378|2376638|P3|Overall Study|Withdrawal by Subject|0
741733|NCT00378378|2376639|P2|Overall Study|Withdrawal by Subject|1
741734|NCT00378378|2376640|P1|Overall Study|Withdrawal by Subject|0
741735|NCT00378508|2376653|P2|Overall Study|Lost to Follow-up|0
741736|NCT00378508|2376654|P1|Overall Study|Lost to Follow-up|1
741737|NCT00378508|2376653|P2|Overall Study|Withdrawal by Subject|3
741738|NCT00378508|2376654|P1|Overall Study|Withdrawal by Subject|1
741739|NCT00378534|2376670|P1|Overall Study|Subjects did not receive a transplant|3
741740|NCT00378534|2376670|P1|Overall Study|Donors|57
741741|NCT00378560|2376676|P2|Overall Study|Laboratory test values abnormal|0
741742|NCT00378560|2376677|P1|Overall Study|Laboratory test values abnormal|1
741743|NCT00378560|2376676|P2|Overall Study|Pregnancy|5
741744|NCT00378560|2376677|P1|Overall Study|Pregnancy|7
741745|NCT00378560|2376676|P2|Overall Study|Moved|3
741746|NCT00378560|2376677|P1|Overall Study|Moved|4
741747|NCT00378560|2376676|P2|Overall Study|Withdrawal by Subject|21
741748|NCT00378560|2376677|P1|Overall Study|Withdrawal by Subject|17
741749|NCT00378560|2376676|P2|Overall Study|Protocol Violation|0
741750|NCT00378560|2376677|P1|Overall Study|Protocol Violation|2
741751|NCT00378560|2376676|P2|Overall Study|Lost to Follow-up|29
741752|NCT00378560|2376677|P1|Overall Study|Lost to Follow-up|24
741753|NCT00378560|2376676|P2|Overall Study|Adverse Event|0
741754|NCT00378560|2376677|P1|Overall Study|Adverse Event|1
741755|NCT00378573|2376691|P1|Follow-up|Withdrawal by Subject|1
741756|NCT00378573|2376691|P1|Follow-up|Lost to Follow-up|1
741757|NCT00378573|2376691|P1|Follow-up|Death|12
741758|NCT00378573|2376691|P1|Treatment Period|Sponsor decision to close study|1
741759|NCT00378573|2376691|P1|Treatment Period|Disease Progression|4
741760|NCT00378573|2376691|P1|Treatment Period|Withdrawal by Subject|2
741761|NCT00378573|2376691|P1|Treatment Period|Physician Decision|1
741762|NCT00378573|2376691|P1|Treatment Period|Adverse Event|9
741763|NCT00378599|2376697|P1|Overall Study|Withdrawal by Subject|5
741764|NCT00378599|2376697|P1|Overall Study|Treatment failure|7
741765|NCT00378599|2376697|P1|Overall Study|Protocol Violation|2
741766|NCT00378599|2376697|P1|Overall Study|Adverse Event|38
741767|NCT00378703|2376705|P4|Overall Study|Other|3
741768|NCT00378703|2376706|P3|Overall Study|Other|2
741769|NCT00378703|2376707|P2|Overall Study|Other|1
741770|NCT00378703|2376708|P1|Overall Study|Other|1
741771|NCT00378703|2376705|P4|Overall Study|Never started treatment|0
741772|NCT00378703|2376706|P3|Overall Study|Never started treatment|0
741773|NCT00378703|2376707|P2|Overall Study|Never started treatment|4
741774|NCT00378703|2376708|P1|Overall Study|Never started treatment|1
741775|NCT00378703|2376705|P4|Overall Study|Ineligible|7
741776|NCT00378703|2376706|P3|Overall Study|Ineligible|7
741777|NCT00378703|2376707|P2|Overall Study|Ineligible|7
741778|NCT00378703|2376708|P1|Overall Study|Ineligible|4
741779|NCT00378703|2376705|P4|Overall Study|Relocation|0
741780|NCT00378703|2376706|P3|Overall Study|Relocation|1
741781|NCT00378703|2376707|P2|Overall Study|Relocation|0
741782|NCT00378703|2376708|P1|Overall Study|Relocation|0
741783|NCT00378703|2376705|P4|Overall Study|Adverse events and progressive disease|1
741784|NCT00378703|2376706|P3|Overall Study|Adverse events and progressive disease|0
741785|NCT00378703|2376707|P2|Overall Study|Adverse events and progressive disease|0
741786|NCT00378703|2376708|P1|Overall Study|Adverse events and progressive disease|0
741787|NCT00378703|2376705|P4|Overall Study|Joint decision of physician and patient|0
741788|NCT00378703|2376706|P3|Overall Study|Joint decision of physician and patient|0
741789|NCT00378703|2376707|P2|Overall Study|Joint decision of physician and patient|0
741790|NCT00378703|2376708|P1|Overall Study|Joint decision of physician and patient|1
741791|NCT00378703|2376705|P4|Overall Study|Surgery|1
741792|NCT00378703|2376706|P3|Overall Study|Surgery|0
741793|NCT00378703|2376707|P2|Overall Study|Surgery|0
741794|NCT00378703|2376708|P1|Overall Study|Surgery|1
741795|NCT00378703|2376705|P4|Overall Study|Symptomatic deterioration|2
741796|NCT00378703|2376706|P3|Overall Study|Symptomatic deterioration|0
741797|NCT00378703|2376707|P2|Overall Study|Symptomatic deterioration|1
741798|NCT00378703|2376708|P1|Overall Study|Symptomatic deterioration|0
741799|NCT00378703|2376705|P4|Overall Study|Other complicated disease|0
741800|NCT00378703|2376706|P3|Overall Study|Other complicated disease|2
741801|NCT00378703|2376707|P2|Overall Study|Other complicated disease|2
741802|NCT00378703|2376708|P1|Overall Study|Other complicated disease|0
741803|NCT00378703|2376705|P4|Overall Study|Alternative therapy|0
741804|NCT00378703|2376706|P3|Overall Study|Alternative therapy|0
741805|NCT00378703|2376707|P2|Overall Study|Alternative therapy|2
741806|NCT00378703|2376708|P1|Overall Study|Alternative therapy|4
741807|NCT00378703|2376705|P4|Overall Study|Physician Decision|0
741808|NCT00378703|2376706|P3|Overall Study|Physician Decision|1
741809|NCT00378703|2376707|P2|Overall Study|Physician Decision|4
741810|NCT00378703|2376708|P1|Overall Study|Physician Decision|1
741811|NCT00378703|2376705|P4|Overall Study|Withdrawal by Subject|7
741812|NCT00378703|2376706|P3|Overall Study|Withdrawal by Subject|5
741813|NCT00378703|2376707|P2|Overall Study|Withdrawal by Subject|8
741814|NCT00378703|2376708|P1|Overall Study|Withdrawal by Subject|4
741815|NCT00378703|2376705|P4|Overall Study|Death|3
741816|NCT00378703|2376706|P3|Overall Study|Death|4
741817|NCT00378703|2376707|P2|Overall Study|Death|2
741818|NCT00378703|2376708|P1|Overall Study|Death|2
741819|NCT00378703|2376705|P4|Overall Study|Adverse Event|18
741820|NCT00378703|2376706|P3|Overall Study|Adverse Event|20
741821|NCT00378703|2376707|P2|Overall Study|Adverse Event|17
741822|NCT00378703|2376708|P1|Overall Study|Adverse Event|11
741823|NCT00378703|2376705|P4|Overall Study|Disease progression|49
741824|NCT00378703|2376706|P3|Overall Study|Disease progression|48
741825|NCT00378703|2376707|P2|Overall Study|Disease progression|43
741826|NCT00378703|2376708|P1|Overall Study|Disease progression|59
741827|NCT00378898|2376732|P2|Overall Study|Protocol Violation|1
741828|NCT00378898|2376733|P1|Overall Study|Protocol Violation|1
741829|NCT00378898|2376732|P2|Overall Study|Withdrawal by Subject|5
741830|NCT00378898|2376733|P1|Overall Study|Withdrawal by Subject|10
741831|NCT00379080|2376744|P3|Overall Study|Withdrawal by Subject|0
741832|NCT00379080|2376745|P2|Overall Study|Withdrawal by Subject|4
741833|NCT00379080|2376746|P1|Overall Study|Withdrawal by Subject|0
741834|NCT00379210|2376796|P2|Overall Study|Withdrawal by Subject|7
741835|NCT00379210|2376797|P1|Overall Study|Withdrawal by Subject|10
741836|NCT00379236|2376805|P3|Open-label Extension|Not specified|7
741837|NCT00379236|2376806|P2|Open-label Extension|Not specified|0
741838|NCT00379236|2376807|P1|Open-label Extension|Not specified|0
741839|NCT00379236|2376805|P3|Open-label Extension|Use of exclusionary medication|3
741840|NCT00379236|2376806|P2|Open-label Extension|Use of exclusionary medication|0
741841|NCT00379236|2376807|P1|Open-label Extension|Use of exclusionary medication|0
741842|NCT00379236|2376805|P3|Open-label Extension|Lost to Follow-up|12
741843|NCT00379236|2376806|P2|Open-label Extension|Lost to Follow-up|0
741844|NCT00379236|2376807|P1|Open-label Extension|Lost to Follow-up|0
741845|NCT00379236|2376805|P3|Open-label Extension|Withdrawal by Subject|13
741846|NCT00379236|2376806|P2|Open-label Extension|Withdrawal by Subject|0
741847|NCT00379236|2376807|P1|Open-label Extension|Withdrawal by Subject|0
741848|NCT00379236|2376805|P3|Open-label Extension|Protocol Violation|7
741849|NCT00379236|2376806|P2|Open-label Extension|Protocol Violation|0
741850|NCT00379236|2376807|P1|Open-label Extension|Protocol Violation|0
741851|NCT00379236|2376805|P3|Open-label Extension|Adverse Event|13
741852|NCT00379236|2376806|P2|Open-label Extension|Adverse Event|0
741853|NCT00379236|2376807|P1|Open-label Extension|Adverse Event|0
741854|NCT00379236|2376805|P3|Double-blind|Data could not be retrieved|0
741855|NCT00379236|2376806|P2|Double-blind|Data could not be retrieved|2
741856|NCT00379236|2376807|P1|Double-blind|Data could not be retrieved|2
741857|NCT00379236|2376805|P3|Double-blind|Not specified|0
741858|NCT00379236|2376806|P2|Double-blind|Not specified|7
741859|NCT00379236|2376807|P1|Double-blind|Not specified|3
741860|NCT00379236|2376805|P3|Double-blind|Use of exclusionary medication|0
741861|NCT00379236|2376806|P2|Double-blind|Use of exclusionary medication|2
741862|NCT00379236|2376807|P1|Double-blind|Use of exclusionary medication|1
741863|NCT00379236|2376805|P3|Double-blind|Lost to Follow-up|0
741864|NCT00379236|2376806|P2|Double-blind|Lost to Follow-up|3
741865|NCT00379236|2376807|P1|Double-blind|Lost to Follow-up|4
741866|NCT00379236|2376805|P3|Double-blind|Withdrawal by Subject|0
741867|NCT00379236|2376806|P2|Double-blind|Withdrawal by Subject|13
741868|NCT00379236|2376807|P1|Double-blind|Withdrawal by Subject|12
741869|NCT00379236|2376805|P3|Double-blind|Protocol Violation|0
741870|NCT00379236|2376806|P2|Double-blind|Protocol Violation|3
741871|NCT00379236|2376807|P1|Double-blind|Protocol Violation|3
741872|NCT00379236|2376805|P3|Double-blind|Adverse Event|0
741873|NCT00379236|2376806|P2|Double-blind|Adverse Event|6
741874|NCT00379236|2376807|P1|Double-blind|Adverse Event|11
741875|NCT00379288|2376854|P4|Overall Study|Administrative|1
741876|NCT00379288|2376855|P3|Overall Study|Administrative|0
741877|NCT00379288|2376856|P2|Overall Study|Administrative|2
741878|NCT00379288|2376857|P1|Overall Study|Administrative|2
741879|NCT00379288|2376854|P4|Overall Study|Did not meet protocol eligibility|2
741880|NCT00379288|2376855|P3|Overall Study|Did not meet protocol eligibility|0
741881|NCT00379288|2376856|P2|Overall Study|Did not meet protocol eligibility|1
741882|NCT00379288|2376857|P1|Overall Study|Did not meet protocol eligibility|0
741883|NCT00379288|2376854|P4|Overall Study|Noncompliance with protocol|1
741884|NCT00379288|2376855|P3|Overall Study|Noncompliance with protocol|2
741885|NCT00379288|2376856|P2|Overall Study|Noncompliance with protocol|6
741886|NCT00379288|2376857|P1|Overall Study|Noncompliance with protocol|8
741887|NCT00379288|2376854|P4|Overall Study|Subject withdrew-related to study drug|1
741888|NCT00379288|2376855|P3|Overall Study|Subject withdrew-related to study drug|0
741889|NCT00379288|2376856|P2|Overall Study|Subject withdrew-related to study drug|0
741890|NCT00379288|2376857|P1|Overall Study|Subject withdrew-related to study drug|1
741891|NCT00379288|2376854|P4|Overall Study|Subject withdrew-unrelated to study drug|2
741892|NCT00379288|2376855|P3|Overall Study|Subject withdrew-unrelated to study drug|4
741893|NCT00379288|2376856|P2|Overall Study|Subject withdrew-unrelated to study drug|3
741894|NCT00379288|2376857|P1|Overall Study|Subject withdrew-unrelated to study drug|0
741895|NCT00379288|2376854|P4|Overall Study|Lost to Follow-up|0
741896|NCT00379288|2376855|P3|Overall Study|Lost to Follow-up|2
741897|NCT00379288|2376856|P2|Overall Study|Lost to Follow-up|3
741898|NCT00379288|2376857|P1|Overall Study|Lost to Follow-up|3
741899|NCT00379288|2376854|P4|Overall Study|Treatment Failure|1
741900|NCT00379288|2376855|P3|Overall Study|Treatment Failure|0
741901|NCT00379288|2376856|P2|Overall Study|Treatment Failure|1
741902|NCT00379288|2376857|P1|Overall Study|Treatment Failure|0
741903|NCT00379288|2376854|P4|Overall Study|Adverse Event|0
741904|NCT00379288|2376855|P3|Overall Study|Adverse Event|2
741905|NCT00379288|2376856|P2|Overall Study|Adverse Event|6
741906|NCT00379288|2376857|P1|Overall Study|Adverse Event|5
741907|NCT00379340|2376872|P5|Overall Study|Delayed nephrectomy and anaplasia|1
741908|NCT00379340|2376873|P4|Overall Study|Delayed nephrectomy and anaplasia|1
741909|NCT00379340|2376874|P3|Overall Study|Delayed nephrectomy and anaplasia|0
741910|NCT00379340|2376875|P2|Overall Study|Delayed nephrectomy and anaplasia|0
741911|NCT00379340|2376876|P1|Overall Study|Delayed nephrectomy and anaplasia|0
741912|NCT00379340|2376872|P5|Overall Study|On more than 1 tumor therapeutic study|0
741913|NCT00379340|2376873|P4|Overall Study|On more than 1 tumor therapeutic study|2
741914|NCT00379340|2376874|P3|Overall Study|On more than 1 tumor therapeutic study|0
741915|NCT00379340|2376875|P2|Overall Study|On more than 1 tumor therapeutic study|0
741916|NCT00379340|2376876|P1|Overall Study|On more than 1 tumor therapeutic study|0
741917|NCT00379340|2376872|P5|Overall Study|Refusal of further protocol therapy|7
741918|NCT00379340|2376873|P4|Overall Study|Refusal of further protocol therapy|1
741919|NCT00379340|2376874|P3|Overall Study|Refusal of further protocol therapy|1
741920|NCT00379340|2376875|P2|Overall Study|Refusal of further protocol therapy|0
741921|NCT00379340|2376876|P1|Overall Study|Refusal of further protocol therapy|1
741922|NCT00379340|2376872|P5|Overall Study|Withdrawal by Subject|0
741923|NCT00379340|2376873|P4|Overall Study|Withdrawal by Subject|1
741924|NCT00379340|2376874|P3|Overall Study|Withdrawal by Subject|0
741925|NCT00379340|2376875|P2|Overall Study|Withdrawal by Subject|0
741926|NCT00379340|2376876|P1|Overall Study|Withdrawal by Subject|0
741927|NCT00379340|2376872|P5|Overall Study|Physician Decision|3
741928|NCT00379340|2376873|P4|Overall Study|Physician Decision|2
741929|NCT00379340|2376874|P3|Overall Study|Physician Decision|1
741930|NCT00379340|2376875|P2|Overall Study|Physician Decision|2
741931|NCT00379340|2376876|P1|Overall Study|Physician Decision|6
741932|NCT00379340|2376872|P5|Overall Study|Lack of Efficacy|3
741933|NCT00379340|2376873|P4|Overall Study|Lack of Efficacy|4
741934|NCT00379340|2376874|P3|Overall Study|Lack of Efficacy|0
741935|NCT00379340|2376875|P2|Overall Study|Lack of Efficacy|1
741936|NCT00379340|2376876|P1|Overall Study|Lack of Efficacy|6
741937|NCT00379340|2376872|P5|Overall Study|Death|0
741938|NCT00379340|2376873|P4|Overall Study|Death|2
741939|NCT00379340|2376874|P3|Overall Study|Death|0
741940|NCT00379340|2376875|P2|Overall Study|Death|0
741941|NCT00379340|2376876|P1|Overall Study|Death|0
741942|NCT00379353|2376891|P2|Overall Study|Conflicting drug treatment|1
741943|NCT00379353|2376892|P1|Overall Study|Conflicting drug treatment|0
741944|NCT00379353|2376891|P2|Overall Study|Non-compliance|0
741945|NCT00379353|2376892|P1|Overall Study|Non-compliance|1
741946|NCT00379353|2376891|P2|Overall Study|Cardiac Tamponade|0
741947|NCT00379353|2376892|P1|Overall Study|Cardiac Tamponade|1
741948|NCT00379353|2376891|P2|Overall Study|Death|0
741949|NCT00379353|2376892|P1|Overall Study|Death|1
741950|NCT00379353|2376891|P2|Overall Study|Withdrawal by Subject|2
741951|NCT00379353|2376892|P1|Overall Study|Withdrawal by Subject|5
741952|NCT00379353|2376891|P2|Overall Study|Hospitalization|3
741953|NCT00379353|2376892|P1|Overall Study|Hospitalization|3
741954|NCT00379587|2376927|P1|Overall Study|Lost to Follow-up|2
741955|NCT00379639|2376939|P5|Overall Study|Other|0
741956|NCT00379639|2376940|P4|Overall Study|Other|0
741957|NCT00379639|2376941|P3|Overall Study|Other|3
741958|NCT00379639|2376942|P2|Overall Study|Other|0
741959|NCT00379639|2376943|P1|Overall Study|Other|0
741960|NCT00379639|2376939|P5|Overall Study|Lost to Follow-up|0
741961|NCT00379639|2376940|P4|Overall Study|Lost to Follow-up|1
741962|NCT00379639|2376941|P3|Overall Study|Lost to Follow-up|0
741963|NCT00379639|2376942|P2|Overall Study|Lost to Follow-up|0
741964|NCT00379639|2376943|P1|Overall Study|Lost to Follow-up|0
741965|NCT00379639|2376939|P5|Overall Study|Adverse Event|1
741966|NCT00379639|2376940|P4|Overall Study|Adverse Event|0
741967|NCT00379639|2376941|P3|Overall Study|Adverse Event|1
741968|NCT00379639|2376942|P2|Overall Study|Adverse Event|0
741969|NCT00379639|2376943|P1|Overall Study|Adverse Event|0
741970|NCT00379639|2376939|P5|Overall Study|Symptomatic Deterioration|1
741971|NCT00379639|2376940|P4|Overall Study|Symptomatic Deterioration|0
741972|NCT00379639|2376941|P3|Overall Study|Symptomatic Deterioration|1
741973|NCT00379639|2376942|P2|Overall Study|Symptomatic Deterioration|0
741974|NCT00379639|2376943|P1|Overall Study|Symptomatic Deterioration|0
741975|NCT00379639|2376939|P5|Overall Study|Physician Decision|0
741976|NCT00379639|2376940|P4|Overall Study|Physician Decision|1
741977|NCT00379639|2376941|P3|Overall Study|Physician Decision|1
741978|NCT00379639|2376942|P2|Overall Study|Physician Decision|2
741979|NCT00379639|2376943|P1|Overall Study|Physician Decision|0
741980|NCT00379639|2376939|P5|Overall Study|Disease Progression|4
741981|NCT00379639|2376940|P4|Overall Study|Disease Progression|4
741982|NCT00379639|2376941|P3|Overall Study|Disease Progression|3
741983|NCT00379639|2376942|P2|Overall Study|Disease Progression|3
741984|NCT00379639|2376943|P1|Overall Study|Disease Progression|3
741985|NCT00379769|2376969|P6|Observational Follow-up|Unknown; Reason Not Provided|1
741986|NCT00379769|2376970|P5|Observational Follow-up|Unknown; Reason Not Provided|1
741987|NCT00379769|2376971|P4|Observational Follow-up|Unknown; Reason Not Provided|0
741988|NCT00379769|2376972|P3|Observational Follow-up|Unknown; Reason Not Provided|0
741989|NCT00379769|2376973|P2|Observational Follow-up|Unknown; Reason Not Provided|0
741990|NCT00379769|2376974|P1|Observational Follow-up|Unknown; Reason Not Provided|0
741991|NCT00379769|2376969|P6|Observational Follow-up|Participant Moved|1
741992|NCT00379769|2376970|P5|Observational Follow-up|Participant Moved|0
741993|NCT00379769|2376971|P4|Observational Follow-up|Participant Moved|0
741994|NCT00379769|2376972|P3|Observational Follow-up|Participant Moved|0
741995|NCT00379769|2376973|P2|Observational Follow-up|Participant Moved|0
741996|NCT00379769|2376974|P1|Observational Follow-up|Participant Moved|0
741997|NCT00379769|2376969|P6|Observational Follow-up|Site Closed Early|7
741998|NCT00379769|2376970|P5|Observational Follow-up|Site Closed Early|6
741999|NCT00379769|2376971|P4|Observational Follow-up|Site Closed Early|0
742000|NCT00379769|2376972|P3|Observational Follow-up|Site Closed Early|0
742001|NCT00379769|2376973|P2|Observational Follow-up|Site Closed Early|0
742002|NCT00379769|2376974|P1|Observational Follow-up|Site Closed Early|0
742003|NCT00379769|2376969|P6|Observational Follow-up|Physician Decision|8
742004|NCT00379769|2376970|P5|Observational Follow-up|Physician Decision|8
742005|NCT00379769|2376971|P4|Observational Follow-up|Physician Decision|0
742006|NCT00379769|2376972|P3|Observational Follow-up|Physician Decision|0
742007|NCT00379769|2376973|P2|Observational Follow-up|Physician Decision|0
742008|NCT00379769|2376974|P1|Observational Follow-up|Physician Decision|0
742009|NCT00379769|2376969|P6|Observational Follow-up|Entered into Another Clinical Trial|22
742010|NCT00379769|2376970|P5|Observational Follow-up|Entered into Another Clinical Trial|18
742011|NCT00379769|2376971|P4|Observational Follow-up|Entered into Another Clinical Trial|0
742012|NCT00379769|2376972|P3|Observational Follow-up|Entered into Another Clinical Trial|0
742013|NCT00379769|2376973|P2|Observational Follow-up|Entered into Another Clinical Trial|0
742014|NCT00379769|2376974|P1|Observational Follow-up|Entered into Another Clinical Trial|0
742015|NCT00379769|2376969|P6|Observational Follow-up|Withdrawal by Subject|12
742016|NCT00379769|2376970|P5|Observational Follow-up|Withdrawal by Subject|12
742017|NCT00379769|2376971|P4|Observational Follow-up|Withdrawal by Subject|0
742018|NCT00379769|2376972|P3|Observational Follow-up|Withdrawal by Subject|0
742019|NCT00379769|2376973|P2|Observational Follow-up|Withdrawal by Subject|0
742020|NCT00379769|2376974|P1|Observational Follow-up|Withdrawal by Subject|0
742021|NCT00379769|2376969|P6|Observational Follow-up|Lost to Follow-up|27
742022|NCT00379769|2376970|P5|Observational Follow-up|Lost to Follow-up|25
742023|NCT00379769|2376971|P4|Observational Follow-up|Lost to Follow-up|0
742024|NCT00379769|2376972|P3|Observational Follow-up|Lost to Follow-up|0
742025|NCT00379769|2376973|P2|Observational Follow-up|Lost to Follow-up|0
742026|NCT00379769|2376974|P1|Observational Follow-up|Lost to Follow-up|0
742027|NCT00379769|2376969|P6|Observational Follow-up|Adverse Event|0
742028|NCT00379769|2376970|P5|Observational Follow-up|Adverse Event|1
742029|NCT00379769|2376971|P4|Observational Follow-up|Adverse Event|0
742030|NCT00379769|2376972|P3|Observational Follow-up|Adverse Event|0
742031|NCT00379769|2376973|P2|Observational Follow-up|Adverse Event|0
742032|NCT00379769|2376974|P1|Observational Follow-up|Adverse Event|0
742033|NCT00379769|2376969|P6|Observational Follow-up|Death|70
742034|NCT00379769|2376970|P5|Observational Follow-up|Death|78
742035|NCT00379769|2376971|P4|Observational Follow-up|Death|0
742036|NCT00379769|2376972|P3|Observational Follow-up|Death|0
742037|NCT00379769|2376973|P2|Observational Follow-up|Death|0
742038|NCT00379769|2376974|P1|Observational Follow-up|Death|0
742039|NCT00379769|2376969|P6|Main Study|Reason unspecified|0
742040|NCT00379769|2376970|P5|Main Study|Reason unspecified|0
742041|NCT00379769|2376971|P4|Main Study|Reason unspecified|0
742042|NCT00379769|2376972|P3|Main Study|Reason unspecified|1
742043|NCT00379769|2376973|P2|Main Study|Reason unspecified|0
742044|NCT00379769|2376974|P1|Main Study|Reason unspecified|0
742045|NCT00379769|2376969|P6|Main Study|Investigator refused to log temperature|0
742046|NCT00379769|2376970|P5|Main Study|Investigator refused to log temperature|0
742047|NCT00379769|2376971|P4|Main Study|Investigator refused to log temperature|0
742048|NCT00379769|2376972|P3|Main Study|Investigator refused to log temperature|1
742049|NCT00379769|2376973|P2|Main Study|Investigator refused to log temperature|0
742050|NCT00379769|2376974|P1|Main Study|Investigator refused to log temperature|0
742051|NCT00379769|2376969|P6|Main Study|Risk of heart failure|0
742052|NCT00379769|2376970|P5|Main Study|Risk of heart failure|0
742053|NCT00379769|2376971|P4|Main Study|Risk of heart failure|0
742054|NCT00379769|2376972|P3|Main Study|Risk of heart failure|0
742055|NCT00379769|2376973|P2|Main Study|Risk of heart failure|1
742056|NCT00379769|2376974|P1|Main Study|Risk of heart failure|0
742057|NCT00379769|2376969|P6|Main Study|Personal reasons|0
742058|NCT00379769|2376970|P5|Main Study|Personal reasons|0
742059|NCT00379769|2376971|P4|Main Study|Personal reasons|0
742060|NCT00379769|2376972|P3|Main Study|Personal reasons|0
742061|NCT00379769|2376973|P2|Main Study|Personal reasons|0
742062|NCT00379769|2376974|P1|Main Study|Personal reasons|1
742063|NCT00379769|2376969|P6|Main Study|Participant completed study at visit 27|0
742064|NCT00379769|2376970|P5|Main Study|Participant completed study at visit 27|0
742065|NCT00379769|2376971|P4|Main Study|Participant completed study at visit 27|0
742066|NCT00379769|2376972|P3|Main Study|Participant completed study at visit 27|0
742067|NCT00379769|2376973|P2|Main Study|Participant completed study at visit 27|0
742068|NCT00379769|2376974|P1|Main Study|Participant completed study at visit 27|1
742069|NCT00379769|2376969|P6|Main Study|Physician Decision|0
742070|NCT00379769|2376970|P5|Main Study|Physician Decision|0
742071|NCT00379769|2376971|P4|Main Study|Physician Decision|1
742072|NCT00379769|2376972|P3|Main Study|Physician Decision|1
742073|NCT00379769|2376973|P2|Main Study|Physician Decision|2
742074|NCT00379769|2376974|P1|Main Study|Physician Decision|2
742075|NCT00379769|2376969|P6|Main Study|Participant did not take study drug|0
742076|NCT00379769|2376970|P5|Main Study|Participant did not take study drug|0
742077|NCT00379769|2376971|P4|Main Study|Participant did not take study drug|0
742078|NCT00379769|2376972|P3|Main Study|Participant did not take study drug|1
742079|NCT00379769|2376973|P2|Main Study|Participant did not take study drug|0
742080|NCT00379769|2376974|P1|Main Study|Participant did not take study drug|0
742081|NCT00379769|2376969|P6|Main Study|Entry criteria violation|0
742082|NCT00379769|2376970|P5|Main Study|Entry criteria violation|0
742083|NCT00379769|2376971|P4|Main Study|Entry criteria violation|1
742084|NCT00379769|2376972|P3|Main Study|Entry criteria violation|1
742085|NCT00379769|2376973|P2|Main Study|Entry criteria violation|0
742086|NCT00379769|2376974|P1|Main Study|Entry criteria violation|0
742087|NCT00379769|2376969|P6|Main Study|Site closed|0
742088|NCT00379769|2376970|P5|Main Study|Site closed|0
742089|NCT00379769|2376971|P4|Main Study|Site closed|8
742090|NCT00379769|2376972|P3|Main Study|Site closed|4
742091|NCT00379769|2376973|P2|Main Study|Site closed|4
742092|NCT00379769|2376974|P1|Main Study|Site closed|4
742093|NCT00379769|2376969|P6|Main Study|Prohibited glucose lowering medication|0
742094|NCT00379769|2376970|P5|Main Study|Prohibited glucose lowering medication|0
742095|NCT00379769|2376971|P4|Main Study|Prohibited glucose lowering medication|1
742096|NCT00379769|2376972|P3|Main Study|Prohibited glucose lowering medication|0
742097|NCT00379769|2376973|P2|Main Study|Prohibited glucose lowering medication|3
742098|NCT00379769|2376974|P1|Main Study|Prohibited glucose lowering medication|0
742099|NCT00379769|2376969|P6|Main Study|Poor compliance|0
742100|NCT00379769|2376970|P5|Main Study|Poor compliance|0
742101|NCT00379769|2376971|P4|Main Study|Poor compliance|1
742102|NCT00379769|2376972|P3|Main Study|Poor compliance|2
742103|NCT00379769|2376973|P2|Main Study|Poor compliance|2
742104|NCT00379769|2376974|P1|Main Study|Poor compliance|3
742105|NCT00379769|2376969|P6|Main Study|Participant moved|0
742106|NCT00379769|2376970|P5|Main Study|Participant moved|0
742107|NCT00379769|2376971|P4|Main Study|Participant moved|3
742108|NCT00379769|2376972|P3|Main Study|Participant moved|3
742109|NCT00379769|2376973|P2|Main Study|Participant moved|2
742110|NCT00379769|2376974|P1|Main Study|Participant moved|3
742111|NCT00379769|2376969|P6|Main Study|Moved to survival status follow-up only|0
742112|NCT00379769|2376970|P5|Main Study|Moved to survival status follow-up only|0
742113|NCT00379769|2376971|P4|Main Study|Moved to survival status follow-up only|36
742114|NCT00379769|2376972|P3|Main Study|Moved to survival status follow-up only|32
742115|NCT00379769|2376973|P2|Main Study|Moved to survival status follow-up only|25
742116|NCT00379769|2376974|P1|Main Study|Moved to survival status follow-up only|27
742117|NCT00379769|2376969|P6|Main Study|Withdrawal by Subject|0
742118|NCT00379769|2376970|P5|Main Study|Withdrawal by Subject|0
742119|NCT00379769|2376971|P4|Main Study|Withdrawal by Subject|70
742120|NCT00379769|2376972|P3|Main Study|Withdrawal by Subject|72
742121|NCT00379769|2376973|P2|Main Study|Withdrawal by Subject|56
742122|NCT00379769|2376974|P1|Main Study|Withdrawal by Subject|46
742123|NCT00379769|2376969|P6|Main Study|Lost to Follow-up|0
742124|NCT00379769|2376970|P5|Main Study|Lost to Follow-up|0
742125|NCT00379769|2376971|P4|Main Study|Lost to Follow-up|26
742126|NCT00379769|2376972|P3|Main Study|Lost to Follow-up|25
742127|NCT00379769|2376973|P2|Main Study|Lost to Follow-up|29
742128|NCT00379769|2376974|P1|Main Study|Lost to Follow-up|29
742129|NCT00379769|2376969|P6|Main Study|Adverse Event|0
742130|NCT00379769|2376970|P5|Main Study|Adverse Event|0
742131|NCT00379769|2376971|P4|Main Study|Adverse Event|11
742132|NCT00379769|2376972|P3|Main Study|Adverse Event|10
742133|NCT00379769|2376973|P2|Main Study|Adverse Event|8
742134|NCT00379769|2376974|P1|Main Study|Adverse Event|5
742135|NCT00379769|2376969|P6|Main Study|Death|0
742136|NCT00379769|2376970|P5|Main Study|Death|0
742137|NCT00379769|2376971|P4|Main Study|Death|72
742138|NCT00379769|2376972|P3|Main Study|Death|54
742139|NCT00379769|2376973|P2|Main Study|Death|67
742140|NCT00379769|2376974|P1|Main Study|Death|57
742141|NCT00379795|2377133|P5|Overall Study|Sponsor's decision|10
742142|NCT00379795|2377134|P4|Overall Study|Sponsor's decision|47
742143|NCT00379795|2377135|P3|Overall Study|Sponsor's decision|54
742144|NCT00379795|2377136|P2|Overall Study|Sponsor's decision|17
742145|NCT00379795|2377137|P1|Overall Study|Sponsor's decision|257
742146|NCT00379795|2377133|P5|Overall Study|Subjects condition mandated intervention|7
742147|NCT00379795|2377134|P4|Overall Study|Subjects condition mandated intervention|5
742148|NCT00379795|2377135|P3|Overall Study|Subjects condition mandated intervention|7
742149|NCT00379795|2377136|P2|Overall Study|Subjects condition mandated intervention|9
742150|NCT00379795|2377137|P1|Overall Study|Subjects condition mandated intervention|34
742151|NCT00379795|2377133|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
742152|NCT00379795|2377134|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
742153|NCT00379795|2377135|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
742154|NCT00379795|2377136|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
742155|NCT00379795|2377137|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
742156|NCT00379795|2377133|P5|Overall Study|Subject non-compliance|1
742157|NCT00379795|2377134|P4|Overall Study|Subject non-compliance|0
742158|NCT00379795|2377135|P3|Overall Study|Subject non-compliance|0
742159|NCT00379795|2377136|P2|Overall Study|Subject non-compliance|2
742160|NCT00379795|2377137|P1|Overall Study|Subject non-compliance|7
742161|NCT00379795|2377133|P5|Overall Study|Withdrawal by Subject|14
742162|NCT00379795|2377134|P4|Overall Study|Withdrawal by Subject|7
742163|NCT00379795|2377135|P3|Overall Study|Withdrawal by Subject|19
742164|NCT00379795|2377136|P2|Overall Study|Withdrawal by Subject|11
742165|NCT00379795|2377137|P1|Overall Study|Withdrawal by Subject|94
742166|NCT00379795|2377133|P5|Overall Study|Physician Decision|2
742167|NCT00379795|2377134|P4|Overall Study|Physician Decision|2
742168|NCT00379795|2377135|P3|Overall Study|Physician Decision|2
742169|NCT00379795|2377136|P2|Overall Study|Physician Decision|0
742170|NCT00379795|2377137|P1|Overall Study|Physician Decision|25
742171|NCT00379795|2377133|P5|Overall Study|Lost to Follow-up|4
742172|NCT00379795|2377134|P4|Overall Study|Lost to Follow-up|1
742173|NCT00379795|2377135|P3|Overall Study|Lost to Follow-up|2
742174|NCT00379795|2377136|P2|Overall Study|Lost to Follow-up|1
742175|NCT00379795|2377137|P1|Overall Study|Lost to Follow-up|8
742176|NCT00379795|2377133|P5|Overall Study|Adverse Event|4
742177|NCT00379795|2377134|P4|Overall Study|Adverse Event|1
742178|NCT00379795|2377135|P3|Overall Study|Adverse Event|3
742179|NCT00379795|2377136|P2|Overall Study|Adverse Event|3
742180|NCT00379795|2377137|P1|Overall Study|Adverse Event|17
742181|NCT00379795|2377133|P5|Overall Study|Death|7
742182|NCT00379795|2377134|P4|Overall Study|Death|4
742183|NCT00379795|2377135|P3|Overall Study|Death|6
742184|NCT00379795|2377136|P2|Overall Study|Death|8
742185|NCT00379795|2377137|P1|Overall Study|Death|31
742186|NCT00379808|2377163|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
742187|NCT00379808|2377164|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
742188|NCT00379834|2377328|P1|Overall Study|Time constraints|2
742189|NCT00379899|2377334|P2|Overall Study|Other|1
742190|NCT00379899|2377335|P1|Overall Study|Other|3
742191|NCT00379899|2377334|P2|Overall Study|Other protocol-specified criteria|4
742192|NCT00379899|2377335|P1|Overall Study|Other protocol-specified criteria|3
742193|NCT00379899|2377334|P2|Overall Study|Coronary artery bypass graft|1
742194|NCT00379899|2377335|P1|Overall Study|Coronary artery bypass graft|1
742195|NCT00379899|2377334|P2|Overall Study|Renal transplantation|4
742196|NCT00379899|2377335|P1|Overall Study|Renal transplantation|5
742197|NCT00379899|2377334|P2|Overall Study|Parathyroidectomy|2
742198|NCT00379899|2377335|P1|Overall Study|Parathyroidectomy|0
742199|NCT00379899|2377334|P2|Overall Study|Noncompliance|1
742200|NCT00379899|2377335|P1|Overall Study|Noncompliance|1
742201|NCT00379899|2377334|P2|Overall Study|Ineligibility determined|1
742202|NCT00379899|2377335|P1|Overall Study|Ineligibility determined|0
742203|NCT00379899|2377334|P2|Overall Study|Withdrawal by Subject|5
742204|NCT00379899|2377335|P1|Overall Study|Withdrawal by Subject|5
742205|NCT00379899|2377334|P2|Overall Study|Physician Decision|4
742206|NCT00379899|2377335|P1|Overall Study|Physician Decision|3
742207|NCT00379899|2377334|P2|Overall Study|Lost to Follow-up|4
742208|NCT00379899|2377335|P1|Overall Study|Lost to Follow-up|2
742209|NCT00379899|2377334|P2|Overall Study|Death|10
742210|NCT00379899|2377335|P1|Overall Study|Death|10
742211|NCT00379899|2377334|P2|Overall Study|Adverse Event|3
742212|NCT00379899|2377335|P1|Overall Study|Adverse Event|7
742213|NCT00379912|2377365|P2|Overall Study|Lack of Efficacy|0
742214|NCT00379912|2377366|P1|Overall Study|Lack of Efficacy|1
742215|NCT00380068|2377394|P1|Overall Study|Lack of Efficacy|5
742216|NCT00380068|2377394|P1|Overall Study|Partipant moved away|1
742217|NCT00380068|2377394|P1|Overall Study|Physician Decision|2
742218|NCT00380068|2377394|P1|Overall Study|Lung transplant|3
742219|NCT00380068|2377394|P1|Overall Study|Addition of other PAH therapeutic agent|1
742220|NCT00380068|2377394|P1|Overall Study|Lost to Follow-up|1
742221|NCT00380068|2377394|P1|Overall Study|Not compliant|6
742222|NCT00380068|2377394|P1|Overall Study|Withdrawal by Subject|10
742223|NCT00380068|2377394|P1|Overall Study|Adverse Event|40
742224|NCT00380081|2377420|P6|Overall Study|Family Emergency|1
742225|NCT00380081|2377421|P5|Overall Study|Family Emergency|0
742226|NCT00380081|2377422|P4|Overall Study|Family Emergency|0
742227|NCT00380081|2377423|P3|Overall Study|Family Emergency|0
742228|NCT00380081|2377424|P2|Overall Study|Family Emergency|0
742229|NCT00380081|2377425|P1|Overall Study|Family Emergency|0
742230|NCT00380081|2377420|P6|Overall Study|Withdrawal by Subject|0
742231|NCT00380081|2377421|P5|Overall Study|Withdrawal by Subject|1
742232|NCT00380081|2377422|P4|Overall Study|Withdrawal by Subject|0
742233|NCT00380081|2377423|P3|Overall Study|Withdrawal by Subject|0
742234|NCT00380081|2377424|P2|Overall Study|Withdrawal by Subject|0
742235|NCT00380081|2377425|P1|Overall Study|Withdrawal by Subject|0
742236|NCT00380250|2377477|P2|Overall Study|Physician Decision|0
742237|NCT00380250|2377478|P1|Overall Study|Physician Decision|1
742238|NCT00380250|2377477|P2|Overall Study|Lost to Follow-up|5
742239|NCT00380250|2377478|P1|Overall Study|Lost to Follow-up|14
742240|NCT00380250|2377477|P2|Overall Study|Protocol Violation|5
742241|NCT00380250|2377478|P1|Overall Study|Protocol Violation|15
742242|NCT00380250|2377477|P2|Overall Study|Lack of Efficacy|8
742243|NCT00380250|2377478|P1|Overall Study|Lack of Efficacy|10
742244|NCT00380250|2377477|P2|Overall Study|Adverse Event|9
742245|NCT00380250|2377478|P1|Overall Study|Adverse Event|20
742246|NCT00380250|2377477|P2|Overall Study|Withdrawal by Subject|28
742247|NCT00380250|2377478|P1|Overall Study|Withdrawal by Subject|39
742248|NCT00380367|2377540|P1|Overall Study|Withdrawal by Subject|1
742249|NCT00380367|2377540|P1|Overall Study|Lost to Follow-up|1
742250|NCT00366301|2377549|P4|Overall Study|Withdrawal by Subject|1
742251|NCT00366301|2377550|P3|Overall Study|Withdrawal by Subject|1
742252|NCT00366301|2377551|P2|Overall Study|Withdrawal by Subject|2
742253|NCT00366301|2377552|P1|Overall Study|Withdrawal by Subject|4
742254|NCT00366301|2377549|P4|Overall Study|Lost to Follow-up|7
742255|NCT00366301|2377550|P3|Overall Study|Lost to Follow-up|3
742256|NCT00366301|2377551|P2|Overall Study|Lost to Follow-up|4
742257|NCT00366301|2377552|P1|Overall Study|Lost to Follow-up|4
742258|NCT00366340|2377564|P2|Toddler Dose|Parent/legal guardian request|1
742259|NCT00366340|2377565|P1|Toddler Dose|Parent/legal guardian request|0
742260|NCT00366340|2377564|P2|Toddler Dose|Failed to return|0
742261|NCT00366340|2377565|P1|Toddler Dose|Failed to return|1
742262|NCT00366340|2377564|P2|After the Infant Series|Lost to Follow-up|1
742263|NCT00366340|2377565|P1|After the Infant Series|Lost to Follow-up|0
742264|NCT00366340|2377564|P2|After the Infant Series|Adverse Event|1
742265|NCT00366340|2377565|P1|After the Infant Series|Adverse Event|0
742266|NCT00366340|2377564|P2|After the Infant Series|Protocol Violation|2
742267|NCT00366340|2377565|P1|After the Infant Series|Protocol Violation|2
742268|NCT00366340|2377564|P2|After the Infant Series|Failed to return|1
742269|NCT00366340|2377565|P1|After the Infant Series|Failed to return|0
742270|NCT00366340|2377564|P2|After the Infant Series|Parent/legal guardian request|1
742271|NCT00366340|2377565|P1|After the Infant Series|Parent/legal guardian request|1
742272|NCT00366340|2377564|P2|Infant Series|Failure to return|0
742273|NCT00366340|2377565|P1|Infant Series|Failure to return|1
742274|NCT00366340|2377564|P2|Infant Series|Lost to Follow-up|1
742275|NCT00366340|2377565|P1|Infant Series|Lost to Follow-up|1
742276|NCT00366340|2377564|P2|Infant Series|Adverse Event|2
742277|NCT00366340|2377565|P1|Infant Series|Adverse Event|0
742278|NCT00366340|2377564|P2|Infant Series|Withdrawal by Subject|3
742279|NCT00366340|2377565|P1|Infant Series|Withdrawal by Subject|3
742280|NCT00366340|2377564|P2|Infant Series|Protocol Violation|4
742281|NCT00366340|2377565|P1|Infant Series|Protocol Violation|3
742282|NCT00366444|2377621|P2|Overall Study|Lack of Efficacy|1
742283|NCT00366444|2377622|P1|Overall Study|Lack of Efficacy|0
742284|NCT00366444|2377621|P2|Overall Study|Withdrawal by Subject|1
742285|NCT00366444|2377622|P1|Overall Study|Withdrawal by Subject|1
742286|NCT00366457|2377648|P1|Overall Study|never began study therapy|2
742287|NCT00366548|2377657|P2|After Infant Series|Lost to Follow-up|0
742288|NCT00366548|2377658|P1|After Infant Series|Lost to Follow-up|1
742289|NCT00366548|2377657|P2|After Infant Series|Adverse Event|0
742290|NCT00366548|2377658|P1|After Infant Series|Adverse Event|2
742291|NCT00366548|2377657|P2|After Infant Series|Withdrawal by Subject|1
742292|NCT00366548|2377658|P1|After Infant Series|Withdrawal by Subject|3
742293|NCT00366548|2377657|P2|Infant Series|Withdrawal by Subject|1
742294|NCT00366548|2377658|P1|Infant Series|Withdrawal by Subject|3
742295|NCT00366548|2377657|P2|Infant Series|Protocol Violation|1
742296|NCT00366548|2377658|P1|Infant Series|Protocol Violation|0
742297|NCT00366548|2377657|P2|Infant Series|Adverse Event|3
742298|NCT00366548|2377658|P1|Infant Series|Adverse Event|1
742299|NCT00366678|2377709|P3|Toddler Dose|protocol deviation|0
742300|NCT00366678|2377710|P2|Toddler Dose|protocol deviation|0
742301|NCT00366678|2377711|P1|Toddler Dose|protocol deviation|1
742302|NCT00366678|2377709|P3|Toddler Dose|Withdrawal by Subject|0
742303|NCT00366678|2377710|P2|Toddler Dose|Withdrawal by Subject|0
742304|NCT00366678|2377711|P1|Toddler Dose|Withdrawal by Subject|1
742305|NCT00366678|2377709|P3|Toddler Dose|Failed to return|0
742306|NCT00366678|2377710|P2|Toddler Dose|Failed to return|0
742307|NCT00366678|2377711|P1|Toddler Dose|Failed to return|1
742308|NCT00366678|2377709|P3|Toddler Dose|Protocol Violation|0
742309|NCT00366678|2377710|P2|Toddler Dose|Protocol Violation|1
742310|NCT00366678|2377711|P1|Toddler Dose|Protocol Violation|2
742311|NCT00366678|2377709|P3|After Infant|Protocol Violation|0
742312|NCT00366678|2377710|P2|After Infant|Protocol Violation|0
742313|NCT00366678|2377711|P1|After Infant|Protocol Violation|1
742314|NCT00366678|2377709|P3|After Infant|Adverse Event|0
742315|NCT00366678|2377710|P2|After Infant|Adverse Event|0
742316|NCT00366678|2377711|P1|After Infant|Adverse Event|1
742317|NCT00366678|2377709|P3|After Infant|Failed to return|0
742318|NCT00366678|2377710|P2|After Infant|Failed to return|5
742319|NCT00366678|2377711|P1|After Infant|Failed to return|5
742320|NCT00366678|2377709|P3|After Infant|Lost to Follow-up|0
742321|NCT00366678|2377710|P2|After Infant|Lost to Follow-up|1
742322|NCT00366678|2377711|P1|After Infant|Lost to Follow-up|2
742323|NCT00366678|2377709|P3|After Infant|Withdrawal by Subject|0
742324|NCT00366678|2377710|P2|After Infant|Withdrawal by Subject|4
742325|NCT00366678|2377711|P1|After Infant|Withdrawal by Subject|8
742326|NCT00366678|2377709|P3|Infant Series|Adverse Event|0
742327|NCT00366678|2377710|P2|Infant Series|Adverse Event|0
742328|NCT00366678|2377711|P1|Infant Series|Adverse Event|1
742329|NCT00366678|2377709|P3|Infant Series|Failed to return|0
742330|NCT00366678|2377710|P2|Infant Series|Failed to return|1
742331|NCT00366678|2377711|P1|Infant Series|Failed to return|1
742332|NCT00366678|2377709|P3|Infant Series|Protocol Violation|0
742333|NCT00366678|2377710|P2|Infant Series|Protocol Violation|3
742334|NCT00366678|2377711|P1|Infant Series|Protocol Violation|4
742335|NCT00366678|2377709|P3|Infant Series|Withdrawal by Subject|0
742336|NCT00366678|2377710|P2|Infant Series|Withdrawal by Subject|6
742337|NCT00366678|2377711|P1|Infant Series|Withdrawal by Subject|8
742338|NCT00367237|2377778|P2|Overall Study|Protocol Violation|5
742339|NCT00367237|2377779|P1|Overall Study|Protocol Violation|2
742340|NCT00367237|2377778|P2|Overall Study|Withdrawal by Subject|4
742341|NCT00367237|2377779|P1|Overall Study|Withdrawal by Subject|0
742342|NCT00367237|2377778|P2|Overall Study|Lost to Follow-up|0
742343|NCT00367237|2377779|P1|Overall Study|Lost to Follow-up|1
742344|NCT00367237|2377778|P2|Overall Study|Adverse Event|2
742345|NCT00367237|2377779|P1|Overall Study|Adverse Event|7
742346|NCT00367341|2377787|P2|Overall Study|Protocol Violation|0
742347|NCT00367341|2377788|P1|Overall Study|Protocol Violation|1
742348|NCT00367341|2377787|P2|Overall Study|Physician Decision|0
742349|NCT00367341|2377788|P1|Overall Study|Physician Decision|1
742350|NCT00367432|2377809|P2|Second Period (up to 54 Months)|Other Reason|2
742351|NCT00367432|2377810|P1|Second Period (up to 54 Months)|Other Reason|6
742352|NCT00367432|2377809|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
742439|NCT00368108|2377945|P1|Overall Study|Protocol Violation|5
742353|NCT00367432|2377810|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
742354|NCT00367432|2377809|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
742355|NCT00367432|2377810|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
742356|NCT00367432|2377809|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
742357|NCT00367432|2377810|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
742358|NCT00367432|2377809|P2|Second Period (up to 54 Months)|Adverse Event|3
742359|NCT00367432|2377810|P1|Second Period (up to 54 Months)|Adverse Event|14
742360|NCT00367432|2377809|P2|First Period (16 Weeks)|Other Reason|0
742361|NCT00367432|2377810|P1|First Period (16 Weeks)|Other Reason|2
742362|NCT00367432|2377809|P2|First Period (16 Weeks)|Withdrawal by Subject|0
742363|NCT00367432|2377810|P1|First Period (16 Weeks)|Withdrawal by Subject|6
742364|NCT00367432|2377809|P2|First Period (16 Weeks)|Lack of Efficacy|0
742365|NCT00367432|2377810|P1|First Period (16 Weeks)|Lack of Efficacy|24
742366|NCT00367432|2377809|P2|First Period (16 Weeks)|Adverse Event|0
742367|NCT00367432|2377810|P1|First Period (16 Weeks)|Adverse Event|6
742368|NCT00367484|2377822|P1|Overall Study|Lack of Efficacy|1
742369|NCT00367484|2377822|P1|Overall Study|The choice of the patient|1
742370|NCT00367484|2377822|P1|Overall Study|Protocol Violation|1
742371|NCT00367484|2377822|P1|Overall Study|Lost to Follow-up|1
742372|NCT00367484|2377822|P1|Overall Study|Travel to USA|1
742373|NCT00367484|2377822|P1|Overall Study|Withdrew informed consent|5
742374|NCT00367484|2377822|P1|Overall Study|Adverse Event|7
742375|NCT00367640|2377836|P4|Overall Study|Any other reason not above-mentioned|4
742376|NCT00367640|2377837|P3|Overall Study|Any other reason not above-mentioned|3
742377|NCT00367640|2377838|P2|Overall Study|Any other reason not above-mentioned|5
742378|NCT00367640|2377839|P1|Overall Study|Any other reason not above-mentioned|7
742379|NCT00367640|2377836|P4|Overall Study|Withdrawal by Subject|6
742380|NCT00367640|2377837|P3|Overall Study|Withdrawal by Subject|8
742381|NCT00367640|2377838|P2|Overall Study|Withdrawal by Subject|11
742382|NCT00367640|2377839|P1|Overall Study|Withdrawal by Subject|8
742383|NCT00367640|2377836|P4|Overall Study|Adverse Event|0
742384|NCT00367640|2377837|P3|Overall Study|Adverse Event|8
742385|NCT00367640|2377838|P2|Overall Study|Adverse Event|6
742386|NCT00367640|2377839|P1|Overall Study|Adverse Event|3
742387|NCT00367744|2377868|P2|Overall Study|Lost to Follow-up|5
742388|NCT00367744|2377869|P1|Overall Study|Lost to Follow-up|4
742389|NCT00367770|2377877|P1|Overall Study|Withdrawal by Subject|1
742390|NCT00367770|2377877|P1|Overall Study|Adverse Event|1
742391|NCT00367835|2377885|P2|Overall Study|History of lead poisoning|1
742392|NCT00367835|2377886|P1|Overall Study|History of lead poisoning|0
742393|NCT00367835|2377885|P2|Overall Study|Did not respond to calls|0
742394|NCT00367835|2377886|P1|Overall Study|Did not respond to calls|1
742395|NCT00367835|2377885|P2|Overall Study|refused blood collection|0
742396|NCT00367835|2377886|P1|Overall Study|refused blood collection|1
742397|NCT00367835|2377885|P2|Overall Study|Subject in juvenile detention center|0
742398|NCT00367835|2377886|P1|Overall Study|Subject in juvenile detention center|1
742399|NCT00367835|2377885|P2|Overall Study|Lack of Efficacy|12
742400|NCT00367835|2377886|P1|Overall Study|Lack of Efficacy|3
742401|NCT00367835|2377885|P2|Overall Study|Lost to Follow-up|4
742402|NCT00367835|2377886|P1|Overall Study|Lost to Follow-up|1
742403|NCT00367835|2377885|P2|Overall Study|Withdrawal by Subject|6
742404|NCT00367835|2377886|P1|Overall Study|Withdrawal by Subject|7
742405|NCT00367835|2377885|P2|Overall Study|Protocol Violation|7
742406|NCT00367835|2377886|P1|Overall Study|Protocol Violation|1
742407|NCT00367835|2377885|P2|Overall Study|Adverse Event|1
742408|NCT00367835|2377886|P1|Overall Study|Adverse Event|14
742409|NCT00367991|2377914|P2|Overall Study|Adverse Event|1
742410|NCT00367991|2377915|P1|Overall Study|Adverse Event|1
742411|NCT00367991|2377914|P2|Overall Study|Withdrawal by Subject|1
742412|NCT00367991|2377915|P1|Overall Study|Withdrawal by Subject|1
742413|NCT00368069|2377923|P2|Overall Study|no blood sampling possible|1
742414|NCT00368069|2377924|P1|Overall Study|no blood sampling possible|0
742415|NCT00368069|2377923|P2|Overall Study|Withdrawal of Consent|1
742416|NCT00368069|2377924|P1|Overall Study|Withdrawal of Consent|2
742417|NCT00368069|2377923|P2|Overall Study|Protocol Violation|2
742418|NCT00368069|2377924|P1|Overall Study|Protocol Violation|0
742419|NCT00368069|2377923|P2|Overall Study|Lost to Follow-up|0
742420|NCT00368069|2377924|P1|Overall Study|Lost to Follow-up|1
742421|NCT00368069|2377923|P2|Overall Study|Lack of Efficacy|1
742422|NCT00368069|2377924|P1|Overall Study|Lack of Efficacy|0
742423|NCT00368069|2377923|P2|Overall Study|Adverse Event|2
742424|NCT00368069|2377924|P1|Overall Study|Adverse Event|5
742425|NCT00368108|2377943|P3|Overall Study|Not Specified|1
742426|NCT00368108|2377944|P2|Overall Study|Not Specified|7
742427|NCT00368108|2377945|P1|Overall Study|Not Specified|3
742428|NCT00368108|2377943|P3|Overall Study|Physician Decision|1
742429|NCT00368108|2377944|P2|Overall Study|Physician Decision|0
742430|NCT00368108|2377945|P1|Overall Study|Physician Decision|2
742431|NCT00368108|2377943|P3|Overall Study|Lack of Efficacy|5
742432|NCT00368108|2377944|P2|Overall Study|Lack of Efficacy|8
742433|NCT00368108|2377945|P1|Overall Study|Lack of Efficacy|7
742434|NCT00368108|2377943|P3|Overall Study|Withdrawal by Subject|5
742435|NCT00368108|2377944|P2|Overall Study|Withdrawal by Subject|3
742436|NCT00368108|2377945|P1|Overall Study|Withdrawal by Subject|9
742437|NCT00368108|2377943|P3|Overall Study|Protocol Violation|9
742438|NCT00368108|2377944|P2|Overall Study|Protocol Violation|9
742440|NCT00368108|2377943|P3|Overall Study|Abnormal Laboratory Value|3
742441|NCT00368108|2377944|P2|Overall Study|Abnormal Laboratory Value|0
742442|NCT00368108|2377945|P1|Overall Study|Abnormal Laboratory Value|0
742443|NCT00368108|2377943|P3|Overall Study|Adverse Event|44
742444|NCT00368108|2377944|P2|Overall Study|Adverse Event|26
742445|NCT00368108|2377945|P1|Overall Study|Adverse Event|38
742446|NCT00368251|2377965|P3|Overall Study|AE, non-serious non-fatal|1
742447|NCT00368251|2377966|P2|Overall Study|AE, non-serious non-fatal|0
742448|NCT00368251|2377967|P1|Overall Study|AE, non-serious non-fatal|0
742449|NCT00368251|2377965|P3|Overall Study|SAE, non-fatal|0
742450|NCT00368251|2377966|P2|Overall Study|SAE, non-fatal|0
742451|NCT00368251|2377967|P1|Overall Study|SAE, non-fatal|1
742452|NCT00368277|2377989|P2|Overall Study|Lost to Follow-up|6
742453|NCT00368277|2377990|P1|Overall Study|Lost to Follow-up|8
742454|NCT00368277|2377989|P2|Overall Study|Patient withdrew consent|28
742455|NCT00368277|2377990|P1|Overall Study|Patient withdrew consent|32
742456|NCT00368277|2377989|P2|Overall Study|Protocol deviation|0
742457|NCT00368277|2377990|P1|Overall Study|Protocol deviation|7
742458|NCT00368277|2377989|P2|Overall Study|Unsatisfactory therapeutic effect|24
742459|NCT00368277|2377990|P1|Overall Study|Unsatisfactory therapeutic effect|31
742460|NCT00368277|2377989|P2|Overall Study|Death|1
742461|NCT00368277|2377990|P1|Overall Study|Death|2
742462|NCT00368277|2377989|P2|Overall Study|Adverse Event|49
742463|NCT00368277|2377990|P1|Overall Study|Adverse Event|33
742464|NCT00368472|2378053|P1|Overall Study|Missing Final Disposition Date|1
742465|NCT00368472|2378053|P1|Overall Study|Not Specified|32
742466|NCT00368472|2378053|P1|Overall Study|Diary non-compliance|1
742467|NCT00368472|2378053|P1|Overall Study|Withdrawal by Subject|40
742468|NCT00368472|2378053|P1|Overall Study|Request of Investigator or Sponsor|3
742469|NCT00368472|2378053|P1|Overall Study|Protocol Violation|2
742470|NCT00368472|2378053|P1|Overall Study|Medication non-compliance|4
742471|NCT00368472|2378053|P1|Overall Study|Adverse Event|22
742472|NCT00368537|2378061|P2|Baseline Participants|Patient uncompliant|1
742473|NCT00368537|2378062|P1|Baseline Participants|Patient uncompliant|0
742474|NCT00368537|2378061|P2|Baseline Participants|No susceptibility|0
742475|NCT00368537|2378062|P1|Baseline Participants|No susceptibility|1
742476|NCT00368537|2378061|P2|Baseline Participants|Death|2
742477|NCT00368537|2378062|P1|Baseline Participants|Death|1
742478|NCT00368537|2378061|P2|Baseline Participants|Withdrawal by Subject|4
742479|NCT00368537|2378062|P1|Baseline Participants|Withdrawal by Subject|6
742480|NCT00368537|2378061|P2|Baseline Participants|Lost to Follow-up|17
742481|NCT00368537|2378062|P1|Baseline Participants|Lost to Follow-up|16
742482|NCT00368537|2378061|P2|Randomization|No study drug dosed|6
742483|NCT00368537|2378062|P1|Randomization|No study drug dosed|13
742484|NCT00368550|2378078|P2|Overall Study|Withdrawal by Subject|10
742485|NCT00368550|2378079|P1|Overall Study|Withdrawal by Subject|17
742486|NCT00368550|2378078|P2|Overall Study|Lack of Efficacy|9
742487|NCT00368550|2378079|P1|Overall Study|Lack of Efficacy|4
742488|NCT00368550|2378078|P2|Overall Study|Adverse Event|4
742489|NCT00368550|2378079|P1|Overall Study|Adverse Event|7
742490|NCT00368641|2378091|P2|Overall Study|Sponsor decision to terminate study|5
742491|NCT00368641|2378092|P1|Overall Study|Sponsor decision to terminate study|2
742492|NCT00368641|2378091|P2|Overall Study|Withdrawal by Subject|0
742493|NCT00368641|2378092|P1|Overall Study|Withdrawal by Subject|1
742494|NCT00368641|2378091|P2|Overall Study|Death|0
742495|NCT00368641|2378092|P1|Overall Study|Death|1
742496|NCT00368641|2378091|P2|Overall Study|Adverse Event|1
742497|NCT00368641|2378092|P1|Overall Study|Adverse Event|2
742498|NCT00368745|2378100|P2|Double-blind Treatment Period|Other|6
742499|NCT00368745|2378101|P1|Double-blind Treatment Period|Other|7
742500|NCT00368745|2378100|P2|Double-blind Treatment Period|Withdrawal by Subject|3
742501|NCT00368745|2378101|P1|Double-blind Treatment Period|Withdrawal by Subject|5
742502|NCT00368745|2378100|P2|Double-blind Treatment Period|Lost to Follow-up|0
742503|NCT00368745|2378101|P1|Double-blind Treatment Period|Lost to Follow-up|1
742504|NCT00368745|2378100|P2|Double-blind Treatment Period|Lack of Efficacy|16
742505|NCT00368745|2378101|P1|Double-blind Treatment Period|Lack of Efficacy|7
742506|NCT00368745|2378100|P2|Double-blind Treatment Period|Adverse Event|6
742507|NCT00368745|2378101|P1|Double-blind Treatment Period|Adverse Event|6
742508|NCT00368849|2378131|P2|Overall Study|Physician Decision|1
742509|NCT00368849|2378132|P1|Overall Study|Physician Decision|0
742510|NCT00368849|2378131|P2|Overall Study|Withdrawal by Subject|1
742511|NCT00368849|2378132|P1|Overall Study|Withdrawal by Subject|0
742512|NCT00368875|2378146|P2|Overall Study|Alternative Therapy|1
742513|NCT00368875|2378147|P1|Overall Study|Alternative Therapy|1
742514|NCT00368875|2378146|P2|Overall Study|Other Reason|2
742515|NCT00368875|2378147|P1|Overall Study|Other Reason|0
742516|NCT00368875|2378146|P2|Overall Study|Withdrawal by Subject|6
742517|NCT00368875|2378147|P1|Overall Study|Withdrawal by Subject|2
742518|NCT00368875|2378146|P2|Overall Study|Progressive disease|27
742519|NCT00368875|2378147|P1|Overall Study|Progressive disease|3
742520|NCT00368875|2378146|P2|Overall Study|Adverse Event|12
742521|NCT00368875|2378147|P1|Overall Study|Adverse Event|0
742522|NCT00368927|2378157|P2|Overall Study|Physician Decision|0
742523|NCT00368927|2378158|P1|Overall Study|Physician Decision|1
742524|NCT00368927|2378157|P2|Overall Study|Withdrawal by Subject|2
742525|NCT00368927|2378158|P1|Overall Study|Withdrawal by Subject|1
742526|NCT00368927|2378157|P2|Overall Study|Adverse Event|1
742527|NCT00368927|2378158|P1|Overall Study|Adverse Event|1
742528|NCT00368927|2378157|P2|Overall Study|Lost to Follow-up|0
742529|NCT00368927|2378158|P1|Overall Study|Lost to Follow-up|2
742530|NCT00368966|2378183|P2|Toddler Dose|Lost to Follow-up|2
742531|NCT00368966|2378184|P1|Toddler Dose|Lost to Follow-up|0
742532|NCT00368966|2378183|P2|Toddler Dose|Withdrawal by Subject|1
742533|NCT00368966|2378184|P1|Toddler Dose|Withdrawal by Subject|1
742534|NCT00368966|2378183|P2|After Infant|Lost to Follow-up|1
742535|NCT00368966|2378184|P1|After Infant|Lost to Follow-up|0
742536|NCT00368966|2378183|P2|After Infant|Death|0
742537|NCT00368966|2378184|P1|After Infant|Death|1
742538|NCT00368966|2378183|P2|After Infant|Withdrawal by Subject|1
742539|NCT00368966|2378184|P1|After Infant|Withdrawal by Subject|1
742540|NCT00368966|2378183|P2|After Infant|Adverse Event|2
742541|NCT00368966|2378184|P1|After Infant|Adverse Event|1
742542|NCT00368966|2378183|P2|After Infant|Failed to return|1
742543|NCT00368966|2378184|P1|After Infant|Failed to return|3
742544|NCT00368966|2378183|P2|Infant Series|Failed to return|0
742545|NCT00368966|2378184|P1|Infant Series|Failed to return|1
742546|NCT00368966|2378183|P2|Infant Series|Adverse Event|1
742547|NCT00368966|2378184|P1|Infant Series|Adverse Event|0
742548|NCT00368966|2378183|P2|Infant Series|Failed to meet eligibility criteria|1
742549|NCT00368966|2378184|P1|Infant Series|Failed to meet eligibility criteria|0
742550|NCT00368966|2378183|P2|Infant Series|Randomization error|1
742551|NCT00368966|2378184|P1|Infant Series|Randomization error|0
742552|NCT00368966|2378183|P2|Infant Series|Lost to Follow-up|0
742553|NCT00368966|2378184|P1|Infant Series|Lost to Follow-up|2
742554|NCT00368966|2378183|P2|Infant Series|Protocol Violation|1
742555|NCT00368966|2378184|P1|Infant Series|Protocol Violation|2
742556|NCT00368966|2378183|P2|Infant Series|Withdrawal by Subject|6
742557|NCT00368966|2378184|P1|Infant Series|Withdrawal by Subject|11
742558|NCT00368979|2378240|P2|Overall Study|Withdrawal by Subject|9
742559|NCT00368979|2378241|P1|Overall Study|Withdrawal by Subject|5
742560|NCT00368979|2378240|P2|Overall Study|Protocol Violation|1
742561|NCT00368979|2378241|P1|Overall Study|Protocol Violation|2
742562|NCT00368979|2378240|P2|Overall Study|Lost to Follow-up|0
742563|NCT00368979|2378241|P1|Overall Study|Lost to Follow-up|1
742564|NCT00368979|2378240|P2|Overall Study|Not specified|1
742565|NCT00368979|2378241|P1|Overall Study|Not specified|3
742566|NCT00368979|2378240|P2|Overall Study|Lack of Efficacy|3
742567|NCT00368979|2378241|P1|Overall Study|Lack of Efficacy|5
742568|NCT00368979|2378240|P2|Overall Study|Adverse Event|16
742569|NCT00368979|2378241|P1|Overall Study|Adverse Event|9
742570|NCT00368992|2378255|P1|Overall Study|Not Specified|9
742571|NCT00368992|2378255|P1|Overall Study|Death|4
742572|NCT00368992|2378255|P1|Overall Study|Adverse Event|26
742573|NCT00368992|2378255|P1|Overall Study|Lack of Efficacy|63
742574|NCT00368992|2378255|P1|Overall Study|Refused treatment|3
742575|NCT00368992|2378255|P1|Overall Study|Ineligible|5
742576|NCT00369122|2378262|P1|Overall Study|No protocol treatment|1
742577|NCT00369122|2378262|P1|Overall Study|Ineligible|10
742578|NCT00369161|2378268|P2|Overall Study|Administrative Problem|2
742579|NCT00369161|2378269|P1|Overall Study|Administrative Problem|2
742580|NCT00369161|2378268|P2|Overall Study|Graft loss|0
742581|NCT00369161|2378269|P1|Overall Study|Graft loss|4
742582|NCT00369161|2378268|P2|Overall Study|Death|2
742583|NCT00369161|2378269|P1|Overall Study|Death|1
742584|NCT00369161|2378268|P2|Overall Study|Withdrawal by Subject|3
742585|NCT00369161|2378269|P1|Overall Study|Withdrawal by Subject|2
742586|NCT00369161|2378268|P2|Overall Study|Protocol Violation|2
742587|NCT00369161|2378269|P1|Overall Study|Protocol Violation|0
742588|NCT00369161|2378268|P2|Overall Study|Lack of Efficacy|1
742589|NCT00369161|2378269|P1|Overall Study|Lack of Efficacy|3
742590|NCT00369161|2378268|P2|Overall Study|Abnormal laboratory value|1
742591|NCT00369161|2378269|P1|Overall Study|Abnormal laboratory value|0
742592|NCT00369161|2378268|P2|Overall Study|Adverse Event|13
742593|NCT00369161|2378269|P1|Overall Study|Adverse Event|15
742594|NCT00369265|2378294|P2|Overall Study|Study terminated|7
742595|NCT00369265|2378295|P1|Overall Study|Study terminated|4
742596|NCT00369278|2378303|P2|Overall Study|Graft loss|2
742597|NCT00369278|2378304|P1|Overall Study|Graft loss|1
742598|NCT00369278|2378303|P2|Overall Study|Lost to Follow-up|0
742599|NCT00369278|2378304|P1|Overall Study|Lost to Follow-up|1
742600|NCT00369278|2378303|P2|Overall Study|Withdrawal by Subject|2
742601|NCT00369278|2378304|P1|Overall Study|Withdrawal by Subject|2
742602|NCT00369278|2378303|P2|Overall Study|Protocol Violation|1
742603|NCT00369278|2378304|P1|Overall Study|Protocol Violation|2
742604|NCT00369278|2378303|P2|Overall Study|Unsatisfactory therapeutic effect|5
742605|NCT00369278|2378304|P1|Overall Study|Unsatisfactory therapeutic effect|4
742606|NCT00369278|2378303|P2|Overall Study|Adverse Event|11
742607|NCT00369278|2378304|P1|Overall Study|Adverse Event|14
742608|NCT00374868|2378369|P1|Overall Study|Other - Not Specified|1
742609|NCT00374868|2378369|P1|Overall Study|Death|2
742610|NCT00374868|2378369|P1|Overall Study|Lost to Follow-up|1
742611|NCT00374868|2378369|P1|Overall Study|Physician Decision|13
742612|NCT00374868|2378369|P1|Overall Study|Progressive Disease|7
742613|NCT00374868|2378369|P1|Overall Study|Adverse Event|12
890732|NCT00880906|2825834|P2|Overall Study|Did not meet criteria following patholog|6
890733|NCT00880906|2825835|P1|Overall Study|Did not meet criteria following patholog|12
890734|NCT00880906|2825834|P2|Overall Study|Lost to Follow-up|1
890735|NCT00880906|2825835|P1|Overall Study|Lost to Follow-up|0
890736|NCT00855335|2825847|P4|Overall Study|Other|5
890737|NCT00855335|2825848|P3|Overall Study|Other|2
890738|NCT00855335|2825849|P2|Overall Study|Other|1
742624|NCT00380588|2378397|P2|Overall Study|Physician Decision|0
742625|NCT00380588|2378398|P1|Overall Study|Physician Decision|2
742626|NCT00380588|2378397|P2|Overall Study|Withdrawal by Subject|3
742627|NCT00380588|2378398|P1|Overall Study|Withdrawal by Subject|1
742628|NCT00380588|2378397|P2|Overall Study|Adverse Event|3
742629|NCT00380588|2378398|P1|Overall Study|Adverse Event|7
742630|NCT00380588|2378397|P2|Overall Study|Next Cycle Not Started|0
742631|NCT00380588|2378398|P1|Overall Study|Next Cycle Not Started|4
742632|NCT00380588|2378397|P2|Overall Study|Unequivocal Disease Progression|34
742633|NCT00380588|2378398|P1|Overall Study|Unequivocal Disease Progression|25
742634|NCT00380692|2378412|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
742635|NCT00380692|2378413|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
742636|NCT00380692|2378412|P2|Study Period III - Open Label|Lack of Efficacy|4
742637|NCT00380692|2378413|P1|Study Period III - Open Label|Lack of Efficacy|0
742638|NCT00380692|2378412|P2|Study Period III - Open Label|Physician Decision|3
742639|NCT00380692|2378413|P1|Study Period III - Open Label|Physician Decision|0
742640|NCT00380692|2378412|P2|Study Period III - Open Label|Withdrawal by Subject|1
742641|NCT00380692|2378413|P1|Study Period III - Open Label|Withdrawal by Subject|0
742642|NCT00380692|2378412|P2|Study Period III - Open Label|Protocol Violation|0
742643|NCT00380692|2378413|P1|Study Period III - Open Label|Protocol Violation|0
742644|NCT00380692|2378412|P2|Study Period III - Open Label|Adverse Event|3
742645|NCT00380692|2378413|P1|Study Period III - Open Label|Adverse Event|5
742646|NCT00380692|2378412|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
742647|NCT00380692|2378413|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
742648|NCT00380692|2378412|P2|Study Period II - Double Blind|Lack of Efficacy|0
742649|NCT00380692|2378413|P1|Study Period II - Double Blind|Lack of Efficacy|1
742650|NCT00380692|2378412|P2|Study Period II - Double Blind|Physician Decision|1
742651|NCT00380692|2378413|P1|Study Period II - Double Blind|Physician Decision|0
742652|NCT00380692|2378412|P2|Study Period II - Double Blind|Withdrawal by Subject|0
742653|NCT00380692|2378413|P1|Study Period II - Double Blind|Withdrawal by Subject|0
742654|NCT00380692|2378412|P2|Study Period II - Double Blind|Protocol Violation|2
742655|NCT00380692|2378413|P1|Study Period II - Double Blind|Protocol Violation|2
742656|NCT00380692|2378412|P2|Study Period II - Double Blind|Adverse Event|0
742657|NCT00380692|2378413|P1|Study Period II - Double Blind|Adverse Event|1
742658|NCT00380718|2378459|P1|Overall Study|Death after 30-day post-therapy followup|17
742659|NCT00380718|2378459|P1|Overall Study|Adverse Event|1
742660|NCT00384293|2378480|P3|Post-randomization Period|Patient Randomized in Error|1
742661|NCT00384293|2378481|P2|Post-randomization Period|Patient Randomized in Error|0
742662|NCT00384293|2378482|P1|Post-randomization Period|Patient Randomized in Error|0
742663|NCT00384293|2378480|P3|Post-randomization Period|Trial Termination|204
742664|NCT00384293|2378481|P2|Post-randomization Period|Trial Termination|180
742665|NCT00384293|2378482|P1|Post-randomization Period|Trial Termination|0
742666|NCT00384293|2378480|P3|Post-randomization Period|Withdrawal by Subject|6
742667|NCT00384293|2378481|P2|Post-randomization Period|Withdrawal by Subject|8
742668|NCT00384293|2378482|P1|Post-randomization Period|Withdrawal by Subject|0
742669|NCT00384293|2378480|P3|Post-randomization Period|Protocol Violation|0
742670|NCT00384293|2378481|P2|Post-randomization Period|Protocol Violation|1
742671|NCT00384293|2378482|P1|Post-randomization Period|Protocol Violation|0
742672|NCT00384293|2378480|P3|Post-randomization Period|Lost to Follow-up|1
742673|NCT00384293|2378481|P2|Post-randomization Period|Lost to Follow-up|2
742674|NCT00384293|2378482|P1|Post-randomization Period|Lost to Follow-up|0
742675|NCT00384293|2378480|P3|Post-randomization Period|Adverse Event|7
742676|NCT00384293|2378481|P2|Post-randomization Period|Adverse Event|23
742677|NCT00384293|2378482|P1|Post-randomization Period|Adverse Event|0
742678|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
742679|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
742680|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
742681|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
742682|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
742683|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
742684|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
742685|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
742686|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
742687|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
742688|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
742689|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
742690|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
890739|NCT00855335|2825850|P1|Overall Study|Other|2
890740|NCT00855335|2825847|P4|Overall Study|Physician Decision|0
742691|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
742692|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
742693|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
742694|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
742695|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
742696|NCT00384293|2378480|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
742697|NCT00384293|2378481|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
742698|NCT00384293|2378482|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
742699|NCT00384332|2378495|P2|Overall Study|Lost to Follow-up|0
742700|NCT00384332|2378496|P1|Overall Study|Lost to Follow-up|4
742701|NCT00384397|2378507|P3|Overall Study|Withdrawal by Subject|15
742702|NCT00384397|2378508|P2|Overall Study|Withdrawal by Subject|17
742703|NCT00384397|2378509|P1|Overall Study|Withdrawal by Subject|14
742704|NCT00384397|2378507|P3|Overall Study|Lost to Follow-up|3
742705|NCT00384397|2378508|P2|Overall Study|Lost to Follow-up|13
742706|NCT00384397|2378509|P1|Overall Study|Lost to Follow-up|11
742707|NCT00384397|2378507|P3|Overall Study|Protocol Violation|13
742708|NCT00384397|2378508|P2|Overall Study|Protocol Violation|15
742709|NCT00384397|2378509|P1|Overall Study|Protocol Violation|7
742710|NCT00384397|2378507|P3|Overall Study|Adverse Event|2
742711|NCT00384397|2378508|P2|Overall Study|Adverse Event|1
742712|NCT00384397|2378509|P1|Overall Study|Adverse Event|0
742713|NCT00384930|2378584|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
742714|NCT00384930|2378585|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
742715|NCT00384930|2378586|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
742716|NCT00384930|2378587|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
742717|NCT00384930|2378588|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
742718|NCT00384930|2378584|P5|Overall Study|Withdrawal by Subject|16
742719|NCT00384930|2378585|P4|Overall Study|Withdrawal by Subject|6
742720|NCT00384930|2378586|P3|Overall Study|Withdrawal by Subject|7
742721|NCT00384930|2378587|P2|Overall Study|Withdrawal by Subject|7
742722|NCT00384930|2378588|P1|Overall Study|Withdrawal by Subject|9
742723|NCT00384930|2378584|P5|Overall Study|Sponsor Decision|0
742724|NCT00384930|2378585|P4|Overall Study|Sponsor Decision|5
742725|NCT00384930|2378586|P3|Overall Study|Sponsor Decision|0
742726|NCT00384930|2378587|P2|Overall Study|Sponsor Decision|4
742727|NCT00384930|2378588|P1|Overall Study|Sponsor Decision|3
742728|NCT00384930|2378584|P5|Overall Study|Protocol Violation|4
742729|NCT00384930|2378585|P4|Overall Study|Protocol Violation|6
742730|NCT00384930|2378586|P3|Overall Study|Protocol Violation|1
742731|NCT00384930|2378587|P2|Overall Study|Protocol Violation|0
742732|NCT00384930|2378588|P1|Overall Study|Protocol Violation|1
742733|NCT00384930|2378584|P5|Overall Study|Physician Decision|1
742734|NCT00384930|2378585|P4|Overall Study|Physician Decision|0
742735|NCT00384930|2378586|P3|Overall Study|Physician Decision|1
742736|NCT00384930|2378587|P2|Overall Study|Physician Decision|1
742737|NCT00384930|2378588|P1|Overall Study|Physician Decision|0
742738|NCT00384930|2378584|P5|Overall Study|Lost to Follow-up|6
742739|NCT00384930|2378585|P4|Overall Study|Lost to Follow-up|4
742740|NCT00384930|2378586|P3|Overall Study|Lost to Follow-up|0
742741|NCT00384930|2378587|P2|Overall Study|Lost to Follow-up|3
742742|NCT00384930|2378588|P1|Overall Study|Lost to Follow-up|5
742743|NCT00384930|2378584|P5|Overall Study|Lack of Efficacy|2
742744|NCT00384930|2378585|P4|Overall Study|Lack of Efficacy|1
742745|NCT00384930|2378586|P3|Overall Study|Lack of Efficacy|2
742746|NCT00384930|2378587|P2|Overall Study|Lack of Efficacy|1
742747|NCT00384930|2378588|P1|Overall Study|Lack of Efficacy|1
742748|NCT00384930|2378584|P5|Overall Study|Entry Criteria Not Met|4
742749|NCT00384930|2378585|P4|Overall Study|Entry Criteria Not Met|8
742750|NCT00384930|2378586|P3|Overall Study|Entry Criteria Not Met|7
742751|NCT00384930|2378587|P2|Overall Study|Entry Criteria Not Met|6
742752|NCT00384930|2378588|P1|Overall Study|Entry Criteria Not Met|2
742753|NCT00384930|2378584|P5|Overall Study|Adverse Event|14
742754|NCT00384930|2378585|P4|Overall Study|Adverse Event|11
742755|NCT00384930|2378586|P3|Overall Study|Adverse Event|12
742756|NCT00384930|2378587|P2|Overall Study|Adverse Event|4
742757|NCT00384930|2378588|P1|Overall Study|Adverse Event|5
742758|NCT00384956|2378642|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
742759|NCT00385203|2378703|P2|Overall Study|Incorrect enrollment|0
742760|NCT00385203|2378704|P1|Overall Study|Incorrect enrollment|2
742761|NCT00385203|2378703|P2|Overall Study|Condition under investigation worsened|3
742762|NCT00385203|2378704|P1|Overall Study|Condition under investigation worsened|18
742763|NCT00385203|2378703|P2|Overall Study|Death|0
742764|NCT00385203|2378704|P1|Overall Study|Death|1
742765|NCT00385203|2378703|P2|Overall Study|Adverse Event|4
742766|NCT00385203|2378704|P1|Overall Study|Adverse Event|5
742767|NCT00385541|2378755|P2|Overall Study|severe pain, clinician requested unblind|1
742768|NCT00385541|2378756|P1|Overall Study|severe pain, clinician requested unblind|0
742769|NCT00385593|2378864|P2|Overall Study|Incorrect randomization|1
742770|NCT00385593|2378865|P1|Overall Study|Incorrect randomization|0
742771|NCT00385593|2378864|P2|Overall Study|Incorrect inclusion|0
742772|NCT00385593|2378865|P1|Overall Study|Incorrect inclusion|2
742773|NCT00385593|2378864|P2|Overall Study|Several reasons|15
742774|NCT00385593|2378865|P1|Overall Study|Several reasons|17
742775|NCT00385593|2378864|P2|Overall Study|Protocol Violation|4
742776|NCT00385593|2378865|P1|Overall Study|Protocol Violation|7
742777|NCT00385593|2378864|P2|Overall Study|Lost to Follow-up|8
742778|NCT00385593|2378865|P1|Overall Study|Lost to Follow-up|12
742779|NCT00385593|2378864|P2|Overall Study|Withdrawal by Subject|7
742780|NCT00385593|2378865|P1|Overall Study|Withdrawal by Subject|17
742781|NCT00385593|2378864|P2|Overall Study|Adverse Event|2
742782|NCT00385593|2378865|P1|Overall Study|Adverse Event|3
742783|NCT00385671|2378884|P3|Overall Study|Withdrawal by Subject|4
742784|NCT00385671|2378885|P2|Overall Study|Withdrawal by Subject|4
742785|NCT00385671|2378886|P1|Overall Study|Withdrawal by Subject|4
742786|NCT00385671|2378884|P3|Overall Study|Sponsor Decision|1
742787|NCT00385671|2378885|P2|Overall Study|Sponsor Decision|2
742788|NCT00385671|2378886|P1|Overall Study|Sponsor Decision|2
742789|NCT00385671|2378884|P3|Overall Study|Protocol Violation|1
742790|NCT00385671|2378885|P2|Overall Study|Protocol Violation|2
742791|NCT00385671|2378886|P1|Overall Study|Protocol Violation|5
742792|NCT00385671|2378884|P3|Overall Study|Physician Decision|2
742793|NCT00385671|2378885|P2|Overall Study|Physician Decision|1
742794|NCT00385671|2378886|P1|Overall Study|Physician Decision|2
742795|NCT00385671|2378884|P3|Overall Study|Lost to Follow-up|5
742796|NCT00385671|2378885|P2|Overall Study|Lost to Follow-up|6
742797|NCT00385671|2378886|P1|Overall Study|Lost to Follow-up|6
742798|NCT00385671|2378884|P3|Overall Study|Lack of Efficacy|5
742799|NCT00385671|2378885|P2|Overall Study|Lack of Efficacy|9
742800|NCT00385671|2378886|P1|Overall Study|Lack of Efficacy|5
742801|NCT00385671|2378884|P3|Overall Study|Adverse Event|18
742802|NCT00385671|2378885|P2|Overall Study|Adverse Event|27
742803|NCT00385671|2378886|P1|Overall Study|Adverse Event|14
742804|NCT00385684|2379040|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
742805|NCT00385684|2379041|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
742806|NCT00385684|2379040|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
742807|NCT00385684|2379041|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
742808|NCT00385684|2379040|P2|FIRST INTERVENTION OF PHASE A|Death|0
742809|NCT00385684|2379041|P1|FIRST INTERVENTION OF PHASE A|Death|1
742810|NCT00385723|2379050|P3|Overall Study|Withdrawal by Subject|2
742811|NCT00385723|2379051|P2|Overall Study|Withdrawal by Subject|0
742812|NCT00385723|2379052|P1|Overall Study|Withdrawal by Subject|1
742813|NCT00385723|2379050|P3|Overall Study|Lost to Follow-up|0
742814|NCT00385723|2379051|P2|Overall Study|Lost to Follow-up|1
742815|NCT00385723|2379052|P1|Overall Study|Lost to Follow-up|1
742816|NCT00385736|2379069|P3|Safety Analysis Set|Other|4
742817|NCT00385736|2379070|P2|Safety Analysis Set|Other|4
742818|NCT00385736|2379071|P1|Safety Analysis Set|Other|1
742819|NCT00385736|2379069|P3|Safety Analysis Set|Protocol Violation|6
742820|NCT00385736|2379070|P2|Safety Analysis Set|Protocol Violation|1
742821|NCT00385736|2379071|P1|Safety Analysis Set|Protocol Violation|2
742822|NCT00385736|2379069|P3|Safety Analysis Set|Lack of Efficacy|31
742823|NCT00385736|2379070|P2|Safety Analysis Set|Lack of Efficacy|16
742824|NCT00385736|2379071|P1|Safety Analysis Set|Lack of Efficacy|38
742825|NCT00385736|2379069|P3|Safety Analysis Set|Lost to Follow-up|2
742826|NCT00385736|2379070|P2|Safety Analysis Set|Lost to Follow-up|2
742827|NCT00385736|2379071|P1|Safety Analysis Set|Lost to Follow-up|0
742828|NCT00385736|2379069|P3|Safety Analysis Set|Withdrawal by Subject|14
742829|NCT00385736|2379070|P2|Safety Analysis Set|Withdrawal by Subject|6
742830|NCT00385736|2379071|P1|Safety Analysis Set|Withdrawal by Subject|6
742831|NCT00385736|2379069|P3|Safety Analysis Set|Adverse Event|23
742832|NCT00385736|2379070|P2|Safety Analysis Set|Adverse Event|15
742833|NCT00385736|2379071|P1|Safety Analysis Set|Adverse Event|23
742834|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Other|4
742835|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Other|4
742836|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Other|0
742837|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
742838|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
742839|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
742840|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
742841|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
742842|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
742843|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
742844|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
742845|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
742846|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
742847|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
742848|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
742849|NCT00385736|2379069|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
742850|NCT00385736|2379070|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
742851|NCT00385736|2379071|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
742852|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Other|1
742853|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Other|0
742854|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Other|0
742855|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
742856|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
742857|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
742858|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
742859|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
742860|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
742861|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
742862|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
742863|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
742864|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
742865|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
742866|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
742867|NCT00385736|2379069|P3|Efficacy Analysis Set - Induction|Adverse Event|4
742868|NCT00385736|2379070|P2|Efficacy Analysis Set - Induction|Adverse Event|6
742869|NCT00385736|2379071|P1|Efficacy Analysis Set - Induction|Adverse Event|5
742870|NCT00385762|2379113|P1|Overall Study|Lost to Follow-up|1
742871|NCT00385762|2379113|P1|Overall Study|Adverse Event|1
742872|NCT00385827|2379138|P3|Part 2|Unspecified|21
742873|NCT00385827|2379139|P2|Part 2|Unspecified|11
742874|NCT00385827|2379140|P1|Part 2|Unspecified|0
742875|NCT00385827|2379138|P3|Part 2|Randomized but not treated|2
742876|NCT00385827|2379139|P2|Part 2|Randomized but not treated|2
742877|NCT00385827|2379140|P1|Part 2|Randomized but not treated|0
742878|NCT00385827|2379138|P3|Part 2|Lack of Efficacy|13
742879|NCT00385827|2379139|P2|Part 2|Lack of Efficacy|14
742880|NCT00385827|2379140|P1|Part 2|Lack of Efficacy|0
742881|NCT00385827|2379138|P3|Part 2|Death|2
742882|NCT00385827|2379139|P2|Part 2|Death|0
742883|NCT00385827|2379140|P1|Part 2|Death|0
742884|NCT00385827|2379138|P3|Part 2|Adverse Event|10
742885|NCT00385827|2379139|P2|Part 2|Adverse Event|6
742886|NCT00385827|2379140|P1|Part 2|Adverse Event|0
742887|NCT00385827|2379138|P3|Part 1|Unspecified|0
742888|NCT00385827|2379139|P2|Part 1|Unspecified|0
742889|NCT00385827|2379140|P1|Part 1|Unspecified|1
742890|NCT00385827|2379138|P3|Part 1|Lack of Efficacy|0
742891|NCT00385827|2379139|P2|Part 1|Lack of Efficacy|0
742892|NCT00385827|2379140|P1|Part 1|Lack of Efficacy|5
742893|NCT00385827|2379138|P3|Part 1|Death|0
742894|NCT00385827|2379139|P2|Part 1|Death|0
742895|NCT00385827|2379140|P1|Part 1|Death|2
742896|NCT00385827|2379138|P3|Part 1|Adverse Event|0
742897|NCT00385827|2379139|P2|Part 1|Adverse Event|0
742898|NCT00385827|2379140|P1|Part 1|Adverse Event|1
742899|NCT00385840|2379162|P2|Overall Study|Lost to Follow-up|13
742900|NCT00385840|2379163|P1|Overall Study|Lost to Follow-up|3
742901|NCT00385840|2379162|P2|Overall Study|Adverse Event|1
742902|NCT00385840|2379163|P1|Overall Study|Adverse Event|1
742903|NCT00385918|2379185|P3|Intervention Phase After Randomization|Lost to Follow-up|0
742904|NCT00385918|2379186|P2|Intervention Phase After Randomization|Lost to Follow-up|0
742905|NCT00385918|2379187|P1|Intervention Phase After Randomization|Lost to Follow-up|1
742906|NCT00385918|2379185|P3|Intervention Phase After Randomization|Physician Decision|0
742907|NCT00385918|2379186|P2|Intervention Phase After Randomization|Physician Decision|0
742908|NCT00385918|2379187|P1|Intervention Phase After Randomization|Physician Decision|1
742909|NCT00385918|2379185|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
742910|NCT00385918|2379186|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
742911|NCT00385918|2379187|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
742912|NCT00385918|2379185|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
742913|NCT00385918|2379186|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
742914|NCT00385918|2379187|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
742915|NCT00385918|2379185|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
742916|NCT00385918|2379186|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
742917|NCT00385918|2379187|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
742918|NCT00385918|2379185|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
742919|NCT00385918|2379186|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
742920|NCT00385918|2379187|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
742921|NCT00385944|2379211|P3|2nd Maintenance Dose Period|Invalid PD Data|0
742922|NCT00385944|2379212|P2|2nd Maintenance Dose Period|Invalid PD Data|3
742923|NCT00385944|2379213|P1|2nd Maintenance Dose Period|Invalid PD Data|2
742924|NCT00385944|2379211|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
742925|NCT00385944|2379212|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
742926|NCT00385944|2379213|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
742927|NCT00385944|2379211|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
742928|NCT00385944|2379212|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
742929|NCT00385944|2379213|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
742930|NCT00385944|2379211|P3|1st Maintenance Dose Period|Physician Decision|0
742931|NCT00385944|2379212|P2|1st Maintenance Dose Period|Physician Decision|0
742932|NCT00385944|2379213|P1|1st Maintenance Dose Period|Physician Decision|1
742933|NCT00386009|2379261|P2|Overall Study|Withdrawal by Subject|4
742934|NCT00386009|2379262|P1|Overall Study|Withdrawal by Subject|5
742935|NCT00386009|2379261|P2|Overall Study|Sponsor Decision|1
742936|NCT00386009|2379262|P1|Overall Study|Sponsor Decision|1
742937|NCT00386009|2379261|P2|Overall Study|Protocol Violation|0
742938|NCT00386009|2379262|P1|Overall Study|Protocol Violation|1
742939|NCT00386009|2379261|P2|Overall Study|Lost to Follow-up|1
742940|NCT00386009|2379262|P1|Overall Study|Lost to Follow-up|1
742941|NCT00386009|2379261|P2|Overall Study|Entry Criteria Not Met|2
742942|NCT00386009|2379262|P1|Overall Study|Entry Criteria Not Met|0
742943|NCT00386009|2379261|P2|Overall Study|Death|0
742944|NCT00386009|2379262|P1|Overall Study|Death|1
742945|NCT00386009|2379261|P2|Overall Study|Adverse Event|2
742946|NCT00386009|2379262|P1|Overall Study|Adverse Event|0
742947|NCT00386022|2379302|P2|Plus Estrogen|Adverse Event|1
742948|NCT00386022|2379303|P1|Plus Estrogen|Adverse Event|0
742949|NCT00386022|2379302|P2|Plus Estrogen|Lost to Follow-up|0
742950|NCT00386022|2379303|P1|Plus Estrogen|Lost to Follow-up|2
742951|NCT00386100|2379313|P2|Overall Study|Participant randomized in error|0
742952|NCT00386100|2379314|P1|Overall Study|Participant randomized in error|1
742953|NCT00386100|2379313|P2|Overall Study|Hb1Ac >8%|1
742954|NCT00386100|2379314|P1|Overall Study|Hb1Ac >8%|0
742955|NCT00386100|2379313|P2|Overall Study|Out of country for 5 months|0
742956|NCT00386100|2379314|P1|Overall Study|Out of country for 5 months|1
742957|NCT00386100|2379313|P2|Overall Study|Positive pregnancy test|3
742958|NCT00386100|2379314|P1|Overall Study|Positive pregnancy test|1
742959|NCT00386100|2379313|P2|Overall Study|Osteoporosis|1
742960|NCT00386100|2379314|P1|Overall Study|Osteoporosis|0
742961|NCT00386100|2379313|P2|Overall Study|7.6% bone loss|0
742962|NCT00386100|2379314|P1|Overall Study|7.6% bone loss|1
742963|NCT00386100|2379313|P2|Overall Study|DBP 93 mmHg at randomization|0
742964|NCT00386100|2379314|P1|Overall Study|DBP 93 mmHg at randomization|1
742965|NCT00386100|2379313|P2|Overall Study|Bone loss by DXA bone scan|0
742966|NCT00386100|2379314|P1|Overall Study|Bone loss by DXA bone scan|1
742967|NCT00386100|2379313|P2|Overall Study|Bad metabolic control & patient security|0
742968|NCT00386100|2379314|P1|Overall Study|Bad metabolic control & patient security|1
742969|NCT00386100|2379313|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
742970|NCT00386100|2379314|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
742971|NCT00386100|2379313|P2|Overall Study|Participant's PCP wanted to stop drug|0
742972|NCT00386100|2379314|P1|Overall Study|Participant's PCP wanted to stop drug|1
742973|NCT00386100|2379313|P2|Overall Study|Didn't meet entry criteria|1
742974|NCT00386100|2379314|P1|Overall Study|Didn't meet entry criteria|1
742975|NCT00386100|2379313|P2|Overall Study|Excessive bone loss vs. baseline value|1
742976|NCT00386100|2379314|P1|Overall Study|Excessive bone loss vs. baseline value|0
742977|NCT00386100|2379313|P2|Overall Study|Participant moving out of state|0
742978|NCT00386100|2379314|P1|Overall Study|Participant moving out of state|2
742979|NCT00386100|2379313|P2|Overall Study|Participant's concern due to CPK levels|0
742980|NCT00386100|2379314|P1|Overall Study|Participant's concern due to CPK levels|1
742981|NCT00386100|2379313|P2|Overall Study|Laboratory findings|0
742982|NCT00386100|2379314|P1|Overall Study|Laboratory findings|1
742983|NCT00386100|2379313|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
742984|NCT00386100|2379314|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
742985|NCT00386100|2379313|P2|Overall Study|Consecutive elevated Hba1C|0
742986|NCT00386100|2379314|P1|Overall Study|Consecutive elevated Hba1C|1
742987|NCT00386100|2379313|P2|Overall Study|BMD <2.5|0
742988|NCT00386100|2379314|P1|Overall Study|BMD <2.5|1
742989|NCT00386100|2379313|P2|Overall Study|Bone mass density (BMD) loss >6%|4
742990|NCT00386100|2379314|P1|Overall Study|Bone mass density (BMD) loss >6%|4
742991|NCT00386100|2379313|P2|Overall Study|Withdrawal by Subject|31
742992|NCT00386100|2379314|P1|Overall Study|Withdrawal by Subject|32
742993|NCT00386100|2379313|P2|Overall Study|Protocol Violation|3
742994|NCT00386100|2379314|P1|Overall Study|Protocol Violation|5
742995|NCT00386100|2379313|P2|Overall Study|Non-compliance|19
742996|NCT00386100|2379314|P1|Overall Study|Non-compliance|18
742997|NCT00386100|2379313|P2|Overall Study|Lost to Follow-up|29
742998|NCT00386100|2379314|P1|Overall Study|Lost to Follow-up|29
742999|NCT00386100|2379313|P2|Overall Study|Insufficient therapeutic effect|6
743000|NCT00386100|2379314|P1|Overall Study|Insufficient therapeutic effect|30
743001|NCT00386100|2379313|P2|Overall Study|Death|1
743002|NCT00386100|2379314|P1|Overall Study|Death|0
743003|NCT00386100|2379313|P2|Overall Study|Adverse Event|25
743004|NCT00386100|2379314|P1|Overall Study|Adverse Event|15
743005|NCT00386100|2379313|P2|Overall Study|Did not receive study medication|4
743006|NCT00386100|2379314|P1|Overall Study|Did not receive study medication|6
743007|NCT00386152|2379379|P3|Overall Study|Withdrawal by Subject|10
743008|NCT00386152|2379380|P2|Overall Study|Withdrawal by Subject|6
743009|NCT00386152|2379381|P1|Overall Study|Withdrawal by Subject|3
743010|NCT00386152|2379379|P3|Overall Study|Protocol Violation|2
743011|NCT00386152|2379380|P2|Overall Study|Protocol Violation|5
743012|NCT00386152|2379381|P1|Overall Study|Protocol Violation|3
743013|NCT00386152|2379379|P3|Overall Study|Completed chemotherapy|1
743014|NCT00386152|2379380|P2|Overall Study|Completed chemotherapy|5
743015|NCT00386152|2379381|P1|Overall Study|Completed chemotherapy|4
743016|NCT00386152|2379379|P3|Overall Study|Lost to Follow-up|0
743017|NCT00386152|2379380|P2|Overall Study|Lost to Follow-up|0
743018|NCT00386152|2379381|P1|Overall Study|Lost to Follow-up|1
743019|NCT00386152|2379379|P3|Overall Study|Physician Decision|4
743020|NCT00386152|2379380|P2|Overall Study|Physician Decision|10
743021|NCT00386152|2379381|P1|Overall Study|Physician Decision|13
743022|NCT00386152|2379379|P3|Overall Study|Disease progression|5
743023|NCT00386152|2379380|P2|Overall Study|Disease progression|4
743024|NCT00386152|2379381|P1|Overall Study|Disease progression|7
743025|NCT00386152|2379379|P3|Overall Study|Death|1
743026|NCT00386152|2379380|P2|Overall Study|Death|0
743027|NCT00386152|2379381|P1|Overall Study|Death|3
743028|NCT00386152|2379379|P3|Overall Study|Chang from original chemo stratification|6
743029|NCT00386152|2379380|P2|Overall Study|Chang from original chemo stratification|5
743030|NCT00386152|2379381|P1|Overall Study|Chang from original chemo stratification|4
743031|NCT00386152|2379379|P3|Overall Study|Adverse Event|4
743032|NCT00386152|2379380|P2|Overall Study|Adverse Event|5
743033|NCT00386152|2379381|P1|Overall Study|Adverse Event|6
743034|NCT00386308|2379432|P2|Overall Study|Other Event|1
743035|NCT00386308|2379433|P1|Overall Study|Other Event|8
743036|NCT00386308|2379432|P2|Overall Study|Withdrawal by Subject|2
743037|NCT00386308|2379433|P1|Overall Study|Withdrawal by Subject|6
743038|NCT00386308|2379432|P2|Overall Study|Lost to Follow-up|6
743039|NCT00386308|2379433|P1|Overall Study|Lost to Follow-up|10
743040|NCT00386308|2379432|P2|Overall Study|Lack of Efficacy|2
743041|NCT00386308|2379433|P1|Overall Study|Lack of Efficacy|0
743042|NCT00386308|2379432|P2|Overall Study|Protocol Violation|5
743043|NCT00386308|2379433|P1|Overall Study|Protocol Violation|2
743044|NCT00386308|2379432|P2|Overall Study|Adverse Event|3
743045|NCT00386308|2379433|P1|Overall Study|Adverse Event|3
743046|NCT00386334|2379447|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
743047|NCT00386334|2379448|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
743048|NCT00386334|2379447|P2|Double Blind Period|Other|3
743049|NCT00386334|2379448|P1|Double Blind Period|Other|3
743050|NCT00386334|2379447|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
743051|NCT00386334|2379448|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
743052|NCT00386334|2379447|P2|Double Blind Period|Lack of Efficacy|11
743053|NCT00386334|2379448|P1|Double Blind Period|Lack of Efficacy|20
743054|NCT00386334|2379447|P2|Double Blind Period|Withdrawal by Subject|13
743055|NCT00386334|2379448|P1|Double Blind Period|Withdrawal by Subject|9
743056|NCT00386334|2379447|P2|Double Blind Period|Protocol Violation|1
743057|NCT00386334|2379448|P1|Double Blind Period|Protocol Violation|1
743058|NCT00386334|2379447|P2|Double Blind Period|Adverse Event|14
743059|NCT00386334|2379448|P1|Double Blind Period|Adverse Event|9
743060|NCT00386360|2379592|P2|Overall Study|Did not take any study medication|2
743061|NCT00386360|2379593|P1|Overall Study|Did not take any study medication|0
743062|NCT00386360|2379592|P2|Overall Study|Withdrawal by Subject|6
743063|NCT00386360|2379593|P1|Overall Study|Withdrawal by Subject|3
743064|NCT00386360|2379592|P2|Overall Study|Protocol Violation|3
743065|NCT00386360|2379593|P1|Overall Study|Protocol Violation|0
743066|NCT00386360|2379592|P2|Overall Study|Lost to Follow-up|2
743067|NCT00386360|2379593|P1|Overall Study|Lost to Follow-up|0
743068|NCT00386360|2379592|P2|Overall Study|Physician Decision|2
743069|NCT00386360|2379593|P1|Overall Study|Physician Decision|2
743070|NCT00386360|2379592|P2|Overall Study|Adverse Event|2
743071|NCT00386360|2379593|P1|Overall Study|Adverse Event|4
743072|NCT00386425|2379628|P3|Overall Study|Withdrawal by Subject|0
743073|NCT00386425|2379629|P2|Overall Study|Withdrawal by Subject|1
743074|NCT00386425|2379630|P1|Overall Study|Withdrawal by Subject|0
743075|NCT00386425|2379628|P3|Overall Study|Physician Decision|0
743076|NCT00386425|2379629|P2|Overall Study|Physician Decision|0
743077|NCT00386425|2379630|P1|Overall Study|Physician Decision|3
743078|NCT00386607|2379663|P2|Extension|Unsatisfactory therapeutic effect|1
743079|NCT00386607|2379664|P1|Extension|Unsatisfactory therapeutic effect|0
743080|NCT00386607|2379663|P2|Extension|Patient withdrew consent|5
743081|NCT00386607|2379664|P1|Extension|Patient withdrew consent|0
743082|NCT00386607|2379663|P2|Extension|Lost to Follow-up|3
743083|NCT00386607|2379664|P1|Extension|Lost to Follow-up|0
743084|NCT00386607|2379663|P2|Extension|Administrative problems|1
743085|NCT00386607|2379664|P1|Extension|Administrative problems|0
743086|NCT00386607|2379663|P2|Extension|Abnormal laboratory value(s)|1
743087|NCT00386607|2379664|P1|Extension|Abnormal laboratory value(s)|0
743088|NCT00386607|2379663|P2|Extension|Adverse Event|6
743089|NCT00386607|2379664|P1|Extension|Adverse Event|0
743090|NCT00386607|2379663|P2|Core|Protocol Deviation|0
743091|NCT00386607|2379664|P1|Core|Protocol Deviation|6
743092|NCT00386607|2379663|P2|Core|Administrative problems|0
743093|NCT00386607|2379664|P1|Core|Administrative problems|1
743094|NCT00386607|2379663|P2|Core|Lost to Follow-up|0
743095|NCT00386607|2379664|P1|Core|Lost to Follow-up|23
743096|NCT00386607|2379663|P2|Core|Patient withdrew consent|0
743097|NCT00386607|2379664|P1|Core|Patient withdrew consent|15
743098|NCT00386607|2379663|P2|Core|Condition no longer requires study drug|0
743099|NCT00386607|2379664|P1|Core|Condition no longer requires study drug|4
743100|NCT00386607|2379663|P2|Core|Unsatisfactory therapeutic effect|0
743101|NCT00386607|2379664|P1|Core|Unsatisfactory therapeutic effect|23
743102|NCT00386607|2379663|P2|Core|Abnormal laboratory value(s)|0
743103|NCT00386607|2379664|P1|Core|Abnormal laboratory value(s)|3
743104|NCT00386607|2379663|P2|Core|Adverse Event|0
743105|NCT00386607|2379664|P1|Core|Adverse Event|40
743106|NCT00366899|2379682|P2|Toddler Dose|Protocol Violation|0
743107|NCT00366899|2379683|P1|Toddler Dose|Protocol Violation|1
743108|NCT00366899|2379682|P2|Toddler Dose|Withdrawal by Subject|1
743109|NCT00366899|2379683|P1|Toddler Dose|Withdrawal by Subject|1
743110|NCT00366899|2379682|P2|After Infant Series|Protocol Violation|0
743111|NCT00366899|2379683|P1|After Infant Series|Protocol Violation|1
743112|NCT00366899|2379682|P2|After Infant Series|Adverse Event|2
743113|NCT00366899|2379683|P1|After Infant Series|Adverse Event|1
743114|NCT00366899|2379682|P2|After Infant Series|Withdrawal by Subject|4
743115|NCT00366899|2379683|P1|After Infant Series|Withdrawal by Subject|1
743116|NCT00366899|2379682|P2|After Infant Series|Lost to Follow-up|3
743117|NCT00366899|2379683|P1|After Infant Series|Lost to Follow-up|4
743118|NCT00366899|2379682|P2|Infant Series|Randomized but not consented|0
743119|NCT00366899|2379683|P1|Infant Series|Randomized but not consented|1
743120|NCT00366899|2379682|P2|Infant Series|Physician Decision|0
743121|NCT00366899|2379683|P1|Infant Series|Physician Decision|1
743122|NCT00366899|2379682|P2|Infant Series|Adverse Event|1
743123|NCT00366899|2379683|P1|Infant Series|Adverse Event|0
743124|NCT00366899|2379682|P2|Infant Series|Lost to Follow-up|2
743125|NCT00366899|2379683|P1|Infant Series|Lost to Follow-up|0
743126|NCT00366899|2379682|P2|Infant Series|Failed to return|1
743127|NCT00366899|2379683|P1|Infant Series|Failed to return|1
743128|NCT00366899|2379682|P2|Infant Series|Protocol Violation|1
743129|NCT00366899|2379683|P1|Infant Series|Protocol Violation|2
743130|NCT00366899|2379682|P2|Infant Series|Withdrawal by Subject|7
743131|NCT00366899|2379683|P1|Infant Series|Withdrawal by Subject|4
743132|NCT00367055|2379743|P2|Overall Study|Participant Living too Far from Hospital|1
743133|NCT00367055|2379744|P1|Overall Study|Participant Living too Far from Hospital|0
743134|NCT00367055|2379743|P2|Overall Study|Stopping Criterion Met|1
743135|NCT00367055|2379744|P1|Overall Study|Stopping Criterion Met|0
743136|NCT00367055|2379743|P2|Overall Study|Protocol Violation|1
743137|NCT00367055|2379744|P1|Overall Study|Protocol Violation|0
743138|NCT00367055|2379743|P2|Overall Study|Lost to Follow-up|1
743139|NCT00367055|2379744|P1|Overall Study|Lost to Follow-up|1
743140|NCT00367055|2379743|P2|Overall Study|Lack of Efficacy|2
743141|NCT00367055|2379744|P1|Overall Study|Lack of Efficacy|1
743142|NCT00367055|2379743|P2|Overall Study|Patient's Willing|2
743143|NCT00367055|2379744|P1|Overall Study|Patient's Willing|3
743144|NCT00367055|2379743|P2|Overall Study|Adverse Event|3
743145|NCT00367055|2379744|P1|Overall Study|Adverse Event|6
743146|NCT00367133|2379761|P3|2 Years|Missed visit|4
743147|NCT00367133|2379762|P2|2 Years|Missed visit|5
743148|NCT00367133|2379763|P1|2 Years|Missed visit|4
743149|NCT00367133|2379761|P3|2 Years|Dropped|33
743150|NCT00367133|2379762|P2|2 Years|Dropped|19
743151|NCT00367133|2379763|P1|2 Years|Dropped|34
743152|NCT00367133|2379761|P3|2 Years|Death|12
743153|NCT00367133|2379762|P2|2 Years|Death|12
743154|NCT00367133|2379763|P1|2 Years|Death|20
743155|NCT00377962|2379815|P2|Extension Study: 12-24 Months|Unspecified reason|3
743156|NCT00377962|2379816|P1|Extension Study: 12-24 Months|Unspecified reason|0
743157|NCT00377962|2379815|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
743158|NCT00377962|2379816|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
743159|NCT00377962|2379815|P2|Extension Study: 12-24 Months|Adverse Event|0
743160|NCT00377962|2379816|P1|Extension Study: 12-24 Months|Adverse Event|8
743161|NCT00377962|2379815|P2|Extension Study: 12-24 Months|Death|1
743162|NCT00377962|2379816|P1|Extension Study: 12-24 Months|Death|1
743163|NCT00377962|2379815|P2|Core Study: 0-12 Months|Unspecified reasons|4
743164|NCT00377962|2379816|P1|Core Study: 0-12 Months|Unspecified reasons|1
743165|NCT00377962|2379815|P2|Core Study: 0-12 Months|Administrative Reason|1
743166|NCT00377962|2379816|P1|Core Study: 0-12 Months|Administrative Reason|1
743167|NCT00377962|2379815|P2|Core Study: 0-12 Months|Withdrew Consent|2
743168|NCT00377962|2379816|P1|Core Study: 0-12 Months|Withdrew Consent|5
743169|NCT00377962|2379815|P2|Core Study: 0-12 Months|Death|0
743170|NCT00377962|2379816|P1|Core Study: 0-12 Months|Death|3
743171|NCT00377962|2379815|P2|Core Study: 0-12 Months|Adverse Event|2
743172|NCT00377962|2379816|P1|Core Study: 0-12 Months|Adverse Event|18
743173|NCT00386776|2379850|P1|Overall Study|Withdrawal by Subject|8
743174|NCT00387010|2379866|P1|Treatment Period|Participant reported study drug stolen|1
743175|NCT00387010|2379866|P1|Treatment Period|Noncompliance with study procedures|3
743176|NCT00387010|2379866|P1|Treatment Period|Noncompliance with study medication|2
743177|NCT00387010|2379866|P1|Treatment Period|Withdrawal by Subject|1
743178|NCT00387010|2379866|P1|Treatment Period|Adverse Event|4
743179|NCT00387010|2379866|P1|Dose Titration Period|Noncompliance with study procedures|7
743180|NCT00387010|2379866|P1|Dose Titration Period|Noncompliance with study medication|8
743181|NCT00387010|2379866|P1|Dose Titration Period|Lost to Follow-up|2
743182|NCT00387010|2379866|P1|Dose Titration Period|Protocol Violation|1
743183|NCT00387010|2379866|P1|Dose Titration Period|Withdrawal by Subject|3
743184|NCT00387010|2379866|P1|Dose Titration Period|Lack of Efficacy|5
743185|NCT00387010|2379866|P1|Dose Titration Period|Adverse Event|12
743186|NCT00387088|2379902|P2|Overall Study|Other|52
743187|NCT00387088|2379903|P1|Overall Study|Other|58
743188|NCT00387088|2379902|P2|Overall Study|Lost to Follow-up|28
743189|NCT00387088|2379903|P1|Overall Study|Lost to Follow-up|22
743190|NCT00387088|2379902|P2|Overall Study|Lack of Efficacy|67
743191|NCT00387088|2379903|P1|Overall Study|Lack of Efficacy|28
743192|NCT00387088|2379902|P2|Overall Study|Withdrawal by Subject|35
743193|NCT00387088|2379903|P1|Overall Study|Withdrawal by Subject|20
743194|NCT00387088|2379902|P2|Overall Study|Protocol Violation|35
743195|NCT00387088|2379903|P1|Overall Study|Protocol Violation|47
743196|NCT00387088|2379902|P2|Overall Study|Adverse Event|156
743197|NCT00387088|2379903|P1|Overall Study|Adverse Event|143
743198|NCT00388947|2379947|P1|Overall Study|Protocol Violation|47
743199|NCT00388973|2379954|P2|Overall Study|Did not complete 2-week follow-up visit|17
743200|NCT00388973|2379955|P1|Overall Study|Did not complete 2-week follow-up visit|17
743201|NCT00388973|2379954|P2|Overall Study|Left region|1
743202|NCT00388973|2379955|P1|Overall Study|Left region|0
743203|NCT00388973|2379954|P2|Overall Study|Did not complete 61 days of treatment|4
743204|NCT00388973|2379955|P1|Overall Study|Did not complete 61 days of treatment|5
743205|NCT00388973|2379954|P2|Overall Study|Study specific Discontinuation Criteria|1
743206|NCT00388973|2379955|P1|Overall Study|Study specific Discontinuation Criteria|0
743207|NCT00388973|2379954|P2|Overall Study|Withdrawal by Subject|17
743208|NCT00388973|2379955|P1|Overall Study|Withdrawal by Subject|14
743209|NCT00388973|2379954|P2|Overall Study|Protocol Violation|0
743210|NCT00388973|2379955|P1|Overall Study|Protocol Violation|3
743211|NCT00388973|2379954|P2|Overall Study|Lack of Efficacy|12
743212|NCT00388973|2379955|P1|Overall Study|Lack of Efficacy|1
743213|NCT00388973|2379954|P2|Overall Study|Adverse Event|6
743214|NCT00388973|2379955|P1|Overall Study|Adverse Event|16
743215|NCT00389064|2379977|P2|Overall Study|Multiple Reasons|11
743216|NCT00389064|2379978|P1|Overall Study|Multiple Reasons|9
743217|NCT00389064|2379977|P2|Overall Study|Protocol Violation|0
743218|NCT00389064|2379978|P1|Overall Study|Protocol Violation|2
743219|NCT00389064|2379977|P2|Overall Study|Lost to Follow-up|2
743220|NCT00389064|2379978|P1|Overall Study|Lost to Follow-up|1
743221|NCT00389064|2379977|P2|Overall Study|Physician Decision|2
743222|NCT00389064|2379978|P1|Overall Study|Physician Decision|2
743223|NCT00389064|2379977|P2|Overall Study|Withdrawal by Subject|27
743224|NCT00389064|2379978|P1|Overall Study|Withdrawal by Subject|17
743225|NCT00389064|2379977|P2|Overall Study|Lack of Efficacy|14
743226|NCT00389064|2379978|P1|Overall Study|Lack of Efficacy|3
743227|NCT00389064|2379977|P2|Overall Study|Adverse Event|3
743228|NCT00389064|2379978|P1|Overall Study|Adverse Event|11
743229|NCT00389207|2380026|P3|Overall Study|Not specified|9
743230|NCT00389207|2380027|P2|Overall Study|Not specified|23
743231|NCT00389207|2380028|P1|Overall Study|Not specified|17
743232|NCT00389207|2380026|P3|Overall Study|Withdrawal by Subject|11
743233|NCT00389207|2380027|P2|Overall Study|Withdrawal by Subject|7
743234|NCT00389207|2380028|P1|Overall Study|Withdrawal by Subject|5
743235|NCT00389207|2380026|P3|Overall Study|Lost to Follow-up|7
743236|NCT00389207|2380027|P2|Overall Study|Lost to Follow-up|9
743237|NCT00389207|2380028|P1|Overall Study|Lost to Follow-up|12
743238|NCT00389207|2380026|P3|Overall Study|Protocol Violation|4
743239|NCT00389207|2380027|P2|Overall Study|Protocol Violation|1
743240|NCT00389207|2380028|P1|Overall Study|Protocol Violation|3
743241|NCT00389207|2380026|P3|Overall Study|Adverse Event|10
743242|NCT00389207|2380027|P2|Overall Study|Adverse Event|32
743243|NCT00389207|2380028|P1|Overall Study|Adverse Event|26
743244|NCT00389324|2380130|P1|Subcutaneous Phase|Lost to Follow-up|1
743245|NCT00389324|2380130|P1|Subcutaneous Phase|Withdrawal by Subject|2
743246|NCT00389324|2380130|P1|Subcutaneous Phase|Non-compliance with study medication|2
743247|NCT00389324|2380130|P1|Subcutaneous Phase|Adverse Event|2
743248|NCT00389324|2380130|P1|Run-In Phase|Withdrawal by Subject|1
743249|NCT00389324|2380130|P1|Run-In Phase|Lost to Follow-up|1
743250|NCT00389324|2380130|P1|Run-In Phase|Adverse Event|1
743251|NCT00389441|2380137|P1|Overall Study|Clinical progression|1
743252|NCT00389441|2380137|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
743253|NCT00389441|2380137|P1|Overall Study|Objective progression or relapse|26
743254|NCT00389441|2380137|P1|Overall Study|Global deterioration of health status|4
743255|NCT00389441|2380137|P1|Overall Study|Protocol Violation|1
743256|NCT00389441|2380137|P1|Overall Study|Physician Decision|1
743257|NCT00389441|2380137|P1|Overall Study|Withdrawal by Subject|4
743258|NCT00389441|2380137|P1|Overall Study|Lost to Follow-up|2
743259|NCT00389441|2380137|P1|Overall Study|Death|4
743260|NCT00389441|2380137|P1|Overall Study|Adverse Event|7
743261|NCT00389519|2380201|P4|Treated|Reason not specified|2
743262|NCT00389519|2380202|P3|Treated|Reason not specified|0
743263|NCT00389519|2380203|P2|Treated|Reason not specified|1
743264|NCT00389519|2380204|P1|Treated|Reason not specified|1
743265|NCT00389519|2380201|P4|Treated|Adverse Event|2
743266|NCT00389519|2380202|P3|Treated|Adverse Event|0
743267|NCT00389519|2380203|P2|Treated|Adverse Event|0
743268|NCT00389519|2380204|P1|Treated|Adverse Event|1
743269|NCT00389519|2380201|P4|Randomized|Did not receive study drug|0
743270|NCT00389519|2380202|P3|Randomized|Did not receive study drug|0
743271|NCT00389519|2380203|P2|Randomized|Did not receive study drug|0
743272|NCT00389519|2380204|P1|Randomized|Did not receive study drug|2
743273|NCT00389519|2380201|P4|Placebo Run-In|Reason not specified|0
743274|NCT00389519|2380202|P3|Placebo Run-In|Reason not specified|0
743275|NCT00389519|2380203|P2|Placebo Run-In|Reason not specified|0
743276|NCT00389519|2380204|P1|Placebo Run-In|Reason not specified|40
743277|NCT00389519|2380201|P4|Placebo Run-In|Withdrawal by Subject|0
743278|NCT00389519|2380202|P3|Placebo Run-In|Withdrawal by Subject|0
743279|NCT00389519|2380203|P2|Placebo Run-In|Withdrawal by Subject|0
743280|NCT00389519|2380204|P1|Placebo Run-In|Withdrawal by Subject|19
743281|NCT00389519|2380201|P4|Placebo Run-In|Did not meet blood pressure criteria|0
743282|NCT00389519|2380202|P3|Placebo Run-In|Did not meet blood pressure criteria|0
743283|NCT00389519|2380203|P2|Placebo Run-In|Did not meet blood pressure criteria|0
743284|NCT00389519|2380204|P1|Placebo Run-In|Did not meet blood pressure criteria|119
743289|NCT00389831|2380293|P2|Overall Study|Lost to Follow-up|1
743290|NCT00389831|2380294|P1|Overall Study|Lost to Follow-up|0
743291|NCT00389831|2380293|P2|Overall Study|Other reasons|2
743292|NCT00389831|2380294|P1|Overall Study|Other reasons|0
743293|NCT00389831|2380293|P2|Overall Study|Did not receive treatment.|2
743294|NCT00389831|2380294|P1|Overall Study|Did not receive treatment.|0
743295|NCT00389831|2380293|P2|Overall Study|Lack of Efficacy|2
743296|NCT00389831|2380294|P1|Overall Study|Lack of Efficacy|0
743297|NCT00390013|2380340|P4|Phase 2 First Treatment|Withdrawal by Subject|0
743298|NCT00390013|2380341|P3|Phase 2 First Treatment|Withdrawal by Subject|0
743299|NCT00390013|2380342|P2|Phase 2 First Treatment|Withdrawal by Subject|1
743300|NCT00390013|2380343|P1|Phase 2 First Treatment|Withdrawal by Subject|0
743301|NCT00390013|2380340|P4|Phase 2 First Treatment|tired|0
743302|NCT00390013|2380341|P3|Phase 2 First Treatment|tired|0
743303|NCT00390013|2380342|P2|Phase 2 First Treatment|tired|0
743304|NCT00390013|2380343|P1|Phase 2 First Treatment|tired|1
743305|NCT00390013|2380340|P4|Phase 1|tired|1
743306|NCT00390013|2380341|P3|Phase 1|tired|0
743307|NCT00390013|2380342|P2|Phase 1|tired|0
743308|NCT00390013|2380343|P1|Phase 1|tired|0
743309|NCT00390221|2380358|P3|Overall Study|Not Specified|2
743310|NCT00390221|2380359|P2|Overall Study|Not Specified|4
743311|NCT00390221|2380360|P1|Overall Study|Not Specified|3
743312|NCT00390221|2380358|P3|Overall Study|Subject Non-compliance|2
743313|NCT00390221|2380359|P2|Overall Study|Subject Non-compliance|0
743314|NCT00390221|2380360|P1|Overall Study|Subject Non-compliance|1
743315|NCT00390221|2380358|P3|Overall Study|Withdrawal by Subject|7
743316|NCT00390221|2380359|P2|Overall Study|Withdrawal by Subject|9
743317|NCT00390221|2380360|P1|Overall Study|Withdrawal by Subject|13
743318|NCT00390221|2380358|P3|Overall Study|Investigator Decision|1
743319|NCT00390221|2380359|P2|Overall Study|Investigator Decision|0
743320|NCT00390221|2380360|P1|Overall Study|Investigator Decision|0
743321|NCT00390221|2380358|P3|Overall Study|Adverse Event|3
743322|NCT00390221|2380359|P2|Overall Study|Adverse Event|4
743323|NCT00390221|2380360|P1|Overall Study|Adverse Event|1
743324|NCT00390221|2380358|P3|Overall Study|Lost to Follow-up|0
743325|NCT00390221|2380359|P2|Overall Study|Lost to Follow-up|3
743326|NCT00390221|2380360|P1|Overall Study|Lost to Follow-up|0
743327|NCT00390416|2380393|P1|Overall Study|Not treated|3
743328|NCT00390416|2380393|P1|Overall Study|Withdrawal by Subject|1
743329|NCT00390455|2380401|P2|Overall Study|Other Medical Reasons|11
743330|NCT00390455|2380402|P1|Overall Study|Other Medical Reasons|7
743331|NCT00390455|2380401|P2|Overall Study|Alternate Treatment|1
743332|NCT00390455|2380402|P1|Overall Study|Alternate Treatment|0
743333|NCT00390455|2380401|P2|Overall Study|Withdrawal by Subject|8
743334|NCT00390455|2380402|P1|Overall Study|Withdrawal by Subject|8
743335|NCT00390455|2380401|P2|Overall Study|Adverse Event|3
743336|NCT00390455|2380402|P1|Overall Study|Adverse Event|17
743337|NCT00390468|2380420|P1|Overall Study|Lack of Efficacy|1
743338|NCT00390468|2380420|P1|Overall Study|Protocol Violation|2
743343|NCT00390572|2380449|P2|Overall Study|health condition|1
743344|NCT00390572|2380450|P1|Overall Study|health condition|0
743345|NCT00390572|2380449|P2|Overall Study|Lost to Follow-up|4
743346|NCT00390572|2380450|P1|Overall Study|Lost to Follow-up|8
743347|NCT00390689|2380482|P3|Overall Study|Investigator's judgement|0
743348|NCT00390689|2380483|P2|Overall Study|Investigator's judgement|0
743349|NCT00390689|2380484|P1|Overall Study|Investigator's judgement|2
743350|NCT00390689|2380482|P3|Overall Study|Protocol Violation|0
743351|NCT00390689|2380483|P2|Overall Study|Protocol Violation|0
743352|NCT00390689|2380484|P1|Overall Study|Protocol Violation|1
743353|NCT00390689|2380482|P3|Overall Study|Lack of Efficacy|1
743354|NCT00390689|2380483|P2|Overall Study|Lack of Efficacy|0
743355|NCT00390689|2380484|P1|Overall Study|Lack of Efficacy|0
743356|NCT00390689|2380482|P3|Overall Study|Adverse Event|2
743357|NCT00390689|2380483|P2|Overall Study|Adverse Event|5
743358|NCT00390689|2380484|P1|Overall Study|Adverse Event|2
743359|NCT00390780|2380544|P2|Overall Study|SAE, death|1
743360|NCT00390780|2380545|P1|Overall Study|SAE, death|0
743361|NCT00390780|2380544|P2|Overall Study|Investigator decision, SAE, other reason|1
743362|NCT00390780|2380545|P1|Overall Study|Investigator decision, SAE, other reason|0
743363|NCT00390780|2380544|P2|Overall Study|Lost to follow up and other reasons|1
743364|NCT00390780|2380545|P1|Overall Study|Lost to follow up and other reasons|0
743365|NCT00390780|2380544|P2|Overall Study|Inclusion criteria not satisfied|2
743366|NCT00390780|2380545|P1|Overall Study|Inclusion criteria not satisfied|0
743367|NCT00390780|2380544|P2|Overall Study|Withdrawal by Subject|2
743368|NCT00390780|2380545|P1|Overall Study|Withdrawal by Subject|1
743369|NCT00390780|2380544|P2|Overall Study|Death|3
743370|NCT00390780|2380545|P1|Overall Study|Death|1
743371|NCT00390780|2380544|P2|Overall Study|Adverse Event|3
743372|NCT00390780|2380545|P1|Overall Study|Adverse Event|2
743373|NCT00390780|2380544|P2|Overall Study|Lost to Follow-up|6
743374|NCT00390780|2380545|P1|Overall Study|Lost to Follow-up|3
743375|NCT00390780|2380544|P2|Overall Study|Protocol Violation|4
743376|NCT00390780|2380545|P1|Overall Study|Protocol Violation|6
743377|NCT00390780|2380544|P2|Overall Study|Not completed|4
743378|NCT00390780|2380545|P1|Overall Study|Not completed|10
743379|NCT00390806|2380577|P2|Overall Study|Ongoing|2
743380|NCT00390806|2380578|P1|Overall Study|Ongoing|4
743381|NCT00390806|2380577|P2|Overall Study|Physician Decision|1
743382|NCT00390806|2380578|P1|Overall Study|Physician Decision|0
743383|NCT00390806|2380577|P2|Overall Study|Death|0
743384|NCT00390806|2380578|P1|Overall Study|Death|1
743385|NCT00390806|2380577|P2|Overall Study|Investigator Decision|6
743386|NCT00390806|2380578|P1|Overall Study|Investigator Decision|4
743387|NCT00390806|2380577|P2|Overall Study|Withdrawal by Subject|15
743388|NCT00390806|2380578|P1|Overall Study|Withdrawal by Subject|12
743389|NCT00390806|2380577|P2|Overall Study|Protocol Violation|2
743390|NCT00390806|2380578|P1|Overall Study|Protocol Violation|2
743391|NCT00390806|2380577|P2|Overall Study|Lost to Follow-up|6
743392|NCT00390806|2380578|P1|Overall Study|Lost to Follow-up|7
743393|NCT00390858|2380646|P2|Overall Study|Withdrawal by Subject|4
743394|NCT00390858|2380647|P1|Overall Study|Withdrawal by Subject|3
743395|NCT00390858|2380646|P2|Overall Study|Lack of Efficacy|1
743396|NCT00390858|2380647|P1|Overall Study|Lack of Efficacy|0
743397|NCT00390858|2380646|P2|Overall Study|Adverse Event|2
743398|NCT00390858|2380647|P1|Overall Study|Adverse Event|6
743399|NCT00390884|2380661|P2|Overall Study|Withdrawal by Subject|2
743400|NCT00390884|2380662|P1|Overall Study|Withdrawal by Subject|2
743401|NCT00391027|2380674|P2|Overall Study|Other|3
743402|NCT00391027|2380675|P1|Overall Study|Other|4
743403|NCT00391027|2380674|P2|Overall Study|Withdrawal by Subject|1
743404|NCT00391027|2380675|P1|Overall Study|Withdrawal by Subject|10
743405|NCT00391027|2380674|P2|Overall Study|Lack of Efficacy|0
743406|NCT00391027|2380675|P1|Overall Study|Lack of Efficacy|3
743407|NCT00391027|2380674|P2|Overall Study|Adverse Event|8
743408|NCT00391027|2380675|P1|Overall Study|Adverse Event|8
743409|NCT00391053|2380717|P4|Overall Study|Withdrawal by Subject|1
743410|NCT00391053|2380718|P3|Overall Study|Withdrawal by Subject|1
743411|NCT00391053|2380719|P2|Overall Study|Withdrawal by Subject|1
743412|NCT00391053|2380720|P1|Overall Study|Withdrawal by Subject|5
743413|NCT00391053|2380717|P4|Overall Study|Lost to Follow-up|5
743414|NCT00391053|2380718|P3|Overall Study|Lost to Follow-up|0
743415|NCT00391053|2380719|P2|Overall Study|Lost to Follow-up|0
743416|NCT00391053|2380720|P1|Overall Study|Lost to Follow-up|1
743417|NCT00391053|2380717|P4|Overall Study|Protocol Violation|0
743418|NCT00391053|2380718|P3|Overall Study|Protocol Violation|0
743419|NCT00391053|2380719|P2|Overall Study|Protocol Violation|0
743420|NCT00391053|2380720|P1|Overall Study|Protocol Violation|2
743421|NCT00391053|2380717|P4|Overall Study|Serious Adverse Events|4
743422|NCT00391053|2380718|P3|Overall Study|Serious Adverse Events|1
743423|NCT00391053|2380719|P2|Overall Study|Serious Adverse Events|0
743424|NCT00391053|2380720|P1|Overall Study|Serious Adverse Events|1
743425|NCT00391092|2380765|P2|Overall Study|Alive in follow-up|84
743426|NCT00391092|2380766|P1|Overall Study|Alive in follow-up|88
743427|NCT00391092|2380765|P2|Overall Study|Alive on treatment|33
743428|NCT00391092|2380766|P1|Overall Study|Alive on treatment|29
743429|NCT00391092|2380765|P2|Overall Study|Lost to Follow-up|18
743430|NCT00391092|2380766|P1|Overall Study|Lost to Follow-up|13
743431|NCT00391092|2380765|P2|Overall Study|Death|81
743432|NCT00391092|2380766|P1|Overall Study|Death|78
743433|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Other|0
743434|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Other|6
743435|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Other|1
743436|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Other|6
743437|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
743438|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
743439|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
743440|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
743441|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Pregnancy|0
743442|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Pregnancy|0
743443|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Pregnancy|2
743444|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Pregnancy|0
743445|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Adverse Event|0
743446|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Adverse Event|4
743447|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Adverse Event|2
743448|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Adverse Event|5
743449|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
743450|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
743451|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
743452|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
743453|NCT00391222|2380787|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
743454|NCT00391222|2380788|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
743455|NCT00391222|2380789|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
743456|NCT00391222|2380790|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
743457|NCT00391222|2380787|P4|Period II (Open-label Risperidone LAI)|Other|24
743458|NCT00391222|2380788|P3|Period II (Open-label Risperidone LAI)|Other|0
743459|NCT00391222|2380789|P2|Period II (Open-label Risperidone LAI)|Other|0
743460|NCT00391222|2380790|P1|Period II (Open-label Risperidone LAI)|Other|0
743461|NCT00391222|2380787|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
743462|NCT00391222|2380788|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
743463|NCT00391222|2380789|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
743464|NCT00391222|2380790|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
743465|NCT00391222|2380787|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
743466|NCT00391222|2380788|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
743467|NCT00391222|2380789|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
743468|NCT00391222|2380790|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
743469|NCT00391222|2380787|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
743470|NCT00391222|2380788|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
743471|NCT00391222|2380789|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
743472|NCT00391222|2380790|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
743473|NCT00391222|2380787|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
743474|NCT00391222|2380788|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
743475|NCT00391222|2380789|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
743476|NCT00391222|2380790|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
743477|NCT00391274|2380816|P2|Overall Study|Death Not Study Related|1
743478|NCT00391274|2380817|P1|Overall Study|Death Not Study Related|0
743479|NCT00391274|2380816|P2|Overall Study|Death Due to Indeterminate Cause|0
743480|NCT00391274|2380817|P1|Overall Study|Death Due to Indeterminate Cause|1
743481|NCT00391274|2380816|P2|Overall Study|Death Due to Adverse Event|3
743482|NCT00391274|2380817|P1|Overall Study|Death Due to Adverse Event|1
743483|NCT00391274|2380816|P2|Overall Study|Withdrawal by Subject|3
743484|NCT00391274|2380817|P1|Overall Study|Withdrawal by Subject|0
743485|NCT00391274|2380816|P2|Overall Study|Physician Decision|2
743486|NCT00391274|2380817|P1|Overall Study|Physician Decision|4
743487|NCT00391274|2380816|P2|Overall Study|Lost to Follow-up|3
743488|NCT00391274|2380817|P1|Overall Study|Lost to Follow-up|0
743489|NCT00391274|2380816|P2|Overall Study|Death Due to Study Disease|45
743490|NCT00391274|2380817|P1|Overall Study|Death Due to Study Disease|55
743491|NCT00380874|2380844|P2|Overall Study|Not related to study drug|2
743492|NCT00380874|2380845|P1|Overall Study|Not related to study drug|3
743493|NCT00380874|2380844|P2|Overall Study|Withdrawal by Subject|1
743494|NCT00380874|2380845|P1|Overall Study|Withdrawal by Subject|2
743495|NCT00380874|2380844|P2|Overall Study|Death|0
743496|NCT00380874|2380845|P1|Overall Study|Death|1
743497|NCT00380874|2380844|P2|Overall Study|Adverse Event|7
743498|NCT00380874|2380845|P1|Overall Study|Adverse Event|7
743499|NCT00380978|2380863|P2|Overall Study|Parous patient|0
743500|NCT00380978|2380864|P1|Overall Study|Parous patient|1
743501|NCT00380978|2380863|P2|Overall Study|Allocation prior to analgesia request|2
743502|NCT00380978|2380864|P1|Overall Study|Allocation prior to analgesia request|1
743503|NCT00380978|2380863|P2|Overall Study|Wrong study envelope|2
743504|NCT00380978|2380864|P1|Overall Study|Wrong study envelope|0
743505|NCT00380978|2380863|P2|Overall Study|Refused allocated intervention|6
743506|NCT00380978|2380864|P1|Overall Study|Refused allocated intervention|0
743507|NCT00381043|2380892|P2|Overall Study|incarcerated|0
743508|NCT00381043|2380893|P1|Overall Study|incarcerated|1
743509|NCT00381043|2380892|P2|Overall Study|wanted more care|1
743510|NCT00381043|2380893|P1|Overall Study|wanted more care|0
743511|NCT00381043|2380892|P2|Overall Study|Withdrawal by Subject|1
743512|NCT00381043|2380893|P1|Overall Study|Withdrawal by Subject|3
743513|NCT00381043|2380892|P2|Overall Study|Lost to Follow-up|6
743514|NCT00381043|2380893|P1|Overall Study|Lost to Follow-up|8
743515|NCT00381095|2380913|P2|Overall Study|Adverse Event|7
743516|NCT00381095|2380914|P1|Overall Study|Adverse Event|2
743517|NCT00381095|2380913|P2|Overall Study|Withdrawal by Subject|3
743518|NCT00381095|2380914|P1|Overall Study|Withdrawal by Subject|3
743519|NCT00381095|2380913|P2|Overall Study|Protocol Violation|1
743520|NCT00381095|2380914|P1|Overall Study|Protocol Violation|1
743521|NCT00381095|2380913|P2|Overall Study|Unspecified|2
743522|NCT00381095|2380914|P1|Overall Study|Unspecified|2
743523|NCT00381095|2380913|P2|Overall Study|Lack of Efficacy|4
743524|NCT00381095|2380914|P1|Overall Study|Lack of Efficacy|2
743525|NCT00381095|2380913|P2|Overall Study|Death|4
743526|NCT00381095|2380914|P1|Overall Study|Death|3
743527|NCT00381238|2380944|P1|Overall Study|Disease progression|1
743528|NCT00381238|2380944|P1|Overall Study|Withdrew by physician|1
743529|NCT00381238|2380944|P1|Overall Study|Lack of Efficacy|2
743530|NCT00381238|2380944|P1|Overall Study|Withdrawal by Subject|4
743531|NCT00381238|2380944|P1|Overall Study|Protocol Violation|1
743532|NCT00381238|2380944|P1|Overall Study|Adverse Event|3
743533|NCT00381303|2380960|P2|Overall Study|Subject primary physician's decision|0
743534|NCT00381303|2380961|P1|Overall Study|Subject primary physician's decision|1
743535|NCT00381303|2380960|P2|Overall Study|Subject did not continue visits|0
743536|NCT00381303|2380961|P1|Overall Study|Subject did not continue visits|1
743537|NCT00381303|2380960|P2|Overall Study|Subject was too busy for appointments|0
743538|NCT00381303|2380961|P1|Overall Study|Subject was too busy for appointments|1
743539|NCT00381303|2380960|P2|Overall Study|No virologic response by week 12|0
743540|NCT00381303|2380961|P1|Overall Study|No virologic response by week 12|1
743541|NCT00381303|2380960|P2|Overall Study|Subject taking too many different meds|0
743542|NCT00381303|2380961|P1|Overall Study|Subject taking too many different meds|1
743543|NCT00381303|2380960|P2|Overall Study|Subject moved out of state|0
743544|NCT00381303|2380961|P1|Overall Study|Subject moved out of state|2
743545|NCT00381303|2380960|P2|Overall Study|Physician's decision to close the site|1
743546|NCT00381303|2380961|P1|Overall Study|Physician's decision to close the site|3
743547|NCT00381303|2380960|P2|Overall Study|Physician Decision|0
743548|NCT00381303|2380961|P1|Overall Study|Physician Decision|1
743549|NCT00381303|2380960|P2|Overall Study|Pregnancy|0
743550|NCT00381303|2380961|P1|Overall Study|Pregnancy|2
743551|NCT00381303|2380960|P2|Overall Study|Ineligible to continue the trial|1
743552|NCT00381303|2380961|P1|Overall Study|Ineligible to continue the trial|2
743553|NCT00381303|2380960|P2|Overall Study|Virologic failure|4
743554|NCT00381303|2380961|P1|Overall Study|Virologic failure|6
743555|NCT00381303|2380960|P2|Overall Study|Withdrawal by Subject|6
743556|NCT00381303|2380961|P1|Overall Study|Withdrawal by Subject|13
743557|NCT00381303|2380960|P2|Overall Study|Non-Adherence|6
743558|NCT00381303|2380961|P1|Overall Study|Non-Adherence|13
743559|NCT00381303|2380960|P2|Overall Study|AE/HIV-related event|6
743560|NCT00381303|2380961|P1|Overall Study|AE/HIV-related event|22
743561|NCT00381303|2380960|P2|Overall Study|Lost to Follow-up|9
743562|NCT00381303|2380961|P1|Overall Study|Lost to Follow-up|25
890741|NCT00855335|2825848|P3|Overall Study|Physician Decision|0
890742|NCT00855335|2825849|P2|Overall Study|Physician Decision|1
890743|NCT00855335|2825850|P1|Overall Study|Physician Decision|1
890744|NCT00855335|2825847|P4|Overall Study|Adverse Event|0
890745|NCT00855335|2825848|P3|Overall Study|Adverse Event|0
890746|NCT00855335|2825849|P2|Overall Study|Adverse Event|0
890747|NCT00855335|2825850|P1|Overall Study|Adverse Event|2
890748|NCT00855335|2825847|P4|Overall Study|Withdrawal by Subject|1
890749|NCT00855335|2825848|P3|Overall Study|Withdrawal by Subject|0
890750|NCT00855335|2825849|P2|Overall Study|Withdrawal by Subject|0
743573|NCT00381849|2381105|P2|Wash Out|Withdrawal by Subject|1
743574|NCT00381849|2381106|P1|Wash Out|Withdrawal by Subject|0
743575|NCT00381888|2381128|P1|Overall Study|Adverse Event|1
743576|NCT00381888|2381128|P1|Overall Study|Surgery was cancelled|2
743577|NCT00381888|2381128|P1|Overall Study|Had laparoscopic surgery|2
743578|NCT00381888|2381128|P1|Overall Study|Protocol Violation|9
743579|NCT00381888|2381128|P1|Overall Study|Physician Decision|1
743580|NCT00381888|2381128|P1|Overall Study|Withdrawal by Subject|1
743581|NCT00381888|2381128|P1|Overall Study|Death|1
743582|NCT00381940|2381133|P1|Overall Study|Ineligible|1
743583|NCT00381940|2381133|P1|Overall Study|Protocol Violation|1
743584|NCT00381940|2381133|P1|Overall Study|Lack of Efficacy|3
890751|NCT00855335|2825850|P1|Overall Study|Withdrawal by Subject|0
890752|NCT00855335|2825847|P4|Overall Study|Lost to Follow-up|1
890753|NCT00855335|2825848|P3|Overall Study|Lost to Follow-up|3
890754|NCT00855335|2825849|P2|Overall Study|Lost to Follow-up|0
890755|NCT00855335|2825850|P1|Overall Study|Lost to Follow-up|0
890756|NCT00819780|2825918|P2|Overall Study|Still in treatment|17
890757|NCT00819780|2825919|P1|Overall Study|Still in treatment|25
890758|NCT00819780|2825918|P2|Overall Study|Did not receive study drug|4
890759|NCT00819780|2825919|P1|Overall Study|Did not receive study drug|3
743601|NCT00382109|2381179|P2|Overall Study|consent withdrawal|1
743602|NCT00382109|2381180|P1|Overall Study|consent withdrawal|0
743603|NCT00382109|2381179|P2|Overall Study|Other|2
743604|NCT00382109|2381180|P1|Overall Study|Other|0
743605|NCT00382109|2381179|P2|Overall Study|ineligible|0
743606|NCT00382109|2381180|P1|Overall Study|ineligible|2
743607|NCT00382109|2381179|P2|Overall Study|Withdrawal by Subject|0
743608|NCT00382109|2381180|P1|Overall Study|Withdrawal by Subject|1
743609|NCT00382109|2381179|P2|Overall Study|Physician Decision|1
743610|NCT00382109|2381180|P1|Overall Study|Physician Decision|6
743611|NCT00382109|2381179|P2|Overall Study|Adverse Event|0
743612|NCT00382109|2381180|P1|Overall Study|Adverse Event|3
743613|NCT00382174|2381217|P3|Overall Study|Wounds merged|2
743614|NCT00382174|2381218|P2|Overall Study|Wounds merged|2
743615|NCT00382174|2381219|P1|Overall Study|Wounds merged|0
743616|NCT00382174|2381217|P3|Overall Study|Failed to meet criteria|1
743617|NCT00382174|2381218|P2|Overall Study|Failed to meet criteria|1
743618|NCT00382174|2381219|P1|Overall Study|Failed to meet criteria|0
743619|NCT00382174|2381217|P3|Overall Study|Physician Decision|2
743620|NCT00382174|2381218|P2|Overall Study|Physician Decision|2
743621|NCT00382174|2381219|P1|Overall Study|Physician Decision|0
743622|NCT00382174|2381217|P3|Overall Study|Non compliance|1
743623|NCT00382174|2381218|P2|Overall Study|Non compliance|0
743624|NCT00382174|2381219|P1|Overall Study|Non compliance|1
743625|NCT00382174|2381217|P3|Overall Study|Withdrawal by Subject|5
743626|NCT00382174|2381218|P2|Overall Study|Withdrawal by Subject|4
743627|NCT00382174|2381219|P1|Overall Study|Withdrawal by Subject|1
743628|NCT00382174|2381217|P3|Overall Study|Adverse Event|5
743629|NCT00382174|2381218|P2|Overall Study|Adverse Event|4
743630|NCT00382174|2381219|P1|Overall Study|Adverse Event|1
743631|NCT00382174|2381217|P3|Overall Study|Lost to Follow-up|5
743632|NCT00382174|2381218|P2|Overall Study|Lost to Follow-up|4
743633|NCT00382174|2381219|P1|Overall Study|Lost to Follow-up|1
743634|NCT00382291|2381233|P3|Overall Study|Lack of Efficacy|1
743635|NCT00382291|2381234|P2|Overall Study|Lack of Efficacy|0
743636|NCT00382291|2381235|P1|Overall Study|Lack of Efficacy|0
743637|NCT00382291|2381233|P3|Overall Study|Physician Decision|0
743638|NCT00382291|2381234|P2|Overall Study|Physician Decision|1
743639|NCT00382291|2381235|P1|Overall Study|Physician Decision|0
743640|NCT00382291|2381233|P3|Overall Study|Withdrawal by Subject|0
743641|NCT00382291|2381234|P2|Overall Study|Withdrawal by Subject|2
743642|NCT00382291|2381235|P1|Overall Study|Withdrawal by Subject|0
743643|NCT00382291|2381233|P3|Overall Study|Temporary study suspension|5
743644|NCT00382291|2381234|P2|Overall Study|Temporary study suspension|2
743645|NCT00382291|2381235|P1|Overall Study|Temporary study suspension|2
743646|NCT00382291|2381233|P3|Overall Study|Protocol Violation|0
743647|NCT00382291|2381234|P2|Overall Study|Protocol Violation|0
743648|NCT00382291|2381235|P1|Overall Study|Protocol Violation|1
743649|NCT00382291|2381233|P3|Overall Study|Adverse Event|2
743650|NCT00382291|2381234|P2|Overall Study|Adverse Event|2
743651|NCT00382291|2381235|P1|Overall Study|Adverse Event|1
743652|NCT00382408|2381248|P2|Overall Study|Not specified|35
743653|NCT00382408|2381249|P1|Overall Study|Not specified|100
743654|NCT00382408|2381248|P2|Overall Study|Lost to Follow-up|8
743655|NCT00382408|2381249|P1|Overall Study|Lost to Follow-up|19
743656|NCT00382408|2381248|P2|Overall Study|Pregnancy|0
743657|NCT00382408|2381249|P1|Overall Study|Pregnancy|2
743658|NCT00382408|2381248|P2|Overall Study|Withdrawal by Subject|6
743659|NCT00382408|2381249|P1|Overall Study|Withdrawal by Subject|17
743660|NCT00382408|2381248|P2|Overall Study|Physician Decision|0
743661|NCT00382408|2381249|P1|Overall Study|Physician Decision|1
743662|NCT00382408|2381248|P2|Overall Study|Protocol Violation|2
743663|NCT00382408|2381249|P1|Overall Study|Protocol Violation|2
743664|NCT00382408|2381248|P2|Overall Study|Did not meet protocol requirement|3
743665|NCT00382408|2381249|P1|Overall Study|Did not meet protocol requirement|3
743666|NCT00382720|2381285|P3|Overall Study|Discontinued at end of study|2
743667|NCT00382720|2381286|P2|Overall Study|Discontinued at end of study|1
743668|NCT00382720|2381287|P1|Overall Study|Discontinued at end of study|0
743669|NCT00382720|2381285|P3|Overall Study|Investigator/Clinical decision|6
743670|NCT00382720|2381286|P2|Overall Study|Investigator/Clinical decision|6
743671|NCT00382720|2381287|P1|Overall Study|Investigator/Clinical decision|5
743672|NCT00382720|2381285|P3|Overall Study|Good prognosis|0
743673|NCT00382720|2381286|P2|Overall Study|Good prognosis|1
743674|NCT00382720|2381287|P1|Overall Study|Good prognosis|0
743675|NCT00382720|2381285|P3|Overall Study|Clinically progressive disease|0
743676|NCT00382720|2381286|P2|Overall Study|Clinically progressive disease|1
743677|NCT00382720|2381287|P1|Overall Study|Clinically progressive disease|0
743678|NCT00382720|2381285|P3|Overall Study|Patient did not receive study medication|4
743679|NCT00382720|2381286|P2|Overall Study|Patient did not receive study medication|1
743680|NCT00382720|2381287|P1|Overall Study|Patient did not receive study medication|1
743681|NCT00382720|2381285|P3|Overall Study|Surgery|4
743682|NCT00382720|2381286|P2|Overall Study|Surgery|1
743683|NCT00382720|2381287|P1|Overall Study|Surgery|1
743684|NCT00382720|2381285|P3|Overall Study|Withdrawal by Subject|12
743685|NCT00382720|2381286|P2|Overall Study|Withdrawal by Subject|20
743686|NCT00382720|2381287|P1|Overall Study|Withdrawal by Subject|11
743687|NCT00382720|2381285|P3|Overall Study|Withdrew consent|2
743688|NCT00382720|2381286|P2|Overall Study|Withdrew consent|1
743689|NCT00382720|2381287|P1|Overall Study|Withdrew consent|1
743690|NCT00382720|2381285|P3|Overall Study|Progressive disease|38
743691|NCT00382720|2381286|P2|Overall Study|Progressive disease|28
743692|NCT00382720|2381287|P1|Overall Study|Progressive disease|37
743693|NCT00382720|2381285|P3|Overall Study|Death|2
743694|NCT00382720|2381286|P2|Overall Study|Death|1
743695|NCT00382720|2381287|P1|Overall Study|Death|0
743696|NCT00382720|2381285|P3|Overall Study|Protocol Violation|1
743697|NCT00382720|2381286|P2|Overall Study|Protocol Violation|5
743698|NCT00382720|2381287|P1|Overall Study|Protocol Violation|2
743699|NCT00382720|2381285|P3|Overall Study|Adverse Event|15
743700|NCT00382720|2381286|P2|Overall Study|Adverse Event|23
743701|NCT00382720|2381287|P1|Overall Study|Adverse Event|21
743702|NCT00382733|2381301|P5|Overall Study|Withdrawal by Subject|0
743703|NCT00382733|2381302|P4|Overall Study|Withdrawal by Subject|0
743704|NCT00382733|2381303|P3|Overall Study|Withdrawal by Subject|0
743705|NCT00382733|2381304|P2|Overall Study|Withdrawal by Subject|1
743706|NCT00382733|2381305|P1|Overall Study|Withdrawal by Subject|0
743707|NCT00382863|2381338|P2|Overall Study|Withdrawal by Subject|25
743708|NCT00382863|2381339|P1|Overall Study|Withdrawal by Subject|5
743709|NCT00382863|2381338|P2|Overall Study|Lost to Follow-up|2
743710|NCT00382863|2381339|P1|Overall Study|Lost to Follow-up|1
743711|NCT00382863|2381338|P2|Overall Study|Death|9
743712|NCT00382863|2381339|P1|Overall Study|Death|9
743713|NCT00382967|2381410|P2|Overall Study|Protocol Violation|1
743714|NCT00382967|2381411|P1|Overall Study|Protocol Violation|1
743715|NCT00382993|2381419|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
743716|NCT00382993|2381420|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
743717|NCT00382993|2381419|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
743718|NCT00382993|2381420|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
743719|NCT00382993|2381419|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
743720|NCT00382993|2381420|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
743721|NCT00382993|2381419|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
743722|NCT00382993|2381420|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
743723|NCT00382993|2381419|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
743724|NCT00382993|2381420|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
743725|NCT00382993|2381419|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
743726|NCT00382993|2381420|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
743727|NCT00382993|2381419|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
743728|NCT00382993|2381420|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
743729|NCT00382993|2381419|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
743730|NCT00382993|2381420|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
743731|NCT00382993|2381419|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
743732|NCT00382993|2381420|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
743733|NCT00382993|2381419|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
743734|NCT00382993|2381420|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
743735|NCT00383019|2381464|P2|Overall Study|Withdrawal by Subject|1
743736|NCT00383019|2381465|P1|Overall Study|Withdrawal by Subject|0
743737|NCT00383019|2381464|P2|Overall Study|Adverse Event|1
743738|NCT00383019|2381465|P1|Overall Study|Adverse Event|5
743739|NCT00383084|2381506|P2|Overall Study|Withdrawal by Subject|10
743740|NCT00383084|2381507|P1|Overall Study|Withdrawal by Subject|12
743741|NCT00383123|2381540|P2|Overall Study|Other reason|6
743742|NCT00383123|2381541|P1|Overall Study|Other reason|10
743743|NCT00383123|2381540|P2|Overall Study|Withdrawal by Subject|18
743744|NCT00383123|2381541|P1|Overall Study|Withdrawal by Subject|27
743745|NCT00383123|2381540|P2|Overall Study|Protocol Violation|1
743746|NCT00383123|2381541|P1|Overall Study|Protocol Violation|5
743747|NCT00383123|2381540|P2|Overall Study|Lost to Follow-up|61
743748|NCT00383123|2381541|P1|Overall Study|Lost to Follow-up|68
743749|NCT00383123|2381540|P2|Overall Study|Adverse Event|0
743750|NCT00383123|2381541|P1|Overall Study|Adverse Event|1
743751|NCT00383149|2381561|P1|Overall Study|Participant Withdrew Consent|1
743752|NCT00383149|2381561|P1|Overall Study|Request to Discontinue Treatment|4
743753|NCT00383149|2381561|P1|Overall Study|Study Drug Toxicity|4
743754|NCT00383149|2381561|P1|Overall Study|Other|1
743755|NCT00383149|2381561|P1|Overall Study|Lost to Follow-up|1
743756|NCT00383149|2381561|P1|Overall Study|Disease Progression|38
743757|NCT00383149|2381561|P1|Overall Study|Death|2
743758|NCT00383149|2381561|P1|Overall Study|Adverse Event not Related to Study Drug|3
743759|NCT00383162|2381578|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
743760|NCT00383162|2381579|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
743761|NCT00383162|2381578|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
743762|NCT00383162|2381579|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
743763|NCT00383162|2381578|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
743764|NCT00383162|2381579|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
743765|NCT00383162|2381578|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
743766|NCT00383162|2381579|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
743767|NCT00383162|2381578|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
743768|NCT00383162|2381579|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
743769|NCT00383162|2381578|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
743770|NCT00383162|2381579|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
743771|NCT00383162|2381578|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
743772|NCT00383162|2381579|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
743773|NCT00383162|2381578|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
743774|NCT00383162|2381579|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
743775|NCT00383162|2381578|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
743776|NCT00383162|2381579|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
743777|NCT00383240|2381625|P4|Overall Study|Administrative|0
743778|NCT00383240|2381626|P3|Overall Study|Administrative|0
743779|NCT00383240|2381627|P2|Overall Study|Administrative|1
743780|NCT00383240|2381628|P1|Overall Study|Administrative|1
743781|NCT00383240|2381625|P4|Overall Study|Did not meet protocol eligibility|3
743782|NCT00383240|2381626|P3|Overall Study|Did not meet protocol eligibility|9
743783|NCT00383240|2381627|P2|Overall Study|Did not meet protocol eligibility|4
743784|NCT00383240|2381628|P1|Overall Study|Did not meet protocol eligibility|9
743785|NCT00383240|2381625|P4|Overall Study|Protocol Violation|6
743786|NCT00383240|2381626|P3|Overall Study|Protocol Violation|9
743787|NCT00383240|2381627|P2|Overall Study|Protocol Violation|5
743788|NCT00383240|2381628|P1|Overall Study|Protocol Violation|4
743789|NCT00383240|2381625|P4|Overall Study|Withdrawal by subjects, reasons related|5
743790|NCT00383240|2381626|P3|Overall Study|Withdrawal by subjects, reasons related|3
743791|NCT00383240|2381627|P2|Overall Study|Withdrawal by subjects, reasons related|1
743792|NCT00383240|2381628|P1|Overall Study|Withdrawal by subjects, reasons related|0
743793|NCT00383240|2381625|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
743794|NCT00383240|2381626|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
743795|NCT00383240|2381627|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
743796|NCT00383240|2381628|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
743797|NCT00383240|2381625|P4|Overall Study|Lost to Follow-up|2
743798|NCT00383240|2381626|P3|Overall Study|Lost to Follow-up|0
743799|NCT00383240|2381627|P2|Overall Study|Lost to Follow-up|0
743800|NCT00383240|2381628|P1|Overall Study|Lost to Follow-up|3
743801|NCT00383240|2381625|P4|Overall Study|Treatment Failure|46
743802|NCT00383240|2381626|P3|Overall Study|Treatment Failure|47
743803|NCT00383240|2381627|P2|Overall Study|Treatment Failure|13
743804|NCT00383240|2381628|P1|Overall Study|Treatment Failure|8
743805|NCT00383240|2381625|P4|Overall Study|Adverse Event|7
743806|NCT00383240|2381626|P3|Overall Study|Adverse Event|9
743807|NCT00383240|2381627|P2|Overall Study|Adverse Event|6
743808|NCT00383240|2381628|P1|Overall Study|Adverse Event|4
743809|NCT00383331|2381670|P2|Overall Study|Protocol Violation|1
743810|NCT00383331|2381671|P1|Overall Study|Protocol Violation|0
743811|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Administrative|0
743812|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Administrative|1
743813|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Administrative|0
743814|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Administrative|1
743815|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Administrative|1
743816|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
743817|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
743818|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
743819|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
743820|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
743821|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
743822|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
743823|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
743824|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
743825|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
743826|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
743827|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
743828|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
743829|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
743830|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
743831|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
743832|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
743833|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
743834|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
743835|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
743836|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
743837|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
743838|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
743839|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
743840|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
743841|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
743842|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
743843|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
743844|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
743845|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
743846|NCT00383435|2381692|P5|26-Week Treatment Safety Extension|Adverse Event|1
743847|NCT00383435|2381693|P4|26-Week Treatment Safety Extension|Adverse Event|5
743848|NCT00383435|2381694|P3|26-Week Treatment Safety Extension|Adverse Event|5
743849|NCT00383435|2381695|P2|26-Week Treatment Safety Extension|Adverse Event|2
743850|NCT00383435|2381696|P1|26-Week Treatment Safety Extension|Adverse Event|4
743851|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Administrative|1
743852|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Administrative|1
743853|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Administrative|1
743854|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Administrative|3
743855|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Administrative|5
743856|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
743857|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
743858|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
743859|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
743860|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
743861|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
743862|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
743863|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
743864|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
743865|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
743866|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
743867|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
743868|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
743869|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
743870|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
743871|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
743872|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
743873|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
743874|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
743875|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
743876|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
743877|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
743878|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
743879|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
743880|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
743881|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
743882|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
743883|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
743884|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
743885|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
743886|NCT00383435|2381692|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
743887|NCT00383435|2381693|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
743888|NCT00383435|2381694|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
743889|NCT00383435|2381695|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
743890|NCT00383435|2381696|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
743891|NCT00383500|2381736|P3|Overall Study|Lost to Follow-up|2
743892|NCT00383500|2381737|P2|Overall Study|Lost to Follow-up|0
743893|NCT00383500|2381738|P1|Overall Study|Lost to Follow-up|0
743894|NCT00383500|2381736|P3|Overall Study|Withdrawal by Subject|0
743895|NCT00383500|2381737|P2|Overall Study|Withdrawal by Subject|3
743896|NCT00383500|2381738|P1|Overall Study|Withdrawal by Subject|8
743897|NCT00383552|2381753|P4|Overall Study|Administrative|1
743898|NCT00383552|2381754|P3|Overall Study|Administrative|1
743899|NCT00383552|2381755|P2|Overall Study|Administrative|0
743900|NCT00383552|2381756|P1|Overall Study|Administrative|1
743901|NCT00383552|2381753|P4|Overall Study|Did not meet protocol eligibility|3
743902|NCT00383552|2381754|P3|Overall Study|Did not meet protocol eligibility|2
743903|NCT00383552|2381755|P2|Overall Study|Did not meet protocol eligibility|6
743904|NCT00383552|2381756|P1|Overall Study|Did not meet protocol eligibility|8
743905|NCT00383552|2381753|P4|Overall Study|Noncompliance with the protocol|10
743906|NCT00383552|2381754|P3|Overall Study|Noncompliance with the protocol|8
743907|NCT00383552|2381755|P2|Overall Study|Noncompliance with the protocol|6
743908|NCT00383552|2381756|P1|Overall Study|Noncompliance with the protocol|11
743909|NCT00383552|2381753|P4|Overall Study|Did not wish to continue (related)|3
743910|NCT00383552|2381754|P3|Overall Study|Did not wish to continue (related)|2
743911|NCT00383552|2381755|P2|Overall Study|Did not wish to continue (related)|0
743912|NCT00383552|2381756|P1|Overall Study|Did not wish to continue (related)|1
743913|NCT00383552|2381753|P4|Overall Study|Did not wish to continue (unrelated)|6
743914|NCT00383552|2381754|P3|Overall Study|Did not wish to continue (unrelated)|5
743915|NCT00383552|2381755|P2|Overall Study|Did not wish to continue (unrelated)|9
743916|NCT00383552|2381756|P1|Overall Study|Did not wish to continue (unrelated)|4
743917|NCT00383552|2381753|P4|Overall Study|Lost to Follow-up|1
743918|NCT00383552|2381754|P3|Overall Study|Lost to Follow-up|5
743919|NCT00383552|2381755|P2|Overall Study|Lost to Follow-up|1
743920|NCT00383552|2381756|P1|Overall Study|Lost to Follow-up|0
743921|NCT00383552|2381753|P4|Overall Study|Lack of Efficacy|42
743922|NCT00383552|2381754|P3|Overall Study|Lack of Efficacy|29
743923|NCT00383552|2381755|P2|Overall Study|Lack of Efficacy|13
743924|NCT00383552|2381756|P1|Overall Study|Lack of Efficacy|4
743925|NCT00383552|2381753|P4|Overall Study|Adverse Event|6
743926|NCT00383552|2381754|P3|Overall Study|Adverse Event|9
743927|NCT00383552|2381755|P2|Overall Study|Adverse Event|6
743928|NCT00383552|2381756|P1|Overall Study|Adverse Event|7
743929|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Administrative|0
743930|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Administrative|1
743931|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Administrative|3
743932|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Administrative|2
743933|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Administrative|1
743934|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
743935|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
743936|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
743937|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
743938|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
743939|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
743940|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
743941|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
743942|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
743943|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
743944|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
743945|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
743946|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
744017|NCT00383786|2381914|P1|Overall Study|Withdrawal by Subject|2
743947|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
743948|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
743949|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
743950|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
743951|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
743952|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
743953|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
743954|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
743955|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
743956|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
743957|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
743958|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
743959|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
743960|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
743961|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
743962|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
743963|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
743964|NCT00383721|2381831|P5|26-Week Treatment Safety Extension|Adverse Event|0
743965|NCT00383721|2381832|P4|26-Week Treatment Safety Extension|Adverse Event|1
743966|NCT00383721|2381833|P3|26-Week Treatment Safety Extension|Adverse Event|10
743967|NCT00383721|2381834|P2|26-Week Treatment Safety Extension|Adverse Event|7
743968|NCT00383721|2381835|P1|26-Week Treatment Safety Extension|Adverse Event|6
743969|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Ongoing|0
743970|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Ongoing|0
743971|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Ongoing|0
743972|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Ongoing|0
743973|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Ongoing|1
743974|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Administrative|3
743975|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Administrative|3
743976|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Administrative|3
743977|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Administrative|3
743978|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Administrative|1
743979|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
743980|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
743981|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
743982|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
743983|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
743984|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
743985|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
743986|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
743987|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
743988|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
743989|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
743990|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
743991|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
743992|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
743993|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
743994|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
743995|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
743996|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
743997|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
743998|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
743999|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
744000|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
744001|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
744002|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
744003|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
744004|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
744005|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
744006|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
744007|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
744008|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
744009|NCT00383721|2381831|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
744010|NCT00383721|2381832|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
744011|NCT00383721|2381833|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
744012|NCT00383721|2381834|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
744013|NCT00383721|2381835|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
744014|NCT00383786|2381913|P2|Overall Study|Physician Decision|1
744015|NCT00383786|2381914|P1|Overall Study|Physician Decision|0
744016|NCT00383786|2381913|P2|Overall Study|Withdrawal by Subject|5
744018|NCT00383786|2381913|P2|Overall Study|Protocol Violation|6
744019|NCT00383786|2381914|P1|Overall Study|Protocol Violation|2
744020|NCT00384033|2381933|P4|Overall Study|Randomized but not treated|2
744021|NCT00384033|2381934|P3|Overall Study|Randomized but not treated|10
744022|NCT00384033|2381935|P2|Overall Study|Randomized but not treated|7
744023|NCT00384033|2381936|P1|Overall Study|Randomized but not treated|3
744024|NCT00384033|2381933|P4|Overall Study|Lack of Efficacy|1
744025|NCT00384033|2381934|P3|Overall Study|Lack of Efficacy|3
744026|NCT00384033|2381935|P2|Overall Study|Lack of Efficacy|3
744027|NCT00384033|2381936|P1|Overall Study|Lack of Efficacy|7
744028|NCT00384033|2381933|P4|Overall Study|Withdrawal by Subject|2
744029|NCT00384033|2381934|P3|Overall Study|Withdrawal by Subject|5
744030|NCT00384033|2381935|P2|Overall Study|Withdrawal by Subject|2
744031|NCT00384033|2381936|P1|Overall Study|Withdrawal by Subject|6
744032|NCT00384033|2381933|P4|Overall Study|Protocol Violation|6
744033|NCT00384033|2381934|P3|Overall Study|Protocol Violation|5
744034|NCT00384033|2381935|P2|Overall Study|Protocol Violation|0
744035|NCT00384033|2381936|P1|Overall Study|Protocol Violation|5
744036|NCT00384033|2381933|P4|Overall Study|Unspecified|0
744037|NCT00384033|2381934|P3|Overall Study|Unspecified|0
744038|NCT00384033|2381935|P2|Overall Study|Unspecified|0
744039|NCT00384033|2381936|P1|Overall Study|Unspecified|2
744040|NCT00384033|2381933|P4|Overall Study|Lost to Follow-up|7
744041|NCT00384033|2381934|P3|Overall Study|Lost to Follow-up|7
744042|NCT00384033|2381935|P2|Overall Study|Lost to Follow-up|12
744043|NCT00384033|2381936|P1|Overall Study|Lost to Follow-up|6
744044|NCT00384033|2381933|P4|Overall Study|Physician Decision|0
744045|NCT00384033|2381934|P3|Overall Study|Physician Decision|0
744046|NCT00384033|2381935|P2|Overall Study|Physician Decision|0
744047|NCT00384033|2381936|P1|Overall Study|Physician Decision|1
744048|NCT00384033|2381933|P4|Overall Study|Failed to return|2
744049|NCT00384033|2381934|P3|Overall Study|Failed to return|2
744050|NCT00384033|2381935|P2|Overall Study|Failed to return|3
744051|NCT00384033|2381936|P1|Overall Study|Failed to return|1
744052|NCT00384033|2381933|P4|Overall Study|Adverse Event|20
744053|NCT00384033|2381934|P3|Overall Study|Adverse Event|11
744054|NCT00384033|2381935|P2|Overall Study|Adverse Event|8
744055|NCT00384033|2381936|P1|Overall Study|Adverse Event|10
744056|NCT00384059|2381980|P2|Toddler Dose|Failed to return|1
744057|NCT00384059|2381981|P1|Toddler Dose|Failed to return|0
744058|NCT00384059|2381980|P2|Toddler Dose|Lost to Follow-up|1
744059|NCT00384059|2381981|P1|Toddler Dose|Lost to Follow-up|1
744060|NCT00384059|2381980|P2|After Infant Series|Lost to Follow-up|1
744061|NCT00384059|2381981|P1|After Infant Series|Lost to Follow-up|0
744062|NCT00384059|2381980|P2|After Infant Series|Physician Decision|1
744063|NCT00384059|2381981|P1|After Infant Series|Physician Decision|0
744064|NCT00384059|2381980|P2|After Infant Series|Adverse Event|1
744065|NCT00384059|2381981|P1|After Infant Series|Adverse Event|0
744066|NCT00384059|2381980|P2|After Infant Series|Failed to Return|2
744067|NCT00384059|2381981|P1|After Infant Series|Failed to Return|0
744068|NCT00384059|2381980|P2|After Infant Series|Withdrawal by Subject|2
744069|NCT00384059|2381981|P1|After Infant Series|Withdrawal by Subject|2
744070|NCT00384059|2381980|P2|After Infant Series|Protocol Violation|3
744071|NCT00384059|2381981|P1|After Infant Series|Protocol Violation|2
744072|NCT00384059|2381980|P2|Infant Series|Lost to Follow-up|1
744073|NCT00384059|2381981|P1|Infant Series|Lost to Follow-up|0
744074|NCT00384059|2381980|P2|Infant Series|Protocol Violation|2
744075|NCT00384059|2381981|P1|Infant Series|Protocol Violation|1
744076|NCT00384059|2381980|P2|Infant Series|Adverse Event|2
744077|NCT00384059|2381981|P1|Infant Series|Adverse Event|1
744078|NCT00384059|2381980|P2|Infant Series|Withdrawal by Subject|2
744079|NCT00384059|2381981|P1|Infant Series|Withdrawal by Subject|2
744080|NCT00384059|2381980|P2|Infant Series|Not consented|6
744081|NCT00384059|2381981|P1|Infant Series|Not consented|2
744082|NCT00384085|2382030|P3|Overall Study|Patient required surgery|0
744083|NCT00384085|2382031|P2|Overall Study|Patient required surgery|1
744084|NCT00384085|2382032|P1|Overall Study|Patient required surgery|0
744085|NCT00384085|2382030|P3|Overall Study|Patient moved|1
744086|NCT00384085|2382031|P2|Overall Study|Patient moved|0
744087|NCT00384085|2382032|P1|Overall Study|Patient moved|1
744088|NCT00384085|2382030|P3|Overall Study|Sponsor decision|1
744089|NCT00384085|2382031|P2|Overall Study|Sponsor decision|2
744090|NCT00384085|2382032|P1|Overall Study|Sponsor decision|1
744091|NCT00384085|2382030|P3|Overall Study|Loss of site personnel|1
744092|NCT00384085|2382031|P2|Overall Study|Loss of site personnel|0
744093|NCT00384085|2382032|P1|Overall Study|Loss of site personnel|1
744094|NCT00384085|2382030|P3|Overall Study|Physician Decision|0
744095|NCT00384085|2382031|P2|Overall Study|Physician Decision|0
744096|NCT00384085|2382032|P1|Overall Study|Physician Decision|1
744097|NCT00384085|2382030|P3|Overall Study|Patient non-compliant|5
744098|NCT00384085|2382031|P2|Overall Study|Patient non-compliant|4
744099|NCT00384085|2382032|P1|Overall Study|Patient non-compliant|4
744100|NCT00384085|2382030|P3|Overall Study|Withdrawal by Subject|29
744101|NCT00384085|2382031|P2|Overall Study|Withdrawal by Subject|19
744102|NCT00384085|2382032|P1|Overall Study|Withdrawal by Subject|14
744103|NCT00384085|2382030|P3|Overall Study|Progressive Disease|0
744104|NCT00384085|2382031|P2|Overall Study|Progressive Disease|1
744105|NCT00384085|2382032|P1|Overall Study|Progressive Disease|0
744106|NCT00384085|2382030|P3|Overall Study|Lost to Follow-up|10
744107|NCT00384085|2382031|P2|Overall Study|Lost to Follow-up|9
744108|NCT00384085|2382032|P1|Overall Study|Lost to Follow-up|9
744109|NCT00384085|2382030|P3|Overall Study|Protocol Violation|2
744110|NCT00384085|2382031|P2|Overall Study|Protocol Violation|2
744111|NCT00384085|2382032|P1|Overall Study|Protocol Violation|2
744112|NCT00384085|2382030|P3|Overall Study|No longer Requires Study Treatment|1
744113|NCT00384085|2382031|P2|Overall Study|No longer Requires Study Treatment|0
744114|NCT00384085|2382032|P1|Overall Study|No longer Requires Study Treatment|1
744115|NCT00384085|2382030|P3|Overall Study|Lack of Efficacy|2
744116|NCT00384085|2382031|P2|Overall Study|Lack of Efficacy|3
744117|NCT00384085|2382032|P1|Overall Study|Lack of Efficacy|0
744118|NCT00384085|2382030|P3|Overall Study|Adverse Event|4
744119|NCT00384085|2382031|P2|Overall Study|Adverse Event|5
744120|NCT00384085|2382032|P1|Overall Study|Adverse Event|5
744121|NCT00384176|2382059|P3|Overall Study|Liver metastases, colon resec. planned|0
744122|NCT00384176|2382060|P2|Overall Study|Liver metastases, colon resec. planned|0
744123|NCT00384176|2382061|P1|Overall Study|Liver metastases, colon resec. planned|1
744124|NCT00384176|2382059|P3|Overall Study|Physician Decision|0
744125|NCT00384176|2382060|P2|Overall Study|Physician Decision|2
744126|NCT00384176|2382061|P1|Overall Study|Physician Decision|0
744127|NCT00384176|2382059|P3|Overall Study|Did not receive study treatment|1
744128|NCT00384176|2382060|P2|Overall Study|Did not receive study treatment|1
744129|NCT00384176|2382061|P1|Overall Study|Did not receive study treatment|0
744130|NCT00384176|2382059|P3|Overall Study|Toxicity of treatment|0
744131|NCT00384176|2382060|P2|Overall Study|Toxicity of treatment|0
744132|NCT00384176|2382061|P1|Overall Study|Toxicity of treatment|1
744133|NCT00384176|2382059|P3|Overall Study|Longer QTC as Visit 1|0
744134|NCT00384176|2382060|P2|Overall Study|Longer QTC as Visit 1|0
744135|NCT00384176|2382061|P1|Overall Study|Longer QTC as Visit 1|1
744136|NCT00384176|2382059|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
744137|NCT00384176|2382060|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
744138|NCT00384176|2382061|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
744139|NCT00384176|2382059|P3|Overall Study|Lost to Follow-up|4
744140|NCT00384176|2382060|P2|Overall Study|Lost to Follow-up|18
744141|NCT00384176|2382061|P1|Overall Study|Lost to Follow-up|16
744142|NCT00384176|2382059|P3|Overall Study|Withdrawal by Subject|22
744143|NCT00384176|2382060|P2|Overall Study|Withdrawal by Subject|48
744144|NCT00384176|2382061|P1|Overall Study|Withdrawal by Subject|52
744145|NCT00384176|2382059|P3|Overall Study|Death|105
744146|NCT00384176|2382060|P2|Overall Study|Death|247
744147|NCT00384176|2382061|P1|Overall Study|Death|239
744148|NCT00384189|2382088|P4|Overall Study|Reason Not Specified|40
744149|NCT00384189|2382089|P3|Overall Study|Reason Not Specified|58
744150|NCT00384189|2382090|P2|Overall Study|Reason Not Specified|57
744151|NCT00384189|2382091|P1|Overall Study|Reason Not Specified|50
744152|NCT00391391|2382166|P4|Overall Study|Withdrawal by Subject|7
744153|NCT00391391|2382167|P3|Overall Study|Withdrawal by Subject|10
744154|NCT00391391|2382168|P2|Overall Study|Withdrawal by Subject|4
744155|NCT00391391|2382169|P1|Overall Study|Withdrawal by Subject|6
744156|NCT00391391|2382166|P4|Overall Study|Protocol Violation|7
744157|NCT00391391|2382167|P3|Overall Study|Protocol Violation|6
744158|NCT00391391|2382168|P2|Overall Study|Protocol Violation|3
744159|NCT00391391|2382169|P1|Overall Study|Protocol Violation|2
744160|NCT00391391|2382166|P4|Overall Study|Lost to Follow-up|4
744161|NCT00391391|2382167|P3|Overall Study|Lost to Follow-up|7
744162|NCT00391391|2382168|P2|Overall Study|Lost to Follow-up|3
744163|NCT00391391|2382169|P1|Overall Study|Lost to Follow-up|1
744164|NCT00391391|2382166|P4|Overall Study|Adverse Event|1
744165|NCT00391391|2382167|P3|Overall Study|Adverse Event|0
744166|NCT00391391|2382168|P2|Overall Study|Adverse Event|0
744167|NCT00391391|2382169|P1|Overall Study|Adverse Event|0
744168|NCT00391586|2382227|P1|Overall Study|Death|4
744169|NCT00391586|2382227|P1|Overall Study|Physician Decision|2
744170|NCT00391586|2382227|P1|Overall Study|Adverse Event|5
744171|NCT00391586|2382227|P1|Overall Study|Progressive disease|13
744172|NCT00391625|2382245|P1|Month 50|Physician Decision|1
744173|NCT00391625|2382245|P1|Month 14|Withdrawal by Subject|1
744174|NCT00392288|2382288|P3|Overall Study|Other|1
744175|NCT00392288|2382289|P2|Overall Study|Other|4
744176|NCT00392288|2382290|P1|Overall Study|Other|3
744177|NCT00392288|2382288|P3|Overall Study|Parent/legal guardian withdrawal|1
744178|NCT00392288|2382289|P2|Overall Study|Parent/legal guardian withdrawal|2
744179|NCT00392288|2382290|P1|Overall Study|Parent/legal guardian withdrawal|1
744180|NCT00392288|2382288|P3|Overall Study|Withdrawal by Subject|2
744181|NCT00392288|2382289|P2|Overall Study|Withdrawal by Subject|0
744182|NCT00392288|2382290|P1|Overall Study|Withdrawal by Subject|1
744183|NCT00392288|2382288|P3|Overall Study|Lost to Follow-up|1
744184|NCT00392288|2382289|P2|Overall Study|Lost to Follow-up|1
744185|NCT00392288|2382290|P1|Overall Study|Lost to Follow-up|1
744186|NCT00392288|2382288|P3|Overall Study|Protocol Violation|1
744187|NCT00392288|2382289|P2|Overall Study|Protocol Violation|3
744188|NCT00392288|2382290|P1|Overall Study|Protocol Violation|1
744189|NCT00392288|2382288|P3|Overall Study|Lack of Efficacy|3
744190|NCT00392288|2382289|P2|Overall Study|Lack of Efficacy|5
744191|NCT00392288|2382290|P1|Overall Study|Lack of Efficacy|8
744192|NCT00392288|2382288|P3|Overall Study|Adverse Event|8
744193|NCT00392288|2382289|P2|Overall Study|Adverse Event|7
744194|NCT00392288|2382290|P1|Overall Study|Adverse Event|17
744195|NCT00392379|2382306|P2|Overall Study|Adverse Event|1
744196|NCT00392379|2382307|P1|Overall Study|Adverse Event|1
744197|NCT00392379|2382306|P2|Overall Study|Lost to Follow-up|9
744198|NCT00392379|2382307|P1|Overall Study|Lost to Follow-up|4
744199|NCT00392379|2382306|P2|Overall Study|Withdrawal by Subject|28
744200|NCT00392379|2382307|P1|Overall Study|Withdrawal by Subject|17
744201|NCT00392665|2382331|P2|Overall Study|Lost to Follow-up|1
744202|NCT00392665|2382332|P1|Overall Study|Lost to Follow-up|1
744203|NCT00392665|2382331|P2|Overall Study|Death|14
744204|NCT00392665|2382332|P1|Overall Study|Death|16
744205|NCT00392769|2382390|P1|Overall Study|Adverse Event|1
744206|NCT00392769|2382390|P1|Overall Study|Clinical Deterioration|9
744207|NCT00392808|2382408|P4|Overall Study|Unable to withdraw blood|2
744208|NCT00392808|2382409|P3|Overall Study|Unable to withdraw blood|1
744209|NCT00392808|2382410|P2|Overall Study|Unable to withdraw blood|1
744210|NCT00392808|2382411|P1|Overall Study|Unable to withdraw blood|3
744211|NCT00392808|2382408|P4|Overall Study|Lost to Follow-up|2
744212|NCT00392808|2382409|P3|Overall Study|Lost to Follow-up|1
744213|NCT00392808|2382410|P2|Overall Study|Lost to Follow-up|2
744214|NCT00392808|2382411|P1|Overall Study|Lost to Follow-up|3
744215|NCT00392925|2382453|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
744216|NCT00392925|2382454|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
744217|NCT00392925|2382455|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
744218|NCT00392925|2382456|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
744219|NCT00392925|2382453|P4|Randomization to Treatment Group Period|Protocol Violation|1
744220|NCT00392925|2382454|P3|Randomization to Treatment Group Period|Protocol Violation|2
744221|NCT00392925|2382455|P2|Randomization to Treatment Group Period|Protocol Violation|0
744222|NCT00392925|2382456|P1|Randomization to Treatment Group Period|Protocol Violation|0
744223|NCT00392925|2382453|P4|Randomization to Treatment Group Period|Adverse Event|5
744224|NCT00392925|2382454|P3|Randomization to Treatment Group Period|Adverse Event|3
744225|NCT00392925|2382455|P2|Randomization to Treatment Group Period|Adverse Event|3
744226|NCT00392925|2382456|P1|Randomization to Treatment Group Period|Adverse Event|0
744227|NCT00392925|2382453|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
744228|NCT00392925|2382454|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
744229|NCT00392925|2382455|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
744230|NCT00392925|2382456|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
744231|NCT00392925|2382453|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
744232|NCT00392925|2382454|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
744233|NCT00392925|2382455|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
744234|NCT00392925|2382456|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
744235|NCT00392925|2382453|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
744236|NCT00392925|2382454|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
744237|NCT00392925|2382455|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
744238|NCT00392925|2382456|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
744239|NCT00392925|2382453|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
744240|NCT00392925|2382454|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
744241|NCT00392925|2382455|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
744242|NCT00392925|2382456|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
744243|NCT00392925|2382453|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
744244|NCT00392925|2382454|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
744245|NCT00392925|2382455|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
744246|NCT00392925|2382456|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
744247|NCT00392925|2382453|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
744248|NCT00392925|2382454|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
744249|NCT00392925|2382455|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
744250|NCT00392925|2382456|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
744251|NCT00393029|2382544|P2|Overall Study|Not treated|1
744252|NCT00393029|2382545|P1|Overall Study|Not treated|0
744253|NCT00393042|2382554|P2|Second Intervetion|Protocol Violation|1
744254|NCT00393042|2382555|P1|Second Intervetion|Protocol Violation|1
744255|NCT00393042|2382554|P2|Second Intervetion|Lost to Follow-up|2
744256|NCT00393042|2382555|P1|Second Intervetion|Lost to Follow-up|0
744257|NCT00393042|2382554|P2|Second Intervetion|Lack of Efficacy|0
744258|NCT00393042|2382555|P1|Second Intervetion|Lack of Efficacy|1
744259|NCT00393042|2382554|P2|Second Intervetion|Withdrawal by Subject|2
744260|NCT00393042|2382555|P1|Second Intervetion|Withdrawal by Subject|0
744261|NCT00393042|2382554|P2|Second Intervetion|Adverse Event|3
744262|NCT00393042|2382555|P1|Second Intervetion|Adverse Event|0
744263|NCT00393042|2382554|P2|First Intervention|Adverse Event|1
744264|NCT00393042|2382555|P1|First Intervention|Adverse Event|0
744265|NCT00393042|2382554|P2|First Intervention|Protocol Violation|0
744266|NCT00393042|2382555|P1|First Intervention|Protocol Violation|1
744267|NCT00393042|2382554|P2|First Intervention|Lost to Follow-up|3
744268|NCT00393042|2382555|P1|First Intervention|Lost to Follow-up|3
744269|NCT00393042|2382554|P2|First Intervention|Withdrawal by Subject|2
744270|NCT00393042|2382555|P1|First Intervention|Withdrawal by Subject|1
744271|NCT00393094|2382629|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
744272|NCT00393094|2382629|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
744273|NCT00393367|2382638|P2|Overall Study|Withdrawal by Subject|2
744274|NCT00393367|2382639|P1|Overall Study|Withdrawal by Subject|0
744275|NCT00393367|2382638|P2|Overall Study|Protocol Violation|5
744276|NCT00393367|2382639|P1|Overall Study|Protocol Violation|2
744277|NCT00393458|2382682|P4|Overall Study|Subject no longer requires study drug|0
744278|NCT00393458|2382683|P3|Overall Study|Subject no longer requires study drug|0
744279|NCT00393458|2382684|P2|Overall Study|Subject no longer requires study drug|1
744280|NCT00393458|2382685|P1|Overall Study|Subject no longer requires study drug|0
744281|NCT00393458|2382682|P4|Overall Study|Abnormal test procedure result(s)|2
744282|NCT00393458|2382683|P3|Overall Study|Abnormal test procedure result(s)|1
744283|NCT00393458|2382684|P2|Overall Study|Abnormal test procedure result(s)|1
744284|NCT00393458|2382685|P1|Overall Study|Abnormal test procedure result(s)|0
744285|NCT00393458|2382682|P4|Overall Study|Death|5
744286|NCT00393458|2382683|P3|Overall Study|Death|5
744287|NCT00393458|2382684|P2|Overall Study|Death|1
744288|NCT00393458|2382685|P1|Overall Study|Death|1
744289|NCT00393458|2382682|P4|Overall Study|Abnormal laboratory value(s)|0
744290|NCT00393458|2382683|P3|Overall Study|Abnormal laboratory value(s)|0
744291|NCT00393458|2382684|P2|Overall Study|Abnormal laboratory value(s)|1
744292|NCT00393458|2382685|P1|Overall Study|Abnormal laboratory value(s)|1
744293|NCT00393458|2382682|P4|Overall Study|Lost to Follow-up|3
744294|NCT00393458|2382683|P3|Overall Study|Lost to Follow-up|5
744295|NCT00393458|2382684|P2|Overall Study|Lost to Follow-up|6
744296|NCT00393458|2382685|P1|Overall Study|Lost to Follow-up|5
744297|NCT00393458|2382682|P4|Overall Study|Administrative problems|2
744298|NCT00393458|2382683|P3|Overall Study|Administrative problems|5
744299|NCT00393458|2382684|P2|Overall Study|Administrative problems|8
744300|NCT00393458|2382685|P1|Overall Study|Administrative problems|7
744301|NCT00393458|2382682|P4|Overall Study|Protocol deviation|10
744302|NCT00393458|2382683|P3|Overall Study|Protocol deviation|11
744303|NCT00393458|2382684|P2|Overall Study|Protocol deviation|11
744304|NCT00393458|2382685|P1|Overall Study|Protocol deviation|11
744305|NCT00393458|2382682|P4|Overall Study|Unsatisfactory therapeutic effect|30
744306|NCT00393458|2382683|P3|Overall Study|Unsatisfactory therapeutic effect|12
744307|NCT00393458|2382684|P2|Overall Study|Unsatisfactory therapeutic effect|9
744308|NCT00393458|2382685|P1|Overall Study|Unsatisfactory therapeutic effect|12
744309|NCT00393458|2382682|P4|Overall Study|Subject withdrew consent|50
744310|NCT00393458|2382683|P3|Overall Study|Subject withdrew consent|33
744311|NCT00393458|2382684|P2|Overall Study|Subject withdrew consent|40
744312|NCT00393458|2382685|P1|Overall Study|Subject withdrew consent|27
744313|NCT00393458|2382682|P4|Overall Study|Adverse Event|35
744314|NCT00393458|2382683|P3|Overall Study|Adverse Event|40
744315|NCT00393458|2382684|P2|Overall Study|Adverse Event|24
744316|NCT00393458|2382685|P1|Overall Study|Adverse Event|35
744317|NCT00393484|2382701|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
744318|NCT00393484|2382702|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
744319|NCT00393484|2382701|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
744320|NCT00393484|2382702|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
744321|NCT00393484|2382701|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
744322|NCT00393484|2382702|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
744323|NCT00393484|2382701|P2|Open-label Period (Weeks 96 to 240)|Death|0
744324|NCT00393484|2382702|P1|Open-label Period (Weeks 96 to 240)|Death|1
744325|NCT00393484|2382701|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
744326|NCT00393484|2382702|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
744327|NCT00393484|2382701|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
744328|NCT00393484|2382702|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
744329|NCT00393484|2382701|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
744330|NCT00393484|2382702|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
744331|NCT00393484|2382701|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
744332|NCT00393484|2382702|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
744333|NCT00393484|2382701|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
744334|NCT00393484|2382702|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
744335|NCT00393484|2382701|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
744336|NCT00393484|2382702|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
744337|NCT00393510|2382736|P2|Overall Study|Physician Decision|9
744338|NCT00393510|2382737|P1|Overall Study|Physician Decision|3
744339|NCT00393523|2382752|P5|Overall Study|Vaccine supply issue|0
744340|NCT00393523|2382753|P4|Overall Study|Vaccine supply issue|0
744341|NCT00393523|2382754|P3|Overall Study|Vaccine supply issue|1
744342|NCT00393523|2382755|P2|Overall Study|Vaccine supply issue|0
744343|NCT00393523|2382756|P1|Overall Study|Vaccine supply issue|0
744344|NCT00393523|2382752|P5|Overall Study|Difficulties in specimen collection|0
744345|NCT00393523|2382753|P4|Overall Study|Difficulties in specimen collection|0
744346|NCT00393523|2382754|P3|Overall Study|Difficulties in specimen collection|1
744347|NCT00393523|2382755|P2|Overall Study|Difficulties in specimen collection|0
744348|NCT00393523|2382756|P1|Overall Study|Difficulties in specimen collection|0
744349|NCT00393523|2382752|P5|Overall Study|Withdrawal by Subject|0
744350|NCT00393523|2382753|P4|Overall Study|Withdrawal by Subject|3
744351|NCT00393523|2382754|P3|Overall Study|Withdrawal by Subject|2
744352|NCT00393523|2382755|P2|Overall Study|Withdrawal by Subject|7
744353|NCT00393523|2382756|P1|Overall Study|Withdrawal by Subject|6
744354|NCT00393523|2382752|P5|Overall Study|Protocol Violation|0
744355|NCT00393523|2382753|P4|Overall Study|Protocol Violation|1
744356|NCT00393523|2382754|P3|Overall Study|Protocol Violation|0
744357|NCT00393523|2382755|P2|Overall Study|Protocol Violation|2
744358|NCT00393523|2382756|P1|Overall Study|Protocol Violation|6
744359|NCT00393523|2382752|P5|Overall Study|Lost to Follow-up|1
744360|NCT00393523|2382753|P4|Overall Study|Lost to Follow-up|2
744361|NCT00393523|2382754|P3|Overall Study|Lost to Follow-up|0
744362|NCT00393523|2382755|P2|Overall Study|Lost to Follow-up|0
744363|NCT00393523|2382756|P1|Overall Study|Lost to Follow-up|0
744364|NCT00393705|2382773|P2|Overall Study|Physician Decision|2
744365|NCT00393705|2382774|P1|Overall Study|Physician Decision|2
744366|NCT00393705|2382773|P2|Overall Study|Withdrawal by Subject|3
744367|NCT00393705|2382774|P1|Overall Study|Withdrawal by Subject|5
744368|NCT00393705|2382773|P2|Overall Study|Protocol Violation|3
744369|NCT00393705|2382774|P1|Overall Study|Protocol Violation|4
744370|NCT00393705|2382773|P2|Overall Study|Entry Criteria Not Met|10
744371|NCT00393705|2382774|P1|Overall Study|Entry Criteria Not Met|10
744372|NCT00393705|2382773|P2|Overall Study|Lost to Follow-up|2
744373|NCT00393705|2382774|P1|Overall Study|Lost to Follow-up|2
744374|NCT00393705|2382773|P2|Overall Study|Death|1
744375|NCT00393705|2382774|P1|Overall Study|Death|0
744376|NCT00393705|2382773|P2|Overall Study|Adverse Event|2
744377|NCT00393705|2382774|P1|Overall Study|Adverse Event|0
744378|NCT00393718|2382800|P2|Overall Study|Move|0
744379|NCT00393718|2382801|P1|Overall Study|Move|1
744380|NCT00393718|2382800|P2|Overall Study|Missed measurement|0
744381|NCT00393718|2382801|P1|Overall Study|Missed measurement|1
744382|NCT00393718|2382800|P2|Overall Study|Withdrawal of consent|1
744383|NCT00393718|2382801|P1|Overall Study|Withdrawal of consent|2
744384|NCT00393718|2382800|P2|Overall Study|Subject decision|0
744385|NCT00393718|2382801|P1|Overall Study|Subject decision|5
744386|NCT00393718|2382800|P2|Overall Study|Hypoglycaemia|2
744387|NCT00393718|2382801|P1|Overall Study|Hypoglycaemia|3
744388|NCT00393718|2382800|P2|Overall Study|Lack of Efficacy|9
744389|NCT00393718|2382801|P1|Overall Study|Lack of Efficacy|10
744390|NCT00393718|2382800|P2|Overall Study|Protocol Violation|2
744391|NCT00393718|2382801|P1|Overall Study|Protocol Violation|1
744392|NCT00393718|2382800|P2|Overall Study|Adverse Event|8
744393|NCT00393718|2382801|P1|Overall Study|Adverse Event|20
744394|NCT00393848|2382844|P4|Overall Study|Personal reasons|0
744395|NCT00393848|2382845|P3|Overall Study|Personal reasons|2
744396|NCT00393848|2382846|P2|Overall Study|Personal reasons|0
744397|NCT00393848|2382847|P1|Overall Study|Personal reasons|0
744398|NCT00393848|2382844|P4|Overall Study|Surgical schedule|1
744399|NCT00393848|2382845|P3|Overall Study|Surgical schedule|0
744400|NCT00393848|2382846|P2|Overall Study|Surgical schedule|0
744401|NCT00393848|2382847|P1|Overall Study|Surgical schedule|0
744402|NCT00393861|2382859|P1|Overall Study|Disease Progression|24
744403|NCT00393861|2382859|P1|Overall Study|Adverse Event|2
744404|NCT00393887|2382890|P2|Overall Study|Lost to Follow-up|9
744405|NCT00393887|2382891|P1|Overall Study|Lost to Follow-up|11
744406|NCT00393887|2382890|P2|Overall Study|Physician Decision|0
744407|NCT00393887|2382891|P1|Overall Study|Physician Decision|5
744408|NCT00393913|2382897|P1|CPAP|TEchnical problem with CPAP|3
744409|NCT00393913|2382897|P1|CPAP|Physician Decision|1
744410|NCT00393913|2382897|P1|CPAP|Withdrawal by Subject|3
744411|NCT00393913|2382897|P1|Initial Assessment|Withdrawal by Subject|16
744412|NCT00393913|2382897|P1|Initial Assessment|diagnosed with other sleep disorder|21
744413|NCT00393939|2382905|P2|Overall Study|Not specified|45
744414|NCT00393939|2382906|P1|Overall Study|Not specified|37
744415|NCT00393939|2382905|P2|Overall Study|Withdrawal by Subject|7
744416|NCT00393939|2382906|P1|Overall Study|Withdrawal by Subject|2
744417|NCT00393939|2382905|P2|Overall Study|Objective progression or relapse|223
744418|NCT00393939|2382906|P1|Overall Study|Objective progression or relapse|239
744419|NCT00393939|2382905|P2|Overall Study|Sponsor|13
744420|NCT00393939|2382906|P1|Overall Study|Sponsor|5
744421|NCT00393939|2382905|P2|Overall Study|Death|4
744422|NCT00393939|2382906|P1|Overall Study|Death|10
744423|NCT00393939|2382905|P2|Overall Study|Lost to Follow-up|4
744424|NCT00393939|2382906|P1|Overall Study|Lost to Follow-up|2
744425|NCT00393939|2382905|P2|Overall Study|Protocol Violation|1
744426|NCT00393939|2382906|P1|Overall Study|Protocol Violation|1
744427|NCT00394082|2382935|P1|Overall Study|Not specified|1
744428|NCT00394082|2382935|P1|Overall Study|Withdrawal by Subject|2
744429|NCT00394082|2382935|P1|Overall Study|Physician Decision|4
744430|NCT00394082|2382935|P1|Overall Study|Adverse Event|4
744431|NCT00394082|2382935|P1|Overall Study|Unacceptable toxicity|15
744432|NCT00394095|2382946|P2|Overall Study|Adverse Event|0
744433|NCT00394095|2382947|P1|Overall Study|Adverse Event|1
744434|NCT00394212|2382957|P2|Overall Study|Withdrawal by Subject|1
744435|NCT00394212|2382958|P1|Overall Study|Withdrawal by Subject|4
744436|NCT00394212|2382957|P2|Overall Study|Lost to Follow-up|0
744437|NCT00394212|2382958|P1|Overall Study|Lost to Follow-up|3
744438|NCT00394251|2382972|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
744439|NCT00394251|2382973|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
744440|NCT00394251|2382972|P2|Overall Study|Withdrawal by Subject|11
744441|NCT00394251|2382973|P1|Overall Study|Withdrawal by Subject|7
744442|NCT00394251|2382972|P2|Overall Study|Protocol Violation|1
744443|NCT00394251|2382973|P1|Overall Study|Protocol Violation|0
744444|NCT00394251|2382972|P2|Overall Study|Physician Decision|1
744445|NCT00394251|2382973|P1|Overall Study|Physician Decision|1
744446|NCT00394251|2382972|P2|Overall Study|Unacceptable Toxicity|18
744447|NCT00394251|2382973|P1|Overall Study|Unacceptable Toxicity|20
744448|NCT00394251|2382972|P2|Overall Study|Adverse Event|5
744449|NCT00394251|2382973|P1|Overall Study|Adverse Event|7
744450|NCT00394355|2383049|P4|Overall Study|Lack of Efficacy|3
744451|NCT00394355|2383050|P3|Overall Study|Lack of Efficacy|2
744452|NCT00394355|2383051|P2|Overall Study|Lack of Efficacy|0
744453|NCT00394355|2383052|P1|Overall Study|Lack of Efficacy|0
744454|NCT00394355|2383049|P4|Overall Study|Administrative|1
744455|NCT00394355|2383050|P3|Overall Study|Administrative|1
744456|NCT00394355|2383051|P2|Overall Study|Administrative|1
744457|NCT00394355|2383052|P1|Overall Study|Administrative|0
744458|NCT00394355|2383049|P4|Overall Study|Noncompliance with protocol|8
744459|NCT00394355|2383050|P3|Overall Study|Noncompliance with protocol|10
744460|NCT00394355|2383051|P2|Overall Study|Noncompliance with protocol|3
744461|NCT00394355|2383052|P1|Overall Study|Noncompliance with protocol|4
744462|NCT00394355|2383049|P4|Overall Study|Lost to Follow-up|3
744463|NCT00394355|2383050|P3|Overall Study|Lost to Follow-up|4
744464|NCT00394355|2383051|P2|Overall Study|Lost to Follow-up|5
744465|NCT00394355|2383052|P1|Overall Study|Lost to Follow-up|7
744466|NCT00394355|2383049|P4|Overall Study|Subject withdrawal - related to drug|0
744467|NCT00394355|2383050|P3|Overall Study|Subject withdrawal - related to drug|0
744468|NCT00394355|2383051|P2|Overall Study|Subject withdrawal - related to drug|0
744469|NCT00394355|2383052|P1|Overall Study|Subject withdrawal - related to drug|1
744470|NCT00394355|2383049|P4|Overall Study|Subject withdrawal - unrelated to drug|6
744471|NCT00394355|2383050|P3|Overall Study|Subject withdrawal - unrelated to drug|10
744472|NCT00394355|2383051|P2|Overall Study|Subject withdrawal - unrelated to drug|14
744473|NCT00394355|2383052|P1|Overall Study|Subject withdrawal - unrelated to drug|12
744474|NCT00394355|2383049|P4|Overall Study|Did not meet protocol eligibility|2
744475|NCT00394355|2383050|P3|Overall Study|Did not meet protocol eligibility|4
744476|NCT00394355|2383051|P2|Overall Study|Did not meet protocol eligibility|5
744477|NCT00394355|2383052|P1|Overall Study|Did not meet protocol eligibility|1
744478|NCT00394355|2383049|P4|Overall Study|Adverse Event|8
744479|NCT00394355|2383050|P3|Overall Study|Adverse Event|7
744480|NCT00394355|2383051|P2|Overall Study|Adverse Event|6
744481|NCT00394355|2383052|P1|Overall Study|Adverse Event|10
744482|NCT00394433|2383074|P1|Overall Study|Alternative Therapy|1
744483|NCT00394433|2383074|P1|Overall Study|Adverse Event|2
744484|NCT00394472|2383083|P2|Overall Study|Lost to Follow-up|1
744485|NCT00394472|2383084|P1|Overall Study|Lost to Follow-up|0
744486|NCT00394472|2383083|P2|Overall Study|Physician Decision|1
744487|NCT00394472|2383084|P1|Overall Study|Physician Decision|0
744488|NCT00394472|2383083|P2|Overall Study|Withdrawal by Subject|2
744489|NCT00394472|2383084|P1|Overall Study|Withdrawal by Subject|0
744490|NCT00394472|2383083|P2|Overall Study|Adverse Event|2
744491|NCT00394472|2383084|P1|Overall Study|Adverse Event|4
744492|NCT00394472|2383083|P2|Overall Study|incorrect enrolment|2
744493|NCT00394472|2383084|P1|Overall Study|incorrect enrolment|4
744494|NCT00394472|2383083|P2|Overall Study|Protocol Violation|3
744495|NCT00394472|2383084|P1|Overall Study|Protocol Violation|1
744496|NCT00394524|2383094|P2|Overall Study|Withdrawal by Subject|10
744497|NCT00394524|2383095|P1|Overall Study|Withdrawal by Subject|11
744498|NCT00394589|2383108|P3|Overall Study|Protocol Violation|2
744499|NCT00394589|2383109|P2|Overall Study|Protocol Violation|0
744500|NCT00394589|2383110|P1|Overall Study|Protocol Violation|4
744501|NCT00394589|2383108|P3|Overall Study|Lack of Efficacy|3
744502|NCT00394589|2383109|P2|Overall Study|Lack of Efficacy|2
744503|NCT00394589|2383110|P1|Overall Study|Lack of Efficacy|2
744504|NCT00394589|2383108|P3|Overall Study|Adverse Event|2
744505|NCT00394589|2383109|P2|Overall Study|Adverse Event|1
744506|NCT00394589|2383110|P1|Overall Study|Adverse Event|2
744507|NCT00394654|2383120|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
744508|NCT00394654|2383121|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
744509|NCT00394654|2383120|P2|Overall Study|Lost to Follow-up|0
744510|NCT00394654|2383121|P1|Overall Study|Lost to Follow-up|1
744511|NCT00394706|2383191|P8|Overall Study|Lost to Follow-up|0
744512|NCT00394706|2383192|P7|Overall Study|Lost to Follow-up|2
744513|NCT00394706|2383193|P6|Overall Study|Lost to Follow-up|5
744514|NCT00394706|2383194|P5|Overall Study|Lost to Follow-up|2
744515|NCT00394706|2383195|P4|Overall Study|Lost to Follow-up|1
744516|NCT00394706|2383196|P3|Overall Study|Lost to Follow-up|8
744517|NCT00394706|2383197|P2|Overall Study|Lost to Follow-up|2
744518|NCT00394706|2383198|P1|Overall Study|Lost to Follow-up|2
744519|NCT00394706|2383191|P8|Overall Study|Withdrawal by Subject|0
744520|NCT00394706|2383192|P7|Overall Study|Withdrawal by Subject|1
744521|NCT00394706|2383193|P6|Overall Study|Withdrawal by Subject|2
744522|NCT00394706|2383194|P5|Overall Study|Withdrawal by Subject|0
744523|NCT00394706|2383195|P4|Overall Study|Withdrawal by Subject|0
744524|NCT00394706|2383196|P3|Overall Study|Withdrawal by Subject|1
744525|NCT00394706|2383197|P2|Overall Study|Withdrawal by Subject|0
744526|NCT00394706|2383198|P1|Overall Study|Withdrawal by Subject|2
744527|NCT00394771|2383220|P4|Overall Study|Not specified|0
744528|NCT00394771|2383221|P3|Overall Study|Not specified|1
744529|NCT00394771|2383222|P2|Overall Study|Not specified|3
744530|NCT00394771|2383223|P1|Overall Study|Not specified|3
744531|NCT00394771|2383220|P4|Overall Study|Lost to Follow-up|10
744532|NCT00394771|2383221|P3|Overall Study|Lost to Follow-up|13
744533|NCT00394771|2383222|P2|Overall Study|Lost to Follow-up|15
744534|NCT00394771|2383223|P1|Overall Study|Lost to Follow-up|15
744535|NCT00394771|2383220|P4|Overall Study|Participant pregnant|2
744536|NCT00394771|2383221|P3|Overall Study|Participant pregnant|2
744537|NCT00394771|2383222|P2|Overall Study|Participant pregnant|1
744538|NCT00394771|2383223|P1|Overall Study|Participant pregnant|0
744539|NCT00394771|2383220|P4|Overall Study|Adverse Event|8
744540|NCT00394771|2383221|P3|Overall Study|Adverse Event|12
744541|NCT00394771|2383222|P2|Overall Study|Adverse Event|5
744542|NCT00394771|2383223|P1|Overall Study|Adverse Event|10
744543|NCT00394771|2383220|P4|Overall Study|Withdrawal by Subject|12
744544|NCT00394771|2383221|P3|Overall Study|Withdrawal by Subject|8
744545|NCT00394771|2383222|P2|Overall Study|Withdrawal by Subject|6
744546|NCT00394771|2383223|P1|Overall Study|Withdrawal by Subject|10
744547|NCT00394771|2383220|P4|Overall Study|Protocol Violation|7
744548|NCT00394771|2383221|P3|Overall Study|Protocol Violation|9
744549|NCT00394771|2383222|P2|Overall Study|Protocol Violation|4
744550|NCT00394771|2383223|P1|Overall Study|Protocol Violation|2
744551|NCT00394771|2383220|P4|Overall Study|Did not meet protocol requirements|0
744552|NCT00394771|2383221|P3|Overall Study|Did not meet protocol requirements|2
744553|NCT00394771|2383222|P2|Overall Study|Did not meet protocol requirements|0
744554|NCT00394771|2383223|P1|Overall Study|Did not meet protocol requirements|1
744555|NCT00394836|2383287|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
744556|NCT00394836|2383288|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
744557|NCT00394836|2383287|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
744558|NCT00394836|2383288|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
744559|NCT00394836|2383287|P2|Extended Follow-up Phase (2-5 Years)|Death|1
744560|NCT00394836|2383288|P1|Extended Follow-up Phase (2-5 Years)|Death|0
744561|NCT00394836|2383287|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
744562|NCT00394836|2383288|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
744563|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Non compliance|1
744564|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Non compliance|0
744565|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
744566|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
744567|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Physician Decision|1
744568|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Physician Decision|0
744569|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
744570|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
744571|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Started alternative treatment|6
744572|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Started alternative treatment|0
744573|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
744574|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
744575|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Death|1
744576|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Death|0
744577|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Patient Refusal|2
744578|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Patient Refusal|1
744579|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Disease Progression|60
744580|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Disease Progression|27
744581|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Protocol Violation|2
744582|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Protocol Violation|0
744583|NCT00394836|2383287|P2|Teatment or Follow-up Phase|Adverse Event|2
744584|NCT00394836|2383288|P1|Teatment or Follow-up Phase|Adverse Event|0
744585|NCT00381381|2383330|P1|Overall Study|Withdrawal by Subject|9
744586|NCT00381381|2383330|P1|Overall Study|Lost to Follow-up|52
744587|NCT00381381|2383330|P1|Overall Study|Adverse Event|3
744588|NCT00381485|2383340|P4|Double-Blind Treatment Period|Administrative|1
744589|NCT00381485|2383341|P3|Double-Blind Treatment Period|Administrative|0
744590|NCT00381485|2383342|P2|Double-Blind Treatment Period|Administrative|1
744591|NCT00381485|2383343|P1|Double-Blind Treatment Period|Administrative|0
744592|NCT00381485|2383340|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
744593|NCT00381485|2383341|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
744594|NCT00381485|2383342|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
744595|NCT00381485|2383343|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
744596|NCT00381485|2383340|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
744597|NCT00381485|2383341|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
744598|NCT00381485|2383342|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
744599|NCT00381485|2383343|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
744600|NCT00381485|2383340|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
744601|NCT00381485|2383341|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
744602|NCT00381485|2383342|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
744603|NCT00381485|2383343|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
744604|NCT00381485|2383340|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
744605|NCT00381485|2383341|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
744606|NCT00381485|2383342|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
744607|NCT00381485|2383343|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
744608|NCT00381485|2383340|P4|Double-Blind Treatment Period|Lost to Follow-up|1
744609|NCT00381485|2383341|P3|Double-Blind Treatment Period|Lost to Follow-up|1
744610|NCT00381485|2383342|P2|Double-Blind Treatment Period|Lost to Follow-up|0
744611|NCT00381485|2383343|P1|Double-Blind Treatment Period|Lost to Follow-up|0
744612|NCT00381485|2383340|P4|Double-Blind Treatment Period|Lack of Efficacy|13
744613|NCT00381485|2383341|P3|Double-Blind Treatment Period|Lack of Efficacy|11
744614|NCT00381485|2383342|P2|Double-Blind Treatment Period|Lack of Efficacy|8
744615|NCT00381485|2383343|P1|Double-Blind Treatment Period|Lack of Efficacy|0
744616|NCT00381485|2383340|P4|Double-Blind Treatment Period|Adverse Event|5
744617|NCT00381485|2383341|P3|Double-Blind Treatment Period|Adverse Event|2
744618|NCT00381485|2383342|P2|Double-Blind Treatment Period|Adverse Event|2
744619|NCT00381485|2383343|P1|Double-Blind Treatment Period|Adverse Event|0
744620|NCT00381485|2383340|P4|Open-Label Run-In Period|Treatment failure|0
744621|NCT00381485|2383341|P3|Open-Label Run-In Period|Treatment failure|0
744622|NCT00381485|2383342|P2|Open-Label Run-In Period|Treatment failure|0
744623|NCT00381485|2383343|P1|Open-Label Run-In Period|Treatment failure|1
744624|NCT00381485|2383340|P4|Open-Label Run-In Period|Lost to Follow-up|0
744625|NCT00381485|2383341|P3|Open-Label Run-In Period|Lost to Follow-up|0
744626|NCT00381485|2383342|P2|Open-Label Run-In Period|Lost to Follow-up|0
744627|NCT00381485|2383343|P1|Open-Label Run-In Period|Lost to Follow-up|3
744628|NCT00381485|2383340|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
744629|NCT00381485|2383341|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
744630|NCT00381485|2383342|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
744631|NCT00381485|2383343|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
744632|NCT00381485|2383340|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
744633|NCT00381485|2383341|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
744634|NCT00381485|2383342|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
744635|NCT00381485|2383343|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
744636|NCT00381485|2383340|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
744637|NCT00381485|2383341|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
744638|NCT00381485|2383342|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
744639|NCT00381485|2383343|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
744640|NCT00381485|2383340|P4|Open-Label Run-In Period|Adverse Event|0
744641|NCT00381485|2383341|P3|Open-Label Run-In Period|Adverse Event|0
744642|NCT00381485|2383342|P2|Open-Label Run-In Period|Adverse Event|0
744643|NCT00381485|2383343|P1|Open-Label Run-In Period|Adverse Event|9
744644|NCT00381563|2383368|P2|Overall Study|Protocol Violation|1
744645|NCT00381563|2383369|P1|Overall Study|Protocol Violation|0
744646|NCT00381563|2383368|P2|Overall Study|Lost to Follow-up|0
744647|NCT00381563|2383369|P1|Overall Study|Lost to Follow-up|2
744648|NCT00381563|2383368|P2|Overall Study|Withdrawal by Subject|5
744649|NCT00381563|2383369|P1|Overall Study|Withdrawal by Subject|5
744650|NCT00381615|2383380|P4|Overall Study|Protocol Violation|0
744651|NCT00381615|2383381|P3|Overall Study|Protocol Violation|1
744652|NCT00381615|2383382|P2|Overall Study|Protocol Violation|0
744653|NCT00381615|2383383|P1|Overall Study|Protocol Violation|0
744654|NCT00381615|2383380|P4|Overall Study|Lost to Follow-up|1
744655|NCT00381615|2383381|P3|Overall Study|Lost to Follow-up|0
744656|NCT00381615|2383382|P2|Overall Study|Lost to Follow-up|2
744657|NCT00381615|2383383|P1|Overall Study|Lost to Follow-up|3
744658|NCT00381615|2383380|P4|Overall Study|Withdrawal by Subject|1
744659|NCT00381615|2383381|P3|Overall Study|Withdrawal by Subject|0
744660|NCT00381615|2383382|P2|Overall Study|Withdrawal by Subject|3
744661|NCT00381615|2383383|P1|Overall Study|Withdrawal by Subject|1
744662|NCT00381641|2383452|P2|Overall Study|Withdrawal by Subject|2
744663|NCT00381641|2383453|P1|Overall Study|Withdrawal by Subject|0
744664|NCT00381680|2383467|P2|Overall Study|Ineligible|1
744665|NCT00381680|2383468|P1|Overall Study|Ineligible|3
744666|NCT00381680|2383467|P2|Overall Study|Other not otherwise specified|2
744667|NCT00381680|2383468|P1|Overall Study|Other not otherwise specified|7
744668|NCT00381680|2383467|P2|Overall Study|Progression|1
744669|NCT00381680|2383468|P1|Overall Study|Progression|1
744670|NCT00381680|2383467|P2|Overall Study|Induction Failure|1
744671|NCT00381680|2383468|P1|Overall Study|Induction Failure|4
744672|NCT00381680|2383467|P2|Overall Study|Relapse|9
744673|NCT00381680|2383468|P1|Overall Study|Relapse|18
744674|NCT00381680|2383467|P2|Overall Study|Stem Cell Transplant|10
744675|NCT00381680|2383468|P1|Overall Study|Stem Cell Transplant|26
744676|NCT00381680|2383467|P2|Overall Study|Delay initiation|0
744677|NCT00381680|2383468|P1|Overall Study|Delay initiation|1
744678|NCT00381680|2383467|P2|Overall Study|Secondary Malignancy|0
744679|NCT00381680|2383468|P1|Overall Study|Secondary Malignancy|3
744680|NCT00381680|2383467|P2|Overall Study|Alternative Therapy|5
744681|NCT00381680|2383468|P1|Overall Study|Alternative Therapy|11
744682|NCT00381680|2383467|P2|Overall Study|Entry onto another COG Trial|2
744683|NCT00381680|2383468|P1|Overall Study|Entry onto another COG Trial|1
744684|NCT00381680|2383467|P2|Overall Study|Withdrawal by Subject|1
744685|NCT00381680|2383468|P1|Overall Study|Withdrawal by Subject|3
744686|NCT00381680|2383467|P2|Overall Study|Physician Decision|6
744687|NCT00381680|2383468|P1|Overall Study|Physician Decision|25
744688|NCT00381680|2383467|P2|Overall Study|Lost to Follow-up|2
744689|NCT00381680|2383468|P1|Overall Study|Lost to Follow-up|3
744690|NCT00381680|2383467|P2|Overall Study|Death|7
744691|NCT00381680|2383468|P1|Overall Study|Death|10
744692|NCT00381680|2383467|P2|Overall Study|Adverse Event|3
744693|NCT00381680|2383468|P1|Overall Study|Adverse Event|9
744694|NCT00381693|2383483|P1|Overall Study|Progression|2
744695|NCT00381693|2383483|P1|Overall Study|Patient Choice|1
744696|NCT00381693|2383483|P1|Overall Study|Adverse Event|4
744697|NCT00381693|2383483|P1|Overall Study|Death|1
744698|NCT00381706|2383496|P3|Overall Study|Never treated|1
744699|NCT00381706|2383497|P2|Overall Study|Never treated|2
744700|NCT00381706|2383498|P1|Overall Study|Never treated|7
744701|NCT00387127|2383523|P2|Overall Study|Sponsor Unblinded|0
744702|NCT00387127|2383524|P1|Overall Study|Sponsor Unblinded|1
744703|NCT00387127|2383523|P2|Overall Study|Serious Adverse Event|1
744704|NCT00387127|2383524|P1|Overall Study|Serious Adverse Event|1
744705|NCT00387127|2383523|P2|Overall Study|Required by Protocol Amendment #4|10
744706|NCT00387127|2383524|P1|Overall Study|Required by Protocol Amendment #4|12
744707|NCT00387127|2383523|P2|Overall Study|Withdrawal by Subject|2
744708|NCT00387127|2383524|P1|Overall Study|Withdrawal by Subject|3
744709|NCT00387127|2383523|P2|Overall Study|Physician Decision|1
744710|NCT00387127|2383524|P1|Overall Study|Physician Decision|0
744711|NCT00387127|2383523|P2|Overall Study|Death|16
744712|NCT00387127|2383524|P1|Overall Study|Death|16
744713|NCT00387127|2383523|P2|Overall Study|Lost to Follow-up|4
744714|NCT00387127|2383524|P1|Overall Study|Lost to Follow-up|0
744715|NCT00387153|2383564|P1|Overall Study|Lack of Response|4
744716|NCT00387153|2383564|P1|Overall Study|Disease Progression|3
744717|NCT00387153|2383564|P1|Overall Study|Adverse Event|1
744718|NCT00387348|2383586|P3|Overall Study|Adverse Event|1
744719|NCT00387348|2383587|P2|Overall Study|Adverse Event|0
744720|NCT00387348|2383588|P1|Overall Study|Adverse Event|1
744721|NCT00387348|2383586|P3|Overall Study|Withdrawal by Subject|2
744722|NCT00387348|2383587|P2|Overall Study|Withdrawal by Subject|2
744723|NCT00387348|2383588|P1|Overall Study|Withdrawal by Subject|0
744724|NCT00387348|2383586|P3|Overall Study|Physician Decision|1
744725|NCT00387348|2383587|P2|Overall Study|Physician Decision|0
744726|NCT00387348|2383588|P1|Overall Study|Physician Decision|1
744727|NCT00387348|2383586|P3|Overall Study|Death|0
744728|NCT00387348|2383587|P2|Overall Study|Death|1
744729|NCT00387348|2383588|P1|Overall Study|Death|1
744730|NCT00387426|2383602|P1|Overall Study|Disease Progression|3
744731|NCT00387426|2383602|P1|Overall Study|Toxicities|4
744732|NCT00387426|2383602|P1|Overall Study|Lack of Response|7
744733|NCT00387647|2383640|P1|Overall Study|Death|18
744734|NCT00387712|2383669|P2|Overall Study|Withdrawal by Subject|12
744735|NCT00387712|2383670|P1|Overall Study|Withdrawal by Subject|6
744736|NCT00387712|2383669|P2|Overall Study|Lost to Follow-up|20
744737|NCT00387712|2383670|P1|Overall Study|Lost to Follow-up|17
744738|NCT00387712|2383669|P2|Overall Study|Physician Decision|4
744739|NCT00387712|2383670|P1|Overall Study|Physician Decision|6
744740|NCT00387725|2383684|P4|Overall Study|Parent/legal guardian request|1
744741|NCT00387725|2383685|P3|Overall Study|Parent/legal guardian request|1
744742|NCT00387725|2383686|P2|Overall Study|Parent/legal guardian request|0
744743|NCT00387725|2383687|P1|Overall Study|Parent/legal guardian request|0
744744|NCT00387725|2383684|P4|Overall Study|Withdrawal by Subject|0
744745|NCT00387725|2383685|P3|Overall Study|Withdrawal by Subject|1
744746|NCT00387725|2383686|P2|Overall Study|Withdrawal by Subject|0
744747|NCT00387725|2383687|P1|Overall Study|Withdrawal by Subject|1
744748|NCT00387725|2383684|P4|Overall Study|Protocol Violation|0
744749|NCT00387725|2383685|P3|Overall Study|Protocol Violation|0
744750|NCT00387725|2383686|P2|Overall Study|Protocol Violation|1
744751|NCT00387725|2383687|P1|Overall Study|Protocol Violation|0
744752|NCT00387725|2383684|P4|Overall Study|Adverse Event|1
744753|NCT00387725|2383685|P3|Overall Study|Adverse Event|0
744754|NCT00387725|2383686|P2|Overall Study|Adverse Event|0
744755|NCT00387725|2383687|P1|Overall Study|Adverse Event|0
744756|NCT00387764|2383709|P1|Overall Study|Death|7
744757|NCT00387764|2383709|P1|Overall Study|Other|2
744758|NCT00387764|2383709|P1|Overall Study|Physician Decision|1
744759|NCT00387764|2383709|P1|Overall Study|Sponsor Terminated Study|1
744760|NCT00387764|2383709|P1|Overall Study|Withdrawal by Subject|8
744761|NCT00387764|2383709|P1|Overall Study|Adverse Event|12
744762|NCT00387790|2383727|P1|Overall Study|Ineligible for study|2
744763|NCT00387790|2383727|P1|Overall Study|Withdrawal by Subject|3
744764|NCT00387790|2383727|P1|Overall Study|Physician Decision|2
744765|NCT00387790|2383727|P1|Overall Study|Lack of Efficacy|2
744766|NCT00387790|2383727|P1|Overall Study|Adverse Event|5
744767|NCT00387881|2383744|P2|Overall Study|Not otherwise specified|7
744768|NCT00387881|2383745|P1|Overall Study|Not otherwise specified|11
744769|NCT00387881|2383744|P2|Overall Study|No opportunity to treat headache|34
744770|NCT00387881|2383745|P1|Overall Study|No opportunity to treat headache|32
744771|NCT00387881|2383744|P2|Overall Study|Not eligible|7
744772|NCT00387881|2383745|P1|Overall Study|Not eligible|6
744773|NCT00387881|2383744|P2|Overall Study|Sponsor terminated Study|1
744774|NCT00387881|2383745|P1|Overall Study|Sponsor terminated Study|0
744775|NCT00387881|2383744|P2|Overall Study|Withdrawal by Subject|18
744776|NCT00387881|2383745|P1|Overall Study|Withdrawal by Subject|15
744777|NCT00387881|2383744|P2|Overall Study|Protocol Violation|12
744778|NCT00387881|2383745|P1|Overall Study|Protocol Violation|2
744779|NCT00387881|2383744|P2|Overall Study|Lost to Follow-up|23
744780|NCT00387881|2383745|P1|Overall Study|Lost to Follow-up|23
744781|NCT00387894|2383767|P1|Overall Study|Withdrawal by Subject|1
744782|NCT00388037|2383776|P1|Overall Study|Protocol Violation|1
744783|NCT00388154|2383780|P1|Overall Study|Withdrawal by Subject|1
744784|NCT00388349|2383785|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
744785|NCT00388349|2383786|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
744786|NCT00388362|2383795|P1|Remained on Study Median of 514 Days|Death|2
744787|NCT00388362|2383795|P1|Enrolled|Withdrawal by Subject|1
744788|NCT00388362|2383795|P1|Enrolled|Loss insurance|1
744789|NCT00388362|2383795|P1|Enrolled|Death|1
744790|NCT00388362|2383795|P1|Enrolled|Adverse Event|9
744791|NCT00388362|2383795|P1|Enrolled|Ineligible|1
744792|NCT00388505|2383824|P2|Overall Study|Unable to classify|3
744793|NCT00388505|2383825|P1|Overall Study|Unable to classify|4
744794|NCT00388505|2383824|P2|Overall Study|Protocol Violation|5
744795|NCT00388505|2383825|P1|Overall Study|Protocol Violation|6
744796|NCT00388505|2383824|P2|Overall Study|Administrative Reason|0
744797|NCT00388505|2383825|P1|Overall Study|Administrative Reason|1
744798|NCT00388505|2383824|P2|Overall Study|Inappropriate Enrollment|1
744799|NCT00388505|2383825|P1|Overall Study|Inappropriate Enrollment|0
744800|NCT00388505|2383824|P2|Overall Study|Lost to Follow-up|3
744801|NCT00388505|2383825|P1|Overall Study|Lost to Follow-up|5
744802|NCT00388505|2383824|P2|Overall Study|Withdrawal by Subject|9
744803|NCT00388505|2383825|P1|Overall Study|Withdrawal by Subject|24
744804|NCT00388505|2383824|P2|Overall Study|Adverse Event or Death|17
744805|NCT00388505|2383825|P1|Overall Study|Adverse Event or Death|43
744806|NCT00388583|2383849|P2|Overall Study|Did not receive vaccine|1
744807|NCT00388583|2383850|P1|Overall Study|Did not receive vaccine|0
744808|NCT00388583|2383849|P2|Overall Study|Serious Adverse Event|0
744809|NCT00388583|2383850|P1|Overall Study|Serious Adverse Event|2
744810|NCT00388583|2383849|P2|Overall Study|Withdrawal by Subject|3
744811|NCT00388583|2383850|P1|Overall Study|Withdrawal by Subject|3
744812|NCT00388583|2383849|P2|Overall Study|Protocol Violation|0
744813|NCT00388583|2383850|P1|Overall Study|Protocol Violation|1
744814|NCT00388726|2383864|P2|Overall Study|Death|2
744815|NCT00388726|2383865|P1|Overall Study|Death|3
744816|NCT00388726|2383864|P2|Overall Study|Physician Decision|13
744817|NCT00388726|2383865|P1|Overall Study|Physician Decision|18
744818|NCT00388726|2383864|P2|Overall Study|Administrative|9
744819|NCT00388726|2383865|P1|Overall Study|Administrative|6
744820|NCT00388726|2383864|P2|Overall Study|Withdrawal by Subject|7
744821|NCT00388726|2383865|P1|Overall Study|Withdrawal by Subject|10
744822|NCT00388726|2383864|P2|Overall Study|Clinical Progression|36
744823|NCT00388726|2383865|P1|Overall Study|Clinical Progression|61
744824|NCT00388726|2383864|P2|Overall Study|Progressive Disease|153
744825|NCT00388726|2383865|P1|Overall Study|Progressive Disease|336
744826|NCT00388726|2383864|P2|Overall Study|Adverse Event|24
744827|NCT00388726|2383865|P1|Overall Study|Adverse Event|50
744828|NCT00394901|2383906|P4|Double-blind Phase|Found not to meet entrance criteria|1
744829|NCT00394901|2383907|P3|Double-blind Phase|Found not to meet entrance criteria|0
744830|NCT00394901|2383908|P2|Double-blind Phase|Found not to meet entrance criteria|0
744831|NCT00394901|2383909|P1|Double-blind Phase|Found not to meet entrance criteria|0
744832|NCT00394901|2383906|P4|Double-blind Phase|Entry into another study was found|0
744833|NCT00394901|2383907|P3|Double-blind Phase|Entry into another study was found|1
744834|NCT00394901|2383908|P2|Double-blind Phase|Entry into another study was found|0
744835|NCT00394901|2383909|P1|Double-blind Phase|Entry into another study was found|0
744836|NCT00394901|2383906|P4|Double-blind Phase|Lack of Compliance|0
744837|NCT00394901|2383907|P3|Double-blind Phase|Lack of Compliance|0
744838|NCT00394901|2383908|P2|Double-blind Phase|Lack of Compliance|3
744839|NCT00394901|2383909|P1|Double-blind Phase|Lack of Compliance|0
744840|NCT00394901|2383906|P4|Double-blind Phase|Subject's Personal Reason|1
744841|NCT00394901|2383907|P3|Double-blind Phase|Subject's Personal Reason|0
744842|NCT00394901|2383908|P2|Double-blind Phase|Subject's Personal Reason|0
744843|NCT00394901|2383909|P1|Double-blind Phase|Subject's Personal Reason|1
744844|NCT00394901|2383906|P4|Double-blind Phase|Death|0
744845|NCT00394901|2383907|P3|Double-blind Phase|Death|0
744846|NCT00394901|2383908|P2|Double-blind Phase|Death|0
744847|NCT00394901|2383909|P1|Double-blind Phase|Death|1
744848|NCT00394901|2383906|P4|Double-blind Phase|Protocol Violation|1
744849|NCT00394901|2383907|P3|Double-blind Phase|Protocol Violation|0
744850|NCT00394901|2383908|P2|Double-blind Phase|Protocol Violation|0
744851|NCT00394901|2383909|P1|Double-blind Phase|Protocol Violation|0
744852|NCT00394901|2383906|P4|Double-blind Phase|Lost to Follow-up|1
744853|NCT00394901|2383907|P3|Double-blind Phase|Lost to Follow-up|0
744854|NCT00394901|2383908|P2|Double-blind Phase|Lost to Follow-up|0
744855|NCT00394901|2383909|P1|Double-blind Phase|Lost to Follow-up|0
744856|NCT00394901|2383906|P4|Double-blind Phase|Withdrawal by Subject|0
744857|NCT00394901|2383907|P3|Double-blind Phase|Withdrawal by Subject|0
744858|NCT00394901|2383908|P2|Double-blind Phase|Withdrawal by Subject|0
744859|NCT00394901|2383909|P1|Double-blind Phase|Withdrawal by Subject|2
744860|NCT00394901|2383906|P4|Double-blind Phase|Lack of Efficacy|3
744861|NCT00394901|2383907|P3|Double-blind Phase|Lack of Efficacy|1
744862|NCT00394901|2383908|P2|Double-blind Phase|Lack of Efficacy|4
744863|NCT00394901|2383909|P1|Double-blind Phase|Lack of Efficacy|6
744864|NCT00394901|2383906|P4|Double-blind Phase|Adverse Event|20
744865|NCT00394901|2383907|P3|Double-blind Phase|Adverse Event|16
744866|NCT00394901|2383908|P2|Double-blind Phase|Adverse Event|7
744867|NCT00394901|2383909|P1|Double-blind Phase|Adverse Event|5
744868|NCT00394901|2383906|P4|Baseline Phase|Protocol Violation|0
744869|NCT00394901|2383907|P3|Baseline Phase|Protocol Violation|1
744870|NCT00394901|2383908|P2|Baseline Phase|Protocol Violation|0
744871|NCT00394901|2383909|P1|Baseline Phase|Protocol Violation|0
744872|NCT00394914|2384136|P3|Treatment Period|Did not meet protocol eligibility|1
744873|NCT00394914|2384137|P2|Treatment Period|Did not meet protocol eligibility|1
744874|NCT00394914|2384138|P1|Treatment Period|Did not meet protocol eligibility|0
744875|NCT00394914|2384136|P3|Treatment Period|Noncompliance with protocol|2
744876|NCT00394914|2384137|P2|Treatment Period|Noncompliance with protocol|3
744877|NCT00394914|2384138|P1|Treatment Period|Noncompliance with protocol|0
744878|NCT00394914|2384136|P3|Treatment Period|Withdrawal by Subject|2
744879|NCT00394914|2384137|P2|Treatment Period|Withdrawal by Subject|2
744880|NCT00394914|2384138|P1|Treatment Period|Withdrawal by Subject|0
744881|NCT00394914|2384136|P3|Treatment Period|Lost to Follow-up|0
744882|NCT00394914|2384137|P2|Treatment Period|Lost to Follow-up|1
744883|NCT00394914|2384138|P1|Treatment Period|Lost to Follow-up|0
744884|NCT00394914|2384136|P3|Treatment Period|Adverse Event|1
744885|NCT00394914|2384137|P2|Treatment Period|Adverse Event|3
744886|NCT00394914|2384138|P1|Treatment Period|Adverse Event|0
744887|NCT00394953|2384164|P2|Second Treatment Period|Not defined|8
744888|NCT00394953|2384165|P1|Second Treatment Period|Not defined|3
744889|NCT00394953|2384164|P2|Second Treatment Period|Renal transplant|6
744890|NCT00394953|2384165|P1|Second Treatment Period|Renal transplant|4
744891|NCT00394953|2384164|P2|Second Treatment Period|Lost to Follow-up|1
744892|NCT00394953|2384165|P1|Second Treatment Period|Lost to Follow-up|0
744893|NCT00394953|2384164|P2|Second Treatment Period|Withdrawal by Subject|3
744894|NCT00394953|2384165|P1|Second Treatment Period|Withdrawal by Subject|3
744895|NCT00394953|2384164|P2|Second Treatment Period|Lack of Efficacy|47
744896|NCT00394953|2384165|P1|Second Treatment Period|Lack of Efficacy|9
744897|NCT00394953|2384164|P2|Second Treatment Period|Death|4
744898|NCT00394953|2384165|P1|Second Treatment Period|Death|8
744899|NCT00394953|2384164|P2|Second Treatment Period|Adverse Event|5
744900|NCT00394953|2384165|P1|Second Treatment Period|Adverse Event|2
744901|NCT00394953|2384164|P2|First Treatment Period|Not defined|1
744902|NCT00394953|2384165|P1|First Treatment Period|Not defined|4
744903|NCT00394953|2384164|P2|First Treatment Period|Renal transplant|7
744904|NCT00394953|2384165|P1|First Treatment Period|Renal transplant|11
744905|NCT00394953|2384164|P2|First Treatment Period|Lost to Follow-up|1
744906|NCT00394953|2384165|P1|First Treatment Period|Lost to Follow-up|0
744907|NCT00394953|2384164|P2|First Treatment Period|Withdrawal by Subject|3
744908|NCT00394953|2384165|P1|First Treatment Period|Withdrawal by Subject|6
744909|NCT00394953|2384164|P2|First Treatment Period|Lack of Efficacy|1
744910|NCT00394953|2384165|P1|First Treatment Period|Lack of Efficacy|1
744911|NCT00394953|2384164|P2|First Treatment Period|Death|7
744912|NCT00394953|2384165|P1|First Treatment Period|Death|6
744913|NCT00394953|2384164|P2|First Treatment Period|Adverse Event|2
744914|NCT00394953|2384165|P1|First Treatment Period|Adverse Event|1
744915|NCT00395018|2384181|P1|Off-Treatment Follow-up|Poor/non-compliance|1
744916|NCT00395018|2384181|P1|Off-Treatment Follow-up|Lost to Follow-up|2
744917|NCT00395018|2384181|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
744918|NCT00395018|2384181|P1|On-Treatment|Subject no longer meets study criteria|2
744919|NCT00395018|2384181|P1|On-Treatment|Poor/non-compliance|2
744920|NCT00395018|2384181|P1|On-Treatment|Other Reason|2
744921|NCT00395018|2384181|P1|On-Treatment|Death|4
744922|NCT00395083|2384256|P2|Overall Study|Developed another disease|3
744923|NCT00395083|2384257|P1|Overall Study|Developed another disease|4
744924|NCT00395083|2384256|P2|Overall Study|Withdrawal by Subject|5
744925|NCT00395083|2384257|P1|Overall Study|Withdrawal by Subject|6
744926|NCT00396084|2384314|P6|Overall Study|Withdrawal by Subject|0
744927|NCT00396084|2384315|P5|Overall Study|Withdrawal by Subject|0
744928|NCT00396084|2384316|P4|Overall Study|Withdrawal by Subject|1
744929|NCT00396084|2384317|P3|Overall Study|Withdrawal by Subject|0
744930|NCT00396084|2384318|P2|Overall Study|Withdrawal by Subject|0
744931|NCT00396084|2384319|P1|Overall Study|Withdrawal by Subject|0
744932|NCT00396084|2384314|P6|Overall Study|Adverse Event|2
744933|NCT00396084|2384315|P5|Overall Study|Adverse Event|1
744934|NCT00396084|2384316|P4|Overall Study|Adverse Event|0
744935|NCT00396084|2384317|P3|Overall Study|Adverse Event|0
744936|NCT00396084|2384318|P2|Overall Study|Adverse Event|0
744937|NCT00396084|2384319|P1|Overall Study|Adverse Event|0
744938|NCT00396097|2384394|P2|Overall Study|Insufficient Clinical Response|4
744939|NCT00396097|2384395|P1|Overall Study|Insufficient Clinical Response|1
744940|NCT00396097|2384394|P2|Overall Study|Adverse Event|5
744941|NCT00396097|2384395|P1|Overall Study|Adverse Event|1
744942|NCT00396097|2384394|P2|Overall Study|Protocol Violation|6
744943|NCT00396097|2384395|P1|Overall Study|Protocol Violation|0
744944|NCT00396097|2384394|P2|Overall Study|Not specified|5
744945|NCT00396097|2384395|P1|Overall Study|Not specified|3
744946|NCT00396097|2384394|P2|Overall Study|Lost to Follow-up|9
744947|NCT00396097|2384395|P1|Overall Study|Lost to Follow-up|4
744948|NCT00396097|2384394|P2|Overall Study|Withdrawal by Subject|17
744949|NCT00396097|2384395|P1|Overall Study|Withdrawal by Subject|17
744950|NCT00396136|2384417|P1|Overall Study|Study device explanted|8
744951|NCT00396136|2384417|P1|Overall Study|Lost to Follow-up|15
744952|NCT00396136|2384417|P1|Overall Study|Withdrawal by Subject|59
744953|NCT00396136|2384417|P1|Overall Study|Death|43
744954|NCT00396162|2384424|P2|Overall Study|Withdrawal by Subject|3
744955|NCT00396162|2384425|P1|Overall Study|Withdrawal by Subject|2
744956|NCT00396253|2384454|P1|Overall Study|Change in eligibility status|1
744957|NCT00396253|2384454|P1|Overall Study|Physician Decision|1
744958|NCT00396253|2384454|P1|Overall Study|Death|3
744959|NCT00396253|2384454|P1|Overall Study|Withdrawal by Subject|7
744960|NCT00396253|2384454|P1|Overall Study|Protocol Violation|1
744961|NCT00396279|2384490|P1|Overall Study|Physician Decision|1
744962|NCT00396279|2384490|P1|Overall Study|Withdrawal by Subject|1
744963|NCT00396279|2384490|P1|Overall Study|Disease progression|2
744964|NCT00396279|2384490|P1|Overall Study|Ongoing in study|26
744965|NCT00396318|2384508|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
744966|NCT00396331|2384523|P1|Overall Study|Death|16
744967|NCT00396331|2384523|P1|Overall Study|Lost to Follow-up|3
744968|NCT00396331|2384523|P1|Overall Study|Did not go on to transplant|5
744969|NCT00396331|2384523|P1|Overall Study|Failed to mobilize - no transplant|8
744970|NCT00396383|2384576|P1|Overall Study|Lost to Follow-up|1
744971|NCT00396383|2384576|P1|Overall Study|Death|2
744972|NCT00396409|2384587|P2|Period 2 - 2008|Lost to Follow-up|1
744973|NCT00396409|2384588|P1|Period 2 - 2008|Lost to Follow-up|3
744974|NCT00396409|2384587|P2|Period 2 - 2008|Withdrawal by Subject|1
744975|NCT00396409|2384588|P1|Period 2 - 2008|Withdrawal by Subject|3
744976|NCT00396409|2384587|P2|Period 2 - 2008|Protocol Violation|0
744977|NCT00396409|2384588|P1|Period 2 - 2008|Protocol Violation|1
744978|NCT00396409|2384587|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
744979|NCT00396409|2384588|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
744980|NCT00396409|2384587|P2|Period 1 - 2007|Lost to Follow-up|3
744981|NCT00396409|2384588|P1|Period 1 - 2007|Lost to Follow-up|2
744982|NCT00396409|2384587|P2|Period 1 - 2007|Withdrawal by Subject|1
744983|NCT00396409|2384588|P1|Period 1 - 2007|Withdrawal by Subject|1
744984|NCT00396409|2384587|P2|Period 1 - 2007|Lack of Efficacy|1
744985|NCT00396409|2384588|P1|Period 1 - 2007|Lack of Efficacy|0
744986|NCT00396409|2384587|P2|Period 1 - 2007|Adverse Event|1
744987|NCT00396409|2384588|P1|Period 1 - 2007|Adverse Event|0
744988|NCT00396565|2384621|P3|Overall Study|Lack of Efficacy|11
744989|NCT00396565|2384622|P2|Overall Study|Lack of Efficacy|64
744990|NCT00396565|2384623|P1|Overall Study|Lack of Efficacy|32
744991|NCT00396565|2384621|P3|Overall Study|Withdrawal by Subject|1
744992|NCT00396565|2384622|P2|Overall Study|Withdrawal by Subject|13
744993|NCT00396565|2384623|P1|Overall Study|Withdrawal by Subject|8
744994|NCT00396565|2384621|P3|Overall Study|Adverse Event|3
744995|NCT00396565|2384622|P2|Overall Study|Adverse Event|13
744996|NCT00396565|2384623|P1|Overall Study|Adverse Event|5
744997|NCT00396565|2384621|P3|Overall Study|Physician Decision|2
744998|NCT00396565|2384622|P2|Overall Study|Physician Decision|1
744999|NCT00396565|2384623|P1|Overall Study|Physician Decision|3
745000|NCT00396591|2384646|P1|Overall Study|Participant request|1
745001|NCT00396591|2384646|P1|Overall Study|Adverse Event|2
745002|NCT00396591|2384646|P1|Overall Study|Disease Progression|13
745003|NCT00396630|2384658|P2|Overall Study|Not vaccinated at Visit 3|3
745004|NCT00396630|2384659|P1|Overall Study|Not vaccinated at Visit 3|3
745005|NCT00396630|2384658|P2|Overall Study|Withdrawal by Subject|1
745006|NCT00396630|2384659|P1|Overall Study|Withdrawal by Subject|1
745007|NCT00396630|2384658|P2|Overall Study|Lost to Follow-up|1
745008|NCT00396630|2384659|P1|Overall Study|Lost to Follow-up|1
745009|NCT00396656|2384676|P2|Second Treatment Period|Adverse Event|1
745010|NCT00396656|2384677|P1|Second Treatment Period|Adverse Event|0
745011|NCT00396656|2384676|P2|First Treatment Period|Withdrawal by Subject|2
745012|NCT00396656|2384677|P1|First Treatment Period|Withdrawal by Subject|0
745013|NCT00396812|2384693|P1|Overall Study|Physician Decision|1
745014|NCT00396877|2384707|P2|Overall Study|Parent(s)/guardian(s)'s request|7
745015|NCT00396877|2384708|P1|Overall Study|Parent(s)/guardian(s)'s request|4
745016|NCT00396877|2384707|P2|Overall Study|Lost to Follow-up|1
745017|NCT00396877|2384708|P1|Overall Study|Lost to Follow-up|2
745018|NCT00397033|2384742|P3|Overall Study|Other|2
745019|NCT00397033|2384743|P2|Overall Study|Other|5
745020|NCT00397033|2384744|P1|Overall Study|Other|0
745021|NCT00397033|2384742|P3|Overall Study|Withdrawal by Subject|5
745022|NCT00397033|2384743|P2|Overall Study|Withdrawal by Subject|7
745023|NCT00397033|2384744|P1|Overall Study|Withdrawal by Subject|12
745024|NCT00397033|2384742|P3|Overall Study|Lost to Follow-up|3
745025|NCT00397033|2384743|P2|Overall Study|Lost to Follow-up|3
745026|NCT00397033|2384744|P1|Overall Study|Lost to Follow-up|3
745027|NCT00397033|2384742|P3|Overall Study|Lack of Efficacy|9
745028|NCT00397033|2384743|P2|Overall Study|Lack of Efficacy|12
745029|NCT00397033|2384744|P1|Overall Study|Lack of Efficacy|22
745030|NCT00397033|2384742|P3|Overall Study|Adverse Event|4
745031|NCT00397033|2384743|P2|Overall Study|Adverse Event|10
745032|NCT00397033|2384744|P1|Overall Study|Adverse Event|7
745033|NCT00397189|2384820|P2|3 Weeks Period|Other|2
745034|NCT00397189|2384821|P1|3 Weeks Period|Other|0
745035|NCT00397189|2384820|P2|3 Weeks Period|Protocol Violation|3
745036|NCT00397189|2384821|P1|3 Weeks Period|Protocol Violation|0
745037|NCT00397189|2384820|P2|3 Weeks Period|Physician Decision|2
745038|NCT00397189|2384821|P1|3 Weeks Period|Physician Decision|0
745039|NCT00397189|2384820|P2|3 Weeks Period|Withdrawal by Subject|9
745040|NCT00397189|2384821|P1|3 Weeks Period|Withdrawal by Subject|13
745041|NCT00397189|2384820|P2|3 Weeks Period|Adverse Event|2
745042|NCT00397189|2384821|P1|3 Weeks Period|Adverse Event|3
745043|NCT00397189|2384820|P2|3 Weeks Period|Lost to Follow-up|4
745044|NCT00397189|2384821|P1|3 Weeks Period|Lost to Follow-up|5
745045|NCT00397215|2384831|P4|Month 6 (Day 180)|Unspecified|0
745046|NCT00397215|2384832|P3|Month 6 (Day 180)|Unspecified|3
745047|NCT00397215|2384833|P2|Month 6 (Day 180)|Unspecified|0
745048|NCT00397215|2384834|P1|Month 6 (Day 180)|Unspecified|2
745049|NCT00397215|2384831|P4|Month 6 (Day 180)|Adverse Event|0
745050|NCT00397215|2384832|P3|Month 6 (Day 180)|Adverse Event|2
745051|NCT00397215|2384833|P2|Month 6 (Day 180)|Adverse Event|3
745052|NCT00397215|2384834|P1|Month 6 (Day 180)|Adverse Event|0
745053|NCT00397215|2384831|P4|Month 0 (Day 0)|Unspecified|3
745054|NCT00397215|2384832|P3|Month 0 (Day 0)|Unspecified|3
745055|NCT00397215|2384833|P2|Month 0 (Day 0)|Unspecified|1
745056|NCT00397215|2384834|P1|Month 0 (Day 0)|Unspecified|4
745057|NCT00397215|2384831|P4|Month 0 (Day 0)|Withdrawal by Subject|1
745058|NCT00397215|2384832|P3|Month 0 (Day 0)|Withdrawal by Subject|3
745059|NCT00397215|2384833|P2|Month 0 (Day 0)|Withdrawal by Subject|3
745060|NCT00397215|2384834|P1|Month 0 (Day 0)|Withdrawal by Subject|3
745061|NCT00397215|2384831|P4|Month 0 (Day 0)|Adverse Event|0
745062|NCT00397215|2384832|P3|Month 0 (Day 0)|Adverse Event|0
745063|NCT00397215|2384833|P2|Month 0 (Day 0)|Adverse Event|1
745064|NCT00397215|2384834|P1|Month 0 (Day 0)|Adverse Event|0
745065|NCT00397254|2384968|P2|Overall Study|Lost to Follow-up|2
745066|NCT00397254|2384969|P1|Overall Study|Lost to Follow-up|2
745067|NCT00397488|2385003|P1|Overall Study|Death|1
745068|NCT00397488|2385003|P1|Overall Study|Adverse Event|3
745069|NCT00397488|2385003|P1|Overall Study|Withdrawal by Subject|3
745070|NCT00397514|2385007|P1|Overall Study|poor echocardiographic windows|1
745071|NCT00397514|2385007|P1|Overall Study|early extubation|2
745072|NCT00397514|2385007|P1|Overall Study|Not able to capture & pace LV intraoper.|4
745073|NCT00397514|2385007|P1|Overall Study|Pacing wire malfunction|1
745074|NCT00397514|2385007|P1|Overall Study|Withdrawal by Subject|1
745075|NCT00397540|2385019|P2|Overall Study|short follow-up duration < 12 months|0
745076|NCT00397540|2385020|P1|Overall Study|short follow-up duration < 12 months|1
745077|NCT00397631|2385028|P2|Overall Study|protocol discontinuation criteria|4
745078|NCT00397631|2385029|P1|Overall Study|protocol discontinuation criteria|1
745079|NCT00397631|2385028|P2|Overall Study|Withdrawal by Subject|14
745080|NCT00397631|2385029|P1|Overall Study|Withdrawal by Subject|7
745081|NCT00397631|2385028|P2|Overall Study|Protocol Violation|1
745082|NCT00397631|2385029|P1|Overall Study|Protocol Violation|0
745083|NCT00397631|2385028|P2|Overall Study|Physician Decision|0
745084|NCT00397631|2385029|P1|Overall Study|Physician Decision|2
745085|NCT00397631|2385028|P2|Overall Study|Lost to Follow-up|9
745086|NCT00397631|2385029|P1|Overall Study|Lost to Follow-up|8
745087|NCT00397631|2385028|P2|Overall Study|Lack of Efficacy|10
745088|NCT00397631|2385029|P1|Overall Study|Lack of Efficacy|7
745089|NCT00397631|2385028|P2|Overall Study|Adverse Event|6
745090|NCT00397631|2385029|P1|Overall Study|Adverse Event|5
745091|NCT00397891|2385065|P5|Overall Study|Withdrawal by Subject|1
745092|NCT00397891|2385066|P4|Overall Study|Withdrawal by Subject|0
745093|NCT00397891|2385067|P3|Overall Study|Withdrawal by Subject|0
745094|NCT00397891|2385068|P2|Overall Study|Withdrawal by Subject|0
745095|NCT00397891|2385069|P1|Overall Study|Withdrawal by Subject|1
745096|NCT00397930|2385173|P2|Overall Study|Missing data|4
745097|NCT00397930|2385174|P1|Overall Study|Missing data|0
745098|NCT00397930|2385173|P2|Overall Study|Withdrawal by Subject|8
745099|NCT00397930|2385174|P1|Overall Study|Withdrawal by Subject|0
745100|NCT00397930|2385173|P2|Overall Study|Did not want to be in control group|1
745101|NCT00397930|2385174|P1|Overall Study|Did not want to be in control group|0
745102|NCT00397930|2385173|P2|Overall Study|Started own yoga program|1
745103|NCT00397930|2385174|P1|Overall Study|Started own yoga program|1
745104|NCT00397930|2385173|P2|Overall Study|Too time-consuming|9
745105|NCT00397930|2385174|P1|Overall Study|Too time-consuming|2
745106|NCT00397930|2385173|P2|Overall Study|Noncompliant|2
745107|NCT00397930|2385174|P1|Overall Study|Noncompliant|3
745108|NCT00397930|2385173|P2|Overall Study|Unknown reasons|14
745109|NCT00397930|2385174|P1|Overall Study|Unknown reasons|9
745110|NCT00397930|2385173|P2|Overall Study|Other medical|4
745111|NCT00397930|2385174|P1|Overall Study|Other medical|9
745112|NCT00397930|2385173|P2|Overall Study|Personal reasons|8
745113|NCT00397930|2385174|P1|Overall Study|Personal reasons|14
745114|NCT00397982|2385180|P1|Overall Study|Unrelated health issues|1
745115|NCT00397982|2385180|P1|Overall Study|noncompliance|1
745116|NCT00397982|2385180|P1|Overall Study|Adverse Event|1
745117|NCT00397982|2385180|P1|Overall Study|Withdrawal by Subject|1
745118|NCT00398047|2385189|P1|Overall Study|all patient progressed before completion|3
745119|NCT00398073|2385201|P2|Overall Study|Withdrawal by Subject|0
745120|NCT00398073|2385202|P1|Overall Study|Withdrawal by Subject|1
745121|NCT00398086|2385215|P3|Overall Study|Withdrawal by Subject|0
745122|NCT00398086|2385216|P2|Overall Study|Withdrawal by Subject|7
745123|NCT00398086|2385217|P1|Overall Study|Withdrawal by Subject|5
745124|NCT00398086|2385215|P3|Overall Study|Physician Decision|0
745125|NCT00398086|2385216|P2|Overall Study|Physician Decision|4
745126|NCT00398086|2385217|P1|Overall Study|Physician Decision|1
745127|NCT00398086|2385215|P3|Overall Study|Adverse Event|0
745128|NCT00398086|2385216|P2|Overall Study|Adverse Event|4
745129|NCT00398086|2385217|P1|Overall Study|Adverse Event|1
745130|NCT00398086|2385215|P3|Overall Study|Unacceptable Toxicity|2
745131|NCT00398086|2385216|P2|Overall Study|Unacceptable Toxicity|8
745132|NCT00398086|2385217|P1|Overall Study|Unacceptable Toxicity|2
745133|NCT00398112|2385249|P1|Overall Study|Death|1
745134|NCT00398112|2385249|P1|Overall Study|Withdrawal by Subject|3
745135|NCT00398112|2385249|P1|Overall Study|Alternative treatment|1
745136|NCT00398112|2385249|P1|Overall Study|Disease progression|9
745137|NCT00398112|2385249|P1|Overall Study|Adverse Event|4
745138|NCT00398138|2385257|P1|Overall Study|Adverse Event|2
745139|NCT00398216|2385267|P5|Overall Study|entrance criteria|2
745140|NCT00398216|2385268|P4|Overall Study|entrance criteria|0
745141|NCT00398216|2385269|P3|Overall Study|entrance criteria|0
745142|NCT00398216|2385270|P2|Overall Study|entrance criteria|0
745143|NCT00398216|2385271|P1|Overall Study|entrance criteria|0
745144|NCT00398216|2385267|P5|Overall Study|administrative reasons|3
745145|NCT00398216|2385268|P4|Overall Study|administrative reasons|3
745146|NCT00398216|2385269|P3|Overall Study|administrative reasons|4
745147|NCT00398216|2385270|P2|Overall Study|administrative reasons|4
745148|NCT00398216|2385271|P1|Overall Study|administrative reasons|3
745149|NCT00398216|2385267|P5|Overall Study|Withdrawal by Subject|2
745150|NCT00398216|2385268|P4|Overall Study|Withdrawal by Subject|1
745151|NCT00398216|2385269|P3|Overall Study|Withdrawal by Subject|3
745152|NCT00398216|2385270|P2|Overall Study|Withdrawal by Subject|0
745153|NCT00398216|2385271|P1|Overall Study|Withdrawal by Subject|1
745154|NCT00398216|2385267|P5|Overall Study|Death|0
745155|NCT00398216|2385268|P4|Overall Study|Death|0
745156|NCT00398216|2385269|P3|Overall Study|Death|0
745157|NCT00398216|2385270|P2|Overall Study|Death|3
745158|NCT00398216|2385271|P1|Overall Study|Death|0
745159|NCT00398216|2385267|P5|Overall Study|Lost to Follow-up|1
745160|NCT00398216|2385268|P4|Overall Study|Lost to Follow-up|4
745161|NCT00398216|2385269|P3|Overall Study|Lost to Follow-up|4
745162|NCT00398216|2385270|P2|Overall Study|Lost to Follow-up|6
745163|NCT00398216|2385271|P1|Overall Study|Lost to Follow-up|1
745164|NCT00398216|2385267|P5|Overall Study|Protocol Violation|5
745165|NCT00398216|2385268|P4|Overall Study|Protocol Violation|7
745166|NCT00398216|2385269|P3|Overall Study|Protocol Violation|5
745167|NCT00398216|2385270|P2|Overall Study|Protocol Violation|4
745168|NCT00398216|2385271|P1|Overall Study|Protocol Violation|2
745169|NCT00398216|2385267|P5|Overall Study|Adverse Event|2
745170|NCT00398216|2385268|P4|Overall Study|Adverse Event|7
745171|NCT00398216|2385269|P3|Overall Study|Adverse Event|5
745172|NCT00398216|2385270|P2|Overall Study|Adverse Event|2
745173|NCT00398216|2385271|P1|Overall Study|Adverse Event|4
745174|NCT00398320|2385298|P1|Overall Study|Physician Decision|1
745175|NCT00398320|2385298|P1|Overall Study|Adverse Event|4
745176|NCT00398320|2385298|P1|Overall Study|Death|1
745177|NCT00398411|2385315|P2|Overall Study|Death|1
745178|NCT00398411|2385316|P1|Overall Study|Death|0
745179|NCT00391768|2385361|P7|Overall Study|Lost to Follow-up|3
745180|NCT00391768|2385362|P6|Overall Study|Lost to Follow-up|2
745181|NCT00391768|2385363|P5|Overall Study|Lost to Follow-up|2
745182|NCT00391768|2385364|P4|Overall Study|Lost to Follow-up|1
745183|NCT00391768|2385365|P3|Overall Study|Lost to Follow-up|0
745184|NCT00391768|2385366|P2|Overall Study|Lost to Follow-up|0
745185|NCT00391768|2385367|P1|Overall Study|Lost to Follow-up|0
745186|NCT00391768|2385361|P7|Overall Study|Withdrawal by Subject|1
745187|NCT00391768|2385362|P6|Overall Study|Withdrawal by Subject|1
745188|NCT00391768|2385363|P5|Overall Study|Withdrawal by Subject|0
745189|NCT00391768|2385364|P4|Overall Study|Withdrawal by Subject|0
745190|NCT00391768|2385365|P3|Overall Study|Withdrawal by Subject|1
745191|NCT00391768|2385366|P2|Overall Study|Withdrawal by Subject|0
745192|NCT00391768|2385367|P1|Overall Study|Withdrawal by Subject|0
745193|NCT00391807|2385432|P1|Overall Study|Various|96
745194|NCT00391807|2385432|P1|Overall Study|Protocol Violation|20
745195|NCT00391807|2385432|P1|Overall Study|Withdrawal by Subject|147
745196|NCT00391807|2385432|P1|Overall Study|Lost to Follow-up|227
745197|NCT00391807|2385432|P1|Overall Study|Pregnancy|25
745198|NCT00391807|2385432|P1|Overall Study|Adverse Event|177
745199|NCT00391807|2385432|P1|Overall Study|Did not receive study medication|23
745200|NCT00391846|2385454|P2|Overall Study|Developed study specific DC criteria|1
745201|NCT00391846|2385455|P1|Overall Study|Developed study specific DC criteria|0
745202|NCT00391846|2385454|P2|Overall Study|Withdrawal by Subject|3
745203|NCT00391846|2385455|P1|Overall Study|Withdrawal by Subject|2
745204|NCT00391846|2385454|P2|Overall Study|Did not meet the required elig. crit|2
745205|NCT00391846|2385455|P1|Overall Study|Did not meet the required elig. crit|2
745206|NCT00391846|2385454|P2|Overall Study|Adverse Event|1
745207|NCT00391846|2385455|P1|Overall Study|Adverse Event|4
745208|NCT00391872|2385477|P2|Overall Study|Lost to Follow-up|0
745209|NCT00391872|2385478|P1|Overall Study|Lost to Follow-up|2
745210|NCT00391872|2385477|P2|Overall Study|Reason unknown|4
745211|NCT00391872|2385478|P1|Overall Study|Reason unknown|2
745212|NCT00391872|2385477|P2|Overall Study|Withdrawal by Subject|249
745213|NCT00391872|2385478|P1|Overall Study|Withdrawal by Subject|296
745214|NCT00391872|2385477|P2|Overall Study|Protocol Violation|2
745215|NCT00391872|2385478|P1|Overall Study|Protocol Violation|7
745216|NCT00391898|2385516|P2|Overall Study|Other|10
745217|NCT00391898|2385517|P1|Overall Study|Other|8
745218|NCT00391898|2385516|P2|Overall Study|Adverse Event|0
745219|NCT00391898|2385517|P1|Overall Study|Adverse Event|3
745220|NCT00391976|2385538|P3|Overall Study|Positive P. aeruginosa antibody test|31
745221|NCT00391976|2385539|P2|Overall Study|Positive P. aeruginosa antibody test|0
745222|NCT00391976|2385540|P1|Overall Study|Positive P. aeruginosa antibody test|0
745223|NCT00391976|2385538|P3|Overall Study|Unable to classify|1
745224|NCT00391976|2385539|P2|Overall Study|Unable to classify|0
745225|NCT00391976|2385540|P1|Overall Study|Unable to classify|0
745226|NCT00391976|2385538|P3|Overall Study|Recurrence/no eradication of infection|0
745227|NCT00391976|2385539|P2|Overall Study|Recurrence/no eradication of infection|19
745228|NCT00391976|2385540|P1|Overall Study|Recurrence/no eradication of infection|21
745229|NCT00391976|2385538|P3|Overall Study|Protocol deviation/violation|1
745230|NCT00391976|2385539|P2|Overall Study|Protocol deviation/violation|2
745231|NCT00391976|2385540|P1|Overall Study|Protocol deviation/violation|4
745232|NCT00391976|2385538|P3|Overall Study|Inappropriate enrollment|0
745233|NCT00391976|2385539|P2|Overall Study|Inappropriate enrollment|1
745234|NCT00391976|2385540|P1|Overall Study|Inappropriate enrollment|1
745235|NCT00391976|2385538|P3|Overall Study|Lost to Follow-up|0
745236|NCT00391976|2385539|P2|Overall Study|Lost to Follow-up|2
745237|NCT00391976|2385540|P1|Overall Study|Lost to Follow-up|1
745238|NCT00391976|2385538|P3|Overall Study|Withdrawal of consent|1
745239|NCT00391976|2385539|P2|Overall Study|Withdrawal of consent|1
745240|NCT00391976|2385540|P1|Overall Study|Withdrawal of consent|0
745241|NCT00391976|2385538|P3|Overall Study|Adverse Event|1
745242|NCT00391976|2385539|P2|Overall Study|Adverse Event|0
745243|NCT00391976|2385540|P1|Overall Study|Adverse Event|0
745244|NCT00392171|2385566|P1|Overall Study|Disease progression|101
745245|NCT00392171|2385566|P1|Overall Study|Did not meet inclusion criteria|4
745246|NCT00392197|2385572|P2|Overall Study|Withdrawal by Subject|6
745247|NCT00392197|2385573|P1|Overall Study|Withdrawal by Subject|4
745248|NCT00392197|2385572|P2|Overall Study|Protocol Violation|5
745249|NCT00392197|2385573|P1|Overall Study|Protocol Violation|7
745250|NCT00392197|2385572|P2|Overall Study|Physician Decision|2
745251|NCT00392197|2385573|P1|Overall Study|Physician Decision|3
745252|NCT00392197|2385572|P2|Overall Study|Lost to Follow-up|1
745253|NCT00392197|2385573|P1|Overall Study|Lost to Follow-up|0
745254|NCT00392197|2385572|P2|Overall Study|Lack of Efficacy|4
745255|NCT00392197|2385573|P1|Overall Study|Lack of Efficacy|3
745256|NCT00392197|2385572|P2|Overall Study|Adverse Event|12
745257|NCT00392197|2385573|P1|Overall Study|Adverse Event|4
745258|NCT00392210|2385583|P2|First Voiding Trial|Physician Decision|2
745259|NCT00392210|2385584|P1|First Voiding Trial|Physician Decision|2
745260|NCT00392223|2385592|P2|Overall Study|Withdrawal by Subject|2
745261|NCT00392223|2385593|P1|Overall Study|Withdrawal by Subject|3
745262|NCT00392223|2385592|P2|Overall Study|Protocol Violation|3
745263|NCT00392223|2385593|P1|Overall Study|Protocol Violation|0
745264|NCT00392223|2385592|P2|Overall Study|Lost to Follow-up|4
745265|NCT00392223|2385593|P1|Overall Study|Lost to Follow-up|1
745266|NCT00392223|2385592|P2|Overall Study|Adverse Event|4
745267|NCT00392223|2385593|P1|Overall Study|Adverse Event|5
745270|NCT00398866|2385625|P3|Overall Study|Unable to complete requirements of study|1
745271|NCT00398866|2385626|P2|Overall Study|Unable to complete requirements of study|1
745272|NCT00398866|2385627|P1|Overall Study|Unable to complete requirements of study|1
745273|NCT00398866|2385625|P3|Overall Study|Withdrawal by Subject|2
745274|NCT00398866|2385626|P2|Overall Study|Withdrawal by Subject|1
745275|NCT00398866|2385627|P1|Overall Study|Withdrawal by Subject|5
745276|NCT00398866|2385625|P3|Overall Study|Lost to Follow-up|4
745277|NCT00398866|2385626|P2|Overall Study|Lost to Follow-up|6
745278|NCT00398866|2385627|P1|Overall Study|Lost to Follow-up|7
745279|NCT00398866|2385625|P3|Overall Study|Lack of Efficacy|1
745280|NCT00398866|2385626|P2|Overall Study|Lack of Efficacy|0
745281|NCT00398866|2385627|P1|Overall Study|Lack of Efficacy|0
745282|NCT00398866|2385625|P3|Overall Study|Adverse Event|0
745283|NCT00398866|2385626|P2|Overall Study|Adverse Event|0
745284|NCT00398866|2385627|P1|Overall Study|Adverse Event|1
745285|NCT00400569|2385643|P1|Overall Study|Death|1
745286|NCT00400712|2385673|P2|Overall Study|Physician Decision|4
745287|NCT00400712|2385674|P1|Overall Study|Physician Decision|5
745288|NCT00400712|2385673|P2|Overall Study|Withdrawal by Subject|12
745289|NCT00400712|2385674|P1|Overall Study|Withdrawal by Subject|11
745290|NCT00400712|2385673|P2|Overall Study|Death|0
745291|NCT00400712|2385674|P1|Overall Study|Death|1
745292|NCT00400764|2385697|P5|Phase II|Withdrawal by Subject|0
745293|NCT00400764|2385698|P4|Phase II|Withdrawal by Subject|1
745294|NCT00400764|2385699|P3|Phase II|Withdrawal by Subject|1
745295|NCT00400764|2385700|P2|Phase II|Withdrawal by Subject|0
745296|NCT00400764|2385701|P1|Phase II|Withdrawal by Subject|0
745297|NCT00400764|2385697|P5|Phase II|Patient began new, non-protocol, therapy|0
745298|NCT00400764|2385698|P4|Phase II|Patient began new, non-protocol, therapy|0
745299|NCT00400764|2385699|P3|Phase II|Patient began new, non-protocol, therapy|1
745300|NCT00400764|2385700|P2|Phase II|Patient began new, non-protocol, therapy|0
745301|NCT00400764|2385701|P1|Phase II|Patient began new, non-protocol, therapy|0
745302|NCT00400764|2385697|P5|Phase II|Sponsor’s decision to terminate|11
745303|NCT00400764|2385698|P4|Phase II|Sponsor’s decision to terminate|22
745304|NCT00400764|2385699|P3|Phase II|Sponsor’s decision to terminate|18
745305|NCT00400764|2385700|P2|Phase II|Sponsor’s decision to terminate|0
745306|NCT00400764|2385701|P1|Phase II|Sponsor’s decision to terminate|0
745307|NCT00400764|2385697|P5|Phase II|Physician Decision|0
745308|NCT00400764|2385698|P4|Phase II|Physician Decision|1
745309|NCT00400764|2385699|P3|Phase II|Physician Decision|1
745310|NCT00400764|2385700|P2|Phase II|Physician Decision|0
745311|NCT00400764|2385701|P1|Phase II|Physician Decision|0
745312|NCT00400764|2385697|P5|Phase II|Lost to Follow-up|0
745313|NCT00400764|2385698|P4|Phase II|Lost to Follow-up|0
745314|NCT00400764|2385699|P3|Phase II|Lost to Follow-up|1
745315|NCT00400764|2385700|P2|Phase II|Lost to Follow-up|0
745316|NCT00400764|2385701|P1|Phase II|Lost to Follow-up|0
745317|NCT00400764|2385697|P5|Phase II|Death|0
745318|NCT00400764|2385698|P4|Phase II|Death|2
745319|NCT00400764|2385699|P3|Phase II|Death|1
745320|NCT00400764|2385700|P2|Phase II|Death|0
745321|NCT00400764|2385701|P1|Phase II|Death|0
745322|NCT00400764|2385697|P5|Phase Ib|Disease Progression|0
745323|NCT00400764|2385698|P4|Phase Ib|Disease Progression|0
745324|NCT00400764|2385699|P3|Phase Ib|Disease Progression|0
745325|NCT00400764|2385700|P2|Phase Ib|Disease Progression|4
745326|NCT00400764|2385701|P1|Phase Ib|Disease Progression|4
745327|NCT00400764|2385697|P5|Phase Ib|Death|0
745328|NCT00400764|2385698|P4|Phase Ib|Death|0
745329|NCT00400764|2385699|P3|Phase Ib|Death|0
745330|NCT00400764|2385700|P2|Phase Ib|Death|0
745331|NCT00400764|2385701|P1|Phase Ib|Death|1
745332|NCT00400764|2385697|P5|Phase Ib|Adverse Event|0
745333|NCT00400764|2385698|P4|Phase Ib|Adverse Event|0
745334|NCT00400764|2385699|P3|Phase Ib|Adverse Event|0
745335|NCT00400764|2385700|P2|Phase Ib|Adverse Event|0
745336|NCT00400764|2385701|P1|Phase Ib|Adverse Event|1
745337|NCT00400946|2385785|P5|Overall Study|Other|1
745338|NCT00400946|2385786|P4|Overall Study|Other|0
745339|NCT00400946|2385787|P3|Overall Study|Other|0
745340|NCT00400946|2385788|P2|Overall Study|Other|0
745341|NCT00400946|2385789|P1|Overall Study|Other|0
745342|NCT00400946|2385785|P5|Overall Study|Clinical|9
745343|NCT00400946|2385786|P4|Overall Study|Clinical|2
745344|NCT00400946|2385787|P3|Overall Study|Clinical|0
745345|NCT00400946|2385788|P2|Overall Study|Clinical|2
745346|NCT00400946|2385789|P1|Overall Study|Clinical|1
745347|NCT00400946|2385785|P5|Overall Study|Withdrawal by Subject|8
745348|NCT00400946|2385786|P4|Overall Study|Withdrawal by Subject|5
745349|NCT00400946|2385787|P3|Overall Study|Withdrawal by Subject|1
745350|NCT00400946|2385788|P2|Overall Study|Withdrawal by Subject|5
745351|NCT00400946|2385789|P1|Overall Study|Withdrawal by Subject|2
745352|NCT00400946|2385785|P5|Overall Study|Transplant in CR1|1
745353|NCT00400946|2385786|P4|Overall Study|Transplant in CR1|10
745354|NCT00400946|2385787|P3|Overall Study|Transplant in CR1|0
745355|NCT00400946|2385788|P2|Overall Study|Transplant in CR1|0
745356|NCT00400946|2385789|P1|Overall Study|Transplant in CR1|0
745357|NCT00400946|2385785|P5|Overall Study|Relapse|5
745358|NCT00400946|2385786|P4|Overall Study|Relapse|1
745359|NCT00400946|2385787|P3|Overall Study|Relapse|1
745360|NCT00400946|2385788|P2|Overall Study|Relapse|2
745361|NCT00400946|2385789|P1|Overall Study|Relapse|9
745362|NCT00400946|2385785|P5|Overall Study|Remission Death|1
745363|NCT00400946|2385786|P4|Overall Study|Remission Death|0
745364|NCT00400946|2385787|P3|Overall Study|Remission Death|0
745365|NCT00400946|2385788|P2|Overall Study|Remission Death|1
745366|NCT00400946|2385789|P1|Overall Study|Remission Death|1
745367|NCT00400946|2385785|P5|Overall Study|Lost to Follow-up|1
745368|NCT00400946|2385786|P4|Overall Study|Lost to Follow-up|0
745369|NCT00400946|2385787|P3|Overall Study|Lost to Follow-up|0
745370|NCT00400946|2385788|P2|Overall Study|Lost to Follow-up|1
745371|NCT00400946|2385789|P1|Overall Study|Lost to Follow-up|1
745372|NCT00400946|2385785|P5|Overall Study|Induction Death|3
745373|NCT00400946|2385786|P4|Overall Study|Induction Death|13
745374|NCT00400946|2385787|P3|Overall Study|Induction Death|0
745375|NCT00400946|2385788|P2|Overall Study|Induction Death|0
745376|NCT00400946|2385789|P1|Overall Study|Induction Death|0
745377|NCT00400946|2385785|P5|Overall Study|Induction Failure|8
745378|NCT00400946|2385786|P4|Overall Study|Induction Failure|11
745379|NCT00400946|2385787|P3|Overall Study|Induction Failure|0
745380|NCT00400946|2385788|P2|Overall Study|Induction Failure|0
745381|NCT00400946|2385789|P1|Overall Study|Induction Failure|0
745382|NCT00400946|2385785|P5|Overall Study|Ineligible|1
745383|NCT00400946|2385786|P4|Overall Study|Ineligible|5
745384|NCT00400946|2385787|P3|Overall Study|Ineligible|0
745385|NCT00400946|2385788|P2|Overall Study|Ineligible|0
745386|NCT00400946|2385789|P1|Overall Study|Ineligible|0
745387|NCT00401193|2385822|P3|Overall Study|Other Event|2
745388|NCT00401193|2385823|P2|Overall Study|Other Event|2
745389|NCT00401193|2385824|P1|Overall Study|Other Event|3
745390|NCT00401193|2385822|P3|Overall Study|Withdrawal by Subject|1
745391|NCT00401193|2385823|P2|Overall Study|Withdrawal by Subject|0
745392|NCT00401193|2385824|P1|Overall Study|Withdrawal by Subject|2
745393|NCT00401193|2385822|P3|Overall Study|Lost to Follow-up|1
745394|NCT00401193|2385823|P2|Overall Study|Lost to Follow-up|5
745395|NCT00401193|2385824|P1|Overall Study|Lost to Follow-up|6
745396|NCT00401193|2385822|P3|Overall Study|Protocol Violation|1
745397|NCT00401193|2385823|P2|Overall Study|Protocol Violation|1
745398|NCT00401193|2385824|P1|Overall Study|Protocol Violation|3
745399|NCT00401193|2385822|P3|Overall Study|Adverse Event|1
745400|NCT00401193|2385823|P2|Overall Study|Adverse Event|3
745401|NCT00401193|2385824|P1|Overall Study|Adverse Event|1
745402|NCT00401245|2385842|P8|Double Blind Tapering Phase|Lack of Efficacy|0
745403|NCT00401245|2385843|P7|Double Blind Tapering Phase|Lack of Efficacy|0
745404|NCT00401245|2385844|P6|Double Blind Tapering Phase|Lack of Efficacy|1
745405|NCT00401245|2385845|P5|Double Blind Tapering Phase|Lack of Efficacy|0
745406|NCT00401245|2385846|P4|Double Blind Tapering Phase|Lack of Efficacy|0
745407|NCT00401245|2385847|P3|Double Blind Tapering Phase|Lack of Efficacy|0
745408|NCT00401245|2385848|P2|Double Blind Tapering Phase|Lack of Efficacy|0
745409|NCT00401245|2385849|P1|Double Blind Tapering Phase|Lack of Efficacy|0
745410|NCT00401245|2385842|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
745411|NCT00401245|2385843|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
745412|NCT00401245|2385844|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
745413|NCT00401245|2385845|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
745414|NCT00401245|2385846|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
745415|NCT00401245|2385847|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
745416|NCT00401245|2385848|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
745417|NCT00401245|2385849|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
745418|NCT00401245|2385842|P8|Double Blind Tapering Phase|Unspecified|2
745419|NCT00401245|2385843|P7|Double Blind Tapering Phase|Unspecified|2
745420|NCT00401245|2385844|P6|Double Blind Tapering Phase|Unspecified|0
745421|NCT00401245|2385845|P5|Double Blind Tapering Phase|Unspecified|1
745422|NCT00401245|2385846|P4|Double Blind Tapering Phase|Unspecified|0
745423|NCT00401245|2385847|P3|Double Blind Tapering Phase|Unspecified|0
745424|NCT00401245|2385848|P2|Double Blind Tapering Phase|Unspecified|0
745425|NCT00401245|2385849|P1|Double Blind Tapering Phase|Unspecified|0
745426|NCT00401245|2385842|P8|Double Blind Tapering Phase|Investigator request|1
745427|NCT00401245|2385843|P7|Double Blind Tapering Phase|Investigator request|0
745428|NCT00401245|2385844|P6|Double Blind Tapering Phase|Investigator request|0
745429|NCT00401245|2385845|P5|Double Blind Tapering Phase|Investigator request|0
745430|NCT00401245|2385846|P4|Double Blind Tapering Phase|Investigator request|0
745431|NCT00401245|2385847|P3|Double Blind Tapering Phase|Investigator request|0
745432|NCT00401245|2385848|P2|Double Blind Tapering Phase|Investigator request|0
745433|NCT00401245|2385849|P1|Double Blind Tapering Phase|Investigator request|0
745434|NCT00401245|2385842|P8|Double Blind Tapering Phase|Adverse Event|4
745435|NCT00401245|2385843|P7|Double Blind Tapering Phase|Adverse Event|2
745436|NCT00401245|2385844|P6|Double Blind Tapering Phase|Adverse Event|1
745437|NCT00401245|2385845|P5|Double Blind Tapering Phase|Adverse Event|1
745438|NCT00401245|2385846|P4|Double Blind Tapering Phase|Adverse Event|0
745439|NCT00401245|2385847|P3|Double Blind Tapering Phase|Adverse Event|0
745440|NCT00401245|2385848|P2|Double Blind Tapering Phase|Adverse Event|0
745441|NCT00401245|2385849|P1|Double Blind Tapering Phase|Adverse Event|0
745442|NCT00401245|2385842|P8|Open Label Phase|Lack of Efficacy|0
745443|NCT00401245|2385843|P7|Open Label Phase|Lack of Efficacy|0
745444|NCT00401245|2385844|P6|Open Label Phase|Lack of Efficacy|0
745445|NCT00401245|2385845|P5|Open Label Phase|Lack of Efficacy|0
745446|NCT00401245|2385846|P4|Open Label Phase|Lack of Efficacy|0
745447|NCT00401245|2385847|P3|Open Label Phase|Lack of Efficacy|3
745448|NCT00401245|2385848|P2|Open Label Phase|Lack of Efficacy|2
745449|NCT00401245|2385849|P1|Open Label Phase|Lack of Efficacy|4
745450|NCT00401245|2385842|P8|Open Label Phase|Withdrawal by Subject|0
745451|NCT00401245|2385843|P7|Open Label Phase|Withdrawal by Subject|0
745452|NCT00401245|2385844|P6|Open Label Phase|Withdrawal by Subject|0
745453|NCT00401245|2385845|P5|Open Label Phase|Withdrawal by Subject|0
745454|NCT00401245|2385846|P4|Open Label Phase|Withdrawal by Subject|1
745455|NCT00401245|2385847|P3|Open Label Phase|Withdrawal by Subject|2
745456|NCT00401245|2385848|P2|Open Label Phase|Withdrawal by Subject|3
745457|NCT00401245|2385849|P1|Open Label Phase|Withdrawal by Subject|3
745458|NCT00401245|2385842|P8|Open Label Phase|Protocol Violation|0
745459|NCT00401245|2385843|P7|Open Label Phase|Protocol Violation|0
745460|NCT00401245|2385844|P6|Open Label Phase|Protocol Violation|0
745461|NCT00401245|2385845|P5|Open Label Phase|Protocol Violation|0
745462|NCT00401245|2385846|P4|Open Label Phase|Protocol Violation|1
745463|NCT00401245|2385847|P3|Open Label Phase|Protocol Violation|0
745464|NCT00401245|2385848|P2|Open Label Phase|Protocol Violation|1
745465|NCT00401245|2385849|P1|Open Label Phase|Protocol Violation|0
745466|NCT00401245|2385842|P8|Open Label Phase|Unspecified|0
745467|NCT00401245|2385843|P7|Open Label Phase|Unspecified|0
745468|NCT00401245|2385844|P6|Open Label Phase|Unspecified|0
745469|NCT00401245|2385845|P5|Open Label Phase|Unspecified|0
745470|NCT00401245|2385846|P4|Open Label Phase|Unspecified|8
745471|NCT00401245|2385847|P3|Open Label Phase|Unspecified|7
745472|NCT00401245|2385848|P2|Open Label Phase|Unspecified|8
745473|NCT00401245|2385849|P1|Open Label Phase|Unspecified|4
745474|NCT00401245|2385842|P8|Open Label Phase|Lost to Follow-up|0
745475|NCT00401245|2385843|P7|Open Label Phase|Lost to Follow-up|0
745476|NCT00401245|2385844|P6|Open Label Phase|Lost to Follow-up|0
745477|NCT00401245|2385845|P5|Open Label Phase|Lost to Follow-up|0
745478|NCT00401245|2385846|P4|Open Label Phase|Lost to Follow-up|4
745479|NCT00401245|2385847|P3|Open Label Phase|Lost to Follow-up|5
745480|NCT00401245|2385848|P2|Open Label Phase|Lost to Follow-up|7
745481|NCT00401245|2385849|P1|Open Label Phase|Lost to Follow-up|5
745482|NCT00401245|2385842|P8|Open Label Phase|Adverse Event|0
745483|NCT00401245|2385843|P7|Open Label Phase|Adverse Event|0
745484|NCT00401245|2385844|P6|Open Label Phase|Adverse Event|0
745485|NCT00401245|2385845|P5|Open Label Phase|Adverse Event|0
745486|NCT00401245|2385846|P4|Open Label Phase|Adverse Event|7
745487|NCT00401245|2385847|P3|Open Label Phase|Adverse Event|6
745488|NCT00401245|2385848|P2|Open Label Phase|Adverse Event|14
745489|NCT00401245|2385849|P1|Open Label Phase|Adverse Event|5
745490|NCT00401245|2385842|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
745491|NCT00401245|2385843|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
745492|NCT00401245|2385844|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
745493|NCT00401245|2385845|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
745494|NCT00401245|2385846|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
745495|NCT00401245|2385847|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
745496|NCT00401245|2385848|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
745497|NCT00401245|2385849|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
745498|NCT00401245|2385842|P8|Double Blind Titration Phase|Withdrawal by Subject|0
745499|NCT00401245|2385843|P7|Double Blind Titration Phase|Withdrawal by Subject|0
745500|NCT00401245|2385844|P6|Double Blind Titration Phase|Withdrawal by Subject|0
745501|NCT00401245|2385845|P5|Double Blind Titration Phase|Withdrawal by Subject|0
745502|NCT00401245|2385846|P4|Double Blind Titration Phase|Withdrawal by Subject|2
745503|NCT00401245|2385847|P3|Double Blind Titration Phase|Withdrawal by Subject|0
745504|NCT00401245|2385848|P2|Double Blind Titration Phase|Withdrawal by Subject|1
745505|NCT00401245|2385849|P1|Double Blind Titration Phase|Withdrawal by Subject|1
745506|NCT00401245|2385842|P8|Double Blind Titration Phase|Protocol Violation|0
745507|NCT00401245|2385843|P7|Double Blind Titration Phase|Protocol Violation|0
745508|NCT00401245|2385844|P6|Double Blind Titration Phase|Protocol Violation|0
745509|NCT00401245|2385845|P5|Double Blind Titration Phase|Protocol Violation|0
745510|NCT00401245|2385846|P4|Double Blind Titration Phase|Protocol Violation|1
745511|NCT00401245|2385847|P3|Double Blind Titration Phase|Protocol Violation|0
745512|NCT00401245|2385848|P2|Double Blind Titration Phase|Protocol Violation|0
745513|NCT00401245|2385849|P1|Double Blind Titration Phase|Protocol Violation|0
745514|NCT00401245|2385842|P8|Double Blind Titration Phase|Unspecified|0
745515|NCT00401245|2385843|P7|Double Blind Titration Phase|Unspecified|0
745516|NCT00401245|2385844|P6|Double Blind Titration Phase|Unspecified|0
745517|NCT00401245|2385845|P5|Double Blind Titration Phase|Unspecified|0
745518|NCT00401245|2385846|P4|Double Blind Titration Phase|Unspecified|0
745519|NCT00401245|2385847|P3|Double Blind Titration Phase|Unspecified|1
745520|NCT00401245|2385848|P2|Double Blind Titration Phase|Unspecified|0
745521|NCT00401245|2385849|P1|Double Blind Titration Phase|Unspecified|0
745522|NCT00401245|2385842|P8|Double Blind Titration Phase|Adverse Event|0
745523|NCT00401245|2385843|P7|Double Blind Titration Phase|Adverse Event|0
745524|NCT00401245|2385844|P6|Double Blind Titration Phase|Adverse Event|0
745525|NCT00401245|2385845|P5|Double Blind Titration Phase|Adverse Event|0
745526|NCT00401245|2385846|P4|Double Blind Titration Phase|Adverse Event|12
745527|NCT00401245|2385847|P3|Double Blind Titration Phase|Adverse Event|5
745528|NCT00401245|2385848|P2|Double Blind Titration Phase|Adverse Event|2
745529|NCT00401245|2385849|P1|Double Blind Titration Phase|Adverse Event|3
745530|NCT00401258|2385914|P1|Overall Study|Adverse Event|7
745531|NCT00401531|2385974|P2|Overall Study|Withdrawal by Subject|2
745532|NCT00401531|2385975|P1|Overall Study|Withdrawal by Subject|3
745533|NCT00401531|2385974|P2|Overall Study|Lost to Follow-up|1
745534|NCT00401531|2385975|P1|Overall Study|Lost to Follow-up|1
745535|NCT00401531|2385974|P2|Overall Study|Protocol Violation|7
745536|NCT00401531|2385975|P1|Overall Study|Protocol Violation|3
745537|NCT00401531|2385974|P2|Overall Study|Adverse Event|0
745538|NCT00401531|2385975|P1|Overall Study|Adverse Event|2
745539|NCT00401544|2385995|P4|Overall Study|Other|2
745540|NCT00401544|2385996|P3|Overall Study|Other|2
745541|NCT00401544|2385997|P2|Overall Study|Other|0
745542|NCT00401544|2385998|P1|Overall Study|Other|0
745543|NCT00401544|2385995|P4|Overall Study|Disease progression|0
745544|NCT00401544|2385996|P3|Overall Study|Disease progression|0
745545|NCT00401544|2385997|P2|Overall Study|Disease progression|1
745546|NCT00401544|2385998|P1|Overall Study|Disease progression|0
745547|NCT00401544|2385995|P4|Overall Study|Ineligibility determined|2
745548|NCT00401544|2385996|P3|Overall Study|Ineligibility determined|0
745549|NCT00401544|2385997|P2|Overall Study|Ineligibility determined|1
745550|NCT00401544|2385998|P1|Overall Study|Ineligibility determined|0
745551|NCT00401544|2385995|P4|Overall Study|Physician Decision|0
745552|NCT00401544|2385996|P3|Overall Study|Physician Decision|0
745553|NCT00401544|2385997|P2|Overall Study|Physician Decision|3
745554|NCT00401544|2385998|P1|Overall Study|Physician Decision|1
745555|NCT00401544|2385995|P4|Overall Study|Withdrawal by Subject|5
745556|NCT00401544|2385996|P3|Overall Study|Withdrawal by Subject|6
745557|NCT00401544|2385997|P2|Overall Study|Withdrawal by Subject|6
745558|NCT00401544|2385998|P1|Overall Study|Withdrawal by Subject|7
745559|NCT00401544|2385995|P4|Overall Study|Lost to Follow-up|1
745560|NCT00401544|2385996|P3|Overall Study|Lost to Follow-up|1
745561|NCT00401544|2385997|P2|Overall Study|Lost to Follow-up|0
745562|NCT00401544|2385998|P1|Overall Study|Lost to Follow-up|2
745563|NCT00401544|2385995|P4|Overall Study|Death|5
745564|NCT00401544|2385996|P3|Overall Study|Death|2
745565|NCT00401544|2385997|P2|Overall Study|Death|6
745566|NCT00401544|2385998|P1|Overall Study|Death|3
745567|NCT00401544|2385995|P4|Overall Study|Adverse Event|1
745568|NCT00401544|2385996|P3|Overall Study|Adverse Event|1
745569|NCT00401544|2385997|P2|Overall Study|Adverse Event|1
745570|NCT00401544|2385998|P1|Overall Study|Adverse Event|5
745571|NCT00401726|2386049|P2|Overall Study|Protocol Deviation|4
745572|NCT00401726|2386050|P1|Overall Study|Protocol Deviation|9
745573|NCT00401726|2386049|P2|Overall Study|Lack of Efficacy|6
745574|NCT00401726|2386050|P1|Overall Study|Lack of Efficacy|4
745575|NCT00401726|2386049|P2|Overall Study|Withdrawal by Subject|24
745576|NCT00401726|2386050|P1|Overall Study|Withdrawal by Subject|18
745577|NCT00401726|2386049|P2|Overall Study|Protocol Violation|3
745578|NCT00401726|2386050|P1|Overall Study|Protocol Violation|6
745579|NCT00401726|2386049|P2|Overall Study|Lost to Follow-up|20
745580|NCT00401726|2386050|P1|Overall Study|Lost to Follow-up|23
745581|NCT00401726|2386049|P2|Overall Study|Physician Decision|6
745582|NCT00401726|2386050|P1|Overall Study|Physician Decision|3
745583|NCT00401726|2386049|P2|Overall Study|Sponsor Request|1
745584|NCT00401726|2386050|P1|Overall Study|Sponsor Request|0
745585|NCT00401726|2386049|P2|Overall Study|Death|3
745586|NCT00401726|2386050|P1|Overall Study|Death|0
745587|NCT00401726|2386049|P2|Overall Study|Adverse Event|45
745588|NCT00401726|2386050|P1|Overall Study|Adverse Event|34
745589|NCT00401752|2386072|P2|Overall Study|Physician Decision|1
745590|NCT00401752|2386073|P1|Overall Study|Physician Decision|1
745591|NCT00401752|2386072|P2|Overall Study|Development of any exclusion criteria|2
745592|NCT00401752|2386073|P1|Overall Study|Development of any exclusion criteria|4
745593|NCT00401752|2386072|P2|Overall Study|Lost to Follow-up|4
745594|NCT00401752|2386073|P1|Overall Study|Lost to Follow-up|1
745595|NCT00401752|2386072|P2|Overall Study|Withdrawal by Subject|6
745596|NCT00401752|2386073|P1|Overall Study|Withdrawal by Subject|2
745597|NCT00401752|2386072|P2|Overall Study|Adverse Event|5
745598|NCT00401752|2386073|P1|Overall Study|Adverse Event|2
745599|NCT00401830|2386108|P2|Overall Study|Other: Personal / Family problems|0
745600|NCT00401830|2386109|P1|Overall Study|Other: Personal / Family problems|1
745601|NCT00401830|2386108|P2|Overall Study|Lost to Follow-up|3
745602|NCT00401830|2386109|P1|Overall Study|Lost to Follow-up|1
745603|NCT00401830|2386108|P2|Overall Study|Non-compliance with drug study|0
745604|NCT00401830|2386109|P1|Overall Study|Non-compliance with drug study|1
745605|NCT00401830|2386108|P2|Overall Study|Protocol Violation|3
745606|NCT00401830|2386109|P1|Overall Study|Protocol Violation|3
745607|NCT00401830|2386108|P2|Overall Study|Withdrawal by Subject|3
745608|NCT00401830|2386109|P1|Overall Study|Withdrawal by Subject|4
745609|NCT00401830|2386108|P2|Overall Study|Lack of Efficacy|5
745610|NCT00401830|2386109|P1|Overall Study|Lack of Efficacy|11
745611|NCT00401830|2386108|P2|Overall Study|Adverse Event|18
745612|NCT00401830|2386109|P1|Overall Study|Adverse Event|10
745613|NCT00401843|2386144|P3|Overall Study|Received incorrect treatment|0
745614|NCT00401843|2386145|P2|Overall Study|Received incorrect treatment|3
745615|NCT00401843|2386146|P1|Overall Study|Received incorrect treatment|0
745616|NCT00401843|2386144|P3|Overall Study|Randomized but not Treated|3
745617|NCT00401843|2386145|P2|Overall Study|Randomized but not Treated|2
745618|NCT00401843|2386146|P1|Overall Study|Randomized but not Treated|0
745619|NCT00401843|2386144|P3|Overall Study|Withdrawal of consent to study agent|17
745620|NCT00401843|2386145|P2|Overall Study|Withdrawal of consent to study agent|15
745621|NCT00401843|2386146|P1|Overall Study|Withdrawal of consent to study agent|1
745622|NCT00401843|2386144|P3|Overall Study|Withdrawal by Subject|5
745623|NCT00401843|2386145|P2|Overall Study|Withdrawal by Subject|5
745624|NCT00401843|2386146|P1|Overall Study|Withdrawal by Subject|1
745625|NCT00401843|2386144|P3|Overall Study|Protocol Violation|1
745626|NCT00401843|2386145|P2|Overall Study|Protocol Violation|0
745627|NCT00401843|2386146|P1|Overall Study|Protocol Violation|0
745628|NCT00401843|2386144|P3|Overall Study|Physician Decision|10
745629|NCT00401843|2386145|P2|Overall Study|Physician Decision|16
745630|NCT00401843|2386146|P1|Overall Study|Physician Decision|0
745631|NCT00401843|2386144|P3|Overall Study|Other Unspecified|5
745632|NCT00401843|2386145|P2|Overall Study|Other Unspecified|3
745633|NCT00401843|2386146|P1|Overall Study|Other Unspecified|0
745634|NCT00401843|2386144|P3|Overall Study|Lost to Follow-up|2
745635|NCT00401843|2386145|P2|Overall Study|Lost to Follow-up|0
745636|NCT00401843|2386146|P1|Overall Study|Lost to Follow-up|0
745637|NCT00401843|2386144|P3|Overall Study|End of Study|2
745638|NCT00401843|2386145|P2|Overall Study|End of Study|1
745639|NCT00401843|2386146|P1|Overall Study|End of Study|1
745640|NCT00401843|2386144|P3|Overall Study|Disease progression|49
745641|NCT00401843|2386145|P2|Overall Study|Disease progression|60
745642|NCT00401843|2386146|P1|Overall Study|Disease progression|10
745643|NCT00401843|2386144|P3|Overall Study|Death|10
745644|NCT00401843|2386145|P2|Overall Study|Death|8
745645|NCT00401843|2386146|P1|Overall Study|Death|0
745646|NCT00401843|2386144|P3|Overall Study|Adverse Event|27
745647|NCT00401843|2386145|P2|Overall Study|Adverse Event|26
745648|NCT00401843|2386146|P1|Overall Study|Adverse Event|7
745649|NCT00401843|2386144|P3|Overall Study|Achieved Complete Response|11
745650|NCT00401843|2386145|P2|Overall Study|Achieved Complete Response|5
745651|NCT00401843|2386146|P1|Overall Study|Achieved Complete Response|1
745652|NCT00401960|2386183|P2|Overall Study|Death|0
745653|NCT00401960|2386184|P1|Overall Study|Death|2
745654|NCT00401960|2386183|P2|Overall Study|Lost to Follow-up|0
745655|NCT00401960|2386184|P1|Overall Study|Lost to Follow-up|3
745656|NCT00401973|2386195|P3|Overall Study|Withdrawal by Subject|9
745657|NCT00401973|2386196|P2|Overall Study|Withdrawal by Subject|12
745658|NCT00401973|2386197|P1|Overall Study|Withdrawal by Subject|4
745659|NCT00401973|2386195|P3|Overall Study|Sponsor Decision|0
745660|NCT00401973|2386196|P2|Overall Study|Sponsor Decision|1
745661|NCT00401973|2386197|P1|Overall Study|Sponsor Decision|0
745662|NCT00401973|2386195|P3|Overall Study|Protocol Violation|3
745663|NCT00401973|2386196|P2|Overall Study|Protocol Violation|2
745664|NCT00401973|2386197|P1|Overall Study|Protocol Violation|1
745665|NCT00401973|2386195|P3|Overall Study|Physician Decision|1
745666|NCT00401973|2386196|P2|Overall Study|Physician Decision|0
745667|NCT00401973|2386197|P1|Overall Study|Physician Decision|2
745668|NCT00401973|2386195|P3|Overall Study|Lost to Follow-up|2
745669|NCT00401973|2386196|P2|Overall Study|Lost to Follow-up|2
745670|NCT00401973|2386197|P1|Overall Study|Lost to Follow-up|2
745671|NCT00401973|2386195|P3|Overall Study|Lack of Efficacy|3
745672|NCT00401973|2386196|P2|Overall Study|Lack of Efficacy|0
745673|NCT00401973|2386197|P1|Overall Study|Lack of Efficacy|0
745674|NCT00401973|2386195|P3|Overall Study|Clinical Relapse|1
745675|NCT00401973|2386196|P2|Overall Study|Clinical Relapse|1
745676|NCT00401973|2386197|P1|Overall Study|Clinical Relapse|0
745677|NCT00401973|2386195|P3|Overall Study|Adverse Event|4
745678|NCT00401973|2386196|P2|Overall Study|Adverse Event|8
745679|NCT00401973|2386197|P1|Overall Study|Adverse Event|2
745680|NCT00402025|2386237|P3|Overall Study|Participant Decision|1
745681|NCT00402025|2386238|P2|Overall Study|Participant Decision|0
745682|NCT00402025|2386239|P1|Overall Study|Participant Decision|0
745683|NCT00402025|2386237|P3|Overall Study|Physician Decision|0
745684|NCT00402025|2386238|P2|Overall Study|Physician Decision|1
745685|NCT00402025|2386239|P1|Overall Study|Physician Decision|1
745686|NCT00402025|2386237|P3|Overall Study|Disease Progression|2
745687|NCT00402025|2386238|P2|Overall Study|Disease Progression|1
745688|NCT00402025|2386239|P1|Overall Study|Disease Progression|1
745689|NCT00402025|2386237|P3|Overall Study|Death|5
745690|NCT00402025|2386238|P2|Overall Study|Death|1
745691|NCT00402025|2386239|P1|Overall Study|Death|0
745692|NCT00402025|2386237|P3|Overall Study|Adverse Event|2
745693|NCT00402025|2386238|P2|Overall Study|Adverse Event|0
745694|NCT00402025|2386239|P1|Overall Study|Adverse Event|0
745695|NCT00402051|2386264|P2|Overall Study|Lost to Follow-up|0
745696|NCT00402051|2386265|P1|Overall Study|Lost to Follow-up|1
745697|NCT00402051|2386264|P2|Overall Study|Death Due to Adverse Event|2
745698|NCT00402051|2386265|P1|Overall Study|Death Due to Adverse Event|0
745699|NCT00402051|2386264|P2|Overall Study|Death Due to Study Disease|1
745700|NCT00402051|2386265|P1|Overall Study|Death Due to Study Disease|2
745701|NCT00402051|2386264|P2|Overall Study|Death - Related to Study Drug|2
745702|NCT00402051|2386265|P1|Overall Study|Death - Related to Study Drug|1
745703|NCT00402051|2386264|P2|Overall Study|Withdrawal by Subject|3
745704|NCT00402051|2386265|P1|Overall Study|Withdrawal by Subject|3
745705|NCT00402051|2386264|P2|Overall Study|Physician Decision|3
745706|NCT00402051|2386265|P1|Overall Study|Physician Decision|7
745707|NCT00402051|2386264|P2|Overall Study|Adverse Event|4
745708|NCT00402051|2386265|P1|Overall Study|Adverse Event|11
745709|NCT00402051|2386264|P2|Overall Study|Progressive Disease|20
745710|NCT00402051|2386265|P1|Overall Study|Progressive Disease|13
745711|NCT00402103|2386281|P2|Overall Study|Administrative problems|0
745712|NCT00402103|2386282|P1|Overall Study|Administrative problems|2
745713|NCT00402103|2386281|P2|Overall Study|Lost to Follow-up|3
745714|NCT00402103|2386282|P1|Overall Study|Lost to Follow-up|6
745715|NCT00402103|2386281|P2|Overall Study|Patient withdrew consent|1
745716|NCT00402103|2386282|P1|Overall Study|Patient withdrew consent|12
745717|NCT00402103|2386281|P2|Overall Study|Protocol Deviation|0
745718|NCT00402103|2386282|P1|Overall Study|Protocol Deviation|8
745719|NCT00402103|2386281|P2|Overall Study|Condition no longer requires study drug|0
745720|NCT00402103|2386282|P1|Overall Study|Condition no longer requires study drug|2
745721|NCT00402103|2386281|P2|Overall Study|Unsatisfactory therapeutic effect|2
745722|NCT00402103|2386282|P1|Overall Study|Unsatisfactory therapeutic effect|1
745723|NCT00402103|2386281|P2|Overall Study|Adverse Event|7
745724|NCT00402103|2386282|P1|Overall Study|Adverse Event|60
890780|NCT00805766|2825996|P1|Increased Dose Period|Withdrawal by Subject|1
890781|NCT00805766|2825996|P1|Increased Dose Period|Pregnancy|1
890782|NCT00805766|2825996|P1|Increased Dose Period|Lack of Efficacy|7
890783|NCT00805766|2825996|P1|Increased Dose Period|Adverse Event|4
890784|NCT00805766|2825996|P1|Screening Period|Responder|2
890785|NCT00805766|2825996|P1|Screening Period|Pregnancy|1
890786|NCT00805766|2825996|P1|Screening Period|Lack of Efficacy|2
890787|NCT00805766|2825996|P1|Screening Period|Adverse Event|1
890788|NCT00801892|2826005|P2|Sham Crossover Period|Lost to Follow-up|2
890789|NCT00801892|2826006|P1|Sham Crossover Period|Lost to Follow-up|0
890790|NCT00801892|2826005|P2|Main Study Period|Withdrawal by Subject|1
890791|NCT00801892|2826006|P1|Main Study Period|Withdrawal by Subject|0
745753|NCT00402233|2386369|P4|Overall Study|Worsening of other pre-existing disease|0
745754|NCT00402233|2386370|P3|Overall Study|Worsening of other pre-existing disease|0
745755|NCT00402233|2386371|P2|Overall Study|Worsening of other pre-existing disease|1
745756|NCT00402233|2386372|P1|Overall Study|Worsening of other pre-existing disease|0
745757|NCT00402233|2386369|P4|Overall Study|Worsening of disease under study|0
745758|NCT00402233|2386370|P3|Overall Study|Worsening of disease under study|0
745759|NCT00402233|2386371|P2|Overall Study|Worsening of disease under study|0
745760|NCT00402233|2386372|P1|Overall Study|Worsening of disease under study|2
745761|NCT00402233|2386369|P4|Overall Study|Withdrawal by Subject|2
745762|NCT00402233|2386370|P3|Overall Study|Withdrawal by Subject|2
745763|NCT00402233|2386371|P2|Overall Study|Withdrawal by Subject|1
745764|NCT00402233|2386372|P1|Overall Study|Withdrawal by Subject|2
745765|NCT00402233|2386369|P4|Overall Study|Protocol Violation|0
745766|NCT00402233|2386370|P3|Overall Study|Protocol Violation|0
745767|NCT00402233|2386371|P2|Overall Study|Protocol Violation|1
745768|NCT00402233|2386372|P1|Overall Study|Protocol Violation|0
745769|NCT00402233|2386369|P4|Overall Study|Adverse Event|9
745770|NCT00402233|2386370|P3|Overall Study|Adverse Event|9
745771|NCT00402233|2386371|P2|Overall Study|Adverse Event|7
745772|NCT00402233|2386372|P1|Overall Study|Adverse Event|1
745773|NCT00402246|2386396|P2|Overall Study|Deterioriating Condition|2
745774|NCT00402246|2386397|P1|Overall Study|Deterioriating Condition|3
745775|NCT00402246|2386396|P2|Overall Study|Center Closure|3
745776|NCT00402246|2386397|P1|Overall Study|Center Closure|5
745777|NCT00402246|2386396|P2|Overall Study|Patient's device explanted|2
745778|NCT00402246|2386397|P1|Overall Study|Patient's device explanted|6
745779|NCT00402246|2386396|P2|Overall Study|Heart Transplant|1
745780|NCT00402246|2386397|P1|Overall Study|Heart Transplant|0
745781|NCT00402246|2386396|P2|Overall Study|Insurance Issues|1
745782|NCT00402246|2386397|P1|Overall Study|Insurance Issues|2
745783|NCT00402246|2386396|P2|Overall Study|Missed Final Visit|2
745784|NCT00402246|2386397|P1|Overall Study|Missed Final Visit|1
745785|NCT00402246|2386396|P2|Overall Study|Protocol Violation|24
745786|NCT00402246|2386397|P1|Overall Study|Protocol Violation|25
745787|NCT00402246|2386396|P2|Overall Study|Physician Decision|26
745788|NCT00402246|2386397|P1|Overall Study|Physician Decision|24
745789|NCT00402246|2386396|P2|Overall Study|Withdrawal by Subject|87
745790|NCT00402246|2386397|P1|Overall Study|Withdrawal by Subject|72
745791|NCT00402246|2386396|P2|Overall Study|Lost to Follow-up|28
745792|NCT00402246|2386397|P1|Overall Study|Lost to Follow-up|20
745793|NCT00402246|2386396|P2|Overall Study|Death|58
745794|NCT00402246|2386397|P1|Overall Study|Death|62
745795|NCT00402285|2386430|P3|Overall Study|insufficient RNA quality|2
745796|NCT00402285|2386431|P2|Overall Study|insufficient RNA quality|6
745797|NCT00402285|2386432|P1|Overall Study|insufficient RNA quality|7
745798|NCT00402324|2386440|P2|Overall Study|Death|0
745799|NCT00402324|2386441|P1|Overall Study|Death|1
745800|NCT00402324|2386440|P2|Overall Study|Adverse Event|4
745801|NCT00402324|2386441|P1|Overall Study|Adverse Event|6
745802|NCT00402324|2386440|P2|Overall Study|Lack of Efficacy|4
745803|NCT00402324|2386441|P1|Overall Study|Lack of Efficacy|1
745804|NCT00402324|2386440|P2|Overall Study|Sponsor Decision|5
745805|NCT00402324|2386441|P1|Overall Study|Sponsor Decision|4
745806|NCT00402324|2386440|P2|Overall Study|Physician Decision|4
745807|NCT00402324|2386441|P1|Overall Study|Physician Decision|2
745808|NCT00402324|2386440|P2|Overall Study|Withdrawal by Subject|2
745809|NCT00402324|2386441|P1|Overall Study|Withdrawal by Subject|5
745810|NCT00402324|2386440|P2|Overall Study|Protocol Violation|7
745811|NCT00402324|2386441|P1|Overall Study|Protocol Violation|8
745812|NCT00402324|2386440|P2|Overall Study|Protocol Entry Criteria Not Met|4
745813|NCT00402324|2386441|P1|Overall Study|Protocol Entry Criteria Not Met|5
745814|NCT00402324|2386440|P2|Overall Study|Lost to Follow-up|11
745815|NCT00402324|2386441|P1|Overall Study|Lost to Follow-up|11
745816|NCT00402337|2386476|P5|Overall Study|Other Reason|0
745817|NCT00402337|2386477|P4|Overall Study|Other Reason|0
745818|NCT00402337|2386478|P3|Overall Study|Other Reason|0
745819|NCT00402337|2386479|P2|Overall Study|Other Reason|1
745820|NCT00402337|2386480|P1|Overall Study|Other Reason|0
745821|NCT00402337|2386476|P5|Overall Study|Physician Decision|0
745822|NCT00402337|2386477|P4|Overall Study|Physician Decision|1
745823|NCT00402337|2386478|P3|Overall Study|Physician Decision|0
745824|NCT00402337|2386479|P2|Overall Study|Physician Decision|0
745825|NCT00402337|2386480|P1|Overall Study|Physician Decision|0
745826|NCT00402337|2386476|P5|Overall Study|Lost to Follow-up|0
745827|NCT00402337|2386477|P4|Overall Study|Lost to Follow-up|2
745828|NCT00402337|2386478|P3|Overall Study|Lost to Follow-up|1
745829|NCT00402337|2386479|P2|Overall Study|Lost to Follow-up|0
745830|NCT00402337|2386480|P1|Overall Study|Lost to Follow-up|0
745831|NCT00402337|2386476|P5|Overall Study|Withdrawal by Subject|4
745832|NCT00402337|2386477|P4|Overall Study|Withdrawal by Subject|6
745833|NCT00402337|2386478|P3|Overall Study|Withdrawal by Subject|1
745834|NCT00402337|2386479|P2|Overall Study|Withdrawal by Subject|3
745835|NCT00402337|2386480|P1|Overall Study|Withdrawal by Subject|5
745836|NCT00402337|2386476|P5|Overall Study|Noncompliance|2
745837|NCT00402337|2386477|P4|Overall Study|Noncompliance|0
745838|NCT00402337|2386478|P3|Overall Study|Noncompliance|0
745839|NCT00402337|2386479|P2|Overall Study|Noncompliance|0
745840|NCT00402337|2386480|P1|Overall Study|Noncompliance|0
745841|NCT00402337|2386476|P5|Overall Study|Adverse Event|2
745842|NCT00402337|2386477|P4|Overall Study|Adverse Event|3
745843|NCT00402337|2386478|P3|Overall Study|Adverse Event|2
745844|NCT00402337|2386479|P2|Overall Study|Adverse Event|2
745845|NCT00402337|2386480|P1|Overall Study|Adverse Event|0
745846|NCT00402363|2386521|P4|Overall Study|"Captured as Other"|2
745847|NCT00402363|2386522|P3|Overall Study|"Captured as Other"|2
745848|NCT00402363|2386523|P2|Overall Study|"Captured as Other"|2
745849|NCT00402363|2386524|P1|Overall Study|"Captured as Other"|6
745850|NCT00402363|2386521|P4|Overall Study|Lost to Follow-up|2
745851|NCT00402363|2386522|P3|Overall Study|Lost to Follow-up|0
745852|NCT00402363|2386523|P2|Overall Study|Lost to Follow-up|4
745853|NCT00402363|2386524|P1|Overall Study|Lost to Follow-up|5
745854|NCT00402363|2386521|P4|Overall Study|Protocol Violation|3
745855|NCT00402363|2386522|P3|Overall Study|Protocol Violation|0
745856|NCT00402363|2386523|P2|Overall Study|Protocol Violation|5
745857|NCT00402363|2386524|P1|Overall Study|Protocol Violation|3
745858|NCT00402363|2386521|P4|Overall Study|Withdrew Consent|1
745859|NCT00402363|2386522|P3|Overall Study|Withdrew Consent|2
745860|NCT00402363|2386523|P2|Overall Study|Withdrew Consent|5
745861|NCT00402363|2386524|P1|Overall Study|Withdrew Consent|10
745862|NCT00402363|2386521|P4|Overall Study|Adverse Event|2
745863|NCT00402363|2386522|P3|Overall Study|Adverse Event|2
745864|NCT00402363|2386523|P2|Overall Study|Adverse Event|14
745865|NCT00402363|2386524|P1|Overall Study|Adverse Event|9
745866|NCT00402597|2386587|P5|Overall Study|reason not specified|20
745867|NCT00402597|2386588|P4|Overall Study|reason not specified|14
745868|NCT00402597|2386589|P3|Overall Study|reason not specified|27
745869|NCT00402597|2386590|P2|Overall Study|reason not specified|4
745870|NCT00402597|2386591|P1|Overall Study|reason not specified|30
745871|NCT00402597|2386587|P5|Overall Study|Withdrawal by Subject|24
745872|NCT00402597|2386588|P4|Overall Study|Withdrawal by Subject|15
745873|NCT00402597|2386589|P3|Overall Study|Withdrawal by Subject|65
745874|NCT00402597|2386590|P2|Overall Study|Withdrawal by Subject|16
745875|NCT00402597|2386591|P1|Overall Study|Withdrawal by Subject|57
745876|NCT00402597|2386587|P5|Overall Study|Lost to Follow-up|3
745877|NCT00402597|2386588|P4|Overall Study|Lost to Follow-up|2
745878|NCT00402597|2386589|P3|Overall Study|Lost to Follow-up|8
745879|NCT00402597|2386590|P2|Overall Study|Lost to Follow-up|1
745880|NCT00402597|2386591|P1|Overall Study|Lost to Follow-up|8
745881|NCT00402597|2386587|P5|Overall Study|Adverse Event|71
745882|NCT00402597|2386588|P4|Overall Study|Adverse Event|39
745883|NCT00402597|2386589|P3|Overall Study|Adverse Event|106
745884|NCT00402597|2386590|P2|Overall Study|Adverse Event|18
745885|NCT00402597|2386591|P1|Overall Study|Adverse Event|81
745886|NCT00402597|2386587|P5|Overall Study|Death|6
745887|NCT00402597|2386588|P4|Overall Study|Death|4
745888|NCT00402597|2386589|P3|Overall Study|Death|6
745889|NCT00402597|2386590|P2|Overall Study|Death|7
745890|NCT00402597|2386591|P1|Overall Study|Death|15
745891|NCT00402649|2386628|P1|Overall Study|Withdrawal by Subject|1
745892|NCT00402649|2386628|P1|Overall Study|Lost to Follow-up|1
745893|NCT00402688|2386641|P3|Overall Study|Patient Left Town and Forgot Medication|1
745894|NCT00402688|2386642|P2|Overall Study|Patient Left Town and Forgot Medication|0
745895|NCT00402688|2386643|P1|Overall Study|Patient Left Town and Forgot Medication|0
745896|NCT00402688|2386641|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
745897|NCT00402688|2386642|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
745898|NCT00402688|2386643|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
745899|NCT00402688|2386641|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
745900|NCT00402688|2386642|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
745901|NCT00402688|2386643|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
745902|NCT00402688|2386641|P3|Overall Study|Lost to Follow-up|2
745903|NCT00402688|2386642|P2|Overall Study|Lost to Follow-up|0
745904|NCT00402688|2386643|P1|Overall Study|Lost to Follow-up|1
745905|NCT00402688|2386641|P3|Overall Study|Protocol Violation|1
745906|NCT00402688|2386642|P2|Overall Study|Protocol Violation|1
745907|NCT00402688|2386643|P1|Overall Study|Protocol Violation|1
745908|NCT00402688|2386641|P3|Overall Study|Lack of Efficacy|5
745909|NCT00402688|2386642|P2|Overall Study|Lack of Efficacy|4
745910|NCT00402688|2386643|P1|Overall Study|Lack of Efficacy|4
745911|NCT00402688|2386641|P3|Overall Study|Physician Decision|1
745912|NCT00402688|2386642|P2|Overall Study|Physician Decision|0
745913|NCT00402688|2386643|P1|Overall Study|Physician Decision|0
745914|NCT00402688|2386641|P3|Overall Study|Withdrawal by Subject|1
745915|NCT00402688|2386642|P2|Overall Study|Withdrawal by Subject|1
745916|NCT00402688|2386643|P1|Overall Study|Withdrawal by Subject|3
745917|NCT00402688|2386641|P3|Overall Study|Adverse Event|3
745918|NCT00402688|2386642|P2|Overall Study|Adverse Event|9
745919|NCT00402688|2386643|P1|Overall Study|Adverse Event|12
745920|NCT00402727|2386679|P2|Overall Study|non-compliance|1
745921|NCT00402727|2386680|P1|Overall Study|non-compliance|0
745922|NCT00402727|2386679|P2|Overall Study|supply problems|1
745923|NCT00402727|2386680|P1|Overall Study|supply problems|2
745924|NCT00402727|2386679|P2|Overall Study|Withdrawal by Subject|7
745925|NCT00402727|2386680|P1|Overall Study|Withdrawal by Subject|3
745926|NCT00402727|2386679|P2|Overall Study|Protocol Violation|4
745927|NCT00402727|2386680|P1|Overall Study|Protocol Violation|0
745928|NCT00402727|2386679|P2|Overall Study|Physician Decision|1
745929|NCT00402727|2386680|P1|Overall Study|Physician Decision|1
745930|NCT00402727|2386679|P2|Overall Study|Lost to Follow-up|11
745931|NCT00402727|2386680|P1|Overall Study|Lost to Follow-up|24
745932|NCT00402727|2386679|P2|Overall Study|Lack of Efficacy|3
745933|NCT00402727|2386680|P1|Overall Study|Lack of Efficacy|1
745934|NCT00402727|2386679|P2|Overall Study|Death|0
745935|NCT00402727|2386680|P1|Overall Study|Death|1
745936|NCT00402727|2386679|P2|Overall Study|Adverse Event|6
745937|NCT00402727|2386680|P1|Overall Study|Adverse Event|10
745938|NCT00402740|2386708|P1|Overall Study|Subject disposition unknown.|1
745939|NCT00402740|2386708|P1|Overall Study|No stent. Completed FU at 30 days.|5
745940|NCT00402740|2386708|P1|Overall Study|Lost to Follow-up|6
745941|NCT00402740|2386708|P1|Overall Study|Death|50
745942|NCT00402740|2386708|P1|Overall Study|Withdrawal by Subject|18
745943|NCT00395226|2386728|P2|Overall Study|Lost to Follow-up|1
745944|NCT00395226|2386729|P1|Overall Study|Lost to Follow-up|0
745945|NCT00395226|2386728|P2|Overall Study|Withdrawal by Subject|1
745946|NCT00395226|2386729|P1|Overall Study|Withdrawal by Subject|0
745947|NCT00395226|2386728|P2|Overall Study|Adverse Event|3
745948|NCT00395226|2386729|P1|Overall Study|Adverse Event|4
745949|NCT00395304|2386766|P6|Treatment Period 3|Other|0
745950|NCT00395304|2386767|P5|Treatment Period 3|Other|0
745951|NCT00395304|2386768|P4|Treatment Period 3|Other|1
745952|NCT00395304|2386769|P3|Treatment Period 3|Other|0
745953|NCT00395304|2386770|P2|Treatment Period 3|Other|0
745954|NCT00395304|2386771|P1|Treatment Period 3|Other|0
745955|NCT00395304|2386766|P6|Treatment Period 3|Physician Decision|0
745956|NCT00395304|2386767|P5|Treatment Period 3|Physician Decision|0
745957|NCT00395304|2386768|P4|Treatment Period 3|Physician Decision|0
745958|NCT00395304|2386769|P3|Treatment Period 3|Physician Decision|0
745959|NCT00395304|2386770|P2|Treatment Period 3|Physician Decision|1
745960|NCT00395304|2386771|P1|Treatment Period 3|Physician Decision|0
745961|NCT00395304|2386766|P6|Treatment Period 3|Lost to Follow-up|0
745962|NCT00395304|2386767|P5|Treatment Period 3|Lost to Follow-up|0
745963|NCT00395304|2386768|P4|Treatment Period 3|Lost to Follow-up|0
745964|NCT00395304|2386769|P3|Treatment Period 3|Lost to Follow-up|0
745965|NCT00395304|2386770|P2|Treatment Period 3|Lost to Follow-up|1
745966|NCT00395304|2386771|P1|Treatment Period 3|Lost to Follow-up|1
745967|NCT00395304|2386766|P6|Treatment Period 3|Withdrawal by Subject|1
745968|NCT00395304|2386767|P5|Treatment Period 3|Withdrawal by Subject|0
745969|NCT00395304|2386768|P4|Treatment Period 3|Withdrawal by Subject|1
745970|NCT00395304|2386769|P3|Treatment Period 3|Withdrawal by Subject|0
745971|NCT00395304|2386770|P2|Treatment Period 3|Withdrawal by Subject|0
745972|NCT00395304|2386771|P1|Treatment Period 3|Withdrawal by Subject|0
745973|NCT00395304|2386766|P6|Treatment Period 2|Other|0
745974|NCT00395304|2386767|P5|Treatment Period 2|Other|0
745975|NCT00395304|2386768|P4|Treatment Period 2|Other|0
745976|NCT00395304|2386769|P3|Treatment Period 2|Other|0
745977|NCT00395304|2386770|P2|Treatment Period 2|Other|1
745978|NCT00395304|2386771|P1|Treatment Period 2|Other|0
745979|NCT00395304|2386766|P6|Treatment Period 2|Physician Decision|0
745980|NCT00395304|2386767|P5|Treatment Period 2|Physician Decision|0
745981|NCT00395304|2386768|P4|Treatment Period 2|Physician Decision|0
745982|NCT00395304|2386769|P3|Treatment Period 2|Physician Decision|1
745983|NCT00395304|2386770|P2|Treatment Period 2|Physician Decision|0
745984|NCT00395304|2386771|P1|Treatment Period 2|Physician Decision|0
745985|NCT00395304|2386766|P6|Treatment Period 2|Lost to Follow-up|0
745986|NCT00395304|2386767|P5|Treatment Period 2|Lost to Follow-up|0
745987|NCT00395304|2386768|P4|Treatment Period 2|Lost to Follow-up|0
745988|NCT00395304|2386769|P3|Treatment Period 2|Lost to Follow-up|0
745989|NCT00395304|2386770|P2|Treatment Period 2|Lost to Follow-up|3
745990|NCT00395304|2386771|P1|Treatment Period 2|Lost to Follow-up|0
745991|NCT00395304|2386766|P6|Treatment Period 2|Withdrawal by Subject|2
745992|NCT00395304|2386767|P5|Treatment Period 2|Withdrawal by Subject|0
745993|NCT00395304|2386768|P4|Treatment Period 2|Withdrawal by Subject|1
745994|NCT00395304|2386769|P3|Treatment Period 2|Withdrawal by Subject|0
745995|NCT00395304|2386770|P2|Treatment Period 2|Withdrawal by Subject|0
745996|NCT00395304|2386771|P1|Treatment Period 2|Withdrawal by Subject|0
745997|NCT00395304|2386766|P6|Treatment Period 1|Physician Decision|0
745998|NCT00395304|2386767|P5|Treatment Period 1|Physician Decision|0
745999|NCT00395304|2386768|P4|Treatment Period 1|Physician Decision|0
746000|NCT00395304|2386769|P3|Treatment Period 1|Physician Decision|0
746001|NCT00395304|2386770|P2|Treatment Period 1|Physician Decision|1
746002|NCT00395304|2386771|P1|Treatment Period 1|Physician Decision|0
746003|NCT00395304|2386766|P6|Treatment Period 1|Lost to Follow-up|1
746004|NCT00395304|2386767|P5|Treatment Period 1|Lost to Follow-up|0
746005|NCT00395304|2386768|P4|Treatment Period 1|Lost to Follow-up|1
746006|NCT00395304|2386769|P3|Treatment Period 1|Lost to Follow-up|0
746007|NCT00395304|2386770|P2|Treatment Period 1|Lost to Follow-up|0
746008|NCT00395304|2386771|P1|Treatment Period 1|Lost to Follow-up|1
746009|NCT00395304|2386766|P6|Treatment Period 1|Withdrawal by Subject|1
746010|NCT00395304|2386767|P5|Treatment Period 1|Withdrawal by Subject|1
746011|NCT00395304|2386768|P4|Treatment Period 1|Withdrawal by Subject|2
746012|NCT00395304|2386769|P3|Treatment Period 1|Withdrawal by Subject|0
746013|NCT00395304|2386770|P2|Treatment Period 1|Withdrawal by Subject|3
746014|NCT00395304|2386771|P1|Treatment Period 1|Withdrawal by Subject|0
746015|NCT00395343|2386777|P2|Overall Study|Unspecified|2
746016|NCT00395343|2386778|P1|Overall Study|Unspecified|5
746017|NCT00395343|2386777|P2|Overall Study|Withdrawal by Subject|12
746018|NCT00395343|2386778|P1|Overall Study|Withdrawal by Subject|11
746019|NCT00395343|2386777|P2|Overall Study|Protocol Violation|8
746020|NCT00395343|2386778|P1|Overall Study|Protocol Violation|6
746021|NCT00395343|2386777|P2|Overall Study|Physician Decision|4
746022|NCT00395343|2386778|P1|Overall Study|Physician Decision|2
746023|NCT00395343|2386777|P2|Overall Study|Lost to Follow-up|4
746024|NCT00395343|2386778|P1|Overall Study|Lost to Follow-up|4
746025|NCT00395343|2386777|P2|Overall Study|Lack of Efficacy|1
746026|NCT00395343|2386778|P1|Overall Study|Lack of Efficacy|0
746027|NCT00395343|2386777|P2|Overall Study|Adverse Event|5
746028|NCT00395343|2386778|P1|Overall Study|Adverse Event|13
746029|NCT00395447|2386798|P2|Overall Study|Withdrawl - Other (not subject)|17
746030|NCT00395447|2386799|P1|Overall Study|Withdrawl - Other (not subject)|8
746031|NCT00395447|2386798|P2|Overall Study|Withdrawal by Subject|19
746032|NCT00395447|2386799|P1|Overall Study|Withdrawal by Subject|24
746033|NCT00395447|2386798|P2|Overall Study|Lost to Follow-up|43
746034|NCT00395447|2386799|P1|Overall Study|Lost to Follow-up|52
746035|NCT00395447|2386798|P2|Overall Study|Death|32
746036|NCT00395447|2386799|P1|Overall Study|Death|37
746037|NCT00395460|2386807|P2|Overall Study|Withdrawal by Subject|0
746038|NCT00395460|2386808|P1|Overall Study|Withdrawal by Subject|1
746039|NCT00395486|2386832|P2|Overall Study|Lost to Follow-up|1
746040|NCT00395486|2386833|P1|Overall Study|Lost to Follow-up|0
746041|NCT00395486|2386832|P2|Overall Study|Withdrawal by Subject|2
746042|NCT00395486|2386833|P1|Overall Study|Withdrawal by Subject|5
746043|NCT00395486|2386832|P2|Overall Study|Adverse Event|2
746044|NCT00395486|2386833|P1|Overall Study|Adverse Event|1
746045|NCT00395512|2386865|P4|Overall Study|Hyperglycemic Rescue|6
746046|NCT00395512|2386866|P3|Overall Study|Hyperglycemic Rescue|4
746047|NCT00395512|2386867|P2|Overall Study|Hyperglycemic Rescue|10
746048|NCT00395512|2386868|P1|Overall Study|Hyperglycemic Rescue|18
746049|NCT00395512|2386865|P4|Overall Study|Other|0
746050|NCT00395512|2386866|P3|Overall Study|Other|0
746051|NCT00395512|2386867|P2|Overall Study|Other|1
746052|NCT00395512|2386868|P1|Overall Study|Other|1
746053|NCT00395512|2386865|P4|Overall Study|Physician Decision|2
746054|NCT00395512|2386866|P3|Overall Study|Physician Decision|2
746055|NCT00395512|2386867|P2|Overall Study|Physician Decision|4
746056|NCT00395512|2386868|P1|Overall Study|Physician Decision|6
746057|NCT00395512|2386865|P4|Overall Study|Withdrawal by Subject|12
746058|NCT00395512|2386866|P3|Overall Study|Withdrawal by Subject|5
746059|NCT00395512|2386867|P2|Overall Study|Withdrawal by Subject|5
746060|NCT00395512|2386868|P1|Overall Study|Withdrawal by Subject|6
746061|NCT00395512|2386865|P4|Overall Study|Lost to Follow-up|5
746062|NCT00395512|2386866|P3|Overall Study|Lost to Follow-up|5
746063|NCT00395512|2386867|P2|Overall Study|Lost to Follow-up|6
746064|NCT00395512|2386868|P1|Overall Study|Lost to Follow-up|2
746065|NCT00395512|2386865|P4|Overall Study|Protocol Violation|7
746066|NCT00395512|2386866|P3|Overall Study|Protocol Violation|6
746067|NCT00395512|2386867|P2|Overall Study|Protocol Violation|3
746068|NCT00395512|2386868|P1|Overall Study|Protocol Violation|2
746069|NCT00395512|2386865|P4|Overall Study|Adverse Event|6
746070|NCT00395512|2386866|P3|Overall Study|Adverse Event|6
746071|NCT00395512|2386867|P2|Overall Study|Adverse Event|8
746072|NCT00395512|2386868|P1|Overall Study|Adverse Event|3
746073|NCT00395629|2387041|P3|Extension Study|Administrative problems|1
746074|NCT00395629|2387042|P2|Extension Study|Administrative problems|0
746075|NCT00395629|2387043|P1|Extension Study|Administrative problems|0
746076|NCT00395629|2387041|P3|Extension Study|Adverse Event|2
746077|NCT00395629|2387042|P2|Extension Study|Adverse Event|0
746078|NCT00395629|2387043|P1|Extension Study|Adverse Event|0
746079|NCT00395629|2387041|P3|Core Study|Lost to Follow-up|1
746080|NCT00395629|2387042|P2|Core Study|Lost to Follow-up|0
746081|NCT00395629|2387043|P1|Core Study|Lost to Follow-up|0
746082|NCT00395629|2387041|P3|Core Study|Withdrawal by Subject|1
746083|NCT00395629|2387042|P2|Core Study|Withdrawal by Subject|1
746084|NCT00395629|2387043|P1|Core Study|Withdrawal by Subject|0
746085|NCT00395629|2387041|P3|Core Study|Protocol Violation|0
746086|NCT00395629|2387042|P2|Core Study|Protocol Violation|0
746087|NCT00395629|2387043|P1|Core Study|Protocol Violation|1
746088|NCT00395629|2387041|P3|Core Study|Abnormal laboratory value(s)|1
746089|NCT00395629|2387042|P2|Core Study|Abnormal laboratory value(s)|0
746090|NCT00395629|2387043|P1|Core Study|Abnormal laboratory value(s)|0
746091|NCT00395629|2387041|P3|Core Study|Adverse Event|4
746092|NCT00395629|2387042|P2|Core Study|Adverse Event|3
746093|NCT00395629|2387043|P1|Core Study|Adverse Event|0
746094|NCT00395642|2387057|P1|Overall Study|Withdrawal by Subject|1
746095|NCT00395642|2387057|P1|Overall Study|Physician Decision|7
746096|NCT00395642|2387057|P1|Overall Study|Lost to Follow-up|1
746097|NCT00395642|2387057|P1|Overall Study|Death|4
746098|NCT00395694|2387063|P2|Continuation Phase|Withdrawal by Subject|2
746099|NCT00395694|2387064|P1|Continuation Phase|Withdrawal by Subject|0
746100|NCT00395694|2387063|P2|Continuation Phase|Poor Compliance|0
746101|NCT00395694|2387064|P1|Continuation Phase|Poor Compliance|1
746102|NCT00395694|2387063|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
746103|NCT00395694|2387064|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
746104|NCT00395694|2387063|P2|Continuation Phase|Lack of Efficacy|11
746105|NCT00395694|2387064|P1|Continuation Phase|Lack of Efficacy|12
746106|NCT00395694|2387063|P2|Continuation Phase|Adverse Event|0
746107|NCT00395694|2387064|P1|Continuation Phase|Adverse Event|1
746108|NCT00395694|2387063|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
746109|NCT00395694|2387064|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
746110|NCT00395733|2387097|P2|Period 2|Technical problems|0
746111|NCT00395733|2387098|P1|Period 2|Technical problems|1
746112|NCT00395733|2387097|P2|Period 2|Adverse Event|2
746113|NCT00395733|2387098|P1|Period 2|Adverse Event|0
746114|NCT00395733|2387097|P2|Period 2|Protocol Violation|1
746115|NCT00395733|2387098|P1|Period 2|Protocol Violation|0
746116|NCT00395733|2387097|P2|Period 2|Withdrawal by Subject|2
746117|NCT00395733|2387098|P1|Period 2|Withdrawal by Subject|1
746118|NCT00395746|2387123|P3|Overall Study|Unable to visit site on schedule|0
746119|NCT00395746|2387124|P2|Overall Study|Unable to visit site on schedule|0
746120|NCT00395746|2387125|P1|Overall Study|Unable to visit site on schedule|1
746121|NCT00395746|2387123|P3|Overall Study|Difficultulty in use of device|1
746122|NCT00395746|2387124|P2|Overall Study|Difficultulty in use of device|0
746123|NCT00395746|2387125|P1|Overall Study|Difficultulty in use of device|0
746124|NCT00395746|2387123|P3|Overall Study|Withdrawal of consent|1
746125|NCT00395746|2387124|P2|Overall Study|Withdrawal of consent|0
746126|NCT00395746|2387125|P1|Overall Study|Withdrawal of consent|0
746127|NCT00395746|2387123|P3|Overall Study|Subject decision|1
746128|NCT00395746|2387124|P2|Overall Study|Subject decision|0
746129|NCT00395746|2387125|P1|Overall Study|Subject decision|0
746130|NCT00395746|2387123|P3|Overall Study|Hypoglycaemia|0
746131|NCT00395746|2387124|P2|Overall Study|Hypoglycaemia|1
746132|NCT00395746|2387125|P1|Overall Study|Hypoglycaemia|2
746133|NCT00395746|2387123|P3|Overall Study|Lack of Efficacy|17
746134|NCT00395746|2387124|P2|Overall Study|Lack of Efficacy|0
746135|NCT00395746|2387125|P1|Overall Study|Lack of Efficacy|2
746136|NCT00395746|2387123|P3|Overall Study|Protocol Violation|0
746137|NCT00395746|2387124|P2|Overall Study|Protocol Violation|1
746138|NCT00395746|2387125|P1|Overall Study|Protocol Violation|0
746139|NCT00395746|2387123|P3|Overall Study|Adverse Event|2
746140|NCT00395746|2387124|P2|Overall Study|Adverse Event|2
746141|NCT00395746|2387125|P1|Overall Study|Adverse Event|5
746142|NCT00395850|2387173|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
746143|NCT00395850|2387174|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
746144|NCT00395850|2387175|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
746145|NCT00395850|2387176|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
746146|NCT00395850|2387173|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
746147|NCT00395850|2387174|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
746148|NCT00395850|2387175|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
746149|NCT00395850|2387176|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
746150|NCT00395850|2387173|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
746151|NCT00395850|2387174|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
746152|NCT00395850|2387175|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
746153|NCT00395850|2387176|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
746154|NCT00395850|2387173|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
746155|NCT00395850|2387174|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
746156|NCT00395850|2387175|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
746157|NCT00395850|2387176|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
746158|NCT00395850|2387173|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
746159|NCT00395850|2387174|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
746160|NCT00395850|2387175|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
746161|NCT00395850|2387176|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
746162|NCT00395850|2387173|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
746163|NCT00395850|2387174|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
746164|NCT00395850|2387175|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
746165|NCT00395850|2387176|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
746166|NCT00395850|2387173|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
746167|NCT00395850|2387174|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
746168|NCT00395850|2387175|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
746252|NCT00404092|2387630|P3|Overall Study|Death|0
746169|NCT00395850|2387176|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
746170|NCT00395863|2387192|P2|Overall Study|Patients did not complete both exams|3
746171|NCT00395863|2387193|P1|Overall Study|Patients did not complete both exams|2
746172|NCT00395967|2387253|P1|Follow-up Period|Lost to Follow-up|1
746173|NCT00395967|2387253|P1|Follow-up Period|Death|1
746174|NCT00395967|2387253|P1|Treatment Period|Failed Mobilization|1
746175|NCT00402987|2387307|P4|Overall Study|Lack of Efficacy|0
746176|NCT00402987|2387308|P3|Overall Study|Lack of Efficacy|1
746177|NCT00402987|2387309|P2|Overall Study|Lack of Efficacy|0
746178|NCT00402987|2387310|P1|Overall Study|Lack of Efficacy|0
746179|NCT00403130|2387472|P1|Overall Study|Withdrawal by Subject|1
746180|NCT00403130|2387472|P1|Overall Study|Lost to Follow up|1
746181|NCT00403130|2387472|P1|Overall Study|Not Eligible|3
746182|NCT00403234|2387483|P4|Overall Study|Adverse Event|0
746183|NCT00403234|2387484|P3|Overall Study|Adverse Event|1
746184|NCT00403234|2387485|P2|Overall Study|Adverse Event|0
746185|NCT00403234|2387486|P1|Overall Study|Adverse Event|1
746186|NCT00403234|2387483|P4|Overall Study|Withdrawal by Subject|0
746187|NCT00403234|2387484|P3|Overall Study|Withdrawal by Subject|0
746188|NCT00403234|2387485|P2|Overall Study|Withdrawal by Subject|1
746189|NCT00403234|2387486|P1|Overall Study|Withdrawal by Subject|0
746190|NCT00403273|2387498|P2|Overall Study|pt. wanted to have a surgical procedure|1
746191|NCT00403273|2387499|P1|Overall Study|pt. wanted to have a surgical procedure|0
746192|NCT00403273|2387498|P2|Overall Study|Physician Decision|1
746193|NCT00403273|2387499|P1|Overall Study|Physician Decision|0
746194|NCT00403273|2387498|P2|Overall Study|Lost to Follow-up|2
746195|NCT00403273|2387499|P1|Overall Study|Lost to Follow-up|3
746196|NCT00403585|2387525|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
746197|NCT00403585|2387525|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
746198|NCT00403585|2387525|P1|Initial Treatment Phase|Lost to Follow-up|2
746199|NCT00403754|2387534|P4|Core Treatment Period 2|Lack of Efficacy|0
746200|NCT00403754|2387535|P3|Core Treatment Period 2|Lack of Efficacy|1
746201|NCT00403754|2387536|P2|Core Treatment Period 2|Lack of Efficacy|0
746202|NCT00403754|2387537|P1|Core Treatment Period 2|Lack of Efficacy|0
746203|NCT00403754|2387534|P4|Core Treatment Period 1|Withdrawal by Subject|0
746204|NCT00403754|2387535|P3|Core Treatment Period 1|Withdrawal by Subject|0
746205|NCT00403754|2387536|P2|Core Treatment Period 1|Withdrawal by Subject|1
746206|NCT00403754|2387537|P1|Core Treatment Period 1|Withdrawal by Subject|0
746207|NCT00403767|2387566|P2|Overall Study|Missing/incomplete data|1
746208|NCT00403767|2387567|P1|Overall Study|Missing/incomplete data|1
746209|NCT00403767|2387566|P2|Overall Study|Study terminated by sponsor|69
746210|NCT00403767|2387567|P1|Overall Study|Study terminated by sponsor|82
746211|NCT00403767|2387566|P2|Overall Study|Clinical efficacy endpoint reached|332
746212|NCT00403767|2387567|P1|Overall Study|Clinical efficacy endpoint reached|300
746213|NCT00403767|2387566|P2|Overall Study|Protocol Violation|124
746214|NCT00403767|2387567|P1|Overall Study|Protocol Violation|142
746215|NCT00403767|2387566|P2|Overall Study|Lost to Follow-up|8
746216|NCT00403767|2387567|P1|Overall Study|Lost to Follow-up|6
746217|NCT00403767|2387566|P2|Overall Study|Investigator dec./not protocol-related|178
746218|NCT00403767|2387567|P1|Overall Study|Investigator dec./not protocol-related|191
746219|NCT00403767|2387566|P2|Overall Study|Consent withdrawn|673
746220|NCT00403767|2387567|P1|Overall Study|Consent withdrawn|671
746221|NCT00403767|2387566|P2|Overall Study|Non-compliant with study medication|164
746222|NCT00403767|2387567|P1|Overall Study|Non-compliant with study medication|134
746223|NCT00403767|2387566|P2|Overall Study|Adverse Event|919
746224|NCT00403767|2387567|P1|Overall Study|Adverse Event|993
746225|NCT00403845|2387591|P4|Treatment Period 3|Adverse Event|1
746226|NCT00403845|2387592|P3|Treatment Period 3|Adverse Event|0
746227|NCT00403845|2387593|P2|Treatment Period 3|Adverse Event|0
746228|NCT00403845|2387594|P1|Treatment Period 3|Adverse Event|0
746229|NCT00403845|2387591|P4|Treatment Period 3|Subject withdrew consent|1
746230|NCT00403845|2387592|P3|Treatment Period 3|Subject withdrew consent|0
746231|NCT00403845|2387593|P2|Treatment Period 3|Subject withdrew consent|0
746232|NCT00403845|2387594|P1|Treatment Period 3|Subject withdrew consent|0
746233|NCT00403845|2387591|P4|Treatment Period 2|Subject withdrew consent|0
746234|NCT00403845|2387592|P3|Treatment Period 2|Subject withdrew consent|0
746235|NCT00403845|2387593|P2|Treatment Period 2|Subject withdrew consent|0
746236|NCT00403845|2387594|P1|Treatment Period 2|Subject withdrew consent|1
746237|NCT00403845|2387591|P4|Treatment Period 1|Subject no longer needs study drug|1
746238|NCT00403845|2387592|P3|Treatment Period 1|Subject no longer needs study drug|0
746239|NCT00403845|2387593|P2|Treatment Period 1|Subject no longer needs study drug|0
746240|NCT00403845|2387594|P1|Treatment Period 1|Subject no longer needs study drug|0
746241|NCT00403845|2387591|P4|Treatment Period 1|Subject withdrew consent|0
746242|NCT00403845|2387592|P3|Treatment Period 1|Subject withdrew consent|0
746243|NCT00403845|2387593|P2|Treatment Period 1|Subject withdrew consent|0
746244|NCT00403845|2387594|P1|Treatment Period 1|Subject withdrew consent|1
746245|NCT00404079|2387618|P2|Overall Study|Lost to follow up, adverse event etc|20
746246|NCT00404079|2387619|P1|Overall Study|Lost to follow up, adverse event etc|22
746247|NCT00404092|2387629|P4|Overall Study|Adverse Event|0
746248|NCT00404092|2387630|P3|Overall Study|Adverse Event|1
746249|NCT00404092|2387631|P2|Overall Study|Adverse Event|0
746250|NCT00404092|2387632|P1|Overall Study|Adverse Event|0
746251|NCT00404092|2387629|P4|Overall Study|Death|0
746253|NCT00404092|2387631|P2|Overall Study|Death|0
746254|NCT00404092|2387632|P1|Overall Study|Death|1
746255|NCT00404248|2387649|P9|Overall Study|pts declining status|0
746256|NCT00404248|2387650|P8|Overall Study|pts declining status|0
746257|NCT00404248|2387651|P7|Overall Study|pts declining status|0
746258|NCT00404248|2387652|P6|Overall Study|pts declining status|0
746259|NCT00404248|2387653|P5|Overall Study|pts declining status|0
746260|NCT00404248|2387654|P4|Overall Study|pts declining status|0
746261|NCT00404248|2387655|P3|Overall Study|pts declining status|0
746262|NCT00404248|2387656|P2|Overall Study|pts declining status|1
746263|NCT00404248|2387657|P1|Overall Study|pts declining status|0
746264|NCT00404352|2387691|P9|Open Label Extension (up to 36 Months)|unspecified|2
746265|NCT00404352|2387692|P8|Open Label Extension (up to 36 Months)|unspecified|0
746266|NCT00404352|2387693|P7|Open Label Extension (up to 36 Months)|unspecified|0
746267|NCT00404352|2387694|P6|Open Label Extension (up to 36 Months)|unspecified|0
746268|NCT00404352|2387695|P5|Open Label Extension (up to 36 Months)|unspecified|0
746269|NCT00404352|2387696|P4|Open Label Extension (up to 36 Months)|unspecified|0
746270|NCT00404352|2387697|P3|Open Label Extension (up to 36 Months)|unspecified|0
746271|NCT00404352|2387698|P2|Open Label Extension (up to 36 Months)|unspecified|0
746272|NCT00404352|2387699|P1|Open Label Extension (up to 36 Months)|unspecified|0
746273|NCT00404352|2387691|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
746274|NCT00404352|2387692|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
746275|NCT00404352|2387693|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
746276|NCT00404352|2387694|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
746277|NCT00404352|2387695|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
746278|NCT00404352|2387696|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
746279|NCT00404352|2387697|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
746280|NCT00404352|2387698|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
746281|NCT00404352|2387699|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
746282|NCT00404352|2387691|P9|Open Label (up to 24 Month)|Disease progression|0
746283|NCT00404352|2387692|P8|Open Label (up to 24 Month)|Disease progression|0
746284|NCT00404352|2387693|P7|Open Label (up to 24 Month)|Disease progression|0
746285|NCT00404352|2387694|P6|Open Label (up to 24 Month)|Disease progression|0
746286|NCT00404352|2387695|P5|Open Label (up to 24 Month)|Disease progression|0
746287|NCT00404352|2387696|P4|Open Label (up to 24 Month)|Disease progression|1
746288|NCT00404352|2387697|P3|Open Label (up to 24 Month)|Disease progression|0
746289|NCT00404352|2387698|P2|Open Label (up to 24 Month)|Disease progression|0
746290|NCT00404352|2387699|P1|Open Label (up to 24 Month)|Disease progression|0
746291|NCT00404352|2387691|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
746292|NCT00404352|2387692|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
746293|NCT00404352|2387693|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
746294|NCT00404352|2387694|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
746295|NCT00404352|2387695|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
746296|NCT00404352|2387696|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
746297|NCT00404352|2387697|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
746298|NCT00404352|2387698|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
746299|NCT00404352|2387699|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
746300|NCT00404352|2387691|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
746301|NCT00404352|2387692|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
746302|NCT00404352|2387693|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
746303|NCT00404352|2387694|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
746304|NCT00404352|2387695|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
746305|NCT00404352|2387696|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
746306|NCT00404352|2387697|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
746307|NCT00404352|2387698|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
746308|NCT00404352|2387699|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
746309|NCT00404352|2387691|P9|Open Label (up to 24 Month)|Pregnancy|0
746310|NCT00404352|2387692|P8|Open Label (up to 24 Month)|Pregnancy|0
746311|NCT00404352|2387693|P7|Open Label (up to 24 Month)|Pregnancy|0
746312|NCT00404352|2387694|P6|Open Label (up to 24 Month)|Pregnancy|1
746313|NCT00404352|2387695|P5|Open Label (up to 24 Month)|Pregnancy|0
746314|NCT00404352|2387696|P4|Open Label (up to 24 Month)|Pregnancy|0
746315|NCT00404352|2387697|P3|Open Label (up to 24 Month)|Pregnancy|0
746316|NCT00404352|2387698|P2|Open Label (up to 24 Month)|Pregnancy|0
746317|NCT00404352|2387699|P1|Open Label (up to 24 Month)|Pregnancy|0
746318|NCT00404352|2387691|P9|Open Label (up to 24 Month)|Adverse Event|0
746319|NCT00404352|2387692|P8|Open Label (up to 24 Month)|Adverse Event|0
746320|NCT00404352|2387693|P7|Open Label (up to 24 Month)|Adverse Event|0
746321|NCT00404352|2387694|P6|Open Label (up to 24 Month)|Adverse Event|1
746322|NCT00404352|2387695|P5|Open Label (up to 24 Month)|Adverse Event|1
746323|NCT00404352|2387696|P4|Open Label (up to 24 Month)|Adverse Event|2
746324|NCT00404352|2387697|P3|Open Label (up to 24 Month)|Adverse Event|0
746325|NCT00404352|2387698|P2|Open Label (up to 24 Month)|Adverse Event|0
746326|NCT00404352|2387699|P1|Open Label (up to 24 Month)|Adverse Event|0
746327|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Unspecified|0
746328|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Unspecified|0
746329|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Unspecified|0
746330|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Unspecified|0
746331|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Unspecified|0
746332|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Unspecified|0
746333|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Unspecified|0
746334|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Unspecified|1
746335|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Unspecified|0
746336|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Physician Decision|0
746337|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Physician Decision|0
746338|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Physician Decision|0
746339|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Physician Decision|0
746340|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Physician Decision|0
746341|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Physician Decision|0
746342|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Physician Decision|1
746343|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Physician Decision|0
746344|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Physician Decision|0
746345|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
746346|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
746347|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
746348|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
746349|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
746350|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
746351|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
746352|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
746353|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
746354|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
746355|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
746356|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
746357|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
746358|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
746359|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
746360|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
746361|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
746362|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
746363|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Poor compliance|0
746364|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Poor compliance|0
746365|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Poor compliance|0
746366|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Poor compliance|0
746367|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Poor compliance|0
746368|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Poor compliance|0
746369|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Poor compliance|0
746370|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Poor compliance|0
746371|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Poor compliance|1
746372|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Disease progression|0
746373|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Disease progression|0
746374|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Disease progression|0
746375|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Disease progression|0
746376|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Disease progression|0
746377|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Disease progression|0
746378|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Disease progression|2
746379|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Disease progression|0
746380|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Disease progression|3
746381|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746382|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746383|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746384|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746385|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746386|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
746387|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
746388|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
746389|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
746390|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
746391|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
746392|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
746393|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
746394|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
746395|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
746396|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
746397|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
746398|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
746399|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Death|0
746400|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Death|0
746401|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Death|0
746402|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Death|0
746403|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Death|0
746404|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Death|0
746405|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Death|1
746406|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Death|0
746407|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Death|0
746408|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Pregnancy|0
746409|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Pregnancy|0
746410|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Pregnancy|0
746411|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Pregnancy|0
746412|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Pregnancy|0
746413|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Pregnancy|0
746414|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Pregnancy|2
746415|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Pregnancy|0
746416|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Pregnancy|0
746417|NCT00404352|2387691|P9|Double Blind (up to 24 Month)|Adverse Event|0
746418|NCT00404352|2387692|P8|Double Blind (up to 24 Month)|Adverse Event|0
746419|NCT00404352|2387693|P7|Double Blind (up to 24 Month)|Adverse Event|0
746420|NCT00404352|2387694|P6|Double Blind (up to 24 Month)|Adverse Event|0
746421|NCT00404352|2387695|P5|Double Blind (up to 24 Month)|Adverse Event|0
746422|NCT00404352|2387696|P4|Double Blind (up to 24 Month)|Adverse Event|0
746423|NCT00404352|2387697|P3|Double Blind (up to 24 Month)|Adverse Event|6
746424|NCT00404352|2387698|P2|Double Blind (up to 24 Month)|Adverse Event|4
746425|NCT00404352|2387699|P1|Double Blind (up to 24 Month)|Adverse Event|5
746426|NCT00404495|2387733|P2|Overall Study|Withdrawal by Subject|0
746427|NCT00404495|2387734|P1|Overall Study|Withdrawal by Subject|1
746428|NCT00404495|2387733|P2|Overall Study|Not specified|0
746429|NCT00404495|2387734|P1|Overall Study|Not specified|1
746430|NCT00404495|2387733|P2|Overall Study|Lost to Follow-up|0
746431|NCT00404495|2387734|P1|Overall Study|Lost to Follow-up|5
746432|NCT00404495|2387733|P2|Overall Study|Death|11
746433|NCT00404495|2387734|P1|Overall Study|Death|37
746448|NCT00404651|2387765|P4|Overall Study|Withdrawal by Subject|6
746449|NCT00404651|2387766|P3|Overall Study|Withdrawal by Subject|16
746450|NCT00404651|2387767|P2|Overall Study|Withdrawal by Subject|12
746451|NCT00404651|2387768|P1|Overall Study|Withdrawal by Subject|14
746452|NCT00404651|2387765|P4|Overall Study|Lost to Follow-up|10
746453|NCT00404651|2387766|P3|Overall Study|Lost to Follow-up|13
746454|NCT00404651|2387767|P2|Overall Study|Lost to Follow-up|11
746455|NCT00404651|2387768|P1|Overall Study|Lost to Follow-up|15
746456|NCT00404651|2387765|P4|Overall Study|Protocol Violation|5
746457|NCT00404651|2387766|P3|Overall Study|Protocol Violation|14
746458|NCT00404651|2387767|P2|Overall Study|Protocol Violation|5
746459|NCT00404651|2387768|P1|Overall Study|Protocol Violation|10
746460|NCT00404651|2387765|P4|Overall Study|Serious Adverse Event|0
746461|NCT00404651|2387766|P3|Overall Study|Serious Adverse Event|2
746462|NCT00404651|2387767|P2|Overall Study|Serious Adverse Event|0
746463|NCT00404651|2387768|P1|Overall Study|Serious Adverse Event|0
746464|NCT00404820|2387796|P2|Overall Study|Other|2
746465|NCT00404820|2387797|P1|Overall Study|Other|0
746466|NCT00404820|2387796|P2|Overall Study|Death|0
746467|NCT00404820|2387797|P1|Overall Study|Death|1
746468|NCT00404820|2387796|P2|Overall Study|Administrative problems|0
746469|NCT00404820|2387797|P1|Overall Study|Administrative problems|2
746470|NCT00404820|2387796|P2|Overall Study|Lost to Follow-up|3
746471|NCT00404820|2387797|P1|Overall Study|Lost to Follow-up|7
746472|NCT00404820|2387796|P2|Overall Study|Withdrawal by Subject|3
746473|NCT00404820|2387797|P1|Overall Study|Withdrawal by Subject|5
746474|NCT00404820|2387796|P2|Overall Study|Adverse Event|16
746475|NCT00404820|2387797|P1|Overall Study|Adverse Event|4
746476|NCT00404924|2387817|P2|Overall Study|Randomised but not received treatment|1
746477|NCT00404924|2387818|P1|Overall Study|Randomised but not received treatment|1
746478|NCT00404924|2387817|P2|Overall Study|Not Specified|11
746479|NCT00404924|2387818|P1|Overall Study|Not Specified|25
746480|NCT00404924|2387817|P2|Overall Study|Withdrawal by Subject|13
746481|NCT00404924|2387818|P1|Overall Study|Withdrawal by Subject|26
746482|NCT00404924|2387817|P2|Overall Study|Lost to Follow-up|1
746483|NCT00404924|2387818|P1|Overall Study|Lost to Follow-up|1
746484|NCT00404924|2387817|P2|Overall Study|Condition under investigation worsened|264
746485|NCT00404924|2387818|P1|Overall Study|Condition under investigation worsened|475
746486|NCT00404924|2387817|P2|Overall Study|Adverse Event|16
746487|NCT00404924|2387818|P1|Overall Study|Adverse Event|75
746488|NCT00405067|2387837|P3|Overall Study|Lost to Follow-up|1
746489|NCT00405067|2387838|P2|Overall Study|Lost to Follow-up|0
746490|NCT00405067|2387839|P1|Overall Study|Lost to Follow-up|0
746491|NCT00405067|2387837|P3|Overall Study|Adverse Event|4
746492|NCT00405067|2387838|P2|Overall Study|Adverse Event|9
746493|NCT00405067|2387839|P1|Overall Study|Adverse Event|4
746494|NCT00405275|2387876|P2|Overall Study|Unwilling to continue|9
746495|NCT00405275|2387877|P1|Overall Study|Unwilling to continue|10
746496|NCT00405275|2387876|P2|Overall Study|Withdrawal by Subject|9
746497|NCT00405275|2387877|P1|Overall Study|Withdrawal by Subject|7
746498|NCT00405275|2387876|P2|Overall Study|Lost to Follow-up|1
746499|NCT00405275|2387877|P1|Overall Study|Lost to Follow-up|5
746500|NCT00405275|2387876|P2|Overall Study|Death|0
746501|NCT00405275|2387877|P1|Overall Study|Death|1
746502|NCT00405548|2387933|P2|Overall Study|Withdrawal by Subject|0
746503|NCT00405548|2387934|P1|Overall Study|Withdrawal by Subject|1
746504|NCT00405548|2387933|P2|Overall Study|Venous access failed during study day|0
746505|NCT00405548|2387934|P1|Overall Study|Venous access failed during study day|1
746506|NCT00405548|2387933|P2|Overall Study|Unable to self-administer shots|0
746507|NCT00405548|2387934|P1|Overall Study|Unable to self-administer shots|1
746508|NCT00405548|2387933|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
746509|NCT00405548|2387934|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
746510|NCT00405548|2387933|P2|Overall Study|Cognitive Memory problems on study day|0
746511|NCT00405548|2387934|P1|Overall Study|Cognitive Memory problems on study day|1
746512|NCT00405587|2387950|P4|Overall Study|Participant not dosed|0
746513|NCT00405587|2387951|P3|Overall Study|Participant not dosed|0
746514|NCT00405587|2387952|P2|Overall Study|Participant not dosed|1
746515|NCT00405587|2387953|P1|Overall Study|Participant not dosed|0
746516|NCT00405587|2387950|P4|Overall Study|Withdrawal by Subject|2
746517|NCT00405587|2387951|P3|Overall Study|Withdrawal by Subject|0
746518|NCT00405587|2387952|P2|Overall Study|Withdrawal by Subject|0
746519|NCT00405587|2387953|P1|Overall Study|Withdrawal by Subject|0
746520|NCT00405587|2387950|P4|Overall Study|Radiation induced necrosis|0
746521|NCT00405587|2387951|P3|Overall Study|Radiation induced necrosis|0
746522|NCT00405587|2387952|P2|Overall Study|Radiation induced necrosis|1
746523|NCT00405587|2387953|P1|Overall Study|Radiation induced necrosis|0
746524|NCT00405587|2387950|P4|Overall Study|Lost to Follow-up|0
746525|NCT00405587|2387951|P3|Overall Study|Lost to Follow-up|1
746526|NCT00405587|2387952|P2|Overall Study|Lost to Follow-up|1
746527|NCT00405587|2387953|P1|Overall Study|Lost to Follow-up|0
746528|NCT00405587|2387950|P4|Overall Study|Adverse Event|0
746529|NCT00405587|2387951|P3|Overall Study|Adverse Event|0
746530|NCT00405587|2387952|P2|Overall Study|Adverse Event|0
746531|NCT00405587|2387953|P1|Overall Study|Adverse Event|1
746532|NCT00405587|2387950|P4|Overall Study|Physician Decision|0
746533|NCT00405587|2387951|P3|Overall Study|Physician Decision|0
746534|NCT00405587|2387952|P2|Overall Study|Physician Decision|2
746535|NCT00405587|2387953|P1|Overall Study|Physician Decision|3
746536|NCT00405587|2387950|P4|Overall Study|Disease Progression|17
746537|NCT00405587|2387951|P3|Overall Study|Disease Progression|21
746538|NCT00405587|2387952|P2|Overall Study|Disease Progression|23
746539|NCT00405587|2387953|P1|Overall Study|Disease Progression|22
746540|NCT00405587|2387950|P4|Overall Study|Death|1
746541|NCT00405587|2387951|P3|Overall Study|Death|0
746542|NCT00405587|2387952|P2|Overall Study|Death|0
746543|NCT00405587|2387953|P1|Overall Study|Death|0
746544|NCT00405639|2388071|P2|Overall Study|Seizure prior to receiving BNP|0
746545|NCT00405639|2388072|P1|Overall Study|Seizure prior to receiving BNP|1
746546|NCT00405639|2388071|P2|Overall Study|Adverse Event|0
746547|NCT00405639|2388072|P1|Overall Study|Adverse Event|1
746548|NCT00405639|2388071|P2|Overall Study|Withdrawal by Subject|0
746549|NCT00405639|2388072|P1|Overall Study|Withdrawal by Subject|1
746550|NCT00405652|2388084|P1|Overall Study|Adverse Event|4
746551|NCT00405756|2388115|P3|Follow-up|Lost to Follow-up|4
746552|NCT00405756|2388116|P2|Follow-up|Lost to Follow-up|8
746553|NCT00405756|2388117|P1|Follow-up|Lost to Follow-up|2
746554|NCT00405756|2388115|P3|Follow-up|Death|24
746555|NCT00405756|2388116|P2|Follow-up|Death|31
746556|NCT00405756|2388117|P1|Follow-up|Death|21
746557|NCT00405756|2388115|P3|Follow-up|Ongoing in Follow-up Period|60
746558|NCT00405756|2388116|P2|Follow-up|Ongoing in Follow-up Period|51
746559|NCT00405756|2388117|P1|Follow-up|Ongoing in Follow-up Period|52
746560|NCT00405756|2388115|P3|Open-label Extension|Unspecified|7
746561|NCT00405756|2388116|P2|Open-label Extension|Unspecified|1
746562|NCT00405756|2388117|P1|Open-label Extension|Unspecified|0
746563|NCT00405756|2388115|P3|Open-label Extension|Death|4
746564|NCT00405756|2388116|P2|Open-label Extension|Death|2
746565|NCT00405756|2388117|P1|Open-label Extension|Death|1
746566|NCT00405756|2388115|P3|Open-label Extension|Withdrawal by Subject|3
746567|NCT00405756|2388116|P2|Open-label Extension|Withdrawal by Subject|3
746568|NCT00405756|2388117|P1|Open-label Extension|Withdrawal by Subject|2
746569|NCT00405756|2388115|P3|Open-label Extension|Disease Progression|26
746570|NCT00405756|2388116|P2|Open-label Extension|Disease Progression|23
746571|NCT00405756|2388117|P1|Open-label Extension|Disease Progression|8
746572|NCT00405756|2388115|P3|Open-label Extension|Adverse Event|7
746573|NCT00405756|2388116|P2|Open-label Extension|Adverse Event|3
746574|NCT00405756|2388117|P1|Open-label Extension|Adverse Event|1
746575|NCT00405756|2388115|P3|Open-label Extension|Ongoing in Open Label Period|25
746576|NCT00405756|2388116|P2|Open-label Extension|Ongoing in Open Label Period|15
746577|NCT00405756|2388117|P1|Open-label Extension|Ongoing in Open Label Period|7
746578|NCT00405756|2388115|P3|Double-blind Treatment|Not Specified|4
746579|NCT00405756|2388116|P2|Double-blind Treatment|Not Specified|4
746580|NCT00405756|2388117|P1|Double-blind Treatment|Not Specified|7
746581|NCT00405756|2388115|P3|Double-blind Treatment|Protocol Violation|2
746582|NCT00405756|2388116|P2|Double-blind Treatment|Protocol Violation|0
746583|NCT00405756|2388117|P1|Double-blind Treatment|Protocol Violation|1
746584|NCT00405756|2388115|P3|Double-blind Treatment|Death|4
746585|NCT00405756|2388116|P2|Double-blind Treatment|Death|4
746586|NCT00405756|2388117|P1|Double-blind Treatment|Death|4
746587|NCT00405756|2388115|P3|Double-blind Treatment|Lost to Follow-up|0
746588|NCT00405756|2388116|P2|Double-blind Treatment|Lost to Follow-up|0
746589|NCT00405756|2388117|P1|Double-blind Treatment|Lost to Follow-up|1
746590|NCT00405756|2388115|P3|Double-blind Treatment|Withdrawal by Subject|10
746591|NCT00405756|2388116|P2|Double-blind Treatment|Withdrawal by Subject|9
746592|NCT00405756|2388117|P1|Double-blind Treatment|Withdrawal by Subject|15
746593|NCT00405756|2388115|P3|Double-blind Treatment|Lack of Efficacy|2
746594|NCT00405756|2388116|P2|Double-blind Treatment|Lack of Efficacy|4
746595|NCT00405756|2388117|P1|Double-blind Treatment|Lack of Efficacy|1
746596|NCT00405756|2388115|P3|Double-blind Treatment|Disease Progression|102
746597|NCT00405756|2388116|P2|Double-blind Treatment|Disease Progression|81
746598|NCT00405756|2388117|P1|Double-blind Treatment|Disease Progression|47
746599|NCT00405756|2388115|P3|Double-blind Treatment|Adverse Event|12
746600|NCT00405756|2388116|P2|Double-blind Treatment|Adverse Event|27
746601|NCT00405756|2388117|P1|Double-blind Treatment|Adverse Event|31
746602|NCT00405756|2388115|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
746603|NCT00405756|2388116|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
746604|NCT00405756|2388117|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
746605|NCT00405821|2388207|P2|Overall Study|initiated ART|8
746606|NCT00405821|2388208|P1|Overall Study|initiated ART|9
746607|NCT00405821|2388207|P2|Overall Study|Protocol Violation|0
746608|NCT00405821|2388208|P1|Overall Study|Protocol Violation|1
746609|NCT00405821|2388207|P2|Overall Study|Lost to Follow-up|7
746610|NCT00405821|2388208|P1|Overall Study|Lost to Follow-up|7
746611|NCT00405821|2388207|P2|Overall Study|Death|7
746612|NCT00405821|2388208|P1|Overall Study|Death|5
746613|NCT00405912|2388221|P3|Overall Study|Lost to Follow-up|4
746614|NCT00405912|2388222|P2|Overall Study|Lost to Follow-up|8
746615|NCT00405912|2388223|P1|Overall Study|Lost to Follow-up|4
746616|NCT00405912|2388221|P3|Overall Study|Withdrawal by Subject|12
746617|NCT00405912|2388222|P2|Overall Study|Withdrawal by Subject|11
746618|NCT00405912|2388223|P1|Overall Study|Withdrawal by Subject|12
746619|NCT00405964|2388245|P2|Overall Study|Protocol Violation|6
746620|NCT00405964|2388246|P1|Overall Study|Protocol Violation|11
746621|NCT00405964|2388245|P2|Overall Study|Withdrawal by Subject|23
746622|NCT00405964|2388246|P1|Overall Study|Withdrawal by Subject|19
746623|NCT00405964|2388245|P2|Overall Study|Lost to Follow-up|5
746624|NCT00405964|2388246|P1|Overall Study|Lost to Follow-up|5
746625|NCT00405964|2388245|P2|Overall Study|Adverse Event|16
746626|NCT00405964|2388246|P1|Overall Study|Adverse Event|7
746627|NCT00405964|2388245|P2|Overall Study|Treatment Failure|45
746628|NCT00405964|2388246|P1|Overall Study|Treatment Failure|17
746629|NCT00406029|2388261|P5|Overall Study|Randomized in Error|1
746630|NCT00406029|2388262|P4|Overall Study|Randomized in Error|3
746631|NCT00406029|2388263|P3|Overall Study|Randomized in Error|2
746632|NCT00406029|2388264|P2|Overall Study|Randomized in Error|0
746633|NCT00406029|2388265|P1|Overall Study|Randomized in Error|0
746634|NCT00406029|2388261|P5|Overall Study|Did Not Meet Eligibility Criteria|0
746635|NCT00406029|2388262|P4|Overall Study|Did Not Meet Eligibility Criteria|0
746636|NCT00406029|2388263|P3|Overall Study|Did Not Meet Eligibility Criteria|1
746637|NCT00406029|2388264|P2|Overall Study|Did Not Meet Eligibility Criteria|0
746638|NCT00406029|2388265|P1|Overall Study|Did Not Meet Eligibility Criteria|0
746639|NCT00406029|2388261|P5|Overall Study|Protocol Violation|0
746640|NCT00406029|2388262|P4|Overall Study|Protocol Violation|2
746641|NCT00406029|2388263|P3|Overall Study|Protocol Violation|0
746642|NCT00406029|2388264|P2|Overall Study|Protocol Violation|2
746643|NCT00406029|2388265|P1|Overall Study|Protocol Violation|1
746644|NCT00406029|2388261|P5|Overall Study|Withdrawal by Subject|0
746645|NCT00406029|2388262|P4|Overall Study|Withdrawal by Subject|2
746646|NCT00406029|2388263|P3|Overall Study|Withdrawal by Subject|2
746647|NCT00406029|2388264|P2|Overall Study|Withdrawal by Subject|4
746648|NCT00406029|2388265|P1|Overall Study|Withdrawal by Subject|3
746649|NCT00406029|2388261|P5|Overall Study|Adverse Event|7
746650|NCT00406029|2388262|P4|Overall Study|Adverse Event|10
746651|NCT00406029|2388263|P3|Overall Study|Adverse Event|5
746652|NCT00406029|2388264|P2|Overall Study|Adverse Event|2
746653|NCT00406029|2388265|P1|Overall Study|Adverse Event|12
746654|NCT00399035|2388379|P3|Overall Study|Severe non-compliance with protocol|0
746655|NCT00399035|2388380|P2|Overall Study|Severe non-compliance with protocol|1
746656|NCT00399035|2388381|P1|Overall Study|Severe non-compliance with protocol|2
746657|NCT00399035|2388379|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
746658|NCT00399035|2388380|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
746659|NCT00399035|2388381|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
746660|NCT00399035|2388379|P3|Overall Study|Withdrawal by Subject|12
746661|NCT00399035|2388380|P2|Overall Study|Withdrawal by Subject|15
746662|NCT00399035|2388381|P1|Overall Study|Withdrawal by Subject|19
746663|NCT00399035|2388379|P3|Overall Study|Lost to Follow-up|5
746664|NCT00399035|2388380|P2|Overall Study|Lost to Follow-up|1
746665|NCT00399035|2388381|P1|Overall Study|Lost to Follow-up|2
746666|NCT00399035|2388379|P3|Overall Study|Death|234
746667|NCT00399035|2388380|P2|Overall Study|Death|141
746668|NCT00399035|2388381|P1|Overall Study|Death|289
746669|NCT00399360|2388426|P4|Overall Study|Withdrawal by Subject|2
746670|NCT00399360|2388427|P3|Overall Study|Withdrawal by Subject|0
746671|NCT00399360|2388428|P2|Overall Study|Withdrawal by Subject|2
746672|NCT00399360|2388429|P1|Overall Study|Withdrawal by Subject|0
746673|NCT00399360|2388426|P4|Overall Study|Adverse Event|0
746674|NCT00399360|2388427|P3|Overall Study|Adverse Event|1
746675|NCT00399360|2388428|P2|Overall Study|Adverse Event|0
746676|NCT00399360|2388429|P1|Overall Study|Adverse Event|0
746677|NCT00399360|2388426|P4|Overall Study|Lost to Follow-up|4
746678|NCT00399360|2388427|P3|Overall Study|Lost to Follow-up|2
746679|NCT00399360|2388428|P2|Overall Study|Lost to Follow-up|1
746680|NCT00399360|2388429|P1|Overall Study|Lost to Follow-up|2
746681|NCT00399516|2388475|P1|Overall Study|Lost to Follow-up|2
746682|NCT00399542|2388481|P2|Overall Study|Physician Decision|1
746683|NCT00399542|2388482|P1|Overall Study|Physician Decision|0
746684|NCT00399542|2388481|P2|Overall Study|Unspecified|0
746685|NCT00399542|2388482|P1|Overall Study|Unspecified|1
746686|NCT00399542|2388481|P2|Overall Study|Lost to Follow-up|6
746687|NCT00399542|2388482|P1|Overall Study|Lost to Follow-up|6
746688|NCT00399542|2388481|P2|Overall Study|Lack of Efficacy|8
746689|NCT00399542|2388482|P1|Overall Study|Lack of Efficacy|18
746690|NCT00399542|2388481|P2|Overall Study|Withdrawal by Subject|10
746691|NCT00399542|2388482|P1|Overall Study|Withdrawal by Subject|28
746692|NCT00399542|2388481|P2|Overall Study|Protocol Violation|3
746693|NCT00399542|2388482|P1|Overall Study|Protocol Violation|13
746694|NCT00399542|2388481|P2|Overall Study|Adverse Event|15
746695|NCT00399542|2388482|P1|Overall Study|Adverse Event|18
746696|NCT00399568|2388546|P2|Overall Study|Lost to Follow-up|2
746697|NCT00399568|2388547|P1|Overall Study|Lost to Follow-up|2
746698|NCT00399568|2388546|P2|Overall Study|Protocol non-compliance|2
746699|NCT00399568|2388547|P1|Overall Study|Protocol non-compliance|2
746700|NCT00399568|2388546|P2|Overall Study|Withdrawal by Subject|3
746701|NCT00399568|2388547|P1|Overall Study|Withdrawal by Subject|7
746702|NCT00399568|2388546|P2|Overall Study|Adverse Event|2
746703|NCT00399568|2388547|P1|Overall Study|Adverse Event|1
746704|NCT00399763|2388561|P2|Overall Study|Lost to Follow-up|3
746705|NCT00399763|2388562|P1|Overall Study|Lost to Follow-up|2
746706|NCT00399893|2388585|P2|Overall Study|Withdrawal by Subject|0
746707|NCT00399893|2388586|P1|Overall Study|Withdrawal by Subject|1
746708|NCT00400153|2388615|P3|Overall Study|Other reasons - not mentioned above|3
746709|NCT00400153|2388616|P2|Overall Study|Other reasons - not mentioned above|5
746710|NCT00400153|2388617|P1|Overall Study|Other reasons - not mentioned above|8
746711|NCT00400153|2388615|P3|Overall Study|Withdrawal by Subject|10
746712|NCT00400153|2388616|P2|Overall Study|Withdrawal by Subject|11
746713|NCT00400153|2388617|P1|Overall Study|Withdrawal by Subject|12
746714|NCT00400153|2388615|P3|Overall Study|Lost to Follow-up|4
746715|NCT00400153|2388616|P2|Overall Study|Lost to Follow-up|1
746716|NCT00400153|2388617|P1|Overall Study|Lost to Follow-up|2
746717|NCT00400153|2388615|P3|Overall Study|Protocol Violation|9
746718|NCT00400153|2388616|P2|Overall Study|Protocol Violation|4
746719|NCT00400153|2388617|P1|Overall Study|Protocol Violation|7
746720|NCT00400153|2388615|P3|Overall Study|AE due to other condition|15
746721|NCT00400153|2388616|P2|Overall Study|AE due to other condition|14
746722|NCT00400153|2388617|P1|Overall Study|AE due to other condition|3
746723|NCT00400153|2388615|P3|Overall Study|AE due to other disease worsening|0
746724|NCT00400153|2388616|P2|Overall Study|AE due to other disease worsening|1
746725|NCT00400153|2388617|P1|Overall Study|AE due to other disease worsening|2
746726|NCT00400153|2388615|P3|Overall Study|AE due to study disease worsening|20
746727|NCT00400153|2388616|P2|Overall Study|AE due to study disease worsening|19
746728|NCT00400153|2388617|P1|Overall Study|AE due to study disease worsening|14
746729|NCT00400179|2388864|P2|Overall Study|Randomization error/patient ineligible|6
746730|NCT00400179|2388865|P1|Overall Study|Randomization error/patient ineligible|1
746731|NCT00400179|2388864|P2|Overall Study|Investigator judgment|1
746732|NCT00400179|2388865|P1|Overall Study|Investigator judgment|0
746733|NCT00400179|2388864|P2|Overall Study|Intercurrent illness|1
746734|NCT00400179|2388865|P1|Overall Study|Intercurrent illness|0
746735|NCT00400179|2388864|P2|Overall Study|Disease progression|1
746736|NCT00400179|2388865|P1|Overall Study|Disease progression|1
746737|NCT00400179|2388864|P2|Overall Study|Withdrew Consent|5
746738|NCT00400179|2388865|P1|Overall Study|Withdrew Consent|1
746739|NCT00400179|2388864|P2|Overall Study|Death|2
746740|NCT00400179|2388865|P1|Overall Study|Death|1
746741|NCT00400179|2388864|P2|Overall Study|Adverse Event|2
746742|NCT00400179|2388865|P1|Overall Study|Adverse Event|2
746743|NCT00400400|2388885|P2|Overall Study|Did not receive study drug|3
746744|NCT00400400|2388886|P1|Overall Study|Did not receive study drug|1
746745|NCT00400400|2388885|P2|Overall Study|Lost to Follow-up|1
746746|NCT00400400|2388886|P1|Overall Study|Lost to Follow-up|0
746747|NCT00400400|2388885|P2|Overall Study|Administrative Problem|0
746748|NCT00400400|2388886|P1|Overall Study|Administrative Problem|1
746749|NCT00400400|2388885|P2|Overall Study|Withdrawal by Subject|3
746750|NCT00400400|2388886|P1|Overall Study|Withdrawal by Subject|1
746751|NCT00400400|2388885|P2|Overall Study|Protocol Violation|0
746752|NCT00400400|2388886|P1|Overall Study|Protocol Violation|2
746753|NCT00400400|2388885|P2|Overall Study|Adverse Event|8
746754|NCT00400400|2388886|P1|Overall Study|Adverse Event|9
746755|NCT00406315|2388991|P1|Overall Study|Withdrawal by Subject|30
746756|NCT00406315|2388991|P1|Overall Study|Lost to Follow-up|21
746757|NCT00406315|2388991|P1|Overall Study|Unspecified|33
746758|NCT00406315|2388991|P1|Overall Study|Lack of Efficacy|13
746759|NCT00406315|2388991|P1|Overall Study|Laboratory Abnormality|4
746760|NCT00406315|2388991|P1|Overall Study|Adverse Event|39
746761|NCT00406315|2388991|P1|Overall Study|Death|1
746762|NCT00406354|2389012|P3|All Randomized and Treated Patients|Physician Decision|1
746763|NCT00406354|2389013|P2|All Randomized and Treated Patients|Physician Decision|0
746764|NCT00406354|2389014|P1|All Randomized and Treated Patients|Physician Decision|0
746765|NCT00406354|2389012|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
746766|NCT00406354|2389013|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
746767|NCT00406354|2389014|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
746768|NCT00406354|2389012|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
746769|NCT00406354|2389013|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
746770|NCT00406354|2389014|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
746771|NCT00406354|2389012|P3|All Randomized and Treated Patients|Adverse Event|1
746772|NCT00406354|2389013|P2|All Randomized and Treated Patients|Adverse Event|2
746773|NCT00406354|2389014|P1|All Randomized and Treated Patients|Adverse Event|6
746774|NCT00406354|2389012|P3|All Randomized and Treated Patients|Lack of Efficacy|17
746775|NCT00406354|2389013|P2|All Randomized and Treated Patients|Lack of Efficacy|4
746776|NCT00406354|2389014|P1|All Randomized and Treated Patients|Lack of Efficacy|7
746777|NCT00406354|2389012|P3|All Randomized Patients|Protocol Violation|1
746778|NCT00406354|2389013|P2|All Randomized Patients|Protocol Violation|0
746779|NCT00406354|2389014|P1|All Randomized Patients|Protocol Violation|0
746780|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
746781|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
746782|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
746783|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
746784|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
746785|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
746786|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
746787|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
746788|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
746789|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
746790|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
746791|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
746792|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
746793|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
746794|NCT00406367|2389087|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
746795|NCT00406367|2389088|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
746796|NCT00406367|2389087|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
746797|NCT00406367|2389088|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
746798|NCT00406367|2389087|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
746799|NCT00406367|2389088|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
746800|NCT00406367|2389087|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
746801|NCT00406367|2389088|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
746802|NCT00406367|2389087|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
746803|NCT00406367|2389088|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
746804|NCT00406393|2389102|P2|Overall Study|Did not undergo transplantation|1
746805|NCT00406393|2389103|P1|Overall Study|Did not undergo transplantation|2
746806|NCT00407797|2389131|P1|Overall Study|Withdrawal by Subject|3
746807|NCT00407797|2389131|P1|Overall Study|Unspecified|7
746808|NCT00407797|2389131|P1|Overall Study|Adverse Event|6
746809|NCT00407797|2389131|P1|Overall Study|Lost to Follow-up|2
746810|NCT00408317|2389173|P2|Second Intervention Period|Withdrawal of consent|1
746811|NCT00408317|2389174|P1|Second Intervention Period|Withdrawal of consent|0
746812|NCT00408317|2389173|P2|Second Intervention Period|Protocol Violation|1
746813|NCT00408317|2389174|P1|Second Intervention Period|Protocol Violation|0
746814|NCT00408317|2389173|P2|Second Intervention Period|Adverse Event|0
746815|NCT00408317|2389174|P1|Second Intervention Period|Adverse Event|2
746816|NCT00408317|2389173|P2|First Intervention Period|Adverse Event|1
746817|NCT00408317|2389174|P1|First Intervention Period|Adverse Event|0
746818|NCT00408408|2389192|P6|Overall Study|No follow up data|3
746819|NCT00408408|2389193|P5|Overall Study|No follow up data|5
746820|NCT00408408|2389194|P4|Overall Study|No follow up data|7
746821|NCT00408408|2389195|P3|Overall Study|No follow up data|0
746822|NCT00408408|2389196|P2|Overall Study|No follow up data|3
746823|NCT00408408|2389197|P1|Overall Study|No follow up data|2
746824|NCT00408421|2389261|P3|Treatment Re-Randomization|Withdrawal by Subject|0
746825|NCT00408421|2389262|P2|Treatment Re-Randomization|Withdrawal by Subject|1
746826|NCT00408421|2389263|P1|Treatment Re-Randomization|Withdrawal by Subject|2
746827|NCT00408421|2389261|P3|Treatment Re-Randomization|Protocol Violation|0
746828|NCT00408421|2389262|P2|Treatment Re-Randomization|Protocol Violation|1
746829|NCT00408421|2389263|P1|Treatment Re-Randomization|Protocol Violation|1
746830|NCT00408421|2389261|P3|Treatment Re-Randomization|Physician Decision|0
746831|NCT00408421|2389262|P2|Treatment Re-Randomization|Physician Decision|3
746832|NCT00408421|2389263|P1|Treatment Re-Randomization|Physician Decision|1
746833|NCT00408421|2389261|P3|Treatment Re-Randomization|Lost to Follow-up|1
746834|NCT00408421|2389262|P2|Treatment Re-Randomization|Lost to Follow-up|0
746835|NCT00408421|2389263|P1|Treatment Re-Randomization|Lost to Follow-up|0
746836|NCT00408421|2389261|P3|Treatment Re-Randomization|Lack of Efficacy|0
746837|NCT00408421|2389262|P2|Treatment Re-Randomization|Lack of Efficacy|0
746838|NCT00408421|2389263|P1|Treatment Re-Randomization|Lack of Efficacy|1
746839|NCT00408421|2389261|P3|Treatment Re-Randomization|Adverse Event|4
746840|NCT00408421|2389262|P2|Treatment Re-Randomization|Adverse Event|2
746841|NCT00408421|2389263|P1|Treatment Re-Randomization|Adverse Event|2
746842|NCT00408421|2389261|P3|Treatment Initial Randomization|Sponsor Decision|0
746843|NCT00408421|2389262|P2|Treatment Initial Randomization|Sponsor Decision|0
746844|NCT00408421|2389263|P1|Treatment Initial Randomization|Sponsor Decision|1
746845|NCT00408421|2389261|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
746846|NCT00408421|2389262|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
746847|NCT00408421|2389263|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
746848|NCT00408421|2389261|P3|Treatment Initial Randomization|Withdrawal by Subject|0
746849|NCT00408421|2389262|P2|Treatment Initial Randomization|Withdrawal by Subject|7
746850|NCT00408421|2389263|P1|Treatment Initial Randomization|Withdrawal by Subject|7
746851|NCT00408421|2389261|P3|Treatment Initial Randomization|Protocol Violation|0
746852|NCT00408421|2389262|P2|Treatment Initial Randomization|Protocol Violation|1
746853|NCT00408421|2389263|P1|Treatment Initial Randomization|Protocol Violation|0
746854|NCT00408421|2389261|P3|Treatment Initial Randomization|Physician Decision|0
746855|NCT00408421|2389262|P2|Treatment Initial Randomization|Physician Decision|0
746856|NCT00408421|2389263|P1|Treatment Initial Randomization|Physician Decision|1
746857|NCT00408421|2389261|P3|Treatment Initial Randomization|Lost to Follow-up|0
746858|NCT00408421|2389262|P2|Treatment Initial Randomization|Lost to Follow-up|3
746859|NCT00408421|2389263|P1|Treatment Initial Randomization|Lost to Follow-up|0
746860|NCT00408421|2389261|P3|Treatment Initial Randomization|Lack of Efficacy|0
746861|NCT00408421|2389262|P2|Treatment Initial Randomization|Lack of Efficacy|2
746862|NCT00408421|2389263|P1|Treatment Initial Randomization|Lack of Efficacy|2
746863|NCT00408421|2389261|P3|Treatment Initial Randomization|Adverse Event|0
746864|NCT00408421|2389262|P2|Treatment Initial Randomization|Adverse Event|9
746865|NCT00408421|2389263|P1|Treatment Initial Randomization|Adverse Event|5
746866|NCT00408499|2389343|P5|Phase II- MTD Expansion|treatment delay|3
746867|NCT00408499|2389344|P4|Phase II- MTD Expansion|treatment delay|0
746868|NCT00408499|2389345|P3|Phase II- MTD Expansion|treatment delay|0
746869|NCT00408499|2389346|P2|Phase II- MTD Expansion|treatment delay|0
746870|NCT00408499|2389347|P1|Phase II- MTD Expansion|treatment delay|0
746871|NCT00408499|2389343|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
746872|NCT00408499|2389344|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
746873|NCT00408499|2389345|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
746874|NCT00408499|2389346|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
746875|NCT00408499|2389347|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
746876|NCT00408499|2389343|P5|Phase II- MTD Expansion|Physician Decision|1
746877|NCT00408499|2389344|P4|Phase II- MTD Expansion|Physician Decision|0
746878|NCT00408499|2389345|P3|Phase II- MTD Expansion|Physician Decision|0
746879|NCT00408499|2389346|P2|Phase II- MTD Expansion|Physician Decision|0
746880|NCT00408499|2389347|P1|Phase II- MTD Expansion|Physician Decision|0
746881|NCT00408499|2389343|P5|Phase II- MTD Expansion|Death|2
746882|NCT00408499|2389344|P4|Phase II- MTD Expansion|Death|0
746883|NCT00408499|2389345|P3|Phase II- MTD Expansion|Death|0
746884|NCT00408499|2389346|P2|Phase II- MTD Expansion|Death|0
746885|NCT00408499|2389347|P1|Phase II- MTD Expansion|Death|0
746886|NCT00408499|2389343|P5|Phase II- MTD Expansion|Adverse Event|9
746887|NCT00408499|2389344|P4|Phase II- MTD Expansion|Adverse Event|0
746888|NCT00408499|2389345|P3|Phase II- MTD Expansion|Adverse Event|0
746889|NCT00408499|2389346|P2|Phase II- MTD Expansion|Adverse Event|0
746890|NCT00408499|2389347|P1|Phase II- MTD Expansion|Adverse Event|0
746891|NCT00408499|2389343|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
746892|NCT00408499|2389344|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
746893|NCT00408499|2389345|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
746894|NCT00408499|2389346|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
746895|NCT00408499|2389347|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
746896|NCT00408499|2389343|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
746897|NCT00408499|2389344|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
746898|NCT00408499|2389345|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
746899|NCT00408499|2389346|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
746900|NCT00408499|2389347|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
746901|NCT00408499|2389343|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
746902|NCT00408499|2389344|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
746903|NCT00408499|2389345|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
746904|NCT00408499|2389346|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
746905|NCT00408499|2389347|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
746906|NCT00408629|2389406|P2|Overall Study|Miscellaneous|15
746907|NCT00408629|2389407|P1|Overall Study|Miscellaneous|11
746908|NCT00408629|2389406|P2|Overall Study|Protocol Violation|5
746909|NCT00408629|2389407|P1|Overall Study|Protocol Violation|1
746910|NCT00408629|2389406|P2|Overall Study|Lack of Efficacy|73
746911|NCT00408629|2389407|P1|Overall Study|Lack of Efficacy|63
746912|NCT00408629|2389406|P2|Overall Study|Lost to Follow-up|1
746913|NCT00408629|2389407|P1|Overall Study|Lost to Follow-up|1
746914|NCT00408629|2389406|P2|Overall Study|Withdrawal by Subject|4
746915|NCT00408629|2389407|P1|Overall Study|Withdrawal by Subject|8
746916|NCT00408629|2389406|P2|Overall Study|Adverse Event|27
746917|NCT00408629|2389407|P1|Overall Study|Adverse Event|13
746918|NCT00408681|2389446|P1|Overall Study|Adverse Event|7
746919|NCT00408681|2389446|P1|Overall Study|Lack of Efficacy|2
746922|NCT00408876|2389471|P4|Overall Study|Physician Decision|0
746923|NCT00408876|2389472|P3|Overall Study|Physician Decision|3
746924|NCT00408876|2389473|P2|Overall Study|Physician Decision|0
746925|NCT00408876|2389474|P1|Overall Study|Physician Decision|1
746926|NCT00408876|2389471|P4|Overall Study|Protocol Violation|3
746927|NCT00408876|2389472|P3|Overall Study|Protocol Violation|4
746928|NCT00408876|2389473|P2|Overall Study|Protocol Violation|3
746929|NCT00408876|2389474|P1|Overall Study|Protocol Violation|0
746930|NCT00408876|2389471|P4|Overall Study|Lost to Follow-up|2
746931|NCT00408876|2389472|P3|Overall Study|Lost to Follow-up|5
746932|NCT00408876|2389473|P2|Overall Study|Lost to Follow-up|6
746933|NCT00408876|2389474|P1|Overall Study|Lost to Follow-up|1
746934|NCT00408876|2389471|P4|Overall Study|Lack of Efficacy|6
746935|NCT00408876|2389472|P3|Overall Study|Lack of Efficacy|5
746936|NCT00408876|2389473|P2|Overall Study|Lack of Efficacy|4
746937|NCT00408876|2389474|P1|Overall Study|Lack of Efficacy|2
746938|NCT00408876|2389471|P4|Overall Study|Withdrawal by Subject|14
746939|NCT00408876|2389472|P3|Overall Study|Withdrawal by Subject|6
746940|NCT00408876|2389473|P2|Overall Study|Withdrawal by Subject|6
746941|NCT00408876|2389474|P1|Overall Study|Withdrawal by Subject|3
746942|NCT00408876|2389471|P4|Overall Study|Adverse Event|10
746943|NCT00408876|2389472|P3|Overall Study|Adverse Event|27
746944|NCT00408876|2389473|P2|Overall Study|Adverse Event|17
746945|NCT00408876|2389474|P1|Overall Study|Adverse Event|9
746948|NCT00408928|2389729|P1|Overall Study|Infection indistinguishable from GVHD|1
746949|NCT00408928|2389729|P1|Overall Study|Death|1
746950|NCT00408928|2389729|P1|Overall Study|Withdrawal by Subject|1
746951|NCT00408993|2389736|P2|Overall Study|Withdrawal by Subject|3
746952|NCT00408993|2389737|P1|Overall Study|Withdrawal by Subject|2
746953|NCT00408993|2389736|P2|Overall Study|Lack of Efficacy|4
746954|NCT00408993|2389737|P1|Overall Study|Lack of Efficacy|1
746955|NCT00408993|2389736|P2|Overall Study|Protocol Violation|6
746956|NCT00408993|2389737|P1|Overall Study|Protocol Violation|1
746957|NCT00408993|2389736|P2|Overall Study|Adverse Event|4
746958|NCT00408993|2389737|P1|Overall Study|Adverse Event|15
746959|NCT00409006|2389771|P2|Overall Study|Physician Decision|2
746960|NCT00409006|2389772|P1|Overall Study|Physician Decision|1
746961|NCT00409006|2389771|P2|Overall Study|Withdrawal by Subject|2
746962|NCT00409006|2389772|P1|Overall Study|Withdrawal by Subject|3
746963|NCT00409006|2389771|P2|Overall Study|Lost to Follow-up|2
746964|NCT00409006|2389772|P1|Overall Study|Lost to Follow-up|1
746965|NCT00409006|2389771|P2|Overall Study|Death|6
746966|NCT00409006|2389772|P1|Overall Study|Death|15
746967|NCT00409175|2389788|P2|Overall Study|Liver transplantation|13
746968|NCT00409175|2389789|P1|Overall Study|Liver transplantation|13
746969|NCT00409175|2389788|P2|Overall Study|Negative genotype|1
746970|NCT00409175|2389789|P1|Overall Study|Negative genotype|0
746971|NCT00409175|2389788|P2|Overall Study|Withdrawal by Subject|2
746972|NCT00409175|2389789|P1|Overall Study|Withdrawal by Subject|1
746973|NCT00409175|2389788|P2|Overall Study|Adverse Event|3
746974|NCT00409175|2389789|P1|Overall Study|Adverse Event|4
746975|NCT00409188|2389815|P2|Overall Study|Ongoing at data cut-off|175
746976|NCT00409188|2389816|P1|Overall Study|Ongoing at data cut-off|383
746977|NCT00409331|2389846|P1|Overall Study|Physician Decision|1
746978|NCT00409344|2389852|P2|Overall Study|no enrollment|0
746979|NCT00409344|2389853|P1|Overall Study|no enrollment|0
746980|NCT00409409|2389873|P2|Overall Study|Any other reason not above-mentioned|1
746981|NCT00409409|2389874|P1|Overall Study|Any other reason not above-mentioned|0
746982|NCT00409409|2389873|P2|Overall Study|Withdrawal by Subject|1
746983|NCT00409409|2389874|P1|Overall Study|Withdrawal by Subject|1
746984|NCT00409409|2389873|P2|Overall Study|Adverse Event|2
746985|NCT00409409|2389874|P1|Overall Study|Adverse Event|7
746986|NCT00409578|2389918|P4|Overall Study|Missing|1
746987|NCT00409578|2389919|P3|Overall Study|Missing|0
746988|NCT00409578|2389920|P2|Overall Study|Missing|1
746989|NCT00409578|2389921|P1|Overall Study|Missing|0
746990|NCT00409578|2389918|P4|Overall Study|Protocol Violation|1
746991|NCT00409578|2389919|P3|Overall Study|Protocol Violation|3
746992|NCT00409578|2389920|P2|Overall Study|Protocol Violation|2
746993|NCT00409578|2389921|P1|Overall Study|Protocol Violation|3
746994|NCT00409578|2389918|P4|Overall Study|Death|2
746995|NCT00409578|2389919|P3|Overall Study|Death|4
746996|NCT00409578|2389920|P2|Overall Study|Death|4
746997|NCT00409578|2389921|P1|Overall Study|Death|2
746998|NCT00409578|2389918|P4|Overall Study|Administrative problems|4
746999|NCT00409578|2389919|P3|Overall Study|Administrative problems|2
747000|NCT00409578|2389920|P2|Overall Study|Administrative problems|9
747001|NCT00409578|2389921|P1|Overall Study|Administrative problems|8
747002|NCT00409578|2389918|P4|Overall Study|Lost to Follow-up|2
747003|NCT00409578|2389919|P3|Overall Study|Lost to Follow-up|2
747004|NCT00409578|2389920|P2|Overall Study|Lost to Follow-up|0
747005|NCT00409578|2389921|P1|Overall Study|Lost to Follow-up|2
747006|NCT00409578|2389918|P4|Overall Study|Withdrawal by Subject|17
747007|NCT00409578|2389919|P3|Overall Study|Withdrawal by Subject|16
747008|NCT00409578|2389920|P2|Overall Study|Withdrawal by Subject|15
747009|NCT00409578|2389921|P1|Overall Study|Withdrawal by Subject|8
747010|NCT00409578|2389918|P4|Overall Study|Subject no longer requires study drug|1
747011|NCT00409578|2389919|P3|Overall Study|Subject no longer requires study drug|0
747012|NCT00409578|2389920|P2|Overall Study|Subject no longer requires study drug|0
747013|NCT00409578|2389921|P1|Overall Study|Subject no longer requires study drug|0
747014|NCT00409578|2389918|P4|Overall Study|Lack of Efficacy|2
747015|NCT00409578|2389919|P3|Overall Study|Lack of Efficacy|0
747016|NCT00409578|2389920|P2|Overall Study|Lack of Efficacy|0
747017|NCT00409578|2389921|P1|Overall Study|Lack of Efficacy|0
747018|NCT00409578|2389918|P4|Overall Study|Abnormal laboratory value(s)|4
747019|NCT00409578|2389919|P3|Overall Study|Abnormal laboratory value(s)|2
747020|NCT00409578|2389920|P2|Overall Study|Abnormal laboratory value(s)|2
747021|NCT00409578|2389921|P1|Overall Study|Abnormal laboratory value(s)|2
747022|NCT00409578|2389918|P4|Overall Study|Adverse Event|33
747023|NCT00409578|2389919|P3|Overall Study|Adverse Event|25
747024|NCT00409578|2389920|P2|Overall Study|Adverse Event|37
747025|NCT00409578|2389921|P1|Overall Study|Adverse Event|27
747026|NCT00409617|2389943|P1|Overall Study|Not described|14
747027|NCT00409617|2389943|P1|Overall Study|Administrative reasons|1
747028|NCT00409617|2389943|P1|Overall Study|Withdrawal by Subject|8
747029|NCT00409617|2389943|P1|Overall Study|Protocol Violation|24
747030|NCT00409617|2389943|P1|Overall Study|Lost to Follow-up|2
747031|NCT00409617|2389943|P1|Overall Study|Lack of Efficacy|54
747032|NCT00409617|2389943|P1|Overall Study|Adverse Event|57
747033|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Non-compliance|1
747034|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Non-compliance|0
747035|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Non-compliance|0
747036|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
747037|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
747038|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
747039|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
747040|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
747041|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
747042|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
747043|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
747044|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
747045|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
747046|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
747047|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
747048|NCT00409682|2389958|P3|EOW Double-blind Maintenance Period|Adverse Event|12
747049|NCT00409682|2389959|P2|EOW Double-blind Maintenance Period|Adverse Event|10
747050|NCT00409682|2389960|P1|EOW Double-blind Maintenance Period|Adverse Event|0
747051|NCT00409682|2389958|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
747052|NCT00409682|2389959|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
747053|NCT00409682|2389960|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
747054|NCT00409682|2389958|P3|Open-label Induction Period|Protocol Violation|0
747055|NCT00409682|2389959|P2|Open-label Induction Period|Protocol Violation|0
747056|NCT00409682|2389960|P1|Open-label Induction Period|Protocol Violation|1
747057|NCT00409682|2389958|P3|Open-label Induction Period|Lack of Efficacy|0
747058|NCT00409682|2389959|P2|Open-label Induction Period|Lack of Efficacy|0
747059|NCT00409682|2389960|P1|Open-label Induction Period|Lack of Efficacy|1
747060|NCT00409682|2389958|P3|Open-label Induction Period|Adverse Event|0
747061|NCT00409682|2389959|P2|Open-label Induction Period|Adverse Event|0
747062|NCT00409682|2389960|P1|Open-label Induction Period|Adverse Event|1
747063|NCT00409708|2389979|P2|Washout|Lost to Follow-up|3
747064|NCT00409708|2389980|P1|Washout|Lost to Follow-up|1
747065|NCT00409708|2389979|P2|Washout|Withdrawal by Subject|5
747066|NCT00409708|2389980|P1|Washout|Withdrawal by Subject|11
747067|NCT00409708|2389979|P2|Washout|Protocol Violation|1
747068|NCT00409708|2389980|P1|Washout|Protocol Violation|0
747069|NCT00409708|2389979|P2|Washout|Lack of Efficacy|1
747070|NCT00409708|2389980|P1|Washout|Lack of Efficacy|9
747071|NCT00409708|2389979|P2|Treatment|Administrative problems|0
747072|NCT00409708|2389980|P1|Treatment|Administrative problems|5
747073|NCT00409708|2389979|P2|Treatment|Lost to Follow-up|6
747074|NCT00409708|2389980|P1|Treatment|Lost to Follow-up|0
747075|NCT00409708|2389979|P2|Treatment|Withdrawal by Subject|8
747076|NCT00409708|2389980|P1|Treatment|Withdrawal by Subject|3
747077|NCT00409708|2389979|P2|Treatment|Protocol Violation|2
747078|NCT00409708|2389980|P1|Treatment|Protocol Violation|6
747079|NCT00409708|2389979|P2|Treatment|Lack of Efficacy|1
747080|NCT00409708|2389980|P1|Treatment|Lack of Efficacy|0
747081|NCT00409708|2389979|P2|Treatment|Abnormal test procedure result(s)|0
747082|NCT00409708|2389980|P1|Treatment|Abnormal test procedure result(s)|1
747083|NCT00409747|2389998|P1|Overall Study|Withdrawal by Subject|1
747084|NCT00409773|2390008|P5|Overall Study|Lack of Eligibility|1
747085|NCT00409773|2390009|P4|Overall Study|Lack of Eligibility|0
747086|NCT00409773|2390010|P3|Overall Study|Lack of Eligibility|0
747087|NCT00409773|2390011|P2|Overall Study|Lack of Eligibility|0
747088|NCT00409773|2390012|P1|Overall Study|Lack of Eligibility|0
747089|NCT00409773|2390008|P5|Overall Study|Withdrawal by Subject|1
747090|NCT00409773|2390009|P4|Overall Study|Withdrawal by Subject|2
747091|NCT00409773|2390010|P3|Overall Study|Withdrawal by Subject|0
747092|NCT00409773|2390011|P2|Overall Study|Withdrawal by Subject|0
747093|NCT00409773|2390012|P1|Overall Study|Withdrawal by Subject|0
747094|NCT00409773|2390008|P5|Overall Study|Protocol Violation|1
747095|NCT00409773|2390009|P4|Overall Study|Protocol Violation|3
747096|NCT00409773|2390010|P3|Overall Study|Protocol Violation|3
747097|NCT00409773|2390011|P2|Overall Study|Protocol Violation|2
747098|NCT00409773|2390012|P1|Overall Study|Protocol Violation|0
747099|NCT00409773|2390008|P5|Overall Study|Physician Decision|0
747100|NCT00409773|2390009|P4|Overall Study|Physician Decision|2
747101|NCT00409773|2390010|P3|Overall Study|Physician Decision|0
747102|NCT00409773|2390011|P2|Overall Study|Physician Decision|0
747103|NCT00409773|2390012|P1|Overall Study|Physician Decision|0
747104|NCT00409773|2390008|P5|Overall Study|Lost to Follow-up|1
747105|NCT00409773|2390009|P4|Overall Study|Lost to Follow-up|3
747106|NCT00409773|2390010|P3|Overall Study|Lost to Follow-up|2
747107|NCT00409773|2390011|P2|Overall Study|Lost to Follow-up|1
747108|NCT00409773|2390012|P1|Overall Study|Lost to Follow-up|6
747109|NCT00409773|2390008|P5|Overall Study|Adverse Event|6
747110|NCT00409773|2390009|P4|Overall Study|Adverse Event|2
747111|NCT00409773|2390010|P3|Overall Study|Adverse Event|4
747112|NCT00409773|2390011|P2|Overall Study|Adverse Event|4
747113|NCT00409773|2390012|P1|Overall Study|Adverse Event|3
747114|NCT00409786|2390094|P1|Overall Study|Withdrawal by Subject|3
747115|NCT00409838|2390104|P2|Long-term Extension Period|Pregnancy|0
747116|NCT00409838|2390105|P1|Long-term Extension Period|Pregnancy|1
747117|NCT00409838|2390104|P2|Long-term Extension Period|Poor compliance/noncompliance|0
747118|NCT00409838|2390105|P1|Long-term Extension Period|Poor compliance/noncompliance|1
747119|NCT00409838|2390104|P2|Long-term Extension Period|Withdrawal by Subject|0
747120|NCT00409838|2390105|P1|Long-term Extension Period|Withdrawal by Subject|3
747121|NCT00409838|2390104|P2|Long-term Extension Period|Lack of Efficacy|0
747122|NCT00409838|2390105|P1|Long-term Extension Period|Lack of Efficacy|2
747123|NCT00409838|2390104|P2|Long-term Extension Period|Death|0
747124|NCT00409838|2390105|P1|Long-term Extension Period|Death|1
747125|NCT00409838|2390104|P2|Long-term Extension Period|Adverse Event|0
747126|NCT00409838|2390105|P1|Long-term Extension Period|Adverse Event|10
747127|NCT00409838|2390104|P2|Short-term Period|Never Treated|0
747128|NCT00409838|2390105|P1|Short-term Period|Never Treated|1
747129|NCT00409838|2390104|P2|Short-term Period|Withdrawal by Subject|3
747130|NCT00409838|2390105|P1|Short-term Period|Withdrawal by Subject|2
747131|NCT00409838|2390104|P2|Short-term Period|Lost to Follow-up|1
747132|NCT00409838|2390105|P1|Short-term Period|Lost to Follow-up|0
747133|NCT00409838|2390104|P2|Short-term Period|Adverse Event|1
747134|NCT00409838|2390105|P1|Short-term Period|Adverse Event|0
747135|NCT00410046|2390166|P1|Overall Study|Lost to Follow-up|1
747136|NCT00410046|2390166|P1|Overall Study|Withdrawal by Subject|1
747137|NCT00410046|2390166|P1|Overall Study|Adverse Event|3
747138|NCT00410072|2390201|P2|After Week 48 to Week 96|Withdrawal by Subject|1
747139|NCT00410072|2390202|P1|After Week 48 to Week 96|Withdrawal by Subject|0
747140|NCT00410072|2390201|P2|After Week 48 to Week 96|Pregnancy|2
747141|NCT00410072|2390202|P1|After Week 48 to Week 96|Pregnancy|0
747142|NCT00410072|2390201|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
747143|NCT00410072|2390202|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
747144|NCT00410072|2390201|P2|After Week 48 to Week 96|Not specified|0
747145|NCT00410072|2390202|P1|After Week 48 to Week 96|Not specified|2
747146|NCT00410072|2390201|P2|After Week 48 to Week 96|Lost to Follow-up|4
747147|NCT00410072|2390202|P1|After Week 48 to Week 96|Lost to Follow-up|2
747148|NCT00410072|2390201|P2|After Week 48 to Week 96|Lack of Efficacy|0
747149|NCT00410072|2390202|P1|After Week 48 to Week 96|Lack of Efficacy|1
747150|NCT00410072|2390201|P2|After Week 48 to Week 96|Death|1
747151|NCT00410072|2390202|P1|After Week 48 to Week 96|Death|0
747152|NCT00410072|2390201|P2|After Week 48 to Week 96|Adverse Event|2
747153|NCT00410072|2390202|P1|After Week 48 to Week 96|Adverse Event|1
747154|NCT00410072|2390201|P2|Day 1 to Week 48|Withdrawal by Subject|2
747155|NCT00410072|2390202|P1|Day 1 to Week 48|Withdrawal by Subject|0
747156|NCT00410072|2390201|P2|Day 1 to Week 48|Pregnancy|2
747157|NCT00410072|2390202|P1|Day 1 to Week 48|Pregnancy|0
747158|NCT00410072|2390201|P2|Day 1 to Week 48|poor compliance/noncompliance|3
747159|NCT00410072|2390202|P1|Day 1 to Week 48|poor compliance/noncompliance|0
747160|NCT00410072|2390201|P2|Day 1 to Week 48|Not specified|1
747161|NCT00410072|2390202|P1|Day 1 to Week 48|Not specified|0
747162|NCT00410072|2390201|P2|Day 1 to Week 48|Lost to Follow-up|2
747163|NCT00410072|2390202|P1|Day 1 to Week 48|Lost to Follow-up|5
747164|NCT00410072|2390201|P2|Day 1 to Week 48|Adverse Event|2
747165|NCT00410072|2390202|P1|Day 1 to Week 48|Adverse Event|1
747166|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
747167|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
747168|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
747169|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
747170|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
747171|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
747172|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Death|10
747173|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Death|2
747174|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
747175|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
747176|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
747177|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
747178|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
747179|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
747180|NCT00410124|2390240|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
747181|NCT00410124|2390241|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
747182|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
747183|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
747184|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Death|4
747185|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Death|7
747186|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
747187|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
747188|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
747189|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
747190|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
747191|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
747192|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
747193|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
747194|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
747195|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
747196|NCT00410124|2390240|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
747197|NCT00410124|2390241|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
747198|NCT00410163|2390281|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
747199|NCT00410163|2390282|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
747200|NCT00410163|2390281|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
747201|NCT00410163|2390282|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
747202|NCT00410163|2390281|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
747203|NCT00410163|2390282|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
747204|NCT00410163|2390281|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
747205|NCT00410163|2390282|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
747206|NCT00410163|2390281|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
747207|NCT00410163|2390282|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
747208|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
747209|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
747210|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
747211|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
747212|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
747213|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
747214|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
747215|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
747216|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
747217|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
747218|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
747219|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
747220|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
747221|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
747222|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Death|1
747223|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Death|1
747224|NCT00410163|2390281|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
747225|NCT00410163|2390282|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
747226|NCT00410202|2390332|P3|Off-treatment Follow up|Lost to Follow-up|0
747227|NCT00410202|2390333|P2|Off-treatment Follow up|Lost to Follow-up|0
747228|NCT00410202|2390334|P1|Off-treatment Follow up|Lost to Follow-up|1
747229|NCT00410202|2390332|P3|Off-treatment Follow up|Follow up not required per protocol|1
747230|NCT00410202|2390333|P2|Off-treatment Follow up|Follow up not required per protocol|0
747231|NCT00410202|2390334|P1|Off-treatment Follow up|Follow up not required per protocol|3
747232|NCT00410202|2390332|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
747233|NCT00410202|2390333|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
747234|NCT00410202|2390334|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
747235|NCT00410202|2390332|P3|On-Treatment|Other Reason|1
747236|NCT00410202|2390333|P2|On-Treatment|Other Reason|0
747237|NCT00410202|2390334|P1|On-Treatment|Other Reason|0
747238|NCT00410202|2390332|P3|On-Treatment|Withdrawal by Subject|1
747239|NCT00410202|2390333|P2|On-Treatment|Withdrawal by Subject|1
747240|NCT00410202|2390334|P1|On-Treatment|Withdrawal by Subject|2
747241|NCT00410202|2390332|P3|On-Treatment|Lack of Efficacy|0
747242|NCT00410202|2390333|P2|On-Treatment|Lack of Efficacy|4
747243|NCT00410202|2390334|P1|On-Treatment|Lack of Efficacy|1
747244|NCT00410202|2390332|P3|On-Treatment|Lost to Follow-up|1
747245|NCT00410202|2390333|P2|On-Treatment|Lost to Follow-up|0
747246|NCT00410202|2390334|P1|On-Treatment|Lost to Follow-up|1
747247|NCT00410202|2390332|P3|On-Treatment|Death|0
747248|NCT00410202|2390333|P2|On-Treatment|Death|0
747249|NCT00410202|2390334|P1|On-Treatment|Death|1
747250|NCT00410202|2390332|P3|On-Treatment|Adverse Event|2
747251|NCT00410202|2390333|P2|On-Treatment|Adverse Event|3
747252|NCT00410202|2390334|P1|On-Treatment|Adverse Event|1
747253|NCT00410202|2390332|P3|On-Treatment|Continuing treatment|66
747254|NCT00410202|2390333|P2|On-Treatment|Continuing treatment|71
747255|NCT00410202|2390334|P1|On-Treatment|Continuing treatment|69
747256|NCT00403455|2390475|P1|Overall Study|Withdrawal by Subject|1
747257|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
747258|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
747259|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
747260|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
747261|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
747262|NCT00403481|2390479|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
747263|NCT00403481|2390479|P1|Olm 40 mg|Other|1
747264|NCT00403481|2390479|P1|Olm 40 mg|Withdrawal by Subject|1
747265|NCT00403481|2390479|P1|Olm 40 mg|Protocol Violation|1
747266|NCT00403481|2390479|P1|Olm 40 mg|Adverse Event|2
747267|NCT00403481|2390479|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
747268|NCT00403481|2390479|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
747269|NCT00403481|2390479|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
747270|NCT00403481|2390479|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
747271|NCT00403546|2390496|P3|Randomized Trial|Early Terminations|16
747272|NCT00403546|2390497|P2|Randomized Trial|Early Terminations|17
747273|NCT00403546|2390498|P1|Randomized Trial|Early Terminations|0
747274|NCT00403546|2390496|P3|Screening Phase|Terminated Prior to Randomization|0
747275|NCT00403546|2390497|P2|Screening Phase|Terminated Prior to Randomization|0
747276|NCT00403546|2390498|P1|Screening Phase|Terminated Prior to Randomization|5
747277|NCT00403546|2390496|P3|Screening Phase|Adverse Event|0
747278|NCT00403546|2390497|P2|Screening Phase|Adverse Event|0
747279|NCT00403546|2390498|P1|Screening Phase|Adverse Event|1
747280|NCT00403546|2390496|P3|Screening Phase|Screening Failure|0
747281|NCT00403546|2390497|P2|Screening Phase|Screening Failure|0
747282|NCT00403546|2390498|P1|Screening Phase|Screening Failure|22
747283|NCT00403546|2390496|P3|Signed Informed Consent/Open-Label|Adverse Event|0
747284|NCT00403546|2390497|P2|Signed Informed Consent/Open-Label|Adverse Event|0
747285|NCT00403546|2390498|P1|Signed Informed Consent/Open-Label|Adverse Event|5
747286|NCT00403546|2390496|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
747287|NCT00403546|2390497|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
747288|NCT00403546|2390498|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
747289|NCT00403546|2390496|P3|Signed Informed Consent/Open-Label|Early Termination|0
747290|NCT00403546|2390497|P2|Signed Informed Consent/Open-Label|Early Termination|0
747291|NCT00403546|2390498|P1|Signed Informed Consent/Open-Label|Early Termination|8
747292|NCT00403546|2390496|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
747293|NCT00403546|2390497|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
747294|NCT00403546|2390498|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
747295|NCT00410384|2390541|P3|Overall Study|Other|4
747296|NCT00410384|2390542|P2|Overall Study|Other|8
747297|NCT00410384|2390543|P1|Overall Study|Other|3
747298|NCT00410384|2390541|P3|Overall Study|Physician Decision|4
747299|NCT00410384|2390542|P2|Overall Study|Physician Decision|3
747300|NCT00410384|2390543|P1|Overall Study|Physician Decision|3
747301|NCT00410384|2390541|P3|Overall Study|Protocol Violation|6
747302|NCT00410384|2390542|P2|Overall Study|Protocol Violation|6
747303|NCT00410384|2390543|P1|Overall Study|Protocol Violation|6
747304|NCT00410384|2390541|P3|Overall Study|Lost to Follow-up|6
747305|NCT00410384|2390542|P2|Overall Study|Lost to Follow-up|6
747306|NCT00410384|2390543|P1|Overall Study|Lost to Follow-up|4
747307|NCT00410384|2390541|P3|Overall Study|Lack of Compliance|2
747308|NCT00410384|2390542|P2|Overall Study|Lack of Compliance|2
747309|NCT00410384|2390543|P1|Overall Study|Lack of Compliance|2
747310|NCT00410384|2390541|P3|Overall Study|Lack of Efficacy|17
747311|NCT00410384|2390542|P2|Overall Study|Lack of Efficacy|12
747312|NCT00410384|2390543|P1|Overall Study|Lack of Efficacy|20
747313|NCT00410384|2390541|P3|Overall Study|Adverse Event|23
747314|NCT00410384|2390542|P2|Overall Study|Adverse Event|18
747315|NCT00410384|2390543|P1|Overall Study|Adverse Event|23
747316|NCT00410384|2390541|P3|Overall Study|Withdrawal by Subject|20
747317|NCT00410384|2390542|P2|Overall Study|Withdrawal by Subject|17
747318|NCT00410384|2390543|P1|Overall Study|Withdrawal by Subject|28
747319|NCT00410410|2390575|P9|Open-Label Period (OL)|not specified|7
747320|NCT00410410|2390576|P8|Open-Label Period (OL)|not specified|0
747321|NCT00410410|2390577|P7|Open-Label Period (OL)|not specified|0
747322|NCT00410410|2390578|P6|Open-Label Period (OL)|not specified|0
747323|NCT00410410|2390579|P5|Open-Label Period (OL)|not specified|0
747324|NCT00410410|2390580|P4|Open-Label Period (OL)|not specified|0
747325|NCT00410410|2390581|P3|Open-Label Period (OL)|not specified|0
747326|NCT00410410|2390582|P2|Open-Label Period (OL)|not specified|0
747327|NCT00410410|2390583|P1|Open-Label Period (OL)|not specified|0
747328|NCT00410410|2390575|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
747329|NCT00410410|2390576|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747330|NCT00410410|2390577|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747331|NCT00410410|2390578|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747332|NCT00410410|2390579|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747333|NCT00410410|2390580|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747334|NCT00410410|2390581|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747335|NCT00410410|2390582|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747336|NCT00410410|2390583|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
747337|NCT00410410|2390575|P9|Open-Label Period (OL)|Pregnancy|1
747338|NCT00410410|2390576|P8|Open-Label Period (OL)|Pregnancy|0
747339|NCT00410410|2390577|P7|Open-Label Period (OL)|Pregnancy|0
747340|NCT00410410|2390578|P6|Open-Label Period (OL)|Pregnancy|0
747341|NCT00410410|2390579|P5|Open-Label Period (OL)|Pregnancy|0
747342|NCT00410410|2390580|P4|Open-Label Period (OL)|Pregnancy|0
747343|NCT00410410|2390581|P3|Open-Label Period (OL)|Pregnancy|0
747344|NCT00410410|2390582|P2|Open-Label Period (OL)|Pregnancy|0
747345|NCT00410410|2390583|P1|Open-Label Period (OL)|Pregnancy|0
747346|NCT00410410|2390575|P9|Open-Label Period (OL)|Withdrawal by Subject|20
747347|NCT00410410|2390576|P8|Open-Label Period (OL)|Withdrawal by Subject|0
747348|NCT00410410|2390577|P7|Open-Label Period (OL)|Withdrawal by Subject|0
747349|NCT00410410|2390578|P6|Open-Label Period (OL)|Withdrawal by Subject|0
747350|NCT00410410|2390579|P5|Open-Label Period (OL)|Withdrawal by Subject|0
747351|NCT00410410|2390580|P4|Open-Label Period (OL)|Withdrawal by Subject|0
747352|NCT00410410|2390581|P3|Open-Label Period (OL)|Withdrawal by Subject|0
747353|NCT00410410|2390582|P2|Open-Label Period (OL)|Withdrawal by Subject|0
747354|NCT00410410|2390583|P1|Open-Label Period (OL)|Withdrawal by Subject|0
747355|NCT00410410|2390575|P9|Open-Label Period (OL)|Lost to Follow-up|4
747356|NCT00410410|2390576|P8|Open-Label Period (OL)|Lost to Follow-up|0
747357|NCT00410410|2390577|P7|Open-Label Period (OL)|Lost to Follow-up|0
747358|NCT00410410|2390578|P6|Open-Label Period (OL)|Lost to Follow-up|0
747359|NCT00410410|2390579|P5|Open-Label Period (OL)|Lost to Follow-up|0
747360|NCT00410410|2390580|P4|Open-Label Period (OL)|Lost to Follow-up|0
747361|NCT00410410|2390581|P3|Open-Label Period (OL)|Lost to Follow-up|0
747362|NCT00410410|2390582|P2|Open-Label Period (OL)|Lost to Follow-up|0
747363|NCT00410410|2390583|P1|Open-Label Period (OL)|Lost to Follow-up|0
747364|NCT00410410|2390575|P9|Open-Label Period (OL)|Lack of Efficacy|161
747365|NCT00410410|2390576|P8|Open-Label Period (OL)|Lack of Efficacy|0
747366|NCT00410410|2390577|P7|Open-Label Period (OL)|Lack of Efficacy|0
747367|NCT00410410|2390578|P6|Open-Label Period (OL)|Lack of Efficacy|0
747368|NCT00410410|2390579|P5|Open-Label Period (OL)|Lack of Efficacy|0
747369|NCT00410410|2390580|P4|Open-Label Period (OL)|Lack of Efficacy|0
747370|NCT00410410|2390581|P3|Open-Label Period (OL)|Lack of Efficacy|0
747371|NCT00410410|2390582|P2|Open-Label Period (OL)|Lack of Efficacy|0
747372|NCT00410410|2390583|P1|Open-Label Period (OL)|Lack of Efficacy|0
747373|NCT00410410|2390575|P9|Open-Label Period (OL)|Adverse Event|10
747374|NCT00410410|2390576|P8|Open-Label Period (OL)|Adverse Event|0
747375|NCT00410410|2390577|P7|Open-Label Period (OL)|Adverse Event|0
747376|NCT00410410|2390578|P6|Open-Label Period (OL)|Adverse Event|0
747377|NCT00410410|2390579|P5|Open-Label Period (OL)|Adverse Event|0
747378|NCT00410410|2390580|P4|Open-Label Period (OL)|Adverse Event|0
747379|NCT00410410|2390581|P3|Open-Label Period (OL)|Adverse Event|0
747380|NCT00410410|2390582|P2|Open-Label Period (OL)|Adverse Event|0
747381|NCT00410410|2390583|P1|Open-Label Period (OL)|Adverse Event|0
747382|NCT00410410|2390575|P9|Open-Label Period (OL)|Death|1
747383|NCT00410410|2390576|P8|Open-Label Period (OL)|Death|0
747384|NCT00410410|2390577|P7|Open-Label Period (OL)|Death|0
747385|NCT00410410|2390578|P6|Open-Label Period (OL)|Death|0
747386|NCT00410410|2390579|P5|Open-Label Period (OL)|Death|0
747387|NCT00410410|2390580|P4|Open-Label Period (OL)|Death|0
747388|NCT00410410|2390581|P3|Open-Label Period (OL)|Death|0
747389|NCT00410410|2390582|P2|Open-Label Period (OL)|Death|0
747390|NCT00410410|2390583|P1|Open-Label Period (OL)|Death|0
747391|NCT00410410|2390575|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747392|NCT00410410|2390576|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
747393|NCT00410410|2390577|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
747394|NCT00410410|2390578|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747395|NCT00410410|2390579|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747396|NCT00410410|2390580|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747397|NCT00410410|2390581|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747398|NCT00410410|2390582|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747399|NCT00410410|2390583|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
747400|NCT00410410|2390575|P9|Maintenance Period (MP)|Withdrawal by Subject|0
747401|NCT00410410|2390576|P8|Maintenance Period (MP)|Withdrawal by Subject|1
747402|NCT00410410|2390577|P7|Maintenance Period (MP)|Withdrawal by Subject|1
747403|NCT00410410|2390578|P6|Maintenance Period (MP)|Withdrawal by Subject|0
747404|NCT00410410|2390579|P5|Maintenance Period (MP)|Withdrawal by Subject|0
747405|NCT00410410|2390580|P4|Maintenance Period (MP)|Withdrawal by Subject|0
747406|NCT00410410|2390581|P3|Maintenance Period (MP)|Withdrawal by Subject|0
747407|NCT00410410|2390582|P2|Maintenance Period (MP)|Withdrawal by Subject|0
747408|NCT00410410|2390583|P1|Maintenance Period (MP)|Withdrawal by Subject|0
747409|NCT00410410|2390575|P9|Maintenance Period (MP)|Lost to Follow-up|0
747410|NCT00410410|2390576|P8|Maintenance Period (MP)|Lost to Follow-up|2
747411|NCT00410410|2390577|P7|Maintenance Period (MP)|Lost to Follow-up|1
747412|NCT00410410|2390578|P6|Maintenance Period (MP)|Lost to Follow-up|0
747413|NCT00410410|2390579|P5|Maintenance Period (MP)|Lost to Follow-up|0
747414|NCT00410410|2390580|P4|Maintenance Period (MP)|Lost to Follow-up|0
747415|NCT00410410|2390581|P3|Maintenance Period (MP)|Lost to Follow-up|0
747416|NCT00410410|2390582|P2|Maintenance Period (MP)|Lost to Follow-up|0
747417|NCT00410410|2390583|P1|Maintenance Period (MP)|Lost to Follow-up|0
747418|NCT00410410|2390575|P9|Maintenance Period (MP)|Lack of Efficacy|0
747419|NCT00410410|2390576|P8|Maintenance Period (MP)|Lack of Efficacy|24
747420|NCT00410410|2390577|P7|Maintenance Period (MP)|Lack of Efficacy|25
747421|NCT00410410|2390578|P6|Maintenance Period (MP)|Lack of Efficacy|0
747422|NCT00410410|2390579|P5|Maintenance Period (MP)|Lack of Efficacy|0
747423|NCT00410410|2390580|P4|Maintenance Period (MP)|Lack of Efficacy|0
747424|NCT00410410|2390581|P3|Maintenance Period (MP)|Lack of Efficacy|0
747425|NCT00410410|2390582|P2|Maintenance Period (MP)|Lack of Efficacy|0
747426|NCT00410410|2390583|P1|Maintenance Period (MP)|Lack of Efficacy|0
747427|NCT00410410|2390575|P9|Maintenance Period (MP)|Adverse Event|0
747428|NCT00410410|2390576|P8|Maintenance Period (MP)|Adverse Event|3
747429|NCT00410410|2390577|P7|Maintenance Period (MP)|Adverse Event|1
747430|NCT00410410|2390578|P6|Maintenance Period (MP)|Adverse Event|0
747431|NCT00410410|2390579|P5|Maintenance Period (MP)|Adverse Event|0
747432|NCT00410410|2390580|P4|Maintenance Period (MP)|Adverse Event|0
747433|NCT00410410|2390581|P3|Maintenance Period (MP)|Adverse Event|0
747434|NCT00410410|2390582|P2|Maintenance Period (MP)|Adverse Event|0
747435|NCT00410410|2390583|P1|Maintenance Period (MP)|Adverse Event|0
747436|NCT00410410|2390575|P9|Maintenance Period (MP)|Death|0
747437|NCT00410410|2390576|P8|Maintenance Period (MP)|Death|0
747438|NCT00410410|2390577|P7|Maintenance Period (MP)|Death|1
747439|NCT00410410|2390578|P6|Maintenance Period (MP)|Death|0
747440|NCT00410410|2390579|P5|Maintenance Period (MP)|Death|0
747441|NCT00410410|2390580|P4|Maintenance Period (MP)|Death|0
747442|NCT00410410|2390581|P3|Maintenance Period (MP)|Death|0
747443|NCT00410410|2390582|P2|Maintenance Period (MP)|Death|0
747444|NCT00410410|2390583|P1|Maintenance Period (MP)|Death|0
747445|NCT00410410|2390575|P9|Induction Period (IP)|not specified|0
747446|NCT00410410|2390576|P8|Induction Period (IP)|not specified|0
747447|NCT00410410|2390577|P7|Induction Period (IP)|not specified|0
747448|NCT00410410|2390578|P6|Induction Period (IP)|not specified|0
747449|NCT00410410|2390579|P5|Induction Period (IP)|not specified|0
747450|NCT00410410|2390580|P4|Induction Period (IP)|not specified|0
747451|NCT00410410|2390581|P3|Induction Period (IP)|not specified|1
747452|NCT00410410|2390582|P2|Induction Period (IP)|not specified|0
747453|NCT00410410|2390583|P1|Induction Period (IP)|not specified|0
747454|NCT00410410|2390575|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
747455|NCT00410410|2390576|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
747456|NCT00410410|2390577|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
747457|NCT00410410|2390578|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
747458|NCT00410410|2390579|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
747459|NCT00410410|2390580|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
747460|NCT00410410|2390581|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
747461|NCT00410410|2390582|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
747462|NCT00410410|2390583|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
747463|NCT00410410|2390575|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747464|NCT00410410|2390576|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747465|NCT00410410|2390577|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747466|NCT00410410|2390578|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747467|NCT00410410|2390579|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747468|NCT00410410|2390580|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747469|NCT00410410|2390581|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
747470|NCT00410410|2390582|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747471|NCT00410410|2390583|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
747472|NCT00410410|2390575|P9|Induction Period (IP)|Withdrawal by Subject|0
747473|NCT00410410|2390576|P8|Induction Period (IP)|Withdrawal by Subject|0
747474|NCT00410410|2390577|P7|Induction Period (IP)|Withdrawal by Subject|0
747475|NCT00410410|2390578|P6|Induction Period (IP)|Withdrawal by Subject|0
747476|NCT00410410|2390579|P5|Induction Period (IP)|Withdrawal by Subject|2
747477|NCT00410410|2390580|P4|Induction Period (IP)|Withdrawal by Subject|5
747478|NCT00410410|2390581|P3|Induction Period (IP)|Withdrawal by Subject|3
747479|NCT00410410|2390582|P2|Induction Period (IP)|Withdrawal by Subject|5
747480|NCT00410410|2390583|P1|Induction Period (IP)|Withdrawal by Subject|3
747481|NCT00410410|2390575|P9|Induction Period (IP)|Lost to Follow-up|0
747482|NCT00410410|2390576|P8|Induction Period (IP)|Lost to Follow-up|0
747483|NCT00410410|2390577|P7|Induction Period (IP)|Lost to Follow-up|0
747484|NCT00410410|2390578|P6|Induction Period (IP)|Lost to Follow-up|1
747485|NCT00410410|2390579|P5|Induction Period (IP)|Lost to Follow-up|0
747486|NCT00410410|2390580|P4|Induction Period (IP)|Lost to Follow-up|3
747487|NCT00410410|2390581|P3|Induction Period (IP)|Lost to Follow-up|2
747488|NCT00410410|2390582|P2|Induction Period (IP)|Lost to Follow-up|2
747489|NCT00410410|2390583|P1|Induction Period (IP)|Lost to Follow-up|2
747490|NCT00410410|2390575|P9|Induction Period (IP)|Lack of Efficacy|0
747491|NCT00410410|2390576|P8|Induction Period (IP)|Lack of Efficacy|0
747492|NCT00410410|2390577|P7|Induction Period (IP)|Lack of Efficacy|0
747493|NCT00410410|2390578|P6|Induction Period (IP)|Lack of Efficacy|7
747494|NCT00410410|2390579|P5|Induction Period (IP)|Lack of Efficacy|7
747495|NCT00410410|2390580|P4|Induction Period (IP)|Lack of Efficacy|8
747496|NCT00410410|2390581|P3|Induction Period (IP)|Lack of Efficacy|8
747497|NCT00410410|2390582|P2|Induction Period (IP)|Lack of Efficacy|24
747498|NCT00410410|2390583|P1|Induction Period (IP)|Lack of Efficacy|26
747499|NCT00410410|2390575|P9|Induction Period (IP)|Adverse Event|0
747500|NCT00410410|2390576|P8|Induction Period (IP)|Adverse Event|0
747501|NCT00410410|2390577|P7|Induction Period (IP)|Adverse Event|0
747502|NCT00410410|2390578|P6|Induction Period (IP)|Adverse Event|0
747503|NCT00410410|2390579|P5|Induction Period (IP)|Adverse Event|1
747504|NCT00410410|2390580|P4|Induction Period (IP)|Adverse Event|4
747505|NCT00410410|2390581|P3|Induction Period (IP)|Adverse Event|2
747506|NCT00410410|2390582|P2|Induction Period (IP)|Adverse Event|4
747507|NCT00410410|2390583|P1|Induction Period (IP)|Adverse Event|3
747508|NCT00410410|2390575|P9|Induction Period (IP)|Death|0
747509|NCT00410410|2390576|P8|Induction Period (IP)|Death|0
747510|NCT00410410|2390577|P7|Induction Period (IP)|Death|0
747511|NCT00410410|2390578|P6|Induction Period (IP)|Death|0
747512|NCT00410410|2390579|P5|Induction Period (IP)|Death|0
747513|NCT00410410|2390580|P4|Induction Period (IP)|Death|0
747514|NCT00410410|2390581|P3|Induction Period (IP)|Death|0
747515|NCT00410410|2390582|P2|Induction Period (IP)|Death|0
747516|NCT00410410|2390583|P1|Induction Period (IP)|Death|1
747517|NCT00410514|2390752|P3|Overall Study|Non-compliant with study procedures|2
747518|NCT00410514|2390753|P2|Overall Study|Non-compliant with study procedures|0
747519|NCT00410514|2390754|P1|Overall Study|Non-compliant with study procedures|0
747520|NCT00410514|2390752|P3|Overall Study|Lost to Follow-up|2
747521|NCT00410514|2390753|P2|Overall Study|Lost to Follow-up|0
747522|NCT00410514|2390754|P1|Overall Study|Lost to Follow-up|0
747523|NCT00410514|2390752|P3|Overall Study|Protocol Violation|1
747524|NCT00410514|2390753|P2|Overall Study|Protocol Violation|1
747525|NCT00410514|2390754|P1|Overall Study|Protocol Violation|0
747526|NCT00410514|2390752|P3|Overall Study|Adverse Event|2
747527|NCT00410514|2390753|P2|Overall Study|Adverse Event|2
747528|NCT00410514|2390754|P1|Overall Study|Adverse Event|2
747529|NCT00410605|2390813|P1|Overall Study|Transferred to another Institution|1
747530|NCT00410605|2390813|P1|Overall Study|Stopped treatmen to collect stem cells|1
747531|NCT00410605|2390813|P1|Overall Study|Started Non-Protocol Therapy|3
747532|NCT00410605|2390813|P1|Overall Study|Withdrawal by Subject|5
747533|NCT00410605|2390813|P1|Overall Study|Physician Decision|3
747534|NCT00410605|2390813|P1|Overall Study|Adverse Event|12
747535|NCT00411151|2390846|P1|Overall Study|Trial prematurely closed|4
747536|NCT00411151|2390846|P1|Overall Study|Protocol Violation|1
747537|NCT00411151|2390846|P1|Overall Study|Lost to Follow-up|2
747538|NCT00411151|2390846|P1|Overall Study|Withdrawal by Subject|2
747539|NCT00411151|2390846|P1|Overall Study|Death|38
747540|NCT00411216|2390858|P2|Overall Study|Ten participants were entered into the c|2
747541|NCT00411216|2390859|P1|Overall Study|Ten participants were entered into the c|0
747542|NCT00411450|2390880|P1|Overall Study|Ongoing at time of data cut-off.|3
747543|NCT00411554|2390924|P2|Overall Study|Patient Moved|0
747544|NCT00411554|2390925|P1|Overall Study|Patient Moved|1
747545|NCT00411554|2390924|P2|Overall Study|Withdrawal by Subject|0
747546|NCT00411554|2390925|P1|Overall Study|Withdrawal by Subject|3
747547|NCT00411554|2390924|P2|Overall Study|Lack of Efficacy|5
747548|NCT00411554|2390925|P1|Overall Study|Lack of Efficacy|2
747549|NCT00411554|2390924|P2|Overall Study|Adverse Event|4
747550|NCT00411554|2390925|P1|Overall Study|Adverse Event|2
747551|NCT00411645|2390942|P2|Overall Study|Lost to Follow-up|0
747552|NCT00411645|2390943|P1|Overall Study|Lost to Follow-up|2
747553|NCT00411645|2390942|P2|Overall Study|Investigator/Sponsor Decision|7
747554|NCT00411645|2390943|P1|Overall Study|Investigator/Sponsor Decision|10
747555|NCT00411645|2390942|P2|Overall Study|Death|135
747556|NCT00411645|2390943|P1|Overall Study|Death|56
747557|NCT00411645|2390942|P2|Overall Study|Consent Withdrawn|22
747558|NCT00411645|2390943|P1|Overall Study|Consent Withdrawn|13
747559|NCT00411671|2390967|P1|Overall Study|Lost to Follow-up|3
747560|NCT00411671|2390967|P1|Overall Study|Death|2
747561|NCT00411671|2390967|P1|Overall Study|Adverse Event|15
747562|NCT00411762|2390992|P1|Overall Study|Withdrawal by Subject|5
747563|NCT00411788|2390997|P1|Overall Study|Adverse Event|1
747564|NCT00411788|2390997|P1|Overall Study|Protocol Violation|1
747565|NCT00412061|2391008|P2|Open Label Phase|New Cancer Therapy|1
747566|NCT00412061|2391009|P1|Open Label Phase|New Cancer Therapy|0
747567|NCT00412061|2391008|P2|Open Label Phase|Lost to Follow-up|2
747568|NCT00412061|2391009|P1|Open Label Phase|Lost to Follow-up|0
747569|NCT00412061|2391008|P2|Open Label Phase|Death|7
747570|NCT00412061|2391009|P1|Open Label Phase|Death|0
747571|NCT00412061|2391008|P2|Open Label Phase|Administrative Problems|13
747572|NCT00412061|2391009|P1|Open Label Phase|Administrative Problems|0
747573|NCT00412061|2391008|P2|Open Label Phase|Withdrawal by Subject|15
747574|NCT00412061|2391009|P1|Open Label Phase|Withdrawal by Subject|0
747575|NCT00412061|2391008|P2|Open Label Phase|Adverse Event|46
747576|NCT00412061|2391009|P1|Open Label Phase|Adverse Event|0
747577|NCT00412061|2391008|P2|Open Label Phase|Disease Progression|86
747578|NCT00412061|2391009|P1|Open Label Phase|Disease Progression|0
747579|NCT00412061|2391008|P2|Double Blind Phase|Lost to Follow-up|1
747580|NCT00412061|2391009|P1|Double Blind Phase|Lost to Follow-up|0
747581|NCT00412061|2391008|P2|Double Blind Phase|New Cander Therapy|1
747582|NCT00412061|2391009|P1|Double Blind Phase|New Cander Therapy|1
747583|NCT00412061|2391008|P2|Double Blind Phase|Protocol Violation|4
747584|NCT00412061|2391009|P1|Double Blind Phase|Protocol Violation|3
747585|NCT00412061|2391008|P2|Double Blind Phase|Death|3
747586|NCT00412061|2391009|P1|Double Blind Phase|Death|6
747587|NCT00412061|2391008|P2|Double Blind Phase|Withdrawal by Subject|20
747588|NCT00412061|2391009|P1|Double Blind Phase|Withdrawal by Subject|18
747589|NCT00412061|2391008|P2|Double Blind Phase|Final Primary Analysis|14
747590|NCT00412061|2391009|P1|Double Blind Phase|Final Primary Analysis|26
747591|NCT00412061|2391008|P2|Double Blind Phase|Adverse Event|16
747592|NCT00412061|2391009|P1|Double Blind Phase|Adverse Event|61
747593|NCT00412061|2391008|P2|Double Blind Phase|Disease Progression|154
747594|NCT00412061|2391009|P1|Double Blind Phase|Disease Progression|101
747595|NCT00412113|2391059|P2|Overall Study|did not receive treatment|0
747596|NCT00412113|2391060|P1|Overall Study|did not receive treatment|1
747597|NCT00412113|2391059|P2|Overall Study|Adverse Event|15
747598|NCT00412113|2391060|P1|Overall Study|Adverse Event|11
747599|NCT00412217|2391114|P2|Overall Study|Not Specified|1
747600|NCT00412217|2391115|P1|Overall Study|Not Specified|1
747601|NCT00412217|2391114|P2|Overall Study|Study Terminated by Sponsor|33
747602|NCT00412217|2391115|P1|Overall Study|Study Terminated by Sponsor|26
747603|NCT00412217|2391114|P2|Overall Study|Lost to Follow-up|4
747604|NCT00412217|2391115|P1|Overall Study|Lost to Follow-up|1
747605|NCT00412217|2391114|P2|Overall Study|Withdrawal by Subject|0
747606|NCT00412217|2391115|P1|Overall Study|Withdrawal by Subject|2
747607|NCT00412217|2391114|P2|Overall Study|Investigator Decision|0
747608|NCT00412217|2391115|P1|Overall Study|Investigator Decision|1
747609|NCT00412217|2391114|P2|Overall Study|Disease Progression|3
747610|NCT00412217|2391115|P1|Overall Study|Disease Progression|2
747611|NCT00412217|2391114|P2|Overall Study|Death|4
747612|NCT00412217|2391115|P1|Overall Study|Death|5
747613|NCT00412217|2391114|P2|Overall Study|Insufficient Data Available|3
747614|NCT00412217|2391115|P1|Overall Study|Insufficient Data Available|8
747615|NCT00412373|2391160|P2|Overall Study|Not Specified|2
747616|NCT00412373|2391161|P1|Overall Study|Not Specified|2
747617|NCT00412373|2391160|P2|Overall Study|Withdrawal by Subject|27
747618|NCT00412373|2391161|P1|Overall Study|Withdrawal by Subject|8
747619|NCT00412373|2391160|P2|Overall Study|Lost to Follow-up|13
747620|NCT00412373|2391161|P1|Overall Study|Lost to Follow-up|7
747621|NCT00412373|2391160|P2|Overall Study|Lack of Efficacy|22
747622|NCT00412373|2391161|P1|Overall Study|Lack of Efficacy|16
747623|NCT00412373|2391160|P2|Overall Study|Adverse Event|13
747624|NCT00412373|2391161|P1|Overall Study|Adverse Event|8
747625|NCT00412542|2391282|P2|Overall Study|Not Eligible|1
747626|NCT00412542|2391283|P1|Overall Study|Not Eligible|0
747627|NCT00412542|2391282|P2|Overall Study|Withdrawal by Subject|2
747628|NCT00412542|2391283|P1|Overall Study|Withdrawal by Subject|0
747629|NCT00412607|2391287|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
747630|NCT00412607|2391287|P1|Overall Study|Death|61
747631|NCT00412607|2391287|P1|Overall Study|Lost to Follow-up|19
747632|NCT00412607|2391287|P1|Overall Study|Withdrawal by Subject|9
747633|NCT00412737|2391300|P2|Overall Study|Failure to Return|2
747634|NCT00412737|2391301|P1|Overall Study|Failure to Return|6
747635|NCT00412737|2391300|P2|Overall Study|Refused Treatment|2
747636|NCT00412737|2391301|P1|Overall Study|Refused Treatment|6
747637|NCT00412737|2391300|P2|Overall Study|Adverse Event|2
747638|NCT00412737|2391301|P1|Overall Study|Adverse Event|3
747639|NCT00412737|2391300|P2|Overall Study|Death|0
747640|NCT00412737|2391301|P1|Overall Study|Death|1
747641|NCT00412750|2391322|P3|Overall Study|Lack of Efficacy|3
747642|NCT00412750|2391323|P2|Overall Study|Lack of Efficacy|0
747643|NCT00412750|2391324|P1|Overall Study|Lack of Efficacy|0
747644|NCT00412750|2391322|P3|Overall Study|Withdrawal by Subject|2
747645|NCT00412750|2391323|P2|Overall Study|Withdrawal by Subject|1
747646|NCT00412750|2391324|P1|Overall Study|Withdrawal by Subject|0
747647|NCT00412750|2391322|P3|Overall Study|Lost to Follow-up|1
747648|NCT00412750|2391323|P2|Overall Study|Lost to Follow-up|0
747649|NCT00412750|2391324|P1|Overall Study|Lost to Follow-up|1
747650|NCT00412750|2391322|P3|Overall Study|Adverse Event|3
747651|NCT00412750|2391323|P2|Overall Study|Adverse Event|3
747652|NCT00412750|2391324|P1|Overall Study|Adverse Event|8
747653|NCT00412750|2391322|P3|Overall Study|Administrative problems|14
747654|NCT00412750|2391323|P2|Overall Study|Administrative problems|17
747655|NCT00412750|2391324|P1|Overall Study|Administrative problems|21
747656|NCT00412750|2391322|P3|Overall Study|Abnormal laboratory value(s)|0
747657|NCT00412750|2391323|P2|Overall Study|Abnormal laboratory value(s)|0
747658|NCT00412750|2391324|P1|Overall Study|Abnormal laboratory value(s)|1
747659|NCT00412854|2391360|P2|Overall Study|Withdrawn for other reasons|11
747660|NCT00412854|2391361|P1|Overall Study|Withdrawn for other reasons|13
747661|NCT00412854|2391360|P2|Overall Study|Withdrawn due to adverse events|5
747662|NCT00412854|2391361|P1|Overall Study|Withdrawn due to adverse events|1
747663|NCT00412893|2391396|P2|Overall Study|Randomized but Never Received Study Drug|6
747664|NCT00412893|2391397|P1|Overall Study|Randomized but Never Received Study Drug|5
747665|NCT00412893|2391396|P2|Overall Study|Administrative Reason|15
747666|NCT00412893|2391397|P1|Overall Study|Administrative Reason|12
747667|NCT00412893|2391396|P2|Overall Study|Did Not Cooperate|9
747668|NCT00412893|2391397|P1|Overall Study|Did Not Cooperate|12
747669|NCT00412893|2391396|P2|Overall Study|Other Protocol Violation|6
747670|NCT00412893|2391397|P1|Overall Study|Other Protocol Violation|10
747671|NCT00412893|2391396|P2|Overall Study|Violation of Selection at Entry|10
747672|NCT00412893|2391397|P1|Overall Study|Violation of Selection at Entry|17
747673|NCT00412893|2391396|P2|Overall Study|Lost to Follow-up|1
747674|NCT00412893|2391397|P1|Overall Study|Lost to Follow-up|2
747675|NCT00412893|2391396|P2|Overall Study|Insufficient Therapeutic Response|23
747676|NCT00412893|2391397|P1|Overall Study|Insufficient Therapeutic Response|39
747677|NCT00412893|2391396|P2|Overall Study|Death|21
747678|NCT00412893|2391397|P1|Overall Study|Death|17
747679|NCT00412893|2391396|P2|Overall Study|Adverse Event|53
747680|NCT00412893|2391397|P1|Overall Study|Adverse Event|31
747681|NCT00412932|2391423|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
747682|NCT00412932|2391423|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
747683|NCT00412932|2391423|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
747684|NCT00412932|2391423|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
747685|NCT00412932|2391423|P1|Olmesartan 40 mg|Withdrawal by Subject|1
747686|NCT00412932|2391423|P1|Olmesartan 40 mg|Lack of Efficacy|3
747687|NCT00412932|2391423|P1|Olmesartan 40 mg|Adverse Event|4
747688|NCT00412932|2391423|P1|Olmesartan (Olm) 20 mg|Other|1
747689|NCT00412932|2391423|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
747690|NCT00412932|2391423|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
747691|NCT00412932|2391423|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
747692|NCT00412932|2391423|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
747693|NCT00412958|2391436|P4|Overall Study|Transport issue|0
747694|NCT00412958|2391437|P3|Overall Study|Transport issue|0
747695|NCT00412958|2391438|P2|Overall Study|Transport issue|1
747696|NCT00412958|2391439|P1|Overall Study|Transport issue|0
747697|NCT00412958|2391436|P4|Overall Study|Death|0
747698|NCT00412958|2391437|P3|Overall Study|Death|0
747699|NCT00412958|2391438|P2|Overall Study|Death|1
747700|NCT00412958|2391439|P1|Overall Study|Death|0
747701|NCT00412958|2391436|P4|Overall Study|Lost to Follow-up|0
747702|NCT00412958|2391437|P3|Overall Study|Lost to Follow-up|0
747703|NCT00412958|2391438|P2|Overall Study|Lost to Follow-up|1
747704|NCT00412958|2391439|P1|Overall Study|Lost to Follow-up|0
747705|NCT00412958|2391436|P4|Overall Study|Adverse Event|0
747706|NCT00412958|2391437|P3|Overall Study|Adverse Event|0
747707|NCT00412958|2391438|P2|Overall Study|Adverse Event|1
747708|NCT00412958|2391439|P1|Overall Study|Adverse Event|0
747709|NCT00412958|2391436|P4|Overall Study|Withdrawal by Subject|1
747710|NCT00412958|2391437|P3|Overall Study|Withdrawal by Subject|0
747711|NCT00412958|2391438|P2|Overall Study|Withdrawal by Subject|0
747712|NCT00412958|2391439|P1|Overall Study|Withdrawal by Subject|3
747713|NCT00412971|2391451|P2|Overall Study|Protocol Violation|1
747714|NCT00412971|2391452|P1|Overall Study|Protocol Violation|13
747715|NCT00412971|2391451|P2|Overall Study|Lost to Follow-up|9
747716|NCT00412971|2391452|P1|Overall Study|Lost to Follow-up|17
747717|NCT00412984|2391463|P2|Overall Study|Not Reported|12
747718|NCT00412984|2391464|P1|Overall Study|Not Reported|11
747719|NCT00412984|2391463|P2|Overall Study|Other Reason|92
747720|NCT00412984|2391464|P1|Overall Study|Other Reason|80
747721|NCT00412984|2391463|P2|Overall Study|Physician Refused to Continue Treatment|89
747722|NCT00412984|2391464|P1|Overall Study|Physician Refused to Continue Treatment|81
747723|NCT00412984|2391463|P2|Overall Study|Administrative Reason by Sponsor|8
747724|NCT00412984|2391464|P1|Overall Study|Administrative Reason by Sponsor|11
747725|NCT00412984|2391463|P2|Overall Study|Subject No Longer Meets Study Criteria|100
747726|NCT00412984|2391464|P1|Overall Study|Subject No Longer Meets Study Criteria|87
747727|NCT00412984|2391463|P2|Overall Study|Pregnancy|0
747728|NCT00412984|2391464|P1|Overall Study|Pregnancy|1
747729|NCT00412984|2391463|P2|Overall Study|Poor/Noncompliance|77
747730|NCT00412984|2391464|P1|Overall Study|Poor/Noncompliance|57
747731|NCT00412984|2391463|P2|Overall Study|Lost to Follow-up|39
747732|NCT00412984|2391464|P1|Overall Study|Lost to Follow-up|51
747733|NCT00412984|2391463|P2|Overall Study|Withdrawal by Subject|989
747734|NCT00412984|2391464|P1|Overall Study|Withdrawal by Subject|921
747735|NCT00412984|2391463|P2|Overall Study|Adverse Event|738
747736|NCT00412984|2391464|P1|Overall Study|Adverse Event|679
747737|NCT00412984|2391463|P2|Overall Study|Death|349
747738|NCT00412984|2391464|P1|Overall Study|Death|331
747739|NCT00413010|2391508|P2|Overall Study|Due to termination of the study|52
747740|NCT00413010|2391509|P1|Overall Study|Due to termination of the study|54
747741|NCT00413010|2391508|P2|Overall Study|Withdrawal by Subject|2
747742|NCT00413010|2391509|P1|Overall Study|Withdrawal by Subject|7
747743|NCT00413010|2391508|P2|Overall Study|Lost to Follow-up|0
747744|NCT00413010|2391509|P1|Overall Study|Lost to Follow-up|3
747745|NCT00413010|2391508|P2|Overall Study|Lack of Efficacy|3
747746|NCT00413010|2391509|P1|Overall Study|Lack of Efficacy|0
747747|NCT00413010|2391508|P2|Overall Study|Laboratory abnormality|2
747748|NCT00413010|2391509|P1|Overall Study|Laboratory abnormality|0
747749|NCT00413010|2391508|P2|Overall Study|Adverse Event|4
747750|NCT00413010|2391509|P1|Overall Study|Adverse Event|8
747751|NCT00413036|2391529|P1|Overall Study|Missing|2
747752|NCT00413036|2391529|P1|Overall Study|Unspecified|26
747753|NCT00413036|2391529|P1|Overall Study|Death|9
747754|NCT00413036|2391529|P1|Overall Study|Withdrawal by Subject|7
747755|NCT00413036|2391529|P1|Overall Study|Lack of Efficacy|129
747756|NCT00413036|2391529|P1|Overall Study|Adverse Event|44
747757|NCT00413049|2391539|P2|Overall Study|Lack of Efficacy|0
747758|NCT00413049|2391540|P1|Overall Study|Lack of Efficacy|1
747759|NCT00413049|2391539|P2|Overall Study|Abnormal laboratory value(s)|0
747760|NCT00413049|2391540|P1|Overall Study|Abnormal laboratory value(s)|1
747761|NCT00413049|2391539|P2|Overall Study|Subject no longer requires study drug|1
747762|NCT00413049|2391540|P1|Overall Study|Subject no longer requires study drug|0
747763|NCT00413049|2391539|P2|Overall Study|Protocol Violation|1
747764|NCT00413049|2391540|P1|Overall Study|Protocol Violation|3
747765|NCT00413049|2391539|P2|Overall Study|Lost to Follow-up|3
747766|NCT00413049|2391540|P1|Overall Study|Lost to Follow-up|2
747767|NCT00413049|2391539|P2|Overall Study|Withdrawal by Subject|5
747768|NCT00413049|2391540|P1|Overall Study|Withdrawal by Subject|7
747769|NCT00413049|2391539|P2|Overall Study|Adverse Event|8
747770|NCT00413049|2391540|P1|Overall Study|Adverse Event|10
747771|NCT00413062|2391558|P2|Overall Study|Other reason|34
747772|NCT00413062|2391559|P1|Overall Study|Other reason|70
747773|NCT00413062|2391558|P2|Overall Study|Lost to Follow-up|73
747774|NCT00413062|2391559|P1|Overall Study|Lost to Follow-up|175
747775|NCT00413062|2391558|P2|Overall Study|Pregnancy wish|6
747776|NCT00413062|2391559|P1|Overall Study|Pregnancy wish|17
747777|NCT00413062|2391558|P2|Overall Study|Pregnancy|5
747778|NCT00413062|2391559|P1|Overall Study|Pregnancy|15
747779|NCT00413062|2391558|P2|Overall Study|Withdrawal of informed consent|36
747780|NCT00413062|2391559|P1|Overall Study|Withdrawal of informed consent|111
747781|NCT00413062|2391558|P2|Overall Study|Pre-treatment (serious) adverse event|0
747782|NCT00413062|2391559|P1|Overall Study|Pre-treatment (serious) adverse event|1
747783|NCT00413062|2391558|P2|Overall Study|Adverse event/serious adverse event|56
747784|NCT00413062|2391559|P1|Overall Study|Adverse event/serious adverse event|289
747785|NCT00413153|2391585|P2|Overall Study|Adverse Event|0
747786|NCT00413153|2391586|P1|Overall Study|Adverse Event|1
747787|NCT00413153|2391585|P2|Overall Study|Withdrawal by Subject|1
747788|NCT00413153|2391586|P1|Overall Study|Withdrawal by Subject|1
747789|NCT00413192|2391612|P4|Overall Study|Not treated|1
747790|NCT00413192|2391613|P3|Overall Study|Not treated|0
747791|NCT00413192|2391614|P2|Overall Study|Not treated|0
747792|NCT00413192|2391615|P1|Overall Study|Not treated|0
747793|NCT00413192|2391612|P4|Overall Study|Not specified|2
747794|NCT00413192|2391613|P3|Overall Study|Not specified|1
747795|NCT00413192|2391614|P2|Overall Study|Not specified|1
747796|NCT00413192|2391615|P1|Overall Study|Not specified|5
747797|NCT00413192|2391612|P4|Overall Study|Intercurrent death|0
747798|NCT00413192|2391613|P3|Overall Study|Intercurrent death|0
747799|NCT00413192|2391614|P2|Overall Study|Intercurrent death|1
747800|NCT00413192|2391615|P1|Overall Study|Intercurrent death|0
747801|NCT00413192|2391612|P4|Overall Study|Intercurrent illness|1
747802|NCT00413192|2391613|P3|Overall Study|Intercurrent illness|0
747803|NCT00413192|2391614|P2|Overall Study|Intercurrent illness|0
747804|NCT00413192|2391615|P1|Overall Study|Intercurrent illness|0
747805|NCT00413192|2391612|P4|Overall Study|Withdrawal by Subject|1
747806|NCT00413192|2391613|P3|Overall Study|Withdrawal by Subject|0
747807|NCT00413192|2391614|P2|Overall Study|Withdrawal by Subject|5
747808|NCT00413192|2391615|P1|Overall Study|Withdrawal by Subject|3
747809|NCT00413192|2391612|P4|Overall Study|Toxicity|2
747810|NCT00413192|2391613|P3|Overall Study|Toxicity|2
747811|NCT00413192|2391614|P2|Overall Study|Toxicity|2
747812|NCT00413192|2391615|P1|Overall Study|Toxicity|3
747813|NCT00413192|2391612|P4|Overall Study|Disease progression|25
747814|NCT00413192|2391613|P3|Overall Study|Disease progression|16
747815|NCT00413192|2391614|P2|Overall Study|Disease progression|31
747816|NCT00413192|2391615|P1|Overall Study|Disease progression|26
747817|NCT00413218|2391655|P2|Overall Study|Withdrawal by Subject|1
747818|NCT00413218|2391656|P1|Overall Study|Withdrawal by Subject|9
747819|NCT00413218|2391655|P2|Overall Study|Missing|0
747820|NCT00413218|2391656|P1|Overall Study|Missing|1
747821|NCT00413218|2391655|P2|Overall Study|Admin|14
747822|NCT00413218|2391656|P1|Overall Study|Admin|20
747823|NCT00413218|2391655|P2|Overall Study|Lost to Follow-up|17
747824|NCT00413218|2391656|P1|Overall Study|Lost to Follow-up|14
747825|NCT00413218|2391655|P2|Overall Study|Death|56
747826|NCT00413218|2391656|P1|Overall Study|Death|57
747827|NCT00413218|2391655|P2|Overall Study|Randomized but didn't receive study drug|8
747828|NCT00413218|2391656|P1|Overall Study|Randomized but didn't receive study drug|2
747829|NCT00413231|2391678|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
747830|NCT00413231|2391678|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
747831|NCT00413231|2391678|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
747832|NCT00413231|2391678|P1|365-day to 60-month Post Treatment|Death|36
747833|NCT00413231|2391678|P1|30-day to 365-day Post Treatment|Death|13
747834|NCT00413231|2391678|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
747835|NCT00413231|2391678|P1|0 to 30-day Post Treatment|Death|5
747836|NCT00413244|2391710|P2|Overall Study|Withdrawal by Subject|1
747837|NCT00413244|2391711|P1|Overall Study|Withdrawal by Subject|10
747838|NCT00413283|2391743|P4|Overall Study|Not specified|0
747839|NCT00413283|2391744|P3|Overall Study|Not specified|1
747840|NCT00413283|2391745|P2|Overall Study|Not specified|0
747841|NCT00413283|2391746|P1|Overall Study|Not specified|0
747842|NCT00413283|2391743|P4|Overall Study|Requirement for alternative therapy|0
747843|NCT00413283|2391744|P3|Overall Study|Requirement for alternative therapy|0
747844|NCT00413283|2391745|P2|Overall Study|Requirement for alternative therapy|2
747845|NCT00413283|2391746|P1|Overall Study|Requirement for alternative therapy|0
747846|NCT00413283|2391743|P4|Overall Study|Protocol deviation|0
747847|NCT00413283|2391744|P3|Overall Study|Protocol deviation|0
747848|NCT00413283|2391745|P2|Overall Study|Protocol deviation|1
747849|NCT00413283|2391746|P1|Overall Study|Protocol deviation|0
747850|NCT00413283|2391743|P4|Overall Study|Ineligibility determined|1
747851|NCT00413283|2391744|P3|Overall Study|Ineligibility determined|0
747852|NCT00413283|2391745|P2|Overall Study|Ineligibility determined|0
747853|NCT00413283|2391746|P1|Overall Study|Ineligibility determined|0
747854|NCT00413283|2391743|P4|Overall Study|Adverse Event|1
747855|NCT00413283|2391744|P3|Overall Study|Adverse Event|0
747856|NCT00413283|2391745|P2|Overall Study|Adverse Event|0
747857|NCT00413283|2391746|P1|Overall Study|Adverse Event|0
747858|NCT00413283|2391743|P4|Overall Study|Death|1
747859|NCT00413283|2391744|P3|Overall Study|Death|1
747860|NCT00413283|2391745|P2|Overall Study|Death|0
747861|NCT00413283|2391746|P1|Overall Study|Death|0
747862|NCT00413283|2391743|P4|Overall Study|Withdrawal by Subject|1
747863|NCT00413283|2391744|P3|Overall Study|Withdrawal by Subject|0
747864|NCT00413283|2391745|P2|Overall Study|Withdrawal by Subject|0
747865|NCT00413283|2391746|P1|Overall Study|Withdrawal by Subject|1
747866|NCT00413374|2391793|P1|Overall Study|Surgery|1
747867|NCT00413374|2391793|P1|Overall Study|Lost to Follow-up|1
747868|NCT00413374|2391793|P1|Overall Study|Adverse Event|1
747869|NCT00413374|2391793|P1|Overall Study|Ineligible due to screening criteria.|3
747870|NCT00413413|2391832|P3|Double-Blind|Lost to Follow-up|2
747871|NCT00413413|2391833|P2|Double-Blind|Lost to Follow-up|4
747872|NCT00413413|2391834|P1|Double-Blind|Lost to Follow-up|3
747873|NCT00413413|2391832|P3|Double-Blind|Subject withdrew consent|9
747874|NCT00413413|2391833|P2|Double-Blind|Subject withdrew consent|6
747875|NCT00413413|2391834|P1|Double-Blind|Subject withdrew consent|4
747876|NCT00413413|2391832|P3|Double-Blind|Protocol deviation|1
747877|NCT00413413|2391833|P2|Double-Blind|Protocol deviation|2
747878|NCT00413413|2391834|P1|Double-Blind|Protocol deviation|1
747879|NCT00413413|2391832|P3|Double-Blind|Unsatisfactory therapeutic effect|1
747880|NCT00413413|2391833|P2|Double-Blind|Unsatisfactory therapeutic effect|2
747881|NCT00413413|2391834|P1|Double-Blind|Unsatisfactory therapeutic effect|1
747882|NCT00413413|2391832|P3|Double-Blind|Adverse Event|5
747883|NCT00413413|2391833|P2|Double-Blind|Adverse Event|0
747884|NCT00413413|2391834|P1|Double-Blind|Adverse Event|6
747885|NCT00413413|2391832|P3|Single-Blind|Lost to Follow-up|0
747886|NCT00413413|2391833|P2|Single-Blind|Lost to Follow-up|8
747887|NCT00413413|2391834|P1|Single-Blind|Lost to Follow-up|0
747888|NCT00413413|2391832|P3|Single-Blind|Withdrawal by Subject|0
747889|NCT00413413|2391833|P2|Single-Blind|Withdrawal by Subject|27
747890|NCT00413413|2391834|P1|Single-Blind|Withdrawal by Subject|0
747891|NCT00413413|2391832|P3|Single-Blind|Protocol Violation|0
747892|NCT00413413|2391833|P2|Single-Blind|Protocol Violation|16
747893|NCT00413413|2391834|P1|Single-Blind|Protocol Violation|0
747894|NCT00413413|2391832|P3|Single-Blind|Subject no longer requires study drug|0
747895|NCT00413413|2391833|P2|Single-Blind|Subject no longer requires study drug|151
747896|NCT00413413|2391834|P1|Single-Blind|Subject no longer requires study drug|0
747897|NCT00413413|2391832|P3|Single-Blind|Lack of Efficacy|0
747898|NCT00413413|2391833|P2|Single-Blind|Lack of Efficacy|5
747899|NCT00413413|2391834|P1|Single-Blind|Lack of Efficacy|0
747900|NCT00413413|2391832|P3|Single-Blind|Adverse Event|0
747901|NCT00413413|2391833|P2|Single-Blind|Adverse Event|9
747902|NCT00413413|2391834|P1|Single-Blind|Adverse Event|0
747903|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
747904|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
747905|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
747906|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
747907|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|non-compliance|2
747908|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|non-compliance|3
747909|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
747910|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
747911|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Physician Decision|0
747912|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Physician Decision|1
747913|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Failed to Return|0
747914|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Failed to Return|1
747915|NCT00406640|2391856|P2|OL Extension Phase for Non-Responders|Adverse Event|6
747916|NCT00406640|2391857|P1|OL Extension Phase for Non-Responders|Adverse Event|6
747917|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
747918|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
747919|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
747920|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
747921|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Protocol Violation|2
747922|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Protocol Violation|2
747923|NCT00406640|2391856|P2|DB Continuation Phase for Responders|non-compliance|5
747924|NCT00406640|2391857|P1|DB Continuation Phase for Responders|non-compliance|7
747925|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
747926|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
747927|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Physician Decision|3
747928|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Physician Decision|2
747929|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Failed to Return|2
747930|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Failed to Return|0
747931|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Death|0
747932|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Death|1
747933|NCT00406640|2391856|P2|DB Continuation Phase for Responders|Adverse Event|11
747934|NCT00406640|2391857|P1|DB Continuation Phase for Responders|Adverse Event|11
747935|NCT00406640|2391856|P2|Acute Phase|Lack of Efficacy|3
747936|NCT00406640|2391857|P1|Acute Phase|Lack of Efficacy|3
747937|NCT00406640|2391856|P2|Acute Phase|Withdrawal by Subject|9
747938|NCT00406640|2391857|P1|Acute Phase|Withdrawal by Subject|11
747939|NCT00406640|2391856|P2|Acute Phase|Protocol Violation|2
747940|NCT00406640|2391857|P1|Acute Phase|Protocol Violation|3
747941|NCT00406640|2391856|P2|Acute Phase|Protocol deviation|10
747942|NCT00406640|2391857|P1|Acute Phase|Protocol deviation|4
747943|NCT00406640|2391856|P2|Acute Phase|Lost to Follow-up|4
747944|NCT00406640|2391857|P1|Acute Phase|Lost to Follow-up|7
747945|NCT00406640|2391856|P2|Acute Phase|Physician Decision|1
747946|NCT00406640|2391857|P1|Acute Phase|Physician Decision|0
747947|NCT00406640|2391856|P2|Acute Phase|Failed to Return|1
747948|NCT00406640|2391857|P1|Acute Phase|Failed to Return|5
747949|NCT00406640|2391856|P2|Acute Phase|Adverse Event|13
747950|NCT00406640|2391857|P1|Acute Phase|Adverse Event|18
747951|NCT00406653|2391891|P7|Open-Label Period|Refused followup|1
747952|NCT00406653|2391892|P6|Open-Label Period|Refused followup|0
747953|NCT00406653|2391893|P5|Open-Label Period|Refused followup|0
747954|NCT00406653|2391894|P4|Open-Label Period|Refused followup|0
747955|NCT00406653|2391895|P3|Open-Label Period|Refused followup|0
747956|NCT00406653|2391896|P2|Open-Label Period|Refused followup|0
747957|NCT00406653|2391897|P1|Open-Label Period|Refused followup|0
747958|NCT00406653|2391891|P7|Open-Label Period|Discontinued by Sponsor|1
747959|NCT00406653|2391892|P6|Open-Label Period|Discontinued by Sponsor|0
747960|NCT00406653|2391893|P5|Open-Label Period|Discontinued by Sponsor|0
747961|NCT00406653|2391894|P4|Open-Label Period|Discontinued by Sponsor|0
747962|NCT00406653|2391895|P3|Open-Label Period|Discontinued by Sponsor|0
747963|NCT00406653|2391896|P2|Open-Label Period|Discontinued by Sponsor|0
747964|NCT00406653|2391897|P1|Open-Label Period|Discontinued by Sponsor|0
747965|NCT00406653|2391891|P7|Open-Label Period|Declined participation but followup done|8
747966|NCT00406653|2391892|P6|Open-Label Period|Declined participation but followup done|0
747967|NCT00406653|2391893|P5|Open-Label Period|Declined participation but followup done|0
747968|NCT00406653|2391894|P4|Open-Label Period|Declined participation but followup done|0
747969|NCT00406653|2391895|P3|Open-Label Period|Declined participation but followup done|0
747970|NCT00406653|2391896|P2|Open-Label Period|Declined participation but followup done|0
747971|NCT00406653|2391897|P1|Open-Label Period|Declined participation but followup done|0
747972|NCT00406653|2391891|P7|Open-Label Period|Administrative Reason By Sponsor|115
747973|NCT00406653|2391892|P6|Open-Label Period|Administrative Reason By Sponsor|0
747974|NCT00406653|2391893|P5|Open-Label Period|Administrative Reason By Sponsor|0
747975|NCT00406653|2391894|P4|Open-Label Period|Administrative Reason By Sponsor|0
747976|NCT00406653|2391895|P3|Open-Label Period|Administrative Reason By Sponsor|0
747977|NCT00406653|2391896|P2|Open-Label Period|Administrative Reason By Sponsor|0
747978|NCT00406653|2391897|P1|Open-Label Period|Administrative Reason By Sponsor|0
747979|NCT00406653|2391891|P7|Open-Label Period|Pregnancy|2
747980|NCT00406653|2391892|P6|Open-Label Period|Pregnancy|0
747981|NCT00406653|2391893|P5|Open-Label Period|Pregnancy|0
747982|NCT00406653|2391894|P4|Open-Label Period|Pregnancy|0
747983|NCT00406653|2391895|P3|Open-Label Period|Pregnancy|0
747984|NCT00406653|2391896|P2|Open-Label Period|Pregnancy|0
747985|NCT00406653|2391897|P1|Open-Label Period|Pregnancy|0
747986|NCT00406653|2391891|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
747987|NCT00406653|2391892|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
747988|NCT00406653|2391893|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
747989|NCT00406653|2391894|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
747990|NCT00406653|2391895|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
747991|NCT00406653|2391896|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
747992|NCT00406653|2391897|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
747993|NCT00406653|2391891|P7|Open-Label Period|Withdrawal of Consent|11
747994|NCT00406653|2391892|P6|Open-Label Period|Withdrawal of Consent|0
747995|NCT00406653|2391893|P5|Open-Label Period|Withdrawal of Consent|0
747996|NCT00406653|2391894|P4|Open-Label Period|Withdrawal of Consent|0
747997|NCT00406653|2391895|P3|Open-Label Period|Withdrawal of Consent|0
747998|NCT00406653|2391896|P2|Open-Label Period|Withdrawal of Consent|0
747999|NCT00406653|2391897|P1|Open-Label Period|Withdrawal of Consent|0
748000|NCT00406653|2391891|P7|Open-Label Period|Lost to Follow-up|6
748001|NCT00406653|2391892|P6|Open-Label Period|Lost to Follow-up|0
748002|NCT00406653|2391893|P5|Open-Label Period|Lost to Follow-up|0
748003|NCT00406653|2391894|P4|Open-Label Period|Lost to Follow-up|0
748004|NCT00406653|2391895|P3|Open-Label Period|Lost to Follow-up|0
748005|NCT00406653|2391896|P2|Open-Label Period|Lost to Follow-up|0
748006|NCT00406653|2391897|P1|Open-Label Period|Lost to Follow-up|0
748007|NCT00406653|2391891|P7|Open-Label Period|Lack of Efficacy|160
748008|NCT00406653|2391892|P6|Open-Label Period|Lack of Efficacy|0
748009|NCT00406653|2391893|P5|Open-Label Period|Lack of Efficacy|0
748010|NCT00406653|2391894|P4|Open-Label Period|Lack of Efficacy|0
748011|NCT00406653|2391895|P3|Open-Label Period|Lack of Efficacy|0
748012|NCT00406653|2391896|P2|Open-Label Period|Lack of Efficacy|0
748013|NCT00406653|2391897|P1|Open-Label Period|Lack of Efficacy|0
748014|NCT00406653|2391891|P7|Open-Label Period|Adverse Event|18
748015|NCT00406653|2391892|P6|Open-Label Period|Adverse Event|0
748016|NCT00406653|2391893|P5|Open-Label Period|Adverse Event|0
748017|NCT00406653|2391894|P4|Open-Label Period|Adverse Event|0
748018|NCT00406653|2391895|P3|Open-Label Period|Adverse Event|0
748019|NCT00406653|2391896|P2|Open-Label Period|Adverse Event|0
748020|NCT00406653|2391897|P1|Open-Label Period|Adverse Event|0
748021|NCT00406653|2391891|P7|Open-Label Period|Death|1
748022|NCT00406653|2391892|P6|Open-Label Period|Death|0
748023|NCT00406653|2391893|P5|Open-Label Period|Death|0
748024|NCT00406653|2391894|P4|Open-Label Period|Death|0
748025|NCT00406653|2391895|P3|Open-Label Period|Death|0
748026|NCT00406653|2391896|P2|Open-Label Period|Death|0
748027|NCT00406653|2391897|P1|Open-Label Period|Death|0
748028|NCT00406653|2391891|P7|Maintenance Period|Error in disease score evaluation|0
748029|NCT00406653|2391892|P6|Maintenance Period|Error in disease score evaluation|0
748030|NCT00406653|2391893|P5|Maintenance Period|Error in disease score evaluation|1
748031|NCT00406653|2391894|P4|Maintenance Period|Error in disease score evaluation|0
748032|NCT00406653|2391895|P3|Maintenance Period|Error in disease score evaluation|0
748033|NCT00406653|2391896|P2|Maintenance Period|Error in disease score evaluation|0
748034|NCT00406653|2391897|P1|Maintenance Period|Error in disease score evaluation|0
748035|NCT00406653|2391891|P7|Maintenance Period|Administrative Reason By Sponsor|0
748036|NCT00406653|2391892|P6|Maintenance Period|Administrative Reason By Sponsor|7
748037|NCT00406653|2391893|P5|Maintenance Period|Administrative Reason By Sponsor|4
748038|NCT00406653|2391894|P4|Maintenance Period|Administrative Reason By Sponsor|0
748039|NCT00406653|2391895|P3|Maintenance Period|Administrative Reason By Sponsor|0
748040|NCT00406653|2391896|P2|Maintenance Period|Administrative Reason By Sponsor|0
748041|NCT00406653|2391897|P1|Maintenance Period|Administrative Reason By Sponsor|0
748042|NCT00406653|2391891|P7|Maintenance Period|Pregnancy|0
748043|NCT00406653|2391892|P6|Maintenance Period|Pregnancy|1
748044|NCT00406653|2391893|P5|Maintenance Period|Pregnancy|0
748045|NCT00406653|2391894|P4|Maintenance Period|Pregnancy|0
748046|NCT00406653|2391895|P3|Maintenance Period|Pregnancy|0
748047|NCT00406653|2391896|P2|Maintenance Period|Pregnancy|0
748048|NCT00406653|2391897|P1|Maintenance Period|Pregnancy|0
748049|NCT00406653|2391891|P7|Maintenance Period|Withdrawal of Consent|0
748050|NCT00406653|2391892|P6|Maintenance Period|Withdrawal of Consent|0
748051|NCT00406653|2391893|P5|Maintenance Period|Withdrawal of Consent|2
748052|NCT00406653|2391894|P4|Maintenance Period|Withdrawal of Consent|0
748053|NCT00406653|2391895|P3|Maintenance Period|Withdrawal of Consent|0
748054|NCT00406653|2391896|P2|Maintenance Period|Withdrawal of Consent|0
748055|NCT00406653|2391897|P1|Maintenance Period|Withdrawal of Consent|0
748056|NCT00406653|2391891|P7|Maintenance Period|Lost to Follow-up|0
748057|NCT00406653|2391892|P6|Maintenance Period|Lost to Follow-up|1
748058|NCT00406653|2391893|P5|Maintenance Period|Lost to Follow-up|2
748059|NCT00406653|2391894|P4|Maintenance Period|Lost to Follow-up|0
748060|NCT00406653|2391895|P3|Maintenance Period|Lost to Follow-up|0
748061|NCT00406653|2391896|P2|Maintenance Period|Lost to Follow-up|0
748062|NCT00406653|2391897|P1|Maintenance Period|Lost to Follow-up|0
748063|NCT00406653|2391891|P7|Maintenance Period|Lack of Efficacy|0
748064|NCT00406653|2391892|P6|Maintenance Period|Lack of Efficacy|26
748065|NCT00406653|2391893|P5|Maintenance Period|Lack of Efficacy|20
748066|NCT00406653|2391894|P4|Maintenance Period|Lack of Efficacy|0
748067|NCT00406653|2391895|P3|Maintenance Period|Lack of Efficacy|0
748068|NCT00406653|2391896|P2|Maintenance Period|Lack of Efficacy|0
748069|NCT00406653|2391897|P1|Maintenance Period|Lack of Efficacy|0
748070|NCT00406653|2391891|P7|Maintenance Period|Adverse Event|0
748071|NCT00406653|2391892|P6|Maintenance Period|Adverse Event|1
748072|NCT00406653|2391893|P5|Maintenance Period|Adverse Event|1
748073|NCT00406653|2391894|P4|Maintenance Period|Adverse Event|0
748074|NCT00406653|2391895|P3|Maintenance Period|Adverse Event|0
748075|NCT00406653|2391896|P2|Maintenance Period|Adverse Event|0
748076|NCT00406653|2391897|P1|Maintenance Period|Adverse Event|0
748077|NCT00406653|2391891|P7|Induction Period|Patient relocated|0
748078|NCT00406653|2391892|P6|Induction Period|Patient relocated|0
748079|NCT00406653|2391893|P5|Induction Period|Patient relocated|0
748080|NCT00406653|2391894|P4|Induction Period|Patient relocated|0
748081|NCT00406653|2391895|P3|Induction Period|Patient relocated|1
748082|NCT00406653|2391896|P2|Induction Period|Patient relocated|0
748083|NCT00406653|2391897|P1|Induction Period|Patient relocated|0
748084|NCT00406653|2391891|P7|Induction Period|Incarcerated|0
748085|NCT00406653|2391892|P6|Induction Period|Incarcerated|0
748086|NCT00406653|2391893|P5|Induction Period|Incarcerated|0
748087|NCT00406653|2391894|P4|Induction Period|Incarcerated|0
748088|NCT00406653|2391895|P3|Induction Period|Incarcerated|1
748089|NCT00406653|2391896|P2|Induction Period|Incarcerated|0
748090|NCT00406653|2391897|P1|Induction Period|Incarcerated|0
748091|NCT00406653|2391891|P7|Induction Period|Given prohibited drug|0
748092|NCT00406653|2391892|P6|Induction Period|Given prohibited drug|0
748093|NCT00406653|2391893|P5|Induction Period|Given prohibited drug|0
748094|NCT00406653|2391894|P4|Induction Period|Given prohibited drug|0
748095|NCT00406653|2391895|P3|Induction Period|Given prohibited drug|2
748096|NCT00406653|2391896|P2|Induction Period|Given prohibited drug|1
748097|NCT00406653|2391897|P1|Induction Period|Given prohibited drug|0
748098|NCT00406653|2391891|P7|Induction Period|Declined participation but followup done|0
748099|NCT00406653|2391892|P6|Induction Period|Declined participation but followup done|0
748100|NCT00406653|2391893|P5|Induction Period|Declined participation but followup done|0
748101|NCT00406653|2391894|P4|Induction Period|Declined participation but followup done|1
748102|NCT00406653|2391895|P3|Induction Period|Declined participation but followup done|1
748103|NCT00406653|2391896|P2|Induction Period|Declined participation but followup done|2
748104|NCT00406653|2391897|P1|Induction Period|Declined participation but followup done|0
748105|NCT00406653|2391891|P7|Induction Period|Pregnancy|0
748106|NCT00406653|2391892|P6|Induction Period|Pregnancy|0
748107|NCT00406653|2391893|P5|Induction Period|Pregnancy|0
748108|NCT00406653|2391894|P4|Induction Period|Pregnancy|0
748109|NCT00406653|2391895|P3|Induction Period|Pregnancy|0
748110|NCT00406653|2391896|P2|Induction Period|Pregnancy|0
748111|NCT00406653|2391897|P1|Induction Period|Pregnancy|1
748112|NCT00406653|2391891|P7|Induction Period|Subject No Longer Meets Study Criteria|0
748113|NCT00406653|2391892|P6|Induction Period|Subject No Longer Meets Study Criteria|0
748114|NCT00406653|2391893|P5|Induction Period|Subject No Longer Meets Study Criteria|0
748115|NCT00406653|2391894|P4|Induction Period|Subject No Longer Meets Study Criteria|2
748116|NCT00406653|2391895|P3|Induction Period|Subject No Longer Meets Study Criteria|0
748117|NCT00406653|2391896|P2|Induction Period|Subject No Longer Meets Study Criteria|0
748118|NCT00406653|2391897|P1|Induction Period|Subject No Longer Meets Study Criteria|0
748119|NCT00406653|2391891|P7|Induction Period|Withdrawal of Consent|0
748120|NCT00406653|2391892|P6|Induction Period|Withdrawal of Consent|0
748121|NCT00406653|2391893|P5|Induction Period|Withdrawal of Consent|0
748122|NCT00406653|2391894|P4|Induction Period|Withdrawal of Consent|2
748123|NCT00406653|2391895|P3|Induction Period|Withdrawal of Consent|1
748124|NCT00406653|2391896|P2|Induction Period|Withdrawal of Consent|5
748125|NCT00406653|2391897|P1|Induction Period|Withdrawal of Consent|2
748126|NCT00406653|2391891|P7|Induction Period|Lost to Follow-up|0
748127|NCT00406653|2391892|P6|Induction Period|Lost to Follow-up|0
748128|NCT00406653|2391893|P5|Induction Period|Lost to Follow-up|0
748129|NCT00406653|2391894|P4|Induction Period|Lost to Follow-up|0
748130|NCT00406653|2391895|P3|Induction Period|Lost to Follow-up|0
748131|NCT00406653|2391896|P2|Induction Period|Lost to Follow-up|2
748132|NCT00406653|2391897|P1|Induction Period|Lost to Follow-up|0
748133|NCT00406653|2391891|P7|Induction Period|Lack of Efficacy|0
748134|NCT00406653|2391892|P6|Induction Period|Lack of Efficacy|0
748135|NCT00406653|2391893|P5|Induction Period|Lack of Efficacy|0
748136|NCT00406653|2391894|P4|Induction Period|Lack of Efficacy|10
748137|NCT00406653|2391895|P3|Induction Period|Lack of Efficacy|8
748138|NCT00406653|2391896|P2|Induction Period|Lack of Efficacy|14
748139|NCT00406653|2391897|P1|Induction Period|Lack of Efficacy|11
748140|NCT00406653|2391891|P7|Induction Period|Adverse Event|0
748141|NCT00406653|2391892|P6|Induction Period|Adverse Event|0
748142|NCT00406653|2391893|P5|Induction Period|Adverse Event|0
748143|NCT00406653|2391894|P4|Induction Period|Adverse Event|11
748144|NCT00406653|2391895|P3|Induction Period|Adverse Event|4
748145|NCT00406653|2391896|P2|Induction Period|Adverse Event|10
748146|NCT00406653|2391897|P1|Induction Period|Adverse Event|1
748147|NCT00406692|2391976|P1|Overall Study|Lack of Efficacy|1
748148|NCT00406692|2391976|P1|Overall Study|Adverse Event|1
748149|NCT00406692|2391976|P1|Overall Study|Physician Decision|1
748150|NCT00406692|2391976|P1|Overall Study|Withdrawal by Subject|4
748151|NCT00406718|2391985|P3|Overall Study|Lost to Follow-up|4
748152|NCT00406718|2391986|P2|Overall Study|Lost to Follow-up|5
748153|NCT00406718|2391987|P1|Overall Study|Lost to Follow-up|2
748154|NCT00406718|2391985|P3|Overall Study|Withdrawal by Subject|4
748155|NCT00406718|2391986|P2|Overall Study|Withdrawal by Subject|9
748156|NCT00406718|2391987|P1|Overall Study|Withdrawal by Subject|2
748157|NCT00406783|2392003|P2|Overall Study|Protocol Violation|4
748158|NCT00406783|2392004|P1|Overall Study|Protocol Violation|4
748159|NCT00406783|2392003|P2|Overall Study|Withdrawal by Subject|4
748160|NCT00406783|2392004|P1|Overall Study|Withdrawal by Subject|1
748161|NCT00406783|2392003|P2|Overall Study|Lost to Follow-up|0
748162|NCT00406783|2392004|P1|Overall Study|Lost to Follow-up|3
748163|NCT00406783|2392003|P2|Overall Study|Treatment Failure|3
748164|NCT00406783|2392004|P1|Overall Study|Treatment Failure|2
748165|NCT00406783|2392003|P2|Overall Study|Adverse Event|4
748166|NCT00406783|2392004|P1|Overall Study|Adverse Event|4
748167|NCT00406848|2392018|P2|Overall Study|Sponsor Decision|1
748168|NCT00406848|2392019|P1|Overall Study|Sponsor Decision|1
748169|NCT00406848|2392018|P2|Overall Study|Physician Decision|2
748170|NCT00406848|2392019|P1|Overall Study|Physician Decision|2
748171|NCT00406848|2392018|P2|Overall Study|Lost to Follow-up|2
748172|NCT00406848|2392019|P1|Overall Study|Lost to Follow-up|6
748173|NCT00406848|2392018|P2|Overall Study|Protocol Violation|6
748174|NCT00406848|2392019|P1|Overall Study|Protocol Violation|10
748175|NCT00406848|2392018|P2|Overall Study|Lack of Efficacy|14
748176|NCT00406848|2392019|P1|Overall Study|Lack of Efficacy|9
748177|NCT00406848|2392018|P2|Overall Study|Adverse Event|7
748178|NCT00406848|2392019|P1|Overall Study|Adverse Event|38
748179|NCT00406848|2392018|P2|Overall Study|Withdrawal by Subject|22
748180|NCT00406848|2392019|P1|Overall Study|Withdrawal by Subject|27
748181|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Physician Decision|0
748182|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Physician Decision|2
748183|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Physician Decision|1
748184|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Patient Decision|0
748185|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Patient Decision|2
748186|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Patient Decision|1
748187|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
748188|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
748189|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
748190|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
748191|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
748192|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
748193|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Adverse Event|0
748194|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Adverse Event|0
748195|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Adverse Event|1
748196|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
748197|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
748198|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
748199|NCT00407030|2392084|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
748200|NCT00407030|2392085|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
748201|NCT00407030|2392086|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
748202|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
748203|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
748204|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
748205|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
748206|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
748207|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
748208|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
748209|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
748210|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
748211|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
748212|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
748213|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
748214|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
748215|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
748216|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
748217|NCT00407030|2392084|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
748218|NCT00407030|2392085|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
748219|NCT00407030|2392086|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
748220|NCT00407511|2392141|P1|Overall Study|Withdrawal by Subject|4
748221|NCT00407511|2392141|P1|Overall Study|Other|5
748222|NCT00407511|2392141|P1|Overall Study|Lost to Follow-up|4
748223|NCT00407511|2392141|P1|Overall Study|Adverse Event|9
748224|NCT00407537|2392157|P2|Overall Study|Withdrawal by Subject|16
748225|NCT00407537|2392158|P1|Overall Study|Withdrawal by Subject|34
748226|NCT00407537|2392157|P2|Overall Study|Unspecified|7
748227|NCT00407537|2392158|P1|Overall Study|Unspecified|6
748228|NCT00407537|2392157|P2|Overall Study|Lost to Follow-up|19
748229|NCT00407537|2392158|P1|Overall Study|Lost to Follow-up|12
748230|NCT00407537|2392157|P2|Overall Study|Adverse Event|0
748231|NCT00407537|2392158|P1|Overall Study|Adverse Event|36
748232|NCT00407537|2392157|P2|Overall Study|Death|2
748233|NCT00407537|2392158|P1|Overall Study|Death|5
748234|NCT00407550|2392208|P2|Overall Study|Insurance or Other medical condition|1
748235|NCT00407550|2392209|P1|Overall Study|Insurance or Other medical condition|2
748236|NCT00407550|2392208|P2|Overall Study|Death|0
748237|NCT00407550|2392209|P1|Overall Study|Death|1
748238|NCT00407550|2392208|P2|Overall Study|Withdrawal by Subject|2
748239|NCT00407550|2392209|P1|Overall Study|Withdrawal by Subject|0
748240|NCT00407550|2392208|P2|Overall Study|Adverse Event|1
748241|NCT00407550|2392209|P1|Overall Study|Adverse Event|0
748242|NCT00407563|2392215|P1|Overall Study|Patient continues on treatment|1
748243|NCT00407745|2392237|P2|Overall Study|Randomized, unknown if treated|1
748244|NCT00407745|2392238|P1|Overall Study|Randomized, unknown if treated|0
748245|NCT00407745|2392237|P2|Overall Study|Unspecified|0
748246|NCT00407745|2392238|P1|Overall Study|Unspecified|2
748247|NCT00407745|2392237|P2|Overall Study|Adverse Event|8
748248|NCT00407745|2392238|P1|Overall Study|Adverse Event|8
748249|NCT00407745|2392237|P2|Overall Study|Protocol Violation|3
748250|NCT00407745|2392238|P1|Overall Study|Protocol Violation|5
748251|NCT00407745|2392237|P2|Overall Study|Withdrawal by Subject|3
748252|NCT00407745|2392238|P1|Overall Study|Withdrawal by Subject|3
748253|NCT00407745|2392237|P2|Overall Study|Lack of Efficacy|2
748254|NCT00407745|2392238|P1|Overall Study|Lack of Efficacy|1
748255|NCT00413660|2392371|P11|Post Week 12|Unspecified|0
748256|NCT00413660|2392372|P10|Post Week 12|Unspecified|0
748257|NCT00413660|2392373|P9|Post Week 12|Unspecified|0
748258|NCT00413660|2392374|P8|Post Week 12|Unspecified|0
748259|NCT00413660|2392375|P7|Post Week 12|Unspecified|1
748260|NCT00413660|2392376|P6|Post Week 12|Unspecified|1
748261|NCT00413660|2392377|P5|Post Week 12|Unspecified|1
748262|NCT00413660|2392378|P4|Post Week 12|Unspecified|0
748263|NCT00413660|2392379|P3|Post Week 12|Unspecified|3
748264|NCT00413660|2392380|P2|Post Week 12|Unspecified|2
748265|NCT00413660|2392381|P1|Post Week 12|Unspecified|1
748266|NCT00413660|2392371|P11|Post Week 12|Withdrawal by Subject|1
748267|NCT00413660|2392372|P10|Post Week 12|Withdrawal by Subject|0
748268|NCT00413660|2392373|P9|Post Week 12|Withdrawal by Subject|0
748269|NCT00413660|2392374|P8|Post Week 12|Withdrawal by Subject|0
748270|NCT00413660|2392375|P7|Post Week 12|Withdrawal by Subject|0
748271|NCT00413660|2392376|P6|Post Week 12|Withdrawal by Subject|0
748272|NCT00413660|2392377|P5|Post Week 12|Withdrawal by Subject|1
748273|NCT00413660|2392378|P4|Post Week 12|Withdrawal by Subject|0
748274|NCT00413660|2392379|P3|Post Week 12|Withdrawal by Subject|1
748275|NCT00413660|2392380|P2|Post Week 12|Withdrawal by Subject|1
748276|NCT00413660|2392381|P1|Post Week 12|Withdrawal by Subject|0
748277|NCT00413660|2392371|P11|Post Week 12|Lost to Follow-up|0
748278|NCT00413660|2392372|P10|Post Week 12|Lost to Follow-up|0
748279|NCT00413660|2392373|P9|Post Week 12|Lost to Follow-up|0
748280|NCT00413660|2392374|P8|Post Week 12|Lost to Follow-up|0
748281|NCT00413660|2392375|P7|Post Week 12|Lost to Follow-up|0
748282|NCT00413660|2392376|P6|Post Week 12|Lost to Follow-up|0
748283|NCT00413660|2392377|P5|Post Week 12|Lost to Follow-up|0
748284|NCT00413660|2392378|P4|Post Week 12|Lost to Follow-up|0
748285|NCT00413660|2392379|P3|Post Week 12|Lost to Follow-up|1
748286|NCT00413660|2392380|P2|Post Week 12|Lost to Follow-up|1
748287|NCT00413660|2392381|P1|Post Week 12|Lost to Follow-up|0
748288|NCT00413660|2392371|P11|Post Week 12|Lack of Efficacy|0
748289|NCT00413660|2392372|P10|Post Week 12|Lack of Efficacy|1
748290|NCT00413660|2392373|P9|Post Week 12|Lack of Efficacy|0
748291|NCT00413660|2392374|P8|Post Week 12|Lack of Efficacy|0
748292|NCT00413660|2392375|P7|Post Week 12|Lack of Efficacy|0
748293|NCT00413660|2392376|P6|Post Week 12|Lack of Efficacy|0
748294|NCT00413660|2392377|P5|Post Week 12|Lack of Efficacy|0
748295|NCT00413660|2392378|P4|Post Week 12|Lack of Efficacy|0
748296|NCT00413660|2392379|P3|Post Week 12|Lack of Efficacy|1
748297|NCT00413660|2392380|P2|Post Week 12|Lack of Efficacy|0
748298|NCT00413660|2392381|P1|Post Week 12|Lack of Efficacy|0
748299|NCT00413660|2392371|P11|Post Week 12|Adverse Event|0
748300|NCT00413660|2392372|P10|Post Week 12|Adverse Event|0
748301|NCT00413660|2392373|P9|Post Week 12|Adverse Event|0
748302|NCT00413660|2392374|P8|Post Week 12|Adverse Event|0
748303|NCT00413660|2392375|P7|Post Week 12|Adverse Event|2
748304|NCT00413660|2392376|P6|Post Week 12|Adverse Event|2
748305|NCT00413660|2392377|P5|Post Week 12|Adverse Event|4
748306|NCT00413660|2392378|P4|Post Week 12|Adverse Event|1
748307|NCT00413660|2392379|P3|Post Week 12|Adverse Event|2
748308|NCT00413660|2392380|P2|Post Week 12|Adverse Event|0
748309|NCT00413660|2392381|P1|Post Week 12|Adverse Event|2
748310|NCT00413660|2392371|P11|Up To Week 12|Unspecified|0
748311|NCT00413660|2392372|P10|Up To Week 12|Unspecified|0
748312|NCT00413660|2392373|P9|Up To Week 12|Unspecified|0
748313|NCT00413660|2392374|P8|Up To Week 12|Unspecified|0
748314|NCT00413660|2392375|P7|Up To Week 12|Unspecified|3
748315|NCT00413660|2392376|P6|Up To Week 12|Unspecified|4
748316|NCT00413660|2392377|P5|Up To Week 12|Unspecified|2
748317|NCT00413660|2392378|P4|Up To Week 12|Unspecified|1
748318|NCT00413660|2392379|P3|Up To Week 12|Unspecified|6
748319|NCT00413660|2392380|P2|Up To Week 12|Unspecified|1
748320|NCT00413660|2392381|P1|Up To Week 12|Unspecified|3
748321|NCT00413660|2392371|P11|Up To Week 12|Randomized, Not Treated|0
748322|NCT00413660|2392372|P10|Up To Week 12|Randomized, Not Treated|0
748323|NCT00413660|2392373|P9|Up To Week 12|Randomized, Not Treated|0
748324|NCT00413660|2392374|P8|Up To Week 12|Randomized, Not Treated|0
748325|NCT00413660|2392375|P7|Up To Week 12|Randomized, Not Treated|0
748326|NCT00413660|2392376|P6|Up To Week 12|Randomized, Not Treated|0
748327|NCT00413660|2392377|P5|Up To Week 12|Randomized, Not Treated|0
748328|NCT00413660|2392378|P4|Up To Week 12|Randomized, Not Treated|1
748329|NCT00413660|2392379|P3|Up To Week 12|Randomized, Not Treated|0
748330|NCT00413660|2392380|P2|Up To Week 12|Randomized, Not Treated|0
748331|NCT00413660|2392381|P1|Up To Week 12|Randomized, Not Treated|1
748332|NCT00413660|2392371|P11|Up To Week 12|Withdrawal by Subject|0
748333|NCT00413660|2392372|P10|Up To Week 12|Withdrawal by Subject|0
748334|NCT00413660|2392373|P9|Up To Week 12|Withdrawal by Subject|0
748335|NCT00413660|2392374|P8|Up To Week 12|Withdrawal by Subject|0
748336|NCT00413660|2392375|P7|Up To Week 12|Withdrawal by Subject|2
748337|NCT00413660|2392376|P6|Up To Week 12|Withdrawal by Subject|2
748338|NCT00413660|2392377|P5|Up To Week 12|Withdrawal by Subject|0
748339|NCT00413660|2392378|P4|Up To Week 12|Withdrawal by Subject|2
748340|NCT00413660|2392379|P3|Up To Week 12|Withdrawal by Subject|0
748341|NCT00413660|2392380|P2|Up To Week 12|Withdrawal by Subject|2
748342|NCT00413660|2392381|P1|Up To Week 12|Withdrawal by Subject|0
748343|NCT00413660|2392371|P11|Up To Week 12|Lost to Follow-up|0
748344|NCT00413660|2392372|P10|Up To Week 12|Lost to Follow-up|0
748345|NCT00413660|2392373|P9|Up To Week 12|Lost to Follow-up|0
748346|NCT00413660|2392374|P8|Up To Week 12|Lost to Follow-up|0
748347|NCT00413660|2392375|P7|Up To Week 12|Lost to Follow-up|0
748348|NCT00413660|2392376|P6|Up To Week 12|Lost to Follow-up|0
748349|NCT00413660|2392377|P5|Up To Week 12|Lost to Follow-up|1
748350|NCT00413660|2392378|P4|Up To Week 12|Lost to Follow-up|0
748351|NCT00413660|2392379|P3|Up To Week 12|Lost to Follow-up|0
748352|NCT00413660|2392380|P2|Up To Week 12|Lost to Follow-up|1
748353|NCT00413660|2392381|P1|Up To Week 12|Lost to Follow-up|0
748354|NCT00413660|2392371|P11|Up To Week 12|Lack of Efficacy|0
748355|NCT00413660|2392372|P10|Up To Week 12|Lack of Efficacy|0
748356|NCT00413660|2392373|P9|Up To Week 12|Lack of Efficacy|0
748357|NCT00413660|2392374|P8|Up To Week 12|Lack of Efficacy|0
748358|NCT00413660|2392375|P7|Up To Week 12|Lack of Efficacy|5
748359|NCT00413660|2392376|P6|Up To Week 12|Lack of Efficacy|0
748360|NCT00413660|2392377|P5|Up To Week 12|Lack of Efficacy|0
748361|NCT00413660|2392378|P4|Up To Week 12|Lack of Efficacy|0
748362|NCT00413660|2392379|P3|Up To Week 12|Lack of Efficacy|0
748363|NCT00413660|2392380|P2|Up To Week 12|Lack of Efficacy|0
748364|NCT00413660|2392381|P1|Up To Week 12|Lack of Efficacy|2
748365|NCT00413660|2392371|P11|Up To Week 12|Adverse Event|0
748366|NCT00413660|2392372|P10|Up To Week 12|Adverse Event|0
748367|NCT00413660|2392373|P9|Up To Week 12|Adverse Event|0
748368|NCT00413660|2392374|P8|Up To Week 12|Adverse Event|0
748369|NCT00413660|2392375|P7|Up To Week 12|Adverse Event|1
748370|NCT00413660|2392376|P6|Up To Week 12|Adverse Event|4
748371|NCT00413660|2392377|P5|Up To Week 12|Adverse Event|6
748372|NCT00413660|2392378|P4|Up To Week 12|Adverse Event|4
748373|NCT00413660|2392379|P3|Up To Week 12|Adverse Event|1
748374|NCT00413660|2392380|P2|Up To Week 12|Adverse Event|3
748375|NCT00413660|2392381|P1|Up To Week 12|Adverse Event|1
748376|NCT00414544|2392740|P1|Overall Study|Lost to Follow-up|14
748377|NCT00414596|2392746|P1|Overall Study|Protocol Violation|2
748378|NCT00414609|2392757|P3|Extension Study|Death|17
748379|NCT00414609|2392758|P2|Extension Study|Death|0
748380|NCT00414609|2392759|P1|Extension Study|Death|0
748381|NCT00414609|2392757|P3|Extension Study|Administrative problems|1
748382|NCT00414609|2392758|P2|Extension Study|Administrative problems|0
748383|NCT00414609|2392759|P1|Extension Study|Administrative problems|0
748384|NCT00414609|2392757|P3|Extension Study|Lost to Follow-up|10
748385|NCT00414609|2392758|P2|Extension Study|Lost to Follow-up|0
748386|NCT00414609|2392759|P1|Extension Study|Lost to Follow-up|0
748387|NCT00414609|2392757|P3|Extension Study|Withdrawal by Subject|13
748388|NCT00414609|2392758|P2|Extension Study|Withdrawal by Subject|0
748389|NCT00414609|2392759|P1|Extension Study|Withdrawal by Subject|0
748390|NCT00414609|2392757|P3|Extension Study|Unsatisfactory therapeutic effect|2
748391|NCT00414609|2392758|P2|Extension Study|Unsatisfactory therapeutic effect|0
748392|NCT00414609|2392759|P1|Extension Study|Unsatisfactory therapeutic effect|0
748393|NCT00414609|2392757|P3|Extension Study|Adverse Event|14
748394|NCT00414609|2392758|P2|Extension Study|Adverse Event|0
748395|NCT00414609|2392759|P1|Extension Study|Adverse Event|0
748396|NCT00414609|2392757|P3|Core Study|Death|0
748397|NCT00414609|2392758|P2|Core Study|Death|14
748398|NCT00414609|2392759|P1|Core Study|Death|7
748399|NCT00414609|2392757|P3|Core Study|Administrative problems|0
748400|NCT00414609|2392758|P2|Core Study|Administrative problems|2
748401|NCT00414609|2392759|P1|Core Study|Administrative problems|0
748402|NCT00414609|2392757|P3|Core Study|Lost to Follow-up|0
748403|NCT00414609|2392758|P2|Core Study|Lost to Follow-up|4
748404|NCT00414609|2392759|P1|Core Study|Lost to Follow-up|7
748405|NCT00414609|2392757|P3|Core Study|Patient withdrew consent|0
748406|NCT00414609|2392758|P2|Core Study|Patient withdrew consent|11
748407|NCT00414609|2392759|P1|Core Study|Patient withdrew consent|10
748408|NCT00414609|2392757|P3|Core Study|Protocol deviation|0
748409|NCT00414609|2392758|P2|Core Study|Protocol deviation|1
748410|NCT00414609|2392759|P1|Core Study|Protocol deviation|0
748411|NCT00414609|2392757|P3|Core Study|Abnormal test procedure results|0
748412|NCT00414609|2392758|P2|Core Study|Abnormal test procedure results|1
748413|NCT00414609|2392759|P1|Core Study|Abnormal test procedure results|1
748414|NCT00414609|2392757|P3|Core Study|Abnormal laboratory values|0
748415|NCT00414609|2392758|P2|Core Study|Abnormal laboratory values|1
748416|NCT00414609|2392759|P1|Core Study|Abnormal laboratory values|0
748417|NCT00414609|2392757|P3|Core Study|Adverse Event|0
748418|NCT00414609|2392758|P2|Core Study|Adverse Event|11
748419|NCT00414609|2392759|P1|Core Study|Adverse Event|9
748420|NCT00414661|2392807|P4|Overall Study|Unspecified|0
748421|NCT00414661|2392808|P3|Overall Study|Unspecified|0
748422|NCT00414661|2392809|P2|Overall Study|Unspecified|3
748423|NCT00414661|2392810|P1|Overall Study|Unspecified|6
748424|NCT00414661|2392807|P4|Overall Study|Withdrawal by Subject|2
748425|NCT00414661|2392808|P3|Overall Study|Withdrawal by Subject|2
748426|NCT00414661|2392809|P2|Overall Study|Withdrawal by Subject|2
748427|NCT00414661|2392810|P1|Overall Study|Withdrawal by Subject|5
748428|NCT00414661|2392807|P4|Overall Study|Lost to Follow-up|1
748429|NCT00414661|2392808|P3|Overall Study|Lost to Follow-up|0
748430|NCT00414661|2392809|P2|Overall Study|Lost to Follow-up|4
748431|NCT00414661|2392810|P1|Overall Study|Lost to Follow-up|1
748432|NCT00414661|2392807|P4|Overall Study|Death|0
748433|NCT00414661|2392808|P3|Overall Study|Death|0
748434|NCT00414661|2392809|P2|Overall Study|Death|5
748435|NCT00414661|2392810|P1|Overall Study|Death|2
748438|NCT00414908|2392881|P2|Overall Study|Protocol Violation|1
748439|NCT00414908|2392882|P1|Overall Study|Protocol Violation|1
748440|NCT00414973|2392908|P4|Overall Study|Death|0
748441|NCT00414973|2392909|P3|Overall Study|Death|1
748442|NCT00414973|2392910|P2|Overall Study|Death|0
748443|NCT00414973|2392911|P1|Overall Study|Death|0
748444|NCT00414973|2392908|P4|Overall Study|Sponsor Decision|0
748445|NCT00414973|2392909|P3|Overall Study|Sponsor Decision|0
748446|NCT00414973|2392910|P2|Overall Study|Sponsor Decision|0
748447|NCT00414973|2392911|P1|Overall Study|Sponsor Decision|1
748448|NCT00414973|2392908|P4|Overall Study|Lost to Follow-up|0
748449|NCT00414973|2392909|P3|Overall Study|Lost to Follow-up|0
748450|NCT00414973|2392910|P2|Overall Study|Lost to Follow-up|2
748451|NCT00414973|2392911|P1|Overall Study|Lost to Follow-up|0
748452|NCT00414973|2392908|P4|Overall Study|Protocol Violation|0
748453|NCT00414973|2392909|P3|Overall Study|Protocol Violation|0
748454|NCT00414973|2392910|P2|Overall Study|Protocol Violation|4
748455|NCT00414973|2392911|P1|Overall Study|Protocol Violation|3
748456|NCT00414973|2392908|P4|Overall Study|Adverse Event|0
748457|NCT00414973|2392909|P3|Overall Study|Adverse Event|1
748458|NCT00414973|2392910|P2|Overall Study|Adverse Event|0
748459|NCT00414973|2392911|P1|Overall Study|Adverse Event|10
748460|NCT00414973|2392908|P4|Overall Study|Withdrawal by Subject|0
748461|NCT00414973|2392909|P3|Overall Study|Withdrawal by Subject|1
748462|NCT00414973|2392910|P2|Overall Study|Withdrawal by Subject|4
748463|NCT00414973|2392911|P1|Overall Study|Withdrawal by Subject|14
748464|NCT00415051|2392929|P1|Overall Study|Protocol Violation|1
748465|NCT00415168|2392936|P1|Overall Study|Withdrawal by Subject|6
748466|NCT00415168|2392936|P1|Overall Study|Sponsor Decision|4
748467|NCT00415168|2392936|P1|Overall Study|Physician Decision|13
748468|NCT00415168|2392936|P1|Overall Study|Lost to Follow-up|3
748469|NCT00415168|2392936|P1|Overall Study|Death|26
748470|NCT00415194|2392948|P2|Overall Study|Death Due to AE (Other Causes)|15
748471|NCT00415194|2392949|P1|Overall Study|Death Due to AE (Other Causes)|27
748472|NCT00415194|2392948|P2|Overall Study|Death Due to Procedural Related AE|1
748473|NCT00415194|2392949|P1|Overall Study|Death Due to Procedural Related AE|0
748474|NCT00415194|2392948|P2|Overall Study|Death Due to Study Drug Related AE|1
748475|NCT00415194|2392949|P1|Overall Study|Death Due to Study Drug Related AE|11
748476|NCT00415194|2392948|P2|Overall Study|Death Due to Study Disease|29
748477|NCT00415194|2392949|P1|Overall Study|Death Due to Study Disease|26
748478|NCT00415194|2392948|P2|Overall Study|Withdrawal by Subject|21
748479|NCT00415194|2392949|P1|Overall Study|Withdrawal by Subject|28
748480|NCT00415194|2392948|P2|Overall Study|Protocol Violation|2
748481|NCT00415194|2392949|P1|Overall Study|Protocol Violation|4
748482|NCT00415194|2392948|P2|Overall Study|Progressive Disease|217
748483|NCT00415194|2392949|P1|Overall Study|Progressive Disease|180
748484|NCT00415194|2392948|P2|Overall Study|Physician Decision|16
748485|NCT00415194|2392949|P1|Overall Study|Physician Decision|10
748486|NCT00415194|2392948|P2|Overall Study|Lost to Follow-up|0
748487|NCT00415194|2392949|P1|Overall Study|Lost to Follow-up|1
748488|NCT00415194|2392948|P2|Overall Study|Entry Criteria Not Met|8
748489|NCT00415194|2392949|P1|Overall Study|Entry Criteria Not Met|4
748490|NCT00415194|2392948|P2|Overall Study|Adverse Event|32
748491|NCT00415194|2392949|P1|Overall Study|Adverse Event|37
748492|NCT00415532|2392987|P2|Safety Follow Up Period|Requirement for alternative therapy|1
748493|NCT00415532|2392988|P1|Safety Follow Up Period|Requirement for alternative therapy|0
748494|NCT00415532|2392987|P2|Safety Follow Up Period|Noncompliance|0
748495|NCT00415532|2392988|P1|Safety Follow Up Period|Noncompliance|1
748496|NCT00415532|2392987|P2|Safety Follow Up Period|Ineligibility determined|1
748497|NCT00415532|2392988|P1|Safety Follow Up Period|Ineligibility determined|1
748498|NCT00415532|2392987|P2|Safety Follow Up Period|Other|4
748499|NCT00415532|2392988|P1|Safety Follow Up Period|Other|1
748500|NCT00415532|2392987|P2|Safety Follow Up Period|Withdrawal by Subject|3
748501|NCT00415532|2392988|P1|Safety Follow Up Period|Withdrawal by Subject|2
748502|NCT00415532|2392987|P2|Safety Follow Up Period|Death|0
748503|NCT00415532|2392988|P1|Safety Follow Up Period|Death|3
748504|NCT00415532|2392987|P2|Safety Follow Up Period|Adverse Event|3
748505|NCT00415532|2392988|P1|Safety Follow Up Period|Adverse Event|1
748506|NCT00415532|2392987|P2|Treatment Period|Requirement for alternative therapy|0
748507|NCT00415532|2392988|P1|Treatment Period|Requirement for alternative therapy|1
748508|NCT00415532|2392987|P2|Treatment Period|Noncompliance|1
748509|NCT00415532|2392988|P1|Treatment Period|Noncompliance|1
748510|NCT00415532|2392987|P2|Treatment Period|Ineligibility determined|1
748511|NCT00415532|2392988|P1|Treatment Period|Ineligibility determined|1
748512|NCT00415532|2392987|P2|Treatment Period|Other|2
748513|NCT00415532|2392988|P1|Treatment Period|Other|2
748514|NCT00415532|2392987|P2|Treatment Period|Withdrawal by Subject|6
748515|NCT00415532|2392988|P1|Treatment Period|Withdrawal by Subject|6
748516|NCT00415532|2392987|P2|Treatment Period|Protocol Violation|0
748517|NCT00415532|2392988|P1|Treatment Period|Protocol Violation|1
748518|NCT00415532|2392987|P2|Treatment Period|Lost to Follow-up|1
748519|NCT00415532|2392988|P1|Treatment Period|Lost to Follow-up|1
748520|NCT00415532|2392987|P2|Treatment Period|Death|1
748521|NCT00415532|2392988|P1|Treatment Period|Death|2
748522|NCT00415532|2392987|P2|Treatment Period|Adverse Event|3
748523|NCT00415532|2392988|P1|Treatment Period|Adverse Event|2
748524|NCT00415597|2393008|P1|Treatment|Multiple Reasons|1
748525|NCT00415597|2393008|P1|Treatment|Sponsor Decision|1
748526|NCT00415597|2393008|P1|Treatment|Administrative|3
748527|NCT00415597|2393008|P1|Treatment|Drug Screen|2
748528|NCT00415597|2393008|P1|Treatment|Lost to Follow-up|28
748529|NCT00415597|2393008|P1|Treatment|Withdrawal by Subject|51
748530|NCT00415597|2393008|P1|Treatment|Physician Decision|3
748531|NCT00415597|2393008|P1|Treatment|Protocol Violation|67
748532|NCT00415597|2393008|P1|Treatment|Lack of Efficacy|39
748533|NCT00415597|2393008|P1|Treatment|Adverse Event|110
748534|NCT00415597|2393008|P1|Enrollment|Protocol Violation|1
748535|NCT00415597|2393008|P1|Enrollment|Withdrawal by Subject|1
748539|NCT00415623|2393035|P2|Overall Study|Withdrawal by Subject|1
748540|NCT00415623|2393036|P1|Overall Study|Withdrawal by Subject|1
748541|NCT00415623|2393035|P2|Overall Study|Death|0
748542|NCT00415623|2393036|P1|Overall Study|Death|1
748543|NCT00415623|2393035|P2|Overall Study|Adverse Event|4
748544|NCT00415623|2393036|P1|Overall Study|Adverse Event|3
748545|NCT00415909|2393080|P1|Overall Study|Death|1
748546|NCT00415909|2393080|P1|Overall Study|Withdrawal by Subject|2
748547|NCT00416078|2393086|P2|Overall Study|Lost to Follow-up|2
748548|NCT00416078|2393087|P1|Overall Study|Lost to Follow-up|4
748549|NCT00416078|2393086|P2|Overall Study|Physician Decision|0
748550|NCT00416078|2393087|P1|Overall Study|Physician Decision|1
748551|NCT00416078|2393086|P2|Overall Study|Withdrawal by Subject|2
748552|NCT00416078|2393087|P1|Overall Study|Withdrawal by Subject|3
748553|NCT00416078|2393086|P2|Overall Study|Death|4
748554|NCT00416078|2393087|P1|Overall Study|Death|3
748555|NCT00416195|2393120|P2|Overall Study|Not Specified|1
748556|NCT00416195|2393121|P1|Overall Study|Not Specified|0
748557|NCT00416195|2393120|P2|Overall Study|Protocol Violation|1
748558|NCT00416195|2393121|P1|Overall Study|Protocol Violation|1
748559|NCT00416195|2393120|P2|Overall Study|Adverse Event|2
748560|NCT00416195|2393121|P1|Overall Study|Adverse Event|1
748561|NCT00416455|2393131|P2|Overall Study|Inadequate pathology|2
748562|NCT00416455|2393132|P1|Overall Study|Inadequate pathology|11
748563|NCT00416455|2393131|P2|Overall Study|PET / CT poor quality|1
748564|NCT00416455|2393132|P1|Overall Study|PET / CT poor quality|2
748565|NCT00416455|2393131|P2|Overall Study|PET / CT not done|5
748566|NCT00416455|2393132|P1|Overall Study|PET / CT not done|3
748567|NCT00416520|2393163|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
748568|NCT00416520|2393164|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
748569|NCT00416520|2393165|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
748570|NCT00416520|2393166|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
748571|NCT00416520|2393163|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
748572|NCT00416520|2393164|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
748573|NCT00416520|2393165|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
748574|NCT00416520|2393166|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
748575|NCT00416520|2393163|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
748576|NCT00416520|2393164|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
748577|NCT00416520|2393165|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
748578|NCT00416520|2393166|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
748579|NCT00416520|2393163|P4|Open-label Period|Other Reasons|0
748580|NCT00416520|2393164|P3|Open-label Period|Other Reasons|0
748581|NCT00416520|2393165|P2|Open-label Period|Other Reasons|12
748582|NCT00416520|2393166|P1|Open-label Period|Other Reasons|3
748583|NCT00416520|2393163|P4|Open-label Period|Withdrawal by Subject|0
748584|NCT00416520|2393164|P3|Open-label Period|Withdrawal by Subject|0
748585|NCT00416520|2393165|P2|Open-label Period|Withdrawal by Subject|5
748586|NCT00416520|2393166|P1|Open-label Period|Withdrawal by Subject|16
748587|NCT00416520|2393163|P4|Open-label Period|Protocol Violation|0
748588|NCT00416520|2393164|P3|Open-label Period|Protocol Violation|0
748589|NCT00416520|2393165|P2|Open-label Period|Protocol Violation|3
748590|NCT00416520|2393166|P1|Open-label Period|Protocol Violation|3
748591|NCT00416520|2393163|P4|Open-label Period|Lack of Efficacy|0
748592|NCT00416520|2393164|P3|Open-label Period|Lack of Efficacy|0
748593|NCT00416520|2393165|P2|Open-label Period|Lack of Efficacy|1
748594|NCT00416520|2393166|P1|Open-label Period|Lack of Efficacy|8
748595|NCT00416520|2393163|P4|Open-label Period|Death|0
748596|NCT00416520|2393164|P3|Open-label Period|Death|0
748597|NCT00416520|2393165|P2|Open-label Period|Death|1
748598|NCT00416520|2393166|P1|Open-label Period|Death|2
748599|NCT00416520|2393163|P4|Open-label Period|Adverse Event|0
748600|NCT00416520|2393164|P3|Open-label Period|Adverse Event|0
748601|NCT00416520|2393165|P2|Open-label Period|Adverse Event|10
748602|NCT00416520|2393166|P1|Open-label Period|Adverse Event|28
748615|NCT00416624|2393204|P4|Overall Study|Cancel|0
748616|NCT00416624|2393205|P3|Overall Study|Cancel|0
748617|NCT00416624|2393206|P2|Overall Study|Cancel|0
748618|NCT00416624|2393207|P1|Overall Study|Cancel|1
748619|NCT00416624|2393204|P4|Overall Study|Not Specified|5
748620|NCT00416624|2393205|P3|Overall Study|Not Specified|5
748621|NCT00416624|2393206|P2|Overall Study|Not Specified|11
748622|NCT00416624|2393207|P1|Overall Study|Not Specified|8
748623|NCT00416624|2393204|P4|Overall Study|Adverse Event|2
748624|NCT00416624|2393205|P3|Overall Study|Adverse Event|2
748625|NCT00416624|2393206|P2|Overall Study|Adverse Event|3
748626|NCT00416624|2393207|P1|Overall Study|Adverse Event|8
748627|NCT00416624|2393204|P4|Overall Study|Death|1
748628|NCT00416624|2393205|P3|Overall Study|Death|7
748629|NCT00416624|2393206|P2|Overall Study|Death|7
748630|NCT00416624|2393207|P1|Overall Study|Death|4
748631|NCT00416624|2393204|P4|Overall Study|Withdrawal by Subject|9
748632|NCT00416624|2393205|P3|Overall Study|Withdrawal by Subject|4
748633|NCT00416624|2393206|P2|Overall Study|Withdrawal by Subject|6
748634|NCT00416624|2393207|P1|Overall Study|Withdrawal by Subject|1
748635|NCT00416715|2393261|P1|Overall Study|Vitamin D levels not evaluable|8
748636|NCT00416715|2393261|P1|Overall Study|Not evaluable for joint aches|7
748637|NCT00416884|2393272|P1|Overall Study|Study terminated due to low accrual|1
748638|NCT00417027|2393279|P3|Overall Study|Protocol Violation|5
748639|NCT00417027|2393280|P2|Overall Study|Protocol Violation|5
748640|NCT00417027|2393281|P1|Overall Study|Protocol Violation|0
748651|NCT00410813|2393332|P2|Overall Study|Death|2
748652|NCT00410813|2393333|P1|Overall Study|Death|0
748653|NCT00410813|2393332|P2|Overall Study|Ineligible|4
748654|NCT00410813|2393333|P1|Overall Study|Ineligible|2
748655|NCT00410813|2393332|P2|Overall Study|Not protocol specified|4
748656|NCT00410813|2393333|P1|Overall Study|Not protocol specified|3
748657|NCT00410813|2393332|P2|Overall Study|Progression|21
748658|NCT00410813|2393333|P1|Overall Study|Progression|32
748659|NCT00410813|2393332|P2|Overall Study|Adverse Event|11
748660|NCT00410813|2393333|P1|Overall Study|Adverse Event|6
748661|NCT00417079|2393370|P2|Overall Study|abnormal liver function tests|1
748662|NCT00417079|2393371|P1|Overall Study|abnormal liver function tests|0
748663|NCT00417079|2393370|P2|Overall Study|Patient unable to come to the clinic|1
748664|NCT00417079|2393371|P1|Overall Study|Patient unable to come to the clinic|0
748665|NCT00417079|2393370|P2|Overall Study|Withdrawal by subject's family|1
748666|NCT00417079|2393371|P1|Overall Study|Withdrawal by subject's family|0
748667|NCT00417079|2393370|P2|Overall Study|Screening error|1
748668|NCT00417079|2393371|P1|Overall Study|Screening error|2
748669|NCT00417079|2393370|P2|Overall Study|Clinical deterioration|0
748670|NCT00417079|2393371|P1|Overall Study|Clinical deterioration|1
748671|NCT00417079|2393370|P2|Overall Study|Non-confirmed Disease progression|1
748672|NCT00417079|2393371|P1|Overall Study|Non-confirmed Disease progression|1
748673|NCT00417079|2393370|P2|Overall Study|Investigator's decision|4
748674|NCT00417079|2393371|P1|Overall Study|Investigator's decision|1
748675|NCT00417079|2393370|P2|Overall Study|Screened failure|1
748676|NCT00417079|2393371|P1|Overall Study|Screened failure|2
748677|NCT00417079|2393370|P2|Overall Study|Not treated|7
748678|NCT00417079|2393371|P1|Overall Study|Not treated|6
748679|NCT00417079|2393370|P2|Overall Study|Withdrawal by Subject|8
748680|NCT00417079|2393371|P1|Overall Study|Withdrawal by Subject|17
748681|NCT00417079|2393370|P2|Overall Study|Lost to Follow-up|0
748682|NCT00417079|2393371|P1|Overall Study|Lost to Follow-up|2
748683|NCT00417079|2393370|P2|Overall Study|Non-compliance to protocol|1
748684|NCT00417079|2393371|P1|Overall Study|Non-compliance to protocol|0
748685|NCT00417079|2393370|P2|Overall Study|Adverse Event|67
748686|NCT00417079|2393371|P1|Overall Study|Adverse Event|32
748687|NCT00417079|2393370|P2|Overall Study|Disease progression|180
748688|NCT00417079|2393371|P1|Overall Study|Disease progression|267
748689|NCT00417170|2393393|P2|Overall Study|Lost to Follow-up|1
748690|NCT00417170|2393394|P1|Overall Study|Lost to Follow-up|0
748691|NCT00417170|2393393|P2|Overall Study|Withdrawal by Subject|1
748692|NCT00417170|2393394|P1|Overall Study|Withdrawal by Subject|1
748693|NCT00417170|2393393|P2|Overall Study|Adverse Event|1
748694|NCT00417170|2393394|P1|Overall Study|Adverse Event|1
748695|NCT00417248|2393408|P1|Overall Study|Lack of Efficacy|1
748696|NCT00417248|2393408|P1|Overall Study|Death|1
748697|NCT00417248|2393408|P1|Overall Study|Study Terminated|6
748698|NCT00419926|2393419|P2|Overall Study|Death|1
748699|NCT00419926|2393420|P1|Overall Study|Death|2
748700|NCT00419926|2393419|P2|Overall Study|Lost to Follow-up|2
748701|NCT00419926|2393420|P1|Overall Study|Lost to Follow-up|1
748702|NCT00419926|2393419|P2|Overall Study|Administrative Problem|4
748703|NCT00419926|2393420|P1|Overall Study|Administrative Problem|4
748704|NCT00419926|2393419|P2|Overall Study|Withdrawal by Subject|3
748705|NCT00419926|2393420|P1|Overall Study|Withdrawal by Subject|7
748706|NCT00419952|2393436|P2|Overall Study|Abnormal ECG|0
748707|NCT00419952|2393437|P1|Overall Study|Abnormal ECG|1
748708|NCT00419952|2393436|P2|Overall Study|Diary or medication non-compliance|4
748709|NCT00419952|2393437|P1|Overall Study|Diary or medication non-compliance|2
748710|NCT00419952|2393436|P2|Overall Study|Occurence of 2 or more exacerbations|0
748711|NCT00419952|2393437|P1|Overall Study|Occurence of 2 or more exacerbations|2
748712|NCT00419952|2393436|P2|Overall Study|Intake of prohibited medication|2
748713|NCT00419952|2393437|P1|Overall Study|Intake of prohibited medication|2
748714|NCT00419952|2393436|P2|Overall Study|Incorrectly enrolled|3
748715|NCT00419952|2393437|P1|Overall Study|Incorrectly enrolled|10
748716|NCT00419952|2393436|P2|Overall Study|Physician Decision|3
748717|NCT00419952|2393437|P1|Overall Study|Physician Decision|1
748718|NCT00419952|2393436|P2|Overall Study|Pregnancy|2
748719|NCT00419952|2393437|P1|Overall Study|Pregnancy|4
748720|NCT00419952|2393436|P2|Overall Study|Protocol Violation|24
748721|NCT00419952|2393437|P1|Overall Study|Protocol Violation|32
748722|NCT00419952|2393436|P2|Overall Study|Lost to Follow-up|34
748723|NCT00419952|2393437|P1|Overall Study|Lost to Follow-up|43
748724|NCT00419952|2393436|P2|Overall Study|Withdrawal by Subject|43
748725|NCT00419952|2393437|P1|Overall Study|Withdrawal by Subject|44
748726|NCT00419952|2393436|P2|Overall Study|Adverse Event|10
748727|NCT00419952|2393437|P1|Overall Study|Adverse Event|8
748728|NCT00420056|2393484|P1|Overall Study|Objective progression or relapse|17
748729|NCT00420095|2393508|P2|Overall Study|Lost to Follow-up|0
748730|NCT00420095|2393509|P1|Overall Study|Lost to Follow-up|1
748731|NCT00420095|2393508|P2|Overall Study|Protocol Violation|1
748732|NCT00420095|2393509|P1|Overall Study|Protocol Violation|1
748733|NCT00420095|2393508|P2|Overall Study|Adverse Event|0
748734|NCT00420095|2393509|P1|Overall Study|Adverse Event|1
748735|NCT00420199|2393540|P2|Overall Study|Participant no longer met study criteria|0
748736|NCT00420199|2393541|P1|Overall Study|Participant no longer met study criteria|1
748737|NCT00420212|2393597|P3|Overall Study|Other-Unspecified|18
748738|NCT00420212|2393598|P2|Overall Study|Other-Unspecified|14
748739|NCT00420212|2393599|P1|Overall Study|Other-Unspecified|21
748740|NCT00420212|2393597|P3|Overall Study|Death|1
748741|NCT00420212|2393598|P2|Overall Study|Death|0
748742|NCT00420212|2393599|P1|Overall Study|Death|0
748743|NCT00420212|2393597|P3|Overall Study|Protocol Violation|8
748744|NCT00420212|2393598|P2|Overall Study|Protocol Violation|4
748745|NCT00420212|2393599|P1|Overall Study|Protocol Violation|4
748746|NCT00420212|2393597|P3|Overall Study|Physician Decision|3
748747|NCT00420212|2393598|P2|Overall Study|Physician Decision|4
748748|NCT00420212|2393599|P1|Overall Study|Physician Decision|4
748749|NCT00420212|2393597|P3|Overall Study|Withdrawal by Subject|19
748750|NCT00420212|2393598|P2|Overall Study|Withdrawal by Subject|22
748751|NCT00420212|2393599|P1|Overall Study|Withdrawal by Subject|31
748752|NCT00420212|2393597|P3|Overall Study|Lost to Follow-up|11
748753|NCT00420212|2393598|P2|Overall Study|Lost to Follow-up|11
748754|NCT00420212|2393599|P1|Overall Study|Lost to Follow-up|9
748755|NCT00420212|2393597|P3|Overall Study|Adverse Event|36
748756|NCT00420212|2393598|P2|Overall Study|Adverse Event|40
748757|NCT00420212|2393599|P1|Overall Study|Adverse Event|22
748758|NCT00420238|2393625|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
748759|NCT00420238|2393626|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
748760|NCT00420238|2393625|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
748761|NCT00420238|2393626|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
748762|NCT00420238|2393625|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
748763|NCT00420238|2393626|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
748764|NCT00420238|2393625|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
748765|NCT00420238|2393626|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
748766|NCT00420238|2393625|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
748767|NCT00420238|2393626|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
748768|NCT00420238|2393625|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
748769|NCT00420238|2393626|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
748770|NCT00420290|2393764|P2|Overall Study|did not meet inclusion/exclusion|1
748771|NCT00420290|2393765|P1|Overall Study|did not meet inclusion/exclusion|1
748772|NCT00420290|2393764|P2|Overall Study|Withdrawal by Subject|2
748773|NCT00420290|2393765|P1|Overall Study|Withdrawal by Subject|0
748774|NCT00420290|2393764|P2|Overall Study|Adverse Event|1
748775|NCT00420290|2393765|P1|Overall Study|Adverse Event|3
748776|NCT00420303|2393781|P2|Overall Study|Physician Decision|1
748777|NCT00420303|2393782|P1|Overall Study|Physician Decision|0
748778|NCT00420303|2393781|P2|Overall Study|Lack of Efficacy|3
748779|NCT00420303|2393782|P1|Overall Study|Lack of Efficacy|0
748780|NCT00420303|2393781|P2|Overall Study|Serious Adverse Event|0
748781|NCT00420303|2393782|P1|Overall Study|Serious Adverse Event|1
748782|NCT00420316|2393794|P2|Overall Study|Lost to Follow-up|8
748783|NCT00420316|2393795|P1|Overall Study|Lost to Follow-up|12
748784|NCT00420316|2393794|P2|Overall Study|Withdrawal by Subject|1
748785|NCT00420316|2393795|P1|Overall Study|Withdrawal by Subject|0
748786|NCT00420342|2393820|P3|Overall Study|Withdrawal by Subject|0
748787|NCT00420342|2393821|P2|Overall Study|Withdrawal by Subject|2
748788|NCT00420342|2393822|P1|Overall Study|Withdrawal by Subject|0
748789|NCT00420342|2393820|P3|Overall Study|Lost to Follow-up|1
748790|NCT00420342|2393821|P2|Overall Study|Lost to Follow-up|0
748791|NCT00420342|2393822|P1|Overall Study|Lost to Follow-up|1
748802|NCT00420420|2393874|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
748803|NCT00420420|2393875|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
748804|NCT00420420|2393874|P2|Overall Study|Withdrawal by Subject|0
748805|NCT00420420|2393875|P1|Overall Study|Withdrawal by Subject|1
748806|NCT00420420|2393874|P2|Overall Study|Protocol Violation|1
748807|NCT00420420|2393875|P1|Overall Study|Protocol Violation|1
748808|NCT00420420|2393874|P2|Overall Study|Adverse Event|3
748809|NCT00420420|2393875|P1|Overall Study|Adverse Event|5
748810|NCT00420511|2393902|P2|Overall Study|Lost to Follow-up|0
748811|NCT00420511|2393903|P1|Overall Study|Lost to Follow-up|1
748812|NCT00420511|2393902|P2|Overall Study|Adverse Event|1
748813|NCT00420511|2393903|P1|Overall Study|Adverse Event|1
748814|NCT00420628|2393915|P2|Overall Study|Adverse Event|0
748815|NCT00420628|2393916|P1|Overall Study|Adverse Event|1
748816|NCT00420628|2393915|P2|Overall Study|Lost to Follow-up|2
748817|NCT00420628|2393916|P1|Overall Study|Lost to Follow-up|3
748818|NCT00420628|2393915|P2|Overall Study|Withdrawn by parent or gaurdian|2
748819|NCT00420628|2393916|P1|Overall Study|Withdrawn by parent or gaurdian|5
748820|NCT00420745|2393932|P2|Overall Study|Age limit exceeded for Dose 2|0
748821|NCT00420745|2393933|P1|Overall Study|Age limit exceeded for Dose 2|1
748822|NCT00420745|2393932|P2|Overall Study|Recurrent pneumonia & bronchitis|1
748823|NCT00420745|2393933|P1|Overall Study|Recurrent pneumonia & bronchitis|0
748824|NCT00420745|2393932|P2|Overall Study|Physician Decision|1
748825|NCT00420745|2393933|P1|Overall Study|Physician Decision|1
748826|NCT00420745|2393932|P2|Overall Study|Protocol Violation|0
748827|NCT00420745|2393933|P1|Overall Study|Protocol Violation|1
748828|NCT00420745|2393932|P2|Overall Study|Lost to Follow-up|2
748829|NCT00420745|2393933|P1|Overall Study|Lost to Follow-up|10
748830|NCT00420745|2393932|P2|Overall Study|Adverse Event|2
748831|NCT00420745|2393933|P1|Overall Study|Adverse Event|2
748832|NCT00420784|2393953|P4|Overall Study|Unspecified|5
748833|NCT00420784|2393954|P3|Overall Study|Unspecified|0
748834|NCT00420784|2393955|P2|Overall Study|Unspecified|2
748835|NCT00420784|2393956|P1|Overall Study|Unspecified|1
748836|NCT00420784|2393953|P4|Overall Study|Virologic Stopping Rule|67
748837|NCT00420784|2393954|P3|Overall Study|Virologic Stopping Rule|41
748838|NCT00420784|2393955|P2|Overall Study|Virologic Stopping Rule|26
748839|NCT00420784|2393956|P1|Overall Study|Virologic Stopping Rule|17
748840|NCT00420784|2393953|P4|Overall Study|Lost to Follow-up|1
748841|NCT00420784|2393954|P3|Overall Study|Lost to Follow-up|2
748842|NCT00420784|2393955|P2|Overall Study|Lost to Follow-up|0
748843|NCT00420784|2393956|P1|Overall Study|Lost to Follow-up|0
748844|NCT00420784|2393953|P4|Overall Study|Withdrawal by Subject|0
748845|NCT00420784|2393954|P3|Overall Study|Withdrawal by Subject|0
748846|NCT00420784|2393955|P2|Overall Study|Withdrawal by Subject|1
748847|NCT00420784|2393956|P1|Overall Study|Withdrawal by Subject|0
748848|NCT00420784|2393953|P4|Overall Study|Adverse Event|5
748849|NCT00420784|2393954|P3|Overall Study|Adverse Event|10
748850|NCT00420784|2393955|P2|Overall Study|Adverse Event|29
748851|NCT00420784|2393956|P1|Overall Study|Adverse Event|11
748852|NCT00420849|2393983|P1|Overall Study|Lost to Follow-up|1
748853|NCT00420849|2393983|P1|Overall Study|Protocol Violation|1
748854|NCT00420849|2393983|P1|Overall Study|Transplant|8
748855|NCT00420849|2393983|P1|Overall Study|Not specified|14
748856|NCT00420849|2393983|P1|Overall Study|Death|18
748857|NCT00420849|2393983|P1|Overall Study|Withdrawal by Subject|28
748858|NCT00420849|2393983|P1|Overall Study|Adverse Event|107
748859|NCT00420849|2393983|P1|Overall Study|Lack of Efficacy|154
748860|NCT00420927|2394055|P7|Period 2|Took prohibited medication|0
748861|NCT00420927|2394056|P6|Period 2|Took prohibited medication|0
748862|NCT00420927|2394057|P5|Period 2|Took prohibited medication|1
748863|NCT00420927|2394058|P4|Period 2|Took prohibited medication|0
748864|NCT00420927|2394059|P3|Period 2|Took prohibited medication|0
748865|NCT00420927|2394060|P2|Period 2|Took prohibited medication|0
748866|NCT00420927|2394061|P1|Period 2|Took prohibited medication|0
748867|NCT00420927|2394055|P7|Period 2|Methotrexate intolerance|1
748868|NCT00420927|2394056|P6|Period 2|Methotrexate intolerance|0
748869|NCT00420927|2394057|P5|Period 2|Methotrexate intolerance|0
748870|NCT00420927|2394058|P4|Period 2|Methotrexate intolerance|0
748871|NCT00420927|2394059|P3|Period 2|Methotrexate intolerance|0
748872|NCT00420927|2394060|P2|Period 2|Methotrexate intolerance|0
748873|NCT00420927|2394061|P1|Period 2|Methotrexate intolerance|0
748874|NCT00420927|2394055|P7|Period 2|Noncompliant with study drug|2
748875|NCT00420927|2394056|P6|Period 2|Noncompliant with study drug|0
748876|NCT00420927|2394057|P5|Period 2|Noncompliant with study drug|0
748877|NCT00420927|2394058|P4|Period 2|Noncompliant with study drug|1
748878|NCT00420927|2394059|P3|Period 2|Noncompliant with study drug|0
748879|NCT00420927|2394060|P2|Period 2|Noncompliant with study drug|0
748880|NCT00420927|2394061|P1|Period 2|Noncompliant with study drug|0
748881|NCT00420927|2394055|P7|Period 2|Randomization error|0
748882|NCT00420927|2394056|P6|Period 2|Randomization error|1
748883|NCT00420927|2394057|P5|Period 2|Randomization error|1
748884|NCT00420927|2394058|P4|Period 2|Randomization error|0
748885|NCT00420927|2394059|P3|Period 2|Randomization error|0
748886|NCT00420927|2394060|P2|Period 2|Randomization error|0
748887|NCT00420927|2394061|P1|Period 2|Randomization error|0
748888|NCT00420927|2394055|P7|Period 2|Sponsor decision|1
748889|NCT00420927|2394056|P6|Period 2|Sponsor decision|0
748890|NCT00420927|2394057|P5|Period 2|Sponsor decision|0
748891|NCT00420927|2394058|P4|Period 2|Sponsor decision|0
748892|NCT00420927|2394059|P3|Period 2|Sponsor decision|1
748893|NCT00420927|2394060|P2|Period 2|Sponsor decision|0
748894|NCT00420927|2394061|P1|Period 2|Sponsor decision|0
748895|NCT00420927|2394055|P7|Period 2|Physician Decision|0
748896|NCT00420927|2394056|P6|Period 2|Physician Decision|1
748897|NCT00420927|2394057|P5|Period 2|Physician Decision|1
748898|NCT00420927|2394058|P4|Period 2|Physician Decision|0
748899|NCT00420927|2394059|P3|Period 2|Physician Decision|0
748900|NCT00420927|2394060|P2|Period 2|Physician Decision|0
748901|NCT00420927|2394061|P1|Period 2|Physician Decision|0
748902|NCT00420927|2394055|P7|Period 2|Subject unable to find transportation|1
748903|NCT00420927|2394056|P6|Period 2|Subject unable to find transportation|0
748904|NCT00420927|2394057|P5|Period 2|Subject unable to find transportation|0
748905|NCT00420927|2394058|P4|Period 2|Subject unable to find transportation|0
748906|NCT00420927|2394059|P3|Period 2|Subject unable to find transportation|0
748907|NCT00420927|2394060|P2|Period 2|Subject unable to find transportation|0
748908|NCT00420927|2394061|P1|Period 2|Subject unable to find transportation|0
748909|NCT00420927|2394055|P7|Period 2|Received wrong treatment/incorrect dose|1
748910|NCT00420927|2394056|P6|Period 2|Received wrong treatment/incorrect dose|0
748911|NCT00420927|2394057|P5|Period 2|Received wrong treatment/incorrect dose|0
748912|NCT00420927|2394058|P4|Period 2|Received wrong treatment/incorrect dose|0
748913|NCT00420927|2394059|P3|Period 2|Received wrong treatment/incorrect dose|0
748914|NCT00420927|2394060|P2|Period 2|Received wrong treatment/incorrect dose|0
748915|NCT00420927|2394061|P1|Period 2|Received wrong treatment/incorrect dose|0
748916|NCT00420927|2394055|P7|Period 2|Lack of efficacy/Loss of efficacy|6
748917|NCT00420927|2394056|P6|Period 2|Lack of efficacy/Loss of efficacy|2
748918|NCT00420927|2394057|P5|Period 2|Lack of efficacy/Loss of efficacy|6
748919|NCT00420927|2394058|P4|Period 2|Lack of efficacy/Loss of efficacy|1
748920|NCT00420927|2394059|P3|Period 2|Lack of efficacy/Loss of efficacy|2
748921|NCT00420927|2394060|P2|Period 2|Lack of efficacy/Loss of efficacy|0
748922|NCT00420927|2394061|P1|Period 2|Lack of efficacy/Loss of efficacy|0
748923|NCT00420927|2394055|P7|Period 2|Lost to Follow-up|9
748924|NCT00420927|2394056|P6|Period 2|Lost to Follow-up|3
748925|NCT00420927|2394057|P5|Period 2|Lost to Follow-up|6
748926|NCT00420927|2394058|P4|Period 2|Lost to Follow-up|2
748927|NCT00420927|2394059|P3|Period 2|Lost to Follow-up|2
748928|NCT00420927|2394060|P2|Period 2|Lost to Follow-up|0
748929|NCT00420927|2394061|P1|Period 2|Lost to Follow-up|0
748930|NCT00420927|2394055|P7|Period 2|Withdrawal by Subject|12
748931|NCT00420927|2394056|P6|Period 2|Withdrawal by Subject|2
748932|NCT00420927|2394057|P5|Period 2|Withdrawal by Subject|11
748933|NCT00420927|2394058|P4|Period 2|Withdrawal by Subject|3
748934|NCT00420927|2394059|P3|Period 2|Withdrawal by Subject|1
748935|NCT00420927|2394060|P2|Period 2|Withdrawal by Subject|0
748936|NCT00420927|2394061|P1|Period 2|Withdrawal by Subject|0
748937|NCT00420927|2394055|P7|Period 2|Adverse Event|20
748938|NCT00420927|2394056|P6|Period 2|Adverse Event|6
748939|NCT00420927|2394057|P5|Period 2|Adverse Event|17
748940|NCT00420927|2394058|P4|Period 2|Adverse Event|3
748941|NCT00420927|2394059|P3|Period 2|Adverse Event|7
748942|NCT00420927|2394060|P2|Period 2|Adverse Event|0
748943|NCT00420927|2394061|P1|Period 2|Adverse Event|0
748944|NCT00420927|2394055|P7|Period 1|Took prohibited medication|0
748945|NCT00420927|2394056|P6|Period 1|Took prohibited medication|0
748946|NCT00420927|2394057|P5|Period 1|Took prohibited medication|0
748947|NCT00420927|2394058|P4|Period 1|Took prohibited medication|0
748948|NCT00420927|2394059|P3|Period 1|Took prohibited medication|0
748949|NCT00420927|2394060|P2|Period 1|Took prohibited medication|3
748950|NCT00420927|2394061|P1|Period 1|Took prohibited medication|1
748951|NCT00420927|2394055|P7|Period 1|Failed to meet entry criteria|0
748952|NCT00420927|2394056|P6|Period 1|Failed to meet entry criteria|0
748953|NCT00420927|2394057|P5|Period 1|Failed to meet entry criteria|0
748954|NCT00420927|2394058|P4|Period 1|Failed to meet entry criteria|0
748955|NCT00420927|2394059|P3|Period 1|Failed to meet entry criteria|0
748956|NCT00420927|2394060|P2|Period 1|Failed to meet entry criteria|7
748957|NCT00420927|2394061|P1|Period 1|Failed to meet entry criteria|8
748958|NCT00420927|2394055|P7|Period 1|Received wrong treatment/incorrect dose|0
748959|NCT00420927|2394056|P6|Period 1|Received wrong treatment/incorrect dose|0
748960|NCT00420927|2394057|P5|Period 1|Received wrong treatment/incorrect dose|0
748961|NCT00420927|2394058|P4|Period 1|Received wrong treatment/incorrect dose|0
748962|NCT00420927|2394059|P3|Period 1|Received wrong treatment/incorrect dose|0
748963|NCT00420927|2394060|P2|Period 1|Received wrong treatment/incorrect dose|1
748964|NCT00420927|2394061|P1|Period 1|Received wrong treatment/incorrect dose|0
748965|NCT00420927|2394055|P7|Period 1|Subject received new diagnosis|0
748966|NCT00420927|2394056|P6|Period 1|Subject received new diagnosis|0
748967|NCT00420927|2394057|P5|Period 1|Subject received new diagnosis|0
748968|NCT00420927|2394058|P4|Period 1|Subject received new diagnosis|0
748969|NCT00420927|2394059|P3|Period 1|Subject received new diagnosis|0
748970|NCT00420927|2394060|P2|Period 1|Subject received new diagnosis|2
748971|NCT00420927|2394061|P1|Period 1|Subject received new diagnosis|0
748972|NCT00420927|2394055|P7|Period 1|Study site closure|0
748973|NCT00420927|2394056|P6|Period 1|Study site closure|0
748974|NCT00420927|2394057|P5|Period 1|Study site closure|0
748975|NCT00420927|2394058|P4|Period 1|Study site closure|0
748976|NCT00420927|2394059|P3|Period 1|Study site closure|0
748977|NCT00420927|2394060|P2|Period 1|Study site closure|1
748978|NCT00420927|2394061|P1|Period 1|Study site closure|0
748979|NCT00420927|2394055|P7|Period 1|Suspected tuberculosis/positive test|0
748980|NCT00420927|2394056|P6|Period 1|Suspected tuberculosis/positive test|0
748981|NCT00420927|2394057|P5|Period 1|Suspected tuberculosis/positive test|0
748982|NCT00420927|2394058|P4|Period 1|Suspected tuberculosis/positive test|0
748983|NCT00420927|2394059|P3|Period 1|Suspected tuberculosis/positive test|0
748984|NCT00420927|2394060|P2|Period 1|Suspected tuberculosis/positive test|1
748985|NCT00420927|2394061|P1|Period 1|Suspected tuberculosis/positive test|1
748986|NCT00420927|2394055|P7|Period 1|Randomization error|0
748987|NCT00420927|2394056|P6|Period 1|Randomization error|0
748988|NCT00420927|2394057|P5|Period 1|Randomization error|0
748989|NCT00420927|2394058|P4|Period 1|Randomization error|0
748990|NCT00420927|2394059|P3|Period 1|Randomization error|0
748991|NCT00420927|2394060|P2|Period 1|Randomization error|0
748992|NCT00420927|2394061|P1|Period 1|Randomization error|1
748993|NCT00420927|2394055|P7|Period 1|Noncompliant with study drug|0
748994|NCT00420927|2394056|P6|Period 1|Noncompliant with study drug|0
748995|NCT00420927|2394057|P5|Period 1|Noncompliant with study drug|0
748996|NCT00420927|2394058|P4|Period 1|Noncompliant with study drug|0
748997|NCT00420927|2394059|P3|Period 1|Noncompliant with study drug|0
748998|NCT00420927|2394060|P2|Period 1|Noncompliant with study drug|1
748999|NCT00420927|2394061|P1|Period 1|Noncompliant with study drug|1
749000|NCT00420927|2394055|P7|Period 1|Subject moved/relocated|0
749001|NCT00420927|2394056|P6|Period 1|Subject moved/relocated|0
749002|NCT00420927|2394057|P5|Period 1|Subject moved/relocated|0
749003|NCT00420927|2394058|P4|Period 1|Subject moved/relocated|0
749004|NCT00420927|2394059|P3|Period 1|Subject moved/relocated|0
749005|NCT00420927|2394060|P2|Period 1|Subject moved/relocated|2
749006|NCT00420927|2394061|P1|Period 1|Subject moved/relocated|0
749007|NCT00420927|2394055|P7|Period 1|Death|0
749008|NCT00420927|2394056|P6|Period 1|Death|0
749009|NCT00420927|2394057|P5|Period 1|Death|0
749010|NCT00420927|2394058|P4|Period 1|Death|0
749011|NCT00420927|2394059|P3|Period 1|Death|0
749012|NCT00420927|2394060|P2|Period 1|Death|0
749013|NCT00420927|2394061|P1|Period 1|Death|2
749014|NCT00420927|2394055|P7|Period 1|Lack of efficacy/Loss of efficacy|0
749015|NCT00420927|2394056|P6|Period 1|Lack of efficacy/Loss of efficacy|0
749016|NCT00420927|2394057|P5|Period 1|Lack of efficacy/Loss of efficacy|0
749017|NCT00420927|2394058|P4|Period 1|Lack of efficacy/Loss of efficacy|0
749018|NCT00420927|2394059|P3|Period 1|Lack of efficacy/Loss of efficacy|0
749019|NCT00420927|2394060|P2|Period 1|Lack of efficacy/Loss of efficacy|6
749020|NCT00420927|2394061|P1|Period 1|Lack of efficacy/Loss of efficacy|1
749021|NCT00420927|2394055|P7|Period 1|Lost to Follow-up|0
749022|NCT00420927|2394056|P6|Period 1|Lost to Follow-up|0
749023|NCT00420927|2394057|P5|Period 1|Lost to Follow-up|0
749024|NCT00420927|2394058|P4|Period 1|Lost to Follow-up|0
749025|NCT00420927|2394059|P3|Period 1|Lost to Follow-up|0
749026|NCT00420927|2394060|P2|Period 1|Lost to Follow-up|6
749027|NCT00420927|2394061|P1|Period 1|Lost to Follow-up|8
749028|NCT00420927|2394055|P7|Period 1|Withdrawal by Subject|0
749029|NCT00420927|2394056|P6|Period 1|Withdrawal by Subject|0
749030|NCT00420927|2394057|P5|Period 1|Withdrawal by Subject|0
749031|NCT00420927|2394058|P4|Period 1|Withdrawal by Subject|0
749032|NCT00420927|2394059|P3|Period 1|Withdrawal by Subject|0
749033|NCT00420927|2394060|P2|Period 1|Withdrawal by Subject|12
749034|NCT00420927|2394061|P1|Period 1|Withdrawal by Subject|7
749035|NCT00420927|2394055|P7|Period 1|Adverse Event|0
749036|NCT00420927|2394056|P6|Period 1|Adverse Event|0
749037|NCT00420927|2394057|P5|Period 1|Adverse Event|0
749038|NCT00420927|2394058|P4|Period 1|Adverse Event|0
749039|NCT00420927|2394059|P3|Period 1|Adverse Event|0
749040|NCT00420927|2394060|P2|Period 1|Adverse Event|15
749041|NCT00420927|2394061|P1|Period 1|Adverse Event|19
749042|NCT00421174|2394177|P2|Overall Study|Ineligible due to infection|0
749043|NCT00421174|2394178|P1|Overall Study|Ineligible due to infection|2
749044|NCT00421174|2394177|P2|Overall Study|Withdrawal by Subject|1
749045|NCT00421174|2394178|P1|Overall Study|Withdrawal by Subject|0
749046|NCT00421343|2394206|P1|Overall Study|Lost to follow-up|3
749047|NCT00421343|2394206|P1|Overall Study|Withdrawal by Subject|2
749048|NCT00421343|2394206|P1|Overall Study|Death|1
749049|NCT00421408|2394212|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
749050|NCT00421408|2394213|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
749051|NCT00421408|2394212|P2|Overall Study|Lost to Follow-up|20
749052|NCT00421408|2394213|P1|Overall Study|Lost to Follow-up|30
749053|NCT00421733|2394243|P3|Overall Study|Protocol deviation|2
749054|NCT00421733|2394244|P2|Overall Study|Protocol deviation|7
749055|NCT00421733|2394245|P1|Overall Study|Protocol deviation|4
749056|NCT00421733|2394243|P3|Overall Study|Sponsor request|3
749057|NCT00421733|2394244|P2|Overall Study|Sponsor request|0
749058|NCT00421733|2394245|P1|Overall Study|Sponsor request|1
749059|NCT00421733|2394243|P3|Overall Study|Did not satisfy entry criteria|2
749060|NCT00421733|2394244|P2|Overall Study|Did not satisfy entry criteria|3
749061|NCT00421733|2394245|P1|Overall Study|Did not satisfy entry criteria|1
749062|NCT00421733|2394243|P3|Overall Study|Administrative|0
749063|NCT00421733|2394244|P2|Overall Study|Administrative|0
749064|NCT00421733|2394245|P1|Overall Study|Administrative|2
749065|NCT00421733|2394243|P3|Overall Study|Required dialysis|0
749066|NCT00421733|2394244|P2|Overall Study|Required dialysis|0
749067|NCT00421733|2394245|P1|Overall Study|Required dialysis|1
749068|NCT00421733|2394243|P3|Overall Study|Death|0
749069|NCT00421733|2394244|P2|Overall Study|Death|3
749070|NCT00421733|2394245|P1|Overall Study|Death|0
749071|NCT00421733|2394243|P3|Overall Study|Withdrawal by Subject|7
749072|NCT00421733|2394244|P2|Overall Study|Withdrawal by Subject|2
749073|NCT00421733|2394245|P1|Overall Study|Withdrawal by Subject|1
749074|NCT00421733|2394243|P3|Overall Study|Lost to Follow-up|4
749075|NCT00421733|2394244|P2|Overall Study|Lost to Follow-up|2
749076|NCT00421733|2394245|P1|Overall Study|Lost to Follow-up|1
749077|NCT00421733|2394243|P3|Overall Study|Adverse Event|2
749078|NCT00421733|2394244|P2|Overall Study|Adverse Event|9
749079|NCT00421733|2394245|P1|Overall Study|Adverse Event|4
749080|NCT00421889|2394272|P9|Overall Study|Lost to Follow-up|1
749081|NCT00421889|2394273|P8|Overall Study|Lost to Follow-up|0
749082|NCT00421889|2394274|P7|Overall Study|Lost to Follow-up|0
749083|NCT00421889|2394275|P6|Overall Study|Lost to Follow-up|0
749084|NCT00421889|2394276|P5|Overall Study|Lost to Follow-up|0
749085|NCT00421889|2394277|P4|Overall Study|Lost to Follow-up|0
749086|NCT00421889|2394278|P3|Overall Study|Lost to Follow-up|0
749087|NCT00421889|2394279|P2|Overall Study|Lost to Follow-up|0
749088|NCT00421889|2394280|P1|Overall Study|Lost to Follow-up|0
749089|NCT00421889|2394272|P9|Overall Study|Patient/Investigator request|3
749090|NCT00421889|2394273|P8|Overall Study|Patient/Investigator request|1
749091|NCT00421889|2394274|P7|Overall Study|Patient/Investigator request|0
749092|NCT00421889|2394275|P6|Overall Study|Patient/Investigator request|9
749093|NCT00421889|2394276|P5|Overall Study|Patient/Investigator request|0
749094|NCT00421889|2394277|P4|Overall Study|Patient/Investigator request|0
749095|NCT00421889|2394278|P3|Overall Study|Patient/Investigator request|0
749096|NCT00421889|2394279|P2|Overall Study|Patient/Investigator request|0
749097|NCT00421889|2394280|P1|Overall Study|Patient/Investigator request|0
749098|NCT00421889|2394272|P9|Overall Study|Progressive disease|5
749099|NCT00421889|2394273|P8|Overall Study|Progressive disease|1
749100|NCT00421889|2394274|P7|Overall Study|Progressive disease|3
749101|NCT00421889|2394275|P6|Overall Study|Progressive disease|21
749102|NCT00421889|2394276|P5|Overall Study|Progressive disease|2
749103|NCT00421889|2394277|P4|Overall Study|Progressive disease|3
749104|NCT00421889|2394278|P3|Overall Study|Progressive disease|2
749105|NCT00421889|2394279|P2|Overall Study|Progressive disease|2
749106|NCT00421889|2394280|P1|Overall Study|Progressive disease|3
749107|NCT00421889|2394272|P9|Overall Study|Death|0
749108|NCT00421889|2394273|P8|Overall Study|Death|0
749109|NCT00421889|2394274|P7|Overall Study|Death|0
749110|NCT00421889|2394275|P6|Overall Study|Death|1
749111|NCT00421889|2394276|P5|Overall Study|Death|1
749112|NCT00421889|2394277|P4|Overall Study|Death|0
749113|NCT00421889|2394278|P3|Overall Study|Death|0
749114|NCT00421889|2394279|P2|Overall Study|Death|0
749115|NCT00421889|2394280|P1|Overall Study|Death|0
749116|NCT00421889|2394272|P9|Overall Study|Withdrawal by Subject|0
749117|NCT00421889|2394273|P8|Overall Study|Withdrawal by Subject|0
749118|NCT00421889|2394274|P7|Overall Study|Withdrawal by Subject|0
749119|NCT00421889|2394275|P6|Overall Study|Withdrawal by Subject|0
749120|NCT00421889|2394276|P5|Overall Study|Withdrawal by Subject|2
749121|NCT00421889|2394277|P4|Overall Study|Withdrawal by Subject|0
749122|NCT00421889|2394278|P3|Overall Study|Withdrawal by Subject|0
749123|NCT00421889|2394279|P2|Overall Study|Withdrawal by Subject|3
749124|NCT00421889|2394280|P1|Overall Study|Withdrawal by Subject|1
749125|NCT00421889|2394272|P9|Overall Study|Adverse Event|2
749126|NCT00421889|2394273|P8|Overall Study|Adverse Event|0
749127|NCT00421889|2394274|P7|Overall Study|Adverse Event|1
749128|NCT00421889|2394275|P6|Overall Study|Adverse Event|4
749129|NCT00421889|2394276|P5|Overall Study|Adverse Event|1
749130|NCT00421889|2394277|P4|Overall Study|Adverse Event|1
749131|NCT00421889|2394278|P3|Overall Study|Adverse Event|1
749132|NCT00421889|2394279|P2|Overall Study|Adverse Event|0
749133|NCT00421889|2394280|P1|Overall Study|Adverse Event|1
749134|NCT00421928|2394325|P3|Overall Study|Death|0
749135|NCT00421928|2394326|P2|Overall Study|Death|1
749136|NCT00421928|2394327|P1|Overall Study|Death|0
749137|NCT00421928|2394325|P3|Overall Study|All other|27
749138|NCT00421928|2394326|P2|Overall Study|All other|21
749139|NCT00421928|2394327|P1|Overall Study|All other|26
749140|NCT00421928|2394325|P3|Overall Study|Study drug non-compliant|4
749141|NCT00421928|2394326|P2|Overall Study|Study drug non-compliant|7
749142|NCT00421928|2394327|P1|Overall Study|Study drug non-compliant|6
749143|NCT00421928|2394325|P3|Overall Study|Lack of Efficacy|35
749144|NCT00421928|2394326|P2|Overall Study|Lack of Efficacy|7
749145|NCT00421928|2394327|P1|Overall Study|Lack of Efficacy|15
749146|NCT00421928|2394325|P3|Overall Study|Withdrawal by Subject|43
749147|NCT00421928|2394326|P2|Overall Study|Withdrawal by Subject|48
749148|NCT00421928|2394327|P1|Overall Study|Withdrawal by Subject|50
749149|NCT00421928|2394325|P3|Overall Study|Lost to Follow-up|3
749150|NCT00421928|2394326|P2|Overall Study|Lost to Follow-up|0
749151|NCT00421928|2394327|P1|Overall Study|Lost to Follow-up|5
749152|NCT00421928|2394325|P3|Overall Study|Adverse Event|22
749153|NCT00421928|2394326|P2|Overall Study|Adverse Event|140
749154|NCT00421928|2394327|P1|Overall Study|Adverse Event|61
749155|NCT00421993|2394361|P4|Overall Study|Subject transportation issues|1
749156|NCT00421993|2394362|P3|Overall Study|Subject transportation issues|0
749157|NCT00421993|2394363|P2|Overall Study|Subject transportation issues|0
749158|NCT00421993|2394364|P1|Overall Study|Subject transportation issues|0
749159|NCT00421993|2394361|P4|Overall Study|Pregnancy|2
749160|NCT00421993|2394362|P3|Overall Study|Pregnancy|1
749161|NCT00421993|2394363|P2|Overall Study|Pregnancy|1
749162|NCT00421993|2394364|P1|Overall Study|Pregnancy|0
749163|NCT00421993|2394361|P4|Overall Study|Lack of Efficacy|5
749164|NCT00421993|2394362|P3|Overall Study|Lack of Efficacy|0
749165|NCT00421993|2394363|P2|Overall Study|Lack of Efficacy|3
749166|NCT00421993|2394364|P1|Overall Study|Lack of Efficacy|0
749167|NCT00421993|2394361|P4|Overall Study|Protocol Violation|1
749168|NCT00421993|2394362|P3|Overall Study|Protocol Violation|0
749169|NCT00421993|2394363|P2|Overall Study|Protocol Violation|2
749170|NCT00421993|2394364|P1|Overall Study|Protocol Violation|2
749171|NCT00421993|2394361|P4|Overall Study|Adverse Event|4
749172|NCT00421993|2394362|P3|Overall Study|Adverse Event|6
749173|NCT00421993|2394363|P2|Overall Study|Adverse Event|1
749174|NCT00421993|2394364|P1|Overall Study|Adverse Event|11
749175|NCT00421993|2394361|P4|Overall Study|Lost to Follow-up|20
749176|NCT00421993|2394362|P3|Overall Study|Lost to Follow-up|22
749177|NCT00421993|2394363|P2|Overall Study|Lost to Follow-up|19
749178|NCT00421993|2394364|P1|Overall Study|Lost to Follow-up|18
749179|NCT00421993|2394361|P4|Overall Study|Withdrawal by Subject|24
749180|NCT00421993|2394362|P3|Overall Study|Withdrawal by Subject|23
749181|NCT00421993|2394363|P2|Overall Study|Withdrawal by Subject|23
749182|NCT00421993|2394364|P1|Overall Study|Withdrawal by Subject|22
890812|NCT00779467|2826118|P4|Overall Study|unavailable research staff|1
890813|NCT00779467|2826119|P3|Overall Study|unavailable research staff|0
890814|NCT00779467|2826120|P2|Overall Study|unavailable research staff|0
890815|NCT00779467|2826121|P1|Overall Study|unavailable research staff|0
890816|NCT00779467|2826118|P4|Overall Study|technical issue|1
890817|NCT00779467|2826119|P3|Overall Study|technical issue|2
890818|NCT00779467|2826120|P2|Overall Study|technical issue|0
890819|NCT00779467|2826121|P1|Overall Study|technical issue|0
890820|NCT00779467|2826118|P4|Overall Study|missing data|4
890821|NCT00779467|2826119|P3|Overall Study|missing data|1
890822|NCT00779467|2826120|P2|Overall Study|missing data|0
890823|NCT00779467|2826121|P1|Overall Study|missing data|1
890824|NCT00779467|2826118|P4|Overall Study|failed inclusion criteria|2
890825|NCT00779467|2826119|P3|Overall Study|failed inclusion criteria|1
890826|NCT00779467|2826120|P2|Overall Study|failed inclusion criteria|3
890827|NCT00779467|2826121|P1|Overall Study|failed inclusion criteria|3
890828|NCT00779467|2826118|P4|Overall Study|Lack of Efficacy|11
890829|NCT00779467|2826119|P3|Overall Study|Lack of Efficacy|6
890830|NCT00779467|2826120|P2|Overall Study|Lack of Efficacy|2
890831|NCT00779467|2826121|P1|Overall Study|Lack of Efficacy|11
890832|NCT00779142|2826159|P1|Overall Study|Screen Failures|3
749237|NCT00422097|2394548|P8|Dose Level 2|Still on treatment|0
749238|NCT00422097|2394549|P7|Dose Level 2|Still on treatment|0
749239|NCT00422097|2394550|P6|Dose Level 2|Still on treatment|0
749240|NCT00422097|2394551|P5|Dose Level 2|Still on treatment|0
749241|NCT00422097|2394552|P4|Dose Level 2|Still on treatment|0
749242|NCT00422097|2394553|P3|Dose Level 2|Still on treatment|0
749243|NCT00422097|2394554|P2|Dose Level 2|Still on treatment|1
749244|NCT00422097|2394555|P1|Dose Level 2|Still on treatment|0
749245|NCT00422162|2394616|P2|Overall Study|Didn't Receive Treatment|1
749246|NCT00422162|2394617|P1|Overall Study|Didn't Receive Treatment|0
749247|NCT00422162|2394616|P2|Overall Study|Not Specified|1
749248|NCT00422162|2394617|P1|Overall Study|Not Specified|0
749249|NCT00422162|2394616|P2|Overall Study|Non-Compliant with Protocol|1
749250|NCT00422162|2394617|P1|Overall Study|Non-Compliant with Protocol|1
749251|NCT00422162|2394616|P2|Overall Study|Lost to Follow-up|2
749252|NCT00422162|2394617|P1|Overall Study|Lost to Follow-up|1
749253|NCT00422162|2394616|P2|Overall Study|Withdrawal by Subject|6
749254|NCT00422162|2394617|P1|Overall Study|Withdrawal by Subject|7
749255|NCT00422162|2394616|P2|Overall Study|Lack of Efficacy|10
749256|NCT00422162|2394617|P1|Overall Study|Lack of Efficacy|4
749257|NCT00422162|2394616|P2|Overall Study|Adverse Event|9
749258|NCT00422162|2394617|P1|Overall Study|Adverse Event|11
749259|NCT00422227|2394677|P2|Overall Study|Withdrawal by Subject|4
749260|NCT00422227|2394678|P1|Overall Study|Withdrawal by Subject|0
749261|NCT00422227|2394677|P2|Overall Study|Lost to Follow-up|3
749262|NCT00422227|2394678|P1|Overall Study|Lost to Follow-up|1
749263|NCT00422227|2394677|P2|Overall Study|Adverse Event|8
749264|NCT00422227|2394678|P1|Overall Study|Adverse Event|3
749265|NCT00422292|2394717|P4|Overall Study|Withdrawal by Subject|13
749266|NCT00422292|2394718|P3|Overall Study|Withdrawal by Subject|7
749267|NCT00422292|2394719|P2|Overall Study|Withdrawal by Subject|25
749268|NCT00422292|2394720|P1|Overall Study|Withdrawal by Subject|6
749269|NCT00422292|2394717|P4|Overall Study|Lost to Follow-up|6
749270|NCT00422292|2394718|P3|Overall Study|Lost to Follow-up|6
749271|NCT00422292|2394719|P2|Overall Study|Lost to Follow-up|12
749272|NCT00422292|2394720|P1|Overall Study|Lost to Follow-up|6
749273|NCT00422292|2394717|P4|Overall Study|Protocol Violation|5
749274|NCT00422292|2394718|P3|Overall Study|Protocol Violation|8
749275|NCT00422292|2394719|P2|Overall Study|Protocol Violation|25
749276|NCT00422292|2394720|P1|Overall Study|Protocol Violation|4
749277|NCT00422292|2394717|P4|Overall Study|Adverse Event|0
749278|NCT00422292|2394718|P3|Overall Study|Adverse Event|1
749279|NCT00422292|2394719|P2|Overall Study|Adverse Event|0
749280|NCT00422292|2394720|P1|Overall Study|Adverse Event|1
749281|NCT00422292|2394717|P4|Overall Study|Serious adverse events|0
749282|NCT00422292|2394718|P3|Overall Study|Serious adverse events|0
749283|NCT00422292|2394719|P2|Overall Study|Serious adverse events|4
749284|NCT00422292|2394720|P1|Overall Study|Serious adverse events|1
749285|NCT00422383|2394751|P5|Overall Study|Withdrawal by Subject|1
749286|NCT00422383|2394752|P4|Overall Study|Withdrawal by Subject|0
749287|NCT00422383|2394753|P3|Overall Study|Withdrawal by Subject|0
749288|NCT00422383|2394754|P2|Overall Study|Withdrawal by Subject|5
749289|NCT00422383|2394755|P1|Overall Study|Withdrawal by Subject|5
749290|NCT00422383|2394751|P5|Overall Study|Protocol Violation|0
749291|NCT00422383|2394752|P4|Overall Study|Protocol Violation|0
749292|NCT00422383|2394753|P3|Overall Study|Protocol Violation|1
749293|NCT00422383|2394754|P2|Overall Study|Protocol Violation|1
749294|NCT00422383|2394755|P1|Overall Study|Protocol Violation|1
749295|NCT00422383|2394751|P5|Overall Study|Lost to Follow-up|1
749296|NCT00422383|2394752|P4|Overall Study|Lost to Follow-up|0
749297|NCT00422383|2394753|P3|Overall Study|Lost to Follow-up|0
749298|NCT00422383|2394754|P2|Overall Study|Lost to Follow-up|1
749299|NCT00422383|2394755|P1|Overall Study|Lost to Follow-up|0
749300|NCT00422383|2394751|P5|Overall Study|Lack of Efficacy|1
749301|NCT00422383|2394752|P4|Overall Study|Lack of Efficacy|1
749302|NCT00422383|2394753|P3|Overall Study|Lack of Efficacy|2
749303|NCT00422383|2394754|P2|Overall Study|Lack of Efficacy|4
749304|NCT00422383|2394755|P1|Overall Study|Lack of Efficacy|4
749305|NCT00422383|2394751|P5|Overall Study|Adverse Event|0
749306|NCT00422383|2394752|P4|Overall Study|Adverse Event|1
749307|NCT00422383|2394753|P3|Overall Study|Adverse Event|1
749308|NCT00422383|2394754|P2|Overall Study|Adverse Event|3
749309|NCT00422383|2394755|P1|Overall Study|Adverse Event|5
749310|NCT00413777|2394896|P2|Fixed-dose Period|Withdrew Consent|1
749311|NCT00413777|2394897|P1|Fixed-dose Period|Withdrew Consent|0
749312|NCT00413777|2394896|P2|Fixed-dose Period|Met Withdrawal Criteria|0
749313|NCT00413777|2394897|P1|Fixed-dose Period|Met Withdrawal Criteria|1
749314|NCT00413777|2394896|P2|Fixed-dose Period|Adverse Event|1
749315|NCT00413777|2394897|P1|Fixed-dose Period|Adverse Event|2
749316|NCT00413777|2394896|P2|Fixed-dose Period|Lost to Follow-up|1
749317|NCT00413777|2394897|P1|Fixed-dose Period|Lost to Follow-up|1
749318|NCT00413894|2394943|P1|Overall Study|Unspecified|18
749319|NCT00413894|2394943|P1|Overall Study|Protocol Violation|11
749320|NCT00413894|2394943|P1|Overall Study|Adverse Event|28
749321|NCT00413894|2394943|P1|Overall Study|Hb <10 grams/deciliter|12
749322|NCT00413894|2394943|P1|Overall Study|Administrative Reasons|1
749323|NCT00413894|2394943|P1|Overall Study|Withdrawal by Subject|10
749324|NCT00413920|2394960|P2|Overall Study|Graft Loss|3
749325|NCT00413920|2394961|P1|Overall Study|Graft Loss|5
749326|NCT00413920|2394960|P2|Overall Study|Death|5
749327|NCT00413920|2394961|P1|Overall Study|Death|3
749328|NCT00413920|2394960|P2|Overall Study|Lack of Efficacy|9
749329|NCT00413920|2394961|P1|Overall Study|Lack of Efficacy|11
749330|NCT00413920|2394960|P2|Overall Study|Adverse Event|11
749331|NCT00413920|2394961|P1|Overall Study|Adverse Event|9
749332|NCT00413959|2394976|P1|Overall Study|Pt had only one cycle.|1
749333|NCT00413972|2394985|P4|Overall Study|Not Specified|1
749334|NCT00413972|2394986|P3|Overall Study|Not Specified|0
749335|NCT00413972|2394987|P2|Overall Study|Not Specified|0
749336|NCT00413972|2394988|P1|Overall Study|Not Specified|0
749337|NCT00413972|2394985|P4|Overall Study|Protocol Violation|0
749338|NCT00413972|2394986|P3|Overall Study|Protocol Violation|2
749339|NCT00413972|2394987|P2|Overall Study|Protocol Violation|0
749340|NCT00413972|2394988|P1|Overall Study|Protocol Violation|0
749341|NCT00413972|2394985|P4|Overall Study|Withdrawal by Subject|2
749342|NCT00413972|2394986|P3|Overall Study|Withdrawal by Subject|7
749343|NCT00413972|2394987|P2|Overall Study|Withdrawal by Subject|5
749344|NCT00413972|2394988|P1|Overall Study|Withdrawal by Subject|4
749345|NCT00413972|2394985|P4|Overall Study|Lost to Follow-up|0
749346|NCT00413972|2394986|P3|Overall Study|Lost to Follow-up|1
749347|NCT00413972|2394987|P2|Overall Study|Lost to Follow-up|2
749348|NCT00413972|2394988|P1|Overall Study|Lost to Follow-up|1
749349|NCT00413972|2394985|P4|Overall Study|Adverse Event|0
749350|NCT00413972|2394986|P3|Overall Study|Adverse Event|0
749351|NCT00413972|2394987|P2|Overall Study|Adverse Event|1
749352|NCT00413972|2394988|P1|Overall Study|Adverse Event|2
749353|NCT00414011|2394998|P1|Overall Study|Withdrawal by Subject|2
749354|NCT00414011|2394998|P1|Overall Study|Physician Decision|3
749355|NCT00414050|2395007|P4|Overall Study|Subject Moved|1
749356|NCT00414050|2395008|P3|Overall Study|Subject Moved|0
749357|NCT00414050|2395009|P2|Overall Study|Subject Moved|0
749358|NCT00414050|2395010|P1|Overall Study|Subject Moved|0
749359|NCT00414050|2395007|P4|Overall Study|Subject discontinued for other reason|1
749360|NCT00414050|2395008|P3|Overall Study|Subject discontinued for other reason|2
749361|NCT00414050|2395009|P2|Overall Study|Subject discontinued for other reason|2
749362|NCT00414050|2395010|P1|Overall Study|Subject discontinued for other reason|1
749363|NCT00414050|2395007|P4|Overall Study|Withdrawal by Subject|4
749364|NCT00414050|2395008|P3|Overall Study|Withdrawal by Subject|2
749365|NCT00414050|2395009|P2|Overall Study|Withdrawal by Subject|3
749366|NCT00414050|2395010|P1|Overall Study|Withdrawal by Subject|5
749367|NCT00414050|2395007|P4|Overall Study|Lost to Follow-up|1
749368|NCT00414050|2395008|P3|Overall Study|Lost to Follow-up|1
749369|NCT00414050|2395009|P2|Overall Study|Lost to Follow-up|2
749370|NCT00414050|2395010|P1|Overall Study|Lost to Follow-up|2
749371|NCT00414050|2395007|P4|Overall Study|Adverse Event|1
749372|NCT00414050|2395008|P3|Overall Study|Adverse Event|1
749373|NCT00414050|2395009|P2|Overall Study|Adverse Event|1
749374|NCT00414050|2395010|P1|Overall Study|Adverse Event|1
749375|NCT00414310|2395050|P2|Overall Study|Not treated|0
749376|NCT00414310|2395051|P1|Overall Study|Not treated|1
749377|NCT00414388|2395057|P1|Overall Study|Adverse Event|1
749378|NCT00414440|2395065|P2|Extension Period|Not included in follow up period|8
749379|NCT00414440|2395066|P1|Extension Period|Not included in follow up period|18
749380|NCT00414440|2395065|P2|Extension Period|Withdrawal by Subject|7
749381|NCT00414440|2395066|P1|Extension Period|Withdrawal by Subject|9
749382|NCT00414440|2395065|P2|Extension Period|Death|2
749383|NCT00414440|2395066|P1|Extension Period|Death|1
749384|NCT00414440|2395065|P2|Extension Period|Administrative|16
749385|NCT00414440|2395066|P1|Extension Period|Administrative|16
749386|NCT00414440|2395065|P2|Extension Period|Other|1
749387|NCT00414440|2395066|P1|Extension Period|Other|1
749388|NCT00414440|2395065|P2|Extension Period|Did not consent to continue follow up|54
749389|NCT00414440|2395066|P1|Extension Period|Did not consent to continue follow up|61
749390|NCT00414440|2395065|P2|Extension Period|Lost to Follow-up|52
749391|NCT00414440|2395066|P1|Extension Period|Lost to Follow-up|44
749392|NCT00414440|2395065|P2|Core Period|Withdrawal by Subject|32
749393|NCT00414440|2395066|P1|Core Period|Withdrawal by Subject|70
749394|NCT00414453|2395080|P1|Overall Study|Abnormal lab work|16
749395|NCT00414466|2395130|P4|Overall Study|Withdrawn by Sponsor|0
749396|NCT00414466|2395131|P3|Overall Study|Withdrawn by Sponsor|0
749397|NCT00414466|2395132|P2|Overall Study|Withdrawn by Sponsor|0
749398|NCT00414466|2395133|P1|Overall Study|Withdrawn by Sponsor|1
749399|NCT00414466|2395130|P4|Overall Study|Lack of Efficacy|0
749400|NCT00414466|2395131|P3|Overall Study|Lack of Efficacy|0
749401|NCT00414466|2395132|P2|Overall Study|Lack of Efficacy|0
749402|NCT00414466|2395133|P1|Overall Study|Lack of Efficacy|1
749403|NCT00414466|2395130|P4|Overall Study|Adverse Event|1
749404|NCT00414466|2395131|P3|Overall Study|Adverse Event|1
749405|NCT00414466|2395132|P2|Overall Study|Adverse Event|0
749406|NCT00414466|2395133|P1|Overall Study|Adverse Event|0
749407|NCT00422422|2395151|P1|Overall Study|AE, non-serious non-fatal|5
749408|NCT00422422|2395151|P1|Overall Study|SAE, non-fatal|1
749409|NCT00422422|2395151|P1|Overall Study|Withdrawal by Subject|2
749410|NCT00422422|2395151|P1|Overall Study|Protocol Violation|1
749411|NCT00422422|2395151|P1|Overall Study|Lack of Efficacy|1
749412|NCT00422513|2395170|P2|Overall Study|Death|7
749413|NCT00422513|2395171|P1|Overall Study|Death|3
749414|NCT00422513|2395170|P2|Overall Study|Adverse Event|4
749415|NCT00422513|2395171|P1|Overall Study|Adverse Event|4
749416|NCT00422513|2395170|P2|Overall Study|early termination of the study|80
749417|NCT00422513|2395171|P1|Overall Study|early termination of the study|67
749418|NCT00422513|2395170|P2|Overall Study|Withdrawal by Subject|1
749419|NCT00422513|2395171|P1|Overall Study|Withdrawal by Subject|2
749420|NCT00422513|2395170|P2|Overall Study|Refused Treatment|2
749421|NCT00422513|2395171|P1|Overall Study|Refused Treatment|4
749422|NCT00422513|2395170|P2|Overall Study|Protocol Violation|7
749423|NCT00422513|2395171|P1|Overall Study|Protocol Violation|23
749424|NCT00422513|2395170|P2|Overall Study|Lack of Efficacy|5
749425|NCT00422513|2395171|P1|Overall Study|Lack of Efficacy|4
749426|NCT00422669|2395190|P3|Overall Study|The study was terminated early.|7
749427|NCT00422669|2395191|P2|Overall Study|The study was terminated early.|100
749428|NCT00422669|2395192|P1|Overall Study|The study was terminated early.|98
749429|NCT00422734|2395226|P2|Overall Study|Partner Decision|3
749430|NCT00422734|2395227|P1|Overall Study|Partner Decision|0
749431|NCT00422734|2395226|P2|Overall Study|Adverse Event|3
749432|NCT00422734|2395227|P1|Overall Study|Adverse Event|0
749433|NCT00422734|2395226|P2|Overall Study|Withdrawal by Subject|8
749434|NCT00422734|2395227|P1|Overall Study|Withdrawal by Subject|12
749435|NCT00422734|2395226|P2|Overall Study|Protocol Violation|6
749436|NCT00422734|2395227|P1|Overall Study|Protocol Violation|1
749437|NCT00422734|2395226|P2|Overall Study|Physician Decision|1
749438|NCT00422734|2395227|P1|Overall Study|Physician Decision|1
749439|NCT00423852|2395259|P1|Overall Study|Removed pior to the high-dose portion|3
749440|NCT00423891|2395278|P3|Post-Dosing Follow Up|Continuing Post Dosing Follow up|1
749441|NCT00423891|2395279|P2|Post-Dosing Follow Up|Continuing Post Dosing Follow up|15
749442|NCT00423891|2395280|P1|Post-Dosing Follow Up|Continuing Post Dosing Follow up|0
749443|NCT00423891|2395278|P3|Post-Dosing Follow Up|Lost to Follow-up|0
749444|NCT00423891|2395279|P2|Post-Dosing Follow Up|Lost to Follow-up|0
749445|NCT00423891|2395280|P1|Post-Dosing Follow Up|Lost to Follow-up|2
749446|NCT00423891|2395278|P3|Post-Dosing Follow Up|Withdrawal by Subject|0
749447|NCT00423891|2395279|P2|Post-Dosing Follow Up|Withdrawal by Subject|2
749448|NCT00423891|2395280|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
749449|NCT00423891|2395278|P3|Treatment|continuing treatment|4
749450|NCT00423891|2395279|P2|Treatment|continuing treatment|0
749451|NCT00423891|2395280|P1|Treatment|continuing treatment|0
749452|NCT00423891|2395278|P3|Treatment|Lost to Follow-up|0
749453|NCT00423891|2395279|P2|Treatment|Lost to Follow-up|0
749454|NCT00423891|2395280|P1|Treatment|Lost to Follow-up|1
749455|NCT00423891|2395278|P3|Treatment|Withdrawal by Subject|0
749456|NCT00423891|2395279|P2|Treatment|Withdrawal by Subject|0
749457|NCT00423891|2395280|P1|Treatment|Withdrawal by Subject|1
749458|NCT00423891|2395278|P3|Enrolled|No longer met criteria|1
749459|NCT00423891|2395279|P2|Enrolled|No longer met criteria|2
749460|NCT00423891|2395280|P1|Enrolled|No longer met criteria|11
749461|NCT00423891|2395278|P3|Enrolled|Lost to Follow-up|1
749462|NCT00423891|2395279|P2|Enrolled|Lost to Follow-up|0
749463|NCT00423891|2395280|P1|Enrolled|Lost to Follow-up|0
749464|NCT00423891|2395278|P3|Enrolled|Withdrawal by Subject|1
749465|NCT00423891|2395279|P2|Enrolled|Withdrawal by Subject|0
749466|NCT00423891|2395280|P1|Enrolled|Withdrawal by Subject|0
749467|NCT00423917|2395347|P1|Overall Study|Ineligible|1
749468|NCT00423917|2395347|P1|Overall Study|Cancel|2
749469|NCT00423930|2395357|P1|Overall Study|Withdrawal by Subject|2
749470|NCT00423943|2395364|P2|Overall Study|Withdrawal by Subject|1
749471|NCT00423943|2395365|P1|Overall Study|Withdrawal by Subject|3
749472|NCT00424008|2395381|P2|Overall Study|Administrative|257
749473|NCT00424008|2395382|P1|Overall Study|Administrative|266
749474|NCT00424008|2395381|P2|Overall Study|Did not meet protocol eligibility|21
749475|NCT00424008|2395382|P1|Overall Study|Did not meet protocol eligibility|16
749476|NCT00424008|2395381|P2|Overall Study|Noncompliance with protocol|7
749477|NCT00424008|2395382|P1|Overall Study|Noncompliance with protocol|13
749478|NCT00424008|2395381|P2|Overall Study|Withdrawal by Subject|8
749479|NCT00424008|2395382|P1|Overall Study|Withdrawal by Subject|5
749480|NCT00424008|2395381|P2|Overall Study|Lost to Follow-up|2
749481|NCT00424008|2395382|P1|Overall Study|Lost to Follow-up|1
749482|NCT00424008|2395381|P2|Overall Study|Lack of Efficacy|34
749483|NCT00424008|2395382|P1|Overall Study|Lack of Efficacy|40
749484|NCT00424008|2395381|P2|Overall Study|Adverse Event|6
749485|NCT00424008|2395382|P1|Overall Study|Adverse Event|8
749486|NCT00424021|2395399|P4|AMB-220-E Study Period|Physician Decision|1
749487|NCT00424021|2395400|P3|AMB-220-E Study Period|Physician Decision|0
749488|NCT00424021|2395401|P2|AMB-220-E Study Period|Physician Decision|0
749489|NCT00424021|2395402|P1|AMB-220-E Study Period|Physician Decision|0
749490|NCT00424021|2395399|P4|AMB-220-E Study Period|Lost to Follow-up|1
749491|NCT00424021|2395400|P3|AMB-220-E Study Period|Lost to Follow-up|1
749492|NCT00424021|2395401|P2|AMB-220-E Study Period|Lost to Follow-up|1
749493|NCT00424021|2395402|P1|AMB-220-E Study Period|Lost to Follow-up|0
749494|NCT00424021|2395399|P4|AMB-220-E Study Period|Death|1
749495|NCT00424021|2395400|P3|AMB-220-E Study Period|Death|1
749496|NCT00424021|2395401|P2|AMB-220-E Study Period|Death|0
749497|NCT00424021|2395402|P1|AMB-220-E Study Period|Death|0
749498|NCT00424021|2395399|P4|AMB-220-E Study Period|Adverse Event|7
749499|NCT00424021|2395400|P3|AMB-220-E Study Period|Adverse Event|3
749500|NCT00424021|2395401|P2|AMB-220-E Study Period|Adverse Event|1
749501|NCT00424021|2395402|P1|AMB-220-E Study Period|Adverse Event|1
749502|NCT00424021|2395399|P4|NCT00046319 Study Period|Lost to Follow-up|0
749503|NCT00424021|2395400|P3|NCT00046319 Study Period|Lost to Follow-up|0
749504|NCT00424021|2395401|P2|NCT00046319 Study Period|Lost to Follow-up|1
749505|NCT00424021|2395402|P1|NCT00046319 Study Period|Lost to Follow-up|0
749506|NCT00424021|2395399|P4|NCT00046319 Study Period|Sponsor discretion|0
749507|NCT00424021|2395400|P3|NCT00046319 Study Period|Sponsor discretion|0
749508|NCT00424021|2395401|P2|NCT00046319 Study Period|Sponsor discretion|1
749509|NCT00424021|2395402|P1|NCT00046319 Study Period|Sponsor discretion|0
749510|NCT00424021|2395399|P4|NCT00046319 Study Period|Withdrawal by Subject|0
749511|NCT00424021|2395400|P3|NCT00046319 Study Period|Withdrawal by Subject|0
749512|NCT00424021|2395401|P2|NCT00046319 Study Period|Withdrawal by Subject|1
749513|NCT00424021|2395402|P1|NCT00046319 Study Period|Withdrawal by Subject|0
749514|NCT00424021|2395399|P4|NCT00046319 Study Period|Adverse Event|1
749515|NCT00424021|2395400|P3|NCT00046319 Study Period|Adverse Event|1
749516|NCT00424021|2395401|P2|NCT00046319 Study Period|Adverse Event|0
749517|NCT00424021|2395402|P1|NCT00046319 Study Period|Adverse Event|1
890880|NCT00696410|2826296|P2|Overall Study|Physician Decision|0
890881|NCT00696410|2826297|P1|Overall Study|Physician Decision|3
890882|NCT00696410|2826296|P2|Overall Study|Withdrawal by Subject|0
890883|NCT00696410|2826297|P1|Overall Study|Withdrawal by Subject|8
890884|NCT00696410|2826296|P2|Overall Study|Lost to Follow-up|0
890885|NCT00696410|2826297|P1|Overall Study|Lost to Follow-up|2
890886|NCT00686166|2826322|P1|Overall Study|Did not begin protocol therapy|4
890887|NCT00686166|2826322|P1|Overall Study|Ineligible|5
890888|NCT00686166|2826322|P1|Overall Study|Not Protocol Specified|1
890889|NCT00686166|2826322|P1|Overall Study|Death|1
890890|NCT00686166|2826322|P1|Overall Study|Progression/Relapse|1
890891|NCT00686166|2826322|P1|Overall Study|Withdrawal by Subject|1
890892|NCT00686166|2826322|P1|Overall Study|Adverse Event|7
890893|NCT00636168|2826366|P2|Treated With Study Drug|Still remains on treatment|94
890894|NCT00636168|2826367|P1|Treated With Study Drug|Still remains on treatment|48
890895|NCT00636168|2826366|P2|Treated With Study Drug|non-specified|1
890896|NCT00636168|2826367|P1|Treated With Study Drug|non-specified|1
890897|NCT00636168|2826366|P2|Treated With Study Drug|No longer meets criteria|0
890898|NCT00636168|2826367|P1|Treated With Study Drug|No longer meets criteria|1
890899|NCT00636168|2826366|P2|Treated With Study Drug|Pregnancy|0
890900|NCT00636168|2826367|P1|Treated With Study Drug|Pregnancy|1
890901|NCT00636168|2826366|P2|Treated With Study Drug|Death|0
890902|NCT00636168|2826367|P1|Treated With Study Drug|Death|3
890903|NCT00636168|2826366|P2|Treated With Study Drug|Poor or non-compliance|3
749552|NCT00424177|2395474|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
749553|NCT00424177|2395474|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
749554|NCT00424177|2395474|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
749555|NCT00424177|2395474|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
749556|NCT00424177|2395474|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
890904|NCT00636168|2826367|P1|Treated With Study Drug|Poor or non-compliance|1
890905|NCT00636168|2826366|P2|Treated With Study Drug|Withdrawal by Subject|20
890906|NCT00636168|2826367|P1|Treated With Study Drug|Withdrawal by Subject|16
890907|NCT00636168|2826366|P2|Treated With Study Drug|Adverse Event|20
890908|NCT00636168|2826367|P1|Treated With Study Drug|Adverse Event|244
749557|NCT00424177|2395474|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
749558|NCT00424177|2395474|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
749559|NCT00424177|2395474|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
749560|NCT00424177|2395474|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
749561|NCT00424177|2395474|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
749562|NCT00424190|2395503|P2|Overall Study|Other|21
749563|NCT00424190|2395504|P1|Overall Study|Other|15
749564|NCT00424190|2395503|P2|Overall Study|Diagnosis of osteomyelitis|1
749565|NCT00424190|2395504|P1|Overall Study|Diagnosis of osteomyelitis|0
749566|NCT00424190|2395503|P2|Overall Study|Request of sponsor or investigator|2
749567|NCT00424190|2395504|P1|Overall Study|Request of sponsor or investigator|0
749568|NCT00424190|2395503|P2|Overall Study|Noncompliance|2
749569|NCT00424190|2395504|P1|Overall Study|Noncompliance|1
749570|NCT00424190|2395503|P2|Overall Study|Death|0
749571|NCT00424190|2395504|P1|Overall Study|Death|3
749572|NCT00424190|2395503|P2|Overall Study|Withdrew consent|4
749573|NCT00424190|2395504|P1|Overall Study|Withdrew consent|3
749574|NCT00424255|2395512|P2|Overall Study|Sponsor Terminated Study|167
749575|NCT00424255|2395513|P1|Overall Study|Sponsor Terminated Study|161
749576|NCT00424255|2395512|P2|Overall Study|Disease Progression|2
749577|NCT00424255|2395513|P1|Overall Study|Disease Progression|0
749578|NCT00424255|2395512|P2|Overall Study|Fatigue|0
749579|NCT00424255|2395513|P1|Overall Study|Fatigue|1
749580|NCT00424255|2395512|P2|Overall Study|Non-compliance by Participants|0
749581|NCT00424255|2395513|P1|Overall Study|Non-compliance by Participants|1
749582|NCT00424255|2395512|P2|Overall Study|Cognitive Disturbance|0
749583|NCT00424255|2395513|P1|Overall Study|Cognitive Disturbance|1
749584|NCT00424255|2395512|P2|Overall Study|Physician Decision|7
749585|NCT00424255|2395513|P1|Overall Study|Physician Decision|3
749586|NCT00424255|2395512|P2|Overall Study|Withdrawal by Subject|38
749587|NCT00424255|2395513|P1|Overall Study|Withdrawal by Subject|34
749588|NCT00424255|2395512|P2|Overall Study|Protocol Violation|1
749589|NCT00424255|2395513|P1|Overall Study|Protocol Violation|0
749590|NCT00424255|2395512|P2|Overall Study|Lost to Follow-up|20
749591|NCT00424255|2395513|P1|Overall Study|Lost to Follow-up|26
749592|NCT00424255|2395512|P2|Overall Study|Death|111
749593|NCT00424255|2395513|P1|Overall Study|Death|115
749594|NCT00424294|2395578|P2|Overall Study|Randomized but not Treated|0
749595|NCT00424294|2395579|P1|Overall Study|Randomized but not Treated|1
749596|NCT00424294|2395578|P2|Overall Study|Unspecified|2
749597|NCT00424294|2395579|P1|Overall Study|Unspecified|0
749598|NCT00424294|2395578|P2|Overall Study|Withdrawal by Subject|2
749599|NCT00424294|2395579|P1|Overall Study|Withdrawal by Subject|1
749600|NCT00424294|2395578|P2|Overall Study|Lack of Efficacy|1
749601|NCT00424294|2395579|P1|Overall Study|Lack of Efficacy|2
749602|NCT00424294|2395578|P2|Overall Study|Adverse Event|10
749603|NCT00424294|2395579|P1|Overall Study|Adverse Event|4
749604|NCT00424346|2395631|P4|Extension Phase|Protocol Violation|0
749605|NCT00424346|2395632|P3|Extension Phase|Protocol Violation|1
749606|NCT00424346|2395633|P2|Extension Phase|Protocol Violation|1
749607|NCT00424346|2395634|P1|Extension Phase|Protocol Violation|0
749608|NCT00424346|2395631|P4|Extension Phase|Death|1
749609|NCT00424346|2395632|P3|Extension Phase|Death|0
749610|NCT00424346|2395633|P2|Extension Phase|Death|0
749611|NCT00424346|2395634|P1|Extension Phase|Death|0
749612|NCT00424346|2395631|P4|Extension Phase|Administrative Problems|35
749613|NCT00424346|2395632|P3|Extension Phase|Administrative Problems|32
749614|NCT00424346|2395633|P2|Extension Phase|Administrative Problems|69
749615|NCT00424346|2395634|P1|Extension Phase|Administrative Problems|0
749616|NCT00424346|2395631|P4|Extension Phase|Lost to Follow-up|0
749617|NCT00424346|2395632|P3|Extension Phase|Lost to Follow-up|0
749618|NCT00424346|2395633|P2|Extension Phase|Lost to Follow-up|2
749619|NCT00424346|2395634|P1|Extension Phase|Lost to Follow-up|0
749620|NCT00424346|2395631|P4|Extension Phase|Withdrawal by Subject|4
749621|NCT00424346|2395632|P3|Extension Phase|Withdrawal by Subject|3
749622|NCT00424346|2395633|P2|Extension Phase|Withdrawal by Subject|5
749623|NCT00424346|2395634|P1|Extension Phase|Withdrawal by Subject|0
749624|NCT00424346|2395631|P4|Extension Phase|Lack of Efficacy|11
749625|NCT00424346|2395632|P3|Extension Phase|Lack of Efficacy|14
749626|NCT00424346|2395633|P2|Extension Phase|Lack of Efficacy|16
749627|NCT00424346|2395634|P1|Extension Phase|Lack of Efficacy|0
749628|NCT00424346|2395631|P4|Extension Phase|Adverse Event|4
749629|NCT00424346|2395632|P3|Extension Phase|Adverse Event|5
749630|NCT00424346|2395633|P2|Extension Phase|Adverse Event|9
749631|NCT00424346|2395634|P1|Extension Phase|Adverse Event|0
749632|NCT00424346|2395631|P4|Core Study|Protocol Violation|0
749633|NCT00424346|2395632|P3|Core Study|Protocol Violation|2
749634|NCT00424346|2395633|P2|Core Study|Protocol Violation|0
749635|NCT00424346|2395634|P1|Core Study|Protocol Violation|0
749636|NCT00424346|2395631|P4|Core Study|Administrative Problems|0
749637|NCT00424346|2395632|P3|Core Study|Administrative Problems|1
749638|NCT00424346|2395633|P2|Core Study|Administrative Problems|0
749639|NCT00424346|2395634|P1|Core Study|Administrative Problems|1
749640|NCT00424346|2395631|P4|Core Study|Lost to Follow-up|0
749641|NCT00424346|2395632|P3|Core Study|Lost to Follow-up|0
749642|NCT00424346|2395633|P2|Core Study|Lost to Follow-up|1
749643|NCT00424346|2395634|P1|Core Study|Lost to Follow-up|1
749644|NCT00424346|2395631|P4|Core Study|Withdrawal by Subject|2
749645|NCT00424346|2395632|P3|Core Study|Withdrawal by Subject|0
749646|NCT00424346|2395633|P2|Core Study|Withdrawal by Subject|0
749647|NCT00424346|2395634|P1|Core Study|Withdrawal by Subject|1
749648|NCT00424346|2395631|P4|Core Study|Lack of Efficacy|4
749649|NCT00424346|2395632|P3|Core Study|Lack of Efficacy|0
749650|NCT00424346|2395633|P2|Core Study|Lack of Efficacy|3
749651|NCT00424346|2395634|P1|Core Study|Lack of Efficacy|1
749652|NCT00424346|2395631|P4|Core Study|Abnormal Laboratory Values|0
749653|NCT00424346|2395632|P3|Core Study|Abnormal Laboratory Values|0
749654|NCT00424346|2395633|P2|Core Study|Abnormal Laboratory Values|1
749655|NCT00424346|2395634|P1|Core Study|Abnormal Laboratory Values|0
749656|NCT00424346|2395631|P4|Core Study|Adverse Event|1
749657|NCT00424346|2395632|P3|Core Study|Adverse Event|1
749658|NCT00424346|2395633|P2|Core Study|Adverse Event|3
749659|NCT00424346|2395634|P1|Core Study|Adverse Event|5
749660|NCT00424372|2395747|P1|Overall Study|Lack of Efficacy|6
749661|NCT00424372|2395747|P1|Overall Study|Protocol Violation|1
749662|NCT00424372|2395747|P1|Overall Study|Withdrawal by Subject|4
749663|NCT00424372|2395747|P1|Overall Study|Health deterioration|1
749664|NCT00424372|2395747|P1|Overall Study|Adverse Event|18
749665|NCT00424372|2395747|P1|Overall Study|Death|1
749666|NCT00424385|2395755|P1|Cohort 1|Withdrawal by Subject|1
749667|NCT00424385|2395755|P1|Cohort 0|Physician Decision|1
749668|NCT00424385|2395755|P1|Cohort 0|Withdrawal by Subject|5
749669|NCT00424398|2395765|P3|Overall Study|Subject met exclusion criteria|0
749670|NCT00424398|2395766|P2|Overall Study|Subject met exclusion criteria|0
749671|NCT00424398|2395767|P1|Overall Study|Subject met exclusion criteria|1
749672|NCT00424398|2395765|P3|Overall Study|Withdrawal by Subject|0
749673|NCT00424398|2395766|P2|Overall Study|Withdrawal by Subject|1
749674|NCT00424398|2395767|P1|Overall Study|Withdrawal by Subject|2
749675|NCT00424476|2395814|P3|Overall Study|Other|9
749676|NCT00424476|2395815|P2|Overall Study|Other|3
749677|NCT00424476|2395816|P1|Overall Study|Other|4
749678|NCT00424476|2395814|P3|Overall Study|Physician Decision|3
749679|NCT00424476|2395815|P2|Overall Study|Physician Decision|2
749680|NCT00424476|2395816|P1|Overall Study|Physician Decision|3
749681|NCT00424476|2395814|P3|Overall Study|Protocol Violation|3
749682|NCT00424476|2395815|P2|Overall Study|Protocol Violation|2
749683|NCT00424476|2395816|P1|Overall Study|Protocol Violation|7
749684|NCT00424476|2395814|P3|Overall Study|Lost to Follow-up|3
749685|NCT00424476|2395815|P2|Overall Study|Lost to Follow-up|6
749686|NCT00424476|2395816|P1|Overall Study|Lost to Follow-up|4
749687|NCT00424476|2395814|P3|Overall Study|Lack of Compliance|1
749688|NCT00424476|2395815|P2|Overall Study|Lack of Compliance|1
749689|NCT00424476|2395816|P1|Overall Study|Lack of Compliance|1
749690|NCT00424476|2395814|P3|Overall Study|Lack of Efficacy|12
749691|NCT00424476|2395815|P2|Overall Study|Lack of Efficacy|12
749692|NCT00424476|2395816|P1|Overall Study|Lack of Efficacy|16
749693|NCT00424476|2395814|P3|Overall Study|Adverse Event|15
749694|NCT00424476|2395815|P2|Overall Study|Adverse Event|16
749695|NCT00424476|2395816|P1|Overall Study|Adverse Event|19
749696|NCT00424476|2395814|P3|Overall Study|Withdrawal by Subject|3
749697|NCT00424476|2395815|P2|Overall Study|Withdrawal by Subject|6
749698|NCT00424476|2395816|P1|Overall Study|Withdrawal by Subject|7
749699|NCT00424515|2395850|P2|Overall Study|Withdrawal by Subject|0
749700|NCT00424515|2395851|P1|Overall Study|Withdrawal by Subject|1
749701|NCT00424515|2395850|P2|Overall Study|Intercurrent Illness|1
749702|NCT00424515|2395851|P1|Overall Study|Intercurrent Illness|0
749703|NCT00424515|2395850|P2|Overall Study|Adverse Event|1
749704|NCT00424515|2395851|P1|Overall Study|Adverse Event|0
749705|NCT00424515|2395850|P2|Overall Study|Progressive Disease|11
749706|NCT00424515|2395851|P1|Overall Study|Progressive Disease|10
749707|NCT00424528|2395864|P3|Overall Study|noncompliance with study requirements|2
749708|NCT00424528|2395865|P2|Overall Study|noncompliance with study requirements|1
749709|NCT00424528|2395866|P1|Overall Study|noncompliance with study requirements|2
749710|NCT00424528|2395864|P3|Overall Study|Lost to Follow-up|0
749711|NCT00424528|2395865|P2|Overall Study|Lost to Follow-up|1
749712|NCT00424528|2395866|P1|Overall Study|Lost to Follow-up|0
749713|NCT00424528|2395864|P3|Overall Study|Protocol Violation|0
749714|NCT00424528|2395865|P2|Overall Study|Protocol Violation|1
749715|NCT00424528|2395866|P1|Overall Study|Protocol Violation|1
749716|NCT00424528|2395864|P3|Overall Study|Adverse Event|2
749717|NCT00424528|2395865|P2|Overall Study|Adverse Event|1
749718|NCT00424528|2395866|P1|Overall Study|Adverse Event|2
749719|NCT00424593|2395938|P2|Dose-Blind Extension Period|Physician Decision|0
749720|NCT00424593|2395939|P1|Dose-Blind Extension Period|Physician Decision|3
749721|NCT00424593|2395938|P2|Dose-Blind Extension Period|Lost to Follow-up|0
749722|NCT00424593|2395939|P1|Dose-Blind Extension Period|Lost to Follow-up|6
749723|NCT00424593|2395938|P2|Dose-Blind Extension Period|Protocol Violation|0
749724|NCT00424593|2395939|P1|Dose-Blind Extension Period|Protocol Violation|9
749725|NCT00424593|2395938|P2|Dose-Blind Extension Period|Lack of Efficacy|0
749726|NCT00424593|2395939|P1|Dose-Blind Extension Period|Lack of Efficacy|9
749727|NCT00424593|2395938|P2|Dose-Blind Extension Period|Adverse Event|0
749728|NCT00424593|2395939|P1|Dose-Blind Extension Period|Adverse Event|18
749729|NCT00424593|2395938|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
749730|NCT00424593|2395939|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
749731|NCT00424593|2395938|P2|Acute Double-Blind Period|Lack of Efficacy|1
749732|NCT00424593|2395939|P1|Acute Double-Blind Period|Lack of Efficacy|0
749733|NCT00424593|2395938|P2|Acute Double-Blind Period|Lost to Follow-up|1
749734|NCT00424593|2395939|P1|Acute Double-Blind Period|Lost to Follow-up|1
749735|NCT00424593|2395938|P2|Acute Double-Blind Period|Physician Decision|2
749736|NCT00424593|2395939|P1|Acute Double-Blind Period|Physician Decision|1
749737|NCT00424593|2395938|P2|Acute Double-Blind Period|Protocol Violation|2
749738|NCT00424593|2395939|P1|Acute Double-Blind Period|Protocol Violation|2
749739|NCT00424593|2395938|P2|Acute Double-Blind Period|Withdrawal by Subject|10
749740|NCT00424593|2395939|P1|Acute Double-Blind Period|Withdrawal by Subject|11
749741|NCT00424593|2395938|P2|Acute Double-Blind Period|Adverse Event|7
749742|NCT00424593|2395939|P1|Acute Double-Blind Period|Adverse Event|16
749743|NCT00424632|2396022|P10|Overall Study|Unspecified|0
749744|NCT00424632|2396023|P9|Overall Study|Unspecified|1
749745|NCT00424632|2396024|P8|Overall Study|Unspecified|0
749746|NCT00424632|2396025|P7|Overall Study|Unspecified|0
749747|NCT00424632|2396026|P6|Overall Study|Unspecified|0
749748|NCT00424632|2396027|P5|Overall Study|Unspecified|0
749749|NCT00424632|2396028|P4|Overall Study|Unspecified|1
749750|NCT00424632|2396029|P3|Overall Study|Unspecified|0
749751|NCT00424632|2396030|P2|Overall Study|Unspecified|0
749752|NCT00424632|2396031|P1|Overall Study|Unspecified|0
749753|NCT00424632|2396022|P10|Overall Study|Objective progression or relapse|4
749754|NCT00424632|2396023|P9|Overall Study|Objective progression or relapse|12
749755|NCT00424632|2396024|P8|Overall Study|Objective progression or relapse|3
749756|NCT00424632|2396025|P7|Overall Study|Objective progression or relapse|7
749757|NCT00424632|2396026|P6|Overall Study|Objective progression or relapse|13
749758|NCT00424632|2396027|P5|Overall Study|Objective progression or relapse|2
749759|NCT00424632|2396028|P4|Overall Study|Objective progression or relapse|2
749760|NCT00424632|2396029|P3|Overall Study|Objective progression or relapse|1
749761|NCT00424632|2396030|P2|Overall Study|Objective progression or relapse|1
749762|NCT00424632|2396031|P1|Overall Study|Objective progression or relapse|1
749763|NCT00424632|2396022|P10|Overall Study|Global deterioration of health status|0
749764|NCT00424632|2396023|P9|Overall Study|Global deterioration of health status|0
749765|NCT00424632|2396024|P8|Overall Study|Global deterioration of health status|0
749766|NCT00424632|2396025|P7|Overall Study|Global deterioration of health status|0
749767|NCT00424632|2396026|P6|Overall Study|Global deterioration of health status|0
749768|NCT00424632|2396027|P5|Overall Study|Global deterioration of health status|1
749769|NCT00424632|2396028|P4|Overall Study|Global deterioration of health status|1
749770|NCT00424632|2396029|P3|Overall Study|Global deterioration of health status|0
749771|NCT00424632|2396030|P2|Overall Study|Global deterioration of health status|0
749772|NCT00424632|2396031|P1|Overall Study|Global deterioration of health status|0
749773|NCT00424632|2396022|P10|Overall Study|Adverse Event|2
749774|NCT00424632|2396023|P9|Overall Study|Adverse Event|3
749775|NCT00424632|2396024|P8|Overall Study|Adverse Event|0
749776|NCT00424632|2396025|P7|Overall Study|Adverse Event|0
749777|NCT00424632|2396026|P6|Overall Study|Adverse Event|0
749778|NCT00424632|2396027|P5|Overall Study|Adverse Event|0
749779|NCT00424632|2396028|P4|Overall Study|Adverse Event|0
749780|NCT00424632|2396029|P3|Overall Study|Adverse Event|0
749781|NCT00424632|2396030|P2|Overall Study|Adverse Event|0
749782|NCT00424632|2396031|P1|Overall Study|Adverse Event|0
749783|NCT00424632|2396022|P10|Overall Study|Death|0
749784|NCT00424632|2396023|P9|Overall Study|Death|0
749785|NCT00424632|2396024|P8|Overall Study|Death|0
749786|NCT00424632|2396025|P7|Overall Study|Death|0
749787|NCT00424632|2396026|P6|Overall Study|Death|2
749788|NCT00424632|2396027|P5|Overall Study|Death|0
749789|NCT00424632|2396028|P4|Overall Study|Death|0
749790|NCT00424632|2396029|P3|Overall Study|Death|0
749791|NCT00424632|2396030|P2|Overall Study|Death|0
749792|NCT00424632|2396031|P1|Overall Study|Death|0
749793|NCT00424645|2396164|P2|Overall Study|Death|0
749794|NCT00424645|2396165|P1|Overall Study|Death|1
749795|NCT00424749|2396171|P1|Overall Study|Withdrawal by Subject|1
749796|NCT00424762|2396178|P2|Overall Study|Lost to Follow-up|3
749797|NCT00424762|2396179|P1|Overall Study|Lost to Follow-up|2
749798|NCT00424762|2396178|P2|Overall Study|Withdrawal by Subject|19
749799|NCT00424762|2396179|P1|Overall Study|Withdrawal by Subject|18
749800|NCT00424775|2396189|P2|Overall Study|Lack of Efficacy|0
749801|NCT00424775|2396190|P1|Overall Study|Lack of Efficacy|1
749802|NCT00424775|2396189|P2|Overall Study|Adverse Event|0
749803|NCT00424775|2396190|P1|Overall Study|Adverse Event|2
749804|NCT00424827|2396198|P1|Overall Study|Adverse Event|1
749805|NCT00425061|2396213|P7|Overall Study|Unspecified|1
749806|NCT00425061|2396214|P6|Overall Study|Unspecified|0
749807|NCT00425061|2396215|P5|Overall Study|Unspecified|3
749808|NCT00425061|2396216|P4|Overall Study|Unspecified|0
749809|NCT00425061|2396217|P3|Overall Study|Unspecified|0
749810|NCT00425061|2396218|P2|Overall Study|Unspecified|0
749811|NCT00425061|2396219|P1|Overall Study|Unspecified|0
749812|NCT00425061|2396213|P7|Overall Study|Physician Decision|0
749813|NCT00425061|2396214|P6|Overall Study|Physician Decision|0
749814|NCT00425061|2396215|P5|Overall Study|Physician Decision|1
749815|NCT00425061|2396216|P4|Overall Study|Physician Decision|0
749816|NCT00425061|2396217|P3|Overall Study|Physician Decision|0
749817|NCT00425061|2396218|P2|Overall Study|Physician Decision|0
749818|NCT00425061|2396219|P1|Overall Study|Physician Decision|0
749819|NCT00425061|2396213|P7|Overall Study|Sponsor's request|15
749820|NCT00425061|2396214|P6|Overall Study|Sponsor's request|4
749821|NCT00425061|2396215|P5|Overall Study|Sponsor's request|19
749822|NCT00425061|2396216|P4|Overall Study|Sponsor's request|0
749823|NCT00425061|2396217|P3|Overall Study|Sponsor's request|0
749824|NCT00425061|2396218|P2|Overall Study|Sponsor's request|0
749825|NCT00425061|2396219|P1|Overall Study|Sponsor's request|0
749826|NCT00425061|2396213|P7|Overall Study|Withdrawal by Subject|3
749827|NCT00425061|2396214|P6|Overall Study|Withdrawal by Subject|0
749828|NCT00425061|2396215|P5|Overall Study|Withdrawal by Subject|1
749829|NCT00425061|2396216|P4|Overall Study|Withdrawal by Subject|0
749830|NCT00425061|2396217|P3|Overall Study|Withdrawal by Subject|0
749831|NCT00425061|2396218|P2|Overall Study|Withdrawal by Subject|1
749832|NCT00425061|2396219|P1|Overall Study|Withdrawal by Subject|0
749833|NCT00425061|2396213|P7|Overall Study|Protocol Violation|0
749834|NCT00425061|2396214|P6|Overall Study|Protocol Violation|0
749835|NCT00425061|2396215|P5|Overall Study|Protocol Violation|0
749836|NCT00425061|2396216|P4|Overall Study|Protocol Violation|0
749837|NCT00425061|2396217|P3|Overall Study|Protocol Violation|0
749838|NCT00425061|2396218|P2|Overall Study|Protocol Violation|0
749839|NCT00425061|2396219|P1|Overall Study|Protocol Violation|1
749840|NCT00425061|2396213|P7|Overall Study|Lost to Follow-up|0
749841|NCT00425061|2396214|P6|Overall Study|Lost to Follow-up|0
749842|NCT00425061|2396215|P5|Overall Study|Lost to Follow-up|0
749843|NCT00425061|2396216|P4|Overall Study|Lost to Follow-up|0
749844|NCT00425061|2396217|P3|Overall Study|Lost to Follow-up|0
749845|NCT00425061|2396218|P2|Overall Study|Lost to Follow-up|1
749846|NCT00425061|2396219|P1|Overall Study|Lost to Follow-up|0
749847|NCT00425061|2396213|P7|Overall Study|Adverse Event|0
749848|NCT00425061|2396214|P6|Overall Study|Adverse Event|0
749849|NCT00425061|2396215|P5|Overall Study|Adverse Event|2
749850|NCT00425061|2396216|P4|Overall Study|Adverse Event|2
749851|NCT00425061|2396217|P3|Overall Study|Adverse Event|0
749852|NCT00425061|2396218|P2|Overall Study|Adverse Event|0
749853|NCT00425061|2396219|P1|Overall Study|Adverse Event|1
749854|NCT00425100|2396335|P1|Overall Study|Withdrawal by Subject|7
749855|NCT00425100|2396335|P1|Overall Study|Protocol Violation|4
749856|NCT00425100|2396335|P1|Overall Study|Lost to Follow-up|2
749857|NCT00425100|2396335|P1|Overall Study|Lack of Efficacy|4
749858|NCT00425100|2396335|P1|Overall Study|Adverse Event|36
749859|NCT00425113|2396374|P2|Overall Study|Withdrawal by Subject|0
749860|NCT00425113|2396375|P1|Overall Study|Withdrawal by Subject|1
749861|NCT00425113|2396374|P2|Overall Study|missing study drug more than 14 days|1
749862|NCT00425113|2396375|P1|Overall Study|missing study drug more than 14 days|0
749863|NCT00425113|2396374|P2|Overall Study|diagnosis of abdominal TB|1
749864|NCT00425113|2396375|P1|Overall Study|diagnosis of abdominal TB|0
749865|NCT00425113|2396374|P2|Overall Study|uncontrolled diabetes mellitus|0
749866|NCT00425113|2396375|P1|Overall Study|uncontrolled diabetes mellitus|1
749867|NCT00425269|2396385|P2|Overall Study|moved or medical reason|4
749868|NCT00425269|2396386|P1|Overall Study|moved or medical reason|5
749869|NCT00425269|2396385|P2|Overall Study|Lost to Follow-up|9
749870|NCT00425269|2396386|P1|Overall Study|Lost to Follow-up|9
749871|NCT00425269|2396385|P2|Overall Study|Pregnancy|7
749872|NCT00425269|2396386|P1|Overall Study|Pregnancy|5
749873|NCT00425308|2396464|P2|Overall Study|Death|0
749874|NCT00425308|2396465|P1|Overall Study|Death|1
749875|NCT00425308|2396464|P2|Overall Study|Withdrawal by Subject|0
749876|NCT00425308|2396465|P1|Overall Study|Withdrawal by Subject|1
749877|NCT00425308|2396464|P2|Overall Study|Adverse Event|1
749878|NCT00425308|2396465|P1|Overall Study|Adverse Event|2
749879|NCT00425373|2396502|P9|Overall Study|Lack of Efficacy|5
749880|NCT00425373|2396503|P8|Overall Study|Lack of Efficacy|0
749881|NCT00425373|2396504|P7|Overall Study|Lack of Efficacy|3
749882|NCT00425373|2396505|P6|Overall Study|Lack of Efficacy|3
749883|NCT00425373|2396506|P5|Overall Study|Lack of Efficacy|1
749884|NCT00425373|2396507|P4|Overall Study|Lack of Efficacy|0
749885|NCT00425373|2396508|P3|Overall Study|Lack of Efficacy|0
749886|NCT00425373|2396509|P2|Overall Study|Lack of Efficacy|0
749887|NCT00425373|2396510|P1|Overall Study|Lack of Efficacy|0
749888|NCT00425373|2396502|P9|Overall Study|Withdrawal by Subject|2
749889|NCT00425373|2396503|P8|Overall Study|Withdrawal by Subject|2
749890|NCT00425373|2396504|P7|Overall Study|Withdrawal by Subject|2
749891|NCT00425373|2396505|P6|Overall Study|Withdrawal by Subject|0
749892|NCT00425373|2396506|P5|Overall Study|Withdrawal by Subject|4
749893|NCT00425373|2396507|P4|Overall Study|Withdrawal by Subject|1
749894|NCT00425373|2396508|P3|Overall Study|Withdrawal by Subject|2
749895|NCT00425373|2396509|P2|Overall Study|Withdrawal by Subject|0
749896|NCT00425373|2396510|P1|Overall Study|Withdrawal by Subject|2
749897|NCT00425373|2396502|P9|Overall Study|Protocol Violation|3
749898|NCT00425373|2396503|P8|Overall Study|Protocol Violation|5
749899|NCT00425373|2396504|P7|Overall Study|Protocol Violation|0
749900|NCT00425373|2396505|P6|Overall Study|Protocol Violation|0
749901|NCT00425373|2396506|P5|Overall Study|Protocol Violation|0
749902|NCT00425373|2396507|P4|Overall Study|Protocol Violation|0
749903|NCT00425373|2396508|P3|Overall Study|Protocol Violation|1
749904|NCT00425373|2396509|P2|Overall Study|Protocol Violation|0
749905|NCT00425373|2396510|P1|Overall Study|Protocol Violation|1
749906|NCT00425373|2396502|P9|Overall Study|Lost to Follow-up|0
749907|NCT00425373|2396503|P8|Overall Study|Lost to Follow-up|0
749908|NCT00425373|2396504|P7|Overall Study|Lost to Follow-up|0
749909|NCT00425373|2396505|P6|Overall Study|Lost to Follow-up|0
749910|NCT00425373|2396506|P5|Overall Study|Lost to Follow-up|1
749911|NCT00425373|2396507|P4|Overall Study|Lost to Follow-up|0
749912|NCT00425373|2396508|P3|Overall Study|Lost to Follow-up|0
749913|NCT00425373|2396509|P2|Overall Study|Lost to Follow-up|1
749914|NCT00425373|2396510|P1|Overall Study|Lost to Follow-up|0
749915|NCT00425373|2396502|P9|Overall Study|Adverse Event|8
749916|NCT00425373|2396503|P8|Overall Study|Adverse Event|3
749917|NCT00425373|2396504|P7|Overall Study|Adverse Event|2
749918|NCT00425373|2396505|P6|Overall Study|Adverse Event|6
749919|NCT00425373|2396506|P5|Overall Study|Adverse Event|4
749920|NCT00425373|2396507|P4|Overall Study|Adverse Event|1
749921|NCT00425373|2396508|P3|Overall Study|Adverse Event|0
749922|NCT00425373|2396509|P2|Overall Study|Adverse Event|2
749923|NCT00425373|2396510|P1|Overall Study|Adverse Event|2
749924|NCT00425438|2396577|P2|Overall Study|Termination by Sponsor|27
749925|NCT00425438|2396578|P1|Overall Study|Termination by Sponsor|25
749926|NCT00425503|2396594|P1|Overall Study|Protocol Violation|1
749927|NCT00425503|2396594|P1|Overall Study|Adverse Event|2
749928|NCT00425607|2396598|P1|Overall Study|Withdrawal by Subject|1
749929|NCT00425607|2396598|P1|Overall Study|Death|1
749930|NCT00425698|2396613|P2|Overall Study|Withdrawal by Subject|1
749931|NCT00425698|2396614|P1|Overall Study|Withdrawal by Subject|0
749932|NCT00425698|2396613|P2|Overall Study|Adverse Event|1
749933|NCT00425698|2396614|P1|Overall Study|Adverse Event|3
749934|NCT00425750|2396620|P1|Overall Study|Progression of disease|18
749935|NCT00425750|2396620|P1|Overall Study|Adverse Event|3
749936|NCT00425750|2396620|P1|Overall Study|Withdrawal by Subject|3
749937|NCT00425750|2396620|P1|Overall Study|Death|1
749938|NCT00425854|2396628|P2|Overall Study|Other Adverse Event|2
749939|NCT00425854|2396629|P1|Overall Study|Other Adverse Event|2
749940|NCT00425854|2396628|P2|Overall Study|Dose reduction toxicity AE|7
749941|NCT00425854|2396629|P1|Overall Study|Dose reduction toxicity AE|8
749942|NCT00425854|2396628|P2|Overall Study|Progressive Disease|12
749943|NCT00425854|2396629|P1|Overall Study|Progressive Disease|19
749944|NCT00425945|2396652|P2|Overall Study|Moved from area|1
749945|NCT00425945|2396653|P1|Overall Study|Moved from area|0
749946|NCT00425945|2396652|P2|Overall Study|Began cancer treatments|0
749947|NCT00425945|2396653|P1|Overall Study|Began cancer treatments|1
749948|NCT00425945|2396652|P2|Overall Study|Began hypertension medication|0
749949|NCT00425945|2396653|P1|Overall Study|Began hypertension medication|1
749950|NCT00425945|2396652|P2|Overall Study|Lost to Follow-up|2
749951|NCT00425945|2396653|P1|Overall Study|Lost to Follow-up|0
749952|NCT00425945|2396652|P2|Overall Study|Inconvenience|2
749953|NCT00425945|2396653|P1|Overall Study|Inconvenience|0
749954|NCT00425945|2396652|P2|Overall Study|Concern about Supplement|0
749955|NCT00425945|2396653|P1|Overall Study|Concern about Supplement|2
749956|NCT00426127|2396689|P1|Overall Study|Removed due to disease progression|1
749957|NCT00426127|2396689|P1|Overall Study|Adverse Event|1
749958|NCT00426231|2396712|P2|Overall Study|Withdrawal by Subject|12
749959|NCT00426231|2396713|P1|Overall Study|Withdrawal by Subject|9
749960|NCT00426270|2396721|P1|Overall Study|Adverse Event|5
749961|NCT00426270|2396721|P1|Overall Study|Incorrectly Enrolled in the Study|1
749962|NCT00426361|2396741|P3|Overall Study|Withdrawal by Subject|0
749963|NCT00426361|2396742|P2|Overall Study|Withdrawal by Subject|3
749964|NCT00426361|2396743|P1|Overall Study|Withdrawal by Subject|1
749965|NCT00426361|2396741|P3|Overall Study|Lost to Follow-up|5
749966|NCT00426361|2396742|P2|Overall Study|Lost to Follow-up|2
749967|NCT00426361|2396743|P1|Overall Study|Lost to Follow-up|3
749968|NCT00417482|2396796|P3|Phase B 2nd 16 Weeks|Death|0
749969|NCT00417482|2396797|P2|Phase B 2nd 16 Weeks|Death|1
749970|NCT00417482|2396798|P1|Phase B 2nd 16 Weeks|Death|1
749971|NCT00417482|2396796|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
749972|NCT00417482|2396797|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
749973|NCT00417482|2396798|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
749974|NCT00417482|2396796|P3|Phase B 2nd 16 Weeks|Adverse Event|1
749975|NCT00417482|2396797|P2|Phase B 2nd 16 Weeks|Adverse Event|0
749976|NCT00417482|2396798|P1|Phase B 2nd 16 Weeks|Adverse Event|0
749977|NCT00417482|2396796|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
749978|NCT00417482|2396797|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
749979|NCT00417482|2396798|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
749980|NCT00417482|2396796|P3|Phase B 1st 16 Weeks|Death|0
749981|NCT00417482|2396797|P2|Phase B 1st 16 Weeks|Death|0
749982|NCT00417482|2396798|P1|Phase B 1st 16 Weeks|Death|1
749983|NCT00417482|2396796|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
749984|NCT00417482|2396797|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
749985|NCT00417482|2396798|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
749986|NCT00417482|2396796|P3|Phase B 1st 16 Weeks|Adverse Event|1
749987|NCT00417482|2396797|P2|Phase B 1st 16 Weeks|Adverse Event|0
749988|NCT00417482|2396798|P1|Phase B 1st 16 Weeks|Adverse Event|2
749989|NCT00417482|2396796|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
749990|NCT00417482|2396797|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
749991|NCT00417482|2396798|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
749992|NCT00417612|2396824|P2|Overall Study|Lost to Follow-up|0
749993|NCT00417612|2396825|P1|Overall Study|Lost to Follow-up|1
749994|NCT00417612|2396824|P2|Overall Study|Protocol Violation|2
749995|NCT00417612|2396825|P1|Overall Study|Protocol Violation|0
749996|NCT00417612|2396824|P2|Overall Study|Adverse Event|0
749997|NCT00417612|2396825|P1|Overall Study|Adverse Event|2
749998|NCT00417612|2396824|P2|Overall Study|Errant diagnosis|1
749999|NCT00417612|2396825|P1|Overall Study|Errant diagnosis|0
750000|NCT00417885|2396848|P1|Overall Study|Transferred to Another Sunitinib Study|2
750001|NCT00417885|2396848|P1|Overall Study|Objective Progression or Relapse|3
750002|NCT00417885|2396848|P1|Overall Study|Adverse Event|1
750003|NCT00417963|2396857|P1|Overall Study|Study device could not be deployed|3
750004|NCT00417963|2396857|P1|Overall Study|Death|17
750005|NCT00417963|2396857|P1|Overall Study|Withdrawal by Subject|18
750006|NCT00417963|2396857|P1|Overall Study|Lost to Follow-up|3
750007|NCT00417976|2396874|P1|Overall Study|Treatment -related toxicity|2
750008|NCT00417976|2396874|P1|Overall Study|Non compliance unrelated to toxicity|1
750019|NCT00418145|2396942|P1|Overall Study|study terminated|6
750020|NCT00418184|2396956|P2|Double-blind Phase|Poor compliance|1
750021|NCT00418184|2396957|P1|Double-blind Phase|Poor compliance|3
750022|NCT00418184|2396956|P2|Double-blind Phase|Adverse Event|1
750023|NCT00418184|2396957|P1|Double-blind Phase|Adverse Event|2
750024|NCT00418184|2396956|P2|Double-blind Phase|Withdrawal by Subject|9
750025|NCT00418184|2396957|P1|Double-blind Phase|Withdrawal by Subject|22
750026|NCT00418314|2396985|P2|Overall Study|Withdrawal by Subject|2
750027|NCT00418314|2396986|P1|Overall Study|Withdrawal by Subject|1
750028|NCT00418379|2396999|P3|Year 5|Any other reason not above-mentioned|3
750029|NCT00418379|2397000|P2|Year 5|Any other reason not above-mentioned|4
750030|NCT00418379|2397001|P1|Year 5|Any other reason not above-mentioned|2
750031|NCT00418379|2396999|P3|Year 5|Adverse Event|0
750032|NCT00418379|2397000|P2|Year 5|Adverse Event|1
750033|NCT00418379|2397001|P1|Year 5|Adverse Event|0
750034|NCT00418379|2396999|P3|Year 4|Any other reason not above-mentioned|0
750035|NCT00418379|2397000|P2|Year 4|Any other reason not above-mentioned|1
750036|NCT00418379|2397001|P1|Year 4|Any other reason not above-mentioned|1
750037|NCT00418379|2396999|P3|Year 4|Withdrawal by Subject|2
750038|NCT00418379|2397000|P2|Year 4|Withdrawal by Subject|3
750039|NCT00418379|2397001|P1|Year 4|Withdrawal by Subject|2
750040|NCT00418379|2396999|P3|Year 4|Adverse Event|0
750041|NCT00418379|2397000|P2|Year 4|Adverse Event|1
750042|NCT00418379|2397001|P1|Year 4|Adverse Event|0
750043|NCT00418379|2396999|P3|Year 3|Any other reason not above-mentioned|1
750044|NCT00418379|2397000|P2|Year 3|Any other reason not above-mentioned|1
750045|NCT00418379|2397001|P1|Year 3|Any other reason not above-mentioned|2
750046|NCT00418379|2396999|P3|Year 3|Withdrawal by Subject|2
750047|NCT00418379|2397000|P2|Year 3|Withdrawal by Subject|1
750048|NCT00418379|2397001|P1|Year 3|Withdrawal by Subject|1
750049|NCT00418379|2396999|P3|Year 2|Any other reason not above-mentioned|6
750050|NCT00418379|2397000|P2|Year 2|Any other reason not above-mentioned|1
750051|NCT00418379|2397001|P1|Year 2|Any other reason not above-mentioned|2
750052|NCT00418379|2396999|P3|Year 2|Withdrawal by Subject|3
750053|NCT00418379|2397000|P2|Year 2|Withdrawal by Subject|1
750054|NCT00418379|2397001|P1|Year 2|Withdrawal by Subject|1
750055|NCT00418379|2396999|P3|Year 2|Adverse Event|1
750056|NCT00418379|2397000|P2|Year 2|Adverse Event|2
750057|NCT00418379|2397001|P1|Year 2|Adverse Event|5
750058|NCT00418379|2396999|P3|Year 1|Any other reason not above-mentioned|7
750059|NCT00418379|2397000|P2|Year 1|Any other reason not above-mentioned|5
750060|NCT00418379|2397001|P1|Year 1|Any other reason not above-mentioned|2
750061|NCT00418379|2396999|P3|Year 1|Withdrawal by Subject|5
750062|NCT00418379|2397000|P2|Year 1|Withdrawal by Subject|8
750063|NCT00418379|2397001|P1|Year 1|Withdrawal by Subject|7
750064|NCT00418379|2396999|P3|Year 1|Adverse Event|3
750065|NCT00418379|2397000|P2|Year 1|Adverse Event|15
750066|NCT00418379|2397001|P1|Year 1|Adverse Event|9
750067|NCT00418522|2397011|P2|Overall Study|Randomized but did not receive treatment|4
750068|NCT00418522|2397012|P1|Overall Study|Randomized but did not receive treatment|7
750069|NCT00418522|2397011|P2|Overall Study|Other|23
750070|NCT00418522|2397012|P1|Overall Study|Other|27
750071|NCT00418522|2397011|P2|Overall Study|Withdrawal by Subject|7
750072|NCT00418522|2397012|P1|Overall Study|Withdrawal by Subject|31
750073|NCT00418522|2397011|P2|Overall Study|Lost to Follow-up|4
750074|NCT00418522|2397012|P1|Overall Study|Lost to Follow-up|10
750075|NCT00418522|2397011|P2|Overall Study|Lack of Efficacy|3
750076|NCT00418522|2397012|P1|Overall Study|Lack of Efficacy|1
750077|NCT00418522|2397011|P2|Overall Study|Adverse Event|1
750078|NCT00418522|2397012|P1|Overall Study|Adverse Event|7
750079|NCT00418561|2397059|P3|Overall Study|Participant's (guardian's) decision|0
750080|NCT00418561|2397060|P2|Overall Study|Participant's (guardian's) decision|1
750081|NCT00418561|2397061|P1|Overall Study|Participant's (guardian's) decision|0
750082|NCT00418665|2397146|P3|Treatment Extension|Death|1
750083|NCT00418665|2397147|P2|Treatment Extension|Death|0
750084|NCT00418665|2397148|P1|Treatment Extension|Death|0
750085|NCT00418665|2397146|P3|Treatment Extension|Physician Decision|1
750086|NCT00418665|2397147|P2|Treatment Extension|Physician Decision|2
750087|NCT00418665|2397148|P1|Treatment Extension|Physician Decision|2
750088|NCT00418665|2397146|P3|Treatment Extension|Requirement for alternative therapy|0
750089|NCT00418665|2397147|P2|Treatment Extension|Requirement for alternative therapy|2
750090|NCT00418665|2397148|P1|Treatment Extension|Requirement for alternative therapy|2
750091|NCT00418665|2397146|P3|Treatment Extension|Withdrawal by Subject|0
750092|NCT00418665|2397147|P2|Treatment Extension|Withdrawal by Subject|0
750093|NCT00418665|2397148|P1|Treatment Extension|Withdrawal by Subject|1
750094|NCT00418665|2397146|P3|Treatment Extension|Adverse Event|0
750095|NCT00418665|2397147|P2|Treatment Extension|Adverse Event|0
750096|NCT00418665|2397148|P1|Treatment Extension|Adverse Event|1
750097|NCT00418665|2397146|P3|Treatment Period|Physician Decision|3
750098|NCT00418665|2397147|P2|Treatment Period|Physician Decision|0
750099|NCT00418665|2397148|P1|Treatment Period|Physician Decision|1
750100|NCT00418665|2397146|P3|Treatment Period|Requirement for alternative therapy|0
750101|NCT00418665|2397147|P2|Treatment Period|Requirement for alternative therapy|0
750102|NCT00418665|2397148|P1|Treatment Period|Requirement for alternative therapy|1
750103|NCT00418665|2397146|P3|Treatment Period|Withdrawal by Subject|1
750104|NCT00418665|2397147|P2|Treatment Period|Withdrawal by Subject|3
750105|NCT00418665|2397148|P1|Treatment Period|Withdrawal by Subject|0
750106|NCT00418665|2397146|P3|Treatment Period|Adverse Event|0
750107|NCT00418665|2397147|P2|Treatment Period|Adverse Event|2
750108|NCT00418665|2397148|P1|Treatment Period|Adverse Event|2
750109|NCT00418665|2397146|P3|Treatment Period|Ineligibility determined|0
750110|NCT00418665|2397147|P2|Treatment Period|Ineligibility determined|1
750111|NCT00418665|2397148|P1|Treatment Period|Ineligibility determined|1
750112|NCT00418691|2397168|P3|Overall Study|Progressive Disease|1
750113|NCT00418691|2397169|P2|Overall Study|Progressive Disease|0
750114|NCT00418691|2397170|P1|Overall Study|Progressive Disease|1
750115|NCT00418691|2397168|P3|Overall Study|Started new medication voiding entry|1
750116|NCT00418691|2397169|P2|Overall Study|Started new medication voiding entry|0
750117|NCT00418691|2397170|P1|Overall Study|Started new medication voiding entry|0
750118|NCT00418691|2397168|P3|Overall Study|Lost to Follow-up|3
750119|NCT00418691|2397169|P2|Overall Study|Lost to Follow-up|2
750120|NCT00418691|2397170|P1|Overall Study|Lost to Follow-up|1
750121|NCT00418717|2397178|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
750122|NCT00418717|2397178|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
750123|NCT00418834|2397185|P2|Overall Study|Withdrawal by Subject|7
750124|NCT00418834|2397186|P1|Overall Study|Withdrawal by Subject|3
750125|NCT00418834|2397185|P2|Overall Study|Protocol Violation|3
750126|NCT00418834|2397186|P1|Overall Study|Protocol Violation|4
750127|NCT00418834|2397185|P2|Overall Study|Lost to Follow-up|1
750128|NCT00418834|2397186|P1|Overall Study|Lost to Follow-up|0
750129|NCT00418834|2397185|P2|Overall Study|Adverse Event|9
750130|NCT00418834|2397186|P1|Overall Study|Adverse Event|16
750131|NCT00418886|2397248|P2|Overall Study|randomised but no treatment received|1
750132|NCT00418886|2397249|P1|Overall Study|randomised but no treatment received|0
750133|NCT00418886|2397248|P2|Overall Study|withdrawn due to other reason|0
750134|NCT00418886|2397249|P1|Overall Study|withdrawn due to other reason|1
750135|NCT00418886|2397248|P2|Overall Study|Lost to Follow-up|6
750136|NCT00418886|2397249|P1|Overall Study|Lost to Follow-up|4
750137|NCT00418886|2397248|P2|Overall Study|Withdrawal by Subject|10
750138|NCT00418886|2397249|P1|Overall Study|Withdrawal by Subject|9
750139|NCT00418886|2397248|P2|Overall Study|Death|147
750140|NCT00418886|2397249|P1|Overall Study|Death|122
750141|NCT00418886|2397248|P2|Overall Study|discontinue treatment survival follow up|91
750142|NCT00418886|2397249|P1|Overall Study|discontinue treatment survival follow up|90
750143|NCT00418938|2397275|P2|Overall Study|Ineligibility Determined|0
750144|NCT00418938|2397276|P1|Overall Study|Ineligibility Determined|1
750145|NCT00418938|2397275|P2|Overall Study|On-going|1
750146|NCT00418938|2397276|P1|Overall Study|On-going|1
750147|NCT00418938|2397275|P2|Overall Study|Adverse Event|1
750148|NCT00418938|2397276|P1|Overall Study|Adverse Event|1
750149|NCT00418938|2397275|P2|Overall Study|Lost to Follow-up|3
750150|NCT00418938|2397276|P1|Overall Study|Lost to Follow-up|1
750151|NCT00418938|2397275|P2|Overall Study|Withdrawal by Subject|15
750152|NCT00418938|2397276|P1|Overall Study|Withdrawal by Subject|16
750153|NCT00418938|2397275|P2|Overall Study|Administrative decision|3
750154|NCT00418938|2397276|P1|Overall Study|Administrative decision|3
750155|NCT00418938|2397275|P2|Overall Study|Reimbursement|0
750156|NCT00418938|2397276|P1|Overall Study|Reimbursement|1
750157|NCT00419003|2397339|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
750158|NCT00419003|2397340|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
750159|NCT00419003|2397339|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
750160|NCT00419003|2397340|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
750161|NCT00419094|2397351|P2|Overall Study|Other: No contact for extended period|1
750162|NCT00419094|2397352|P1|Overall Study|Other: No contact for extended period|0
750163|NCT00419094|2397351|P2|Overall Study|Other: Patient non-compliant|1
750164|NCT00419094|2397352|P1|Overall Study|Other: Patient non-compliant|0
750165|NCT00419094|2397351|P2|Overall Study|Other: Error determining exit criteria|0
750166|NCT00419094|2397352|P1|Overall Study|Other: Error determining exit criteria|1
750167|NCT00419094|2397351|P2|Overall Study|Withdrawal of consent|5
750168|NCT00419094|2397352|P1|Overall Study|Withdrawal of consent|1
750169|NCT00419094|2397351|P2|Overall Study|Protocol Violation|14
750170|NCT00419094|2397352|P1|Overall Study|Protocol Violation|1
750171|NCT00419094|2397351|P2|Overall Study|Lost to Follow-up|2
750172|NCT00419094|2397352|P1|Overall Study|Lost to Follow-up|0
750173|NCT00419094|2397351|P2|Overall Study|Lack of Efficacy|0
750174|NCT00419094|2397352|P1|Overall Study|Lack of Efficacy|1
750175|NCT00419094|2397351|P2|Overall Study|Adverse Event|7
750176|NCT00419094|2397352|P1|Overall Study|Adverse Event|3
750177|NCT00419120|2397364|P1|Long Term Follow up Period|study ongoing|10
750178|NCT00419159|2397371|P2|Overall Study|Disease progression|76
750179|NCT00419159|2397372|P1|Overall Study|Disease progression|79
750180|NCT00419159|2397371|P2|Overall Study|Death|2
750181|NCT00419159|2397372|P1|Overall Study|Death|2
750182|NCT00419159|2397371|P2|Overall Study|Lost to Follow-up|1
750183|NCT00419159|2397372|P1|Overall Study|Lost to Follow-up|0
750184|NCT00419159|2397371|P2|Overall Study|Withdrawal by Subject|3
750185|NCT00419159|2397372|P1|Overall Study|Withdrawal by Subject|10
750186|NCT00419159|2397371|P2|Overall Study|Protocol Violation|0
750187|NCT00419159|2397372|P1|Overall Study|Protocol Violation|1
750188|NCT00419159|2397371|P2|Overall Study|Subject's no longer requires study drug|1
750189|NCT00419159|2397372|P1|Overall Study|Subject's no longer requires study drug|0
750190|NCT00419159|2397371|P2|Overall Study|Abnormal laboratory value(s)|2
750191|NCT00419159|2397372|P1|Overall Study|Abnormal laboratory value(s)|0
750192|NCT00419159|2397371|P2|Overall Study|Adverse Event|15
750193|NCT00419159|2397372|P1|Overall Study|Adverse Event|7
750194|NCT00419263|2397389|P3|Overall Study|Withdrawal by Subject|1
750195|NCT00419263|2397390|P2|Overall Study|Withdrawal by Subject|0
750196|NCT00419263|2397391|P1|Overall Study|Withdrawal by Subject|0
750197|NCT00419263|2397389|P3|Overall Study|Adverse Event|1
750198|NCT00419263|2397390|P2|Overall Study|Adverse Event|0
750199|NCT00419263|2397391|P1|Overall Study|Adverse Event|0
750200|NCT00419263|2397389|P3|Overall Study|Randomized in Error, Not Treated|0
750201|NCT00419263|2397390|P2|Overall Study|Randomized in Error, Not Treated|1
750202|NCT00419263|2397391|P1|Overall Study|Randomized in Error, Not Treated|1
750203|NCT00419263|2397389|P3|Overall Study|Lost to Follow-up|1
750204|NCT00419263|2397390|P2|Overall Study|Lost to Follow-up|1
750205|NCT00419263|2397391|P1|Overall Study|Lost to Follow-up|2
750206|NCT00419341|2397429|P1|Efficacy Period|Termination of study site|1
750207|NCT00419341|2397429|P1|Efficacy Period|Non-compliance|1
750208|NCT00419341|2397429|P1|Efficacy Period|Lost to Follow-up|1
750209|NCT00419341|2397429|P1|Efficacy Period|Protocol Violation|1
750210|NCT00419341|2397429|P1|Efficacy Period|Withdrawal by Subject|6
750211|NCT00419341|2397429|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
750212|NCT00419341|2397429|P1|Wash in/Wash Out Period|Adverse Event|2
750213|NCT00419341|2397429|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
750214|NCT00419380|2397452|P2|Overall Study|Withdrawal by Subject|1
750215|NCT00419380|2397453|P1|Overall Study|Withdrawal by Subject|0
750216|NCT00419380|2397452|P2|Overall Study|Lost to Follow-up|1
750217|NCT00419380|2397453|P1|Overall Study|Lost to Follow-up|0
750218|NCT00419380|2397452|P2|Overall Study|Physician Decision|1
750219|NCT00419380|2397453|P1|Overall Study|Physician Decision|0
750220|NCT00419380|2397452|P2|Overall Study|Lack of Efficacy|7
750221|NCT00419380|2397453|P1|Overall Study|Lack of Efficacy|1
750222|NCT00419393|2397461|P1|Overall Study|Other: Investigator decision|1
750223|NCT00419393|2397461|P1|Overall Study|Other: Other health problems|1
750224|NCT00419393|2397461|P1|Overall Study|Other: Site closure|1
750225|NCT00419393|2397461|P1|Overall Study|Other: Subject had temporal lobectomy|1
750226|NCT00419393|2397461|P1|Overall Study|Other: Sponsor request|3
750227|NCT00419393|2397461|P1|Overall Study|Withdrawal by Subject|7
750228|NCT00419393|2397461|P1|Overall Study|Protocol Violation|5
750229|NCT00419393|2397461|P1|Overall Study|Adverse Event|5
750230|NCT00419744|2397485|P3|Overall Study|Incorrect medication kit dispensed|1
750231|NCT00419744|2397486|P2|Overall Study|Incorrect medication kit dispensed|0
750232|NCT00419744|2397487|P1|Overall Study|Incorrect medication kit dispensed|0
750233|NCT00419744|2397485|P3|Overall Study|Spirometry mouthpiece issues|2
750234|NCT00419744|2397486|P2|Overall Study|Spirometry mouthpiece issues|1
750235|NCT00419744|2397487|P1|Overall Study|Spirometry mouthpiece issues|0
750236|NCT00419744|2397485|P3|Overall Study|Physician Decision|6
750237|NCT00419744|2397486|P2|Overall Study|Physician Decision|5
750238|NCT00419744|2397487|P1|Overall Study|Physician Decision|10
750239|NCT00419744|2397485|P3|Overall Study|Moving out of state|1
750240|NCT00419744|2397486|P2|Overall Study|Moving out of state|0
750241|NCT00419744|2397487|P1|Overall Study|Moving out of state|2
750242|NCT00419744|2397485|P3|Overall Study|Randomized in error|7
750243|NCT00419744|2397486|P2|Overall Study|Randomized in error|6
750244|NCT00419744|2397487|P1|Overall Study|Randomized in error|9
750245|NCT00419744|2397485|P3|Overall Study|Protocol Violation|8
750246|NCT00419744|2397486|P2|Overall Study|Protocol Violation|7
750247|NCT00419744|2397487|P1|Overall Study|Protocol Violation|4
750248|NCT00419744|2397485|P3|Overall Study|Lost to Follow-up|6
750249|NCT00419744|2397486|P2|Overall Study|Lost to Follow-up|10
750250|NCT00419744|2397487|P1|Overall Study|Lost to Follow-up|8
750251|NCT00419744|2397485|P3|Overall Study|Withdrawal by Subject|52
750252|NCT00419744|2397486|P2|Overall Study|Withdrawal by Subject|49
750253|NCT00419744|2397487|P1|Overall Study|Withdrawal by Subject|45
750254|NCT00419744|2397485|P3|Overall Study|Adverse Event|50
750255|NCT00419744|2397486|P2|Overall Study|Adverse Event|40
750256|NCT00419744|2397487|P1|Overall Study|Adverse Event|39
750257|NCT00419757|2397518|P2|Overall Study|Multiple reasons|1
750258|NCT00419757|2397519|P1|Overall Study|Multiple reasons|3
750259|NCT00419757|2397518|P2|Overall Study|Study specific discontinuation criteria|8
750260|NCT00419757|2397519|P1|Overall Study|Study specific discontinuation criteria|4
750261|NCT00419757|2397518|P2|Overall Study|Protocol Violation|3
750262|NCT00419757|2397519|P1|Overall Study|Protocol Violation|2
750263|NCT00419757|2397518|P2|Overall Study|Withdrawal by Subject|1
750264|NCT00419757|2397519|P1|Overall Study|Withdrawal by Subject|7
750265|NCT00419757|2397518|P2|Overall Study|Lost to Follow-up|4
750266|NCT00419757|2397519|P1|Overall Study|Lost to Follow-up|1
750267|NCT00419757|2397518|P2|Overall Study|Adverse Event|4
750268|NCT00419757|2397519|P1|Overall Study|Adverse Event|1
750269|NCT00419770|2397557|P2|Overall Study|Withdrawal by Subject|1
750270|NCT00419770|2397558|P1|Overall Study|Withdrawal by Subject|5
750271|NCT00426556|2397568|P4|Phase II - Extension Phase|Adverse Event|2
750272|NCT00426556|2397569|P3|Phase II - Extension Phase|Adverse Event|0
750273|NCT00426556|2397570|P2|Phase II - Extension Phase|Adverse Event|0
750274|NCT00426556|2397571|P1|Phase II - Extension Phase|Adverse Event|0
750275|NCT00426556|2397568|P4|Phase II - Extension Phase|Disease Progression|21
750276|NCT00426556|2397569|P3|Phase II - Extension Phase|Disease Progression|0
750277|NCT00426556|2397570|P2|Phase II - Extension Phase|Disease Progression|0
750278|NCT00426556|2397571|P1|Phase II - Extension Phase|Disease Progression|0
750279|NCT00426556|2397568|P4|Phase II - Core Phase|Adverse Event|8
750280|NCT00426556|2397569|P3|Phase II - Core Phase|Adverse Event|0
750281|NCT00426556|2397570|P2|Phase II - Core Phase|Adverse Event|0
750282|NCT00426556|2397571|P1|Phase II - Core Phase|Adverse Event|0
750283|NCT00426556|2397568|P4|Phase II - Core Phase|Disease Progression|16
750284|NCT00426556|2397569|P3|Phase II - Core Phase|Disease Progression|0
750285|NCT00426556|2397570|P2|Phase II - Core Phase|Disease Progression|0
750286|NCT00426556|2397571|P1|Phase II - Core Phase|Disease Progression|0
750287|NCT00426556|2397568|P4|Phase II - Core Phase|Withdrawal by Subject|3
750288|NCT00426556|2397569|P3|Phase II - Core Phase|Withdrawal by Subject|0
750289|NCT00426556|2397570|P2|Phase II - Core Phase|Withdrawal by Subject|0
750290|NCT00426556|2397571|P1|Phase II - Core Phase|Withdrawal by Subject|0
750291|NCT00426556|2397568|P4|Phase I - Extension Phase|Disease Progression|0
750292|NCT00426556|2397569|P3|Phase I - Extension Phase|Disease Progression|6
750293|NCT00426556|2397570|P2|Phase I - Extension Phase|Disease Progression|5
750294|NCT00426556|2397571|P1|Phase I - Extension Phase|Disease Progression|5
750295|NCT00426556|2397568|P4|Phase I - Extension Phase|Adverse Event|0
750296|NCT00426556|2397569|P3|Phase I - Extension Phase|Adverse Event|1
750297|NCT00426556|2397570|P2|Phase I - Extension Phase|Adverse Event|1
750298|NCT00426556|2397571|P1|Phase I - Extension Phase|Adverse Event|0
750299|NCT00426556|2397568|P4|Phase I - Core Phase|Death|0
750300|NCT00426556|2397569|P3|Phase I - Core Phase|Death|0
750301|NCT00426556|2397570|P2|Phase I - Core Phase|Death|1
750302|NCT00426556|2397571|P1|Phase I - Core Phase|Death|0
750303|NCT00426556|2397568|P4|Phase I - Core Phase|Adverse Event|0
750304|NCT00426556|2397569|P3|Phase I - Core Phase|Adverse Event|1
750305|NCT00426556|2397570|P2|Phase I - Core Phase|Adverse Event|3
750306|NCT00426556|2397571|P1|Phase I - Core Phase|Adverse Event|1
750307|NCT00426556|2397568|P4|Phase I - Core Phase|Disease Progression|0
750308|NCT00426556|2397569|P3|Phase I - Core Phase|Disease Progression|2
750309|NCT00426556|2397570|P2|Phase I - Core Phase|Disease Progression|6
750310|NCT00426556|2397571|P1|Phase I - Core Phase|Disease Progression|0
750311|NCT00426660|2397593|P1|Overall Study|Enrolled Not Treated|15
750312|NCT00426660|2397593|P1|Overall Study|Protocol Violation|1
750313|NCT00426660|2397593|P1|Overall Study|Withdrawal by Subject|18
750314|NCT00426660|2397593|P1|Overall Study|Unspecified|23
750315|NCT00426660|2397593|P1|Overall Study|Lost to Follow-up|15
750316|NCT00426660|2397593|P1|Overall Study|Insufficient Clinical Response|22
750317|NCT00426660|2397593|P1|Overall Study|Adverse Event|23
750318|NCT00426660|2397593|P1|Overall Study|Death|14
750319|NCT00426751|2397622|P2|Overall Study|Other Reasons|12
750320|NCT00426751|2397623|P1|Overall Study|Other Reasons|7
750321|NCT00426751|2397622|P2|Overall Study|Consent Withdrawn|1
750322|NCT00426751|2397623|P1|Overall Study|Consent Withdrawn|0
750323|NCT00426751|2397622|P2|Overall Study|Lost to Follow-up|6
750324|NCT00426751|2397623|P1|Overall Study|Lost to Follow-up|7
750325|NCT00426751|2397622|P2|Overall Study|Adverse Event|1
750326|NCT00426751|2397623|P1|Overall Study|Adverse Event|8
750327|NCT00427349|2397671|P1|Overall Study|Never started therapy|1
750328|NCT00427349|2397671|P1|Overall Study|Ineligible|1
750329|NCT00427349|2397671|P1|Overall Study|Other|2
750330|NCT00427349|2397671|P1|Overall Study|Alternative therapy|1
750331|NCT00427349|2397671|P1|Overall Study|Withdrawal by Subject|3
750332|NCT00427349|2397671|P1|Overall Study|Death|1
750333|NCT00427349|2397671|P1|Overall Study|Adverse Event|14
750334|NCT00427349|2397671|P1|Overall Study|Lack of Efficacy|23
750335|NCT00427635|2397683|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
750336|NCT00427635|2397684|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
750337|NCT00427635|2397683|P2|Treatment Phase|Withdrawal by Subject|0
750338|NCT00427635|2397684|P1|Treatment Phase|Withdrawal by Subject|1
750339|NCT00427700|2397720|P2|Overall Study|Pregnancy|2
750340|NCT00427700|2397721|P1|Overall Study|Pregnancy|0
750341|NCT00427700|2397720|P2|Overall Study|no induction of menses|4
750342|NCT00427700|2397721|P1|Overall Study|no induction of menses|1
750343|NCT00427700|2397720|P2|Overall Study|Lost to Follow-up|5
750344|NCT00427700|2397721|P1|Overall Study|Lost to Follow-up|2
750345|NCT00427778|2397733|P2|First Intervention (4 Weeks)|anxious about using ring|0
750346|NCT00427778|2397734|P1|First Intervention (4 Weeks)|anxious about using ring|1
750347|NCT00427778|2397733|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
750348|NCT00427778|2397734|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
750349|NCT00427778|2397733|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
750350|NCT00427778|2397734|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
750351|NCT00427778|2397733|P2|First Intervention (4 Weeks)|no longer interested|0
750352|NCT00427778|2397734|P1|First Intervention (4 Weeks)|no longer interested|1
750353|NCT00427895|2397777|P8|Vax 2/Year 3 to 4|Failed to Return|0
750354|NCT00427895|2397778|P7|Vax 2/Year 3 to 4|Failed to Return|0
750355|NCT00427895|2397779|P6|Vax 2/Year 3 to 4|Failed to Return|0
750356|NCT00427895|2397780|P5|Vax 2/Year 3 to 4|Failed to Return|1
750357|NCT00427895|2397781|P4|Vax 2/Year 3 to 4|Failed to Return|0
750358|NCT00427895|2397782|P3|Vax 2/Year 3 to 4|Failed to Return|0
750359|NCT00427895|2397783|P2|Vax 2/Year 3 to 4|Failed to Return|0
750360|NCT00427895|2397784|P1|Vax 2/Year 3 to 4|Failed to Return|0
750361|NCT00427895|2397777|P8|Vax 2/Year 3 to 4|Protocol Violation|1
750362|NCT00427895|2397778|P7|Vax 2/Year 3 to 4|Protocol Violation|0
750363|NCT00427895|2397779|P6|Vax 2/Year 3 to 4|Protocol Violation|0
750364|NCT00427895|2397780|P5|Vax 2/Year 3 to 4|Protocol Violation|0
750365|NCT00427895|2397781|P4|Vax 2/Year 3 to 4|Protocol Violation|0
750366|NCT00427895|2397782|P3|Vax 2/Year 3 to 4|Protocol Violation|0
750367|NCT00427895|2397783|P2|Vax 2/Year 3 to 4|Protocol Violation|0
750368|NCT00427895|2397784|P1|Vax 2/Year 3 to 4|Protocol Violation|0
750369|NCT00427895|2397777|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
750370|NCT00427895|2397778|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
750371|NCT00427895|2397779|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
750372|NCT00427895|2397780|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
750373|NCT00427895|2397781|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
750374|NCT00427895|2397782|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
750375|NCT00427895|2397783|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
750376|NCT00427895|2397784|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
750377|NCT00427895|2397777|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
750378|NCT00427895|2397778|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
750379|NCT00427895|2397779|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
750380|NCT00427895|2397780|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
750381|NCT00427895|2397781|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
750382|NCT00427895|2397782|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
750383|NCT00427895|2397783|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
750384|NCT00427895|2397784|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
750385|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Unspecified|0
750386|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Unspecified|0
750387|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Unspecified|0
750388|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Unspecified|0
750389|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Unspecified|2
750390|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Unspecified|0
750391|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Unspecified|0
750392|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Unspecified|0
750393|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
750394|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
750395|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
750396|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
750397|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
750398|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
750399|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
750400|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
750401|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Death|0
750402|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Death|0
750403|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Death|0
750404|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Death|0
750405|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Death|0
750406|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Death|0
750407|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Death|0
750408|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Death|1
750409|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
750410|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
750411|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
750412|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
750413|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
750414|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
750415|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
750416|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
750417|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
750418|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
750419|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
750420|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
750421|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
750422|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
750423|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
750424|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
750425|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
750426|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
750427|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
750428|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
750429|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
750430|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
750431|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
750432|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
750433|NCT00427895|2397777|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
750434|NCT00427895|2397778|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
750435|NCT00427895|2397779|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
750436|NCT00427895|2397780|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
750437|NCT00427895|2397781|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
750438|NCT00427895|2397782|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
750439|NCT00427895|2397783|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
750440|NCT00427895|2397784|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
750441|NCT00427895|2397777|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750442|NCT00427895|2397778|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750443|NCT00427895|2397779|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750444|NCT00427895|2397780|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750445|NCT00427895|2397781|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
750446|NCT00427895|2397782|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750447|NCT00427895|2397783|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750448|NCT00427895|2397784|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
750449|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750450|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750451|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750452|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750453|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Unspecified|2
750454|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Unspecified|1
750455|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750456|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
750457|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
750458|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
750459|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
750460|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
750461|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
750462|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
750463|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
750464|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
750465|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750466|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750467|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750468|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750469|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
750470|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750471|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750472|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
750473|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
750474|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
750475|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
750476|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
750477|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
750478|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
750479|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
750480|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
750481|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750482|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750483|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750484|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750485|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750486|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
750487|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
750488|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
750489|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
750490|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
750491|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
750492|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
750493|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
750494|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
750495|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
750496|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
750497|NCT00427895|2397777|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
750498|NCT00427895|2397778|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
750499|NCT00427895|2397779|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
750500|NCT00427895|2397780|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
750501|NCT00427895|2397781|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
750502|NCT00427895|2397782|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
750503|NCT00427895|2397783|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
750504|NCT00427895|2397784|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
750505|NCT00427921|2397839|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
750506|NCT00427921|2397839|P1|Overall Study|Adverse Event + Withdrawn from Study|1
750507|NCT00427921|2397839|P1|Overall Study|Adverse Event + Lost Response|1
750508|NCT00427921|2397839|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
750509|NCT00427921|2397839|P1|Overall Study|Adverse Event + Worsening of CD|1
750510|NCT00427921|2397839|P1|Overall Study|Adverse Event + No Response|1
750511|NCT00427921|2397839|P1|Overall Study|Adverse Event + Withdrew Consent|1
750512|NCT00427921|2397839|P1|Overall Study|Adverse Event + Hospitalization|1
750513|NCT00427921|2397839|P1|Overall Study|Other reason not specified|10
750514|NCT00427921|2397839|P1|Overall Study|Lost to Follow-up|2
750515|NCT00427921|2397839|P1|Overall Study|Withdrawal by Subject|4
750516|NCT00427921|2397839|P1|Overall Study|Adverse Event|26
750517|NCT00427934|2397862|P4|Overall Study|Withdrawal by Subject|3
750518|NCT00427934|2397863|P3|Overall Study|Withdrawal by Subject|1
750519|NCT00427934|2397864|P2|Overall Study|Withdrawal by Subject|0
750520|NCT00427934|2397865|P1|Overall Study|Withdrawal by Subject|0
750521|NCT00427934|2397862|P4|Overall Study|Other|5
750522|NCT00427934|2397863|P3|Overall Study|Other|11
750523|NCT00427934|2397864|P2|Overall Study|Other|0
750524|NCT00427934|2397865|P1|Overall Study|Other|0
750525|NCT00427934|2397862|P4|Overall Study|Randomized But Did Not Receive Treatment|1
750526|NCT00427934|2397863|P3|Overall Study|Randomized But Did Not Receive Treatment|1
750527|NCT00427934|2397864|P2|Overall Study|Randomized But Did Not Receive Treatment|0
750528|NCT00427934|2397865|P1|Overall Study|Randomized But Did Not Receive Treatment|0
750529|NCT00427934|2397862|P4|Overall Study|Lack of Efficacy|2
750530|NCT00427934|2397863|P3|Overall Study|Lack of Efficacy|5
750531|NCT00427934|2397864|P2|Overall Study|Lack of Efficacy|0
750532|NCT00427934|2397865|P1|Overall Study|Lack of Efficacy|0
750533|NCT00427934|2397862|P4|Overall Study|Adverse Event|4
750534|NCT00427934|2397863|P3|Overall Study|Adverse Event|5
750535|NCT00427934|2397864|P2|Overall Study|Adverse Event|0
750536|NCT00427934|2397865|P1|Overall Study|Adverse Event|1
750537|NCT00427960|2397935|P2|Overall Study|Not Specified|1
750538|NCT00427960|2397936|P1|Overall Study|Not Specified|0
750539|NCT00427960|2397935|P2|Overall Study|Withdrawal by Subject|3
750540|NCT00427960|2397936|P1|Overall Study|Withdrawal by Subject|0
750541|NCT00427960|2397935|P2|Overall Study|Adverse Event|0
750542|NCT00427960|2397936|P1|Overall Study|Adverse Event|2
750543|NCT00427999|2397977|P1|Overall Study|Death|1
750544|NCT00427999|2397977|P1|Overall Study|Withdrawal by Subject|9
750545|NCT00427999|2397977|P1|Overall Study|Protocol Violation|2
750546|NCT00427999|2397977|P1|Overall Study|Unsatisfactory therapeutic effect|13
750547|NCT00427999|2397977|P1|Overall Study|Abnormal laboratory values|1
750548|NCT00427999|2397977|P1|Overall Study|Adverse Event|6
750549|NCT00428090|2397994|P4|Overall Study|Raised Creatinine Value|1
750550|NCT00428090|2397995|P3|Overall Study|Raised Creatinine Value|0
750551|NCT00428090|2397996|P2|Overall Study|Raised Creatinine Value|0
750552|NCT00428090|2397997|P1|Overall Study|Raised Creatinine Value|0
750553|NCT00428090|2397994|P4|Overall Study|Excluded for heart insufficiency|0
750554|NCT00428090|2397995|P3|Overall Study|Excluded for heart insufficiency|1
750555|NCT00428090|2397996|P2|Overall Study|Excluded for heart insufficiency|0
750556|NCT00428090|2397997|P1|Overall Study|Excluded for heart insufficiency|0
750557|NCT00428090|2397994|P4|Overall Study|Serious adverse event|0
750558|NCT00428090|2397995|P3|Overall Study|Serious adverse event|1
750559|NCT00428090|2397996|P2|Overall Study|Serious adverse event|0
750560|NCT00428090|2397997|P1|Overall Study|Serious adverse event|0
750561|NCT00428090|2397994|P4|Overall Study|Deterioration of cognitive status|0
750562|NCT00428090|2397995|P3|Overall Study|Deterioration of cognitive status|1
750563|NCT00428090|2397996|P2|Overall Study|Deterioration of cognitive status|0
750564|NCT00428090|2397997|P1|Overall Study|Deterioration of cognitive status|0
750565|NCT00428090|2397994|P4|Overall Study|High MMSE scores|0
750566|NCT00428090|2397995|P3|Overall Study|High MMSE scores|1
750567|NCT00428090|2397996|P2|Overall Study|High MMSE scores|0
750568|NCT00428090|2397997|P1|Overall Study|High MMSE scores|0
750569|NCT00428090|2397994|P4|Overall Study|Insufficient AD documentation|0
750570|NCT00428090|2397995|P3|Overall Study|Insufficient AD documentation|1
750571|NCT00428090|2397996|P2|Overall Study|Insufficient AD documentation|0
750572|NCT00428090|2397997|P1|Overall Study|Insufficient AD documentation|0
750573|NCT00428090|2397994|P4|Overall Study|Excluded for concerning QTc value|0
750574|NCT00428090|2397995|P3|Overall Study|Excluded for concerning QTc value|1
750575|NCT00428090|2397996|P2|Overall Study|Excluded for concerning QTc value|0
750576|NCT00428090|2397997|P1|Overall Study|Excluded for concerning QTc value|0
750577|NCT00428090|2397994|P4|Overall Study|Worsening of AD|0
750578|NCT00428090|2397995|P3|Overall Study|Worsening of AD|1
750579|NCT00428090|2397996|P2|Overall Study|Worsening of AD|0
750580|NCT00428090|2397997|P1|Overall Study|Worsening of AD|0
750581|NCT00428090|2397994|P4|Overall Study|Mental status of par. was|0
750582|NCT00428090|2397995|P3|Overall Study|Mental status of par. was|0
750583|NCT00428090|2397996|P2|Overall Study|Mental status of par. was|1
750584|NCT00428090|2397997|P1|Overall Study|Mental status of par. was|0
750585|NCT00428090|2397994|P4|Overall Study|Medical monitor terminated par.|0
750586|NCT00428090|2397995|P3|Overall Study|Medical monitor terminated par.|0
750587|NCT00428090|2397996|P2|Overall Study|Medical monitor terminated par.|1
750588|NCT00428090|2397997|P1|Overall Study|Medical monitor terminated par.|0
750589|NCT00428090|2397994|P4|Overall Study|Visit 7 exceed the visit window|0
750590|NCT00428090|2397995|P3|Overall Study|Visit 7 exceed the visit window|0
750591|NCT00428090|2397996|P2|Overall Study|Visit 7 exceed the visit window|1
750592|NCT00428090|2397997|P1|Overall Study|Visit 7 exceed the visit window|0
750593|NCT00428090|2397994|P4|Overall Study|Death of par.|0
750594|NCT00428090|2397995|P3|Overall Study|Death of par.|1
750595|NCT00428090|2397996|P2|Overall Study|Death of par.|0
750596|NCT00428090|2397997|P1|Overall Study|Death of par.|1
750597|NCT00428090|2397994|P4|Overall Study|Prohibited medication used for SAE|0
750598|NCT00428090|2397995|P3|Overall Study|Prohibited medication used for SAE|0
750599|NCT00428090|2397996|P2|Overall Study|Prohibited medication used for SAE|0
750600|NCT00428090|2397997|P1|Overall Study|Prohibited medication used for SAE|1
750601|NCT00428090|2397994|P4|Overall Study|Follow-Up visit not possible|0
750602|NCT00428090|2397995|P3|Overall Study|Follow-Up visit not possible|0
750603|NCT00428090|2397996|P2|Overall Study|Follow-Up visit not possible|0
750604|NCT00428090|2397997|P1|Overall Study|Follow-Up visit not possible|1
750605|NCT00428090|2397994|P4|Overall Study|Par. did not returned to visit|1
750606|NCT00428090|2397995|P3|Overall Study|Par. did not returned to visit|0
750607|NCT00428090|2397996|P2|Overall Study|Par. did not returned to visit|0
750608|NCT00428090|2397997|P1|Overall Study|Par. did not returned to visit|1
750609|NCT00428090|2397994|P4|Overall Study|Non-compliance|3
750610|NCT00428090|2397995|P3|Overall Study|Non-compliance|1
750611|NCT00428090|2397996|P2|Overall Study|Non-compliance|0
750612|NCT00428090|2397997|P1|Overall Study|Non-compliance|4
750613|NCT00428090|2397994|P4|Overall Study|Sponsor terminated study|0
750614|NCT00428090|2397995|P3|Overall Study|Sponsor terminated study|0
750615|NCT00428090|2397996|P2|Overall Study|Sponsor terminated study|1
750616|NCT00428090|2397997|P1|Overall Study|Sponsor terminated study|0
750617|NCT00428090|2397994|P4|Overall Study|Withdrawal by Subject|5
750618|NCT00428090|2397995|P3|Overall Study|Withdrawal by Subject|15
750619|NCT00428090|2397996|P2|Overall Study|Withdrawal by Subject|12
750620|NCT00428090|2397997|P1|Overall Study|Withdrawal by Subject|10
750621|NCT00428090|2397994|P4|Overall Study|Protocol Violation|3
750622|NCT00428090|2397995|P3|Overall Study|Protocol Violation|3
750623|NCT00428090|2397996|P2|Overall Study|Protocol Violation|1
750624|NCT00428090|2397997|P1|Overall Study|Protocol Violation|3
750625|NCT00428090|2397994|P4|Overall Study|Lost to Follow-up|4
750626|NCT00428090|2397995|P3|Overall Study|Lost to Follow-up|1
750627|NCT00428090|2397996|P2|Overall Study|Lost to Follow-up|6
750628|NCT00428090|2397997|P1|Overall Study|Lost to Follow-up|3
750629|NCT00428090|2397994|P4|Overall Study|Adverse Event|11
750630|NCT00428090|2397995|P3|Overall Study|Adverse Event|10
750631|NCT00428090|2397996|P2|Overall Study|Adverse Event|8
750632|NCT00428090|2397997|P1|Overall Study|Adverse Event|10
750633|NCT00428116|2398113|P2|Overall Study|Lost to Follow-up|0
750634|NCT00428116|2398114|P1|Overall Study|Lost to Follow-up|1
750635|NCT00428116|2398113|P2|Overall Study|Withdrawal by Subject|0
750636|NCT00428116|2398114|P1|Overall Study|Withdrawal by Subject|1
750637|NCT00428116|2398113|P2|Overall Study|Death|0
750638|NCT00428116|2398114|P1|Overall Study|Death|1
750639|NCT00428220|2398129|P1|Overall Study|Other|23
750640|NCT00428220|2398129|P1|Overall Study|Adverse Event|51
750641|NCT00428220|2398129|P1|Overall Study|Participant refused continued treatment|7
750642|NCT00428220|2398129|P1|Overall Study|Objective progression or relapse|123
750643|NCT00428220|2398129|P1|Overall Study|Lost to Follow-up|4
750644|NCT00428220|2398129|P1|Overall Study|Global deterioration of health status|7
750645|NCT00428220|2398129|P1|Overall Study|Participant died|8
750646|NCT00428246|2398148|P3|Overall Study|Adverse Event|0
750647|NCT00428246|2398149|P2|Overall Study|Adverse Event|0
750648|NCT00428246|2398150|P1|Overall Study|Adverse Event|1
750649|NCT00428246|2398148|P3|Overall Study|Withdrawal by Subject|1
750650|NCT00428246|2398149|P2|Overall Study|Withdrawal by Subject|0
750651|NCT00428246|2398150|P1|Overall Study|Withdrawal by Subject|0
750652|NCT00428389|2398173|P2|Extension Phase|Administrative problems|1
750653|NCT00428389|2398174|P1|Extension Phase|Administrative problems|1
750654|NCT00428389|2398173|P2|Extension Phase|Protocol Violation|2
750655|NCT00428389|2398174|P1|Extension Phase|Protocol Violation|3
750656|NCT00428389|2398173|P2|Extension Phase|Death|0
750657|NCT00428389|2398174|P1|Extension Phase|Death|1
750658|NCT00428389|2398173|P2|Extension Phase|Lost to Follow-up|3
750659|NCT00428389|2398174|P1|Extension Phase|Lost to Follow-up|0
750660|NCT00428389|2398173|P2|Extension Phase|Withdrawal by Subject|6
750661|NCT00428389|2398174|P1|Extension Phase|Withdrawal by Subject|6
750662|NCT00428389|2398173|P2|Extension Phase|Lack of Efficacy|3
750663|NCT00428389|2398174|P1|Extension Phase|Lack of Efficacy|4
750664|NCT00428389|2398173|P2|Extension Phase|Adverse Event|11
750665|NCT00428389|2398174|P1|Extension Phase|Adverse Event|17
750666|NCT00428389|2398173|P2|Core Phase|Protocol deviation|2
750667|NCT00428389|2398174|P1|Core Phase|Protocol deviation|0
750668|NCT00428389|2398173|P2|Core Phase|Withdrawal by Subject|4
750669|NCT00428389|2398174|P1|Core Phase|Withdrawal by Subject|3
750670|NCT00428389|2398173|P2|Core Phase|Abnormal test procedure result(s)|1
750671|NCT00428389|2398174|P1|Core Phase|Abnormal test procedure result(s)|0
750672|NCT00428389|2398173|P2|Core Phase|Lack of Efficacy|0
750673|NCT00428389|2398174|P1|Core Phase|Lack of Efficacy|2
750674|NCT00428389|2398173|P2|Core Phase|Adverse Event|4
750675|NCT00428389|2398174|P1|Core Phase|Adverse Event|6
750676|NCT00428441|2398192|P1|Overall Study|Lost to Follow-up|1
750677|NCT00428597|2398225|P2|Overall Study|Death|3
750678|NCT00428597|2398226|P1|Overall Study|Death|1
750679|NCT00428597|2398225|P2|Overall Study|Pregnancy|0
750680|NCT00428597|2398226|P1|Overall Study|Pregnancy|1
750681|NCT00428597|2398225|P2|Overall Study|Lost to Follow-up|1
750682|NCT00428597|2398226|P1|Overall Study|Lost to Follow-up|0
750683|NCT00428597|2398225|P2|Overall Study|Other|1
750684|NCT00428597|2398226|P1|Overall Study|Other|1
750685|NCT00428597|2398225|P2|Overall Study|Withdrawal by Subject|1
750686|NCT00428597|2398226|P1|Overall Study|Withdrawal by Subject|2
750687|NCT00428597|2398225|P2|Overall Study|Protocol Violation|1
750688|NCT00428597|2398226|P1|Overall Study|Protocol Violation|2
750689|NCT00428597|2398225|P2|Overall Study|Global Deterioration of Health Status|5
750690|NCT00428597|2398226|P1|Overall Study|Global Deterioration of Health Status|1
750691|NCT00428597|2398225|P2|Overall Study|Adverse Event|7
750692|NCT00428597|2398226|P1|Overall Study|Adverse Event|15
750693|NCT00428597|2398225|P2|Overall Study|Study Terminated by Sponsor|16
750694|NCT00428597|2398226|P1|Overall Study|Study Terminated by Sponsor|41
750695|NCT00428597|2398225|P2|Overall Study|Objective Progression or Relapse|47
750696|NCT00428597|2398226|P1|Overall Study|Objective Progression or Relapse|19
750697|NCT00428597|2398225|P2|Overall Study|Randomized but not treated|3
750698|NCT00428597|2398226|P1|Overall Study|Randomized but not treated|3
750699|NCT00428792|2398268|P2|Overall Study|Lost to Follow-up|1
750700|NCT00428792|2398269|P1|Overall Study|Lost to Follow-up|0
750701|NCT00428792|2398268|P2|Overall Study|Lack of Efficacy|3
750702|NCT00428792|2398269|P1|Overall Study|Lack of Efficacy|1
750703|NCT00428844|2398296|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
750704|NCT00428844|2398297|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
750705|NCT00428844|2398298|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
750706|NCT00428844|2398296|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
750707|NCT00428844|2398297|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
750708|NCT00428844|2398298|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
750709|NCT00428844|2398296|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
750710|NCT00428844|2398297|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
750711|NCT00428844|2398298|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
750712|NCT00428844|2398296|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
750713|NCT00428844|2398297|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
750714|NCT00428844|2398298|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
750715|NCT00428844|2398296|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
750716|NCT00428844|2398297|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
750717|NCT00428844|2398298|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
750718|NCT00428844|2398296|P3|Completed Study Drug Treatment|Randomized Not Treated|1
750719|NCT00428844|2398297|P2|Completed Study Drug Treatment|Randomized Not Treated|0
750720|NCT00428844|2398298|P1|Completed Study Drug Treatment|Randomized Not Treated|0
750721|NCT00428844|2398296|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
750722|NCT00428844|2398297|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
750723|NCT00428844|2398298|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
750724|NCT00428844|2398296|P3|Completed Study Drug Treatment|Protocol Violation|1
750725|NCT00428844|2398297|P2|Completed Study Drug Treatment|Protocol Violation|1
750726|NCT00428844|2398298|P1|Completed Study Drug Treatment|Protocol Violation|0
750727|NCT00428844|2398296|P3|Completed Study Drug Treatment|Adverse Event|4
750728|NCT00428844|2398297|P2|Completed Study Drug Treatment|Adverse Event|4
750729|NCT00428844|2398298|P1|Completed Study Drug Treatment|Adverse Event|2
750730|NCT00428948|2398328|P2|Overall Study|Protocol Deviation|1
750731|NCT00428948|2398329|P1|Overall Study|Protocol Deviation|1
750732|NCT00428948|2398328|P2|Overall Study|Subject Withdrew Consent|30
750733|NCT00428948|2398329|P1|Overall Study|Subject Withdrew Consent|50
750734|NCT00428948|2398328|P2|Overall Study|Investigator Withdrew Subject|4
750735|NCT00428948|2398329|P1|Overall Study|Investigator Withdrew Subject|3
750736|NCT00428948|2398328|P2|Overall Study|Subject Met Withdrawal Criteria|0
750737|NCT00428948|2398329|P1|Overall Study|Subject Met Withdrawal Criteria|4
750738|NCT00428948|2398328|P2|Overall Study|Adverse Event|24
750739|NCT00428948|2398329|P1|Overall Study|Adverse Event|148
750740|NCT00428948|2398328|P2|Overall Study|Lost to Follow-up|8
750741|NCT00428948|2398329|P1|Overall Study|Lost to Follow-up|15
750742|NCT00429026|2398368|P1|Overall Study|Inevaluable for response.|40
750743|NCT00429104|2398372|P1|Overall Study|Protocol Violation|1
750748|NCT00429182|2398398|P1|Overall Study|Not eligible|5
750749|NCT00429182|2398398|P1|Overall Study|Not evaluable, Disease Progression|2
750750|NCT00429273|2398406|P3|Overall Study|Adverse Event|2
750751|NCT00429273|2398407|P2|Overall Study|Adverse Event|1
750752|NCT00429273|2398408|P1|Overall Study|Adverse Event|1
750753|NCT00429273|2398406|P3|Overall Study|Physician Decision|5
750754|NCT00429273|2398407|P2|Overall Study|Physician Decision|5
750755|NCT00429273|2398408|P1|Overall Study|Physician Decision|6
750756|NCT00429273|2398406|P3|Overall Study|Lost to Follow-up|2
750757|NCT00429273|2398407|P2|Overall Study|Lost to Follow-up|2
750758|NCT00429273|2398408|P1|Overall Study|Lost to Follow-up|1
750759|NCT00429299|2398419|P3|Overall Study|Withdrawal by Subject|3
750760|NCT00429299|2398420|P2|Overall Study|Withdrawal by Subject|1
750761|NCT00429299|2398421|P1|Overall Study|Withdrawal by Subject|0
750762|NCT00429299|2398419|P3|Overall Study|Protocol Violation|0
750763|NCT00429299|2398420|P2|Overall Study|Protocol Violation|0
750764|NCT00429299|2398421|P1|Overall Study|Protocol Violation|1
750765|NCT00429299|2398419|P3|Overall Study|Adverse Event|1
750766|NCT00429299|2398420|P2|Overall Study|Adverse Event|5
750767|NCT00429299|2398421|P1|Overall Study|Adverse Event|2
750768|NCT00429299|2398419|P3|Overall Study|Disease Progression|0
750769|NCT00429299|2398420|P2|Overall Study|Disease Progression|1
750770|NCT00429299|2398421|P1|Overall Study|Disease Progression|1
750771|NCT00429364|2398452|P2|Overall Study|Pregnancy|1
750772|NCT00429364|2398453|P1|Overall Study|Pregnancy|0
750773|NCT00429364|2398452|P2|Overall Study|Underwent aortic root surgery|18
750774|NCT00429364|2398453|P1|Overall Study|Underwent aortic root surgery|10
750775|NCT00429364|2398452|P2|Overall Study|Death|1
750776|NCT00429364|2398453|P1|Overall Study|Death|0
750777|NCT00429364|2398452|P2|Overall Study|Lost to Follow-up|6
750778|NCT00429364|2398453|P1|Overall Study|Lost to Follow-up|7
750779|NCT00429364|2398452|P2|Overall Study|Physician Decision|2
750780|NCT00429364|2398453|P1|Overall Study|Physician Decision|4
750781|NCT00429364|2398452|P2|Overall Study|Withdrawal by Subject|5
750782|NCT00429364|2398453|P1|Overall Study|Withdrawal by Subject|11
750783|NCT00429416|2398518|P1|Overall Study|Death|1
750784|NCT00429494|2398526|P1|Overall Study|Death|6
750785|NCT00429494|2398526|P1|Overall Study|Withdrawal by Subject|9
750786|NCT00429572|2398534|P1|Overall Study|Disease progression|1
750787|NCT00422903|2398555|P2|Overall Study|Informed Consent Withdrawn|2
750788|NCT00422903|2398556|P1|Overall Study|Informed Consent Withdrawn|1
750789|NCT00422903|2398555|P2|Overall Study|Adverse Event|2
750790|NCT00422903|2398556|P1|Overall Study|Adverse Event|0
750791|NCT00422903|2398555|P2|Overall Study|Disease Progression|1
750792|NCT00422903|2398556|P1|Overall Study|Disease Progression|3
750793|NCT00422942|2398580|P1|Overall Study|Study terminated by Sponsor|3
750794|NCT00423046|2398599|P2|Overall Study|Unspecified|345
750795|NCT00423046|2398600|P1|Overall Study|Unspecified|340
750796|NCT00423085|2398669|P4|52-Week Open-Label Extension Phase|Death|2
750797|NCT00423085|2398670|P3|52-Week Open-Label Extension Phase|Death|0
750798|NCT00423085|2398671|P2|52-Week Open-Label Extension Phase|Death|0
750799|NCT00423085|2398672|P1|52-Week Open-Label Extension Phase|Death|0
750800|NCT00423085|2398669|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
750801|NCT00423085|2398670|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
750802|NCT00423085|2398671|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
750803|NCT00423085|2398672|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
750804|NCT00423085|2398669|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
750805|NCT00423085|2398670|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
750806|NCT00423085|2398671|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
750807|NCT00423085|2398672|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
750808|NCT00423085|2398669|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
750809|NCT00423085|2398670|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
750810|NCT00423085|2398671|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
750811|NCT00423085|2398672|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
750812|NCT00423085|2398669|P4|52-Week Open-Label Extension Phase|Adverse Event|97
750813|NCT00423085|2398670|P3|52-Week Open-Label Extension Phase|Adverse Event|0
750814|NCT00423085|2398671|P2|52-Week Open-Label Extension Phase|Adverse Event|0
750815|NCT00423085|2398672|P1|52-Week Open-Label Extension Phase|Adverse Event|0
750816|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
750817|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
750818|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
750819|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
750820|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Death|0
750821|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Death|0
750822|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Death|1
750823|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Death|1
750824|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
750825|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
750826|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
750827|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
750828|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
750829|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
750830|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
750831|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
750918|NCT00423449|2398871|P1|Overall Study|Progressive Disease|1
750832|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
750833|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
750834|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
750835|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
750836|NCT00423085|2398669|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
750837|NCT00423085|2398670|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
750838|NCT00423085|2398671|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
750839|NCT00423085|2398672|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
750840|NCT00423098|2398701|P2|Overall Study|Death|0
750841|NCT00423098|2398702|P1|Overall Study|Death|2
750842|NCT00423098|2398701|P2|Overall Study|Administrative problems|1
750843|NCT00423098|2398702|P1|Overall Study|Administrative problems|0
750844|NCT00423098|2398701|P2|Overall Study|Unsatisfactory therapeutic effect|1
750845|NCT00423098|2398702|P1|Overall Study|Unsatisfactory therapeutic effect|0
750846|NCT00423098|2398701|P2|Overall Study|Adverse Event|2
750847|NCT00423098|2398702|P1|Overall Study|Adverse Event|1
750848|NCT00423150|2398726|P1|Overall Study|Administrative|4
750849|NCT00423150|2398726|P1|Overall Study|Non-compliance with protocol|1
750850|NCT00423150|2398726|P1|Overall Study|Withdrawal by Subject|1
750851|NCT00423150|2398726|P1|Overall Study|Progression of disease being studied|69
750852|NCT00423150|2398726|P1|Overall Study|Adverse Event|11
750853|NCT00423176|2398732|P2|Overall Study|Did not meet protocol eligibility|4
750854|NCT00423176|2398733|P1|Overall Study|Did not meet protocol eligibility|2
750855|NCT00423176|2398732|P2|Overall Study|Protocol Violation|3
750856|NCT00423176|2398733|P1|Overall Study|Protocol Violation|1
750857|NCT00423176|2398732|P2|Overall Study|Withdrawal by Subject|3
750858|NCT00423176|2398733|P1|Overall Study|Withdrawal by Subject|4
750859|NCT00423176|2398732|P2|Overall Study|Lost to Follow-up|7
750860|NCT00423176|2398733|P1|Overall Study|Lost to Follow-up|4
750861|NCT00423176|2398732|P2|Overall Study|Treatment Failure|6
750862|NCT00423176|2398733|P1|Overall Study|Treatment Failure|1
750863|NCT00423176|2398732|P2|Overall Study|Adverse Event|6
750864|NCT00423176|2398733|P1|Overall Study|Adverse Event|4
750865|NCT00423189|2398744|P3|Overall Study|Death|0
750866|NCT00423189|2398745|P2|Overall Study|Death|1
750867|NCT00423189|2398746|P1|Overall Study|Death|0
750868|NCT00423267|2398768|P2|Period A|Administrative|0
750869|NCT00423267|2398769|P1|Period A|Administrative|1
750870|NCT00423267|2398768|P2|Period A|Non-compliance with protocol|0
750871|NCT00423267|2398769|P1|Period A|Non-compliance with protocol|1
750872|NCT00423267|2398768|P2|Period A|Withdrawal by Subject|1
750873|NCT00423267|2398769|P1|Period A|Withdrawal by Subject|0
750874|NCT00423293|2398786|P1|Overall Study|Ineligible / No protocol treatment|11
750875|NCT00423319|2398792|P2|Overall Study|Not specified|22
750876|NCT00423319|2398793|P1|Overall Study|Not specified|23
750877|NCT00423319|2398792|P2|Overall Study|No longer meets study criteria|15
750878|NCT00423319|2398793|P1|Overall Study|No longer meets study criteria|15
750879|NCT00423319|2398792|P2|Overall Study|Poor compliance or noncompliance|1
750880|NCT00423319|2398793|P1|Overall Study|Poor compliance or noncompliance|1
750881|NCT00423319|2398792|P2|Overall Study|Lost to Follow-up|3
750882|NCT00423319|2398793|P1|Overall Study|Lost to Follow-up|4
750883|NCT00423319|2398792|P2|Overall Study|Withdrawal by Subject|99
750884|NCT00423319|2398793|P1|Overall Study|Withdrawal by Subject|86
750885|NCT00423319|2398792|P2|Overall Study|Adverse Event|112
750886|NCT00423319|2398793|P1|Overall Study|Adverse Event|93
750887|NCT00423319|2398792|P2|Overall Study|Death|0
750888|NCT00423319|2398793|P1|Overall Study|Death|2
750889|NCT00423332|2398827|P2|Overall Study|Unblinded before 12 weeks|3
750890|NCT00423332|2398828|P1|Overall Study|Unblinded before 12 weeks|1
750891|NCT00423332|2398827|P2|Overall Study|Progressive at Week 6|1
750892|NCT00423332|2398828|P1|Overall Study|Progressive at Week 6|0
750893|NCT00423332|2398827|P2|Overall Study|Condition under investigation worsened|1
750894|NCT00423332|2398828|P1|Overall Study|Condition under investigation worsened|1
750895|NCT00423332|2398827|P2|Overall Study|Withdrawal by Subject|0
750896|NCT00423332|2398828|P1|Overall Study|Withdrawal by Subject|1
750897|NCT00423332|2398827|P2|Overall Study|Adverse Event|2
750898|NCT00423332|2398828|P1|Overall Study|Adverse Event|6
750899|NCT00423449|2398867|P5|Overall Study|Protocol Violation|0
750900|NCT00423449|2398868|P4|Overall Study|Protocol Violation|1
750901|NCT00423449|2398869|P3|Overall Study|Protocol Violation|2
750902|NCT00423449|2398870|P2|Overall Study|Protocol Violation|0
750903|NCT00423449|2398871|P1|Overall Study|Protocol Violation|0
750904|NCT00423449|2398867|P5|Overall Study|Not Specified|0
750905|NCT00423449|2398868|P4|Overall Study|Not Specified|1
750906|NCT00423449|2398869|P3|Overall Study|Not Specified|0
750907|NCT00423449|2398870|P2|Overall Study|Not Specified|0
750908|NCT00423449|2398871|P1|Overall Study|Not Specified|0
750909|NCT00423449|2398867|P5|Overall Study|Laboratory Adverse Event|0
750910|NCT00423449|2398868|P4|Overall Study|Laboratory Adverse Event|0
750911|NCT00423449|2398869|P3|Overall Study|Laboratory Adverse Event|2
750912|NCT00423449|2398870|P2|Overall Study|Laboratory Adverse Event|1
750913|NCT00423449|2398871|P1|Overall Study|Laboratory Adverse Event|0
750914|NCT00423449|2398867|P5|Overall Study|Progressive Disease|4
750915|NCT00423449|2398868|P4|Overall Study|Progressive Disease|11
750916|NCT00423449|2398869|P3|Overall Study|Progressive Disease|8
750917|NCT00423449|2398870|P2|Overall Study|Progressive Disease|3
750919|NCT00423449|2398867|P5|Overall Study|Death|1
750920|NCT00423449|2398868|P4|Overall Study|Death|1
750921|NCT00423449|2398869|P3|Overall Study|Death|2
750922|NCT00423449|2398870|P2|Overall Study|Death|0
750923|NCT00423449|2398871|P1|Overall Study|Death|1
750924|NCT00423449|2398867|P5|Overall Study|Clinical Adverse Event|2
750925|NCT00423449|2398868|P4|Overall Study|Clinical Adverse Event|8
750926|NCT00423449|2398869|P3|Overall Study|Clinical Adverse Event|1
750927|NCT00423449|2398870|P2|Overall Study|Clinical Adverse Event|0
750928|NCT00423449|2398871|P1|Overall Study|Clinical Adverse Event|1
750929|NCT00423488|2398896|P2|Overall Study|No post baseline data|0
750930|NCT00423488|2398897|P1|Overall Study|No post baseline data|3
750931|NCT00423488|2398896|P2|Overall Study|No evidence of study drug intake|1
750932|NCT00423488|2398897|P1|Overall Study|No evidence of study drug intake|2
750933|NCT00423579|2398905|P2|Overall Study|Diagnosis of diabetes|1
750934|NCT00423579|2398906|P1|Overall Study|Diagnosis of diabetes|0
750935|NCT00423579|2398905|P2|Overall Study|Protocol Violation|3
750936|NCT00423579|2398906|P1|Overall Study|Protocol Violation|1
750937|NCT00423579|2398905|P2|Overall Study|Lost to Follow-up|0
750938|NCT00423579|2398906|P1|Overall Study|Lost to Follow-up|3
750939|NCT00423592|2398912|P1|Overall Study|Adverse Event (post Week 12)|5
750940|NCT00423592|2398912|P1|Overall Study|Adverse Event (through Week 12)|2
750941|NCT00423605|2398931|P1|Overall Study|Not one of the pre-specified options|5
750942|NCT00423605|2398931|P1|Overall Study|Protocol Violation|7
750943|NCT00423605|2398931|P1|Overall Study|Physician Decision|8
750944|NCT00423605|2398931|P1|Overall Study|Sponsor Decision|3
750945|NCT00423605|2398931|P1|Overall Study|Lack of Efficacy|38
750946|NCT00423605|2398931|P1|Overall Study|Lost to Follow-up|15
750947|NCT00423605|2398931|P1|Overall Study|Withdrawal by Subject|36
750948|NCT00423605|2398931|P1|Overall Study|Adverse Event|129
750949|NCT00423657|2398937|P2|Overall Study|Request of sponsor/investigator|0
750950|NCT00423657|2398938|P1|Overall Study|Request of sponsor/investigator|1
750951|NCT00423657|2398937|P2|Overall Study|Other|16
750952|NCT00423657|2398938|P1|Overall Study|Other|15
750953|NCT00423657|2398937|P2|Overall Study|Non-compliance|1
750954|NCT00423657|2398938|P1|Overall Study|Non-compliance|0
750955|NCT00423657|2398937|P2|Overall Study|Withdrew consent|8
750956|NCT00423657|2398938|P1|Overall Study|Withdrew consent|10
750957|NCT00423670|2398951|P8|Follow-up Period|Non-compliance with protocol|2
750958|NCT00423670|2398952|P7|Follow-up Period|Non-compliance with protocol|3
750959|NCT00423670|2398953|P6|Follow-up Period|Non-compliance with protocol|0
750960|NCT00423670|2398954|P5|Follow-up Period|Non-compliance with protocol|0
750961|NCT00423670|2398955|P4|Follow-up Period|Non-compliance with protocol|1
750962|NCT00423670|2398956|P3|Follow-up Period|Non-compliance with protocol|1
750963|NCT00423670|2398957|P2|Follow-up Period|Non-compliance with protocol|0
750964|NCT00423670|2398958|P1|Follow-up Period|Non-compliance with protocol|2
750965|NCT00423670|2398951|P8|Follow-up Period|Subject withdrew (not treatment related)|1
750966|NCT00423670|2398952|P7|Follow-up Period|Subject withdrew (not treatment related)|1
750967|NCT00423670|2398953|P6|Follow-up Period|Subject withdrew (not treatment related)|0
750968|NCT00423670|2398954|P5|Follow-up Period|Subject withdrew (not treatment related)|1
750969|NCT00423670|2398955|P4|Follow-up Period|Subject withdrew (not treatment related)|1
750970|NCT00423670|2398956|P3|Follow-up Period|Subject withdrew (not treatment related)|2
750971|NCT00423670|2398957|P2|Follow-up Period|Subject withdrew (not treatment related)|4
750972|NCT00423670|2398958|P1|Follow-up Period|Subject withdrew (not treatment related)|1
750973|NCT00423670|2398951|P8|Follow-up Period|Lost to Follow-up|0
750974|NCT00423670|2398952|P7|Follow-up Period|Lost to Follow-up|5
750975|NCT00423670|2398953|P6|Follow-up Period|Lost to Follow-up|0
750976|NCT00423670|2398954|P5|Follow-up Period|Lost to Follow-up|1
750977|NCT00423670|2398955|P4|Follow-up Period|Lost to Follow-up|3
750978|NCT00423670|2398956|P3|Follow-up Period|Lost to Follow-up|8
750979|NCT00423670|2398957|P2|Follow-up Period|Lost to Follow-up|12
750980|NCT00423670|2398958|P1|Follow-up Period|Lost to Follow-up|0
750981|NCT00423670|2398951|P8|Treatment Period|Non-compliance with protocol|2
750982|NCT00423670|2398952|P7|Treatment Period|Non-compliance with protocol|2
750983|NCT00423670|2398953|P6|Treatment Period|Non-compliance with protocol|0
750984|NCT00423670|2398954|P5|Treatment Period|Non-compliance with protocol|2
750985|NCT00423670|2398955|P4|Treatment Period|Non-compliance with protocol|3
750986|NCT00423670|2398956|P3|Treatment Period|Non-compliance with protocol|1
750987|NCT00423670|2398957|P2|Treatment Period|Non-compliance with protocol|1
750988|NCT00423670|2398958|P1|Treatment Period|Non-compliance with protocol|3
750989|NCT00423670|2398951|P8|Treatment Period|Investigator decision|1
750990|NCT00423670|2398952|P7|Treatment Period|Investigator decision|0
750991|NCT00423670|2398953|P6|Treatment Period|Investigator decision|0
750992|NCT00423670|2398954|P5|Treatment Period|Investigator decision|0
750993|NCT00423670|2398955|P4|Treatment Period|Investigator decision|0
750994|NCT00423670|2398956|P3|Treatment Period|Investigator decision|0
750995|NCT00423670|2398957|P2|Treatment Period|Investigator decision|0
750996|NCT00423670|2398958|P1|Treatment Period|Investigator decision|0
750997|NCT00423670|2398951|P8|Treatment Period|Subject withdrew (not treatment related)|0
750998|NCT00423670|2398952|P7|Treatment Period|Subject withdrew (not treatment related)|3
750999|NCT00423670|2398953|P6|Treatment Period|Subject withdrew (not treatment related)|0
751000|NCT00423670|2398954|P5|Treatment Period|Subject withdrew (not treatment related)|5
751001|NCT00423670|2398955|P4|Treatment Period|Subject withdrew (not treatment related)|4
751002|NCT00423670|2398956|P3|Treatment Period|Subject withdrew (not treatment related)|4
751003|NCT00423670|2398957|P2|Treatment Period|Subject withdrew (not treatment related)|9
751004|NCT00423670|2398958|P1|Treatment Period|Subject withdrew (not treatment related)|3
751005|NCT00423670|2398951|P8|Treatment Period|Lost to Follow-up|1
751006|NCT00423670|2398952|P7|Treatment Period|Lost to Follow-up|3
751007|NCT00423670|2398953|P6|Treatment Period|Lost to Follow-up|0
751008|NCT00423670|2398954|P5|Treatment Period|Lost to Follow-up|6
751009|NCT00423670|2398955|P4|Treatment Period|Lost to Follow-up|1
751010|NCT00423670|2398956|P3|Treatment Period|Lost to Follow-up|3
751011|NCT00423670|2398957|P2|Treatment Period|Lost to Follow-up|1
751012|NCT00423670|2398958|P1|Treatment Period|Lost to Follow-up|2
751013|NCT00423670|2398951|P8|Treatment Period|Protocol-defined clinical event|15
751014|NCT00423670|2398952|P7|Treatment Period|Protocol-defined clinical event|16
751015|NCT00423670|2398953|P6|Treatment Period|Protocol-defined clinical event|4
751016|NCT00423670|2398954|P5|Treatment Period|Protocol-defined clinical event|5
751017|NCT00423670|2398955|P4|Treatment Period|Protocol-defined clinical event|12
751018|NCT00423670|2398956|P3|Treatment Period|Protocol-defined clinical event|4
751019|NCT00423670|2398957|P2|Treatment Period|Protocol-defined clinical event|7
751020|NCT00423670|2398958|P1|Treatment Period|Protocol-defined clinical event|0
751021|NCT00423670|2398951|P8|Treatment Period|Adverse Event|2
751022|NCT00423670|2398952|P7|Treatment Period|Adverse Event|7
751023|NCT00423670|2398953|P6|Treatment Period|Adverse Event|4
751024|NCT00423670|2398954|P5|Treatment Period|Adverse Event|9
751025|NCT00423670|2398955|P4|Treatment Period|Adverse Event|20
751026|NCT00423670|2398956|P3|Treatment Period|Adverse Event|15
751027|NCT00423670|2398957|P2|Treatment Period|Adverse Event|12
751028|NCT00423670|2398958|P1|Treatment Period|Adverse Event|8
751029|NCT00423670|2398951|P8|Treatment Period|Switched to Arm 8 at TW 24|0
751030|NCT00423670|2398952|P7|Treatment Period|Switched to Arm 8 at TW 24|0
751031|NCT00423670|2398953|P6|Treatment Period|Switched to Arm 8 at TW 24|0
751032|NCT00423670|2398954|P5|Treatment Period|Switched to Arm 8 at TW 24|0
751033|NCT00423670|2398955|P4|Treatment Period|Switched to Arm 8 at TW 24|0
751034|NCT00423670|2398956|P3|Treatment Period|Switched to Arm 8 at TW 24|0
751035|NCT00423670|2398957|P2|Treatment Period|Switched to Arm 8 at TW 24|0
751036|NCT00423670|2398958|P1|Treatment Period|Switched to Arm 8 at TW 24|36
751037|NCT00423722|2399031|P2|Overall Study|Withdrawal by Subject|2
751038|NCT00423722|2399032|P1|Overall Study|Withdrawal by Subject|4
751039|NCT00423722|2399031|P2|Overall Study|Unable to complete questionnaires|4
751040|NCT00423722|2399032|P1|Overall Study|Unable to complete questionnaires|4
751041|NCT00423722|2399031|P2|Overall Study|Declined to participate|3
751042|NCT00423722|2399032|P1|Overall Study|Declined to participate|2
751043|NCT00423722|2399031|P2|Overall Study|Death|4
751044|NCT00423722|2399032|P1|Overall Study|Death|4
751045|NCT00423735|2399055|P3|Overall Study|Ineligible / No protocol treatment|0
751046|NCT00423735|2399056|P2|Overall Study|Ineligible / No protocol treatment|6
751047|NCT00423735|2399057|P1|Overall Study|Ineligible / No protocol treatment|8
751048|NCT00423800|2399080|P2|Overall Study|Protocol Violation|1
751049|NCT00423800|2399081|P1|Overall Study|Protocol Violation|0
751050|NCT00423813|2399093|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
751051|NCT00423813|2399094|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
751052|NCT00423813|2399095|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
751053|NCT00423813|2399093|P3|Overall Study|Will start exclusionary medications|0
751054|NCT00423813|2399094|P2|Overall Study|Will start exclusionary medications|1
751055|NCT00423813|2399095|P1|Overall Study|Will start exclusionary medications|0
751056|NCT00423813|2399093|P3|Overall Study|Subject started night shift work|0
751057|NCT00423813|2399094|P2|Overall Study|Subject started night shift work|0
751058|NCT00423813|2399095|P1|Overall Study|Subject started night shift work|1
751059|NCT00423813|2399093|P3|Overall Study|Pregnancy|1
751060|NCT00423813|2399094|P2|Overall Study|Pregnancy|0
751061|NCT00423813|2399095|P1|Overall Study|Pregnancy|0
751062|NCT00423813|2399093|P3|Overall Study|Protocol Violation|4
751063|NCT00423813|2399094|P2|Overall Study|Protocol Violation|4
751064|NCT00423813|2399095|P1|Overall Study|Protocol Violation|9
751065|NCT00423813|2399093|P3|Overall Study|Sponsor Decision|0
751066|NCT00423813|2399094|P2|Overall Study|Sponsor Decision|1
751067|NCT00423813|2399095|P1|Overall Study|Sponsor Decision|0
751068|NCT00423813|2399093|P3|Overall Study|Physician Decision|0
751069|NCT00423813|2399094|P2|Overall Study|Physician Decision|0
751070|NCT00423813|2399095|P1|Overall Study|Physician Decision|2
751071|NCT00423813|2399093|P3|Overall Study|Lack of Efficacy|19
751072|NCT00423813|2399094|P2|Overall Study|Lack of Efficacy|18
751073|NCT00423813|2399095|P1|Overall Study|Lack of Efficacy|23
751074|NCT00423813|2399093|P3|Overall Study|Lost to Follow-up|4
751075|NCT00423813|2399094|P2|Overall Study|Lost to Follow-up|4
751076|NCT00423813|2399095|P1|Overall Study|Lost to Follow-up|5
751077|NCT00423813|2399093|P3|Overall Study|Withdrawal by Subject|5
751078|NCT00423813|2399094|P2|Overall Study|Withdrawal by Subject|8
751079|NCT00423813|2399095|P1|Overall Study|Withdrawal by Subject|6
751080|NCT00423813|2399093|P3|Overall Study|Adverse Event|40
751081|NCT00423813|2399094|P2|Overall Study|Adverse Event|30
751082|NCT00423813|2399095|P1|Overall Study|Adverse Event|11
751083|NCT00429663|2399105|P2|Overall Study|Death|0
751084|NCT00429663|2399106|P1|Overall Study|Death|4
751085|NCT00429663|2399105|P2|Overall Study|Withdrawal by Subject|5
751086|NCT00429663|2399106|P1|Overall Study|Withdrawal by Subject|2
751087|NCT00429663|2399105|P2|Overall Study|Physician Decision|3
751088|NCT00429663|2399106|P1|Overall Study|Physician Decision|6
751089|NCT00429663|2399105|P2|Overall Study|Lost to Follow-up|31
751090|NCT00429663|2399106|P1|Overall Study|Lost to Follow-up|24
751095|NCT00429923|2399141|P3|Overall Study|Early Termination|0
751096|NCT00429923|2399142|P2|Overall Study|Early Termination|1
751097|NCT00429923|2399143|P1|Overall Study|Early Termination|0
751098|NCT00429923|2399141|P3|Overall Study|Withdrew Consent|1
751099|NCT00429923|2399142|P2|Overall Study|Withdrew Consent|0
751100|NCT00429923|2399143|P1|Overall Study|Withdrew Consent|1
751101|NCT00429923|2399141|P3|Overall Study|Lost to Follow-up|2
751102|NCT00429923|2399142|P2|Overall Study|Lost to Follow-up|0
751103|NCT00429923|2399143|P1|Overall Study|Lost to Follow-up|0
751104|NCT00429923|2399141|P3|Overall Study|Lack of Efficacy|33
751105|NCT00429923|2399142|P2|Overall Study|Lack of Efficacy|1
751106|NCT00429923|2399143|P1|Overall Study|Lack of Efficacy|4
751107|NCT00429923|2399141|P3|Overall Study|Adverse Event|3
751108|NCT00429923|2399142|P2|Overall Study|Adverse Event|2
751109|NCT00429923|2399143|P1|Overall Study|Adverse Event|0
751110|NCT00433914|2399160|P2|Overall Study|Lost to Follow-up|1
751111|NCT00433914|2399161|P1|Overall Study|Lost to Follow-up|0
751112|NCT00433914|2399160|P2|Overall Study|Withdrawal by Subject|2
751113|NCT00433914|2399161|P1|Overall Study|Withdrawal by Subject|0
751114|NCT00434057|2399211|P1|Overall Study|Withdrawal by Subject|1
751115|NCT00434109|2399215|P1|Overall Study|had embolism, did not receive sunitinib|3
751116|NCT00434109|2399215|P1|Overall Study|Protocol Violation|1
751117|NCT00434109|2399215|P1|Overall Study|Adverse Event|5
751118|NCT00434109|2399215|P1|Overall Study|Physician Decision|9
751119|NCT00434122|2399226|P2|Overall Study|Travelling of subject.|0
751120|NCT00434122|2399227|P1|Overall Study|Travelling of subject.|1
751121|NCT00434122|2399226|P2|Overall Study|Low follicular response.|2
751122|NCT00434122|2399227|P1|Overall Study|Low follicular response.|1
751123|NCT00434122|2399226|P2|Overall Study|Large follicle size|2
751124|NCT00434122|2399227|P1|Overall Study|Large follicle size|2
751125|NCT00434122|2399226|P2|Overall Study|Personal reasons|1
751126|NCT00434122|2399227|P1|Overall Study|Personal reasons|1
751127|NCT00434122|2399226|P2|Overall Study|loss of subject contact|1
751128|NCT00434122|2399227|P1|Overall Study|loss of subject contact|1
751129|NCT00434122|2399226|P2|Overall Study|Non-compliance with protocol|1
751130|NCT00434122|2399227|P1|Overall Study|Non-compliance with protocol|0
751131|NCT00434148|2399238|P2|Overall Study|Abnormal test procedure result|1
751132|NCT00434148|2399239|P1|Overall Study|Abnormal test procedure result|0
751133|NCT00434148|2399238|P2|Overall Study|Condition no longer requires study drug|0
751134|NCT00434148|2399239|P1|Overall Study|Condition no longer requires study drug|1
751135|NCT00434148|2399238|P2|Overall Study|Lost to Follow-up|1
751136|NCT00434148|2399239|P1|Overall Study|Lost to Follow-up|0
751137|NCT00434148|2399238|P2|Overall Study|Administrative problems|10
751138|NCT00434148|2399239|P1|Overall Study|Administrative problems|6
751139|NCT00434148|2399238|P2|Overall Study|Protocol Violation|0
751140|NCT00434148|2399239|P1|Overall Study|Protocol Violation|4
751141|NCT00434148|2399238|P2|Overall Study|Withdrawal by Subject|15
751142|NCT00434148|2399239|P1|Overall Study|Withdrawal by Subject|15
751143|NCT00434148|2399238|P2|Overall Study|Lack of Efficacy|28
751144|NCT00434148|2399239|P1|Overall Study|Lack of Efficacy|25
751145|NCT00434148|2399238|P2|Overall Study|Adverse Event|18
751146|NCT00434148|2399239|P1|Overall Study|Adverse Event|18
751147|NCT00434161|2399276|P3|Overall Study|Logistical error study assessments|3
751148|NCT00434161|2399277|P2|Overall Study|Logistical error study assessments|0
751149|NCT00434161|2399278|P1|Overall Study|Logistical error study assessments|1
751150|NCT00434161|2399276|P3|Overall Study|Withdrawal by Subject|3
751151|NCT00434161|2399277|P2|Overall Study|Withdrawal by Subject|0
751152|NCT00434161|2399278|P1|Overall Study|Withdrawal by Subject|2
751153|NCT00434161|2399276|P3|Overall Study|Non-Compliance|0
751154|NCT00434161|2399277|P2|Overall Study|Non-Compliance|1
751155|NCT00434161|2399278|P1|Overall Study|Non-Compliance|1
751156|NCT00434161|2399276|P3|Overall Study|Death|1
751157|NCT00434161|2399277|P2|Overall Study|Death|0
751158|NCT00434161|2399278|P1|Overall Study|Death|1
751159|NCT00434161|2399276|P3|Overall Study|Lost to Follow-up|0
751160|NCT00434161|2399277|P2|Overall Study|Lost to Follow-up|1
751161|NCT00434161|2399278|P1|Overall Study|Lost to Follow-up|0
751162|NCT00434161|2399276|P3|Overall Study|Adverse Event|4
751163|NCT00434161|2399277|P2|Overall Study|Adverse Event|1
751164|NCT00434161|2399278|P1|Overall Study|Adverse Event|5
751165|NCT00434213|2399320|P1|Overall Study|Non-compliant to study schedule|1
751166|NCT00434213|2399320|P1|Overall Study|Application site reaction|1
751167|NCT00434213|2399320|P1|Overall Study|Unable to comply with study visit window|2
751168|NCT00434213|2399320|P1|Overall Study|Protocol Violation|3
751169|NCT00434213|2399320|P1|Overall Study|Withdrawal by Subject|7
751170|NCT00434213|2399320|P1|Overall Study|Lost to Follow-up|14
751171|NCT00434213|2399320|P1|Overall Study|Lack of Efficacy|9
751172|NCT00434213|2399320|P1|Overall Study|Adverse Event|12
751173|NCT00434252|2399341|P2|Overall Study|Withdrawal by Subject|7
751174|NCT00434252|2399342|P1|Overall Study|Withdrawal by Subject|3
751175|NCT00434252|2399341|P2|Overall Study|Physician Decision|8
751176|NCT00434252|2399342|P1|Overall Study|Physician Decision|4
751177|NCT00434252|2399341|P2|Overall Study|Lost to Follow-up|1
751178|NCT00434252|2399342|P1|Overall Study|Lost to Follow-up|0
751179|NCT00434252|2399341|P2|Overall Study|Death|2
751180|NCT00434252|2399342|P1|Overall Study|Death|1
751181|NCT00434252|2399341|P2|Overall Study|Adverse Event|13
751182|NCT00434252|2399342|P1|Overall Study|Adverse Event|6
751183|NCT00434252|2399341|P2|Overall Study|Lack of Efficacy|100
751184|NCT00434252|2399342|P1|Overall Study|Lack of Efficacy|50
751188|NCT00434330|2399415|P6|Overall Study|Subject Not Compliant With Study|0
751189|NCT00434330|2399416|P5|Overall Study|Subject Not Compliant With Study|0
751190|NCT00434330|2399417|P4|Overall Study|Subject Not Compliant With Study|0
751191|NCT00434330|2399418|P3|Overall Study|Subject Not Compliant With Study|1
751192|NCT00434330|2399419|P2|Overall Study|Subject Not Compliant With Study|0
751193|NCT00434330|2399420|P1|Overall Study|Subject Not Compliant With Study|0
751194|NCT00434330|2399415|P6|Overall Study|Renal transplant|0
751195|NCT00434330|2399416|P5|Overall Study|Renal transplant|0
751196|NCT00434330|2399417|P4|Overall Study|Renal transplant|1
751197|NCT00434330|2399418|P3|Overall Study|Renal transplant|0
751198|NCT00434330|2399419|P2|Overall Study|Renal transplant|0
751199|NCT00434330|2399420|P1|Overall Study|Renal transplant|0
751200|NCT00434330|2399415|P6|Overall Study|Withdrawal by Subject|0
751201|NCT00434330|2399416|P5|Overall Study|Withdrawal by Subject|0
751202|NCT00434330|2399417|P4|Overall Study|Withdrawal by Subject|1
751203|NCT00434330|2399418|P3|Overall Study|Withdrawal by Subject|1
751204|NCT00434330|2399419|P2|Overall Study|Withdrawal by Subject|0
751205|NCT00434330|2399420|P1|Overall Study|Withdrawal by Subject|0
751206|NCT00434330|2399415|P6|Overall Study|Death|1
751207|NCT00434330|2399416|P5|Overall Study|Death|1
751208|NCT00434330|2399417|P4|Overall Study|Death|0
751209|NCT00434330|2399418|P3|Overall Study|Death|0
751210|NCT00434330|2399419|P2|Overall Study|Death|0
751211|NCT00434330|2399420|P1|Overall Study|Death|1
751212|NCT00434330|2399415|P6|Overall Study|Adverse Event|0
751213|NCT00434330|2399416|P5|Overall Study|Adverse Event|0
751214|NCT00434330|2399417|P4|Overall Study|Adverse Event|0
751215|NCT00434330|2399418|P3|Overall Study|Adverse Event|1
751216|NCT00434330|2399419|P2|Overall Study|Adverse Event|0
751217|NCT00434330|2399420|P1|Overall Study|Adverse Event|0
751218|NCT00434421|2399470|P1|Overall Study|Non-compliance with study treatment|1
751219|NCT00434421|2399470|P1|Overall Study|Withdrawal by Subject|1
751220|NCT00434590|2399492|P2|Overall Study|Administrative problems|5
751221|NCT00434590|2399493|P1|Overall Study|Administrative problems|5
751222|NCT00434642|2399501|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
751223|NCT00434642|2399502|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
751224|NCT00434642|2399501|P2|Open-label Treatment Phase|Adverse Event|5
751225|NCT00434642|2399502|P1|Open-label Treatment Phase|Adverse Event|0
751226|NCT00434642|2399501|P2|Blinded Treatment Phase|Did not Receive Treatment|1
751227|NCT00434642|2399502|P1|Blinded Treatment Phase|Did not Receive Treatment|4
751228|NCT00434642|2399501|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
751229|NCT00434642|2399502|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
751230|NCT00434642|2399501|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
751231|NCT00434642|2399502|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
751232|NCT00434642|2399501|P2|Blinded Treatment Phase|Physician Decision|27
751233|NCT00434642|2399502|P1|Blinded Treatment Phase|Physician Decision|19
751234|NCT00434642|2399501|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
751235|NCT00434642|2399502|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
751236|NCT00434642|2399501|P2|Blinded Treatment Phase|Clinical Disease Progression|5
751237|NCT00434642|2399502|P1|Blinded Treatment Phase|Clinical Disease Progression|4
751238|NCT00434642|2399501|P2|Blinded Treatment Phase|Adverse Event|58
751239|NCT00434642|2399502|P1|Blinded Treatment Phase|Adverse Event|12
751240|NCT00434759|2399520|P2|Overall Study|family affairs|0
751241|NCT00434759|2399521|P1|Overall Study|family affairs|2
751242|NCT00434759|2399520|P2|Overall Study|Withdrawal by Subject|1
751243|NCT00434759|2399521|P1|Overall Study|Withdrawal by Subject|17
751244|NCT00434759|2399520|P2|Overall Study|Lack of Efficacy|4
751245|NCT00434759|2399521|P1|Overall Study|Lack of Efficacy|5
751246|NCT00434876|2399537|P2|Overall Study|Lost to Follow-up|1
751247|NCT00434876|2399538|P1|Overall Study|Lost to Follow-up|1
751248|NCT00434954|2399552|P2|Overall Study|Subject decision|22
751249|NCT00434954|2399553|P1|Overall Study|Subject decision|8
751250|NCT00434954|2399552|P2|Overall Study|Sponsor decision|0
751251|NCT00434954|2399553|P1|Overall Study|Sponsor decision|1
751252|NCT00434954|2399552|P2|Overall Study|Protocol Violation|27
751253|NCT00434954|2399553|P1|Overall Study|Protocol Violation|36
751254|NCT00434954|2399552|P2|Overall Study|Physician Decision|3
751255|NCT00434954|2399553|P1|Overall Study|Physician Decision|6
751256|NCT00434954|2399552|P2|Overall Study|Lost to Follow-up|1
751257|NCT00434954|2399553|P1|Overall Study|Lost to Follow-up|0
751258|NCT00434954|2399552|P2|Overall Study|Entry criteria not met|16
751259|NCT00434954|2399553|P1|Overall Study|Entry criteria not met|14
751260|NCT00434954|2399552|P2|Overall Study|Adverse Event|2
751261|NCT00434954|2399553|P1|Overall Study|Adverse Event|17
751262|NCT00434967|2399585|P4|Overall Study|Patient Disposition Challenges|3
751263|NCT00434967|2399586|P3|Overall Study|Patient Disposition Challenges|0
751264|NCT00434967|2399587|P2|Overall Study|Patient Disposition Challenges|0
751265|NCT00434967|2399588|P1|Overall Study|Patient Disposition Challenges|2
751266|NCT00434967|2399585|P4|Overall Study|Physician Decision|0
751267|NCT00434967|2399586|P3|Overall Study|Physician Decision|1
751268|NCT00434967|2399587|P2|Overall Study|Physician Decision|1
751269|NCT00434967|2399588|P1|Overall Study|Physician Decision|1
751270|NCT00434967|2399585|P4|Overall Study|Protocol Violation|1
751271|NCT00434967|2399586|P3|Overall Study|Protocol Violation|0
751272|NCT00434967|2399587|P2|Overall Study|Protocol Violation|1
751273|NCT00434967|2399588|P1|Overall Study|Protocol Violation|0
751274|NCT00434967|2399585|P4|Overall Study|Randomized in error|1
751275|NCT00434967|2399586|P3|Overall Study|Randomized in error|0
751276|NCT00434967|2399587|P2|Overall Study|Randomized in error|0
751277|NCT00434967|2399588|P1|Overall Study|Randomized in error|0
751278|NCT00434967|2399585|P4|Overall Study|Withdrawal by Subject|6
751279|NCT00434967|2399586|P3|Overall Study|Withdrawal by Subject|4
751280|NCT00434967|2399587|P2|Overall Study|Withdrawal by Subject|2
751281|NCT00434967|2399588|P1|Overall Study|Withdrawal by Subject|2
751282|NCT00434967|2399585|P4|Overall Study|Lost to Follow-up|0
751283|NCT00434967|2399586|P3|Overall Study|Lost to Follow-up|1
751284|NCT00434967|2399587|P2|Overall Study|Lost to Follow-up|0
751285|NCT00434967|2399588|P1|Overall Study|Lost to Follow-up|0
751286|NCT00434967|2399585|P4|Overall Study|Adverse Event|3
751287|NCT00434967|2399586|P3|Overall Study|Adverse Event|3
751288|NCT00434967|2399587|P2|Overall Study|Adverse Event|4
751289|NCT00434967|2399588|P1|Overall Study|Adverse Event|2
751290|NCT00435019|2399635|P2|Overall Study|Personal reasons for withdrawal|7
751291|NCT00435019|2399636|P1|Overall Study|Personal reasons for withdrawal|8
751292|NCT00435019|2399635|P2|Overall Study|Protocol Violation|1
751293|NCT00435019|2399636|P1|Overall Study|Protocol Violation|3
751294|NCT00435019|2399635|P2|Overall Study|Lack of Efficacy|2
751295|NCT00435019|2399636|P1|Overall Study|Lack of Efficacy|1
751296|NCT00435019|2399635|P2|Overall Study|Adverse Event|0
751297|NCT00435019|2399636|P1|Overall Study|Adverse Event|1
751298|NCT00435045|2399648|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
751299|NCT00435045|2399649|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
751300|NCT00435045|2399648|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
751301|NCT00435045|2399649|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
751302|NCT00435045|2399648|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
751303|NCT00435045|2399649|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
751304|NCT00435045|2399648|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
751305|NCT00435045|2399649|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
751306|NCT00435045|2399648|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
751307|NCT00435045|2399649|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
751308|NCT00435045|2399648|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
751309|NCT00435045|2399649|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
751310|NCT00435045|2399648|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
751311|NCT00435045|2399649|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
751312|NCT00435045|2399648|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
751313|NCT00435045|2399649|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
751314|NCT00435045|2399648|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
751315|NCT00435045|2399649|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
751316|NCT00435045|2399648|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
751317|NCT00435045|2399649|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
751318|NCT00435045|2399648|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
751319|NCT00435045|2399649|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
751320|NCT00435162|2399706|P6|Period 2 (2 Weeks)|Adverse Event|0
751321|NCT00435162|2399707|P5|Period 2 (2 Weeks)|Adverse Event|0
751322|NCT00435162|2399708|P4|Period 2 (2 Weeks)|Adverse Event|0
751323|NCT00435162|2399709|P3|Period 2 (2 Weeks)|Adverse Event|0
751324|NCT00435162|2399710|P2|Period 2 (2 Weeks)|Adverse Event|1
751325|NCT00435162|2399711|P1|Period 2 (2 Weeks)|Adverse Event|0
751326|NCT00435188|2399731|P2|Overall Study|Lost to Follow-up|6
751327|NCT00435188|2399732|P1|Overall Study|Lost to Follow-up|5
751328|NCT00435188|2399731|P2|Overall Study|Withdrawal by Subject|11
751329|NCT00435188|2399732|P1|Overall Study|Withdrawal by Subject|16
751330|NCT00435188|2399731|P2|Overall Study|Death|6
751331|NCT00435188|2399732|P1|Overall Study|Death|1
751332|NCT00435370|2399774|P2|Overall Study|Antipsychotic medication changed|2
751333|NCT00435370|2399775|P1|Overall Study|Antipsychotic medication changed|4
751334|NCT00435370|2399774|P2|Overall Study|Withdrawal by Subject|10
751335|NCT00435370|2399775|P1|Overall Study|Withdrawal by Subject|10
751336|NCT00435370|2399774|P2|Overall Study|Adverse Event|8
751337|NCT00435370|2399775|P1|Overall Study|Adverse Event|8
751338|NCT00435409|2399783|P3|Overall Study|Sponsor decision|0
751339|NCT00435409|2399784|P2|Overall Study|Sponsor decision|3
751340|NCT00435409|2399785|P1|Overall Study|Sponsor decision|0
751341|NCT00435409|2399783|P3|Overall Study|Adverse Event|8
751342|NCT00435409|2399784|P2|Overall Study|Adverse Event|0
751343|NCT00435409|2399785|P1|Overall Study|Adverse Event|0
751344|NCT00435409|2399783|P3|Overall Study|Not specified|1
751345|NCT00435409|2399784|P2|Overall Study|Not specified|30
751346|NCT00435409|2399785|P1|Overall Study|Not specified|45
751347|NCT00435409|2399783|P3|Overall Study|Withdrawal by Subject|1
751348|NCT00435409|2399784|P2|Overall Study|Withdrawal by Subject|7
751349|NCT00435409|2399785|P1|Overall Study|Withdrawal by Subject|8
751350|NCT00435409|2399783|P3|Overall Study|Global deterioration of health status|4
751351|NCT00435409|2399784|P2|Overall Study|Global deterioration of health status|0
751352|NCT00435409|2399785|P1|Overall Study|Global deterioration of health status|0
751353|NCT00435409|2399783|P3|Overall Study|Objective progression or relapse|58
751354|NCT00435409|2399784|P2|Overall Study|Objective progression or relapse|93
751355|NCT00435409|2399785|P1|Overall Study|Objective progression or relapse|158
751356|NCT00435409|2399783|P3|Overall Study|Death|6
751357|NCT00435409|2399784|P2|Overall Study|Death|6
751358|NCT00435409|2399785|P1|Overall Study|Death|8
751359|NCT00435409|2399783|P3|Overall Study|Lost to Follow-up|0
751360|NCT00435409|2399784|P2|Overall Study|Lost to Follow-up|2
751361|NCT00435409|2399785|P1|Overall Study|Lost to Follow-up|1
751362|NCT00435409|2399783|P3|Overall Study|Protocol Violation|0
751363|NCT00435409|2399784|P2|Overall Study|Protocol Violation|2
751364|NCT00435409|2399785|P1|Overall Study|Protocol Violation|1
751365|NCT00435487|2399807|P2|Overall Study|Received Drug in Other Treatment Group|1
751366|NCT00435487|2399808|P1|Overall Study|Received Drug in Other Treatment Group|0
751367|NCT00435487|2399807|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
751368|NCT00435487|2399808|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
751369|NCT00435487|2399807|P2|Overall Study|Withdrawal by Subject|1
751370|NCT00435487|2399808|P1|Overall Study|Withdrawal by Subject|2
751371|NCT00435487|2399807|P2|Overall Study|Other|2
751372|NCT00435487|2399808|P1|Overall Study|Other|5
751373|NCT00435487|2399807|P2|Overall Study|Lost to Follow-up|2
751374|NCT00435487|2399808|P1|Overall Study|Lost to Follow-up|2
751375|NCT00435487|2399807|P2|Overall Study|Adverse Event|3
751376|NCT00435487|2399808|P1|Overall Study|Adverse Event|0
751377|NCT00435487|2399807|P2|Overall Study|Death|4
751378|NCT00435487|2399808|P1|Overall Study|Death|3
751379|NCT00435825|2399884|P4|Overall Study|Did not complete full follow-up period|5
751380|NCT00435825|2399885|P3|Overall Study|Did not complete full follow-up period|4
751381|NCT00435825|2399886|P2|Overall Study|Did not complete full follow-up period|6
751382|NCT00435825|2399887|P1|Overall Study|Did not complete full follow-up period|6
751383|NCT00435825|2399884|P4|Overall Study|Did not enter follow-up|3
751384|NCT00435825|2399885|P3|Overall Study|Did not enter follow-up|1
751385|NCT00435825|2399886|P2|Overall Study|Did not enter follow-up|4
751386|NCT00435825|2399887|P1|Overall Study|Did not enter follow-up|0
751387|NCT00435825|2399884|P4|Overall Study|Did not receive study drug|0
751388|NCT00435825|2399885|P3|Overall Study|Did not receive study drug|2
751389|NCT00435825|2399886|P2|Overall Study|Did not receive study drug|0
751390|NCT00435825|2399887|P1|Overall Study|Did not receive study drug|1
751391|NCT00435825|2399884|P4|Overall Study|Failure to return|0
751392|NCT00435825|2399885|P3|Overall Study|Failure to return|4
751393|NCT00435825|2399886|P2|Overall Study|Failure to return|0
751394|NCT00435825|2399887|P1|Overall Study|Failure to return|5
751395|NCT00435825|2399884|P4|Overall Study|Refused treatment|5
751396|NCT00435825|2399885|P3|Overall Study|Refused treatment|0
751397|NCT00435825|2399886|P2|Overall Study|Refused treatment|0
751398|NCT00435825|2399887|P1|Overall Study|Refused treatment|2
751399|NCT00435825|2399884|P4|Overall Study|Other Protocol Violation|0
751400|NCT00435825|2399885|P3|Overall Study|Other Protocol Violation|0
751401|NCT00435825|2399886|P2|Overall Study|Other Protocol Violation|0
751402|NCT00435825|2399887|P1|Overall Study|Other Protocol Violation|1
751403|NCT00435825|2399884|P4|Overall Study|Insufficient Therapeutic Response|3
751404|NCT00435825|2399885|P3|Overall Study|Insufficient Therapeutic Response|0
751405|NCT00435825|2399886|P2|Overall Study|Insufficient Therapeutic Response|1
751406|NCT00435825|2399887|P1|Overall Study|Insufficient Therapeutic Response|3
751407|NCT00435825|2399884|P4|Overall Study|Abnormality of Laboratory Test|0
751408|NCT00435825|2399885|P3|Overall Study|Abnormality of Laboratory Test|0
751409|NCT00435825|2399886|P2|Overall Study|Abnormality of Laboratory Test|1
751410|NCT00435825|2399887|P1|Overall Study|Abnormality of Laboratory Test|0
751411|NCT00435942|2399972|P2|Overall Study|Other|1
751412|NCT00435942|2399973|P1|Overall Study|Other|0
751413|NCT00435942|2399972|P2|Overall Study|Technical Failure|0
751414|NCT00435942|2399973|P1|Overall Study|Technical Failure|3
751415|NCT00435942|2399972|P2|Overall Study|Conversion to Open Repair|0
751416|NCT00435942|2399973|P1|Overall Study|Conversion to Open Repair|1
751417|NCT00435942|2399972|P2|Overall Study|Lost to Follow-up|16
751418|NCT00435942|2399973|P1|Overall Study|Lost to Follow-up|0
751419|NCT00435942|2399972|P2|Overall Study|Withdrawal by Subject|0
751420|NCT00435942|2399973|P1|Overall Study|Withdrawal by Subject|2
751421|NCT00435942|2399972|P2|Overall Study|Death|10
751422|NCT00435942|2399973|P1|Overall Study|Death|17
751423|NCT00435994|2399983|P3|Overall Study|Lost to Follow-up|0
751424|NCT00435994|2399984|P2|Overall Study|Lost to Follow-up|0
751425|NCT00435994|2399985|P1|Overall Study|Lost to Follow-up|7
751426|NCT00436007|2399997|P3|Overall Study|Unspecified|1
751427|NCT00436007|2399998|P2|Overall Study|Unspecified|0
751428|NCT00436007|2399999|P1|Overall Study|Unspecified|0
751429|NCT00436007|2399997|P3|Overall Study|Death|3
751430|NCT00436007|2399998|P2|Overall Study|Death|1
751431|NCT00436007|2399999|P1|Overall Study|Death|0
751432|NCT00436007|2399997|P3|Overall Study|Physician Decision|2
751433|NCT00436007|2399998|P2|Overall Study|Physician Decision|0
751434|NCT00436007|2399999|P1|Overall Study|Physician Decision|0
751435|NCT00436007|2399997|P3|Overall Study|Lost to Follow-up|13
751436|NCT00436007|2399998|P2|Overall Study|Lost to Follow-up|10
751437|NCT00436007|2399999|P1|Overall Study|Lost to Follow-up|14
751438|NCT00436007|2399997|P3|Overall Study|Withdrawal by Subject|4
751439|NCT00436007|2399998|P2|Overall Study|Withdrawal by Subject|3
751440|NCT00436007|2399999|P1|Overall Study|Withdrawal by Subject|5
751441|NCT00436163|2400078|P1|Overall Study|Adverse Event|1
751442|NCT00436163|2400078|P1|Overall Study|Lost to Follow-up|2
751443|NCT00436215|2400089|P1|Overall Study|Small bowel obstruction|1
751444|NCT00436215|2400089|P1|Overall Study|Refused further treatment|3
751445|NCT00436332|2400095|P1|Overall Study|Never Received Treatment|3
751446|NCT00436332|2400095|P1|Overall Study|Ineligible|2
751447|NCT00436332|2400095|P1|Overall Study|Not Protocol Specified|6
751448|NCT00436332|2400095|P1|Overall Study|Death|2
751449|NCT00436332|2400095|P1|Overall Study|Progression|59
751450|NCT00436332|2400095|P1|Overall Study|Withdrawal by Subject|2
751451|NCT00436332|2400095|P1|Overall Study|Adverse Event|9
751452|NCT00436345|2400104|P2|Overall Study|ICU resident beyond follow-up period|0
751453|NCT00436345|2400105|P1|Overall Study|ICU resident beyond follow-up period|3
751454|NCT00426764|2400158|P1|Overall Study|Other|2
751455|NCT00426764|2400158|P1|Overall Study|Protocol Violation|1
751456|NCT00426764|2400158|P1|Overall Study|Physician Decision|1
751457|NCT00426764|2400158|P1|Overall Study|Withdrawal by Subject|3
751458|NCT00426764|2400158|P1|Overall Study|Adverse Event|19
751459|NCT00426764|2400158|P1|Overall Study|Progressive disease|72
751460|NCT00426842|2400172|P1|Overall Study|Lost to Follow-up|1
751461|NCT00427011|2400182|P1|Overall Study|Not specified|12
751462|NCT00427011|2400182|P1|Overall Study|Lack of Efficacy|2
751463|NCT00427011|2400182|P1|Overall Study|Withdrawal by Subject|1
751464|NCT00427011|2400182|P1|Overall Study|Adverse Event|10
751465|NCT00436436|2400204|P1|Overall Study|Death|6
751466|NCT00436436|2400204|P1|Overall Study|Adverse Event|2
751467|NCT00436436|2400204|P1|Overall Study|Progression|4
751468|NCT00436501|2400215|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
751469|NCT00436501|2400216|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
751470|NCT00436501|2400215|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
751471|NCT00436501|2400216|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
751472|NCT00436553|2400230|P3|Overall Study|Withdrawal by Subject|3
751473|NCT00436553|2400231|P2|Overall Study|Withdrawal by Subject|6
751474|NCT00436553|2400232|P1|Overall Study|Withdrawal by Subject|5
751475|NCT00436553|2400230|P3|Overall Study|Protocol Violation|0
751476|NCT00436553|2400231|P2|Overall Study|Protocol Violation|0
751477|NCT00436553|2400232|P1|Overall Study|Protocol Violation|1
751478|NCT00436553|2400230|P3|Overall Study|Lost to Follow-up|0
751479|NCT00436553|2400231|P2|Overall Study|Lost to Follow-up|2
751480|NCT00436553|2400232|P1|Overall Study|Lost to Follow-up|0
751481|NCT00436553|2400230|P3|Overall Study|Death|3
751482|NCT00436553|2400231|P2|Overall Study|Death|1
751483|NCT00436553|2400232|P1|Overall Study|Death|3
751484|NCT00436553|2400230|P3|Overall Study|Adverse Event|4
751485|NCT00436553|2400231|P2|Overall Study|Adverse Event|3
751486|NCT00436553|2400232|P1|Overall Study|Adverse Event|4
751487|NCT00436566|2400251|P1|Overall Study|Protocol Violation|1
751488|NCT00436566|2400251|P1|Overall Study|Withdrawal by Subject|2
751489|NCT00436605|2400255|P1|Overall Study|Protocol Violation|3
751490|NCT00436618|2400263|P3|Overall Study|Still on treatment|7
751491|NCT00436618|2400264|P2|Overall Study|Still on treatment|2
751492|NCT00436618|2400265|P1|Overall Study|Still on treatment|1
751493|NCT00436618|2400263|P3|Overall Study|New Primary or Other Reasons|12
751494|NCT00436618|2400264|P2|Overall Study|New Primary or Other Reasons|2
751495|NCT00436618|2400265|P1|Overall Study|New Primary or Other Reasons|6
751496|NCT00436618|2400263|P3|Overall Study|Death|3
751497|NCT00436618|2400264|P2|Overall Study|Death|2
751498|NCT00436618|2400265|P1|Overall Study|Death|4
751499|NCT00436618|2400263|P3|Overall Study|Other Medical Problems|7
751500|NCT00436618|2400264|P2|Overall Study|Other Medical Problems|1
751501|NCT00436618|2400265|P1|Overall Study|Other Medical Problems|3
751502|NCT00436618|2400263|P3|Overall Study|Alternate Treatment|12
751503|NCT00436618|2400264|P2|Overall Study|Alternate Treatment|4
751504|NCT00436618|2400265|P1|Overall Study|Alternate Treatment|3
751505|NCT00436618|2400263|P3|Overall Study|Adverse Event|9
751506|NCT00436618|2400264|P2|Overall Study|Adverse Event|8
751507|NCT00436618|2400265|P1|Overall Study|Adverse Event|8
751508|NCT00436618|2400263|P3|Overall Study|Withdrawal by Subject|11
751509|NCT00436618|2400264|P2|Overall Study|Withdrawal by Subject|8
751510|NCT00436618|2400265|P1|Overall Study|Withdrawal by Subject|5
751511|NCT00436644|2400282|P1|Overall Study|Death|1
751512|NCT00436644|2400282|P1|Overall Study|Adverse Event|2
751513|NCT00437983|2400291|P2|Overall Study|Withdrawal by Subject|6
751514|NCT00437983|2400292|P1|Overall Study|Withdrawal by Subject|5
751515|NCT00437983|2400291|P2|Overall Study|Protocol Violation|1
751516|NCT00437983|2400292|P1|Overall Study|Protocol Violation|2
751517|NCT00437983|2400291|P2|Overall Study|Adverse Event|6
751518|NCT00437983|2400292|P1|Overall Study|Adverse Event|6
751519|NCT00438360|2400332|P2|Overall Study|not specified|15
751520|NCT00438360|2400333|P1|Overall Study|not specified|24
751521|NCT00438360|2400332|P2|Overall Study|Lack of Efficacy|27
751522|NCT00438360|2400333|P1|Overall Study|Lack of Efficacy|42
751523|NCT00438360|2400332|P2|Overall Study|Adverse Event|1
751524|NCT00438360|2400333|P1|Overall Study|Adverse Event|6
751525|NCT00438399|2400350|P6|Overall Study|Patien stopped study at visit 4 by error|0
751526|NCT00438399|2400351|P5|Overall Study|Patien stopped study at visit 4 by error|0
751527|NCT00438399|2400352|P4|Overall Study|Patien stopped study at visit 4 by error|0
751528|NCT00438399|2400353|P3|Overall Study|Patien stopped study at visit 4 by error|0
751529|NCT00438399|2400354|P2|Overall Study|Patien stopped study at visit 4 by error|0
751530|NCT00438399|2400355|P1|Overall Study|Patien stopped study at visit 4 by error|1
751531|NCT00438399|2400350|P6|Overall Study|Pregnancy|1
751532|NCT00438399|2400351|P5|Overall Study|Pregnancy|0
751533|NCT00438399|2400352|P4|Overall Study|Pregnancy|0
751534|NCT00438399|2400353|P3|Overall Study|Pregnancy|0
751535|NCT00438399|2400354|P2|Overall Study|Pregnancy|0
751536|NCT00438399|2400355|P1|Overall Study|Pregnancy|0
751537|NCT00438399|2400350|P6|Overall Study|Subje stopped study|0
751538|NCT00438399|2400351|P5|Overall Study|Subje stopped study|0
751539|NCT00438399|2400352|P4|Overall Study|Subje stopped study|0
751540|NCT00438399|2400353|P3|Overall Study|Subje stopped study|1
751541|NCT00438399|2400354|P2|Overall Study|Subje stopped study|0
751542|NCT00438399|2400355|P1|Overall Study|Subje stopped study|0
751543|NCT00438399|2400350|P6|Overall Study|Protocol Violation|1
751544|NCT00438399|2400351|P5|Overall Study|Protocol Violation|0
751545|NCT00438399|2400352|P4|Overall Study|Protocol Violation|0
751546|NCT00438399|2400353|P3|Overall Study|Protocol Violation|1
751547|NCT00438399|2400354|P2|Overall Study|Protocol Violation|0
751548|NCT00438399|2400355|P1|Overall Study|Protocol Violation|0
751549|NCT00438399|2400350|P6|Overall Study|Withdrawal by Subject|2
751550|NCT00438399|2400351|P5|Overall Study|Withdrawal by Subject|2
751551|NCT00438399|2400352|P4|Overall Study|Withdrawal by Subject|2
751552|NCT00438399|2400353|P3|Overall Study|Withdrawal by Subject|3
751553|NCT00438399|2400354|P2|Overall Study|Withdrawal by Subject|6
751554|NCT00438399|2400355|P1|Overall Study|Withdrawal by Subject|5
751555|NCT00438399|2400350|P6|Overall Study|Adverse Event|1
751556|NCT00438399|2400351|P5|Overall Study|Adverse Event|0
751557|NCT00438399|2400352|P4|Overall Study|Adverse Event|1
751558|NCT00438399|2400353|P3|Overall Study|Adverse Event|1
751559|NCT00438399|2400354|P2|Overall Study|Adverse Event|0
751560|NCT00438399|2400355|P1|Overall Study|Adverse Event|0
751561|NCT00438399|2400350|P6|Overall Study|Lost to Follow-up|1
751562|NCT00438399|2400351|P5|Overall Study|Lost to Follow-up|1
751563|NCT00438399|2400352|P4|Overall Study|Lost to Follow-up|1
751564|NCT00438399|2400353|P3|Overall Study|Lost to Follow-up|1
751565|NCT00438399|2400354|P2|Overall Study|Lost to Follow-up|2
751566|NCT00438399|2400355|P1|Overall Study|Lost to Follow-up|2
751567|NCT00438464|2400412|P2|Overall Study|Incomplete data submission|2
751568|NCT00438464|2400413|P1|Overall Study|Incomplete data submission|0
751569|NCT00438464|2400412|P2|Overall Study|Terminated Early|5
751570|NCT00438464|2400413|P1|Overall Study|Terminated Early|14
751571|NCT00438659|2400476|P2|Overall Study|Cancel|2
751572|NCT00438659|2400477|P1|Overall Study|Cancel|5
751573|NCT00438659|2400476|P2|Overall Study|Discontinued Mometasone/Placebo|2
751574|NCT00438659|2400477|P1|Overall Study|Discontinued Mometasone/Placebo|1
751575|NCT00438672|2400501|P2|Overall Study|Lost to Follow-up|9
751576|NCT00438672|2400502|P1|Overall Study|Lost to Follow-up|7
751577|NCT00438815|2400548|P1|Overall Study|Death|1
751578|NCT00438815|2400548|P1|Overall Study|Withdrawal by Subject|6
751579|NCT00438815|2400548|P1|Overall Study|Lost to Follow-up|6
751580|NCT00438815|2400548|P1|Overall Study|Transitioned to commercial C1INH-nf|6
751581|NCT00438815|2400548|P1|Overall Study|Noncompliance with protocol requirements|9
751582|NCT00438815|2400548|P1|Overall Study|3-month follow-up no longer required|12
751583|NCT00438815|2400548|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
751584|NCT00439140|2400612|P3|Treatment Cycle 2|Lost to Follow-up|0
751585|NCT00439140|2400613|P2|Treatment Cycle 2|Lost to Follow-up|1
751586|NCT00439140|2400614|P1|Treatment Cycle 2|Lost to Follow-up|1
751587|NCT00439140|2400612|P3|Treatment Cycle 2|Withdrawal by Subject|0
751588|NCT00439140|2400613|P2|Treatment Cycle 2|Withdrawal by Subject|0
751589|NCT00439140|2400614|P1|Treatment Cycle 2|Withdrawal by Subject|1
751590|NCT00439140|2400612|P3|Treatment Cycle 1|Withdrawal by Subject|0
751591|NCT00439140|2400613|P2|Treatment Cycle 1|Withdrawal by Subject|1
751592|NCT00439140|2400614|P1|Treatment Cycle 1|Withdrawal by Subject|0
751593|NCT00439140|2400612|P3|Treatment Cycle 1|Personal reasons|0
751594|NCT00439140|2400613|P2|Treatment Cycle 1|Personal reasons|2
751595|NCT00439140|2400614|P1|Treatment Cycle 1|Personal reasons|0
751596|NCT00439140|2400612|P3|Treatment Cycle 1|Lost to Follow-up|1
751597|NCT00439140|2400613|P2|Treatment Cycle 1|Lost to Follow-up|1
751598|NCT00439140|2400614|P1|Treatment Cycle 1|Lost to Follow-up|1
751599|NCT00439179|2400647|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
751600|NCT00439179|2400648|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
751601|NCT00439179|2400649|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
751602|NCT00439179|2400650|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
751603|NCT00439218|2400664|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
751604|NCT00439231|2400675|P1|Overall Study|Lack of Efficacy|28
751605|NCT00439244|2400682|P3|Overall Study|Administrative problems|0
751606|NCT00439244|2400683|P2|Overall Study|Administrative problems|0
751607|NCT00439244|2400684|P1|Overall Study|Administrative problems|1
751608|NCT00439244|2400682|P3|Overall Study|Protocol Violation|0
751609|NCT00439244|2400683|P2|Overall Study|Protocol Violation|1
751610|NCT00439244|2400684|P1|Overall Study|Protocol Violation|0
751611|NCT00439244|2400682|P3|Overall Study|Death|0
751612|NCT00439244|2400683|P2|Overall Study|Death|1
751613|NCT00439244|2400684|P1|Overall Study|Death|0
751614|NCT00439244|2400682|P3|Overall Study|Lost to Follow-up|2
751615|NCT00439244|2400683|P2|Overall Study|Lost to Follow-up|1
751616|NCT00439244|2400684|P1|Overall Study|Lost to Follow-up|2
751617|NCT00439244|2400682|P3|Overall Study|Withdrawal by Subject|2
751618|NCT00439244|2400683|P2|Overall Study|Withdrawal by Subject|1
751619|NCT00439244|2400684|P1|Overall Study|Withdrawal by Subject|3
751620|NCT00439244|2400682|P3|Overall Study|Adverse Event|3
751621|NCT00439244|2400683|P2|Overall Study|Adverse Event|2
751622|NCT00439244|2400684|P1|Overall Study|Adverse Event|5
751623|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
751624|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
751625|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
751626|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
751627|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
751628|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
751629|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
751630|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
751631|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
751632|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
751633|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
751634|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
751635|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
751636|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
751637|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
751638|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
751639|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
751640|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
751641|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
751642|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
751643|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
751644|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
751645|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
751646|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
751647|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
751648|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
751649|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
751650|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
751651|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
751652|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
751653|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
751654|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
751655|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
751656|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
751657|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
751658|NCT00439270|2400709|P5|Phase 2 (51.6 Months)|Disease progression|0
751659|NCT00439270|2400710|P4|Phase 2 (51.6 Months)|Disease progression|18
751660|NCT00439270|2400711|P3|Phase 2 (51.6 Months)|Disease progression|0
751661|NCT00439270|2400712|P2|Phase 2 (51.6 Months)|Disease progression|0
751662|NCT00439270|2400713|P1|Phase 2 (51.6 Months)|Disease progression|0
751663|NCT00439270|2400709|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
751664|NCT00439270|2400710|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
751665|NCT00439270|2400711|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
751666|NCT00439270|2400712|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
751667|NCT00439270|2400713|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
751668|NCT00439270|2400709|P5|Phase 1 (18.1 Months)|Disease progression|3
751669|NCT00439270|2400710|P4|Phase 1 (18.1 Months)|Disease progression|0
751670|NCT00439270|2400711|P3|Phase 1 (18.1 Months)|Disease progression|3
751671|NCT00439270|2400712|P2|Phase 1 (18.1 Months)|Disease progression|2
751672|NCT00439270|2400713|P1|Phase 1 (18.1 Months)|Disease progression|3
751673|NCT00439309|2400754|P2|Follow-Up|Late response by subject|1
751674|NCT00439309|2400755|P1|Follow-Up|Late response by subject|0
751675|NCT00439309|2400754|P2|Follow-Up|Withdrawal by Subject|1
751676|NCT00439309|2400755|P1|Follow-Up|Withdrawal by Subject|0
751677|NCT00439309|2400754|P2|Follow-Up|Lost to Follow-up|0
751678|NCT00439309|2400755|P1|Follow-Up|Lost to Follow-up|2
751679|NCT00439309|2400754|P2|Follow-Up|Death|0
751680|NCT00439309|2400755|P1|Follow-Up|Death|1
751681|NCT00439517|2400815|P2|Overall Study|Subject in survival follow-up|0
751682|NCT00439517|2400816|P1|Overall Study|Subject in survival follow-up|1
751683|NCT00439517|2400815|P2|Overall Study|Subject on treatment|0
751684|NCT00439517|2400816|P1|Overall Study|Subject on treatment|1
751685|NCT00439569|2400838|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
751686|NCT00439569|2400838|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
751687|NCT00439569|2400838|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
751688|NCT00439647|2400855|P2|Overall Study|Lack of Efficacy|4
751689|NCT00439647|2400856|P1|Overall Study|Lack of Efficacy|0
751690|NCT00439647|2400855|P2|Overall Study|Protocol Violation|4
751691|NCT00439647|2400856|P1|Overall Study|Protocol Violation|3
751692|NCT00439647|2400855|P2|Overall Study|Lost to Follow-up|12
751693|NCT00439647|2400856|P1|Overall Study|Lost to Follow-up|4
751694|NCT00439647|2400855|P2|Overall Study|Adverse Event|11
751695|NCT00439647|2400856|P1|Overall Study|Adverse Event|11
751696|NCT00439647|2400855|P2|Overall Study|Death|18
751697|NCT00439647|2400856|P1|Overall Study|Death|15
751698|NCT00439647|2400855|P2|Overall Study|Withdrawal by Subject|22
751699|NCT00439647|2400856|P1|Overall Study|Withdrawal by Subject|25
751700|NCT00439725|2400890|P2|Observational Period|Participant convenience|0
751701|NCT00439725|2400891|P1|Observational Period|Participant convenience|1
751702|NCT00439725|2400890|P2|Observational Period|Technical problems|0
751703|NCT00439725|2400891|P1|Observational Period|Technical problems|1
751704|NCT00439725|2400890|P2|Observational Period|Clinical endpoint reached|1
751705|NCT00439725|2400891|P1|Observational Period|Clinical endpoint reached|3
751706|NCT00439725|2400890|P2|Observational Period|Study termination by sponsor|1
751707|NCT00439725|2400891|P1|Observational Period|Study termination by sponsor|1
751708|NCT00439725|2400890|P2|Observational Period|Death|2
751709|NCT00439725|2400891|P1|Observational Period|Death|0
751710|NCT00439725|2400890|P2|Observational Period|Lost to Follow-up|1
751711|NCT00439725|2400891|P1|Observational Period|Lost to Follow-up|0
751712|NCT00439725|2400890|P2|Observational Period|Withdrawal by Subject|2
751713|NCT00439725|2400891|P1|Observational Period|Withdrawal by Subject|2
751714|NCT00439725|2400890|P2|Treatment Period|Participant did not receive treatment|4
751715|NCT00439725|2400891|P1|Treatment Period|Participant did not receive treatment|4
751716|NCT00439725|2400890|P2|Treatment Period|Death|1
751717|NCT00439725|2400891|P1|Treatment Period|Death|1
751718|NCT00439725|2400890|P2|Treatment Period|Protocol driven decision point|1
751719|NCT00439725|2400891|P1|Treatment Period|Protocol driven decision point|1
751720|NCT00439725|2400890|P2|Treatment Period|Participant convenience|0
751721|NCT00439725|2400891|P1|Treatment Period|Participant convenience|1
751722|NCT00439725|2400890|P2|Treatment Period|Lost to Follow-up|1
751723|NCT00439725|2400891|P1|Treatment Period|Lost to Follow-up|1
751724|NCT00439725|2400890|P2|Treatment Period|Technical problems|0
751725|NCT00439725|2400891|P1|Treatment Period|Technical problems|1
751726|NCT00439725|2400890|P2|Treatment Period|Clinical endpoint reached|50
751727|NCT00439725|2400891|P1|Treatment Period|Clinical endpoint reached|6
751728|NCT00439725|2400890|P2|Treatment Period|Protocol Violation|1
751729|NCT00439725|2400891|P1|Treatment Period|Protocol Violation|2
751730|NCT00439725|2400890|P2|Treatment Period|Physician Decision|1
751731|NCT00439725|2400891|P1|Treatment Period|Physician Decision|1
751732|NCT00439725|2400890|P2|Treatment Period|Adverse Event|18
751733|NCT00439725|2400891|P1|Treatment Period|Adverse Event|39
751734|NCT00439725|2400890|P2|Treatment Period|Site closed by investigator|2
751735|NCT00439725|2400891|P1|Treatment Period|Site closed by investigator|1
751736|NCT00439725|2400890|P2|Treatment Period|Study terminated by sponsor|148
751737|NCT00439725|2400891|P1|Treatment Period|Study terminated by sponsor|156
751738|NCT00439725|2400890|P2|Treatment Period|Withdrawal by Subject|19
751739|NCT00439725|2400891|P1|Treatment Period|Withdrawal by Subject|22
751740|NCT00439738|2400937|P2|Overall Study|Abnormal Lab Values|0
751741|NCT00439738|2400938|P1|Overall Study|Abnormal Lab Values|1
751742|NCT00439738|2400937|P2|Overall Study|Lack of Efficacy|2
751743|NCT00439738|2400938|P1|Overall Study|Lack of Efficacy|2
751744|NCT00439738|2400937|P2|Overall Study|Protocol Violation|3
751745|NCT00439738|2400938|P1|Overall Study|Protocol Violation|6
751746|NCT00439738|2400937|P2|Overall Study|Lost to Follow-up|6
751747|NCT00439738|2400938|P1|Overall Study|Lost to Follow-up|5
751748|NCT00439738|2400937|P2|Overall Study|Adverse Event|4
751749|NCT00439738|2400938|P1|Overall Study|Adverse Event|6
751750|NCT00439738|2400937|P2|Overall Study|Withdrawal by Subject|13
751751|NCT00439738|2400938|P1|Overall Study|Withdrawal by Subject|16
751752|NCT00439777|2400956|P2|Observational Period|Technical problems|1
751753|NCT00439777|2400957|P1|Observational Period|Technical problems|0
751754|NCT00439777|2400956|P2|Observational Period|Lack of Efficacy|0
751755|NCT00439777|2400957|P1|Observational Period|Lack of Efficacy|1
751756|NCT00439777|2400956|P2|Observational Period|Protocol driven decision point|1
751757|NCT00439777|2400957|P1|Observational Period|Protocol driven decision point|0
751758|NCT00439777|2400956|P2|Observational Period|Study terminated by sponsor|1
751759|NCT00439777|2400957|P1|Observational Period|Study terminated by sponsor|3
751760|NCT00439777|2400956|P2|Observational Period|Death|20
751761|NCT00439777|2400957|P1|Observational Period|Death|27
751762|NCT00439777|2400956|P2|Observational Period|Lost to Follow-up|11
751763|NCT00439777|2400957|P1|Observational Period|Lost to Follow-up|1
751764|NCT00439777|2400956|P2|Observational Period|Withdrawal by Subject|5
751765|NCT00439777|2400957|P1|Observational Period|Withdrawal by Subject|9
751766|NCT00439777|2400956|P2|Observational Period|Protocol Violation|2
751767|NCT00439777|2400957|P1|Observational Period|Protocol Violation|0
751768|NCT00439777|2400956|P2|Treatment Period|Participant convenience|8
751769|NCT00439777|2400957|P1|Treatment Period|Participant convenience|12
751770|NCT00439777|2400956|P2|Treatment Period|Technical problems|1
751771|NCT00439777|2400957|P1|Treatment Period|Technical problems|3
751772|NCT00439777|2400956|P2|Treatment Period|Clinical endpoint reached|13
751773|NCT00439777|2400957|P1|Treatment Period|Clinical endpoint reached|26
751774|NCT00439777|2400956|P2|Treatment Period|Physician Decision|18
751775|NCT00439777|2400957|P1|Treatment Period|Physician Decision|7
751776|NCT00439777|2400956|P2|Treatment Period|Protocol driven decision point|3
751777|NCT00439777|2400957|P1|Treatment Period|Protocol driven decision point|1
751778|NCT00439777|2400956|P2|Treatment Period|Lost to Follow-up|10
751779|NCT00439777|2400957|P1|Treatment Period|Lost to Follow-up|8
751780|NCT00439777|2400956|P2|Treatment Period|Lack of Efficacy|4
751781|NCT00439777|2400957|P1|Treatment Period|Lack of Efficacy|1
751782|NCT00439777|2400956|P2|Treatment Period|Withdrawal by Subject|118
751783|NCT00439777|2400957|P1|Treatment Period|Withdrawal by Subject|66
751784|NCT00439777|2400956|P2|Treatment Period|Protocol Violation|30
751785|NCT00439777|2400957|P1|Treatment Period|Protocol Violation|23
751786|NCT00439777|2400956|P2|Treatment Period|Adverse Event|92
751787|NCT00439777|2400957|P1|Treatment Period|Adverse Event|111
751788|NCT00439777|2400956|P2|Treatment Period|Did not take study treatment|8
751789|NCT00439777|2400957|P1|Treatment Period|Did not take study treatment|7
751790|NCT00439777|2400956|P2|Treatment Period|Site closed by investigator|1
751791|NCT00439777|2400957|P1|Treatment Period|Site closed by investigator|0
751792|NCT00439777|2400956|P2|Treatment Period|Study terminated by sponsor|132
751793|NCT00439777|2400957|P1|Treatment Period|Study terminated by sponsor|125
751794|NCT00439777|2400956|P2|Treatment Period|Death|21
751795|NCT00439777|2400957|P1|Treatment Period|Death|29
751796|NCT00440011|2401012|P2|Overall Study|Withdrawal by Subject|0
751797|NCT00440011|2401013|P1|Overall Study|Withdrawal by Subject|1
751798|NCT00440011|2401012|P2|Overall Study|Protocol Violation|1
751799|NCT00440011|2401013|P1|Overall Study|Protocol Violation|1
751800|NCT00440011|2401012|P2|Overall Study|Lost to Follow-up|2
751801|NCT00440011|2401013|P1|Overall Study|Lost to Follow-up|0
751802|NCT00440011|2401012|P2|Overall Study|Adverse Event|0
751803|NCT00440011|2401013|P1|Overall Study|Adverse Event|2
751804|NCT00440115|2401039|P3|Overall Study|Incarceration|1
751805|NCT00440115|2401040|P2|Overall Study|Incarceration|2
751806|NCT00440115|2401041|P1|Overall Study|Incarceration|0
751807|NCT00440115|2401039|P3|Overall Study|Death|5
751808|NCT00440115|2401040|P2|Overall Study|Death|9
751809|NCT00440115|2401041|P1|Overall Study|Death|7
751810|NCT00440193|2401066|P2|Observational Period|Participant convenience|0
751811|NCT00440193|2401067|P1|Observational Period|Participant convenience|2
751812|NCT00440193|2401066|P2|Observational Period|Clinical endpoint reached|0
751813|NCT00440193|2401067|P1|Observational Period|Clinical endpoint reached|1
751814|NCT00440193|2401066|P2|Observational Period|Physician Decision|0
751815|NCT00440193|2401067|P1|Observational Period|Physician Decision|1
751816|NCT00440193|2401066|P2|Observational Period|Withdrawal by Subject|8
751817|NCT00440193|2401067|P1|Observational Period|Withdrawal by Subject|11
751818|NCT00440193|2401066|P2|Observational Period|Protocol Violation|0
751819|NCT00440193|2401067|P1|Observational Period|Protocol Violation|1
751820|NCT00440193|2401066|P2|Observational Period|Lost to Follow-up|8
751821|NCT00440193|2401067|P1|Observational Period|Lost to Follow-up|12
751822|NCT00440193|2401066|P2|Observational Period|Death|20
751823|NCT00440193|2401067|P1|Observational Period|Death|15
751824|NCT00440193|2401066|P2|Observational Period|Adverse Event|2
751825|NCT00440193|2401067|P1|Observational Period|Adverse Event|2
751826|NCT00440193|2401066|P2|Treatment Period|Site closed by investigator|2
751827|NCT00440193|2401067|P1|Treatment Period|Site closed by investigator|0
751828|NCT00440193|2401066|P2|Treatment Period|Participant did not receive treatment|13
751829|NCT00440193|2401067|P1|Treatment Period|Participant did not receive treatment|7
751830|NCT00440193|2401066|P2|Treatment Period|Participant convenience|2
751831|NCT00440193|2401067|P1|Treatment Period|Participant convenience|5
751832|NCT00440193|2401066|P2|Treatment Period|Technical problems|1
751833|NCT00440193|2401067|P1|Treatment Period|Technical problems|1
751834|NCT00440193|2401066|P2|Treatment Period|Switch to commercial drug|2
751835|NCT00440193|2401067|P1|Treatment Period|Switch to commercial drug|0
751836|NCT00440193|2401066|P2|Treatment Period|Protocol driven decision point|2
751837|NCT00440193|2401067|P1|Treatment Period|Protocol driven decision point|2
751838|NCT00440193|2401066|P2|Treatment Period|Study terminated by sponsor|94
751839|NCT00440193|2401067|P1|Treatment Period|Study terminated by sponsor|102
751840|NCT00440193|2401066|P2|Treatment Period|Clinical endpoint reached|25
751841|NCT00440193|2401067|P1|Treatment Period|Clinical endpoint reached|28
751842|NCT00440193|2401066|P2|Treatment Period|Withdrawal by Subject|77
751843|NCT00440193|2401067|P1|Treatment Period|Withdrawal by Subject|36
751844|NCT00440193|2401066|P2|Treatment Period|Protocol Violation|19
751845|NCT00440193|2401067|P1|Treatment Period|Protocol Violation|16
751846|NCT00440193|2401066|P2|Treatment Period|Physician Decision|6
751847|NCT00440193|2401067|P1|Treatment Period|Physician Decision|3
751848|NCT00440193|2401066|P2|Treatment Period|Lost to Follow-up|18
751849|NCT00440193|2401067|P1|Treatment Period|Lost to Follow-up|12
751850|NCT00440193|2401066|P2|Treatment Period|Lack of Efficacy|1
751851|NCT00440193|2401067|P1|Treatment Period|Lack of Efficacy|0
751852|NCT00440193|2401066|P2|Treatment Period|Death|22
751853|NCT00440193|2401067|P1|Treatment Period|Death|19
751854|NCT00440193|2401066|P2|Treatment Period|Adverse Event|67
751855|NCT00440193|2401067|P1|Treatment Period|Adverse Event|74
751856|NCT00431444|2401103|P2|Overall Study|Administrative Problems|1
751857|NCT00431444|2401104|P1|Overall Study|Administrative Problems|0
751858|NCT00431444|2401103|P2|Overall Study|Lost to Follow-up|0
751859|NCT00431444|2401104|P1|Overall Study|Lost to Follow-up|1
751860|NCT00431444|2401103|P2|Overall Study|Withdrawal by Subject|1
751861|NCT00431444|2401104|P1|Overall Study|Withdrawal by Subject|1
751862|NCT00431444|2401103|P2|Overall Study|Adverse Event|1
751863|NCT00431444|2401104|P1|Overall Study|Adverse Event|2
751864|NCT00431444|2401103|P2|Overall Study|Protocol Violation|4
751865|NCT00431444|2401104|P1|Overall Study|Protocol Violation|1
751866|NCT00431496|2401128|P1|Overall Study|Protocol-specified criteria|5
751867|NCT00431496|2401128|P1|Overall Study|Withdrawal by Subject|2
751868|NCT00431496|2401128|P1|Overall Study|Lost to Follow-up|1
751869|NCT00431496|2401128|P1|Overall Study|Adverse Event|3
751870|NCT00431834|2401146|P1|Overall Study|Lost to Follow-up|1
751871|NCT00431834|2401146|P1|Overall Study|Missed Endpoint Visit|2
751872|NCT00431834|2401146|P1|Overall Study|Death|3
751873|NCT00431834|2401146|P1|Overall Study|Withdrawal by Subject|7
751874|NCT00431847|2401157|P5|Overall Study|Protocol Violation|1
751875|NCT00431847|2401158|P4|Overall Study|Protocol Violation|0
751876|NCT00431847|2401159|P3|Overall Study|Protocol Violation|0
751877|NCT00431847|2401160|P2|Overall Study|Protocol Violation|0
751878|NCT00431847|2401161|P1|Overall Study|Protocol Violation|0
751879|NCT00431847|2401157|P5|Overall Study|completion of less than two study visits|0
751880|NCT00431847|2401158|P4|Overall Study|completion of less than two study visits|14
751881|NCT00431847|2401159|P3|Overall Study|completion of less than two study visits|4
751882|NCT00431847|2401160|P2|Overall Study|completion of less than two study visits|3
751883|NCT00431847|2401161|P1|Overall Study|completion of less than two study visits|6
751884|NCT00431951|2401239|P4|Overall Study|Adverse Event|0
751885|NCT00431951|2401240|P3|Overall Study|Adverse Event|1
751886|NCT00431951|2401241|P2|Overall Study|Adverse Event|0
751887|NCT00431951|2401242|P1|Overall Study|Adverse Event|0
751888|NCT00431951|2401239|P4|Overall Study|Withdrawal by Subject|0
751889|NCT00431951|2401240|P3|Overall Study|Withdrawal by Subject|0
751890|NCT00431951|2401241|P2|Overall Study|Withdrawal by Subject|1
751891|NCT00431951|2401242|P1|Overall Study|Withdrawal by Subject|0
751892|NCT00431951|2401239|P4|Overall Study|Lost to Follow-up|0
751893|NCT00431951|2401240|P3|Overall Study|Lost to Follow-up|0
751894|NCT00431951|2401241|P2|Overall Study|Lost to Follow-up|1
751895|NCT00431951|2401242|P1|Overall Study|Lost to Follow-up|0
751896|NCT00431951|2401239|P4|Overall Study|Inability to follow study procedures|2
751897|NCT00431951|2401240|P3|Overall Study|Inability to follow study procedures|1
751898|NCT00431951|2401241|P2|Overall Study|Inability to follow study procedures|0
751899|NCT00431951|2401242|P1|Overall Study|Inability to follow study procedures|1
751900|NCT00431964|2401302|P2|Overall Study|Due to Unstable Health|1
751901|NCT00431964|2401303|P1|Overall Study|Due to Unstable Health|0
751902|NCT00431964|2401302|P2|Overall Study|Parental Consent Withdrawn|2
751903|NCT00431964|2401303|P1|Overall Study|Parental Consent Withdrawn|0
751904|NCT00431964|2401302|P2|Overall Study|Withdrawal by Subject|1
751905|NCT00431964|2401303|P1|Overall Study|Withdrawal by Subject|2
751906|NCT00431964|2401302|P2|Overall Study|Physician Decision|2
751907|NCT00431964|2401303|P1|Overall Study|Physician Decision|2
751908|NCT00431964|2401302|P2|Overall Study|Lost to Follow-up|2
751909|NCT00431964|2401303|P1|Overall Study|Lost to Follow-up|1
751910|NCT00431964|2401302|P2|Overall Study|Adverse Event|0
751911|NCT00431964|2401303|P1|Overall Study|Adverse Event|1
890909|NCT00636168|2826366|P2|Treated With Study Drug|Recurrence of disease|273
890910|NCT00636168|2826367|P1|Treated With Study Drug|Recurrence of disease|132
890911|NCT00636168|2826366|P2|Randomized to Study Drug|No longer met study criteria|0
890912|NCT00636168|2826367|P1|Randomized to Study Drug|No longer met study criteria|1
890913|NCT00636168|2826366|P2|Randomized to Study Drug|Adverse Event|0
890914|NCT00636168|2826367|P1|Randomized to Study Drug|Adverse Event|1
890915|NCT00636168|2826366|P2|Randomized to Study Drug|Withdrawal by Subject|2
890916|NCT00636168|2826367|P1|Randomized to Study Drug|Withdrawal by Subject|2
890917|NCT00619983|2826417|P4|Test Drug Alone|Failure of daily diary device|2
890918|NCT00619983|2826418|P3|Test Drug Alone|Failure of daily diary device|2
890919|NCT00619983|2826419|P2|Test Drug Alone|Failure of daily diary device|1
890920|NCT00619983|2826420|P1|Test Drug Alone|Failure of daily diary device|1
890921|NCT00619983|2826417|P4|Test Drug Alone|Withdrawal by Subject|1
751927|NCT00432237|2401426|P4|Overall Study|Lack of Qualifying Event|84
751928|NCT00432237|2401427|P3|Overall Study|Lack of Qualifying Event|69
751929|NCT00432237|2401428|P2|Overall Study|Lack of Qualifying Event|71
751930|NCT00432237|2401429|P1|Overall Study|Lack of Qualifying Event|38
751931|NCT00432237|2401426|P4|Overall Study|Withdrawal by Subject|11
751932|NCT00432237|2401427|P3|Overall Study|Withdrawal by Subject|9
751933|NCT00432237|2401428|P2|Overall Study|Withdrawal by Subject|6
751934|NCT00432237|2401429|P1|Overall Study|Withdrawal by Subject|5
751935|NCT00432237|2401426|P4|Overall Study|Protocol Violation|8
751936|NCT00432237|2401427|P3|Overall Study|Protocol Violation|11
751937|NCT00432237|2401428|P2|Overall Study|Protocol Violation|10
751938|NCT00432237|2401429|P1|Overall Study|Protocol Violation|13
751939|NCT00432237|2401426|P4|Overall Study|Pregnancy|0
751940|NCT00432237|2401427|P3|Overall Study|Pregnancy|0
751941|NCT00432237|2401428|P2|Overall Study|Pregnancy|1
751942|NCT00432237|2401429|P1|Overall Study|Pregnancy|0
751943|NCT00432237|2401426|P4|Overall Study|Physician Decision|1
751944|NCT00432237|2401427|P3|Overall Study|Physician Decision|2
751945|NCT00432237|2401428|P2|Overall Study|Physician Decision|3
751946|NCT00432237|2401429|P1|Overall Study|Physician Decision|1
751947|NCT00432237|2401426|P4|Overall Study|Lost to Follow-up|18
751948|NCT00432237|2401427|P3|Overall Study|Lost to Follow-up|18
751949|NCT00432237|2401428|P2|Overall Study|Lost to Follow-up|10
751950|NCT00432237|2401429|P1|Overall Study|Lost to Follow-up|10
751951|NCT00432237|2401426|P4|Overall Study|Lack of Efficacy|1
751952|NCT00432237|2401427|P3|Overall Study|Lack of Efficacy|0
751953|NCT00432237|2401428|P2|Overall Study|Lack of Efficacy|0
751954|NCT00432237|2401429|P1|Overall Study|Lack of Efficacy|0
751955|NCT00432237|2401426|P4|Overall Study|Adverse Event|1
751956|NCT00432237|2401427|P3|Overall Study|Adverse Event|0
751957|NCT00432237|2401428|P2|Overall Study|Adverse Event|0
751958|NCT00432237|2401429|P1|Overall Study|Adverse Event|0
751959|NCT00432276|2401469|P2|Overall Study|Other|3
751960|NCT00432276|2401470|P1|Overall Study|Other|2
751961|NCT00432276|2401469|P2|Overall Study|Physician Decision|8
751962|NCT00432276|2401470|P1|Overall Study|Physician Decision|6
751963|NCT00432276|2401469|P2|Overall Study|Withdrawal by Subject|20
751964|NCT00432276|2401470|P1|Overall Study|Withdrawal by Subject|25
751965|NCT00432276|2401469|P2|Overall Study|Lost to Follow-up|2
751966|NCT00432276|2401470|P1|Overall Study|Lost to Follow-up|6
751967|NCT00432276|2401469|P2|Overall Study|Protocol Violation|20
751968|NCT00432276|2401470|P1|Overall Study|Protocol Violation|25
751969|NCT00432276|2401469|P2|Overall Study|Adverse Event|16
751970|NCT00432276|2401470|P1|Overall Study|Adverse Event|13
751971|NCT00432276|2401469|P2|Overall Study|Hyperglycemic Rescue|87
751972|NCT00432276|2401470|P1|Overall Study|Hyperglycemic Rescue|44
751973|NCT00432380|2401586|P3|Overall Study|Adverse Event|0
751974|NCT00432380|2401587|P2|Overall Study|Adverse Event|0
751975|NCT00432380|2401588|P1|Overall Study|Adverse Event|1
751976|NCT00432380|2401586|P3|Overall Study|Migrated/moved from study area|1
751977|NCT00432380|2401587|P2|Overall Study|Migrated/moved from study area|4
751978|NCT00432380|2401588|P1|Overall Study|Migrated/moved from study area|3
751979|NCT00432562|2401639|P2|Overall Study|Death|0
751980|NCT00432562|2401640|P1|Overall Study|Death|3
751981|NCT00432666|2401675|P2|Open-Label Extension Period|Physician Decision|0
751982|NCT00432666|2401676|P1|Open-Label Extension Period|Physician Decision|3
751983|NCT00432666|2401675|P2|Open-Label Extension Period|Consent withdrawn|0
751984|NCT00432666|2401676|P1|Open-Label Extension Period|Consent withdrawn|10
751985|NCT00432666|2401675|P2|Open-Label Extension Period|Adverse Event|0
751986|NCT00432666|2401676|P1|Open-Label Extension Period|Adverse Event|5
751987|NCT00432666|2401675|P2|Open-Label Extension Period|Lack of Efficacy|0
751988|NCT00432666|2401676|P1|Open-Label Extension Period|Lack of Efficacy|6
751989|NCT00432666|2401675|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
751990|NCT00432666|2401676|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
751991|NCT00432666|2401675|P2|Main Period|Consent Withdrawn|0
751992|NCT00432666|2401676|P1|Main Period|Consent Withdrawn|1
751993|NCT00432666|2401675|P2|Main Period|Adverse Event|1
751994|NCT00432666|2401676|P1|Main Period|Adverse Event|1
751995|NCT00432744|2401840|P2|Months 7 - 12|Too disabled to score|1
751996|NCT00432744|2401841|P1|Months 7 - 12|Too disabled to score|0
751997|NCT00432744|2401840|P2|Months 7 - 12|Withdrawal by Subject|0
751998|NCT00432744|2401841|P1|Months 7 - 12|Withdrawal by Subject|1
751999|NCT00432744|2401840|P2|Months 0-6|Too disabled to score|0
752000|NCT00432744|2401841|P1|Months 0-6|Too disabled to score|1
752001|NCT00432744|2401840|P2|Months 0-6|Withdrawal by Subject|4
752002|NCT00432744|2401841|P1|Months 0-6|Withdrawal by Subject|4
752003|NCT00432809|2401854|P3|1 Year Follow-up|Withdrawal by Subject|1
752004|NCT00432809|2401855|P2|1 Year Follow-up|Withdrawal by Subject|0
752005|NCT00432809|2401856|P1|1 Year Follow-up|Withdrawal by Subject|7
752006|NCT00432809|2401854|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
752007|NCT00432809|2401855|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
752008|NCT00432809|2401856|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
752009|NCT00432835|2401929|P2|Overall Study|Adverse event: lead dislodgement.|7
752010|NCT00432835|2401930|P1|Overall Study|Adverse event: lead dislodgement.|6
752011|NCT00432991|2401942|P2|Overall Study|Protocol Violation|12
752012|NCT00432991|2401943|P1|Overall Study|Protocol Violation|7
752013|NCT00433004|2401955|P2|Overall Study|Lost to Follow-up|7
752014|NCT00433004|2401956|P1|Overall Study|Lost to Follow-up|5
752015|NCT00433017|2401968|P2|Overall Study|Subject no longer requires study drug|1
752016|NCT00433017|2401969|P1|Overall Study|Subject no longer requires study drug|1
752017|NCT00433017|2401968|P2|Overall Study|Death|2
752018|NCT00433017|2401969|P1|Overall Study|Death|2
752019|NCT00433017|2401968|P2|Overall Study|Protocol Violation|0
752020|NCT00433017|2401969|P1|Overall Study|Protocol Violation|1
752021|NCT00433017|2401968|P2|Overall Study|Administrative problems|86
752022|NCT00433017|2401969|P1|Overall Study|Administrative problems|80
752023|NCT00433017|2401968|P2|Overall Study|Lost to Follow-up|4
752024|NCT00433017|2401969|P1|Overall Study|Lost to Follow-up|3
752025|NCT00433017|2401968|P2|Overall Study|Withdrawal by Subject|5
752026|NCT00433017|2401969|P1|Overall Study|Withdrawal by Subject|4
752027|NCT00433017|2401968|P2|Overall Study|Adverse Event|3
752028|NCT00433017|2401969|P1|Overall Study|Adverse Event|5
752029|NCT00433160|2401985|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
752030|NCT00433160|2401986|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
752031|NCT00433160|2401985|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
752032|NCT00433160|2401986|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
752033|NCT00433160|2401985|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
752034|NCT00433160|2401986|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
752035|NCT00433160|2401985|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
752036|NCT00433160|2401986|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
752037|NCT00433160|2401985|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
752038|NCT00433160|2401986|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
752039|NCT00433160|2401985|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
752040|NCT00433160|2401986|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
752041|NCT00433160|2401985|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
752042|NCT00433160|2401986|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
752043|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
752044|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
752045|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
752046|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
752047|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
752048|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
752049|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
752050|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
752051|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
752052|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
752053|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
752054|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
752055|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
752056|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
752057|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Death|0
752058|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Death|0
752059|NCT00433160|2401985|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
752060|NCT00433160|2401986|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
752061|NCT00433199|2402036|P2|Open-Label Period|Administrative|1
752062|NCT00433199|2402037|P1|Open-Label Period|Administrative|0
752063|NCT00433199|2402036|P2|Open-Label Period|Protocol Violation|2
752064|NCT00433199|2402037|P1|Open-Label Period|Protocol Violation|0
752065|NCT00433199|2402036|P2|Open-Label Period|Withdrawal by Subject|7
752066|NCT00433199|2402037|P1|Open-Label Period|Withdrawal by Subject|0
752067|NCT00433199|2402036|P2|Open-Label Period|Lost to Follow-up|3
752068|NCT00433199|2402037|P1|Open-Label Period|Lost to Follow-up|0
752069|NCT00433199|2402036|P2|Open-Label Period|Lack of Efficacy|2
752070|NCT00433199|2402037|P1|Open-Label Period|Lack of Efficacy|0
752071|NCT00433199|2402036|P2|Open-Label Period|Adverse Event|19
752072|NCT00433199|2402037|P1|Open-Label Period|Adverse Event|0
752073|NCT00433199|2402036|P2|Double-Blind Period|Administrative|5
752074|NCT00433199|2402037|P1|Double-Blind Period|Administrative|1
752075|NCT00433199|2402036|P2|Double-Blind Period|Protocol Violation|10
752076|NCT00433199|2402037|P1|Double-Blind Period|Protocol Violation|1
752077|NCT00433199|2402036|P2|Double-Blind Period|Withdrawal by Subject|19
752078|NCT00433199|2402037|P1|Double-Blind Period|Withdrawal by Subject|8
752079|NCT00433199|2402036|P2|Double-Blind Period|Lost to Follow-up|5
752080|NCT00433199|2402037|P1|Double-Blind Period|Lost to Follow-up|2
752081|NCT00433199|2402036|P2|Double-Blind Period|Lack of Efficacy|2
752082|NCT00433199|2402037|P1|Double-Blind Period|Lack of Efficacy|0
752083|NCT00433199|2402036|P2|Double-Blind Period|Adverse Event|25
752084|NCT00433199|2402037|P1|Double-Blind Period|Adverse Event|0
752085|NCT00433290|2402057|P2|Overall Study|Lost to Follow-up|0
752086|NCT00433290|2402058|P1|Overall Study|Lost to Follow-up|1
752087|NCT00433290|2402057|P2|Overall Study|Entry Criteria Not Met|1
752088|NCT00433290|2402058|P1|Overall Study|Entry Criteria Not Met|0
752089|NCT00433290|2402057|P2|Overall Study|Physician Decision|0
752090|NCT00433290|2402058|P1|Overall Study|Physician Decision|2
752091|NCT00433290|2402057|P2|Overall Study|Protocol Violation|2
752092|NCT00433290|2402058|P1|Overall Study|Protocol Violation|3
752093|NCT00433290|2402057|P2|Overall Study|Withdrawal by Subject|2
752094|NCT00433290|2402058|P1|Overall Study|Withdrawal by Subject|4
752095|NCT00433290|2402057|P2|Overall Study|Lack of Efficacy|5
752096|NCT00433290|2402058|P1|Overall Study|Lack of Efficacy|1
752097|NCT00433290|2402057|P2|Overall Study|Adverse Event|7
752098|NCT00433290|2402058|P1|Overall Study|Adverse Event|24
752099|NCT00433329|2402125|P1|Overall Study|Physician Decision|1
752100|NCT00433329|2402125|P1|Overall Study|Lost to Follow-up|1
752101|NCT00433329|2402125|P1|Overall Study|Moved out of state|1
752102|NCT00433329|2402125|P1|Overall Study|Discontinued sildenafil|2
752103|NCT00433329|2402125|P1|Overall Study|Withdrew consent|3
752104|NCT00433329|2402125|P1|Overall Study|Death|4
752105|NCT00433329|2402125|P1|Overall Study|Adverse Event|9
752106|NCT00433381|2402131|P2|Overall Study|Lost to follow-up before 6 months|0
752107|NCT00433381|2402132|P1|Overall Study|Lost to follow-up before 6 months|2
752108|NCT00433381|2402131|P2|Overall Study|Ineligible / no protocol treatment|3
752109|NCT00433381|2402132|P1|Overall Study|Ineligible / no protocol treatment|3
752110|NCT00433446|2402138|P1|Overall Study|Ineligible|9
752111|NCT00433446|2402138|P1|Overall Study|Other - Not Protocol specified|3
752112|NCT00433446|2402138|P1|Overall Study|Progression|44
752113|NCT00433446|2402138|P1|Overall Study|Refusal Unrelated to Adverse Event|1
752114|NCT00433446|2402138|P1|Overall Study|Adverse Event|4
752115|NCT00433537|2402146|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
752116|NCT00433537|2402147|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
752117|NCT00433537|2402148|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
752118|NCT00433537|2402146|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
752119|NCT00433537|2402147|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
752120|NCT00433537|2402148|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
752121|NCT00433537|2402146|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
752122|NCT00433537|2402147|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
752123|NCT00433537|2402148|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
752124|NCT00433537|2402146|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
752125|NCT00433537|2402147|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
752126|NCT00433537|2402148|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
752127|NCT00433537|2402146|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
752128|NCT00433537|2402147|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
752129|NCT00433537|2402148|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
752130|NCT00433537|2402146|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
752131|NCT00433537|2402147|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
752132|NCT00433537|2402148|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
752133|NCT00433537|2402146|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
752134|NCT00433537|2402147|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
752135|NCT00433537|2402148|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
752136|NCT00433537|2402146|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
752137|NCT00433537|2402147|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
752138|NCT00433537|2402148|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
752139|NCT00433537|2402146|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
752140|NCT00433537|2402147|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
752141|NCT00433537|2402148|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
752142|NCT00433654|2402174|P2|Overall Study|Withdrawal by Subject|2
752143|NCT00433654|2402175|P1|Overall Study|Withdrawal by Subject|1
752144|NCT00433654|2402174|P2|Overall Study|Subject not yet due for visit|0
752145|NCT00433654|2402175|P1|Overall Study|Subject not yet due for visit|4
752146|NCT00433654|2402174|P2|Overall Study|Missed visit|3
752147|NCT00433654|2402175|P1|Overall Study|Missed visit|6
752148|NCT00433654|2402174|P2|Overall Study|Death|0
752149|NCT00433654|2402175|P1|Overall Study|Death|4
752150|NCT00433771|2402211|P1|Overall Study|Failure to deploy stent|1
752151|NCT00433771|2402211|P1|Overall Study|Death|2
752152|NCT00433771|2402211|P1|Overall Study|Treated and later found to be ineligible|2
752153|NCT00433771|2402211|P1|Overall Study|screen fail|14
752154|NCT00433836|2402229|P2|Overall Study|Abnormal laboratory values|1
752155|NCT00433836|2402230|P1|Overall Study|Abnormal laboratory values|0
752156|NCT00433836|2402229|P2|Overall Study|Condition no longer requires study drug|1
752157|NCT00433836|2402230|P1|Overall Study|Condition no longer requires study drug|0
752158|NCT00433836|2402229|P2|Overall Study|Protocol Violation|2
752159|NCT00433836|2402230|P1|Overall Study|Protocol Violation|0
752160|NCT00433836|2402229|P2|Overall Study|Unsatisfactory therapeutic effect|1
752161|NCT00433836|2402230|P1|Overall Study|Unsatisfactory therapeutic effect|1
752162|NCT00433836|2402229|P2|Overall Study|Withdrawal by Subject|1
752163|NCT00433836|2402230|P1|Overall Study|Withdrawal by Subject|2
752164|NCT00433836|2402229|P2|Overall Study|Lost to Follow-up|0
752165|NCT00433836|2402230|P1|Overall Study|Lost to Follow-up|3
752166|NCT00433836|2402229|P2|Overall Study|Adverse Event|0
752167|NCT00433836|2402230|P1|Overall Study|Adverse Event|7
752168|NCT00440232|2402244|P2|Overall Study|Onset of headache within 4 hours of fast|2
752169|NCT00440232|2402245|P1|Overall Study|Onset of headache within 4 hours of fast|2
752170|NCT00440232|2402244|P2|Overall Study|Unable to treat within allowed time|1
752171|NCT00440232|2402245|P1|Overall Study|Unable to treat within allowed time|0
752172|NCT00440232|2402244|P2|Overall Study|Lost to Follow-up|1
752173|NCT00440232|2402245|P1|Overall Study|Lost to Follow-up|1
752174|NCT00440271|2402255|P2|Overall Study|Other|0
752175|NCT00440271|2402256|P1|Overall Study|Other|2
752176|NCT00440271|2402255|P2|Overall Study|Due to closure of trial|10
752177|NCT00440271|2402256|P1|Overall Study|Due to closure of trial|8
752178|NCT00440271|2402255|P2|Overall Study|Lack of Efficacy|1
752179|NCT00440271|2402256|P1|Overall Study|Lack of Efficacy|0
752180|NCT00440271|2402255|P2|Overall Study|Withdrawal by Subject|2
752181|NCT00440271|2402256|P1|Overall Study|Withdrawal by Subject|0
752182|NCT00440271|2402255|P2|Overall Study|Lost to Follow-up|0
752183|NCT00440271|2402256|P1|Overall Study|Lost to Follow-up|1
752184|NCT00440271|2402255|P2|Overall Study|Adverse Event|1
752185|NCT00440271|2402256|P1|Overall Study|Adverse Event|0
752186|NCT00440271|2402255|P2|Overall Study|Protocol Violation|1
752187|NCT00440271|2402256|P1|Overall Study|Protocol Violation|1
752188|NCT00440297|2402290|P2|Overall Study|Randomized by mistake|0
752189|NCT00440297|2402291|P1|Overall Study|Randomized by mistake|1
752190|NCT00440297|2402290|P2|Overall Study|Withdrawal by Subject|6
752191|NCT00440297|2402291|P1|Overall Study|Withdrawal by Subject|1
752192|NCT00440297|2402290|P2|Overall Study|Protocol Violation|7
752193|NCT00440297|2402291|P1|Overall Study|Protocol Violation|11
752194|NCT00440297|2402290|P2|Overall Study|Physician Decision|0
752195|NCT00440297|2402291|P1|Overall Study|Physician Decision|1
752196|NCT00440297|2402290|P2|Overall Study|Lost to Follow-up|0
752197|NCT00440297|2402291|P1|Overall Study|Lost to Follow-up|1
752198|NCT00440297|2402290|P2|Overall Study|Adverse Event|5
752199|NCT00440297|2402291|P1|Overall Study|Adverse Event|8
752200|NCT00440310|2402307|P2|Overall Study|Status Unknown|3
752201|NCT00440310|2402308|P1|Overall Study|Status Unknown|1
752202|NCT00440310|2402307|P2|Overall Study|Other|0
752203|NCT00440310|2402308|P1|Overall Study|Other|1
752204|NCT00440310|2402307|P2|Overall Study|No Reply at EOS|7
752205|NCT00440310|2402308|P1|Overall Study|No Reply at EOS|7
752206|NCT00440310|2402307|P2|Overall Study|Withdrawal by Subject|14
752207|NCT00440310|2402308|P1|Overall Study|Withdrawal by Subject|15
752208|NCT00440310|2402307|P2|Overall Study|Protocol Violation|1
752209|NCT00440310|2402308|P1|Overall Study|Protocol Violation|0
752210|NCT00440310|2402307|P2|Overall Study|Lost to Follow-up|5
752211|NCT00440310|2402308|P1|Overall Study|Lost to Follow-up|4
752212|NCT00440401|2402316|P2|Overall Study|Not specified|5
752213|NCT00440401|2402317|P1|Overall Study|Not specified|2
752214|NCT00440401|2402316|P2|Overall Study|Adverse Event|1
752215|NCT00440401|2402317|P1|Overall Study|Adverse Event|2
752216|NCT00440466|2402328|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
752217|NCT00440466|2402329|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
752218|NCT00440466|2402330|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
752219|NCT00440466|2402328|P3|Overall Study|Began Dialysis|1
752220|NCT00440466|2402329|P2|Overall Study|Began Dialysis|0
752221|NCT00440466|2402330|P1|Overall Study|Began Dialysis|0
752222|NCT00440466|2402328|P3|Overall Study|Withdrawal by Subject|9
752223|NCT00440466|2402329|P2|Overall Study|Withdrawal by Subject|5
752224|NCT00440466|2402330|P1|Overall Study|Withdrawal by Subject|2
752225|NCT00440466|2402328|P3|Overall Study|Protocol Violation|4
752226|NCT00440466|2402329|P2|Overall Study|Protocol Violation|0
752227|NCT00440466|2402330|P1|Overall Study|Protocol Violation|2
752228|NCT00440466|2402328|P3|Overall Study|Physician Decision|1
752229|NCT00440466|2402329|P2|Overall Study|Physician Decision|0
752230|NCT00440466|2402330|P1|Overall Study|Physician Decision|2
752231|NCT00440466|2402328|P3|Overall Study|Lost to Follow-up|2
752232|NCT00440466|2402329|P2|Overall Study|Lost to Follow-up|0
752233|NCT00440466|2402330|P1|Overall Study|Lost to Follow-up|1
752234|NCT00440466|2402328|P3|Overall Study|Adverse Event|11
752235|NCT00440466|2402329|P2|Overall Study|Adverse Event|4
752236|NCT00440466|2402330|P1|Overall Study|Adverse Event|3
752237|NCT00440466|2402328|P3|Overall Study|Death|9
752238|NCT00440466|2402329|P2|Overall Study|Death|2
752239|NCT00440466|2402330|P1|Overall Study|Death|3
752240|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
752241|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
752242|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
752243|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Other|2
752244|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Other|0
752245|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Other|0
752246|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
752247|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
752248|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
752249|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
752250|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
752251|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
752252|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
752253|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
752254|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
752255|NCT00440518|2402387|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
752256|NCT00440518|2402388|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
752257|NCT00440518|2402389|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
752258|NCT00440518|2402387|P3|Randomized /Titration Period|Adverse Event|0
752259|NCT00440518|2402388|P2|Randomized /Titration Period|Adverse Event|3
752260|NCT00440518|2402389|P1|Randomized /Titration Period|Adverse Event|2
752261|NCT00440518|2402387|P3|Randomized /Titration Period|Lost to Follow-up|1
752262|NCT00440518|2402388|P2|Randomized /Titration Period|Lost to Follow-up|2
752263|NCT00440518|2402389|P1|Randomized /Titration Period|Lost to Follow-up|2
752264|NCT00440518|2402387|P3|Randomized /Titration Period|Other|0
752265|NCT00440518|2402388|P2|Randomized /Titration Period|Other|0
752266|NCT00440518|2402389|P1|Randomized /Titration Period|Other|1
752267|NCT00440518|2402387|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
752268|NCT00440518|2402388|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
752269|NCT00440518|2402389|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
752270|NCT00440518|2402387|P3|Randomized /Titration Period|Protocol Deviation|0
752271|NCT00440518|2402388|P2|Randomized /Titration Period|Protocol Deviation|0
752272|NCT00440518|2402389|P1|Randomized /Titration Period|Protocol Deviation|1
752273|NCT00440518|2402387|P3|Randomized /Titration Period|Subject Withdrew Consent|0
752274|NCT00440518|2402388|P2|Randomized /Titration Period|Subject Withdrew Consent|1
752275|NCT00440518|2402389|P1|Randomized /Titration Period|Subject Withdrew Consent|4
752276|NCT00440518|2402387|P3|Randomized /Titration Period|Lack of Efficacy|1
752277|NCT00440518|2402388|P2|Randomized /Titration Period|Lack of Efficacy|0
752278|NCT00440518|2402389|P1|Randomized /Titration Period|Lack of Efficacy|1
752279|NCT00440531|2402412|P3|Overall Study|see pre-assignment details|0
752280|NCT00440531|2402413|P2|Overall Study|see pre-assignment details|0
752281|NCT00440531|2402414|P1|Overall Study|see pre-assignment details|2
752282|NCT00440531|2402412|P3|Overall Study|Lost to Follow-up|5
752283|NCT00440531|2402413|P2|Overall Study|Lost to Follow-up|3
752284|NCT00440531|2402414|P1|Overall Study|Lost to Follow-up|4
752285|NCT00440531|2402412|P3|Overall Study|Protocol Violation|0
752286|NCT00440531|2402413|P2|Overall Study|Protocol Violation|2
752287|NCT00440531|2402414|P1|Overall Study|Protocol Violation|1
752288|NCT00440531|2402412|P3|Overall Study|Withdrawal by Subject|0
752289|NCT00440531|2402413|P2|Overall Study|Withdrawal by Subject|0
752290|NCT00440531|2402414|P1|Overall Study|Withdrawal by Subject|2
752291|NCT00440531|2402412|P3|Overall Study|Adverse Event|2
752292|NCT00440531|2402413|P2|Overall Study|Adverse Event|0
752293|NCT00440531|2402414|P1|Overall Study|Adverse Event|1
752294|NCT00441441|2402430|P2|Overall Study|Not specified|3
752295|NCT00441441|2402431|P1|Overall Study|Not specified|3
752296|NCT00441441|2402430|P2|Overall Study|Withdrawal by Subject|2
752297|NCT00441441|2402431|P1|Overall Study|Withdrawal by Subject|1
752298|NCT00441441|2402430|P2|Overall Study|Exacerbation of asthma|2
752299|NCT00441441|2402431|P1|Overall Study|Exacerbation of asthma|1
752300|NCT00441441|2402430|P2|Overall Study|Protocol Violation|6
752301|NCT00441441|2402431|P1|Overall Study|Protocol Violation|4
752302|NCT00441441|2402430|P2|Overall Study|Adverse Event|1
752303|NCT00441441|2402431|P1|Overall Study|Adverse Event|2
752304|NCT00441467|2402489|P1|Overall Study|Progressive disease|9
752305|NCT00441467|2402489|P1|Overall Study|Withdrawal by Subject|3
752306|NCT00441467|2402489|P1|Overall Study|Adverse Event|6
752307|NCT00441480|2402497|P2|Overall Study|Withdrawal by Subject|3
752308|NCT00441480|2402498|P1|Overall Study|Withdrawal by Subject|2
752309|NCT00441480|2402497|P2|Overall Study|Protocol Violation|1
752310|NCT00441480|2402498|P1|Overall Study|Protocol Violation|1
752311|NCT00441545|2402530|P2|Second Intervention|Subject moved|1
752312|NCT00441545|2402531|P1|Second Intervention|Subject moved|0
752313|NCT00441545|2402530|P2|Second Intervention|Subject exceeded safety criteria|0
752314|NCT00441545|2402531|P1|Second Intervention|Subject exceeded safety criteria|1
752315|NCT00441545|2402530|P2|Second Intervention|Lack of Efficacy|1
752316|NCT00441545|2402531|P1|Second Intervention|Lack of Efficacy|0
752317|NCT00441545|2402530|P2|Second Intervention|Kidney Transplant|1
752318|NCT00441545|2402531|P1|Second Intervention|Kidney Transplant|1
752319|NCT00441545|2402530|P2|Second Intervention|Withdrawal by Subject|1
752320|NCT00441545|2402531|P1|Second Intervention|Withdrawal by Subject|1
752321|NCT00441545|2402530|P2|Second Intervention|Protocol Violation|1
752322|NCT00441545|2402531|P1|Second Intervention|Protocol Violation|4
752323|NCT00441545|2402530|P2|Second Intervention|Adverse Event|2
752324|NCT00441545|2402531|P1|Second Intervention|Adverse Event|5
752325|NCT00441545|2402530|P2|First Intervention|Sponsor's request|0
752326|NCT00441545|2402531|P1|First Intervention|Sponsor's request|1
752327|NCT00441545|2402530|P2|First Intervention|Site error|0
752328|NCT00441545|2402531|P1|First Intervention|Site error|1
752329|NCT00441545|2402530|P2|First Intervention|Extended hospitalization|0
752330|NCT00441545|2402531|P1|First Intervention|Extended hospitalization|1
752331|NCT00441545|2402530|P2|First Intervention|Subject met an exclusionary criteria|0
752332|NCT00441545|2402531|P1|First Intervention|Subject met an exclusionary criteria|1
752333|NCT00441545|2402530|P2|First Intervention|Subject exceeded safety criteria|1
752334|NCT00441545|2402531|P1|First Intervention|Subject exceeded safety criteria|0
752335|NCT00441545|2402530|P2|First Intervention|Lack of Efficacy|0
752336|NCT00441545|2402531|P1|First Intervention|Lack of Efficacy|2
752337|NCT00441545|2402530|P2|First Intervention|Kidney transplant|1
752338|NCT00441545|2402531|P1|First Intervention|Kidney transplant|1
752339|NCT00441545|2402530|P2|First Intervention|Withdrawal by Subject|3
752340|NCT00441545|2402531|P1|First Intervention|Withdrawal by Subject|3
752341|NCT00441545|2402530|P2|First Intervention|Protocol Violation|2
752342|NCT00441545|2402531|P1|First Intervention|Protocol Violation|2
752343|NCT00441545|2402530|P2|First Intervention|Adverse Event|5
752344|NCT00441545|2402531|P1|First Intervention|Adverse Event|6
752345|NCT00441584|2402547|P1|Overall Study|Failure to meet eligibility criteria|3
752346|NCT00441584|2402547|P1|Overall Study|Lost to Follow-up|4
752347|NCT00441584|2402547|P1|Overall Study|Protocol Violation|5
752348|NCT00441584|2402547|P1|Overall Study|Adverse Event|6
752349|NCT00441584|2402547|P1|Overall Study|Withdrawal by Subject|8
752350|NCT00441584|2402547|P1|Overall Study|Lack of Efficacy|79
752351|NCT00441701|2402561|P10|Overall Study|Withdrawal by Subject|0
752352|NCT00441701|2402562|P9|Overall Study|Withdrawal by Subject|0
752353|NCT00441701|2402563|P8|Overall Study|Withdrawal by Subject|0
752354|NCT00441701|2402564|P7|Overall Study|Withdrawal by Subject|0
752355|NCT00441701|2402565|P6|Overall Study|Withdrawal by Subject|0
752356|NCT00441701|2402566|P5|Overall Study|Withdrawal by Subject|0
752357|NCT00441701|2402567|P4|Overall Study|Withdrawal by Subject|1
752358|NCT00441701|2402568|P3|Overall Study|Withdrawal by Subject|1
752359|NCT00441701|2402569|P2|Overall Study|Withdrawal by Subject|2
752360|NCT00441701|2402570|P1|Overall Study|Withdrawal by Subject|0
752361|NCT00441701|2402561|P10|Overall Study|Lack of Efficacy|0
752362|NCT00441701|2402562|P9|Overall Study|Lack of Efficacy|0
752363|NCT00441701|2402563|P8|Overall Study|Lack of Efficacy|0
752364|NCT00441701|2402564|P7|Overall Study|Lack of Efficacy|0
752365|NCT00441701|2402565|P6|Overall Study|Lack of Efficacy|1
752366|NCT00441701|2402566|P5|Overall Study|Lack of Efficacy|0
752367|NCT00441701|2402567|P4|Overall Study|Lack of Efficacy|2
752368|NCT00441701|2402568|P3|Overall Study|Lack of Efficacy|2
752369|NCT00441701|2402569|P2|Overall Study|Lack of Efficacy|0
752370|NCT00441701|2402570|P1|Overall Study|Lack of Efficacy|2
752371|NCT00441701|2402561|P10|Overall Study|Adverse Event|0
752372|NCT00441701|2402562|P9|Overall Study|Adverse Event|0
752373|NCT00441701|2402563|P8|Overall Study|Adverse Event|0
752374|NCT00441701|2402564|P7|Overall Study|Adverse Event|0
752375|NCT00441701|2402565|P6|Overall Study|Adverse Event|2
752376|NCT00441701|2402566|P5|Overall Study|Adverse Event|2
752377|NCT00441701|2402567|P4|Overall Study|Adverse Event|0
752378|NCT00441701|2402568|P3|Overall Study|Adverse Event|1
752379|NCT00441701|2402569|P2|Overall Study|Adverse Event|2
752380|NCT00441701|2402570|P1|Overall Study|Adverse Event|3
752381|NCT00441727|2402655|P3|Overall Study|Various reason specified|5
752382|NCT00441727|2402656|P2|Overall Study|Various reason specified|8
752383|NCT00441727|2402657|P1|Overall Study|Various reason specified|6
752384|NCT00441727|2402655|P3|Overall Study|Safety Reasons|3
752385|NCT00441727|2402656|P2|Overall Study|Safety Reasons|1
752386|NCT00441727|2402657|P1|Overall Study|Safety Reasons|3
752387|NCT00441727|2402655|P3|Overall Study|Lost to Follow-up|5
752388|NCT00441727|2402656|P2|Overall Study|Lost to Follow-up|6
752389|NCT00441727|2402657|P1|Overall Study|Lost to Follow-up|5
752390|NCT00441727|2402655|P3|Overall Study|Withdrawal by Subject|47
752391|NCT00441727|2402656|P2|Overall Study|Withdrawal by Subject|34
752392|NCT00441727|2402657|P1|Overall Study|Withdrawal by Subject|40
752393|NCT00441727|2402655|P3|Overall Study|Lack of Efficacy|48
752394|NCT00441727|2402656|P2|Overall Study|Lack of Efficacy|8
752395|NCT00441727|2402657|P1|Overall Study|Lack of Efficacy|7
752396|NCT00441727|2402655|P3|Overall Study|Adverse Event|28
752397|NCT00441727|2402656|P2|Overall Study|Adverse Event|33
752398|NCT00441727|2402657|P1|Overall Study|Adverse Event|26
752399|NCT00441727|2402655|P3|Overall Study|Protocol Violation|32
752400|NCT00441727|2402656|P2|Overall Study|Protocol Violation|28
752401|NCT00441727|2402657|P1|Overall Study|Protocol Violation|19
752402|NCT00441792|2402711|P2|Overall Study|Lost to Follow-up|2
752403|NCT00441792|2402712|P1|Overall Study|Lost to Follow-up|0
752404|NCT00441974|2402720|P1|Overall Study|Protocol Violation|7
752405|NCT00441974|2402720|P1|Overall Study|Lost to Follow-up|80
752406|NCT00441974|2402720|P1|Overall Study|Consent Withdrawn|35
752407|NCT00441974|2402720|P1|Overall Study|Adverse Event|6
752408|NCT00442117|2402755|P2|Overall Study|Met Withdrawal Criteria|1
752409|NCT00442117|2402756|P1|Overall Study|Met Withdrawal Criteria|2
752410|NCT00442117|2402755|P2|Overall Study|Non compliance with protocol|5
752411|NCT00442117|2402756|P1|Overall Study|Non compliance with protocol|3
752412|NCT00442117|2402755|P2|Overall Study|Major Deviation|20
752413|NCT00442117|2402756|P1|Overall Study|Major Deviation|25
752414|NCT00442117|2402755|P2|Overall Study|Withdrawal by Subject|2
752415|NCT00442117|2402756|P1|Overall Study|Withdrawal by Subject|2
752416|NCT00442117|2402755|P2|Overall Study|Lost to Follow-up|2
752417|NCT00442117|2402756|P1|Overall Study|Lost to Follow-up|1
752418|NCT00442117|2402755|P2|Overall Study|Lack of Efficacy|6
752419|NCT00442117|2402756|P1|Overall Study|Lack of Efficacy|2
752420|NCT00442117|2402755|P2|Overall Study|Adverse Event|2
752421|NCT00442117|2402756|P1|Overall Study|Adverse Event|3
752422|NCT00442286|2402820|P2|Overall Study|Patient Injury|0
752423|NCT00442286|2402821|P1|Overall Study|Patient Injury|1
752424|NCT00442286|2402820|P2|Overall Study|System explanted|0
752425|NCT00442286|2402821|P1|Overall Study|System explanted|1
752426|NCT00442286|2402820|P2|Overall Study|Withdrawal by Subject|0
752427|NCT00442286|2402821|P1|Overall Study|Withdrawal by Subject|2
752428|NCT00442286|2402820|P2|Overall Study|Lost to Follow-up|0
752429|NCT00442286|2402821|P1|Overall Study|Lost to Follow-up|1
752430|NCT00442286|2402820|P2|Overall Study|Death|2
752431|NCT00442286|2402821|P1|Overall Study|Death|2
752432|NCT00442351|2402847|P2|Overall Study|Not specified|1
752433|NCT00442351|2402848|P1|Overall Study|Not specified|0
752434|NCT00442351|2402847|P2|Overall Study|Did not meet protocol eligibility|0
752435|NCT00442351|2402848|P1|Overall Study|Did not meet protocol eligibility|1
752436|NCT00442351|2402847|P2|Overall Study|Administrative|5
752437|NCT00442351|2402848|P1|Overall Study|Administrative|6
752438|NCT00442416|2402860|P2|Overall Study|Administrative/Other|33
752439|NCT00442416|2402861|P1|Overall Study|Administrative/Other|27
752440|NCT00442416|2402860|P2|Overall Study|Withdrew consent|2
752441|NCT00442416|2402861|P1|Overall Study|Withdrew consent|1
752442|NCT00442416|2402860|P2|Overall Study|Protocol Violation|3
752443|NCT00442416|2402861|P1|Overall Study|Protocol Violation|2
752444|NCT00442416|2402860|P2|Overall Study|Lack of Efficacy|0
752445|NCT00442416|2402861|P1|Overall Study|Lack of Efficacy|2
752446|NCT00442416|2402860|P2|Overall Study|Death|0
752447|NCT00442416|2402861|P1|Overall Study|Death|1
752448|NCT00442416|2402860|P2|Overall Study|Adverse Event|1
752449|NCT00442416|2402861|P1|Overall Study|Adverse Event|4
752450|NCT00442468|2402894|P1|Overall Study|Did not complete all study procedures|88
752451|NCT00442468|2402894|P1|Overall Study|Withdrawal by Subject|91
752452|NCT00442468|2402894|P1|Overall Study|Adverse Event|4
752453|NCT00442546|2402932|P3|Overall Study|Randomized But Not Treated|6
752454|NCT00442546|2402933|P2|Overall Study|Randomized But Not Treated|4
752455|NCT00442546|2402934|P1|Overall Study|Randomized But Not Treated|5
752456|NCT00442546|2402932|P3|Overall Study|Withdrawal by Subject|7
752457|NCT00442546|2402933|P2|Overall Study|Withdrawal by Subject|5
752458|NCT00442546|2402934|P1|Overall Study|Withdrawal by Subject|5
752459|NCT00442546|2402932|P3|Overall Study|Other|6
752460|NCT00442546|2402933|P2|Overall Study|Other|9
752461|NCT00442546|2402934|P1|Overall Study|Other|4
752462|NCT00442546|2402932|P3|Overall Study|Lost to Follow-up|1
752463|NCT00442546|2402933|P2|Overall Study|Lost to Follow-up|2
752464|NCT00442546|2402934|P1|Overall Study|Lost to Follow-up|1
752465|NCT00442546|2402932|P3|Overall Study|Adverse Event|13
752466|NCT00442546|2402933|P2|Overall Study|Adverse Event|17
752467|NCT00442546|2402934|P1|Overall Study|Adverse Event|11
752468|NCT00442559|2403058|P2|Overall Study|Withdrawal by Subject|0
752469|NCT00442559|2403059|P1|Overall Study|Withdrawal by Subject|1
752470|NCT00442559|2403058|P2|Overall Study|Protocol Violation|1
752471|NCT00442559|2403059|P1|Overall Study|Protocol Violation|1
752472|NCT00442559|2403058|P2|Overall Study|Lost to Follow-up|34
752473|NCT00442559|2403059|P1|Overall Study|Lost to Follow-up|32
752474|NCT00442572|2403073|P2|Overall Study|Withdrawal by Subject|1
752475|NCT00442572|2403074|P1|Overall Study|Withdrawal by Subject|0
752476|NCT00442572|2403073|P2|Overall Study|Lost to Follow-up|1
752477|NCT00442572|2403074|P1|Overall Study|Lost to Follow-up|0
752478|NCT00442572|2403073|P2|Overall Study|Relapse|1
752479|NCT00442572|2403074|P1|Overall Study|Relapse|8
752480|NCT00442598|2403115|P3|Overall Study|Death|0
752481|NCT00442598|2403116|P2|Overall Study|Death|1
752482|NCT00442598|2403117|P1|Overall Study|Death|0
752483|NCT00442598|2403115|P3|Overall Study|Reduced creatinine clearance|0
752484|NCT00442598|2403116|P2|Overall Study|Reduced creatinine clearance|0
752485|NCT00442598|2403117|P1|Overall Study|Reduced creatinine clearance|1
752486|NCT00442598|2403115|P3|Overall Study|CA125 progression|0
752487|NCT00442598|2403116|P2|Overall Study|CA125 progression|1
752488|NCT00442598|2403117|P1|Overall Study|CA125 progression|0
752489|NCT00442598|2403115|P3|Overall Study|Clinical deterioration|0
752490|NCT00442598|2403116|P2|Overall Study|Clinical deterioration|2
752491|NCT00442598|2403117|P1|Overall Study|Clinical deterioration|1
752492|NCT00442598|2403115|P3|Overall Study|Tumor progression|0
752493|NCT00442598|2403116|P2|Overall Study|Tumor progression|4
752494|NCT00442598|2403117|P1|Overall Study|Tumor progression|3
752495|NCT00442598|2403115|P3|Overall Study|Adverse Event|0
752496|NCT00442598|2403116|P2|Overall Study|Adverse Event|0
752497|NCT00442598|2403117|P1|Overall Study|Adverse Event|1
752498|NCT00442702|2403179|P2|Evaluation Period|Site closure|1
752499|NCT00442702|2403180|P1|Evaluation Period|Site closure|0
752500|NCT00442702|2403179|P2|Evaluation Period|Failure to return|0
752501|NCT00442702|2403180|P1|Evaluation Period|Failure to return|1
752502|NCT00442702|2403179|P2|Evaluation Period|Renal transplant|1
752503|NCT00442702|2403180|P1|Evaluation Period|Renal transplant|0
752504|NCT00442702|2403179|P2|Evaluation Period|Refused treatment|1
752505|NCT00442702|2403180|P1|Evaluation Period|Refused treatment|1
752506|NCT00442702|2403179|P2|Evaluation Period|Insufficient Therapeutic Response|0
752507|NCT00442702|2403180|P1|Evaluation Period|Insufficient Therapeutic Response|1
752508|NCT00442702|2403179|P2|Evaluation Period|Death|1
752509|NCT00442702|2403180|P1|Evaluation Period|Death|1
752510|NCT00442702|2403179|P2|Evaluation Period|Adverse Event|0
752511|NCT00442702|2403180|P1|Evaluation Period|Adverse Event|1
752512|NCT00442702|2403179|P2|Titration Period|Hospitalized in another hospital|0
752513|NCT00442702|2403180|P1|Titration Period|Hospitalized in another hospital|1
752514|NCT00442702|2403179|P2|Titration Period|Failure to return|0
752515|NCT00442702|2403180|P1|Titration Period|Failure to return|1
752516|NCT00442702|2403179|P2|Titration Period|Refused Treatment|1
752517|NCT00442702|2403180|P1|Titration Period|Refused Treatment|4
752518|NCT00442702|2403179|P2|Titration Period|Insufficient Therapeutic Response|0
752519|NCT00442702|2403180|P1|Titration Period|Insufficient Therapeutic Response|1
752520|NCT00442702|2403179|P2|Titration Period|Death|2
752521|NCT00442702|2403180|P1|Titration Period|Death|3
752522|NCT00442702|2403179|P2|Titration Period|Adverse Event|0
752523|NCT00442702|2403180|P1|Titration Period|Adverse Event|2
752524|NCT00442897|2403194|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
752525|NCT00442897|2403195|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
752526|NCT00442897|2403194|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
752527|NCT00442897|2403195|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
752528|NCT00442897|2403194|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
752529|NCT00442897|2403195|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
752530|NCT00442897|2403194|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
752531|NCT00442897|2403195|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
752532|NCT00442897|2403194|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
752533|NCT00442897|2403195|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
752534|NCT00442897|2403194|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
752535|NCT00442897|2403195|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
752536|NCT00442897|2403194|P2|Base Study (12 Week Follow-up)|Death|1
752537|NCT00442897|2403195|P1|Base Study (12 Week Follow-up)|Death|0
752538|NCT00442897|2403194|P2|Base Study (12 Week Follow-up)|Adverse Event|0
752539|NCT00442897|2403195|P1|Base Study (12 Week Follow-up)|Adverse Event|1
752540|NCT00442936|2403207|P4|Overall Study|Protocol Violation|1
752541|NCT00442936|2403208|P3|Overall Study|Protocol Violation|1
752542|NCT00442936|2403209|P2|Overall Study|Protocol Violation|0
752543|NCT00442936|2403210|P1|Overall Study|Protocol Violation|1
752544|NCT00442962|2403256|P1|Overall Study|Lost to Follow-up|7
752545|NCT00442962|2403256|P1|Overall Study|Pregnancy|1
752546|NCT00443040|2403273|P3|Overall Study|Converted to an open laparotomy|1
752547|NCT00443040|2403274|P2|Overall Study|Converted to an open laparotomy|0
752548|NCT00443040|2403275|P1|Overall Study|Converted to an open laparotomy|3
752549|NCT00443040|2403273|P3|Overall Study|Withdrawal by Subject|0
752550|NCT00443040|2403274|P2|Overall Study|Withdrawal by Subject|0
752551|NCT00443040|2403275|P1|Overall Study|Withdrawal by Subject|1
752552|NCT00443053|2403285|P2|Overall Study|Physician Decision|4
752553|NCT00443053|2403286|P1|Overall Study|Physician Decision|0
752554|NCT00443053|2403285|P2|Overall Study|Other|4
752555|NCT00443053|2403286|P1|Overall Study|Other|3
752556|NCT00443053|2403285|P2|Overall Study|Noncompliance|1
752557|NCT00443053|2403286|P1|Overall Study|Noncompliance|2
752558|NCT00443053|2403285|P2|Overall Study|Did Not Meet Eligibility Criteria|0
752559|NCT00443053|2403286|P1|Overall Study|Did Not Meet Eligibility Criteria|1
752560|NCT00443053|2403285|P2|Overall Study|Lost to Follow-up|5
752561|NCT00443053|2403286|P1|Overall Study|Lost to Follow-up|4
752562|NCT00443053|2403285|P2|Overall Study|Withdrawal by Subject|18
752563|NCT00443053|2403286|P1|Overall Study|Withdrawal by Subject|9
752564|NCT00443053|2403285|P2|Overall Study|Adverse Event|1
752565|NCT00443053|2403286|P1|Overall Study|Adverse Event|2
752566|NCT00443118|2403307|P3|Overall Study|Withdrawal by Subject|0
752567|NCT00443118|2403308|P2|Overall Study|Withdrawal by Subject|0
752568|NCT00443118|2403309|P1|Overall Study|Withdrawal by Subject|1
752569|NCT00443118|2403307|P3|Overall Study|unknown primary outcome|0
752570|NCT00443118|2403308|P2|Overall Study|unknown primary outcome|1
752571|NCT00443118|2403309|P1|Overall Study|unknown primary outcome|3
752572|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
752573|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
752574|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
752575|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
752576|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
752577|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
752578|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
752579|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
752580|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
752581|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
752582|NCT00443209|2403355|P2|Months 13 to 18 Treatment Period|Adverse Event|0
752583|NCT00443209|2403356|P1|Months 13 to 18 Treatment Period|Adverse Event|1
752584|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Not Treated|43
752585|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Not Treated|71
752586|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Missing|1
752587|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Missing|2
752588|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
752589|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
752590|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
752591|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
752592|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Pregnancy|4
752593|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Pregnancy|3
752594|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Physician Decision|4
752595|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Physician Decision|8
752596|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
752597|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
752598|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
752599|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
752600|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
752601|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
752602|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
752603|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
752604|NCT00443209|2403355|P2|Months 1 to 12 Treatment Period|Adverse Event|11
752605|NCT00443209|2403356|P1|Months 1 to 12 Treatment Period|Adverse Event|22
752606|NCT00443261|2403370|P1|Overall Study|Death|1
752607|NCT00443430|2403380|P2|Overall Study|Adverse Event|1
752608|NCT00443430|2403381|P1|Overall Study|Adverse Event|1
752609|NCT00443430|2403380|P2|Overall Study|Lack of Efficacy|3
752610|NCT00443430|2403381|P1|Overall Study|Lack of Efficacy|3
752611|NCT00443456|2403391|P1|Overall Study|Withdrawal by Subject|1
752612|NCT00443456|2403391|P1|Overall Study|Move|1
752613|NCT00443456|2403391|P1|Overall Study|Adverse Event|16
752614|NCT00443534|2403424|P1|Overall Study|Enrolled, Not Treated|1
752615|NCT00443534|2403424|P1|Overall Study|Unspecified|10
752616|NCT00443534|2403424|P1|Overall Study|Study Terminated by Sponsor|12
752617|NCT00443534|2403424|P1|Overall Study|Withdrawal by Subject|8
752618|NCT00443534|2403424|P1|Overall Study|Death|9
752619|NCT00443534|2403424|P1|Overall Study|Adverse Event|16
752620|NCT00443534|2403424|P1|Overall Study|Lack of Efficacy|67
752621|NCT00443560|2403433|P2|Overall Study|Multiple pregnancies or fetal demise|4
752622|NCT00443560|2403434|P1|Overall Study|Multiple pregnancies or fetal demise|2
752623|NCT00443560|2403433|P2|Overall Study|No intrathecal dose|26
752624|NCT00443560|2403434|P1|Overall Study|No intrathecal dose|58
752625|NCT00443599|2403446|P2|Overall Study|Cardiopulmonary bypass canceled|1
752626|NCT00443599|2403447|P1|Overall Study|Cardiopulmonary bypass canceled|3
752627|NCT00443599|2403446|P2|Overall Study|Death|1
752628|NCT00443599|2403447|P1|Overall Study|Death|1
752629|NCT00443599|2403446|P2|Overall Study|Physician Decision|1
752630|NCT00443599|2403447|P1|Overall Study|Physician Decision|2
752631|NCT00443651|2403481|P2|Overall Study|Pregnancy|1
752632|NCT00443651|2403482|P1|Overall Study|Pregnancy|0
752633|NCT00443651|2403481|P2|Overall Study|Physician Decision|4
752634|NCT00443651|2403482|P1|Overall Study|Physician Decision|13
752635|NCT00443651|2403481|P2|Overall Study|Patient's/Guardian's Decision|30
752636|NCT00443651|2403482|P1|Overall Study|Patient's/Guardian's Decision|58
752637|NCT00443651|2403481|P2|Overall Study|Lost to Follow-up|12
752638|NCT00443651|2403482|P1|Overall Study|Lost to Follow-up|18
752639|NCT00443651|2403481|P2|Overall Study|Adverse Event|6
752640|NCT00443651|2403482|P1|Overall Study|Adverse Event|5
752641|NCT00443651|2403481|P2|Overall Study|Death|5
752642|NCT00443651|2403482|P1|Overall Study|Death|1
752643|NCT00443703|2403502|P2|Overall Study|Progressive Disease|0
752644|NCT00443703|2403503|P1|Overall Study|Progressive Disease|1
752645|NCT00443703|2403502|P2|Overall Study|Withdrawal by Subject|6
752646|NCT00443703|2403503|P1|Overall Study|Withdrawal by Subject|9
752647|NCT00443703|2403502|P2|Overall Study|Protocol Violation|1
752648|NCT00443703|2403503|P1|Overall Study|Protocol Violation|1
752649|NCT00443703|2403502|P2|Overall Study|Physician Decision|2
752650|NCT00443703|2403503|P1|Overall Study|Physician Decision|4
752651|NCT00443703|2403502|P2|Overall Study|Lost to Follow-up|4
752652|NCT00443703|2403503|P1|Overall Study|Lost to Follow-up|0
752653|NCT00443703|2403502|P2|Overall Study|Lack of Efficacy|1
752654|NCT00443703|2403503|P1|Overall Study|Lack of Efficacy|3
752655|NCT00443703|2403502|P2|Overall Study|Adverse Event|3
752656|NCT00443703|2403503|P1|Overall Study|Adverse Event|7
752657|NCT00443703|2403502|P2|Overall Study|Never Treated|1
752658|NCT00443703|2403503|P1|Overall Study|Never Treated|3
752659|NCT00443729|2403555|P2|Overall Study|Withdrawal by Subject|1
752660|NCT00443729|2403556|P1|Overall Study|Withdrawal by Subject|3
752661|NCT00443729|2403555|P2|Overall Study|Protocol Violation|1
752662|NCT00443729|2403556|P1|Overall Study|Protocol Violation|1
752663|NCT00443729|2403555|P2|Overall Study|Physician Decision|1
752664|NCT00443729|2403556|P1|Overall Study|Physician Decision|2
752665|NCT00443729|2403555|P2|Overall Study|Lost to Follow-up|1
752666|NCT00443729|2403556|P1|Overall Study|Lost to Follow-up|0
752667|NCT00443729|2403555|P2|Overall Study|Lack of Efficacy|2
752668|NCT00443729|2403556|P1|Overall Study|Lack of Efficacy|4
752669|NCT00443729|2403555|P2|Overall Study|Never Treated|1
752670|NCT00443729|2403556|P1|Overall Study|Never Treated|0
752671|NCT00443755|2403604|P2|Overall Study|Withdrawal by Subject|1
752672|NCT00443755|2403605|P1|Overall Study|Withdrawal by Subject|2
890922|NCT00619983|2826418|P3|Test Drug Alone|Withdrawal by Subject|0
890923|NCT00619983|2826419|P2|Test Drug Alone|Withdrawal by Subject|0
890924|NCT00619983|2826420|P1|Test Drug Alone|Withdrawal by Subject|1
890925|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
890926|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
890927|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
752681|NCT00443820|2403645|P4|Overall Study|Death|0
752682|NCT00443820|2403646|P3|Overall Study|Death|1
752683|NCT00443820|2403647|P2|Overall Study|Death|0
752684|NCT00443820|2403648|P1|Overall Study|Death|0
752685|NCT00443820|2403645|P4|Overall Study|Administrative problems|1
752686|NCT00443820|2403646|P3|Overall Study|Administrative problems|0
752687|NCT00443820|2403647|P2|Overall Study|Administrative problems|0
752688|NCT00443820|2403648|P1|Overall Study|Administrative problems|0
752689|NCT00443820|2403645|P4|Overall Study|Lost to Follow-up|5
752690|NCT00443820|2403646|P3|Overall Study|Lost to Follow-up|6
752691|NCT00443820|2403647|P2|Overall Study|Lost to Follow-up|8
752692|NCT00443820|2403648|P1|Overall Study|Lost to Follow-up|9
752693|NCT00443820|2403645|P4|Overall Study|Withdrawal by Subject|9
752694|NCT00443820|2403646|P3|Overall Study|Withdrawal by Subject|8
752695|NCT00443820|2403647|P2|Overall Study|Withdrawal by Subject|7
752696|NCT00443820|2403648|P1|Overall Study|Withdrawal by Subject|6
752697|NCT00443820|2403645|P4|Overall Study|Protocol Violation|1
752698|NCT00443820|2403646|P3|Overall Study|Protocol Violation|2
752699|NCT00443820|2403647|P2|Overall Study|Protocol Violation|1
752700|NCT00443820|2403648|P1|Overall Study|Protocol Violation|2
752701|NCT00443820|2403645|P4|Overall Study|Lack of Efficacy|1
752702|NCT00443820|2403646|P3|Overall Study|Lack of Efficacy|1
752703|NCT00443820|2403647|P2|Overall Study|Lack of Efficacy|2
752704|NCT00443820|2403648|P1|Overall Study|Lack of Efficacy|3
752705|NCT00443820|2403645|P4|Overall Study|Adverse Event|0
752706|NCT00443820|2403646|P3|Overall Study|Adverse Event|0
752707|NCT00443820|2403647|P2|Overall Study|Adverse Event|1
752708|NCT00443820|2403648|P1|Overall Study|Adverse Event|1
752709|NCT00430027|2403670|P1|Overall Study|Study terminated|8
752710|NCT00430092|2403677|P3|Overall Study|Withdrawal by Subject|1
752711|NCT00430092|2403678|P2|Overall Study|Withdrawal by Subject|1
752712|NCT00430092|2403679|P1|Overall Study|Withdrawal by Subject|0
752713|NCT00430092|2403677|P3|Overall Study|Protocol Violation|1
752714|NCT00430092|2403678|P2|Overall Study|Protocol Violation|1
752715|NCT00430092|2403679|P1|Overall Study|Protocol Violation|0
752716|NCT00430092|2403677|P3|Overall Study|Lost to Follow-up|0
752717|NCT00430092|2403678|P2|Overall Study|Lost to Follow-up|0
752718|NCT00430092|2403679|P1|Overall Study|Lost to Follow-up|1
752719|NCT00430092|2403677|P3|Overall Study|Lack of Efficacy|54
752720|NCT00430092|2403678|P2|Overall Study|Lack of Efficacy|2
752721|NCT00430092|2403679|P1|Overall Study|Lack of Efficacy|5
752722|NCT00430092|2403677|P3|Overall Study|Adverse Event|1
752723|NCT00430092|2403678|P2|Overall Study|Adverse Event|0
752724|NCT00430092|2403679|P1|Overall Study|Adverse Event|0
752725|NCT00430248|2403687|P3|Overall Study|Reason Not Specified|11
752726|NCT00430248|2403688|P2|Overall Study|Reason Not Specified|8
752727|NCT00430248|2403689|P1|Overall Study|Reason Not Specified|8
752728|NCT00430248|2403687|P3|Overall Study|Gout Flare|2
752729|NCT00430248|2403688|P2|Overall Study|Gout Flare|7
752730|NCT00430248|2403689|P1|Overall Study|Gout Flare|3
752731|NCT00430248|2403687|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
752732|NCT00430248|2403688|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
752733|NCT00430248|2403689|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
752734|NCT00430248|2403687|P3|Overall Study|Withdrawal by Subject|16
752735|NCT00430248|2403688|P2|Overall Study|Withdrawal by Subject|20
752736|NCT00430248|2403689|P1|Overall Study|Withdrawal by Subject|14
752737|NCT00430248|2403687|P3|Overall Study|Therapeutic Failure|1
752738|NCT00430248|2403688|P2|Overall Study|Therapeutic Failure|1
752739|NCT00430248|2403689|P1|Overall Study|Therapeutic Failure|1
752740|NCT00430248|2403687|P3|Overall Study|Lost to Follow-up|28
752741|NCT00430248|2403688|P2|Overall Study|Lost to Follow-up|33
752742|NCT00430248|2403689|P1|Overall Study|Lost to Follow-up|28
752743|NCT00430248|2403687|P3|Overall Study|Personal Reasons|9
752744|NCT00430248|2403688|P2|Overall Study|Personal Reasons|24
752745|NCT00430248|2403689|P1|Overall Study|Personal Reasons|12
752746|NCT00430248|2403687|P3|Overall Study|Protocol Violation|4
752747|NCT00430248|2403688|P2|Overall Study|Protocol Violation|2
752748|NCT00430248|2403689|P1|Overall Study|Protocol Violation|10
752749|NCT00430248|2403687|P3|Overall Study|Adverse Event|64
752750|NCT00430248|2403688|P2|Overall Study|Adverse Event|61
752751|NCT00430248|2403689|P1|Overall Study|Adverse Event|49
752752|NCT00430300|2403749|P4|Overall Study|Unspecified|1
752753|NCT00430300|2403750|P3|Overall Study|Unspecified|0
752754|NCT00430300|2403751|P2|Overall Study|Unspecified|0
752755|NCT00430300|2403752|P1|Overall Study|Unspecified|0
752756|NCT00430300|2403749|P4|Overall Study|Laboratory abnormality|0
752757|NCT00430300|2403750|P3|Overall Study|Laboratory abnormality|0
752758|NCT00430300|2403751|P2|Overall Study|Laboratory abnormality|0
752759|NCT00430300|2403752|P1|Overall Study|Laboratory abnormality|1
752760|NCT00430300|2403749|P4|Overall Study|Withdrawal by Subject|0
752761|NCT00430300|2403750|P3|Overall Study|Withdrawal by Subject|5
752762|NCT00430300|2403751|P2|Overall Study|Withdrawal by Subject|0
752763|NCT00430300|2403752|P1|Overall Study|Withdrawal by Subject|1
752764|NCT00430300|2403749|P4|Overall Study|Adverse Event|1
752765|NCT00430300|2403750|P3|Overall Study|Adverse Event|1
752766|NCT00430300|2403751|P2|Overall Study|Adverse Event|2
752767|NCT00430300|2403752|P1|Overall Study|Adverse Event|0
752768|NCT00430352|2403854|P1|Overall Study|Not specified|48
752769|NCT00430352|2403854|P1|Overall Study|Death|5
752770|NCT00430352|2403854|P1|Overall Study|Adverse Event|16
752771|NCT00430352|2403854|P1|Overall Study|Withdrawal by Subject|11
752772|NCT00430352|2403854|P1|Overall Study|Disease progression|58
752773|NCT00430495|2403872|P4|Overall Study|Randomized but not Treated|0
752774|NCT00430495|2403873|P3|Overall Study|Randomized but not Treated|0
752775|NCT00430495|2403874|P2|Overall Study|Randomized but not Treated|0
752776|NCT00430495|2403875|P1|Overall Study|Randomized but not Treated|2
752777|NCT00430495|2403872|P4|Overall Study|Unspecified|4
752778|NCT00430495|2403873|P3|Overall Study|Unspecified|5
752779|NCT00430495|2403874|P2|Overall Study|Unspecified|2
752780|NCT00430495|2403875|P1|Overall Study|Unspecified|8
752781|NCT00430495|2403872|P4|Overall Study|Disease Progression|0
752782|NCT00430495|2403873|P3|Overall Study|Disease Progression|0
752783|NCT00430495|2403874|P2|Overall Study|Disease Progression|1
752784|NCT00430495|2403875|P1|Overall Study|Disease Progression|1
752785|NCT00430495|2403872|P4|Overall Study|Protocol Violation|0
752786|NCT00430495|2403873|P3|Overall Study|Protocol Violation|1
752787|NCT00430495|2403874|P2|Overall Study|Protocol Violation|0
752788|NCT00430495|2403875|P1|Overall Study|Protocol Violation|1
752789|NCT00430495|2403872|P4|Overall Study|Lost to Follow-up|0
752790|NCT00430495|2403873|P3|Overall Study|Lost to Follow-up|4
752791|NCT00430495|2403874|P2|Overall Study|Lost to Follow-up|1
752792|NCT00430495|2403875|P1|Overall Study|Lost to Follow-up|0
752793|NCT00430495|2403872|P4|Overall Study|Death|0
752794|NCT00430495|2403873|P3|Overall Study|Death|1
752795|NCT00430495|2403874|P2|Overall Study|Death|0
752796|NCT00430495|2403875|P1|Overall Study|Death|0
752797|NCT00430495|2403872|P4|Overall Study|Adverse Event|0
752798|NCT00430495|2403873|P3|Overall Study|Adverse Event|2
752799|NCT00430495|2403874|P2|Overall Study|Adverse Event|3
752800|NCT00430495|2403875|P1|Overall Study|Adverse Event|2
752801|NCT00430508|2403917|P4|Overall Study|not specified|0
752802|NCT00430508|2403918|P3|Overall Study|not specified|3
752803|NCT00430508|2403919|P2|Overall Study|not specified|1
752804|NCT00430508|2403920|P1|Overall Study|not specified|1
752805|NCT00430508|2403917|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
752806|NCT00430508|2403918|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
752807|NCT00430508|2403919|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
752808|NCT00430508|2403920|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
752809|NCT00430508|2403917|P4|Overall Study|responder at visit 4|0
752810|NCT00430508|2403918|P3|Overall Study|responder at visit 4|2
752811|NCT00430508|2403919|P2|Overall Study|responder at visit 4|0
752812|NCT00430508|2403920|P1|Overall Study|responder at visit 4|0
752813|NCT00430508|2403917|P4|Overall Study|Withdrawal by Subject|1
752814|NCT00430508|2403918|P3|Overall Study|Withdrawal by Subject|1
752815|NCT00430508|2403919|P2|Overall Study|Withdrawal by Subject|1
752816|NCT00430508|2403920|P1|Overall Study|Withdrawal by Subject|0
752817|NCT00430508|2403917|P4|Overall Study|Adverse Event|3
752818|NCT00430508|2403918|P3|Overall Study|Adverse Event|5
752819|NCT00430508|2403919|P2|Overall Study|Adverse Event|3
752820|NCT00430508|2403920|P1|Overall Study|Adverse Event|2
752821|NCT00430638|2403975|P2|Overall Study|Not specified|2
752822|NCT00430638|2403976|P1|Overall Study|Not specified|2
752823|NCT00430638|2403975|P2|Overall Study|Non-compliant|1
752824|NCT00430638|2403976|P1|Overall Study|Non-compliant|2
752825|NCT00430638|2403975|P2|Overall Study|Withdrawal by Subject|6
752826|NCT00430638|2403976|P1|Overall Study|Withdrawal by Subject|4
752827|NCT00430638|2403975|P2|Overall Study|Protocol Violation|4
752828|NCT00430638|2403976|P1|Overall Study|Protocol Violation|6
752829|NCT00430638|2403975|P2|Overall Study|Lost to Follow-up|7
752830|NCT00430638|2403976|P1|Overall Study|Lost to Follow-up|1
752831|NCT00430638|2403975|P2|Overall Study|Uncontrolled blood pressure|13
752832|NCT00430638|2403976|P1|Overall Study|Uncontrolled blood pressure|48
752833|NCT00430638|2403975|P2|Overall Study|Adverse Event|15
752834|NCT00430638|2403976|P1|Overall Study|Adverse Event|15
752835|NCT00430677|2403995|P3|Long-term Extension Period|Poor compliance/noncompliance|0
752836|NCT00430677|2403996|P2|Long-term Extension Period|Poor compliance/noncompliance|0
752837|NCT00430677|2403997|P1|Long-term Extension Period|Poor compliance/noncompliance|1
752838|NCT00430677|2403995|P3|Long-term Extension Period|Not specified|1
752839|NCT00430677|2403996|P2|Long-term Extension Period|Not specified|1
752840|NCT00430677|2403997|P1|Long-term Extension Period|Not specified|2
752841|NCT00430677|2403995|P3|Long-term Extension Period|Administrative reason by sponsor|46
752842|NCT00430677|2403996|P2|Long-term Extension Period|Administrative reason by sponsor|49
752843|NCT00430677|2403997|P1|Long-term Extension Period|Administrative reason by sponsor|41
752844|NCT00430677|2403995|P3|Long-term Extension Period|Pregnancy|0
752845|NCT00430677|2403996|P2|Long-term Extension Period|Pregnancy|1
752846|NCT00430677|2403997|P1|Long-term Extension Period|Pregnancy|1
752847|NCT00430677|2403995|P3|Long-term Extension Period|Withdrawal by Subject|2
752848|NCT00430677|2403996|P2|Long-term Extension Period|Withdrawal by Subject|1
752849|NCT00430677|2403997|P1|Long-term Extension Period|Withdrawal by Subject|5
752850|NCT00430677|2403995|P3|Long-term Extension Period|Lost to Follow-up|1
752851|NCT00430677|2403996|P2|Long-term Extension Period|Lost to Follow-up|1
752852|NCT00430677|2403997|P1|Long-term Extension Period|Lost to Follow-up|1
752853|NCT00430677|2403995|P3|Long-term Extension Period|Lack of Efficacy|8
752854|NCT00430677|2403996|P2|Long-term Extension Period|Lack of Efficacy|3
752855|NCT00430677|2403997|P1|Long-term Extension Period|Lack of Efficacy|5
752856|NCT00430677|2403995|P3|Long-term Extension Period|Adverse Event|5
752857|NCT00430677|2403996|P2|Long-term Extension Period|Adverse Event|2
752858|NCT00430677|2403997|P1|Long-term Extension Period|Adverse Event|3
752859|NCT00430677|2403995|P3|Long-term Extension Period|Death|0
752860|NCT00430677|2403996|P2|Long-term Extension Period|Death|0
752861|NCT00430677|2403997|P1|Long-term Extension Period|Death|1
752862|NCT00430677|2403995|P3|Short-term Period|Pregnancy|0
752863|NCT00430677|2403996|P2|Short-term Period|Pregnancy|2
752864|NCT00430677|2403997|P1|Short-term Period|Pregnancy|0
752865|NCT00430677|2403995|P3|Short-term Period|Poor compliance/ noncompliance|0
752866|NCT00430677|2403996|P2|Short-term Period|Poor compliance/ noncompliance|1
752867|NCT00430677|2403997|P1|Short-term Period|Poor compliance/ noncompliance|0
752868|NCT00430677|2403995|P3|Short-term Period|Participant no longer met study criteria|2
752869|NCT00430677|2403996|P2|Short-term Period|Participant no longer met study criteria|1
752870|NCT00430677|2403997|P1|Short-term Period|Participant no longer met study criteria|1
752871|NCT00430677|2403995|P3|Short-term Period|Withdrawal by Subject|2
752872|NCT00430677|2403996|P2|Short-term Period|Withdrawal by Subject|1
752873|NCT00430677|2403997|P1|Short-term Period|Withdrawal by Subject|1
752874|NCT00430677|2403995|P3|Short-term Period|Lack of Efficacy|4
752875|NCT00430677|2403996|P2|Short-term Period|Lack of Efficacy|6
752876|NCT00430677|2403997|P1|Short-term Period|Lack of Efficacy|5
752877|NCT00430677|2403995|P3|Short-term Period|Adverse Event|9
752878|NCT00430677|2403996|P2|Short-term Period|Adverse Event|13
752879|NCT00430677|2403997|P1|Short-term Period|Adverse Event|15
752880|NCT00430677|2403995|P3|Short-term Period|Death|5
752881|NCT00430677|2403996|P2|Short-term Period|Death|1
752882|NCT00430677|2403997|P1|Short-term Period|Death|1
752883|NCT00430716|2404121|P3|Open Label Phase|Study terminated by sponsor|4
752884|NCT00430716|2404122|P2|Open Label Phase|Study terminated by sponsor|5
752885|NCT00430716|2404123|P1|Open Label Phase|Study terminated by sponsor|4
752886|NCT00430716|2404121|P3|Open Label Phase|Protocol Violation|0
752887|NCT00430716|2404122|P2|Open Label Phase|Protocol Violation|0
752888|NCT00430716|2404123|P1|Open Label Phase|Protocol Violation|1
752889|NCT00430716|2404121|P3|Open Label Phase|Unspecified|1
752890|NCT00430716|2404122|P2|Open Label Phase|Unspecified|1
752891|NCT00430716|2404123|P1|Open Label Phase|Unspecified|3
752892|NCT00430716|2404121|P3|Open Label Phase|No longer willing to participate|1
752893|NCT00430716|2404122|P2|Open Label Phase|No longer willing to participate|1
752894|NCT00430716|2404123|P1|Open Label Phase|No longer willing to participate|0
752895|NCT00430716|2404121|P3|Open Label Phase|Lost to Follow-up|1
752896|NCT00430716|2404122|P2|Open Label Phase|Lost to Follow-up|0
752897|NCT00430716|2404123|P1|Open Label Phase|Lost to Follow-up|1
752898|NCT00430716|2404121|P3|Double Blind Phase|Not met eligibility criteria|0
752899|NCT00430716|2404122|P2|Double Blind Phase|Not met eligibility criteria|0
752900|NCT00430716|2404123|P1|Double Blind Phase|Not met eligibility criteria|1
752901|NCT00430716|2404121|P3|Double Blind Phase|Adverse Event|3
752902|NCT00430716|2404122|P2|Double Blind Phase|Adverse Event|1
752903|NCT00430716|2404123|P1|Double Blind Phase|Adverse Event|1
752904|NCT00430716|2404121|P3|Double Blind Phase|Study terminated by sponsor|2
752905|NCT00430716|2404122|P2|Double Blind Phase|Study terminated by sponsor|1
752906|NCT00430716|2404123|P1|Double Blind Phase|Study terminated by sponsor|1
752907|NCT00430716|2404121|P3|Double Blind Phase|Unspecified|0
752908|NCT00430716|2404122|P2|Double Blind Phase|Unspecified|2
752909|NCT00430716|2404123|P1|Double Blind Phase|Unspecified|0
752910|NCT00430716|2404121|P3|Double Blind Phase|No longer willing to participate|1
752911|NCT00430716|2404122|P2|Double Blind Phase|No longer willing to participate|1
752912|NCT00430716|2404123|P1|Double Blind Phase|No longer willing to participate|2
752913|NCT00430716|2404121|P3|Double Blind Phase|Death|0
752914|NCT00430716|2404122|P2|Double Blind Phase|Death|0
752915|NCT00430716|2404123|P1|Double Blind Phase|Death|1
752916|NCT00430755|2404152|P1|Overall Study|Withdrawal by Subject|53
752917|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Other|0
752918|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Other|1
752919|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Other|4
752920|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
752921|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
752922|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
752923|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
752924|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
752925|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
752926|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
752927|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
752928|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
752929|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
752930|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
752931|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
752932|NCT00430781|2404178|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
752933|NCT00430781|2404179|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
752934|NCT00430781|2404180|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
752935|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Ongoing|32
752936|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Ongoing|29
752937|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Ongoing|0
752938|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Other|0
752939|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Other|1
752940|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Other|0
752941|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Physician Decision|6
752942|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Physician Decision|6
752943|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Physician Decision|0
752944|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
752945|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
752946|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
752947|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Protocol Violation|0
752948|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Protocol Violation|1
752949|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Protocol Violation|0
752950|NCT00430781|2404178|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
752951|NCT00430781|2404179|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
752952|NCT00430781|2404180|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
752953|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Ongoing|25
752954|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Ongoing|20
752955|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Ongoing|23
752956|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Physician Decision|3
752957|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Physician Decision|3
752958|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Physician Decision|2
752959|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
752960|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
752961|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
752962|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Death|0
752963|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Death|1
752964|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Death|0
752965|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Disease Progression|22
752966|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Disease Progression|30
752967|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Disease Progression|16
752968|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
752969|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
752970|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
752971|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
752972|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
752973|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
752974|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
752975|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
752976|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
752977|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
752978|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
752979|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
752980|NCT00430781|2404178|P3|Interim Analysis; 11 February 2008|Adverse Event|7
752981|NCT00430781|2404179|P2|Interim Analysis; 11 February 2008|Adverse Event|3
752982|NCT00430781|2404180|P1|Interim Analysis; 11 February 2008|Adverse Event|10
752983|NCT00430937|2404205|P2|Overall Study|Unable to classify|1
752984|NCT00430937|2404206|P1|Overall Study|Unable to classify|0
752985|NCT00430937|2404205|P2|Overall Study|Protocol discontinuation criteria met|2
752986|NCT00430937|2404206|P1|Overall Study|Protocol discontinuation criteria met|1
752987|NCT00430937|2404205|P2|Overall Study|Administrative reasons|0
752988|NCT00430937|2404206|P1|Overall Study|Administrative reasons|1
752989|NCT00430937|2404205|P2|Overall Study|Inappropriate enrollment|1
752990|NCT00430937|2404206|P1|Overall Study|Inappropriate enrollment|2
752991|NCT00430937|2404205|P2|Overall Study|Lack of Efficacy|5
752992|NCT00430937|2404206|P1|Overall Study|Lack of Efficacy|6
752993|NCT00430937|2404205|P2|Overall Study|Protocol Violation|2
752994|NCT00430937|2404206|P1|Overall Study|Protocol Violation|3
752995|NCT00430937|2404205|P2|Overall Study|Withdrawal by Subject|2
752996|NCT00430937|2404206|P1|Overall Study|Withdrawal by Subject|5
752997|NCT00430937|2404205|P2|Overall Study|Lost to Follow-up|6
752998|NCT00430937|2404206|P1|Overall Study|Lost to Follow-up|6
752999|NCT00430937|2404205|P2|Overall Study|Death|1
753000|NCT00430937|2404206|P1|Overall Study|Death|0
753001|NCT00430937|2404205|P2|Overall Study|Adverse Event|8
753002|NCT00430937|2404206|P1|Overall Study|Adverse Event|3
890928|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
890929|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
890930|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
890931|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
890932|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
753009|NCT00431067|2404246|P1|Overall Study|Non-compliance,lost to follow-up|2
753010|NCT00431067|2404246|P1|Overall Study|Progressive disease|30
753011|NCT00431067|2404246|P1|Overall Study|Other Adverse Event|9
753012|NCT00436748|2404272|P2|Overall Study|Other|0
753013|NCT00436748|2404273|P1|Overall Study|Other|3
753014|NCT00436748|2404272|P2|Overall Study|Protocol-specified Criteria|4
753015|NCT00436748|2404273|P1|Overall Study|Protocol-specified Criteria|5
753016|NCT00436748|2404272|P2|Overall Study|Lost to Follow-up|1
753017|NCT00436748|2404273|P1|Overall Study|Lost to Follow-up|0
753018|NCT00436748|2404272|P2|Overall Study|Administrative Decision|0
753019|NCT00436748|2404273|P1|Overall Study|Administrative Decision|1
753020|NCT00436748|2404272|P2|Overall Study|Consent Withdrawn|4
753021|NCT00436748|2404273|P1|Overall Study|Consent Withdrawn|1
753022|NCT00436748|2404272|P2|Overall Study|Adverse Event|2
753023|NCT00436748|2404273|P1|Overall Study|Adverse Event|0
753024|NCT00436748|2404272|P2|Overall Study|Ineligibility Determined|1
753025|NCT00436748|2404273|P1|Overall Study|Ineligibility Determined|1
753026|NCT00436826|2404309|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
753027|NCT00436826|2404310|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
753028|NCT00436826|2404311|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
753029|NCT00436826|2404312|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
753030|NCT00436826|2404313|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
753031|NCT00436826|2404314|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
753032|NCT00436826|2404309|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
753033|NCT00436826|2404310|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
753034|NCT00436826|2404311|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
753035|NCT00436826|2404312|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
753036|NCT00436826|2404313|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
753037|NCT00436826|2404314|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
753038|NCT00436826|2404309|P6|Double Blind Period|Unspecified|0
753039|NCT00436826|2404310|P5|Double Blind Period|Unspecified|0
753040|NCT00436826|2404311|P4|Double Blind Period|Unspecified|0
753041|NCT00436826|2404312|P3|Double Blind Period|Unspecified|0
753042|NCT00436826|2404313|P2|Double Blind Period|Unspecified|11
753043|NCT00436826|2404314|P1|Double Blind Period|Unspecified|10
753044|NCT00436826|2404309|P6|Double Blind Period|Protocol Violation|0
753045|NCT00436826|2404310|P5|Double Blind Period|Protocol Violation|0
753046|NCT00436826|2404311|P4|Double Blind Period|Protocol Violation|0
753047|NCT00436826|2404312|P3|Double Blind Period|Protocol Violation|0
753048|NCT00436826|2404313|P2|Double Blind Period|Protocol Violation|0
753049|NCT00436826|2404314|P1|Double Blind Period|Protocol Violation|1
753050|NCT00436826|2404309|P6|Double Blind Period|Adverse Event|0
753051|NCT00436826|2404310|P5|Double Blind Period|Adverse Event|0
753052|NCT00436826|2404311|P4|Double Blind Period|Adverse Event|0
753053|NCT00436826|2404312|P3|Double Blind Period|Adverse Event|0
753054|NCT00436826|2404313|P2|Double Blind Period|Adverse Event|0
753055|NCT00436826|2404314|P1|Double Blind Period|Adverse Event|2
753056|NCT00436852|2404336|P2|Overall Study|Ineligible|0
753057|NCT00436852|2404337|P1|Overall Study|Ineligible|1
753058|NCT00436852|2404336|P2|Overall Study|Withdrawal by Subject|4
753059|NCT00436852|2404337|P1|Overall Study|Withdrawal by Subject|2
753060|NCT00436852|2404336|P2|Overall Study|Lack of Efficacy|7
753061|NCT00436852|2404337|P1|Overall Study|Lack of Efficacy|9
753062|NCT00436852|2404336|P2|Overall Study|Death|34
753063|NCT00436852|2404337|P1|Overall Study|Death|23
753064|NCT00436917|2404354|P1|Overall Study|Still on treatment|47
753065|NCT00436917|2404354|P1|Overall Study|Adverse Event|1
753066|NCT00436917|2404354|P1|Overall Study|Withdrawal by Subject|6
753067|NCT00436956|2404358|P2|Overall Study|Not evaluable|0
753068|NCT00436956|2404359|P1|Overall Study|Not evaluable|1
753069|NCT00436982|2404421|P2|Overall Study|Did not receive allocated intervention|1
753070|NCT00436982|2404422|P1|Overall Study|Did not receive allocated intervention|0
753071|NCT00436982|2404421|P2|Overall Study|Withdrawal by Subject|1
753072|NCT00436982|2404422|P1|Overall Study|Withdrawal by Subject|2
753073|NCT00436982|2404421|P2|Overall Study|Adverse Event|3
753074|NCT00436982|2404422|P1|Overall Study|Adverse Event|3
753075|NCT00437034|2404428|P1|Overall Study|Disease progression during treatment|5
753076|NCT00437034|2404428|P1|Overall Study|Adverse Event|1
753077|NCT00437073|2404434|P2|Overall Study|Physician Decision|1
753078|NCT00437073|2404435|P1|Overall Study|Physician Decision|0
753079|NCT00437073|2404434|P2|Overall Study|Sponsor Terminated Study|0
753080|NCT00437073|2404435|P1|Overall Study|Sponsor Terminated Study|1
753081|NCT00437125|2404463|P1|Overall Study|Physician Decision|1
753082|NCT00437125|2404463|P1|Overall Study|Withdrawal by Caregiver|2
753083|NCT00437125|2404463|P1|Overall Study|Withdrawal by Subject|13
753084|NCT00437125|2404463|P1|Overall Study|Lost to Follow-up|1
753085|NCT00437125|2404463|P1|Overall Study|Lack of Efficacy|1
753086|NCT00437125|2404463|P1|Overall Study|Clinical Relapse|1
753087|NCT00437125|2404463|P1|Overall Study|Death|1
753088|NCT00437125|2404463|P1|Overall Study|Adverse Event|12
753089|NCT00437203|2404492|P10|Overall Study|Unspecified|0
753090|NCT00437203|2404493|P9|Overall Study|Unspecified|0
753091|NCT00437203|2404494|P8|Overall Study|Unspecified|0
753092|NCT00437203|2404495|P7|Overall Study|Unspecified|1
753093|NCT00437203|2404496|P6|Overall Study|Unspecified|0
753094|NCT00437203|2404497|P5|Overall Study|Unspecified|0
753095|NCT00437203|2404498|P4|Overall Study|Unspecified|0
753096|NCT00437203|2404499|P3|Overall Study|Unspecified|0
753097|NCT00437203|2404500|P2|Overall Study|Unspecified|1
753098|NCT00437203|2404501|P1|Overall Study|Unspecified|0
753099|NCT00437203|2404492|P10|Overall Study|Objective progression or relapse|2
753100|NCT00437203|2404493|P9|Overall Study|Objective progression or relapse|2
753101|NCT00437203|2404494|P8|Overall Study|Objective progression or relapse|1
753102|NCT00437203|2404495|P7|Overall Study|Objective progression or relapse|6
753103|NCT00437203|2404496|P6|Overall Study|Objective progression or relapse|3
753104|NCT00437203|2404497|P5|Overall Study|Objective progression or relapse|3
753105|NCT00437203|2404498|P4|Overall Study|Objective progression or relapse|3
753106|NCT00437203|2404499|P3|Overall Study|Objective progression or relapse|2
753107|NCT00437203|2404500|P2|Overall Study|Objective progression or relapse|6
753108|NCT00437203|2404501|P1|Overall Study|Objective progression or relapse|5
753109|NCT00437203|2404492|P10|Overall Study|Study terminated by sponsor|0
753110|NCT00437203|2404493|P9|Overall Study|Study terminated by sponsor|1
753111|NCT00437203|2404494|P8|Overall Study|Study terminated by sponsor|0
753112|NCT00437203|2404495|P7|Overall Study|Study terminated by sponsor|0
753113|NCT00437203|2404496|P6|Overall Study|Study terminated by sponsor|0
753114|NCT00437203|2404497|P5|Overall Study|Study terminated by sponsor|0
753115|NCT00437203|2404498|P4|Overall Study|Study terminated by sponsor|0
753116|NCT00437203|2404499|P3|Overall Study|Study terminated by sponsor|0
753117|NCT00437203|2404500|P2|Overall Study|Study terminated by sponsor|0
753118|NCT00437203|2404501|P1|Overall Study|Study terminated by sponsor|0
753119|NCT00437203|2404492|P10|Overall Study|Adverse Event|1
753120|NCT00437203|2404493|P9|Overall Study|Adverse Event|0
753121|NCT00437203|2404494|P8|Overall Study|Adverse Event|1
753122|NCT00437203|2404495|P7|Overall Study|Adverse Event|0
753123|NCT00437203|2404496|P6|Overall Study|Adverse Event|0
753124|NCT00437203|2404497|P5|Overall Study|Adverse Event|0
753125|NCT00437203|2404498|P4|Overall Study|Adverse Event|0
753126|NCT00437203|2404499|P3|Overall Study|Adverse Event|0
753127|NCT00437203|2404500|P2|Overall Study|Adverse Event|1
753128|NCT00437203|2404501|P1|Overall Study|Adverse Event|1
753129|NCT00437203|2404492|P10|Overall Study|Death|1
753130|NCT00437203|2404493|P9|Overall Study|Death|0
753131|NCT00437203|2404494|P8|Overall Study|Death|1
753132|NCT00437203|2404495|P7|Overall Study|Death|0
753133|NCT00437203|2404496|P6|Overall Study|Death|0
753134|NCT00437203|2404497|P5|Overall Study|Death|0
753135|NCT00437203|2404498|P4|Overall Study|Death|0
753136|NCT00437203|2404499|P3|Overall Study|Death|1
753137|NCT00437203|2404500|P2|Overall Study|Death|0
753138|NCT00437203|2404501|P1|Overall Study|Death|0
753139|NCT00437281|2404625|P20|Overall Study|Lost to Follow-up|1
753140|NCT00437281|2404626|P19|Overall Study|Lost to Follow-up|0
753141|NCT00437281|2404627|P18|Overall Study|Lost to Follow-up|0
753142|NCT00437281|2404628|P17|Overall Study|Lost to Follow-up|0
753143|NCT00437281|2404629|P16|Overall Study|Lost to Follow-up|0
753144|NCT00437281|2404630|P15|Overall Study|Lost to Follow-up|0
753145|NCT00437281|2404631|P14|Overall Study|Lost to Follow-up|0
753146|NCT00437281|2404632|P13|Overall Study|Lost to Follow-up|0
753147|NCT00437281|2404633|P12|Overall Study|Lost to Follow-up|0
753148|NCT00437281|2404634|P11|Overall Study|Lost to Follow-up|0
753149|NCT00437281|2404635|P10|Overall Study|Lost to Follow-up|0
753150|NCT00437281|2404636|P9|Overall Study|Lost to Follow-up|0
753151|NCT00437281|2404637|P8|Overall Study|Lost to Follow-up|0
753152|NCT00437281|2404638|P7|Overall Study|Lost to Follow-up|0
753153|NCT00437281|2404639|P6|Overall Study|Lost to Follow-up|0
753154|NCT00437281|2404640|P5|Overall Study|Lost to Follow-up|0
753155|NCT00437281|2404641|P4|Overall Study|Lost to Follow-up|0
753156|NCT00437281|2404642|P3|Overall Study|Lost to Follow-up|0
753157|NCT00437281|2404643|P2|Overall Study|Lost to Follow-up|0
753158|NCT00437281|2404644|P1|Overall Study|Lost to Follow-up|0
753159|NCT00437281|2404625|P20|Overall Study|Adverse Event|0
753160|NCT00437281|2404626|P19|Overall Study|Adverse Event|1
753161|NCT00437281|2404627|P18|Overall Study|Adverse Event|0
753162|NCT00437281|2404628|P17|Overall Study|Adverse Event|0
753163|NCT00437281|2404629|P16|Overall Study|Adverse Event|0
753164|NCT00437281|2404630|P15|Overall Study|Adverse Event|1
753165|NCT00437281|2404631|P14|Overall Study|Adverse Event|1
753166|NCT00437281|2404632|P13|Overall Study|Adverse Event|0
753167|NCT00437281|2404633|P12|Overall Study|Adverse Event|0
753168|NCT00437281|2404634|P11|Overall Study|Adverse Event|0
753169|NCT00437281|2404635|P10|Overall Study|Adverse Event|1
753170|NCT00437281|2404636|P9|Overall Study|Adverse Event|0
753171|NCT00437281|2404637|P8|Overall Study|Adverse Event|0
753172|NCT00437281|2404638|P7|Overall Study|Adverse Event|0
753173|NCT00437281|2404639|P6|Overall Study|Adverse Event|1
753174|NCT00437281|2404640|P5|Overall Study|Adverse Event|0
753175|NCT00437281|2404641|P4|Overall Study|Adverse Event|1
753176|NCT00437281|2404642|P3|Overall Study|Adverse Event|0
753177|NCT00437281|2404643|P2|Overall Study|Adverse Event|0
753178|NCT00437281|2404644|P1|Overall Study|Adverse Event|0
753179|NCT00437489|2404945|P2|Overall Study|Lost to Follow-up|1
753180|NCT00437489|2404946|P1|Overall Study|Lost to Follow-up|0
753181|NCT00437489|2404945|P2|Overall Study|Study terminated by sponsor|21
753182|NCT00437489|2404946|P1|Overall Study|Study terminated by sponsor|23
753183|NCT00437645|2404960|P2|Overall Study|Condition no longer requires study drug|1
753184|NCT00437645|2404961|P1|Overall Study|Condition no longer requires study drug|1
753185|NCT00437645|2404960|P2|Overall Study|Lack of Efficacy|1
753186|NCT00437645|2404961|P1|Overall Study|Lack of Efficacy|2
753187|NCT00437645|2404960|P2|Overall Study|Administrative problems|1
753188|NCT00437645|2404961|P1|Overall Study|Administrative problems|2
753189|NCT00437645|2404960|P2|Overall Study|Lost to Follow-up|3
753190|NCT00437645|2404961|P1|Overall Study|Lost to Follow-up|2
753191|NCT00437645|2404960|P2|Overall Study|Protocol Violation|3
753192|NCT00437645|2404961|P1|Overall Study|Protocol Violation|3
753193|NCT00437645|2404960|P2|Overall Study|Withdrawal by Subject|22
753194|NCT00437645|2404961|P1|Overall Study|Withdrawal by Subject|10
753195|NCT00437645|2404960|P2|Overall Study|Adverse Event|84
753196|NCT00437645|2404961|P1|Overall Study|Adverse Event|15
753197|NCT00443872|2404975|P1|Overall Study|Adverse Event|8
753198|NCT00443872|2404975|P1|Overall Study|Lost to Follow-up|2
753199|NCT00443872|2404975|P1|Overall Study|Protocol Violation|7
753200|NCT00443898|2404992|P4|Overall Study|Death|0
753201|NCT00443898|2404993|P3|Overall Study|Death|0
753202|NCT00443898|2404994|P2|Overall Study|Death|1
753203|NCT00443898|2404995|P1|Overall Study|Death|0
753204|NCT00443898|2404992|P4|Overall Study|Lost to Follow-up|10
753205|NCT00443898|2404993|P3|Overall Study|Lost to Follow-up|14
753206|NCT00443898|2404994|P2|Overall Study|Lost to Follow-up|10
753207|NCT00443898|2404995|P1|Overall Study|Lost to Follow-up|10
753208|NCT00443898|2404992|P4|Overall Study|Withdrawal by Subject|6
753209|NCT00443898|2404993|P3|Overall Study|Withdrawal by Subject|10
753210|NCT00443898|2404994|P2|Overall Study|Withdrawal by Subject|10
753211|NCT00443898|2404995|P1|Overall Study|Withdrawal by Subject|11
753212|NCT00443898|2404992|P4|Overall Study|Protocol Violation|0
753213|NCT00443898|2404993|P3|Overall Study|Protocol Violation|1
753214|NCT00443898|2404994|P2|Overall Study|Protocol Violation|1
753215|NCT00443898|2404995|P1|Overall Study|Protocol Violation|1
753216|NCT00443898|2404992|P4|Overall Study|Lack of Efficacy|1
753217|NCT00443898|2404993|P3|Overall Study|Lack of Efficacy|3
753218|NCT00443898|2404994|P2|Overall Study|Lack of Efficacy|3
753219|NCT00443898|2404995|P1|Overall Study|Lack of Efficacy|2
753220|NCT00443898|2404992|P4|Overall Study|Adverse Event|1
753221|NCT00443898|2404993|P3|Overall Study|Adverse Event|1
753222|NCT00443898|2404994|P2|Overall Study|Adverse Event|0
753223|NCT00443898|2404995|P1|Overall Study|Adverse Event|0
753224|NCT00444067|2405019|P2|Overall Study|Lost to Follow-up|1
753225|NCT00444067|2405020|P1|Overall Study|Lost to Follow-up|0
753226|NCT00444106|2405033|P3|Overall Study|Abnormal Test Procedure Results|1
753227|NCT00444106|2405034|P2|Overall Study|Abnormal Test Procedure Results|0
753228|NCT00444106|2405035|P1|Overall Study|Abnormal Test Procedure Results|0
753229|NCT00444106|2405033|P3|Overall Study|Lost to Follow-up|0
753230|NCT00444106|2405034|P2|Overall Study|Lost to Follow-up|1
753231|NCT00444106|2405035|P1|Overall Study|Lost to Follow-up|2
753232|NCT00444145|2405050|P1|Overall Study|Screen Failures|5
753233|NCT00444145|2405050|P1|Overall Study|non-compliant|11
753234|NCT00444145|2405050|P1|Overall Study|Lost to Follow-up|1
753235|NCT00444145|2405050|P1|Overall Study|Withdrawal by Subject|2
753236|NCT00446849|2405054|P1|Maintenance Phase|concomitant medication use|1
753237|NCT00446849|2405054|P1|Maintenance Phase|hydrocodone use|1
753238|NCT00446849|2405054|P1|Maintenance Phase|study closure|1
753239|NCT00446849|2405054|P1|Maintenance Phase|antibiotic use|1
753240|NCT00446849|2405054|P1|Maintenance Phase|prohibited medication use|2
753241|NCT00446849|2405054|P1|Maintenance Phase|noncompliance|2
753242|NCT00446849|2405054|P1|Maintenance Phase|Pregnancy|1
753243|NCT00446849|2405054|P1|Maintenance Phase|Lost to Follow-up|3
753244|NCT00446849|2405054|P1|Maintenance Phase|Consent withdrawn|5
753245|NCT00446849|2405054|P1|Maintenance Phase|Adverse Event|6
753246|NCT00446849|2405054|P1|Maintenance Phase|Protocol Violation|7
753247|NCT00446849|2405054|P1|Maintenance Phase|Lack of Efficacy|40
753248|NCT00446849|2405054|P1|Acute Phase|noncompliance|1
753249|NCT00446849|2405054|P1|Acute Phase|Physician Decision|1
753250|NCT00446849|2405054|P1|Acute Phase|Lost to Follow-up|2
753251|NCT00446849|2405054|P1|Acute Phase|Consent withdrawn|4
753252|NCT00446849|2405054|P1|Acute Phase|Protocol Violation|10
753253|NCT00446849|2405054|P1|Acute Phase|Lack of Efficacy|64
753254|NCT00446992|2405064|P1|Overall Study|Lost to Follow-up|5
753255|NCT00446992|2405064|P1|Overall Study|Adverse Event|11
753256|NCT00447005|2405076|P1|Overall Study|Lack of Efficacy|11
753257|NCT00447005|2405076|P1|Overall Study|Adverse Event|1
753258|NCT00447057|2405094|P4|Overall Study|Death, study drug related|0
753259|NCT00447057|2405095|P3|Overall Study|Death, study drug related|0
753260|NCT00447057|2405096|P2|Overall Study|Death, study drug related|1
753261|NCT00447057|2405097|P1|Overall Study|Death, study drug related|0
753262|NCT00447057|2405094|P4|Overall Study|Death due to adverse event|2
753263|NCT00447057|2405095|P3|Overall Study|Death due to adverse event|1
753264|NCT00447057|2405096|P2|Overall Study|Death due to adverse event|0
753265|NCT00447057|2405097|P1|Overall Study|Death due to adverse event|0
753266|NCT00447057|2405094|P4|Overall Study|Progressive disease|18
753267|NCT00447057|2405095|P3|Overall Study|Progressive disease|13
753268|NCT00447057|2405096|P2|Overall Study|Progressive disease|43
753269|NCT00447057|2405097|P1|Overall Study|Progressive disease|58
753270|NCT00447057|2405094|P4|Overall Study|Sponsor decision|0
753271|NCT00447057|2405095|P3|Overall Study|Sponsor decision|0
753272|NCT00447057|2405096|P2|Overall Study|Sponsor decision|1
753273|NCT00447057|2405097|P1|Overall Study|Sponsor decision|1
753274|NCT00447057|2405094|P4|Overall Study|Physician Decision|1
753275|NCT00447057|2405095|P3|Overall Study|Physician Decision|3
753276|NCT00447057|2405096|P2|Overall Study|Physician Decision|6
753277|NCT00447057|2405097|P1|Overall Study|Physician Decision|9
753278|NCT00447057|2405094|P4|Overall Study|Withdrawal by Subject|1
753279|NCT00447057|2405095|P3|Overall Study|Withdrawal by Subject|1
753280|NCT00447057|2405096|P2|Overall Study|Withdrawal by Subject|5
753281|NCT00447057|2405097|P1|Overall Study|Withdrawal by Subject|4
753282|NCT00447057|2405094|P4|Overall Study|Protocol Violation|0
753283|NCT00447057|2405095|P3|Overall Study|Protocol Violation|0
753284|NCT00447057|2405096|P2|Overall Study|Protocol Violation|1
753285|NCT00447057|2405097|P1|Overall Study|Protocol Violation|0
753286|NCT00447057|2405094|P4|Overall Study|Entry criteria not met|0
753287|NCT00447057|2405095|P3|Overall Study|Entry criteria not met|0
753288|NCT00447057|2405096|P2|Overall Study|Entry criteria not met|1
753289|NCT00447057|2405097|P1|Overall Study|Entry criteria not met|1
753290|NCT00447057|2405094|P4|Overall Study|Lost to Follow-up|0
753291|NCT00447057|2405095|P3|Overall Study|Lost to Follow-up|0
753292|NCT00447057|2405096|P2|Overall Study|Lost to Follow-up|1
753293|NCT00447057|2405097|P1|Overall Study|Lost to Follow-up|0
753294|NCT00447057|2405094|P4|Overall Study|Death due to study disease|1
753295|NCT00447057|2405095|P3|Overall Study|Death due to study disease|1
753296|NCT00447057|2405096|P2|Overall Study|Death due to study disease|4
753297|NCT00447057|2405097|P1|Overall Study|Death due to study disease|6
753298|NCT00447057|2405094|P4|Overall Study|Adverse Event|3
753299|NCT00447057|2405095|P3|Overall Study|Adverse Event|0
753300|NCT00447057|2405096|P2|Overall Study|Adverse Event|10
753301|NCT00447057|2405097|P1|Overall Study|Adverse Event|4
753302|NCT00447226|2405119|P2|Double-blind Phase|Disease Progression|3
753303|NCT00447226|2405120|P1|Double-blind Phase|Disease Progression|4
753304|NCT00447226|2405119|P2|12-Week Open-label Phase|Physician Decision|1
753305|NCT00447226|2405120|P1|12-Week Open-label Phase|Physician Decision|0
753306|NCT00447226|2405119|P2|12-Week Open-label Phase|Disease Progression|20
753307|NCT00447226|2405120|P1|12-Week Open-label Phase|Disease Progression|0
753308|NCT00447226|2405119|P2|12-Week Open-label Phase|Protocol Violation|1
753309|NCT00447226|2405120|P1|12-Week Open-label Phase|Protocol Violation|0
753310|NCT00447226|2405119|P2|12-Week Open-label Phase|Adverse Event|3
753311|NCT00447226|2405120|P1|12-Week Open-label Phase|Adverse Event|0
753312|NCT00447265|2405138|P2|Overall Study|Physician Decision|0
753313|NCT00447265|2405139|P1|Overall Study|Physician Decision|1
753314|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
753315|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
753316|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
753317|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
753318|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
753319|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
753320|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
753321|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
753322|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
753323|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
753324|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
753325|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
753326|NCT00447278|2405154|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
753327|NCT00447278|2405155|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
753328|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
753329|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
753330|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
753331|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
753332|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Physician Decision|1
753333|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Physician Decision|4
753334|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
753335|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
753336|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Protocol Violation|7
753337|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Protocol Violation|10
753338|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
753339|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
753340|NCT00447278|2405154|P2|Period II (6 Month Open-Label)|Adverse Event|3
753341|NCT00447278|2405155|P1|Period II (6 Month Open-Label)|Adverse Event|7
753342|NCT00447382|2405185|P2|Overall Study|Unclassified|5
753343|NCT00447382|2405186|P1|Overall Study|Unclassified|2
753344|NCT00447382|2405185|P2|Overall Study|Protocol Violation|0
753345|NCT00447382|2405186|P1|Overall Study|Protocol Violation|2
753346|NCT00447382|2405185|P2|Overall Study|Lack of Efficacy|0
753347|NCT00447382|2405186|P1|Overall Study|Lack of Efficacy|1
753348|NCT00447382|2405185|P2|Overall Study|Adverse Event|1
753349|NCT00447382|2405186|P1|Overall Study|Adverse Event|1
753350|NCT00447421|2405238|P1|Overall Study|Sponsor Decision|2
753351|NCT00447421|2405238|P1|Overall Study|Adverse Event|3
753352|NCT00447421|2405238|P1|Overall Study|Lack of Efficacy|1
753353|NCT00447499|2405248|P1|Overall Study|Physician Decision|1
753354|NCT00447499|2405248|P1|Overall Study|Sponsor Decision|1
753355|NCT00447499|2405248|P1|Overall Study|Patient Decision|4
753356|NCT00447499|2405248|P1|Overall Study|Adverse Event|1
753357|NCT00447590|2405258|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
753358|NCT00447590|2405258|P1|Overall Study|Lost to Follow-up|24
753359|NCT00447590|2405258|P1|Overall Study|Withdrawal by Subject|26
753360|NCT00447603|2405267|P3|Filter Period|Study terminated by Sponsor|10
753361|NCT00447603|2405268|P2|Filter Period|Study terminated by Sponsor|1
753362|NCT00447603|2405269|P1|Filter Period|Study terminated by Sponsor|0
753363|NCT00447603|2405267|P3|Filter Period|Screen Failure|4
753364|NCT00447603|2405268|P2|Filter Period|Screen Failure|3
753365|NCT00447603|2405269|P1|Filter Period|Screen Failure|0
753366|NCT00447603|2405267|P3|Filter Period|Adverse Event|1
753367|NCT00447603|2405268|P2|Filter Period|Adverse Event|0
753368|NCT00447603|2405269|P1|Filter Period|Adverse Event|0
753369|NCT00447603|2405267|P3|Screening|Study Terminated by Sponsor|0
753370|NCT00447603|2405268|P2|Screening|Study Terminated by Sponsor|0
753371|NCT00447603|2405269|P1|Screening|Study Terminated by Sponsor|15
753372|NCT00447603|2405267|P3|Screening|Screen Failure|0
753373|NCT00447603|2405268|P2|Screening|Screen Failure|0
753374|NCT00447603|2405269|P1|Screening|Screen Failure|4
753375|NCT00447603|2405267|P3|Screening|Protocol Violation|0
753376|NCT00447603|2405268|P2|Screening|Protocol Violation|0
753377|NCT00447603|2405269|P1|Screening|Protocol Violation|1
753378|NCT00447603|2405267|P3|Screening|Withdrawal by Subject|0
753379|NCT00447603|2405268|P2|Screening|Withdrawal by Subject|0
753380|NCT00447603|2405269|P1|Screening|Withdrawal by Subject|1
753381|NCT00447876|2405291|P2|Overall Study|Deterioration of symptomology|0
753382|NCT00447876|2405292|P1|Overall Study|Deterioration of symptomology|1
753383|NCT00447876|2405291|P2|Overall Study|Lost to Follow-up|0
753384|NCT00447876|2405292|P1|Overall Study|Lost to Follow-up|1
753385|NCT00447876|2405291|P2|Overall Study|Withdrawal by Subject|4
753386|NCT00447876|2405292|P1|Overall Study|Withdrawal by Subject|1
753387|NCT00447902|2405324|P2|Overall Study|Lack of Efficacy|1
753388|NCT00447902|2405325|P1|Overall Study|Lack of Efficacy|2
753389|NCT00447902|2405324|P2|Overall Study|included patients who discontinued|1
753390|NCT00447902|2405325|P1|Overall Study|included patients who discontinued|1
753391|NCT00447902|2405324|P2|Overall Study|Withdrawal by Subject|1
753392|NCT00447902|2405325|P1|Overall Study|Withdrawal by Subject|0
753393|NCT00447902|2405324|P2|Overall Study|Protocol Violation|0
753394|NCT00447902|2405325|P1|Overall Study|Protocol Violation|1
753395|NCT00447902|2405324|P2|Overall Study|Adverse Event|3
753396|NCT00447902|2405325|P1|Overall Study|Adverse Event|0
753397|NCT00448019|2405365|P1|Overall Study|Insurance Issues|1
753398|NCT00448019|2405365|P1|Overall Study|Death|2
753399|NCT00448019|2405365|P1|Overall Study|Disease progression|1
753400|NCT00448019|2405365|P1|Overall Study|Withdrawal by Subject|3
753401|NCT00448123|2405373|P2|Overall Study|Physician Decision|6
753402|NCT00448123|2405374|P1|Overall Study|Physician Decision|6
753403|NCT00448123|2405373|P2|Overall Study|Lost to Follow-up|6
753404|NCT00448123|2405374|P1|Overall Study|Lost to Follow-up|9
753405|NCT00448136|2405386|P2|Overall Study|Investigator's decision (progression)|0
753406|NCT00448136|2405387|P1|Overall Study|Investigator's decision (progression)|1
753407|NCT00448136|2405386|P2|Overall Study|Death|8
753408|NCT00448136|2405387|P1|Overall Study|Death|3
753409|NCT00448279|2405470|P2|Overall Study|Protocol Violation|1
753410|NCT00448279|2405471|P1|Overall Study|Protocol Violation|0
753411|NCT00448279|2405470|P2|Overall Study|Not specified|4
753412|NCT00448279|2405471|P1|Overall Study|Not specified|6
753413|NCT00448279|2405470|P2|Overall Study|Withdrawal by Subject|3
753414|NCT00448279|2405471|P1|Overall Study|Withdrawal by Subject|4
753415|NCT00448279|2405470|P2|Overall Study|Disease progression|18
753416|NCT00448279|2405471|P1|Overall Study|Disease progression|16
753417|NCT00448279|2405470|P2|Overall Study|Adverse Event|1
753418|NCT00448279|2405471|P1|Overall Study|Adverse Event|1
753419|NCT00448279|2405470|P2|Overall Study|Lost to Follow-up|2
753420|NCT00448279|2405471|P1|Overall Study|Lost to Follow-up|2
753421|NCT00448344|2405489|P2|Overall Study|Physician Decision|2
753422|NCT00448344|2405490|P1|Overall Study|Physician Decision|1
753423|NCT00448344|2405489|P2|Overall Study|Death|4
753424|NCT00448344|2405490|P1|Overall Study|Death|3
753425|NCT00448344|2405489|P2|Overall Study|Withdrawal by Subject|8
753426|NCT00448344|2405490|P1|Overall Study|Withdrawal by Subject|6
753427|NCT00448344|2405489|P2|Overall Study|Lost to Follow-up|22
753428|NCT00448344|2405490|P1|Overall Study|Lost to Follow-up|20
753429|NCT00448435|2405521|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
753430|NCT00448435|2405522|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
753431|NCT00448448|2405550|P2|Overall Study|Signed consent lost|1
753432|NCT00448448|2405551|P1|Overall Study|Signed consent lost|0
753433|NCT00448448|2405550|P2|Overall Study|Wrong diagnosis (n=3) or other|1
753434|NCT00448448|2405551|P1|Overall Study|Wrong diagnosis (n=3) or other|2
753435|NCT00448448|2405550|P2|Overall Study|Lost to Follow-up|1
753436|NCT00448448|2405551|P1|Overall Study|Lost to Follow-up|2
753437|NCT00448448|2405550|P2|Overall Study|On protocol when study ended|36
753438|NCT00448448|2405551|P1|Overall Study|On protocol when study ended|83
753439|NCT00448448|2405550|P2|Overall Study|Withdrawal by Subject|2
753440|NCT00448448|2405551|P1|Overall Study|Withdrawal by Subject|13
753441|NCT00448539|2405559|P2|Overall Study|Lost to Follow-up|3
753442|NCT00448539|2405560|P1|Overall Study|Lost to Follow-up|1
753443|NCT00448539|2405559|P2|Overall Study|Change of meds|3
753444|NCT00448539|2405560|P1|Overall Study|Change of meds|2
753445|NCT00448539|2405559|P2|Overall Study|Miscellaneous|1
753446|NCT00448539|2405560|P1|Overall Study|Miscellaneous|2
753447|NCT00448539|2405559|P2|Overall Study|Lack of Efficacy|40
753448|NCT00448539|2405560|P1|Overall Study|Lack of Efficacy|27
753449|NCT00448539|2405559|P2|Overall Study|Adverse Event|26
753450|NCT00448539|2405560|P1|Overall Study|Adverse Event|9
753451|NCT00448539|2405559|P2|Overall Study|Diary non-compliance|0
753452|NCT00448539|2405560|P1|Overall Study|Diary non-compliance|1
753453|NCT00448539|2405559|P2|Overall Study|Withdrawal by Subject|24
753454|NCT00448539|2405560|P1|Overall Study|Withdrawal by Subject|20
753455|NCT00448539|2405559|P2|Overall Study|Request of the investigator or sponsor|54
753456|NCT00448539|2405560|P1|Overall Study|Request of the investigator or sponsor|67
753457|NCT00448539|2405559|P2|Overall Study|Protocol Violation|0
753458|NCT00448539|2405560|P1|Overall Study|Protocol Violation|1
753459|NCT00448539|2405559|P2|Overall Study|Medication non-compliance|1
753460|NCT00448539|2405560|P1|Overall Study|Medication non-compliance|4
753461|NCT00448591|2405566|P1|Overall Study|Termination of Study|70
753462|NCT00448591|2405566|P1|Overall Study|Not specified|154
753463|NCT00448591|2405566|P1|Overall Study|Treatment Regimen Completed|70
753464|NCT00448591|2405566|P1|Overall Study|Lost to Follow-up|19
753465|NCT00448591|2405566|P1|Overall Study|Protocol Violation|41
753466|NCT00448591|2405566|P1|Overall Study|Adverse Event|382
753467|NCT00448591|2405566|P1|Overall Study|Progressive Disease|1382
753468|NCT00448591|2405566|P1|Overall Study|Withdrawal by Subject|178
753469|NCT00448708|2405628|P2|Overall Study|not listed|2
753470|NCT00448708|2405629|P1|Overall Study|not listed|0
753471|NCT00448708|2405628|P2|Overall Study|Lost to Follow-up|8
753472|NCT00448708|2405629|P1|Overall Study|Lost to Follow-up|6
753473|NCT00448708|2405628|P2|Overall Study|Withdrawal by Subject|4
753474|NCT00448708|2405629|P1|Overall Study|Withdrawal by Subject|8
753475|NCT00448708|2405628|P2|Overall Study|Death|17
753476|NCT00448708|2405629|P1|Overall Study|Death|21
753477|NCT00448760|2405637|P1|Overall Study|Death|3
753478|NCT00448864|2405647|P3|Overall Study|Protocol Violation|0
753479|NCT00448864|2405648|P2|Overall Study|Protocol Violation|2
753480|NCT00448864|2405649|P1|Overall Study|Protocol Violation|0
753481|NCT00448864|2405647|P3|Overall Study|Withdrawal by Subject|0
753482|NCT00448864|2405648|P2|Overall Study|Withdrawal by Subject|2
753483|NCT00448864|2405649|P1|Overall Study|Withdrawal by Subject|0
753484|NCT00448864|2405647|P3|Overall Study|Physician Decision|1
753485|NCT00448864|2405648|P2|Overall Study|Physician Decision|0
753486|NCT00448864|2405649|P1|Overall Study|Physician Decision|1
753487|NCT00448864|2405647|P3|Overall Study|Lost to Follow-up|0
753488|NCT00448864|2405648|P2|Overall Study|Lost to Follow-up|1
753489|NCT00448864|2405649|P1|Overall Study|Lost to Follow-up|3
753490|NCT00448864|2405647|P3|Overall Study|Death|0
753491|NCT00448864|2405648|P2|Overall Study|Death|0
753492|NCT00448864|2405649|P1|Overall Study|Death|1
753493|NCT00448916|2405669|P4|Overall Study|Protocol Violation|1
753494|NCT00448916|2405670|P3|Overall Study|Protocol Violation|0
753495|NCT00448916|2405671|P2|Overall Study|Protocol Violation|0
753496|NCT00448916|2405672|P1|Overall Study|Protocol Violation|0
753497|NCT00448916|2405669|P4|Overall Study|Lost to Follow-up|1
753498|NCT00448916|2405670|P3|Overall Study|Lost to Follow-up|0
753499|NCT00448916|2405671|P2|Overall Study|Lost to Follow-up|1
753500|NCT00448916|2405672|P1|Overall Study|Lost to Follow-up|0
753501|NCT00448916|2405669|P4|Overall Study|Not specified|0
753502|NCT00448916|2405670|P3|Overall Study|Not specified|0
753503|NCT00448916|2405671|P2|Overall Study|Not specified|0
753504|NCT00448916|2405672|P1|Overall Study|Not specified|1
753505|NCT00448916|2405669|P4|Overall Study|Withdrawal by Subject|1
753506|NCT00448916|2405670|P3|Overall Study|Withdrawal by Subject|1
753507|NCT00448916|2405671|P2|Overall Study|Withdrawal by Subject|3
753508|NCT00448916|2405672|P1|Overall Study|Withdrawal by Subject|3
753509|NCT00448916|2405669|P4|Overall Study|Lack of Efficacy|1
753510|NCT00448916|2405670|P3|Overall Study|Lack of Efficacy|2
753511|NCT00448916|2405671|P2|Overall Study|Lack of Efficacy|0
753512|NCT00448916|2405672|P1|Overall Study|Lack of Efficacy|1
753513|NCT00448916|2405669|P4|Overall Study|Adverse Event|2
753514|NCT00448916|2405670|P3|Overall Study|Adverse Event|3
753515|NCT00448916|2405671|P2|Overall Study|Adverse Event|2
753516|NCT00448916|2405672|P1|Overall Study|Adverse Event|2
753517|NCT00449033|2405745|P2|Follow-up Period|Reason Missing|113
753518|NCT00449033|2405746|P1|Follow-up Period|Reason Missing|120
753519|NCT00449033|2405745|P2|Follow-up Period|Lost to Follow-up|10
753520|NCT00449033|2405746|P1|Follow-up Period|Lost to Follow-up|6
753521|NCT00449033|2405745|P2|Follow-up Period|Death|311
753522|NCT00449033|2405746|P1|Follow-up Period|Death|299
753523|NCT00449033|2405745|P2|Treatment Period|Treatment Ongoing|4
753524|NCT00449033|2405746|P1|Treatment Period|Treatment Ongoing|6
753525|NCT00449033|2405745|P2|Treatment Period|Reason Missing|4
753526|NCT00449033|2405746|P1|Treatment Period|Reason Missing|0
753527|NCT00449033|2405745|P2|Treatment Period|Second Malignancy|1
753528|NCT00449033|2405746|P1|Treatment Period|Second Malignancy|0
753529|NCT00449033|2405745|P2|Treatment Period|Non-compliance|8
753530|NCT00449033|2405746|P1|Treatment Period|Non-compliance|7
753531|NCT00449033|2405745|P2|Treatment Period|Amended Protocol Criteria|18
753532|NCT00449033|2405746|P1|Treatment Period|Amended Protocol Criteria|22
753533|NCT00449033|2405745|P2|Treatment Period|Consent Withdrawn|20
753534|NCT00449033|2405746|P1|Treatment Period|Consent Withdrawn|36
753535|NCT00449033|2405745|P2|Treatment Period|Disease Progression|288
753536|NCT00449033|2405746|P1|Treatment Period|Disease Progression|231
753537|NCT00449033|2405745|P2|Treatment Period|Protocol Violation|7
753538|NCT00449033|2405746|P1|Treatment Period|Protocol Violation|8
753539|NCT00449033|2405745|P2|Treatment Period|Physician Decision|5
753540|NCT00449033|2405746|P1|Treatment Period|Physician Decision|4
753541|NCT00449033|2405745|P2|Treatment Period|Lost to Follow-up|2
753542|NCT00449033|2405746|P1|Treatment Period|Lost to Follow-up|0
753543|NCT00449033|2405745|P2|Treatment Period|Death|12
753544|NCT00449033|2405746|P1|Treatment Period|Death|21
753545|NCT00449033|2405745|P2|Treatment Period|Adverse Event|83
753546|NCT00449033|2405746|P1|Treatment Period|Adverse Event|117
753547|NCT00449072|2405793|P2|Overall Study|Relocation|2
753548|NCT00449072|2405794|P1|Overall Study|Relocation|3
753549|NCT00449072|2405793|P2|Overall Study|Sponsor decision|3
753550|NCT00449072|2405794|P1|Overall Study|Sponsor decision|1
753551|NCT00449072|2405793|P2|Overall Study|Non-compliance|5
753552|NCT00449072|2405794|P1|Overall Study|Non-compliance|2
753553|NCT00449072|2405793|P2|Overall Study|Excluded medication|2
753554|NCT00449072|2405794|P1|Overall Study|Excluded medication|0
753555|NCT00449072|2405793|P2|Overall Study|Not treated|1
753556|NCT00449072|2405794|P1|Overall Study|Not treated|0
753557|NCT00449072|2405793|P2|Overall Study|Physician Decision|0
753558|NCT00449072|2405794|P1|Overall Study|Physician Decision|1
753559|NCT00449072|2405793|P2|Overall Study|Lack of Efficacy|1
753560|NCT00449072|2405794|P1|Overall Study|Lack of Efficacy|1
753561|NCT00449072|2405793|P2|Overall Study|Withdrawal by Subject|8
753562|NCT00449072|2405794|P1|Overall Study|Withdrawal by Subject|11
753563|NCT00449072|2405793|P2|Overall Study|Lost to Follow-up|7
753564|NCT00449072|2405794|P1|Overall Study|Lost to Follow-up|5
753565|NCT00449072|2405793|P2|Overall Study|Protocol Violation|12
753566|NCT00449072|2405794|P1|Overall Study|Protocol Violation|14
753567|NCT00449072|2405793|P2|Overall Study|Adverse Event|1
753568|NCT00449072|2405794|P1|Overall Study|Adverse Event|3
753569|NCT00449150|2405821|P3|Overall Study|Protocol Violation|1
753570|NCT00449150|2405822|P2|Overall Study|Protocol Violation|2
753571|NCT00449150|2405823|P1|Overall Study|Protocol Violation|1
753572|NCT00449150|2405821|P3|Overall Study|Withdrawal by Subject|21
753573|NCT00449150|2405822|P2|Overall Study|Withdrawal by Subject|18
753574|NCT00449150|2405823|P1|Overall Study|Withdrawal by Subject|17
753575|NCT00449150|2405821|P3|Overall Study|Not specified|14
753576|NCT00449150|2405822|P2|Overall Study|Not specified|13
753577|NCT00449150|2405823|P1|Overall Study|Not specified|16
753578|NCT00449150|2405821|P3|Overall Study|Lack of Efficacy|2
753579|NCT00449150|2405822|P2|Overall Study|Lack of Efficacy|2
753580|NCT00449150|2405823|P1|Overall Study|Lack of Efficacy|1
753581|NCT00449150|2405821|P3|Overall Study|Adverse Event|9
753582|NCT00449150|2405822|P2|Overall Study|Adverse Event|18
753583|NCT00449150|2405823|P1|Overall Study|Adverse Event|11
753584|NCT00449163|2405831|P1|Overall Study|Physician Decision|3
753585|NCT00449176|2405841|P3|Overall Study|all other|20
753586|NCT00449176|2405842|P2|Overall Study|all other|19
753587|NCT00449176|2405843|P1|Overall Study|all other|22
753588|NCT00449176|2405841|P3|Overall Study|Study drug non-compliant|11
753589|NCT00449176|2405842|P2|Overall Study|Study drug non-compliant|11
753590|NCT00449176|2405843|P1|Overall Study|Study drug non-compliant|14
753591|NCT00449176|2405841|P3|Overall Study|Lack of Efficacy|50
753592|NCT00449176|2405842|P2|Overall Study|Lack of Efficacy|7
753593|NCT00449176|2405843|P1|Overall Study|Lack of Efficacy|13
753594|NCT00449176|2405841|P3|Overall Study|Adverse Event|15
753595|NCT00449176|2405842|P2|Overall Study|Adverse Event|107
753596|NCT00449176|2405843|P1|Overall Study|Adverse Event|51
753597|NCT00449176|2405841|P3|Overall Study|Lost to Follow-up|12
753598|NCT00449176|2405842|P2|Overall Study|Lost to Follow-up|8
753599|NCT00449176|2405843|P1|Overall Study|Lost to Follow-up|13
753600|NCT00449176|2405841|P3|Overall Study|Withdrawal by Subject|59
753601|NCT00449176|2405842|P2|Overall Study|Withdrawal by Subject|43
753602|NCT00449176|2405843|P1|Overall Study|Withdrawal by Subject|39
753603|NCT00440557|2405872|P3|Overall Study|Patient had surgery|0
753604|NCT00440557|2405873|P2|Overall Study|Patient had surgery|0
753605|NCT00440557|2405874|P1|Overall Study|Patient had surgery|1
753606|NCT00440557|2405872|P3|Overall Study|Patient transferred to nursing home|0
753607|NCT00440557|2405873|P2|Overall Study|Patient transferred to nursing home|1
753608|NCT00440557|2405874|P1|Overall Study|Patient transferred to nursing home|0
753609|NCT00440557|2405872|P3|Overall Study|Principal Investigator's office closed|4
753610|NCT00440557|2405873|P2|Overall Study|Principal Investigator's office closed|6
753611|NCT00440557|2405874|P1|Overall Study|Principal Investigator's office closed|3
753612|NCT00440557|2405872|P3|Overall Study|Patient moved|1
753613|NCT00440557|2405873|P2|Overall Study|Patient moved|2
753614|NCT00440557|2405874|P1|Overall Study|Patient moved|1
753615|NCT00440557|2405872|P3|Overall Study|Principal Investigator decision|1
753616|NCT00440557|2405873|P2|Overall Study|Principal Investigator decision|3
753617|NCT00440557|2405874|P1|Overall Study|Principal Investigator decision|0
753618|NCT00440557|2405872|P3|Overall Study|Began Dialysis|4
753619|NCT00440557|2405873|P2|Overall Study|Began Dialysis|1
753620|NCT00440557|2405874|P1|Overall Study|Began Dialysis|4
753621|NCT00440557|2405872|P3|Overall Study|Death|3
753622|NCT00440557|2405873|P2|Overall Study|Death|6
753623|NCT00440557|2405874|P1|Overall Study|Death|2
753624|NCT00440557|2405872|P3|Overall Study|Adverse Event|5
753625|NCT00440557|2405873|P2|Overall Study|Adverse Event|3
753626|NCT00440557|2405874|P1|Overall Study|Adverse Event|3
753627|NCT00440557|2405872|P3|Overall Study|Lost to Follow-up|6
753628|NCT00440557|2405873|P2|Overall Study|Lost to Follow-up|2
753629|NCT00440557|2405874|P1|Overall Study|Lost to Follow-up|1
753630|NCT00440557|2405872|P3|Overall Study|Withdrawal by Subject|11
753631|NCT00440557|2405873|P2|Overall Study|Withdrawal by Subject|5
753632|NCT00440557|2405874|P1|Overall Study|Withdrawal by Subject|10
753633|NCT00440700|2405906|P3|Overall Study|Withdrawal by Subject|4
753634|NCT00440700|2405907|P2|Overall Study|Withdrawal by Subject|8
753635|NCT00440700|2405908|P1|Overall Study|Withdrawal by Subject|8
753636|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
753637|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
753638|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
753639|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
753640|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
753641|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Physician Decision|1
753642|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Physician Decision|0
753643|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Physician Decision|0
753644|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Physician Decision|0
753645|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Physician Decision|0
753646|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Other|0
753647|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Other|1
753648|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Other|0
753649|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Other|0
753650|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Other|0
753651|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
753652|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
753653|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
753654|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
753655|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
753656|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Sponsor Request|1
753657|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Sponsor Request|1
753658|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Sponsor Request|0
753659|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Sponsor Request|0
753660|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Sponsor Request|0
753661|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Participant Moved|1
753662|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Participant Moved|1
753663|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Participant Moved|0
753664|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Participant Moved|0
753665|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Participant Moved|0
753666|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Pregnancy|0
753667|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Pregnancy|3
753668|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Pregnancy|0
753669|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Pregnancy|0
753670|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Pregnancy|0
753671|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
753672|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
753673|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
753674|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
753675|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
753676|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Protocol Violation|0
753677|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Protocol Violation|1
753678|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Protocol Violation|0
753679|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Protocol Violation|0
753680|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Protocol Violation|0
753681|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
753682|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
753683|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
753684|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
753685|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
753686|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Non-compliance|1
753687|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Non-compliance|1
753688|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Non-compliance|0
753689|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Non-compliance|0
753690|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Non-compliance|0
753691|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
753692|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
753693|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
753694|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
753695|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
753696|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
753697|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
753698|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
753699|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
753700|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
753701|NCT00440947|2405949|P5|Optional 60-Week Extension Phase|Adverse Event|3
753702|NCT00440947|2405950|P4|Optional 60-Week Extension Phase|Adverse Event|1
753703|NCT00440947|2405951|P3|Optional 60-Week Extension Phase|Adverse Event|0
753704|NCT00440947|2405952|P2|Optional 60-Week Extension Phase|Adverse Event|0
753705|NCT00440947|2405953|P1|Optional 60-Week Extension Phase|Adverse Event|0
753706|NCT00440947|2405949|P5|48-Week Randomization Phase|Physician Decision|0
753707|NCT00440947|2405950|P4|48-Week Randomization Phase|Physician Decision|0
753708|NCT00440947|2405951|P3|48-Week Randomization Phase|Physician Decision|0
753709|NCT00440947|2405952|P2|48-Week Randomization Phase|Physician Decision|2
753710|NCT00440947|2405953|P1|48-Week Randomization Phase|Physician Decision|0
753711|NCT00440947|2405949|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
753712|NCT00440947|2405950|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
753713|NCT00440947|2405951|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
753714|NCT00440947|2405952|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
753715|NCT00440947|2405953|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
753716|NCT00440947|2405949|P5|48-Week Randomization Phase|Incarceration|0
753717|NCT00440947|2405950|P4|48-Week Randomization Phase|Incarceration|0
753718|NCT00440947|2405951|P3|48-Week Randomization Phase|Incarceration|0
753719|NCT00440947|2405952|P2|48-Week Randomization Phase|Incarceration|3
753720|NCT00440947|2405953|P1|48-Week Randomization Phase|Incarceration|0
753721|NCT00440947|2405949|P5|48-Week Randomization Phase|Pregnancy|0
753722|NCT00440947|2405950|P4|48-Week Randomization Phase|Pregnancy|0
753723|NCT00440947|2405951|P3|48-Week Randomization Phase|Pregnancy|1
753724|NCT00440947|2405952|P2|48-Week Randomization Phase|Pregnancy|0
753725|NCT00440947|2405953|P1|48-Week Randomization Phase|Pregnancy|0
753726|NCT00440947|2405949|P5|48-Week Randomization Phase|Withdrawal by Subject|0
753727|NCT00440947|2405950|P4|48-Week Randomization Phase|Withdrawal by Subject|0
753728|NCT00440947|2405951|P3|48-Week Randomization Phase|Withdrawal by Subject|4
753729|NCT00440947|2405952|P2|48-Week Randomization Phase|Withdrawal by Subject|2
753730|NCT00440947|2405953|P1|48-Week Randomization Phase|Withdrawal by Subject|0
753731|NCT00440947|2405949|P5|48-Week Randomization Phase|Protocol Violation|0
753732|NCT00440947|2405950|P4|48-Week Randomization Phase|Protocol Violation|0
753733|NCT00440947|2405951|P3|48-Week Randomization Phase|Protocol Violation|1
753734|NCT00440947|2405952|P2|48-Week Randomization Phase|Protocol Violation|0
753735|NCT00440947|2405953|P1|48-Week Randomization Phase|Protocol Violation|0
753736|NCT00440947|2405949|P5|48-Week Randomization Phase|Lost to Follow-up|0
753737|NCT00440947|2405950|P4|48-Week Randomization Phase|Lost to Follow-up|0
753738|NCT00440947|2405951|P3|48-Week Randomization Phase|Lost to Follow-up|8
753739|NCT00440947|2405952|P2|48-Week Randomization Phase|Lost to Follow-up|2
753740|NCT00440947|2405953|P1|48-Week Randomization Phase|Lost to Follow-up|0
753741|NCT00440947|2405949|P5|48-Week Randomization Phase|Non-compliance|0
753742|NCT00440947|2405950|P4|48-Week Randomization Phase|Non-compliance|0
753743|NCT00440947|2405951|P3|48-Week Randomization Phase|Non-compliance|4
753744|NCT00440947|2405952|P2|48-Week Randomization Phase|Non-compliance|3
753745|NCT00440947|2405953|P1|48-Week Randomization Phase|Non-compliance|0
753746|NCT00440947|2405949|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
753747|NCT00440947|2405950|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
753748|NCT00440947|2405951|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
753749|NCT00440947|2405952|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
753750|NCT00440947|2405953|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
753751|NCT00440947|2405949|P5|48-Week Randomization Phase|Adverse Event|0
753752|NCT00440947|2405950|P4|48-Week Randomization Phase|Adverse Event|0
753753|NCT00440947|2405951|P3|48-Week Randomization Phase|Adverse Event|5
753754|NCT00440947|2405952|P2|48-Week Randomization Phase|Adverse Event|2
753755|NCT00440947|2405953|P1|48-Week Randomization Phase|Adverse Event|0
753756|NCT00440947|2405949|P5|36-Week Induction Phase|Pregnancy|0
753757|NCT00440947|2405950|P4|36-Week Induction Phase|Pregnancy|0
753758|NCT00440947|2405951|P3|36-Week Induction Phase|Pregnancy|0
753759|NCT00440947|2405952|P2|36-Week Induction Phase|Pregnancy|0
753760|NCT00440947|2405953|P1|36-Week Induction Phase|Pregnancy|1
753761|NCT00440947|2405949|P5|36-Week Induction Phase|Incarceration|0
753762|NCT00440947|2405950|P4|36-Week Induction Phase|Incarceration|0
753763|NCT00440947|2405951|P3|36-Week Induction Phase|Incarceration|0
753764|NCT00440947|2405952|P2|36-Week Induction Phase|Incarceration|0
753765|NCT00440947|2405953|P1|36-Week Induction Phase|Incarceration|3
753766|NCT00440947|2405949|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
753767|NCT00440947|2405950|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
753768|NCT00440947|2405951|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
753769|NCT00440947|2405952|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
753770|NCT00440947|2405953|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
753771|NCT00440947|2405949|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
753772|NCT00440947|2405950|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
753773|NCT00440947|2405951|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
753774|NCT00440947|2405952|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
753775|NCT00440947|2405953|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
753776|NCT00440947|2405949|P5|36-Week Induction Phase|Took Exclusionary Medications|0
753777|NCT00440947|2405950|P4|36-Week Induction Phase|Took Exclusionary Medications|0
753778|NCT00440947|2405951|P3|36-Week Induction Phase|Took Exclusionary Medications|0
753779|NCT00440947|2405952|P2|36-Week Induction Phase|Took Exclusionary Medications|0
753780|NCT00440947|2405953|P1|36-Week Induction Phase|Took Exclusionary Medications|1
753781|NCT00440947|2405949|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
753782|NCT00440947|2405950|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
753783|NCT00440947|2405951|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
753784|NCT00440947|2405952|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
753785|NCT00440947|2405953|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
753786|NCT00440947|2405949|P5|36-Week Induction Phase|Withdrawal by Subject|0
753787|NCT00440947|2405950|P4|36-Week Induction Phase|Withdrawal by Subject|0
753788|NCT00440947|2405951|P3|36-Week Induction Phase|Withdrawal by Subject|0
753789|NCT00440947|2405952|P2|36-Week Induction Phase|Withdrawal by Subject|0
753790|NCT00440947|2405953|P1|36-Week Induction Phase|Withdrawal by Subject|7
753791|NCT00440947|2405949|P5|36-Week Induction Phase|Lost to Follow-up|0
753792|NCT00440947|2405950|P4|36-Week Induction Phase|Lost to Follow-up|0
753793|NCT00440947|2405951|P3|36-Week Induction Phase|Lost to Follow-up|0
753794|NCT00440947|2405952|P2|36-Week Induction Phase|Lost to Follow-up|0
753795|NCT00440947|2405953|P1|36-Week Induction Phase|Lost to Follow-up|16
753796|NCT00440947|2405949|P5|36-Week Induction Phase|Non-compliance|0
753797|NCT00440947|2405950|P4|36-Week Induction Phase|Non-compliance|0
753798|NCT00440947|2405951|P3|36-Week Induction Phase|Non-compliance|0
753799|NCT00440947|2405952|P2|36-Week Induction Phase|Non-compliance|0
753800|NCT00440947|2405953|P1|36-Week Induction Phase|Non-compliance|10
753801|NCT00440947|2405949|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
753802|NCT00440947|2405950|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
753803|NCT00440947|2405951|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
753804|NCT00440947|2405952|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
753805|NCT00440947|2405953|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
753806|NCT00440947|2405949|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
753807|NCT00440947|2405950|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
753808|NCT00440947|2405951|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
753809|NCT00440947|2405952|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
753810|NCT00440947|2405953|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
753811|NCT00440947|2405949|P5|36-Week Induction Phase|Adverse Event|0
753812|NCT00440947|2405950|P4|36-Week Induction Phase|Adverse Event|0
753813|NCT00440947|2405951|P3|36-Week Induction Phase|Adverse Event|0
753814|NCT00440947|2405952|P2|36-Week Induction Phase|Adverse Event|0
753815|NCT00440947|2405953|P1|36-Week Induction Phase|Adverse Event|16
753816|NCT00441012|2406006|P2|Overall Study|Subject Randomized but Not Vaccinated|0
753817|NCT00441012|2406007|P1|Overall Study|Subject Randomized but Not Vaccinated|1
753818|NCT00441012|2406006|P2|Overall Study|Withdrawal by Subject|0
753819|NCT00441012|2406007|P1|Overall Study|Withdrawal by Subject|4
753820|NCT00441012|2406006|P2|Overall Study|Protocol Violation|9
753821|NCT00441012|2406007|P1|Overall Study|Protocol Violation|10
753822|NCT00441012|2406006|P2|Overall Study|Lost to Follow-up|3
753823|NCT00441012|2406007|P1|Overall Study|Lost to Follow-up|3
753824|NCT00441012|2406006|P2|Overall Study|Adverse Event|1
753825|NCT00441012|2406007|P1|Overall Study|Adverse Event|0
753826|NCT00441064|2406023|P2|Overall Study|Patient withdrew consent|2
753827|NCT00441064|2406024|P1|Overall Study|Patient withdrew consent|5
753828|NCT00441064|2406023|P2|Overall Study|Protocol Deviation|2
753829|NCT00441064|2406024|P1|Overall Study|Protocol Deviation|3
753830|NCT00441064|2406023|P2|Overall Study|Unsatisfactory therapeutic effect|0
753831|NCT00441064|2406024|P1|Overall Study|Unsatisfactory therapeutic effect|1
753832|NCT00441064|2406023|P2|Overall Study|Abnormal test procedure results|1
753833|NCT00441064|2406024|P1|Overall Study|Abnormal test procedure results|0
753834|NCT00441064|2406023|P2|Overall Study|Abnormal laboratory values|2
753835|NCT00441064|2406024|P1|Overall Study|Abnormal laboratory values|0
753836|NCT00441064|2406023|P2|Overall Study|Adverse Event|0
753837|NCT00441064|2406024|P1|Overall Study|Adverse Event|1
753838|NCT00441103|2406036|P2|Overall Study|Participant decided to stop|1
753839|NCT00441103|2406037|P1|Overall Study|Participant decided to stop|0
753840|NCT00441103|2406036|P2|Overall Study|Participant's reason|1
753841|NCT00441103|2406037|P1|Overall Study|Participant's reason|0
753842|NCT00441103|2406036|P2|Overall Study|Participant decided to withdraw|0
753843|NCT00441103|2406037|P1|Overall Study|Participant decided to withdraw|1
753844|NCT00441103|2406036|P2|Overall Study|Non-compliant|1
753845|NCT00441103|2406037|P1|Overall Study|Non-compliant|0
753846|NCT00441103|2406036|P2|Overall Study|Inclusion criteria absent|0
753847|NCT00441103|2406037|P1|Overall Study|Inclusion criteria absent|1
753848|NCT00441103|2406036|P2|Overall Study|Participant refused MRI|0
753849|NCT00441103|2406037|P1|Overall Study|Participant refused MRI|1
753850|NCT00441103|2406036|P2|Overall Study|Participant unable to use Rebiject II|0
753851|NCT00441103|2406037|P1|Overall Study|Participant unable to use Rebiject II|1
753852|NCT00441103|2406036|P2|Overall Study|Protocol Violation|0
753853|NCT00441103|2406037|P1|Overall Study|Protocol Violation|1
753854|NCT00441103|2406036|P2|Overall Study|Lost to Follow-up|0
753855|NCT00441103|2406037|P1|Overall Study|Lost to Follow-up|1
753856|NCT00441103|2406036|P2|Overall Study|Disease Progression|0
753857|NCT00441103|2406037|P1|Overall Study|Disease Progression|2
753858|NCT00441103|2406036|P2|Overall Study|Death|0
753859|NCT00441103|2406037|P1|Overall Study|Death|1
753860|NCT00441103|2406036|P2|Overall Study|Adverse Event|1
753861|NCT00441103|2406037|P1|Overall Study|Adverse Event|2
753862|NCT00441116|2406050|P2|Overall Study|Did not meet Eligibility Criteria|1
753863|NCT00441116|2406051|P1|Overall Study|Did not meet Eligibility Criteria|1
753864|NCT00441116|2406050|P2|Overall Study|Withdrawal by Subject|0
753865|NCT00441116|2406051|P1|Overall Study|Withdrawal by Subject|1
753866|NCT00441116|2406050|P2|Overall Study|Adverse Event|1
753867|NCT00441116|2406051|P1|Overall Study|Adverse Event|1
753892|NCT00441168|2406142|P2|Follow-up Period|Other|3
753893|NCT00441168|2406143|P1|Follow-up Period|Other|1
753894|NCT00441168|2406142|P2|Follow-up Period|Withdrawal by Subject|0
753895|NCT00441168|2406143|P1|Follow-up Period|Withdrawal by Subject|3
753896|NCT00441168|2406142|P2|Follow-up Period|Lost to Follow-up|6
753897|NCT00441168|2406143|P1|Follow-up Period|Lost to Follow-up|5
753898|NCT00441168|2406142|P2|Follow-up Period|Death|0
753899|NCT00441168|2406143|P1|Follow-up Period|Death|3
753900|NCT00441168|2406142|P2|Treatment Period|refractory disease|0
753901|NCT00441168|2406143|P1|Treatment Period|refractory disease|1
753902|NCT00441168|2406142|P2|Treatment Period|qualified for stem-cell transplantation|0
753903|NCT00441168|2406143|P1|Treatment Period|qualified for stem-cell transplantation|3
753904|NCT00441168|2406142|P2|Treatment Period|Withdrawal by Subject|0
753905|NCT00441168|2406143|P1|Treatment Period|Withdrawal by Subject|3
753906|NCT00441168|2406142|P2|Treatment Period|Lost to Follow-up|1
753907|NCT00441168|2406143|P1|Treatment Period|Lost to Follow-up|0
753908|NCT00441168|2406142|P2|Treatment Period|Protocol Violation|1
753909|NCT00441168|2406143|P1|Treatment Period|Protocol Violation|0
753910|NCT00441168|2406142|P2|Treatment Period|Progressive Disease|2
753911|NCT00441168|2406143|P1|Treatment Period|Progressive Disease|0
753912|NCT00441168|2406142|P2|Treatment Period|Adverse Event|2
753913|NCT00441168|2406143|P1|Treatment Period|Adverse Event|1
753914|NCT00441168|2406142|P2|Treatment Period|Death|0
753915|NCT00441168|2406143|P1|Treatment Period|Death|3
753916|NCT00441272|2406174|P2|Overall Study|Study terminated prior to enrollment|25
753917|NCT00441272|2406175|P1|Overall Study|Study terminated prior to enrollment|25
753918|NCT00441337|2406218|P4|Overall Study|Did not meet inclusion criteria|0
753919|NCT00441337|2406219|P3|Overall Study|Did not meet inclusion criteria|1
753920|NCT00441337|2406220|P2|Overall Study|Did not meet inclusion criteria|0
753921|NCT00441337|2406221|P1|Overall Study|Did not meet inclusion criteria|0
753922|NCT00441337|2406218|P4|Overall Study|Sponsor Decision|2
753923|NCT00441337|2406219|P3|Overall Study|Sponsor Decision|1
753924|NCT00441337|2406220|P2|Overall Study|Sponsor Decision|0
753925|NCT00441337|2406221|P1|Overall Study|Sponsor Decision|0
753926|NCT00441337|2406218|P4|Overall Study|Lost to Follow-up|1
753927|NCT00441337|2406219|P3|Overall Study|Lost to Follow-up|0
753928|NCT00441337|2406220|P2|Overall Study|Lost to Follow-up|0
753929|NCT00441337|2406221|P1|Overall Study|Lost to Follow-up|0
753930|NCT00441337|2406218|P4|Overall Study|Disease Progression|18
753931|NCT00441337|2406219|P3|Overall Study|Disease Progression|4
753932|NCT00441337|2406220|P2|Overall Study|Disease Progression|6
753933|NCT00441337|2406221|P1|Overall Study|Disease Progression|6
753934|NCT00441363|2406301|P2|Overall Study|not specified|0
753935|NCT00441363|2406302|P1|Overall Study|not specified|2
753936|NCT00441363|2406301|P2|Overall Study|Lost to Follow-up|2
753937|NCT00441363|2406302|P1|Overall Study|Lost to Follow-up|2
753938|NCT00441363|2406301|P2|Overall Study|Physician Decision|7
753939|NCT00441363|2406302|P1|Overall Study|Physician Decision|6
753940|NCT00441363|2406301|P2|Overall Study|Withdrawal by Subject|4
753941|NCT00441363|2406302|P1|Overall Study|Withdrawal by Subject|3
753942|NCT00441363|2406301|P2|Overall Study|Adverse Event|2
753943|NCT00441363|2406302|P1|Overall Study|Adverse Event|4
753944|NCT00449540|2406312|P3|Treatment Phase|did not experience or treat migraine|17
753945|NCT00449540|2406313|P2|Treatment Phase|did not experience or treat migraine|20
753946|NCT00449540|2406314|P1|Treatment Phase|did not experience or treat migraine|0
753947|NCT00449540|2406312|P3|Pretreatment Phase|No migraine experienced|0
753948|NCT00449540|2406313|P2|Pretreatment Phase|No migraine experienced|0
753949|NCT00449540|2406314|P1|Pretreatment Phase|No migraine experienced|66
753950|NCT00449644|2406332|P4|Overall Study|Rolled-over to treatment with TMC207|1
753951|NCT00449644|2406333|P3|Overall Study|Rolled-over to treatment with TMC207|0
753952|NCT00449644|2406334|P2|Overall Study|Rolled-over to treatment with TMC207|0
753953|NCT00449644|2406335|P1|Overall Study|Rolled-over to treatment with TMC207|0
753954|NCT00449644|2406332|P4|Overall Study|Not specified|0
753955|NCT00449644|2406333|P3|Overall Study|Not specified|1
753956|NCT00449644|2406334|P2|Overall Study|Not specified|4
753957|NCT00449644|2406335|P1|Overall Study|Not specified|1
753958|NCT00449644|2406332|P4|Overall Study|Inclusion/exclusion criteria not met|6
753959|NCT00449644|2406333|P3|Overall Study|Inclusion/exclusion criteria not met|2
753960|NCT00449644|2406334|P2|Overall Study|Inclusion/exclusion criteria not met|0
753961|NCT00449644|2406335|P1|Overall Study|Inclusion/exclusion criteria not met|0
753962|NCT00449644|2406332|P4|Overall Study|Withdrawal by Subject|7
753963|NCT00449644|2406333|P3|Overall Study|Withdrawal by Subject|6
753964|NCT00449644|2406334|P2|Overall Study|Withdrawal by Subject|4
753965|NCT00449644|2406335|P1|Overall Study|Withdrawal by Subject|3
753966|NCT00449644|2406332|P4|Overall Study|Protocol Violation|7
753967|NCT00449644|2406333|P3|Overall Study|Protocol Violation|3
753968|NCT00449644|2406334|P2|Overall Study|Protocol Violation|4
753969|NCT00449644|2406335|P1|Overall Study|Protocol Violation|4
753970|NCT00449644|2406332|P4|Overall Study|Pregnancy|2
753971|NCT00449644|2406333|P3|Overall Study|Pregnancy|3
753972|NCT00449644|2406334|P2|Overall Study|Pregnancy|0
753973|NCT00449644|2406335|P1|Overall Study|Pregnancy|0
753974|NCT00449644|2406332|P4|Overall Study|Lost to Follow-up|3
753975|NCT00449644|2406333|P3|Overall Study|Lost to Follow-up|5
753976|NCT00449644|2406334|P2|Overall Study|Lost to Follow-up|1
753977|NCT00449644|2406335|P1|Overall Study|Lost to Follow-up|1
753978|NCT00449644|2406332|P4|Overall Study|Death|1
753979|NCT00449644|2406333|P3|Overall Study|Death|6
753980|NCT00449644|2406334|P2|Overall Study|Death|0
753981|NCT00449644|2406335|P1|Overall Study|Death|1
753982|NCT00449644|2406332|P4|Overall Study|Adverse Event|5
753983|NCT00449644|2406333|P3|Overall Study|Adverse Event|3
753984|NCT00449644|2406334|P2|Overall Study|Adverse Event|0
753985|NCT00449644|2406335|P1|Overall Study|Adverse Event|0
753986|NCT00449696|2406355|P2|Overall Study|Others|0
753987|NCT00449696|2406356|P1|Overall Study|Others|7
753988|NCT00449696|2406355|P2|Overall Study|Lost to Follow-up|3
753989|NCT00449696|2406356|P1|Overall Study|Lost to Follow-up|2
753990|NCT00449696|2406355|P2|Overall Study|Withdrawal by Subject|5
753991|NCT00449696|2406356|P1|Overall Study|Withdrawal by Subject|5
753992|NCT00449696|2406355|P2|Overall Study|Other Treatment Required|1
753993|NCT00449696|2406356|P1|Overall Study|Other Treatment Required|6
753994|NCT00452673|2406382|P5|Dose Expansion Period|not specified|2
753995|NCT00452673|2406383|P4|Dose Expansion Period|not specified|0
753996|NCT00452673|2406384|P3|Dose Expansion Period|not specified|0
753997|NCT00452673|2406385|P2|Dose Expansion Period|not specified|0
753998|NCT00452673|2406386|P1|Dose Expansion Period|not specified|0
753999|NCT00452673|2406382|P5|Dose Expansion Period|Disease Progression|19
754000|NCT00452673|2406383|P4|Dose Expansion Period|Disease Progression|0
754001|NCT00452673|2406384|P3|Dose Expansion Period|Disease Progression|0
754002|NCT00452673|2406385|P2|Dose Expansion Period|Disease Progression|0
754003|NCT00452673|2406386|P1|Dose Expansion Period|Disease Progression|0
754004|NCT00452673|2406382|P5|Dose Escalation Period|Withdrawal by Subject|0
754005|NCT00452673|2406383|P4|Dose Escalation Period|Withdrawal by Subject|1
754006|NCT00452673|2406384|P3|Dose Escalation Period|Withdrawal by Subject|0
754007|NCT00452673|2406385|P2|Dose Escalation Period|Withdrawal by Subject|0
754008|NCT00452673|2406386|P1|Dose Escalation Period|Withdrawal by Subject|0
754009|NCT00452673|2406382|P5|Dose Escalation Period|Adverse Event|0
754010|NCT00452673|2406383|P4|Dose Escalation Period|Adverse Event|1
754011|NCT00452673|2406384|P3|Dose Escalation Period|Adverse Event|0
754012|NCT00452673|2406385|P2|Dose Escalation Period|Adverse Event|0
754013|NCT00452673|2406386|P1|Dose Escalation Period|Adverse Event|0
754014|NCT00452673|2406382|P5|Dose Escalation Period|not specified|0
754015|NCT00452673|2406383|P4|Dose Escalation Period|not specified|0
754016|NCT00452673|2406384|P3|Dose Escalation Period|not specified|1
754017|NCT00452673|2406385|P2|Dose Escalation Period|not specified|0
754018|NCT00452673|2406386|P1|Dose Escalation Period|not specified|0
754019|NCT00452673|2406382|P5|Dose Escalation Period|study drug toxicity|0
754020|NCT00452673|2406383|P4|Dose Escalation Period|study drug toxicity|1
754021|NCT00452673|2406384|P3|Dose Escalation Period|study drug toxicity|3
754022|NCT00452673|2406385|P2|Dose Escalation Period|study drug toxicity|3
754023|NCT00452673|2406386|P1|Dose Escalation Period|study drug toxicity|1
754024|NCT00452673|2406382|P5|Dose Escalation Period|Disease Progression|0
754025|NCT00452673|2406383|P4|Dose Escalation Period|Disease Progression|6
754026|NCT00452673|2406384|P3|Dose Escalation Period|Disease Progression|2
754027|NCT00452673|2406385|P2|Dose Escalation Period|Disease Progression|6
754028|NCT00452673|2406386|P1|Dose Escalation Period|Disease Progression|6
754029|NCT00452699|2406418|P2|Overall Study|Other|7
754030|NCT00452699|2406419|P1|Overall Study|Other|12
754031|NCT00452699|2406418|P2|Overall Study|Withdrawal by Subject|25
754032|NCT00452699|2406419|P1|Overall Study|Withdrawal by Subject|26
754033|NCT00452699|2406418|P2|Overall Study|Protocol Violation|25
754034|NCT00452699|2406419|P1|Overall Study|Protocol Violation|21
754035|NCT00452699|2406418|P2|Overall Study|Lost to Follow-up|9
754036|NCT00452699|2406419|P1|Overall Study|Lost to Follow-up|6
754037|NCT00452699|2406418|P2|Overall Study|Lack of Efficacy|4
754038|NCT00452699|2406419|P1|Overall Study|Lack of Efficacy|6
754039|NCT00452699|2406418|P2|Overall Study|Adverse Event|3
754040|NCT00452699|2406419|P1|Overall Study|Adverse Event|10
754041|NCT00452790|2406433|P2|Toddler Dose|Parent/legal guardian request|1
754042|NCT00452790|2406434|P1|Toddler Dose|Parent/legal guardian request|0
754043|NCT00452790|2406433|P2|Toddler Dose|Failed to return|1
754044|NCT00452790|2406434|P1|Toddler Dose|Failed to return|0
754045|NCT00452790|2406433|P2|After Infant Series|Other reasons|0
754046|NCT00452790|2406434|P1|After Infant Series|Other reasons|1
754047|NCT00452790|2406433|P2|After Infant Series|Failed to return|0
754048|NCT00452790|2406434|P1|After Infant Series|Failed to return|1
754049|NCT00452790|2406433|P2|After Infant Series|Lost to Follow-up|0
754050|NCT00452790|2406434|P1|After Infant Series|Lost to Follow-up|4
754051|NCT00452790|2406433|P2|After Infant Series|Parent/legal guardian request|3
754052|NCT00452790|2406434|P1|After Infant Series|Parent/legal guardian request|1
754053|NCT00452790|2406433|P2|After Infant Series|Adverse Event|1
754054|NCT00452790|2406434|P1|After Infant Series|Adverse Event|4
754055|NCT00452790|2406433|P2|After Infant Series|Investigator request|10
754056|NCT00452790|2406434|P1|After Infant Series|Investigator request|10
754057|NCT00452790|2406433|P2|Infant Series|Death|1
754058|NCT00452790|2406434|P1|Infant Series|Death|0
754059|NCT00452790|2406433|P2|Infant Series|Investigator request|1
754060|NCT00452790|2406434|P1|Infant Series|Investigator request|0
754061|NCT00452790|2406433|P2|Infant Series|Other reasons|2
754062|NCT00452790|2406434|P1|Infant Series|Other reasons|1
754063|NCT00452790|2406433|P2|Infant Series|Adverse Event|2
754064|NCT00452790|2406434|P1|Infant Series|Adverse Event|1
754065|NCT00452790|2406433|P2|Infant Series|Lost to Follow-up|2
754066|NCT00452790|2406434|P1|Infant Series|Lost to Follow-up|2
754067|NCT00452790|2406433|P2|Infant Series|Protocol Violation|3
754068|NCT00452790|2406434|P1|Infant Series|Protocol Violation|1
754069|NCT00452790|2406433|P2|Infant Series|Failed to return|1
754070|NCT00452790|2406434|P1|Infant Series|Failed to return|4
754071|NCT00452790|2406433|P2|Infant Series|Parent/legal guardian request|6
754072|NCT00452790|2406434|P1|Infant Series|Parent/legal guardian request|8
754073|NCT00452790|2406433|P2|Infant Series|Clinical hold - consent withdrawn|123
754074|NCT00452790|2406434|P1|Infant Series|Clinical hold - consent withdrawn|118
754075|NCT00453063|2406474|P2|Overall Study|Protocol Violation|0
754076|NCT00453063|2406475|P1|Overall Study|Protocol Violation|1
754077|NCT00453063|2406474|P2|Overall Study|Withdrawal by Subject|1
754078|NCT00453063|2406475|P1|Overall Study|Withdrawal by Subject|1
754079|NCT00453063|2406474|P2|Overall Study|Adverse Event|2
754080|NCT00453063|2406475|P1|Overall Study|Adverse Event|1
754081|NCT00453102|2406489|P1|Overall Study|Withdrawal by Subject|2
754082|NCT00453154|2406501|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
754083|NCT00453154|2406502|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
754084|NCT00453154|2406503|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
754085|NCT00453154|2406504|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
754086|NCT00453154|2406501|P4|Double BIind Maintenance|Medical Issues|1
754087|NCT00453154|2406502|P3|Double BIind Maintenance|Medical Issues|3
754088|NCT00453154|2406503|P2|Double BIind Maintenance|Medical Issues|0
754089|NCT00453154|2406504|P1|Double BIind Maintenance|Medical Issues|0
754090|NCT00453154|2406501|P4|Double BIind Maintenance|Progression|26
754091|NCT00453154|2406502|P3|Double BIind Maintenance|Progression|29
754092|NCT00453154|2406503|P2|Double BIind Maintenance|Progression|0
754093|NCT00453154|2406504|P1|Double BIind Maintenance|Progression|0
754094|NCT00453154|2406501|P4|Double BIind Maintenance|Withdrawal by Subject|4
754095|NCT00453154|2406502|P3|Double BIind Maintenance|Withdrawal by Subject|4
754096|NCT00453154|2406503|P2|Double BIind Maintenance|Withdrawal by Subject|0
754097|NCT00453154|2406504|P1|Double BIind Maintenance|Withdrawal by Subject|0
754098|NCT00453154|2406501|P4|Double BIind Maintenance|Death|1
754099|NCT00453154|2406502|P3|Double BIind Maintenance|Death|2
754100|NCT00453154|2406503|P2|Double BIind Maintenance|Death|0
754101|NCT00453154|2406504|P1|Double BIind Maintenance|Death|0
754102|NCT00453154|2406501|P4|Double BIind Maintenance|Adverse Event|12
754103|NCT00453154|2406502|P3|Double BIind Maintenance|Adverse Event|3
754104|NCT00453154|2406503|P2|Double BIind Maintenance|Adverse Event|0
754105|NCT00453154|2406504|P1|Double BIind Maintenance|Adverse Event|0
890933|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
890934|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
890935|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
754110|NCT00453206|2406540|P1|Overall Study|Death|1
754111|NCT00453310|2406544|P1|Overall Study|Progression of Disease|10
754112|NCT00453349|2406555|P2|Completed Study|Lost to follow up after study treatment|11
754113|NCT00453349|2406556|P1|Completed Study|Lost to follow up after study treatment|2
754114|NCT00453349|2406555|P2|Completed Study|Withdrawal by Subject|5
754115|NCT00453349|2406556|P1|Completed Study|Withdrawal by Subject|3
754116|NCT00453349|2406555|P2|Completed Study|Protocol Violation|1
754117|NCT00453349|2406556|P1|Completed Study|Protocol Violation|1
754118|NCT00453349|2406555|P2|Completed Study|Lost to Follow-up|5
754119|NCT00453349|2406556|P1|Completed Study|Lost to Follow-up|7
754120|NCT00453349|2406555|P2|Completed Study|Lack of Efficacy|1
754121|NCT00453349|2406556|P1|Completed Study|Lack of Efficacy|2
754122|NCT00453349|2406555|P2|Completed Study|Adverse Event|11
754123|NCT00453349|2406556|P1|Completed Study|Adverse Event|12
754124|NCT00453349|2406555|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
754125|NCT00453349|2406556|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
754126|NCT00453349|2406555|P2|Randomized|Withdrawal by Subject|5
754127|NCT00453349|2406556|P1|Randomized|Withdrawal by Subject|3
754128|NCT00453349|2406555|P2|Randomized|Protocol Violation|1
754129|NCT00453349|2406556|P1|Randomized|Protocol Violation|1
754130|NCT00453349|2406555|P2|Randomized|Lost to Follow-up|5
754131|NCT00453349|2406556|P1|Randomized|Lost to Follow-up|7
754132|NCT00453349|2406555|P2|Randomized|Lack of Efficacy|1
754133|NCT00453349|2406556|P1|Randomized|Lack of Efficacy|2
754134|NCT00453349|2406555|P2|Randomized|Adverse Event|11
754135|NCT00453349|2406556|P1|Randomized|Adverse Event|12
754136|NCT00453362|2406582|P1|Overall Study|Screening Failure|14
754137|NCT00453362|2406582|P1|Overall Study|Progression of disease|56
754138|NCT00453362|2406582|P1|Overall Study|Withdrawal by Subject|3
754139|NCT00453362|2406582|P1|Overall Study|Physician Decision|2
754140|NCT00453362|2406582|P1|Overall Study|Death|7
754141|NCT00453362|2406582|P1|Overall Study|Adverse Event|5
754142|NCT00453973|2406637|P2|Overall Study|Sponsor Decision to Terminate Study|30
754143|NCT00453973|2406638|P1|Overall Study|Sponsor Decision to Terminate Study|35
754144|NCT00453973|2406637|P2|Overall Study|Site closed by sponsor|0
754145|NCT00453973|2406638|P1|Overall Study|Site closed by sponsor|3
754146|NCT00453973|2406637|P2|Overall Study|Renal transplant|1
754147|NCT00453973|2406638|P1|Overall Study|Renal transplant|1
754148|NCT00453973|2406637|P2|Overall Study|Relocation|0
754149|NCT00453973|2406638|P1|Overall Study|Relocation|1
754150|NCT00453973|2406637|P2|Overall Study|PI Decision|2
754151|NCT00453973|2406638|P1|Overall Study|PI Decision|0
754152|NCT00453973|2406637|P2|Overall Study|Withdrawal by Subject|6
754153|NCT00453973|2406638|P1|Overall Study|Withdrawal by Subject|7
754154|NCT00453973|2406637|P2|Overall Study|Adverse Event|9
754155|NCT00453973|2406638|P1|Overall Study|Adverse Event|4
754156|NCT00453986|2406649|P5|Overall Study|Lost to Follow-up|0
754157|NCT00453986|2406650|P4|Overall Study|Lost to Follow-up|2
754158|NCT00453986|2406651|P3|Overall Study|Lost to Follow-up|6
754159|NCT00453986|2406652|P2|Overall Study|Lost to Follow-up|5
754160|NCT00453986|2406653|P1|Overall Study|Lost to Follow-up|6
754161|NCT00453999|2406749|P3|Overall Study|Subject Request|0
754162|NCT00453999|2406750|P2|Overall Study|Subject Request|1
754163|NCT00453999|2406751|P1|Overall Study|Subject Request|2
754164|NCT00453999|2406749|P3|Overall Study|Withdrawal by Subject|1
754165|NCT00453999|2406750|P2|Overall Study|Withdrawal by Subject|1
754166|NCT00453999|2406751|P1|Overall Study|Withdrawal by Subject|2
754167|NCT00453999|2406749|P3|Overall Study|Lost to Follow-up|1
754168|NCT00453999|2406750|P2|Overall Study|Lost to Follow-up|1
754169|NCT00453999|2406751|P1|Overall Study|Lost to Follow-up|0
754170|NCT00453999|2406749|P3|Overall Study|Adverse Event|1
754171|NCT00453999|2406750|P2|Overall Study|Adverse Event|2
754172|NCT00453999|2406751|P1|Overall Study|Adverse Event|1
754173|NCT00454051|2406776|P2|Overall Study|Protocol Violation|1
754174|NCT00454051|2406777|P1|Overall Study|Protocol Violation|1
754175|NCT00454051|2406776|P2|Overall Study|Withdrawal by Subject|0
754176|NCT00454051|2406777|P1|Overall Study|Withdrawal by Subject|1
754177|NCT00454051|2406776|P2|Overall Study|Adverse Event|2
754178|NCT00454051|2406777|P1|Overall Study|Adverse Event|1
754179|NCT00454116|2406810|P3|Overall Study|Other|0
754180|NCT00454116|2406811|P2|Overall Study|Other|2
754181|NCT00454116|2406812|P1|Overall Study|Other|2
754182|NCT00454116|2406810|P3|Overall Study|Withdrawal by Subject|1
754183|NCT00454116|2406811|P2|Overall Study|Withdrawal by Subject|3
754184|NCT00454116|2406812|P1|Overall Study|Withdrawal by Subject|3
754185|NCT00454116|2406810|P3|Overall Study|Condition under investigation worsened|18
754186|NCT00454116|2406811|P2|Overall Study|Condition under investigation worsened|13
754187|NCT00454116|2406812|P1|Overall Study|Condition under investigation worsened|17
754188|NCT00454116|2406810|P3|Overall Study|Adverse Event|9
754189|NCT00454116|2406811|P2|Overall Study|Adverse Event|11
754190|NCT00454116|2406812|P1|Overall Study|Adverse Event|5
754191|NCT00454142|2406820|P1|Overall Study|Withdrawal by Subject|1
754192|NCT00454181|2406837|P2|Overall Study|Withdrawal by Subject|0
754193|NCT00454181|2406838|P1|Overall Study|Withdrawal by Subject|2
754194|NCT00454181|2406837|P2|Overall Study|Protocol Violation|1
754195|NCT00454181|2406838|P1|Overall Study|Protocol Violation|1
754196|NCT00454181|2406837|P2|Overall Study|Lost to Follow-up|1
754197|NCT00454181|2406838|P1|Overall Study|Lost to Follow-up|11
754198|NCT00454181|2406837|P2|Overall Study|Adverse Event|1
754199|NCT00454181|2406838|P1|Overall Study|Adverse Event|1
754200|NCT00454194|2406856|P2|Overall Study|Other Unspecified Reason|2
754201|NCT00454194|2406857|P1|Overall Study|Other Unspecified Reason|2
754202|NCT00454194|2406856|P2|Overall Study|Other Medical Problems|2
754203|NCT00454194|2406857|P1|Overall Study|Other Medical Problems|1
754204|NCT00454194|2406856|P2|Overall Study|Withdrawal by Subject|8
754205|NCT00454194|2406857|P1|Overall Study|Withdrawal by Subject|12
754206|NCT00454194|2406856|P2|Overall Study|Adverse Event|2
754207|NCT00454194|2406857|P1|Overall Study|Adverse Event|7
754208|NCT00454207|2406875|P2|Overall Study|Protocol Violation|1
754209|NCT00454207|2406876|P1|Overall Study|Protocol Violation|0
754210|NCT00454207|2406875|P2|Overall Study|Lack of Efficacy|0
754211|NCT00454207|2406876|P1|Overall Study|Lack of Efficacy|1
754212|NCT00454207|2406875|P2|Overall Study|Adverse Event|1
754213|NCT00454207|2406876|P1|Overall Study|Adverse Event|3
754214|NCT00454246|2406922|P3|Overall Study|Early termination of study|9
754215|NCT00454246|2406923|P2|Overall Study|Early termination of study|26
754216|NCT00454246|2406924|P1|Overall Study|Early termination of study|62
754217|NCT00454246|2406922|P3|Overall Study|Failure to return|0
754218|NCT00454246|2406923|P2|Overall Study|Failure to return|0
754219|NCT00454246|2406924|P1|Overall Study|Failure to return|1
754220|NCT00454246|2406922|P3|Overall Study|Refused Treatment|0
754221|NCT00454246|2406923|P2|Overall Study|Refused Treatment|1
754222|NCT00454246|2406924|P1|Overall Study|Refused Treatment|1
754223|NCT00454246|2406922|P3|Overall Study|Protocol Violation|0
754224|NCT00454246|2406923|P2|Overall Study|Protocol Violation|0
754225|NCT00454246|2406924|P1|Overall Study|Protocol Violation|1
754226|NCT00454246|2406922|P3|Overall Study|Violation of selection criteria at entry|0
754227|NCT00454246|2406923|P2|Overall Study|Violation of selection criteria at entry|0
754228|NCT00454246|2406924|P1|Overall Study|Violation of selection criteria at entry|6
754229|NCT00454246|2406922|P3|Overall Study|Adverse Event|0
754230|NCT00454246|2406923|P2|Overall Study|Adverse Event|2
754231|NCT00454246|2406924|P1|Overall Study|Adverse Event|2
754232|NCT00454363|2406955|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
754233|NCT00454363|2406956|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
754234|NCT00454363|2406955|P2|Overall Study|Adverse Event|2
754235|NCT00454363|2406956|P1|Overall Study|Adverse Event|1
754236|NCT00454571|2406990|P2|Overall Study|Withdrawal by Subject|5
754237|NCT00454571|2406991|P1|Overall Study|Withdrawal by Subject|10
754238|NCT00454571|2406990|P2|Overall Study|Protocol Violation|0
754239|NCT00454571|2406991|P1|Overall Study|Protocol Violation|1
754240|NCT00454571|2406990|P2|Overall Study|Physician Decision|1
754241|NCT00454571|2406991|P1|Overall Study|Physician Decision|0
754242|NCT00454571|2406990|P2|Overall Study|Adverse Event|0
754243|NCT00454571|2406991|P1|Overall Study|Adverse Event|2
754244|NCT00454584|2407002|P6|After Controlled Period|Unspecified|17
754245|NCT00454584|2407003|P5|After Controlled Period|Unspecified|5
754246|NCT00454584|2407004|P4|After Controlled Period|Unspecified|13
754247|NCT00454584|2407005|P3|After Controlled Period|Unspecified|0
754248|NCT00454584|2407006|P2|After Controlled Period|Unspecified|0
754249|NCT00454584|2407007|P1|After Controlled Period|Unspecified|0
754250|NCT00454584|2407002|P6|After Controlled Period|Unspecified|0
754251|NCT00454584|2407003|P5|After Controlled Period|Unspecified|0
754252|NCT00454584|2407004|P4|After Controlled Period|Unspecified|1
754253|NCT00454584|2407005|P3|After Controlled Period|Unspecified|0
754254|NCT00454584|2407006|P2|After Controlled Period|Unspecified|0
754255|NCT00454584|2407007|P1|After Controlled Period|Unspecified|0
754256|NCT00454584|2407002|P6|After Controlled Period|Lost to Follow-up|6
754257|NCT00454584|2407003|P5|After Controlled Period|Lost to Follow-up|4
754258|NCT00454584|2407004|P4|After Controlled Period|Lost to Follow-up|2
754259|NCT00454584|2407005|P3|After Controlled Period|Lost to Follow-up|0
754260|NCT00454584|2407006|P2|After Controlled Period|Lost to Follow-up|0
754261|NCT00454584|2407007|P1|After Controlled Period|Lost to Follow-up|0
754262|NCT00454584|2407002|P6|After Controlled Period|Lack of Efficacy|0
754263|NCT00454584|2407003|P5|After Controlled Period|Lack of Efficacy|0
754264|NCT00454584|2407004|P4|After Controlled Period|Lack of Efficacy|1
754265|NCT00454584|2407005|P3|After Controlled Period|Lack of Efficacy|0
754266|NCT00454584|2407006|P2|After Controlled Period|Lack of Efficacy|0
754267|NCT00454584|2407007|P1|After Controlled Period|Lack of Efficacy|0
754268|NCT00454584|2407002|P6|After Controlled Period|Adverse Event|9
754269|NCT00454584|2407003|P5|After Controlled Period|Adverse Event|3
754270|NCT00454584|2407004|P4|After Controlled Period|Adverse Event|9
754271|NCT00454584|2407005|P3|After Controlled Period|Adverse Event|0
754272|NCT00454584|2407006|P2|After Controlled Period|Adverse Event|0
754273|NCT00454584|2407007|P1|After Controlled Period|Adverse Event|0
754274|NCT00454584|2407002|P6|Controlled Period|unspecified|0
754275|NCT00454584|2407003|P5|Controlled Period|unspecified|0
754276|NCT00454584|2407004|P4|Controlled Period|unspecified|0
754277|NCT00454584|2407005|P3|Controlled Period|unspecified|2
754278|NCT00454584|2407006|P2|Controlled Period|unspecified|4
754279|NCT00454584|2407007|P1|Controlled Period|unspecified|5
754280|NCT00454584|2407002|P6|Controlled Period|Lost to Follow-up|0
754281|NCT00454584|2407003|P5|Controlled Period|Lost to Follow-up|0
754282|NCT00454584|2407004|P4|Controlled Period|Lost to Follow-up|0
754283|NCT00454584|2407005|P3|Controlled Period|Lost to Follow-up|2
754284|NCT00454584|2407006|P2|Controlled Period|Lost to Follow-up|2
754285|NCT00454584|2407007|P1|Controlled Period|Lost to Follow-up|1
754286|NCT00454584|2407002|P6|Controlled Period|Adverse Event|0
754287|NCT00454584|2407003|P5|Controlled Period|Adverse Event|0
754288|NCT00454584|2407004|P4|Controlled Period|Adverse Event|0
754289|NCT00454584|2407005|P3|Controlled Period|Adverse Event|1
754290|NCT00454584|2407006|P2|Controlled Period|Adverse Event|2
754291|NCT00454584|2407007|P1|Controlled Period|Adverse Event|5
754292|NCT00454636|2407031|P4|Overall Study|Lost to Follow-up|0
754293|NCT00454636|2407032|P3|Overall Study|Lost to Follow-up|0
754294|NCT00454636|2407033|P2|Overall Study|Lost to Follow-up|1
754295|NCT00454636|2407034|P1|Overall Study|Lost to Follow-up|0
754296|NCT00454636|2407031|P4|Overall Study|Patient refusal|2
754297|NCT00454636|2407032|P3|Overall Study|Patient refusal|3
754298|NCT00454636|2407033|P2|Overall Study|Patient refusal|1
754299|NCT00454636|2407034|P1|Overall Study|Patient refusal|1
754300|NCT00454636|2407031|P4|Overall Study|Death|1
754301|NCT00454636|2407032|P3|Overall Study|Death|1
754302|NCT00454636|2407033|P2|Overall Study|Death|1
754303|NCT00454636|2407034|P1|Overall Study|Death|6
754304|NCT00454636|2407031|P4|Overall Study|Protocol Violation|3
754305|NCT00454636|2407032|P3|Overall Study|Protocol Violation|3
754306|NCT00454636|2407033|P2|Overall Study|Protocol Violation|2
754307|NCT00454636|2407034|P1|Overall Study|Protocol Violation|3
754308|NCT00454636|2407031|P4|Overall Study|Disease Progression|11
754309|NCT00454636|2407032|P3|Overall Study|Disease Progression|4
754310|NCT00454636|2407033|P2|Overall Study|Disease Progression|12
754311|NCT00454636|2407034|P1|Overall Study|Disease Progression|11
754312|NCT00454636|2407031|P4|Overall Study|Adverse Event|15
754313|NCT00454636|2407032|P3|Overall Study|Adverse Event|9
754314|NCT00454636|2407033|P2|Overall Study|Adverse Event|6
754315|NCT00454636|2407034|P1|Overall Study|Adverse Event|10
754316|NCT00454649|2407074|P10|Overall Study|Withdrawal by Subject|0
754317|NCT00454649|2407075|P9|Overall Study|Withdrawal by Subject|1
754318|NCT00454649|2407076|P8|Overall Study|Withdrawal by Subject|2
754319|NCT00454649|2407077|P7|Overall Study|Withdrawal by Subject|0
754320|NCT00454649|2407078|P6|Overall Study|Withdrawal by Subject|1
754321|NCT00454649|2407079|P5|Overall Study|Withdrawal by Subject|0
754322|NCT00454649|2407080|P4|Overall Study|Withdrawal by Subject|0
754323|NCT00454649|2407081|P3|Overall Study|Withdrawal by Subject|0
754324|NCT00454649|2407082|P2|Overall Study|Withdrawal by Subject|0
754325|NCT00454649|2407083|P1|Overall Study|Withdrawal by Subject|0
754326|NCT00454649|2407074|P10|Overall Study|Unspecified|1
754327|NCT00454649|2407075|P9|Overall Study|Unspecified|3
754328|NCT00454649|2407076|P8|Overall Study|Unspecified|0
754329|NCT00454649|2407077|P7|Overall Study|Unspecified|0
754330|NCT00454649|2407078|P6|Overall Study|Unspecified|0
754331|NCT00454649|2407079|P5|Overall Study|Unspecified|0
754332|NCT00454649|2407080|P4|Overall Study|Unspecified|3
754333|NCT00454649|2407081|P3|Overall Study|Unspecified|5
754334|NCT00454649|2407082|P2|Overall Study|Unspecified|1
754335|NCT00454649|2407083|P1|Overall Study|Unspecified|1
754336|NCT00454649|2407074|P10|Overall Study|Lost to Follow-up|0
754337|NCT00454649|2407075|P9|Overall Study|Lost to Follow-up|0
754338|NCT00454649|2407076|P8|Overall Study|Lost to Follow-up|0
754339|NCT00454649|2407077|P7|Overall Study|Lost to Follow-up|1
754340|NCT00454649|2407078|P6|Overall Study|Lost to Follow-up|0
754341|NCT00454649|2407079|P5|Overall Study|Lost to Follow-up|0
754342|NCT00454649|2407080|P4|Overall Study|Lost to Follow-up|0
754343|NCT00454649|2407081|P3|Overall Study|Lost to Follow-up|1
754344|NCT00454649|2407082|P2|Overall Study|Lost to Follow-up|0
754345|NCT00454649|2407083|P1|Overall Study|Lost to Follow-up|0
754346|NCT00454649|2407074|P10|Overall Study|Adverse Event|2
754347|NCT00454649|2407075|P9|Overall Study|Adverse Event|6
754348|NCT00454649|2407076|P8|Overall Study|Adverse Event|4
754349|NCT00454649|2407077|P7|Overall Study|Adverse Event|3
754350|NCT00454649|2407078|P6|Overall Study|Adverse Event|2
754351|NCT00454649|2407079|P5|Overall Study|Adverse Event|1
754352|NCT00454649|2407080|P4|Overall Study|Adverse Event|0
754353|NCT00454649|2407081|P3|Overall Study|Adverse Event|3
754354|NCT00454649|2407082|P2|Overall Study|Adverse Event|1
754355|NCT00454649|2407083|P1|Overall Study|Adverse Event|0
754356|NCT00454649|2407074|P10|Overall Study|Lack of Efficacy|2
754357|NCT00454649|2407075|P9|Overall Study|Lack of Efficacy|10
754358|NCT00454649|2407076|P8|Overall Study|Lack of Efficacy|13
754359|NCT00454649|2407077|P7|Overall Study|Lack of Efficacy|5
754360|NCT00454649|2407078|P6|Overall Study|Lack of Efficacy|4
754361|NCT00454649|2407079|P5|Overall Study|Lack of Efficacy|0
754362|NCT00454649|2407080|P4|Overall Study|Lack of Efficacy|3
754363|NCT00454649|2407081|P3|Overall Study|Lack of Efficacy|10
754364|NCT00454649|2407082|P2|Overall Study|Lack of Efficacy|2
754365|NCT00454649|2407083|P1|Overall Study|Lack of Efficacy|2
754366|NCT00454779|2407210|P2|Second-line Treatment Phase|Ongoing|1
754367|NCT00454779|2407211|P1|Second-line Treatment Phase|Ongoing|0
754368|NCT00454779|2407210|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
754369|NCT00454779|2407211|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
754370|NCT00454779|2407210|P2|Second-line Treatment Phase|Withdrawal by Subject|1
754371|NCT00454779|2407211|P1|Second-line Treatment Phase|Withdrawal by Subject|0
754372|NCT00454779|2407210|P2|First-line Treatment Phase|Ongoing|0
754373|NCT00454779|2407211|P1|First-line Treatment Phase|Ongoing|1
754374|NCT00454779|2407210|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
754375|NCT00454779|2407211|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
754376|NCT00454779|2407210|P2|First-line Treatment Phase|Protocol Violation|1
754377|NCT00454779|2407211|P1|First-line Treatment Phase|Protocol Violation|0
754378|NCT00454779|2407210|P2|First-line Treatment Phase|Lost to Follow-up|0
754379|NCT00454779|2407211|P1|First-line Treatment Phase|Lost to Follow-up|1
754380|NCT00454779|2407210|P2|First-line Treatment Phase|Withdrawal by Subject|4
754381|NCT00454779|2407211|P1|First-line Treatment Phase|Withdrawal by Subject|2
754382|NCT00454779|2407210|P2|First-line Treatment Phase|Lack of Efficacy|2
754383|NCT00454779|2407211|P1|First-line Treatment Phase|Lack of Efficacy|0
754384|NCT00454805|2407241|P2|Overall Study|In order to begin radiotherapy|0
754385|NCT00454805|2407242|P1|Overall Study|In order to begin radiotherapy|1
754386|NCT00454805|2407241|P2|Overall Study|Disease progression|19
754387|NCT00454805|2407242|P1|Overall Study|Disease progression|16
754388|NCT00454805|2407241|P2|Overall Study|Death|2
754389|NCT00454805|2407242|P1|Overall Study|Death|0
754390|NCT00454805|2407241|P2|Overall Study|Withdrawal by Subject|2
754391|NCT00454805|2407242|P1|Overall Study|Withdrawal by Subject|9
754392|NCT00454818|2407264|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
754393|NCT00454818|2407265|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
754394|NCT00454818|2407266|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
754395|NCT00454818|2407267|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
754396|NCT00454818|2407268|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
754397|NCT00454818|2407264|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
754398|NCT00454818|2407265|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
754399|NCT00454818|2407266|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
754400|NCT00454818|2407267|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
754401|NCT00454818|2407268|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
754402|NCT00454818|2407264|P5|Phase 2: Randomized Double-blind|Death|1
754403|NCT00454818|2407265|P4|Phase 2: Randomized Double-blind|Death|0
754404|NCT00454818|2407266|P3|Phase 2: Randomized Double-blind|Death|0
754405|NCT00454818|2407267|P2|Phase 2: Randomized Double-blind|Death|1
754406|NCT00454818|2407268|P1|Phase 2: Randomized Double-blind|Death|0
754407|NCT00454818|2407264|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
754408|NCT00454818|2407265|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
754409|NCT00454818|2407266|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
754410|NCT00454818|2407267|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
754411|NCT00454818|2407268|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
754412|NCT00454818|2407264|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
754413|NCT00454818|2407265|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
754414|NCT00454818|2407266|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
754415|NCT00454818|2407267|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
754416|NCT00454818|2407268|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
754417|NCT00454818|2407264|P5|Phase I: Open-label Dose-escalation|Death|0
754418|NCT00454818|2407265|P4|Phase I: Open-label Dose-escalation|Death|0
754419|NCT00454818|2407266|P3|Phase I: Open-label Dose-escalation|Death|0
754420|NCT00454818|2407267|P2|Phase I: Open-label Dose-escalation|Death|1
754421|NCT00454818|2407268|P1|Phase I: Open-label Dose-escalation|Death|0
754422|NCT00454818|2407264|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
754423|NCT00454818|2407265|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
754424|NCT00454818|2407266|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
754425|NCT00454818|2407267|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
754426|NCT00454818|2407268|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
754427|NCT00454857|2407345|P1|Overall Study|Reason unknown|1
754428|NCT00454857|2407345|P1|Overall Study|Other|11
754429|NCT00454857|2407345|P1|Overall Study|Death|5
754430|NCT00454857|2407345|P1|Overall Study|Noncompliance|6
754431|NCT00454857|2407345|P1|Overall Study|Lost to Follow-up|16
754432|NCT00454857|2407345|P1|Overall Study|Withdrawal by Subject|15
754433|NCT00454909|2407365|P3|Overall Study|Others|0
754434|NCT00454909|2407366|P2|Overall Study|Others|0
754435|NCT00454909|2407367|P1|Overall Study|Others|1
754436|NCT00454909|2407365|P3|Overall Study|Lost to follow-up (complete vaccination)|1
754437|NCT00454909|2407366|P2|Overall Study|Lost to follow-up (complete vaccination)|3
754438|NCT00454909|2407367|P1|Overall Study|Lost to follow-up (complete vaccination)|5
754439|NCT00454909|2407365|P3|Overall Study|Migrated/moved from study area|1
754440|NCT00454909|2407366|P2|Overall Study|Migrated/moved from study area|0
754441|NCT00454909|2407367|P1|Overall Study|Migrated/moved from study area|0
754442|NCT00454909|2407365|P3|Overall Study|Withdrawal by Subject|0
754443|NCT00454909|2407366|P2|Overall Study|Withdrawal by Subject|0
754444|NCT00454909|2407367|P1|Overall Study|Withdrawal by Subject|1
754445|NCT00454987|2407408|P3|Booster Period|Lost to Follow-up|0
754446|NCT00454987|2407409|P2|Booster Period|Lost to Follow-up|0
754447|NCT00454987|2407410|P1|Booster Period|Lost to Follow-up|1
754448|NCT00454987|2407408|P3|Booster Period|Withdrawal by Subject|0
754449|NCT00454987|2407409|P2|Booster Period|Withdrawal by Subject|1
754450|NCT00454987|2407410|P1|Booster Period|Withdrawal by Subject|0
754451|NCT00454987|2407408|P3|Booster Period|Adverse Event|0
754452|NCT00454987|2407409|P2|Booster Period|Adverse Event|0
754453|NCT00454987|2407410|P1|Booster Period|Adverse Event|1
890936|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
890937|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
890938|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
890939|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
890940|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
890941|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
890942|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
890943|NCT00611455|2826449|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
890944|NCT00611455|2826450|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
890945|NCT00611455|2826451|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
890946|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
890947|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
890948|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
890949|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
890950|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
890951|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
890952|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
890953|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
890954|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
890955|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
890956|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
890957|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
890958|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
890959|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
890960|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
890961|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
890962|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
890963|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
754487|NCT00444457|2407555|P4|Toddler Dose|Protocol Violation|1
754488|NCT00444457|2407556|P3|Toddler Dose|Protocol Violation|0
754489|NCT00444457|2407557|P2|Toddler Dose|Protocol Violation|0
754490|NCT00444457|2407558|P1|Toddler Dose|Protocol Violation|1
754491|NCT00444457|2407555|P4|Toddler Dose|Parent or legal guardian request|1
754492|NCT00444457|2407556|P3|Toddler Dose|Parent or legal guardian request|2
754493|NCT00444457|2407557|P2|Toddler Dose|Parent or legal guardian request|3
754494|NCT00444457|2407558|P1|Toddler Dose|Parent or legal guardian request|0
754495|NCT00444457|2407555|P4|Toddler Dose|Failed to return|3
754496|NCT00444457|2407556|P3|Toddler Dose|Failed to return|1
754497|NCT00444457|2407557|P2|Toddler Dose|Failed to return|2
754498|NCT00444457|2407558|P1|Toddler Dose|Failed to return|2
754499|NCT00444457|2407555|P4|Toddler Dose|Lost to Follow-up|3
754500|NCT00444457|2407556|P3|Toddler Dose|Lost to Follow-up|1
754501|NCT00444457|2407557|P2|Toddler Dose|Lost to Follow-up|1
754502|NCT00444457|2407558|P1|Toddler Dose|Lost to Follow-up|4
754503|NCT00444457|2407555|P4|After Infant Series|Unspecified|0
754504|NCT00444457|2407556|P3|After Infant Series|Unspecified|0
754505|NCT00444457|2407557|P2|After Infant Series|Unspecified|1
754506|NCT00444457|2407558|P1|After Infant Series|Unspecified|0
754507|NCT00444457|2407555|P4|After Infant Series|Investigator request|1
754508|NCT00444457|2407556|P3|After Infant Series|Investigator request|0
754509|NCT00444457|2407557|P2|After Infant Series|Investigator request|0
754510|NCT00444457|2407558|P1|After Infant Series|Investigator request|0
754511|NCT00444457|2407555|P4|After Infant Series|Adverse Event|0
754512|NCT00444457|2407556|P3|After Infant Series|Adverse Event|0
754513|NCT00444457|2407557|P2|After Infant Series|Adverse Event|2
754514|NCT00444457|2407558|P1|After Infant Series|Adverse Event|2
754515|NCT00444457|2407555|P4|After Infant Series|Protocol Violation|2
754516|NCT00444457|2407556|P3|After Infant Series|Protocol Violation|2
754517|NCT00444457|2407557|P2|After Infant Series|Protocol Violation|4
754518|NCT00444457|2407558|P1|After Infant Series|Protocol Violation|2
754519|NCT00444457|2407555|P4|After Infant Series|Lost to Follow-up|2
754520|NCT00444457|2407556|P3|After Infant Series|Lost to Follow-up|5
754521|NCT00444457|2407557|P2|After Infant Series|Lost to Follow-up|5
754522|NCT00444457|2407558|P1|After Infant Series|Lost to Follow-up|5
754523|NCT00444457|2407555|P4|After Infant Series|Failed to return|1
754524|NCT00444457|2407556|P3|After Infant Series|Failed to return|5
754525|NCT00444457|2407557|P2|After Infant Series|Failed to return|6
754526|NCT00444457|2407558|P1|After Infant Series|Failed to return|7
754527|NCT00444457|2407555|P4|After Infant Series|Parent or legal guardian request|3
754528|NCT00444457|2407556|P3|After Infant Series|Parent or legal guardian request|6
754529|NCT00444457|2407557|P2|After Infant Series|Parent or legal guardian request|11
754530|NCT00444457|2407558|P1|After Infant Series|Parent or legal guardian request|4
754531|NCT00444457|2407555|P4|After Infant Series|Other|1
754532|NCT00444457|2407556|P3|After Infant Series|Other|1
754533|NCT00444457|2407557|P2|After Infant Series|Other|1
754534|NCT00444457|2407558|P1|After Infant Series|Other|0
754535|NCT00444457|2407555|P4|Infant Series|Death|1
754536|NCT00444457|2407556|P3|Infant Series|Death|1
754537|NCT00444457|2407557|P2|Infant Series|Death|1
754538|NCT00444457|2407558|P1|Infant Series|Death|0
754539|NCT00444457|2407555|P4|Infant Series|Adverse Event|0
754540|NCT00444457|2407556|P3|Infant Series|Adverse Event|2
754541|NCT00444457|2407557|P2|Infant Series|Adverse Event|2
754542|NCT00444457|2407558|P1|Infant Series|Adverse Event|1
754543|NCT00444457|2407555|P4|Infant Series|Unspecified|0
754544|NCT00444457|2407556|P3|Infant Series|Unspecified|4
754545|NCT00444457|2407557|P2|Infant Series|Unspecified|2
754546|NCT00444457|2407558|P1|Infant Series|Unspecified|0
754547|NCT00444457|2407555|P4|Infant Series|Investigator request|2
754548|NCT00444457|2407556|P3|Infant Series|Investigator request|3
754549|NCT00444457|2407557|P2|Infant Series|Investigator request|3
754550|NCT00444457|2407558|P1|Infant Series|Investigator request|4
754551|NCT00444457|2407555|P4|Infant Series|Failed to return|2
754552|NCT00444457|2407556|P3|Infant Series|Failed to return|4
754553|NCT00444457|2407557|P2|Infant Series|Failed to return|4
754554|NCT00444457|2407558|P1|Infant Series|Failed to return|5
754555|NCT00444457|2407555|P4|Infant Series|Protocol Violation|3
754556|NCT00444457|2407556|P3|Infant Series|Protocol Violation|6
754557|NCT00444457|2407557|P2|Infant Series|Protocol Violation|8
754558|NCT00444457|2407558|P1|Infant Series|Protocol Violation|16
754559|NCT00444457|2407555|P4|Infant Series|Lost to Follow-up|6
754560|NCT00444457|2407556|P3|Infant Series|Lost to Follow-up|7
754561|NCT00444457|2407557|P2|Infant Series|Lost to Follow-up|11
754562|NCT00444457|2407558|P1|Infant Series|Lost to Follow-up|10
754563|NCT00444457|2407555|P4|Infant Series|Parent or legal guardian request|14
754564|NCT00444457|2407556|P3|Infant Series|Parent or legal guardian request|34
754565|NCT00444457|2407557|P2|Infant Series|Parent or legal guardian request|29
754566|NCT00444457|2407558|P1|Infant Series|Parent or legal guardian request|18
754567|NCT00444457|2407555|P4|Infant Series|Other|0
754568|NCT00444457|2407556|P3|Infant Series|Other|0
754569|NCT00444457|2407557|P2|Infant Series|Other|1
754570|NCT00444457|2407558|P1|Infant Series|Other|0
754571|NCT00444535|2407620|P1|Overall Study|Adverse Event|3
754572|NCT00444535|2407620|P1|Overall Study|Investigator decision|2
754573|NCT00444535|2407620|P1|Overall Study|Withdrawal by Subject|3
754574|NCT00444535|2407620|P1|Overall Study|Treatment is ongoing|16
754575|NCT00444587|2407629|P2|Overall Study|Missing|5
754576|NCT00444587|2407630|P1|Overall Study|Missing|0
754577|NCT00444587|2407629|P2|Overall Study|Protocol Violation|0
754578|NCT00444587|2407630|P1|Overall Study|Protocol Violation|1
754579|NCT00444587|2407629|P2|Overall Study|Investigator decision|0
754580|NCT00444587|2407630|P1|Overall Study|Investigator decision|3
754581|NCT00444587|2407629|P2|Overall Study|Refused treatment/did not cooperate|1
754582|NCT00444587|2407630|P1|Overall Study|Refused treatment/did not cooperate|4
754583|NCT00444587|2407629|P2|Overall Study|Progression of the disease|8
754584|NCT00444587|2407630|P1|Overall Study|Progression of the disease|73
754585|NCT00444587|2407629|P2|Overall Study|Death|1
754586|NCT00444587|2407630|P1|Overall Study|Death|2
754587|NCT00444600|2407655|P4|Overall Study|Missed visit|1
754588|NCT00444600|2407656|P3|Overall Study|Missed visit|0
754589|NCT00444600|2407657|P2|Overall Study|Missed visit|0
754590|NCT00444600|2407658|P1|Overall Study|Missed visit|1
754591|NCT00444600|2407655|P4|Overall Study|Dropped|7
754592|NCT00444600|2407656|P3|Overall Study|Dropped|7
754593|NCT00444600|2407657|P2|Overall Study|Dropped|11
754594|NCT00444600|2407658|P1|Overall Study|Dropped|11
754595|NCT00444600|2407655|P4|Overall Study|Death|2
754596|NCT00444600|2407656|P3|Overall Study|Death|3
754597|NCT00444600|2407657|P2|Overall Study|Death|5
754598|NCT00444600|2407658|P1|Overall Study|Death|7
754599|NCT00444626|2407748|P1|Initial Treatment Period|Lost to Follow-up|9
754600|NCT00444626|2407748|P1|Initial Treatment Period|Adverse Event|1
754601|NCT00444626|2407748|P1|Initial Treatment Period|Withdrawal by Subject|2
754602|NCT00444795|2407774|P1|Overall Study|Treated Prior to the Contract Date|2
754603|NCT00444795|2407774|P1|Overall Study|Not Treated|1
754604|NCT00444912|2407781|P2|Overall Study|Participant Failed Mobilization|0
754605|NCT00444912|2407782|P1|Overall Study|Participant Failed Mobilization|1
754606|NCT00444912|2407781|P2|Overall Study|Lost to Follow-up|0
754607|NCT00444912|2407782|P1|Overall Study|Lost to Follow-up|1
754608|NCT00444912|2407781|P2|Overall Study|Death|2
754609|NCT00444912|2407782|P1|Overall Study|Death|1
754610|NCT00444925|2407813|P3|Double-blind Treatment Period|Other|12
754611|NCT00444925|2407814|P2|Double-blind Treatment Period|Other|7
754612|NCT00444925|2407815|P1|Double-blind Treatment Period|Other|7
754613|NCT00444925|2407813|P3|Double-blind Treatment Period|Withdrawal by Subject|7
754614|NCT00444925|2407814|P2|Double-blind Treatment Period|Withdrawal by Subject|8
754615|NCT00444925|2407815|P1|Double-blind Treatment Period|Withdrawal by Subject|6
754616|NCT00444925|2407813|P3|Double-blind Treatment Period|Lost to Follow-up|5
754617|NCT00444925|2407814|P2|Double-blind Treatment Period|Lost to Follow-up|8
754618|NCT00444925|2407815|P1|Double-blind Treatment Period|Lost to Follow-up|4
754619|NCT00444925|2407813|P3|Double-blind Treatment Period|Lack of Efficacy|13
754620|NCT00444925|2407814|P2|Double-blind Treatment Period|Lack of Efficacy|5
754621|NCT00444925|2407815|P1|Double-blind Treatment Period|Lack of Efficacy|5
754622|NCT00444925|2407813|P3|Double-blind Treatment Period|Adverse Event|44
754623|NCT00444925|2407814|P2|Double-blind Treatment Period|Adverse Event|28
754624|NCT00444925|2407815|P1|Double-blind Treatment Period|Adverse Event|6
754625|NCT00444925|2407813|P3|Double-blind Treatment Period|Death|0
754626|NCT00444925|2407814|P2|Double-blind Treatment Period|Death|0
754627|NCT00444925|2407815|P1|Double-blind Treatment Period|Death|2
754628|NCT00444925|2407813|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
754629|NCT00444925|2407814|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
754630|NCT00444925|2407815|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
754631|NCT00444951|2407880|P3|Overall Study|Withdrawal by Subject|3
754632|NCT00444951|2407881|P2|Overall Study|Withdrawal by Subject|5
754633|NCT00444951|2407882|P1|Overall Study|Withdrawal by Subject|4
754634|NCT00444951|2407880|P3|Overall Study|Lost to Follow-up|0
754635|NCT00444951|2407881|P2|Overall Study|Lost to Follow-up|1
754636|NCT00444951|2407882|P1|Overall Study|Lost to Follow-up|1
890964|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
890965|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
890966|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
890967|NCT00611455|2826449|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
890968|NCT00611455|2826450|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
890969|NCT00611455|2826451|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
890970|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
754646|NCT00445146|2407930|P1|Overall Study|Pregnancy|1
754647|NCT00445146|2407930|P1|Overall Study|Protocol Violation|4
754648|NCT00445146|2407930|P1|Overall Study|Death|9
754649|NCT00445146|2407930|P1|Overall Study|Lost to Follow-up|13
754650|NCT00445146|2407930|P1|Overall Study|Adverse Event|13
754651|NCT00445146|2407930|P1|Overall Study|Investigator’s Discretion|22
754652|NCT00445146|2407930|P1|Overall Study|Lack of Efficacy|28
754653|NCT00445146|2407930|P1|Overall Study|Withdrew Consent|29
754654|NCT00445224|2407968|P2|Specific Exercises|Withdrawal by Subject|0
754655|NCT00445224|2407969|P1|Specific Exercises|Withdrawal by Subject|1
754656|NCT00445224|2407968|P2|Specific Exercises|Withdrawal by Subject|3
754657|NCT00445224|2407969|P1|Specific Exercises|Withdrawal by Subject|3
754658|NCT00445328|2408122|P2|Overall Study|Protocol Violation|0
754659|NCT00445328|2408123|P1|Overall Study|Protocol Violation|1
754660|NCT00445328|2408122|P2|Overall Study|Withdrawal by Subject|0
754661|NCT00445328|2408123|P1|Overall Study|Withdrawal by Subject|2
754662|NCT00445328|2408122|P2|Overall Study|Other|2
754663|NCT00445328|2408123|P1|Overall Study|Other|0
754664|NCT00445328|2408122|P2|Overall Study|Adverse Event|3
754665|NCT00445328|2408123|P1|Overall Study|Adverse Event|0
754666|NCT00445328|2408122|P2|Overall Study|Death|1
754667|NCT00445328|2408123|P1|Overall Study|Death|0
754668|NCT00445341|2408141|P1|Overall Study|taken off treatment too early|1
754669|NCT00445341|2408141|P1|Overall Study|refused further treatment|1
754670|NCT00445432|2408149|P4|148 Weeks of Adalimumab Treatment|Not specified|9
754671|NCT00445432|2408150|P3|148 Weeks of Adalimumab Treatment|Not specified|0
754672|NCT00445432|2408151|P2|148 Weeks of Adalimumab Treatment|Not specified|0
754673|NCT00445432|2408152|P1|148 Weeks of Adalimumab Treatment|Not specified|0
754674|NCT00445432|2408149|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
754675|NCT00445432|2408150|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
754676|NCT00445432|2408151|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
754677|NCT00445432|2408152|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
754678|NCT00445432|2408149|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
754679|NCT00445432|2408150|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
754680|NCT00445432|2408151|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
754681|NCT00445432|2408152|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
754682|NCT00445432|2408149|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
754683|NCT00445432|2408150|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
754684|NCT00445432|2408151|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
754685|NCT00445432|2408152|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
754686|NCT00445432|2408149|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
754687|NCT00445432|2408150|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
754688|NCT00445432|2408151|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
754689|NCT00445432|2408152|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
754690|NCT00445432|2408149|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
754691|NCT00445432|2408150|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
754692|NCT00445432|2408151|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
754693|NCT00445432|2408152|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
754694|NCT00445432|2408149|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
754695|NCT00445432|2408150|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
754696|NCT00445432|2408151|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
754697|NCT00445432|2408152|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
754698|NCT00445549|2408200|P1|Overall Study|progressive disease|12
754699|NCT00445679|2408214|P4|Overall Study|Lack of Efficacy|0
754700|NCT00445679|2408215|P3|Overall Study|Lack of Efficacy|2
754701|NCT00445679|2408216|P2|Overall Study|Lack of Efficacy|6
754702|NCT00445679|2408217|P1|Overall Study|Lack of Efficacy|2
754703|NCT00445679|2408214|P4|Overall Study|Withdrawal by Subject|18
754704|NCT00445679|2408215|P3|Overall Study|Withdrawal by Subject|20
754705|NCT00445679|2408216|P2|Overall Study|Withdrawal by Subject|14
754706|NCT00445679|2408217|P1|Overall Study|Withdrawal by Subject|8
754707|NCT00445679|2408214|P4|Overall Study|Protocol Violation|1
754708|NCT00445679|2408215|P3|Overall Study|Protocol Violation|3
754709|NCT00445679|2408216|P2|Overall Study|Protocol Violation|3
754710|NCT00445679|2408217|P1|Overall Study|Protocol Violation|2
754711|NCT00445679|2408214|P4|Overall Study|Withdrawal of Informed Consent|0
754712|NCT00445679|2408215|P3|Overall Study|Withdrawal of Informed Consent|1
754713|NCT00445679|2408216|P2|Overall Study|Withdrawal of Informed Consent|0
754714|NCT00445679|2408217|P1|Overall Study|Withdrawal of Informed Consent|0
754715|NCT00445679|2408214|P4|Overall Study|Compliance|2
754716|NCT00445679|2408215|P3|Overall Study|Compliance|1
754717|NCT00445679|2408216|P2|Overall Study|Compliance|2
754718|NCT00445679|2408217|P1|Overall Study|Compliance|3
754719|NCT00445679|2408214|P4|Overall Study|Lost to Follow-up|5
754720|NCT00445679|2408215|P3|Overall Study|Lost to Follow-up|6
754721|NCT00445679|2408216|P2|Overall Study|Lost to Follow-up|6
754722|NCT00445679|2408217|P1|Overall Study|Lost to Follow-up|10
754723|NCT00445679|2408214|P4|Overall Study|Physician Decision|0
754724|NCT00445679|2408215|P3|Overall Study|Physician Decision|1
754725|NCT00445679|2408216|P2|Overall Study|Physician Decision|0
754726|NCT00445679|2408217|P1|Overall Study|Physician Decision|0
754727|NCT00445679|2408214|P4|Overall Study|Failed to return|2
754728|NCT00445679|2408215|P3|Overall Study|Failed to return|2
754729|NCT00445679|2408216|P2|Overall Study|Failed to return|3
754730|NCT00445679|2408217|P1|Overall Study|Failed to return|1
754731|NCT00445679|2408214|P4|Overall Study|Adverse Event|19
754732|NCT00445679|2408215|P3|Overall Study|Adverse Event|30
754733|NCT00445679|2408216|P2|Overall Study|Adverse Event|12
754734|NCT00445679|2408217|P1|Overall Study|Adverse Event|22
754735|NCT00445770|2408283|P3|Overall Study|Not specified|6
754736|NCT00445770|2408284|P2|Overall Study|Not specified|5
754737|NCT00445770|2408285|P1|Overall Study|Not specified|6
754738|NCT00445770|2408283|P3|Overall Study|Lost to Follow-up|0
754739|NCT00445770|2408284|P2|Overall Study|Lost to Follow-up|2
754740|NCT00445770|2408285|P1|Overall Study|Lost to Follow-up|0
754741|NCT00445770|2408283|P3|Overall Study|Lack of Efficacy|6
754742|NCT00445770|2408284|P2|Overall Study|Lack of Efficacy|13
754743|NCT00445770|2408285|P1|Overall Study|Lack of Efficacy|38
754744|NCT00445770|2408283|P3|Overall Study|Adverse Event|19
754745|NCT00445770|2408284|P2|Overall Study|Adverse Event|15
754746|NCT00445770|2408285|P1|Overall Study|Adverse Event|9
890971|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
890972|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
890973|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
754751|NCT00445939|2408362|P4|Period B - Week 4 - Week 8|Adverse Event|1
754752|NCT00445939|2408363|P3|Period B - Week 4 - Week 8|Adverse Event|0
754753|NCT00445939|2408364|P2|Period B - Week 4 - Week 8|Adverse Event|0
754754|NCT00445939|2408365|P1|Period B - Week 4 - Week 8|Adverse Event|2
754755|NCT00445939|2408362|P4|Period A - Week 0 - Week 4|Adverse Event|0
754756|NCT00445939|2408363|P3|Period A - Week 0 - Week 4|Adverse Event|0
754757|NCT00445939|2408364|P2|Period A - Week 0 - Week 4|Adverse Event|2
754758|NCT00445939|2408365|P1|Period A - Week 0 - Week 4|Adverse Event|1
754759|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
754760|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
754761|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
754762|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
754763|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
754764|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
754765|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
754766|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
754767|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
754768|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
754769|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
754770|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
754771|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
754772|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
754773|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Death|2
754774|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Death|2
754775|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
754776|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
754777|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
754778|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
754779|NCT00446030|2408390|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
754780|NCT00446030|2408391|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
754781|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
754782|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
754783|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
754784|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
754785|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
754786|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
754787|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
754788|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
754789|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
754790|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
754791|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
754792|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
754793|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
754794|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
754795|NCT00446030|2408390|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
754796|NCT00446030|2408391|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
754797|NCT00446095|2408404|P5|Phase I (28 Days)|Lack of Efficacy|3
754798|NCT00446095|2408405|P4|Phase I (28 Days)|Lack of Efficacy|0
754799|NCT00446095|2408406|P3|Phase I (28 Days)|Lack of Efficacy|0
754800|NCT00446095|2408407|P2|Phase I (28 Days)|Lack of Efficacy|0
754801|NCT00446095|2408408|P1|Phase I (28 Days)|Lack of Efficacy|0
754802|NCT00446095|2408404|P5|Phase I (28 Days)|Adverse Event|0
754803|NCT00446095|2408405|P4|Phase I (28 Days)|Adverse Event|1
754804|NCT00446095|2408406|P3|Phase I (28 Days)|Adverse Event|0
754805|NCT00446095|2408407|P2|Phase I (28 Days)|Adverse Event|0
754806|NCT00446095|2408408|P1|Phase I (28 Days)|Adverse Event|0
754807|NCT00446095|2408404|P5|Phase II (8 Weeks)|Ongoing|0
754808|NCT00446095|2408405|P4|Phase II (8 Weeks)|Ongoing|0
754809|NCT00446095|2408406|P3|Phase II (8 Weeks)|Ongoing|1
754810|NCT00446095|2408407|P2|Phase II (8 Weeks)|Ongoing|0
754811|NCT00446095|2408408|P1|Phase II (8 Weeks)|Ongoing|0
754812|NCT00446095|2408404|P5|Phase II (8 Weeks)|Lack of Efficacy|0
754813|NCT00446095|2408405|P4|Phase II (8 Weeks)|Lack of Efficacy|0
754814|NCT00446095|2408406|P3|Phase II (8 Weeks)|Lack of Efficacy|1
754815|NCT00446095|2408407|P2|Phase II (8 Weeks)|Lack of Efficacy|2
754816|NCT00446095|2408408|P1|Phase II (8 Weeks)|Lack of Efficacy|9
754817|NCT00446095|2408404|P5|Phase II (8 Weeks)|Physician Decision|0
754818|NCT00446095|2408405|P4|Phase II (8 Weeks)|Physician Decision|0
754819|NCT00446095|2408406|P3|Phase II (8 Weeks)|Physician Decision|0
754820|NCT00446095|2408407|P2|Phase II (8 Weeks)|Physician Decision|0
754821|NCT00446095|2408408|P1|Phase II (8 Weeks)|Physician Decision|1
754822|NCT00446095|2408404|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
754823|NCT00446095|2408405|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
754824|NCT00446095|2408406|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
754825|NCT00446095|2408407|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
754826|NCT00446095|2408408|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
754827|NCT00446095|2408404|P5|Phase II (8 Weeks)|Adverse Event|0
754828|NCT00446095|2408405|P4|Phase II (8 Weeks)|Adverse Event|0
754829|NCT00446095|2408406|P3|Phase II (8 Weeks)|Adverse Event|1
754830|NCT00446095|2408407|P2|Phase II (8 Weeks)|Adverse Event|1
754831|NCT00446095|2408408|P1|Phase II (8 Weeks)|Adverse Event|0
754832|NCT00446095|2408404|P5|Phase II (8 Weeks)|Lost to Follow-up|0
754833|NCT00446095|2408405|P4|Phase II (8 Weeks)|Lost to Follow-up|0
754834|NCT00446095|2408406|P3|Phase II (8 Weeks)|Lost to Follow-up|0
754835|NCT00446095|2408407|P2|Phase II (8 Weeks)|Lost to Follow-up|0
754836|NCT00446095|2408408|P1|Phase II (8 Weeks)|Lost to Follow-up|1
754837|NCT00446134|2408433|P4|Overall Study|Reason Not Completed|2
754838|NCT00446134|2408434|P3|Overall Study|Reason Not Completed|1
754839|NCT00446134|2408435|P2|Overall Study|Reason Not Completed|0
754840|NCT00446134|2408436|P1|Overall Study|Reason Not Completed|3
754841|NCT00446134|2408433|P4|Overall Study|Adverse Event-Diarrhea|0
754842|NCT00446134|2408434|P3|Overall Study|Adverse Event-Diarrhea|2
754843|NCT00446134|2408435|P2|Overall Study|Adverse Event-Diarrhea|1
754844|NCT00446134|2408436|P1|Overall Study|Adverse Event-Diarrhea|1
754845|NCT00446134|2408433|P4|Overall Study|Physician Decision|2
754846|NCT00446134|2408434|P3|Overall Study|Physician Decision|0
754847|NCT00446134|2408435|P2|Overall Study|Physician Decision|0
754848|NCT00446134|2408436|P1|Overall Study|Physician Decision|0
754849|NCT00446134|2408433|P4|Overall Study|Withdrawal by Subject|3
754850|NCT00446134|2408434|P3|Overall Study|Withdrawal by Subject|1
754851|NCT00446134|2408435|P2|Overall Study|Withdrawal by Subject|3
754852|NCT00446134|2408436|P1|Overall Study|Withdrawal by Subject|3
754853|NCT00446134|2408433|P4|Overall Study|Lost to Follow-up|1
754854|NCT00446134|2408434|P3|Overall Study|Lost to Follow-up|1
754855|NCT00446134|2408435|P2|Overall Study|Lost to Follow-up|3
754856|NCT00446134|2408436|P1|Overall Study|Lost to Follow-up|1
754857|NCT00446134|2408433|P4|Overall Study|Protocol Violation|0
754858|NCT00446134|2408434|P3|Overall Study|Protocol Violation|1
754859|NCT00446134|2408435|P2|Overall Study|Protocol Violation|2
754860|NCT00446134|2408436|P1|Overall Study|Protocol Violation|0
754861|NCT00446134|2408433|P4|Overall Study|Lack of Efficacy|19
754862|NCT00446134|2408434|P3|Overall Study|Lack of Efficacy|24
754863|NCT00446134|2408435|P2|Overall Study|Lack of Efficacy|19
754864|NCT00446134|2408436|P1|Overall Study|Lack of Efficacy|19
754865|NCT00446134|2408433|P4|Overall Study|Adverse Event|18
754866|NCT00446134|2408434|P3|Overall Study|Adverse Event|13
754867|NCT00446134|2408435|P2|Overall Study|Adverse Event|17
754868|NCT00446134|2408436|P1|Overall Study|Adverse Event|7
754869|NCT00446199|2408473|P4|Overall Study|Move|0
754870|NCT00446199|2408474|P3|Overall Study|Move|0
754871|NCT00446199|2408475|P2|Overall Study|Move|1
754872|NCT00446199|2408476|P1|Overall Study|Move|0
754873|NCT00446199|2408473|P4|Overall Study|In-/Exclusion criterion violated|1
754874|NCT00446199|2408474|P3|Overall Study|In-/Exclusion criterion violated|2
754875|NCT00446199|2408475|P2|Overall Study|In-/Exclusion criterion violated|1
754876|NCT00446199|2408476|P1|Overall Study|In-/Exclusion criterion violated|2
754877|NCT00446199|2408473|P4|Overall Study|Lost interest in study participation|0
754878|NCT00446199|2408474|P3|Overall Study|Lost interest in study participation|0
754879|NCT00446199|2408475|P2|Overall Study|Lost interest in study participation|1
754880|NCT00446199|2408476|P1|Overall Study|Lost interest in study participation|0
754881|NCT00446199|2408473|P4|Overall Study|Hormone fear|1
754882|NCT00446199|2408474|P3|Overall Study|Hormone fear|0
754883|NCT00446199|2408475|P2|Overall Study|Hormone fear|0
754884|NCT00446199|2408476|P1|Overall Study|Hormone fear|0
754885|NCT00446199|2408473|P4|Overall Study|Non-compliant with visit schedule|2
754886|NCT00446199|2408474|P3|Overall Study|Non-compliant with visit schedule|1
754887|NCT00446199|2408475|P2|Overall Study|Non-compliant with visit schedule|1
754888|NCT00446199|2408476|P1|Overall Study|Non-compliant with visit schedule|1
754889|NCT00446199|2408473|P4|Overall Study|Non-compliant with study drug|0
754890|NCT00446199|2408474|P3|Overall Study|Non-compliant with study drug|5
754891|NCT00446199|2408475|P2|Overall Study|Non-compliant with study drug|0
754892|NCT00446199|2408476|P1|Overall Study|Non-compliant with study drug|1
754893|NCT00446199|2408473|P4|Overall Study|Lack of Efficacy|1
754894|NCT00446199|2408474|P3|Overall Study|Lack of Efficacy|0
754895|NCT00446199|2408475|P2|Overall Study|Lack of Efficacy|0
754896|NCT00446199|2408476|P1|Overall Study|Lack of Efficacy|1
754897|NCT00446199|2408473|P4|Overall Study|Randomization in Error|1
754898|NCT00446199|2408474|P3|Overall Study|Randomization in Error|1
754899|NCT00446199|2408475|P2|Overall Study|Randomization in Error|0
754900|NCT00446199|2408476|P1|Overall Study|Randomization in Error|2
754901|NCT00446199|2408473|P4|Overall Study|Site termination|1
754902|NCT00446199|2408474|P3|Overall Study|Site termination|0
754903|NCT00446199|2408475|P2|Overall Study|Site termination|0
754904|NCT00446199|2408476|P1|Overall Study|Site termination|2
754905|NCT00446199|2408473|P4|Overall Study|Withdrawal by Subject|10
754906|NCT00446199|2408474|P3|Overall Study|Withdrawal by Subject|9
754907|NCT00446199|2408475|P2|Overall Study|Withdrawal by Subject|5
754908|NCT00446199|2408476|P1|Overall Study|Withdrawal by Subject|2
754909|NCT00446199|2408473|P4|Overall Study|Protocol Violation|3
754910|NCT00446199|2408474|P3|Overall Study|Protocol Violation|1
754911|NCT00446199|2408475|P2|Overall Study|Protocol Violation|2
754912|NCT00446199|2408476|P1|Overall Study|Protocol Violation|1
754913|NCT00446199|2408473|P4|Overall Study|Lost to Follow-up|6
754914|NCT00446199|2408474|P3|Overall Study|Lost to Follow-up|2
754915|NCT00446199|2408475|P2|Overall Study|Lost to Follow-up|5
754916|NCT00446199|2408476|P1|Overall Study|Lost to Follow-up|4
754917|NCT00446199|2408473|P4|Overall Study|Adverse Event|4
754918|NCT00446199|2408474|P3|Overall Study|Adverse Event|6
754919|NCT00446199|2408475|P2|Overall Study|Adverse Event|4
754920|NCT00446199|2408476|P1|Overall Study|Adverse Event|7
754921|NCT00446251|2408554|P1|Overall Study|Lost to Follow-up|1
754922|NCT00446251|2408554|P1|Overall Study|Rituximab Infusion Reaction|2
754923|NCT00446251|2408554|P1|Overall Study|On-study Transplants|2
754924|NCT00446446|2408573|P1|Overall Study|On Treatment at Time of Data Cut-off|1
754925|NCT00446446|2408573|P1|Overall Study|Adverse Event|1
754926|NCT00446446|2408573|P1|Overall Study|Disease Progession|2
754927|NCT00446446|2408573|P1|Overall Study|Other|4
754928|NCT00446446|2408573|P1|Overall Study|Withdrawal by Subject|6
754929|NCT00446446|2408573|P1|Overall Study|Death|10
754930|NCT00446459|2408584|P1|12 Months|14 subjects to MMF + Rituximab Study|14
754931|NCT00446459|2408584|P1|12 Months|Protocol Violation|4
754932|NCT00446459|2408584|P1|8 Months|Protocol Violation|12
754933|NCT00446511|2408596|P4|Overall Study|Administrative Problems|1
754934|NCT00446511|2408597|P3|Overall Study|Administrative Problems|4
754935|NCT00446511|2408598|P2|Overall Study|Administrative Problems|0
754936|NCT00446511|2408599|P1|Overall Study|Administrative Problems|3
754937|NCT00446511|2408596|P4|Overall Study|Withdrawal by Subject|3
754938|NCT00446511|2408597|P3|Overall Study|Withdrawal by Subject|0
754939|NCT00446511|2408598|P2|Overall Study|Withdrawal by Subject|0
754940|NCT00446511|2408599|P1|Overall Study|Withdrawal by Subject|0
754941|NCT00446511|2408596|P4|Overall Study|Protocol Violation|1
754942|NCT00446511|2408597|P3|Overall Study|Protocol Violation|0
754943|NCT00446511|2408598|P2|Overall Study|Protocol Violation|0
754944|NCT00446511|2408599|P1|Overall Study|Protocol Violation|0
754945|NCT00446511|2408596|P4|Overall Study|Adverse Event|1
754946|NCT00446511|2408597|P3|Overall Study|Adverse Event|3
754947|NCT00446511|2408598|P2|Overall Study|Adverse Event|2
754948|NCT00446511|2408599|P1|Overall Study|Adverse Event|7
754949|NCT00446563|2408625|P2|Overall Study|Administrative problems|1
754950|NCT00446563|2408626|P1|Overall Study|Administrative problems|0
754951|NCT00446563|2408625|P2|Overall Study|Withdrawal by Subject|1
754952|NCT00446563|2408626|P1|Overall Study|Withdrawal by Subject|2
754953|NCT00446563|2408625|P2|Overall Study|Unsatisfactory therapeutic effect|3
754954|NCT00446563|2408626|P1|Overall Study|Unsatisfactory therapeutic effect|0
754955|NCT00446563|2408625|P2|Overall Study|Abnormal test procedure result(s)|0
754956|NCT00446563|2408626|P1|Overall Study|Abnormal test procedure result(s)|1
754957|NCT00446563|2408625|P2|Overall Study|Abnormal laboratory value(s)|1
754958|NCT00446563|2408626|P1|Overall Study|Abnormal laboratory value(s)|0
754959|NCT00446563|2408625|P2|Overall Study|Adverse Event|3
754960|NCT00446563|2408626|P1|Overall Study|Adverse Event|4
754961|NCT00446641|2408662|P2|Overall Study|Lost to Follow-up|1
754962|NCT00446641|2408663|P1|Overall Study|Lost to Follow-up|1
754963|NCT00446641|2408662|P2|Overall Study|poor compliance|6
754964|NCT00446641|2408663|P1|Overall Study|poor compliance|8
754965|NCT00446641|2408662|P2|Overall Study|Withdrawal by Subject|3
754966|NCT00446641|2408663|P1|Overall Study|Withdrawal by Subject|8
754967|NCT00446654|2408683|P2|Overall Study|Adverse Event|0
754968|NCT00446654|2408684|P1|Overall Study|Adverse Event|1
754969|NCT00446654|2408683|P2|Overall Study|Withdrawal by Subject|0
754970|NCT00446654|2408684|P1|Overall Study|Withdrawal by Subject|1
754971|NCT00446797|2408692|P2|Overall Study|did not meet entrance criteria|1
754972|NCT00446797|2408693|P1|Overall Study|did not meet entrance criteria|0
754973|NCT00446797|2408692|P2|Overall Study|subject entered at another site|1
754974|NCT00446797|2408693|P1|Overall Study|subject entered at another site|0
754975|NCT00446797|2408692|P2|Overall Study|Protocol Violation|3
754976|NCT00446797|2408693|P1|Overall Study|Protocol Violation|1
754977|NCT00446797|2408692|P2|Overall Study|Withdrawal by Subject|2
754978|NCT00446797|2408693|P1|Overall Study|Withdrawal by Subject|2
754979|NCT00446797|2408692|P2|Overall Study|Lost to Follow-up|3
754980|NCT00446797|2408693|P1|Overall Study|Lost to Follow-up|5
754981|NCT00446797|2408692|P2|Overall Study|Lack of Efficacy|2
754982|NCT00446797|2408693|P1|Overall Study|Lack of Efficacy|0
754983|NCT00455195|2408739|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
754984|NCT00455195|2408740|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
754985|NCT00455195|2408739|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
754986|NCT00455195|2408740|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
754987|NCT00455195|2408739|P2|Double-blind Study AGLU02704|Death|0
754988|NCT00455195|2408740|P1|Double-blind Study AGLU02704|Death|1
754989|NCT00455195|2408739|P2|Double-blind Study AGLU02704|Adverse Event|1
754990|NCT00455195|2408740|P1|Double-blind Study AGLU02704|Adverse Event|2
754993|NCT00455429|2408785|P4|Overall Study|Unspecified|1
754994|NCT00455429|2408786|P3|Overall Study|Unspecified|0
754995|NCT00455429|2408787|P2|Overall Study|Unspecified|2
754996|NCT00455429|2408788|P1|Overall Study|Unspecified|0
754997|NCT00455429|2408785|P4|Overall Study|Non-compliance|1
754998|NCT00455429|2408786|P3|Overall Study|Non-compliance|0
754999|NCT00455429|2408787|P2|Overall Study|Non-compliance|0
755000|NCT00455429|2408788|P1|Overall Study|Non-compliance|0
755001|NCT00455429|2408785|P4|Overall Study|Personal Reason|0
755002|NCT00455429|2408786|P3|Overall Study|Personal Reason|0
755003|NCT00455429|2408787|P2|Overall Study|Personal Reason|0
755004|NCT00455429|2408788|P1|Overall Study|Personal Reason|1
755005|NCT00455429|2408785|P4|Overall Study|Randomly assigned but not treated|2
755006|NCT00455429|2408786|P3|Overall Study|Randomly assigned but not treated|0
755007|NCT00455429|2408787|P2|Overall Study|Randomly assigned but not treated|0
755008|NCT00455429|2408788|P1|Overall Study|Randomly assigned but not treated|0
755009|NCT00455429|2408785|P4|Overall Study|Adverse Event|3
755010|NCT00455429|2408786|P3|Overall Study|Adverse Event|0
755011|NCT00455429|2408787|P2|Overall Study|Adverse Event|1
755012|NCT00455429|2408788|P1|Overall Study|Adverse Event|0
755013|NCT00455429|2408785|P4|Overall Study|Lack of Efficacy|1
755014|NCT00455429|2408786|P3|Overall Study|Lack of Efficacy|0
755015|NCT00455429|2408787|P2|Overall Study|Lack of Efficacy|1
755016|NCT00455429|2408788|P1|Overall Study|Lack of Efficacy|0
755017|NCT00455429|2408785|P4|Overall Study|Withdrawal by Subject|0
755018|NCT00455429|2408786|P3|Overall Study|Withdrawal by Subject|1
755019|NCT00455429|2408787|P2|Overall Study|Withdrawal by Subject|1
755020|NCT00455429|2408788|P1|Overall Study|Withdrawal by Subject|0
755021|NCT00455429|2408785|P4|Overall Study|Lost to Follow-up|3
755022|NCT00455429|2408786|P3|Overall Study|Lost to Follow-up|0
755023|NCT00455429|2408787|P2|Overall Study|Lost to Follow-up|0
755024|NCT00455429|2408788|P1|Overall Study|Lost to Follow-up|1
755025|NCT00455429|2408785|P4|Overall Study|Study Terminated by Sponsor|3
755026|NCT00455429|2408786|P3|Overall Study|Study Terminated by Sponsor|0
755027|NCT00455429|2408787|P2|Overall Study|Study Terminated by Sponsor|0
755028|NCT00455429|2408788|P1|Overall Study|Study Terminated by Sponsor|0
755029|NCT00455455|2408845|P2|Washout|Withdrawal by Subject|0
755030|NCT00455455|2408846|P1|Washout|Withdrawal by Subject|1
755031|NCT00455455|2408845|P2|Washout|Withdrawal by Subject|1
755032|NCT00455455|2408846|P1|Washout|Withdrawal by Subject|0
755033|NCT00455858|2408930|P1|Overall Study|Withdrawal|1
755034|NCT00455858|2408930|P1|Overall Study|Well controlled FPG without insulin|1
755035|NCT00455858|2408930|P1|Overall Study|Lack of Efficacy|1
755036|NCT00455858|2408930|P1|Overall Study|Protocol Violation|1
755037|NCT00455858|2408930|P1|Overall Study|Lost to Follow-up|2
755038|NCT00456495|2408981|P1|Overall Study|Physician Decision|2
755039|NCT00456521|2408994|P2|Overall Study|Drug non-compliance, moved, other|11
755040|NCT00456521|2408995|P1|Overall Study|Drug non-compliance, moved, other|26
755041|NCT00456521|2408994|P2|Overall Study|Pregnancy|1
755042|NCT00456521|2408995|P1|Overall Study|Pregnancy|1
755043|NCT00456521|2408994|P2|Overall Study|Protocol Violation|0
755044|NCT00456521|2408995|P1|Overall Study|Protocol Violation|4
755045|NCT00456521|2408994|P2|Overall Study|Lack of Efficacy|6
755046|NCT00456521|2408995|P1|Overall Study|Lack of Efficacy|3
755047|NCT00456521|2408994|P2|Overall Study|Lost to Follow-up|17
755048|NCT00456521|2408995|P1|Overall Study|Lost to Follow-up|22
755049|NCT00456521|2408994|P2|Overall Study|Withdrawal by Subject|24
755050|NCT00456521|2408995|P1|Overall Study|Withdrawal by Subject|43
755051|NCT00456521|2408994|P2|Overall Study|Adverse Event|25
755052|NCT00456521|2408995|P1|Overall Study|Adverse Event|150
755053|NCT00456599|2409050|P1|Overall Study|Withdrawal by Subject|2
755054|NCT00456599|2409050|P1|Overall Study|Non-compliance|1
755055|NCT00456612|2409056|P1|Overall Study|Withdrawal by Subject|3
755056|NCT00456755|2409069|P2|Overall Study|Lost to Follow-up|1
755057|NCT00456755|2409070|P1|Overall Study|Lost to Follow-up|2
755058|NCT00456846|2409099|P2|Overall Study|Unspecified|2
755059|NCT00456846|2409100|P1|Overall Study|Unspecified|0
755060|NCT00456846|2409099|P2|Overall Study|Participant Discretion|5
755061|NCT00456846|2409100|P1|Overall Study|Participant Discretion|1
755062|NCT00456846|2409099|P2|Overall Study|Protocol Deviation|0
755063|NCT00456846|2409100|P1|Overall Study|Protocol Deviation|2
755064|NCT00456846|2409099|P2|Overall Study|Physician Decision|6
755065|NCT00456846|2409100|P1|Overall Study|Physician Decision|11
755066|NCT00456846|2409099|P2|Overall Study|Adverse Event|15
755067|NCT00456846|2409100|P1|Overall Study|Adverse Event|2
755068|NCT00457002|2409156|P2|Overall Study|treated for 1 day; missing status/reason|0
755069|NCT00457002|2409157|P1|Overall Study|treated for 1 day; missing status/reason|1
755070|NCT00457002|2409156|P2|Overall Study|non-specified|38
755071|NCT00457002|2409157|P1|Overall Study|non-specified|29
755072|NCT00457002|2409156|P2|Overall Study|Administrative reason by Sponsor|0
755073|NCT00457002|2409157|P1|Overall Study|Administrative reason by Sponsor|1
755074|NCT00457002|2409156|P2|Overall Study|No longer met criteria|37
755075|NCT00457002|2409157|P1|Overall Study|No longer met criteria|41
755076|NCT00457002|2409156|P2|Overall Study|Poor/Non-compliance|33
755077|NCT00457002|2409157|P1|Overall Study|Poor/Non-compliance|46
755078|NCT00457002|2409156|P2|Overall Study|Lost to Follow-up|71
755079|NCT00457002|2409157|P1|Overall Study|Lost to Follow-up|72
755080|NCT00457002|2409156|P2|Overall Study|Withdrawal by Subject|271
755081|NCT00457002|2409157|P1|Overall Study|Withdrawal by Subject|299
755082|NCT00457002|2409156|P2|Overall Study|Adverse Event|260
755083|NCT00457002|2409157|P1|Overall Study|Adverse Event|284
755084|NCT00457002|2409156|P2|Overall Study|Death|47
755085|NCT00457002|2409157|P1|Overall Study|Death|40
755086|NCT00457015|2409227|P2|Overall Study|Left study site against medical advice|1
755087|NCT00457015|2409228|P1|Overall Study|Left study site against medical advice|0
755088|NCT00457249|2409269|P2|Overall Study|Serious Adverse Events|0
755089|NCT00457249|2409270|P1|Overall Study|Serious Adverse Events|2
755090|NCT00457249|2409269|P2|Overall Study|Withdrawal by Subject|1
755091|NCT00457249|2409270|P1|Overall Study|Withdrawal by Subject|3
755092|NCT00457249|2409269|P2|Overall Study|Protocol Violation|1
755093|NCT00457249|2409270|P1|Overall Study|Protocol Violation|4
755094|NCT00457249|2409269|P2|Overall Study|Lost to Follow-up|0
755095|NCT00457249|2409270|P1|Overall Study|Lost to Follow-up|3
755096|NCT00457301|2409284|P2|Overall Study|Death|7
755097|NCT00457301|2409285|P1|Overall Study|Death|5
755098|NCT00457301|2409284|P2|Overall Study|Censored out of the study|14
755099|NCT00457301|2409285|P1|Overall Study|Censored out of the study|15
755100|NCT00457301|2409284|P2|Overall Study|Withdrawal by Subject|3
755101|NCT00457301|2409285|P1|Overall Study|Withdrawal by Subject|3
755102|NCT00457392|2409299|P2|Overall Study|Randomized, Not Treated|3
755103|NCT00457392|2409300|P1|Overall Study|Randomized, Not Treated|7
755104|NCT00457392|2409299|P2|Overall Study|Study Terminated by Sponsor|4
755105|NCT00457392|2409300|P1|Overall Study|Study Terminated by Sponsor|1
755106|NCT00457392|2409299|P2|Overall Study|Unspecified|4
755107|NCT00457392|2409300|P1|Overall Study|Unspecified|7
755108|NCT00457392|2409299|P2|Overall Study|Protocol Violation|3
755109|NCT00457392|2409300|P1|Overall Study|Protocol Violation|4
755110|NCT00457392|2409299|P2|Overall Study|Lost to Follow-up|7
755111|NCT00457392|2409300|P1|Overall Study|Lost to Follow-up|6
755112|NCT00457392|2409299|P2|Overall Study|Withdrawal by Subject|8
755113|NCT00457392|2409300|P1|Overall Study|Withdrawal by Subject|14
755114|NCT00457392|2409299|P2|Overall Study|Global Deterioration of Health Status|8
755115|NCT00457392|2409300|P1|Overall Study|Global Deterioration of Health Status|22
755116|NCT00457392|2409299|P2|Overall Study|Adverse Event|41
755117|NCT00457392|2409300|P1|Overall Study|Adverse Event|84
755118|NCT00457392|2409299|P2|Overall Study|Death|106
755119|NCT00457392|2409300|P1|Overall Study|Death|106
755120|NCT00457392|2409299|P2|Overall Study|Objective Progression or Relapse|296
755121|NCT00457392|2409300|P1|Overall Study|Objective Progression or Relapse|229
755122|NCT00457418|2409316|P1|Post PK Maintenance|Lost to Follow-up|1
755123|NCT00457418|2409316|P1|Post PK Maintenance|Withdrawal by Subject|11
755124|NCT00457418|2409316|P1|Post PK Maintenance|Progression of Disease|6
755125|NCT00457418|2409316|P1|Post PK Maintenance|Adverse Event|10
755126|NCT00457418|2409316|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
755127|NCT00457418|2409316|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
755128|NCT00457418|2409316|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
755129|NCT00457691|2409328|P2|Overall Study|Disease progression, study terminated|196
755130|NCT00457691|2409329|P1|Overall Study|Disease progression, study terminated|180
755131|NCT00457691|2409328|P2|Overall Study|Subject refused (reason other than AE)|19
755132|NCT00457691|2409329|P1|Overall Study|Subject refused (reason other than AE)|14
755133|NCT00457691|2409328|P2|Overall Study|Study terminated by Sponsor|1
755134|NCT00457691|2409329|P1|Overall Study|Study terminated by Sponsor|1
755135|NCT00457691|2409328|P2|Overall Study|Lost to Follow-up|14
755136|NCT00457691|2409329|P1|Overall Study|Lost to Follow-up|23
755137|NCT00457691|2409328|P2|Overall Study|Protocol Violation|3
755138|NCT00457691|2409329|P1|Overall Study|Protocol Violation|1
755139|NCT00457691|2409328|P2|Overall Study|Death|148
755140|NCT00457691|2409329|P1|Overall Study|Death|163
755141|NCT00457691|2409328|P2|Overall Study|Adverse Event|1
755142|NCT00457691|2409329|P1|Overall Study|Adverse Event|4
755143|NCT00457743|2409365|P3|Overall Study|Lack of Efficacy|3
755144|NCT00457743|2409366|P2|Overall Study|Lack of Efficacy|23
755145|NCT00457743|2409367|P1|Overall Study|Lack of Efficacy|3
755146|NCT00457743|2409365|P3|Overall Study|Adverse Event|0
755147|NCT00457743|2409366|P2|Overall Study|Adverse Event|4
755148|NCT00457743|2409367|P1|Overall Study|Adverse Event|0
755149|NCT00457821|2409424|P8|Part 2|Withdrawal by Subject|1
755150|NCT00457821|2409425|P7|Part 2|Withdrawal by Subject|0
755151|NCT00457821|2409426|P6|Part 2|Withdrawal by Subject|0
755152|NCT00457821|2409427|P5|Part 2|Withdrawal by Subject|0
755153|NCT00457821|2409428|P4|Part 2|Withdrawal by Subject|0
755154|NCT00457821|2409429|P3|Part 2|Withdrawal by Subject|0
755155|NCT00457821|2409430|P2|Part 2|Withdrawal by Subject|0
755156|NCT00457821|2409431|P1|Part 2|Withdrawal by Subject|0
755157|NCT00444275|2409486|P5|Maintenance Treatment Phase|Ineffectiveness|14
755158|NCT00444275|2409487|P4|Maintenance Treatment Phase|Ineffectiveness|3
755159|NCT00444275|2409488|P3|Maintenance Treatment Phase|Ineffectiveness|5
755160|NCT00444275|2409489|P2|Maintenance Treatment Phase|Ineffectiveness|0
755161|NCT00444275|2409490|P1|Maintenance Treatment Phase|Ineffectiveness|0
755162|NCT00444275|2409486|P5|Maintenance Treatment Phase|Protocol Violation|87
755163|NCT00444275|2409487|P4|Maintenance Treatment Phase|Protocol Violation|88
755164|NCT00444275|2409488|P3|Maintenance Treatment Phase|Protocol Violation|103
755165|NCT00444275|2409489|P2|Maintenance Treatment Phase|Protocol Violation|0
755166|NCT00444275|2409490|P1|Maintenance Treatment Phase|Protocol Violation|0
755167|NCT00444275|2409486|P5|Maintenance Treatment Phase|Patient's wish|20
755168|NCT00444275|2409487|P4|Maintenance Treatment Phase|Patient's wish|9
755169|NCT00444275|2409488|P3|Maintenance Treatment Phase|Patient's wish|19
755170|NCT00444275|2409489|P2|Maintenance Treatment Phase|Patient's wish|0
755171|NCT00444275|2409490|P1|Maintenance Treatment Phase|Patient's wish|0
755172|NCT00444275|2409486|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
755173|NCT00444275|2409487|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
755174|NCT00444275|2409488|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
755175|NCT00444275|2409489|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
755176|NCT00444275|2409490|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
755177|NCT00444275|2409486|P5|Maintenance Treatment Phase|Adverse Event|13
755178|NCT00444275|2409487|P4|Maintenance Treatment Phase|Adverse Event|2
755179|NCT00444275|2409488|P3|Maintenance Treatment Phase|Adverse Event|3
755180|NCT00444275|2409489|P2|Maintenance Treatment Phase|Adverse Event|0
755181|NCT00444275|2409490|P1|Maintenance Treatment Phase|Adverse Event|0
755182|NCT00444275|2409486|P5|Maintenance Treatment Phase|Lost to Follow-up|10
755183|NCT00444275|2409487|P4|Maintenance Treatment Phase|Lost to Follow-up|14
755184|NCT00444275|2409488|P3|Maintenance Treatment Phase|Lost to Follow-up|8
755185|NCT00444275|2409489|P2|Maintenance Treatment Phase|Lost to Follow-up|0
755186|NCT00444275|2409490|P1|Maintenance Treatment Phase|Lost to Follow-up|0
755187|NCT00444275|2409486|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
755188|NCT00444275|2409487|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
755189|NCT00444275|2409488|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
755190|NCT00444275|2409489|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
755191|NCT00444275|2409490|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
755192|NCT00449787|2409546|P2|Overall Study|Did not require medication|92
755193|NCT00449787|2409547|P1|Overall Study|Did not require medication|95
755194|NCT00449787|2409546|P2|Overall Study|Lost to Follow-up|8
755195|NCT00449787|2409547|P1|Overall Study|Lost to Follow-up|10
755196|NCT00449865|2409559|P2|Overall Study|Study was stopped|328
755197|NCT00449865|2409560|P1|Overall Study|Study was stopped|324
755198|NCT00449865|2409559|P2|Overall Study|Protocol Violation|7
755199|NCT00449865|2409560|P1|Overall Study|Protocol Violation|8
755200|NCT00449865|2409559|P2|Overall Study|Death|40
755201|NCT00449865|2409560|P1|Overall Study|Death|31
755202|NCT00449865|2409559|P2|Overall Study|Physician Decision|12
755203|NCT00449865|2409560|P1|Overall Study|Physician Decision|13
755204|NCT00449865|2409559|P2|Overall Study|Lost to Follow-up|37
755205|NCT00449865|2409560|P1|Overall Study|Lost to Follow-up|36
755206|NCT00449865|2409559|P2|Overall Study|Withdrawal by Subject|110
755207|NCT00449865|2409560|P1|Overall Study|Withdrawal by Subject|110
755208|NCT00449930|2409568|P2|Overall Study|Glycemic discontinuation criteria|1
755209|NCT00449930|2409569|P1|Overall Study|Glycemic discontinuation criteria|1
755210|NCT00449930|2409568|P2|Overall Study|Withdrawal by Subject|23
755211|NCT00449930|2409569|P1|Overall Study|Withdrawal by Subject|16
755212|NCT00449930|2409568|P2|Overall Study|Protocol Violation|15
755213|NCT00449930|2409569|P1|Overall Study|Protocol Violation|14
755214|NCT00449930|2409568|P2|Overall Study|Physician Decision|2
755215|NCT00449930|2409569|P1|Overall Study|Physician Decision|1
755216|NCT00449930|2409568|P2|Overall Study|Lost to Follow-up|14
755217|NCT00449930|2409569|P1|Overall Study|Lost to Follow-up|9
755218|NCT00449930|2409568|P2|Overall Study|Lack of Efficacy|1
755219|NCT00449930|2409569|P1|Overall Study|Lack of Efficacy|10
755220|NCT00449930|2409568|P2|Overall Study|Trial Terminated ( Site Closed)|0
755221|NCT00449930|2409569|P1|Overall Study|Trial Terminated ( Site Closed)|1
755222|NCT00449930|2409568|P2|Overall Study|Adverse Event|19
755223|NCT00449930|2409569|P1|Overall Study|Adverse Event|9
755224|NCT00449956|2409586|P3|Overall Study|Physician Decision|1
755225|NCT00449956|2409587|P2|Overall Study|Physician Decision|1
755226|NCT00449956|2409588|P1|Overall Study|Physician Decision|2
755227|NCT00449956|2409586|P3|Overall Study|Withdrawal by Subject|0
755228|NCT00449956|2409587|P2|Overall Study|Withdrawal by Subject|1
755229|NCT00449956|2409588|P1|Overall Study|Withdrawal by Subject|0
755230|NCT00449956|2409586|P3|Overall Study|Protocol Violation|1
755231|NCT00449956|2409587|P2|Overall Study|Protocol Violation|1
755232|NCT00449956|2409588|P1|Overall Study|Protocol Violation|1
755233|NCT00449956|2409586|P3|Overall Study|Lack of Efficacy|1
755234|NCT00449956|2409587|P2|Overall Study|Lack of Efficacy|0
755235|NCT00449956|2409588|P1|Overall Study|Lack of Efficacy|0
755236|NCT00449956|2409586|P3|Overall Study|Adverse Event|6
755237|NCT00449956|2409587|P2|Overall Study|Adverse Event|1
755238|NCT00449956|2409588|P1|Overall Study|Adverse Event|7
755239|NCT00450112|2409604|P2|Overall Study|Others|3
755240|NCT00450112|2409605|P1|Overall Study|Others|2
755241|NCT00450112|2409604|P2|Overall Study|Lost to Follow-up|1
755242|NCT00450112|2409605|P1|Overall Study|Lost to Follow-up|2
755243|NCT00450112|2409604|P2|Overall Study|Withdrawal by Subject|1
755244|NCT00450112|2409605|P1|Overall Study|Withdrawal by Subject|4
755245|NCT00450112|2409604|P2|Overall Study|Other Treatment Required|1
755246|NCT00450112|2409605|P1|Overall Study|Other Treatment Required|5
755247|NCT00450216|2409629|P2|Overall Study|misc|20
755248|NCT00450216|2409630|P1|Overall Study|misc|21
755249|NCT00450216|2409629|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
755250|NCT00450216|2409630|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
755251|NCT00450216|2409629|P2|Overall Study|Lost to Follow-up|9
755252|NCT00450216|2409630|P1|Overall Study|Lost to Follow-up|16
755253|NCT00450216|2409629|P2|Overall Study|Withdrawal by Subject|26
755254|NCT00450216|2409630|P1|Overall Study|Withdrawal by Subject|48
755255|NCT00450216|2409629|P2|Overall Study|Adverse Event|23
755256|NCT00450216|2409630|P1|Overall Study|Adverse Event|38
755257|NCT00450255|2409657|P1|Overall Study|Prior RFA ablation of liver|1
755258|NCT00450333|2409672|P4|Overall Study|Death|2
755259|NCT00450333|2409673|P3|Overall Study|Death|2
755260|NCT00450333|2409674|P2|Overall Study|Death|2
755261|NCT00450333|2409675|P1|Overall Study|Death|3
755262|NCT00450333|2409672|P4|Overall Study|Kidney transplant|3
755263|NCT00450333|2409673|P3|Overall Study|Kidney transplant|1
755264|NCT00450333|2409674|P2|Overall Study|Kidney transplant|0
755265|NCT00450333|2409675|P1|Overall Study|Kidney transplant|1
755266|NCT00450333|2409672|P4|Overall Study|Withdrawal by Subject|0
755267|NCT00450333|2409673|P3|Overall Study|Withdrawal by Subject|3
755268|NCT00450333|2409674|P2|Overall Study|Withdrawal by Subject|0
755269|NCT00450333|2409675|P1|Overall Study|Withdrawal by Subject|1
755270|NCT00450333|2409672|P4|Overall Study|Protocol Violation|0
755271|NCT00450333|2409673|P3|Overall Study|Protocol Violation|1
755272|NCT00450333|2409674|P2|Overall Study|Protocol Violation|0
755273|NCT00450333|2409675|P1|Overall Study|Protocol Violation|1
755274|NCT00450333|2409672|P4|Overall Study|Adverse Event|2
755275|NCT00450333|2409673|P3|Overall Study|Adverse Event|2
755276|NCT00450333|2409674|P2|Overall Study|Adverse Event|7
755277|NCT00450333|2409675|P1|Overall Study|Adverse Event|1
755278|NCT00450333|2409672|P4|Overall Study|Study terminated|21
755279|NCT00450333|2409673|P3|Overall Study|Study terminated|16
755280|NCT00450333|2409674|P2|Overall Study|Study terminated|54
755281|NCT00450333|2409675|P1|Overall Study|Study terminated|47
755282|NCT00450372|2409693|P1|Overall Study|Physician Decision|1
755283|NCT00450385|2409702|P1|Overall Study|Other|3
755284|NCT00450385|2409702|P1|Overall Study|Physician Decision|1
755285|NCT00450385|2409702|P1|Overall Study|Adverse Event|1
755286|NCT00450385|2409702|P1|Overall Study|Lack of Efficacy|2
755287|NCT00450385|2409702|P1|Overall Study|Withdrawal by Subject|2
755288|NCT00450385|2409702|P1|Overall Study|Protocol Violation|1
755289|NCT00450385|2409702|P1|Overall Study|Death|3
755290|NCT00450437|2409722|P4|Overall Study|Unable to Classify|0
755291|NCT00450437|2409723|P3|Overall Study|Unable to Classify|1
755292|NCT00450437|2409724|P2|Overall Study|Unable to Classify|0
755293|NCT00450437|2409725|P1|Overall Study|Unable to Classify|1
755294|NCT00450437|2409722|P4|Overall Study|Administrative reason|0
755295|NCT00450437|2409723|P3|Overall Study|Administrative reason|1
755296|NCT00450437|2409724|P2|Overall Study|Administrative reason|0
755297|NCT00450437|2409725|P1|Overall Study|Administrative reason|0
755298|NCT00450437|2409722|P4|Overall Study|Inappropriate enrollment|0
755299|NCT00450437|2409723|P3|Overall Study|Inappropriate enrollment|3
755300|NCT00450437|2409724|P2|Overall Study|Inappropriate enrollment|1
755301|NCT00450437|2409725|P1|Overall Study|Inappropriate enrollment|4
755302|NCT00450437|2409722|P4|Overall Study|Protocol Violation|1
755303|NCT00450437|2409723|P3|Overall Study|Protocol Violation|0
755304|NCT00450437|2409724|P2|Overall Study|Protocol Violation|1
755305|NCT00450437|2409725|P1|Overall Study|Protocol Violation|0
755306|NCT00450437|2409722|P4|Overall Study|Lost to Follow-up|9
755307|NCT00450437|2409723|P3|Overall Study|Lost to Follow-up|19
755308|NCT00450437|2409724|P2|Overall Study|Lost to Follow-up|12
755309|NCT00450437|2409725|P1|Overall Study|Lost to Follow-up|31
755310|NCT00450437|2409722|P4|Overall Study|Withdrawal by Subject|1
755311|NCT00450437|2409723|P3|Overall Study|Withdrawal by Subject|0
755312|NCT00450437|2409724|P2|Overall Study|Withdrawal by Subject|2
755313|NCT00450437|2409725|P1|Overall Study|Withdrawal by Subject|10
755314|NCT00450450|2409749|P2|Overall Study|Missing Data|0
755315|NCT00450450|2409750|P1|Overall Study|Missing Data|2
755316|NCT00450450|2409749|P2|Overall Study|Relapse|0
755317|NCT00450450|2409750|P1|Overall Study|Relapse|2
755318|NCT00450450|2409749|P2|Overall Study|Death|3
755319|NCT00450450|2409750|P1|Overall Study|Death|1
755320|NCT00450580|2409774|P2|Overall Study|Withdrawal due to pregnancy|1
755321|NCT00450580|2409775|P1|Overall Study|Withdrawal due to pregnancy|0
755322|NCT00450580|2409774|P2|Overall Study|Patient could not swallow Norvir|0
755323|NCT00450580|2409775|P1|Overall Study|Patient could not swallow Norvir|1
755324|NCT00450580|2409774|P2|Overall Study|Patient went to Brazil|0
755325|NCT00450580|2409775|P1|Overall Study|Patient went to Brazil|1
755326|NCT00450580|2409774|P2|Overall Study|Could not comply with scheduled visits|0
755327|NCT00450580|2409775|P1|Overall Study|Could not comply with scheduled visits|1
755328|NCT00450580|2409774|P2|Overall Study|Protocol-defined virologic failure|0
755329|NCT00450580|2409775|P1|Overall Study|Protocol-defined virologic failure|1
755330|NCT00450580|2409774|P2|Overall Study|Protocol Violation|1
755331|NCT00450580|2409775|P1|Overall Study|Protocol Violation|1
755332|NCT00450580|2409774|P2|Overall Study|Withdrawal by Subject|2
755333|NCT00450580|2409775|P1|Overall Study|Withdrawal by Subject|2
755334|NCT00450580|2409774|P2|Overall Study|Lost to Follow-up|5
755335|NCT00450580|2409775|P1|Overall Study|Lost to Follow-up|4
755336|NCT00450580|2409774|P2|Overall Study|Adverse Event|7
755337|NCT00450580|2409775|P1|Overall Study|Adverse Event|5
755338|NCT00450619|2409795|P2|Overall Study|Adverse Event|0
755339|NCT00450619|2409796|P1|Overall Study|Adverse Event|1
755340|NCT00450619|2409795|P2|Overall Study|did not progress; refused further trmt|1
755341|NCT00450619|2409796|P1|Overall Study|did not progress; refused further trmt|1
755342|NCT00450619|2409795|P2|Overall Study|refused treatment after randomization|0
755343|NCT00450619|2409796|P1|Overall Study|refused treatment after randomization|2
755344|NCT00450658|2409822|P2|Overall Study|misc|10
755345|NCT00450658|2409823|P1|Overall Study|misc|21
755346|NCT00450658|2409822|P2|Overall Study|UGI ulcer|34
755347|NCT00450658|2409823|P1|Overall Study|UGI ulcer|33
755348|NCT00450658|2409822|P2|Overall Study|Lost to Follow-up|5
755349|NCT00450658|2409823|P1|Overall Study|Lost to Follow-up|22
755350|NCT00450658|2409822|P2|Overall Study|Withdrawal by Subject|26
755351|NCT00450658|2409823|P1|Overall Study|Withdrawal by Subject|43
755352|NCT00450658|2409822|P2|Overall Study|Adverse Event|15
755353|NCT00450658|2409823|P1|Overall Study|Adverse Event|24
755354|NCT00450723|2409835|P1|Overall Study|Physician Decision|5
755355|NCT00450749|2409844|P3|Overall Study|Noncompliant|0
755356|NCT00450749|2409845|P2|Overall Study|Noncompliant|1
755357|NCT00450749|2409846|P1|Overall Study|Noncompliant|0
755358|NCT00450749|2409844|P3|Overall Study|Withdrawal by Subject|2
755359|NCT00450749|2409845|P2|Overall Study|Withdrawal by Subject|0
755360|NCT00450749|2409846|P1|Overall Study|Withdrawal by Subject|0
755361|NCT00450801|2409854|P1|Overall Study|Death|1
755362|NCT00450866|2409865|P2|Overall Study|Physician Decision|0
755363|NCT00450866|2409866|P1|Overall Study|Physician Decision|1
755364|NCT00450866|2409865|P2|Overall Study|Death|0
755365|NCT00450866|2409866|P1|Overall Study|Death|1
755366|NCT00450866|2409865|P2|Overall Study|Withdrawal by Subject|2
755367|NCT00450866|2409866|P1|Overall Study|Withdrawal by Subject|5
755368|NCT00450866|2409865|P2|Overall Study|Adverse Event|1
755369|NCT00450866|2409866|P1|Overall Study|Adverse Event|0
755370|NCT00451191|2409894|P2|Overall Study|withdrawal or received alternate tx|11
755371|NCT00451191|2409895|P1|Overall Study|withdrawal or received alternate tx|15
755372|NCT00451204|2409903|P2|Overall Study|Other|2
755373|NCT00451204|2409904|P1|Overall Study|Other|1
755374|NCT00451204|2409903|P2|Overall Study|Patient refusal|4
755375|NCT00451204|2409904|P1|Overall Study|Patient refusal|8
755376|NCT00451204|2409903|P2|Overall Study|Protocol Violation|0
755377|NCT00451204|2409904|P1|Overall Study|Protocol Violation|1
755378|NCT00451204|2409903|P2|Overall Study|Lost to Follow-up|4
755379|NCT00451204|2409904|P1|Overall Study|Lost to Follow-up|4
755380|NCT00451204|2409903|P2|Overall Study|Lack of Efficacy|4
755381|NCT00451204|2409904|P1|Overall Study|Lack of Efficacy|4
755382|NCT00451204|2409903|P2|Overall Study|Adverse Event|6
755383|NCT00451204|2409904|P1|Overall Study|Adverse Event|4
755384|NCT00451282|2409922|P2|Overall Study|Lost to Follow-up|5
755385|NCT00451282|2409923|P1|Overall Study|Lost to Follow-up|6
755386|NCT00451451|2409939|P4|Overall Study|Other Reasons for Not Completing Study|14
755387|NCT00451451|2409940|P3|Overall Study|Other Reasons for Not Completing Study|17
755388|NCT00451451|2409941|P2|Overall Study|Other Reasons for Not Completing Study|30
755389|NCT00451451|2409942|P1|Overall Study|Other Reasons for Not Completing Study|34
755390|NCT00451451|2409939|P4|Overall Study|Death|1
755391|NCT00451451|2409940|P3|Overall Study|Death|0
755392|NCT00451451|2409941|P2|Overall Study|Death|0
755393|NCT00451451|2409942|P1|Overall Study|Death|1
755394|NCT00451451|2409939|P4|Overall Study|Subject Non-Compliance|3
755395|NCT00451451|2409940|P3|Overall Study|Subject Non-Compliance|3
755396|NCT00451451|2409941|P2|Overall Study|Subject Non-Compliance|4
755397|NCT00451451|2409942|P1|Overall Study|Subject Non-Compliance|8
755398|NCT00451451|2409939|P4|Overall Study|Investigator Decision|2
755399|NCT00451451|2409940|P3|Overall Study|Investigator Decision|1
755400|NCT00451451|2409941|P2|Overall Study|Investigator Decision|2
755401|NCT00451451|2409942|P1|Overall Study|Investigator Decision|6
755402|NCT00451451|2409939|P4|Overall Study|Consent Withdrawn|17
755403|NCT00451451|2409940|P3|Overall Study|Consent Withdrawn|17
755404|NCT00451451|2409941|P2|Overall Study|Consent Withdrawn|9
755405|NCT00451451|2409942|P1|Overall Study|Consent Withdrawn|14
755406|NCT00451451|2409939|P4|Overall Study|Lost to Follow-up|11
755407|NCT00451451|2409940|P3|Overall Study|Lost to Follow-up|8
755408|NCT00451451|2409941|P2|Overall Study|Lost to Follow-up|9
755409|NCT00451451|2409942|P1|Overall Study|Lost to Follow-up|11
755410|NCT00451451|2409939|P4|Overall Study|Adverse Event|10
755411|NCT00451451|2409940|P3|Overall Study|Adverse Event|26
755412|NCT00451451|2409941|P2|Overall Study|Adverse Event|21
755413|NCT00451451|2409942|P1|Overall Study|Adverse Event|11
755414|NCT00451906|2409980|P1|Overall Study|Did not complete final visit|4
755415|NCT00451906|2409980|P1|Overall Study|Other Reasons|121
755416|NCT00451906|2409980|P1|Overall Study|Termination of the study|108
755417|NCT00451906|2409980|P1|Overall Study|Progressive disease|1328
755418|NCT00451906|2409980|P1|Overall Study|Protocol Violation|21
755419|NCT00451906|2409980|P1|Overall Study|Withdrawal by Subject|111
755420|NCT00451906|2409980|P1|Overall Study|Lost to Follow-up|31
755421|NCT00451906|2409980|P1|Overall Study|Adverse Event|515
755422|NCT00451958|2409992|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
755423|NCT00451958|2409993|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
755424|NCT00451958|2409994|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
755425|NCT00451958|2409995|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
755426|NCT00451958|2409996|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
755427|NCT00451958|2409992|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
755428|NCT00451958|2409993|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
755429|NCT00451958|2409994|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
755430|NCT00451958|2409995|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
755431|NCT00451958|2409996|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
755432|NCT00451958|2409992|P5|CS21A (NCT00451958)|Physician Decision|0
755433|NCT00451958|2409993|P4|CS21A (NCT00451958)|Physician Decision|4
755434|NCT00451958|2409994|P3|CS21A (NCT00451958)|Physician Decision|4
755435|NCT00451958|2409995|P2|CS21A (NCT00451958)|Physician Decision|4
755436|NCT00451958|2409996|P1|CS21A (NCT00451958)|Physician Decision|2
755437|NCT00451958|2409992|P5|CS21A (NCT00451958)|Protocol Violation|0
755438|NCT00451958|2409993|P4|CS21A (NCT00451958)|Protocol Violation|0
755439|NCT00451958|2409994|P3|CS21A (NCT00451958)|Protocol Violation|2
755440|NCT00451958|2409995|P2|CS21A (NCT00451958)|Protocol Violation|3
755441|NCT00451958|2409996|P1|CS21A (NCT00451958)|Protocol Violation|1
755442|NCT00451958|2409992|P5|CS21A (NCT00451958)|Lost to Follow-up|0
755443|NCT00451958|2409993|P4|CS21A (NCT00451958)|Lost to Follow-up|1
755444|NCT00451958|2409994|P3|CS21A (NCT00451958)|Lost to Follow-up|1
755445|NCT00451958|2409995|P2|CS21A (NCT00451958)|Lost to Follow-up|5
755446|NCT00451958|2409996|P1|CS21A (NCT00451958)|Lost to Follow-up|6
755447|NCT00451958|2409992|P5|CS21A (NCT00451958)|Adverse Event|0
755448|NCT00451958|2409993|P4|CS21A (NCT00451958)|Adverse Event|17
755449|NCT00451958|2409994|P3|CS21A (NCT00451958)|Adverse Event|14
755450|NCT00451958|2409995|P2|CS21A (NCT00451958)|Adverse Event|34
755451|NCT00451958|2409996|P1|CS21A (NCT00451958)|Adverse Event|21
755452|NCT00452114|2410028|P2|Overall Study|Physician Decision|3
755453|NCT00452114|2410029|P1|Overall Study|Physician Decision|3
755454|NCT00452348|2410077|P2|Overall Study|Other|9
755455|NCT00452348|2410078|P1|Overall Study|Other|9
755456|NCT00452348|2410077|P2|Overall Study|Withdrawal by Subject|21
755457|NCT00452348|2410078|P1|Overall Study|Withdrawal by Subject|18
755458|NCT00452348|2410077|P2|Overall Study|Protocol Violation|28
755459|NCT00452348|2410078|P1|Overall Study|Protocol Violation|22
755460|NCT00452348|2410077|P2|Overall Study|Lost to Follow-up|8
755461|NCT00452348|2410078|P1|Overall Study|Lost to Follow-up|14
755462|NCT00452348|2410077|P2|Overall Study|Lack of Efficacy|9
755463|NCT00452348|2410078|P1|Overall Study|Lack of Efficacy|10
755464|NCT00452348|2410077|P2|Overall Study|Adverse Event|9
755465|NCT00452348|2410078|P1|Overall Study|Adverse Event|6
755466|NCT00452361|2410092|P2|Overall Study|Premature termination|9
755467|NCT00452361|2410093|P1|Overall Study|Premature termination|13
755468|NCT00452361|2410092|P2|Overall Study|Withdrawal by Subject|1
755469|NCT00452361|2410093|P1|Overall Study|Withdrawal by Subject|0
755470|NCT00452361|2410092|P2|Overall Study|Adverse Event|0
755471|NCT00452361|2410093|P1|Overall Study|Adverse Event|8
755472|NCT00452400|2410153|P5|Overall Study|Other reasons not listed above|1
755473|NCT00452400|2410154|P4|Overall Study|Other reasons not listed above|1
755474|NCT00452400|2410155|P3|Overall Study|Other reasons not listed above|0
755475|NCT00452400|2410156|P2|Overall Study|Other reasons not listed above|0
755476|NCT00452400|2410157|P1|Overall Study|Other reasons not listed above|0
755477|NCT00452400|2410153|P5|Overall Study|Lack of Efficacy|0
755478|NCT00452400|2410154|P4|Overall Study|Lack of Efficacy|0
755479|NCT00452400|2410155|P3|Overall Study|Lack of Efficacy|0
755480|NCT00452400|2410156|P2|Overall Study|Lack of Efficacy|0
755481|NCT00452400|2410157|P1|Overall Study|Lack of Efficacy|2
755482|NCT00452400|2410153|P5|Overall Study|Withdrawal by Subject|0
755483|NCT00452400|2410154|P4|Overall Study|Withdrawal by Subject|0
755484|NCT00452400|2410155|P3|Overall Study|Withdrawal by Subject|1
755485|NCT00452400|2410156|P2|Overall Study|Withdrawal by Subject|0
755486|NCT00452400|2410157|P1|Overall Study|Withdrawal by Subject|1
755487|NCT00452400|2410153|P5|Overall Study|Lost to Follow-up|0
755488|NCT00452400|2410154|P4|Overall Study|Lost to Follow-up|0
755489|NCT00452400|2410155|P3|Overall Study|Lost to Follow-up|0
755490|NCT00452400|2410156|P2|Overall Study|Lost to Follow-up|0
755491|NCT00452400|2410157|P1|Overall Study|Lost to Follow-up|1
755492|NCT00452400|2410153|P5|Overall Study|Protocol Violation|0
755493|NCT00452400|2410154|P4|Overall Study|Protocol Violation|0
755494|NCT00452400|2410155|P3|Overall Study|Protocol Violation|1
755495|NCT00452400|2410156|P2|Overall Study|Protocol Violation|0
755496|NCT00452400|2410157|P1|Overall Study|Protocol Violation|0
755497|NCT00452400|2410153|P5|Overall Study|Adverse Event|2
755498|NCT00452400|2410154|P4|Overall Study|Adverse Event|0
755499|NCT00452400|2410155|P3|Overall Study|Adverse Event|5
755500|NCT00452400|2410156|P2|Overall Study|Adverse Event|1
755501|NCT00452400|2410157|P1|Overall Study|Adverse Event|1
755502|NCT00452452|2410349|P3|Overall Study|Lost to Follow-up|0
755503|NCT00452452|2410350|P2|Overall Study|Lost to Follow-up|0
755504|NCT00452452|2410351|P1|Overall Study|Lost to Follow-up|1
755505|NCT00452452|2410349|P3|Overall Study|Withdrawal by Subject|0
755506|NCT00452452|2410350|P2|Overall Study|Withdrawal by Subject|0
755507|NCT00452452|2410351|P1|Overall Study|Withdrawal by Subject|1
755508|NCT00452452|2410349|P3|Overall Study|Protocol Violation|1
755509|NCT00452452|2410350|P2|Overall Study|Protocol Violation|0
755510|NCT00452452|2410351|P1|Overall Study|Protocol Violation|0
755511|NCT00452530|2410376|P2|Overall Study|Not specified|11
755512|NCT00452530|2410377|P1|Overall Study|Not specified|7
755513|NCT00452530|2410376|P2|Overall Study|No longer met study criteria|22
755514|NCT00452530|2410377|P1|Overall Study|No longer met study criteria|18
755515|NCT00452530|2410376|P2|Overall Study|Poor compliance/noncompliance|2
755516|NCT00452530|2410377|P1|Overall Study|Poor compliance/noncompliance|1
755517|NCT00452530|2410376|P2|Overall Study|Lost to Follow-up|0
755518|NCT00452530|2410377|P1|Overall Study|Lost to Follow-up|1
755519|NCT00452530|2410376|P2|Overall Study|Withdrawal by Subject|57
755520|NCT00452530|2410377|P1|Overall Study|Withdrawal by Subject|68
755521|NCT00452530|2410376|P2|Overall Study|Adverse Event|44
755522|NCT00452530|2410377|P1|Overall Study|Adverse Event|40
755523|NCT00452530|2410376|P2|Overall Study|Death|0
755524|NCT00452530|2410377|P1|Overall Study|Death|1
755525|NCT00458211|2410410|P1|Overall Study|Protocol Violation|2
755526|NCT00458211|2410410|P1|Overall Study|Withdrawal by Subject|2
755527|NCT00458211|2410410|P1|Overall Study|Lack of Efficacy|12
755528|NCT00458302|2410437|P2|Overall Study|Other|2
755529|NCT00458302|2410438|P1|Overall Study|Other|4
755530|NCT00458302|2410437|P2|Overall Study|Lost to Follow-up|0
755531|NCT00458302|2410438|P1|Overall Study|Lost to Follow-up|2
755532|NCT00458302|2410437|P2|Overall Study|Study Termination By Sponsor|0
755533|NCT00458302|2410438|P1|Overall Study|Study Termination By Sponsor|1
755534|NCT00458302|2410437|P2|Overall Study|Inc/Exc Criteria Not Met|1
755535|NCT00458302|2410438|P1|Overall Study|Inc/Exc Criteria Not Met|1
755536|NCT00458302|2410437|P2|Overall Study|Withdrawal by Subject|4
755537|NCT00458302|2410438|P1|Overall Study|Withdrawal by Subject|6
755538|NCT00458302|2410437|P2|Overall Study|Protocol Violation|2
755539|NCT00458302|2410438|P1|Overall Study|Protocol Violation|0
755540|NCT00458302|2410437|P2|Overall Study|Pregnancy|1
755541|NCT00458302|2410438|P1|Overall Study|Pregnancy|2
755542|NCT00458302|2410437|P2|Overall Study|Adverse Event|14
755543|NCT00458302|2410438|P1|Overall Study|Adverse Event|4
755544|NCT00463437|2410494|P4|Overall Study|Other|7
755545|NCT00463437|2410495|P3|Overall Study|Other|6
755546|NCT00463437|2410496|P2|Overall Study|Other|11
755547|NCT00463437|2410497|P1|Overall Study|Other|4
755548|NCT00463567|2410566|P7|Overall Study|Death|0
755549|NCT00463567|2410567|P6|Overall Study|Death|0
755550|NCT00463567|2410568|P5|Overall Study|Death|0
755551|NCT00463567|2410569|P4|Overall Study|Death|0
755552|NCT00463567|2410570|P3|Overall Study|Death|2
755553|NCT00463567|2410571|P2|Overall Study|Death|0
755554|NCT00463567|2410572|P1|Overall Study|Death|1
755555|NCT00463567|2410566|P7|Overall Study|Abnormal test procedure result(s)|0
755556|NCT00463567|2410567|P6|Overall Study|Abnormal test procedure result(s)|2
755557|NCT00463567|2410568|P5|Overall Study|Abnormal test procedure result(s)|0
755558|NCT00463567|2410569|P4|Overall Study|Abnormal test procedure result(s)|2
755559|NCT00463567|2410570|P3|Overall Study|Abnormal test procedure result(s)|6
755560|NCT00463567|2410571|P2|Overall Study|Abnormal test procedure result(s)|1
755561|NCT00463567|2410572|P1|Overall Study|Abnormal test procedure result(s)|1
755562|NCT00463567|2410566|P7|Overall Study|Abnormal lab value(s)|0
755563|NCT00463567|2410567|P6|Overall Study|Abnormal lab value(s)|0
755564|NCT00463567|2410568|P5|Overall Study|Abnormal lab value(s)|1
755565|NCT00463567|2410569|P4|Overall Study|Abnormal lab value(s)|1
755566|NCT00463567|2410570|P3|Overall Study|Abnormal lab value(s)|2
755567|NCT00463567|2410571|P2|Overall Study|Abnormal lab value(s)|1
755568|NCT00463567|2410572|P1|Overall Study|Abnormal lab value(s)|1
755569|NCT00463567|2410566|P7|Overall Study|Lack of Efficacy|1
755570|NCT00463567|2410567|P6|Overall Study|Lack of Efficacy|0
755571|NCT00463567|2410568|P5|Overall Study|Lack of Efficacy|1
755572|NCT00463567|2410569|P4|Overall Study|Lack of Efficacy|17
755573|NCT00463567|2410570|P3|Overall Study|Lack of Efficacy|9
755574|NCT00463567|2410571|P2|Overall Study|Lack of Efficacy|9
755575|NCT00463567|2410572|P1|Overall Study|Lack of Efficacy|4
755576|NCT00463567|2410566|P7|Overall Study|Administrative problems|2
755577|NCT00463567|2410567|P6|Overall Study|Administrative problems|2
755578|NCT00463567|2410568|P5|Overall Study|Administrative problems|3
755579|NCT00463567|2410569|P4|Overall Study|Administrative problems|9
755580|NCT00463567|2410570|P3|Overall Study|Administrative problems|6
755581|NCT00463567|2410571|P2|Overall Study|Administrative problems|3
755582|NCT00463567|2410572|P1|Overall Study|Administrative problems|5
755583|NCT00463567|2410566|P7|Overall Study|Lost to Follow-up|1
755584|NCT00463567|2410567|P6|Overall Study|Lost to Follow-up|1
755585|NCT00463567|2410568|P5|Overall Study|Lost to Follow-up|1
755586|NCT00463567|2410569|P4|Overall Study|Lost to Follow-up|8
755587|NCT00463567|2410570|P3|Overall Study|Lost to Follow-up|13
755588|NCT00463567|2410571|P2|Overall Study|Lost to Follow-up|6
755589|NCT00463567|2410572|P1|Overall Study|Lost to Follow-up|12
755590|NCT00463567|2410566|P7|Overall Study|Protocol Deviation|2
755591|NCT00463567|2410567|P6|Overall Study|Protocol Deviation|1
755592|NCT00463567|2410568|P5|Overall Study|Protocol Deviation|1
755593|NCT00463567|2410569|P4|Overall Study|Protocol Deviation|11
755594|NCT00463567|2410570|P3|Overall Study|Protocol Deviation|14
755595|NCT00463567|2410571|P2|Overall Study|Protocol Deviation|9
755596|NCT00463567|2410572|P1|Overall Study|Protocol Deviation|13
755597|NCT00463567|2410566|P7|Overall Study|Withdrawal by Subject|1
755598|NCT00463567|2410567|P6|Overall Study|Withdrawal by Subject|5
755599|NCT00463567|2410568|P5|Overall Study|Withdrawal by Subject|6
755600|NCT00463567|2410569|P4|Overall Study|Withdrawal by Subject|37
755601|NCT00463567|2410570|P3|Overall Study|Withdrawal by Subject|20
755602|NCT00463567|2410571|P2|Overall Study|Withdrawal by Subject|22
755603|NCT00463567|2410572|P1|Overall Study|Withdrawal by Subject|29
755604|NCT00463567|2410566|P7|Overall Study|Adverse Event|4
755605|NCT00463567|2410567|P6|Overall Study|Adverse Event|10
755606|NCT00463567|2410568|P5|Overall Study|Adverse Event|10
755607|NCT00463567|2410569|P4|Overall Study|Adverse Event|46
755608|NCT00463567|2410570|P3|Overall Study|Adverse Event|17
755609|NCT00463567|2410571|P2|Overall Study|Adverse Event|26
755610|NCT00463567|2410572|P1|Overall Study|Adverse Event|29
755617|NCT00463606|2410617|P3|Overall Study|Protocol Violation|1
755618|NCT00463606|2410618|P2|Overall Study|Protocol Violation|0
755619|NCT00463606|2410619|P1|Overall Study|Protocol Violation|0
755620|NCT00463606|2410617|P3|Overall Study|Participation in another ABT-335 trial|0
755621|NCT00463606|2410618|P2|Overall Study|Participation in another ABT-335 trial|0
755622|NCT00463606|2410619|P1|Overall Study|Participation in another ABT-335 trial|1
755623|NCT00463606|2410617|P3|Overall Study|Patient randomized in error|0
755624|NCT00463606|2410618|P2|Overall Study|Patient randomized in error|0
755625|NCT00463606|2410619|P1|Overall Study|Patient randomized in error|1
755626|NCT00463606|2410617|P3|Overall Study|Coordinator error|0
755627|NCT00463606|2410618|P2|Overall Study|Coordinator error|0
755628|NCT00463606|2410619|P1|Overall Study|Coordinator error|1
755629|NCT00463606|2410617|P3|Overall Study|Exclusion criteria violation|0
755630|NCT00463606|2410618|P2|Overall Study|Exclusion criteria violation|0
755631|NCT00463606|2410619|P1|Overall Study|Exclusion criteria violation|2
755632|NCT00463606|2410617|P3|Overall Study|Sponsor request|0
755633|NCT00463606|2410618|P2|Overall Study|Sponsor request|1
755634|NCT00463606|2410619|P1|Overall Study|Sponsor request|0
755635|NCT00463606|2410617|P3|Overall Study|Physician Decision|0
755636|NCT00463606|2410618|P2|Overall Study|Physician Decision|1
755637|NCT00463606|2410619|P1|Overall Study|Physician Decision|0
755638|NCT00463606|2410617|P3|Overall Study|Subject moved out of town|0
755639|NCT00463606|2410618|P2|Overall Study|Subject moved out of town|0
755640|NCT00463606|2410619|P1|Overall Study|Subject moved out of town|1
755641|NCT00463606|2410617|P3|Overall Study|Subject noncompliance|0
755642|NCT00463606|2410618|P2|Overall Study|Subject noncompliance|1
755643|NCT00463606|2410619|P1|Overall Study|Subject noncompliance|1
755644|NCT00463606|2410617|P3|Overall Study|Lost to Follow-up|3
755645|NCT00463606|2410618|P2|Overall Study|Lost to Follow-up|2
755646|NCT00463606|2410619|P1|Overall Study|Lost to Follow-up|2
755647|NCT00463606|2410617|P3|Overall Study|Withdrawal by Subject|5
755648|NCT00463606|2410618|P2|Overall Study|Withdrawal by Subject|11
755649|NCT00463606|2410619|P1|Overall Study|Withdrawal by Subject|11
755650|NCT00463606|2410617|P3|Overall Study|Adverse Event|11
755651|NCT00463606|2410618|P2|Overall Study|Adverse Event|18
755652|NCT00463606|2410619|P1|Overall Study|Adverse Event|21
755653|NCT00463788|2410644|P2|Overall Study|Randomized but not treated|1
755654|NCT00463788|2410645|P1|Overall Study|Randomized but not treated|1
755655|NCT00463788|2410644|P2|Overall Study|Unspecified|0
755656|NCT00463788|2410645|P1|Overall Study|Unspecified|3
755657|NCT00463788|2410644|P2|Overall Study|Protocol Violation|1
755658|NCT00463788|2410645|P1|Overall Study|Protocol Violation|0
755659|NCT00463788|2410644|P2|Overall Study|Lost to Follow-up|0
755660|NCT00463788|2410645|P1|Overall Study|Lost to Follow-up|1
755661|NCT00463788|2410644|P2|Overall Study|Symptomatic Deterioration|3
755662|NCT00463788|2410645|P1|Overall Study|Symptomatic Deterioration|2
755663|NCT00463788|2410644|P2|Overall Study|Death|3
755664|NCT00463788|2410645|P1|Overall Study|Death|4
755665|NCT00463788|2410644|P2|Overall Study|Withdrawal by Subject|2
755666|NCT00463788|2410645|P1|Overall Study|Withdrawal by Subject|6
755667|NCT00463788|2410644|P2|Overall Study|Adverse Event|2
755668|NCT00463788|2410645|P1|Overall Study|Adverse Event|6
755669|NCT00463788|2410644|P2|Overall Study|Progressive Disease|42
755670|NCT00463788|2410645|P1|Overall Study|Progressive Disease|86
755671|NCT00463801|2410660|P1|Overall Study|No longer require therapy|1
755672|NCT00463801|2410660|P1|Overall Study|Lost to Follow-up|5
755673|NCT00463801|2410660|P1|Overall Study|Adverse Event|4
755674|NCT00463801|2410660|P1|Overall Study|Lack of Efficacy|2
755675|NCT00463801|2410660|P1|Overall Study|Protocol Violation|1
755679|NCT00463866|2410670|P2|Overall Study|Unspecified|22
755680|NCT00463866|2410671|P1|Overall Study|Unspecified|22
755681|NCT00463866|2410670|P2|Overall Study|Mis-Randomization of subject|1
755682|NCT00463866|2410671|P1|Overall Study|Mis-Randomization of subject|0
755683|NCT00463866|2410670|P2|Overall Study|Safety Reason|3
755684|NCT00463866|2410671|P1|Overall Study|Safety Reason|1
755685|NCT00463866|2410670|P2|Overall Study|Severe Non-Compliance to Protocol|21
755686|NCT00463866|2410671|P1|Overall Study|Severe Non-Compliance to Protocol|25
755687|NCT00463866|2410670|P2|Overall Study|Incorrect Enrolment|66
755688|NCT00463866|2410671|P1|Overall Study|Incorrect Enrolment|64
755689|NCT00463866|2410670|P2|Overall Study|Lost to Follow-up|55
755690|NCT00463866|2410671|P1|Overall Study|Lost to Follow-up|46
755691|NCT00463866|2410670|P2|Overall Study|Withdrawal by Subject|79
755692|NCT00463866|2410671|P1|Overall Study|Withdrawal by Subject|81
755693|NCT00463866|2410670|P2|Overall Study|Adverse Event|93
755694|NCT00463866|2410671|P1|Overall Study|Adverse Event|70
755695|NCT00464087|2410694|P3|Overall Study|No PCI per inclusion criteria|29
755696|NCT00464087|2410695|P2|Overall Study|No PCI per inclusion criteria|0
755697|NCT00464087|2410696|P1|Overall Study|No PCI per inclusion criteria|0
755698|NCT00464269|2410753|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
755699|NCT00464269|2410754|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
755700|NCT00464269|2410755|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
755701|NCT00464269|2410756|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
755702|NCT00464269|2410753|P4|Overall Study|AE, non-serious non-fatal|4
755703|NCT00464269|2410754|P3|Overall Study|AE, non-serious non-fatal|3
755704|NCT00464269|2410755|P2|Overall Study|AE, non-serious non-fatal|8
755705|NCT00464269|2410756|P1|Overall Study|AE, non-serious non-fatal|2
755706|NCT00464269|2410753|P4|Overall Study|SAE, non-fatal|1
755707|NCT00464269|2410754|P3|Overall Study|SAE, non-fatal|0
755708|NCT00464269|2410755|P2|Overall Study|SAE, non-fatal|0
755709|NCT00464269|2410756|P1|Overall Study|SAE, non-fatal|0
755710|NCT00464269|2410753|P4|Overall Study|AE, serious fatal|1
755711|NCT00464269|2410754|P3|Overall Study|AE, serious fatal|1
755712|NCT00464269|2410755|P2|Overall Study|AE, serious fatal|0
755713|NCT00464269|2410756|P1|Overall Study|AE, serious fatal|0
755714|NCT00464269|2410753|P4|Overall Study|Other reason|1
755715|NCT00464269|2410754|P3|Overall Study|Other reason|1
755716|NCT00464269|2410755|P2|Overall Study|Other reason|3
755717|NCT00464269|2410756|P1|Overall Study|Other reason|3
755718|NCT00464269|2410753|P4|Overall Study|Withdrawal by Subject|1
755719|NCT00464269|2410754|P3|Overall Study|Withdrawal by Subject|1
755720|NCT00464269|2410755|P2|Overall Study|Withdrawal by Subject|2
755721|NCT00464269|2410756|P1|Overall Study|Withdrawal by Subject|0
755722|NCT00464269|2410753|P4|Overall Study|Lost to Follow-up|1
755723|NCT00464269|2410754|P3|Overall Study|Lost to Follow-up|0
755724|NCT00464269|2410755|P2|Overall Study|Lost to Follow-up|4
755725|NCT00464269|2410756|P1|Overall Study|Lost to Follow-up|0
755726|NCT00464269|2410753|P4|Overall Study|Lack of Efficacy|0
755727|NCT00464269|2410754|P3|Overall Study|Lack of Efficacy|0
755728|NCT00464269|2410755|P2|Overall Study|Lack of Efficacy|0
755729|NCT00464269|2410756|P1|Overall Study|Lack of Efficacy|1
755730|NCT00464308|2410857|P3|Overall Study|Physician Decision|0
755731|NCT00464308|2410858|P2|Overall Study|Physician Decision|0
755732|NCT00464308|2410859|P1|Overall Study|Physician Decision|1
755733|NCT00464308|2410857|P3|Overall Study|Patient discontinued and other reasons|23
755734|NCT00464308|2410858|P2|Overall Study|Patient discontinued and other reasons|17
755735|NCT00464308|2410859|P1|Overall Study|Patient discontinued and other reasons|17
755736|NCT00464308|2410857|P3|Overall Study|Lost to Follow-up|20
755737|NCT00464308|2410858|P2|Overall Study|Lost to Follow-up|19
755738|NCT00464308|2410859|P1|Overall Study|Lost to Follow-up|29
755739|NCT00464308|2410857|P3|Overall Study|Adverse Event|16
755740|NCT00464308|2410858|P2|Overall Study|Adverse Event|27
755741|NCT00464308|2410859|P1|Overall Study|Adverse Event|22
755742|NCT00464334|2410896|P11|Overall Study|Withdrawal by Subject|0
755743|NCT00464334|2410897|P10|Overall Study|Withdrawal by Subject|0
755744|NCT00464334|2410898|P9|Overall Study|Withdrawal by Subject|3
755745|NCT00464334|2410899|P8|Overall Study|Withdrawal by Subject|1
755746|NCT00464334|2410900|P7|Overall Study|Withdrawal by Subject|2
755747|NCT00464334|2410901|P6|Overall Study|Withdrawal by Subject|2
755748|NCT00464334|2410902|P5|Overall Study|Withdrawal by Subject|2
755749|NCT00464334|2410903|P4|Overall Study|Withdrawal by Subject|2
755750|NCT00464334|2410904|P3|Overall Study|Withdrawal by Subject|4
755751|NCT00464334|2410905|P2|Overall Study|Withdrawal by Subject|7
755752|NCT00464334|2410906|P1|Overall Study|Withdrawal by Subject|1
755753|NCT00464334|2410896|P11|Overall Study|Study Terminated by Sponsor|0
755754|NCT00464334|2410897|P10|Overall Study|Study Terminated by Sponsor|0
755755|NCT00464334|2410898|P9|Overall Study|Study Terminated by Sponsor|0
755756|NCT00464334|2410899|P8|Overall Study|Study Terminated by Sponsor|0
755757|NCT00464334|2410900|P7|Overall Study|Study Terminated by Sponsor|0
755758|NCT00464334|2410901|P6|Overall Study|Study Terminated by Sponsor|0
755759|NCT00464334|2410902|P5|Overall Study|Study Terminated by Sponsor|0
755760|NCT00464334|2410903|P4|Overall Study|Study Terminated by Sponsor|1
755761|NCT00464334|2410904|P3|Overall Study|Study Terminated by Sponsor|0
755762|NCT00464334|2410905|P2|Overall Study|Study Terminated by Sponsor|0
755763|NCT00464334|2410906|P1|Overall Study|Study Terminated by Sponsor|0
755764|NCT00464334|2410896|P11|Overall Study|Progressive Disease|0
755765|NCT00464334|2410897|P10|Overall Study|Progressive Disease|0
755766|NCT00464334|2410898|P9|Overall Study|Progressive Disease|1
755767|NCT00464334|2410899|P8|Overall Study|Progressive Disease|0
755768|NCT00464334|2410900|P7|Overall Study|Progressive Disease|0
755769|NCT00464334|2410901|P6|Overall Study|Progressive Disease|1
755770|NCT00464334|2410902|P5|Overall Study|Progressive Disease|0
755771|NCT00464334|2410903|P4|Overall Study|Progressive Disease|0
755772|NCT00464334|2410904|P3|Overall Study|Progressive Disease|0
755773|NCT00464334|2410905|P2|Overall Study|Progressive Disease|0
755774|NCT00464334|2410906|P1|Overall Study|Progressive Disease|0
755775|NCT00464334|2410896|P11|Overall Study|Lost to Follow-up|2
755776|NCT00464334|2410897|P10|Overall Study|Lost to Follow-up|0
755777|NCT00464334|2410898|P9|Overall Study|Lost to Follow-up|0
755778|NCT00464334|2410899|P8|Overall Study|Lost to Follow-up|0
755779|NCT00464334|2410900|P7|Overall Study|Lost to Follow-up|1
755780|NCT00464334|2410901|P6|Overall Study|Lost to Follow-up|0
755781|NCT00464334|2410902|P5|Overall Study|Lost to Follow-up|1
755782|NCT00464334|2410903|P4|Overall Study|Lost to Follow-up|0
755783|NCT00464334|2410904|P3|Overall Study|Lost to Follow-up|1
755784|NCT00464334|2410905|P2|Overall Study|Lost to Follow-up|0
755785|NCT00464334|2410906|P1|Overall Study|Lost to Follow-up|0
755786|NCT00464334|2410896|P11|Overall Study|Lack of Efficacy|0
755787|NCT00464334|2410897|P10|Overall Study|Lack of Efficacy|0
755788|NCT00464334|2410898|P9|Overall Study|Lack of Efficacy|0
755789|NCT00464334|2410899|P8|Overall Study|Lack of Efficacy|0
755790|NCT00464334|2410900|P7|Overall Study|Lack of Efficacy|0
755791|NCT00464334|2410901|P6|Overall Study|Lack of Efficacy|0
755792|NCT00464334|2410902|P5|Overall Study|Lack of Efficacy|0
755793|NCT00464334|2410903|P4|Overall Study|Lack of Efficacy|0
755794|NCT00464334|2410904|P3|Overall Study|Lack of Efficacy|0
755795|NCT00464334|2410905|P2|Overall Study|Lack of Efficacy|1
755796|NCT00464334|2410906|P1|Overall Study|Lack of Efficacy|0
755797|NCT00464334|2410896|P11|Overall Study|Adverse Event|2
755798|NCT00464334|2410897|P10|Overall Study|Adverse Event|1
755799|NCT00464334|2410898|P9|Overall Study|Adverse Event|2
755800|NCT00464334|2410899|P8|Overall Study|Adverse Event|0
755801|NCT00464334|2410900|P7|Overall Study|Adverse Event|0
755802|NCT00464334|2410901|P6|Overall Study|Adverse Event|1
755803|NCT00464334|2410902|P5|Overall Study|Adverse Event|1
755804|NCT00464334|2410903|P4|Overall Study|Adverse Event|1
755805|NCT00464334|2410904|P3|Overall Study|Adverse Event|0
755806|NCT00464334|2410905|P2|Overall Study|Adverse Event|0
755807|NCT00464334|2410906|P1|Overall Study|Adverse Event|0
755808|NCT00464490|2410995|P2|Overall Study|Physician Decision|11
755809|NCT00464490|2410996|P1|Overall Study|Physician Decision|11
755810|NCT00464542|2411002|P1|Pre-treatment|Withdrawal by Subject|2
890974|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
755812|NCT00464672|2411091|P6|Overall Study|Lost to Follow-up|0
755813|NCT00464672|2411092|P5|Overall Study|Lost to Follow-up|1
755814|NCT00464672|2411093|P4|Overall Study|Lost to Follow-up|0
755815|NCT00464672|2411094|P3|Overall Study|Lost to Follow-up|0
755816|NCT00464672|2411095|P2|Overall Study|Lost to Follow-up|10
755817|NCT00464672|2411096|P1|Overall Study|Lost to Follow-up|25
755818|NCT00464672|2411091|P6|Overall Study|withdrawal of consent|4
755819|NCT00464672|2411092|P5|Overall Study|withdrawal of consent|9
755820|NCT00464672|2411093|P4|Overall Study|withdrawal of consent|1
755821|NCT00464672|2411094|P3|Overall Study|withdrawal of consent|0
755822|NCT00464672|2411095|P2|Overall Study|withdrawal of consent|0
755823|NCT00464672|2411096|P1|Overall Study|withdrawal of consent|0
755824|NCT00464737|2411200|P3|Overall Study|Other: Subject's disability per sponsor|1
755825|NCT00464737|2411201|P2|Overall Study|Other: Subject's disability per sponsor|0
755826|NCT00464737|2411202|P1|Overall Study|Other: Subject's disability per sponsor|0
755827|NCT00464737|2411200|P3|Overall Study|Other: Personal family reasons|1
755828|NCT00464737|2411201|P2|Overall Study|Other: Personal family reasons|0
755829|NCT00464737|2411202|P1|Overall Study|Other: Personal family reasons|0
755830|NCT00464737|2411200|P3|Overall Study|Other: Study demands too great|0
755831|NCT00464737|2411201|P2|Overall Study|Other: Study demands too great|1
755832|NCT00464737|2411202|P1|Overall Study|Other: Study demands too great|0
755833|NCT00464737|2411200|P3|Overall Study|Other: Subject left town; family illness|0
755834|NCT00464737|2411201|P2|Overall Study|Other: Subject left town; family illness|0
755835|NCT00464737|2411202|P1|Overall Study|Other: Subject left town; family illness|1
755836|NCT00464737|2411200|P3|Overall Study|Other: Subject's schedule doesn't permit|0
755837|NCT00464737|2411201|P2|Overall Study|Other: Subject's schedule doesn't permit|0
755838|NCT00464737|2411202|P1|Overall Study|Other: Subject's schedule doesn't permit|1
755839|NCT00464737|2411200|P3|Overall Study|Lost to Follow-up|5
755840|NCT00464737|2411201|P2|Overall Study|Lost to Follow-up|2
755841|NCT00464737|2411202|P1|Overall Study|Lost to Follow-up|5
755842|NCT00464737|2411200|P3|Overall Study|Non-compliance|1
755843|NCT00464737|2411201|P2|Overall Study|Non-compliance|1
755844|NCT00464737|2411202|P1|Overall Study|Non-compliance|0
755845|NCT00464737|2411200|P3|Overall Study|Protocol Violation|5
755846|NCT00464737|2411201|P2|Overall Study|Protocol Violation|1
755847|NCT00464737|2411202|P1|Overall Study|Protocol Violation|1
755848|NCT00464737|2411200|P3|Overall Study|Withdrawal by Subject|5
755849|NCT00464737|2411201|P2|Overall Study|Withdrawal by Subject|3
755850|NCT00464737|2411202|P1|Overall Study|Withdrawal by Subject|5
755851|NCT00464737|2411200|P3|Overall Study|Lack of Efficacy|4
755852|NCT00464737|2411201|P2|Overall Study|Lack of Efficacy|7
755853|NCT00464737|2411202|P1|Overall Study|Lack of Efficacy|7
755854|NCT00464737|2411200|P3|Overall Study|Adverse Event|33
755855|NCT00464737|2411201|P2|Overall Study|Adverse Event|17
755856|NCT00464737|2411202|P1|Overall Study|Adverse Event|12
755857|NCT00464945|2411251|P2|Toddler Dose|Lost to Follow-up|1
755858|NCT00464945|2411252|P1|Toddler Dose|Lost to Follow-up|0
755859|NCT00464945|2411251|P2|After Infant Series|Withdrawal by Subject|2
755860|NCT00464945|2411252|P1|After Infant Series|Withdrawal by Subject|0
755861|NCT00464945|2411251|P2|Infant Series|Lost to Follow-up|0
755862|NCT00464945|2411252|P1|Infant Series|Lost to Follow-up|1
755863|NCT00464945|2411251|P2|Infant Series|Protocol Violation|0
755864|NCT00464945|2411252|P1|Infant Series|Protocol Violation|1
755865|NCT00464945|2411251|P2|Infant Series|Withdrawal by parent/guardian request|1
755866|NCT00464945|2411252|P1|Infant Series|Withdrawal by parent/guardian request|2
755867|NCT00465101|2411315|P1|Overall Study|Withdrew consent prior to procedure|3
755868|NCT00465101|2411315|P1|Overall Study|Physician Decision|1
755869|NCT00465101|2411315|P1|Overall Study|Withdrawal by Subject|25
755870|NCT00465101|2411315|P1|Overall Study|Death|3
755871|NCT00465101|2411315|P1|Overall Study|Unable to obtain IRB approval|1
755872|NCT00465101|2411315|P1|Overall Study|Site closed due to IRB expiration|1
755873|NCT00465101|2411315|P1|Overall Study|Patient postponed procedure|1
755874|NCT00465101|2411315|P1|Overall Study|Pt. Insurance not accepted at center|2
755875|NCT00465101|2411315|P1|Overall Study|Other|6
755876|NCT00465101|2411315|P1|Overall Study|Lost to Follow-up|5
755877|NCT00465101|2411315|P1|Overall Study|Did not meet study criteria|4
755878|NCT00465101|2411315|P1|Overall Study|Change in health precluded follow up|4
755879|NCT00465101|2411315|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
755880|NCT00465179|2411348|P1|Overall Study|Progression of Disease|47
755881|NCT00465179|2411348|P1|Overall Study|Withdrawal by Subject|2
755882|NCT00465179|2411348|P1|Overall Study|Adverse Event|4
755883|NCT00465361|2411354|P1|Baseline Assessment|Personal Issues/Scheduling|4
755884|NCT00465569|2411373|P2|Overall Study|persistent eczema during dose escalation|0
755885|NCT00465569|2411374|P1|Overall Study|persistent eczema during dose escalation|1
890975|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
890976|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
890977|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
890978|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
890979|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
890980|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
890981|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
890982|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
890983|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
890984|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
890985|NCT00611455|2826449|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
890986|NCT00611455|2826450|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
890987|NCT00611455|2826451|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
890988|NCT00550420|2826593|P1|Overall Study|Prohibited medicine|1
755902|NCT00465738|2411416|P2|Overall Study|Other|5
755903|NCT00465738|2411417|P1|Overall Study|Other|2
755904|NCT00465738|2411416|P2|Overall Study|Withdrawal by Subject|0
755905|NCT00465738|2411417|P1|Overall Study|Withdrawal by Subject|2
755906|NCT00465738|2411416|P2|Overall Study|Adverse Event|1
755907|NCT00465738|2411417|P1|Overall Study|Adverse Event|0
755908|NCT00465738|2411416|P2|Overall Study|Lost to Follow-up|0
755909|NCT00465738|2411417|P1|Overall Study|Lost to Follow-up|2
755910|NCT00465816|2411510|P3|Overall Study|Lost to Follow-up|2
755911|NCT00465816|2411511|P2|Overall Study|Lost to Follow-up|0
755912|NCT00465816|2411512|P1|Overall Study|Lost to Follow-up|0
755913|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|All other|6
755914|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|All other|4
755915|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
755916|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
755917|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
755918|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
755919|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
755920|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
755921|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
755922|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
755923|NCT00455520|2411616|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
755924|NCT00455520|2411617|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
755925|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|All other|0
755926|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|All other|33
755927|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
755928|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
755929|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
755930|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
755931|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|Adverse Event|0
755932|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|Adverse Event|100
755933|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
755934|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
755935|NCT00455520|2411616|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
755936|NCT00455520|2411617|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
755937|NCT00455533|2411635|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
755938|NCT00455533|2411636|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
755939|NCT00455533|2411637|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
755940|NCT00455533|2411635|P3|Period Two: Randomized Period|Study Drug Toxicity|0
755941|NCT00455533|2411636|P2|Period Two: Randomized Period|Study Drug Toxicity|2
755942|NCT00455533|2411637|P1|Period Two: Randomized Period|Study Drug Toxicity|0
755943|NCT00455533|2411635|P3|Period Two: Randomized Period|Other - need reasons|0
755944|NCT00455533|2411636|P2|Period Two: Randomized Period|Other - need reasons|1
755945|NCT00455533|2411637|P1|Period Two: Randomized Period|Other - need reasons|0
755946|NCT00455533|2411635|P3|Period Two: Randomized Period|Lost to Follow-up|1
755947|NCT00455533|2411636|P2|Period Two: Randomized Period|Lost to Follow-up|0
755948|NCT00455533|2411637|P1|Period Two: Randomized Period|Lost to Follow-up|0
755949|NCT00455533|2411635|P3|Period Two: Randomized Period|Disease Progression|1
755950|NCT00455533|2411636|P2|Period Two: Randomized Period|Disease Progression|1
755951|NCT00455533|2411637|P1|Period Two: Randomized Period|Disease Progression|0
755952|NCT00455533|2411635|P3|Period Two: Randomized Period|Death|3
755953|NCT00455533|2411636|P2|Period Two: Randomized Period|Death|0
755954|NCT00455533|2411637|P1|Period Two: Randomized Period|Death|0
755955|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
755956|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
755957|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
755958|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
755959|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
755960|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
755961|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
755962|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
755963|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
755964|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
755965|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
755966|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
755967|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
755968|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
755969|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
755970|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Not Reported|0
755971|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Not Reported|0
755972|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Not Reported|1
755973|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
755974|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
755975|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
755976|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Disease Progression|0
755977|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Disease Progression|0
755978|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Disease Progression|5
755979|NCT00455533|2411635|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
755980|NCT00455533|2411636|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
755981|NCT00455533|2411637|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
755982|NCT00465972|2411686|P2|Overall Study|Withdrawal by Subject|1
755983|NCT00465972|2411687|P1|Overall Study|Withdrawal by Subject|2
755984|NCT00465985|2411695|P2|Part III - Open-label Treatment Period|Adverse Event|0
755985|NCT00465985|2411696|P1|Part III - Open-label Treatment Period|Adverse Event|1
755986|NCT00465985|2411695|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
755987|NCT00465985|2411696|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
755988|NCT00465985|2411695|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
755989|NCT00465985|2411696|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
755990|NCT00465985|2411695|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
755991|NCT00465985|2411696|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
755992|NCT00466167|2411725|P3|Overall Study|Not treated|0
755993|NCT00466167|2411726|P2|Overall Study|Not treated|0
755994|NCT00466167|2411727|P1|Overall Study|Not treated|1
755995|NCT00466167|2411725|P3|Overall Study|patient did not meet inclusion criteria|1
755996|NCT00466167|2411726|P2|Overall Study|patient did not meet inclusion criteria|0
755997|NCT00466167|2411727|P1|Overall Study|patient did not meet inclusion criteria|1
755998|NCT00466167|2411725|P3|Overall Study|Withdrawal by Subject|6
755999|NCT00466167|2411726|P2|Overall Study|Withdrawal by Subject|1
756000|NCT00466167|2411727|P1|Overall Study|Withdrawal by Subject|4
756001|NCT00466167|2411725|P3|Overall Study|Lost to Follow-up|2
756002|NCT00466167|2411726|P2|Overall Study|Lost to Follow-up|2
756003|NCT00466167|2411727|P1|Overall Study|Lost to Follow-up|3
756004|NCT00466167|2411725|P3|Overall Study|Protocol Violation|2
756005|NCT00466167|2411726|P2|Overall Study|Protocol Violation|1
756006|NCT00466167|2411727|P1|Overall Study|Protocol Violation|1
756007|NCT00466167|2411725|P3|Overall Study|Lack of Efficacy|3
756008|NCT00466167|2411726|P2|Overall Study|Lack of Efficacy|0
756009|NCT00466167|2411727|P1|Overall Study|Lack of Efficacy|2
756010|NCT00466167|2411725|P3|Overall Study|Adverse Event|7
756011|NCT00466167|2411726|P2|Overall Study|Adverse Event|8
756012|NCT00466167|2411727|P1|Overall Study|Adverse Event|8
756013|NCT00466193|2411785|P2|Overall Study|Patient refused Visit 4 procedures|0
756014|NCT00466193|2411786|P1|Overall Study|Patient refused Visit 4 procedures|1
756015|NCT00466193|2411785|P2|Overall Study|Withdrawal by Subject|2
756016|NCT00466193|2411786|P1|Overall Study|Withdrawal by Subject|7
756017|NCT00466193|2411785|P2|Overall Study|Protocol Violation|1
756018|NCT00466193|2411786|P1|Overall Study|Protocol Violation|1
756019|NCT00466193|2411785|P2|Overall Study|Physician Decision|0
756020|NCT00466193|2411786|P1|Overall Study|Physician Decision|1
756021|NCT00466193|2411785|P2|Overall Study|Lost to Follow-up|4
756022|NCT00466193|2411786|P1|Overall Study|Lost to Follow-up|2
756023|NCT00466193|2411785|P2|Overall Study|Adverse Event|1
756024|NCT00466193|2411786|P1|Overall Study|Adverse Event|0
756025|NCT00466947|2411820|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
756026|NCT00466947|2411821|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
756197|NCT00467779|2412395|P8|Stage 3|Adverse Event|0
756027|NCT00466947|2411820|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
890989|NCT00550420|2826593|P1|Overall Study|Exclusion criteria|1
756028|NCT00466947|2411821|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
756029|NCT00466947|2411820|P2|Study End Analysis Period|Other – Forbidden vaccination|10
756030|NCT00466947|2411821|P1|Study End Analysis Period|Other – Forbidden vaccination|21
756031|NCT00466947|2411820|P2|Study End Analysis Period|Withdrawal by Subject|1267
756032|NCT00466947|2411821|P1|Study End Analysis Period|Withdrawal by Subject|1264
756033|NCT00466947|2411820|P2|Study End Analysis Period|Protocol Violation|17
756034|NCT00466947|2411821|P1|Study End Analysis Period|Protocol Violation|9
756035|NCT00466947|2411820|P2|Study End Analysis Period|Physician Decision|29
756036|NCT00466947|2411821|P1|Study End Analysis Period|Physician Decision|29
756037|NCT00466947|2411820|P2|Study End Analysis Period|Lost to Follow-up|1167
756038|NCT00466947|2411821|P1|Study End Analysis Period|Lost to Follow-up|1137
756039|NCT00466947|2411820|P2|Study End Analysis Period|Adverse Event|43
756040|NCT00466947|2411821|P1|Study End Analysis Period|Adverse Event|35
756041|NCT00466947|2411820|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
756042|NCT00466947|2411821|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
756044|NCT00467259|2411976|P2|Overall Study|Site Closed|1
756045|NCT00467259|2411977|P1|Overall Study|Site Closed|2
756046|NCT00467259|2411976|P2|Overall Study|Lost to Follow-up|34
756047|NCT00467259|2411977|P1|Overall Study|Lost to Follow-up|14
756048|NCT00467259|2411976|P2|Overall Study|Physician Decision|2
756049|NCT00467259|2411977|P1|Overall Study|Physician Decision|0
756050|NCT00467259|2411976|P2|Overall Study|Withdrawal by Subject|108
756051|NCT00467259|2411977|P1|Overall Study|Withdrawal by Subject|34
756052|NCT00467259|2411976|P2|Overall Study|Protocol Violation|7
756053|NCT00467259|2411977|P1|Overall Study|Protocol Violation|1
756054|NCT00467259|2411976|P2|Overall Study|Adverse Event|90
756055|NCT00467259|2411977|P1|Overall Study|Adverse Event|24
756056|NCT00467285|2411989|P2|Overall Study|Lost to Follow-up|4
756057|NCT00467285|2411990|P1|Overall Study|Lost to Follow-up|4
756058|NCT00467363|2412010|P2|Overall Study|Lost to Follow-up|70
756059|NCT00467363|2412011|P1|Overall Study|Lost to Follow-up|80
756060|NCT00467519|2412058|P2|Overall Study|Withdrawal by Subject|10
756061|NCT00467519|2412059|P1|Overall Study|Withdrawal by Subject|4
756062|NCT00467519|2412058|P2|Overall Study|Lost to Follow-up|9
756063|NCT00467519|2412059|P1|Overall Study|Lost to Follow-up|2
756064|NCT00467519|2412058|P2|Overall Study|Protocol Violation|4
756065|NCT00467519|2412059|P1|Overall Study|Protocol Violation|8
756066|NCT00467558|2412077|P2|Overall Study|Lost to Follow-up|0
756067|NCT00467558|2412078|P1|Overall Study|Lost to Follow-up|2
756068|NCT00467584|2412089|P3|Overall Study|Withdrawal by Subject|1
756069|NCT00467584|2412090|P2|Overall Study|Withdrawal by Subject|5
756070|NCT00467584|2412091|P1|Overall Study|Withdrawal by Subject|4
756071|NCT00467597|2412103|P2|Overall Study|Withdrawal by Subject|0
756072|NCT00467597|2412104|P1|Overall Study|Withdrawal by Subject|2
756073|NCT00467610|2412114|P1|Overall Study|Withdrawal by Subject|1
756074|NCT00467649|2412123|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
756075|NCT00467649|2412124|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
756076|NCT00467649|2412125|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
756077|NCT00467649|2412126|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
756078|NCT00467649|2412127|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
756079|NCT00467649|2412128|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
756080|NCT00467649|2412123|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
756081|NCT00467649|2412124|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
756082|NCT00467649|2412125|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
756083|NCT00467649|2412126|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
756084|NCT00467649|2412127|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
756085|NCT00467649|2412128|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
756086|NCT00467649|2412123|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
756087|NCT00467649|2412124|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
756088|NCT00467649|2412125|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
756089|NCT00467649|2412126|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
756090|NCT00467649|2412127|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
756091|NCT00467649|2412128|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
756092|NCT00467649|2412123|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
756093|NCT00467649|2412124|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
756094|NCT00467649|2412125|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
756095|NCT00467649|2412126|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
756096|NCT00467649|2412127|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
756097|NCT00467649|2412128|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
756098|NCT00467649|2412123|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
756099|NCT00467649|2412124|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
756100|NCT00467649|2412125|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
756101|NCT00467649|2412126|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
756102|NCT00467649|2412127|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
756103|NCT00467649|2412128|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
756104|NCT00467649|2412123|P6|Phase 1 (Randomized Population)|Investigator Decision|0
756105|NCT00467649|2412124|P5|Phase 1 (Randomized Population)|Investigator Decision|0
756106|NCT00467649|2412125|P4|Phase 1 (Randomized Population)|Investigator Decision|0
756107|NCT00467649|2412126|P3|Phase 1 (Randomized Population)|Investigator Decision|0
756108|NCT00467649|2412127|P2|Phase 1 (Randomized Population)|Investigator Decision|0
756109|NCT00467649|2412128|P1|Phase 1 (Randomized Population)|Investigator Decision|1
756110|NCT00467649|2412123|P6|Phase 1 (Randomized Population)|Adverse Event|0
756111|NCT00467649|2412124|P5|Phase 1 (Randomized Population)|Adverse Event|0
756112|NCT00467649|2412125|P4|Phase 1 (Randomized Population)|Adverse Event|0
756113|NCT00467649|2412126|P3|Phase 1 (Randomized Population)|Adverse Event|0
756114|NCT00467649|2412127|P2|Phase 1 (Randomized Population)|Adverse Event|0
756115|NCT00467649|2412128|P1|Phase 1 (Randomized Population)|Adverse Event|2
756116|NCT00467740|2412173|P5|Overall Study|Lack of Efficacy|0
756117|NCT00467740|2412174|P4|Overall Study|Lack of Efficacy|0
756118|NCT00467740|2412175|P3|Overall Study|Lack of Efficacy|0
756119|NCT00467740|2412176|P2|Overall Study|Lack of Efficacy|1
756120|NCT00467740|2412177|P1|Overall Study|Lack of Efficacy|0
756121|NCT00467740|2412173|P5|Overall Study|Withdrawal by Subject|0
756122|NCT00467740|2412174|P4|Overall Study|Withdrawal by Subject|1
756123|NCT00467740|2412175|P3|Overall Study|Withdrawal by Subject|0
756124|NCT00467740|2412176|P2|Overall Study|Withdrawal by Subject|1
756125|NCT00467740|2412177|P1|Overall Study|Withdrawal by Subject|1
756126|NCT00467740|2412173|P5|Overall Study|Lost to Follow-up|0
756127|NCT00467740|2412174|P4|Overall Study|Lost to Follow-up|0
756128|NCT00467740|2412175|P3|Overall Study|Lost to Follow-up|0
756129|NCT00467740|2412176|P2|Overall Study|Lost to Follow-up|1
756130|NCT00467740|2412177|P1|Overall Study|Lost to Follow-up|0
756131|NCT00467740|2412173|P5|Overall Study|Protocol Violation|0
756132|NCT00467740|2412174|P4|Overall Study|Protocol Violation|0
756133|NCT00467740|2412175|P3|Overall Study|Protocol Violation|1
756134|NCT00467740|2412176|P2|Overall Study|Protocol Violation|0
756135|NCT00467740|2412177|P1|Overall Study|Protocol Violation|0
756136|NCT00467740|2412173|P5|Overall Study|Adverse Event|0
756137|NCT00467740|2412174|P4|Overall Study|Adverse Event|0
756138|NCT00467740|2412175|P3|Overall Study|Adverse Event|1
756139|NCT00467740|2412176|P2|Overall Study|Adverse Event|0
756140|NCT00467740|2412177|P1|Overall Study|Adverse Event|0
756141|NCT00467753|2412366|P2|Overall Study|Adverse Event|0
756142|NCT00467753|2412367|P1|Overall Study|Adverse Event|2
756143|NCT00467753|2412366|P2|Overall Study|Lost to Follow-up|2
756144|NCT00467753|2412367|P1|Overall Study|Lost to Follow-up|1
756145|NCT00467779|2412388|P15|Stage 3|Unspecified Reason|5
756146|NCT00467779|2412389|P14|Stage 3|Unspecified Reason|0
756147|NCT00467779|2412390|P13|Stage 3|Unspecified Reason|0
756148|NCT00467779|2412391|P12|Stage 3|Unspecified Reason|0
756149|NCT00467779|2412392|P11|Stage 3|Unspecified Reason|0
756150|NCT00467779|2412393|P10|Stage 3|Unspecified Reason|0
756151|NCT00467779|2412394|P9|Stage 3|Unspecified Reason|0
756152|NCT00467779|2412395|P8|Stage 3|Unspecified Reason|0
756153|NCT00467779|2412396|P7|Stage 3|Unspecified Reason|0
756154|NCT00467779|2412397|P6|Stage 3|Unspecified Reason|0
756155|NCT00467779|2412398|P5|Stage 3|Unspecified Reason|0
756156|NCT00467779|2412399|P4|Stage 3|Unspecified Reason|0
756157|NCT00467779|2412400|P3|Stage 3|Unspecified Reason|0
756158|NCT00467779|2412401|P2|Stage 3|Unspecified Reason|0
756159|NCT00467779|2412402|P1|Stage 3|Unspecified Reason|0
756160|NCT00467779|2412388|P15|Stage 3|Disease Progression|9
756161|NCT00467779|2412389|P14|Stage 3|Disease Progression|0
756162|NCT00467779|2412390|P13|Stage 3|Disease Progression|0
756163|NCT00467779|2412391|P12|Stage 3|Disease Progression|0
756164|NCT00467779|2412392|P11|Stage 3|Disease Progression|0
756165|NCT00467779|2412393|P10|Stage 3|Disease Progression|0
756166|NCT00467779|2412394|P9|Stage 3|Disease Progression|0
756167|NCT00467779|2412395|P8|Stage 3|Disease Progression|0
756168|NCT00467779|2412396|P7|Stage 3|Disease Progression|0
756169|NCT00467779|2412397|P6|Stage 3|Disease Progression|0
756170|NCT00467779|2412398|P5|Stage 3|Disease Progression|0
756171|NCT00467779|2412399|P4|Stage 3|Disease Progression|0
756172|NCT00467779|2412400|P3|Stage 3|Disease Progression|0
756173|NCT00467779|2412401|P2|Stage 3|Disease Progression|0
756174|NCT00467779|2412402|P1|Stage 3|Disease Progression|0
756175|NCT00467779|2412388|P15|Stage 3|Death|1
756176|NCT00467779|2412389|P14|Stage 3|Death|0
756177|NCT00467779|2412390|P13|Stage 3|Death|0
756178|NCT00467779|2412391|P12|Stage 3|Death|0
756179|NCT00467779|2412392|P11|Stage 3|Death|0
756180|NCT00467779|2412393|P10|Stage 3|Death|0
756181|NCT00467779|2412394|P9|Stage 3|Death|0
756182|NCT00467779|2412395|P8|Stage 3|Death|0
756183|NCT00467779|2412396|P7|Stage 3|Death|0
756184|NCT00467779|2412397|P6|Stage 3|Death|0
756185|NCT00467779|2412398|P5|Stage 3|Death|0
756186|NCT00467779|2412399|P4|Stage 3|Death|0
756187|NCT00467779|2412400|P3|Stage 3|Death|0
756188|NCT00467779|2412401|P2|Stage 3|Death|0
756189|NCT00467779|2412402|P1|Stage 3|Death|0
756190|NCT00467779|2412388|P15|Stage 3|Adverse Event|2
756191|NCT00467779|2412389|P14|Stage 3|Adverse Event|0
756192|NCT00467779|2412390|P13|Stage 3|Adverse Event|0
756193|NCT00467779|2412391|P12|Stage 3|Adverse Event|0
756194|NCT00467779|2412392|P11|Stage 3|Adverse Event|0
756195|NCT00467779|2412393|P10|Stage 3|Adverse Event|0
756196|NCT00467779|2412394|P9|Stage 3|Adverse Event|0
756198|NCT00467779|2412396|P7|Stage 3|Adverse Event|0
756199|NCT00467779|2412397|P6|Stage 3|Adverse Event|0
756200|NCT00467779|2412398|P5|Stage 3|Adverse Event|0
756201|NCT00467779|2412399|P4|Stage 3|Adverse Event|0
756202|NCT00467779|2412400|P3|Stage 3|Adverse Event|0
756203|NCT00467779|2412401|P2|Stage 3|Adverse Event|0
756204|NCT00467779|2412402|P1|Stage 3|Adverse Event|0
756205|NCT00467779|2412388|P15|Stage 2A|Withdrawal by Subject|0
756206|NCT00467779|2412389|P14|Stage 2A|Withdrawal by Subject|1
756207|NCT00467779|2412390|P13|Stage 2A|Withdrawal by Subject|0
756208|NCT00467779|2412391|P12|Stage 2A|Withdrawal by Subject|0
756209|NCT00467779|2412392|P11|Stage 2A|Withdrawal by Subject|0
756210|NCT00467779|2412393|P10|Stage 2A|Withdrawal by Subject|0
756211|NCT00467779|2412394|P9|Stage 2A|Withdrawal by Subject|0
756212|NCT00467779|2412395|P8|Stage 2A|Withdrawal by Subject|0
756213|NCT00467779|2412396|P7|Stage 2A|Withdrawal by Subject|0
756214|NCT00467779|2412397|P6|Stage 2A|Withdrawal by Subject|0
756215|NCT00467779|2412398|P5|Stage 2A|Withdrawal by Subject|0
756216|NCT00467779|2412399|P4|Stage 2A|Withdrawal by Subject|0
756217|NCT00467779|2412400|P3|Stage 2A|Withdrawal by Subject|0
756218|NCT00467779|2412401|P2|Stage 2A|Withdrawal by Subject|0
756219|NCT00467779|2412402|P1|Stage 2A|Withdrawal by Subject|0
756220|NCT00467779|2412388|P15|Stage 2A|Unspecified Reason|0
756221|NCT00467779|2412389|P14|Stage 2A|Unspecified Reason|7
756222|NCT00467779|2412390|P13|Stage 2A|Unspecified Reason|0
756223|NCT00467779|2412391|P12|Stage 2A|Unspecified Reason|0
756224|NCT00467779|2412392|P11|Stage 2A|Unspecified Reason|0
756225|NCT00467779|2412393|P10|Stage 2A|Unspecified Reason|0
756226|NCT00467779|2412394|P9|Stage 2A|Unspecified Reason|0
756227|NCT00467779|2412395|P8|Stage 2A|Unspecified Reason|0
756228|NCT00467779|2412396|P7|Stage 2A|Unspecified Reason|0
756229|NCT00467779|2412397|P6|Stage 2A|Unspecified Reason|0
756230|NCT00467779|2412398|P5|Stage 2A|Unspecified Reason|0
756231|NCT00467779|2412399|P4|Stage 2A|Unspecified Reason|0
756232|NCT00467779|2412400|P3|Stage 2A|Unspecified Reason|0
756233|NCT00467779|2412401|P2|Stage 2A|Unspecified Reason|0
756234|NCT00467779|2412402|P1|Stage 2A|Unspecified Reason|0
756235|NCT00467779|2412388|P15|Stage 2A|Disease Progression|0
756236|NCT00467779|2412389|P14|Stage 2A|Disease Progression|10
756237|NCT00467779|2412390|P13|Stage 2A|Disease Progression|0
756238|NCT00467779|2412391|P12|Stage 2A|Disease Progression|0
756239|NCT00467779|2412392|P11|Stage 2A|Disease Progression|0
756240|NCT00467779|2412393|P10|Stage 2A|Disease Progression|0
756241|NCT00467779|2412394|P9|Stage 2A|Disease Progression|0
756242|NCT00467779|2412395|P8|Stage 2A|Disease Progression|0
756243|NCT00467779|2412396|P7|Stage 2A|Disease Progression|0
756244|NCT00467779|2412397|P6|Stage 2A|Disease Progression|0
756245|NCT00467779|2412398|P5|Stage 2A|Disease Progression|0
756246|NCT00467779|2412399|P4|Stage 2A|Disease Progression|0
756247|NCT00467779|2412400|P3|Stage 2A|Disease Progression|0
756248|NCT00467779|2412401|P2|Stage 2A|Disease Progression|0
756249|NCT00467779|2412402|P1|Stage 2A|Disease Progression|0
756250|NCT00467779|2412388|P15|Stage 2A|Death|0
756251|NCT00467779|2412389|P14|Stage 2A|Death|1
756252|NCT00467779|2412390|P13|Stage 2A|Death|0
756253|NCT00467779|2412391|P12|Stage 2A|Death|0
756254|NCT00467779|2412392|P11|Stage 2A|Death|0
756255|NCT00467779|2412393|P10|Stage 2A|Death|0
756256|NCT00467779|2412394|P9|Stage 2A|Death|0
756257|NCT00467779|2412395|P8|Stage 2A|Death|0
756258|NCT00467779|2412396|P7|Stage 2A|Death|0
756259|NCT00467779|2412397|P6|Stage 2A|Death|0
756260|NCT00467779|2412398|P5|Stage 2A|Death|0
756261|NCT00467779|2412399|P4|Stage 2A|Death|0
756262|NCT00467779|2412400|P3|Stage 2A|Death|0
756263|NCT00467779|2412401|P2|Stage 2A|Death|0
756264|NCT00467779|2412402|P1|Stage 2A|Death|0
756265|NCT00467779|2412388|P15|Stage 2A|Adverse Event|0
756266|NCT00467779|2412389|P14|Stage 2A|Adverse Event|2
756267|NCT00467779|2412390|P13|Stage 2A|Adverse Event|0
756268|NCT00467779|2412391|P12|Stage 2A|Adverse Event|0
756269|NCT00467779|2412392|P11|Stage 2A|Adverse Event|0
756270|NCT00467779|2412393|P10|Stage 2A|Adverse Event|0
756271|NCT00467779|2412394|P9|Stage 2A|Adverse Event|0
756272|NCT00467779|2412395|P8|Stage 2A|Adverse Event|0
756273|NCT00467779|2412396|P7|Stage 2A|Adverse Event|0
756274|NCT00467779|2412397|P6|Stage 2A|Adverse Event|0
756275|NCT00467779|2412398|P5|Stage 2A|Adverse Event|0
756276|NCT00467779|2412399|P4|Stage 2A|Adverse Event|0
756277|NCT00467779|2412400|P3|Stage 2A|Adverse Event|0
756278|NCT00467779|2412401|P2|Stage 2A|Adverse Event|0
756279|NCT00467779|2412402|P1|Stage 2A|Adverse Event|0
756280|NCT00467779|2412388|P15|Stage 2|Unspecified Reason|0
756281|NCT00467779|2412389|P14|Stage 2|Unspecified Reason|0
756282|NCT00467779|2412390|P13|Stage 2|Unspecified Reason|0
756283|NCT00467779|2412391|P12|Stage 2|Unspecified Reason|0
756284|NCT00467779|2412392|P11|Stage 2|Unspecified Reason|0
756285|NCT00467779|2412393|P10|Stage 2|Unspecified Reason|0
756286|NCT00467779|2412394|P9|Stage 2|Unspecified Reason|3
756287|NCT00467779|2412395|P8|Stage 2|Unspecified Reason|0
756288|NCT00467779|2412396|P7|Stage 2|Unspecified Reason|0
756289|NCT00467779|2412397|P6|Stage 2|Unspecified Reason|0
756290|NCT00467779|2412398|P5|Stage 2|Unspecified Reason|0
756291|NCT00467779|2412399|P4|Stage 2|Unspecified Reason|0
756292|NCT00467779|2412400|P3|Stage 2|Unspecified Reason|0
756293|NCT00467779|2412401|P2|Stage 2|Unspecified Reason|0
756294|NCT00467779|2412402|P1|Stage 2|Unspecified Reason|0
756295|NCT00467779|2412388|P15|Stage 2|Disease Progression|0
756296|NCT00467779|2412389|P14|Stage 2|Disease Progression|0
756297|NCT00467779|2412390|P13|Stage 2|Disease Progression|0
756298|NCT00467779|2412391|P12|Stage 2|Disease Progression|0
756299|NCT00467779|2412392|P11|Stage 2|Disease Progression|0
756300|NCT00467779|2412393|P10|Stage 2|Disease Progression|0
756301|NCT00467779|2412394|P9|Stage 2|Disease Progression|16
756302|NCT00467779|2412395|P8|Stage 2|Disease Progression|0
756303|NCT00467779|2412396|P7|Stage 2|Disease Progression|0
756304|NCT00467779|2412397|P6|Stage 2|Disease Progression|0
756305|NCT00467779|2412398|P5|Stage 2|Disease Progression|0
756306|NCT00467779|2412399|P4|Stage 2|Disease Progression|0
756307|NCT00467779|2412400|P3|Stage 2|Disease Progression|0
756308|NCT00467779|2412401|P2|Stage 2|Disease Progression|0
756309|NCT00467779|2412402|P1|Stage 2|Disease Progression|0
756310|NCT00467779|2412388|P15|Stage 2|Death|0
756311|NCT00467779|2412389|P14|Stage 2|Death|0
756312|NCT00467779|2412390|P13|Stage 2|Death|0
756313|NCT00467779|2412391|P12|Stage 2|Death|0
756314|NCT00467779|2412392|P11|Stage 2|Death|0
756315|NCT00467779|2412393|P10|Stage 2|Death|0
756316|NCT00467779|2412394|P9|Stage 2|Death|1
756317|NCT00467779|2412395|P8|Stage 2|Death|0
756318|NCT00467779|2412396|P7|Stage 2|Death|0
756319|NCT00467779|2412397|P6|Stage 2|Death|0
756320|NCT00467779|2412398|P5|Stage 2|Death|0
756321|NCT00467779|2412399|P4|Stage 2|Death|0
756322|NCT00467779|2412400|P3|Stage 2|Death|0
756323|NCT00467779|2412401|P2|Stage 2|Death|0
756324|NCT00467779|2412402|P1|Stage 2|Death|0
756325|NCT00467779|2412388|P15|Stage 2|Adverse Event|0
756326|NCT00467779|2412389|P14|Stage 2|Adverse Event|0
756327|NCT00467779|2412390|P13|Stage 2|Adverse Event|0
756328|NCT00467779|2412391|P12|Stage 2|Adverse Event|0
756329|NCT00467779|2412392|P11|Stage 2|Adverse Event|0
756330|NCT00467779|2412393|P10|Stage 2|Adverse Event|0
756331|NCT00467779|2412394|P9|Stage 2|Adverse Event|1
756332|NCT00467779|2412395|P8|Stage 2|Adverse Event|0
756333|NCT00467779|2412396|P7|Stage 2|Adverse Event|0
756334|NCT00467779|2412397|P6|Stage 2|Adverse Event|0
756335|NCT00467779|2412398|P5|Stage 2|Adverse Event|0
756336|NCT00467779|2412399|P4|Stage 2|Adverse Event|0
756337|NCT00467779|2412400|P3|Stage 2|Adverse Event|0
756338|NCT00467779|2412401|P2|Stage 2|Adverse Event|0
756339|NCT00467779|2412402|P1|Stage 2|Adverse Event|0
756340|NCT00467779|2412388|P15|Stage 1A|Unspecified Reason|0
756341|NCT00467779|2412389|P14|Stage 1A|Unspecified Reason|0
756342|NCT00467779|2412390|P13|Stage 1A|Unspecified Reason|1
756343|NCT00467779|2412391|P12|Stage 1A|Unspecified Reason|1
756344|NCT00467779|2412392|P11|Stage 1A|Unspecified Reason|0
756345|NCT00467779|2412393|P10|Stage 1A|Unspecified Reason|0
756346|NCT00467779|2412394|P9|Stage 1A|Unspecified Reason|0
756347|NCT00467779|2412395|P8|Stage 1A|Unspecified Reason|0
756348|NCT00467779|2412396|P7|Stage 1A|Unspecified Reason|0
756349|NCT00467779|2412397|P6|Stage 1A|Unspecified Reason|0
756350|NCT00467779|2412398|P5|Stage 1A|Unspecified Reason|0
756351|NCT00467779|2412399|P4|Stage 1A|Unspecified Reason|0
756352|NCT00467779|2412400|P3|Stage 1A|Unspecified Reason|0
756353|NCT00467779|2412401|P2|Stage 1A|Unspecified Reason|0
756354|NCT00467779|2412402|P1|Stage 1A|Unspecified Reason|0
756355|NCT00467779|2412388|P15|Stage 1A|Withdrawal by Subject|0
756356|NCT00467779|2412389|P14|Stage 1A|Withdrawal by Subject|0
756357|NCT00467779|2412390|P13|Stage 1A|Withdrawal by Subject|1
756358|NCT00467779|2412391|P12|Stage 1A|Withdrawal by Subject|1
756359|NCT00467779|2412392|P11|Stage 1A|Withdrawal by Subject|1
756360|NCT00467779|2412393|P10|Stage 1A|Withdrawal by Subject|0
756361|NCT00467779|2412394|P9|Stage 1A|Withdrawal by Subject|0
756362|NCT00467779|2412395|P8|Stage 1A|Withdrawal by Subject|0
756363|NCT00467779|2412396|P7|Stage 1A|Withdrawal by Subject|0
756364|NCT00467779|2412397|P6|Stage 1A|Withdrawal by Subject|0
756365|NCT00467779|2412398|P5|Stage 1A|Withdrawal by Subject|0
756366|NCT00467779|2412399|P4|Stage 1A|Withdrawal by Subject|0
756367|NCT00467779|2412400|P3|Stage 1A|Withdrawal by Subject|0
756368|NCT00467779|2412401|P2|Stage 1A|Withdrawal by Subject|0
756369|NCT00467779|2412402|P1|Stage 1A|Withdrawal by Subject|0
756370|NCT00467779|2412388|P15|Stage 1A|Physician Decision|0
756371|NCT00467779|2412389|P14|Stage 1A|Physician Decision|0
756372|NCT00467779|2412390|P13|Stage 1A|Physician Decision|0
756373|NCT00467779|2412391|P12|Stage 1A|Physician Decision|0
756374|NCT00467779|2412392|P11|Stage 1A|Physician Decision|0
756375|NCT00467779|2412393|P10|Stage 1A|Physician Decision|1
756376|NCT00467779|2412394|P9|Stage 1A|Physician Decision|0
756377|NCT00467779|2412395|P8|Stage 1A|Physician Decision|0
756378|NCT00467779|2412396|P7|Stage 1A|Physician Decision|0
756379|NCT00467779|2412397|P6|Stage 1A|Physician Decision|0
756380|NCT00467779|2412398|P5|Stage 1A|Physician Decision|0
756381|NCT00467779|2412399|P4|Stage 1A|Physician Decision|0
756382|NCT00467779|2412400|P3|Stage 1A|Physician Decision|0
756383|NCT00467779|2412401|P2|Stage 1A|Physician Decision|0
756384|NCT00467779|2412402|P1|Stage 1A|Physician Decision|0
756385|NCT00467779|2412388|P15|Stage 1A|Disease Progression|0
756386|NCT00467779|2412389|P14|Stage 1A|Disease Progression|0
756387|NCT00467779|2412390|P13|Stage 1A|Disease Progression|2
756388|NCT00467779|2412391|P12|Stage 1A|Disease Progression|5
756389|NCT00467779|2412392|P11|Stage 1A|Disease Progression|2
756390|NCT00467779|2412393|P10|Stage 1A|Disease Progression|2
756391|NCT00467779|2412394|P9|Stage 1A|Disease Progression|0
756392|NCT00467779|2412395|P8|Stage 1A|Disease Progression|0
756393|NCT00467779|2412396|P7|Stage 1A|Disease Progression|0
756394|NCT00467779|2412397|P6|Stage 1A|Disease Progression|0
756395|NCT00467779|2412398|P5|Stage 1A|Disease Progression|0
756396|NCT00467779|2412399|P4|Stage 1A|Disease Progression|0
756397|NCT00467779|2412400|P3|Stage 1A|Disease Progression|0
756398|NCT00467779|2412401|P2|Stage 1A|Disease Progression|0
756399|NCT00467779|2412402|P1|Stage 1A|Disease Progression|0
756400|NCT00467779|2412388|P15|Stage 1A|Death|0
756401|NCT00467779|2412389|P14|Stage 1A|Death|0
756402|NCT00467779|2412390|P13|Stage 1A|Death|1
756403|NCT00467779|2412391|P12|Stage 1A|Death|1
756404|NCT00467779|2412392|P11|Stage 1A|Death|0
756405|NCT00467779|2412393|P10|Stage 1A|Death|0
756406|NCT00467779|2412394|P9|Stage 1A|Death|0
756407|NCT00467779|2412395|P8|Stage 1A|Death|0
756408|NCT00467779|2412396|P7|Stage 1A|Death|0
756409|NCT00467779|2412397|P6|Stage 1A|Death|0
756410|NCT00467779|2412398|P5|Stage 1A|Death|0
756411|NCT00467779|2412399|P4|Stage 1A|Death|0
756412|NCT00467779|2412400|P3|Stage 1A|Death|0
756413|NCT00467779|2412401|P2|Stage 1A|Death|0
756414|NCT00467779|2412402|P1|Stage 1A|Death|0
756415|NCT00467779|2412388|P15|Stage 1A|Adverse Event|0
756416|NCT00467779|2412389|P14|Stage 1A|Adverse Event|0
756417|NCT00467779|2412390|P13|Stage 1A|Adverse Event|1
756418|NCT00467779|2412391|P12|Stage 1A|Adverse Event|0
756419|NCT00467779|2412392|P11|Stage 1A|Adverse Event|0
756420|NCT00467779|2412393|P10|Stage 1A|Adverse Event|0
756421|NCT00467779|2412394|P9|Stage 1A|Adverse Event|0
756422|NCT00467779|2412395|P8|Stage 1A|Adverse Event|0
756423|NCT00467779|2412396|P7|Stage 1A|Adverse Event|0
756424|NCT00467779|2412397|P6|Stage 1A|Adverse Event|0
756425|NCT00467779|2412398|P5|Stage 1A|Adverse Event|0
756426|NCT00467779|2412399|P4|Stage 1A|Adverse Event|0
756427|NCT00467779|2412400|P3|Stage 1A|Adverse Event|0
756428|NCT00467779|2412401|P2|Stage 1A|Adverse Event|0
756429|NCT00467779|2412402|P1|Stage 1A|Adverse Event|0
756430|NCT00467779|2412388|P15|Stage 1|Withdrawal by Subject|0
756431|NCT00467779|2412389|P14|Stage 1|Withdrawal by Subject|0
756432|NCT00467779|2412390|P13|Stage 1|Withdrawal by Subject|0
756433|NCT00467779|2412391|P12|Stage 1|Withdrawal by Subject|0
756434|NCT00467779|2412392|P11|Stage 1|Withdrawal by Subject|0
756435|NCT00467779|2412393|P10|Stage 1|Withdrawal by Subject|0
756436|NCT00467779|2412394|P9|Stage 1|Withdrawal by Subject|0
756437|NCT00467779|2412395|P8|Stage 1|Withdrawal by Subject|1
756438|NCT00467779|2412396|P7|Stage 1|Withdrawal by Subject|1
756439|NCT00467779|2412397|P6|Stage 1|Withdrawal by Subject|0
756440|NCT00467779|2412398|P5|Stage 1|Withdrawal by Subject|0
756441|NCT00467779|2412399|P4|Stage 1|Withdrawal by Subject|0
756442|NCT00467779|2412400|P3|Stage 1|Withdrawal by Subject|0
756443|NCT00467779|2412401|P2|Stage 1|Withdrawal by Subject|0
756444|NCT00467779|2412402|P1|Stage 1|Withdrawal by Subject|0
756445|NCT00467779|2412388|P15|Stage 1|Physician Decision|0
756446|NCT00467779|2412389|P14|Stage 1|Physician Decision|0
756447|NCT00467779|2412390|P13|Stage 1|Physician Decision|0
756448|NCT00467779|2412391|P12|Stage 1|Physician Decision|0
756449|NCT00467779|2412392|P11|Stage 1|Physician Decision|0
756450|NCT00467779|2412393|P10|Stage 1|Physician Decision|0
756451|NCT00467779|2412394|P9|Stage 1|Physician Decision|0
756452|NCT00467779|2412395|P8|Stage 1|Physician Decision|0
756453|NCT00467779|2412396|P7|Stage 1|Physician Decision|0
756454|NCT00467779|2412397|P6|Stage 1|Physician Decision|0
756455|NCT00467779|2412398|P5|Stage 1|Physician Decision|0
756456|NCT00467779|2412399|P4|Stage 1|Physician Decision|0
756457|NCT00467779|2412400|P3|Stage 1|Physician Decision|0
756458|NCT00467779|2412401|P2|Stage 1|Physician Decision|1
756459|NCT00467779|2412402|P1|Stage 1|Physician Decision|0
756460|NCT00467779|2412388|P15|Stage 1|Unspecified Reason|0
756461|NCT00467779|2412389|P14|Stage 1|Unspecified Reason|0
756462|NCT00467779|2412390|P13|Stage 1|Unspecified Reason|0
756463|NCT00467779|2412391|P12|Stage 1|Unspecified Reason|0
756464|NCT00467779|2412392|P11|Stage 1|Unspecified Reason|0
756465|NCT00467779|2412393|P10|Stage 1|Unspecified Reason|0
756466|NCT00467779|2412394|P9|Stage 1|Unspecified Reason|0
756467|NCT00467779|2412395|P8|Stage 1|Unspecified Reason|0
756468|NCT00467779|2412396|P7|Stage 1|Unspecified Reason|0
756469|NCT00467779|2412397|P6|Stage 1|Unspecified Reason|2
756470|NCT00467779|2412398|P5|Stage 1|Unspecified Reason|1
756471|NCT00467779|2412399|P4|Stage 1|Unspecified Reason|0
756472|NCT00467779|2412400|P3|Stage 1|Unspecified Reason|1
756473|NCT00467779|2412401|P2|Stage 1|Unspecified Reason|0
756474|NCT00467779|2412402|P1|Stage 1|Unspecified Reason|1
756475|NCT00467779|2412388|P15|Stage 1|Disease Progression|0
756476|NCT00467779|2412389|P14|Stage 1|Disease Progression|0
756477|NCT00467779|2412390|P13|Stage 1|Disease Progression|0
756478|NCT00467779|2412391|P12|Stage 1|Disease Progression|0
756479|NCT00467779|2412392|P11|Stage 1|Disease Progression|0
756480|NCT00467779|2412393|P10|Stage 1|Disease Progression|0
756481|NCT00467779|2412394|P9|Stage 1|Disease Progression|0
756482|NCT00467779|2412395|P8|Stage 1|Disease Progression|5
756483|NCT00467779|2412396|P7|Stage 1|Disease Progression|4
756484|NCT00467779|2412397|P6|Stage 1|Disease Progression|2
756485|NCT00467779|2412398|P5|Stage 1|Disease Progression|2
756486|NCT00467779|2412399|P4|Stage 1|Disease Progression|3
756487|NCT00467779|2412400|P3|Stage 1|Disease Progression|2
756488|NCT00467779|2412401|P2|Stage 1|Disease Progression|2
756489|NCT00467779|2412402|P1|Stage 1|Disease Progression|2
756490|NCT00467779|2412388|P15|Stage 1|Adverse Event|0
756491|NCT00467779|2412389|P14|Stage 1|Adverse Event|0
756492|NCT00467779|2412390|P13|Stage 1|Adverse Event|0
756493|NCT00467779|2412391|P12|Stage 1|Adverse Event|0
756494|NCT00467779|2412392|P11|Stage 1|Adverse Event|0
756495|NCT00467779|2412393|P10|Stage 1|Adverse Event|0
756496|NCT00467779|2412394|P9|Stage 1|Adverse Event|0
756497|NCT00467779|2412395|P8|Stage 1|Adverse Event|1
756498|NCT00467779|2412396|P7|Stage 1|Adverse Event|2
756499|NCT00467779|2412397|P6|Stage 1|Adverse Event|1
756500|NCT00467779|2412398|P5|Stage 1|Adverse Event|0
756501|NCT00467779|2412399|P4|Stage 1|Adverse Event|0
756502|NCT00467779|2412400|P3|Stage 1|Adverse Event|0
756503|NCT00467779|2412401|P2|Stage 1|Adverse Event|0
756504|NCT00467779|2412402|P1|Stage 1|Adverse Event|1
756505|NCT00467831|2412574|P1|Overall Study|Withdrawal by Subject|1
756506|NCT00467831|2412574|P1|Overall Study|Death|2
756507|NCT00467857|2412596|P2|Overall Study|Discontinuation reason missing|3
756508|NCT00467857|2412597|P1|Overall Study|Discontinuation reason missing|0
756509|NCT00467857|2412596|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
756510|NCT00467857|2412597|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
756511|NCT00467857|2412596|P2|Overall Study|Emergency care required|1
756512|NCT00467857|2412597|P1|Overall Study|Emergency care required|0
756513|NCT00467857|2412596|P2|Overall Study|Discharged from court service|1
756514|NCT00467857|2412597|P1|Overall Study|Discharged from court service|0
756515|NCT00467857|2412596|P2|Overall Study|Death|1
756516|NCT00467857|2412597|P1|Overall Study|Death|0
756517|NCT00467857|2412596|P2|Overall Study|Withdrew consent|0
756518|NCT00467857|2412597|P1|Overall Study|Withdrew consent|2
756519|NCT00467857|2412596|P2|Overall Study|Adverse Event|0
756520|NCT00467857|2412597|P1|Overall Study|Adverse Event|1
756521|NCT00467870|2412635|P6|Overall Study|Other/Unknown|0
756522|NCT00467870|2412636|P5|Overall Study|Other/Unknown|4
756523|NCT00467870|2412637|P4|Overall Study|Other/Unknown|5
756524|NCT00467870|2412638|P3|Overall Study|Other/Unknown|1
756525|NCT00467870|2412639|P2|Overall Study|Other/Unknown|5
756526|NCT00467870|2412640|P1|Overall Study|Other/Unknown|8
756527|NCT00467870|2412635|P6|Overall Study|Subject Non-compliance|0
756528|NCT00467870|2412636|P5|Overall Study|Subject Non-compliance|5
756529|NCT00467870|2412637|P4|Overall Study|Subject Non-compliance|1
756530|NCT00467870|2412638|P3|Overall Study|Subject Non-compliance|0
756531|NCT00467870|2412639|P2|Overall Study|Subject Non-compliance|4
756532|NCT00467870|2412640|P1|Overall Study|Subject Non-compliance|3
756533|NCT00467870|2412635|P6|Overall Study|Lost to Follow-up|0
756534|NCT00467870|2412636|P5|Overall Study|Lost to Follow-up|3
756535|NCT00467870|2412637|P4|Overall Study|Lost to Follow-up|1
756536|NCT00467870|2412638|P3|Overall Study|Lost to Follow-up|1
756537|NCT00467870|2412639|P2|Overall Study|Lost to Follow-up|3
756538|NCT00467870|2412640|P1|Overall Study|Lost to Follow-up|5
756539|NCT00467870|2412635|P6|Overall Study|Withdrawal by Subject|1
756540|NCT00467870|2412636|P5|Overall Study|Withdrawal by Subject|10
756541|NCT00467870|2412637|P4|Overall Study|Withdrawal by Subject|9
756542|NCT00467870|2412638|P3|Overall Study|Withdrawal by Subject|0
756543|NCT00467870|2412639|P2|Overall Study|Withdrawal by Subject|21
756544|NCT00467870|2412640|P1|Overall Study|Withdrawal by Subject|14
756545|NCT00467870|2412635|P6|Overall Study|Protocol Violation|0
756546|NCT00467870|2412636|P5|Overall Study|Protocol Violation|0
756547|NCT00467870|2412637|P4|Overall Study|Protocol Violation|2
756548|NCT00467870|2412638|P3|Overall Study|Protocol Violation|1
756549|NCT00467870|2412639|P2|Overall Study|Protocol Violation|1
756550|NCT00467870|2412640|P1|Overall Study|Protocol Violation|2
756551|NCT00467870|2412635|P6|Overall Study|Adverse Event|1
756552|NCT00467870|2412636|P5|Overall Study|Adverse Event|15
756553|NCT00467870|2412637|P4|Overall Study|Adverse Event|15
756554|NCT00467870|2412638|P3|Overall Study|Adverse Event|1
756555|NCT00467870|2412639|P2|Overall Study|Adverse Event|9
756556|NCT00467870|2412640|P1|Overall Study|Adverse Event|13
756557|NCT00467896|2412681|P1|Overall Study|Patient had no improvement|1
756558|NCT00467896|2412681|P1|Overall Study|Started inhaled Remodulin|1
756559|NCT00467896|2412681|P1|Overall Study|Started intravenous prostacyclin|1
756560|NCT00467896|2412681|P1|Overall Study|Mainly used Prodose not I-neb® device|1
756561|NCT00467896|2412681|P1|Overall Study|Patient weaned off iloprost|1
756562|NCT00467896|2412681|P1|Overall Study|Patient had atrial septostomy|1
756563|NCT00467896|2412681|P1|Overall Study|Patient received transplant|2
756564|NCT00467896|2412681|P1|Overall Study|Changed therapy|2
756565|NCT00467896|2412681|P1|Overall Study|Non-compliance|3
756566|NCT00467896|2412681|P1|Overall Study|Serious Adverse Event|13
756567|NCT00467896|2412681|P1|Overall Study|Adverse Event|7
756568|NCT00467896|2412681|P1|Overall Study|Consent Withdrawal|18
756569|NCT00467961|2412701|P1|Overall Study|Disease Progression|2
756570|NCT00467961|2412701|P1|Overall Study|Technical Failures|5
756571|NCT00468052|2412707|P2|Overall Study|Protocol Violation|8
756572|NCT00468052|2412708|P1|Overall Study|Protocol Violation|7
756573|NCT00468104|2412726|P2|Second Intervention|discarded for malposition of chest tube|2
756574|NCT00468104|2412727|P1|Second Intervention|discarded for malposition of chest tube|0
756575|NCT00468104|2412726|P2|Second Intervention|Withdrawal by Subject|2
756576|NCT00468104|2412727|P1|Second Intervention|Withdrawal by Subject|5
756577|NCT00468104|2412726|P2|First Intervention|trapped lung|0
756578|NCT00468104|2412727|P1|First Intervention|trapped lung|1
756579|NCT00468104|2412726|P2|First Intervention|associated prolonged pneumothorax|0
756580|NCT00468104|2412727|P1|First Intervention|associated prolonged pneumothorax|1
756581|NCT00468104|2412726|P2|First Intervention|large lung mass with minimal effusion|0
756582|NCT00468104|2412727|P1|First Intervention|large lung mass with minimal effusion|1
756583|NCT00468104|2412726|P2|First Intervention|malposition/blocked chest tube tube|0
756584|NCT00468104|2412727|P1|First Intervention|malposition/blocked chest tube tube|2
756585|NCT00468104|2412726|P2|First Intervention|died within 3 weeks|0
756586|NCT00468104|2412727|P1|First Intervention|died within 3 weeks|1
756587|NCT00468104|2412726|P2|First Intervention|bleeding at chest tube site--first dose|0
756588|NCT00468104|2412727|P1|First Intervention|bleeding at chest tube site--first dose|1
756589|NCT00468104|2412726|P2|First Intervention|Protocol Violation|1
756590|NCT00468104|2412727|P1|First Intervention|Protocol Violation|2
756591|NCT00468143|2412742|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
756592|NCT00468143|2412743|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
756593|NCT00468143|2412742|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
756594|NCT00468143|2412743|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
756595|NCT00468286|2412767|P2|Overall Study|Physician Decision|1
756596|NCT00468286|2412768|P1|Overall Study|Physician Decision|0
756597|NCT00468286|2412767|P2|Overall Study|Withdrawal by Subject|3
756598|NCT00468286|2412768|P1|Overall Study|Withdrawal by Subject|4
756599|NCT00468286|2412767|P2|Overall Study|Protocol Violation|2
756600|NCT00468286|2412768|P1|Overall Study|Protocol Violation|2
756601|NCT00468286|2412767|P2|Overall Study|Adverse Event|6
756602|NCT00468286|2412768|P1|Overall Study|Adverse Event|1
756603|NCT00468299|2412792|P2|Overall Study|Withdrawal by Subject|1
756604|NCT00468299|2412793|P1|Overall Study|Withdrawal by Subject|0
756605|NCT00468312|2412803|P2|Overall Study|Did not meet protocol eligibility|1
756606|NCT00468312|2412804|P1|Overall Study|Did not meet protocol eligibility|0
756607|NCT00468312|2412803|P2|Overall Study|Protocol Violation|1
756608|NCT00468312|2412804|P1|Overall Study|Protocol Violation|2
756609|NCT00468312|2412803|P2|Overall Study|Withdrawal by Subject|1
756610|NCT00468312|2412804|P1|Overall Study|Withdrawal by Subject|0
756611|NCT00468312|2412803|P2|Overall Study|Lack of Efficacy|1
756612|NCT00468312|2412804|P1|Overall Study|Lack of Efficacy|0
756613|NCT00468312|2412803|P2|Overall Study|Adverse Event|1
756614|NCT00468312|2412804|P1|Overall Study|Adverse Event|2
756615|NCT00468481|2412820|P2|Overall Study|Other|0
756616|NCT00468481|2412821|P1|Overall Study|Other|6
756617|NCT00468481|2412820|P2|Overall Study|Non-Compliance|0
756618|NCT00468481|2412821|P1|Overall Study|Non-Compliance|5
756619|NCT00468481|2412820|P2|Overall Study|Moved out of area|1
756620|NCT00468481|2412821|P1|Overall Study|Moved out of area|4
756621|NCT00468481|2412820|P2|Overall Study|Egg Donor|0
756622|NCT00468481|2412821|P1|Overall Study|Egg Donor|1
756623|NCT00468481|2412820|P2|Overall Study|Prohibited Medication|1
756624|NCT00468481|2412821|P1|Overall Study|Prohibited Medication|1
756625|NCT00468481|2412820|P2|Overall Study|susp/diag malignant/premalignant disease|0
756626|NCT00468481|2412821|P1|Overall Study|susp/diag malignant/premalignant disease|1
756627|NCT00468481|2412820|P2|Overall Study|Withdrawal by Subject|3
756628|NCT00468481|2412821|P1|Overall Study|Withdrawal by Subject|12
756629|NCT00468481|2412820|P2|Overall Study|Protocol Violation|8
756630|NCT00468481|2412821|P1|Overall Study|Protocol Violation|18
756631|NCT00468481|2412820|P2|Overall Study|Pregnancy|0
756632|NCT00468481|2412821|P1|Overall Study|Pregnancy|2
756633|NCT00468481|2412820|P2|Overall Study|Lost to Follow-up|8
756634|NCT00468481|2412821|P1|Overall Study|Lost to Follow-up|25
756635|NCT00468481|2412820|P2|Overall Study|Adverse Event|3
756636|NCT00468481|2412821|P1|Overall Study|Adverse Event|13
756637|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Other|14
756638|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Other|17
756639|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
756640|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
756641|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Failure to return|2
756642|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Failure to return|1
756643|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Refused treatment|7
756644|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Refused treatment|4
756645|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
756646|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
756647|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
756648|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
756649|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Death|0
756650|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Death|1
756651|NCT00468546|2412921|P2|Week 24 to Week 104 Analysis|Adverse Event|5
756652|NCT00468546|2412922|P1|Week 24 to Week 104 Analysis|Adverse Event|2
756653|NCT00468546|2412921|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
756654|NCT00468546|2412922|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
756655|NCT00468546|2412921|P2|Week 24 Analysis|Went onto rescue therapy|0
756656|NCT00468546|2412922|P1|Week 24 Analysis|Went onto rescue therapy|1
756657|NCT00468546|2412921|P2|Week 24 Analysis|Due to clinical hold|0
756658|NCT00468546|2412922|P1|Week 24 Analysis|Due to clinical hold|1
756659|NCT00468546|2412921|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
756660|NCT00468546|2412922|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
756661|NCT00468546|2412921|P2|Week 24 Analysis|Rescue therapy|0
756662|NCT00468546|2412922|P1|Week 24 Analysis|Rescue therapy|2
756663|NCT00468546|2412921|P2|Week 24 Analysis|Failure to return|4
756664|NCT00468546|2412922|P1|Week 24 Analysis|Failure to return|3
756665|NCT00468546|2412921|P2|Week 24 Analysis|Adverse Event|8
756666|NCT00468546|2412922|P1|Week 24 Analysis|Adverse Event|1
756667|NCT00468546|2412921|P2|Week 24 Analysis|Refused treatment|5
756668|NCT00468546|2412922|P1|Week 24 Analysis|Refused treatment|5
756669|NCT00468546|2412921|P2|Week 24 Analysis|Lack of Efficacy|37
756670|NCT00468546|2412922|P1|Week 24 Analysis|Lack of Efficacy|83
756671|NCT00468559|2412952|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
756672|NCT00468559|2412953|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
756673|NCT00468559|2412954|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
756674|NCT00468559|2412952|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
756675|NCT00468559|2412953|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
756676|NCT00468559|2412954|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
756677|NCT00468559|2412952|P3|Open-label Treatment Phase|Withdrawal by Subject|0
756678|NCT00468559|2412953|P2|Open-label Treatment Phase|Withdrawal by Subject|0
756679|NCT00468559|2412954|P1|Open-label Treatment Phase|Withdrawal by Subject|4
756680|NCT00468559|2412952|P3|Open-label Treatment Phase|Lack of Efficacy|0
756681|NCT00468559|2412953|P2|Open-label Treatment Phase|Lack of Efficacy|0
756682|NCT00468559|2412954|P1|Open-label Treatment Phase|Lack of Efficacy|9
756683|NCT00468559|2412952|P3|Open-label Treatment Phase|Adverse Event|0
756684|NCT00468559|2412953|P2|Open-label Treatment Phase|Adverse Event|0
756685|NCT00468559|2412954|P1|Open-label Treatment Phase|Adverse Event|5
756686|NCT00468585|2412984|P4|Overall Study|Withdrawal by Subject|1
756687|NCT00468585|2412985|P3|Overall Study|Withdrawal by Subject|2
756688|NCT00468585|2412986|P2|Overall Study|Withdrawal by Subject|0
756689|NCT00468585|2412987|P1|Overall Study|Withdrawal by Subject|0
756690|NCT00468585|2412984|P4|Overall Study|Adverse Event|0
756691|NCT00468585|2412985|P3|Overall Study|Adverse Event|1
756692|NCT00468585|2412986|P2|Overall Study|Adverse Event|0
756693|NCT00468585|2412987|P1|Overall Study|Adverse Event|0
756694|NCT00468585|2412984|P4|Overall Study|Patient found to be ineligible|0
756695|NCT00468585|2412985|P3|Overall Study|Patient found to be ineligible|1
756696|NCT00468585|2412986|P2|Overall Study|Patient found to be ineligible|0
756697|NCT00468585|2412987|P1|Overall Study|Patient found to be ineligible|0
756698|NCT00468585|2412984|P4|Overall Study|Patient not treated|0
756699|NCT00468585|2412985|P3|Overall Study|Patient not treated|1
756700|NCT00468585|2412986|P2|Overall Study|Patient not treated|0
756701|NCT00468585|2412987|P1|Overall Study|Patient not treated|1
756702|NCT00468650|2412997|P1|Overall Study|Protocol Violation|1
756703|NCT00468650|2412997|P1|Overall Study|Withdrawal by Subject|2
756704|NCT00468650|2412997|P1|Overall Study|Lost to Follow-up|4
756705|NCT00468676|2413043|P2|Overall Study|Death|1
756706|NCT00468676|2413044|P1|Overall Study|Death|2
756707|NCT00468676|2413043|P2|Overall Study|Lost to Follow-up|11
756708|NCT00468676|2413044|P1|Overall Study|Lost to Follow-up|14
756709|NCT00468728|2413063|P2|Follow-up|mITT failure|31
756710|NCT00468728|2413064|P1|Follow-up|mITT failure|34
756711|NCT00468728|2413063|P2|Treatment|criteria for mITT population|11
756712|NCT00468728|2413064|P1|Treatment|criteria for mITT population|4
756713|NCT00468819|2413077|P3|Overall Study|Drop-outs (Treatment never received)|0
756714|NCT00468819|2413078|P2|Overall Study|Drop-outs (Treatment never received)|0
756715|NCT00468819|2413079|P1|Overall Study|Drop-outs (Treatment never received)|2
756716|NCT00468819|2413077|P3|Overall Study|Lost to Follow-up|1
756717|NCT00468819|2413078|P2|Overall Study|Lost to Follow-up|0
756718|NCT00468819|2413079|P1|Overall Study|Lost to Follow-up|0
756719|NCT00468819|2413077|P3|Overall Study|Withdrawal by Subject|1
756720|NCT00468819|2413078|P2|Overall Study|Withdrawal by Subject|0
756721|NCT00468819|2413079|P1|Overall Study|Withdrawal by Subject|4
756722|NCT00468845|2413160|P3|Overall Study|Randomized, not treated|2
756723|NCT00468845|2413161|P2|Overall Study|Randomized, not treated|4
756724|NCT00468845|2413162|P1|Overall Study|Randomized, not treated|1
756725|NCT00468845|2413160|P3|Overall Study|No longer willing to participate|10
756726|NCT00468845|2413161|P2|Overall Study|No longer willing to participate|6
756727|NCT00468845|2413162|P1|Overall Study|No longer willing to participate|5
756728|NCT00468845|2413160|P3|Overall Study|Unspecified|5
756729|NCT00468845|2413161|P2|Overall Study|Unspecified|9
756730|NCT00468845|2413162|P1|Overall Study|Unspecified|4
756731|NCT00468845|2413160|P3|Overall Study|Lost to Follow-up|2
756732|NCT00468845|2413161|P2|Overall Study|Lost to Follow-up|1
756733|NCT00468845|2413162|P1|Overall Study|Lost to Follow-up|2
756734|NCT00468845|2413160|P3|Overall Study|Adverse Event|11
756735|NCT00468845|2413161|P2|Overall Study|Adverse Event|14
756736|NCT00468845|2413162|P1|Overall Study|Adverse Event|9
756737|NCT00468858|2413299|P3|Overall Study|Other|1
756738|NCT00468858|2413300|P2|Overall Study|Other|0
756739|NCT00468858|2413301|P1|Overall Study|Other|0
756740|NCT00468858|2413299|P3|Overall Study|Lost to Follow-up|5
756741|NCT00468858|2413300|P2|Overall Study|Lost to Follow-up|2
756742|NCT00468858|2413301|P1|Overall Study|Lost to Follow-up|1
756743|NCT00468858|2413299|P3|Overall Study|Relocation|3
756744|NCT00468858|2413300|P2|Overall Study|Relocation|3
756745|NCT00468858|2413301|P1|Overall Study|Relocation|1
756746|NCT00468858|2413299|P3|Overall Study|Withdrawal by Subject|5
756747|NCT00468858|2413300|P2|Overall Study|Withdrawal by Subject|4
756748|NCT00468858|2413301|P1|Overall Study|Withdrawal by Subject|7
756749|NCT00468858|2413299|P3|Overall Study|Adverse Event|0
756750|NCT00468858|2413300|P2|Overall Study|Adverse Event|1
756751|NCT00468858|2413301|P1|Overall Study|Adverse Event|0
756752|NCT00468910|2413421|P2|Overall Study|Medical Contraindication|1
756753|NCT00468910|2413422|P1|Overall Study|Medical Contraindication|0
756754|NCT00468910|2413421|P2|Overall Study|Withdrawal by Subject|1
756755|NCT00468910|2413422|P1|Overall Study|Withdrawal by Subject|2
756756|NCT00468910|2413421|P2|Overall Study|Lost to Follow-up|1
756757|NCT00468910|2413422|P1|Overall Study|Lost to Follow-up|2
756758|NCT00469079|2413441|P3|Overall Study|Ineligible|0
756759|NCT00469079|2413442|P2|Overall Study|Ineligible|1
756760|NCT00469079|2413443|P1|Overall Study|Ineligible|0
756761|NCT00469079|2413441|P3|Overall Study|Withdrawal by Subject|2
756762|NCT00469079|2413442|P2|Overall Study|Withdrawal by Subject|2
756763|NCT00469079|2413443|P1|Overall Study|Withdrawal by Subject|1
756764|NCT00469079|2413441|P3|Overall Study|Lost to Follow-up|10
756765|NCT00469079|2413442|P2|Overall Study|Lost to Follow-up|8
756766|NCT00469079|2413443|P1|Overall Study|Lost to Follow-up|4
756767|NCT00469079|2413441|P3|Overall Study|Adverse Event|2
756768|NCT00469079|2413442|P2|Overall Study|Adverse Event|3
756769|NCT00469079|2413443|P1|Overall Study|Adverse Event|1
756770|NCT00469079|2413441|P3|Overall Study|Lack of Efficacy|5
756771|NCT00469079|2413442|P2|Overall Study|Lack of Efficacy|8
756772|NCT00469079|2413443|P1|Overall Study|Lack of Efficacy|3
756773|NCT00469092|2413462|P2|Overall Study|Use of Corticosteroid|0
756774|NCT00469092|2413463|P1|Overall Study|Use of Corticosteroid|1
756775|NCT00469092|2413462|P2|Overall Study|Abnormal lab value|0
756776|NCT00469092|2413463|P1|Overall Study|Abnormal lab value|1
756777|NCT00469092|2413462|P2|Overall Study|Hypoglycaemic Episodes|1
756778|NCT00469092|2413463|P1|Overall Study|Hypoglycaemic Episodes|1
756779|NCT00469092|2413462|P2|Overall Study|Use of lipid lowering drug|0
756780|NCT00469092|2413463|P1|Overall Study|Use of lipid lowering drug|1
756781|NCT00469092|2413462|P2|Overall Study|Contraindication metformin/glimepiride|0
756782|NCT00469092|2413463|P1|Overall Study|Contraindication metformin/glimepiride|1
756783|NCT00469092|2413462|P2|Overall Study|Incorrectly Randomised|3
756784|NCT00469092|2413463|P1|Overall Study|Incorrectly Randomised|4
756785|NCT00469092|2413462|P2|Overall Study|Withdrawal Criteria|4
756786|NCT00469092|2413463|P1|Overall Study|Withdrawal Criteria|3
756787|NCT00469092|2413462|P2|Overall Study|Withdrawal by Subject|4
756788|NCT00469092|2413463|P1|Overall Study|Withdrawal by Subject|4
756789|NCT00469092|2413462|P2|Overall Study|Protocol Violation|3
756790|NCT00469092|2413463|P1|Overall Study|Protocol Violation|3
756791|NCT00469092|2413462|P2|Overall Study|Lost to Follow-up|2
756792|NCT00469092|2413463|P1|Overall Study|Lost to Follow-up|1
756793|NCT00469092|2413462|P2|Overall Study|Lack of Efficacy|0
756794|NCT00469092|2413463|P1|Overall Study|Lack of Efficacy|1
756795|NCT00469092|2413462|P2|Overall Study|Adverse Event|4
756796|NCT00469092|2413463|P1|Overall Study|Adverse Event|5
756797|NCT00469209|2413482|P3|Overall Study|Adverse Event|1
756798|NCT00469209|2413483|P2|Overall Study|Adverse Event|0
756799|NCT00469209|2413484|P1|Overall Study|Adverse Event|1
756800|NCT00458536|2413510|P1|Overall Study|Progressive disease during treatment|2
756801|NCT00458536|2413510|P1|Overall Study|Withdrawal by Subject|1
756802|NCT00458536|2413510|P1|Overall Study|Ineligible due to toxicity|1
756803|NCT00458536|2413510|P1|Overall Study|Patient did not have surgery|1
756804|NCT00458536|2413510|P1|Overall Study|Did not have renal cell carcinoma|2
756805|NCT00458536|2413510|P1|Overall Study|No measurable disease after surgery|2
756806|NCT00458536|2413510|P1|Overall Study|Unable to make vaccine|3
756807|NCT00458536|2413510|P1|Overall Study|Disease progression prior to treatment|7
756808|NCT00458705|2413514|P1|Overall Study|Not Treated|1
756809|NCT00458705|2413514|P1|Overall Study|Adverse Event|4
756810|NCT00459043|2413531|P2|Overall Study|Withdrawal by Subject|0
756811|NCT00459043|2413532|P1|Overall Study|Withdrawal by Subject|1
756812|NCT00459056|2413544|P2|First Intervention (First Three Months)|Lost to Follow-up|1
756813|NCT00459056|2413545|P1|First Intervention (First Three Months)|Lost to Follow-up|1
756814|NCT00459108|2413551|P1|Overall Study|Progression|1
756815|NCT00459108|2413551|P1|Overall Study|Death|2
756816|NCT00459108|2413551|P1|Overall Study|Adverse Event|3
756817|NCT00459108|2413551|P1|Overall Study|Withdrawal by Subject|5
756818|NCT00459134|2413562|P2|Overall Study|Multiple Reasons|3
756819|NCT00459134|2413563|P1|Overall Study|Multiple Reasons|2
756820|NCT00459134|2413562|P2|Overall Study|Progression|0
756821|NCT00459134|2413563|P1|Overall Study|Progression|1
756822|NCT00459134|2413562|P2|Overall Study|Toxicity|5
756823|NCT00459134|2413563|P1|Overall Study|Toxicity|4
756824|NCT00459134|2413562|P2|Overall Study|Surgery|2
756825|NCT00459134|2413563|P1|Overall Study|Surgery|1
756826|NCT00459134|2413562|P2|Overall Study|Lost to Follow-up|7
756827|NCT00459134|2413563|P1|Overall Study|Lost to Follow-up|6
756828|NCT00459134|2413562|P2|Overall Study|Withdrawal by Subject|7
756829|NCT00459134|2413563|P1|Overall Study|Withdrawal by Subject|8
756830|NCT00459134|2413562|P2|Overall Study|Physician Decision|1
756831|NCT00459134|2413563|P1|Overall Study|Physician Decision|1
756832|NCT00459186|2413571|P1|PET Imaging and Assessment|Adverse Event|3
756833|NCT00459186|2413571|P1|Single Agent RAD001|Withdrawal by Subject|1
756834|NCT00459290|2413576|P1|Overall Study|Ineligible|2
756835|NCT00459290|2413576|P1|Overall Study|Adverse Event|3
756836|NCT00459316|2413605|P3|Step 3|Withdrawal by Subject|1
756837|NCT00459316|2413606|P2|Step 3|Withdrawal by Subject|0
756838|NCT00459316|2413607|P1|Step 3|Withdrawal by Subject|3
756839|NCT00459316|2413605|P3|Steps 1 & 2|Lost to Follow-up|2
756840|NCT00459316|2413606|P2|Steps 1 & 2|Lost to Follow-up|0
756841|NCT00459316|2413607|P1|Steps 1 & 2|Lost to Follow-up|5
756842|NCT00459316|2413605|P3|Steps 1 & 2|Not willing to adhere to regulations|0
756843|NCT00459316|2413606|P2|Steps 1 & 2|Not willing to adhere to regulations|0
756844|NCT00459316|2413607|P1|Steps 1 & 2|Not willing to adhere to regulations|1
756845|NCT00459316|2413605|P3|Steps 1 & 2|Withdrawal by Subject|0
756846|NCT00459316|2413606|P2|Steps 1 & 2|Withdrawal by Subject|1
756847|NCT00459316|2413607|P1|Steps 1 & 2|Withdrawal by Subject|6
756848|NCT00459316|2413605|P3|Steps 1 & 2|Not able to get to clinic|0
756849|NCT00459316|2413606|P2|Steps 1 & 2|Not able to get to clinic|4
756850|NCT00459316|2413607|P1|Steps 1 & 2|Not able to get to clinic|7
756851|NCT00459316|2413605|P3|Steps 1 & 2|Death|0
756852|NCT00459316|2413606|P2|Steps 1 & 2|Death|1
756853|NCT00459316|2413607|P1|Steps 1 & 2|Death|1
756854|NCT00459316|2413605|P3|Steps 1 & 2|Other eligibility failure|0
756855|NCT00459316|2413606|P2|Steps 1 & 2|Other eligibility failure|1
756856|NCT00459316|2413607|P1|Steps 1 & 2|Other eligibility failure|1
756857|NCT00459342|2413661|P1|Overall Study|Not eligible|1
756858|NCT00459355|2413668|P2|Overall Study|Subject no longer met inc criteria|18
756859|NCT00459355|2413669|P1|Overall Study|Subject no longer met inc criteria|20
756860|NCT00459537|2413702|P2|Overall Study|Missing|0
756861|NCT00459537|2413703|P1|Overall Study|Missing|1
756862|NCT00459537|2413702|P2|Overall Study|Protocol Violation|3
756863|NCT00459537|2413703|P1|Overall Study|Protocol Violation|4
756864|NCT00459537|2413702|P2|Overall Study|Administrative problems|0
756865|NCT00459537|2413703|P1|Overall Study|Administrative problems|3
756866|NCT00459537|2413702|P2|Overall Study|Lost to Follow-up|30
756867|NCT00459537|2413703|P1|Overall Study|Lost to Follow-up|27
756868|NCT00459537|2413702|P2|Overall Study|Withdrawal by Subject|26
756869|NCT00459537|2413703|P1|Overall Study|Withdrawal by Subject|20
756870|NCT00459537|2413702|P2|Overall Study|Lack of Efficacy|11
756871|NCT00459537|2413703|P1|Overall Study|Lack of Efficacy|10
756872|NCT00459537|2413702|P2|Overall Study|Adverse Event|6
756873|NCT00459537|2413703|P1|Overall Study|Adverse Event|1
756874|NCT00459667|2413720|P3|Overall Study|No treatment administered|1
756875|NCT00459667|2413721|P2|Overall Study|No treatment administered|3
756876|NCT00459667|2413722|P1|Overall Study|No treatment administered|6
756877|NCT00459667|2413720|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
756878|NCT00459667|2413721|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
756879|NCT00459667|2413722|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
756880|NCT00459667|2413720|P3|Overall Study|Other disease modifying treatment|1
756881|NCT00459667|2413721|P2|Overall Study|Other disease modifying treatment|2
756882|NCT00459667|2413722|P1|Overall Study|Other disease modifying treatment|1
756883|NCT00459667|2413720|P3|Overall Study|Withdrawal by Subject|5
756884|NCT00459667|2413721|P2|Overall Study|Withdrawal by Subject|5
756885|NCT00459667|2413722|P1|Overall Study|Withdrawal by Subject|3
756886|NCT00459667|2413720|P3|Overall Study|Protocol Violation|0
756887|NCT00459667|2413721|P2|Overall Study|Protocol Violation|0
756888|NCT00459667|2413722|P1|Overall Study|Protocol Violation|1
756889|NCT00459667|2413720|P3|Overall Study|Pregnancy|1
756890|NCT00459667|2413721|P2|Overall Study|Pregnancy|1
756891|NCT00459667|2413722|P1|Overall Study|Pregnancy|1
756892|NCT00459667|2413720|P3|Overall Study|Lost to Follow-up|3
756893|NCT00459667|2413721|P2|Overall Study|Lost to Follow-up|9
756894|NCT00459667|2413722|P1|Overall Study|Lost to Follow-up|5
756895|NCT00459667|2413720|P3|Overall Study|Adverse Event|8
756896|NCT00459667|2413721|P2|Overall Study|Adverse Event|12
756897|NCT00459667|2413722|P1|Overall Study|Adverse Event|9
756898|NCT00459706|2413744|P2|Overall Study|Unspecified|1
756899|NCT00459706|2413745|P1|Overall Study|Unspecified|0
756900|NCT00459706|2413744|P2|Overall Study|Failed to Return|0
756901|NCT00459706|2413745|P1|Overall Study|Failed to Return|1
756902|NCT00459706|2413744|P2|Overall Study|Protocol Violation|1
756903|NCT00459706|2413745|P1|Overall Study|Protocol Violation|2
756904|NCT00459706|2413744|P2|Overall Study|Discontinuation of Study by Sponsor|0
756905|NCT00459706|2413745|P1|Overall Study|Discontinuation of Study by Sponsor|1
756906|NCT00459706|2413744|P2|Overall Study|Physician Decision|0
756907|NCT00459706|2413745|P1|Overall Study|Physician Decision|2
756908|NCT00459706|2413744|P2|Overall Study|Withdrawal by Subject|6
756909|NCT00459706|2413745|P1|Overall Study|Withdrawal by Subject|1
756910|NCT00459706|2413744|P2|Overall Study|Adverse Event|13
756911|NCT00459706|2413745|P1|Overall Study|Adverse Event|19
756912|NCT00459875|2413915|P1|Overall Study|Adverse Event|2
756913|NCT00459875|2413915|P1|Overall Study|Ineligible participant|1
756914|NCT00459953|2413921|P2|Overall Study|not analyzed-household member in study|1
756915|NCT00459953|2413922|P1|Overall Study|not analyzed-household member in study|1
756916|NCT00459979|2413928|P1|Overall Study|Protocol Violation|1
756917|NCT00459979|2413928|P1|Overall Study|Withdrawal by Subject|1
756918|NCT00460031|2413938|P1|Overall Study|Death|1
756919|NCT00460031|2413938|P1|Overall Study|Withdrawal by Subject|5
756920|NCT00460031|2413938|P1|Overall Study|Adverse Event|5
756921|NCT00461032|2413957|P2|Overall Study|Not Specified|5
756922|NCT00461032|2413958|P1|Overall Study|Not Specified|7
756923|NCT00461032|2413957|P2|Overall Study|Patient Moved or Relocated|1
756924|NCT00461032|2413958|P1|Overall Study|Patient Moved or Relocated|2
756925|NCT00461032|2413957|P2|Overall Study|Withdrawal by Subject|15
756926|NCT00461032|2413958|P1|Overall Study|Withdrawal by Subject|7
756927|NCT00461032|2413957|P2|Overall Study|Protocol Violation|4
756928|NCT00461032|2413958|P1|Overall Study|Protocol Violation|4
756929|NCT00461032|2413957|P2|Overall Study|Lost to Follow-up|12
756930|NCT00461032|2413958|P1|Overall Study|Lost to Follow-up|7
756931|NCT00461032|2413957|P2|Overall Study|Lack of Efficacy|1
756932|NCT00461032|2413958|P1|Overall Study|Lack of Efficacy|5
756933|NCT00461032|2413957|P2|Overall Study|Adverse Event|6
756934|NCT00461032|2413958|P1|Overall Study|Adverse Event|5
756935|NCT00461123|2414001|P2|Overall Study|Withdrawal by Subject|3
756936|NCT00461123|2414002|P1|Overall Study|Withdrawal by Subject|1
756937|NCT00461123|2414001|P2|Overall Study|Protocol Violation|2
756938|NCT00461123|2414002|P1|Overall Study|Protocol Violation|3
756939|NCT00461123|2414001|P2|Overall Study|Lost to Follow-up|1
756940|NCT00461123|2414002|P1|Overall Study|Lost to Follow-up|1
756941|NCT00461123|2414001|P2|Overall Study|Adverse Event|0
756942|NCT00461123|2414002|P1|Overall Study|Adverse Event|1
756943|NCT00461175|2414018|P2|Overall Study|Protocol Violation|365
756944|NCT00461175|2414019|P1|Overall Study|Protocol Violation|522
756945|NCT00461253|2414029|P2|Overall Study|administrative|7773
756946|NCT00461253|2414030|P1|Overall Study|administrative|773
756947|NCT00461253|2414029|P2|Overall Study|no response|11789
756948|NCT00461253|2414030|P1|Overall Study|no response|2609
756949|NCT00461253|2414029|P2|Overall Study|Protocol Violation|236
756950|NCT00461253|2414030|P1|Overall Study|Protocol Violation|613
756951|NCT00461253|2414029|P2|Overall Study|Death|0
756952|NCT00461253|2414030|P1|Overall Study|Death|985
756953|NCT00461305|2414060|P2|Continued Treatment|Other (missing drug etc)|0
756954|NCT00461305|2414061|P1|Continued Treatment|Other (missing drug etc)|2
756955|NCT00461305|2414060|P2|Continued Treatment|Partially missing diary|0
756956|NCT00461305|2414061|P1|Continued Treatment|Partially missing diary|2
756957|NCT00461305|2414060|P2|Continued Treatment|Withdrawal by Subject|0
756958|NCT00461305|2414061|P1|Continued Treatment|Withdrawal by Subject|48
756959|NCT00461305|2414060|P2|Continued Treatment|Protocol Violation|0
756960|NCT00461305|2414061|P1|Continued Treatment|Protocol Violation|13
756961|NCT00461305|2414060|P2|Continued Treatment|Lost to Follow-up|0
756962|NCT00461305|2414061|P1|Continued Treatment|Lost to Follow-up|4
756963|NCT00461305|2414060|P2|Continued Treatment|Adverse Event|0
756964|NCT00461305|2414061|P1|Continued Treatment|Adverse Event|26
756965|NCT00461305|2414060|P2|Treatment|Other (missing drug etc)|0
756966|NCT00461305|2414061|P1|Treatment|Other (missing drug etc)|2
756967|NCT00461305|2414060|P2|Treatment|Partially missing diary|0
756968|NCT00461305|2414061|P1|Treatment|Partially missing diary|2
756969|NCT00461305|2414060|P2|Treatment|Study drug not taken|0
756970|NCT00461305|2414061|P1|Treatment|Study drug not taken|1
756971|NCT00461305|2414060|P2|Treatment|Never dispensed|0
756972|NCT00461305|2414061|P1|Treatment|Never dispensed|5
756973|NCT00461305|2414060|P2|Treatment|Withdrawal by Subject|2
756974|NCT00461305|2414061|P1|Treatment|Withdrawal by Subject|48
756975|NCT00461305|2414060|P2|Treatment|Protocol Violation|2
756976|NCT00461305|2414061|P1|Treatment|Protocol Violation|13
756977|NCT00461305|2414060|P2|Treatment|Lost to Follow-up|2
756978|NCT00461305|2414061|P1|Treatment|Lost to Follow-up|4
756979|NCT00461305|2414060|P2|Treatment|Adverse Event|3
756980|NCT00461305|2414061|P1|Treatment|Adverse Event|26
756981|NCT00461500|2414134|P2|Overall Study|Lost to Follow-up|2
756982|NCT00461500|2414135|P1|Overall Study|Lost to Follow-up|2
756983|NCT00461500|2414134|P2|Overall Study|No Longer Willing to Take Part in Study|0
756984|NCT00461500|2414135|P1|Overall Study|No Longer Willing to Take Part in Study|1
756985|NCT00461500|2414134|P2|Overall Study|Drug Treatment Misuse|0
756986|NCT00461500|2414135|P1|Overall Study|Drug Treatment Misuse|1
756987|NCT00461500|2414134|P2|Overall Study|Study Stopped|2
756988|NCT00461500|2414135|P1|Overall Study|Study Stopped|1
756989|NCT00461500|2414134|P2|Overall Study|Expired Drug Treatment|1
756990|NCT00461500|2414135|P1|Overall Study|Expired Drug Treatment|1
756991|NCT00461500|2414134|P2|Overall Study|Lack of Efficacy|1
756992|NCT00461500|2414135|P1|Overall Study|Lack of Efficacy|0
756993|NCT00461500|2414134|P2|Overall Study|Adverse Event|0
756994|NCT00461500|2414135|P1|Overall Study|Adverse Event|1
756995|NCT00461630|2414199|P2|Overall Study|Lost to Follow-up|95
756996|NCT00461630|2414200|P1|Overall Study|Lost to Follow-up|108
756997|NCT00461630|2414199|P2|Overall Study|Death|732
756998|NCT00461630|2414200|P1|Overall Study|Death|798
756999|NCT00461682|2414214|P1|Overall Study|Protocol Violation|1
757000|NCT00461708|2414242|P2|Overall Study|Death|1
757001|NCT00461708|2414243|P1|Overall Study|Death|8
757002|NCT00461708|2414242|P2|Overall Study|Not specified|4
757003|NCT00461708|2414243|P1|Overall Study|Not specified|4
757004|NCT00461708|2414242|P2|Overall Study|Withdrawal by Subject|2
757005|NCT00461708|2414243|P1|Overall Study|Withdrawal by Subject|8
757006|NCT00461708|2414242|P2|Overall Study|Physician Decision|4
757007|NCT00461708|2414243|P1|Overall Study|Physician Decision|10
757008|NCT00461708|2414242|P2|Overall Study|Lack of Efficacy|20
757009|NCT00461708|2414243|P1|Overall Study|Lack of Efficacy|68
757010|NCT00461708|2414242|P2|Overall Study|Adverse Event|7
757011|NCT00461708|2414243|P1|Overall Study|Adverse Event|17
757012|NCT00461786|2414304|P1|Overall Study|Inevaluable (Never Treated)|1
757013|NCT00461786|2414304|P1|Overall Study|Entry Criteria Not Met|2
757014|NCT00461812|2414312|P1|Overall Study|study terminated|10
757015|NCT00461981|2414323|P2|Overall Study|Withdrawal by Subject|3
757016|NCT00461981|2414324|P1|Overall Study|Withdrawal by Subject|2
757017|NCT00461981|2414323|P2|Overall Study|Lost to Follow-up|6
757018|NCT00461981|2414324|P1|Overall Study|Lost to Follow-up|9
757019|NCT00462306|2414552|P2|Overall Study|insufficient data|13
757020|NCT00462306|2414553|P1|Overall Study|insufficient data|0
757021|NCT00462345|2414572|P1|Overall Study|Did not complete second course|1
757022|NCT00462345|2414572|P1|Overall Study|Withdrawal by Subject|2
757023|NCT00462384|2414594|P1|Overall Study|Unspecified|4
757024|NCT00462384|2414594|P1|Overall Study|Withdrawal by Subject|1
757025|NCT00462384|2414594|P1|Overall Study|Death|2
757026|NCT00462384|2414594|P1|Overall Study|Adverse Event|2
757027|NCT00462462|2414624|P2|Overall Study|Physician Decision|1
757028|NCT00462462|2414625|P1|Overall Study|Physician Decision|0
757029|NCT00462501|2414633|P1|Overall Study|Adverse Event|2
757030|NCT00462501|2414633|P1|Overall Study|Not treated|3
757031|NCT00462670|2414668|P2|Overall Study|Resolution of signs and symptoms|2
757032|NCT00462670|2414669|P1|Overall Study|Resolution of signs and symptoms|0
757033|NCT00462670|2414668|P2|Overall Study|Protocol Violation|0
757034|NCT00462670|2414669|P1|Overall Study|Protocol Violation|1
757035|NCT00462670|2414668|P2|Overall Study|Lack of Efficacy|0
757036|NCT00462670|2414669|P1|Overall Study|Lack of Efficacy|1
757037|NCT00462670|2414668|P2|Overall Study|Adverse Event|5
757038|NCT00462670|2414669|P1|Overall Study|Adverse Event|3
757039|NCT00462709|2414677|P1|Overall Study|Withdrew to start treatment with Cetor|1
757040|NCT00462709|2414677|P1|Overall Study|Physician Decision|1
757041|NCT00462709|2414677|P1|Overall Study|Logistical reasons|2
757042|NCT00462709|2414677|P1|Overall Study|Death|2
757043|NCT00462709|2414677|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
757044|NCT00462709|2414677|P1|Overall Study|Withdrawal by Subject|8
757045|NCT00462709|2414677|P1|Overall Study|Lost to Follow-up|10
757046|NCT00462709|2414677|P1|Overall Study|Transitioned to commercial C1INH-nf|40
757047|NCT00462748|2414724|P3|Overall Study|Discontinued after 41 days Rx|0
757048|NCT00462748|2414725|P2|Overall Study|Discontinued after 41 days Rx|0
757049|NCT00462748|2414726|P1|Overall Study|Discontinued after 41 days Rx|1
757050|NCT00462748|2414724|P3|Overall Study|Lost to Follow-up|1
757051|NCT00462748|2414725|P2|Overall Study|Lost to Follow-up|1
757052|NCT00462748|2414726|P1|Overall Study|Lost to Follow-up|1
757053|NCT00462748|2414724|P3|Overall Study|Withdrew consent|0
757054|NCT00462748|2414725|P2|Overall Study|Withdrew consent|3
757055|NCT00462748|2414726|P1|Overall Study|Withdrew consent|3
757056|NCT00462748|2414724|P3|Overall Study|Protocol Violation|1
757057|NCT00462748|2414725|P2|Overall Study|Protocol Violation|2
757058|NCT00462748|2414726|P1|Overall Study|Protocol Violation|0
757059|NCT00462748|2414724|P3|Overall Study|Adverse Event|9
757060|NCT00462748|2414725|P2|Overall Study|Adverse Event|5
757061|NCT00462748|2414726|P1|Overall Study|Adverse Event|7
757066|NCT00462865|2414753|P1|Overall Study|Adverse Event|1
890990|NCT00550420|2826593|P1|Overall Study|Out of Electrocardiogram criteria|1
890991|NCT00550420|2826593|P1|Overall Study|Caregiver's decision to withdraw|1
890992|NCT00550420|2826593|P1|Overall Study|Unethical stop of enrollment|2
890993|NCT00550420|2826593|P1|Overall Study|Lack of curative effect|1
890994|NCT00550420|2826593|P1|Overall Study|Investigators opinion|1
890995|NCT00550420|2826593|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
890996|NCT00550420|2826593|P1|Overall Study|Missing|2
890997|NCT00550420|2826593|P1|Overall Study|Still in study at termination|206
890998|NCT00550420|2826593|P1|Overall Study|Withdrawal by Subject|30
890999|NCT00550420|2826593|P1|Overall Study|Protocol Violation|11
891000|NCT00550420|2826593|P1|Overall Study|Lost to Follow-up|8
891001|NCT00550420|2826593|P1|Overall Study|Adverse Event|28
891009|NCT00529035|2826645|P1|Overall Study|Withdrawal by Subject|1
891010|NCT00521339|2826656|P3|Treatment Extension Phase|Death|1
891011|NCT00521339|2826657|P2|Treatment Extension Phase|Death|0
891012|NCT00521339|2826658|P1|Treatment Extension Phase|Death|0
891013|NCT00521339|2826656|P3|Treatment Extension Phase|Withdrawal by Subject|2
891014|NCT00521339|2826657|P2|Treatment Extension Phase|Withdrawal by Subject|0
891015|NCT00521339|2826658|P1|Treatment Extension Phase|Withdrawal by Subject|0
891016|NCT00521339|2826656|P3|Treatment Phase|Protocol Violation|0
891017|NCT00521339|2826657|P2|Treatment Phase|Protocol Violation|0
891018|NCT00521339|2826658|P1|Treatment Phase|Protocol Violation|1
891019|NCT00521339|2826656|P3|Treatment Phase|Lost to Follow-up|0
891020|NCT00521339|2826657|P2|Treatment Phase|Lost to Follow-up|0
891021|NCT00521339|2826658|P1|Treatment Phase|Lost to Follow-up|1
891022|NCT00521339|2826656|P3|Treatment Phase|Withdrawal by Subject|0
757103|NCT00462982|2414854|P1|Overall Study|Patient Not Treated|2
757104|NCT00462982|2414854|P1|Overall Study|Adverse Event|1
757105|NCT00463047|2414858|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
757106|NCT00463047|2414859|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
757107|NCT00463047|2414858|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
757108|NCT00463047|2414859|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
757109|NCT00463047|2414858|P2|Double-Blind Treatment Period 2|Adverse Event|1
757110|NCT00463047|2414859|P1|Double-Blind Treatment Period 2|Adverse Event|0
757111|NCT00463047|2414858|P2|Double-Blind Treatment Period 1|Not specified|0
757112|NCT00463047|2414859|P1|Double-Blind Treatment Period 1|Not specified|1
757113|NCT00463047|2414858|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
757114|NCT00463047|2414859|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
757115|NCT00463047|2414858|P2|Double-Blind Treatment Period 1|Protocol Violation|2
757116|NCT00463047|2414859|P1|Double-Blind Treatment Period 1|Protocol Violation|1
757117|NCT00463047|2414858|P2|Double-Blind Treatment Period 1|Adverse Event|2
757118|NCT00463047|2414859|P1|Double-Blind Treatment Period 1|Adverse Event|0
757119|NCT00463047|2414858|P2|Titration Period 2|Not specified|2
757120|NCT00463047|2414859|P1|Titration Period 2|Not specified|3
757121|NCT00463047|2414858|P2|Titration Period 2|Non-compliance procedures|1
757122|NCT00463047|2414859|P1|Titration Period 2|Non-compliance procedures|4
757123|NCT00463047|2414858|P2|Titration Period 2|Non-compliance study medication|2
757124|NCT00463047|2414859|P1|Titration Period 2|Non-compliance study medication|4
757125|NCT00463047|2414858|P2|Titration Period 2|Lost to Follow-up|2
757126|NCT00463047|2414859|P1|Titration Period 2|Lost to Follow-up|1
757127|NCT00463047|2414858|P2|Titration Period 2|Protocol Violation|3
757128|NCT00463047|2414859|P1|Titration Period 2|Protocol Violation|2
757129|NCT00463047|2414858|P2|Titration Period 2|Withdrawal by Subject|0
757130|NCT00463047|2414859|P1|Titration Period 2|Withdrawal by Subject|1
757131|NCT00463047|2414858|P2|Titration Period 2|Lack of Efficacy|4
757132|NCT00463047|2414859|P1|Titration Period 2|Lack of Efficacy|6
757133|NCT00463047|2414858|P2|Titration Period 2|Adverse Event|9
757134|NCT00463047|2414859|P1|Titration Period 2|Adverse Event|9
757135|NCT00463047|2414858|P2|Titration Period 1|Not specified|2
757136|NCT00463047|2414859|P1|Titration Period 1|Not specified|0
757137|NCT00463047|2414858|P2|Titration Period 1|Non-compliance procedures|10
757138|NCT00463047|2414859|P1|Titration Period 1|Non-compliance procedures|4
757139|NCT00463047|2414858|P2|Titration Period 1|Withdrawal by Subject|5
757140|NCT00463047|2414859|P1|Titration Period 1|Withdrawal by Subject|3
757141|NCT00463047|2414858|P2|Titration Period 1|Protocol Violation|5
757142|NCT00463047|2414859|P1|Titration Period 1|Protocol Violation|5
757143|NCT00463047|2414858|P2|Titration Period 1|Non-compliance with study medication|5
757144|NCT00463047|2414859|P1|Titration Period 1|Non-compliance with study medication|3
757145|NCT00463047|2414858|P2|Titration Period 1|Lost to Follow-up|0
757146|NCT00463047|2414859|P1|Titration Period 1|Lost to Follow-up|2
757147|NCT00463047|2414858|P2|Titration Period 1|Lack of Efficacy|4
757148|NCT00463047|2414859|P1|Titration Period 1|Lack of Efficacy|10
757149|NCT00463047|2414858|P2|Titration Period 1|Adverse Event|8
757150|NCT00463047|2414859|P1|Titration Period 1|Adverse Event|10
757151|NCT00463229|2414946|P2|Overall Study|Death|3
757152|NCT00463229|2414947|P1|Overall Study|Death|4
757153|NCT00463229|2414946|P2|Overall Study|Lost to Follow-up|7
757154|NCT00463229|2414947|P1|Overall Study|Lost to Follow-up|5
757155|NCT00463346|2414955|P2|Overall Study|Withdrawal by Subject|3
757156|NCT00463346|2414956|P1|Overall Study|Withdrawal by Subject|3
757157|NCT00463385|2414968|P4|Overall Study|1 participant received commercial drug|0
757158|NCT00463385|2414969|P3|Overall Study|1 participant received commercial drug|0
757159|NCT00463385|2414970|P2|Overall Study|1 participant received commercial drug|1
757160|NCT00463385|2414971|P1|Overall Study|1 participant received commercial drug|0
757161|NCT00463385|2414968|P4|Overall Study|Missing|2
757162|NCT00463385|2414969|P3|Overall Study|Missing|0
757163|NCT00463385|2414970|P2|Overall Study|Missing|0
757164|NCT00463385|2414971|P1|Overall Study|Missing|2
757165|NCT00463385|2414968|P4|Overall Study|Death|0
757166|NCT00463385|2414969|P3|Overall Study|Death|2
757167|NCT00463385|2414970|P2|Overall Study|Death|1
757168|NCT00463385|2414971|P1|Overall Study|Death|2
757169|NCT00463385|2414968|P4|Overall Study|Lost to Follow-up|1
757170|NCT00463385|2414969|P3|Overall Study|Lost to Follow-up|0
757171|NCT00463385|2414970|P2|Overall Study|Lost to Follow-up|0
757172|NCT00463385|2414971|P1|Overall Study|Lost to Follow-up|0
757173|NCT00463385|2414968|P4|Overall Study|Withdrawal by Subject|4
757174|NCT00463385|2414969|P3|Overall Study|Withdrawal by Subject|3
757175|NCT00463385|2414970|P2|Overall Study|Withdrawal by Subject|3
757176|NCT00463385|2414971|P1|Overall Study|Withdrawal by Subject|3
757177|NCT00463385|2414968|P4|Overall Study|Lack of Efficacy|9
757178|NCT00463385|2414969|P3|Overall Study|Lack of Efficacy|7
757179|NCT00463385|2414970|P2|Overall Study|Lack of Efficacy|6
757180|NCT00463385|2414971|P1|Overall Study|Lack of Efficacy|6
757181|NCT00463385|2414968|P4|Overall Study|Adverse Event|2
757182|NCT00463385|2414969|P3|Overall Study|Adverse Event|4
757183|NCT00463385|2414970|P2|Overall Study|Adverse Event|8
757184|NCT00463385|2414971|P1|Overall Study|Adverse Event|5
757185|NCT00463385|2414968|P4|Overall Study|Unspecified|4
757186|NCT00463385|2414969|P3|Overall Study|Unspecified|6
757187|NCT00463385|2414970|P2|Overall Study|Unspecified|3
757188|NCT00463385|2414971|P1|Overall Study|Unspecified|4
757189|NCT00469456|2415023|P2|Overall Study|Withdrawal by Subject|1
757190|NCT00469456|2415024|P1|Overall Study|Withdrawal by Subject|4
757191|NCT00469456|2415023|P2|Overall Study|Protocol Violation|0
757192|NCT00469456|2415024|P1|Overall Study|Protocol Violation|1
757193|NCT00469456|2415023|P2|Overall Study|Adverse Event|3
757194|NCT00469456|2415024|P1|Overall Study|Adverse Event|4
757195|NCT00470054|2415047|P1|Overall Study|Ineligible|1
757196|NCT00470067|2415055|P1|Overall Study|Disease Progression|6
757197|NCT00470067|2415055|P1|Overall Study|Death|1
757198|NCT00470158|2415085|P5|Overall Study|Protocol Violation|0
757199|NCT00470158|2415086|P4|Overall Study|Protocol Violation|0
757200|NCT00470158|2415087|P3|Overall Study|Protocol Violation|0
757201|NCT00470158|2415088|P2|Overall Study|Protocol Violation|0
757202|NCT00470158|2415089|P1|Overall Study|Protocol Violation|1
757203|NCT00470158|2415085|P5|Overall Study|Lost to Follow-up|4
757204|NCT00470158|2415086|P4|Overall Study|Lost to Follow-up|5
757205|NCT00470158|2415087|P3|Overall Study|Lost to Follow-up|8
757206|NCT00470158|2415088|P2|Overall Study|Lost to Follow-up|8
757207|NCT00470158|2415089|P1|Overall Study|Lost to Follow-up|7
757208|NCT00470158|2415085|P5|Overall Study|Death|2
757209|NCT00470158|2415086|P4|Overall Study|Death|0
757210|NCT00470158|2415087|P3|Overall Study|Death|0
757211|NCT00470158|2415088|P2|Overall Study|Death|0
757212|NCT00470158|2415089|P1|Overall Study|Death|0
757213|NCT00470184|2415101|P1|Overall Study|recurrence|1
757214|NCT00470184|2415101|P1|Overall Study|other|5
757215|NCT00470184|2415101|P1|Overall Study|Withdrawal by Subject|4
757216|NCT00470184|2415101|P1|Overall Study|Adverse Event|3
757217|NCT00470184|2415101|P1|Overall Study|disease Progression|4
757218|NCT00470184|2415101|P1|Overall Study|Not treated (other)|1
757219|NCT00470184|2415101|P1|Overall Study|Not Treated(became ineligible)|4
757220|NCT00470262|2415110|P2|Overall Study|Withdrawal by Subject|0
757221|NCT00470262|2415111|P1|Overall Study|Withdrawal by Subject|2
757222|NCT00470275|2415119|P1|Overall Study|Withdrawal by Subject|2
757223|NCT00470275|2415119|P1|Overall Study|Lack of Efficacy|7
757224|NCT00470275|2415119|P1|Overall Study|Death|1
757225|NCT00470418|2415142|P2|Overall Study|Withdrawal by Subject|0
757226|NCT00470418|2415143|P1|Overall Study|Withdrawal by Subject|1
757227|NCT00470470|2415151|P1|Overall Study|Not treated|1
757228|NCT00470470|2415151|P1|Overall Study|Death|2
757229|NCT00470470|2415151|P1|Overall Study|Adverse Event|2
757230|NCT00470535|2415156|P1|Overall Study|Other|2
757231|NCT00470535|2415156|P1|Overall Study|Death|1
757232|NCT00470535|2415156|P1|Overall Study|Adverse Event|1
757233|NCT00470535|2415156|P1|Overall Study|Withdrawal by Subject|1
757234|NCT00470535|2415156|P1|Overall Study|Disease Progression|13
757235|NCT00470626|2415201|P1|Overall Study|Withdrawal by Subject|7
757236|NCT00470626|2415201|P1|Overall Study|Lost to Follow-up|10
757237|NCT00470834|2415209|P2|Extension Period (24 Months)|Disease Progression|1
757238|NCT00470834|2415210|P1|Extension Period (24 Months)|Disease Progression|0
757239|NCT00470834|2415209|P2|Extension Period (24 Months)|Non-compliance|1
757240|NCT00470834|2415210|P1|Extension Period (24 Months)|Non-compliance|0
757241|NCT00470834|2415209|P2|Extension Period (24 Months)|Lost to Follow-up|1
757242|NCT00470834|2415210|P1|Extension Period (24 Months)|Lost to Follow-up|0
757243|NCT00470834|2415209|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
757244|NCT00470834|2415210|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
757245|NCT00470834|2415209|P2|Extension Period (24 Months)|Physician Decision|3
757246|NCT00470834|2415210|P1|Extension Period (24 Months)|Physician Decision|4
757247|NCT00470834|2415209|P2|Extension Period (24 Months)|Withdrawal by Subject|5
757248|NCT00470834|2415210|P1|Extension Period (24 Months)|Withdrawal by Subject|2
757249|NCT00470834|2415209|P2|Extension Period (24 Months)|Adverse Event|4
757250|NCT00470834|2415210|P1|Extension Period (24 Months)|Adverse Event|3
757251|NCT00470834|2415209|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
757252|NCT00470834|2415210|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
757253|NCT00470834|2415209|P2|Treatment Period (18 Months)|Lack of Efficacy|0
757254|NCT00470834|2415210|P1|Treatment Period (18 Months)|Lack of Efficacy|1
757255|NCT00470834|2415209|P2|Treatment Period (18 Months)|Non-compliance|0
757256|NCT00470834|2415210|P1|Treatment Period (18 Months)|Non-compliance|1
757257|NCT00470834|2415209|P2|Treatment Period (18 Months)|Lost to Follow-up|0
757258|NCT00470834|2415210|P1|Treatment Period (18 Months)|Lost to Follow-up|1
757259|NCT00470834|2415209|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
757260|NCT00470834|2415210|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
757261|NCT00470834|2415209|P2|Treatment Period (18 Months)|Protocol Violation|1
757262|NCT00470834|2415210|P1|Treatment Period (18 Months)|Protocol Violation|3
757263|NCT00470834|2415209|P2|Treatment Period (18 Months)|Physician Decision|4
757264|NCT00470834|2415210|P1|Treatment Period (18 Months)|Physician Decision|4
757265|NCT00470834|2415209|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
757266|NCT00470834|2415210|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
757267|NCT00470834|2415209|P2|Treatment Period (18 Months)|Adverse Event|6
757268|NCT00470834|2415210|P1|Treatment Period (18 Months)|Adverse Event|7
757269|NCT00470834|2415209|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
757270|NCT00470834|2415210|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
757271|NCT00470847|2415224|P1|Overall Study|Pt still receiving treatment|1
757272|NCT00471107|2415247|P3|Overall Study|Technical problems/data loss|3
757273|NCT00471107|2415248|P2|Overall Study|Technical problems/data loss|1
757274|NCT00471107|2415249|P1|Overall Study|Technical problems/data loss|3
757275|NCT00471146|2415259|P2|Overall Study|Unspecified|5
757276|NCT00471146|2415260|P1|Overall Study|Unspecified|4
757277|NCT00471146|2415259|P2|Overall Study|Randomized but not treated|8
757278|NCT00471146|2415260|P1|Overall Study|Randomized but not treated|9
757279|NCT00471146|2415259|P2|Overall Study|Global deterioration of health status|14
757280|NCT00471146|2415260|P1|Overall Study|Global deterioration of health status|12
757281|NCT00471146|2415259|P2|Overall Study|Objective progression or relapse|87
757282|NCT00471146|2415260|P1|Overall Study|Objective progression or relapse|84
757283|NCT00471146|2415259|P2|Overall Study|Protocol Violation|2
757284|NCT00471146|2415260|P1|Overall Study|Protocol Violation|2
757285|NCT00471146|2415259|P2|Overall Study|Lost to Follow-up|2
757286|NCT00471146|2415260|P1|Overall Study|Lost to Follow-up|4
757287|NCT00471146|2415259|P2|Overall Study|Death|12
757288|NCT00471146|2415260|P1|Overall Study|Death|11
757289|NCT00471146|2415259|P2|Overall Study|Withdrawal by Subject|11
757290|NCT00471146|2415260|P1|Overall Study|Withdrawal by Subject|14
757291|NCT00471146|2415259|P2|Overall Study|Adverse Event|33
757292|NCT00471146|2415260|P1|Overall Study|Adverse Event|32
891023|NCT00521339|2826657|P2|Treatment Phase|Withdrawal by Subject|0
891024|NCT00521339|2826658|P1|Treatment Phase|Withdrawal by Subject|3
891025|NCT00521339|2826656|P3|Treatment Phase|Lack of Efficacy|0
891026|NCT00521339|2826657|P2|Treatment Phase|Lack of Efficacy|0
891027|NCT00521339|2826658|P1|Treatment Phase|Lack of Efficacy|3
891028|NCT00521339|2826656|P3|Treatment Phase|Intolerability to study drug|0
891029|NCT00521339|2826657|P2|Treatment Phase|Intolerability to study drug|0
891030|NCT00521339|2826658|P1|Treatment Phase|Intolerability to study drug|2
891031|NCT00521339|2826656|P3|Treatment Phase|Adverse Event|0
891032|NCT00521339|2826657|P2|Treatment Phase|Adverse Event|0
891033|NCT00521339|2826658|P1|Treatment Phase|Adverse Event|2
891034|NCT00490139|2826725|P4|Overall Study|Participant Withdrew Consent|116
891035|NCT00490139|2826726|P3|Overall Study|Participant Withdrew Consent|208
891036|NCT00490139|2826727|P2|Overall Study|Participant Withdrew Consent|110
891037|NCT00490139|2826728|P1|Overall Study|Participant Withdrew Consent|146
891038|NCT00490139|2826725|P4|Overall Study|Lost to Follow-up|56
891039|NCT00490139|2826726|P3|Overall Study|Lost to Follow-up|58
891040|NCT00490139|2826727|P2|Overall Study|Lost to Follow-up|46
891041|NCT00490139|2826728|P1|Overall Study|Lost to Follow-up|56
891042|NCT00490139|2826725|P4|Overall Study|Death|135
891043|NCT00490139|2826726|P3|Overall Study|Death|168
891044|NCT00490139|2826727|P2|Overall Study|Death|119
891045|NCT00490139|2826728|P1|Overall Study|Death|106
891046|NCT00471237|2826765|P7|Overall Study|Participant's decision|0
891047|NCT00471237|2826766|P6|Overall Study|Participant's decision|1
891048|NCT00471237|2826767|P5|Overall Study|Participant's decision|0
891049|NCT00471237|2826768|P4|Overall Study|Participant's decision|0
891050|NCT00471237|2826769|P3|Overall Study|Participant's decision|0
891051|NCT00471237|2826770|P2|Overall Study|Participant's decision|0
891052|NCT00471237|2826771|P1|Overall Study|Participant's decision|0
891053|NCT00471237|2826765|P7|Overall Study|Participant shifted residence|0
891054|NCT00471237|2826766|P6|Overall Study|Participant shifted residence|0
891055|NCT00471237|2826767|P5|Overall Study|Participant shifted residence|1
891056|NCT00471237|2826768|P4|Overall Study|Participant shifted residence|0
891057|NCT00471237|2826769|P3|Overall Study|Participant shifted residence|0
891058|NCT00471237|2826770|P2|Overall Study|Participant shifted residence|0
891059|NCT00471237|2826771|P1|Overall Study|Participant shifted residence|0
891060|NCT00471237|2826765|P7|Overall Study|Administration of prohibited medicine|0
891061|NCT00471237|2826766|P6|Overall Study|Administration of prohibited medicine|0
891062|NCT00471237|2826767|P5|Overall Study|Administration of prohibited medicine|1
891063|NCT00471237|2826768|P4|Overall Study|Administration of prohibited medicine|0
891064|NCT00471237|2826769|P3|Overall Study|Administration of prohibited medicine|0
891065|NCT00471237|2826770|P2|Overall Study|Administration of prohibited medicine|0
891066|NCT00471237|2826771|P1|Overall Study|Administration of prohibited medicine|0
891067|NCT00471237|2826765|P7|Overall Study|Participant lost medication|0
891068|NCT00471237|2826766|P6|Overall Study|Participant lost medication|0
891069|NCT00471237|2826767|P5|Overall Study|Participant lost medication|1
891070|NCT00471237|2826768|P4|Overall Study|Participant lost medication|0
891071|NCT00471237|2826769|P3|Overall Study|Participant lost medication|0
891072|NCT00471237|2826770|P2|Overall Study|Participant lost medication|0
891073|NCT00471237|2826771|P1|Overall Study|Participant lost medication|0
891074|NCT00471237|2826765|P7|Overall Study|High parathyroid hormone|0
891075|NCT00471237|2826766|P6|Overall Study|High parathyroid hormone|0
891076|NCT00471237|2826767|P5|Overall Study|High parathyroid hormone|0
757435|NCT00471354|2415493|P1|Overall Study|Withdrawal by Subject|1
891077|NCT00471237|2826768|P4|Overall Study|High parathyroid hormone|0
891078|NCT00471237|2826769|P3|Overall Study|High parathyroid hormone|1
891079|NCT00471237|2826770|P2|Overall Study|High parathyroid hormone|0
891080|NCT00471237|2826771|P1|Overall Study|High parathyroid hormone|0
891081|NCT00471237|2826765|P7|Overall Study|Participant planned to travel to abraod|0
891082|NCT00471237|2826766|P6|Overall Study|Participant planned to travel to abraod|1
891083|NCT00471237|2826767|P5|Overall Study|Participant planned to travel to abraod|0
891084|NCT00471237|2826768|P4|Overall Study|Participant planned to travel to abraod|0
891085|NCT00471237|2826769|P3|Overall Study|Participant planned to travel to abraod|0
891086|NCT00471237|2826770|P2|Overall Study|Participant planned to travel to abraod|0
891087|NCT00471237|2826771|P1|Overall Study|Participant planned to travel to abraod|1
891088|NCT00471237|2826765|P7|Overall Study|Early stopping due to non-efficacy|0
891089|NCT00471237|2826766|P6|Overall Study|Early stopping due to non-efficacy|0
891090|NCT00471237|2826767|P5|Overall Study|Early stopping due to non-efficacy|1
891091|NCT00471237|2826768|P4|Overall Study|Early stopping due to non-efficacy|0
891092|NCT00471237|2826769|P3|Overall Study|Early stopping due to non-efficacy|0
891093|NCT00471237|2826770|P2|Overall Study|Early stopping due to non-efficacy|0
891094|NCT00471237|2826771|P1|Overall Study|Early stopping due to non-efficacy|1
891095|NCT00471237|2826765|P7|Overall Study|Met serum creatinine withdrawal criteria|0
891096|NCT00471237|2826766|P6|Overall Study|Met serum creatinine withdrawal criteria|0
891097|NCT00471237|2826767|P5|Overall Study|Met serum creatinine withdrawal criteria|0
891098|NCT00471237|2826768|P4|Overall Study|Met serum creatinine withdrawal criteria|2
891099|NCT00471237|2826769|P3|Overall Study|Met serum creatinine withdrawal criteria|2
891100|NCT00471237|2826770|P2|Overall Study|Met serum creatinine withdrawal criteria|0
891101|NCT00471237|2826771|P1|Overall Study|Met serum creatinine withdrawal criteria|1
891102|NCT00471237|2826765|P7|Overall Study|Non-compliance|0
891103|NCT00471237|2826766|P6|Overall Study|Non-compliance|0
891104|NCT00471237|2826767|P5|Overall Study|Non-compliance|0
891105|NCT00471237|2826768|P4|Overall Study|Non-compliance|1
891106|NCT00471237|2826769|P3|Overall Study|Non-compliance|0
891107|NCT00471237|2826770|P2|Overall Study|Non-compliance|1
891108|NCT00471237|2826771|P1|Overall Study|Non-compliance|0
891109|NCT00471237|2826765|P7|Overall Study|Sponsor terminated study|0
891110|NCT00471237|2826766|P6|Overall Study|Sponsor terminated study|24
891111|NCT00471237|2826767|P5|Overall Study|Sponsor terminated study|18
891112|NCT00471237|2826768|P4|Overall Study|Sponsor terminated study|22
891113|NCT00471237|2826769|P3|Overall Study|Sponsor terminated study|19
891114|NCT00471237|2826770|P2|Overall Study|Sponsor terminated study|23
891115|NCT00471237|2826771|P1|Overall Study|Sponsor terminated study|20
891116|NCT00471237|2826765|P7|Overall Study|Withdrawal by Subject|2
891117|NCT00471237|2826766|P6|Overall Study|Withdrawal by Subject|4
891118|NCT00471237|2826767|P5|Overall Study|Withdrawal by Subject|7
891119|NCT00471237|2826768|P4|Overall Study|Withdrawal by Subject|8
891120|NCT00471237|2826769|P3|Overall Study|Withdrawal by Subject|5
757391|NCT00471276|2415443|P1|Overall Study|Refused treatment|6
757392|NCT00471276|2415443|P1|Overall Study|Unspecified|3
757393|NCT00471276|2415443|P1|Overall Study|Global deterioration of health status|1
757394|NCT00471276|2415443|P1|Overall Study|Objective progression or relapse|54
757395|NCT00471276|2415443|P1|Overall Study|Protocol Violation|1
757396|NCT00471276|2415443|P1|Overall Study|Adverse Event|16
757397|NCT00471276|2415443|P1|Overall Study|Death|2
757398|NCT00471315|2415466|P1|Overall Study|Withdrawal by Subject|1
757399|NCT00471315|2415466|P1|Overall Study|Adverse Event|7
757400|NCT00471328|2415473|P2|Extension Phase|Administrative Problem|0
757401|NCT00471328|2415474|P1|Extension Phase|Administrative Problem|1
757402|NCT00471328|2415473|P2|Extension Phase|New cancer Therapy|0
757403|NCT00471328|2415474|P1|Extension Phase|New cancer Therapy|1
757404|NCT00471328|2415473|P2|Extension Phase|Disease Progression|44
757405|NCT00471328|2415474|P1|Extension Phase|Disease Progression|32
757406|NCT00471328|2415473|P2|Extension Phase|Treatment duration as per protocol|1
757407|NCT00471328|2415474|P1|Extension Phase|Treatment duration as per protocol|0
757408|NCT00471328|2415473|P2|Extension Phase|Protocol Deviation|1
757409|NCT00471328|2415474|P1|Extension Phase|Protocol Deviation|3
757410|NCT00471328|2415473|P2|Extension Phase|Death|7
757411|NCT00471328|2415474|P1|Extension Phase|Death|1
757412|NCT00471328|2415473|P2|Extension Phase|Withdrawal by Subject|2
757413|NCT00471328|2415474|P1|Extension Phase|Withdrawal by Subject|0
757414|NCT00471328|2415473|P2|Extension Phase|Adverse Event|12
757415|NCT00471328|2415474|P1|Extension Phase|Adverse Event|3
757416|NCT00471328|2415473|P2|Core Phase|Protocol Deviation|1
757417|NCT00471328|2415474|P1|Core Phase|Protocol Deviation|0
757418|NCT00471328|2415473|P2|Core Phase|Administrative Problem|1
757419|NCT00471328|2415474|P1|Core Phase|Administrative Problem|0
757420|NCT00471328|2415473|P2|Core Phase|Disease Progression|53
757421|NCT00471328|2415474|P1|Core Phase|Disease Progression|78
757422|NCT00471328|2415473|P2|Core Phase|Abnormal laboratory value|0
757423|NCT00471328|2415474|P1|Core Phase|Abnormal laboratory value|1
757424|NCT00471328|2415473|P2|Core Phase|Withdrawal by Subject|2
757425|NCT00471328|2415474|P1|Core Phase|Withdrawal by Subject|2
757426|NCT00471328|2415473|P2|Core Phase|Death|4
757427|NCT00471328|2415474|P1|Core Phase|Death|8
757428|NCT00471328|2415473|P2|Core Phase|Adverse Event|6
757429|NCT00471328|2415474|P1|Core Phase|Adverse Event|18
757430|NCT00471354|2415493|P1|Overall Study|Patient/Caregiver Decision|12
757431|NCT00471354|2415493|P1|Overall Study|Lack of Efficacy|5
757432|NCT00471354|2415493|P1|Overall Study|Lost to Follow-up|3
757433|NCT00471354|2415493|P1|Overall Study|Sponsor Decision|1
757434|NCT00471354|2415493|P1|Overall Study|Physician Decision|4
757436|NCT00471354|2415493|P1|Overall Study|Protocol Violation|12
757437|NCT00471354|2415493|P1|Overall Study|Adverse Event|13
757438|NCT00471354|2415493|P1|Overall Study|Protocol Entry Criteria Not Met|1
757439|NCT00471445|2415512|P2|Overall Study|Protocol Violation|1
757440|NCT00471445|2415513|P1|Overall Study|Protocol Violation|0
757441|NCT00471445|2415512|P2|Overall Study|Ineligible|0
757442|NCT00471445|2415513|P1|Overall Study|Ineligible|1
757443|NCT00471445|2415512|P2|Overall Study|Withdrawal by Subject|1
757444|NCT00471445|2415513|P1|Overall Study|Withdrawal by Subject|1
757475|NCT00471536|2415532|P1|Overall Study|Withdrawal by Subject|1
757476|NCT00471718|2415560|P1|Overall Study|Withdrawal by Subject|1
757477|NCT00471718|2415560|P1|Overall Study|disease progression|22
757478|NCT00471718|2415560|P1|Overall Study|other complicating disease|1
757479|NCT00471718|2415560|P1|Overall Study|Adverse Event|3
757480|NCT00471822|2415569|P1|Overall Study|Protocol Violation|2
757481|NCT00472030|2415579|P2|Overall Study|Physician Decision|0
757482|NCT00472030|2415580|P1|Overall Study|Physician Decision|1
757483|NCT00472082|2415611|P1|Overall Study|Study prematurely terminated|5
757484|NCT00472199|2415618|P2|Overall Study|patient was asymptomatic|0
757485|NCT00472199|2415619|P1|Overall Study|patient was asymptomatic|1
757486|NCT00472199|2415618|P2|Overall Study|personal reason|1
757487|NCT00472199|2415619|P1|Overall Study|personal reason|0
757488|NCT00472199|2415618|P2|Overall Study|Withdrawal by Subject|5
757489|NCT00472199|2415619|P1|Overall Study|Withdrawal by Subject|6
757490|NCT00472199|2415618|P2|Overall Study|Protocol Violation|2
757491|NCT00472199|2415619|P1|Overall Study|Protocol Violation|3
757492|NCT00472199|2415618|P2|Overall Study|Lost to Follow-up|4
757493|NCT00472199|2415619|P1|Overall Study|Lost to Follow-up|2
757494|NCT00472199|2415618|P2|Overall Study|Lack of Efficacy|25
757495|NCT00472199|2415619|P1|Overall Study|Lack of Efficacy|4
757496|NCT00472199|2415618|P2|Overall Study|Adverse Event|23
757497|NCT00472199|2415619|P1|Overall Study|Adverse Event|19
757498|NCT00472290|2415685|P1|Overall Study|Requirement for alternative therapy|7
757499|NCT00472290|2415685|P1|Overall Study|Adverse Event|6
757500|NCT00472290|2415685|P1|Overall Study|Withdrawal by Subject|5
757501|NCT00472290|2415685|P1|Overall Study|Disease Progression|4
757502|NCT00472290|2415685|P1|Overall Study|Lack of Efficacy|1
757503|NCT00472290|2415685|P1|Overall Study|Lost to Follow-up|1
757504|NCT00472290|2415685|P1|Overall Study|Death|3
757505|NCT00472290|2415685|P1|Overall Study|Administrative Decision|37
757506|NCT00472290|2415685|P1|Overall Study|Protocol Specified Criteria|7
757507|NCT00472290|2415685|P1|Overall Study|Progression of Therapy-Related MDS|1
757508|NCT00472303|2415697|P3|Maintenance Phase|not specified|0
757509|NCT00472303|2415698|P2|Maintenance Phase|not specified|1
757510|NCT00472303|2415699|P1|Maintenance Phase|not specified|1
757511|NCT00472303|2415697|P3|Maintenance Phase|Resolution of pain|1
757512|NCT00472303|2415698|P2|Maintenance Phase|Resolution of pain|0
757513|NCT00472303|2415699|P1|Maintenance Phase|Resolution of pain|0
757514|NCT00472303|2415697|P3|Maintenance Phase|Trial medication non-compliant|1
757515|NCT00472303|2415698|P2|Maintenance Phase|Trial medication non-compliant|0
757516|NCT00472303|2415699|P1|Maintenance Phase|Trial medication non-compliant|0
757517|NCT00472303|2415697|P3|Maintenance Phase|Withdrawal by Subject|3
757518|NCT00472303|2415698|P2|Maintenance Phase|Withdrawal by Subject|7
757519|NCT00472303|2415699|P1|Maintenance Phase|Withdrawal by Subject|6
757520|NCT00472303|2415697|P3|Maintenance Phase|Lack of Efficacy|4
757521|NCT00472303|2415698|P2|Maintenance Phase|Lack of Efficacy|2
757522|NCT00472303|2415699|P1|Maintenance Phase|Lack of Efficacy|2
757523|NCT00472303|2415697|P3|Maintenance Phase|Death|2
757524|NCT00472303|2415698|P2|Maintenance Phase|Death|0
757525|NCT00472303|2415699|P1|Maintenance Phase|Death|3
757526|NCT00472303|2415697|P3|Maintenance Phase|Adverse Event|6
757527|NCT00472303|2415698|P2|Maintenance Phase|Adverse Event|6
757528|NCT00472303|2415699|P1|Maintenance Phase|Adverse Event|5
757529|NCT00472303|2415697|P3|Discontinuations After Titration Phase|not specified|0
757530|NCT00472303|2415698|P2|Discontinuations After Titration Phase|not specified|0
757531|NCT00472303|2415699|P1|Discontinuations After Titration Phase|not specified|5
757532|NCT00472303|2415697|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
757533|NCT00472303|2415698|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
757534|NCT00472303|2415699|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
757535|NCT00472303|2415697|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
757536|NCT00472303|2415698|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
757537|NCT00472303|2415699|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
757538|NCT00472303|2415697|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
757539|NCT00472303|2415698|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
757540|NCT00472303|2415699|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
757541|NCT00472303|2415697|P3|Discontinuations After Titration Phase|Adverse Event|0
757542|NCT00472303|2415698|P2|Discontinuations After Titration Phase|Adverse Event|0
757543|NCT00472303|2415699|P1|Discontinuations After Titration Phase|Adverse Event|6
757544|NCT00472303|2415697|P3|Titration Phase|not specified|0
757545|NCT00472303|2415698|P2|Titration Phase|not specified|1
757546|NCT00472303|2415699|P1|Titration Phase|not specified|3
757547|NCT00472303|2415697|P3|Titration Phase|Trial Medication non-compliant|0
757548|NCT00472303|2415698|P2|Titration Phase|Trial Medication non-compliant|1
757549|NCT00472303|2415699|P1|Titration Phase|Trial Medication non-compliant|4
757550|NCT00472303|2415697|P3|Titration Phase|Withdrawal by Subject|0
757551|NCT00472303|2415698|P2|Titration Phase|Withdrawal by Subject|13
757552|NCT00472303|2415699|P1|Titration Phase|Withdrawal by Subject|16
757553|NCT00472303|2415697|P3|Titration Phase|Lack of Efficacy|0
757554|NCT00472303|2415698|P2|Titration Phase|Lack of Efficacy|0
757555|NCT00472303|2415699|P1|Titration Phase|Lack of Efficacy|10
757556|NCT00472303|2415697|P3|Titration Phase|Death|0
757557|NCT00472303|2415698|P2|Titration Phase|Death|2
757558|NCT00472303|2415699|P1|Titration Phase|Death|4
757559|NCT00472303|2415697|P3|Titration Phase|Adverse Event|0
757560|NCT00472303|2415698|P2|Titration Phase|Adverse Event|12
757561|NCT00472303|2415699|P1|Titration Phase|Adverse Event|22
757562|NCT00472420|2415762|P1|Follow-up Period|Protocol Violation|1
757563|NCT00472420|2415762|P1|Follow-up Period|Lost to Follow-up|2
757564|NCT00472420|2415762|P1|Follow-up Period|Physician Decision|9
757565|NCT00472420|2415762|P1|Follow-up Period|Death|5
757566|NCT00472420|2415762|P1|Induction Treatment Period|Death|3
757567|NCT00472420|2415762|P1|Induction Treatment Period|Non-compliance|1
757568|NCT00472420|2415762|P1|Induction Treatment Period|Adverse Event|3
757569|NCT00472420|2415762|P1|Induction Treatment Period|Physician Decision|9
757570|NCT00472446|2415772|P4|Overall Study|Questionnaires not returned|4
757571|NCT00472446|2415773|P3|Overall Study|Questionnaires not returned|6
757572|NCT00472446|2415774|P2|Overall Study|Questionnaires not returned|6
757573|NCT00472446|2415775|P1|Overall Study|Questionnaires not returned|5
757574|NCT00472446|2415772|P4|Overall Study|Reintervention|1
757575|NCT00472446|2415773|P3|Overall Study|Reintervention|1
757576|NCT00472446|2415774|P2|Overall Study|Reintervention|0
757577|NCT00472446|2415775|P1|Overall Study|Reintervention|0
757578|NCT00472446|2415772|P4|Overall Study|Protocol Violation|1
757579|NCT00472446|2415773|P3|Overall Study|Protocol Violation|0
757580|NCT00472446|2415774|P2|Overall Study|Protocol Violation|0
757581|NCT00472446|2415775|P1|Overall Study|Protocol Violation|0
757582|NCT00460109|2415805|P1|Overall Study|Death|1
757583|NCT00460239|2415813|P9|Overall Study|Withdrawal by Subject|0
757584|NCT00460239|2415814|P8|Overall Study|Withdrawal by Subject|0
757585|NCT00460239|2415815|P7|Overall Study|Withdrawal by Subject|0
757586|NCT00460239|2415816|P6|Overall Study|Withdrawal by Subject|1
757587|NCT00460239|2415817|P5|Overall Study|Withdrawal by Subject|0
757588|NCT00460239|2415818|P4|Overall Study|Withdrawal by Subject|0
757589|NCT00460239|2415819|P3|Overall Study|Withdrawal by Subject|0
757590|NCT00460239|2415820|P2|Overall Study|Withdrawal by Subject|0
757591|NCT00460239|2415821|P1|Overall Study|Withdrawal by Subject|0
757592|NCT00460239|2415813|P9|Overall Study|Physician Decision|0
757593|NCT00460239|2415814|P8|Overall Study|Physician Decision|0
757594|NCT00460239|2415815|P7|Overall Study|Physician Decision|0
757595|NCT00460239|2415816|P6|Overall Study|Physician Decision|2
757596|NCT00460239|2415817|P5|Overall Study|Physician Decision|0
757597|NCT00460239|2415818|P4|Overall Study|Physician Decision|0
757598|NCT00460239|2415819|P3|Overall Study|Physician Decision|0
757599|NCT00460239|2415820|P2|Overall Study|Physician Decision|1
757600|NCT00460239|2415821|P1|Overall Study|Physician Decision|0
757601|NCT00460265|2415892|P2|Overall Study|Ongoing|47
757602|NCT00460265|2415893|P1|Overall Study|Ongoing|60
757603|NCT00460265|2415892|P2|Overall Study|Withdrawal by Subject|25
757604|NCT00460265|2415893|P1|Overall Study|Withdrawal by Subject|10
757605|NCT00460265|2415892|P2|Overall Study|Physician Decision|2
757606|NCT00460265|2415893|P1|Overall Study|Physician Decision|1
757607|NCT00460265|2415892|P2|Overall Study|Lost to Follow-up|15
757608|NCT00460265|2415893|P1|Overall Study|Lost to Follow-up|14
757609|NCT00460408|2415913|P4|Overall Study|Unspecified|0
757610|NCT00460408|2415914|P3|Overall Study|Unspecified|0
757611|NCT00460408|2415915|P2|Overall Study|Unspecified|2
757612|NCT00460408|2415916|P1|Overall Study|Unspecified|12
757613|NCT00460408|2415913|P4|Overall Study|Insufficient clinical response|0
757614|NCT00460408|2415914|P3|Overall Study|Insufficient clinical response|5
757615|NCT00460408|2415915|P2|Overall Study|Insufficient clinical response|1
757616|NCT00460408|2415916|P1|Overall Study|Insufficient clinical response|5
757617|NCT00460408|2415913|P4|Overall Study|Withdrawal by Subject|0
757618|NCT00460408|2415914|P3|Overall Study|Withdrawal by Subject|0
757619|NCT00460408|2415915|P2|Overall Study|Withdrawal by Subject|0
757620|NCT00460408|2415916|P1|Overall Study|Withdrawal by Subject|31
757621|NCT00460408|2415913|P4|Overall Study|Lost to Follow-up|0
757622|NCT00460408|2415914|P3|Overall Study|Lost to Follow-up|1
757623|NCT00460408|2415915|P2|Overall Study|Lost to Follow-up|0
757624|NCT00460408|2415916|P1|Overall Study|Lost to Follow-up|11
757625|NCT00460408|2415913|P4|Overall Study|Death|0
757626|NCT00460408|2415914|P3|Overall Study|Death|0
757627|NCT00460408|2415915|P2|Overall Study|Death|0
757628|NCT00460408|2415916|P1|Overall Study|Death|7
757629|NCT00460408|2415913|P4|Overall Study|Adverse Event|0
757630|NCT00460408|2415914|P3|Overall Study|Adverse Event|0
757631|NCT00460408|2415915|P2|Overall Study|Adverse Event|0
757632|NCT00460408|2415916|P1|Overall Study|Adverse Event|1
757633|NCT00460434|2416002|P2|Overall Study|Lost to Follow-up|7
757634|NCT00460434|2416003|P1|Overall Study|Lost to Follow-up|3
757635|NCT00460564|2416081|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757636|NCT00460564|2416082|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757637|NCT00460564|2416083|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757638|NCT00460564|2416084|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
757639|NCT00460564|2416085|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757640|NCT00460564|2416086|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757641|NCT00460564|2416087|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757642|NCT00460564|2416088|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
757643|NCT00460564|2416081|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757644|NCT00460564|2416082|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757645|NCT00460564|2416083|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
757646|NCT00460564|2416084|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
757647|NCT00460564|2416085|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757648|NCT00460564|2416086|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757649|NCT00460564|2416087|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757650|NCT00460564|2416088|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757651|NCT00460564|2416081|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
757652|NCT00460564|2416082|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
757653|NCT00460564|2416083|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
757654|NCT00460564|2416084|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
757655|NCT00460564|2416085|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
757656|NCT00460564|2416086|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
757657|NCT00460564|2416087|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
757658|NCT00460564|2416088|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
757659|NCT00460564|2416081|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757660|NCT00460564|2416082|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757661|NCT00460564|2416083|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757662|NCT00460564|2416084|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757663|NCT00460564|2416085|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757664|NCT00460564|2416086|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757665|NCT00460564|2416087|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757666|NCT00460564|2416088|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
757667|NCT00460564|2416081|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
757668|NCT00460564|2416082|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
757669|NCT00460564|2416083|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
757670|NCT00460564|2416084|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
757671|NCT00460564|2416085|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
757672|NCT00460564|2416086|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
757673|NCT00460564|2416087|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
757674|NCT00460564|2416088|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
757675|NCT00460577|2416184|P2|Overall Study|Protocol Violation|6
757676|NCT00460577|2416185|P1|Overall Study|Protocol Violation|2
757677|NCT00460603|2416211|P12|Phase 2|Randomized, but not treated|0
757678|NCT00460603|2416212|P11|Phase 2|Randomized, but not treated|0
757679|NCT00460603|2416213|P10|Phase 2|Randomized, but not treated|3
757680|NCT00460603|2416214|P9|Phase 2|Randomized, but not treated|0
757681|NCT00460603|2416215|P8|Phase 2|Randomized, but not treated|0
757682|NCT00460603|2416216|P7|Phase 2|Randomized, but not treated|0
757683|NCT00460603|2416217|P6|Phase 2|Randomized, but not treated|0
757684|NCT00460603|2416218|P5|Phase 2|Randomized, but not treated|0
757685|NCT00460603|2416219|P4|Phase 2|Randomized, but not treated|0
757686|NCT00460603|2416220|P3|Phase 2|Randomized, but not treated|0
757687|NCT00460603|2416221|P2|Phase 2|Randomized, but not treated|0
757688|NCT00460603|2416222|P1|Phase 2|Randomized, but not treated|0
757689|NCT00460603|2416211|P12|Phase 2|Withdrawal by Subject|5
757690|NCT00460603|2416212|P11|Phase 2|Withdrawal by Subject|4
757691|NCT00460603|2416213|P10|Phase 2|Withdrawal by Subject|5
757692|NCT00460603|2416214|P9|Phase 2|Withdrawal by Subject|0
757693|NCT00460603|2416215|P8|Phase 2|Withdrawal by Subject|0
757694|NCT00460603|2416216|P7|Phase 2|Withdrawal by Subject|0
757695|NCT00460603|2416217|P6|Phase 2|Withdrawal by Subject|0
757696|NCT00460603|2416218|P5|Phase 2|Withdrawal by Subject|0
757697|NCT00460603|2416219|P4|Phase 2|Withdrawal by Subject|0
757698|NCT00460603|2416220|P3|Phase 2|Withdrawal by Subject|0
757699|NCT00460603|2416221|P2|Phase 2|Withdrawal by Subject|0
757700|NCT00460603|2416222|P1|Phase 2|Withdrawal by Subject|0
757701|NCT00460603|2416211|P12|Phase 2|Global Deterioration of Health Status|0
757702|NCT00460603|2416212|P11|Phase 2|Global Deterioration of Health Status|1
757703|NCT00460603|2416213|P10|Phase 2|Global Deterioration of Health Status|0
757704|NCT00460603|2416214|P9|Phase 2|Global Deterioration of Health Status|0
757705|NCT00460603|2416215|P8|Phase 2|Global Deterioration of Health Status|0
757706|NCT00460603|2416216|P7|Phase 2|Global Deterioration of Health Status|0
757707|NCT00460603|2416217|P6|Phase 2|Global Deterioration of Health Status|0
757708|NCT00460603|2416218|P5|Phase 2|Global Deterioration of Health Status|0
757709|NCT00460603|2416219|P4|Phase 2|Global Deterioration of Health Status|0
757710|NCT00460603|2416220|P3|Phase 2|Global Deterioration of Health Status|0
757711|NCT00460603|2416221|P2|Phase 2|Global Deterioration of Health Status|0
757712|NCT00460603|2416222|P1|Phase 2|Global Deterioration of Health Status|0
757713|NCT00460603|2416211|P12|Phase 2|Objective Progression or Relapse|17
757714|NCT00460603|2416212|P11|Phase 2|Objective Progression or Relapse|10
757715|NCT00460603|2416213|P10|Phase 2|Objective Progression or Relapse|9
757716|NCT00460603|2416214|P9|Phase 2|Objective Progression or Relapse|0
757717|NCT00460603|2416215|P8|Phase 2|Objective Progression or Relapse|0
757718|NCT00460603|2416216|P7|Phase 2|Objective Progression or Relapse|0
757719|NCT00460603|2416217|P6|Phase 2|Objective Progression or Relapse|0
757720|NCT00460603|2416218|P5|Phase 2|Objective Progression or Relapse|0
757721|NCT00460603|2416219|P4|Phase 2|Objective Progression or Relapse|0
757722|NCT00460603|2416220|P3|Phase 2|Objective Progression or Relapse|0
757723|NCT00460603|2416221|P2|Phase 2|Objective Progression or Relapse|0
757724|NCT00460603|2416222|P1|Phase 2|Objective Progression or Relapse|0
757725|NCT00460603|2416211|P12|Phase 2|Unspecified|7
757726|NCT00460603|2416212|P11|Phase 2|Unspecified|16
757727|NCT00460603|2416213|P10|Phase 2|Unspecified|6
757728|NCT00460603|2416214|P9|Phase 2|Unspecified|0
757729|NCT00460603|2416215|P8|Phase 2|Unspecified|0
757730|NCT00460603|2416216|P7|Phase 2|Unspecified|0
757731|NCT00460603|2416217|P6|Phase 2|Unspecified|0
757732|NCT00460603|2416218|P5|Phase 2|Unspecified|0
757733|NCT00460603|2416219|P4|Phase 2|Unspecified|0
757734|NCT00460603|2416220|P3|Phase 2|Unspecified|0
757735|NCT00460603|2416221|P2|Phase 2|Unspecified|0
757736|NCT00460603|2416222|P1|Phase 2|Unspecified|0
757737|NCT00460603|2416211|P12|Phase 2|Lost to Follow-up|0
757738|NCT00460603|2416212|P11|Phase 2|Lost to Follow-up|0
757739|NCT00460603|2416213|P10|Phase 2|Lost to Follow-up|1
757740|NCT00460603|2416214|P9|Phase 2|Lost to Follow-up|0
757741|NCT00460603|2416215|P8|Phase 2|Lost to Follow-up|0
757742|NCT00460603|2416216|P7|Phase 2|Lost to Follow-up|0
757743|NCT00460603|2416217|P6|Phase 2|Lost to Follow-up|0
757744|NCT00460603|2416218|P5|Phase 2|Lost to Follow-up|0
757745|NCT00460603|2416219|P4|Phase 2|Lost to Follow-up|0
757746|NCT00460603|2416220|P3|Phase 2|Lost to Follow-up|0
757747|NCT00460603|2416221|P2|Phase 2|Lost to Follow-up|0
757748|NCT00460603|2416222|P1|Phase 2|Lost to Follow-up|0
757749|NCT00460603|2416211|P12|Phase 2|Protocol Violation|0
757750|NCT00460603|2416212|P11|Phase 2|Protocol Violation|1
757751|NCT00460603|2416213|P10|Phase 2|Protocol Violation|1
757752|NCT00460603|2416214|P9|Phase 2|Protocol Violation|0
757753|NCT00460603|2416215|P8|Phase 2|Protocol Violation|0
757754|NCT00460603|2416216|P7|Phase 2|Protocol Violation|0
757755|NCT00460603|2416217|P6|Phase 2|Protocol Violation|0
757756|NCT00460603|2416218|P5|Phase 2|Protocol Violation|0
757757|NCT00460603|2416219|P4|Phase 2|Protocol Violation|0
757758|NCT00460603|2416220|P3|Phase 2|Protocol Violation|0
757759|NCT00460603|2416221|P2|Phase 2|Protocol Violation|0
757760|NCT00460603|2416222|P1|Phase 2|Protocol Violation|0
757761|NCT00460603|2416211|P12|Phase 2|Death|2
757762|NCT00460603|2416212|P11|Phase 2|Death|2
757763|NCT00460603|2416213|P10|Phase 2|Death|4
757764|NCT00460603|2416214|P9|Phase 2|Death|0
757765|NCT00460603|2416215|P8|Phase 2|Death|0
757766|NCT00460603|2416216|P7|Phase 2|Death|0
757767|NCT00460603|2416217|P6|Phase 2|Death|0
757768|NCT00460603|2416218|P5|Phase 2|Death|0
757769|NCT00460603|2416219|P4|Phase 2|Death|0
757770|NCT00460603|2416220|P3|Phase 2|Death|0
757771|NCT00460603|2416221|P2|Phase 2|Death|0
757772|NCT00460603|2416222|P1|Phase 2|Death|0
757773|NCT00460603|2416211|P12|Phase 2|Adverse Event|10
757774|NCT00460603|2416212|P11|Phase 2|Adverse Event|9
757775|NCT00460603|2416213|P10|Phase 2|Adverse Event|12
757776|NCT00460603|2416214|P9|Phase 2|Adverse Event|0
757777|NCT00460603|2416215|P8|Phase 2|Adverse Event|0
757778|NCT00460603|2416216|P7|Phase 2|Adverse Event|0
757779|NCT00460603|2416217|P6|Phase 2|Adverse Event|0
757780|NCT00460603|2416218|P5|Phase 2|Adverse Event|0
757781|NCT00460603|2416219|P4|Phase 2|Adverse Event|0
757782|NCT00460603|2416220|P3|Phase 2|Adverse Event|0
757783|NCT00460603|2416221|P2|Phase 2|Adverse Event|0
757784|NCT00460603|2416222|P1|Phase 2|Adverse Event|0
757785|NCT00460603|2416211|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757786|NCT00460603|2416212|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757787|NCT00460603|2416213|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
757788|NCT00460603|2416214|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757789|NCT00460603|2416215|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757790|NCT00460603|2416216|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757791|NCT00460603|2416217|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757792|NCT00460603|2416218|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757793|NCT00460603|2416219|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757794|NCT00460603|2416220|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757795|NCT00460603|2416221|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757796|NCT00460603|2416222|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
757797|NCT00460603|2416211|P12|Phase 1|Unspecified|0
757798|NCT00460603|2416212|P11|Phase 1|Unspecified|0
757799|NCT00460603|2416213|P10|Phase 1|Unspecified|0
757800|NCT00460603|2416214|P9|Phase 1|Unspecified|0
757801|NCT00460603|2416215|P8|Phase 1|Unspecified|1
757802|NCT00460603|2416216|P7|Phase 1|Unspecified|0
757803|NCT00460603|2416217|P6|Phase 1|Unspecified|2
757804|NCT00460603|2416218|P5|Phase 1|Unspecified|1
757805|NCT00460603|2416219|P4|Phase 1|Unspecified|1
757806|NCT00460603|2416220|P3|Phase 1|Unspecified|1
757807|NCT00460603|2416221|P2|Phase 1|Unspecified|3
757808|NCT00460603|2416222|P1|Phase 1|Unspecified|0
757809|NCT00460603|2416211|P12|Phase 1|Withdrawal by Subject|0
757810|NCT00460603|2416212|P11|Phase 1|Withdrawal by Subject|0
757811|NCT00460603|2416213|P10|Phase 1|Withdrawal by Subject|0
757812|NCT00460603|2416214|P9|Phase 1|Withdrawal by Subject|2
757813|NCT00460603|2416215|P8|Phase 1|Withdrawal by Subject|0
757814|NCT00460603|2416216|P7|Phase 1|Withdrawal by Subject|1
757815|NCT00460603|2416217|P6|Phase 1|Withdrawal by Subject|0
757816|NCT00460603|2416218|P5|Phase 1|Withdrawal by Subject|3
757817|NCT00460603|2416219|P4|Phase 1|Withdrawal by Subject|1
757818|NCT00460603|2416220|P3|Phase 1|Withdrawal by Subject|1
757819|NCT00460603|2416221|P2|Phase 1|Withdrawal by Subject|2
757820|NCT00460603|2416222|P1|Phase 1|Withdrawal by Subject|1
757821|NCT00460603|2416211|P12|Phase 1|Lack of Efficacy|0
757822|NCT00460603|2416212|P11|Phase 1|Lack of Efficacy|0
757823|NCT00460603|2416213|P10|Phase 1|Lack of Efficacy|0
757824|NCT00460603|2416214|P9|Phase 1|Lack of Efficacy|11
757825|NCT00460603|2416215|P8|Phase 1|Lack of Efficacy|2
757826|NCT00460603|2416216|P7|Phase 1|Lack of Efficacy|2
757827|NCT00460603|2416217|P6|Phase 1|Lack of Efficacy|2
757828|NCT00460603|2416218|P5|Phase 1|Lack of Efficacy|2
757829|NCT00460603|2416219|P4|Phase 1|Lack of Efficacy|2
757830|NCT00460603|2416220|P3|Phase 1|Lack of Efficacy|1
757831|NCT00460603|2416221|P2|Phase 1|Lack of Efficacy|0
757832|NCT00460603|2416222|P1|Phase 1|Lack of Efficacy|1
757833|NCT00460603|2416211|P12|Phase 1|Adverse Event|0
757834|NCT00460603|2416212|P11|Phase 1|Adverse Event|0
757835|NCT00460603|2416213|P10|Phase 1|Adverse Event|0
757836|NCT00460603|2416214|P9|Phase 1|Adverse Event|4
757837|NCT00460603|2416215|P8|Phase 1|Adverse Event|0
757838|NCT00460603|2416216|P7|Phase 1|Adverse Event|3
757839|NCT00460603|2416217|P6|Phase 1|Adverse Event|0
757840|NCT00460603|2416218|P5|Phase 1|Adverse Event|0
757841|NCT00460603|2416219|P4|Phase 1|Adverse Event|2
757842|NCT00460603|2416220|P3|Phase 1|Adverse Event|1
757843|NCT00460603|2416221|P2|Phase 1|Adverse Event|1
757844|NCT00460603|2416222|P1|Phase 1|Adverse Event|3
757845|NCT00460603|2416211|P12|Phase 1|Death|0
757846|NCT00460603|2416212|P11|Phase 1|Death|0
757847|NCT00460603|2416213|P10|Phase 1|Death|0
757848|NCT00460603|2416214|P9|Phase 1|Death|1
757849|NCT00460603|2416215|P8|Phase 1|Death|0
757850|NCT00460603|2416216|P7|Phase 1|Death|0
757851|NCT00460603|2416217|P6|Phase 1|Death|0
757852|NCT00460603|2416218|P5|Phase 1|Death|0
757853|NCT00460603|2416219|P4|Phase 1|Death|2
757854|NCT00460603|2416220|P3|Phase 1|Death|0
757855|NCT00460603|2416221|P2|Phase 1|Death|0
757856|NCT00460603|2416222|P1|Phase 1|Death|1
757857|NCT00460655|2416316|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
757858|NCT00460655|2416317|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
757859|NCT00460655|2416318|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
757860|NCT00460655|2416319|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
757861|NCT00460655|2416316|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
757862|NCT00460655|2416317|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
757863|NCT00460655|2416318|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757864|NCT00460655|2416319|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
757865|NCT00460655|2416316|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
757866|NCT00460655|2416317|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
757867|NCT00460655|2416318|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
757868|NCT00460655|2416319|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
757869|NCT00460655|2416316|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
891121|NCT00471237|2826770|P2|Overall Study|Withdrawal by Subject|6
757870|NCT00460655|2416317|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
757871|NCT00460655|2416318|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
757872|NCT00460655|2416319|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
757873|NCT00460655|2416316|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757874|NCT00460655|2416317|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757875|NCT00460655|2416318|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
757876|NCT00460655|2416319|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
757877|NCT00460655|2416316|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
757878|NCT00460655|2416317|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
757879|NCT00460655|2416318|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
757880|NCT00460655|2416319|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
757881|NCT00460746|2416351|P1|Overall Study|Lost to Follow-up|1
757882|NCT00460746|2416351|P1|Overall Study|Adverse Event|1
757883|NCT00460798|2416364|P1|Overall Study|Missing/Incomplete Dosing Information|27
757884|NCT00460798|2416364|P1|Overall Study|Ongoing at Date of Cut-Off|82
757885|NCT00460798|2416364|P1|Overall Study|Unspecified|27
757886|NCT00460798|2416364|P1|Overall Study|Progressive Disease|99
757887|NCT00460798|2416364|P1|Overall Study|Lost to Follow-up|19
757888|NCT00460798|2416364|P1|Overall Study|Adverse Event|27
757889|NCT00460798|2416364|P1|Overall Study|Death|59
757890|NCT00460811|2416377|P5|Overall Study|Lost to Follow-up|6
757891|NCT00460811|2416378|P4|Overall Study|Lost to Follow-up|3
757892|NCT00460811|2416379|P3|Overall Study|Lost to Follow-up|5
757893|NCT00460811|2416380|P2|Overall Study|Lost to Follow-up|2
757894|NCT00460811|2416381|P1|Overall Study|Lost to Follow-up|3
757895|NCT00460811|2416377|P5|Overall Study|Physician Decision|0
757896|NCT00460811|2416378|P4|Overall Study|Physician Decision|0
757897|NCT00460811|2416379|P3|Overall Study|Physician Decision|0
757898|NCT00460811|2416380|P2|Overall Study|Physician Decision|0
757899|NCT00460811|2416381|P1|Overall Study|Physician Decision|1
757900|NCT00460811|2416377|P5|Overall Study|Withdrawal by Subject|11
757901|NCT00460811|2416378|P4|Overall Study|Withdrawal by Subject|3
757902|NCT00460811|2416379|P3|Overall Study|Withdrawal by Subject|6
757903|NCT00460811|2416380|P2|Overall Study|Withdrawal by Subject|7
757904|NCT00460811|2416381|P1|Overall Study|Withdrawal by Subject|7
757905|NCT00460811|2416377|P5|Overall Study|Noncompliance|1
757906|NCT00460811|2416378|P4|Overall Study|Noncompliance|2
757907|NCT00460811|2416379|P3|Overall Study|Noncompliance|0
757908|NCT00460811|2416380|P2|Overall Study|Noncompliance|0
757909|NCT00460811|2416381|P1|Overall Study|Noncompliance|1
757910|NCT00460811|2416377|P5|Overall Study|Adverse Event|2
757911|NCT00460811|2416378|P4|Overall Study|Adverse Event|10
757912|NCT00460811|2416379|P3|Overall Study|Adverse Event|3
757913|NCT00460811|2416380|P2|Overall Study|Adverse Event|6
757914|NCT00460811|2416381|P1|Overall Study|Adverse Event|4
757915|NCT00466505|2416451|P1|Overall Study|Adverse Event|4
757916|NCT00466505|2416451|P1|Overall Study|disease progression|13
757917|NCT00466687|2416463|P1|Overall Study|Disease progression|29
757918|NCT00466687|2416463|P1|Overall Study|Withdrawal by Subject|1
757919|NCT00466687|2416463|P1|Overall Study|Other complicating illness|3
757920|NCT00466687|2416463|P1|Overall Study|Adverse Event|1
757921|NCT00472641|2416541|P1|Overall Study|Lost to Follow-up|1
757922|NCT00472641|2416541|P1|Overall Study|Adverse Event|3
757923|NCT00472641|2416541|P1|Overall Study|Lack of Efficacy|3
757924|NCT00474487|2416599|P4|Overall Study|Death|0
757925|NCT00474487|2416600|P3|Overall Study|Death|0
757926|NCT00474487|2416601|P2|Overall Study|Death|1
757927|NCT00474487|2416602|P1|Overall Study|Death|0
757928|NCT00474487|2416599|P4|Overall Study|Inappropriate enrollment|0
757929|NCT00474487|2416600|P3|Overall Study|Inappropriate enrollment|7
757930|NCT00474487|2416601|P2|Overall Study|Inappropriate enrollment|0
757931|NCT00474487|2416602|P1|Overall Study|Inappropriate enrollment|4
757932|NCT00474487|2416599|P4|Overall Study|Lost to Follow-up|0
757933|NCT00474487|2416600|P3|Overall Study|Lost to Follow-up|7
757934|NCT00474487|2416601|P2|Overall Study|Lost to Follow-up|1
757935|NCT00474487|2416602|P1|Overall Study|Lost to Follow-up|20
757936|NCT00474487|2416599|P4|Overall Study|Withdrawal by Subject|0
757937|NCT00474487|2416600|P3|Overall Study|Withdrawal by Subject|0
757938|NCT00474487|2416601|P2|Overall Study|Withdrawal by Subject|0
757939|NCT00474487|2416602|P1|Overall Study|Withdrawal by Subject|6
891122|NCT00471237|2826771|P1|Overall Study|Withdrawal by Subject|8
891123|NCT00471237|2826765|P7|Overall Study|Protocol Violation|1
891124|NCT00471237|2826766|P6|Overall Study|Protocol Violation|4
891125|NCT00471237|2826767|P5|Overall Study|Protocol Violation|2
891126|NCT00471237|2826768|P4|Overall Study|Protocol Violation|2
891127|NCT00471237|2826769|P3|Overall Study|Protocol Violation|3
891128|NCT00471237|2826770|P2|Overall Study|Protocol Violation|6
891129|NCT00471237|2826771|P1|Overall Study|Protocol Violation|3
891130|NCT00471237|2826765|P7|Overall Study|Lost to Follow-up|0
891131|NCT00471237|2826766|P6|Overall Study|Lost to Follow-up|0
891132|NCT00471237|2826767|P5|Overall Study|Lost to Follow-up|3
891133|NCT00471237|2826768|P4|Overall Study|Lost to Follow-up|2
891134|NCT00471237|2826769|P3|Overall Study|Lost to Follow-up|0
891135|NCT00471237|2826770|P2|Overall Study|Lost to Follow-up|1
891136|NCT00471237|2826771|P1|Overall Study|Lost to Follow-up|1
891137|NCT00471237|2826765|P7|Overall Study|Adverse Event|0
891138|NCT00471237|2826766|P6|Overall Study|Adverse Event|5
891139|NCT00471237|2826767|P5|Overall Study|Adverse Event|7
891140|NCT00471237|2826768|P4|Overall Study|Adverse Event|8
891141|NCT00471237|2826769|P3|Overall Study|Adverse Event|4
891142|NCT00471237|2826770|P2|Overall Study|Adverse Event|5
891143|NCT00471237|2826771|P1|Overall Study|Adverse Event|6
891147|NCT00445848|2826929|P1|Overall Study|Other-Not protocol specified|5
891148|NCT00445848|2826929|P1|Overall Study|Progression|62
891149|NCT00445848|2826929|P1|Overall Study|Withdrawal by Subject|4
891150|NCT00445848|2826929|P1|Overall Study|Adverse Event|14
891163|NCT00382018|2826976|P4|Overall Study|Other, not protocol specified|1
891164|NCT00382018|2826977|P3|Overall Study|Other, not protocol specified|3
891165|NCT00382018|2826978|P2|Overall Study|Other, not protocol specified|16
891166|NCT00382018|2826979|P1|Overall Study|Other, not protocol specified|0
891167|NCT00382018|2826976|P4|Overall Study|Withdrawal by Subject|4
891168|NCT00382018|2826977|P3|Overall Study|Withdrawal by Subject|3
891169|NCT00382018|2826978|P2|Overall Study|Withdrawal by Subject|4
891170|NCT00382018|2826979|P1|Overall Study|Withdrawal by Subject|0
891171|NCT00382018|2826976|P4|Overall Study|Death|11
891172|NCT00382018|2826977|P3|Overall Study|Death|7
891173|NCT00382018|2826978|P2|Overall Study|Death|9
891174|NCT00382018|2826979|P1|Overall Study|Death|0
891175|NCT00382018|2826976|P4|Overall Study|Progression|43
891176|NCT00382018|2826977|P3|Overall Study|Progression|51
891177|NCT00382018|2826978|P2|Overall Study|Progression|136
891178|NCT00382018|2826979|P1|Overall Study|Progression|0
891179|NCT00376961|2826997|P2|Maintenance|Ineligible|3
891180|NCT00376961|2826998|P1|Maintenance|Ineligible|0
891181|NCT00376961|2826997|P2|Maintenance|Progression/relapse|18
891182|NCT00376961|2826998|P1|Maintenance|Progression/relapse|0
891183|NCT00376961|2826997|P2|Maintenance|Refusal Unrelated to Adverse Event|1
891184|NCT00376961|2826998|P1|Maintenance|Refusal Unrelated to Adverse Event|0
891185|NCT00376961|2826997|P2|Maintenance|Adverse Event|1
891186|NCT00376961|2826998|P1|Maintenance|Adverse Event|0
891187|NCT00376961|2826997|P2|Initial Registration|Ineligible|0
891188|NCT00376961|2826998|P1|Initial Registration|Ineligible|3
891189|NCT00376961|2826997|P2|Initial Registration|Progression/relapse|0
891190|NCT00376961|2826998|P1|Initial Registration|Progression/relapse|1
891191|NCT00376961|2826997|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
891192|NCT00376961|2826998|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
891193|NCT00376961|2826997|P2|Initial Registration|Adverse Event|0
891194|NCT00376961|2826998|P1|Initial Registration|Adverse Event|1
891199|NCT00349921|2827073|P4|First Spinal Injection|Adverse Event|0
891200|NCT00349921|2827074|P3|First Spinal Injection|Adverse Event|1
891201|NCT00349921|2827075|P2|First Spinal Injection|Adverse Event|0
891202|NCT00349921|2827076|P1|First Spinal Injection|Adverse Event|0
891203|NCT00349921|2827073|P4|First Spinal Injection|Physician Decision|0
891204|NCT00349921|2827074|P3|First Spinal Injection|Physician Decision|0
891205|NCT00349921|2827075|P2|First Spinal Injection|Physician Decision|0
891206|NCT00349921|2827076|P1|First Spinal Injection|Physician Decision|1
891208|NCT00348556|2827090|P1|Overall Study|Adverse Event|1
891209|NCT00233987|2827174|P1|Overall Study|Ineligible|4
891210|NCT00233987|2827174|P1|Overall Study|Eligible but No Treatment Received|2
891211|NCT00233987|2827174|P1|Overall Study|Other - Not Protocol Specified|5
891212|NCT00233987|2827174|P1|Overall Study|Reason Under Review|1
891213|NCT00233987|2827174|P1|Overall Study|Lack of Efficacy|2
891214|NCT00233987|2827174|P1|Overall Study|Withdrawal by Subject|1
891215|NCT00206323|2827183|P2|Overall Study|Lost to Follow-up|1
891216|NCT00206323|2827184|P1|Overall Study|Lost to Follow-up|1
891217|NCT00206323|2827183|P2|Overall Study|Adverse Event|1
891218|NCT00206323|2827184|P1|Overall Study|Adverse Event|1
891219|NCT00206323|2827183|P2|Overall Study|Lack of Efficacy|1
891220|NCT00206323|2827184|P1|Overall Study|Lack of Efficacy|4
891221|NCT00211081|2827190|P1|Overall Study|Withdrawal by Subject|2
891222|NCT00178464|2827230|P1|Overall Study|Physician Decision|1
891223|NCT00178464|2827230|P1|Overall Study|Withdrawal by Subject|1
891225|NCT00094328|2827273|P1|Overall Study|Lost to Follow-up|1
891226|NCT00070317|2827290|P1|Overall Study|Ineligible-Inadequate pathology|6
891227|NCT00070317|2827290|P1|Overall Study|Ineligible-Improper prior treatment|2
891228|NCT00070317|2827290|P1|Overall Study|Ineligible required test not done|1
891229|NCT00070317|2827290|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
891230|NCT00070317|2827290|P1|Overall Study|Inevaluable (Never Treated)|1
891231|NCT00064337|2827301|P1|Maintenance|Death|1
891232|NCT00064337|2827301|P1|Maintenance|Not protocol-specified|2
891233|NCT00064337|2827301|P1|Maintenance|On treatment at time of analysis|2
891234|NCT00064337|2827301|P1|Maintenance|Progression|2
891235|NCT00064337|2827301|P1|Maintenance|Adverse Event|3
891236|NCT00064337|2827301|P1|Transplant|Progression|2
891237|NCT00064337|2827301|P1|Transplant|Patient Refusal|2
891238|NCT00064337|2827301|P1|Transplant|Death|3
891239|NCT00064337|2827301|P1|Transplant|Not protocol-specified|5
891240|NCT00064337|2827301|P1|Transplant|Adverse Event|9
891241|NCT00064337|2827301|P1|PBSCC or Induction/PBSCC|Death|2
891242|NCT00064337|2827301|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
891243|NCT00064337|2827301|P1|PBSCC or Induction/PBSCC|Progression|3
891244|NCT00064337|2827301|P1|PBSCC or Induction/PBSCC|Adverse Event|6
891245|NCT00064337|2827301|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
758076|NCT00474539|2416818|P2|Toddler Dose|Protocol Violation|0
758077|NCT00474539|2416819|P1|Toddler Dose|Protocol Violation|1
758078|NCT00474539|2416818|P2|After Infant Series|Withdrawal by Subject|0
758079|NCT00474539|2416819|P1|After Infant Series|Withdrawal by Subject|1
758080|NCT00474539|2416818|P2|After Infant Series|Lost to Follow-up|0
758081|NCT00474539|2416819|P1|After Infant Series|Lost to Follow-up|3
758082|NCT00474539|2416818|P2|Infant Series|Protocol Violation|1
758083|NCT00474539|2416819|P1|Infant Series|Protocol Violation|0
758084|NCT00474539|2416818|P2|Infant Series|Lost to Follow-up|1
758085|NCT00474539|2416819|P1|Infant Series|Lost to Follow-up|2
758086|NCT00474539|2416818|P2|Infant Series|Randomization error|0
758087|NCT00474539|2416819|P1|Infant Series|Randomization error|5
758088|NCT00474539|2416818|P2|Infant Series|Withdrawal by Subject|4
758089|NCT00474539|2416819|P1|Infant Series|Withdrawal by Subject|3
758090|NCT00474630|2416869|P2|Overall Study|Drug noncompliance, other|4
758091|NCT00474630|2416870|P1|Overall Study|Drug noncompliance, other|11
758092|NCT00474630|2416869|P2|Overall Study|Lack of Efficacy|6
758093|NCT00474630|2416870|P1|Overall Study|Lack of Efficacy|5
758094|NCT00474630|2416869|P2|Overall Study|Protocol Violation|4
758095|NCT00474630|2416870|P1|Overall Study|Protocol Violation|3
758096|NCT00474630|2416869|P2|Overall Study|Withdrawal by Subject|15
758097|NCT00474630|2416870|P1|Overall Study|Withdrawal by Subject|21
758098|NCT00474630|2416869|P2|Overall Study|Lost to Follow-up|15
758099|NCT00474630|2416870|P1|Overall Study|Lost to Follow-up|22
758100|NCT00474630|2416869|P2|Overall Study|Adverse Event|26
758101|NCT00474630|2416870|P1|Overall Study|Adverse Event|98
758102|NCT00474708|2416926|P2|Overall Study|Physician Decision|6
758103|NCT00474708|2416927|P1|Overall Study|Physician Decision|9
758104|NCT00474708|2416926|P2|Overall Study|Lost to Follow-up|9
758105|NCT00474708|2416927|P1|Overall Study|Lost to Follow-up|18
758106|NCT00474708|2416926|P2|Overall Study|Lack of compliance|4
758107|NCT00474708|2416927|P1|Overall Study|Lack of compliance|12
758108|NCT00474708|2416926|P2|Overall Study|Withdrawal by Subject|0
758109|NCT00474708|2416927|P1|Overall Study|Withdrawal by Subject|7
758110|NCT00474708|2416926|P2|Overall Study|Suicide ideation/behavior|1
758111|NCT00474708|2416927|P1|Overall Study|Suicide ideation/behavior|0
758112|NCT00474708|2416926|P2|Overall Study|Lack of Efficacy|5
758113|NCT00474708|2416927|P1|Overall Study|Lack of Efficacy|11
758114|NCT00474760|2416942|P7|Overall Study|Terminated by sponsor|2
758115|NCT00474760|2416943|P6|Overall Study|Terminated by sponsor|0
758116|NCT00474760|2416944|P5|Overall Study|Terminated by sponsor|0
758117|NCT00474760|2416945|P4|Overall Study|Terminated by sponsor|0
758118|NCT00474760|2416946|P3|Overall Study|Terminated by sponsor|0
758119|NCT00474760|2416947|P2|Overall Study|Terminated by sponsor|0
758120|NCT00474760|2416948|P1|Overall Study|Terminated by sponsor|0
758121|NCT00474760|2416942|P7|Overall Study|Progressive disease|7
758122|NCT00474760|2416943|P6|Overall Study|Progressive disease|20
758123|NCT00474760|2416944|P5|Overall Study|Progressive disease|8
758124|NCT00474760|2416945|P4|Overall Study|Progressive disease|2
758125|NCT00474760|2416946|P3|Overall Study|Progressive disease|3
758126|NCT00474760|2416947|P2|Overall Study|Progressive disease|2
758127|NCT00474760|2416948|P1|Overall Study|Progressive disease|3
758128|NCT00474760|2416942|P7|Overall Study|Unspecified|0
758129|NCT00474760|2416943|P6|Overall Study|Unspecified|0
758130|NCT00474760|2416944|P5|Overall Study|Unspecified|1
758131|NCT00474760|2416945|P4|Overall Study|Unspecified|0
758132|NCT00474760|2416946|P3|Overall Study|Unspecified|0
758133|NCT00474760|2416947|P2|Overall Study|Unspecified|1
758134|NCT00474760|2416948|P1|Overall Study|Unspecified|0
758135|NCT00474760|2416942|P7|Overall Study|Withdrawal by Subject|1
758136|NCT00474760|2416943|P6|Overall Study|Withdrawal by Subject|1
758137|NCT00474760|2416944|P5|Overall Study|Withdrawal by Subject|0
758138|NCT00474760|2416945|P4|Overall Study|Withdrawal by Subject|1
758139|NCT00474760|2416946|P3|Overall Study|Withdrawal by Subject|0
758140|NCT00474760|2416947|P2|Overall Study|Withdrawal by Subject|0
758141|NCT00474760|2416948|P1|Overall Study|Withdrawal by Subject|0
758142|NCT00474760|2416942|P7|Overall Study|Laboratory abnormality|0
758143|NCT00474760|2416943|P6|Overall Study|Laboratory abnormality|1
758144|NCT00474760|2416944|P5|Overall Study|Laboratory abnormality|0
758145|NCT00474760|2416945|P4|Overall Study|Laboratory abnormality|0
758146|NCT00474760|2416946|P3|Overall Study|Laboratory abnormality|0
758147|NCT00474760|2416947|P2|Overall Study|Laboratory abnormality|0
758148|NCT00474760|2416948|P1|Overall Study|Laboratory abnormality|0
758149|NCT00474760|2416942|P7|Overall Study|Adverse Event|0
758150|NCT00474760|2416943|P6|Overall Study|Adverse Event|7
758151|NCT00474760|2416944|P5|Overall Study|Adverse Event|1
758152|NCT00474760|2416945|P4|Overall Study|Adverse Event|0
758153|NCT00474760|2416946|P3|Overall Study|Adverse Event|0
758154|NCT00474760|2416947|P2|Overall Study|Adverse Event|0
758155|NCT00474760|2416948|P1|Overall Study|Adverse Event|0
758156|NCT00474760|2416942|P7|Overall Study|Death|0
758157|NCT00474760|2416943|P6|Overall Study|Death|0
758158|NCT00474760|2416944|P5|Overall Study|Death|2
758159|NCT00474760|2416945|P4|Overall Study|Death|0
758160|NCT00474760|2416946|P3|Overall Study|Death|0
758161|NCT00474760|2416947|P2|Overall Study|Death|0
758162|NCT00474760|2416948|P1|Overall Study|Death|0
758163|NCT00474786|2417055|P2|Overall Study|Not specified|0
758164|NCT00474786|2417056|P1|Overall Study|Not specified|5
758165|NCT00474786|2417055|P2|Overall Study|Withdrawal by Subject|15
758166|NCT00474786|2417056|P1|Overall Study|Withdrawal by Subject|15
758167|NCT00474786|2417055|P2|Overall Study|Protocol Violation|0
758168|NCT00474786|2417056|P1|Overall Study|Protocol Violation|2
758169|NCT00474786|2417055|P2|Overall Study|Lost to Follow-up|7
758170|NCT00474786|2417056|P1|Overall Study|Lost to Follow-up|4
758171|NCT00474786|2417055|P2|Overall Study|Discontinuation of Study by Sponsor|59
758172|NCT00474786|2417056|P1|Overall Study|Discontinuation of Study by Sponsor|42
758173|NCT00474786|2417055|P2|Overall Study|Death|170
758174|NCT00474786|2417056|P1|Overall Study|Death|189
758175|NCT00474786|2417055|P2|Overall Study|Investigator Request|1
758176|NCT00474786|2417056|P1|Overall Study|Investigator Request|2
758177|NCT00474786|2417055|P2|Overall Study|Not Meeting Study Criteria|1
758178|NCT00474786|2417056|P1|Overall Study|Not Meeting Study Criteria|0
758179|NCT00474812|2417074|P1|Overall Study|No Initiation of treatment|2
758180|NCT00474812|2417074|P1|Overall Study|Withdrawal by Subject|5
758181|NCT00474903|2417096|P3|Overall Study|Protocol Violation|2
758182|NCT00474903|2417097|P2|Overall Study|Protocol Violation|5
758183|NCT00474903|2417098|P1|Overall Study|Protocol Violation|1
758184|NCT00474929|2417114|P5|Overall Study|Physician Decision|0
758185|NCT00474929|2417115|P4|Overall Study|Physician Decision|2
758186|NCT00474929|2417116|P3|Overall Study|Physician Decision|1
758187|NCT00474929|2417117|P2|Overall Study|Physician Decision|0
758188|NCT00474929|2417118|P1|Overall Study|Physician Decision|0
758189|NCT00474929|2417114|P5|Overall Study|Unrelated medical condition|0
758190|NCT00474929|2417115|P4|Overall Study|Unrelated medical condition|0
758191|NCT00474929|2417116|P3|Overall Study|Unrelated medical condition|1
758192|NCT00474929|2417117|P2|Overall Study|Unrelated medical condition|0
758193|NCT00474929|2417118|P1|Overall Study|Unrelated medical condition|0
758194|NCT00474929|2417114|P5|Overall Study|Withdrawal by Subject|0
758195|NCT00474929|2417115|P4|Overall Study|Withdrawal by Subject|0
758196|NCT00474929|2417116|P3|Overall Study|Withdrawal by Subject|0
758197|NCT00474929|2417117|P2|Overall Study|Withdrawal by Subject|1
758198|NCT00474929|2417118|P1|Overall Study|Withdrawal by Subject|0
758199|NCT00474955|2417132|P1|Overall Study|Personal reasons|5
758200|NCT00474955|2417132|P1|Overall Study|Drug unavailability|1
758201|NCT00474955|2417132|P1|Overall Study|Adverse Event|2
758202|NCT00474968|2417145|P2|Overall Study|Sample not collected|1
758203|NCT00474968|2417146|P1|Overall Study|Sample not collected|1
758204|NCT00474968|2417145|P2|Overall Study|Protocol Violation|8
758205|NCT00474968|2417146|P1|Overall Study|Protocol Violation|9
758206|NCT00474968|2417145|P2|Overall Study|Withdrawal by Subject|7
758207|NCT00474968|2417146|P1|Overall Study|Withdrawal by Subject|8
758208|NCT00474994|2417156|P1|Overall Study|Patient found to be ineligible|1
758209|NCT00474994|2417156|P1|Overall Study|Patient evaluable for toxicity only|3
758210|NCT00474994|2417156|P1|Overall Study|Patient Not treated|1
758211|NCT00475033|2417162|P2|Toddler Dose|Lost to Follow-up|0
758212|NCT00475033|2417163|P1|Toddler Dose|Lost to Follow-up|1
758213|NCT00475033|2417162|P2|Toddler Dose|Failed to return|0
758214|NCT00475033|2417163|P1|Toddler Dose|Failed to return|1
758215|NCT00475033|2417162|P2|Toddler Dose|Parent or legal guardian request|0
758216|NCT00475033|2417163|P1|Toddler Dose|Parent or legal guardian request|2
758217|NCT00475033|2417162|P2|After the Infant Series|Unspecified|1
758218|NCT00475033|2417163|P1|After the Infant Series|Unspecified|0
758219|NCT00475033|2417162|P2|After the Infant Series|Lost to Follow-up|0
758220|NCT00475033|2417163|P1|After the Infant Series|Lost to Follow-up|1
758221|NCT00475033|2417162|P2|After the Infant Series|Protocol Violation|0
758222|NCT00475033|2417163|P1|After the Infant Series|Protocol Violation|1
758223|NCT00475033|2417162|P2|After the Infant Series|Failed to return|1
758224|NCT00475033|2417163|P1|After the Infant Series|Failed to return|2
758225|NCT00475033|2417162|P2|After the Infant Series|Parent or legal guardian request|2
758226|NCT00475033|2417163|P1|After the Infant Series|Parent or legal guardian request|2
758227|NCT00475033|2417162|P2|After the Infant Series|Adverse Event|4
758228|NCT00475033|2417163|P1|After the Infant Series|Adverse Event|0
758229|NCT00475033|2417162|P2|Infant Series|Adverse Event|2
758230|NCT00475033|2417163|P1|Infant Series|Adverse Event|0
758231|NCT00475033|2417162|P2|Infant Series|Lost to Follow-up|0
758232|NCT00475033|2417163|P1|Infant Series|Lost to Follow-up|2
758233|NCT00475033|2417162|P2|Infant Series|Protocol Violation|2
758234|NCT00475033|2417163|P1|Infant Series|Protocol Violation|1
758235|NCT00475033|2417162|P2|Infant Series|Parent or legal guardian request|5
758236|NCT00475033|2417163|P1|Infant Series|Parent or legal guardian request|1
758237|NCT00475033|2417162|P2|Infant Series|Failed to return|4
758238|NCT00475033|2417163|P1|Infant Series|Failed to return|3
758239|NCT00475176|2417244|P1|Overall Study|Protocol Violation|1
758240|NCT00475176|2417244|P1|Overall Study|Withdrawal by Subject|1
758241|NCT00475176|2417244|P1|Overall Study|Adverse Event|2
758242|NCT00475228|2417251|P2|Overall Study|Lost to Follow-up|17
758243|NCT00475228|2417252|P1|Overall Study|Lost to Follow-up|17
758244|NCT00475306|2417275|P4|Overall Study|Protocol Violation|1
758245|NCT00475306|2417276|P3|Overall Study|Protocol Violation|0
758246|NCT00475306|2417277|P2|Overall Study|Protocol Violation|1
758247|NCT00475306|2417278|P1|Overall Study|Protocol Violation|1
758248|NCT00475423|2417313|P1|Overall Study|Lost to Follow-up|7
758249|NCT00475423|2417313|P1|Overall Study|Reason not specified|1
758250|NCT00475423|2417313|P1|Overall Study|Death|1
758251|NCT00475423|2417313|P1|Overall Study|Lack of Efficacy|8
758252|NCT00475423|2417313|P1|Overall Study|Withdrawal by Subject|6
758253|NCT00475423|2417313|P1|Overall Study|Adverse Event|4
758254|NCT00475423|2417313|P1|Overall Study|Protocol Violation|5
758255|NCT00475657|2417391|P1|Overall Study|Sponsor's Decision|3
758256|NCT00475657|2417391|P1|Overall Study|Death|1
758257|NCT00475670|2417401|P2|Overall Study|Not Specified|3
758258|NCT00475670|2417402|P1|Overall Study|Not Specified|0
758259|NCT00475670|2417401|P2|Overall Study|Failure to Return|1
758260|NCT00475670|2417402|P1|Overall Study|Failure to Return|0
758261|NCT00475670|2417401|P2|Overall Study|Refused treatment|2
758262|NCT00475670|2417402|P1|Overall Study|Refused treatment|0
758263|NCT00475670|2417401|P2|Overall Study|Lack of Efficacy|34
758264|NCT00475670|2417402|P1|Overall Study|Lack of Efficacy|3
758265|NCT00475670|2417401|P2|Overall Study|Death|1
758266|NCT00475670|2417402|P1|Overall Study|Death|0
758267|NCT00475709|2417426|P1|Overall Study|Lost to Follow-up|21
758268|NCT00475709|2417426|P1|Overall Study|Device Explant|6
758269|NCT00475709|2417426|P1|Overall Study|Death|41
758270|NCT00475709|2417426|P1|Overall Study|Did not meet eligibility criteria|8
758271|NCT00475722|2417434|P2|Overall Study|Protocol Violation|0
758272|NCT00475722|2417435|P1|Overall Study|Protocol Violation|3
758273|NCT00475722|2417434|P2|Overall Study|Withdrawal by Subject|12
758274|NCT00475722|2417435|P1|Overall Study|Withdrawal by Subject|12
758275|NCT00475735|2417447|P6|Treatment Period 2|Withdrawal by Subject|0
758276|NCT00475735|2417448|P5|Treatment Period 2|Withdrawal by Subject|1
758277|NCT00475735|2417449|P4|Treatment Period 2|Withdrawal by Subject|0
758278|NCT00475735|2417450|P3|Treatment Period 2|Withdrawal by Subject|0
758279|NCT00475735|2417451|P2|Treatment Period 2|Withdrawal by Subject|0
758280|NCT00475735|2417452|P1|Treatment Period 2|Withdrawal by Subject|0
758281|NCT00475735|2417447|P6|Treatment Period 2|Lack of Efficacy|1
758282|NCT00475735|2417448|P5|Treatment Period 2|Lack of Efficacy|0
758283|NCT00475735|2417449|P4|Treatment Period 2|Lack of Efficacy|0
758284|NCT00475735|2417450|P3|Treatment Period 2|Lack of Efficacy|0
758285|NCT00475735|2417451|P2|Treatment Period 2|Lack of Efficacy|0
758286|NCT00475735|2417452|P1|Treatment Period 2|Lack of Efficacy|0
758287|NCT00475735|2417447|P6|Treatment Period 2|Adverse Event|0
758288|NCT00475735|2417448|P5|Treatment Period 2|Adverse Event|0
758289|NCT00475735|2417449|P4|Treatment Period 2|Adverse Event|2
758290|NCT00475735|2417450|P3|Treatment Period 2|Adverse Event|0
758291|NCT00475735|2417451|P2|Treatment Period 2|Adverse Event|1
758292|NCT00475735|2417452|P1|Treatment Period 2|Adverse Event|0
758293|NCT00475735|2417447|P6|Treatment Washout|Protocol Violation|0
758294|NCT00475735|2417448|P5|Treatment Washout|Protocol Violation|0
758295|NCT00475735|2417449|P4|Treatment Washout|Protocol Violation|0
758296|NCT00475735|2417450|P3|Treatment Washout|Protocol Violation|0
758297|NCT00475735|2417451|P2|Treatment Washout|Protocol Violation|1
758298|NCT00475735|2417452|P1|Treatment Washout|Protocol Violation|0
758299|NCT00475735|2417447|P6|Treatment Washout|Lost to Follow-up|0
758300|NCT00475735|2417448|P5|Treatment Washout|Lost to Follow-up|0
758301|NCT00475735|2417449|P4|Treatment Washout|Lost to Follow-up|0
758302|NCT00475735|2417450|P3|Treatment Washout|Lost to Follow-up|0
758303|NCT00475735|2417451|P2|Treatment Washout|Lost to Follow-up|1
758304|NCT00475735|2417452|P1|Treatment Washout|Lost to Follow-up|0
758305|NCT00475735|2417447|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
758306|NCT00475735|2417448|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
758307|NCT00475735|2417449|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
758308|NCT00475735|2417450|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
758309|NCT00475735|2417451|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
758310|NCT00475735|2417452|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
758311|NCT00475735|2417447|P6|Treatment Period 1|DC due to AE but continuing|2
758312|NCT00475735|2417448|P5|Treatment Period 1|DC due to AE but continuing|2
758313|NCT00475735|2417449|P4|Treatment Period 1|DC due to AE but continuing|1
758314|NCT00475735|2417450|P3|Treatment Period 1|DC due to AE but continuing|0
758315|NCT00475735|2417451|P2|Treatment Period 1|DC due to AE but continuing|0
758316|NCT00475735|2417452|P1|Treatment Period 1|DC due to AE but continuing|0
758317|NCT00475735|2417447|P6|Treatment Period 1|Withdrawal by Subject|0
758318|NCT00475735|2417448|P5|Treatment Period 1|Withdrawal by Subject|0
758319|NCT00475735|2417449|P4|Treatment Period 1|Withdrawal by Subject|0
758320|NCT00475735|2417450|P3|Treatment Period 1|Withdrawal by Subject|0
758321|NCT00475735|2417451|P2|Treatment Period 1|Withdrawal by Subject|1
758322|NCT00475735|2417452|P1|Treatment Period 1|Withdrawal by Subject|1
758323|NCT00475735|2417447|P6|Treatment Period 1|Protocol Violation|0
758324|NCT00475735|2417448|P5|Treatment Period 1|Protocol Violation|0
758325|NCT00475735|2417449|P4|Treatment Period 1|Protocol Violation|1
758326|NCT00475735|2417450|P3|Treatment Period 1|Protocol Violation|0
758327|NCT00475735|2417451|P2|Treatment Period 1|Protocol Violation|0
758328|NCT00475735|2417452|P1|Treatment Period 1|Protocol Violation|0
758329|NCT00475735|2417447|P6|Treatment Period 1|Lost to Follow-up|1
758330|NCT00475735|2417448|P5|Treatment Period 1|Lost to Follow-up|0
758331|NCT00475735|2417449|P4|Treatment Period 1|Lost to Follow-up|0
758332|NCT00475735|2417450|P3|Treatment Period 1|Lost to Follow-up|0
758333|NCT00475735|2417451|P2|Treatment Period 1|Lost to Follow-up|0
758334|NCT00475735|2417452|P1|Treatment Period 1|Lost to Follow-up|0
758335|NCT00475735|2417447|P6|Treatment Period 1|Lack of Efficacy|0
758336|NCT00475735|2417448|P5|Treatment Period 1|Lack of Efficacy|0
758337|NCT00475735|2417449|P4|Treatment Period 1|Lack of Efficacy|0
758338|NCT00475735|2417450|P3|Treatment Period 1|Lack of Efficacy|0
758339|NCT00475735|2417451|P2|Treatment Period 1|Lack of Efficacy|0
758340|NCT00475735|2417452|P1|Treatment Period 1|Lack of Efficacy|1
758341|NCT00475735|2417447|P6|Treatment Period 1|Adverse Event|0
758342|NCT00475735|2417448|P5|Treatment Period 1|Adverse Event|0
758343|NCT00475735|2417449|P4|Treatment Period 1|Adverse Event|0
758344|NCT00475735|2417450|P3|Treatment Period 1|Adverse Event|0
758345|NCT00475735|2417451|P2|Treatment Period 1|Adverse Event|0
758346|NCT00475735|2417452|P1|Treatment Period 1|Adverse Event|2
758347|NCT00475852|2417482|P2|Overall Study|Lost to Follow-up|68
758348|NCT00475852|2417483|P1|Overall Study|Lost to Follow-up|54
758349|NCT00475852|2417482|P2|Overall Study|Withdrawal by Subject|24
758350|NCT00475852|2417483|P1|Overall Study|Withdrawal by Subject|19
758351|NCT00475852|2417482|P2|Overall Study|Death|456
758352|NCT00475852|2417483|P1|Overall Study|Death|444
758353|NCT00475865|2417514|P3|Overall Study|Other than above|0
758354|NCT00475865|2417515|P2|Overall Study|Other than above|1
758355|NCT00475865|2417516|P1|Overall Study|Other than above|0
758356|NCT00475865|2417514|P3|Overall Study|Participant did not wish to continue|0
758357|NCT00475865|2417515|P2|Overall Study|Participant did not wish to continue|0
758358|NCT00475865|2417516|P1|Overall Study|Participant did not wish to continue|1
758359|NCT00475865|2417514|P3|Overall Study|Progressive disease|2
758360|NCT00475865|2417515|P2|Overall Study|Progressive disease|1
758361|NCT00475865|2417516|P1|Overall Study|Progressive disease|0
758362|NCT00475865|2417514|P3|Overall Study|Lack of Efficacy|0
758363|NCT00475865|2417515|P2|Overall Study|Lack of Efficacy|0
758364|NCT00475865|2417516|P1|Overall Study|Lack of Efficacy|1
758365|NCT00475865|2417514|P3|Overall Study|Adverse Event|4
758366|NCT00475865|2417515|P2|Overall Study|Adverse Event|3
758367|NCT00475865|2417516|P1|Overall Study|Adverse Event|0
758368|NCT00476008|2417573|P2|Overall Study|Death|0
758369|NCT00476008|2417574|P1|Overall Study|Death|1
758370|NCT00476008|2417573|P2|Overall Study|Withdrawal by Subject|1
758371|NCT00476008|2417574|P1|Overall Study|Withdrawal by Subject|0
758372|NCT00476008|2417573|P2|Overall Study|Physician Decision: Medication Noncompli|1
758373|NCT00476008|2417574|P1|Overall Study|Physician Decision: Medication Noncompli|2
758374|NCT00476008|2417573|P2|Overall Study|Placebo concerns|2
758375|NCT00476008|2417574|P1|Overall Study|Placebo concerns|2
758376|NCT00476008|2417573|P2|Overall Study|Adverse Event|4
758377|NCT00476008|2417574|P1|Overall Study|Adverse Event|4
758378|NCT00476086|2417615|P1|Overall Study|Progressive Disease|4
758379|NCT00476086|2417615|P1|Overall Study|Alternative therapy|1
758380|NCT00476151|2417623|P2|Overall Study|Physician Decision|2
758381|NCT00476151|2417624|P1|Overall Study|Physician Decision|0
758382|NCT00476151|2417623|P2|Overall Study|Withdrawal by Subject|0
758383|NCT00476151|2417624|P1|Overall Study|Withdrawal by Subject|2
758384|NCT00476151|2417623|P2|Overall Study|Protocol Violation|3
758385|NCT00476151|2417624|P1|Overall Study|Protocol Violation|1
758386|NCT00476151|2417623|P2|Overall Study|Adverse Event|2
758387|NCT00476151|2417624|P1|Overall Study|Adverse Event|0
758388|NCT00476229|2417630|P1|Overall Study|Progressive shortness of breath|1
758389|NCT00476476|2417647|P2|Overall Study|Progressive Disease|17
758390|NCT00476476|2417648|P1|Overall Study|Progressive Disease|0
758391|NCT00476476|2417647|P2|Overall Study|Adverse Event|7
758392|NCT00476476|2417648|P1|Overall Study|Adverse Event|2
758393|NCT00476593|2417657|P4|Overall Study|Lost to Follow-up|22
758394|NCT00476593|2417658|P3|Overall Study|Lost to Follow-up|8
758395|NCT00476593|2417659|P2|Overall Study|Lost to Follow-up|2
758396|NCT00476593|2417660|P1|Overall Study|Lost to Follow-up|10
758397|NCT00476957|2417724|P2|Overall Study|Lost to Follow-up|193
758398|NCT00476957|2417725|P1|Overall Study|Lost to Follow-up|176
758399|NCT00469833|2417733|P1|Overall Study|No IV access|2
758400|NCT00469859|2417745|P2|Overall Study|Inevaluable|2
758401|NCT00469859|2417746|P1|Overall Study|Inevaluable|0
758402|NCT00469898|2417754|P1|Overall Study|Decreased performance status|1
758403|NCT00469898|2417754|P1|Overall Study|Disease progression|9
758404|NCT00469898|2417754|P1|Overall Study|Death|4
758405|NCT00469898|2417754|P1|Overall Study|Withdrawal by Subject|4
758406|NCT00469898|2417754|P1|Overall Study|Adverse Event|7
758407|NCT00477152|2417761|P1|Overall Study|Adverse Event|1
758408|NCT00477152|2417761|P1|Overall Study|Parent withdrew consent|2
758409|NCT00477165|2417770|P2|Overall Study|Adverse Event|2
758410|NCT00477165|2417771|P1|Overall Study|Adverse Event|7
758411|NCT00477269|2417810|P3|Open Label Extension|Death|4
758412|NCT00477269|2417811|P2|Open Label Extension|Death|0
758413|NCT00477269|2417812|P1|Open Label Extension|Death|0
758414|NCT00477269|2417810|P3|Open Label Extension|Adminiatrative problems|2
758415|NCT00477269|2417811|P2|Open Label Extension|Adminiatrative problems|0
758416|NCT00477269|2417812|P1|Open Label Extension|Adminiatrative problems|0
758417|NCT00477269|2417810|P3|Open Label Extension|unsatisfactory therapeutic effects|2
758418|NCT00477269|2417811|P2|Open Label Extension|unsatisfactory therapeutic effects|0
758419|NCT00477269|2417812|P1|Open Label Extension|unsatisfactory therapeutic effects|0
758420|NCT00477269|2417810|P3|Open Label Extension|Abnormal laboratory values|1
758421|NCT00477269|2417811|P2|Open Label Extension|Abnormal laboratory values|0
758422|NCT00477269|2417812|P1|Open Label Extension|Abnormal laboratory values|0
758423|NCT00477269|2417810|P3|Open Label Extension|Adverse Event|4
758424|NCT00477269|2417811|P2|Open Label Extension|Adverse Event|0
758425|NCT00477269|2417812|P1|Open Label Extension|Adverse Event|0
758426|NCT00477269|2417810|P3|Core Study|Withdrawn Consent|0
758427|NCT00477269|2417811|P2|Core Study|Withdrawn Consent|1
758428|NCT00477269|2417812|P1|Core Study|Withdrawn Consent|0
758429|NCT00477269|2417810|P3|Core Study|Death|0
758430|NCT00477269|2417811|P2|Core Study|Death|3
758431|NCT00477269|2417812|P1|Core Study|Death|3
758432|NCT00477269|2417810|P3|Core Study|Adverse Event|0
758433|NCT00477269|2417811|P2|Core Study|Adverse Event|4
758434|NCT00477269|2417812|P1|Core Study|Adverse Event|6
758435|NCT00477295|2417866|P2|Overall Study|Not specified|3
758436|NCT00477295|2417867|P1|Overall Study|Not specified|4
758437|NCT00477295|2417866|P2|Overall Study|Lost to Follow-up|11
758438|NCT00477295|2417867|P1|Overall Study|Lost to Follow-up|21
758439|NCT00477295|2417866|P2|Overall Study|Physician Decision|5
758440|NCT00477295|2417867|P1|Overall Study|Physician Decision|4
758441|NCT00477295|2417866|P2|Overall Study|Protocol Violation|8
758442|NCT00477295|2417867|P1|Overall Study|Protocol Violation|3
758443|NCT00477295|2417866|P2|Overall Study|Lack of Efficacy|23
758444|NCT00477295|2417867|P1|Overall Study|Lack of Efficacy|23
758445|NCT00477295|2417866|P2|Overall Study|Withdrawal by Subject|24
758446|NCT00477295|2417867|P1|Overall Study|Withdrawal by Subject|35
758447|NCT00477295|2417866|P2|Overall Study|Adverse Event|35
758448|NCT00477295|2417867|P1|Overall Study|Adverse Event|31
758449|NCT00477594|2417895|P2|Follow-up Period|Other|0
758450|NCT00477594|2417896|P1|Follow-up Period|Other|1
758451|NCT00477594|2417895|P2|Follow-up Period|Withdrawal by Subject|1
758452|NCT00477594|2417896|P1|Follow-up Period|Withdrawal by Subject|2
758453|NCT00477594|2417895|P2|Year 3|Withdrawal by Subject|0
758454|NCT00477594|2417896|P1|Year 3|Withdrawal by Subject|1
758455|NCT00477594|2417895|P2|Year 3|Adverse Event|0
758456|NCT00477594|2417896|P1|Year 3|Adverse Event|1
758457|NCT00477594|2417895|P2|Year 1 and Year 2|Other|0
758458|NCT00477594|2417896|P1|Year 1 and Year 2|Other|1
758459|NCT00477594|2417895|P2|Year 1 and Year 2|Withdrawal by Subject|1
758460|NCT00477594|2417896|P1|Year 1 and Year 2|Withdrawal by Subject|2
758461|NCT00477594|2417895|P2|Year 1 and Year 2|Physician Decision|1
758462|NCT00477594|2417896|P1|Year 1 and Year 2|Physician Decision|2
758463|NCT00477594|2417895|P2|Year 1 and Year 2|Adverse Event|2
758464|NCT00477594|2417896|P1|Year 1 and Year 2|Adverse Event|4
758465|NCT00477607|2417954|P2|Overall Study|Lost to Follow-up|7
758466|NCT00477607|2417955|P1|Overall Study|Lost to Follow-up|7
758467|NCT00477633|2417965|P1|Overall Study|Various (Moving, Enrollment closed)|75
758468|NCT00477633|2417965|P1|Overall Study|Protocol Violation|25
758469|NCT00477633|2417965|P1|Overall Study|Withdrawal by Subject|149
758470|NCT00477633|2417965|P1|Overall Study|Lost to Follow-up|271
758471|NCT00477633|2417965|P1|Overall Study|Pregnancy|23
758472|NCT00477633|2417965|P1|Overall Study|Adverse Event|143
758473|NCT00477633|2417965|P1|Overall Study|Did not receive treatment|23
758474|NCT00477672|2417974|P3|Overall Study|Discretion of Sponsor|0
758475|NCT00477672|2417975|P2|Overall Study|Discretion of Sponsor|2
758476|NCT00477672|2417976|P1|Overall Study|Discretion of Sponsor|1
758477|NCT00477672|2417974|P3|Overall Study|Consent withdrawn|10
758478|NCT00477672|2417975|P2|Overall Study|Consent withdrawn|5
758479|NCT00477672|2417976|P1|Overall Study|Consent withdrawn|2
758480|NCT00477672|2417974|P3|Overall Study|Protocol noncompliance|0
758481|NCT00477672|2417975|P2|Overall Study|Protocol noncompliance|2
758482|NCT00477672|2417976|P1|Overall Study|Protocol noncompliance|0
758483|NCT00477672|2417974|P3|Overall Study|Physician Decision|0
758484|NCT00477672|2417975|P2|Overall Study|Physician Decision|0
758485|NCT00477672|2417976|P1|Overall Study|Physician Decision|1
758486|NCT00477672|2417974|P3|Overall Study|Disease progression|0
758487|NCT00477672|2417975|P2|Overall Study|Disease progression|1
758488|NCT00477672|2417976|P1|Overall Study|Disease progression|0
758489|NCT00477672|2417974|P3|Overall Study|Death|0
758490|NCT00477672|2417975|P2|Overall Study|Death|1
758491|NCT00477672|2417976|P1|Overall Study|Death|0
758492|NCT00477672|2417974|P3|Overall Study|Adverse Event|6
758493|NCT00477672|2417975|P2|Overall Study|Adverse Event|5
758494|NCT00477672|2417976|P1|Overall Study|Adverse Event|3
758495|NCT00477750|2417992|P1|Overall Study|Currently Receiving Treatment|11
758496|NCT00477971|2417998|P2|Overall Study|Alternative treatment|1
758497|NCT00477971|2417999|P1|Overall Study|Alternative treatment|3
758498|NCT00477971|2417998|P2|Overall Study|Death|4
758499|NCT00477971|2417999|P1|Overall Study|Death|2
758500|NCT00477971|2417998|P2|Overall Study|Adverse Event|0
758501|NCT00477971|2417999|P1|Overall Study|Adverse Event|3
758502|NCT00477971|2417998|P2|Overall Study|Withdrawal by Subject|1
758503|NCT00477971|2417999|P1|Overall Study|Withdrawal by Subject|3
758504|NCT00477971|2417998|P2|Overall Study|Disease progression|0
758505|NCT00477971|2417999|P1|Overall Study|Disease progression|6
758506|NCT00478023|2418016|P5|Overall Study|Lack of pain, Technical difficulties|3
758507|NCT00478023|2418017|P4|Overall Study|Lack of pain, Technical difficulties|6
758508|NCT00478023|2418018|P3|Overall Study|Lack of pain, Technical difficulties|5
758509|NCT00478023|2418019|P2|Overall Study|Lack of pain, Technical difficulties|3
758510|NCT00478023|2418020|P1|Overall Study|Lack of pain, Technical difficulties|7
758511|NCT00478023|2418016|P5|Overall Study|Withdrawal by Subject|5
758512|NCT00478023|2418017|P4|Overall Study|Withdrawal by Subject|4
758513|NCT00478023|2418018|P3|Overall Study|Withdrawal by Subject|2
758514|NCT00478023|2418019|P2|Overall Study|Withdrawal by Subject|3
758515|NCT00478023|2418020|P1|Overall Study|Withdrawal by Subject|2
758516|NCT00478023|2418016|P5|Overall Study|Lost to Follow-up|0
758517|NCT00478023|2418017|P4|Overall Study|Lost to Follow-up|1
758518|NCT00478023|2418018|P3|Overall Study|Lost to Follow-up|1
758519|NCT00478023|2418019|P2|Overall Study|Lost to Follow-up|1
758520|NCT00478023|2418020|P1|Overall Study|Lost to Follow-up|3
758521|NCT00478023|2418016|P5|Overall Study|Lack of Efficacy|41
758522|NCT00478023|2418017|P4|Overall Study|Lack of Efficacy|5
758523|NCT00478023|2418018|P3|Overall Study|Lack of Efficacy|4
758524|NCT00478023|2418019|P2|Overall Study|Lack of Efficacy|10
758525|NCT00478023|2418020|P1|Overall Study|Lack of Efficacy|11
758526|NCT00478023|2418016|P5|Overall Study|Death|0
758527|NCT00478023|2418017|P4|Overall Study|Death|0
758528|NCT00478023|2418018|P3|Overall Study|Death|0
758529|NCT00478023|2418019|P2|Overall Study|Death|0
758530|NCT00478023|2418020|P1|Overall Study|Death|1
758531|NCT00478023|2418016|P5|Overall Study|Adverse Event|6
758532|NCT00478023|2418017|P4|Overall Study|Adverse Event|14
758533|NCT00478023|2418018|P3|Overall Study|Adverse Event|8
758534|NCT00478023|2418019|P2|Overall Study|Adverse Event|7
758535|NCT00478023|2418020|P1|Overall Study|Adverse Event|11
758536|NCT00478140|2418050|P1|Overall Study|Disease Progression|3
758537|NCT00478205|2418088|P2|Overall Study|Not specified|12
758538|NCT00478205|2418089|P1|Overall Study|Not specified|24
758539|NCT00478205|2418088|P2|Overall Study|Lack of Efficacy|0
758540|NCT00478205|2418089|P1|Overall Study|Lack of Efficacy|1
758541|NCT00478205|2418088|P2|Overall Study|Withdrawal by Subject|22
758542|NCT00478205|2418089|P1|Overall Study|Withdrawal by Subject|61
758543|NCT00478205|2418088|P2|Overall Study|Request of Investigator or Sponsor|5
758544|NCT00478205|2418089|P1|Overall Study|Request of Investigator or Sponsor|4
758545|NCT00478205|2418088|P2|Overall Study|Protocol Violation|5
758546|NCT00478205|2418089|P1|Overall Study|Protocol Violation|15
758547|NCT00478205|2418088|P2|Overall Study|Medication Non-compliance|4
758548|NCT00478205|2418089|P1|Overall Study|Medication Non-compliance|9
758549|NCT00478205|2418088|P2|Overall Study|Adverse Event|39
758550|NCT00478205|2418089|P1|Overall Study|Adverse Event|182
758551|NCT00478231|2418116|P1|Overall Study|Randomized, not treated|3
758552|NCT00478231|2418116|P1|Overall Study|Adverse Event|5
758553|NCT00478231|2418116|P1|Overall Study|Unspecified|9
758554|NCT00478231|2418116|P1|Overall Study|Withdrawal by Subject|6
758555|NCT00478231|2418116|P1|Overall Study|Lost to Follow-up|7
758556|NCT00478231|2418116|P1|Overall Study|Lack of Efficacy|47
758557|NCT00478231|2418116|P1|Overall Study|Death|7
758558|NCT00478244|2418135|P1|Overall Study|Did not receive transplant|1
758559|NCT00478257|2418150|P2|Overall Study|Withdrawal by Subject|3
758560|NCT00478257|2418151|P1|Overall Study|Withdrawal by Subject|8
758561|NCT00478608|2418182|P1|Overall Study|Protocol Violation|3
758562|NCT00478608|2418182|P1|Overall Study|Withdrawal by Subject|2
758563|NCT00478608|2418182|P1|Overall Study|Serious Adverse Event|14
758564|NCT00478608|2418182|P1|Overall Study|Adverse Event|1
758565|NCT00478647|2418190|P1|Overall Study|Withdrawal by Subject|1
758566|NCT00478647|2418190|P1|Overall Study|Adverse Event|1
758567|NCT00478673|2418198|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
758568|NCT00478673|2418198|P1|12-Months Post-Procedure|Missed Visit|25
758569|NCT00478673|2418198|P1|12-Months Post-Procedure|Withdrawal by Subject|6
758570|NCT00478673|2418198|P1|12-Months Post-Procedure|Lost to Follow-up|4
758571|NCT00478673|2418198|P1|12-Months Post-Procedure|Death|23
758572|NCT00478673|2418198|P1|30-Days Post-Procedure|Missed Visit|7
758573|NCT00478673|2418198|P1|30-Days Post-Procedure|Withdrawal by Subject|1
758574|NCT00478673|2418198|P1|30-Days Post-Procedure|Death|2
758575|NCT00478777|2418203|P1|Overall Study|Not treated with lenalidomide|6
758576|NCT00478777|2418203|P1|Overall Study|End of therapy|2
758577|NCT00478777|2418203|P1|Overall Study|Lymphocytes infusion|1
758578|NCT00478777|2418203|P1|Overall Study|Lack of compliance|1
758579|NCT00478777|2418203|P1|Overall Study|Intolerance of therapy|1
758580|NCT00478777|2418203|P1|Overall Study|Physician Decision|1
758581|NCT00478777|2418203|P1|Overall Study|Lost to Follow-up|3
758582|NCT00478777|2418203|P1|Overall Study|Protocol Violation|3
758583|NCT00478777|2418203|P1|Overall Study|Death|3
758584|NCT00478777|2418203|P1|Overall Study|Withdrawal by Subject|4
758585|NCT00478777|2418203|P1|Overall Study|Lack of Efficacy|23
758586|NCT00478777|2418203|P1|Overall Study|Adverse Event|29
758587|NCT00478881|2418212|P2|Overall Study|Non-Compliance with Study Medication|2
758588|NCT00478881|2418213|P1|Overall Study|Non-Compliance with Study Medication|0
758589|NCT00478881|2418212|P2|Overall Study|Withdrawal by Subject|2
758590|NCT00478881|2418213|P1|Overall Study|Withdrawal by Subject|6
758591|NCT00478881|2418212|P2|Overall Study|Protocol Violation|2
758592|NCT00478881|2418213|P1|Overall Study|Protocol Violation|2
758593|NCT00478881|2418212|P2|Overall Study|Lost to Follow-up|1
758594|NCT00478881|2418213|P1|Overall Study|Lost to Follow-up|0
758595|NCT00478881|2418212|P2|Overall Study|Lack of Efficacy|3
758596|NCT00478881|2418213|P1|Overall Study|Lack of Efficacy|0
758597|NCT00478881|2418212|P2|Overall Study|Adverse Event|12
758598|NCT00478881|2418213|P1|Overall Study|Adverse Event|31
758599|NCT00479232|2418274|P6|Overall Study|Withdrew Consent|3
758600|NCT00479232|2418275|P5|Overall Study|Withdrew Consent|1
758601|NCT00479232|2418276|P4|Overall Study|Withdrew Consent|0
758602|NCT00479232|2418277|P3|Overall Study|Withdrew Consent|6
758603|NCT00479232|2418278|P2|Overall Study|Withdrew Consent|2
758604|NCT00479232|2418279|P1|Overall Study|Withdrew Consent|0
758605|NCT00479232|2418274|P6|Overall Study|Progressive Disease|12
758606|NCT00479232|2418275|P5|Overall Study|Progressive Disease|3
758607|NCT00479232|2418276|P4|Overall Study|Progressive Disease|3
758608|NCT00479232|2418277|P3|Overall Study|Progressive Disease|12
758609|NCT00479232|2418278|P2|Overall Study|Progressive Disease|1
758610|NCT00479232|2418279|P1|Overall Study|Progressive Disease|3
758611|NCT00479232|2418274|P6|Overall Study|Physician Decision|1
758612|NCT00479232|2418275|P5|Overall Study|Physician Decision|0
758613|NCT00479232|2418276|P4|Overall Study|Physician Decision|0
758614|NCT00479232|2418277|P3|Overall Study|Physician Decision|2
758615|NCT00479232|2418278|P2|Overall Study|Physician Decision|0
758616|NCT00479232|2418279|P1|Overall Study|Physician Decision|0
758617|NCT00479232|2418274|P6|Overall Study|Lack of Efficacy|4
758618|NCT00479232|2418275|P5|Overall Study|Lack of Efficacy|0
758619|NCT00479232|2418276|P4|Overall Study|Lack of Efficacy|0
758620|NCT00479232|2418277|P3|Overall Study|Lack of Efficacy|2
758621|NCT00479232|2418278|P2|Overall Study|Lack of Efficacy|0
758622|NCT00479232|2418279|P1|Overall Study|Lack of Efficacy|0
758623|NCT00479232|2418274|P6|Overall Study|Deviation from Protocol|0
758624|NCT00479232|2418275|P5|Overall Study|Deviation from Protocol|0
758625|NCT00479232|2418276|P4|Overall Study|Deviation from Protocol|0
758626|NCT00479232|2418277|P3|Overall Study|Deviation from Protocol|1
758627|NCT00479232|2418278|P2|Overall Study|Deviation from Protocol|0
758628|NCT00479232|2418279|P1|Overall Study|Deviation from Protocol|0
758629|NCT00479232|2418274|P6|Overall Study|Adverse Event|10
758630|NCT00479232|2418275|P5|Overall Study|Adverse Event|0
758631|NCT00479232|2418276|P4|Overall Study|Adverse Event|0
758632|NCT00479232|2418277|P3|Overall Study|Adverse Event|5
758633|NCT00479232|2418278|P2|Overall Study|Adverse Event|0
758634|NCT00479232|2418279|P1|Overall Study|Adverse Event|0
758635|NCT00479336|2418308|P4|Overall Study|Resolution of all hepatic edema findings|0
758636|NCT00479336|2418309|P3|Overall Study|Resolution of all hepatic edema findings|0
758637|NCT00479336|2418310|P2|Overall Study|Resolution of all hepatic edema findings|1
758638|NCT00479336|2418311|P1|Overall Study|Resolution of all hepatic edema findings|1
758639|NCT00479336|2418308|P4|Overall Study|Physician Decision|2
758640|NCT00479336|2418309|P3|Overall Study|Physician Decision|0
758641|NCT00479336|2418310|P2|Overall Study|Physician Decision|1
758642|NCT00479336|2418311|P1|Overall Study|Physician Decision|0
758643|NCT00479336|2418308|P4|Overall Study|Withdrawal by Subject|0
758644|NCT00479336|2418309|P3|Overall Study|Withdrawal by Subject|0
758645|NCT00479336|2418310|P2|Overall Study|Withdrawal by Subject|2
758646|NCT00479336|2418311|P1|Overall Study|Withdrawal by Subject|1
758647|NCT00479336|2418308|P4|Overall Study|Protocol Violation|0
758648|NCT00479336|2418309|P3|Overall Study|Protocol Violation|0
758649|NCT00479336|2418310|P2|Overall Study|Protocol Violation|1
758650|NCT00479336|2418311|P1|Overall Study|Protocol Violation|0
758651|NCT00479336|2418308|P4|Overall Study|Lack of Efficacy|0
758652|NCT00479336|2418309|P3|Overall Study|Lack of Efficacy|0
758653|NCT00479336|2418310|P2|Overall Study|Lack of Efficacy|0
758654|NCT00479336|2418311|P1|Overall Study|Lack of Efficacy|1
758655|NCT00479336|2418308|P4|Overall Study|Adverse Event|3
758656|NCT00479336|2418309|P3|Overall Study|Adverse Event|1
758657|NCT00479336|2418310|P2|Overall Study|Adverse Event|1
758658|NCT00479336|2418311|P1|Overall Study|Adverse Event|1
758659|NCT00479388|2418327|P2|Overall Study|Withdrawal by Subject|17
758660|NCT00479388|2418328|P1|Overall Study|Withdrawal by Subject|32
758661|NCT00479388|2418327|P2|Overall Study|Protocol Violation|9
758662|NCT00479388|2418328|P1|Overall Study|Protocol Violation|10
758663|NCT00479388|2418327|P2|Overall Study|Lost to Follow-up|2
758664|NCT00479388|2418328|P1|Overall Study|Lost to Follow-up|0
758665|NCT00479388|2418327|P2|Overall Study|Adverse Event|45
758666|NCT00479388|2418328|P1|Overall Study|Adverse Event|90
758667|NCT00479401|2418341|P3|Overall Study|Exclusion criteria, relocation|0
758668|NCT00479401|2418342|P2|Overall Study|Exclusion criteria, relocation|3
758669|NCT00479401|2418343|P1|Overall Study|Exclusion criteria, relocation|4
758670|NCT00479401|2418341|P3|Overall Study|Withdrawal by Subject|2
758671|NCT00479401|2418342|P2|Overall Study|Withdrawal by Subject|10
758672|NCT00479401|2418343|P1|Overall Study|Withdrawal by Subject|16
758673|NCT00479401|2418341|P3|Overall Study|Lost to Follow-up|1
758674|NCT00479401|2418342|P2|Overall Study|Lost to Follow-up|1
758675|NCT00479401|2418343|P1|Overall Study|Lost to Follow-up|1
758676|NCT00479401|2418341|P3|Overall Study|Protocol Violation|1
758677|NCT00479401|2418342|P2|Overall Study|Protocol Violation|1
758678|NCT00479401|2418343|P1|Overall Study|Protocol Violation|2
758679|NCT00479401|2418341|P3|Overall Study|Lack of Efficacy|4
758680|NCT00479401|2418342|P2|Overall Study|Lack of Efficacy|2
758681|NCT00479401|2418343|P1|Overall Study|Lack of Efficacy|2
758682|NCT00479401|2418341|P3|Overall Study|Adverse Event|4
758683|NCT00479401|2418342|P2|Overall Study|Adverse Event|20
758684|NCT00479401|2418343|P1|Overall Study|Adverse Event|24
758685|NCT00479466|2418402|P6|Overall Study|Withdrawal by Subject|1
758686|NCT00479466|2418403|P5|Overall Study|Withdrawal by Subject|3
758687|NCT00479466|2418404|P4|Overall Study|Withdrawal by Subject|2
758688|NCT00479466|2418405|P3|Overall Study|Withdrawal by Subject|0
758689|NCT00479466|2418406|P2|Overall Study|Withdrawal by Subject|5
758690|NCT00479466|2418407|P1|Overall Study|Withdrawal by Subject|3
758691|NCT00479466|2418402|P6|Overall Study|Protocol Violation|0
758692|NCT00479466|2418403|P5|Overall Study|Protocol Violation|0
758693|NCT00479466|2418404|P4|Overall Study|Protocol Violation|0
758694|NCT00479466|2418405|P3|Overall Study|Protocol Violation|0
758695|NCT00479466|2418406|P2|Overall Study|Protocol Violation|0
758696|NCT00479466|2418407|P1|Overall Study|Protocol Violation|1
758697|NCT00479466|2418402|P6|Overall Study|Pregnancy|0
758698|NCT00479466|2418403|P5|Overall Study|Pregnancy|1
758699|NCT00479466|2418404|P4|Overall Study|Pregnancy|0
758700|NCT00479466|2418405|P3|Overall Study|Pregnancy|0
758701|NCT00479466|2418406|P2|Overall Study|Pregnancy|0
758702|NCT00479466|2418407|P1|Overall Study|Pregnancy|0
758703|NCT00479466|2418402|P6|Overall Study|Physician Decision|0
758704|NCT00479466|2418403|P5|Overall Study|Physician Decision|0
758705|NCT00479466|2418404|P4|Overall Study|Physician Decision|0
758706|NCT00479466|2418405|P3|Overall Study|Physician Decision|1
758707|NCT00479466|2418406|P2|Overall Study|Physician Decision|1
758708|NCT00479466|2418407|P1|Overall Study|Physician Decision|2
758709|NCT00479466|2418402|P6|Overall Study|Lost to Follow-up|2
758710|NCT00479466|2418403|P5|Overall Study|Lost to Follow-up|2
758711|NCT00479466|2418404|P4|Overall Study|Lost to Follow-up|0
758712|NCT00479466|2418405|P3|Overall Study|Lost to Follow-up|1
758713|NCT00479466|2418406|P2|Overall Study|Lost to Follow-up|1
758714|NCT00479466|2418407|P1|Overall Study|Lost to Follow-up|0
758715|NCT00479466|2418402|P6|Overall Study|Lack of Efficacy|0
758716|NCT00479466|2418403|P5|Overall Study|Lack of Efficacy|0
758717|NCT00479466|2418404|P4|Overall Study|Lack of Efficacy|0
758718|NCT00479466|2418405|P3|Overall Study|Lack of Efficacy|1
758719|NCT00479466|2418406|P2|Overall Study|Lack of Efficacy|0
758720|NCT00479466|2418407|P1|Overall Study|Lack of Efficacy|2
758721|NCT00479466|2418402|P6|Overall Study|Hyperglycemia|1
758722|NCT00479466|2418403|P5|Overall Study|Hyperglycemia|0
758723|NCT00479466|2418404|P4|Overall Study|Hyperglycemia|0
758724|NCT00479466|2418405|P3|Overall Study|Hyperglycemia|0
758725|NCT00479466|2418406|P2|Overall Study|Hyperglycemia|0
758726|NCT00479466|2418407|P1|Overall Study|Hyperglycemia|0
758727|NCT00479466|2418402|P6|Overall Study|Adverse Event|0
758728|NCT00479466|2418403|P5|Overall Study|Adverse Event|2
758729|NCT00479466|2418404|P4|Overall Study|Adverse Event|1
758730|NCT00479466|2418405|P3|Overall Study|Adverse Event|0
758731|NCT00479466|2418406|P2|Overall Study|Adverse Event|1
758732|NCT00479466|2418407|P1|Overall Study|Adverse Event|5
758733|NCT00479557|2418440|P7|Overall Study|Not specified|0
758734|NCT00479557|2418441|P6|Overall Study|Not specified|3
758735|NCT00479557|2418442|P5|Overall Study|Not specified|0
758736|NCT00479557|2418443|P4|Overall Study|Not specified|0
758737|NCT00479557|2418444|P3|Overall Study|Not specified|1
758738|NCT00479557|2418445|P2|Overall Study|Not specified|3
758739|NCT00479557|2418446|P1|Overall Study|Not specified|2
758740|NCT00479557|2418440|P7|Overall Study|Subject Request|1
758741|NCT00479557|2418441|P6|Overall Study|Subject Request|4
758742|NCT00479557|2418442|P5|Overall Study|Subject Request|1
758743|NCT00479557|2418443|P4|Overall Study|Subject Request|1
758744|NCT00479557|2418444|P3|Overall Study|Subject Request|1
758745|NCT00479557|2418445|P2|Overall Study|Subject Request|0
758746|NCT00479557|2418446|P1|Overall Study|Subject Request|3
758747|NCT00479557|2418440|P7|Overall Study|Investigator Request|0
758748|NCT00479557|2418441|P6|Overall Study|Investigator Request|0
758749|NCT00479557|2418442|P5|Overall Study|Investigator Request|0
758750|NCT00479557|2418443|P4|Overall Study|Investigator Request|0
758751|NCT00479557|2418444|P3|Overall Study|Investigator Request|1
758752|NCT00479557|2418445|P2|Overall Study|Investigator Request|0
758753|NCT00479557|2418446|P1|Overall Study|Investigator Request|0
758754|NCT00479557|2418440|P7|Overall Study|Caregiver Request|0
758755|NCT00479557|2418441|P6|Overall Study|Caregiver Request|2
758756|NCT00479557|2418442|P5|Overall Study|Caregiver Request|1
758757|NCT00479557|2418443|P4|Overall Study|Caregiver Request|0
758758|NCT00479557|2418444|P3|Overall Study|Caregiver Request|2
758759|NCT00479557|2418445|P2|Overall Study|Caregiver Request|2
758760|NCT00479557|2418446|P1|Overall Study|Caregiver Request|2
758761|NCT00479557|2418440|P7|Overall Study|AE not related to Study Drug|1
758762|NCT00479557|2418441|P6|Overall Study|AE not related to Study Drug|2
758763|NCT00479557|2418442|P5|Overall Study|AE not related to Study Drug|2
758764|NCT00479557|2418443|P4|Overall Study|AE not related to Study Drug|0
758765|NCT00479557|2418444|P3|Overall Study|AE not related to Study Drug|0
758766|NCT00479557|2418445|P2|Overall Study|AE not related to Study Drug|3
758767|NCT00479557|2418446|P1|Overall Study|AE not related to Study Drug|1
758768|NCT00479557|2418440|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
758769|NCT00479557|2418441|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
758770|NCT00479557|2418442|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
758771|NCT00479557|2418443|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
758772|NCT00479557|2418444|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
758773|NCT00479557|2418445|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
758774|NCT00479557|2418446|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
758775|NCT00479557|2418440|P7|Overall Study|Lost to Follow-up|0
758776|NCT00479557|2418441|P6|Overall Study|Lost to Follow-up|0
758777|NCT00479557|2418442|P5|Overall Study|Lost to Follow-up|0
758778|NCT00479557|2418443|P4|Overall Study|Lost to Follow-up|2
758779|NCT00479557|2418444|P3|Overall Study|Lost to Follow-up|0
758780|NCT00479557|2418445|P2|Overall Study|Lost to Follow-up|2
758781|NCT00479557|2418446|P1|Overall Study|Lost to Follow-up|0
758782|NCT00479557|2418440|P7|Overall Study|Lack of Efficacy|0
758783|NCT00479557|2418441|P6|Overall Study|Lack of Efficacy|0
758784|NCT00479557|2418442|P5|Overall Study|Lack of Efficacy|0
758785|NCT00479557|2418443|P4|Overall Study|Lack of Efficacy|0
758786|NCT00479557|2418444|P3|Overall Study|Lack of Efficacy|0
758787|NCT00479557|2418445|P2|Overall Study|Lack of Efficacy|0
758788|NCT00479557|2418446|P1|Overall Study|Lack of Efficacy|1
758789|NCT00479557|2418440|P7|Overall Study|Death|0
758790|NCT00479557|2418441|P6|Overall Study|Death|1
758791|NCT00479557|2418442|P5|Overall Study|Death|0
758792|NCT00479557|2418443|P4|Overall Study|Death|0
758793|NCT00479557|2418444|P3|Overall Study|Death|0
758794|NCT00479557|2418445|P2|Overall Study|Death|0
758795|NCT00479557|2418446|P1|Overall Study|Death|0
758796|NCT00479674|2418483|P1|Overall Study|none provided|3
758797|NCT00479674|2418483|P1|Overall Study|Physician Decision|14
758798|NCT00479674|2418483|P1|Overall Study|Withdrawal by Subject|6
758799|NCT00479674|2418483|P1|Overall Study|Adverse Event|18
758800|NCT00479713|2418493|P2|Overall Study|Withdrawal by Subject|1
758801|NCT00479713|2418494|P1|Overall Study|Withdrawal by Subject|4
758802|NCT00479713|2418493|P2|Overall Study|Protocol Violation|1
758803|NCT00479713|2418494|P1|Overall Study|Protocol Violation|0
758804|NCT00479713|2418493|P2|Overall Study|Lost to Follow-up|1
758805|NCT00479713|2418494|P1|Overall Study|Lost to Follow-up|0
758806|NCT00479713|2418493|P2|Overall Study|Death|0
758807|NCT00479713|2418494|P1|Overall Study|Death|1
758808|NCT00479713|2418493|P2|Overall Study|Adverse Event|6
758809|NCT00479713|2418494|P1|Overall Study|Adverse Event|8
758810|NCT00479765|2418518|P1|Overall Study|study terminated|4
758811|NCT00479856|2418522|P1|Overall Study|Physician Decision|1
758812|NCT00479856|2418522|P1|Overall Study|Withdrawal by Subject|1
758813|NCT00479856|2418522|P1|Overall Study|Adverse Event|1
758814|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
758815|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
758816|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
758817|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
758818|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
758819|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
758820|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
758821|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
758822|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
758823|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
758824|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
758825|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
758826|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Other|2
758827|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Other|2
758828|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Other|0
758829|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Other|5
758830|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
758831|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
758832|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
758833|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
758834|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
758835|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
758836|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
758837|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
758838|NCT00479882|2418535|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
758839|NCT00479882|2418536|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
758840|NCT00479882|2418537|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
758841|NCT00479882|2418538|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
758842|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
758843|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
758844|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
758845|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
758846|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
758847|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
758848|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
758849|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
758850|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
758851|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
758852|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
758853|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
758854|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
758855|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
758856|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
758857|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
758858|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
758859|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
758860|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
758861|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
758862|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
758863|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
758864|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
758865|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
758866|NCT00479882|2418535|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
758867|NCT00479882|2418536|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
758868|NCT00479882|2418537|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
758869|NCT00479882|2418538|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
758870|NCT00473083|2418671|P3|Overall Study|Adverse Event|0
758871|NCT00473083|2418672|P2|Overall Study|Adverse Event|0
758872|NCT00473083|2418673|P1|Overall Study|Adverse Event|1
758873|NCT00473265|2418699|P1|Overall Study|Off treatment early|15
758874|NCT00473265|2418699|P1|Overall Study|Unrelated adverse event|5
758875|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
758876|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
758877|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
758878|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
758879|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
758880|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
758881|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
758882|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
758883|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
758884|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Subject's Decision|4
758885|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Subject's Decision|3
758886|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Subject's Decision|1
758887|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Physician's Decision|3
758888|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Physician's Decision|1
758889|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Physician's Decision|2
758890|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
758891|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
758892|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
758893|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Death|1
758894|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Death|2
758895|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Death|2
758896|NCT00473330|2418711|P3|Open-label Extension Through Month 60|Adverse Event|2
758897|NCT00473330|2418712|P2|Open-label Extension Through Month 60|Adverse Event|0
758898|NCT00473330|2418713|P1|Open-label Extension Through Month 60|Adverse Event|0
758899|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
758900|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
758901|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
758902|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
758903|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
758904|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
758905|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
758906|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
758907|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
758908|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Subject's Decision|3
758909|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Subject's Decision|3
758910|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Subject's Decision|1
758911|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Physician's Decision|3
758912|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Physician's Decision|1
758913|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Physician's Decision|2
758914|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
758915|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
758916|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
758917|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Death|0
758918|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Death|0
758919|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Death|2
758920|NCT00473330|2418711|P3|Open-label Extension Through Month 48|Adverse Event|2
758921|NCT00473330|2418712|P2|Open-label Extension Through Month 48|Adverse Event|0
758922|NCT00473330|2418713|P1|Open-label Extension Through Month 48|Adverse Event|0
758923|NCT00473330|2418711|P3|Core Study|Subject's Decision|19
758924|NCT00473330|2418712|P2|Core Study|Subject's Decision|8
758925|NCT00473330|2418713|P1|Core Study|Subject's Decision|9
758926|NCT00473330|2418711|P3|Core Study|Subject Required Other Therapy|3
758927|NCT00473330|2418712|P2|Core Study|Subject Required Other Therapy|1
758928|NCT00473330|2418713|P1|Core Study|Subject Required Other Therapy|0
758929|NCT00473330|2418711|P3|Core Study|Subject Non-compliance|1
758930|NCT00473330|2418712|P2|Core Study|Subject Non-compliance|2
758931|NCT00473330|2418713|P1|Core Study|Subject Non-compliance|1
758932|NCT00473330|2418711|P3|Core Study|Physician Decision|3
758933|NCT00473330|2418712|P2|Core Study|Physician Decision|1
758934|NCT00473330|2418713|P1|Core Study|Physician Decision|2
758935|NCT00473330|2418711|P3|Core Study|Lost to Follow-up|10
758936|NCT00473330|2418712|P2|Core Study|Lost to Follow-up|5
758937|NCT00473330|2418713|P1|Core Study|Lost to Follow-up|5
758938|NCT00473330|2418711|P3|Core Study|Death|4
758939|NCT00473330|2418712|P2|Core Study|Death|4
758940|NCT00473330|2418713|P1|Core Study|Death|6
758941|NCT00473330|2418711|P3|Core Study|Adverse Event|1
758942|NCT00473330|2418712|P2|Core Study|Adverse Event|4
758943|NCT00473330|2418713|P1|Core Study|Adverse Event|4
758944|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
758945|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
758946|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
758947|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
758948|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
758949|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
758950|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Subject's Decision|6
758951|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Subject's Decision|1
758952|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Subject's Decision|7
758953|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
758954|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
758955|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
758956|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Death|4
758957|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Death|7
758958|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Death|1
758959|NCT00473382|2418771|P3|Open-label Extension Through Month 60|Adverse Event|2
758960|NCT00473382|2418772|P2|Open-label Extension Through Month 60|Adverse Event|0
758961|NCT00473382|2418773|P1|Open-label Extension Through Month 60|Adverse Event|0
758962|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
758963|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
758964|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
758965|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
758966|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
758967|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
758968|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Subject's Decision|6
758969|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Subject's Decision|1
758970|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Subject's Decision|5
758971|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
758972|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
758973|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
758974|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Death|3
758975|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Death|3
758976|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Death|1
758977|NCT00473382|2418771|P3|Open-label Extension Through Month 48|Adverse Event|1
758978|NCT00473382|2418772|P2|Open-label Extension Through Month 48|Adverse Event|0
758979|NCT00473382|2418773|P1|Open-label Extension Through Month 48|Adverse Event|0
758980|NCT00473382|2418771|P3|Core Study|Subject's decision|10
758981|NCT00473382|2418772|P2|Core Study|Subject's decision|11
758982|NCT00473382|2418773|P1|Core Study|Subject's decision|12
758983|NCT00473382|2418771|P3|Core Study|Subject needed other treatment|2
758984|NCT00473382|2418772|P2|Core Study|Subject needed other treatment|3
758985|NCT00473382|2418773|P1|Core Study|Subject needed other treatment|1
758986|NCT00473382|2418771|P3|Core Study|Subject non-compliance|1
758987|NCT00473382|2418772|P2|Core Study|Subject non-compliance|2
758988|NCT00473382|2418773|P1|Core Study|Subject non-compliance|5
758989|NCT00473382|2418771|P3|Core Study|Physician Decision|2
758990|NCT00473382|2418772|P2|Core Study|Physician Decision|2
758991|NCT00473382|2418773|P1|Core Study|Physician Decision|1
758992|NCT00473382|2418771|P3|Core Study|Lost to Follow-up|3
758993|NCT00473382|2418772|P2|Core Study|Lost to Follow-up|3
758994|NCT00473382|2418773|P1|Core Study|Lost to Follow-up|3
758995|NCT00473382|2418771|P3|Core Study|Death|10
758996|NCT00473382|2418772|P2|Core Study|Death|5
758997|NCT00473382|2418773|P1|Core Study|Death|3
758998|NCT00473382|2418771|P3|Core Study|Adverse Event|1
758999|NCT00473382|2418772|P2|Core Study|Adverse Event|1
759000|NCT00473382|2418773|P1|Core Study|Adverse Event|3
759001|NCT00473434|2418828|P1|Overall Study|No longer required|1
759002|NCT00473434|2418828|P1|Overall Study|Switching to trial medication|1
759003|NCT00473434|2418828|P1|Overall Study|Ceased in favor of Paliperidone|1
759004|NCT00473434|2418828|P1|Overall Study|Reason not specified|6
759005|NCT00473434|2418828|P1|Overall Study|Safety evaluation|1
759006|NCT00473434|2418828|P1|Overall Study|Patient was selling medication to others|1
759007|NCT00473434|2418828|P1|Overall Study|Adverse Event|3
759008|NCT00473434|2418828|P1|Overall Study|Lack of Efficacy|3
759009|NCT00473434|2418828|P1|Overall Study|Compliance|3
759010|NCT00473434|2418828|P1|Overall Study|Withdrawal by Subject|9
759011|NCT00473434|2418828|P1|Overall Study|Physician Decision|3
759012|NCT00473512|2418895|P5|Period 2 (Phase 2)|Unspecified|0
759013|NCT00473512|2418896|P4|Period 2 (Phase 2)|Unspecified|3
759014|NCT00473512|2418897|P3|Period 2 (Phase 2)|Unspecified|0
759015|NCT00473512|2418898|P2|Period 2 (Phase 2)|Unspecified|0
759016|NCT00473512|2418899|P1|Period 2 (Phase 2)|Unspecified|1
759017|NCT00473512|2418895|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
759018|NCT00473512|2418896|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
759019|NCT00473512|2418897|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
759020|NCT00473512|2418898|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
759021|NCT00473512|2418899|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
759022|NCT00473512|2418895|P5|Period 2 (Phase 2)|Disease Progression|1
759023|NCT00473512|2418896|P4|Period 2 (Phase 2)|Disease Progression|17
759024|NCT00473512|2418897|P3|Period 2 (Phase 2)|Disease Progression|2
759025|NCT00473512|2418898|P2|Period 2 (Phase 2)|Disease Progression|2
759026|NCT00473512|2418899|P1|Period 2 (Phase 2)|Disease Progression|0
759027|NCT00473512|2418895|P5|Period 2 (Phase 2)|Death|1
759028|NCT00473512|2418896|P4|Period 2 (Phase 2)|Death|1
759029|NCT00473512|2418897|P3|Period 2 (Phase 2)|Death|0
759030|NCT00473512|2418898|P2|Period 2 (Phase 2)|Death|0
759031|NCT00473512|2418899|P1|Period 2 (Phase 2)|Death|0
759032|NCT00473512|2418895|P5|Period 2 (Phase 2)|Adverse Event|0
759033|NCT00473512|2418896|P4|Period 2 (Phase 2)|Adverse Event|1
759034|NCT00473512|2418897|P3|Period 2 (Phase 2)|Adverse Event|0
759035|NCT00473512|2418898|P2|Period 2 (Phase 2)|Adverse Event|0
759036|NCT00473512|2418899|P1|Period 2 (Phase 2)|Adverse Event|0
759037|NCT00473512|2418895|P5|Period 1 (Phase 1)|Unspecified|0
759038|NCT00473512|2418896|P4|Period 1 (Phase 1)|Unspecified|1
759039|NCT00473512|2418897|P3|Period 1 (Phase 1)|Unspecified|0
759040|NCT00473512|2418898|P2|Period 1 (Phase 1)|Unspecified|0
759041|NCT00473512|2418899|P1|Period 1 (Phase 1)|Unspecified|0
759042|NCT00473512|2418895|P5|Period 1 (Phase 1)|Disease Progression|1
759043|NCT00473512|2418896|P4|Period 1 (Phase 1)|Disease Progression|10
759044|NCT00473512|2418897|P3|Period 1 (Phase 1)|Disease Progression|0
759045|NCT00473512|2418898|P2|Period 1 (Phase 1)|Disease Progression|1
759046|NCT00473512|2418899|P1|Period 1 (Phase 1)|Disease Progression|1
759047|NCT00473512|2418895|P5|Period 1 (Phase 1)|Death|0
759048|NCT00473512|2418896|P4|Period 1 (Phase 1)|Death|1
759049|NCT00473512|2418897|P3|Period 1 (Phase 1)|Death|0
759050|NCT00473512|2418898|P2|Period 1 (Phase 1)|Death|0
759051|NCT00473512|2418899|P1|Period 1 (Phase 1)|Death|0
759052|NCT00473512|2418895|P5|Period 1 (Phase 1)|Adverse Event|0
759053|NCT00473512|2418896|P4|Period 1 (Phase 1)|Adverse Event|5
759054|NCT00473512|2418897|P3|Period 1 (Phase 1)|Adverse Event|0
759055|NCT00473512|2418898|P2|Period 1 (Phase 1)|Adverse Event|0
759056|NCT00473512|2418899|P1|Period 1 (Phase 1)|Adverse Event|0
759057|NCT00473564|2418957|P1|Overall Study|robot surgery aborted in OR|23
759058|NCT00473590|2418964|P2|Overall Study|Other|1
759059|NCT00473590|2418965|P1|Overall Study|Other|0
759060|NCT00473590|2418964|P2|Overall Study|Withdrawal by Subject|3
759061|NCT00473590|2418965|P1|Overall Study|Withdrawal by Subject|5
759062|NCT00473590|2418964|P2|Overall Study|Physician Decision|4
759063|NCT00473590|2418965|P1|Overall Study|Physician Decision|2
759064|NCT00473590|2418964|P2|Overall Study|Non–protocol-specified therapy|5
759065|NCT00473590|2418965|P1|Overall Study|Non–protocol-specified therapy|7
759066|NCT00473590|2418964|P2|Overall Study|Progression not resulting in death|20
759067|NCT00473590|2418965|P1|Overall Study|Progression not resulting in death|24
759068|NCT00473590|2418964|P2|Overall Study|Death|2
759069|NCT00473590|2418965|P1|Overall Study|Death|4
759070|NCT00473590|2418964|P2|Overall Study|Adverse Event|3
759071|NCT00473590|2418965|P1|Overall Study|Adverse Event|3
759072|NCT00473655|2418997|P3|Overall Study|Lost to Follow-up|8
759073|NCT00473655|2418998|P2|Overall Study|Lost to Follow-up|5
759074|NCT00473655|2418999|P1|Overall Study|Lost to Follow-up|9
759075|NCT00473668|2419034|P3|Overall Study|Unspecified|4
759076|NCT00473668|2419035|P2|Overall Study|Unspecified|3
759077|NCT00473668|2419036|P1|Overall Study|Unspecified|2
759078|NCT00473668|2419034|P3|Overall Study|Lost to Follow-up|6
759079|NCT00473668|2419035|P2|Overall Study|Lost to Follow-up|4
759080|NCT00473668|2419036|P1|Overall Study|Lost to Follow-up|0
759081|NCT00473668|2419034|P3|Overall Study|Migrated/moved from study area|0
759082|NCT00473668|2419035|P2|Overall Study|Migrated/moved from study area|2
759083|NCT00473668|2419036|P1|Overall Study|Migrated/moved from study area|3
759084|NCT00473668|2419034|P3|Overall Study|Withdrawal by Subject|0
759085|NCT00473668|2419035|P2|Overall Study|Withdrawal by Subject|2
759086|NCT00473668|2419036|P1|Overall Study|Withdrawal by Subject|0
759087|NCT00473746|2419091|P5|Period 2 (Phase 2)|Reason not specified|3
759088|NCT00473746|2419092|P4|Period 2 (Phase 2)|Reason not specified|0
759089|NCT00473746|2419093|P3|Period 2 (Phase 2)|Reason not specified|0
759090|NCT00473746|2419094|P2|Period 2 (Phase 2)|Reason not specified|0
759091|NCT00473746|2419095|P1|Period 2 (Phase 2)|Reason not specified|0
759092|NCT00473746|2419091|P5|Period 2 (Phase 2)|Progressive Disease|20
759093|NCT00473746|2419092|P4|Period 2 (Phase 2)|Progressive Disease|0
759094|NCT00473746|2419093|P3|Period 2 (Phase 2)|Progressive Disease|0
759095|NCT00473746|2419094|P2|Period 2 (Phase 2)|Progressive Disease|0
759096|NCT00473746|2419095|P1|Period 2 (Phase 2)|Progressive Disease|0
759097|NCT00473746|2419091|P5|Period 2 (Phase 2)|Death|1
759098|NCT00473746|2419092|P4|Period 2 (Phase 2)|Death|0
759099|NCT00473746|2419093|P3|Period 2 (Phase 2)|Death|0
759100|NCT00473746|2419094|P2|Period 2 (Phase 2)|Death|0
759101|NCT00473746|2419095|P1|Period 2 (Phase 2)|Death|0
759102|NCT00473746|2419091|P5|Period 2 (Phase 2)|Adverse Event|3
759103|NCT00473746|2419092|P4|Period 2 (Phase 2)|Adverse Event|0
759104|NCT00473746|2419093|P3|Period 2 (Phase 2)|Adverse Event|0
759105|NCT00473746|2419094|P2|Period 2 (Phase 2)|Adverse Event|0
759106|NCT00473746|2419095|P1|Period 2 (Phase 2)|Adverse Event|0
759107|NCT00473746|2419091|P5|Period 1 (Phase 1)|Reason not specified|0
759108|NCT00473746|2419092|P4|Period 1 (Phase 1)|Reason not specified|0
759109|NCT00473746|2419093|P3|Period 1 (Phase 1)|Reason not specified|0
759110|NCT00473746|2419094|P2|Period 1 (Phase 1)|Reason not specified|1
759111|NCT00473746|2419095|P1|Period 1 (Phase 1)|Reason not specified|0
759112|NCT00473746|2419091|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
759113|NCT00473746|2419092|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
759114|NCT00473746|2419093|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
759115|NCT00473746|2419094|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
759116|NCT00473746|2419095|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
759117|NCT00473746|2419091|P5|Period 1 (Phase 1)|Progressive Disease|0
759118|NCT00473746|2419092|P4|Period 1 (Phase 1)|Progressive Disease|10
759119|NCT00473746|2419093|P3|Period 1 (Phase 1)|Progressive Disease|6
759120|NCT00473746|2419094|P2|Period 1 (Phase 1)|Progressive Disease|6
759121|NCT00473746|2419095|P1|Period 1 (Phase 1)|Progressive Disease|5
759122|NCT00473746|2419091|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
759123|NCT00473746|2419092|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
759124|NCT00473746|2419093|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
759125|NCT00473746|2419094|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
759126|NCT00473746|2419095|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
759127|NCT00473746|2419091|P5|Period 1 (Phase 1)|Adverse Event|0
759128|NCT00473746|2419092|P4|Period 1 (Phase 1)|Adverse Event|0
759129|NCT00473746|2419093|P3|Period 1 (Phase 1)|Adverse Event|0
759130|NCT00473746|2419094|P2|Period 1 (Phase 1)|Adverse Event|0
759131|NCT00473746|2419095|P1|Period 1 (Phase 1)|Adverse Event|1
759132|NCT00473824|2419142|P2|Overall Study|Withdrawal by physician|0
759133|NCT00473824|2419143|P1|Overall Study|Withdrawal by physician|1
759134|NCT00473824|2419142|P2|Overall Study|Lost to Follow-up|0
759135|NCT00473824|2419143|P1|Overall Study|Lost to Follow-up|1
759136|NCT00473824|2419142|P2|Overall Study|Death|0
759137|NCT00473824|2419143|P1|Overall Study|Death|1
759138|NCT00473824|2419142|P2|Overall Study|Adverse Event|0
759139|NCT00473824|2419143|P1|Overall Study|Adverse Event|1
759140|NCT00473824|2419142|P2|Overall Study|Virologic Breakthrough|0
759141|NCT00473824|2419143|P1|Overall Study|Virologic Breakthrough|1
759142|NCT00473876|2419160|P2|Overall Study|Lost to Follow-up|1
759143|NCT00473876|2419161|P1|Overall Study|Lost to Follow-up|3
759144|NCT00473889|2419171|P2|Overall Study|Withdrawal by Subject|0
759145|NCT00473889|2419172|P1|Overall Study|Withdrawal by Subject|5
759146|NCT00473889|2419171|P2|Overall Study|Trial Terminated|6
759147|NCT00473889|2419172|P1|Overall Study|Trial Terminated|3
759148|NCT00473889|2419171|P2|Overall Study|Physician Decision|5
759149|NCT00473889|2419172|P1|Overall Study|Physician Decision|10
759150|NCT00473889|2419171|P2|Overall Study|Lost to Follow-up|1
759151|NCT00473889|2419172|P1|Overall Study|Lost to Follow-up|2
759152|NCT00473889|2419171|P2|Overall Study|Lack of Efficacy|29
759153|NCT00473889|2419172|P1|Overall Study|Lack of Efficacy|28
759154|NCT00473889|2419171|P2|Overall Study|Protocol Violation|2
759155|NCT00473889|2419172|P1|Overall Study|Protocol Violation|4
759156|NCT00473889|2419171|P2|Overall Study|Adverse Event|17
759157|NCT00473889|2419172|P1|Overall Study|Adverse Event|30
759158|NCT00473889|2419171|P2|Overall Study|Did not receive study medication|4
759159|NCT00473889|2419172|P1|Overall Study|Did not receive study medication|1
759160|NCT00474045|2419184|P2|Overall Study|Withdrawal criteria|50
759161|NCT00474045|2419185|P1|Overall Study|Withdrawal criteria|60
759162|NCT00474045|2419184|P2|Overall Study|Withdrawal by Subject|18
759163|NCT00474045|2419185|P1|Overall Study|Withdrawal by Subject|16
759164|NCT00474045|2419184|P2|Overall Study|Protocol Violation|12
759165|NCT00474045|2419185|P1|Overall Study|Protocol Violation|10
759166|NCT00474045|2419184|P2|Overall Study|Lost to Follow-up|1
759167|NCT00474045|2419185|P1|Overall Study|Lost to Follow-up|1
759168|NCT00474045|2419184|P2|Overall Study|Lack of Efficacy|9
759169|NCT00474045|2419185|P1|Overall Study|Lack of Efficacy|0
759170|NCT00474045|2419184|P2|Overall Study|Unclassified|3
759171|NCT00474045|2419185|P1|Overall Study|Unclassified|1
759172|NCT00474045|2419184|P2|Overall Study|Adverse Event|8
759173|NCT00474045|2419185|P1|Overall Study|Adverse Event|18
759174|NCT00474058|2419285|P2|Overall Study|Other|0
759175|NCT00474058|2419286|P1|Overall Study|Other|2
759176|NCT00474058|2419285|P2|Overall Study|Withdrawal by Subject|7
759177|NCT00474058|2419286|P1|Overall Study|Withdrawal by Subject|11
759178|NCT00474058|2419285|P2|Overall Study|Lack of Efficacy|4
759179|NCT00474058|2419286|P1|Overall Study|Lack of Efficacy|0
759180|NCT00474058|2419285|P2|Overall Study|Adverse Event|6
759181|NCT00474058|2419286|P1|Overall Study|Adverse Event|11
759182|NCT00474175|2419328|P3|Overall Study|Administrative|0
759183|NCT00474175|2419329|P2|Overall Study|Administrative|1
759184|NCT00474175|2419330|P1|Overall Study|Administrative|0
759185|NCT00474175|2419328|P3|Overall Study|Protocol Violation|1
759186|NCT00474175|2419329|P2|Overall Study|Protocol Violation|2
759187|NCT00474175|2419330|P1|Overall Study|Protocol Violation|0
759188|NCT00474175|2419328|P3|Overall Study|Ineligible|1
759189|NCT00474175|2419329|P2|Overall Study|Ineligible|3
759190|NCT00474175|2419330|P1|Overall Study|Ineligible|1
759191|NCT00474175|2419328|P3|Overall Study|Withdrawal by Subject|1
759192|NCT00474175|2419329|P2|Overall Study|Withdrawal by Subject|1
759193|NCT00474175|2419330|P1|Overall Study|Withdrawal by Subject|0
759194|NCT00474175|2419328|P3|Overall Study|Lack of Efficacy|1
759195|NCT00474175|2419329|P2|Overall Study|Lack of Efficacy|0
759196|NCT00474175|2419330|P1|Overall Study|Lack of Efficacy|0
759197|NCT00474188|2419365|P1|Overall Study|Study discontinued by sponsor|5
759198|NCT00474188|2419365|P1|Overall Study|Withdrawal by Subject|1
759199|NCT00474240|2419383|P6|Overall Study|Removed due to lab value|1
759200|NCT00474240|2419384|P5|Overall Study|Removed due to lab value|0
759201|NCT00474240|2419385|P4|Overall Study|Removed due to lab value|0
759202|NCT00474240|2419386|P3|Overall Study|Removed due to lab value|0
759203|NCT00474240|2419387|P2|Overall Study|Removed due to lab value|0
759204|NCT00474240|2419388|P1|Overall Study|Removed due to lab value|0
759205|NCT00474240|2419383|P6|Overall Study|Adverse Event|16
759206|NCT00474240|2419384|P5|Overall Study|Adverse Event|5
759207|NCT00474240|2419385|P4|Overall Study|Adverse Event|14
759208|NCT00474240|2419386|P3|Overall Study|Adverse Event|9
759209|NCT00474240|2419387|P2|Overall Study|Adverse Event|0
759210|NCT00474240|2419388|P1|Overall Study|Adverse Event|0
759211|NCT00474240|2419383|P6|Overall Study|Withdrawal by Subject|1
759212|NCT00474240|2419384|P5|Overall Study|Withdrawal by Subject|3
759213|NCT00474240|2419385|P4|Overall Study|Withdrawal by Subject|2
759214|NCT00474240|2419386|P3|Overall Study|Withdrawal by Subject|0
759215|NCT00474240|2419387|P2|Overall Study|Withdrawal by Subject|1
759216|NCT00474240|2419388|P1|Overall Study|Withdrawal by Subject|1
759217|NCT00474383|2419408|P2|Extension|Progressive Disease|5
759218|NCT00474383|2419409|P1|Extension|Progressive Disease|0
759219|NCT00474383|2419408|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
759220|NCT00474383|2419409|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
759221|NCT00474383|2419408|P2|Main Study|Other|0
759222|NCT00474383|2419409|P1|Main Study|Other|1
759223|NCT00474383|2419408|P2|Main Study|Progressive Disease|0
759224|NCT00474383|2419409|P1|Main Study|Progressive Disease|23
759225|NCT00474383|2419408|P2|Main Study|Symptomatic Deterioration|0
759226|NCT00474383|2419409|P1|Main Study|Symptomatic Deterioration|1
759227|NCT00474383|2419408|P2|Main Study|Adverse Event|0
759228|NCT00474383|2419409|P1|Main Study|Adverse Event|11
759229|NCT00480324|2419422|P2|Overall Study|Subject’s mother pregnant|1
759230|NCT00480324|2419423|P1|Overall Study|Subject’s mother pregnant|0
759231|NCT00480324|2419422|P2|Overall Study|Lost to Follow-up|8
759232|NCT00480324|2419423|P1|Overall Study|Lost to Follow-up|17
759233|NCT00480324|2419422|P2|Overall Study|Withdrawal by Subject|5
759234|NCT00480324|2419423|P1|Overall Study|Withdrawal by Subject|14
759235|NCT00480324|2419422|P2|Overall Study|Protocol Violation|1
759236|NCT00480324|2419423|P1|Overall Study|Protocol Violation|0
759237|NCT00480324|2419422|P2|Overall Study|Adverse Event|1
759238|NCT00480324|2419423|P1|Overall Study|Adverse Event|1
759239|NCT00480493|2419451|P2|Overall Study|moved|7
759240|NCT00480493|2419452|P1|Overall Study|moved|2
759241|NCT00480857|2419462|P1|Overall Study|Lack of Efficacy|2
759242|NCT00481065|2419482|P8|Overall Study|Unable to classify|0
759243|NCT00481065|2419483|P7|Overall Study|Unable to classify|0
759244|NCT00481065|2419484|P6|Overall Study|Unable to classify|0
759245|NCT00481065|2419485|P5|Overall Study|Unable to classify|1
759246|NCT00481065|2419486|P4|Overall Study|Unable to classify|0
759247|NCT00481065|2419487|P3|Overall Study|Unable to classify|2
759248|NCT00481065|2419488|P2|Overall Study|Unable to classify|1
759249|NCT00481065|2419489|P1|Overall Study|Unable to classify|0
759250|NCT00481065|2419482|P8|Overall Study|Protocol Violation|2
759251|NCT00481065|2419483|P7|Overall Study|Protocol Violation|3
759252|NCT00481065|2419484|P6|Overall Study|Protocol Violation|6
759253|NCT00481065|2419485|P5|Overall Study|Protocol Violation|2
759254|NCT00481065|2419486|P4|Overall Study|Protocol Violation|1
759255|NCT00481065|2419487|P3|Overall Study|Protocol Violation|1
759256|NCT00481065|2419488|P2|Overall Study|Protocol Violation|1
759257|NCT00481065|2419489|P1|Overall Study|Protocol Violation|2
759258|NCT00481065|2419482|P8|Overall Study|Administrative reason|0
759259|NCT00481065|2419483|P7|Overall Study|Administrative reason|1
759260|NCT00481065|2419484|P6|Overall Study|Administrative reason|2
759261|NCT00481065|2419485|P5|Overall Study|Administrative reason|0
759262|NCT00481065|2419486|P4|Overall Study|Administrative reason|0
759263|NCT00481065|2419487|P3|Overall Study|Administrative reason|0
759264|NCT00481065|2419488|P2|Overall Study|Administrative reason|0
759265|NCT00481065|2419489|P1|Overall Study|Administrative reason|0
759266|NCT00481065|2419482|P8|Overall Study|Inappropriate enrollment|1
759267|NCT00481065|2419483|P7|Overall Study|Inappropriate enrollment|0
759268|NCT00481065|2419484|P6|Overall Study|Inappropriate enrollment|1
759269|NCT00481065|2419485|P5|Overall Study|Inappropriate enrollment|2
759270|NCT00481065|2419486|P4|Overall Study|Inappropriate enrollment|0
759271|NCT00481065|2419487|P3|Overall Study|Inappropriate enrollment|2
759272|NCT00481065|2419488|P2|Overall Study|Inappropriate enrollment|0
759273|NCT00481065|2419489|P1|Overall Study|Inappropriate enrollment|4
759274|NCT00481065|2419482|P8|Overall Study|Lost to Follow-up|5
759275|NCT00481065|2419483|P7|Overall Study|Lost to Follow-up|2
759276|NCT00481065|2419484|P6|Overall Study|Lost to Follow-up|3
759277|NCT00481065|2419485|P5|Overall Study|Lost to Follow-up|3
759278|NCT00481065|2419486|P4|Overall Study|Lost to Follow-up|3
759279|NCT00481065|2419487|P3|Overall Study|Lost to Follow-up|4
759280|NCT00481065|2419488|P2|Overall Study|Lost to Follow-up|2
759281|NCT00481065|2419489|P1|Overall Study|Lost to Follow-up|4
759282|NCT00481065|2419482|P8|Overall Study|Withdrawal by Subject|10
759283|NCT00481065|2419483|P7|Overall Study|Withdrawal by Subject|9
759284|NCT00481065|2419484|P6|Overall Study|Withdrawal by Subject|12
759285|NCT00481065|2419485|P5|Overall Study|Withdrawal by Subject|13
759286|NCT00481065|2419486|P4|Overall Study|Withdrawal by Subject|11
759287|NCT00481065|2419487|P3|Overall Study|Withdrawal by Subject|7
759288|NCT00481065|2419488|P2|Overall Study|Withdrawal by Subject|12
759289|NCT00481065|2419489|P1|Overall Study|Withdrawal by Subject|11
759290|NCT00481065|2419482|P8|Overall Study|Adverse event or death|1
759291|NCT00481065|2419483|P7|Overall Study|Adverse event or death|1
759292|NCT00481065|2419484|P6|Overall Study|Adverse event or death|0
759293|NCT00481065|2419485|P5|Overall Study|Adverse event or death|2
759294|NCT00481065|2419486|P4|Overall Study|Adverse event or death|0
759295|NCT00481065|2419487|P3|Overall Study|Adverse event or death|3
759296|NCT00481065|2419488|P2|Overall Study|Adverse event or death|1
759297|NCT00481065|2419489|P1|Overall Study|Adverse event or death|1
759298|NCT00481078|2419577|P2|Overall Study|Brain metastasis|1
759299|NCT00481078|2419578|P1|Overall Study|Brain metastasis|0
759300|NCT00481078|2419577|P2|Overall Study|Received other treatment|1
759301|NCT00481078|2419578|P1|Overall Study|Received other treatment|2
759302|NCT00481078|2419577|P2|Overall Study|Information not available|0
759303|NCT00481078|2419578|P1|Overall Study|Information not available|1
759304|NCT00481078|2419577|P2|Overall Study|Withdrawal by Subject|1
759305|NCT00481078|2419578|P1|Overall Study|Withdrawal by Subject|7
759306|NCT00481078|2419577|P2|Overall Study|Intercurrent illness|0
759307|NCT00481078|2419578|P1|Overall Study|Intercurrent illness|1
759308|NCT00481078|2419577|P2|Overall Study|Death|3
759309|NCT00481078|2419578|P1|Overall Study|Death|5
759310|NCT00481078|2419577|P2|Overall Study|Adverse Event|3
759311|NCT00481078|2419578|P1|Overall Study|Adverse Event|15
759312|NCT00481078|2419577|P2|Overall Study|Progression of disease|11
759313|NCT00481078|2419578|P1|Overall Study|Progression of disease|11
759314|NCT00481195|2419590|P2|Overall Study|Miscellaneous|2
759315|NCT00481195|2419591|P1|Overall Study|Miscellaneous|2
759316|NCT00481195|2419590|P2|Overall Study|Withdrawal by Subject|9
759317|NCT00481195|2419591|P1|Overall Study|Withdrawal by Subject|3
759318|NCT00481195|2419590|P2|Overall Study|Protocol Violation|7
759319|NCT00481195|2419591|P1|Overall Study|Protocol Violation|10
759320|NCT00481195|2419590|P2|Overall Study|Physician Decision|1
759321|NCT00481195|2419591|P1|Overall Study|Physician Decision|3
759322|NCT00481195|2419590|P2|Overall Study|Lost to Follow-up|6
759323|NCT00481195|2419591|P1|Overall Study|Lost to Follow-up|4
759324|NCT00481195|2419590|P2|Overall Study|Lack of Efficacy|3
759325|NCT00481195|2419591|P1|Overall Study|Lack of Efficacy|1
759326|NCT00481195|2419590|P2|Overall Study|Adverse Event|11
759327|NCT00481195|2419591|P1|Overall Study|Adverse Event|16
759328|NCT00481247|2419677|P2|Overall Study|Did not receive treatment|2
759329|NCT00481247|2419678|P1|Overall Study|Did not receive treatment|1
759330|NCT00481247|2419677|P2|Overall Study|Varied|15
759331|NCT00481247|2419678|P1|Overall Study|Varied|6
759332|NCT00481247|2419677|P2|Overall Study|Administrative reason by sponsor|162
759333|NCT00481247|2419678|P1|Overall Study|Administrative reason by sponsor|157
759334|NCT00481247|2419677|P2|Overall Study|Poor compliance/noncompliance|7
759335|NCT00481247|2419678|P1|Overall Study|Poor compliance/noncompliance|1
759336|NCT00481247|2419677|P2|Overall Study|Lost to Follow-up|2
759337|NCT00481247|2419678|P1|Overall Study|Lost to Follow-up|1
759338|NCT00481247|2419677|P2|Overall Study|Pregnancy|1
759339|NCT00481247|2419678|P1|Overall Study|Pregnancy|2
759340|NCT00481247|2419677|P2|Overall Study|Withdrawal by Subject|13
759341|NCT00481247|2419678|P1|Overall Study|Withdrawal by Subject|8
759342|NCT00481247|2419677|P2|Overall Study|AE unrelated to study drug|4
759343|NCT00481247|2419678|P1|Overall Study|AE unrelated to study drug|13
759344|NCT00481247|2419677|P2|Overall Study|Treatment failure|14
759345|NCT00481247|2419678|P1|Overall Study|Treatment failure|10
759346|NCT00481247|2419677|P2|Overall Study|Intolerance|17
759347|NCT00481247|2419678|P1|Overall Study|Intolerance|42
759348|NCT00481247|2419677|P2|Overall Study|Disease progression|22
759349|NCT00481247|2419678|P1|Overall Study|Disease progression|18
759350|NCT00481247|2419677|P2|Overall Study|Death|1
759351|NCT00481247|2419678|P1|Overall Study|Death|0
759352|NCT00481676|2419728|P2|Overall Study|Administrative problem|0
759353|NCT00481676|2419729|P1|Overall Study|Administrative problem|1
759354|NCT00481676|2419728|P2|Overall Study|Unsatisfactory therapeutic effect|4
759355|NCT00481676|2419729|P1|Overall Study|Unsatisfactory therapeutic effect|1
759356|NCT00481676|2419728|P2|Overall Study|Adverse Event|1
759357|NCT00481676|2419729|P1|Overall Study|Adverse Event|0
759358|NCT00481767|2419753|P2|Overall Study|Lost to Follow-up|10
759359|NCT00481767|2419754|P1|Overall Study|Lost to Follow-up|16
759360|NCT00481767|2419753|P2|Overall Study|Withdrawal by Subject|11
759361|NCT00481767|2419754|P1|Overall Study|Withdrawal by Subject|16
759362|NCT00481871|2419800|P5|Overall Study|Progressive Disease - pt withdrew|0
759363|NCT00481871|2419801|P4|Overall Study|Progressive Disease - pt withdrew|0
759364|NCT00481871|2419802|P3|Overall Study|Progressive Disease - pt withdrew|1
759365|NCT00481871|2419803|P2|Overall Study|Progressive Disease - pt withdrew|0
759366|NCT00481871|2419804|P1|Overall Study|Progressive Disease - pt withdrew|0
759367|NCT00481988|2419820|P2|Overall Study|Withdrawal by Subject|1
759368|NCT00481988|2419821|P1|Overall Study|Withdrawal by Subject|1
759369|NCT00482014|2419833|P4|Overall Study|Sponsor Decision|1
759370|NCT00482014|2419834|P3|Overall Study|Sponsor Decision|1
759371|NCT00482014|2419835|P2|Overall Study|Sponsor Decision|2
759372|NCT00482014|2419836|P1|Overall Study|Sponsor Decision|1
759373|NCT00482014|2419833|P4|Overall Study|Lack of Efficacy|6
759374|NCT00482014|2419834|P3|Overall Study|Lack of Efficacy|4
759375|NCT00482014|2419835|P2|Overall Study|Lack of Efficacy|0
759376|NCT00482014|2419836|P1|Overall Study|Lack of Efficacy|1
759377|NCT00482014|2419833|P4|Overall Study|Death|4
759378|NCT00482014|2419834|P3|Overall Study|Death|1
759379|NCT00482014|2419835|P2|Overall Study|Death|2
759380|NCT00482014|2419836|P1|Overall Study|Death|1
759381|NCT00482014|2419833|P4|Overall Study|Adverse Event|8
759382|NCT00482014|2419834|P3|Overall Study|Adverse Event|2
759383|NCT00482014|2419835|P2|Overall Study|Adverse Event|0
759384|NCT00482014|2419836|P1|Overall Study|Adverse Event|3
759385|NCT00482014|2419833|P4|Overall Study|Withdrawal by Subject|4
759386|NCT00482014|2419834|P3|Overall Study|Withdrawal by Subject|3
759387|NCT00482014|2419835|P2|Overall Study|Withdrawal by Subject|2
759388|NCT00482014|2419836|P1|Overall Study|Withdrawal by Subject|1
759389|NCT00482170|2419860|P2|Overall Study|Unspecified reason|2
759390|NCT00482170|2419861|P1|Overall Study|Unspecified reason|0
759391|NCT00482170|2419860|P2|Overall Study|Lost to Follow-up|0
759392|NCT00482170|2419861|P1|Overall Study|Lost to Follow-up|2
759393|NCT00482170|2419860|P2|Overall Study|Protocol Violation|3
759394|NCT00482170|2419861|P1|Overall Study|Protocol Violation|2
759395|NCT00482170|2419860|P2|Overall Study|Withdrawal by Subject|1
759396|NCT00482170|2419861|P1|Overall Study|Withdrawal by Subject|6
759397|NCT00482170|2419860|P2|Overall Study|Adverse Event|14
759398|NCT00482170|2419861|P1|Overall Study|Adverse Event|5
759399|NCT00482274|2419979|P1|Overall Study|Adverse Event|1
759400|NCT00482391|2419987|P1|Overall Study|Death|1
759401|NCT00482391|2419987|P1|Overall Study|Adverse Event|1
759402|NCT00482391|2419987|P1|Overall Study|Withdrawal by Subject|1
759403|NCT00482612|2420019|P4|Follow-up Period|Reasons not related to trial|3
759404|NCT00482612|2420020|P3|Follow-up Period|Reasons not related to trial|1
759405|NCT00482612|2420021|P2|Follow-up Period|Reasons not related to trial|0
759406|NCT00482612|2420022|P1|Follow-up Period|Reasons not related to trial|1
759407|NCT00482612|2420019|P4|Follow-up Period|Withdrawal by Subject|2
759408|NCT00482612|2420020|P3|Follow-up Period|Withdrawal by Subject|7
759409|NCT00482612|2420021|P2|Follow-up Period|Withdrawal by Subject|5
759410|NCT00482612|2420022|P1|Follow-up Period|Withdrawal by Subject|3
759411|NCT00482612|2420019|P4|Follow-up Period|Lack of Efficacy|0
759412|NCT00482612|2420020|P3|Follow-up Period|Lack of Efficacy|1
759413|NCT00482612|2420021|P2|Follow-up Period|Lack of Efficacy|0
759414|NCT00482612|2420022|P1|Follow-up Period|Lack of Efficacy|2
759415|NCT00482612|2420019|P4|Follow-up Period|Adverse Event|0
759416|NCT00482612|2420020|P3|Follow-up Period|Adverse Event|9
759417|NCT00482612|2420021|P2|Follow-up Period|Adverse Event|7
759418|NCT00482612|2420022|P1|Follow-up Period|Adverse Event|4
759419|NCT00482612|2420019|P4|Follow-up Period|Lost to Follow-up|1
759420|NCT00482612|2420020|P3|Follow-up Period|Lost to Follow-up|2
759421|NCT00482612|2420021|P2|Follow-up Period|Lost to Follow-up|4
759422|NCT00482612|2420022|P1|Follow-up Period|Lost to Follow-up|0
759423|NCT00482612|2420019|P4|Follow-up Period|Lack of compliance|0
759424|NCT00482612|2420020|P3|Follow-up Period|Lack of compliance|1
759425|NCT00482612|2420021|P2|Follow-up Period|Lack of compliance|0
759426|NCT00482612|2420022|P1|Follow-up Period|Lack of compliance|0
759427|NCT00482612|2420019|P4|Follow-up Period|Unspecified|2
759428|NCT00482612|2420020|P3|Follow-up Period|Unspecified|1
759429|NCT00482612|2420021|P2|Follow-up Period|Unspecified|2
759430|NCT00482612|2420022|P1|Follow-up Period|Unspecified|4
759431|NCT00482612|2420019|P4|In-treatment Period|No study medication administered|0
759432|NCT00482612|2420020|P3|In-treatment Period|No study medication administered|1
759433|NCT00482612|2420021|P2|In-treatment Period|No study medication administered|0
759434|NCT00482612|2420022|P1|In-treatment Period|No study medication administered|0
759435|NCT00482703|2420059|P2|Overall Study|Poor compliance|0
759436|NCT00482703|2420060|P1|Overall Study|Poor compliance|1
759437|NCT00482729|2420107|P2|Overall Study|Withdrawal by Subject|69
759438|NCT00482729|2420108|P1|Overall Study|Withdrawal by Subject|67
759439|NCT00482729|2420107|P2|Overall Study|Protocol Violation|18
759440|NCT00482729|2420108|P1|Overall Study|Protocol Violation|10
759441|NCT00482729|2420107|P2|Overall Study|Pregnancy|2
759442|NCT00482729|2420108|P1|Overall Study|Pregnancy|4
759443|NCT00482729|2420107|P2|Overall Study|Physician Decision|7
759444|NCT00482729|2420108|P1|Overall Study|Physician Decision|10
759445|NCT00482729|2420107|P2|Overall Study|Lost to Follow-up|66
759446|NCT00482729|2420108|P1|Overall Study|Lost to Follow-up|86
759447|NCT00482729|2420107|P2|Overall Study|Lack of Efficacy|16
759448|NCT00482729|2420108|P1|Overall Study|Lack of Efficacy|4
759449|NCT00482729|2420107|P2|Overall Study|Hyperglycemia Criteria|5
759450|NCT00482729|2420108|P1|Overall Study|Hyperglycemia Criteria|7
759451|NCT00482729|2420107|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
759452|NCT00482729|2420108|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
759453|NCT00482729|2420107|P2|Overall Study|Adverse Event|33
759454|NCT00482729|2420108|P1|Overall Study|Adverse Event|29
759455|NCT00483002|2420139|P1|Overall Study|Unspecified|967
759456|NCT00483002|2420139|P1|Overall Study|Other|2
759457|NCT00483002|2420139|P1|Overall Study|Lost to Follow-up|962
759458|NCT00483002|2420139|P1|Overall Study|Lack of Efficacy|555
759459|NCT00483002|2420139|P1|Overall Study|Adverse Event|68
759460|NCT00483041|2420147|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
759461|NCT00483041|2420148|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
759462|NCT00483119|2420180|P2|Overall Study|Physician Decision|0
759463|NCT00483119|2420181|P1|Overall Study|Physician Decision|1
759464|NCT00483119|2420180|P2|Overall Study|Adverse Event|1
759465|NCT00483119|2420181|P1|Overall Study|Adverse Event|0
759466|NCT00483184|2420196|P3|Overall Study|Protocol Violation|1
759467|NCT00483184|2420197|P2|Overall Study|Protocol Violation|0
759468|NCT00483184|2420198|P1|Overall Study|Protocol Violation|1
759469|NCT00483184|2420196|P3|Overall Study|Adverse Event|2
759470|NCT00483184|2420197|P2|Overall Study|Adverse Event|2
759471|NCT00483184|2420198|P1|Overall Study|Adverse Event|1
759472|NCT00483184|2420196|P3|Overall Study|Lost to Follow-up|0
759473|NCT00483184|2420197|P2|Overall Study|Lost to Follow-up|0
759474|NCT00483184|2420198|P1|Overall Study|Lost to Follow-up|1
759475|NCT00483184|2420196|P3|Overall Study|Withdrawal by Subject|0
759476|NCT00483184|2420197|P2|Overall Study|Withdrawal by Subject|2
759477|NCT00483184|2420198|P1|Overall Study|Withdrawal by Subject|2
759478|NCT00483327|2420226|P1|Overall Study|Patient Non Compliance|2
759479|NCT00483327|2420226|P1|Overall Study|Lost to Follow-up|4
759480|NCT00483327|2420226|P1|Overall Study|Withdrawal by Subject|3
759481|NCT00483327|2420226|P1|Overall Study|Adverse Event|1
759482|NCT00477334|2420235|P2|Overall Study|Protocol Violation|1
759483|NCT00477334|2420236|P1|Overall Study|Protocol Violation|7
759484|NCT00477334|2420235|P2|Overall Study|Administrative Problems|15
759485|NCT00477334|2420236|P1|Overall Study|Administrative Problems|39
759486|NCT00477334|2420235|P2|Overall Study|Lost to Follow-up|4
759487|NCT00477334|2420236|P1|Overall Study|Lost to Follow-up|15
759488|NCT00477334|2420235|P2|Overall Study|Withdrawal by Subject|1
759489|NCT00477334|2420236|P1|Overall Study|Withdrawal by Subject|2
759490|NCT00477334|2420235|P2|Overall Study|Adverse Event|2
759491|NCT00477334|2420236|P1|Overall Study|Adverse Event|1
759492|NCT00477334|2420235|P2|Overall Study|Discontinued prior to taking study drug|53
759493|NCT00477334|2420236|P1|Overall Study|Discontinued prior to taking study drug|106
759494|NCT00477386|2420262|P2|Overall Study|Withdrawal by Subject|0
759495|NCT00477386|2420263|P1|Overall Study|Withdrawal by Subject|1
759496|NCT00477386|2420262|P2|Overall Study|Physician Decision|0
759497|NCT00477386|2420263|P1|Overall Study|Physician Decision|1
759498|NCT00477386|2420262|P2|Overall Study|Other|2
759499|NCT00477386|2420263|P1|Overall Study|Other|1
759500|NCT00477386|2420262|P2|Overall Study|Disease progression, refractory|3
759501|NCT00477386|2420263|P1|Overall Study|Disease progression, refractory|1
759502|NCT00477386|2420262|P2|Overall Study|Disease progression, relapse|4
759503|NCT00477386|2420263|P1|Overall Study|Disease progression, relapse|3
759504|NCT00477386|2420262|P2|Overall Study|Adverse Event|8
759505|NCT00477386|2420263|P1|Overall Study|Adverse Event|4
759506|NCT00477464|2420290|P1|Overall Study|Completion of protocol-defined follow-up|14
759507|NCT00477464|2420290|P1|Overall Study|Death|36
759508|NCT00477464|2420290|P1|Overall Study|Lost to Follow-up|1
759509|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
759510|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
759511|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
759512|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
759513|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
759514|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
759515|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
759516|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
759517|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
759518|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
759519|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
759520|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
759521|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
759522|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
759523|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
759524|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
759525|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
759526|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
759527|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759528|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759529|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759530|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759531|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759532|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759533|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759534|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
759535|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
759536|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
759537|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
759538|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759539|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759540|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
759541|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759542|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759543|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759544|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
759545|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
759546|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
759547|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
759548|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
759549|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
759550|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
759551|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
759552|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
759553|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
759554|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
759555|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
759556|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
759557|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
759558|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
759559|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
759560|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
759561|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
759562|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
759563|NCT00477490|2420318|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
759564|NCT00477490|2420319|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
759565|NCT00477490|2420320|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
759566|NCT00477490|2420321|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
759567|NCT00477490|2420322|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
759568|NCT00477490|2420323|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
759569|NCT00477490|2420324|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
759570|NCT00477490|2420325|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
759571|NCT00477490|2420326|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
759572|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Not Reported|0
759573|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Not Reported|0
759574|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Not Reported|0
759575|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Not Reported|0
759576|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Not Reported|1
759577|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Not Reported|0
759578|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Not Reported|3
759579|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Not Reported|2
759580|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Not Reported|1
759581|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Other, not specified|0
759582|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Other, not specified|0
759583|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Other, not specified|0
759584|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Other, not specified|0
759585|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Other, not specified|1
759586|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Other, not specified|1
759587|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Other, not specified|0
759588|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Other, not specified|4
759589|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Other, not specified|2
759590|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
759591|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
759592|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
759593|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
759594|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
759595|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
759596|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
759597|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
759598|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
759599|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
759600|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
759601|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
759602|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
759603|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
759604|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
759605|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
759606|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
759607|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
759608|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Protocol Violation|0
759609|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Protocol Violation|0
759610|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Protocol Violation|0
759611|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Protocol Violation|0
759612|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Protocol Violation|1
759613|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Protocol Violation|0
759614|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Protocol Violation|0
759615|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Protocol Violation|0
759616|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Protocol Violation|2
759617|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759618|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759619|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759620|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759621|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
759622|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
759623|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759624|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
759625|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
759626|NCT00477490|2420318|P9|Part I: 4 Week Efficacy|Adverse Event|0
759627|NCT00477490|2420319|P8|Part I: 4 Week Efficacy|Adverse Event|0
759628|NCT00477490|2420320|P7|Part I: 4 Week Efficacy|Adverse Event|0
759629|NCT00477490|2420321|P6|Part I: 4 Week Efficacy|Adverse Event|0
759630|NCT00477490|2420322|P5|Part I: 4 Week Efficacy|Adverse Event|6
759631|NCT00477490|2420323|P4|Part I: 4 Week Efficacy|Adverse Event|5
759632|NCT00477490|2420324|P3|Part I: 4 Week Efficacy|Adverse Event|0
759633|NCT00477490|2420325|P2|Part I: 4 Week Efficacy|Adverse Event|4
759634|NCT00477490|2420326|P1|Part I: 4 Week Efficacy|Adverse Event|1
759635|NCT00483379|2420412|P2|Treatment Period|Withdrawal by Subject|0
759636|NCT00483379|2420413|P1|Treatment Period|Withdrawal by Subject|1
759637|NCT00483379|2420412|P2|Treatment Period|Adverse Event|0
759638|NCT00483379|2420413|P1|Treatment Period|Adverse Event|1
759639|NCT00483405|2420449|P1|Overall Study|Other complicating disease|1
759640|NCT00483405|2420449|P1|Overall Study|Withdrawal by Subject|2
759641|NCT00483405|2420449|P1|Overall Study|Death|3
759642|NCT00483405|2420449|P1|Overall Study|Lack of Efficacy|14
759643|NCT00483405|2420449|P1|Overall Study|Adverse Event|8
759644|NCT00483548|2420469|P2|Overall Study|Withdrawal by Subject|2
759645|NCT00483548|2420470|P1|Overall Study|Withdrawal by Subject|5
759646|NCT00483548|2420469|P2|Overall Study|Lost to Follow-up|4
759647|NCT00483548|2420470|P1|Overall Study|Lost to Follow-up|3
759648|NCT00483548|2420469|P2|Overall Study|Non-compliance with medication|0
759649|NCT00483548|2420470|P1|Overall Study|Non-compliance with medication|2
759650|NCT00483548|2420469|P2|Overall Study|Unable to comply with protocol schedule|0
759651|NCT00483548|2420470|P1|Overall Study|Unable to comply with protocol schedule|1
759652|NCT00483548|2420469|P2|Overall Study|Protocol required discontinuation|6
759653|NCT00483548|2420470|P1|Overall Study|Protocol required discontinuation|6
759654|NCT00483548|2420469|P2|Overall Study|Pregnancy|0
759655|NCT00483548|2420470|P1|Overall Study|Pregnancy|1
759656|NCT00483548|2420469|P2|Overall Study|Protocol Violation|7
759657|NCT00483548|2420470|P1|Overall Study|Protocol Violation|11
759658|NCT00483548|2420469|P2|Overall Study|Lack of Efficacy|8
759659|NCT00483548|2420470|P1|Overall Study|Lack of Efficacy|4
759660|NCT00483548|2420469|P2|Overall Study|Laboratory abnormality|2
759661|NCT00483548|2420470|P1|Overall Study|Laboratory abnormality|1
759662|NCT00483548|2420469|P2|Overall Study|Adverse Event|14
759663|NCT00483548|2420470|P1|Overall Study|Adverse Event|25
759664|NCT00483548|2420469|P2|Overall Study|Randomized; not treated with study drug|3
759665|NCT00483548|2420470|P1|Overall Study|Randomized; not treated with study drug|1
759666|NCT00483574|2420510|P2|Overall Study|Withdrawal by Subject|0
759667|NCT00483574|2420511|P1|Overall Study|Withdrawal by Subject|52
759668|NCT00483574|2420510|P2|Overall Study|Lost to Follow-up|4
759669|NCT00483574|2420511|P1|Overall Study|Lost to Follow-up|16
759670|NCT00483574|2420510|P2|Overall Study|Protocol Violation|9
759671|NCT00483574|2420511|P1|Overall Study|Protocol Violation|28
759672|NCT00483574|2420510|P2|Overall Study|Adverse Event|0
759673|NCT00483574|2420511|P1|Overall Study|Adverse Event|6
759674|NCT00483652|2420521|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
759675|NCT00483652|2420522|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
759676|NCT00483652|2420521|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
759677|NCT00483652|2420522|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
759678|NCT00483652|2420521|P2|Double-blind Treatment Period|Adverse Event|4
759679|NCT00483652|2420522|P1|Double-blind Treatment Period|Adverse Event|3
759680|NCT00483652|2420521|P2|Double-blind Treatment Period|Protocol Violation|1
759681|NCT00483652|2420522|P1|Double-blind Treatment Period|Protocol Violation|2
759682|NCT00489476|2420534|P4|Overall Study|Lost to Follow-up|0
759683|NCT00489476|2420535|P3|Overall Study|Lost to Follow-up|0
759684|NCT00489476|2420536|P2|Overall Study|Lost to Follow-up|1
759685|NCT00489476|2420537|P1|Overall Study|Lost to Follow-up|0
759686|NCT00489489|2420558|P3|Overall Study|Other than above|0
759687|NCT00489489|2420559|P2|Overall Study|Other than above|1
759688|NCT00489489|2420560|P1|Overall Study|Other than above|0
759689|NCT00489489|2420558|P3|Overall Study|Participant did not wish to continue|0
759690|NCT00489489|2420559|P2|Overall Study|Participant did not wish to continue|1
759691|NCT00489489|2420560|P1|Overall Study|Participant did not wish to continue|1
759692|NCT00489489|2420558|P3|Overall Study|Progressive disease|0
759693|NCT00489489|2420559|P2|Overall Study|Progressive disease|1
759694|NCT00489489|2420560|P1|Overall Study|Progressive disease|0
759695|NCT00489489|2420558|P3|Overall Study|Protocol Violation|1
759696|NCT00489489|2420559|P2|Overall Study|Protocol Violation|0
759697|NCT00489489|2420560|P1|Overall Study|Protocol Violation|1
759698|NCT00489489|2420558|P3|Overall Study|Adverse Event|1
759699|NCT00489489|2420559|P2|Overall Study|Adverse Event|1
759700|NCT00489489|2420560|P1|Overall Study|Adverse Event|1
759701|NCT00489489|2420558|P3|Overall Study|Not treated due to protocol violation|1
759702|NCT00489489|2420559|P2|Overall Study|Not treated due to protocol violation|1
759703|NCT00489489|2420560|P1|Overall Study|Not treated due to protocol violation|0
759704|NCT00489541|2420590|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
759705|NCT00489541|2420591|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
759706|NCT00489541|2420590|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
759707|NCT00489541|2420591|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
759708|NCT00489541|2420590|P2|12-Month Clinical Follow-up|Death|2
759709|NCT00489541|2420591|P1|12-Month Clinical Follow-up|Death|3
759710|NCT00489541|2420590|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
759711|NCT00489541|2420591|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
759712|NCT00489541|2420590|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
759713|NCT00489541|2420591|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
759714|NCT00489541|2420590|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
759715|NCT00489541|2420591|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
759716|NCT00489554|2420599|P1|Overall Study|Lost to Follow-up|1
759717|NCT00489554|2420599|P1|Overall Study|Withdrawal by Subject|1
759718|NCT00489554|2420599|P1|Overall Study|Adverse Event|2
759719|NCT00489736|2420619|P2|Overall Study|Not coded/ Not pre-specified|8
759720|NCT00489736|2420620|P1|Overall Study|Not coded/ Not pre-specified|5
759721|NCT00489736|2420619|P2|Overall Study|Poor compliance|2
759722|NCT00489736|2420620|P1|Overall Study|Poor compliance|6
759723|NCT00489736|2420619|P2|Overall Study|Adverse Event|45
759724|NCT00489736|2420620|P1|Overall Study|Adverse Event|32
759725|NCT00489736|2420619|P2|Overall Study|Lack of Efficacy|14
759726|NCT00489736|2420620|P1|Overall Study|Lack of Efficacy|53
759727|NCT00489853|2420630|P3|Treatment Period 3|Study specific discontinuation criteria|0
759728|NCT00489853|2420631|P2|Treatment Period 3|Study specific discontinuation criteria|1
759729|NCT00489853|2420632|P1|Treatment Period 3|Study specific discontinuation criteria|0
759730|NCT00489853|2420630|P3|Wash-out Period 2|Study specific discontinuation criteria|2
759731|NCT00489853|2420631|P2|Wash-out Period 2|Study specific discontinuation criteria|2
759732|NCT00489853|2420632|P1|Wash-out Period 2|Study specific discontinuation criteria|3
759733|NCT00489853|2420630|P3|Wash-out Period 2|Adverse Event|0
759734|NCT00489853|2420631|P2|Wash-out Period 2|Adverse Event|1
759735|NCT00489853|2420632|P1|Wash-out Period 2|Adverse Event|1
759736|NCT00489853|2420630|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
759737|NCT00489853|2420631|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
759738|NCT00489853|2420632|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
759739|NCT00489853|2420630|P3|Wash-out Period 1|Protocol Violation|1
759740|NCT00489853|2420631|P2|Wash-out Period 1|Protocol Violation|1
759741|NCT00489853|2420632|P1|Wash-out Period 1|Protocol Violation|0
759742|NCT00489853|2420630|P3|Wash-out Period 1|Adverse Event|1
759743|NCT00489853|2420631|P2|Wash-out Period 1|Adverse Event|1
759744|NCT00489853|2420632|P1|Wash-out Period 1|Adverse Event|0
759745|NCT00489853|2420630|P3|Wash-out Period 1|Withdrawal by Subject|0
759746|NCT00489853|2420631|P2|Wash-out Period 1|Withdrawal by Subject|0
759747|NCT00489853|2420632|P1|Wash-out Period 1|Withdrawal by Subject|1
759748|NCT00490022|2420779|P2|Overall Study|Subject failed to disclose concommitant|1
759749|NCT00490022|2420780|P1|Overall Study|Subject failed to disclose concommitant|0
759750|NCT00490022|2420779|P2|Overall Study|Withdrawal by Subject|0
759751|NCT00490022|2420780|P1|Overall Study|Withdrawal by Subject|1
759752|NCT00490022|2420779|P2|Overall Study|Adverse Event|2
759753|NCT00490022|2420780|P1|Overall Study|Adverse Event|0
759754|NCT00490035|2420792|P4|Overall Study|AE of unknown type|0
759755|NCT00490035|2420793|P3|Overall Study|AE of unknown type|2
759756|NCT00490035|2420794|P2|Overall Study|AE of unknown type|0
759757|NCT00490035|2420795|P1|Overall Study|AE of unknown type|0
759758|NCT00490035|2420792|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
759759|NCT00490035|2420793|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
759760|NCT00490035|2420794|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
759761|NCT00490035|2420795|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
759762|NCT00490035|2420792|P4|Overall Study|AE, serious fatal|0
759763|NCT00490035|2420793|P3|Overall Study|AE, serious fatal|0
759764|NCT00490035|2420794|P2|Overall Study|AE, serious fatal|0
759765|NCT00490035|2420795|P1|Overall Study|AE, serious fatal|1
759766|NCT00490035|2420792|P4|Overall Study|Other reason|1
759767|NCT00490035|2420793|P3|Overall Study|Other reason|3
759768|NCT00490035|2420794|P2|Overall Study|Other reason|1
759769|NCT00490035|2420795|P1|Overall Study|Other reason|0
759770|NCT00490035|2420792|P4|Overall Study|Withdrawal by Subject|0
759771|NCT00490035|2420793|P3|Overall Study|Withdrawal by Subject|1
759772|NCT00490035|2420794|P2|Overall Study|Withdrawal by Subject|1
759773|NCT00490035|2420795|P1|Overall Study|Withdrawal by Subject|2
759774|NCT00490035|2420792|P4|Overall Study|Lost to Follow-up|0
759775|NCT00490035|2420793|P3|Overall Study|Lost to Follow-up|1
759776|NCT00490035|2420794|P2|Overall Study|Lost to Follow-up|0
759777|NCT00490035|2420795|P1|Overall Study|Lost to Follow-up|2
759778|NCT00490035|2420792|P4|Overall Study|AE, non-serious non-fatal|5
759779|NCT00490035|2420793|P3|Overall Study|AE, non-serious non-fatal|4
759780|NCT00490035|2420794|P2|Overall Study|AE, non-serious non-fatal|4
759781|NCT00490035|2420795|P1|Overall Study|AE, non-serious non-fatal|3
759782|NCT00490061|2420893|P1|Overall Study|Physician Decision|1
891246|NCT02586493|2827330|P1|Overall Study|Withdrawal by Subject|1
891247|NCT02586493|2827330|P1|Overall Study|Lost to Follow-up|1
891248|NCT02586493|2827330|P1|Overall Study|Protocol Violation|6
891249|NCT02586493|2827330|P1|Overall Study|Adverse Event|4
891250|NCT02570165|2827343|P7|Overall Study|Withdrawal Request by GSK|0
891251|NCT02570165|2827344|P6|Overall Study|Withdrawal Request by GSK|0
891252|NCT02570165|2827345|P5|Overall Study|Withdrawal Request by GSK|0
891253|NCT02570165|2827346|P4|Overall Study|Withdrawal Request by GSK|0
891254|NCT02570165|2827347|P3|Overall Study|Withdrawal Request by GSK|2
891255|NCT02570165|2827348|P2|Overall Study|Withdrawal Request by GSK|0
891256|NCT02570165|2827349|P1|Overall Study|Withdrawal Request by GSK|0
759795|NCT00490490|2420967|P1|Completed Assessment for TTP|Lost to Follow-up|2
759796|NCT00490490|2420967|P1|Completed Assessment for TTP|Withdrawal by Subject|1
759797|NCT00490542|2420975|P2|Overall Study|Lack of Efficacy|1
759798|NCT00490542|2420976|P1|Overall Study|Lack of Efficacy|1
759799|NCT00490542|2420975|P2|Overall Study|Adverse Event|3
759800|NCT00490542|2420976|P1|Overall Study|Adverse Event|3
759801|NCT00490542|2420975|P2|Overall Study|Lost to Follow-up|0
759802|NCT00490542|2420976|P1|Overall Study|Lost to Follow-up|3
759803|NCT00490555|2420986|P4|Overall Study|noncompliant with drug administration|0
759804|NCT00490555|2420987|P3|Overall Study|noncompliant with drug administration|2
759805|NCT00490555|2420988|P2|Overall Study|noncompliant with drug administration|0
759806|NCT00490555|2420989|P1|Overall Study|noncompliant with drug administration|0
759807|NCT00490646|2421017|P2|Overall Study|Never Treated (withdrew consent)|1
759808|NCT00490646|2421018|P1|Overall Study|Never Treated (withdrew consent)|0
759809|NCT00490646|2421017|P2|Overall Study|Never Treated (had an adverse event)|0
759810|NCT00490646|2421018|P1|Overall Study|Never Treated (had an adverse event)|1
759811|NCT00490646|2421017|P2|Overall Study|Still on trastuzumab monotherapy|1
759812|NCT00490646|2421018|P1|Overall Study|Still on trastuzumab monotherapy|1
759813|NCT00490698|2421038|P1|Overall Study|Physician Decision|2
759814|NCT00490698|2421038|P1|Overall Study|Disease Progression|7
759815|NCT00490698|2421038|P1|Overall Study|Withdrawal by Subject|1
759816|NCT00490724|2421045|P3|Period II|Treatment Discontinuation|3
759817|NCT00490724|2421046|P2|Period II|Treatment Discontinuation|1
759818|NCT00490724|2421047|P1|Period II|Treatment Discontinuation|3
759819|NCT00490724|2421045|P3|Period I|Physician Decision|1
759820|NCT00490724|2421046|P2|Period I|Physician Decision|0
759821|NCT00490724|2421047|P1|Period I|Physician Decision|0
759822|NCT00490815|2421131|P2|Overall Study|Death|3
759823|NCT00490815|2421132|P1|Overall Study|Death|1
759824|NCT00490815|2421131|P2|Overall Study|Lost to Follow-up|3
759825|NCT00490815|2421132|P1|Overall Study|Lost to Follow-up|1
759826|NCT00490815|2421131|P2|Overall Study|Withdrawal by Subject|0
759827|NCT00490815|2421132|P1|Overall Study|Withdrawal by Subject|4
759828|NCT00490815|2421131|P2|Overall Study|Adverse Event|3
759829|NCT00490815|2421132|P1|Overall Study|Adverse Event|2
759830|NCT00490841|2421140|P1|Overall Study|30 day f/u, only non-study stent used|3
759831|NCT00490841|2421140|P1|Overall Study|Lost to Follow-up|1
759832|NCT00490841|2421140|P1|Overall Study|Withdrawal by Subject|4
759833|NCT00490841|2421140|P1|Overall Study|Death|5
759834|NCT00490919|2421162|P3|Double-blind Phase|Administrative|6
759835|NCT00490919|2421163|P2|Double-blind Phase|Administrative|6
759836|NCT00490919|2421164|P1|Double-blind Phase|Administrative|0
759837|NCT00490919|2421162|P3|Double-blind Phase|Lack of Efficacy|36
759838|NCT00490919|2421163|P2|Double-blind Phase|Lack of Efficacy|22
759839|NCT00490919|2421164|P1|Double-blind Phase|Lack of Efficacy|0
759840|NCT00490919|2421162|P3|Double-blind Phase|Lost to Follow-up|11
759841|NCT00490919|2421163|P2|Double-blind Phase|Lost to Follow-up|8
759842|NCT00490919|2421164|P1|Double-blind Phase|Lost to Follow-up|0
759843|NCT00490919|2421162|P3|Double-blind Phase|Withdrawal by Subject|11
759844|NCT00490919|2421163|P2|Double-blind Phase|Withdrawal by Subject|10
759845|NCT00490919|2421164|P1|Double-blind Phase|Withdrawal by Subject|0
759846|NCT00490919|2421162|P3|Double-blind Phase|Adverse Event|20
759847|NCT00490919|2421163|P2|Double-blind Phase|Adverse Event|40
759848|NCT00490919|2421164|P1|Double-blind Phase|Adverse Event|0
759849|NCT00490919|2421162|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
759850|NCT00490919|2421163|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
759851|NCT00490919|2421164|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
759852|NCT00490919|2421162|P3|Open-label Run-in Period|Administrative|0
759853|NCT00490919|2421163|P2|Open-label Run-in Period|Administrative|0
759854|NCT00490919|2421164|P1|Open-label Run-in Period|Administrative|40
759855|NCT00490919|2421162|P3|Open-label Run-in Period|Lack of Efficacy|0
759856|NCT00490919|2421163|P2|Open-label Run-in Period|Lack of Efficacy|0
759857|NCT00490919|2421164|P1|Open-label Run-in Period|Lack of Efficacy|143
759858|NCT00490919|2421162|P3|Open-label Run-in Period|Lost to Follow-up|0
759859|NCT00490919|2421163|P2|Open-label Run-in Period|Lost to Follow-up|0
759860|NCT00490919|2421164|P1|Open-label Run-in Period|Lost to Follow-up|21
759861|NCT00490919|2421162|P3|Open-label Run-in Period|Withdrawal by Subject|0
759862|NCT00490919|2421163|P2|Open-label Run-in Period|Withdrawal by Subject|0
759863|NCT00490919|2421164|P1|Open-label Run-in Period|Withdrawal by Subject|37
759864|NCT00490919|2421162|P3|Open-label Run-in Period|Adverse Event|0
759865|NCT00490919|2421163|P2|Open-label Run-in Period|Adverse Event|0
759866|NCT00490919|2421164|P1|Open-label Run-in Period|Adverse Event|239
759867|NCT00490945|2421180|P5|Overall Study|Adverse Event|0
759868|NCT00490945|2421181|P4|Overall Study|Adverse Event|0
759869|NCT00490945|2421182|P3|Overall Study|Adverse Event|0
759870|NCT00490945|2421183|P2|Overall Study|Adverse Event|1
759871|NCT00490945|2421184|P1|Overall Study|Adverse Event|0
759872|NCT00490971|2421220|P5|Maintenance|Not specified|3
759873|NCT00490971|2421221|P4|Maintenance|Not specified|9
759874|NCT00490971|2421222|P3|Maintenance|Not specified|11
759875|NCT00490971|2421223|P2|Maintenance|Not specified|0
759876|NCT00490971|2421224|P1|Maintenance|Not specified|0
759877|NCT00490971|2421220|P5|Maintenance|Withdrawal by Subject|18
759878|NCT00490971|2421221|P4|Maintenance|Withdrawal by Subject|28
759879|NCT00490971|2421222|P3|Maintenance|Withdrawal by Subject|26
759880|NCT00490971|2421223|P2|Maintenance|Withdrawal by Subject|0
759881|NCT00490971|2421224|P1|Maintenance|Withdrawal by Subject|0
759882|NCT00490971|2421220|P5|Maintenance|Protocol Violation|1
759883|NCT00490971|2421221|P4|Maintenance|Protocol Violation|1
759884|NCT00490971|2421222|P3|Maintenance|Protocol Violation|4
759885|NCT00490971|2421223|P2|Maintenance|Protocol Violation|0
759886|NCT00490971|2421224|P1|Maintenance|Protocol Violation|0
759887|NCT00490971|2421220|P5|Maintenance|Pregnancy|0
759888|NCT00490971|2421221|P4|Maintenance|Pregnancy|0
759889|NCT00490971|2421222|P3|Maintenance|Pregnancy|1
759890|NCT00490971|2421223|P2|Maintenance|Pregnancy|0
759891|NCT00490971|2421224|P1|Maintenance|Pregnancy|0
759892|NCT00490971|2421220|P5|Maintenance|Lost to Follow-up|10
759893|NCT00490971|2421221|P4|Maintenance|Lost to Follow-up|8
759894|NCT00490971|2421222|P3|Maintenance|Lost to Follow-up|5
759895|NCT00490971|2421223|P2|Maintenance|Lost to Follow-up|0
759896|NCT00490971|2421224|P1|Maintenance|Lost to Follow-up|0
759897|NCT00490971|2421220|P5|Maintenance|Death|0
759898|NCT00490971|2421221|P4|Maintenance|Death|2
759899|NCT00490971|2421222|P3|Maintenance|Death|0
759900|NCT00490971|2421223|P2|Maintenance|Death|0
759901|NCT00490971|2421224|P1|Maintenance|Death|0
759902|NCT00490971|2421220|P5|Maintenance|Adverse Event|7
759903|NCT00490971|2421221|P4|Maintenance|Adverse Event|5
759904|NCT00490971|2421222|P3|Maintenance|Adverse Event|4
759905|NCT00490971|2421223|P2|Maintenance|Adverse Event|0
759906|NCT00490971|2421224|P1|Maintenance|Adverse Event|0
759907|NCT00490971|2421220|P5|Acute/Continuation|Not specified|0
759908|NCT00490971|2421221|P4|Acute/Continuation|Not specified|0
759909|NCT00490971|2421222|P3|Acute/Continuation|Not specified|0
759910|NCT00490971|2421223|P2|Acute/Continuation|Not specified|4
759911|NCT00490971|2421224|P1|Acute/Continuation|Not specified|11
759912|NCT00490971|2421220|P5|Acute/Continuation|Withdrawal by Subject|0
759913|NCT00490971|2421221|P4|Acute/Continuation|Withdrawal by Subject|0
759914|NCT00490971|2421222|P3|Acute/Continuation|Withdrawal by Subject|0
759915|NCT00490971|2421223|P2|Acute/Continuation|Withdrawal by Subject|24
759916|NCT00490971|2421224|P1|Acute/Continuation|Withdrawal by Subject|92
759917|NCT00490971|2421220|P5|Acute/Continuation|Protocol Violation|0
759918|NCT00490971|2421221|P4|Acute/Continuation|Protocol Violation|0
759919|NCT00490971|2421222|P3|Acute/Continuation|Protocol Violation|0
759920|NCT00490971|2421223|P2|Acute/Continuation|Protocol Violation|2
759921|NCT00490971|2421224|P1|Acute/Continuation|Protocol Violation|10
759922|NCT00490971|2421220|P5|Acute/Continuation|Lost to Follow-up|0
759923|NCT00490971|2421221|P4|Acute/Continuation|Lost to Follow-up|0
759924|NCT00490971|2421222|P3|Acute/Continuation|Lost to Follow-up|0
759925|NCT00490971|2421223|P2|Acute/Continuation|Lost to Follow-up|7
759926|NCT00490971|2421224|P1|Acute/Continuation|Lost to Follow-up|23
759927|NCT00490971|2421220|P5|Acute/Continuation|Lack of Efficacy|0
759928|NCT00490971|2421221|P4|Acute/Continuation|Lack of Efficacy|0
759929|NCT00490971|2421222|P3|Acute/Continuation|Lack of Efficacy|0
759930|NCT00490971|2421223|P2|Acute/Continuation|Lack of Efficacy|12
759931|NCT00490971|2421224|P1|Acute/Continuation|Lack of Efficacy|106
759932|NCT00490971|2421220|P5|Acute/Continuation|Death|0
759933|NCT00490971|2421221|P4|Acute/Continuation|Death|0
759934|NCT00490971|2421222|P3|Acute/Continuation|Death|0
759935|NCT00490971|2421223|P2|Acute/Continuation|Death|0
759936|NCT00490971|2421224|P1|Acute/Continuation|Death|2
759937|NCT00490971|2421220|P5|Acute/Continuation|Adverse Event|0
759938|NCT00490971|2421221|P4|Acute/Continuation|Adverse Event|0
759939|NCT00490971|2421222|P3|Acute/Continuation|Adverse Event|0
759940|NCT00490971|2421223|P2|Acute/Continuation|Adverse Event|13
759941|NCT00490971|2421224|P1|Acute/Continuation|Adverse Event|62
759942|NCT00491075|2421266|P1|Overall Study|Physician Decision|1
759943|NCT00491075|2421266|P1|Overall Study|Withdrawal by Subject|1
759944|NCT00491179|2421272|P2|Overall Study|Withdrawal by Subject|1
759945|NCT00491179|2421273|P1|Overall Study|Withdrawal by Subject|2
759946|NCT00491179|2421272|P2|Overall Study|Adverse Event|1
759947|NCT00491179|2421273|P1|Overall Study|Adverse Event|5
759948|NCT00491400|2421307|P2|Overall Study|Withdrawal by Subject|4
759949|NCT00491400|2421308|P1|Overall Study|Withdrawal by Subject|5
759950|NCT00491504|2421320|P4|Overall Study|Protocol Violation|2
759951|NCT00491504|2421321|P3|Overall Study|Protocol Violation|3
759952|NCT00491504|2421322|P2|Overall Study|Protocol Violation|0
759953|NCT00491504|2421323|P1|Overall Study|Protocol Violation|0
759954|NCT00491504|2421320|P4|Overall Study|Withdrawal by Subject|2
759955|NCT00491504|2421321|P3|Overall Study|Withdrawal by Subject|1
759956|NCT00491504|2421322|P2|Overall Study|Withdrawal by Subject|0
759957|NCT00491504|2421323|P1|Overall Study|Withdrawal by Subject|0
759958|NCT00491504|2421320|P4|Overall Study|Adverse Event|0
759959|NCT00491504|2421321|P3|Overall Study|Adverse Event|0
759960|NCT00491504|2421322|P2|Overall Study|Adverse Event|1
759961|NCT00491504|2421323|P1|Overall Study|Adverse Event|0
759962|NCT00491530|2421334|P3|Overall Study|Use of Prohibited Medication|1
759963|NCT00491530|2421335|P2|Overall Study|Use of Prohibited Medication|0
759964|NCT00491530|2421336|P1|Overall Study|Use of Prohibited Medication|0
759965|NCT00491530|2421334|P3|Overall Study|Patient Request|0
759966|NCT00491530|2421335|P2|Overall Study|Patient Request|1
759967|NCT00491530|2421336|P1|Overall Study|Patient Request|0
759968|NCT00491530|2421334|P3|Overall Study|Investigator Discretion|0
759969|NCT00491530|2421335|P2|Overall Study|Investigator Discretion|1
759970|NCT00491530|2421336|P1|Overall Study|Investigator Discretion|0
759971|NCT00491530|2421334|P3|Overall Study|Lack of Efficacy|0
759972|NCT00491530|2421335|P2|Overall Study|Lack of Efficacy|1
759973|NCT00491530|2421336|P1|Overall Study|Lack of Efficacy|0
759974|NCT00491530|2421334|P3|Overall Study|Lost to Follow-up|2
759975|NCT00491530|2421335|P2|Overall Study|Lost to Follow-up|2
759976|NCT00491530|2421336|P1|Overall Study|Lost to Follow-up|3
759977|NCT00491530|2421334|P3|Overall Study|Withdrawal by Subject|0
759978|NCT00491530|2421335|P2|Overall Study|Withdrawal by Subject|0
759979|NCT00491530|2421336|P1|Overall Study|Withdrawal by Subject|3
759980|NCT00491530|2421334|P3|Overall Study|Adverse Event|2
759981|NCT00491530|2421335|P2|Overall Study|Adverse Event|1
759982|NCT00491530|2421336|P1|Overall Study|Adverse Event|6
759983|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
759984|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
759985|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
759986|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
759987|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
759988|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
759989|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
759990|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
759991|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
759992|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
759993|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
759994|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
759995|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
759996|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
759997|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
759998|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
759999|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
760000|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
760001|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
760002|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
760003|NCT00491556|2421364|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
760087|NCT00492024|2421571|P1|Follow up|Lost to Follow-up|1
760004|NCT00491556|2421365|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
760005|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
760006|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
760007|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
760008|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
760009|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
760010|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
760011|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
760012|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
760013|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
760014|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
760015|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
760016|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
760017|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
760018|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
760019|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
760020|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
760021|NCT00491556|2421364|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
760022|NCT00491556|2421365|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
760023|NCT00491608|2421421|P1|Overall Study|Withdrawal by Subject|1
760024|NCT00491608|2421421|P1|Overall Study|Death|2
760025|NCT00491764|2421443|P6|Overall Study|Administrative|0
760026|NCT00491764|2421444|P5|Overall Study|Administrative|0
760027|NCT00491764|2421445|P4|Overall Study|Administrative|1
760028|NCT00491764|2421446|P3|Overall Study|Administrative|2
760029|NCT00491764|2421447|P2|Overall Study|Administrative|0
760030|NCT00491764|2421448|P1|Overall Study|Administrative|1
760031|NCT00491764|2421443|P6|Overall Study|Did not Meet Protocol Eligibility|1
760032|NCT00491764|2421444|P5|Overall Study|Did not Meet Protocol Eligibility|1
760033|NCT00491764|2421445|P4|Overall Study|Did not Meet Protocol Eligibility|0
760034|NCT00491764|2421446|P3|Overall Study|Did not Meet Protocol Eligibility|1
760035|NCT00491764|2421447|P2|Overall Study|Did not Meet Protocol Eligibility|1
760036|NCT00491764|2421448|P1|Overall Study|Did not Meet Protocol Eligibility|0
760037|NCT00491764|2421443|P6|Overall Study|Non Compliance with the Protocol|0
760038|NCT00491764|2421444|P5|Overall Study|Non Compliance with the Protocol|0
760039|NCT00491764|2421445|P4|Overall Study|Non Compliance with the Protocol|0
760040|NCT00491764|2421446|P3|Overall Study|Non Compliance with the Protocol|0
760041|NCT00491764|2421447|P2|Overall Study|Non Compliance with the Protocol|0
760042|NCT00491764|2421448|P1|Overall Study|Non Compliance with the Protocol|1
760043|NCT00491764|2421443|P6|Overall Study|Withdrawal by Subject|4
760044|NCT00491764|2421444|P5|Overall Study|Withdrawal by Subject|2
760045|NCT00491764|2421445|P4|Overall Study|Withdrawal by Subject|2
760046|NCT00491764|2421446|P3|Overall Study|Withdrawal by Subject|1
760047|NCT00491764|2421447|P2|Overall Study|Withdrawal by Subject|3
760048|NCT00491764|2421448|P1|Overall Study|Withdrawal by Subject|2
760049|NCT00491764|2421443|P6|Overall Study|Lost to Follow-up|3
760050|NCT00491764|2421444|P5|Overall Study|Lost to Follow-up|0
760051|NCT00491764|2421445|P4|Overall Study|Lost to Follow-up|1
760052|NCT00491764|2421446|P3|Overall Study|Lost to Follow-up|0
760053|NCT00491764|2421447|P2|Overall Study|Lost to Follow-up|1
760054|NCT00491764|2421448|P1|Overall Study|Lost to Follow-up|0
760055|NCT00491764|2421443|P6|Overall Study|Adverse Event|1
760056|NCT00491764|2421444|P5|Overall Study|Adverse Event|0
760057|NCT00491764|2421445|P4|Overall Study|Adverse Event|4
760058|NCT00491764|2421446|P3|Overall Study|Adverse Event|4
760059|NCT00491764|2421447|P2|Overall Study|Adverse Event|2
760060|NCT00491764|2421448|P1|Overall Study|Adverse Event|1
760061|NCT00491894|2421487|P1|Overall Study|Other-Intake of prohibited medication|1
760062|NCT00491894|2421487|P1|Overall Study|Protocol Violation|2
760063|NCT00491894|2421487|P1|Overall Study|Physician Decision|2
760064|NCT00491894|2421487|P1|Overall Study|Other-Failed to meet any criteria|2
760065|NCT00491894|2421487|P1|Overall Study|Lack of Efficacy|2
760066|NCT00491894|2421487|P1|Overall Study|Lost to Follow-up|3
760067|NCT00491894|2421487|P1|Overall Study|Death|3
760068|NCT00491894|2421487|P1|Overall Study|Withdrawal by Subject|5
760069|NCT00491894|2421487|P1|Overall Study|Adverse Event|14
760070|NCT00480532|2421499|P4|Overall Study|Protocol Violation|0
760071|NCT00480532|2421500|P3|Overall Study|Protocol Violation|1
760072|NCT00480532|2421501|P2|Overall Study|Protocol Violation|0
760073|NCT00480532|2421502|P1|Overall Study|Protocol Violation|0
760074|NCT00480532|2421499|P4|Overall Study|Withdrawal by Subject|1
760075|NCT00480532|2421500|P3|Overall Study|Withdrawal by Subject|3
760076|NCT00480532|2421501|P2|Overall Study|Withdrawal by Subject|4
760077|NCT00480532|2421502|P1|Overall Study|Withdrawal by Subject|2
760078|NCT00480636|2421520|P1|Overall Study|Lost to follow-up; subsequently died|1
760079|NCT00480636|2421520|P1|Overall Study|Unspecified|2
760080|NCT00480636|2421520|P1|Overall Study|Lost to Follow-up|4
760081|NCT00480636|2421520|P1|Overall Study|Death|12
760082|NCT00480779|2421543|P2|Overall Study|Job and Health-related|3
760083|NCT00480779|2421544|P1|Overall Study|Job and Health-related|0
760084|NCT00480779|2421543|P2|Overall Study|Other|0
760085|NCT00480779|2421544|P1|Overall Study|Other|2
760086|NCT00492024|2421570|P2|Follow up|Lost to Follow-up|1
760088|NCT00492024|2421570|P2|Follow up|Lack of Efficacy|1
760089|NCT00492024|2421571|P1|Follow up|Lack of Efficacy|0
760090|NCT00492024|2421570|P2|Treatment|Withdrawal by Subject|0
760091|NCT00492024|2421571|P1|Treatment|Withdrawal by Subject|2
760092|NCT00492024|2421570|P2|Treatment|Lost to Follow-up|1
760093|NCT00492024|2421571|P1|Treatment|Lost to Follow-up|3
760094|NCT00492024|2421570|P2|Treatment|Lack of Efficacy|20
760095|NCT00492024|2421571|P1|Treatment|Lack of Efficacy|21
760096|NCT00492024|2421570|P2|Treatment|Adverse Event|1
760097|NCT00492024|2421571|P1|Treatment|Adverse Event|3
760098|NCT00492063|2421591|P4|Overall Study|Protocol Violation|1
760099|NCT00492063|2421592|P3|Overall Study|Protocol Violation|0
760100|NCT00492063|2421593|P2|Overall Study|Protocol Violation|0
760101|NCT00492063|2421594|P1|Overall Study|Protocol Violation|0
760102|NCT00492063|2421591|P4|Overall Study|Lost to Follow-up|3
760103|NCT00492063|2421592|P3|Overall Study|Lost to Follow-up|5
760104|NCT00492063|2421593|P2|Overall Study|Lost to Follow-up|11
760105|NCT00492063|2421594|P1|Overall Study|Lost to Follow-up|6
760106|NCT00492063|2421591|P4|Overall Study|Withdrawal by Subject|4
760107|NCT00492063|2421592|P3|Overall Study|Withdrawal by Subject|5
760108|NCT00492063|2421593|P2|Overall Study|Withdrawal by Subject|3
760109|NCT00492063|2421594|P1|Overall Study|Withdrawal by Subject|4
760110|NCT00492063|2421591|P4|Overall Study|Death|2
760111|NCT00492063|2421592|P3|Overall Study|Death|1
760112|NCT00492063|2421593|P2|Overall Study|Death|0
760113|NCT00492063|2421594|P1|Overall Study|Death|0
760114|NCT00492232|2421634|P2|Open-Label Treatment|Withdrawal by Subject|0
760115|NCT00492232|2421635|P1|Open-Label Treatment|Withdrawal by Subject|1
760116|NCT00492232|2421634|P2|Double-Blind Treatment|Randomized not treated|0
760117|NCT00492232|2421635|P1|Double-Blind Treatment|Randomized not treated|1
760118|NCT00492232|2421634|P2|Double-Blind Treatment|Other|5
760119|NCT00492232|2421635|P1|Double-Blind Treatment|Other|6
760120|NCT00492232|2421634|P2|Double-Blind Treatment|Lack of Efficacy|0
760121|NCT00492232|2421635|P1|Double-Blind Treatment|Lack of Efficacy|1
760122|NCT00492232|2421634|P2|Double-Blind Treatment|Withdrawal by Subject|8
760123|NCT00492232|2421635|P1|Double-Blind Treatment|Withdrawal by Subject|4
760124|NCT00492232|2421634|P2|Double-Blind Treatment|Lost to Follow-up|3
760125|NCT00492232|2421635|P1|Double-Blind Treatment|Lost to Follow-up|2
760126|NCT00492232|2421634|P2|Double-Blind Treatment|Protocol Violation|7
760127|NCT00492232|2421635|P1|Double-Blind Treatment|Protocol Violation|3
760128|NCT00492232|2421634|P2|Double-Blind Treatment|Adverse Event|2
760129|NCT00492232|2421635|P1|Double-Blind Treatment|Adverse Event|1
760130|NCT00492232|2421634|P2|Placebo Run-in|Missing|2
760131|NCT00492232|2421635|P1|Placebo Run-in|Missing|0
760132|NCT00492232|2421634|P2|Placebo Run-in|Other|6
760133|NCT00492232|2421635|P1|Placebo Run-in|Other|0
760134|NCT00492232|2421634|P2|Placebo Run-in|Entrance criteria not met|45
760135|NCT00492232|2421635|P1|Placebo Run-in|Entrance criteria not met|0
760136|NCT00492232|2421634|P2|Placebo Run-in|Pregnancy|1
760137|NCT00492232|2421635|P1|Placebo Run-in|Pregnancy|0
760138|NCT00492232|2421634|P2|Placebo Run-in|Withdrawal by Subject|8
760139|NCT00492232|2421635|P1|Placebo Run-in|Withdrawal by Subject|0
760140|NCT00492232|2421634|P2|Placebo Run-in|Lost to Follow-up|3
760141|NCT00492232|2421635|P1|Placebo Run-in|Lost to Follow-up|0
760142|NCT00492232|2421634|P2|Placebo Run-in|Protocol Violation|3
760143|NCT00492232|2421635|P1|Placebo Run-in|Protocol Violation|0
760144|NCT00492232|2421634|P2|Placebo Run-in|Adverse Event|2
760145|NCT00492232|2421635|P1|Placebo Run-in|Adverse Event|0
760146|NCT00493012|2421686|P2|Overall Study|Lost to Follow-up|17
760147|NCT00493012|2421687|P1|Overall Study|Lost to Follow-up|18
760148|NCT00493038|2421715|P2|Follow-up|Lost to Follow-up|0
760149|NCT00493038|2421716|P1|Follow-up|Lost to Follow-up|1
760150|NCT00493038|2421715|P2|Treatment|Other|1
760151|NCT00493038|2421716|P1|Treatment|Other|0
760152|NCT00493038|2421715|P2|Treatment|Withdrawal by Subject|12
760153|NCT00493038|2421716|P1|Treatment|Withdrawal by Subject|11
760154|NCT00493038|2421715|P2|Treatment|Lost to Follow-up|3
760155|NCT00493038|2421716|P1|Treatment|Lost to Follow-up|5
760156|NCT00493038|2421715|P2|Treatment|Adverse Event|4
760157|NCT00493038|2421716|P1|Treatment|Adverse Event|8
760158|NCT00493220|2421740|P6|Third Intervention|Withdrawal by Subject|0
760159|NCT00493220|2421741|P5|Third Intervention|Withdrawal by Subject|0
760160|NCT00493220|2421742|P4|Third Intervention|Withdrawal by Subject|0
760161|NCT00493220|2421743|P3|Third Intervention|Withdrawal by Subject|0
760162|NCT00493220|2421744|P2|Third Intervention|Withdrawal by Subject|0
760163|NCT00493220|2421745|P1|Third Intervention|Withdrawal by Subject|1
760164|NCT00493246|2421770|P8|Overall Study|Lost to Follow-up|0
760165|NCT00493246|2421771|P7|Overall Study|Lost to Follow-up|1
760166|NCT00493246|2421772|P6|Overall Study|Lost to Follow-up|0
760167|NCT00493246|2421773|P5|Overall Study|Lost to Follow-up|0
760168|NCT00493246|2421774|P4|Overall Study|Lost to Follow-up|0
760169|NCT00493246|2421775|P3|Overall Study|Lost to Follow-up|0
760170|NCT00493246|2421776|P2|Overall Study|Lost to Follow-up|0
760171|NCT00493246|2421777|P1|Overall Study|Lost to Follow-up|0
760172|NCT00493246|2421770|P8|Overall Study|No access to draw blood|0
760173|NCT00493246|2421771|P7|Overall Study|No access to draw blood|0
760174|NCT00493246|2421772|P6|Overall Study|No access to draw blood|1
760175|NCT00493246|2421773|P5|Overall Study|No access to draw blood|0
760176|NCT00493246|2421774|P4|Overall Study|No access to draw blood|0
760177|NCT00493246|2421775|P3|Overall Study|No access to draw blood|0
760178|NCT00493246|2421776|P2|Overall Study|No access to draw blood|0
760179|NCT00493246|2421777|P1|Overall Study|No access to draw blood|0
760180|NCT00493246|2421770|P8|Overall Study|Withdrawal by Subject|0
760181|NCT00493246|2421771|P7|Overall Study|Withdrawal by Subject|0
760182|NCT00493246|2421772|P6|Overall Study|Withdrawal by Subject|0
760183|NCT00493246|2421773|P5|Overall Study|Withdrawal by Subject|1
760184|NCT00493246|2421774|P4|Overall Study|Withdrawal by Subject|0
760185|NCT00493246|2421775|P3|Overall Study|Withdrawal by Subject|0
760186|NCT00493246|2421776|P2|Overall Study|Withdrawal by Subject|0
760187|NCT00493246|2421777|P1|Overall Study|Withdrawal by Subject|0
760188|NCT00493285|2421841|P6|Overall Study|Lost to Follow-up|0
760189|NCT00493285|2421842|P5|Overall Study|Lost to Follow-up|1
760190|NCT00493285|2421843|P4|Overall Study|Lost to Follow-up|0
760191|NCT00493285|2421844|P3|Overall Study|Lost to Follow-up|0
760192|NCT00493285|2421845|P2|Overall Study|Lost to Follow-up|0
760193|NCT00493285|2421846|P1|Overall Study|Lost to Follow-up|0
760194|NCT00493311|2422072|P2|Overall Study|Need for rescue medication|2
760195|NCT00493311|2422073|P1|Overall Study|Need for rescue medication|2
760196|NCT00493454|2422087|P1|Overall Study|Withdrawal by Subject|1
760197|NCT00493636|2422093|P2|Overall Study|Mis-randomization|1
760198|NCT00493636|2422094|P1|Overall Study|Mis-randomization|1
760199|NCT00493636|2422093|P2|Overall Study|Disease progression/recurrence/relapse|1
760200|NCT00493636|2422094|P1|Overall Study|Disease progression/recurrence/relapse|0
760201|NCT00493636|2422093|P2|Overall Study|Withdrawal by Subject|0
760202|NCT00493636|2422094|P1|Overall Study|Withdrawal by Subject|1
760203|NCT00493649|2422108|P1|Overall Study|Other|13
760204|NCT00493649|2422108|P1|Overall Study|Lost to Follow-up|1
760205|NCT00493649|2422108|P1|Overall Study|Disease Progression|1
760206|NCT00493649|2422108|P1|Overall Study|Investigator Request|2
760207|NCT00493649|2422108|P1|Overall Study|Patient Request|21
760208|NCT00493649|2422108|P1|Overall Study|Adverse Event|44
760209|NCT00493779|2422119|P1|Overall Study|Logistical issue at site|1
760210|NCT00493974|2422137|P2|Overall Study|Lost to Follow-up|6
760211|NCT00493974|2422138|P1|Overall Study|Lost to Follow-up|4
760212|NCT00493974|2422137|P2|Overall Study|Withdrawal by Subject|6
760213|NCT00493974|2422138|P1|Overall Study|Withdrawal by Subject|8
760214|NCT00493974|2422137|P2|Overall Study|Death|2
760215|NCT00493974|2422138|P1|Overall Study|Death|1
760216|NCT00494013|2422158|P2|Overall Study|Sponsor Decision|1
760217|NCT00494013|2422159|P1|Overall Study|Sponsor Decision|0
760218|NCT00494013|2422158|P2|Overall Study|Withdrawal by Subject|14
760219|NCT00494013|2422159|P1|Overall Study|Withdrawal by Subject|13
760220|NCT00494013|2422158|P2|Overall Study|Protocol Violation|5
760221|NCT00494013|2422159|P1|Overall Study|Protocol Violation|8
760222|NCT00494013|2422158|P2|Overall Study|Physician Decision|5
760223|NCT00494013|2422159|P1|Overall Study|Physician Decision|3
760224|NCT00494013|2422158|P2|Overall Study|Lost to Follow-up|6
760225|NCT00494013|2422159|P1|Overall Study|Lost to Follow-up|5
760226|NCT00494013|2422158|P2|Overall Study|Entry Criteria Not Met|4
760227|NCT00494013|2422159|P1|Overall Study|Entry Criteria Not Met|1
760228|NCT00494013|2422158|P2|Overall Study|Adverse Event|1
760229|NCT00494013|2422159|P1|Overall Study|Adverse Event|0
760230|NCT00494026|2422187|P1|Overall Study|Sponsor Decision|4
760231|NCT00494091|2422197|P2|Overall Study|Withdrawal by Subject|7
760232|NCT00494091|2422198|P1|Overall Study|Withdrawal by Subject|0
760233|NCT00494091|2422197|P2|Overall Study|Not Specified|11
760234|NCT00494091|2422198|P1|Overall Study|Not Specified|1
760235|NCT00494091|2422197|P2|Overall Study|Lost to Follow-up|4
760236|NCT00494091|2422198|P1|Overall Study|Lost to Follow-up|0
760237|NCT00494091|2422197|P2|Overall Study|Death|54
760238|NCT00494091|2422198|P1|Overall Study|Death|5
760239|NCT00494221|2422242|P3|Overall Study|Withdrawal by Subject|0
760240|NCT00494221|2422243|P2|Overall Study|Withdrawal by Subject|2
760241|NCT00494221|2422244|P1|Overall Study|Withdrawal by Subject|1
760242|NCT00494221|2422242|P3|Overall Study|Death|14
760243|NCT00494221|2422243|P2|Overall Study|Death|9
760244|NCT00494221|2422244|P1|Overall Study|Death|15
760245|NCT00494234|2422266|P2|Overall Study|Death|1
760246|NCT00494234|2422267|P1|Overall Study|Death|2
760247|NCT00494234|2422266|P2|Overall Study|Withdrawal by Subject|0
760248|NCT00494234|2422267|P1|Overall Study|Withdrawal by Subject|1
760249|NCT00494234|2422266|P2|Overall Study|Lack of Efficacy|9
760250|NCT00494234|2422267|P1|Overall Study|Lack of Efficacy|12
760251|NCT00494299|2422285|P2|Overall Study|Protocol Driven Decision Point|22
760252|NCT00494299|2422286|P1|Overall Study|Protocol Driven Decision Point|11
760253|NCT00494299|2422285|P2|Overall Study|Site Closed by Sponsor|0
760254|NCT00494299|2422286|P1|Overall Study|Site Closed by Sponsor|6
760255|NCT00494299|2422285|P2|Overall Study|Participant Did Not Take Study Drug|2
760256|NCT00494299|2422286|P1|Overall Study|Participant Did Not Take Study Drug|0
760257|NCT00494299|2422285|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
760258|NCT00494299|2422286|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
760259|NCT00494299|2422285|P2|Overall Study|Withdrawal by Subject|3
760260|NCT00494299|2422286|P1|Overall Study|Withdrawal by Subject|8
760261|NCT00494299|2422285|P2|Overall Study|Protocol Violation|2
760262|NCT00494299|2422286|P1|Overall Study|Protocol Violation|1
760263|NCT00494299|2422285|P2|Overall Study|Physician Decision|2
760264|NCT00494299|2422286|P1|Overall Study|Physician Decision|0
760265|NCT00494299|2422285|P2|Overall Study|Lost to Follow-up|0
760266|NCT00494299|2422286|P1|Overall Study|Lost to Follow-up|1
760267|NCT00494299|2422285|P2|Overall Study|Adverse Event|13
760268|NCT00494299|2422286|P1|Overall Study|Adverse Event|93
891257|NCT02570165|2827343|P7|Overall Study|Par. did not Meet Continuation Criteria|0
891258|NCT02570165|2827344|P6|Overall Study|Par. did not Meet Continuation Criteria|1
891259|NCT02570165|2827345|P5|Overall Study|Par. did not Meet Continuation Criteria|0
891260|NCT02570165|2827346|P4|Overall Study|Par. did not Meet Continuation Criteria|0
891261|NCT02570165|2827347|P3|Overall Study|Par. did not Meet Continuation Criteria|0
891262|NCT02570165|2827348|P2|Overall Study|Par. did not Meet Continuation Criteria|0
891263|NCT02570165|2827349|P1|Overall Study|Par. did not Meet Continuation Criteria|0
891264|NCT02570165|2827343|P7|Overall Study|Withdrawal by Subject|0
891265|NCT02570165|2827344|P6|Overall Study|Withdrawal by Subject|0
891266|NCT02570165|2827345|P5|Overall Study|Withdrawal by Subject|1
760281|NCT00494481|2422315|P2|Overall Study|Never received IP|0
760282|NCT00494481|2422316|P1|Overall Study|Never received IP|2
760283|NCT00494481|2422315|P2|Overall Study|Other|0
760284|NCT00494481|2422316|P1|Overall Study|Other|1
760285|NCT00494481|2422315|P2|Overall Study|Adverse Event|11
760286|NCT00494481|2422316|P1|Overall Study|Adverse Event|15
760287|NCT00494481|2422315|P2|Overall Study|Condition under investigation worsened|13
760288|NCT00494481|2422316|P1|Overall Study|Condition under investigation worsened|11
760289|NCT00494507|2422343|P4|Open-Label Phase|Worsening Disease|2
760290|NCT00494507|2422344|P3|Open-Label Phase|Worsening Disease|0
760291|NCT00494507|2422345|P2|Open-Label Phase|Worsening Disease|0
760292|NCT00494507|2422346|P1|Open-Label Phase|Worsening Disease|0
760293|NCT00494507|2422343|P4|Open-Label Phase|Adverse Event|3
760294|NCT00494507|2422344|P3|Open-Label Phase|Adverse Event|5
760295|NCT00494507|2422345|P2|Open-Label Phase|Adverse Event|1
760296|NCT00494507|2422346|P1|Open-Label Phase|Adverse Event|0
760297|NCT00494507|2422343|P4|Double-Blind Phase|Negative DNA test|1
760298|NCT00494507|2422344|P3|Double-Blind Phase|Negative DNA test|0
760299|NCT00494507|2422345|P2|Double-Blind Phase|Negative DNA test|0
760300|NCT00494507|2422346|P1|Double-Blind Phase|Negative DNA test|0
760301|NCT00494507|2422343|P4|Double-Blind Phase|Subject Non-compliance|0
760302|NCT00494507|2422344|P3|Double-Blind Phase|Subject Non-compliance|1
760303|NCT00494507|2422345|P2|Double-Blind Phase|Subject Non-compliance|0
760304|NCT00494507|2422346|P1|Double-Blind Phase|Subject Non-compliance|0
760305|NCT00494507|2422343|P4|Double-Blind Phase|Withdrawal by Subject|0
760306|NCT00494507|2422344|P3|Double-Blind Phase|Withdrawal by Subject|0
760307|NCT00494507|2422345|P2|Double-Blind Phase|Withdrawal by Subject|0
760308|NCT00494507|2422346|P1|Double-Blind Phase|Withdrawal by Subject|1
760309|NCT00494507|2422343|P4|Double-Blind Phase|Adverse Event|0
760310|NCT00494507|2422344|P3|Double-Blind Phase|Adverse Event|1
760311|NCT00494507|2422345|P2|Double-Blind Phase|Adverse Event|0
760312|NCT00494507|2422346|P1|Double-Blind Phase|Adverse Event|2
760313|NCT00494676|2422398|P2|Second Intervention|Withdrawal by Subject|1
760314|NCT00494676|2422399|P1|Second Intervention|Withdrawal by Subject|1
760315|NCT00494676|2422398|P2|First Intervention|Withdrawal by Subject|3
760316|NCT00494676|2422399|P1|First Intervention|Withdrawal by Subject|1
760317|NCT00494676|2422398|P2|Allocation|Withdrawal by Subject|4
760318|NCT00494676|2422399|P1|Allocation|Withdrawal by Subject|2
760319|NCT00494780|2422408|P2|Overall Study|Insurance Issues|1
760320|NCT00494780|2422409|P1|Overall Study|Insurance Issues|0
760321|NCT00494780|2422408|P2|Overall Study|Residual Tumour Mass|1
760322|NCT00494780|2422409|P1|Overall Study|Residual Tumour Mass|0
760323|NCT00494780|2422408|P2|Overall Study|Non-compliance|0
760324|NCT00494780|2422409|P1|Overall Study|Non-compliance|1
760325|NCT00494780|2422408|P2|Overall Study|New Treatment|2
760326|NCT00494780|2422409|P1|Overall Study|New Treatment|2
760327|NCT00494780|2422408|P2|Overall Study|Progression of Study Disease|8
760328|NCT00494780|2422409|P1|Overall Study|Progression of Study Disease|7
760329|NCT00494780|2422408|P2|Overall Study|Withdrew before Dosed|1
760330|NCT00494780|2422409|P1|Overall Study|Withdrew before Dosed|0
760331|NCT00494780|2422408|P2|Overall Study|Adverse Event|0
760332|NCT00494780|2422409|P1|Overall Study|Adverse Event|1
760333|NCT00494871|2422458|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
760334|NCT00494871|2422459|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
760335|NCT00494871|2422458|P2|Follow-up (FU) Period|Withdrawal by Subject|5
760336|NCT00494871|2422459|P1|Follow-up (FU) Period|Withdrawal by Subject|5
760337|NCT00494871|2422458|P2|Follow-up (FU) Period|Protocol Violation|0
760338|NCT00494871|2422459|P1|Follow-up (FU) Period|Protocol Violation|1
760339|NCT00494871|2422458|P2|Follow-up (FU) Period|Physician Decision|1
760340|NCT00494871|2422459|P1|Follow-up (FU) Period|Physician Decision|0
760341|NCT00494871|2422458|P2|Follow-up (FU) Period|Lost to Follow-up|2
760342|NCT00494871|2422459|P1|Follow-up (FU) Period|Lost to Follow-up|6
760343|NCT00494871|2422458|P2|Follow-up (FU) Period|Death|12
760344|NCT00494871|2422459|P1|Follow-up (FU) Period|Death|13
760345|NCT00494871|2422458|P2|Follow-up (FU) Period|Adverse Event|1
760346|NCT00494871|2422459|P1|Follow-up (FU) Period|Adverse Event|1
760347|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
760348|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
760349|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
760350|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
760351|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
760352|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
760353|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
760354|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
760355|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
760356|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
760357|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
760358|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
760359|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
760360|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
760361|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
760362|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
760363|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Physician Decision|13
760364|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Physician Decision|4
760365|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Death|3
760366|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Death|8
760367|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
760368|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
760369|NCT00494871|2422458|P2|Double-blind (DB) Treatment Period|Adverse Event|70
760370|NCT00494871|2422459|P1|Double-blind (DB) Treatment Period|Adverse Event|73
760371|NCT00495131|2422507|P2|Overall Study|Withdrawal by Subject|0
760372|NCT00495131|2422508|P1|Overall Study|Withdrawal by Subject|1
760373|NCT00495131|2422507|P2|Overall Study|Lost to Follow-up|2
760374|NCT00495131|2422508|P1|Overall Study|Lost to Follow-up|0
760375|NCT00495131|2422507|P2|Overall Study|Lack of Efficacy|2
760376|NCT00495131|2422508|P1|Overall Study|Lack of Efficacy|0
760377|NCT00495131|2422507|P2|Overall Study|Adverse Event|2
760378|NCT00495131|2422508|P1|Overall Study|Adverse Event|6
760379|NCT00495391|2422536|P2|Overall Study|Withdrawal by Subject|3
760380|NCT00495391|2422537|P1|Overall Study|Withdrawal by Subject|2
760381|NCT00495391|2422536|P2|Overall Study|Lack of Efficacy|18
760382|NCT00495391|2422537|P1|Overall Study|Lack of Efficacy|34
760383|NCT00483704|2422560|P3|Treatment|Physician Decision|4
760384|NCT00483704|2422561|P2|Treatment|Physician Decision|1
760385|NCT00483704|2422562|P1|Treatment|Physician Decision|0
760386|NCT00483704|2422560|P3|Treatment|Pregnancy|0
760387|NCT00483704|2422561|P2|Treatment|Pregnancy|1
760388|NCT00483704|2422562|P1|Treatment|Pregnancy|0
760389|NCT00483704|2422560|P3|Treatment|Lack of Efficacy|1
760390|NCT00483704|2422561|P2|Treatment|Lack of Efficacy|1
760391|NCT00483704|2422562|P1|Treatment|Lack of Efficacy|1
760392|NCT00483704|2422560|P3|Treatment|Lost to Follow-up|5
760393|NCT00483704|2422561|P2|Treatment|Lost to Follow-up|7
760394|NCT00483704|2422562|P1|Treatment|Lost to Follow-up|2
760395|NCT00483704|2422560|P3|Treatment|Protocol Violation|5
760396|NCT00483704|2422561|P2|Treatment|Protocol Violation|3
760397|NCT00483704|2422562|P1|Treatment|Protocol Violation|6
760398|NCT00483704|2422560|P3|Treatment|Withdrawal by Subject|21
760399|NCT00483704|2422561|P2|Treatment|Withdrawal by Subject|12
760400|NCT00483704|2422562|P1|Treatment|Withdrawal by Subject|16
760401|NCT00483704|2422560|P3|Treatment|Adverse Event|4
760402|NCT00483704|2422561|P2|Treatment|Adverse Event|5
760403|NCT00483704|2422562|P1|Treatment|Adverse Event|3
760404|NCT00483704|2422560|P3|Treatment|Lack of qualifying migraines|116
760405|NCT00483704|2422561|P2|Treatment|Lack of qualifying migraines|99
760406|NCT00483704|2422562|P1|Treatment|Lack of qualifying migraines|101
760407|NCT00483704|2422560|P3|Randomization|Lack of qualifying migraines|31
760408|NCT00483704|2422561|P2|Randomization|Lack of qualifying migraines|25
760409|NCT00483704|2422562|P1|Randomization|Lack of qualifying migraines|21
760410|NCT00483704|2422560|P3|Randomization|Progressive disease|1
760411|NCT00483704|2422561|P2|Randomization|Progressive disease|0
760412|NCT00483704|2422562|P1|Randomization|Progressive disease|0
760413|NCT00483704|2422560|P3|Randomization|Physician Decision|0
760414|NCT00483704|2422561|P2|Randomization|Physician Decision|4
760415|NCT00483704|2422562|P1|Randomization|Physician Decision|2
760416|NCT00483704|2422560|P3|Randomization|Pregnancy|0
760417|NCT00483704|2422561|P2|Randomization|Pregnancy|0
760418|NCT00483704|2422562|P1|Randomization|Pregnancy|1
760419|NCT00483704|2422560|P3|Randomization|Lost to Follow-up|19
760420|NCT00483704|2422561|P2|Randomization|Lost to Follow-up|14
760421|NCT00483704|2422562|P1|Randomization|Lost to Follow-up|14
760422|NCT00483704|2422560|P3|Randomization|Protocol Violation|22
760423|NCT00483704|2422561|P2|Randomization|Protocol Violation|25
760424|NCT00483704|2422562|P1|Randomization|Protocol Violation|14
760425|NCT00483704|2422560|P3|Randomization|Withdrawal by Subject|18
760426|NCT00483704|2422561|P2|Randomization|Withdrawal by Subject|28
760427|NCT00483704|2422562|P1|Randomization|Withdrawal by Subject|19
760428|NCT00483717|2422608|P2|Overall Study|Withdrawal by Subject|0
760429|NCT00483717|2422609|P1|Overall Study|Withdrawal by Subject|1
760430|NCT00483717|2422608|P2|Overall Study|Lost to Follow-up|0
760431|NCT00483717|2422609|P1|Overall Study|Lost to Follow-up|1
760432|NCT00483717|2422608|P2|Overall Study|No treatment for migraine|13
760433|NCT00483717|2422609|P1|Overall Study|No treatment for migraine|16
760434|NCT00483717|2422608|P2|Overall Study|Time of dosing missing|1
760435|NCT00483717|2422609|P1|Overall Study|Time of dosing missing|1
760436|NCT00483717|2422608|P2|Overall Study|Protocol Violation|7
760437|NCT00483717|2422609|P1|Overall Study|Protocol Violation|5
760438|NCT00483756|2422632|P3|Overall Study|Randomized, Not Treated|4
760439|NCT00483756|2422633|P2|Overall Study|Randomized, Not Treated|4
760440|NCT00483756|2422634|P1|Overall Study|Randomized, Not Treated|1
760441|NCT00483756|2422632|P3|Overall Study|Unspecified|3
760442|NCT00483756|2422633|P2|Overall Study|Unspecified|4
760443|NCT00483756|2422634|P1|Overall Study|Unspecified|2
760444|NCT00483756|2422632|P3|Overall Study|Withdrawal by Subject|4
760445|NCT00483756|2422633|P2|Overall Study|Withdrawal by Subject|3
760446|NCT00483756|2422634|P1|Overall Study|Withdrawal by Subject|5
760447|NCT00483756|2422632|P3|Overall Study|Lost to Follow-up|0
760448|NCT00483756|2422633|P2|Overall Study|Lost to Follow-up|1
760449|NCT00483756|2422634|P1|Overall Study|Lost to Follow-up|3
760450|NCT00483756|2422632|P3|Overall Study|Lack of Efficacy|0
760451|NCT00483756|2422633|P2|Overall Study|Lack of Efficacy|0
760452|NCT00483756|2422634|P1|Overall Study|Lack of Efficacy|1
760453|NCT00483756|2422632|P3|Overall Study|Adverse Event|40
760454|NCT00483756|2422633|P2|Overall Study|Adverse Event|38
760455|NCT00483756|2422634|P1|Overall Study|Adverse Event|19
760456|NCT00483756|2422632|P3|Overall Study|Death|1
760457|NCT00483756|2422633|P2|Overall Study|Death|0
760458|NCT00483756|2422634|P1|Overall Study|Death|2
760459|NCT00483938|2422703|P7|Overall Study|Unspecified|32
760460|NCT00483938|2422704|P6|Overall Study|Unspecified|4
760461|NCT00483938|2422705|P5|Overall Study|Unspecified|0
760462|NCT00483938|2422706|P4|Overall Study|Unspecified|4
760463|NCT00483938|2422707|P3|Overall Study|Unspecified|0
760464|NCT00483938|2422708|P2|Overall Study|Unspecified|9
760465|NCT00483938|2422709|P1|Overall Study|Unspecified|3
760466|NCT00483938|2422703|P7|Overall Study|Death|0
760467|NCT00483938|2422704|P6|Overall Study|Death|0
760468|NCT00483938|2422705|P5|Overall Study|Death|0
760469|NCT00483938|2422706|P4|Overall Study|Death|0
760470|NCT00483938|2422707|P3|Overall Study|Death|0
760471|NCT00483938|2422708|P2|Overall Study|Death|2
760472|NCT00483938|2422709|P1|Overall Study|Death|0
760473|NCT00483938|2422703|P7|Overall Study|Lost to Follow-up|3
760474|NCT00483938|2422704|P6|Overall Study|Lost to Follow-up|1
760475|NCT00483938|2422705|P5|Overall Study|Lost to Follow-up|1
760476|NCT00483938|2422706|P4|Overall Study|Lost to Follow-up|2
760477|NCT00483938|2422707|P3|Overall Study|Lost to Follow-up|0
760478|NCT00483938|2422708|P2|Overall Study|Lost to Follow-up|2
760479|NCT00483938|2422709|P1|Overall Study|Lost to Follow-up|1
760480|NCT00483938|2422703|P7|Overall Study|Withdrawal by Subject|2
760481|NCT00483938|2422704|P6|Overall Study|Withdrawal by Subject|3
760482|NCT00483938|2422705|P5|Overall Study|Withdrawal by Subject|1
760483|NCT00483938|2422706|P4|Overall Study|Withdrawal by Subject|0
760484|NCT00483938|2422707|P3|Overall Study|Withdrawal by Subject|0
760485|NCT00483938|2422708|P2|Overall Study|Withdrawal by Subject|6
760486|NCT00483938|2422709|P1|Overall Study|Withdrawal by Subject|1
760487|NCT00483938|2422703|P7|Overall Study|Protocol Violation|3
760488|NCT00483938|2422704|P6|Overall Study|Protocol Violation|0
760489|NCT00483938|2422705|P5|Overall Study|Protocol Violation|0
760490|NCT00483938|2422706|P4|Overall Study|Protocol Violation|0
760491|NCT00483938|2422707|P3|Overall Study|Protocol Violation|0
760492|NCT00483938|2422708|P2|Overall Study|Protocol Violation|0
760493|NCT00483938|2422709|P1|Overall Study|Protocol Violation|0
760494|NCT00484094|2422730|P1|Overall Study|Other|3
760495|NCT00484094|2422730|P1|Overall Study|Discontinued|39
760496|NCT00484159|2422742|P3|Overall Study|Lost to Follow-up|0
760497|NCT00484159|2422743|P2|Overall Study|Lost to Follow-up|1
760498|NCT00484159|2422744|P1|Overall Study|Lost to Follow-up|1
760499|NCT00484185|2422755|P1|Overall Study|Death|2
760500|NCT00484185|2422755|P1|Overall Study|Randomized but not treated|5
760501|NCT00484185|2422755|P1|Overall Study|Unspecified|20
760502|NCT00484185|2422755|P1|Overall Study|Lost to Follow-up|44
760503|NCT00484289|2422777|P3|Post Marketing Phase|Adverse Event|0
760504|NCT00484289|2422778|P2|Post Marketing Phase|Adverse Event|1
760505|NCT00484289|2422779|P1|Post Marketing Phase|Adverse Event|0
760506|NCT00484289|2422777|P3|Long Term Phase|Other Reason|1
760507|NCT00484289|2422778|P2|Long Term Phase|Other Reason|5
760508|NCT00484289|2422779|P1|Long Term Phase|Other Reason|0
760509|NCT00484289|2422777|P3|Long Term Phase|Inadequate response|4
760510|NCT00484289|2422778|P2|Long Term Phase|Inadequate response|7
760511|NCT00484289|2422779|P1|Long Term Phase|Inadequate response|2
760512|NCT00484289|2422777|P3|Long Term Phase|Withdrawal by Subject|6
760513|NCT00484289|2422778|P2|Long Term Phase|Withdrawal by Subject|7
760514|NCT00484289|2422779|P1|Long Term Phase|Withdrawal by Subject|0
760515|NCT00484289|2422777|P3|Long Term Phase|Adverse Event|5
760516|NCT00484289|2422778|P2|Long Term Phase|Adverse Event|17
760517|NCT00484289|2422779|P1|Long Term Phase|Adverse Event|1
760518|NCT00484315|2422853|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
760519|NCT00484315|2422854|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
760520|NCT00484315|2422853|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
760521|NCT00484315|2422854|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
760522|NCT00484315|2422853|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
760523|NCT00484315|2422854|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
760524|NCT00484315|2422853|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
760525|NCT00484315|2422854|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
760526|NCT00484315|2422853|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
760527|NCT00484315|2422854|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
760528|NCT00484315|2422853|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
760529|NCT00484315|2422854|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
760530|NCT00484315|2422853|P2|12-Month Clinical Follow-up|Death|2
760531|NCT00484315|2422854|P1|12-Month Clinical Follow-up|Death|6
760532|NCT00484419|2422874|P3|Overall Study|sponsor decision, randomized in error|2
760533|NCT00484419|2422875|P2|Overall Study|sponsor decision, randomized in error|0
760534|NCT00484419|2422876|P1|Overall Study|sponsor decision, randomized in error|0
760535|NCT00484419|2422874|P3|Overall Study|subject relocated|0
760536|NCT00484419|2422875|P2|Overall Study|subject relocated|1
760537|NCT00484419|2422876|P1|Overall Study|subject relocated|0
760538|NCT00484419|2422874|P3|Overall Study|subject unable to receive medication|0
760539|NCT00484419|2422875|P2|Overall Study|subject unable to receive medication|0
760540|NCT00484419|2422876|P1|Overall Study|subject unable to receive medication|1
760541|NCT00484419|2422874|P3|Overall Study|Physician Decision|1
760542|NCT00484419|2422875|P2|Overall Study|Physician Decision|1
760543|NCT00484419|2422876|P1|Overall Study|Physician Decision|1
760544|NCT00484419|2422874|P3|Overall Study|required restricted medication|1
760545|NCT00484419|2422875|P2|Overall Study|required restricted medication|0
760546|NCT00484419|2422876|P1|Overall Study|required restricted medication|1
760547|NCT00484419|2422874|P3|Overall Study|subject met discontinuation criteria|4
760548|NCT00484419|2422875|P2|Overall Study|subject met discontinuation criteria|2
760549|NCT00484419|2422876|P1|Overall Study|subject met discontinuation criteria|2
760550|NCT00484419|2422874|P3|Overall Study|Withdrawal by Subject|1
760551|NCT00484419|2422875|P2|Overall Study|Withdrawal by Subject|1
760552|NCT00484419|2422876|P1|Overall Study|Withdrawal by Subject|3
760553|NCT00484419|2422874|P3|Overall Study|Lost to Follow-up|2
760554|NCT00484419|2422875|P2|Overall Study|Lost to Follow-up|0
760555|NCT00484419|2422876|P1|Overall Study|Lost to Follow-up|1
760556|NCT00484419|2422874|P3|Overall Study|Adverse Event|0
760557|NCT00484419|2422875|P2|Overall Study|Adverse Event|0
760558|NCT00484419|2422876|P1|Overall Study|Adverse Event|3
760559|NCT00484679|2422932|P1|Overall Study|Withdrawal by Subject|3
760560|NCT00484939|2422938|P2|Overall Study|Reason Not Specified|6
760561|NCT00484939|2422939|P1|Overall Study|Reason Not Specified|11
760562|NCT00484939|2422938|P2|Overall Study|Screen Failure|2
760563|NCT00484939|2422939|P1|Overall Study|Screen Failure|2
760564|NCT00484939|2422938|P2|Overall Study|Disease progression|88
760565|NCT00484939|2422939|P1|Overall Study|Disease progression|67
760566|NCT00484939|2422938|P2|Overall Study|Discretion of Investigator or Sponsor|3
760567|NCT00484939|2422939|P1|Overall Study|Discretion of Investigator or Sponsor|7
760568|NCT00484939|2422938|P2|Overall Study|Lost to Follow-up|3
760569|NCT00484939|2422939|P1|Overall Study|Lost to Follow-up|0
760570|NCT00484939|2422938|P2|Overall Study|Protocol Violation|3
760571|NCT00484939|2422939|P1|Overall Study|Protocol Violation|3
760572|NCT00484939|2422938|P2|Overall Study|Patient Withdrew Consent|10
760573|NCT00484939|2422939|P1|Overall Study|Patient Withdrew Consent|19
760574|NCT00484939|2422938|P2|Overall Study|Adverse Event|12
760575|NCT00484939|2422939|P1|Overall Study|Adverse Event|22
760576|NCT00484939|2422938|P2|Overall Study|Death|13
760577|NCT00484939|2422939|P1|Overall Study|Death|9
760578|NCT00485069|2422961|P2|Overall Study|Withdrawal by Subject|6
760579|NCT00485069|2422962|P1|Overall Study|Withdrawal by Subject|6
760580|NCT00485069|2422961|P2|Overall Study|Protocol Violation|1
760581|NCT00485069|2422962|P1|Overall Study|Protocol Violation|0
760582|NCT00485069|2422961|P2|Overall Study|Lack of Efficacy|1
760583|NCT00485069|2422962|P1|Overall Study|Lack of Efficacy|2
760584|NCT00485069|2422961|P2|Overall Study|Adverse Event|4
760585|NCT00485069|2422962|P1|Overall Study|Adverse Event|10
760586|NCT00485134|2423013|P8|Overall Study|Pregnancy|0
760587|NCT00485134|2423014|P7|Overall Study|Pregnancy|1
760588|NCT00485134|2423015|P6|Overall Study|Pregnancy|0
760589|NCT00485134|2423016|P5|Overall Study|Pregnancy|0
760590|NCT00485134|2423017|P4|Overall Study|Pregnancy|0
760591|NCT00485134|2423018|P3|Overall Study|Pregnancy|0
760592|NCT00485134|2423019|P2|Overall Study|Pregnancy|0
760593|NCT00485134|2423020|P1|Overall Study|Pregnancy|0
760594|NCT00485134|2423013|P8|Overall Study|Unable to comply with study schedule|1
760595|NCT00485134|2423014|P7|Overall Study|Unable to comply with study schedule|0
760596|NCT00485134|2423015|P6|Overall Study|Unable to comply with study schedule|0
760597|NCT00485134|2423016|P5|Overall Study|Unable to comply with study schedule|0
760598|NCT00485134|2423017|P4|Overall Study|Unable to comply with study schedule|0
760599|NCT00485134|2423018|P3|Overall Study|Unable to comply with study schedule|0
760600|NCT00485134|2423019|P2|Overall Study|Unable to comply with study schedule|0
760601|NCT00485134|2423020|P1|Overall Study|Unable to comply with study schedule|0
760602|NCT00485134|2423013|P8|Overall Study|Non-compliance|0
760603|NCT00485134|2423014|P7|Overall Study|Non-compliance|2
760604|NCT00485134|2423015|P6|Overall Study|Non-compliance|2
760605|NCT00485134|2423016|P5|Overall Study|Non-compliance|1
760606|NCT00485134|2423017|P4|Overall Study|Non-compliance|0
760607|NCT00485134|2423018|P3|Overall Study|Non-compliance|0
760608|NCT00485134|2423019|P2|Overall Study|Non-compliance|0
760609|NCT00485134|2423020|P1|Overall Study|Non-compliance|0
760610|NCT00485134|2423013|P8|Overall Study|Positive drug test|0
760611|NCT00485134|2423014|P7|Overall Study|Positive drug test|0
760612|NCT00485134|2423015|P6|Overall Study|Positive drug test|1
760613|NCT00485134|2423016|P5|Overall Study|Positive drug test|2
760614|NCT00485134|2423017|P4|Overall Study|Positive drug test|0
760615|NCT00485134|2423018|P3|Overall Study|Positive drug test|0
760616|NCT00485134|2423019|P2|Overall Study|Positive drug test|0
760617|NCT00485134|2423020|P1|Overall Study|Positive drug test|0
760618|NCT00485134|2423013|P8|Overall Study|Withdrew for adverse event|0
760619|NCT00485134|2423014|P7|Overall Study|Withdrew for adverse event|0
760620|NCT00485134|2423015|P6|Overall Study|Withdrew for adverse event|0
760621|NCT00485134|2423016|P5|Overall Study|Withdrew for adverse event|0
760622|NCT00485134|2423017|P4|Overall Study|Withdrew for adverse event|0
760623|NCT00485134|2423018|P3|Overall Study|Withdrew for adverse event|1
760624|NCT00485134|2423019|P2|Overall Study|Withdrew for adverse event|0
760625|NCT00485134|2423020|P1|Overall Study|Withdrew for adverse event|0
760626|NCT00485134|2423013|P8|Overall Study|Change in health status|0
760627|NCT00485134|2423014|P7|Overall Study|Change in health status|0
760628|NCT00485134|2423015|P6|Overall Study|Change in health status|1
760629|NCT00485134|2423016|P5|Overall Study|Change in health status|0
760630|NCT00485134|2423017|P4|Overall Study|Change in health status|1
760631|NCT00485134|2423018|P3|Overall Study|Change in health status|2
760632|NCT00485134|2423019|P2|Overall Study|Change in health status|1
760633|NCT00485134|2423020|P1|Overall Study|Change in health status|0
760634|NCT00485134|2423013|P8|Overall Study|Withdrawal by Subject|0
760635|NCT00485134|2423014|P7|Overall Study|Withdrawal by Subject|0
760636|NCT00485134|2423015|P6|Overall Study|Withdrawal by Subject|0
760637|NCT00485134|2423016|P5|Overall Study|Withdrawal by Subject|0
760638|NCT00485134|2423017|P4|Overall Study|Withdrawal by Subject|0
760639|NCT00485134|2423018|P3|Overall Study|Withdrawal by Subject|0
760640|NCT00485134|2423019|P2|Overall Study|Withdrawal by Subject|1
760641|NCT00485134|2423020|P1|Overall Study|Withdrawal by Subject|0
760642|NCT00485134|2423013|P8|Overall Study|Lost to Follow-up|0
760643|NCT00485134|2423014|P7|Overall Study|Lost to Follow-up|0
760644|NCT00485134|2423015|P6|Overall Study|Lost to Follow-up|0
760645|NCT00485134|2423016|P5|Overall Study|Lost to Follow-up|0
760646|NCT00485134|2423017|P4|Overall Study|Lost to Follow-up|0
760647|NCT00485134|2423018|P3|Overall Study|Lost to Follow-up|0
760648|NCT00485134|2423019|P2|Overall Study|Lost to Follow-up|0
760649|NCT00485134|2423020|P1|Overall Study|Lost to Follow-up|1
760650|NCT00485173|2423042|P2|Overall Study|Lost to Follow-up|61
760651|NCT00485173|2423043|P1|Overall Study|Lost to Follow-up|32
760652|NCT00485173|2423042|P2|Overall Study|Death|3
760653|NCT00485173|2423043|P1|Overall Study|Death|4
760654|NCT00485264|2423089|P6|Overall Study|Data frozen before reaching week 48|0
760655|NCT00485264|2423090|P5|Overall Study|Data frozen before reaching week 48|0
760656|NCT00485264|2423091|P4|Overall Study|Data frozen before reaching week 48|9
760657|NCT00485264|2423092|P3|Overall Study|Data frozen before reaching week 48|0
760658|NCT00485264|2423093|P2|Overall Study|Data frozen before reaching week 48|0
760659|NCT00485264|2423094|P1|Overall Study|Data frozen before reaching week 48|0
760660|NCT00485264|2423089|P6|Overall Study|Lack of Efficacy|0
760661|NCT00485264|2423090|P5|Overall Study|Lack of Efficacy|0
760662|NCT00485264|2423091|P4|Overall Study|Lack of Efficacy|1
760663|NCT00485264|2423092|P3|Overall Study|Lack of Efficacy|0
760664|NCT00485264|2423093|P2|Overall Study|Lack of Efficacy|0
760665|NCT00485264|2423094|P1|Overall Study|Lack of Efficacy|0
760666|NCT00485264|2423089|P6|Overall Study|Physician Decision|0
760667|NCT00485264|2423090|P5|Overall Study|Physician Decision|0
760668|NCT00485264|2423091|P4|Overall Study|Physician Decision|0
760669|NCT00485264|2423092|P3|Overall Study|Physician Decision|0
760670|NCT00485264|2423093|P2|Overall Study|Physician Decision|1
760671|NCT00485264|2423094|P1|Overall Study|Physician Decision|0
760672|NCT00485264|2423089|P6|Overall Study|Non-compliant|0
760673|NCT00485264|2423090|P5|Overall Study|Non-compliant|0
760674|NCT00485264|2423091|P4|Overall Study|Non-compliant|0
760675|NCT00485264|2423092|P3|Overall Study|Non-compliant|0
760676|NCT00485264|2423093|P2|Overall Study|Non-compliant|0
760677|NCT00485264|2423094|P1|Overall Study|Non-compliant|6
760678|NCT00485303|2423178|P1|Overall Study|Treatment ongoing at cutoff date|2
760679|NCT00485303|2423178|P1|Overall Study|Initiation of new anti-cancer treatment|2
760680|NCT00485303|2423178|P1|Overall Study|Unspecified|3
760681|NCT00485303|2423178|P1|Overall Study|Progressive Disease|44
760682|NCT00485303|2423178|P1|Overall Study|Adverse Event|5
760683|NCT00485472|2423207|P2|Overall Study|Lost to Follow-up|1
760684|NCT00485472|2423208|P1|Overall Study|Lost to Follow-up|0
760685|NCT00485472|2423207|P2|Overall Study|Unspecified|1
760686|NCT00485472|2423208|P1|Overall Study|Unspecified|2
760687|NCT00485472|2423207|P2|Overall Study|Protocol Violation|1
760688|NCT00485472|2423208|P1|Overall Study|Protocol Violation|0
760689|NCT00485472|2423207|P2|Overall Study|Withdrawal by Subject|0
760690|NCT00485472|2423208|P1|Overall Study|Withdrawal by Subject|1
760691|NCT00485472|2423207|P2|Overall Study|Lack of Efficacy|4
760692|NCT00485472|2423208|P1|Overall Study|Lack of Efficacy|5
760693|NCT00485472|2423207|P2|Overall Study|Adverse Event|5
760694|NCT00485472|2423208|P1|Overall Study|Adverse Event|8
760695|NCT00486954|2423238|P5|Randomized Part|Sponsor Terminated Study|13
760696|NCT00486954|2423239|P4|Randomized Part|Sponsor Terminated Study|19
760697|NCT00486954|2423240|P3|Randomized Part|Sponsor Terminated Study|0
760698|NCT00486954|2423241|P2|Randomized Part|Sponsor Terminated Study|0
760699|NCT00486954|2423242|P1|Randomized Part|Sponsor Terminated Study|0
760700|NCT00486954|2423238|P5|Randomized Part|Withdrawal by Subject|0
760701|NCT00486954|2423239|P4|Randomized Part|Withdrawal by Subject|1
760702|NCT00486954|2423240|P3|Randomized Part|Withdrawal by Subject|0
760703|NCT00486954|2423241|P2|Randomized Part|Withdrawal by Subject|0
760704|NCT00486954|2423242|P1|Randomized Part|Withdrawal by Subject|0
760705|NCT00486954|2423238|P5|Randomized Part|Lost to Follow-up|1
760706|NCT00486954|2423239|P4|Randomized Part|Lost to Follow-up|0
760707|NCT00486954|2423240|P3|Randomized Part|Lost to Follow-up|0
760708|NCT00486954|2423241|P2|Randomized Part|Lost to Follow-up|0
760709|NCT00486954|2423242|P1|Randomized Part|Lost to Follow-up|0
760710|NCT00486954|2423238|P5|Pilot Part|Disease Progression|0
760711|NCT00486954|2423239|P4|Pilot Part|Disease Progression|0
760712|NCT00486954|2423240|P3|Pilot Part|Disease Progression|1
760713|NCT00486954|2423241|P2|Pilot Part|Disease Progression|0
760714|NCT00486954|2423242|P1|Pilot Part|Disease Progression|2
760715|NCT00486954|2423238|P5|Pilot Part|Adverse Event|0
760716|NCT00486954|2423239|P4|Pilot Part|Adverse Event|0
760717|NCT00486954|2423240|P3|Pilot Part|Adverse Event|5
760718|NCT00486954|2423241|P2|Pilot Part|Adverse Event|0
760719|NCT00486954|2423242|P1|Pilot Part|Adverse Event|4
760720|NCT00487084|2423341|P3|Overall Study|Did not receive intervention|5
760721|NCT00487084|2423342|P2|Overall Study|Did not receive intervention|3
760722|NCT00487084|2423343|P1|Overall Study|Did not receive intervention|4
760723|NCT00487162|2423362|P2|Overall Study|Withdrawal by Subject|3
760724|NCT00487162|2423363|P1|Overall Study|Withdrawal by Subject|2
760725|NCT00487162|2423362|P2|Overall Study|Physician Decision|1
760726|NCT00487162|2423363|P1|Overall Study|Physician Decision|0
760727|NCT00487162|2423362|P2|Overall Study|Adverse Event|1
760728|NCT00487162|2423363|P1|Overall Study|Adverse Event|0
760729|NCT00487188|2423373|P3|Maintenance Phase|Administrative|1
760730|NCT00487188|2423374|P2|Maintenance Phase|Administrative|0
760731|NCT00487188|2423375|P1|Maintenance Phase|Administrative|0
760732|NCT00487188|2423373|P3|Maintenance Phase|Lost to Follow-up|0
760733|NCT00487188|2423374|P2|Maintenance Phase|Lost to Follow-up|0
760734|NCT00487188|2423375|P1|Maintenance Phase|Lost to Follow-up|1
760735|NCT00487188|2423373|P3|Maintenance Phase|Death|0
760736|NCT00487188|2423374|P2|Maintenance Phase|Death|0
760737|NCT00487188|2423375|P1|Maintenance Phase|Death|1
760738|NCT00487188|2423373|P3|Maintenance Phase|Adverse Event|0
760739|NCT00487188|2423374|P2|Maintenance Phase|Adverse Event|0
760740|NCT00487188|2423375|P1|Maintenance Phase|Adverse Event|1
760741|NCT00487188|2423373|P3|Induction Phase|Administrative|0
760742|NCT00487188|2423374|P2|Induction Phase|Administrative|1
760743|NCT00487188|2423375|P1|Induction Phase|Administrative|0
760744|NCT00487188|2423373|P3|Induction Phase|Lost to Follow-up|0
760745|NCT00487188|2423374|P2|Induction Phase|Lost to Follow-up|2
760746|NCT00487188|2423375|P1|Induction Phase|Lost to Follow-up|2
760747|NCT00487188|2423373|P3|Induction Phase|Refused Treatment|0
760748|NCT00487188|2423374|P2|Induction Phase|Refused Treatment|2
760749|NCT00487188|2423375|P1|Induction Phase|Refused Treatment|1
760750|NCT00487188|2423373|P3|Induction Phase|Protocol Violation|0
760751|NCT00487188|2423374|P2|Induction Phase|Protocol Violation|0
760752|NCT00487188|2423375|P1|Induction Phase|Protocol Violation|1
760753|NCT00487188|2423373|P3|Induction Phase|Lack of Efficacy|0
760754|NCT00487188|2423374|P2|Induction Phase|Lack of Efficacy|1
760755|NCT00487188|2423375|P1|Induction Phase|Lack of Efficacy|0
760756|NCT00487188|2423373|P3|Induction Phase|Adverse Event|0
760757|NCT00487188|2423374|P2|Induction Phase|Adverse Event|0
760758|NCT00487188|2423375|P1|Induction Phase|Adverse Event|5
760759|NCT00487188|2423373|P3|Induction Phase|Abnormality of Laboratory Test|0
760760|NCT00487188|2423374|P2|Induction Phase|Abnormality of Laboratory Test|1
760761|NCT00487188|2423375|P1|Induction Phase|Abnormality of Laboratory Test|0
760762|NCT00487240|2423414|P2|Overall Study|Physician Decision|0
760763|NCT00487240|2423415|P1|Overall Study|Physician Decision|2
760764|NCT00487240|2423414|P2|Overall Study|Sponsor Decision|1
760765|NCT00487240|2423415|P1|Overall Study|Sponsor Decision|2
760766|NCT00487240|2423414|P2|Overall Study|Entry Criteria Not Met|4
760767|NCT00487240|2423415|P1|Overall Study|Entry Criteria Not Met|3
760768|NCT00487240|2423414|P2|Overall Study|Protocol Violation|5
760769|NCT00487240|2423415|P1|Overall Study|Protocol Violation|5
760770|NCT00487240|2423414|P2|Overall Study|Adverse Event|4
760771|NCT00487240|2423415|P1|Overall Study|Adverse Event|0
760772|NCT00487240|2423414|P2|Overall Study|Lost to Follow-up|6
760773|NCT00487240|2423415|P1|Overall Study|Lost to Follow-up|7
760774|NCT00487240|2423414|P2|Overall Study|Withdrawal by Subject|6
760775|NCT00487240|2423415|P1|Overall Study|Withdrawal by Subject|12
760776|NCT00487279|2423443|P2|Overall Study|Withdrawal by Subject|2
760777|NCT00487279|2423444|P1|Overall Study|Withdrawal by Subject|0
760778|NCT00487279|2423443|P2|Overall Study|Death|0
760779|NCT00487279|2423444|P1|Overall Study|Death|1
760780|NCT00487435|2423458|P1|Overall Study|Other|83
760781|NCT00487435|2423458|P1|Overall Study|Study Medication Non-Compliant|32
760782|NCT00487435|2423458|P1|Overall Study|Resolution Of Pain|1
760783|NCT00487435|2423458|P1|Overall Study|Withdrawal by Subject|132
760784|NCT00487435|2423458|P1|Overall Study|Pregnancy|2
760785|NCT00487435|2423458|P1|Overall Study|Lost to Follow-up|54
760786|NCT00487435|2423458|P1|Overall Study|Lack of Efficacy|33
760787|NCT00487435|2423458|P1|Overall Study|Death|2
760788|NCT00487435|2423458|P1|Overall Study|Adverse Event|146
891267|NCT02570165|2827346|P4|Overall Study|Withdrawal by Subject|2
891268|NCT02570165|2827347|P3|Overall Study|Withdrawal by Subject|0
891269|NCT02570165|2827348|P2|Overall Study|Withdrawal by Subject|0
891270|NCT02570165|2827349|P1|Overall Study|Withdrawal by Subject|0
891271|NCT02570165|2827343|P7|Overall Study|Physician Decision|0
891272|NCT02570165|2827344|P6|Overall Study|Physician Decision|0
891273|NCT02570165|2827345|P5|Overall Study|Physician Decision|0
891274|NCT02570165|2827346|P4|Overall Study|Physician Decision|0
891275|NCT02570165|2827347|P3|Overall Study|Physician Decision|0
891276|NCT02570165|2827348|P2|Overall Study|Physician Decision|1
891277|NCT02570165|2827349|P1|Overall Study|Physician Decision|0
891278|NCT02570165|2827343|P7|Overall Study|Lost to Follow-up|0
760801|NCT00487552|2423504|P1|Overall Study|Stent not placed|1
760802|NCT00487552|2423504|P1|Overall Study|Death due to progressive malignancy|2
760803|NCT00487552|2423504|P1|Overall Study|Unsuccessful magnet placements|3
760804|NCT00487578|2423515|P2|Overall Study|Lost to Follow-up|1
760805|NCT00487578|2423516|P1|Overall Study|Lost to Follow-up|0
760806|NCT00487578|2423515|P2|Overall Study|Lack of Efficacy|1
760807|NCT00487578|2423516|P1|Overall Study|Lack of Efficacy|0
760808|NCT00487578|2423515|P2|Overall Study|Adverse Event|2
760809|NCT00487578|2423516|P1|Overall Study|Adverse Event|1
760810|NCT00487695|2423542|P2|Second Procedure|Withdrawal by Subject|2
760811|NCT00487695|2423543|P1|Second Procedure|Withdrawal by Subject|1
760812|NCT00487695|2423542|P2|Second Procedure|active wheezing|1
760813|NCT00487695|2423543|P1|Second Procedure|active wheezing|0
760814|NCT00487695|2423542|P2|First Procedure|esophageal stricture found (excl crit)|0
760815|NCT00487695|2423543|P1|First Procedure|esophageal stricture found (excl crit)|1
760816|NCT00487695|2423542|P2|First Procedure|active wheezing (did not have procedure)|0
760817|NCT00487695|2423543|P1|First Procedure|active wheezing (did not have procedure)|1
760818|NCT00487695|2423542|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
760819|NCT00487695|2423543|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
760820|NCT00487747|2423567|P1|Overall Study|Lack of Efficacy|1
760821|NCT00487747|2423567|P1|Overall Study|Lost to Follow-up|9
760822|NCT00487747|2423567|P1|Overall Study|Adverse Event|1
760823|NCT00487825|2423578|P2|Overall Study|not specified|2
760824|NCT00487825|2423579|P1|Overall Study|not specified|3
760825|NCT00487825|2423578|P2|Overall Study|Lack of Efficacy|1
760826|NCT00487825|2423579|P1|Overall Study|Lack of Efficacy|1
760827|NCT00487825|2423578|P2|Overall Study|Adverse Event|2
760828|NCT00487825|2423579|P1|Overall Study|Adverse Event|2
760829|NCT00487942|2423595|P4|Overall Study|Withdrawal by Subject|0
760830|NCT00487942|2423596|P3|Overall Study|Withdrawal by Subject|2
760831|NCT00487942|2423597|P2|Overall Study|Withdrawal by Subject|1
760832|NCT00487942|2423598|P1|Overall Study|Withdrawal by Subject|0
760833|NCT00487942|2423595|P4|Overall Study|Protocol Violation|0
760834|NCT00487942|2423596|P3|Overall Study|Protocol Violation|0
760835|NCT00487942|2423597|P2|Overall Study|Protocol Violation|1
760836|NCT00487942|2423598|P1|Overall Study|Protocol Violation|1
760837|NCT00487942|2423595|P4|Overall Study|Lost to Follow-up|1
760838|NCT00487942|2423596|P3|Overall Study|Lost to Follow-up|0
760839|NCT00487942|2423597|P2|Overall Study|Lost to Follow-up|0
760840|NCT00487942|2423598|P1|Overall Study|Lost to Follow-up|1
760841|NCT00487942|2423595|P4|Overall Study|Adverse Event|1
760842|NCT00487942|2423596|P3|Overall Study|Adverse Event|1
760843|NCT00487942|2423597|P2|Overall Study|Adverse Event|1
760844|NCT00487942|2423598|P1|Overall Study|Adverse Event|1
760845|NCT00487981|2423980|P1|Overall Study|Hypothyroidism diagnosis|1
760846|NCT00488033|2423986|P2|Overall Study|Withdrawal by Subject|0
760847|NCT00488033|2423987|P1|Overall Study|Withdrawal by Subject|1
760848|NCT00488293|2424024|P2|Overall Study|Misrandomization/Other Unspecified|1
760849|NCT00488293|2424025|P1|Overall Study|Misrandomization/Other Unspecified|1
760850|NCT00488293|2424024|P2|Overall Study|Death|1
760851|NCT00488293|2424025|P1|Overall Study|Death|2
760852|NCT00488293|2424024|P2|Overall Study|Withdrawal by Subject|3
760853|NCT00488293|2424025|P1|Overall Study|Withdrawal by Subject|5
760854|NCT00488293|2424024|P2|Overall Study|Lost to Follow-up|25
760855|NCT00488293|2424025|P1|Overall Study|Lost to Follow-up|28
760856|NCT00488319|2424052|P3|Overall Study|Other reasons for withdrawal|12
760857|NCT00488319|2424053|P2|Overall Study|Other reasons for withdrawal|4
760858|NCT00488319|2424054|P1|Overall Study|Other reasons for withdrawal|0
760859|NCT00488319|2424052|P3|Overall Study|Withdrawal by Subject|44
760860|NCT00488319|2424053|P2|Overall Study|Withdrawal by Subject|20
760861|NCT00488319|2424054|P1|Overall Study|Withdrawal by Subject|5
760862|NCT00488319|2424052|P3|Overall Study|Lost to Follow-up|16
760863|NCT00488319|2424053|P2|Overall Study|Lost to Follow-up|5
760864|NCT00488319|2424054|P1|Overall Study|Lost to Follow-up|3
760865|NCT00488319|2424052|P3|Overall Study|Lack of Efficacy|27
760866|NCT00488319|2424053|P2|Overall Study|Lack of Efficacy|12
760867|NCT00488319|2424054|P1|Overall Study|Lack of Efficacy|6
760868|NCT00488319|2424052|P3|Overall Study|Adverse Event|23
760869|NCT00488319|2424053|P2|Overall Study|Adverse Event|2
760870|NCT00488319|2424054|P1|Overall Study|Adverse Event|1
760871|NCT00488345|2424142|P3|Overall Study|Parent/legal guardian request|1
760872|NCT00488345|2424143|P2|Overall Study|Parent/legal guardian request|1
760873|NCT00488345|2424144|P1|Overall Study|Parent/legal guardian request|0
760874|NCT00488345|2424142|P3|Overall Study|Surgical team recommendation|0
760875|NCT00488345|2424143|P2|Overall Study|Surgical team recommendation|1
760876|NCT00488345|2424144|P1|Overall Study|Surgical team recommendation|0
760877|NCT00488345|2424142|P3|Overall Study|Institutional Review Board review|1
760878|NCT00488345|2424143|P2|Overall Study|Institutional Review Board review|0
760879|NCT00488345|2424144|P1|Overall Study|Institutional Review Board review|0
760880|NCT00488345|2424142|P3|Overall Study|Unable to administer antibiotics at home|0
760881|NCT00488345|2424143|P2|Overall Study|Unable to administer antibiotics at home|1
760882|NCT00488345|2424144|P1|Overall Study|Unable to administer antibiotics at home|0
760883|NCT00488345|2424142|P3|Overall Study|Adverse Event|1
760884|NCT00488345|2424143|P2|Overall Study|Adverse Event|1
760885|NCT00488345|2424144|P1|Overall Study|Adverse Event|0
760886|NCT00488475|2424167|P1|Overall Study|Unspecified|1754
760887|NCT00488514|2424208|P1|Overall Study|Increased use of concomitant medication|1
760888|NCT00488514|2424208|P1|Overall Study|Increase in number of migraines|2
760889|NCT00488514|2424208|P1|Overall Study|Participant had too few migraines|5
760890|NCT00488514|2424208|P1|Overall Study|Investigator decision|1
760891|NCT00488514|2424208|P1|Overall Study|Withdrawn per medical monitor decision|2
760892|NCT00488514|2424208|P1|Overall Study|Postive drug screen|1
760893|NCT00488514|2424208|P1|Overall Study|Did not meet criteria for treatment|30
760894|NCT00488514|2424208|P1|Overall Study|Lack of Efficacy|28
760895|NCT00488514|2424208|P1|Overall Study|Withdrawal by Subject|106
760896|NCT00488514|2424208|P1|Overall Study|Protocol Violation|32
760897|NCT00488514|2424208|P1|Overall Study|Lost to Follow-up|44
760898|NCT00488514|2424208|P1|Overall Study|Adverse Event|41
760899|NCT00488592|2424281|P1|Overall Study|Enrolled but not treated|1
760900|NCT00488592|2424281|P1|Overall Study|Disease progression|1
760901|NCT00488592|2424281|P1|Overall Study|Withdrawal by Subject|1
760902|NCT00488618|2424287|P2|Overall Study|Lost to Follow-up|0
760903|NCT00488618|2424288|P1|Overall Study|Lost to Follow-up|1
760904|NCT00488618|2424287|P2|Overall Study|Withdrawal of Consent|13
760905|NCT00488618|2424288|P1|Overall Study|Withdrawal of Consent|15
760906|NCT00488618|2424287|P2|Overall Study|Protocol Violation|2
760907|NCT00488618|2424288|P1|Overall Study|Protocol Violation|0
760908|NCT00488618|2424287|P2|Overall Study|Insufficient Therapeutic Response|11
760909|NCT00488618|2424288|P1|Overall Study|Insufficient Therapeutic Response|18
760910|NCT00488618|2424287|P2|Overall Study|Adverse Event|17
760911|NCT00488618|2424288|P1|Overall Study|Adverse Event|13
760912|NCT00488631|2424302|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760913|NCT00488631|2424303|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
760914|NCT00488631|2424304|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
760915|NCT00488631|2424305|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
760916|NCT00488631|2424306|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760917|NCT00488631|2424307|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760918|NCT00488631|2424308|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760919|NCT00488631|2424309|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760920|NCT00488631|2424310|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760921|NCT00488631|2424311|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
760922|NCT00488631|2424302|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760923|NCT00488631|2424303|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
760924|NCT00488631|2424304|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760925|NCT00488631|2424305|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
760926|NCT00488631|2424306|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760927|NCT00488631|2424307|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760928|NCT00488631|2424308|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760929|NCT00488631|2424309|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760930|NCT00488631|2424310|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760931|NCT00488631|2424311|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
760932|NCT00488631|2424302|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
760933|NCT00488631|2424303|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
760934|NCT00488631|2424304|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
760935|NCT00488631|2424305|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
760936|NCT00488631|2424306|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760937|NCT00488631|2424307|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760938|NCT00488631|2424308|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760939|NCT00488631|2424309|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760940|NCT00488631|2424310|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760941|NCT00488631|2424311|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
760942|NCT00488631|2424302|P10|Open Label Study Extension (Week 54-228)|Death|0
760943|NCT00488631|2424303|P9|Open Label Study Extension (Week 54-228)|Death|1
760944|NCT00488631|2424304|P8|Open Label Study Extension (Week 54-228)|Death|0
760945|NCT00488631|2424305|P7|Open Label Study Extension (Week 54-228)|Death|0
760946|NCT00488631|2424306|P6|Open Label Study Extension (Week 54-228)|Death|0
760947|NCT00488631|2424307|P5|Open Label Study Extension (Week 54-228)|Death|0
760948|NCT00488631|2424308|P4|Open Label Study Extension (Week 54-228)|Death|0
760949|NCT00488631|2424309|P3|Open Label Study Extension (Week 54-228)|Death|0
760950|NCT00488631|2424310|P2|Open Label Study Extension (Week 54-228)|Death|0
760951|NCT00488631|2424311|P1|Open Label Study Extension (Week 54-228)|Death|0
760952|NCT00488631|2424302|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
760953|NCT00488631|2424303|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
760954|NCT00488631|2424304|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
760955|NCT00488631|2424305|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
760956|NCT00488631|2424306|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
760957|NCT00488631|2424307|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
760958|NCT00488631|2424308|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
760959|NCT00488631|2424309|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
760960|NCT00488631|2424310|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
760961|NCT00488631|2424311|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
760962|NCT00488631|2424302|P10|Double Blind Period (Week 0-54)|Unspecified|0
760963|NCT00488631|2424303|P9|Double Blind Period (Week 0-54)|Unspecified|0
760964|NCT00488631|2424304|P8|Double Blind Period (Week 0-54)|Unspecified|0
760965|NCT00488631|2424305|P7|Double Blind Period (Week 0-54)|Unspecified|0
760966|NCT00488631|2424306|P6|Double Blind Period (Week 0-54)|Unspecified|34
760967|NCT00488631|2424307|P5|Double Blind Period (Week 0-54)|Unspecified|14
760968|NCT00488631|2424308|P4|Double Blind Period (Week 0-54)|Unspecified|11
760969|NCT00488631|2424309|P3|Double Blind Period (Week 0-54)|Unspecified|10
760970|NCT00488631|2424310|P2|Double Blind Period (Week 0-54)|Unspecified|12
760971|NCT00488631|2424311|P1|Double Blind Period (Week 0-54)|Unspecified|6
760972|NCT00488631|2424302|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
760973|NCT00488631|2424303|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
760974|NCT00488631|2424304|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
760975|NCT00488631|2424305|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
760976|NCT00488631|2424306|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
760977|NCT00488631|2424307|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
760978|NCT00488631|2424308|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
760979|NCT00488631|2424309|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
760980|NCT00488631|2424310|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
760981|NCT00488631|2424311|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
760982|NCT00488631|2424302|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
760983|NCT00488631|2424303|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
760984|NCT00488631|2424304|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
760985|NCT00488631|2424305|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
760986|NCT00488631|2424306|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
760987|NCT00488631|2424307|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
760988|NCT00488631|2424308|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
760989|NCT00488631|2424309|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
760990|NCT00488631|2424310|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
760991|NCT00488631|2424311|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
760992|NCT00488631|2424302|P10|Double Blind Period (Week 0-54)|Death|0
760993|NCT00488631|2424303|P9|Double Blind Period (Week 0-54)|Death|0
760994|NCT00488631|2424304|P8|Double Blind Period (Week 0-54)|Death|0
760995|NCT00488631|2424305|P7|Double Blind Period (Week 0-54)|Death|0
760996|NCT00488631|2424306|P6|Double Blind Period (Week 0-54)|Death|1
760997|NCT00488631|2424307|P5|Double Blind Period (Week 0-54)|Death|0
760998|NCT00488631|2424308|P4|Double Blind Period (Week 0-54)|Death|0
760999|NCT00488631|2424309|P3|Double Blind Period (Week 0-54)|Death|0
761000|NCT00488631|2424310|P2|Double Blind Period (Week 0-54)|Death|0
761001|NCT00488631|2424311|P1|Double Blind Period (Week 0-54)|Death|0
761002|NCT00488631|2424302|P10|Double Blind Period (Week 0-54)|Adverse Event|0
761003|NCT00488631|2424303|P9|Double Blind Period (Week 0-54)|Adverse Event|0
761004|NCT00488631|2424304|P8|Double Blind Period (Week 0-54)|Adverse Event|0
761005|NCT00488631|2424305|P7|Double Blind Period (Week 0-54)|Adverse Event|0
761006|NCT00488631|2424306|P6|Double Blind Period (Week 0-54)|Adverse Event|50
761007|NCT00488631|2424307|P5|Double Blind Period (Week 0-54)|Adverse Event|30
761008|NCT00488631|2424308|P4|Double Blind Period (Week 0-54)|Adverse Event|12
761009|NCT00488631|2424309|P3|Double Blind Period (Week 0-54)|Adverse Event|12
761010|NCT00488631|2424310|P2|Double Blind Period (Week 0-54)|Adverse Event|12
761011|NCT00488631|2424311|P1|Double Blind Period (Week 0-54)|Adverse Event|17
761012|NCT00488644|2424346|P1|Overall Study|Not Evaluable|1
761013|NCT00488644|2424346|P1|Overall Study|Not Eligible|1
891279|NCT02570165|2827344|P6|Overall Study|Lost to Follow-up|0
891280|NCT02570165|2827345|P5|Overall Study|Lost to Follow-up|0
891281|NCT02570165|2827346|P4|Overall Study|Lost to Follow-up|1
891282|NCT02570165|2827347|P3|Overall Study|Lost to Follow-up|1
891283|NCT02570165|2827348|P2|Overall Study|Lost to Follow-up|0
891284|NCT02570165|2827349|P1|Overall Study|Lost to Follow-up|0
891285|NCT02570165|2827343|P7|Overall Study|Par. Reached Stopping Criteria|0
891286|NCT02570165|2827344|P6|Overall Study|Par. Reached Stopping Criteria|1
891287|NCT02570165|2827345|P5|Overall Study|Par. Reached Stopping Criteria|1
891288|NCT02570165|2827346|P4|Overall Study|Par. Reached Stopping Criteria|2
891289|NCT02570165|2827347|P3|Overall Study|Par. Reached Stopping Criteria|0
891290|NCT02570165|2827348|P2|Overall Study|Par. Reached Stopping Criteria|1
891291|NCT02570165|2827349|P1|Overall Study|Par. Reached Stopping Criteria|1
891292|NCT02570165|2827343|P7|Overall Study|Lack of Efficacy|0
891293|NCT02570165|2827344|P6|Overall Study|Lack of Efficacy|0
891294|NCT02570165|2827345|P5|Overall Study|Lack of Efficacy|4
891295|NCT02570165|2827346|P4|Overall Study|Lack of Efficacy|0
891296|NCT02570165|2827347|P3|Overall Study|Lack of Efficacy|0
891297|NCT02570165|2827348|P2|Overall Study|Lack of Efficacy|1
891298|NCT02570165|2827349|P1|Overall Study|Lack of Efficacy|0
891299|NCT02570165|2827343|P7|Overall Study|Adverse Event|0
891300|NCT02570165|2827344|P6|Overall Study|Adverse Event|0
891301|NCT02570165|2827345|P5|Overall Study|Adverse Event|0
761038|NCT00488826|2424438|P3|Overall Study|Protocol Deviations|1
761039|NCT00488826|2424439|P2|Overall Study|Protocol Deviations|1
761040|NCT00488826|2424440|P1|Overall Study|Protocol Deviations|2
761041|NCT00488826|2424438|P3|Overall Study|Lost to Follow-up|0
761042|NCT00488826|2424439|P2|Overall Study|Lost to Follow-up|1
761043|NCT00488826|2424440|P1|Overall Study|Lost to Follow-up|5
761044|NCT00488826|2424438|P3|Overall Study|Adverse Event|4
761045|NCT00488826|2424439|P2|Overall Study|Adverse Event|15
761046|NCT00488826|2424440|P1|Overall Study|Adverse Event|9
761047|NCT00488826|2424438|P3|Overall Study|Protocol Violation|2
761048|NCT00488826|2424439|P2|Overall Study|Protocol Violation|0
761049|NCT00488826|2424440|P1|Overall Study|Protocol Violation|0
761050|NCT00488826|2424438|P3|Overall Study|Withdrawal by Subject|19
761051|NCT00488826|2424439|P2|Overall Study|Withdrawal by Subject|35
761052|NCT00488826|2424440|P1|Overall Study|Withdrawal by Subject|40
761053|NCT00489216|2424461|P1|Overall Study|Adverse Event|1
761054|NCT00489255|2424472|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
761055|NCT00489255|2424473|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
761056|NCT00489255|2424472|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
761057|NCT00489255|2424473|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
761058|NCT00489255|2424472|P2|Period 3: Days 57 to 84|Adverse Event|3
761059|NCT00489255|2424473|P1|Period 3: Days 57 to 84|Adverse Event|3
761060|NCT00489255|2424472|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
761061|NCT00489255|2424473|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
761062|NCT00489255|2424472|P2|Period 2: Days 29 to 56|Adverse Event|1
761063|NCT00489255|2424473|P1|Period 2: Days 29 to 56|Adverse Event|3
761064|NCT00489255|2424472|P2|Period 1: Days 1 to 28|Noncompliance|0
761065|NCT00489255|2424473|P1|Period 1: Days 1 to 28|Noncompliance|2
761066|NCT00489255|2424472|P2|Period 1: Days 1 to 28|Physician Decision|4
761067|NCT00489255|2424473|P1|Period 1: Days 1 to 28|Physician Decision|1
761068|NCT00489255|2424472|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
761069|NCT00489255|2424473|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
761070|NCT00489255|2424472|P2|Period 1: Days 1 to 28|Adverse Event|8
761071|NCT00489255|2424473|P1|Period 1: Days 1 to 28|Adverse Event|21
761072|NCT00489255|2424472|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
761073|NCT00489255|2424473|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
761074|NCT00489359|2424559|P2|Overall Study|Adverse Event|16
761075|NCT00489359|2424560|P1|Overall Study|Adverse Event|0
761076|NCT00489359|2424559|P2|Overall Study|Withdrawal by Subject|5
761077|NCT00489359|2424560|P1|Overall Study|Withdrawal by Subject|1
761078|NCT00489359|2424559|P2|Overall Study|Lost to Follow-up|0
761079|NCT00489359|2424560|P1|Overall Study|Lost to Follow-up|1
761080|NCT00489359|2424559|P2|Overall Study|Progressive Disease|6
761081|NCT00489359|2424560|P1|Overall Study|Progressive Disease|5
761082|NCT00489359|2424559|P2|Overall Study|Death|2
761083|NCT00489359|2424560|P1|Overall Study|Death|0
761084|NCT00489411|2424585|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
761085|NCT00489411|2424586|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
761086|NCT00489411|2424585|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
761087|NCT00489411|2424586|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
761088|NCT00489411|2424585|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
761089|NCT00489411|2424586|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
761090|NCT00489411|2424585|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
761091|NCT00489411|2424586|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
761092|NCT00489411|2424585|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
761093|NCT00489411|2424586|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
761094|NCT00489424|2424601|P3|Overall Study|Administrative problems|1
761095|NCT00489424|2424602|P2|Overall Study|Administrative problems|2
761096|NCT00489424|2424603|P1|Overall Study|Administrative problems|0
761097|NCT00489424|2424601|P3|Overall Study|Lack of Efficacy|0
761098|NCT00489424|2424602|P2|Overall Study|Lack of Efficacy|0
761099|NCT00489424|2424603|P1|Overall Study|Lack of Efficacy|1
761100|NCT00489424|2424601|P3|Overall Study|Adverse Event|4
761101|NCT00489424|2424602|P2|Overall Study|Adverse Event|3
761102|NCT00489424|2424603|P1|Overall Study|Adverse Event|3
761103|NCT00495495|2424632|P1|Overall Study|Protocol Violation|99
761104|NCT00495521|2424647|P2|Overall Study|Physician Decision|1
761105|NCT00495521|2424648|P1|Overall Study|Physician Decision|0
761106|NCT00495586|2424680|P2|Overall Study|Withdrawal by Subject|4
761107|NCT00495586|2424681|P1|Overall Study|Withdrawal by Subject|4
761108|NCT00495612|2424691|P2|Overall Study|Subject's Decision to Withdraw|0
761109|NCT00495612|2424692|P1|Overall Study|Subject's Decision to Withdraw|3
761110|NCT00495612|2424691|P2|Overall Study|Lost to Follow-up|0
761111|NCT00495612|2424692|P1|Overall Study|Lost to Follow-up|1
761112|NCT00495625|2424708|P1|Overall Study|Did not complete at least 1 42 day cycle|10
761113|NCT00495677|2424724|P7|Stage 1 (25 Days)|Adverse Event|0
761114|NCT00495677|2424725|P6|Stage 1 (25 Days)|Adverse Event|0
761115|NCT00495677|2424726|P5|Stage 1 (25 Days)|Adverse Event|0
761116|NCT00495677|2424727|P4|Stage 1 (25 Days)|Adverse Event|0
761117|NCT00495677|2424728|P3|Stage 1 (25 Days)|Adverse Event|1
761118|NCT00495677|2424729|P2|Stage 1 (25 Days)|Adverse Event|0
761119|NCT00495677|2424730|P1|Stage 1 (25 Days)|Adverse Event|0
761120|NCT00495755|2424785|P1|Overall Study|Adverse Event|3
761121|NCT00495794|2424792|P2|Overall Study|Pharmacist did not activate patient|0
761122|NCT00495794|2424793|P1|Overall Study|Pharmacist did not activate patient|522
761123|NCT00496054|2424803|P1|Overall Study|Lost to Follow-up|7
761124|NCT00496054|2424803|P1|Overall Study|Adverse Event|1
761125|NCT00496080|2424830|P1|Overall Study|Physician Decision|6
761126|NCT00496080|2424830|P1|Overall Study|Withdrawal by Subject|5
761127|NCT00496080|2424830|P1|Overall Study|Surgical re-intervention|7
761128|NCT00496080|2424830|P1|Overall Study|Lost to Follow-up|9
761129|NCT00496197|2424840|P1|Overall Study|Protocol Violation|8
761130|NCT00496197|2424840|P1|Overall Study|Unspecified|14
761131|NCT00496197|2424840|P1|Overall Study|Pathogen not isolated baseline specimen|4
761132|NCT00496197|2424840|P1|Overall Study|Withdrawal by Subject|11
761133|NCT00496197|2424840|P1|Overall Study|Lost to Follow-up|11
761134|NCT00496197|2424840|P1|Overall Study|Insufficient bacteriological response|10
761135|NCT00496197|2424840|P1|Overall Study|Insufficient clinical response|3
761136|NCT00496197|2424840|P1|Overall Study|Does not meet entrance criteria|5
761137|NCT00496197|2424840|P1|Overall Study|Adverse Event|13
761138|NCT00496197|2424840|P1|Overall Study|Discontinued study due to death|43
761139|NCT00496366|2424893|P1|Overall Study|Death|1
761140|NCT00496470|2424908|P2|Overall Study|Other reason|2
761141|NCT00496470|2424909|P1|Overall Study|Other reason|0
761142|NCT00496470|2424908|P2|Overall Study|Incorrectly enrolled|5
761143|NCT00496470|2424909|P1|Overall Study|Incorrectly enrolled|13
761144|NCT00496470|2424908|P2|Overall Study|Withdrawal by Subject|12
761145|NCT00496470|2424909|P1|Overall Study|Withdrawal by Subject|5
761146|NCT00496470|2424908|P2|Overall Study|Adverse Event|10
761147|NCT00496470|2424909|P1|Overall Study|Adverse Event|8
761148|NCT00496483|2424987|P1|Overall Study|Lack of Efficacy|1
761149|NCT00496483|2424987|P1|Overall Study|Adverse Event|2
761150|NCT00496483|2424987|P1|Overall Study|Not dosed|9
761151|NCT00496587|2425002|P1|Overall Study|Complications unrelated|2
761152|NCT00496587|2425002|P1|Overall Study|Death|1
761153|NCT00496587|2425002|P1|Overall Study|Withdrawal by Subject|2
761154|NCT00496587|2425002|P1|Overall Study|Progressive Disease|24
761155|NCT00496587|2425002|P1|Overall Study|Adverse Event|2
761156|NCT00496626|2425010|P2|Overall Study|Relocated|1
761157|NCT00496626|2425011|P1|Overall Study|Relocated|0
761158|NCT00496626|2425010|P2|Overall Study|Withdrawal by Subject|4
761159|NCT00496626|2425011|P1|Overall Study|Withdrawal by Subject|5
761160|NCT00496626|2425010|P2|Overall Study|Protocol Violation|0
761161|NCT00496626|2425011|P1|Overall Study|Protocol Violation|1
761162|NCT00496626|2425010|P2|Overall Study|Lost to Follow-up|1
761163|NCT00496626|2425011|P1|Overall Study|Lost to Follow-up|0
761164|NCT00496730|2425025|P2|Overall Study|Withdrawal by Subject|2
761165|NCT00496730|2425026|P1|Overall Study|Withdrawal by Subject|2
761166|NCT00496730|2425025|P2|Overall Study|Lost to Follow-up|3
761167|NCT00496730|2425026|P1|Overall Study|Lost to Follow-up|4
891302|NCT02570165|2827346|P4|Overall Study|Adverse Event|0
891303|NCT02570165|2827347|P3|Overall Study|Adverse Event|2
761170|NCT00496782|2425063|P2|Overall Study|Protocol Violation|2
761171|NCT00496782|2425064|P1|Overall Study|Protocol Violation|1
761172|NCT00496834|2425103|P2|Overall Study|Blood Pressure control failure|1
761173|NCT00496834|2425104|P1|Overall Study|Blood Pressure control failure|2
761174|NCT00496834|2425103|P2|Overall Study|Lost to Follow-up|0
761175|NCT00496834|2425104|P1|Overall Study|Lost to Follow-up|2
761176|NCT00496834|2425103|P2|Overall Study|IP administration violation|0
761177|NCT00496834|2425104|P1|Overall Study|IP administration violation|2
761178|NCT00496834|2425103|P2|Overall Study|Adverse Event|3
761179|NCT00496834|2425104|P1|Overall Study|Adverse Event|5
761180|NCT00496834|2425103|P2|Overall Study|Inclusion/exclusion criteria not met|2
761181|NCT00496834|2425104|P1|Overall Study|Inclusion/exclusion criteria not met|3
761182|NCT00496834|2425103|P2|Overall Study|Contraindicated medication administered|1
761183|NCT00496834|2425104|P1|Overall Study|Contraindicated medication administered|0
761184|NCT00496834|2425103|P2|Overall Study|Withdrawal by Subject|6
761185|NCT00496834|2425104|P1|Overall Study|Withdrawal by Subject|4
761186|NCT00496873|2425141|P1|Overall Study|Withdrawal by Subject|3
761187|NCT00496873|2425141|P1|Overall Study|Death|2
761188|NCT00496873|2425141|P1|Overall Study|Ineligible|2
891304|NCT02570165|2827348|P2|Overall Study|Adverse Event|0
891305|NCT02570165|2827349|P1|Overall Study|Adverse Event|1
761191|NCT00497146|2425186|P2|Long-term Follow-up Period|Other|1
761192|NCT00497146|2425187|P1|Long-term Follow-up Period|Other|0
761193|NCT00497146|2425186|P2|Long-term Follow-up Period|Lost to Follow-up|1
761194|NCT00497146|2425187|P1|Long-term Follow-up Period|Lost to Follow-up|5
761195|NCT00497146|2425186|P2|Long-term Follow-up Period|Withdrawal by Subject|2
761196|NCT00497146|2425187|P1|Long-term Follow-up Period|Withdrawal by Subject|8
761197|NCT00497146|2425186|P2|Long-term Follow-up Period|Adverse Event|2
761198|NCT00497146|2425187|P1|Long-term Follow-up Period|Adverse Event|2
761199|NCT00497146|2425186|P2|Treatment Period|Other Reason|3
761200|NCT00497146|2425187|P1|Treatment Period|Other Reason|2
761201|NCT00497146|2425186|P2|Treatment Period|Unable to dose reduce per protocol|1
761202|NCT00497146|2425187|P1|Treatment Period|Unable to dose reduce per protocol|4
761203|NCT00497146|2425186|P2|Treatment Period|Change in RAAS inhibitor therapy|2
761204|NCT00497146|2425187|P1|Treatment Period|Change in RAAS inhibitor therapy|5
761205|NCT00497146|2425186|P2|Treatment Period|Required dialysis|1
761206|NCT00497146|2425187|P1|Treatment Period|Required dialysis|4
761207|NCT00497146|2425186|P2|Treatment Period|Lost to Follow-up|3
761208|NCT00497146|2425187|P1|Treatment Period|Lost to Follow-up|1
761209|NCT00497146|2425186|P2|Treatment Period|Withdrawal by Subject|9
761210|NCT00497146|2425187|P1|Treatment Period|Withdrawal by Subject|5
761211|NCT00497146|2425186|P2|Treatment Period|Adverse Event|2
761212|NCT00497146|2425187|P1|Treatment Period|Adverse Event|6
761213|NCT00497198|2425229|P2|Overall Study|Withdrawal by Subject|1
761214|NCT00497198|2425230|P1|Overall Study|Withdrawal by Subject|0
761215|NCT00497198|2425229|P2|Overall Study|Physician Decision|2
761216|NCT00497198|2425230|P1|Overall Study|Physician Decision|1
761217|NCT00497198|2425229|P2|Overall Study|Adverse Event|2
761218|NCT00497198|2425230|P1|Overall Study|Adverse Event|4
761219|NCT00497796|2425303|P2|Overall Study|Not applicable (randomized not treated)|4
761220|NCT00497796|2425304|P1|Overall Study|Not applicable (randomized not treated)|0
761221|NCT00497796|2425303|P2|Overall Study|Lost to Follow-up|1
761222|NCT00497796|2425304|P1|Overall Study|Lost to Follow-up|0
761223|NCT00497796|2425303|P2|Overall Study|Investigator/sponsor discretion|34
761224|NCT00497796|2425304|P1|Overall Study|Investigator/sponsor discretion|31
761225|NCT00497796|2425303|P2|Overall Study|Consent withdrawn|3
761226|NCT00497796|2425304|P1|Overall Study|Consent withdrawn|10
761227|NCT00497796|2425303|P2|Overall Study|CMV infection or disease treatment|4
761228|NCT00497796|2425304|P1|Overall Study|CMV infection or disease treatment|30
761229|NCT00497796|2425303|P2|Overall Study|Adverse event (related)|4
761230|NCT00497796|2425304|P1|Overall Study|Adverse event (related)|5
761231|NCT00497796|2425303|P2|Overall Study|Adverse event (not related)|9
761232|NCT00497796|2425304|P1|Overall Study|Adverse event (not related)|9
761233|NCT00497874|2425334|P2|Overall Study|Unable to schedule|24
761234|NCT00497874|2425335|P1|Overall Study|Unable to schedule|37
761235|NCT00497874|2425334|P2|Overall Study|Unable to contact|67
761236|NCT00497874|2425335|P1|Overall Study|Unable to contact|52
761237|NCT00497874|2425334|P2|Overall Study|Death|4
761238|NCT00497874|2425335|P1|Overall Study|Death|2
761239|NCT00497874|2425334|P2|Overall Study|Illness|4
761240|NCT00497874|2425335|P1|Overall Study|Illness|8
761241|NCT00497874|2425334|P2|Overall Study|Withdrawal by Subject|17
761242|NCT00497874|2425335|P1|Overall Study|Withdrawal by Subject|48
761243|NCT00498173|2425353|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
761244|NCT00498173|2425354|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
761245|NCT00498173|2425355|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
761246|NCT00498186|2425383|P1|Overall Study|Other|10
761247|NCT00498186|2425383|P1|Overall Study|Lost to Follow-up|3
761248|NCT00498186|2425383|P1|Overall Study|Withdrawal by Subject|18
761249|NCT00498186|2425383|P1|Overall Study|Unsatisfactory compliance of subject|12
761250|NCT00498186|2425383|P1|Overall Study|Adverse Event|89
761251|NCT00498186|2425383|P1|Overall Study|Lack of Efficacy|31
761252|NCT00498186|2425383|P1|Overall Study|Protocol Violation|10
761254|NCT00498368|2425394|P2|Overall Study|Withdrawal by Subject|2
761255|NCT00498368|2425395|P1|Overall Study|Withdrawal by Subject|3
761256|NCT00498433|2425410|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
761257|NCT00498433|2425411|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
761258|NCT00498433|2425412|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
761259|NCT00498433|2425410|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
761260|NCT00498433|2425411|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
761261|NCT00498433|2425412|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
761262|NCT00498433|2425410|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
761263|NCT00498433|2425411|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
761264|NCT00498433|2425412|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
761265|NCT00498433|2425410|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
761266|NCT00498433|2425411|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
761267|NCT00498433|2425412|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
761268|NCT00498485|2425457|P2|Overall Study|Adverse Event|5
761269|NCT00498485|2425458|P1|Overall Study|Adverse Event|1
761270|NCT00485732|2425480|P2|Overall Study|Lost to Follow-up|2
761271|NCT00485732|2425481|P1|Overall Study|Lost to Follow-up|2
761272|NCT00485732|2425480|P2|Overall Study|Withdrawal by Subject|4
761273|NCT00485732|2425481|P1|Overall Study|Withdrawal by Subject|5
761274|NCT00485732|2425480|P2|Overall Study|Protocol Violation|3
761275|NCT00485732|2425481|P1|Overall Study|Protocol Violation|1
761276|NCT00485758|2425503|P2|Overall Study|Study Terminated by Sponsor|0
761277|NCT00485758|2425504|P1|Overall Study|Study Terminated by Sponsor|3
761278|NCT00485758|2425503|P2|Overall Study|Withdrawal by Subject|27
761279|NCT00485758|2425504|P1|Overall Study|Withdrawal by Subject|32
761280|NCT00485758|2425503|P2|Overall Study|Protocol Violation|2
761281|NCT00485758|2425504|P1|Overall Study|Protocol Violation|11
761282|NCT00485758|2425503|P2|Overall Study|Physician Decision|3
761283|NCT00485758|2425504|P1|Overall Study|Physician Decision|3
761284|NCT00485758|2425503|P2|Overall Study|Lost to Follow-up|1
761285|NCT00485758|2425504|P1|Overall Study|Lost to Follow-up|5
761286|NCT00485758|2425503|P2|Overall Study|Death|1
761287|NCT00485758|2425504|P1|Overall Study|Death|0
761288|NCT00485758|2425503|P2|Overall Study|Adverse Event|31
761289|NCT00485758|2425504|P1|Overall Study|Adverse Event|102
761290|NCT00486044|2425587|P2|Overall Study|Lost to Follow-up|1
761291|NCT00486044|2425588|P1|Overall Study|Lost to Follow-up|0
761292|NCT00486044|2425587|P2|Overall Study|Adverse Event|1
761293|NCT00486044|2425588|P1|Overall Study|Adverse Event|0
761294|NCT00486044|2425587|P2|Overall Study|Withdrawal by Subject|1
761295|NCT00486044|2425588|P1|Overall Study|Withdrawal by Subject|2
761296|NCT00486226|2425600|P1|Overall Study|Lost to Follow-up|8
761297|NCT00486226|2425600|P1|Overall Study|Withdrawal by Subject|1
761298|NCT00486226|2425600|P1|Overall Study|Adverse Event|1
761299|NCT00486226|2425600|P1|Overall Study|Death|3
761300|NCT00486252|2425608|P1|Overall Study|Other|18
761301|NCT00486252|2425608|P1|Overall Study|Lost to Follow-up|24
761302|NCT00486252|2425608|P1|Overall Study|Lack of Efficacy|9
761303|NCT00486252|2425608|P1|Overall Study|Adverse Event|7
761304|NCT00486265|2425623|P1|Overall Study|Lack of Efficacy|8
761305|NCT00486265|2425623|P1|Overall Study|Adverse Event|1
761306|NCT00486278|2425627|P1|Overall Study|Physician Decision|2
761307|NCT00486278|2425627|P1|Overall Study|Withdrawal by Subject|2
761308|NCT00486278|2425627|P1|Overall Study|Adverse Event|5
761309|NCT00486291|2425763|P2|Overall Study|requirement for restricted medication|3
761310|NCT00486291|2425764|P1|Overall Study|requirement for restricted medication|0
761311|NCT00486291|2425763|P2|Overall Study|protocol non-compliance|15
761312|NCT00486291|2425764|P1|Overall Study|protocol non-compliance|10
761313|NCT00486291|2425763|P2|Overall Study|Lost to Follow-up|7
761314|NCT00486291|2425764|P1|Overall Study|Lost to Follow-up|3
761315|NCT00486291|2425763|P2|Overall Study|Adverse Event|4
761316|NCT00486291|2425764|P1|Overall Study|Adverse Event|3
761317|NCT00486330|2425772|P1|Overall Study|Adverse Event|2
761318|NCT00486434|2425778|P2|Overall Study|Personal reasons|6
761319|NCT00486434|2425779|P1|Overall Study|Personal reasons|5
761320|NCT00486434|2425778|P2|Overall Study|Death|2
761321|NCT00486434|2425779|P1|Overall Study|Death|1
761322|NCT00486434|2425778|P2|Overall Study|Lost to Follow-up|3
761323|NCT00486434|2425779|P1|Overall Study|Lost to Follow-up|2
761324|NCT00486434|2425778|P2|Overall Study|Lack of Efficacy|19
761325|NCT00486434|2425779|P1|Overall Study|Lack of Efficacy|12
761326|NCT00486434|2425778|P2|Overall Study|Protocol Violation|21
761327|NCT00486434|2425779|P1|Overall Study|Protocol Violation|22
761328|NCT00486434|2425778|P2|Overall Study|Adverse Event|44
761329|NCT00486434|2425779|P1|Overall Study|Adverse Event|118
761330|NCT00486434|2425778|P2|Overall Study|Withdrawal by Subject|39
761331|NCT00486434|2425779|P1|Overall Study|Withdrawal by Subject|34
761332|NCT00486720|2425840|P2|Overall Study|Progressive Disease|1
761333|NCT00486720|2425841|P1|Overall Study|Progressive Disease|0
761334|NCT00486720|2425840|P2|Overall Study|Withdrawal by Subject|1
761335|NCT00486720|2425841|P1|Overall Study|Withdrawal by Subject|3
761336|NCT00486720|2425840|P2|Overall Study|Protocol Violation|0
761337|NCT00486720|2425841|P1|Overall Study|Protocol Violation|1
761338|NCT00486720|2425840|P2|Overall Study|Physician Decision|2
761339|NCT00486720|2425841|P1|Overall Study|Physician Decision|1
761340|NCT00486720|2425840|P2|Overall Study|Lack of Efficacy|6
761341|NCT00486720|2425841|P1|Overall Study|Lack of Efficacy|4
761342|NCT00486720|2425840|P2|Overall Study|Adverse Event|2
761343|NCT00486720|2425841|P1|Overall Study|Adverse Event|1
761344|NCT00486759|2425851|P2|Safety Follow-up|Adverse event/intercurrent illness|0
761345|NCT00486759|2425852|P1|Safety Follow-up|Adverse event/intercurrent illness|4
761346|NCT00486759|2425851|P2|Safety Follow-up|Refused treatment/did not cooperate|4
761347|NCT00486759|2425852|P1|Safety Follow-up|Refused treatment/did not cooperate|6
761348|NCT00486759|2425851|P2|Safety Follow-up|Administrative/not specified|6
761349|NCT00486759|2425852|P1|Safety Follow-up|Administrative/not specified|8
761350|NCT00486759|2425851|P2|Safety Follow-up|Failure to return|6
761351|NCT00486759|2425852|P1|Safety Follow-up|Failure to return|9
761352|NCT00486759|2425851|P2|Safety Follow-up|Withdrew consent|23
761353|NCT00486759|2425852|P1|Safety Follow-up|Withdrew consent|32
761354|NCT00486759|2425851|P2|Safety Follow-up|Death|29
761355|NCT00486759|2425852|P1|Safety Follow-up|Death|40
761356|NCT00486759|2425851|P2|Safety Follow-up|Insufficient therapeutic response|50
761357|NCT00486759|2425852|P1|Safety Follow-up|Insufficient therapeutic response|40
761358|NCT00486759|2425851|P2|Treatment|Failure to return|1
761359|NCT00486759|2425852|P1|Treatment|Failure to return|1
761360|NCT00486759|2425851|P2|Treatment|Other protocol violation|5
761361|NCT00486759|2425852|P1|Treatment|Other protocol violation|1
761362|NCT00486759|2425851|P2|Treatment|Violation of selection criteria at entry|3
761363|NCT00486759|2425852|P1|Treatment|Violation of selection criteria at entry|3
761364|NCT00486759|2425851|P2|Treatment|Refused treatment|7
761365|NCT00486759|2425852|P1|Treatment|Refused treatment|10
761366|NCT00486759|2425851|P2|Treatment|Administrative/reason not specified|21
761367|NCT00486759|2425852|P1|Treatment|Administrative/reason not specified|17
761368|NCT00486759|2425851|P2|Treatment|Withdrew consent|12
761369|NCT00486759|2425852|P1|Treatment|Withdrew consent|15
761370|NCT00486759|2425851|P2|Treatment|Death|10
761371|NCT00486759|2425852|P1|Treatment|Death|17
761372|NCT00486759|2425851|P2|Treatment|Insufficient therapeutic response|39
761373|NCT00486759|2425852|P1|Treatment|Insufficient therapeutic response|37
761374|NCT00486759|2425851|P2|Treatment|Adverse event/intercurrent illness|39
761375|NCT00486759|2425852|P1|Treatment|Adverse event/intercurrent illness|86
761376|NCT00486811|2425865|P3|Overall Study|All other|7
761377|NCT00486811|2425866|P2|Overall Study|All other|11
761378|NCT00486811|2425867|P1|Overall Study|All other|18
761379|NCT00486811|2425865|P3|Overall Study|Study drug non-compliant|3
761380|NCT00486811|2425866|P2|Overall Study|Study drug non-compliant|6
761381|NCT00486811|2425867|P1|Overall Study|Study drug non-compliant|5
761382|NCT00486811|2425865|P3|Overall Study|Withdrawal by Subject|58
761383|NCT00486811|2425866|P2|Overall Study|Withdrawal by Subject|44
761384|NCT00486811|2425867|P1|Overall Study|Withdrawal by Subject|33
761385|NCT00486811|2425865|P3|Overall Study|Lost to Follow-up|4
761386|NCT00486811|2425866|P2|Overall Study|Lost to Follow-up|6
761387|NCT00486811|2425867|P1|Overall Study|Lost to Follow-up|4
761388|NCT00486811|2425865|P3|Overall Study|Lack of Efficacy|7
761389|NCT00486811|2425866|P2|Overall Study|Lack of Efficacy|14
761390|NCT00486811|2425867|P1|Overall Study|Lack of Efficacy|34
761391|NCT00486811|2425865|P3|Overall Study|Adverse Event|135
761392|NCT00486811|2425866|P2|Overall Study|Adverse Event|60
761393|NCT00486811|2425867|P1|Overall Study|Adverse Event|28
761394|NCT00486837|2425910|P2|Overall Study|No sputum, devise issues, exacerbation|4
761395|NCT00486837|2425911|P1|Overall Study|No sputum, devise issues, exacerbation|3
761396|NCT00486837|2425910|P2|Overall Study|Protocol Violation|2
761397|NCT00486837|2425911|P1|Overall Study|Protocol Violation|4
761398|NCT00486837|2425910|P2|Overall Study|Adverse Event|1
761399|NCT00486837|2425911|P1|Overall Study|Adverse Event|1
761400|NCT00486837|2425910|P2|Overall Study|Withdrawal by Subject|0
761401|NCT00486837|2425911|P1|Overall Study|Withdrawal by Subject|1
761402|NCT00486902|2425974|P2|Overall Study|No toradol due to hemmorhage or allergy|1
761403|NCT00486902|2425975|P1|Overall Study|No toradol due to hemmorhage or allergy|3
761404|NCT00486902|2425974|P2|Overall Study|Did not meet inclusion criteria|0
761405|NCT00486902|2425975|P1|Overall Study|Did not meet inclusion criteria|1
761406|NCT00486902|2425974|P2|Overall Study|spinal anesthetic protocal violation|1
761407|NCT00486902|2425975|P1|Overall Study|spinal anesthetic protocal violation|1
761408|NCT00486902|2425974|P2|Overall Study|decision for postpartum tubal ligation|1
761409|NCT00486902|2425975|P1|Overall Study|decision for postpartum tubal ligation|3
761410|NCT00486902|2425974|P2|Overall Study|Withdrawal by Subject|2
761411|NCT00486902|2425975|P1|Overall Study|Withdrawal by Subject|1
761412|NCT00492284|2425999|P4|Overall Study|Withdrawal by Subject|2
761413|NCT00492284|2426000|P3|Overall Study|Withdrawal by Subject|0
761414|NCT00492284|2426001|P2|Overall Study|Withdrawal by Subject|0
761415|NCT00492284|2426002|P1|Overall Study|Withdrawal by Subject|1
761416|NCT00492284|2425999|P4|Overall Study|Death|5
761417|NCT00492284|2426000|P3|Overall Study|Death|2
761418|NCT00492284|2426001|P2|Overall Study|Death|3
761419|NCT00492284|2426002|P1|Overall Study|Death|0
761420|NCT00492284|2425999|P4|Overall Study|Lost to Follow-up|1
761421|NCT00492284|2426000|P3|Overall Study|Lost to Follow-up|3
761422|NCT00492284|2426001|P2|Overall Study|Lost to Follow-up|0
761423|NCT00492284|2426002|P1|Overall Study|Lost to Follow-up|0
761424|NCT00492284|2425999|P4|Overall Study|Adverse Event|2
761425|NCT00492284|2426000|P3|Overall Study|Adverse Event|1
761426|NCT00492284|2426001|P2|Overall Study|Adverse Event|1
761427|NCT00492284|2426002|P1|Overall Study|Adverse Event|0
761428|NCT00492297|2426044|P1|Survival Only Follow-up|Study terminated by sponsor|12
761429|NCT00492297|2426044|P1|Survival Only Follow-up|Lack of Efficacy|1
761430|NCT00492297|2426044|P1|Survival Only Follow-up|Death|46
761431|NCT00492297|2426044|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
761432|NCT00492297|2426044|P1|Active Follow-up 30(+4) Days Duration|Death|17
761433|NCT00492297|2426044|P1|Treatment|Study terminated by sponsor|3
761434|NCT00492297|2426044|P1|Treatment|Death|2
761435|NCT00492531|2426078|P2|Overall Study|Withdrawn(More than one reason selected)|23
761436|NCT00492531|2426079|P1|Overall Study|Withdrawn(More than one reason selected)|22
761437|NCT00492557|2426105|P2|Overall Study|Lost to Follow-up|1
761438|NCT00492557|2426106|P1|Overall Study|Lost to Follow-up|0
761439|NCT00492557|2426105|P2|Overall Study|Failed to return|0
761440|NCT00492557|2426106|P1|Overall Study|Failed to return|1
761441|NCT00492557|2426105|P2|Overall Study|Adverse Event|0
761442|NCT00492557|2426106|P1|Overall Study|Adverse Event|1
761443|NCT00492557|2426105|P2|Overall Study|Death|1
761444|NCT00492557|2426106|P1|Overall Study|Death|1
761445|NCT00492557|2426105|P2|Overall Study|Unspecified|2
761446|NCT00492557|2426106|P1|Overall Study|Unspecified|2
761447|NCT00492557|2426105|P2|Overall Study|Protocol Violation|8
761448|NCT00492557|2426106|P1|Overall Study|Protocol Violation|7
761449|NCT00492557|2426105|P2|Overall Study|Subject request|11
761450|NCT00492557|2426106|P1|Overall Study|Subject request|12
761451|NCT00492726|2426143|P2|Overall Study|Non compliant with study medication|3
761452|NCT00492726|2426144|P1|Overall Study|Non compliant with study medication|0
761453|NCT00492726|2426143|P2|Overall Study|Withdrawal by Subject|3
761454|NCT00492726|2426144|P1|Overall Study|Withdrawal by Subject|6
761455|NCT00492726|2426143|P2|Overall Study|Physician Decision|1
761456|NCT00492726|2426144|P1|Overall Study|Physician Decision|0
761457|NCT00492726|2426143|P2|Overall Study|Lost to Follow-up|19
761458|NCT00492726|2426144|P1|Overall Study|Lost to Follow-up|27
761459|NCT00492726|2426143|P2|Overall Study|Lack of Efficacy|2
761460|NCT00492726|2426144|P1|Overall Study|Lack of Efficacy|0
761461|NCT00492726|2426143|P2|Overall Study|Death|2
761462|NCT00492726|2426144|P1|Overall Study|Death|7
761463|NCT00492726|2426143|P2|Overall Study|Adverse Event|6
761464|NCT00492726|2426144|P1|Overall Study|Adverse Event|10
761465|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
761466|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
761467|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
761468|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
761469|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
761470|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
761471|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
761472|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
761473|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
761474|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
761475|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
761476|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
761477|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
761478|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
761479|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
761480|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
761481|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
761482|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
761483|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
761484|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
761485|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
761486|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
761487|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
761488|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
761489|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Death|1
761490|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Death|45
761491|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Death|5
761492|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Death|75
761493|NCT00492752|2426170|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
761494|NCT00492752|2426171|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
761495|NCT00492752|2426172|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
761496|NCT00492752|2426173|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
761497|NCT00492752|2426170|P4|Double Blind Treatment|Protocol Violation|0
761498|NCT00492752|2426171|P3|Double Blind Treatment|Protocol Violation|1
761499|NCT00492752|2426172|P2|Double Blind Treatment|Protocol Violation|0
761500|NCT00492752|2426173|P1|Double Blind Treatment|Protocol Violation|0
761501|NCT00492752|2426170|P4|Double Blind Treatment|Adverse Event|0
761502|NCT00492752|2426171|P3|Double Blind Treatment|Adverse Event|0
761503|NCT00492752|2426172|P2|Double Blind Treatment|Adverse Event|0
761504|NCT00492752|2426173|P1|Double Blind Treatment|Adverse Event|1
761505|NCT00492752|2426170|P4|Double Blind Treatment|Death|0
761506|NCT00492752|2426171|P3|Double Blind Treatment|Death|2
761507|NCT00492752|2426172|P2|Double Blind Treatment|Death|0
761508|NCT00492752|2426173|P1|Double Blind Treatment|Death|13
761509|NCT00492856|2426206|P4|Post-consolidation|Observation Arm|0
761510|NCT00492856|2426207|P3|Post-consolidation|Observation Arm|27
761511|NCT00492856|2426208|P2|Post-consolidation|Observation Arm|0
761512|NCT00492856|2426209|P1|Post-consolidation|Observation Arm|0
761513|NCT00492856|2426206|P4|Post-consolidation|Lost to Follow-up|0
761514|NCT00492856|2426207|P3|Post-consolidation|Lost to Follow-up|0
761515|NCT00492856|2426208|P2|Post-consolidation|Lost to Follow-up|2
761516|NCT00492856|2426209|P1|Post-consolidation|Lost to Follow-up|0
761517|NCT00492856|2426206|P4|Post-consolidation|Not protocol specified|0
761518|NCT00492856|2426207|P3|Post-consolidation|Not protocol specified|0
761519|NCT00492856|2426208|P2|Post-consolidation|Not protocol specified|1
761520|NCT00492856|2426209|P1|Post-consolidation|Not protocol specified|0
761521|NCT00492856|2426206|P4|Post-consolidation|Death|0
761522|NCT00492856|2426207|P3|Post-consolidation|Death|0
761523|NCT00492856|2426208|P2|Post-consolidation|Death|1
761524|NCT00492856|2426209|P1|Post-consolidation|Death|0
761525|NCT00492856|2426206|P4|Post-consolidation|Withdrawal by Subject|0
761526|NCT00492856|2426207|P3|Post-consolidation|Withdrawal by Subject|0
761527|NCT00492856|2426208|P2|Post-consolidation|Withdrawal by Subject|4
761528|NCT00492856|2426209|P1|Post-consolidation|Withdrawal by Subject|0
761529|NCT00492856|2426206|P4|Post-consolidation|Adverse Event|1
761530|NCT00492856|2426207|P3|Post-consolidation|Adverse Event|0
761531|NCT00492856|2426208|P2|Post-consolidation|Adverse Event|4
761532|NCT00492856|2426209|P1|Post-consolidation|Adverse Event|0
761533|NCT00492856|2426206|P4|Consolidation|Lost to Follow-up|0
761534|NCT00492856|2426207|P3|Consolidation|Lost to Follow-up|0
761535|NCT00492856|2426208|P2|Consolidation|Lost to Follow-up|0
761536|NCT00492856|2426209|P1|Consolidation|Lost to Follow-up|1
761537|NCT00492856|2426206|P4|Consolidation|Not protocol specified|0
761538|NCT00492856|2426207|P3|Consolidation|Not protocol specified|0
761539|NCT00492856|2426208|P2|Consolidation|Not protocol specified|0
761540|NCT00492856|2426209|P1|Consolidation|Not protocol specified|2
761541|NCT00492856|2426206|P4|Consolidation|Adverse Event|0
761542|NCT00492856|2426207|P3|Consolidation|Adverse Event|0
761543|NCT00492856|2426208|P2|Consolidation|Adverse Event|0
761544|NCT00492856|2426209|P1|Consolidation|Adverse Event|6
761545|NCT00492856|2426206|P4|Induction|Death|0
761546|NCT00492856|2426207|P3|Induction|Death|0
761547|NCT00492856|2426208|P2|Induction|Death|0
761548|NCT00492856|2426209|P1|Induction|Death|3
761549|NCT00492856|2426206|P4|Induction|Withdrawal by Subject|0
761550|NCT00492856|2426207|P3|Induction|Withdrawal by Subject|0
761551|NCT00492856|2426208|P2|Induction|Withdrawal by Subject|0
761552|NCT00492856|2426209|P1|Induction|Withdrawal by Subject|1
761553|NCT00492856|2426206|P4|Induction|Adverse Event|0
761554|NCT00492856|2426207|P3|Induction|Adverse Event|0
761555|NCT00492856|2426208|P2|Induction|Adverse Event|0
761556|NCT00492856|2426209|P1|Induction|Adverse Event|2
761557|NCT00498602|2426237|P7|Overall Study|Not specified|0
761558|NCT00498602|2426238|P6|Overall Study|Not specified|3
761559|NCT00498602|2426239|P5|Overall Study|Not specified|0
761560|NCT00498602|2426240|P4|Overall Study|Not specified|0
761561|NCT00498602|2426241|P3|Overall Study|Not specified|1
761562|NCT00498602|2426242|P2|Overall Study|Not specified|3
761563|NCT00498602|2426243|P1|Overall Study|Not specified|2
761564|NCT00498602|2426237|P7|Overall Study|Subject Request|1
761565|NCT00498602|2426238|P6|Overall Study|Subject Request|4
761566|NCT00498602|2426239|P5|Overall Study|Subject Request|1
761567|NCT00498602|2426240|P4|Overall Study|Subject Request|1
761568|NCT00498602|2426241|P3|Overall Study|Subject Request|1
761569|NCT00498602|2426242|P2|Overall Study|Subject Request|0
761570|NCT00498602|2426243|P1|Overall Study|Subject Request|3
761571|NCT00498602|2426237|P7|Overall Study|Investigator Request|0
761572|NCT00498602|2426238|P6|Overall Study|Investigator Request|0
761573|NCT00498602|2426239|P5|Overall Study|Investigator Request|0
761574|NCT00498602|2426240|P4|Overall Study|Investigator Request|0
761575|NCT00498602|2426241|P3|Overall Study|Investigator Request|1
761576|NCT00498602|2426242|P2|Overall Study|Investigator Request|0
761577|NCT00498602|2426243|P1|Overall Study|Investigator Request|0
761578|NCT00498602|2426237|P7|Overall Study|Caregiver Request|0
761579|NCT00498602|2426238|P6|Overall Study|Caregiver Request|2
761580|NCT00498602|2426239|P5|Overall Study|Caregiver Request|1
761581|NCT00498602|2426240|P4|Overall Study|Caregiver Request|0
761582|NCT00498602|2426241|P3|Overall Study|Caregiver Request|2
761583|NCT00498602|2426242|P2|Overall Study|Caregiver Request|2
761584|NCT00498602|2426243|P1|Overall Study|Caregiver Request|2
761585|NCT00498602|2426237|P7|Overall Study|AE not related to Study Drug|1
761586|NCT00498602|2426238|P6|Overall Study|AE not related to Study Drug|2
761587|NCT00498602|2426239|P5|Overall Study|AE not related to Study Drug|2
761588|NCT00498602|2426240|P4|Overall Study|AE not related to Study Drug|0
761589|NCT00498602|2426241|P3|Overall Study|AE not related to Study Drug|0
761590|NCT00498602|2426242|P2|Overall Study|AE not related to Study Drug|3
761591|NCT00498602|2426243|P1|Overall Study|AE not related to Study Drug|1
761592|NCT00498602|2426237|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
761593|NCT00498602|2426238|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
761594|NCT00498602|2426239|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
761595|NCT00498602|2426240|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
761596|NCT00498602|2426241|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
761597|NCT00498602|2426242|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
761598|NCT00498602|2426243|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
761599|NCT00498602|2426237|P7|Overall Study|Lost to Follow-up|0
761600|NCT00498602|2426238|P6|Overall Study|Lost to Follow-up|0
761601|NCT00498602|2426239|P5|Overall Study|Lost to Follow-up|0
761602|NCT00498602|2426240|P4|Overall Study|Lost to Follow-up|2
761603|NCT00498602|2426241|P3|Overall Study|Lost to Follow-up|0
761604|NCT00498602|2426242|P2|Overall Study|Lost to Follow-up|2
761605|NCT00498602|2426243|P1|Overall Study|Lost to Follow-up|0
761606|NCT00498602|2426237|P7|Overall Study|Lack of Efficacy|0
761607|NCT00498602|2426238|P6|Overall Study|Lack of Efficacy|0
761608|NCT00498602|2426239|P5|Overall Study|Lack of Efficacy|0
761609|NCT00498602|2426240|P4|Overall Study|Lack of Efficacy|0
761610|NCT00498602|2426241|P3|Overall Study|Lack of Efficacy|0
761611|NCT00498602|2426242|P2|Overall Study|Lack of Efficacy|0
761612|NCT00498602|2426243|P1|Overall Study|Lack of Efficacy|1
761613|NCT00498602|2426237|P7|Overall Study|Death|0
761614|NCT00498602|2426238|P6|Overall Study|Death|1
761615|NCT00498602|2426239|P5|Overall Study|Death|0
761616|NCT00498602|2426240|P4|Overall Study|Death|0
761617|NCT00498602|2426241|P3|Overall Study|Death|0
761618|NCT00498602|2426242|P2|Overall Study|Death|0
761619|NCT00498602|2426243|P1|Overall Study|Death|0
761620|NCT00498797|2426325|P2|Overall Study|Other|1
761621|NCT00498797|2426326|P1|Overall Study|Other|3
761622|NCT00498797|2426325|P2|Overall Study|Condition under investigation worsened|21
761623|NCT00498797|2426326|P1|Overall Study|Condition under investigation worsened|19
761624|NCT00498797|2426325|P2|Overall Study|Adverse Event|5
761625|NCT00498797|2426326|P1|Overall Study|Adverse Event|12
761626|NCT00498797|2426325|P2|Overall Study|Withdrawal by Subject|2
761627|NCT00498797|2426326|P1|Overall Study|Withdrawal by Subject|4
761628|NCT00499252|2426334|P1|Overall Study|<no further label>|3
761629|NCT00499252|2426334|P1|Overall Study|Ineligible|4
761630|NCT00499252|2426334|P1|Overall Study|Refused further treatment|2
761631|NCT00499252|2426334|P1|Overall Study|Adverse Event|3
761632|NCT00499369|2426354|P5|Overall Study|Ineligible|0
761633|NCT00499369|2426355|P4|Overall Study|Ineligible|1
761634|NCT00499369|2426356|P3|Overall Study|Ineligible|1
761635|NCT00499369|2426357|P2|Overall Study|Ineligible|2
761636|NCT00499369|2426358|P1|Overall Study|Ineligible|2
761637|NCT00499369|2426354|P5|Overall Study|Not protocol specified|0
761638|NCT00499369|2426355|P4|Overall Study|Not protocol specified|1
761639|NCT00499369|2426356|P3|Overall Study|Not protocol specified|3
761640|NCT00499369|2426357|P2|Overall Study|Not protocol specified|0
761641|NCT00499369|2426358|P1|Overall Study|Not protocol specified|2
761642|NCT00499369|2426354|P5|Overall Study|Death|0
761643|NCT00499369|2426355|P4|Overall Study|Death|0
761644|NCT00499369|2426356|P3|Overall Study|Death|0
761645|NCT00499369|2426357|P2|Overall Study|Death|1
761646|NCT00499369|2426358|P1|Overall Study|Death|0
761647|NCT00499369|2426354|P5|Overall Study|Progression|10
761648|NCT00499369|2426355|P4|Overall Study|Progression|6
761649|NCT00499369|2426356|P3|Overall Study|Progression|9
761650|NCT00499369|2426357|P2|Overall Study|Progression|12
761651|NCT00499369|2426358|P1|Overall Study|Progression|10
761652|NCT00499369|2426354|P5|Overall Study|Withdrawal by Subject|0
761653|NCT00499369|2426355|P4|Overall Study|Withdrawal by Subject|0
761654|NCT00499369|2426356|P3|Overall Study|Withdrawal by Subject|1
761655|NCT00499369|2426357|P2|Overall Study|Withdrawal by Subject|1
761656|NCT00499369|2426358|P1|Overall Study|Withdrawal by Subject|0
761657|NCT00499369|2426354|P5|Overall Study|Adverse Event|2
761658|NCT00499369|2426355|P4|Overall Study|Adverse Event|1
761659|NCT00499369|2426356|P3|Overall Study|Adverse Event|3
761660|NCT00499369|2426357|P2|Overall Study|Adverse Event|2
761661|NCT00499369|2426358|P1|Overall Study|Adverse Event|2
761662|NCT00499460|2426395|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
761663|NCT00499460|2426396|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
761664|NCT00499460|2426395|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
761665|NCT00499460|2426396|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
761666|NCT00499460|2426395|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
761667|NCT00499460|2426396|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
761668|NCT00499486|2426431|P1|Overall Study|Withdrawal by Subject|16
761669|NCT00499590|2426440|P3|Overall Study|Not treated|1
761670|NCT00499590|2426441|P2|Overall Study|Not treated|0
761671|NCT00499590|2426442|P1|Overall Study|Not treated|1
761672|NCT00499590|2426440|P3|Overall Study|Study Terminated|112
761673|NCT00499590|2426441|P2|Overall Study|Study Terminated|112
761674|NCT00499590|2426442|P1|Overall Study|Study Terminated|112
761675|NCT00499603|2426455|P2|Overall Study|Adverse Event|1
761676|NCT00499603|2426456|P1|Overall Study|Adverse Event|0
761677|NCT00499616|2426470|P4|Overall Study|Patient/Parent Refusal|0
761678|NCT00499616|2426471|P3|Overall Study|Patient/Parent Refusal|3
761679|NCT00499616|2426472|P2|Overall Study|Patient/Parent Refusal|5
761680|NCT00499616|2426473|P1|Overall Study|Patient/Parent Refusal|1
761681|NCT00499616|2426470|P4|Overall Study|Not evaluable|41
761682|NCT00499616|2426471|P3|Overall Study|Not evaluable|0
761683|NCT00499616|2426472|P2|Overall Study|Not evaluable|0
761684|NCT00499616|2426473|P1|Overall Study|Not evaluable|0
761685|NCT00499616|2426470|P4|Overall Study|Ineligible|15
761686|NCT00499616|2426471|P3|Overall Study|Ineligible|0
761687|NCT00499616|2426472|P2|Overall Study|Ineligible|2
761688|NCT00499616|2426473|P1|Overall Study|Ineligible|1
761689|NCT00499616|2426470|P4|Overall Study|Withdrawal by Subject|0
761690|NCT00499616|2426471|P3|Overall Study|Withdrawal by Subject|1
761691|NCT00499616|2426472|P2|Overall Study|Withdrawal by Subject|0
761692|NCT00499616|2426473|P1|Overall Study|Withdrawal by Subject|1
761693|NCT00499616|2426470|P4|Overall Study|Physician Decision|0
761694|NCT00499616|2426471|P3|Overall Study|Physician Decision|9
761695|NCT00499616|2426472|P2|Overall Study|Physician Decision|16
761696|NCT00499616|2426473|P1|Overall Study|Physician Decision|6
761697|NCT00499616|2426470|P4|Overall Study|Lost to Follow-up|0
761698|NCT00499616|2426471|P3|Overall Study|Lost to Follow-up|1
761699|NCT00499616|2426472|P2|Overall Study|Lost to Follow-up|0
761700|NCT00499616|2426473|P1|Overall Study|Lost to Follow-up|0
761701|NCT00499616|2426470|P4|Overall Study|Lack of Efficacy|0
761702|NCT00499616|2426471|P3|Overall Study|Lack of Efficacy|19
761703|NCT00499616|2426472|P2|Overall Study|Lack of Efficacy|0
761704|NCT00499616|2426473|P1|Overall Study|Lack of Efficacy|5
761705|NCT00499616|2426470|P4|Overall Study|Death|1
761706|NCT00499616|2426471|P3|Overall Study|Death|3
761707|NCT00499616|2426472|P2|Overall Study|Death|5
761708|NCT00499616|2426473|P1|Overall Study|Death|1
761709|NCT00499681|2426527|P2|Overall Study|disease progression|1
761710|NCT00499681|2426528|P1|Overall Study|disease progression|0
761711|NCT00499681|2426527|P2|Overall Study|toxicity|1
761712|NCT00499681|2426528|P1|Overall Study|toxicity|0
761713|NCT00499694|2426534|P1|Overall Study|Patient never received treatment.|1
761714|NCT00499863|2426540|P2|Overall Study|Lost to Follow-up|1
761715|NCT00499863|2426541|P1|Overall Study|Lost to Follow-up|1
761716|NCT00499863|2426540|P2|Overall Study|Sponsor decision|2
761717|NCT00499863|2426541|P1|Overall Study|Sponsor decision|2
761718|NCT00499863|2426540|P2|Overall Study|Adverse Event|2
761719|NCT00499863|2426541|P1|Overall Study|Adverse Event|8
761720|NCT00499863|2426540|P2|Overall Study|Withdrawal by Subject|4
761721|NCT00499863|2426541|P1|Overall Study|Withdrawal by Subject|6
761722|NCT00499863|2426540|P2|Overall Study|Protocol Violation|7
761723|NCT00499863|2426541|P1|Overall Study|Protocol Violation|12
761724|NCT00499863|2426540|P2|Overall Study|Lack of Efficacy|27
761725|NCT00499863|2426541|P1|Overall Study|Lack of Efficacy|21
761726|NCT00499889|2426569|P1|Overall Study|Infection prior to treatment|1
761727|NCT00500071|2426584|P1|30-day Safety Follow-up|Lost to Follow-up|17
761728|NCT00500071|2426584|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
761729|NCT00500071|2426584|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
761730|NCT00500071|2426584|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
761731|NCT00500071|2426584|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
761732|NCT00500071|2426584|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
761733|NCT00500071|2426584|P1|Screening and Washout Phase|Protocol Violation|1
761734|NCT00500110|2426593|P1|Overall Study|Withdrawal by Subject|3
761735|NCT00500149|2426597|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
761736|NCT00500149|2426598|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
761737|NCT00500149|2426597|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
761738|NCT00500149|2426598|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
761739|NCT00500149|2426597|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
761740|NCT00500149|2426598|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
761741|NCT00500149|2426597|P2|First Intervention (Cross-over Phase)|Adverse Event|1
761742|NCT00500149|2426598|P1|First Intervention (Cross-over Phase)|Adverse Event|0
761743|NCT00500149|2426597|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
761744|NCT00500149|2426598|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
761745|NCT00500149|2426597|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
761746|NCT00500149|2426598|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
761747|NCT00500149|2426597|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
761748|NCT00500149|2426598|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
761749|NCT00500266|2426619|P1|Overall Study|Assigned, not treated|4
761750|NCT00500266|2426619|P1|Overall Study|Withdrawal by Subject|3
761751|NCT00500266|2426619|P1|Overall Study|Lost to Follow-up|3
761752|NCT00500266|2426619|P1|Overall Study|Death|3
761753|NCT00500292|2426629|P3|Overall Study|Other|4
761754|NCT00500292|2426630|P2|Overall Study|Other|1
761755|NCT00500292|2426631|P1|Overall Study|Other|1
761756|NCT00500292|2426629|P3|Overall Study|Withdrawal by Subject|0
761757|NCT00500292|2426630|P2|Overall Study|Withdrawal by Subject|1
761758|NCT00500292|2426631|P1|Overall Study|Withdrawal by Subject|0
761759|NCT00500292|2426629|P3|Overall Study|Condition under investigation worsened|19
761760|NCT00500292|2426630|P2|Overall Study|Condition under investigation worsened|23
761761|NCT00500292|2426631|P1|Overall Study|Condition under investigation worsened|21
761762|NCT00500292|2426629|P3|Overall Study|Adverse Event|4
761763|NCT00500292|2426630|P2|Overall Study|Adverse Event|6
761764|NCT00500292|2426631|P1|Overall Study|Adverse Event|3
761765|NCT00500318|2426641|P2|Overall Study|Other Reason|1
761766|NCT00500318|2426642|P1|Overall Study|Other Reason|0
761767|NCT00500318|2426641|P2|Overall Study|Lack of Efficacy|3
761768|NCT00500318|2426642|P1|Overall Study|Lack of Efficacy|0
761769|NCT00500318|2426641|P2|Overall Study|Withdrawal by Subject|2
761770|NCT00500318|2426642|P1|Overall Study|Withdrawal by Subject|1
761771|NCT00500318|2426641|P2|Overall Study|Protocol Violation|3
761772|NCT00500318|2426642|P1|Overall Study|Protocol Violation|1
761773|NCT00500318|2426641|P2|Overall Study|Adverse Event|8
761774|NCT00500318|2426642|P1|Overall Study|Adverse Event|3
761775|NCT00500357|2426656|P1|Overall Study|Death|1
761776|NCT00500370|2426677|P2|Overall Study|Subject Decision|17
761777|NCT00500370|2426678|P1|Overall Study|Subject Decision|10
761778|NCT00500370|2426677|P2|Overall Study|Sponsor Decision|0
761779|NCT00500370|2426678|P1|Overall Study|Sponsor Decision|2
761780|NCT00500370|2426677|P2|Overall Study|Protocol Violation|4
761781|NCT00500370|2426678|P1|Overall Study|Protocol Violation|2
761782|NCT00500370|2426677|P2|Overall Study|Lost to Follow-up|10
761783|NCT00500370|2426678|P1|Overall Study|Lost to Follow-up|10
761784|NCT00500370|2426677|P2|Overall Study|Adverse Event|3
761785|NCT00500370|2426678|P1|Overall Study|Adverse Event|9
761786|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Missing|3
761787|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
761788|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Death|1
761789|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Administrative problems|1
761790|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
761791|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
761792|NCT00500539|2426731|P1|Follow-up Period (16 Weeks)|Adverse Event|1
761793|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
761794|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Administrative problems|2
761795|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
761796|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
761797|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
761798|NCT00500539|2426731|P1|Treatment Period (24 Weeks)|Adverse Event|4
891306|NCT02472639|2827374|P2|Overall Study|Physician Decision|3
891307|NCT02472639|2827375|P1|Overall Study|Physician Decision|4
891308|NCT02207088|2827400|P1|Overall Study|Adverse Event|2
891309|NCT02152605|2827408|P2|Overall Study|Withdrew consent|2
891310|NCT02152605|2827409|P1|Overall Study|Withdrew consent|4
891311|NCT02152605|2827408|P2|Overall Study|Lost to Follow-up|0
891312|NCT02152605|2827409|P1|Overall Study|Lost to Follow-up|1
891313|NCT02152605|2827408|P2|Overall Study|Protocol deviation|4
891314|NCT02152605|2827409|P1|Overall Study|Protocol deviation|1
891315|NCT02152605|2827408|P2|Overall Study|Lack of Efficacy|4
891316|NCT02152605|2827409|P1|Overall Study|Lack of Efficacy|7
891317|NCT02152605|2827408|P2|Overall Study|Adverse Event|8
891318|NCT02152605|2827409|P1|Overall Study|Adverse Event|6
891319|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
891320|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
891321|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
761815|NCT00500760|2426777|P2|Overall Study|Other|2
761816|NCT00500760|2426778|P1|Overall Study|Other|1
761817|NCT00500760|2426777|P2|Overall Study|Lost to Follow-up|0
761818|NCT00500760|2426778|P1|Overall Study|Lost to Follow-up|3
761819|NCT00500760|2426777|P2|Overall Study|Administrative decision|0
761820|NCT00500760|2426778|P1|Overall Study|Administrative decision|2
761821|NCT00500760|2426777|P2|Overall Study|Withdrawal by Subject|7
761822|NCT00500760|2426778|P1|Overall Study|Withdrawal by Subject|5
761823|NCT00500760|2426777|P2|Overall Study|Death|15
761824|NCT00500760|2426778|P1|Overall Study|Death|32
761825|NCT00501007|2426796|P2|Overall Study|Inclusion criteria not met.|25
761826|NCT00501007|2426797|P1|Overall Study|Inclusion criteria not met.|29
891322|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
891323|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
891324|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
891325|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
891326|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
891327|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
891328|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
891329|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
891330|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
891331|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
891332|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
761843|NCT00501085|2426812|P1|Overall Study|Other loss to follow-up|32
761844|NCT00501085|2426812|P1|Overall Study|Study closed by sponsor|109
761845|NCT00501085|2426812|P1|Overall Study|Non-Compliance|24
761846|NCT00501085|2426812|P1|Overall Study|Adverse Event|4
761847|NCT00501085|2426812|P1|Overall Study|Explantation Surgery|26
761848|NCT00501085|2426812|P1|Overall Study|Revision Surgery|7
761849|NCT00501085|2426812|P1|Overall Study|Subject Decision|1
761850|NCT00501085|2426812|P1|Overall Study|Withdrawal by Subject|34
761851|NCT00501085|2426812|P1|Overall Study|Lost to Follow-up|195
761852|NCT00501228|2426820|P1|Overall Study|Withdrawal by Subject|1
761853|NCT00501293|2426826|P2|Maintenance Period|Application site reaction|0
761854|NCT00501293|2426827|P1|Maintenance Period|Application site reaction|1
761855|NCT00501293|2426826|P2|Maintenance Period|Would not wear patch|0
761856|NCT00501293|2426827|P1|Maintenance Period|Would not wear patch|1
761857|NCT00501293|2426826|P2|Maintenance Period|Went into rehabilitation|0
761858|NCT00501293|2426827|P1|Maintenance Period|Went into rehabilitation|1
761859|NCT00501293|2426826|P2|Maintenance Period|Noncompliant with study medication|0
761860|NCT00501293|2426827|P1|Maintenance Period|Noncompliant with study medication|5
761861|NCT00501293|2426826|P2|Maintenance Period|Lack of Efficacy|1
761862|NCT00501293|2426827|P1|Maintenance Period|Lack of Efficacy|4
761863|NCT00501293|2426826|P2|Maintenance Period|Protocol Violation|1
761864|NCT00501293|2426827|P1|Maintenance Period|Protocol Violation|2
761865|NCT00501293|2426826|P2|Maintenance Period|Adverse Event|6
761866|NCT00501293|2426827|P1|Maintenance Period|Adverse Event|6
761867|NCT00501293|2426826|P2|Maintenance Period|Lost to Follow-up|7
761868|NCT00501293|2426827|P1|Maintenance Period|Lost to Follow-up|12
761869|NCT00501293|2426826|P2|Maintenance Period|Withdrawal by Subject|13
761870|NCT00501293|2426827|P1|Maintenance Period|Withdrawal by Subject|14
761871|NCT00501293|2426826|P2|Optimization Period|Enrolled in error|0
761872|NCT00501293|2426827|P1|Optimization Period|Enrolled in error|1
761873|NCT00501540|2426858|P1|Overall Study|Death|5
761874|NCT00501644|2426889|P1|Overall Study|Withdrawal by Subject|1
761875|NCT00501644|2426889|P1|Overall Study|Adverse Event|4
761876|NCT00495820|2426895|P2|Overall Study|Adverse Event|1
761877|NCT00495820|2426896|P1|Overall Study|Adverse Event|1
761878|NCT00501852|2426906|P1|Overall Study|Withdrawal by Subject|2
761879|NCT00501852|2426906|P1|Overall Study|Adverse Event|3
761880|NCT00501969|2426952|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
761881|NCT00501969|2426952|P1|Overall Study|Other: Admin Request from the Sponsor|3
761882|NCT00501969|2426952|P1|Overall Study|Other: As Required by Local EC|2
761883|NCT00501969|2426952|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
761884|NCT00501969|2426952|P1|Overall Study|Other: Pat Pending Surgery for PD|1
761885|NCT00501969|2426952|P1|Overall Study|Other: Patient is Going to Have DBS|1
761886|NCT00501969|2426952|P1|Overall Study|Other: Patients + Investigator Agreement|1
761887|NCT00501969|2426952|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
761888|NCT00501969|2426952|P1|Overall Study|Other: Sponsor Stopped Study|12
761889|NCT00501969|2426952|P1|Overall Study|Other: Sponsor Termination at Site|1
761890|NCT00501969|2426952|P1|Overall Study|Other: Sponsors Request|10
761891|NCT00501969|2426952|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
761892|NCT00501969|2426952|P1|Overall Study|Lost to Follow-up|4
761893|NCT00501969|2426952|P1|Overall Study|Subject withdrew consent|51
761894|NCT00501969|2426952|P1|Overall Study|Unsatisfactory compliance of subject|7
761895|NCT00501969|2426952|P1|Overall Study|Adverse Event|76
761896|NCT00501969|2426952|P1|Overall Study|Lack of Efficacy|29
761897|NCT00501969|2426952|P1|Overall Study|Major Protocol Violation|4
761898|NCT00504231|2426967|P4|Overall Study|Discrepant chart documentation re route|0
761899|NCT00504231|2426968|P3|Overall Study|Discrepant chart documentation re route|1
761900|NCT00504231|2426969|P2|Overall Study|Discrepant chart documentation re route|0
761901|NCT00504231|2426970|P1|Overall Study|Discrepant chart documentation re route|0
761902|NCT00504257|2426988|P1|Overall Study|ineligible histology|2
761903|NCT00504257|2426988|P1|Overall Study|Withdrawal by Subject|2
761904|NCT00504426|2427000|P4|Overall Study|Withdrawal by Subject|0
761905|NCT00504426|2427001|P3|Overall Study|Withdrawal by Subject|0
761906|NCT00504426|2427002|P2|Overall Study|Withdrawal by Subject|0
761907|NCT00504426|2427003|P1|Overall Study|Withdrawal by Subject|2
761908|NCT00504426|2427000|P4|Overall Study|Protocol Violation|0
761909|NCT00504426|2427001|P3|Overall Study|Protocol Violation|2
761910|NCT00504426|2427002|P2|Overall Study|Protocol Violation|1
761911|NCT00504426|2427003|P1|Overall Study|Protocol Violation|1
761912|NCT00504426|2427000|P4|Overall Study|Adverse Event|0
761913|NCT00504426|2427001|P3|Overall Study|Adverse Event|2
761914|NCT00504426|2427002|P2|Overall Study|Adverse Event|0
761915|NCT00504426|2427003|P1|Overall Study|Adverse Event|0
761916|NCT00504556|2427026|P5|Overall Study|not in safety analysis set|1
761917|NCT00504556|2427027|P4|Overall Study|not in safety analysis set|0
761918|NCT00504556|2427028|P3|Overall Study|not in safety analysis set|1
761919|NCT00504556|2427029|P2|Overall Study|not in safety analysis set|1
761920|NCT00504556|2427030|P1|Overall Study|not in safety analysis set|0
761921|NCT00504556|2427026|P5|Overall Study|not specified|0
761922|NCT00504556|2427027|P4|Overall Study|not specified|3
761923|NCT00504556|2427028|P3|Overall Study|not specified|2
761924|NCT00504556|2427029|P2|Overall Study|not specified|2
761925|NCT00504556|2427030|P1|Overall Study|not specified|2
761926|NCT00504556|2427026|P5|Overall Study|data monitor committee decision|0
761927|NCT00504556|2427027|P4|Overall Study|data monitor committee decision|100
761928|NCT00504556|2427028|P3|Overall Study|data monitor committee decision|0
761929|NCT00504556|2427029|P2|Overall Study|data monitor committee decision|0
761930|NCT00504556|2427030|P1|Overall Study|data monitor committee decision|0
761931|NCT00504556|2427026|P5|Overall Study|did not meet entry criteria|0
761932|NCT00504556|2427027|P4|Overall Study|did not meet entry criteria|1
761933|NCT00504556|2427028|P3|Overall Study|did not meet entry criteria|1
761934|NCT00504556|2427029|P2|Overall Study|did not meet entry criteria|0
761935|NCT00504556|2427030|P1|Overall Study|did not meet entry criteria|2
761936|NCT00504556|2427026|P5|Overall Study|administrative reasons|2
761937|NCT00504556|2427027|P4|Overall Study|administrative reasons|1
761938|NCT00504556|2427028|P3|Overall Study|administrative reasons|2
761939|NCT00504556|2427029|P2|Overall Study|administrative reasons|2
761940|NCT00504556|2427030|P1|Overall Study|administrative reasons|0
761941|NCT00504556|2427026|P5|Overall Study|Withdrawal by Subject|12
761942|NCT00504556|2427027|P4|Overall Study|Withdrawal by Subject|8
761943|NCT00504556|2427028|P3|Overall Study|Withdrawal by Subject|7
761944|NCT00504556|2427029|P2|Overall Study|Withdrawal by Subject|16
761945|NCT00504556|2427030|P1|Overall Study|Withdrawal by Subject|16
761946|NCT00504556|2427026|P5|Overall Study|Lost to Follow-up|1
761947|NCT00504556|2427027|P4|Overall Study|Lost to Follow-up|1
761948|NCT00504556|2427028|P3|Overall Study|Lost to Follow-up|1
761949|NCT00504556|2427029|P2|Overall Study|Lost to Follow-up|0
761950|NCT00504556|2427030|P1|Overall Study|Lost to Follow-up|0
761951|NCT00504556|2427026|P5|Overall Study|Protocol Violation|2
761952|NCT00504556|2427027|P4|Overall Study|Protocol Violation|1
761953|NCT00504556|2427028|P3|Overall Study|Protocol Violation|2
761954|NCT00504556|2427029|P2|Overall Study|Protocol Violation|3
761955|NCT00504556|2427030|P1|Overall Study|Protocol Violation|1
761956|NCT00504556|2427026|P5|Overall Study|Death|2
761957|NCT00504556|2427027|P4|Overall Study|Death|0
761958|NCT00504556|2427028|P3|Overall Study|Death|1
761959|NCT00504556|2427029|P2|Overall Study|Death|3
761960|NCT00504556|2427030|P1|Overall Study|Death|3
761961|NCT00504556|2427026|P5|Overall Study|Adverse Event|5
761962|NCT00504556|2427027|P4|Overall Study|Adverse Event|13
761963|NCT00504556|2427028|P3|Overall Study|Adverse Event|14
761964|NCT00504556|2427029|P2|Overall Study|Adverse Event|11
761965|NCT00504556|2427030|P1|Overall Study|Adverse Event|11
761966|NCT00504595|2427094|P4|Overall Study|Not specified|0
761967|NCT00504595|2427095|P3|Overall Study|Not specified|2
761968|NCT00504595|2427096|P2|Overall Study|Not specified|0
761969|NCT00504595|2427097|P1|Overall Study|Not specified|0
761970|NCT00504595|2427094|P4|Overall Study|Lack of Efficacy|0
761971|NCT00504595|2427095|P3|Overall Study|Lack of Efficacy|0
761972|NCT00504595|2427096|P2|Overall Study|Lack of Efficacy|0
761973|NCT00504595|2427097|P1|Overall Study|Lack of Efficacy|1
761974|NCT00504725|2427120|P2|Overall Study|Protocol Violation|0
761975|NCT00504725|2427121|P1|Overall Study|Protocol Violation|1
761976|NCT00504777|2427135|P1|Overall Study|Adverse Event|1
761977|NCT00504881|2427144|P2|Overall Study|AE of unknown type|0
761978|NCT00504881|2427145|P1|Overall Study|AE of unknown type|1
761979|NCT00504881|2427144|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
761980|NCT00504881|2427145|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
761981|NCT00504881|2427144|P2|Overall Study|AE, non-serious non-fatal|14
761982|NCT00504881|2427145|P1|Overall Study|AE, non-serious non-fatal|4
761983|NCT00504881|2427144|P2|Overall Study|SAE, non-fatal|6
761984|NCT00504881|2427145|P1|Overall Study|SAE, non-fatal|2
761985|NCT00504881|2427144|P2|Overall Study|AE, serious fatal|1
761986|NCT00504881|2427145|P1|Overall Study|AE, serious fatal|0
761987|NCT00504881|2427144|P2|Overall Study|Safety Visit not performed|1
761988|NCT00504881|2427145|P1|Overall Study|Safety Visit not performed|0
761989|NCT00504881|2427144|P2|Overall Study|No Birth Control|1
761990|NCT00504881|2427145|P1|Overall Study|No Birth Control|0
761991|NCT00504881|2427144|P2|Overall Study|Non-Compliance|0
761992|NCT00504881|2427145|P1|Overall Study|Non-Compliance|1
761993|NCT00504881|2427144|P2|Overall Study|Withdrawal by Subject|4
761994|NCT00504881|2427145|P1|Overall Study|Withdrawal by Subject|1
761995|NCT00504881|2427144|P2|Overall Study|Lost to Follow-up|2
761996|NCT00504881|2427145|P1|Overall Study|Lost to Follow-up|0
761997|NCT00504881|2427144|P2|Overall Study|Lack of Efficacy|5
761998|NCT00504881|2427145|P1|Overall Study|Lack of Efficacy|1
761999|NCT00505076|2427211|P3|Overall Study|Withdrawal by Subject|2
762000|NCT00505076|2427212|P2|Overall Study|Withdrawal by Subject|1
762001|NCT00505076|2427213|P1|Overall Study|Withdrawal by Subject|0
762002|NCT00505076|2427211|P3|Overall Study|Protocol Violation|2
762003|NCT00505076|2427212|P2|Overall Study|Protocol Violation|1
762004|NCT00505076|2427213|P1|Overall Study|Protocol Violation|2
762005|NCT00505076|2427211|P3|Overall Study|Adverse Event|1
762006|NCT00505076|2427212|P2|Overall Study|Adverse Event|0
762007|NCT00505076|2427213|P1|Overall Study|Adverse Event|1
762008|NCT00505284|2427232|P5|Overall Study|Not specified|4
762009|NCT00505284|2427233|P4|Overall Study|Not specified|4
762010|NCT00505284|2427234|P3|Overall Study|Not specified|0
762011|NCT00505284|2427235|P2|Overall Study|Not specified|0
762012|NCT00505284|2427236|P1|Overall Study|Not specified|5
762013|NCT00505284|2427232|P5|Overall Study|Physician Decision|0
762014|NCT00505284|2427233|P4|Overall Study|Physician Decision|0
762015|NCT00505284|2427234|P3|Overall Study|Physician Decision|0
762016|NCT00505284|2427235|P2|Overall Study|Physician Decision|1
762017|NCT00505284|2427236|P1|Overall Study|Physician Decision|0
762018|NCT00505284|2427232|P5|Overall Study|Lack of Efficacy|1
762019|NCT00505284|2427233|P4|Overall Study|Lack of Efficacy|1
762020|NCT00505284|2427234|P3|Overall Study|Lack of Efficacy|1
762021|NCT00505284|2427235|P2|Overall Study|Lack of Efficacy|1
762022|NCT00505284|2427236|P1|Overall Study|Lack of Efficacy|0
762023|NCT00505284|2427232|P5|Overall Study|Withdrawal by Subject|6
762024|NCT00505284|2427233|P4|Overall Study|Withdrawal by Subject|0
762025|NCT00505284|2427234|P3|Overall Study|Withdrawal by Subject|1
762026|NCT00505284|2427235|P2|Overall Study|Withdrawal by Subject|6
762027|NCT00505284|2427236|P1|Overall Study|Withdrawal by Subject|2
762028|NCT00505284|2427232|P5|Overall Study|Protocol Violation|0
762029|NCT00505284|2427233|P4|Overall Study|Protocol Violation|0
762030|NCT00505284|2427234|P3|Overall Study|Protocol Violation|1
762031|NCT00505284|2427235|P2|Overall Study|Protocol Violation|1
762032|NCT00505284|2427236|P1|Overall Study|Protocol Violation|0
762033|NCT00505284|2427232|P5|Overall Study|Adverse Event|22
762034|NCT00505284|2427233|P4|Overall Study|Adverse Event|14
762035|NCT00505284|2427234|P3|Overall Study|Adverse Event|9
762036|NCT00505284|2427235|P2|Overall Study|Adverse Event|7
762037|NCT00505284|2427236|P1|Overall Study|Adverse Event|3
762038|NCT00505375|2427316|P2|Overall Study|Travel issues|1
762039|NCT00505375|2427317|P1|Overall Study|Travel issues|0
762040|NCT00505375|2427316|P2|Overall Study|Pregnancy|0
762041|NCT00505375|2427317|P1|Overall Study|Pregnancy|1
762042|NCT00505375|2427316|P2|Overall Study|Lost to Follow-up|2
762043|NCT00505375|2427317|P1|Overall Study|Lost to Follow-up|0
762044|NCT00505375|2427316|P2|Overall Study|Withdrawal by Subject|2
762045|NCT00505375|2427317|P1|Overall Study|Withdrawal by Subject|2
762046|NCT00505375|2427316|P2|Overall Study|Death|0
762047|NCT00505375|2427317|P1|Overall Study|Death|1
762048|NCT00505414|2427325|P5|Maintenance Phase|underlying disease and therapy required|0
762049|NCT00505414|2427326|P4|Maintenance Phase|underlying disease and therapy required|0
762050|NCT00505414|2427327|P3|Maintenance Phase|underlying disease and therapy required|2
762051|NCT00505414|2427328|P2|Maintenance Phase|underlying disease and therapy required|2
762052|NCT00505414|2427329|P1|Maintenance Phase|underlying disease and therapy required|0
762053|NCT00505414|2427325|P5|Maintenance Phase|Withdrawal by Subject|0
762054|NCT00505414|2427326|P4|Maintenance Phase|Withdrawal by Subject|0
762055|NCT00505414|2427327|P3|Maintenance Phase|Withdrawal by Subject|1
762056|NCT00505414|2427328|P2|Maintenance Phase|Withdrawal by Subject|0
762057|NCT00505414|2427329|P1|Maintenance Phase|Withdrawal by Subject|0
762058|NCT00505414|2427325|P5|Maintenance Phase|Lack of Efficacy|0
762059|NCT00505414|2427326|P4|Maintenance Phase|Lack of Efficacy|0
762060|NCT00505414|2427327|P3|Maintenance Phase|Lack of Efficacy|1
762061|NCT00505414|2427328|P2|Maintenance Phase|Lack of Efficacy|1
762062|NCT00505414|2427329|P1|Maintenance Phase|Lack of Efficacy|2
762063|NCT00505414|2427325|P5|Maintenance Phase|Death|0
762064|NCT00505414|2427326|P4|Maintenance Phase|Death|0
762065|NCT00505414|2427327|P3|Maintenance Phase|Death|1
762066|NCT00505414|2427328|P2|Maintenance Phase|Death|0
762067|NCT00505414|2427329|P1|Maintenance Phase|Death|2
762068|NCT00505414|2427325|P5|Maintenance Phase|Adverse Event|0
762069|NCT00505414|2427326|P4|Maintenance Phase|Adverse Event|0
762070|NCT00505414|2427327|P3|Maintenance Phase|Adverse Event|3
762071|NCT00505414|2427328|P2|Maintenance Phase|Adverse Event|2
762072|NCT00505414|2427329|P1|Maintenance Phase|Adverse Event|2
762073|NCT00505414|2427325|P5|Titration Phase|Underlying disease and therapy required|3
762074|NCT00505414|2427326|P4|Titration Phase|Underlying disease and therapy required|7
762075|NCT00505414|2427327|P3|Titration Phase|Underlying disease and therapy required|0
762076|NCT00505414|2427328|P2|Titration Phase|Underlying disease and therapy required|0
762077|NCT00505414|2427329|P1|Titration Phase|Underlying disease and therapy required|0
762078|NCT00505414|2427325|P5|Titration Phase|Withdrawal by Subject|4
762079|NCT00505414|2427326|P4|Titration Phase|Withdrawal by Subject|3
762080|NCT00505414|2427327|P3|Titration Phase|Withdrawal by Subject|0
762081|NCT00505414|2427328|P2|Titration Phase|Withdrawal by Subject|0
762082|NCT00505414|2427329|P1|Titration Phase|Withdrawal by Subject|0
762083|NCT00505414|2427325|P5|Titration Phase|Protocol Violation|1
762084|NCT00505414|2427326|P4|Titration Phase|Protocol Violation|0
762085|NCT00505414|2427327|P3|Titration Phase|Protocol Violation|0
762086|NCT00505414|2427328|P2|Titration Phase|Protocol Violation|0
762087|NCT00505414|2427329|P1|Titration Phase|Protocol Violation|0
762088|NCT00505414|2427325|P5|Titration Phase|Lack of Efficacy|1
762089|NCT00505414|2427326|P4|Titration Phase|Lack of Efficacy|10
762090|NCT00505414|2427327|P3|Titration Phase|Lack of Efficacy|0
762091|NCT00505414|2427328|P2|Titration Phase|Lack of Efficacy|0
762092|NCT00505414|2427329|P1|Titration Phase|Lack of Efficacy|0
762093|NCT00505414|2427325|P5|Titration Phase|Death|0
762094|NCT00505414|2427326|P4|Titration Phase|Death|2
762095|NCT00505414|2427327|P3|Titration Phase|Death|0
762096|NCT00505414|2427328|P2|Titration Phase|Death|0
762097|NCT00505414|2427329|P1|Titration Phase|Death|0
762098|NCT00505414|2427325|P5|Titration Phase|Adverse Event|3
762099|NCT00505414|2427326|P4|Titration Phase|Adverse Event|8
762100|NCT00505414|2427327|P3|Titration Phase|Adverse Event|0
762101|NCT00505414|2427328|P2|Titration Phase|Adverse Event|0
762102|NCT00505414|2427329|P1|Titration Phase|Adverse Event|0
762103|NCT00505622|2427353|P3|Overall Study|Study termination by sponsor|90
762104|NCT00505622|2427354|P2|Overall Study|Study termination by sponsor|98
762105|NCT00505622|2427355|P1|Overall Study|Study termination by sponsor|115
762106|NCT00505622|2427353|P3|Overall Study|Withdrawal by Subject|2
762107|NCT00505622|2427354|P2|Overall Study|Withdrawal by Subject|3
762108|NCT00505622|2427355|P1|Overall Study|Withdrawal by Subject|0
762109|NCT00505622|2427353|P3|Overall Study|Protocol Violation|0
762110|NCT00505622|2427354|P2|Overall Study|Protocol Violation|1
762111|NCT00505622|2427355|P1|Overall Study|Protocol Violation|1
762112|NCT00505622|2427353|P3|Overall Study|Adverse Event|4
762113|NCT00505622|2427354|P2|Overall Study|Adverse Event|6
762114|NCT00505622|2427355|P1|Overall Study|Adverse Event|5
762115|NCT00505661|2427376|P1|Overall Study|Not Eligible|4
762116|NCT00505687|2427380|P1|Overall Study|Other: As Per Sponsor|8
762117|NCT00505687|2427380|P1|Overall Study|Other: Disease Progression|1
762118|NCT00505687|2427380|P1|Overall Study|Other: Neupro Given In Hospital|1
762119|NCT00505687|2427380|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
762120|NCT00505687|2427380|P1|Overall Study|Other: Prolonged Hospitalization|1
762121|NCT00505687|2427380|P1|Overall Study|Other: Scheduled DBS Surgery|1
762122|NCT00505687|2427380|P1|Overall Study|Other: Underwent Implantation Of DBS|1
762123|NCT00505687|2427380|P1|Overall Study|Lost to Follow-up|1
762124|NCT00505687|2427380|P1|Overall Study|Subject withdrew consent|15
762125|NCT00505687|2427380|P1|Overall Study|Adverse Event|48
762126|NCT00505687|2427380|P1|Overall Study|Lack of Efficacy|15
762127|NCT00505687|2427380|P1|Overall Study|Important protocol violation|2
762128|NCT00505752|2427390|P4|Overall Study|Unspecified|2
762129|NCT00505752|2427391|P3|Overall Study|Unspecified|1
762130|NCT00505752|2427392|P2|Overall Study|Unspecified|2
762131|NCT00505752|2427393|P1|Overall Study|Unspecified|1
762132|NCT00505752|2427390|P4|Overall Study|All embryos/blastocysts discarded|1
762133|NCT00505752|2427391|P3|Overall Study|All embryos/blastocysts discarded|1
762134|NCT00505752|2427392|P2|Overall Study|All embryos/blastocysts discarded|0
762135|NCT00505752|2427393|P1|Overall Study|All embryos/blastocysts discarded|0
762136|NCT00505752|2427390|P4|Overall Study|No Fertilization|1
762137|NCT00505752|2427391|P3|Overall Study|No Fertilization|2
762138|NCT00505752|2427392|P2|Overall Study|No Fertilization|1
762139|NCT00505752|2427393|P1|Overall Study|No Fertilization|1
762140|NCT00505752|2427390|P4|Overall Study|No oocytes retrieved|1
762141|NCT00505752|2427391|P3|Overall Study|No oocytes retrieved|0
762142|NCT00505752|2427392|P2|Overall Study|No oocytes retrieved|2
762143|NCT00505752|2427393|P1|Overall Study|No oocytes retrieved|0
762144|NCT00505752|2427390|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
762145|NCT00505752|2427391|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
762146|NCT00505752|2427392|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
762147|NCT00505752|2427393|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
762148|NCT00505752|2427390|P4|Overall Study|Lack of ovarian response|0
762149|NCT00505752|2427391|P3|Overall Study|Lack of ovarian response|0
762150|NCT00505752|2427392|P2|Overall Study|Lack of ovarian response|3
762151|NCT00505752|2427393|P1|Overall Study|Lack of ovarian response|1
762152|NCT00505752|2427390|P4|Overall Study|Lost to Follow-up|0
762153|NCT00505752|2427391|P3|Overall Study|Lost to Follow-up|0
762154|NCT00505752|2427392|P2|Overall Study|Lost to Follow-up|0
762155|NCT00505752|2427393|P1|Overall Study|Lost to Follow-up|1
762156|NCT00505752|2427390|P4|Overall Study|Adverse Event|0
762157|NCT00505752|2427391|P3|Overall Study|Adverse Event|1
762158|NCT00505752|2427392|P2|Overall Study|Adverse Event|0
762159|NCT00505752|2427393|P1|Overall Study|Adverse Event|1
762160|NCT00505765|2427410|P3|Overall Study|Noncompliance|3
762161|NCT00505765|2427411|P2|Overall Study|Noncompliance|1
762162|NCT00505765|2427412|P1|Overall Study|Noncompliance|0
762163|NCT00505765|2427410|P3|Overall Study|Adverse Event|0
762164|NCT00505765|2427411|P2|Overall Study|Adverse Event|2
762165|NCT00505765|2427412|P1|Overall Study|Adverse Event|1
762166|NCT00505765|2427410|P3|Overall Study|Withdrawal by Subject|0
762167|NCT00505765|2427411|P2|Overall Study|Withdrawal by Subject|0
762168|NCT00505765|2427412|P1|Overall Study|Withdrawal by Subject|1
762169|NCT00505778|2427437|P2|Overall Study|Took No Study Drug|2
762170|NCT00505778|2427438|P1|Overall Study|Took No Study Drug|2
762171|NCT00505778|2427437|P2|Overall Study|Relapse|65
762172|NCT00505778|2427438|P1|Overall Study|Relapse|65
762173|NCT00505778|2427437|P2|Overall Study|Withdrawal by Subject|14
762174|NCT00505778|2427438|P1|Overall Study|Withdrawal by Subject|29
762175|NCT00505778|2427437|P2|Overall Study|Protocol Violation|9
762176|NCT00505778|2427438|P1|Overall Study|Protocol Violation|7
762177|NCT00505778|2427437|P2|Overall Study|Unable to Meet Protocol Criteria|1
762178|NCT00505778|2427438|P1|Overall Study|Unable to Meet Protocol Criteria|4
762179|NCT00505778|2427437|P2|Overall Study|Lost to Follow-up|23
762180|NCT00505778|2427438|P1|Overall Study|Lost to Follow-up|17
762181|NCT00505778|2427437|P2|Overall Study|Physician Decision|14
762182|NCT00505778|2427438|P1|Overall Study|Physician Decision|8
762183|NCT00505778|2427437|P2|Overall Study|Adverse Event|7
762184|NCT00505778|2427438|P1|Overall Study|Adverse Event|2
762185|NCT00505921|2427465|P1|Overall Study|Failed to Mobilize|8
762186|NCT00505921|2427465|P1|Overall Study|Ineligible|1
762187|NCT00505934|2427469|P1|Overall Study|Other: IV dose needed to be changed|1
762188|NCT00505934|2427469|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
762189|NCT00505934|2427469|P1|Overall Study|Adverse Event|1
762190|NCT00506077|2427499|P2|Treatment Period 2|Withdrawal by Subject|0
762191|NCT00506077|2427500|P1|Treatment Period 2|Withdrawal by Subject|1
762192|NCT00506077|2427499|P2|Treatment Period 2|Adverse Event|1
762193|NCT00506077|2427500|P1|Treatment Period 2|Adverse Event|0
762194|NCT00506077|2427499|P2|Treatment Period 1|Withdrawal by Subject|0
762195|NCT00506077|2427500|P1|Treatment Period 1|Withdrawal by Subject|2
762196|NCT00506077|2427499|P2|Treatment Period 1|Lost to Follow-up|2
762197|NCT00506077|2427500|P1|Treatment Period 1|Lost to Follow-up|0
762198|NCT00506077|2427499|P2|Treatment Period 1|Adverse Event|1
762199|NCT00506077|2427500|P1|Treatment Period 1|Adverse Event|2
762200|NCT00506285|2427527|P2|6-month Open Label Phase|Withdrawal by Subject|5
762201|NCT00506285|2427528|P1|6-month Open Label Phase|Withdrawal by Subject|9
762202|NCT00506285|2427527|P2|6-month Open Label Phase|Lost to Follow-up|7
762203|NCT00506285|2427528|P1|6-month Open Label Phase|Lost to Follow-up|1
762204|NCT00506285|2427527|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
762205|NCT00506285|2427528|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
762206|NCT00506285|2427527|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
762207|NCT00506285|2427528|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
762208|NCT00506285|2427527|P2|3 Week Screening Phase|Withdrawal by Subject|10
762209|NCT00506285|2427528|P1|3 Week Screening Phase|Withdrawal by Subject|17
762210|NCT00506350|2427545|P9|Overall Study|Not specified|2
762211|NCT00506350|2427546|P8|Overall Study|Not specified|2
762212|NCT00506350|2427547|P7|Overall Study|Not specified|0
762213|NCT00506350|2427548|P6|Overall Study|Not specified|0
762214|NCT00506350|2427549|P5|Overall Study|Not specified|3
762215|NCT00506350|2427550|P4|Overall Study|Not specified|0
762216|NCT00506350|2427551|P3|Overall Study|Not specified|3
762217|NCT00506350|2427552|P2|Overall Study|Not specified|1
762218|NCT00506350|2427553|P1|Overall Study|Not specified|1
762219|NCT00506350|2427545|P9|Overall Study|Medical Reason|0
762220|NCT00506350|2427546|P8|Overall Study|Medical Reason|0
762221|NCT00506350|2427547|P7|Overall Study|Medical Reason|0
762222|NCT00506350|2427548|P6|Overall Study|Medical Reason|0
762223|NCT00506350|2427549|P5|Overall Study|Medical Reason|1
762224|NCT00506350|2427550|P4|Overall Study|Medical Reason|0
762225|NCT00506350|2427551|P3|Overall Study|Medical Reason|0
762226|NCT00506350|2427552|P2|Overall Study|Medical Reason|0
762227|NCT00506350|2427553|P1|Overall Study|Medical Reason|0
762228|NCT00506350|2427545|P9|Overall Study|Lost to Follow-up|2
762229|NCT00506350|2427546|P8|Overall Study|Lost to Follow-up|0
762230|NCT00506350|2427547|P7|Overall Study|Lost to Follow-up|0
762231|NCT00506350|2427548|P6|Overall Study|Lost to Follow-up|1
762232|NCT00506350|2427549|P5|Overall Study|Lost to Follow-up|2
762233|NCT00506350|2427550|P4|Overall Study|Lost to Follow-up|1
762234|NCT00506350|2427551|P3|Overall Study|Lost to Follow-up|1
762235|NCT00506350|2427552|P2|Overall Study|Lost to Follow-up|1
762236|NCT00506350|2427553|P1|Overall Study|Lost to Follow-up|1
762237|NCT00506350|2427545|P9|Overall Study|Withdrawal by Subject|0
762238|NCT00506350|2427546|P8|Overall Study|Withdrawal by Subject|2
762239|NCT00506350|2427547|P7|Overall Study|Withdrawal by Subject|1
762240|NCT00506350|2427548|P6|Overall Study|Withdrawal by Subject|1
762241|NCT00506350|2427549|P5|Overall Study|Withdrawal by Subject|4
762242|NCT00506350|2427550|P4|Overall Study|Withdrawal by Subject|1
762243|NCT00506350|2427551|P3|Overall Study|Withdrawal by Subject|1
762244|NCT00506350|2427552|P2|Overall Study|Withdrawal by Subject|1
762245|NCT00506350|2427553|P1|Overall Study|Withdrawal by Subject|0
762246|NCT00506350|2427545|P9|Overall Study|Protocol Violation|0
762247|NCT00506350|2427546|P8|Overall Study|Protocol Violation|0
762248|NCT00506350|2427547|P7|Overall Study|Protocol Violation|1
762249|NCT00506350|2427548|P6|Overall Study|Protocol Violation|0
762250|NCT00506350|2427549|P5|Overall Study|Protocol Violation|0
762251|NCT00506350|2427550|P4|Overall Study|Protocol Violation|0
762252|NCT00506350|2427551|P3|Overall Study|Protocol Violation|1
762253|NCT00506350|2427552|P2|Overall Study|Protocol Violation|0
762254|NCT00506350|2427553|P1|Overall Study|Protocol Violation|0
762255|NCT00506350|2427545|P9|Overall Study|Adverse Event|1
762256|NCT00506350|2427546|P8|Overall Study|Adverse Event|1
762257|NCT00506350|2427547|P7|Overall Study|Adverse Event|0
762258|NCT00506350|2427548|P6|Overall Study|Adverse Event|0
762259|NCT00506350|2427549|P5|Overall Study|Adverse Event|0
762260|NCT00506350|2427550|P4|Overall Study|Adverse Event|0
762261|NCT00506350|2427551|P3|Overall Study|Adverse Event|0
762262|NCT00506350|2427552|P2|Overall Study|Adverse Event|0
762263|NCT00506350|2427553|P1|Overall Study|Adverse Event|0
762264|NCT00506350|2427545|P9|Overall Study|Serious Adverse Event|0
762265|NCT00506350|2427546|P8|Overall Study|Serious Adverse Event|0
762266|NCT00506350|2427547|P7|Overall Study|Serious Adverse Event|0
762267|NCT00506350|2427548|P6|Overall Study|Serious Adverse Event|0
762268|NCT00506350|2427549|P5|Overall Study|Serious Adverse Event|0
762269|NCT00506350|2427550|P4|Overall Study|Serious Adverse Event|0
762270|NCT00506350|2427551|P3|Overall Study|Serious Adverse Event|0
762271|NCT00506350|2427552|P2|Overall Study|Serious Adverse Event|0
762272|NCT00506350|2427553|P1|Overall Study|Serious Adverse Event|1
762273|NCT00506389|2427701|P3|In-treatment Period|Randomized but not treated|1
762274|NCT00506389|2427702|P2|In-treatment Period|Randomized but not treated|1
762275|NCT00506389|2427703|P1|In-treatment Period|Randomized but not treated|4
762276|NCT00506389|2427701|P3|In-treatment Period|Adverse Event|2
762277|NCT00506389|2427702|P2|In-treatment Period|Adverse Event|5
762278|NCT00506389|2427703|P1|In-treatment Period|Adverse Event|11
762279|NCT00506389|2427701|P3|In-treatment Period|Lack of Efficacy|0
762280|NCT00506389|2427702|P2|In-treatment Period|Lack of Efficacy|2
762281|NCT00506389|2427703|P1|In-treatment Period|Lack of Efficacy|0
762282|NCT00506389|2427701|P3|In-treatment Period|Withdrawal by Subject|4
762283|NCT00506389|2427702|P2|In-treatment Period|Withdrawal by Subject|3
762284|NCT00506389|2427703|P1|In-treatment Period|Withdrawal by Subject|3
762285|NCT00506389|2427701|P3|In-treatment Period|Reasons not related to trial|0
762286|NCT00506389|2427702|P2|In-treatment Period|Reasons not related to trial|1
762287|NCT00506389|2427703|P1|In-treatment Period|Reasons not related to trial|4
762288|NCT00506389|2427701|P3|In-treatment Period|Lack of compliance|0
762289|NCT00506389|2427702|P2|In-treatment Period|Lack of compliance|0
762290|NCT00506389|2427703|P1|In-treatment Period|Lack of compliance|1
762291|NCT00506389|2427701|P3|In-treatment Period|Lost to Follow-up|1
762292|NCT00506389|2427702|P2|In-treatment Period|Lost to Follow-up|0
762293|NCT00506389|2427703|P1|In-treatment Period|Lost to Follow-up|0
762294|NCT00506389|2427701|P3|In-treatment Period|Not specified|4
762295|NCT00506389|2427702|P2|In-treatment Period|Not specified|3
762296|NCT00506389|2427703|P1|In-treatment Period|Not specified|3
762297|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
762298|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
762299|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
762300|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
762301|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
762302|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762303|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762304|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762305|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
762306|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
762307|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
762308|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
762309|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
762310|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762311|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762312|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762313|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
762314|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762315|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762316|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762317|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
762318|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
762319|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
762320|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
762321|NCT00506415|2427720|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
762322|NCT00506415|2427721|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
762323|NCT00506415|2427722|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
762324|NCT00506415|2427723|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
762325|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
762326|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
762327|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
762328|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
762329|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
762330|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
762331|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
762332|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
762333|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
762334|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
762335|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
762336|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
762337|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
762338|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
762339|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
762340|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
762341|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
762342|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
762343|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
762344|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
762345|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
762346|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
762347|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
762348|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
762349|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Death|0
762350|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Death|3
762351|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Death|5
762352|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Death|0
762353|NCT00506415|2427720|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
762354|NCT00506415|2427721|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
762355|NCT00506415|2427722|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
762356|NCT00506415|2427723|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
762357|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
762358|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
762359|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
762360|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
762361|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
762362|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
762363|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
762364|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
762365|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
762366|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
762367|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
762368|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
762369|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762370|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762371|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
762372|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
762373|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762374|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762375|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
762376|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
762377|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762378|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762379|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
762380|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
762381|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
762382|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
762383|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
762384|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
762385|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
762386|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
762387|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
762388|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
762389|NCT00506415|2427720|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
762390|NCT00506415|2427721|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
762391|NCT00506415|2427722|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
762392|NCT00506415|2427723|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
762393|NCT00506441|2427745|P2|Period 2; Double-blind Period|Other Reason|1
762394|NCT00506441|2427746|P1|Period 2; Double-blind Period|Other Reason|1
762395|NCT00506441|2427745|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
762396|NCT00506441|2427746|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
762397|NCT00506441|2427745|P2|Period 2; Double-blind Period|Physician Decision|1
762398|NCT00506441|2427746|P1|Period 2; Double-blind Period|Physician Decision|1
762399|NCT00506441|2427745|P2|Period 2; Double-blind Period|Lack of Efficacy|2
762400|NCT00506441|2427746|P1|Period 2; Double-blind Period|Lack of Efficacy|0
762401|NCT00506441|2427745|P2|Period 2; Double-blind Period|Adverse Event|1
762402|NCT00506441|2427746|P1|Period 2; Double-blind Period|Adverse Event|0
762403|NCT00506441|2427745|P2|Period 1; Open-label Period|Other Reasons|0
762404|NCT00506441|2427746|P1|Period 1; Open-label Period|Other Reasons|13
762405|NCT00506441|2427745|P2|Period 1; Open-label Period|Withdrawal by Subject|0
762406|NCT00506441|2427746|P1|Period 1; Open-label Period|Withdrawal by Subject|13
762407|NCT00506441|2427745|P2|Period 1; Open-label Period|Protocol Violation|0
762408|NCT00506441|2427746|P1|Period 1; Open-label Period|Protocol Violation|9
762409|NCT00506441|2427745|P2|Period 1; Open-label Period|Physician Decision|0
762410|NCT00506441|2427746|P1|Period 1; Open-label Period|Physician Decision|5
762411|NCT00506441|2427745|P2|Period 1; Open-label Period|Lost to Follow-up|0
762412|NCT00506441|2427746|P1|Period 1; Open-label Period|Lost to Follow-up|2
762413|NCT00506441|2427745|P2|Period 1; Open-label Period|Lack of Efficacy|0
762414|NCT00506441|2427746|P1|Period 1; Open-label Period|Lack of Efficacy|13
762415|NCT00506441|2427745|P2|Period 1; Open-label Period|Adverse Event|0
762416|NCT00506441|2427746|P1|Period 1; Open-label Period|Adverse Event|21
762417|NCT00506454|2427756|P2|Overall Study|Withdrawal by Subject|1
762418|NCT00506454|2427757|P1|Overall Study|Withdrawal by Subject|1
762419|NCT00506493|2427763|P1|Overall Study|Withdrawal by Subject|5
762420|NCT00506493|2427763|P1|Overall Study|Death|6
762421|NCT00506662|2427776|P2|Overall Study|Not recorded|6
762422|NCT00506662|2427777|P1|Overall Study|Not recorded|4
762423|NCT00506662|2427776|P2|Overall Study|Trial terminated|16
762424|NCT00506662|2427777|P1|Overall Study|Trial terminated|10
762425|NCT00506662|2427776|P2|Overall Study|Protocol Violation|4
762426|NCT00506662|2427777|P1|Overall Study|Protocol Violation|2
762427|NCT00506662|2427776|P2|Overall Study|Lack of Efficacy|0
762428|NCT00506662|2427777|P1|Overall Study|Lack of Efficacy|1
762429|NCT00506662|2427776|P2|Overall Study|Adverse Event|2
762430|NCT00506662|2427777|P1|Overall Study|Adverse Event|0
762431|NCT00499031|2427847|P1|Overall Study|Never treated|1
762432|NCT00499031|2427847|P1|Overall Study|Required test not done|1
762433|NCT00499031|2427847|P1|Overall Study|Improper pre-protocol treatment|1
762435|NCT00506831|2427894|P1|Overall Study|Withdrawal by Subject|1
762436|NCT00506831|2427894|P1|Overall Study|Death|1
762437|NCT00506883|2427906|P3|Overall Study|Other|1
762438|NCT00506883|2427907|P2|Overall Study|Other|1
762439|NCT00506883|2427908|P1|Overall Study|Other|5
762440|NCT00506883|2427906|P3|Overall Study|Lack of Efficacy|1
762441|NCT00506883|2427907|P2|Overall Study|Lack of Efficacy|1
762442|NCT00506883|2427908|P1|Overall Study|Lack of Efficacy|0
762443|NCT00506883|2427906|P3|Overall Study|Withdrawal by Subject|1
762444|NCT00506883|2427907|P2|Overall Study|Withdrawal by Subject|0
762445|NCT00506883|2427908|P1|Overall Study|Withdrawal by Subject|1
762446|NCT00506883|2427906|P3|Overall Study|Lost to Follow-up|1
762447|NCT00506883|2427907|P2|Overall Study|Lost to Follow-up|1
762448|NCT00506883|2427908|P1|Overall Study|Lost to Follow-up|1
762449|NCT00506922|2427921|P5|Overall Study|Withdrawal by Subject|1
762450|NCT00506922|2427922|P4|Overall Study|Withdrawal by Subject|0
762451|NCT00506922|2427923|P3|Overall Study|Withdrawal by Subject|0
762452|NCT00506922|2427924|P2|Overall Study|Withdrawal by Subject|0
762453|NCT00506922|2427925|P1|Overall Study|Withdrawal by Subject|0
762454|NCT00506922|2427921|P5|Overall Study|Physician Decision|0
762455|NCT00506922|2427922|P4|Overall Study|Physician Decision|2
762456|NCT00506922|2427923|P3|Overall Study|Physician Decision|0
762457|NCT00506922|2427924|P2|Overall Study|Physician Decision|0
762458|NCT00506922|2427925|P1|Overall Study|Physician Decision|0
762459|NCT00506948|2427933|P1|Overall Study|Physician Decision|1
762460|NCT00506948|2427933|P1|Overall Study|Adverse Event|5
762461|NCT00506948|2427933|P1|Overall Study|Death|4
762462|NCT00507416|2427940|P3|Overall Study|Did not Receive Study Treatment|4
762463|NCT00507416|2427941|P2|Overall Study|Did not Receive Study Treatment|9
762464|NCT00507416|2427942|P1|Overall Study|Did not Receive Study Treatment|3
762465|NCT00507416|2427940|P3|Overall Study|Other|13
762466|NCT00507416|2427941|P2|Overall Study|Other|16
762467|NCT00507416|2427942|P1|Overall Study|Other|11
762468|NCT00507416|2427940|P3|Overall Study|Patient declined further treatment|11
762469|NCT00507416|2427941|P2|Overall Study|Patient declined further treatment|14
762470|NCT00507416|2427942|P1|Overall Study|Patient declined further treatment|18
762471|NCT00507416|2427940|P3|Overall Study|Progressive Disease|13
762472|NCT00507416|2427941|P2|Overall Study|Progressive Disease|10
762473|NCT00507416|2427942|P1|Overall Study|Progressive Disease|20
762474|NCT00507416|2427940|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
762475|NCT00507416|2427941|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
762476|NCT00507416|2427942|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
762477|NCT00507416|2427940|P3|Overall Study|Protocol Violation|0
762478|NCT00507416|2427941|P2|Overall Study|Protocol Violation|2
762479|NCT00507416|2427942|P1|Overall Study|Protocol Violation|1
762480|NCT00507416|2427940|P3|Overall Study|Adverse Event|65
762481|NCT00507416|2427941|P2|Overall Study|Adverse Event|67
762482|NCT00507416|2427942|P1|Overall Study|Adverse Event|58
762483|NCT00507429|2427973|P2|Maintenance Phase|Progressive Disease|0
762484|NCT00507429|2427974|P1|Maintenance Phase|Progressive Disease|14
762485|NCT00507429|2427973|P2|Treatment Phase|Other|3
762486|NCT00507429|2427974|P1|Treatment Phase|Other|6
762487|NCT00507429|2427973|P2|Treatment Phase|Physician Decision|2
762488|NCT00507429|2427974|P1|Treatment Phase|Physician Decision|4
762489|NCT00507429|2427973|P2|Treatment Phase|Withdrawal by Subject|3
762490|NCT00507429|2427974|P1|Treatment Phase|Withdrawal by Subject|3
762491|NCT00507429|2427973|P2|Treatment Phase|Adverse Event|5
762492|NCT00507429|2427974|P1|Treatment Phase|Adverse Event|12
762493|NCT00507429|2427973|P2|Treatment Phase|Disease Progression|5
762494|NCT00507429|2427974|P1|Treatment Phase|Disease Progression|12
762495|NCT00507442|2427986|P4|Overall Study|Not Specified|2
762496|NCT00507442|2427987|P3|Overall Study|Not Specified|2
762497|NCT00507442|2427988|P2|Overall Study|Not Specified|5
762498|NCT00507442|2427989|P1|Overall Study|Not Specified|2
762499|NCT00507442|2427986|P4|Overall Study|Withdrawal by Subject|1
762500|NCT00507442|2427987|P3|Overall Study|Withdrawal by Subject|2
762501|NCT00507442|2427988|P2|Overall Study|Withdrawal by Subject|4
762502|NCT00507442|2427989|P1|Overall Study|Withdrawal by Subject|4
762503|NCT00507442|2427986|P4|Overall Study|Progressive Disease|0
762504|NCT00507442|2427987|P3|Overall Study|Progressive Disease|2
762505|NCT00507442|2427988|P2|Overall Study|Progressive Disease|4
762506|NCT00507442|2427989|P1|Overall Study|Progressive Disease|2
762507|NCT00507442|2427986|P4|Overall Study|Physician Decision|1
762508|NCT00507442|2427987|P3|Overall Study|Physician Decision|4
762509|NCT00507442|2427988|P2|Overall Study|Physician Decision|2
762510|NCT00507442|2427989|P1|Overall Study|Physician Decision|0
762511|NCT00507442|2427986|P4|Overall Study|Lost to Follow-up|0
762512|NCT00507442|2427987|P3|Overall Study|Lost to Follow-up|1
762513|NCT00507442|2427988|P2|Overall Study|Lost to Follow-up|0
762514|NCT00507442|2427989|P1|Overall Study|Lost to Follow-up|0
762515|NCT00507442|2427986|P4|Overall Study|Protocol Violation|0
762516|NCT00507442|2427987|P3|Overall Study|Protocol Violation|0
762517|NCT00507442|2427988|P2|Overall Study|Protocol Violation|1
762518|NCT00507442|2427989|P1|Overall Study|Protocol Violation|0
762519|NCT00507442|2427986|P4|Overall Study|Adverse Event|1
762520|NCT00507442|2427987|P3|Overall Study|Adverse Event|4
762521|NCT00507442|2427988|P2|Overall Study|Adverse Event|11
762522|NCT00507442|2427989|P1|Overall Study|Adverse Event|8
762523|NCT00507455|2428042|P3|Overall Study|Other - miscellaneous reason|1
762524|NCT00507455|2428043|P2|Overall Study|Other - miscellaneous reason|0
762525|NCT00507455|2428044|P1|Overall Study|Other - miscellaneous reason|1
762526|NCT00507455|2428042|P3|Overall Study|Lack of Efficacy|0
762527|NCT00507455|2428043|P2|Overall Study|Lack of Efficacy|1
762528|NCT00507455|2428044|P1|Overall Study|Lack of Efficacy|0
762529|NCT00507455|2428042|P3|Overall Study|Lost to Follow-up|2
762530|NCT00507455|2428043|P2|Overall Study|Lost to Follow-up|0
762531|NCT00507455|2428044|P1|Overall Study|Lost to Follow-up|2
762532|NCT00507455|2428042|P3|Overall Study|Protocol Violation|1
762533|NCT00507455|2428043|P2|Overall Study|Protocol Violation|1
762534|NCT00507455|2428044|P1|Overall Study|Protocol Violation|4
762535|NCT00507455|2428042|P3|Overall Study|Withdrawal by Subject|2
762536|NCT00507455|2428043|P2|Overall Study|Withdrawal by Subject|1
762537|NCT00507455|2428044|P1|Overall Study|Withdrawal by Subject|2
762538|NCT00507455|2428042|P3|Overall Study|Adverse Event|6
762539|NCT00507455|2428043|P2|Overall Study|Adverse Event|3
762540|NCT00507455|2428044|P1|Overall Study|Adverse Event|3
762541|NCT00507507|2428105|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
762542|NCT00507507|2428106|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
762543|NCT00507507|2428105|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
762544|NCT00507507|2428106|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
762545|NCT00507507|2428105|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
762546|NCT00507507|2428106|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
762547|NCT00507507|2428105|P2|Treatment Period|Withdrawal by Subject|47
762548|NCT00507507|2428106|P1|Treatment Period|Withdrawal by Subject|46
762549|NCT00507507|2428105|P2|Treatment Period|Adverse Event|1
762550|NCT00507507|2428106|P1|Treatment Period|Adverse Event|1
762551|NCT00507507|2428105|P2|Treatment Period|Protocol Violation|2
762552|NCT00507507|2428106|P1|Treatment Period|Protocol Violation|1
762553|NCT00507507|2428105|P2|Treatment Period|Physician Decision|1
762554|NCT00507507|2428106|P1|Treatment Period|Physician Decision|4
762555|NCT00507507|2428105|P2|Treatment Period|Lost to Follow-up|2
762556|NCT00507507|2428106|P1|Treatment Period|Lost to Follow-up|0
762557|NCT00507546|2428140|P2|Overall Study|Physician Decision|1
762558|NCT00507546|2428141|P1|Overall Study|Physician Decision|0
762559|NCT00507546|2428140|P2|Overall Study|Protocol Violation|0
762560|NCT00507546|2428141|P1|Overall Study|Protocol Violation|1
762561|NCT00507546|2428140|P2|Overall Study|Withdrawal by Subject|0
762562|NCT00507546|2428141|P1|Overall Study|Withdrawal by Subject|1
762563|NCT00507689|2428165|P2|Randomized Period|Withdrawal by Subject|1
762564|NCT00507689|2428166|P1|Randomized Period|Withdrawal by Subject|0
762565|NCT00507689|2428165|P2|Randomized Period|Adverse Event|1
762566|NCT00507689|2428166|P1|Randomized Period|Adverse Event|1
762567|NCT00507689|2428165|P2|Pre-Randomization Period|Withdrawal by Subject|0
762568|NCT00507689|2428166|P1|Pre-Randomization Period|Withdrawal by Subject|1
762569|NCT00507689|2428165|P2|Pre-Randomization Period|Physician Decision|0
762570|NCT00507689|2428166|P1|Pre-Randomization Period|Physician Decision|1
762571|NCT00507689|2428165|P2|Pre-Randomization Period|Adverse Event|0
762572|NCT00507689|2428166|P1|Pre-Randomization Period|Adverse Event|1
762573|NCT00507819|2428187|P2|Washout (6 Weeks)|Withdrawal by Subject|0
762574|NCT00507819|2428188|P1|Washout (6 Weeks)|Withdrawal by Subject|1
762575|NCT00508001|2428203|P3|Overall Study|Withdrawal by Subject|1
762576|NCT00508001|2428204|P2|Overall Study|Withdrawal by Subject|4
762577|NCT00508001|2428205|P1|Overall Study|Withdrawal by Subject|4
762578|NCT00508001|2428203|P3|Overall Study|Death|1
762579|NCT00508001|2428204|P2|Overall Study|Death|1
762580|NCT00508001|2428205|P1|Overall Study|Death|0
762581|NCT00508001|2428203|P3|Overall Study|condition under investigation worsened|1
762582|NCT00508001|2428204|P2|Overall Study|condition under investigation worsened|7
762583|NCT00508001|2428205|P1|Overall Study|condition under investigation worsened|13
762584|NCT00508001|2428203|P3|Overall Study|Adverse Event|4
762585|NCT00508001|2428204|P2|Overall Study|Adverse Event|0
762586|NCT00508001|2428205|P1|Overall Study|Adverse Event|2
762587|NCT00508027|2428222|P1|Dose Level 2|Withdrawal by Subject|2
762588|NCT00508027|2428222|P1|Dose Level 2|Lost to Follow-up|2
762589|NCT00508027|2428222|P1|Dose Level 1|Physician Decision|2
762590|NCT00508027|2428222|P1|Dose Level 1|Withdrawal by Subject|2
762591|NCT00508027|2428222|P1|Dose Level 1|Lost to Follow-up|4
762592|NCT00508144|2428282|P1|Overall Study|Death|5
762593|NCT00508144|2428282|P1|Overall Study|Not eligible|6
762594|NCT00508157|2428288|P2|Overall Study|Other known cause|1
762595|NCT00508157|2428289|P1|Overall Study|Other known cause|0
762596|NCT00508157|2428288|P2|Overall Study|Subject no longer met study criteria|1
762597|NCT00508157|2428289|P1|Overall Study|Subject no longer met study criteria|0
762598|NCT00508157|2428288|P2|Overall Study|Lost to Follow-up|0
762599|NCT00508157|2428289|P1|Overall Study|Lost to Follow-up|1
762600|NCT00508157|2428288|P2|Overall Study|Subject Withdrew Consent|0
762601|NCT00508157|2428289|P1|Overall Study|Subject Withdrew Consent|1
762602|NCT00508157|2428288|P2|Overall Study|Adverse Event|1
762603|NCT00508157|2428289|P1|Overall Study|Adverse Event|0
762604|NCT00508274|2428311|P1|Overall Study|Withdrawal by Subject|1
762605|NCT00508274|2428311|P1|Overall Study|Adverse Event|1
762606|NCT00508391|2428322|P2|Second Treatment|Withdrawal by Subject|0
762607|NCT00508391|2428323|P1|Second Treatment|Withdrawal by Subject|2
762608|NCT00508391|2428322|P2|First Treatment|Withdrawal by Subject|3
762609|NCT00508391|2428323|P1|First Treatment|Withdrawal by Subject|6
762610|NCT00508404|2428334|P1|Overall Study|Other - Not Specified|3
762611|NCT00508404|2428334|P1|Overall Study|Lost to Follow-up|2
762612|NCT00508404|2428334|P1|Overall Study|Protocol-specified Criteria|2
762613|NCT00508404|2428334|P1|Overall Study|Withdrawal by Subject|3
762614|NCT00508404|2428334|P1|Overall Study|Physician Decision|2
762615|NCT00508404|2428334|P1|Overall Study|Death|16
762616|NCT00508404|2428334|P1|Overall Study|Adverse Event|2
762617|NCT00508404|2428334|P1|Overall Study|Ongoing at Data Cut-off|12
762618|NCT00508482|2428371|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
762619|NCT00508482|2428372|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
762620|NCT00508482|2428373|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
762621|NCT00508482|2428371|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
762622|NCT00508482|2428372|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
762623|NCT00508482|2428373|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
762624|NCT00508482|2428371|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
762625|NCT00508482|2428372|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
762626|NCT00508482|2428373|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
762627|NCT00508651|2428414|P2|Overall Study|Withdrawal by Subject|1
762628|NCT00508651|2428415|P1|Overall Study|Withdrawal by Subject|1
762629|NCT00508651|2428414|P2|Overall Study|Lost to Follow-up|1
762630|NCT00508651|2428415|P1|Overall Study|Lost to Follow-up|3
762631|NCT00508742|2428500|P2|Period 3: Toddler Dose|Unspecified|4
762632|NCT00508742|2428501|P1|Period 3: Toddler Dose|Unspecified|5
762633|NCT00508742|2428500|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
762634|NCT00508742|2428501|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
762635|NCT00508742|2428500|P2|Period 3: Toddler Dose|Lost to Follow-up|3
762636|NCT00508742|2428501|P1|Period 3: Toddler Dose|Lost to Follow-up|2
762637|NCT00508742|2428500|P2|Period 3: Toddler Dose|Adverse Event|0
762638|NCT00508742|2428501|P1|Period 3: Toddler Dose|Adverse Event|1
762639|NCT00508742|2428500|P2|Period 2: After Infant Series|Unspecified|1
762640|NCT00508742|2428501|P1|Period 2: After Infant Series|Unspecified|2
762641|NCT00508742|2428500|P2|Period 2: After Infant Series|Failed to Return|0
762642|NCT00508742|2428501|P1|Period 2: After Infant Series|Failed to Return|1
762643|NCT00508742|2428500|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
762644|NCT00508742|2428501|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
762645|NCT00508742|2428500|P2|Period 2: After Infant Series|Protocol Violation|0
762646|NCT00508742|2428501|P1|Period 2: After Infant Series|Protocol Violation|1
762647|NCT00508742|2428500|P2|Period 2: After Infant Series|Lost to Follow-up|1
762648|NCT00508742|2428501|P1|Period 2: After Infant Series|Lost to Follow-up|1
762649|NCT00508742|2428500|P2|Period 2: After Infant Series|Adverse Event|6
762650|NCT00508742|2428501|P1|Period 2: After Infant Series|Adverse Event|2
762651|NCT00508742|2428500|P2|Period 1: Infant Series|Unspecified|1
762652|NCT00508742|2428501|P1|Period 1: Infant Series|Unspecified|4
762653|NCT00508742|2428500|P2|Period 1: Infant Series|Physician Decision|0
762654|NCT00508742|2428501|P1|Period 1: Infant Series|Physician Decision|1
762655|NCT00508742|2428500|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
762656|NCT00508742|2428501|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
762657|NCT00508742|2428500|P2|Period 1: Infant Series|Protocol Violation|0
762658|NCT00508742|2428501|P1|Period 1: Infant Series|Protocol Violation|1
762659|NCT00508742|2428500|P2|Period 1: Infant Series|Adverse Event|4
762660|NCT00508742|2428501|P1|Period 1: Infant Series|Adverse Event|5
762661|NCT00508755|2428515|P1|Overall Study|Withdrawal by Subject|1
762662|NCT00508820|2428523|P2|Overall Study|Protocol-specified Criteria|12
762663|NCT00508820|2428524|P1|Overall Study|Protocol-specified Criteria|3
762664|NCT00508820|2428523|P2|Overall Study|Requirement for alternative therapy|15
762665|NCT00508820|2428524|P1|Overall Study|Requirement for alternative therapy|7
762666|NCT00508820|2428523|P2|Overall Study|Noncompliance|0
762667|NCT00508820|2428524|P1|Overall Study|Noncompliance|1
762668|NCT00508820|2428523|P2|Overall Study|Other|2
762669|NCT00508820|2428524|P1|Overall Study|Other|11
762670|NCT00508820|2428523|P2|Overall Study|Withdrawal by Subject|12
762671|NCT00508820|2428524|P1|Overall Study|Withdrawal by Subject|10
762672|NCT00508820|2428523|P2|Overall Study|Protocol Violation|0
762673|NCT00508820|2428524|P1|Overall Study|Protocol Violation|2
762674|NCT00508820|2428523|P2|Overall Study|Pregnancy|2
762675|NCT00508820|2428524|P1|Overall Study|Pregnancy|0
762676|NCT00508820|2428523|P2|Overall Study|Physician Decision|2
762677|NCT00508820|2428524|P1|Overall Study|Physician Decision|8
762678|NCT00508820|2428523|P2|Overall Study|Lost to Follow-up|1
762679|NCT00508820|2428524|P1|Overall Study|Lost to Follow-up|1
762680|NCT00508820|2428523|P2|Overall Study|Death|8
762681|NCT00508820|2428524|P1|Overall Study|Death|6
762682|NCT00508820|2428523|P2|Overall Study|Adverse Event|10
762683|NCT00508820|2428524|P1|Overall Study|Adverse Event|6
762684|NCT00508872|2428534|P1|Overall Study|Physician Decision|1
762685|NCT00508872|2428534|P1|Overall Study|Lost to Follow-up|1
762686|NCT00508924|2428542|P4|Overall Study|Protocol Violation|1
762687|NCT00508924|2428543|P3|Overall Study|Protocol Violation|1
762688|NCT00508924|2428544|P2|Overall Study|Protocol Violation|0
762689|NCT00508924|2428545|P1|Overall Study|Protocol Violation|0
762690|NCT00509028|2428561|P2|Overall Study|Non-compliance|1
762691|NCT00509028|2428562|P1|Overall Study|Non-compliance|2
762692|NCT00509028|2428561|P2|Overall Study|Protocol Violation|2
762693|NCT00509028|2428562|P1|Overall Study|Protocol Violation|4
762694|NCT00509028|2428561|P2|Overall Study|Lost to Follow-up|1
762695|NCT00509028|2428562|P1|Overall Study|Lost to Follow-up|0
762696|NCT00509028|2428561|P2|Overall Study|Withdrawal by Subject|3
762697|NCT00509028|2428562|P1|Overall Study|Withdrawal by Subject|4
762698|NCT00509028|2428561|P2|Overall Study|Adverse Event|0
762699|NCT00509028|2428562|P1|Overall Study|Adverse Event|2
762700|NCT00509067|2428603|P2|Overall Study|Protocol Violation|3
762701|NCT00509067|2428604|P1|Overall Study|Protocol Violation|0
762702|NCT00509067|2428603|P2|Overall Study|Adverse Event|1
762703|NCT00509067|2428604|P1|Overall Study|Adverse Event|3
762704|NCT00509067|2428603|P2|Overall Study|Lost to Follow-up|1
762705|NCT00509067|2428604|P1|Overall Study|Lost to Follow-up|1
762706|NCT00509106|2428612|P2|Overall Study|Death|6
762707|NCT00509106|2428613|P1|Overall Study|Death|6
762708|NCT00509106|2428612|P2|Overall Study|Other|0
762709|NCT00509106|2428613|P1|Overall Study|Other|1
762710|NCT00509106|2428612|P2|Overall Study|Lost to Follow-up|10
762711|NCT00509106|2428613|P1|Overall Study|Lost to Follow-up|16
762712|NCT00509106|2428612|P2|Overall Study|Withdrew consent|8
762713|NCT00509106|2428613|P1|Overall Study|Withdrew consent|4
762714|NCT00509106|2428612|P2|Overall Study|At the request of sponsor/investigator|2
762715|NCT00509106|2428613|P1|Overall Study|At the request of sponsor/investigator|1
762716|NCT00509106|2428612|P2|Overall Study|Noncompliance|1
762717|NCT00509106|2428613|P1|Overall Study|Noncompliance|0
762718|NCT00509106|2428612|P2|Overall Study|Adverse Event|2
762719|NCT00509106|2428613|P1|Overall Study|Adverse Event|3
762720|NCT00509223|2428636|P2|Overall Study|Did not meet revised inclusion criteria|62
762721|NCT00509223|2428637|P1|Overall Study|Did not meet revised inclusion criteria|56
762722|NCT00509223|2428636|P2|Overall Study|Including: subject change of address|2
762723|NCT00509223|2428637|P1|Overall Study|Including: subject change of address|5
762724|NCT00509223|2428636|P2|Overall Study|Withdrawal by Subject|6
762725|NCT00509223|2428637|P1|Overall Study|Withdrawal by Subject|25
762726|NCT00509223|2428636|P2|Overall Study|Adverse Event|1
762727|NCT00509223|2428637|P1|Overall Study|Adverse Event|1
762728|NCT00509223|2428636|P2|Overall Study|Lost to Follow-up|1
762729|NCT00509223|2428637|P1|Overall Study|Lost to Follow-up|1
762730|NCT00509236|2428645|P2|Overall Study|Scheduled Kidney Transplant|0
762731|NCT00509236|2428646|P1|Overall Study|Scheduled Kidney Transplant|1
762732|NCT00509236|2428645|P2|Overall Study|Excluded Medication|1
762733|NCT00509236|2428646|P1|Overall Study|Excluded Medication|1
762734|NCT00509236|2428645|P2|Overall Study|Protocol Violation|0
762735|NCT00509236|2428646|P1|Overall Study|Protocol Violation|3
762736|NCT00509236|2428645|P2|Overall Study|Withdrawal by Subject|10
762737|NCT00509236|2428646|P1|Overall Study|Withdrawal by Subject|5
762738|NCT00509236|2428645|P2|Overall Study|Adverse Event|9
762739|NCT00509236|2428646|P1|Overall Study|Adverse Event|7
762740|NCT00509262|2428665|P2|Overall Study|Withdrawal by Subject|11
762741|NCT00509262|2428666|P1|Overall Study|Withdrawal by Subject|24
762742|NCT00509262|2428665|P2|Overall Study|Protocol Violation|2
762743|NCT00509262|2428666|P1|Overall Study|Protocol Violation|2
762744|NCT00509262|2428665|P2|Overall Study|Physician Decision|3
762745|NCT00509262|2428666|P1|Overall Study|Physician Decision|1
762746|NCT00509262|2428665|P2|Overall Study|Lost to Follow-up|6
762747|NCT00509262|2428666|P1|Overall Study|Lost to Follow-up|1
762748|NCT00509262|2428665|P2|Overall Study|Lack of Efficacy|0
762749|NCT00509262|2428666|P1|Overall Study|Lack of Efficacy|1
762750|NCT00509262|2428665|P2|Overall Study|Not specified|2
762751|NCT00509262|2428666|P1|Overall Study|Not specified|2
762752|NCT00509262|2428665|P2|Overall Study|Adverse Event|18
762753|NCT00509262|2428666|P1|Overall Study|Adverse Event|16
762754|NCT00509366|2428694|P5|Overall Study|Not Treated (Screen Failure)|0
762755|NCT00509366|2428695|P4|Overall Study|Not Treated (Screen Failure)|0
762756|NCT00509366|2428696|P3|Overall Study|Not Treated (Screen Failure)|1
762757|NCT00509366|2428697|P2|Overall Study|Not Treated (Screen Failure)|1
762758|NCT00509366|2428698|P1|Overall Study|Not Treated (Screen Failure)|1
762759|NCT00509600|2428778|P1|Overall Study|Adverse Event|1
762760|NCT00509769|2428782|P1|Overall Study|Use of prohibited therapies during study|1
762761|NCT00509769|2428782|P1|Overall Study|Physician Decision|8
762762|NCT00509769|2428782|P1|Overall Study|Patient’s decision|1
762763|NCT00509769|2428782|P1|Overall Study|Adverse Event|4
762764|NCT00509769|2428782|P1|Overall Study|Progressive disease|77
762765|NCT00509795|2428795|P4|Overall Study|Withdrawal by Subject|8
762766|NCT00509795|2428796|P3|Overall Study|Withdrawal by Subject|7
762767|NCT00509795|2428797|P2|Overall Study|Withdrawal by Subject|5
762768|NCT00509795|2428798|P1|Overall Study|Withdrawal by Subject|10
762769|NCT00509795|2428795|P4|Overall Study|Protocol Violation|1
762770|NCT00509795|2428796|P3|Overall Study|Protocol Violation|3
762771|NCT00509795|2428797|P2|Overall Study|Protocol Violation|0
762772|NCT00509795|2428798|P1|Overall Study|Protocol Violation|3
762773|NCT00509795|2428795|P4|Overall Study|OTHER|1
762774|NCT00509795|2428796|P3|Overall Study|OTHER|4
762775|NCT00509795|2428797|P2|Overall Study|OTHER|0
762776|NCT00509795|2428798|P1|Overall Study|OTHER|1
762777|NCT00509795|2428795|P4|Overall Study|Lost to Follow-up|4
762778|NCT00509795|2428796|P3|Overall Study|Lost to Follow-up|4
762779|NCT00509795|2428797|P2|Overall Study|Lost to Follow-up|2
762780|NCT00509795|2428798|P1|Overall Study|Lost to Follow-up|1
762781|NCT00509795|2428795|P4|Overall Study|Lack of Efficacy|2
762782|NCT00509795|2428796|P3|Overall Study|Lack of Efficacy|2
762783|NCT00509795|2428797|P2|Overall Study|Lack of Efficacy|0
762784|NCT00509795|2428798|P1|Overall Study|Lack of Efficacy|0
762785|NCT00509795|2428795|P4|Overall Study|Death|7
762786|NCT00509795|2428796|P3|Overall Study|Death|2
762787|NCT00509795|2428797|P2|Overall Study|Death|1
762788|NCT00509795|2428798|P1|Overall Study|Death|3
762789|NCT00509795|2428795|P4|Overall Study|Adverse Event|4
762790|NCT00509795|2428796|P3|Overall Study|Adverse Event|5
762791|NCT00509795|2428797|P2|Overall Study|Adverse Event|3
762792|NCT00509795|2428798|P1|Overall Study|Adverse Event|4
762793|NCT00502203|2428829|P1|Overall Study|Inevaluable|1
762794|NCT00502242|2428844|P2|Overall Study|Withdrawal by Subject|7
762795|NCT00502242|2428845|P1|Overall Study|Withdrawal by Subject|6
762796|NCT00502242|2428844|P2|Overall Study|Protocol Violation|1
762797|NCT00502242|2428845|P1|Overall Study|Protocol Violation|3
762798|NCT00502242|2428844|P2|Overall Study|Other - Unspecified|14
762799|NCT00502242|2428845|P1|Overall Study|Other - Unspecified|8
762800|NCT00502242|2428844|P2|Overall Study|Physician Decision|3
762801|NCT00502242|2428845|P1|Overall Study|Physician Decision|2
762802|NCT00502242|2428844|P2|Overall Study|Adverse Event|20
762803|NCT00502242|2428845|P1|Overall Study|Adverse Event|31
762804|NCT00502242|2428844|P2|Overall Study|Lack of Efficacy|11
762805|NCT00502242|2428845|P1|Overall Study|Lack of Efficacy|1
762806|NCT00502320|2428898|P2|Overall Study|Adverse Event|5
762807|NCT00502320|2428899|P1|Overall Study|Adverse Event|3
762808|NCT00502320|2428898|P2|Overall Study|Screen Failure|1
762809|NCT00502320|2428899|P1|Overall Study|Screen Failure|0
762810|NCT00502320|2428898|P2|Overall Study|No longer met criteria|0
762811|NCT00502320|2428899|P1|Overall Study|No longer met criteria|1
762812|NCT00502320|2428898|P2|Overall Study|Withdrew Consent|0
762813|NCT00502320|2428899|P1|Overall Study|Withdrew Consent|1
762814|NCT00502320|2428898|P2|Overall Study|Lost to Follow-up|1
762815|NCT00502320|2428899|P1|Overall Study|Lost to Follow-up|1
762816|NCT00502593|2428921|P12|Overall Study|Lost to Follow-up|0
762817|NCT00502593|2428922|P11|Overall Study|Lost to Follow-up|1
762818|NCT00502593|2428923|P10|Overall Study|Lost to Follow-up|0
762819|NCT00502593|2428924|P9|Overall Study|Lost to Follow-up|3
762820|NCT00502593|2428925|P8|Overall Study|Lost to Follow-up|0
762821|NCT00502593|2428926|P7|Overall Study|Lost to Follow-up|0
762822|NCT00502593|2428927|P6|Overall Study|Lost to Follow-up|0
762823|NCT00502593|2428928|P5|Overall Study|Lost to Follow-up|0
762824|NCT00502593|2428929|P4|Overall Study|Lost to Follow-up|1
762825|NCT00502593|2428930|P3|Overall Study|Lost to Follow-up|1
762826|NCT00502593|2428931|P2|Overall Study|Lost to Follow-up|1
762827|NCT00502593|2428932|P1|Overall Study|Lost to Follow-up|2
762828|NCT00502593|2428921|P12|Overall Study|Withdrawal by Subject|0
762829|NCT00502593|2428922|P11|Overall Study|Withdrawal by Subject|1
762830|NCT00502593|2428923|P10|Overall Study|Withdrawal by Subject|0
762831|NCT00502593|2428924|P9|Overall Study|Withdrawal by Subject|3
762832|NCT00502593|2428925|P8|Overall Study|Withdrawal by Subject|0
762833|NCT00502593|2428926|P7|Overall Study|Withdrawal by Subject|3
762834|NCT00502593|2428927|P6|Overall Study|Withdrawal by Subject|0
762835|NCT00502593|2428928|P5|Overall Study|Withdrawal by Subject|2
762836|NCT00502593|2428929|P4|Overall Study|Withdrawal by Subject|2
762837|NCT00502593|2428930|P3|Overall Study|Withdrawal by Subject|6
762838|NCT00502593|2428931|P2|Overall Study|Withdrawal by Subject|0
762839|NCT00502593|2428932|P1|Overall Study|Withdrawal by Subject|0
762840|NCT00502593|2428921|P12|Overall Study|Withdrawn unspecified reason|0
762841|NCT00502593|2428922|P11|Overall Study|Withdrawn unspecified reason|0
762842|NCT00502593|2428923|P10|Overall Study|Withdrawn unspecified reason|0
762843|NCT00502593|2428924|P9|Overall Study|Withdrawn unspecified reason|0
762844|NCT00502593|2428925|P8|Overall Study|Withdrawn unspecified reason|0
762845|NCT00502593|2428926|P7|Overall Study|Withdrawn unspecified reason|2
762846|NCT00502593|2428927|P6|Overall Study|Withdrawn unspecified reason|0
762847|NCT00502593|2428928|P5|Overall Study|Withdrawn unspecified reason|2
762848|NCT00502593|2428929|P4|Overall Study|Withdrawn unspecified reason|1
762849|NCT00502593|2428930|P3|Overall Study|Withdrawn unspecified reason|3
762850|NCT00502593|2428931|P2|Overall Study|Withdrawn unspecified reason|1
762851|NCT00502593|2428932|P1|Overall Study|Withdrawn unspecified reason|1
762852|NCT00502671|2429446|P1|Overall Study|Adverse Event|19
762853|NCT00502671|2429446|P1|Overall Study|Protocol Violation|16
762854|NCT00502671|2429446|P1|Overall Study|Lost to Follow-up|7
762855|NCT00502671|2429446|P1|Overall Study|Personal Reasons|22
762856|NCT00502671|2429446|P1|Overall Study|Disease Progression|13
762857|NCT00502697|2429453|P2|Overall Study|did not meet assignment criteria|2
762858|NCT00502697|2429454|P1|Overall Study|did not meet assignment criteria|4
762859|NCT00502697|2429453|P2|Overall Study|found not to meet eligibility criteria|4
762860|NCT00502697|2429454|P1|Overall Study|found not to meet eligibility criteria|3
762861|NCT00502697|2429453|P2|Overall Study|disenrolled due to pregnancy loss|5
762862|NCT00502697|2429454|P1|Overall Study|disenrolled due to pregnancy loss|3
762863|NCT00502697|2429453|P2|Overall Study|Withdrawal by Subject|1
762864|NCT00502697|2429454|P1|Overall Study|Withdrawal by Subject|3
762865|NCT00502775|2429465|P3|Overall Study|Subject took disallowed drug|1
762866|NCT00502775|2429466|P2|Overall Study|Subject took disallowed drug|0
762867|NCT00502775|2429467|P1|Overall Study|Subject took disallowed drug|0
762868|NCT00502775|2429465|P3|Overall Study|Subject in jail|0
762869|NCT00502775|2429466|P2|Overall Study|Subject in jail|1
762870|NCT00502775|2429467|P1|Overall Study|Subject in jail|0
762871|NCT00502775|2429465|P3|Overall Study|Declining pollen counts|1
762872|NCT00502775|2429466|P2|Overall Study|Declining pollen counts|1
762873|NCT00502775|2429467|P1|Overall Study|Declining pollen counts|0
762874|NCT00502775|2429465|P3|Overall Study|Outside pollen area more than 48 hours|0
762875|NCT00502775|2429466|P2|Overall Study|Outside pollen area more than 48 hours|1
762876|NCT00502775|2429467|P1|Overall Study|Outside pollen area more than 48 hours|0
762877|NCT00502775|2429465|P3|Overall Study|Non-compliance|2
762878|NCT00502775|2429466|P2|Overall Study|Non-compliance|2
762879|NCT00502775|2429467|P1|Overall Study|Non-compliance|0
762880|NCT00502775|2429465|P3|Overall Study|Randomized in error|1
762881|NCT00502775|2429466|P2|Overall Study|Randomized in error|1
762882|NCT00502775|2429467|P1|Overall Study|Randomized in error|0
762883|NCT00502775|2429465|P3|Overall Study|Logpad compliance <80%|0
762884|NCT00502775|2429466|P2|Overall Study|Logpad compliance <80%|0
762885|NCT00502775|2429467|P1|Overall Study|Logpad compliance <80%|1
762886|NCT00502775|2429465|P3|Overall Study|Subject unable to swallow capsule|1
762887|NCT00502775|2429466|P2|Overall Study|Subject unable to swallow capsule|0
762888|NCT00502775|2429467|P1|Overall Study|Subject unable to swallow capsule|1
762889|NCT00502775|2429465|P3|Overall Study|Non-compliance with eDiary|1
762890|NCT00502775|2429466|P2|Overall Study|Non-compliance with eDiary|1
762891|NCT00502775|2429467|P1|Overall Study|Non-compliance with eDiary|4
762892|NCT00502775|2429465|P3|Overall Study|Sponsor Terminated Study|1
762893|NCT00502775|2429466|P2|Overall Study|Sponsor Terminated Study|0
762894|NCT00502775|2429467|P1|Overall Study|Sponsor Terminated Study|1
762895|NCT00502775|2429465|P3|Overall Study|Withdrawal by Subject|2
762896|NCT00502775|2429466|P2|Overall Study|Withdrawal by Subject|1
762897|NCT00502775|2429467|P1|Overall Study|Withdrawal by Subject|1
762898|NCT00502775|2429465|P3|Overall Study|Protocol Violation|2
762899|NCT00502775|2429466|P2|Overall Study|Protocol Violation|5
762900|NCT00502775|2429467|P1|Overall Study|Protocol Violation|1
762901|NCT00502775|2429465|P3|Overall Study|Adverse Event|1
762902|NCT00502775|2429466|P2|Overall Study|Adverse Event|2
762903|NCT00502775|2429467|P1|Overall Study|Adverse Event|1
762904|NCT00502801|2429508|P1|End of Therapy to Test of Cure|OTHER|2
762905|NCT00502801|2429508|P1|End of Therapy to Test of Cure|Death|3
762906|NCT00502801|2429508|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
762907|NCT00502801|2429508|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
762908|NCT00502801|2429508|P1|Treatment Period|OTHER|30
762909|NCT00502801|2429508|P1|Treatment Period|Death|14
762910|NCT00502801|2429508|P1|Treatment Period|Adverse Event|7
762911|NCT00502801|2429508|P1|Treatment Period|Withdrawal by Subject|3
762912|NCT00502840|2429513|P1|Overall Study|Not specified|20
762913|NCT00502840|2429513|P1|Overall Study|Administrative problems|1
762914|NCT00502840|2429513|P1|Overall Study|Lost to Follow-up|6
762915|NCT00502840|2429513|P1|Overall Study|Withdrawal by Subject|5
762916|NCT00502840|2429513|P1|Overall Study|Protocol Violation|4
762917|NCT00502840|2429513|P1|Overall Study|Lack of Efficacy|11
762918|NCT00502840|2429513|P1|Overall Study|Additional or changed therapy|48
762919|NCT00502840|2429513|P1|Overall Study|Adverse Event|5
762920|NCT00502996|2429585|P1|Overall Study|Adverse Event|2
762921|NCT00502996|2429585|P1|Overall Study|Withdrawal Informed Consent|6
762922|NCT00502996|2429585|P1|Overall Study|Treatment failure|25
762923|NCT00502996|2429585|P1|Overall Study|Protocol Violation|2
762924|NCT00502996|2429585|P1|Overall Study|Lost to Follow-up|9
762925|NCT00503009|2429612|P3|Overall Study|Physician Decision|1
762926|NCT00503009|2429613|P2|Overall Study|Physician Decision|1
762927|NCT00503009|2429614|P1|Overall Study|Physician Decision|0
762928|NCT00503009|2429612|P3|Overall Study|Withdrawal by Subject|1
762929|NCT00503009|2429613|P2|Overall Study|Withdrawal by Subject|1
762930|NCT00503009|2429614|P1|Overall Study|Withdrawal by Subject|0
762931|NCT00503009|2429612|P3|Overall Study|Protocol Violation|1
762932|NCT00503009|2429613|P2|Overall Study|Protocol Violation|0
762933|NCT00503009|2429614|P1|Overall Study|Protocol Violation|1
762934|NCT00503139|2429665|P1|Overall Study|Protocol Violation|4
762935|NCT00503139|2429665|P1|Overall Study|Case Report Forms were not collected|4
762936|NCT00503308|2429678|P2|Overall Study|Protocol Violation|1
762937|NCT00503308|2429679|P1|Overall Study|Protocol Violation|2
762938|NCT00503399|2429687|P2|Overall Study|Lost to Follow-up|2
762939|NCT00503399|2429688|P1|Overall Study|Lost to Follow-up|0
762940|NCT00503399|2429687|P2|Overall Study|Adverse Event|3
762941|NCT00503399|2429688|P1|Overall Study|Adverse Event|0
762942|NCT00503399|2429687|P2|Overall Study|Withdrawal by Subject|2
762943|NCT00503399|2429688|P1|Overall Study|Withdrawal by Subject|4
762944|NCT00503399|2429687|P2|Overall Study|Protocol Violation|0
762945|NCT00503399|2429688|P1|Overall Study|Protocol Violation|1
762946|NCT00503399|2429687|P2|Overall Study|Death|1
762947|NCT00503399|2429688|P1|Overall Study|Death|2
762948|NCT00503425|2429710|P1|Overall Study|Missing Data/Unknown|4
762949|NCT00503425|2429710|P1|Overall Study|Death|3
762950|NCT00503425|2429710|P1|Overall Study|Lost to Follow-up|3
762951|NCT00503425|2429710|P1|Overall Study|Withdrawal by Subject|8
762952|NCT00503425|2429710|P1|Overall Study|Lack of Efficacy|25
762953|NCT00503425|2429710|P1|Overall Study|Adverse Event|5
762954|NCT00503425|2429710|P1|Overall Study|Participant files lost|6
762955|NCT00503698|2429720|P2|Overall Study|Not exposed to trial drug|6
762956|NCT00503698|2429721|P1|Overall Study|Not exposed to trial drug|11
762957|NCT00503698|2429720|P2|Overall Study|Unclassified|32
762958|NCT00503698|2429721|P1|Overall Study|Unclassified|48
762959|NCT00503698|2429720|P2|Overall Study|Critically ill|0
762960|NCT00503698|2429721|P1|Overall Study|Critically ill|2
762961|NCT00503698|2429720|P2|Overall Study|Move to nonparticipating dialysis center|1
762962|NCT00503698|2429721|P1|Overall Study|Move to nonparticipating dialysis center|2
762963|NCT00503698|2429720|P2|Overall Study|Switch to peritoneal or home dialysis|2
762964|NCT00503698|2429721|P1|Overall Study|Switch to peritoneal or home dialysis|2
762965|NCT00503698|2429720|P2|Overall Study|Any condition in exclusion criteria|6
762966|NCT00503698|2429721|P1|Overall Study|Any condition in exclusion criteria|4
762967|NCT00503698|2429720|P2|Overall Study|Pregnancy/intention to become pregnant|0
762968|NCT00503698|2429721|P1|Overall Study|Pregnancy/intention to become pregnant|1
762969|NCT00503698|2429720|P2|Overall Study|End hemodialysis due to renal transplant|4
762970|NCT00503698|2429721|P1|Overall Study|End hemodialysis due to renal transplant|10
762971|NCT00503698|2429720|P2|Overall Study|Trial terminated|253
762972|NCT00503698|2429721|P1|Overall Study|Trial terminated|216
762973|NCT00503698|2429720|P2|Overall Study|Lack of Efficacy|4
762974|NCT00503698|2429721|P1|Overall Study|Lack of Efficacy|3
762975|NCT00503698|2429720|P2|Overall Study|Death|0
762976|NCT00503698|2429721|P1|Overall Study|Death|1
762977|NCT00503698|2429720|P2|Overall Study|Adverse Event|41
762978|NCT00503698|2429721|P1|Overall Study|Adverse Event|52
762979|NCT00503698|2429720|P2|Overall Study|Protocol Violation|6
762980|NCT00503698|2429721|P1|Overall Study|Protocol Violation|5
762981|NCT00503776|2429744|P4|Overall Study|Physician Decision|1
762982|NCT00503776|2429745|P3|Overall Study|Physician Decision|1
762983|NCT00503776|2429746|P2|Overall Study|Physician Decision|0
762984|NCT00503776|2429747|P1|Overall Study|Physician Decision|0
762985|NCT00503776|2429744|P4|Overall Study|Withdrawal by Subject|1
762986|NCT00503776|2429745|P3|Overall Study|Withdrawal by Subject|1
762987|NCT00503776|2429746|P2|Overall Study|Withdrawal by Subject|0
762988|NCT00503776|2429747|P1|Overall Study|Withdrawal by Subject|1
762989|NCT00503841|2429773|P1|Overall Study|All screen failures|44
762990|NCT00503906|2429777|P1|Overall Study|Withdrawal by Subject|1
762991|NCT00503984|2429788|P6|Overall Study|Death|0
762992|NCT00503984|2429789|P5|Overall Study|Death|1
762993|NCT00503984|2429790|P4|Overall Study|Death|0
762994|NCT00503984|2429791|P3|Overall Study|Death|0
762995|NCT00503984|2429792|P2|Overall Study|Death|0
762996|NCT00503984|2429793|P1|Overall Study|Death|0
762997|NCT00503984|2429788|P6|Overall Study|Adverse Event|0
762998|NCT00503984|2429789|P5|Overall Study|Adverse Event|0
762999|NCT00503984|2429790|P4|Overall Study|Adverse Event|0
763000|NCT00503984|2429791|P3|Overall Study|Adverse Event|0
763001|NCT00503984|2429792|P2|Overall Study|Adverse Event|1
763002|NCT00503984|2429793|P1|Overall Study|Adverse Event|0
763003|NCT00503984|2429788|P6|Overall Study|Protocol Violation|0
763004|NCT00503984|2429789|P5|Overall Study|Protocol Violation|0
763005|NCT00503984|2429790|P4|Overall Study|Protocol Violation|0
763006|NCT00503984|2429791|P3|Overall Study|Protocol Violation|0
763007|NCT00503984|2429792|P2|Overall Study|Protocol Violation|1
763008|NCT00503984|2429793|P1|Overall Study|Protocol Violation|0
763009|NCT00503997|2429819|P1|Overall Study|Withdrawal by Subject|1
763010|NCT00503997|2429819|P1|Overall Study|Death|1
763011|NCT00503997|2429819|P1|Overall Study|Adverse Event|5
763012|NCT00503997|2429819|P1|Overall Study|disease progression|1
763013|NCT00504075|2429823|P1|Overall Study|Required other therapeutic intervention|1
763014|NCT00504075|2429823|P1|Overall Study|Withdrawal by Subject|1
763015|NCT00504075|2429823|P1|Overall Study|Lost to Follow-up|5
763016|NCT00504075|2429823|P1|Overall Study|Adverse Event|1
763017|NCT00504153|2429829|P1|Overall Study|Death|1
763018|NCT00504153|2429829|P1|Overall Study|Adverse Event|4
763019|NCT00504153|2429829|P1|Overall Study|Withdrawal by Subject|1
763020|NCT00504166|2429839|P2|Overall Study|Lost to Follow-up|3
763021|NCT00504166|2429840|P1|Overall Study|Lost to Follow-up|1
763022|NCT00504166|2429839|P2|Overall Study|Physician Decision|1
763023|NCT00504166|2429840|P1|Overall Study|Physician Decision|1
763024|NCT00504166|2429839|P2|Overall Study|Withdrawal by Subject|6
763025|NCT00504166|2429840|P1|Overall Study|Withdrawal by Subject|3
763026|NCT00504166|2429839|P2|Overall Study|Adverse Event|4
763027|NCT00504166|2429840|P1|Overall Study|Adverse Event|1
763028|NCT00509899|2429871|P8|Overall Study|Lack of Efficacy|0
763029|NCT00509899|2429872|P7|Overall Study|Lack of Efficacy|0
763030|NCT00509899|2429873|P6|Overall Study|Lack of Efficacy|1
763031|NCT00509899|2429874|P5|Overall Study|Lack of Efficacy|0
763032|NCT00509899|2429875|P4|Overall Study|Lack of Efficacy|0
763033|NCT00509899|2429876|P3|Overall Study|Lack of Efficacy|2
763034|NCT00509899|2429877|P2|Overall Study|Lack of Efficacy|0
763035|NCT00509899|2429878|P1|Overall Study|Lack of Efficacy|1
763036|NCT00509899|2429871|P8|Overall Study|Death|1
763037|NCT00509899|2429872|P7|Overall Study|Death|1
763038|NCT00509899|2429873|P6|Overall Study|Death|1
763039|NCT00509899|2429874|P5|Overall Study|Death|1
763040|NCT00509899|2429875|P4|Overall Study|Death|0
763041|NCT00509899|2429876|P3|Overall Study|Death|3
763042|NCT00509899|2429877|P2|Overall Study|Death|2
763043|NCT00509899|2429878|P1|Overall Study|Death|2
763044|NCT00509899|2429871|P8|Overall Study|Intercurrent Illness|0
763045|NCT00509899|2429872|P7|Overall Study|Intercurrent Illness|0
763046|NCT00509899|2429873|P6|Overall Study|Intercurrent Illness|1
763047|NCT00509899|2429874|P5|Overall Study|Intercurrent Illness|0
763048|NCT00509899|2429875|P4|Overall Study|Intercurrent Illness|1
763049|NCT00509899|2429876|P3|Overall Study|Intercurrent Illness|0
763050|NCT00509899|2429877|P2|Overall Study|Intercurrent Illness|0
763051|NCT00509899|2429878|P1|Overall Study|Intercurrent Illness|1
763052|NCT00509899|2429871|P8|Overall Study|Physician Decision|0
763053|NCT00509899|2429872|P7|Overall Study|Physician Decision|0
763054|NCT00509899|2429873|P6|Overall Study|Physician Decision|4
763055|NCT00509899|2429874|P5|Overall Study|Physician Decision|1
763056|NCT00509899|2429875|P4|Overall Study|Physician Decision|0
763057|NCT00509899|2429876|P3|Overall Study|Physician Decision|7
763058|NCT00509899|2429877|P2|Overall Study|Physician Decision|2
763059|NCT00509899|2429878|P1|Overall Study|Physician Decision|4
763060|NCT00509899|2429871|P8|Overall Study|Withdrawal by Subject|0
763061|NCT00509899|2429872|P7|Overall Study|Withdrawal by Subject|0
763062|NCT00509899|2429873|P6|Overall Study|Withdrawal by Subject|2
763063|NCT00509899|2429874|P5|Overall Study|Withdrawal by Subject|3
763064|NCT00509899|2429875|P4|Overall Study|Withdrawal by Subject|0
763065|NCT00509899|2429876|P3|Overall Study|Withdrawal by Subject|3
763066|NCT00509899|2429877|P2|Overall Study|Withdrawal by Subject|2
763067|NCT00509899|2429878|P1|Overall Study|Withdrawal by Subject|6
763068|NCT00509899|2429871|P8|Overall Study|Unacceptable Toxicity|0
763069|NCT00509899|2429872|P7|Overall Study|Unacceptable Toxicity|0
763070|NCT00509899|2429873|P6|Overall Study|Unacceptable Toxicity|0
763071|NCT00509899|2429874|P5|Overall Study|Unacceptable Toxicity|0
763072|NCT00509899|2429875|P4|Overall Study|Unacceptable Toxicity|2
763073|NCT00509899|2429876|P3|Overall Study|Unacceptable Toxicity|0
763074|NCT00509899|2429877|P2|Overall Study|Unacceptable Toxicity|0
763075|NCT00509899|2429878|P1|Overall Study|Unacceptable Toxicity|1
763076|NCT00509899|2429871|P8|Overall Study|Progressive disease|0
763077|NCT00509899|2429872|P7|Overall Study|Progressive disease|0
763078|NCT00509899|2429873|P6|Overall Study|Progressive disease|1
763079|NCT00509899|2429874|P5|Overall Study|Progressive disease|0
763080|NCT00509899|2429875|P4|Overall Study|Progressive disease|1
763081|NCT00509899|2429876|P3|Overall Study|Progressive disease|5
763082|NCT00509899|2429877|P2|Overall Study|Progressive disease|3
763083|NCT00509899|2429878|P1|Overall Study|Progressive disease|1
763084|NCT00509925|2429916|P2|Overall Study|Personal reasons|1
763085|NCT00509925|2429917|P1|Overall Study|Personal reasons|0
763086|NCT00510068|2429959|P2|Open-label Period|Abnormal laboratory value (s)|0
763087|NCT00510068|2429960|P1|Open-label Period|Abnormal laboratory value (s)|1
763088|NCT00510068|2429959|P2|Open-label Period|Protocol Violation|0
763089|NCT00510068|2429960|P1|Open-label Period|Protocol Violation|2
763090|NCT00510068|2429959|P2|Open-label Period|New cancer therapy|0
763091|NCT00510068|2429960|P1|Open-label Period|New cancer therapy|7
763092|NCT00510068|2429959|P2|Open-label Period|Death|0
763093|NCT00510068|2429960|P1|Open-label Period|Death|7
763094|NCT00510068|2429959|P2|Open-label Period|Administrative problems|0
763095|NCT00510068|2429960|P1|Open-label Period|Administrative problems|17
763096|NCT00510068|2429959|P2|Open-label Period|Withdrawal by Subject|0
763097|NCT00510068|2429960|P1|Open-label Period|Withdrawal by Subject|21
763098|NCT00510068|2429959|P2|Open-label Period|Adverse Event|0
763099|NCT00510068|2429960|P1|Open-label Period|Adverse Event|46
763100|NCT00510068|2429959|P2|Open-label Period|Disease Progression|0
763101|NCT00510068|2429960|P1|Open-label Period|Disease Progression|124
763102|NCT00510068|2429959|P2|Double-blind Period|Protocol Violation|0
763103|NCT00510068|2429960|P1|Double-blind Period|Protocol Violation|6
763104|NCT00510068|2429959|P2|Double-blind Period|Lost to Follow-up|0
763105|NCT00510068|2429960|P1|Double-blind Period|Lost to Follow-up|1
763106|NCT00510068|2429959|P2|Double-blind Period|Abnormal test result (s)|0
763107|NCT00510068|2429960|P1|Double-blind Period|Abnormal test result (s)|1
763108|NCT00510068|2429959|P2|Double-blind Period|Death|3
763109|NCT00510068|2429960|P1|Double-blind Period|Death|4
763110|NCT00510068|2429959|P2|Double-blind Period|Withdrawal by Subject|6
763111|NCT00510068|2429960|P1|Double-blind Period|Withdrawal by Subject|8
763112|NCT00510068|2429959|P2|Double-blind Period|Adverse Event|7
763113|NCT00510068|2429960|P1|Double-blind Period|Adverse Event|37
763114|NCT00510068|2429959|P2|Double-blind Period|Final primary analysis|18
763115|NCT00510068|2429960|P1|Double-blind Period|Final primary analysis|52
763116|NCT00510068|2429959|P2|Double-blind Period|Disease progression|169
763117|NCT00510068|2429960|P1|Double-blind Period|Disease progression|98
763118|NCT00510146|2430003|P2|Open-Label Treatment|Sponsor Decision|0
763119|NCT00510146|2430004|P1|Open-Label Treatment|Sponsor Decision|2
763120|NCT00510146|2430003|P2|Open-Label Treatment|Clinical Relapse|1
763121|NCT00510146|2430004|P1|Open-Label Treatment|Clinical Relapse|1
763122|NCT00510146|2430003|P2|Open-Label Treatment|Withdrawal by Subject|12
763123|NCT00510146|2430004|P1|Open-Label Treatment|Withdrawal by Subject|24
763124|NCT00510146|2430003|P2|Open-Label Treatment|Protocol Violation|2
763125|NCT00510146|2430004|P1|Open-Label Treatment|Protocol Violation|4
763126|NCT00510146|2430003|P2|Open-Label Treatment|Physician Decision|1
763127|NCT00510146|2430004|P1|Open-Label Treatment|Physician Decision|3
763128|NCT00510146|2430003|P2|Open-Label Treatment|Lost to Follow-up|1
763129|NCT00510146|2430004|P1|Open-Label Treatment|Lost to Follow-up|10
763130|NCT00510146|2430003|P2|Open-Label Treatment|Lack of Efficacy|0
763131|NCT00510146|2430004|P1|Open-Label Treatment|Lack of Efficacy|4
763132|NCT00510146|2430003|P2|Open-Label Treatment|Death|1
763133|NCT00510146|2430004|P1|Open-Label Treatment|Death|1
763134|NCT00510146|2430003|P2|Open-Label Treatment|Adverse Event|8
763135|NCT00510146|2430004|P1|Open-Label Treatment|Adverse Event|22
763136|NCT00510146|2430003|P2|Double-Blind Treatment|Entry Criteria Not Met|0
763137|NCT00510146|2430004|P1|Double-Blind Treatment|Entry Criteria Not Met|3
763138|NCT00510146|2430003|P2|Double-Blind Treatment|Clinical Relapse|1
763139|NCT00510146|2430004|P1|Double-Blind Treatment|Clinical Relapse|0
763140|NCT00510146|2430003|P2|Double-Blind Treatment|Withdrawal by Subject|13
763141|NCT00510146|2430004|P1|Double-Blind Treatment|Withdrawal by Subject|27
763142|NCT00510146|2430003|P2|Double-Blind Treatment|Protocol Violation|2
763143|NCT00510146|2430004|P1|Double-Blind Treatment|Protocol Violation|1
763144|NCT00510146|2430003|P2|Double-Blind Treatment|Physician Decision|0
763145|NCT00510146|2430004|P1|Double-Blind Treatment|Physician Decision|6
763146|NCT00510146|2430003|P2|Double-Blind Treatment|Lost to Follow-up|7
763147|NCT00510146|2430004|P1|Double-Blind Treatment|Lost to Follow-up|3
763148|NCT00510146|2430003|P2|Double-Blind Treatment|Lack of Efficacy|13
763149|NCT00510146|2430004|P1|Double-Blind Treatment|Lack of Efficacy|6
763150|NCT00510146|2430003|P2|Double-Blind Treatment|Adverse Event|13
763151|NCT00510146|2430004|P1|Double-Blind Treatment|Adverse Event|30
763152|NCT00510484|2430093|P2|Wash-out Period|Adverse Event|1
763153|NCT00510484|2430094|P1|Wash-out Period|Adverse Event|0
763154|NCT00510510|2430122|P3|Overall Study|Protocol Violation|4
763155|NCT00510510|2430123|P2|Overall Study|Protocol Violation|3
763156|NCT00510510|2430124|P1|Overall Study|Protocol Violation|0
763157|NCT00510510|2430122|P3|Overall Study|Lost to Follow-up|1
763158|NCT00510510|2430123|P2|Overall Study|Lost to Follow-up|0
763159|NCT00510510|2430124|P1|Overall Study|Lost to Follow-up|0
763160|NCT00510510|2430122|P3|Overall Study|Withdrawal by Subject|3
763161|NCT00510510|2430123|P2|Overall Study|Withdrawal by Subject|2
763162|NCT00510510|2430124|P1|Overall Study|Withdrawal by Subject|1
763163|NCT00510510|2430122|P3|Overall Study|Subjects no longer requires study drug|2
763164|NCT00510510|2430123|P2|Overall Study|Subjects no longer requires study drug|0
763165|NCT00510510|2430124|P1|Overall Study|Subjects no longer requires study drug|0
763166|NCT00510510|2430122|P3|Overall Study|Lack of Efficacy|1
763167|NCT00510510|2430123|P2|Overall Study|Lack of Efficacy|1
763168|NCT00510510|2430124|P1|Overall Study|Lack of Efficacy|0
763169|NCT00510510|2430122|P3|Overall Study|Adverse Event|6
763170|NCT00510510|2430123|P2|Overall Study|Adverse Event|3
763171|NCT00510510|2430124|P1|Overall Study|Adverse Event|4
763172|NCT00510653|2430135|P1|Overall Study|Monetary|3
763173|NCT00510653|2430135|P1|Overall Study|Withdrawal by Subject|8
763174|NCT00510692|2430141|P2|Overall Study|Withdrawal by Subject|0
763175|NCT00510692|2430142|P1|Overall Study|Withdrawal by Subject|1
763176|NCT00510692|2430141|P2|Overall Study|Adverse Event|3
763177|NCT00510692|2430142|P1|Overall Study|Adverse Event|1
763178|NCT00510783|2430162|P2|Overall Study|Protocol Violation|1
763179|NCT00510783|2430163|P1|Overall Study|Protocol Violation|0
763180|NCT00510783|2430162|P2|Overall Study|Withdrawal by Subject|3
763181|NCT00510783|2430163|P1|Overall Study|Withdrawal by Subject|2
763182|NCT00510783|2430162|P2|Overall Study|Lost to Follow-up|25
763183|NCT00510783|2430163|P1|Overall Study|Lost to Follow-up|29
763184|NCT00510835|2430188|P3|Overall Study|Withdrawal by Subject|2
763185|NCT00510835|2430189|P2|Overall Study|Withdrawal by Subject|2
763186|NCT00510835|2430190|P1|Overall Study|Withdrawal by Subject|6
763187|NCT00510874|2430205|P7|Overall Study|Lost to Follow-up|1
763188|NCT00510874|2430206|P6|Overall Study|Lost to Follow-up|0
763189|NCT00510874|2430207|P5|Overall Study|Lost to Follow-up|4
763190|NCT00510874|2430208|P4|Overall Study|Lost to Follow-up|3
763191|NCT00510874|2430209|P3|Overall Study|Lost to Follow-up|1
763192|NCT00510874|2430210|P2|Overall Study|Lost to Follow-up|3
763193|NCT00510874|2430211|P1|Overall Study|Lost to Follow-up|2
763194|NCT00510874|2430205|P7|Overall Study|Withdrawal by Subject|0
763195|NCT00510874|2430206|P6|Overall Study|Withdrawal by Subject|0
763196|NCT00510874|2430207|P5|Overall Study|Withdrawal by Subject|3
763197|NCT00510874|2430208|P4|Overall Study|Withdrawal by Subject|0
763198|NCT00510874|2430209|P3|Overall Study|Withdrawal by Subject|0
763199|NCT00510874|2430210|P2|Overall Study|Withdrawal by Subject|1
763200|NCT00510874|2430211|P1|Overall Study|Withdrawal by Subject|1
763201|NCT00510887|2430311|P1|Overall Study|Lost to Follow-up|1
763202|NCT00510952|2430322|P2|Overall Study|Did Not Receive Study Drug|0
763203|NCT00510952|2430323|P1|Overall Study|Did Not Receive Study Drug|2
763204|NCT00510952|2430322|P2|Overall Study|Withdrawal by Subject|7
763205|NCT00510952|2430323|P1|Overall Study|Withdrawal by Subject|6
763206|NCT00510952|2430322|P2|Overall Study|Sponsor Decision|0
763207|NCT00510952|2430323|P1|Overall Study|Sponsor Decision|1
763208|NCT00510952|2430322|P2|Overall Study|Protocol Violation|4
763209|NCT00510952|2430323|P1|Overall Study|Protocol Violation|7
763210|NCT00510952|2430322|P2|Overall Study|Physician Decision|1
763211|NCT00510952|2430323|P1|Overall Study|Physician Decision|1
763212|NCT00510952|2430322|P2|Overall Study|Lost to Follow-up|3
763213|NCT00510952|2430323|P1|Overall Study|Lost to Follow-up|5
763214|NCT00510952|2430322|P2|Overall Study|Entry Criteria Not Met|1
763215|NCT00510952|2430323|P1|Overall Study|Entry Criteria Not Met|3
763216|NCT00510952|2430322|P2|Overall Study|Adverse Event|0
763217|NCT00510952|2430323|P1|Overall Study|Adverse Event|1
763218|NCT00511004|2430352|P3|Overall Study|Lost to Follow-up|4
763219|NCT00511004|2430353|P2|Overall Study|Lost to Follow-up|0
763220|NCT00511004|2430354|P1|Overall Study|Lost to Follow-up|0
763221|NCT00511108|2430381|P4|Overall Study|Withdrawal by Subject|2
763222|NCT00511108|2430382|P3|Overall Study|Withdrawal by Subject|3
763223|NCT00511108|2430383|P2|Overall Study|Withdrawal by Subject|0
763224|NCT00511108|2430384|P1|Overall Study|Withdrawal by Subject|4
763225|NCT00511108|2430381|P4|Overall Study|Physician Decision|1
763226|NCT00511108|2430382|P3|Overall Study|Physician Decision|0
763227|NCT00511108|2430383|P2|Overall Study|Physician Decision|0
763228|NCT00511108|2430384|P1|Overall Study|Physician Decision|0
763229|NCT00511108|2430381|P4|Overall Study|Lost to Follow-up|0
763230|NCT00511108|2430382|P3|Overall Study|Lost to Follow-up|1
763231|NCT00511108|2430383|P2|Overall Study|Lost to Follow-up|2
763232|NCT00511108|2430384|P1|Overall Study|Lost to Follow-up|0
763233|NCT00511108|2430381|P4|Overall Study|Adverse Event|2
763234|NCT00511108|2430382|P3|Overall Study|Adverse Event|1
763235|NCT00511108|2430383|P2|Overall Study|Adverse Event|0
763236|NCT00511108|2430384|P1|Overall Study|Adverse Event|2
763237|NCT00511134|2430404|P2|Overall Study|Withdrawal by Subject|2
763238|NCT00511134|2430405|P1|Overall Study|Withdrawal by Subject|0
763239|NCT00511147|2430413|P1|Overall Study|Required platelet transfusion|1
763240|NCT00511147|2430413|P1|Overall Study|Disease progression|5
763241|NCT00511147|2430413|P1|Overall Study|Withdrawal by Subject|1
763242|NCT00511199|2430427|P2|Overall Study|Other Reason|37
763243|NCT00511199|2430428|P1|Overall Study|Other Reason|78
763244|NCT00511199|2430427|P2|Overall Study|Lost to Follow-up|17
763245|NCT00511199|2430428|P1|Overall Study|Lost to Follow-up|40
763246|NCT00511199|2430427|P2|Overall Study|Pregnancy Wish|8
763247|NCT00511199|2430428|P1|Overall Study|Pregnancy Wish|16
763248|NCT00511199|2430427|P2|Overall Study|Pregnancy|3
763249|NCT00511199|2430428|P1|Overall Study|Pregnancy|6
763250|NCT00511199|2430427|P2|Overall Study|Withdrawal of Informed Consent|4
763251|NCT00511199|2430428|P1|Overall Study|Withdrawal of Informed Consent|19
763252|NCT00511199|2430427|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
763253|NCT00511199|2430428|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
763254|NCT00511199|2430427|P2|Overall Study|Unacceptable Vaginal Bleeding|4
763255|NCT00511199|2430428|P1|Overall Study|Unacceptable Vaginal Bleeding|63
763256|NCT00511238|2430454|P2|Overall Study|various reasons|14
763257|NCT00511238|2430455|P1|Overall Study|various reasons|4
763258|NCT00511238|2430454|P2|Overall Study|Progressive Disease|157
763259|NCT00511238|2430455|P1|Overall Study|Progressive Disease|23
763260|NCT00511238|2430454|P2|Overall Study|Withdrawal by Subject|22
763261|NCT00511238|2430455|P1|Overall Study|Withdrawal by Subject|2
763262|NCT00511238|2430454|P2|Overall Study|Adverse Event|33
763263|NCT00511238|2430455|P1|Overall Study|Adverse Event|13
763264|NCT00511342|2430474|P2|Overall Study|Other Reason|2
763265|NCT00511342|2430475|P1|Overall Study|Other Reason|2
763266|NCT00511342|2430474|P2|Overall Study|Lost to Follow-up|5
763267|NCT00511342|2430475|P1|Overall Study|Lost to Follow-up|1
763268|NCT00511342|2430474|P2|Overall Study|Pregnancy wish|1
763269|NCT00511342|2430475|P1|Overall Study|Pregnancy wish|0
763270|NCT00511342|2430474|P2|Overall Study|Pregnancy|1
763271|NCT00511342|2430475|P1|Overall Study|Pregnancy|0
763272|NCT00511342|2430474|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
763273|NCT00511342|2430475|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
763274|NCT00511342|2430474|P2|Overall Study|Unacceptable vaginal bleeding|1
763275|NCT00511342|2430475|P1|Overall Study|Unacceptable vaginal bleeding|2
763276|NCT00511355|2430501|P2|Overall Study|Other reason pre-treatment|1
763277|NCT00511355|2430502|P1|Overall Study|Other reason pre-treatment|0
763278|NCT00511355|2430501|P2|Overall Study|Withdrawal of informed consent|1
763279|NCT00511355|2430502|P1|Overall Study|Withdrawal of informed consent|0
763280|NCT00511355|2430501|P2|Overall Study|Pre-treatment (serious) adverse event|1
763281|NCT00511355|2430502|P1|Overall Study|Pre-treatment (serious) adverse event|0
763282|NCT00511355|2430501|P2|Overall Study|Other Reason|1
763283|NCT00511355|2430502|P1|Overall Study|Other Reason|0
763284|NCT00511355|2430501|P2|Overall Study|Lost to Follow-up|1
763285|NCT00511355|2430502|P1|Overall Study|Lost to Follow-up|2
763286|NCT00511355|2430501|P2|Overall Study|Pregnancy Wish|0
763287|NCT00511355|2430502|P1|Overall Study|Pregnancy Wish|1
763288|NCT00511355|2430501|P2|Overall Study|Adverse Event|4
763289|NCT00511355|2430502|P1|Overall Study|Adverse Event|4
763290|NCT00511433|2430602|P2|Overall Study|Other Reason|1
763291|NCT00511433|2430603|P1|Overall Study|Other Reason|1
763292|NCT00511433|2430602|P2|Overall Study|Adverse Event|0
763293|NCT00511433|2430603|P1|Overall Study|Adverse Event|5
763294|NCT00511472|2430643|P2|Overall Study|Not reported|2
763295|NCT00511472|2430644|P1|Overall Study|Not reported|2
763296|NCT00511472|2430643|P2|Overall Study|Laboratory Adverse Event|2
763297|NCT00511472|2430644|P1|Overall Study|Laboratory Adverse Event|0
763298|NCT00511472|2430643|P2|Overall Study|Clinical Adverse Event|2
763299|NCT00511472|2430644|P1|Overall Study|Clinical Adverse Event|1
763300|NCT00511667|2430663|P2|Overall Study|Other|1
763301|NCT00511667|2430664|P1|Overall Study|Other|2
763302|NCT00511667|2430663|P2|Overall Study|Site terminated|1
763303|NCT00511667|2430664|P1|Overall Study|Site terminated|6
763304|NCT00511667|2430663|P2|Overall Study|Withdrawal by Subject|0
763305|NCT00511667|2430664|P1|Overall Study|Withdrawal by Subject|2
763306|NCT00511667|2430663|P2|Overall Study|Protocol Violation|1
763307|NCT00511667|2430664|P1|Overall Study|Protocol Violation|1
763308|NCT00511667|2430663|P2|Overall Study|Adverse Event|0
763309|NCT00511667|2430664|P1|Overall Study|Adverse Event|1
763310|NCT00511797|2430716|P4|Overall Study|Other (moving etc)|2
763311|NCT00511797|2430717|P3|Overall Study|Other (moving etc)|1
763312|NCT00511797|2430718|P2|Overall Study|Other (moving etc)|0
763313|NCT00511797|2430719|P1|Overall Study|Other (moving etc)|1
763314|NCT00511797|2430716|P4|Overall Study|Partially missing diary|0
763315|NCT00511797|2430717|P3|Overall Study|Partially missing diary|1
763316|NCT00511797|2430718|P2|Overall Study|Partially missing diary|0
763317|NCT00511797|2430719|P1|Overall Study|Partially missing diary|0
763318|NCT00511797|2430716|P4|Overall Study|Study drug not taken|1
763319|NCT00511797|2430717|P3|Overall Study|Study drug not taken|0
763320|NCT00511797|2430718|P2|Overall Study|Study drug not taken|1
763321|NCT00511797|2430719|P1|Overall Study|Study drug not taken|0
763322|NCT00511797|2430716|P4|Overall Study|Never dispensed|3
763323|NCT00511797|2430717|P3|Overall Study|Never dispensed|1
763324|NCT00511797|2430718|P2|Overall Study|Never dispensed|0
763325|NCT00511797|2430719|P1|Overall Study|Never dispensed|1
763326|NCT00511797|2430716|P4|Overall Study|Withdrawal by Subject|2
763327|NCT00511797|2430717|P3|Overall Study|Withdrawal by Subject|4
763328|NCT00511797|2430718|P2|Overall Study|Withdrawal by Subject|3
763329|NCT00511797|2430719|P1|Overall Study|Withdrawal by Subject|3
763330|NCT00511797|2430716|P4|Overall Study|Protocol Violation|3
763331|NCT00511797|2430717|P3|Overall Study|Protocol Violation|2
763332|NCT00511797|2430718|P2|Overall Study|Protocol Violation|2
763333|NCT00511797|2430719|P1|Overall Study|Protocol Violation|0
763334|NCT00511797|2430716|P4|Overall Study|Pregnancy|1
763335|NCT00511797|2430717|P3|Overall Study|Pregnancy|0
763336|NCT00511797|2430718|P2|Overall Study|Pregnancy|0
763337|NCT00511797|2430719|P1|Overall Study|Pregnancy|0
763338|NCT00511797|2430716|P4|Overall Study|Lost to Follow-up|1
763339|NCT00511797|2430717|P3|Overall Study|Lost to Follow-up|0
763340|NCT00511797|2430718|P2|Overall Study|Lost to Follow-up|0
763341|NCT00511797|2430719|P1|Overall Study|Lost to Follow-up|1
763342|NCT00511797|2430716|P4|Overall Study|Adverse Event|2
763343|NCT00511797|2430717|P3|Overall Study|Adverse Event|2
763344|NCT00511797|2430718|P2|Overall Study|Adverse Event|2
763345|NCT00511797|2430719|P1|Overall Study|Adverse Event|1
763346|NCT00511810|2430823|P2|Overall Study|Refused second scn|1
763347|NCT00511810|2430824|P1|Overall Study|Refused second scn|0
763348|NCT00511810|2430823|P2|Overall Study|Lack of Efficacy|2
763349|NCT00511810|2430824|P1|Overall Study|Lack of Efficacy|0
763350|NCT00511810|2430823|P2|Overall Study|Lost to Follow-up|2
763351|NCT00511810|2430824|P1|Overall Study|Lost to Follow-up|1
763352|NCT00511836|2430832|P2|Double-blind Period|Lost to Follow-up|0
763353|NCT00511836|2430833|P1|Double-blind Period|Lost to Follow-up|1
763354|NCT00511901|2430866|P2|Overall Study|Withdrawal by Subject|3
763355|NCT00511901|2430867|P1|Overall Study|Withdrawal by Subject|1
763356|NCT00512096|2430909|P1|Overall Study|Lack of Efficacy|3
763357|NCT00512096|2430909|P1|Overall Study|Withdrawal by Subject|2
763358|NCT00512096|2430909|P1|Overall Study|Adverse Event|2
763360|NCT00512252|2430921|P3|Overall Study|Death|1
763361|NCT00512252|2430922|P2|Overall Study|Death|0
763362|NCT00512252|2430923|P1|Overall Study|Death|0
763363|NCT00512252|2430921|P3|Overall Study|Protocol Violation|1
763364|NCT00512252|2430922|P2|Overall Study|Protocol Violation|0
763365|NCT00512252|2430923|P1|Overall Study|Protocol Violation|0
763366|NCT00512252|2430921|P3|Overall Study|Lost to Follow-up|1
763367|NCT00512252|2430922|P2|Overall Study|Lost to Follow-up|0
763368|NCT00512252|2430923|P1|Overall Study|Lost to Follow-up|0
763369|NCT00512707|2430970|P2|Overall Study|Unable to tolerate the smell of the gel|0
763370|NCT00512707|2430971|P1|Overall Study|Unable to tolerate the smell of the gel|1
763371|NCT00512707|2430970|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
763372|NCT00512707|2430971|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
763373|NCT00512707|2430970|P2|Overall Study|Developed skin irritation|1
763374|NCT00512707|2430971|P1|Overall Study|Developed skin irritation|2
763375|NCT00512707|2430970|P2|Overall Study|Lost to Follow-up|11
763376|NCT00512707|2430971|P1|Overall Study|Lost to Follow-up|5
763377|NCT00507130|2431005|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
763378|NCT00507130|2431006|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
763379|NCT00507130|2431007|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
763380|NCT00507130|2431008|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
763381|NCT00507130|2431005|P4|Overall Study|Lost to Follow-up|1
763382|NCT00507130|2431006|P3|Overall Study|Lost to Follow-up|1
763383|NCT00507130|2431007|P2|Overall Study|Lost to Follow-up|0
763384|NCT00507130|2431008|P1|Overall Study|Lost to Follow-up|0
763385|NCT00512798|2431061|P2|Overall Study|Withdrawal by Subject|0
763386|NCT00512798|2431062|P1|Overall Study|Withdrawal by Subject|3
763387|NCT00512798|2431061|P2|Overall Study|Progression of disease|20
763388|NCT00512798|2431062|P1|Overall Study|Progression of disease|14
763389|NCT00512798|2431061|P2|Overall Study|Adverse Event|4
763390|NCT00512798|2431062|P1|Overall Study|Adverse Event|2
763391|NCT00512798|2431061|P2|Overall Study|Death|3
763392|NCT00512798|2431062|P1|Overall Study|Death|0
763393|NCT00512902|2431076|P1|Overall Study|Lost to Follow-up|1
763394|NCT00512902|2431076|P1|Overall Study|Adverse Event|7
763395|NCT00513019|2431086|P2|Overall Study|Withdrawal by Subject|5
763396|NCT00513019|2431087|P1|Overall Study|Withdrawal by Subject|4
763397|NCT00513019|2431086|P2|Overall Study|Adverse Event|0
763398|NCT00513019|2431087|P1|Overall Study|Adverse Event|1
763399|NCT00513071|2431093|P1|Overall Study|Physician Decision|3
763400|NCT00513071|2431093|P1|Overall Study|Withdrawal by Subject|1
763401|NCT00513071|2431093|P1|Overall Study|Adverse Event|1
763402|NCT00514514|2431107|P3|Extension - 4 Years|Adverse Event|3
763403|NCT00514514|2431108|P2|Extension - 4 Years|Adverse Event|6
763404|NCT00514514|2431109|P1|Extension - 4 Years|Adverse Event|9
763405|NCT00514514|2431107|P3|Extension - 4 Years|Death|6
763406|NCT00514514|2431108|P2|Extension - 4 Years|Death|3
763407|NCT00514514|2431109|P1|Extension - 4 Years|Death|8
763408|NCT00514514|2431107|P3|Extension - 4 Years|Administrative problems|1
763409|NCT00514514|2431108|P2|Extension - 4 Years|Administrative problems|1
763410|NCT00514514|2431109|P1|Extension - 4 Years|Administrative problems|3
763411|NCT00514514|2431107|P3|Extension - 4 Years|Lost to Follow-up|9
763412|NCT00514514|2431108|P2|Extension - 4 Years|Lost to Follow-up|10
763413|NCT00514514|2431109|P1|Extension - 4 Years|Lost to Follow-up|12
763414|NCT00514514|2431107|P3|Extension - 4 Years|Withdrawal by Subject|2
763415|NCT00514514|2431108|P2|Extension - 4 Years|Withdrawal by Subject|2
763416|NCT00514514|2431109|P1|Extension - 4 Years|Withdrawal by Subject|5
763417|NCT00514514|2431107|P3|Randomized - 9 Month|Adverse Event|27
763418|NCT00514514|2431108|P2|Randomized - 9 Month|Adverse Event|44
763419|NCT00514514|2431109|P1|Randomized - 9 Month|Adverse Event|25
763420|NCT00514514|2431107|P3|Randomized - 9 Month|Abnormal laboratory values|1
763421|NCT00514514|2431108|P2|Randomized - 9 Month|Abnormal laboratory values|3
763422|NCT00514514|2431109|P1|Randomized - 9 Month|Abnormal laboratory values|0
763423|NCT00514514|2431107|P3|Randomized - 9 Month|Lack of Efficacy|1
763424|NCT00514514|2431108|P2|Randomized - 9 Month|Lack of Efficacy|3
763425|NCT00514514|2431109|P1|Randomized - 9 Month|Lack of Efficacy|2
763426|NCT00514514|2431107|P3|Randomized - 9 Month|Protocol Violation|0
763427|NCT00514514|2431108|P2|Randomized - 9 Month|Protocol Violation|1
763428|NCT00514514|2431109|P1|Randomized - 9 Month|Protocol Violation|1
763429|NCT00514514|2431107|P3|Randomized - 9 Month|Withdrawal by Subject|5
763430|NCT00514514|2431108|P2|Randomized - 9 Month|Withdrawal by Subject|7
763431|NCT00514514|2431109|P1|Randomized - 9 Month|Withdrawal by Subject|7
763432|NCT00514514|2431107|P3|Randomized - 9 Month|Administrative problems|2
763433|NCT00514514|2431108|P2|Randomized - 9 Month|Administrative problems|1
763434|NCT00514514|2431109|P1|Randomized - 9 Month|Administrative problems|1
763435|NCT00514514|2431107|P3|Randomized - 9 Month|Death|2
763436|NCT00514514|2431108|P2|Randomized - 9 Month|Death|2
763437|NCT00514514|2431109|P1|Randomized - 9 Month|Death|3
763438|NCT00514514|2431107|P3|Pre-phase|Withdrawal by Subject|0
763439|NCT00514514|2431108|P2|Pre-phase|Withdrawal by Subject|0
763440|NCT00514514|2431109|P1|Pre-phase|Withdrawal by Subject|66
763441|NCT00514514|2431107|P3|Pre-phase|Adverse Event|0
763442|NCT00514514|2431108|P2|Pre-phase|Adverse Event|0
763443|NCT00514514|2431109|P1|Pre-phase|Adverse Event|137
763444|NCT00514514|2431107|P3|Pre-phase|Lack of Efficacy|0
763445|NCT00514514|2431108|P2|Pre-phase|Lack of Efficacy|0
763446|NCT00514514|2431109|P1|Pre-phase|Lack of Efficacy|35
763447|NCT00514514|2431107|P3|Pre-phase|abnormal lab values|0
763448|NCT00514514|2431108|P2|Pre-phase|abnormal lab values|0
763449|NCT00514514|2431109|P1|Pre-phase|abnormal lab values|23
763450|NCT00514514|2431107|P3|Pre-phase|Lost to Follow-up|0
763451|NCT00514514|2431108|P2|Pre-phase|Lost to Follow-up|0
763452|NCT00514514|2431109|P1|Pre-phase|Lost to Follow-up|2
763453|NCT00514514|2431107|P3|Pre-phase|abnormal test procedure results|0
763454|NCT00514514|2431108|P2|Pre-phase|abnormal test procedure results|0
763455|NCT00514514|2431109|P1|Pre-phase|abnormal test procedure results|15
763456|NCT00514514|2431107|P3|Pre-phase|condition no longer requires study drug|0
763457|NCT00514514|2431108|P2|Pre-phase|condition no longer requires study drug|0
763458|NCT00514514|2431109|P1|Pre-phase|condition no longer requires study drug|7
763459|NCT00514514|2431107|P3|Pre-phase|Protocol Violation|0
763460|NCT00514514|2431108|P2|Pre-phase|Protocol Violation|0
763461|NCT00514514|2431109|P1|Pre-phase|Protocol Violation|6
763462|NCT00514514|2431107|P3|Pre-phase|administrative problems|0
763463|NCT00514514|2431108|P2|Pre-phase|administrative problems|0
763464|NCT00514514|2431109|P1|Pre-phase|administrative problems|2
763465|NCT00514514|2431107|P3|Pre-phase|Death|0
763466|NCT00514514|2431108|P2|Pre-phase|Death|0
763467|NCT00514514|2431109|P1|Pre-phase|Death|10
763468|NCT00514683|2431163|P5|Overall Study|Reason other than listed above|1
763469|NCT00514683|2431164|P4|Overall Study|Reason other than listed above|0
763470|NCT00514683|2431165|P3|Overall Study|Reason other than listed above|2
763471|NCT00514683|2431166|P2|Overall Study|Reason other than listed above|1
763472|NCT00514683|2431167|P1|Overall Study|Reason other than listed above|0
763473|NCT00514683|2431163|P5|Overall Study|Withdrawal by Subject|4
763474|NCT00514683|2431164|P4|Overall Study|Withdrawal by Subject|0
763475|NCT00514683|2431165|P3|Overall Study|Withdrawal by Subject|1
763476|NCT00514683|2431166|P2|Overall Study|Withdrawal by Subject|2
763477|NCT00514683|2431167|P1|Overall Study|Withdrawal by Subject|2
763478|NCT00514683|2431163|P5|Overall Study|Protocol Violation|0
763479|NCT00514683|2431164|P4|Overall Study|Protocol Violation|1
763480|NCT00514683|2431165|P3|Overall Study|Protocol Violation|0
763481|NCT00514683|2431166|P2|Overall Study|Protocol Violation|1
763482|NCT00514683|2431167|P1|Overall Study|Protocol Violation|1
763483|NCT00514683|2431163|P5|Overall Study|Adverse Event|27
763484|NCT00514683|2431164|P4|Overall Study|Adverse Event|13
763485|NCT00514683|2431165|P3|Overall Study|Adverse Event|15
763486|NCT00514683|2431166|P2|Overall Study|Adverse Event|20
763487|NCT00514683|2431167|P1|Overall Study|Adverse Event|21
763488|NCT00514683|2431163|P5|Overall Study|Not treated|1
763489|NCT00514683|2431164|P4|Overall Study|Not treated|0
763490|NCT00514683|2431165|P3|Overall Study|Not treated|0
763491|NCT00514683|2431166|P2|Overall Study|Not treated|1
763492|NCT00514683|2431167|P1|Overall Study|Not treated|2
763493|NCT00514735|2431373|P2|Overall Study|Lost to Follow-up|1
763494|NCT00514735|2431374|P1|Overall Study|Lost to Follow-up|0
763495|NCT00514735|2431373|P2|Overall Study|Death|0
763496|NCT00514735|2431374|P1|Overall Study|Death|1
763497|NCT00514735|2431373|P2|Overall Study|Withdrawal by Subject|5
763498|NCT00514735|2431374|P1|Overall Study|Withdrawal by Subject|13
763499|NCT00514813|2431396|P4|Overall Study|Death|2
763500|NCT00514813|2431397|P3|Overall Study|Death|3
763501|NCT00514813|2431398|P2|Overall Study|Death|2
763502|NCT00514813|2431399|P1|Overall Study|Death|0
763503|NCT00514813|2431396|P4|Overall Study|Kidney transplant|0
763504|NCT00514813|2431397|P3|Overall Study|Kidney transplant|2
763505|NCT00514813|2431398|P2|Overall Study|Kidney transplant|6
763506|NCT00514813|2431399|P1|Overall Study|Kidney transplant|0
763507|NCT00514813|2431396|P4|Overall Study|Lack of Efficacy|0
763508|NCT00514813|2431397|P3|Overall Study|Lack of Efficacy|0
763509|NCT00514813|2431398|P2|Overall Study|Lack of Efficacy|1
763510|NCT00514813|2431399|P1|Overall Study|Lack of Efficacy|0
763511|NCT00514813|2431396|P4|Overall Study|Withdrawal by Subject|0
763512|NCT00514813|2431397|P3|Overall Study|Withdrawal by Subject|0
763513|NCT00514813|2431398|P2|Overall Study|Withdrawal by Subject|1
763514|NCT00514813|2431399|P1|Overall Study|Withdrawal by Subject|0
763515|NCT00514813|2431396|P4|Overall Study|Protocol Violation|0
763516|NCT00514813|2431397|P3|Overall Study|Protocol Violation|0
763517|NCT00514813|2431398|P2|Overall Study|Protocol Violation|0
763518|NCT00514813|2431399|P1|Overall Study|Protocol Violation|1
763519|NCT00514813|2431396|P4|Overall Study|Adverse Event|0
763520|NCT00514813|2431397|P3|Overall Study|Adverse Event|2
763521|NCT00514813|2431398|P2|Overall Study|Adverse Event|2
763522|NCT00514813|2431399|P1|Overall Study|Adverse Event|0
763523|NCT00514813|2431396|P4|Overall Study|Study terminated|2
763524|NCT00514813|2431397|P3|Overall Study|Study terminated|40
763525|NCT00514813|2431398|P2|Overall Study|Study terminated|74
763526|NCT00514813|2431399|P1|Overall Study|Study terminated|14
763527|NCT00514904|2431446|P2|Overall Study|Lost to Follow-up|3
763528|NCT00514904|2431447|P1|Overall Study|Lost to Follow-up|21
763529|NCT00514904|2431446|P2|Overall Study|Withdrawal by Subject|2
763530|NCT00514904|2431447|P1|Overall Study|Withdrawal by Subject|3
763531|NCT00514917|2431483|P2|Overall Study|Undefined|5
763532|NCT00514917|2431484|P1|Overall Study|Undefined|11
763533|NCT00514917|2431483|P2|Overall Study|Discontinued due to study closure|81
763534|NCT00514917|2431484|P1|Overall Study|Discontinued due to study closure|88
763535|NCT00514917|2431483|P2|Overall Study|Withdrawal by Subject|16
763536|NCT00514917|2431484|P1|Overall Study|Withdrawal by Subject|18
763537|NCT00514917|2431483|P2|Overall Study|Lost to Follow-up|3
763538|NCT00514917|2431484|P1|Overall Study|Lost to Follow-up|4
763539|NCT00514917|2431483|P2|Overall Study|Protocol Violation|0
763540|NCT00514917|2431484|P1|Overall Study|Protocol Violation|1
763541|NCT00514917|2431483|P2|Overall Study|Death|10
763542|NCT00514917|2431484|P1|Overall Study|Death|4
763543|NCT00514943|2431512|P2|Stage 2|Other than stated above|2
763544|NCT00514943|2431513|P1|Stage 2|Other than stated above|0
763545|NCT00514943|2431512|P2|Stage 2|Patient refused to continue study meds|0
763546|NCT00514943|2431513|P1|Stage 2|Patient refused to continue study meds|2
763547|NCT00514943|2431512|P2|Stage 2|Other Adverse Event|10
763548|NCT00514943|2431513|P1|Stage 2|Other Adverse Event|3
763549|NCT00514943|2431512|P2|Stage 2|Progressive disease|24
763550|NCT00514943|2431513|P1|Stage 2|Progressive disease|27
763551|NCT00514943|2431512|P2|Stage 1|Other than stated above|7
763552|NCT00514943|2431513|P1|Stage 1|Other than stated above|1
763553|NCT00514943|2431512|P2|Stage 1|Patient refused to continue study meds|3
763554|NCT00514943|2431513|P1|Stage 1|Patient refused to continue study meds|8
763555|NCT00514943|2431512|P2|Stage 1|Not treated|2
763556|NCT00514943|2431513|P1|Stage 1|Not treated|1
763557|NCT00514943|2431512|P2|Stage 1|Other Adverse Event|6
763558|NCT00514943|2431513|P1|Stage 1|Other Adverse Event|16
763559|NCT00514943|2431512|P2|Stage 1|Progressive disease|8
763560|NCT00514943|2431513|P1|Stage 1|Progressive disease|4
763561|NCT00515008|2431571|P2|Overall Study|Scheduling conflict|0
763562|NCT00515008|2431572|P1|Overall Study|Scheduling conflict|1
763563|NCT00515008|2431571|P2|Overall Study|Left the Boston Area|1
763564|NCT00515008|2431572|P1|Overall Study|Left the Boston Area|1
763565|NCT00515008|2431571|P2|Overall Study|Declined|3
763566|NCT00515008|2431572|P1|Overall Study|Declined|0
763567|NCT00515008|2431571|P2|Overall Study|Lost to Follow-up|0
763568|NCT00515008|2431572|P1|Overall Study|Lost to Follow-up|1
763569|NCT00515034|2431598|P4|Overall Study|Other|1
763570|NCT00515034|2431599|P3|Overall Study|Other|2
763571|NCT00515034|2431600|P2|Overall Study|Other|0
763572|NCT00515034|2431601|P1|Overall Study|Other|1
763573|NCT00515034|2431598|P4|Overall Study|Physician Decision|1
763574|NCT00515034|2431599|P3|Overall Study|Physician Decision|1
763575|NCT00515034|2431600|P2|Overall Study|Physician Decision|0
763576|NCT00515034|2431601|P1|Overall Study|Physician Decision|0
763577|NCT00515034|2431598|P4|Overall Study|Withdrawal by Subject|0
763578|NCT00515034|2431599|P3|Overall Study|Withdrawal by Subject|3
763579|NCT00515034|2431600|P2|Overall Study|Withdrawal by Subject|0
763580|NCT00515034|2431601|P1|Overall Study|Withdrawal by Subject|1
763581|NCT00515034|2431598|P4|Overall Study|Death|3
763582|NCT00515034|2431599|P3|Overall Study|Death|1
763583|NCT00515034|2431600|P2|Overall Study|Death|2
763584|NCT00515034|2431601|P1|Overall Study|Death|4
763585|NCT00515034|2431598|P4|Overall Study|Adverse Event|0
763586|NCT00515034|2431599|P3|Overall Study|Adverse Event|1
763587|NCT00515034|2431600|P2|Overall Study|Adverse Event|0
763588|NCT00515034|2431601|P1|Overall Study|Adverse Event|2
763589|NCT00515073|2431619|P1|Overall Study|Physician Decision|1
763590|NCT00515073|2431619|P1|Overall Study|Withdrawal by Subject|1
763591|NCT00515086|2431627|P4|Overall Study|Death|0
763592|NCT00515086|2431628|P3|Overall Study|Death|0
763593|NCT00515086|2431629|P2|Overall Study|Death|0
763594|NCT00515086|2431630|P1|Overall Study|Death|2
763595|NCT00515086|2431627|P4|Overall Study|Study drug no longer required|0
763596|NCT00515086|2431628|P3|Overall Study|Study drug no longer required|0
763597|NCT00515086|2431629|P2|Overall Study|Study drug no longer required|1
763598|NCT00515086|2431630|P1|Overall Study|Study drug no longer required|0
763599|NCT00515086|2431627|P4|Overall Study|Lost to Follow-up|0
763600|NCT00515086|2431628|P3|Overall Study|Lost to Follow-up|0
763601|NCT00515086|2431629|P2|Overall Study|Lost to Follow-up|0
763602|NCT00515086|2431630|P1|Overall Study|Lost to Follow-up|1
763603|NCT00515086|2431627|P4|Overall Study|Unsatisfactory therapeutic effect|2
763604|NCT00515086|2431628|P3|Overall Study|Unsatisfactory therapeutic effect|3
763605|NCT00515086|2431629|P2|Overall Study|Unsatisfactory therapeutic effect|3
763606|NCT00515086|2431630|P1|Overall Study|Unsatisfactory therapeutic effect|18
763607|NCT00515086|2431627|P4|Overall Study|Withdrawal by Subject|1
763608|NCT00515086|2431628|P3|Overall Study|Withdrawal by Subject|0
763609|NCT00515086|2431629|P2|Overall Study|Withdrawal by Subject|0
763610|NCT00515086|2431630|P1|Overall Study|Withdrawal by Subject|1
763611|NCT00515086|2431627|P4|Overall Study|Administrative|0
763612|NCT00515086|2431628|P3|Overall Study|Administrative|0
763613|NCT00515086|2431629|P2|Overall Study|Administrative|1
763614|NCT00515086|2431630|P1|Overall Study|Administrative|1
763615|NCT00515086|2431627|P4|Overall Study|Adverse Event|3
763616|NCT00515086|2431628|P3|Overall Study|Adverse Event|2
763617|NCT00515086|2431629|P2|Overall Study|Adverse Event|1
763618|NCT00515086|2431630|P1|Overall Study|Adverse Event|1
763619|NCT00515099|2431659|P2|Overall Study|IRB Recommendation|0
763620|NCT00515099|2431660|P1|Overall Study|IRB Recommendation|1
763621|NCT00515099|2431659|P2|Overall Study|Withdrawal by Subject|0
763622|NCT00515099|2431660|P1|Overall Study|Withdrawal by Subject|2
763623|NCT00515099|2431659|P2|Overall Study|Lost to Follow-up|4
763624|NCT00515099|2431660|P1|Overall Study|Lost to Follow-up|0
763625|NCT00515112|2431680|P2|Overall Study|The study was terminated|2
763626|NCT00515112|2431681|P1|Overall Study|The study was terminated|3
763627|NCT00515112|2431680|P2|Overall Study|Death|1
763628|NCT00515112|2431681|P1|Overall Study|Death|0
763629|NCT00515216|2431727|P1|Overall Study|Withdrawal by Subject|1
763630|NCT00515294|2431753|P4|Overall Study|Caffeine amount inaccurate|0
763631|NCT00515294|2431754|P3|Overall Study|Caffeine amount inaccurate|7
763632|NCT00515294|2431755|P2|Overall Study|Caffeine amount inaccurate|0
763633|NCT00515294|2431756|P1|Overall Study|Caffeine amount inaccurate|5
763634|NCT00515294|2431753|P4|Overall Study|Driver simulator problems|3
763635|NCT00515294|2431754|P3|Overall Study|Driver simulator problems|1
763636|NCT00515294|2431755|P2|Overall Study|Driver simulator problems|1
763637|NCT00515294|2431756|P1|Overall Study|Driver simulator problems|1
763638|NCT00515294|2431753|P4|Overall Study|Lost to Follow-up|1
763639|NCT00515294|2431754|P3|Overall Study|Lost to Follow-up|3
763640|NCT00515294|2431755|P2|Overall Study|Lost to Follow-up|2
763641|NCT00515294|2431756|P1|Overall Study|Lost to Follow-up|3
763642|NCT00515463|2431801|P2|Overall Study|Other|1
763643|NCT00515463|2431802|P1|Overall Study|Other|0
763644|NCT00515463|2431801|P2|Overall Study|Lost to Follow-up|5
763645|NCT00515463|2431802|P1|Overall Study|Lost to Follow-up|6
763646|NCT00515463|2431801|P2|Overall Study|Withdrawal by Subject|4
763647|NCT00515463|2431802|P1|Overall Study|Withdrawal by Subject|3
763648|NCT00515463|2431801|P2|Overall Study|Adverse Event|2
763649|NCT00515463|2431802|P1|Overall Study|Adverse Event|1
763650|NCT00515463|2431801|P2|Overall Study|Physician Decision|2
763651|NCT00515463|2431802|P1|Overall Study|Physician Decision|4
763652|NCT00515502|2431952|P12|Treatment Period 2|Adverse Event|0
763653|NCT00515502|2431953|P11|Treatment Period 2|Adverse Event|0
763654|NCT00515502|2431954|P10|Treatment Period 2|Adverse Event|0
763655|NCT00515502|2431955|P9|Treatment Period 2|Adverse Event|0
763656|NCT00515502|2431956|P8|Treatment Period 2|Adverse Event|0
763657|NCT00515502|2431957|P7|Treatment Period 2|Adverse Event|0
763658|NCT00515502|2431958|P6|Treatment Period 2|Adverse Event|0
763659|NCT00515502|2431959|P5|Treatment Period 2|Adverse Event|0
763660|NCT00515502|2431960|P4|Treatment Period 2|Adverse Event|0
763661|NCT00515502|2431961|P3|Treatment Period 2|Adverse Event|0
763662|NCT00515502|2431962|P2|Treatment Period 2|Adverse Event|1
763663|NCT00515502|2431963|P1|Treatment Period 2|Adverse Event|0
763664|NCT00515502|2431952|P12|Treatment Period 1|Adverse Event|1
763665|NCT00515502|2431953|P11|Treatment Period 1|Adverse Event|0
763666|NCT00515502|2431954|P10|Treatment Period 1|Adverse Event|0
763667|NCT00515502|2431955|P9|Treatment Period 1|Adverse Event|1
763668|NCT00515502|2431956|P8|Treatment Period 1|Adverse Event|0
763669|NCT00515502|2431957|P7|Treatment Period 1|Adverse Event|1
763670|NCT00515502|2431958|P6|Treatment Period 1|Adverse Event|0
763671|NCT00515502|2431959|P5|Treatment Period 1|Adverse Event|0
763672|NCT00515502|2431960|P4|Treatment Period 1|Adverse Event|0
763673|NCT00515502|2431961|P3|Treatment Period 1|Adverse Event|0
763674|NCT00515502|2431962|P2|Treatment Period 1|Adverse Event|0
763675|NCT00515502|2431963|P1|Treatment Period 1|Adverse Event|0
763676|NCT00515541|2432125|P4|Overall Study|Withdrawal by Subject|2
763677|NCT00515541|2432126|P3|Overall Study|Withdrawal by Subject|0
763678|NCT00515541|2432127|P2|Overall Study|Withdrawal by Subject|2
763679|NCT00515541|2432128|P1|Overall Study|Withdrawal by Subject|0
763680|NCT00515541|2432125|P4|Overall Study|No show for appointments|2
763681|NCT00515541|2432126|P3|Overall Study|No show for appointments|0
763682|NCT00515541|2432127|P2|Overall Study|No show for appointments|1
763683|NCT00515541|2432128|P1|Overall Study|No show for appointments|0
763684|NCT00515541|2432125|P4|Overall Study|Physician Decision|1
763685|NCT00515541|2432126|P3|Overall Study|Physician Decision|0
763686|NCT00515541|2432127|P2|Overall Study|Physician Decision|2
763687|NCT00515541|2432128|P1|Overall Study|Physician Decision|0
763688|NCT00515619|2432150|P1|Overall Study|Other: Subject interested in other AED|1
763689|NCT00515619|2432150|P1|Overall Study|Other: Drug available on license|1
763690|NCT00515619|2432150|P1|Overall Study|Other: Request from sponsor|1
763691|NCT00515619|2432150|P1|Overall Study|Other: Subject became pregnant|1
763692|NCT00515619|2432150|P1|Overall Study|Other: Investigator decision|1
763693|NCT00515619|2432150|P1|Overall Study|Other: Subject moved to another country|1
763694|NCT00515619|2432150|P1|Overall Study|Other: Subject required surgery|1
763695|NCT00515619|2432150|P1|Overall Study|Other: Subject cannot attend visits|2
763696|NCT00515619|2432150|P1|Overall Study|Other: Site discontinuing trials|2
763697|NCT00515619|2432150|P1|Overall Study|Unsatisfactory compliance|6
763698|NCT00515619|2432150|P1|Overall Study|Lost to Follow-up|4
763699|NCT00515619|2432150|P1|Overall Study|Protocol Violation|3
763700|NCT00515619|2432150|P1|Overall Study|Withdrawal by Subject|66
763701|NCT00515619|2432150|P1|Overall Study|Lack of Efficacy|92
763702|NCT00515619|2432150|P1|Overall Study|Adverse Event|34
763703|NCT00515671|2432160|P2|Overall Study|incarcerated|2
763704|NCT00515671|2432161|P1|Overall Study|incarcerated|1
763705|NCT00515671|2432160|P2|Overall Study|Withdrawal by Subject|5
763706|NCT00515671|2432161|P1|Overall Study|Withdrawal by Subject|3
763707|NCT00515671|2432160|P2|Overall Study|Lost to Follow-up|10
763708|NCT00515671|2432161|P1|Overall Study|Lost to Follow-up|13
763709|NCT00515827|2432182|P2|Second Intervention (12 Weeks)|Consent withdraw|0
763710|NCT00515827|2432183|P1|Second Intervention (12 Weeks)|Consent withdraw|1
763711|NCT00515827|2432182|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
763712|NCT00515827|2432183|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
763713|NCT00516048|2432218|P3|Overall Study|Subject Decision|0
763714|NCT00516048|2432219|P2|Overall Study|Subject Decision|2
763715|NCT00516048|2432220|P1|Overall Study|Subject Decision|0
763716|NCT00516048|2432218|P3|Overall Study|Death|1
763717|NCT00516048|2432219|P2|Overall Study|Death|0
763718|NCT00516048|2432220|P1|Overall Study|Death|0
763719|NCT00516074|2432236|P2|Overall Study|Loss of Glucose Control|0
763720|NCT00516074|2432237|P1|Overall Study|Loss of Glucose Control|2
763721|NCT00516074|2432236|P2|Overall Study|Subject Decision|2
763722|NCT00516074|2432237|P1|Overall Study|Subject Decision|4
763723|NCT00516074|2432236|P2|Overall Study|Adverse Event|1
763724|NCT00516074|2432237|P1|Overall Study|Adverse Event|0
763725|NCT00516139|2432253|P1|Overall Study|Lack of Efficacy|1
763726|NCT00516139|2432253|P1|Overall Study|Withdrawal by Subject|8
763727|NCT00516139|2432253|P1|Overall Study|Protocol Violation|1
763728|NCT00516139|2432253|P1|Overall Study|Lost to Follow-up|1
763729|NCT00516139|2432253|P1|Overall Study|Adverse Event|27
763730|NCT00516269|2432299|P2|Overall Study|Protocol Violation|1
763731|NCT00516269|2432300|P1|Overall Study|Protocol Violation|0
763732|NCT00516269|2432299|P2|Overall Study|Lost to Follow-up|1
763733|NCT00516269|2432300|P1|Overall Study|Lost to Follow-up|0
763734|NCT00516269|2432299|P2|Overall Study|Adverse Event|1
763735|NCT00516269|2432300|P1|Overall Study|Adverse Event|2
763736|NCT00516295|2432309|P3|Overall Study|Ineligible|0
763737|NCT00516295|2432310|P2|Overall Study|Ineligible|0
763738|NCT00516295|2432311|P1|Overall Study|Ineligible|1
763739|NCT00516295|2432309|P3|Overall Study|Lack of Efficacy|0
763740|NCT00516295|2432310|P2|Overall Study|Lack of Efficacy|0
763741|NCT00516295|2432311|P1|Overall Study|Lack of Efficacy|2
763742|NCT00516321|2432324|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
763743|NCT00516321|2432325|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
763744|NCT00516321|2432326|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
763745|NCT00516321|2432324|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
763746|NCT00516321|2432325|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
763747|NCT00516321|2432326|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
763748|NCT00516321|2432324|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
763749|NCT00516321|2432325|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
763750|NCT00516321|2432326|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
763751|NCT00516321|2432324|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
763752|NCT00516321|2432325|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
763753|NCT00516321|2432326|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
763754|NCT00516321|2432324|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
763755|NCT00516321|2432325|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
763756|NCT00516321|2432326|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
763757|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
763758|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
763759|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
763760|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
763761|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
763762|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
763763|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
763764|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
763765|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
763766|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
763767|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
763768|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
763769|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
763770|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
763771|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
763772|NCT00516321|2432324|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
763773|NCT00516321|2432325|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
763774|NCT00516321|2432326|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
763775|NCT00516386|2432374|P1|Overall Study|Lost to Follow-up|2
763776|NCT00516386|2432374|P1|Overall Study|not interested in the study|4
763777|NCT00516737|2432402|P2|Overall Study|Lack of Qualifying Event|6
763778|NCT00516737|2432403|P1|Overall Study|Lack of Qualifying Event|9
763779|NCT00516737|2432402|P2|Overall Study|Withdrawal by Subject|1
763780|NCT00516737|2432403|P1|Overall Study|Withdrawal by Subject|0
763781|NCT00516737|2432402|P2|Overall Study|Physician Decision|1
763782|NCT00516737|2432403|P1|Overall Study|Physician Decision|0
763783|NCT00516737|2432402|P2|Overall Study|Lost to Follow-up|0
763784|NCT00516737|2432403|P1|Overall Study|Lost to Follow-up|2
763785|NCT00516893|2432421|P1|Overall Study|Received Medication From Another Study|1
763786|NCT00516893|2432421|P1|Overall Study|Pregnancy|1
763787|NCT00516893|2432421|P1|Overall Study|Relocated|1
763788|NCT00516893|2432421|P1|Overall Study|Persistent Antibodies per Protocol|6
763789|NCT00516893|2432421|P1|Overall Study|Death|1
763790|NCT00516893|2432421|P1|Overall Study|Noncompliance|2
763791|NCT00516893|2432421|P1|Overall Study|Withdrawal by Subject|2
763792|NCT00516893|2432421|P1|Overall Study|Adverse Event|3
763793|NCT00516893|2432421|P1|Overall Study|Lost to Follow-up|4
763794|NCT00510276|2432437|P2|Extension Open-Label Phase|Subject Decision|9
763795|NCT00510276|2432438|P1|Extension Open-Label Phase|Subject Decision|7
763796|NCT00510276|2432437|P2|Extension Open-Label Phase|Sponsor Decision|0
763797|NCT00510276|2432438|P1|Extension Open-Label Phase|Sponsor Decision|1
763798|NCT00510276|2432437|P2|Extension Open-Label Phase|Protocol Violation|1
763799|NCT00510276|2432438|P1|Extension Open-Label Phase|Protocol Violation|0
763800|NCT00510276|2432437|P2|Extension Open-Label Phase|Physician Decision|3
763801|NCT00510276|2432438|P1|Extension Open-Label Phase|Physician Decision|2
763802|NCT00510276|2432437|P2|Extension Open-Label Phase|Lost to Follow-up|10
763803|NCT00510276|2432438|P1|Extension Open-Label Phase|Lost to Follow-up|12
763804|NCT00510276|2432437|P2|Extension Open-Label Phase|Lack of Efficacy|7
763805|NCT00510276|2432438|P1|Extension Open-Label Phase|Lack of Efficacy|2
763806|NCT00510276|2432437|P2|Extension Open-Label Phase|Adverse Event|18
763807|NCT00510276|2432438|P1|Extension Open-Label Phase|Adverse Event|9
763808|NCT00510276|2432437|P2|Acute Double-Blind Phase|Subject Decision|28
763809|NCT00510276|2432438|P1|Acute Double-Blind Phase|Subject Decision|26
763810|NCT00510276|2432437|P2|Acute Double-Blind Phase|Sponsor Decision|1
763811|NCT00510276|2432438|P1|Acute Double-Blind Phase|Sponsor Decision|2
763812|NCT00510276|2432437|P2|Acute Double-Blind Phase|Protocol Violation|3
763813|NCT00510276|2432438|P1|Acute Double-Blind Phase|Protocol Violation|4
763814|NCT00510276|2432437|P2|Acute Double-Blind Phase|Physician Decision|3
763815|NCT00510276|2432438|P1|Acute Double-Blind Phase|Physician Decision|0
763816|NCT00510276|2432437|P2|Acute Double-Blind Phase|Lost to Follow-up|49
763817|NCT00510276|2432438|P1|Acute Double-Blind Phase|Lost to Follow-up|48
763818|NCT00510276|2432437|P2|Acute Double-Blind Phase|Lack of Efficacy|4
763819|NCT00510276|2432438|P1|Acute Double-Blind Phase|Lack of Efficacy|3
763820|NCT00510276|2432437|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
763821|NCT00510276|2432438|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
763822|NCT00510276|2432437|P2|Acute Double-Blind Phase|Adverse Event|6
763823|NCT00510276|2432438|P1|Acute Double-Blind Phase|Adverse Event|21
763824|NCT00510289|2432523|P1|Overall Study|Progressed prior to starting drug|2
763825|NCT00510289|2432523|P1|Overall Study|Lost to Follow-up|1
763826|NCT00510289|2432523|P1|Overall Study|Refused bone marrow biopsy|2
763827|NCT00510289|2432523|P1|Overall Study|Withdrawal by Subject|7
763828|NCT00516906|2432533|P2|Overall Study|Final Dressing Removal Data not captured|2
763829|NCT00516906|2432534|P1|Overall Study|Final Dressing Removal Data not captured|6
763830|NCT00517192|2432603|P2|Overall Study|Early termination of the trial|18
763831|NCT00517192|2432604|P1|Overall Study|Early termination of the trial|16
763832|NCT00517192|2432603|P2|Overall Study|Withdrawal by Subject|0
763833|NCT00517192|2432604|P1|Overall Study|Withdrawal by Subject|1
763834|NCT00517192|2432603|P2|Overall Study|Lost to Follow-up|1
763835|NCT00517192|2432604|P1|Overall Study|Lost to Follow-up|1
763836|NCT00517192|2432603|P2|Overall Study|Adverse Event|1
763837|NCT00517192|2432604|P1|Overall Study|Adverse Event|1
763838|NCT00518284|2432656|P4|Overall Study|Study Termination|2
763839|NCT00518284|2432657|P3|Overall Study|Study Termination|1
763840|NCT00518284|2432658|P2|Overall Study|Study Termination|2
763841|NCT00518284|2432659|P1|Overall Study|Study Termination|0
763842|NCT00518284|2432656|P4|Overall Study|Adverse Event|0
763843|NCT00518284|2432657|P3|Overall Study|Adverse Event|0
763844|NCT00518284|2432658|P2|Overall Study|Adverse Event|1
763845|NCT00518284|2432659|P1|Overall Study|Adverse Event|0
763846|NCT00518323|2432717|P4|Overall Study|Prohibited medication and others|0
763847|NCT00518323|2432718|P3|Overall Study|Prohibited medication and others|1
763848|NCT00518323|2432719|P2|Overall Study|Prohibited medication and others|1
763849|NCT00518323|2432720|P1|Overall Study|Prohibited medication and others|3
763850|NCT00518323|2432717|P4|Overall Study|Adverse Event|0
763851|NCT00518323|2432718|P3|Overall Study|Adverse Event|1
763852|NCT00518323|2432719|P2|Overall Study|Adverse Event|1
763853|NCT00518323|2432720|P1|Overall Study|Adverse Event|1
763854|NCT00518323|2432717|P4|Overall Study|Lost to Follow-up|3
763855|NCT00518323|2432718|P3|Overall Study|Lost to Follow-up|1
763856|NCT00518323|2432719|P2|Overall Study|Lost to Follow-up|2
763857|NCT00518323|2432720|P1|Overall Study|Lost to Follow-up|0
763858|NCT00518323|2432717|P4|Overall Study|Withdrawal by Subject|2
763859|NCT00518323|2432718|P3|Overall Study|Withdrawal by Subject|4
763860|NCT00518323|2432719|P2|Overall Study|Withdrawal by Subject|2
763861|NCT00518323|2432720|P1|Overall Study|Withdrawal by Subject|1
763862|NCT00518323|2432717|P4|Overall Study|Lack of Efficacy|20
763863|NCT00518323|2432718|P3|Overall Study|Lack of Efficacy|4
763864|NCT00518323|2432719|P2|Overall Study|Lack of Efficacy|2
763865|NCT00518323|2432720|P1|Overall Study|Lack of Efficacy|14
763866|NCT00518336|2432748|P2|Year 9|Personal reasons|0
763867|NCT00518336|2432749|P1|Year 9|Personal reasons|1
763868|NCT00518336|2432748|P2|Year 9|Lost to Follow-up|0
763869|NCT00518336|2432749|P1|Year 9|Lost to Follow-up|3
763870|NCT00518336|2432748|P2|Year 9|Migrated/moved from study area|1
763871|NCT00518336|2432749|P1|Year 9|Migrated/moved from study area|1
763872|NCT00518336|2432748|P2|Year 8|Could not attend in time|1
763873|NCT00518336|2432749|P1|Year 8|Could not attend in time|0
763874|NCT00518336|2432748|P2|Year 8|Lost to Follow-up|1
763875|NCT00518336|2432749|P1|Year 8|Lost to Follow-up|1
763876|NCT00518336|2432748|P2|Year 7|Could not attend in time|3
763877|NCT00518336|2432749|P1|Year 7|Could not attend in time|0
763878|NCT00518336|2432748|P2|Year 7|Lost to Follow-up|0
763879|NCT00518336|2432749|P1|Year 7|Lost to Follow-up|2
763880|NCT00518531|2432913|P2|Treatment Period 2|Non-compliance|2
763881|NCT00518531|2432914|P1|Treatment Period 2|Non-compliance|1
763882|NCT00518531|2432913|P2|Treatment Period 2|Protocol-specified criteria|1
763883|NCT00518531|2432914|P1|Treatment Period 2|Protocol-specified criteria|0
763884|NCT00518531|2432913|P2|Treatment Period 2|Adverse Event|7
763885|NCT00518531|2432914|P1|Treatment Period 2|Adverse Event|1
763886|NCT00518531|2432913|P2|Treatment Period 2|Complete out of scheduled visit window|2
763887|NCT00518531|2432914|P1|Treatment Period 2|Complete out of scheduled visit window|1
763888|NCT00518531|2432913|P2|Treatment Period 2|Withdrawal by Subject|8
763889|NCT00518531|2432914|P1|Treatment Period 2|Withdrawal by Subject|0
763890|NCT00518531|2432913|P2|Treatment Period 1|Early crossover|3
763891|NCT00518531|2432914|P1|Treatment Period 1|Early crossover|1
763892|NCT00518531|2432913|P2|Treatment Period 1|Withdrawal by Subject|6
763893|NCT00518531|2432914|P1|Treatment Period 1|Withdrawal by Subject|4
763894|NCT00518531|2432913|P2|Treatment Period 1|Protocol Violation|0
763895|NCT00518531|2432914|P1|Treatment Period 1|Protocol Violation|2
763896|NCT00518531|2432913|P2|Treatment Period 1|Physician Decision|0
763897|NCT00518531|2432914|P1|Treatment Period 1|Physician Decision|1
763898|NCT00518531|2432913|P2|Treatment Period 1|Lost to Follow-up|3
763899|NCT00518531|2432914|P1|Treatment Period 1|Lost to Follow-up|5
763900|NCT00518531|2432913|P2|Treatment Period 1|Adverse Event|0
763901|NCT00518531|2432914|P1|Treatment Period 1|Adverse Event|5
763902|NCT00518622|2432956|P8|Overall Study|Study medication taken incorrectly|0
763903|NCT00518622|2432957|P7|Overall Study|Study medication taken incorrectly|0
763904|NCT00518622|2432958|P6|Overall Study|Study medication taken incorrectly|0
763905|NCT00518622|2432959|P5|Overall Study|Study medication taken incorrectly|0
763906|NCT00518622|2432960|P4|Overall Study|Study medication taken incorrectly|0
763907|NCT00518622|2432961|P3|Overall Study|Study medication taken incorrectly|0
763908|NCT00518622|2432962|P2|Overall Study|Study medication taken incorrectly|1
763909|NCT00518622|2432963|P1|Overall Study|Study medication taken incorrectly|0
763910|NCT00518622|2432956|P8|Overall Study|Lost to Follow-up|0
763911|NCT00518622|2432957|P7|Overall Study|Lost to Follow-up|0
763912|NCT00518622|2432958|P6|Overall Study|Lost to Follow-up|0
763913|NCT00518622|2432959|P5|Overall Study|Lost to Follow-up|0
763914|NCT00518622|2432960|P4|Overall Study|Lost to Follow-up|0
763915|NCT00518622|2432961|P3|Overall Study|Lost to Follow-up|1
763916|NCT00518622|2432962|P2|Overall Study|Lost to Follow-up|0
763917|NCT00518622|2432963|P1|Overall Study|Lost to Follow-up|0
763918|NCT00518687|2432991|P2|Overall Study|Withdrawal by Subject|110
763919|NCT00518687|2432992|P1|Overall Study|Withdrawal by Subject|110
763920|NCT00518687|2432991|P2|Overall Study|Study terminated by sponsor|918
763921|NCT00518687|2432992|P1|Overall Study|Study terminated by sponsor|930
763922|NCT00518687|2432991|P2|Overall Study|Protocol Violation|10
763923|NCT00518687|2432992|P1|Overall Study|Protocol Violation|8
763924|NCT00518687|2432991|P2|Overall Study|Progressive disease|2
763925|NCT00518687|2432992|P1|Overall Study|Progressive disease|2
763926|NCT00518687|2432991|P2|Overall Study|Physician Decision|48
763927|NCT00518687|2432992|P1|Overall Study|Physician Decision|42
763928|NCT00518687|2432991|P2|Overall Study|Lost to Follow-up|155
763929|NCT00518687|2432992|P1|Overall Study|Lost to Follow-up|144
763930|NCT00518687|2432991|P2|Overall Study|Adverse Event|177
763931|NCT00518687|2432992|P1|Overall Study|Adverse Event|201
763932|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
763933|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
763934|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Subject decision|0
763935|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Subject decision|2
763936|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
763937|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
763938|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
763939|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
763940|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Creatine increased|0
763941|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Creatine increased|1
763942|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Change in treatment|1
763943|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Change in treatment|1
763944|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
763945|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
763946|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
763947|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
763948|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
763949|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
763950|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
763951|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
763952|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
763953|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
763954|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
763955|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
763956|NCT00518882|2433071|P2|Open-Label Extension, Week 26-78|Adverse Event|9
763957|NCT00518882|2433072|P1|Open-Label Extension, Week 26-78|Adverse Event|3
763958|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Mutual consent|1
763959|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Mutual consent|0
763960|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
763961|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
763962|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
763963|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
763964|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Loss of trust|1
763965|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Loss of trust|0
763966|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
763967|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
763968|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Subject decision|1
763969|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Subject decision|1
763970|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Lost to follow up|1
763971|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Lost to follow up|2
763972|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
763973|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
763974|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Protocol Violation|3
763975|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Protocol Violation|4
763976|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
763977|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
763978|NCT00518882|2433071|P2|Double-Blind, Week 0-26|Adverse Event|31
763979|NCT00518882|2433072|P1|Double-Blind, Week 0-26|Adverse Event|23
763980|NCT00518986|2433188|P2|Overall Study|Non-Specific|1
763981|NCT00518986|2433189|P1|Overall Study|Non-Specific|2
763982|NCT00518986|2433188|P2|Overall Study|Withdrawal by Subject|4
763983|NCT00518986|2433189|P1|Overall Study|Withdrawal by Subject|4
763984|NCT00518986|2433188|P2|Overall Study|Protocol Violation|7
763985|NCT00518986|2433189|P1|Overall Study|Protocol Violation|5
763986|NCT00518986|2433188|P2|Overall Study|Physician Decision|3
763987|NCT00518986|2433189|P1|Overall Study|Physician Decision|0
763988|NCT00518986|2433188|P2|Overall Study|Lost to Follow-up|2
763989|NCT00518986|2433189|P1|Overall Study|Lost to Follow-up|3
763990|NCT00518986|2433188|P2|Overall Study|Lack of Efficacy|2
763991|NCT00518986|2433189|P1|Overall Study|Lack of Efficacy|0
763992|NCT00518986|2433188|P2|Overall Study|Adverse Event|7
763993|NCT00518986|2433189|P1|Overall Study|Adverse Event|12
763994|NCT00519077|2433313|P1|Overall Study|Other|2
763995|NCT00519077|2433313|P1|Overall Study|Death|6
763996|NCT00519194|2433329|P1|Overall Study|Lost to Follow-up|3
763997|NCT00519194|2433329|P1|Overall Study|Death|9
763998|NCT00519194|2433329|P1|Overall Study|Withdrawal by Subject|9
763999|NCT00519285|2433335|P2|Overall Study|Treatment ongoing|2
764000|NCT00519285|2433336|P1|Overall Study|Treatment ongoing|1
764001|NCT00519285|2433335|P2|Overall Study|Not treated|7
764002|NCT00519285|2433336|P1|Overall Study|Not treated|8
764003|NCT00519285|2433335|P2|Overall Study|Reason unspecified|8
764004|NCT00519285|2433336|P1|Overall Study|Reason unspecified|5
764005|NCT00519285|2433335|P2|Overall Study|Poor compliance to protocol|7
764006|NCT00519285|2433336|P1|Overall Study|Poor compliance to protocol|5
764007|NCT00519285|2433335|P2|Overall Study|Consent withdrawn|5
764008|NCT00519285|2433336|P1|Overall Study|Consent withdrawn|4
764009|NCT00519285|2433335|P2|Overall Study|Participant's request|84
764010|NCT00519285|2433336|P1|Overall Study|Participant's request|53
764011|NCT00519285|2433335|P2|Overall Study|Physician Decision|47
764012|NCT00519285|2433336|P1|Overall Study|Physician Decision|75
764013|NCT00519285|2433335|P2|Overall Study|Disease progression|186
764014|NCT00519285|2433336|P1|Overall Study|Disease progression|334
764015|NCT00519285|2433335|P2|Overall Study|Adverse Event|266
764016|NCT00519285|2433336|P1|Overall Study|Adverse Event|127
764017|NCT00519376|2433362|P16|Treatment Period 4|Lost to Follow-up|0
764018|NCT00519376|2433363|P15|Treatment Period 4|Lost to Follow-up|0
764019|NCT00519376|2433364|P14|Treatment Period 4|Lost to Follow-up|0
764020|NCT00519376|2433365|P13|Treatment Period 4|Lost to Follow-up|0
764021|NCT00519376|2433366|P12|Treatment Period 4|Lost to Follow-up|0
764022|NCT00519376|2433367|P11|Treatment Period 4|Lost to Follow-up|0
764023|NCT00519376|2433368|P10|Treatment Period 4|Lost to Follow-up|0
764024|NCT00519376|2433369|P9|Treatment Period 4|Lost to Follow-up|0
764025|NCT00519376|2433370|P8|Treatment Period 4|Lost to Follow-up|0
764026|NCT00519376|2433371|P7|Treatment Period 4|Lost to Follow-up|0
764027|NCT00519376|2433372|P6|Treatment Period 4|Lost to Follow-up|0
764028|NCT00519376|2433373|P5|Treatment Period 4|Lost to Follow-up|0
764029|NCT00519376|2433374|P4|Treatment Period 4|Lost to Follow-up|0
764030|NCT00519376|2433375|P3|Treatment Period 4|Lost to Follow-up|1
764031|NCT00519376|2433376|P2|Treatment Period 4|Lost to Follow-up|0
764032|NCT00519376|2433377|P1|Treatment Period 4|Lost to Follow-up|0
764033|NCT00519376|2433362|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764034|NCT00519376|2433363|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764035|NCT00519376|2433364|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764036|NCT00519376|2433365|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
764037|NCT00519376|2433366|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764038|NCT00519376|2433367|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764039|NCT00519376|2433368|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764040|NCT00519376|2433369|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764041|NCT00519376|2433370|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764042|NCT00519376|2433371|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764043|NCT00519376|2433372|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764044|NCT00519376|2433373|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764045|NCT00519376|2433374|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764046|NCT00519376|2433375|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764047|NCT00519376|2433376|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764048|NCT00519376|2433377|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
764049|NCT00519428|2433502|P3|Overall Study|unstated|2
764050|NCT00519428|2433503|P2|Overall Study|unstated|3
764051|NCT00519428|2433504|P1|Overall Study|unstated|1
764052|NCT00519428|2433502|P3|Overall Study|Withdrawal by Subject|7
764053|NCT00519428|2433503|P2|Overall Study|Withdrawal by Subject|3
764054|NCT00519428|2433504|P1|Overall Study|Withdrawal by Subject|8
764055|NCT00519428|2433502|P3|Overall Study|Lost to Follow-up|6
764056|NCT00519428|2433503|P2|Overall Study|Lost to Follow-up|7
764057|NCT00519428|2433504|P1|Overall Study|Lost to Follow-up|7
764058|NCT00519428|2433502|P3|Overall Study|Adverse Event|10
764059|NCT00519428|2433503|P2|Overall Study|Adverse Event|2
764060|NCT00519428|2433504|P1|Overall Study|Adverse Event|5
764061|NCT00519532|2433524|P1|Overall Study|Lost to Follow-up|2
764062|NCT00519532|2433524|P1|Overall Study|Withdrawal by Subject|5
764063|NCT00519532|2433524|P1|Overall Study|Adverse Event|11
764064|NCT00519623|2433560|P1|Overall Study|Adverse Event|1
764065|NCT00519636|2433569|P4|Post Study Period|Subject randomized in error|1
764066|NCT00519636|2433570|P3|Post Study Period|Subject randomized in error|0
764067|NCT00519636|2433571|P2|Post Study Period|Subject randomized in error|0
764068|NCT00519636|2433572|P1|Post Study Period|Subject randomized in error|0
764069|NCT00519636|2433569|P4|Treatment Period 2|Subject misrandomized|1
764070|NCT00519636|2433570|P3|Treatment Period 2|Subject misrandomized|0
764071|NCT00519636|2433571|P2|Treatment Period 2|Subject misrandomized|0
764072|NCT00519636|2433572|P1|Treatment Period 2|Subject misrandomized|0
764073|NCT00519636|2433569|P4|Treatment Period 2|Per doctors request|0
764074|NCT00519636|2433570|P3|Treatment Period 2|Per doctors request|1
764075|NCT00519636|2433571|P2|Treatment Period 2|Per doctors request|0
764076|NCT00519636|2433572|P1|Treatment Period 2|Per doctors request|0
764077|NCT00519636|2433569|P4|Treatment Period 2|Subject randomized in error|0
764078|NCT00519636|2433570|P3|Treatment Period 2|Subject randomized in error|0
764079|NCT00519636|2433571|P2|Treatment Period 2|Subject randomized in error|1
764080|NCT00519636|2433572|P1|Treatment Period 2|Subject randomized in error|0
764081|NCT00519636|2433569|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
764082|NCT00519636|2433570|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
764083|NCT00519636|2433571|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
764084|NCT00519636|2433572|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
764085|NCT00519636|2433569|P4|Washout Period|Prohibited medications|0
764086|NCT00519636|2433570|P3|Washout Period|Prohibited medications|1
764087|NCT00519636|2433571|P2|Washout Period|Prohibited medications|0
764088|NCT00519636|2433572|P1|Washout Period|Prohibited medications|0
764089|NCT00519636|2433569|P4|Washout Period|Subject randomized in error|0
764090|NCT00519636|2433570|P3|Washout Period|Subject randomized in error|1
764091|NCT00519636|2433571|P2|Washout Period|Subject randomized in error|0
764092|NCT00519636|2433572|P1|Washout Period|Subject randomized in error|0
764093|NCT00519636|2433569|P4|Washout Period|Per doctors request|0
764094|NCT00519636|2433570|P3|Washout Period|Per doctors request|0
764095|NCT00519636|2433571|P2|Washout Period|Per doctors request|1
764096|NCT00519636|2433572|P1|Washout Period|Per doctors request|0
764097|NCT00519636|2433569|P4|Washout Period|Non-compliant|0
764098|NCT00519636|2433570|P3|Washout Period|Non-compliant|0
764099|NCT00519636|2433571|P2|Washout Period|Non-compliant|1
764100|NCT00519636|2433572|P1|Washout Period|Non-compliant|0
764101|NCT00519636|2433569|P4|Washout Period|Participating in study at another site|0
764102|NCT00519636|2433570|P3|Washout Period|Participating in study at another site|0
764103|NCT00519636|2433571|P2|Washout Period|Participating in study at another site|0
764104|NCT00519636|2433572|P1|Washout Period|Participating in study at another site|1
764105|NCT00519636|2433569|P4|Washout Period|Out of pollen area > 48 hours|0
764106|NCT00519636|2433570|P3|Washout Period|Out of pollen area > 48 hours|0
764107|NCT00519636|2433571|P2|Washout Period|Out of pollen area > 48 hours|0
764108|NCT00519636|2433572|P1|Washout Period|Out of pollen area > 48 hours|1
764109|NCT00519636|2433569|P4|Washout Period|Failed to meet continuation criteria|3
764110|NCT00519636|2433570|P3|Washout Period|Failed to meet continuation criteria|9
764111|NCT00519636|2433571|P2|Washout Period|Failed to meet continuation criteria|11
764112|NCT00519636|2433572|P1|Washout Period|Failed to meet continuation criteria|14
764113|NCT00519636|2433569|P4|Washout Period|Withdrawal by Subject|0
764114|NCT00519636|2433570|P3|Washout Period|Withdrawal by Subject|1
764115|NCT00519636|2433571|P2|Washout Period|Withdrawal by Subject|0
764116|NCT00519636|2433572|P1|Washout Period|Withdrawal by Subject|1
764117|NCT00519636|2433569|P4|Washout Period|Protocol Violation|2
764118|NCT00519636|2433570|P3|Washout Period|Protocol Violation|1
764119|NCT00519636|2433571|P2|Washout Period|Protocol Violation|0
764120|NCT00519636|2433572|P1|Washout Period|Protocol Violation|0
764121|NCT00519636|2433569|P4|Washout Period|Lost to Follow-up|0
764122|NCT00519636|2433570|P3|Washout Period|Lost to Follow-up|0
764123|NCT00519636|2433571|P2|Washout Period|Lost to Follow-up|0
764124|NCT00519636|2433572|P1|Washout Period|Lost to Follow-up|1
764125|NCT00519636|2433569|P4|Washout Period|Adverse Event|0
764126|NCT00519636|2433570|P3|Washout Period|Adverse Event|1
764127|NCT00519636|2433571|P2|Washout Period|Adverse Event|1
764128|NCT00519636|2433572|P1|Washout Period|Adverse Event|2
764129|NCT00519636|2433569|P4|Treatment Period 1|Sponsor request due to missed visit|0
764130|NCT00519636|2433570|P3|Treatment Period 1|Sponsor request due to missed visit|0
764131|NCT00519636|2433571|P2|Treatment Period 1|Sponsor request due to missed visit|0
764132|NCT00519636|2433572|P1|Treatment Period 1|Sponsor request due to missed visit|1
764133|NCT00519636|2433569|P4|Treatment Period 1|Adverse Event|0
764134|NCT00519636|2433570|P3|Treatment Period 1|Adverse Event|1
764135|NCT00519636|2433571|P2|Treatment Period 1|Adverse Event|0
764136|NCT00519636|2433572|P1|Treatment Period 1|Adverse Event|1
764137|NCT00519649|2433602|P1|Overall Study|Withdrawal by Subject|1
764138|NCT00519779|2433613|P2|Overall Study|Withdrawal by Subject|1
764139|NCT00519779|2433614|P1|Overall Study|Withdrawal by Subject|0
764140|NCT00519831|2433638|P1|Overall Study|Adverse Event|3
764141|NCT00519896|2433645|P1|Overall Study|Adverse Event|1
764142|NCT00519896|2433645|P1|Overall Study|Protocol Violation|1
764143|NCT00520013|2433654|P3|Overall Study|Physician Decision|3
764144|NCT00520013|2433655|P2|Overall Study|Physician Decision|0
764145|NCT00520013|2433656|P1|Overall Study|Physician Decision|0
764146|NCT00520013|2433654|P3|Overall Study|Death|0
764147|NCT00520013|2433655|P2|Overall Study|Death|1
764148|NCT00520013|2433656|P1|Overall Study|Death|0
764149|NCT00520013|2433654|P3|Overall Study|Clinical Progression|0
764150|NCT00520013|2433655|P2|Overall Study|Clinical Progression|1
764151|NCT00520013|2433656|P1|Overall Study|Clinical Progression|3
764152|NCT00520013|2433654|P3|Overall Study|Progressive Disease|0
764153|NCT00520013|2433655|P2|Overall Study|Progressive Disease|3
764154|NCT00520013|2433656|P1|Overall Study|Progressive Disease|7
764155|NCT00520013|2433654|P3|Overall Study|Adverse Event|7
764156|NCT00520013|2433655|P2|Overall Study|Adverse Event|10
764157|NCT00520013|2433656|P1|Overall Study|Adverse Event|2
764158|NCT00520013|2433654|P3|Overall Study|Withdrawal by Subject|1
764159|NCT00520013|2433655|P2|Overall Study|Withdrawal by Subject|0
764160|NCT00520013|2433656|P1|Overall Study|Withdrawal by Subject|0
764161|NCT00520130|2433668|P2|Overall Study|Physician Decision|1
764162|NCT00520130|2433669|P1|Overall Study|Physician Decision|1
764163|NCT00520130|2433668|P2|Overall Study|Disease progression on study|0
764164|NCT00520130|2433669|P1|Overall Study|Disease progression on study|4
764171|NCT00520351|2433769|P2|First Intervention|Withdrawal by Subject|1
764172|NCT00520351|2433770|P1|First Intervention|Withdrawal by Subject|1
764173|NCT00520403|2433782|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
764174|NCT00520403|2433782|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
764175|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
764176|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
764177|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Death|2
764178|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
764179|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
764180|NCT00520403|2433782|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
764181|NCT00520494|2433793|P1|Overall Study|Withdrawal by Subject|1
764182|NCT00520546|2433816|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
764183|NCT00520546|2433816|P1|Overall Study|Withdrawal by Subject|1
764184|NCT00520572|2433837|P6|Overall Study|Did not receive Treatment|0
764185|NCT00520572|2433838|P5|Overall Study|Did not receive Treatment|0
764186|NCT00520572|2433839|P4|Overall Study|Did not receive Treatment|0
764187|NCT00520572|2433840|P3|Overall Study|Did not receive Treatment|1
764188|NCT00520572|2433841|P2|Overall Study|Did not receive Treatment|0
764189|NCT00520572|2433842|P1|Overall Study|Did not receive Treatment|1
764190|NCT00520572|2433837|P6|Overall Study|Long break in taking Medication|0
764191|NCT00520572|2433838|P5|Overall Study|Long break in taking Medication|0
764192|NCT00520572|2433839|P4|Overall Study|Long break in taking Medication|1
764193|NCT00520572|2433840|P3|Overall Study|Long break in taking Medication|0
764194|NCT00520572|2433841|P2|Overall Study|Long break in taking Medication|0
764195|NCT00520572|2433842|P1|Overall Study|Long break in taking Medication|0
764196|NCT00520572|2433837|P6|Overall Study|Oral corticotherapy for acute urticaria|0
764197|NCT00520572|2433838|P5|Overall Study|Oral corticotherapy for acute urticaria|0
764198|NCT00520572|2433839|P4|Overall Study|Oral corticotherapy for acute urticaria|0
764199|NCT00520572|2433840|P3|Overall Study|Oral corticotherapy for acute urticaria|0
764200|NCT00520572|2433841|P2|Overall Study|Oral corticotherapy for acute urticaria|1
764201|NCT00520572|2433842|P1|Overall Study|Oral corticotherapy for acute urticaria|0
764202|NCT00520572|2433837|P6|Overall Study|Incorrect enrollment|0
764203|NCT00520572|2433838|P5|Overall Study|Incorrect enrollment|1
764204|NCT00520572|2433839|P4|Overall Study|Incorrect enrollment|0
764205|NCT00520572|2433840|P3|Overall Study|Incorrect enrollment|1
764206|NCT00520572|2433841|P2|Overall Study|Incorrect enrollment|0
764207|NCT00520572|2433842|P1|Overall Study|Incorrect enrollment|1
764208|NCT00520572|2433837|P6|Overall Study|Lost to Follow-up|0
764209|NCT00520572|2433838|P5|Overall Study|Lost to Follow-up|1
764210|NCT00520572|2433839|P4|Overall Study|Lost to Follow-up|0
764211|NCT00520572|2433840|P3|Overall Study|Lost to Follow-up|0
764212|NCT00520572|2433841|P2|Overall Study|Lost to Follow-up|0
764213|NCT00520572|2433842|P1|Overall Study|Lost to Follow-up|0
764214|NCT00520572|2433837|P6|Overall Study|Lack of Efficacy|0
764215|NCT00520572|2433838|P5|Overall Study|Lack of Efficacy|1
764216|NCT00520572|2433839|P4|Overall Study|Lack of Efficacy|2
764217|NCT00520572|2433840|P3|Overall Study|Lack of Efficacy|1
764218|NCT00520572|2433841|P2|Overall Study|Lack of Efficacy|1
764219|NCT00520572|2433842|P1|Overall Study|Lack of Efficacy|1
764220|NCT00520572|2433837|P6|Overall Study|Protocol Violation|0
764221|NCT00520572|2433838|P5|Overall Study|Protocol Violation|0
764222|NCT00520572|2433839|P4|Overall Study|Protocol Violation|0
764223|NCT00520572|2433840|P3|Overall Study|Protocol Violation|1
764224|NCT00520572|2433841|P2|Overall Study|Protocol Violation|0
764225|NCT00520572|2433842|P1|Overall Study|Protocol Violation|0
764226|NCT00520572|2433837|P6|Overall Study|Withdrawal by Subject|0
764227|NCT00520572|2433838|P5|Overall Study|Withdrawal by Subject|2
764228|NCT00520572|2433839|P4|Overall Study|Withdrawal by Subject|2
764229|NCT00520572|2433840|P3|Overall Study|Withdrawal by Subject|5
764230|NCT00520572|2433841|P2|Overall Study|Withdrawal by Subject|9
764231|NCT00520572|2433842|P1|Overall Study|Withdrawal by Subject|0
764232|NCT00520572|2433837|P6|Overall Study|Adverse Event|2
764233|NCT00520572|2433838|P5|Overall Study|Adverse Event|7
764234|NCT00520572|2433839|P4|Overall Study|Adverse Event|9
764235|NCT00520572|2433840|P3|Overall Study|Adverse Event|6
764236|NCT00520572|2433841|P2|Overall Study|Adverse Event|3
764237|NCT00520572|2433842|P1|Overall Study|Adverse Event|9
764238|NCT00520676|2433882|P2|Overall Study|Withdrawal by Subject|11
764239|NCT00520676|2433883|P1|Overall Study|Withdrawal by Subject|7
764240|NCT00520676|2433882|P2|Overall Study|Physician Decision|1
764241|NCT00520676|2433883|P1|Overall Study|Physician Decision|4
764242|NCT00520676|2433882|P2|Overall Study|Lost to Follow-up|10
764243|NCT00520676|2433883|P1|Overall Study|Lost to Follow-up|6
764244|NCT00520676|2433882|P2|Overall Study|Death|81
764245|NCT00520676|2433883|P1|Overall Study|Death|84
764246|NCT00513240|2433905|P2|Overall Study|Withdrawal by Subject|4
764247|NCT00513240|2433906|P1|Overall Study|Withdrawal by Subject|7
764248|NCT00513240|2433905|P2|Overall Study|Death|3
764249|NCT00513240|2433906|P1|Overall Study|Death|3
764250|NCT00513240|2433905|P2|Overall Study|Did not have intended surgery|0
764251|NCT00513240|2433906|P1|Overall Study|Did not have intended surgery|3
764252|NCT00513305|2433934|P2|Overall Study|Sponsor Decision|2
764253|NCT00513305|2433935|P1|Overall Study|Sponsor Decision|0
764254|NCT00513305|2433934|P2|Overall Study|Persistent hypocellularity|1
764255|NCT00513305|2433935|P1|Overall Study|Persistent hypocellularity|0
764256|NCT00513305|2433934|P2|Overall Study|Physician Decision|0
764257|NCT00513305|2433935|P1|Overall Study|Physician Decision|1
764258|NCT00513305|2433934|P2|Overall Study|Hematologic counts did not recover|0
764259|NCT00513305|2433935|P1|Overall Study|Hematologic counts did not recover|1
764260|NCT00513305|2433934|P2|Overall Study|Eligible for stem cell transplant|0
764261|NCT00513305|2433935|P1|Overall Study|Eligible for stem cell transplant|1
764262|NCT00513305|2433934|P2|Overall Study|Disease progression|5
764263|NCT00513305|2433935|P1|Overall Study|Disease progression|8
764264|NCT00513305|2433934|P2|Overall Study|Withdrawal by Subject|2
764265|NCT00513305|2433935|P1|Overall Study|Withdrawal by Subject|1
764266|NCT00513305|2433934|P2|Overall Study|Lack of Efficacy|13
764267|NCT00513305|2433935|P1|Overall Study|Lack of Efficacy|8
764268|NCT00513305|2433934|P2|Overall Study|Death (through Consolidation Treatment)|2
764269|NCT00513305|2433935|P1|Overall Study|Death (through Consolidation Treatment)|2
764270|NCT00513305|2433934|P2|Overall Study|Adverse Event|2
764271|NCT00513305|2433935|P1|Overall Study|Adverse Event|6
764272|NCT00513357|2433964|P2|Overall Study|Disease Progression|1
764273|NCT00513357|2433965|P1|Overall Study|Disease Progression|2
764274|NCT00513357|2433964|P2|Overall Study|Withdrawal by Subject|4
764275|NCT00513357|2433965|P1|Overall Study|Withdrawal by Subject|5
764276|NCT00513357|2433964|P2|Overall Study|Death|0
764277|NCT00513357|2433965|P1|Overall Study|Death|2
764278|NCT00513357|2433964|P2|Overall Study|Adverse Event|2
764279|NCT00513357|2433965|P1|Overall Study|Adverse Event|4
764280|NCT00513357|2433964|P2|Overall Study|did not receive allocated placebo|3
764281|NCT00513357|2433965|P1|Overall Study|did not receive allocated placebo|2
764282|NCT00513409|2434001|P2|Overall Study|Visit 3 not done|2
764283|NCT00513409|2434002|P1|Overall Study|Visit 3 not done|1
764284|NCT00513409|2434001|P2|Overall Study|Physician Decision|0
764285|NCT00513409|2434002|P1|Overall Study|Physician Decision|1
764286|NCT00513409|2434001|P2|Overall Study|Lost to Follow-up|1
764287|NCT00513409|2434002|P1|Overall Study|Lost to Follow-up|0
764288|NCT00513409|2434001|P2|Overall Study|Withdrawal by Subject|2
764289|NCT00513409|2434002|P1|Overall Study|Withdrawal by Subject|0
764290|NCT00513409|2434001|P2|Overall Study|Adverse Event|1
764291|NCT00513409|2434002|P1|Overall Study|Adverse Event|0
764292|NCT00513474|2434035|P2|Overall Study|Participant Withdrew Consent|0
764293|NCT00513474|2434036|P1|Overall Study|Participant Withdrew Consent|1
764294|NCT00513474|2434035|P2|Overall Study|Death|9
764295|NCT00513474|2434036|P1|Overall Study|Death|6
764296|NCT00513500|2434050|P2|Overall Study|Hospitalized|14
764297|NCT00513500|2434051|P1|Overall Study|Hospitalized|4
764298|NCT00513500|2434050|P2|Overall Study|Death|1
764299|NCT00513500|2434051|P1|Overall Study|Death|2
764300|NCT00513500|2434050|P2|Overall Study|Lost to Follow-up|39
764301|NCT00513500|2434051|P1|Overall Study|Lost to Follow-up|35
764302|NCT00513604|2434081|P5|Overall Study|Death during treatment|0
764303|NCT00513604|2434082|P4|Overall Study|Death during treatment|0
764304|NCT00513604|2434083|P3|Overall Study|Death during treatment|2
764305|NCT00513604|2434084|P2|Overall Study|Death during treatment|3
764306|NCT00513604|2434085|P1|Overall Study|Death during treatment|0
764307|NCT00513604|2434081|P5|Overall Study|Not treated|0
764308|NCT00513604|2434082|P4|Overall Study|Not treated|0
764309|NCT00513604|2434083|P3|Overall Study|Not treated|1
764310|NCT00513604|2434084|P2|Overall Study|Not treated|0
764311|NCT00513604|2434085|P1|Overall Study|Not treated|2
764312|NCT00513682|2434118|P1|Washout Phase|Adverse Event|2
764313|NCT00513695|2434127|P1|Overall Study|Progression prior to surgery|3
764314|NCT00513695|2434127|P1|Overall Study|Discontinued therapy|2
764315|NCT00513708|2434139|P3|Overall Study|Lost to Follow-up|4
764316|NCT00513708|2434140|P2|Overall Study|Lost to Follow-up|4
764317|NCT00513708|2434141|P1|Overall Study|Lost to Follow-up|4
764318|NCT00514020|2434180|P1|Overall Study|"patients moved to the no tx group"|6
764319|NCT00514020|2434180|P1|Overall Study|patient went to radiation treatment|1
764320|NCT00514020|2434180|P1|Overall Study|other complicating disease|2
764321|NCT00514020|2434180|P1|Overall Study|disease progression|9
764322|NCT00514020|2434180|P1|Overall Study|Physician Decision|1
764323|NCT00514020|2434180|P1|Overall Study|Withdrawal by Subject|3
764324|NCT00514020|2434180|P1|Overall Study|Adverse Event|6
764325|NCT00520741|2434197|P2|Overall Study|Other reasons for premature termination|6
764326|NCT00520741|2434198|P1|Overall Study|Other reasons for premature termination|0
764327|NCT00520741|2434197|P2|Overall Study|Lost to Follow-up|4
764328|NCT00520741|2434198|P1|Overall Study|Lost to Follow-up|4
764329|NCT00520741|2434197|P2|Overall Study|Unsatisfactory compliance of subject|3
764330|NCT00520741|2434198|P1|Overall Study|Unsatisfactory compliance of subject|4
764331|NCT00520741|2434197|P2|Overall Study|Protocol Violation|15
764332|NCT00520741|2434198|P1|Overall Study|Protocol Violation|2
764333|NCT00520741|2434197|P2|Overall Study|Withdrawal by Subject|11
764334|NCT00520741|2434198|P1|Overall Study|Withdrawal by Subject|0
764335|NCT00520741|2434197|P2|Overall Study|Lack of Efficacy|30
764336|NCT00520741|2434198|P1|Overall Study|Lack of Efficacy|11
764337|NCT00520741|2434197|P2|Overall Study|Adverse Event|56
764338|NCT00520741|2434198|P1|Overall Study|Adverse Event|16
764339|NCT00520767|2434214|P1|Overall Study|Death|2
764340|NCT00520845|2434218|P1|Overall Study|Alternative Therapy|1
764341|NCT00520845|2434218|P1|Overall Study|Withdrawal by Subject|1
764342|NCT00520845|2434218|P1|Overall Study|Disease Progression, relapse|13
764343|NCT00520845|2434218|P1|Overall Study|Adverse Event|4
764344|NCT00520845|2434218|P1|Overall Study|Death|3
764345|NCT00520936|2434234|P8|Overall Study|Protocol Violation|0
764346|NCT00520936|2434235|P7|Overall Study|Protocol Violation|1
764347|NCT00520936|2434236|P6|Overall Study|Protocol Violation|0
764348|NCT00520936|2434237|P5|Overall Study|Protocol Violation|1
764349|NCT00520936|2434238|P4|Overall Study|Protocol Violation|0
764350|NCT00520936|2434239|P3|Overall Study|Protocol Violation|1
764351|NCT00520936|2434240|P2|Overall Study|Protocol Violation|1
764352|NCT00520936|2434241|P1|Overall Study|Protocol Violation|0
764353|NCT00520936|2434234|P8|Overall Study|Death|0
764354|NCT00520936|2434235|P7|Overall Study|Death|1
764355|NCT00520936|2434236|P6|Overall Study|Death|0
764356|NCT00520936|2434237|P5|Overall Study|Death|0
764357|NCT00520936|2434238|P4|Overall Study|Death|0
764358|NCT00520936|2434239|P3|Overall Study|Death|0
764359|NCT00520936|2434240|P2|Overall Study|Death|0
764360|NCT00520936|2434241|P1|Overall Study|Death|0
764361|NCT00520936|2434234|P8|Overall Study|Toxicity Requiring Removal from Study|0
764362|NCT00520936|2434235|P7|Overall Study|Toxicity Requiring Removal from Study|2
764363|NCT00520936|2434236|P6|Overall Study|Toxicity Requiring Removal from Study|0
764364|NCT00520936|2434237|P5|Overall Study|Toxicity Requiring Removal from Study|0
764365|NCT00520936|2434238|P4|Overall Study|Toxicity Requiring Removal from Study|0
764366|NCT00520936|2434239|P3|Overall Study|Toxicity Requiring Removal from Study|0
764367|NCT00520936|2434240|P2|Overall Study|Toxicity Requiring Removal from Study|1
764368|NCT00520936|2434241|P1|Overall Study|Toxicity Requiring Removal from Study|0
764369|NCT00520936|2434234|P8|Overall Study|Withdrawal by Subject|1
764370|NCT00520936|2434235|P7|Overall Study|Withdrawal by Subject|0
764371|NCT00520936|2434236|P6|Overall Study|Withdrawal by Subject|0
764372|NCT00520936|2434237|P5|Overall Study|Withdrawal by Subject|0
764373|NCT00520936|2434238|P4|Overall Study|Withdrawal by Subject|0
764374|NCT00520936|2434239|P3|Overall Study|Withdrawal by Subject|0
764375|NCT00520936|2434240|P2|Overall Study|Withdrawal by Subject|0
764376|NCT00520936|2434241|P1|Overall Study|Withdrawal by Subject|0
764377|NCT00520936|2434234|P8|Overall Study|Physician Decision|0
764378|NCT00520936|2434235|P7|Overall Study|Physician Decision|0
764379|NCT00520936|2434236|P6|Overall Study|Physician Decision|0
764380|NCT00520936|2434237|P5|Overall Study|Physician Decision|0
764381|NCT00520936|2434238|P4|Overall Study|Physician Decision|0
764382|NCT00520936|2434239|P3|Overall Study|Physician Decision|1
764383|NCT00520936|2434240|P2|Overall Study|Physician Decision|2
764384|NCT00520936|2434241|P1|Overall Study|Physician Decision|0
764385|NCT00520975|2434270|P2|Overall Study|Not start protocol therapy|2
764386|NCT00520975|2434271|P1|Overall Study|Not start protocol therapy|1
764387|NCT00520975|2434270|P2|Overall Study|Other reasons|2
764388|NCT00520975|2434271|P1|Overall Study|Other reasons|4
764389|NCT00520975|2434270|P2|Overall Study|Other therapy|4
764390|NCT00520975|2434271|P1|Overall Study|Other therapy|2
764391|NCT00520975|2434270|P2|Overall Study|Withdrawal by Subject|5
764392|NCT00520975|2434271|P1|Overall Study|Withdrawal by Subject|3
764393|NCT00520975|2434270|P2|Overall Study|Death|2
764394|NCT00520975|2434271|P1|Overall Study|Death|0
764395|NCT00520975|2434270|P2|Overall Study|Adverse Event|10
764396|NCT00520975|2434271|P1|Overall Study|Adverse Event|7
764397|NCT00520975|2434270|P2|Overall Study|Disease progression|23
764398|NCT00520975|2434271|P1|Overall Study|Disease progression|31
764399|NCT00521001|2434295|P1|Overall Study|Ineligible|1
764400|NCT00521014|2434302|P1|Overall Study|Inevaluable, not treated|1
891333|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
891334|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
891335|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
891336|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
891337|NCT02105974|2827455|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
891338|NCT02105974|2827456|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
891339|NCT02105974|2827457|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
891340|NCT02105974|2827455|P3|2 Week Run-in Period|Investigator discretion|0
891341|NCT02105974|2827456|P2|2 Week Run-in Period|Investigator discretion|0
891342|NCT02105974|2827457|P1|2 Week Run-in Period|Investigator discretion|8
891343|NCT02105974|2827455|P3|2 Week Run-in Period|Withdrew consent|0
891344|NCT02105974|2827456|P2|2 Week Run-in Period|Withdrew consent|0
891345|NCT02105974|2827457|P1|2 Week Run-in Period|Withdrew consent|23
891346|NCT02105974|2827455|P3|2 Week Run-in Period|Lost to Follow-up|0
891347|NCT02105974|2827456|P2|2 Week Run-in Period|Lost to Follow-up|0
891348|NCT02105974|2827457|P1|2 Week Run-in Period|Lost to Follow-up|2
891349|NCT02105974|2827455|P3|2 Week Run-in Period|Study closed/terminated|0
891350|NCT02105974|2827456|P2|2 Week Run-in Period|Study closed/terminated|0
891351|NCT02105974|2827457|P1|2 Week Run-in Period|Study closed/terminated|1
891352|NCT02105974|2827455|P3|2 Week Run-in Period|Adverse Event|0
891353|NCT02105974|2827456|P2|2 Week Run-in Period|Adverse Event|0
891354|NCT02105974|2827457|P1|2 Week Run-in Period|Adverse Event|6
891355|NCT02105974|2827455|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
764425|NCT00521365|2434384|P1|Overall Study|Usage of not allowed drugs|6
764426|NCT00521365|2434384|P1|Overall Study|Drug compliance|3
764427|NCT00521365|2434384|P1|Overall Study|Protocol deviation|2
764428|NCT00521365|2434384|P1|Overall Study|Lost to Follow-up|6
764429|NCT00521365|2434384|P1|Overall Study|Adverse Event|3
764430|NCT00521586|2434418|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
764431|NCT00521586|2434419|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
764432|NCT00521586|2434418|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
764433|NCT00521586|2434419|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
764434|NCT00521586|2434418|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
764435|NCT00521586|2434419|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
764436|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
764437|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
764438|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
764439|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
764440|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|26
764441|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|22
764442|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
764443|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
764444|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
764445|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
764446|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
764447|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
764448|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
764449|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
764450|NCT00521586|2434418|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
764451|NCT00521586|2434419|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
764452|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Failed to return|1
764453|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Failed to return|0
764454|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Death|0
764455|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Death|1
764456|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Adverse Event|1
764457|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Adverse Event|0
764458|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Investigator request|0
764459|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Investigator request|2
764460|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Other, unspecified|1
764461|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Other, unspecified|3
764462|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Protocol Violation|5
764463|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Protocol Violation|2
764464|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
764465|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
764466|NCT00521586|2434418|P2|Initial Vaccination (Year 0)|Subject request|11
764467|NCT00521586|2434419|P1|Initial Vaccination (Year 0)|Subject request|8
764468|NCT00521599|2434480|P3|Overall Study|Did not meet protocol eligibility|1
764469|NCT00521599|2434481|P2|Overall Study|Did not meet protocol eligibility|2
764470|NCT00521599|2434482|P1|Overall Study|Did not meet protocol eligibility|2
764471|NCT00521599|2434480|P3|Overall Study|Protocol Violation|2
764472|NCT00521599|2434481|P2|Overall Study|Protocol Violation|4
764473|NCT00521599|2434482|P1|Overall Study|Protocol Violation|2
764474|NCT00521599|2434480|P3|Overall Study|Withdrawal by subject treatment related|2
764475|NCT00521599|2434481|P2|Overall Study|Withdrawal by subject treatment related|1
764476|NCT00521599|2434482|P1|Overall Study|Withdrawal by subject treatment related|3
764477|NCT00521599|2434480|P3|Overall Study|Withdrawal by Subject|1
764478|NCT00521599|2434481|P2|Overall Study|Withdrawal by Subject|5
764479|NCT00521599|2434482|P1|Overall Study|Withdrawal by Subject|3
764480|NCT00521599|2434480|P3|Overall Study|Lost to Follow-up|2
764481|NCT00521599|2434481|P2|Overall Study|Lost to Follow-up|1
764482|NCT00521599|2434482|P1|Overall Study|Lost to Follow-up|2
764483|NCT00521599|2434480|P3|Overall Study|Treatment Failure|22
764484|NCT00521599|2434481|P2|Overall Study|Treatment Failure|9
764485|NCT00521599|2434482|P1|Overall Study|Treatment Failure|8
764486|NCT00521599|2434480|P3|Overall Study|Adverse Event|6
764487|NCT00521599|2434481|P2|Overall Study|Adverse Event|7
764488|NCT00521599|2434482|P1|Overall Study|Adverse Event|5
764489|NCT00522041|2434528|P2|Overall Study|Did not receive treatment|1
764490|NCT00522041|2434529|P1|Overall Study|Did not receive treatment|0
764491|NCT00522041|2434528|P2|Overall Study|Voluntary withdrawal|4
764492|NCT00522041|2434529|P1|Overall Study|Voluntary withdrawal|5
764493|NCT00522041|2434528|P2|Overall Study|Lost to Follow-up|4
764494|NCT00522041|2434529|P1|Overall Study|Lost to Follow-up|1
764495|NCT00522041|2434528|P2|Overall Study|Protocol Violation|0
764496|NCT00522041|2434529|P1|Overall Study|Protocol Violation|2
764497|NCT00522041|2434528|P2|Overall Study|Adverse Event|3
764498|NCT00522041|2434529|P1|Overall Study|Adverse Event|9
764499|NCT00522275|2434550|P1|Overall Study|Other: Subject had surgery for epilepsy|2
764500|NCT00522275|2434550|P1|Overall Study|Other: Subject ran out of medication|1
764501|NCT00522275|2434550|P1|Overall Study|Other: Sponsor request|2
764502|NCT00522275|2434550|P1|Overall Study|Other: Travel to / from site difficulty|3
764503|NCT00522275|2434550|P1|Overall Study|Other: Site / clinic closed|4
764504|NCT00522275|2434550|P1|Overall Study|Other: Subject arrested|1
764505|NCT00522275|2434550|P1|Overall Study|Other: Subject relocated|2
764506|NCT00522275|2434550|P1|Overall Study|Other: Subject is pregnant|2
764507|NCT00522275|2434550|P1|Overall Study|Other: Subject wants to become pregnant|2
764508|NCT00522275|2434550|P1|Overall Study|Lost to Follow-up|8
764509|NCT00522275|2434550|P1|Overall Study|Unsatisfactory compliance|11
764510|NCT00522275|2434550|P1|Overall Study|Protocol deviation|1
764511|NCT00522275|2434550|P1|Overall Study|Subject withdrew consent|16
764512|NCT00522275|2434550|P1|Overall Study|Lack of Efficacy|80
764513|NCT00522275|2434550|P1|Overall Study|Adverse Event|35
764514|NCT00522301|2434558|P1|Overall Study|Adverse Event|5
764515|NCT00522301|2434558|P1|Overall Study|Withdrawal by Subject|1
764516|NCT00522379|2434567|P5|Overall Study|Subject Withdrawal|0
764517|NCT00522379|2434568|P4|Overall Study|Subject Withdrawal|1
764518|NCT00522379|2434569|P3|Overall Study|Subject Withdrawal|0
764519|NCT00522379|2434570|P2|Overall Study|Subject Withdrawal|0
764520|NCT00522379|2434571|P1|Overall Study|Subject Withdrawal|0
764521|NCT00522379|2434567|P5|Overall Study|Site Closed|0
764522|NCT00522379|2434568|P4|Overall Study|Site Closed|1
764523|NCT00522379|2434569|P3|Overall Study|Site Closed|0
764524|NCT00522379|2434570|P2|Overall Study|Site Closed|0
764525|NCT00522379|2434571|P1|Overall Study|Site Closed|0
764526|NCT00522379|2434567|P5|Overall Study|Family Problem|0
764527|NCT00522379|2434568|P4|Overall Study|Family Problem|0
764528|NCT00522379|2434569|P3|Overall Study|Family Problem|1
764529|NCT00522379|2434570|P2|Overall Study|Family Problem|0
764530|NCT00522379|2434571|P1|Overall Study|Family Problem|0
764531|NCT00522379|2434567|P5|Overall Study|Sponsor Request|0
764532|NCT00522379|2434568|P4|Overall Study|Sponsor Request|0
764533|NCT00522379|2434569|P3|Overall Study|Sponsor Request|0
764534|NCT00522379|2434570|P2|Overall Study|Sponsor Request|1
764535|NCT00522379|2434571|P1|Overall Study|Sponsor Request|0
764536|NCT00522379|2434567|P5|Overall Study|Subject Moved|0
764537|NCT00522379|2434568|P4|Overall Study|Subject Moved|0
764538|NCT00522379|2434569|P3|Overall Study|Subject Moved|0
764539|NCT00522379|2434570|P2|Overall Study|Subject Moved|1
764540|NCT00522379|2434571|P1|Overall Study|Subject Moved|1
764541|NCT00522379|2434567|P5|Overall Study|Dispensing error|0
764542|NCT00522379|2434568|P4|Overall Study|Dispensing error|1
764543|NCT00522379|2434569|P3|Overall Study|Dispensing error|0
764544|NCT00522379|2434570|P2|Overall Study|Dispensing error|0
764545|NCT00522379|2434571|P1|Overall Study|Dispensing error|1
764546|NCT00522379|2434567|P5|Overall Study|Randomization error|1
764547|NCT00522379|2434568|P4|Overall Study|Randomization error|0
764548|NCT00522379|2434569|P3|Overall Study|Randomization error|0
764549|NCT00522379|2434570|P2|Overall Study|Randomization error|0
764550|NCT00522379|2434571|P1|Overall Study|Randomization error|0
764551|NCT00522379|2434567|P5|Overall Study|Lost to Follow-up|2
764552|NCT00522379|2434568|P4|Overall Study|Lost to Follow-up|2
764553|NCT00522379|2434569|P3|Overall Study|Lost to Follow-up|4
764554|NCT00522379|2434570|P2|Overall Study|Lost to Follow-up|0
764555|NCT00522379|2434571|P1|Overall Study|Lost to Follow-up|1
764556|NCT00522379|2434567|P5|Overall Study|Unsatisfactory Subject Compliance|0
764557|NCT00522379|2434568|P4|Overall Study|Unsatisfactory Subject Compliance|0
764558|NCT00522379|2434569|P3|Overall Study|Unsatisfactory Subject Compliance|0
764559|NCT00522379|2434570|P2|Overall Study|Unsatisfactory Subject Compliance|2
764560|NCT00522379|2434571|P1|Overall Study|Unsatisfactory Subject Compliance|1
764561|NCT00522379|2434567|P5|Overall Study|Protocol Violation|0
764562|NCT00522379|2434568|P4|Overall Study|Protocol Violation|0
764563|NCT00522379|2434569|P3|Overall Study|Protocol Violation|2
764564|NCT00522379|2434570|P2|Overall Study|Protocol Violation|1
764565|NCT00522379|2434571|P1|Overall Study|Protocol Violation|1
764566|NCT00522379|2434567|P5|Overall Study|Withdrawal by Subject|0
764567|NCT00522379|2434568|P4|Overall Study|Withdrawal by Subject|2
764568|NCT00522379|2434569|P3|Overall Study|Withdrawal by Subject|1
764569|NCT00522379|2434570|P2|Overall Study|Withdrawal by Subject|3
764570|NCT00522379|2434571|P1|Overall Study|Withdrawal by Subject|2
764571|NCT00522379|2434567|P5|Overall Study|Lack of Efficacy|7
764572|NCT00522379|2434568|P4|Overall Study|Lack of Efficacy|2
764573|NCT00522379|2434569|P3|Overall Study|Lack of Efficacy|2
764574|NCT00522379|2434570|P2|Overall Study|Lack of Efficacy|0
764575|NCT00522379|2434571|P1|Overall Study|Lack of Efficacy|3
764576|NCT00522379|2434567|P5|Overall Study|Adverse Event|17
764577|NCT00522379|2434568|P4|Overall Study|Adverse Event|5
764578|NCT00522379|2434569|P3|Overall Study|Adverse Event|12
764579|NCT00522379|2434570|P2|Overall Study|Adverse Event|15
764580|NCT00522379|2434571|P1|Overall Study|Adverse Event|12
764581|NCT00522392|2434675|P2|Overall Study|Non-compliance|1
764582|NCT00522392|2434676|P1|Overall Study|Non-compliance|0
764583|NCT00522392|2434675|P2|Overall Study|Physician Decision|1
764584|NCT00522392|2434676|P1|Overall Study|Physician Decision|0
764585|NCT00522392|2434675|P2|Overall Study|Withdrawal by Subject|1
764586|NCT00522392|2434676|P1|Overall Study|Withdrawal by Subject|1
764587|NCT00522392|2434675|P2|Overall Study|Adverse Event|7
764588|NCT00522392|2434676|P1|Overall Study|Adverse Event|7
764589|NCT00522392|2434675|P2|Overall Study|Disease progression|3
764590|NCT00522392|2434676|P1|Overall Study|Disease progression|0
764591|NCT00522418|2434690|P2|Overall Study|Lack of Efficacy|1
764592|NCT00522418|2434691|P1|Overall Study|Lack of Efficacy|0
764593|NCT00522418|2434690|P2|Overall Study|Consent Withdraw|2
764594|NCT00522418|2434691|P1|Overall Study|Consent Withdraw|1
764595|NCT00522418|2434690|P2|Overall Study|Reason Not Specified|1
764596|NCT00522418|2434691|P1|Overall Study|Reason Not Specified|3
764597|NCT00522418|2434690|P2|Overall Study|Noncompliance|2
764598|NCT00522418|2434691|P1|Overall Study|Noncompliance|2
764599|NCT00522418|2434690|P2|Overall Study|Early Study Termination|47
764600|NCT00522418|2434691|P1|Overall Study|Early Study Termination|46
764601|NCT00522418|2434690|P2|Overall Study|Local IRB Consent Violation|5
764602|NCT00522418|2434691|P1|Overall Study|Local IRB Consent Violation|5
764603|NCT00522431|2434737|P1|Overall Study|Other/unknown|1
764604|NCT00522431|2434737|P1|Overall Study|Subject non-compliance|1
764605|NCT00522431|2434737|P1|Overall Study|Withdrawal by Subject|2
764606|NCT00522431|2434737|P1|Overall Study|Protocol Violation|2
764607|NCT00522431|2434737|P1|Overall Study|Adverse Event|5
764608|NCT00522457|2434742|P1|Overall Study|Adverse Event|2
764609|NCT00522457|2434742|P1|Overall Study|Due to disease progression|16
764610|NCT00522626|2434748|P1|Overall Study|Lost to Follow-up|7
764611|NCT00522873|2434758|P2|Overall Study|Never Received Medication|0
764612|NCT00522873|2434759|P1|Overall Study|Never Received Medication|1
764613|NCT00522873|2434758|P2|Overall Study|Medication Errors|1
764614|NCT00522873|2434759|P1|Overall Study|Medication Errors|1
764615|NCT00522873|2434758|P2|Overall Study|Personal Reasons|1
764616|NCT00522873|2434759|P1|Overall Study|Personal Reasons|8
764617|NCT00522873|2434758|P2|Overall Study|Lost to Follow-up|3
764618|NCT00522873|2434759|P1|Overall Study|Lost to Follow-up|11
764619|NCT00522873|2434758|P2|Overall Study|Protocol Violation|4
764620|NCT00522873|2434759|P1|Overall Study|Protocol Violation|14
764621|NCT00522873|2434758|P2|Overall Study|Withdrawal by Subject|9
764622|NCT00522873|2434759|P1|Overall Study|Withdrawal by Subject|20
764623|NCT00522873|2434758|P2|Overall Study|Adverse Event|26
764624|NCT00522873|2434759|P1|Overall Study|Adverse Event|41
764625|NCT00522951|2434781|P2|Period 2|residual contrast medium|1
764626|NCT00522951|2434782|P1|Period 2|residual contrast medium|1
764627|NCT00522951|2434781|P2|Period 2|Withdrawal by Subject|0
764628|NCT00522951|2434782|P1|Period 2|Withdrawal by Subject|1
764629|NCT00522951|2434781|P2|Washout Period|Death|1
764630|NCT00522951|2434782|P1|Washout Period|Death|0
764631|NCT00522951|2434781|P2|Washout Period|Adverse Event|1
764632|NCT00522951|2434782|P1|Washout Period|Adverse Event|0
764633|NCT00522951|2434781|P2|Period 1|body motion|1
764634|NCT00522951|2434782|P1|Period 1|body motion|0
764635|NCT00523341|2434828|P2|Overall Study|Disease Progression|0
764636|NCT00523341|2434829|P1|Overall Study|Disease Progression|1
764637|NCT00523341|2434828|P2|Overall Study|Ineligibility Determined|4
764638|NCT00523341|2434829|P1|Overall Study|Ineligibility Determined|3
764639|NCT00523341|2434828|P2|Overall Study|Protocol Deviation|5
764640|NCT00523341|2434829|P1|Overall Study|Protocol Deviation|6
764641|NCT00523341|2434828|P2|Overall Study|Requirement for Alternative Therapy|14
764642|NCT00523341|2434829|P1|Overall Study|Requirement for Alternative Therapy|4
764643|NCT00523341|2434828|P2|Overall Study|Physician Decision|13
764644|NCT00523341|2434829|P1|Overall Study|Physician Decision|14
764645|NCT00523341|2434828|P2|Overall Study|Non-compliance|13
764646|NCT00523341|2434829|P1|Overall Study|Non-compliance|20
764647|NCT00523341|2434828|P2|Overall Study|Lost to Follow-up|61
764648|NCT00523341|2434829|P1|Overall Study|Lost to Follow-up|73
764649|NCT00523341|2434828|P2|Overall Study|Death|110
764650|NCT00523341|2434829|P1|Overall Study|Death|101
764651|NCT00523341|2434828|P2|Overall Study|Adverse Event|155
764652|NCT00523341|2434829|P1|Overall Study|Adverse Event|122
764653|NCT00523341|2434828|P2|Overall Study|Other|198
764654|NCT00523341|2434829|P1|Overall Study|Other|181
764655|NCT00523341|2434828|P2|Overall Study|Withdrawal by Subject|427
764656|NCT00523341|2434829|P1|Overall Study|Withdrawal by Subject|399
764657|NCT00523367|2434929|P1|Overall Study|4 Withdrawn by PI|4
764658|NCT00523367|2434929|P1|Overall Study|19 screen failures|19
764659|NCT00523419|2434933|P1|Overall Study|Death due to Adverse Event|2
764660|NCT00523419|2434933|P1|Overall Study|Death due to Study Disease|4
764661|NCT00523419|2434933|P1|Overall Study|Progressive Disease|22
764662|NCT00523419|2434933|P1|Overall Study|Physician Decision|2
764663|NCT00523419|2434933|P1|Overall Study|Withdrawal by Subject|1
764664|NCT00523419|2434933|P1|Overall Study|Adverse Event|1
764665|NCT00523549|2434945|P2|Overall Study|Lost to Follow-up|5
764666|NCT00523549|2434946|P1|Overall Study|Lost to Follow-up|3
764667|NCT00523549|2434945|P2|Overall Study|Patient withdrew consent|6
764668|NCT00523549|2434946|P1|Overall Study|Patient withdrew consent|7
764669|NCT00523549|2434945|P2|Overall Study|Protocol Deviation|1
764670|NCT00523549|2434946|P1|Overall Study|Protocol Deviation|3
764671|NCT00523549|2434945|P2|Overall Study|Unsatisfactory therapeutic effect|1
764672|NCT00523549|2434946|P1|Overall Study|Unsatisfactory therapeutic effect|0
764673|NCT00523549|2434945|P2|Overall Study|Adverse Event|3
764674|NCT00523549|2434946|P1|Overall Study|Adverse Event|6
764675|NCT00523640|2434973|P1|Overall Study|Death|1
764676|NCT00523705|2434981|P2|Overall Study|No time for study.|1
764677|NCT00523705|2434982|P1|Overall Study|No time for study.|0
764678|NCT00523718|2434996|P2|Overall Study|Protocol Violation|0
764679|NCT00523718|2434997|P1|Overall Study|Protocol Violation|2
764680|NCT00523718|2434996|P2|Overall Study|Withdrawal by Subject|0
764681|NCT00523718|2434997|P1|Overall Study|Withdrawal by Subject|1
764682|NCT00523744|2435009|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
764683|NCT00523744|2435009|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
764684|NCT00523744|2435009|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
764685|NCT00523744|2435009|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
764686|NCT00523744|2435009|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
764687|NCT00523744|2435009|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
764688|NCT00517296|2435028|P2|Overall Study|Withdrawal by Subject|0
764689|NCT00517296|2435029|P1|Overall Study|Withdrawal by Subject|1
764690|NCT00517361|2435039|P1|Overall Study|The study was terminated|5
764691|NCT00517361|2435039|P1|Overall Study|Death|6
764692|NCT00517413|2435046|P1|Overall Study|Other-Reasons|23
764693|NCT00517413|2435046|P1|Overall Study|Failure to return|1
764694|NCT00517413|2435046|P1|Overall Study|Withdrawal by Subject|2
764695|NCT00517413|2435046|P1|Overall Study|Protocol Violation|15
764696|NCT00517413|2435046|P1|Overall Study|Death|13
764697|NCT00517413|2435046|P1|Overall Study|Adverse Event|7
764698|NCT00517634|2435158|P6|Second Treatment Period|Withdrawal by Subject|0
764699|NCT00517634|2435159|P5|Second Treatment Period|Withdrawal by Subject|1
764700|NCT00517634|2435160|P4|Second Treatment Period|Withdrawal by Subject|0
764701|NCT00517634|2435161|P3|Second Treatment Period|Withdrawal by Subject|0
764702|NCT00517634|2435162|P2|Second Treatment Period|Withdrawal by Subject|0
764703|NCT00517634|2435163|P1|Second Treatment Period|Withdrawal by Subject|0
764704|NCT00517699|2435174|P1|Overall Study|Study terminated by Sponsor|2
764705|NCT00517699|2435174|P1|Overall Study|Administrative error|1
764706|NCT00517699|2435174|P1|Overall Study|Lack of Efficacy|1
764707|NCT00517699|2435174|P1|Overall Study|Withdrawal by Subject|1
764708|NCT00517751|2435182|P1|Overall Study|Missing|3
764709|NCT00517751|2435182|P1|Overall Study|Patient not due for visit|76
764710|NCT00517751|2435182|P1|Overall Study|patient not over due|6
764711|NCT00517751|2435182|P1|Overall Study|Lost to Follow-up|4
764712|NCT00517751|2435182|P1|Overall Study|Withdrawal by Subject|37
764713|NCT00517751|2435182|P1|Overall Study|Death|3
764714|NCT00517829|2435207|P2|Overall Study|Other|1
764715|NCT00517829|2435208|P1|Overall Study|Other|3
764716|NCT00517829|2435207|P2|Overall Study|Investigator Request|3
764717|NCT00517829|2435208|P1|Overall Study|Investigator Request|5
764718|NCT00517829|2435207|P2|Overall Study|Patient Request|5
764719|NCT00517829|2435208|P1|Overall Study|Patient Request|6
764720|NCT00517829|2435207|P2|Overall Study|Disease Progression|32
764721|NCT00517829|2435208|P1|Overall Study|Disease Progression|39
764722|NCT00517829|2435207|P2|Overall Study|Adverse Event|34
764723|NCT00517829|2435208|P1|Overall Study|Adverse Event|22
764724|NCT00517881|2435222|P1|Overall Study|Renal transplantation|2
764725|NCT00517881|2435222|P1|Overall Study|Adverse Event|1
764726|NCT00517881|2435222|P1|Overall Study|Protocol Violation|2
764727|NCT00517933|2435234|P2|Period 2|Underwent lung transplant|2
764728|NCT00517933|2435235|P1|Period 2|Underwent lung transplant|0
764729|NCT00517933|2435234|P2|Period 2|Withdrawal by Subject|3
764730|NCT00517933|2435235|P1|Period 2|Withdrawal by Subject|1
764731|NCT00517933|2435234|P2|Period 2|Physician Decision|0
764732|NCT00517933|2435235|P1|Period 2|Physician Decision|1
764733|NCT00517933|2435234|P2|Period 2|Adverse Event|4
764734|NCT00517933|2435235|P1|Period 2|Adverse Event|2
764735|NCT00517933|2435234|P2|Period 2|Death|4
764736|NCT00517933|2435235|P1|Period 2|Death|2
764737|NCT00517933|2435234|P2|Period 1|Underwent lung transplant|1
764738|NCT00517933|2435235|P1|Period 1|Underwent lung transplant|0
764739|NCT00517933|2435234|P2|Period 1|Lost to Follow-up|0
764740|NCT00517933|2435235|P1|Period 1|Lost to Follow-up|2
764741|NCT00517933|2435234|P2|Period 1|Adverse Event|4
764742|NCT00517933|2435235|P1|Period 1|Adverse Event|4
764743|NCT00517933|2435234|P2|Period 1|Death|1
764744|NCT00517933|2435235|P1|Period 1|Death|2
764745|NCT00518011|2435301|P2|Overall Study|Withdrawal by Subject|0
764746|NCT00518011|2435302|P1|Overall Study|Withdrawal by Subject|1
764747|NCT00518011|2435301|P2|Overall Study|Other Reasons|2
764748|NCT00518011|2435302|P1|Overall Study|Other Reasons|3
764749|NCT00518011|2435301|P2|Overall Study|Disease Progression|2
764750|NCT00518011|2435302|P1|Overall Study|Disease Progression|2
764751|NCT00518011|2435301|P2|Overall Study|Adverse Event|3
764752|NCT00518011|2435302|P1|Overall Study|Adverse Event|2
764753|NCT00518011|2435301|P2|Overall Study|Death|1
764754|NCT00518011|2435302|P1|Overall Study|Death|1
764755|NCT00518115|2435349|P10|Overall Study|Moved Out of State|1
764756|NCT00518115|2435350|P9|Overall Study|Moved Out of State|0
764757|NCT00518115|2435351|P8|Overall Study|Moved Out of State|0
764758|NCT00518115|2435352|P7|Overall Study|Moved Out of State|0
764759|NCT00518115|2435353|P6|Overall Study|Moved Out of State|0
764760|NCT00518115|2435354|P5|Overall Study|Moved Out of State|0
764761|NCT00518115|2435355|P4|Overall Study|Moved Out of State|0
764762|NCT00518115|2435356|P3|Overall Study|Moved Out of State|0
764763|NCT00518115|2435357|P2|Overall Study|Moved Out of State|0
764764|NCT00518115|2435358|P1|Overall Study|Moved Out of State|0
764765|NCT00518115|2435349|P10|Overall Study|Withdrew Consent|0
764766|NCT00518115|2435350|P9|Overall Study|Withdrew Consent|0
764767|NCT00518115|2435351|P8|Overall Study|Withdrew Consent|0
764768|NCT00518115|2435352|P7|Overall Study|Withdrew Consent|0
764769|NCT00518115|2435353|P6|Overall Study|Withdrew Consent|1
764770|NCT00518115|2435354|P5|Overall Study|Withdrew Consent|0
764771|NCT00518115|2435355|P4|Overall Study|Withdrew Consent|0
764772|NCT00518115|2435356|P3|Overall Study|Withdrew Consent|0
764773|NCT00518115|2435357|P2|Overall Study|Withdrew Consent|0
764774|NCT00518115|2435358|P1|Overall Study|Withdrew Consent|0
764775|NCT00518115|2435349|P10|Overall Study|Family Emergency; Had to Go to England|0
764776|NCT00518115|2435350|P9|Overall Study|Family Emergency; Had to Go to England|0
764777|NCT00518115|2435351|P8|Overall Study|Family Emergency; Had to Go to England|0
764778|NCT00518115|2435352|P7|Overall Study|Family Emergency; Had to Go to England|0
764779|NCT00518115|2435353|P6|Overall Study|Family Emergency; Had to Go to England|0
764780|NCT00518115|2435354|P5|Overall Study|Family Emergency; Had to Go to England|1
764781|NCT00518115|2435355|P4|Overall Study|Family Emergency; Had to Go to England|0
764782|NCT00518115|2435356|P3|Overall Study|Family Emergency; Had to Go to England|0
764783|NCT00518115|2435357|P2|Overall Study|Family Emergency; Had to Go to England|0
764784|NCT00518115|2435358|P1|Overall Study|Family Emergency; Had to Go to England|0
764785|NCT00518115|2435349|P10|Overall Study|Violation of Exclusion Criteria|0
764786|NCT00518115|2435350|P9|Overall Study|Violation of Exclusion Criteria|0
764787|NCT00518115|2435351|P8|Overall Study|Violation of Exclusion Criteria|0
764788|NCT00518115|2435352|P7|Overall Study|Violation of Exclusion Criteria|1
764789|NCT00518115|2435353|P6|Overall Study|Violation of Exclusion Criteria|0
764790|NCT00518115|2435354|P5|Overall Study|Violation of Exclusion Criteria|0
764791|NCT00518115|2435355|P4|Overall Study|Violation of Exclusion Criteria|1
764792|NCT00518115|2435356|P3|Overall Study|Violation of Exclusion Criteria|0
764793|NCT00518115|2435357|P2|Overall Study|Violation of Exclusion Criteria|0
764794|NCT00518115|2435358|P1|Overall Study|Violation of Exclusion Criteria|0
764795|NCT00518115|2435349|P10|Overall Study|Wrong Monotherapy Administered|0
764796|NCT00518115|2435350|P9|Overall Study|Wrong Monotherapy Administered|0
764797|NCT00518115|2435351|P8|Overall Study|Wrong Monotherapy Administered|0
764798|NCT00518115|2435352|P7|Overall Study|Wrong Monotherapy Administered|1
764799|NCT00518115|2435353|P6|Overall Study|Wrong Monotherapy Administered|0
764800|NCT00518115|2435354|P5|Overall Study|Wrong Monotherapy Administered|0
764801|NCT00518115|2435355|P4|Overall Study|Wrong Monotherapy Administered|0
764802|NCT00518115|2435356|P3|Overall Study|Wrong Monotherapy Administered|1
764803|NCT00518115|2435357|P2|Overall Study|Wrong Monotherapy Administered|0
764804|NCT00518115|2435358|P1|Overall Study|Wrong Monotherapy Administered|0
764805|NCT00518115|2435349|P10|Overall Study|Different Monotherapy Diabetic Drug|0
764806|NCT00518115|2435350|P9|Overall Study|Different Monotherapy Diabetic Drug|1
764807|NCT00518115|2435351|P8|Overall Study|Different Monotherapy Diabetic Drug|0
764808|NCT00518115|2435352|P7|Overall Study|Different Monotherapy Diabetic Drug|0
764809|NCT00518115|2435353|P6|Overall Study|Different Monotherapy Diabetic Drug|0
764810|NCT00518115|2435354|P5|Overall Study|Different Monotherapy Diabetic Drug|0
764811|NCT00518115|2435355|P4|Overall Study|Different Monotherapy Diabetic Drug|0
764812|NCT00518115|2435356|P3|Overall Study|Different Monotherapy Diabetic Drug|1
764813|NCT00518115|2435357|P2|Overall Study|Different Monotherapy Diabetic Drug|0
764814|NCT00518115|2435358|P1|Overall Study|Different Monotherapy Diabetic Drug|0
764815|NCT00518115|2435349|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
764816|NCT00518115|2435350|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
764817|NCT00518115|2435351|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
764818|NCT00518115|2435352|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
764819|NCT00518115|2435353|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
764820|NCT00518115|2435354|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
764821|NCT00518115|2435355|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
764822|NCT00518115|2435356|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
764823|NCT00518115|2435357|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
764824|NCT00518115|2435358|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
764825|NCT00518115|2435349|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
764826|NCT00518115|2435350|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
764827|NCT00518115|2435351|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
764828|NCT00518115|2435352|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
764829|NCT00518115|2435353|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
764830|NCT00518115|2435354|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
764831|NCT00518115|2435355|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
764832|NCT00518115|2435356|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
764833|NCT00518115|2435357|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
764834|NCT00518115|2435358|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
764835|NCT00518115|2435349|P10|Overall Study|Non-Compliance|1
764836|NCT00518115|2435350|P9|Overall Study|Non-Compliance|0
764837|NCT00518115|2435351|P8|Overall Study|Non-Compliance|1
764838|NCT00518115|2435352|P7|Overall Study|Non-Compliance|1
764839|NCT00518115|2435353|P6|Overall Study|Non-Compliance|1
764840|NCT00518115|2435354|P5|Overall Study|Non-Compliance|1
764841|NCT00518115|2435355|P4|Overall Study|Non-Compliance|0
764842|NCT00518115|2435356|P3|Overall Study|Non-Compliance|1
764843|NCT00518115|2435357|P2|Overall Study|Non-Compliance|0
764844|NCT00518115|2435358|P1|Overall Study|Non-Compliance|1
764845|NCT00518115|2435349|P10|Overall Study|Lack of Efficacy|0
764846|NCT00518115|2435350|P9|Overall Study|Lack of Efficacy|0
764847|NCT00518115|2435351|P8|Overall Study|Lack of Efficacy|1
764848|NCT00518115|2435352|P7|Overall Study|Lack of Efficacy|0
764849|NCT00518115|2435353|P6|Overall Study|Lack of Efficacy|0
764850|NCT00518115|2435354|P5|Overall Study|Lack of Efficacy|0
764851|NCT00518115|2435355|P4|Overall Study|Lack of Efficacy|1
764852|NCT00518115|2435356|P3|Overall Study|Lack of Efficacy|1
764853|NCT00518115|2435357|P2|Overall Study|Lack of Efficacy|0
764854|NCT00518115|2435358|P1|Overall Study|Lack of Efficacy|1
764855|NCT00518115|2435349|P10|Overall Study|Withdrawal by Subject|3
764856|NCT00518115|2435350|P9|Overall Study|Withdrawal by Subject|1
764857|NCT00518115|2435351|P8|Overall Study|Withdrawal by Subject|2
764858|NCT00518115|2435352|P7|Overall Study|Withdrawal by Subject|0
764859|NCT00518115|2435353|P6|Overall Study|Withdrawal by Subject|1
764860|NCT00518115|2435354|P5|Overall Study|Withdrawal by Subject|2
764861|NCT00518115|2435355|P4|Overall Study|Withdrawal by Subject|0
764862|NCT00518115|2435356|P3|Overall Study|Withdrawal by Subject|5
764863|NCT00518115|2435357|P2|Overall Study|Withdrawal by Subject|1
764864|NCT00518115|2435358|P1|Overall Study|Withdrawal by Subject|1
764865|NCT00518115|2435349|P10|Overall Study|Protocol Violation|0
764866|NCT00518115|2435350|P9|Overall Study|Protocol Violation|0
764867|NCT00518115|2435351|P8|Overall Study|Protocol Violation|0
764868|NCT00518115|2435352|P7|Overall Study|Protocol Violation|0
764869|NCT00518115|2435353|P6|Overall Study|Protocol Violation|0
764870|NCT00518115|2435354|P5|Overall Study|Protocol Violation|0
764871|NCT00518115|2435355|P4|Overall Study|Protocol Violation|0
764872|NCT00518115|2435356|P3|Overall Study|Protocol Violation|1
764873|NCT00518115|2435357|P2|Overall Study|Protocol Violation|3
764874|NCT00518115|2435358|P1|Overall Study|Protocol Violation|1
764875|NCT00518115|2435349|P10|Overall Study|Lost to Follow-up|1
764876|NCT00518115|2435350|P9|Overall Study|Lost to Follow-up|1
764877|NCT00518115|2435351|P8|Overall Study|Lost to Follow-up|1
764878|NCT00518115|2435352|P7|Overall Study|Lost to Follow-up|0
764879|NCT00518115|2435353|P6|Overall Study|Lost to Follow-up|3
764880|NCT00518115|2435354|P5|Overall Study|Lost to Follow-up|1
764881|NCT00518115|2435355|P4|Overall Study|Lost to Follow-up|3
764882|NCT00518115|2435356|P3|Overall Study|Lost to Follow-up|2
764883|NCT00518115|2435357|P2|Overall Study|Lost to Follow-up|0
764884|NCT00518115|2435358|P1|Overall Study|Lost to Follow-up|0
764885|NCT00518115|2435349|P10|Overall Study|Adverse Event|9
764886|NCT00518115|2435350|P9|Overall Study|Adverse Event|2
764887|NCT00518115|2435351|P8|Overall Study|Adverse Event|10
764888|NCT00518115|2435352|P7|Overall Study|Adverse Event|5
764889|NCT00518115|2435353|P6|Overall Study|Adverse Event|5
764890|NCT00518115|2435354|P5|Overall Study|Adverse Event|5
764891|NCT00518115|2435355|P4|Overall Study|Adverse Event|6
764892|NCT00518115|2435356|P3|Overall Study|Adverse Event|5
764893|NCT00518115|2435357|P2|Overall Study|Adverse Event|1
764894|NCT00518115|2435358|P1|Overall Study|Adverse Event|6
764895|NCT00518180|2435517|P3|Overall Study|Adverse Event|0
764896|NCT00518180|2435518|P2|Overall Study|Adverse Event|0
764897|NCT00518180|2435519|P1|Overall Study|Adverse Event|1
764898|NCT00518180|2435517|P3|Overall Study|Unable to classify|0
764899|NCT00518180|2435518|P2|Overall Study|Unable to classify|2
764900|NCT00518180|2435519|P1|Overall Study|Unable to classify|0
764901|NCT00518180|2435517|P3|Overall Study|Protocol Violation|4
764902|NCT00518180|2435518|P2|Overall Study|Protocol Violation|7
764903|NCT00518180|2435519|P1|Overall Study|Protocol Violation|5
764904|NCT00518180|2435517|P3|Overall Study|Administrative reason|2
764905|NCT00518180|2435518|P2|Overall Study|Administrative reason|2
764906|NCT00518180|2435519|P1|Overall Study|Administrative reason|0
764907|NCT00518180|2435517|P3|Overall Study|Lost to Follow-up|34
764908|NCT00518180|2435518|P2|Overall Study|Lost to Follow-up|28
764909|NCT00518180|2435519|P1|Overall Study|Lost to Follow-up|30
764910|NCT00518180|2435517|P3|Overall Study|Withdrawal by Subject|42
764911|NCT00518180|2435518|P2|Overall Study|Withdrawal by Subject|30
764912|NCT00518180|2435519|P1|Overall Study|Withdrawal by Subject|29
764913|NCT00518206|2435563|P2|Overall Study|Completion Status Unknown|0
764914|NCT00518206|2435564|P1|Overall Study|Completion Status Unknown|1
764915|NCT00518206|2435563|P2|Overall Study|Reason Unknown|0
764916|NCT00518206|2435564|P1|Overall Study|Reason Unknown|1
764917|NCT00518206|2435563|P2|Overall Study|Drug Supply Issue|0
764918|NCT00518206|2435564|P1|Overall Study|Drug Supply Issue|1
764919|NCT00518206|2435563|P2|Overall Study|Withdrawal by Subject|0
764920|NCT00518206|2435564|P1|Overall Study|Withdrawal by Subject|2
764921|NCT00518206|2435563|P2|Overall Study|Disease Progression Requiring Therapy|6
764922|NCT00518206|2435564|P1|Overall Study|Disease Progression Requiring Therapy|6
764923|NCT00523848|2435582|P1|Overall Study|Other, unspecified|4
764924|NCT00523848|2435582|P1|Overall Study|Disease Progression|5
764925|NCT00523848|2435582|P1|Overall Study|NOT TREATED (Became ineligible)|2
764926|NCT00523848|2435582|P1|Overall Study|Withdrawal by Subject|2
764927|NCT00523848|2435582|P1|Overall Study|Adverse Event|11
764928|NCT00523978|2435600|P2|Overall Study|Death|0
764929|NCT00523978|2435601|P1|Overall Study|Death|1
764930|NCT00523978|2435600|P2|Overall Study|Screen Failures|1
764931|NCT00523978|2435601|P1|Overall Study|Screen Failures|5
764932|NCT00523978|2435600|P2|Overall Study|Withdrawal by Subject|7
764933|NCT00523978|2435601|P1|Overall Study|Withdrawal by Subject|3
764934|NCT00523991|2435615|P2|Overall Study|Other reason (not specified)|0
764935|NCT00523991|2435616|P1|Overall Study|Other reason (not specified)|3
764936|NCT00523991|2435615|P2|Overall Study|Withdrawal by Subject|17
764937|NCT00523991|2435616|P1|Overall Study|Withdrawal by Subject|7
764938|NCT00523991|2435615|P2|Overall Study|Lost to Follow-up|1
764939|NCT00523991|2435616|P1|Overall Study|Lost to Follow-up|4
764940|NCT00523991|2435615|P2|Overall Study|Protocol Violation|4
764941|NCT00523991|2435616|P1|Overall Study|Protocol Violation|1
764942|NCT00523991|2435615|P2|Overall Study|Adverse Event|5
764943|NCT00523991|2435616|P1|Overall Study|Adverse Event|6
764944|NCT00524030|2435896|P2|Overall Study|Death|1
764945|NCT00524030|2435897|P1|Overall Study|Death|0
764946|NCT00524030|2435896|P2|Overall Study|Adverse Event|21
764947|NCT00524030|2435897|P1|Overall Study|Adverse Event|3
764948|NCT00524030|2435896|P2|Overall Study|Pregnancy|0
764949|NCT00524030|2435897|P1|Overall Study|Pregnancy|1
764950|NCT00524030|2435896|P2|Overall Study|Protocol Violation|1
764951|NCT00524030|2435897|P1|Overall Study|Protocol Violation|0
764952|NCT00524030|2435896|P2|Overall Study|Noncompliance/Investigator discretion|2
764953|NCT00524030|2435897|P1|Overall Study|Noncompliance/Investigator discretion|0
764954|NCT00524030|2435896|P2|Overall Study|Withdrawal by Subject|8
764955|NCT00524030|2435897|P1|Overall Study|Withdrawal by Subject|3
764956|NCT00524030|2435896|P2|Overall Study|Lost to Follow-up|2
764957|NCT00524030|2435897|P1|Overall Study|Lost to Follow-up|0
764958|NCT00524030|2435896|P2|Overall Study|Lack of Efficacy|24
764959|NCT00524030|2435897|P1|Overall Study|Lack of Efficacy|10
764960|NCT00524043|2435916|P3|Overall Study|Various (eg, incarceration)|0
764961|NCT00524043|2435917|P2|Overall Study|Various (eg, incarceration)|1
764962|NCT00524043|2435918|P1|Overall Study|Various (eg, incarceration)|2
764963|NCT00524043|2435916|P3|Overall Study|Lost to Follow-up|3
764964|NCT00524043|2435917|P2|Overall Study|Lost to Follow-up|5
764965|NCT00524043|2435918|P1|Overall Study|Lost to Follow-up|3
764966|NCT00524043|2435916|P3|Overall Study|Adverse Event|7
764967|NCT00524043|2435917|P2|Overall Study|Adverse Event|2
764968|NCT00524043|2435918|P1|Overall Study|Adverse Event|5
764969|NCT00524043|2435916|P3|Overall Study|Withdrawal by Subject|7
764970|NCT00524043|2435917|P2|Overall Study|Withdrawal by Subject|7
764971|NCT00524043|2435918|P1|Overall Study|Withdrawal by Subject|5
764972|NCT00524043|2435916|P3|Overall Study|Lack of Efficacy|14
764973|NCT00524043|2435917|P2|Overall Study|Lack of Efficacy|13
764974|NCT00524043|2435918|P1|Overall Study|Lack of Efficacy|15
764975|NCT00524121|2435938|P1|Overall Study|Not treated (changed mind)|1
764976|NCT00524121|2435938|P1|Overall Study|Not treated (became ineligible)|4
764977|NCT00524121|2435938|P1|Overall Study|Death|1
764978|NCT00524121|2435938|P1|Overall Study|unspecified|1
764979|NCT00524121|2435938|P1|Overall Study|Patient refused|2
764980|NCT00524121|2435938|P1|Overall Study|Adverse Event|4
764981|NCT00524121|2435938|P1|Overall Study|Disease progression|6
764982|NCT00525824|2436002|P4|Overall Study|Other|1
764983|NCT00525824|2436003|P3|Overall Study|Other|3
764984|NCT00525824|2436004|P2|Overall Study|Other|3
764985|NCT00525824|2436005|P1|Overall Study|Other|1
764986|NCT00525824|2436002|P4|Overall Study|Safety reasons|0
764987|NCT00525824|2436003|P3|Overall Study|Safety reasons|1
764988|NCT00525824|2436004|P2|Overall Study|Safety reasons|0
764989|NCT00525824|2436005|P1|Overall Study|Safety reasons|1
764990|NCT00525824|2436002|P4|Overall Study|Severe non-compliance|1
764991|NCT00525824|2436003|P3|Overall Study|Severe non-compliance|1
764992|NCT00525824|2436004|P2|Overall Study|Severe non-compliance|1
764993|NCT00525824|2436005|P1|Overall Study|Severe non-compliance|0
764994|NCT00525824|2436002|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
764995|NCT00525824|2436003|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
764996|NCT00525824|2436004|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
764997|NCT00525824|2436005|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
764998|NCT00525824|2436002|P4|Overall Study|Lost to Follow-up|0
764999|NCT00525824|2436003|P3|Overall Study|Lost to Follow-up|4
765000|NCT00525824|2436004|P2|Overall Study|Lost to Follow-up|2
765001|NCT00525824|2436005|P1|Overall Study|Lost to Follow-up|4
765002|NCT00525824|2436002|P4|Overall Study|Withdrawal by Subject|4
765003|NCT00525824|2436003|P3|Overall Study|Withdrawal by Subject|3
765004|NCT00525824|2436004|P2|Overall Study|Withdrawal by Subject|9
765005|NCT00525824|2436005|P1|Overall Study|Withdrawal by Subject|5
765006|NCT00525824|2436002|P4|Overall Study|Adverse Event|7
765007|NCT00525824|2436003|P3|Overall Study|Adverse Event|6
765008|NCT00525824|2436004|P2|Overall Study|Adverse Event|11
765009|NCT00525824|2436005|P1|Overall Study|Adverse Event|7
765010|NCT00525902|2436080|P1|Overall Study|Lack of Efficacy|1
765011|NCT00525915|2436087|P2|Overall Study|Unrelated illness|0
765012|NCT00525915|2436088|P1|Overall Study|Unrelated illness|1
765013|NCT00525915|2436087|P2|Overall Study|Refused Surgery|2
765014|NCT00525915|2436088|P1|Overall Study|Refused Surgery|1
765015|NCT00525915|2436087|P2|Overall Study|Withdrawal by Subject|0
765016|NCT00525915|2436088|P1|Overall Study|Withdrawal by Subject|1
765017|NCT00525915|2436087|P2|Overall Study|Disease Progression|6
765018|NCT00525915|2436088|P1|Overall Study|Disease Progression|5
765019|NCT00525915|2436087|P2|Overall Study|Non-Compliance|1
765020|NCT00525915|2436088|P1|Overall Study|Non-Compliance|0
765021|NCT00526097|2436105|P2|Overall Study|Other|1
765022|NCT00526097|2436106|P1|Overall Study|Other|2
765023|NCT00526097|2436105|P2|Overall Study|Withdrawal by Subject|1
765024|NCT00526097|2436106|P1|Overall Study|Withdrawal by Subject|3
765025|NCT00526097|2436105|P2|Overall Study|Protocol Violation|10
765026|NCT00526097|2436106|P1|Overall Study|Protocol Violation|4
765027|NCT00526097|2436105|P2|Overall Study|Adverse Event|44
765028|NCT00526097|2436106|P1|Overall Study|Adverse Event|6
765029|NCT00526110|2436284|P2|Overall Study|Poor Tolerance|5
765030|NCT00526110|2436285|P1|Overall Study|Poor Tolerance|0
765031|NCT00526110|2436284|P2|Overall Study|Withdrawal by Subject|2
765032|NCT00526110|2436285|P1|Overall Study|Withdrawal by Subject|0
765033|NCT00526110|2436284|P2|Overall Study|Maximal Response|6
765034|NCT00526110|2436285|P1|Overall Study|Maximal Response|0
765035|NCT00526110|2436284|P2|Overall Study|Disease Progression|19
765036|NCT00526110|2436285|P1|Overall Study|Disease Progression|0
765037|NCT00526110|2436284|P2|Overall Study|Adverse Event|9
765038|NCT00526110|2436285|P1|Overall Study|Adverse Event|2
765039|NCT00526162|2436315|P1|Overall Study|Device not implanted|3
765040|NCT00526227|2436326|P1|Overall Study|Death|1
765041|NCT00526227|2436326|P1|Overall Study|Device not implanted|1
765042|NCT00526331|2436335|P1|Overall Study|Sponsor Termination|55
765043|NCT00526630|2436410|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
765044|NCT00526630|2436411|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
765045|NCT00526630|2436410|P2|First Intervention Period - 12 Weeks|Withdrawn|3
765046|NCT00526630|2436411|P1|First Intervention Period - 12 Weeks|Withdrawn|0
765047|NCT00526669|2436439|P2|Combined Treatment Phase|Death|2
765048|NCT00526669|2436440|P1|Combined Treatment Phase|Death|0
765049|NCT00526669|2436439|P2|Combined Treatment Phase|Sponsor Terminated Study|2
765050|NCT00526669|2436440|P1|Combined Treatment Phase|Sponsor Terminated Study|0
765051|NCT00526669|2436439|P2|Combined Treatment Phase|Withdrawal by Subject|2
765052|NCT00526669|2436440|P1|Combined Treatment Phase|Withdrawal by Subject|0
765053|NCT00526669|2436439|P2|Combined Treatment Phase|Lost to Follow-up|2
765054|NCT00526669|2436440|P1|Combined Treatment Phase|Lost to Follow-up|0
765055|NCT00526799|2436471|P2|Overall Study|Intercurrent Complicating Disease|1
765056|NCT00526799|2436472|P1|Overall Study|Intercurrent Complicating Disease|0
765057|NCT00526799|2436471|P2|Overall Study|Withdrawal by Subject|0
765058|NCT00526799|2436472|P1|Overall Study|Withdrawal by Subject|1
891356|NCT02105974|2827456|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
891357|NCT02105974|2827457|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
765061|NCT00526994|2436492|P3|Overall Study|incarcerated, impaired, incomplete|3
765062|NCT00526994|2436493|P2|Overall Study|incarcerated, impaired, incomplete|3
765063|NCT00526994|2436494|P1|Overall Study|incarcerated, impaired, incomplete|4
765064|NCT00526994|2436492|P3|Overall Study|Withdrawal by Subject|5
765065|NCT00526994|2436493|P2|Overall Study|Withdrawal by Subject|7
765066|NCT00526994|2436494|P1|Overall Study|Withdrawal by Subject|2
765067|NCT00526994|2436492|P3|Overall Study|Death|3
765068|NCT00526994|2436493|P2|Overall Study|Death|3
765069|NCT00526994|2436494|P1|Overall Study|Death|4
765070|NCT00526994|2436492|P3|Overall Study|Lost to Follow-up|96
765071|NCT00526994|2436493|P2|Overall Study|Lost to Follow-up|108
765072|NCT00526994|2436494|P1|Overall Study|Lost to Follow-up|98
765073|NCT00527072|2436511|P1|Overall Study|Withdrawal by Subject|7
765074|NCT00527072|2436511|P1|Overall Study|Protocol Violation|2
765075|NCT00527072|2436511|P1|Overall Study|Lost to Follow-up|3
765076|NCT00527072|2436511|P1|Overall Study|Lack of Efficacy|11
765077|NCT00527072|2436511|P1|Overall Study|Adverse Event|13
765078|NCT00527111|2436527|P2|Overall Study|Other|2
765079|NCT00527111|2436528|P1|Overall Study|Other|2
765080|NCT00527111|2436527|P2|Overall Study|Patient Request|5
765081|NCT00527111|2436528|P1|Overall Study|Patient Request|2
765082|NCT00527111|2436527|P2|Overall Study|Investigator Request|1
765083|NCT00527111|2436528|P1|Overall Study|Investigator Request|2
765084|NCT00527111|2436527|P2|Overall Study|Death|1
765085|NCT00527111|2436528|P1|Overall Study|Death|0
765086|NCT00527111|2436527|P2|Overall Study|Adverse Event|13
765087|NCT00527111|2436528|P1|Overall Study|Adverse Event|14
765088|NCT00527319|2436554|P3|Overall Study|Adverse Event|1
765089|NCT00527319|2436555|P2|Overall Study|Adverse Event|0
765090|NCT00527319|2436556|P1|Overall Study|Adverse Event|0
765091|NCT00527319|2436554|P3|Overall Study|Intercurrent Medical Illness|3
765092|NCT00527319|2436555|P2|Overall Study|Intercurrent Medical Illness|1
765093|NCT00527319|2436556|P1|Overall Study|Intercurrent Medical Illness|0
765094|NCT00527319|2436554|P3|Overall Study|Death|1
765095|NCT00527319|2436555|P2|Overall Study|Death|3
765096|NCT00527319|2436556|P1|Overall Study|Death|0
765097|NCT00527319|2436554|P3|Overall Study|Lost to Follow-up|0
765098|NCT00527319|2436555|P2|Overall Study|Lost to Follow-up|0
765099|NCT00527319|2436556|P1|Overall Study|Lost to Follow-up|1
765100|NCT00527319|2436554|P3|Overall Study|Withdrawal by Subject|1
765101|NCT00527319|2436555|P2|Overall Study|Withdrawal by Subject|0
765102|NCT00527319|2436556|P1|Overall Study|Withdrawal by Subject|5
765103|NCT00527332|2436569|P2|Overall Study|Withdrew consent|1
765104|NCT00527332|2436570|P1|Overall Study|Withdrew consent|5
765105|NCT00527332|2436569|P2|Overall Study|Protocol Violation|8
765106|NCT00527332|2436570|P1|Overall Study|Protocol Violation|4
765107|NCT00527397|2436576|P1|Overall Study|Study terminated by sponsor|13
765108|NCT00527397|2436576|P1|Overall Study|Withdrawal by Subject|6
765109|NCT00527397|2436576|P1|Overall Study|Protocol Violation|1
765110|NCT00527397|2436576|P1|Overall Study|Lack of Efficacy|1
765111|NCT00527397|2436576|P1|Overall Study|Adverse Event|3
765112|NCT00527423|2436600|P1|Overall Study|Death|9
765113|NCT00527423|2436600|P1|Overall Study|OTHER|4
765114|NCT00527423|2436600|P1|Overall Study|Lost to Follow-up|4
765115|NCT00527423|2436600|P1|Overall Study|Withdrawal by Subject|10
765116|NCT00527423|2436600|P1|Overall Study|Physician Decision|4
765117|NCT00527423|2436600|P1|Overall Study|Adverse Event|5
765118|NCT00527423|2436600|P1|Overall Study|Protocol Violation|1
891358|NCT02105974|2827455|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
891359|NCT02105974|2827456|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
891360|NCT02105974|2827457|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
765123|NCT00527514|2436696|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
765124|NCT00527514|2436696|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
765125|NCT00527514|2436696|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
765126|NCT00527514|2436696|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
765127|NCT00527514|2436696|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
765128|NCT00527514|2436696|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
765129|NCT00527514|2436696|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
765130|NCT00527605|2436725|P2|Overall Study|Protocol Violation|2
765131|NCT00527605|2436726|P1|Overall Study|Protocol Violation|1
765132|NCT00527605|2436725|P2|Overall Study|Lost to Follow-up|2
765133|NCT00527605|2436726|P1|Overall Study|Lost to Follow-up|6
765134|NCT00527605|2436725|P2|Overall Study|Withdrawal by Subject|7
765135|NCT00527605|2436726|P1|Overall Study|Withdrawal by Subject|3
765136|NCT00527605|2436725|P2|Overall Study|Adverse Event|0
765137|NCT00527605|2436726|P1|Overall Study|Adverse Event|3
765138|NCT00527618|2436762|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
765139|NCT00527618|2436763|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
765140|NCT00527618|2436762|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
765141|NCT00527618|2436763|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
765142|NCT00527618|2436762|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
765143|NCT00527618|2436763|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
765144|NCT00527618|2436762|P2|Week 13-14 (Washout)|Lost to Follow-up|0
765145|NCT00527618|2436763|P1|Week 13-14 (Washout)|Lost to Follow-up|1
765146|NCT00527618|2436762|P2|Week 1-12 (First Intervention)|Adverse Event|1
765147|NCT00527618|2436763|P1|Week 1-12 (First Intervention)|Adverse Event|0
765148|NCT00527618|2436762|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
765149|NCT00527618|2436763|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
891361|NCT01957163|2827470|P3|Overall Study|Withdrawal by Subject|4
891362|NCT01957163|2827471|P2|Overall Study|Withdrawal by Subject|2
891363|NCT01957163|2827472|P1|Overall Study|Withdrawal by Subject|4
891364|NCT01957163|2827470|P3|Overall Study|Lost to Follow-up|0
891365|NCT01957163|2827471|P2|Overall Study|Lost to Follow-up|1
891366|NCT01957163|2827472|P1|Overall Study|Lost to Follow-up|0
891367|NCT01957163|2827470|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
891368|NCT01957163|2827471|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
891369|NCT01957163|2827472|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
891370|NCT01957163|2827470|P3|Overall Study|Protocol Violation|0
891371|NCT01957163|2827471|P2|Overall Study|Protocol Violation|2
891372|NCT01957163|2827472|P1|Overall Study|Protocol Violation|1
891373|NCT01957163|2827470|P3|Overall Study|Lack of Efficacy|9
891374|NCT01957163|2827471|P2|Overall Study|Lack of Efficacy|4
891375|NCT01957163|2827472|P1|Overall Study|Lack of Efficacy|5
891376|NCT01957163|2827470|P3|Overall Study|Adverse Event|4
891377|NCT01957163|2827471|P2|Overall Study|Adverse Event|2
891378|NCT01957163|2827472|P1|Overall Study|Adverse Event|5
891379|NCT01940354|2827485|P2|Overall Study|Withdrawal by Subject|2
891380|NCT01940354|2827486|P1|Overall Study|Withdrawal by Subject|4
765180|NCT00527748|2436862|P1|Overall Study|Other|3
765181|NCT00527787|2436868|P2|Overall Study|misc|2
765182|NCT00527787|2436869|P1|Overall Study|misc|5
765183|NCT00527787|2436868|P2|Overall Study|Duodenal Ulcer|10
765184|NCT00527787|2436869|P1|Overall Study|Duodenal Ulcer|1
765185|NCT00527787|2436868|P2|Overall Study|Lost to Follow-up|2
765186|NCT00527787|2436869|P1|Overall Study|Lost to Follow-up|5
765187|NCT00527787|2436868|P2|Overall Study|Withdrawal by Subject|25
765188|NCT00527787|2436869|P1|Overall Study|Withdrawal by Subject|13
765189|NCT00527787|2436868|P2|Overall Study|Adverse Event|24
765190|NCT00527787|2436869|P1|Overall Study|Adverse Event|14
765191|NCT00527826|2436893|P2|Overall Study|Participant moved away|1
765192|NCT00527826|2436894|P1|Overall Study|Participant moved away|0
765193|NCT00527826|2436893|P2|Overall Study|Additional Intake of Viani forte|1
765194|NCT00527826|2436894|P1|Overall Study|Additional Intake of Viani forte|0
765195|NCT00527826|2436893|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
765196|NCT00527826|2436894|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
765197|NCT00527826|2436893|P2|Overall Study|Inclusion Criteria Not Met|3
765198|NCT00527826|2436894|P1|Overall Study|Inclusion Criteria Not Met|3
765199|NCT00527826|2436893|P2|Overall Study|Withdrawal by Subject|8
765200|NCT00527826|2436894|P1|Overall Study|Withdrawal by Subject|5
765201|NCT00527826|2436893|P2|Overall Study|Lost to Follow-up|2
765202|NCT00527826|2436894|P1|Overall Study|Lost to Follow-up|3
765203|NCT00527826|2436893|P2|Overall Study|Adverse Event|10
765204|NCT00527826|2436894|P1|Overall Study|Adverse Event|10
765205|NCT00527904|2436954|P1|Overall Study|misc|22
765206|NCT00527904|2436954|P1|Overall Study|Lost to Follow-up|8
765207|NCT00527904|2436954|P1|Overall Study|Withdrawal by Subject|21
765208|NCT00527904|2436954|P1|Overall Study|Adverse Event|45
765209|NCT00527982|2436995|P2|Overall Study|Physician Decision|0
765210|NCT00527982|2436996|P1|Overall Study|Physician Decision|1
765211|NCT00528021|2437006|P4|Overall Study|Lack of Efficacy|9
765212|NCT00528021|2437007|P3|Overall Study|Lack of Efficacy|7
765213|NCT00528021|2437008|P2|Overall Study|Lack of Efficacy|13
765214|NCT00528021|2437009|P1|Overall Study|Lack of Efficacy|17
765215|NCT00521053|2437019|P1|Observation Phase|Physician Decision|1
765216|NCT00521053|2437019|P1|Observation Phase|Other non-study melanoma treatment|1
765217|NCT00521053|2437019|P1|Observation Phase|Adverse Event|1
765218|NCT00521053|2437019|P1|Observation Phase|Death|2
765219|NCT00521053|2437019|P1|Observation Phase|Additional PV-10 via alternate protocol|8
765220|NCT00521053|2437019|P1|Observation Phase|Disease Progression|55
765221|NCT00521079|2437031|P2|Overall Study|Withdrawal by Subject|3
765222|NCT00521079|2437032|P1|Overall Study|Withdrawal by Subject|5
765223|NCT00521079|2437031|P2|Overall Study|Lost to Follow-up|1
765224|NCT00521079|2437032|P1|Overall Study|Lost to Follow-up|2
765225|NCT00521079|2437031|P2|Overall Study|Adverse Event|1
765226|NCT00521079|2437032|P1|Overall Study|Adverse Event|7
765227|NCT00521144|2437047|P5|Overall Study|Progressive Disease|6
765228|NCT00521144|2437048|P4|Overall Study|Progressive Disease|0
765229|NCT00521144|2437049|P3|Overall Study|Progressive Disease|2
765230|NCT00521144|2437050|P2|Overall Study|Progressive Disease|2
765231|NCT00521144|2437051|P1|Overall Study|Progressive Disease|4
765232|NCT00521144|2437047|P5|Overall Study|Adverse Event|1
765233|NCT00521144|2437048|P4|Overall Study|Adverse Event|0
765234|NCT00521144|2437049|P3|Overall Study|Adverse Event|0
765235|NCT00521144|2437050|P2|Overall Study|Adverse Event|1
765236|NCT00521144|2437051|P1|Overall Study|Adverse Event|0
765237|NCT00521144|2437047|P5|Overall Study|Not Treated|0
765238|NCT00521144|2437048|P4|Overall Study|Not Treated|1
765239|NCT00521144|2437049|P3|Overall Study|Not Treated|0
765240|NCT00521144|2437050|P2|Overall Study|Not Treated|0
765241|NCT00521144|2437051|P1|Overall Study|Not Treated|0
765242|NCT00528112|2437065|P2|Extension Phase|Protocol Violation|2
765243|NCT00528112|2437066|P1|Extension Phase|Protocol Violation|0
765244|NCT00528112|2437065|P2|Extension Phase|Adverse Event|36
765245|NCT00528112|2437066|P1|Extension Phase|Adverse Event|0
765246|NCT00528112|2437065|P2|Extension Phase|Death|1
765247|NCT00528112|2437066|P1|Extension Phase|Death|0
765248|NCT00528112|2437065|P2|Extension Phase|Lost to Follow-up|12
765249|NCT00528112|2437066|P1|Extension Phase|Lost to Follow-up|0
765250|NCT00528112|2437065|P2|Extension Phase|Pregnancy|3
765251|NCT00528112|2437066|P1|Extension Phase|Pregnancy|0
765252|NCT00528112|2437065|P2|Extension Phase|Other reasons|100
765253|NCT00528112|2437066|P1|Extension Phase|Other reasons|0
765254|NCT00528112|2437065|P2|Extension Phase|Withdrawal by Subject|3
765255|NCT00528112|2437066|P1|Extension Phase|Withdrawal by Subject|0
765256|NCT00528112|2437065|P2|Treatment up to 3 Years|Other reasons|186
765257|NCT00528112|2437066|P1|Treatment up to 3 Years|Other reasons|186
765258|NCT00528112|2437065|P2|Treatment up to 3 Years|Pregnancy|10
765259|NCT00528112|2437066|P1|Treatment up to 3 Years|Pregnancy|9
765260|NCT00528112|2437065|P2|Treatment up to 3 Years|Lost to Follow-up|61
765261|NCT00528112|2437066|P1|Treatment up to 3 Years|Lost to Follow-up|63
765262|NCT00528112|2437065|P2|Treatment up to 3 Years|Death|1
765263|NCT00528112|2437066|P1|Treatment up to 3 Years|Death|0
765264|NCT00528112|2437065|P2|Treatment up to 3 Years|Protocol Violation|16
765265|NCT00528112|2437066|P1|Treatment up to 3 Years|Protocol Violation|16
765266|NCT00528112|2437065|P2|Treatment up to 3 Years|Withdrawal by Subject|31
765267|NCT00528112|2437066|P1|Treatment up to 3 Years|Withdrawal by Subject|26
765268|NCT00528112|2437065|P2|Treatment up to 3 Years|Adverse Event|278
765269|NCT00528112|2437066|P1|Treatment up to 3 Years|Adverse Event|313
765270|NCT00528931|2437138|P1|Overall Study|Lost to Follow-up|1
765271|NCT00528957|2437148|P2|Second Extension (Week 144 to Week 240)|Poor adherence|0
765272|NCT00528957|2437149|P1|Second Extension (Week 144 to Week 240)|Poor adherence|1
765273|NCT00528957|2437148|P2|Second Extension (Week 144 to Week 240)|Lack of Efficacy|0
765274|NCT00528957|2437149|P1|Second Extension (Week 144 to Week 240)|Lack of Efficacy|1
765275|NCT00528957|2437148|P2|Second Extension (Week 144 to Week 240)|Adverse Event|2
765276|NCT00528957|2437149|P1|Second Extension (Week 144 to Week 240)|Adverse Event|2
765277|NCT00528957|2437148|P2|Second Extension (Week 144 to Week 240)|Physician Decision|0
765278|NCT00528957|2437149|P1|Second Extension (Week 144 to Week 240)|Physician Decision|2
765279|NCT00528957|2437148|P2|Second Extension (Week 144 to Week 240)|Study Ongoing|38
765280|NCT00528957|2437149|P1|Second Extension (Week 144 to Week 240)|Study Ongoing|28
765281|NCT00528957|2437148|P2|First Extension (Week 48 to Week 144)|Adverse Event|0
765282|NCT00528957|2437149|P1|First Extension (Week 48 to Week 144)|Adverse Event|1
765283|NCT00528957|2437148|P2|First Extension (Week 48 to Week 144)|Withdrawal by Subject|1
765284|NCT00528957|2437149|P1|First Extension (Week 48 to Week 144)|Withdrawal by Subject|0
765285|NCT00528957|2437148|P2|First Extension (Week 48 to Week 144)|Physician Decision|0
765286|NCT00528957|2437149|P1|First Extension (Week 48 to Week 144)|Physician Decision|2
765287|NCT00528957|2437148|P2|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|0
765288|NCT00528957|2437149|P1|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|1
765289|NCT00528957|2437148|P2|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|0
765290|NCT00528957|2437149|P1|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|1
765291|NCT00528957|2437148|P2|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|1
765292|NCT00528957|2437149|P1|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|2
765294|NCT00529087|2437206|P3|Overall Study|Protocol deviation|2
765295|NCT00529087|2437207|P2|Overall Study|Protocol deviation|1
765296|NCT00529087|2437208|P1|Overall Study|Protocol deviation|1
765297|NCT00529087|2437206|P3|Overall Study|Withdrawal by Subject|3
765298|NCT00529087|2437207|P2|Overall Study|Withdrawal by Subject|3
765299|NCT00529087|2437208|P1|Overall Study|Withdrawal by Subject|3
765300|NCT00529087|2437206|P3|Overall Study|Protocol Violation|6
765301|NCT00529087|2437207|P2|Overall Study|Protocol Violation|7
765302|NCT00529087|2437208|P1|Overall Study|Protocol Violation|8
765303|NCT00529087|2437206|P3|Overall Study|Lost to Follow-up|1
765304|NCT00529087|2437207|P2|Overall Study|Lost to Follow-up|4
765305|NCT00529087|2437208|P1|Overall Study|Lost to Follow-up|6
765306|NCT00529087|2437206|P3|Overall Study|Adverse Event|4
765307|NCT00529087|2437207|P2|Overall Study|Adverse Event|13
765308|NCT00529087|2437208|P1|Overall Study|Adverse Event|10
765309|NCT00529100|2437275|P2|Overall Study|Participant Ineligibility|1
765310|NCT00529100|2437276|P1|Overall Study|Participant Ineligibility|0
765311|NCT00529100|2437275|P2|Overall Study|Withdrawal by Subject|1
765312|NCT00529100|2437276|P1|Overall Study|Withdrawal by Subject|0
765313|NCT00529100|2437275|P2|Overall Study|Progressive Disease|1
765314|NCT00529100|2437276|P1|Overall Study|Progressive Disease|0
765315|NCT00529100|2437275|P2|Overall Study|Protocol Violation|1
765316|NCT00529100|2437276|P1|Overall Study|Protocol Violation|0
765317|NCT00529100|2437275|P2|Overall Study|Adverse Event|5
765318|NCT00529100|2437276|P1|Overall Study|Adverse Event|0
765319|NCT00529152|2437307|P1|Overall Study|Lost to Follow-up|1
765320|NCT00529152|2437307|P1|Overall Study|Withdrawal by Subject|2
765321|NCT00529152|2437307|P1|Overall Study|Adverse Event|2
765322|NCT00529217|2437342|P1|Overall Study|Unable to adhere to study schedule|2
765323|NCT00529217|2437342|P1|Overall Study|Lack of Efficacy|2
765324|NCT00529243|2437347|P1|Overall Study|Relocated|1
765325|NCT00529243|2437347|P1|Overall Study|Death|1
765326|NCT00529243|2437347|P1|Overall Study|Adverse Event|1
765327|NCT00529308|2437369|P2|Overall Study|Withdrawal by Subject|1
765328|NCT00529308|2437370|P1|Overall Study|Withdrawal by Subject|1
765329|NCT00529399|2437387|P3|Overall Study|Non-compliant|0
765330|NCT00529399|2437388|P2|Overall Study|Non-compliant|1
765331|NCT00529399|2437389|P1|Overall Study|Non-compliant|0
765332|NCT00529399|2437387|P3|Overall Study|Withdrawal by Subject|1
765333|NCT00529399|2437388|P2|Overall Study|Withdrawal by Subject|0
765334|NCT00529399|2437389|P1|Overall Study|Withdrawal by Subject|1
765335|NCT00529399|2437387|P3|Overall Study|Lost to Follow-up|1
765336|NCT00529399|2437388|P2|Overall Study|Lost to Follow-up|0
765337|NCT00529399|2437389|P1|Overall Study|Lost to Follow-up|1
765338|NCT00529451|2437401|P4|Overall Study|Administrative problems|2
765339|NCT00529451|2437402|P3|Overall Study|Administrative problems|0
765340|NCT00529451|2437403|P2|Overall Study|Administrative problems|1
765341|NCT00529451|2437404|P1|Overall Study|Administrative problems|1
765342|NCT00529451|2437401|P4|Overall Study|Protocol deviation|1
765343|NCT00529451|2437402|P3|Overall Study|Protocol deviation|4
765344|NCT00529451|2437403|P2|Overall Study|Protocol deviation|1
765345|NCT00529451|2437404|P1|Overall Study|Protocol deviation|1
765346|NCT00529451|2437401|P4|Overall Study|Lost to Follow-up|4
765347|NCT00529451|2437402|P3|Overall Study|Lost to Follow-up|4
765348|NCT00529451|2437403|P2|Overall Study|Lost to Follow-up|7
765349|NCT00529451|2437404|P1|Overall Study|Lost to Follow-up|4
765350|NCT00529451|2437401|P4|Overall Study|Unsatisfactory therapeutic response|4
765351|NCT00529451|2437402|P3|Overall Study|Unsatisfactory therapeutic response|5
765352|NCT00529451|2437403|P2|Overall Study|Unsatisfactory therapeutic response|2
765353|NCT00529451|2437404|P1|Overall Study|Unsatisfactory therapeutic response|6
765354|NCT00529451|2437401|P4|Overall Study|Adverse Event|8
765355|NCT00529451|2437402|P3|Overall Study|Adverse Event|14
765356|NCT00529451|2437403|P2|Overall Study|Adverse Event|16
765357|NCT00529451|2437404|P1|Overall Study|Adverse Event|9
765358|NCT00529451|2437401|P4|Overall Study|Subject withdrew consent|12
765359|NCT00529451|2437402|P3|Overall Study|Subject withdrew consent|13
765360|NCT00529451|2437403|P2|Overall Study|Subject withdrew consent|21
765361|NCT00529451|2437404|P1|Overall Study|Subject withdrew consent|16
765362|NCT00529516|2437444|P3|Overall Study|Lost to Follow-up|1
765363|NCT00529516|2437445|P2|Overall Study|Lost to Follow-up|0
765364|NCT00529516|2437446|P1|Overall Study|Lost to Follow-up|0
765365|NCT00529516|2437444|P3|Overall Study|Withdrawal by Subject|0
765366|NCT00529516|2437445|P2|Overall Study|Withdrawal by Subject|1
765367|NCT00529516|2437446|P1|Overall Study|Withdrawal by Subject|1
765368|NCT00529516|2437444|P3|Overall Study|Adverse Event|0
765369|NCT00529516|2437445|P2|Overall Study|Adverse Event|1
765370|NCT00529516|2437446|P1|Overall Study|Adverse Event|2
765371|NCT00529529|2437517|P3|Overall Study|Administrative problems|3
765372|NCT00529529|2437518|P2|Overall Study|Administrative problems|0
765373|NCT00529529|2437519|P1|Overall Study|Administrative problems|1
765374|NCT00529529|2437517|P3|Overall Study|Abnormal test procedure result(s)|0
765375|NCT00529529|2437518|P2|Overall Study|Abnormal test procedure result(s)|0
765376|NCT00529529|2437519|P1|Overall Study|Abnormal test procedure result(s)|1
765377|NCT00529529|2437517|P3|Overall Study|Death|0
765378|NCT00529529|2437518|P2|Overall Study|Death|0
765379|NCT00529529|2437519|P1|Overall Study|Death|2
765380|NCT00529529|2437517|P3|Overall Study|Unsatisfactory therapeutic effect|2
765381|NCT00529529|2437518|P2|Overall Study|Unsatisfactory therapeutic effect|2
765382|NCT00529529|2437519|P1|Overall Study|Unsatisfactory therapeutic effect|2
765383|NCT00529529|2437517|P3|Overall Study|Lost to Follow-up|1
765384|NCT00529529|2437518|P2|Overall Study|Lost to Follow-up|3
765385|NCT00529529|2437519|P1|Overall Study|Lost to Follow-up|5
765386|NCT00529529|2437517|P3|Overall Study|Protocol deviation|5
765387|NCT00529529|2437518|P2|Overall Study|Protocol deviation|12
765388|NCT00529529|2437519|P1|Overall Study|Protocol deviation|8
765389|NCT00529529|2437517|P3|Overall Study|Subject withdrew consent|12
765390|NCT00529529|2437518|P2|Overall Study|Subject withdrew consent|9
765391|NCT00529529|2437519|P1|Overall Study|Subject withdrew consent|12
765392|NCT00529529|2437517|P3|Overall Study|Adverse Event|8
765393|NCT00529529|2437518|P2|Overall Study|Adverse Event|17
765394|NCT00529529|2437519|P1|Overall Study|Adverse Event|12
765395|NCT00529542|2437577|P2|Overall Study|Lost to Follow-up|1
765396|NCT00529542|2437578|P1|Overall Study|Lost to Follow-up|0
765397|NCT00529542|2437577|P2|Overall Study|Withdrawal by Subject|0
765398|NCT00529542|2437578|P1|Overall Study|Withdrawal by Subject|1
765399|NCT00529568|2437633|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
765400|NCT00529568|2437634|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
765401|NCT00529568|2437635|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
765402|NCT00529568|2437633|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
765403|NCT00529568|2437634|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
765404|NCT00529568|2437635|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
765405|NCT00529568|2437633|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
765406|NCT00529568|2437634|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
765407|NCT00529568|2437635|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
765408|NCT00529568|2437633|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
765409|NCT00529568|2437634|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
765410|NCT00529568|2437635|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
765411|NCT00529568|2437633|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
765412|NCT00529568|2437634|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
765413|NCT00529568|2437635|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
765414|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
765415|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
765416|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
765417|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
765418|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
765419|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
765420|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
765421|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
765422|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
765423|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
765424|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
765425|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
765426|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
765427|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
765428|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
765429|NCT00529568|2437633|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
765430|NCT00529568|2437634|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
765431|NCT00529568|2437635|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
765432|NCT00529633|2437685|P2|Overall Study|Withdrawal by Subject|1
765433|NCT00529633|2437686|P1|Overall Study|Withdrawal by Subject|1
765434|NCT00529659|2437698|P2|Overall Study|Withdrawal by Subject|6
765435|NCT00529659|2437699|P1|Overall Study|Withdrawal by Subject|1
765436|NCT00529659|2437698|P2|Overall Study|Protocol Violation|6
765437|NCT00529659|2437699|P1|Overall Study|Protocol Violation|2
765438|NCT00529659|2437698|P2|Overall Study|Physician Decision|2
765439|NCT00529659|2437699|P1|Overall Study|Physician Decision|0
765440|NCT00529659|2437698|P2|Overall Study|Lost to Follow-up|2
765441|NCT00529659|2437699|P1|Overall Study|Lost to Follow-up|0
765442|NCT00529659|2437698|P2|Overall Study|Adverse Event|7
765443|NCT00529659|2437699|P1|Overall Study|Adverse Event|8
765444|NCT00529763|2437718|P3|Overall Study|Patient Withdrew Consent|2
765445|NCT00529763|2437719|P2|Overall Study|Patient Withdrew Consent|3
765446|NCT00529763|2437720|P1|Overall Study|Patient Withdrew Consent|2
765447|NCT00529763|2437718|P3|Overall Study|Study Drug Toxicity|1
765448|NCT00529763|2437719|P2|Overall Study|Study Drug Toxicity|6
765449|NCT00529763|2437720|P1|Overall Study|Study Drug Toxicity|1
765450|NCT00529763|2437718|P3|Overall Study|Stem Cell Transplant|0
765451|NCT00529763|2437719|P2|Overall Study|Stem Cell Transplant|3
765452|NCT00529763|2437720|P1|Overall Study|Stem Cell Transplant|0
765453|NCT00529763|2437718|P3|Overall Study|Lost to Follow-up|1
765454|NCT00529763|2437719|P2|Overall Study|Lost to Follow-up|1
765455|NCT00529763|2437720|P1|Overall Study|Lost to Follow-up|0
765456|NCT00529763|2437718|P3|Overall Study|Disease Progression|1
765457|NCT00529763|2437719|P2|Overall Study|Disease Progression|16
765458|NCT00529763|2437720|P1|Overall Study|Disease Progression|6
765459|NCT00529763|2437718|P3|Overall Study|Death|1
765460|NCT00529763|2437719|P2|Overall Study|Death|1
765461|NCT00529763|2437720|P1|Overall Study|Death|0
765462|NCT00529763|2437718|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
765463|NCT00529763|2437719|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
765464|NCT00529763|2437720|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
765465|NCT00529789|2437756|P1|Study Period IV|Lost to Follow-up|3
765466|NCT00529789|2437756|P1|Study Period IV|Lack of Efficacy|1
765467|NCT00529789|2437756|P1|Study Period IV|Adverse Event|1
765468|NCT00529789|2437756|P1|Study Period IV|Parent/Caregiver Decision|1
765469|NCT00529789|2437756|P1|Study Period II/III|Lost to Follow-up|3
765470|NCT00529789|2437756|P1|Study Period II/III|Physician Decision|3
765471|NCT00529789|2437756|P1|Study Period II/III|Protocol Violation|3
765472|NCT00529789|2437756|P1|Study Period II/III|Withdrawal by Subject|1
765473|NCT00529789|2437756|P1|Study Period II/III|Lack of Efficacy|2
765474|NCT00529789|2437756|P1|Study Period II/III|Adverse Event|3
765475|NCT00529789|2437756|P1|Study Period II/III|Parent/Caregiver Decision|9
765476|NCT00530023|2437780|P2|Overall Study|Withdrawal by Subject|1
765477|NCT00530023|2437781|P1|Overall Study|Withdrawal by Subject|0
765478|NCT00530075|2437795|P1|Overall Study|Withdrawal by Subject|1
765479|NCT00530075|2437795|P1|Overall Study|Protocol Violation|1
765480|NCT00530075|2437795|P1|Overall Study|Lack of Efficacy|3
765481|NCT00530075|2437795|P1|Overall Study|Death|1
765482|NCT00530075|2437795|P1|Overall Study|Adverse Event|1
765483|NCT00530088|2437806|P1|Overall Study|Other Not Specified|2
765484|NCT00530088|2437806|P1|Overall Study|Physician Decision|4
765485|NCT00530088|2437806|P1|Overall Study|Disease Progression|4
765486|NCT00530257|2437811|P1|Overall Study|Lost to Follow-up|1
765487|NCT00530270|2437841|P2|Overall Study|Protocol Violation|0
765488|NCT00530270|2437842|P1|Overall Study|Protocol Violation|1
765489|NCT00530335|2437856|P1|Overall Study|Physician Decision|1
765490|NCT00530335|2437856|P1|Overall Study|Withdrawal by Subject|1
765491|NCT00530335|2437856|P1|Overall Study|Protocol Violation|1
765492|NCT00530335|2437856|P1|Overall Study|Adverse Event|3
765493|NCT00530348|2437873|P2|Overall Study|Noncompliance with inclusion criterion 3|1
765494|NCT00530348|2437874|P1|Overall Study|Noncompliance with inclusion criterion 3|0
765495|NCT00530348|2437873|P2|Overall Study|Randomised in error|0
765496|NCT00530348|2437874|P1|Overall Study|Randomised in error|1
765497|NCT00530348|2437873|P2|Overall Study|Withdrawal by Subject|12
765498|NCT00530348|2437874|P1|Overall Study|Withdrawal by Subject|12
765499|NCT00530348|2437873|P2|Overall Study|Pregnancy|0
765500|NCT00530348|2437874|P1|Overall Study|Pregnancy|1
765501|NCT00530348|2437873|P2|Overall Study|Physician Decision|2
765502|NCT00530348|2437874|P1|Overall Study|Physician Decision|1
765503|NCT00530348|2437873|P2|Overall Study|Lost to Follow-up|2
765504|NCT00530348|2437874|P1|Overall Study|Lost to Follow-up|0
765505|NCT00530348|2437873|P2|Overall Study|Lack of Efficacy|0
765506|NCT00530348|2437874|P1|Overall Study|Lack of Efficacy|2
765507|NCT00530348|2437873|P2|Overall Study|Death|1
765508|NCT00530348|2437874|P1|Overall Study|Death|0
765509|NCT00530348|2437873|P2|Overall Study|Adverse Event|1
765510|NCT00530348|2437874|P1|Overall Study|Adverse Event|5
765511|NCT00530439|2437892|P2|Overall Study|Severe malformation/abortion|3
765512|NCT00530439|2437893|P1|Overall Study|Severe malformation/abortion|0
765513|NCT00530439|2437892|P2|Overall Study|Twin pregnancy|2
765514|NCT00530439|2437893|P1|Overall Study|Twin pregnancy|0
765515|NCT00530439|2437892|P2|Overall Study|Misclassification|0
765516|NCT00530439|2437893|P1|Overall Study|Misclassification|2
765517|NCT00530439|2437892|P2|Overall Study|Missed abortion|4
765518|NCT00530439|2437893|P1|Overall Study|Missed abortion|1
765519|NCT00530439|2437892|P2|Overall Study|Withdraw|14
765520|NCT00530439|2437893|P1|Overall Study|Withdraw|18
765521|NCT00530439|2437892|P2|Overall Study|GDM|3
765522|NCT00530439|2437893|P1|Overall Study|GDM|9
765523|NCT00530504|2437899|P1|Overall Study|Exited study due to other reasons|33
765524|NCT00530504|2437899|P1|Overall Study|Withdrawal by Subject|39
765525|NCT00530504|2437899|P1|Overall Study|Lost to Follow-up|26
765526|NCT00530504|2437899|P1|Overall Study|Death|54
765527|NCT00530712|2437907|P1|12 Month Follow-up Visit|Death|9
765528|NCT00530712|2437907|P1|12 Month Follow-up Visit|Lost to Follow-up|7
765529|NCT00530712|2437907|P1|12 Month Follow-up Visit|Missed Visit|3
765530|NCT00530712|2437907|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
765531|NCT00530712|2437907|P1|6 Month Follow-up Visit|Death|2
765532|NCT00530712|2437907|P1|6 Month Follow-up Visit|Lost to Follow-up|3
765533|NCT00530712|2437907|P1|6 Month Follow-up Visit|Missed Visit|3
765534|NCT00530712|2437907|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
765535|NCT00530712|2437907|P1|30 Day Follow-up Visit|Missed Visit|5
765536|NCT00530712|2437907|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
765537|NCT00530777|2437973|P2|Overall Study|Unable to adhere to visit schedule|1
765538|NCT00530777|2437974|P1|Overall Study|Unable to adhere to visit schedule|5
765539|NCT00530777|2437973|P2|Overall Study|Withdrawal by Subject|1
765540|NCT00530777|2437974|P1|Overall Study|Withdrawal by Subject|0
765541|NCT00530777|2437973|P2|Overall Study|Physician Decision|0
765542|NCT00530777|2437974|P1|Overall Study|Physician Decision|1
765543|NCT00530777|2437973|P2|Overall Study|Death|2
765544|NCT00530777|2437974|P1|Overall Study|Death|1
765545|NCT00530777|2437973|P2|Overall Study|Lost to Follow-up|1
765546|NCT00530777|2437974|P1|Overall Study|Lost to Follow-up|0
765547|NCT00530790|2437982|P1|Overall Study|Physician Decision|1
765548|NCT00530790|2437982|P1|Overall Study|Withdrawal by Subject|2
765549|NCT00530790|2437982|P1|Overall Study|Adverse Event|2
765550|NCT00530816|2438005|P3|Overall Study|Withdrawal by Subject|6
765551|NCT00530816|2438006|P2|Overall Study|Withdrawal by Subject|2
765552|NCT00530816|2438007|P1|Overall Study|Withdrawal by Subject|1
765553|NCT00530816|2438005|P3|Overall Study|Other|4
765554|NCT00530816|2438006|P2|Overall Study|Other|3
765555|NCT00530816|2438007|P1|Overall Study|Other|3
765556|NCT00530816|2438005|P3|Overall Study|Adverse Event|7
765557|NCT00530816|2438006|P2|Overall Study|Adverse Event|13
765558|NCT00530816|2438007|P1|Overall Study|Adverse Event|6
765559|NCT00530816|2438005|P3|Overall Study|Progressive Disease|24
765560|NCT00530816|2438006|P2|Overall Study|Progressive Disease|24
765561|NCT00530816|2438007|P1|Overall Study|Progressive Disease|16
765562|NCT00530842|2438035|P2|Period 2|Individual different reasons|0
765563|NCT00530842|2438036|P1|Period 2|Individual different reasons|2
765564|NCT00530842|2438035|P2|Period 2|Withdrawal by Subject|2
765565|NCT00530842|2438036|P1|Period 2|Withdrawal by Subject|1
765566|NCT00530842|2438035|P2|Period 2|Protocol Violation|0
765567|NCT00530842|2438036|P1|Period 2|Protocol Violation|1
765568|NCT00530842|2438035|P2|Period 2|Lost to Follow-up|4
765569|NCT00530842|2438036|P1|Period 2|Lost to Follow-up|0
765570|NCT00530842|2438035|P2|Period 2|Lack of Efficacy|0
765571|NCT00530842|2438036|P1|Period 2|Lack of Efficacy|1
765572|NCT00530842|2438035|P2|Period 2|Adverse Event|3
765573|NCT00530842|2438036|P1|Period 2|Adverse Event|3
765574|NCT00530842|2438035|P2|Period 1|Individual different reasons|3
765575|NCT00530842|2438036|P1|Period 1|Individual different reasons|2
765576|NCT00530842|2438035|P2|Period 1|Withdrawal by Subject|3
765577|NCT00530842|2438036|P1|Period 1|Withdrawal by Subject|2
765578|NCT00530842|2438035|P2|Period 1|Protocol Violation|1
765579|NCT00530842|2438036|P1|Period 1|Protocol Violation|2
765580|NCT00530842|2438035|P2|Period 1|Lack of Efficacy|1
765581|NCT00530842|2438036|P1|Period 1|Lack of Efficacy|1
765582|NCT00530842|2438035|P2|Period 1|Adverse Event|3
765583|NCT00530842|2438036|P1|Period 1|Adverse Event|7
765584|NCT00530842|2438035|P2|Overall Study|Individual different reasons|3
765585|NCT00530842|2438036|P1|Overall Study|Individual different reasons|4
765586|NCT00530842|2438035|P2|Overall Study|Withdrawal by Subject|5
765587|NCT00530842|2438036|P1|Overall Study|Withdrawal by Subject|4
765588|NCT00530842|2438035|P2|Overall Study|Protocol Violation|2
765589|NCT00530842|2438036|P1|Overall Study|Protocol Violation|3
765590|NCT00530842|2438035|P2|Overall Study|Lost to Follow-up|4
765591|NCT00530842|2438036|P1|Overall Study|Lost to Follow-up|0
765592|NCT00530842|2438035|P2|Overall Study|Lack of Efficacy|1
765593|NCT00530842|2438036|P1|Overall Study|Lack of Efficacy|2
765594|NCT00530842|2438035|P2|Overall Study|Adverse Event|6
765595|NCT00530842|2438036|P1|Overall Study|Adverse Event|10
765596|NCT00530855|2438160|P1|Overall Study|Other reason for premature termination|17
765597|NCT00530855|2438160|P1|Overall Study|Lost to Follow-up|9
765598|NCT00530855|2438160|P1|Overall Study|Unsatisfactory compliance of subject|11
765599|NCT00530855|2438160|P1|Overall Study|Protocol Violation|3
765600|NCT00530855|2438160|P1|Overall Study|Non Fatal Non Serious AE|12
765601|NCT00530855|2438160|P1|Overall Study|Non Fatal Serious AE|7
765602|NCT00530855|2438160|P1|Overall Study|Fatal Serious AE|3
765603|NCT00530855|2438160|P1|Overall Study|Withdrawal by Subject|30
765604|NCT00530855|2438160|P1|Overall Study|Lack of Efficacy|20
765605|NCT00530894|2438171|P4|Overall Study|Alive and censored prior to 1 year|0
765606|NCT00530894|2438172|P3|Overall Study|Alive and censored prior to 1 year|0
765607|NCT00530894|2438173|P2|Overall Study|Alive and censored prior to 1 year|0
765608|NCT00530894|2438174|P1|Overall Study|Alive and censored prior to 1 year|2
765609|NCT00530894|2438171|P4|Overall Study|Withdrawal by Subject|5
765610|NCT00530894|2438172|P3|Overall Study|Withdrawal by Subject|0
765611|NCT00530894|2438173|P2|Overall Study|Withdrawal by Subject|23
765612|NCT00530894|2438174|P1|Overall Study|Withdrawal by Subject|1
765613|NCT00530894|2438171|P4|Overall Study|Lost to Follow-up|0
765614|NCT00530894|2438172|P3|Overall Study|Lost to Follow-up|0
765615|NCT00530894|2438173|P2|Overall Study|Lost to Follow-up|3
765616|NCT00530894|2438174|P1|Overall Study|Lost to Follow-up|1
765617|NCT00530894|2438171|P4|Overall Study|Death|89
765618|NCT00530894|2438172|P3|Overall Study|Death|55
765619|NCT00530894|2438173|P2|Overall Study|Death|89
765620|NCT00530894|2438174|P1|Overall Study|Death|84
765621|NCT00530920|2438205|P3|Overall Study|Withdrawal by Subject|1
765622|NCT00530920|2438206|P2|Overall Study|Withdrawal by Subject|0
765623|NCT00530920|2438207|P1|Overall Study|Withdrawal by Subject|0
765624|NCT00530920|2438205|P3|Overall Study|Adverse Event|3
765625|NCT00530920|2438206|P2|Overall Study|Adverse Event|0
765626|NCT00530920|2438207|P1|Overall Study|Adverse Event|0
765627|NCT00530920|2438205|P3|Overall Study|Randomized but not treated|0
765628|NCT00530920|2438206|P2|Overall Study|Randomized but not treated|2
765629|NCT00530920|2438207|P1|Overall Study|Randomized but not treated|0
765630|NCT00530946|2438267|P4|Overall Study|Noncompliance|0
765631|NCT00530946|2438268|P3|Overall Study|Noncompliance|0
765632|NCT00530946|2438269|P2|Overall Study|Noncompliance|0
765633|NCT00530946|2438270|P1|Overall Study|Noncompliance|1
765634|NCT00530946|2438267|P4|Overall Study|Protocol Violation|1
765635|NCT00530946|2438268|P3|Overall Study|Protocol Violation|0
765636|NCT00530946|2438269|P2|Overall Study|Protocol Violation|0
765637|NCT00530946|2438270|P1|Overall Study|Protocol Violation|0
765638|NCT00530946|2438267|P4|Overall Study|Adverse Event|1
765639|NCT00530946|2438268|P3|Overall Study|Adverse Event|1
765640|NCT00530946|2438269|P2|Overall Study|Adverse Event|2
765641|NCT00530946|2438270|P1|Overall Study|Adverse Event|1
765642|NCT00531011|2438322|P2|Overall Study|Physician Decision|3
765643|NCT00531011|2438323|P1|Overall Study|Physician Decision|0
765644|NCT00531011|2438322|P2|Overall Study|Lost to Follow-up|0
765645|NCT00531011|2438323|P1|Overall Study|Lost to Follow-up|1
765646|NCT00531011|2438322|P2|Overall Study|Death|0
765647|NCT00531011|2438323|P1|Overall Study|Death|1
765648|NCT00531011|2438322|P2|Overall Study|Withdrawal by Subject|4
765649|NCT00531011|2438323|P1|Overall Study|Withdrawal by Subject|2
765650|NCT00531050|2438371|P6|Part 2: Period 3|Abnormal test procedure|1
765651|NCT00531050|2438372|P5|Part 2: Period 3|Abnormal test procedure|0
765652|NCT00531050|2438373|P4|Part 2: Period 3|Abnormal test procedure|0
765653|NCT00531050|2438374|P3|Part 2: Period 3|Abnormal test procedure|0
765654|NCT00531050|2438375|P2|Part 2: Period 3|Abnormal test procedure|0
765655|NCT00531050|2438376|P1|Part 2: Period 3|Abnormal test procedure|1
765656|NCT00531050|2438371|P6|Part 2: Period 1|Adverse Event|1
765657|NCT00531050|2438372|P5|Part 2: Period 1|Adverse Event|0
765658|NCT00531050|2438373|P4|Part 2: Period 1|Adverse Event|0
765659|NCT00531050|2438374|P3|Part 2: Period 1|Adverse Event|0
765660|NCT00531050|2438375|P2|Part 2: Period 1|Adverse Event|0
765661|NCT00531050|2438376|P1|Part 2: Period 1|Adverse Event|0
765662|NCT00531050|2438371|P6|Part 1: Period 3|Adverse Event|0
765663|NCT00531050|2438372|P5|Part 1: Period 3|Adverse Event|0
765664|NCT00531050|2438373|P4|Part 1: Period 3|Adverse Event|0
765665|NCT00531050|2438374|P3|Part 1: Period 3|Adverse Event|0
765666|NCT00531050|2438375|P2|Part 1: Period 3|Adverse Event|0
765667|NCT00531050|2438376|P1|Part 1: Period 3|Adverse Event|1
765668|NCT00531050|2438371|P6|Part 1: Period 1|Protocol Deviation|0
765669|NCT00531050|2438372|P5|Part 1: Period 1|Protocol Deviation|0
765670|NCT00531050|2438373|P4|Part 1: Period 1|Protocol Deviation|1
765671|NCT00531050|2438374|P3|Part 1: Period 1|Protocol Deviation|0
765672|NCT00531050|2438375|P2|Part 1: Period 1|Protocol Deviation|0
765673|NCT00531050|2438376|P1|Part 1: Period 1|Protocol Deviation|0
765674|NCT00531050|2438371|P6|Part 1: Period 1|Adverse Event|0
765675|NCT00531050|2438372|P5|Part 1: Period 1|Adverse Event|0
765676|NCT00531050|2438373|P4|Part 1: Period 1|Adverse Event|0
765677|NCT00531050|2438374|P3|Part 1: Period 1|Adverse Event|0
765678|NCT00531050|2438375|P2|Part 1: Period 1|Adverse Event|1
765679|NCT00531050|2438376|P1|Part 1: Period 1|Adverse Event|0
765680|NCT00531206|2438403|P1|Overall Study|including non-related adverse events|8
765681|NCT00531206|2438403|P1|Overall Study|Lost to Follow-up|5
765682|NCT00531206|2438403|P1|Overall Study|Lack of Efficacy|2
765683|NCT00531206|2438403|P1|Overall Study|Adverse Event related|5
765684|NCT00531284|2438444|P17|Overall Study|Other|0
765685|NCT00531284|2438445|P16|Overall Study|Other|0
765686|NCT00531284|2438446|P15|Overall Study|Other|1
765687|NCT00531284|2438447|P14|Overall Study|Other|0
765688|NCT00531284|2438448|P13|Overall Study|Other|0
765689|NCT00531284|2438449|P12|Overall Study|Other|2
765690|NCT00531284|2438450|P11|Overall Study|Other|0
765691|NCT00531284|2438451|P10|Overall Study|Other|1
765692|NCT00531284|2438452|P9|Overall Study|Other|2
765693|NCT00531284|2438453|P8|Overall Study|Other|0
765694|NCT00531284|2438454|P7|Overall Study|Other|0
765695|NCT00531284|2438455|P6|Overall Study|Other|1
765696|NCT00531284|2438456|P5|Overall Study|Other|2
765697|NCT00531284|2438457|P4|Overall Study|Other|10
765698|NCT00531284|2438458|P3|Overall Study|Other|0
765699|NCT00531284|2438459|P2|Overall Study|Other|0
765700|NCT00531284|2438460|P1|Overall Study|Other|1
765701|NCT00531284|2438444|P17|Overall Study|Withdrawal by Subject|1
765702|NCT00531284|2438445|P16|Overall Study|Withdrawal by Subject|1
765703|NCT00531284|2438446|P15|Overall Study|Withdrawal by Subject|0
765704|NCT00531284|2438447|P14|Overall Study|Withdrawal by Subject|1
765705|NCT00531284|2438448|P13|Overall Study|Withdrawal by Subject|0
765706|NCT00531284|2438449|P12|Overall Study|Withdrawal by Subject|3
765707|NCT00531284|2438450|P11|Overall Study|Withdrawal by Subject|0
765708|NCT00531284|2438451|P10|Overall Study|Withdrawal by Subject|0
765709|NCT00531284|2438452|P9|Overall Study|Withdrawal by Subject|0
765710|NCT00531284|2438453|P8|Overall Study|Withdrawal by Subject|0
765711|NCT00531284|2438454|P7|Overall Study|Withdrawal by Subject|0
765712|NCT00531284|2438455|P6|Overall Study|Withdrawal by Subject|0
765713|NCT00531284|2438456|P5|Overall Study|Withdrawal by Subject|0
765714|NCT00531284|2438457|P4|Overall Study|Withdrawal by Subject|4
765715|NCT00531284|2438458|P3|Overall Study|Withdrawal by Subject|0
765716|NCT00531284|2438459|P2|Overall Study|Withdrawal by Subject|0
765717|NCT00531284|2438460|P1|Overall Study|Withdrawal by Subject|1
765718|NCT00531284|2438444|P17|Overall Study|Adverse Event|2
765719|NCT00531284|2438445|P16|Overall Study|Adverse Event|0
765720|NCT00531284|2438446|P15|Overall Study|Adverse Event|1
765721|NCT00531284|2438447|P14|Overall Study|Adverse Event|1
765722|NCT00531284|2438448|P13|Overall Study|Adverse Event|0
765723|NCT00531284|2438449|P12|Overall Study|Adverse Event|5
765724|NCT00531284|2438450|P11|Overall Study|Adverse Event|0
765725|NCT00531284|2438451|P10|Overall Study|Adverse Event|0
765726|NCT00531284|2438452|P9|Overall Study|Adverse Event|3
765727|NCT00531284|2438453|P8|Overall Study|Adverse Event|2
765728|NCT00531284|2438454|P7|Overall Study|Adverse Event|3
765729|NCT00531284|2438455|P6|Overall Study|Adverse Event|2
765730|NCT00531284|2438456|P5|Overall Study|Adverse Event|0
765731|NCT00531284|2438457|P4|Overall Study|Adverse Event|7
765732|NCT00531284|2438458|P3|Overall Study|Adverse Event|1
765733|NCT00531284|2438459|P2|Overall Study|Adverse Event|1
765734|NCT00531284|2438460|P1|Overall Study|Adverse Event|0
765735|NCT00531284|2438444|P17|Overall Study|Progressive Disease|5
765736|NCT00531284|2438445|P16|Overall Study|Progressive Disease|11
765737|NCT00531284|2438446|P15|Overall Study|Progressive Disease|2
765738|NCT00531284|2438447|P14|Overall Study|Progressive Disease|1
765739|NCT00531284|2438448|P13|Overall Study|Progressive Disease|2
765740|NCT00531284|2438449|P12|Overall Study|Progressive Disease|14
765741|NCT00531284|2438450|P11|Overall Study|Progressive Disease|3
765742|NCT00531284|2438451|P10|Overall Study|Progressive Disease|3
765743|NCT00531284|2438452|P9|Overall Study|Progressive Disease|6
765744|NCT00531284|2438453|P8|Overall Study|Progressive Disease|8
765745|NCT00531284|2438454|P7|Overall Study|Progressive Disease|3
765746|NCT00531284|2438455|P6|Overall Study|Progressive Disease|4
765747|NCT00531284|2438456|P5|Overall Study|Progressive Disease|4
765748|NCT00531284|2438457|P4|Overall Study|Progressive Disease|42
765749|NCT00531284|2438458|P3|Overall Study|Progressive Disease|5
765750|NCT00531284|2438459|P2|Overall Study|Progressive Disease|3
765751|NCT00531284|2438460|P1|Overall Study|Progressive Disease|1
765752|NCT00531427|2438612|P2|Overall Study|Administrative|9
765753|NCT00531427|2438613|P1|Overall Study|Administrative|4
765754|NCT00531427|2438612|P2|Overall Study|Lack of Efficacy|39
765755|NCT00531427|2438613|P1|Overall Study|Lack of Efficacy|14
765756|NCT00531427|2438612|P2|Overall Study|Lost to Follow-up|3
765757|NCT00531427|2438613|P1|Overall Study|Lost to Follow-up|4
765758|NCT00531427|2438612|P2|Overall Study|Adverse Event|30
765759|NCT00531427|2438613|P1|Overall Study|Adverse Event|44
765760|NCT00531427|2438612|P2|Overall Study|Withdrawal by Subject|13
765761|NCT00531427|2438613|P1|Overall Study|Withdrawal by Subject|7
765762|NCT00524134|2438624|P1|Overall Study|Physician Decision|1
765763|NCT00524134|2438624|P1|Overall Study|Withdrawal by Subject|1
765764|NCT00524303|2438654|P3|Overall Study|Completed 5 years|1
765765|NCT00524303|2438655|P2|Overall Study|Completed 5 years|0
765766|NCT00524303|2438656|P1|Overall Study|Completed 5 years|0
765767|NCT00524303|2438654|P3|Overall Study|Physician Decision|1
765768|NCT00524303|2438655|P2|Overall Study|Physician Decision|0
765769|NCT00524303|2438656|P1|Overall Study|Physician Decision|0
765770|NCT00524303|2438654|P3|Overall Study|Sponsor Request|1
765771|NCT00524303|2438655|P2|Overall Study|Sponsor Request|0
765772|NCT00524303|2438656|P1|Overall Study|Sponsor Request|0
765773|NCT00524303|2438654|P3|Overall Study|Disease Recurrence|0
765774|NCT00524303|2438655|P2|Overall Study|Disease Recurrence|1
765775|NCT00524303|2438656|P1|Overall Study|Disease Recurrence|0
765776|NCT00524303|2438654|P3|Overall Study|Disease Progression|1
765777|NCT00524303|2438655|P2|Overall Study|Disease Progression|4
765778|NCT00524303|2438656|P1|Overall Study|Disease Progression|0
765779|NCT00524303|2438654|P3|Overall Study|Worsening Peripheral Neuropathy|0
765780|NCT00524303|2438655|P2|Overall Study|Worsening Peripheral Neuropathy|0
765781|NCT00524303|2438656|P1|Overall Study|Worsening Peripheral Neuropathy|1
765782|NCT00524303|2438654|P3|Overall Study|Did not Complete Study Dosing|0
765783|NCT00524303|2438655|P2|Overall Study|Did not Complete Study Dosing|0
765784|NCT00524303|2438656|P1|Overall Study|Did not Complete Study Dosing|1
765785|NCT00524303|2438654|P3|Overall Study|Adverse Event|3
765786|NCT00524303|2438655|P2|Overall Study|Adverse Event|2
765787|NCT00524303|2438656|P1|Overall Study|Adverse Event|1
765788|NCT00524303|2438654|P3|Overall Study|Death|3
765789|NCT00524303|2438655|P2|Overall Study|Death|2
765790|NCT00524303|2438656|P1|Overall Study|Death|0
765791|NCT00524303|2438654|P3|Overall Study|Withdrawal by Subject|4
765792|NCT00524303|2438655|P2|Overall Study|Withdrawal by Subject|0
765793|NCT00524303|2438656|P1|Overall Study|Withdrawal by Subject|3
765794|NCT00524303|2438654|P3|Overall Study|Protocol Violation|1
765795|NCT00524303|2438655|P2|Overall Study|Protocol Violation|1
765796|NCT00524303|2438656|P1|Overall Study|Protocol Violation|0
765797|NCT00524303|2438654|P3|Overall Study|Lost to Follow-up|3
765798|NCT00524303|2438655|P2|Overall Study|Lost to Follow-up|0
765799|NCT00524303|2438656|P1|Overall Study|Lost to Follow-up|6
765800|NCT00524316|2438684|P1|Overall Study|Disease Progression|7
765801|NCT00524316|2438684|P1|Overall Study|Adverse Event|7
765802|NCT00524316|2438684|P1|Overall Study|Withdrawal by Subject|2
765803|NCT00524368|2438700|P2|Overall Study|Unspecified|2
765804|NCT00524368|2438701|P1|Overall Study|Unspecified|3
765805|NCT00524368|2438700|P2|Overall Study|Ineligible to Continue the study|5
765806|NCT00524368|2438701|P1|Overall Study|Ineligible to Continue the study|2
765807|NCT00524368|2438700|P2|Overall Study|Sponsor's Decision|0
765808|NCT00524368|2438701|P1|Overall Study|Sponsor's Decision|2
765809|NCT00524368|2438700|P2|Overall Study|Reached a Virologic Endpoint|2
765810|NCT00524368|2438701|P1|Overall Study|Reached a Virologic Endpoint|3
765811|NCT00524368|2438700|P2|Overall Study|Non-compliant|9
765812|NCT00524368|2438701|P1|Overall Study|Non-compliant|8
765813|NCT00524368|2438700|P2|Overall Study|Withdrawal by Subject|5
765814|NCT00524368|2438701|P1|Overall Study|Withdrawal by Subject|4
765815|NCT00524368|2438700|P2|Overall Study|Lost to Follow-up|13
765816|NCT00524368|2438701|P1|Overall Study|Lost to Follow-up|9
765817|NCT00524368|2438700|P2|Overall Study|Adverse Event|12
765818|NCT00524368|2438701|P1|Overall Study|Adverse Event|10
765819|NCT00524420|2438735|P2|Overall Study|Lack of Efficacy|0
765820|NCT00524420|2438736|P1|Overall Study|Lack of Efficacy|1
765821|NCT00524459|2438748|P1|Overall Study|Other|1
765822|NCT00524459|2438748|P1|Overall Study|Withdrawal by Subject|1
765823|NCT00524485|2438756|P1|Overall Study|Withdrawal by Subject|5
891393|NCT01802632|2827733|P6|Overall Study|Other (not specified)|1
765826|NCT00524680|2438820|P4|Overall Study|Withdrawal by Subject|1
765827|NCT00524680|2438821|P3|Overall Study|Withdrawal by Subject|1
765828|NCT00524680|2438822|P2|Overall Study|Withdrawal by Subject|0
765829|NCT00524680|2438823|P1|Overall Study|Withdrawal by Subject|1
765830|NCT00524680|2438820|P4|Overall Study|not specified|3
765831|NCT00524680|2438821|P3|Overall Study|not specified|2
765832|NCT00524680|2438822|P2|Overall Study|not specified|1
765833|NCT00524680|2438823|P1|Overall Study|not specified|0
765834|NCT00524680|2438820|P4|Overall Study|Adverse Event|1
765835|NCT00524680|2438821|P3|Overall Study|Adverse Event|0
765836|NCT00524680|2438822|P2|Overall Study|Adverse Event|0
765837|NCT00524680|2438823|P1|Overall Study|Adverse Event|2
765838|NCT00524680|2438820|P4|Overall Study|progression|1
765839|NCT00524680|2438821|P3|Overall Study|progression|0
765840|NCT00524680|2438822|P2|Overall Study|progression|0
765841|NCT00524680|2438823|P1|Overall Study|progression|0
765842|NCT00524745|2438849|P4|Overall Study|subject withdrawal or lost to follow up|22
765843|NCT00524745|2438850|P3|Overall Study|subject withdrawal or lost to follow up|29
765844|NCT00524745|2438851|P2|Overall Study|subject withdrawal or lost to follow up|13
765845|NCT00524745|2438852|P1|Overall Study|subject withdrawal or lost to follow up|34
765846|NCT00524771|2438876|P2|Overall Study|Protocol Violation|585
765847|NCT00524771|2438877|P1|Overall Study|Protocol Violation|220
765848|NCT00525031|2438894|P2|Overall Study|Disease Progression|1
765849|NCT00525031|2438895|P1|Overall Study|Disease Progression|1
765850|NCT00525148|2438914|P4|Overall Study|Other than stated|3
765851|NCT00525148|2438915|P3|Overall Study|Other than stated|0
765852|NCT00525148|2438916|P2|Overall Study|Other than stated|1
765853|NCT00525148|2438917|P1|Overall Study|Other than stated|2
765854|NCT00525148|2438914|P4|Overall Study|Refused continuation of study medication|1
765855|NCT00525148|2438915|P3|Overall Study|Refused continuation of study medication|0
765856|NCT00525148|2438916|P2|Overall Study|Refused continuation of study medication|2
765857|NCT00525148|2438917|P1|Overall Study|Refused continuation of study medication|0
765858|NCT00525148|2438914|P4|Overall Study|Progressive disease|49
765859|NCT00525148|2438915|P3|Overall Study|Progressive disease|6
765860|NCT00525148|2438916|P2|Overall Study|Progressive disease|30
765861|NCT00525148|2438917|P1|Overall Study|Progressive disease|18
765862|NCT00525148|2438914|P4|Overall Study|Other Adverse Event|8
765863|NCT00525148|2438915|P3|Overall Study|Other Adverse Event|1
765864|NCT00525148|2438916|P2|Overall Study|Other Adverse Event|5
765865|NCT00525148|2438917|P1|Overall Study|Other Adverse Event|3
765866|NCT00525161|2438935|P1|Overall Study|Adverse Event|1
765867|NCT00525265|2438994|P2|Overall Study|Protocol Violation|0
765868|NCT00525265|2438995|P1|Overall Study|Protocol Violation|1
765869|NCT00525499|2439016|P4|Overall Study|Protocol Violation|0
765870|NCT00525499|2439017|P3|Overall Study|Protocol Violation|1
765871|NCT00525499|2439018|P2|Overall Study|Protocol Violation|1
765872|NCT00525499|2439019|P1|Overall Study|Protocol Violation|0
765873|NCT00525499|2439016|P4|Overall Study|Withdrawal by Subject|2
765874|NCT00525499|2439017|P3|Overall Study|Withdrawal by Subject|5
765875|NCT00525499|2439018|P2|Overall Study|Withdrawal by Subject|1
765876|NCT00525499|2439019|P1|Overall Study|Withdrawal by Subject|5
765877|NCT00525499|2439016|P4|Overall Study|Adverse Event|1
765878|NCT00525499|2439017|P3|Overall Study|Adverse Event|0
765879|NCT00525499|2439018|P2|Overall Study|Adverse Event|1
765880|NCT00525499|2439019|P1|Overall Study|Adverse Event|0
765881|NCT00525499|2439016|P4|Overall Study|Lost to Follow-up|4
765882|NCT00525499|2439017|P3|Overall Study|Lost to Follow-up|1
765883|NCT00525499|2439018|P2|Overall Study|Lost to Follow-up|4
765884|NCT00525499|2439019|P1|Overall Study|Lost to Follow-up|2
765885|NCT00525512|2439035|P4|Open-Label Phase|Other reason (not specified)|5
765886|NCT00525512|2439036|P3|Open-Label Phase|Other reason (not specified)|4
765887|NCT00525512|2439037|P2|Open-Label Phase|Other reason (not specified)|0
765888|NCT00525512|2439038|P1|Open-Label Phase|Other reason (not specified)|0
765889|NCT00525512|2439035|P4|Open-Label Phase|Lost to Follow-up|0
765890|NCT00525512|2439036|P3|Open-Label Phase|Lost to Follow-up|1
765891|NCT00525512|2439037|P2|Open-Label Phase|Lost to Follow-up|0
765892|NCT00525512|2439038|P1|Open-Label Phase|Lost to Follow-up|0
765893|NCT00525512|2439035|P4|Open-Label Phase|Adverse Event|0
765894|NCT00525512|2439036|P3|Open-Label Phase|Adverse Event|1
765895|NCT00525512|2439037|P2|Open-Label Phase|Adverse Event|0
765896|NCT00525512|2439038|P1|Open-Label Phase|Adverse Event|0
765897|NCT00525512|2439035|P4|Double-Blind Phase|Other reason (not specified)|0
765898|NCT00525512|2439036|P3|Double-Blind Phase|Other reason (not specified)|0
765899|NCT00525512|2439037|P2|Double-Blind Phase|Other reason (not specified)|13
765900|NCT00525512|2439038|P1|Double-Blind Phase|Other reason (not specified)|12
765901|NCT00525512|2439035|P4|Double-Blind Phase|Lack of Efficacy|0
765902|NCT00525512|2439036|P3|Double-Blind Phase|Lack of Efficacy|0
765903|NCT00525512|2439037|P2|Double-Blind Phase|Lack of Efficacy|5
765904|NCT00525512|2439038|P1|Double-Blind Phase|Lack of Efficacy|13
765905|NCT00525512|2439035|P4|Double-Blind Phase|Withdrawal by Subject|0
765906|NCT00525512|2439036|P3|Double-Blind Phase|Withdrawal by Subject|0
765907|NCT00525512|2439037|P2|Double-Blind Phase|Withdrawal by Subject|12
765908|NCT00525512|2439038|P1|Double-Blind Phase|Withdrawal by Subject|17
765909|NCT00525512|2439035|P4|Double-Blind Phase|Lost to Follow-up|0
765910|NCT00525512|2439036|P3|Double-Blind Phase|Lost to Follow-up|0
765911|NCT00525512|2439037|P2|Double-Blind Phase|Lost to Follow-up|7
765912|NCT00525512|2439038|P1|Double-Blind Phase|Lost to Follow-up|3
765913|NCT00525512|2439035|P4|Double-Blind Phase|Protocol Violation|0
765914|NCT00525512|2439036|P3|Double-Blind Phase|Protocol Violation|0
765915|NCT00525512|2439037|P2|Double-Blind Phase|Protocol Violation|1
765916|NCT00525512|2439038|P1|Double-Blind Phase|Protocol Violation|3
765917|NCT00525512|2439035|P4|Double-Blind Phase|Adverse Event|0
765918|NCT00525512|2439036|P3|Double-Blind Phase|Adverse Event|0
765919|NCT00525512|2439037|P2|Double-Blind Phase|Adverse Event|28
765920|NCT00525512|2439038|P1|Double-Blind Phase|Adverse Event|48
765921|NCT00531479|2439189|P2|Overall Study|Did not receive treatment|3
765922|NCT00531479|2439190|P1|Overall Study|Did not receive treatment|2
765923|NCT00531479|2439189|P2|Overall Study|Withdrawal by Subject|6
765924|NCT00531479|2439190|P1|Overall Study|Withdrawal by Subject|6
765925|NCT00531479|2439189|P2|Overall Study|Unspecified|1
765926|NCT00531479|2439190|P1|Overall Study|Unspecified|0
765927|NCT00531479|2439189|P2|Overall Study|Lost to Follow-up|2
765928|NCT00531479|2439190|P1|Overall Study|Lost to Follow-up|0
765929|NCT00531479|2439189|P2|Overall Study|Death|71
765930|NCT00531479|2439190|P1|Overall Study|Death|68
765931|NCT00531752|2439244|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
765932|NCT00531752|2439245|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
765933|NCT00531752|2439246|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
765934|NCT00531752|2439247|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
765935|NCT00531752|2439244|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
765936|NCT00531752|2439245|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
765937|NCT00531752|2439246|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
765938|NCT00531752|2439247|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
765939|NCT00531752|2439244|P4|Second Double-blind Intervention Period|unspecified|0
765940|NCT00531752|2439245|P3|Second Double-blind Intervention Period|unspecified|0
765941|NCT00531752|2439246|P2|Second Double-blind Intervention Period|unspecified|1
765942|NCT00531752|2439247|P1|Second Double-blind Intervention Period|unspecified|1
765943|NCT00531752|2439244|P4|Second Double-blind Intervention Period|Adverse Event|0
765944|NCT00531752|2439245|P3|Second Double-blind Intervention Period|Adverse Event|0
765945|NCT00531752|2439246|P2|Second Double-blind Intervention Period|Adverse Event|1
765946|NCT00531752|2439247|P1|Second Double-blind Intervention Period|Adverse Event|1
765947|NCT00531752|2439244|P4|First Double-blind Intervention Period|Randomized but not treated|0
765948|NCT00531752|2439245|P3|First Double-blind Intervention Period|Randomized but not treated|0
765949|NCT00531752|2439246|P2|First Double-blind Intervention Period|Randomized but not treated|0
765950|NCT00531752|2439247|P1|First Double-blind Intervention Period|Randomized but not treated|1
765951|NCT00531752|2439244|P4|First Double-blind Intervention Period|Lost to Follow-up|1
765952|NCT00531752|2439245|P3|First Double-blind Intervention Period|Lost to Follow-up|1
765953|NCT00531752|2439246|P2|First Double-blind Intervention Period|Lost to Follow-up|0
765954|NCT00531752|2439247|P1|First Double-blind Intervention Period|Lost to Follow-up|0
765955|NCT00531752|2439244|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
765956|NCT00531752|2439245|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
765957|NCT00531752|2439246|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
765958|NCT00531752|2439247|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
765959|NCT00531752|2439244|P4|First Double-blind Intervention Period|unspecified|0
765960|NCT00531752|2439245|P3|First Double-blind Intervention Period|unspecified|4
765961|NCT00531752|2439246|P2|First Double-blind Intervention Period|unspecified|4
765962|NCT00531752|2439247|P1|First Double-blind Intervention Period|unspecified|1
765963|NCT00531752|2439244|P4|First Double-blind Intervention Period|Adverse Event|1
765964|NCT00531752|2439245|P3|First Double-blind Intervention Period|Adverse Event|1
765965|NCT00531752|2439246|P2|First Double-blind Intervention Period|Adverse Event|0
765966|NCT00531752|2439247|P1|First Double-blind Intervention Period|Adverse Event|2
765967|NCT00532129|2439324|P1|Follow-up Period|Unspecified|6
765968|NCT00532129|2439324|P1|Follow-up Period|Lost to Follow-up|1
765969|NCT00532129|2439324|P1|Follow-up Period|Disease progression|57
765970|NCT00532129|2439324|P1|Follow-up Period|Adverse event/Serious adverse event|1
765971|NCT00532129|2439324|P1|Treatment Period|Unspecified|5
765972|NCT00532129|2439324|P1|Treatment Period|Protocol Violation|1
765973|NCT00532129|2439324|P1|Treatment Period|Disease progression|3
765974|NCT00532129|2439324|P1|Treatment Period|Physician Decision|15
765975|NCT00532129|2439324|P1|Treatment Period|Adverse event/Serious adverse event|25
765976|NCT00532155|2439344|P2|Overall Study|Did not receive study medication|6
765977|NCT00532155|2439345|P1|Overall Study|Did not receive study medication|2
765978|NCT00532155|2439344|P2|Overall Study|Study termination stop further treatment|0
765979|NCT00532155|2439345|P1|Overall Study|Study termination stop further treatment|4
765980|NCT00532155|2439344|P2|Overall Study|Study terminated by sponsor|0
765981|NCT00532155|2439345|P1|Overall Study|Study terminated by sponsor|1
765982|NCT00532155|2439344|P2|Overall Study|Study stopped|0
765983|NCT00532155|2439345|P1|Overall Study|Study stopped|1
765984|NCT00532155|2439344|P2|Overall Study|Had brain metastasis, was mis-randomized|0
765985|NCT00532155|2439345|P1|Overall Study|Had brain metastasis, was mis-randomized|1
765986|NCT00532155|2439344|P2|Overall Study|Progressive disease (by incorrect scan)|1
765987|NCT00532155|2439345|P1|Overall Study|Progressive disease (by incorrect scan)|0
765988|NCT00532155|2439344|P2|Overall Study|Promotor ended study|0
765989|NCT00532155|2439345|P1|Overall Study|Promotor ended study|1
765990|NCT00532155|2439344|P2|Overall Study|Occurence of a secondary cancer|1
765991|NCT00532155|2439345|P1|Overall Study|Occurence of a secondary cancer|0
765992|NCT00532155|2439344|P2|Overall Study|Occurence of a second cancer|1
765993|NCT00532155|2439345|P1|Overall Study|Occurence of a second cancer|0
765994|NCT00532155|2439344|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
765995|NCT00532155|2439345|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
765996|NCT00532155|2439344|P2|Overall Study|Moved|0
765997|NCT00532155|2439345|P1|Overall Study|Moved|1
765998|NCT00532155|2439344|P2|Overall Study|Consent withdrawn|7
765999|NCT00532155|2439345|P1|Overall Study|Consent withdrawn|5
766000|NCT00532155|2439344|P2|Overall Study|Withdrawal by Subject|44
766001|NCT00532155|2439345|P1|Overall Study|Withdrawal by Subject|23
766002|NCT00532155|2439344|P2|Overall Study|Physician Decision|15
766003|NCT00532155|2439345|P1|Overall Study|Physician Decision|16
766004|NCT00532155|2439344|P2|Overall Study|Lost to Follow-up|0
766005|NCT00532155|2439345|P1|Overall Study|Lost to Follow-up|2
766006|NCT00532155|2439344|P2|Overall Study|Protocol Violation|3
766007|NCT00532155|2439345|P1|Overall Study|Protocol Violation|1
766008|NCT00532155|2439344|P2|Overall Study|Lack of Efficacy|255
766009|NCT00532155|2439345|P1|Overall Study|Lack of Efficacy|332
766010|NCT00532155|2439344|P2|Overall Study|Adverse Event|123
766011|NCT00532155|2439345|P1|Overall Study|Adverse Event|66
766012|NCT00532259|2439359|P1|Overall Study|Protocol Violation|1
766013|NCT00532259|2439359|P1|Overall Study|Physician Decision|3
766014|NCT00532259|2439359|P1|Overall Study|Lost to Follow-up|3
766015|NCT00532259|2439359|P1|Overall Study|Lack of Efficacy|21
766016|NCT00532259|2439359|P1|Overall Study|Death|1
766017|NCT00532259|2439359|P1|Overall Study|Adverse Event|1
766018|NCT00532259|2439359|P1|Overall Study|Withdrawal by Subject|2
766019|NCT00532298|2439370|P6|Overall Study|Lost to Follow-up|1
766020|NCT00532298|2439371|P5|Overall Study|Lost to Follow-up|0
766021|NCT00532298|2439372|P4|Overall Study|Lost to Follow-up|0
766022|NCT00532298|2439373|P3|Overall Study|Lost to Follow-up|1
766023|NCT00532298|2439374|P2|Overall Study|Lost to Follow-up|1
766024|NCT00532298|2439375|P1|Overall Study|Lost to Follow-up|1
766025|NCT00532298|2439370|P6|Overall Study|Adverse Event|1
766026|NCT00532298|2439371|P5|Overall Study|Adverse Event|1
766027|NCT00532298|2439372|P4|Overall Study|Adverse Event|0
766028|NCT00532298|2439373|P3|Overall Study|Adverse Event|0
766029|NCT00532298|2439374|P2|Overall Study|Adverse Event|0
766030|NCT00532298|2439375|P1|Overall Study|Adverse Event|1
766031|NCT00532441|2439455|P2|Overall Study|Death|0
766032|NCT00532441|2439456|P1|Overall Study|Death|1
766033|NCT00532493|2439471|P2|Overall Study|Contraindicative Medication|0
766034|NCT00532493|2439472|P1|Overall Study|Contraindicative Medication|1
766035|NCT00532493|2439471|P2|Overall Study|Subject Moved Away|1
766036|NCT00532493|2439472|P1|Overall Study|Subject Moved Away|3
766037|NCT00532493|2439471|P2|Overall Study|Protocol Deviation|0
766038|NCT00532493|2439472|P1|Overall Study|Protocol Deviation|1
766039|NCT00532493|2439471|P2|Overall Study|Adverse Event|5
766040|NCT00532493|2439472|P1|Overall Study|Adverse Event|6
766041|NCT00532493|2439471|P2|Overall Study|Physician Decision|6
766042|NCT00532493|2439472|P1|Overall Study|Physician Decision|1
766043|NCT00532493|2439471|P2|Overall Study|Withdrawal by Subject|9
766044|NCT00532493|2439472|P1|Overall Study|Withdrawal by Subject|7
766045|NCT00532493|2439471|P2|Overall Study|Lost to Follow-up|7
766046|NCT00532493|2439472|P1|Overall Study|Lost to Follow-up|10
766047|NCT00532493|2439471|P2|Overall Study|Death|1
766048|NCT00532493|2439472|P1|Overall Study|Death|1
766049|NCT00532779|2439505|P3|Overall Study|Drug noncompliance, moved, other|29
766050|NCT00532779|2439506|P2|Overall Study|Drug noncompliance, moved, other|23
766051|NCT00532779|2439507|P1|Overall Study|Drug noncompliance, moved, other|14
766052|NCT00532779|2439505|P3|Overall Study|Death|0
766053|NCT00532779|2439506|P2|Overall Study|Death|1
766054|NCT00532779|2439507|P1|Overall Study|Death|0
766055|NCT00532779|2439505|P3|Overall Study|Pregnancy|3
766056|NCT00532779|2439506|P2|Overall Study|Pregnancy|5
766057|NCT00532779|2439507|P1|Overall Study|Pregnancy|2
766058|NCT00532779|2439505|P3|Overall Study|Protocol Violation|7
766059|NCT00532779|2439506|P2|Overall Study|Protocol Violation|9
766060|NCT00532779|2439507|P1|Overall Study|Protocol Violation|5
766061|NCT00532779|2439505|P3|Overall Study|Lack of Efficacy|40
766062|NCT00532779|2439506|P2|Overall Study|Lack of Efficacy|12
766063|NCT00532779|2439507|P1|Overall Study|Lack of Efficacy|12
766064|NCT00532779|2439505|P3|Overall Study|Withdrawal by Subject|90
766065|NCT00532779|2439506|P2|Overall Study|Withdrawal by Subject|60
766066|NCT00532779|2439507|P1|Overall Study|Withdrawal by Subject|63
766067|NCT00532779|2439505|P3|Overall Study|Lost to Follow-up|66
766068|NCT00532779|2439506|P2|Overall Study|Lost to Follow-up|65
766069|NCT00532779|2439507|P1|Overall Study|Lost to Follow-up|76
766070|NCT00532779|2439505|P3|Overall Study|Adverse Event|56
766071|NCT00532779|2439506|P2|Overall Study|Adverse Event|112
766072|NCT00532779|2439507|P1|Overall Study|Adverse Event|122
766073|NCT00532883|2439570|P4|Overall Study|Early Study Termination|4
766074|NCT00532883|2439571|P3|Overall Study|Early Study Termination|1
766075|NCT00532883|2439572|P2|Overall Study|Early Study Termination|4
766076|NCT00532883|2439573|P1|Overall Study|Early Study Termination|4
766077|NCT00532883|2439570|P4|Overall Study|Subject was Nonadherent|0
766078|NCT00532883|2439571|P3|Overall Study|Subject was Nonadherent|1
766079|NCT00532883|2439572|P2|Overall Study|Subject was Nonadherent|1
766080|NCT00532883|2439573|P1|Overall Study|Subject was Nonadherent|0
766081|NCT00532883|2439570|P4|Overall Study|Withdrawal by Subject|0
766082|NCT00532883|2439571|P3|Overall Study|Withdrawal by Subject|1
766083|NCT00532883|2439572|P2|Overall Study|Withdrawal by Subject|1
766084|NCT00532883|2439573|P1|Overall Study|Withdrawal by Subject|0
766085|NCT00532883|2439570|P4|Overall Study|Lost to Follow-up|0
766086|NCT00532883|2439571|P3|Overall Study|Lost to Follow-up|1
766087|NCT00532883|2439572|P2|Overall Study|Lost to Follow-up|1
766088|NCT00532883|2439573|P1|Overall Study|Lost to Follow-up|1
766089|NCT00532883|2439570|P4|Overall Study|Adverse Event|1
766090|NCT00532883|2439571|P3|Overall Study|Adverse Event|0
766091|NCT00532883|2439572|P2|Overall Study|Adverse Event|0
766092|NCT00532883|2439573|P1|Overall Study|Adverse Event|1
766093|NCT00532935|2439585|P2|Overall Study|Protocol Specific Criteria|15
766094|NCT00532935|2439586|P1|Overall Study|Protocol Specific Criteria|11
766095|NCT00532935|2439585|P2|Overall Study|Withdrawal by Subject|9
766096|NCT00532935|2439586|P1|Overall Study|Withdrawal by Subject|10
766097|NCT00532935|2439585|P2|Overall Study|Protocol Violation|2
766098|NCT00532935|2439586|P1|Overall Study|Protocol Violation|4
766099|NCT00532935|2439585|P2|Overall Study|Pregnancy|0
766100|NCT00532935|2439586|P1|Overall Study|Pregnancy|1
766101|NCT00532935|2439585|P2|Overall Study|Physician Decision|5
766102|NCT00532935|2439586|P1|Overall Study|Physician Decision|4
766103|NCT00532935|2439585|P2|Overall Study|Lost to Follow-up|6
766104|NCT00532935|2439586|P1|Overall Study|Lost to Follow-up|10
766105|NCT00532935|2439585|P2|Overall Study|Lack of Efficacy|3
766106|NCT00532935|2439586|P1|Overall Study|Lack of Efficacy|0
766107|NCT00532935|2439585|P2|Overall Study|Adverse Event|12
766108|NCT00532935|2439586|P1|Overall Study|Adverse Event|11
766109|NCT00532948|2439603|P3|Overall Study|Failure to return|0
766110|NCT00532948|2439604|P2|Overall Study|Failure to return|1
766111|NCT00532948|2439605|P1|Overall Study|Failure to return|0
766112|NCT00532948|2439603|P3|Overall Study|Violation of selection criteria at entry|0
766113|NCT00532948|2439604|P2|Overall Study|Violation of selection criteria at entry|1
766114|NCT00532948|2439605|P1|Overall Study|Violation of selection criteria at entry|0
766115|NCT00532948|2439603|P3|Overall Study|Death|4
766116|NCT00532948|2439604|P2|Overall Study|Death|3
766117|NCT00532948|2439605|P1|Overall Study|Death|3
766118|NCT00532948|2439603|P3|Overall Study|Protocol Violation|0
766119|NCT00532948|2439604|P2|Overall Study|Protocol Violation|0
766120|NCT00532948|2439605|P1|Overall Study|Protocol Violation|1
766125|NCT00533507|2439683|P1|Overall Study|Withdrawal by Subject|1
766126|NCT00533702|2439711|P2|Overall Study|Found ineligible after randomization|1
766127|NCT00533702|2439712|P1|Overall Study|Found ineligible after randomization|2
766128|NCT00533702|2439711|P2|Overall Study|Withdrawal by Subject|1
766129|NCT00533702|2439712|P1|Overall Study|Withdrawal by Subject|3
766130|NCT00533897|2439739|P8|Long Term Extension (LTE)|not specified|6
766131|NCT00533897|2439740|P7|Long Term Extension (LTE)|not specified|1
766132|NCT00533897|2439741|P6|Long Term Extension (LTE)|not specified|0
766133|NCT00533897|2439742|P5|Long Term Extension (LTE)|not specified|0
766134|NCT00533897|2439743|P4|Long Term Extension (LTE)|not specified|0
766135|NCT00533897|2439744|P3|Long Term Extension (LTE)|not specified|0
766136|NCT00533897|2439745|P2|Long Term Extension (LTE)|not specified|0
766137|NCT00533897|2439746|P1|Long Term Extension (LTE)|not specified|0
766138|NCT00533897|2439739|P8|Long Term Extension (LTE)|Lost to Follow-up|1
766139|NCT00533897|2439740|P7|Long Term Extension (LTE)|Lost to Follow-up|1
766140|NCT00533897|2439741|P6|Long Term Extension (LTE)|Lost to Follow-up|0
766141|NCT00533897|2439742|P5|Long Term Extension (LTE)|Lost to Follow-up|0
766142|NCT00533897|2439743|P4|Long Term Extension (LTE)|Lost to Follow-up|0
766143|NCT00533897|2439744|P3|Long Term Extension (LTE)|Lost to Follow-up|0
766144|NCT00533897|2439745|P2|Long Term Extension (LTE)|Lost to Follow-up|0
766145|NCT00533897|2439746|P1|Long Term Extension (LTE)|Lost to Follow-up|0
766146|NCT00533897|2439739|P8|Long Term Extension (LTE)|Pregnancy|2
766147|NCT00533897|2439740|P7|Long Term Extension (LTE)|Pregnancy|0
766148|NCT00533897|2439741|P6|Long Term Extension (LTE)|Pregnancy|0
766149|NCT00533897|2439742|P5|Long Term Extension (LTE)|Pregnancy|0
766150|NCT00533897|2439743|P4|Long Term Extension (LTE)|Pregnancy|0
766151|NCT00533897|2439744|P3|Long Term Extension (LTE)|Pregnancy|0
766152|NCT00533897|2439745|P2|Long Term Extension (LTE)|Pregnancy|0
766153|NCT00533897|2439746|P1|Long Term Extension (LTE)|Pregnancy|0
766154|NCT00533897|2439739|P8|Long Term Extension (LTE)|Adverse Event|5
766155|NCT00533897|2439740|P7|Long Term Extension (LTE)|Adverse Event|2
766156|NCT00533897|2439741|P6|Long Term Extension (LTE)|Adverse Event|0
766157|NCT00533897|2439742|P5|Long Term Extension (LTE)|Adverse Event|0
766158|NCT00533897|2439743|P4|Long Term Extension (LTE)|Adverse Event|0
766159|NCT00533897|2439744|P3|Long Term Extension (LTE)|Adverse Event|0
766160|NCT00533897|2439745|P2|Long Term Extension (LTE)|Adverse Event|0
766161|NCT00533897|2439746|P1|Long Term Extension (LTE)|Adverse Event|0
766162|NCT00533897|2439739|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
766163|NCT00533897|2439740|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
766164|NCT00533897|2439741|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
766165|NCT00533897|2439742|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
766166|NCT00533897|2439743|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
766167|NCT00533897|2439744|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
766168|NCT00533897|2439745|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
766169|NCT00533897|2439746|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
766170|NCT00533897|2439739|P8|Long Term Extension (LTE)|Lack of Efficacy|3
766171|NCT00533897|2439740|P7|Long Term Extension (LTE)|Lack of Efficacy|5
766172|NCT00533897|2439741|P6|Long Term Extension (LTE)|Lack of Efficacy|0
766173|NCT00533897|2439742|P5|Long Term Extension (LTE)|Lack of Efficacy|0
766174|NCT00533897|2439743|P4|Long Term Extension (LTE)|Lack of Efficacy|0
766175|NCT00533897|2439744|P3|Long Term Extension (LTE)|Lack of Efficacy|0
766176|NCT00533897|2439745|P2|Long Term Extension (LTE)|Lack of Efficacy|0
766177|NCT00533897|2439746|P1|Long Term Extension (LTE)|Lack of Efficacy|0
766178|NCT00533897|2439739|P8|Long Term Extension (LTE)|Death|3
766179|NCT00533897|2439740|P7|Long Term Extension (LTE)|Death|1
766180|NCT00533897|2439741|P6|Long Term Extension (LTE)|Death|0
766181|NCT00533897|2439742|P5|Long Term Extension (LTE)|Death|0
766182|NCT00533897|2439743|P4|Long Term Extension (LTE)|Death|0
766183|NCT00533897|2439744|P3|Long Term Extension (LTE)|Death|0
766184|NCT00533897|2439745|P2|Long Term Extension (LTE)|Death|0
766185|NCT00533897|2439746|P1|Long Term Extension (LTE)|Death|0
766186|NCT00533897|2439739|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
766187|NCT00533897|2439740|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
766188|NCT00533897|2439741|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
766189|NCT00533897|2439742|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
766190|NCT00533897|2439743|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
766191|NCT00533897|2439744|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
766192|NCT00533897|2439745|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
766193|NCT00533897|2439746|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
766194|NCT00533897|2439739|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766195|NCT00533897|2439740|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766196|NCT00533897|2439741|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
766197|NCT00533897|2439742|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766198|NCT00533897|2439743|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766199|NCT00533897|2439744|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766200|NCT00533897|2439745|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766201|NCT00533897|2439746|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
766202|NCT00533897|2439739|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766203|NCT00533897|2439740|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766204|NCT00533897|2439741|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
766205|NCT00533897|2439742|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766206|NCT00533897|2439743|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766207|NCT00533897|2439744|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766208|NCT00533897|2439745|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766209|NCT00533897|2439746|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
766210|NCT00533897|2439739|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766211|NCT00533897|2439740|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766212|NCT00533897|2439741|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766213|NCT00533897|2439742|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766214|NCT00533897|2439743|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766215|NCT00533897|2439744|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
766216|NCT00533897|2439745|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766217|NCT00533897|2439746|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
766218|NCT00533897|2439739|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766219|NCT00533897|2439740|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766220|NCT00533897|2439741|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766221|NCT00533897|2439742|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766222|NCT00533897|2439743|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766223|NCT00533897|2439744|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
766224|NCT00533897|2439745|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
766225|NCT00533897|2439746|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
766226|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766227|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766228|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766229|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766230|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766231|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766232|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
766233|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
766234|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
766235|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
766236|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
766237|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
766238|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
766239|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
766240|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
766241|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
766242|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766243|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766244|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766245|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766246|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766247|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766248|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
766249|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
766250|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
766251|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
766252|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
766253|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
766254|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
766255|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
766256|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
766257|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
766258|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766259|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766260|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766261|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766262|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766263|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766264|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
766265|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
766266|NCT00533897|2439739|P8|Lead-in (LI) Period 1|Adverse Event|0
766267|NCT00533897|2439740|P7|Lead-in (LI) Period 1|Adverse Event|0
766268|NCT00533897|2439741|P6|Lead-in (LI) Period 1|Adverse Event|0
766269|NCT00533897|2439742|P5|Lead-in (LI) Period 1|Adverse Event|0
766270|NCT00533897|2439743|P4|Lead-in (LI) Period 1|Adverse Event|0
766271|NCT00533897|2439744|P3|Lead-in (LI) Period 1|Adverse Event|0
766272|NCT00533897|2439745|P2|Lead-in (LI) Period 1|Adverse Event|0
766273|NCT00533897|2439746|P1|Lead-in (LI) Period 1|Adverse Event|1
766274|NCT00533949|2439888|P4|Overall Study|Withdrawal by Subject|1
766275|NCT00533949|2439889|P3|Overall Study|Withdrawal by Subject|1
766276|NCT00533949|2439890|P2|Overall Study|Withdrawal by Subject|2
766277|NCT00533949|2439891|P1|Overall Study|Withdrawal by Subject|3
766278|NCT00533949|2439888|P4|Overall Study|Protocol Violation|9
766279|NCT00533949|2439889|P3|Overall Study|Protocol Violation|9
766280|NCT00533949|2439890|P2|Overall Study|Protocol Violation|12
766281|NCT00533949|2439891|P1|Overall Study|Protocol Violation|12
766282|NCT00534092|2439932|P2|Overall Study|personal reasons/family concerns|0
766283|NCT00534092|2439933|P1|Overall Study|personal reasons/family concerns|1
766284|NCT00534092|2439932|P2|Overall Study|Lost to Follow-up|0
766285|NCT00534092|2439933|P1|Overall Study|Lost to Follow-up|1
766286|NCT00534105|2439958|P2|Overall Study|Lost to Follow-up|39
766287|NCT00534105|2439959|P1|Overall Study|Lost to Follow-up|23
766288|NCT00534248|2439977|P2|Overall Study|Withdrawal by Subject|255
766289|NCT00534248|2439978|P1|Overall Study|Withdrawal by Subject|263
766290|NCT00534248|2439977|P2|Overall Study|Protocol Violation|4
766291|NCT00534248|2439978|P1|Overall Study|Protocol Violation|3
766292|NCT00534248|2439977|P2|Overall Study|Physician Decision|7
766293|NCT00534248|2439978|P1|Overall Study|Physician Decision|10
766294|NCT00534248|2439977|P2|Overall Study|Other protocol specified criteria|3
766295|NCT00534248|2439978|P1|Overall Study|Other protocol specified criteria|13
766296|NCT00534248|2439977|P2|Overall Study|Lost to Follow-up|375
766297|NCT00534248|2439978|P1|Overall Study|Lost to Follow-up|353
766298|NCT00534248|2439977|P2|Overall Study|Adverse Event|29
766299|NCT00534248|2439978|P1|Overall Study|Adverse Event|19
766300|NCT00534313|2439992|P4|Long-term Period|Not specified|2
766301|NCT00534313|2439993|P3|Long-term Period|Not specified|2
766302|NCT00534313|2439994|P2|Long-term Period|Not specified|2
766303|NCT00534313|2439995|P1|Long-term Period|Not specified|1
766304|NCT00534313|2439992|P4|Long-term Period|Administrative reason by sponsor|18
766305|NCT00534313|2439993|P3|Long-term Period|Administrative reason by sponsor|26
766306|NCT00534313|2439994|P2|Long-term Period|Administrative reason by sponsor|15
766307|NCT00534313|2439995|P1|Long-term Period|Administrative reason by sponsor|17
766308|NCT00534313|2439992|P4|Long-term Period|Poor compliance/noncompliance|0
766309|NCT00534313|2439993|P3|Long-term Period|Poor compliance/noncompliance|1
766310|NCT00534313|2439994|P2|Long-term Period|Poor compliance/noncompliance|1
766311|NCT00534313|2439995|P1|Long-term Period|Poor compliance/noncompliance|0
766312|NCT00534313|2439992|P4|Long-term Period|No longer meets study criteria|0
766313|NCT00534313|2439993|P3|Long-term Period|No longer meets study criteria|0
766314|NCT00534313|2439994|P2|Long-term Period|No longer meets study criteria|1
766315|NCT00534313|2439995|P1|Long-term Period|No longer meets study criteria|0
766316|NCT00534313|2439992|P4|Long-term Period|Withdrawal by Subject|0
766317|NCT00534313|2439993|P3|Long-term Period|Withdrawal by Subject|0
766318|NCT00534313|2439994|P2|Long-term Period|Withdrawal by Subject|2
766319|NCT00534313|2439995|P1|Long-term Period|Withdrawal by Subject|2
766320|NCT00534313|2439992|P4|Long-term Period|Lost to Follow-up|0
766321|NCT00534313|2439993|P3|Long-term Period|Lost to Follow-up|0
766322|NCT00534313|2439994|P2|Long-term Period|Lost to Follow-up|2
766323|NCT00534313|2439995|P1|Long-term Period|Lost to Follow-up|1
766324|NCT00534313|2439992|P4|Long-term Period|Lack of Efficacy|12
766325|NCT00534313|2439993|P3|Long-term Period|Lack of Efficacy|14
766326|NCT00534313|2439994|P2|Long-term Period|Lack of Efficacy|10
766327|NCT00534313|2439995|P1|Long-term Period|Lack of Efficacy|14
766328|NCT00534313|2439992|P4|Long-term Period|Adverse Event|1
766329|NCT00534313|2439993|P3|Long-term Period|Adverse Event|0
766330|NCT00534313|2439994|P2|Long-term Period|Adverse Event|1
766331|NCT00534313|2439995|P1|Long-term Period|Adverse Event|2
766332|NCT00534313|2439992|P4|Short-term Period|Pregnancy|0
766333|NCT00534313|2439993|P3|Short-term Period|Pregnancy|1
766334|NCT00534313|2439994|P2|Short-term Period|Pregnancy|0
766335|NCT00534313|2439995|P1|Short-term Period|Pregnancy|0
766336|NCT00534313|2439992|P4|Short-term Period|Participant withdrew consent|2
766337|NCT00534313|2439993|P3|Short-term Period|Participant withdrew consent|0
766338|NCT00534313|2439994|P2|Short-term Period|Participant withdrew consent|0
766339|NCT00534313|2439995|P1|Short-term Period|Participant withdrew consent|2
766340|NCT00534313|2439992|P4|Short-term Period|Participant not meeting study criteria|1
766341|NCT00534313|2439993|P3|Short-term Period|Participant not meeting study criteria|0
766342|NCT00534313|2439994|P2|Short-term Period|Participant not meeting study criteria|0
766343|NCT00534313|2439995|P1|Short-term Period|Participant not meeting study criteria|0
766344|NCT00534313|2439992|P4|Short-term Period|Lack of Efficacy|3
766345|NCT00534313|2439993|P3|Short-term Period|Lack of Efficacy|0
766346|NCT00534313|2439994|P2|Short-term Period|Lack of Efficacy|4
766347|NCT00534313|2439995|P1|Short-term Period|Lack of Efficacy|3
766348|NCT00534313|2439992|P4|Short-term Period|Adverse Event|3
766349|NCT00534313|2439993|P3|Short-term Period|Adverse Event|1
766350|NCT00534313|2439994|P2|Short-term Period|Adverse Event|2
766351|NCT00534313|2439995|P1|Short-term Period|Adverse Event|1
766352|NCT00534352|2440088|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
766353|NCT00534352|2440088|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
766354|NCT00534352|2440088|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
766355|NCT00534352|2440088|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
766356|NCT00534352|2440088|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
766357|NCT00534352|2440088|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
766358|NCT00534404|2440148|P3|Overall Study|Lost to Follow-up|201
766359|NCT00534404|2440149|P2|Overall Study|Lost to Follow-up|138
766360|NCT00534404|2440150|P1|Overall Study|Lost to Follow-up|170
766361|NCT00534404|2440148|P3|Overall Study|Removed by study staff|1
766362|NCT00534404|2440149|P2|Overall Study|Removed by study staff|3
766363|NCT00534404|2440150|P1|Overall Study|Removed by study staff|2
766364|NCT00534404|2440148|P3|Overall Study|Withdrawal by Subject|38
766365|NCT00534404|2440149|P2|Overall Study|Withdrawal by Subject|2
766366|NCT00534404|2440150|P1|Overall Study|Withdrawal by Subject|8
766367|NCT00534404|2440148|P3|Overall Study|Death|2
766368|NCT00534404|2440149|P2|Overall Study|Death|0
766369|NCT00534404|2440150|P1|Overall Study|Death|0
766370|NCT00534495|2440178|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
766371|NCT00534495|2440179|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
766372|NCT00534495|2440180|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
766373|NCT00534495|2440178|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
766374|NCT00534495|2440179|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
766375|NCT00534495|2440180|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
766376|NCT00534495|2440178|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
766377|NCT00534495|2440179|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
766378|NCT00534495|2440180|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
766379|NCT00534495|2440178|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
766380|NCT00534495|2440179|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
766381|NCT00534495|2440180|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
766382|NCT00534495|2440178|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
766383|NCT00534495|2440179|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
766384|NCT00534495|2440180|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
766385|NCT00534495|2440178|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
766386|NCT00534495|2440179|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
766387|NCT00534495|2440180|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
766388|NCT00534495|2440178|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
766389|NCT00534495|2440179|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
766390|NCT00534495|2440180|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
766391|NCT00534495|2440178|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
766392|NCT00534495|2440179|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
766393|NCT00534495|2440180|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
766394|NCT00534495|2440178|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
766395|NCT00534495|2440179|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
766396|NCT00534495|2440180|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
766397|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
766398|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
766399|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
766400|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
766401|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
766402|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
766403|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
766404|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
766405|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
766406|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
766407|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766408|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
766409|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766410|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766411|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766412|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766413|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
766414|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
766415|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766416|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766417|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766418|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
766419|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
766420|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766421|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766422|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766423|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
766424|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
766425|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
766426|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
766427|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
766428|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
766429|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
766430|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
766431|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
766432|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
766433|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
766434|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
766435|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
766436|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
766437|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
766438|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
766439|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
766440|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
766441|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
766442|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
766443|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
766444|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
766445|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
766446|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
766447|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
766448|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
766449|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
766450|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
766451|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
766452|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
766453|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
766454|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
766455|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
766456|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
766457|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
766458|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
766459|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
766460|NCT00528372|2440212|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
766461|NCT00528372|2440213|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
766462|NCT00528372|2440214|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
766463|NCT00528372|2440215|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
766464|NCT00528372|2440216|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
766465|NCT00528372|2440217|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
766466|NCT00528372|2440218|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
766467|NCT00528372|2440219|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
766468|NCT00528372|2440220|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
766469|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766470|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
766471|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766472|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766473|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766474|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
766475|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766476|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
766477|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
766551|NCT00528528|2440480|P1|Overall Study|Ongoing participant|0
766478|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766479|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766480|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766481|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
766482|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766483|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766484|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
766485|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
766486|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
766487|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766488|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766489|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766490|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
766491|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766492|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
766493|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766494|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766495|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
766496|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
766497|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
766498|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
766499|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
766500|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
766501|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
766502|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
766503|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
766504|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
766505|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
766506|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
766507|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
766508|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
766509|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
766510|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
766511|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
766512|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
766513|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
766514|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
766515|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
766516|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
766517|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
766518|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
766519|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
766520|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
766521|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
766522|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
766523|NCT00528372|2440212|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766524|NCT00528372|2440213|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766525|NCT00528372|2440214|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766526|NCT00528372|2440215|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766527|NCT00528372|2440216|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766528|NCT00528372|2440217|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766529|NCT00528372|2440218|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766530|NCT00528372|2440219|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
766531|NCT00528372|2440220|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
766532|NCT00528411|2440340|P3|Overall Study|Prior commitment medication|0
766533|NCT00528411|2440341|P2|Overall Study|Prior commitment medication|1
766534|NCT00528411|2440342|P1|Overall Study|Prior commitment medication|0
766535|NCT00528411|2440340|P3|Overall Study|Severe non-compliance to protocol|0
766536|NCT00528411|2440341|P2|Overall Study|Severe non-compliance to protocol|1
766537|NCT00528411|2440342|P1|Overall Study|Severe non-compliance to protocol|0
766538|NCT00528411|2440340|P3|Overall Study|Incorrect Enrolment|0
766539|NCT00528411|2440341|P2|Overall Study|Incorrect Enrolment|1
766540|NCT00528411|2440342|P1|Overall Study|Incorrect Enrolment|1
766541|NCT00528411|2440340|P3|Overall Study|Adverse Event|1
766542|NCT00528411|2440341|P2|Overall Study|Adverse Event|0
766543|NCT00528411|2440342|P1|Overall Study|Adverse Event|4
766548|NCT00528528|2440477|P4|Overall Study|Ongoing participant|0
766549|NCT00528528|2440478|P3|Overall Study|Ongoing participant|1
766550|NCT00528528|2440479|P2|Overall Study|Ongoing participant|0
766552|NCT00528528|2440477|P4|Overall Study|Withdrawal by Subject|1
766553|NCT00528528|2440478|P3|Overall Study|Withdrawal by Subject|1
766554|NCT00528528|2440479|P2|Overall Study|Withdrawal by Subject|2
766555|NCT00528528|2440480|P1|Overall Study|Withdrawal by Subject|3
766556|NCT00528528|2440477|P4|Overall Study|Unspecified|0
766557|NCT00528528|2440478|P3|Overall Study|Unspecified|0
766558|NCT00528528|2440479|P2|Overall Study|Unspecified|1
766559|NCT00528528|2440480|P1|Overall Study|Unspecified|0
766560|NCT00528528|2440477|P4|Overall Study|Ineligible to continue the trial|1
766561|NCT00528528|2440478|P3|Overall Study|Ineligible to continue the trial|0
766562|NCT00528528|2440479|P2|Overall Study|Ineligible to continue the trial|0
766563|NCT00528528|2440480|P1|Overall Study|Ineligible to continue the trial|0
766564|NCT00528528|2440477|P4|Overall Study|Lost to Follow-up|1
766565|NCT00528528|2440478|P3|Overall Study|Lost to Follow-up|1
766566|NCT00528528|2440479|P2|Overall Study|Lost to Follow-up|0
766567|NCT00528528|2440480|P1|Overall Study|Lost to Follow-up|0
766568|NCT00528567|2440541|P2|Overall Study|Administrative/Other|75
766569|NCT00528567|2440542|P1|Overall Study|Administrative/Other|22
766570|NCT00528567|2440541|P2|Overall Study|Other Protocol Violation|21
766571|NCT00528567|2440542|P1|Overall Study|Other Protocol Violation|5
766572|NCT00528567|2440541|P2|Overall Study|Failure to Return|4
766573|NCT00528567|2440542|P1|Overall Study|Failure to Return|1
766574|NCT00528567|2440541|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
766575|NCT00528567|2440542|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
766576|NCT00528567|2440541|P2|Overall Study|Withdrew Consent|55
766577|NCT00528567|2440542|P1|Overall Study|Withdrew Consent|59
766578|NCT00528567|2440541|P2|Overall Study|Violation Criteria at Entry|17
766579|NCT00528567|2440542|P1|Overall Study|Violation Criteria at Entry|3
766580|NCT00528567|2440541|P2|Overall Study|Adverse Event/Intermittent Illness|29
766581|NCT00528567|2440542|P1|Overall Study|Adverse Event/Intermittent Illness|255
766582|NCT00528567|2440541|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
766583|NCT00528567|2440542|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
766584|NCT00528567|2440541|P2|Overall Study|Death|5
766585|NCT00528567|2440542|P1|Overall Study|Death|4
766595|NCT00528775|2440593|P1|Overall Study|Other not specified|1
766596|NCT00528801|2440607|P2|Overall Study|Administrative Reasons|1
766597|NCT00528801|2440608|P1|Overall Study|Administrative Reasons|0
766598|NCT00528801|2440607|P2|Overall Study|Lost to Follow-up|4
766599|NCT00528801|2440608|P1|Overall Study|Lost to Follow-up|15
766600|NCT00528801|2440607|P2|Overall Study|Protocol Violation|5
766601|NCT00528801|2440608|P1|Overall Study|Protocol Violation|11
766602|NCT00528801|2440607|P2|Overall Study|Withdrawal by Subject|1
766603|NCT00528801|2440608|P1|Overall Study|Withdrawal by Subject|1
766610|NCT00528866|2440622|P1|Overall Study|Protocol Violation|6
766611|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
766612|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
766613|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
766614|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
766615|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
766616|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
766617|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
766618|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
766619|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
766620|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
766621|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
766622|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
766623|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
766624|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
766625|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
766626|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
766627|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Death|0
766628|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Death|0
766629|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Death|1
766630|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Death|0
766631|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
766632|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
766633|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
766712|NCT00534638|2440747|P1|Overall Study|Blinded treatment broken|2
766634|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
766635|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
766636|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
766637|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
766638|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
766639|NCT00528879|2440638|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
766640|NCT00528879|2440639|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
766641|NCT00528879|2440640|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
766642|NCT00528879|2440641|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
766643|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
766644|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
766645|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
766646|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
766647|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
766648|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
766649|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
766650|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
766651|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
766652|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
766653|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
766654|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
766655|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
766656|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
766657|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
766658|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
766659|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
766660|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
766661|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
766662|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
766663|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
766664|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
766665|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
766666|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
766667|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
766668|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
766669|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
766670|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
766671|NCT00528879|2440638|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
766672|NCT00528879|2440639|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
766673|NCT00528879|2440640|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
766674|NCT00528879|2440641|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
766675|NCT00534599|2440709|P2|Overall Study|Unspecified|0
766676|NCT00534599|2440710|P1|Overall Study|Unspecified|7
766677|NCT00534599|2440709|P2|Overall Study|Withdrawal by Subject|6
766678|NCT00534599|2440710|P1|Overall Study|Withdrawal by Subject|4
766679|NCT00534599|2440709|P2|Overall Study|Lost to Follow-up|14
766680|NCT00534599|2440710|P1|Overall Study|Lost to Follow-up|11
766681|NCT00534599|2440709|P2|Overall Study|Protocol Violation|3
766682|NCT00534599|2440710|P1|Overall Study|Protocol Violation|1
766683|NCT00534599|2440709|P2|Overall Study|Generalized anxiety disorder worsened|1
766684|NCT00534599|2440710|P1|Overall Study|Generalized anxiety disorder worsened|0
766685|NCT00534599|2440709|P2|Overall Study|Lack of Efficacy|1
766686|NCT00534599|2440710|P1|Overall Study|Lack of Efficacy|0
766687|NCT00534599|2440709|P2|Overall Study|Developed study-specific d/c criteria|0
766688|NCT00534599|2440710|P1|Overall Study|Developed study-specific d/c criteria|5
766689|NCT00534599|2440709|P2|Overall Study|Mis-randomization|2
766690|NCT00534599|2440710|P1|Overall Study|Mis-randomization|2
766691|NCT00534599|2440709|P2|Overall Study|Incorrect enrollment|1
766692|NCT00534599|2440710|P1|Overall Study|Incorrect enrollment|2
766693|NCT00534599|2440709|P2|Overall Study|Adverse Event|4
766694|NCT00534599|2440710|P1|Overall Study|Adverse Event|25
766695|NCT00534638|2440746|P2|Overall Study|Refused participation to study|883
766696|NCT00534638|2440747|P1|Overall Study|Refused participation to study|1665
766697|NCT00534638|2440746|P2|Overall Study|Rejected origin of signature|2
766698|NCT00534638|2440747|P1|Overall Study|Rejected origin of signature|0
766699|NCT00534638|2440746|P2|Overall Study|Received without ICF|1
766700|NCT00534638|2440747|P1|Overall Study|Received without ICF|0
766701|NCT00534638|2440746|P2|Overall Study|Subject unable to read|1
766702|NCT00534638|2440747|P1|Overall Study|Subject unable to read|0
766703|NCT00534638|2440746|P2|Overall Study|ICF not returned|1
766704|NCT00534638|2440747|P1|Overall Study|ICF not returned|0
766705|NCT00534638|2440746|P2|Overall Study|Mentally disabled|0
766706|NCT00534638|2440747|P1|Overall Study|Mentally disabled|1
766707|NCT00534638|2440746|P2|Overall Study|Death|5
766708|NCT00534638|2440747|P1|Overall Study|Death|5
766709|NCT00534638|2440746|P2|Overall Study|Pregnancy|4
766710|NCT00534638|2440747|P1|Overall Study|Pregnancy|6
766711|NCT00534638|2440746|P2|Overall Study|Blinded treatment broken|0
766713|NCT00534638|2440746|P2|Overall Study|Urticaria|0
766714|NCT00534638|2440747|P1|Overall Study|Urticaria|1
766715|NCT00534638|2440746|P2|Overall Study|Already received HPV vaccine|1
766716|NCT00534638|2440747|P1|Overall Study|Already received HPV vaccine|0
766717|NCT00534638|2440746|P2|Overall Study|Lost to Follow-up|10875
766718|NCT00534638|2440747|P1|Overall Study|Lost to Follow-up|4793
766719|NCT00534638|2440746|P2|Overall Study|Migrated/moved from study area|13
766720|NCT00534638|2440747|P1|Overall Study|Migrated/moved from study area|14
766721|NCT00534638|2440746|P2|Overall Study|Withdrawal by Subject|5
766722|NCT00534638|2440747|P1|Overall Study|Withdrawal by Subject|4
766723|NCT00536263|2440807|P3|Overall Study|Did not meet protocol eligibility|2
766724|NCT00536263|2440808|P2|Overall Study|Did not meet protocol eligibility|2
766725|NCT00536263|2440809|P1|Overall Study|Did not meet protocol eligibility|1
766726|NCT00536263|2440807|P3|Overall Study|Noncompliance with protocol|1
766727|NCT00536263|2440808|P2|Overall Study|Noncompliance with protocol|0
766728|NCT00536263|2440809|P1|Overall Study|Noncompliance with protocol|0
766729|NCT00536263|2440807|P3|Overall Study|Subject withdrew - treatment related|2
766730|NCT00536263|2440808|P2|Overall Study|Subject withdrew - treatment related|3
766731|NCT00536263|2440809|P1|Overall Study|Subject withdrew - treatment related|0
766732|NCT00536263|2440807|P3|Overall Study|Subject withdrew - not treatment related|5
766733|NCT00536263|2440808|P2|Overall Study|Subject withdrew - not treatment related|0
766734|NCT00536263|2440809|P1|Overall Study|Subject withdrew - not treatment related|2
766735|NCT00536263|2440807|P3|Overall Study|Lost to Follow-up|4
766736|NCT00536263|2440808|P2|Overall Study|Lost to Follow-up|4
766737|NCT00536263|2440809|P1|Overall Study|Lost to Follow-up|3
766738|NCT00536263|2440807|P3|Overall Study|Adverse Event|7
766739|NCT00536263|2440808|P2|Overall Study|Adverse Event|5
766740|NCT00536263|2440809|P1|Overall Study|Adverse Event|5
766741|NCT00536380|2440863|P3|Overall Study|Administrative|1
766742|NCT00536380|2440864|P2|Overall Study|Administrative|0
766743|NCT00536380|2440865|P1|Overall Study|Administrative|0
766744|NCT00536380|2440863|P3|Overall Study|Did not meet protocol eligibility|1
766745|NCT00536380|2440864|P2|Overall Study|Did not meet protocol eligibility|0
766746|NCT00536380|2440865|P1|Overall Study|Did not meet protocol eligibility|0
766747|NCT00536380|2440863|P3|Overall Study|Noncompliance with protocol|2
766748|NCT00536380|2440864|P2|Overall Study|Noncompliance with protocol|2
766749|NCT00536380|2440865|P1|Overall Study|Noncompliance with protocol|3
766750|NCT00536380|2440863|P3|Overall Study|Withdrawal related to study drug|2
766751|NCT00536380|2440864|P2|Overall Study|Withdrawal related to study drug|5
766752|NCT00536380|2440865|P1|Overall Study|Withdrawal related to study drug|7
766753|NCT00536380|2440863|P3|Overall Study|Withdrawal unrelated to study drug|1
766754|NCT00536380|2440864|P2|Overall Study|Withdrawal unrelated to study drug|0
766755|NCT00536380|2440865|P1|Overall Study|Withdrawal unrelated to study drug|2
766756|NCT00536380|2440863|P3|Overall Study|Lost to Follow-up|1
766757|NCT00536380|2440864|P2|Overall Study|Lost to Follow-up|0
766758|NCT00536380|2440865|P1|Overall Study|Lost to Follow-up|0
766759|NCT00536380|2440863|P3|Overall Study|Adverse Event|2
766760|NCT00536380|2440864|P2|Overall Study|Adverse Event|2
766761|NCT00536380|2440865|P1|Overall Study|Adverse Event|0
766762|NCT00536471|2440877|P4|Overall Study|Sponsor Decision|2
766763|NCT00536471|2440878|P3|Overall Study|Sponsor Decision|3
766764|NCT00536471|2440879|P2|Overall Study|Sponsor Decision|1
766765|NCT00536471|2440880|P1|Overall Study|Sponsor Decision|0
766766|NCT00536471|2440877|P4|Overall Study|Death|2
766767|NCT00536471|2440878|P3|Overall Study|Death|1
766768|NCT00536471|2440879|P2|Overall Study|Death|0
766769|NCT00536471|2440880|P1|Overall Study|Death|0
766770|NCT00536471|2440877|P4|Overall Study|Physician Decision|2
766771|NCT00536471|2440878|P3|Overall Study|Physician Decision|3
766772|NCT00536471|2440879|P2|Overall Study|Physician Decision|1
766773|NCT00536471|2440880|P1|Overall Study|Physician Decision|11
766774|NCT00536471|2440877|P4|Overall Study|Protocol Violation|3
766775|NCT00536471|2440878|P3|Overall Study|Protocol Violation|2
766776|NCT00536471|2440879|P2|Overall Study|Protocol Violation|1
766777|NCT00536471|2440880|P1|Overall Study|Protocol Violation|8
766778|NCT00536471|2440877|P4|Overall Study|Lack of Efficacy|9
766779|NCT00536471|2440878|P3|Overall Study|Lack of Efficacy|11
766780|NCT00536471|2440879|P2|Overall Study|Lack of Efficacy|18
766781|NCT00536471|2440880|P1|Overall Study|Lack of Efficacy|17
766782|NCT00536471|2440877|P4|Overall Study|Withdrawal by Subject|21
766783|NCT00536471|2440878|P3|Overall Study|Withdrawal by Subject|43
766784|NCT00536471|2440879|P2|Overall Study|Withdrawal by Subject|24
766785|NCT00536471|2440880|P1|Overall Study|Withdrawal by Subject|40
766786|NCT00536471|2440877|P4|Overall Study|Adverse Event|13
766787|NCT00536471|2440878|P3|Overall Study|Adverse Event|28
766788|NCT00536471|2440879|P2|Overall Study|Adverse Event|16
766789|NCT00536471|2440880|P1|Overall Study|Adverse Event|32
766790|NCT00536471|2440877|P4|Overall Study|Lost to Follow-up|22
766791|NCT00536471|2440878|P3|Overall Study|Lost to Follow-up|48
766792|NCT00536471|2440879|P2|Overall Study|Lost to Follow-up|23
766793|NCT00536471|2440880|P1|Overall Study|Lost to Follow-up|48
766794|NCT00536484|2441124|P2|Overall Study|Other|0
766795|NCT00536484|2441125|P1|Overall Study|Other|4
766796|NCT00536484|2441124|P2|Overall Study|Lack of Efficacy|5
766797|NCT00536484|2441125|P1|Overall Study|Lack of Efficacy|16
766798|NCT00536484|2441124|P2|Overall Study|Lost to Follow-up|6
766799|NCT00536484|2441125|P1|Overall Study|Lost to Follow-up|8
766800|NCT00536484|2441124|P2|Overall Study|Withdrawal by Subject|11
766801|NCT00536484|2441125|P1|Overall Study|Withdrawal by Subject|11
766802|NCT00536484|2441124|P2|Overall Study|Adverse Event|34
766803|NCT00536484|2441125|P1|Overall Study|Adverse Event|21
766804|NCT00536510|2441157|P2|Overall Study|Patient Discontinued for Other Reasons|2
766805|NCT00536510|2441158|P1|Overall Study|Patient Discontinued for Other Reasons|2
766806|NCT00536510|2441157|P2|Overall Study|Laboratory Adverse Event|1
766807|NCT00536510|2441158|P1|Overall Study|Laboratory Adverse Event|2
766808|NCT00536510|2441157|P2|Overall Study|Flushing with Product|0
766809|NCT00536510|2441158|P1|Overall Study|Flushing with Product|20
766810|NCT00536510|2441157|P2|Overall Study|Withdrawal by Subject|9
766811|NCT00536510|2441158|P1|Overall Study|Withdrawal by Subject|16
766812|NCT00536510|2441157|P2|Overall Study|Protocol Violation|5
766813|NCT00536510|2441158|P1|Overall Study|Protocol Violation|4
766814|NCT00536510|2441157|P2|Overall Study|Lost to Follow-up|8
766815|NCT00536510|2441158|P1|Overall Study|Lost to Follow-up|11
766816|NCT00536510|2441157|P2|Overall Study|Adverse Event|4
766817|NCT00536510|2441158|P1|Overall Study|Adverse Event|27
766818|NCT00536575|2441166|P1|Overall Study|Death|1
766819|NCT00536575|2441166|P1|Overall Study|Withdrawal by Subject|1
766820|NCT00536731|2441173|P3|Overall Study|Other|0
766821|NCT00536731|2441174|P2|Overall Study|Other|1
766822|NCT00536731|2441175|P1|Overall Study|Other|1
766823|NCT00536731|2441173|P3|Overall Study|Safety reasons|1
766824|NCT00536731|2441174|P2|Overall Study|Safety reasons|0
766825|NCT00536731|2441175|P1|Overall Study|Safety reasons|0
766826|NCT00536731|2441173|P3|Overall Study|Intake of prohibited conc. medication|1
766827|NCT00536731|2441174|P2|Overall Study|Intake of prohibited conc. medication|0
766828|NCT00536731|2441175|P1|Overall Study|Intake of prohibited conc. medication|0
766829|NCT00536731|2441173|P3|Overall Study|Withdrawal by Subject|0
766830|NCT00536731|2441174|P2|Overall Study|Withdrawal by Subject|2
766831|NCT00536731|2441175|P1|Overall Study|Withdrawal by Subject|0
766832|NCT00536731|2441173|P3|Overall Study|Adverse Event|3
766833|NCT00536731|2441174|P2|Overall Study|Adverse Event|2
766834|NCT00536731|2441175|P1|Overall Study|Adverse Event|3
766835|NCT00536744|2441221|P2|Overall Study|PI tried alternative treatment|3
766836|NCT00536744|2441222|P1|Overall Study|PI tried alternative treatment|1
766837|NCT00536744|2441221|P2|Overall Study|Withdrawal by Subject|8
766838|NCT00536744|2441222|P1|Overall Study|Withdrawal by Subject|7
766839|NCT00536744|2441221|P2|Overall Study|Lost to Follow-up|5
766840|NCT00536744|2441222|P1|Overall Study|Lost to Follow-up|3
766841|NCT00536744|2441221|P2|Overall Study|Physician Decision|1
766842|NCT00536744|2441222|P1|Overall Study|Physician Decision|3
766843|NCT00536744|2441221|P2|Overall Study|Death|1
766844|NCT00536744|2441222|P1|Overall Study|Death|2
766845|NCT00536744|2441221|P2|Overall Study|Adverse Event|10
766846|NCT00536744|2441222|P1|Overall Study|Adverse Event|13
766847|NCT00536809|2441228|P1|Phase II|Referred for surgical resection|1
766848|NCT00536809|2441228|P1|Phase II|Adverse Event|1
766849|NCT00536874|2441249|P1|Overall Study|Withdrawal by Subject|1
766850|NCT00536874|2441249|P1|Overall Study|Death|2
766851|NCT00536874|2441249|P1|Overall Study|Adverse Event|1
766852|NCT00536978|2441284|P1|Overall Study|Not eligible for Adback Infusion|22
766853|NCT00536991|2441288|P1|Overall Study|patient ineligible|2
766854|NCT00536991|2441288|P1|Overall Study|Physician Decision|1
766855|NCT00536991|2441288|P1|Overall Study|Withdrawal by Subject|10
766856|NCT00537017|2441295|P1|Follow-up Phase|Withdrawal by Subject|9
766857|NCT00537017|2441295|P1|Treatment Phase|Protocol Violation|2
766858|NCT00537017|2441295|P1|Treatment Phase|Withdrawal by Subject|13
766859|NCT00537017|2441295|P1|Treatment Phase|Adverse Event|19
766860|NCT00537030|2441306|P1|Overall Study|Inevaluable|3
766861|NCT00537030|2441306|P1|Overall Study|Confirm patient ineligibility|1
766862|NCT00537030|2441306|P1|Overall Study|Disease progression or relapse during ac|1
766863|NCT00537030|2441306|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
766864|NCT00537030|2441306|P1|Overall Study|Withdrawal by Subject|2
766865|NCT00537030|2441306|P1|Overall Study|Physician Decision|2
766866|NCT00537056|2441310|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
766867|NCT00537082|2441325|P3|Overall Study|Discontinued before initiating treatment|0
766868|NCT00537082|2441326|P2|Overall Study|Discontinued before initiating treatment|0
766869|NCT00537082|2441327|P1|Overall Study|Discontinued before initiating treatment|3
766870|NCT00537082|2441325|P3|Overall Study|Withdrawal by Subject|0
766871|NCT00537082|2441326|P2|Overall Study|Withdrawal by Subject|1
766872|NCT00537082|2441327|P1|Overall Study|Withdrawal by Subject|0
766873|NCT00537082|2441325|P3|Overall Study|Lack of Efficacy|2
766874|NCT00537082|2441326|P2|Overall Study|Lack of Efficacy|0
766875|NCT00537082|2441327|P1|Overall Study|Lack of Efficacy|0
766876|NCT00537082|2441325|P3|Overall Study|Protocol Violation|1
766877|NCT00537082|2441326|P2|Overall Study|Protocol Violation|2
766878|NCT00537082|2441327|P1|Overall Study|Protocol Violation|0
766879|NCT00537082|2441325|P3|Overall Study|Adverse Event|3
766880|NCT00537082|2441326|P2|Overall Study|Adverse Event|6
766881|NCT00537082|2441327|P1|Overall Study|Adverse Event|6
766896|NCT00537199|2441359|P1|Overall Study|Study Terminated|1
766897|NCT00537238|2441365|P2|Overall Study|Unspecified|52
766898|NCT00537238|2441366|P1|Overall Study|Unspecified|44
766899|NCT00537238|2441365|P2|Overall Study|Does not meet entrance criteria|2
766900|NCT00537238|2441366|P1|Overall Study|Does not meet entrance criteria|0
766901|NCT00537238|2441365|P2|Overall Study|Protocol Violation|19
766902|NCT00537238|2441366|P1|Overall Study|Protocol Violation|15
766903|NCT00537238|2441365|P2|Overall Study|Withdrawal by Subject|47
766904|NCT00537238|2441366|P1|Overall Study|Withdrawal by Subject|51
766905|NCT00537238|2441365|P2|Overall Study|Lost to Follow-up|8
766906|NCT00537238|2441366|P1|Overall Study|Lost to Follow-up|12
766907|NCT00537238|2441365|P2|Overall Study|Lack of Efficacy|21
766908|NCT00537238|2441366|P1|Overall Study|Lack of Efficacy|20
766909|NCT00537238|2441365|P2|Overall Study|Adverse Event|22
766910|NCT00537238|2441366|P1|Overall Study|Adverse Event|31
766911|NCT00537238|2441365|P2|Overall Study|Death|2
766912|NCT00537238|2441366|P1|Overall Study|Death|1
766913|NCT00537277|2441386|P1|Overall Study|Non-compliance with trial procedures|15
766914|NCT00537277|2441386|P1|Overall Study|Inability to tolerate trial medication|4
766915|NCT00537277|2441386|P1|Overall Study|Unclassified|4
766916|NCT00537277|2441386|P1|Overall Study|Protocol Violation|11
766917|NCT00537277|2441386|P1|Overall Study|Lost to Follow-up|12
766918|NCT00537277|2441386|P1|Overall Study|Lack of Efficacy|2
766919|NCT00537277|2441386|P1|Overall Study|Adverse Event|1
766920|NCT00537303|2441397|P2|Overall Study|Unclassified|7
766921|NCT00537303|2441398|P1|Overall Study|Unclassified|8
766922|NCT00537303|2441397|P2|Overall Study|Withdrawal criteria|3
766923|NCT00537303|2441398|P1|Overall Study|Withdrawal criteria|3
766924|NCT00537303|2441397|P2|Overall Study|Protocol Violation|4
766925|NCT00537303|2441398|P1|Overall Study|Protocol Violation|8
766926|NCT00537303|2441397|P2|Overall Study|Lack of Efficacy|7
766927|NCT00537303|2441398|P1|Overall Study|Lack of Efficacy|6
766928|NCT00537303|2441397|P2|Overall Study|Adverse Event|4
766929|NCT00537303|2441398|P1|Overall Study|Adverse Event|1
891394|NCT01802632|2827734|P5|Overall Study|Other (not specified)|0
891395|NCT01802632|2827735|P4|Overall Study|Other (not specified)|1
891396|NCT01802632|2827736|P3|Overall Study|Other (not specified)|7
891397|NCT01802632|2827737|P2|Overall Study|Other (not specified)|0
891398|NCT01802632|2827738|P1|Overall Study|Other (not specified)|0
891399|NCT01802632|2827733|P6|Overall Study|Ongoing Study at Data Cut-off|22
891400|NCT01802632|2827734|P5|Overall Study|Ongoing Study at Data Cut-off|6
891401|NCT01802632|2827735|P4|Overall Study|Ongoing Study at Data Cut-off|50
891402|NCT01802632|2827736|P3|Overall Study|Ongoing Study at Data Cut-off|115
891403|NCT01802632|2827737|P2|Overall Study|Ongoing Study at Data Cut-off|16
891404|NCT01802632|2827738|P1|Overall Study|Ongoing Study at Data Cut-off|168
891405|NCT01802632|2827733|P6|Overall Study|Objective Disease Progression|4
891406|NCT01802632|2827734|P5|Overall Study|Objective Disease Progression|4
891407|NCT01802632|2827735|P4|Overall Study|Objective Disease Progression|6
891408|NCT01802632|2827736|P3|Overall Study|Objective Disease Progression|104
891409|NCT01802632|2827737|P2|Overall Study|Objective Disease Progression|12
891410|NCT01802632|2827738|P1|Overall Study|Objective Disease Progression|1
891411|NCT01802632|2827733|P6|Overall Study|Withdrawal by Subject|1
891412|NCT01802632|2827734|P5|Overall Study|Withdrawal by Subject|0
891413|NCT01802632|2827735|P4|Overall Study|Withdrawal by Subject|3
891414|NCT01802632|2827736|P3|Overall Study|Withdrawal by Subject|7
891415|NCT01802632|2827737|P2|Overall Study|Withdrawal by Subject|2
891416|NCT01802632|2827738|P1|Overall Study|Withdrawal by Subject|4
891417|NCT01802632|2827733|P6|Overall Study|Death|0
891418|NCT01802632|2827734|P5|Overall Study|Death|2
891419|NCT01802632|2827735|P4|Overall Study|Death|0
891420|NCT01802632|2827736|P3|Overall Study|Death|38
891421|NCT01802632|2827737|P2|Overall Study|Death|1
891422|NCT01802632|2827738|P1|Overall Study|Death|28
891433|NCT01774591|2827765|P2|Overall Study|Adverse Event|2
891434|NCT01774591|2827766|P1|Overall Study|Adverse Event|0
891435|NCT01774591|2827765|P2|Overall Study|Withdrawal by Subject|1
891436|NCT01774591|2827766|P1|Overall Study|Withdrawal by Subject|0
891437|NCT01774591|2827765|P2|Overall Study|Physician Decision|1
891438|NCT01774591|2827766|P1|Overall Study|Physician Decision|1
891439|NCT01772134|2827779|P3|Overall Study|Randomized Study Medication Not Received|1
891440|NCT01772134|2827780|P2|Overall Study|Randomized Study Medication Not Received|0
891441|NCT01772134|2827781|P1|Overall Study|Randomized Study Medication Not Received|2
891442|NCT01772134|2827779|P3|Overall Study|Protocol-defined Stopping Criteria|0
891443|NCT01772134|2827780|P2|Overall Study|Protocol-defined Stopping Criteria|0
891444|NCT01772134|2827781|P1|Overall Study|Protocol-defined Stopping Criteria|1
891445|NCT01772134|2827779|P3|Overall Study|Lack of Efficacy|3
891446|NCT01772134|2827780|P2|Overall Study|Lack of Efficacy|5
891447|NCT01772134|2827781|P1|Overall Study|Lack of Efficacy|11
891448|NCT01772134|2827779|P3|Overall Study|Protocol Deviation|3
891449|NCT01772134|2827780|P2|Overall Study|Protocol Deviation|3
891450|NCT01772134|2827781|P1|Overall Study|Protocol Deviation|4
891451|NCT01772134|2827779|P3|Overall Study|Lost to Follow-up|0
891452|NCT01772134|2827780|P2|Overall Study|Lost to Follow-up|0
891453|NCT01772134|2827781|P1|Overall Study|Lost to Follow-up|2
891454|NCT01772134|2827779|P3|Overall Study|Withdrew Consent|5
891455|NCT01772134|2827780|P2|Overall Study|Withdrew Consent|1
891456|NCT01772134|2827781|P1|Overall Study|Withdrew Consent|3
891457|NCT01772134|2827779|P3|Overall Study|Adverse Event|10
891458|NCT01772134|2827780|P2|Overall Study|Adverse Event|5
891459|NCT01772134|2827781|P1|Overall Study|Adverse Event|6
891460|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
891461|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
891462|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
891463|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Physician Decision|2
891464|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Physician Decision|2
891465|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Physician Decision|0
891466|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
891467|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
767014|NCT00537329|2441451|P1|Overall Study|Unspecified|1
767015|NCT00537329|2441451|P1|Overall Study|Withdrawal by Subject|4
767016|NCT00537329|2441451|P1|Overall Study|Lost to Follow-up|6
767017|NCT00537329|2441451|P1|Overall Study|Lack of Efficacy|2
767018|NCT00537329|2441451|P1|Overall Study|Adverse Event|3
767019|NCT00537329|2441451|P1|Overall Study|Death|10
767020|NCT00537381|2441467|P2|Overall Study|Unspecified|3
767021|NCT00537381|2441468|P1|Overall Study|Unspecified|5
767022|NCT00537381|2441467|P2|Overall Study|Sponsor decision|9
767023|NCT00537381|2441468|P1|Overall Study|Sponsor decision|14
767024|NCT00537381|2441467|P2|Overall Study|Disease Progression|18
767025|NCT00537381|2441468|P1|Overall Study|Disease Progression|9
767026|NCT00537381|2441467|P2|Overall Study|Physician Decision|6
767027|NCT00537381|2441468|P1|Overall Study|Physician Decision|7
767028|NCT00537381|2441467|P2|Overall Study|Withdrawal by Subject|14
767029|NCT00537381|2441468|P1|Overall Study|Withdrawal by Subject|5
767030|NCT00537381|2441467|P2|Overall Study|Death|3
767031|NCT00537381|2441468|P1|Overall Study|Death|3
767032|NCT00537381|2441467|P2|Overall Study|Adverse Event|9
767033|NCT00537381|2441468|P1|Overall Study|Adverse Event|13
767034|NCT00537394|2441491|P3|2nd Year of Follow-up|Clinic site closure|0
767035|NCT00537394|2441492|P2|2nd Year of Follow-up|Clinic site closure|0
767036|NCT00537394|2441493|P1|2nd Year of Follow-up|Clinic site closure|1
767037|NCT00537394|2441491|P3|2nd Year of Follow-up|Lost to Follow-up|2
767038|NCT00537394|2441492|P2|2nd Year of Follow-up|Lost to Follow-up|7
767039|NCT00537394|2441493|P1|2nd Year of Follow-up|Lost to Follow-up|6
767040|NCT00537394|2441491|P3|2nd Year of Follow-up|Withdrawal by Subject|2
767041|NCT00537394|2441492|P2|2nd Year of Follow-up|Withdrawal by Subject|1
767042|NCT00537394|2441493|P1|2nd Year of Follow-up|Withdrawal by Subject|0
767043|NCT00537394|2441491|P3|2nd Year of Follow-up|Death|2
767044|NCT00537394|2441492|P2|2nd Year of Follow-up|Death|1
767045|NCT00537394|2441493|P1|2nd Year of Follow-up|Death|4
767046|NCT00537394|2441491|P3|First Year of Follow-up|Lost to Follow-up|1
767047|NCT00537394|2441492|P2|First Year of Follow-up|Lost to Follow-up|5
767048|NCT00537394|2441493|P1|First Year of Follow-up|Lost to Follow-up|1
767049|NCT00537394|2441491|P3|First Year of Follow-up|Withdrawal by Subject|1
767050|NCT00537394|2441492|P2|First Year of Follow-up|Withdrawal by Subject|6
767051|NCT00537394|2441493|P1|First Year of Follow-up|Withdrawal by Subject|3
767052|NCT00537394|2441491|P3|First Year of Follow-up|Severe debilitation|1
767053|NCT00537394|2441492|P2|First Year of Follow-up|Severe debilitation|0
767054|NCT00537394|2441493|P1|First Year of Follow-up|Severe debilitation|1
767055|NCT00537394|2441491|P3|First Year of Follow-up|Death|0
767056|NCT00537394|2441492|P2|First Year of Follow-up|Death|0
767057|NCT00537394|2441493|P1|First Year of Follow-up|Death|7
767058|NCT00537485|2441575|P2|Overall Study|Physician Decision|0
767059|NCT00537485|2441576|P1|Overall Study|Physician Decision|1
767060|NCT00537485|2441575|P2|Overall Study|Withdrawal by Subject|3
767061|NCT00537485|2441576|P1|Overall Study|Withdrawal by Subject|1
767062|NCT00537485|2441575|P2|Overall Study|Withdrawal by Subject|2
767063|NCT00537485|2441576|P1|Overall Study|Withdrawal by Subject|3
767064|NCT00537485|2441575|P2|Overall Study|Adverse Event|5
767065|NCT00537485|2441576|P1|Overall Study|Adverse Event|10
767066|NCT00537745|2441638|P1|Overall Study|Subject unable to provide Interlock info|1
767067|NCT00537745|2441638|P1|Overall Study|Withdrawal by Subject|2
767068|NCT00537745|2441638|P1|Overall Study|Did not meet eligibility criteria|2
767069|NCT00537771|2441645|P2|Overall Study|Severe Non-Compliance to Protocol|2
767070|NCT00537771|2441646|P1|Overall Study|Severe Non-Compliance to Protocol|4
767071|NCT00537771|2441645|P2|Overall Study|Protocol Violation|6
767072|NCT00537771|2441646|P1|Overall Study|Protocol Violation|2
767073|NCT00537771|2441645|P2|Overall Study|Lost to Follow-up|15
767074|NCT00537771|2441646|P1|Overall Study|Lost to Follow-up|9
767075|NCT00537771|2441645|P2|Overall Study|Adverse Event|15
767076|NCT00537771|2441646|P1|Overall Study|Adverse Event|8
767077|NCT00537771|2441645|P2|Overall Study|Withdrawal by Subject|23
767078|NCT00537771|2441646|P1|Overall Study|Withdrawal by Subject|6
767079|NCT00537810|2441660|P4|Overall Study|Medically withdrawn|1
767080|NCT00537810|2441661|P3|Overall Study|Medically withdrawn|0
767081|NCT00537810|2441662|P2|Overall Study|Medically withdrawn|2
767082|NCT00537810|2441663|P1|Overall Study|Medically withdrawn|2
767083|NCT00537810|2441660|P4|Overall Study|Withdrawal by Subject|3
767084|NCT00537810|2441661|P3|Overall Study|Withdrawal by Subject|4
767085|NCT00537810|2441662|P2|Overall Study|Withdrawal by Subject|11
767086|NCT00537810|2441663|P1|Overall Study|Withdrawal by Subject|4
767087|NCT00537823|2441679|P2|Overall Study|Adverse Event|0
767088|NCT00537823|2441680|P1|Overall Study|Adverse Event|2
767089|NCT00537940|2441704|P2|Overall Study|Unspecified|12
767090|NCT00537940|2441705|P1|Overall Study|Unspecified|10
767091|NCT00537940|2441704|P2|Overall Study|Study terminated by sponsor|3
767092|NCT00537940|2441705|P1|Overall Study|Study terminated by sponsor|2
767093|NCT00537940|2441704|P2|Overall Study|Pregnancy|1
767094|NCT00537940|2441705|P1|Overall Study|Pregnancy|1
767095|NCT00537940|2441704|P2|Overall Study|Protocol Violation|4
767096|NCT00537940|2441705|P1|Overall Study|Protocol Violation|6
767097|NCT00537940|2441704|P2|Overall Study|Withdrawal by Subject|95
767098|NCT00537940|2441705|P1|Overall Study|Withdrawal by Subject|113
767099|NCT00537940|2441704|P2|Overall Study|Lost to Follow-up|29
767100|NCT00537940|2441705|P1|Overall Study|Lost to Follow-up|23
767101|NCT00537940|2441704|P2|Overall Study|Lack of Efficacy|16
767102|NCT00537940|2441705|P1|Overall Study|Lack of Efficacy|8
767103|NCT00537940|2441704|P2|Overall Study|Adverse Event|19
767104|NCT00537940|2441705|P1|Overall Study|Adverse Event|20
767105|NCT00537979|2441729|P2|Overall Study|Heart failure|1
767106|NCT00537979|2441730|P1|Overall Study|Heart failure|0
767107|NCT00537979|2441729|P2|Overall Study|Kidney transplant|3
767108|NCT00537979|2441730|P1|Overall Study|Kidney transplant|0
767109|NCT00537979|2441729|P2|Overall Study|Death|3
767110|NCT00537979|2441730|P1|Overall Study|Death|0
767111|NCT00537979|2441729|P2|Overall Study|Non-compliance with treatment/procedure|2
767112|NCT00537979|2441730|P1|Overall Study|Non-compliance with treatment/procedure|2
767113|NCT00537979|2441729|P2|Overall Study|Lack of Efficacy|1
767114|NCT00537979|2441730|P1|Overall Study|Lack of Efficacy|0
767115|NCT00537979|2441729|P2|Overall Study|Lost to Follow-up|4
767116|NCT00537979|2441730|P1|Overall Study|Lost to Follow-up|1
767117|NCT00537979|2441729|P2|Overall Study|Withdrawal by Subject|4
767118|NCT00537979|2441730|P1|Overall Study|Withdrawal by Subject|1
767119|NCT00537979|2441729|P2|Overall Study|Adverse Event|2
767120|NCT00537979|2441730|P1|Overall Study|Adverse Event|2
767121|NCT00538291|2441796|P1|Overall Study|Withdrawal by Subject|1
767122|NCT00538291|2441796|P1|Overall Study|Adverse Event|2
767123|NCT00538473|2441850|P2|Overall Study|Adverse Event|0
767124|NCT00538473|2441851|P1|Overall Study|Adverse Event|1
767125|NCT00538590|2441898|P2|Overall Study|Death|0
767126|NCT00538590|2441899|P1|Overall Study|Death|1
767127|NCT00538629|2441922|P1|Overall Study|Subject's untimely distrust of medicine|1
767128|NCT00538629|2441922|P1|Overall Study|Lost to Follow-up|6
767129|NCT00538629|2441922|P1|Overall Study|Lack of Efficacy|12
767130|NCT00538629|2441922|P1|Overall Study|Adverse Event|2
767131|NCT00538629|2441922|P1|Overall Study|At subject's request|1
767132|NCT00531934|2442068|P2|Overall Study|Not specified|2
767133|NCT00531934|2442069|P1|Overall Study|Not specified|2
767134|NCT00531934|2442068|P2|Overall Study|Withdrawal by Subject|1
767135|NCT00531934|2442069|P1|Overall Study|Withdrawal by Subject|1
767136|NCT00531934|2442068|P2|Overall Study|Death|10
767137|NCT00531934|2442069|P1|Overall Study|Death|7
767138|NCT00531934|2442068|P2|Overall Study|Progression|42
767139|NCT00531934|2442069|P1|Overall Study|Progression|52
767140|NCT00531934|2442068|P2|Overall Study|Adverse Event|8
767141|NCT00531934|2442069|P1|Overall Study|Adverse Event|4
767142|NCT00531947|2442139|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
767143|NCT00531947|2442140|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
767144|NCT00531947|2442139|P2|Overall Study|Non-Compliance|7
767145|NCT00531947|2442140|P1|Overall Study|Non-Compliance|4
767146|NCT00531947|2442139|P2|Overall Study|Protocol Violation|1
767147|NCT00531947|2442140|P1|Overall Study|Protocol Violation|2
767148|NCT00531947|2442139|P2|Overall Study|Withdrawal by Subject|19
767149|NCT00531947|2442140|P1|Overall Study|Withdrawal by Subject|14
767150|NCT00531947|2442139|P2|Overall Study|Lost to Follow-up|9
767151|NCT00531947|2442140|P1|Overall Study|Lost to Follow-up|12
767152|NCT00531947|2442139|P2|Overall Study|Adverse Event|10
767153|NCT00531947|2442140|P1|Overall Study|Adverse Event|5
767154|NCT00531960|2442184|P2|Overall Study|Not Specified|10
767155|NCT00531960|2442185|P1|Overall Study|Not Specified|4
767156|NCT00531960|2442184|P2|Overall Study|Refused Treatment|6
767157|NCT00531960|2442185|P1|Overall Study|Refused Treatment|5
767158|NCT00531960|2442184|P2|Overall Study|Violation of Selection Criteria|0
767159|NCT00531960|2442185|P1|Overall Study|Violation of Selection Criteria|2
767160|NCT00531960|2442184|P2|Overall Study|Lack of Efficacy|41
767161|NCT00531960|2442185|P1|Overall Study|Lack of Efficacy|42
767162|NCT00531960|2442184|P2|Overall Study|Death|2
767163|NCT00531960|2442185|P1|Overall Study|Death|3
767164|NCT00531960|2442184|P2|Overall Study|Adverse Event|4
767165|NCT00531960|2442185|P1|Overall Study|Adverse Event|5
767166|NCT00538733|2442201|P1|Overall Study|still on therapy|1
767167|NCT00538733|2442201|P1|Overall Study|declined to participate|2
767168|NCT00538733|2442201|P1|Overall Study|Death|1
767169|NCT00538733|2442201|P1|Overall Study|Adverse Event|8
767170|NCT00538785|2442210|P2|Overall Study|Lost to Follow-up|0
767171|NCT00538785|2442211|P1|Overall Study|Lost to Follow-up|1
767172|NCT00538785|2442210|P2|Overall Study|Withdrawal of consent|7
767173|NCT00538785|2442211|P1|Overall Study|Withdrawal of consent|9
767174|NCT00538785|2442210|P2|Overall Study|Death|10
767175|NCT00538785|2442211|P1|Overall Study|Death|9
767176|NCT00538902|2442259|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
767177|NCT00538902|2442260|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
767178|NCT00538902|2442261|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
767179|NCT00538902|2442259|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
767180|NCT00538902|2442260|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
767181|NCT00538902|2442261|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
767182|NCT00538902|2442259|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
767183|NCT00538902|2442260|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
767184|NCT00538902|2442261|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
767185|NCT00538902|2442259|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
767186|NCT00538902|2442260|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
767187|NCT00538902|2442261|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
767188|NCT00538902|2442259|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
767189|NCT00538902|2442260|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
767190|NCT00538902|2442261|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
767191|NCT00538902|2442259|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
767192|NCT00538902|2442260|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
767193|NCT00538902|2442261|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
767194|NCT00538902|2442259|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
767195|NCT00538902|2442260|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
767196|NCT00538902|2442261|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
767197|NCT00538902|2442259|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
767198|NCT00538902|2442260|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
767199|NCT00538902|2442261|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
767200|NCT00539006|2442312|P4|Treatment Period 2|Other|0
767201|NCT00539006|2442313|P3|Treatment Period 2|Other|0
767202|NCT00539006|2442314|P2|Treatment Period 2|Other|1
767203|NCT00539006|2442315|P1|Treatment Period 2|Other|0
767204|NCT00539006|2442312|P4|Treatment Period 2|Protocol Violation|0
767205|NCT00539006|2442313|P3|Treatment Period 2|Protocol Violation|0
767206|NCT00539006|2442314|P2|Treatment Period 2|Protocol Violation|0
767207|NCT00539006|2442315|P1|Treatment Period 2|Protocol Violation|1
767208|NCT00539006|2442312|P4|Washout|Other|3
767209|NCT00539006|2442313|P3|Washout|Other|2
767210|NCT00539006|2442314|P2|Washout|Other|1
767211|NCT00539006|2442315|P1|Washout|Other|1
767212|NCT00539006|2442312|P4|Washout|Failed to meet continuation criteria|6
767213|NCT00539006|2442313|P3|Washout|Failed to meet continuation criteria|14
767214|NCT00539006|2442314|P2|Washout|Failed to meet continuation criteria|5
767215|NCT00539006|2442315|P1|Washout|Failed to meet continuation criteria|16
767216|NCT00539006|2442312|P4|Washout|Withdrawal by Subject|0
767217|NCT00539006|2442313|P3|Washout|Withdrawal by Subject|0
767218|NCT00539006|2442314|P2|Washout|Withdrawal by Subject|2
767219|NCT00539006|2442315|P1|Washout|Withdrawal by Subject|0
767220|NCT00539006|2442312|P4|Washout|Protocol Violation|0
767221|NCT00539006|2442313|P3|Washout|Protocol Violation|0
767222|NCT00539006|2442314|P2|Washout|Protocol Violation|1
767223|NCT00539006|2442315|P1|Washout|Protocol Violation|1
767224|NCT00539006|2442312|P4|Washout|Adverse Event|0
767225|NCT00539006|2442313|P3|Washout|Adverse Event|0
767226|NCT00539006|2442314|P2|Washout|Adverse Event|1
767227|NCT00539006|2442315|P1|Washout|Adverse Event|2
767228|NCT00539006|2442312|P4|Treatment Period 1|Lack of Efficacy|1
767229|NCT00539006|2442313|P3|Treatment Period 1|Lack of Efficacy|0
767230|NCT00539006|2442314|P2|Treatment Period 1|Lack of Efficacy|0
767231|NCT00539006|2442315|P1|Treatment Period 1|Lack of Efficacy|0
767232|NCT00539006|2442312|P4|Treatment Period 1|Protocol Violation|0
767233|NCT00539006|2442313|P3|Treatment Period 1|Protocol Violation|1
767234|NCT00539006|2442314|P2|Treatment Period 1|Protocol Violation|0
767235|NCT00539006|2442315|P1|Treatment Period 1|Protocol Violation|0
767236|NCT00539006|2442312|P4|Treatment Period 1|Lost to Follow-up|0
767237|NCT00539006|2442313|P3|Treatment Period 1|Lost to Follow-up|1
767238|NCT00539006|2442314|P2|Treatment Period 1|Lost to Follow-up|0
767239|NCT00539006|2442315|P1|Treatment Period 1|Lost to Follow-up|0
767240|NCT00539006|2442312|P4|Pre-treatment|Other|0
767241|NCT00539006|2442313|P3|Pre-treatment|Other|0
767242|NCT00539006|2442314|P2|Pre-treatment|Other|1
767243|NCT00539006|2442315|P1|Pre-treatment|Other|0
767244|NCT00539032|2442347|P2|Overall Study|Withdrawal by Subject|1
767245|NCT00539032|2442348|P1|Overall Study|Withdrawal by Subject|2
767246|NCT00539864|2442360|P2|Overall Study|Withdrawal by Subject|1
767247|NCT00539864|2442361|P1|Overall Study|Withdrawal by Subject|1
767248|NCT00539864|2442360|P2|Overall Study|Lost to Follow-up|1
767249|NCT00539864|2442361|P1|Overall Study|Lost to Follow-up|0
767250|NCT00539994|2442387|P3|Overall Study|Physician Decision|1
767251|NCT00539994|2442388|P2|Overall Study|Physician Decision|0
767252|NCT00539994|2442389|P1|Overall Study|Physician Decision|0
767253|NCT00539994|2442387|P3|Overall Study|Withdrawal by Subject|1
767254|NCT00539994|2442388|P2|Overall Study|Withdrawal by Subject|0
767255|NCT00539994|2442389|P1|Overall Study|Withdrawal by Subject|1
767256|NCT00539994|2442387|P3|Overall Study|Lost to Follow-up|0
767257|NCT00539994|2442388|P2|Overall Study|Lost to Follow-up|1
767258|NCT00539994|2442389|P1|Overall Study|Lost to Follow-up|2
767259|NCT00540046|2442428|P2|Overall Study|Lost to Follow-up|23
767260|NCT00540046|2442429|P1|Overall Study|Lost to Follow-up|33
767261|NCT00540124|2442440|P3|Overall Study|Withdrawal by Subject|0
767262|NCT00540124|2442441|P2|Overall Study|Withdrawal by Subject|1
767263|NCT00540124|2442442|P1|Overall Study|Withdrawal by Subject|1
767264|NCT00540124|2442440|P3|Overall Study|Lack of Efficacy|0
767265|NCT00540124|2442441|P2|Overall Study|Lack of Efficacy|0
767266|NCT00540124|2442442|P1|Overall Study|Lack of Efficacy|1
767267|NCT00540124|2442440|P3|Overall Study|Entry Criteria Not Met|0
767268|NCT00540124|2442441|P2|Overall Study|Entry Criteria Not Met|0
767269|NCT00540124|2442442|P1|Overall Study|Entry Criteria Not Met|2
767270|NCT00540124|2442440|P3|Overall Study|Adverse Event|1
767271|NCT00540124|2442441|P2|Overall Study|Adverse Event|2
767272|NCT00540124|2442442|P1|Overall Study|Adverse Event|0
767273|NCT00540228|2442491|P5|Overall Study|Lost to Follow-up|0
767274|NCT00540228|2442492|P4|Overall Study|Lost to Follow-up|0
767275|NCT00540228|2442493|P3|Overall Study|Lost to Follow-up|0
767276|NCT00540228|2442494|P2|Overall Study|Lost to Follow-up|1
767277|NCT00540228|2442495|P1|Overall Study|Lost to Follow-up|1
767278|NCT00540228|2442491|P5|Overall Study|Adverse Event|0
767279|NCT00540228|2442492|P4|Overall Study|Adverse Event|0
767280|NCT00540228|2442493|P3|Overall Study|Adverse Event|0
767281|NCT00540228|2442494|P2|Overall Study|Adverse Event|0
767282|NCT00540228|2442495|P1|Overall Study|Adverse Event|2
767283|NCT00540293|2442562|P1|Overall Study|Protocol violation, & subject schedule|12
767284|NCT00540293|2442562|P1|Overall Study|Withdrawal by Subject|6
767285|NCT00540293|2442562|P1|Overall Study|Adverse event not related to study drug|7
767286|NCT00540293|2442562|P1|Overall Study|Adverse event related to study drug|10
767287|NCT00540423|2442607|P3|Open-Label Treatment Period|Lack of Efficacy|2
767288|NCT00540423|2442608|P2|Open-Label Treatment Period|Lack of Efficacy|0
767289|NCT00540423|2442609|P1|Open-Label Treatment Period|Lack of Efficacy|0
767290|NCT00540423|2442607|P3|Double-Blind Treatment Period|Adverse Event|0
767291|NCT00540423|2442608|P2|Double-Blind Treatment Period|Adverse Event|1
767292|NCT00540423|2442609|P1|Double-Blind Treatment Period|Adverse Event|0
767293|NCT00540436|2442659|P1|Second 12-Week Treatment Period|Adverse Event|1
767294|NCT00540436|2442659|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
767295|NCT00540436|2442659|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
767296|NCT00540436|2442659|P1|First 12-Week Treatment Period|Adverse Event|1
767297|NCT00540449|2442674|P2|Overall Study|Not specified|4
767298|NCT00540449|2442675|P1|Overall Study|Not specified|1
767299|NCT00540449|2442674|P2|Overall Study|Withdrawal by Subject|10
767300|NCT00540449|2442675|P1|Overall Study|Withdrawal by Subject|10
767301|NCT00540449|2442674|P2|Overall Study|Subject Reached A Virologic Endpoint|8
767302|NCT00540449|2442675|P1|Overall Study|Subject Reached A Virologic Endpoint|32
767303|NCT00540449|2442674|P2|Overall Study|Subject Non-Compliant|5
767304|NCT00540449|2442675|P1|Overall Study|Subject Non-Compliant|7
767305|NCT00540449|2442674|P2|Overall Study|Lost to Follow-up|17
767306|NCT00540449|2442675|P1|Overall Study|Lost to Follow-up|19
767307|NCT00540449|2442674|P2|Overall Study|Subject Ineligible To Continue The Trial|1
767308|NCT00540449|2442675|P1|Overall Study|Subject Ineligible To Continue The Trial|2
767309|NCT00540449|2442674|P2|Overall Study|Sponsor's Decision|1
767310|NCT00540449|2442675|P1|Overall Study|Sponsor's Decision|1
767311|NCT00540449|2442674|P2|Overall Study|Adverse Event|32
767312|NCT00540449|2442675|P1|Overall Study|Adverse Event|12
767313|NCT00540514|2442699|P2|Overall Study|Paclitaxel not available|2
767314|NCT00540514|2442700|P1|Overall Study|Paclitaxel not available|0
767315|NCT00540514|2442699|P2|Overall Study|Excluded prior to treatment|7
767316|NCT00540514|2442700|P1|Overall Study|Excluded prior to treatment|7
767317|NCT00540514|2442699|P2|Overall Study|Withdrawal by Subject|67
767318|NCT00540514|2442700|P1|Overall Study|Withdrawal by Subject|65
767319|NCT00540514|2442699|P2|Overall Study|Lost to Follow-up|1
767320|NCT00540514|2442700|P1|Overall Study|Lost to Follow-up|1
767321|NCT00540514|2442699|P2|Overall Study|Protocol Deviation|4
767322|NCT00540514|2442700|P1|Overall Study|Protocol Deviation|3
767323|NCT00540514|2442699|P2|Overall Study|Physician Decision|99
767324|NCT00540514|2442700|P1|Overall Study|Physician Decision|86
767325|NCT00540514|2442699|P2|Overall Study|Adverse Event|24
767326|NCT00540514|2442700|P1|Overall Study|Adverse Event|20
767327|NCT00540514|2442699|P2|Overall Study|Unacceptable Toxicity|62
767328|NCT00540514|2442700|P1|Overall Study|Unacceptable Toxicity|61
767329|NCT00540514|2442699|P2|Overall Study|Still on treatment|0
767330|NCT00540514|2442700|P1|Overall Study|Still on treatment|3
767331|NCT00540592|2442745|P10|Overall Study|Withdrawal by Subject|0
767332|NCT00540592|2442746|P9|Overall Study|Withdrawal by Subject|0
767333|NCT00540592|2442747|P8|Overall Study|Withdrawal by Subject|0
767334|NCT00540592|2442748|P7|Overall Study|Withdrawal by Subject|0
767335|NCT00540592|2442749|P6|Overall Study|Withdrawal by Subject|0
767336|NCT00540592|2442750|P5|Overall Study|Withdrawal by Subject|0
767337|NCT00540592|2442751|P4|Overall Study|Withdrawal by Subject|1
767338|NCT00540592|2442752|P3|Overall Study|Withdrawal by Subject|1
767339|NCT00540592|2442753|P2|Overall Study|Withdrawal by Subject|0
767340|NCT00540592|2442754|P1|Overall Study|Withdrawal by Subject|0
767341|NCT00540592|2442745|P10|Overall Study|Lost to Follow-up|0
767342|NCT00540592|2442746|P9|Overall Study|Lost to Follow-up|0
767343|NCT00540592|2442747|P8|Overall Study|Lost to Follow-up|0
767344|NCT00540592|2442748|P7|Overall Study|Lost to Follow-up|0
767345|NCT00540592|2442749|P6|Overall Study|Lost to Follow-up|0
767346|NCT00540592|2442750|P5|Overall Study|Lost to Follow-up|0
767347|NCT00540592|2442751|P4|Overall Study|Lost to Follow-up|0
767348|NCT00540592|2442752|P3|Overall Study|Lost to Follow-up|0
767349|NCT00540592|2442753|P2|Overall Study|Lost to Follow-up|0
767350|NCT00540592|2442754|P1|Overall Study|Lost to Follow-up|2
767351|NCT00540592|2442745|P10|Overall Study|Adverse Event|2
767352|NCT00540592|2442746|P9|Overall Study|Adverse Event|1
767353|NCT00540592|2442747|P8|Overall Study|Adverse Event|1
767354|NCT00540592|2442748|P7|Overall Study|Adverse Event|0
767355|NCT00540592|2442749|P6|Overall Study|Adverse Event|0
767356|NCT00540592|2442750|P5|Overall Study|Adverse Event|1
767357|NCT00540592|2442751|P4|Overall Study|Adverse Event|0
767358|NCT00540592|2442752|P3|Overall Study|Adverse Event|0
767359|NCT00540592|2442753|P2|Overall Study|Adverse Event|1
767360|NCT00540592|2442754|P1|Overall Study|Adverse Event|0
767361|NCT00540644|2442988|P2|Overall Study|Noncomplilance|0
767362|NCT00540644|2442989|P1|Overall Study|Noncomplilance|1
767363|NCT00540644|2442988|P2|Overall Study|Withdrawal by Subject|2
767364|NCT00540644|2442989|P1|Overall Study|Withdrawal by Subject|2
767365|NCT00540644|2442988|P2|Overall Study|Physician Decision|5
767366|NCT00540644|2442989|P1|Overall Study|Physician Decision|0
767367|NCT00540644|2442988|P2|Overall Study|Disease Progression|1
767368|NCT00540644|2442989|P1|Overall Study|Disease Progression|3
767369|NCT00540644|2442988|P2|Overall Study|Adverse Event|1
767370|NCT00540644|2442989|P1|Overall Study|Adverse Event|3
767371|NCT00541034|2443020|P1|Overall Study|Non-Compliance|3
767373|NCT00541229|2443045|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
767374|NCT00541229|2443046|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
767375|NCT00541229|2443047|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
767376|NCT00541229|2443048|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
767377|NCT00541229|2443049|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
767378|NCT00541229|2443050|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
767379|NCT00541229|2443045|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
767380|NCT00541229|2443046|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
767381|NCT00541229|2443047|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
767382|NCT00541229|2443048|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
767383|NCT00541229|2443049|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
767384|NCT00541229|2443050|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
767385|NCT00541229|2443045|P6|Treatment Period III (Week 11)|Adverse Event|0
767386|NCT00541229|2443046|P5|Treatment Period III (Week 11)|Adverse Event|1
767387|NCT00541229|2443047|P4|Treatment Period III (Week 11)|Adverse Event|0
767388|NCT00541229|2443048|P3|Treatment Period III (Week 11)|Adverse Event|0
767389|NCT00541229|2443049|P2|Treatment Period III (Week 11)|Adverse Event|0
767390|NCT00541229|2443050|P1|Treatment Period III (Week 11)|Adverse Event|0
767391|NCT00541229|2443045|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
767392|NCT00541229|2443046|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
767393|NCT00541229|2443047|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
767394|NCT00541229|2443048|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
767395|NCT00541229|2443049|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
767396|NCT00541229|2443050|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
767397|NCT00541229|2443045|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
767398|NCT00541229|2443046|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
767399|NCT00541229|2443047|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
767400|NCT00541229|2443048|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
767401|NCT00541229|2443049|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
767402|NCT00541229|2443050|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
767403|NCT00541229|2443045|P6|Washout Period II (Week 7-10)|Protocol Violation|0
767404|NCT00541229|2443046|P5|Washout Period II (Week 7-10)|Protocol Violation|0
767405|NCT00541229|2443047|P4|Washout Period II (Week 7-10)|Protocol Violation|0
767406|NCT00541229|2443048|P3|Washout Period II (Week 7-10)|Protocol Violation|0
767407|NCT00541229|2443049|P2|Washout Period II (Week 7-10)|Protocol Violation|0
767408|NCT00541229|2443050|P1|Washout Period II (Week 7-10)|Protocol Violation|1
767409|NCT00541229|2443045|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
767410|NCT00541229|2443046|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
767411|NCT00541229|2443047|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
767490|NCT00541450|2443093|P2|Phase A|Withdrawal by Subject|7
767412|NCT00541229|2443048|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
767413|NCT00541229|2443049|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
767414|NCT00541229|2443050|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
767415|NCT00541229|2443045|P6|Treatment Period II (Week 6)|Protocol Violation|1
767416|NCT00541229|2443046|P5|Treatment Period II (Week 6)|Protocol Violation|1
767417|NCT00541229|2443047|P4|Treatment Period II (Week 6)|Protocol Violation|0
767418|NCT00541229|2443048|P3|Treatment Period II (Week 6)|Protocol Violation|0
767419|NCT00541229|2443049|P2|Treatment Period II (Week 6)|Protocol Violation|0
767420|NCT00541229|2443050|P1|Treatment Period II (Week 6)|Protocol Violation|0
767421|NCT00541229|2443045|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
767422|NCT00541229|2443046|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
767423|NCT00541229|2443047|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
767424|NCT00541229|2443048|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
767425|NCT00541229|2443049|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
767426|NCT00541229|2443050|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
767427|NCT00541229|2443045|P6|Washout Period I (Week 2-5)|Protocol Violation|1
767428|NCT00541229|2443046|P5|Washout Period I (Week 2-5)|Protocol Violation|0
767429|NCT00541229|2443047|P4|Washout Period I (Week 2-5)|Protocol Violation|0
767430|NCT00541229|2443048|P3|Washout Period I (Week 2-5)|Protocol Violation|0
767431|NCT00541229|2443049|P2|Washout Period I (Week 2-5)|Protocol Violation|0
767432|NCT00541229|2443050|P1|Washout Period I (Week 2-5)|Protocol Violation|0
767433|NCT00541229|2443045|P6|Washout Period I (Week 2-5)|Physician Decision|0
767434|NCT00541229|2443046|P5|Washout Period I (Week 2-5)|Physician Decision|0
767435|NCT00541229|2443047|P4|Washout Period I (Week 2-5)|Physician Decision|1
767436|NCT00541229|2443048|P3|Washout Period I (Week 2-5)|Physician Decision|0
767437|NCT00541229|2443049|P2|Washout Period I (Week 2-5)|Physician Decision|0
767438|NCT00541229|2443050|P1|Washout Period I (Week 2-5)|Physician Decision|0
767439|NCT00541229|2443045|P6|Washout Period I (Week 2-5)|Adverse Event|0
767440|NCT00541229|2443046|P5|Washout Period I (Week 2-5)|Adverse Event|0
767441|NCT00541229|2443047|P4|Washout Period I (Week 2-5)|Adverse Event|0
767442|NCT00541229|2443048|P3|Washout Period I (Week 2-5)|Adverse Event|1
767443|NCT00541229|2443049|P2|Washout Period I (Week 2-5)|Adverse Event|0
767444|NCT00541229|2443050|P1|Washout Period I (Week 2-5)|Adverse Event|1
767445|NCT00541229|2443045|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
767446|NCT00541229|2443046|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
767447|NCT00541229|2443047|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
767448|NCT00541229|2443048|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
767449|NCT00541229|2443049|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
767450|NCT00541229|2443050|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
767451|NCT00541229|2443045|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
767452|NCT00541229|2443046|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
767453|NCT00541229|2443047|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
767454|NCT00541229|2443048|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
767455|NCT00541229|2443049|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
767456|NCT00541229|2443050|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
767457|NCT00541229|2443045|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
767458|NCT00541229|2443046|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
767459|NCT00541229|2443047|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
767460|NCT00541229|2443048|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
767461|NCT00541229|2443049|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
767462|NCT00541229|2443050|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
767463|NCT00541229|2443045|P6|Treatment Period I (Week 1)|Physician Decision|0
767464|NCT00541229|2443046|P5|Treatment Period I (Week 1)|Physician Decision|0
767465|NCT00541229|2443047|P4|Treatment Period I (Week 1)|Physician Decision|0
767466|NCT00541229|2443048|P3|Treatment Period I (Week 1)|Physician Decision|1
767467|NCT00541229|2443049|P2|Treatment Period I (Week 1)|Physician Decision|0
767468|NCT00541229|2443050|P1|Treatment Period I (Week 1)|Physician Decision|0
767469|NCT00541307|2443069|P1|Overall Study|Surgical Bypass|5
767470|NCT00541307|2443069|P1|Overall Study|Subject returned early (outside window)|1
767471|NCT00541307|2443069|P1|Overall Study|Lost to Follow-up|4
767472|NCT00541307|2443069|P1|Overall Study|Withdrawal by Subject|6
767473|NCT00541307|2443069|P1|Overall Study|Physician Decision|3
767474|NCT00541307|2443069|P1|Overall Study|Death|5
767475|NCT00541346|2443077|P1|Follow-up|Adverse Event|1
767476|NCT00541450|2443093|P2|Phase B|Withdrawal by Subject|6
767477|NCT00541450|2443094|P1|Phase B|Withdrawal by Subject|8
767478|NCT00541450|2443093|P2|Phase B|Protocol Violation|3
767479|NCT00541450|2443094|P1|Phase B|Protocol Violation|3
767480|NCT00541450|2443093|P2|Phase B|Pregnancy|1
767481|NCT00541450|2443094|P1|Phase B|Pregnancy|0
767482|NCT00541450|2443093|P2|Phase B|Physician Decision|2
767483|NCT00541450|2443094|P1|Phase B|Physician Decision|4
767484|NCT00541450|2443093|P2|Phase B|Lost to Follow-up|4
767485|NCT00541450|2443094|P1|Phase B|Lost to Follow-up|6
767486|NCT00541450|2443093|P2|Phase B|Hyperglycemia|9
767487|NCT00541450|2443094|P1|Phase B|Hyperglycemia|10
767488|NCT00541450|2443093|P2|Phase B|Adverse Event|6
767489|NCT00541450|2443094|P1|Phase B|Adverse Event|6
767491|NCT00541450|2443094|P1|Phase A|Withdrawal by Subject|7
767492|NCT00541450|2443093|P2|Phase A|Protocol Violation|3
767493|NCT00541450|2443094|P1|Phase A|Protocol Violation|2
767494|NCT00541450|2443093|P2|Phase A|Physician Decision|0
767495|NCT00541450|2443094|P1|Phase A|Physician Decision|2
767496|NCT00541450|2443093|P2|Phase A|Lost to Follow-up|4
767497|NCT00541450|2443094|P1|Phase A|Lost to Follow-up|6
767498|NCT00541450|2443093|P2|Phase A|Hyperglycemia|1
767499|NCT00541450|2443094|P1|Phase A|Hyperglycemia|0
767500|NCT00541450|2443093|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
767501|NCT00541450|2443094|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
767502|NCT00541450|2443093|P2|Phase A|Adverse Event|0
767503|NCT00541450|2443094|P1|Phase A|Adverse Event|3
767504|NCT00541658|2443119|P3|Overall Study|Took No Study Drug|0
767505|NCT00541658|2443120|P2|Overall Study|Took No Study Drug|0
767506|NCT00541658|2443121|P1|Overall Study|Took No Study Drug|1
767507|NCT00541658|2443119|P3|Overall Study|Withdrawal by Subject|32
767508|NCT00541658|2443120|P2|Overall Study|Withdrawal by Subject|32
767509|NCT00541658|2443121|P1|Overall Study|Withdrawal by Subject|28
767510|NCT00541658|2443119|P3|Overall Study|Protocol Violation|1
767511|NCT00541658|2443120|P2|Overall Study|Protocol Violation|1
767512|NCT00541658|2443121|P1|Overall Study|Protocol Violation|0
767513|NCT00541658|2443119|P3|Overall Study|Lost to Follow-up|6
767514|NCT00541658|2443120|P2|Overall Study|Lost to Follow-up|3
767515|NCT00541658|2443121|P1|Overall Study|Lost to Follow-up|3
767516|NCT00541658|2443119|P3|Overall Study|Physician Decision|4
767517|NCT00541658|2443120|P2|Overall Study|Physician Decision|0
767518|NCT00541658|2443121|P1|Overall Study|Physician Decision|0
767519|NCT00541658|2443119|P3|Overall Study|Adverse Event|25
767520|NCT00541658|2443120|P2|Overall Study|Adverse Event|37
767521|NCT00541658|2443121|P1|Overall Study|Adverse Event|28
767522|NCT00541775|2443290|P3|Overall Study|Withdrawal by Subject and Other|2
767523|NCT00541775|2443291|P2|Overall Study|Withdrawal by Subject and Other|0
767524|NCT00541775|2443292|P1|Overall Study|Withdrawal by Subject and Other|5
767525|NCT00541775|2443290|P3|Overall Study|Protocol Violation|0
767526|NCT00541775|2443291|P2|Overall Study|Protocol Violation|0
767527|NCT00541775|2443292|P1|Overall Study|Protocol Violation|1
767528|NCT00541775|2443290|P3|Overall Study|Lost to Follow-up|2
767529|NCT00541775|2443291|P2|Overall Study|Lost to Follow-up|0
767530|NCT00541775|2443292|P1|Overall Study|Lost to Follow-up|0
767531|NCT00541775|2443290|P3|Overall Study|Lack of Efficacy|3
767532|NCT00541775|2443291|P2|Overall Study|Lack of Efficacy|0
767533|NCT00541775|2443292|P1|Overall Study|Lack of Efficacy|0
767534|NCT00541775|2443290|P3|Overall Study|Adverse Event|1
767535|NCT00541775|2443291|P2|Overall Study|Adverse Event|2
767536|NCT00541775|2443292|P1|Overall Study|Adverse Event|3
767537|NCT00541970|2443310|P4|Month 60|Protocol Violation|72
767538|NCT00541970|2443311|P3|Month 60|Protocol Violation|82
767539|NCT00541970|2443312|P2|Month 60|Protocol Violation|77
767540|NCT00541970|2443313|P1|Month 60|Protocol Violation|78
767541|NCT00541970|2443310|P4|Month 48|Lost to Follow-up|73
767542|NCT00541970|2443311|P3|Month 48|Lost to Follow-up|68
767543|NCT00541970|2443312|P2|Month 48|Lost to Follow-up|68
767544|NCT00541970|2443313|P1|Month 48|Lost to Follow-up|66
767545|NCT00541970|2443310|P4|Month 48|Unspecified|0
767546|NCT00541970|2443311|P3|Month 48|Unspecified|1
767547|NCT00541970|2443312|P2|Month 48|Unspecified|1
767548|NCT00541970|2443313|P1|Month 48|Unspecified|3
767549|NCT00541970|2443310|P4|Month 48|Withdrawal by Subject|2
767550|NCT00541970|2443311|P3|Month 48|Withdrawal by Subject|4
767551|NCT00541970|2443312|P2|Month 48|Withdrawal by Subject|4
767552|NCT00541970|2443313|P1|Month 48|Withdrawal by Subject|2
767553|NCT00541970|2443310|P4|Month 36|Protocol Violation|60
767554|NCT00541970|2443311|P3|Month 36|Protocol Violation|66
767555|NCT00541970|2443312|P2|Month 36|Protocol Violation|66
767556|NCT00541970|2443313|P1|Month 36|Protocol Violation|61
767557|NCT00541970|2443310|P4|Month 24|Protocol Violation|21
767558|NCT00541970|2443311|P3|Month 24|Protocol Violation|31
767559|NCT00541970|2443312|P2|Month 24|Protocol Violation|31
767560|NCT00541970|2443313|P1|Month 24|Protocol Violation|29
767561|NCT00541970|2443310|P4|Month 24|Adverse Event|1
767562|NCT00541970|2443311|P3|Month 24|Adverse Event|1
767563|NCT00541970|2443312|P2|Month 24|Adverse Event|1
767564|NCT00541970|2443313|P1|Month 24|Adverse Event|0
767565|NCT00541970|2443310|P4|Month 18|Protocol Violation|16
767566|NCT00541970|2443311|P3|Month 18|Protocol Violation|24
767567|NCT00541970|2443312|P2|Month 18|Protocol Violation|23
767568|NCT00541970|2443313|P1|Month 18|Protocol Violation|14
767569|NCT00541970|2443310|P4|Month 18|Adverse Event|1
767570|NCT00541970|2443311|P3|Month 18|Adverse Event|1
767571|NCT00541970|2443312|P2|Month 18|Adverse Event|1
767572|NCT00541970|2443313|P1|Month 18|Adverse Event|0
767573|NCT00541970|2443310|P4|Month 12|Protocol Violation|15
767574|NCT00541970|2443311|P3|Month 12|Protocol Violation|20
767575|NCT00541970|2443312|P2|Month 12|Protocol Violation|21
767576|NCT00541970|2443313|P1|Month 12|Protocol Violation|12
767577|NCT00541970|2443310|P4|Month 12|Adverse Event|1
767578|NCT00541970|2443311|P3|Month 12|Adverse Event|1
767579|NCT00541970|2443312|P2|Month 12|Adverse Event|1
767580|NCT00541970|2443313|P1|Month 12|Adverse Event|0
767581|NCT00541970|2443310|P4|Month 7|Protocol Violation|5
767582|NCT00541970|2443311|P3|Month 7|Protocol Violation|11
767583|NCT00541970|2443312|P2|Month 7|Protocol Violation|13
767584|NCT00541970|2443313|P1|Month 7|Protocol Violation|9
767585|NCT00542178|2443468|P8|Overall Study|did not complete year 4 follow-up|85
767586|NCT00542178|2443469|P7|Overall Study|did not complete year 4 follow-up|87
767587|NCT00542178|2443470|P6|Overall Study|did not complete year 4 follow-up|89
767588|NCT00542178|2443471|P5|Overall Study|did not complete year 4 follow-up|64
767589|NCT00542178|2443472|P4|Overall Study|did not complete year 4 follow-up|62
767590|NCT00542178|2443473|P3|Overall Study|did not complete year 4 follow-up|74
767591|NCT00542178|2443474|P2|Overall Study|did not complete year 4 follow-up|80
767592|NCT00542178|2443475|P1|Overall Study|did not complete year 4 follow-up|75
767593|NCT00534976|2443506|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
767594|NCT00534976|2443507|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
767595|NCT00534976|2443506|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
767596|NCT00534976|2443507|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
767597|NCT00534976|2443506|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
767598|NCT00534976|2443507|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
767599|NCT00535132|2443558|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
767600|NCT00535132|2443559|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
767601|NCT00535132|2443558|P2|Safety Analysis Set|Did Not Receive Study Medication|2
767602|NCT00535132|2443559|P1|Safety Analysis Set|Did Not Receive Study Medication|2
767603|NCT00535145|2443609|P1|Phase II|Subject non-compliance|2
767604|NCT00535145|2443609|P1|Phase II|Withdrawal by Subject|5
767605|NCT00535145|2443609|P1|Phase II|Lost to Follow-up|5
767606|NCT00535145|2443609|P1|Phase II|Lack of Efficacy|1
767607|NCT00535145|2443609|P1|Phase II|Adverse Event|2
767608|NCT00535145|2443609|P1|Phase I|(diagnosis)|3
767609|NCT00535145|2443609|P1|Phase I|(PI decision)|1
767610|NCT00535145|2443609|P1|Phase I|(protocol violation)|1
767611|NCT00535145|2443609|P1|Phase I|(eligibility)|8
767612|NCT00535145|2443609|P1|Phase I|Withdrawal by Subject|6
767613|NCT00535145|2443609|P1|Phase I|Lost to Follow-up|7
767614|NCT00535145|2443609|P1|Phase I|Adverse Event|3
767615|NCT00535223|2443621|P2|Overall Study|Withdrawal by Subject|1
767616|NCT00535223|2443622|P1|Overall Study|Withdrawal by Subject|4
767617|NCT00535262|2443630|P1|Overall Study|No funding|3
767618|NCT00535288|2443639|P5|Overall Study|Not specified|1
767619|NCT00535288|2443640|P4|Overall Study|Not specified|2
767620|NCT00535288|2443641|P3|Overall Study|Not specified|1
767621|NCT00535288|2443642|P2|Overall Study|Not specified|1
767622|NCT00535288|2443643|P1|Overall Study|Not specified|2
767623|NCT00535288|2443639|P5|Overall Study|Unwilling to cooperate|4
767624|NCT00535288|2443640|P4|Overall Study|Unwilling to cooperate|3
767625|NCT00535288|2443641|P3|Overall Study|Unwilling to cooperate|3
767626|NCT00535288|2443642|P2|Overall Study|Unwilling to cooperate|6
767627|NCT00535288|2443643|P1|Overall Study|Unwilling to cooperate|6
767628|NCT00535288|2443639|P5|Overall Study|Lack of Efficacy|7
767629|NCT00535288|2443640|P4|Overall Study|Lack of Efficacy|4
767630|NCT00535288|2443641|P3|Overall Study|Lack of Efficacy|4
767631|NCT00535288|2443642|P2|Overall Study|Lack of Efficacy|3
767632|NCT00535288|2443643|P1|Overall Study|Lack of Efficacy|26
767633|NCT00535288|2443639|P5|Overall Study|Lost to Follow-up|0
767634|NCT00535288|2443640|P4|Overall Study|Lost to Follow-up|0
767635|NCT00535288|2443641|P3|Overall Study|Lost to Follow-up|0
767636|NCT00535288|2443642|P2|Overall Study|Lost to Follow-up|3
767637|NCT00535288|2443643|P1|Overall Study|Lost to Follow-up|0
767638|NCT00535288|2443639|P5|Overall Study|Adverse Event|30
767639|NCT00535288|2443640|P4|Overall Study|Adverse Event|20
767640|NCT00535288|2443641|P3|Overall Study|Adverse Event|25
767641|NCT00535288|2443642|P2|Overall Study|Adverse Event|19
767642|NCT00535288|2443643|P1|Overall Study|Adverse Event|20
767643|NCT00535405|2443744|P5|Overall Study|Withdrawal by Subject|8
767644|NCT00535405|2443745|P4|Overall Study|Withdrawal by Subject|10
767645|NCT00535405|2443746|P3|Overall Study|Withdrawal by Subject|10
767646|NCT00535405|2443747|P2|Overall Study|Withdrawal by Subject|11
767647|NCT00535405|2443748|P1|Overall Study|Withdrawal by Subject|5
767648|NCT00535405|2443744|P5|Overall Study|Protocol Violation|0
767649|NCT00535405|2443745|P4|Overall Study|Protocol Violation|1
767650|NCT00535405|2443746|P3|Overall Study|Protocol Violation|2
767651|NCT00535405|2443747|P2|Overall Study|Protocol Violation|2
767652|NCT00535405|2443748|P1|Overall Study|Protocol Violation|2
767653|NCT00535405|2443744|P5|Overall Study|Physician Decision|1
767654|NCT00535405|2443745|P4|Overall Study|Physician Decision|1
767655|NCT00535405|2443746|P3|Overall Study|Physician Decision|0
767656|NCT00535405|2443747|P2|Overall Study|Physician Decision|2
767657|NCT00535405|2443748|P1|Overall Study|Physician Decision|3
767658|NCT00535405|2443744|P5|Overall Study|Lost to Follow-up|1
767659|NCT00535405|2443745|P4|Overall Study|Lost to Follow-up|2
767660|NCT00535405|2443746|P3|Overall Study|Lost to Follow-up|3
767661|NCT00535405|2443747|P2|Overall Study|Lost to Follow-up|3
767662|NCT00535405|2443748|P1|Overall Study|Lost to Follow-up|1
767663|NCT00535405|2443744|P5|Overall Study|Adverse Event|6
767664|NCT00535405|2443745|P4|Overall Study|Adverse Event|8
767665|NCT00535405|2443746|P3|Overall Study|Adverse Event|3
767666|NCT00535405|2443747|P2|Overall Study|Adverse Event|8
767667|NCT00535405|2443748|P1|Overall Study|Adverse Event|6
767668|NCT00535496|2443787|P4|Overall Study|Not treated with sugammadex|0
767669|NCT00535496|2443788|P3|Overall Study|Not treated with sugammadex|0
767670|NCT00535496|2443789|P2|Overall Study|Not treated with sugammadex|1
767671|NCT00535496|2443790|P1|Overall Study|Not treated with sugammadex|0
767672|NCT00535496|2443787|P4|Overall Study|Lost to Follow-up|0
767673|NCT00535496|2443788|P3|Overall Study|Lost to Follow-up|0
767674|NCT00535496|2443789|P2|Overall Study|Lost to Follow-up|1
767675|NCT00535496|2443790|P1|Overall Study|Lost to Follow-up|0
767676|NCT00535730|2443826|P2|Overall Study|Withdrawal by Subject|4
767677|NCT00535730|2443827|P1|Overall Study|Withdrawal by Subject|0
767678|NCT00535730|2443826|P2|Overall Study|Protocol Violation|0
767679|NCT00535730|2443827|P1|Overall Study|Protocol Violation|1
767680|NCT00535730|2443826|P2|Overall Study|Physician Decision|1
767681|NCT00535730|2443827|P1|Overall Study|Physician Decision|0
767682|NCT00535730|2443826|P2|Overall Study|Lost to Follow-up|1
767683|NCT00535730|2443827|P1|Overall Study|Lost to Follow-up|0
767684|NCT00535730|2443826|P2|Overall Study|Adverse Event|1
767685|NCT00535730|2443827|P1|Overall Study|Adverse Event|1
767686|NCT00535847|2443887|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
767687|NCT00535847|2443888|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
767688|NCT00535847|2443889|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
767689|NCT00535847|2443887|P3|Overall Study|Non compliance|0
767690|NCT00535847|2443888|P2|Overall Study|Non compliance|1
767691|NCT00535847|2443889|P1|Overall Study|Non compliance|1
767692|NCT00535847|2443887|P3|Overall Study|Adverse Event|2
767693|NCT00535847|2443888|P2|Overall Study|Adverse Event|3
767694|NCT00535847|2443889|P1|Overall Study|Adverse Event|5
767695|NCT00536107|2443958|P2|Overall Study|Study Termination|4
767696|NCT00536107|2443959|P1|Overall Study|Study Termination|2
767697|NCT00536107|2443958|P2|Overall Study|Withdrawal by Subject|1
767698|NCT00536107|2443959|P1|Overall Study|Withdrawal by Subject|0
767699|NCT00536107|2443958|P2|Overall Study|Incorrect enrolment|0
767700|NCT00536107|2443959|P1|Overall Study|Incorrect enrolment|1
767701|NCT00536107|2443958|P2|Overall Study|Death|1
767702|NCT00536107|2443959|P1|Overall Study|Death|5
767703|NCT00536120|2443969|P2|Overall Study|Missed Study Visit|1
767704|NCT00536120|2443970|P1|Overall Study|Missed Study Visit|0
767705|NCT00536120|2443969|P2|Overall Study|Steroid Use|2
767706|NCT00536120|2443970|P1|Overall Study|Steroid Use|0
767707|NCT00536120|2443969|P2|Overall Study|Sponsor Decision Due to Lab Values|0
767708|NCT00536120|2443970|P1|Overall Study|Sponsor Decision Due to Lab Values|1
767709|NCT00536120|2443969|P2|Overall Study|Non-compliance|0
767710|NCT00536120|2443970|P1|Overall Study|Non-compliance|1
767711|NCT00536120|2443969|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
767712|NCT00536120|2443970|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
767713|NCT00536120|2443969|P2|Overall Study|Lost to Follow-up|0
767714|NCT00536120|2443970|P1|Overall Study|Lost to Follow-up|1
767715|NCT00536198|2443993|P2|Overall Study|Protocol Violation|1
767716|NCT00536198|2443994|P1|Overall Study|Protocol Violation|0
767717|NCT00536198|2443993|P2|Overall Study|Pregnancy|1
767718|NCT00536198|2443994|P1|Overall Study|Pregnancy|1
767719|NCT00536198|2443993|P2|Overall Study|Rescue|9
767720|NCT00536198|2443994|P1|Overall Study|Rescue|3
767721|NCT00536198|2443993|P2|Overall Study|Adverse Event|2
767722|NCT00536198|2443994|P1|Overall Study|Adverse Event|2
767723|NCT00536198|2443993|P2|Overall Study|Withdrawal by Subject|12
767724|NCT00536198|2443994|P1|Overall Study|Withdrawal by Subject|16
767725|NCT00536198|2443993|P2|Overall Study|Lost to Follow-up|14
767726|NCT00536198|2443994|P1|Overall Study|Lost to Follow-up|15
767727|NCT00542269|2444025|P3|Overall Study|Administrative problems|1
767728|NCT00542269|2444026|P2|Overall Study|Administrative problems|1
767729|NCT00542269|2444027|P1|Overall Study|Administrative problems|1
767730|NCT00542269|2444025|P3|Overall Study|Withdrawal by Subject|0
767731|NCT00542269|2444026|P2|Overall Study|Withdrawal by Subject|0
767732|NCT00542269|2444027|P1|Overall Study|Withdrawal by Subject|1
767733|NCT00542269|2444025|P3|Overall Study|Protocol Violation|0
767734|NCT00542269|2444026|P2|Overall Study|Protocol Violation|1
767735|NCT00542269|2444027|P1|Overall Study|Protocol Violation|1
767736|NCT00542269|2444025|P3|Overall Study|Adverse Event|5
767737|NCT00542269|2444026|P2|Overall Study|Adverse Event|4
767738|NCT00542269|2444027|P1|Overall Study|Adverse Event|10
767739|NCT00542321|2444063|P2|Overall Study|Death|1
767740|NCT00542321|2444064|P1|Overall Study|Death|0
767741|NCT00542386|2444084|P6|Overall Study|Other Reasons|2
767742|NCT00542386|2444085|P5|Overall Study|Other Reasons|4
767743|NCT00542386|2444086|P4|Overall Study|Other Reasons|3
767744|NCT00542386|2444087|P3|Overall Study|Other Reasons|4
767745|NCT00542386|2444088|P2|Overall Study|Other Reasons|1
767746|NCT00542386|2444089|P1|Overall Study|Other Reasons|4
767747|NCT00542386|2444084|P6|Overall Study|Withdrawal by Subject|7
767748|NCT00542386|2444085|P5|Overall Study|Withdrawal by Subject|15
767749|NCT00542386|2444086|P4|Overall Study|Withdrawal by Subject|11
767750|NCT00542386|2444087|P3|Overall Study|Withdrawal by Subject|10
767751|NCT00542386|2444088|P2|Overall Study|Withdrawal by Subject|8
767752|NCT00542386|2444089|P1|Overall Study|Withdrawal by Subject|5
767753|NCT00542386|2444084|P6|Overall Study|Protocol Violation|4
767754|NCT00542386|2444085|P5|Overall Study|Protocol Violation|0
767755|NCT00542386|2444086|P4|Overall Study|Protocol Violation|0
767756|NCT00542386|2444087|P3|Overall Study|Protocol Violation|1
767757|NCT00542386|2444088|P2|Overall Study|Protocol Violation|0
767758|NCT00542386|2444089|P1|Overall Study|Protocol Violation|0
767759|NCT00542386|2444084|P6|Overall Study|Physician Decision|0
767760|NCT00542386|2444085|P5|Overall Study|Physician Decision|0
767761|NCT00542386|2444086|P4|Overall Study|Physician Decision|1
767762|NCT00542386|2444087|P3|Overall Study|Physician Decision|0
767763|NCT00542386|2444088|P2|Overall Study|Physician Decision|0
767764|NCT00542386|2444089|P1|Overall Study|Physician Decision|1
767765|NCT00542386|2444084|P6|Overall Study|Lack of Efficacy|31
767766|NCT00542386|2444085|P5|Overall Study|Lack of Efficacy|7
767767|NCT00542386|2444086|P4|Overall Study|Lack of Efficacy|13
767768|NCT00542386|2444087|P3|Overall Study|Lack of Efficacy|10
767769|NCT00542386|2444088|P2|Overall Study|Lack of Efficacy|12
767770|NCT00542386|2444089|P1|Overall Study|Lack of Efficacy|32
767771|NCT00542386|2444084|P6|Overall Study|Death|2
767772|NCT00542386|2444085|P5|Overall Study|Death|1
767773|NCT00542386|2444086|P4|Overall Study|Death|2
767774|NCT00542386|2444087|P3|Overall Study|Death|1
767775|NCT00542386|2444088|P2|Overall Study|Death|0
767776|NCT00542386|2444089|P1|Overall Study|Death|0
767777|NCT00542386|2444084|P6|Overall Study|Adverse Event|4
767778|NCT00542386|2444085|P5|Overall Study|Adverse Event|13
767779|NCT00542386|2444086|P4|Overall Study|Adverse Event|8
767780|NCT00542386|2444087|P3|Overall Study|Adverse Event|7
767781|NCT00542386|2444088|P2|Overall Study|Adverse Event|7
767782|NCT00542386|2444089|P1|Overall Study|Adverse Event|1
891468|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
891469|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
891470|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
891471|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
891472|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Protocol Violation|2
891473|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Protocol Violation|4
891474|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Protocol Violation|0
891475|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
891476|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
891477|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
891478|NCT01706328|2827800|P3|12-week Double-blind Treatment Period|Adverse Event|16
891479|NCT01706328|2827801|P2|12-week Double-blind Treatment Period|Adverse Event|14
891480|NCT01706328|2827802|P1|12-week Double-blind Treatment Period|Adverse Event|0
891481|NCT01706328|2827800|P3|2-week Run-in Period|Lost to Follow-up|0
891482|NCT01706328|2827801|P2|2-week Run-in Period|Lost to Follow-up|0
891483|NCT01706328|2827802|P1|2-week Run-in Period|Lost to Follow-up|2
891484|NCT01706328|2827800|P3|2-week Run-in Period|Adverse Event|0
891485|NCT01706328|2827801|P2|2-week Run-in Period|Adverse Event|0
891486|NCT01706328|2827802|P1|2-week Run-in Period|Adverse Event|4
891487|NCT01706328|2827800|P3|2-week Run-in Period|Physician Decision|0
891488|NCT01706328|2827801|P2|2-week Run-in Period|Physician Decision|0
891489|NCT01706328|2827802|P1|2-week Run-in Period|Physician Decision|4
891490|NCT01706328|2827800|P3|2-week Run-in Period|Withdrawal by Subject|0
891491|NCT01706328|2827801|P2|2-week Run-in Period|Withdrawal by Subject|0
891492|NCT01706328|2827802|P1|2-week Run-in Period|Withdrawal by Subject|15
891493|NCT01706328|2827800|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
891494|NCT01706328|2827801|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
891495|NCT01706328|2827802|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
891496|NCT01686633|2827815|P3|Overall Study|Lost to Follow-up|1
891497|NCT01686633|2827816|P2|Overall Study|Lost to Follow-up|1
891498|NCT01686633|2827817|P1|Overall Study|Lost to Follow-up|0
891499|NCT01686633|2827815|P3|Overall Study|Protocol-defined Stopping Criteria|1
891500|NCT01686633|2827816|P2|Overall Study|Protocol-defined Stopping Criteria|0
891501|NCT01686633|2827817|P1|Overall Study|Protocol-defined Stopping Criteria|1
891502|NCT01686633|2827815|P3|Overall Study|Protocol Violation|0
891503|NCT01686633|2827816|P2|Overall Study|Protocol Violation|3
891504|NCT01686633|2827817|P1|Overall Study|Protocol Violation|2
891505|NCT01686633|2827815|P3|Overall Study|Adverse Event|3
891506|NCT01686633|2827816|P2|Overall Study|Adverse Event|3
891507|NCT01686633|2827817|P1|Overall Study|Adverse Event|4
891508|NCT01686633|2827815|P3|Overall Study|Physician Decision|4
891509|NCT01686633|2827816|P2|Overall Study|Physician Decision|4
891510|NCT01686633|2827817|P1|Overall Study|Physician Decision|3
891511|NCT01686633|2827815|P3|Overall Study|Withdrawal by Subject|5
891512|NCT01686633|2827816|P2|Overall Study|Withdrawal by Subject|8
891513|NCT01686633|2827817|P1|Overall Study|Withdrawal by Subject|8
891514|NCT01686633|2827815|P3|Overall Study|Lack of Efficacy|11
891515|NCT01686633|2827816|P2|Overall Study|Lack of Efficacy|13
891516|NCT01686633|2827817|P1|Overall Study|Lack of Efficacy|33
891517|NCT01630616|2827868|P6|Overall Study|Withdrawal by Subject|0
891518|NCT01630616|2827869|P5|Overall Study|Withdrawal by Subject|0
891519|NCT01630616|2827870|P4|Overall Study|Withdrawal by Subject|2
891520|NCT01630616|2827871|P3|Overall Study|Withdrawal by Subject|0
891521|NCT01630616|2827872|P2|Overall Study|Withdrawal by Subject|0
891522|NCT01630616|2827873|P1|Overall Study|Withdrawal by Subject|0
891523|NCT01630616|2827868|P6|Overall Study|Adverse Event|0
891524|NCT01630616|2827869|P5|Overall Study|Adverse Event|0
891525|NCT01630616|2827870|P4|Overall Study|Adverse Event|1
767843|NCT00542880|2444166|P2|Period 3|Adverse Event|2
767844|NCT00542880|2444167|P1|Period 3|Adverse Event|0
767845|NCT00542880|2444166|P2|Period 2|Not specified|1
767846|NCT00542880|2444167|P1|Period 2|Not specified|0
767847|NCT00542880|2444166|P2|Period 2|Severe non-compliance|1
767848|NCT00542880|2444167|P1|Period 2|Severe non-compliance|0
767849|NCT00542880|2444166|P2|Period 2|Discontinuation criteria|0
767850|NCT00542880|2444167|P1|Period 2|Discontinuation criteria|2
767851|NCT00542880|2444166|P2|Period 2|Eligibility not fulfilled|1
767852|NCT00542880|2444167|P1|Period 2|Eligibility not fulfilled|0
767853|NCT00542880|2444166|P2|Period 2|Adverse Event|7
767854|NCT00542880|2444167|P1|Period 2|Adverse Event|5
767855|NCT00542880|2444166|P2|Period 1|Protocol Violation|1
767856|NCT00542880|2444167|P1|Period 1|Protocol Violation|0
767857|NCT00542880|2444166|P2|Period 1|Withdrawal by Subject|1
767858|NCT00542880|2444167|P1|Period 1|Withdrawal by Subject|1
767859|NCT00542880|2444166|P2|Period 1|Development of study-specific criteria|2
767860|NCT00542880|2444167|P1|Period 1|Development of study-specific criteria|1
767861|NCT00542880|2444166|P2|Period 1|Adverse Event|2
767862|NCT00542880|2444167|P1|Period 1|Adverse Event|2
767863|NCT00542880|2444166|P2|Period 1|Eligibility criteria not fulfilled|6
767864|NCT00542880|2444167|P1|Period 1|Eligibility criteria not fulfilled|2
767865|NCT00542997|2444208|P1|Efficacy Period|Adverse Event|3
767866|NCT00542997|2444208|P1|Wash in / Wash Out Period|Adverse Event|3
767867|NCT00542997|2444208|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
767868|NCT00543140|2444238|P1|Overall Study|Conversion to different procedure|1
767869|NCT00543140|2444238|P1|Overall Study|Subject moved|1
767870|NCT00543140|2444238|P1|Overall Study|Death|1
767871|NCT00543140|2444238|P1|Overall Study|SAE leading to explant of SAGB|3
767872|NCT00543140|2444238|P1|Overall Study|Insufficient weight loss|10
767873|NCT00543140|2444238|P1|Overall Study|Protocol Violation|10
767874|NCT00543140|2444238|P1|Overall Study|Withdrawal by Subject|13
767875|NCT00543140|2444238|P1|Overall Study|Lost to Follow-up|33
767876|NCT00543296|2444246|P1|Overall Study|Physician Decision|7
767921|NCT00543569|2444305|P4|Overall Study|Randomized but never received study drug|3
767922|NCT00543569|2444306|P3|Overall Study|Randomized but never received study drug|5
767923|NCT00543569|2444307|P2|Overall Study|Randomized but never received study drug|3
767924|NCT00543569|2444308|P1|Overall Study|Randomized but never received study drug|3
767925|NCT00543569|2444305|P4|Overall Study|Miscellaneous Reasons|4
767926|NCT00543569|2444306|P3|Overall Study|Miscellaneous Reasons|11
767927|NCT00543569|2444307|P2|Overall Study|Miscellaneous Reasons|3
767928|NCT00543569|2444308|P1|Overall Study|Miscellaneous Reasons|7
767929|NCT00543569|2444305|P4|Overall Study|Lost to Follow-up|1
767930|NCT00543569|2444306|P3|Overall Study|Lost to Follow-up|1
767931|NCT00543569|2444307|P2|Overall Study|Lost to Follow-up|0
767932|NCT00543569|2444308|P1|Overall Study|Lost to Follow-up|0
767933|NCT00543569|2444305|P4|Overall Study|Death|1
767934|NCT00543569|2444306|P3|Overall Study|Death|3
767935|NCT00543569|2444307|P2|Overall Study|Death|2
767936|NCT00543569|2444308|P1|Overall Study|Death|2
767937|NCT00543725|2444412|P2|Overall Study|Not specified|3
767938|NCT00543725|2444413|P1|Overall Study|Not specified|3
767939|NCT00543725|2444412|P2|Overall Study|Lost to Follow-up|11
767940|NCT00543725|2444413|P1|Overall Study|Lost to Follow-up|15
767941|NCT00543725|2444412|P2|Overall Study|Withdrawal by Subject|13
767942|NCT00543725|2444413|P1|Overall Study|Withdrawal by Subject|4
767943|NCT00543725|2444412|P2|Overall Study|Protocol Violation|1
767944|NCT00543725|2444413|P1|Overall Study|Protocol Violation|0
767945|NCT00543725|2444412|P2|Overall Study|Subject Reached A Virologic Endpoint|14
767946|NCT00543725|2444413|P1|Overall Study|Subject Reached A Virologic Endpoint|22
767947|NCT00543725|2444412|P2|Overall Study|Subject Ineligible To Continue The Trial|0
767948|NCT00543725|2444413|P1|Overall Study|Subject Ineligible To Continue The Trial|2
767949|NCT00543725|2444412|P2|Overall Study|Subject Non-Compliant|4
767950|NCT00543725|2444413|P1|Overall Study|Subject Non-Compliant|4
767951|NCT00543725|2444412|P2|Overall Study|Sponsor's Decision|1
767952|NCT00543725|2444413|P1|Overall Study|Sponsor's Decision|0
767953|NCT00543725|2444412|P2|Overall Study|Adverse Event|27
767954|NCT00543725|2444413|P1|Overall Study|Adverse Event|18
767955|NCT00543803|2444444|P1|Overall Study|not specified|86
767956|NCT00543803|2444444|P1|Overall Study|Lost to Follow-up|20
767957|NCT00543803|2444444|P1|Overall Study|Lack of Efficacy|22
767958|NCT00543803|2444444|P1|Overall Study|Adverse Event|14
767959|NCT00543855|2444465|P4|Overall Study|Protocol Violation|0
767960|NCT00543855|2444466|P3|Overall Study|Protocol Violation|0
767961|NCT00543855|2444467|P2|Overall Study|Protocol Violation|0
767962|NCT00543855|2444468|P1|Overall Study|Protocol Violation|1
767963|NCT00543855|2444465|P4|Overall Study|Withdrawal by Subject|0
767964|NCT00543855|2444466|P3|Overall Study|Withdrawal by Subject|2
767965|NCT00543855|2444467|P2|Overall Study|Withdrawal by Subject|1
767966|NCT00543855|2444468|P1|Overall Study|Withdrawal by Subject|0
767967|NCT00543855|2444465|P4|Overall Study|Lost to Follow-up|0
767968|NCT00543855|2444466|P3|Overall Study|Lost to Follow-up|1
767969|NCT00543855|2444467|P2|Overall Study|Lost to Follow-up|0
767970|NCT00543855|2444468|P1|Overall Study|Lost to Follow-up|0
767971|NCT00543855|2444465|P4|Overall Study|Adverse Event|4
767972|NCT00543855|2444466|P3|Overall Study|Adverse Event|3
767973|NCT00543855|2444467|P2|Overall Study|Adverse Event|1
767974|NCT00543855|2444468|P1|Overall Study|Adverse Event|3
767975|NCT00543985|2444490|P1|Overall Study|Withdrawal by Subject|4
767976|NCT00544167|2444497|P1|Overall Study|Physician Decision|8
767977|NCT00544167|2444497|P1|Overall Study|Adverse Event|21
767978|NCT00544440|2444501|P1|Overall Study|Unspecified|5
767979|NCT00544440|2444501|P1|Overall Study|Progressive Disease|47
767980|NCT00544440|2444501|P1|Overall Study|Subject Non-compliance|1
767981|NCT00544440|2444501|P1|Overall Study|Withdrawal by Subject|2
767982|NCT00544440|2444501|P1|Overall Study|Adverse Event|1
767983|NCT00544440|2444501|P1|Overall Study|Other|1
767984|NCT00544544|2444508|P1|Overall Study|Lost to Follow-up|1
767985|NCT00544544|2444508|P1|Overall Study|Adverse Event|1
767986|NCT00544544|2444508|P1|Overall Study|Withdrawal by Subject|1
767987|NCT00544557|2444512|P1|Overall Study|Unspecified|98
767988|NCT00544557|2444512|P1|Overall Study|Lack of Efficacy|196
767989|NCT00544557|2444512|P1|Overall Study|Adverse Event|140
767990|NCT00544648|2444545|P2|Overall Study|progression of disease|0
767991|NCT00544648|2444546|P1|Overall Study|progression of disease|1
767992|NCT00544648|2444545|P2|Overall Study|Adverse Event|1
767993|NCT00544648|2444546|P1|Overall Study|Adverse Event|1
767994|NCT00544648|2444545|P2|Overall Study|Withdrawal by Subject|0
767995|NCT00544648|2444546|P1|Overall Study|Withdrawal by Subject|1
767996|NCT00544817|2444601|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
767997|NCT00544817|2444601|P1|Follow-up Systemic Therapy|Physician Decision|3
767998|NCT00544817|2444601|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
767999|NCT00544817|2444601|P1|No Treatment Interval|Adverse Event|1
768000|NCT00544817|2444601|P1|No Treatment Interval|Physician Decision|3
768001|NCT00544817|2444601|P1|No Treatment Interval|Lack of Efficacy|8
768002|NCT00544817|2444601|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
768003|NCT00544817|2444601|P1|Combined Modality|Adverse Event|2
768004|NCT00544817|2444601|P1|Combined Modality|Worsening Neurologic Symptoms|2
768005|NCT00544817|2444601|P1|Combined Modality|Lack of Efficacy|2
768006|NCT00544869|2444610|P3|Overall Study|Physician Decision|0
768007|NCT00544869|2444611|P2|Overall Study|Physician Decision|0
768008|NCT00544869|2444612|P1|Overall Study|Physician Decision|2
768009|NCT00544869|2444610|P3|Overall Study|Lack of Efficacy|0
768010|NCT00544869|2444611|P2|Overall Study|Lack of Efficacy|1
768011|NCT00544869|2444612|P1|Overall Study|Lack of Efficacy|1
768012|NCT00544869|2444610|P3|Overall Study|Adverse Event|0
768013|NCT00544869|2444611|P2|Overall Study|Adverse Event|1
768014|NCT00544869|2444612|P1|Overall Study|Adverse Event|6
768015|NCT00544869|2444610|P3|Overall Study|Rsolution of congenitive symptoms|0
768016|NCT00544869|2444611|P2|Overall Study|Rsolution of congenitive symptoms|0
768017|NCT00544869|2444612|P1|Overall Study|Rsolution of congenitive symptoms|3
768018|NCT00544882|2444622|P3|Cycle 3: Follow-up|Pregnancy|0
768019|NCT00544882|2444623|P2|Cycle 3: Follow-up|Pregnancy|1
768020|NCT00544882|2444624|P1|Cycle 3: Follow-up|Pregnancy|0
768021|NCT00544882|2444622|P3|Cycle 3: Follow-up|Noncompliance|0
768022|NCT00544882|2444623|P2|Cycle 3: Follow-up|Noncompliance|1
768023|NCT00544882|2444624|P1|Cycle 3: Follow-up|Noncompliance|0
768024|NCT00544882|2444622|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
768025|NCT00544882|2444623|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
768026|NCT00544882|2444624|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
768027|NCT00544882|2444622|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
768028|NCT00544882|2444623|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
768029|NCT00544882|2444624|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
768030|NCT00544882|2444622|P3|Cycle 1: Run-in Cycle|Adverse Event|0
768031|NCT00544882|2444623|P2|Cycle 1: Run-in Cycle|Adverse Event|0
768032|NCT00544882|2444624|P1|Cycle 1: Run-in Cycle|Adverse Event|1
768033|NCT00544882|2444622|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
768034|NCT00544882|2444623|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
768035|NCT00544882|2444624|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
768036|NCT00545051|2444676|P2|Overall Study|Administrative reasons|1
768037|NCT00545051|2444677|P1|Overall Study|Administrative reasons|0
768038|NCT00545051|2444676|P2|Overall Study|Withdrawal by Subject|1
768039|NCT00545051|2444677|P1|Overall Study|Withdrawal by Subject|0
768040|NCT00545051|2444676|P2|Overall Study|Protocol Violation|0
768041|NCT00545051|2444677|P1|Overall Study|Protocol Violation|1
768042|NCT00545051|2444676|P2|Overall Study|Violation of inclusion/exclusion|2
768043|NCT00545051|2444677|P1|Overall Study|Violation of inclusion/exclusion|0
768044|NCT00545051|2444676|P2|Overall Study|Death|0
768045|NCT00545051|2444677|P1|Overall Study|Death|1
768046|NCT00545051|2444676|P2|Overall Study|Adverse Event|3
768047|NCT00545051|2444677|P1|Overall Study|Adverse Event|7
768048|NCT00545064|2444691|P1|Overall Study|inclement weather|1
768049|NCT00545064|2444691|P1|Overall Study|cancel all appointments, no rebooking|1
768050|NCT00545064|2444691|P1|Overall Study|did not complete course of treatment|1
768051|NCT00545064|2444691|P1|Overall Study|Withdrawal by Subject|2
768052|NCT00545064|2444691|P1|Overall Study|Lost to Follow-up|3
768053|NCT00545103|2444704|P4|Overall Study|Death|0
768054|NCT00545103|2444705|P3|Overall Study|Death|0
768055|NCT00545103|2444706|P2|Overall Study|Death|1
768056|NCT00545103|2444707|P1|Overall Study|Death|0
768057|NCT00545103|2444704|P4|Overall Study|Subject met endpoint under protocol v. 1|0
768058|NCT00545103|2444705|P3|Overall Study|Subject met endpoint under protocol v. 1|1
768059|NCT00545103|2444706|P2|Overall Study|Subject met endpoint under protocol v. 1|0
768060|NCT00545103|2444707|P1|Overall Study|Subject met endpoint under protocol v. 1|0
768061|NCT00545103|2444704|P4|Overall Study|Does not want to take study drug anymore|0
768062|NCT00545103|2444705|P3|Overall Study|Does not want to take study drug anymore|1
768063|NCT00545103|2444706|P2|Overall Study|Does not want to take study drug anymore|0
768064|NCT00545103|2444707|P1|Overall Study|Does not want to take study drug anymore|1
768065|NCT00545103|2444704|P4|Overall Study|Use of prohibited medication|0
768066|NCT00545103|2444705|P3|Overall Study|Use of prohibited medication|1
768067|NCT00545103|2444706|P2|Overall Study|Use of prohibited medication|0
768068|NCT00545103|2444707|P1|Overall Study|Use of prohibited medication|0
768069|NCT00545103|2444704|P4|Overall Study|Subject moved|0
768070|NCT00545103|2444705|P3|Overall Study|Subject moved|0
768071|NCT00545103|2444706|P2|Overall Study|Subject moved|1
768072|NCT00545103|2444707|P1|Overall Study|Subject moved|0
768073|NCT00545103|2444704|P4|Overall Study|Investigator decision|0
768074|NCT00545103|2444705|P3|Overall Study|Investigator decision|1
768075|NCT00545103|2444706|P2|Overall Study|Investigator decision|0
768076|NCT00545103|2444707|P1|Overall Study|Investigator decision|0
768077|NCT00545103|2444704|P4|Overall Study|Noncompliance|0
768078|NCT00545103|2444705|P3|Overall Study|Noncompliance|0
768079|NCT00545103|2444706|P2|Overall Study|Noncompliance|1
768080|NCT00545103|2444707|P1|Overall Study|Noncompliance|0
768081|NCT00545103|2444704|P4|Overall Study|Subject's decision|0
768082|NCT00545103|2444705|P3|Overall Study|Subject's decision|0
768083|NCT00545103|2444706|P2|Overall Study|Subject's decision|0
768084|NCT00545103|2444707|P1|Overall Study|Subject's decision|1
768085|NCT00545103|2444704|P4|Overall Study|Personal reasons|0
768086|NCT00545103|2444705|P3|Overall Study|Personal reasons|0
768087|NCT00545103|2444706|P2|Overall Study|Personal reasons|0
768088|NCT00545103|2444707|P1|Overall Study|Personal reasons|1
768089|NCT00545103|2444704|P4|Overall Study|Diverticulitis crisis|1
768090|NCT00545103|2444705|P3|Overall Study|Diverticulitis crisis|0
768091|NCT00545103|2444706|P2|Overall Study|Diverticulitis crisis|0
768092|NCT00545103|2444707|P1|Overall Study|Diverticulitis crisis|0
768093|NCT00545103|2444704|P4|Overall Study|Wish to start a family|1
768094|NCT00545103|2444705|P3|Overall Study|Wish to start a family|0
768095|NCT00545103|2444706|P2|Overall Study|Wish to start a family|0
768096|NCT00545103|2444707|P1|Overall Study|Wish to start a family|0
768097|NCT00545103|2444704|P4|Overall Study|Investigational product not taken|1
768098|NCT00545103|2444705|P3|Overall Study|Investigational product not taken|0
768099|NCT00545103|2444706|P2|Overall Study|Investigational product not taken|0
768100|NCT00545103|2444707|P1|Overall Study|Investigational product not taken|1
768101|NCT00545103|2444704|P4|Overall Study|Difficult to open package|1
768102|NCT00545103|2444705|P3|Overall Study|Difficult to open package|0
768103|NCT00545103|2444706|P2|Overall Study|Difficult to open package|0
768104|NCT00545103|2444707|P1|Overall Study|Difficult to open package|0
768105|NCT00545103|2444704|P4|Overall Study|Suspected recurrence of diverticulitis|3
768106|NCT00545103|2444705|P3|Overall Study|Suspected recurrence of diverticulitis|0
768107|NCT00545103|2444706|P2|Overall Study|Suspected recurrence of diverticulitis|0
768108|NCT00545103|2444707|P1|Overall Study|Suspected recurrence of diverticulitis|1
768109|NCT00545103|2444704|P4|Overall Study|Protocol Violation|0
768110|NCT00545103|2444705|P3|Overall Study|Protocol Violation|3
768111|NCT00545103|2444706|P2|Overall Study|Protocol Violation|2
768112|NCT00545103|2444707|P1|Overall Study|Protocol Violation|1
768113|NCT00545103|2444704|P4|Overall Study|Lost to Follow-up|4
768114|NCT00545103|2444705|P3|Overall Study|Lost to Follow-up|3
768115|NCT00545103|2444706|P2|Overall Study|Lost to Follow-up|6
768116|NCT00545103|2444707|P1|Overall Study|Lost to Follow-up|4
768117|NCT00545103|2444704|P4|Overall Study|Adverse Event|10
768118|NCT00545103|2444705|P3|Overall Study|Adverse Event|17
768119|NCT00545103|2444706|P2|Overall Study|Adverse Event|12
768120|NCT00545103|2444707|P1|Overall Study|Adverse Event|11
768121|NCT00545103|2444704|P4|Overall Study|Withdrawal by Subject|22
768122|NCT00545103|2444705|P3|Overall Study|Withdrawal by Subject|18
768123|NCT00545103|2444706|P2|Overall Study|Withdrawal by Subject|10
768124|NCT00545103|2444707|P1|Overall Study|Withdrawal by Subject|6
768125|NCT00545103|2444704|P4|Overall Study|Lack of Efficacy|27
768126|NCT00545103|2444705|P3|Overall Study|Lack of Efficacy|31
768127|NCT00545103|2444706|P2|Overall Study|Lack of Efficacy|45
768128|NCT00545103|2444707|P1|Overall Study|Lack of Efficacy|48
768129|NCT00545168|2444757|P3|Overall Study|Visit for Day 21 was not done in error|2
768130|NCT00545168|2444758|P2|Overall Study|Visit for Day 21 was not done in error|0
768131|NCT00545168|2444759|P1|Overall Study|Visit for Day 21 was not done in error|1
768132|NCT00545168|2444757|P3|Overall Study|Protocol Violation|1
768133|NCT00545168|2444758|P2|Overall Study|Protocol Violation|0
768134|NCT00545168|2444759|P1|Overall Study|Protocol Violation|1
768135|NCT00545168|2444757|P3|Overall Study|Withdrawal by Subject|13
768136|NCT00545168|2444758|P2|Overall Study|Withdrawal by Subject|0
768137|NCT00545168|2444759|P1|Overall Study|Withdrawal by Subject|9
768138|NCT00545168|2444757|P3|Overall Study|Lost to Follow-up|5
768139|NCT00545168|2444758|P2|Overall Study|Lost to Follow-up|5
768140|NCT00545168|2444759|P1|Overall Study|Lost to Follow-up|5
768141|NCT00545233|2444779|P2|Overall Study|Physician Decision|1
768142|NCT00545233|2444780|P1|Overall Study|Physician Decision|2
768143|NCT00545233|2444779|P2|Overall Study|Insufficient response|15
768144|NCT00545233|2444780|P1|Overall Study|Insufficient response|14
768145|NCT00545233|2444779|P2|Overall Study|Failure to Return|6
768146|NCT00545233|2444780|P1|Overall Study|Failure to Return|4
768147|NCT00545233|2444779|P2|Overall Study|Refused Treatment|7
768148|NCT00545233|2444780|P1|Overall Study|Refused Treatment|9
768149|NCT00545233|2444779|P2|Overall Study|Protocol Violation|0
768150|NCT00545233|2444780|P1|Overall Study|Protocol Violation|2
768151|NCT00545233|2444779|P2|Overall Study|Violation of Selection Criteria at Entry|1
768152|NCT00545233|2444780|P1|Overall Study|Violation of Selection Criteria at Entry|5
768153|NCT00545233|2444779|P2|Overall Study|Adverse Event|5
768154|NCT00545233|2444780|P1|Overall Study|Adverse Event|10
768155|NCT00545272|2444833|P6|Overall Study|Lost to Follow-up|0
768156|NCT00545272|2444834|P5|Overall Study|Lost to Follow-up|1
768157|NCT00545272|2444835|P4|Overall Study|Lost to Follow-up|0
768158|NCT00545272|2444836|P3|Overall Study|Lost to Follow-up|0
768159|NCT00545272|2444837|P2|Overall Study|Lost to Follow-up|0
768160|NCT00545272|2444838|P1|Overall Study|Lost to Follow-up|0
768161|NCT00545272|2444833|P6|Overall Study|Abnormal test procedure result(s)|0
768162|NCT00545272|2444834|P5|Overall Study|Abnormal test procedure result(s)|1
768163|NCT00545272|2444835|P4|Overall Study|Abnormal test procedure result(s)|0
768164|NCT00545272|2444836|P3|Overall Study|Abnormal test procedure result(s)|0
768165|NCT00545272|2444837|P2|Overall Study|Abnormal test procedure result(s)|0
768166|NCT00545272|2444838|P1|Overall Study|Abnormal test procedure result(s)|0
768167|NCT00545272|2444833|P6|Overall Study|Abnormal laboratory value(s)|1
768168|NCT00545272|2444834|P5|Overall Study|Abnormal laboratory value(s)|0
768169|NCT00545272|2444835|P4|Overall Study|Abnormal laboratory value(s)|0
768170|NCT00545272|2444836|P3|Overall Study|Abnormal laboratory value(s)|0
768171|NCT00545272|2444837|P2|Overall Study|Abnormal laboratory value(s)|0
768172|NCT00545272|2444838|P1|Overall Study|Abnormal laboratory value(s)|0
768173|NCT00545272|2444833|P6|Overall Study|Adverse Event|1
768174|NCT00545272|2444834|P5|Overall Study|Adverse Event|0
768175|NCT00545272|2444835|P4|Overall Study|Adverse Event|0
768176|NCT00545272|2444836|P3|Overall Study|Adverse Event|1
768177|NCT00545272|2444837|P2|Overall Study|Adverse Event|0
768178|NCT00545272|2444838|P1|Overall Study|Adverse Event|0
768179|NCT00545272|2444833|P6|Overall Study|Protocol deviation|1
768180|NCT00545272|2444834|P5|Overall Study|Protocol deviation|0
768181|NCT00545272|2444835|P4|Overall Study|Protocol deviation|1
768182|NCT00545272|2444836|P3|Overall Study|Protocol deviation|0
768183|NCT00545272|2444837|P2|Overall Study|Protocol deviation|1
768184|NCT00545272|2444838|P1|Overall Study|Protocol deviation|0
768185|NCT00545298|2444891|P3|Overall Study|Issues with Standard of Care|1
768186|NCT00545298|2444892|P2|Overall Study|Issues with Standard of Care|0
768187|NCT00545298|2444893|P1|Overall Study|Issues with Standard of Care|2
768188|NCT00545363|2444906|P2|Overall Study|Unspecified|1
768189|NCT00545363|2444907|P1|Overall Study|Unspecified|1
768190|NCT00545363|2444906|P2|Overall Study|Lost to Follow-up|0
768191|NCT00545363|2444907|P1|Overall Study|Lost to Follow-up|2
768192|NCT00545363|2444906|P2|Overall Study|Did not meet entry criteria|1
768193|NCT00545363|2444907|P1|Overall Study|Did not meet entry criteria|1
768194|NCT00545363|2444906|P2|Overall Study|Non-compliance|1
768195|NCT00545363|2444907|P1|Overall Study|Non-compliance|3
768196|NCT00545363|2444906|P2|Overall Study|Withdrawal by Subject|5
768197|NCT00545363|2444907|P1|Overall Study|Withdrawal by Subject|6
768198|NCT00545363|2444906|P2|Overall Study|Adverse Event|7
768199|NCT00545363|2444907|P1|Overall Study|Adverse Event|6
768200|NCT00539188|2444930|P2|Overall Study|Lost to Follow-up|1
768201|NCT00539188|2444931|P1|Overall Study|Lost to Follow-up|2
768202|NCT00539188|2444930|P2|Overall Study|Withdrawal by Subject|0
768203|NCT00539188|2444931|P1|Overall Study|Withdrawal by Subject|1
768204|NCT00539240|2444946|P3|Overall Study|Adverse Event|10
768205|NCT00539240|2444947|P2|Overall Study|Adverse Event|1
768206|NCT00539240|2444948|P1|Overall Study|Adverse Event|3
768207|NCT00539240|2444946|P3|Overall Study|Lost to Follow-up|1
768208|NCT00539240|2444947|P2|Overall Study|Lost to Follow-up|3
768209|NCT00539240|2444948|P1|Overall Study|Lost to Follow-up|2
768210|NCT00539240|2444946|P3|Overall Study|Protocol Violation|4
768211|NCT00539240|2444947|P2|Overall Study|Protocol Violation|1
768212|NCT00539240|2444948|P1|Overall Study|Protocol Violation|1
768213|NCT00539240|2444946|P3|Overall Study|Withdrawal by Subject|0
768214|NCT00539240|2444947|P2|Overall Study|Withdrawal by Subject|2
768215|NCT00539240|2444948|P1|Overall Study|Withdrawal by Subject|0
768216|NCT00539279|2444972|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
768217|NCT00539279|2444973|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
768218|NCT00539279|2444972|P2|Post-Treatment Assessment|Lost to Follow-up|9
768219|NCT00539279|2444973|P1|Post-Treatment Assessment|Lost to Follow-up|12
768220|NCT00539279|2444972|P2|Treatment|Death|0
768221|NCT00539279|2444973|P1|Treatment|Death|1
768222|NCT00539279|2444972|P2|Treatment|Withdrawal by Subject|8
768223|NCT00539279|2444973|P1|Treatment|Withdrawal by Subject|10
768224|NCT00539305|2444993|P2|Overall Study|Withdrawal by Subject|1
768225|NCT00539305|2444994|P1|Overall Study|Withdrawal by Subject|0
768226|NCT00539305|2444993|P2|Overall Study|Substance Use|1
768227|NCT00539305|2444994|P1|Overall Study|Substance Use|0
768228|NCT00539305|2444993|P2|Overall Study|Adverse Event|0
768229|NCT00539305|2444994|P1|Overall Study|Adverse Event|1
768230|NCT00539513|2445008|P2|Overall Study|Lost to Follow-up|1
768231|NCT00539513|2445009|P1|Overall Study|Lost to Follow-up|0
768232|NCT00539513|2445008|P2|Overall Study|Withdrawal by Subject|1
768233|NCT00539513|2445009|P1|Overall Study|Withdrawal by Subject|2
768234|NCT00539591|2445066|P3|Overall Study|Disease progression|3
768235|NCT00539591|2445067|P2|Overall Study|Disease progression|2
768236|NCT00539591|2445068|P1|Overall Study|Disease progression|2
768237|NCT00539591|2445066|P3|Overall Study|Toxicity|0
768238|NCT00539591|2445067|P2|Overall Study|Toxicity|0
768239|NCT00539591|2445068|P1|Overall Study|Toxicity|3
768240|NCT00539734|2445185|P1|Overall Study|Protocol Violation|1
768241|NCT00545402|2445192|P2|Overall Study|Reason not specified|1
768242|NCT00545402|2445193|P1|Overall Study|Reason not specified|1
768243|NCT00545402|2445192|P2|Overall Study|Protocol Violation|0
768244|NCT00545402|2445193|P1|Overall Study|Protocol Violation|1
768245|NCT00545402|2445192|P2|Overall Study|Withdrawal by Subject|1
768246|NCT00545402|2445193|P1|Overall Study|Withdrawal by Subject|0
768247|NCT00545402|2445192|P2|Overall Study|Graft loss|4
768248|NCT00545402|2445193|P1|Overall Study|Graft loss|2
768249|NCT00545402|2445192|P2|Overall Study|Death|7
768250|NCT00545402|2445193|P1|Overall Study|Death|5
768251|NCT00545402|2445192|P2|Overall Study|Use of unauthorized immunosuppressant|7
768252|NCT00545402|2445193|P1|Overall Study|Use of unauthorized immunosuppressant|8
768253|NCT00545402|2445192|P2|Overall Study|Discontinuation of treatment|9
768254|NCT00545402|2445193|P1|Overall Study|Discontinuation of treatment|17
768255|NCT00545441|2445211|P2|Overall Study|Patients were not treated|3
768256|NCT00545441|2445212|P1|Overall Study|Patients were not treated|1
768257|NCT00545441|2445211|P2|Overall Study|Persistence or recurrence of fistula|2
768258|NCT00545441|2445212|P1|Overall Study|Persistence or recurrence of fistula|5
768259|NCT00545441|2445211|P2|Overall Study|Withdrawal by Subject|1
768260|NCT00545441|2445212|P1|Overall Study|Withdrawal by Subject|1
768261|NCT00545441|2445211|P2|Overall Study|Technical failure|1
768262|NCT00545441|2445212|P1|Overall Study|Technical failure|0
768263|NCT00545441|2445211|P2|Overall Study|Lost to Follow-up|5
768264|NCT00545441|2445212|P1|Overall Study|Lost to Follow-up|9
768265|NCT00545441|2445211|P2|Overall Study|Fistula draining at 6 months|4
768266|NCT00545441|2445212|P1|Overall Study|Fistula draining at 6 months|2
768267|NCT00545571|2445227|P1|Overall Study|Kidney Transplantation|3
768268|NCT00545571|2445227|P1|Overall Study|Early Termination of Study|24
768269|NCT00545571|2445227|P1|Overall Study|Transfusion|12
768270|NCT00545571|2445227|P1|Overall Study|Screen Failure|16
768271|NCT00545571|2445227|P1|Overall Study|Refused Treatment|1
768272|NCT00545571|2445227|P1|Overall Study|Protocol Violation|2
768273|NCT00545571|2445227|P1|Overall Study|Lack of Efficacy|1
768274|NCT00545571|2445227|P1|Overall Study|Death|5
768275|NCT00545571|2445227|P1|Overall Study|Adverse Event|2
768276|NCT00545571|2445227|P1|Overall Study|Administrative Reasons|1
891526|NCT01630616|2827871|P3|Overall Study|Adverse Event|0
891527|NCT01630616|2827872|P2|Overall Study|Adverse Event|0
891528|NCT01630616|2827873|P1|Overall Study|Adverse Event|0
891529|NCT01627327|2827948|P2|Overall Study|Withdrawal by Subject|3
891530|NCT01627327|2827949|P1|Overall Study|Withdrawal by Subject|3
891531|NCT01627327|2827948|P2|Overall Study|Physician Decision|0
891532|NCT01627327|2827949|P1|Overall Study|Physician Decision|1
768283|NCT00545688|2445286|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
768284|NCT00545688|2445287|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
768285|NCT00545688|2445288|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
768286|NCT00545688|2445289|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
768287|NCT00545688|2445286|P4|Follow-Up Period|Unspecified Reason|8
768288|NCT00545688|2445287|P3|Follow-Up Period|Unspecified Reason|6
768289|NCT00545688|2445288|P2|Follow-Up Period|Unspecified Reason|5
768290|NCT00545688|2445289|P1|Follow-Up Period|Unspecified Reason|2
768291|NCT00545688|2445286|P4|Follow-Up Period|Lost to Follow-up|1
768292|NCT00545688|2445287|P3|Follow-Up Period|Lost to Follow-up|3
768293|NCT00545688|2445288|P2|Follow-Up Period|Lost to Follow-up|3
768294|NCT00545688|2445289|P1|Follow-Up Period|Lost to Follow-up|3
768295|NCT00545688|2445286|P4|Follow-Up Period|Refused Treatment|2
768296|NCT00545688|2445287|P3|Follow-Up Period|Refused Treatment|0
768297|NCT00545688|2445288|P2|Follow-Up Period|Refused Treatment|2
768298|NCT00545688|2445289|P1|Follow-Up Period|Refused Treatment|6
768299|NCT00545688|2445286|P4|Follow-Up Period|Disease Progression|9
768300|NCT00545688|2445287|P3|Follow-Up Period|Disease Progression|9
768301|NCT00545688|2445288|P2|Follow-Up Period|Disease Progression|5
768302|NCT00545688|2445289|P1|Follow-Up Period|Disease Progression|6
768303|NCT00545688|2445286|P4|Follow-Up Period|Death|6
768304|NCT00545688|2445287|P3|Follow-Up Period|Death|2
768305|NCT00545688|2445288|P2|Follow-Up Period|Death|2
768306|NCT00545688|2445289|P1|Follow-Up Period|Death|4
768307|NCT00545688|2445286|P4|Adjuvant Treatment Period|Unknown Reason|0
768308|NCT00545688|2445287|P3|Adjuvant Treatment Period|Unknown Reason|0
768309|NCT00545688|2445288|P2|Adjuvant Treatment Period|Unknown Reason|1
768310|NCT00545688|2445289|P1|Adjuvant Treatment Period|Unknown Reason|0
768311|NCT00545688|2445286|P4|Adjuvant Treatment Period|Adverse Event|2
768312|NCT00545688|2445287|P3|Adjuvant Treatment Period|Adverse Event|2
768313|NCT00545688|2445288|P2|Adjuvant Treatment Period|Adverse Event|3
768314|NCT00545688|2445289|P1|Adjuvant Treatment Period|Adverse Event|0
768315|NCT00545688|2445286|P4|Adjuvant Treatment Period|Lost to Follow-up|0
768316|NCT00545688|2445287|P3|Adjuvant Treatment Period|Lost to Follow-up|1
768317|NCT00545688|2445288|P2|Adjuvant Treatment Period|Lost to Follow-up|0
768318|NCT00545688|2445289|P1|Adjuvant Treatment Period|Lost to Follow-up|1
768319|NCT00545688|2445286|P4|Adjuvant Treatment Period|Refused Treatment|5
768320|NCT00545688|2445287|P3|Adjuvant Treatment Period|Refused Treatment|1
768321|NCT00545688|2445288|P2|Adjuvant Treatment Period|Refused Treatment|1
768322|NCT00545688|2445289|P1|Adjuvant Treatment Period|Refused Treatment|1
768323|NCT00545688|2445286|P4|Adjuvant Treatment Period|Disease Progression|7
768324|NCT00545688|2445287|P3|Adjuvant Treatment Period|Disease Progression|0
768325|NCT00545688|2445288|P2|Adjuvant Treatment Period|Disease Progression|3
768326|NCT00545688|2445289|P1|Adjuvant Treatment Period|Disease Progression|3
768327|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
768328|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
768329|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
768330|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
768331|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
768332|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
768333|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
768334|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
768335|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
768336|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
768337|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
768338|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
768339|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Death|0
768340|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Death|0
768341|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Death|1
768342|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Death|0
768343|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
768344|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
768345|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
768346|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
768347|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
768348|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
768349|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
768350|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
768351|NCT00545688|2445286|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
768352|NCT00545688|2445287|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
768353|NCT00545688|2445288|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
768354|NCT00545688|2445289|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
768355|NCT00546715|2445363|P4|Overall Study|Withdrawal by Subject|0
768356|NCT00546715|2445364|P3|Overall Study|Withdrawal by Subject|0
768357|NCT00546715|2445365|P2|Overall Study|Withdrawal by Subject|1
768358|NCT00546715|2445366|P1|Overall Study|Withdrawal by Subject|0
768359|NCT00546754|2445430|P2|Overall Study|Missing|7
768360|NCT00546754|2445431|P1|Overall Study|Missing|14
768361|NCT00546754|2445430|P2|Overall Study|Patient's Decision|1
768362|NCT00546754|2445431|P1|Overall Study|Patient's Decision|0
768363|NCT00546754|2445430|P2|Overall Study|Elevated Creatinine and Potassium levels|1
768364|NCT00546754|2445431|P1|Overall Study|Elevated Creatinine and Potassium levels|0
768365|NCT00546754|2445430|P2|Overall Study|Missing Cooperation|0
768366|NCT00546754|2445431|P1|Overall Study|Missing Cooperation|1
768367|NCT00546754|2445430|P2|Overall Study|Suicide|0
768368|NCT00546754|2445431|P1|Overall Study|Suicide|1
768369|NCT00546754|2445430|P2|Overall Study|Hip Replacement|0
768370|NCT00546754|2445431|P1|Overall Study|Hip Replacement|1
768371|NCT00546754|2445430|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
768372|NCT00546754|2445431|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
768373|NCT00546754|2445430|P2|Overall Study|Dyspnea|0
768374|NCT00546754|2445431|P1|Overall Study|Dyspnea|1
768375|NCT00546754|2445430|P2|Overall Study|Withdrawal by Subject|7
768376|NCT00546754|2445431|P1|Overall Study|Withdrawal by Subject|6
768377|NCT00546754|2445430|P2|Overall Study|Protocol Violation|0
768378|NCT00546754|2445431|P1|Overall Study|Protocol Violation|3
768379|NCT00546754|2445430|P2|Overall Study|Lost to Follow-up|15
768380|NCT00546754|2445431|P1|Overall Study|Lost to Follow-up|9
768381|NCT00546754|2445430|P2|Overall Study|Lack of Efficacy|1
768382|NCT00546754|2445431|P1|Overall Study|Lack of Efficacy|1
768383|NCT00546754|2445430|P2|Overall Study|Adverse Event|16
768384|NCT00546754|2445431|P1|Overall Study|Adverse Event|11
768385|NCT00546754|2445430|P2|Overall Study|Serious Adverse Event|1
768386|NCT00546754|2445431|P1|Overall Study|Serious Adverse Event|1
768387|NCT00546819|2445463|P2|Overall Study|Withdrawal by Subject|2
768388|NCT00546819|2445464|P1|Overall Study|Withdrawal by Subject|4
768389|NCT00546819|2445463|P2|Overall Study|Lost to Follow-up|1
768390|NCT00546819|2445464|P1|Overall Study|Lost to Follow-up|2
768391|NCT00546819|2445463|P2|Overall Study|Adverse Event|3
768392|NCT00546819|2445464|P1|Overall Study|Adverse Event|2
768403|NCT00546910|2445628|P2|Overall Study|Withdrawal by Subject|0
768404|NCT00546910|2445629|P1|Overall Study|Withdrawal by Subject|2
768405|NCT00546910|2445628|P2|Overall Study|Physician Decision|1
768406|NCT00546910|2445629|P1|Overall Study|Physician Decision|0
768407|NCT00546910|2445628|P2|Overall Study|Lack of Efficacy|7
768408|NCT00546910|2445629|P1|Overall Study|Lack of Efficacy|5
768409|NCT00546910|2445628|P2|Overall Study|Adverse Event|3
768410|NCT00546910|2445629|P1|Overall Study|Adverse Event|2
768411|NCT00547118|2445649|P2|Overall Study|Did not qualify prior to starting drug|2
768412|NCT00547118|2445650|P1|Overall Study|Did not qualify prior to starting drug|0
768413|NCT00547118|2445649|P2|Overall Study|Withdrawal by Subject|0
768414|NCT00547118|2445650|P1|Overall Study|Withdrawal by Subject|1
768415|NCT00547157|2445658|P2|Overall Study|Lost to Follow-up|2
768416|NCT00547157|2445659|P1|Overall Study|Lost to Follow-up|4
768417|NCT00547157|2445658|P2|Overall Study|Administrative decision|2
768418|NCT00547157|2445659|P1|Overall Study|Administrative decision|3
768419|NCT00547157|2445658|P2|Overall Study|Withdrawal by Subject|1
768420|NCT00547157|2445659|P1|Overall Study|Withdrawal by Subject|3
768421|NCT00547157|2445658|P2|Overall Study|Death|18
768422|NCT00547157|2445659|P1|Overall Study|Death|38
768423|NCT00547157|2445658|P2|Overall Study|Other|0
768424|NCT00547157|2445659|P1|Overall Study|Other|1
768425|NCT00547365|2445675|P1|Overall Study|death (not related to study)|4
768426|NCT00547365|2445675|P1|Overall Study|Protocol Violation|2
768427|NCT00547365|2445675|P1|Overall Study|Lost to Follow-up|1
768428|NCT00547365|2445675|P1|Overall Study|Physician Decision|1
768429|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
768430|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
768431|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Not Specified|2
768432|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Not Specified|0
768433|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
768434|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
768435|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
768436|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
768437|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Adverse Event|9
768438|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Adverse Event|0
768439|NCT00547521|2445686|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
768440|NCT00547521|2445687|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
768441|NCT00547521|2445686|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
768442|NCT00547521|2445687|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
768443|NCT00547521|2445686|P2|Short Term Study (4 Months)|Withdrawal of consent|1
768444|NCT00547521|2445687|P1|Short Term Study (4 Months)|Withdrawal of consent|0
768445|NCT00547521|2445686|P2|Short Term Study (4 Months)|Lack of Efficacy|2
768446|NCT00547521|2445687|P1|Short Term Study (4 Months)|Lack of Efficacy|0
768447|NCT00547521|2445686|P2|Short Term Study (4 Months)|Adverse Event|0
768448|NCT00547521|2445687|P1|Short Term Study (4 Months)|Adverse Event|1
768449|NCT00547534|2445757|P1|Overall Study|Disease Progression|4
768450|NCT00547534|2445757|P1|Overall Study|Adverse Event|7
768451|NCT00547703|2445784|P2|Overall Study|Lost to Follow-up|0
768452|NCT00547703|2445785|P1|Overall Study|Lost to Follow-up|1
768453|NCT00547911|2445795|P6|Overall Study|Adverse Event|0
768454|NCT00547911|2445796|P5|Overall Study|Adverse Event|0
768455|NCT00547911|2445797|P4|Overall Study|Adverse Event|1
768456|NCT00547911|2445798|P3|Overall Study|Adverse Event|0
768457|NCT00547911|2445799|P2|Overall Study|Adverse Event|0
768458|NCT00547911|2445800|P1|Overall Study|Adverse Event|0
768459|NCT00548145|2445846|P2|Overall Study|Physician Decision|1
768460|NCT00548145|2445847|P1|Overall Study|Physician Decision|1
768461|NCT00548145|2445846|P2|Overall Study|Withdrawal by Subject|2
768462|NCT00548145|2445847|P1|Overall Study|Withdrawal by Subject|0
768463|NCT00548145|2445846|P2|Overall Study|Death|1
768464|NCT00548145|2445847|P1|Overall Study|Death|0
768465|NCT00548184|2445853|P1|Overall Study|Found Her2 negative|1
768466|NCT00548184|2445853|P1|Overall Study|took other drug|1
768467|NCT00548184|2445853|P1|Overall Study|Adverse Event|3
768468|NCT00548249|2445862|P5|Overall Study|Sponsor's request|0
768469|NCT00548249|2445863|P4|Overall Study|Sponsor's request|1
768470|NCT00548249|2445864|P3|Overall Study|Sponsor's request|0
768471|NCT00548249|2445865|P2|Overall Study|Sponsor's request|0
768472|NCT00548249|2445866|P1|Overall Study|Sponsor's request|0
768473|NCT00548249|2445862|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
768474|NCT00548249|2445863|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
768475|NCT00548249|2445864|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
768476|NCT00548249|2445865|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
768477|NCT00548249|2445866|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
768478|NCT00548249|2445862|P5|Overall Study|Withdrawal by Subject|0
768479|NCT00548249|2445863|P4|Overall Study|Withdrawal by Subject|0
768480|NCT00548249|2445864|P3|Overall Study|Withdrawal by Subject|0
768481|NCT00548249|2445865|P2|Overall Study|Withdrawal by Subject|0
768482|NCT00548249|2445866|P1|Overall Study|Withdrawal by Subject|2
768483|NCT00548249|2445862|P5|Overall Study|Prolonged hospitalization|0
768484|NCT00548249|2445863|P4|Overall Study|Prolonged hospitalization|1
768485|NCT00548249|2445864|P3|Overall Study|Prolonged hospitalization|2
768486|NCT00548249|2445865|P2|Overall Study|Prolonged hospitalization|0
768487|NCT00548249|2445866|P1|Overall Study|Prolonged hospitalization|0
768488|NCT00548249|2445862|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
768489|NCT00548249|2445863|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
768490|NCT00548249|2445864|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
768491|NCT00548249|2445865|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
768492|NCT00548249|2445866|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
768493|NCT00548249|2445862|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
768494|NCT00548249|2445863|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
768495|NCT00548249|2445864|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
768496|NCT00548249|2445865|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
768497|NCT00548249|2445866|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
768498|NCT00548249|2445862|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
768499|NCT00548249|2445863|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
768500|NCT00548249|2445864|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
768501|NCT00548249|2445865|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
768502|NCT00548249|2445866|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
768503|NCT00548249|2445862|P5|Overall Study|Adverse Event|1
768504|NCT00548249|2445863|P4|Overall Study|Adverse Event|1
768505|NCT00548249|2445864|P3|Overall Study|Adverse Event|0
768506|NCT00548249|2445865|P2|Overall Study|Adverse Event|2
768507|NCT00548249|2445866|P1|Overall Study|Adverse Event|2
768508|NCT00548249|2445862|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
768509|NCT00548249|2445863|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
768510|NCT00548249|2445864|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
768511|NCT00548249|2445865|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
768512|NCT00548249|2445866|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
768513|NCT00548249|2445862|P5|Overall Study|Miscellaneous|2
768514|NCT00548249|2445863|P4|Overall Study|Miscellaneous|0
768515|NCT00548249|2445864|P3|Overall Study|Miscellaneous|2
768516|NCT00548249|2445865|P2|Overall Study|Miscellaneous|3
768517|NCT00548249|2445866|P1|Overall Study|Miscellaneous|2
768518|NCT00548249|2445862|P5|Overall Study|Protocol Violation|3
768519|NCT00548249|2445863|P4|Overall Study|Protocol Violation|0
768520|NCT00548249|2445864|P3|Overall Study|Protocol Violation|4
768521|NCT00548249|2445865|P2|Overall Study|Protocol Violation|1
768522|NCT00548249|2445866|P1|Overall Study|Protocol Violation|1
768523|NCT00548249|2445862|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
768524|NCT00548249|2445863|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
768525|NCT00548249|2445864|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
768526|NCT00548249|2445865|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
768527|NCT00548249|2445866|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
768528|NCT00548249|2445862|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
768529|NCT00548249|2445863|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
768530|NCT00548249|2445864|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
768531|NCT00548249|2445865|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
768532|NCT00548249|2445866|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
768533|NCT00548262|2445903|P1|Overall Study|Withdrawal by Subject|1
768534|NCT00548262|2445903|P1|Overall Study|Unspecified|3
768535|NCT00548262|2445903|P1|Overall Study|Lost to Follow-up|1
768536|NCT00548262|2445903|P1|Overall Study|Lack of Efficacy|4
768537|NCT00548262|2445903|P1|Overall Study|Adverse Event|2
768538|NCT00548262|2445903|P1|Overall Study|Death|21
768539|NCT00548327|2445930|P2|Overall Study|Adverse Event|1
768540|NCT00548327|2445931|P1|Overall Study|Adverse Event|0
768541|NCT00548340|2445952|P3|Overall Study|Other|1
768542|NCT00548340|2445953|P2|Overall Study|Other|1
768543|NCT00548340|2445954|P1|Overall Study|Other|1
768544|NCT00548340|2445952|P3|Overall Study|Withdrawal by Subject|3
768545|NCT00548340|2445953|P2|Overall Study|Withdrawal by Subject|4
768546|NCT00548340|2445954|P1|Overall Study|Withdrawal by Subject|2
768547|NCT00548340|2445952|P3|Overall Study|Lost to Follow-up|0
768548|NCT00548340|2445953|P2|Overall Study|Lost to Follow-up|1
768549|NCT00548340|2445954|P1|Overall Study|Lost to Follow-up|1
768550|NCT00548340|2445952|P3|Overall Study|Adverse Event|2
768551|NCT00548340|2445953|P2|Overall Study|Adverse Event|2
768552|NCT00548340|2445954|P1|Overall Study|Adverse Event|2
768553|NCT00548340|2445952|P3|Overall Study|Protocol Violation|3
768554|NCT00548340|2445953|P2|Overall Study|Protocol Violation|3
768555|NCT00548340|2445954|P1|Overall Study|Protocol Violation|2
768556|NCT00548405|2445974|P3|Overall Study|Randomized but not treated|0
768557|NCT00548405|2445975|P2|Overall Study|Randomized but not treated|0
768558|NCT00548405|2445976|P1|Overall Study|Randomized but not treated|1
768559|NCT00548405|2445974|P3|Overall Study|Sponsor decision|0
768560|NCT00548405|2445975|P2|Overall Study|Sponsor decision|0
768561|NCT00548405|2445976|P1|Overall Study|Sponsor decision|1
768562|NCT00548405|2445974|P3|Overall Study|Death|1
768563|NCT00548405|2445975|P2|Overall Study|Death|1
768564|NCT00548405|2445976|P1|Overall Study|Death|0
768565|NCT00548405|2445974|P3|Overall Study|Lost to Follow-up|2
768566|NCT00548405|2445975|P2|Overall Study|Lost to Follow-up|1
768567|NCT00548405|2445976|P1|Overall Study|Lost to Follow-up|1
768568|NCT00548405|2445974|P3|Overall Study|Withdrawal by Subject|5
768569|NCT00548405|2445975|P2|Overall Study|Withdrawal by Subject|12
768570|NCT00548405|2445976|P1|Overall Study|Withdrawal by Subject|36
768571|NCT00548405|2445974|P3|Overall Study|Protocol Violation|0
768572|NCT00548405|2445975|P2|Overall Study|Protocol Violation|0
768573|NCT00548405|2445976|P1|Overall Study|Protocol Violation|1
768574|NCT00548405|2445974|P3|Overall Study|Pregnancy|0
768575|NCT00548405|2445975|P2|Overall Study|Pregnancy|0
768576|NCT00548405|2445976|P1|Overall Study|Pregnancy|1
768577|NCT00548405|2445974|P3|Overall Study|Physician Decision|1
768578|NCT00548405|2445975|P2|Overall Study|Physician Decision|4
768579|NCT00548405|2445976|P1|Overall Study|Physician Decision|3
768580|NCT00548405|2445974|P3|Overall Study|Lack of Efficacy|0
768581|NCT00548405|2445975|P2|Overall Study|Lack of Efficacy|0
768582|NCT00548405|2445976|P1|Overall Study|Lack of Efficacy|6
768583|NCT00548405|2445974|P3|Overall Study|Adverse Event|0
768584|NCT00548405|2445975|P2|Overall Study|Adverse Event|2
768585|NCT00548405|2445976|P1|Overall Study|Adverse Event|6
768586|NCT00548548|2446016|P2|Overall Study|Lost to Follow-up|18
768587|NCT00548548|2446017|P1|Overall Study|Lost to Follow-up|17
768588|NCT00548548|2446016|P2|Overall Study|Death|348
768589|NCT00548548|2446017|P1|Overall Study|Death|345
768590|NCT00548717|2446048|P2|Overall Study|Alternative treatment for GVHD|0
768591|NCT00548717|2446049|P1|Overall Study|Alternative treatment for GVHD|1
768592|NCT00548717|2446048|P2|Overall Study|Relapse|0
768593|NCT00548717|2446049|P1|Overall Study|Relapse|3
768594|NCT00548717|2446048|P2|Overall Study|Death|2
768595|NCT00548717|2446049|P1|Overall Study|Death|5
768596|NCT00548808|2446068|P2|Overall Study|Sponsor Decision|1
768597|NCT00548808|2446069|P1|Overall Study|Sponsor Decision|1
768598|NCT00548808|2446068|P2|Overall Study|Lack of Efficacy|0
768599|NCT00548808|2446069|P1|Overall Study|Lack of Efficacy|2
768600|NCT00548808|2446068|P2|Overall Study|Entry Criteria Not Met|2
768601|NCT00548808|2446069|P1|Overall Study|Entry Criteria Not Met|2
768602|NCT00548808|2446068|P2|Overall Study|Death|0
768603|NCT00548808|2446069|P1|Overall Study|Death|2
768604|NCT00548808|2446068|P2|Overall Study|Adverse Event|5
768605|NCT00548808|2446069|P1|Overall Study|Adverse Event|4
768606|NCT00548808|2446068|P2|Overall Study|Physician Decision|3
768607|NCT00548808|2446069|P1|Overall Study|Physician Decision|6
768608|NCT00548808|2446068|P2|Overall Study|Withdrawal by Subject|4
768609|NCT00548808|2446069|P1|Overall Study|Withdrawal by Subject|8
768610|NCT00548808|2446068|P2|Overall Study|Protocol Violation|8
768611|NCT00548808|2446069|P1|Overall Study|Protocol Violation|8
768612|NCT00548808|2446068|P2|Overall Study|Lost to Follow-up|3
768613|NCT00548808|2446069|P1|Overall Study|Lost to Follow-up|9
768614|NCT00548847|2446091|P1|Overall Study|Disease progression|7
768615|NCT00549055|2446109|P1|Overall Study|Very low visual acuity (VA)|1
768616|NCT00549055|2446109|P1|Overall Study|Choroidal neovascularization|1
768617|NCT00549055|2446109|P1|Overall Study|Growth choroidal neovascularisation|1
768618|NCT00549055|2446109|P1|Overall Study|Vitreous hemorrhage|1
768619|NCT00549055|2446109|P1|Overall Study|Active choroidal neovascula increased|1
768620|NCT00549055|2446109|P1|Overall Study|Decrease of size|1
768621|NCT00549055|2446109|P1|Overall Study|Progression to fibrosis|2
768622|NCT00549055|2446109|P1|Overall Study|Stabilization|5
768623|NCT00549055|2446109|P1|Overall Study|Lack of efficacy|18
768624|NCT00549055|2446109|P1|Overall Study|Adverse Event|4
768625|NCT00549198|2446138|P2|Overall Study|Not Exposed to Study Drug|4
768626|NCT00549198|2446139|P1|Overall Study|Not Exposed to Study Drug|3
768627|NCT00549198|2446138|P2|Overall Study|Pregnancy|3
768628|NCT00549198|2446139|P1|Overall Study|Pregnancy|0
768629|NCT00549198|2446138|P2|Overall Study|No scan facilities|2
768630|NCT00549198|2446139|P1|Overall Study|No scan facilities|0
768631|NCT00549198|2446138|P2|Overall Study|Participant overweight, no scan possible|0
768632|NCT00549198|2446139|P1|Overall Study|Participant overweight, no scan possible|1
768633|NCT00549198|2446138|P2|Overall Study|Participant planning pregnancy|0
768634|NCT00549198|2446139|P1|Overall Study|Participant planning pregnancy|1
768635|NCT00549198|2446138|P2|Overall Study|Prohibited Medication|2
768636|NCT00549198|2446139|P1|Overall Study|Prohibited Medication|1
768637|NCT00549198|2446138|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
768638|NCT00549198|2446139|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
768639|NCT00549198|2446138|P2|Overall Study|Participant not able to perform Week 96|0
768640|NCT00549198|2446139|P1|Overall Study|Participant not able to perform Week 96|1
768641|NCT00549198|2446138|P2|Overall Study|Participant Moved|0
768642|NCT00549198|2446139|P1|Overall Study|Participant Moved|2
768643|NCT00549198|2446138|P2|Overall Study|Disease Progression|0
768644|NCT00549198|2446139|P1|Overall Study|Disease Progression|1
768645|NCT00549198|2446138|P2|Overall Study|Withdrawal by Subject|7
768646|NCT00549198|2446139|P1|Overall Study|Withdrawal by Subject|7
768647|NCT00549198|2446138|P2|Overall Study|Investigator Decision|3
768648|NCT00549198|2446139|P1|Overall Study|Investigator Decision|4
768649|NCT00549198|2446138|P2|Overall Study|Protocol Violation|2
768650|NCT00549198|2446139|P1|Overall Study|Protocol Violation|7
768651|NCT00549198|2446138|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
768652|NCT00549198|2446139|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
768653|NCT00549198|2446138|P2|Overall Study|Lost to Follow-up|8
768654|NCT00549198|2446139|P1|Overall Study|Lost to Follow-up|7
768655|NCT00549198|2446138|P2|Overall Study|Non-compliance|4
768656|NCT00549198|2446139|P1|Overall Study|Non-compliance|2
768657|NCT00549198|2446138|P2|Overall Study|Protocol-defined Virological Failure|0
768658|NCT00549198|2446139|P1|Overall Study|Protocol-defined Virological Failure|7
768659|NCT00549198|2446138|P2|Overall Study|Insufficient Viral Load Response|2
768660|NCT00549198|2446139|P1|Overall Study|Insufficient Viral Load Response|4
768661|NCT00549198|2446138|P2|Overall Study|Adverse Event|26
768662|NCT00549198|2446139|P1|Overall Study|Adverse Event|28
768663|NCT00542789|2446328|P2|Overall Study|Recurrence of Gastric Ulcer|57
768664|NCT00542789|2446329|P1|Overall Study|Recurrence of Gastric Ulcer|8
768665|NCT00542789|2446328|P2|Overall Study|Protocol Violation|1
768666|NCT00542789|2446329|P1|Overall Study|Protocol Violation|8
768667|NCT00542789|2446328|P2|Overall Study|Withdrawal by Subject|3
768668|NCT00542789|2446329|P1|Overall Study|Withdrawal by Subject|7
768669|NCT00542789|2446328|P2|Overall Study|Adverse Event|17
768670|NCT00542789|2446329|P1|Overall Study|Adverse Event|18
768671|NCT00542815|2446342|P3|Overall Study|Other reasons|10
768672|NCT00542815|2446343|P2|Overall Study|Other reasons|10
768673|NCT00542815|2446344|P1|Overall Study|Other reasons|24
768674|NCT00542815|2446342|P3|Overall Study|Withdrawal by Subject|8
768675|NCT00542815|2446343|P2|Overall Study|Withdrawal by Subject|5
768676|NCT00542815|2446344|P1|Overall Study|Withdrawal by Subject|41
768677|NCT00542815|2446342|P3|Overall Study|Protocol Violation|2
768678|NCT00542815|2446343|P2|Overall Study|Protocol Violation|1
768679|NCT00542815|2446344|P1|Overall Study|Protocol Violation|1
768680|NCT00542815|2446342|P3|Overall Study|Physician Decision|0
768681|NCT00542815|2446343|P2|Overall Study|Physician Decision|1
768682|NCT00542815|2446344|P1|Overall Study|Physician Decision|2
768683|NCT00542815|2446342|P3|Overall Study|Lack of Efficacy|0
768684|NCT00542815|2446343|P2|Overall Study|Lack of Efficacy|2
768685|NCT00542815|2446344|P1|Overall Study|Lack of Efficacy|9
768686|NCT00542815|2446342|P3|Overall Study|Death|3
768687|NCT00542815|2446343|P2|Overall Study|Death|7
768688|NCT00542815|2446344|P1|Overall Study|Death|10
768689|NCT00542815|2446342|P3|Overall Study|Adverse Event|9
768690|NCT00542815|2446343|P2|Overall Study|Adverse Event|6
768691|NCT00542815|2446344|P1|Overall Study|Adverse Event|19
768692|NCT00542828|2446355|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
768693|NCT00542828|2446355|P1|Overall Study|Study Prematurely Discontinued|7
768694|NCT00542828|2446355|P1|Overall Study|Need for Prohibited Treatment|3
768695|NCT00542828|2446355|P1|Overall Study|Physician Decision|1
768696|NCT00549302|2446372|P3|Open-Label|Withdrawal by Subject|6
768697|NCT00549302|2446373|P2|Open-Label|Withdrawal by Subject|0
768698|NCT00549302|2446374|P1|Open-Label|Withdrawal by Subject|0
768699|NCT00549302|2446372|P3|Open-Label|New drug pulmonary atrial hypertension|2
768700|NCT00549302|2446373|P2|Open-Label|New drug pulmonary atrial hypertension|0
768701|NCT00549302|2446374|P1|Open-Label|New drug pulmonary atrial hypertension|0
768702|NCT00549302|2446372|P3|Open-Label|Unspecified|3
768703|NCT00549302|2446373|P2|Open-Label|Unspecified|0
768704|NCT00549302|2446374|P1|Open-Label|Unspecified|0
768705|NCT00549302|2446372|P3|Open-Label|Lost to Follow-up|2
768706|NCT00549302|2446373|P2|Open-Label|Lost to Follow-up|0
768707|NCT00549302|2446374|P1|Open-Label|Lost to Follow-up|0
768708|NCT00549302|2446372|P3|Open-Label|Investigator Decision|5
768709|NCT00549302|2446373|P2|Open-Label|Investigator Decision|0
768710|NCT00549302|2446374|P1|Open-Label|Investigator Decision|0
768711|NCT00549302|2446372|P3|Open-Label|Death|40
768712|NCT00549302|2446373|P2|Open-Label|Death|0
768713|NCT00549302|2446374|P1|Open-Label|Death|0
768714|NCT00549302|2446372|P3|Open-Label|Adverse Event|11
768715|NCT00549302|2446373|P2|Open-Label|Adverse Event|0
768716|NCT00549302|2446374|P1|Open-Label|Adverse Event|0
768717|NCT00549302|2446372|P3|Double-Blind|New condition or starts new therapy|0
768718|NCT00549302|2446373|P2|Double-Blind|New condition or starts new therapy|2
768719|NCT00549302|2446374|P1|Double-Blind|New condition or starts new therapy|0
768720|NCT00549302|2446372|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
768721|NCT00549302|2446373|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
768722|NCT00549302|2446374|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
768723|NCT00549302|2446372|P3|Double-Blind|Lost to Follow-up|0
768724|NCT00549302|2446373|P2|Double-Blind|Lost to Follow-up|2
768725|NCT00549302|2446374|P1|Double-Blind|Lost to Follow-up|1
768726|NCT00549302|2446372|P3|Double-Blind|Sponsor Decision|0
768727|NCT00549302|2446373|P2|Double-Blind|Sponsor Decision|1
768728|NCT00549302|2446374|P1|Double-Blind|Sponsor Decision|0
768729|NCT00549302|2446372|P3|Double-Blind|Investigator Decision|0
768730|NCT00549302|2446373|P2|Double-Blind|Investigator Decision|5
768731|NCT00549302|2446374|P1|Double-Blind|Investigator Decision|1
768732|NCT00549302|2446372|P3|Double-Blind|Withdrawal by Subject|0
768733|NCT00549302|2446373|P2|Double-Blind|Withdrawal by Subject|8
768734|NCT00549302|2446374|P1|Double-Blind|Withdrawal by Subject|3
768735|NCT00549302|2446372|P3|Double-Blind|Adverse Event|0
768736|NCT00549302|2446373|P2|Double-Blind|Adverse Event|16
768737|NCT00549302|2446374|P1|Double-Blind|Adverse Event|3
768738|NCT00549302|2446372|P3|Double-Blind|Death|0
768739|NCT00549302|2446373|P2|Double-Blind|Death|9
768740|NCT00549302|2446374|P1|Double-Blind|Death|2
768741|NCT00549328|2446384|P1|Overall Study|Use of Prohibited Medication|1
768742|NCT00549328|2446384|P1|Overall Study|Death|1
768743|NCT00549328|2446384|P1|Overall Study|Disease Progression|10
768744|NCT00549328|2446384|P1|Overall Study|Adverse Event|2
768745|NCT00549445|2446408|P2|Overall Study|Sputum & Blood Samples Not Available|17
768746|NCT00549445|2446409|P1|Overall Study|Sputum & Blood Samples Not Available|15
768747|NCT00549549|2446419|P4|Overall Study|Randomized but not treated|1
768748|NCT00549549|2446420|P3|Overall Study|Randomized but not treated|1
768749|NCT00549549|2446421|P2|Overall Study|Randomized but not treated|0
768750|NCT00549549|2446422|P1|Overall Study|Randomized but not treated|0
768751|NCT00549549|2446419|P4|Overall Study|Unspecified|11
768752|NCT00549549|2446420|P3|Overall Study|Unspecified|9
768753|NCT00549549|2446421|P2|Overall Study|Unspecified|9
768754|NCT00549549|2446422|P1|Overall Study|Unspecified|9
768755|NCT00549549|2446419|P4|Overall Study|Withdrawal by Subject|0
768756|NCT00549549|2446420|P3|Overall Study|Withdrawal by Subject|1
768757|NCT00549549|2446421|P2|Overall Study|Withdrawal by Subject|4
768758|NCT00549549|2446422|P1|Overall Study|Withdrawal by Subject|0
768759|NCT00549549|2446419|P4|Overall Study|Lost to Follow-up|2
768760|NCT00549549|2446420|P3|Overall Study|Lost to Follow-up|1
768761|NCT00549549|2446421|P2|Overall Study|Lost to Follow-up|0
768762|NCT00549549|2446422|P1|Overall Study|Lost to Follow-up|1
768763|NCT00549549|2446419|P4|Overall Study|Lack of Efficacy|2
768764|NCT00549549|2446420|P3|Overall Study|Lack of Efficacy|4
768765|NCT00549549|2446421|P2|Overall Study|Lack of Efficacy|6
768766|NCT00549549|2446422|P1|Overall Study|Lack of Efficacy|9
768767|NCT00549549|2446419|P4|Overall Study|Adverse Event|9
768768|NCT00549549|2446420|P3|Overall Study|Adverse Event|1
768769|NCT00549549|2446421|P2|Overall Study|Adverse Event|3
768770|NCT00549549|2446422|P1|Overall Study|Adverse Event|5
768771|NCT00549562|2446488|P1|Overall Study|Lack of Efficacy|1
768772|NCT00549562|2446488|P1|Overall Study|Adverse Event|1
768773|NCT00550953|2446498|P2|Overall Study|Not able to visit the site|3
768774|NCT00550953|2446499|P1|Overall Study|Not able to visit the site|2
768775|NCT00550953|2446498|P2|Overall Study|Adverse Event|3
768776|NCT00550953|2446499|P1|Overall Study|Adverse Event|4
768777|NCT00551031|2446524|P5|Overall Study|Did not receive vaccine|0
768778|NCT00551031|2446525|P4|Overall Study|Did not receive vaccine|0
768779|NCT00551031|2446526|P3|Overall Study|Did not receive vaccine|0
768780|NCT00551031|2446527|P2|Overall Study|Did not receive vaccine|2
768781|NCT00551031|2446528|P1|Overall Study|Did not receive vaccine|1
768782|NCT00551031|2446524|P5|Overall Study|Serious Adverse Event|0
768783|NCT00551031|2446525|P4|Overall Study|Serious Adverse Event|0
768784|NCT00551031|2446526|P3|Overall Study|Serious Adverse Event|1
768785|NCT00551031|2446527|P2|Overall Study|Serious Adverse Event|2
768786|NCT00551031|2446528|P1|Overall Study|Serious Adverse Event|0
768787|NCT00551031|2446524|P5|Overall Study|Withdrawal by Subject|0
768788|NCT00551031|2446525|P4|Overall Study|Withdrawal by Subject|2
768789|NCT00551031|2446526|P3|Overall Study|Withdrawal by Subject|1
768790|NCT00551031|2446527|P2|Overall Study|Withdrawal by Subject|4
768791|NCT00551031|2446528|P1|Overall Study|Withdrawal by Subject|0
768792|NCT00551031|2446524|P5|Overall Study|Lost to Follow-up|1
768793|NCT00551031|2446525|P4|Overall Study|Lost to Follow-up|1
768794|NCT00551031|2446526|P3|Overall Study|Lost to Follow-up|0
768795|NCT00551031|2446527|P2|Overall Study|Lost to Follow-up|1
768796|NCT00551031|2446528|P1|Overall Study|Lost to Follow-up|0
768797|NCT00551031|2446524|P5|Overall Study|Protocol Violation|0
768798|NCT00551031|2446525|P4|Overall Study|Protocol Violation|0
768799|NCT00551031|2446526|P3|Overall Study|Protocol Violation|0
768800|NCT00551031|2446527|P2|Overall Study|Protocol Violation|1
768801|NCT00551031|2446528|P1|Overall Study|Protocol Violation|1
768802|NCT00551031|2446524|P5|Overall Study|Adverse Event|0
768803|NCT00551031|2446525|P4|Overall Study|Adverse Event|0
768804|NCT00551031|2446526|P3|Overall Study|Adverse Event|0
768805|NCT00551031|2446527|P2|Overall Study|Adverse Event|1
768806|NCT00551031|2446528|P1|Overall Study|Adverse Event|0
768807|NCT00551135|2446569|P4|Overall Study|Withdrawal by Subject|1
768808|NCT00551135|2446570|P3|Overall Study|Withdrawal by Subject|3
768809|NCT00551135|2446571|P2|Overall Study|Withdrawal by Subject|0
768810|NCT00551135|2446572|P1|Overall Study|Withdrawal by Subject|1
768811|NCT00551135|2446569|P4|Overall Study|Unspecified|2
768812|NCT00551135|2446570|P3|Overall Study|Unspecified|1
768813|NCT00551135|2446571|P2|Overall Study|Unspecified|2
768814|NCT00551135|2446572|P1|Overall Study|Unspecified|3
768815|NCT00551135|2446569|P4|Overall Study|Lost to Follow-up|1
768816|NCT00551135|2446570|P3|Overall Study|Lost to Follow-up|0
768817|NCT00551135|2446571|P2|Overall Study|Lost to Follow-up|0
768818|NCT00551135|2446572|P1|Overall Study|Lost to Follow-up|0
768819|NCT00551135|2446569|P4|Overall Study|Adverse Event|1
768820|NCT00551135|2446570|P3|Overall Study|Adverse Event|1
768821|NCT00551135|2446571|P2|Overall Study|Adverse Event|0
768822|NCT00551135|2446572|P1|Overall Study|Adverse Event|1
768823|NCT00551161|2446686|P1|Overall Study|Withdrawal by Subject|1
768824|NCT00551213|2446720|P2|Overall Study|Not Treated|2
768825|NCT00551213|2446721|P1|Overall Study|Not Treated|1
768826|NCT00551213|2446720|P2|Overall Study|Withdrawal by Subject|0
768827|NCT00551213|2446721|P1|Overall Study|Withdrawal by Subject|2
768828|NCT00551213|2446720|P2|Overall Study|Progressive Disease|12
768829|NCT00551213|2446721|P1|Overall Study|Progressive Disease|41
768830|NCT00551213|2446720|P2|Overall Study|Adverse Event|3
768831|NCT00551213|2446721|P1|Overall Study|Adverse Event|6
768832|NCT00551291|2446737|P1|Overall Study|Physician Decision|1
768833|NCT00551369|2446743|P1|Overall Study|Not treated per protocol and re|1
768834|NCT00551369|2446743|P1|Overall Study|Withdrawal by Subject|1
768835|NCT00551369|2446743|P1|Overall Study|Protocol Violation|5
768836|NCT00551421|2446750|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
768837|NCT00551525|2446757|P1|Overall Study|Protocol Violation|5
768838|NCT00551642|2446768|P2|Overall Study|Inclusion/Exclusion criteria|4
768839|NCT00551642|2446769|P1|Overall Study|Inclusion/Exclusion criteria|4
768840|NCT00551642|2446768|P2|Overall Study|Delivery device failure|3
768841|NCT00551642|2446769|P1|Overall Study|Delivery device failure|1
768842|NCT00551642|2446768|P2|Overall Study|Physician Decision|1
768843|NCT00551642|2446769|P1|Overall Study|Physician Decision|0
768844|NCT00551642|2446768|P2|Overall Study|Protocol Violation|11
768845|NCT00551642|2446769|P1|Overall Study|Protocol Violation|6
768846|NCT00551642|2446768|P2|Overall Study|Death|31
768847|NCT00551642|2446769|P1|Overall Study|Death|33
768848|NCT00551642|2446768|P2|Overall Study|Adverse Event|12
768849|NCT00551642|2446769|P1|Overall Study|Adverse Event|15
768850|NCT00551642|2446768|P2|Overall Study|Withdrawal by Subject|1
768851|NCT00551642|2446769|P1|Overall Study|Withdrawal by Subject|2
891533|NCT01627327|2827948|P2|Overall Study|Lost to Follow-up|3
891534|NCT01627327|2827949|P1|Overall Study|Lost to Follow-up|1
891535|NCT01627327|2827948|P2|Overall Study|Protocol Violation|10
891536|NCT01627327|2827949|P1|Overall Study|Protocol Violation|4
891537|NCT01627327|2827948|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
891538|NCT01627327|2827949|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
768861|NCT00552058|2446863|P2|Overall Study|Other: Early Roll Over|0
768862|NCT00552058|2446864|P1|Overall Study|Other: Early Roll Over|1
768863|NCT00552058|2446863|P2|Overall Study|Other: Sponsors Decision|1
768864|NCT00552058|2446864|P1|Overall Study|Other: Sponsors Decision|0
768865|NCT00552058|2446863|P2|Overall Study|Other: Randomized in error|1
768866|NCT00552058|2446864|P1|Overall Study|Other: Randomized in error|0
768867|NCT00552058|2446863|P2|Overall Study|Other: Positive Stool Result|1
768868|NCT00552058|2446864|P1|Overall Study|Other: Positive Stool Result|0
768869|NCT00552058|2446863|P2|Overall Study|Other: Low CDAI score, entry violation|1
768870|NCT00552058|2446864|P1|Overall Study|Other: Low CDAI score, entry violation|0
768871|NCT00552058|2446863|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
768872|NCT00552058|2446864|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
768873|NCT00552058|2446863|P2|Overall Study|Other: Non Compliance|2
768874|NCT00552058|2446864|P1|Overall Study|Other: Non Compliance|1
768875|NCT00552058|2446863|P2|Overall Study|Other: Protocol Violation|1
768876|NCT00552058|2446864|P1|Overall Study|Other: Protocol Violation|0
768877|NCT00552058|2446863|P2|Overall Study|Withdrawal by Subject|4
768878|NCT00552058|2446864|P1|Overall Study|Withdrawal by Subject|4
768879|NCT00552058|2446863|P2|Overall Study|Lost to Follow-up|0
768880|NCT00552058|2446864|P1|Overall Study|Lost to Follow-up|1
768881|NCT00552058|2446863|P2|Overall Study|Lack of Efficacy|5
768882|NCT00552058|2446864|P1|Overall Study|Lack of Efficacy|1
768883|NCT00552058|2446863|P2|Overall Study|Adverse Event|7
768884|NCT00552058|2446864|P1|Overall Study|Adverse Event|8
768885|NCT00552084|2446904|P2|Overall Study|change in anti-arrythmic drug|1
768886|NCT00552084|2446905|P1|Overall Study|change in anti-arrythmic drug|1
768887|NCT00552084|2446904|P2|Overall Study|Protocol Violation|0
768888|NCT00552084|2446905|P1|Overall Study|Protocol Violation|1
768889|NCT00552084|2446904|P2|Overall Study|Withdrawal by Subject|5
768890|NCT00552084|2446905|P1|Overall Study|Withdrawal by Subject|4
768891|NCT00552084|2446904|P2|Overall Study|Adverse Event|3
768892|NCT00552084|2446905|P1|Overall Study|Adverse Event|2
768893|NCT00552110|2446916|P5|Overall Study|Nonserious Adverse Event (AE)|0
768894|NCT00552110|2446917|P4|Overall Study|Nonserious Adverse Event (AE)|1
768895|NCT00552110|2446918|P3|Overall Study|Nonserious Adverse Event (AE)|0
768896|NCT00552110|2446919|P2|Overall Study|Nonserious Adverse Event (AE)|0
768897|NCT00552110|2446920|P1|Overall Study|Nonserious Adverse Event (AE)|1
768898|NCT00552110|2446916|P5|Overall Study|Increased Blood Pressure at Visit 2|0
768899|NCT00552110|2446917|P4|Overall Study|Increased Blood Pressure at Visit 2|1
768900|NCT00552110|2446918|P3|Overall Study|Increased Blood Pressure at Visit 2|0
768901|NCT00552110|2446919|P2|Overall Study|Increased Blood Pressure at Visit 2|0
768902|NCT00552110|2446920|P1|Overall Study|Increased Blood Pressure at Visit 2|0
768903|NCT00552110|2446916|P5|Overall Study|Delay of Study due to Relabeling|0
768904|NCT00552110|2446917|P4|Overall Study|Delay of Study due to Relabeling|1
768905|NCT00552110|2446918|P3|Overall Study|Delay of Study due to Relabeling|0
768906|NCT00552110|2446919|P2|Overall Study|Delay of Study due to Relabeling|0
768907|NCT00552110|2446920|P1|Overall Study|Delay of Study due to Relabeling|0
768908|NCT00552110|2446916|P5|Overall Study|Use of Prohibited Medication|0
768909|NCT00552110|2446917|P4|Overall Study|Use of Prohibited Medication|0
768910|NCT00552110|2446918|P3|Overall Study|Use of Prohibited Medication|0
768911|NCT00552110|2446919|P2|Overall Study|Use of Prohibited Medication|1
768912|NCT00552110|2446920|P1|Overall Study|Use of Prohibited Medication|1
768913|NCT00552110|2446916|P5|Overall Study|Withdrawn per Sponsor|1
768914|NCT00552110|2446917|P4|Overall Study|Withdrawn per Sponsor|0
768915|NCT00552110|2446918|P3|Overall Study|Withdrawn per Sponsor|0
768916|NCT00552110|2446919|P2|Overall Study|Withdrawn per Sponsor|1
768917|NCT00552110|2446920|P1|Overall Study|Withdrawn per Sponsor|0
768918|NCT00552110|2446916|P5|Overall Study|Failed to Comply With Study Requirements|1
768919|NCT00552110|2446917|P4|Overall Study|Failed to Comply With Study Requirements|0
768920|NCT00552110|2446918|P3|Overall Study|Failed to Comply With Study Requirements|1
768921|NCT00552110|2446919|P2|Overall Study|Failed to Comply With Study Requirements|1
768922|NCT00552110|2446920|P1|Overall Study|Failed to Comply With Study Requirements|1
768923|NCT00552110|2446916|P5|Overall Study|Lost to Follow-up|1
768924|NCT00552110|2446917|P4|Overall Study|Lost to Follow-up|1
768925|NCT00552110|2446918|P3|Overall Study|Lost to Follow-up|0
768926|NCT00552110|2446919|P2|Overall Study|Lost to Follow-up|0
768927|NCT00552110|2446920|P1|Overall Study|Lost to Follow-up|0
768928|NCT00552110|2446916|P5|Overall Study|Withdrawal by Subject|2
768929|NCT00552110|2446917|P4|Overall Study|Withdrawal by Subject|3
768930|NCT00552110|2446918|P3|Overall Study|Withdrawal by Subject|0
768931|NCT00552110|2446919|P2|Overall Study|Withdrawal by Subject|2
768932|NCT00552110|2446920|P1|Overall Study|Withdrawal by Subject|0
768933|NCT00552110|2446916|P5|Overall Study|Lack of Efficacy|4
768934|NCT00552110|2446917|P4|Overall Study|Lack of Efficacy|1
768935|NCT00552110|2446918|P3|Overall Study|Lack of Efficacy|0
768936|NCT00552110|2446919|P2|Overall Study|Lack of Efficacy|0
768937|NCT00552110|2446920|P1|Overall Study|Lack of Efficacy|1
768938|NCT00552110|2446916|P5|Overall Study|Serious or Life-Threatening AE|0
768939|NCT00552110|2446917|P4|Overall Study|Serious or Life-Threatening AE|0
768940|NCT00552110|2446918|P3|Overall Study|Serious or Life-Threatening AE|1
768941|NCT00552110|2446919|P2|Overall Study|Serious or Life-Threatening AE|0
768942|NCT00552110|2446920|P1|Overall Study|Serious or Life-Threatening AE|0
768943|NCT00552175|2446940|P3|Overall Study|Reason Not Specified|1
768944|NCT00552175|2446941|P2|Overall Study|Reason Not Specified|1
768945|NCT00552175|2446942|P1|Overall Study|Reason Not Specified|3
768946|NCT00552175|2446940|P3|Overall Study|Entry Criteria Not Met|0
768947|NCT00552175|2446941|P2|Overall Study|Entry Criteria Not Met|1
768948|NCT00552175|2446942|P1|Overall Study|Entry Criteria Not Met|1
768949|NCT00552175|2446940|P3|Overall Study|Lost to Follow-up|1
768950|NCT00552175|2446941|P2|Overall Study|Lost to Follow-up|0
768951|NCT00552175|2446942|P1|Overall Study|Lost to Follow-up|0
768952|NCT00552175|2446940|P3|Overall Study|Withdrawal by Subject|1
768953|NCT00552175|2446941|P2|Overall Study|Withdrawal by Subject|2
768954|NCT00552175|2446942|P1|Overall Study|Withdrawal by Subject|2
768955|NCT00552175|2446940|P3|Overall Study|Adverse Event|10
768956|NCT00552175|2446941|P2|Overall Study|Adverse Event|9
768957|NCT00552175|2446942|P1|Overall Study|Adverse Event|9
768958|NCT00552175|2446940|P3|Overall Study|Lack of Efficacy|1
768959|NCT00552175|2446941|P2|Overall Study|Lack of Efficacy|0
768960|NCT00552175|2446942|P1|Overall Study|Lack of Efficacy|2
768961|NCT00552188|2446979|P2|Overall Study|Subject returned to home country|1
768962|NCT00552188|2446980|P1|Overall Study|Subject returned to home country|0
768963|NCT00552188|2446979|P2|Overall Study|Withdrawal of consent|1
768964|NCT00552188|2446980|P1|Overall Study|Withdrawal of consent|0
768965|NCT00552188|2446979|P2|Overall Study|Lost to Follow-up|1
768966|NCT00552188|2446980|P1|Overall Study|Lost to Follow-up|2
768967|NCT00552188|2446979|P2|Overall Study|Adverse Event|2
768968|NCT00552188|2446980|P1|Overall Study|Adverse Event|0
768969|NCT00552240|2446990|P2|Overall Study|not specified|0
768970|NCT00552240|2446991|P1|Overall Study|not specified|1
768971|NCT00552240|2446990|P2|Overall Study|Lack of Efficacy|0
768972|NCT00552240|2446991|P1|Overall Study|Lack of Efficacy|6
768973|NCT00552240|2446990|P2|Overall Study|Withdrawal by Subject|2
768974|NCT00552240|2446991|P1|Overall Study|Withdrawal by Subject|2
768975|NCT00552240|2446990|P2|Overall Study|Lost to Follow-up|6
768976|NCT00552240|2446991|P1|Overall Study|Lost to Follow-up|5
768977|NCT00552240|2446990|P2|Overall Study|Protocol Violation|1
768978|NCT00552240|2446991|P1|Overall Study|Protocol Violation|1
768979|NCT00552240|2446990|P2|Overall Study|Adverse Event|9
768980|NCT00552240|2446991|P1|Overall Study|Adverse Event|9
768981|NCT00552279|2447093|P2|Overall Study|Other|1
768982|NCT00552279|2447094|P1|Overall Study|Other|1
768983|NCT00552279|2447093|P2|Overall Study|Lost to Follow-up|0
768984|NCT00552279|2447094|P1|Overall Study|Lost to Follow-up|1
768985|NCT00552279|2447093|P2|Overall Study|Withdrawal by Subject|1
768986|NCT00552279|2447094|P1|Overall Study|Withdrawal by Subject|12
768987|NCT00552279|2447093|P2|Overall Study|Adverse Event|1
768988|NCT00552279|2447094|P1|Overall Study|Adverse Event|0
768989|NCT00552305|2447118|P1|Overall Study|Other: Subject went to rehab|1
768990|NCT00552305|2447118|P1|Overall Study|Other: Subject incarcerated|1
768991|NCT00552305|2447118|P1|Overall Study|Other: Subject moved from area|2
768992|NCT00552305|2447118|P1|Overall Study|Other: Health problems, not drug related|1
768993|NCT00552305|2447118|P1|Overall Study|Other: Subject became pregnant|1
768994|NCT00552305|2447118|P1|Overall Study|Other: Subject underwent surgery|4
768995|NCT00552305|2447118|P1|Overall Study|Other: Unable to attend visits|1
768996|NCT00552305|2447118|P1|Overall Study|Other: Personal problems|1
768997|NCT00552305|2447118|P1|Overall Study|Other: Site closed|4
768998|NCT00552305|2447118|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
768999|NCT00552305|2447118|P1|Overall Study|AE/Other: prohibited drug required|1
769000|NCT00552305|2447118|P1|Overall Study|Poor compliance/lost to follow-up|1
769001|NCT00552305|2447118|P1|Overall Study|Unsatisfactory compliance|11
769002|NCT00552305|2447118|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
769003|NCT00552305|2447118|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
769004|NCT00552305|2447118|P1|Overall Study|Lack of efficacy/withdrew consent|1
769005|NCT00552305|2447118|P1|Overall Study|Withdrawal by Subject|44
769006|NCT00552305|2447118|P1|Overall Study|Protocol Violation|3
769007|NCT00552305|2447118|P1|Overall Study|Lost to Follow-up|4
769008|NCT00552305|2447118|P1|Overall Study|Lack of Efficacy|120
769009|NCT00552305|2447118|P1|Overall Study|Adverse Event|43
769010|NCT00552344|2447126|P1|Overall Study|Other Reason|22
769011|NCT00552344|2447126|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
769012|NCT00552344|2447126|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
769013|NCT00552344|2447126|P1|Overall Study|AE, non-serious non-fatal|38
769014|NCT00552344|2447126|P1|Overall Study|SAE, non-fatal|6
769015|NCT00552344|2447126|P1|Overall Study|Withdrawal by Subject|48
769016|NCT00552344|2447126|P1|Overall Study|Lost to Follow-up|8
769017|NCT00552344|2447126|P1|Overall Study|Loss of efficacy|75
769018|NCT00552344|2447126|P1|Overall Study|Lack of Efficacy|55
769019|NCT00552396|2447142|P7|Overall Study|protocol withdrawal criteria|9
769020|NCT00552396|2447143|P6|Overall Study|protocol withdrawal criteria|3
769021|NCT00552396|2447144|P5|Overall Study|protocol withdrawal criteria|3
769022|NCT00552396|2447145|P4|Overall Study|protocol withdrawal criteria|6
769023|NCT00552396|2447146|P3|Overall Study|protocol withdrawal criteria|3
769024|NCT00552396|2447147|P2|Overall Study|protocol withdrawal criteria|3
769025|NCT00552396|2447148|P1|Overall Study|protocol withdrawal criteria|3
769026|NCT00552513|2447215|P2|Overall Study|Lost to Follow-up|1
769027|NCT00552513|2447216|P1|Overall Study|Lost to Follow-up|5
769028|NCT00552578|2447228|P2|Overall Study|Lost to Follow-up|1
769029|NCT00552578|2447229|P1|Overall Study|Lost to Follow-up|1
769030|NCT00552669|2447241|P2|Overall Study|Death|7
769031|NCT00552669|2447242|P1|Overall Study|Death|3
769032|NCT00552760|2447265|P2|Overall Study|Medication Change|0
769033|NCT00552760|2447266|P1|Overall Study|Medication Change|1
769034|NCT00552760|2447265|P2|Overall Study|Withdrawal by Subject|0
769035|NCT00552760|2447266|P1|Overall Study|Withdrawal by Subject|3
769036|NCT00552760|2447265|P2|Overall Study|Medical Condition|1
769037|NCT00552760|2447266|P1|Overall Study|Medical Condition|1
769038|NCT00552760|2447265|P2|Overall Study|Non-compliance|1
769039|NCT00552760|2447266|P1|Overall Study|Non-compliance|1
769040|NCT00552760|2447265|P2|Overall Study|Lost to Follow-up|1
769041|NCT00552760|2447266|P1|Overall Study|Lost to Follow-up|1
769042|NCT00552760|2447265|P2|Overall Study|Protocol Violation|1
769043|NCT00552760|2447266|P1|Overall Study|Protocol Violation|0
769044|NCT00552760|2447265|P2|Overall Study|Relapsed- Mixed Event|5
769045|NCT00552760|2447266|P1|Overall Study|Relapsed- Mixed Event|3
769046|NCT00552760|2447265|P2|Overall Study|Relapse- Manic Event|3
769047|NCT00552760|2447266|P1|Overall Study|Relapse- Manic Event|3
769048|NCT00552760|2447265|P2|Overall Study|Relapsed- Depressed Event|16
769049|NCT00552760|2447266|P1|Overall Study|Relapsed- Depressed Event|10
769050|NCT00552760|2447265|P2|Overall Study|Adverse Event|5
769051|NCT00552760|2447266|P1|Overall Study|Adverse Event|3
769052|NCT00553150|2447313|P4|Overall Study|Ineligible|1
769053|NCT00553150|2447314|P3|Overall Study|Ineligible|0
769054|NCT00553150|2447315|P2|Overall Study|Ineligible|0
769055|NCT00553150|2447316|P1|Overall Study|Ineligible|0
769056|NCT00553150|2447313|P4|Overall Study|Protocol Violation|1
769057|NCT00553150|2447314|P3|Overall Study|Protocol Violation|0
769058|NCT00553150|2447315|P2|Overall Study|Protocol Violation|0
769059|NCT00553150|2447316|P1|Overall Study|Protocol Violation|0
769060|NCT00553150|2447313|P4|Overall Study|Withdrawal by Subject|2
769061|NCT00553150|2447314|P3|Overall Study|Withdrawal by Subject|0
769062|NCT00553150|2447315|P2|Overall Study|Withdrawal by Subject|0
769063|NCT00553150|2447316|P1|Overall Study|Withdrawal by Subject|0
769064|NCT00553202|2447328|P1|Overall Study|Fails to meet organ function|6
769065|NCT00553202|2447328|P1|Overall Study|No donor identified|16
769066|NCT00553202|2447328|P1|Overall Study|Withdrawal by Subject|1
769067|NCT00553202|2447328|P1|Overall Study|Physician Decision|28
769068|NCT00553202|2447328|P1|Overall Study|Lost to Follow-up|1
769069|NCT00553202|2447328|P1|Overall Study|Death|16
769070|NCT00553267|2447339|P3|Overall Study|Specified category|1
769071|NCT00553267|2447340|P2|Overall Study|Specified category|2
769072|NCT00553267|2447341|P1|Overall Study|Specified category|1
769073|NCT00553267|2447339|P3|Overall Study|Consent withdrawn|1
769074|NCT00553267|2447340|P2|Overall Study|Consent withdrawn|3
769075|NCT00553267|2447341|P1|Overall Study|Consent withdrawn|2
769076|NCT00553267|2447339|P3|Overall Study|Lost to Follow-up|1
769077|NCT00553267|2447340|P2|Overall Study|Lost to Follow-up|0
769078|NCT00553267|2447341|P1|Overall Study|Lost to Follow-up|0
769079|NCT00553267|2447339|P3|Overall Study|Non compliant with protocol|2
769080|NCT00553267|2447340|P2|Overall Study|Non compliant with protocol|3
769081|NCT00553267|2447341|P1|Overall Study|Non compliant with protocol|3
769082|NCT00553267|2447339|P3|Overall Study|Adverse Event|5
769083|NCT00553267|2447340|P2|Overall Study|Adverse Event|10
769084|NCT00553267|2447341|P1|Overall Study|Adverse Event|8
769085|NCT00553280|2447376|P1|Overall Study|Physician Decision|1
769086|NCT00553280|2447376|P1|Overall Study|Withdrawal by Subject|3
769087|NCT00553280|2447376|P1|Overall Study|Lack of Efficacy|3
769088|NCT00553280|2447376|P1|Overall Study|Adverse Event|19
769089|NCT00553319|2447388|P3|Overall Study|moved|1
769090|NCT00553319|2447389|P2|Overall Study|moved|0
769091|NCT00553319|2447390|P1|Overall Study|moved|1
769092|NCT00553319|2447388|P3|Overall Study|incarceration|0
769093|NCT00553319|2447389|P2|Overall Study|incarceration|0
769094|NCT00553319|2447390|P1|Overall Study|incarceration|1
769095|NCT00553319|2447388|P3|Overall Study|non-compliance|2
769096|NCT00553319|2447389|P2|Overall Study|non-compliance|0
769097|NCT00553319|2447390|P1|Overall Study|non-compliance|0
769098|NCT00553319|2447388|P3|Overall Study|wanted treatment elsewhere|1
769099|NCT00553319|2447389|P2|Overall Study|wanted treatment elsewhere|1
769100|NCT00553319|2447390|P1|Overall Study|wanted treatment elsewhere|2
769101|NCT00553319|2447388|P3|Overall Study|Lost to Follow-up|5
769102|NCT00553319|2447389|P2|Overall Study|Lost to Follow-up|9
769103|NCT00553319|2447390|P1|Overall Study|Lost to Follow-up|10
769104|NCT00553332|2447401|P1|Overall Study|ineligible, incorrect diagnosis|1
769105|NCT00553358|2447413|P3|Overall Study|Other: Reason Not Specified|20
769106|NCT00553358|2447414|P2|Overall Study|Other: Reason Not Specified|4
769107|NCT00553358|2447415|P1|Overall Study|Other: Reason Not Specified|15
769108|NCT00553358|2447413|P3|Overall Study|Missing|1
769109|NCT00553358|2447414|P2|Overall Study|Missing|1
769110|NCT00553358|2447415|P1|Overall Study|Missing|1
769111|NCT00553358|2447413|P3|Overall Study|Participant Withdrawal from Drug|3
769112|NCT00553358|2447414|P2|Overall Study|Participant Withdrawal from Drug|0
769113|NCT00553358|2447415|P1|Overall Study|Participant Withdrawal from Drug|0
769114|NCT00553358|2447413|P3|Overall Study|Recurrence of Disease|1
769115|NCT00553358|2447414|P2|Overall Study|Recurrence of Disease|4
769116|NCT00553358|2447415|P1|Overall Study|Recurrence of Disease|3
769117|NCT00553358|2447413|P3|Overall Study|Withdrawal by Subject|1
769118|NCT00553358|2447414|P2|Overall Study|Withdrawal by Subject|0
769119|NCT00553358|2447415|P1|Overall Study|Withdrawal by Subject|5
769120|NCT00553358|2447413|P3|Overall Study|Protocol Violation|1
769121|NCT00553358|2447414|P2|Overall Study|Protocol Violation|1
769122|NCT00553358|2447415|P1|Overall Study|Protocol Violation|0
769123|NCT00553358|2447413|P3|Overall Study|Lost to Follow-up|1
769124|NCT00553358|2447414|P2|Overall Study|Lost to Follow-up|0
769125|NCT00553358|2447415|P1|Overall Study|Lost to Follow-up|0
769126|NCT00553358|2447413|P3|Overall Study|Adverse Event|32
769127|NCT00553358|2447414|P2|Overall Study|Adverse Event|2
769128|NCT00553358|2447415|P1|Overall Study|Adverse Event|29
769129|NCT00545740|2447445|P4|Overall Study|Husband against study|0
769130|NCT00545740|2447446|P3|Overall Study|Husband against study|1
769131|NCT00545740|2447447|P2|Overall Study|Husband against study|0
769132|NCT00545740|2447448|P1|Overall Study|Husband against study|0
769133|NCT00545740|2447445|P4|Overall Study|Patient difficulties|0
769134|NCT00545740|2447446|P3|Overall Study|Patient difficulties|0
769135|NCT00545740|2447447|P2|Overall Study|Patient difficulties|1
769136|NCT00545740|2447448|P1|Overall Study|Patient difficulties|0
769137|NCT00545740|2447445|P4|Overall Study|Non-adherence to visits|0
769138|NCT00545740|2447446|P3|Overall Study|Non-adherence to visits|0
769139|NCT00545740|2447447|P2|Overall Study|Non-adherence to visits|1
769140|NCT00545740|2447448|P1|Overall Study|Non-adherence to visits|0
769141|NCT00545740|2447445|P4|Overall Study|Lack of time|0
769142|NCT00545740|2447446|P3|Overall Study|Lack of time|0
769143|NCT00545740|2447447|P2|Overall Study|Lack of time|1
769144|NCT00545740|2447448|P1|Overall Study|Lack of time|0
769145|NCT00545740|2447445|P4|Overall Study|Sponsor decision|0
769146|NCT00545740|2447446|P3|Overall Study|Sponsor decision|0
769147|NCT00545740|2447447|P2|Overall Study|Sponsor decision|1
769148|NCT00545740|2447448|P1|Overall Study|Sponsor decision|0
769149|NCT00545740|2447445|P4|Overall Study|Accepted only monthly telephone calls|0
769150|NCT00545740|2447446|P3|Overall Study|Accepted only monthly telephone calls|0
769151|NCT00545740|2447447|P2|Overall Study|Accepted only monthly telephone calls|0
769152|NCT00545740|2447448|P1|Overall Study|Accepted only monthly telephone calls|1
769153|NCT00545740|2447445|P4|Overall Study|Physician Decision|0
769154|NCT00545740|2447446|P3|Overall Study|Physician Decision|3
769155|NCT00545740|2447447|P2|Overall Study|Physician Decision|0
769156|NCT00545740|2447448|P1|Overall Study|Physician Decision|0
769157|NCT00545740|2447445|P4|Overall Study|Missed visit|0
769158|NCT00545740|2447446|P3|Overall Study|Missed visit|0
769159|NCT00545740|2447447|P2|Overall Study|Missed visit|0
769160|NCT00545740|2447448|P1|Overall Study|Missed visit|1
769161|NCT00545740|2447445|P4|Overall Study|Site closure|0
769162|NCT00545740|2447446|P3|Overall Study|Site closure|0
769163|NCT00545740|2447447|P2|Overall Study|Site closure|0
769164|NCT00545740|2447448|P1|Overall Study|Site closure|1
769165|NCT00545740|2447445|P4|Overall Study|Suspected Diverticulitis Recurrence|1
769166|NCT00545740|2447446|P3|Overall Study|Suspected Diverticulitis Recurrence|1
769167|NCT00545740|2447447|P2|Overall Study|Suspected Diverticulitis Recurrence|1
769168|NCT00545740|2447448|P1|Overall Study|Suspected Diverticulitis Recurrence|1
769169|NCT00545740|2447445|P4|Overall Study|Diverticulitis attack|1
769170|NCT00545740|2447446|P3|Overall Study|Diverticulitis attack|1
769171|NCT00545740|2447447|P2|Overall Study|Diverticulitis attack|0
769172|NCT00545740|2447448|P1|Overall Study|Diverticulitis attack|0
769173|NCT00545740|2447445|P4|Overall Study|Moved|0
769174|NCT00545740|2447446|P3|Overall Study|Moved|1
769175|NCT00545740|2447447|P2|Overall Study|Moved|0
769176|NCT00545740|2447448|P1|Overall Study|Moved|2
769177|NCT00545740|2447445|P4|Overall Study|Non-compliance|0
769178|NCT00545740|2447446|P3|Overall Study|Non-compliance|1
769179|NCT00545740|2447447|P2|Overall Study|Non-compliance|2
769180|NCT00545740|2447448|P1|Overall Study|Non-compliance|0
769181|NCT00545740|2447445|P4|Overall Study|Protocol Violation|0
769182|NCT00545740|2447446|P3|Overall Study|Protocol Violation|1
769183|NCT00545740|2447447|P2|Overall Study|Protocol Violation|3
769184|NCT00545740|2447448|P1|Overall Study|Protocol Violation|1
769185|NCT00545740|2447445|P4|Overall Study|Lost to Follow-up|6
769186|NCT00545740|2447446|P3|Overall Study|Lost to Follow-up|5
769187|NCT00545740|2447447|P2|Overall Study|Lost to Follow-up|5
769188|NCT00545740|2447448|P1|Overall Study|Lost to Follow-up|7
769189|NCT00545740|2447445|P4|Overall Study|Adverse Event|9
769190|NCT00545740|2447446|P3|Overall Study|Adverse Event|19
769191|NCT00545740|2447447|P2|Overall Study|Adverse Event|18
769192|NCT00545740|2447448|P1|Overall Study|Adverse Event|10
769193|NCT00545740|2447445|P4|Overall Study|Withdrawal by Subject|18
769194|NCT00545740|2447446|P3|Overall Study|Withdrawal by Subject|16
769195|NCT00545740|2447447|P2|Overall Study|Withdrawal by Subject|15
769196|NCT00545740|2447448|P1|Overall Study|Withdrawal by Subject|17
769197|NCT00545740|2447445|P4|Overall Study|Lack of Efficacy|36
769198|NCT00545740|2447446|P3|Overall Study|Lack of Efficacy|47
769199|NCT00545740|2447447|P2|Overall Study|Lack of Efficacy|35
769200|NCT00545740|2447448|P1|Overall Study|Lack of Efficacy|34
769201|NCT00545753|2447485|P3|Overall Study|Protocol Violation|4
769202|NCT00545753|2447486|P2|Overall Study|Protocol Violation|1
769203|NCT00545753|2447487|P1|Overall Study|Protocol Violation|3
769204|NCT00545753|2447485|P3|Overall Study|Lost to Follow-up|12
769205|NCT00545753|2447486|P2|Overall Study|Lost to Follow-up|3
769206|NCT00545753|2447487|P1|Overall Study|Lost to Follow-up|13
769207|NCT00545753|2447485|P3|Overall Study|Withdrawal by Subject|10
769208|NCT00545753|2447486|P2|Overall Study|Withdrawal by Subject|1
769209|NCT00545753|2447487|P1|Overall Study|Withdrawal by Subject|0
769210|NCT00545779|2447500|P1|Overall Study|Failure to return|3
769211|NCT00545779|2447500|P1|Overall Study|Adverse Event/intercurrent illness|5
769212|NCT00545779|2447500|P1|Overall Study|Withdrawal by Subject|20
769213|NCT00545779|2447500|P1|Overall Study|Did not cooperate|7
769214|NCT00545779|2447500|P1|Overall Study|Other protocol violation|1
769215|NCT00545779|2447500|P1|Overall Study|Violation of selection criteria at entry|8
769216|NCT00545792|2447513|P1|Overall Study|Withdrawal by Subject|1
891539|NCT01627327|2827948|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
891540|NCT01627327|2827949|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
891541|NCT01627327|2827948|P2|Overall Study|Adverse Event|12
769220|NCT00545948|2447535|P3|Overall Study|Not Treated|7
769221|NCT00545948|2447536|P2|Overall Study|Not Treated|1
769222|NCT00545948|2447537|P1|Overall Study|Not Treated|1
769223|NCT00546000|2447558|P1|Overall Study|Baseline HPA Axis Supression|2
769224|NCT00546000|2447558|P1|Overall Study|Lost to Follow-up|1
769225|NCT00546000|2447558|P1|Overall Study|Adverse Event|1
769226|NCT00546052|2447563|P1|Overall Study|Non Compliance|7
769227|NCT00546052|2447563|P1|Overall Study|Withdrawal by Subject|20
769228|NCT00546052|2447563|P1|Overall Study|Protocol Violation|9
769229|NCT00546052|2447563|P1|Overall Study|Lost to Follow-up|144
769230|NCT00546052|2447563|P1|Overall Study|Adverse Event|47
769231|NCT00546078|2447583|P2|Overall Study|Other reason|1
769232|NCT00546078|2447584|P1|Overall Study|Other reason|1
769233|NCT00546078|2447583|P2|Overall Study|Withdrawal by Subject|3
769234|NCT00546078|2447584|P1|Overall Study|Withdrawal by Subject|2
769235|NCT00546078|2447583|P2|Overall Study|Lost to Follow-up|3
769236|NCT00546078|2447584|P1|Overall Study|Lost to Follow-up|1
769237|NCT00546117|2447633|P2|Overall Study|Inability to schedule follow-up visit|0
769238|NCT00546117|2447634|P1|Overall Study|Inability to schedule follow-up visit|1
769239|NCT00546117|2447633|P2|Overall Study|Withdrawal by Subject|0
769240|NCT00546117|2447634|P1|Overall Study|Withdrawal by Subject|3
769241|NCT00546260|2447654|P2|Overall Study|Drug not given pre diagnostic angiogr|2
769242|NCT00546260|2447655|P1|Overall Study|Drug not given pre diagnostic angiogr|8
769243|NCT00546351|2447681|P1|Overall Study|Other reasons for premature termination|17
769244|NCT00546351|2447681|P1|Overall Study|Unsatisfactory compliance|9
769245|NCT00546351|2447681|P1|Overall Study|Protocol Deviation|1
769246|NCT00546351|2447681|P1|Overall Study|Lost to Follow-up|9
769247|NCT00546351|2447681|P1|Overall Study|Withdrawal by Subject|109
769248|NCT00546351|2447681|P1|Overall Study|Lack of Efficacy|15
769249|NCT00546351|2447681|P1|Overall Study|Adverse Event|76
769250|NCT00546364|2447712|P3|Overall Study|Sponsor decision|1
769251|NCT00546364|2447713|P2|Overall Study|Sponsor decision|0
769252|NCT00546364|2447714|P1|Overall Study|Sponsor decision|0
769253|NCT00546364|2447712|P3|Overall Study|Physician Decision|1
769254|NCT00546364|2447713|P2|Overall Study|Physician Decision|0
769255|NCT00546364|2447714|P1|Overall Study|Physician Decision|0
769256|NCT00546364|2447712|P3|Overall Study|Target lesions resected|0
769257|NCT00546364|2447713|P2|Overall Study|Target lesions resected|0
769258|NCT00546364|2447714|P1|Overall Study|Target lesions resected|1
769259|NCT00546364|2447712|P3|Overall Study|Palliative treatment|1
769260|NCT00546364|2447713|P2|Overall Study|Palliative treatment|0
769261|NCT00546364|2447714|P1|Overall Study|Palliative treatment|1
769262|NCT00546364|2447712|P3|Overall Study|Mixed response|0
769263|NCT00546364|2447713|P2|Overall Study|Mixed response|0
769264|NCT00546364|2447714|P1|Overall Study|Mixed response|1
769265|NCT00546364|2447712|P3|Overall Study|Prior taxotere|0
769266|NCT00546364|2447713|P2|Overall Study|Prior taxotere|0
769267|NCT00546364|2447714|P1|Overall Study|Prior taxotere|1
769268|NCT00546364|2447712|P3|Overall Study|Withdrawal by Subject|3
769269|NCT00546364|2447713|P2|Overall Study|Withdrawal by Subject|6
769270|NCT00546364|2447714|P1|Overall Study|Withdrawal by Subject|5
769271|NCT00546364|2447712|P3|Overall Study|No longer meets study criteria|0
769272|NCT00546364|2447713|P2|Overall Study|No longer meets study criteria|1
769273|NCT00546364|2447714|P1|Overall Study|No longer meets study criteria|1
769274|NCT00546364|2447712|P3|Overall Study|Poor compliance/noncompliance|1
769275|NCT00546364|2447713|P2|Overall Study|Poor compliance/noncompliance|0
769276|NCT00546364|2447714|P1|Overall Study|Poor compliance/noncompliance|0
769277|NCT00546364|2447712|P3|Overall Study|Administrative reason by sponsor|0
769278|NCT00546364|2447713|P2|Overall Study|Administrative reason by sponsor|0
769279|NCT00546364|2447714|P1|Overall Study|Administrative reason by sponsor|1
769280|NCT00546364|2447712|P3|Overall Study|Completed and off treatment|2
769281|NCT00546364|2447713|P2|Overall Study|Completed and off treatment|0
769282|NCT00546364|2447714|P1|Overall Study|Completed and off treatment|1
769283|NCT00546364|2447712|P3|Overall Study|Disease progression|8
769284|NCT00546364|2447713|P2|Overall Study|Disease progression|11
769285|NCT00546364|2447714|P1|Overall Study|Disease progression|5
769286|NCT00546377|2447749|P1|Overall Study|Adverse Event|6
769287|NCT00546377|2447749|P1|Overall Study|Deemed ineligible|1
769288|NCT00546481|2447760|P3|Maintenance Phase (CERA)|Other Reason|1
769289|NCT00546481|2447761|P2|Maintenance Phase (CERA)|Other Reason|0
769290|NCT00546481|2447762|P1|Maintenance Phase (CERA)|Other Reason|0
769291|NCT00546481|2447760|P3|Maintenance Phase (CERA)|Kidney transplantation|1
769292|NCT00546481|2447761|P2|Maintenance Phase (CERA)|Kidney transplantation|0
769293|NCT00546481|2447762|P1|Maintenance Phase (CERA)|Kidney transplantation|0
769294|NCT00546481|2447760|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
769295|NCT00546481|2447761|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
769296|NCT00546481|2447762|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
769297|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
769298|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
769299|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
769300|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
769301|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
769302|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
769303|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
769304|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
769305|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
769306|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
769307|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
769308|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
769309|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
769310|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
769311|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
769312|NCT00546481|2447760|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
769313|NCT00546481|2447761|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
769314|NCT00546481|2447762|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
769315|NCT00546572|2447787|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
769316|NCT00546572|2447788|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
769317|NCT00546572|2447787|P2|Vax 2 / Year 1|Adverse Event|0
769318|NCT00546572|2447788|P1|Vax 2 / Year 1|Adverse Event|1
769319|NCT00546572|2447787|P2|Vax 2 / Year 1|Unspecified|1
769320|NCT00546572|2447788|P1|Vax 2 / Year 1|Unspecified|1
769321|NCT00546572|2447787|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
769322|NCT00546572|2447788|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
769323|NCT00546572|2447787|P2|Vax 1 / Year 0|Lost to Follow-up|1
769324|NCT00546572|2447788|P1|Vax 1 / Year 0|Lost to Follow-up|0
769325|NCT00546572|2447787|P2|Vax 1 / Year 0|Adverse Event|1
769326|NCT00546572|2447788|P1|Vax 1 / Year 0|Adverse Event|0
769327|NCT00546572|2447787|P2|Vax 1 / Year 0|Death|2
769328|NCT00546572|2447788|P1|Vax 1 / Year 0|Death|2
769329|NCT00546572|2447787|P2|Vax 1 / Year 0|Protocol Violation|4
769330|NCT00546572|2447788|P1|Vax 1 / Year 0|Protocol Violation|3
769331|NCT00546572|2447787|P2|Vax 1 / Year 0|Withdrawal by Subject|2
769332|NCT00546572|2447788|P1|Vax 1 / Year 0|Withdrawal by Subject|3
769333|NCT00546572|2447787|P2|Vax 1 / Year 0|Randomized, not treated|1
769334|NCT00546572|2447788|P1|Vax 1 / Year 0|Randomized, not treated|1
769335|NCT00546637|2447832|P2|Overall Study|Randomized, but not treated|1
769336|NCT00546637|2447833|P1|Overall Study|Randomized, but not treated|3
769337|NCT00546637|2447832|P2|Overall Study|Withdrawal by Subject|9
769338|NCT00546637|2447833|P1|Overall Study|Withdrawal by Subject|7
769339|NCT00546637|2447832|P2|Overall Study|Unspecified|12
769340|NCT00546637|2447833|P1|Overall Study|Unspecified|10
769341|NCT00546637|2447832|P2|Overall Study|Lost to Follow-up|2
769342|NCT00546637|2447833|P1|Overall Study|Lost to Follow-up|2
769343|NCT00546637|2447832|P2|Overall Study|Lack of Efficacy|5
769344|NCT00546637|2447833|P1|Overall Study|Lack of Efficacy|5
769345|NCT00546637|2447832|P2|Overall Study|Adverse Event|20
769346|NCT00546637|2447833|P1|Overall Study|Adverse Event|46
769347|NCT00553436|2447905|P1|Overall Study|Conversion to another procedure|1
769348|NCT00553462|2447911|P1|Overall Study|Physician Decision|1
769349|NCT00553462|2447911|P1|Overall Study|Withdrawal by Subject|5
769350|NCT00553462|2447911|P1|Overall Study|Progression|4
769351|NCT00553462|2447911|P1|Overall Study|Adverse Event|4
769352|NCT00553475|2447920|P3|Overall Study|Due to moving|0
769353|NCT00553475|2447921|P2|Overall Study|Due to moving|1
769354|NCT00553475|2447922|P1|Overall Study|Due to moving|0
769355|NCT00553475|2447920|P3|Overall Study|Physician Decision|0
769356|NCT00553475|2447921|P2|Overall Study|Physician Decision|0
769357|NCT00553475|2447922|P1|Overall Study|Physician Decision|1
769358|NCT00553475|2447920|P3|Overall Study|Withdrawal by Subject|0
769359|NCT00553475|2447921|P2|Overall Study|Withdrawal by Subject|1
769360|NCT00553475|2447922|P1|Overall Study|Withdrawal by Subject|1
769361|NCT00553475|2447920|P3|Overall Study|Lack of Efficacy|0
769362|NCT00553475|2447921|P2|Overall Study|Lack of Efficacy|1
769363|NCT00553475|2447922|P1|Overall Study|Lack of Efficacy|7
769364|NCT00553475|2447920|P3|Overall Study|Adverse Event|13
769365|NCT00553475|2447921|P2|Overall Study|Adverse Event|17
769366|NCT00553475|2447922|P1|Overall Study|Adverse Event|7
769367|NCT00553501|2448044|P1|Overall Study|Progression|1
769368|NCT00553501|2448044|P1|Overall Study|Death|1
769369|NCT00553501|2448044|P1|Overall Study|Adverse Event|2
769370|NCT00553514|2448055|P5|Overall Study|Unspecified|1
769371|NCT00553514|2448056|P4|Overall Study|Unspecified|0
769372|NCT00553514|2448057|P3|Overall Study|Unspecified|0
769373|NCT00553514|2448058|P2|Overall Study|Unspecified|1
769374|NCT00553514|2448059|P1|Overall Study|Unspecified|1
769375|NCT00553514|2448055|P5|Overall Study|Risk of multiple pregnancy|0
769376|NCT00553514|2448056|P4|Overall Study|Risk of multiple pregnancy|1
769377|NCT00553514|2448057|P3|Overall Study|Risk of multiple pregnancy|0
769378|NCT00553514|2448058|P2|Overall Study|Risk of multiple pregnancy|2
769379|NCT00553514|2448059|P1|Overall Study|Risk of multiple pregnancy|0
769380|NCT00553514|2448055|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
769381|NCT00553514|2448056|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
769382|NCT00553514|2448057|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
769383|NCT00553514|2448058|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
769384|NCT00553514|2448059|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
769385|NCT00553514|2448055|P5|Overall Study|Lack of ovarian response|6
769386|NCT00553514|2448056|P4|Overall Study|Lack of ovarian response|5
769387|NCT00553514|2448057|P3|Overall Study|Lack of ovarian response|5
769388|NCT00553514|2448058|P2|Overall Study|Lack of ovarian response|5
769389|NCT00553514|2448059|P1|Overall Study|Lack of ovarian response|4
769390|NCT00553514|2448055|P5|Overall Study|Protocol deviation|0
769391|NCT00553514|2448056|P4|Overall Study|Protocol deviation|1
769392|NCT00553514|2448057|P3|Overall Study|Protocol deviation|0
769393|NCT00553514|2448058|P2|Overall Study|Protocol deviation|0
769394|NCT00553514|2448059|P1|Overall Study|Protocol deviation|0
769395|NCT00553605|2448098|P2|Overall Study|Randomized but not treated|0
769396|NCT00553605|2448099|P1|Overall Study|Randomized but not treated|2
769397|NCT00553605|2448098|P2|Overall Study|Did not receive full dose|0
769398|NCT00553605|2448099|P1|Overall Study|Did not receive full dose|1
769399|NCT00553605|2448098|P2|Overall Study|Did not meet entrance criteria|3
769400|NCT00553605|2448099|P1|Overall Study|Did not meet entrance criteria|1
769401|NCT00553631|2448125|P2|Overall Study|Lost to Follow-up|0
769402|NCT00553631|2448126|P1|Overall Study|Lost to Follow-up|1
769403|NCT00553631|2448125|P2|Overall Study|Withdrawal by Subject|1
769404|NCT00553631|2448126|P1|Overall Study|Withdrawal by Subject|0
769405|NCT00553644|2448146|P1|Overall Study|Alternative therapy|6
769406|NCT00553644|2448146|P1|Overall Study|Physician Decision|1
769407|NCT00553644|2448146|P1|Overall Study|Withdrawal by Subject|4
769408|NCT00553644|2448146|P1|Overall Study|Adverse Event|17
769409|NCT00553696|2448157|P4|Overall Study|Withdrawal by Subject|0
769410|NCT00553696|2448158|P3|Overall Study|Withdrawal by Subject|0
769411|NCT00553696|2448159|P2|Overall Study|Withdrawal by Subject|1
769412|NCT00553696|2448160|P1|Overall Study|Withdrawal by Subject|0
769413|NCT00553696|2448157|P4|Overall Study|Objective progression or relapse|0
769414|NCT00553696|2448158|P3|Overall Study|Objective progression or relapse|6
769415|NCT00553696|2448159|P2|Overall Study|Objective progression or relapse|9
769416|NCT00553696|2448160|P1|Overall Study|Objective progression or relapse|2
769417|NCT00553696|2448157|P4|Overall Study|Global deterioration of health status|0
769418|NCT00553696|2448158|P3|Overall Study|Global deterioration of health status|0
769419|NCT00553696|2448159|P2|Overall Study|Global deterioration of health status|2
769420|NCT00553696|2448160|P1|Overall Study|Global deterioration of health status|0
769421|NCT00553696|2448157|P4|Overall Study|Adverse Event|1
769422|NCT00553696|2448158|P3|Overall Study|Adverse Event|0
769423|NCT00553696|2448159|P2|Overall Study|Adverse Event|4
769424|NCT00553696|2448160|P1|Overall Study|Adverse Event|2
769425|NCT00554099|2448218|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
769426|NCT00554099|2448219|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
769427|NCT00554099|2448220|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
769428|NCT00554099|2448218|P3|Non-Treatment Phase (9 Months)|Relapse|1
769429|NCT00554099|2448219|P2|Non-Treatment Phase (9 Months)|Relapse|1
769430|NCT00554099|2448220|P1|Non-Treatment Phase (9 Months)|Relapse|2
769431|NCT00554099|2448218|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
769432|NCT00554099|2448219|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
769433|NCT00554099|2448220|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
769434|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
769435|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
769436|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
769437|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Protocol Violation|2
769438|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Protocol Violation|0
769439|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Protocol Violation|0
769440|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
769441|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
769442|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
769443|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
769444|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
769445|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
769446|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Physician Decision|0
769447|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Physician Decision|0
769448|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Physician Decision|3
769449|NCT00554099|2448218|P3|Treatment Period (12 Weeks)|Adverse Event|1
769450|NCT00554099|2448219|P2|Treatment Period (12 Weeks)|Adverse Event|5
769451|NCT00554099|2448220|P1|Treatment Period (12 Weeks)|Adverse Event|3
769452|NCT00554190|2448249|P1|Overall Study|Termination forms not completed|10
769453|NCT00554216|2448258|P3|Overall Study|Lack of Efficacy|0
769454|NCT00554216|2448259|P2|Overall Study|Lack of Efficacy|3
769455|NCT00554216|2448260|P1|Overall Study|Lack of Efficacy|15
769456|NCT00554216|2448258|P3|Overall Study|not specified|10
769457|NCT00554216|2448259|P2|Overall Study|not specified|7
769458|NCT00554216|2448260|P1|Overall Study|not specified|12
769459|NCT00554216|2448258|P3|Overall Study|Restricted med|1
769460|NCT00554216|2448259|P2|Overall Study|Restricted med|1
769461|NCT00554216|2448260|P1|Overall Study|Restricted med|3
769462|NCT00554216|2448258|P3|Overall Study|Pregnancy|14
769463|NCT00554216|2448259|P2|Overall Study|Pregnancy|1
769464|NCT00554216|2448260|P1|Overall Study|Pregnancy|2
769465|NCT00554216|2448258|P3|Overall Study|Non compliance|5
769466|NCT00554216|2448259|P2|Overall Study|Non compliance|4
769467|NCT00554216|2448260|P1|Overall Study|Non compliance|10
769468|NCT00554216|2448258|P3|Overall Study|Withdrawal by Subject|43
769469|NCT00554216|2448259|P2|Overall Study|Withdrawal by Subject|31
769470|NCT00554216|2448260|P1|Overall Study|Withdrawal by Subject|92
769471|NCT00554216|2448258|P3|Overall Study|Adverse Event|36
769472|NCT00554216|2448259|P2|Overall Study|Adverse Event|16
769473|NCT00554216|2448260|P1|Overall Study|Adverse Event|16
769474|NCT00554216|2448258|P3|Overall Study|Lost to Follow-up|63
769475|NCT00554216|2448259|P2|Overall Study|Lost to Follow-up|31
769476|NCT00554216|2448260|P1|Overall Study|Lost to Follow-up|92
769477|NCT00554229|2448273|P2|Overall Study|Randomised but no treatment received|0
769478|NCT00554229|2448274|P1|Overall Study|Randomised but no treatment received|1
769479|NCT00554229|2448273|P2|Overall Study|Reason not otherwise captured, eg; death|140
769480|NCT00554229|2448274|P1|Overall Study|Reason not otherwise captured, eg; death|119
769481|NCT00554229|2448273|P2|Overall Study|Protocol Violation|3
769482|NCT00554229|2448274|P1|Overall Study|Protocol Violation|3
769483|NCT00554229|2448273|P2|Overall Study|Adverse Event|39
769484|NCT00554229|2448274|P1|Overall Study|Adverse Event|71
769485|NCT00554229|2448273|P2|Overall Study|Withdrawal by Subject|37
769486|NCT00554229|2448274|P1|Overall Study|Withdrawal by Subject|29
769487|NCT00554229|2448273|P2|Overall Study|Lost to Follow-up|6
769488|NCT00554229|2448274|P1|Overall Study|Lost to Follow-up|3
891542|NCT01627327|2827949|P1|Overall Study|Adverse Event|6
891543|NCT01587898|2827963|P4|Overall Study|Met haemoglobin stopping criteria|0
891544|NCT01587898|2827964|P3|Overall Study|Met haemoglobin stopping criteria|1
891545|NCT01587898|2827965|P2|Overall Study|Met haemoglobin stopping criteria|1
891546|NCT01587898|2827966|P1|Overall Study|Met haemoglobin stopping criteria|1
891547|NCT01587898|2827963|P4|Overall Study|Withdrawal by Subject|0
891548|NCT01587898|2827964|P3|Overall Study|Withdrawal by Subject|0
891549|NCT01587898|2827965|P2|Overall Study|Withdrawal by Subject|1
891550|NCT01587898|2827966|P1|Overall Study|Withdrawal by Subject|2
769498|NCT00554619|2448351|P1|Overall Study|Liver Function Test Abnormality|1
769499|NCT00554619|2448351|P1|Overall Study|Physician Decision|1
769500|NCT00554619|2448351|P1|Overall Study|Adverse Event|1
769501|NCT00554801|2448381|P2|Overall Study|Withdrawal by Subject|0
769502|NCT00554801|2448382|P1|Overall Study|Withdrawal by Subject|14
769503|NCT00554801|2448381|P2|Overall Study|left area before completion|0
769504|NCT00554801|2448382|P1|Overall Study|left area before completion|5
769505|NCT00554840|2448390|P2|Overall Study|Physician Decision|1
769506|NCT00554840|2448391|P1|Overall Study|Physician Decision|0
769507|NCT00555009|2448465|P2|Overall Study|Terminated by Sponsor|5
769508|NCT00555009|2448466|P1|Overall Study|Terminated by Sponsor|2
769509|NCT00555009|2448465|P2|Overall Study|Withdrawal by Subject|1
769510|NCT00555009|2448466|P1|Overall Study|Withdrawal by Subject|0
769511|NCT00555061|2448498|P1|Overall Study|Participant enrolled, but never treated|1
769512|NCT00555061|2448498|P1|Overall Study|Withdrawal by Subject|2
769513|NCT00555061|2448498|P1|Overall Study|Lost to Follow-up|2
769514|NCT00555061|2448498|P1|Overall Study|Protocol Violation|1
769515|NCT00555061|2448498|P1|Overall Study|Adverse Event|3
769516|NCT00555217|2448536|P2|Overall Study|close out sites|17
769517|NCT00555217|2448537|P1|Overall Study|close out sites|21
769518|NCT00555217|2448536|P2|Overall Study|Lost to Follow-up|20
769519|NCT00555217|2448537|P1|Overall Study|Lost to Follow-up|19
769520|NCT00555217|2448536|P2|Overall Study|Withdrawal by Subject|31
769521|NCT00555217|2448537|P1|Overall Study|Withdrawal by Subject|35
891551|NCT01587898|2827963|P4|Overall Study|Lost to Follow-up|1
891552|NCT01587898|2827964|P3|Overall Study|Lost to Follow-up|0
891553|NCT01587898|2827965|P2|Overall Study|Lost to Follow-up|0
891554|NCT01587898|2827966|P1|Overall Study|Lost to Follow-up|0
891555|NCT01587898|2827963|P4|Overall Study|Protocol Violation|1
891556|NCT01587898|2827964|P3|Overall Study|Protocol Violation|1
891557|NCT01587898|2827965|P2|Overall Study|Protocol Violation|2
891558|NCT01587898|2827966|P1|Overall Study|Protocol Violation|0
891559|NCT01587898|2827963|P4|Overall Study|Adverse Event|0
891560|NCT01587898|2827964|P3|Overall Study|Adverse Event|0
891561|NCT01587898|2827965|P2|Overall Study|Adverse Event|1
891562|NCT01587898|2827966|P1|Overall Study|Adverse Event|1
891563|NCT01519960|2828145|P3|Overall Study|Lost to Follow-up|0
891564|NCT01519960|2828146|P2|Overall Study|Lost to Follow-up|1
891565|NCT01519960|2828147|P1|Overall Study|Lost to Follow-up|0
891566|NCT01519960|2828145|P3|Overall Study|Withdrawal by Subject|0
891567|NCT01519960|2828146|P2|Overall Study|Withdrawal by Subject|4
891568|NCT01519960|2828147|P1|Overall Study|Withdrawal by Subject|0
891569|NCT01519960|2828145|P3|Overall Study|Adverse Event|0
891570|NCT01519960|2828146|P2|Overall Study|Adverse Event|1
891571|NCT01519960|2828147|P1|Overall Study|Adverse Event|0
891572|NCT01519960|2828145|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
891573|NCT01519960|2828146|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
891574|NCT01519960|2828147|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
891575|NCT01519960|2828145|P3|Overall Study|Ongoing in Follow-Up|10
891576|NCT01519960|2828146|P2|Overall Study|Ongoing in Follow-Up|11
891577|NCT01519960|2828147|P1|Overall Study|Ongoing in Follow-Up|101
891578|NCT01484496|2828255|P4|Period 2|Other|6
891579|NCT01484496|2828256|P3|Period 2|Other|9
891580|NCT01484496|2828257|P2|Period 2|Other|0
891581|NCT01484496|2828258|P1|Period 2|Other|0
891582|NCT01484496|2828255|P4|Period 2|Adverse Event|13
891583|NCT01484496|2828256|P3|Period 2|Adverse Event|5
891584|NCT01484496|2828257|P2|Period 2|Adverse Event|0
891585|NCT01484496|2828258|P1|Period 2|Adverse Event|0
891586|NCT01484496|2828255|P4|Period 2|Lack of Efficacy|3
891587|NCT01484496|2828256|P3|Period 2|Lack of Efficacy|1
891588|NCT01484496|2828257|P2|Period 2|Lack of Efficacy|0
891589|NCT01484496|2828258|P1|Period 2|Lack of Efficacy|0
891590|NCT01484496|2828255|P4|Period 1|Unable to Visit Site|0
891591|NCT01484496|2828256|P3|Period 1|Unable to Visit Site|0
891592|NCT01484496|2828257|P2|Period 1|Unable to Visit Site|2
891593|NCT01484496|2828258|P1|Period 1|Unable to Visit Site|0
891594|NCT01484496|2828255|P4|Period 1|Lack of Compliance|0
891595|NCT01484496|2828256|P3|Period 1|Lack of Compliance|0
891596|NCT01484496|2828257|P2|Period 1|Lack of Compliance|1
891597|NCT01484496|2828258|P1|Period 1|Lack of Compliance|2
891598|NCT01484496|2828255|P4|Period 1|Treatment Failure|0
891599|NCT01484496|2828256|P3|Period 1|Treatment Failure|0
891600|NCT01484496|2828257|P2|Period 1|Treatment Failure|6
891601|NCT01484496|2828258|P1|Period 1|Treatment Failure|3
891602|NCT01484496|2828255|P4|Period 1|Positive Pregnancy|0
891603|NCT01484496|2828256|P3|Period 1|Positive Pregnancy|0
891604|NCT01484496|2828257|P2|Period 1|Positive Pregnancy|6
891605|NCT01484496|2828258|P1|Period 1|Positive Pregnancy|1
891606|NCT01484496|2828255|P4|Period 1|Lost to Follow-up|0
891607|NCT01484496|2828256|P3|Period 1|Lost to Follow-up|0
891608|NCT01484496|2828257|P2|Period 1|Lost to Follow-up|6
891609|NCT01484496|2828258|P1|Period 1|Lost to Follow-up|2
891610|NCT01484496|2828255|P4|Period 1|Withdrawal by Subject|0
891611|NCT01484496|2828256|P3|Period 1|Withdrawal by Subject|0
891612|NCT01484496|2828257|P2|Period 1|Withdrawal by Subject|12
891613|NCT01484496|2828258|P1|Period 1|Withdrawal by Subject|15
891614|NCT01484496|2828255|P4|Period 1|Adverse Event|0
891615|NCT01484496|2828256|P3|Period 1|Adverse Event|0
891616|NCT01484496|2828257|P2|Period 1|Adverse Event|40
891617|NCT01484496|2828258|P1|Period 1|Adverse Event|25
891618|NCT01484496|2828255|P4|Period 1|Lack of Efficacy|0
769582|NCT00555425|2448871|P2|Overall Study|Became pregnant and transferred care|1
769583|NCT00555425|2448872|P1|Overall Study|Became pregnant and transferred care|0
769584|NCT00555425|2448871|P2|Overall Study|Met criteria for protective transfer|3
769585|NCT00555425|2448872|P1|Overall Study|Met criteria for protective transfer|16
769586|NCT00555425|2448871|P2|Overall Study|Missed 3 physician management visits|0
769587|NCT00555425|2448872|P1|Overall Study|Missed 3 physician management visits|1
769588|NCT00555425|2448871|P2|Overall Study|Missed Medication > 1 wk|15
769589|NCT00555425|2448872|P1|Overall Study|Missed Medication > 1 wk|34
769590|NCT00555438|2448890|P1|Between 10 Days and 30 Days Postoperativ|Death|5
769591|NCT00555438|2448890|P1|10 Days Post-operative|Death|4
769592|NCT00555477|2448911|P2|Overall Study|Physician Decision|2
769593|NCT00555477|2448912|P1|Overall Study|Physician Decision|1
769594|NCT00555477|2448911|P2|Overall Study|Withdrawal by Subject|2
769595|NCT00555477|2448912|P1|Overall Study|Withdrawal by Subject|1
769596|NCT00555477|2448911|P2|Overall Study|Adverse Event|9
769597|NCT00555477|2448912|P1|Overall Study|Adverse Event|0
769598|NCT00555568|2448920|P3|Overall Study|Lost to Follow-up|16
769599|NCT00555568|2448921|P2|Overall Study|Lost to Follow-up|16
769600|NCT00555568|2448922|P1|Overall Study|Lost to Follow-up|26
769601|NCT00555620|2448948|P6|Overall Study|Not specified|3
769602|NCT00555620|2448949|P5|Overall Study|Not specified|0
769603|NCT00555620|2448950|P4|Overall Study|Not specified|1
769604|NCT00555620|2448951|P3|Overall Study|Not specified|0
769605|NCT00555620|2448952|P2|Overall Study|Not specified|0
769606|NCT00555620|2448953|P1|Overall Study|Not specified|0
769607|NCT00555620|2448948|P6|Overall Study|Participant refused treatment|1
769608|NCT00555620|2448949|P5|Overall Study|Participant refused treatment|0
769609|NCT00555620|2448950|P4|Overall Study|Participant refused treatment|0
769610|NCT00555620|2448951|P3|Overall Study|Participant refused treatment|1
769611|NCT00555620|2448952|P2|Overall Study|Participant refused treatment|1
769612|NCT00555620|2448953|P1|Overall Study|Participant refused treatment|0
769613|NCT00555620|2448948|P6|Overall Study|Objective progression or relapse|16
769614|NCT00555620|2448949|P5|Overall Study|Objective progression or relapse|3
769615|NCT00555620|2448950|P4|Overall Study|Objective progression or relapse|17
769616|NCT00555620|2448951|P3|Overall Study|Objective progression or relapse|12
769617|NCT00555620|2448952|P2|Overall Study|Objective progression or relapse|5
769618|NCT00555620|2448953|P1|Overall Study|Objective progression or relapse|6
769619|NCT00555620|2448948|P6|Overall Study|Adverse Event|1
769620|NCT00555620|2448949|P5|Overall Study|Adverse Event|0
769621|NCT00555620|2448950|P4|Overall Study|Adverse Event|5
769622|NCT00555620|2448951|P3|Overall Study|Adverse Event|1
769623|NCT00555620|2448952|P2|Overall Study|Adverse Event|0
769624|NCT00555620|2448953|P1|Overall Study|Adverse Event|0
769625|NCT00555620|2448948|P6|Overall Study|Study terminated by sponsor|0
769626|NCT00555620|2448949|P5|Overall Study|Study terminated by sponsor|0
769627|NCT00555620|2448950|P4|Overall Study|Study terminated by sponsor|0
769628|NCT00555620|2448951|P3|Overall Study|Study terminated by sponsor|1
769629|NCT00555620|2448952|P2|Overall Study|Study terminated by sponsor|0
769630|NCT00555620|2448953|P1|Overall Study|Study terminated by sponsor|0
769631|NCT00555620|2448948|P6|Overall Study|Death|1
769632|NCT00555620|2448949|P5|Overall Study|Death|0
769633|NCT00555620|2448950|P4|Overall Study|Death|0
769634|NCT00555620|2448951|P3|Overall Study|Death|0
769635|NCT00555620|2448952|P2|Overall Study|Death|1
769636|NCT00555620|2448953|P1|Overall Study|Death|0
769637|NCT00555672|2449067|P2|Overall Study|Participant refused|0
769638|NCT00555672|2449068|P1|Overall Study|Participant refused|2
769639|NCT00555672|2449067|P2|Overall Study|Unspecified|1
769640|NCT00555672|2449068|P1|Overall Study|Unspecified|3
769641|NCT00555672|2449067|P2|Overall Study|Objective progression or relapse|5
769642|NCT00555672|2449068|P1|Overall Study|Objective progression or relapse|11
769643|NCT00555672|2449067|P2|Overall Study|Adverse Event|2
769644|NCT00555672|2449068|P1|Overall Study|Adverse Event|8
769645|NCT00555672|2449067|P2|Overall Study|Death|2
769646|NCT00555672|2449068|P1|Overall Study|Death|0
769647|NCT00555906|2449174|P5|Phase 2|Randomized but not Treated|2
769648|NCT00555906|2449175|P4|Phase 2|Randomized but not Treated|0
769649|NCT00555906|2449176|P3|Phase 2|Randomized but not Treated|0
769650|NCT00555906|2449177|P2|Phase 2|Randomized but not Treated|0
891619|NCT01484496|2828256|P3|Period 1|Lack of Efficacy|0
891620|NCT01484496|2828257|P2|Period 1|Lack of Efficacy|15
891621|NCT01484496|2828258|P1|Period 1|Lack of Efficacy|10
891622|NCT01484496|2828255|P4|Period 1|Physician Decision|0
769651|NCT00555906|2449178|P1|Phase 2|Randomized but not Treated|0
769652|NCT00555906|2449174|P5|Phase 2|Unspecified|6
769653|NCT00555906|2449175|P4|Phase 2|Unspecified|0
769654|NCT00555906|2449176|P3|Phase 2|Unspecified|0
769655|NCT00555906|2449177|P2|Phase 2|Unspecified|0
769656|NCT00555906|2449178|P1|Phase 2|Unspecified|0
769657|NCT00555906|2449174|P5|Phase 2|Withdrawal by Subject|2
769658|NCT00555906|2449175|P4|Phase 2|Withdrawal by Subject|0
769659|NCT00555906|2449176|P3|Phase 2|Withdrawal by Subject|0
769660|NCT00555906|2449177|P2|Phase 2|Withdrawal by Subject|0
769661|NCT00555906|2449178|P1|Phase 2|Withdrawal by Subject|0
769662|NCT00555906|2449174|P5|Phase 2|Objective Progression or Relapse|16
769663|NCT00555906|2449175|P4|Phase 2|Objective Progression or Relapse|0
769664|NCT00555906|2449176|P3|Phase 2|Objective Progression or Relapse|0
769665|NCT00555906|2449177|P2|Phase 2|Objective Progression or Relapse|0
769666|NCT00555906|2449178|P1|Phase 2|Objective Progression or Relapse|0
769667|NCT00555906|2449174|P5|Phase 2|Global Deterioration of Health Status|2
769668|NCT00555906|2449175|P4|Phase 2|Global Deterioration of Health Status|0
769669|NCT00555906|2449176|P3|Phase 2|Global Deterioration of Health Status|0
769670|NCT00555906|2449177|P2|Phase 2|Global Deterioration of Health Status|0
769671|NCT00555906|2449178|P1|Phase 2|Global Deterioration of Health Status|0
769672|NCT00555906|2449174|P5|Phase 2|Adverse Event|4
769673|NCT00555906|2449175|P4|Phase 2|Adverse Event|0
769674|NCT00555906|2449176|P3|Phase 2|Adverse Event|0
769675|NCT00555906|2449177|P2|Phase 2|Adverse Event|0
769676|NCT00555906|2449178|P1|Phase 2|Adverse Event|0
769677|NCT00555906|2449174|P5|Phase 1|Withdrawal by Subject|0
769678|NCT00555906|2449175|P4|Phase 1|Withdrawal by Subject|1
769679|NCT00555906|2449176|P3|Phase 1|Withdrawal by Subject|0
769680|NCT00555906|2449177|P2|Phase 1|Withdrawal by Subject|0
769681|NCT00555906|2449178|P1|Phase 1|Withdrawal by Subject|0
769682|NCT00555906|2449174|P5|Phase 1|Adverse Event|0
769683|NCT00555906|2449175|P4|Phase 1|Adverse Event|2
769684|NCT00555906|2449176|P3|Phase 1|Adverse Event|3
769685|NCT00555906|2449177|P2|Phase 1|Adverse Event|0
769686|NCT00555906|2449178|P1|Phase 1|Adverse Event|0
769687|NCT00555906|2449174|P5|Phase 1|Global Deterioration of Health Status|0
769688|NCT00555906|2449175|P4|Phase 1|Global Deterioration of Health Status|1
769689|NCT00555906|2449176|P3|Phase 1|Global Deterioration of Health Status|1
769690|NCT00555906|2449177|P2|Phase 1|Global Deterioration of Health Status|1
769691|NCT00555906|2449178|P1|Phase 1|Global Deterioration of Health Status|0
769692|NCT00555906|2449174|P5|Phase 1|Objective Progression or Relapse|0
769693|NCT00555906|2449175|P4|Phase 1|Objective Progression or Relapse|1
769694|NCT00555906|2449176|P3|Phase 1|Objective Progression or Relapse|3
769695|NCT00555906|2449177|P2|Phase 1|Objective Progression or Relapse|5
769696|NCT00555906|2449178|P1|Phase 1|Objective Progression or Relapse|3
769697|NCT00556075|2449237|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
769698|NCT00556075|2449238|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
769699|NCT00556075|2449239|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
769700|NCT00556075|2449237|P3|Overall Study|Personal issues|0
769701|NCT00556075|2449238|P2|Overall Study|Personal issues|1
769702|NCT00556075|2449239|P1|Overall Study|Personal issues|4
769703|NCT00556075|2449237|P3|Overall Study|Adverse Event|0
769704|NCT00556075|2449238|P2|Overall Study|Adverse Event|2
769705|NCT00556075|2449239|P1|Overall Study|Adverse Event|1
769706|NCT00556075|2449237|P3|Overall Study|Not eligible|2
769707|NCT00556075|2449238|P2|Overall Study|Not eligible|1
769708|NCT00556075|2449239|P1|Overall Study|Not eligible|1
769709|NCT00556075|2449237|P3|Overall Study|Protocol Violation|3
769710|NCT00556075|2449238|P2|Overall Study|Protocol Violation|1
769711|NCT00556075|2449239|P1|Overall Study|Protocol Violation|1
769712|NCT00556075|2449237|P3|Overall Study|Withdrawal by Subject|0
769713|NCT00556075|2449238|P2|Overall Study|Withdrawal by Subject|3
769714|NCT00556075|2449239|P1|Overall Study|Withdrawal by Subject|3
769715|NCT00556075|2449237|P3|Overall Study|Lost to Follow-up|3
769716|NCT00556075|2449238|P2|Overall Study|Lost to Follow-up|0
769717|NCT00556075|2449239|P1|Overall Study|Lost to Follow-up|3
769718|NCT00556166|2449267|P1|Overall Study|Withdrawal by Subject|1
769719|NCT00556322|2449274|P2|Overall Study|Death|14
769720|NCT00556322|2449275|P1|Overall Study|Death|20
769721|NCT00556322|2449274|P2|Overall Study|Ongoing at data cutoff|5
769722|NCT00556322|2449275|P1|Overall Study|Ongoing at data cutoff|3
769723|NCT00556322|2449274|P2|Overall Study|Protocol Violation|1
769724|NCT00556322|2449275|P1|Overall Study|Protocol Violation|5
769725|NCT00556322|2449274|P2|Overall Study|Withdrawal by Subject|7
769726|NCT00556322|2449275|P1|Overall Study|Withdrawal by Subject|19
769727|NCT00556322|2449274|P2|Overall Study|Lost to Follow-up|3
769728|NCT00556322|2449275|P1|Overall Study|Lost to Follow-up|5
769729|NCT00556322|2449274|P2|Overall Study|Unspecified|1
769730|NCT00556322|2449275|P1|Overall Study|Unspecified|4
769731|NCT00556322|2449274|P2|Overall Study|Adverse Event|4
769732|NCT00556322|2449275|P1|Overall Study|Adverse Event|7
769733|NCT00556322|2449274|P2|Overall Study|Insufficient therapeutic response|168
769734|NCT00556322|2449275|P1|Overall Study|Insufficient therapeutic response|158
891623|NCT01484496|2828256|P3|Period 1|Physician Decision|0
891624|NCT01484496|2828257|P2|Period 1|Physician Decision|1
891625|NCT01484496|2828258|P1|Period 1|Physician Decision|5
891626|NCT01484496|2828255|P4|Period 1|Protocol Violation|0
891627|NCT01484496|2828256|P3|Period 1|Protocol Violation|0
891628|NCT01484496|2828257|P2|Period 1|Protocol Violation|4
769741|NCT00556426|2449354|P1|Overall Study|Death|6
769742|NCT00556426|2449354|P1|Overall Study|Withdrawal by Subject|3
769743|NCT00549601|2449365|P3|Received Study Drug|Withdrawal by Subject|1
769744|NCT00549601|2449366|P2|Received Study Drug|Withdrawal by Subject|0
769745|NCT00549601|2449367|P1|Received Study Drug|Withdrawal by Subject|2
769746|NCT00549601|2449365|P3|Received Study Drug|Protocol Violation|1
769747|NCT00549601|2449366|P2|Received Study Drug|Protocol Violation|4
769748|NCT00549601|2449367|P1|Received Study Drug|Protocol Violation|3
769749|NCT00549601|2449365|P3|Received Study Drug|Lost to Follow-up|1
769750|NCT00549601|2449366|P2|Received Study Drug|Lost to Follow-up|1
769751|NCT00549601|2449367|P1|Received Study Drug|Lost to Follow-up|0
769752|NCT00549601|2449365|P3|Received Study Drug|Death|0
769753|NCT00549601|2449366|P2|Received Study Drug|Death|1
769754|NCT00549601|2449367|P1|Received Study Drug|Death|0
769755|NCT00549601|2449365|P3|Received Study Drug|Adverse Event|1
769756|NCT00549601|2449366|P2|Received Study Drug|Adverse Event|5
769757|NCT00549601|2449367|P1|Received Study Drug|Adverse Event|2
769758|NCT00549601|2449365|P3|Randomized|Withdrawal by Subject|1
769759|NCT00549601|2449366|P2|Randomized|Withdrawal by Subject|1
769760|NCT00549601|2449367|P1|Randomized|Withdrawal by Subject|0
769761|NCT00549601|2449365|P3|Randomized|Protocol Violation|1
769762|NCT00549601|2449366|P2|Randomized|Protocol Violation|0
769763|NCT00549601|2449367|P1|Randomized|Protocol Violation|0
769764|NCT00549640|2449391|P2|Overall Study|Lost to Follow-up|4
769765|NCT00549640|2449392|P1|Overall Study|Lost to Follow-up|7
769766|NCT00549640|2449391|P2|Overall Study|Adverse Event|0
769767|NCT00549640|2449392|P1|Overall Study|Adverse Event|5
769768|NCT00549640|2449391|P2|Overall Study|Withdrawal by Subject|12
769769|NCT00549640|2449392|P1|Overall Study|Withdrawal by Subject|6
769770|NCT00549718|2449406|P4|Overall Study|Administrative|1
769771|NCT00549718|2449407|P3|Overall Study|Administrative|2
769772|NCT00549718|2449408|P2|Overall Study|Administrative|2
769773|NCT00549718|2449409|P1|Overall Study|Administrative|2
769774|NCT00549718|2449406|P4|Overall Study|Withdrawal by Subject|13
769775|NCT00549718|2449407|P3|Overall Study|Withdrawal by Subject|12
769776|NCT00549718|2449408|P2|Overall Study|Withdrawal by Subject|18
769777|NCT00549718|2449409|P1|Overall Study|Withdrawal by Subject|9
769778|NCT00549718|2449406|P4|Overall Study|Lost to Follow-up|6
769779|NCT00549718|2449407|P3|Overall Study|Lost to Follow-up|0
769780|NCT00549718|2449408|P2|Overall Study|Lost to Follow-up|2
769781|NCT00549718|2449409|P1|Overall Study|Lost to Follow-up|4
769782|NCT00549718|2449406|P4|Overall Study|Adverse Event|3
769783|NCT00549718|2449407|P3|Overall Study|Adverse Event|7
769784|NCT00549718|2449408|P2|Overall Study|Adverse Event|8
769785|NCT00549718|2449409|P1|Overall Study|Adverse Event|6
769786|NCT00549718|2449406|P4|Overall Study|Insufficient clinical response|32
769787|NCT00549718|2449407|P3|Overall Study|Insufficient clinical response|18
769788|NCT00549718|2449408|P2|Overall Study|Insufficient clinical response|7
769789|NCT00549718|2449409|P1|Overall Study|Insufficient clinical response|20
769790|NCT00549757|2449425|P2|Extension Period (in Average 9 Months)|Patient's request|436
769791|NCT00549757|2449426|P1|Extension Period (in Average 9 Months)|Patient's request|421
769792|NCT00549757|2449425|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
769793|NCT00549757|2449426|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
769794|NCT00549757|2449425|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
769795|NCT00549757|2449426|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
769796|NCT00549757|2449425|P2|Extension Period (in Average 9 Months)|Death|136
769797|NCT00549757|2449426|P1|Extension Period (in Average 9 Months)|Death|143
769798|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
769799|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
769800|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
769801|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
769802|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
769803|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
769804|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Death|200
769805|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Death|188
769806|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
769807|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
769808|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
769809|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
769810|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
769811|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
769812|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
769813|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
769814|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
769815|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
769816|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
769817|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
769818|NCT00549757|2449425|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
769980|NCT00550446|2449854|P5|Post Week 12|Unspecified|0
769819|NCT00549757|2449426|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
769820|NCT00549770|2449492|P8|Overall Study|Adverse Event|4
769821|NCT00549770|2449493|P7|Overall Study|Adverse Event|5
769822|NCT00549770|2449494|P6|Overall Study|Adverse Event|0
769823|NCT00549770|2449495|P5|Overall Study|Adverse Event|1
769824|NCT00549770|2449496|P4|Overall Study|Adverse Event|2
769825|NCT00549770|2449497|P3|Overall Study|Adverse Event|1
769826|NCT00549770|2449498|P2|Overall Study|Adverse Event|3
769827|NCT00549770|2449499|P1|Overall Study|Adverse Event|1
769828|NCT00549770|2449492|P8|Overall Study|Abnormal laboratory values|0
769829|NCT00549770|2449493|P7|Overall Study|Abnormal laboratory values|0
769830|NCT00549770|2449494|P6|Overall Study|Abnormal laboratory values|1
769831|NCT00549770|2449495|P5|Overall Study|Abnormal laboratory values|0
769832|NCT00549770|2449496|P4|Overall Study|Abnormal laboratory values|0
769833|NCT00549770|2449497|P3|Overall Study|Abnormal laboratory values|0
769834|NCT00549770|2449498|P2|Overall Study|Abnormal laboratory values|0
769835|NCT00549770|2449499|P1|Overall Study|Abnormal laboratory values|0
769836|NCT00549770|2449492|P8|Overall Study|Abnormal test procedure results|1
769837|NCT00549770|2449493|P7|Overall Study|Abnormal test procedure results|1
769838|NCT00549770|2449494|P6|Overall Study|Abnormal test procedure results|1
769839|NCT00549770|2449495|P5|Overall Study|Abnormal test procedure results|0
769840|NCT00549770|2449496|P4|Overall Study|Abnormal test procedure results|2
769841|NCT00549770|2449497|P3|Overall Study|Abnormal test procedure results|0
769842|NCT00549770|2449498|P2|Overall Study|Abnormal test procedure results|0
769843|NCT00549770|2449499|P1|Overall Study|Abnormal test procedure results|0
769844|NCT00549770|2449492|P8|Overall Study|Lack of Efficacy|8
769845|NCT00549770|2449493|P7|Overall Study|Lack of Efficacy|3
769846|NCT00549770|2449494|P6|Overall Study|Lack of Efficacy|1
769847|NCT00549770|2449495|P5|Overall Study|Lack of Efficacy|5
769848|NCT00549770|2449496|P4|Overall Study|Lack of Efficacy|3
769849|NCT00549770|2449497|P3|Overall Study|Lack of Efficacy|2
769850|NCT00549770|2449498|P2|Overall Study|Lack of Efficacy|0
769851|NCT00549770|2449499|P1|Overall Study|Lack of Efficacy|1
769852|NCT00549770|2449492|P8|Overall Study|Withdrawal by Subject|9
769853|NCT00549770|2449493|P7|Overall Study|Withdrawal by Subject|4
769854|NCT00549770|2449494|P6|Overall Study|Withdrawal by Subject|6
769855|NCT00549770|2449495|P5|Overall Study|Withdrawal by Subject|6
769856|NCT00549770|2449496|P4|Overall Study|Withdrawal by Subject|5
769857|NCT00549770|2449497|P3|Overall Study|Withdrawal by Subject|4
769858|NCT00549770|2449498|P2|Overall Study|Withdrawal by Subject|6
769859|NCT00549770|2449499|P1|Overall Study|Withdrawal by Subject|4
769860|NCT00549770|2449492|P8|Overall Study|Lost to Follow-up|0
769861|NCT00549770|2449493|P7|Overall Study|Lost to Follow-up|0
769862|NCT00549770|2449494|P6|Overall Study|Lost to Follow-up|2
769863|NCT00549770|2449495|P5|Overall Study|Lost to Follow-up|3
769864|NCT00549770|2449496|P4|Overall Study|Lost to Follow-up|2
769865|NCT00549770|2449497|P3|Overall Study|Lost to Follow-up|2
769866|NCT00549770|2449498|P2|Overall Study|Lost to Follow-up|0
769867|NCT00549770|2449499|P1|Overall Study|Lost to Follow-up|0
769868|NCT00549770|2449492|P8|Overall Study|Administrative problems|1
769869|NCT00549770|2449493|P7|Overall Study|Administrative problems|0
769870|NCT00549770|2449494|P6|Overall Study|Administrative problems|0
769871|NCT00549770|2449495|P5|Overall Study|Administrative problems|0
769872|NCT00549770|2449496|P4|Overall Study|Administrative problems|0
769873|NCT00549770|2449497|P3|Overall Study|Administrative problems|0
769874|NCT00549770|2449498|P2|Overall Study|Administrative problems|1
769875|NCT00549770|2449499|P1|Overall Study|Administrative problems|0
769876|NCT00549770|2449492|P8|Overall Study|Protocol deviation|2
769877|NCT00549770|2449493|P7|Overall Study|Protocol deviation|1
769878|NCT00549770|2449494|P6|Overall Study|Protocol deviation|2
769879|NCT00549770|2449495|P5|Overall Study|Protocol deviation|2
769880|NCT00549770|2449496|P4|Overall Study|Protocol deviation|2
769881|NCT00549770|2449497|P3|Overall Study|Protocol deviation|1
769882|NCT00549770|2449498|P2|Overall Study|Protocol deviation|1
769883|NCT00549770|2449499|P1|Overall Study|Protocol deviation|1
769884|NCT00549900|2449620|P1|Overall Study|Adverse Event|1
769885|NCT00549939|2449632|P3|40-week Open Label Treatment Period|Other|4
769886|NCT00549939|2449633|P2|40-week Open Label Treatment Period|Other|1
769887|NCT00549939|2449634|P1|40-week Open Label Treatment Period|Other|0
769888|NCT00549939|2449632|P3|40-week Open Label Treatment Period|Protocol Violation|0
769889|NCT00549939|2449633|P2|40-week Open Label Treatment Period|Protocol Violation|1
769890|NCT00549939|2449634|P1|40-week Open Label Treatment Period|Protocol Violation|0
769891|NCT00549939|2449632|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
769892|NCT00549939|2449633|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
769893|NCT00549939|2449634|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
769894|NCT00549939|2449632|P3|40-week Open Label Treatment Period|Adverse Event|1
769895|NCT00549939|2449633|P2|40-week Open Label Treatment Period|Adverse Event|2
769896|NCT00549939|2449634|P1|40-week Open Label Treatment Period|Adverse Event|0
769897|NCT00549939|2449632|P3|12-week Double Blind Treatment Period|Too many blood draws|0
769898|NCT00549939|2449633|P2|12-week Double Blind Treatment Period|Too many blood draws|1
769899|NCT00549939|2449634|P1|12-week Double Blind Treatment Period|Too many blood draws|0
769900|NCT00549939|2449632|P3|12-week Double Blind Treatment Period|Adverse Event|2
769901|NCT00549939|2449633|P2|12-week Double Blind Treatment Period|Adverse Event|1
769902|NCT00549939|2449634|P1|12-week Double Blind Treatment Period|Adverse Event|1
769903|NCT00550043|2449666|P5|Overall Study|Other Reasons- Unspecified|0
769904|NCT00550043|2449667|P4|Overall Study|Other Reasons- Unspecified|1
769905|NCT00550043|2449668|P3|Overall Study|Other Reasons- Unspecified|0
769906|NCT00550043|2449669|P2|Overall Study|Other Reasons- Unspecified|1
769907|NCT00550043|2449670|P1|Overall Study|Other Reasons- Unspecified|0
769908|NCT00550043|2449666|P5|Overall Study|Subject Withdrew Consent|0
769909|NCT00550043|2449667|P4|Overall Study|Subject Withdrew Consent|0
769910|NCT00550043|2449668|P3|Overall Study|Subject Withdrew Consent|1
769911|NCT00550043|2449669|P2|Overall Study|Subject Withdrew Consent|2
769912|NCT00550043|2449670|P1|Overall Study|Subject Withdrew Consent|0
769913|NCT00550043|2449666|P5|Overall Study|Adverse Event|1
769914|NCT00550043|2449667|P4|Overall Study|Adverse Event|1
769915|NCT00550043|2449668|P3|Overall Study|Adverse Event|0
769916|NCT00550043|2449669|P2|Overall Study|Adverse Event|0
769917|NCT00550043|2449670|P1|Overall Study|Adverse Event|0
769918|NCT00550147|2449722|P1|Quetiapine Addition Treatment Period|Moved out of state|1
769919|NCT00550147|2449722|P1|Quetiapine Addition Treatment Period|Noncompliance|2
769920|NCT00550147|2449722|P1|Quetiapine Addition Treatment Period|Adverse Event|3
769921|NCT00550147|2449722|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
769922|NCT00550147|2449722|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
769923|NCT00550173|2449743|P3|Overall Study|Lost to Follow-up|3
769924|NCT00550173|2449744|P2|Overall Study|Lost to Follow-up|4
769925|NCT00550173|2449745|P1|Overall Study|Lost to Follow-up|4
769926|NCT00550173|2449743|P3|Overall Study|Sponsor Decision|1
769927|NCT00550173|2449744|P2|Overall Study|Sponsor Decision|7
769928|NCT00550173|2449745|P1|Overall Study|Sponsor Decision|13
769929|NCT00550173|2449743|P3|Overall Study|Withdrawal by Subject|17
769930|NCT00550173|2449744|P2|Overall Study|Withdrawal by Subject|12
769931|NCT00550173|2449745|P1|Overall Study|Withdrawal by Subject|9
769932|NCT00550173|2449743|P3|Overall Study|Physician Decision|2
769933|NCT00550173|2449744|P2|Overall Study|Physician Decision|2
769934|NCT00550173|2449745|P1|Overall Study|Physician Decision|1
769935|NCT00550173|2449743|P3|Overall Study|Death|50
769936|NCT00550173|2449744|P2|Overall Study|Death|38
769937|NCT00550173|2449745|P1|Overall Study|Death|45
769938|NCT00550407|2449806|P3|26-Week Randomized Phase|Withdrawal by Subject|3
769939|NCT00550407|2449807|P2|26-Week Randomized Phase|Withdrawal by Subject|1
769940|NCT00550407|2449808|P1|26-Week Randomized Phase|Withdrawal by Subject|0
769941|NCT00550407|2449806|P3|26-Week Randomized Phase|Investigator Discretion|0
769942|NCT00550407|2449807|P2|26-Week Randomized Phase|Investigator Discretion|1
769943|NCT00550407|2449808|P1|26-Week Randomized Phase|Investigator Discretion|0
769944|NCT00550407|2449806|P3|26-Week Randomized Phase|Lack of Efficacy|19
769945|NCT00550407|2449807|P2|26-Week Randomized Phase|Lack of Efficacy|36
769946|NCT00550407|2449808|P1|26-Week Randomized Phase|Lack of Efficacy|0
769947|NCT00550407|2449806|P3|26-Week Randomized Phase|Adverse Event|2
769948|NCT00550407|2449807|P2|26-Week Randomized Phase|Adverse Event|5
769949|NCT00550407|2449808|P1|26-Week Randomized Phase|Adverse Event|0
769950|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
769951|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
769952|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
769953|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
769954|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
769955|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
769956|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
769957|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
769958|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
769959|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
769960|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
769961|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
769962|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
769963|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
769964|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
769965|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
769966|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
769967|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
769968|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
769969|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
769970|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
769971|NCT00550407|2449806|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
769972|NCT00550407|2449807|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
769973|NCT00550407|2449808|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
769974|NCT00550446|2449848|P11|Post Week 12|Unspecified|0
769975|NCT00550446|2449849|P10|Post Week 12|Unspecified|1
769976|NCT00550446|2449850|P9|Post Week 12|Unspecified|1
769977|NCT00550446|2449851|P8|Post Week 12|Unspecified|0
769978|NCT00550446|2449852|P7|Post Week 12|Unspecified|1
769979|NCT00550446|2449853|P6|Post Week 12|Unspecified|0
769981|NCT00550446|2449855|P4|Post Week 12|Unspecified|1
769982|NCT00550446|2449856|P3|Post Week 12|Unspecified|0
769983|NCT00550446|2449857|P2|Post Week 12|Unspecified|1
769984|NCT00550446|2449858|P1|Post Week 12|Unspecified|1
769985|NCT00550446|2449848|P11|Post Week 12|Withdrawal by Subject|0
769986|NCT00550446|2449849|P10|Post Week 12|Withdrawal by Subject|0
769987|NCT00550446|2449850|P9|Post Week 12|Withdrawal by Subject|0
769988|NCT00550446|2449851|P8|Post Week 12|Withdrawal by Subject|0
769989|NCT00550446|2449852|P7|Post Week 12|Withdrawal by Subject|0
769990|NCT00550446|2449853|P6|Post Week 12|Withdrawal by Subject|0
769991|NCT00550446|2449854|P5|Post Week 12|Withdrawal by Subject|1
769992|NCT00550446|2449855|P4|Post Week 12|Withdrawal by Subject|0
769993|NCT00550446|2449856|P3|Post Week 12|Withdrawal by Subject|0
769994|NCT00550446|2449857|P2|Post Week 12|Withdrawal by Subject|0
769995|NCT00550446|2449858|P1|Post Week 12|Withdrawal by Subject|0
769996|NCT00550446|2449848|P11|Post Week 12|Lost to Follow-up|0
769997|NCT00550446|2449849|P10|Post Week 12|Lost to Follow-up|0
769998|NCT00550446|2449850|P9|Post Week 12|Lost to Follow-up|0
769999|NCT00550446|2449851|P8|Post Week 12|Lost to Follow-up|0
770000|NCT00550446|2449852|P7|Post Week 12|Lost to Follow-up|1
770001|NCT00550446|2449853|P6|Post Week 12|Lost to Follow-up|0
770002|NCT00550446|2449854|P5|Post Week 12|Lost to Follow-up|0
770003|NCT00550446|2449855|P4|Post Week 12|Lost to Follow-up|1
770004|NCT00550446|2449856|P3|Post Week 12|Lost to Follow-up|1
770005|NCT00550446|2449857|P2|Post Week 12|Lost to Follow-up|0
770006|NCT00550446|2449858|P1|Post Week 12|Lost to Follow-up|0
770007|NCT00550446|2449848|P11|Post Week 12|Lack of Efficacy|1
770008|NCT00550446|2449849|P10|Post Week 12|Lack of Efficacy|2
770009|NCT00550446|2449850|P9|Post Week 12|Lack of Efficacy|1
770010|NCT00550446|2449851|P8|Post Week 12|Lack of Efficacy|1
770011|NCT00550446|2449852|P7|Post Week 12|Lack of Efficacy|0
770012|NCT00550446|2449853|P6|Post Week 12|Lack of Efficacy|0
770013|NCT00550446|2449854|P5|Post Week 12|Lack of Efficacy|0
770014|NCT00550446|2449855|P4|Post Week 12|Lack of Efficacy|0
770015|NCT00550446|2449856|P3|Post Week 12|Lack of Efficacy|1
770016|NCT00550446|2449857|P2|Post Week 12|Lack of Efficacy|0
770017|NCT00550446|2449858|P1|Post Week 12|Lack of Efficacy|0
770018|NCT00550446|2449848|P11|Post Week 12|Adverse Event|0
770019|NCT00550446|2449849|P10|Post Week 12|Adverse Event|4
770020|NCT00550446|2449850|P9|Post Week 12|Adverse Event|0
770021|NCT00550446|2449851|P8|Post Week 12|Adverse Event|0
770022|NCT00550446|2449852|P7|Post Week 12|Adverse Event|0
770023|NCT00550446|2449853|P6|Post Week 12|Adverse Event|1
770024|NCT00550446|2449854|P5|Post Week 12|Adverse Event|1
770025|NCT00550446|2449855|P4|Post Week 12|Adverse Event|1
770026|NCT00550446|2449856|P3|Post Week 12|Adverse Event|1
770027|NCT00550446|2449857|P2|Post Week 12|Adverse Event|1
770028|NCT00550446|2449858|P1|Post Week 12|Adverse Event|2
770029|NCT00550446|2449848|P11|Up To Week 12|Randomized not treated|0
770030|NCT00550446|2449849|P10|Up To Week 12|Randomized not treated|0
770031|NCT00550446|2449850|P9|Up To Week 12|Randomized not treated|0
770032|NCT00550446|2449851|P8|Up To Week 12|Randomized not treated|0
770033|NCT00550446|2449852|P7|Up To Week 12|Randomized not treated|0
770034|NCT00550446|2449853|P6|Up To Week 12|Randomized not treated|0
770035|NCT00550446|2449854|P5|Up To Week 12|Randomized not treated|0
770036|NCT00550446|2449855|P4|Up To Week 12|Randomized not treated|0
770037|NCT00550446|2449856|P3|Up To Week 12|Randomized not treated|1
770038|NCT00550446|2449857|P2|Up To Week 12|Randomized not treated|1
770039|NCT00550446|2449858|P1|Up To Week 12|Randomized not treated|0
770040|NCT00550446|2449848|P11|Up To Week 12|Unspecified|0
770041|NCT00550446|2449849|P10|Up To Week 12|Unspecified|0
770042|NCT00550446|2449850|P9|Up To Week 12|Unspecified|0
770043|NCT00550446|2449851|P8|Up To Week 12|Unspecified|0
770044|NCT00550446|2449852|P7|Up To Week 12|Unspecified|4
770045|NCT00550446|2449853|P6|Up To Week 12|Unspecified|1
770046|NCT00550446|2449854|P5|Up To Week 12|Unspecified|0
770047|NCT00550446|2449855|P4|Up To Week 12|Unspecified|0
770048|NCT00550446|2449856|P3|Up To Week 12|Unspecified|0
770049|NCT00550446|2449857|P2|Up To Week 12|Unspecified|0
770050|NCT00550446|2449858|P1|Up To Week 12|Unspecified|3
770051|NCT00550446|2449848|P11|Up To Week 12|Withdrawal by Subject|0
770052|NCT00550446|2449849|P10|Up To Week 12|Withdrawal by Subject|0
770053|NCT00550446|2449850|P9|Up To Week 12|Withdrawal by Subject|0
770054|NCT00550446|2449851|P8|Up To Week 12|Withdrawal by Subject|0
770055|NCT00550446|2449852|P7|Up To Week 12|Withdrawal by Subject|3
770056|NCT00550446|2449853|P6|Up To Week 12|Withdrawal by Subject|1
770057|NCT00550446|2449854|P5|Up To Week 12|Withdrawal by Subject|0
770058|NCT00550446|2449855|P4|Up To Week 12|Withdrawal by Subject|2
770059|NCT00550446|2449856|P3|Up To Week 12|Withdrawal by Subject|3
770060|NCT00550446|2449857|P2|Up To Week 12|Withdrawal by Subject|0
770061|NCT00550446|2449858|P1|Up To Week 12|Withdrawal by Subject|2
770062|NCT00550446|2449848|P11|Up To Week 12|Lost to Follow-up|0
770063|NCT00550446|2449849|P10|Up To Week 12|Lost to Follow-up|0
770064|NCT00550446|2449850|P9|Up To Week 12|Lost to Follow-up|0
770065|NCT00550446|2449851|P8|Up To Week 12|Lost to Follow-up|0
770066|NCT00550446|2449852|P7|Up To Week 12|Lost to Follow-up|2
770067|NCT00550446|2449853|P6|Up To Week 12|Lost to Follow-up|1
770068|NCT00550446|2449854|P5|Up To Week 12|Lost to Follow-up|1
770069|NCT00550446|2449855|P4|Up To Week 12|Lost to Follow-up|0
770070|NCT00550446|2449856|P3|Up To Week 12|Lost to Follow-up|0
770071|NCT00550446|2449857|P2|Up To Week 12|Lost to Follow-up|1
770072|NCT00550446|2449858|P1|Up To Week 12|Lost to Follow-up|0
770073|NCT00550446|2449848|P11|Up To Week 12|Lack of Efficacy|0
770074|NCT00550446|2449849|P10|Up To Week 12|Lack of Efficacy|0
770075|NCT00550446|2449850|P9|Up To Week 12|Lack of Efficacy|0
770076|NCT00550446|2449851|P8|Up To Week 12|Lack of Efficacy|0
770077|NCT00550446|2449852|P7|Up To Week 12|Lack of Efficacy|3
770078|NCT00550446|2449853|P6|Up To Week 12|Lack of Efficacy|3
770079|NCT00550446|2449854|P5|Up To Week 12|Lack of Efficacy|0
770080|NCT00550446|2449855|P4|Up To Week 12|Lack of Efficacy|1
770081|NCT00550446|2449856|P3|Up To Week 12|Lack of Efficacy|0
770082|NCT00550446|2449857|P2|Up To Week 12|Lack of Efficacy|1
770083|NCT00550446|2449858|P1|Up To Week 12|Lack of Efficacy|3
770084|NCT00550446|2449848|P11|Up To Week 12|Adverse Event|0
770085|NCT00550446|2449849|P10|Up To Week 12|Adverse Event|0
770086|NCT00550446|2449850|P9|Up To Week 12|Adverse Event|0
770087|NCT00550446|2449851|P8|Up To Week 12|Adverse Event|0
770088|NCT00550446|2449852|P7|Up To Week 12|Adverse Event|1
770089|NCT00550446|2449853|P6|Up To Week 12|Adverse Event|2
770090|NCT00550446|2449854|P5|Up To Week 12|Adverse Event|2
770091|NCT00550446|2449855|P4|Up To Week 12|Adverse Event|0
770092|NCT00550446|2449856|P3|Up To Week 12|Adverse Event|0
770093|NCT00550446|2449857|P2|Up To Week 12|Adverse Event|2
770094|NCT00550446|2449858|P1|Up To Week 12|Adverse Event|2
891629|NCT01484496|2828258|P1|Period 1|Protocol Violation|3
891630|NCT01387230|2828273|P3|Overall Study|Withdrawal by Subject|0
891631|NCT01387230|2828274|P2|Overall Study|Withdrawal by Subject|1
891632|NCT01387230|2828275|P1|Overall Study|Withdrawal by Subject|4
770099|NCT00550537|2450355|P1|Overall Study|Treated closer to home|4
770100|NCT00550537|2450355|P1|Overall Study|Declining performance status|2
770101|NCT00550537|2450355|P1|Overall Study|Other complicating ilness|3
770102|NCT00550537|2450355|P1|Overall Study|Change in treatment plan|4
770103|NCT00550537|2450355|P1|Overall Study|Withdrawal by Subject|7
770104|NCT00550537|2450355|P1|Overall Study|Disease progression before|46
770105|NCT00550537|2450355|P1|Overall Study|Adverse Event|20
770106|NCT00550537|2450355|P1|Overall Study|Death|18
770107|NCT00550550|2450372|P2|Overall Study|Randomized But Not Treated|0
770108|NCT00550550|2450373|P1|Overall Study|Randomized But Not Treated|1
770109|NCT00550550|2450372|P2|Overall Study|Did Not Meet Protocol Eligibility|1
770110|NCT00550550|2450373|P1|Overall Study|Did Not Meet Protocol Eligibility|1
770111|NCT00550550|2450372|P2|Overall Study|Protocol Violation|14
770112|NCT00550550|2450373|P1|Overall Study|Protocol Violation|5
770113|NCT00550550|2450372|P2|Overall Study|Withdrawal by Subject|8
770114|NCT00550550|2450373|P1|Overall Study|Withdrawal by Subject|10
770115|NCT00550550|2450372|P2|Overall Study|Lost to Follow-up|0
770116|NCT00550550|2450373|P1|Overall Study|Lost to Follow-up|4
770117|NCT00550550|2450372|P2|Overall Study|Treatment Failure|1
770118|NCT00550550|2450373|P1|Overall Study|Treatment Failure|0
770119|NCT00550550|2450372|P2|Overall Study|Adverse Event|5
770120|NCT00550550|2450373|P1|Overall Study|Adverse Event|13
770121|NCT00550680|2450406|P1|Overall Study|Screen Failure|6
770122|NCT00550680|2450406|P1|Overall Study|Refused Treatment|19
770123|NCT00550680|2450406|P1|Overall Study|Protocol Violation|7
770124|NCT00550680|2450406|P1|Overall Study|Not Specified|10
770125|NCT00550680|2450406|P1|Overall Study|Lack of Efficacy|1
770126|NCT00550680|2450406|P1|Overall Study|Lost to Follow-up|3
770127|NCT00550680|2450406|P1|Overall Study|Early Improvement|1
770128|NCT00550680|2450406|P1|Overall Study|Death|3
770129|NCT00550680|2450406|P1|Overall Study|Adverse Event|5
770130|NCT00550680|2450406|P1|Overall Study|Administrative Reasons|1
770131|NCT00550732|2450415|P1|Overall Study|Adverse Event|1
770132|NCT00550732|2450415|P1|Overall Study|Palliative care|1
770133|NCT00550732|2450415|P1|Overall Study|Lost to Follow-up|1
770134|NCT00550732|2450415|P1|Overall Study|Physician Decision|2
770135|NCT00550732|2450415|P1|Overall Study|Withdrawal by Subject|2
770136|NCT00550732|2450415|P1|Overall Study|Death|4
770137|NCT00550745|2450428|P2|Overall Study|Screen failure|0
770138|NCT00550745|2450429|P1|Overall Study|Screen failure|1
770139|NCT00550745|2450428|P2|Overall Study|Withdrawal by Subject|10
770140|NCT00550745|2450429|P1|Overall Study|Withdrawal by Subject|17
770141|NCT00550745|2450428|P2|Overall Study|Protocol Violation|2
770142|NCT00550745|2450429|P1|Overall Study|Protocol Violation|4
770143|NCT00550745|2450428|P2|Overall Study|Physician Decision|2
770144|NCT00550745|2450429|P1|Overall Study|Physician Decision|0
770145|NCT00550745|2450428|P2|Overall Study|Lost to Follow-up|30
770146|NCT00550745|2450429|P1|Overall Study|Lost to Follow-up|45
770147|NCT00550745|2450428|P2|Overall Study|Death|16
770148|NCT00550745|2450429|P1|Overall Study|Death|20
770149|NCT00550771|2450439|P2|Overall Study|Protocol Violation|5
770150|NCT00550771|2450440|P1|Overall Study|Protocol Violation|4
770151|NCT00550771|2450439|P2|Overall Study|Withdrawal by Subject|1
770152|NCT00550771|2450440|P1|Overall Study|Withdrawal by Subject|0
770153|NCT00550771|2450439|P2|Overall Study|Physician Decision|0
770154|NCT00550771|2450440|P1|Overall Study|Physician Decision|2
770155|NCT00550771|2450439|P2|Overall Study|Discontinued for study-related reasons|1
770156|NCT00550771|2450440|P1|Overall Study|Discontinued for study-related reasons|0
770157|NCT00550771|2450439|P2|Overall Study|Adverse Event|3
770158|NCT00550771|2450440|P1|Overall Study|Adverse Event|11
770159|NCT00550836|2450454|P2|Overall Study|Withdrawal by Subject|9
770160|NCT00550836|2450455|P1|Overall Study|Withdrawal by Subject|3
770161|NCT00556673|2450581|P2|Overall Study|Protocol deviation|2
770162|NCT00556673|2450582|P1|Overall Study|Protocol deviation|3
770163|NCT00556712|2450620|P2|Overall Study|Ongoing at Data Cutoff|66
770164|NCT00556712|2450621|P1|Overall Study|Ongoing at Data Cutoff|32
770165|NCT00556712|2450620|P2|Overall Study|Not Specified|2
770166|NCT00556712|2450621|P1|Overall Study|Not Specified|2
770167|NCT00556712|2450620|P2|Overall Study|Failure to Return|3
770168|NCT00556712|2450621|P1|Overall Study|Failure to Return|2
770169|NCT00556712|2450620|P2|Overall Study|Refused Treatment|16
770170|NCT00556712|2450621|P1|Overall Study|Refused Treatment|17
770171|NCT00556712|2450620|P2|Overall Study|Protocol Violation|2
770172|NCT00556712|2450621|P1|Overall Study|Protocol Violation|3
770173|NCT00556712|2450620|P2|Overall Study|Progressive Disease|320
770174|NCT00556712|2450621|P1|Overall Study|Progressive Disease|383
770175|NCT00556712|2450620|P2|Overall Study|Death|10
770176|NCT00556712|2450621|P1|Overall Study|Death|5
770177|NCT00556712|2450620|P2|Overall Study|Adverse Event|19
770178|NCT00556712|2450621|P1|Overall Study|Adverse Event|7
770179|NCT00558285|2450702|P5|Overall Study|Protocol deviation|0
770180|NCT00558285|2450703|P4|Overall Study|Protocol deviation|1
770181|NCT00558285|2450704|P3|Overall Study|Protocol deviation|0
770182|NCT00558285|2450705|P2|Overall Study|Protocol deviation|1
770183|NCT00558285|2450706|P1|Overall Study|Protocol deviation|1
770184|NCT00558285|2450702|P5|Overall Study|Administrative problems|1
770185|NCT00558285|2450703|P4|Overall Study|Administrative problems|1
770186|NCT00558285|2450704|P3|Overall Study|Administrative problems|0
770187|NCT00558285|2450705|P2|Overall Study|Administrative problems|0
770188|NCT00558285|2450706|P1|Overall Study|Administrative problems|0
770189|NCT00558285|2450702|P5|Overall Study|Lost to Follow-up|0
770190|NCT00558285|2450703|P4|Overall Study|Lost to Follow-up|0
770191|NCT00558285|2450704|P3|Overall Study|Lost to Follow-up|0
770192|NCT00558285|2450705|P2|Overall Study|Lost to Follow-up|1
770193|NCT00558285|2450706|P1|Overall Study|Lost to Follow-up|1
770194|NCT00558285|2450702|P5|Overall Study|Subject withdrew consent|1
770195|NCT00558285|2450703|P4|Overall Study|Subject withdrew consent|1
770196|NCT00558285|2450704|P3|Overall Study|Subject withdrew consent|1
770197|NCT00558285|2450705|P2|Overall Study|Subject withdrew consent|0
770198|NCT00558285|2450706|P1|Overall Study|Subject withdrew consent|2
770199|NCT00558285|2450702|P5|Overall Study|Abnormal test procedure result(s)|0
770200|NCT00558285|2450703|P4|Overall Study|Abnormal test procedure result(s)|0
770201|NCT00558285|2450704|P3|Overall Study|Abnormal test procedure result(s)|0
770202|NCT00558285|2450705|P2|Overall Study|Abnormal test procedure result(s)|0
770203|NCT00558285|2450706|P1|Overall Study|Abnormal test procedure result(s)|1
770204|NCT00558285|2450702|P5|Overall Study|Adverse Event|2
770205|NCT00558285|2450703|P4|Overall Study|Adverse Event|1
770206|NCT00558285|2450704|P3|Overall Study|Adverse Event|4
770207|NCT00558285|2450705|P2|Overall Study|Adverse Event|1
770208|NCT00558285|2450706|P1|Overall Study|Adverse Event|1
770209|NCT00558363|2450750|P2|Overall Study|Hospitalized; Unable to Continue|1
770210|NCT00558363|2450751|P1|Overall Study|Hospitalized; Unable to Continue|0
770211|NCT00558363|2450750|P2|Overall Study|Randomized in Error|2
770212|NCT00558363|2450751|P1|Overall Study|Randomized in Error|1
770213|NCT00558363|2450750|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
770214|NCT00558363|2450751|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
770215|NCT00558363|2450750|P2|Overall Study|Lost to Follow-up|1
770216|NCT00558363|2450751|P1|Overall Study|Lost to Follow-up|0
770217|NCT00558363|2450750|P2|Overall Study|Protocol Violation|1
770218|NCT00558363|2450751|P1|Overall Study|Protocol Violation|2
770219|NCT00558363|2450750|P2|Overall Study|Lack of Efficacy|2
770220|NCT00558363|2450751|P1|Overall Study|Lack of Efficacy|2
770221|NCT00558363|2450750|P2|Overall Study|Adverse Event|5
770222|NCT00558363|2450751|P1|Overall Study|Adverse Event|5
770223|NCT00558363|2450750|P2|Overall Study|Withdrawal by Subject|4
770224|NCT00558363|2450751|P1|Overall Study|Withdrawal by Subject|11
770225|NCT00558363|2450750|P2|Overall Study|Physician Decision|4
770226|NCT00558363|2450751|P1|Overall Study|Physician Decision|18
770227|NCT00558428|2450805|P4|Overall Study|Other|1
770228|NCT00558428|2450806|P3|Overall Study|Other|0
770229|NCT00558428|2450807|P2|Overall Study|Other|0
770230|NCT00558428|2450808|P1|Overall Study|Other|3
770231|NCT00558428|2450805|P4|Overall Study|Consent withdrawn|1
770232|NCT00558428|2450806|P3|Overall Study|Consent withdrawn|0
770233|NCT00558428|2450807|P2|Overall Study|Consent withdrawn|1
770234|NCT00558428|2450808|P1|Overall Study|Consent withdrawn|2
770235|NCT00558428|2450805|P4|Overall Study|Non compliant with protocol|3
770236|NCT00558428|2450806|P3|Overall Study|Non compliant with protocol|0
770237|NCT00558428|2450807|P2|Overall Study|Non compliant with protocol|0
770238|NCT00558428|2450808|P1|Overall Study|Non compliant with protocol|1
770239|NCT00558428|2450805|P4|Overall Study|Lack of Efficacy|2
770240|NCT00558428|2450806|P3|Overall Study|Lack of Efficacy|1
770241|NCT00558428|2450807|P2|Overall Study|Lack of Efficacy|0
770242|NCT00558428|2450808|P1|Overall Study|Lack of Efficacy|0
770243|NCT00558428|2450805|P4|Overall Study|Lost to Follow-up|0
770244|NCT00558428|2450806|P3|Overall Study|Lost to Follow-up|0
770245|NCT00558428|2450807|P2|Overall Study|Lost to Follow-up|1
770246|NCT00558428|2450808|P1|Overall Study|Lost to Follow-up|0
770247|NCT00558428|2450805|P4|Overall Study|Adverse Event|4
770248|NCT00558428|2450806|P3|Overall Study|Adverse Event|3
770249|NCT00558428|2450807|P2|Overall Study|Adverse Event|22
770250|NCT00558428|2450808|P1|Overall Study|Adverse Event|6
770251|NCT00558467|2450848|P2|Overall Study|Patient moving out of state|1
770252|NCT00558467|2450849|P1|Overall Study|Patient moving out of state|0
770253|NCT00558467|2450848|P2|Overall Study|Lack of Efficacy|1
770254|NCT00558467|2450849|P1|Overall Study|Lack of Efficacy|0
770255|NCT00558467|2450848|P2|Overall Study|Adverse Event|2
770256|NCT00558467|2450849|P1|Overall Study|Adverse Event|1
770257|NCT00558558|2450905|P1|Overall Study|Lack of Efficacy|4
770258|NCT00558558|2450905|P1|Overall Study|Withdrawal by Subject|1
770259|NCT00558558|2450905|P1|Overall Study|Unable to swallow|1
770260|NCT00558636|2450993|P2|Follow-up|Premature termination of the study|7
770261|NCT00558636|2450994|P1|Follow-up|Premature termination of the study|12
770262|NCT00558636|2450993|P2|Treatment|Disease progression|5
770263|NCT00558636|2450994|P1|Treatment|Disease progression|1
770264|NCT00558636|2450993|P2|Treatment|Premature termination of the study|37
770265|NCT00558636|2450994|P1|Treatment|Premature termination of the study|35
770266|NCT00558636|2450993|P2|Treatment|Withdrawal by Subject|0
770267|NCT00558636|2450994|P1|Treatment|Withdrawal by Subject|2
770268|NCT00558636|2450993|P2|Treatment|Adverse Event|2
770269|NCT00558636|2450994|P1|Treatment|Adverse Event|9
770270|NCT00558701|2451014|P2|Overall Study|Protocol Deviations|4
770271|NCT00558701|2451015|P1|Overall Study|Protocol Deviations|1
770272|NCT00558753|2451023|P2|Overall Study|Lost to Follow-up|7
770273|NCT00558753|2451024|P1|Overall Study|Lost to Follow-up|5
770274|NCT00558831|2451083|P1|Overall Study|Lost to Follow-up|1
770275|NCT00558896|2451107|P7|Overall Study|Continues on treatment|6
770276|NCT00558896|2451108|P6|Overall Study|Continues on treatment|25
770277|NCT00558896|2451109|P5|Overall Study|Continues on treatment|9
770278|NCT00558896|2451110|P4|Overall Study|Continues on treatment|1
770279|NCT00558896|2451111|P3|Overall Study|Continues on treatment|0
770280|NCT00558896|2451112|P2|Overall Study|Continues on treatment|1
770281|NCT00558896|2451113|P1|Overall Study|Continues on treatment|10
770282|NCT00558896|2451107|P7|Overall Study|Physician discretion|3
770283|NCT00558896|2451108|P6|Overall Study|Physician discretion|3
770284|NCT00558896|2451109|P5|Overall Study|Physician discretion|1
770285|NCT00558896|2451110|P4|Overall Study|Physician discretion|2
770286|NCT00558896|2451111|P3|Overall Study|Physician discretion|1
770287|NCT00558896|2451112|P2|Overall Study|Physician discretion|2
770288|NCT00558896|2451113|P1|Overall Study|Physician discretion|3
770289|NCT00558896|2451107|P7|Overall Study|Alternative Treatment|1
770290|NCT00558896|2451108|P6|Overall Study|Alternative Treatment|7
770291|NCT00558896|2451109|P5|Overall Study|Alternative Treatment|6
770292|NCT00558896|2451110|P4|Overall Study|Alternative Treatment|2
770293|NCT00558896|2451111|P3|Overall Study|Alternative Treatment|0
770294|NCT00558896|2451112|P2|Overall Study|Alternative Treatment|2
770295|NCT00558896|2451113|P1|Overall Study|Alternative Treatment|2
770296|NCT00558896|2451107|P7|Overall Study|Withdrawal by Subject|5
770297|NCT00558896|2451108|P6|Overall Study|Withdrawal by Subject|5
770298|NCT00558896|2451109|P5|Overall Study|Withdrawal by Subject|1
770299|NCT00558896|2451110|P4|Overall Study|Withdrawal by Subject|1
770300|NCT00558896|2451111|P3|Overall Study|Withdrawal by Subject|1
770301|NCT00558896|2451112|P2|Overall Study|Withdrawal by Subject|1
770302|NCT00558896|2451113|P1|Overall Study|Withdrawal by Subject|2
770303|NCT00558896|2451107|P7|Overall Study|Death|6
770304|NCT00558896|2451108|P6|Overall Study|Death|2
770305|NCT00558896|2451109|P5|Overall Study|Death|2
770306|NCT00558896|2451110|P4|Overall Study|Death|3
770307|NCT00558896|2451111|P3|Overall Study|Death|2
770308|NCT00558896|2451112|P2|Overall Study|Death|0
770309|NCT00558896|2451113|P1|Overall Study|Death|3
770310|NCT00558896|2451107|P7|Overall Study|Adverse Event|3
770311|NCT00558896|2451108|P6|Overall Study|Adverse Event|10
770312|NCT00558896|2451109|P5|Overall Study|Adverse Event|4
770313|NCT00558896|2451110|P4|Overall Study|Adverse Event|3
770314|NCT00558896|2451111|P3|Overall Study|Adverse Event|1
770315|NCT00558896|2451112|P2|Overall Study|Adverse Event|1
770316|NCT00558896|2451113|P1|Overall Study|Adverse Event|1
770317|NCT00559104|2451149|P2|Overall Study|Lack of Efficacy|0
770318|NCT00559104|2451150|P1|Overall Study|Lack of Efficacy|9
770319|NCT00559273|2451162|P2|Evaluation Period (8 Weeks)|Physician Decision|1
770320|NCT00559273|2451163|P1|Evaluation Period (8 Weeks)|Physician Decision|0
770321|NCT00559273|2451162|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
770322|NCT00559273|2451163|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
770323|NCT00559273|2451162|P2|Evaluation Period (8 Weeks)|Adverse Event|1
770324|NCT00559273|2451163|P1|Evaluation Period (8 Weeks)|Adverse Event|0
770325|NCT00559273|2451162|P2|Evaluation Period (8 Weeks)|Death|3
770326|NCT00559273|2451163|P1|Evaluation Period (8 Weeks)|Death|1
770327|NCT00559273|2451162|P2|Correction Period (20 Weeks)|Did not received study treatment|0
770328|NCT00559273|2451163|P1|Correction Period (20 Weeks)|Did not received study treatment|2
770329|NCT00559273|2451162|P2|Correction Period (20 Weeks)|Participant treated by another center|1
770330|NCT00559273|2451163|P1|Correction Period (20 Weeks)|Participant treated by another center|0
770331|NCT00559273|2451162|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
770332|NCT00559273|2451163|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
770333|NCT00559273|2451162|P2|Correction Period (20 Weeks)|Adverse Event|1
770334|NCT00559273|2451163|P1|Correction Period (20 Weeks)|Adverse Event|2
770335|NCT00559273|2451162|P2|Correction Period (20 Weeks)|Death|4
770336|NCT00559273|2451163|P1|Correction Period (20 Weeks)|Death|3
770337|NCT00559364|2451185|P2|Overall Study|Inclusion/exclusion criteria failure|0
770338|NCT00559364|2451186|P1|Overall Study|Inclusion/exclusion criteria failure|1
770339|NCT00559377|2451196|P1|Overall Study|Withdrawal by Subject|9
770340|NCT00559507|2451204|P1|Overall Study|Not treated, patient ineligible|3
770341|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
770342|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
770343|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|non-specified|0
770344|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|non-specified|71
770345|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
770346|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
770347|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
770348|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
770349|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
770350|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
770351|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Death|0
770352|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Death|20
770353|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
770354|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
770355|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
770356|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
770357|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
770358|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
770359|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
770360|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
770361|NCT00559585|2451212|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
770362|NCT00559585|2451213|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
770363|NCT00559585|2451212|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
770364|NCT00559585|2451213|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
770365|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
770366|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
770367|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Investigator Decision|1
770368|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Investigator Decision|0
770369|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
770370|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
770371|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
770372|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
770373|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Early Discontinuation|1
770374|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Early Discontinuation|0
770375|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
770376|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
770377|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
770378|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
770379|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Missed Doses|1
770380|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Missed Doses|0
770381|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
770382|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
770383|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
770384|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
770385|NCT00559585|2451212|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
770386|NCT00559585|2451213|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
770387|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Death|1
770388|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Death|1
770389|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
770390|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
770391|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
770392|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
770393|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
770394|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
770395|NCT00559585|2451212|P2|Double Blind ST Period Main Study|Adverse Event|25
770396|NCT00559585|2451213|P1|Double Blind ST Period Main Study|Adverse Event|17
770397|NCT00559637|2451273|P1|Overall Study|Inclusion or exclusion criteria violated|2
770398|NCT00559637|2451273|P1|Overall Study|Change of home|1
770399|NCT00559637|2451273|P1|Overall Study|Change of center|1
770400|NCT00559637|2451273|P1|Overall Study|Delayed administration of C.E.R.A|1
770401|NCT00559637|2451273|P1|Overall Study|Participation in another study|1
770402|NCT00559637|2451273|P1|Overall Study|Suspected lung cancer|1
770403|NCT00559637|2451273|P1|Overall Study|Started requiring dialysis after month 7|2
770404|NCT00559637|2451273|P1|Overall Study|Insufficient response|3
770405|NCT00559637|2451273|P1|Overall Study|Failure to return|6
770406|NCT00559637|2451273|P1|Overall Study|Withdrawal criteria fulfilled|4
770407|NCT00559637|2451273|P1|Overall Study|Protocol Violation|6
770408|NCT00559637|2451273|P1|Overall Study|Withdrawal by Subject|4
770409|NCT00559637|2451273|P1|Overall Study|Adverse Event|22
770410|NCT00559754|2451284|P1|Overall Study|Withdrawal by Subject|2
770411|NCT00559754|2451284|P1|Overall Study|Investigator criteria|2
770412|NCT00559754|2451284|P1|Overall Study|Protocol Violation|1
770413|NCT00559754|2451284|P1|Overall Study|Adverse Event|5
770414|NCT00559754|2451284|P1|Overall Study|Disease progression|1
770415|NCT00559949|2451317|P1|Overall Study|No disease evaluation per protocol|1
770416|NCT00559949|2451317|P1|Overall Study|Withdrawal by Subject|4
770417|NCT00559949|2451317|P1|Overall Study|Adverse Event|1
770418|NCT00559949|2451317|P1|Overall Study|Progressive Disease during cycle 1|1
770419|NCT00559962|2451332|P8|Overall Study|Inclusion/exclusion criteria not met|0
770420|NCT00559962|2451333|P7|Overall Study|Inclusion/exclusion criteria not met|1
770421|NCT00559962|2451334|P6|Overall Study|Inclusion/exclusion criteria not met|0
770422|NCT00559962|2451335|P5|Overall Study|Inclusion/exclusion criteria not met|0
770423|NCT00559962|2451336|P4|Overall Study|Inclusion/exclusion criteria not met|0
770424|NCT00559962|2451337|P3|Overall Study|Inclusion/exclusion criteria not met|0
770425|NCT00559962|2451338|P2|Overall Study|Inclusion/exclusion criteria not met|0
770426|NCT00559962|2451339|P1|Overall Study|Inclusion/exclusion criteria not met|0
770427|NCT00559962|2451332|P8|Overall Study|Withdrawal by Subject|2
770428|NCT00559962|2451333|P7|Overall Study|Withdrawal by Subject|0
770429|NCT00559962|2451334|P6|Overall Study|Withdrawal by Subject|1
770430|NCT00559962|2451335|P5|Overall Study|Withdrawal by Subject|3
770431|NCT00559962|2451336|P4|Overall Study|Withdrawal by Subject|0
770432|NCT00559962|2451337|P3|Overall Study|Withdrawal by Subject|2
770433|NCT00559962|2451338|P2|Overall Study|Withdrawal by Subject|1
770434|NCT00559962|2451339|P1|Overall Study|Withdrawal by Subject|1
770435|NCT00559962|2451332|P8|Overall Study|Lost to Follow-up|0
770436|NCT00559962|2451333|P7|Overall Study|Lost to Follow-up|0
770437|NCT00559962|2451334|P6|Overall Study|Lost to Follow-up|0
770438|NCT00559962|2451335|P5|Overall Study|Lost to Follow-up|0
770439|NCT00559962|2451336|P4|Overall Study|Lost to Follow-up|0
770440|NCT00559962|2451337|P3|Overall Study|Lost to Follow-up|0
770441|NCT00559962|2451338|P2|Overall Study|Lost to Follow-up|1
770442|NCT00559962|2451339|P1|Overall Study|Lost to Follow-up|0
770443|NCT00559962|2451332|P8|Overall Study|Adverse Event|2
770444|NCT00559962|2451333|P7|Overall Study|Adverse Event|4
770445|NCT00559962|2451334|P6|Overall Study|Adverse Event|4
770446|NCT00559962|2451335|P5|Overall Study|Adverse Event|11
770447|NCT00559962|2451336|P4|Overall Study|Adverse Event|5
770448|NCT00559962|2451337|P3|Overall Study|Adverse Event|8
770449|NCT00559962|2451338|P2|Overall Study|Adverse Event|7
770450|NCT00559962|2451339|P1|Overall Study|Adverse Event|1
770459|NCT00560066|2451370|P2|Overall Study|Missing primary reason|2
770460|NCT00560066|2451371|P1|Overall Study|Missing primary reason|0
770461|NCT00560066|2451370|P2|Overall Study|Administrative reason|5
770462|NCT00560066|2451371|P1|Overall Study|Administrative reason|0
770463|NCT00560066|2451370|P2|Overall Study|Protocol Violation|1
770464|NCT00560066|2451371|P1|Overall Study|Protocol Violation|0
770465|NCT00560066|2451370|P2|Overall Study|Lost to Follow-up|10
770466|NCT00560066|2451371|P1|Overall Study|Lost to Follow-up|4
770467|NCT00560066|2451370|P2|Overall Study|Withdrawal by Subject|3
770468|NCT00560066|2451371|P1|Overall Study|Withdrawal by Subject|0
770469|NCT00560066|2451370|P2|Overall Study|Death|1
770470|NCT00560066|2451371|P1|Overall Study|Death|2
770471|NCT00560105|2451403|P2|Overall Study|musculoskeletal chest discomfort with us|2
770472|NCT00560105|2451404|P1|Overall Study|musculoskeletal chest discomfort with us|1
770473|NCT00560235|2451419|P3|Phase 2|Ongoing at Date of Cut-Off|1
770474|NCT00560235|2451420|P2|Phase 2|Ongoing at Date of Cut-Off|0
770475|NCT00560235|2451421|P1|Phase 2|Ongoing at Date of Cut-Off|0
770476|NCT00560235|2451419|P3|Phase 2|Discontinued|96
770477|NCT00560235|2451420|P2|Phase 2|Discontinued|0
770478|NCT00560235|2451421|P1|Phase 2|Discontinued|0
770479|NCT00560235|2451419|P3|Phase 1B|Discontinued|0
770480|NCT00560235|2451420|P2|Phase 1B|Discontinued|19
770481|NCT00560235|2451421|P1|Phase 1B|Discontinued|0
770482|NCT00560235|2451419|P3|Phase 1|Discontinued|0
770483|NCT00560235|2451420|P2|Phase 1|Discontinued|0
770484|NCT00560235|2451421|P1|Phase 1|Discontinued|8
770485|NCT00560313|2451450|P1|Overall Study|Protocol Violation|1
770486|NCT00560313|2451450|P1|Overall Study|Lost to Follow-up|1
770487|NCT00560313|2451450|P1|Overall Study|Withdrawal by Subject|2
770488|NCT00560313|2451450|P1|Overall Study|Adverse Events or Death|2
770489|NCT00560352|2451477|P3|Overall Study|Maximum clinical benefit|0
770490|NCT00560352|2451478|P2|Overall Study|Maximum clinical benefit|0
770491|NCT00560352|2451479|P1|Overall Study|Maximum clinical benefit|1
770492|NCT00560352|2451477|P3|Overall Study|Withdrawal by Subject|1
770493|NCT00560352|2451478|P2|Overall Study|Withdrawal by Subject|1
770494|NCT00560352|2451479|P1|Overall Study|Withdrawal by Subject|1
770495|NCT00560352|2451477|P3|Overall Study|Disease progression|1
770496|NCT00560352|2451478|P2|Overall Study|Disease progression|1
770497|NCT00560352|2451479|P1|Overall Study|Disease progression|0
770498|NCT00560352|2451477|P3|Overall Study|Study drug toxicity|1
770499|NCT00560352|2451478|P2|Overall Study|Study drug toxicity|0
770500|NCT00560352|2451479|P1|Overall Study|Study drug toxicity|3
770501|NCT00560352|2451477|P3|Overall Study|Adverse event unrelated to study drug|1
770502|NCT00560352|2451478|P2|Overall Study|Adverse event unrelated to study drug|1
770503|NCT00560352|2451479|P1|Overall Study|Adverse event unrelated to study drug|2
770504|NCT00560391|2451501|P5|Overall Study|Still on treatment|2
770505|NCT00560391|2451502|P4|Overall Study|Still on treatment|1
770506|NCT00560391|2451503|P3|Overall Study|Still on treatment|0
770507|NCT00560391|2451504|P2|Overall Study|Still on treatment|0
770508|NCT00560391|2451505|P1|Overall Study|Still on treatment|0
770509|NCT00560404|2451560|P2|Overall Study|Other withdrawal reason|5
770510|NCT00560404|2451561|P1|Overall Study|Other withdrawal reason|13
770511|NCT00560404|2451560|P2|Overall Study|Failure to return|2
770512|NCT00560404|2451561|P1|Overall Study|Failure to return|1
770513|NCT00560404|2451560|P2|Overall Study|Withdrew Consent|0
770514|NCT00560404|2451561|P1|Overall Study|Withdrew Consent|4
770515|NCT00560404|2451560|P2|Overall Study|Administrative Reasons|1
770516|NCT00560404|2451561|P1|Overall Study|Administrative Reasons|1
770517|NCT00560404|2451560|P2|Overall Study|Protocol Violation|7
770518|NCT00560404|2451561|P1|Overall Study|Protocol Violation|12
770519|NCT00560404|2451560|P2|Overall Study|Death|3
770520|NCT00560404|2451561|P1|Overall Study|Death|3
770521|NCT00560404|2451560|P2|Overall Study|Adverse Event|3
770522|NCT00560404|2451561|P1|Overall Study|Adverse Event|2
770523|NCT00560417|2451605|P2|Overall Study|Withdrawal by Subject|3
770524|NCT00560417|2451606|P1|Overall Study|Withdrawal by Subject|3
770525|NCT00560417|2451605|P2|Overall Study|Sponsor Decision|0
770526|NCT00560417|2451606|P1|Overall Study|Sponsor Decision|2
770527|NCT00560417|2451605|P2|Overall Study|Protocol Violation|5
770528|NCT00560417|2451606|P1|Overall Study|Protocol Violation|6
770529|NCT00560417|2451605|P2|Overall Study|Physician Decision|6
770530|NCT00560417|2451606|P1|Overall Study|Physician Decision|2
770531|NCT00560417|2451605|P2|Overall Study|Lost to Follow-up|1
770532|NCT00560417|2451606|P1|Overall Study|Lost to Follow-up|0
770533|NCT00560417|2451605|P2|Overall Study|Entry Criteria Not Met|0
770534|NCT00560417|2451606|P1|Overall Study|Entry Criteria Not Met|1
770535|NCT00560417|2451605|P2|Overall Study|Adverse Event|2
770536|NCT00560417|2451606|P1|Overall Study|Adverse Event|3
770537|NCT00560508|2451634|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
770538|NCT00560508|2451635|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
770539|NCT00560508|2451634|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
770540|NCT00560508|2451635|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
770541|NCT00560508|2451634|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
770542|NCT00560508|2451635|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
770543|NCT00560508|2451634|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
770544|NCT00560508|2451635|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
770545|NCT00560508|2451634|P2|12 Week Double-blind Period|Withdrawal by Subject|1
770546|NCT00560508|2451635|P1|12 Week Double-blind Period|Withdrawal by Subject|1
770547|NCT00560508|2451634|P2|12 Week Double-blind Period|Protocol Violation|0
770548|NCT00560508|2451635|P1|12 Week Double-blind Period|Protocol Violation|1
770549|NCT00560508|2451634|P2|12 Week Double-blind Period|Adverse Event|2
770550|NCT00560508|2451635|P1|12 Week Double-blind Period|Adverse Event|3
770551|NCT00560573|2451715|P6|Overall Study|Enrolled, not treated|0
770552|NCT00560573|2451716|P5|Overall Study|Enrolled, not treated|1
770553|NCT00560573|2451717|P4|Overall Study|Enrolled, not treated|0
770554|NCT00560573|2451718|P3|Overall Study|Enrolled, not treated|0
770555|NCT00560573|2451719|P2|Overall Study|Enrolled, not treated|0
770556|NCT00560573|2451720|P1|Overall Study|Enrolled, not treated|0
770557|NCT00560573|2451715|P6|Overall Study|Unspecified|3
770558|NCT00560573|2451716|P5|Overall Study|Unspecified|3
770559|NCT00560573|2451717|P4|Overall Study|Unspecified|3
770560|NCT00560573|2451718|P3|Overall Study|Unspecified|2
770561|NCT00560573|2451719|P2|Overall Study|Unspecified|2
770562|NCT00560573|2451720|P1|Overall Study|Unspecified|2
770563|NCT00560573|2451715|P6|Overall Study|Withdrawal by Subject|0
770564|NCT00560573|2451716|P5|Overall Study|Withdrawal by Subject|1
770565|NCT00560573|2451717|P4|Overall Study|Withdrawal by Subject|1
770566|NCT00560573|2451718|P3|Overall Study|Withdrawal by Subject|0
770567|NCT00560573|2451719|P2|Overall Study|Withdrawal by Subject|0
770568|NCT00560573|2451720|P1|Overall Study|Withdrawal by Subject|0
770569|NCT00560573|2451715|P6|Overall Study|Lost to Follow-up|0
770570|NCT00560573|2451716|P5|Overall Study|Lost to Follow-up|1
770571|NCT00560573|2451717|P4|Overall Study|Lost to Follow-up|1
770572|NCT00560573|2451718|P3|Overall Study|Lost to Follow-up|0
770573|NCT00560573|2451719|P2|Overall Study|Lost to Follow-up|0
770574|NCT00560573|2451720|P1|Overall Study|Lost to Follow-up|0
770575|NCT00560573|2451715|P6|Overall Study|Death|10
770576|NCT00560573|2451716|P5|Overall Study|Death|1
770577|NCT00560573|2451717|P4|Overall Study|Death|5
770578|NCT00560573|2451718|P3|Overall Study|Death|4
770579|NCT00560573|2451719|P2|Overall Study|Death|1
770580|NCT00560573|2451720|P1|Overall Study|Death|4
770581|NCT00560703|2451783|P2|Overall Study|non-compliance|1
770582|NCT00560703|2451784|P1|Overall Study|non-compliance|0
770583|NCT00560703|2451783|P2|Overall Study|Withdrawal by Subject|1
770584|NCT00560703|2451784|P1|Overall Study|Withdrawal by Subject|0
770585|NCT00560703|2451783|P2|Overall Study|Protocol Violation|2
770586|NCT00560703|2451784|P1|Overall Study|Protocol Violation|0
770587|NCT00560703|2451783|P2|Overall Study|Adverse Event|2
770588|NCT00560703|2451784|P1|Overall Study|Adverse Event|0
770589|NCT00560794|2451792|P1|Overall Study|Received Bone Marrow Transplant|6
770590|NCT00560794|2451792|P1|Overall Study|Hematological Relapse|1
770591|NCT00560794|2451792|P1|Overall Study|Minimal Residual Disease Relapse|1
770592|NCT00560794|2451792|P1|Overall Study|Patient was not Compliant|1
770593|NCT00560794|2451792|P1|Overall Study|Adverse Event|2
770594|NCT00560833|2451814|P5|Overall Study|Never received drug|1
770595|NCT00560833|2451815|P4|Overall Study|Never received drug|0
770596|NCT00560833|2451816|P3|Overall Study|Never received drug|0
770597|NCT00560833|2451817|P2|Overall Study|Never received drug|1
770598|NCT00560833|2451818|P1|Overall Study|Never received drug|0
770599|NCT00560833|2451814|P5|Overall Study|Unspecified|0
770600|NCT00560833|2451815|P4|Overall Study|Unspecified|0
770601|NCT00560833|2451816|P3|Overall Study|Unspecified|3
770602|NCT00560833|2451817|P2|Overall Study|Unspecified|1
770603|NCT00560833|2451818|P1|Overall Study|Unspecified|1
770604|NCT00560833|2451814|P5|Overall Study|Participant uncooperative|2
770605|NCT00560833|2451815|P4|Overall Study|Participant uncooperative|4
770606|NCT00560833|2451816|P3|Overall Study|Participant uncooperative|4
770607|NCT00560833|2451817|P2|Overall Study|Participant uncooperative|5
770608|NCT00560833|2451818|P1|Overall Study|Participant uncooperative|5
770609|NCT00560833|2451814|P5|Overall Study|Lack of Efficacy|4
770610|NCT00560833|2451815|P4|Overall Study|Lack of Efficacy|4
770611|NCT00560833|2451816|P3|Overall Study|Lack of Efficacy|6
770612|NCT00560833|2451817|P2|Overall Study|Lack of Efficacy|9
770613|NCT00560833|2451818|P1|Overall Study|Lack of Efficacy|22
770614|NCT00560833|2451814|P5|Overall Study|Lost to Follow-up|0
770615|NCT00560833|2451815|P4|Overall Study|Lost to Follow-up|0
770616|NCT00560833|2451816|P3|Overall Study|Lost to Follow-up|1
770617|NCT00560833|2451817|P2|Overall Study|Lost to Follow-up|0
770618|NCT00560833|2451818|P1|Overall Study|Lost to Follow-up|0
770619|NCT00560833|2451814|P5|Overall Study|Adverse Event|35
770620|NCT00560833|2451815|P4|Overall Study|Adverse Event|23
770621|NCT00560833|2451816|P3|Overall Study|Adverse Event|25
770622|NCT00560833|2451817|P2|Overall Study|Adverse Event|10
770623|NCT00560833|2451818|P1|Overall Study|Adverse Event|16
770624|NCT00553787|2451870|P3|Overall Study|not specified|13
770625|NCT00553787|2451871|P2|Overall Study|not specified|10
770626|NCT00553787|2451872|P1|Overall Study|not specified|18
770627|NCT00553787|2451870|P3|Overall Study|Requirement for restricted medication|5
770628|NCT00553787|2451871|P2|Overall Study|Requirement for restricted medication|7
770629|NCT00553787|2451872|P1|Overall Study|Requirement for restricted medication|8
770630|NCT00553787|2451870|P3|Overall Study|non compliance|11
770631|NCT00553787|2451871|P2|Overall Study|non compliance|0
770632|NCT00553787|2451872|P1|Overall Study|non compliance|4
770633|NCT00553787|2451870|P3|Overall Study|Pregnancy|2
770634|NCT00553787|2451871|P2|Overall Study|Pregnancy|1
770635|NCT00553787|2451872|P1|Overall Study|Pregnancy|0
770636|NCT00553787|2451870|P3|Overall Study|Lack of Efficacy|3
770637|NCT00553787|2451871|P2|Overall Study|Lack of Efficacy|1
770638|NCT00553787|2451872|P1|Overall Study|Lack of Efficacy|31
770639|NCT00553787|2451870|P3|Overall Study|Withdrawal by Subject|83
770640|NCT00553787|2451871|P2|Overall Study|Withdrawal by Subject|40
770641|NCT00553787|2451872|P1|Overall Study|Withdrawal by Subject|151
770642|NCT00553787|2451870|P3|Overall Study|Lost to Follow-up|78
770643|NCT00553787|2451871|P2|Overall Study|Lost to Follow-up|44
770644|NCT00553787|2451872|P1|Overall Study|Lost to Follow-up|132
770645|NCT00553787|2451870|P3|Overall Study|Adverse Event|67
770646|NCT00553787|2451871|P2|Overall Study|Adverse Event|21
770647|NCT00553787|2451872|P1|Overall Study|Adverse Event|34
770648|NCT00560885|2451902|P1|Overall Study|Withdrawal by Subject|1
770649|NCT00560885|2451902|P1|Overall Study|Death|7
770650|NCT00560937|2451911|P2|Overall Study|Physician Decision|1
770651|NCT00560937|2451912|P1|Overall Study|Physician Decision|1
770652|NCT00560937|2451911|P2|Overall Study|Withdrawal by Subject|1
770653|NCT00560937|2451912|P1|Overall Study|Withdrawal by Subject|0
770654|NCT00560950|2451930|P2|Overall Study|Lost to Follow-up|0
770655|NCT00560950|2451931|P1|Overall Study|Lost to Follow-up|1
770656|NCT00561015|2451988|P6|Overall Study|Participant non-compliance|0
770657|NCT00561015|2451989|P5|Overall Study|Participant non-compliance|0
770658|NCT00561015|2451990|P4|Overall Study|Participant non-compliance|0
770659|NCT00561015|2451991|P3|Overall Study|Participant non-compliance|0
770660|NCT00561015|2451992|P2|Overall Study|Participant non-compliance|0
770661|NCT00561015|2451993|P1|Overall Study|Participant non-compliance|2
770662|NCT00561015|2451988|P6|Overall Study|Lost to Follow-up|3
770663|NCT00561015|2451989|P5|Overall Study|Lost to Follow-up|0
770664|NCT00561015|2451990|P4|Overall Study|Lost to Follow-up|1
770665|NCT00561015|2451991|P3|Overall Study|Lost to Follow-up|0
770666|NCT00561015|2451992|P2|Overall Study|Lost to Follow-up|0
770667|NCT00561015|2451993|P1|Overall Study|Lost to Follow-up|2
770668|NCT00561015|2451988|P6|Overall Study|Adverse Event|0
770669|NCT00561015|2451989|P5|Overall Study|Adverse Event|1
770670|NCT00561015|2451990|P4|Overall Study|Adverse Event|0
770671|NCT00561015|2451991|P3|Overall Study|Adverse Event|0
770672|NCT00561015|2451992|P2|Overall Study|Adverse Event|0
770673|NCT00561015|2451993|P1|Overall Study|Adverse Event|0
770674|NCT00561912|2452080|P1|Overall Study|ineligible|1
770675|NCT00561925|2452087|P5|Open-Label Extension Period|Declined entry into extension period|50
770676|NCT00561925|2452088|P4|Open-Label Extension Period|Declined entry into extension period|43
770677|NCT00561925|2452089|P3|Open-Label Extension Period|Declined entry into extension period|0
770678|NCT00561925|2452090|P2|Open-Label Extension Period|Declined entry into extension period|0
770679|NCT00561925|2452091|P1|Open-Label Extension Period|Declined entry into extension period|0
770680|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Other|0
770681|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Other|0
770682|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Other|11
770683|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Other|8
770684|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Other|0
770685|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
770686|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
770687|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
770688|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
770689|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
770690|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Death|0
770691|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Death|0
770692|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Death|3
770693|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Death|6
770694|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Death|0
770695|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Pregnancy|0
770696|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Pregnancy|0
770697|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Pregnancy|9
770698|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Pregnancy|1
770699|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Pregnancy|0
770700|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
770701|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
770702|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
770703|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
770704|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
770705|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
770706|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
770707|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
770708|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
770709|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
770710|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
770711|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
770712|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
770713|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
770714|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
770715|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
770716|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
770717|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
770718|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
770719|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
770720|NCT00561925|2452087|P5|144-week Double-blind, Double-dummy|Adverse Event|0
770721|NCT00561925|2452088|P4|144-week Double-blind, Double-dummy|Adverse Event|0
770722|NCT00561925|2452089|P3|144-week Double-blind, Double-dummy|Adverse Event|43
770723|NCT00561925|2452090|P2|144-week Double-blind, Double-dummy|Adverse Event|48
770724|NCT00561925|2452091|P1|144-week Double-blind, Double-dummy|Adverse Event|0
770725|NCT00561925|2452087|P5|14 Day Lead-In Period|Other|0
770726|NCT00561925|2452088|P4|14 Day Lead-In Period|Other|0
770727|NCT00561925|2452089|P3|14 Day Lead-In Period|Other|0
770728|NCT00561925|2452090|P2|14 Day Lead-In Period|Other|0
770729|NCT00561925|2452091|P1|14 Day Lead-In Period|Other|5
770730|NCT00561925|2452087|P5|14 Day Lead-In Period|Withdrawal by Subject|0
770731|NCT00561925|2452088|P4|14 Day Lead-In Period|Withdrawal by Subject|0
770732|NCT00561925|2452089|P3|14 Day Lead-In Period|Withdrawal by Subject|0
770733|NCT00561925|2452090|P2|14 Day Lead-In Period|Withdrawal by Subject|0
770734|NCT00561925|2452091|P1|14 Day Lead-In Period|Withdrawal by Subject|4
770735|NCT00561925|2452087|P5|14 Day Lead-In Period|Lost to Follow-up|0
770736|NCT00561925|2452088|P4|14 Day Lead-In Period|Lost to Follow-up|0
770737|NCT00561925|2452089|P3|14 Day Lead-In Period|Lost to Follow-up|0
770738|NCT00561925|2452090|P2|14 Day Lead-In Period|Lost to Follow-up|0
770739|NCT00561925|2452091|P1|14 Day Lead-In Period|Lost to Follow-up|4
770740|NCT00561925|2452087|P5|14 Day Lead-In Period|In/Exclusion criteria|0
770741|NCT00561925|2452088|P4|14 Day Lead-In Period|In/Exclusion criteria|0
770742|NCT00561925|2452089|P3|14 Day Lead-In Period|In/Exclusion criteria|0
770743|NCT00561925|2452090|P2|14 Day Lead-In Period|In/Exclusion criteria|0
770744|NCT00561925|2452091|P1|14 Day Lead-In Period|In/Exclusion criteria|4
770745|NCT00561925|2452087|P5|14 Day Lead-In Period|Adverse Event|0
770746|NCT00561925|2452088|P4|14 Day Lead-In Period|Adverse Event|0
770747|NCT00561925|2452089|P3|14 Day Lead-In Period|Adverse Event|0
770748|NCT00561925|2452090|P2|14 Day Lead-In Period|Adverse Event|0
770749|NCT00561925|2452091|P1|14 Day Lead-In Period|Adverse Event|38
770750|NCT00561951|2452143|P3|Overall Study|Adverse Event Occured Before Treatment|1
770751|NCT00561951|2452144|P2|Overall Study|Adverse Event Occured Before Treatment|2
770752|NCT00561951|2452145|P1|Overall Study|Adverse Event Occured Before Treatment|1
770753|NCT00561951|2452143|P3|Overall Study|Meet Withdrawal Criterion|1
770754|NCT00561951|2452144|P2|Overall Study|Meet Withdrawal Criterion|1
770755|NCT00561951|2452145|P1|Overall Study|Meet Withdrawal Criterion|0
770756|NCT00561951|2452143|P3|Overall Study|Pregnancy|0
770757|NCT00561951|2452144|P2|Overall Study|Pregnancy|1
770758|NCT00561951|2452145|P1|Overall Study|Pregnancy|0
770759|NCT00561951|2452143|P3|Overall Study|Physician Decision|0
770760|NCT00561951|2452144|P2|Overall Study|Physician Decision|0
770761|NCT00561951|2452145|P1|Overall Study|Physician Decision|1
770762|NCT00561951|2452143|P3|Overall Study|Protocol Violation|4
770763|NCT00561951|2452144|P2|Overall Study|Protocol Violation|3
770764|NCT00561951|2452145|P1|Overall Study|Protocol Violation|4
770765|NCT00561951|2452143|P3|Overall Study|Withdrawal by Subject|10
770766|NCT00561951|2452144|P2|Overall Study|Withdrawal by Subject|9
770767|NCT00561951|2452145|P1|Overall Study|Withdrawal by Subject|10
770768|NCT00561951|2452143|P3|Overall Study|Lost to Follow-up|0
770769|NCT00561951|2452144|P2|Overall Study|Lost to Follow-up|1
770770|NCT00561951|2452145|P1|Overall Study|Lost to Follow-up|1
770771|NCT00561951|2452143|P3|Overall Study|Lack of Efficacy|2
770772|NCT00561951|2452144|P2|Overall Study|Lack of Efficacy|3
770773|NCT00561951|2452145|P1|Overall Study|Lack of Efficacy|5
770774|NCT00561951|2452143|P3|Overall Study|Adverse Event|14
770775|NCT00561951|2452144|P2|Overall Study|Adverse Event|14
770776|NCT00561951|2452145|P1|Overall Study|Adverse Event|11
770777|NCT00561977|2452201|P3|Overall Study|Pregnancy|1
770778|NCT00561977|2452202|P2|Overall Study|Pregnancy|1
770779|NCT00561977|2452203|P1|Overall Study|Pregnancy|0
770780|NCT00561977|2452201|P3|Overall Study|Withdrawal by Subject|1
770781|NCT00561977|2452202|P2|Overall Study|Withdrawal by Subject|2
770782|NCT00561977|2452203|P1|Overall Study|Withdrawal by Subject|0
770783|NCT00562094|2452226|P1|Overall Study|Lost to Follow-up|62
770784|NCT00562120|2452238|P4|First Intervention Period|Randomized but not Treated|0
770785|NCT00562120|2452239|P3|First Intervention Period|Randomized but not Treated|0
770786|NCT00562120|2452240|P2|First Intervention Period|Randomized but not Treated|0
770787|NCT00562120|2452241|P1|First Intervention Period|Randomized but not Treated|1
770788|NCT00562120|2452238|P4|First Intervention Period|Adverse Event|0
770789|NCT00562120|2452239|P3|First Intervention Period|Adverse Event|0
770790|NCT00562120|2452240|P2|First Intervention Period|Adverse Event|0
770791|NCT00562120|2452241|P1|First Intervention Period|Adverse Event|1
770792|NCT00562159|2452275|P2|Overall Study|Did not meet protocol eligibility|1
770793|NCT00562159|2452276|P1|Overall Study|Did not meet protocol eligibility|1
770794|NCT00562159|2452275|P2|Overall Study|Protocol Violation|12
770795|NCT00562159|2452276|P1|Overall Study|Protocol Violation|12
770796|NCT00562159|2452275|P2|Overall Study|Withdrawal by Subject|8
770797|NCT00562159|2452276|P1|Overall Study|Withdrawal by Subject|9
770798|NCT00562159|2452275|P2|Overall Study|Lost to Follow-up|4
770799|NCT00562159|2452276|P1|Overall Study|Lost to Follow-up|5
770800|NCT00562159|2452275|P2|Overall Study|Adverse Event|8
770801|NCT00562159|2452276|P1|Overall Study|Adverse Event|11
770802|NCT00562302|2452290|P2|Overall Study|Not stated|4
770803|NCT00562302|2452291|P1|Overall Study|Not stated|1
770804|NCT00562302|2452290|P2|Overall Study|Lung resection prior to study completion|7
770805|NCT00562302|2452291|P1|Overall Study|Lung resection prior to study completion|7
770806|NCT00562302|2452290|P2|Overall Study|Death|2
770807|NCT00562302|2452291|P1|Overall Study|Death|1
770808|NCT00562302|2452290|P2|Overall Study|Withdrawal by Subject|8
770809|NCT00562302|2452291|P1|Overall Study|Withdrawal by Subject|7
770810|NCT00562302|2452290|P2|Overall Study|Non-compliance|2
770811|NCT00562302|2452291|P1|Overall Study|Non-compliance|1
770812|NCT00562302|2452290|P2|Overall Study|Adverse Event|6
770813|NCT00562302|2452291|P1|Overall Study|Adverse Event|0
770814|NCT00562302|2452290|P2|Overall Study|Lost to Follow-up|3
770815|NCT00562302|2452291|P1|Overall Study|Lost to Follow-up|3
770816|NCT00562354|2452332|P2|Overall Study|Lost to Follow-up|1
770817|NCT00562354|2452333|P1|Overall Study|Lost to Follow-up|0
770818|NCT00562354|2452332|P2|Overall Study|Physician Decision|1
770819|NCT00562354|2452333|P1|Overall Study|Physician Decision|0
770832|NCT00562588|2452409|P2|Overall Study|Other|2
770833|NCT00562588|2452410|P1|Overall Study|Other|0
770834|NCT00562588|2452409|P2|Overall Study|Withdrawal by Subject|9
770835|NCT00562588|2452410|P1|Overall Study|Withdrawal by Subject|10
770836|NCT00562588|2452409|P2|Overall Study|Lost to Follow-up|4
770837|NCT00562588|2452410|P1|Overall Study|Lost to Follow-up|12
770838|NCT00562588|2452409|P2|Overall Study|Protocol Violation|26
770839|NCT00562588|2452410|P1|Overall Study|Protocol Violation|30
770840|NCT00562588|2452409|P2|Overall Study|Adverse Event|58
770841|NCT00562588|2452410|P1|Overall Study|Adverse Event|40
770842|NCT00562627|2452441|P3|Overall Study|Protocol Violation|1
770843|NCT00562627|2452442|P2|Overall Study|Protocol Violation|1
770844|NCT00562627|2452443|P1|Overall Study|Protocol Violation|1
770845|NCT00562861|2452459|P2|Overall Study|Lost to Follow-up|3
770846|NCT00562861|2452460|P1|Overall Study|Lost to Follow-up|7
770847|NCT00562861|2452459|P2|Overall Study|noncompliance, moved|2
770848|NCT00562861|2452460|P1|Overall Study|noncompliance, moved|7
770849|NCT00562861|2452459|P2|Overall Study|Lack of Efficacy|5
770850|NCT00562861|2452460|P1|Overall Study|Lack of Efficacy|5
770851|NCT00562861|2452459|P2|Overall Study|Adverse Event|1
770852|NCT00562861|2452460|P1|Overall Study|Adverse Event|1
770853|NCT00563316|2452478|P1|Overall Study|Other|1
770854|NCT00563316|2452478|P1|Overall Study|On-going in study as of 16 July 2009.|5
770855|NCT00563316|2452478|P1|Overall Study|Death|1
770856|NCT00563316|2452478|P1|Overall Study|Lost to Follow-up|2
770857|NCT00563316|2452478|P1|Overall Study|Physician Decision|1
770858|NCT00563316|2452478|P1|Overall Study|Adverse Event|2
770859|NCT00563368|2452496|P7|Overall Study|not specified|0
770860|NCT00563368|2452497|P6|Overall Study|not specified|4
770861|NCT00563368|2452498|P5|Overall Study|not specified|4
770862|NCT00563368|2452499|P4|Overall Study|not specified|4
770863|NCT00563368|2452500|P3|Overall Study|not specified|3
770864|NCT00563368|2452501|P2|Overall Study|not specified|5
770865|NCT00563368|2452502|P1|Overall Study|not specified|5
770866|NCT00563368|2452496|P7|Overall Study|requirement for restricted medication|0
770867|NCT00563368|2452497|P6|Overall Study|requirement for restricted medication|0
770868|NCT00563368|2452498|P5|Overall Study|requirement for restricted medication|0
770869|NCT00563368|2452499|P4|Overall Study|requirement for restricted medication|0
770870|NCT00563368|2452500|P3|Overall Study|requirement for restricted medication|2
770871|NCT00563368|2452501|P2|Overall Study|requirement for restricted medication|0
770872|NCT00563368|2452502|P1|Overall Study|requirement for restricted medication|0
770873|NCT00563368|2452496|P7|Overall Study|Pregnancy|0
770874|NCT00563368|2452497|P6|Overall Study|Pregnancy|2
770875|NCT00563368|2452498|P5|Overall Study|Pregnancy|1
770876|NCT00563368|2452499|P4|Overall Study|Pregnancy|2
770877|NCT00563368|2452500|P3|Overall Study|Pregnancy|1
770878|NCT00563368|2452501|P2|Overall Study|Pregnancy|0
770879|NCT00563368|2452502|P1|Overall Study|Pregnancy|1
770880|NCT00563368|2452496|P7|Overall Study|protocol non-compliance|3
770881|NCT00563368|2452497|P6|Overall Study|protocol non-compliance|1
770882|NCT00563368|2452498|P5|Overall Study|protocol non-compliance|0
770883|NCT00563368|2452499|P4|Overall Study|protocol non-compliance|1
770884|NCT00563368|2452500|P3|Overall Study|protocol non-compliance|2
770885|NCT00563368|2452501|P2|Overall Study|protocol non-compliance|1
770886|NCT00563368|2452502|P1|Overall Study|protocol non-compliance|1
770887|NCT00563368|2452496|P7|Overall Study|Withdrawal by Subject|4
770888|NCT00563368|2452497|P6|Overall Study|Withdrawal by Subject|5
770889|NCT00563368|2452498|P5|Overall Study|Withdrawal by Subject|8
770890|NCT00563368|2452499|P4|Overall Study|Withdrawal by Subject|7
770891|NCT00563368|2452500|P3|Overall Study|Withdrawal by Subject|5
770892|NCT00563368|2452501|P2|Overall Study|Withdrawal by Subject|6
770893|NCT00563368|2452502|P1|Overall Study|Withdrawal by Subject|11
770894|NCT00563368|2452496|P7|Overall Study|Adverse Event|17
770895|NCT00563368|2452497|P6|Overall Study|Adverse Event|10
770896|NCT00563368|2452498|P5|Overall Study|Adverse Event|6
770897|NCT00563368|2452499|P4|Overall Study|Adverse Event|9
770898|NCT00563368|2452500|P3|Overall Study|Adverse Event|5
770899|NCT00563368|2452501|P2|Overall Study|Adverse Event|4
770900|NCT00563368|2452502|P1|Overall Study|Adverse Event|3
770901|NCT00563368|2452496|P7|Overall Study|Lost to Follow-up|9
770902|NCT00563368|2452497|P6|Overall Study|Lost to Follow-up|8
770903|NCT00563368|2452498|P5|Overall Study|Lost to Follow-up|9
770904|NCT00563368|2452499|P4|Overall Study|Lost to Follow-up|6
770905|NCT00563368|2452500|P3|Overall Study|Lost to Follow-up|12
770906|NCT00563368|2452501|P2|Overall Study|Lost to Follow-up|14
770907|NCT00563368|2452502|P1|Overall Study|Lost to Follow-up|14
770908|NCT00563381|2452527|P2|Overall Study|Individual different reasons|34
770909|NCT00563381|2452528|P1|Overall Study|Individual different reasons|24
770910|NCT00563381|2452527|P2|Overall Study|Lack of Efficacy|24
770911|NCT00563381|2452528|P1|Overall Study|Lack of Efficacy|32
770912|NCT00563381|2452527|P2|Overall Study|Withdrawal by Subject|209
770913|NCT00563381|2452528|P1|Overall Study|Withdrawal by Subject|192
770914|NCT00563381|2452527|P2|Overall Study|Lost to Follow-up|15
770915|NCT00563381|2452528|P1|Overall Study|Lost to Follow-up|7
770916|NCT00563381|2452527|P2|Overall Study|Protocol Violation|74
770917|NCT00563381|2452528|P1|Overall Study|Protocol Violation|66
770918|NCT00563381|2452527|P2|Overall Study|Adverse Event|292
770919|NCT00563381|2452528|P1|Overall Study|Adverse Event|264
770920|NCT00563706|2452616|P9|DB Treatment Period (Day 1 up to Day 28)|Unspecified|2
770921|NCT00563706|2452617|P8|DB Treatment Period (Day 1 up to Day 28)|Unspecified|1
770922|NCT00563706|2452618|P7|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770923|NCT00563706|2452619|P6|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770924|NCT00563706|2452620|P5|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770925|NCT00563706|2452621|P4|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770926|NCT00563706|2452622|P3|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770927|NCT00563706|2452623|P2|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770928|NCT00563706|2452624|P1|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
770929|NCT00563706|2452616|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770930|NCT00563706|2452617|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
770931|NCT00563706|2452618|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770932|NCT00563706|2452619|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770933|NCT00563706|2452620|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770934|NCT00563706|2452621|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770935|NCT00563706|2452622|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770936|NCT00563706|2452623|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
770937|NCT00563706|2452624|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
770938|NCT00563706|2452616|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
770939|NCT00563706|2452617|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
770940|NCT00563706|2452618|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
770941|NCT00563706|2452619|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
770942|NCT00563706|2452620|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
770943|NCT00563706|2452621|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
770944|NCT00563706|2452622|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
770945|NCT00563706|2452623|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
770946|NCT00563706|2452624|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
770947|NCT00563706|2452616|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
770948|NCT00563706|2452617|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
770949|NCT00563706|2452618|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
770950|NCT00563706|2452619|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
770951|NCT00563706|2452620|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
770952|NCT00563706|2452621|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
770953|NCT00563706|2452622|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
770954|NCT00563706|2452623|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
770955|NCT00563706|2452624|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
770956|NCT00563706|2452616|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
770957|NCT00563706|2452617|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
770958|NCT00563706|2452618|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
770959|NCT00563706|2452619|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
770960|NCT00563706|2452620|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
770961|NCT00563706|2452621|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
770962|NCT00563706|2452622|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
770963|NCT00563706|2452623|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
770964|NCT00563706|2452624|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
770965|NCT00563797|2452727|P2|Overall Study|Lost to Follow-up|2
770966|NCT00563797|2452728|P1|Overall Study|Lost to Follow-up|7
770967|NCT00564278|2452746|P2|Overall Study|Withdrawal by Subject|7
770968|NCT00564278|2452747|P1|Overall Study|Withdrawal by Subject|11
770969|NCT00564278|2452746|P2|Overall Study|Physician Decision|2
770970|NCT00564278|2452747|P1|Overall Study|Physician Decision|1
770971|NCT00564278|2452746|P2|Overall Study|Lost to Follow-up|33
770972|NCT00564278|2452747|P1|Overall Study|Lost to Follow-up|35
770973|NCT00556894|2452766|P3|Overall Study|Withdrawal by Subject|1
770974|NCT00556894|2452767|P2|Overall Study|Withdrawal by Subject|1
770975|NCT00556894|2452768|P1|Overall Study|Withdrawal by Subject|1
770976|NCT00556894|2452766|P3|Overall Study|Change in therapy|2
770977|NCT00556894|2452767|P2|Overall Study|Change in therapy|1
770978|NCT00556894|2452768|P1|Overall Study|Change in therapy|2
770979|NCT00556894|2452766|P3|Overall Study|regulatory decision in Bulgaria|13
770980|NCT00556894|2452767|P2|Overall Study|regulatory decision in Bulgaria|14
770981|NCT00556894|2452768|P1|Overall Study|regulatory decision in Bulgaria|10
770982|NCT00556894|2452766|P3|Overall Study|Death|0
770983|NCT00556894|2452767|P2|Overall Study|Death|0
770984|NCT00556894|2452768|P1|Overall Study|Death|1
770985|NCT00556894|2452766|P3|Overall Study|Adverse Event|3
770986|NCT00556894|2452767|P2|Overall Study|Adverse Event|3
770987|NCT00556894|2452768|P1|Overall Study|Adverse Event|2
770988|NCT00556933|2452780|P4|CNI Withdrawal vs. Minimization|Death|1
770989|NCT00556933|2452781|P3|CNI Withdrawal vs. Minimization|Death|0
770990|NCT00556933|2452782|P2|CNI Withdrawal vs. Minimization|Death|0
770991|NCT00556933|2452783|P1|CNI Withdrawal vs. Minimization|Death|0
770992|NCT00556933|2452780|P4|CNI Withdrawal vs. Minimization|Graft loss|0
770993|NCT00556933|2452781|P3|CNI Withdrawal vs. Minimization|Graft loss|2
770994|NCT00556933|2452782|P2|CNI Withdrawal vs. Minimization|Graft loss|1
770995|NCT00556933|2452783|P1|CNI Withdrawal vs. Minimization|Graft loss|0
770996|NCT00556933|2452780|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
770997|NCT00556933|2452781|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
770998|NCT00556933|2452782|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
771076|NCT00557466|2453037|P4|Overall Study|Subject withdrew consent|0
770999|NCT00556933|2452783|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
771000|NCT00556933|2452780|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
771001|NCT00556933|2452781|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
771002|NCT00556933|2452782|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
771003|NCT00556933|2452783|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
771004|NCT00556933|2452780|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
771005|NCT00556933|2452781|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
771006|NCT00556933|2452782|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
771007|NCT00556933|2452783|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
771008|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
771009|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
771010|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
771011|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
771012|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
771013|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
771014|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
771015|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
771016|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Death|0
771017|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Death|0
771018|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Death|1
771019|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Death|0
771020|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
771021|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
771022|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
771023|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
771024|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
771025|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
771026|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
771027|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
771028|NCT00556933|2452780|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
771029|NCT00556933|2452781|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
771030|NCT00556933|2452782|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
771031|NCT00556933|2452783|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
771032|NCT00556998|2452848|P1|Voriconazole Oral|Intolerant of oral treatment|1
771033|NCT00556998|2452848|P1|Voriconazole Oral|Adverse Event|1
771034|NCT00556998|2452848|P1|Voriconazole Intravenous (IV)|unspecified|4
771035|NCT00556998|2452848|P1|Voriconazole Intravenous (IV)|Adverse Event|1
771036|NCT00557076|2452870|P2|Overall Study|Unblinding|1
771037|NCT00557076|2452871|P1|Overall Study|Unblinding|0
771038|NCT00557245|2452882|P3|Overall Study|Ineligible|2
771039|NCT00557245|2452883|P2|Overall Study|Ineligible|4
771040|NCT00557245|2452884|P1|Overall Study|Ineligible|5
771041|NCT00557245|2452882|P3|Overall Study|Lost to Follow-up|10
771042|NCT00557245|2452883|P2|Overall Study|Lost to Follow-up|8
771043|NCT00557245|2452884|P1|Overall Study|Lost to Follow-up|7
771044|NCT00557310|2452945|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
771045|NCT00557310|2452945|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
771046|NCT00557310|2452945|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
771047|NCT00557310|2452945|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
771048|NCT00557310|2452945|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
771049|NCT00557310|2452945|P1|Main Study (0 - 18 Months)|Adverse Event|4
771050|NCT00557323|2452965|P1|Overall Study|Administrative change|2
771051|NCT00557323|2452965|P1|Overall Study|Withdrawal by Subject|2
771052|NCT00557323|2452965|P1|Overall Study|Death|3
771053|NCT00557440|2453007|P3|Treatment Period 1|Adverse Event|1
771054|NCT00557440|2453008|P2|Treatment Period 1|Adverse Event|0
771055|NCT00557440|2453009|P1|Treatment Period 1|Adverse Event|0
771056|NCT00557466|2453035|P6|Overall Study|Lost to Follow-up|0
771057|NCT00557466|2453036|P5|Overall Study|Lost to Follow-up|0
771058|NCT00557466|2453037|P4|Overall Study|Lost to Follow-up|1
771059|NCT00557466|2453038|P3|Overall Study|Lost to Follow-up|0
771060|NCT00557466|2453039|P2|Overall Study|Lost to Follow-up|0
771061|NCT00557466|2453040|P1|Overall Study|Lost to Follow-up|0
771062|NCT00557466|2453035|P6|Overall Study|Abnormal test procedure results|0
771063|NCT00557466|2453036|P5|Overall Study|Abnormal test procedure results|0
771064|NCT00557466|2453037|P4|Overall Study|Abnormal test procedure results|0
771065|NCT00557466|2453038|P3|Overall Study|Abnormal test procedure results|1
771066|NCT00557466|2453039|P2|Overall Study|Abnormal test procedure results|0
771067|NCT00557466|2453040|P1|Overall Study|Abnormal test procedure results|0
771068|NCT00557466|2453035|P6|Overall Study|Administrative problems|0
771069|NCT00557466|2453036|P5|Overall Study|Administrative problems|0
771070|NCT00557466|2453037|P4|Overall Study|Administrative problems|0
771071|NCT00557466|2453038|P3|Overall Study|Administrative problems|1
771072|NCT00557466|2453039|P2|Overall Study|Administrative problems|1
771073|NCT00557466|2453040|P1|Overall Study|Administrative problems|0
771074|NCT00557466|2453035|P6|Overall Study|Subject withdrew consent|2
771075|NCT00557466|2453036|P5|Overall Study|Subject withdrew consent|1
771077|NCT00557466|2453038|P3|Overall Study|Subject withdrew consent|0
771078|NCT00557466|2453039|P2|Overall Study|Subject withdrew consent|0
771079|NCT00557466|2453040|P1|Overall Study|Subject withdrew consent|0
771080|NCT00557466|2453035|P6|Overall Study|Protocol deviation|0
771081|NCT00557466|2453036|P5|Overall Study|Protocol deviation|0
771082|NCT00557466|2453037|P4|Overall Study|Protocol deviation|2
771083|NCT00557466|2453038|P3|Overall Study|Protocol deviation|0
771084|NCT00557466|2453039|P2|Overall Study|Protocol deviation|1
771085|NCT00557466|2453040|P1|Overall Study|Protocol deviation|0
771086|NCT00557466|2453035|P6|Overall Study|Abnormal laboratory value(s)|0
771087|NCT00557466|2453036|P5|Overall Study|Abnormal laboratory value(s)|0
771088|NCT00557466|2453037|P4|Overall Study|Abnormal laboratory value(s)|0
771089|NCT00557466|2453038|P3|Overall Study|Abnormal laboratory value(s)|0
771090|NCT00557466|2453039|P2|Overall Study|Abnormal laboratory value(s)|2
771091|NCT00557466|2453040|P1|Overall Study|Abnormal laboratory value(s)|1
771092|NCT00557466|2453035|P6|Overall Study|Adverse Event|4
771093|NCT00557466|2453036|P5|Overall Study|Adverse Event|2
771094|NCT00557466|2453037|P4|Overall Study|Adverse Event|1
771095|NCT00557466|2453038|P3|Overall Study|Adverse Event|4
771096|NCT00557466|2453039|P2|Overall Study|Adverse Event|1
771097|NCT00557466|2453040|P1|Overall Study|Adverse Event|3
771098|NCT00557492|2453090|P1|Overall Study|Change in health insurance|1
771099|NCT00557505|2453111|P9|Overall Study|Withdrawal by Subject|1
771100|NCT00557505|2453112|P8|Overall Study|Withdrawal by Subject|0
771101|NCT00557505|2453113|P7|Overall Study|Withdrawal by Subject|0
771102|NCT00557505|2453114|P6|Overall Study|Withdrawal by Subject|0
771103|NCT00557505|2453115|P5|Overall Study|Withdrawal by Subject|0
771104|NCT00557505|2453116|P4|Overall Study|Withdrawal by Subject|1
771105|NCT00557505|2453117|P3|Overall Study|Withdrawal by Subject|0
771106|NCT00557505|2453118|P2|Overall Study|Withdrawal by Subject|0
771107|NCT00557505|2453119|P1|Overall Study|Withdrawal by Subject|0
771108|NCT00557505|2453111|P9|Overall Study|Objective progression or relapse|15
771109|NCT00557505|2453112|P8|Overall Study|Objective progression or relapse|5
771110|NCT00557505|2453113|P7|Overall Study|Objective progression or relapse|2
771111|NCT00557505|2453114|P6|Overall Study|Objective progression or relapse|3
771112|NCT00557505|2453115|P5|Overall Study|Objective progression or relapse|2
771113|NCT00557505|2453116|P4|Overall Study|Objective progression or relapse|2
771114|NCT00557505|2453117|P3|Overall Study|Objective progression or relapse|3
771115|NCT00557505|2453118|P2|Overall Study|Objective progression or relapse|3
771116|NCT00557505|2453119|P1|Overall Study|Objective progression or relapse|2
771117|NCT00557505|2453111|P9|Overall Study|Global deterioration of health|0
771118|NCT00557505|2453112|P8|Overall Study|Global deterioration of health|0
771119|NCT00557505|2453113|P7|Overall Study|Global deterioration of health|0
771120|NCT00557505|2453114|P6|Overall Study|Global deterioration of health|0
771121|NCT00557505|2453115|P5|Overall Study|Global deterioration of health|0
771122|NCT00557505|2453116|P4|Overall Study|Global deterioration of health|0
771123|NCT00557505|2453117|P3|Overall Study|Global deterioration of health|0
771124|NCT00557505|2453118|P2|Overall Study|Global deterioration of health|0
771125|NCT00557505|2453119|P1|Overall Study|Global deterioration of health|1
771126|NCT00557505|2453111|P9|Overall Study|Adverse Event|0
771127|NCT00557505|2453112|P8|Overall Study|Adverse Event|0
771128|NCT00557505|2453113|P7|Overall Study|Adverse Event|1
771129|NCT00557505|2453114|P6|Overall Study|Adverse Event|0
771130|NCT00557505|2453115|P5|Overall Study|Adverse Event|0
771131|NCT00557505|2453116|P4|Overall Study|Adverse Event|0
771132|NCT00557505|2453117|P3|Overall Study|Adverse Event|1
771133|NCT00557505|2453118|P2|Overall Study|Adverse Event|0
771134|NCT00557505|2453119|P1|Overall Study|Adverse Event|0
771135|NCT00557505|2453111|P9|Overall Study|Death|1
771136|NCT00557505|2453112|P8|Overall Study|Death|0
771137|NCT00557505|2453113|P7|Overall Study|Death|0
771138|NCT00557505|2453114|P6|Overall Study|Death|0
771139|NCT00557505|2453115|P5|Overall Study|Death|0
771140|NCT00557505|2453116|P4|Overall Study|Death|0
771141|NCT00557505|2453117|P3|Overall Study|Death|0
771142|NCT00557505|2453118|P2|Overall Study|Death|0
771143|NCT00557505|2453119|P1|Overall Study|Death|0
771144|NCT00557622|2453285|P2|12-Week Treatment Phase|Lost to Follow-up|1
771145|NCT00557622|2453286|P1|12-Week Treatment Phase|Lost to Follow-up|0
771146|NCT00557622|2453285|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
771147|NCT00557622|2453286|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
771148|NCT00557622|2453285|P2|4-Week Run-in Phase|Withdrawal by Subject|0
771149|NCT00557622|2453286|P1|4-Week Run-in Phase|Withdrawal by Subject|1
771150|NCT00557830|2453309|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
771151|NCT00557830|2453310|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
771152|NCT00557830|2453311|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
771153|NCT00557830|2453309|P3|Screening Treatment Phase|Adverse Event|0
771154|NCT00557830|2453310|P2|Screening Treatment Phase|Adverse Event|0
771155|NCT00557830|2453311|P1|Screening Treatment Phase|Adverse Event|2
771156|NCT00557830|2453309|P3|Screening Treatment Phase|Withdrawal by Subject|0
771157|NCT00557830|2453310|P2|Screening Treatment Phase|Withdrawal by Subject|0
771158|NCT00557830|2453311|P1|Screening Treatment Phase|Withdrawal by Subject|1
771159|NCT00557856|2453331|P9|Part 2: Exploratory Phase|global deterioration of health status|1
771160|NCT00557856|2453332|P8|Part 2: Exploratory Phase|global deterioration of health status|0
771236|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|Death|0
771161|NCT00557856|2453333|P7|Part 2: Exploratory Phase|global deterioration of health status|0
771162|NCT00557856|2453334|P6|Part 2: Exploratory Phase|global deterioration of health status|0
771163|NCT00557856|2453335|P5|Part 2: Exploratory Phase|global deterioration of health status|0
771164|NCT00557856|2453336|P4|Part 2: Exploratory Phase|global deterioration of health status|0
771165|NCT00557856|2453337|P3|Part 2: Exploratory Phase|global deterioration of health status|0
771166|NCT00557856|2453338|P2|Part 2: Exploratory Phase|global deterioration of health status|0
771167|NCT00557856|2453339|P1|Part 2: Exploratory Phase|global deterioration of health status|0
771168|NCT00557856|2453331|P9|Part 2: Exploratory Phase|Death|2
771169|NCT00557856|2453332|P8|Part 2: Exploratory Phase|Death|0
771170|NCT00557856|2453333|P7|Part 2: Exploratory Phase|Death|0
771171|NCT00557856|2453334|P6|Part 2: Exploratory Phase|Death|0
771172|NCT00557856|2453335|P5|Part 2: Exploratory Phase|Death|0
771173|NCT00557856|2453336|P4|Part 2: Exploratory Phase|Death|0
771174|NCT00557856|2453337|P3|Part 2: Exploratory Phase|Death|0
771175|NCT00557856|2453338|P2|Part 2: Exploratory Phase|Death|0
771176|NCT00557856|2453339|P1|Part 2: Exploratory Phase|Death|0
771177|NCT00557856|2453331|P9|Part 2: Exploratory Phase|unspecified|1
771178|NCT00557856|2453332|P8|Part 2: Exploratory Phase|unspecified|0
771179|NCT00557856|2453333|P7|Part 2: Exploratory Phase|unspecified|0
771180|NCT00557856|2453334|P6|Part 2: Exploratory Phase|unspecified|0
771181|NCT00557856|2453335|P5|Part 2: Exploratory Phase|unspecified|0
771182|NCT00557856|2453336|P4|Part 2: Exploratory Phase|unspecified|0
771183|NCT00557856|2453337|P3|Part 2: Exploratory Phase|unspecified|0
771184|NCT00557856|2453338|P2|Part 2: Exploratory Phase|unspecified|0
771185|NCT00557856|2453339|P1|Part 2: Exploratory Phase|unspecified|0
771186|NCT00557856|2453331|P9|Part 2: Exploratory Phase|Adverse Event|4
771187|NCT00557856|2453332|P8|Part 2: Exploratory Phase|Adverse Event|0
771188|NCT00557856|2453333|P7|Part 2: Exploratory Phase|Adverse Event|0
771189|NCT00557856|2453334|P6|Part 2: Exploratory Phase|Adverse Event|0
771190|NCT00557856|2453335|P5|Part 2: Exploratory Phase|Adverse Event|0
771191|NCT00557856|2453336|P4|Part 2: Exploratory Phase|Adverse Event|0
771192|NCT00557856|2453337|P3|Part 2: Exploratory Phase|Adverse Event|0
771193|NCT00557856|2453338|P2|Part 2: Exploratory Phase|Adverse Event|0
771194|NCT00557856|2453339|P1|Part 2: Exploratory Phase|Adverse Event|0
771195|NCT00557856|2453331|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
771196|NCT00557856|2453332|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
771197|NCT00557856|2453333|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
771198|NCT00557856|2453334|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
771199|NCT00557856|2453335|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
771200|NCT00557856|2453336|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
771201|NCT00557856|2453337|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
771202|NCT00557856|2453338|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
771203|NCT00557856|2453339|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
771204|NCT00557856|2453331|P9|Part 2: Exploratory Phase|objective progression or relapse|15
771205|NCT00557856|2453332|P8|Part 2: Exploratory Phase|objective progression or relapse|0
771206|NCT00557856|2453333|P7|Part 2: Exploratory Phase|objective progression or relapse|0
771207|NCT00557856|2453334|P6|Part 2: Exploratory Phase|objective progression or relapse|0
771208|NCT00557856|2453335|P5|Part 2: Exploratory Phase|objective progression or relapse|0
771209|NCT00557856|2453336|P4|Part 2: Exploratory Phase|objective progression or relapse|0
771210|NCT00557856|2453337|P3|Part 2: Exploratory Phase|objective progression or relapse|0
771211|NCT00557856|2453338|P2|Part 2: Exploratory Phase|objective progression or relapse|0
771212|NCT00557856|2453339|P1|Part 2: Exploratory Phase|objective progression or relapse|0
771213|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
771214|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
771215|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
771216|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
771217|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
771218|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
771219|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
771220|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
771221|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
771222|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
771223|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
771224|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
771225|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
771226|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
771227|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
771228|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
771229|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
771230|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
771231|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|Death|0
771232|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|Death|0
771233|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|Death|0
771234|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|Death|1
771235|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|Death|0
771237|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|Death|0
771238|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|Death|0
771239|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|Death|0
771240|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|unspecified|0
771241|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|unspecified|1
771242|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|unspecified|0
771243|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|unspecified|0
771244|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|unspecified|0
771245|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|unspecified|1
771246|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|unspecified|1
771247|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|unspecified|0
771248|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|unspecified|0
771249|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|Adverse Event|0
771250|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|Adverse Event|2
771251|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|Adverse Event|1
771252|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|Adverse Event|3
771253|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|Adverse Event|1
771254|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|Adverse Event|1
771255|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|Adverse Event|1
771256|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|Adverse Event|0
771257|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|Adverse Event|1
771258|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771259|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771260|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771261|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771262|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771263|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771264|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
771265|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
771266|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
771267|NCT00557856|2453331|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
771268|NCT00557856|2453332|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
771269|NCT00557856|2453333|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
771270|NCT00557856|2453334|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
771271|NCT00557856|2453335|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
771272|NCT00557856|2453336|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
771273|NCT00557856|2453337|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
771274|NCT00557856|2453338|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
771275|NCT00557856|2453339|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
771276|NCT00558025|2453562|P2|Overall Study|Protocol Violation|0
771277|NCT00558025|2453563|P1|Overall Study|Protocol Violation|1
771278|NCT00558025|2453562|P2|Overall Study|Withdrawal by Subject|2
771279|NCT00558025|2453563|P1|Overall Study|Withdrawal by Subject|2
771280|NCT00558025|2453562|P2|Overall Study|Adverse Event|1
771281|NCT00558025|2453563|P1|Overall Study|Adverse Event|1
771282|NCT00558064|2453587|P2|Overall Study|No visit within allowance period|0
771283|NCT00558064|2453588|P1|Overall Study|No visit within allowance period|1
771284|NCT00558064|2453587|P2|Overall Study|Withdrawal by Subject|1
771285|NCT00558064|2453588|P1|Overall Study|Withdrawal by Subject|0
771286|NCT00558064|2453587|P2|Overall Study|Lost to Follow-up|1
771287|NCT00558064|2453588|P1|Overall Study|Lost to Follow-up|0
771288|NCT00558064|2453587|P2|Overall Study|Protocol Violation|0
771289|NCT00558064|2453588|P1|Overall Study|Protocol Violation|1
771290|NCT00558064|2453587|P2|Overall Study|Lack of Efficacy|1
771291|NCT00558064|2453588|P1|Overall Study|Lack of Efficacy|0
771292|NCT00558064|2453587|P2|Overall Study|Adverse Event|2
771293|NCT00558064|2453588|P1|Overall Study|Adverse Event|3
771294|NCT00558103|2453613|P6|Monotherapy Extension Phase|Disease Progression|8
771295|NCT00558103|2453614|P5|Monotherapy Extension Phase|Disease Progression|0
771296|NCT00558103|2453615|P4|Monotherapy Extension Phase|Disease Progression|0
771297|NCT00558103|2453616|P3|Monotherapy Extension Phase|Disease Progression|0
771298|NCT00558103|2453617|P2|Monotherapy Extension Phase|Disease Progression|0
771299|NCT00558103|2453618|P1|Monotherapy Extension Phase|Disease Progression|0
771300|NCT00558103|2453613|P6|Monotherapy Extension Phase|Protocol Violation|1
771301|NCT00558103|2453614|P5|Monotherapy Extension Phase|Protocol Violation|0
771302|NCT00558103|2453615|P4|Monotherapy Extension Phase|Protocol Violation|0
771303|NCT00558103|2453616|P3|Monotherapy Extension Phase|Protocol Violation|0
771304|NCT00558103|2453617|P2|Monotherapy Extension Phase|Protocol Violation|0
771305|NCT00558103|2453618|P1|Monotherapy Extension Phase|Protocol Violation|0
771306|NCT00558103|2453613|P6|Randomized Treatment Phase|Adverse Event|0
771307|NCT00558103|2453614|P5|Randomized Treatment Phase|Adverse Event|1
771308|NCT00558103|2453615|P4|Randomized Treatment Phase|Adverse Event|1
771309|NCT00558103|2453616|P3|Randomized Treatment Phase|Adverse Event|0
771310|NCT00558103|2453617|P2|Randomized Treatment Phase|Adverse Event|0
771311|NCT00558103|2453618|P1|Randomized Treatment Phase|Adverse Event|0
771312|NCT00558103|2453613|P6|Randomized Treatment Phase|Disease Progression|0
771313|NCT00558103|2453614|P5|Randomized Treatment Phase|Disease Progression|0
771314|NCT00558103|2453615|P4|Randomized Treatment Phase|Disease Progression|0
771315|NCT00558103|2453616|P3|Randomized Treatment Phase|Disease Progression|1
771316|NCT00558103|2453617|P2|Randomized Treatment Phase|Disease Progression|0
771317|NCT00558103|2453618|P1|Randomized Treatment Phase|Disease Progression|1
771318|NCT00558103|2453613|P6|Randomized Treatment Phase|Withdrawal by Subject|0
771319|NCT00558103|2453614|P5|Randomized Treatment Phase|Withdrawal by Subject|1
771320|NCT00558103|2453615|P4|Randomized Treatment Phase|Withdrawal by Subject|0
771321|NCT00558103|2453616|P3|Randomized Treatment Phase|Withdrawal by Subject|0
771322|NCT00558103|2453617|P2|Randomized Treatment Phase|Withdrawal by Subject|2
771323|NCT00558103|2453618|P1|Randomized Treatment Phase|Withdrawal by Subject|2
771324|NCT00558103|2453613|P6|Randomized Treatment Phase|Lost to Follow-up|0
771325|NCT00558103|2453614|P5|Randomized Treatment Phase|Lost to Follow-up|3
771326|NCT00558103|2453615|P4|Randomized Treatment Phase|Lost to Follow-up|1
771327|NCT00558103|2453616|P3|Randomized Treatment Phase|Lost to Follow-up|2
771328|NCT00558103|2453617|P2|Randomized Treatment Phase|Lost to Follow-up|2
771329|NCT00558103|2453618|P1|Randomized Treatment Phase|Lost to Follow-up|2
771330|NCT00558259|2453663|P2|Overall Study|Withdrawal by Subject|13
771331|NCT00558259|2453664|P1|Overall Study|Withdrawal by Subject|12
771332|NCT00558259|2453663|P2|Overall Study|Protocol Violation|5
771333|NCT00558259|2453664|P1|Overall Study|Protocol Violation|9
771334|NCT00558259|2453663|P2|Overall Study|Adverse Event|81
771335|NCT00558259|2453664|P1|Overall Study|Adverse Event|50
771336|NCT00558272|2453686|P2|Overall Study|Withdrawal by Subject|1
771337|NCT00558272|2453687|P1|Overall Study|Withdrawal by Subject|0
771338|NCT00558272|2453686|P2|Overall Study|Incorrectly enrolled|0
771339|NCT00558272|2453687|P1|Overall Study|Incorrectly enrolled|1
771340|NCT00558272|2453686|P2|Overall Study|AZ study team decision|1
771341|NCT00558272|2453687|P1|Overall Study|AZ study team decision|0
771342|NCT00558272|2453686|P2|Overall Study|Dev. of study specific discon. criteria|0
771343|NCT00558272|2453687|P1|Overall Study|Dev. of study specific discon. criteria|1
771344|NCT00558272|2453686|P2|Overall Study|Death|0
771345|NCT00558272|2453687|P1|Overall Study|Death|1
771346|NCT00558272|2453686|P2|Overall Study|Adverse Event|0
771347|NCT00558272|2453687|P1|Overall Study|Adverse Event|10
771348|NCT00564486|2453761|P4|Overall Study|Lost to Follow-up|2
771349|NCT00564486|2453762|P3|Overall Study|Lost to Follow-up|2
771350|NCT00564486|2453763|P2|Overall Study|Lost to Follow-up|0
771351|NCT00564486|2453764|P1|Overall Study|Lost to Follow-up|3
771352|NCT00564486|2453761|P4|Overall Study|Subject refused to have blood drawn|0
771353|NCT00564486|2453762|P3|Overall Study|Subject refused to have blood drawn|1
771354|NCT00564486|2453763|P2|Overall Study|Subject refused to have blood drawn|0
771355|NCT00564486|2453764|P1|Overall Study|Subject refused to have blood drawn|0
771356|NCT00564486|2453761|P4|Overall Study|Withdrawal by Subject|5
771357|NCT00564486|2453762|P3|Overall Study|Withdrawal by Subject|0
771358|NCT00564486|2453763|P2|Overall Study|Withdrawal by Subject|0
771359|NCT00564486|2453764|P1|Overall Study|Withdrawal by Subject|4
771360|NCT00564486|2453761|P4|Overall Study|Adverse Event|0
771361|NCT00564486|2453762|P3|Overall Study|Adverse Event|0
771362|NCT00564486|2453763|P2|Overall Study|Adverse Event|1
771363|NCT00564486|2453764|P1|Overall Study|Adverse Event|0
771364|NCT00564629|2453782|P2|Overall Study|Vomited within 2 hours of receiving drug|9
771365|NCT00564629|2453783|P1|Overall Study|Vomited within 2 hours of receiving drug|15
771366|NCT00567879|2453857|P6|Overall Study|Disease progression|3
771367|NCT00567879|2453858|P5|Overall Study|Disease progression|11
771368|NCT00567879|2453859|P4|Overall Study|Disease progression|5
771369|NCT00567879|2453860|P3|Overall Study|Disease progression|15
771370|NCT00567879|2453861|P2|Overall Study|Disease progression|7
771371|NCT00567879|2453862|P1|Overall Study|Disease progression|5
771372|NCT00567879|2453857|P6|Overall Study|New cancer therapy|0
771373|NCT00567879|2453858|P5|Overall Study|New cancer therapy|0
771374|NCT00567879|2453859|P4|Overall Study|New cancer therapy|0
771375|NCT00567879|2453860|P3|Overall Study|New cancer therapy|1
771376|NCT00567879|2453861|P2|Overall Study|New cancer therapy|0
771377|NCT00567879|2453862|P1|Overall Study|New cancer therapy|0
771378|NCT00567879|2453857|P6|Overall Study|Withdrawal by Subject|0
771379|NCT00567879|2453858|P5|Overall Study|Withdrawal by Subject|0
771380|NCT00567879|2453859|P4|Overall Study|Withdrawal by Subject|1
771381|NCT00567879|2453860|P3|Overall Study|Withdrawal by Subject|3
771382|NCT00567879|2453861|P2|Overall Study|Withdrawal by Subject|0
771383|NCT00567879|2453862|P1|Overall Study|Withdrawal by Subject|0
771384|NCT00567879|2453857|P6|Overall Study|Abnormal test procedure(s)|0
771385|NCT00567879|2453858|P5|Overall Study|Abnormal test procedure(s)|0
771386|NCT00567879|2453859|P4|Overall Study|Abnormal test procedure(s)|0
771387|NCT00567879|2453860|P3|Overall Study|Abnormal test procedure(s)|1
771388|NCT00567879|2453861|P2|Overall Study|Abnormal test procedure(s)|0
771389|NCT00567879|2453862|P1|Overall Study|Abnormal test procedure(s)|0
771390|NCT00567879|2453857|P6|Overall Study|Adverse Event|0
771391|NCT00567879|2453858|P5|Overall Study|Adverse Event|1
771392|NCT00567879|2453859|P4|Overall Study|Adverse Event|0
771393|NCT00567879|2453860|P3|Overall Study|Adverse Event|1
771394|NCT00567879|2453861|P2|Overall Study|Adverse Event|0
771395|NCT00567879|2453862|P1|Overall Study|Adverse Event|2
771396|NCT00567892|2453885|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
771397|NCT00567892|2453886|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
771398|NCT00567892|2453887|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
771399|NCT00567892|2453888|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
891633|NCT01387230|2828273|P3|Overall Study|Lost to Follow-up|1
771400|NCT00567892|2453885|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
771401|NCT00567892|2453886|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
771402|NCT00567892|2453887|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
771403|NCT00567892|2453888|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
771404|NCT00567996|2453903|P3|Overall Study|Patient's inability to use the device|0
771405|NCT00567996|2453904|P2|Overall Study|Patient's inability to use the device|1
771406|NCT00567996|2453905|P1|Overall Study|Patient's inability to use the device|0
771407|NCT00567996|2453903|P3|Overall Study|Death|2
771408|NCT00567996|2453904|P2|Overall Study|Death|0
771409|NCT00567996|2453905|P1|Overall Study|Death|1
771410|NCT00567996|2453903|P3|Overall Study|Administrative problems|0
771411|NCT00567996|2453904|P2|Overall Study|Administrative problems|1
771412|NCT00567996|2453905|P1|Overall Study|Administrative problems|1
771413|NCT00567996|2453903|P3|Overall Study|Unsatisfactory therapeutic effect|15
771414|NCT00567996|2453904|P2|Overall Study|Unsatisfactory therapeutic effect|2
771415|NCT00567996|2453905|P1|Overall Study|Unsatisfactory therapeutic effect|1
771416|NCT00567996|2453903|P3|Overall Study|Lost to Follow-up|2
771417|NCT00567996|2453904|P2|Overall Study|Lost to Follow-up|5
771418|NCT00567996|2453905|P1|Overall Study|Lost to Follow-up|2
771419|NCT00567996|2453903|P3|Overall Study|Abnormal test procedure result(s)|1
771420|NCT00567996|2453904|P2|Overall Study|Abnormal test procedure result(s)|1
771421|NCT00567996|2453905|P1|Overall Study|Abnormal test procedure result(s)|2
771422|NCT00567996|2453903|P3|Overall Study|Abnormal Lab value(s)|2
771423|NCT00567996|2453904|P2|Overall Study|Abnormal Lab value(s)|1
771424|NCT00567996|2453905|P1|Overall Study|Abnormal Lab value(s)|2
771425|NCT00567996|2453903|P3|Overall Study|Withdrawal by Subject|22
771426|NCT00567996|2453904|P2|Overall Study|Withdrawal by Subject|12
771427|NCT00567996|2453905|P1|Overall Study|Withdrawal by Subject|8
771428|NCT00567996|2453903|P3|Overall Study|Protocol Deviation|13
771429|NCT00567996|2453904|P2|Overall Study|Protocol Deviation|11
771430|NCT00567996|2453905|P1|Overall Study|Protocol Deviation|9
771431|NCT00567996|2453903|P3|Overall Study|Adverse Event|13
771432|NCT00567996|2453904|P2|Overall Study|Adverse Event|16
771433|NCT00567996|2453905|P1|Overall Study|Adverse Event|18
771434|NCT00568061|2453956|P2|Overall Study|Adverse Event|1
771435|NCT00568061|2453957|P1|Overall Study|Adverse Event|0
771436|NCT00568061|2453956|P2|Overall Study|Inclusion / exclusion criteria|1
771437|NCT00568061|2453957|P1|Overall Study|Inclusion / exclusion criteria|5
891634|NCT01387230|2828274|P2|Overall Study|Lost to Follow-up|0
891635|NCT01387230|2828275|P1|Overall Study|Lost to Follow-up|0
891636|NCT01387230|2828273|P3|Overall Study|Protocol-defined Stopping Criteria|5
891637|NCT01387230|2828274|P2|Overall Study|Protocol-defined Stopping Criteria|0
891638|NCT01387230|2828275|P1|Overall Study|Protocol-defined Stopping Criteria|6
891639|NCT01387230|2828273|P3|Overall Study|Lack of Efficacy|4
891640|NCT01387230|2828274|P2|Overall Study|Lack of Efficacy|5
891641|NCT01387230|2828275|P1|Overall Study|Lack of Efficacy|8
891642|NCT01387230|2828273|P3|Overall Study|Adverse Event|3
891643|NCT01387230|2828274|P2|Overall Study|Adverse Event|1
891644|NCT01387230|2828275|P1|Overall Study|Adverse Event|0
891645|NCT01323972|2828300|P4|Overall Study|Lost to Follow-up|1
891646|NCT01323972|2828301|P3|Overall Study|Lost to Follow-up|1
891647|NCT01323972|2828302|P2|Overall Study|Lost to Follow-up|1
891648|NCT01323972|2828303|P1|Overall Study|Lost to Follow-up|0
891649|NCT01323972|2828300|P4|Overall Study|Migrated/moved from study area|0
891650|NCT01323972|2828301|P3|Overall Study|Migrated/moved from study area|0
891651|NCT01323972|2828302|P2|Overall Study|Migrated/moved from study area|2
891652|NCT01323972|2828303|P1|Overall Study|Migrated/moved from study area|1
891653|NCT01323972|2828300|P4|Overall Study|Withdrawal by Subject|0
891654|NCT01323972|2828301|P3|Overall Study|Withdrawal by Subject|1
891655|NCT01323972|2828302|P2|Overall Study|Withdrawal by Subject|0
891656|NCT01323972|2828303|P1|Overall Study|Withdrawal by Subject|1
891657|NCT01251367|2828335|P1|Overall Study|End of Study Visit Performed in Error|1
891658|NCT01251367|2828335|P1|Overall Study|Subject had Personal or Medical Issues|4
891659|NCT01251367|2828335|P1|Overall Study|No Study Drug Available|1
891660|NCT01251367|2828335|P1|Overall Study|Subject Required Alternative Treatment|7
891661|NCT01251367|2828335|P1|Overall Study|Lost to Follow-up|5
891662|NCT01251367|2828335|P1|Overall Study|Withdrawal by Subject|36
891663|NCT01251367|2828335|P1|Overall Study|Adverse Event|19
891664|NCT01251367|2828335|P1|Overall Study|Lack of Efficacy|2
891665|NCT01251367|2828335|P1|Overall Study|Protocol Violation|1
891666|NCT01165177|2828381|P2|Overall Study|Death|1
891667|NCT01165177|2828382|P1|Overall Study|Death|0
891668|NCT01165177|2828381|P2|Overall Study|Personal Reasons|4
891669|NCT01165177|2828382|P1|Overall Study|Personal Reasons|1
891670|NCT01165177|2828381|P2|Overall Study|Physician Decision|1
891671|NCT01165177|2828382|P1|Overall Study|Physician Decision|0
891672|NCT01165177|2828381|P2|Overall Study|Non-serious Adverse Event|20
891673|NCT01165177|2828382|P1|Overall Study|Non-serious Adverse Event|32
891674|NCT01165177|2828381|P2|Overall Study|Migrated/moved from study area|43
891675|NCT01165177|2828382|P1|Overall Study|Migrated/moved from study area|48
891676|NCT01165177|2828381|P2|Overall Study|Subject missed visit|2
891677|NCT01165177|2828382|P1|Overall Study|Subject missed visit|5
891678|NCT01165177|2828381|P2|Overall Study|Previous health issues worsening|11
891679|NCT01165177|2828382|P1|Overall Study|Previous health issues worsening|9
891680|NCT01165177|2828381|P2|Overall Study|Subject non-compliant with procedures|2
891681|NCT01165177|2828382|P1|Overall Study|Subject non-compliant with procedures|12
891682|NCT01165177|2828381|P2|Overall Study|Site closure|5
891683|NCT01165177|2828382|P1|Overall Study|Site closure|7
891684|NCT01165177|2828381|P2|Overall Study|Protocol Violation|22
891685|NCT01165177|2828382|P1|Overall Study|Protocol Violation|19
891686|NCT01165177|2828381|P2|Overall Study|Lost to Follow-up|195
891687|NCT01165177|2828382|P1|Overall Study|Lost to Follow-up|188
891688|NCT01165177|2828381|P2|Overall Study|Serious Adverse Event|240
891689|NCT01165177|2828382|P1|Overall Study|Serious Adverse Event|229
891690|NCT01165177|2828381|P2|Overall Study|Withdrawal by Subject|356
891691|NCT01165177|2828382|P1|Overall Study|Withdrawal by Subject|372
891692|NCT01159912|2828507|P3|Overall Study|Withdrawal by Subject|3
891693|NCT01159912|2828508|P2|Overall Study|Withdrawal by Subject|3
891694|NCT01159912|2828509|P1|Overall Study|Withdrawal by Subject|10
891695|NCT01159912|2828507|P3|Overall Study|Physician Decision|3
891696|NCT01159912|2828508|P2|Overall Study|Physician Decision|0
891697|NCT01159912|2828509|P1|Overall Study|Physician Decision|0
891698|NCT01159912|2828507|P3|Overall Study|Lost to Follow-up|0
891699|NCT01159912|2828508|P2|Overall Study|Lost to Follow-up|0
891700|NCT01159912|2828509|P1|Overall Study|Lost to Follow-up|4
891701|NCT01159912|2828507|P3|Overall Study|Protocol Violation|3
891702|NCT01159912|2828508|P2|Overall Study|Protocol Violation|2
891703|NCT01159912|2828509|P1|Overall Study|Protocol Violation|1
891704|NCT01159912|2828507|P3|Overall Study|Lack of Efficacy|14
891705|NCT01159912|2828508|P2|Overall Study|Lack of Efficacy|15
891706|NCT01159912|2828509|P1|Overall Study|Lack of Efficacy|23
891707|NCT01159912|2828507|P3|Overall Study|Adverse Event|3
891708|NCT01159912|2828508|P2|Overall Study|Adverse Event|2
891709|NCT01159912|2828509|P1|Overall Study|Adverse Event|2
891710|NCT01072149|2828532|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891711|NCT01072149|2828533|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891712|NCT01072149|2828534|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891713|NCT01072149|2828535|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891714|NCT01072149|2828536|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
891715|NCT01072149|2828537|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891716|NCT01072149|2828538|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891717|NCT01072149|2828539|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891718|NCT01072149|2828540|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
771522|NCT00568334|2454001|P2|Overall Study|Lost to Follow-up|0
771523|NCT00568334|2454002|P1|Overall Study|Lost to Follow-up|1
771524|NCT00568334|2454001|P2|Overall Study|Withdrawal by Subject|1
771525|NCT00568334|2454002|P1|Overall Study|Withdrawal by Subject|0
771526|NCT00568399|2454035|P1|Overall Study|Withdrawal by Subject|8
771527|NCT00568399|2454035|P1|Overall Study|Adverse Event|5
771528|NCT00568399|2454035|P1|Overall Study|Death|2
771529|NCT00568451|2454043|P4|Overall Study|Disease Progression|7
771530|NCT00568451|2454044|P3|Overall Study|Disease Progression|2
771531|NCT00568451|2454045|P2|Overall Study|Disease Progression|0
771532|NCT00568451|2454046|P1|Overall Study|Disease Progression|0
771533|NCT00568555|2454064|P2|Overall Study|Withdrawal by Subject|1
771534|NCT00568555|2454065|P1|Overall Study|Withdrawal by Subject|1
771535|NCT00568685|2454082|P3|Overall Study|Protocol Violation|0
771536|NCT00568685|2454083|P2|Overall Study|Protocol Violation|0
771537|NCT00568685|2454084|P1|Overall Study|Protocol Violation|1
771538|NCT00568685|2454082|P3|Overall Study|Withdrawal by Subject|2
771539|NCT00568685|2454083|P2|Overall Study|Withdrawal by Subject|2
771540|NCT00568685|2454084|P1|Overall Study|Withdrawal by Subject|7
771541|NCT00568685|2454082|P3|Overall Study|Adverse Event|3
771542|NCT00568685|2454083|P2|Overall Study|Adverse Event|3
771543|NCT00568685|2454084|P1|Overall Study|Adverse Event|2
771544|NCT00568776|2454120|P4|Overall Study|Miscellaeneous|4
771545|NCT00568776|2454121|P3|Overall Study|Miscellaeneous|1
771546|NCT00568776|2454122|P2|Overall Study|Miscellaeneous|3
771547|NCT00568776|2454123|P1|Overall Study|Miscellaeneous|3
771548|NCT00568776|2454120|P4|Overall Study|Sponsor Decision|42
771549|NCT00568776|2454121|P3|Overall Study|Sponsor Decision|41
771550|NCT00568776|2454122|P2|Overall Study|Sponsor Decision|2
771551|NCT00568776|2454123|P1|Overall Study|Sponsor Decision|2
771552|NCT00568776|2454120|P4|Overall Study|Loss of Caregiver|2
771553|NCT00568776|2454121|P3|Overall Study|Loss of Caregiver|1
771554|NCT00568776|2454122|P2|Overall Study|Loss of Caregiver|2
771555|NCT00568776|2454123|P1|Overall Study|Loss of Caregiver|0
771556|NCT00568776|2454120|P4|Overall Study|Withdrawal by Subject|7
771557|NCT00568776|2454121|P3|Overall Study|Withdrawal by Subject|13
771558|NCT00568776|2454122|P2|Overall Study|Withdrawal by Subject|15
771559|NCT00568776|2454123|P1|Overall Study|Withdrawal by Subject|13
771560|NCT00568776|2454120|P4|Overall Study|Protocol Violation|1
771561|NCT00568776|2454121|P3|Overall Study|Protocol Violation|1
771562|NCT00568776|2454122|P2|Overall Study|Protocol Violation|0
771563|NCT00568776|2454123|P1|Overall Study|Protocol Violation|1
771564|NCT00568776|2454120|P4|Overall Study|Lost to Follow-up|1
771565|NCT00568776|2454121|P3|Overall Study|Lost to Follow-up|1
771566|NCT00568776|2454122|P2|Overall Study|Lost to Follow-up|1
771567|NCT00568776|2454123|P1|Overall Study|Lost to Follow-up|1
771568|NCT00568776|2454120|P4|Overall Study|Lack of Efficacy|4
771569|NCT00568776|2454121|P3|Overall Study|Lack of Efficacy|2
891719|NCT01072149|2828541|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891720|NCT01072149|2828542|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
771570|NCT00568776|2454122|P2|Overall Study|Lack of Efficacy|2
771571|NCT00568776|2454123|P1|Overall Study|Lack of Efficacy|2
771572|NCT00568776|2454120|P4|Overall Study|Physician Decision|0
771573|NCT00568776|2454121|P3|Overall Study|Physician Decision|0
771574|NCT00568776|2454122|P2|Overall Study|Physician Decision|2
771575|NCT00568776|2454123|P1|Overall Study|Physician Decision|0
771576|NCT00568776|2454120|P4|Overall Study|Death|3
771577|NCT00568776|2454121|P3|Overall Study|Death|4
771578|NCT00568776|2454122|P2|Overall Study|Death|1
771579|NCT00568776|2454123|P1|Overall Study|Death|0
771580|NCT00568776|2454120|P4|Overall Study|Adverse Event|8
771581|NCT00568776|2454121|P3|Overall Study|Adverse Event|10
771582|NCT00568776|2454122|P2|Overall Study|Adverse Event|8
771583|NCT00568776|2454123|P1|Overall Study|Adverse Event|8
771584|NCT00568958|2454170|P2|Follow-Up|Family Emergency|0
771585|NCT00568958|2454171|P1|Follow-Up|Family Emergency|1
771586|NCT00568958|2454170|P2|Follow-Up|Physician Decision|1
771587|NCT00568958|2454171|P1|Follow-Up|Physician Decision|1
771588|NCT00568958|2454170|P2|Follow-Up|Withdrawal by Subject|3
771589|NCT00568958|2454171|P1|Follow-Up|Withdrawal by Subject|6
771590|NCT00568958|2454170|P2|Allocation|Physician Decision|0
771591|NCT00568958|2454171|P1|Allocation|Physician Decision|2
771592|NCT00568958|2454170|P2|Allocation|Withdrawal by Subject|3
771593|NCT00568958|2454171|P1|Allocation|Withdrawal by Subject|7
771594|NCT00569127|2454208|P2|Overall Study|Still on Treatment|3
771595|NCT00569127|2454209|P1|Overall Study|Still on Treatment|7
771596|NCT00569127|2454208|P2|Overall Study|Not Eligible|11
771597|NCT00569127|2454209|P1|Overall Study|Not Eligible|14
771598|NCT00569127|2454208|P2|Overall Study|Lost to Follow-up|3
771599|NCT00569127|2454209|P1|Overall Study|Lost to Follow-up|0
771600|NCT00569127|2454208|P2|Overall Study|Not Specified|19
771601|NCT00569127|2454209|P1|Overall Study|Not Specified|20
771602|NCT00569127|2454208|P2|Overall Study|Death|3
771603|NCT00569127|2454209|P1|Overall Study|Death|4
771604|NCT00569127|2454208|P2|Overall Study|Progression|100
771605|NCT00569127|2454209|P1|Overall Study|Progression|99
771606|NCT00569127|2454208|P2|Overall Study|Withdrawal by Subject|27
771607|NCT00569127|2454209|P1|Overall Study|Withdrawal by Subject|13
771608|NCT00569127|2454208|P2|Overall Study|Adverse Event|47
771609|NCT00569127|2454209|P1|Overall Study|Adverse Event|57
771610|NCT00569166|2454228|P3|Overall Study|Lost to Follow-up|1
771611|NCT00569166|2454229|P2|Overall Study|Lost to Follow-up|1
771612|NCT00569166|2454230|P1|Overall Study|Lost to Follow-up|2
771613|NCT00569166|2454228|P3|Overall Study|Withdrawal by Subject|3
771614|NCT00569166|2454229|P2|Overall Study|Withdrawal by Subject|5
771615|NCT00569166|2454230|P1|Overall Study|Withdrawal by Subject|7
771616|NCT00569231|2454290|P1|Overall Study|Non-compliance|2
771617|NCT00569231|2454290|P1|Overall Study|Car accident injury|1
771618|NCT00569231|2454290|P1|Overall Study|Withdrawal by Subject|1
771619|NCT00569231|2454290|P1|Overall Study|Airfare expense|2
771620|NCT00569231|2454290|P1|Overall Study|Study unrelated surgery|1
771621|NCT00569270|2454297|P2|Period: First Intervention|Protocol Violation|1
771622|NCT00569270|2454298|P1|Period: First Intervention|Protocol Violation|0
771623|NCT00569374|2454333|P1|Overall Study|Withdrawal by Subject|4
771624|NCT00569582|2454354|P1|Overall Study|Subject was non-compliant.|1
771625|NCT00569582|2454354|P1|Overall Study|Subject was too ill to travel.|1
771626|NCT00569582|2454354|P1|Overall Study|Adverse Event|7
771627|NCT00569582|2454354|P1|Overall Study|Death|2
771628|NCT00569582|2454354|P1|Overall Study|Withdrawal by Subject|5
771629|NCT00569777|2454369|P2|Overall Study|pregnant|0
771630|NCT00569777|2454370|P1|Overall Study|pregnant|1
771631|NCT00569777|2454369|P2|Overall Study|did not meet exclusion criteria|2
771632|NCT00569777|2454370|P1|Overall Study|did not meet exclusion criteria|1
771633|NCT00569777|2454369|P2|Overall Study|scheduled eye surgery|1
771634|NCT00569777|2454370|P1|Overall Study|scheduled eye surgery|0
771635|NCT00569777|2454369|P2|Overall Study|Lost to Follow-up|0
771636|NCT00569777|2454370|P1|Overall Study|Lost to Follow-up|1
771637|NCT00569777|2454369|P2|Overall Study|Adverse Event|0
771638|NCT00569777|2454370|P1|Overall Study|Adverse Event|3
771639|NCT00569777|2454369|P2|Overall Study|Withdrawal by Subject|0
771640|NCT00569777|2454370|P1|Overall Study|Withdrawal by Subject|4
771641|NCT00569803|2454420|P8|Overall Study|Withdrawal by Subject|1
771642|NCT00569803|2454421|P7|Overall Study|Withdrawal by Subject|0
771643|NCT00569803|2454422|P6|Overall Study|Withdrawal by Subject|0
771644|NCT00569803|2454423|P5|Overall Study|Withdrawal by Subject|0
771645|NCT00569803|2454424|P4|Overall Study|Withdrawal by Subject|0
771646|NCT00569803|2454425|P3|Overall Study|Withdrawal by Subject|0
771647|NCT00569803|2454426|P2|Overall Study|Withdrawal by Subject|0
771648|NCT00569803|2454427|P1|Overall Study|Withdrawal by Subject|0
771649|NCT00569803|2454420|P8|Overall Study|injection syringe leaked during dosing|0
771650|NCT00569803|2454421|P7|Overall Study|injection syringe leaked during dosing|0
771651|NCT00569803|2454422|P6|Overall Study|injection syringe leaked during dosing|0
771652|NCT00569803|2454423|P5|Overall Study|injection syringe leaked during dosing|0
771653|NCT00569803|2454424|P4|Overall Study|injection syringe leaked during dosing|1
771654|NCT00569803|2454425|P3|Overall Study|injection syringe leaked during dosing|0
771655|NCT00569803|2454426|P2|Overall Study|injection syringe leaked during dosing|0
771656|NCT00569803|2454427|P1|Overall Study|injection syringe leaked during dosing|0
771657|NCT00569803|2454420|P8|Overall Study|Lost to Follow-up|0
771658|NCT00569803|2454421|P7|Overall Study|Lost to Follow-up|0
771659|NCT00569803|2454422|P6|Overall Study|Lost to Follow-up|0
771660|NCT00569803|2454423|P5|Overall Study|Lost to Follow-up|0
771661|NCT00569803|2454424|P4|Overall Study|Lost to Follow-up|0
771662|NCT00569803|2454425|P3|Overall Study|Lost to Follow-up|0
771663|NCT00569803|2454426|P2|Overall Study|Lost to Follow-up|0
771664|NCT00569803|2454427|P1|Overall Study|Lost to Follow-up|1
771665|NCT00569946|2454560|P1|Overall Study|Global Deterioration of Health Status|1
771666|NCT00569946|2454560|P1|Overall Study|Objective Progression or Relapse|42
771667|NCT00569946|2454560|P1|Overall Study|Adverse Event|16
771668|NCT00570037|2454578|P2|Overall Study|Could not reach for 6-8 week contact|69
771669|NCT00570037|2454579|P1|Overall Study|Could not reach for 6-8 week contact|44
771670|NCT00570141|2454598|P1|Overall Study|Lost to Follow-up|1
771671|NCT00570141|2454598|P1|Overall Study|Missed visits|1
771672|NCT00570141|2454598|P1|Overall Study|Adverse Event|1
771673|NCT00561340|2454605|P2|Overall Study|refused to drink pediasure|0
771674|NCT00561340|2454606|P1|Overall Study|refused to drink pediasure|6
771675|NCT00561353|2454624|P10|Overall Study|Withdrawal by Subject|0
771676|NCT00561353|2454625|P9|Overall Study|Withdrawal by Subject|0
771677|NCT00561353|2454626|P8|Overall Study|Withdrawal by Subject|0
771678|NCT00561353|2454627|P7|Overall Study|Withdrawal by Subject|0
771679|NCT00561353|2454628|P6|Overall Study|Withdrawal by Subject|0
771680|NCT00561353|2454629|P5|Overall Study|Withdrawal by Subject|0
771681|NCT00561353|2454630|P4|Overall Study|Withdrawal by Subject|0
771682|NCT00561353|2454631|P3|Overall Study|Withdrawal by Subject|0
771683|NCT00561353|2454632|P2|Overall Study|Withdrawal by Subject|2
771684|NCT00561353|2454633|P1|Overall Study|Withdrawal by Subject|0
771685|NCT00561353|2454624|P10|Overall Study|Lost to Follow-up|0
771686|NCT00561353|2454625|P9|Overall Study|Lost to Follow-up|0
771687|NCT00561353|2454626|P8|Overall Study|Lost to Follow-up|0
771688|NCT00561353|2454627|P7|Overall Study|Lost to Follow-up|0
771689|NCT00561353|2454628|P6|Overall Study|Lost to Follow-up|0
771690|NCT00561353|2454629|P5|Overall Study|Lost to Follow-up|0
771691|NCT00561353|2454630|P4|Overall Study|Lost to Follow-up|0
771692|NCT00561353|2454631|P3|Overall Study|Lost to Follow-up|1
771693|NCT00561353|2454632|P2|Overall Study|Lost to Follow-up|0
771694|NCT00561353|2454633|P1|Overall Study|Lost to Follow-up|2
771695|NCT00561353|2454624|P10|Overall Study|Adverse Event|1
771696|NCT00561353|2454625|P9|Overall Study|Adverse Event|0
771697|NCT00561353|2454626|P8|Overall Study|Adverse Event|0
771698|NCT00561353|2454627|P7|Overall Study|Adverse Event|1
771699|NCT00561353|2454628|P6|Overall Study|Adverse Event|0
771700|NCT00561353|2454629|P5|Overall Study|Adverse Event|0
771701|NCT00561353|2454630|P4|Overall Study|Adverse Event|2
771702|NCT00561353|2454631|P3|Overall Study|Adverse Event|0
771703|NCT00561353|2454632|P2|Overall Study|Adverse Event|0
771704|NCT00561353|2454633|P1|Overall Study|Adverse Event|0
771705|NCT00561353|2454624|P10|Overall Study|Not specified|0
771706|NCT00561353|2454625|P9|Overall Study|Not specified|0
771707|NCT00561353|2454626|P8|Overall Study|Not specified|0
771708|NCT00561353|2454627|P7|Overall Study|Not specified|0
771709|NCT00561353|2454628|P6|Overall Study|Not specified|2
771710|NCT00561353|2454629|P5|Overall Study|Not specified|0
771711|NCT00561353|2454630|P4|Overall Study|Not specified|0
771712|NCT00561353|2454631|P3|Overall Study|Not specified|1
771713|NCT00561353|2454632|P2|Overall Study|Not specified|0
771714|NCT00561353|2454633|P1|Overall Study|Not specified|1
771715|NCT00561353|2454624|P10|Overall Study|Subject ineligible to continue the trial|1
771716|NCT00561353|2454625|P9|Overall Study|Subject ineligible to continue the trial|2
771717|NCT00561353|2454626|P8|Overall Study|Subject ineligible to continue the trial|0
771718|NCT00561353|2454627|P7|Overall Study|Subject ineligible to continue the trial|1
771719|NCT00561353|2454628|P6|Overall Study|Subject ineligible to continue the trial|1
771720|NCT00561353|2454629|P5|Overall Study|Subject ineligible to continue the trial|0
771721|NCT00561353|2454630|P4|Overall Study|Subject ineligible to continue the trial|0
771722|NCT00561353|2454631|P3|Overall Study|Subject ineligible to continue the trial|0
771723|NCT00561353|2454632|P2|Overall Study|Subject ineligible to continue the trial|0
771724|NCT00561353|2454633|P1|Overall Study|Subject ineligible to continue the trial|0
771725|NCT00561353|2454624|P10|Overall Study|Subject reached a virologic endpoint|0
771726|NCT00561353|2454625|P9|Overall Study|Subject reached a virologic endpoint|5
771727|NCT00561353|2454626|P8|Overall Study|Subject reached a virologic endpoint|4
771728|NCT00561353|2454627|P7|Overall Study|Subject reached a virologic endpoint|4
771729|NCT00561353|2454628|P6|Overall Study|Subject reached a virologic endpoint|3
771730|NCT00561353|2454629|P5|Overall Study|Subject reached a virologic endpoint|1
771731|NCT00561353|2454630|P4|Overall Study|Subject reached a virologic endpoint|4
771732|NCT00561353|2454631|P3|Overall Study|Subject reached a virologic endpoint|1
771733|NCT00561353|2454632|P2|Overall Study|Subject reached a virologic endpoint|1
771734|NCT00561353|2454633|P1|Overall Study|Subject reached a virologic endpoint|2
771735|NCT00561392|2454786|P1|Overall Study|Administrative problems|4
771736|NCT00561392|2454786|P1|Overall Study|Withdrawal by Subject|8
771737|NCT00561392|2454786|P1|Overall Study|Protocol Violation|1
771738|NCT00561392|2454786|P1|Overall Study|Lack of Efficacy|2
771739|NCT00561392|2454786|P1|Overall Study|Adverse Event|38
771740|NCT00561470|2454822|P2|Overall Study|Ongoing Treatment|14
771741|NCT00561470|2454823|P1|Overall Study|Ongoing Treatment|11
771742|NCT00561470|2454822|P2|Overall Study|Planning surgery|1
771743|NCT00561470|2454823|P1|Overall Study|Planning surgery|1
771744|NCT00561470|2454822|P2|Overall Study|Missed visit window|4
771745|NCT00561470|2454823|P1|Overall Study|Missed visit window|1
771746|NCT00561470|2454822|P2|Overall Study|Randomized but not treated|5
771747|NCT00561470|2454823|P1|Overall Study|Randomized but not treated|5
771748|NCT00561470|2454822|P2|Overall Study|Unauthorized procedure|1
771749|NCT00561470|2454823|P1|Overall Study|Unauthorized procedure|3
771750|NCT00561470|2454822|P2|Overall Study|Metastatic surgery|12
771751|NCT00561470|2454823|P1|Overall Study|Metastatic surgery|10
771752|NCT00561470|2454822|P2|Overall Study|Subject request|77
771753|NCT00561470|2454823|P1|Overall Study|Subject request|43
771754|NCT00561470|2454822|P2|Overall Study|Consent Withdrawn|6
771755|NCT00561470|2454823|P1|Overall Study|Consent Withdrawn|2
771756|NCT00561470|2454822|P2|Overall Study|Physician Decision|20
771757|NCT00561470|2454823|P1|Overall Study|Physician Decision|21
771758|NCT00561470|2454822|P2|Overall Study|Lost to Follow-up|0
771759|NCT00561470|2454823|P1|Overall Study|Lost to Follow-up|2
771760|NCT00561470|2454822|P2|Overall Study|poor compliance to protocol|4
771761|NCT00561470|2454823|P1|Overall Study|poor compliance to protocol|4
771762|NCT00561470|2454822|P2|Overall Study|Disease progression|305
771763|NCT00561470|2454823|P1|Overall Study|Disease progression|437
771764|NCT00561470|2454822|P2|Overall Study|Adverse Event|163
771765|NCT00561470|2454823|P1|Overall Study|Adverse Event|74
771766|NCT00561574|2454839|P2|Overall Study|Unspecified|7
771767|NCT00561574|2454840|P1|Overall Study|Unspecified|5
771768|NCT00561574|2454839|P2|Overall Study|Lost to Follow-up|0
771769|NCT00561574|2454840|P1|Overall Study|Lost to Follow-up|1
771770|NCT00561574|2454839|P2|Overall Study|Reason Unrelated to Trial|2
771771|NCT00561574|2454840|P1|Overall Study|Reason Unrelated to Trial|6
771772|NCT00561574|2454839|P2|Overall Study|Withdrawal by Subject|4
771773|NCT00561574|2454840|P1|Overall Study|Withdrawal by Subject|4
771774|NCT00561574|2454839|P2|Overall Study|Lack of Efficacy|21
771775|NCT00561574|2454840|P1|Overall Study|Lack of Efficacy|11
771776|NCT00561574|2454839|P2|Overall Study|Adverse Event|24
771777|NCT00561574|2454840|P1|Overall Study|Adverse Event|21
771778|NCT00561652|2454929|P2|Overall Study|Withdrawal by Subject|1
771779|NCT00561652|2454930|P1|Overall Study|Withdrawal by Subject|0
771780|NCT00561678|2454950|P2|Overall Study|anesthesia provider refusal|0
771781|NCT00561678|2454951|P1|Overall Study|anesthesia provider refusal|1
771782|NCT00561678|2454950|P2|Overall Study|surgery rescheduled to different site|2
771783|NCT00561678|2454951|P1|Overall Study|surgery rescheduled to different site|2
771784|NCT00561678|2454950|P2|Overall Study|surgery cancelled|1
771785|NCT00561678|2454951|P1|Overall Study|surgery cancelled|1
771786|NCT00561678|2454950|P2|Overall Study|Withdrawal by Subject|3
771787|NCT00561678|2454951|P1|Overall Study|Withdrawal by Subject|4
771788|NCT00561730|2454967|P1|Overall Study|Not specified reasons|1
771789|NCT00561730|2454967|P1|Overall Study|Lost to Follow-up|5
771790|NCT00561730|2454967|P1|Overall Study|Handling of the drug|1
771791|NCT00561730|2454967|P1|Overall Study|Adverse Event|2
771792|NCT00561795|2454983|P4|Overall Study|Physician Decision|0
771793|NCT00561795|2454984|P3|Overall Study|Physician Decision|0
771794|NCT00561795|2454985|P2|Overall Study|Physician Decision|0
771795|NCT00561795|2454986|P1|Overall Study|Physician Decision|1
771796|NCT00561795|2454983|P4|Overall Study|Study Closed/Terminated|0
771797|NCT00561795|2454984|P3|Overall Study|Study Closed/Terminated|0
771798|NCT00561795|2454985|P2|Overall Study|Study Closed/Terminated|3
771799|NCT00561795|2454986|P1|Overall Study|Study Closed/Terminated|0
771800|NCT00561795|2454983|P4|Overall Study|Adverse Event|0
771801|NCT00561795|2454984|P3|Overall Study|Adverse Event|0
771802|NCT00561795|2454985|P2|Overall Study|Adverse Event|3
771803|NCT00561795|2454986|P1|Overall Study|Adverse Event|3
771804|NCT00561821|2455010|P4|Overall Study|Adverse Event|1
771805|NCT00561821|2455011|P3|Overall Study|Adverse Event|1
771806|NCT00561821|2455012|P2|Overall Study|Adverse Event|3
771807|NCT00561821|2455013|P1|Overall Study|Adverse Event|2
771808|NCT00561821|2455010|P4|Overall Study|Other (reason not specified)|0
771809|NCT00561821|2455011|P3|Overall Study|Other (reason not specified)|0
771810|NCT00561821|2455012|P2|Overall Study|Other (reason not specified)|1
771811|NCT00561821|2455013|P1|Overall Study|Other (reason not specified)|1
771812|NCT00561821|2455010|P4|Overall Study|Reasons not related to trial|0
771813|NCT00561821|2455011|P3|Overall Study|Reasons not related to trial|0
771814|NCT00561821|2455012|P2|Overall Study|Reasons not related to trial|1
771815|NCT00561821|2455013|P1|Overall Study|Reasons not related to trial|2
771816|NCT00561821|2455010|P4|Overall Study|Withdrawal by Subject|2
771817|NCT00561821|2455011|P3|Overall Study|Withdrawal by Subject|0
771818|NCT00561821|2455012|P2|Overall Study|Withdrawal by Subject|1
771819|NCT00561821|2455013|P1|Overall Study|Withdrawal by Subject|0
771820|NCT00561821|2455010|P4|Overall Study|Not treated|0
771821|NCT00561821|2455011|P3|Overall Study|Not treated|1
771822|NCT00561821|2455012|P2|Overall Study|Not treated|0
771823|NCT00561821|2455013|P1|Overall Study|Not treated|0
771824|NCT00570232|2455087|P1|Overall Study|discontinued due to noncompliance|2
771825|NCT00570232|2455087|P1|Overall Study|discontinued due to recurrence|8
771826|NCT00570232|2455087|P1|Overall Study|discontinued due to medical condition|3
771827|NCT00570232|2455087|P1|Overall Study|Adverse Event|10
771828|NCT00570310|2455095|P2|Overall Study|Lack of Efficacy|4
771829|NCT00570310|2455096|P1|Overall Study|Lack of Efficacy|1
771830|NCT00570310|2455095|P2|Overall Study|Adverse Event|2
771831|NCT00570310|2455096|P1|Overall Study|Adverse Event|1
771832|NCT00570401|2455132|P1|Overall Study|Adverse Event|2
771833|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
771834|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
771835|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
771836|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
771837|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
771838|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
771839|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Physician Decision|4
771840|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Physician Decision|2
771841|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Physician Decision|0
771842|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Adverse Event|5
771843|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Adverse Event|5
771844|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Adverse Event|0
771845|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
771846|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
771847|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
771848|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Protocol Violation|15
771849|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Protocol Violation|12
771850|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Protocol Violation|0
771851|NCT00570492|2455138|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
771852|NCT00570492|2455139|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
771853|NCT00570492|2455140|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
771854|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
771855|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
771856|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
771857|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Adverse Event|0
771858|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Adverse Event|0
771859|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Adverse Event|1
771860|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
771861|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
771862|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
771863|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Protocol Violation|0
771864|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Protocol Violation|0
771865|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Protocol Violation|15
771866|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
771867|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
771868|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
771869|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
771870|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
771871|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
771872|NCT00570492|2455138|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
771873|NCT00570492|2455139|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
771874|NCT00570492|2455140|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
771875|NCT00570505|2455178|P1|Overall Study|Other loss to follow-up|4
771876|NCT00570505|2455178|P1|Overall Study|Lost to Follow-up|23
771877|NCT00570505|2455178|P1|Overall Study|Withdrawal by Subject|7
771878|NCT00570505|2455178|P1|Overall Study|Adverse Event|7
771879|NCT00571103|2455189|P1|Overall Study|Lost to Follow-up|1
771880|NCT00571103|2455189|P1|Overall Study|Withdrawal by Subject|1
771881|NCT00571649|2455248|P2|Follow-up Period|Protocol Violation|12
771882|NCT00571649|2455249|P1|Follow-up Period|Protocol Violation|5
771883|NCT00571649|2455248|P2|Follow-up Period|Patient convenience|121
771884|NCT00571649|2455249|P1|Follow-up Period|Patient convenience|136
771885|NCT00571649|2455248|P2|Follow-up Period|Lost to Follow-up|92
771886|NCT00571649|2455249|P1|Follow-up Period|Lost to Follow-up|95
771887|NCT00571649|2455248|P2|Follow-up Period|Physician Decision|13
771888|NCT00571649|2455249|P1|Follow-up Period|Physician Decision|7
771889|NCT00571649|2455248|P2|Follow-up Period|Death|133
771890|NCT00571649|2455249|P1|Follow-up Period|Death|132
771891|NCT00571649|2455248|P2|Follow-up Period|Withdrawal by Subject|115
771892|NCT00571649|2455249|P1|Follow-up Period|Withdrawal by Subject|119
771893|NCT00571649|2455248|P2|Follow-up Period|Clinical endpoint reached|2
771894|NCT00571649|2455249|P1|Follow-up Period|Clinical endpoint reached|5
771895|NCT00571649|2455248|P2|Follow-up Period|Adverse Event|40
771896|NCT00571649|2455249|P1|Follow-up Period|Adverse Event|46
771897|NCT00571649|2455248|P2|Treatment Period|Technical problems|5
771898|NCT00571649|2455249|P1|Treatment Period|Technical problems|3
771899|NCT00571649|2455248|P2|Treatment Period|Protocol Violation|92
771900|NCT00571649|2455249|P1|Treatment Period|Protocol Violation|90
771901|NCT00571649|2455248|P2|Treatment Period|Patient convenience|13
771902|NCT00571649|2455249|P1|Treatment Period|Patient convenience|11
771903|NCT00571649|2455248|P2|Treatment Period|Non-compliant with study medication|89
771904|NCT00571649|2455249|P1|Treatment Period|Non-compliant with study medication|88
771905|NCT00571649|2455248|P2|Treatment Period|Lost to Follow-up|41
771906|NCT00571649|2455249|P1|Treatment Period|Lost to Follow-up|43
771907|NCT00571649|2455248|P2|Treatment Period|Physician Decision|9
771908|NCT00571649|2455249|P1|Treatment Period|Physician Decision|8
771909|NCT00571649|2455248|P2|Treatment Period|Death|59
771910|NCT00571649|2455249|P1|Treatment Period|Death|76
771911|NCT00571649|2455248|P2|Treatment Period|Withdrawal by Subject|255
771912|NCT00571649|2455249|P1|Treatment Period|Withdrawal by Subject|285
771913|NCT00571649|2455248|P2|Treatment Period|Clinical endpoint reached|56
771914|NCT00571649|2455249|P1|Treatment Period|Clinical endpoint reached|50
771915|NCT00571649|2455248|P2|Treatment Period|Adverse Event|385
771916|NCT00571649|2455249|P1|Treatment Period|Adverse Event|438
771917|NCT00571662|2455281|P1|Overall Study|Adverse Event|5
771918|NCT00571662|2455281|P1|Overall Study|psychiatric instability|1
771919|NCT00571662|2455281|P1|Overall Study|Withdrawal by Subject|2
771920|NCT00571688|2455289|P2|Overall Study|subject moved out of the area|0
771921|NCT00571688|2455290|P1|Overall Study|subject moved out of the area|1
771922|NCT00571688|2455289|P2|Overall Study|subject did not tolerate Consta|0
771923|NCT00571688|2455290|P1|Overall Study|subject did not tolerate Consta|1
771924|NCT00571688|2455289|P2|Overall Study|Lost to Follow-up|6
771925|NCT00571688|2455290|P1|Overall Study|Lost to Follow-up|3
771926|NCT00571701|2455298|P2|Second Intervention 12 Months|Withdrawal by Subject|0
771927|NCT00571701|2455299|P1|Second Intervention 12 Months|Withdrawal by Subject|3
771928|NCT00571701|2455298|P2|Second Intervention 12 Months|Adverse Event|1
771929|NCT00571701|2455299|P1|Second Intervention 12 Months|Adverse Event|0
771930|NCT00571701|2455298|P2|First Intervention 12 Months|Death|0
771931|NCT00571701|2455299|P1|First Intervention 12 Months|Death|1
771932|NCT00571701|2455298|P2|First Intervention 12 Months|Withdrawal by Subject|1
771933|NCT00571701|2455299|P1|First Intervention 12 Months|Withdrawal by Subject|2
771934|NCT00571922|2455325|P2|Overall Study|Completion unknown|36
771935|NCT00571922|2455326|P1|Overall Study|Completion unknown|36
771936|NCT00571948|2455336|P2|Overall Study|Parent were afraid of blood colection|5
771937|NCT00571948|2455337|P1|Overall Study|Parent were afraid of blood colection|2
771938|NCT00571948|2455336|P2|Overall Study|infant refused study meal|4
771939|NCT00571948|2455337|P1|Overall Study|infant refused study meal|3
771940|NCT00571948|2455336|P2|Overall Study|Protocol Violation|3
771941|NCT00571948|2455337|P1|Overall Study|Protocol Violation|3
771942|NCT00571948|2455336|P2|Overall Study|Withdrawal by Subject|2
771943|NCT00571948|2455337|P1|Overall Study|Withdrawal by Subject|1
771944|NCT00571948|2455336|P2|Overall Study|Lost to Follow-up|0
771945|NCT00571948|2455337|P1|Overall Study|Lost to Follow-up|2
771946|NCT00572039|2455363|P2|Overall Study|Ill|1
771947|NCT00572039|2455364|P1|Overall Study|Ill|5
771948|NCT00572039|2455363|P2|Overall Study|Death|3
771949|NCT00572039|2455364|P1|Overall Study|Death|2
771950|NCT00572039|2455363|P2|Overall Study|Withdrawal by Subject|6
771951|NCT00572039|2455364|P1|Overall Study|Withdrawal by Subject|9
771952|NCT00572156|2455391|P4|Overall Study|Sponsor Decision|19
771953|NCT00572156|2455392|P3|Overall Study|Sponsor Decision|17
771954|NCT00572156|2455393|P2|Overall Study|Sponsor Decision|16
771955|NCT00572156|2455394|P1|Overall Study|Sponsor Decision|20
771956|NCT00572156|2455391|P4|Overall Study|Patient/Parent Decision|3
771957|NCT00572156|2455392|P3|Overall Study|Patient/Parent Decision|4
771958|NCT00572156|2455393|P2|Overall Study|Patient/Parent Decision|6
771959|NCT00572156|2455394|P1|Overall Study|Patient/Parent Decision|1
771960|NCT00572156|2455391|P4|Overall Study|Protocol Violation|2
771961|NCT00572156|2455392|P3|Overall Study|Protocol Violation|0
771962|NCT00572156|2455393|P2|Overall Study|Protocol Violation|2
771963|NCT00572156|2455394|P1|Overall Study|Protocol Violation|1
771964|NCT00572156|2455391|P4|Overall Study|Lost to Follow-up|0
771965|NCT00572156|2455392|P3|Overall Study|Lost to Follow-up|1
771966|NCT00572156|2455393|P2|Overall Study|Lost to Follow-up|1
771967|NCT00572156|2455394|P1|Overall Study|Lost to Follow-up|1
771968|NCT00572156|2455391|P4|Overall Study|Adverse Event|1
771969|NCT00572156|2455392|P3|Overall Study|Adverse Event|5
771970|NCT00572156|2455393|P2|Overall Study|Adverse Event|1
771971|NCT00572156|2455394|P1|Overall Study|Adverse Event|3
771980|NCT00572572|2455492|P2|Overall Study|Withdrawal by Subject|6
771981|NCT00572572|2455493|P1|Overall Study|Withdrawal by Subject|3
771982|NCT00572624|2455511|P2|Overall Study|Health issues unrelated to the study|0
771983|NCT00572624|2455512|P1|Overall Study|Health issues unrelated to the study|1
771984|NCT00572624|2455511|P2|Overall Study|Problem with vascular access|0
771985|NCT00572624|2455512|P1|Overall Study|Problem with vascular access|1
771986|NCT00572624|2455511|P2|Overall Study|Refused to do the stress test|0
771987|NCT00572624|2455512|P1|Overall Study|Refused to do the stress test|1
771988|NCT00572624|2455511|P2|Overall Study|Admitted to being a smoker|0
771989|NCT00572624|2455512|P1|Overall Study|Admitted to being a smoker|1
771990|NCT00572624|2455511|P2|Overall Study|Started a new job-- no time for study|0
771991|NCT00572624|2455512|P1|Overall Study|Started a new job-- no time for study|1
771992|NCT00572624|2455511|P2|Overall Study|Medication change|0
771993|NCT00572624|2455512|P1|Overall Study|Medication change|1
771994|NCT00572624|2455511|P2|Overall Study|Wanted to do a different diet program|0
771995|NCT00572624|2455512|P1|Overall Study|Wanted to do a different diet program|1
771996|NCT00572624|2455511|P2|Overall Study|Lost to Follow-up|4
771997|NCT00572624|2455512|P1|Overall Study|Lost to Follow-up|10
771998|NCT00572728|2455538|P1|Overall Study|Pathology missing|1
771999|NCT00572728|2455538|P1|Overall Study|FLT2 after second chemotherapy initiated|7
772000|NCT00572728|2455538|P1|Overall Study|Second chemotherapy not initiated|1
772001|NCT00572728|2455538|P1|Overall Study|FLT2 not completed|5
772002|NCT00572728|2455538|P1|Overall Study|First Chemotherapy not initiated|2
772003|NCT00572728|2455538|P1|Overall Study|FLT1 not completed|4
772004|NCT00572728|2455538|P1|Overall Study|Offstudy due to complicating disease|1
772005|NCT00572728|2455538|P1|Overall Study|Enrolled under Amendment 4|5
772006|NCT00572728|2455538|P1|Overall Study|Ineligible|3
772007|NCT00572728|2455538|P1|Overall Study|Withdrawal by Subject|10
772008|NCT00572832|2455552|P2|Overall Study|Pregnancy|1
772009|NCT00572832|2455553|P1|Overall Study|Pregnancy|0
772010|NCT00572832|2455552|P2|Overall Study|Lost to Follow-up|11
772011|NCT00572832|2455553|P1|Overall Study|Lost to Follow-up|0
772012|NCT00572910|2455584|P11|Overall Study|Withdrawal by Subject|1
772013|NCT00572910|2455585|P10|Overall Study|Withdrawal by Subject|2
772014|NCT00572910|2455586|P9|Overall Study|Withdrawal by Subject|2
772015|NCT00572910|2455587|P8|Overall Study|Withdrawal by Subject|2
772016|NCT00572910|2455588|P7|Overall Study|Withdrawal by Subject|0
772017|NCT00572910|2455589|P6|Overall Study|Withdrawal by Subject|3
772018|NCT00572910|2455590|P5|Overall Study|Withdrawal by Subject|1
772019|NCT00572910|2455591|P4|Overall Study|Withdrawal by Subject|0
772020|NCT00572910|2455592|P3|Overall Study|Withdrawal by Subject|1
772021|NCT00572910|2455593|P2|Overall Study|Withdrawal by Subject|0
772022|NCT00572910|2455594|P1|Overall Study|Withdrawal by Subject|3
772023|NCT00572910|2455584|P11|Overall Study|Lost to Follow-up|0
772024|NCT00572910|2455585|P10|Overall Study|Lost to Follow-up|1
772025|NCT00572910|2455586|P9|Overall Study|Lost to Follow-up|0
772026|NCT00572910|2455587|P8|Overall Study|Lost to Follow-up|0
772027|NCT00572910|2455588|P7|Overall Study|Lost to Follow-up|0
772028|NCT00572910|2455589|P6|Overall Study|Lost to Follow-up|0
772029|NCT00572910|2455590|P5|Overall Study|Lost to Follow-up|1
772030|NCT00572910|2455591|P4|Overall Study|Lost to Follow-up|2
772031|NCT00572910|2455592|P3|Overall Study|Lost to Follow-up|1
772032|NCT00572910|2455593|P2|Overall Study|Lost to Follow-up|1
772033|NCT00572910|2455594|P1|Overall Study|Lost to Follow-up|0
772034|NCT00572910|2455584|P11|Overall Study|Adverse Event|2
772035|NCT00572910|2455585|P10|Overall Study|Adverse Event|3
772036|NCT00572910|2455586|P9|Overall Study|Adverse Event|1
772037|NCT00572910|2455587|P8|Overall Study|Adverse Event|2
772038|NCT00572910|2455588|P7|Overall Study|Adverse Event|4
772039|NCT00572910|2455589|P6|Overall Study|Adverse Event|0
772040|NCT00572910|2455590|P5|Overall Study|Adverse Event|0
772041|NCT00572910|2455591|P4|Overall Study|Adverse Event|2
772042|NCT00572910|2455592|P3|Overall Study|Adverse Event|0
772043|NCT00572910|2455593|P2|Overall Study|Adverse Event|2
772044|NCT00572910|2455594|P1|Overall Study|Adverse Event|1
772045|NCT00573066|2455640|P1|Overall Study|Postoperative bleeding|1
772046|NCT00573066|2455640|P1|Overall Study|IV malfunction|1
772047|NCT00573066|2455640|P1|Overall Study|Exclusion criteria|18
772048|NCT00573131|2455646|P2|Overall Study|Withdrawal by Subject|8
772049|NCT00573131|2455647|P1|Overall Study|Withdrawal by Subject|10
772050|NCT00573144|2455655|P2|Overall Study|Withdrawal by Subject|3
772051|NCT00573144|2455656|P1|Overall Study|Withdrawal by Subject|2
772052|NCT00573157|2455668|P2|Overall Study|Unspecified|1
772053|NCT00573157|2455669|P1|Overall Study|Unspecified|1
772054|NCT00573157|2455668|P2|Overall Study|Adverse Event|1
772055|NCT00573157|2455669|P1|Overall Study|Adverse Event|3
772056|NCT00573170|2455679|P6|Third Treatment Period|Lost to Follow-up|2
772057|NCT00573170|2455680|P5|Third Treatment Period|Lost to Follow-up|0
772058|NCT00573170|2455681|P4|Third Treatment Period|Lost to Follow-up|0
772059|NCT00573170|2455682|P3|Third Treatment Period|Lost to Follow-up|0
772060|NCT00573170|2455683|P2|Third Treatment Period|Lost to Follow-up|0
772061|NCT00573170|2455684|P1|Third Treatment Period|Lost to Follow-up|0
772062|NCT00573170|2455679|P6|Third Treatment Period|Withdrawal by Subject|0
772063|NCT00573170|2455680|P5|Third Treatment Period|Withdrawal by Subject|0
772064|NCT00573170|2455681|P4|Third Treatment Period|Withdrawal by Subject|0
772065|NCT00573170|2455682|P3|Third Treatment Period|Withdrawal by Subject|0
772066|NCT00573170|2455683|P2|Third Treatment Period|Withdrawal by Subject|0
772067|NCT00573170|2455684|P1|Third Treatment Period|Withdrawal by Subject|1
772068|NCT00573170|2455679|P6|Second Washout Period|Other|2
772069|NCT00573170|2455680|P5|Second Washout Period|Other|6
772070|NCT00573170|2455681|P4|Second Washout Period|Other|4
772071|NCT00573170|2455682|P3|Second Washout Period|Other|1
772072|NCT00573170|2455683|P2|Second Washout Period|Other|2
772073|NCT00573170|2455684|P1|Second Washout Period|Other|1
772074|NCT00573170|2455679|P6|Second Washout Period|Lost to Follow-up|0
772075|NCT00573170|2455680|P5|Second Washout Period|Lost to Follow-up|0
772076|NCT00573170|2455681|P4|Second Washout Period|Lost to Follow-up|1
772077|NCT00573170|2455682|P3|Second Washout Period|Lost to Follow-up|0
772078|NCT00573170|2455683|P2|Second Washout Period|Lost to Follow-up|0
772079|NCT00573170|2455684|P1|Second Washout Period|Lost to Follow-up|0
772080|NCT00573170|2455679|P6|Second Washout Period|Withdrawal by Subject|0
772081|NCT00573170|2455680|P5|Second Washout Period|Withdrawal by Subject|1
772082|NCT00573170|2455681|P4|Second Washout Period|Withdrawal by Subject|0
772083|NCT00573170|2455682|P3|Second Washout Period|Withdrawal by Subject|2
772084|NCT00573170|2455683|P2|Second Washout Period|Withdrawal by Subject|1
772085|NCT00573170|2455684|P1|Second Washout Period|Withdrawal by Subject|1
772086|NCT00573170|2455679|P6|Second Washout Period|Protocol Violation|0
772087|NCT00573170|2455680|P5|Second Washout Period|Protocol Violation|0
772088|NCT00573170|2455681|P4|Second Washout Period|Protocol Violation|0
772089|NCT00573170|2455682|P3|Second Washout Period|Protocol Violation|1
772090|NCT00573170|2455683|P2|Second Washout Period|Protocol Violation|1
772091|NCT00573170|2455684|P1|Second Washout Period|Protocol Violation|2
772092|NCT00573170|2455679|P6|Second Washout Period|Adverse Event|0
772093|NCT00573170|2455680|P5|Second Washout Period|Adverse Event|1
772094|NCT00573170|2455681|P4|Second Washout Period|Adverse Event|0
772095|NCT00573170|2455682|P3|Second Washout Period|Adverse Event|0
772096|NCT00573170|2455683|P2|Second Washout Period|Adverse Event|0
772097|NCT00573170|2455684|P1|Second Washout Period|Adverse Event|1
772098|NCT00573170|2455679|P6|First Washout Period|Other|0
772099|NCT00573170|2455680|P5|First Washout Period|Other|0
772100|NCT00573170|2455681|P4|First Washout Period|Other|1
772101|NCT00573170|2455682|P3|First Washout Period|Other|1
772102|NCT00573170|2455683|P2|First Washout Period|Other|0
772103|NCT00573170|2455684|P1|First Washout Period|Other|4
772104|NCT00573170|2455679|P6|First Washout Period|Withdrawal by Subject|3
772105|NCT00573170|2455680|P5|First Washout Period|Withdrawal by Subject|3
772106|NCT00573170|2455681|P4|First Washout Period|Withdrawal by Subject|2
772107|NCT00573170|2455682|P3|First Washout Period|Withdrawal by Subject|0
772108|NCT00573170|2455683|P2|First Washout Period|Withdrawal by Subject|0
772109|NCT00573170|2455684|P1|First Washout Period|Withdrawal by Subject|2
772110|NCT00573170|2455679|P6|First Washout Period|Lost to Follow-up|2
772111|NCT00573170|2455680|P5|First Washout Period|Lost to Follow-up|0
772112|NCT00573170|2455681|P4|First Washout Period|Lost to Follow-up|2
772113|NCT00573170|2455682|P3|First Washout Period|Lost to Follow-up|0
772114|NCT00573170|2455683|P2|First Washout Period|Lost to Follow-up|1
772115|NCT00573170|2455684|P1|First Washout Period|Lost to Follow-up|1
772116|NCT00573170|2455679|P6|First Washout Period|Lack of Efficacy|1
772117|NCT00573170|2455680|P5|First Washout Period|Lack of Efficacy|0
772118|NCT00573170|2455681|P4|First Washout Period|Lack of Efficacy|0
772119|NCT00573170|2455682|P3|First Washout Period|Lack of Efficacy|0
772120|NCT00573170|2455683|P2|First Washout Period|Lack of Efficacy|0
772121|NCT00573170|2455684|P1|First Washout Period|Lack of Efficacy|0
772122|NCT00573170|2455679|P6|First Washout Period|Adverse Event|1
772123|NCT00573170|2455680|P5|First Washout Period|Adverse Event|0
772124|NCT00573170|2455681|P4|First Washout Period|Adverse Event|0
772125|NCT00573170|2455682|P3|First Washout Period|Adverse Event|0
772126|NCT00573170|2455683|P2|First Washout Period|Adverse Event|1
772127|NCT00573170|2455684|P1|First Washout Period|Adverse Event|1
772128|NCT00573170|2455679|P6|First Treatment Period|Did Not Treat Attack 1|0
772129|NCT00573170|2455680|P5|First Treatment Period|Did Not Treat Attack 1|1
772130|NCT00573170|2455681|P4|First Treatment Period|Did Not Treat Attack 1|0
772131|NCT00573170|2455682|P3|First Treatment Period|Did Not Treat Attack 1|0
772132|NCT00573170|2455683|P2|First Treatment Period|Did Not Treat Attack 1|0
772133|NCT00573170|2455684|P1|First Treatment Period|Did Not Treat Attack 1|0
772134|NCT00573183|2455760|P2|Overall Study|Unspecified|2
772135|NCT00573183|2455761|P1|Overall Study|Unspecified|5
772136|NCT00573183|2455760|P2|Overall Study|Incarceration|8
772137|NCT00573183|2455761|P1|Overall Study|Incarceration|5
772138|NCT00573183|2455760|P2|Overall Study|Adverse Event|0
772139|NCT00573183|2455761|P1|Overall Study|Adverse Event|2
772140|NCT00573183|2455760|P2|Overall Study|Death|1
772141|NCT00573183|2455761|P1|Overall Study|Death|0
772142|NCT00573183|2455760|P2|Overall Study|Withdrawal by Subject|2
772143|NCT00573183|2455761|P1|Overall Study|Withdrawal by Subject|8
772144|NCT00573183|2455760|P2|Overall Study|Lost to Follow-up|50
772145|NCT00573183|2455761|P1|Overall Study|Lost to Follow-up|52
772146|NCT00573248|2455771|P2|Overall Study|scheduling conflicts|11
772147|NCT00573248|2455772|P1|Overall Study|scheduling conflicts|15
772148|NCT00573313|2455826|P4|Overall Study|Protocol Violation|0
772149|NCT00573313|2455827|P3|Overall Study|Protocol Violation|6
772150|NCT00573313|2455828|P2|Overall Study|Protocol Violation|0
772151|NCT00573313|2455829|P1|Overall Study|Protocol Violation|5
772152|NCT00573391|2455839|P2|Overall Study|Death|0
772153|NCT00573391|2455840|P1|Overall Study|Death|1
772154|NCT00573391|2455839|P2|Overall Study|study stopped|2
772155|NCT00573391|2455840|P1|Overall Study|study stopped|2
772156|NCT00573430|2455849|P3|Overall Study|Eligibility criteria not fulfilled|3
772157|NCT00573430|2455850|P2|Overall Study|Eligibility criteria not fulfilled|0
772158|NCT00573430|2455851|P1|Overall Study|Eligibility criteria not fulfilled|0
772159|NCT00573430|2455849|P3|Overall Study|Protocol Violation|1
772160|NCT00573430|2455850|P2|Overall Study|Protocol Violation|1
772161|NCT00573430|2455851|P1|Overall Study|Protocol Violation|0
772162|NCT00573430|2455849|P3|Overall Study|Withdrawal by Subject|1
772163|NCT00573430|2455850|P2|Overall Study|Withdrawal by Subject|0
772164|NCT00573430|2455851|P1|Overall Study|Withdrawal by Subject|1
772165|NCT00573430|2455849|P3|Overall Study|Adverse Event|2
772166|NCT00573430|2455850|P2|Overall Study|Adverse Event|0
772167|NCT00573430|2455851|P1|Overall Study|Adverse Event|0
772168|NCT00573430|2455849|P3|Overall Study|Incorrect enrollment of randomization|3
772169|NCT00573430|2455850|P2|Overall Study|Incorrect enrollment of randomization|4
772170|NCT00573430|2455851|P1|Overall Study|Incorrect enrollment of randomization|0
772171|NCT00573443|2455874|P3|Open-Label Extension Phase|Not Specified|0
772172|NCT00573443|2455875|P2|Open-Label Extension Phase|Not Specified|0
772173|NCT00573443|2455876|P1|Open-Label Extension Phase|Not Specified|2
772174|NCT00573443|2455874|P3|Open-Label Extension Phase|Protocol Violation|0
772175|NCT00573443|2455875|P2|Open-Label Extension Phase|Protocol Violation|0
772176|NCT00573443|2455876|P1|Open-Label Extension Phase|Protocol Violation|2
772177|NCT00573443|2455874|P3|Open-Label Extension Phase|Withdrawal by Subject|0
772178|NCT00573443|2455875|P2|Open-Label Extension Phase|Withdrawal by Subject|0
772179|NCT00573443|2455876|P1|Open-Label Extension Phase|Withdrawal by Subject|3
772180|NCT00573443|2455874|P3|Open-Label Extension Phase|Serious Adverse Event|0
772181|NCT00573443|2455875|P2|Open-Label Extension Phase|Serious Adverse Event|0
772182|NCT00573443|2455876|P1|Open-Label Extension Phase|Serious Adverse Event|5
772183|NCT00573443|2455874|P3|Open-Label Extension Phase|Adverse Event|0
772184|NCT00573443|2455875|P2|Open-Label Extension Phase|Adverse Event|0
772185|NCT00573443|2455876|P1|Open-Label Extension Phase|Adverse Event|3
772186|NCT00573443|2455874|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
772187|NCT00573443|2455875|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
772188|NCT00573443|2455876|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
772189|NCT00573443|2455874|P3|Open-Label Extension Phase|Lost to Follow-up|0
772190|NCT00573443|2455875|P2|Open-Label Extension Phase|Lost to Follow-up|0
772191|NCT00573443|2455876|P1|Open-Label Extension Phase|Lost to Follow-up|1
772192|NCT00573443|2455874|P3|Double-Blind Phase|Not specified|3
772193|NCT00573443|2455875|P2|Double-Blind Phase|Not specified|2
772194|NCT00573443|2455876|P1|Double-Blind Phase|Not specified|0
772195|NCT00573443|2455874|P3|Double-Blind Phase|Protocol Violation|1
772196|NCT00573443|2455875|P2|Double-Blind Phase|Protocol Violation|2
772197|NCT00573443|2455876|P1|Double-Blind Phase|Protocol Violation|0
772198|NCT00573443|2455874|P3|Double-Blind Phase|Withdrawal by Subject|7
772199|NCT00573443|2455875|P2|Double-Blind Phase|Withdrawal by Subject|2
772200|NCT00573443|2455876|P1|Double-Blind Phase|Withdrawal by Subject|2
772201|NCT00573443|2455874|P3|Double-Blind Phase|Medication refusal due to AE|0
772202|NCT00573443|2455875|P2|Double-Blind Phase|Medication refusal due to AE|2
772203|NCT00573443|2455876|P1|Double-Blind Phase|Medication refusal due to AE|2
772204|NCT00573443|2455874|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
772205|NCT00573443|2455875|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
772206|NCT00573443|2455876|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
772207|NCT00573443|2455874|P3|Double-Blind Phase|Adverse Event|0
772208|NCT00573443|2455875|P2|Double-Blind Phase|Adverse Event|5
772209|NCT00573443|2455876|P1|Double-Blind Phase|Adverse Event|1
772210|NCT00573443|2455874|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
772211|NCT00573443|2455875|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
772212|NCT00573443|2455876|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
772213|NCT00573443|2455874|P3|Double-Blind Phase|Lost to Follow-up|2
772214|NCT00573443|2455875|P2|Double-Blind Phase|Lost to Follow-up|3
772215|NCT00573443|2455876|P1|Double-Blind Phase|Lost to Follow-up|1
772216|NCT00573469|2455906|P3|Overall Study|Not Specified|3
772217|NCT00573469|2455907|P2|Overall Study|Not Specified|1
772218|NCT00573469|2455908|P1|Overall Study|Not Specified|5
772219|NCT00573469|2455906|P3|Overall Study|Withdrawal by Subject|0
772220|NCT00573469|2455907|P2|Overall Study|Withdrawal by Subject|2
772221|NCT00573469|2455908|P1|Overall Study|Withdrawal by Subject|0
772222|NCT00573469|2455906|P3|Overall Study|Adverse Event|1
772223|NCT00573469|2455907|P2|Overall Study|Adverse Event|1
772224|NCT00573469|2455908|P1|Overall Study|Adverse Event|1
772225|NCT00573534|2455961|P1|Overall Study|oppositional behavior|3
772226|NCT00565058|2455968|P2|Overall Study|Adverse Event|0
772227|NCT00565058|2455969|P1|Overall Study|Adverse Event|1
772228|NCT00565136|2455998|P1|Overall Study|Protocol Violation|1
772229|NCT00565136|2455998|P1|Overall Study|Withdrawal by Subject|1
772230|NCT00565136|2455998|P1|Overall Study|Lost to Follow-up|1
772231|NCT00565409|2456032|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
772232|NCT00565409|2456033|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
772233|NCT00565409|2456034|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
772234|NCT00565409|2456035|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
772235|NCT00565409|2456032|P4|Period 2 Double-Blind|unspecified|9
772236|NCT00565409|2456033|P3|Period 2 Double-Blind|unspecified|5
772237|NCT00565409|2456034|P2|Period 2 Double-Blind|unspecified|4
772238|NCT00565409|2456035|P1|Period 2 Double-Blind|unspecified|0
772239|NCT00565409|2456032|P4|Period 2 Double-Blind|Lost to Follow-up|0
772240|NCT00565409|2456033|P3|Period 2 Double-Blind|Lost to Follow-up|1
772241|NCT00565409|2456034|P2|Period 2 Double-Blind|Lost to Follow-up|0
772242|NCT00565409|2456035|P1|Period 2 Double-Blind|Lost to Follow-up|0
772243|NCT00565409|2456032|P4|Period 2 Double-Blind|Protocol Violation|2
772244|NCT00565409|2456033|P3|Period 2 Double-Blind|Protocol Violation|6
772245|NCT00565409|2456034|P2|Period 2 Double-Blind|Protocol Violation|4
772246|NCT00565409|2456035|P1|Period 2 Double-Blind|Protocol Violation|0
772247|NCT00565409|2456032|P4|Period 2 Double-Blind|Death|0
772248|NCT00565409|2456033|P3|Period 2 Double-Blind|Death|0
772249|NCT00565409|2456034|P2|Period 2 Double-Blind|Death|2
772250|NCT00565409|2456035|P1|Period 2 Double-Blind|Death|0
772251|NCT00565409|2456032|P4|Period 2 Double-Blind|Adverse Event|5
772252|NCT00565409|2456033|P3|Period 2 Double-Blind|Adverse Event|4
772253|NCT00565409|2456034|P2|Period 2 Double-Blind|Adverse Event|7
772254|NCT00565409|2456035|P1|Period 2 Double-Blind|Adverse Event|0
772255|NCT00565409|2456032|P4|After Period 1, Prior to Period 2|did not meet criteria|0
772256|NCT00565409|2456033|P3|After Period 1, Prior to Period 2|did not meet criteria|0
772257|NCT00565409|2456034|P2|After Period 1, Prior to Period 2|did not meet criteria|0
772258|NCT00565409|2456035|P1|After Period 1, Prior to Period 2|did not meet criteria|152
772259|NCT00565409|2456032|P4|Period 1 Open Label|no conclusion of participation record|0
772260|NCT00565409|2456033|P3|Period 1 Open Label|no conclusion of participation record|0
772261|NCT00565409|2456034|P2|Period 1 Open Label|no conclusion of participation record|0
772262|NCT00565409|2456035|P1|Period 1 Open Label|no conclusion of participation record|1
772263|NCT00565409|2456032|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
772264|NCT00565409|2456033|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
772265|NCT00565409|2456034|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
772266|NCT00565409|2456035|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
772267|NCT00565409|2456032|P4|Period 1 Open Label|Protocol Violation|0
772268|NCT00565409|2456033|P3|Period 1 Open Label|Protocol Violation|0
772269|NCT00565409|2456034|P2|Period 1 Open Label|Protocol Violation|0
772270|NCT00565409|2456035|P1|Period 1 Open Label|Protocol Violation|14
772271|NCT00565409|2456032|P4|Period 1 Open Label|unspecified|0
772272|NCT00565409|2456033|P3|Period 1 Open Label|unspecified|0
772273|NCT00565409|2456034|P2|Period 1 Open Label|unspecified|0
772274|NCT00565409|2456035|P1|Period 1 Open Label|unspecified|21
772275|NCT00565409|2456032|P4|Period 1 Open Label|Lost to Follow-up|0
772276|NCT00565409|2456033|P3|Period 1 Open Label|Lost to Follow-up|0
772277|NCT00565409|2456034|P2|Period 1 Open Label|Lost to Follow-up|0
772278|NCT00565409|2456035|P1|Period 1 Open Label|Lost to Follow-up|1
772279|NCT00565409|2456032|P4|Period 1 Open Label|Death|0
772280|NCT00565409|2456033|P3|Period 1 Open Label|Death|0
772281|NCT00565409|2456034|P2|Period 1 Open Label|Death|0
772282|NCT00565409|2456035|P1|Period 1 Open Label|Death|2
772283|NCT00565409|2456032|P4|Period 1 Open Label|Adverse Event|0
772284|NCT00565409|2456033|P3|Period 1 Open Label|Adverse Event|0
772285|NCT00565409|2456034|P2|Period 1 Open Label|Adverse Event|0
772286|NCT00565409|2456035|P1|Period 1 Open Label|Adverse Event|17
772287|NCT00565448|2456139|P2|Overall Study|Withdrawal by Subject|0
772288|NCT00565448|2456140|P1|Overall Study|Withdrawal by Subject|1
772289|NCT00565448|2456139|P2|Overall Study|Disease progression|0
772290|NCT00565448|2456140|P1|Overall Study|Disease progression|1
772291|NCT00565448|2456139|P2|Overall Study|Adverse Event|2
772292|NCT00565448|2456140|P1|Overall Study|Adverse Event|1
772293|NCT00565604|2456170|P1|Overall Study|Lost to Follow-up|2
772294|NCT00565604|2456170|P1|Overall Study|Failure to treat|2
772295|NCT00565617|2456177|P1|Overall Study|Withdrawal by Subject|1
772296|NCT00565721|2456202|P1|Overall Study|Other reasons|6
772297|NCT00565721|2456202|P1|Overall Study|Physician Decision|2
772298|NCT00565721|2456202|P1|Overall Study|Technical Problems|1
772299|NCT00565721|2456202|P1|Overall Study|Lost to Follow-up|6
772300|NCT00565721|2456202|P1|Overall Study|Screen Failure|2
772301|NCT00565747|2456223|P2|Overall Study|No embryo transfer|73
772302|NCT00565747|2456224|P1|Overall Study|No embryo transfer|67
772303|NCT00565812|2456237|P3|Overall Study|Physician Decision|0
772304|NCT00565812|2456238|P2|Overall Study|Physician Decision|0
772305|NCT00565812|2456239|P1|Overall Study|Physician Decision|2
772306|NCT00565812|2456237|P3|Overall Study|Follow-up Visit Not Completed|1
772307|NCT00565812|2456238|P2|Overall Study|Follow-up Visit Not Completed|0
772308|NCT00565812|2456239|P1|Overall Study|Follow-up Visit Not Completed|2
772309|NCT00565812|2456237|P3|Overall Study|Low Compliance|1
772310|NCT00565812|2456238|P2|Overall Study|Low Compliance|0
772311|NCT00565812|2456239|P1|Overall Study|Low Compliance|1
772312|NCT00565812|2456237|P3|Overall Study|Surgical Intervention|2
772313|NCT00565812|2456238|P2|Overall Study|Surgical Intervention|1
772314|NCT00565812|2456239|P1|Overall Study|Surgical Intervention|0
772315|NCT00565812|2456237|P3|Overall Study|Research Site Closure|8
772316|NCT00565812|2456238|P2|Overall Study|Research Site Closure|1
772317|NCT00565812|2456239|P1|Overall Study|Research Site Closure|6
772318|NCT00565812|2456237|P3|Overall Study|Domestic Reasons|3
772319|NCT00565812|2456238|P2|Overall Study|Domestic Reasons|1
772320|NCT00565812|2456239|P1|Overall Study|Domestic Reasons|7
772321|NCT00565812|2456237|P3|Overall Study|Sponsor Decision|1
772322|NCT00565812|2456238|P2|Overall Study|Sponsor Decision|5
772323|NCT00565812|2456239|P1|Overall Study|Sponsor Decision|1
772324|NCT00565812|2456237|P3|Overall Study|Relocated Out of Area|9
772325|NCT00565812|2456238|P2|Overall Study|Relocated Out of Area|8
772326|NCT00565812|2456239|P1|Overall Study|Relocated Out of Area|5
772327|NCT00565812|2456237|P3|Overall Study|Jury Duty|0
772328|NCT00565812|2456238|P2|Overall Study|Jury Duty|0
772329|NCT00565812|2456239|P1|Overall Study|Jury Duty|1
772330|NCT00565812|2456237|P3|Overall Study|Adverse Event|40
772331|NCT00565812|2456238|P2|Overall Study|Adverse Event|54
772332|NCT00565812|2456239|P1|Overall Study|Adverse Event|41
772333|NCT00565812|2456237|P3|Overall Study|Protocol Violation|4
772334|NCT00565812|2456238|P2|Overall Study|Protocol Violation|6
772335|NCT00565812|2456239|P1|Overall Study|Protocol Violation|2
772336|NCT00565812|2456237|P3|Overall Study|Work Schedule|1
772337|NCT00565812|2456238|P2|Overall Study|Work Schedule|3
772338|NCT00565812|2456239|P1|Overall Study|Work Schedule|5
772339|NCT00565812|2456237|P3|Overall Study|Withdrawal by Subject|48
772340|NCT00565812|2456238|P2|Overall Study|Withdrawal by Subject|47
772341|NCT00565812|2456239|P1|Overall Study|Withdrawal by Subject|58
772342|NCT00565812|2456237|P3|Overall Study|Lost to Follow-up|8
772343|NCT00565812|2456238|P2|Overall Study|Lost to Follow-up|8
772344|NCT00565812|2456239|P1|Overall Study|Lost to Follow-up|10
772345|NCT00565812|2456237|P3|Overall Study|Did not Meet Entrance Criteria|1
772346|NCT00565812|2456238|P2|Overall Study|Did not Meet Entrance Criteria|0
772347|NCT00565812|2456239|P1|Overall Study|Did not Meet Entrance Criteria|1
772348|NCT00565812|2456237|P3|Overall Study|Death|3
772349|NCT00565812|2456238|P2|Overall Study|Death|1
772350|NCT00565812|2456239|P1|Overall Study|Death|2
772351|NCT00566020|2456376|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
772352|NCT00566020|2456377|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
772353|NCT00566020|2456376|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
772354|NCT00566020|2456377|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
772355|NCT00566020|2456376|P2|46-week Long-term Administration Phase|Physician Decision|7
772356|NCT00566020|2456377|P1|46-week Long-term Administration Phase|Physician Decision|0
772357|NCT00566020|2456376|P2|46-week Long-term Administration Phase|Adverse Event|7
772358|NCT00566020|2456377|P1|46-week Long-term Administration Phase|Adverse Event|0
772359|NCT00566020|2456376|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
772360|NCT00566020|2456377|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
772361|NCT00566020|2456376|P2|6-week Dosage Adjustment Phase|Adverse Event|0
772362|NCT00566020|2456377|P1|6-week Dosage Adjustment Phase|Adverse Event|5
772363|NCT00566111|2456404|P2|Overall Study|Adverse Event|2
772364|NCT00566111|2456405|P1|Overall Study|Adverse Event|0
772365|NCT00566254|2456436|P2|Overall Study|Not Specified|2
772366|NCT00566254|2456437|P1|Overall Study|Not Specified|0
772367|NCT00566254|2456436|P2|Overall Study|Lack of Efficacy|6
772368|NCT00566254|2456437|P1|Overall Study|Lack of Efficacy|5
772369|NCT00566254|2456436|P2|Overall Study|Withdrawal by Subject|2
772370|NCT00566254|2456437|P1|Overall Study|Withdrawal by Subject|1
772371|NCT00566254|2456436|P2|Overall Study|Protocol Violation|3
772372|NCT00566254|2456437|P1|Overall Study|Protocol Violation|1
772373|NCT00566254|2456436|P2|Overall Study|Adverse Event|1
772374|NCT00566254|2456437|P1|Overall Study|Adverse Event|3
772375|NCT00566631|2456478|P1|Part 2: Extension Phase|Unspecified|5
772376|NCT00566631|2456478|P1|Part 2: Extension Phase|Death|1
772377|NCT00566631|2456478|P1|Part 2: Extension Phase|Lost to Follow-up|6
772378|NCT00566631|2456478|P1|Part 2: Extension Phase|Adverse Event|11
772379|NCT00566631|2456478|P1|Part 2: Extension Phase|Withdrawal by Subject|34
772380|NCT00566631|2456478|P1|Part 2: Extension Phase|Lack of Efficacy|25
772381|NCT00566631|2456478|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
772382|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
772383|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
772384|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
772385|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
772386|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Adverse Event|9
772387|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Physician Decision|1
772388|NCT00566631|2456478|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
772389|NCT00566696|2456493|P1|Overall Study|Non-Patient Donors|37
772390|NCT00566696|2456493|P1|Overall Study|Physician Decision|1
772391|NCT00566696|2456493|P1|Overall Study|Health Status Change|1
772392|NCT00566696|2456493|P1|Overall Study|Muromonab not available|1
772393|NCT00566696|2456493|P1|Overall Study|Met Exclusion Criteria|2
772394|NCT00566709|2456503|P2|Overall Study|Protocol Violation|0
772395|NCT00566709|2456504|P1|Overall Study|Protocol Violation|5
772396|NCT00566722|2456523|P3|Overall Study|Noncompliant with drug administration|1
772397|NCT00566722|2456524|P2|Overall Study|Noncompliant with drug administration|0
772398|NCT00566722|2456525|P1|Overall Study|Noncompliant with drug administration|0
772399|NCT00566722|2456523|P3|Overall Study|Serious adverse event|0
772400|NCT00566722|2456524|P2|Overall Study|Serious adverse event|1
772401|NCT00566722|2456525|P1|Overall Study|Serious adverse event|0
772402|NCT00566722|2456523|P3|Overall Study|Did not meet exclusion criteria|2
772403|NCT00566722|2456524|P2|Overall Study|Did not meet exclusion criteria|0
772404|NCT00566722|2456525|P1|Overall Study|Did not meet exclusion criteria|0
772405|NCT00566722|2456523|P3|Overall Study|Lack of Efficacy|4
772406|NCT00566722|2456524|P2|Overall Study|Lack of Efficacy|2
772407|NCT00566722|2456525|P1|Overall Study|Lack of Efficacy|1
772408|NCT00566722|2456523|P3|Overall Study|Lost to Follow-up|1
772409|NCT00566722|2456524|P2|Overall Study|Lost to Follow-up|1
772410|NCT00566722|2456525|P1|Overall Study|Lost to Follow-up|1
772411|NCT00566722|2456523|P3|Overall Study|Withdrawal by Subject|1
772412|NCT00566722|2456524|P2|Overall Study|Withdrawal by Subject|0
772413|NCT00566722|2456525|P1|Overall Study|Withdrawal by Subject|0
772414|NCT00566722|2456523|P3|Overall Study|Adverse Event|0
772415|NCT00566722|2456524|P2|Overall Study|Adverse Event|1
772416|NCT00566722|2456525|P1|Overall Study|Adverse Event|0
772417|NCT00566735|2456571|P2|Overall Study|Switched into a manic episode|1
772418|NCT00566735|2456572|P1|Overall Study|Switched into a manic episode|0
772419|NCT00566735|2456571|P2|Overall Study|Refused neuropsychological testing|5
772420|NCT00566735|2456572|P1|Overall Study|Refused neuropsychological testing|2
772421|NCT00566735|2456571|P2|Overall Study|Withdrawal by Subject|1
772422|NCT00566735|2456572|P1|Overall Study|Withdrawal by Subject|0
772423|NCT00566852|2456584|P2|Overall Study|Missing reason not reported|20
772424|NCT00566852|2456585|P1|Overall Study|Missing reason not reported|16
772425|NCT00566852|2456584|P2|Overall Study|Missing reason not specified|2
772426|NCT00566852|2456585|P1|Overall Study|Missing reason not specified|1
772427|NCT00566852|2456584|P2|Overall Study|Not tested due to disability|12
772428|NCT00566852|2456585|P1|Overall Study|Not tested due to disability|6
772429|NCT00566852|2456584|P2|Overall Study|Patient refusal|37
772430|NCT00566852|2456585|P1|Overall Study|Patient refusal|37
772431|NCT00566852|2456584|P2|Overall Study|Withdrawal by Subject|25
772432|NCT00566852|2456585|P1|Overall Study|Withdrawal by Subject|30
772433|NCT00566852|2456584|P2|Overall Study|Death|78
772434|NCT00566852|2456585|P1|Overall Study|Death|95
772435|NCT00566852|2456584|P2|Overall Study|Protocol Violation|24
772436|NCT00566852|2456585|P1|Overall Study|Protocol Violation|22
772437|NCT00566982|2456644|P2|Overall Study|Other-family problems & doctor's request|2
772438|NCT00566982|2456645|P1|Overall Study|Other-family problems & doctor's request|0
772439|NCT00566982|2456644|P2|Overall Study|Lost to Follow-up|1
772440|NCT00566982|2456645|P1|Overall Study|Lost to Follow-up|0
772441|NCT00566982|2456644|P2|Overall Study|Protocol Violation|4
772442|NCT00566982|2456645|P1|Overall Study|Protocol Violation|1
772443|NCT00566982|2456644|P2|Overall Study|Withdrawal by Subject|14
772444|NCT00566982|2456645|P1|Overall Study|Withdrawal by Subject|1
772445|NCT00566982|2456644|P2|Overall Study|Adverse Event|48
772446|NCT00566982|2456645|P1|Overall Study|Adverse Event|6
772447|NCT00566995|2456667|P1|Overall Study|Withdrew consent|4
772448|NCT00566995|2456667|P1|Overall Study|Physician Decision|1
772449|NCT00566995|2456667|P1|Overall Study|Toxicity|3
772450|NCT00567112|2456681|P3|Washout Period 3 (3 Days)|Protocol Violation|0
772451|NCT00567112|2456682|P2|Washout Period 3 (3 Days)|Protocol Violation|0
772452|NCT00567112|2456683|P1|Washout Period 3 (3 Days)|Protocol Violation|1
772453|NCT00567112|2456681|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
772454|NCT00567112|2456682|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
772455|NCT00567112|2456683|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
772456|NCT00567112|2456681|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
772457|NCT00567112|2456682|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
772458|NCT00567112|2456683|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
772459|NCT00567164|2456708|P3|Overall Study|Missing|0
772460|NCT00567164|2456709|P2|Overall Study|Missing|0
772461|NCT00567164|2456710|P1|Overall Study|Missing|1
772462|NCT00567164|2456708|P3|Overall Study|Primary Reason coded as 'Other'|16
772463|NCT00567164|2456709|P2|Overall Study|Primary Reason coded as 'Other'|8
772464|NCT00567164|2456710|P1|Overall Study|Primary Reason coded as 'Other'|37
772465|NCT00567164|2456708|P3|Overall Study|Pregnancy|6
772466|NCT00567164|2456709|P2|Overall Study|Pregnancy|4
772467|NCT00567164|2456710|P1|Overall Study|Pregnancy|20
772468|NCT00567164|2456708|P3|Overall Study|Lost to Follow-up|21
772469|NCT00567164|2456709|P2|Overall Study|Lost to Follow-up|23
772470|NCT00567164|2456710|P1|Overall Study|Lost to Follow-up|202
772471|NCT00567164|2456708|P3|Overall Study|Death|1
772472|NCT00567164|2456709|P2|Overall Study|Death|0
772473|NCT00567164|2456710|P1|Overall Study|Death|0
772474|NCT00567164|2456708|P3|Overall Study|Adverse Event|9
772475|NCT00567164|2456709|P2|Overall Study|Adverse Event|13
772476|NCT00567164|2456710|P1|Overall Study|Adverse Event|92
772477|NCT00567164|2456708|P3|Overall Study|Protocol Violation|2
772478|NCT00567164|2456709|P2|Overall Study|Protocol Violation|4
772479|NCT00567164|2456710|P1|Overall Study|Protocol Violation|23
772480|NCT00567164|2456708|P3|Overall Study|Withdrawal by Subject|17
772481|NCT00567164|2456709|P2|Overall Study|Withdrawal by Subject|21
772482|NCT00567164|2456710|P1|Overall Study|Withdrawal by Subject|171
772483|NCT00567190|2456784|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
772484|NCT00567190|2456785|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
772485|NCT00567190|2456784|P2|Overall Study|Death|221
772486|NCT00567190|2456785|P1|Overall Study|Death|168
772487|NCT00567255|2456821|P2|Overall Study|Drug noncompliance,moved,other|15
772488|NCT00567255|2456822|P1|Overall Study|Drug noncompliance,moved,other|25
772489|NCT00567255|2456821|P2|Overall Study|Pregnancy|0
772490|NCT00567255|2456822|P1|Overall Study|Pregnancy|6
772491|NCT00567255|2456821|P2|Overall Study|Protocol Violation|8
772492|NCT00567255|2456822|P1|Overall Study|Protocol Violation|20
772493|NCT00567255|2456821|P2|Overall Study|Lack of Efficacy|33
772494|NCT00567255|2456822|P1|Overall Study|Lack of Efficacy|19
772495|NCT00567255|2456821|P2|Overall Study|Withdrawal by Subject|56
772496|NCT00567255|2456822|P1|Overall Study|Withdrawal by Subject|75
772497|NCT00567255|2456821|P2|Overall Study|Lost to Follow-up|48
772498|NCT00567255|2456822|P1|Overall Study|Lost to Follow-up|77
772499|NCT00567255|2456821|P2|Overall Study|Adverse Event|68
772500|NCT00567255|2456822|P1|Overall Study|Adverse Event|241
772501|NCT00567268|2456866|P1|Overall Study|"Safety Evaluation Not Assessable"|1
772502|NCT00567268|2456866|P1|Overall Study|No Drug Administration|4
772503|NCT00567268|2456866|P1|Overall Study|No Visit After First Day of Treatment|2
772504|NCT00567268|2456866|P1|Overall Study|Lost to Follow-up|36
772505|NCT00567268|2456866|P1|Overall Study|Protocol Violation|7
772506|NCT00567476|2456935|P2|Overall Study|Non-adherence to protocol|1
772507|NCT00567476|2456936|P1|Overall Study|Non-adherence to protocol|0
772508|NCT00567476|2456935|P2|Overall Study|Medical Decision|1
772509|NCT00567476|2456936|P1|Overall Study|Medical Decision|0
772510|NCT00567476|2456935|P2|Overall Study|Administrative issues|0
772511|NCT00567476|2456936|P1|Overall Study|Administrative issues|1
772512|NCT00567476|2456935|P2|Overall Study|Lost to Follow-up|1
772513|NCT00567476|2456936|P1|Overall Study|Lost to Follow-up|0
772514|NCT00567476|2456935|P2|Overall Study|Protocol Violation|1
772515|NCT00567476|2456936|P1|Overall Study|Protocol Violation|4
772516|NCT00567476|2456935|P2|Overall Study|Pregnancy|0
772517|NCT00567476|2456936|P1|Overall Study|Pregnancy|1
772518|NCT00567476|2456935|P2|Overall Study|Adverse Event|0
772519|NCT00567476|2456936|P1|Overall Study|Adverse Event|2
772520|NCT00567502|2456964|P4|Overall Study|Never Initiated Treatment|72
772521|NCT00567502|2456965|P3|Overall Study|Never Initiated Treatment|0
772522|NCT00567502|2456966|P2|Overall Study|Never Initiated Treatment|0
772523|NCT00567502|2456967|P1|Overall Study|Never Initiated Treatment|0
772524|NCT00567502|2456964|P4|Overall Study|Sponsor request|1
772525|NCT00567502|2456965|P3|Overall Study|Sponsor request|30
772526|NCT00567502|2456966|P2|Overall Study|Sponsor request|0
772527|NCT00567502|2456967|P1|Overall Study|Sponsor request|9
772528|NCT00567502|2456964|P4|Overall Study|Participant request|1
772529|NCT00567502|2456965|P3|Overall Study|Participant request|33
772530|NCT00567502|2456966|P2|Overall Study|Participant request|1
772531|NCT00567502|2456967|P1|Overall Study|Participant request|12
772532|NCT00567502|2456964|P4|Overall Study|Unspecified|6
772533|NCT00567502|2456965|P3|Overall Study|Unspecified|134
772534|NCT00567502|2456966|P2|Overall Study|Unspecified|2
772535|NCT00567502|2456967|P1|Overall Study|Unspecified|64
772536|NCT00567502|2456964|P4|Overall Study|Death|5
772537|NCT00567502|2456965|P3|Overall Study|Death|360
772538|NCT00567502|2456966|P2|Overall Study|Death|16
772539|NCT00567502|2456967|P1|Overall Study|Death|65
772540|NCT00567502|2456964|P4|Overall Study|Lost to Follow-up|2
772541|NCT00567502|2456965|P3|Overall Study|Lost to Follow-up|351
772542|NCT00567502|2456966|P2|Overall Study|Lost to Follow-up|14
772543|NCT00567502|2456967|P1|Overall Study|Lost to Follow-up|91
772544|NCT00567541|2457004|P2|Overall Study|Adverse Event|1
772545|NCT00567541|2457005|P1|Overall Study|Adverse Event|0
772546|NCT00567567|2457014|P3|Overall Study|Unable adequate stem cell for transplant|2
772547|NCT00567567|2457015|P2|Overall Study|Unable adequate stem cell for transplant|0
772548|NCT00567567|2457016|P1|Overall Study|Unable adequate stem cell for transplant|0
772549|NCT00567567|2457014|P3|Overall Study|Enrolled another COG therapeutic study|0
772550|NCT00567567|2457015|P2|Overall Study|Enrolled another COG therapeutic study|80
772551|NCT00567567|2457016|P1|Overall Study|Enrolled another COG therapeutic study|99
772552|NCT00567567|2457014|P3|Overall Study|Refusal by patient/parent/guardian|122
772553|NCT00567567|2457015|P2|Overall Study|Refusal by patient/parent/guardian|16
772554|NCT00567567|2457016|P1|Overall Study|Refusal by patient/parent/guardian|9
772555|NCT00567567|2457014|P3|Overall Study|Ineligible|9
772556|NCT00567567|2457015|P2|Overall Study|Ineligible|0
772557|NCT00567567|2457016|P1|Overall Study|Ineligible|4
772558|NCT00567567|2457014|P3|Overall Study|Withdrawal by Subject|2
772559|NCT00567567|2457015|P2|Overall Study|Withdrawal by Subject|0
772560|NCT00567567|2457016|P1|Overall Study|Withdrawal by Subject|0
772561|NCT00567567|2457014|P3|Overall Study|Physician Decision|84
772562|NCT00567567|2457015|P2|Overall Study|Physician Decision|18
772563|NCT00567567|2457016|P1|Overall Study|Physician Decision|16
772564|NCT00567567|2457014|P3|Overall Study|Lost to Follow-up|1
772565|NCT00567567|2457015|P2|Overall Study|Lost to Follow-up|0
772566|NCT00567567|2457016|P1|Overall Study|Lost to Follow-up|0
772567|NCT00567567|2457014|P3|Overall Study|Lack of Efficacy|48
772568|NCT00567567|2457015|P2|Overall Study|Lack of Efficacy|17
772569|NCT00567567|2457016|P1|Overall Study|Lack of Efficacy|16
772570|NCT00567567|2457014|P3|Overall Study|Death|5
772571|NCT00567567|2457015|P2|Overall Study|Death|1
772572|NCT00567567|2457016|P1|Overall Study|Death|8
772573|NCT00567567|2457014|P3|Overall Study|Adverse Event|5
772574|NCT00567567|2457015|P2|Overall Study|Adverse Event|2
772575|NCT00567567|2457016|P1|Overall Study|Adverse Event|0
772576|NCT00567593|2457040|P1|Overall Study|Physician Decision|1
772577|NCT00567593|2457040|P1|Overall Study|Adverse Event|1
772578|NCT00573755|2457046|P2|Overall Study|Still receiving treatment|0
772579|NCT00573755|2457047|P1|Overall Study|Still receiving treatment|1
772580|NCT00573768|2457066|P3|Overall Study|Lost to Follow-up|1
772581|NCT00573768|2457067|P2|Overall Study|Lost to Follow-up|0
772582|NCT00573768|2457068|P1|Overall Study|Lost to Follow-up|0
772583|NCT00573768|2457066|P3|Overall Study|Withdrawal by Subject|0
772584|NCT00573768|2457067|P2|Overall Study|Withdrawal by Subject|1
772585|NCT00573768|2457068|P1|Overall Study|Withdrawal by Subject|0
772586|NCT00573768|2457066|P3|Overall Study|Protocol Violation|1
772587|NCT00573768|2457067|P2|Overall Study|Protocol Violation|0
772588|NCT00573768|2457068|P1|Overall Study|Protocol Violation|1
772589|NCT00573768|2457066|P3|Overall Study|Adverse Event|2
772590|NCT00573768|2457067|P2|Overall Study|Adverse Event|1
772591|NCT00573768|2457068|P1|Overall Study|Adverse Event|1
772592|NCT00573859|2457076|P1|Smoking Versus Abstinence|Scheduling conflicts|12
772593|NCT00573859|2457076|P1|Medication Versus Placebo|Scheduling conflicts|12
772594|NCT00573937|2457084|P2|Overall Study|Study Terminated|1
772595|NCT00573937|2457085|P1|Overall Study|Study Terminated|0
772596|NCT00575380|2457104|P2|Overall Study|Various|2
772597|NCT00575380|2457105|P1|Overall Study|Various|0
772598|NCT00575380|2457104|P2|Overall Study|Adverse Event|1
772599|NCT00575380|2457105|P1|Overall Study|Adverse Event|0
772600|NCT00575380|2457104|P2|Overall Study|Withdrawal by Subject|0
772601|NCT00575380|2457105|P1|Overall Study|Withdrawal by Subject|1
772602|NCT00575510|2457116|P3|Overall Study|Pregnancy|1
772603|NCT00575510|2457117|P2|Overall Study|Pregnancy|0
772604|NCT00575510|2457118|P1|Overall Study|Pregnancy|0
772605|NCT00575510|2457116|P3|Overall Study|Clinic Called Patient|7
772606|NCT00575510|2457117|P2|Overall Study|Clinic Called Patient|7
772607|NCT00575510|2457118|P1|Overall Study|Clinic Called Patient|7
772608|NCT00575510|2457116|P3|Overall Study|Withdrawal by Subject|0
772609|NCT00575510|2457117|P2|Overall Study|Withdrawal by Subject|0
772610|NCT00575510|2457118|P1|Overall Study|Withdrawal by Subject|1
772611|NCT00575510|2457116|P3|Overall Study|Lost to Follow-up|9
772612|NCT00575510|2457117|P2|Overall Study|Lost to Follow-up|6
772613|NCT00575510|2457118|P1|Overall Study|Lost to Follow-up|4
772614|NCT00575588|2457131|P2|Overall Study|Impossible to determine HbA1c|1
772615|NCT00575588|2457132|P1|Overall Study|Impossible to determine HbA1c|0
772616|NCT00575588|2457131|P2|Overall Study|Patient moved|3
772617|NCT00575588|2457132|P1|Overall Study|Patient moved|1
772618|NCT00575588|2457131|P2|Overall Study|Elevated triglyceride|0
772619|NCT00575588|2457132|P1|Overall Study|Elevated triglyceride|1
772620|NCT00575588|2457131|P2|Overall Study|Safety reasons|1
772621|NCT00575588|2457132|P1|Overall Study|Safety reasons|2
772622|NCT00575588|2457131|P2|Overall Study|Severe non-compliance to protocol|7
772623|NCT00575588|2457132|P1|Overall Study|Severe non-compliance to protocol|5
772624|NCT00575588|2457131|P2|Overall Study|Study specific discontinuation criteria|218
772625|NCT00575588|2457132|P1|Overall Study|Study specific discontinuation criteria|203
772626|NCT00575588|2457131|P2|Overall Study|Incorrect enrollment|4
772627|NCT00575588|2457132|P1|Overall Study|Incorrect enrollment|8
772628|NCT00575588|2457131|P2|Overall Study|Death|2
772629|NCT00575588|2457132|P1|Overall Study|Death|4
772630|NCT00575588|2457131|P2|Overall Study|Lost to Follow-up|3
772631|NCT00575588|2457132|P1|Overall Study|Lost to Follow-up|1
772632|NCT00575588|2457131|P2|Overall Study|Withdrawal by Subject|31
772633|NCT00575588|2457132|P1|Overall Study|Withdrawal by Subject|27
772634|NCT00575588|2457131|P2|Overall Study|Adverse Event|13
772635|NCT00575588|2457132|P1|Overall Study|Adverse Event|11
772636|NCT00575666|2457154|P2|Overall Study|Physician Decision|1
772637|NCT00575666|2457155|P1|Overall Study|Physician Decision|1
772638|NCT00575666|2457154|P2|Overall Study|Withdrawal by Subject|2
772639|NCT00575666|2457155|P1|Overall Study|Withdrawal by Subject|3
772640|NCT00576056|2457202|P1|Overall Study|Physician Decision|1
772641|NCT00576056|2457202|P1|Overall Study|did not meet eligibility criteria|8
772642|NCT00576056|2457202|P1|Overall Study|Withdrawal by Subject|2
772643|NCT00576056|2457202|P1|Overall Study|Lack of Efficacy|1
772644|NCT00576056|2457202|P1|Overall Study|Death|1
772645|NCT00576056|2457202|P1|Overall Study|Adverse Event|1
772646|NCT00576199|2457211|P1|Overall Study|Reason Unspecified|2
772647|NCT00576199|2457211|P1|Overall Study|Refused Treatment|2
772648|NCT00576199|2457211|P1|Overall Study|Insufficient Therapeutic Response|14
772649|NCT00576199|2457211|P1|Overall Study|Adverse Event|12
772650|NCT00576303|2457229|P1|Long Term Safety Period|Early withdrawal|16
772651|NCT00576303|2457229|P1|Efficacy Evaluation Period|Early withdrawal|5
772652|NCT00576303|2457229|P1|Dose Titration Period|Early withdrawal|17
772653|NCT00576316|2457238|P1|Overall Study|Protocol Violation|9
772654|NCT00576316|2457238|P1|Overall Study|Withdrawal by Subject|2
772655|NCT00576316|2457238|P1|Overall Study|Adverse Event|9
772656|NCT00576381|2457243|P1|Overall Study|Adverse Event|4
772657|NCT00576381|2457243|P1|Overall Study|Reoperation|3
772658|NCT00576420|2457250|P3|Overall Study|Death|1
772659|NCT00576420|2457251|P2|Overall Study|Death|0
772660|NCT00576420|2457252|P1|Overall Study|Death|0
772661|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
772662|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
772663|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
772664|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
772665|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
772666|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
772667|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
772668|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
772669|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
772670|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
772671|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
772672|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
772673|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
772674|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
772675|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
772676|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Medical reasons|6
772677|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Medical reasons|0
772678|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Medical reasons|0
772679|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Medical reasons|0
772680|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Medical reasons|0
772681|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Medical reasons|0
772682|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Medical reasons|0
772683|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Medical reasons|0
772684|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Medical reasons|0
772685|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Medical reasons|0
772686|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Medical reasons|0
772687|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Medical reasons|0
772688|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Medical reasons|0
772689|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Medical reasons|0
772690|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Medical reasons|0
772691|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
772692|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
772693|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
772694|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
772695|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
772696|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
772697|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
772698|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
772699|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
772700|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
772701|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
772702|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
772703|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
772704|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
772705|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
772706|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Side effects|8
772707|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Side effects|0
772708|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Side effects|0
772709|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Side effects|0
772710|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Side effects|0
772711|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Side effects|0
772712|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Side effects|0
772713|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Side effects|0
772714|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Side effects|0
772715|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Side effects|0
772716|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Side effects|0
772717|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Side effects|0
772718|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Side effects|0
772719|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Side effects|0
772720|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Side effects|0
772721|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Insufficient data|0
772722|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Insufficient data|4
772723|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Insufficient data|0
772724|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Insufficient data|0
772725|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Insufficient data|0
772726|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Insufficient data|0
772727|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Insufficient data|0
772728|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Insufficient data|0
772729|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Insufficient data|0
772730|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Insufficient data|0
772731|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Insufficient data|0
772732|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Insufficient data|0
772733|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Insufficient data|0
772734|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Insufficient data|0
772735|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Insufficient data|0
772736|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Declined to participate|0
772737|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Declined to participate|7
772738|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Declined to participate|0
772739|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Declined to participate|0
772740|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Declined to participate|0
772741|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Declined to participate|0
772742|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Declined to participate|0
772743|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Declined to participate|0
772744|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Declined to participate|0
772745|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Declined to participate|0
772746|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Declined to participate|0
772747|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Declined to participate|0
772748|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Declined to participate|0
772749|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Declined to participate|0
772750|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Declined to participate|0
772751|NCT00576472|2457432|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
772752|NCT00576472|2457433|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
772753|NCT00576472|2457434|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
772754|NCT00576472|2457435|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
772755|NCT00576472|2457436|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
772756|NCT00576472|2457437|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
772757|NCT00576472|2457438|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
772758|NCT00576472|2457439|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
772759|NCT00576472|2457440|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
772760|NCT00576472|2457441|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
772761|NCT00576472|2457442|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
772762|NCT00576472|2457443|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
772763|NCT00576472|2457444|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
772764|NCT00576472|2457445|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
772765|NCT00576472|2457446|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
772766|NCT00576472|2457432|P15|MPH Cross Over Phase|Did not complete cross over phase|0
772767|NCT00576472|2457433|P14|MPH Cross Over Phase|Did not complete cross over phase|0
772768|NCT00576472|2457434|P13|MPH Cross Over Phase|Did not complete cross over phase|0
772769|NCT00576472|2457435|P12|MPH Cross Over Phase|Did not complete cross over phase|1
772770|NCT00576472|2457436|P11|MPH Cross Over Phase|Did not complete cross over phase|1
772771|NCT00576472|2457437|P10|MPH Cross Over Phase|Did not complete cross over phase|0
772772|NCT00576472|2457438|P9|MPH Cross Over Phase|Did not complete cross over phase|2
772773|NCT00576472|2457439|P8|MPH Cross Over Phase|Did not complete cross over phase|0
772774|NCT00576472|2457440|P7|MPH Cross Over Phase|Did not complete cross over phase|0
772775|NCT00576472|2457441|P6|MPH Cross Over Phase|Did not complete cross over phase|0
772776|NCT00576472|2457442|P5|MPH Cross Over Phase|Did not complete cross over phase|0
772777|NCT00576472|2457443|P4|MPH Cross Over Phase|Did not complete cross over phase|0
772778|NCT00576472|2457444|P3|MPH Cross Over Phase|Did not complete cross over phase|0
772779|NCT00576472|2457445|P2|MPH Cross Over Phase|Did not complete cross over phase|0
772780|NCT00576472|2457446|P1|MPH Cross Over Phase|Did not complete cross over phase|0
772781|NCT00576472|2457432|P15|MPH Cross Over Phase|Physician Decision|0
772782|NCT00576472|2457433|P14|MPH Cross Over Phase|Physician Decision|0
772783|NCT00576472|2457434|P13|MPH Cross Over Phase|Physician Decision|0
772784|NCT00576472|2457435|P12|MPH Cross Over Phase|Physician Decision|0
772785|NCT00576472|2457436|P11|MPH Cross Over Phase|Physician Decision|0
772786|NCT00576472|2457437|P10|MPH Cross Over Phase|Physician Decision|0
772787|NCT00576472|2457438|P9|MPH Cross Over Phase|Physician Decision|0
772788|NCT00576472|2457439|P8|MPH Cross Over Phase|Physician Decision|0
772789|NCT00576472|2457440|P7|MPH Cross Over Phase|Physician Decision|4
772790|NCT00576472|2457441|P6|MPH Cross Over Phase|Physician Decision|0
772791|NCT00576472|2457442|P5|MPH Cross Over Phase|Physician Decision|0
772792|NCT00576472|2457443|P4|MPH Cross Over Phase|Physician Decision|0
772793|NCT00576472|2457444|P3|MPH Cross Over Phase|Physician Decision|0
772794|NCT00576472|2457445|P2|MPH Cross Over Phase|Physician Decision|0
772795|NCT00576472|2457446|P1|MPH Cross Over Phase|Physician Decision|0
772796|NCT00576472|2457432|P15|MPH Cross Over Phase|Ineligible due to disease|0
772797|NCT00576472|2457433|P14|MPH Cross Over Phase|Ineligible due to disease|0
772798|NCT00576472|2457434|P13|MPH Cross Over Phase|Ineligible due to disease|0
772799|NCT00576472|2457435|P12|MPH Cross Over Phase|Ineligible due to disease|0
772800|NCT00576472|2457436|P11|MPH Cross Over Phase|Ineligible due to disease|0
772801|NCT00576472|2457437|P10|MPH Cross Over Phase|Ineligible due to disease|0
772802|NCT00576472|2457438|P9|MPH Cross Over Phase|Ineligible due to disease|0
772803|NCT00576472|2457439|P8|MPH Cross Over Phase|Ineligible due to disease|0
772804|NCT00576472|2457440|P7|MPH Cross Over Phase|Ineligible due to disease|2
772805|NCT00576472|2457441|P6|MPH Cross Over Phase|Ineligible due to disease|0
772806|NCT00576472|2457442|P5|MPH Cross Over Phase|Ineligible due to disease|0
772807|NCT00576472|2457443|P4|MPH Cross Over Phase|Ineligible due to disease|0
772808|NCT00576472|2457444|P3|MPH Cross Over Phase|Ineligible due to disease|0
772809|NCT00576472|2457445|P2|MPH Cross Over Phase|Ineligible due to disease|0
772810|NCT00576472|2457446|P1|MPH Cross Over Phase|Ineligible due to disease|0
772811|NCT00576472|2457432|P15|MPH Cross Over Phase|Withdrawal by Subject|0
772812|NCT00576472|2457433|P14|MPH Cross Over Phase|Withdrawal by Subject|0
772813|NCT00576472|2457434|P13|MPH Cross Over Phase|Withdrawal by Subject|0
772814|NCT00576472|2457435|P12|MPH Cross Over Phase|Withdrawal by Subject|0
772815|NCT00576472|2457436|P11|MPH Cross Over Phase|Withdrawal by Subject|0
772816|NCT00576472|2457437|P10|MPH Cross Over Phase|Withdrawal by Subject|0
772817|NCT00576472|2457438|P9|MPH Cross Over Phase|Withdrawal by Subject|0
772818|NCT00576472|2457439|P8|MPH Cross Over Phase|Withdrawal by Subject|0
772819|NCT00576472|2457440|P7|MPH Cross Over Phase|Withdrawal by Subject|6
772820|NCT00576472|2457441|P6|MPH Cross Over Phase|Withdrawal by Subject|0
772821|NCT00576472|2457442|P5|MPH Cross Over Phase|Withdrawal by Subject|0
772822|NCT00576472|2457443|P4|MPH Cross Over Phase|Withdrawal by Subject|0
772823|NCT00576472|2457444|P3|MPH Cross Over Phase|Withdrawal by Subject|0
772824|NCT00576472|2457445|P2|MPH Cross Over Phase|Withdrawal by Subject|0
772825|NCT00576472|2457446|P1|MPH Cross Over Phase|Withdrawal by Subject|0
772826|NCT00576472|2457432|P15|MPH In-Lab Phase|Psychiatric exclusion|0
772827|NCT00576472|2457433|P14|MPH In-Lab Phase|Psychiatric exclusion|0
772828|NCT00576472|2457434|P13|MPH In-Lab Phase|Psychiatric exclusion|0
772829|NCT00576472|2457435|P12|MPH In-Lab Phase|Psychiatric exclusion|0
772830|NCT00576472|2457436|P11|MPH In-Lab Phase|Psychiatric exclusion|0
772831|NCT00576472|2457437|P10|MPH In-Lab Phase|Psychiatric exclusion|0
772832|NCT00576472|2457438|P9|MPH In-Lab Phase|Psychiatric exclusion|0
772833|NCT00576472|2457439|P8|MPH In-Lab Phase|Psychiatric exclusion|0
772834|NCT00576472|2457440|P7|MPH In-Lab Phase|Psychiatric exclusion|0
772835|NCT00576472|2457441|P6|MPH In-Lab Phase|Psychiatric exclusion|0
772836|NCT00576472|2457442|P5|MPH In-Lab Phase|Psychiatric exclusion|0
772837|NCT00576472|2457443|P4|MPH In-Lab Phase|Psychiatric exclusion|10
772838|NCT00576472|2457444|P3|MPH In-Lab Phase|Psychiatric exclusion|0
772839|NCT00576472|2457445|P2|MPH In-Lab Phase|Psychiatric exclusion|0
772840|NCT00576472|2457446|P1|MPH In-Lab Phase|Psychiatric exclusion|0
772841|NCT00576472|2457432|P15|MPH In-Lab Phase|No attention/academic problems|0
772842|NCT00576472|2457433|P14|MPH In-Lab Phase|No attention/academic problems|0
772843|NCT00576472|2457434|P13|MPH In-Lab Phase|No attention/academic problems|0
772844|NCT00576472|2457435|P12|MPH In-Lab Phase|No attention/academic problems|0
772845|NCT00576472|2457436|P11|MPH In-Lab Phase|No attention/academic problems|0
772846|NCT00576472|2457437|P10|MPH In-Lab Phase|No attention/academic problems|0
772847|NCT00576472|2457438|P9|MPH In-Lab Phase|No attention/academic problems|0
772848|NCT00576472|2457439|P8|MPH In-Lab Phase|No attention/academic problems|0
772849|NCT00576472|2457440|P7|MPH In-Lab Phase|No attention/academic problems|0
772850|NCT00576472|2457441|P6|MPH In-Lab Phase|No attention/academic problems|0
772851|NCT00576472|2457442|P5|MPH In-Lab Phase|No attention/academic problems|0
772852|NCT00576472|2457443|P4|MPH In-Lab Phase|No attention/academic problems|245
772853|NCT00576472|2457444|P3|MPH In-Lab Phase|No attention/academic problems|0
772854|NCT00576472|2457445|P2|MPH In-Lab Phase|No attention/academic problems|0
772855|NCT00576472|2457446|P1|MPH In-Lab Phase|No attention/academic problems|0
772856|NCT00576472|2457432|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772857|NCT00576472|2457433|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772858|NCT00576472|2457434|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772859|NCT00576472|2457435|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772860|NCT00576472|2457436|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772861|NCT00576472|2457437|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772862|NCT00576472|2457438|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772863|NCT00576472|2457439|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772864|NCT00576472|2457440|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772865|NCT00576472|2457441|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772866|NCT00576472|2457442|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772867|NCT00576472|2457443|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
772868|NCT00576472|2457444|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772869|NCT00576472|2457445|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772870|NCT00576472|2457446|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
772871|NCT00576472|2457432|P15|MPH In-Lab Phase|Lost to Follow-up|0
772872|NCT00576472|2457433|P14|MPH In-Lab Phase|Lost to Follow-up|0
772873|NCT00576472|2457434|P13|MPH In-Lab Phase|Lost to Follow-up|0
772874|NCT00576472|2457435|P12|MPH In-Lab Phase|Lost to Follow-up|0
772875|NCT00576472|2457436|P11|MPH In-Lab Phase|Lost to Follow-up|0
772876|NCT00576472|2457437|P10|MPH In-Lab Phase|Lost to Follow-up|0
772877|NCT00576472|2457438|P9|MPH In-Lab Phase|Lost to Follow-up|0
772878|NCT00576472|2457439|P8|MPH In-Lab Phase|Lost to Follow-up|0
772879|NCT00576472|2457440|P7|MPH In-Lab Phase|Lost to Follow-up|0
772880|NCT00576472|2457441|P6|MPH In-Lab Phase|Lost to Follow-up|0
772881|NCT00576472|2457442|P5|MPH In-Lab Phase|Lost to Follow-up|0
772882|NCT00576472|2457443|P4|MPH In-Lab Phase|Lost to Follow-up|1
772883|NCT00576472|2457444|P3|MPH In-Lab Phase|Lost to Follow-up|0
772884|NCT00576472|2457445|P2|MPH In-Lab Phase|Lost to Follow-up|0
772885|NCT00576472|2457446|P1|MPH In-Lab Phase|Lost to Follow-up|0
772886|NCT00576472|2457432|P15|MPH In-Lab Phase|Declined participation in medication pha|0
772887|NCT00576472|2457433|P14|MPH In-Lab Phase|Declined participation in medication pha|0
772888|NCT00576472|2457434|P13|MPH In-Lab Phase|Declined participation in medication pha|0
772889|NCT00576472|2457435|P12|MPH In-Lab Phase|Declined participation in medication pha|0
772890|NCT00576472|2457436|P11|MPH In-Lab Phase|Declined participation in medication pha|0
772891|NCT00576472|2457437|P10|MPH In-Lab Phase|Declined participation in medication pha|0
772892|NCT00576472|2457438|P9|MPH In-Lab Phase|Declined participation in medication pha|0
772893|NCT00576472|2457439|P8|MPH In-Lab Phase|Declined participation in medication pha|0
772894|NCT00576472|2457440|P7|MPH In-Lab Phase|Declined participation in medication pha|0
772895|NCT00576472|2457441|P6|MPH In-Lab Phase|Declined participation in medication pha|0
772896|NCT00576472|2457442|P5|MPH In-Lab Phase|Declined participation in medication pha|0
772897|NCT00576472|2457443|P4|MPH In-Lab Phase|Declined participation in medication pha|75
772898|NCT00576472|2457444|P3|MPH In-Lab Phase|Declined participation in medication pha|0
772899|NCT00576472|2457445|P2|MPH In-Lab Phase|Declined participation in medication pha|0
772900|NCT00576472|2457446|P1|MPH In-Lab Phase|Declined participation in medication pha|0
772901|NCT00576576|2457549|P1|Overall Study|Protocol Violation|1
772902|NCT00576576|2457549|P1|Overall Study|Lost to Follow-up|6
772903|NCT00576628|2457555|P1|Overall Study|Dialysis|15
772904|NCT00576628|2457555|P1|Overall Study|Transplantation|1
772905|NCT00576628|2457555|P1|Overall Study|The patient move into other town|1
772906|NCT00576628|2457555|P1|Overall Study|Progression of Renal Failure|1
772907|NCT00576628|2457555|P1|Overall Study|Progression of Kidney Disease|1
772908|NCT00576628|2457555|P1|Overall Study|RBC transfusion|1
772909|NCT00576628|2457555|P1|Overall Study|Pregnancy|1
772910|NCT00576628|2457555|P1|Overall Study|Refused Treatment|8
772911|NCT00576628|2457555|P1|Overall Study|Failure to return|1
772912|NCT00576628|2457555|P1|Overall Study|Death|2
772913|NCT00576628|2457555|P1|Overall Study|Adverse Event|11
772914|NCT00576693|2457577|P2|Overall Study|Withdrawal by Subject|13
772915|NCT00576693|2457578|P1|Overall Study|Withdrawal by Subject|3
772916|NCT00576693|2457577|P2|Overall Study|Lost to Follow-up|11
772917|NCT00576693|2457578|P1|Overall Study|Lost to Follow-up|7
772918|NCT00576732|2457587|P6|OPEN LABEL|Protocol Violation|0
772919|NCT00576732|2457588|P5|OPEN LABEL|Protocol Violation|1
772920|NCT00576732|2457589|P4|OPEN LABEL|Protocol Violation|2
772921|NCT00576732|2457590|P3|OPEN LABEL|Protocol Violation|0
772922|NCT00576732|2457591|P2|OPEN LABEL|Protocol Violation|0
772923|NCT00576732|2457592|P1|OPEN LABEL|Protocol Violation|0
772924|NCT00576732|2457587|P6|OPEN LABEL|Lack of Efficacy|3
772925|NCT00576732|2457588|P5|OPEN LABEL|Lack of Efficacy|2
772926|NCT00576732|2457589|P4|OPEN LABEL|Lack of Efficacy|2
772927|NCT00576732|2457590|P3|OPEN LABEL|Lack of Efficacy|0
772928|NCT00576732|2457591|P2|OPEN LABEL|Lack of Efficacy|0
772929|NCT00576732|2457592|P1|OPEN LABEL|Lack of Efficacy|0
772930|NCT00576732|2457587|P6|OPEN LABEL|OTHER|2
772931|NCT00576732|2457588|P5|OPEN LABEL|OTHER|0
772932|NCT00576732|2457589|P4|OPEN LABEL|OTHER|0
772933|NCT00576732|2457590|P3|OPEN LABEL|OTHER|0
772934|NCT00576732|2457591|P2|OPEN LABEL|OTHER|0
772935|NCT00576732|2457592|P1|OPEN LABEL|OTHER|0
772936|NCT00576732|2457587|P6|OPEN LABEL|Withdrawal by Subject|1
772937|NCT00576732|2457588|P5|OPEN LABEL|Withdrawal by Subject|0
772938|NCT00576732|2457589|P4|OPEN LABEL|Withdrawal by Subject|1
772939|NCT00576732|2457590|P3|OPEN LABEL|Withdrawal by Subject|0
772940|NCT00576732|2457591|P2|OPEN LABEL|Withdrawal by Subject|0
772941|NCT00576732|2457592|P1|OPEN LABEL|Withdrawal by Subject|0
772942|NCT00576732|2457587|P6|OPEN LABEL|Lost to Follow-up|1
772943|NCT00576732|2457588|P5|OPEN LABEL|Lost to Follow-up|1
772944|NCT00576732|2457589|P4|OPEN LABEL|Lost to Follow-up|2
772945|NCT00576732|2457590|P3|OPEN LABEL|Lost to Follow-up|0
772946|NCT00576732|2457591|P2|OPEN LABEL|Lost to Follow-up|0
772947|NCT00576732|2457592|P1|OPEN LABEL|Lost to Follow-up|0
772948|NCT00576732|2457587|P6|OPEN LABEL|Adverse Event|1
772949|NCT00576732|2457588|P5|OPEN LABEL|Adverse Event|0
772950|NCT00576732|2457589|P4|OPEN LABEL|Adverse Event|4
772951|NCT00576732|2457590|P3|OPEN LABEL|Adverse Event|0
772952|NCT00576732|2457591|P2|OPEN LABEL|Adverse Event|0
772953|NCT00576732|2457592|P1|OPEN LABEL|Adverse Event|0
772954|NCT00576732|2457587|P6|DOUBLE BLIND|Protocol Violation|0
772955|NCT00576732|2457588|P5|DOUBLE BLIND|Protocol Violation|0
772956|NCT00576732|2457589|P4|DOUBLE BLIND|Protocol Violation|0
772957|NCT00576732|2457590|P3|DOUBLE BLIND|Protocol Violation|0
772958|NCT00576732|2457591|P2|DOUBLE BLIND|Protocol Violation|0
772959|NCT00576732|2457592|P1|DOUBLE BLIND|Protocol Violation|1
772960|NCT00576732|2457587|P6|DOUBLE BLIND|Lack of Efficacy|0
772961|NCT00576732|2457588|P5|DOUBLE BLIND|Lack of Efficacy|0
772962|NCT00576732|2457589|P4|DOUBLE BLIND|Lack of Efficacy|0
772963|NCT00576732|2457590|P3|DOUBLE BLIND|Lack of Efficacy|0
772964|NCT00576732|2457591|P2|DOUBLE BLIND|Lack of Efficacy|1
772965|NCT00576732|2457592|P1|DOUBLE BLIND|Lack of Efficacy|6
772966|NCT00576732|2457587|P6|DOUBLE BLIND|OTHER|0
772967|NCT00576732|2457588|P5|DOUBLE BLIND|OTHER|0
772968|NCT00576732|2457589|P4|DOUBLE BLIND|OTHER|0
772969|NCT00576732|2457590|P3|DOUBLE BLIND|OTHER|1
772970|NCT00576732|2457591|P2|DOUBLE BLIND|OTHER|2
772971|NCT00576732|2457592|P1|DOUBLE BLIND|OTHER|0
772972|NCT00576732|2457587|P6|DOUBLE BLIND|Withdrawal by Subject|0
772973|NCT00576732|2457588|P5|DOUBLE BLIND|Withdrawal by Subject|0
772974|NCT00576732|2457589|P4|DOUBLE BLIND|Withdrawal by Subject|0
772975|NCT00576732|2457590|P3|DOUBLE BLIND|Withdrawal by Subject|3
772976|NCT00576732|2457591|P2|DOUBLE BLIND|Withdrawal by Subject|1
772977|NCT00576732|2457592|P1|DOUBLE BLIND|Withdrawal by Subject|1
772978|NCT00576732|2457587|P6|DOUBLE BLIND|Lost to Follow-up|0
772979|NCT00576732|2457588|P5|DOUBLE BLIND|Lost to Follow-up|0
772980|NCT00576732|2457589|P4|DOUBLE BLIND|Lost to Follow-up|0
772981|NCT00576732|2457590|P3|DOUBLE BLIND|Lost to Follow-up|1
772982|NCT00576732|2457591|P2|DOUBLE BLIND|Lost to Follow-up|1
772983|NCT00576732|2457592|P1|DOUBLE BLIND|Lost to Follow-up|0
772984|NCT00576732|2457587|P6|DOUBLE BLIND|Adverse Event|0
772985|NCT00576732|2457588|P5|DOUBLE BLIND|Adverse Event|0
772986|NCT00576732|2457589|P4|DOUBLE BLIND|Adverse Event|0
772987|NCT00576732|2457590|P3|DOUBLE BLIND|Adverse Event|1
772988|NCT00576732|2457591|P2|DOUBLE BLIND|Adverse Event|0
772989|NCT00576732|2457592|P1|DOUBLE BLIND|Adverse Event|0
772990|NCT00576758|2457624|P2|Follow-up Period|Withdrew consent|1
772991|NCT00576758|2457625|P1|Follow-up Period|Withdrew consent|2
772992|NCT00576758|2457624|P2|Follow-up Period|Insufficient therapeutic response|5
772993|NCT00576758|2457625|P1|Follow-up Period|Insufficient therapeutic response|16
772994|NCT00576758|2457624|P2|Follow-up Period|Death|3
772995|NCT00576758|2457625|P1|Follow-up Period|Death|3
772996|NCT00576758|2457624|P2|Follow-up Period|Administrative/Other|8
772997|NCT00576758|2457625|P1|Follow-up Period|Administrative/Other|6
772998|NCT00576758|2457624|P2|Extension Treatment Period|Administrative/Other|1
772999|NCT00576758|2457625|P1|Extension Treatment Period|Administrative/Other|3
773000|NCT00576758|2457624|P2|Extension Treatment Period|Insufficient therapeutic response|33
773001|NCT00576758|2457625|P1|Extension Treatment Period|Insufficient therapeutic response|30
773002|NCT00576758|2457624|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
773003|NCT00576758|2457625|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
773004|NCT00576758|2457624|P2|Extension Treatment Period|Death|1
773005|NCT00576758|2457625|P1|Extension Treatment Period|Death|1
773006|NCT00576758|2457624|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
773007|NCT00576758|2457625|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
773008|NCT00576758|2457624|P2|Induction Treatment Period|Withdrew consent|0
773009|NCT00576758|2457625|P1|Induction Treatment Period|Withdrew consent|1
773010|NCT00576758|2457624|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
773011|NCT00576758|2457625|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
773012|NCT00576758|2457624|P2|Induction Treatment Period|Death|0
773013|NCT00576758|2457625|P1|Induction Treatment Period|Death|1
773014|NCT00576758|2457624|P2|Induction Treatment Period|Violation of selection criteria at entry|1
773015|NCT00576758|2457625|P1|Induction Treatment Period|Violation of selection criteria at entry|1
773016|NCT00576758|2457624|P2|Induction Treatment Period|Insufficient therapeutic response|0
773017|NCT00576758|2457625|P1|Induction Treatment Period|Insufficient therapeutic response|2
773018|NCT00576758|2457624|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
773019|NCT00576758|2457625|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
773020|NCT00576823|2457671|P3|40-week Safety Extension Phase|Lack of Efficacy|0
773021|NCT00576823|2457672|P2|40-week Safety Extension Phase|Lack of Efficacy|0
773022|NCT00576823|2457673|P1|40-week Safety Extension Phase|Lack of Efficacy|1
773023|NCT00576823|2457671|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
773024|NCT00576823|2457672|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
773025|NCT00576823|2457673|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
773026|NCT00576901|2457687|P1|Overall Study|Protocol Violation|1
773027|NCT00576901|2457687|P1|Overall Study|Disease course|1
773028|NCT00576901|2457687|P1|Overall Study|Withdrawal by Subject|1
773029|NCT00576927|2457697|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
773030|NCT00576927|2457697|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
773031|NCT00576927|2457697|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
773032|NCT00576927|2457697|P1|Sleep Hygiene Behavioral Intervention|Death|1
773033|NCT00576927|2457697|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
773034|NCT00576927|2457697|P1|Baseline|Withdrawal by Subject|3
773035|NCT00576927|2457697|P1|Baseline|Medication Change by PCP of subject|1
773036|NCT00576927|2457697|P1|Baseline|Physician Decision|9
773037|NCT00576927|2457697|P1|Clinical Assessment|Physician Decision|1
773038|NCT00576927|2457697|P1|Clinical Assessment|Withdrawal by Subject|10
773039|NCT00576927|2457697|P1|Clinical Assessment|Death|1
773040|NCT00576927|2457697|P1|Clinical Assessment|Lack of Efficacy|24
773041|NCT00577005|2457711|P2|Overall Study|Withdrawal by Subject|1
773042|NCT00577005|2457712|P1|Overall Study|Withdrawal by Subject|2
773043|NCT00577005|2457711|P2|Overall Study|Lost to Follow-up|2
773044|NCT00577005|2457712|P1|Overall Study|Lost to Follow-up|3
773045|NCT00577031|2457724|P1|Overall Study|Death|6
773046|NCT00577031|2457724|P1|Overall Study|Medical decision|14
773047|NCT00577031|2457724|P1|Overall Study|Need for surgery|17
773048|NCT00577031|2457724|P1|Overall Study|Participant non-compliance|5
773049|NCT00577031|2457724|P1|Overall Study|Participant withdrew consent|13
773050|NCT00577031|2457724|P1|Overall Study|Protocol Violation|5
773051|NCT00577031|2457724|P1|Overall Study|Progression of disease|93
773052|NCT00577031|2457724|P1|Overall Study|Adverse Event|52
773053|NCT00577096|2457754|P2|Short Term Participation|Death|1
773054|NCT00577096|2457755|P1|Short Term Participation|Death|1
773055|NCT00577096|2457754|P2|Short Term Participation|Withdrawal by Subject|5
773056|NCT00577096|2457755|P1|Short Term Participation|Withdrawal by Subject|3
773057|NCT00577096|2457754|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
773058|NCT00577096|2457755|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
773059|NCT00577122|2457781|P2|Overall Study|Alternative Therapy|1
773060|NCT00577122|2457782|P1|Overall Study|Alternative Therapy|0
773061|NCT00577122|2457781|P2|Overall Study|Prog, refract disease during active trt|5
773062|NCT00577122|2457782|P1|Overall Study|Prog, refract disease during active trt|8
773063|NCT00577122|2457781|P2|Overall Study|Progression, relapse during active trt|8
773064|NCT00577122|2457782|P1|Overall Study|Progression, relapse during active trt|6
773065|NCT00577122|2457781|P2|Overall Study|Adverse Event|2
773066|NCT00577122|2457782|P1|Overall Study|Adverse Event|0
773067|NCT00577382|2457925|P2|Overall Study|Lost to Follow-up|2
773068|NCT00577382|2457926|P1|Overall Study|Lost to Follow-up|2
773069|NCT00577382|2457925|P2|Overall Study|Death|1
773070|NCT00577382|2457926|P1|Overall Study|Death|1
773071|NCT00577382|2457925|P2|Overall Study|Intercurrent Illness|2
773072|NCT00577382|2457926|P1|Overall Study|Intercurrent Illness|1
773073|NCT00577382|2457925|P2|Overall Study|Progressive Disease|19
773074|NCT00577382|2457926|P1|Overall Study|Progressive Disease|17
773075|NCT00577382|2457925|P2|Overall Study|Withdrawal by Subject|1
773076|NCT00577382|2457926|P1|Overall Study|Withdrawal by Subject|0
773077|NCT00577382|2457925|P2|Overall Study|Adverse Event|6
773078|NCT00577382|2457926|P1|Overall Study|Adverse Event|0
773079|NCT00577395|2457940|P2|Overall Study|Study was terminated early by Sponsor|6
773080|NCT00577395|2457941|P1|Overall Study|Study was terminated early by Sponsor|7
773081|NCT00577408|2457951|P2|Overall Study|Psychiatric hospitalization|1
773082|NCT00577408|2457952|P1|Overall Study|Psychiatric hospitalization|0
773083|NCT00577408|2457951|P2|Overall Study|Death|1
773084|NCT00577408|2457952|P1|Overall Study|Death|0
773085|NCT00577408|2457951|P2|Overall Study|Scheduling Issues|3
773086|NCT00577408|2457952|P1|Overall Study|Scheduling Issues|0
773087|NCT00577408|2457951|P2|Overall Study|Moved out of state|1
773088|NCT00577408|2457952|P1|Overall Study|Moved out of state|0
773089|NCT00577408|2457951|P2|Overall Study|Refused Oral Naltrexone|1
773090|NCT00577408|2457952|P1|Overall Study|Refused Oral Naltrexone|0
773091|NCT00577408|2457951|P2|Overall Study|Non-compliance with study meds|3
773092|NCT00577408|2457952|P1|Overall Study|Non-compliance with study meds|0
773093|NCT00577408|2457951|P2|Overall Study|Continued opioid use|2
773094|NCT00577408|2457952|P1|Overall Study|Continued opioid use|3
773095|NCT00577408|2457951|P2|Overall Study|Stopped attending study visits|11
773096|NCT00577408|2457952|P1|Overall Study|Stopped attending study visits|9
773097|NCT00577460|2457961|P3|Overall Study|not specified|2
773098|NCT00577460|2457962|P2|Overall Study|not specified|3
773099|NCT00577460|2457963|P1|Overall Study|not specified|0
773100|NCT00577460|2457961|P3|Overall Study|Withdrawal by Subject|6
773101|NCT00577460|2457962|P2|Overall Study|Withdrawal by Subject|5
773102|NCT00577460|2457963|P1|Overall Study|Withdrawal by Subject|5
773103|NCT00577460|2457961|P3|Overall Study|Lost to Follow-up|4
773104|NCT00577460|2457962|P2|Overall Study|Lost to Follow-up|3
773105|NCT00577460|2457963|P1|Overall Study|Lost to Follow-up|0
773106|NCT00577460|2457961|P3|Overall Study|Protocol Violation|1
773107|NCT00577460|2457962|P2|Overall Study|Protocol Violation|1
773108|NCT00577460|2457963|P1|Overall Study|Protocol Violation|0
773109|NCT00577460|2457961|P3|Overall Study|Adverse Event|14
773110|NCT00577460|2457962|P2|Overall Study|Adverse Event|7
773111|NCT00577460|2457963|P1|Overall Study|Adverse Event|11
773112|NCT00577473|2458072|P2|Overall Study|Lack of Efficacy|7
773113|NCT00577473|2458073|P1|Overall Study|Lack of Efficacy|8
773114|NCT00577473|2458072|P2|Overall Study|Physician Decision|2
773115|NCT00577473|2458073|P1|Overall Study|Physician Decision|2
773116|NCT00577473|2458072|P2|Overall Study|Withdrawal by Subject|6
773117|NCT00577473|2458073|P1|Overall Study|Withdrawal by Subject|2
773118|NCT00577473|2458072|P2|Overall Study|Adverse Event|5
773119|NCT00577473|2458073|P1|Overall Study|Adverse Event|8
773120|NCT00577473|2458072|P2|Overall Study|Protocol Violation|4
773121|NCT00577473|2458073|P1|Overall Study|Protocol Violation|1
773122|NCT00577629|2458105|P1|Long Term Follow-Up|Physician Decision|1
773123|NCT00577629|2458105|P1|Long Term Follow-Up|Withdrawal by Subject|4
773124|NCT00577629|2458105|P1|Long Term Follow-Up|Lost to Follow-up|5
773125|NCT00577629|2458105|P1|Long Term Follow-Up|Death|15
773126|NCT00577629|2458105|P1|Treatment Period|Death|1
773127|NCT00577642|2458113|P1|Overall Study|Clinical Disease Progression|1
773128|NCT00577655|2458119|P2|Overall Study|Lost to Follow-up|1
773129|NCT00577655|2458120|P1|Overall Study|Lost to Follow-up|1
773130|NCT00577655|2458119|P2|Overall Study|Protocol Violation|1
773131|NCT00577655|2458120|P1|Overall Study|Protocol Violation|0
773132|NCT00577655|2458119|P2|Overall Study|Patient Request|2
773133|NCT00577655|2458120|P1|Overall Study|Patient Request|0
773134|NCT00577707|2458158|P1|Overall Study|Withdrawal by Subject|3
773135|NCT00577720|2458166|P4|Overall Study|Withdrawal by Subject|2
773136|NCT00577720|2458167|P3|Overall Study|Withdrawal by Subject|0
773137|NCT00577720|2458168|P2|Overall Study|Withdrawal by Subject|0
773138|NCT00577720|2458169|P1|Overall Study|Withdrawal by Subject|2
773139|NCT00577720|2458166|P4|Overall Study|Protocol Violation|1
773140|NCT00577720|2458167|P3|Overall Study|Protocol Violation|0
773141|NCT00577720|2458168|P2|Overall Study|Protocol Violation|0
773142|NCT00577720|2458169|P1|Overall Study|Protocol Violation|0
773143|NCT00577720|2458166|P4|Overall Study|Lost to Follow-up|0
773144|NCT00577720|2458167|P3|Overall Study|Lost to Follow-up|1
773145|NCT00577720|2458168|P2|Overall Study|Lost to Follow-up|0
773146|NCT00577720|2458169|P1|Overall Study|Lost to Follow-up|0
773147|NCT00577720|2458166|P4|Overall Study|Adverse Event|4
773148|NCT00577720|2458167|P3|Overall Study|Adverse Event|0
773149|NCT00577720|2458168|P2|Overall Study|Adverse Event|1
773150|NCT00577720|2458169|P1|Overall Study|Adverse Event|2
773151|NCT00577772|2458189|P2|Overall Study|Lost to Follow-up|1
773152|NCT00577772|2458190|P1|Overall Study|Lost to Follow-up|0
773153|NCT00577824|2458199|P3|Overall Study|Protocol Violation|0
773154|NCT00577824|2458200|P2|Overall Study|Protocol Violation|1
773155|NCT00577824|2458201|P1|Overall Study|Protocol Violation|1
773156|NCT00577824|2458199|P3|Overall Study|Patient decision|1
773157|NCT00577824|2458200|P2|Overall Study|Patient decision|1
773158|NCT00577824|2458201|P1|Overall Study|Patient decision|0
773159|NCT00577824|2458199|P3|Overall Study|Adverse Event|1
773160|NCT00577824|2458200|P2|Overall Study|Adverse Event|18
773161|NCT00577824|2458201|P1|Overall Study|Adverse Event|6
773162|NCT00577863|2458259|P2|Overall Study|Did Not Receive at Least One Injection|1
773163|NCT00577863|2458260|P1|Overall Study|Did Not Receive at Least One Injection|0
773164|NCT00577863|2458259|P2|Overall Study|Sponsor Decision|7
773165|NCT00577863|2458260|P1|Overall Study|Sponsor Decision|2
773166|NCT00577863|2458259|P2|Overall Study|Withdrawal by Subject|2
773167|NCT00577863|2458260|P1|Overall Study|Withdrawal by Subject|0
773168|NCT00577863|2458259|P2|Overall Study|Entry Criteria Exclusion|0
773169|NCT00577863|2458260|P1|Overall Study|Entry Criteria Exclusion|1
773170|NCT00577863|2458259|P2|Overall Study|Lost to Follow-up|2
773171|NCT00577863|2458260|P1|Overall Study|Lost to Follow-up|2
773172|NCT00577863|2458259|P2|Overall Study|Death|0
773173|NCT00577863|2458260|P1|Overall Study|Death|1
773174|NCT00577863|2458259|P2|Overall Study|Adverse Event|2
773175|NCT00577863|2458260|P1|Overall Study|Adverse Event|4
773176|NCT00564733|2458327|P1|Overall Study|Ineligible|5
773177|NCT00564733|2458327|P1|Overall Study|Withdrawal by Subject|4
773178|NCT00564850|2458331|P1|Overall Study|Protocol Violation|2
773179|NCT00564889|2458356|P1|Overall Study|Other, not specified|4
773180|NCT00564889|2458356|P1|Overall Study|Disease progression|3
773181|NCT00564889|2458356|P1|Overall Study|Alternative treatment|3
773182|NCT00564889|2458356|P1|Overall Study|Adverse Event|12
773183|NCT00564889|2458356|P1|Overall Study|Death|7
773184|NCT00564902|2458367|P3|Overall Study|Death|0
773185|NCT00564902|2458368|P2|Overall Study|Death|1
773186|NCT00564902|2458369|P1|Overall Study|Death|1
773187|NCT00564902|2458367|P3|Overall Study|Withdrawal by Subject|4
773188|NCT00564902|2458368|P2|Overall Study|Withdrawal by Subject|3
773189|NCT00564902|2458369|P1|Overall Study|Withdrawal by Subject|0
773197|NCT00570687|2458464|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773198|NCT00570687|2458465|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773199|NCT00570687|2458466|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773200|NCT00570687|2458467|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
773201|NCT00570687|2458468|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773202|NCT00570687|2458469|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773203|NCT00570687|2458470|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773204|NCT00570687|2458471|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773205|NCT00570687|2458472|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773206|NCT00570687|2458473|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773207|NCT00570687|2458464|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773208|NCT00570687|2458465|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
773209|NCT00570687|2458466|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773210|NCT00570687|2458467|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773211|NCT00570687|2458468|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773212|NCT00570687|2458469|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773213|NCT00570687|2458470|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773214|NCT00570687|2458471|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773215|NCT00570687|2458472|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773216|NCT00570687|2458473|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773217|NCT00570687|2458464|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
773218|NCT00570687|2458465|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
773219|NCT00570687|2458466|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
773220|NCT00570687|2458467|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
773221|NCT00570687|2458468|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
773222|NCT00570687|2458469|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
773223|NCT00570687|2458470|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773224|NCT00570687|2458471|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773225|NCT00570687|2458472|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773226|NCT00570687|2458473|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
773227|NCT00570713|2458501|P2|Overall Study|Discontinuation of Study by the Sponsor|7
773228|NCT00570713|2458502|P1|Overall Study|Discontinuation of Study by the Sponsor|10
773229|NCT00570713|2458501|P2|Overall Study|Withdrawal by Subject|3
773230|NCT00570713|2458502|P1|Overall Study|Withdrawal by Subject|3
773231|NCT00570713|2458501|P2|Overall Study|Physician Decision|2
773232|NCT00570713|2458502|P1|Overall Study|Physician Decision|2
773233|NCT00570713|2458501|P2|Overall Study|Lack of Efficacy|49
773234|NCT00570713|2458502|P1|Overall Study|Lack of Efficacy|40
773235|NCT00570713|2458501|P2|Overall Study|Death|7
773236|NCT00570713|2458502|P1|Overall Study|Death|7
773237|NCT00570713|2458501|P2|Overall Study|Adverse Event|9
773238|NCT00570713|2458502|P1|Overall Study|Adverse Event|16
773239|NCT00570739|2458516|P4|Overall Study|Not specified|3
773240|NCT00570739|2458517|P3|Overall Study|Not specified|5
773241|NCT00570739|2458518|P2|Overall Study|Not specified|2
773242|NCT00570739|2458519|P1|Overall Study|Not specified|0
773243|NCT00570739|2458516|P4|Overall Study|Met discontinuation criteria|1
773244|NCT00570739|2458517|P3|Overall Study|Met discontinuation criteria|1
773245|NCT00570739|2458518|P2|Overall Study|Met discontinuation criteria|0
773246|NCT00570739|2458519|P1|Overall Study|Met discontinuation criteria|1
773247|NCT00570739|2458516|P4|Overall Study|Required restricted medication|0
773248|NCT00570739|2458517|P3|Overall Study|Required restricted medication|1
773249|NCT00570739|2458518|P2|Overall Study|Required restricted medication|0
773250|NCT00570739|2458519|P1|Overall Study|Required restricted medication|0
773251|NCT00570739|2458516|P4|Overall Study|Withdrawal by Subject|5
773252|NCT00570739|2458517|P3|Overall Study|Withdrawal by Subject|3
773253|NCT00570739|2458518|P2|Overall Study|Withdrawal by Subject|7
773254|NCT00570739|2458519|P1|Overall Study|Withdrawal by Subject|7
773255|NCT00570739|2458516|P4|Overall Study|Physician Decision|0
773256|NCT00570739|2458517|P3|Overall Study|Physician Decision|0
773257|NCT00570739|2458518|P2|Overall Study|Physician Decision|1
773258|NCT00570739|2458519|P1|Overall Study|Physician Decision|1
773259|NCT00570739|2458516|P4|Overall Study|Lost to Follow-up|1
773260|NCT00570739|2458517|P3|Overall Study|Lost to Follow-up|4
773261|NCT00570739|2458518|P2|Overall Study|Lost to Follow-up|5
773262|NCT00570739|2458519|P1|Overall Study|Lost to Follow-up|4
773263|NCT00570739|2458516|P4|Overall Study|Adverse Event|2
773264|NCT00570739|2458517|P3|Overall Study|Adverse Event|2
773265|NCT00570739|2458518|P2|Overall Study|Adverse Event|6
773266|NCT00570739|2458519|P1|Overall Study|Adverse Event|8
773267|NCT00570778|2458688|P4|Overall Study|Subject no longer requires study drug|0
773268|NCT00570778|2458689|P3|Overall Study|Subject no longer requires study drug|0
773269|NCT00570778|2458690|P2|Overall Study|Subject no longer requires study drug|1
773270|NCT00570778|2458691|P1|Overall Study|Subject no longer requires study drug|0
773271|NCT00570778|2458688|P4|Overall Study|Lost to Follow-up|0
773272|NCT00570778|2458689|P3|Overall Study|Lost to Follow-up|1
773273|NCT00570778|2458690|P2|Overall Study|Lost to Follow-up|0
773274|NCT00570778|2458691|P1|Overall Study|Lost to Follow-up|0
773275|NCT00570778|2458688|P4|Overall Study|Unsatisfactory therapeutic effect|0
773276|NCT00570778|2458689|P3|Overall Study|Unsatisfactory therapeutic effect|0
773277|NCT00570778|2458690|P2|Overall Study|Unsatisfactory therapeutic effect|0
773278|NCT00570778|2458691|P1|Overall Study|Unsatisfactory therapeutic effect|1
773279|NCT00570778|2458688|P4|Overall Study|Abnormal test procedure|0
773280|NCT00570778|2458689|P3|Overall Study|Abnormal test procedure|0
773281|NCT00570778|2458690|P2|Overall Study|Abnormal test procedure|0
773282|NCT00570778|2458691|P1|Overall Study|Abnormal test procedure|1
773283|NCT00570778|2458688|P4|Overall Study|Subject withdrew consent|1
773284|NCT00570778|2458689|P3|Overall Study|Subject withdrew consent|0
773285|NCT00570778|2458690|P2|Overall Study|Subject withdrew consent|1
773286|NCT00570778|2458691|P1|Overall Study|Subject withdrew consent|0
773287|NCT00570778|2458688|P4|Overall Study|Adverse Event|1
773288|NCT00570778|2458689|P3|Overall Study|Adverse Event|4
773289|NCT00570778|2458690|P2|Overall Study|Adverse Event|1
773290|NCT00570778|2458691|P1|Overall Study|Adverse Event|0
773291|NCT00570778|2458688|P4|Overall Study|Protocol deviation|2
773292|NCT00570778|2458689|P3|Overall Study|Protocol deviation|2
773293|NCT00570778|2458690|P2|Overall Study|Protocol deviation|1
773294|NCT00570778|2458691|P1|Overall Study|Protocol deviation|2
773295|NCT00570908|2458709|P1|Overall Study|Withdrawal by Subject|2
773296|NCT00570908|2458709|P1|Overall Study|Adverse Event|5
773297|NCT00570921|2458713|P1|Overall Study|Physician Decision|1
773298|NCT00570921|2458713|P1|Overall Study|Protocol Violation|1
773299|NCT00571038|2458730|P2|Overall Study|Moved out of state|2
773300|NCT00571038|2458731|P1|Overall Study|Moved out of state|2
773301|NCT00571038|2458730|P2|Overall Study|Withdrawal by Subject|3
773302|NCT00571038|2458731|P1|Overall Study|Withdrawal by Subject|1
773303|NCT00571038|2458730|P2|Overall Study|Death|5
773304|NCT00571038|2458731|P1|Overall Study|Death|7
773305|NCT00571038|2458730|P2|Overall Study|Lost to Follow-up|4
773306|NCT00571038|2458731|P1|Overall Study|Lost to Follow-up|1
773307|NCT00577889|2458780|P3|Overall Study|Withdrawal by Subject|0
773308|NCT00577889|2458781|P2|Overall Study|Withdrawal by Subject|0
773309|NCT00577889|2458782|P1|Overall Study|Withdrawal by Subject|1
773310|NCT00578136|2458808|P2|Overall Study|Not given intervention|1
773311|NCT00578136|2458809|P1|Overall Study|Not given intervention|1
773312|NCT00578227|2458954|P3|Overall Study|Withdrawal by Subject|3
773313|NCT00578227|2458955|P2|Overall Study|Withdrawal by Subject|1
773314|NCT00578227|2458956|P1|Overall Study|Withdrawal by Subject|5
773315|NCT00578227|2458954|P3|Overall Study|Lost to Follow-up|1
773316|NCT00578227|2458955|P2|Overall Study|Lost to Follow-up|1
773317|NCT00578227|2458956|P1|Overall Study|Lost to Follow-up|0
773318|NCT00578864|2459028|P2|Overall Study|Death|0
773319|NCT00578864|2459029|P1|Overall Study|Death|1
773320|NCT00578877|2459045|P2|Overall Study|did not provide follow-up data|17
773321|NCT00578877|2459046|P1|Overall Study|did not provide follow-up data|12
773322|NCT00578877|2459045|P2|Overall Study|early discontinue|101
773323|NCT00578877|2459046|P1|Overall Study|early discontinue|61
773324|NCT00578877|2459045|P2|Overall Study|Lost to Follow-up|10
773325|NCT00578877|2459046|P1|Overall Study|Lost to Follow-up|8
773326|NCT00578942|2459083|P1|Overall Study|Lost to Follow-up|1
773327|NCT00579059|2459157|P2|Overall Study|Study Canceled at 1 Year|10
773328|NCT00579059|2459158|P1|Overall Study|Study Canceled at 1 Year|21
773329|NCT00579098|2459168|P2|Overall Study|AF returned after ablation|2
773330|NCT00579098|2459169|P1|Overall Study|AF returned after ablation|3
773331|NCT00579098|2459168|P2|Overall Study|Withdrawal by Subject|3
773332|NCT00579098|2459169|P1|Overall Study|Withdrawal by Subject|2
773333|NCT00579098|2459168|P2|Overall Study|Adverse Event|3
773334|NCT00579098|2459169|P1|Overall Study|Adverse Event|2
773335|NCT00579098|2459168|P2|Overall Study|Lost to Follow-up|0
773336|NCT00579098|2459169|P1|Overall Study|Lost to Follow-up|2
773337|NCT00579254|2459201|P1|Overall Study|Discontinued when study terminated|73
773338|NCT00579254|2459201|P1|Overall Study|Lost to Follow-up|39
773339|NCT00579345|2459213|P8|Overall Study|Death|0
773340|NCT00579345|2459214|P7|Overall Study|Death|0
773341|NCT00579345|2459215|P6|Overall Study|Death|0
773342|NCT00579345|2459216|P5|Overall Study|Death|0
773343|NCT00579345|2459217|P4|Overall Study|Death|1
773344|NCT00579345|2459218|P3|Overall Study|Death|1
773345|NCT00579345|2459219|P2|Overall Study|Death|1
773346|NCT00579345|2459220|P1|Overall Study|Death|1
773347|NCT00579345|2459213|P8|Overall Study|Protocol Violation|1
773348|NCT00579345|2459214|P7|Overall Study|Protocol Violation|0
773349|NCT00579345|2459215|P6|Overall Study|Protocol Violation|0
773350|NCT00579345|2459216|P5|Overall Study|Protocol Violation|0
773351|NCT00579345|2459217|P4|Overall Study|Protocol Violation|0
773352|NCT00579345|2459218|P3|Overall Study|Protocol Violation|0
773353|NCT00579345|2459219|P2|Overall Study|Protocol Violation|0
773354|NCT00579345|2459220|P1|Overall Study|Protocol Violation|1
773355|NCT00579345|2459213|P8|Overall Study|Adverse Event|0
773356|NCT00579345|2459214|P7|Overall Study|Adverse Event|0
773357|NCT00579345|2459215|P6|Overall Study|Adverse Event|0
773358|NCT00579345|2459216|P5|Overall Study|Adverse Event|0
773359|NCT00579345|2459217|P4|Overall Study|Adverse Event|0
773360|NCT00579345|2459218|P3|Overall Study|Adverse Event|1
773361|NCT00579345|2459219|P2|Overall Study|Adverse Event|0
773362|NCT00579345|2459220|P1|Overall Study|Adverse Event|0
773363|NCT00579345|2459213|P8|Overall Study|Lost to Follow-up|0
773364|NCT00579345|2459214|P7|Overall Study|Lost to Follow-up|0
773365|NCT00579345|2459215|P6|Overall Study|Lost to Follow-up|0
773366|NCT00579345|2459216|P5|Overall Study|Lost to Follow-up|0
773367|NCT00579345|2459217|P4|Overall Study|Lost to Follow-up|0
773368|NCT00579345|2459218|P3|Overall Study|Lost to Follow-up|0
773369|NCT00579345|2459219|P2|Overall Study|Lost to Follow-up|0
773370|NCT00579345|2459220|P1|Overall Study|Lost to Follow-up|1
773371|NCT00579345|2459213|P8|Overall Study|Withdrawal by Subject|1
773372|NCT00579345|2459214|P7|Overall Study|Withdrawal by Subject|0
773373|NCT00579345|2459215|P6|Overall Study|Withdrawal by Subject|0
773374|NCT00579345|2459216|P5|Overall Study|Withdrawal by Subject|0
773375|NCT00579345|2459217|P4|Overall Study|Withdrawal by Subject|0
773376|NCT00579345|2459218|P3|Overall Study|Withdrawal by Subject|0
773377|NCT00579345|2459219|P2|Overall Study|Withdrawal by Subject|0
773378|NCT00579345|2459220|P1|Overall Study|Withdrawal by Subject|2
773379|NCT00579501|2459252|P1|Overall Study|Radiation therapy before surgery|1
773380|NCT00579501|2459252|P1|Overall Study|Secondary lesion|1
773381|NCT00579501|2459252|P1|Overall Study|toxicity|1
773382|NCT00579501|2459252|P1|Overall Study|End of neoadjuvant therapy|25
773383|NCT00579501|2459252|P1|Overall Study|Death|1
773384|NCT00579670|2459262|P5|Overall Study|Withdrawal by Subject|0
773385|NCT00579670|2459263|P4|Overall Study|Withdrawal by Subject|0
773386|NCT00579670|2459264|P3|Overall Study|Withdrawal by Subject|1
773387|NCT00579670|2459265|P2|Overall Study|Withdrawal by Subject|0
773388|NCT00579670|2459266|P1|Overall Study|Withdrawal by Subject|0
773389|NCT00579670|2459262|P5|Overall Study|Other|0
773390|NCT00579670|2459263|P4|Overall Study|Other|2
773391|NCT00579670|2459264|P3|Overall Study|Other|1
773392|NCT00579670|2459265|P2|Overall Study|Other|0
773393|NCT00579670|2459266|P1|Overall Study|Other|0
773394|NCT00579670|2459262|P5|Overall Study|Lost to Follow-up|0
773395|NCT00579670|2459263|P4|Overall Study|Lost to Follow-up|4
773396|NCT00579670|2459264|P3|Overall Study|Lost to Follow-up|0
773397|NCT00579670|2459265|P2|Overall Study|Lost to Follow-up|1
773398|NCT00579670|2459266|P1|Overall Study|Lost to Follow-up|0
773399|NCT00579670|2459262|P5|Overall Study|Lack of Efficacy|0
773400|NCT00579670|2459263|P4|Overall Study|Lack of Efficacy|14
773401|NCT00579670|2459264|P3|Overall Study|Lack of Efficacy|1
773402|NCT00579670|2459265|P2|Overall Study|Lack of Efficacy|0
773403|NCT00579670|2459266|P1|Overall Study|Lack of Efficacy|0
773404|NCT00579670|2459262|P5|Overall Study|Adverse Event|0
773405|NCT00579670|2459263|P4|Overall Study|Adverse Event|2
773406|NCT00579670|2459264|P3|Overall Study|Adverse Event|1
773407|NCT00579670|2459265|P2|Overall Study|Adverse Event|0
773408|NCT00579670|2459266|P1|Overall Study|Adverse Event|1
773409|NCT00579670|2459262|P5|Overall Study|Death|0
773410|NCT00579670|2459263|P4|Overall Study|Death|0
773411|NCT00579670|2459264|P3|Overall Study|Death|0
773412|NCT00579670|2459265|P2|Overall Study|Death|0
773413|NCT00579670|2459266|P1|Overall Study|Death|1
773414|NCT00579826|2459499|P2|Overall Study|Withdrawal by Subject|3
773415|NCT00579826|2459500|P1|Overall Study|Withdrawal by Subject|5
773416|NCT00579982|2459510|P1|Overall Study|Protocol Violation|4
773417|NCT00579982|2459510|P1|Overall Study|Adverse Event|4
773418|NCT00580034|2459529|P2|Overall Study|Toxicity|0
773419|NCT00580034|2459530|P1|Overall Study|Toxicity|10
891721|NCT01072149|2828543|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891722|NCT01072149|2828544|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891723|NCT01072149|2828545|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891724|NCT01072149|2828546|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891725|NCT01072149|2828547|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
891726|NCT01072149|2828548|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891727|NCT01072149|2828549|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
891728|NCT01072149|2828532|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
891729|NCT01072149|2828533|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
891730|NCT01072149|2828534|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
891731|NCT01072149|2828535|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
891732|NCT01072149|2828536|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
891733|NCT01072149|2828537|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
891734|NCT01072149|2828538|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
891735|NCT01072149|2828539|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
773436|NCT00580723|2459634|P1|Overall Study|Lost to Follow-up|5
773437|NCT00580723|2459634|P1|Overall Study|Did not want to participate in extension|3
773438|NCT00580788|2459644|P4|Overall Study|Adverse Event|1
773439|NCT00580788|2459645|P3|Overall Study|Adverse Event|0
773440|NCT00580788|2459646|P2|Overall Study|Adverse Event|0
773441|NCT00580788|2459647|P1|Overall Study|Adverse Event|0
773442|NCT00580801|2459708|P3|Overall Study|Travel|0
773443|NCT00580801|2459709|P2|Overall Study|Travel|0
773444|NCT00580801|2459710|P1|Overall Study|Travel|1
773445|NCT00580801|2459708|P3|Overall Study|Participant non-compliant|1
773446|NCT00580801|2459709|P2|Overall Study|Participant non-compliant|0
773447|NCT00580801|2459710|P1|Overall Study|Participant non-compliant|0
773448|NCT00580801|2459708|P3|Overall Study|Reached a virologic endpoint|2
773449|NCT00580801|2459709|P2|Overall Study|Reached a virologic endpoint|1
773450|NCT00580801|2459710|P1|Overall Study|Reached a virologic endpoint|0
773451|NCT00580801|2459708|P3|Overall Study|Lost to Follow-up|0
773452|NCT00580801|2459709|P2|Overall Study|Lost to Follow-up|0
773453|NCT00580801|2459710|P1|Overall Study|Lost to Follow-up|2
773454|NCT00580801|2459708|P3|Overall Study|Adverse Event|0
773455|NCT00580801|2459709|P2|Overall Study|Adverse Event|0
773456|NCT00580801|2459710|P1|Overall Study|Adverse Event|2
773457|NCT00580801|2459708|P3|Overall Study|Physician Decision|0
773458|NCT00580801|2459709|P2|Overall Study|Physician Decision|0
773459|NCT00580801|2459710|P1|Overall Study|Physician Decision|1
773460|NCT00580840|2459745|P4|Double-Blind|Other: Forbidden Medication|0
773461|NCT00580840|2459746|P3|Double-Blind|Other: Forbidden Medication|1
773462|NCT00580840|2459747|P2|Double-Blind|Other: Forbidden Medication|0
773463|NCT00580840|2459748|P1|Double-Blind|Other: Forbidden Medication|0
773464|NCT00580840|2459745|P4|Double-Blind|Other: Discontinued Methotrexate|0
773465|NCT00580840|2459746|P3|Double-Blind|Other: Discontinued Methotrexate|0
773466|NCT00580840|2459747|P2|Double-Blind|Other: Discontinued Methotrexate|1
773467|NCT00580840|2459748|P1|Double-Blind|Other: Discontinued Methotrexate|0
773468|NCT00580840|2459745|P4|Double-Blind|Withdrawal by Subject|2
773469|NCT00580840|2459746|P3|Double-Blind|Withdrawal by Subject|2
773470|NCT00580840|2459747|P2|Double-Blind|Withdrawal by Subject|1
773471|NCT00580840|2459748|P1|Double-Blind|Withdrawal by Subject|0
773472|NCT00580840|2459745|P4|Double-Blind|Lost to Follow-up|2
773473|NCT00580840|2459746|P3|Double-Blind|Lost to Follow-up|0
773474|NCT00580840|2459747|P2|Double-Blind|Lost to Follow-up|1
773475|NCT00580840|2459748|P1|Double-Blind|Lost to Follow-up|0
773476|NCT00580840|2459745|P4|Double-Blind|Loss of Efficacy|10
773477|NCT00580840|2459746|P3|Double-Blind|Loss of Efficacy|2
773478|NCT00580840|2459747|P2|Double-Blind|Loss of Efficacy|1
773479|NCT00580840|2459748|P1|Double-Blind|Loss of Efficacy|0
773480|NCT00580840|2459745|P4|Double-Blind|Adverse Event|1
773481|NCT00580840|2459746|P3|Double-Blind|Adverse Event|4
773482|NCT00580840|2459747|P2|Double-Blind|Adverse Event|3
773483|NCT00580840|2459748|P1|Double-Blind|Adverse Event|0
773484|NCT00580840|2459745|P4|Run-in|Other: Exclusionary Lab Value|0
773485|NCT00580840|2459746|P3|Run-in|Other: Exclusionary Lab Value|0
773486|NCT00580840|2459747|P2|Run-in|Other: Exclusionary Lab Value|0
773487|NCT00580840|2459748|P1|Run-in|Other: Exclusionary Lab Value|1
773488|NCT00580840|2459745|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
773489|NCT00580840|2459746|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
773490|NCT00580840|2459747|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
773491|NCT00580840|2459748|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
773492|NCT00580840|2459745|P4|Run-in|Other: Per Sponsor Request|0
773493|NCT00580840|2459746|P3|Run-in|Other: Per Sponsor Request|0
773494|NCT00580840|2459747|P2|Run-in|Other: Per Sponsor Request|0
773495|NCT00580840|2459748|P1|Run-in|Other: Per Sponsor Request|2
773496|NCT00580840|2459745|P4|Run-in|Withdrawal by Subject|0
773497|NCT00580840|2459746|P3|Run-in|Withdrawal by Subject|0
773498|NCT00580840|2459747|P2|Run-in|Withdrawal by Subject|0
773499|NCT00580840|2459748|P1|Run-in|Withdrawal by Subject|5
773500|NCT00580840|2459745|P4|Run-in|Lost to Follow-up|0
773501|NCT00580840|2459746|P3|Run-in|Lost to Follow-up|0
773502|NCT00580840|2459747|P2|Run-in|Lost to Follow-up|0
773503|NCT00580840|2459748|P1|Run-in|Lost to Follow-up|4
773504|NCT00580840|2459745|P4|Run-in|Loss of Efficacy|0
773505|NCT00580840|2459746|P3|Run-in|Loss of Efficacy|0
773506|NCT00580840|2459747|P2|Run-in|Loss of Efficacy|0
773507|NCT00580840|2459748|P1|Run-in|Loss of Efficacy|1
773508|NCT00580840|2459745|P4|Run-in|Lack of Efficacy|0
773509|NCT00580840|2459746|P3|Run-in|Lack of Efficacy|0
773510|NCT00580840|2459747|P2|Run-in|Lack of Efficacy|0
773511|NCT00580840|2459748|P1|Run-in|Lack of Efficacy|93
773512|NCT00580840|2459745|P4|Run-in|Adverse Event|0
773513|NCT00580840|2459746|P3|Run-in|Adverse Event|0
773514|NCT00580840|2459747|P2|Run-in|Adverse Event|0
773515|NCT00580840|2459748|P1|Run-in|Adverse Event|17
773516|NCT00580866|2459871|P2|Overall Study|Lost to Follow-up|2
773517|NCT00580866|2459872|P1|Overall Study|Lost to Follow-up|2
773518|NCT00580970|2459891|P1|Treatment (Lovastatin)|Death|1
773519|NCT00580970|2459891|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
773520|NCT00580970|2459891|P1|Treatment (Lovastatin)|Physician Decision|4
891736|NCT01072149|2828540|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
773521|NCT00580970|2459891|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
773522|NCT00580970|2459891|P1|Treatment (Lovastatin)|Non-compliance|6
773523|NCT00580970|2459891|P1|Pre-treatment|Non-compliance|1
773524|NCT00580983|2459895|P1|Overall Study|Did not complete 12 mon post RT studies|7
773525|NCT00581100|2459908|P2|Overall Study|Unspecified|0
773526|NCT00581100|2459909|P1|Overall Study|Unspecified|3
773527|NCT00581100|2459908|P2|Overall Study|Withdrawal by Subject|4
773528|NCT00581100|2459909|P1|Overall Study|Withdrawal by Subject|1
773529|NCT00581100|2459908|P2|Overall Study|Adverse Event|1
773530|NCT00581100|2459909|P1|Overall Study|Adverse Event|2
773531|NCT00581100|2459908|P2|Overall Study|Death|0
773532|NCT00581100|2459909|P1|Overall Study|Death|1
773533|NCT00581113|2459947|P2|Overall Study|Withdrawal by Subject|1
773534|NCT00581113|2459948|P1|Overall Study|Withdrawal by Subject|0
891737|NCT01072149|2828541|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
891738|NCT01072149|2828542|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
891739|NCT01072149|2828543|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
891740|NCT01072149|2828544|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
891741|NCT01072149|2828545|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
891742|NCT01072149|2828546|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
891743|NCT01072149|2828547|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
891744|NCT01072149|2828548|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
891745|NCT01072149|2828549|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
891746|NCT01072149|2828532|P18|Washout Period 2 (14 Days)|Adverse Event|0
891747|NCT01072149|2828533|P17|Washout Period 2 (14 Days)|Adverse Event|0
773549|NCT00574145|2460037|P2|Overall Study|Withdrawal by Subject|1
773550|NCT00574145|2460038|P1|Overall Study|Withdrawal by Subject|2
773551|NCT00574249|2460054|P2|Overall Study|PPD test taken twice|1
773552|NCT00574249|2460055|P1|Overall Study|PPD test taken twice|0
773553|NCT00574249|2460054|P2|Overall Study|Excluded by company|1
773554|NCT00574249|2460055|P1|Overall Study|Excluded by company|0
773555|NCT00574249|2460054|P2|Overall Study|Pregnancy|0
773556|NCT00574249|2460055|P1|Overall Study|Pregnancy|1
773557|NCT00574249|2460054|P2|Overall Study|Physician Decision|0
773558|NCT00574249|2460055|P1|Overall Study|Physician Decision|1
773559|NCT00574249|2460054|P2|Overall Study|Withdrawal by Subject|0
773560|NCT00574249|2460055|P1|Overall Study|Withdrawal by Subject|3
773561|NCT00574249|2460054|P2|Overall Study|History of carcinoma|0
773562|NCT00574249|2460055|P1|Overall Study|History of carcinoma|1
773563|NCT00574249|2460054|P2|Overall Study|Protocol Violation|2
773564|NCT00574249|2460055|P1|Overall Study|Protocol Violation|5
773565|NCT00574249|2460054|P2|Overall Study|Lost to Follow-up|3
773566|NCT00574249|2460055|P1|Overall Study|Lost to Follow-up|4
773567|NCT00574249|2460054|P2|Overall Study|Lack of Efficacy|3
773568|NCT00574249|2460055|P1|Overall Study|Lack of Efficacy|5
773569|NCT00574249|2460054|P2|Overall Study|Adverse Event|18
773570|NCT00574249|2460055|P1|Overall Study|Adverse Event|6
773571|NCT00574275|2460097|P2|Overall Study|Operation for curative intent|1
773572|NCT00574275|2460098|P1|Overall Study|Operation for curative intent|0
773573|NCT00574275|2460097|P2|Overall Study|Insurance change|1
773574|NCT00574275|2460098|P1|Overall Study|Insurance change|0
773575|NCT00574275|2460097|P2|Overall Study|Patient and Investigator decision|1
773576|NCT00574275|2460098|P1|Overall Study|Patient and Investigator decision|0
773577|NCT00574275|2460097|P2|Overall Study|Protocol Violation|1
773578|NCT00574275|2460098|P1|Overall Study|Protocol Violation|0
773579|NCT00574275|2460097|P2|Overall Study|Physician Decision|1
773580|NCT00574275|2460098|P1|Overall Study|Physician Decision|1
773581|NCT00574275|2460097|P2|Overall Study|Error calculating tumor measurement|0
773582|NCT00574275|2460098|P1|Overall Study|Error calculating tumor measurement|1
773583|NCT00574275|2460097|P2|Overall Study|Withdrawal by Subject|17
773584|NCT00574275|2460098|P1|Overall Study|Withdrawal by Subject|15
773585|NCT00574275|2460097|P2|Overall Study|Study stopped based on DMC decision|23
773586|NCT00574275|2460098|P1|Overall Study|Study stopped based on DMC decision|62
773587|NCT00574275|2460097|P2|Overall Study|Lost to Follow-up|1
773588|NCT00574275|2460098|P1|Overall Study|Lost to Follow-up|2
773589|NCT00574275|2460097|P2|Overall Study|Disease progression|146
773590|NCT00574275|2460098|P1|Overall Study|Disease progression|160
773591|NCT00574275|2460097|P2|Overall Study|Adverse Event|76
773592|NCT00574275|2460098|P1|Overall Study|Adverse Event|32
773593|NCT00574275|2460097|P2|Overall Study|Randomized but not treated|3
773594|NCT00574275|2460098|P1|Overall Study|Randomized but not treated|2
773595|NCT00574288|2460121|P7|Overall Study|Ongoing|14
773596|NCT00574288|2460122|P6|Overall Study|Ongoing|0
773597|NCT00574288|2460123|P5|Overall Study|Ongoing|0
773598|NCT00574288|2460124|P4|Overall Study|Ongoing|0
773599|NCT00574288|2460125|P3|Overall Study|Ongoing|0
773600|NCT00574288|2460126|P2|Overall Study|Ongoing|0
773601|NCT00574288|2460127|P1|Overall Study|Ongoing|0
773602|NCT00574288|2460121|P7|Overall Study|Progressive disease|23
773603|NCT00574288|2460122|P6|Overall Study|Progressive disease|30
773604|NCT00574288|2460123|P5|Overall Study|Progressive disease|0
773605|NCT00574288|2460124|P4|Overall Study|Progressive disease|2
773606|NCT00574288|2460125|P3|Overall Study|Progressive disease|0
773607|NCT00574288|2460126|P2|Overall Study|Progressive disease|0
773608|NCT00574288|2460127|P1|Overall Study|Progressive disease|10
773609|NCT00574288|2460121|P7|Overall Study|Physician Decision|4
773610|NCT00574288|2460122|P6|Overall Study|Physician Decision|0
773611|NCT00574288|2460123|P5|Overall Study|Physician Decision|0
773612|NCT00574288|2460124|P4|Overall Study|Physician Decision|0
773613|NCT00574288|2460125|P3|Overall Study|Physician Decision|0
773614|NCT00574288|2460126|P2|Overall Study|Physician Decision|0
773615|NCT00574288|2460127|P1|Overall Study|Physician Decision|0
773616|NCT00574288|2460121|P7|Overall Study|Adverse Event|1
773617|NCT00574288|2460122|P6|Overall Study|Adverse Event|0
773618|NCT00574288|2460123|P5|Overall Study|Adverse Event|1
773619|NCT00574288|2460124|P4|Overall Study|Adverse Event|0
773620|NCT00574288|2460125|P3|Overall Study|Adverse Event|0
773621|NCT00574288|2460126|P2|Overall Study|Adverse Event|1
773622|NCT00574288|2460127|P1|Overall Study|Adverse Event|3
773623|NCT00574405|2460172|P2|Overall Study|Withdrawal by Subject|2
773624|NCT00574405|2460173|P1|Overall Study|Withdrawal by Subject|3
773625|NCT00574795|2460243|P1|Toddler Dose|Withdrawal by Subject|1
773626|NCT00574795|2460243|P1|After Infant Series|Adverse Event|2
773627|NCT00574795|2460243|P1|After Infant Series|Withdrawal by Subject|1
773628|NCT00574795|2460243|P1|Infant Series|Adverse Event|1
773629|NCT00574795|2460243|P1|Infant Series|Protocol Violation|2
773630|NCT00574795|2460243|P1|Infant Series|Withdrawal by Subject|2
773631|NCT00574847|2460275|P2|Overall Study|Did not receive medication (declined)|5
773632|NCT00574847|2460276|P1|Overall Study|Did not receive medication (declined)|2
773633|NCT00574847|2460275|P2|Overall Study|Physician Decision|0
773634|NCT00574847|2460276|P1|Overall Study|Physician Decision|1
773635|NCT00574847|2460275|P2|Overall Study|Withdrawal by Subject|2
773636|NCT00574847|2460276|P1|Overall Study|Withdrawal by Subject|2
773637|NCT00574847|2460275|P2|Overall Study|Death|0
773638|NCT00574847|2460276|P1|Overall Study|Death|1
773639|NCT00574847|2460275|P2|Overall Study|Adverse Event|0
773640|NCT00574847|2460276|P1|Overall Study|Adverse Event|2
773641|NCT00574873|2460310|P2|Overall Study|Extension Study|0
773642|NCT00574873|2460311|P1|Overall Study|Extension Study|126
773643|NCT00574873|2460310|P2|Overall Study|Blank, site closed per local regulations|2
773644|NCT00574873|2460311|P1|Overall Study|Blank, site closed per local regulations|2
773645|NCT00574873|2460310|P2|Overall Study|Discontinuation of study by sponsor|199
773646|NCT00574873|2460311|P1|Overall Study|Discontinuation of study by sponsor|5
773647|NCT00574873|2460310|P2|Overall Study|Unspecified|4
773648|NCT00574873|2460311|P1|Overall Study|Unspecified|40
773649|NCT00574873|2460310|P2|Overall Study|Lost to Follow-up|5
773650|NCT00574873|2460311|P1|Overall Study|Lost to Follow-up|14
773651|NCT00574873|2460310|P2|Overall Study|Death|14
773652|NCT00574873|2460311|P1|Overall Study|Death|15
773653|NCT00574873|2460310|P2|Overall Study|Investigator request|8
773654|NCT00574873|2460311|P1|Overall Study|Investigator request|18
773655|NCT00574873|2460310|P2|Overall Study|Withdrawal by Subject|19
773656|NCT00574873|2460311|P1|Overall Study|Withdrawal by Subject|18
773657|NCT00574912|2460327|P1|Overall Study|Physician Decision|2
773658|NCT00574912|2460327|P1|Overall Study|scheduling conflicts|3
773659|NCT00574912|2460327|P1|Overall Study|Could not place IV lines.|3
891748|NCT01072149|2828534|P16|Washout Period 2 (14 Days)|Adverse Event|1
891749|NCT01072149|2828535|P15|Washout Period 2 (14 Days)|Adverse Event|0
773662|NCT00575094|2460390|P1|Overall Study|Withdrawal by Subject|1
773663|NCT00575094|2460390|P1|Overall Study|Adverse Event|2
773664|NCT00581360|2460530|P1|Overall Study|Withdrawal by Subject|1
773665|NCT00581542|2460584|P2|Overall Study|Lost to Follow-up|21
773666|NCT00581542|2460585|P1|Overall Study|Lost to Follow-up|9
773667|NCT00581542|2460584|P2|Overall Study|they met an exclusion criteria|2
773668|NCT00581542|2460585|P1|Overall Study|they met an exclusion criteria|2
773669|NCT00581555|2460595|P2|Overall Study|Other reasons|4
773670|NCT00581555|2460596|P1|Overall Study|Other reasons|16
773671|NCT00581555|2460595|P2|Overall Study|Lost to Follow-up|2
773672|NCT00581555|2460596|P1|Overall Study|Lost to Follow-up|2
773673|NCT00581555|2460595|P2|Overall Study|Withdrawal by Subject|9
773674|NCT00581555|2460596|P1|Overall Study|Withdrawal by Subject|18
773675|NCT00581555|2460595|P2|Overall Study|Physician Decision|2
773676|NCT00581555|2460596|P1|Overall Study|Physician Decision|3
773677|NCT00581555|2460595|P2|Overall Study|Adverse Event|3
773678|NCT00581555|2460596|P1|Overall Study|Adverse Event|4
773679|NCT00582712|2460638|P1|Overall Study|Complicating disease requiring treatment|1
773680|NCT00582712|2460638|P1|Overall Study|Withdrawal by Subject|1
773681|NCT00582712|2460638|P1|Overall Study|Lack of Efficacy|1
773682|NCT00582712|2460638|P1|Overall Study|Adverse Event|1
773683|NCT00582738|2460644|P2|Overall Study|Withdrawal by Subject|3
773684|NCT00582738|2460645|P1|Overall Study|Withdrawal by Subject|0
773685|NCT00582738|2460644|P2|Overall Study|Protocol Violation|1
773686|NCT00582738|2460645|P1|Overall Study|Protocol Violation|1
773687|NCT00582738|2460644|P2|Overall Study|Other|0
773688|NCT00582738|2460645|P1|Overall Study|Other|1
773689|NCT00582738|2460644|P2|Overall Study|Graft Lost|1
773690|NCT00582738|2460645|P1|Overall Study|Graft Lost|0
773691|NCT00582738|2460644|P2|Overall Study|Adverse Event|5
773692|NCT00582738|2460645|P1|Overall Study|Adverse Event|0
773693|NCT00582738|2460644|P2|Overall Study|Administrative Problems|8
773694|NCT00582738|2460645|P1|Overall Study|Administrative Problems|7
773696|NCT00582816|2460676|P1|Overall Study|Engraftment Failure|3
773697|NCT00582907|2460693|P4|2nd Course|Lack of Efficacy|0
773698|NCT00582907|2460694|P3|2nd Course|Lack of Efficacy|0
773699|NCT00582907|2460695|P2|2nd Course|Lack of Efficacy|0
773700|NCT00582907|2460696|P1|2nd Course|Lack of Efficacy|1
773701|NCT00582907|2460693|P4|1st Course|Lost to Follow-up|1
773702|NCT00582907|2460694|P3|1st Course|Lost to Follow-up|0
773703|NCT00582907|2460695|P2|1st Course|Lost to Follow-up|0
773704|NCT00582907|2460696|P1|1st Course|Lost to Follow-up|0
773705|NCT00582907|2460693|P4|1st Course|Withdrawal by Subject|0
773706|NCT00582907|2460694|P3|1st Course|Withdrawal by Subject|0
773707|NCT00582907|2460695|P2|1st Course|Withdrawal by Subject|0
773708|NCT00582907|2460696|P1|1st Course|Withdrawal by Subject|1
773709|NCT00582933|2460728|P1|Overall Study|Physician Decision|3
773710|NCT00582972|2460736|P1|Overall Study|Protocol Violation|2
773711|NCT00583115|2460741|P1|Overall Study|Death|1
773712|NCT00583219|2460746|P1|Phase 2|Withdrawal by Subject|1
773713|NCT00583362|2460763|P1|Overall Study|Withdrawal by Subject|57
773714|NCT00583362|2460763|P1|Overall Study|Protocol Violation|2
773715|NCT00583362|2460763|P1|Overall Study|Physician Decision|19
773716|NCT00583362|2460763|P1|Overall Study|Sponsor request due to missed doses|1
773717|NCT00583362|2460763|P1|Overall Study|Behavioral problems and non-compliance|1
773718|NCT00583362|2460763|P1|Overall Study|Misunderstanding of protocol|1
773719|NCT00583362|2460763|P1|Overall Study|Missed visits due to staff changes|1
773720|NCT00583362|2460763|P1|Overall Study|Subject moved out of the country/state|2
773721|NCT00583362|2460763|P1|Overall Study|Subject not dosed in LBSL99|1
773722|NCT00583362|2460763|P1|Overall Study|Current site closed|7
773723|NCT00583362|2460763|P1|Overall Study|Miscommunication of visit window|5
773724|NCT00583362|2460763|P1|Overall Study|Pregnancy|7
773725|NCT00583362|2460763|P1|Overall Study|Non-compliance with study drug|28
773726|NCT00583362|2460763|P1|Overall Study|Lost to Follow-up|4
773727|NCT00583362|2460763|P1|Overall Study|Lack of Efficacy|22
773728|NCT00583362|2460763|P1|Overall Study|Adverse Event|44
773729|NCT00583453|2460789|P2|Overall Study|discontinued intervention|2
773730|NCT00583453|2460790|P1|Overall Study|discontinued intervention|0
773731|NCT00583557|2460829|P1|Overall Study|Did not receive belimumab in LBRA99|2
773732|NCT00583557|2460829|P1|Overall Study|Other|5
773733|NCT00583557|2460829|P1|Overall Study|Lack of Compliance|5
773734|NCT00583557|2460829|P1|Overall Study|Lack of Efficacy|31
773735|NCT00583557|2460829|P1|Overall Study|Adverse Event|9
773736|NCT00583557|2460829|P1|Overall Study|Withdrawal by Subject|18
773737|NCT00583596|2460833|P1|Overall Study|Outside f-up window|26
773738|NCT00583596|2460833|P1|Overall Study|Not consented|15
773739|NCT00583596|2460833|P1|Overall Study|Data not complete|1
773740|NCT00583596|2460833|P1|Overall Study|Lost to Follow-up|94
773741|NCT00583596|2460833|P1|Overall Study|Withdrawal by Subject|6
773742|NCT00583596|2460833|P1|Overall Study|Death|2
773743|NCT00583596|2460833|P1|Overall Study|Excluded due to Hurricane Katrina|30
773744|NCT00583596|2460833|P1|Overall Study|Lost to Follow-up|110
773745|NCT00583947|2460956|P2|Cross-over Period|not specified|1
773746|NCT00583947|2460957|P1|Cross-over Period|not specified|1
773747|NCT00583947|2460956|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
773748|NCT00583947|2460957|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
773749|NCT00583947|2460956|P2|Cross-over Period|Withdrawal by Subject|0
773750|NCT00583947|2460957|P1|Cross-over Period|Withdrawal by Subject|2
773751|NCT00583947|2460956|P2|Cross-over Period|Adverse Event|0
773752|NCT00583947|2460957|P1|Cross-over Period|Adverse Event|2
773753|NCT00584194|2461011|P1|Overall Study|Not specified|135
773754|NCT00584415|2461033|P1|Overall Study|Adverse Event|7
773755|NCT00584454|2461038|P1|Overall Study|Clinical Hold|2
773756|NCT00584454|2461038|P1|Overall Study|Relocation|1
773757|NCT00584454|2461038|P1|Overall Study|Adverse Event|1
773758|NCT00584727|2461056|P6|Third Intervention|Protocol Violation|2
773759|NCT00584727|2461057|P5|Third Intervention|Protocol Violation|4
773760|NCT00584727|2461058|P4|Third Intervention|Protocol Violation|0
773761|NCT00584727|2461059|P3|Third Intervention|Protocol Violation|1
773762|NCT00584727|2461060|P2|Third Intervention|Protocol Violation|0
773763|NCT00584727|2461061|P1|Third Intervention|Protocol Violation|0
773764|NCT00584727|2461056|P6|First Intervention|Discontinuation|0
773765|NCT00584727|2461057|P5|First Intervention|Discontinuation|0
773766|NCT00584727|2461058|P4|First Intervention|Discontinuation|0
773767|NCT00584727|2461059|P3|First Intervention|Discontinuation|1
773768|NCT00584727|2461060|P2|First Intervention|Discontinuation|0
773769|NCT00584727|2461061|P1|First Intervention|Discontinuation|0
773770|NCT00584740|2461087|P2|Overall Study|Lost to Follow-up|1
773771|NCT00584740|2461088|P1|Overall Study|Lost to Follow-up|0
773772|NCT00584740|2461087|P2|Overall Study|Withdrawal by Subject|2
773773|NCT00584740|2461088|P1|Overall Study|Withdrawal by Subject|3
773774|NCT00584740|2461087|P2|Overall Study|Lack of Efficacy|2
773775|NCT00584740|2461088|P1|Overall Study|Lack of Efficacy|8
773776|NCT00584740|2461087|P2|Overall Study|Adverse Event|1
773777|NCT00584740|2461088|P1|Overall Study|Adverse Event|1
773778|NCT00584844|2461146|P1|Overall Study|Screen Failure|20
773779|NCT00584844|2461146|P1|Overall Study|Withdrawal by Subject|59
773780|NCT00584909|2461161|P1|Overall Study|Adverse Event|4
773781|NCT00584987|2461185|P4|Overall Study|Adverse Event|1
773782|NCT00584987|2461186|P3|Overall Study|Adverse Event|0
773783|NCT00584987|2461187|P2|Overall Study|Adverse Event|0
773784|NCT00584987|2461188|P1|Overall Study|Adverse Event|0
773785|NCT00584987|2461185|P4|Overall Study|Protocol Violation|0
773786|NCT00584987|2461186|P3|Overall Study|Protocol Violation|1
773787|NCT00584987|2461187|P2|Overall Study|Protocol Violation|1
773788|NCT00584987|2461188|P1|Overall Study|Protocol Violation|1
773789|NCT00585039|2461237|P2|Overall Study|medication spilled|0
773790|NCT00585039|2461238|P1|Overall Study|medication spilled|2
773791|NCT00585078|2461246|P1|Overall Study|Death|1
773792|NCT00585078|2461246|P1|Overall Study|Adverse Event|10
773793|NCT00585078|2461246|P1|Overall Study|Disease Progression|24
773794|NCT00585078|2461246|P1|Overall Study|Poor performance status|1
773795|NCT00585078|2461246|P1|Overall Study|Withdrawal by Subject|4
773796|NCT00578318|2461332|P2|Overall Study|Physician Decision|0
773797|NCT00578318|2461333|P1|Overall Study|Physician Decision|1
773798|NCT00578318|2461332|P2|Overall Study|Lost to Follow-up|0
773799|NCT00578318|2461333|P1|Overall Study|Lost to Follow-up|2
891750|NCT01072149|2828536|P14|Washout Period 2 (14 Days)|Adverse Event|0
891751|NCT01072149|2828537|P13|Washout Period 2 (14 Days)|Adverse Event|0
891752|NCT01072149|2828538|P12|Washout Period 2 (14 Days)|Adverse Event|0
891753|NCT01072149|2828539|P11|Washout Period 2 (14 Days)|Adverse Event|0
773804|NCT00578565|2461422|P1|Overall Study|Adverse Event|3
773805|NCT00578786|2461454|P3|Overall Study|Qualified but Not Enrolled in Extension|0
773806|NCT00578786|2461455|P2|Overall Study|Qualified but Not Enrolled in Extension|3
773807|NCT00578786|2461456|P1|Overall Study|Qualified but Not Enrolled in Extension|0
773808|NCT00578786|2461454|P3|Overall Study|Not Otherwise Specified|1
773809|NCT00578786|2461455|P2|Overall Study|Not Otherwise Specified|4
773810|NCT00578786|2461456|P1|Overall Study|Not Otherwise Specified|0
773811|NCT00578786|2461454|P3|Overall Study|Pregnancy|0
773812|NCT00578786|2461455|P2|Overall Study|Pregnancy|1
773813|NCT00578786|2461456|P1|Overall Study|Pregnancy|0
773814|NCT00578786|2461454|P3|Overall Study|Lost to Follow-up|0
773815|NCT00578786|2461455|P2|Overall Study|Lost to Follow-up|4
773816|NCT00578786|2461456|P1|Overall Study|Lost to Follow-up|0
773817|NCT00578786|2461454|P3|Overall Study|Sponsor Decision|1
773818|NCT00578786|2461455|P2|Overall Study|Sponsor Decision|0
773819|NCT00578786|2461456|P1|Overall Study|Sponsor Decision|0
773820|NCT00578786|2461454|P3|Overall Study|Physician Decision|1
773821|NCT00578786|2461455|P2|Overall Study|Physician Decision|0
773822|NCT00578786|2461456|P1|Overall Study|Physician Decision|1
773823|NCT00578786|2461454|P3|Overall Study|Protocol Violation|1
773824|NCT00578786|2461455|P2|Overall Study|Protocol Violation|3
773825|NCT00578786|2461456|P1|Overall Study|Protocol Violation|0
773826|NCT00578786|2461454|P3|Overall Study|Withdrawal by Subject|5
773827|NCT00578786|2461455|P2|Overall Study|Withdrawal by Subject|8
773828|NCT00578786|2461456|P1|Overall Study|Withdrawal by Subject|7
773829|NCT00578786|2461454|P3|Overall Study|Early Escape from Prior Study|2
773830|NCT00578786|2461455|P2|Overall Study|Early Escape from Prior Study|1
773831|NCT00578786|2461456|P1|Overall Study|Early Escape from Prior Study|2
773832|NCT00578786|2461454|P3|Overall Study|Lack of Efficacy|2
773833|NCT00578786|2461455|P2|Overall Study|Lack of Efficacy|5
773834|NCT00578786|2461456|P1|Overall Study|Lack of Efficacy|2
773835|NCT00578786|2461454|P3|Overall Study|Adverse Event|17
773836|NCT00578786|2461455|P2|Overall Study|Adverse Event|37
773837|NCT00578786|2461456|P1|Overall Study|Adverse Event|27
773838|NCT00578812|2461537|P2|Overall Study|Not treated|7
773839|NCT00578812|2461538|P1|Overall Study|Not treated|6
773840|NCT00585169|2461574|P1|Overall Study|Withdrawal by Subject|1
773841|NCT00585221|2461585|P1|Overall Study|Protocol Violation|8
773842|NCT00585286|2461590|P1|Overall Study|Lost to Follow-up|1
773843|NCT00585312|2461599|P2|Overall Study|Study terminated by the sponsor|31
773844|NCT00585312|2461600|P1|Overall Study|Study terminated by the sponsor|34
773845|NCT00585312|2461599|P2|Overall Study|Withdrawal by Subject|1
773846|NCT00585312|2461600|P1|Overall Study|Withdrawal by Subject|5
773847|NCT00585312|2461599|P2|Overall Study|Reason not specified|0
773848|NCT00585312|2461600|P1|Overall Study|Reason not specified|2
773849|NCT00585312|2461599|P2|Overall Study|Lost to Follow-up|1
773850|NCT00585312|2461600|P1|Overall Study|Lost to Follow-up|1
773851|NCT00585312|2461599|P2|Overall Study|Lack of Efficacy|11
773852|NCT00585312|2461600|P1|Overall Study|Lack of Efficacy|6
773853|NCT00585312|2461599|P2|Overall Study|Adverse Event|0
773854|NCT00585312|2461600|P1|Overall Study|Adverse Event|3
773855|NCT00585351|2461618|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773856|NCT00585351|2461619|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773857|NCT00585351|2461620|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
773858|NCT00585351|2461621|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
773859|NCT00585351|2461622|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773860|NCT00585351|2461623|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773861|NCT00585351|2461624|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773862|NCT00585351|2461625|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
773863|NCT00585351|2461618|P8|Enrollment Period (Intervention)|Death|0
773864|NCT00585351|2461619|P7|Enrollment Period (Intervention)|Death|1
773865|NCT00585351|2461620|P6|Enrollment Period (Intervention)|Death|0
773866|NCT00585351|2461621|P5|Enrollment Period (Intervention)|Death|1
773867|NCT00585351|2461622|P4|Enrollment Period (Intervention)|Death|0
773868|NCT00585351|2461623|P3|Enrollment Period (Intervention)|Death|0
773869|NCT00585351|2461624|P2|Enrollment Period (Intervention)|Death|0
773870|NCT00585351|2461625|P1|Enrollment Period (Intervention)|Death|0
773871|NCT00585351|2461618|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
891754|NCT01072149|2828540|P10|Washout Period 2 (14 Days)|Adverse Event|0
773872|NCT00585351|2461619|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
773873|NCT00585351|2461620|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
773874|NCT00585351|2461621|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
773875|NCT00585351|2461622|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
773876|NCT00585351|2461623|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
773877|NCT00585351|2461624|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
773878|NCT00585351|2461625|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
773879|NCT00585351|2461618|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773880|NCT00585351|2461619|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773881|NCT00585351|2461620|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773882|NCT00585351|2461621|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773883|NCT00585351|2461622|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773884|NCT00585351|2461623|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
773885|NCT00585351|2461624|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
773886|NCT00585351|2461625|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
773887|NCT00585351|2461618|P8|Notification Period (Informed Consent)|No study medication on flight|0
773888|NCT00585351|2461619|P7|Notification Period (Informed Consent)|No study medication on flight|0
773889|NCT00585351|2461620|P6|Notification Period (Informed Consent)|No study medication on flight|0
773890|NCT00585351|2461621|P5|Notification Period (Informed Consent)|No study medication on flight|0
773891|NCT00585351|2461622|P4|Notification Period (Informed Consent)|No study medication on flight|0
773892|NCT00585351|2461623|P3|Notification Period (Informed Consent)|No study medication on flight|0
773893|NCT00585351|2461624|P2|Notification Period (Informed Consent)|No study medication on flight|1
773894|NCT00585351|2461625|P1|Notification Period (Informed Consent)|No study medication on flight|0
773895|NCT00585351|2461618|P8|Notification Period (Informed Consent)|Flight aborted|0
773896|NCT00585351|2461619|P7|Notification Period (Informed Consent)|Flight aborted|0
773897|NCT00585351|2461620|P6|Notification Period (Informed Consent)|Flight aborted|0
773898|NCT00585351|2461621|P5|Notification Period (Informed Consent)|Flight aborted|0
773899|NCT00585351|2461622|P4|Notification Period (Informed Consent)|Flight aborted|0
773900|NCT00585351|2461623|P3|Notification Period (Informed Consent)|Flight aborted|0
773901|NCT00585351|2461624|P2|Notification Period (Informed Consent)|Flight aborted|1
773902|NCT00585351|2461625|P1|Notification Period (Informed Consent)|Flight aborted|2
773903|NCT00585351|2461618|P8|Notification Period (Informed Consent)|Physician Decision|0
773904|NCT00585351|2461619|P7|Notification Period (Informed Consent)|Physician Decision|0
773905|NCT00585351|2461620|P6|Notification Period (Informed Consent)|Physician Decision|0
773906|NCT00585351|2461621|P5|Notification Period (Informed Consent)|Physician Decision|0
773907|NCT00585351|2461622|P4|Notification Period (Informed Consent)|Physician Decision|0
773908|NCT00585351|2461623|P3|Notification Period (Informed Consent)|Physician Decision|0
773909|NCT00585351|2461624|P2|Notification Period (Informed Consent)|Physician Decision|2
773910|NCT00585351|2461625|P1|Notification Period (Informed Consent)|Physician Decision|0
773911|NCT00585468|2461645|P2|First Intervention|Withdrawal by Subject|1
773912|NCT00585468|2461646|P1|First Intervention|Withdrawal by Subject|1
773913|NCT00585923|2461674|P2|Overall Study|Physician decided not to continue|33
773914|NCT00585923|2461675|P1|Overall Study|Physician decided not to continue|31
773915|NCT00585975|2461691|P2|Overall Study|Enrollment met/over-enrolled|9
773916|NCT00585975|2461692|P1|Overall Study|Enrollment met/over-enrolled|10
773917|NCT00585975|2461691|P2|Overall Study|Lost to Follow-up|1
773918|NCT00585975|2461692|P1|Overall Study|Lost to Follow-up|2
773919|NCT00585975|2461691|P2|Overall Study|Withdrawal by Subject|3
773920|NCT00585975|2461692|P1|Overall Study|Withdrawal by Subject|3
773921|NCT00586066|2461702|P2|Overall Study|Withdrawal of consent|2
773922|NCT00586066|2461703|P1|Overall Study|Withdrawal of consent|4
773923|NCT00586066|2461702|P2|Overall Study|Physician Decision|0
773924|NCT00586066|2461703|P1|Overall Study|Physician Decision|1
773925|NCT00586066|2461702|P2|Overall Study|Adverse Event|2
773926|NCT00586066|2461703|P1|Overall Study|Adverse Event|2
773927|NCT00586066|2461702|P2|Overall Study|Lack of Efficacy|3
773928|NCT00586066|2461703|P1|Overall Study|Lack of Efficacy|5
773929|NCT00586066|2461702|P2|Overall Study|Lost to Follow-up|3
773930|NCT00586066|2461703|P1|Overall Study|Lost to Follow-up|6
773931|NCT00586105|2461713|P1|Overall Study|Reason not reported|1
773932|NCT00586105|2461713|P1|Overall Study|Switched to commercial drug|9
773933|NCT00586105|2461713|P1|Overall Study|Disease progression|19
773934|NCT00586105|2461713|P1|Overall Study|Withdrawal by Subject|3
773935|NCT00586105|2461713|P1|Overall Study|Protocol Violation|1
773936|NCT00586105|2461713|P1|Overall Study|Death|2
773937|NCT00586105|2461713|P1|Overall Study|Adverse Event|4
773938|NCT00586157|2461726|P2|Second Intervention|Adverse Event|1
773939|NCT00586157|2461727|P1|Second Intervention|Adverse Event|0
773940|NCT00586157|2461726|P2|Second Intervention|Worsening behavior|0
773941|NCT00586157|2461727|P1|Second Intervention|Worsening behavior|1
773942|NCT00586157|2461726|P2|Second Intervention|Withdrawal by Subject|0
773943|NCT00586157|2461727|P1|Second Intervention|Withdrawal by Subject|1
773944|NCT00586157|2461726|P2|First Intervention|Worsening behavior|0
773945|NCT00586157|2461727|P1|First Intervention|Worsening behavior|1
773946|NCT00586313|2461768|P1|Overall Study|Lack of Efficacy|2
773947|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Other|2
773948|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
773949|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
773950|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
773951|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Death|2
773952|NCT00586326|2461773|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
773953|NCT00586326|2461773|P1|Device Placed toTreatment-ITT|Physician Decision|1
773954|NCT00586326|2461773|P1|Device Placed toTreatment-ITT|Positive Margins|3
773955|NCT00586326|2461773|P1|Device Placed toTreatment-ITT|Microinvasion|1
773956|NCT00586326|2461773|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
773957|NCT00586326|2461773|P1|Device Placed toTreatment-ITT|Skin Distance|7
773958|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Other|1
773959|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
773960|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
773961|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
773962|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
773963|NCT00586326|2461773|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
891755|NCT01072149|2828541|P9|Washout Period 2 (14 Days)|Adverse Event|0
891756|NCT01072149|2828542|P8|Washout Period 2 (14 Days)|Adverse Event|0
891757|NCT01072149|2828543|P7|Washout Period 2 (14 Days)|Adverse Event|0
891758|NCT01072149|2828544|P6|Washout Period 2 (14 Days)|Adverse Event|0
891759|NCT01072149|2828545|P5|Washout Period 2 (14 Days)|Adverse Event|0
891760|NCT01072149|2828546|P4|Washout Period 2 (14 Days)|Adverse Event|0
773970|NCT00586469|2461883|P2|Overall Study|Adverse Event|1
773971|NCT00586469|2461884|P1|Overall Study|Adverse Event|0
773972|NCT00586495|2461925|P1|Follow-up|Switch to commercial drug|10
773973|NCT00586495|2461925|P1|Follow-up|Protocol driven decision point|37
773974|NCT00586495|2461925|P1|Follow-up|Withdrawal by Subject|4
773975|NCT00586495|2461925|P1|Follow-up|Lost to Follow-up|1
773976|NCT00586495|2461925|P1|Follow-up|Death|40
773977|NCT00586495|2461925|P1|Treatment Period|Switch to commercial drug|10
773978|NCT00586495|2461925|P1|Treatment Period|Disease progression, recurrence/relapse|71
773979|NCT00586495|2461925|P1|Treatment Period|Withdrawal by Subject|1
773980|NCT00586495|2461925|P1|Treatment Period|Protocol Violation|1
773981|NCT00586495|2461925|P1|Treatment Period|Death|1
773982|NCT00586495|2461925|P1|Treatment Period|Adverse Event|11
773983|NCT00586521|2461935|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
773984|NCT00586612|2461948|P2|Booster Phase|Lost to Follow-up|1
773985|NCT00586612|2461949|P1|Booster Phase|Lost to Follow-up|3
773986|NCT00586612|2461948|P2|Primary Phase|Withdrawal by Subject|2
773987|NCT00586612|2461949|P1|Primary Phase|Withdrawal by Subject|0
773988|NCT00586612|2461948|P2|Primary Phase|Lost to Follow-up|1
773989|NCT00586612|2461949|P1|Primary Phase|Lost to Follow-up|0
773990|NCT00586612|2461948|P2|Primary Phase|Protocol Violation|0
773991|NCT00586612|2461949|P1|Primary Phase|Protocol Violation|1
773992|NCT00586625|2462017|P2|Overall Study|Subject unable to return for visit|0
773993|NCT00586625|2462018|P1|Overall Study|Subject unable to return for visit|2
773994|NCT00586625|2462017|P2|Overall Study|Subject non-compliance|1
773995|NCT00586625|2462018|P1|Overall Study|Subject non-compliance|0
773996|NCT00586625|2462017|P2|Overall Study|Withdrawal by Subject|10
773997|NCT00586625|2462018|P1|Overall Study|Withdrawal by Subject|32
773998|NCT00586625|2462017|P2|Overall Study|Protocol Violation|0
773999|NCT00586625|2462018|P1|Overall Study|Protocol Violation|3
774000|NCT00586625|2462017|P2|Overall Study|Adverse Event|6
774001|NCT00586625|2462018|P1|Overall Study|Adverse Event|6
774002|NCT00586664|2462027|P3|Overall Study|Exclusion criteria met|0
774003|NCT00586664|2462028|P2|Overall Study|Exclusion criteria met|0
774004|NCT00586664|2462029|P1|Overall Study|Exclusion criteria met|2
774005|NCT00586664|2462027|P3|Overall Study|Withdrawal by Subject|1
774006|NCT00586664|2462028|P2|Overall Study|Withdrawal by Subject|7
774007|NCT00586664|2462029|P1|Overall Study|Withdrawal by Subject|3
774008|NCT00586690|2462075|P2|Overall Study|Lab can't accommodate|0
774009|NCT00586690|2462076|P1|Overall Study|Lab can't accommodate|1
774010|NCT00586690|2462075|P2|Overall Study|Lack of Efficacy|0
774011|NCT00586690|2462076|P1|Overall Study|Lack of Efficacy|2
774012|NCT00586690|2462075|P2|Overall Study|Adverse Event|0
774013|NCT00586690|2462076|P1|Overall Study|Adverse Event|1
774014|NCT00586690|2462075|P2|Overall Study|Disease Progression|0
774015|NCT00586690|2462076|P1|Overall Study|Disease Progression|10
774016|NCT00586690|2462075|P2|Overall Study|Death|0
774017|NCT00586690|2462076|P1|Overall Study|Death|2
774018|NCT00586703|2462083|P1|Overall Study|Death|12
774019|NCT00586820|2462113|P2|Overall Study|Unsuccessful PCI|0
774020|NCT00586820|2462114|P1|Overall Study|Unsuccessful PCI|1
774021|NCT00586846|2462122|P1|Overall Study|Evaluable for Toxicity Only|4
774022|NCT00586846|2462122|P1|Overall Study|Death|1
774023|NCT00586846|2462122|P1|Overall Study|Physician Decision|1
774024|NCT00586898|2462126|P1|Overall Study|Evaluable for Toxicity Only|5
774025|NCT00586898|2462126|P1|Overall Study|Patiemt Non-compliance|1
774026|NCT00586898|2462126|P1|Overall Study|Adverse Event|1
774027|NCT00587054|2462146|P1|Overall Study|Patient not treated|9
774028|NCT00587158|2462175|P2|Overall Study|Subject did not want to take study med|1
774029|NCT00587158|2462176|P1|Overall Study|Subject did not want to take study med|0
774030|NCT00587158|2462175|P2|Overall Study|Death|1
774031|NCT00587158|2462176|P1|Overall Study|Death|0
774032|NCT00587158|2462175|P2|Overall Study|Lost to Follow-up|2
774033|NCT00587158|2462176|P1|Overall Study|Lost to Follow-up|1
774034|NCT00587158|2462175|P2|Overall Study|Physician Decision|1
774035|NCT00587158|2462176|P1|Overall Study|Physician Decision|0
774036|NCT00587158|2462175|P2|Overall Study|Did not want to do 24 hr urine collect.|3
774037|NCT00587158|2462176|P1|Overall Study|Did not want to do 24 hr urine collect.|4
774038|NCT00587171|2462208|P2|Overall Study|Lost to Follow-up|1
774039|NCT00587171|2462209|P1|Overall Study|Lost to Follow-up|1
774040|NCT00587223|2462237|P1|Overall Study|Adverse Event|1
774041|NCT00587288|2462254|P2|Overall Study|Protocol Violation|0
774042|NCT00587288|2462255|P1|Overall Study|Protocol Violation|1
774043|NCT00587288|2462254|P2|Overall Study|Lack of Efficacy|8
774044|NCT00587288|2462255|P1|Overall Study|Lack of Efficacy|2
774045|NCT00587288|2462254|P2|Overall Study|Adverse Event|1
774046|NCT00587288|2462255|P1|Overall Study|Adverse Event|0
774047|NCT00587431|2462275|P2|Overall Study|Withdrawal by Subject|1
774048|NCT00587431|2462276|P1|Overall Study|Withdrawal by Subject|0
774049|NCT00587431|2462275|P2|Overall Study|Adverse Event|0
774050|NCT00587431|2462276|P1|Overall Study|Adverse Event|1
774051|NCT00587457|2462288|P3|Overall Study|Development of neutralizing Abs|1
774052|NCT00587457|2462289|P2|Overall Study|Development of neutralizing Abs|0
774053|NCT00587457|2462290|P1|Overall Study|Development of neutralizing Abs|0
774054|NCT00587457|2462288|P3|Overall Study|Undefined|1
774055|NCT00587457|2462289|P2|Overall Study|Undefined|0
774056|NCT00587457|2462290|P1|Overall Study|Undefined|0
774057|NCT00587457|2462288|P3|Overall Study|Initiation of alternative therapy|0
774058|NCT00587457|2462289|P2|Overall Study|Initiation of alternative therapy|1
774059|NCT00587457|2462290|P1|Overall Study|Initiation of alternative therapy|0
774060|NCT00587457|2462288|P3|Overall Study|Disease progression|2
774061|NCT00587457|2462289|P2|Overall Study|Disease progression|0
774062|NCT00587457|2462290|P1|Overall Study|Disease progression|2
774063|NCT00587457|2462288|P3|Overall Study|Adverse Event|1
774064|NCT00587457|2462289|P2|Overall Study|Adverse Event|2
774065|NCT00587457|2462290|P1|Overall Study|Adverse Event|1
774066|NCT00587587|2462358|P2|Overall Study|Lost to Follow-up|1
774067|NCT00587587|2462359|P1|Overall Study|Lost to Follow-up|6
774068|NCT00587639|2462379|P1|Overall Study|Withdrawal by Subject|1
774069|NCT00587795|2462434|P2|Overall Study|Withdrawal by Subject|0
774070|NCT00587795|2462435|P1|Overall Study|Withdrawal by Subject|1
774071|NCT00587847|2462457|P1|Overall Study|Adverse Event|2
774072|NCT00587847|2462457|P1|Overall Study|Lack of Efficacy|5
774073|NCT00587860|2462464|P2|Overall Study|Withdrawal by Subject|3
774074|NCT00587860|2462465|P1|Overall Study|Withdrawal by Subject|3
774075|NCT00587860|2462464|P2|Overall Study|Lost to Follow-up|2
774076|NCT00587860|2462465|P1|Overall Study|Lost to Follow-up|2
774077|NCT00587964|2462485|P1|Overall Study|Progression of Disease|4
774078|NCT00587964|2462485|P1|Overall Study|Patient did not receive intervention|5
774079|NCT00587964|2462485|P1|Overall Study|Patient found to be ineligible|1
774080|NCT00587964|2462485|P1|Overall Study|Lost to Follow-up|1
774081|NCT00587964|2462485|P1|Overall Study|Withdrawal by Subject|1
774082|NCT00588094|2462502|P1|Overall Study|Progression of Disease|2
774083|NCT00588094|2462502|P1|Overall Study|Adverse Event|3
774084|NCT00588146|2462506|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
774085|NCT00588146|2462507|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
774086|NCT00588237|2462532|P1|Overall Study|Patien not treated|1
774087|NCT00588237|2462532|P1|Overall Study|Evaluable for toxicity only|3
774088|NCT00588341|2462536|P1|Overall Study|Patient ineligible|1
774089|NCT00588341|2462536|P1|Overall Study|Not treated due to metastatic disease|1
774090|NCT00588341|2462536|P1|Overall Study|Withdrawal by Subject|3
774091|NCT00588354|2462542|P2|Baseline to 4 Weeks|Lost to Follow-up|1
774092|NCT00588354|2462543|P1|Baseline to 4 Weeks|Lost to Follow-up|0
774093|NCT00588354|2462542|P2|Baseline to 2 Weeks|Lack of Efficacy|0
774094|NCT00588354|2462543|P1|Baseline to 2 Weeks|Lack of Efficacy|1
774095|NCT00588354|2462542|P2|Baseline to 2 Weeks|Adverse Event|0
774096|NCT00588354|2462543|P1|Baseline to 2 Weeks|Adverse Event|1
774097|NCT00581776|2462563|P1|Overall Study|Disease progression or no response|3
774098|NCT00581828|2462570|P1|Overall Study|Protocol Violation|1
774099|NCT00581919|2462587|P1|Overall Study|Withdrawal by Subject|1
774100|NCT00581919|2462587|P1|Overall Study|Started Non-Protocol Therapy|2
774101|NCT00581919|2462587|P1|Overall Study|Other Complicating Disease|1
774102|NCT00581919|2462587|P1|Overall Study|Physician Decision|1
774103|NCT00581919|2462587|P1|Overall Study|Disease Progression|10
774104|NCT00581919|2462587|P1|Overall Study|Death|1
774105|NCT00581919|2462587|P1|Overall Study|Adverse Event|8
774106|NCT00581945|2462595|P2|Overall Study|Death|0
774107|NCT00581945|2462596|P1|Overall Study|Death|1
774108|NCT00581945|2462595|P2|Overall Study|Withdrawal by Subject|6
774109|NCT00581945|2462596|P1|Overall Study|Withdrawal by Subject|2
774110|NCT00581945|2462595|P2|Overall Study|Unsatisfactory therapeutic effect|0
774111|NCT00581945|2462596|P1|Overall Study|Unsatisfactory therapeutic effect|2
774112|NCT00581945|2462595|P2|Overall Study|Adverse Event|4
774113|NCT00581945|2462596|P1|Overall Study|Adverse Event|4
891761|NCT01072149|2828547|P3|Washout Period 2 (14 Days)|Adverse Event|0
774116|NCT00582036|2462644|P2|Overall Study|Withdrawal by Subject|1
774117|NCT00582036|2462645|P1|Overall Study|Withdrawal by Subject|0
774118|NCT00582114|2462658|P2|Overall Study|Stopped by data safety monitoring board|20
774119|NCT00582114|2462659|P1|Overall Study|Stopped by data safety monitoring board|19
774120|NCT00582114|2462658|P2|Overall Study|Physician Decision|6
774121|NCT00582114|2462659|P1|Overall Study|Physician Decision|0
774122|NCT00582114|2462658|P2|Overall Study|Adverse Event|1
774123|NCT00582114|2462659|P1|Overall Study|Adverse Event|1
774124|NCT00582114|2462658|P2|Overall Study|Withdrawal by Subject|16
774125|NCT00582114|2462659|P1|Overall Study|Withdrawal by Subject|8
774126|NCT00582114|2462658|P2|Overall Study|Lost to Follow-up|6
774127|NCT00582114|2462659|P1|Overall Study|Lost to Follow-up|7
774128|NCT00582114|2462658|P2|Overall Study|Kidney Transplant|1
774129|NCT00582114|2462659|P1|Overall Study|Kidney Transplant|3
774130|NCT00582114|2462658|P2|Overall Study|Death|4
774131|NCT00582114|2462659|P1|Overall Study|Death|4
774132|NCT00582309|2462675|P3|Overall Study|Protocol Violation|2
774133|NCT00582309|2462676|P2|Overall Study|Protocol Violation|0
774134|NCT00582309|2462677|P1|Overall Study|Protocol Violation|0
774135|NCT00582426|2462705|P2|Overall Study|Use of illicit drugs|0
774136|NCT00582426|2462706|P1|Overall Study|Use of illicit drugs|1
774137|NCT00582426|2462705|P2|Overall Study|Disease Progression|2
774138|NCT00582426|2462706|P1|Overall Study|Disease Progression|2
774139|NCT00582426|2462705|P2|Overall Study|Withdrawal by Subject|2
774140|NCT00582426|2462706|P1|Overall Study|Withdrawal by Subject|3
774141|NCT00582426|2462705|P2|Overall Study|Death|3
774142|NCT00582426|2462706|P1|Overall Study|Death|4
774143|NCT00582426|2462705|P2|Overall Study|Protocol Violation|2
774144|NCT00582426|2462706|P1|Overall Study|Protocol Violation|6
774145|NCT00582426|2462705|P2|Overall Study|Adverse Event|2
774146|NCT00582426|2462706|P1|Overall Study|Adverse Event|4
774147|NCT00582426|2462705|P2|Overall Study|Lost to Follow-up|2
774148|NCT00582426|2462706|P1|Overall Study|Lost to Follow-up|0
774149|NCT00582491|2462734|P2|Overall Study|Withdrawal by Subject|0
774150|NCT00582491|2462735|P1|Overall Study|Withdrawal by Subject|1
774151|NCT00582556|2462769|P3|Overall Study|Physician Decision|1
774152|NCT00582556|2462770|P2|Overall Study|Physician Decision|0
774153|NCT00582556|2462771|P1|Overall Study|Physician Decision|0
774154|NCT00582556|2462769|P3|Overall Study|Withdrawal by Subject|1
774155|NCT00582556|2462770|P2|Overall Study|Withdrawal by Subject|1
774156|NCT00582556|2462771|P1|Overall Study|Withdrawal by Subject|0
774157|NCT00582608|2462788|P1|Overall Study|Lack of accrual|4
774158|NCT00582608|2462788|P1|Overall Study|Patient Ineligible|1
774159|NCT00582608|2462788|P1|Overall Study|Not Treated|7
774160|NCT00588445|2462808|P1|Overall Study|Not Treated|10
774161|NCT00588445|2462808|P1|Overall Study|Disease Progression|1
774162|NCT00588445|2462808|P1|Overall Study|Withdrawal by Subject|3
774163|NCT00588445|2462808|P1|Overall Study|Protocol Violation|1
774164|NCT00588640|2462829|P1|Overall Study|Ineligible Patient|1
774165|NCT00588640|2462829|P1|Overall Study|Physician Decision|1
774166|NCT00588666|2462833|P1|Overall Study|Adverse Event|4
774167|NCT00588692|2462840|P2|Overall Study|Death|0
774168|NCT00588692|2462841|P1|Overall Study|Death|1
774169|NCT00588692|2462840|P2|Overall Study|Cancer|0
774170|NCT00588692|2462841|P1|Overall Study|Cancer|1
774171|NCT00588692|2462840|P2|Overall Study|Severe Peptic Ulcer Disease|0
774172|NCT00588692|2462841|P1|Overall Study|Severe Peptic Ulcer Disease|1
774173|NCT00588692|2462840|P2|Overall Study|Hip Surgery|1
774174|NCT00588692|2462841|P1|Overall Study|Hip Surgery|0
774175|NCT00588692|2462840|P2|Overall Study|Withdrawal by Subject|2
774176|NCT00588692|2462841|P1|Overall Study|Withdrawal by Subject|4
774177|NCT00592007|2462877|P1|Overall Study|patient ineligible (out of lab range)|1
774178|NCT00592007|2462877|P1|Overall Study|Withdrawal by Subject|1
774179|NCT00592072|2462882|P2|Wash Out Period|Lost to Follow-up|1
774180|NCT00592072|2462883|P1|Wash Out Period|Lost to Follow-up|1
774181|NCT00592319|2462974|P2|Overall Study|Lost to Follow-up|3
774182|NCT00592319|2462975|P1|Overall Study|Lost to Follow-up|0
774183|NCT00592358|2462983|P1|Overall Study|Inability to swallow pills|1
774184|NCT00592358|2462983|P1|Overall Study|Lack of Efficacy|2
774185|NCT00592358|2462983|P1|Overall Study|Adverse Event|1
774186|NCT00592358|2462983|P1|Overall Study|Withdrawal by Subject|2
774187|NCT00592384|2462990|P2|Overall Study|Withdrawal by Subject|6
774188|NCT00592384|2462991|P1|Overall Study|Withdrawal by Subject|5
774189|NCT00592631|2463038|P2|Overall Study|Lost to Follow-up|2
774190|NCT00592631|2463039|P1|Overall Study|Lost to Follow-up|0
774191|NCT00592683|2463047|P2|Overall Study|Lost to Follow-up|1
774192|NCT00592683|2463048|P1|Overall Study|Lost to Follow-up|0
774193|NCT00592683|2463047|P2|Overall Study|Other|0
774194|NCT00592683|2463048|P1|Overall Study|Other|1
774195|NCT00592683|2463047|P2|Overall Study|Study drug expired|0
774196|NCT00592683|2463048|P1|Overall Study|Study drug expired|1
774197|NCT00592683|2463047|P2|Overall Study|Protocol Violation|0
774198|NCT00592683|2463048|P1|Overall Study|Protocol Violation|1
774199|NCT00592683|2463047|P2|Overall Study|Adverse Event|2
774200|NCT00592683|2463048|P1|Overall Study|Adverse Event|0
774201|NCT00592683|2463047|P2|Overall Study|Withdrawal by Subject|0
774202|NCT00592683|2463048|P1|Overall Study|Withdrawal by Subject|1
774203|NCT00592683|2463047|P2|Overall Study|Found ineligible|1
774204|NCT00592683|2463048|P1|Overall Study|Found ineligible|0
774205|NCT00592774|2463074|P5|Overall Study|Not specified|2
774206|NCT00592774|2463075|P4|Overall Study|Not specified|0
774207|NCT00592774|2463076|P3|Overall Study|Not specified|1
774208|NCT00592774|2463077|P2|Overall Study|Not specified|1
774209|NCT00592774|2463078|P1|Overall Study|Not specified|0
774210|NCT00592774|2463074|P5|Overall Study|Physician Decision|1
774211|NCT00592774|2463075|P4|Overall Study|Physician Decision|0
774212|NCT00592774|2463076|P3|Overall Study|Physician Decision|1
774213|NCT00592774|2463077|P2|Overall Study|Physician Decision|1
774214|NCT00592774|2463078|P1|Overall Study|Physician Decision|0
774215|NCT00592774|2463074|P5|Overall Study|Lack of Efficacy|2
774216|NCT00592774|2463075|P4|Overall Study|Lack of Efficacy|0
774217|NCT00592774|2463076|P3|Overall Study|Lack of Efficacy|0
774218|NCT00592774|2463077|P2|Overall Study|Lack of Efficacy|3
774219|NCT00592774|2463078|P1|Overall Study|Lack of Efficacy|3
774220|NCT00592774|2463074|P5|Overall Study|Withdrawal by Subject|0
774221|NCT00592774|2463075|P4|Overall Study|Withdrawal by Subject|0
774222|NCT00592774|2463076|P3|Overall Study|Withdrawal by Subject|0
774223|NCT00592774|2463077|P2|Overall Study|Withdrawal by Subject|7
774224|NCT00592774|2463078|P1|Overall Study|Withdrawal by Subject|3
774225|NCT00592774|2463074|P5|Overall Study|Protocol Violation|1
774226|NCT00592774|2463075|P4|Overall Study|Protocol Violation|0
774227|NCT00592774|2463076|P3|Overall Study|Protocol Violation|0
774228|NCT00592774|2463077|P2|Overall Study|Protocol Violation|1
774229|NCT00592774|2463078|P1|Overall Study|Protocol Violation|0
774230|NCT00592774|2463074|P5|Overall Study|Adverse Event|8
774231|NCT00592774|2463075|P4|Overall Study|Adverse Event|14
774232|NCT00592774|2463076|P3|Overall Study|Adverse Event|2
774233|NCT00592774|2463077|P2|Overall Study|Adverse Event|19
774234|NCT00592774|2463078|P1|Overall Study|Adverse Event|5
774235|NCT00592839|2463138|P3|Overall Study|Lost to Follow-up|1
774236|NCT00592839|2463139|P2|Overall Study|Lost to Follow-up|1
774237|NCT00592839|2463140|P1|Overall Study|Lost to Follow-up|0
774238|NCT00592839|2463138|P3|Overall Study|Adverse Event|0
774239|NCT00592839|2463139|P2|Overall Study|Adverse Event|1
774240|NCT00592839|2463140|P1|Overall Study|Adverse Event|0
774241|NCT00592839|2463138|P3|Overall Study|Protocol Violation|2
774242|NCT00592839|2463139|P2|Overall Study|Protocol Violation|1
774243|NCT00592839|2463140|P1|Overall Study|Protocol Violation|1
774244|NCT00592839|2463138|P3|Overall Study|Withdrawal by Subject|3
774245|NCT00592839|2463139|P2|Overall Study|Withdrawal by Subject|1
774246|NCT00592839|2463140|P1|Overall Study|Withdrawal by Subject|1
774247|NCT00592852|2463163|P1|Overall Study|Withdrawal by Subject|1
774248|NCT00592852|2463163|P1|Overall Study|Found ineligible|1
774249|NCT00592852|2463163|P1|Overall Study|Adverse Event|3
774250|NCT00592852|2463163|P1|Overall Study|Non-compliance|1
774251|NCT00592904|2463172|P4|Overall Study|Not specified|0
774252|NCT00592904|2463173|P3|Overall Study|Not specified|0
774253|NCT00592904|2463174|P2|Overall Study|Not specified|3
774254|NCT00592904|2463175|P1|Overall Study|Not specified|3
774255|NCT00592904|2463172|P4|Overall Study|Physician Decision|0
774256|NCT00592904|2463173|P3|Overall Study|Physician Decision|1
774257|NCT00592904|2463174|P2|Overall Study|Physician Decision|3
774258|NCT00592904|2463175|P1|Overall Study|Physician Decision|0
774259|NCT00592904|2463172|P4|Overall Study|Lack of Efficacy|3
774260|NCT00592904|2463173|P3|Overall Study|Lack of Efficacy|2
774261|NCT00592904|2463174|P2|Overall Study|Lack of Efficacy|7
774262|NCT00592904|2463175|P1|Overall Study|Lack of Efficacy|2
774263|NCT00592904|2463172|P4|Overall Study|Withdrawal by Subject|2
774264|NCT00592904|2463173|P3|Overall Study|Withdrawal by Subject|1
774265|NCT00592904|2463174|P2|Overall Study|Withdrawal by Subject|16
774266|NCT00592904|2463175|P1|Overall Study|Withdrawal by Subject|4
774267|NCT00592904|2463172|P4|Overall Study|Protocol Violation|1
774268|NCT00592904|2463173|P3|Overall Study|Protocol Violation|0
774269|NCT00592904|2463174|P2|Overall Study|Protocol Violation|1
774270|NCT00592904|2463175|P1|Overall Study|Protocol Violation|1
774271|NCT00592904|2463172|P4|Overall Study|Adverse Event|5
774272|NCT00592904|2463173|P3|Overall Study|Adverse Event|13
774273|NCT00592904|2463174|P2|Overall Study|Adverse Event|25
774274|NCT00592904|2463175|P1|Overall Study|Adverse Event|15
774275|NCT00593112|2463216|P2|Overall Study|Withdrawal by Subject|0
774276|NCT00593112|2463217|P1|Overall Study|Withdrawal by Subject|5
774277|NCT00593112|2463216|P2|Overall Study|Unreadable Scan|0
774278|NCT00593112|2463217|P1|Overall Study|Unreadable Scan|1
774279|NCT00593112|2463216|P2|Overall Study|Abnormal Scan|0
774280|NCT00593112|2463217|P1|Overall Study|Abnormal Scan|1
774281|NCT00593112|2463216|P2|Overall Study|Scan Anxiety|0
774282|NCT00593112|2463217|P1|Overall Study|Scan Anxiety|3
774283|NCT00593333|2463244|P2|Overall Study|Lost to Follow-up|11
774284|NCT00593333|2463245|P1|Overall Study|Lost to Follow-up|10
774285|NCT00593606|2463352|P1|Overall Study|Screen Failure|3
774286|NCT00593606|2463352|P1|Overall Study|Run-In Failure|5
774287|NCT00593606|2463352|P1|Overall Study|Lost to Follow-up|2
774288|NCT00593606|2463352|P1|Overall Study|Protocol Violation|3
774289|NCT00593606|2463352|P1|Overall Study|Withdrawal by Subject|1
774290|NCT00593606|2463352|P1|Overall Study|Adverse Event|13
774291|NCT00593684|2463464|P2|Overall Study|Death|1
774292|NCT00593684|2463465|P1|Overall Study|Death|2
774293|NCT00593736|2463481|P4|Treatment Period and Placebo Run-out|Various|0
774294|NCT00593736|2463482|P3|Treatment Period and Placebo Run-out|Various|1
774295|NCT00593736|2463483|P2|Treatment Period and Placebo Run-out|Various|1
774296|NCT00593736|2463484|P1|Treatment Period and Placebo Run-out|Various|1
774297|NCT00593736|2463481|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
774298|NCT00593736|2463482|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
774299|NCT00593736|2463483|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
774378|NCT00594204|2463866|P1|Overall Study|Lack of Efficacy|3
774300|NCT00593736|2463484|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
774301|NCT00593736|2463481|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
774302|NCT00593736|2463482|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
774303|NCT00593736|2463483|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
774304|NCT00593736|2463484|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
774305|NCT00593736|2463481|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
774306|NCT00593736|2463482|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
774307|NCT00593736|2463483|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
774308|NCT00593736|2463484|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
774309|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Various|25
774310|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Various|0
774311|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Various|0
774312|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Various|0
774313|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
774314|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
774315|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
774316|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
774317|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Study Termination|15
774318|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Study Termination|0
774319|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Study Termination|0
774320|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Study Termination|0
774321|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
774322|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
774323|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
774324|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
774325|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
774326|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
774327|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
774328|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
774329|NCT00593736|2463481|P4|Screening Period and Placebo Run-in|Adverse Event|3
774330|NCT00593736|2463482|P3|Screening Period and Placebo Run-in|Adverse Event|0
774331|NCT00593736|2463483|P2|Screening Period and Placebo Run-in|Adverse Event|0
774332|NCT00593736|2463484|P1|Screening Period and Placebo Run-in|Adverse Event|0
774333|NCT00593814|2463732|P2|Overall Study|Physician Decision|0
774334|NCT00593814|2463733|P1|Overall Study|Physician Decision|3
774335|NCT00593814|2463732|P2|Overall Study|Lost to Follow-up|0
774336|NCT00593814|2463733|P1|Overall Study|Lost to Follow-up|7
774337|NCT00593814|2463732|P2|Overall Study|Withdrawal by Subject|0
774338|NCT00593814|2463733|P1|Overall Study|Withdrawal by Subject|7
774339|NCT00593814|2463732|P2|Overall Study|Death|0
774340|NCT00593814|2463733|P1|Overall Study|Death|7
774341|NCT00593827|2463741|P2|Overall Study|On Active Treatment/Pending|2
774342|NCT00593827|2463742|P1|Overall Study|On Active Treatment/Pending|0
774343|NCT00593840|2463764|P1|Overall Study|Withdrawal by Subject|1
774344|NCT00593918|2463781|P2|Overall Study|Withdrawal by Subject|24
774345|NCT00593918|2463782|P1|Overall Study|Withdrawal by Subject|5
774346|NCT00593957|2463793|P3|Overall Study|Physician Decision|2
774347|NCT00593957|2463794|P2|Overall Study|Physician Decision|1
774348|NCT00593957|2463795|P1|Overall Study|Physician Decision|0
774349|NCT00594035|2463836|P2|Overall Study|Subject couldn't return due to job|1
774350|NCT00594035|2463837|P1|Overall Study|Subject couldn't return due to job|0
774351|NCT00594035|2463836|P2|Overall Study|Subject transferred to nursing home|1
774352|NCT00594035|2463837|P1|Overall Study|Subject transferred to nursing home|0
774353|NCT00594035|2463836|P2|Overall Study|Withdrawal by Subject|0
774354|NCT00594035|2463837|P1|Overall Study|Withdrawal by Subject|1
774355|NCT00594035|2463836|P2|Overall Study|Lost to Follow-up|1
774356|NCT00594035|2463837|P1|Overall Study|Lost to Follow-up|1
774357|NCT00594100|2463843|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
774358|NCT00594100|2463843|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
774359|NCT00594100|2463843|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
774360|NCT00594100|2463843|P1|Procedure|Technical Failure|9
774361|NCT00594165|2463852|P1|Overall Study|Other: Site terminated participation|2
774362|NCT00594165|2463852|P1|Overall Study|Other: Subject enrolled in other trial|1
774363|NCT00594165|2463852|P1|Overall Study|Other: House bound; can't get to clinic|1
774364|NCT00594165|2463852|P1|Overall Study|Other: Brain surgery controlled symptoms|1
774365|NCT00594165|2463852|P1|Overall Study|Other: Subject moving|3
774366|NCT00594165|2463852|P1|Overall Study|Other: PI discretion|5
774367|NCT00594165|2463852|P1|Overall Study|Lost to Follow-up|4
774368|NCT00594165|2463852|P1|Overall Study|Study ended per sponsor|102
774369|NCT00594165|2463852|P1|Overall Study|Subject withdrew consent|27
774370|NCT00594165|2463852|P1|Overall Study|Unsatisfactory compliance of subject|6
774371|NCT00594165|2463852|P1|Overall Study|Adverse Event|52
774372|NCT00594165|2463852|P1|Overall Study|Lack of Efficacy|12
774373|NCT00594165|2463852|P1|Overall Study|Major protocol violation|1
774374|NCT00594178|2463858|P1|Overall Study|Physician Decision|5
774375|NCT00594204|2463865|P2|Overall Study|Randomized but not treated|1
774376|NCT00594204|2463866|P1|Overall Study|Randomized but not treated|4
774377|NCT00594204|2463865|P2|Overall Study|Lack of Efficacy|4
774379|NCT00594204|2463865|P2|Overall Study|Unspecified|3
774380|NCT00594204|2463866|P1|Overall Study|Unspecified|4
774381|NCT00594204|2463865|P2|Overall Study|Withdrawal by Subject|29
774382|NCT00594204|2463866|P1|Overall Study|Withdrawal by Subject|23
774383|NCT00594204|2463865|P2|Overall Study|Lost to Follow-up|5
774384|NCT00594204|2463866|P1|Overall Study|Lost to Follow-up|9
774385|NCT00594204|2463865|P2|Overall Study|Adverse Event|3
774386|NCT00594204|2463866|P1|Overall Study|Adverse Event|15
774387|NCT00594386|2463901|P1|Overall Study|Other: Loss of drivers license|1
774388|NCT00594386|2463901|P1|Overall Study|Other: Patient wants prescription Neupro|1
774389|NCT00594386|2463901|P1|Overall Study|Other: Site terminated participation|1
774390|NCT00594386|2463901|P1|Overall Study|Other: Sponsor closure of study|1
774391|NCT00594386|2463901|P1|Overall Study|Other: Study terminated per investigator|2
774392|NCT00594386|2463901|P1|Overall Study|Other: Subject admitted to nursing home|1
774393|NCT00594386|2463901|P1|Overall Study|Other: Subject moved to Seattle|1
774394|NCT00594386|2463901|P1|Overall Study|Other: Patient went off patch (hospital)|1
774395|NCT00594386|2463901|P1|Overall Study|Lost to Follow-up|6
774396|NCT00594386|2463901|P1|Overall Study|Study ended per sponsor|115
774397|NCT00594386|2463901|P1|Overall Study|Subject withdrew consent|35
774398|NCT00594386|2463901|P1|Overall Study|Unsatisfactory compliance of subject|11
774399|NCT00594386|2463901|P1|Overall Study|Adverse Event|68
774400|NCT00594386|2463901|P1|Overall Study|Lack of Efficacy|12
774401|NCT00594386|2463901|P1|Overall Study|Major protocol violation|2
774402|NCT00594399|2463909|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
774403|NCT00594399|2463910|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
774404|NCT00594399|2463911|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
774405|NCT00594399|2463909|P3|Rerandomization Arm 1 Only|Death|0
774406|NCT00594399|2463910|P2|Rerandomization Arm 1 Only|Death|1
774407|NCT00594399|2463911|P1|Rerandomization Arm 1 Only|Death|2
774408|NCT00594399|2463909|P3|Initial 3 Month Counseling|Family illness|0
774409|NCT00594399|2463910|P2|Initial 3 Month Counseling|Family illness|0
774410|NCT00594399|2463911|P1|Initial 3 Month Counseling|Family illness|1
774411|NCT00594399|2463909|P3|Initial 3 Month Counseling|Moved|0
774412|NCT00594399|2463910|P2|Initial 3 Month Counseling|Moved|0
774413|NCT00594399|2463911|P1|Initial 3 Month Counseling|Moved|1
774414|NCT00594399|2463909|P3|Initial 3 Month Counseling|Pain|0
774415|NCT00594399|2463910|P2|Initial 3 Month Counseling|Pain|0
774416|NCT00594399|2463911|P1|Initial 3 Month Counseling|Pain|2
774417|NCT00594399|2463909|P3|Initial 3 Month Counseling|Too busy|0
774418|NCT00594399|2463910|P2|Initial 3 Month Counseling|Too busy|1
774419|NCT00594399|2463911|P1|Initial 3 Month Counseling|Too busy|7
774420|NCT00594399|2463909|P3|Initial 3 Month Counseling|Personal issues|0
774421|NCT00594399|2463910|P2|Initial 3 Month Counseling|Personal issues|0
774422|NCT00594399|2463911|P1|Initial 3 Month Counseling|Personal issues|2
774423|NCT00594399|2463909|P3|Initial 3 Month Counseling|Lack of Interest|0
774424|NCT00594399|2463910|P2|Initial 3 Month Counseling|Lack of Interest|3
774425|NCT00594399|2463911|P1|Initial 3 Month Counseling|Lack of Interest|3
774426|NCT00594399|2463909|P3|Initial 3 Month Counseling|Not ready to exercise|0
774427|NCT00594399|2463910|P2|Initial 3 Month Counseling|Not ready to exercise|0
774428|NCT00594399|2463911|P1|Initial 3 Month Counseling|Not ready to exercise|1
774429|NCT00594464|2464048|P1|Overall Study|Delay in operation|2
774430|NCT00594464|2464048|P1|Overall Study|Withdrawal by Subject|1
774431|NCT00585533|2464064|P1|Overall Study|objective or symptomatic progression|9
774432|NCT00585585|2464069|P1|Overall Study|Adverse Event|1
774433|NCT00585689|2464115|P1|Overall Study|Death|1
774434|NCT00585689|2464115|P1|Overall Study|Patient had unresectable disease|1
774435|NCT00585689|2464115|P1|Overall Study|Patient Declined Surgery|1
774436|NCT00585689|2464115|P1|Overall Study|Adverse Event|1
774437|NCT00585689|2464115|P1|Overall Study|Received different ABI-007 schedule|3
774438|NCT00594516|2464130|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
774439|NCT00594516|2464131|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
774440|NCT00594516|2464132|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
774441|NCT00594516|2464130|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
774442|NCT00594516|2464131|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
774443|NCT00594516|2464132|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
774444|NCT00594516|2464130|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
774445|NCT00594516|2464131|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
774446|NCT00594516|2464132|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
774447|NCT00594516|2464130|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
774448|NCT00594516|2464131|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
774449|NCT00594516|2464132|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
774450|NCT00594516|2464130|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
774451|NCT00594516|2464131|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
774452|NCT00594516|2464132|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
774453|NCT00594516|2464130|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
774454|NCT00594516|2464131|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
774455|NCT00594516|2464132|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
774456|NCT00594516|2464130|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
774457|NCT00594516|2464131|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
774458|NCT00594516|2464132|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
774459|NCT00594516|2464130|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
774460|NCT00594516|2464131|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
774461|NCT00594516|2464132|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
774462|NCT00594516|2464130|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
774463|NCT00594516|2464131|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
774464|NCT00594516|2464132|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
774465|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
774466|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
774467|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
774468|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
774469|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
774470|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
774471|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
774472|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
774473|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
774474|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
774475|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
774476|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
774477|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
774478|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
774479|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
774480|NCT00594568|2464143|P3|Safety Follow Up (SFU)-Optional|Death|0
774481|NCT00594568|2464144|P2|Safety Follow Up (SFU)-Optional|Death|1
774482|NCT00594568|2464145|P1|Safety Follow Up (SFU)-Optional|Death|0
774483|NCT00594568|2464143|P3|Delayed Start|Sponsor Decision|59
774484|NCT00594568|2464144|P2|Delayed Start|Sponsor Decision|66
774485|NCT00594568|2464145|P1|Delayed Start|Sponsor Decision|77
774486|NCT00594568|2464143|P3|Delayed Start|Caregiver Decision|2
774487|NCT00594568|2464144|P2|Delayed Start|Caregiver Decision|6
774488|NCT00594568|2464145|P1|Delayed Start|Caregiver Decision|5
774489|NCT00594568|2464143|P3|Delayed Start|Lost to Follow-up|1
774490|NCT00594568|2464144|P2|Delayed Start|Lost to Follow-up|0
774491|NCT00594568|2464145|P1|Delayed Start|Lost to Follow-up|0
774492|NCT00594568|2464143|P3|Delayed Start|Physician Decision|1
774493|NCT00594568|2464144|P2|Delayed Start|Physician Decision|0
774494|NCT00594568|2464145|P1|Delayed Start|Physician Decision|0
774495|NCT00594568|2464143|P3|Delayed Start|Withdrawal by Subject|0
774496|NCT00594568|2464144|P2|Delayed Start|Withdrawal by Subject|3
774497|NCT00594568|2464145|P1|Delayed Start|Withdrawal by Subject|4
774498|NCT00594568|2464143|P3|Delayed Start|Adverse Event|2
774499|NCT00594568|2464144|P2|Delayed Start|Adverse Event|2
774500|NCT00594568|2464145|P1|Delayed Start|Adverse Event|12
774501|NCT00594568|2464143|P3|Delayed Start|Death|1
774502|NCT00594568|2464144|P2|Delayed Start|Death|0
774503|NCT00594568|2464145|P1|Delayed Start|Death|0
774504|NCT00594568|2464143|P3|Initial Treatment|Entry criteria exclusion|1
774505|NCT00594568|2464144|P2|Initial Treatment|Entry criteria exclusion|1
774506|NCT00594568|2464145|P1|Initial Treatment|Entry criteria exclusion|0
774507|NCT00594568|2464143|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
774508|NCT00594568|2464144|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
774509|NCT00594568|2464145|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
774510|NCT00594568|2464143|P3|Initial Treatment|Caregiver decision|36
774511|NCT00594568|2464144|P2|Initial Treatment|Caregiver decision|36
774512|NCT00594568|2464145|P1|Initial Treatment|Caregiver decision|21
774513|NCT00594568|2464143|P3|Initial Treatment|Sponsor decision|147
774514|NCT00594568|2464144|P2|Initial Treatment|Sponsor decision|142
774515|NCT00594568|2464145|P1|Initial Treatment|Sponsor decision|193
774516|NCT00594568|2464143|P3|Initial Treatment|Withdrawal by Subject|46
774517|NCT00594568|2464144|P2|Initial Treatment|Withdrawal by Subject|31
774518|NCT00594568|2464145|P1|Initial Treatment|Withdrawal by Subject|25
774519|NCT00594568|2464143|P3|Initial Treatment|Protocol Violation|5
774520|NCT00594568|2464144|P2|Initial Treatment|Protocol Violation|2
774521|NCT00594568|2464145|P1|Initial Treatment|Protocol Violation|2
774522|NCT00594568|2464143|P3|Initial Treatment|Physician Decision|4
774523|NCT00594568|2464144|P2|Initial Treatment|Physician Decision|2
774524|NCT00594568|2464145|P1|Initial Treatment|Physician Decision|3
774525|NCT00594568|2464143|P3|Initial Treatment|Lost to Follow-up|4
774526|NCT00594568|2464144|P2|Initial Treatment|Lost to Follow-up|1
774527|NCT00594568|2464145|P1|Initial Treatment|Lost to Follow-up|4
774528|NCT00594568|2464143|P3|Initial Treatment|Death|15
774529|NCT00594568|2464144|P2|Initial Treatment|Death|11
774530|NCT00594568|2464145|P1|Initial Treatment|Death|6
774531|NCT00594568|2464143|P3|Initial Treatment|Adverse Event|144
774532|NCT00594568|2464144|P2|Initial Treatment|Adverse Event|121
774533|NCT00594568|2464145|P1|Initial Treatment|Adverse Event|51
774534|NCT00594646|2464233|P1|Overall Study|Lost to Follow-up|15
774535|NCT00594646|2464233|P1|Overall Study|Withdrawal by Subject|1
774536|NCT00594659|2464241|P3|Overall Study|Lost to Follow-up|7
774537|NCT00594659|2464242|P2|Overall Study|Lost to Follow-up|9
774538|NCT00594659|2464243|P1|Overall Study|Lost to Follow-up|13
774539|NCT00594815|2464271|P1|Overall Study|Toxicity|4
774540|NCT00594815|2464271|P1|Overall Study|Withdrawal by Subject|2
774541|NCT00594815|2464271|P1|Overall Study|Never Treated|3
774542|NCT00597519|2464276|P1|Overall Study|Death|1
774543|NCT00597584|2464297|P2|Overall Study|Renal transplant|7
774544|NCT00597584|2464298|P1|Overall Study|Renal transplant|9
774545|NCT00597584|2464297|P2|Overall Study|Relocation|6
774546|NCT00597584|2464298|P1|Overall Study|Relocation|8
774547|NCT00597584|2464297|P2|Overall Study|Never dosed|0
774548|NCT00597584|2464298|P1|Overall Study|Never dosed|1
774549|NCT00597584|2464297|P2|Overall Study|Lost ability to consent|1
774550|NCT00597584|2464298|P1|Overall Study|Lost ability to consent|1
774551|NCT00597584|2464297|P2|Overall Study|Discontinued Dialysis|1
774552|NCT00597584|2464298|P1|Overall Study|Discontinued Dialysis|0
774553|NCT00597584|2464297|P2|Overall Study|Withdrawal by Subject|12
774554|NCT00597584|2464298|P1|Overall Study|Withdrawal by Subject|44
774555|NCT00597584|2464297|P2|Overall Study|Pregnancy|0
774556|NCT00597584|2464298|P1|Overall Study|Pregnancy|2
774557|NCT00597584|2464297|P2|Overall Study|Physician Decision|0
774558|NCT00597584|2464298|P1|Overall Study|Physician Decision|3
774559|NCT00597584|2464297|P2|Overall Study|Lost to Follow-up|4
774560|NCT00597584|2464298|P1|Overall Study|Lost to Follow-up|2
774561|NCT00597584|2464297|P2|Overall Study|Lack of Efficacy|0
774562|NCT00597584|2464298|P1|Overall Study|Lack of Efficacy|1
774563|NCT00597584|2464297|P2|Overall Study|Death|30
774564|NCT00597584|2464298|P1|Overall Study|Death|53
774565|NCT00597584|2464297|P2|Overall Study|Adverse Event|2
774566|NCT00597584|2464298|P1|Overall Study|Adverse Event|4
774567|NCT00597701|2464324|P2|Overall Study|Did not start intervention (pharmacy er)|2
774568|NCT00597701|2464325|P1|Overall Study|Did not start intervention (pharmacy er)|0
774569|NCT00597701|2464324|P2|Overall Study|Physician Decision|0
774570|NCT00597701|2464325|P1|Overall Study|Physician Decision|2
774571|NCT00597701|2464324|P2|Overall Study|Death|1
774572|NCT00597701|2464325|P1|Overall Study|Death|0
774573|NCT00597701|2464324|P2|Overall Study|Withdrawal by Subject|5
774574|NCT00597701|2464325|P1|Overall Study|Withdrawal by Subject|5
774575|NCT00597714|2464333|P3|Overall Study|Recipient death|10
774576|NCT00597714|2464334|P2|Overall Study|Recipient death|0
774577|NCT00597714|2464335|P1|Overall Study|Recipient death|0
774578|NCT00597714|2464333|P3|Overall Study|Death|0
774579|NCT00597714|2464334|P2|Overall Study|Death|46
774580|NCT00597714|2464335|P1|Overall Study|Death|56
774581|NCT00597753|2464369|P2|Overall Study|Site elected to close|4
774582|NCT00597753|2464370|P1|Overall Study|Site elected to close|2
774583|NCT00597753|2464369|P2|Overall Study|Site closed by sponsor|7
774584|NCT00597753|2464370|P1|Overall Study|Site closed by sponsor|19
774585|NCT00597753|2464369|P2|Overall Study|Renal transplant|3
774586|NCT00597753|2464370|P1|Overall Study|Renal transplant|10
774587|NCT00597753|2464369|P2|Overall Study|Relocation|6
774588|NCT00597753|2464370|P1|Overall Study|Relocation|17
774589|NCT00597753|2464369|P2|Overall Study|Noncompliance|1
774590|NCT00597753|2464370|P1|Overall Study|Noncompliance|2
774591|NCT00597753|2464369|P2|Overall Study|Never dosed|0
774592|NCT00597753|2464370|P1|Overall Study|Never dosed|2
774593|NCT00597753|2464369|P2|Overall Study|Discontinued Dialysis|1
774594|NCT00597753|2464370|P1|Overall Study|Discontinued Dialysis|0
774595|NCT00597753|2464369|P2|Overall Study|Withdrawal by Subject|12
774596|NCT00597753|2464370|P1|Overall Study|Withdrawal by Subject|35
774597|NCT00597753|2464369|P2|Overall Study|Pregnancy|0
774598|NCT00597753|2464370|P1|Overall Study|Pregnancy|1
774599|NCT00597753|2464369|P2|Overall Study|Physician Decision|1
774600|NCT00597753|2464370|P1|Overall Study|Physician Decision|5
774601|NCT00597753|2464369|P2|Overall Study|Lost to Follow-up|3
774602|NCT00597753|2464370|P1|Overall Study|Lost to Follow-up|10
774603|NCT00597753|2464369|P2|Overall Study|Lack of Efficacy|0
774604|NCT00597753|2464370|P1|Overall Study|Lack of Efficacy|2
774605|NCT00597753|2464369|P2|Overall Study|Death|29
774606|NCT00597753|2464370|P1|Overall Study|Death|55
774607|NCT00597753|2464369|P2|Overall Study|Adverse Event|2
774608|NCT00597753|2464370|P1|Overall Study|Adverse Event|6
774609|NCT00598078|2464422|P2|Period 2 (Day 2)|Adverse Event|0
774610|NCT00598078|2464423|P1|Period 2 (Day 2)|Adverse Event|1
774611|NCT00598273|2464434|P3|Overall Study|Started dialysis|5
774612|NCT00598273|2464435|P2|Overall Study|Started dialysis|4
774613|NCT00598273|2464436|P1|Overall Study|Started dialysis|6
774614|NCT00598273|2464434|P3|Overall Study|Site elected to close|0
774615|NCT00598273|2464435|P2|Overall Study|Site elected to close|0
774616|NCT00598273|2464436|P1|Overall Study|Site elected to close|1
774617|NCT00598273|2464434|P3|Overall Study|Renal transplant|1
774618|NCT00598273|2464435|P2|Overall Study|Renal transplant|0
774619|NCT00598273|2464436|P1|Overall Study|Renal transplant|1
774620|NCT00598273|2464434|P3|Overall Study|Relocation|4
774621|NCT00598273|2464435|P2|Overall Study|Relocation|2
774622|NCT00598273|2464436|P1|Overall Study|Relocation|0
774623|NCT00598273|2464434|P3|Overall Study|Noncompliance|3
774624|NCT00598273|2464435|P2|Overall Study|Noncompliance|2
774625|NCT00598273|2464436|P1|Overall Study|Noncompliance|3
774626|NCT00598273|2464434|P3|Overall Study|Withdrawal by Subject|10
774627|NCT00598273|2464435|P2|Overall Study|Withdrawal by Subject|10
774628|NCT00598273|2464436|P1|Overall Study|Withdrawal by Subject|12
774629|NCT00598273|2464434|P3|Overall Study|Physician Decision|1
774630|NCT00598273|2464435|P2|Overall Study|Physician Decision|0
774631|NCT00598273|2464436|P1|Overall Study|Physician Decision|0
774632|NCT00598273|2464434|P3|Overall Study|Lost to Follow-up|5
774633|NCT00598273|2464435|P2|Overall Study|Lost to Follow-up|3
774634|NCT00598273|2464436|P1|Overall Study|Lost to Follow-up|8
774635|NCT00598273|2464434|P3|Overall Study|Death|8
774636|NCT00598273|2464435|P2|Overall Study|Death|12
774637|NCT00598273|2464436|P1|Overall Study|Death|6
774638|NCT00598273|2464434|P3|Overall Study|Adverse Event|2
774639|NCT00598273|2464435|P2|Overall Study|Adverse Event|5
774640|NCT00598273|2464436|P1|Overall Study|Adverse Event|4
774641|NCT00598442|2464453|P3|Overall Study|Started dialysis|0
774642|NCT00598442|2464454|P2|Overall Study|Started dialysis|0
774643|NCT00598442|2464455|P1|Overall Study|Started dialysis|1
774644|NCT00598442|2464453|P3|Overall Study|Site closed by sponsor|1
774645|NCT00598442|2464454|P2|Overall Study|Site closed by sponsor|2
774646|NCT00598442|2464455|P1|Overall Study|Site closed by sponsor|5
774647|NCT00598442|2464453|P3|Overall Study|Renal transplant|1
774648|NCT00598442|2464454|P2|Overall Study|Renal transplant|0
774649|NCT00598442|2464455|P1|Overall Study|Renal transplant|0
774650|NCT00598442|2464453|P3|Overall Study|Relocation|0
774651|NCT00598442|2464454|P2|Overall Study|Relocation|4
774652|NCT00598442|2464455|P1|Overall Study|Relocation|1
774653|NCT00598442|2464453|P3|Overall Study|Noncompliance|1
774654|NCT00598442|2464454|P2|Overall Study|Noncompliance|2
774655|NCT00598442|2464455|P1|Overall Study|Noncompliance|0
774656|NCT00598442|2464453|P3|Overall Study|Withdrawal by Subject|6
774657|NCT00598442|2464454|P2|Overall Study|Withdrawal by Subject|16
774658|NCT00598442|2464455|P1|Overall Study|Withdrawal by Subject|8
774659|NCT00598442|2464453|P3|Overall Study|Physician Decision|1
774660|NCT00598442|2464454|P2|Overall Study|Physician Decision|1
774661|NCT00598442|2464455|P1|Overall Study|Physician Decision|2
774662|NCT00598442|2464453|P3|Overall Study|Lost to Follow-up|3
774663|NCT00598442|2464454|P2|Overall Study|Lost to Follow-up|3
774664|NCT00598442|2464455|P1|Overall Study|Lost to Follow-up|4
774665|NCT00598442|2464453|P3|Overall Study|Death|11
774666|NCT00598442|2464454|P2|Overall Study|Death|11
774667|NCT00598442|2464455|P1|Overall Study|Death|19
774668|NCT00598442|2464453|P3|Overall Study|Adverse Event|0
774669|NCT00598442|2464454|P2|Overall Study|Adverse Event|0
774670|NCT00598442|2464455|P1|Overall Study|Adverse Event|3
774671|NCT00598559|2464479|P3|Overall Study|Subject unable/unwilling to attend visit|0
774672|NCT00598559|2464480|P2|Overall Study|Subject unable/unwilling to attend visit|7
774673|NCT00598559|2464481|P1|Overall Study|Subject unable/unwilling to attend visit|4
774674|NCT00598559|2464479|P3|Overall Study|Early discharge from hospital|3
774675|NCT00598559|2464480|P2|Overall Study|Early discharge from hospital|12
774676|NCT00598559|2464481|P1|Overall Study|Early discharge from hospital|9
774677|NCT00598559|2464479|P3|Overall Study|Protocol Non-compliance|0
774678|NCT00598559|2464480|P2|Overall Study|Protocol Non-compliance|0
774679|NCT00598559|2464481|P1|Overall Study|Protocol Non-compliance|1
774680|NCT00598559|2464479|P3|Overall Study|Withdrawal by Subject|0
774681|NCT00598559|2464480|P2|Overall Study|Withdrawal by Subject|2
774682|NCT00598559|2464481|P1|Overall Study|Withdrawal by Subject|2
774683|NCT00598559|2464479|P3|Overall Study|Adverse Event|0
774684|NCT00598559|2464480|P2|Overall Study|Adverse Event|7
774685|NCT00598559|2464481|P1|Overall Study|Adverse Event|11
774686|NCT00598585|2464500|P2|Overall Study|Lost to Follow-up|0
774687|NCT00598585|2464501|P1|Overall Study|Lost to Follow-up|1
774688|NCT00598650|2464507|P1|Overall Study|Physician Decision|2
774689|NCT00598650|2464507|P1|Overall Study|Prohibited Concomitant Medication|2
774690|NCT00598650|2464507|P1|Overall Study|Not eligible|1
774691|NCT00598650|2464507|P1|Overall Study|No treatment for 3 weeks|1
774692|NCT00598650|2464507|P1|Overall Study|Adverse Event|18
774693|NCT00598650|2464507|P1|Overall Study|Withdrawal by Subject|3
774694|NCT00598702|2464535|P8|Overall Study|Dose limiting toxicity|0
774695|NCT00598702|2464536|P7|Overall Study|Dose limiting toxicity|0
774696|NCT00598702|2464537|P6|Overall Study|Dose limiting toxicity|1
774697|NCT00598702|2464538|P5|Overall Study|Dose limiting toxicity|1
774698|NCT00598702|2464539|P4|Overall Study|Dose limiting toxicity|1
774699|NCT00598702|2464540|P3|Overall Study|Dose limiting toxicity|0
774700|NCT00598702|2464541|P2|Overall Study|Dose limiting toxicity|0
774701|NCT00598702|2464542|P1|Overall Study|Dose limiting toxicity|0
774702|NCT00598702|2464535|P8|Overall Study|Physician Decision|0
774703|NCT00598702|2464536|P7|Overall Study|Physician Decision|0
774704|NCT00598702|2464537|P6|Overall Study|Physician Decision|0
774705|NCT00598702|2464538|P5|Overall Study|Physician Decision|1
774706|NCT00598702|2464539|P4|Overall Study|Physician Decision|0
774707|NCT00598702|2464540|P3|Overall Study|Physician Decision|0
774708|NCT00598702|2464541|P2|Overall Study|Physician Decision|0
774709|NCT00598702|2464542|P1|Overall Study|Physician Decision|0
774710|NCT00598702|2464535|P8|Overall Study|Withdrawal by Subject|0
774711|NCT00598702|2464536|P7|Overall Study|Withdrawal by Subject|0
774712|NCT00598702|2464537|P6|Overall Study|Withdrawal by Subject|0
774713|NCT00598702|2464538|P5|Overall Study|Withdrawal by Subject|1
774714|NCT00598702|2464539|P4|Overall Study|Withdrawal by Subject|1
774715|NCT00598702|2464540|P3|Overall Study|Withdrawal by Subject|0
774716|NCT00598702|2464541|P2|Overall Study|Withdrawal by Subject|0
774717|NCT00598702|2464542|P1|Overall Study|Withdrawal by Subject|0
774718|NCT00598702|2464535|P8|Overall Study|Adverse Event|0
774719|NCT00598702|2464536|P7|Overall Study|Adverse Event|0
774720|NCT00598702|2464537|P6|Overall Study|Adverse Event|0
774721|NCT00598702|2464538|P5|Overall Study|Adverse Event|0
774722|NCT00598702|2464539|P4|Overall Study|Adverse Event|1
774723|NCT00598702|2464540|P3|Overall Study|Adverse Event|0
774724|NCT00598702|2464541|P2|Overall Study|Adverse Event|0
774725|NCT00598702|2464542|P1|Overall Study|Adverse Event|0
774726|NCT00598702|2464535|P8|Overall Study|Early discharge from hospital|0
774727|NCT00598702|2464536|P7|Overall Study|Early discharge from hospital|1
774728|NCT00598702|2464537|P6|Overall Study|Early discharge from hospital|10
774729|NCT00598702|2464538|P5|Overall Study|Early discharge from hospital|0
774730|NCT00598702|2464539|P4|Overall Study|Early discharge from hospital|5
774731|NCT00598702|2464540|P3|Overall Study|Early discharge from hospital|2
774732|NCT00598702|2464541|P2|Overall Study|Early discharge from hospital|0
774733|NCT00598702|2464542|P1|Overall Study|Early discharge from hospital|0
774734|NCT00598702|2464535|P8|Overall Study|Not specified|0
774735|NCT00598702|2464536|P7|Overall Study|Not specified|0
774736|NCT00598702|2464537|P6|Overall Study|Not specified|1
774737|NCT00598702|2464538|P5|Overall Study|Not specified|0
774738|NCT00598702|2464539|P4|Overall Study|Not specified|0
774739|NCT00598702|2464540|P3|Overall Study|Not specified|0
774740|NCT00598702|2464541|P2|Overall Study|Not specified|2
774741|NCT00598702|2464542|P1|Overall Study|Not specified|0
774742|NCT00598832|2464617|P2|Overall Study|Non compliance|0
774743|NCT00598832|2464618|P1|Overall Study|Non compliance|1
774744|NCT00598832|2464617|P2|Overall Study|Physician Decision|4
774745|NCT00598832|2464618|P1|Overall Study|Physician Decision|1
774746|NCT00598832|2464617|P2|Overall Study|Pregnancy|2
774747|NCT00598832|2464618|P1|Overall Study|Pregnancy|2
774748|NCT00598832|2464617|P2|Overall Study|Lost to Follow-up|29
774749|NCT00598832|2464618|P1|Overall Study|Lost to Follow-up|24
774750|NCT00598832|2464617|P2|Overall Study|Protocol Violation|2
774751|NCT00598832|2464618|P1|Overall Study|Protocol Violation|0
774752|NCT00598832|2464617|P2|Overall Study|Withdrawal by Subject|36
774753|NCT00598832|2464618|P1|Overall Study|Withdrawal by Subject|25
774754|NCT00598832|2464617|P2|Overall Study|Adverse Event|2
774755|NCT00598832|2464618|P1|Overall Study|Adverse Event|6
774756|NCT00598832|2464617|P2|Overall Study|Lack of Efficacy|7
774757|NCT00598832|2464618|P1|Overall Study|Lack of Efficacy|3
774758|NCT00598871|2464634|P2|Overall Study|Adverse Event|1
774759|NCT00598871|2464635|P1|Overall Study|Adverse Event|0
774760|NCT00599027|2464650|P2|Overall Study|Treatment Failure|1
774761|NCT00599027|2464651|P1|Overall Study|Treatment Failure|0
774762|NCT00599027|2464650|P2|Overall Study|Adverse Event|1
774763|NCT00599027|2464651|P1|Overall Study|Adverse Event|0
774764|NCT00599027|2464650|P2|Overall Study|Withdrawal by Subject|1
774765|NCT00599027|2464651|P1|Overall Study|Withdrawal by Subject|1
774766|NCT00599196|2464680|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
774767|NCT00599196|2464680|P1|Overall Study|Other: Patient Stopped Due To Moving|1
774768|NCT00599196|2464680|P1|Overall Study|Other: Pt Moved To Australia|1
774769|NCT00599196|2464680|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
774770|NCT00599196|2464680|P1|Overall Study|Other: Spouse Withdrew Consent|1
774771|NCT00599196|2464680|P1|Overall Study|Other: Patient Leaving For Israel|1
774772|NCT00599196|2464680|P1|Overall Study|Lost to Follow-up|17
774773|NCT00599196|2464680|P1|Overall Study|Study ended per sponsor|197
774774|NCT00599196|2464680|P1|Overall Study|Subject withdrew consent|43
774775|NCT00599196|2464680|P1|Overall Study|Unsatisfactory compliance of subject|3
774776|NCT00599196|2464680|P1|Overall Study|Adverse Event|93
774777|NCT00599196|2464680|P1|Overall Study|Lack of Efficacy|22
774778|NCT00599313|2464719|P1|Overall Study|Ineligible|1
774779|NCT00599313|2464719|P1|Overall Study|Patient Request|4
774780|NCT00599313|2464719|P1|Overall Study|Disease Progression|12
774781|NCT00599313|2464719|P1|Overall Study|Adverse Event|19
774782|NCT00599326|2464728|P1|Overall Study|Noncompliant|1
774783|NCT00599326|2464728|P1|Overall Study|Lost to Follow-up|1
774784|NCT00599339|2464733|P1|Overall Study|Study Termination Status Unknown|12
774785|NCT00599339|2464733|P1|Overall Study|No valid data consent|36
774786|NCT00599339|2464733|P1|Overall Study|Lost to Follow-up|221
774787|NCT00599339|2464733|P1|Overall Study|Other Reason|179
774788|NCT00599339|2464733|P1|Overall Study|Withdrawal by Subject|137
774789|NCT00599339|2464733|P1|Overall Study|Adverse Event|79
774790|NCT00599521|2464837|P2|Overall Study|Pregnancy|2
774791|NCT00599521|2464838|P1|Overall Study|Pregnancy|0
774792|NCT00599521|2464837|P2|Overall Study|Lost to Follow-up|23
774793|NCT00599521|2464838|P1|Overall Study|Lost to Follow-up|23
774794|NCT00599521|2464837|P2|Overall Study|Protocol Violation|1
774795|NCT00599521|2464838|P1|Overall Study|Protocol Violation|1
774796|NCT00599521|2464837|P2|Overall Study|Withdrawal by Subject|34
774797|NCT00599521|2464838|P1|Overall Study|Withdrawal by Subject|28
774798|NCT00599521|2464837|P2|Overall Study|Adverse Event|1
774799|NCT00599521|2464838|P1|Overall Study|Adverse Event|4
774800|NCT00599521|2464837|P2|Overall Study|Lack of Efficacy|8
774801|NCT00599521|2464838|P1|Overall Study|Lack of Efficacy|4
774802|NCT00599755|2464852|P1|Overall Study|No data available|1
774803|NCT00599755|2464852|P1|Overall Study|Other Reason|2
774804|NCT00599755|2464852|P1|Overall Study|Progression of Disease|3
774805|NCT00599755|2464852|P1|Overall Study|Withdrawal by Subject|2
774806|NCT00599755|2464852|P1|Overall Study|Adverse Event|11
774807|NCT00599924|2464887|P7|Overall Study|Other|2
774808|NCT00599924|2464888|P6|Overall Study|Other|0
774809|NCT00599924|2464889|P5|Overall Study|Other|2
774810|NCT00599924|2464890|P4|Overall Study|Other|1
774811|NCT00599924|2464891|P3|Overall Study|Other|0
774812|NCT00599924|2464892|P2|Overall Study|Other|0
774813|NCT00599924|2464893|P1|Overall Study|Other|0
774814|NCT00599924|2464887|P7|Overall Study|Withdrawal by Subject|0
774815|NCT00599924|2464888|P6|Overall Study|Withdrawal by Subject|0
774816|NCT00599924|2464889|P5|Overall Study|Withdrawal by Subject|1
774817|NCT00599924|2464890|P4|Overall Study|Withdrawal by Subject|0
774818|NCT00599924|2464891|P3|Overall Study|Withdrawal by Subject|1
774819|NCT00599924|2464892|P2|Overall Study|Withdrawal by Subject|0
774820|NCT00599924|2464893|P1|Overall Study|Withdrawal by Subject|0
774821|NCT00599924|2464887|P7|Overall Study|Protocol Violation|0
774822|NCT00599924|2464888|P6|Overall Study|Protocol Violation|0
774823|NCT00599924|2464889|P5|Overall Study|Protocol Violation|0
774824|NCT00599924|2464890|P4|Overall Study|Protocol Violation|1
774825|NCT00599924|2464891|P3|Overall Study|Protocol Violation|0
774826|NCT00599924|2464892|P2|Overall Study|Protocol Violation|0
774827|NCT00599924|2464893|P1|Overall Study|Protocol Violation|0
774828|NCT00599924|2464887|P7|Overall Study|Death|1
774829|NCT00599924|2464888|P6|Overall Study|Death|2
774830|NCT00599924|2464889|P5|Overall Study|Death|0
774831|NCT00599924|2464890|P4|Overall Study|Death|2
774832|NCT00599924|2464891|P3|Overall Study|Death|0
774833|NCT00599924|2464892|P2|Overall Study|Death|0
774834|NCT00599924|2464893|P1|Overall Study|Death|0
774835|NCT00599924|2464887|P7|Overall Study|Adverse Event|2
774836|NCT00599924|2464888|P6|Overall Study|Adverse Event|0
774837|NCT00599924|2464889|P5|Overall Study|Adverse Event|0
774838|NCT00599924|2464890|P4|Overall Study|Adverse Event|2
774839|NCT00599924|2464891|P3|Overall Study|Adverse Event|0
774840|NCT00599924|2464892|P2|Overall Study|Adverse Event|0
774841|NCT00599924|2464893|P1|Overall Study|Adverse Event|0
774842|NCT00599924|2464887|P7|Overall Study|Lack of Efficacy|0
774843|NCT00599924|2464888|P6|Overall Study|Lack of Efficacy|2
774844|NCT00599924|2464889|P5|Overall Study|Lack of Efficacy|3
774845|NCT00599924|2464890|P4|Overall Study|Lack of Efficacy|2
774846|NCT00599924|2464891|P3|Overall Study|Lack of Efficacy|1
774847|NCT00599924|2464892|P2|Overall Study|Lack of Efficacy|5
774848|NCT00599924|2464893|P1|Overall Study|Lack of Efficacy|3
774849|NCT00600028|2464991|P2|Second Intervention (12 Weeks)|Adverse Event|2
774850|NCT00600028|2464992|P1|Second Intervention (12 Weeks)|Adverse Event|0
774851|NCT00600028|2464991|P2|First Intervention (12 Weeks)|Adverse Event|1
774852|NCT00600028|2464992|P1|First Intervention (12 Weeks)|Adverse Event|0
774853|NCT00600028|2464991|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
774854|NCT00600028|2464992|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
774855|NCT00588731|2465006|P2|Overall Study|Withdrawal by Subject|2
774856|NCT00588731|2465007|P1|Overall Study|Withdrawal by Subject|3
774857|NCT00588822|2465024|P1|Overall Study|progression of disease|8
774858|NCT00588861|2465046|P2|10 Years|Incomplete due to study termination|114
774859|NCT00588861|2465047|P1|10 Years|Incomplete due to study termination|107
774860|NCT00588861|2465046|P2|8 Years|Patients did not return for follow-up|114
774861|NCT00588861|2465047|P1|8 Years|Patients did not return for follow-up|105
774862|NCT00588861|2465046|P2|6 Years|Patients did not return for follow-up|109
774863|NCT00588861|2465047|P1|6 Years|Patients did not return for follow-up|104
774864|NCT00588861|2465046|P2|4 Years|Patients did not return for follow-up|103
774865|NCT00588861|2465047|P1|4 Years|Patients did not return for follow-up|91
774866|NCT00588861|2465046|P2|2 Years|Patients did not return for follow-up|87
774867|NCT00588861|2465047|P1|2 Years|Patients did not return for follow-up|92
774868|NCT00588861|2465046|P2|1 Year|Patients did not return for follow-up|82
774869|NCT00588861|2465047|P1|1 Year|Patients did not return for follow-up|89
774870|NCT00588861|2465046|P2|6 Months|Patients did not return for follow-up|73
774871|NCT00588861|2465047|P1|6 Months|Patients did not return for follow-up|98
774872|NCT00588861|2465046|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
774873|NCT00588861|2465047|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
774874|NCT00588952|2465063|P2|Overall Study|Withdrawal by Subject|5
774875|NCT00588952|2465064|P1|Overall Study|Withdrawal by Subject|3
774876|NCT00588952|2465063|P2|Overall Study|Adverse Event|2
774877|NCT00588952|2465064|P1|Overall Study|Adverse Event|0
774878|NCT00589108|2465095|P3|Overall Study|Death|4
774879|NCT00589108|2465096|P2|Overall Study|Death|3
774880|NCT00589108|2465097|P1|Overall Study|Death|3
774881|NCT00589108|2465095|P3|Overall Study|Lost to Follow-up|1
774882|NCT00589108|2465096|P2|Overall Study|Lost to Follow-up|1
774883|NCT00589108|2465097|P1|Overall Study|Lost to Follow-up|1
774884|NCT00589472|2465117|P1|Overall Study|Adverse Event|1
774885|NCT00589602|2465154|P1|Overall Study|Did not collect enough CD34+ cells|1
774886|NCT00589628|2465164|P2|Overall Study|Lost to Follow-up|1
774887|NCT00589628|2465165|P1|Overall Study|Lost to Follow-up|0
774888|NCT00589667|2465171|P1|Overall Study|Withdrawal by Subject|1
774889|NCT00589667|2465171|P1|Overall Study|Adverse Event|2
774890|NCT00589693|2465178|P2|Overall Study|Protocol Violation|1
774891|NCT00589693|2465179|P1|Overall Study|Protocol Violation|1
774892|NCT00589693|2465178|P2|Overall Study|Physician Decision|1
774893|NCT00589693|2465179|P1|Overall Study|Physician Decision|0
774894|NCT00589693|2465178|P2|Overall Study|Lost to Follow-up|0
774895|NCT00589693|2465179|P1|Overall Study|Lost to Follow-up|1
774896|NCT00589693|2465178|P2|Overall Study|Lack of Efficacy|1
774897|NCT00589693|2465179|P1|Overall Study|Lack of Efficacy|0
774898|NCT00589693|2465178|P2|Overall Study|Death|16
774899|NCT00589693|2465179|P1|Overall Study|Death|26
774900|NCT00589693|2465178|P2|Overall Study|Adverse Event|4
774901|NCT00589693|2465179|P1|Overall Study|Adverse Event|4
774902|NCT00589693|2465178|P2|Overall Study|randomized in error|6
774903|NCT00589693|2465179|P1|Overall Study|randomized in error|12
774904|NCT00589784|2465195|P2|Overall Study|Adverse Event|4
774905|NCT00589784|2465196|P1|Overall Study|Adverse Event|0
774906|NCT00589784|2465195|P2|Overall Study|Patient inevaluable|0
774907|NCT00589784|2465196|P1|Overall Study|Patient inevaluable|1
774908|NCT00589784|2465195|P2|Overall Study|Withdrawal by Subject|6
774909|NCT00589784|2465196|P1|Overall Study|Withdrawal by Subject|0
774910|NCT00589914|2465223|P2|Overall Study|Other|17
774911|NCT00589914|2465224|P1|Overall Study|Other|22
774912|NCT00589914|2465223|P2|Overall Study|Withdrawal by Subject|49
774913|NCT00589914|2465224|P1|Overall Study|Withdrawal by Subject|55
774914|NCT00589914|2465223|P2|Overall Study|Pregnancy|0
774915|NCT00589914|2465224|P1|Overall Study|Pregnancy|1
774916|NCT00589914|2465223|P2|Overall Study|Lost to Follow-up|18
774917|NCT00589914|2465224|P1|Overall Study|Lost to Follow-up|11
774918|NCT00589914|2465223|P2|Overall Study|Lack of Efficacy|43
774919|NCT00589914|2465224|P1|Overall Study|Lack of Efficacy|40
774920|NCT00589914|2465223|P2|Overall Study|Death|0
774921|NCT00589914|2465224|P1|Overall Study|Death|2
774922|NCT00589914|2465223|P2|Overall Study|Adverse Event|10
774923|NCT00589914|2465224|P1|Overall Study|Adverse Event|19
774924|NCT00589979|2465236|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
774925|NCT00589979|2465237|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
774926|NCT00589979|2465238|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
774927|NCT00589979|2465236|P3|Double-Blind Treatment Period 3|Protocol Violation|0
774928|NCT00589979|2465237|P2|Double-Blind Treatment Period 3|Protocol Violation|1
774929|NCT00589979|2465238|P1|Double-Blind Treatment Period 3|Protocol Violation|0
774930|NCT00589979|2465236|P3|Double-Blind Treatment Period 2|Other|1
774931|NCT00589979|2465237|P2|Double-Blind Treatment Period 2|Other|0
774932|NCT00589979|2465238|P1|Double-Blind Treatment Period 2|Other|0
774933|NCT00589979|2465236|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
774934|NCT00589979|2465237|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
774935|NCT00589979|2465238|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
774936|NCT00589979|2465236|P3|Double-Blind Treatment Period 2|Adverse Event|0
774937|NCT00589979|2465237|P2|Double-Blind Treatment Period 2|Adverse Event|1
774938|NCT00589979|2465238|P1|Double-Blind Treatment Period 2|Adverse Event|0
774939|NCT00589979|2465236|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
774940|NCT00589979|2465237|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
774941|NCT00589979|2465238|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
774942|NCT00589979|2465236|P3|Double-Blind Treatment Period 1|Protocol Violation|1
774943|NCT00589979|2465237|P2|Double-Blind Treatment Period 1|Protocol Violation|1
774944|NCT00589979|2465238|P1|Double-Blind Treatment Period 1|Protocol Violation|0
774945|NCT00589979|2465236|P3|Double-Blind Treatment Period 1|Adverse Event|0
774946|NCT00589979|2465237|P2|Double-Blind Treatment Period 1|Adverse Event|1
774947|NCT00589979|2465238|P1|Double-Blind Treatment Period 1|Adverse Event|0
774948|NCT00589979|2465236|P3|Run-In Period|Informed Consent Withdrawn|0
774949|NCT00589979|2465237|P2|Run-In Period|Informed Consent Withdrawn|0
774950|NCT00589979|2465238|P1|Run-In Period|Informed Consent Withdrawn|4
774951|NCT00589979|2465236|P3|Run-In Period|Withdrawal by Subject|0
774952|NCT00589979|2465237|P2|Run-In Period|Withdrawal by Subject|0
774953|NCT00589979|2465238|P1|Run-In Period|Withdrawal by Subject|10
774954|NCT00589979|2465236|P3|Run-In Period|Did not qualify for randomization|0
774955|NCT00589979|2465237|P2|Run-In Period|Did not qualify for randomization|0
774956|NCT00589979|2465238|P1|Run-In Period|Did not qualify for randomization|54
774957|NCT00589979|2465236|P3|Run-In Period|Protocol Violation|0
774958|NCT00589979|2465237|P2|Run-In Period|Protocol Violation|0
774959|NCT00589979|2465238|P1|Run-In Period|Protocol Violation|3
774960|NCT00589979|2465236|P3|Run-In Period|Adverse Event|0
774961|NCT00589979|2465237|P2|Run-In Period|Adverse Event|0
774962|NCT00589979|2465238|P1|Run-In Period|Adverse Event|5
774963|NCT00590031|2465295|P1|Overall Study|Admin Hold|1
774964|NCT00590031|2465295|P1|Overall Study|Metastatic Disease|1
774965|NCT00590031|2465295|P1|Overall Study|Withdrawal by Subject|1
774966|NCT00590031|2465295|P1|Overall Study|Adverse Event|3
774967|NCT00590044|2465302|P2|Overall Study|Protocol Violation|0
774968|NCT00590044|2465303|P1|Overall Study|Protocol Violation|1
774969|NCT00590044|2465302|P2|Overall Study|wrong insulin arm assigned|0
774970|NCT00590044|2465303|P1|Overall Study|wrong insulin arm assigned|1
774971|NCT00590044|2465302|P2|Overall Study|Withdrawal by Subject|2
774972|NCT00590044|2465303|P1|Overall Study|Withdrawal by Subject|2
774973|NCT00590135|2465309|P1|Overall Study|Primary endpoint measure not obtainable|59
774974|NCT00590317|2465339|P2|Overall Study|Lack of Efficacy|5
774975|NCT00590317|2465340|P1|Overall Study|Lack of Efficacy|1
774976|NCT00590538|2465381|P1|Overall Study|Study terminated before completed|2
774977|NCT00590564|2465389|P1|Overall Study|Patient Non-compliance|6
774978|NCT00590564|2465389|P1|Overall Study|Patient Found to be Ineligible|1
774979|NCT00590564|2465389|P1|Overall Study|Protocol Violation|1
774980|NCT00590564|2465389|P1|Overall Study|Lost to Follow-up|6
774981|NCT00590564|2465389|P1|Overall Study|Withdrawal by Subject|4
774982|NCT00590577|2465397|P4|Overall Study|Various reasons|2
774983|NCT00590577|2465398|P3|Overall Study|Various reasons|1
774984|NCT00590577|2465399|P2|Overall Study|Various reasons|3
774985|NCT00590577|2465400|P1|Overall Study|Various reasons|1
774986|NCT00590577|2465397|P4|Overall Study|Pregnancy|0
774987|NCT00590577|2465398|P3|Overall Study|Pregnancy|0
774988|NCT00590577|2465399|P2|Overall Study|Pregnancy|1
774989|NCT00590577|2465400|P1|Overall Study|Pregnancy|0
774990|NCT00590577|2465397|P4|Overall Study|Lost to Follow-up|9
774991|NCT00590577|2465398|P3|Overall Study|Lost to Follow-up|6
774992|NCT00590577|2465399|P2|Overall Study|Lost to Follow-up|6
774993|NCT00590577|2465400|P1|Overall Study|Lost to Follow-up|12
774994|NCT00590577|2465397|P4|Overall Study|Adverse Event|11
774995|NCT00590577|2465398|P3|Overall Study|Adverse Event|13
774996|NCT00590577|2465399|P2|Overall Study|Adverse Event|10
774997|NCT00590577|2465400|P1|Overall Study|Adverse Event|10
774998|NCT00590577|2465397|P4|Overall Study|Withdrawal by Subject|26
774999|NCT00590577|2465398|P3|Overall Study|Withdrawal by Subject|30
775000|NCT00590577|2465399|P2|Overall Study|Withdrawal by Subject|28
775001|NCT00590577|2465400|P1|Overall Study|Withdrawal by Subject|23
775002|NCT00590577|2465397|P4|Overall Study|Lack of Efficacy|45
775003|NCT00590577|2465398|P3|Overall Study|Lack of Efficacy|23
775004|NCT00590577|2465399|P2|Overall Study|Lack of Efficacy|28
775005|NCT00590577|2465400|P1|Overall Study|Lack of Efficacy|31
775006|NCT00590590|2465421|P3|Overall Study|Did not complete study|0
775007|NCT00590590|2465422|P2|Overall Study|Did not complete study|1
775008|NCT00590590|2465423|P1|Overall Study|Did not complete study|0
775009|NCT00590590|2465421|P3|Overall Study|Did not complete due to study closure|1
775010|NCT00590590|2465422|P2|Overall Study|Did not complete due to study closure|1
775011|NCT00590590|2465423|P1|Overall Study|Did not complete due to study closure|1
775012|NCT00590590|2465421|P3|Overall Study|Withdrawal by Subject|1
775013|NCT00590590|2465422|P2|Overall Study|Withdrawal by Subject|1
775014|NCT00590590|2465423|P1|Overall Study|Withdrawal by Subject|0
775015|NCT00590590|2465421|P3|Overall Study|Lost to Follow-up|2
775016|NCT00590590|2465422|P2|Overall Study|Lost to Follow-up|1
775017|NCT00590590|2465423|P1|Overall Study|Lost to Follow-up|4
775018|NCT00590590|2465421|P3|Overall Study|Protocol Violation|2
775019|NCT00590590|2465422|P2|Overall Study|Protocol Violation|0
775020|NCT00590590|2465423|P1|Overall Study|Protocol Violation|0
775021|NCT00590590|2465421|P3|Overall Study|Adverse Event|0
775022|NCT00590590|2465422|P2|Overall Study|Adverse Event|0
775023|NCT00590590|2465423|P1|Overall Study|Adverse Event|1
775024|NCT00590590|2465421|P3|Overall Study|Lack of Efficacy|0
775025|NCT00590590|2465422|P2|Overall Study|Lack of Efficacy|2
775026|NCT00590590|2465423|P1|Overall Study|Lack of Efficacy|1
775027|NCT00590720|2465448|P2|Overall Study|Withdrawal by Subject|1
775028|NCT00590720|2465449|P1|Overall Study|Withdrawal by Subject|0
775029|NCT00590720|2465448|P2|Overall Study|Lost to Follow-up|0
775030|NCT00590720|2465449|P1|Overall Study|Lost to Follow-up|1
775031|NCT00590759|2465491|P1|Overall Study|Lost to Follow-up|28
775032|NCT00590759|2465491|P1|Overall Study|Death|52
775033|NCT00590902|2465527|P1|Overall Study|Death|1
775034|NCT00590967|2465533|P2|Overall Study|Did not receive chemo per protocol|0
775035|NCT00590967|2465534|P1|Overall Study|Did not receive chemo per protocol|1
775036|NCT00590967|2465533|P2|Overall Study|Did not sign consent form|1
775037|NCT00590967|2465534|P1|Overall Study|Did not sign consent form|0
775038|NCT00590967|2465533|P2|Overall Study|Non-compliant|2
775039|NCT00590967|2465534|P1|Overall Study|Non-compliant|0
775040|NCT00590967|2465533|P2|Overall Study|Poor performance status|1
775041|NCT00590967|2465534|P1|Overall Study|Poor performance status|0
775042|NCT00590967|2465533|P2|Overall Study|Ineligible|0
775043|NCT00590967|2465534|P1|Overall Study|Ineligible|1
775044|NCT00590967|2465533|P2|Overall Study|Withdrawal by Subject|1
775045|NCT00590967|2465534|P1|Overall Study|Withdrawal by Subject|1
775046|NCT00591006|2465546|P24|Overall Study|Adverse Event|0
775047|NCT00591006|2465547|P23|Overall Study|Adverse Event|1
775048|NCT00591006|2465548|P22|Overall Study|Adverse Event|0
775049|NCT00591006|2465549|P21|Overall Study|Adverse Event|0
775050|NCT00591006|2465550|P20|Overall Study|Adverse Event|0
775051|NCT00591006|2465551|P19|Overall Study|Adverse Event|0
775052|NCT00591006|2465552|P18|Overall Study|Adverse Event|0
775053|NCT00591006|2465553|P17|Overall Study|Adverse Event|0
775054|NCT00591006|2465554|P16|Overall Study|Adverse Event|0
775055|NCT00591006|2465555|P15|Overall Study|Adverse Event|0
775056|NCT00591006|2465556|P14|Overall Study|Adverse Event|0
775057|NCT00591006|2465557|P13|Overall Study|Adverse Event|0
775058|NCT00591006|2465558|P12|Overall Study|Adverse Event|0
775059|NCT00591006|2465559|P11|Overall Study|Adverse Event|0
775060|NCT00591006|2465560|P10|Overall Study|Adverse Event|0
775061|NCT00591006|2465561|P9|Overall Study|Adverse Event|0
775062|NCT00591006|2465562|P8|Overall Study|Adverse Event|0
775063|NCT00591006|2465563|P7|Overall Study|Adverse Event|0
775064|NCT00591006|2465564|P6|Overall Study|Adverse Event|0
775065|NCT00591006|2465565|P5|Overall Study|Adverse Event|0
775066|NCT00591006|2465566|P4|Overall Study|Adverse Event|0
775067|NCT00591006|2465567|P3|Overall Study|Adverse Event|0
775068|NCT00591006|2465568|P2|Overall Study|Adverse Event|0
775069|NCT00591006|2465569|P1|Overall Study|Adverse Event|0
775070|NCT00591006|2465546|P24|Overall Study|Withdrawal by Subject|1
775071|NCT00591006|2465547|P23|Overall Study|Withdrawal by Subject|0
775072|NCT00591006|2465548|P22|Overall Study|Withdrawal by Subject|0
775073|NCT00591006|2465549|P21|Overall Study|Withdrawal by Subject|0
775074|NCT00591006|2465550|P20|Overall Study|Withdrawal by Subject|0
775075|NCT00591006|2465551|P19|Overall Study|Withdrawal by Subject|0
775076|NCT00591006|2465552|P18|Overall Study|Withdrawal by Subject|0
775077|NCT00591006|2465553|P17|Overall Study|Withdrawal by Subject|0
775078|NCT00591006|2465554|P16|Overall Study|Withdrawal by Subject|1
775079|NCT00591006|2465555|P15|Overall Study|Withdrawal by Subject|0
775080|NCT00591006|2465556|P14|Overall Study|Withdrawal by Subject|0
775081|NCT00591006|2465557|P13|Overall Study|Withdrawal by Subject|0
775082|NCT00591006|2465558|P12|Overall Study|Withdrawal by Subject|0
775083|NCT00591006|2465559|P11|Overall Study|Withdrawal by Subject|0
775084|NCT00591006|2465560|P10|Overall Study|Withdrawal by Subject|0
775085|NCT00591006|2465561|P9|Overall Study|Withdrawal by Subject|0
775086|NCT00591006|2465562|P8|Overall Study|Withdrawal by Subject|0
775087|NCT00591006|2465563|P7|Overall Study|Withdrawal by Subject|0
775088|NCT00591006|2465564|P6|Overall Study|Withdrawal by Subject|0
775089|NCT00591006|2465565|P5|Overall Study|Withdrawal by Subject|0
775090|NCT00591006|2465566|P4|Overall Study|Withdrawal by Subject|0
775091|NCT00591006|2465567|P3|Overall Study|Withdrawal by Subject|0
775092|NCT00591006|2465568|P2|Overall Study|Withdrawal by Subject|0
775093|NCT00591006|2465569|P1|Overall Study|Withdrawal by Subject|0
775094|NCT00591149|2465599|P1|Overall Study|Withdrawal by Subject|1
775095|NCT00591149|2465599|P1|Overall Study|Adverse Event|4
775096|NCT00591214|2465603|P1|Overall Study|Withdrawal by Subject|1
775097|NCT00591214|2465603|P1|Overall Study|Physician Decision|7
775098|NCT00591253|2465633|P3|Overall Study|Other|3
775099|NCT00591253|2465634|P2|Overall Study|Other|5
775100|NCT00591253|2465635|P1|Overall Study|Other|5
775101|NCT00591253|2465633|P3|Overall Study|Lack of Efficacy|3
775102|NCT00591253|2465634|P2|Overall Study|Lack of Efficacy|0
775103|NCT00591253|2465635|P1|Overall Study|Lack of Efficacy|1
775104|NCT00591253|2465633|P3|Overall Study|Withdrawal by Subject|6
775105|NCT00591253|2465634|P2|Overall Study|Withdrawal by Subject|7
775106|NCT00591253|2465635|P1|Overall Study|Withdrawal by Subject|1
775107|NCT00591253|2465633|P3|Overall Study|Lost to Follow-up|0
775108|NCT00591253|2465634|P2|Overall Study|Lost to Follow-up|4
775109|NCT00591253|2465635|P1|Overall Study|Lost to Follow-up|2
775110|NCT00591253|2465633|P3|Overall Study|Protocol Violation|2
775111|NCT00591253|2465634|P2|Overall Study|Protocol Violation|2
775112|NCT00591253|2465635|P1|Overall Study|Protocol Violation|2
775113|NCT00591253|2465633|P3|Overall Study|Adverse Event|1
775114|NCT00591253|2465634|P2|Overall Study|Adverse Event|3
775115|NCT00591253|2465635|P1|Overall Study|Adverse Event|3
775116|NCT00591266|2465688|P3|Overall Study|Other|5
775117|NCT00591266|2465689|P2|Overall Study|Other|4
775118|NCT00591266|2465690|P1|Overall Study|Other|1
775119|NCT00591266|2465688|P3|Overall Study|Lack of Efficacy|0
775120|NCT00591266|2465689|P2|Overall Study|Lack of Efficacy|2
775121|NCT00591266|2465690|P1|Overall Study|Lack of Efficacy|0
775122|NCT00591266|2465688|P3|Overall Study|Withdrawal by Subject|5
775123|NCT00591266|2465689|P2|Overall Study|Withdrawal by Subject|2
775124|NCT00591266|2465690|P1|Overall Study|Withdrawal by Subject|6
775125|NCT00591266|2465688|P3|Overall Study|Protocol Violation|1
775126|NCT00591266|2465689|P2|Overall Study|Protocol Violation|0
775127|NCT00591266|2465690|P1|Overall Study|Protocol Violation|0
775128|NCT00591266|2465688|P3|Overall Study|Lost to Follow-up|0
775129|NCT00591266|2465689|P2|Overall Study|Lost to Follow-up|1
775130|NCT00591266|2465690|P1|Overall Study|Lost to Follow-up|0
775131|NCT00591266|2465688|P3|Overall Study|Adverse Event|3
775132|NCT00591266|2465689|P2|Overall Study|Adverse Event|2
775133|NCT00591266|2465690|P1|Overall Study|Adverse Event|2
775134|NCT00591344|2465755|P2|Overall Study|Did not want to come off medication|1
775135|NCT00591344|2465756|P1|Overall Study|Did not want to come off medication|0
775136|NCT00591344|2465755|P2|Overall Study|Lost to Follow-up|1
775137|NCT00591344|2465756|P1|Overall Study|Lost to Follow-up|0
775138|NCT00591344|2465755|P2|Overall Study|Death|1
775139|NCT00591344|2465756|P1|Overall Study|Death|0
775140|NCT00591344|2465755|P2|Overall Study|Underwent DBS|2
775141|NCT00591344|2465756|P1|Overall Study|Underwent DBS|2
775142|NCT00591344|2465755|P2|Overall Study|Medical complications|3
775143|NCT00591344|2465756|P1|Overall Study|Medical complications|1
775144|NCT00591344|2465755|P2|Overall Study|Moved out of state|0
775145|NCT00591344|2465756|P1|Overall Study|Moved out of state|1
775146|NCT00591344|2465755|P2|Overall Study|Transportation issues|0
775147|NCT00591344|2465756|P1|Overall Study|Transportation issues|1
775148|NCT00591370|2465766|P1|Overall Study|Not Treated|2
775149|NCT00591565|2465772|P1|Overall Study|lost follow up, withdrawn|5
775150|NCT00591578|2465779|P3|Open-Label Extension Phase|Other|0
775151|NCT00591578|2465780|P2|Open-Label Extension Phase|Other|0
775152|NCT00591578|2465781|P1|Open-Label Extension Phase|Other|1
775153|NCT00591578|2465779|P3|Open-Label Extension Phase|Withdrawal by Subject|0
775154|NCT00591578|2465780|P2|Open-Label Extension Phase|Withdrawal by Subject|1
775155|NCT00591578|2465781|P1|Open-Label Extension Phase|Withdrawal by Subject|1
775156|NCT00591578|2465779|P3|Open-Label Extension Phase|Lost to Follow-up|0
775157|NCT00591578|2465780|P2|Open-Label Extension Phase|Lost to Follow-up|4
775158|NCT00591578|2465781|P1|Open-Label Extension Phase|Lost to Follow-up|1
775159|NCT00591578|2465779|P3|Open-Label Extension Phase|Adverse Event|0
775160|NCT00591578|2465780|P2|Open-Label Extension Phase|Adverse Event|5
775161|NCT00591578|2465781|P1|Open-Label Extension Phase|Adverse Event|3
775162|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Other|4
775163|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Other|9
775164|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Other|4
775165|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
775166|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
775167|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
775168|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Pregnancy|0
775169|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Pregnancy|0
775170|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Pregnancy|1
775171|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
775172|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
775173|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
775174|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
775175|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
775176|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
775177|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Protocol Violation|3
775178|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Protocol Violation|2
775179|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Protocol Violation|3
775180|NCT00591578|2465779|P3|Double-Blind Treatment Phase|Adverse Event|19
775181|NCT00591578|2465780|P2|Double-Blind Treatment Phase|Adverse Event|26
775182|NCT00591578|2465781|P1|Double-Blind Treatment Phase|Adverse Event|20
775183|NCT00591591|2465834|P2|Overall Study|Lack of Efficacy|2
775184|NCT00591591|2465835|P1|Overall Study|Lack of Efficacy|10
775185|NCT00591591|2465834|P2|Overall Study|Withdrawal by Subject|37
775186|NCT00591591|2465835|P1|Overall Study|Withdrawal by Subject|1
775187|NCT00591721|2465851|P2|Overall Study|Intervention not received|8
775188|NCT00591721|2465852|P1|Overall Study|Intervention not received|10
775189|NCT00591721|2465851|P2|Overall Study|Lost to Follow-up|4
775190|NCT00591721|2465852|P1|Overall Study|Lost to Follow-up|1
775191|NCT00591721|2465851|P2|Overall Study|Withdrawal by Subject|10
775192|NCT00591721|2465852|P1|Overall Study|Withdrawal by Subject|10
775193|NCT00591734|2465858|P1|Overall Study|Intercurrent Illness|8
775194|NCT00591734|2465858|P1|Overall Study|Physician Decision|5
775195|NCT00591734|2465858|P1|Overall Study|Adverse Event|5
775196|NCT00591734|2465858|P1|Overall Study|Lack of Efficacy|35
775197|NCT00591773|2465874|P3|Overall Study|Other|4
775198|NCT00591773|2465875|P2|Overall Study|Other|1
775199|NCT00591773|2465876|P1|Overall Study|Other|1
775200|NCT00591773|2465874|P3|Overall Study|Lack of Efficacy|2
775201|NCT00591773|2465875|P2|Overall Study|Lack of Efficacy|2
775202|NCT00591773|2465876|P1|Overall Study|Lack of Efficacy|1
775203|NCT00591773|2465874|P3|Overall Study|Withdrawal by Subject|3
775204|NCT00591773|2465875|P2|Overall Study|Withdrawal by Subject|5
775205|NCT00591773|2465876|P1|Overall Study|Withdrawal by Subject|2
775206|NCT00591773|2465874|P3|Overall Study|Lost to Follow-up|1
775207|NCT00591773|2465875|P2|Overall Study|Lost to Follow-up|4
775208|NCT00591773|2465876|P1|Overall Study|Lost to Follow-up|1
775209|NCT00591773|2465874|P3|Overall Study|Protocol Violation|0
775210|NCT00591773|2465875|P2|Overall Study|Protocol Violation|3
775211|NCT00591773|2465876|P1|Overall Study|Protocol Violation|2
775212|NCT00591773|2465874|P3|Overall Study|Adverse Event|6
775213|NCT00591773|2465875|P2|Overall Study|Adverse Event|9
775214|NCT00591773|2465876|P1|Overall Study|Adverse Event|9
775215|NCT00591851|2465959|P1|Overall Study|Progressive Disease|1
775216|NCT00591851|2465959|P1|Overall Study|Adverse Event|2
775217|NCT00591851|2465959|P1|Overall Study|Withdrawal by Subject|3
775218|NCT00591864|2465963|P1|Overall Study|Incomplete Imaging|5
775219|NCT00600067|2465971|P2|Overall Study|Lack of Efficacy|0
775220|NCT00600067|2465972|P1|Overall Study|Lack of Efficacy|1
775221|NCT00600067|2465971|P2|Overall Study|protocol non-compliance|3
775222|NCT00600067|2465972|P1|Overall Study|protocol non-compliance|0
775223|NCT00600067|2465971|P2|Overall Study|Lost to Follow-up|3
775224|NCT00600067|2465972|P1|Overall Study|Lost to Follow-up|2
775225|NCT00600067|2465971|P2|Overall Study|Adverse Event|1
775226|NCT00600067|2465972|P1|Overall Study|Adverse Event|0
775227|NCT00600119|2465999|P6|Follow-up Period|Other|0
775228|NCT00600119|2466000|P5|Follow-up Period|Other|0
775229|NCT00600119|2466001|P4|Follow-up Period|Other|0
775230|NCT00600119|2466002|P3|Follow-up Period|Other|0
775231|NCT00600119|2466003|P2|Follow-up Period|Other|0
775232|NCT00600119|2466004|P1|Follow-up Period|Other|1
775233|NCT00600119|2465999|P6|Follow-up Period|Adverse Event|1
775234|NCT00600119|2466000|P5|Follow-up Period|Adverse Event|0
775235|NCT00600119|2466001|P4|Follow-up Period|Adverse Event|0
775236|NCT00600119|2466002|P3|Follow-up Period|Adverse Event|0
775237|NCT00600119|2466003|P2|Follow-up Period|Adverse Event|0
775238|NCT00600119|2466004|P1|Follow-up Period|Adverse Event|0
775239|NCT00600119|2465999|P6|Double-blind Treatment Period|Adverse Event|10
775240|NCT00600119|2466000|P5|Double-blind Treatment Period|Adverse Event|2
775241|NCT00600119|2466001|P4|Double-blind Treatment Period|Adverse Event|1
775242|NCT00600119|2466002|P3|Double-blind Treatment Period|Adverse Event|0
775243|NCT00600119|2466003|P2|Double-blind Treatment Period|Adverse Event|1
775244|NCT00600119|2466004|P1|Double-blind Treatment Period|Adverse Event|1
775245|NCT00600119|2465999|P6|Double-blind Treatment Period|Lost to Follow-up|0
775246|NCT00600119|2466000|P5|Double-blind Treatment Period|Lost to Follow-up|0
775247|NCT00600119|2466001|P4|Double-blind Treatment Period|Lost to Follow-up|0
775248|NCT00600119|2466002|P3|Double-blind Treatment Period|Lost to Follow-up|0
775249|NCT00600119|2466003|P2|Double-blind Treatment Period|Lost to Follow-up|1
775250|NCT00600119|2466004|P1|Double-blind Treatment Period|Lost to Follow-up|0
775323|NCT00600171|2466042|P6|Overall Study|Lost to Follow-up|0
775251|NCT00600119|2465999|P6|Double-blind Treatment Period|Physician Decision|0
775252|NCT00600119|2466000|P5|Double-blind Treatment Period|Physician Decision|0
775253|NCT00600119|2466001|P4|Double-blind Treatment Period|Physician Decision|0
775254|NCT00600119|2466002|P3|Double-blind Treatment Period|Physician Decision|0
775255|NCT00600119|2466003|P2|Double-blind Treatment Period|Physician Decision|0
775256|NCT00600119|2466004|P1|Double-blind Treatment Period|Physician Decision|2
775257|NCT00600119|2465999|P6|Double-blind Treatment Period|Sponsor Decision|0
775258|NCT00600119|2466000|P5|Double-blind Treatment Period|Sponsor Decision|1
775259|NCT00600119|2466001|P4|Double-blind Treatment Period|Sponsor Decision|0
775260|NCT00600119|2466002|P3|Double-blind Treatment Period|Sponsor Decision|0
775261|NCT00600119|2466003|P2|Double-blind Treatment Period|Sponsor Decision|1
775262|NCT00600119|2466004|P1|Double-blind Treatment Period|Sponsor Decision|0
775263|NCT00600119|2465999|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
775264|NCT00600119|2466000|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
775265|NCT00600119|2466001|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
775266|NCT00600119|2466002|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
775267|NCT00600119|2466003|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
775268|NCT00600119|2466004|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
775269|NCT00600119|2465999|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
775270|NCT00600119|2466000|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
775271|NCT00600119|2466001|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
775272|NCT00600119|2466002|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
775273|NCT00600119|2466003|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
775274|NCT00600119|2466004|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
775275|NCT00600119|2465999|P6|Double-blind Treatment Period|Other|1
775276|NCT00600119|2466000|P5|Double-blind Treatment Period|Other|2
775277|NCT00600119|2466001|P4|Double-blind Treatment Period|Other|0
775278|NCT00600119|2466002|P3|Double-blind Treatment Period|Other|0
775279|NCT00600119|2466003|P2|Double-blind Treatment Period|Other|0
775280|NCT00600119|2466004|P1|Double-blind Treatment Period|Other|0
775281|NCT00600119|2465999|P6|Double-blind Treatment Period|Withdrawal by Subject|3
775282|NCT00600119|2466000|P5|Double-blind Treatment Period|Withdrawal by Subject|0
775283|NCT00600119|2466001|P4|Double-blind Treatment Period|Withdrawal by Subject|1
775284|NCT00600119|2466002|P3|Double-blind Treatment Period|Withdrawal by Subject|0
775285|NCT00600119|2466003|P2|Double-blind Treatment Period|Withdrawal by Subject|0
775286|NCT00600119|2466004|P1|Double-blind Treatment Period|Withdrawal by Subject|2
775287|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
775288|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
775289|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
775290|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
775291|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
775292|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
775293|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Adverse Event|1
775294|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Adverse Event|0
775295|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Adverse Event|1
775296|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Adverse Event|0
775297|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Adverse Event|0
775298|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Adverse Event|0
775299|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
775300|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
775301|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
775302|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
775303|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
775304|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
775305|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
775306|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
775307|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
775308|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
775309|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
775310|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
775311|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
775312|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
775313|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
775314|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
775315|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
775316|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
775317|NCT00600119|2465999|P6|Single-blind Placebo run-in Period|Other - Not specified|1
775318|NCT00600119|2466000|P5|Single-blind Placebo run-in Period|Other - Not specified|1
775319|NCT00600119|2466001|P4|Single-blind Placebo run-in Period|Other - Not specified|0
775320|NCT00600119|2466002|P3|Single-blind Placebo run-in Period|Other - Not specified|0
775321|NCT00600119|2466003|P2|Single-blind Placebo run-in Period|Other - Not specified|0
775322|NCT00600119|2466004|P1|Single-blind Placebo run-in Period|Other - Not specified|1
775324|NCT00600171|2466043|P5|Overall Study|Lost to Follow-up|0
775325|NCT00600171|2466044|P4|Overall Study|Lost to Follow-up|1
775326|NCT00600171|2466045|P3|Overall Study|Lost to Follow-up|0
775327|NCT00600171|2466046|P2|Overall Study|Lost to Follow-up|0
775328|NCT00600171|2466047|P1|Overall Study|Lost to Follow-up|0
775329|NCT00600171|2466042|P6|Overall Study|Physician Decision|2
775330|NCT00600171|2466043|P5|Overall Study|Physician Decision|0
775331|NCT00600171|2466044|P4|Overall Study|Physician Decision|1
775332|NCT00600171|2466045|P3|Overall Study|Physician Decision|0
775333|NCT00600171|2466046|P2|Overall Study|Physician Decision|1
775334|NCT00600171|2466047|P1|Overall Study|Physician Decision|0
775335|NCT00600171|2466042|P6|Overall Study|Withdrawal by Subject|1
775336|NCT00600171|2466043|P5|Overall Study|Withdrawal by Subject|1
775337|NCT00600171|2466044|P4|Overall Study|Withdrawal by Subject|1
775338|NCT00600171|2466045|P3|Overall Study|Withdrawal by Subject|0
775339|NCT00600171|2466046|P2|Overall Study|Withdrawal by Subject|0
775340|NCT00600171|2466047|P1|Overall Study|Withdrawal by Subject|3
775341|NCT00600171|2466042|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
775342|NCT00600171|2466043|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
775343|NCT00600171|2466044|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
775344|NCT00600171|2466045|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
775345|NCT00600171|2466046|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
775346|NCT00600171|2466047|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
775347|NCT00600171|2466042|P6|Overall Study|Protocol Violation|0
775348|NCT00600171|2466043|P5|Overall Study|Protocol Violation|0
775349|NCT00600171|2466044|P4|Overall Study|Protocol Violation|1
775350|NCT00600171|2466045|P3|Overall Study|Protocol Violation|0
775351|NCT00600171|2466046|P2|Overall Study|Protocol Violation|2
775352|NCT00600171|2466047|P1|Overall Study|Protocol Violation|1
775353|NCT00600171|2466042|P6|Overall Study|Lack of Efficacy|0
775354|NCT00600171|2466043|P5|Overall Study|Lack of Efficacy|4
775355|NCT00600171|2466044|P4|Overall Study|Lack of Efficacy|5
775356|NCT00600171|2466045|P3|Overall Study|Lack of Efficacy|3
775357|NCT00600171|2466046|P2|Overall Study|Lack of Efficacy|12
775358|NCT00600171|2466047|P1|Overall Study|Lack of Efficacy|9
775359|NCT00600171|2466042|P6|Overall Study|Adverse Event|0
775360|NCT00600171|2466043|P5|Overall Study|Adverse Event|1
775361|NCT00600171|2466044|P4|Overall Study|Adverse Event|0
775362|NCT00600171|2466045|P3|Overall Study|Adverse Event|0
775363|NCT00600171|2466046|P2|Overall Study|Adverse Event|1
775364|NCT00600171|2466047|P1|Overall Study|Adverse Event|0
775365|NCT00600353|2466117|P2|Overall Study|History of prepartive regimen|1
775366|NCT00600353|2466118|P1|Overall Study|History of prepartive regimen|0
775367|NCT00600353|2466117|P2|Overall Study|history of malignancy within 5 years|0
775368|NCT00600353|2466118|P1|Overall Study|history of malignancy within 5 years|1
775369|NCT00600821|2466132|P2|Overall Study|Unspecified|3
775370|NCT00600821|2466133|P1|Overall Study|Unspecified|2
775371|NCT00600821|2466132|P2|Overall Study|Randomized but not treated|1
775372|NCT00600821|2466133|P1|Overall Study|Randomized but not treated|0
775373|NCT00600821|2466132|P2|Overall Study|Objective progression or relapse|1
775374|NCT00600821|2466133|P1|Overall Study|Objective progression or relapse|0
775375|NCT00600821|2466132|P2|Overall Study|Terminated by sponsor|6
775376|NCT00600821|2466133|P1|Overall Study|Terminated by sponsor|8
775377|NCT00600821|2466132|P2|Overall Study|Withdrawal by Subject|1
775378|NCT00600821|2466133|P1|Overall Study|Withdrawal by Subject|1
775379|NCT00600821|2466132|P2|Overall Study|Lost to Follow-up|2
775380|NCT00600821|2466133|P1|Overall Study|Lost to Follow-up|2
775381|NCT00600821|2466132|P2|Overall Study|Death|46
775382|NCT00600821|2466133|P1|Overall Study|Death|45
775383|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Death|0
775384|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Death|1
775385|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
775386|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
775387|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
775388|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
775389|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Administrative Problems|4
775390|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Administrative Problems|4
775391|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
775392|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
775393|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
775394|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
775395|NCT00600886|2466161|P2|Extension - After Crossover (CAS)|Adverse Event|1
775396|NCT00600886|2466162|P1|Extension - After Crossover (CAS)|Adverse Event|19
775397|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
775398|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
775399|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Death|1
775400|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Death|1
775401|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
775402|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
775403|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Adverse Event|1
775404|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Adverse Event|4
775405|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
775406|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
775407|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
775408|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
775409|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
775410|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
775411|NCT00600886|2466161|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
775412|NCT00600886|2466162|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
775413|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Death|1
775414|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Death|0
775415|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
775416|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
775417|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
775418|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
775419|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
775420|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
775421|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
775422|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
775423|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
775424|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
775425|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
775426|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
775427|NCT00600886|2466161|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
775428|NCT00600886|2466162|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
775429|NCT00600938|2466226|P4|Extension Study|Death|0
775430|NCT00600938|2466227|P3|Extension Study|Death|0
775431|NCT00600938|2466228|P2|Extension Study|Death|0
775432|NCT00600938|2466229|P1|Extension Study|Death|1
775433|NCT00600938|2466226|P4|Extension Study|Lost to Follow-up|0
775434|NCT00600938|2466227|P3|Extension Study|Lost to Follow-up|2
775435|NCT00600938|2466228|P2|Extension Study|Lost to Follow-up|1
775436|NCT00600938|2466229|P1|Extension Study|Lost to Follow-up|1
775437|NCT00600938|2466226|P4|Extension Study|Withdrawal by Subject|0
775438|NCT00600938|2466227|P3|Extension Study|Withdrawal by Subject|3
775439|NCT00600938|2466228|P2|Extension Study|Withdrawal by Subject|2
775440|NCT00600938|2466229|P1|Extension Study|Withdrawal by Subject|2
775441|NCT00600938|2466226|P4|Extension Study|Unsatisfactory therapeutic effect|0
775442|NCT00600938|2466227|P3|Extension Study|Unsatisfactory therapeutic effect|1
775443|NCT00600938|2466228|P2|Extension Study|Unsatisfactory therapeutic effect|1
775444|NCT00600938|2466229|P1|Extension Study|Unsatisfactory therapeutic effect|4
775445|NCT00600938|2466226|P4|Extension Study|Abnormal test procedure results|1
775446|NCT00600938|2466227|P3|Extension Study|Abnormal test procedure results|1
775447|NCT00600938|2466228|P2|Extension Study|Abnormal test procedure results|1
775448|NCT00600938|2466229|P1|Extension Study|Abnormal test procedure results|0
775449|NCT00600938|2466226|P4|Extension Study|Adverse Event|0
775450|NCT00600938|2466227|P3|Extension Study|Adverse Event|2
775451|NCT00600938|2466228|P2|Extension Study|Adverse Event|0
775452|NCT00600938|2466229|P1|Extension Study|Adverse Event|1
775453|NCT00600938|2466226|P4|Core Study|Protocol Violation|0
775454|NCT00600938|2466227|P3|Core Study|Protocol Violation|0
775455|NCT00600938|2466228|P2|Core Study|Protocol Violation|2
775456|NCT00600938|2466229|P1|Core Study|Protocol Violation|1
775457|NCT00600938|2466226|P4|Core Study|Death|0
775458|NCT00600938|2466227|P3|Core Study|Death|0
775459|NCT00600938|2466228|P2|Core Study|Death|1
775460|NCT00600938|2466229|P1|Core Study|Death|1
775461|NCT00600938|2466226|P4|Core Study|Lost to Follow-up|0
775462|NCT00600938|2466227|P3|Core Study|Lost to Follow-up|0
775463|NCT00600938|2466228|P2|Core Study|Lost to Follow-up|2
775464|NCT00600938|2466229|P1|Core Study|Lost to Follow-up|3
775465|NCT00600938|2466226|P4|Core Study|Patient withdrew consent|0
775466|NCT00600938|2466227|P3|Core Study|Patient withdrew consent|0
775467|NCT00600938|2466228|P2|Core Study|Patient withdrew consent|12
775468|NCT00600938|2466229|P1|Core Study|Patient withdrew consent|7
775469|NCT00600938|2466226|P4|Core Study|Unsatisfactory therapeutic effect|0
775470|NCT00600938|2466227|P3|Core Study|Unsatisfactory therapeutic effect|0
775471|NCT00600938|2466228|P2|Core Study|Unsatisfactory therapeutic effect|2
775472|NCT00600938|2466229|P1|Core Study|Unsatisfactory therapeutic effect|1
775473|NCT00600938|2466226|P4|Core Study|Abnormal test procedure result(s)|0
775474|NCT00600938|2466227|P3|Core Study|Abnormal test procedure result(s)|0
775475|NCT00600938|2466228|P2|Core Study|Abnormal test procedure result(s)|2
775476|NCT00600938|2466229|P1|Core Study|Abnormal test procedure result(s)|3
775477|NCT00601107|2466295|P4|Overall Study|Undefined|0
775478|NCT00601107|2466296|P3|Overall Study|Undefined|1
775479|NCT00601107|2466297|P2|Overall Study|Undefined|0
775480|NCT00601107|2466298|P1|Overall Study|Undefined|1
775481|NCT00601107|2466295|P4|Overall Study|Worsening of Psoriasis|4
775482|NCT00601107|2466296|P3|Overall Study|Worsening of Psoriasis|1
775483|NCT00601107|2466297|P2|Overall Study|Worsening of Psoriasis|1
775484|NCT00601107|2466298|P1|Overall Study|Worsening of Psoriasis|4
775485|NCT00601107|2466295|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
775486|NCT00601107|2466296|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
775577|NCT00602472|2466715|P1|Overall Study|Withdrawal by Subject|8
775487|NCT00601107|2466297|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
775488|NCT00601107|2466298|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
775489|NCT00601107|2466295|P4|Overall Study|Lost to Follow-up|3
775490|NCT00601107|2466296|P3|Overall Study|Lost to Follow-up|0
775491|NCT00601107|2466297|P2|Overall Study|Lost to Follow-up|3
775492|NCT00601107|2466298|P1|Overall Study|Lost to Follow-up|3
775493|NCT00601107|2466295|P4|Overall Study|Withdrawal by Subject|4
775494|NCT00601107|2466296|P3|Overall Study|Withdrawal by Subject|7
775495|NCT00601107|2466297|P2|Overall Study|Withdrawal by Subject|4
775496|NCT00601107|2466298|P1|Overall Study|Withdrawal by Subject|5
775497|NCT00601107|2466295|P4|Overall Study|Adverse Event|0
775498|NCT00601107|2466296|P3|Overall Study|Adverse Event|3
775499|NCT00601107|2466297|P2|Overall Study|Adverse Event|1
775500|NCT00601107|2466298|P1|Overall Study|Adverse Event|0
775501|NCT00601250|2466322|P2|Overall Study|Other incl. lack of efficacy|9
775502|NCT00601250|2466323|P1|Overall Study|Other incl. lack of efficacy|2
775503|NCT00601250|2466322|P2|Overall Study|Withdrawal by Subject|13
775504|NCT00601250|2466323|P1|Overall Study|Withdrawal by Subject|4
775505|NCT00601250|2466322|P2|Overall Study|Lost to Follow-up|6
775506|NCT00601250|2466323|P1|Overall Study|Lost to Follow-up|2
775507|NCT00601250|2466322|P2|Overall Study|Protocol Violation|2
775508|NCT00601250|2466323|P1|Overall Study|Protocol Violation|3
775509|NCT00601250|2466322|P2|Overall Study|Adverse Event|9
775510|NCT00601250|2466323|P1|Overall Study|Adverse Event|3
775511|NCT00601354|2466359|P2|Overall Study|Lost to Follow-up|5
775512|NCT00601354|2466360|P1|Overall Study|Lost to Follow-up|4
775513|NCT00601419|2466374|P1|Overall Study|Missed Visits|1
775514|NCT00601419|2466374|P1|Overall Study|Lost to Follow-up|3
775515|NCT00601458|2466401|P3|Overall Study|Early Termination|1
775516|NCT00601458|2466402|P2|Overall Study|Early Termination|1
775517|NCT00601458|2466403|P1|Overall Study|Early Termination|0
775518|NCT00601458|2466401|P3|Overall Study|Protocol Violation|1
775519|NCT00601458|2466402|P2|Overall Study|Protocol Violation|2
775520|NCT00601458|2466403|P1|Overall Study|Protocol Violation|3
775521|NCT00601458|2466401|P3|Overall Study|Incomplete Data|0
775522|NCT00601458|2466402|P2|Overall Study|Incomplete Data|2
775523|NCT00601458|2466403|P1|Overall Study|Incomplete Data|0
775524|NCT00601458|2466401|P3|Overall Study|Dosing Error|0
775525|NCT00601458|2466402|P2|Overall Study|Dosing Error|0
775526|NCT00601458|2466403|P1|Overall Study|Dosing Error|1
775527|NCT00601523|2466416|P2|Overall Study|not specified|1
775528|NCT00601523|2466417|P1|Overall Study|not specified|9
775529|NCT00601523|2466416|P2|Overall Study|Withdrawal by Subject|9
775530|NCT00601523|2466417|P1|Overall Study|Withdrawal by Subject|18
775531|NCT00601523|2466416|P2|Overall Study|Lost to Follow-up|1
775532|NCT00601523|2466417|P1|Overall Study|Lost to Follow-up|0
775533|NCT00601523|2466416|P2|Overall Study|Protocol Violation|1
775534|NCT00601523|2466417|P1|Overall Study|Protocol Violation|5
775535|NCT00601523|2466416|P2|Overall Study|Lack of Efficacy|0
775536|NCT00601523|2466417|P1|Overall Study|Lack of Efficacy|3
775537|NCT00601523|2466416|P2|Overall Study|Adverse Event|14
775538|NCT00601523|2466417|P1|Overall Study|Adverse Event|42
775539|NCT00601640|2466461|P3|Overall Study|change in eligibility status|1
775540|NCT00601640|2466462|P2|Overall Study|change in eligibility status|1
775541|NCT00601640|2466463|P1|Overall Study|change in eligibility status|0
775542|NCT00601640|2466461|P3|Overall Study|intercurrent illness|0
775543|NCT00601640|2466462|P2|Overall Study|intercurrent illness|0
775544|NCT00601640|2466463|P1|Overall Study|intercurrent illness|1
775545|NCT00601640|2466461|P3|Overall Study|Adverse Event|2
775546|NCT00601640|2466462|P2|Overall Study|Adverse Event|4
775547|NCT00601640|2466463|P1|Overall Study|Adverse Event|0
775548|NCT00601640|2466461|P3|Overall Study|Death|0
775549|NCT00601640|2466462|P2|Overall Study|Death|0
775550|NCT00601640|2466463|P1|Overall Study|Death|1
775551|NCT00601640|2466461|P3|Overall Study|Withdrawal by Subject|7
775552|NCT00601640|2466462|P2|Overall Study|Withdrawal by Subject|0
775553|NCT00601640|2466463|P1|Overall Study|Withdrawal by Subject|3
775554|NCT00601835|2466558|P2|Overall Study|Relocate|2
775555|NCT00601835|2466559|P1|Overall Study|Relocate|12
775556|NCT00601835|2466558|P2|Overall Study|Adverse Event|1
775557|NCT00601835|2466559|P1|Overall Study|Adverse Event|1
775558|NCT00601835|2466558|P2|Overall Study|Lost to Follow-up|5
775559|NCT00601835|2466559|P1|Overall Study|Lost to Follow-up|37
775560|NCT00601835|2466558|P2|Overall Study|Physician Decision|0
775561|NCT00601835|2466559|P1|Overall Study|Physician Decision|1
775562|NCT00601835|2466558|P2|Overall Study|Withdrawal by Subject|6
775563|NCT00601835|2466559|P1|Overall Study|Withdrawal by Subject|9
891762|NCT01072149|2828548|P2|Washout Period 2 (14 Days)|Adverse Event|0
775566|NCT00602420|2466677|P2|Overall Study|Adverse Event|0
775567|NCT00602420|2466678|P1|Overall Study|Adverse Event|1
775568|NCT00602420|2466677|P2|Overall Study|Withdrawal by Subject|17
775569|NCT00602420|2466678|P1|Overall Study|Withdrawal by Subject|18
775570|NCT00602420|2466677|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
775571|NCT00602420|2466678|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
775572|NCT00602420|2466677|P2|Overall Study|Death|4
775573|NCT00602420|2466678|P1|Overall Study|Death|1
775574|NCT00602472|2466714|P2|Overall Study|Other incl. lack of efficacy|2
775575|NCT00602472|2466715|P1|Overall Study|Other incl. lack of efficacy|4
775576|NCT00602472|2466714|P2|Overall Study|Withdrawal by Subject|14
775578|NCT00602472|2466714|P2|Overall Study|Protocol Violation|19
775579|NCT00602472|2466715|P1|Overall Study|Protocol Violation|4
775580|NCT00602472|2466714|P2|Overall Study|Adverse Event|23
775581|NCT00602472|2466715|P1|Overall Study|Adverse Event|5
775582|NCT00602537|2466747|P2|Follow Up Study Comparison|Withdrawal by Subject|2
775583|NCT00602537|2466748|P1|Follow Up Study Comparison|Withdrawal by Subject|2
775584|NCT00602537|2466747|P2|Follow Up Study Comparison|Lost to Follow-up|1
775585|NCT00602537|2466748|P1|Follow Up Study Comparison|Lost to Follow-up|8
775586|NCT00602537|2466747|P2|Follow Up Study Comparison|Adverse Event|0
775587|NCT00602537|2466748|P1|Follow Up Study Comparison|Adverse Event|1
775588|NCT00602537|2466747|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
775589|NCT00602537|2466748|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
775590|NCT00602537|2466747|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
775591|NCT00602537|2466748|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
775592|NCT00602537|2466747|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
775593|NCT00602537|2466748|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
775594|NCT00602537|2466747|P2|12 Week Double Blind Comparison|Adverse Event|5
775595|NCT00602537|2466748|P1|12 Week Double Blind Comparison|Adverse Event|2
775596|NCT00602641|2466758|P2|Overall Study|Other|1
775597|NCT00602641|2466759|P1|Overall Study|Other|3
775598|NCT00602641|2466758|P2|Overall Study|Administrative Closure|1
775599|NCT00602641|2466759|P1|Overall Study|Administrative Closure|1
775600|NCT00602641|2466758|P2|Overall Study|Physician Decision|4
775601|NCT00602641|2466759|P1|Overall Study|Physician Decision|5
775602|NCT00602641|2466758|P2|Overall Study|Other Complicating Disease|2
775603|NCT00602641|2466759|P1|Overall Study|Other Complicating Disease|5
775604|NCT00602641|2466758|P2|Overall Study|Alternative therapy|2
775605|NCT00602641|2466759|P1|Overall Study|Alternative therapy|5
775606|NCT00602641|2466758|P2|Overall Study|Withdrawal by Subject|12
775607|NCT00602641|2466759|P1|Overall Study|Withdrawal by Subject|15
775608|NCT00602641|2466758|P2|Overall Study|Death|5
775609|NCT00602641|2466759|P1|Overall Study|Death|6
775610|NCT00602641|2466758|P2|Overall Study|Disease progression|55
775611|NCT00602641|2466759|P1|Overall Study|Disease progression|38
775612|NCT00602641|2466758|P2|Overall Study|Adverse Event|53
775613|NCT00602641|2466759|P1|Overall Study|Adverse Event|62
775614|NCT00602641|2466758|P2|Overall Study|Still on treatment at time of analysis|15
775615|NCT00602641|2466759|P1|Overall Study|Still on treatment at time of analysis|8
775616|NCT00602641|2466758|P2|Overall Study|Never started protocol therapy|2
775617|NCT00602641|2466759|P1|Overall Study|Never started protocol therapy|6
775618|NCT00602927|2466786|P2|Period 3: 13 Days|MRI data quality|2
775619|NCT00602927|2466787|P1|Period 3: 13 Days|MRI data quality|2
775620|NCT00602927|2466786|P2|Period 3: 13 Days|Protocol Violation|1
775621|NCT00602927|2466787|P1|Period 3: 13 Days|Protocol Violation|0
775622|NCT00602927|2466786|P2|Period 2: 14 Days|Protocol Violation|2
775623|NCT00602927|2466787|P1|Period 2: 14 Days|Protocol Violation|0
775624|NCT00602927|2466786|P2|Period 1: 13 Days|Claustrophobia|1
775625|NCT00602927|2466787|P1|Period 1: 13 Days|Claustrophobia|0
775626|NCT00602927|2466786|P2|Period 1: 13 Days|Time|0
775627|NCT00602927|2466787|P1|Period 1: 13 Days|Time|1
775628|NCT00602927|2466786|P2|Period 1: 13 Days|MRI scanner technical issue|0
775629|NCT00602927|2466787|P1|Period 1: 13 Days|MRI scanner technical issue|1
775630|NCT00602927|2466786|P2|Period 1: 13 Days|Protocol Violation|4
775631|NCT00602927|2466787|P1|Period 1: 13 Days|Protocol Violation|2
775632|NCT00602979|2466800|P5|Overall Study|Failed Intubation|0
775633|NCT00602979|2466801|P4|Overall Study|Failed Intubation|1
775634|NCT00602979|2466802|P3|Overall Study|Failed Intubation|0
775635|NCT00602979|2466803|P2|Overall Study|Failed Intubation|1
775636|NCT00602979|2466804|P1|Overall Study|Failed Intubation|0
775637|NCT00602979|2466800|P5|Overall Study|Lost to Follow-up|3
775638|NCT00602979|2466801|P4|Overall Study|Lost to Follow-up|2
775639|NCT00602979|2466802|P3|Overall Study|Lost to Follow-up|3
775640|NCT00602979|2466803|P2|Overall Study|Lost to Follow-up|2
775641|NCT00602979|2466804|P1|Overall Study|Lost to Follow-up|3
775642|NCT00603239|2466848|P2|Overall Study|Subject decision|1
775643|NCT00603239|2466849|P1|Overall Study|Subject decision|2
775644|NCT00603239|2466848|P2|Overall Study|Protocol Violation|0
775645|NCT00603239|2466849|P1|Overall Study|Protocol Violation|2
775646|NCT00603239|2466848|P2|Overall Study|Physician Decision|0
775647|NCT00603239|2466849|P1|Overall Study|Physician Decision|2
775648|NCT00603239|2466848|P2|Overall Study|Lost to Follow-up|1
775649|NCT00603239|2466849|P1|Overall Study|Lost to Follow-up|2
775650|NCT00603239|2466848|P2|Overall Study|Loss of glucose control|0
775651|NCT00603239|2466849|P1|Overall Study|Loss of glucose control|3
775652|NCT00603239|2466848|P2|Overall Study|Entry criteria not met|1
775653|NCT00603239|2466849|P1|Overall Study|Entry criteria not met|0
775654|NCT00603239|2466848|P2|Overall Study|Adverse Event|1
775655|NCT00603239|2466849|P1|Overall Study|Adverse Event|4
775656|NCT00603265|2466878|P3|Overall Study|Protocol Violation|0
775657|NCT00603265|2466879|P2|Overall Study|Protocol Violation|0
775658|NCT00603265|2466880|P1|Overall Study|Protocol Violation|1
775659|NCT00603265|2466878|P3|Overall Study|Participant Left Country, No Responses|0
775660|NCT00603265|2466879|P2|Overall Study|Participant Left Country, No Responses|1
775661|NCT00603265|2466880|P1|Overall Study|Participant Left Country, No Responses|0
775662|NCT00603265|2466878|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
775663|NCT00603265|2466879|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
775664|NCT00603265|2466880|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
775665|NCT00603265|2466878|P3|Overall Study|Lost to Follow-up|0
775666|NCT00603265|2466879|P2|Overall Study|Lost to Follow-up|1
775667|NCT00603265|2466880|P1|Overall Study|Lost to Follow-up|0
775668|NCT00603265|2466878|P3|Overall Study|Lack of Efficacy|3
775669|NCT00603265|2466879|P2|Overall Study|Lack of Efficacy|0
775670|NCT00603265|2466880|P1|Overall Study|Lack of Efficacy|3
775671|NCT00603265|2466878|P3|Overall Study|Withdrawal by Subject|1
775672|NCT00603265|2466879|P2|Overall Study|Withdrawal by Subject|2
775673|NCT00603265|2466880|P1|Overall Study|Withdrawal by Subject|1
775674|NCT00603265|2466878|P3|Overall Study|Adverse Event|1
775675|NCT00603265|2466879|P2|Overall Study|Adverse Event|11
775676|NCT00603265|2466880|P1|Overall Study|Adverse Event|2
775677|NCT00603278|2466912|P6|Overall Study|Lost to Follow-up|0
775678|NCT00603278|2466913|P5|Overall Study|Lost to Follow-up|1
775679|NCT00603278|2466914|P4|Overall Study|Lost to Follow-up|0
775680|NCT00603278|2466915|P3|Overall Study|Lost to Follow-up|0
775681|NCT00603278|2466916|P2|Overall Study|Lost to Follow-up|0
775682|NCT00603278|2466917|P1|Overall Study|Lost to Follow-up|1
775683|NCT00603278|2466912|P6|Overall Study|Physician Decision|1
775684|NCT00603278|2466913|P5|Overall Study|Physician Decision|2
775685|NCT00603278|2466914|P4|Overall Study|Physician Decision|0
775686|NCT00603278|2466915|P3|Overall Study|Physician Decision|0
775687|NCT00603278|2466916|P2|Overall Study|Physician Decision|1
775688|NCT00603278|2466917|P1|Overall Study|Physician Decision|0
775689|NCT00603278|2466912|P6|Overall Study|Protocol Violation|1
775690|NCT00603278|2466913|P5|Overall Study|Protocol Violation|0
775691|NCT00603278|2466914|P4|Overall Study|Protocol Violation|1
775692|NCT00603278|2466915|P3|Overall Study|Protocol Violation|1
775693|NCT00603278|2466916|P2|Overall Study|Protocol Violation|0
775694|NCT00603278|2466917|P1|Overall Study|Protocol Violation|3
775695|NCT00603278|2466912|P6|Overall Study|Withdrawal by Subject|2
775696|NCT00603278|2466913|P5|Overall Study|Withdrawal by Subject|1
775697|NCT00603278|2466914|P4|Overall Study|Withdrawal by Subject|2
775698|NCT00603278|2466915|P3|Overall Study|Withdrawal by Subject|1
775699|NCT00603278|2466916|P2|Overall Study|Withdrawal by Subject|3
775700|NCT00603278|2466917|P1|Overall Study|Withdrawal by Subject|2
775701|NCT00603278|2466912|P6|Overall Study|Adverse Event|1
775702|NCT00603278|2466913|P5|Overall Study|Adverse Event|2
775703|NCT00603278|2466914|P4|Overall Study|Adverse Event|0
775704|NCT00603278|2466915|P3|Overall Study|Adverse Event|1
775705|NCT00603278|2466916|P2|Overall Study|Adverse Event|3
775706|NCT00603278|2466917|P1|Overall Study|Adverse Event|0
775707|NCT00603278|2466912|P6|Overall Study|Lack of Efficacy|14
775708|NCT00603278|2466913|P5|Overall Study|Lack of Efficacy|7
775709|NCT00603278|2466914|P4|Overall Study|Lack of Efficacy|8
775710|NCT00603278|2466915|P3|Overall Study|Lack of Efficacy|11
775711|NCT00603278|2466916|P2|Overall Study|Lack of Efficacy|10
775712|NCT00603278|2466917|P1|Overall Study|Lack of Efficacy|35
775713|NCT00603304|2467081|P2|Overall Study|Patient Decision|0
775714|NCT00603304|2467082|P1|Overall Study|Patient Decision|2
775715|NCT00603304|2467081|P2|Overall Study|Not Specified|0
775716|NCT00603304|2467082|P1|Overall Study|Not Specified|2
775717|NCT00603304|2467081|P2|Overall Study|Moved Away|2
775718|NCT00603304|2467082|P1|Overall Study|Moved Away|0
775719|NCT00603304|2467081|P2|Overall Study|Non-Compliant|1
775720|NCT00603304|2467082|P1|Overall Study|Non-Compliant|0
775721|NCT00603304|2467081|P2|Overall Study|Exclusionary Medication|3
775722|NCT00603304|2467082|P1|Overall Study|Exclusionary Medication|2
775723|NCT00603304|2467081|P2|Overall Study|Crossed Over to Open Label Therapy|3
775724|NCT00603304|2467082|P1|Overall Study|Crossed Over to Open Label Therapy|3
775725|NCT00603304|2467081|P2|Overall Study|Unacceptable Treatment Toxicity|8
775726|NCT00603304|2467082|P1|Overall Study|Unacceptable Treatment Toxicity|5
775727|NCT00603304|2467081|P2|Overall Study|Adverse Event|2
775728|NCT00603304|2467082|P1|Overall Study|Adverse Event|4
775729|NCT00603304|2467081|P2|Overall Study|Protocol Violation|0
775730|NCT00603304|2467082|P1|Overall Study|Protocol Violation|1
775731|NCT00603304|2467081|P2|Overall Study|Withdrawal by Subject|5
775732|NCT00603304|2467082|P1|Overall Study|Withdrawal by Subject|8
775733|NCT00603304|2467081|P2|Overall Study|Lost to Follow-up|7
775734|NCT00603304|2467082|P1|Overall Study|Lost to Follow-up|5
775735|NCT00603382|2467122|P6|Overall Study|Withdrawal by Subject|1
775736|NCT00603382|2467123|P5|Overall Study|Withdrawal by Subject|0
775737|NCT00603382|2467124|P4|Overall Study|Withdrawal by Subject|1
775738|NCT00603382|2467125|P3|Overall Study|Withdrawal by Subject|1
775739|NCT00603382|2467126|P2|Overall Study|Withdrawal by Subject|3
775740|NCT00603382|2467127|P1|Overall Study|Withdrawal by Subject|3
775741|NCT00603382|2467122|P6|Overall Study|Physician Decision|3
775742|NCT00603382|2467123|P5|Overall Study|Physician Decision|1
775743|NCT00603382|2467124|P4|Overall Study|Physician Decision|0
775744|NCT00603382|2467125|P3|Overall Study|Physician Decision|2
775745|NCT00603382|2467126|P2|Overall Study|Physician Decision|0
775746|NCT00603382|2467127|P1|Overall Study|Physician Decision|0
775747|NCT00603382|2467122|P6|Overall Study|Lost to Follow-up|1
775748|NCT00603382|2467123|P5|Overall Study|Lost to Follow-up|0
775749|NCT00603382|2467124|P4|Overall Study|Lost to Follow-up|1
775750|NCT00603382|2467125|P3|Overall Study|Lost to Follow-up|1
775751|NCT00603382|2467126|P2|Overall Study|Lost to Follow-up|1
775752|NCT00603382|2467127|P1|Overall Study|Lost to Follow-up|0
775753|NCT00603382|2467122|P6|Overall Study|Protocol Violation|0
775754|NCT00603382|2467123|P5|Overall Study|Protocol Violation|1
775755|NCT00603382|2467124|P4|Overall Study|Protocol Violation|2
775756|NCT00603382|2467125|P3|Overall Study|Protocol Violation|1
775757|NCT00603382|2467126|P2|Overall Study|Protocol Violation|0
775758|NCT00603382|2467127|P1|Overall Study|Protocol Violation|1
775759|NCT00603382|2467122|P6|Overall Study|Lack of Efficacy|11
775760|NCT00603382|2467123|P5|Overall Study|Lack of Efficacy|6
775761|NCT00603382|2467124|P4|Overall Study|Lack of Efficacy|6
775762|NCT00603382|2467125|P3|Overall Study|Lack of Efficacy|3
775763|NCT00603382|2467126|P2|Overall Study|Lack of Efficacy|9
775764|NCT00603382|2467127|P1|Overall Study|Lack of Efficacy|14
775765|NCT00603382|2467122|P6|Overall Study|Adverse Event|2
775766|NCT00603382|2467123|P5|Overall Study|Adverse Event|1
775767|NCT00603382|2467124|P4|Overall Study|Adverse Event|2
775768|NCT00603382|2467125|P3|Overall Study|Adverse Event|1
775769|NCT00603382|2467126|P2|Overall Study|Adverse Event|1
775770|NCT00603382|2467127|P1|Overall Study|Adverse Event|0
775771|NCT00594958|2467276|P3|Overall Study|administrative|2
775772|NCT00594958|2467277|P2|Overall Study|administrative|0
775773|NCT00594958|2467278|P1|Overall Study|administrative|3
775774|NCT00594958|2467276|P3|Overall Study|Lost to Follow-up|3
775775|NCT00594958|2467277|P2|Overall Study|Lost to Follow-up|0
775776|NCT00594958|2467278|P1|Overall Study|Lost to Follow-up|5
775777|NCT00594958|2467276|P3|Overall Study|Protocol Violation|2
775778|NCT00594958|2467277|P2|Overall Study|Protocol Violation|0
775779|NCT00594958|2467278|P1|Overall Study|Protocol Violation|1
775780|NCT00594958|2467276|P3|Overall Study|Pregnancy|0
775781|NCT00594958|2467277|P2|Overall Study|Pregnancy|2
775782|NCT00594958|2467278|P1|Overall Study|Pregnancy|0
775783|NCT00594958|2467276|P3|Overall Study|Adverse Event|2
775784|NCT00594958|2467277|P2|Overall Study|Adverse Event|1
775785|NCT00594958|2467278|P1|Overall Study|Adverse Event|4
775786|NCT00594958|2467276|P3|Overall Study|Withdrawal by Subject|1
775787|NCT00594958|2467277|P2|Overall Study|Withdrawal by Subject|0
775788|NCT00594958|2467278|P1|Overall Study|Withdrawal by Subject|1
775789|NCT00595075|2467288|P2|Overall Study|Withdrawal by Subject|0
775790|NCT00595075|2467289|P1|Overall Study|Withdrawal by Subject|1
775791|NCT00595127|2467323|P1|Overall Study|joined another trial|1
775792|NCT00595127|2467323|P1|Overall Study|Relapsed|3
775793|NCT00595127|2467323|P1|Overall Study|Death|6
775794|NCT00595309|2467353|P1|Overall Study|personal reason|1
775795|NCT00595309|2467353|P1|Overall Study|acute infection after V0|1
775796|NCT00595309|2467353|P1|Overall Study|planned vaccination against yellow fever|1
775797|NCT00595309|2467353|P1|Overall Study|Lost to Follow-up|1
775798|NCT00595335|2467359|P2|Six Months to Twelve Months|Disease Progression|0
775799|NCT00595335|2467360|P1|Six Months to Twelve Months|Disease Progression|1
775800|NCT00595335|2467359|P2|Six Months to Twelve Months|Withdrawal by Subject|1
775801|NCT00595335|2467360|P1|Six Months to Twelve Months|Withdrawal by Subject|0
775802|NCT00595335|2467359|P2|Baseline to Six Months|Adverse Event|0
775803|NCT00595335|2467360|P1|Baseline to Six Months|Adverse Event|1
775804|NCT00595335|2467359|P2|Baseline to Six Months|Disease Progression|1
775805|NCT00595335|2467360|P1|Baseline to Six Months|Disease Progression|1
775806|NCT00595335|2467359|P2|Baseline to Six Months|Withdrawal by Subject|1
775807|NCT00595335|2467360|P1|Baseline to Six Months|Withdrawal by Subject|0
775808|NCT00595413|2467397|P4|Overall Study|Unspecified|0
775809|NCT00595413|2467398|P3|Overall Study|Unspecified|5
775810|NCT00595413|2467399|P2|Overall Study|Unspecified|1
775811|NCT00595413|2467400|P1|Overall Study|Unspecified|5
775812|NCT00595413|2467397|P4|Overall Study|Death|0
775813|NCT00595413|2467398|P3|Overall Study|Death|1
775814|NCT00595413|2467399|P2|Overall Study|Death|0
775815|NCT00595413|2467400|P1|Overall Study|Death|0
775816|NCT00595413|2467397|P4|Overall Study|Lost to Follow-up|3
775817|NCT00595413|2467398|P3|Overall Study|Lost to Follow-up|1
775818|NCT00595413|2467399|P2|Overall Study|Lost to Follow-up|2
775819|NCT00595413|2467400|P1|Overall Study|Lost to Follow-up|2
775820|NCT00595413|2467397|P4|Overall Study|Adverse Event|1
775821|NCT00595413|2467398|P3|Overall Study|Adverse Event|1
775822|NCT00595413|2467399|P2|Overall Study|Adverse Event|2
775823|NCT00595413|2467400|P1|Overall Study|Adverse Event|0
775824|NCT00595465|2467429|P3|Overall Study|administrative reason|1
775825|NCT00595465|2467430|P2|Overall Study|administrative reason|0
775826|NCT00595465|2467431|P1|Overall Study|administrative reason|0
775827|NCT00595465|2467429|P3|Overall Study|Lost to Follow-up|2
775828|NCT00595465|2467430|P2|Overall Study|Lost to Follow-up|0
775829|NCT00595465|2467431|P1|Overall Study|Lost to Follow-up|0
775830|NCT00595465|2467429|P3|Overall Study|Protocol Violation|0
775831|NCT00595465|2467430|P2|Overall Study|Protocol Violation|1
775832|NCT00595465|2467431|P1|Overall Study|Protocol Violation|2
775833|NCT00595465|2467429|P3|Overall Study|Pregnancy|1
775834|NCT00595465|2467430|P2|Overall Study|Pregnancy|0
775835|NCT00595465|2467431|P1|Overall Study|Pregnancy|0
775836|NCT00595465|2467429|P3|Overall Study|Adverse Event|3
775837|NCT00595465|2467430|P2|Overall Study|Adverse Event|3
775838|NCT00595465|2467431|P1|Overall Study|Adverse Event|4
775839|NCT00595504|2467441|P2|Overall Study|Physician Decision|0
775840|NCT00595504|2467442|P1|Overall Study|Physician Decision|1
775841|NCT00595504|2467441|P2|Overall Study|Withdrawal by Subject|3
775842|NCT00595504|2467442|P1|Overall Study|Withdrawal by Subject|1
775843|NCT00595517|2467452|P1|Overall Study|No intention to attend regularly|1
775844|NCT00595517|2467452|P1|Overall Study|usage of prohibited treatment|1
775845|NCT00595517|2467452|P1|Overall Study|Recurrence of ulcer|5
775846|NCT00595517|2467452|P1|Overall Study|Protocol Violation|2
775847|NCT00595517|2467452|P1|Overall Study|Withdrawal by Subject|4
775848|NCT00595517|2467452|P1|Overall Study|Adverse Event|6
775849|NCT00595582|2467480|P1|Overall Study|Physician Decision|5
775850|NCT00595582|2467480|P1|Overall Study|Adverse Event|2
775851|NCT00595582|2467480|P1|Overall Study|Lost to Follow-up|1
775852|NCT00595582|2467480|P1|Overall Study|Pilot study that PI terminated|2
775853|NCT00595764|2467486|P2|Overall Study|Withdrawal by Subject|0
775854|NCT00595764|2467487|P1|Overall Study|Withdrawal by Subject|4
775855|NCT00595764|2467486|P2|Overall Study|Missed 3 PM visits|7
775856|NCT00595764|2467487|P1|Overall Study|Missed 3 PM visits|1
775857|NCT00595764|2467486|P2|Overall Study|Missed Medication >1 week|17
775858|NCT00595764|2467487|P1|Overall Study|Missed Medication >1 week|10
775859|NCT00595764|2467486|P2|Overall Study|Protocol Violation|19
775860|NCT00595764|2467487|P1|Overall Study|Protocol Violation|24
775861|NCT00595868|2467516|P2|Overall Study|Lost to Follow-up|50
775862|NCT00595868|2467517|P1|Overall Study|Lost to Follow-up|45
775863|NCT00595920|2467530|P1|Overall Study|The OLTERMS study was discontinued by th|116
775864|NCT00595959|2467553|P1|Overall Study|Lost to Follow-up|1
775865|NCT00595959|2467553|P1|Overall Study|Withdrawal by Subject|1
891763|NCT01072149|2828549|P1|Washout Period 2 (14 Days)|Adverse Event|0
891764|NCT01072149|2828532|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891765|NCT01072149|2828533|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891766|NCT01072149|2828534|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
775870|NCT00596362|2467617|P1|Overall Study|Progressive Disease|1
775871|NCT00596427|2467623|P2|Overall Study|Protocol Violation|0
775872|NCT00596427|2467624|P1|Overall Study|Protocol Violation|1
775873|NCT00596427|2467623|P2|Overall Study|Increased Fasting Triacylglycerol level|0
775874|NCT00596427|2467624|P1|Overall Study|Increased Fasting Triacylglycerol level|1
775875|NCT00596427|2467623|P2|Overall Study|Withdrawal by Subject|2
775876|NCT00596427|2467624|P1|Overall Study|Withdrawal by Subject|2
775877|NCT00596466|2467674|P1|Overall Study|Enrolled, not treated|2
775878|NCT00596466|2467674|P1|Overall Study|Unpecified|2
775879|NCT00596466|2467674|P1|Overall Study|Protocol Violation|2
775880|NCT00596466|2467674|P1|Overall Study|Withdrawal by Subject|2
775881|NCT00596466|2467674|P1|Overall Study|Adverse Event|4
775882|NCT00596466|2467674|P1|Overall Study|Lack of Efficacy|5
775883|NCT00596635|2467695|P3|Overall Study|Could not provide urine specimen|2
775884|NCT00596635|2467696|P2|Overall Study|Could not provide urine specimen|2
775885|NCT00596635|2467697|P1|Overall Study|Could not provide urine specimen|1
775886|NCT00596635|2467695|P3|Overall Study|Hip fracture|3
775887|NCT00596635|2467696|P2|Overall Study|Hip fracture|3
775888|NCT00596635|2467697|P1|Overall Study|Hip fracture|2
775889|NCT00596635|2467695|P3|Overall Study|Treatment for symptomatic UTI|3
775890|NCT00596635|2467696|P2|Overall Study|Treatment for symptomatic UTI|6
775891|NCT00596635|2467697|P1|Overall Study|Treatment for symptomatic UTI|4
775892|NCT00596635|2467695|P3|Overall Study|Lost to Follow-up|0
775893|NCT00596635|2467696|P2|Overall Study|Lost to Follow-up|2
775894|NCT00596635|2467697|P1|Overall Study|Lost to Follow-up|0
775895|NCT00596687|2467713|P2|Overall Study|cancelled surgery|1
775896|NCT00596687|2467714|P1|Overall Study|cancelled surgery|1
775897|NCT00596687|2467713|P2|Overall Study|Withdrawal by Subject|1
775898|NCT00596687|2467714|P1|Overall Study|Withdrawal by Subject|3
775899|NCT00596687|2467713|P2|Overall Study|continuous insulin infusion during TPN|1
775900|NCT00596687|2467714|P1|Overall Study|continuous insulin infusion during TPN|2
775901|NCT00596687|2467713|P2|Overall Study|< 24 hours of insulin treatment|6
775902|NCT00596687|2467714|P1|Overall Study|< 24 hours of insulin treatment|8
775903|NCT00596752|2467724|P2|Overall Study|Protocol Violation|0
775904|NCT00596752|2467725|P1|Overall Study|Protocol Violation|1
775905|NCT00596752|2467724|P2|Overall Study|Lack of Efficacy|7
775906|NCT00596752|2467725|P1|Overall Study|Lack of Efficacy|4
775907|NCT00596752|2467724|P2|Overall Study|Unsatisfactory Compliance|6
775908|NCT00596752|2467725|P1|Overall Study|Unsatisfactory Compliance|9
775909|NCT00596752|2467724|P2|Overall Study|Withdrawal by Subject|9
775910|NCT00596752|2467725|P1|Overall Study|Withdrawal by Subject|12
775911|NCT00596752|2467724|P2|Overall Study|Lost to Follow-up|38
775912|NCT00596752|2467725|P1|Overall Study|Lost to Follow-up|22
775913|NCT00596752|2467724|P2|Overall Study|Adverse Event|34
775914|NCT00596752|2467725|P1|Overall Study|Adverse Event|34
775915|NCT00596752|2467724|P2|Overall Study|Other Reason|49
775916|NCT00596752|2467725|P1|Overall Study|Other Reason|44
775917|NCT00596817|2467756|P2|Double-blind Period|Other Reasons|18
775918|NCT00596817|2467757|P1|Double-blind Period|Other Reasons|10
775919|NCT00596817|2467756|P2|Double-blind Period|Lost to Follow-up|2
775920|NCT00596817|2467757|P1|Double-blind Period|Lost to Follow-up|0
775921|NCT00596817|2467756|P2|Double-blind Period|Withdrawal of Consent|3
775922|NCT00596817|2467757|P1|Double-blind Period|Withdrawal of Consent|7
775923|NCT00596817|2467756|P2|Double-blind Period|Protocol Violation|8
775924|NCT00596817|2467757|P1|Double-blind Period|Protocol Violation|11
775925|NCT00596817|2467756|P2|Double-blind Period|Non-compliance With Study Product|4
775926|NCT00596817|2467757|P1|Double-blind Period|Non-compliance With Study Product|3
775927|NCT00596817|2467756|P2|Double-blind Period|Lack of Efficacy|28
775928|NCT00596817|2467757|P1|Double-blind Period|Lack of Efficacy|52
775929|NCT00596817|2467756|P2|Double-blind Period|Adverse Event|16
775930|NCT00596817|2467757|P1|Double-blind Period|Adverse Event|5
775931|NCT00596817|2467756|P2|Open-label Period to Double-blind Period|Other Reasons|14
775932|NCT00596817|2467757|P1|Open-label Period to Double-blind Period|Other Reasons|0
775933|NCT00596817|2467756|P2|Open-label Period to Double-blind Period|Not Eligible|49
775934|NCT00596817|2467757|P1|Open-label Period to Double-blind Period|Not Eligible|0
775935|NCT00596817|2467756|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
775936|NCT00596817|2467757|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
775937|NCT00596817|2467756|P2|Open-label Period to Double-blind Period|Adverse Event|5
775938|NCT00596817|2467757|P1|Open-label Period to Double-blind Period|Adverse Event|0
775939|NCT00596817|2467756|P2|Open-label Period|Other Reasons|65
775940|NCT00596817|2467757|P1|Open-label Period|Other Reasons|0
775941|NCT00596817|2467756|P2|Open-label Period|Lack of Efficacy|33
775942|NCT00596817|2467757|P1|Open-label Period|Lack of Efficacy|0
775943|NCT00596817|2467756|P2|Open-label Period|Adverse Event|49
775944|NCT00596817|2467757|P1|Open-label Period|Adverse Event|0
775945|NCT00596830|2467782|P2|Overall Study|Randomized but not treated|7
775946|NCT00596830|2467783|P1|Overall Study|Randomized but not treated|3
775947|NCT00596830|2467782|P2|Overall Study|Follow-up was discontinued|0
775948|NCT00596830|2467783|P1|Overall Study|Follow-up was discontinued|1
775949|NCT00596830|2467782|P2|Overall Study|Study terminated by sponsor|62
775950|NCT00596830|2467783|P1|Overall Study|Study terminated by sponsor|51
775951|NCT00596830|2467782|P2|Overall Study|Withdrawal by Subject|12
775952|NCT00596830|2467783|P1|Overall Study|Withdrawal by Subject|22
775953|NCT00596830|2467782|P2|Overall Study|Lost to Follow-up|11
775954|NCT00596830|2467783|P1|Overall Study|Lost to Follow-up|7
775955|NCT00596830|2467782|P2|Overall Study|Death|247
775956|NCT00596830|2467783|P1|Overall Study|Death|258
775959|NCT00596947|2467819|P2|Overall Study|Lost to Follow-up|0
775960|NCT00596947|2467820|P1|Overall Study|Lost to Follow-up|1
775961|NCT00596947|2467819|P2|Overall Study|study halted due to low enrollment|3
775962|NCT00596947|2467820|P1|Overall Study|study halted due to low enrollment|5
775963|NCT00596960|2467862|P2|Overall Study|No alcohol use data|1
775964|NCT00596960|2467863|P1|Overall Study|No alcohol use data|0
775965|NCT00596960|2467862|P2|Overall Study|Protocol Violation|1
775966|NCT00596960|2467863|P1|Overall Study|Protocol Violation|0
775967|NCT00596960|2467862|P2|Overall Study|Physician Decision|0
775968|NCT00596960|2467863|P1|Overall Study|Physician Decision|1
775969|NCT00596960|2467862|P2|Overall Study|Incarcerated|0
775970|NCT00596960|2467863|P1|Overall Study|Incarcerated|2
775971|NCT00596960|2467862|P2|Overall Study|Withdrawal by Subject|0
775972|NCT00596960|2467863|P1|Overall Study|Withdrawal by Subject|1
775973|NCT00596960|2467862|P2|Overall Study|Lost to Follow-up|5
775974|NCT00596960|2467863|P1|Overall Study|Lost to Follow-up|6
775975|NCT00596960|2467862|P2|Overall Study|Death|2
775976|NCT00596960|2467863|P1|Overall Study|Death|1
775977|NCT00597012|2467875|P2|Overall Study|Lost to Follow-up|2
775978|NCT00597012|2467876|P1|Overall Study|Lost to Follow-up|0
775979|NCT00597012|2467875|P2|Overall Study|Ineligible|0
775980|NCT00597012|2467876|P1|Overall Study|Ineligible|2
775981|NCT00597012|2467875|P2|Overall Study|Withdrawal by Subject|4
775982|NCT00597012|2467876|P1|Overall Study|Withdrawal by Subject|7
775983|NCT00597012|2467875|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
775984|NCT00597012|2467876|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
775985|NCT00597012|2467875|P2|Overall Study|Death|1
775986|NCT00597012|2467876|P1|Overall Study|Death|1
775987|NCT00597116|2467900|P2|Overall Study|Progressive disease|6
775988|NCT00597116|2467901|P1|Overall Study|Progressive disease|11
775989|NCT00597116|2467900|P2|Overall Study|Lost to Follow-up|0
775990|NCT00597116|2467901|P1|Overall Study|Lost to Follow-up|1
775991|NCT00597116|2467900|P2|Overall Study|Death|1
775992|NCT00597116|2467901|P1|Overall Study|Death|0
775993|NCT00597116|2467900|P2|Overall Study|Physician Decision|1
775994|NCT00597116|2467901|P1|Overall Study|Physician Decision|0
775995|NCT00597116|2467900|P2|Overall Study|Withdrawal by Subject|2
775996|NCT00597116|2467901|P1|Overall Study|Withdrawal by Subject|0
775997|NCT00597116|2467900|P2|Overall Study|Adverse Event|1
775998|NCT00597116|2467901|P1|Overall Study|Adverse Event|2
775999|NCT00597207|2467915|P2|Overall Study|Lost to Follow-up|7
776000|NCT00597207|2467916|P1|Overall Study|Lost to Follow-up|5
776001|NCT00597376|2467953|P2|Overall Study|Adverse Event|1
776002|NCT00597376|2467954|P1|Overall Study|Adverse Event|4
776003|NCT00597376|2467953|P2|Overall Study|Withdrawal by Subject|3
776004|NCT00597376|2467954|P1|Overall Study|Withdrawal by Subject|4
776005|NCT00597506|2468007|P1|Overall Study|Subject is being followed for survival|1
776006|NCT00603447|2468030|P7|Overall Study|Withdrew Consent|1
776007|NCT00603447|2468031|P6|Overall Study|Withdrew Consent|0
776008|NCT00603447|2468032|P5|Overall Study|Withdrew Consent|1
776009|NCT00603447|2468033|P4|Overall Study|Withdrew Consent|0
776010|NCT00603447|2468034|P3|Overall Study|Withdrew Consent|0
776011|NCT00603447|2468035|P2|Overall Study|Withdrew Consent|2
776012|NCT00603447|2468036|P1|Overall Study|Withdrew Consent|0
776013|NCT00603447|2468030|P7|Overall Study|Other|13
776014|NCT00603447|2468031|P6|Overall Study|Other|0
776015|NCT00603447|2468032|P5|Overall Study|Other|3
776016|NCT00603447|2468033|P4|Overall Study|Other|0
776017|NCT00603447|2468034|P3|Overall Study|Other|1
776018|NCT00603447|2468035|P2|Overall Study|Other|0
776019|NCT00603447|2468036|P1|Overall Study|Other|0
776020|NCT00603447|2468030|P7|Overall Study|Adverse Event|10
776021|NCT00603447|2468031|P6|Overall Study|Adverse Event|2
776022|NCT00603447|2468032|P5|Overall Study|Adverse Event|1
776023|NCT00603447|2468033|P4|Overall Study|Adverse Event|2
776024|NCT00603447|2468034|P3|Overall Study|Adverse Event|1
776025|NCT00603447|2468035|P2|Overall Study|Adverse Event|1
776026|NCT00603447|2468036|P1|Overall Study|Adverse Event|0
776027|NCT00603473|2468058|P1|Overall Study|Protocol Violation|1
776028|NCT00603473|2468058|P1|Overall Study|Lack of Efficacy|4
776029|NCT00603473|2468058|P1|Overall Study|Adverse Event|4
776030|NCT00603512|2468069|P5|Overall Study|Randomized but not treated|0
776031|NCT00603512|2468070|P4|Overall Study|Randomized but not treated|2
776032|NCT00603512|2468071|P3|Overall Study|Randomized but not treated|1
776033|NCT00603512|2468072|P2|Overall Study|Randomized but not treated|1
776034|NCT00603512|2468073|P1|Overall Study|Randomized but not treated|0
776035|NCT00603512|2468069|P5|Overall Study|Withdrawal by Subject|1
776036|NCT00603512|2468070|P4|Overall Study|Withdrawal by Subject|0
776037|NCT00603512|2468071|P3|Overall Study|Withdrawal by Subject|0
776038|NCT00603512|2468072|P2|Overall Study|Withdrawal by Subject|0
776039|NCT00603512|2468073|P1|Overall Study|Withdrawal by Subject|0
776040|NCT00603512|2468069|P5|Overall Study|Unspecified|1
776041|NCT00603512|2468070|P4|Overall Study|Unspecified|1
776042|NCT00603512|2468071|P3|Overall Study|Unspecified|0
776043|NCT00603512|2468072|P2|Overall Study|Unspecified|1
776044|NCT00603512|2468073|P1|Overall Study|Unspecified|2
776045|NCT00603512|2468069|P5|Overall Study|Lack of Efficacy|1
776046|NCT00603512|2468070|P4|Overall Study|Lack of Efficacy|0
776047|NCT00603512|2468071|P3|Overall Study|Lack of Efficacy|0
776048|NCT00603512|2468072|P2|Overall Study|Lack of Efficacy|1
776049|NCT00603512|2468073|P1|Overall Study|Lack of Efficacy|0
776050|NCT00603512|2468069|P5|Overall Study|Adverse Event|2
776051|NCT00603512|2468070|P4|Overall Study|Adverse Event|4
776052|NCT00603512|2468071|P3|Overall Study|Adverse Event|4
776053|NCT00603512|2468072|P2|Overall Study|Adverse Event|2
776054|NCT00603512|2468073|P1|Overall Study|Adverse Event|0
776055|NCT00603525|2468217|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
776056|NCT00603525|2468218|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
776057|NCT00603525|2468219|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
776058|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
776059|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
776060|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
776061|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
776062|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
776063|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
776064|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
776065|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
776066|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
776067|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
776068|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
776069|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
776070|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
776071|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
776072|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
776073|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
776074|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
776075|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
776076|NCT00603525|2468217|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
776077|NCT00603525|2468218|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
776078|NCT00603525|2468219|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
776079|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
776080|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
776081|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
776082|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
776083|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
776084|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
776085|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
776086|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
776087|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
776088|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
776089|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
776090|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
776091|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
776092|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
776093|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
776094|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
776095|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
776096|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
776097|NCT00603525|2468217|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
776098|NCT00603525|2468218|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
776099|NCT00603525|2468219|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
776100|NCT00603538|2468349|P3|Overall Study|Objective progression or relapse|0
776101|NCT00603538|2468350|P2|Overall Study|Objective progression or relapse|0
776102|NCT00603538|2468351|P1|Overall Study|Objective progression or relapse|3
776103|NCT00603538|2468349|P3|Overall Study|Adverse Event|2
776104|NCT00603538|2468350|P2|Overall Study|Adverse Event|4
776105|NCT00603538|2468351|P1|Overall Study|Adverse Event|0
776106|NCT00603590|2468402|P2|Overall Study|Cardiovascular event|1
776107|NCT00603590|2468403|P1|Overall Study|Cardiovascular event|0
776108|NCT00603590|2468402|P2|Overall Study|Lost to Follow-up|4
776109|NCT00603590|2468403|P1|Overall Study|Lost to Follow-up|8
776110|NCT00603590|2468402|P2|Overall Study|Adverse Event|0
776111|NCT00603590|2468403|P1|Overall Study|Adverse Event|2
776112|NCT00603590|2468402|P2|Overall Study|Patient discontinued study drug|15
776113|NCT00603590|2468403|P1|Overall Study|Patient discontinued study drug|22
776114|NCT00603590|2468402|P2|Overall Study|Refused blood test|1
776115|NCT00603590|2468403|P1|Overall Study|Refused blood test|5
776116|NCT00603590|2468402|P2|Overall Study|Did not attend study clinic|30
776117|NCT00603590|2468403|P1|Overall Study|Did not attend study clinic|39
776118|NCT00604162|2468461|P1|Overall Study|Withdrawal by Subject|1
776119|NCT00604162|2468461|P1|Overall Study|Physician Decision|3
891767|NCT01072149|2828535|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891768|NCT01072149|2828536|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891769|NCT01072149|2828537|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891770|NCT01072149|2828538|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891771|NCT01072149|2828539|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891772|NCT01072149|2828540|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891773|NCT01072149|2828541|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891774|NCT01072149|2828542|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891775|NCT01072149|2828543|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891776|NCT01072149|2828544|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891777|NCT01072149|2828545|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891778|NCT01072149|2828546|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891779|NCT01072149|2828547|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891780|NCT01072149|2828548|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891781|NCT01072149|2828549|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
891782|NCT01072149|2828532|P18|Washout Period 2 (14 Days)|Physician Decision|0
891783|NCT01072149|2828533|P17|Washout Period 2 (14 Days)|Physician Decision|0
891784|NCT01072149|2828534|P16|Washout Period 2 (14 Days)|Physician Decision|0
891785|NCT01072149|2828535|P15|Washout Period 2 (14 Days)|Physician Decision|0
891786|NCT01072149|2828536|P14|Washout Period 2 (14 Days)|Physician Decision|0
891787|NCT01072149|2828537|P13|Washout Period 2 (14 Days)|Physician Decision|0
891788|NCT01072149|2828538|P12|Washout Period 2 (14 Days)|Physician Decision|0
891789|NCT01072149|2828539|P11|Washout Period 2 (14 Days)|Physician Decision|0
891790|NCT01072149|2828540|P10|Washout Period 2 (14 Days)|Physician Decision|0
891791|NCT01072149|2828541|P9|Washout Period 2 (14 Days)|Physician Decision|0
776147|NCT00604188|2468532|P2|Overall Study|Did not receive study drug|1
776148|NCT00604188|2468533|P1|Overall Study|Did not receive study drug|0
776149|NCT00604188|2468532|P2|Overall Study|Non-compliance with protocol|4
776150|NCT00604188|2468533|P1|Overall Study|Non-compliance with protocol|4
776151|NCT00604188|2468532|P2|Overall Study|Withdrawal by Subject|1
776152|NCT00604188|2468533|P1|Overall Study|Withdrawal by Subject|5
776153|NCT00604188|2468532|P2|Overall Study|Lost to Follow-up|15
776154|NCT00604188|2468533|P1|Overall Study|Lost to Follow-up|17
776155|NCT00604188|2468532|P2|Overall Study|Adverse Event|4
776156|NCT00604188|2468533|P1|Overall Study|Adverse Event|1
776157|NCT00604214|2468555|P2|Day 91 to Day 180|Withdrawal by Subject|1
776158|NCT00604214|2468556|P1|Day 91 to Day 180|Withdrawal by Subject|1
776159|NCT00604214|2468555|P2|Day 91 to Day 180|Lost to Follow-up|8
776160|NCT00604214|2468556|P1|Day 91 to Day 180|Lost to Follow-up|6
776161|NCT00604214|2468555|P2|Day 91 to Day 180|Death|23
776162|NCT00604214|2468556|P1|Day 91 to Day 180|Death|19
776163|NCT00604214|2468555|P2|Day 29 to Day 90|Withdrawal by Subject|6
776164|NCT00604214|2468556|P1|Day 29 to Day 90|Withdrawal by Subject|0
776165|NCT00604214|2468555|P2|Day 29 to Day 90|Lost to Follow-up|6
776166|NCT00604214|2468556|P1|Day 29 to Day 90|Lost to Follow-up|4
776167|NCT00604214|2468555|P2|Day 29 to Day 90|Death|67
776168|NCT00604214|2468556|P1|Day 29 to Day 90|Death|64
776169|NCT00604214|2468555|P2|Baseline to Day 28|Withdrawal by Subject|7
776170|NCT00604214|2468556|P1|Baseline to Day 28|Withdrawal by Subject|3
776171|NCT00604214|2468555|P2|Baseline to Day 28|Lost to Follow-up|4
776172|NCT00604214|2468556|P1|Baseline to Day 28|Lost to Follow-up|2
776173|NCT00604214|2468555|P2|Baseline to Day 28|Death|202
776174|NCT00604214|2468556|P1|Baseline to Day 28|Death|223
776175|NCT00604279|2468588|P2|Overall Study|unspecified|4
776176|NCT00604279|2468589|P1|Overall Study|unspecified|8
776177|NCT00604279|2468588|P2|Overall Study|Adverse Event|5
776178|NCT00604279|2468589|P1|Overall Study|Adverse Event|4
776179|NCT00604279|2468588|P2|Overall Study|Withdrawal by Subject|5
776180|NCT00604279|2468589|P1|Overall Study|Withdrawal by Subject|16
776181|NCT00604279|2468588|P2|Overall Study|Protocol Violation|1
776182|NCT00604279|2468589|P1|Overall Study|Protocol Violation|3
776183|NCT00604279|2468588|P2|Overall Study|Pregnancy|0
776184|NCT00604279|2468589|P1|Overall Study|Pregnancy|2
776185|NCT00604279|2468588|P2|Overall Study|Lost to Follow-up|14
776186|NCT00604279|2468589|P1|Overall Study|Lost to Follow-up|9
776187|NCT00604279|2468588|P2|Overall Study|Lack of Efficacy|9
776188|NCT00604279|2468589|P1|Overall Study|Lack of Efficacy|22
776189|NCT00604383|2468605|P2|Overall Study|Physician Decision|3
776190|NCT00604383|2468606|P1|Overall Study|Physician Decision|0
776191|NCT00604383|2468605|P2|Overall Study|Adverse Event|9
776192|NCT00604383|2468606|P1|Overall Study|Adverse Event|16
776193|NCT00604383|2468605|P2|Overall Study|Death|22
776194|NCT00604383|2468606|P1|Overall Study|Death|14
776195|NCT00604383|2468605|P2|Overall Study|Lost to Follow-up|19
776196|NCT00604383|2468606|P1|Overall Study|Lost to Follow-up|24
776197|NCT00604383|2468605|P2|Overall Study|Withdrawal by Subject|31
776198|NCT00604383|2468606|P1|Overall Study|Withdrawal by Subject|33
776199|NCT00604500|2468625|P1|Overall Study|Did not meet protocol eligibility|1
776200|NCT00604500|2468625|P1|Overall Study|Administrative|1
776201|NCT00604500|2468625|P1|Overall Study|Withdrawal by Subject|4
776202|NCT00604500|2468625|P1|Overall Study|Treatment Failure|1
776203|NCT00604500|2468625|P1|Overall Study|Protocol Violation|2
776204|NCT00604500|2468625|P1|Overall Study|Adverse Event|2
776205|NCT00604565|2468643|P2|Overall Study|Study terminated|3
776206|NCT00604565|2468644|P1|Overall Study|Study terminated|0
776207|NCT00604669|2468652|P1|Overall Study|lack of information in chart|7
776208|NCT00604695|2468658|P2|Overall Study|Did not receive first bolus.|4
776209|NCT00604695|2468659|P1|Overall Study|Did not receive first bolus.|0
776210|NCT00604708|2468683|P2|Overall Study|Adverse Event|6
776211|NCT00604708|2468684|P1|Overall Study|Adverse Event|6
776212|NCT00604708|2468683|P2|Overall Study|administrative reasons|11
776213|NCT00604708|2468684|P1|Overall Study|administrative reasons|9
776214|NCT00604708|2468683|P2|Overall Study|Lost to Follow-up|5
776215|NCT00604708|2468684|P1|Overall Study|Lost to Follow-up|5
776216|NCT00604708|2468683|P2|Overall Study|Protocol Violation|8
776217|NCT00604708|2468684|P1|Overall Study|Protocol Violation|2
776218|NCT00604708|2468683|P2|Overall Study|Withdrawal by Subject|10
776219|NCT00604708|2468684|P1|Overall Study|Withdrawal by Subject|9
776220|NCT00604721|2468692|P1|Overall Study|Withdrawal by Subject|1
776221|NCT00604721|2468692|P1|Overall Study|Physician Decision|1
776222|NCT00604786|2468700|P2|Overall Study|Lost to Follow-up|0
776223|NCT00604786|2468701|P1|Overall Study|Lost to Follow-up|2
776224|NCT00604825|2468739|P4|Overall Study|Exclusion criterion met|1
776225|NCT00604825|2468740|P3|Overall Study|Exclusion criterion met|0
776226|NCT00604825|2468741|P2|Overall Study|Exclusion criterion met|0
776227|NCT00604825|2468742|P1|Overall Study|Exclusion criterion met|0
776228|NCT00604825|2468739|P4|Overall Study|Physician Decision|1
776229|NCT00604825|2468740|P3|Overall Study|Physician Decision|0
776230|NCT00604825|2468741|P2|Overall Study|Physician Decision|0
776231|NCT00604825|2468742|P1|Overall Study|Physician Decision|0
776232|NCT00604825|2468739|P4|Overall Study|Did not meet eligibility criteria|0
776233|NCT00604825|2468740|P3|Overall Study|Did not meet eligibility criteria|2
776234|NCT00604825|2468741|P2|Overall Study|Did not meet eligibility criteria|0
776235|NCT00604825|2468742|P1|Overall Study|Did not meet eligibility criteria|0
776236|NCT00604825|2468739|P4|Overall Study|Lack of Efficacy|0
776237|NCT00604825|2468740|P3|Overall Study|Lack of Efficacy|1
776238|NCT00604825|2468741|P2|Overall Study|Lack of Efficacy|2
776239|NCT00604825|2468742|P1|Overall Study|Lack of Efficacy|3
776240|NCT00604825|2468739|P4|Overall Study|Withdrawal by Subject|5
776241|NCT00604825|2468740|P3|Overall Study|Withdrawal by Subject|5
776242|NCT00604825|2468741|P2|Overall Study|Withdrawal by Subject|3
776243|NCT00604825|2468742|P1|Overall Study|Withdrawal by Subject|4
776244|NCT00604825|2468739|P4|Overall Study|Protocol Violation|0
776245|NCT00604825|2468740|P3|Overall Study|Protocol Violation|0
776246|NCT00604825|2468741|P2|Overall Study|Protocol Violation|1
776247|NCT00604825|2468742|P1|Overall Study|Protocol Violation|0
776248|NCT00604825|2468739|P4|Overall Study|Lost to Follow-up|0
776249|NCT00604825|2468740|P3|Overall Study|Lost to Follow-up|1
776250|NCT00604825|2468741|P2|Overall Study|Lost to Follow-up|3
776251|NCT00604825|2468742|P1|Overall Study|Lost to Follow-up|0
776252|NCT00604825|2468739|P4|Overall Study|Adverse Event|4
776253|NCT00604825|2468740|P3|Overall Study|Adverse Event|7
776254|NCT00604825|2468741|P2|Overall Study|Adverse Event|6
776255|NCT00604825|2468742|P1|Overall Study|Adverse Event|2
776256|NCT00605033|2468964|P2|Overall Study|Protocol Violation|1
776257|NCT00605033|2468965|P1|Overall Study|Protocol Violation|1
776258|NCT00605033|2468964|P2|Overall Study|Withdrawal by Subject|4
776259|NCT00605033|2468965|P1|Overall Study|Withdrawal by Subject|3
776260|NCT00605033|2468964|P2|Overall Study|Lost to Follow-up|1
776261|NCT00605033|2468965|P1|Overall Study|Lost to Follow-up|1
776262|NCT00605033|2468964|P2|Overall Study|Adverse Event|2
776263|NCT00605033|2468965|P1|Overall Study|Adverse Event|2
776264|NCT00605085|2468998|P2|Overall Study|administrative reasons|8
776265|NCT00605085|2468999|P1|Overall Study|administrative reasons|18
776266|NCT00605085|2468998|P2|Overall Study|Lost to Follow-up|5
776267|NCT00605085|2468999|P1|Overall Study|Lost to Follow-up|10
776268|NCT00605085|2468998|P2|Overall Study|Protocol Violation|2
776269|NCT00605085|2468999|P1|Overall Study|Protocol Violation|3
776270|NCT00605085|2468998|P2|Overall Study|Pregnancy|0
776271|NCT00605085|2468999|P1|Overall Study|Pregnancy|2
776272|NCT00605085|2468998|P2|Overall Study|Adverse Event|5
776273|NCT00605085|2468999|P1|Overall Study|Adverse Event|9
776274|NCT00605085|2468998|P2|Overall Study|Withdrawal by Subject|5
776275|NCT00605085|2468999|P1|Overall Study|Withdrawal by Subject|8
776276|NCT00605176|2469012|P3|Overall Study|Other (not due to AE)|0
776277|NCT00605176|2469013|P2|Overall Study|Other (not due to AE)|1
776278|NCT00605176|2469014|P1|Overall Study|Other (not due to AE)|1
776279|NCT00605176|2469012|P3|Overall Study|Use of concomitant therapy|1
776280|NCT00605176|2469013|P2|Overall Study|Use of concomitant therapy|0
776281|NCT00605176|2469014|P1|Overall Study|Use of concomitant therapy|1
776282|NCT00605176|2469012|P3|Overall Study|Non-complicance with study procedures|0
776283|NCT00605176|2469013|P2|Overall Study|Non-complicance with study procedures|0
776284|NCT00605176|2469014|P1|Overall Study|Non-complicance with study procedures|1
776285|NCT00605176|2469012|P3|Overall Study|Lost to Follow-up|1
776286|NCT00605176|2469013|P2|Overall Study|Lost to Follow-up|2
776287|NCT00605176|2469014|P1|Overall Study|Lost to Follow-up|2
776288|NCT00605176|2469012|P3|Overall Study|Withdrawal by Subject|4
776289|NCT00605176|2469013|P2|Overall Study|Withdrawal by Subject|2
776290|NCT00605176|2469014|P1|Overall Study|Withdrawal by Subject|4
776291|NCT00605176|2469012|P3|Overall Study|Adverse Event|3
776292|NCT00605176|2469013|P2|Overall Study|Adverse Event|1
776293|NCT00605176|2469014|P1|Overall Study|Adverse Event|2
776294|NCT00605267|2469040|P2|Overall Study|Withdrawal by Subject|3
776295|NCT00605267|2469041|P1|Overall Study|Withdrawal by Subject|2
776296|NCT00605267|2469040|P2|Overall Study|Lack of Efficacy|5
776297|NCT00605267|2469041|P1|Overall Study|Lack of Efficacy|1
776298|NCT00605267|2469040|P2|Overall Study|Adverse Event|1
776299|NCT00605267|2469041|P1|Overall Study|Adverse Event|0
776300|NCT00605280|2469083|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
776301|NCT00605280|2469084|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
776302|NCT00605280|2469085|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
776303|NCT00605280|2469086|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
776304|NCT00605280|2469083|P4|Year 3 Extension|Unspecified|0
776305|NCT00605280|2469084|P3|Year 3 Extension|Unspecified|0
776306|NCT00605280|2469085|P2|Year 3 Extension|Unspecified|0
776307|NCT00605280|2469086|P1|Year 3 Extension|Unspecified|2
776308|NCT00605280|2469083|P4|Year 3 Extension|Withdrawal by Subject|5
776309|NCT00605280|2469084|P3|Year 3 Extension|Withdrawal by Subject|0
776310|NCT00605280|2469085|P2|Year 3 Extension|Withdrawal by Subject|0
776311|NCT00605280|2469086|P1|Year 3 Extension|Withdrawal by Subject|2
776312|NCT00605280|2469083|P4|Year 3 Extension|Physician Decision|2
776313|NCT00605280|2469084|P3|Year 3 Extension|Physician Decision|0
776314|NCT00605280|2469085|P2|Year 3 Extension|Physician Decision|0
776315|NCT00605280|2469086|P1|Year 3 Extension|Physician Decision|0
776316|NCT00605280|2469083|P4|Year 3 Extension|Adverse Event|2
776317|NCT00605280|2469084|P3|Year 3 Extension|Adverse Event|0
776318|NCT00605280|2469085|P2|Year 3 Extension|Adverse Event|0
776319|NCT00605280|2469086|P1|Year 3 Extension|Adverse Event|2
776320|NCT00605280|2469083|P4|Year 2|Lost to Follow-up or Patient non-comply|2
776321|NCT00605280|2469084|P3|Year 2|Lost to Follow-up or Patient non-comply|0
776322|NCT00605280|2469085|P2|Year 2|Lost to Follow-up or Patient non-comply|0
776323|NCT00605280|2469086|P1|Year 2|Lost to Follow-up or Patient non-comply|4
776324|NCT00605280|2469083|P4|Year 2|Unspecified|1
776325|NCT00605280|2469084|P3|Year 2|Unspecified|0
776326|NCT00605280|2469085|P2|Year 2|Unspecified|0
776327|NCT00605280|2469086|P1|Year 2|Unspecified|1
776328|NCT00605280|2469083|P4|Year 2|Withdrawal by Subject|4
776329|NCT00605280|2469084|P3|Year 2|Withdrawal by Subject|0
776330|NCT00605280|2469085|P2|Year 2|Withdrawal by Subject|0
776331|NCT00605280|2469086|P1|Year 2|Withdrawal by Subject|4
776332|NCT00605280|2469083|P4|Year 2|Physician Decision|11
776333|NCT00605280|2469084|P3|Year 2|Physician Decision|4
776334|NCT00605280|2469085|P2|Year 2|Physician Decision|6
776335|NCT00605280|2469086|P1|Year 2|Physician Decision|11
776336|NCT00605280|2469083|P4|Year 2|Adverse Event|4
776337|NCT00605280|2469084|P3|Year 2|Adverse Event|2
776338|NCT00605280|2469085|P2|Year 2|Adverse Event|0
776339|NCT00605280|2469086|P1|Year 2|Adverse Event|4
776340|NCT00605280|2469083|P4|Year 1|Lost to Follow-up or Patient non-comply|2
776341|NCT00605280|2469084|P3|Year 1|Lost to Follow-up or Patient non-comply|0
776342|NCT00605280|2469085|P2|Year 1|Lost to Follow-up or Patient non-comply|1
776343|NCT00605280|2469086|P1|Year 1|Lost to Follow-up or Patient non-comply|5
776344|NCT00605280|2469083|P4|Year 1|Unspecified|1
776345|NCT00605280|2469084|P3|Year 1|Unspecified|0
776346|NCT00605280|2469085|P2|Year 1|Unspecified|1
776347|NCT00605280|2469086|P1|Year 1|Unspecified|2
776348|NCT00605280|2469083|P4|Year 1|Withdrawal by Subject|4
776349|NCT00605280|2469084|P3|Year 1|Withdrawal by Subject|0
776350|NCT00605280|2469085|P2|Year 1|Withdrawal by Subject|4
776351|NCT00605280|2469086|P1|Year 1|Withdrawal by Subject|2
776352|NCT00605280|2469083|P4|Year 1|Physician Decision|6
776353|NCT00605280|2469084|P3|Year 1|Physician Decision|0
776354|NCT00605280|2469085|P2|Year 1|Physician Decision|4
776355|NCT00605280|2469086|P1|Year 1|Physician Decision|7
776356|NCT00605280|2469083|P4|Year 1|Adverse Event|5
776357|NCT00605280|2469084|P3|Year 1|Adverse Event|1
776358|NCT00605280|2469085|P2|Year 1|Adverse Event|1
776359|NCT00605280|2469086|P1|Year 1|Adverse Event|3
776360|NCT00605280|2469083|P4|Year 1|Protocol Violation|1
776361|NCT00605280|2469084|P3|Year 1|Protocol Violation|0
776362|NCT00605280|2469085|P2|Year 1|Protocol Violation|0
776363|NCT00605280|2469086|P1|Year 1|Protocol Violation|0
776364|NCT00605293|2469120|P2|Overall Study|Principal Investigator Decision|1
776365|NCT00605293|2469121|P1|Overall Study|Principal Investigator Decision|0
776366|NCT00605293|2469120|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
776367|NCT00605293|2469121|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
776368|NCT00605293|2469120|P2|Overall Study|Incorrect Epoetin Beta Administration|0
776369|NCT00605293|2469121|P1|Overall Study|Incorrect Epoetin Beta Administration|1
776370|NCT00605293|2469120|P2|Overall Study|Renal Transplantation|1
776371|NCT00605293|2469121|P1|Overall Study|Renal Transplantation|3
776372|NCT00605293|2469120|P2|Overall Study|Blood Transfusion|1
776373|NCT00605293|2469121|P1|Overall Study|Blood Transfusion|7
776374|NCT00605293|2469120|P2|Overall Study|Holidays Dialysis Out|0
776375|NCT00605293|2469121|P1|Overall Study|Holidays Dialysis Out|1
776376|NCT00605293|2469120|P2|Overall Study|Adverse Event|0
776377|NCT00605293|2469121|P1|Overall Study|Adverse Event|1
776378|NCT00605293|2469120|P2|Overall Study|Insufficient Therapeutic Response|0
776379|NCT00605293|2469121|P1|Overall Study|Insufficient Therapeutic Response|2
776380|NCT00605293|2469120|P2|Overall Study|Death|1
776381|NCT00605293|2469121|P1|Overall Study|Death|2
776382|NCT00605306|2469139|P2|Overall Study|Adverse Event|1
776383|NCT00605306|2469140|P1|Overall Study|Adverse Event|0
776384|NCT00605345|2469154|P2|Overall Study|Protocol Violation|2
776385|NCT00605345|2469155|P1|Overall Study|Protocol Violation|0
776386|NCT00605345|2469154|P2|Overall Study|Adverse Event|1
776387|NCT00605345|2469155|P1|Overall Study|Adverse Event|0
776388|NCT00605345|2469154|P2|Overall Study|Withdrawal by Subject|0
776389|NCT00605345|2469155|P1|Overall Study|Withdrawal by Subject|1
776390|NCT00605475|2469234|P10|Overall Study|Withdrawal by Subject|1
776391|NCT00605475|2469235|P9|Overall Study|Withdrawal by Subject|0
776392|NCT00605475|2469236|P8|Overall Study|Withdrawal by Subject|0
776393|NCT00605475|2469237|P7|Overall Study|Withdrawal by Subject|0
776394|NCT00605475|2469238|P6|Overall Study|Withdrawal by Subject|2
776395|NCT00605475|2469239|P5|Overall Study|Withdrawal by Subject|0
776396|NCT00605475|2469240|P4|Overall Study|Withdrawal by Subject|0
776397|NCT00605475|2469241|P3|Overall Study|Withdrawal by Subject|0
776398|NCT00605475|2469242|P2|Overall Study|Withdrawal by Subject|0
776399|NCT00605475|2469243|P1|Overall Study|Withdrawal by Subject|0
776400|NCT00605475|2469234|P10|Overall Study|Protocol Violation|0
776401|NCT00605475|2469235|P9|Overall Study|Protocol Violation|0
776402|NCT00605475|2469236|P8|Overall Study|Protocol Violation|0
776403|NCT00605475|2469237|P7|Overall Study|Protocol Violation|0
776404|NCT00605475|2469238|P6|Overall Study|Protocol Violation|0
776405|NCT00605475|2469239|P5|Overall Study|Protocol Violation|1
776406|NCT00605475|2469240|P4|Overall Study|Protocol Violation|0
776407|NCT00605475|2469241|P3|Overall Study|Protocol Violation|0
776408|NCT00605475|2469242|P2|Overall Study|Protocol Violation|0
776409|NCT00605475|2469243|P1|Overall Study|Protocol Violation|0
776410|NCT00605475|2469234|P10|Overall Study|Lost to Follow-up|1
776411|NCT00605475|2469235|P9|Overall Study|Lost to Follow-up|1
776412|NCT00605475|2469236|P8|Overall Study|Lost to Follow-up|0
776413|NCT00605475|2469237|P7|Overall Study|Lost to Follow-up|0
776414|NCT00605475|2469238|P6|Overall Study|Lost to Follow-up|0
776415|NCT00605475|2469239|P5|Overall Study|Lost to Follow-up|0
776416|NCT00605475|2469240|P4|Overall Study|Lost to Follow-up|0
776417|NCT00605475|2469241|P3|Overall Study|Lost to Follow-up|0
776418|NCT00605475|2469242|P2|Overall Study|Lost to Follow-up|0
776419|NCT00605475|2469243|P1|Overall Study|Lost to Follow-up|0
776420|NCT00605475|2469234|P10|Overall Study|Administrative problems|0
776421|NCT00605475|2469235|P9|Overall Study|Administrative problems|0
776422|NCT00605475|2469236|P8|Overall Study|Administrative problems|0
776423|NCT00605475|2469237|P7|Overall Study|Administrative problems|1
776424|NCT00605475|2469238|P6|Overall Study|Administrative problems|0
776425|NCT00605475|2469239|P5|Overall Study|Administrative problems|0
776426|NCT00605475|2469240|P4|Overall Study|Administrative problems|0
776427|NCT00605475|2469241|P3|Overall Study|Administrative problems|0
776428|NCT00605475|2469242|P2|Overall Study|Administrative problems|0
776429|NCT00605475|2469243|P1|Overall Study|Administrative problems|0
776430|NCT00605475|2469234|P10|Overall Study|Abnormal Laboratory Values|0
776431|NCT00605475|2469235|P9|Overall Study|Abnormal Laboratory Values|1
776432|NCT00605475|2469236|P8|Overall Study|Abnormal Laboratory Values|0
776433|NCT00605475|2469237|P7|Overall Study|Abnormal Laboratory Values|0
776434|NCT00605475|2469238|P6|Overall Study|Abnormal Laboratory Values|0
776435|NCT00605475|2469239|P5|Overall Study|Abnormal Laboratory Values|0
776436|NCT00605475|2469240|P4|Overall Study|Abnormal Laboratory Values|0
776437|NCT00605475|2469241|P3|Overall Study|Abnormal Laboratory Values|0
776438|NCT00605475|2469242|P2|Overall Study|Abnormal Laboratory Values|0
776439|NCT00605475|2469243|P1|Overall Study|Abnormal Laboratory Values|0
776440|NCT00605540|2469365|P1|Overall Study|Lost to Follow-up|23
776441|NCT00605540|2469365|P1|Overall Study|Death|15
776442|NCT00605657|2469373|P1|Overall Study|Protocol Violation|1
776443|NCT00605657|2469373|P1|Overall Study|Adverse Event|1
776444|NCT00605722|2469389|P1|Overall Study|Failure to return|1
776445|NCT00605722|2469389|P1|Overall Study|Insufficient therapeutic response|44
776446|NCT00605722|2469389|P1|Overall Study|Adverse Event|6
776447|NCT00605813|2469399|P1|Overall Study|Protocol Violation|25
891792|NCT01072149|2828542|P8|Washout Period 2 (14 Days)|Physician Decision|0
891793|NCT01072149|2828543|P7|Washout Period 2 (14 Days)|Physician Decision|0
776451|NCT00605865|2469425|P1|Overall Study|Protocol Violation|115
776452|NCT00605917|2469477|P1|Overall Study|Protocol Violation|79
776453|NCT00606008|2469516|P1|Overall Study|Withdrawal by Subject|4
776454|NCT00606008|2469516|P1|Overall Study|Adverse Event|1
776455|NCT00606021|2469532|P3|Maintenance Phase|Lost to Follow-up|2
776456|NCT00606021|2469533|P2|Maintenance Phase|Lost to Follow-up|5
776457|NCT00606021|2469534|P1|Maintenance Phase|Lost to Follow-up|0
776458|NCT00606021|2469532|P3|Maintenance Phase|Physician Decision|0
776459|NCT00606021|2469533|P2|Maintenance Phase|Physician Decision|1
776460|NCT00606021|2469534|P1|Maintenance Phase|Physician Decision|0
776461|NCT00606021|2469532|P3|Maintenance Phase|Death|15
776462|NCT00606021|2469533|P2|Maintenance Phase|Death|17
776463|NCT00606021|2469534|P1|Maintenance Phase|Death|0
776464|NCT00606021|2469532|P3|Induction Phase|Lost to Follow-up|0
776465|NCT00606021|2469533|P2|Induction Phase|Lost to Follow-up|0
776466|NCT00606021|2469534|P1|Induction Phase|Lost to Follow-up|10
776467|NCT00606021|2469532|P3|Induction Phase|Withdrawal by Subject|0
776468|NCT00606021|2469533|P2|Induction Phase|Withdrawal by Subject|0
776469|NCT00606021|2469534|P1|Induction Phase|Withdrawal by Subject|2
776470|NCT00606021|2469532|P3|Induction Phase|Physician Decision|0
776471|NCT00606021|2469533|P2|Induction Phase|Physician Decision|0
776472|NCT00606021|2469534|P1|Induction Phase|Physician Decision|2
776473|NCT00606021|2469532|P3|Induction Phase|Death|0
776474|NCT00606021|2469533|P2|Induction Phase|Death|0
776475|NCT00606021|2469534|P1|Induction Phase|Death|73
776476|NCT00606034|2469552|P1|Overall Study|incarceration|1
776477|NCT00606086|2469560|P2|Overall Study|Randomized, not treated|2
776478|NCT00606086|2469561|P1|Overall Study|Randomized, not treated|1
776479|NCT00606086|2469560|P2|Overall Study|Non-compliance|1
776480|NCT00606086|2469561|P1|Overall Study|Non-compliance|0
776481|NCT00606086|2469560|P2|Overall Study|Withdrawal by Subject|3
776482|NCT00606086|2469561|P1|Overall Study|Withdrawal by Subject|5
776483|NCT00606086|2469560|P2|Overall Study|Protocol Violation|0
776484|NCT00606086|2469561|P1|Overall Study|Protocol Violation|1
776485|NCT00606086|2469560|P2|Overall Study|Lost to Follow-up|8
776486|NCT00606086|2469561|P1|Overall Study|Lost to Follow-up|4
776487|NCT00606086|2469560|P2|Overall Study|Adverse Event|1
776488|NCT00606086|2469561|P1|Overall Study|Adverse Event|1
776489|NCT00606177|2469586|P2|Overall Study|Change of residence or other commitments|1
776490|NCT00606177|2469587|P1|Overall Study|Change of residence or other commitments|1
776491|NCT00606177|2469586|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
776492|NCT00606177|2469587|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
776493|NCT00606177|2469586|P2|Overall Study|Progression to depressive phase|1
776494|NCT00606177|2469587|P1|Overall Study|Progression to depressive phase|6
776495|NCT00606177|2469586|P2|Overall Study|Withdrawal by Subject|6
776496|NCT00606177|2469587|P1|Overall Study|Withdrawal by Subject|5
776497|NCT00606177|2469586|P2|Overall Study|Protocol Violation|4
776498|NCT00606177|2469587|P1|Overall Study|Protocol Violation|1
776499|NCT00606177|2469586|P2|Overall Study|Physician Decision|0
776500|NCT00606177|2469587|P1|Overall Study|Physician Decision|1
776501|NCT00606177|2469586|P2|Overall Study|Lack of Efficacy|7
776502|NCT00606177|2469587|P1|Overall Study|Lack of Efficacy|3
776503|NCT00606177|2469586|P2|Overall Study|Adverse Event|5
776504|NCT00606177|2469587|P1|Overall Study|Adverse Event|9
776505|NCT00606229|2469595|P1|Overall Study|change of residence or other commitments|2
776506|NCT00606229|2469595|P1|Overall Study|does not meet inclusion criterion 1-3|4
776507|NCT00606229|2469595|P1|Overall Study|Withdrawal by Subject|4
776508|NCT00606229|2469595|P1|Overall Study|Lack of Efficacy|1
776509|NCT00606229|2469595|P1|Overall Study|Adverse Event|11
776510|NCT00606281|2469602|P2|Overall Study|Change of residence or other commitments|1
776511|NCT00606281|2469603|P1|Overall Study|Change of residence or other commitments|1
776512|NCT00606281|2469602|P2|Overall Study|Progression to depressive phase|1
776513|NCT00606281|2469603|P1|Overall Study|Progression to depressive phase|1
776514|NCT00606281|2469602|P2|Overall Study|Withdrawal by Subject|13
776515|NCT00606281|2469603|P1|Overall Study|Withdrawal by Subject|11
776516|NCT00606281|2469602|P2|Overall Study|Protocol Violation|3
776517|NCT00606281|2469603|P1|Overall Study|Protocol Violation|3
776518|NCT00606281|2469602|P2|Overall Study|Physician Decision|1
776519|NCT00606281|2469603|P1|Overall Study|Physician Decision|0
776520|NCT00606281|2469602|P2|Overall Study|Lack of Efficacy|35
776521|NCT00606281|2469603|P1|Overall Study|Lack of Efficacy|28
776522|NCT00606281|2469602|P2|Overall Study|Death|0
776523|NCT00606281|2469603|P1|Overall Study|Death|1
776524|NCT00606281|2469602|P2|Overall Study|Adverse Event|12
776525|NCT00606281|2469603|P1|Overall Study|Adverse Event|11
776526|NCT00606320|2469611|P1|Overall Study|Progression to depressive phase|4
776527|NCT00606320|2469611|P1|Overall Study|Withdrawal by Subject|10
776528|NCT00606320|2469611|P1|Overall Study|Protocol Violation|8
776529|NCT00606320|2469611|P1|Overall Study|Physician Decision|7
776530|NCT00606320|2469611|P1|Overall Study|Lack of Efficacy|5
776531|NCT00606320|2469611|P1|Overall Study|Adverse Event|3
776532|NCT00589121|2469627|P2|Overall Study|No protocol treatment received|1
776533|NCT00589121|2469628|P1|Overall Study|No protocol treatment received|0
776534|NCT00589121|2469627|P2|Overall Study|Protocol Violation|6
776535|NCT00589121|2469628|P1|Overall Study|Protocol Violation|2
776536|NCT00589290|2469658|P1|Overall Study|Withdrawal by Subject|1
776537|NCT00589303|2469668|P2|Overall Study|Withdrawal by Subject|1
776538|NCT00589303|2469669|P1|Overall Study|Withdrawal by Subject|2
776539|NCT00594854|2469677|P2|Overall Study|Study terminated|10
776540|NCT00594854|2469678|P1|Overall Study|Study terminated|7
776541|NCT00594880|2469690|P2|Overall Study|Lost to Follow-up|0
776542|NCT00594880|2469691|P1|Overall Study|Lost to Follow-up|1
776543|NCT00594880|2469690|P2|Overall Study|Withdrawal by Subject|1
776544|NCT00594880|2469691|P1|Overall Study|Withdrawal by Subject|1
776545|NCT00594906|2469703|P2|Overall Study|Death|1
776546|NCT00594906|2469704|P1|Overall Study|Death|0
776547|NCT00594906|2469703|P2|Overall Study|Physician Decision|1
776548|NCT00594906|2469704|P1|Overall Study|Physician Decision|0
776549|NCT00594906|2469703|P2|Overall Study|Physician Decision|0
776550|NCT00594906|2469704|P1|Overall Study|Physician Decision|1
776551|NCT00600613|2469721|P1|Overall Study|Protocol Deviation|1
776552|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
776553|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
776554|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
776555|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
776556|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
776557|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
776558|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
776559|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
776560|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
776561|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
776562|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
776563|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
776564|NCT00600756|2469770|P2|Overall Study Analysis After 12 Months|Adverse Event|44
776565|NCT00600756|2469771|P1|Overall Study Analysis After 12 Months|Adverse Event|53
776566|NCT00600756|2469770|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
776567|NCT00600756|2469771|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
776568|NCT00600756|2469770|P2|Analysis After 6 Months|Lost to Follow-up|8
776569|NCT00600756|2469771|P1|Analysis After 6 Months|Lost to Follow-up|10
776570|NCT00600756|2469770|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
776571|NCT00600756|2469771|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
776572|NCT00600756|2469770|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
776573|NCT00600756|2469771|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
776574|NCT00600756|2469770|P2|Analysis After 6 Months|Incorrect Enrollment|21
776575|NCT00600756|2469771|P1|Analysis After 6 Months|Incorrect Enrollment|12
776576|NCT00600756|2469770|P2|Analysis After 6 Months|Withdrawal by Subject|30
776577|NCT00600756|2469771|P1|Analysis After 6 Months|Withdrawal by Subject|38
776578|NCT00600756|2469770|P2|Analysis After 6 Months|Adverse Event|33
776579|NCT00600756|2469771|P1|Analysis After 6 Months|Adverse Event|43
776580|NCT00606502|2469839|P2|Treatment|Treatment ongoing at time of data cutoff|3
776581|NCT00606502|2469840|P1|Treatment|Treatment ongoing at time of data cutoff|0
776582|NCT00606502|2469839|P2|Randomization|Randomized but not treated|0
776583|NCT00606502|2469840|P1|Randomization|Randomized but not treated|3
776584|NCT00606580|2469868|P3|Overall Study|Withdrawal by Subject|0
776585|NCT00606580|2469869|P2|Overall Study|Withdrawal by Subject|1
776586|NCT00606580|2469870|P1|Overall Study|Withdrawal by Subject|0
776587|NCT00606580|2469868|P3|Overall Study|Withdrawal by investigator|6
776588|NCT00606580|2469869|P2|Overall Study|Withdrawal by investigator|1
776589|NCT00606580|2469870|P1|Overall Study|Withdrawal by investigator|0
776590|NCT00606580|2469868|P3|Overall Study|Clinical failures|12
776591|NCT00606580|2469869|P2|Overall Study|Clinical failures|0
776592|NCT00606580|2469870|P1|Overall Study|Clinical failures|1
776593|NCT00606580|2469868|P3|Overall Study|Lost to Follow-up|4
776594|NCT00606580|2469869|P2|Overall Study|Lost to Follow-up|1
776595|NCT00606580|2469870|P1|Overall Study|Lost to Follow-up|1
776596|NCT00606593|2469911|P10|Overall Study|Administrative/Other|0
776597|NCT00606593|2469912|P9|Overall Study|Administrative/Other|0
776598|NCT00606593|2469913|P8|Overall Study|Administrative/Other|0
776599|NCT00606593|2469914|P7|Overall Study|Administrative/Other|0
776600|NCT00606593|2469915|P6|Overall Study|Administrative/Other|0
776601|NCT00606593|2469916|P5|Overall Study|Administrative/Other|0
776602|NCT00606593|2469917|P4|Overall Study|Administrative/Other|0
776603|NCT00606593|2469918|P3|Overall Study|Administrative/Other|1
776604|NCT00606593|2469919|P2|Overall Study|Administrative/Other|0
776605|NCT00606593|2469920|P1|Overall Study|Administrative/Other|0
776606|NCT00606593|2469911|P10|Overall Study|Withdrawal of consent|0
776607|NCT00606593|2469912|P9|Overall Study|Withdrawal of consent|0
776608|NCT00606593|2469913|P8|Overall Study|Withdrawal of consent|0
776609|NCT00606593|2469914|P7|Overall Study|Withdrawal of consent|0
776610|NCT00606593|2469915|P6|Overall Study|Withdrawal of consent|0
776611|NCT00606593|2469916|P5|Overall Study|Withdrawal of consent|0
776612|NCT00606593|2469917|P4|Overall Study|Withdrawal of consent|0
776613|NCT00606593|2469918|P3|Overall Study|Withdrawal of consent|1
776614|NCT00606593|2469919|P2|Overall Study|Withdrawal of consent|0
776615|NCT00606593|2469920|P1|Overall Study|Withdrawal of consent|1
776616|NCT00606593|2469911|P10|Overall Study|Adverse Event|0
776617|NCT00606593|2469912|P9|Overall Study|Adverse Event|1
776618|NCT00606593|2469913|P8|Overall Study|Adverse Event|2
776619|NCT00606593|2469914|P7|Overall Study|Adverse Event|1
776620|NCT00606593|2469915|P6|Overall Study|Adverse Event|0
776621|NCT00606593|2469916|P5|Overall Study|Adverse Event|1
776622|NCT00606593|2469917|P4|Overall Study|Adverse Event|1
776623|NCT00606593|2469918|P3|Overall Study|Adverse Event|0
776624|NCT00606593|2469919|P2|Overall Study|Adverse Event|0
776625|NCT00606593|2469920|P1|Overall Study|Adverse Event|0
776626|NCT00606632|2469938|P1|Overall Study|Miscellaneous reasons|9
776627|NCT00606632|2469938|P1|Overall Study|Withdrawal by Subject|13
776628|NCT00606684|2469951|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
776629|NCT00606684|2469952|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
776630|NCT00606684|2469953|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
776631|NCT00606684|2469954|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
776632|NCT00606684|2469955|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
776633|NCT00606684|2469956|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
776634|NCT00606684|2469957|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
776635|NCT00606684|2469951|P7|Double-Blind Treatment Period|Physician Decision|2
776636|NCT00606684|2469952|P6|Double-Blind Treatment Period|Physician Decision|1
776637|NCT00606684|2469953|P5|Double-Blind Treatment Period|Physician Decision|3
776638|NCT00606684|2469954|P4|Double-Blind Treatment Period|Physician Decision|0
776639|NCT00606684|2469955|P3|Double-Blind Treatment Period|Physician Decision|1
776640|NCT00606684|2469956|P2|Double-Blind Treatment Period|Physician Decision|5
776641|NCT00606684|2469957|P1|Double-Blind Treatment Period|Physician Decision|0
776642|NCT00606684|2469951|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
776643|NCT00606684|2469952|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
776644|NCT00606684|2469953|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
776645|NCT00606684|2469954|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
776646|NCT00606684|2469955|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
776647|NCT00606684|2469956|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
776648|NCT00606684|2469957|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
776649|NCT00606684|2469951|P7|Double-Blind Treatment Period|Protocol Violation|4
776650|NCT00606684|2469952|P6|Double-Blind Treatment Period|Protocol Violation|3
776651|NCT00606684|2469953|P5|Double-Blind Treatment Period|Protocol Violation|0
776652|NCT00606684|2469954|P4|Double-Blind Treatment Period|Protocol Violation|3
776653|NCT00606684|2469955|P3|Double-Blind Treatment Period|Protocol Violation|5
776654|NCT00606684|2469956|P2|Double-Blind Treatment Period|Protocol Violation|5
776655|NCT00606684|2469957|P1|Double-Blind Treatment Period|Protocol Violation|0
776656|NCT00606684|2469951|P7|Double-Blind Treatment Period|Lack of Efficacy|0
776657|NCT00606684|2469952|P6|Double-Blind Treatment Period|Lack of Efficacy|0
776658|NCT00606684|2469953|P5|Double-Blind Treatment Period|Lack of Efficacy|1
776659|NCT00606684|2469954|P4|Double-Blind Treatment Period|Lack of Efficacy|0
776660|NCT00606684|2469955|P3|Double-Blind Treatment Period|Lack of Efficacy|0
776661|NCT00606684|2469956|P2|Double-Blind Treatment Period|Lack of Efficacy|1
776662|NCT00606684|2469957|P1|Double-Blind Treatment Period|Lack of Efficacy|0
776663|NCT00606684|2469951|P7|Double-Blind Treatment Period|Adverse Event|1
776664|NCT00606684|2469952|P6|Double-Blind Treatment Period|Adverse Event|0
776665|NCT00606684|2469953|P5|Double-Blind Treatment Period|Adverse Event|2
776666|NCT00606684|2469954|P4|Double-Blind Treatment Period|Adverse Event|4
776667|NCT00606684|2469955|P3|Double-Blind Treatment Period|Adverse Event|2
776668|NCT00606684|2469956|P2|Double-Blind Treatment Period|Adverse Event|3
776669|NCT00606684|2469957|P1|Double-Blind Treatment Period|Adverse Event|0
776670|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776671|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776672|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776673|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776674|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776675|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
776676|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
776677|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Adverse Event|0
776678|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Adverse Event|0
776679|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Adverse Event|0
776680|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Adverse Event|0
776681|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Adverse Event|0
776682|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Adverse Event|0
776683|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Adverse Event|2
776684|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776685|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776686|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776687|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776688|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776689|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
776690|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
776691|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776692|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776693|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776694|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776695|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776696|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
776697|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
776698|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Physician Decision|0
776699|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Physician Decision|0
776700|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Physician Decision|0
776701|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Physician Decision|0
776702|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Physician Decision|0
776703|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Physician Decision|0
776704|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Physician Decision|18
776705|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776706|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776707|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776708|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776709|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776710|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
776711|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
776712|NCT00606684|2469951|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776713|NCT00606684|2469952|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776714|NCT00606684|2469953|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776715|NCT00606684|2469954|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776716|NCT00606684|2469955|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776717|NCT00606684|2469956|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
776718|NCT00606684|2469957|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
776719|NCT00606801|2469991|P2|Intervention|Protocol Violation|3
776720|NCT00606801|2469992|P1|Intervention|Protocol Violation|3
776721|NCT00607373|2470024|P2|Follow-up Period|Withdrawal by Subject|3
776722|NCT00607373|2470025|P1|Follow-up Period|Withdrawal by Subject|1
776723|NCT00607373|2470024|P2|Follow-up Period|Protocol Violation|1
776724|NCT00607373|2470025|P1|Follow-up Period|Protocol Violation|0
776725|NCT00607373|2470024|P2|Follow-up Period|Not specified|1
776726|NCT00607373|2470025|P1|Follow-up Period|Not specified|0
776727|NCT00607373|2470024|P2|Treatment Period|Withdrawal by Subject|1
776728|NCT00607373|2470025|P1|Treatment Period|Withdrawal by Subject|0
776729|NCT00607373|2470024|P2|Treatment Period|Physician Decision|1
776730|NCT00607373|2470025|P1|Treatment Period|Physician Decision|0
776731|NCT00607373|2470024|P2|Treatment Period|Adverse Event|4
776732|NCT00607373|2470025|P1|Treatment Period|Adverse Event|0
776733|NCT00607386|2470069|P1|Overall Study|Physician Decision|1
776734|NCT00607724|2470154|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776735|NCT00607724|2470155|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776736|NCT00607724|2470156|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776737|NCT00607724|2470157|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
776738|NCT00607724|2470158|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776739|NCT00607724|2470159|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776740|NCT00607724|2470160|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
776741|NCT00607724|2470154|P7|Stage 2: Expanded Cohort|Physician Decision|0
776742|NCT00607724|2470155|P6|Stage 2: Expanded Cohort|Physician Decision|1
776743|NCT00607724|2470156|P5|Stage 2: Expanded Cohort|Physician Decision|1
776744|NCT00607724|2470157|P4|Stage 2: Expanded Cohort|Physician Decision|0
776745|NCT00607724|2470158|P3|Stage 2: Expanded Cohort|Physician Decision|0
776746|NCT00607724|2470159|P2|Stage 2: Expanded Cohort|Physician Decision|0
776747|NCT00607724|2470160|P1|Stage 2: Expanded Cohort|Physician Decision|0
776748|NCT00607724|2470154|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
776749|NCT00607724|2470155|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
776750|NCT00607724|2470156|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
776751|NCT00607724|2470157|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
776752|NCT00607724|2470158|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
776753|NCT00607724|2470159|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
776754|NCT00607724|2470160|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
776755|NCT00607724|2470154|P7|Stage 2: Expanded Cohort|Adverse Event|1
776756|NCT00607724|2470155|P6|Stage 2: Expanded Cohort|Adverse Event|0
776757|NCT00607724|2470156|P5|Stage 2: Expanded Cohort|Adverse Event|0
776758|NCT00607724|2470157|P4|Stage 2: Expanded Cohort|Adverse Event|0
776759|NCT00607724|2470158|P3|Stage 2: Expanded Cohort|Adverse Event|0
776760|NCT00607724|2470159|P2|Stage 2: Expanded Cohort|Adverse Event|0
776761|NCT00607724|2470160|P1|Stage 2: Expanded Cohort|Adverse Event|0
776762|NCT00607724|2470154|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
776763|NCT00607724|2470155|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
776764|NCT00607724|2470156|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
776765|NCT00607724|2470157|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
776766|NCT00607724|2470158|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
776767|NCT00607724|2470159|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
776768|NCT00607724|2470160|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
776769|NCT00607789|2470238|P2|Overall Study|Withdrawal by Subject|0
776770|NCT00607789|2470239|P1|Overall Study|Withdrawal by Subject|1
776771|NCT00607789|2470238|P2|Overall Study|Lost to Follow-up|5
776772|NCT00607789|2470239|P1|Overall Study|Lost to Follow-up|0
776773|NCT00607789|2470238|P2|Overall Study|Inadequate adherence|0
776774|NCT00607789|2470239|P1|Overall Study|Inadequate adherence|3
776775|NCT00607789|2470238|P2|Overall Study|Lack of Efficacy|1
776776|NCT00607789|2470239|P1|Overall Study|Lack of Efficacy|0
776777|NCT00607789|2470238|P2|Overall Study|Adverse Event|0
776778|NCT00607789|2470239|P1|Overall Study|Adverse Event|3
776779|NCT00607880|2470285|P2|Overall Study|Unable to place port due to occlusion|0
776780|NCT00607880|2470286|P1|Overall Study|Unable to place port due to occlusion|1
776781|NCT00607893|2470300|P2|Overall Study|Withdrew due to hypertensive urgency|1
776782|NCT00607893|2470301|P1|Overall Study|Withdrew due to hypertensive urgency|1
776783|NCT00607893|2470300|P2|Overall Study|Declined to be treated|0
776784|NCT00607893|2470301|P1|Overall Study|Declined to be treated|1
776785|NCT00607893|2470300|P2|Overall Study|withdrew could not tolerate CPAP|1
776786|NCT00607893|2470301|P1|Overall Study|withdrew could not tolerate CPAP|0
776787|NCT00607893|2470300|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
776788|NCT00607893|2470301|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
776789|NCT00607893|2470300|P2|Overall Study|withdrew due to loss of interest|1
776790|NCT00607893|2470301|P1|Overall Study|withdrew due to loss of interest|0
776791|NCT00607893|2470300|P2|Overall Study|Lost to Follow-up|0
776792|NCT00607893|2470301|P1|Overall Study|Lost to Follow-up|4
776793|NCT00607919|2470329|P2|Open-Label Phase|Parent/Caregiver Decision|2
776794|NCT00607919|2470330|P1|Open-Label Phase|Parent/Caregiver Decision|1
776795|NCT00607919|2470329|P2|Open-Label Phase|Withdrawal by Subject|2
776796|NCT00607919|2470330|P1|Open-Label Phase|Withdrawal by Subject|2
776797|NCT00607919|2470329|P2|Open-Label Phase|Protocol Violation|2
776798|NCT00607919|2470330|P1|Open-Label Phase|Protocol Violation|2
776799|NCT00607919|2470329|P2|Open-Label Phase|Lost to Follow-up|1
776800|NCT00607919|2470330|P1|Open-Label Phase|Lost to Follow-up|4
776801|NCT00607919|2470329|P2|Open-Label Phase|Adverse Event|5
776802|NCT00607919|2470330|P1|Open-Label Phase|Adverse Event|1
776803|NCT00607919|2470329|P2|Acute Phase|Withdrawal by Subject|3
776804|NCT00607919|2470330|P1|Acute Phase|Withdrawal by Subject|3
776805|NCT00607919|2470329|P2|Acute Phase|Protocol Violation|1
776806|NCT00607919|2470330|P1|Acute Phase|Protocol Violation|5
776807|NCT00607919|2470329|P2|Acute Phase|Parent/Caregiver Decision|4
776808|NCT00607919|2470330|P1|Acute Phase|Parent/Caregiver Decision|6
776809|NCT00607919|2470329|P2|Acute Phase|Lost to Follow-up|3
776810|NCT00607919|2470330|P1|Acute Phase|Lost to Follow-up|9
776811|NCT00607919|2470329|P2|Acute Phase|Lack of Efficacy|2
776812|NCT00607919|2470330|P1|Acute Phase|Lack of Efficacy|1
776813|NCT00607919|2470329|P2|Acute Phase|Entry Criteria Not Met|1
776814|NCT00607919|2470330|P1|Acute Phase|Entry Criteria Not Met|1
776815|NCT00607919|2470329|P2|Acute Phase|Adverse Event|2
776816|NCT00607919|2470330|P1|Acute Phase|Adverse Event|9
776817|NCT00607997|2470390|P4|Overall Study|Other without explanation|1
776818|NCT00607997|2470391|P3|Overall Study|Other without explanation|4
776819|NCT00607997|2470392|P2|Overall Study|Other without explanation|0
776820|NCT00607997|2470393|P1|Overall Study|Other without explanation|2
776821|NCT00607997|2470390|P4|Overall Study|Relapse, recurrent illness|0
776822|NCT00607997|2470391|P3|Overall Study|Relapse, recurrent illness|2
776823|NCT00607997|2470392|P2|Overall Study|Relapse, recurrent illness|0
776824|NCT00607997|2470393|P1|Overall Study|Relapse, recurrent illness|4
776825|NCT00607997|2470390|P4|Overall Study|Physician Decision|0
776826|NCT00607997|2470391|P3|Overall Study|Physician Decision|0
776827|NCT00607997|2470392|P2|Overall Study|Physician Decision|1
776828|NCT00607997|2470393|P1|Overall Study|Physician Decision|4
776829|NCT00607997|2470390|P4|Overall Study|Adverse Event|0
776830|NCT00607997|2470391|P3|Overall Study|Adverse Event|2
776831|NCT00607997|2470392|P2|Overall Study|Adverse Event|1
776832|NCT00607997|2470393|P1|Overall Study|Adverse Event|3
776833|NCT00607997|2470390|P4|Overall Study|Death|5
776834|NCT00607997|2470391|P3|Overall Study|Death|2
776835|NCT00607997|2470392|P2|Overall Study|Death|5
776836|NCT00607997|2470393|P1|Overall Study|Death|8
776837|NCT00607997|2470390|P4|Overall Study|Lack of Efficacy|10
776838|NCT00607997|2470391|P3|Overall Study|Lack of Efficacy|14
776839|NCT00607997|2470392|P2|Overall Study|Lack of Efficacy|20
776840|NCT00607997|2470393|P1|Overall Study|Lack of Efficacy|6
776841|NCT00608023|2470452|P3|Overall Study|Unknown reason|0
776842|NCT00608023|2470453|P2|Overall Study|Unknown reason|3
776843|NCT00608023|2470454|P1|Overall Study|Unknown reason|0
776844|NCT00608023|2470452|P3|Overall Study|Protocol Violation|1
776845|NCT00608023|2470453|P2|Overall Study|Protocol Violation|3
776846|NCT00608023|2470454|P1|Overall Study|Protocol Violation|1
776847|NCT00608023|2470452|P3|Overall Study|Lost to Follow-up|1
776848|NCT00608023|2470453|P2|Overall Study|Lost to Follow-up|2
776849|NCT00608023|2470454|P1|Overall Study|Lost to Follow-up|2
776850|NCT00608023|2470452|P3|Overall Study|Adverse Event|5
776851|NCT00608023|2470453|P2|Overall Study|Adverse Event|4
776852|NCT00608023|2470454|P1|Overall Study|Adverse Event|1
776853|NCT00608023|2470452|P3|Overall Study|Withdrawal by Subject|7
776854|NCT00608023|2470453|P2|Overall Study|Withdrawal by Subject|10
776855|NCT00608023|2470454|P1|Overall Study|Withdrawal by Subject|8
776856|NCT00608205|2470487|P2|Overall Study|Patient non-compliant|1
776857|NCT00608205|2470488|P1|Overall Study|Patient non-compliant|0
776858|NCT00608205|2470487|P2|Overall Study|Adverse Event|2
776859|NCT00608205|2470488|P1|Overall Study|Adverse Event|3
776860|NCT00608244|2470576|P1|Overall Study|Low trough levels|1
776861|NCT00608244|2470576|P1|Overall Study|Adverse Event|1
776862|NCT00608322|2470587|P2|Overall Study|Death|1
776863|NCT00608322|2470588|P1|Overall Study|Death|2
776864|NCT00608426|2470596|P2|Overall Study|refused, health issues, wrong address|348
776865|NCT00608426|2470597|P1|Overall Study|refused, health issues, wrong address|319
776866|NCT00608426|2470596|P2|Overall Study|Lost to Follow-up|521
776867|NCT00608426|2470597|P1|Overall Study|Lost to Follow-up|485
776868|NCT00608426|2470596|P2|Overall Study|Death|36
776869|NCT00608426|2470597|P1|Overall Study|Death|32
776870|NCT00608517|2470762|P3|Overall Study|Death|0
776871|NCT00608517|2470763|P2|Overall Study|Death|0
776872|NCT00608517|2470764|P1|Overall Study|Death|1
776875|NCT00608543|2470803|P1|Overall Study|Adverse Event|4
776876|NCT00608569|2470814|P2|Overall Study|Unable to adhere with study requirements|1
776877|NCT00608569|2470815|P1|Overall Study|Unable to adhere with study requirements|0
776878|NCT00608569|2470814|P2|Overall Study|Adverse Event|0
776879|NCT00608569|2470815|P1|Overall Study|Adverse Event|1
776880|NCT00608569|2470814|P2|Overall Study|Withdrawal by Subject|0
776881|NCT00608569|2470815|P1|Overall Study|Withdrawal by Subject|1
776882|NCT00608569|2470814|P2|Overall Study|Lost to Follow-up|5
776883|NCT00608569|2470815|P1|Overall Study|Lost to Follow-up|4
776884|NCT00608569|2470814|P2|Overall Study|Death|3
776885|NCT00608569|2470815|P1|Overall Study|Death|4
776886|NCT00608582|2470837|P2|Overall Study|Early stage Design Change|3
776887|NCT00608582|2470838|P1|Overall Study|Early stage Design Change|0
776888|NCT00608582|2470837|P2|Overall Study|Illicit Drug Use|0
776889|NCT00608582|2470838|P1|Overall Study|Illicit Drug Use|1
776890|NCT00608582|2470837|P2|Overall Study|No Best Response in Phase 1 located|1
776891|NCT00608582|2470838|P1|Overall Study|No Best Response in Phase 1 located|1
776892|NCT00608582|2470837|P2|Overall Study|Lost to Follow-up|0
776893|NCT00608582|2470838|P1|Overall Study|Lost to Follow-up|2
776894|NCT00608829|2470866|P1|Overall Study|Subject refuses to follow up or return.|5
776895|NCT00608829|2470866|P1|Overall Study|Withdrawal by Subject|4
776896|NCT00608829|2470866|P1|Overall Study|Death|6
776897|NCT00608842|2470874|P4|Overall Study|Lost to Follow-up|0
776898|NCT00608842|2470875|P3|Overall Study|Lost to Follow-up|0
776899|NCT00608842|2470876|P2|Overall Study|Lost to Follow-up|0
776900|NCT00608842|2470877|P1|Overall Study|Lost to Follow-up|1
776901|NCT00608842|2470874|P4|Overall Study|Participant's Request|1
776902|NCT00608842|2470875|P3|Overall Study|Participant's Request|2
776903|NCT00608842|2470876|P2|Overall Study|Participant's Request|1
776904|NCT00608842|2470877|P1|Overall Study|Participant's Request|0
776905|NCT00608868|2470911|P1|Overall Study|Physician Decision|2
776906|NCT00608868|2470911|P1|Overall Study|Adverse Event|1
776907|NCT00608868|2470911|P1|Overall Study|Lost to Follow-up|2
776908|NCT00608868|2470911|P1|Overall Study|Protocol Violation|3
776909|NCT00608868|2470911|P1|Overall Study|Withdrawal by Subject|7
776910|NCT00608881|2470920|P2|Overall Study|Institutionalized|2
776911|NCT00608881|2470921|P1|Overall Study|Institutionalized|1
776912|NCT00608881|2470920|P2|Overall Study|Physician Decision|5
776913|NCT00608881|2470921|P1|Overall Study|Physician Decision|5
776914|NCT00608881|2470920|P2|Overall Study|Withdrawal by Subject|29
776915|NCT00608881|2470921|P1|Overall Study|Withdrawal by Subject|18
776916|NCT00608881|2470920|P2|Overall Study|Lost to Follow-up|14
776917|NCT00608881|2470921|P1|Overall Study|Lost to Follow-up|28
776918|NCT00608881|2470920|P2|Overall Study|Adverse Event|3
776919|NCT00608881|2470921|P1|Overall Study|Adverse Event|5
776920|NCT00608881|2470920|P2|Overall Study|Death|13
776921|NCT00608881|2470921|P1|Overall Study|Death|22
776922|NCT00608907|2470958|P3|Overall Study|Progressive Disease|0
776923|NCT00608907|2470959|P2|Overall Study|Progressive Disease|0
776924|NCT00608907|2470960|P1|Overall Study|Progressive Disease|1
776925|NCT00608907|2470958|P3|Overall Study|Withdrawal by Subject|0
776926|NCT00608907|2470959|P2|Overall Study|Withdrawal by Subject|0
776927|NCT00608907|2470960|P1|Overall Study|Withdrawal by Subject|4
776928|NCT00608907|2470958|P3|Overall Study|Death|0
776929|NCT00608907|2470959|P2|Overall Study|Death|0
776930|NCT00608907|2470960|P1|Overall Study|Death|1
776931|NCT00608907|2470958|P3|Overall Study|Adverse Event|1
776932|NCT00608907|2470959|P2|Overall Study|Adverse Event|0
776933|NCT00608907|2470960|P1|Overall Study|Adverse Event|6
776934|NCT00608959|2470970|P1|Part 1|Did not meet eligibility criteria|1
776935|NCT00608985|2470984|P4|Overall Study|Lost to Follow-up|0
776936|NCT00608985|2470985|P3|Overall Study|Lost to Follow-up|0
776937|NCT00608985|2470986|P2|Overall Study|Lost to Follow-up|1
776938|NCT00608985|2470987|P1|Overall Study|Lost to Follow-up|2
776939|NCT00608985|2470984|P4|Overall Study|Withdrawal of Consent|1
776940|NCT00608985|2470985|P3|Overall Study|Withdrawal of Consent|1
776941|NCT00608985|2470986|P2|Overall Study|Withdrawal of Consent|1
776942|NCT00608985|2470987|P1|Overall Study|Withdrawal of Consent|5
776943|NCT00608985|2470984|P4|Overall Study|Administrative/Other|2
776944|NCT00608985|2470985|P3|Overall Study|Administrative/Other|1
776945|NCT00608985|2470986|P2|Overall Study|Administrative/Other|4
776946|NCT00608985|2470987|P1|Overall Study|Administrative/Other|7
776947|NCT00608985|2470984|P4|Overall Study|Adverse Event|6
776948|NCT00608985|2470985|P3|Overall Study|Adverse Event|4
776949|NCT00608985|2470986|P2|Overall Study|Adverse Event|7
776950|NCT00608985|2470987|P1|Overall Study|Adverse Event|2
776951|NCT00609167|2471019|P2|Overall Study|Stem Cell Transplant|6
776952|NCT00609167|2471020|P1|Overall Study|Stem Cell Transplant|0
776953|NCT00609167|2471019|P2|Overall Study|Disease Progression|0
776954|NCT00609167|2471020|P1|Overall Study|Disease Progression|1
776955|NCT00609167|2471019|P2|Overall Study|Adverse Event|1
776956|NCT00609167|2471020|P1|Overall Study|Adverse Event|5
776957|NCT00609167|2471019|P2|Overall Study|Lack of Efficacy|0
776958|NCT00609167|2471020|P1|Overall Study|Lack of Efficacy|1
776959|NCT00609167|2471019|P2|Overall Study|Withdrawal by Subject|0
776960|NCT00609167|2471020|P1|Overall Study|Withdrawal by Subject|1
776961|NCT00609245|2471042|P1|Overall Study|Adverse Event|1
776962|NCT00609336|2471048|P1|Overall Study|LA or Met at Surgery|9
776963|NCT00609336|2471048|P1|Overall Study|Death|1
776964|NCT00609336|2471048|P1|Overall Study|Protocol Violation|3
776965|NCT00609362|2471062|P2|Overall Study|Adverse Event|0
776966|NCT00609362|2471063|P1|Overall Study|Adverse Event|1
776967|NCT00609362|2471062|P2|Overall Study|Withdrawal by Subject|1
776968|NCT00609362|2471063|P1|Overall Study|Withdrawal by Subject|2
776969|NCT00609466|2471076|P3|Overall Study|Lack of Efficacy|2
776970|NCT00609466|2471077|P2|Overall Study|Lack of Efficacy|2
776971|NCT00609466|2471078|P1|Overall Study|Lack of Efficacy|0
776972|NCT00609466|2471076|P3|Overall Study|Adverse Event|1
776973|NCT00609466|2471077|P2|Overall Study|Adverse Event|3
776974|NCT00609466|2471078|P1|Overall Study|Adverse Event|2
776975|NCT00609466|2471076|P3|Overall Study|Withdrawal by Subject|1
776976|NCT00609466|2471077|P2|Overall Study|Withdrawal by Subject|1
776977|NCT00609466|2471078|P1|Overall Study|Withdrawal by Subject|0
776978|NCT00609492|2471107|P3|Overall Study|Lost to Follow-up|4
776979|NCT00609492|2471108|P2|Overall Study|Lost to Follow-up|1
776980|NCT00609492|2471109|P1|Overall Study|Lost to Follow-up|1
776981|NCT00609492|2471107|P3|Overall Study|Withdrawal by Subject|3
776982|NCT00609492|2471108|P2|Overall Study|Withdrawal by Subject|2
776983|NCT00609492|2471109|P1|Overall Study|Withdrawal by Subject|0
776984|NCT00609518|2471193|P2|Overall Study|Death from Adverse Event|2
776985|NCT00609518|2471194|P1|Overall Study|Death from Adverse Event|2
776986|NCT00609518|2471193|P2|Overall Study|Physician Decision|3
776987|NCT00609518|2471194|P1|Overall Study|Physician Decision|1
776988|NCT00609518|2471193|P2|Overall Study|Lost to Follow-up|0
776989|NCT00609518|2471194|P1|Overall Study|Lost to Follow-up|3
776990|NCT00609518|2471193|P2|Overall Study|Withdrawal by Subject|3
776991|NCT00609518|2471194|P1|Overall Study|Withdrawal by Subject|5
776992|NCT00609518|2471193|P2|Overall Study|Death from Study Disease|32
776993|NCT00609518|2471194|P1|Overall Study|Death from Study Disease|32
776994|NCT00609622|2471208|P2|Overall Study|Global deterioration of health status|2
776995|NCT00609622|2471209|P1|Overall Study|Global deterioration of health status|6
776996|NCT00609622|2471208|P2|Overall Study|Unspecified|14
776997|NCT00609622|2471209|P1|Overall Study|Unspecified|7
776998|NCT00609622|2471208|P2|Overall Study|Study terminated by sponsor|3
776999|NCT00609622|2471209|P1|Overall Study|Study terminated by sponsor|16
777000|NCT00609622|2471208|P2|Overall Study|Objective progression or relapse|41
777001|NCT00609622|2471209|P1|Overall Study|Objective progression or relapse|47
777002|NCT00609622|2471208|P2|Overall Study|Protocol Violation|1
777003|NCT00609622|2471209|P1|Overall Study|Protocol Violation|1
777004|NCT00609622|2471208|P2|Overall Study|Death|4
777005|NCT00609622|2471209|P1|Overall Study|Death|1
777006|NCT00609622|2471208|P2|Overall Study|Withdrawal by Subject|20
777007|NCT00609622|2471209|P1|Overall Study|Withdrawal by Subject|4
777008|NCT00609622|2471208|P2|Overall Study|Adverse Event|10
777009|NCT00609622|2471209|P1|Overall Study|Adverse Event|14
777010|NCT00609674|2471231|P2|Overall Study|Withdrew consent|1
777011|NCT00609674|2471232|P1|Overall Study|Withdrew consent|2
777012|NCT00609674|2471231|P2|Overall Study|Lost to Follow-up|0
777013|NCT00609674|2471232|P1|Overall Study|Lost to Follow-up|1
777014|NCT00609674|2471231|P2|Overall Study|Protocol Violation|5
777015|NCT00609674|2471232|P1|Overall Study|Protocol Violation|3
777016|NCT00609674|2471231|P2|Overall Study|Adverse Event|1
777017|NCT00609674|2471232|P1|Overall Study|Adverse Event|1
777018|NCT00609765|2471273|P1|Overall Study|Study ended prior to 12 months|1
777019|NCT00609869|2471291|P1|Overall Study|Mantle cell: not evaluable|4
777020|NCT00609869|2471291|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
777021|NCT00609869|2471291|P1|Overall Study|Hepatitis B infection|1
777022|NCT00609869|2471291|P1|Overall Study|Severe tumor flare reaction|1
777023|NCT00609869|2471291|P1|Overall Study|Seizures|1
777024|NCT00609869|2471291|P1|Overall Study|Withdrawal by Subject|1
777025|NCT00609869|2471291|P1|Overall Study|Severe hematologic toxicity|1
777026|NCT00609869|2471291|P1|Overall Study|Withdrawn, ischemic stroke|1
777027|NCT00609947|2471297|P1|Overall Study|Death|1
777028|NCT00603733|2471304|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
777029|NCT00603733|2471305|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
777030|NCT00603733|2471304|P2|Maintenance Phase ITT|Physician Decision|1
777031|NCT00603733|2471305|P1|Maintenance Phase ITT|Physician Decision|0
777032|NCT00603733|2471304|P2|Maintenance Phase ITT|Lack of Efficacy|2
777033|NCT00603733|2471305|P1|Maintenance Phase ITT|Lack of Efficacy|2
777034|NCT00603733|2471304|P2|Maintenance Phase ITT|Lost to Follow-up|1
777035|NCT00603733|2471305|P1|Maintenance Phase ITT|Lost to Follow-up|0
777036|NCT00603733|2471304|P2|Maintenance Phase ITT|Protocol Violation|1
777037|NCT00603733|2471305|P1|Maintenance Phase ITT|Protocol Violation|1
777038|NCT00603733|2471304|P2|Maintenance Phase ITT|Withdrawal by Subject|0
777039|NCT00603733|2471305|P1|Maintenance Phase ITT|Withdrawal by Subject|1
777040|NCT00603733|2471304|P2|Maintenance Phase ITT|Adverse Event|6
777041|NCT00603733|2471305|P1|Maintenance Phase ITT|Adverse Event|3
777042|NCT00603733|2471304|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
777043|NCT00603733|2471305|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
777044|NCT00603733|2471304|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
777045|NCT00603733|2471305|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
777046|NCT00603733|2471304|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
777047|NCT00603733|2471305|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
777048|NCT00603733|2471304|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
777049|NCT00603733|2471305|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
777050|NCT00603733|2471304|P2|Run-In Phase - 4 Weeks|Adverse Event|1
777051|NCT00603733|2471305|P1|Run-In Phase - 4 Weeks|Adverse Event|2
777052|NCT00603733|2471304|P2|Active Phase ITT|Subject moved, site closed|1
777053|NCT00603733|2471305|P1|Active Phase ITT|Subject moved, site closed|1
777054|NCT00603733|2471304|P2|Active Phase ITT|Lack of Efficacy|2
777055|NCT00603733|2471305|P1|Active Phase ITT|Lack of Efficacy|1
777056|NCT00603733|2471304|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
777057|NCT00603733|2471305|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
777058|NCT00603733|2471304|P2|Active Phase ITT|Lost to Follow-up|1
777059|NCT00603733|2471305|P1|Active Phase ITT|Lost to Follow-up|0
777060|NCT00603733|2471304|P2|Active Phase ITT|Withdrawal by Subject|3
777061|NCT00603733|2471305|P1|Active Phase ITT|Withdrawal by Subject|0
777062|NCT00603733|2471304|P2|Active Phase ITT|Adverse Event|7
777063|NCT00603733|2471305|P1|Active Phase ITT|Adverse Event|8
777064|NCT00603746|2471321|P6|Overall Study|Withdrawal by Subject|1
777065|NCT00603746|2471322|P5|Overall Study|Withdrawal by Subject|3
777066|NCT00603746|2471323|P4|Overall Study|Withdrawal by Subject|1
777067|NCT00603746|2471324|P3|Overall Study|Withdrawal by Subject|0
777068|NCT00603746|2471325|P2|Overall Study|Withdrawal by Subject|0
777069|NCT00603746|2471326|P1|Overall Study|Withdrawal by Subject|1
777070|NCT00603746|2471321|P6|Overall Study|Physician Decision|0
777071|NCT00603746|2471322|P5|Overall Study|Physician Decision|1
777072|NCT00603746|2471323|P4|Overall Study|Physician Decision|0
777073|NCT00603746|2471324|P3|Overall Study|Physician Decision|0
777074|NCT00603746|2471325|P2|Overall Study|Physician Decision|0
777075|NCT00603746|2471326|P1|Overall Study|Physician Decision|1
777076|NCT00603746|2471321|P6|Overall Study|Lost to Follow-up|0
777077|NCT00603746|2471322|P5|Overall Study|Lost to Follow-up|0
777078|NCT00603746|2471323|P4|Overall Study|Lost to Follow-up|0
777079|NCT00603746|2471324|P3|Overall Study|Lost to Follow-up|1
777080|NCT00603746|2471325|P2|Overall Study|Lost to Follow-up|1
777081|NCT00603746|2471326|P1|Overall Study|Lost to Follow-up|0
777082|NCT00603746|2471321|P6|Overall Study|Protocol Violation|0
777083|NCT00603746|2471322|P5|Overall Study|Protocol Violation|1
777084|NCT00603746|2471323|P4|Overall Study|Protocol Violation|0
777085|NCT00603746|2471324|P3|Overall Study|Protocol Violation|1
777086|NCT00603746|2471325|P2|Overall Study|Protocol Violation|3
777087|NCT00603746|2471326|P1|Overall Study|Protocol Violation|0
777088|NCT00603746|2471321|P6|Overall Study|Lack of Efficacy|8
777089|NCT00603746|2471322|P5|Overall Study|Lack of Efficacy|12
777090|NCT00603746|2471323|P4|Overall Study|Lack of Efficacy|11
777091|NCT00603746|2471324|P3|Overall Study|Lack of Efficacy|6
777092|NCT00603746|2471325|P2|Overall Study|Lack of Efficacy|11
777093|NCT00603746|2471326|P1|Overall Study|Lack of Efficacy|34
777094|NCT00603746|2471321|P6|Overall Study|Adverse Event|4
777095|NCT00603746|2471322|P5|Overall Study|Adverse Event|0
777096|NCT00603746|2471323|P4|Overall Study|Adverse Event|1
777097|NCT00603746|2471324|P3|Overall Study|Adverse Event|0
777098|NCT00603746|2471325|P2|Overall Study|Adverse Event|3
777099|NCT00603746|2471326|P1|Overall Study|Adverse Event|2
777100|NCT00603798|2471475|P3|Overall Study|Not due to AE|4
777101|NCT00603798|2471476|P2|Overall Study|Not due to AE|1
777102|NCT00603798|2471477|P1|Overall Study|Not due to AE|1
777103|NCT00603798|2471475|P3|Overall Study|Non-compliance with study procedures|0
777104|NCT00603798|2471476|P2|Overall Study|Non-compliance with study procedures|1
777105|NCT00603798|2471477|P1|Overall Study|Non-compliance with study procedures|0
777106|NCT00603798|2471475|P3|Overall Study|Lost to Follow-up|1
777107|NCT00603798|2471476|P2|Overall Study|Lost to Follow-up|0
777108|NCT00603798|2471477|P1|Overall Study|Lost to Follow-up|1
777109|NCT00603798|2471475|P3|Overall Study|Withdrawal by Subject|4
777110|NCT00603798|2471476|P2|Overall Study|Withdrawal by Subject|3
777111|NCT00603798|2471477|P1|Overall Study|Withdrawal by Subject|4
777112|NCT00603798|2471475|P3|Overall Study|Adverse Event|1
777113|NCT00603798|2471476|P2|Overall Study|Adverse Event|2
777114|NCT00603798|2471477|P1|Overall Study|Adverse Event|4
777115|NCT00603837|2471496|P2|Overall Study|Physician Decision|0
777116|NCT00603837|2471497|P1|Overall Study|Physician Decision|3
777117|NCT00603915|2471526|P1|Overall Study|Physician Decision|1
777118|NCT00609973|2471533|P2|Overall Study|Withdrawal by Subject|1
777119|NCT00609973|2471534|P1|Overall Study|Withdrawal by Subject|0
777120|NCT00609973|2471533|P2|Overall Study|Lost to Follow-up|1
777121|NCT00609973|2471534|P1|Overall Study|Lost to Follow-up|2
777122|NCT00609973|2471533|P2|Overall Study|Protocol Violation|3
777123|NCT00609973|2471534|P1|Overall Study|Protocol Violation|4
777124|NCT00609973|2471533|P2|Overall Study|Adverse Event|1
777125|NCT00609973|2471534|P1|Overall Study|Adverse Event|2
777126|NCT00609986|2471544|P2|Overall Study|Did not receive transplant or treatment|3
777127|NCT00609986|2471545|P1|Overall Study|Did not receive transplant or treatment|8
777128|NCT00610129|2471557|P1|Overall Study|Not treated since patients ineligible|3
777129|NCT00610155|2471561|P6|Period 3|Adverse Event|0
777130|NCT00610155|2471562|P5|Period 3|Adverse Event|0
777131|NCT00610155|2471563|P4|Period 3|Adverse Event|0
777132|NCT00610155|2471564|P3|Period 3|Adverse Event|0
777133|NCT00610155|2471565|P2|Period 3|Adverse Event|0
777134|NCT00610155|2471566|P1|Period 3|Adverse Event|1
777135|NCT00610155|2471561|P6|Period 1|Withdrawal by Subject|0
777136|NCT00610155|2471562|P5|Period 1|Withdrawal by Subject|0
777137|NCT00610155|2471563|P4|Period 1|Withdrawal by Subject|0
777138|NCT00610155|2471564|P3|Period 1|Withdrawal by Subject|1
777139|NCT00610155|2471565|P2|Period 1|Withdrawal by Subject|0
777140|NCT00610155|2471566|P1|Period 1|Withdrawal by Subject|0
777141|NCT00610168|2471615|P2|Overall Study|Withdrawal by Subject|0
777142|NCT00610168|2471616|P1|Overall Study|Withdrawal by Subject|2
777143|NCT00610207|2471635|P1|Overall Study|Lost to Follow-up|3
777144|NCT00611247|2471642|P2|Overall Study|Lack of Efficacy|16
777145|NCT00611247|2471643|P1|Overall Study|Lack of Efficacy|1
777146|NCT00611247|2471642|P2|Overall Study|Death|5
777147|NCT00611247|2471643|P1|Overall Study|Death|1
891794|NCT01072149|2828544|P6|Washout Period 2 (14 Days)|Physician Decision|0
891795|NCT01072149|2828545|P5|Washout Period 2 (14 Days)|Physician Decision|0
891796|NCT01072149|2828546|P4|Washout Period 2 (14 Days)|Physician Decision|0
891797|NCT01072149|2828547|P3|Washout Period 2 (14 Days)|Physician Decision|0
891798|NCT01072149|2828548|P2|Washout Period 2 (14 Days)|Physician Decision|0
891799|NCT01072149|2828549|P1|Washout Period 2 (14 Days)|Physician Decision|1
891800|NCT01072149|2828532|P18|Treatment Period 2 (28 Days)|Physician Decision|0
891801|NCT01072149|2828533|P17|Treatment Period 2 (28 Days)|Physician Decision|0
891802|NCT01072149|2828534|P16|Treatment Period 2 (28 Days)|Physician Decision|0
891803|NCT01072149|2828535|P15|Treatment Period 2 (28 Days)|Physician Decision|0
891804|NCT01072149|2828536|P14|Treatment Period 2 (28 Days)|Physician Decision|0
891805|NCT01072149|2828537|P13|Treatment Period 2 (28 Days)|Physician Decision|0
891806|NCT01072149|2828538|P12|Treatment Period 2 (28 Days)|Physician Decision|0
891807|NCT01072149|2828539|P11|Treatment Period 2 (28 Days)|Physician Decision|0
891808|NCT01072149|2828540|P10|Treatment Period 2 (28 Days)|Physician Decision|0
891809|NCT01072149|2828541|P9|Treatment Period 2 (28 Days)|Physician Decision|0
891810|NCT01072149|2828542|P8|Treatment Period 2 (28 Days)|Physician Decision|1
891811|NCT01072149|2828543|P7|Treatment Period 2 (28 Days)|Physician Decision|0
891812|NCT01072149|2828544|P6|Treatment Period 2 (28 Days)|Physician Decision|0
891813|NCT01072149|2828545|P5|Treatment Period 2 (28 Days)|Physician Decision|0
891814|NCT01072149|2828546|P4|Treatment Period 2 (28 Days)|Physician Decision|0
891815|NCT01072149|2828547|P3|Treatment Period 2 (28 Days)|Physician Decision|0
891816|NCT01072149|2828548|P2|Treatment Period 2 (28 Days)|Physician Decision|0
891817|NCT01072149|2828549|P1|Treatment Period 2 (28 Days)|Physician Decision|0
891818|NCT01072149|2828532|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891819|NCT01072149|2828533|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891820|NCT01072149|2828534|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891821|NCT01072149|2828535|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891822|NCT01072149|2828536|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891823|NCT01072149|2828537|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891824|NCT01072149|2828538|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891825|NCT01072149|2828539|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891826|NCT01072149|2828540|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891827|NCT01072149|2828541|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891828|NCT01072149|2828542|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891829|NCT01072149|2828543|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891830|NCT01072149|2828544|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891831|NCT01072149|2828545|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891832|NCT01072149|2828546|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891833|NCT01072149|2828547|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
891834|NCT01072149|2828548|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891835|NCT01072149|2828549|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
891836|NCT01072149|2828532|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891837|NCT01072149|2828533|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891838|NCT01072149|2828534|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891839|NCT01072149|2828535|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891840|NCT01072149|2828536|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891841|NCT01072149|2828537|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891842|NCT01072149|2828538|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891843|NCT01072149|2828539|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891844|NCT01072149|2828540|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891845|NCT01072149|2828541|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891846|NCT01072149|2828542|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891847|NCT01072149|2828543|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891848|NCT01072149|2828544|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891849|NCT01072149|2828545|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891850|NCT01072149|2828546|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891851|NCT01072149|2828547|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891852|NCT01072149|2828548|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
891853|NCT01072149|2828549|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
891854|NCT01072149|2828532|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891855|NCT01072149|2828533|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891856|NCT01072149|2828534|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891857|NCT01072149|2828535|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891858|NCT01072149|2828536|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891859|NCT01072149|2828537|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891860|NCT01072149|2828538|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
777211|NCT00611533|2471841|P2|Second Intervention (6 Weeks)|Adverse Event|2
777212|NCT00611533|2471842|P1|Second Intervention (6 Weeks)|Adverse Event|0
777213|NCT00611533|2471841|P2|First Intervention (6 Weeks)|Adverse Event|1
777214|NCT00611533|2471842|P1|First Intervention (6 Weeks)|Adverse Event|0
777215|NCT00611533|2471841|P2|First Intervention (6 Weeks)|Never started study|1
777216|NCT00611533|2471842|P1|First Intervention (6 Weeks)|Never started study|0
777217|NCT00611559|2471864|P3|Overall Study|Protocol Violation|1
777218|NCT00611559|2471865|P2|Overall Study|Protocol Violation|0
777219|NCT00611559|2471866|P1|Overall Study|Protocol Violation|1
777220|NCT00611559|2471864|P3|Overall Study|Lost to Follow-up|0
777221|NCT00611559|2471865|P2|Overall Study|Lost to Follow-up|1
777222|NCT00611559|2471866|P1|Overall Study|Lost to Follow-up|0
777223|NCT00611715|2471932|P2|Overall Study|two patients are still on treatment|0
777224|NCT00611715|2471933|P1|Overall Study|two patients are still on treatment|2
777225|NCT00611715|2471932|P2|Overall Study|Death|0
777226|NCT00611715|2471933|P1|Overall Study|Death|1
777227|NCT00611715|2471932|P2|Overall Study|Adverse Event|1
777228|NCT00611715|2471933|P1|Overall Study|Adverse Event|9
777229|NCT00611715|2471932|P2|Overall Study|Withdrawal by Subject|1
777230|NCT00611715|2471933|P1|Overall Study|Withdrawal by Subject|5
777231|NCT00611715|2471932|P2|Overall Study|Disease Progression|4
777232|NCT00611715|2471933|P1|Overall Study|Disease Progression|24
777233|NCT00611767|2471947|P2|Overall Study|Physician Decision|0
777234|NCT00611767|2471948|P1|Overall Study|Physician Decision|1
777235|NCT00611767|2471947|P2|Overall Study|didn't like the medication|1
777236|NCT00611767|2471948|P1|Overall Study|didn't like the medication|1
777237|NCT00611767|2471947|P2|Overall Study|Thiopental not available|0
777238|NCT00611767|2471948|P1|Overall Study|Thiopental not available|3
777239|NCT00611767|2471947|P2|Overall Study|Withdrawal by Subject|1
777240|NCT00611767|2471948|P1|Overall Study|Withdrawal by Subject|4
777241|NCT00611806|2472110|P2|Overall Study|Lost to Follow-up|0
777242|NCT00611806|2472111|P1|Overall Study|Lost to Follow-up|6
777243|NCT00611806|2472110|P2|Overall Study|Adverse Event|1
777244|NCT00611806|2472111|P1|Overall Study|Adverse Event|2
777245|NCT00611806|2472110|P2|Overall Study|Withdrawal by Subject|2
777246|NCT00611806|2472111|P1|Overall Study|Withdrawal by Subject|8
777247|NCT00611884|2472127|P4|Overall Study|Unclassified|3
777248|NCT00611884|2472128|P3|Overall Study|Unclassified|2
777249|NCT00611884|2472129|P2|Overall Study|Unclassified|4
777250|NCT00611884|2472130|P1|Overall Study|Unclassified|7
777251|NCT00611884|2472127|P4|Overall Study|Lack of Efficacy|0
777252|NCT00611884|2472128|P3|Overall Study|Lack of Efficacy|0
777253|NCT00611884|2472129|P2|Overall Study|Lack of Efficacy|1
777254|NCT00611884|2472130|P1|Overall Study|Lack of Efficacy|0
777255|NCT00611884|2472127|P4|Overall Study|Non-Compliance|2
777256|NCT00611884|2472128|P3|Overall Study|Non-Compliance|2
777257|NCT00611884|2472129|P2|Overall Study|Non-Compliance|4
777258|NCT00611884|2472130|P1|Overall Study|Non-Compliance|1
777259|NCT00611884|2472127|P4|Overall Study|Adverse Event|1
777260|NCT00611884|2472128|P3|Overall Study|Adverse Event|0
777261|NCT00611884|2472129|P2|Overall Study|Adverse Event|0
777262|NCT00611884|2472130|P1|Overall Study|Adverse Event|1
777263|NCT00612040|2472212|P3|Overall Study|Unclassified|5
777264|NCT00612040|2472213|P2|Overall Study|Unclassified|2
777265|NCT00612040|2472214|P1|Overall Study|Unclassified|2
777266|NCT00612040|2472212|P3|Overall Study|Lack of Efficacy|0
777267|NCT00612040|2472213|P2|Overall Study|Lack of Efficacy|1
777268|NCT00612040|2472214|P1|Overall Study|Lack of Efficacy|2
777269|NCT00612040|2472212|P3|Overall Study|Protocol Violation|1
777270|NCT00612040|2472213|P2|Overall Study|Protocol Violation|2
777271|NCT00612040|2472214|P1|Overall Study|Protocol Violation|1
777272|NCT00612040|2472212|P3|Overall Study|Adverse Event|1
777273|NCT00612040|2472213|P2|Overall Study|Adverse Event|2
777274|NCT00612040|2472214|P1|Overall Study|Adverse Event|0
777275|NCT00612066|2472258|P1|Overall Study|Adverse Event|1
891861|NCT01072149|2828539|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
777276|NCT00612105|2472264|P2|Period Title 3: 3-Week Taper Phase|Other|0
777277|NCT00612105|2472265|P1|Period Title 3: 3-Week Taper Phase|Other|1
777278|NCT00612105|2472264|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
777279|NCT00612105|2472265|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
777280|NCT00612105|2472264|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
777281|NCT00612105|2472265|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
777282|NCT00612105|2472264|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
777283|NCT00612105|2472265|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
777284|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Other|1
777285|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Other|0
777286|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
777287|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
777288|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
777289|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
777290|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
777291|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
777292|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
777293|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
777294|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
777295|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
777296|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
777297|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
777298|NCT00612105|2472264|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
777299|NCT00612105|2472265|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
777300|NCT00612313|2472323|P2|Overall Study|Lost to Follow-up|4
777301|NCT00612313|2472324|P1|Overall Study|Lost to Follow-up|11
777302|NCT00612313|2472323|P2|Overall Study|Withdrawal by Subject|9
777303|NCT00612313|2472324|P1|Overall Study|Withdrawal by Subject|6
777304|NCT00612352|2472346|P2|Overall Study|didn't return calls/show up on test date|1
777305|NCT00612352|2472347|P1|Overall Study|didn't return calls/show up on test date|4
777306|NCT00612352|2472346|P2|Overall Study|moved out of state|0
777307|NCT00612352|2472347|P1|Overall Study|moved out of state|1
777308|NCT00612352|2472346|P2|Overall Study|Withdrawal by Subject|5
777309|NCT00612352|2472347|P1|Overall Study|Withdrawal by Subject|3
777310|NCT00612352|2472346|P2|Overall Study|Adverse Event|0
777311|NCT00612352|2472347|P1|Overall Study|Adverse Event|1
777321|NCT00612508|2472529|P2|Overall Study|Withdrawal by Subject|4
777322|NCT00612508|2472530|P1|Overall Study|Withdrawal by Subject|3
777323|NCT00612534|2472542|P4|Overall Study|Other Reason|0
777324|NCT00612534|2472543|P3|Overall Study|Other Reason|0
777325|NCT00612534|2472544|P2|Overall Study|Other Reason|1
777326|NCT00612534|2472545|P1|Overall Study|Other Reason|0
777327|NCT00612534|2472542|P4|Overall Study|Lack of Efficacy|16
777328|NCT00612534|2472543|P3|Overall Study|Lack of Efficacy|5
777329|NCT00612534|2472544|P2|Overall Study|Lack of Efficacy|12
777330|NCT00612534|2472545|P1|Overall Study|Lack of Efficacy|13
777331|NCT00612534|2472542|P4|Overall Study|Adverse Event|1
777332|NCT00612534|2472543|P3|Overall Study|Adverse Event|2
777333|NCT00612534|2472544|P2|Overall Study|Adverse Event|4
777334|NCT00612534|2472545|P1|Overall Study|Adverse Event|0
777335|NCT00612677|2472613|P1|Overall Study|study closed before treatment started|1
777336|NCT00612690|2472621|P2|Overall Study|Withdrawal by Site|0
777337|NCT00612690|2472622|P1|Overall Study|Withdrawal by Site|11
777338|NCT00612690|2472621|P2|Overall Study|Withdrawal by Subject|20
777339|NCT00612690|2472622|P1|Overall Study|Withdrawal by Subject|32
777340|NCT00612690|2472621|P2|Overall Study|Lost to Follow-up|98
777341|NCT00612690|2472622|P1|Overall Study|Lost to Follow-up|72
777342|NCT00612807|2472632|P2|Overall Study|Withdrawal by Subject|0
777343|NCT00612807|2472633|P1|Overall Study|Withdrawal by Subject|2
777344|NCT00613015|2472661|P6|Overall Study|Lost to Follow-up|3
777345|NCT00613015|2472662|P5|Overall Study|Lost to Follow-up|2
777346|NCT00613015|2472663|P4|Overall Study|Lost to Follow-up|3
777347|NCT00613015|2472664|P3|Overall Study|Lost to Follow-up|3
777348|NCT00613015|2472665|P2|Overall Study|Lost to Follow-up|1
777349|NCT00613015|2472666|P1|Overall Study|Lost to Follow-up|0
777350|NCT00613080|2472703|P1|Overall Study|Ineligible / no protocol treatment|11
777351|NCT00613106|2472709|P2|Overall Study|misc|3
777352|NCT00613106|2472710|P1|Overall Study|misc|4
777353|NCT00613106|2472709|P2|Overall Study|Lost to Follow-up|2
777354|NCT00613106|2472710|P1|Overall Study|Lost to Follow-up|7
777355|NCT00613106|2472709|P2|Overall Study|Withdrawal by Subject|3
777356|NCT00613106|2472710|P1|Overall Study|Withdrawal by Subject|6
777357|NCT00613106|2472709|P2|Overall Study|Adverse Event|1
777358|NCT00613106|2472710|P1|Overall Study|Adverse Event|3
777359|NCT00613301|2472716|P1|Overall Study|Irregularly enrolled patients|12
777360|NCT00613301|2472716|P1|Overall Study|No data was collected|53
777361|NCT00613301|2472716|P1|Overall Study|Physician Decision|2
777362|NCT00613301|2472716|P1|Overall Study|Lack of Efficacy|13
777363|NCT00613301|2472716|P1|Overall Study|Death|6
777364|NCT00613301|2472716|P1|Overall Study|Withdrawal by Subject|5
777365|NCT00613301|2472716|P1|Overall Study|Lost to Follow-up|88
777366|NCT00613301|2472716|P1|Overall Study|Adverse Event|49
777367|NCT00613314|2472723|P1|Overall Study|Other reason not defined above|90
777368|NCT00613314|2472723|P1|Overall Study|Lost to Follow-up|46
777369|NCT00613314|2472723|P1|Overall Study|Protocol Violation|14
777370|NCT00613314|2472723|P1|Overall Study|Adverse Event|5
777371|NCT00613327|2472731|P1|Overall Study|Unspecified|47
777372|NCT00613327|2472731|P1|Overall Study|Protocol Violation|2
777373|NCT00613327|2472731|P1|Overall Study|Withdrawal by Subject|6
777374|NCT00613327|2472731|P1|Overall Study|Lost to Follow-up|8
777375|NCT00613327|2472731|P1|Overall Study|Adverse Event|38
777376|NCT00613366|2472752|P2|Overall Study|Withdrawal by Subject|2
777377|NCT00613366|2472753|P1|Overall Study|Withdrawal by Subject|3
777378|NCT00613509|2472785|P2|Cycle 1|Other administrative reason|1
777379|NCT00613509|2472786|P1|Cycle 1|Other administrative reason|0
777380|NCT00613509|2472785|P2|Cycle 1|Unacceptable Toxicity|0
777381|NCT00613509|2472786|P1|Cycle 1|Unacceptable Toxicity|1
777382|NCT00613509|2472785|P2|Cycle 1|Disease Progression|6
777383|NCT00613509|2472786|P1|Cycle 1|Disease Progression|2
777384|NCT00613509|2472785|P2|Cycle 1|Adverse Event|1
777385|NCT00613509|2472786|P1|Cycle 1|Adverse Event|2
777386|NCT00613574|2472808|P1|Overall Study|Other|1
777387|NCT00613574|2472808|P1|Overall Study|Lost to Follow-up|2
777388|NCT00613574|2472808|P1|Overall Study|Adverse Event|3
777389|NCT00613626|2472821|P3|Overall Study|Ineligible|0
777390|NCT00613626|2472822|P2|Overall Study|Ineligible|1
777391|NCT00613626|2472823|P1|Overall Study|Ineligible|0
777392|NCT00606892|2472839|P2|First Intervention|Protocol Violation|4
777393|NCT00606892|2472840|P1|First Intervention|Protocol Violation|1
777394|NCT00606905|2472874|P2|Overall Study|Withdrew|5
777395|NCT00606905|2472875|P1|Overall Study|Withdrew|5
777396|NCT00606905|2472874|P2|Overall Study|Non-Index Pregnancy|4
777397|NCT00606905|2472875|P1|Overall Study|Non-Index Pregnancy|1
777398|NCT00606905|2472874|P2|Overall Study|No Pregnancy|6
777399|NCT00606905|2472875|P1|Overall Study|No Pregnancy|9
777400|NCT00606931|2472881|P1|Overall Study|Withdrawal by Subject|3
777401|NCT00607048|2472898|P6|Overall Study|Unspecified|1
777402|NCT00607048|2472899|P5|Overall Study|Unspecified|0
777403|NCT00607048|2472900|P4|Overall Study|Unspecified|0
777404|NCT00607048|2472901|P3|Overall Study|Unspecified|0
777405|NCT00607048|2472902|P2|Overall Study|Unspecified|1
777406|NCT00607048|2472903|P1|Overall Study|Unspecified|1
777407|NCT00607048|2472898|P6|Overall Study|Withdrawal by Subject|2
777408|NCT00607048|2472899|P5|Overall Study|Withdrawal by Subject|0
777409|NCT00607048|2472900|P4|Overall Study|Withdrawal by Subject|1
777410|NCT00607048|2472901|P3|Overall Study|Withdrawal by Subject|0
777411|NCT00607048|2472902|P2|Overall Study|Withdrawal by Subject|0
777412|NCT00607048|2472903|P1|Overall Study|Withdrawal by Subject|0
777413|NCT00607048|2472898|P6|Overall Study|Objective disease progression - relapse|2
777414|NCT00607048|2472899|P5|Overall Study|Objective disease progression - relapse|2
777415|NCT00607048|2472900|P4|Overall Study|Objective disease progression - relapse|2
777416|NCT00607048|2472901|P3|Overall Study|Objective disease progression - relapse|4
777417|NCT00607048|2472902|P2|Overall Study|Objective disease progression - relapse|2
777418|NCT00607048|2472903|P1|Overall Study|Objective disease progression - relapse|1
777419|NCT00607048|2472898|P6|Overall Study|Global deterioration of health|0
777420|NCT00607048|2472899|P5|Overall Study|Global deterioration of health|0
777421|NCT00607048|2472900|P4|Overall Study|Global deterioration of health|0
777422|NCT00607048|2472901|P3|Overall Study|Global deterioration of health|0
777423|NCT00607048|2472902|P2|Overall Study|Global deterioration of health|0
777424|NCT00607048|2472903|P1|Overall Study|Global deterioration of health|1
777425|NCT00607048|2472898|P6|Overall Study|Adverse Event|0
777426|NCT00607048|2472899|P5|Overall Study|Adverse Event|4
777427|NCT00607048|2472900|P4|Overall Study|Adverse Event|0
777428|NCT00607048|2472901|P3|Overall Study|Adverse Event|0
777429|NCT00607048|2472902|P2|Overall Study|Adverse Event|1
777430|NCT00607048|2472903|P1|Overall Study|Adverse Event|0
777431|NCT00607087|2472988|P3|Period 3|Adverse Event|0
777432|NCT00607087|2472989|P2|Period 3|Adverse Event|1
777433|NCT00607087|2472990|P1|Period 3|Adverse Event|0
777434|NCT00607087|2472988|P3|Period 3|Withdrawal by Subject|0
777435|NCT00607087|2472989|P2|Period 3|Withdrawal by Subject|1
777436|NCT00607087|2472990|P1|Period 3|Withdrawal by Subject|2
777437|NCT00607087|2472988|P3|Period 2|Poor compliance to protocol|1
777438|NCT00607087|2472989|P2|Period 2|Poor compliance to protocol|0
777439|NCT00607087|2472990|P1|Period 2|Poor compliance to protocol|0
777440|NCT00607087|2472988|P3|Period 2|Adverse Event|3
777441|NCT00607087|2472989|P2|Period 2|Adverse Event|1
777442|NCT00607087|2472990|P1|Period 2|Adverse Event|0
777443|NCT00607087|2472988|P3|Period 2|Other reason|0
777444|NCT00607087|2472989|P2|Period 2|Other reason|1
777445|NCT00607087|2472990|P1|Period 2|Other reason|1
777446|NCT00607087|2472988|P3|Period 2|Withdrawal by Subject|1
777447|NCT00607087|2472989|P2|Period 2|Withdrawal by Subject|1
777448|NCT00607087|2472990|P1|Period 2|Withdrawal by Subject|0
777449|NCT00607087|2472988|P3|Period 1|Other reason|2
777450|NCT00607087|2472989|P2|Period 1|Other reason|4
777451|NCT00607087|2472990|P1|Period 1|Other reason|0
777452|NCT00607087|2472988|P3|Period 1|Lost to Follow-up|0
777453|NCT00607087|2472989|P2|Period 1|Lost to Follow-up|0
777454|NCT00607087|2472990|P1|Period 1|Lost to Follow-up|1
777455|NCT00607087|2472988|P3|Period 1|Poor compliance to protocol|0
777456|NCT00607087|2472989|P2|Period 1|Poor compliance to protocol|0
777457|NCT00607087|2472990|P1|Period 1|Poor compliance to protocol|1
777458|NCT00607087|2472988|P3|Period 1|Adverse Event|0
777459|NCT00607087|2472989|P2|Period 1|Adverse Event|0
777460|NCT00607087|2472990|P1|Period 1|Adverse Event|3
777461|NCT00607087|2472988|P3|Period 1|Withdrawal by Subject|3
777462|NCT00607087|2472989|P2|Period 1|Withdrawal by Subject|2
777463|NCT00607087|2472990|P1|Period 1|Withdrawal by Subject|7
777464|NCT00607087|2472988|P3|Overall Study|Lost to Follow-up|0
777465|NCT00607087|2472989|P2|Overall Study|Lost to Follow-up|0
777466|NCT00607087|2472990|P1|Overall Study|Lost to Follow-up|1
777467|NCT00607087|2472988|P3|Overall Study|Poor compliance to protocol|1
777468|NCT00607087|2472989|P2|Overall Study|Poor compliance to protocol|0
777469|NCT00607087|2472990|P1|Overall Study|Poor compliance to protocol|1
777470|NCT00607087|2472988|P3|Overall Study|Other reason|2
777471|NCT00607087|2472989|P2|Overall Study|Other reason|5
777472|NCT00607087|2472990|P1|Overall Study|Other reason|1
777473|NCT00607087|2472988|P3|Overall Study|Adverse Event|3
777474|NCT00607087|2472989|P2|Overall Study|Adverse Event|2
777475|NCT00607087|2472990|P1|Overall Study|Adverse Event|3
777476|NCT00607087|2472988|P3|Overall Study|Withdrawal by Subject|4
777477|NCT00607087|2472989|P2|Overall Study|Withdrawal by Subject|4
777478|NCT00607087|2472990|P1|Overall Study|Withdrawal by Subject|9
777479|NCT00613730|2473093|P1|Overall Study|Administrative decision|1
777480|NCT00613730|2473093|P1|Overall Study|Disease progression|2
777481|NCT00613821|2473101|P2|Overall Study|Physician Decision|1
777482|NCT00613821|2473102|P1|Overall Study|Physician Decision|1
777483|NCT00613821|2473101|P2|Overall Study|Withdrawal by Subject|0
777484|NCT00613821|2473102|P1|Overall Study|Withdrawal by Subject|1
777485|NCT00613925|2473110|P2|Overall Study|1 did not tolerate outpatient biopsy|1
777486|NCT00613925|2473111|P1|Overall Study|1 did not tolerate outpatient biopsy|0
777487|NCT00613938|2473123|P4|Overall Study|Other|3
777488|NCT00613938|2473124|P3|Overall Study|Other|1
777489|NCT00613938|2473125|P2|Overall Study|Other|2
777490|NCT00613938|2473126|P1|Overall Study|Other|1
777491|NCT00613938|2473123|P4|Overall Study|Lack of Efficacy|9
777492|NCT00613938|2473124|P3|Overall Study|Lack of Efficacy|5
777493|NCT00613938|2473125|P2|Overall Study|Lack of Efficacy|18
777494|NCT00613938|2473126|P1|Overall Study|Lack of Efficacy|16
777495|NCT00613938|2473123|P4|Overall Study|Adverse Event|5
777496|NCT00613938|2473124|P3|Overall Study|Adverse Event|8
777497|NCT00613938|2473125|P2|Overall Study|Adverse Event|4
777498|NCT00613938|2473126|P1|Overall Study|Adverse Event|1
777499|NCT00613938|2473123|P4|Overall Study|Withdrawal by Subject|9
777500|NCT00613938|2473124|P3|Overall Study|Withdrawal by Subject|9
777501|NCT00613938|2473125|P2|Overall Study|Withdrawal by Subject|4
777502|NCT00613938|2473126|P1|Overall Study|Withdrawal by Subject|2
777503|NCT00613951|2473159|P3|Overall Study|Unclassified|2
777504|NCT00613951|2473160|P2|Overall Study|Unclassified|3
777505|NCT00613951|2473161|P1|Overall Study|Unclassified|5
777506|NCT00613951|2473159|P3|Overall Study|Protocol Violation|1
777507|NCT00613951|2473160|P2|Overall Study|Protocol Violation|1
777508|NCT00613951|2473161|P1|Overall Study|Protocol Violation|1
777509|NCT00613951|2473159|P3|Overall Study|Lack of Efficacy|1
777510|NCT00613951|2473160|P2|Overall Study|Lack of Efficacy|1
777511|NCT00613951|2473161|P1|Overall Study|Lack of Efficacy|0
777512|NCT00613951|2473159|P3|Overall Study|Adverse Event|1
777513|NCT00613951|2473160|P2|Overall Study|Adverse Event|0
777514|NCT00613951|2473161|P1|Overall Study|Adverse Event|1
777515|NCT00615719|2473202|P1|Overall Study|Physician Decision|5
777516|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
777517|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
777518|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
777519|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
777520|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
777521|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Not reported|0
777522|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Not reported|4
777523|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Not reported|1
777524|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Not reported|4
777525|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Not reported|6
777526|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Not specified|0
777527|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Not specified|8
777528|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Not specified|8
777529|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Not specified|7
777530|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Not specified|10
777531|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
777532|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
777533|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
777534|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
777535|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
777536|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
777537|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
777538|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
777539|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
777540|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
777541|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
777542|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
777543|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
777544|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
777545|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
777546|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
777547|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
777548|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
777549|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
777550|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
777551|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
777552|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
777553|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
777554|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
777555|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
777556|NCT00615836|2473210|P5|Extension Study (FE992026 CS31)|Adverse Event|0
777557|NCT00615836|2473211|P4|Extension Study (FE992026 CS31)|Adverse Event|13
777558|NCT00615836|2473212|P3|Extension Study (FE992026 CS31)|Adverse Event|15
777559|NCT00615836|2473213|P2|Extension Study (FE992026 CS31)|Adverse Event|12
777560|NCT00615836|2473214|P1|Extension Study (FE992026 CS31)|Adverse Event|7
777561|NCT00615901|2473274|P1|Overall Study|Adverse Event|7
777562|NCT00615901|2473274|P1|Overall Study|Withdrawal by Subject|2
777563|NCT00615914|2473278|P1|Overall Study|Irregularly enrolled patients|10
777564|NCT00615914|2473278|P1|Overall Study|No treatment|2
777565|NCT00615914|2473278|P1|Overall Study|No data was collected.|65
777566|NCT00615914|2473278|P1|Overall Study|Physician Decision|4
777567|NCT00615914|2473278|P1|Overall Study|Withdrawal by Subject|16
777568|NCT00615914|2473278|P1|Overall Study|Lost to Follow-up|187
777569|NCT00615914|2473278|P1|Overall Study|Lack of Efficacy|59
777570|NCT00615914|2473278|P1|Overall Study|Death|20
777571|NCT00615914|2473278|P1|Overall Study|Adverse Event|274
777572|NCT00615992|2473302|P1|Overall Study|Protocol Violation|67
777573|NCT00616018|2473311|P1|Overall Study|Protocol Violation|3
777574|NCT00616239|2473336|P1|Overall Study|Withdrawal by Subject|2
777575|NCT00616421|2473347|P3|Overall Study|Unable to classify|0
777576|NCT00616421|2473348|P2|Overall Study|Unable to classify|0
777577|NCT00616421|2473349|P1|Overall Study|Unable to classify|1
777578|NCT00616421|2473347|P3|Overall Study|Protocol Violation|2
777579|NCT00616421|2473348|P2|Overall Study|Protocol Violation|1
777580|NCT00616421|2473349|P1|Overall Study|Protocol Violation|0
777581|NCT00616421|2473347|P3|Overall Study|Administrative reason|0
777582|NCT00616421|2473348|P2|Overall Study|Administrative reason|0
777583|NCT00616421|2473349|P1|Overall Study|Administrative reason|1
777584|NCT00616421|2473347|P3|Overall Study|Inappropriate enrollment|1
777585|NCT00616421|2473348|P2|Overall Study|Inappropriate enrollment|0
777586|NCT00616421|2473349|P1|Overall Study|Inappropriate enrollment|3
777587|NCT00616421|2473347|P3|Overall Study|Lost to Follow-up|30
777588|NCT00616421|2473348|P2|Overall Study|Lost to Follow-up|26
777589|NCT00616421|2473349|P1|Overall Study|Lost to Follow-up|12
777590|NCT00616421|2473347|P3|Overall Study|Withdrawal by Subject|8
777591|NCT00616421|2473348|P2|Overall Study|Withdrawal by Subject|11
777592|NCT00616421|2473349|P1|Overall Study|Withdrawal by Subject|9
777593|NCT00616434|2473388|P2|Overall Study|Protocol deviation|1
777594|NCT00616434|2473389|P1|Overall Study|Protocol deviation|0
777595|NCT00616434|2473388|P2|Overall Study|Withdrawal by Subject|1
777596|NCT00616434|2473389|P1|Overall Study|Withdrawal by Subject|1
777597|NCT00616434|2473388|P2|Overall Study|Physician Decision|4
777598|NCT00616434|2473389|P1|Overall Study|Physician Decision|0
777599|NCT00616434|2473388|P2|Overall Study|Adverse Event|2
777600|NCT00616434|2473389|P1|Overall Study|Adverse Event|5
777601|NCT00616603|2473415|P3|Overall Study|Physician Decision|2
777602|NCT00616603|2473416|P2|Overall Study|Physician Decision|0
777603|NCT00616603|2473417|P1|Overall Study|Physician Decision|2
777604|NCT00616629|2473430|P5|Overall Study|AV-block|0
777605|NCT00616629|2473431|P4|Overall Study|AV-block|0
777606|NCT00616629|2473432|P3|Overall Study|AV-block|0
777607|NCT00616629|2473433|P2|Overall Study|AV-block|0
777608|NCT00616629|2473434|P1|Overall Study|AV-block|1
777609|NCT00616629|2473430|P5|Overall Study|Protocol Violation|0
777610|NCT00616629|2473431|P4|Overall Study|Protocol Violation|0
777611|NCT00616629|2473432|P3|Overall Study|Protocol Violation|1
777612|NCT00616629|2473433|P2|Overall Study|Protocol Violation|2
777613|NCT00616629|2473434|P1|Overall Study|Protocol Violation|1
777614|NCT00616642|2473478|P2|Overall Study|Withdrawal by Subject|1
777615|NCT00616642|2473479|P1|Overall Study|Withdrawal by Subject|0
777616|NCT00616655|2473488|P3|Overall Study|unspecified|5
777617|NCT00616655|2473489|P2|Overall Study|unspecified|6
777618|NCT00616655|2473490|P1|Overall Study|unspecified|6
777619|NCT00616655|2473488|P3|Overall Study|Does not meet in/ex criteria|2
777620|NCT00616655|2473489|P2|Overall Study|Does not meet in/ex criteria|0
777621|NCT00616655|2473490|P1|Overall Study|Does not meet in/ex criteria|0
777622|NCT00616655|2473488|P3|Overall Study|Withdrawal by Subject|11
777623|NCT00616655|2473489|P2|Overall Study|Withdrawal by Subject|7
777624|NCT00616655|2473490|P1|Overall Study|Withdrawal by Subject|9
777625|NCT00616655|2473488|P3|Overall Study|Protocol Violation|3
777626|NCT00616655|2473489|P2|Overall Study|Protocol Violation|4
777627|NCT00616655|2473490|P1|Overall Study|Protocol Violation|2
777628|NCT00616655|2473488|P3|Overall Study|Lost to Follow-up|10
777629|NCT00616655|2473489|P2|Overall Study|Lost to Follow-up|12
777630|NCT00616655|2473490|P1|Overall Study|Lost to Follow-up|3
777631|NCT00616655|2473488|P3|Overall Study|Lack of Efficacy|5
777632|NCT00616655|2473489|P2|Overall Study|Lack of Efficacy|5
777633|NCT00616655|2473490|P1|Overall Study|Lack of Efficacy|5
777634|NCT00616655|2473488|P3|Overall Study|Adverse Event|12
777635|NCT00616655|2473489|P2|Overall Study|Adverse Event|7
777636|NCT00616655|2473490|P1|Overall Study|Adverse Event|10
891862|NCT01072149|2828540|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891863|NCT01072149|2828541|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891864|NCT01072149|2828542|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
777641|NCT00616902|2473556|P2|Overall Study|Termination of study|6
777642|NCT00616902|2473557|P1|Overall Study|Termination of study|6
777643|NCT00616928|2473585|P4|Overall Study|Lost to Follow-up|0
777644|NCT00616928|2473586|P3|Overall Study|Lost to Follow-up|0
777645|NCT00616928|2473587|P2|Overall Study|Lost to Follow-up|7
777646|NCT00616928|2473588|P1|Overall Study|Lost to Follow-up|5
777647|NCT00616928|2473585|P4|Overall Study|Unspecified|5
777648|NCT00616928|2473586|P3|Overall Study|Unspecified|15
777649|NCT00616928|2473587|P2|Overall Study|Unspecified|8
777650|NCT00616928|2473588|P1|Overall Study|Unspecified|51
777651|NCT00616928|2473585|P4|Overall Study|Adverse Event|2
777652|NCT00616928|2473586|P3|Overall Study|Adverse Event|2
777653|NCT00616928|2473587|P2|Overall Study|Adverse Event|3
777654|NCT00616928|2473588|P1|Overall Study|Adverse Event|6
777655|NCT00616967|2473652|P3|Overall Study|Withdrawal by Subject|1
777656|NCT00616967|2473653|P2|Overall Study|Withdrawal by Subject|0
777657|NCT00616967|2473654|P1|Overall Study|Withdrawal by Subject|0
777658|NCT00617084|2473708|P2|Overall Study|Missed 12 Months visit|19
777659|NCT00617084|2473709|P1|Overall Study|Missed 12 Months visit|16
777660|NCT00617084|2473708|P2|Overall Study|Withdrawal by Subject|7
777661|NCT00617084|2473709|P1|Overall Study|Withdrawal by Subject|5
777662|NCT00617123|2473734|P2|Study Treatment Period|Noncompliance with Protocol|1
777663|NCT00617123|2473735|P1|Study Treatment Period|Noncompliance with Protocol|0
777664|NCT00617123|2473734|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
777665|NCT00617123|2473735|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
777666|NCT00617123|2473734|P2|Study Treatment Period|Adverse Event|3
777667|NCT00617123|2473735|P1|Study Treatment Period|Adverse Event|7
777668|NCT00617123|2473734|P2|Study Treatment Period|Withdrawal by Subject|12
777669|NCT00617123|2473735|P1|Study Treatment Period|Withdrawal by Subject|8
777670|NCT00617123|2473734|P2|Referral Screening Period|Adverse Event|1
777671|NCT00617123|2473735|P1|Referral Screening Period|Adverse Event|0
777672|NCT00617123|2473734|P2|Referral Screening Period|Did Not Wish To Continue|1
777673|NCT00617123|2473735|P1|Referral Screening Period|Did Not Wish To Continue|3
777674|NCT00617123|2473734|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
777675|NCT00617123|2473735|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
777676|NCT00617201|2473769|P2|Overall Study|Lost to Follow-up|13
777677|NCT00617201|2473770|P1|Overall Study|Lost to Follow-up|9
777678|NCT00617240|2473780|P2|Overall Study|Lack of Efficacy|0
777679|NCT00617240|2473781|P1|Overall Study|Lack of Efficacy|1
777680|NCT00617279|2473801|P2|Overall Study|Death|2
777681|NCT00617279|2473802|P1|Overall Study|Death|1
777682|NCT00617279|2473801|P2|Overall Study|Lost to Follow-up|0
777683|NCT00617279|2473802|P1|Overall Study|Lost to Follow-up|1
777684|NCT00617279|2473801|P2|Overall Study|Graft abandonment|0
777685|NCT00617279|2473802|P1|Overall Study|Graft abandonment|2
777686|NCT00617279|2473801|P2|Overall Study|Study terminated by Sponsor|15
777687|NCT00617279|2473802|P1|Overall Study|Study terminated by Sponsor|10
777688|NCT00617305|2473859|P3|Overall Study|Withdrawal by Subject|0
777689|NCT00617305|2473860|P2|Overall Study|Withdrawal by Subject|0
777690|NCT00617305|2473861|P1|Overall Study|Withdrawal by Subject|1
777691|NCT00617305|2473859|P3|Overall Study|Protocol Violation|1
777692|NCT00617305|2473860|P2|Overall Study|Protocol Violation|0
777693|NCT00617305|2473861|P1|Overall Study|Protocol Violation|1
777694|NCT00617305|2473859|P3|Overall Study|Physician Decision|0
777695|NCT00617305|2473860|P2|Overall Study|Physician Decision|0
777696|NCT00617305|2473861|P1|Overall Study|Physician Decision|1
777697|NCT00617305|2473859|P3|Overall Study|Death|0
777698|NCT00617305|2473860|P2|Overall Study|Death|0
777699|NCT00617305|2473861|P1|Overall Study|Death|1
777700|NCT00617305|2473859|P3|Overall Study|Adverse Event|0
777701|NCT00617305|2473860|P2|Overall Study|Adverse Event|0
777702|NCT00617305|2473861|P1|Overall Study|Adverse Event|4
777703|NCT00617357|2473915|P1|Overall Study|Physician Decision|1
777704|NCT00617357|2473915|P1|Overall Study|Withdrawal by Subject|1
777705|NCT00617357|2473915|P1|Overall Study|insurance concerns|2
777706|NCT00617357|2473915|P1|Overall Study|Death|5
777707|NCT00617357|2473915|P1|Overall Study|Lost to Follow-up|7
777723|NCT00617461|2473945|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
777724|NCT00617461|2473946|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
777725|NCT00617461|2473945|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
777726|NCT00617461|2473946|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
777727|NCT00617461|2473945|P2|Second Treatment Intervention Period|Lack of Efficacy|3
777728|NCT00617461|2473946|P1|Second Treatment Intervention Period|Lack of Efficacy|0
777729|NCT00617461|2473945|P2|Second Treatment Intervention Period|Adverse Event|1
777730|NCT00617461|2473946|P1|Second Treatment Intervention Period|Adverse Event|0
777731|NCT00617461|2473945|P2|4-Day Crossover Period|Withdrawal by Subject|0
777732|NCT00617461|2473946|P1|4-Day Crossover Period|Withdrawal by Subject|1
777733|NCT00617461|2473945|P2|First Treatment Intervention Period|Withdrawal by Subject|0
777734|NCT00617461|2473946|P1|First Treatment Intervention Period|Withdrawal by Subject|4
777735|NCT00617461|2473945|P2|First Treatment Intervention Period|Investigator Discretion|1
777736|NCT00617461|2473946|P1|First Treatment Intervention Period|Investigator Discretion|1
777737|NCT00617461|2473945|P2|First Treatment Intervention Period|Lost to Follow-up|1
777738|NCT00617461|2473946|P1|First Treatment Intervention Period|Lost to Follow-up|0
777739|NCT00617461|2473945|P2|First Treatment Intervention Period|Protocol Violation|1
777740|NCT00617461|2473946|P1|First Treatment Intervention Period|Protocol Violation|2
777741|NCT00617461|2473945|P2|First Treatment Intervention Period|Lack of Efficacy|0
777742|NCT00617461|2473946|P1|First Treatment Intervention Period|Lack of Efficacy|1
777743|NCT00617461|2473945|P2|First Treatment Intervention Period|Adverse Event|0
777744|NCT00617461|2473946|P1|First Treatment Intervention Period|Adverse Event|2
777745|NCT00617591|2473999|P1|Overall Study|Withdrew consent during Maintenance|6
777746|NCT00617591|2473999|P1|Overall Study|Withdrew consent during Induction|4
777747|NCT00617604|2474009|P2|Overall Study|Randomized but Never Received Study Drug|3
777748|NCT00617604|2474010|P1|Overall Study|Randomized but Never Received Study Drug|3
777749|NCT00617604|2474009|P2|Overall Study|Withdrawal by Subject|6
777750|NCT00617604|2474010|P1|Overall Study|Withdrawal by Subject|4
777751|NCT00617604|2474009|P2|Overall Study|Miscellaneous Reasons|10
777752|NCT00617604|2474010|P1|Overall Study|Miscellaneous Reasons|8
777753|NCT00617604|2474009|P2|Overall Study|Lost to Follow-up|0
777754|NCT00617604|2474010|P1|Overall Study|Lost to Follow-up|1
777755|NCT00617604|2474009|P2|Overall Study|Death|1
777756|NCT00617604|2474010|P1|Overall Study|Death|2
777757|NCT00617669|2474056|P2|Overall Study|Patients randomized but not treated|3
777758|NCT00617669|2474057|P1|Overall Study|Patients randomized but not treated|2
777759|NCT00617669|2474056|P2|Overall Study|Reason not otherwise captured, eg; death|290
777760|NCT00617669|2474057|P1|Overall Study|Reason not otherwise captured, eg; death|265
777761|NCT00617669|2474056|P2|Overall Study|Protocol Violation|3
777762|NCT00617669|2474057|P1|Overall Study|Protocol Violation|2
777763|NCT00617669|2474056|P2|Overall Study|Adverse Event|76
777764|NCT00617669|2474057|P1|Overall Study|Adverse Event|87
777765|NCT00617669|2474056|P2|Overall Study|Lost to Follow-up|2
777766|NCT00617669|2474057|P1|Overall Study|Lost to Follow-up|3
777767|NCT00617669|2474056|P2|Overall Study|Withdrawal by Subject|77
777768|NCT00617669|2474057|P1|Overall Study|Withdrawal by Subject|71
777769|NCT00617708|2474080|P3|Overall Study|Not eligible|5
777770|NCT00617708|2474081|P2|Overall Study|Not eligible|3
777771|NCT00617708|2474082|P1|Overall Study|Not eligible|1
777772|NCT00617708|2474080|P3|Overall Study|Not protocol specified|2
777773|NCT00617708|2474081|P2|Overall Study|Not protocol specified|4
777774|NCT00617708|2474082|P1|Overall Study|Not protocol specified|1
777775|NCT00617708|2474080|P3|Overall Study|Progression/Relapse|36
777776|NCT00617708|2474081|P2|Overall Study|Progression/Relapse|40
777777|NCT00617708|2474082|P1|Overall Study|Progression/Relapse|7
777778|NCT00617708|2474080|P3|Overall Study|Death|5
777779|NCT00617708|2474081|P2|Overall Study|Death|6
777780|NCT00617708|2474082|P1|Overall Study|Death|0
777781|NCT00617708|2474080|P3|Overall Study|Withdrawal by Subject|7
777782|NCT00617708|2474081|P2|Overall Study|Withdrawal by Subject|1
777783|NCT00617708|2474082|P1|Overall Study|Withdrawal by Subject|1
777784|NCT00617708|2474080|P3|Overall Study|Adverse Event|9
777785|NCT00617708|2474081|P2|Overall Study|Adverse Event|6
777786|NCT00617708|2474082|P1|Overall Study|Adverse Event|0
777787|NCT00617773|2474097|P1|Overall Study|Protocol Violation|1
777788|NCT00617773|2474097|P1|Overall Study|Progressive disease|19
777789|NCT00617773|2474097|P1|Overall Study|Death|1
777790|NCT00617773|2474097|P1|Overall Study|Withdrawal by Subject|1
777791|NCT00617773|2474097|P1|Overall Study|Lack of compliance with the protocol|1
777792|NCT00617773|2474097|P1|Overall Study|Physician Decision|1
777793|NCT00617851|2474116|P4|Overall Study|Unable to classify|0
777794|NCT00617851|2474117|P3|Overall Study|Unable to classify|1
777795|NCT00617851|2474118|P2|Overall Study|Unable to classify|0
777796|NCT00617851|2474119|P1|Overall Study|Unable to classify|1
777797|NCT00617851|2474116|P4|Overall Study|Inappropriate Enrollment|1
777798|NCT00617851|2474117|P3|Overall Study|Inappropriate Enrollment|1
777799|NCT00617851|2474118|P2|Overall Study|Inappropriate Enrollment|4
777800|NCT00617851|2474119|P1|Overall Study|Inappropriate Enrollment|5
777801|NCT00617851|2474116|P4|Overall Study|Lost to Follow-up|19
777802|NCT00617851|2474117|P3|Overall Study|Lost to Follow-up|31
777803|NCT00617851|2474118|P2|Overall Study|Lost to Follow-up|29
777804|NCT00617851|2474119|P1|Overall Study|Lost to Follow-up|27
777805|NCT00617851|2474116|P4|Overall Study|Withdrawal by Subject|4
777806|NCT00617851|2474117|P3|Overall Study|Withdrawal by Subject|12
777807|NCT00617851|2474118|P2|Overall Study|Withdrawal by Subject|7
777808|NCT00617851|2474119|P1|Overall Study|Withdrawal by Subject|14
777809|NCT00617851|2474116|P4|Overall Study|Death|1
777810|NCT00617851|2474117|P3|Overall Study|Death|0
777811|NCT00617851|2474118|P2|Overall Study|Death|0
777812|NCT00617851|2474119|P1|Overall Study|Death|0
777813|NCT00617890|2474161|P4|Overall Study|Not treated|1
777814|NCT00617890|2474162|P3|Overall Study|Not treated|1
777815|NCT00617890|2474163|P2|Overall Study|Not treated|0
777816|NCT00617890|2474164|P1|Overall Study|Not treated|1
777817|NCT00617890|2474161|P4|Overall Study|Adverse Event|8
777818|NCT00617890|2474162|P3|Overall Study|Adverse Event|3
777819|NCT00617890|2474163|P2|Overall Study|Adverse Event|0
777820|NCT00617890|2474164|P1|Overall Study|Adverse Event|1
777821|NCT00617890|2474161|P4|Overall Study|Protocol Violation|0
777822|NCT00617890|2474162|P3|Overall Study|Protocol Violation|0
777823|NCT00617890|2474163|P2|Overall Study|Protocol Violation|1
777824|NCT00617890|2474164|P1|Overall Study|Protocol Violation|2
777825|NCT00617890|2474161|P4|Overall Study|Withdrawal by Subject|2
777826|NCT00617890|2474162|P3|Overall Study|Withdrawal by Subject|0
777827|NCT00617890|2474163|P2|Overall Study|Withdrawal by Subject|1
777828|NCT00617890|2474164|P1|Overall Study|Withdrawal by Subject|4
777829|NCT00617890|2474161|P4|Overall Study|Lost to Follow-up|2
777830|NCT00617890|2474162|P3|Overall Study|Lost to Follow-up|1
777831|NCT00617890|2474163|P2|Overall Study|Lost to Follow-up|0
777832|NCT00617890|2474164|P1|Overall Study|Lost to Follow-up|0
777833|NCT00617890|2474161|P4|Overall Study|Lack of Efficacy|97
777834|NCT00617890|2474162|P3|Overall Study|Lack of Efficacy|30
777835|NCT00617890|2474163|P2|Overall Study|Lack of Efficacy|26
777836|NCT00617890|2474164|P1|Overall Study|Lack of Efficacy|23
777837|NCT00617890|2474161|P4|Overall Study|Treatment ongoing at data cut-off|5
777838|NCT00617890|2474162|P3|Overall Study|Treatment ongoing at data cut-off|0
777839|NCT00617890|2474163|P2|Overall Study|Treatment ongoing at data cut-off|0
777840|NCT00617890|2474164|P1|Overall Study|Treatment ongoing at data cut-off|0
777841|NCT00617903|2474198|P2|Overall Study|noncompliance|1
777842|NCT00617903|2474199|P1|Overall Study|noncompliance|0
777843|NCT00617903|2474198|P2|Overall Study|Adverse Event|1
777844|NCT00617903|2474199|P1|Overall Study|Adverse Event|0
777845|NCT00617903|2474198|P2|Overall Study|Lack of Efficacy|1
777846|NCT00617903|2474199|P1|Overall Study|Lack of Efficacy|0
777847|NCT00617903|2474198|P2|Overall Study|Lost to Follow-up|1
777848|NCT00617903|2474199|P1|Overall Study|Lost to Follow-up|1
777849|NCT00617903|2474198|P2|Overall Study|Withdrawal by Subject|3
777850|NCT00617903|2474199|P1|Overall Study|Withdrawal by Subject|2
777851|NCT00617929|2474241|P1|Overall Study|Physician Decision|1
777852|NCT00618072|2474278|P3|Overall Study|Physician Decision|1
777853|NCT00618072|2474279|P2|Overall Study|Physician Decision|1
777854|NCT00618072|2474280|P1|Overall Study|Physician Decision|0
777855|NCT00618072|2474278|P3|Overall Study|Lost to Follow-up|3
777856|NCT00618072|2474279|P2|Overall Study|Lost to Follow-up|0
777857|NCT00618072|2474280|P1|Overall Study|Lost to Follow-up|2
777858|NCT00610363|2474321|P2|Overall Study|Other than specified above|1
777859|NCT00610363|2474322|P1|Overall Study|Other than specified above|1
777860|NCT00610363|2474321|P2|Overall Study|Withdrawal by Subject|0
777861|NCT00610363|2474322|P1|Overall Study|Withdrawal by Subject|1
777862|NCT00610363|2474321|P2|Overall Study|Lost to Follow-up|0
777863|NCT00610363|2474322|P1|Overall Study|Lost to Follow-up|4
777864|NCT00610363|2474321|P2|Overall Study|Lack of Efficacy|0
777865|NCT00610363|2474322|P1|Overall Study|Lack of Efficacy|2
777866|NCT00610363|2474321|P2|Overall Study|Adverse Event|1
777867|NCT00610363|2474322|P1|Overall Study|Adverse Event|3
777868|NCT00610363|2474321|P2|Overall Study|Non-compliance with protocol|1
777869|NCT00610363|2474322|P1|Overall Study|Non-compliance with protocol|0
777870|NCT00610441|2474344|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
777871|NCT00610441|2474345|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
777872|NCT00610441|2474346|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
777873|NCT00610441|2474347|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
777874|NCT00610441|2474344|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
777875|NCT00610441|2474345|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
777876|NCT00610441|2474346|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
777877|NCT00610441|2474347|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
777878|NCT00610441|2474344|P4|Treatment Period 2 - 3 Weeks|Unspecified|1
777879|NCT00610441|2474345|P3|Treatment Period 2 - 3 Weeks|Unspecified|0
777880|NCT00610441|2474346|P2|Treatment Period 2 - 3 Weeks|Unspecified|1
777881|NCT00610441|2474347|P1|Treatment Period 2 - 3 Weeks|Unspecified|1
777882|NCT00610441|2474344|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
777883|NCT00610441|2474345|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
777884|NCT00610441|2474346|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
777885|NCT00610441|2474347|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
777886|NCT00610441|2474344|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
777887|NCT00610441|2474345|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
777888|NCT00610441|2474346|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
777889|NCT00610441|2474347|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
777890|NCT00610441|2474344|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
777891|NCT00610441|2474345|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
777892|NCT00610441|2474346|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
777893|NCT00610441|2474347|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
777894|NCT00610441|2474344|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
777895|NCT00610441|2474345|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
777896|NCT00610441|2474346|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
777897|NCT00610441|2474347|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
777898|NCT00610441|2474344|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
777899|NCT00610441|2474345|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
777900|NCT00610441|2474346|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
777901|NCT00610441|2474347|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
777902|NCT00610441|2474344|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
777903|NCT00610441|2474345|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
777904|NCT00610441|2474346|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
777905|NCT00610441|2474347|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
777906|NCT00610649|2474455|P11|Overall Study|Withdrawal by Subject|0
777907|NCT00610649|2474456|P10|Overall Study|Withdrawal by Subject|1
777908|NCT00610649|2474457|P9|Overall Study|Withdrawal by Subject|0
777909|NCT00610649|2474458|P8|Overall Study|Withdrawal by Subject|0
777910|NCT00610649|2474459|P7|Overall Study|Withdrawal by Subject|0
777911|NCT00610649|2474460|P6|Overall Study|Withdrawal by Subject|0
777912|NCT00610649|2474461|P5|Overall Study|Withdrawal by Subject|0
777913|NCT00610649|2474462|P4|Overall Study|Withdrawal by Subject|0
777914|NCT00610649|2474463|P3|Overall Study|Withdrawal by Subject|0
777915|NCT00610649|2474464|P2|Overall Study|Withdrawal by Subject|0
777916|NCT00610649|2474465|P1|Overall Study|Withdrawal by Subject|0
777917|NCT00610649|2474455|P11|Overall Study|Family Emergency|0
777918|NCT00610649|2474456|P10|Overall Study|Family Emergency|0
777919|NCT00610649|2474457|P9|Overall Study|Family Emergency|0
777920|NCT00610649|2474458|P8|Overall Study|Family Emergency|0
777921|NCT00610649|2474459|P7|Overall Study|Family Emergency|0
777922|NCT00610649|2474460|P6|Overall Study|Family Emergency|0
777923|NCT00610649|2474461|P5|Overall Study|Family Emergency|0
777924|NCT00610649|2474462|P4|Overall Study|Family Emergency|0
777925|NCT00610649|2474463|P3|Overall Study|Family Emergency|0
777926|NCT00610649|2474464|P2|Overall Study|Family Emergency|1
777927|NCT00610649|2474465|P1|Overall Study|Family Emergency|0
777928|NCT00610649|2474455|P11|Overall Study|Adverse Event|1
777929|NCT00610649|2474456|P10|Overall Study|Adverse Event|0
777930|NCT00610649|2474457|P9|Overall Study|Adverse Event|0
777931|NCT00610649|2474458|P8|Overall Study|Adverse Event|0
777932|NCT00610649|2474459|P7|Overall Study|Adverse Event|0
777933|NCT00610649|2474460|P6|Overall Study|Adverse Event|0
777934|NCT00610649|2474461|P5|Overall Study|Adverse Event|0
777935|NCT00610649|2474462|P4|Overall Study|Adverse Event|0
777936|NCT00610649|2474463|P3|Overall Study|Adverse Event|0
777937|NCT00610649|2474464|P2|Overall Study|Adverse Event|0
777938|NCT00610649|2474465|P1|Overall Study|Adverse Event|1
777939|NCT00610675|2474519|P1|Overall Study|Other reason (not specified)|25
777940|NCT00610675|2474519|P1|Overall Study|Lost to Follow-up|31
777941|NCT00610675|2474519|P1|Overall Study|Lack of Compliance|7
777942|NCT00610675|2474519|P1|Overall Study|Reasons unrelated to trial|27
777943|NCT00610675|2474519|P1|Overall Study|Withdrawal by Subject|28
777944|NCT00610675|2474519|P1|Overall Study|Insufficient Effect|31
777945|NCT00610675|2474519|P1|Overall Study|Adverse Event|67
777946|NCT00610675|2474519|P1|Overall Study|Untreated|4
777947|NCT00610714|2474560|P2|Overall Study|Study completion at 120 PFS events|2
777948|NCT00610714|2474561|P1|Overall Study|Study completion at 120 PFS events|2
777949|NCT00610714|2474560|P2|Overall Study|Withdrawal by Subject|3
777950|NCT00610714|2474561|P1|Overall Study|Withdrawal by Subject|9
777951|NCT00610714|2474560|P2|Overall Study|Death|18
777952|NCT00610714|2474561|P1|Overall Study|Death|12
777953|NCT00610714|2474560|P2|Overall Study|Adverse Event|1
777954|NCT00610714|2474561|P1|Overall Study|Adverse Event|3
777955|NCT00610857|2474577|P1|Overall Study|Not evaluable for response|2
777956|NCT00611026|2474600|P3|Double-blind Treatment Period|Unspecified|18
777957|NCT00611026|2474601|P2|Double-blind Treatment Period|Unspecified|20
777958|NCT00611026|2474602|P1|Double-blind Treatment Period|Unspecified|13
777959|NCT00611026|2474600|P3|Double-blind Treatment Period|Withdrawal by Subject|16
777960|NCT00611026|2474601|P2|Double-blind Treatment Period|Withdrawal by Subject|19
777961|NCT00611026|2474602|P1|Double-blind Treatment Period|Withdrawal by Subject|7
777962|NCT00611026|2474600|P3|Double-blind Treatment Period|Lost to Follow-up|14
777963|NCT00611026|2474601|P2|Double-blind Treatment Period|Lost to Follow-up|11
777964|NCT00611026|2474602|P1|Double-blind Treatment Period|Lost to Follow-up|6
777965|NCT00611026|2474600|P3|Double-blind Treatment Period|Lack of Efficacy|4
777966|NCT00611026|2474601|P2|Double-blind Treatment Period|Lack of Efficacy|10
777967|NCT00611026|2474602|P1|Double-blind Treatment Period|Lack of Efficacy|11
777968|NCT00611026|2474600|P3|Double-blind Treatment Period|Adverse Event|46
777969|NCT00611026|2474601|P2|Double-blind Treatment Period|Adverse Event|28
777970|NCT00611026|2474602|P1|Double-blind Treatment Period|Adverse Event|9
777971|NCT00611026|2474600|P3|Double-blind Treatment Period|Death|0
777972|NCT00611026|2474601|P2|Double-blind Treatment Period|Death|0
777973|NCT00611026|2474602|P1|Double-blind Treatment Period|Death|1
777974|NCT00611026|2474600|P3|Randomized to Double-blind Treatment|Not treated|3
777975|NCT00611026|2474601|P2|Randomized to Double-blind Treatment|Not treated|1
777976|NCT00611026|2474602|P1|Randomized to Double-blind Treatment|Not treated|2
891865|NCT01072149|2828543|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891866|NCT01072149|2828544|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891867|NCT01072149|2828545|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891868|NCT01072149|2828546|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891869|NCT01072149|2828547|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891870|NCT01072149|2828548|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891871|NCT01072149|2828549|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
891872|NCT01072149|2828532|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
891873|NCT01072149|2828533|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
891874|NCT01072149|2828534|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
891875|NCT01072149|2828535|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
891876|NCT01072149|2828536|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
777993|NCT00618371|2474701|P1|Overall Study|Withdrawal by Subject|2
777994|NCT00618410|2474706|P2|Washout Period (2 Weeks)|Physician Decision|1
777995|NCT00618410|2474707|P1|Washout Period (2 Weeks)|Physician Decision|0
777996|NCT00618449|2474738|P2|Overall Study|Lost to Follow-up|110
777997|NCT00618449|2474739|P1|Overall Study|Lost to Follow-up|98
777998|NCT00618514|2474747|P3|Overall Study|Lost to Follow-up|4
777999|NCT00618514|2474748|P2|Overall Study|Lost to Follow-up|12
778000|NCT00618514|2474749|P1|Overall Study|Lost to Follow-up|11
778001|NCT00618618|2474782|P4|Overall Study|Death|0
778002|NCT00618618|2474783|P3|Overall Study|Death|0
778003|NCT00618618|2474784|P2|Overall Study|Death|1
778004|NCT00618618|2474785|P1|Overall Study|Death|0
778005|NCT00618618|2474782|P4|Overall Study|Did Not Meet Entry Criteria|0
778006|NCT00618618|2474783|P3|Overall Study|Did Not Meet Entry Criteria|1
778007|NCT00618618|2474784|P2|Overall Study|Did Not Meet Entry Criteria|0
778008|NCT00618618|2474785|P1|Overall Study|Did Not Meet Entry Criteria|0
778009|NCT00618618|2474782|P4|Overall Study|Non-compliance|0
778010|NCT00618618|2474783|P3|Overall Study|Non-compliance|0
778011|NCT00618618|2474784|P2|Overall Study|Non-compliance|1
778012|NCT00618618|2474785|P1|Overall Study|Non-compliance|1
778013|NCT00618618|2474782|P4|Overall Study|Lost to Follow-up|1
778014|NCT00618618|2474783|P3|Overall Study|Lost to Follow-up|0
778015|NCT00618618|2474784|P2|Overall Study|Lost to Follow-up|0
778016|NCT00618618|2474785|P1|Overall Study|Lost to Follow-up|3
778017|NCT00618618|2474782|P4|Overall Study|Inability to Complete Study Procedures|0
778018|NCT00618618|2474783|P3|Overall Study|Inability to Complete Study Procedures|0
778019|NCT00618618|2474784|P2|Overall Study|Inability to Complete Study Procedures|1
778020|NCT00618618|2474785|P1|Overall Study|Inability to Complete Study Procedures|0
778021|NCT00618618|2474782|P4|Overall Study|Patient Request|0
778022|NCT00618618|2474783|P3|Overall Study|Patient Request|2
778023|NCT00618618|2474784|P2|Overall Study|Patient Request|0
778024|NCT00618618|2474785|P1|Overall Study|Patient Request|0
778025|NCT00618722|2474835|P4|Overall Study|Miscellaneous Reasons|1
778026|NCT00618722|2474836|P3|Overall Study|Miscellaneous Reasons|1
778027|NCT00618722|2474837|P2|Overall Study|Miscellaneous Reasons|0
778028|NCT00618722|2474838|P1|Overall Study|Miscellaneous Reasons|0
778029|NCT00618722|2474835|P4|Overall Study|Lost to Follow-up|2
778030|NCT00618722|2474836|P3|Overall Study|Lost to Follow-up|0
778031|NCT00618722|2474837|P2|Overall Study|Lost to Follow-up|0
778032|NCT00618722|2474838|P1|Overall Study|Lost to Follow-up|2
778033|NCT00618722|2474835|P4|Overall Study|Inability to Complete Study Procedure|0
778034|NCT00618722|2474836|P3|Overall Study|Inability to Complete Study Procedure|0
778035|NCT00618722|2474837|P2|Overall Study|Inability to Complete Study Procedure|1
778036|NCT00618722|2474838|P1|Overall Study|Inability to Complete Study Procedure|0
778037|NCT00618722|2474835|P4|Overall Study|Patient Request|1
778038|NCT00618722|2474836|P3|Overall Study|Patient Request|1
778039|NCT00618722|2474837|P2|Overall Study|Patient Request|1
778040|NCT00618722|2474838|P1|Overall Study|Patient Request|1
778041|NCT00618722|2474835|P4|Overall Study|Refusal of Treatment|0
778042|NCT00618722|2474836|P3|Overall Study|Refusal of Treatment|1
778043|NCT00618722|2474837|P2|Overall Study|Refusal of Treatment|0
778044|NCT00618722|2474838|P1|Overall Study|Refusal of Treatment|0
778045|NCT00618748|2474875|P3|Overall Study|Withdrawal by Subject|5
778046|NCT00618748|2474876|P2|Overall Study|Withdrawal by Subject|1
778047|NCT00618748|2474877|P1|Overall Study|Withdrawal by Subject|4
778048|NCT00618748|2474875|P3|Overall Study|Physician Decision|1
778049|NCT00618748|2474876|P2|Overall Study|Physician Decision|1
778050|NCT00618748|2474877|P1|Overall Study|Physician Decision|3
778051|NCT00618748|2474875|P3|Overall Study|Adverse Event|8
778052|NCT00618748|2474876|P2|Overall Study|Adverse Event|3
778053|NCT00618748|2474877|P1|Overall Study|Adverse Event|4
778054|NCT00618774|2474920|P2|Overall Study|Withdrawal by Subject|0
778055|NCT00618774|2474921|P1|Overall Study|Withdrawal by Subject|1
778056|NCT00618774|2474920|P2|Overall Study|Adverse Event|3
778057|NCT00618774|2474921|P1|Overall Study|Adverse Event|5
778058|NCT00618787|2474953|P2|Overall Study|Lost to Follow-up|0
778059|NCT00618787|2474954|P1|Overall Study|Lost to Follow-up|1
778060|NCT00618787|2474953|P2|Overall Study|Withdrawal by Subject|1
778061|NCT00618787|2474954|P1|Overall Study|Withdrawal by Subject|2
778062|NCT00618787|2474953|P2|Overall Study|Adverse Event|1
778063|NCT00618787|2474954|P1|Overall Study|Adverse Event|0
778064|NCT00618813|2474960|P1|Overall Study|Withdrawal by Subject|1
778065|NCT00618813|2474960|P1|Overall Study|Physician Decision|2
778066|NCT00618813|2474960|P1|Overall Study|Lack of Efficacy|1
778067|NCT00618826|2474968|P1|Overall Study|Adverse Event|1
778068|NCT00618956|2474984|P2|Overall Study|did not meet criteria, non-compliance|1
778069|NCT00618956|2474985|P1|Overall Study|did not meet criteria, non-compliance|2
778070|NCT00618956|2474984|P2|Overall Study|Protocol Violation|2
778071|NCT00618956|2474985|P1|Overall Study|Protocol Violation|2
778072|NCT00618956|2474984|P2|Overall Study|Lost to Follow-up|5
778073|NCT00618956|2474985|P1|Overall Study|Lost to Follow-up|4
778074|NCT00618956|2474984|P2|Overall Study|Withdrawal by Subject|7
778075|NCT00618956|2474985|P1|Overall Study|Withdrawal by Subject|5
778076|NCT00618956|2474984|P2|Overall Study|Lack of Efficacy|1
778077|NCT00618956|2474985|P1|Overall Study|Lack of Efficacy|2
778078|NCT00618956|2474984|P2|Overall Study|Adverse Event|34
778079|NCT00618956|2474985|P1|Overall Study|Adverse Event|10
778080|NCT00618982|2475001|P1|Overall Study|ongoing, still treated with study med.|25
778081|NCT00618982|2475001|P1|Overall Study|Protocol Violation|1
778082|NCT00618982|2475001|P1|Overall Study|Withdrawal by Subject|1
778083|NCT00618982|2475001|P1|Overall Study|Adverse Event|23
778084|NCT00618995|2475022|P4|Period 4|Adverse Event|0
778085|NCT00618995|2475023|P3|Period 4|Adverse Event|0
778086|NCT00618995|2475024|P2|Period 4|Adverse Event|0
778087|NCT00618995|2475025|P1|Period 4|Adverse Event|1
778088|NCT00618995|2475022|P4|Period 2|Protocol Violation|0
778089|NCT00618995|2475023|P3|Period 2|Protocol Violation|1
778090|NCT00618995|2475024|P2|Period 2|Protocol Violation|0
778091|NCT00618995|2475025|P1|Period 2|Protocol Violation|0
778092|NCT00618995|2475022|P4|Period 1|Protocol Violation|0
778093|NCT00618995|2475023|P3|Period 1|Protocol Violation|1
778094|NCT00618995|2475024|P2|Period 1|Protocol Violation|1
778095|NCT00618995|2475025|P1|Period 1|Protocol Violation|0
778096|NCT00618995|2475022|P4|Period 1|Adverse Event|0
778097|NCT00618995|2475023|P3|Period 1|Adverse Event|1
778098|NCT00618995|2475024|P2|Period 1|Adverse Event|0
778099|NCT00618995|2475025|P1|Period 1|Adverse Event|0
778100|NCT00619099|2475057|P2|Overall Study|Physician Decision|6
778101|NCT00619099|2475058|P1|Overall Study|Physician Decision|9
778102|NCT00619099|2475057|P2|Overall Study|Withdrawal by Subject|2
778103|NCT00619099|2475058|P1|Overall Study|Withdrawal by Subject|10
778104|NCT00619099|2475057|P2|Overall Study|Emergence of Clinically Significant Lab|2
778105|NCT00619099|2475058|P1|Overall Study|Emergence of Clinically Significant Lab|1
778106|NCT00619099|2475057|P2|Overall Study|Adverse Event|3
778107|NCT00619099|2475058|P1|Overall Study|Adverse Event|4
778108|NCT00619099|2475057|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
778109|NCT00619099|2475058|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
778110|NCT00619099|2475057|P2|Overall Study|Progressive Disease|5
778111|NCT00619099|2475058|P1|Overall Study|Progressive Disease|7
778112|NCT00619151|2475070|P2|Overall Study|Study terminated prior to followup|0
778113|NCT00619151|2475071|P1|Overall Study|Study terminated prior to followup|1
778114|NCT00619177|2475079|P1|Overall Study|Not specified reasons|6
778115|NCT00619177|2475079|P1|Overall Study|Missing termination information|481
778116|NCT00619177|2475079|P1|Overall Study|Lack of Efficacy|1
778117|NCT00619177|2475079|P1|Overall Study|Lost to Follow-up|2
778118|NCT00619177|2475079|P1|Overall Study|Adverse Event|18
778119|NCT00619229|2475102|P2|Overall Study|Investigator planned Cataract Operation|0
778120|NCT00619229|2475103|P1|Overall Study|Investigator planned Cataract Operation|1
778121|NCT00619229|2475102|P2|Overall Study|Termination of the Study by the Sponsor|1
778122|NCT00619229|2475103|P1|Overall Study|Termination of the Study by the Sponsor|1
778123|NCT00619229|2475102|P2|Overall Study|Lost to Follow-up|0
778124|NCT00619229|2475103|P1|Overall Study|Lost to Follow-up|1
778125|NCT00619229|2475102|P2|Overall Study|Withdrawal by Subject|1
778126|NCT00619229|2475103|P1|Overall Study|Withdrawal by Subject|1
778127|NCT00619307|2475135|P2|Overall Study|MS attack plus steroids|1
778128|NCT00619307|2475136|P1|Overall Study|MS attack plus steroids|0
778129|NCT00619307|2475135|P2|Overall Study|Severe migraine|1
778130|NCT00619307|2475136|P1|Overall Study|Severe migraine|0
778131|NCT00619307|2475135|P2|Overall Study|Withdrew consent|0
778132|NCT00619307|2475136|P1|Overall Study|Withdrew consent|1
778133|NCT00619307|2475135|P2|Overall Study|Protocol Violation|0
778134|NCT00619307|2475136|P1|Overall Study|Protocol Violation|3
778135|NCT00619307|2475135|P2|Overall Study|Lost to Follow-up|1
778136|NCT00619307|2475136|P1|Overall Study|Lost to Follow-up|0
778137|NCT00619307|2475135|P2|Overall Study|Adverse Event|1
778138|NCT00619307|2475136|P1|Overall Study|Adverse Event|0
778139|NCT00619359|2475152|P2|Overall Study|Progressive Disease|1
778140|NCT00619359|2475153|P1|Overall Study|Progressive Disease|3
778141|NCT00619359|2475152|P2|Overall Study|Withdrawal by Subject|20
778142|NCT00619359|2475153|P1|Overall Study|Withdrawal by Subject|19
778143|NCT00619359|2475152|P2|Overall Study|Protocol Violation|1
778144|NCT00619359|2475153|P1|Overall Study|Protocol Violation|1
778145|NCT00619359|2475152|P2|Overall Study|Physician Decision|7
778146|NCT00619359|2475153|P1|Overall Study|Physician Decision|0
778147|NCT00619359|2475152|P2|Overall Study|Lost to Follow-up|16
778148|NCT00619359|2475153|P1|Overall Study|Lost to Follow-up|12
778149|NCT00619359|2475152|P2|Overall Study|Adverse Event|36
778150|NCT00619359|2475153|P1|Overall Study|Adverse Event|32
778151|NCT00619385|2475166|P3|Overall Study|Other|1
778152|NCT00619385|2475167|P2|Overall Study|Other|2
778153|NCT00619385|2475168|P1|Overall Study|Other|1
778154|NCT00619385|2475166|P3|Overall Study|Adverse Event|3
778155|NCT00619385|2475167|P2|Overall Study|Adverse Event|0
778156|NCT00619385|2475168|P1|Overall Study|Adverse Event|0
778157|NCT00619476|2475185|P4|Overall Study|Withdrawal by Subject|4
778158|NCT00619476|2475186|P3|Overall Study|Withdrawal by Subject|5
778159|NCT00619476|2475187|P2|Overall Study|Withdrawal by Subject|7
778160|NCT00619476|2475188|P1|Overall Study|Withdrawal by Subject|5
778161|NCT00619476|2475185|P4|Overall Study|Investigator Discretion|0
778162|NCT00619476|2475186|P3|Overall Study|Investigator Discretion|2
778163|NCT00619476|2475187|P2|Overall Study|Investigator Discretion|2
778164|NCT00619476|2475188|P1|Overall Study|Investigator Discretion|2
778165|NCT00619476|2475185|P4|Overall Study|Lost to Follow-up|1
778166|NCT00619476|2475186|P3|Overall Study|Lost to Follow-up|0
778167|NCT00619476|2475187|P2|Overall Study|Lost to Follow-up|2
778168|NCT00619476|2475188|P1|Overall Study|Lost to Follow-up|1
778169|NCT00619476|2475185|P4|Overall Study|Protocol Violation|9
778170|NCT00619476|2475186|P3|Overall Study|Protocol Violation|4
778171|NCT00619476|2475187|P2|Overall Study|Protocol Violation|4
778172|NCT00619476|2475188|P1|Overall Study|Protocol Violation|5
778173|NCT00619476|2475185|P4|Overall Study|Lack of Efficacy|4
778174|NCT00619476|2475186|P3|Overall Study|Lack of Efficacy|1
778175|NCT00619476|2475187|P2|Overall Study|Lack of Efficacy|1
778176|NCT00619476|2475188|P1|Overall Study|Lack of Efficacy|6
778177|NCT00619476|2475185|P4|Overall Study|Adverse Event|16
778178|NCT00619476|2475186|P3|Overall Study|Adverse Event|12
778179|NCT00619476|2475187|P2|Overall Study|Adverse Event|6
778180|NCT00619476|2475188|P1|Overall Study|Adverse Event|12
778181|NCT00619489|2475272|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
778182|NCT00619489|2475273|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
778183|NCT00619489|2475272|P2|Overall Study|Lack of Efficacy|11
778184|NCT00619489|2475273|P1|Overall Study|Lack of Efficacy|0
778185|NCT00619489|2475272|P2|Overall Study|Withdrawal by Subject|1
778186|NCT00619489|2475273|P1|Overall Study|Withdrawal by Subject|1
778187|NCT00619489|2475272|P2|Overall Study|Adverse Event|7
778188|NCT00619489|2475273|P1|Overall Study|Adverse Event|0
778189|NCT00619502|2475293|P2|Overall Study|Lost to Follow-up|10
778190|NCT00619502|2475294|P1|Overall Study|Lost to Follow-up|8
778191|NCT00619619|2475312|P8|Overall Study|Adverse Event|2
778192|NCT00619619|2475313|P7|Overall Study|Adverse Event|0
778193|NCT00619619|2475314|P6|Overall Study|Adverse Event|0
778194|NCT00619619|2475315|P5|Overall Study|Adverse Event|2
778195|NCT00619619|2475316|P4|Overall Study|Adverse Event|0
778196|NCT00619619|2475317|P3|Overall Study|Adverse Event|0
778197|NCT00619619|2475318|P2|Overall Study|Adverse Event|0
778198|NCT00619619|2475319|P1|Overall Study|Adverse Event|0
778199|NCT00619619|2475312|P8|Overall Study|Protocol Violation|1
778200|NCT00619619|2475313|P7|Overall Study|Protocol Violation|1
778201|NCT00619619|2475314|P6|Overall Study|Protocol Violation|0
778202|NCT00619619|2475315|P5|Overall Study|Protocol Violation|0
778203|NCT00619619|2475316|P4|Overall Study|Protocol Violation|1
778204|NCT00619619|2475317|P3|Overall Study|Protocol Violation|0
778205|NCT00619619|2475318|P2|Overall Study|Protocol Violation|0
778206|NCT00619619|2475319|P1|Overall Study|Protocol Violation|0
778207|NCT00619619|2475312|P8|Overall Study|Physician Decision|0
778208|NCT00619619|2475313|P7|Overall Study|Physician Decision|0
778209|NCT00619619|2475314|P6|Overall Study|Physician Decision|0
778210|NCT00619619|2475315|P5|Overall Study|Physician Decision|0
778211|NCT00619619|2475316|P4|Overall Study|Physician Decision|0
778212|NCT00619619|2475317|P3|Overall Study|Physician Decision|1
778213|NCT00619619|2475318|P2|Overall Study|Physician Decision|0
778214|NCT00619619|2475319|P1|Overall Study|Physician Decision|0
778215|NCT00619645|2475404|P1|Overall Study|Adverse Event|1
778216|NCT00619801|2475426|P2|Overall Study|Loss of efficacy|1
778217|NCT00619801|2475427|P1|Overall Study|Loss of efficacy|0
778218|NCT00619801|2475426|P2|Overall Study|Withdrawal by Subject|1
778219|NCT00619801|2475427|P1|Overall Study|Withdrawal by Subject|1
778220|NCT00619801|2475426|P2|Overall Study|Lack of Efficacy|1
778221|NCT00619801|2475427|P1|Overall Study|Lack of Efficacy|0
778222|NCT00619827|2475459|P2|Overall Study|Withdrawal by Subject|2
778223|NCT00619827|2475460|P1|Overall Study|Withdrawal by Subject|2
778224|NCT00619827|2475459|P2|Overall Study|Adverse Event|2
778225|NCT00619827|2475460|P1|Overall Study|Adverse Event|1
778226|NCT00619892|2475468|P2|Overall Study|Intercurrent illness|1
778227|NCT00619892|2475469|P1|Overall Study|Intercurrent illness|0
778228|NCT00619892|2475468|P2|Overall Study|Lost to Follow-up|1
778229|NCT00619892|2475469|P1|Overall Study|Lost to Follow-up|0
778230|NCT00619892|2475468|P2|Overall Study|Adverse Event|0
778231|NCT00619892|2475469|P1|Overall Study|Adverse Event|3
778232|NCT00619918|2475479|P2|Overall Study|Left before receiving first dose|8
778233|NCT00619918|2475480|P1|Overall Study|Left before receiving first dose|5
778234|NCT00619918|2475479|P2|Overall Study|Transfer to outside facility|3
778235|NCT00619918|2475480|P1|Overall Study|Transfer to outside facility|3
778236|NCT00619918|2475479|P2|Overall Study|Physician Decision|8
778237|NCT00619918|2475480|P1|Overall Study|Physician Decision|8
778238|NCT00619918|2475479|P2|Overall Study|Withdrawal by Subject|3
778239|NCT00619918|2475480|P1|Overall Study|Withdrawal by Subject|4
778240|NCT00619957|2475490|P2|Month 48 Open-Label|Withdrawal by Subject|9
778241|NCT00619957|2475491|P1|Month 48 Open-Label|Withdrawal by Subject|6
778242|NCT00619957|2475490|P2|Month 48 Open-Label|Lost to Follow-up|4
778243|NCT00619957|2475491|P1|Month 48 Open-Label|Lost to Follow-up|2
778244|NCT00619957|2475490|P2|Month 48 Open-Label|Adverse Event|4
778245|NCT00619957|2475491|P1|Month 48 Open-Label|Adverse Event|4
778246|NCT00619957|2475490|P2|Month 24 Double-Blind|Did not take any study medication|1
778247|NCT00619957|2475491|P1|Month 24 Double-Blind|Did not take any study medication|0
778248|NCT00619957|2475490|P2|Month 24 Double-Blind|Lost to Follow-up|0
778249|NCT00619957|2475491|P1|Month 24 Double-Blind|Lost to Follow-up|1
778250|NCT00619957|2475490|P2|Month 24 Double-Blind|Withdrawal by Subject|9
778251|NCT00619957|2475491|P1|Month 24 Double-Blind|Withdrawal by Subject|7
778252|NCT00619957|2475490|P2|Month 24 Double-Blind|Protocol Violation|0
778253|NCT00619957|2475491|P1|Month 24 Double-Blind|Protocol Violation|1
778254|NCT00619957|2475490|P2|Month 24 Double-Blind|Adverse Event|7
778255|NCT00619957|2475491|P1|Month 24 Double-Blind|Adverse Event|9
891877|NCT01072149|2828537|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
891878|NCT01072149|2828538|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
891879|NCT01072149|2828539|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
891880|NCT01072149|2828540|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
891881|NCT01072149|2828541|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
891882|NCT01072149|2828542|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
891883|NCT01072149|2828543|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
778264|NCT00620022|2475603|P2|Treatment Period 2|Adverse Event|2
778265|NCT00620022|2475604|P1|Treatment Period 2|Adverse Event|2
778266|NCT00620022|2475603|P2|Treatment Period 1|Subject withdrew consent|0
778267|NCT00620022|2475604|P1|Treatment Period 1|Subject withdrew consent|1
778268|NCT00620022|2475603|P2|Treatment Period 1|Adverse Event|6
778269|NCT00620022|2475604|P1|Treatment Period 1|Adverse Event|4
778270|NCT00620035|2475612|P1|Overall Study|Other Reason|38
778271|NCT00620035|2475612|P1|Overall Study|Withdrawal of Informed Consent|1
778272|NCT00620035|2475612|P1|Overall Study|Adverse Event|106
778273|NCT00620074|2475622|P1|Overall Study|Adverse Event|1
778274|NCT00620113|2475634|P4|Overall Study|Withdrawal by Subject|5
778275|NCT00620113|2475635|P3|Overall Study|Withdrawal by Subject|3
778276|NCT00620113|2475636|P2|Overall Study|Withdrawal by Subject|1
778277|NCT00620113|2475637|P1|Overall Study|Withdrawal by Subject|5
778278|NCT00620113|2475634|P4|Overall Study|Protocol Violation|0
778279|NCT00620113|2475635|P3|Overall Study|Protocol Violation|0
778280|NCT00620113|2475636|P2|Overall Study|Protocol Violation|1
778281|NCT00620113|2475637|P1|Overall Study|Protocol Violation|2
778282|NCT00620113|2475634|P4|Overall Study|Physician Decision|2
778283|NCT00620113|2475635|P3|Overall Study|Physician Decision|0
778284|NCT00620113|2475636|P2|Overall Study|Physician Decision|0
778285|NCT00620113|2475637|P1|Overall Study|Physician Decision|1
778286|NCT00620113|2475634|P4|Overall Study|Lack of Efficacy|2
778287|NCT00620113|2475635|P3|Overall Study|Lack of Efficacy|0
778288|NCT00620113|2475636|P2|Overall Study|Lack of Efficacy|3
778289|NCT00620113|2475637|P1|Overall Study|Lack of Efficacy|2
778290|NCT00620113|2475634|P4|Overall Study|Adverse Event|1
778291|NCT00620113|2475635|P3|Overall Study|Adverse Event|2
778292|NCT00620113|2475636|P2|Overall Study|Adverse Event|2
778293|NCT00620113|2475637|P1|Overall Study|Adverse Event|3
778294|NCT00620282|2475703|P3|Overall Study|Withdrawal by Subject|0
778295|NCT00620282|2475704|P2|Overall Study|Withdrawal by Subject|1
778296|NCT00620282|2475705|P1|Overall Study|Withdrawal by Subject|0
778297|NCT00620282|2475703|P3|Overall Study|Arterial line unable to be placed|1
778298|NCT00620282|2475704|P2|Overall Study|Arterial line unable to be placed|0
778299|NCT00620282|2475705|P1|Overall Study|Arterial line unable to be placed|0
778300|NCT00620282|2475703|P3|Overall Study|Adverse Event|0
778301|NCT00620282|2475704|P2|Overall Study|Adverse Event|1
778302|NCT00620282|2475705|P1|Overall Study|Adverse Event|0
778303|NCT00620373|2475752|P1|Overall Study|Unverified cancer status|33
778304|NCT00620464|2475781|P2|Overall Study|Used prohibited medication|0
778305|NCT00620464|2475782|P1|Overall Study|Used prohibited medication|1
778306|NCT00620464|2475781|P2|Overall Study|Personal|2
778307|NCT00620464|2475782|P1|Overall Study|Personal|2
778308|NCT00620464|2475781|P2|Overall Study|Planning Pregnancy|4
778309|NCT00620464|2475782|P1|Overall Study|Planning Pregnancy|1
778310|NCT00620464|2475781|P2|Overall Study|Lost to Follow-up|1
778311|NCT00620464|2475782|P1|Overall Study|Lost to Follow-up|1
778312|NCT00620464|2475781|P2|Overall Study|Adverse Event|17
778313|NCT00620464|2475782|P1|Overall Study|Adverse Event|15
778314|NCT00620542|2475792|P4|Part B (2 Year Core Study)|IVUS not available|2
778315|NCT00620542|2475793|P3|Part B (2 Year Core Study)|IVUS not available|3
778316|NCT00620542|2475794|P2|Part B (2 Year Core Study)|IVUS not available|0
778317|NCT00620542|2475795|P1|Part B (2 Year Core Study)|IVUS not available|0
778318|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
778319|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
778320|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
778321|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
778322|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Safety reasons|3
778323|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Safety reasons|2
778324|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Safety reasons|0
778325|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Safety reasons|0
778326|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Protocol Violation|16
778327|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Protocol Violation|13
778328|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Protocol Violation|0
778329|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Protocol Violation|0
778330|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
778331|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
778332|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
778333|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
778334|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
778335|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
778336|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
778337|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
778338|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Protocol Violation|5
778339|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Protocol Violation|3
778340|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Protocol Violation|0
778341|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Protocol Violation|0
778342|NCT00620542|2475792|P4|Part B (2 Year Core Study)|Adverse Event|49
778343|NCT00620542|2475793|P3|Part B (2 Year Core Study)|Adverse Event|46
778344|NCT00620542|2475794|P2|Part B (2 Year Core Study)|Adverse Event|0
778345|NCT00620542|2475795|P1|Part B (2 Year Core Study)|Adverse Event|0
778346|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
778347|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
778348|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
778349|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
778350|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
778351|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
778352|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
778353|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
778354|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
778355|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
778356|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
778357|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
778358|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
778359|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
778360|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
778361|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
778362|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
778363|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
778364|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
778365|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
778366|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
778367|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
778368|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
778369|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
778370|NCT00620542|2475792|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
778371|NCT00620542|2475793|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
778372|NCT00620542|2475794|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
778373|NCT00620542|2475795|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
778374|NCT00620555|2475833|P1|Overall Study|Visit failure against planned|1
778375|NCT00620555|2475833|P1|Overall Study|Choice of other treatment|1
778376|NCT00620555|2475833|P1|Overall Study|Withdrawal by Subject|1
778377|NCT00620555|2475833|P1|Overall Study|Lack of Efficacy|12
778378|NCT00620555|2475833|P1|Overall Study|Protocol Violation|2
778379|NCT00620555|2475833|P1|Overall Study|Adverse Event|4
778380|NCT00620659|2475840|P6|Treatment Period 3|Withdrawal by Subject|0
778381|NCT00620659|2475841|P5|Treatment Period 3|Withdrawal by Subject|0
778382|NCT00620659|2475842|P4|Treatment Period 3|Withdrawal by Subject|1
778383|NCT00620659|2475843|P3|Treatment Period 3|Withdrawal by Subject|0
778384|NCT00620659|2475844|P2|Treatment Period 3|Withdrawal by Subject|0
778385|NCT00620659|2475845|P1|Treatment Period 3|Withdrawal by Subject|0
778386|NCT00620659|2475840|P6|Treatment Period 3|Adverse Event|0
778387|NCT00620659|2475841|P5|Treatment Period 3|Adverse Event|0
778388|NCT00620659|2475842|P4|Treatment Period 3|Adverse Event|0
778389|NCT00620659|2475843|P3|Treatment Period 3|Adverse Event|0
778390|NCT00620659|2475844|P2|Treatment Period 3|Adverse Event|2
778391|NCT00620659|2475845|P1|Treatment Period 3|Adverse Event|0
778392|NCT00620659|2475840|P6|Placebo Washout Period 2|Adverse Event|0
778393|NCT00620659|2475841|P5|Placebo Washout Period 2|Adverse Event|0
778394|NCT00620659|2475842|P4|Placebo Washout Period 2|Adverse Event|0
778395|NCT00620659|2475843|P3|Placebo Washout Period 2|Adverse Event|0
778396|NCT00620659|2475844|P2|Placebo Washout Period 2|Adverse Event|0
778397|NCT00620659|2475845|P1|Placebo Washout Period 2|Adverse Event|2
778398|NCT00620659|2475840|P6|Treatment Period 2|Withdrawal by Subject|0
778399|NCT00620659|2475841|P5|Treatment Period 2|Withdrawal by Subject|3
778400|NCT00620659|2475842|P4|Treatment Period 2|Withdrawal by Subject|0
778401|NCT00620659|2475843|P3|Treatment Period 2|Withdrawal by Subject|1
778402|NCT00620659|2475844|P2|Treatment Period 2|Withdrawal by Subject|0
778403|NCT00620659|2475845|P1|Treatment Period 2|Withdrawal by Subject|0
778404|NCT00620659|2475840|P6|Treatment Period 2|Adverse Event|0
778405|NCT00620659|2475841|P5|Treatment Period 2|Adverse Event|2
778406|NCT00620659|2475842|P4|Treatment Period 2|Adverse Event|0
778407|NCT00620659|2475843|P3|Treatment Period 2|Adverse Event|0
778408|NCT00620659|2475844|P2|Treatment Period 2|Adverse Event|3
778409|NCT00620659|2475845|P1|Treatment Period 2|Adverse Event|0
778410|NCT00620659|2475840|P6|Placebo Washout Period 1|Withdrawal by Subject|0
778411|NCT00620659|2475841|P5|Placebo Washout Period 1|Withdrawal by Subject|0
778412|NCT00620659|2475842|P4|Placebo Washout Period 1|Withdrawal by Subject|1
778413|NCT00620659|2475843|P3|Placebo Washout Period 1|Withdrawal by Subject|0
778414|NCT00620659|2475844|P2|Placebo Washout Period 1|Withdrawal by Subject|0
778415|NCT00620659|2475845|P1|Placebo Washout Period 1|Withdrawal by Subject|0
778416|NCT00620659|2475840|P6|Treatment Period 1|Withdrawal by Subject|0
778417|NCT00620659|2475841|P5|Treatment Period 1|Withdrawal by Subject|1
778418|NCT00620659|2475842|P4|Treatment Period 1|Withdrawal by Subject|0
778419|NCT00620659|2475843|P3|Treatment Period 1|Withdrawal by Subject|1
778420|NCT00620659|2475844|P2|Treatment Period 1|Withdrawal by Subject|0
778421|NCT00620659|2475845|P1|Treatment Period 1|Withdrawal by Subject|1
778422|NCT00620659|2475840|P6|Treatment Period 1|Protocol Violation|0
778423|NCT00620659|2475841|P5|Treatment Period 1|Protocol Violation|0
778424|NCT00620659|2475842|P4|Treatment Period 1|Protocol Violation|0
778425|NCT00620659|2475843|P3|Treatment Period 1|Protocol Violation|0
778426|NCT00620659|2475844|P2|Treatment Period 1|Protocol Violation|0
778427|NCT00620659|2475845|P1|Treatment Period 1|Protocol Violation|1
778428|NCT00620659|2475840|P6|Treatment Period 1|Adverse Event|0
778429|NCT00620659|2475841|P5|Treatment Period 1|Adverse Event|0
778430|NCT00620659|2475842|P4|Treatment Period 1|Adverse Event|3
778431|NCT00620659|2475843|P3|Treatment Period 1|Adverse Event|0
778432|NCT00620659|2475844|P2|Treatment Period 1|Adverse Event|0
778433|NCT00620659|2475845|P1|Treatment Period 1|Adverse Event|1
778434|NCT00620750|2475874|P1|Overall Study|Lost to Follow-up|25
778435|NCT00620763|2475878|P2|Period: Second Intervention|Withdrawal by Subject|0
778436|NCT00620763|2475879|P1|Period: Second Intervention|Withdrawal by Subject|1
778437|NCT00620763|2475878|P2|Period: First Intervention|Protocol Violation|3
778438|NCT00620763|2475879|P1|Period: First Intervention|Protocol Violation|0
778439|NCT00620763|2475878|P2|Period: First Intervention|Withdrawal by Subject|2
778440|NCT00620763|2475879|P1|Period: First Intervention|Withdrawal by Subject|0
778441|NCT00620776|2475887|P2|Overall Study|Withdrawal by Subject|2
778442|NCT00620776|2475888|P1|Overall Study|Withdrawal by Subject|3
778443|NCT00620776|2475887|P2|Overall Study|Lost to Follow-up|5
778444|NCT00620776|2475888|P1|Overall Study|Lost to Follow-up|2
778445|NCT00620776|2475887|P2|Overall Study|Lack of Efficacy|1
778446|NCT00620776|2475888|P1|Overall Study|Lack of Efficacy|2
778447|NCT00620776|2475887|P2|Overall Study|Adverse Event|3
778448|NCT00620776|2475888|P1|Overall Study|Adverse Event|2
778449|NCT00620776|2475887|P2|Overall Study|Did not receive treatment|5
778450|NCT00620776|2475888|P1|Overall Study|Did not receive treatment|3
778451|NCT00620815|2475919|P3|Overall Study|Protocol Violation|1
778452|NCT00620815|2475920|P2|Overall Study|Protocol Violation|2
778453|NCT00620815|2475921|P1|Overall Study|Protocol Violation|1
778454|NCT00620815|2475919|P3|Overall Study|Inappropriate enrolment|1
778455|NCT00620815|2475920|P2|Overall Study|Inappropriate enrolment|0
778456|NCT00620815|2475921|P1|Overall Study|Inappropriate enrolment|0
778457|NCT00620815|2475919|P3|Overall Study|Lost to Follow-up|3
778458|NCT00620815|2475920|P2|Overall Study|Lost to Follow-up|6
778459|NCT00620815|2475921|P1|Overall Study|Lost to Follow-up|1
778460|NCT00620815|2475919|P3|Overall Study|Withdrawal by Subject|0
778461|NCT00620815|2475920|P2|Overall Study|Withdrawal by Subject|2
778462|NCT00620815|2475921|P1|Overall Study|Withdrawal by Subject|1
778463|NCT00620815|2475919|P3|Overall Study|Adverse Event|2
778464|NCT00620815|2475920|P2|Overall Study|Adverse Event|1
778465|NCT00620815|2475921|P1|Overall Study|Adverse Event|1
778466|NCT00620854|2475982|P6|Washout 1|Withdrawal by Subject|0
778467|NCT00620854|2475983|P5|Washout 1|Withdrawal by Subject|0
778468|NCT00620854|2475984|P4|Washout 1|Withdrawal by Subject|1
778469|NCT00620854|2475985|P3|Washout 1|Withdrawal by Subject|1
778470|NCT00620854|2475986|P2|Washout 1|Withdrawal by Subject|0
778471|NCT00620854|2475987|P1|Washout 1|Withdrawal by Subject|0
778472|NCT00614055|2476001|P3|Overall Study|Unclassified|2
778473|NCT00614055|2476002|P2|Overall Study|Unclassified|4
778474|NCT00614055|2476003|P1|Overall Study|Unclassified|1
778475|NCT00614055|2476001|P3|Overall Study|Lack of Efficacy|2
778476|NCT00614055|2476002|P2|Overall Study|Lack of Efficacy|0
778477|NCT00614055|2476003|P1|Overall Study|Lack of Efficacy|0
778478|NCT00614055|2476001|P3|Overall Study|Protocol Violation|1
778479|NCT00614055|2476002|P2|Overall Study|Protocol Violation|2
778480|NCT00614055|2476003|P1|Overall Study|Protocol Violation|2
778481|NCT00614055|2476001|P3|Overall Study|Adverse Event|0
778482|NCT00614055|2476002|P2|Overall Study|Adverse Event|0
778483|NCT00614055|2476003|P1|Overall Study|Adverse Event|1
778484|NCT00614120|2476051|P4|Overall Study|Lost to Follow-up|4
778485|NCT00614120|2476052|P3|Overall Study|Lost to Follow-up|3
778486|NCT00614120|2476053|P2|Overall Study|Lost to Follow-up|2
778487|NCT00614120|2476054|P1|Overall Study|Lost to Follow-up|1
778488|NCT00614120|2476051|P4|Overall Study|Taken inhibition medication eg Prandin|1
778489|NCT00614120|2476052|P3|Overall Study|Taken inhibition medication eg Prandin|1
778490|NCT00614120|2476053|P2|Overall Study|Taken inhibition medication eg Prandin|0
778491|NCT00614120|2476054|P1|Overall Study|Taken inhibition medication eg Prandin|0
778492|NCT00614120|2476051|P4|Overall Study|Late syphilis, latent|0
778493|NCT00614120|2476052|P3|Overall Study|Late syphilis, latent|0
778494|NCT00614120|2476053|P2|Overall Study|Late syphilis, latent|0
778495|NCT00614120|2476054|P1|Overall Study|Late syphilis, latent|1
778496|NCT00614120|2476051|P4|Overall Study|Lack of trial product|0
778497|NCT00614120|2476052|P3|Overall Study|Lack of trial product|2
778498|NCT00614120|2476053|P2|Overall Study|Lack of trial product|3
778499|NCT00614120|2476054|P1|Overall Study|Lack of trial product|3
778500|NCT00614120|2476051|P4|Overall Study|Hypoglycaemia|1
778501|NCT00614120|2476052|P3|Overall Study|Hypoglycaemia|0
778502|NCT00614120|2476053|P2|Overall Study|Hypoglycaemia|0
778503|NCT00614120|2476054|P1|Overall Study|Hypoglycaemia|0
778504|NCT00614120|2476051|P4|Overall Study|hCG positive (not pregnant)|0
778505|NCT00614120|2476052|P3|Overall Study|hCG positive (not pregnant)|1
778506|NCT00614120|2476053|P2|Overall Study|hCG positive (not pregnant)|0
778507|NCT00614120|2476054|P1|Overall Study|hCG positive (not pregnant)|0
778508|NCT00614120|2476051|P4|Overall Study|Did not meet trial criteria|1
778509|NCT00614120|2476052|P3|Overall Study|Did not meet trial criteria|1
778510|NCT00614120|2476053|P2|Overall Study|Did not meet trial criteria|1
778511|NCT00614120|2476054|P1|Overall Study|Did not meet trial criteria|0
778512|NCT00614120|2476051|P4|Overall Study|Withdrawal by Subject|3
778513|NCT00614120|2476052|P3|Overall Study|Withdrawal by Subject|16
778514|NCT00614120|2476053|P2|Overall Study|Withdrawal by Subject|10
778515|NCT00614120|2476054|P1|Overall Study|Withdrawal by Subject|9
778516|NCT00614120|2476051|P4|Overall Study|Withdrawal criteria|0
778517|NCT00614120|2476052|P3|Overall Study|Withdrawal criteria|0
778518|NCT00614120|2476053|P2|Overall Study|Withdrawal criteria|0
778519|NCT00614120|2476054|P1|Overall Study|Withdrawal criteria|1
778520|NCT00614120|2476051|P4|Overall Study|Protocol Violation|1
778521|NCT00614120|2476052|P3|Overall Study|Protocol Violation|3
778522|NCT00614120|2476053|P2|Overall Study|Protocol Violation|5
778523|NCT00614120|2476054|P1|Overall Study|Protocol Violation|2
778524|NCT00614120|2476051|P4|Overall Study|Lack of Efficacy|2
778525|NCT00614120|2476052|P3|Overall Study|Lack of Efficacy|2
778526|NCT00614120|2476053|P2|Overall Study|Lack of Efficacy|3
778527|NCT00614120|2476054|P1|Overall Study|Lack of Efficacy|3
778528|NCT00614120|2476051|P4|Overall Study|Adverse Event|3
778529|NCT00614120|2476052|P3|Overall Study|Adverse Event|30
778530|NCT00614120|2476053|P2|Overall Study|Adverse Event|22
778531|NCT00614120|2476054|P1|Overall Study|Adverse Event|9
778532|NCT00614380|2476110|P4|Overall Study|Consent withdrawn|0
778533|NCT00614380|2476111|P3|Overall Study|Consent withdrawn|0
778534|NCT00614380|2476112|P2|Overall Study|Consent withdrawn|1
778535|NCT00614380|2476113|P1|Overall Study|Consent withdrawn|3
778536|NCT00614380|2476110|P4|Overall Study|Non compliant with the protocol|2
778537|NCT00614380|2476111|P3|Overall Study|Non compliant with the protocol|1
778538|NCT00614380|2476112|P2|Overall Study|Non compliant with the protocol|2
778539|NCT00614380|2476113|P1|Overall Study|Non compliant with the protocol|12
778540|NCT00614380|2476110|P4|Overall Study|Lost to Follow-up|0
778541|NCT00614380|2476111|P3|Overall Study|Lost to Follow-up|0
778542|NCT00614380|2476112|P2|Overall Study|Lost to Follow-up|1
778543|NCT00614380|2476113|P1|Overall Study|Lost to Follow-up|6
778544|NCT00614380|2476110|P4|Overall Study|Adverse Event|0
778545|NCT00614380|2476111|P3|Overall Study|Adverse Event|0
778546|NCT00614380|2476112|P2|Overall Study|Adverse Event|4
778547|NCT00614380|2476113|P1|Overall Study|Adverse Event|14
778548|NCT00614393|2476167|P5|Overall Study|Not Treated|2
778549|NCT00614393|2476168|P4|Overall Study|Not Treated|0
778550|NCT00614393|2476169|P3|Overall Study|Not Treated|0
778551|NCT00614393|2476170|P2|Overall Study|Not Treated|0
778552|NCT00614393|2476171|P1|Overall Study|Not Treated|0
778553|NCT00614393|2476167|P5|Overall Study|Other|2
778554|NCT00614393|2476168|P4|Overall Study|Other|4
778555|NCT00614393|2476169|P3|Overall Study|Other|0
778556|NCT00614393|2476170|P2|Overall Study|Other|0
778557|NCT00614393|2476171|P1|Overall Study|Other|4
778558|NCT00614393|2476167|P5|Overall Study|Withdrawal by Subject|13
778559|NCT00614393|2476168|P4|Overall Study|Withdrawal by Subject|16
778560|NCT00614393|2476169|P3|Overall Study|Withdrawal by Subject|1
778561|NCT00614393|2476170|P2|Overall Study|Withdrawal by Subject|1
778562|NCT00614393|2476171|P1|Overall Study|Withdrawal by Subject|20
778563|NCT00614393|2476167|P5|Overall Study|Terminated by Sponsor|1
778564|NCT00614393|2476168|P4|Overall Study|Terminated by Sponsor|0
778565|NCT00614393|2476169|P3|Overall Study|Terminated by Sponsor|0
778566|NCT00614393|2476170|P2|Overall Study|Terminated by Sponsor|0
778567|NCT00614393|2476171|P1|Overall Study|Terminated by Sponsor|0
778568|NCT00614393|2476167|P5|Overall Study|Protocol Violation|0
778569|NCT00614393|2476168|P4|Overall Study|Protocol Violation|0
778570|NCT00614393|2476169|P3|Overall Study|Protocol Violation|0
778571|NCT00614393|2476170|P2|Overall Study|Protocol Violation|0
778572|NCT00614393|2476171|P1|Overall Study|Protocol Violation|1
778573|NCT00614393|2476167|P5|Overall Study|Progressive Disease|130
778574|NCT00614393|2476168|P4|Overall Study|Progressive Disease|138
778575|NCT00614393|2476169|P3|Overall Study|Progressive Disease|5
778576|NCT00614393|2476170|P2|Overall Study|Progressive Disease|5
778577|NCT00614393|2476171|P1|Overall Study|Progressive Disease|118
778578|NCT00614393|2476167|P5|Overall Study|Physician Decision|9
778579|NCT00614393|2476168|P4|Overall Study|Physician Decision|8
778580|NCT00614393|2476169|P3|Overall Study|Physician Decision|1
778581|NCT00614393|2476170|P2|Overall Study|Physician Decision|0
778582|NCT00614393|2476171|P1|Overall Study|Physician Decision|17
778583|NCT00614393|2476167|P5|Overall Study|Lost to Follow-up|2
778584|NCT00614393|2476168|P4|Overall Study|Lost to Follow-up|1
778585|NCT00614393|2476169|P3|Overall Study|Lost to Follow-up|0
778586|NCT00614393|2476170|P2|Overall Study|Lost to Follow-up|0
778587|NCT00614393|2476171|P1|Overall Study|Lost to Follow-up|0
778588|NCT00614393|2476167|P5|Overall Study|Adverse Event|21
778589|NCT00614393|2476168|P4|Overall Study|Adverse Event|13
778590|NCT00614393|2476169|P3|Overall Study|Adverse Event|3
778591|NCT00614393|2476170|P2|Overall Study|Adverse Event|2
778592|NCT00614393|2476171|P1|Overall Study|Adverse Event|20
778593|NCT00614523|2476242|P2|Overall Study|Administrative Decision|46
778594|NCT00614523|2476243|P1|Overall Study|Administrative Decision|23
778595|NCT00614523|2476242|P2|Overall Study|Disease Progression|8
778596|NCT00614523|2476243|P1|Overall Study|Disease Progression|0
778597|NCT00614523|2476242|P2|Overall Study|Ineligibility Determined|2
778598|NCT00614523|2476243|P1|Overall Study|Ineligibility Determined|1
778599|NCT00614523|2476242|P2|Overall Study|Other|11
778600|NCT00614523|2476243|P1|Overall Study|Other|6
778601|NCT00614523|2476242|P2|Overall Study|Withdrawal by Subject|22
778602|NCT00614523|2476243|P1|Overall Study|Withdrawal by Subject|12
778603|NCT00614523|2476242|P2|Overall Study|Protocol Violation|2
778604|NCT00614523|2476243|P1|Overall Study|Protocol Violation|3
778605|NCT00614523|2476242|P2|Overall Study|Lost to Follow-up|1
778606|NCT00614523|2476243|P1|Overall Study|Lost to Follow-up|0
778607|NCT00614523|2476242|P2|Overall Study|Lack of Efficacy|11
778608|NCT00614523|2476243|P1|Overall Study|Lack of Efficacy|9
778609|NCT00614523|2476242|P2|Overall Study|Death|8
778610|NCT00614523|2476243|P1|Overall Study|Death|5
778611|NCT00614523|2476242|P2|Overall Study|Adverse Event|20
778612|NCT00614523|2476243|P1|Overall Study|Adverse Event|4
778613|NCT00614575|2476267|P1|Overall Study|No treatment|1
778614|NCT00614575|2476267|P1|Overall Study|Irregularly enrolled patients|23
778615|NCT00614575|2476267|P1|Overall Study|No data were collected.|18
778616|NCT00614575|2476267|P1|Overall Study|Physician Decision|2
778617|NCT00614575|2476267|P1|Overall Study|Death|3
778618|NCT00614575|2476267|P1|Overall Study|Withdrawal by Subject|6
778619|NCT00614575|2476267|P1|Overall Study|Lack of Efficacy|14
778620|NCT00614575|2476267|P1|Overall Study|Lost to Follow-up|55
778621|NCT00614575|2476267|P1|Overall Study|Adverse Event|106
778622|NCT00614614|2476278|P5|Booster Vaccination Phase|Unspecified|1
778623|NCT00614614|2476279|P4|Booster Vaccination Phase|Unspecified|2
778624|NCT00614614|2476280|P3|Booster Vaccination Phase|Unspecified|3
778625|NCT00614614|2476281|P2|Booster Vaccination Phase|Unspecified|1
778626|NCT00614614|2476282|P1|Booster Vaccination Phase|Unspecified|0
778627|NCT00614614|2476278|P5|Booster Vaccination Phase|Protocol Violation|0
778628|NCT00614614|2476279|P4|Booster Vaccination Phase|Protocol Violation|3
778629|NCT00614614|2476280|P3|Booster Vaccination Phase|Protocol Violation|2
778630|NCT00614614|2476281|P2|Booster Vaccination Phase|Protocol Violation|0
778631|NCT00614614|2476282|P1|Booster Vaccination Phase|Protocol Violation|0
778632|NCT00614614|2476278|P5|Booster Vaccination Phase|Lost to Follow-up|8
778633|NCT00614614|2476279|P4|Booster Vaccination Phase|Lost to Follow-up|10
778634|NCT00614614|2476280|P3|Booster Vaccination Phase|Lost to Follow-up|17
778635|NCT00614614|2476281|P2|Booster Vaccination Phase|Lost to Follow-up|5
778636|NCT00614614|2476282|P1|Booster Vaccination Phase|Lost to Follow-up|0
778637|NCT00614614|2476278|P5|Booster Vaccination Phase|Withdrawal by Subject|4
778638|NCT00614614|2476279|P4|Booster Vaccination Phase|Withdrawal by Subject|3
778639|NCT00614614|2476280|P3|Booster Vaccination Phase|Withdrawal by Subject|4
778640|NCT00614614|2476281|P2|Booster Vaccination Phase|Withdrawal by Subject|0
778641|NCT00614614|2476282|P1|Booster Vaccination Phase|Withdrawal by Subject|0
778642|NCT00614614|2476278|P5|Booster Vaccination Phase|Adverse Event|0
778643|NCT00614614|2476279|P4|Booster Vaccination Phase|Adverse Event|1
778644|NCT00614614|2476280|P3|Booster Vaccination Phase|Adverse Event|1
778645|NCT00614614|2476281|P2|Booster Vaccination Phase|Adverse Event|0
778646|NCT00614614|2476282|P1|Booster Vaccination Phase|Adverse Event|0
778647|NCT00614614|2476278|P5|Primary Vaccination Phase|Unspecified|0
778648|NCT00614614|2476279|P4|Primary Vaccination Phase|Unspecified|0
778649|NCT00614614|2476280|P3|Primary Vaccination Phase|Unspecified|0
778650|NCT00614614|2476281|P2|Primary Vaccination Phase|Unspecified|0
778651|NCT00614614|2476282|P1|Primary Vaccination Phase|Unspecified|4
778652|NCT00614614|2476278|P5|Primary Vaccination Phase|Protocol Violation|0
778653|NCT00614614|2476279|P4|Primary Vaccination Phase|Protocol Violation|0
778654|NCT00614614|2476280|P3|Primary Vaccination Phase|Protocol Violation|0
778655|NCT00614614|2476281|P2|Primary Vaccination Phase|Protocol Violation|3
778656|NCT00614614|2476282|P1|Primary Vaccination Phase|Protocol Violation|9
778657|NCT00614614|2476278|P5|Primary Vaccination Phase|Lost to Follow-up|0
778658|NCT00614614|2476279|P4|Primary Vaccination Phase|Lost to Follow-up|0
778659|NCT00614614|2476280|P3|Primary Vaccination Phase|Lost to Follow-up|0
778660|NCT00614614|2476281|P2|Primary Vaccination Phase|Lost to Follow-up|8
778661|NCT00614614|2476282|P1|Primary Vaccination Phase|Lost to Follow-up|26
778662|NCT00614614|2476278|P5|Primary Vaccination Phase|Withdrawal by Subject|0
778663|NCT00614614|2476279|P4|Primary Vaccination Phase|Withdrawal by Subject|0
778664|NCT00614614|2476280|P3|Primary Vaccination Phase|Withdrawal by Subject|0
778665|NCT00614614|2476281|P2|Primary Vaccination Phase|Withdrawal by Subject|6
778666|NCT00614614|2476282|P1|Primary Vaccination Phase|Withdrawal by Subject|45
778667|NCT00614614|2476278|P5|Primary Vaccination Phase|Adverse Event|0
778668|NCT00614614|2476279|P4|Primary Vaccination Phase|Adverse Event|0
778669|NCT00614614|2476280|P3|Primary Vaccination Phase|Adverse Event|0
778670|NCT00614614|2476281|P2|Primary Vaccination Phase|Adverse Event|0
778671|NCT00614614|2476282|P1|Primary Vaccination Phase|Adverse Event|6
778672|NCT00614744|2476407|P2|Overall Study|Incomplete for Behavior Issues|2
778673|NCT00614744|2476408|P1|Overall Study|Incomplete for Behavior Issues|0
778674|NCT00614744|2476407|P2|Overall Study|Lost to Follow-up|4
778675|NCT00614744|2476408|P1|Overall Study|Lost to Follow-up|5
778676|NCT00614874|2476432|P1|Overall Study|Withdrawal by Subject|1
778677|NCT00614874|2476432|P1|Overall Study|Protocol Violation|1
778678|NCT00614926|2476446|P2|Overall Study|Adverse Event|0
778679|NCT00614926|2476447|P1|Overall Study|Adverse Event|3
778680|NCT00614926|2476446|P2|Overall Study|Burden of travel|0
778681|NCT00614926|2476447|P1|Overall Study|Burden of travel|1
778682|NCT00614939|2476457|P2|Overall Study|Hospitalized due to kidney transplant|0
778683|NCT00614939|2476458|P1|Overall Study|Hospitalized due to kidney transplant|1
778684|NCT00614939|2476457|P2|Overall Study|Poor/non-compliance|0
778685|NCT00614939|2476458|P1|Overall Study|Poor/non-compliance|4
778686|NCT00614939|2476457|P2|Overall Study|Death|3
778687|NCT00614939|2476458|P1|Overall Study|Death|4
778688|NCT00614939|2476457|P2|Overall Study|Incorrect enrollment|2
778689|NCT00614939|2476458|P1|Overall Study|Incorrect enrollment|1
778690|NCT00614939|2476457|P2|Overall Study|Adverse Event|5
778691|NCT00614939|2476458|P1|Overall Study|Adverse Event|2
778692|NCT00614939|2476457|P2|Overall Study|Study specific discontinuation criteris|16
778693|NCT00614939|2476458|P1|Overall Study|Study specific discontinuation criteris|13
778694|NCT00614939|2476457|P2|Overall Study|Withdrawal by Subject|17
778695|NCT00614939|2476458|P1|Overall Study|Withdrawal by Subject|10
778696|NCT00614991|2476496|P6|Overall Study|Adverse Event|0
778697|NCT00614991|2476497|P5|Overall Study|Adverse Event|1
778698|NCT00614991|2476498|P4|Overall Study|Adverse Event|0
778699|NCT00614991|2476499|P3|Overall Study|Adverse Event|0
778700|NCT00614991|2476500|P2|Overall Study|Adverse Event|3
778701|NCT00614991|2476501|P1|Overall Study|Adverse Event|3
778702|NCT00615017|2476539|P6|Overall Study|Physician discontinued drug|1
778703|NCT00615017|2476540|P5|Overall Study|Physician discontinued drug|0
778704|NCT00615017|2476541|P4|Overall Study|Physician discontinued drug|0
778705|NCT00615017|2476542|P3|Overall Study|Physician discontinued drug|0
778706|NCT00615017|2476543|P2|Overall Study|Physician discontinued drug|0
778707|NCT00615017|2476544|P1|Overall Study|Physician discontinued drug|0
778708|NCT00615017|2476539|P6|Overall Study|Transferred out of Intensive Care Unit|0
778709|NCT00615017|2476540|P5|Overall Study|Transferred out of Intensive Care Unit|0
778710|NCT00615017|2476541|P4|Overall Study|Transferred out of Intensive Care Unit|1
778711|NCT00615017|2476542|P3|Overall Study|Transferred out of Intensive Care Unit|0
778712|NCT00615017|2476543|P2|Overall Study|Transferred out of Intensive Care Unit|0
778713|NCT00615017|2476544|P1|Overall Study|Transferred out of Intensive Care Unit|0
778714|NCT00615017|2476539|P6|Overall Study|Sepsis resolved|0
778715|NCT00615017|2476540|P5|Overall Study|Sepsis resolved|0
778716|NCT00615017|2476541|P4|Overall Study|Sepsis resolved|0
778717|NCT00615017|2476542|P3|Overall Study|Sepsis resolved|1
778718|NCT00615017|2476543|P2|Overall Study|Sepsis resolved|0
778719|NCT00615017|2476544|P1|Overall Study|Sepsis resolved|0
778720|NCT00615017|2476539|P6|Overall Study|Death|1
778721|NCT00615017|2476540|P5|Overall Study|Death|1
778722|NCT00615017|2476541|P4|Overall Study|Death|0
778723|NCT00615017|2476542|P3|Overall Study|Death|2
778724|NCT00615017|2476543|P2|Overall Study|Death|0
778725|NCT00615017|2476544|P1|Overall Study|Death|0
778726|NCT00615017|2476539|P6|Overall Study|Adverse Event|1
778727|NCT00615017|2476540|P5|Overall Study|Adverse Event|0
778728|NCT00615017|2476541|P4|Overall Study|Adverse Event|0
778729|NCT00615017|2476542|P3|Overall Study|Adverse Event|2
778730|NCT00615017|2476543|P2|Overall Study|Adverse Event|1
778731|NCT00615017|2476544|P1|Overall Study|Adverse Event|0
778732|NCT00615030|2476696|P12|Period III|Administrative problems|0
778733|NCT00615030|2476697|P11|Period III|Administrative problems|0
778734|NCT00615030|2476698|P10|Period III|Administrative problems|0
778735|NCT00615030|2476699|P9|Period III|Administrative problems|0
778736|NCT00615030|2476700|P8|Period III|Administrative problems|0
778737|NCT00615030|2476701|P7|Period III|Administrative problems|0
778738|NCT00615030|2476702|P6|Period III|Administrative problems|0
778739|NCT00615030|2476703|P5|Period III|Administrative problems|0
778740|NCT00615030|2476704|P4|Period III|Administrative problems|1
778741|NCT00615030|2476705|P3|Period III|Administrative problems|0
778742|NCT00615030|2476706|P2|Period III|Administrative problems|0
778743|NCT00615030|2476707|P1|Period III|Administrative problems|1
778744|NCT00615030|2476696|P12|Period II|Subject withdrew consent|0
778745|NCT00615030|2476697|P11|Period II|Subject withdrew consent|0
778746|NCT00615030|2476698|P10|Period II|Subject withdrew consent|0
778747|NCT00615030|2476699|P9|Period II|Subject withdrew consent|0
778748|NCT00615030|2476700|P8|Period II|Subject withdrew consent|0
778749|NCT00615030|2476701|P7|Period II|Subject withdrew consent|1
778750|NCT00615030|2476702|P6|Period II|Subject withdrew consent|0
778751|NCT00615030|2476703|P5|Period II|Subject withdrew consent|0
778752|NCT00615030|2476704|P4|Period II|Subject withdrew consent|1
778753|NCT00615030|2476705|P3|Period II|Subject withdrew consent|0
778754|NCT00615030|2476706|P2|Period II|Subject withdrew consent|0
778755|NCT00615030|2476707|P1|Period II|Subject withdrew consent|0
778756|NCT00615030|2476696|P12|Period II|Adverse Event|0
778757|NCT00615030|2476697|P11|Period II|Adverse Event|0
778758|NCT00615030|2476698|P10|Period II|Adverse Event|0
778759|NCT00615030|2476699|P9|Period II|Adverse Event|1
778760|NCT00615030|2476700|P8|Period II|Adverse Event|0
778761|NCT00615030|2476701|P7|Period II|Adverse Event|0
778762|NCT00615030|2476702|P6|Period II|Adverse Event|0
778763|NCT00615030|2476703|P5|Period II|Adverse Event|0
778764|NCT00615030|2476704|P4|Period II|Adverse Event|0
778765|NCT00615030|2476705|P3|Period II|Adverse Event|1
778766|NCT00615030|2476706|P2|Period II|Adverse Event|0
778767|NCT00615030|2476707|P1|Period II|Adverse Event|0
778768|NCT00615030|2476696|P12|Period I|Abnormal laboratory value(s)|0
778769|NCT00615030|2476697|P11|Period I|Abnormal laboratory value(s)|0
778770|NCT00615030|2476698|P10|Period I|Abnormal laboratory value(s)|0
778771|NCT00615030|2476699|P9|Period I|Abnormal laboratory value(s)|0
778772|NCT00615030|2476700|P8|Period I|Abnormal laboratory value(s)|0
778773|NCT00615030|2476701|P7|Period I|Abnormal laboratory value(s)|0
778774|NCT00615030|2476702|P6|Period I|Abnormal laboratory value(s)|1
778775|NCT00615030|2476703|P5|Period I|Abnormal laboratory value(s)|0
778776|NCT00615030|2476704|P4|Period I|Abnormal laboratory value(s)|0
778777|NCT00615030|2476705|P3|Period I|Abnormal laboratory value(s)|0
778778|NCT00615030|2476706|P2|Period I|Abnormal laboratory value(s)|0
778779|NCT00615030|2476707|P1|Period I|Abnormal laboratory value(s)|0
778780|NCT00615030|2476696|P12|Period I|Subject withdrew consent|1
778781|NCT00615030|2476697|P11|Period I|Subject withdrew consent|1
778782|NCT00615030|2476698|P10|Period I|Subject withdrew consent|0
778783|NCT00615030|2476699|P9|Period I|Subject withdrew consent|1
778784|NCT00615030|2476700|P8|Period I|Subject withdrew consent|0
778785|NCT00615030|2476701|P7|Period I|Subject withdrew consent|0
778786|NCT00615030|2476702|P6|Period I|Subject withdrew consent|0
778787|NCT00615030|2476703|P5|Period I|Subject withdrew consent|0
778788|NCT00615030|2476704|P4|Period I|Subject withdrew consent|0
778789|NCT00615030|2476705|P3|Period I|Subject withdrew consent|0
778790|NCT00615030|2476706|P2|Period I|Subject withdrew consent|0
778791|NCT00615030|2476707|P1|Period I|Subject withdrew consent|0
778792|NCT00615030|2476696|P12|Period I|Protocol deviation|0
778793|NCT00615030|2476697|P11|Period I|Protocol deviation|0
778794|NCT00615030|2476698|P10|Period I|Protocol deviation|0
778795|NCT00615030|2476699|P9|Period I|Protocol deviation|0
778796|NCT00615030|2476700|P8|Period I|Protocol deviation|0
778797|NCT00615030|2476701|P7|Period I|Protocol deviation|0
778798|NCT00615030|2476702|P6|Period I|Protocol deviation|0
778799|NCT00615030|2476703|P5|Period I|Protocol deviation|0
778800|NCT00615030|2476704|P4|Period I|Protocol deviation|0
778801|NCT00615030|2476705|P3|Period I|Protocol deviation|0
778802|NCT00615030|2476706|P2|Period I|Protocol deviation|0
778803|NCT00615030|2476707|P1|Period I|Protocol deviation|1
778804|NCT00615030|2476696|P12|Period I|Administrative problem|0
778805|NCT00615030|2476697|P11|Period I|Administrative problem|0
778806|NCT00615030|2476698|P10|Period I|Administrative problem|0
778807|NCT00615030|2476699|P9|Period I|Administrative problem|0
778808|NCT00615030|2476700|P8|Period I|Administrative problem|0
778809|NCT00615030|2476701|P7|Period I|Administrative problem|0
778810|NCT00615030|2476702|P6|Period I|Administrative problem|0
778811|NCT00615030|2476703|P5|Period I|Administrative problem|1
778812|NCT00615030|2476704|P4|Period I|Administrative problem|0
778813|NCT00615030|2476705|P3|Period I|Administrative problem|0
778814|NCT00615030|2476706|P2|Period I|Administrative problem|0
778815|NCT00615030|2476707|P1|Period I|Administrative problem|0
778816|NCT00615056|2476725|P4|Overall Study|Randomized but not treated|0
778817|NCT00615056|2476726|P3|Overall Study|Randomized but not treated|0
778818|NCT00615056|2476727|P2|Overall Study|Randomized but not treated|0
778819|NCT00615056|2476728|P1|Overall Study|Randomized but not treated|3
778820|NCT00615056|2476725|P4|Overall Study|Discontinued by Sponsor|0
778821|NCT00615056|2476726|P3|Overall Study|Discontinued by Sponsor|0
778822|NCT00615056|2476727|P2|Overall Study|Discontinued by Sponsor|0
778823|NCT00615056|2476728|P1|Overall Study|Discontinued by Sponsor|1
778824|NCT00615056|2476725|P4|Overall Study|Withdrawal by Subject|0
778825|NCT00615056|2476726|P3|Overall Study|Withdrawal by Subject|1
778826|NCT00615056|2476727|P2|Overall Study|Withdrawal by Subject|1
778827|NCT00615056|2476728|P1|Overall Study|Withdrawal by Subject|0
778828|NCT00615056|2476725|P4|Overall Study|Objective progression or relapse|0
778829|NCT00615056|2476726|P3|Overall Study|Objective progression or relapse|0
778830|NCT00615056|2476727|P2|Overall Study|Objective progression or relapse|2
778831|NCT00615056|2476728|P1|Overall Study|Objective progression or relapse|0
778832|NCT00615056|2476725|P4|Overall Study|Unspecified|7
778833|NCT00615056|2476726|P3|Overall Study|Unspecified|10
778834|NCT00615056|2476727|P2|Overall Study|Unspecified|15
778835|NCT00615056|2476728|P1|Overall Study|Unspecified|13
778836|NCT00615056|2476725|P4|Overall Study|Lost to Follow-up|5
778837|NCT00615056|2476726|P3|Overall Study|Lost to Follow-up|4
778838|NCT00615056|2476727|P2|Overall Study|Lost to Follow-up|2
778839|NCT00615056|2476728|P1|Overall Study|Lost to Follow-up|1
778840|NCT00615056|2476725|P4|Overall Study|Death|23
778841|NCT00615056|2476726|P3|Overall Study|Death|21
778842|NCT00615056|2476727|P2|Overall Study|Death|31
778843|NCT00615056|2476728|P1|Overall Study|Death|31
778844|NCT00615069|2476758|P1|Overall Study|Withdrawal by Subject|4
778845|NCT00615069|2476758|P1|Overall Study|Physician Decision|2
778846|NCT00615069|2476758|P1|Overall Study|Death|10
778847|NCT00615108|2476763|P1|Overall Study|Lost to Follow-up|15
778848|NCT00615108|2476763|P1|Overall Study|Other|370
778849|NCT00615108|2476763|P1|Overall Study|Adverse Event|122
778850|NCT00615199|2476782|P4|Overall Study|Withdrawal by Subject|0
778851|NCT00615199|2476783|P3|Overall Study|Withdrawal by Subject|0
778852|NCT00615199|2476784|P2|Overall Study|Withdrawal by Subject|1
778853|NCT00615199|2476785|P1|Overall Study|Withdrawal by Subject|2
778854|NCT00615199|2476782|P4|Overall Study|Unspecified|1
778855|NCT00615199|2476783|P3|Overall Study|Unspecified|0
778856|NCT00615199|2476784|P2|Overall Study|Unspecified|0
778857|NCT00615199|2476785|P1|Overall Study|Unspecified|0
778858|NCT00615199|2476782|P4|Overall Study|Lost to Follow-up|0
778859|NCT00615199|2476783|P3|Overall Study|Lost to Follow-up|0
778860|NCT00615199|2476784|P2|Overall Study|Lost to Follow-up|0
778861|NCT00615199|2476785|P1|Overall Study|Lost to Follow-up|1
778862|NCT00615199|2476782|P4|Overall Study|Lack of Efficacy|1
778863|NCT00615199|2476783|P3|Overall Study|Lack of Efficacy|0
778864|NCT00615199|2476784|P2|Overall Study|Lack of Efficacy|0
778865|NCT00615199|2476785|P1|Overall Study|Lack of Efficacy|2
778866|NCT00615199|2476782|P4|Overall Study|Adverse Event|0
778867|NCT00615199|2476783|P3|Overall Study|Adverse Event|1
778868|NCT00615199|2476784|P2|Overall Study|Adverse Event|1
778869|NCT00615199|2476785|P1|Overall Study|Adverse Event|3
778870|NCT00615264|2476821|P2|Overall Study|Dermal Hypersensitivity|3
778871|NCT00615264|2476822|P1|Overall Study|Dermal Hypersensitivity|0
778872|NCT00615264|2476821|P2|Overall Study|Not defined|4
778873|NCT00615264|2476822|P1|Overall Study|Not defined|7
778874|NCT00615264|2476821|P2|Overall Study|Protocol Violation|7
778875|NCT00615264|2476822|P1|Overall Study|Protocol Violation|11
778876|NCT00615264|2476821|P2|Overall Study|Death|1
778877|NCT00615264|2476822|P1|Overall Study|Death|1
778878|NCT00615264|2476821|P2|Overall Study|Adverse Event|5
778879|NCT00615264|2476822|P1|Overall Study|Adverse Event|8
778880|NCT00615264|2476821|P2|Overall Study|Lost to Follow-up|13
778881|NCT00615264|2476822|P1|Overall Study|Lost to Follow-up|6
778882|NCT00615264|2476821|P2|Overall Study|Withdrawal by Subject|19
778883|NCT00615264|2476822|P1|Overall Study|Withdrawal by Subject|17
778884|NCT00615290|2476830|P1|Overall Study|Other|2
778885|NCT00615290|2476830|P1|Overall Study|Withdrawal by Subject|1
778886|NCT00615290|2476830|P1|Overall Study|Lost to Follow-up|3
778887|NCT00615290|2476830|P1|Overall Study|Adverse Event|2
778888|NCT00615459|2476863|P4|Period III|Unsatisfactory therapeutic effect|0
778889|NCT00615459|2476864|P3|Period III|Unsatisfactory therapeutic effect|0
778890|NCT00615459|2476865|P2|Period III|Unsatisfactory therapeutic effect|1
778891|NCT00615459|2476866|P1|Period III|Unsatisfactory therapeutic effect|0
778892|NCT00615459|2476863|P4|Period III|Administrative problems|0
778893|NCT00615459|2476864|P3|Period III|Administrative problems|1
778894|NCT00615459|2476865|P2|Period III|Administrative problems|1
778895|NCT00615459|2476866|P1|Period III|Administrative problems|0
778896|NCT00615459|2476863|P4|Period III|Adverse Event|0
778897|NCT00615459|2476864|P3|Period III|Adverse Event|0
778898|NCT00615459|2476865|P2|Period III|Adverse Event|1
778899|NCT00615459|2476866|P1|Period III|Adverse Event|0
778900|NCT00615459|2476863|P4|Period II|Lost to Follow-up|1
778901|NCT00615459|2476864|P3|Period II|Lost to Follow-up|0
778902|NCT00615459|2476865|P2|Period II|Lost to Follow-up|0
778903|NCT00615459|2476866|P1|Period II|Lost to Follow-up|0
778904|NCT00615459|2476863|P4|Period II|Adverse Event|0
778905|NCT00615459|2476864|P3|Period II|Adverse Event|0
778906|NCT00615459|2476865|P2|Period II|Adverse Event|0
778907|NCT00615459|2476866|P1|Period II|Adverse Event|1
778908|NCT00615459|2476863|P4|Period I|Abnormal test procedure results|0
778909|NCT00615459|2476864|P3|Period I|Abnormal test procedure results|1
778910|NCT00615459|2476865|P2|Period I|Abnormal test procedure results|1
778911|NCT00615459|2476866|P1|Period I|Abnormal test procedure results|1
778912|NCT00615459|2476863|P4|Period I|Subject withdrew consent|1
778913|NCT00615459|2476864|P3|Period I|Subject withdrew consent|0
778914|NCT00615459|2476865|P2|Period I|Subject withdrew consent|0
778915|NCT00615459|2476866|P1|Period I|Subject withdrew consent|1
778916|NCT00615459|2476863|P4|Period I|Adverse Event|0
778917|NCT00615459|2476864|P3|Period I|Adverse Event|1
778918|NCT00615459|2476865|P2|Period I|Adverse Event|0
778919|NCT00615459|2476866|P1|Period I|Adverse Event|2
778920|NCT00615550|2476891|P2|Overall Study|Lost to Follow-up|1
778921|NCT00615550|2476892|P1|Overall Study|Lost to Follow-up|6
778922|NCT00621023|2476914|P1|Overall Study|Follow up discontinued|1
778923|NCT00621023|2476914|P1|Overall Study|Death|5
778924|NCT00621140|2476937|P2|Overall Study|Other incl. lack of efficacy|5
778925|NCT00621140|2476938|P1|Overall Study|Other incl. lack of efficacy|6
778926|NCT00621140|2476937|P2|Overall Study|Withdrawal by Subject|6
778927|NCT00621140|2476938|P1|Overall Study|Withdrawal by Subject|4
778928|NCT00621140|2476937|P2|Overall Study|Lost to Follow-up|2
778929|NCT00621140|2476938|P1|Overall Study|Lost to Follow-up|1
778930|NCT00621140|2476937|P2|Overall Study|Adverse Event|5
778931|NCT00621140|2476938|P1|Overall Study|Adverse Event|4
778932|NCT00621153|2476972|P2|Overall Study|Withdrawal by Subject|5
778933|NCT00621153|2476973|P1|Overall Study|Withdrawal by Subject|4
778934|NCT00621153|2476972|P2|Overall Study|Lost to Follow-up|1
778935|NCT00621153|2476973|P1|Overall Study|Lost to Follow-up|5
778936|NCT00621153|2476972|P2|Overall Study|Adverse Event|2
778937|NCT00621153|2476973|P1|Overall Study|Adverse Event|3
778938|NCT00621153|2476972|P2|Overall Study|Safety Reason|7
778939|NCT00621153|2476973|P1|Overall Study|Safety Reason|8
778940|NCT00621192|2476983|P4|Overall Study|Final Assessments not Completed|1
778941|NCT00621192|2476984|P3|Overall Study|Final Assessments not Completed|3
778942|NCT00621192|2476985|P2|Overall Study|Final Assessments not Completed|0
778943|NCT00621192|2476986|P1|Overall Study|Final Assessments not Completed|0
778944|NCT00621192|2476983|P4|Overall Study|Death|0
778945|NCT00621192|2476984|P3|Overall Study|Death|0
778946|NCT00621192|2476985|P2|Overall Study|Death|5
778947|NCT00621192|2476986|P1|Overall Study|Death|2
778948|NCT00621192|2476983|P4|Overall Study|Adverse Event|1
778949|NCT00621192|2476984|P3|Overall Study|Adverse Event|0
778950|NCT00621192|2476985|P2|Overall Study|Adverse Event|1
778951|NCT00621192|2476986|P1|Overall Study|Adverse Event|0
778952|NCT00621192|2476983|P4|Overall Study|Protocol Violation|1
778953|NCT00621192|2476984|P3|Overall Study|Protocol Violation|0
778954|NCT00621192|2476985|P2|Overall Study|Protocol Violation|0
778955|NCT00621192|2476986|P1|Overall Study|Protocol Violation|1
778956|NCT00621192|2476983|P4|Overall Study|Physician Decision|0
778957|NCT00621192|2476984|P3|Overall Study|Physician Decision|0
778958|NCT00621192|2476985|P2|Overall Study|Physician Decision|3
778959|NCT00621192|2476986|P1|Overall Study|Physician Decision|1
778960|NCT00621192|2476983|P4|Overall Study|Withdrawal by Subject|0
778961|NCT00621192|2476984|P3|Overall Study|Withdrawal by Subject|2
778962|NCT00621192|2476985|P2|Overall Study|Withdrawal by Subject|0
778963|NCT00621192|2476986|P1|Overall Study|Withdrawal by Subject|0
778964|NCT00621244|2477012|P4|Overall Study|Administrative problems|2
778965|NCT00621244|2477013|P3|Overall Study|Administrative problems|0
778966|NCT00621244|2477014|P2|Overall Study|Administrative problems|1
778967|NCT00621244|2477015|P1|Overall Study|Administrative problems|5
778968|NCT00621244|2477012|P4|Overall Study|Adverse Event|2
778969|NCT00621244|2477013|P3|Overall Study|Adverse Event|9
778970|NCT00621244|2477014|P2|Overall Study|Adverse Event|7
778971|NCT00621244|2477015|P1|Overall Study|Adverse Event|27
778972|NCT00621244|2477012|P4|Overall Study|Death|1
778973|NCT00621244|2477013|P3|Overall Study|Death|1
778974|NCT00621244|2477014|P2|Overall Study|Death|3
778975|NCT00621244|2477015|P1|Overall Study|Death|3
778976|NCT00621244|2477012|P4|Overall Study|Disease progression|15
778977|NCT00621244|2477013|P3|Overall Study|Disease progression|20
778978|NCT00621244|2477014|P2|Overall Study|Disease progression|20
778979|NCT00621244|2477015|P1|Overall Study|Disease progression|44
778980|NCT00621244|2477012|P4|Overall Study|Withdrawal by Subject|3
778981|NCT00621244|2477013|P3|Overall Study|Withdrawal by Subject|3
778982|NCT00621244|2477014|P2|Overall Study|Withdrawal by Subject|3
778983|NCT00621244|2477015|P1|Overall Study|Withdrawal by Subject|7
778984|NCT00621257|2477120|P5|Overall Study|Withdrawal by Subject|1
778985|NCT00621257|2477121|P4|Overall Study|Withdrawal by Subject|1
778986|NCT00621257|2477122|P3|Overall Study|Withdrawal by Subject|0
778987|NCT00621257|2477123|P2|Overall Study|Withdrawal by Subject|0
778988|NCT00621257|2477124|P1|Overall Study|Withdrawal by Subject|0
778989|NCT00621257|2477120|P5|Overall Study|Physician Decision|1
778990|NCT00621257|2477121|P4|Overall Study|Physician Decision|1
778991|NCT00621257|2477122|P3|Overall Study|Physician Decision|0
778992|NCT00621257|2477123|P2|Overall Study|Physician Decision|2
778993|NCT00621257|2477124|P1|Overall Study|Physician Decision|0
778994|NCT00621257|2477120|P5|Overall Study|Adverse Event|0
778995|NCT00621257|2477121|P4|Overall Study|Adverse Event|0
778996|NCT00621257|2477122|P3|Overall Study|Adverse Event|1
778997|NCT00621257|2477123|P2|Overall Study|Adverse Event|1
778998|NCT00621257|2477124|P1|Overall Study|Adverse Event|0
778999|NCT00621257|2477120|P5|Overall Study|Lost to Follow-up|7
779000|NCT00621257|2477121|P4|Overall Study|Lost to Follow-up|4
779001|NCT00621257|2477122|P3|Overall Study|Lost to Follow-up|2
779002|NCT00621257|2477123|P2|Overall Study|Lost to Follow-up|0
779003|NCT00621257|2477124|P1|Overall Study|Lost to Follow-up|4
779004|NCT00621296|2477136|P1|Overall Study|Stopping Criteria|3
779005|NCT00621296|2477136|P1|Overall Study|Unmatch Criteria|1
779006|NCT00621296|2477136|P1|Overall Study|Physician Decision|7
779007|NCT00621296|2477136|P1|Overall Study|Lack of Efficacy|1
779008|NCT00621296|2477136|P1|Overall Study|Adverse Event|2
779009|NCT00621322|2477146|P6|Overall Study|Migrated/moved from study area|2
779010|NCT00621322|2477147|P5|Overall Study|Migrated/moved from study area|0
779011|NCT00621322|2477148|P4|Overall Study|Migrated/moved from study area|1
779012|NCT00621322|2477149|P3|Overall Study|Migrated/moved from study area|1
779013|NCT00621322|2477150|P2|Overall Study|Migrated/moved from study area|0
779014|NCT00621322|2477151|P1|Overall Study|Migrated/moved from study area|1
779015|NCT00621322|2477146|P6|Overall Study|Withdrawal by Subject|2
779016|NCT00621322|2477147|P5|Overall Study|Withdrawal by Subject|0
779017|NCT00621322|2477148|P4|Overall Study|Withdrawal by Subject|1
779018|NCT00621322|2477149|P3|Overall Study|Withdrawal by Subject|0
779019|NCT00621322|2477150|P2|Overall Study|Withdrawal by Subject|0
779020|NCT00621322|2477151|P1|Overall Study|Withdrawal by Subject|0
779021|NCT00621322|2477146|P6|Overall Study|Physician Decision|0
779022|NCT00621322|2477147|P5|Overall Study|Physician Decision|0
779023|NCT00621322|2477148|P4|Overall Study|Physician Decision|1
779024|NCT00621322|2477149|P3|Overall Study|Physician Decision|1
779025|NCT00621322|2477150|P2|Overall Study|Physician Decision|0
779026|NCT00621322|2477151|P1|Overall Study|Physician Decision|0
779027|NCT00621322|2477146|P6|Overall Study|Lost to Follow-up|0
779028|NCT00621322|2477147|P5|Overall Study|Lost to Follow-up|1
779029|NCT00621322|2477148|P4|Overall Study|Lost to Follow-up|0
779030|NCT00621322|2477149|P3|Overall Study|Lost to Follow-up|0
779031|NCT00621322|2477150|P2|Overall Study|Lost to Follow-up|0
779032|NCT00621322|2477151|P1|Overall Study|Lost to Follow-up|0
779033|NCT00622284|2477255|P2|Overall Study|Other reason (not specified)|24
779034|NCT00622284|2477256|P1|Overall Study|Other reason (not specified)|33
779035|NCT00622284|2477255|P2|Overall Study|Withdrawal by Subject|24
779036|NCT00622284|2477256|P1|Overall Study|Withdrawal by Subject|27
779037|NCT00622284|2477255|P2|Overall Study|Lost to Follow-up|13
779038|NCT00622284|2477256|P1|Overall Study|Lost to Follow-up|11
779039|NCT00622284|2477255|P2|Overall Study|Protocol Violation|5
779040|NCT00622284|2477256|P1|Overall Study|Protocol Violation|12
779041|NCT00622284|2477255|P2|Overall Study|Adverse Event|90
779042|NCT00622284|2477256|P1|Overall Study|Adverse Event|61
779043|NCT00622284|2477255|P2|Overall Study|Lack of Efficacy|15
779044|NCT00622284|2477256|P1|Overall Study|Lack of Efficacy|45
779045|NCT00622336|2477318|P1|Extension Phase|Unspecified|9
779046|NCT00622336|2477318|P1|Extension Phase|Lost to Follow-up|1
779047|NCT00622336|2477318|P1|Extension Phase|Withdrawal by Subject|1
779048|NCT00622336|2477318|P1|Extension Phase|Lack of therapeutic effect|2
779049|NCT00622336|2477318|P1|Extension Phase|Progressive Disease|6
779050|NCT00622336|2477318|P1|Extension Phase|Adverse Event|2
779051|NCT00622336|2477318|P1|Treatment Phase|Lost to Follow-up|2
779052|NCT00622336|2477318|P1|Treatment Phase|Withdrawal by Subject|13
779053|NCT00622336|2477318|P1|Treatment Phase|Lack of therapeutic effect|13
779054|NCT00622336|2477318|P1|Treatment Phase|Death|14
779055|NCT00622336|2477318|P1|Treatment Phase|Unspecified|40
779056|NCT00622336|2477318|P1|Treatment Phase|Adverse Event|46
779057|NCT00622336|2477318|P1|Treatment Phase|Progression of Disease|181
779058|NCT00622388|2477327|P1|Overall Study|Insurance Expired|1
779059|NCT00622388|2477327|P1|Overall Study|Withdrew Consent|1
779060|NCT00622388|2477327|P1|Overall Study|Took Prohibited Medication|2
779061|NCT00622388|2477327|P1|Overall Study|Received Alternate Anticancer Therapy|8
779062|NCT00622388|2477327|P1|Overall Study|Death|3
779063|NCT00622388|2477327|P1|Overall Study|Participant Refusal|1
779064|NCT00622388|2477327|P1|Overall Study|Protocol Violation|3
779065|NCT00622388|2477327|P1|Overall Study|Adverse Event|6
779066|NCT00622388|2477327|P1|Overall Study|Disease Progression|47
779070|NCT00622440|2477367|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
779071|NCT00622440|2477368|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
779072|NCT00622440|2477367|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
779073|NCT00622440|2477368|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
779074|NCT00622440|2477367|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
779075|NCT00622440|2477368|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
779076|NCT00622440|2477367|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
779077|NCT00622440|2477368|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
779078|NCT00622635|2477391|P6|Treatment Period 3|Withdrawal by Subject|0
779079|NCT00622635|2477392|P5|Treatment Period 3|Withdrawal by Subject|0
779080|NCT00622635|2477393|P4|Treatment Period 3|Withdrawal by Subject|1
779081|NCT00622635|2477394|P3|Treatment Period 3|Withdrawal by Subject|0
779082|NCT00622635|2477395|P2|Treatment Period 3|Withdrawal by Subject|0
779083|NCT00622635|2477396|P1|Treatment Period 3|Withdrawal by Subject|0
779084|NCT00622635|2477391|P6|Treatment Period 3|Adverse Event|0
779085|NCT00622635|2477392|P5|Treatment Period 3|Adverse Event|0
779086|NCT00622635|2477393|P4|Treatment Period 3|Adverse Event|2
779087|NCT00622635|2477394|P3|Treatment Period 3|Adverse Event|0
779088|NCT00622635|2477395|P2|Treatment Period 3|Adverse Event|0
779089|NCT00622635|2477396|P1|Treatment Period 3|Adverse Event|0
779090|NCT00622635|2477391|P6|Treatment Period 2|Adverse Event|0
779091|NCT00622635|2477392|P5|Treatment Period 2|Adverse Event|0
779092|NCT00622635|2477393|P4|Treatment Period 2|Adverse Event|0
779093|NCT00622635|2477394|P3|Treatment Period 2|Adverse Event|0
779094|NCT00622635|2477395|P2|Treatment Period 2|Adverse Event|0
779095|NCT00622635|2477396|P1|Treatment Period 2|Adverse Event|1
779096|NCT00622635|2477391|P6|Treatment Period 1|Abnormal test procedure result(s)|0
779097|NCT00622635|2477392|P5|Treatment Period 1|Abnormal test procedure result(s)|1
779098|NCT00622635|2477393|P4|Treatment Period 1|Abnormal test procedure result(s)|0
779099|NCT00622635|2477394|P3|Treatment Period 1|Abnormal test procedure result(s)|0
779100|NCT00622635|2477395|P2|Treatment Period 1|Abnormal test procedure result(s)|0
779101|NCT00622635|2477396|P1|Treatment Period 1|Abnormal test procedure result(s)|0
779102|NCT00622635|2477391|P6|Treatment Period 1|Withdrawal by Subject|0
779103|NCT00622635|2477392|P5|Treatment Period 1|Withdrawal by Subject|0
779104|NCT00622635|2477393|P4|Treatment Period 1|Withdrawal by Subject|0
779105|NCT00622635|2477394|P3|Treatment Period 1|Withdrawal by Subject|0
779106|NCT00622635|2477395|P2|Treatment Period 1|Withdrawal by Subject|1
779107|NCT00622635|2477396|P1|Treatment Period 1|Withdrawal by Subject|0
779108|NCT00622635|2477391|P6|Treatment Period 1|Adverse Event|0
779109|NCT00622635|2477392|P5|Treatment Period 1|Adverse Event|0
779110|NCT00622635|2477393|P4|Treatment Period 1|Adverse Event|0
779111|NCT00622635|2477394|P3|Treatment Period 1|Adverse Event|1
779112|NCT00622635|2477395|P2|Treatment Period 1|Adverse Event|0
779113|NCT00622635|2477396|P1|Treatment Period 1|Adverse Event|0
779114|NCT00622700|2477464|P7|Extension Treatment Period|Other than specified above|1
779115|NCT00622700|2477465|P6|Extension Treatment Period|Other than specified above|1
779116|NCT00622700|2477466|P5|Extension Treatment Period|Other than specified above|0
779117|NCT00622700|2477467|P4|Extension Treatment Period|Other than specified above|0
779118|NCT00622700|2477468|P3|Extension Treatment Period|Other than specified above|0
779119|NCT00622700|2477469|P2|Extension Treatment Period|Other than specified above|0
779120|NCT00622700|2477470|P1|Extension Treatment Period|Other than specified above|0
779121|NCT00622700|2477464|P7|Extension Treatment Period|Missing|0
779122|NCT00622700|2477465|P6|Extension Treatment Period|Missing|1
779123|NCT00622700|2477466|P5|Extension Treatment Period|Missing|3
779124|NCT00622700|2477467|P4|Extension Treatment Period|Missing|2
779125|NCT00622700|2477468|P3|Extension Treatment Period|Missing|0
779126|NCT00622700|2477469|P2|Extension Treatment Period|Missing|0
779127|NCT00622700|2477470|P1|Extension Treatment Period|Missing|0
779128|NCT00622700|2477464|P7|Extension Treatment Period|Withdrawal by Subject|10
779129|NCT00622700|2477465|P6|Extension Treatment Period|Withdrawal by Subject|6
779130|NCT00622700|2477466|P5|Extension Treatment Period|Withdrawal by Subject|16
779131|NCT00622700|2477467|P4|Extension Treatment Period|Withdrawal by Subject|11
779132|NCT00622700|2477468|P3|Extension Treatment Period|Withdrawal by Subject|0
779133|NCT00622700|2477469|P2|Extension Treatment Period|Withdrawal by Subject|0
779134|NCT00622700|2477470|P1|Extension Treatment Period|Withdrawal by Subject|0
779135|NCT00622700|2477464|P7|Extension Treatment Period|Progressive Disease|2
779136|NCT00622700|2477465|P6|Extension Treatment Period|Progressive Disease|0
779137|NCT00622700|2477466|P5|Extension Treatment Period|Progressive Disease|2
779138|NCT00622700|2477467|P4|Extension Treatment Period|Progressive Disease|1
779139|NCT00622700|2477468|P3|Extension Treatment Period|Progressive Disease|0
779140|NCT00622700|2477469|P2|Extension Treatment Period|Progressive Disease|0
779141|NCT00622700|2477470|P1|Extension Treatment Period|Progressive Disease|0
779142|NCT00622700|2477464|P7|Extension Treatment Period|Lost to Follow-up|0
779143|NCT00622700|2477465|P6|Extension Treatment Period|Lost to Follow-up|0
779144|NCT00622700|2477466|P5|Extension Treatment Period|Lost to Follow-up|1
779145|NCT00622700|2477467|P4|Extension Treatment Period|Lost to Follow-up|0
779146|NCT00622700|2477468|P3|Extension Treatment Period|Lost to Follow-up|0
779147|NCT00622700|2477469|P2|Extension Treatment Period|Lost to Follow-up|0
779148|NCT00622700|2477470|P1|Extension Treatment Period|Lost to Follow-up|0
779149|NCT00622700|2477464|P7|Extension Treatment Period|Protocol Violation|0
779150|NCT00622700|2477465|P6|Extension Treatment Period|Protocol Violation|2
779151|NCT00622700|2477466|P5|Extension Treatment Period|Protocol Violation|0
779152|NCT00622700|2477467|P4|Extension Treatment Period|Protocol Violation|0
779153|NCT00622700|2477468|P3|Extension Treatment Period|Protocol Violation|0
779154|NCT00622700|2477469|P2|Extension Treatment Period|Protocol Violation|0
779155|NCT00622700|2477470|P1|Extension Treatment Period|Protocol Violation|0
779156|NCT00622700|2477464|P7|Extension Treatment Period|Lack of Efficacy|9
779157|NCT00622700|2477465|P6|Extension Treatment Period|Lack of Efficacy|1
779158|NCT00622700|2477466|P5|Extension Treatment Period|Lack of Efficacy|8
779159|NCT00622700|2477467|P4|Extension Treatment Period|Lack of Efficacy|2
779160|NCT00622700|2477468|P3|Extension Treatment Period|Lack of Efficacy|0
779161|NCT00622700|2477469|P2|Extension Treatment Period|Lack of Efficacy|0
779162|NCT00622700|2477470|P1|Extension Treatment Period|Lack of Efficacy|0
779163|NCT00622700|2477464|P7|Extension Treatment Period|Adverse Event|8
779164|NCT00622700|2477465|P6|Extension Treatment Period|Adverse Event|6
779165|NCT00622700|2477466|P5|Extension Treatment Period|Adverse Event|9
779166|NCT00622700|2477467|P4|Extension Treatment Period|Adverse Event|5
779167|NCT00622700|2477468|P3|Extension Treatment Period|Adverse Event|0
779168|NCT00622700|2477469|P2|Extension Treatment Period|Adverse Event|0
779169|NCT00622700|2477470|P1|Extension Treatment Period|Adverse Event|0
779170|NCT00622700|2477464|P7|Core Treatment Period|Other than specified above|0
779171|NCT00622700|2477465|P6|Core Treatment Period|Other than specified above|0
779172|NCT00622700|2477466|P5|Core Treatment Period|Other than specified above|0
779173|NCT00622700|2477467|P4|Core Treatment Period|Other than specified above|0
779174|NCT00622700|2477468|P3|Core Treatment Period|Other than specified above|5
779175|NCT00622700|2477469|P2|Core Treatment Period|Other than specified above|2
779176|NCT00622700|2477470|P1|Core Treatment Period|Other than specified above|2
779177|NCT00622700|2477464|P7|Core Treatment Period|Withdrawal by Subject|0
779178|NCT00622700|2477465|P6|Core Treatment Period|Withdrawal by Subject|0
779179|NCT00622700|2477466|P5|Core Treatment Period|Withdrawal by Subject|0
779180|NCT00622700|2477467|P4|Core Treatment Period|Withdrawal by Subject|0
779181|NCT00622700|2477468|P3|Core Treatment Period|Withdrawal by Subject|15
779182|NCT00622700|2477469|P2|Core Treatment Period|Withdrawal by Subject|18
779183|NCT00622700|2477470|P1|Core Treatment Period|Withdrawal by Subject|12
779184|NCT00622700|2477464|P7|Core Treatment Period|Progressive Disease|0
779185|NCT00622700|2477465|P6|Core Treatment Period|Progressive Disease|0
779186|NCT00622700|2477466|P5|Core Treatment Period|Progressive Disease|0
779187|NCT00622700|2477467|P4|Core Treatment Period|Progressive Disease|0
779188|NCT00622700|2477468|P3|Core Treatment Period|Progressive Disease|0
779189|NCT00622700|2477469|P2|Core Treatment Period|Progressive Disease|1
779190|NCT00622700|2477470|P1|Core Treatment Period|Progressive Disease|3
779191|NCT00622700|2477464|P7|Core Treatment Period|Death|0
779192|NCT00622700|2477465|P6|Core Treatment Period|Death|0
779193|NCT00622700|2477466|P5|Core Treatment Period|Death|0
779194|NCT00622700|2477467|P4|Core Treatment Period|Death|0
779195|NCT00622700|2477468|P3|Core Treatment Period|Death|0
779196|NCT00622700|2477469|P2|Core Treatment Period|Death|0
779197|NCT00622700|2477470|P1|Core Treatment Period|Death|1
779198|NCT00622700|2477464|P7|Core Treatment Period|Lost to Follow-up|0
779199|NCT00622700|2477465|P6|Core Treatment Period|Lost to Follow-up|0
779200|NCT00622700|2477466|P5|Core Treatment Period|Lost to Follow-up|0
779201|NCT00622700|2477467|P4|Core Treatment Period|Lost to Follow-up|0
779202|NCT00622700|2477468|P3|Core Treatment Period|Lost to Follow-up|1
779203|NCT00622700|2477469|P2|Core Treatment Period|Lost to Follow-up|1
779204|NCT00622700|2477470|P1|Core Treatment Period|Lost to Follow-up|1
779205|NCT00622700|2477464|P7|Core Treatment Period|Lack of Efficacy|0
779206|NCT00622700|2477465|P6|Core Treatment Period|Lack of Efficacy|0
779207|NCT00622700|2477466|P5|Core Treatment Period|Lack of Efficacy|0
779208|NCT00622700|2477467|P4|Core Treatment Period|Lack of Efficacy|0
779209|NCT00622700|2477468|P3|Core Treatment Period|Lack of Efficacy|12
779210|NCT00622700|2477469|P2|Core Treatment Period|Lack of Efficacy|6
779211|NCT00622700|2477470|P1|Core Treatment Period|Lack of Efficacy|19
779212|NCT00622700|2477464|P7|Core Treatment Period|Adverse Event|0
779213|NCT00622700|2477465|P6|Core Treatment Period|Adverse Event|0
779214|NCT00622700|2477466|P5|Core Treatment Period|Adverse Event|0
779215|NCT00622700|2477467|P4|Core Treatment Period|Adverse Event|0
779216|NCT00622700|2477468|P3|Core Treatment Period|Adverse Event|18
779217|NCT00622700|2477469|P2|Core Treatment Period|Adverse Event|25
779218|NCT00622700|2477470|P1|Core Treatment Period|Adverse Event|18
779219|NCT00622700|2477464|P7|Core Treatment Period|Randomized but Not Treated|0
779220|NCT00622700|2477465|P6|Core Treatment Period|Randomized but Not Treated|0
779221|NCT00622700|2477466|P5|Core Treatment Period|Randomized but Not Treated|0
779222|NCT00622700|2477467|P4|Core Treatment Period|Randomized but Not Treated|0
779223|NCT00622700|2477468|P3|Core Treatment Period|Randomized but Not Treated|2
779224|NCT00622700|2477469|P2|Core Treatment Period|Randomized but Not Treated|2
779225|NCT00622700|2477470|P1|Core Treatment Period|Randomized but Not Treated|0
779226|NCT00622713|2477529|P1|Overall Study|Did not meet eligibility criteria|1
779227|NCT00622713|2477529|P1|Overall Study|Subject no longer required study drug|1
779228|NCT00622713|2477529|P1|Overall Study|Death|2
779229|NCT00622713|2477529|P1|Overall Study|Lost to Follow-up|5
779230|NCT00622713|2477529|P1|Overall Study|Withdrawal by Subject|11
779231|NCT00622713|2477529|P1|Overall Study|Administrative problems|4
779232|NCT00622713|2477529|P1|Overall Study|Adverse Event|35
779233|NCT00622726|2477539|P2|August, 2010 to April, 2013|Death|5
779234|NCT00622726|2477540|P1|August, 2010 to April, 2013|Death|1
779235|NCT00622726|2477539|P2|March, 2008 to August, 2010|Death|2
779236|NCT00622726|2477540|P1|March, 2008 to August, 2010|Death|5
779237|NCT00622739|2477552|P2|Overall Study|Lost to Follow-up|1
779238|NCT00622739|2477553|P1|Overall Study|Lost to Follow-up|0
779239|NCT00622739|2477552|P2|Overall Study|Withdrawal by Subject|1
779240|NCT00622739|2477553|P1|Overall Study|Withdrawal by Subject|0
779241|NCT00622739|2477552|P2|Overall Study|Lack of Efficacy|2
779242|NCT00622739|2477553|P1|Overall Study|Lack of Efficacy|0
779243|NCT00622739|2477552|P2|Overall Study|Adverse Event|2
779244|NCT00622739|2477553|P1|Overall Study|Adverse Event|1
779245|NCT00622739|2477552|P2|Overall Study|Physician Decision|0
779246|NCT00622739|2477553|P1|Overall Study|Physician Decision|1
779247|NCT00622869|2477562|P3|Overall Study|Missing|1
779248|NCT00622869|2477563|P2|Overall Study|Missing|1
779249|NCT00622869|2477564|P1|Overall Study|Missing|0
779250|NCT00622869|2477562|P3|Overall Study|Graft Loss|2
779251|NCT00622869|2477563|P2|Overall Study|Graft Loss|3
779252|NCT00622869|2477564|P1|Overall Study|Graft Loss|5
779253|NCT00622869|2477562|P3|Overall Study|Lost to Follow-up|2
779254|NCT00622869|2477563|P2|Overall Study|Lost to Follow-up|4
779255|NCT00622869|2477564|P1|Overall Study|Lost to Follow-up|2
779256|NCT00622869|2477562|P3|Overall Study|Death|10
779257|NCT00622869|2477563|P2|Overall Study|Death|15
779258|NCT00622869|2477564|P1|Overall Study|Death|12
779259|NCT00622869|2477562|P3|Overall Study|Administrative Problems|13
779260|NCT00622869|2477563|P2|Overall Study|Administrative Problems|17
779261|NCT00622869|2477564|P1|Overall Study|Administrative Problems|11
779262|NCT00622869|2477562|P3|Overall Study|Subject Withdrew Consent|11
779263|NCT00622869|2477563|P2|Overall Study|Subject Withdrew Consent|17
779264|NCT00622869|2477564|P1|Overall Study|Subject Withdrew Consent|13
779265|NCT00622908|2477583|P2|Overall Study|Termination by study sponser|1
779266|NCT00622908|2477584|P1|Overall Study|Termination by study sponser|0
779267|NCT00622908|2477583|P2|Overall Study|Refusal|1
779268|NCT00622908|2477584|P1|Overall Study|Refusal|0
779269|NCT00622908|2477583|P2|Overall Study|Lost to Follow-up|0
779270|NCT00622908|2477584|P1|Overall Study|Lost to Follow-up|1
779271|NCT00622908|2477583|P2|Overall Study|Lack of Efficacy|7
779272|NCT00622908|2477584|P1|Overall Study|Lack of Efficacy|1
779273|NCT00622908|2477583|P2|Overall Study|Adverse Event|1
779274|NCT00622908|2477584|P1|Overall Study|Adverse Event|0
779275|NCT00622908|2477583|P2|Overall Study|Protocol Violation|0
779276|NCT00622908|2477584|P1|Overall Study|Protocol Violation|1
779277|NCT00623103|2477604|P2|Overall Study|Protocol deviation|1
779278|NCT00623103|2477605|P1|Overall Study|Protocol deviation|2
779279|NCT00623103|2477604|P2|Overall Study|Death|11
779280|NCT00623103|2477605|P1|Overall Study|Death|11
779281|NCT00623103|2477604|P2|Overall Study|Administrative problems|4
779282|NCT00623103|2477605|P1|Overall Study|Administrative problems|2
779283|NCT00623103|2477604|P2|Overall Study|Lost to Follow-up|1
779284|NCT00623103|2477605|P1|Overall Study|Lost to Follow-up|4
779285|NCT00623103|2477604|P2|Overall Study|Withdrawal by Subject|24
779286|NCT00623103|2477605|P1|Overall Study|Withdrawal by Subject|18
779287|NCT00623103|2477604|P2|Overall Study|Unsatisfactory therapeutic effect|12
779288|NCT00623103|2477605|P1|Overall Study|Unsatisfactory therapeutic effect|4
779289|NCT00623103|2477604|P2|Overall Study|Adverse Event|60
779290|NCT00623103|2477605|P1|Overall Study|Adverse Event|70
779291|NCT00623194|2477640|P1|Overall Study|Unclassified|1
779292|NCT00623194|2477640|P1|Overall Study|Protocol Violation|3
779293|NCT00623194|2477640|P1|Overall Study|Lack of Efficacy|1
779294|NCT00623233|2477660|P1|Overall Study|Withdrawal by Subject|3
779295|NCT00623233|2477660|P1|Overall Study|Lost to Follow-up|1
779296|NCT00623233|2477660|P1|Overall Study|Physician Decision|10
779297|NCT00623233|2477660|P1|Overall Study|Adverse Event|10
779298|NCT00623428|2477669|P2|Follow-up Period|Death|1
779299|NCT00623428|2477670|P1|Follow-up Period|Death|0
779300|NCT00623428|2477669|P2|Follow-up Period|Reason not specified|1
779301|NCT00623428|2477670|P1|Follow-up Period|Reason not specified|1
779302|NCT00623428|2477669|P2|Follow-up Period|Did not cooperate|3
779303|NCT00623428|2477670|P1|Follow-up Period|Did not cooperate|0
779304|NCT00623428|2477669|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
779305|NCT00623428|2477670|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
779306|NCT00623428|2477669|P2|Follow-up Period|Patient withdrew consent|4
779307|NCT00623428|2477670|P1|Follow-up Period|Patient withdrew consent|5
779308|NCT00623428|2477669|P2|Follow-up Period|Failure to return|2
779309|NCT00623428|2477670|P1|Follow-up Period|Failure to return|10
779310|NCT00623428|2477669|P2|Follow-up Period|Relapse post-treatment|3
779311|NCT00623428|2477670|P1|Follow-up Period|Relapse post-treatment|11
779312|NCT00623428|2477669|P2|Treatment Period|Withdrawal by Subject|1
779313|NCT00623428|2477670|P1|Treatment Period|Withdrawal by Subject|0
779314|NCT00623428|2477669|P2|Treatment Period|Other|1
779315|NCT00623428|2477670|P1|Treatment Period|Other|0
779316|NCT00623428|2477669|P2|Treatment Period|Insufficient therapeutic response|2
779317|NCT00623428|2477670|P1|Treatment Period|Insufficient therapeutic response|0
779318|NCT00623428|2477669|P2|Treatment Period|Did not cooperate / refused treatment|13
779319|NCT00623428|2477670|P1|Treatment Period|Did not cooperate / refused treatment|0
779320|NCT00623428|2477669|P2|Treatment Period|Death|1
779321|NCT00623428|2477670|P1|Treatment Period|Death|0
779322|NCT00623428|2477669|P2|Treatment Period|Adverse event/intercurrent illness|9
779323|NCT00623428|2477670|P1|Treatment Period|Adverse event/intercurrent illness|0
779324|NCT00623467|2477692|P1|Overall Study|Withdrawal by Subject|2
779325|NCT00623467|2477692|P1|Overall Study|Protocol Violation|4
779326|NCT00623467|2477692|P1|Overall Study|Lost to Follow-up|1
779327|NCT00623480|2477758|P2|Overall Study|Site closed by sponsor|1
779328|NCT00623480|2477759|P1|Overall Study|Site closed by sponsor|0
779329|NCT00623480|2477758|P2|Overall Study|Protocol Violation|1
779330|NCT00623480|2477759|P1|Overall Study|Protocol Violation|0
779331|NCT00623480|2477758|P2|Overall Study|Non-compliant with study medication|0
779332|NCT00623480|2477759|P1|Overall Study|Non-compliant with study medication|4
779333|NCT00623480|2477758|P2|Overall Study|Lack of Efficacy|0
779334|NCT00623480|2477759|P1|Overall Study|Lack of Efficacy|1
779335|NCT00623480|2477758|P2|Overall Study|Withdrawal by Subject|4
779336|NCT00623480|2477759|P1|Overall Study|Withdrawal by Subject|2
779337|NCT00623480|2477758|P2|Overall Study|Lost to Follow-up|1
779338|NCT00623480|2477759|P1|Overall Study|Lost to Follow-up|0
779339|NCT00623545|2477784|P1|Overall Study|Withdrawal by Subject|4
779340|NCT00623545|2477784|P1|Overall Study|Adverse Event|6
779341|NCT00623597|2477791|P2|Overall Study|Failed to return|0
779342|NCT00623597|2477792|P1|Overall Study|Failed to return|1
779343|NCT00623727|2477890|P2|Open Label Follow-up|Participant convenience|1
779344|NCT00623727|2477891|P1|Open Label Follow-up|Participant convenience|0
779345|NCT00623727|2477890|P2|Open Label Follow-up|Study termination|6
779346|NCT00623727|2477891|P1|Open Label Follow-up|Study termination|0
779347|NCT00623727|2477890|P2|Open Label Follow-up|Withdrawal by Subject|1
779348|NCT00623727|2477891|P1|Open Label Follow-up|Withdrawal by Subject|0
779349|NCT00623727|2477890|P2|Double Blind (DB)|Protocol Violation|2
779350|NCT00623727|2477891|P1|Double Blind (DB)|Protocol Violation|2
779351|NCT00623727|2477890|P2|Double Blind (DB)|Lost to Follow-up|1
779352|NCT00623727|2477891|P1|Double Blind (DB)|Lost to Follow-up|1
779353|NCT00623727|2477890|P2|Double Blind (DB)|Termination of the double-blind period|21
779354|NCT00623727|2477891|P1|Double Blind (DB)|Termination of the double-blind period|22
779355|NCT00623727|2477890|P2|Double Blind (DB)|Lack of Efficacy|2
779356|NCT00623727|2477891|P1|Double Blind (DB)|Lack of Efficacy|2
779357|NCT00623727|2477890|P2|Double Blind (DB)|Withdrawal by Subject|2
779358|NCT00623727|2477891|P1|Double Blind (DB)|Withdrawal by Subject|8
779359|NCT00623727|2477890|P2|Double Blind (DB)|Physician Decision|1
779360|NCT00623727|2477891|P1|Double Blind (DB)|Physician Decision|0
779361|NCT00623727|2477890|P2|Double Blind (DB)|Adverse Event|3
779362|NCT00623727|2477891|P1|Double Blind (DB)|Adverse Event|1
891884|NCT01072149|2828544|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
891885|NCT01072149|2828545|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
891886|NCT01072149|2828546|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
891887|NCT01072149|2828547|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
891888|NCT01072149|2828548|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
891889|NCT01072149|2828549|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
891890|NCT01072149|2828532|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891891|NCT01072149|2828533|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891892|NCT01072149|2828534|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891893|NCT01072149|2828535|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
779373|NCT00623779|2477939|P3|Overall Study|Criteria from CSR|1
779374|NCT00623779|2477940|P2|Overall Study|Criteria from CSR|0
779375|NCT00623779|2477941|P1|Overall Study|Criteria from CSR|2
779376|NCT00623779|2477939|P3|Overall Study|Adverse Event|0
779377|NCT00623779|2477940|P2|Overall Study|Adverse Event|3
779378|NCT00623779|2477941|P1|Overall Study|Adverse Event|1
779379|NCT00623805|2477990|P2|Overall Study|Reason not Specified|6
779380|NCT00623805|2477991|P1|Overall Study|Reason not Specified|3
779381|NCT00623805|2477990|P2|Overall Study|Protocol Violation|1
779382|NCT00623805|2477991|P1|Overall Study|Protocol Violation|1
779383|NCT00623805|2477990|P2|Overall Study|Lost to Follow-up|2
779384|NCT00623805|2477991|P1|Overall Study|Lost to Follow-up|2
779385|NCT00623805|2477990|P2|Overall Study|Lack of Efficacy|7
779386|NCT00623805|2477991|P1|Overall Study|Lack of Efficacy|3
779387|NCT00623805|2477990|P2|Overall Study|Death|0
779388|NCT00623805|2477991|P1|Overall Study|Death|2
779389|NCT00623805|2477990|P2|Overall Study|Adverse Event|6
779390|NCT00623805|2477991|P1|Overall Study|Adverse Event|9
779391|NCT00623831|2478007|P2|Overall Study|Progressive Disease|1
779392|NCT00623831|2478008|P1|Overall Study|Progressive Disease|0
779393|NCT00623831|2478007|P2|Overall Study|Withdrawal by Subject|0
779394|NCT00623831|2478008|P1|Overall Study|Withdrawal by Subject|1
779395|NCT00623935|2478018|P1|Overall Study|Patient Declined Transplant|1
779396|NCT00623935|2478018|P1|Overall Study|Death|1
779397|NCT00624052|2478044|P4|Overall Study|Changed job/ran out if meds|0
779398|NCT00624052|2478045|P3|Overall Study|Changed job/ran out if meds|0
779399|NCT00624052|2478046|P2|Overall Study|Changed job/ran out if meds|2
779400|NCT00624052|2478047|P1|Overall Study|Changed job/ran out if meds|0
779401|NCT00624052|2478044|P4|Overall Study|Consent withdrawn|0
779402|NCT00624052|2478045|P3|Overall Study|Consent withdrawn|1
779403|NCT00624052|2478046|P2|Overall Study|Consent withdrawn|1
779404|NCT00624052|2478047|P1|Overall Study|Consent withdrawn|3
779405|NCT00624052|2478044|P4|Overall Study|Non compliant with the protocol|1
779406|NCT00624052|2478045|P3|Overall Study|Non compliant with the protocol|1
779407|NCT00624052|2478046|P2|Overall Study|Non compliant with the protocol|1
779408|NCT00624052|2478047|P1|Overall Study|Non compliant with the protocol|2
779409|NCT00624052|2478044|P4|Overall Study|Lost to Follow-up|0
779410|NCT00624052|2478045|P3|Overall Study|Lost to Follow-up|1
779411|NCT00624052|2478046|P2|Overall Study|Lost to Follow-up|3
779412|NCT00624052|2478047|P1|Overall Study|Lost to Follow-up|2
779413|NCT00624052|2478044|P4|Overall Study|Lack of Efficacy|0
779414|NCT00624052|2478045|P3|Overall Study|Lack of Efficacy|0
779415|NCT00624052|2478046|P2|Overall Study|Lack of Efficacy|1
779416|NCT00624052|2478047|P1|Overall Study|Lack of Efficacy|1
779417|NCT00624052|2478044|P4|Overall Study|Adverse Event|3
779418|NCT00624052|2478045|P3|Overall Study|Adverse Event|0
779419|NCT00624052|2478046|P2|Overall Study|Adverse Event|6
779420|NCT00624052|2478047|P1|Overall Study|Adverse Event|7
779421|NCT00624065|2478098|P2|Overall Study|Met protocol-defined stopping criteria|9
779422|NCT00624065|2478099|P1|Overall Study|Met protocol-defined stopping criteria|4
779423|NCT00624065|2478098|P2|Overall Study|Lack of Efficacy|3
779424|NCT00624065|2478099|P1|Overall Study|Lack of Efficacy|0
779425|NCT00624065|2478098|P2|Overall Study|Consent withdrawn|5
779426|NCT00624065|2478099|P1|Overall Study|Consent withdrawn|6
891894|NCT01072149|2828536|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
779427|NCT00624065|2478098|P2|Overall Study|Lost to Follow-up|1
779428|NCT00624065|2478099|P1|Overall Study|Lost to Follow-up|4
779429|NCT00624065|2478098|P2|Overall Study|Adverse Event|6
779430|NCT00624065|2478099|P1|Overall Study|Adverse Event|5
779431|NCT00624286|2478152|P2|Overall Study|Death|1
779432|NCT00624286|2478153|P1|Overall Study|Death|0
779433|NCT00624286|2478152|P2|Overall Study|Abnormal test procedure result(s)|1
779434|NCT00624286|2478153|P1|Overall Study|Abnormal test procedure result(s)|0
779435|NCT00624286|2478152|P2|Overall Study|Not stated|1
779436|NCT00624286|2478153|P1|Overall Study|Not stated|0
779437|NCT00624286|2478152|P2|Overall Study|Lack of Efficacy|6
779438|NCT00624286|2478153|P1|Overall Study|Lack of Efficacy|1
779439|NCT00624286|2478152|P2|Overall Study|Administrative problems|0
779440|NCT00624286|2478153|P1|Overall Study|Administrative problems|3
779441|NCT00624286|2478152|P2|Overall Study|Lost to Follow-up|2
779442|NCT00624286|2478153|P1|Overall Study|Lost to Follow-up|3
779443|NCT00624286|2478152|P2|Overall Study|Withdrawal by Subject|4
779444|NCT00624286|2478153|P1|Overall Study|Withdrawal by Subject|5
779445|NCT00624286|2478152|P2|Overall Study|Adverse Event|3
779446|NCT00624286|2478153|P1|Overall Study|Adverse Event|6
779447|NCT00624286|2478152|P2|Overall Study|Protocol Deviation|9
779448|NCT00624286|2478153|P1|Overall Study|Protocol Deviation|7
779449|NCT00624338|2478164|P3|Overall Study|Randomized but not treated|3
779450|NCT00624338|2478165|P2|Overall Study|Randomized but not treated|1
779451|NCT00624338|2478166|P1|Overall Study|Randomized but not treated|2
779452|NCT00624338|2478164|P3|Overall Study|Unspecified|9
779453|NCT00624338|2478165|P2|Overall Study|Unspecified|5
779454|NCT00624338|2478166|P1|Overall Study|Unspecified|15
779455|NCT00624338|2478164|P3|Overall Study|Termination of 150 mg group by Sponsor|0
779456|NCT00624338|2478165|P2|Overall Study|Termination of 150 mg group by Sponsor|55
779457|NCT00624338|2478166|P1|Overall Study|Termination of 150 mg group by Sponsor|0
779458|NCT00624338|2478164|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
779459|NCT00624338|2478165|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
779460|NCT00624338|2478166|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
779461|NCT00624338|2478164|P3|Overall Study|Death|0
779462|NCT00624338|2478165|P2|Overall Study|Death|2
779463|NCT00624338|2478166|P1|Overall Study|Death|0
779464|NCT00624338|2478164|P3|Overall Study|Protocol Violation|2
779465|NCT00624338|2478165|P2|Overall Study|Protocol Violation|3
779466|NCT00624338|2478166|P1|Overall Study|Protocol Violation|3
779467|NCT00624338|2478164|P3|Overall Study|Lack of Efficacy|14
779468|NCT00624338|2478165|P2|Overall Study|Lack of Efficacy|3
779469|NCT00624338|2478166|P1|Overall Study|Lack of Efficacy|11
779470|NCT00624338|2478164|P3|Overall Study|Lost to Follow-up|0
779471|NCT00624338|2478165|P2|Overall Study|Lost to Follow-up|0
779472|NCT00624338|2478166|P1|Overall Study|Lost to Follow-up|1
779473|NCT00624338|2478164|P3|Overall Study|Adverse Event|18
779474|NCT00624338|2478165|P2|Overall Study|Adverse Event|14
779475|NCT00624338|2478166|P1|Overall Study|Adverse Event|14
779476|NCT00624377|2478186|P1|Overall Study|Non-evaluable population|84
779477|NCT00624377|2478186|P1|Overall Study|Other|91
779478|NCT00624377|2478186|P1|Overall Study|Adverse Event|14
779479|NCT00624377|2478186|P1|Overall Study|Withdrawal by Subject|100
779480|NCT00624377|2478186|P1|Overall Study|Lost to Follow-up|355
779481|NCT00624468|2478240|P4|Safety Follow-up (SFU) Period|Unspecified|1
779482|NCT00624468|2478241|P3|Safety Follow-up (SFU) Period|Unspecified|1
779483|NCT00624468|2478242|P2|Safety Follow-up (SFU) Period|Unspecified|0
779484|NCT00624468|2478243|P1|Safety Follow-up (SFU) Period|Unspecified|0
779485|NCT00624468|2478240|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
779486|NCT00624468|2478241|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
779487|NCT00624468|2478242|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
779488|NCT00624468|2478243|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
779489|NCT00624468|2478240|P4|Double-blind Period|Withdrew Prematurely|0
779490|NCT00624468|2478241|P3|Double-blind Period|Withdrew Prematurely|0
779491|NCT00624468|2478242|P2|Double-blind Period|Withdrew Prematurely|1
779492|NCT00624468|2478243|P1|Double-blind Period|Withdrew Prematurely|1
779493|NCT00624468|2478240|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
779494|NCT00624468|2478241|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
779495|NCT00624468|2478242|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
779496|NCT00624468|2478243|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
779497|NCT00624520|2478271|P2|Overall Study|Death|1
779498|NCT00624520|2478272|P1|Overall Study|Death|0
779499|NCT00624520|2478271|P2|Overall Study|Withdrawal by Subject|7
779500|NCT00624520|2478272|P1|Overall Study|Withdrawal by Subject|12
779501|NCT00624585|2478318|P1|Overall Study|Adverse Event|3
779502|NCT00624585|2478318|P1|Overall Study|Disease Progression|6
779503|NCT00624585|2478318|P1|Overall Study|Death|3
779504|NCT00624780|2478331|P6|Follow-up (Week 26)|Unspecified|0
779505|NCT00624780|2478332|P5|Follow-up (Week 26)|Unspecified|0
779506|NCT00624780|2478333|P4|Follow-up (Week 26)|Unspecified|0
779507|NCT00624780|2478334|P3|Follow-up (Week 26)|Unspecified|0
779508|NCT00624780|2478335|P2|Follow-up (Week 26)|Unspecified|1
779509|NCT00624780|2478336|P1|Follow-up (Week 26)|Unspecified|1
779510|NCT00624780|2478331|P6|Follow-up (Week 26)|Withdrawal by Subject|0
779511|NCT00624780|2478332|P5|Follow-up (Week 26)|Withdrawal by Subject|0
779512|NCT00624780|2478333|P4|Follow-up (Week 26)|Withdrawal by Subject|0
779513|NCT00624780|2478334|P3|Follow-up (Week 26)|Withdrawal by Subject|0
779514|NCT00624780|2478335|P2|Follow-up (Week 26)|Withdrawal by Subject|0
779515|NCT00624780|2478336|P1|Follow-up (Week 26)|Withdrawal by Subject|1
779516|NCT00624780|2478331|P6|Follow-up (Week 26)|Lost to Follow-up|0
779517|NCT00624780|2478332|P5|Follow-up (Week 26)|Lost to Follow-up|1
779518|NCT00624780|2478333|P4|Follow-up (Week 26)|Lost to Follow-up|0
779519|NCT00624780|2478334|P3|Follow-up (Week 26)|Lost to Follow-up|1
779520|NCT00624780|2478335|P2|Follow-up (Week 26)|Lost to Follow-up|0
779521|NCT00624780|2478336|P1|Follow-up (Week 26)|Lost to Follow-up|0
779522|NCT00624780|2478331|P6|Follow-up (Week 26)|Adverse Event|0
779523|NCT00624780|2478332|P5|Follow-up (Week 26)|Adverse Event|1
779524|NCT00624780|2478333|P4|Follow-up (Week 26)|Adverse Event|0
779525|NCT00624780|2478334|P3|Follow-up (Week 26)|Adverse Event|0
779526|NCT00624780|2478335|P2|Follow-up (Week 26)|Adverse Event|0
779527|NCT00624780|2478336|P1|Follow-up (Week 26)|Adverse Event|0
779528|NCT00624780|2478331|P6|Follow-up (Week 26)|Death|0
779529|NCT00624780|2478332|P5|Follow-up (Week 26)|Death|0
779530|NCT00624780|2478333|P4|Follow-up (Week 26)|Death|0
779531|NCT00624780|2478334|P3|Follow-up (Week 26)|Death|1
779532|NCT00624780|2478335|P2|Follow-up (Week 26)|Death|0
779533|NCT00624780|2478336|P1|Follow-up (Week 26)|Death|0
779534|NCT00624780|2478331|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
779535|NCT00624780|2478332|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
779536|NCT00624780|2478333|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
779537|NCT00624780|2478334|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
779538|NCT00624780|2478335|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
779539|NCT00624780|2478336|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
779540|NCT00624780|2478331|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
779541|NCT00624780|2478332|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
779542|NCT00624780|2478333|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
779543|NCT00624780|2478334|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
779544|NCT00624780|2478335|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
779545|NCT00624780|2478336|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
779546|NCT00624780|2478331|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
779547|NCT00624780|2478332|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
779548|NCT00624780|2478333|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
779549|NCT00624780|2478334|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
779550|NCT00624780|2478335|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
779551|NCT00624780|2478336|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
779552|NCT00624780|2478331|P6|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
779553|NCT00624780|2478332|P5|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
779554|NCT00624780|2478333|P4|Fixed Dosing (Week 13 to Week 24)|Unspecified|1
779555|NCT00624780|2478334|P3|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
779556|NCT00624780|2478335|P2|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
779557|NCT00624780|2478336|P1|Fixed Dosing (Week 13 to Week 24)|Unspecified|5
779558|NCT00624780|2478331|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
779559|NCT00624780|2478332|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
779560|NCT00624780|2478333|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
779561|NCT00624780|2478334|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
779562|NCT00624780|2478335|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
779563|NCT00624780|2478336|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
779564|NCT00624780|2478331|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
779565|NCT00624780|2478332|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
779566|NCT00624780|2478333|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
779567|NCT00624780|2478334|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
779568|NCT00624780|2478335|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
779569|NCT00624780|2478336|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
779570|NCT00624780|2478331|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
779571|NCT00624780|2478332|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
779572|NCT00624780|2478333|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
779573|NCT00624780|2478334|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
779574|NCT00624780|2478335|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
779575|NCT00624780|2478336|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
779576|NCT00624780|2478331|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
779577|NCT00624780|2478332|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
779578|NCT00624780|2478333|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
779579|NCT00624780|2478334|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
779580|NCT00624780|2478335|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
779581|NCT00624780|2478336|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
779582|NCT00624780|2478331|P6|Treatment Optimization (Up to Week 12)|Unspecified|0
779583|NCT00624780|2478332|P5|Treatment Optimization (Up to Week 12)|Unspecified|9
779584|NCT00624780|2478333|P4|Treatment Optimization (Up to Week 12)|Unspecified|2
779585|NCT00624780|2478334|P3|Treatment Optimization (Up to Week 12)|Unspecified|8
779586|NCT00624780|2478335|P2|Treatment Optimization (Up to Week 12)|Unspecified|4
779587|NCT00624780|2478336|P1|Treatment Optimization (Up to Week 12)|Unspecified|10
779588|NCT00624780|2478331|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
779589|NCT00624780|2478332|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
779590|NCT00624780|2478333|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
779591|NCT00624780|2478334|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
779592|NCT00624780|2478335|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
779593|NCT00624780|2478336|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
779594|NCT00624780|2478331|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
779595|NCT00624780|2478332|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
779596|NCT00624780|2478333|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
779597|NCT00624780|2478334|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
779598|NCT00624780|2478335|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
779599|NCT00624780|2478336|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
779600|NCT00624780|2478331|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
779601|NCT00624780|2478332|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
779602|NCT00624780|2478333|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
779603|NCT00624780|2478334|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
779604|NCT00624780|2478335|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
779605|NCT00624780|2478336|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
779606|NCT00624780|2478331|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
779607|NCT00624780|2478332|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
779608|NCT00624780|2478333|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
779609|NCT00624780|2478334|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
779610|NCT00624780|2478335|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
779611|NCT00624780|2478336|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
779612|NCT00624832|2478535|P4|Overall Study|Abnormal Laboratory Value|0
779613|NCT00624832|2478536|P3|Overall Study|Abnormal Laboratory Value|0
779614|NCT00624832|2478537|P2|Overall Study|Abnormal Laboratory Value|0
779615|NCT00624832|2478538|P1|Overall Study|Abnormal Laboratory Value|2
779616|NCT00624832|2478535|P4|Overall Study|Adverse Event|1
779617|NCT00624832|2478536|P3|Overall Study|Adverse Event|0
779618|NCT00624832|2478537|P2|Overall Study|Adverse Event|1
779619|NCT00624832|2478538|P1|Overall Study|Adverse Event|0
779620|NCT00627393|2478552|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
779621|NCT00627393|2478553|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
779622|NCT00627393|2478552|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
779623|NCT00627393|2478553|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
779624|NCT00627393|2478552|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
779625|NCT00627393|2478553|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
779626|NCT00627393|2478552|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
779627|NCT00627393|2478553|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
779628|NCT00627445|2478595|P2|Overall Study|Other|8
779629|NCT00627445|2478596|P1|Overall Study|Other|6
779630|NCT00627445|2478595|P2|Overall Study|Lack of Efficacy|1
779631|NCT00627445|2478596|P1|Overall Study|Lack of Efficacy|0
779632|NCT00627445|2478595|P2|Overall Study|Adverse Event|3
779633|NCT00627445|2478596|P1|Overall Study|Adverse Event|3
779634|NCT00627458|2478619|P3|Overall Study|Lost to Follow-up|0
779635|NCT00627458|2478620|P2|Overall Study|Lost to Follow-up|1
779636|NCT00627458|2478621|P1|Overall Study|Lost to Follow-up|1
779637|NCT00627458|2478619|P3|Overall Study|Withdrawal by Subject|5
779638|NCT00627458|2478620|P2|Overall Study|Withdrawal by Subject|6
779639|NCT00627458|2478621|P1|Overall Study|Withdrawal by Subject|2
779640|NCT00627458|2478619|P3|Overall Study|Migrated from study area|1
779641|NCT00627458|2478620|P2|Overall Study|Migrated from study area|0
779642|NCT00627458|2478621|P1|Overall Study|Migrated from study area|1
779643|NCT00627497|2478698|P4|Overall Study|Lost to Follow-up|0
779644|NCT00627497|2478699|P3|Overall Study|Lost to Follow-up|0
779645|NCT00627497|2478700|P2|Overall Study|Lost to Follow-up|1
779646|NCT00627497|2478701|P1|Overall Study|Lost to Follow-up|1
779647|NCT00627523|2478761|P2|Overall Study|Not specified|0
779648|NCT00627523|2478762|P1|Overall Study|Not specified|1
779649|NCT00627523|2478761|P2|Overall Study|Withdrawal by Subject|2
779650|NCT00627523|2478762|P1|Overall Study|Withdrawal by Subject|0
779651|NCT00627523|2478761|P2|Overall Study|Lack of Efficacy|0
779652|NCT00627523|2478762|P1|Overall Study|Lack of Efficacy|1
779653|NCT00627705|2478817|P2|Overall Study|Lost to Follow-up|1
779654|NCT00627705|2478818|P1|Overall Study|Lost to Follow-up|0
779655|NCT00627705|2478817|P2|Overall Study|Withdrawal by Subject|2
779656|NCT00627705|2478818|P1|Overall Study|Withdrawal by Subject|0
779657|NCT00627705|2478817|P2|Overall Study|Adverse Event|0
779658|NCT00627705|2478818|P1|Overall Study|Adverse Event|1
779659|NCT00627705|2478817|P2|Overall Study|Unwilling to take the compound (taste)|3
779660|NCT00627705|2478818|P1|Overall Study|Unwilling to take the compound (taste)|1
779661|NCT00627926|2478847|P3|Overall Study|Noncompliance/unspecified|17
779662|NCT00627926|2478848|P2|Overall Study|Noncompliance/unspecified|23
779663|NCT00627926|2478849|P1|Overall Study|Noncompliance/unspecified|8
779664|NCT00627926|2478847|P3|Overall Study|Lack of Efficacy|38
779665|NCT00627926|2478848|P2|Overall Study|Lack of Efficacy|40
779666|NCT00627926|2478849|P1|Overall Study|Lack of Efficacy|118
779667|NCT00627926|2478847|P3|Overall Study|Withdrawal by Subject|0
779668|NCT00627926|2478848|P2|Overall Study|Withdrawal by Subject|1
779669|NCT00627926|2478849|P1|Overall Study|Withdrawal by Subject|2
779670|NCT00627926|2478847|P3|Overall Study|Lost to Follow-up|4
779671|NCT00627926|2478848|P2|Overall Study|Lost to Follow-up|3
779672|NCT00627926|2478849|P1|Overall Study|Lost to Follow-up|4
779673|NCT00627926|2478847|P3|Overall Study|Death|0
779674|NCT00627926|2478848|P2|Overall Study|Death|0
779675|NCT00627926|2478849|P1|Overall Study|Death|1
779676|NCT00627926|2478847|P3|Overall Study|Adverse Event|36
779677|NCT00627926|2478848|P2|Overall Study|Adverse Event|37
779678|NCT00627926|2478849|P1|Overall Study|Adverse Event|26
779679|NCT00628030|2478904|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
779680|NCT00628030|2478905|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
779681|NCT00628030|2478904|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
779682|NCT00628030|2478905|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
779683|NCT00628030|2478904|P2|Baseline to Post-Assessment|Lost to Follow-up|29
779684|NCT00628030|2478905|P1|Baseline to Post-Assessment|Lost to Follow-up|28
779685|NCT00628108|2478921|P2|Overall Study|Withdrawal by Subject|0
779686|NCT00628108|2478922|P1|Overall Study|Withdrawal by Subject|1
779687|NCT00628108|2478921|P2|Overall Study|Adverse Event|3
779688|NCT00628108|2478922|P1|Overall Study|Adverse Event|0
779689|NCT00628212|2478980|P4|Overall Study|Physician Decision|3
779690|NCT00628212|2478981|P3|Overall Study|Physician Decision|2
779691|NCT00628212|2478982|P2|Overall Study|Physician Decision|1
779692|NCT00628212|2478983|P1|Overall Study|Physician Decision|1
779693|NCT00628212|2478980|P4|Overall Study|Adverse Event|2
779694|NCT00628212|2478981|P3|Overall Study|Adverse Event|1
779695|NCT00628212|2478982|P2|Overall Study|Adverse Event|0
779696|NCT00628212|2478983|P1|Overall Study|Adverse Event|2
779697|NCT00628251|2479008|P3|Cross-over/ Continuation of Olaparib|Other|0
779698|NCT00628251|2479009|P2|Cross-over/ Continuation of Olaparib|Other|1
779699|NCT00628251|2479010|P1|Cross-over/ Continuation of Olaparib|Other|1
779700|NCT00628251|2479008|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
779701|NCT00628251|2479009|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
779702|NCT00628251|2479010|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
779703|NCT00628251|2479008|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
779704|NCT00628251|2479009|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
779705|NCT00628251|2479010|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
779706|NCT00628251|2479008|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
779707|NCT00628251|2479009|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
779708|NCT00628251|2479010|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
779709|NCT00628251|2479008|P3|Randomised Part|Did not receive cross over treatment|8
779710|NCT00628251|2479009|P2|Randomised Part|Did not receive cross over treatment|0
779711|NCT00628251|2479010|P1|Randomised Part|Did not receive cross over treatment|0
779712|NCT00628355|2479051|P2|Overall Study|Withdrawal by Subject|1
779713|NCT00628355|2479052|P1|Overall Study|Withdrawal by Subject|1
779714|NCT00628446|2479064|P1|Overall Study|Protocol Violation|3
779715|NCT00628446|2479064|P1|Overall Study|Withdrawal by Subject|1
779716|NCT00628446|2479064|P1|Overall Study|Lost to Follow-up|3
779717|NCT00628758|2479099|P2|Overall Study|Treatment Failure|2
779718|NCT00628758|2479100|P1|Overall Study|Treatment Failure|0
779719|NCT00628758|2479099|P2|Overall Study|Investigator Moved|0
779720|NCT00628758|2479100|P1|Overall Study|Investigator Moved|3
779721|NCT00628758|2479099|P2|Overall Study|Pregnancy|2
779722|NCT00628758|2479100|P1|Overall Study|Pregnancy|2
779723|NCT00628758|2479099|P2|Overall Study|Lost to Follow-up|31
779724|NCT00628758|2479100|P1|Overall Study|Lost to Follow-up|25
779725|NCT00628758|2479099|P2|Overall Study|Protocol Violation|1
779726|NCT00628758|2479100|P1|Overall Study|Protocol Violation|5
779727|NCT00628758|2479099|P2|Overall Study|Death|0
779728|NCT00628758|2479100|P1|Overall Study|Death|1
779729|NCT00628758|2479099|P2|Overall Study|Withdrawal by Subject|3
779730|NCT00628758|2479100|P1|Overall Study|Withdrawal by Subject|6
779731|NCT00628758|2479099|P2|Overall Study|Adverse Event|3
779732|NCT00628758|2479100|P1|Overall Study|Adverse Event|2
779733|NCT00628862|2479115|P3|Overall Study|COPD Exacerbation|0
779734|NCT00628862|2479116|P2|Overall Study|COPD Exacerbation|1
779735|NCT00628862|2479117|P1|Overall Study|COPD Exacerbation|0
779736|NCT00628862|2479115|P3|Overall Study|Protocol Violation|0
779737|NCT00628862|2479116|P2|Overall Study|Protocol Violation|0
779738|NCT00628862|2479117|P1|Overall Study|Protocol Violation|1
779739|NCT00628862|2479115|P3|Overall Study|Lost to Follow-up|1
779740|NCT00628862|2479116|P2|Overall Study|Lost to Follow-up|2
779741|NCT00628862|2479117|P1|Overall Study|Lost to Follow-up|0
779742|NCT00628862|2479115|P3|Overall Study|Withdrawal by Subject|11
779743|NCT00628862|2479116|P2|Overall Study|Withdrawal by Subject|6
779744|NCT00628862|2479117|P1|Overall Study|Withdrawal by Subject|4
779745|NCT00628862|2479115|P3|Overall Study|Adverse Event|10
779746|NCT00628862|2479116|P2|Overall Study|Adverse Event|8
779747|NCT00628862|2479117|P1|Overall Study|Adverse Event|6
779748|NCT00628927|2479194|P2|Overall Study|Equipment failure|0
779749|NCT00628927|2479195|P1|Overall Study|Equipment failure|1
779750|NCT00628927|2479194|P2|Overall Study|Lost to Follow-up|0
779751|NCT00628927|2479195|P1|Overall Study|Lost to Follow-up|1
779752|NCT00628927|2479194|P2|Overall Study|Problems performing blood draw|0
779753|NCT00628927|2479195|P1|Overall Study|Problems performing blood draw|6
779754|NCT00629239|2479219|P2|Overall Study|Physician Decision|0
779755|NCT00629239|2479220|P1|Overall Study|Physician Decision|1
779756|NCT00629239|2479219|P2|Overall Study|Adverse Event|4
779757|NCT00629239|2479220|P1|Overall Study|Adverse Event|7
779758|NCT00629265|2479254|P2|Overall Study|Unknown Reason|2
779759|NCT00629265|2479255|P1|Overall Study|Unknown Reason|2
779760|NCT00629265|2479254|P2|Overall Study|Unrelated Medical Complications|1
779761|NCT00629265|2479255|P1|Overall Study|Unrelated Medical Complications|3
779762|NCT00629265|2479254|P2|Overall Study|Needed Esophageal Dilation|1
779763|NCT00629265|2479255|P1|Overall Study|Needed Esophageal Dilation|4
779764|NCT00629265|2479254|P2|Overall Study|Other CA Requiring Treatment|3
779765|NCT00629265|2479255|P1|Overall Study|Other CA Requiring Treatment|1
779766|NCT00629265|2479254|P2|Overall Study|HNC Recurrence|0
779767|NCT00629265|2479255|P1|Overall Study|HNC Recurrence|4
779768|NCT00629265|2479254|P2|Overall Study|Adverse Event|0
779769|NCT00629265|2479255|P1|Overall Study|Adverse Event|2
779770|NCT00629265|2479254|P2|Overall Study|Death|0
779771|NCT00629265|2479255|P1|Overall Study|Death|1
779772|NCT00629265|2479254|P2|Overall Study|Withdrawal by Subject|8
779773|NCT00629265|2479255|P1|Overall Study|Withdrawal by Subject|11
779774|NCT00629265|2479254|P2|Overall Study|Lost to Follow-up|5
779775|NCT00629265|2479255|P1|Overall Study|Lost to Follow-up|4
779776|NCT00629707|2479277|P2|Overall Study|Physician Decision|1
779777|NCT00629707|2479278|P1|Overall Study|Physician Decision|0
779778|NCT00629707|2479277|P2|Overall Study|Withdrawal by Subject|1
779779|NCT00629707|2479278|P1|Overall Study|Withdrawal by Subject|0
779780|NCT00629772|2479286|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
779781|NCT00629772|2479287|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
779782|NCT00629772|2479286|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
779783|NCT00629772|2479287|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
779784|NCT00621504|2479307|P2|Overall Study|Death|6
779785|NCT00621504|2479308|P1|Overall Study|Death|6
779786|NCT00621504|2479307|P2|Overall Study|Other|0
779787|NCT00621504|2479308|P1|Overall Study|Other|1
779788|NCT00621504|2479307|P2|Overall Study|Lost to Follow-up|10
779789|NCT00621504|2479308|P1|Overall Study|Lost to Follow-up|8
779790|NCT00621504|2479307|P2|Overall Study|Withdrew consent|6
779791|NCT00621504|2479308|P1|Overall Study|Withdrew consent|9
779792|NCT00621504|2479307|P2|Overall Study|At the request of sponsor/investigator|0
779793|NCT00621504|2479308|P1|Overall Study|At the request of sponsor/investigator|1
779794|NCT00621504|2479307|P2|Overall Study|Adverse Event|3
779795|NCT00621504|2479308|P1|Overall Study|Adverse Event|1
779796|NCT00621517|2479316|P2|Overall Study|Adverse Event|0
779797|NCT00621517|2479317|P1|Overall Study|Adverse Event|1
779798|NCT00621517|2479316|P2|Overall Study|Withdrawal by Subject|4
779799|NCT00621517|2479317|P1|Overall Study|Withdrawal by Subject|3
779800|NCT00621517|2479316|P2|Overall Study|Lost to Follow-up|3
779801|NCT00621517|2479317|P1|Overall Study|Lost to Follow-up|3
779802|NCT00621543|2479340|P1|Overall Study|Lost to Follow-up|23
779803|NCT00621582|2479345|P1|Overall Study|issues not identified by investigators|18
779804|NCT00621582|2479345|P1|Overall Study|Lost to Follow-up|24
779805|NCT00621582|2479345|P1|Overall Study|Protocol Violation|57
779806|NCT00621582|2479345|P1|Overall Study|Adverse Event|7
779807|NCT00621621|2479355|P2|Overall Study|Subjects were exited at EP study|0
779808|NCT00621621|2479356|P1|Overall Study|Subjects were exited at EP study|30
779809|NCT00621764|2479381|P4|Overall Study|Protocol Violation|1
779810|NCT00621764|2479382|P3|Overall Study|Protocol Violation|0
779811|NCT00621764|2479383|P2|Overall Study|Protocol Violation|0
779812|NCT00621764|2479384|P1|Overall Study|Protocol Violation|0
779833|NCT00621842|2479424|P1|Overall Study|Lack of Efficacy|2
779834|NCT00621842|2479424|P1|Overall Study|Protocol Violation|4
779835|NCT00621842|2479424|P1|Overall Study|Withdrawal by Subject|7
779836|NCT00621842|2479424|P1|Overall Study|Adverse Event|6
779837|NCT00621855|2479444|P5|Overall Study|Patients did not receive study drug|2
779838|NCT00621855|2479445|P4|Overall Study|Patients did not receive study drug|4
779839|NCT00621855|2479446|P3|Overall Study|Patients did not receive study drug|5
779840|NCT00621855|2479447|P2|Overall Study|Patients did not receive study drug|3
779841|NCT00621855|2479448|P1|Overall Study|Patients did not receive study drug|3
779842|NCT00621855|2479444|P5|Overall Study|Other|4
779843|NCT00621855|2479445|P4|Overall Study|Other|5
779844|NCT00621855|2479446|P3|Overall Study|Other|6
779845|NCT00621855|2479447|P2|Overall Study|Other|7
779846|NCT00621855|2479448|P1|Overall Study|Other|9
779847|NCT00621855|2479444|P5|Overall Study|Withdrawal by Subject|9
779848|NCT00621855|2479445|P4|Overall Study|Withdrawal by Subject|13
779849|NCT00621855|2479446|P3|Overall Study|Withdrawal by Subject|13
779850|NCT00621855|2479447|P2|Overall Study|Withdrawal by Subject|11
779851|NCT00621855|2479448|P1|Overall Study|Withdrawal by Subject|16
779852|NCT00621855|2479444|P5|Overall Study|Protocol Violation|8
779853|NCT00621855|2479445|P4|Overall Study|Protocol Violation|7
779854|NCT00621855|2479446|P3|Overall Study|Protocol Violation|6
779855|NCT00621855|2479447|P2|Overall Study|Protocol Violation|8
779856|NCT00621855|2479448|P1|Overall Study|Protocol Violation|16
779857|NCT00621855|2479444|P5|Overall Study|Lost to Follow-up|1
779858|NCT00621855|2479445|P4|Overall Study|Lost to Follow-up|4
779859|NCT00621855|2479446|P3|Overall Study|Lost to Follow-up|3
779860|NCT00621855|2479447|P2|Overall Study|Lost to Follow-up|1
779861|NCT00621855|2479448|P1|Overall Study|Lost to Follow-up|0
779862|NCT00621855|2479444|P5|Overall Study|Adverse Event|31
779863|NCT00621855|2479445|P4|Overall Study|Adverse Event|34
779864|NCT00621855|2479446|P3|Overall Study|Adverse Event|48
779865|NCT00621855|2479447|P2|Overall Study|Adverse Event|31
779866|NCT00621855|2479448|P1|Overall Study|Adverse Event|32
779867|NCT00621959|2479518|P2|Overall Study|Other|3
779868|NCT00621959|2479519|P1|Overall Study|Other|1
779869|NCT00621959|2479518|P2|Overall Study|Withdrawal by Subject|1
779870|NCT00621959|2479519|P1|Overall Study|Withdrawal by Subject|1
779871|NCT00621959|2479518|P2|Overall Study|Lost to Follow-up|2
779872|NCT00621959|2479519|P1|Overall Study|Lost to Follow-up|0
779873|NCT00621959|2479518|P2|Overall Study|Lack of Efficacy|1
779874|NCT00621959|2479519|P1|Overall Study|Lack of Efficacy|1
779875|NCT00621959|2479518|P2|Overall Study|Adverse Event|2
779876|NCT00621959|2479519|P1|Overall Study|Adverse Event|4
779877|NCT00621985|2479527|P1|Dexamethasone Admission|Adverse Event|1
779878|NCT00622167|2479533|P1|Overall Study|Did not meet angiographic criteria|20
779879|NCT00630058|2479552|P2|Overall Study|stopping criteria|2
779880|NCT00630058|2479553|P1|Overall Study|stopping criteria|3
779881|NCT00630058|2479552|P2|Overall Study|Withdrawal by Subject|1
779882|NCT00630058|2479553|P1|Overall Study|Withdrawal by Subject|0
779883|NCT00630058|2479552|P2|Overall Study|Adverse Event|1
779884|NCT00630058|2479553|P1|Overall Study|Adverse Event|1
779885|NCT00632424|2479581|P1|Overall Study|Study Drug Toxicity|1
779886|NCT00632424|2479581|P1|Overall Study|Disease Progression|17
779887|NCT00632463|2479606|P3|Overall Study|Adverse Event|0
779888|NCT00632463|2479607|P2|Overall Study|Adverse Event|1
779889|NCT00632463|2479608|P1|Overall Study|Adverse Event|0
779890|NCT00632502|2479640|P2|Overall Study|Randomized not treated|0
779891|NCT00632502|2479641|P1|Overall Study|Randomized not treated|3
779892|NCT00632502|2479640|P2|Overall Study|Adverse Event|1
779893|NCT00632502|2479641|P1|Overall Study|Adverse Event|0
779894|NCT00632541|2479666|P1|Overall Study|Adverse Event|7
779895|NCT00632736|2479700|P1|Overall Study|Other|16
779896|NCT00632736|2479700|P1|Overall Study|Non-compliance|10
779897|NCT00632736|2479700|P1|Overall Study|Sponsor terminated study|5
779898|NCT00632736|2479700|P1|Overall Study|Lack of Efficacy|5
779899|NCT00632736|2479700|P1|Overall Study|Withdrawal by Subject|99
779900|NCT00632736|2479700|P1|Overall Study|Protocol Violation|14
779901|NCT00632736|2479700|P1|Overall Study|Lost to Follow-up|15
779902|NCT00632736|2479700|P1|Overall Study|Adverse Event|104
779903|NCT00632749|2479719|P14|Overall Study|Reason other than those specified above|2
779904|NCT00632749|2479720|P13|Overall Study|Reason other than those specified above|0
779905|NCT00632749|2479721|P12|Overall Study|Reason other than those specified above|1
779906|NCT00632749|2479722|P11|Overall Study|Reason other than those specified above|2
779907|NCT00632749|2479723|P10|Overall Study|Reason other than those specified above|0
779908|NCT00632749|2479724|P9|Overall Study|Reason other than those specified above|0
779909|NCT00632749|2479725|P8|Overall Study|Reason other than those specified above|0
779910|NCT00632749|2479726|P7|Overall Study|Reason other than those specified above|1
779911|NCT00632749|2479727|P6|Overall Study|Reason other than those specified above|0
779912|NCT00632749|2479728|P5|Overall Study|Reason other than those specified above|1
779913|NCT00632749|2479729|P4|Overall Study|Reason other than those specified above|0
779914|NCT00632749|2479730|P3|Overall Study|Reason other than those specified above|0
779915|NCT00632749|2479731|P2|Overall Study|Reason other than those specified above|2
779916|NCT00632749|2479732|P1|Overall Study|Reason other than those specified above|0
779917|NCT00632749|2479719|P14|Overall Study|Refuse to continue medication|0
779918|NCT00632749|2479720|P13|Overall Study|Refuse to continue medication|0
779919|NCT00632749|2479721|P12|Overall Study|Refuse to continue medication|0
779920|NCT00632749|2479722|P11|Overall Study|Refuse to continue medication|0
779921|NCT00632749|2479723|P10|Overall Study|Refuse to continue medication|1
779922|NCT00632749|2479724|P9|Overall Study|Refuse to continue medication|0
779923|NCT00632749|2479725|P8|Overall Study|Refuse to continue medication|0
779924|NCT00632749|2479726|P7|Overall Study|Refuse to continue medication|0
779925|NCT00632749|2479727|P6|Overall Study|Refuse to continue medication|0
779926|NCT00632749|2479728|P5|Overall Study|Refuse to continue medication|0
779927|NCT00632749|2479729|P4|Overall Study|Refuse to continue medication|1
779928|NCT00632749|2479730|P3|Overall Study|Refuse to continue medication|0
779929|NCT00632749|2479731|P2|Overall Study|Refuse to continue medication|0
779930|NCT00632749|2479732|P1|Overall Study|Refuse to continue medication|0
779931|NCT00632749|2479719|P14|Overall Study|Other Adverse event|0
779932|NCT00632749|2479720|P13|Overall Study|Other Adverse event|1
779933|NCT00632749|2479721|P12|Overall Study|Other Adverse event|0
779934|NCT00632749|2479722|P11|Overall Study|Other Adverse event|1
779935|NCT00632749|2479723|P10|Overall Study|Other Adverse event|0
779936|NCT00632749|2479724|P9|Overall Study|Other Adverse event|2
779937|NCT00632749|2479725|P8|Overall Study|Other Adverse event|2
779938|NCT00632749|2479726|P7|Overall Study|Other Adverse event|1
779939|NCT00632749|2479727|P6|Overall Study|Other Adverse event|4
779940|NCT00632749|2479728|P5|Overall Study|Other Adverse event|2
779941|NCT00632749|2479729|P4|Overall Study|Other Adverse event|1
779942|NCT00632749|2479730|P3|Overall Study|Other Adverse event|1
779943|NCT00632749|2479731|P2|Overall Study|Other Adverse event|1
779944|NCT00632749|2479732|P1|Overall Study|Other Adverse event|1
779945|NCT00632749|2479719|P14|Overall Study|Progressive disease|4
779946|NCT00632749|2479720|P13|Overall Study|Progressive disease|2
779947|NCT00632749|2479721|P12|Overall Study|Progressive disease|3
779948|NCT00632749|2479722|P11|Overall Study|Progressive disease|4
779949|NCT00632749|2479723|P10|Overall Study|Progressive disease|2
779950|NCT00632749|2479724|P9|Overall Study|Progressive disease|3
779951|NCT00632749|2479725|P8|Overall Study|Progressive disease|2
779952|NCT00632749|2479726|P7|Overall Study|Progressive disease|3
779953|NCT00632749|2479727|P6|Overall Study|Progressive disease|4
779954|NCT00632749|2479728|P5|Overall Study|Progressive disease|4
779955|NCT00632749|2479729|P4|Overall Study|Progressive disease|2
779956|NCT00632749|2479730|P3|Overall Study|Progressive disease|2
779957|NCT00632749|2479731|P2|Overall Study|Progressive disease|2
779958|NCT00632749|2479732|P1|Overall Study|Progressive disease|3
779959|NCT00632931|2480063|P3|Part 2|Withdrawal by Subject|3
779960|NCT00632931|2480064|P2|Part 2|Withdrawal by Subject|0
779961|NCT00632931|2480065|P1|Part 2|Withdrawal by Subject|0
779962|NCT00632931|2480063|P3|Part 2|Lack of Efficacy|17
779963|NCT00632931|2480064|P2|Part 2|Lack of Efficacy|0
779964|NCT00632931|2480065|P1|Part 2|Lack of Efficacy|0
779965|NCT00632931|2480063|P3|Part 2|Death|1
779966|NCT00632931|2480064|P2|Part 2|Death|0
779967|NCT00632931|2480065|P1|Part 2|Death|0
779968|NCT00632931|2480063|P3|Part 2|Adverse Event|3
779969|NCT00632931|2480064|P2|Part 2|Adverse Event|0
779970|NCT00632931|2480065|P1|Part 2|Adverse Event|0
779971|NCT00632931|2480063|P3|Part 1, Period 1|Withdrawal by Subject|0
779972|NCT00632931|2480064|P2|Part 1, Period 1|Withdrawal by Subject|0
779973|NCT00632931|2480065|P1|Part 1, Period 1|Withdrawal by Subject|1
779974|NCT00632931|2480063|P3|Part 1, Period 1|Protocol Violation|0
779975|NCT00632931|2480064|P2|Part 1, Period 1|Protocol Violation|0
779976|NCT00632931|2480065|P1|Part 1, Period 1|Protocol Violation|1
779977|NCT00633074|2480111|P2|Overall Study|Adverse Event|0
779978|NCT00633074|2480112|P1|Overall Study|Adverse Event|1
779979|NCT00633126|2480147|P1|Overall Study|Did not receive full dose|1
779980|NCT00633139|2480155|P3|Overall Study|Withdrawal by Subject|0
779981|NCT00633139|2480156|P2|Overall Study|Withdrawal by Subject|1
779982|NCT00633139|2480157|P1|Overall Study|Withdrawal by Subject|0
779983|NCT00633139|2480155|P3|Overall Study|Non compliance|1
779984|NCT00633139|2480156|P2|Overall Study|Non compliance|0
779985|NCT00633139|2480157|P1|Overall Study|Non compliance|0
779986|NCT00633152|2480173|P2|Overall Study|Miscellaneous Other|2
779987|NCT00633152|2480174|P1|Overall Study|Miscellaneous Other|3
779988|NCT00633152|2480173|P2|Overall Study|Lost to Follow-up|1
779989|NCT00633152|2480174|P1|Overall Study|Lost to Follow-up|4
779990|NCT00633152|2480173|P2|Overall Study|Withdrawal by Subject|1
779991|NCT00633152|2480174|P1|Overall Study|Withdrawal by Subject|1
779992|NCT00633152|2480173|P2|Overall Study|Randomized, did not receive study drug|2
779993|NCT00633152|2480174|P1|Overall Study|Randomized, did not receive study drug|5
779994|NCT00633152|2480173|P2|Overall Study|Adverse Event|0
779995|NCT00633152|2480174|P1|Overall Study|Adverse Event|1
779996|NCT00633217|2480184|P2|Overall Study|Withdrew Consent|3
779997|NCT00633217|2480185|P1|Overall Study|Withdrew Consent|3
779998|NCT00633217|2480184|P2|Overall Study|Investigator Discretion|0
779999|NCT00633217|2480185|P1|Overall Study|Investigator Discretion|2
780000|NCT00633217|2480184|P2|Overall Study|Lost to Follow-up|2
780001|NCT00633217|2480185|P1|Overall Study|Lost to Follow-up|2
780002|NCT00633217|2480184|P2|Overall Study|Protocol Violation|7
780003|NCT00633217|2480185|P1|Overall Study|Protocol Violation|3
780004|NCT00633217|2480184|P2|Overall Study|Lack of Efficacy|2
780005|NCT00633217|2480185|P1|Overall Study|Lack of Efficacy|0
780006|NCT00633217|2480184|P2|Overall Study|Adverse Event|9
780007|NCT00633217|2480185|P1|Overall Study|Adverse Event|5
780008|NCT00633243|2480197|P2|Overall Study|Couldn't tolerate side-effects|1
780009|NCT00633243|2480198|P1|Overall Study|Couldn't tolerate side-effects|1
780010|NCT00633243|2480197|P2|Overall Study|Mental Health--Depression|1
780011|NCT00633243|2480198|P1|Overall Study|Mental Health--Depression|0
780012|NCT00633243|2480197|P2|Overall Study|Not comfortable with self-injecting|1
780013|NCT00633243|2480198|P1|Overall Study|Not comfortable with self-injecting|0
780014|NCT00633243|2480197|P2|Overall Study|Homeless--no refrigeration for meds|1
780015|NCT00633243|2480198|P1|Overall Study|Homeless--no refrigeration for meds|0
780016|NCT00633243|2480197|P2|Overall Study|incarceration|2
780017|NCT00633243|2480198|P1|Overall Study|incarceration|0
780018|NCT00633243|2480197|P2|Overall Study|Withdrawal by Subject|1
780019|NCT00633243|2480198|P1|Overall Study|Withdrawal by Subject|0
780020|NCT00633360|2480219|P2|Overall Study|Protocol Violation|1
780021|NCT00633360|2480220|P1|Overall Study|Protocol Violation|0
780022|NCT00633360|2480219|P2|Overall Study|Adverse Event|1
780023|NCT00633360|2480220|P1|Overall Study|Adverse Event|3
780024|NCT00633360|2480219|P2|Overall Study|Lost to Follow-up|1
780025|NCT00633360|2480220|P1|Overall Study|Lost to Follow-up|1
780026|NCT00633464|2480243|P2|Overall Study|Never Treated (Randomized in error)|1
780027|NCT00633464|2480244|P1|Overall Study|Never Treated (Randomized in error)|0
780028|NCT00633464|2480243|P2|Overall Study|Never Treated (Not met study criteria)|1
780029|NCT00633464|2480244|P1|Overall Study|Never Treated (Not met study criteria)|0
780030|NCT00633477|2480266|P2|Overall Study|Randomized but not treated|0
780031|NCT00633477|2480267|P1|Overall Study|Randomized but not treated|1
780032|NCT00633477|2480266|P2|Overall Study|Death|0
780033|NCT00633477|2480267|P1|Overall Study|Death|1
780034|NCT00633594|2480284|P3|Overall Study|Disease Progression|1
780035|NCT00633594|2480285|P2|Overall Study|Disease Progression|0
780036|NCT00633594|2480286|P1|Overall Study|Disease Progression|0
780037|NCT00633594|2480284|P3|Overall Study|Death|2
780038|NCT00633594|2480285|P2|Overall Study|Death|1
780039|NCT00633594|2480286|P1|Overall Study|Death|0
780040|NCT00633594|2480284|P3|Overall Study|Adverse Event|7
780041|NCT00633594|2480285|P2|Overall Study|Adverse Event|4
780042|NCT00633594|2480286|P1|Overall Study|Adverse Event|0
780043|NCT00633750|2480313|P1|Overall Study|Withdrawal by Subject|3
780044|NCT00633750|2480313|P1|Overall Study|Adverse Event|2
780045|NCT00633880|2480331|P3|Open Label Titration|Withdrawal by Subject|0
780046|NCT00633880|2480332|P2|Open Label Titration|Withdrawal by Subject|0
780047|NCT00633880|2480333|P1|Open Label Titration|Withdrawal by Subject|4
780048|NCT00633880|2480331|P3|Open Label Titration|Physician Decision|0
780049|NCT00633880|2480332|P2|Open Label Titration|Physician Decision|0
780050|NCT00633880|2480333|P1|Open Label Titration|Physician Decision|1
780051|NCT00633880|2480331|P3|Open Label Titration|Protocol Violation|0
780052|NCT00633880|2480332|P2|Open Label Titration|Protocol Violation|0
780053|NCT00633880|2480333|P1|Open Label Titration|Protocol Violation|6
780054|NCT00633880|2480331|P3|Open Label Titration|Treatment Failure|0
780055|NCT00633880|2480332|P2|Open Label Titration|Treatment Failure|0
780056|NCT00633880|2480333|P1|Open Label Titration|Treatment Failure|55
780057|NCT00633880|2480331|P3|Open Label Titration|Adverse Event|0
780058|NCT00633880|2480332|P2|Open Label Titration|Adverse Event|0
780059|NCT00633880|2480333|P1|Open Label Titration|Adverse Event|13
780060|NCT00633880|2480331|P3|Open Label Titration|Lack of Efficacy|0
780061|NCT00633880|2480332|P2|Open Label Titration|Lack of Efficacy|0
780062|NCT00633880|2480333|P1|Open Label Titration|Lack of Efficacy|1
780063|NCT00633893|2480363|P3|Overall Study|not specified|31
780064|NCT00633893|2480364|P2|Overall Study|not specified|33
780065|NCT00633893|2480365|P1|Overall Study|not specified|28
780066|NCT00633893|2480363|P3|Overall Study|Not meet/no longer meets criteria|4
780067|NCT00633893|2480364|P2|Overall Study|Not meet/no longer meets criteria|6
780068|NCT00633893|2480365|P1|Overall Study|Not meet/no longer meets criteria|4
780069|NCT00633893|2480363|P3|Overall Study|Pregnancy|1
780070|NCT00633893|2480364|P2|Overall Study|Pregnancy|1
780071|NCT00633893|2480365|P1|Overall Study|Pregnancy|2
780072|NCT00633893|2480363|P3|Overall Study|Poor/non-compliance|3
780073|NCT00633893|2480364|P2|Overall Study|Poor/non-compliance|12
780074|NCT00633893|2480365|P1|Overall Study|Poor/non-compliance|5
780075|NCT00633893|2480363|P3|Overall Study|Lost to Follow-up|8
780076|NCT00633893|2480364|P2|Overall Study|Lost to Follow-up|4
780077|NCT00633893|2480365|P1|Overall Study|Lost to Follow-up|2
780078|NCT00633893|2480363|P3|Overall Study|Withdrawal by Subject|6
780079|NCT00633893|2480364|P2|Overall Study|Withdrawal by Subject|12
780080|NCT00633893|2480365|P1|Overall Study|Withdrawal by Subject|7
780081|NCT00633893|2480363|P3|Overall Study|Adverse Event|126
780082|NCT00633893|2480364|P2|Overall Study|Adverse Event|58
780083|NCT00633893|2480365|P1|Overall Study|Adverse Event|65
780084|NCT00633893|2480363|P3|Overall Study|Death|9
780085|NCT00633893|2480364|P2|Overall Study|Death|3
780086|NCT00633893|2480365|P1|Overall Study|Death|1
780087|NCT00633932|2480456|P3|Overall Study|Moved Away|0
780088|NCT00633932|2480457|P2|Overall Study|Moved Away|0
780089|NCT00633932|2480458|P1|Overall Study|Moved Away|1
780090|NCT00633932|2480456|P3|Overall Study|Doctor's judgement|0
780091|NCT00633932|2480457|P2|Overall Study|Doctor's judgement|0
780092|NCT00633932|2480458|P1|Overall Study|Doctor's judgement|1
780093|NCT00633932|2480456|P3|Overall Study|Physician Decision|1
780094|NCT00633932|2480457|P2|Overall Study|Physician Decision|0
780095|NCT00633932|2480458|P1|Overall Study|Physician Decision|0
780096|NCT00633932|2480456|P3|Overall Study|Protocol Violation|3
780097|NCT00633932|2480457|P2|Overall Study|Protocol Violation|2
780098|NCT00633932|2480458|P1|Overall Study|Protocol Violation|5
780099|NCT00633932|2480456|P3|Overall Study|Lost to Follow-up|2
780100|NCT00633932|2480457|P2|Overall Study|Lost to Follow-up|0
780101|NCT00633932|2480458|P1|Overall Study|Lost to Follow-up|1
780102|NCT00633932|2480456|P3|Overall Study|Withdrawal by Subject|1
780103|NCT00633932|2480457|P2|Overall Study|Withdrawal by Subject|9
780104|NCT00633932|2480458|P1|Overall Study|Withdrawal by Subject|3
780105|NCT00633932|2480456|P3|Overall Study|Adverse Event|4
780106|NCT00633932|2480457|P2|Overall Study|Adverse Event|3
780107|NCT00633932|2480458|P1|Overall Study|Adverse Event|1
780108|NCT00633984|2480471|P2|Overall Study|Hospitalized|0
780109|NCT00633984|2480472|P1|Overall Study|Hospitalized|1
780110|NCT00633984|2480471|P2|Overall Study|Withdrawal by Subject|7
780111|NCT00633984|2480472|P1|Overall Study|Withdrawal by Subject|8
780112|NCT00633984|2480471|P2|Overall Study|Lost to Follow-up|6
780113|NCT00633984|2480472|P1|Overall Study|Lost to Follow-up|0
780114|NCT00634010|2480482|P2|Overall Study|Non-Compliant|1
780115|NCT00634010|2480483|P1|Overall Study|Non-Compliant|1
780116|NCT00634010|2480482|P2|Overall Study|Disease Progression|1
780117|NCT00634010|2480483|P1|Overall Study|Disease Progression|1
780118|NCT00634010|2480482|P2|Overall Study|Physician Decision|1
780119|NCT00634010|2480483|P1|Overall Study|Physician Decision|1
780120|NCT00634010|2480482|P2|Overall Study|Withdrawal by Subject|6
780121|NCT00634010|2480483|P1|Overall Study|Withdrawal by Subject|5
780122|NCT00634010|2480482|P2|Overall Study|Adverse Event|5
780123|NCT00634010|2480483|P1|Overall Study|Adverse Event|2
780124|NCT00634036|2480491|P2|Overall Study|Withdrawal by Subject|1
780125|NCT00634036|2480492|P1|Overall Study|Withdrawal by Subject|1
780126|NCT00634036|2480491|P2|Overall Study|Lost to Follow-up|1
780127|NCT00634036|2480492|P1|Overall Study|Lost to Follow-up|1
780128|NCT00634049|2480504|P1|Overall Study|Screening failure|1
780129|NCT00634049|2480504|P1|Overall Study|Died prior to receiving study drug|1
780130|NCT00634049|2480504|P1|Overall Study|Never received study drug|1
780131|NCT00634088|2480585|P4|Time Period 3: Dose Level 3|Progressive disease|0
780132|NCT00634088|2480586|P3|Time Period 3: Dose Level 3|Progressive disease|1
780133|NCT00634088|2480587|P2|Time Period 3: Dose Level 3|Progressive disease|0
780134|NCT00634088|2480588|P1|Time Period 3: Dose Level 3|Progressive disease|0
780135|NCT00634088|2480585|P4|Time Period 2: Dose Level 2|Progressive disease|0
780136|NCT00634088|2480586|P3|Time Period 2: Dose Level 2|Progressive disease|0
780137|NCT00634088|2480587|P2|Time Period 2: Dose Level 2|Progressive disease|1
780138|NCT00634088|2480588|P1|Time Period 2: Dose Level 2|Progressive disease|0
780139|NCT00634088|2480585|P4|Time Period 2: Dose Level 2|Adverse Event|0
780140|NCT00634088|2480586|P3|Time Period 2: Dose Level 2|Adverse Event|0
780141|NCT00634088|2480587|P2|Time Period 2: Dose Level 2|Adverse Event|2
780142|NCT00634088|2480588|P1|Time Period 2: Dose Level 2|Adverse Event|0
780143|NCT00634088|2480585|P4|Time Period 1: Dose Level 1|Adverse Event|0
780144|NCT00634088|2480586|P3|Time Period 1: Dose Level 1|Adverse Event|0
780145|NCT00634088|2480587|P2|Time Period 1: Dose Level 1|Adverse Event|0
780146|NCT00634088|2480588|P1|Time Period 1: Dose Level 1|Adverse Event|3
780147|NCT00634088|2480585|P4|Time Period 1: Dose Level 1|Physician Decision|0
780148|NCT00634088|2480586|P3|Time Period 1: Dose Level 1|Physician Decision|0
780149|NCT00634088|2480587|P2|Time Period 1: Dose Level 1|Physician Decision|0
780150|NCT00634088|2480588|P1|Time Period 1: Dose Level 1|Physician Decision|1
780151|NCT00634088|2480585|P4|Time Period 1: Dose Level 1|Disease progression|0
780152|NCT00634088|2480586|P3|Time Period 1: Dose Level 1|Disease progression|0
780153|NCT00634088|2480587|P2|Time Period 1: Dose Level 1|Disease progression|0
780154|NCT00634088|2480588|P1|Time Period 1: Dose Level 1|Disease progression|2
780155|NCT00634114|2480642|P3|Overall Study|Other reason|1
780156|NCT00634114|2480643|P2|Overall Study|Other reason|1
780157|NCT00634114|2480644|P1|Overall Study|Other reason|1
780158|NCT00634114|2480642|P3|Overall Study|Difficult to continue|1
780159|NCT00634114|2480643|P2|Overall Study|Difficult to continue|1
780160|NCT00634114|2480644|P1|Overall Study|Difficult to continue|3
780161|NCT00634114|2480642|P3|Overall Study|Recurrence of reflux esophagitis|21
780162|NCT00634114|2480643|P2|Overall Study|Recurrence of reflux esophagitis|15
780163|NCT00634114|2480644|P1|Overall Study|Recurrence of reflux esophagitis|5
780164|NCT00634114|2480642|P3|Overall Study|Incorrect enrolment|0
780165|NCT00634114|2480643|P2|Overall Study|Incorrect enrolment|1
780166|NCT00634114|2480644|P1|Overall Study|Incorrect enrolment|0
780167|NCT00634114|2480642|P3|Overall Study|Pregnancy|0
780168|NCT00634114|2480643|P2|Overall Study|Pregnancy|0
780169|NCT00634114|2480644|P1|Overall Study|Pregnancy|1
780170|NCT00634114|2480642|P3|Overall Study|Protocol Violation|1
780171|NCT00634114|2480643|P2|Overall Study|Protocol Violation|3
780172|NCT00634114|2480644|P1|Overall Study|Protocol Violation|3
780173|NCT00634114|2480642|P3|Overall Study|Lost to Follow-up|1
780174|NCT00634114|2480643|P2|Overall Study|Lost to Follow-up|0
780175|NCT00634114|2480644|P1|Overall Study|Lost to Follow-up|0
780176|NCT00634114|2480642|P3|Overall Study|Withdrawal by Subject|11
780177|NCT00634114|2480643|P2|Overall Study|Withdrawal by Subject|6
780178|NCT00634114|2480644|P1|Overall Study|Withdrawal by Subject|9
780179|NCT00634114|2480642|P3|Overall Study|Adverse Event|3
780180|NCT00634114|2480643|P2|Overall Study|Adverse Event|8
780181|NCT00634114|2480644|P1|Overall Study|Adverse Event|6
780182|NCT00634179|2480667|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
780183|NCT00634244|2480677|P3|Overall Study|Other complicating disease|0
780184|NCT00634244|2480678|P2|Overall Study|Other complicating disease|1
780185|NCT00634244|2480679|P1|Overall Study|Other complicating disease|0
780186|NCT00634244|2480677|P3|Overall Study|Disease progression/relapse|0
780187|NCT00634244|2480678|P2|Overall Study|Disease progression/relapse|1
780188|NCT00634244|2480679|P1|Overall Study|Disease progression/relapse|0
780189|NCT00634244|2480677|P3|Overall Study|Physician Decision|0
780190|NCT00634244|2480678|P2|Overall Study|Physician Decision|1
780191|NCT00634244|2480679|P1|Overall Study|Physician Decision|0
780192|NCT00634244|2480677|P3|Overall Study|Withdrawal by Subject|0
780193|NCT00634244|2480678|P2|Overall Study|Withdrawal by Subject|1
780194|NCT00634244|2480679|P1|Overall Study|Withdrawal by Subject|0
780195|NCT00634244|2480677|P3|Overall Study|Adverse Event|0
780196|NCT00634244|2480678|P2|Overall Study|Adverse Event|2
780197|NCT00634244|2480679|P1|Overall Study|Adverse Event|0
780198|NCT00634244|2480677|P3|Overall Study|Death|0
780199|NCT00634244|2480678|P2|Overall Study|Death|6
780200|NCT00634244|2480679|P1|Overall Study|Death|1
780201|NCT00634244|2480677|P3|Overall Study|Never started treatment|0
780202|NCT00634244|2480678|P2|Overall Study|Never started treatment|1
780203|NCT00634244|2480679|P1|Overall Study|Never started treatment|0
780204|NCT00634504|2480732|P2|Overall Study|Protocol Violation|0
780205|NCT00634504|2480733|P1|Overall Study|Protocol Violation|1
780206|NCT00634543|2480741|P2|Overall Study|Lost to Follow-up|1
780207|NCT00634543|2480742|P1|Overall Study|Lost to Follow-up|0
780208|NCT00634543|2480741|P2|Overall Study|Withdrawal by Subject|4
780209|NCT00634543|2480742|P1|Overall Study|Withdrawal by Subject|4
780210|NCT00634543|2480741|P2|Overall Study|Adverse Event|11
780211|NCT00634543|2480742|P1|Overall Study|Adverse Event|11
780212|NCT00634543|2480741|P2|Overall Study|Protocol Violation|3
780213|NCT00634543|2480742|P1|Overall Study|Protocol Violation|3
780214|NCT00634543|2480741|P2|Overall Study|Unspecified|2
780215|NCT00634543|2480742|P1|Overall Study|Unspecified|1
780216|NCT00634569|2480760|P2|Overall Study|Physician Decision|1
780217|NCT00634569|2480761|P1|Overall Study|Physician Decision|0
780218|NCT00634569|2480760|P2|Overall Study|Withdrawal by Subject|4
780219|NCT00634569|2480761|P1|Overall Study|Withdrawal by Subject|0
780220|NCT00634647|2480785|P1|Overall Study|declined to participate before treatment|1
780221|NCT00634647|2480785|P1|Overall Study|refused further treatment|3
780222|NCT00634647|2480785|P1|Overall Study|death on study|5
780223|NCT00634751|2480794|P4|Pancreatic and Bilial Tract Cancer|Death|1
780224|NCT00634751|2480795|P3|Pancreatic and Bilial Tract Cancer|Death|1
780225|NCT00634751|2480796|P2|Pancreatic and Bilial Tract Cancer|Death|0
780226|NCT00634751|2480797|P1|Pancreatic and Bilial Tract Cancer|Death|0
780227|NCT00634751|2480794|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
780228|NCT00634751|2480795|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
780229|NCT00634751|2480796|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
780230|NCT00634751|2480797|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
780231|NCT00634751|2480794|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
780232|NCT00634751|2480795|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
780233|NCT00634751|2480796|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
780234|NCT00634751|2480797|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
780235|NCT00625131|2480817|P3|Overall Study|Withdrawal by Subject|5
780236|NCT00625131|2480818|P2|Overall Study|Withdrawal by Subject|0
780237|NCT00625131|2480819|P1|Overall Study|Withdrawal by Subject|1
780238|NCT00625131|2480817|P3|Overall Study|Lost to Follow-up|0
780239|NCT00625131|2480818|P2|Overall Study|Lost to Follow-up|2
780240|NCT00625131|2480819|P1|Overall Study|Lost to Follow-up|3
780242|NCT00625365|2480836|P1|Overall Study|VSD|1
780243|NCT00625365|2480836|P1|Overall Study|No IV access|5
780244|NCT00625365|2480836|P1|Overall Study|Withdrawal by Subject|1
780245|NCT00625586|2480892|P1|Overall Study|Adverse Event|1
780246|NCT00625742|2480911|P1|Overall Study|Ineligible|1
780247|NCT00625742|2480911|P1|Overall Study|Lost to Follow-up|4
780248|NCT00625742|2480911|P1|Overall Study|Adverse Event|4
780249|NCT00625742|2480911|P1|Overall Study|Withdrawal by Subject|1
780250|NCT00625742|2480911|P1|Overall Study|Disease Progression|2
780251|NCT00625820|2480916|P1|Overall Study|Withdrawal by Subject|1
780252|NCT00625872|2480924|P2|Overall Study|Randomized but not treated|1
780253|NCT00625872|2480925|P1|Overall Study|Randomized but not treated|0
780254|NCT00625872|2480924|P2|Overall Study|Terminated by sponsor|5
780255|NCT00625872|2480925|P1|Overall Study|Terminated by sponsor|2
780256|NCT00625872|2480924|P2|Overall Study|Does not meet inclusion criteria|0
780257|NCT00625872|2480925|P1|Overall Study|Does not meet inclusion criteria|1
780258|NCT00625872|2480924|P2|Overall Study|Withdrawal by Subject|0
780259|NCT00625872|2480925|P1|Overall Study|Withdrawal by Subject|1
780260|NCT00626028|2481045|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
780261|NCT00626028|2481046|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
780262|NCT00626028|2481045|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
780263|NCT00626028|2481046|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
780264|NCT00626028|2481045|P2|Treatment 1 NO First, O2 Last|Device Failure|1
780265|NCT00626028|2481046|P1|Treatment 1 NO First, O2 Last|Device Failure|0
780266|NCT00626028|2481045|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
780267|NCT00626028|2481046|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
780268|NCT00626093|2481056|P1|Overall Study|One of the required devices not implante|6
780269|NCT00626093|2481056|P1|Overall Study|Protocol Violation|1
780270|NCT00626093|2481056|P1|Overall Study|Withdrawal by Subject|6
780271|NCT00626093|2481056|P1|Overall Study|Physician Decision|4
780272|NCT00626093|2481056|P1|Overall Study|Death|1
780273|NCT00626093|2481056|P1|Overall Study|Lost to Follow-up|5
780274|NCT00626275|2481065|P8|Part B|Withdrawal by Subject|1
780275|NCT00626275|2481066|P7|Part B|Withdrawal by Subject|0
780276|NCT00626275|2481067|P6|Part B|Withdrawal by Subject|0
780277|NCT00626275|2481068|P5|Part B|Withdrawal by Subject|0
780278|NCT00626275|2481069|P4|Part B|Withdrawal by Subject|0
780279|NCT00626275|2481070|P3|Part B|Withdrawal by Subject|0
780280|NCT00626275|2481071|P2|Part B|Withdrawal by Subject|0
780281|NCT00626275|2481072|P1|Part B|Withdrawal by Subject|0
780282|NCT00626275|2481065|P8|Part B|Lost to Follow-up|0
780283|NCT00626275|2481066|P7|Part B|Lost to Follow-up|1
780284|NCT00626275|2481067|P6|Part B|Lost to Follow-up|0
780285|NCT00626275|2481068|P5|Part B|Lost to Follow-up|0
780286|NCT00626275|2481069|P4|Part B|Lost to Follow-up|0
780287|NCT00626275|2481070|P3|Part B|Lost to Follow-up|0
780288|NCT00626275|2481071|P2|Part B|Lost to Follow-up|0
780289|NCT00626275|2481072|P1|Part B|Lost to Follow-up|0
780290|NCT00626275|2481065|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
780291|NCT00626275|2481066|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
780292|NCT00626275|2481067|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
780293|NCT00626275|2481068|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
780294|NCT00626275|2481069|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
780295|NCT00626275|2481070|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
780296|NCT00626275|2481071|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
780297|NCT00626275|2481072|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
780298|NCT00626275|2481065|P8|Part A - Treatment Period 1|Adverse Event|0
780299|NCT00626275|2481066|P7|Part A - Treatment Period 1|Adverse Event|0
780300|NCT00626275|2481067|P6|Part A - Treatment Period 1|Adverse Event|0
780301|NCT00626275|2481068|P5|Part A - Treatment Period 1|Adverse Event|0
780302|NCT00626275|2481069|P4|Part A - Treatment Period 1|Adverse Event|0
780303|NCT00626275|2481070|P3|Part A - Treatment Period 1|Adverse Event|0
780304|NCT00626275|2481071|P2|Part A - Treatment Period 1|Adverse Event|0
780305|NCT00626275|2481072|P1|Part A - Treatment Period 1|Adverse Event|1
780306|NCT00626327|2481115|P3|Overall Study|Protocol Violation|26
780307|NCT00626327|2481116|P2|Overall Study|Protocol Violation|4
780308|NCT00626327|2481117|P1|Overall Study|Protocol Violation|26
780309|NCT00626327|2481115|P3|Overall Study|Administrative Reason|6
780310|NCT00626327|2481116|P2|Overall Study|Administrative Reason|0
780311|NCT00626327|2481117|P1|Overall Study|Administrative Reason|2
780312|NCT00626327|2481115|P3|Overall Study|Inappropriate enrollment|3
780313|NCT00626327|2481116|P2|Overall Study|Inappropriate enrollment|5
780314|NCT00626327|2481117|P1|Overall Study|Inappropriate enrollment|4
780315|NCT00626327|2481115|P3|Overall Study|Lost to Follow-up|23
780316|NCT00626327|2481116|P2|Overall Study|Lost to Follow-up|21
780317|NCT00626327|2481117|P1|Overall Study|Lost to Follow-up|24
780318|NCT00626327|2481115|P3|Overall Study|Adverse Event|0
780319|NCT00626327|2481116|P2|Overall Study|Adverse Event|0
780320|NCT00626327|2481117|P1|Overall Study|Adverse Event|1
780321|NCT00626327|2481115|P3|Overall Study|Withdrawal by Subject|30
780322|NCT00626327|2481116|P2|Overall Study|Withdrawal by Subject|29
780323|NCT00626327|2481117|P1|Overall Study|Withdrawal by Subject|21
780324|NCT00626392|2481153|P6|Coadministration Period|Other|1
780325|NCT00626392|2481154|P5|Coadministration Period|Other|1
780326|NCT00626392|2481155|P4|Coadministration Period|Other|1
780327|NCT00626392|2481156|P3|Coadministration Period|Other|3
780328|NCT00626392|2481157|P2|Coadministration Period|Other|2
780329|NCT00626392|2481158|P1|Coadministration Period|Other|0
780330|NCT00626392|2481153|P6|Coadministration Period|Protocol Violation|0
780331|NCT00626392|2481154|P5|Coadministration Period|Protocol Violation|1
780332|NCT00626392|2481155|P4|Coadministration Period|Protocol Violation|1
780333|NCT00626392|2481156|P3|Coadministration Period|Protocol Violation|0
780334|NCT00626392|2481157|P2|Coadministration Period|Protocol Violation|1
780335|NCT00626392|2481158|P1|Coadministration Period|Protocol Violation|0
780336|NCT00626392|2481153|P6|Coadministration Period|Withdrawal by Subject|1
780337|NCT00626392|2481154|P5|Coadministration Period|Withdrawal by Subject|0
780338|NCT00626392|2481155|P4|Coadministration Period|Withdrawal by Subject|1
780339|NCT00626392|2481156|P3|Coadministration Period|Withdrawal by Subject|0
780340|NCT00626392|2481157|P2|Coadministration Period|Withdrawal by Subject|1
780341|NCT00626392|2481158|P1|Coadministration Period|Withdrawal by Subject|1
780342|NCT00626392|2481153|P6|Coadministration Period|Adverse Event|4
780343|NCT00626392|2481154|P5|Coadministration Period|Adverse Event|3
780344|NCT00626392|2481155|P4|Coadministration Period|Adverse Event|4
780345|NCT00626392|2481156|P3|Coadministration Period|Adverse Event|7
780346|NCT00626392|2481157|P2|Coadministration Period|Adverse Event|1
780347|NCT00626392|2481158|P1|Coadministration Period|Adverse Event|3
780348|NCT00626392|2481153|P6|Run-in Period|Noncompliance|0
780349|NCT00626392|2481154|P5|Run-in Period|Noncompliance|0
780350|NCT00626392|2481155|P4|Run-in Period|Noncompliance|0
780351|NCT00626392|2481156|P3|Run-in Period|Noncompliance|1
780352|NCT00626392|2481157|P2|Run-in Period|Noncompliance|0
780353|NCT00626392|2481158|P1|Run-in Period|Noncompliance|1
780354|NCT00626392|2481153|P6|Run-in Period|Withdrawal by Subject|1
780355|NCT00626392|2481154|P5|Run-in Period|Withdrawal by Subject|3
780356|NCT00626392|2481155|P4|Run-in Period|Withdrawal by Subject|1
780357|NCT00626392|2481156|P3|Run-in Period|Withdrawal by Subject|1
780358|NCT00626392|2481157|P2|Run-in Period|Withdrawal by Subject|1
780359|NCT00626392|2481158|P1|Run-in Period|Withdrawal by Subject|0
780360|NCT00626392|2481153|P6|Run-in Period|Adverse Event|0
780361|NCT00626392|2481154|P5|Run-in Period|Adverse Event|1
780362|NCT00626392|2481155|P4|Run-in Period|Adverse Event|0
780363|NCT00626392|2481156|P3|Run-in Period|Adverse Event|1
780364|NCT00626392|2481157|P2|Run-in Period|Adverse Event|0
780365|NCT00626392|2481158|P1|Run-in Period|Adverse Event|0
780366|NCT00626522|2481199|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
780367|NCT00626522|2481200|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
780368|NCT00626522|2481201|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
780369|NCT00626522|2481202|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
780370|NCT00626522|2481203|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
780371|NCT00626522|2481204|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
780372|NCT00626522|2481199|P6|Overall Study|Inconsistent reason reported|0
780373|NCT00626522|2481200|P5|Overall Study|Inconsistent reason reported|0
780374|NCT00626522|2481201|P4|Overall Study|Inconsistent reason reported|0
780375|NCT00626522|2481202|P3|Overall Study|Inconsistent reason reported|0
780376|NCT00626522|2481203|P2|Overall Study|Inconsistent reason reported|0
780377|NCT00626522|2481204|P1|Overall Study|Inconsistent reason reported|1
780378|NCT00626522|2481199|P6|Overall Study|Lost to Follow-up|0
780379|NCT00626522|2481200|P5|Overall Study|Lost to Follow-up|0
780380|NCT00626522|2481201|P4|Overall Study|Lost to Follow-up|0
780381|NCT00626522|2481202|P3|Overall Study|Lost to Follow-up|0
780382|NCT00626522|2481203|P2|Overall Study|Lost to Follow-up|1
780383|NCT00626522|2481204|P1|Overall Study|Lost to Follow-up|0
780384|NCT00626522|2481199|P6|Overall Study|COPD exacerbation|0
780385|NCT00626522|2481200|P5|Overall Study|COPD exacerbation|1
780386|NCT00626522|2481201|P4|Overall Study|COPD exacerbation|1
780387|NCT00626522|2481202|P3|Overall Study|COPD exacerbation|0
780388|NCT00626522|2481203|P2|Overall Study|COPD exacerbation|0
780389|NCT00626522|2481204|P1|Overall Study|COPD exacerbation|0
780390|NCT00626522|2481199|P6|Overall Study|Withdrawal by Subject|1
780391|NCT00626522|2481200|P5|Overall Study|Withdrawal by Subject|4
780392|NCT00626522|2481201|P4|Overall Study|Withdrawal by Subject|0
780393|NCT00626522|2481202|P3|Overall Study|Withdrawal by Subject|5
780394|NCT00626522|2481203|P2|Overall Study|Withdrawal by Subject|5
780395|NCT00626522|2481204|P1|Overall Study|Withdrawal by Subject|2
780396|NCT00626522|2481199|P6|Overall Study|Adverse Event|1
780397|NCT00626522|2481200|P5|Overall Study|Adverse Event|1
780398|NCT00626522|2481201|P4|Overall Study|Adverse Event|0
780399|NCT00626522|2481202|P3|Overall Study|Adverse Event|2
780400|NCT00626522|2481203|P2|Overall Study|Adverse Event|1
780401|NCT00626522|2481204|P1|Overall Study|Adverse Event|2
780402|NCT00626522|2481199|P6|Overall Study|Protocol Violation|0
780403|NCT00626522|2481200|P5|Overall Study|Protocol Violation|1
780404|NCT00626522|2481201|P4|Overall Study|Protocol Violation|0
780405|NCT00626522|2481202|P3|Overall Study|Protocol Violation|0
780406|NCT00626522|2481203|P2|Overall Study|Protocol Violation|0
780407|NCT00626522|2481204|P1|Overall Study|Protocol Violation|0
780408|NCT00626548|2481244|P2|Overall Study|Other termination reason|613
780409|NCT00626548|2481245|P1|Overall Study|Other termination reason|493
780410|NCT00626548|2481244|P2|Overall Study|Lost to Follow-up|2
780411|NCT00626548|2481245|P1|Overall Study|Lost to Follow-up|2
780412|NCT00626548|2481244|P2|Overall Study|Protocol Violation|11
780413|NCT00626548|2481245|P1|Overall Study|Protocol Violation|4
780414|NCT00626548|2481244|P2|Overall Study|Withdrawal by Subject|46
780415|NCT00626548|2481245|P1|Overall Study|Withdrawal by Subject|42
780416|NCT00626548|2481244|P2|Overall Study|Adverse Event|44
780417|NCT00626548|2481245|P1|Overall Study|Adverse Event|164
780418|NCT00626561|2481253|P1|Overall Study|Disease Progression|2
780419|NCT00626561|2481253|P1|Overall Study|Withdrawal by Subject|2
780420|NCT00626639|2481268|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
780421|NCT00626639|2481269|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
780422|NCT00626821|2481380|P1|Overall Study|other/unknown reason|104
780423|NCT00626821|2481380|P1|Overall Study|Product dysfunction|21
780424|NCT00626821|2481380|P1|Overall Study|Physician Decision|9
780425|NCT00626821|2481380|P1|Overall Study|Withdrawal by Subject|10
780426|NCT00626821|2481380|P1|Overall Study|Protocol Violation|33
780427|NCT00626821|2481380|P1|Overall Study|Adverse Event|44
780428|NCT00626925|2481386|P2|Overall Study|Time constraints|1
780429|NCT00626925|2481387|P1|Overall Study|Time constraints|3
780430|NCT00626925|2481386|P2|Overall Study|Lack of Efficacy|4
780431|NCT00626925|2481387|P1|Overall Study|Lack of Efficacy|1
780432|NCT00626925|2481386|P2|Overall Study|Adverse effect|2
780433|NCT00626925|2481387|P1|Overall Study|Adverse effect|6
780434|NCT00626925|2481386|P2|Overall Study|relapse|0
780435|NCT00626925|2481387|P1|Overall Study|relapse|1
780436|NCT00626925|2481386|P2|Overall Study|Lost to Follow-up|2
780437|NCT00626925|2481387|P1|Overall Study|Lost to Follow-up|1
780438|NCT00627016|2481415|P2|Overall Study|Pregnancy|0
780439|NCT00627016|2481416|P1|Overall Study|Pregnancy|1
780440|NCT00627016|2481415|P2|Overall Study|Placed on Excluded Drugs|0
780441|NCT00627016|2481416|P1|Overall Study|Placed on Excluded Drugs|1
780442|NCT00627016|2481415|P2|Overall Study|Lack of Efficacy|0
780443|NCT00627016|2481416|P1|Overall Study|Lack of Efficacy|1
780444|NCT00627016|2481415|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
780445|NCT00627016|2481416|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
780446|NCT00627016|2481415|P2|Overall Study|Withdrawal by Subject|1
780447|NCT00627016|2481416|P1|Overall Study|Withdrawal by Subject|2
780448|NCT00627016|2481415|P2|Overall Study|Lost to Follow-up|1
780449|NCT00627016|2481416|P1|Overall Study|Lost to Follow-up|0
780450|NCT00627016|2481415|P2|Overall Study|Protocol Violation|2
780451|NCT00627016|2481416|P1|Overall Study|Protocol Violation|0
780452|NCT00627016|2481415|P2|Overall Study|Adverse Event|1
780453|NCT00627016|2481416|P1|Overall Study|Adverse Event|1
780454|NCT00627042|2481426|P1|Overall Study|Withdrawal by Subject|2
780455|NCT00627094|2481438|P2|Overall Study|Other reason|0
780456|NCT00627094|2481439|P1|Overall Study|Other reason|1
780457|NCT00627094|2481438|P2|Overall Study|ulcer healed|7
780458|NCT00627094|2481439|P1|Overall Study|ulcer healed|1
780459|NCT00627094|2481438|P2|Overall Study|Withdrawal by Subject|1
780460|NCT00627094|2481439|P1|Overall Study|Withdrawal by Subject|1
780461|NCT00627094|2481438|P2|Overall Study|Lost to Follow-up|0
780462|NCT00627094|2481439|P1|Overall Study|Lost to Follow-up|1
780463|NCT00627094|2481438|P2|Overall Study|Adverse Event|7
780464|NCT00627094|2481439|P1|Overall Study|Adverse Event|8
780465|NCT00634842|2481453|P2|Overall Study|Subject off study drug for too long|1
780466|NCT00634842|2481454|P1|Overall Study|Subject off study drug for too long|0
780467|NCT00634842|2481453|P2|Overall Study|No wish to keep taking Avandia|1
780468|NCT00634842|2481454|P1|Overall Study|No wish to keep taking Avandia|0
780469|NCT00634842|2481453|P2|Overall Study|No need of study drug to treat diabetes|1
780470|NCT00634842|2481454|P1|Overall Study|No need of study drug to treat diabetes|0
780471|NCT00634842|2481453|P2|Overall Study|Discontinued due to injection|2
780472|NCT00634842|2481454|P1|Overall Study|Discontinued due to injection|0
780473|NCT00634842|2481453|P2|Overall Study|Lack of time and intolerance to drug|1
780474|NCT00634842|2481454|P1|Overall Study|Lack of time and intolerance to drug|0
780475|NCT00634842|2481453|P2|Overall Study|Withdrawal by Subject|3
780476|NCT00634842|2481454|P1|Overall Study|Withdrawal by Subject|1
780477|NCT00634842|2481453|P2|Overall Study|Physician Decision|0
780478|NCT00634842|2481454|P1|Overall Study|Physician Decision|1
780479|NCT00634842|2481453|P2|Overall Study|Lost to Follow-up|2
780480|NCT00634842|2481454|P1|Overall Study|Lost to Follow-up|1
780481|NCT00634842|2481453|P2|Overall Study|Inclusion criteria were not met|0
780482|NCT00634842|2481454|P1|Overall Study|Inclusion criteria were not met|1
780483|NCT00634842|2481453|P2|Overall Study|Move to another state|0
780484|NCT00634842|2481454|P1|Overall Study|Move to another state|1
780485|NCT00634842|2481453|P2|Overall Study|Protocol Violation|4
780486|NCT00634842|2481454|P1|Overall Study|Protocol Violation|8
780487|NCT00634842|2481453|P2|Overall Study|Adverse Event|3
780488|NCT00634842|2481454|P1|Overall Study|Adverse Event|2
780489|NCT00634907|2481468|P2|Overall Study|Withdrawal by Subject|8
780490|NCT00634907|2481469|P1|Overall Study|Withdrawal by Subject|11
780491|NCT00634907|2481468|P2|Overall Study|Physician Decision|9
780492|NCT00634907|2481469|P1|Overall Study|Physician Decision|3
780493|NCT00634907|2481468|P2|Overall Study|Withdrawal by Subject|0
780494|NCT00634907|2481469|P1|Overall Study|Withdrawal by Subject|3
780495|NCT00634920|2481494|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
780496|NCT00634920|2481495|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
780497|NCT00634920|2481496|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
780498|NCT00634920|2481494|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
780499|NCT00634920|2481495|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
780500|NCT00634920|2481496|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
780501|NCT00634920|2481494|P3|Period 2 - Post-Randomization|Death|0
780502|NCT00634920|2481495|P2|Period 2 - Post-Randomization|Death|5
780503|NCT00634920|2481496|P1|Period 2 - Post-Randomization|Death|2
780504|NCT00634920|2481494|P3|Period 2 - Post-Randomization|Rejection|0
780505|NCT00634920|2481495|P2|Period 2 - Post-Randomization|Rejection|5
780506|NCT00634920|2481496|P1|Period 2 - Post-Randomization|Rejection|11
780507|NCT00634920|2481494|P3|Period 2 - Post-Randomization|Adverse Event|0
780508|NCT00634920|2481495|P2|Period 2 - Post-Randomization|Adverse Event|9
780509|NCT00634920|2481496|P1|Period 2 - Post-Randomization|Adverse Event|37
780510|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Other issues|6
780511|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Other issues|0
780512|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Other issues|0
780513|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Non-Compliance|3
780514|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Non-Compliance|0
780515|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Non-Compliance|0
780516|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
780517|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
780518|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
780519|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Rejections|55
780520|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Rejections|0
780521|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Rejections|0
780522|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Wound healing problems|16
780523|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Wound healing problems|0
780524|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Wound healing problems|0
780525|NCT00634920|2481494|P3|Period 1 - Pre-Randomization|Adverse Event|36
780526|NCT00634920|2481495|P2|Period 1 - Pre-Randomization|Adverse Event|0
780527|NCT00634920|2481496|P1|Period 1 - Pre-Randomization|Adverse Event|0
780528|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Unspecified|1
780529|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Unspecified|0
780530|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Unspecified|5
780531|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Unspecified|0
780532|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Unspecified|0
780533|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
780534|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
780535|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
780536|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
780537|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
780538|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
780539|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
780540|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
780541|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
780542|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
780543|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Protocol Violation|1
780544|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Protocol Violation|0
780545|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Protocol Violation|0
780546|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Protocol Violation|0
780547|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Protocol Violation|0
780548|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Physician Decision|0
780549|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Physician Decision|0
780550|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Physician Decision|1
780551|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Physician Decision|1
780552|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Physician Decision|0
780553|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
780554|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
780555|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
780556|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
780557|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
780558|NCT00634933|2481541|P5|Part B: Week 24 to Week 52|Adverse Event|0
780559|NCT00634933|2481542|P4|Part B: Week 24 to Week 52|Adverse Event|1
780560|NCT00634933|2481543|P3|Part B: Week 24 to Week 52|Adverse Event|1
780561|NCT00634933|2481544|P2|Part B: Week 24 to Week 52|Adverse Event|1
780562|NCT00634933|2481545|P1|Part B: Week 24 to Week 52|Adverse Event|0
780563|NCT00634933|2481541|P5|Between Part A and Part B|Physician Decision|0
780564|NCT00634933|2481542|P4|Between Part A and Part B|Physician Decision|0
780565|NCT00634933|2481543|P3|Between Part A and Part B|Physician Decision|0
780566|NCT00634933|2481544|P2|Between Part A and Part B|Physician Decision|1
780567|NCT00634933|2481545|P1|Between Part A and Part B|Physician Decision|0
780568|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Unspecified|0
780569|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Unspecified|0
780570|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Unspecified|5
780571|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Unspecified|8
780572|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Unspecified|1
780573|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
780574|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
780575|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
780576|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
780577|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
780578|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
780579|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
780580|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
780581|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
780582|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
780583|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
780584|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
780585|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
780586|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
780587|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
780588|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Investigator Request|0
780589|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Investigator Request|0
780590|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Investigator Request|1
780591|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Investigator Request|1
780592|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Investigator Request|1
780593|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Failed to Return|0
780594|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Failed to Return|0
780595|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Failed to Return|0
780596|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Failed to Return|0
780597|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Failed to Return|1
780598|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Death|0
780599|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Death|0
780600|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Death|0
780601|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Death|0
780602|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Death|1
780603|NCT00634933|2481541|P5|Part A: Baseline to Week 24|Adverse Event|0
780604|NCT00634933|2481542|P4|Part A: Baseline to Week 24|Adverse Event|0
780605|NCT00634933|2481543|P3|Part A: Baseline to Week 24|Adverse Event|8
780606|NCT00634933|2481544|P2|Part A: Baseline to Week 24|Adverse Event|4
780607|NCT00634933|2481545|P1|Part A: Baseline to Week 24|Adverse Event|4
780608|NCT00635024|2481611|P1|Overall Study|Adverse Event|1
780609|NCT00635050|2481619|P1|Overall Study|Withdrawal by Subject|1
780610|NCT00635089|2481626|P1|Overall Study|Not Specified|31
780611|NCT00635089|2481626|P1|Overall Study|Lost to Follow-up|8
780612|NCT00635089|2481626|P1|Overall Study|Protocol Deviation|4
780613|NCT00635089|2481626|P1|Overall Study|Lack of Efficacy|28
780614|NCT00635089|2481626|P1|Overall Study|Adverse Event|7
780615|NCT00635102|2481655|P2|Overall Study|Withdrawal by Subject|8
780616|NCT00635102|2481656|P1|Overall Study|Withdrawal by Subject|7
780617|NCT00635154|2481781|P1|Overall Study|Still on treatment|21
780618|NCT00635154|2481781|P1|Overall Study|Other|4
780619|NCT00635154|2481781|P1|Overall Study|Alternative Treatment|8
780620|NCT00635661|2481791|P1|Overall Study|Withdrawal by Subject|4
780621|NCT00635804|2481812|P8|Overall Study|Withdrawal by Subject|0
780622|NCT00635804|2481813|P7|Overall Study|Withdrawal by Subject|0
780623|NCT00635804|2481814|P6|Overall Study|Withdrawal by Subject|0
780624|NCT00635804|2481815|P5|Overall Study|Withdrawal by Subject|0
780625|NCT00635804|2481816|P4|Overall Study|Withdrawal by Subject|0
780626|NCT00635804|2481817|P3|Overall Study|Withdrawal by Subject|0
780627|NCT00635804|2481818|P2|Overall Study|Withdrawal by Subject|0
780628|NCT00635804|2481819|P1|Overall Study|Withdrawal by Subject|1
780629|NCT00635804|2481812|P8|Overall Study|Adverse Event|0
780630|NCT00635804|2481813|P7|Overall Study|Adverse Event|0
780631|NCT00635804|2481814|P6|Overall Study|Adverse Event|1
780632|NCT00635804|2481815|P5|Overall Study|Adverse Event|0
780633|NCT00635804|2481816|P4|Overall Study|Adverse Event|0
780634|NCT00635804|2481817|P3|Overall Study|Adverse Event|0
780635|NCT00635804|2481818|P2|Overall Study|Adverse Event|0
780636|NCT00635804|2481819|P1|Overall Study|Adverse Event|0
780637|NCT00635882|2481982|P6|Overall Study|Protocol Violation|0
780638|NCT00635882|2481983|P5|Overall Study|Protocol Violation|0
780639|NCT00635882|2481984|P4|Overall Study|Protocol Violation|0
780640|NCT00635882|2481985|P3|Overall Study|Protocol Violation|0
780641|NCT00635882|2481986|P2|Overall Study|Protocol Violation|0
780642|NCT00635882|2481987|P1|Overall Study|Protocol Violation|1
780643|NCT00636155|2482082|P1|Overall Study|Physician Decision|5
780644|NCT00636155|2482082|P1|Overall Study|Stem cell transplant|1
780645|NCT00636155|2482082|P1|Overall Study|Withdrawal by Subject|3
780646|NCT00636155|2482082|P1|Overall Study|Lack of Efficacy|1
780647|NCT00636155|2482082|P1|Overall Study|Adverse Event|8
891895|NCT01072149|2828537|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891896|NCT01072149|2828538|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891897|NCT01072149|2828539|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891898|NCT01072149|2828540|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891899|NCT01072149|2828541|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891900|NCT01072149|2828542|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891901|NCT01072149|2828543|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891902|NCT01072149|2828544|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891903|NCT01072149|2828545|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891904|NCT01072149|2828546|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891905|NCT01072149|2828547|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
891906|NCT01072149|2828548|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891907|NCT01072149|2828549|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
891908|NCT01029366|2828569|P2|Overall Study|manufacturing failure|1
891909|NCT01029366|2828570|P1|Overall Study|manufacturing failure|0
891910|NCT01029366|2828569|P2|Overall Study|disease progression|0
891911|NCT01029366|2828570|P1|Overall Study|disease progression|2
891912|NCT01029366|2828569|P2|Overall Study|Death|1
891913|NCT01029366|2828570|P1|Overall Study|Death|1
891914|NCT01029366|2828569|P2|Overall Study|Withdrawal by Subject|0
891915|NCT01029366|2828570|P1|Overall Study|Withdrawal by Subject|1
891916|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Physician Decision|8
891917|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Physician Decision|6
891918|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Physician Decision|6
780672|NCT00636194|2482113|P2|Overall Study|Protocol Violation|0
780673|NCT00636194|2482114|P1|Overall Study|Protocol Violation|2
780674|NCT00636194|2482113|P2|Overall Study|Study related symptoms and complaints|0
780675|NCT00636194|2482114|P1|Overall Study|Study related symptoms and complaints|1
780676|NCT00636207|2482127|P7|Overall Study|Withdrawal by Subject|0
780677|NCT00636207|2482128|P6|Overall Study|Withdrawal by Subject|0
780678|NCT00636207|2482129|P5|Overall Study|Withdrawal by Subject|1
780679|NCT00636207|2482130|P4|Overall Study|Withdrawal by Subject|0
780680|NCT00636207|2482131|P3|Overall Study|Withdrawal by Subject|0
780681|NCT00636207|2482132|P2|Overall Study|Withdrawal by Subject|1
780682|NCT00636207|2482133|P1|Overall Study|Withdrawal by Subject|0
780683|NCT00636207|2482127|P7|Overall Study|Adverse Event|0
780684|NCT00636207|2482128|P6|Overall Study|Adverse Event|0
780685|NCT00636207|2482129|P5|Overall Study|Adverse Event|0
780686|NCT00636207|2482130|P4|Overall Study|Adverse Event|0
780687|NCT00636207|2482131|P3|Overall Study|Adverse Event|0
780688|NCT00636207|2482132|P2|Overall Study|Adverse Event|0
780689|NCT00636207|2482133|P1|Overall Study|Adverse Event|1
780690|NCT00636363|2482202|P3|Overall Study|Withdrawal by Subject|2
780691|NCT00636363|2482203|P2|Overall Study|Withdrawal by Subject|3
780692|NCT00636363|2482204|P1|Overall Study|Withdrawal by Subject|1
780693|NCT00636363|2482202|P3|Overall Study|Lost to Follow-up|2
780694|NCT00636363|2482203|P2|Overall Study|Lost to Follow-up|4
780695|NCT00636363|2482204|P1|Overall Study|Lost to Follow-up|3
780696|NCT00636363|2482202|P3|Overall Study|Protocol Violation|0
780697|NCT00636363|2482203|P2|Overall Study|Protocol Violation|3
780698|NCT00636363|2482204|P1|Overall Study|Protocol Violation|0
780699|NCT00636363|2482202|P3|Overall Study|Lack of motivation|1
780700|NCT00636363|2482203|P2|Overall Study|Lack of motivation|0
891919|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Physician Decision|4
780701|NCT00636363|2482204|P1|Overall Study|Lack of motivation|1
780702|NCT00636363|2482202|P3|Overall Study|Missed > 1 visit|3
780703|NCT00636363|2482203|P2|Overall Study|Missed > 1 visit|1
780704|NCT00636363|2482204|P1|Overall Study|Missed > 1 visit|0
780705|NCT00636363|2482202|P3|Overall Study|Met ineligibility criteria|3
780706|NCT00636363|2482203|P2|Overall Study|Met ineligibility criteria|0
780707|NCT00636363|2482204|P1|Overall Study|Met ineligibility criteria|0
780708|NCT00636363|2482202|P3|Overall Study|Study related symptoms/complaints|4
780709|NCT00636363|2482203|P2|Overall Study|Study related symptoms/complaints|7
780710|NCT00636363|2482204|P1|Overall Study|Study related symptoms/complaints|8
780711|NCT00636363|2482202|P3|Overall Study|Positive slit lamp finding|1
780712|NCT00636363|2482203|P2|Overall Study|Positive slit lamp finding|2
780713|NCT00636363|2482204|P1|Overall Study|Positive slit lamp finding|0
780714|NCT00636363|2482202|P3|Overall Study|Adverse Event|1
780715|NCT00636363|2482203|P2|Overall Study|Adverse Event|0
780716|NCT00636363|2482204|P1|Overall Study|Adverse Event|0
780717|NCT00636363|2482202|P3|Overall Study|Conjunctivitis|1
780718|NCT00636363|2482203|P2|Overall Study|Conjunctivitis|0
780719|NCT00636363|2482204|P1|Overall Study|Conjunctivitis|0
780720|NCT00636441|2482236|P7|Overall Study|Screen Failure|17
780721|NCT00636441|2482237|P6|Overall Study|Screen Failure|0
780722|NCT00636441|2482238|P5|Overall Study|Screen Failure|0
780723|NCT00636441|2482239|P4|Overall Study|Screen Failure|0
780724|NCT00636441|2482240|P3|Overall Study|Screen Failure|0
780725|NCT00636441|2482241|P2|Overall Study|Screen Failure|0
780726|NCT00636441|2482242|P1|Overall Study|Screen Failure|0
780727|NCT00636441|2482236|P7|Overall Study|Late, ineligible|1
780728|NCT00636441|2482237|P6|Overall Study|Late, ineligible|0
780729|NCT00636441|2482238|P5|Overall Study|Late, ineligible|0
780730|NCT00636441|2482239|P4|Overall Study|Late, ineligible|0
780731|NCT00636441|2482240|P3|Overall Study|Late, ineligible|0
780732|NCT00636441|2482241|P2|Overall Study|Late, ineligible|0
780733|NCT00636441|2482242|P1|Overall Study|Late, ineligible|0
780734|NCT00636441|2482236|P7|Overall Study|Adverse Event|0
780735|NCT00636441|2482237|P6|Overall Study|Adverse Event|1
780736|NCT00636441|2482238|P5|Overall Study|Adverse Event|0
780737|NCT00636441|2482239|P4|Overall Study|Adverse Event|0
780738|NCT00636441|2482240|P3|Overall Study|Adverse Event|1
780739|NCT00636441|2482241|P2|Overall Study|Adverse Event|1
780740|NCT00636441|2482242|P1|Overall Study|Adverse Event|0
780741|NCT00636610|2482273|P2|Overall Study|Reason for discontinuation not available|2
780742|NCT00636610|2482274|P1|Overall Study|Reason for discontinuation not available|3
780743|NCT00636610|2482273|P2|Overall Study|Disease progression - clinical|3
780744|NCT00636610|2482274|P1|Overall Study|Disease progression - clinical|8
780745|NCT00636610|2482273|P2|Overall Study|Disease progression - radiographic|51
780746|NCT00636610|2482274|P1|Overall Study|Disease progression - radiographic|41
780747|NCT00636610|2482273|P2|Overall Study|Subject decision to withdraw|11
780748|NCT00636610|2482274|P1|Overall Study|Subject decision to withdraw|15
780749|NCT00636610|2482273|P2|Overall Study|Physician decision to withdraw patient|9
780750|NCT00636610|2482274|P1|Overall Study|Physician decision to withdraw patient|15
780751|NCT00636610|2482273|P2|Overall Study|Death|3
780752|NCT00636610|2482274|P1|Overall Study|Death|6
780753|NCT00636610|2482273|P2|Overall Study|Adverse Event|4
780754|NCT00636610|2482274|P1|Overall Study|Adverse Event|4
780755|NCT00636636|2482286|P2|Overall Study|Withdrawal by Subject|9
780756|NCT00636636|2482287|P1|Overall Study|Withdrawal by Subject|4
780757|NCT00636636|2482286|P2|Overall Study|Death|1
780758|NCT00636636|2482287|P1|Overall Study|Death|0
780759|NCT00636636|2482286|P2|Overall Study|Lost to Follow-up|1
780760|NCT00636636|2482287|P1|Overall Study|Lost to Follow-up|0
780761|NCT00636636|2482286|P2|Overall Study|Protocol Violation|2
780762|NCT00636636|2482287|P1|Overall Study|Protocol Violation|2
780763|NCT00636636|2482286|P2|Overall Study|Lack of Efficacy|12
780764|NCT00636636|2482287|P1|Overall Study|Lack of Efficacy|7
780765|NCT00636636|2482286|P2|Overall Study|Adverse Event|8
780766|NCT00636636|2482287|P1|Overall Study|Adverse Event|19
780767|NCT00636636|2482286|P2|Overall Study|Other reason|6
780768|NCT00636636|2482287|P1|Overall Study|Other reason|4
780769|NCT00636792|2482341|P1|Overall Study|Other|3
780770|NCT00636792|2482341|P1|Overall Study|Withdrawal by Subject|3
780771|NCT00636792|2482341|P1|Overall Study|Progressive Disease|4
780772|NCT00636792|2482341|P1|Overall Study|Physician Decision|7
780773|NCT00636792|2482341|P1|Overall Study|Adverse Event|16
780774|NCT00636818|2482356|P1|Overall Study|Withdrawal by Subject|4
780775|NCT00636818|2482356|P1|Overall Study|Protocol Violation|1
780776|NCT00636818|2482356|P1|Overall Study|Entry Criteria Exclusion|3
780777|NCT00636818|2482356|P1|Overall Study|Lost to Follow-up|2
780778|NCT00636818|2482356|P1|Overall Study|Adverse Event|1
780779|NCT00636961|2482373|P2|Period 2|Adverse Event|0
780780|NCT00636961|2482374|P1|Period 2|Adverse Event|1
780781|NCT00636961|2482373|P2|Period 1|Administrative problems|1
780782|NCT00636961|2482374|P1|Period 1|Administrative problems|1
780783|NCT00636987|2482388|P1|Overall Study|5 year visit window not complete|69
780784|NCT00636987|2482388|P1|Overall Study|Lost to Follow-up|63
780785|NCT00636987|2482388|P1|Overall Study|Explanted|13
780786|NCT00636987|2482388|P1|Overall Study|Death|44
780787|NCT00637000|2482398|P2|Overall Study|Withdrawal by Subject|3
780788|NCT00637000|2482399|P1|Overall Study|Withdrawal by Subject|4
780795|NCT00637195|2482484|P2|Overall Study|Withdrawal by Subject|1
780796|NCT00637195|2482485|P1|Overall Study|Withdrawal by Subject|0
780797|NCT00637195|2482484|P2|Overall Study|Other|0
780798|NCT00637195|2482485|P1|Overall Study|Other|2
780799|NCT00637195|2482484|P2|Overall Study|Lost to Follow-up|0
780800|NCT00637195|2482485|P1|Overall Study|Lost to Follow-up|1
780801|NCT00637273|2482535|P3|Overall Study|Loss of Glucose Control|1
780802|NCT00637273|2482536|P2|Overall Study|Loss of Glucose Control|1
780803|NCT00637273|2482537|P1|Overall Study|Loss of Glucose Control|1
780804|NCT00637273|2482535|P3|Overall Study|Administrative|0
780805|NCT00637273|2482536|P2|Overall Study|Administrative|0
780806|NCT00637273|2482537|P1|Overall Study|Administrative|2
780807|NCT00637273|2482535|P3|Overall Study|Investigator Decision|1
780808|NCT00637273|2482536|P2|Overall Study|Investigator Decision|3
780809|NCT00637273|2482537|P1|Overall Study|Investigator Decision|1
780810|NCT00637273|2482535|P3|Overall Study|Withdrawal of Consent|18
780811|NCT00637273|2482536|P2|Overall Study|Withdrawal of Consent|6
780812|NCT00637273|2482537|P1|Overall Study|Withdrawal of Consent|18
780813|NCT00637273|2482535|P3|Overall Study|Protocol Violation|1
780814|NCT00637273|2482536|P2|Overall Study|Protocol Violation|4
780815|NCT00637273|2482537|P1|Overall Study|Protocol Violation|2
780816|NCT00637273|2482535|P3|Overall Study|Lost to Follow-up|13
780817|NCT00637273|2482536|P2|Overall Study|Lost to Follow-up|9
780818|NCT00637273|2482537|P1|Overall Study|Lost to Follow-up|8
780819|NCT00637273|2482535|P3|Overall Study|Adverse Event|7
780820|NCT00637273|2482536|P2|Overall Study|Adverse Event|5
780821|NCT00637273|2482537|P1|Overall Study|Adverse Event|11
780822|NCT00637377|2482602|P4|Overall Study|Other (no further information available)|5
780823|NCT00637377|2482603|P3|Overall Study|Other (no further information available)|10
780824|NCT00637377|2482604|P2|Overall Study|Other (no further information available)|6
780825|NCT00637377|2482605|P1|Overall Study|Other (no further information available)|7
780826|NCT00637377|2482602|P4|Overall Study|Withdrawal by Subject|11
780827|NCT00637377|2482603|P3|Overall Study|Withdrawal by Subject|13
780828|NCT00637377|2482604|P2|Overall Study|Withdrawal by Subject|15
780829|NCT00637377|2482605|P1|Overall Study|Withdrawal by Subject|11
780830|NCT00637377|2482602|P4|Overall Study|Protocol Violation|0
780831|NCT00637377|2482603|P3|Overall Study|Protocol Violation|1
780832|NCT00637377|2482604|P2|Overall Study|Protocol Violation|1
780833|NCT00637377|2482605|P1|Overall Study|Protocol Violation|2
780834|NCT00637377|2482602|P4|Overall Study|Lost to Follow-up|2
780835|NCT00637377|2482603|P3|Overall Study|Lost to Follow-up|2
780836|NCT00637377|2482604|P2|Overall Study|Lost to Follow-up|1
780837|NCT00637377|2482605|P1|Overall Study|Lost to Follow-up|4
780838|NCT00637377|2482602|P4|Overall Study|Lack of Efficacy|1
780839|NCT00637377|2482603|P3|Overall Study|Lack of Efficacy|1
780840|NCT00637377|2482604|P2|Overall Study|Lack of Efficacy|0
780841|NCT00637377|2482605|P1|Overall Study|Lack of Efficacy|0
780842|NCT00637377|2482602|P4|Overall Study|Death|1
780843|NCT00637377|2482603|P3|Overall Study|Death|2
780844|NCT00637377|2482604|P2|Overall Study|Death|3
780845|NCT00637377|2482605|P1|Overall Study|Death|1
780846|NCT00637377|2482602|P4|Overall Study|Adverse Event|9
780847|NCT00637377|2482603|P3|Overall Study|Adverse Event|8
780848|NCT00637377|2482604|P2|Overall Study|Adverse Event|6
780849|NCT00637377|2482605|P1|Overall Study|Adverse Event|2
780850|NCT00637416|2482633|P2|Overall Study|Unable to take study drug|1
780851|NCT00637416|2482634|P1|Overall Study|Unable to take study drug|0
780852|NCT00637416|2482633|P2|Overall Study|Lost to Follow-up|1
780853|NCT00637416|2482634|P1|Overall Study|Lost to Follow-up|1
780854|NCT00637572|2482653|P2|Overall Study|Illicit Drug Use|0
780855|NCT00637572|2482654|P1|Overall Study|Illicit Drug Use|1
780856|NCT00637572|2482653|P2|Overall Study|Withdrawal by Subject|2
780857|NCT00637572|2482654|P1|Overall Study|Withdrawal by Subject|0
780858|NCT00637572|2482653|P2|Overall Study|Physician Decision|1
780859|NCT00637572|2482654|P1|Overall Study|Physician Decision|1
780860|NCT00637572|2482653|P2|Overall Study|Lost to Follow-up|1
780861|NCT00637572|2482654|P1|Overall Study|Lost to Follow-up|0
780862|NCT00637572|2482653|P2|Overall Study|Death|1
780863|NCT00637572|2482654|P1|Overall Study|Death|0
780864|NCT00637572|2482653|P2|Overall Study|Adverse Event|2
780865|NCT00637572|2482654|P1|Overall Study|Adverse Event|1
780866|NCT00637728|2482682|P3|Double-blind Phase|Study Discontinued|0
780867|NCT00637728|2482683|P2|Double-blind Phase|Study Discontinued|1
780868|NCT00637728|2482684|P1|Double-blind Phase|Study Discontinued|1
780869|NCT00637728|2482682|P3|Double-blind Phase|Non-compliance|0
780870|NCT00637728|2482683|P2|Double-blind Phase|Non-compliance|0
780871|NCT00637728|2482684|P1|Double-blind Phase|Non-compliance|2
780872|NCT00637728|2482682|P3|Double-blind Phase|Adverse Event|0
780873|NCT00637728|2482683|P2|Double-blind Phase|Adverse Event|0
780874|NCT00637728|2482684|P1|Double-blind Phase|Adverse Event|1
780875|NCT00637806|2482715|P4|Extension Phase|Study Discontinued|1
780876|NCT00637806|2482716|P3|Extension Phase|Study Discontinued|0
780877|NCT00637806|2482717|P2|Extension Phase|Study Discontinued|0
780878|NCT00637806|2482718|P1|Extension Phase|Study Discontinued|0
780879|NCT00637806|2482715|P4|Double-blind Phase|Study Discontinued|0
780880|NCT00637806|2482716|P3|Double-blind Phase|Study Discontinued|1
780881|NCT00637806|2482717|P2|Double-blind Phase|Study Discontinued|0
780882|NCT00637806|2482718|P1|Double-blind Phase|Study Discontinued|2
780883|NCT00638027|2482772|P2|Overall Study|Adverse Event|2
780884|NCT00638027|2482773|P1|Overall Study|Adverse Event|0
780885|NCT00638157|2482785|P2|Overall Study|Randomized, not treated|0
780886|NCT00638157|2482786|P1|Overall Study|Randomized, not treated|2
780887|NCT00638157|2482785|P2|Overall Study|Not Specified|2
780888|NCT00638157|2482786|P1|Overall Study|Not Specified|1
780889|NCT00638157|2482785|P2|Overall Study|Physician Decision|0
780890|NCT00638157|2482786|P1|Overall Study|Physician Decision|1
780891|NCT00638157|2482785|P2|Overall Study|Lost to Follow-up|0
780892|NCT00638157|2482786|P1|Overall Study|Lost to Follow-up|1
780893|NCT00638157|2482785|P2|Overall Study|Microbiological failure|0
780894|NCT00638157|2482786|P1|Overall Study|Microbiological failure|1
780895|NCT00638157|2482785|P2|Overall Study|Clinical (symptomatic) failure|1
780896|NCT00638157|2482786|P1|Overall Study|Clinical (symptomatic) failure|1
780897|NCT00638157|2482785|P2|Overall Study|Adverse Event|1
780898|NCT00638157|2482786|P1|Overall Study|Adverse Event|0
780899|NCT00630292|2482794|P1|Overall Study|Withdrawal by Subject|1
780900|NCT00630305|2482798|P1|Overall Study|Inability to insert contact lens|1
780901|NCT00630305|2482798|P1|Overall Study|Withdrawal by Subject|1
780902|NCT00630331|2482823|P3|Overall Study|Protocol Violation|6
780903|NCT00630331|2482824|P2|Overall Study|Protocol Violation|5
780904|NCT00630331|2482825|P1|Overall Study|Protocol Violation|4
780905|NCT00630331|2482823|P3|Overall Study|Unable to classify|3
780906|NCT00630331|2482824|P2|Overall Study|Unable to classify|4
780907|NCT00630331|2482825|P1|Overall Study|Unable to classify|9
780908|NCT00630331|2482823|P3|Overall Study|Inappropriate enrollment|3
780909|NCT00630331|2482824|P2|Overall Study|Inappropriate enrollment|6
780910|NCT00630331|2482825|P1|Overall Study|Inappropriate enrollment|3
780911|NCT00630331|2482823|P3|Overall Study|Lost to Follow-up|170
780912|NCT00630331|2482824|P2|Overall Study|Lost to Follow-up|143
780913|NCT00630331|2482825|P1|Overall Study|Lost to Follow-up|175
780914|NCT00630331|2482823|P3|Overall Study|Withdrawal by Subject|5
780915|NCT00630331|2482824|P2|Overall Study|Withdrawal by Subject|7
780916|NCT00630331|2482825|P1|Overall Study|Withdrawal by Subject|12
780917|NCT00630331|2482823|P3|Overall Study|Adverse Event|0
780918|NCT00630331|2482824|P2|Overall Study|Adverse Event|0
780919|NCT00630331|2482825|P1|Overall Study|Adverse Event|1
780920|NCT00630331|2482823|P3|Overall Study|Death|1
780921|NCT00630331|2482824|P2|Overall Study|Death|1
780922|NCT00630331|2482825|P1|Overall Study|Death|2
780923|NCT00630396|2482870|P1|Overall Study|Lost to Follow-up|3
780924|NCT00630396|2482870|P1|Overall Study|Death|4
780925|NCT00630539|2482922|P4|Overall Study|Withdrawal by Subject|1
780926|NCT00630539|2482923|P3|Overall Study|Withdrawal by Subject|0
780927|NCT00630539|2482924|P2|Overall Study|Withdrawal by Subject|1
780928|NCT00630539|2482925|P1|Overall Study|Withdrawal by Subject|0
780929|NCT00630539|2482922|P4|Overall Study|Adverse Event|2
780930|NCT00630539|2482923|P3|Overall Study|Adverse Event|1
780931|NCT00630539|2482924|P2|Overall Study|Adverse Event|3
780932|NCT00630539|2482925|P1|Overall Study|Adverse Event|1
780933|NCT00630747|2483019|P1|Overall Study|Returned to country of origin|1
780934|NCT00630747|2483019|P1|Overall Study|Transferred to Study TKT031NPU|7
780935|NCT00630747|2483019|P1|Overall Study|Death|1
780936|NCT00630786|2483031|P3|Overall Study|Not specified|0
780937|NCT00630786|2483032|P2|Overall Study|Not specified|0
780938|NCT00630786|2483033|P1|Overall Study|Not specified|1
780939|NCT00630786|2483031|P3|Overall Study|Lost to Follow-up|0
780940|NCT00630786|2483032|P2|Overall Study|Lost to Follow-up|1
780941|NCT00630786|2483033|P1|Overall Study|Lost to Follow-up|0
780942|NCT00630786|2483031|P3|Overall Study|Withdrawal by Subject|1
780943|NCT00630786|2483032|P2|Overall Study|Withdrawal by Subject|1
780944|NCT00630786|2483033|P1|Overall Study|Withdrawal by Subject|0
780945|NCT00630786|2483031|P3|Overall Study|Physician Decision|1
780946|NCT00630786|2483032|P2|Overall Study|Physician Decision|0
780947|NCT00630786|2483033|P1|Overall Study|Physician Decision|0
780948|NCT00630825|2483056|P4|Overall Study|Withdrawal by Subject|3
780949|NCT00630825|2483057|P3|Overall Study|Withdrawal by Subject|2
780950|NCT00630825|2483058|P2|Overall Study|Withdrawal by Subject|2
780951|NCT00630825|2483059|P1|Overall Study|Withdrawal by Subject|2
780952|NCT00630825|2483056|P4|Overall Study|Physician Decision|0
780953|NCT00630825|2483057|P3|Overall Study|Physician Decision|0
780954|NCT00630825|2483058|P2|Overall Study|Physician Decision|0
780955|NCT00630825|2483059|P1|Overall Study|Physician Decision|1
780956|NCT00630825|2483056|P4|Overall Study|Lost to Follow-up|1
780957|NCT00630825|2483057|P3|Overall Study|Lost to Follow-up|1
780958|NCT00630825|2483058|P2|Overall Study|Lost to Follow-up|1
780959|NCT00630825|2483059|P1|Overall Study|Lost to Follow-up|1
780960|NCT00630825|2483056|P4|Overall Study|Entry Criteria Not Met|1
780961|NCT00630825|2483057|P3|Overall Study|Entry Criteria Not Met|2
780962|NCT00630825|2483058|P2|Overall Study|Entry Criteria Not Met|0
780963|NCT00630825|2483059|P1|Overall Study|Entry Criteria Not Met|1
780964|NCT00630825|2483056|P4|Overall Study|Adverse Event|1
780965|NCT00630825|2483057|P3|Overall Study|Adverse Event|3
780966|NCT00630825|2483058|P2|Overall Study|Adverse Event|4
780967|NCT00630825|2483059|P1|Overall Study|Adverse Event|4
780968|NCT00630838|2483130|P2|Overall Study|Lost to Follow-up|1
780969|NCT00630838|2483131|P1|Overall Study|Lost to Follow-up|0
780970|NCT00630838|2483130|P2|Overall Study|Death|1
780971|NCT00630838|2483131|P1|Overall Study|Death|0
780972|NCT00630864|2483139|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
780973|NCT00630864|2483139|P1|Part 1 (up to Week 6)|Adverse Event|1
780974|NCT00630877|2483179|P3|Overall Study|Personal reasons|1
780975|NCT00630877|2483180|P2|Overall Study|Personal reasons|0
780976|NCT00630877|2483181|P1|Overall Study|Personal reasons|0
780977|NCT00630877|2483179|P3|Overall Study|Protocol violation|1
780978|NCT00630877|2483180|P2|Overall Study|Protocol violation|0
780979|NCT00630877|2483181|P1|Overall Study|Protocol violation|1
780980|NCT00630877|2483179|P3|Overall Study|Noncompliance|1
780981|NCT00630877|2483180|P2|Overall Study|Noncompliance|3
780982|NCT00630877|2483181|P1|Overall Study|Noncompliance|2
780983|NCT00630877|2483179|P3|Overall Study|Lost to Follow-up|0
780984|NCT00630877|2483180|P2|Overall Study|Lost to Follow-up|0
780985|NCT00630877|2483181|P1|Overall Study|Lost to Follow-up|2
780986|NCT00630877|2483179|P3|Overall Study|Withdrawal by Subject|0
780987|NCT00630877|2483180|P2|Overall Study|Withdrawal by Subject|4
780988|NCT00630877|2483181|P1|Overall Study|Withdrawal by Subject|3
780989|NCT00630877|2483179|P3|Overall Study|Adverse Event|7
780990|NCT00630877|2483180|P2|Overall Study|Adverse Event|8
780991|NCT00630877|2483181|P1|Overall Study|Adverse Event|11
780992|NCT00630916|2483199|P1|Overall Study|Lack of Efficacy|3
780993|NCT00630916|2483199|P1|Overall Study|Physician Decision|47
780994|NCT00630916|2483199|P1|Overall Study|Protocol Violation|7
780995|NCT00630916|2483199|P1|Overall Study|Withdrawal by Subject|30
780996|NCT00630916|2483199|P1|Overall Study|Lost to Follow-up|5
780997|NCT00630916|2483199|P1|Overall Study|Explant|8
780998|NCT00630916|2483199|P1|Overall Study|Death|110
780999|NCT00630994|2483222|P1|Overall Study|Other|1
781000|NCT00630994|2483222|P1|Overall Study|Lack of Efficacy|1
781001|NCT00630994|2483222|P1|Overall Study|Disease Progression|1
781002|NCT00630994|2483222|P1|Overall Study|Adverse Event|1
781003|NCT00631007|2483236|P6|Overall Study|Other|0
781004|NCT00631007|2483237|P5|Overall Study|Other|1
781005|NCT00631007|2483238|P4|Overall Study|Other|0
781006|NCT00631007|2483239|P3|Overall Study|Other|0
781007|NCT00631007|2483240|P2|Overall Study|Other|1
781008|NCT00631007|2483241|P1|Overall Study|Other|2
781009|NCT00631007|2483236|P6|Overall Study|Withdrawal by Subject|3
781010|NCT00631007|2483237|P5|Overall Study|Withdrawal by Subject|1
781011|NCT00631007|2483238|P4|Overall Study|Withdrawal by Subject|2
781012|NCT00631007|2483239|P3|Overall Study|Withdrawal by Subject|2
781013|NCT00631007|2483240|P2|Overall Study|Withdrawal by Subject|5
781014|NCT00631007|2483241|P1|Overall Study|Withdrawal by Subject|4
781015|NCT00631007|2483236|P6|Overall Study|Persistent Hyperglycemia|5
781016|NCT00631007|2483237|P5|Overall Study|Persistent Hyperglycemia|2
781017|NCT00631007|2483238|P4|Overall Study|Persistent Hyperglycemia|1
781018|NCT00631007|2483239|P3|Overall Study|Persistent Hyperglycemia|5
781019|NCT00631007|2483240|P2|Overall Study|Persistent Hyperglycemia|2
781020|NCT00631007|2483241|P1|Overall Study|Persistent Hyperglycemia|2
781021|NCT00631007|2483236|P6|Overall Study|Physician Decision|2
781022|NCT00631007|2483237|P5|Overall Study|Physician Decision|0
781023|NCT00631007|2483238|P4|Overall Study|Physician Decision|0
781024|NCT00631007|2483239|P3|Overall Study|Physician Decision|1
781025|NCT00631007|2483240|P2|Overall Study|Physician Decision|0
781026|NCT00631007|2483241|P1|Overall Study|Physician Decision|1
781027|NCT00631007|2483236|P6|Overall Study|Lost to Follow-up|3
781028|NCT00631007|2483237|P5|Overall Study|Lost to Follow-up|5
781029|NCT00631007|2483238|P4|Overall Study|Lost to Follow-up|4
781030|NCT00631007|2483239|P3|Overall Study|Lost to Follow-up|2
781031|NCT00631007|2483240|P2|Overall Study|Lost to Follow-up|1
781032|NCT00631007|2483241|P1|Overall Study|Lost to Follow-up|2
781033|NCT00631007|2483236|P6|Overall Study|Adverse Event|2
781034|NCT00631007|2483237|P5|Overall Study|Adverse Event|3
781035|NCT00631007|2483238|P4|Overall Study|Adverse Event|2
781036|NCT00631007|2483239|P3|Overall Study|Adverse Event|0
781037|NCT00631007|2483240|P2|Overall Study|Adverse Event|2
781038|NCT00631007|2483241|P1|Overall Study|Adverse Event|0
781039|NCT00631020|2483261|P1|Overall Study|Incarcerated|1
781040|NCT00631020|2483261|P1|Overall Study|Lost to Follow-up|7
781041|NCT00631189|2483274|P4|Treatment Phase|patient did not take pravastatin|0
781042|NCT00631189|2483275|P3|Treatment Phase|patient did not take pravastatin|1
781043|NCT00631189|2483276|P2|Treatment Phase|patient did not take pravastatin|0
781044|NCT00631189|2483277|P1|Treatment Phase|patient did not take pravastatin|0
781045|NCT00631189|2483274|P4|Treatment Phase|Pregnancy|0
781046|NCT00631189|2483275|P3|Treatment Phase|Pregnancy|1
781047|NCT00631189|2483276|P2|Treatment Phase|Pregnancy|0
781048|NCT00631189|2483277|P1|Treatment Phase|Pregnancy|0
781049|NCT00631189|2483274|P4|Treatment Phase|Lost to Follow-up|0
781050|NCT00631189|2483275|P3|Treatment Phase|Lost to Follow-up|0
781051|NCT00631189|2483276|P2|Treatment Phase|Lost to Follow-up|1
781052|NCT00631189|2483277|P1|Treatment Phase|Lost to Follow-up|0
781053|NCT00631189|2483274|P4|Treatment Phase|Adverse Event|4
781054|NCT00631189|2483275|P3|Treatment Phase|Adverse Event|2
781055|NCT00631189|2483276|P2|Treatment Phase|Adverse Event|3
781056|NCT00631189|2483277|P1|Treatment Phase|Adverse Event|0
781057|NCT00631189|2483274|P4|Treatment Phase|Protocol Violation|2
781058|NCT00631189|2483275|P3|Treatment Phase|Protocol Violation|6
781059|NCT00631189|2483276|P2|Treatment Phase|Protocol Violation|1
781060|NCT00631189|2483277|P1|Treatment Phase|Protocol Violation|0
781061|NCT00631189|2483274|P4|Treatment Phase|Withdrawal by Subject|1
781062|NCT00631189|2483275|P3|Treatment Phase|Withdrawal by Subject|1
781063|NCT00631189|2483276|P2|Treatment Phase|Withdrawal by Subject|2
781064|NCT00631189|2483277|P1|Treatment Phase|Withdrawal by Subject|0
781065|NCT00631189|2483274|P4|Initial Phase|Withdrawal by Subject|0
781066|NCT00631189|2483275|P3|Initial Phase|Withdrawal by Subject|0
781067|NCT00631189|2483276|P2|Initial Phase|Withdrawal by Subject|0
781068|NCT00631189|2483277|P1|Initial Phase|Withdrawal by Subject|4
781069|NCT00631189|2483274|P4|Initial Phase|Protocol Violation|0
781070|NCT00631189|2483275|P3|Initial Phase|Protocol Violation|0
781071|NCT00631189|2483276|P2|Initial Phase|Protocol Violation|0
781072|NCT00631189|2483277|P1|Initial Phase|Protocol Violation|347
781073|NCT00631371|2483338|P2|Overall Study|Death|239
781074|NCT00631371|2483339|P1|Overall Study|Death|263
781075|NCT00631371|2483338|P2|Overall Study|Discontinuation of study by Sponsor|76
781076|NCT00631371|2483339|P1|Overall Study|Discontinuation of study by Sponsor|70
781077|NCT00631371|2483338|P2|Overall Study|subject request|45
781078|NCT00631371|2483339|P1|Overall Study|subject request|38
781079|NCT00631371|2483338|P2|Overall Study|Other reason|12
781080|NCT00631371|2483339|P1|Overall Study|Other reason|5
781081|NCT00631371|2483338|P2|Overall Study|Lost to Follow-up|19
781082|NCT00631371|2483339|P1|Overall Study|Lost to Follow-up|24
781083|NCT00631410|2483353|P2|Overall Study|Surgery|0
781084|NCT00631410|2483354|P1|Overall Study|Surgery|1
781085|NCT00631410|2483353|P2|Overall Study|Objective Progression or Relapse|3
781086|NCT00631410|2483354|P1|Overall Study|Objective Progression or Relapse|4
781087|NCT00631410|2483353|P2|Overall Study|Adverse Event|3
781088|NCT00631410|2483354|P1|Overall Study|Adverse Event|1
781089|NCT00631475|2483380|P1|Overall Study|Preparation for lung transplant|8
781090|NCT00631475|2483380|P1|Overall Study|Withdrew consent|5
781091|NCT00631475|2483380|P1|Overall Study|Adverse Event|14
781092|NCT00631475|2483380|P1|Overall Study|Death|18
781093|NCT00631488|2483391|P3|Overall Study|Protocol Violation|1
781094|NCT00631488|2483392|P2|Overall Study|Protocol Violation|0
781095|NCT00631488|2483393|P1|Overall Study|Protocol Violation|0
781096|NCT00631488|2483391|P3|Overall Study|Physician Decision|1
781097|NCT00631488|2483392|P2|Overall Study|Physician Decision|0
781098|NCT00631488|2483393|P1|Overall Study|Physician Decision|1
781099|NCT00631488|2483391|P3|Overall Study|Lost to Follow-up|0
781100|NCT00631488|2483392|P2|Overall Study|Lost to Follow-up|2
781101|NCT00631488|2483393|P1|Overall Study|Lost to Follow-up|2
781102|NCT00631488|2483391|P3|Overall Study|Adverse Event|0
781103|NCT00631488|2483392|P2|Overall Study|Adverse Event|0
781104|NCT00631488|2483393|P1|Overall Study|Adverse Event|1
781105|NCT00631540|2483413|P1|Overall Study|Core Lab Data Unavailable|3
781106|NCT00631540|2483413|P1|Overall Study|Lost to Follow-up|2
781107|NCT00631540|2483413|P1|Overall Study|Death|4
781108|NCT00631540|2483413|P1|Overall Study|Withdrawal by Subject|5
781109|NCT00631657|2483424|P3|7-Day Discontinuation Period|Unspecified|0
781110|NCT00631657|2483425|P2|7-Day Discontinuation Period|Unspecified|0
781111|NCT00631657|2483426|P1|7-Day Discontinuation Period|Unspecified|1
781112|NCT00631657|2483424|P3|7-Day Discontinuation Period|Not Treated|1
781113|NCT00631657|2483425|P2|7-Day Discontinuation Period|Not Treated|1
781114|NCT00631657|2483426|P1|7-Day Discontinuation Period|Not Treated|1
781115|NCT00631657|2483424|P3|6-Month Treatment Period|Not Treated|1
781116|NCT00631657|2483425|P2|6-Month Treatment Period|Not Treated|0
781117|NCT00631657|2483426|P1|6-Month Treatment Period|Not Treated|2
781118|NCT00631657|2483424|P3|6-Month Treatment Period|Unspecified|4
781119|NCT00631657|2483425|P2|6-Month Treatment Period|Unspecified|0
781120|NCT00631657|2483426|P1|6-Month Treatment Period|Unspecified|16
781121|NCT00631657|2483424|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
781122|NCT00631657|2483425|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
781123|NCT00631657|2483426|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
781124|NCT00631657|2483424|P3|6-Month Treatment Period|Lost to Follow-up|2
781125|NCT00631657|2483425|P2|6-Month Treatment Period|Lost to Follow-up|0
781126|NCT00631657|2483426|P1|6-Month Treatment Period|Lost to Follow-up|7
781127|NCT00631657|2483424|P3|6-Month Treatment Period|Lack of Efficacy|25
781128|NCT00631657|2483425|P2|6-Month Treatment Period|Lack of Efficacy|0
781129|NCT00631657|2483426|P1|6-Month Treatment Period|Lack of Efficacy|34
781130|NCT00631657|2483424|P3|6-Month Treatment Period|Withdrawal by Subject|5
781131|NCT00631657|2483425|P2|6-Month Treatment Period|Withdrawal by Subject|0
781132|NCT00631657|2483426|P1|6-Month Treatment Period|Withdrawal by Subject|14
781133|NCT00631657|2483424|P3|6-Month Treatment Period|Adverse Event|7
781134|NCT00631657|2483425|P2|6-Month Treatment Period|Adverse Event|0
781135|NCT00631657|2483426|P1|6-Month Treatment Period|Adverse Event|47
781136|NCT00631696|2483472|P2|Overall Study|Adverse Event|0
781137|NCT00631696|2483473|P1|Overall Study|Adverse Event|5
781138|NCT00631696|2483472|P2|Overall Study|Study terminated by sponsor|3
781139|NCT00631696|2483473|P1|Overall Study|Study terminated by sponsor|3
781140|NCT00631696|2483472|P2|Overall Study|Protocol Violation|9
781141|NCT00631696|2483473|P1|Overall Study|Protocol Violation|9
781142|NCT00631696|2483472|P2|Overall Study|Unspecified|8
781143|NCT00631696|2483473|P1|Overall Study|Unspecified|8
781144|NCT00631696|2483472|P2|Overall Study|Withdrawal by Subject|9
781145|NCT00631696|2483473|P1|Overall Study|Withdrawal by Subject|2
781146|NCT00631696|2483472|P2|Overall Study|Lost to Follow-up|10
781147|NCT00631696|2483473|P1|Overall Study|Lost to Follow-up|7
781148|NCT00631696|2483472|P2|Overall Study|Follow up after database release date|0
781149|NCT00631696|2483473|P1|Overall Study|Follow up after database release date|1
781150|NCT00631696|2483472|P2|Overall Study|Discontinued after database release date|0
781151|NCT00631696|2483473|P1|Overall Study|Discontinued after database release date|1
781152|NCT00631696|2483472|P2|Overall Study|Entered, not randomized to treatment|1
781153|NCT00631696|2483473|P1|Overall Study|Entered, not randomized to treatment|1
781154|NCT00631917|2483510|P2|Overall Study|Death|0
781155|NCT00631917|2483511|P1|Overall Study|Death|1
781156|NCT00631917|2483510|P2|Overall Study|Administrative problems|0
781157|NCT00631917|2483511|P1|Overall Study|Administrative problems|2
781158|NCT00631917|2483510|P2|Overall Study|Lost to Follow-up|7
781159|NCT00631917|2483511|P1|Overall Study|Lost to Follow-up|7
781160|NCT00631917|2483510|P2|Overall Study|Subject withdrew consent|33
781161|NCT00631917|2483511|P1|Overall Study|Subject withdrew consent|25
781162|NCT00631917|2483510|P2|Overall Study|Protocol deviation|5
781163|NCT00631917|2483511|P1|Overall Study|Protocol deviation|6
781164|NCT00631917|2483510|P2|Overall Study|No longer required study drug|1
781165|NCT00631917|2483511|P1|Overall Study|No longer required study drug|0
781166|NCT00631917|2483510|P2|Overall Study|Unsatisfactory therapeutic effect|14
781167|NCT00631917|2483511|P1|Overall Study|Unsatisfactory therapeutic effect|8
781168|NCT00631917|2483510|P2|Overall Study|Abnormal test procedure result(s)|2
781169|NCT00631917|2483511|P1|Overall Study|Abnormal test procedure result(s)|3
781170|NCT00631917|2483510|P2|Overall Study|Abnormal laboratory value(s)|1
781171|NCT00631917|2483511|P1|Overall Study|Abnormal laboratory value(s)|2
781172|NCT00631917|2483510|P2|Overall Study|Adverse Event|45
781173|NCT00631917|2483511|P1|Overall Study|Adverse Event|34
781174|NCT00631969|2483527|P2|Overall Study|No Drug Exposure|2
781175|NCT00631969|2483528|P1|Overall Study|No Drug Exposure|2
781176|NCT00631969|2483527|P2|Overall Study|Noncompliant With Study Medication|1
781177|NCT00631969|2483528|P1|Overall Study|Noncompliant With Study Medication|0
781178|NCT00631969|2483527|P2|Overall Study|Consent Withdrawn|7
781179|NCT00631969|2483528|P1|Overall Study|Consent Withdrawn|5
781180|NCT00631969|2483527|P2|Overall Study|Protocol Violation|1
781181|NCT00631969|2483528|P1|Overall Study|Protocol Violation|1
781182|NCT00631969|2483527|P2|Overall Study|Lost to Follow-up|1
781183|NCT00631969|2483528|P1|Overall Study|Lost to Follow-up|2
781184|NCT00631969|2483527|P2|Overall Study|Lack of Efficacy|8
781185|NCT00631969|2483528|P1|Overall Study|Lack of Efficacy|2
781186|NCT00631969|2483527|P2|Overall Study|Adverse Event|1
781187|NCT00631969|2483528|P1|Overall Study|Adverse Event|3
781188|NCT00632021|2483574|P2|Overall Study|Withdrawal/death|7
781189|NCT00632021|2483575|P1|Overall Study|Withdrawal/death|4
781190|NCT00632099|2483585|P2|Overall Study|Lost to Follow-up|3
781191|NCT00632099|2483586|P1|Overall Study|Lost to Follow-up|3
781192|NCT00632125|2483592|P1|Overall Study|Moved to other dialysis unit, etc.|102
781193|NCT00632125|2483592|P1|Overall Study|Development of uncontrolled hypertension|5
781194|NCT00632125|2483592|P1|Overall Study|Non-compliance|8
781195|NCT00632125|2483592|P1|Overall Study|Need for systemic immunosuppressive medi|8
781196|NCT00632125|2483592|P1|Overall Study|Renal transplantation|17
781197|NCT00632125|2483592|P1|Overall Study|Adverse Event|36
781198|NCT00632125|2483592|P1|Overall Study|Withdrawal by Subject|44
781199|NCT00632125|2483592|P1|Overall Study|Death|82
781200|NCT00632203|2483598|P2|Overall Study|Did not start study treatment|0
781201|NCT00632203|2483599|P1|Overall Study|Did not start study treatment|1
781202|NCT00632229|2483619|P2|Overall Study|Undisclosed reasons within the first wee|1
781203|NCT00632229|2483620|P1|Overall Study|Undisclosed reasons within the first wee|0
781204|NCT00632229|2483619|P2|Overall Study|Lack of Efficacy|2
781205|NCT00632229|2483620|P1|Overall Study|Lack of Efficacy|0
781206|NCT00632229|2483619|P2|Overall Study|Lost to Follow-up|3
781207|NCT00632229|2483620|P1|Overall Study|Lost to Follow-up|0
781208|NCT00632229|2483619|P2|Overall Study|Adverse Event|0
781209|NCT00632229|2483620|P1|Overall Study|Adverse Event|6
781210|NCT00638183|2483633|P1|Overall Study|Other reason not defined above|27
781211|NCT00638183|2483633|P1|Overall Study|Lost to Follow-up|46
781212|NCT00638183|2483633|P1|Overall Study|Physician Decision|9
781213|NCT00638183|2483633|P1|Overall Study|Lack of Efficacy|14
781214|NCT00638183|2483633|P1|Overall Study|Adverse Event|23
781215|NCT00638235|2483661|P9|Overall Study|Lost to Follow-up|18
781216|NCT00638235|2483662|P8|Overall Study|Lost to Follow-up|1
781217|NCT00638235|2483663|P7|Overall Study|Lost to Follow-up|0
781218|NCT00638235|2483664|P6|Overall Study|Lost to Follow-up|26
781219|NCT00638235|2483665|P5|Overall Study|Lost to Follow-up|13
781220|NCT00638235|2483666|P4|Overall Study|Lost to Follow-up|10
781221|NCT00638235|2483667|P3|Overall Study|Lost to Follow-up|18
781222|NCT00638235|2483668|P2|Overall Study|Lost to Follow-up|3
781223|NCT00638235|2483669|P1|Overall Study|Lost to Follow-up|31
781224|NCT00638378|2484080|P1|Overall Study|Physician Decision|4
781225|NCT00638378|2484080|P1|Overall Study|Disease progression|15
781226|NCT00638378|2484080|P1|Overall Study|Adverse Event|1
781227|NCT00638378|2484080|P1|Overall Study|Death|2
781228|NCT00638443|2484087|P2|First Intervention|Adverse Event|1
781229|NCT00638443|2484088|P1|First Intervention|Adverse Event|2
781230|NCT00638963|2484133|P2|Overall Study|Withdrawal by Subject|0
781231|NCT00638963|2484134|P1|Overall Study|Withdrawal by Subject|1
781232|NCT00638989|2484156|P3|Overall Study|Lost to Follow-up|1
781233|NCT00638989|2484157|P2|Overall Study|Lost to Follow-up|0
781234|NCT00638989|2484158|P1|Overall Study|Lost to Follow-up|0
781235|NCT00639002|2484196|P1|Overall Study|Lack of Efficacy|1
781236|NCT00639002|2484196|P1|Overall Study|Physician Decision|6
781237|NCT00639002|2484196|P1|Overall Study|Disease progression|3
781238|NCT00639002|2484196|P1|Overall Study|Protocol Violation|1
781239|NCT00639002|2484196|P1|Overall Study|Adverse Event|1
781240|NCT00639002|2484196|P1|Overall Study|Death|1
781241|NCT00639223|2484236|P2|Overall Study|Lost to Follow-up|2
781242|NCT00639223|2484237|P1|Overall Study|Lost to Follow-up|0
781243|NCT00639379|2484245|P2|Period 1 - 2 Weeks|lens issue|0
781244|NCT00639379|2484246|P1|Period 1 - 2 Weeks|lens issue|3
781245|NCT00639379|2484245|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
781246|NCT00639379|2484246|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
781247|NCT00639457|2484287|P2|Overall Study|Withdrawal by Subject|3
781248|NCT00639457|2484288|P1|Overall Study|Withdrawal by Subject|2
781249|NCT00639509|2484322|P1|Overall Study|Death|1
781250|NCT00639678|2484332|P4|Overall Study|Lack of Compliance|0
781251|NCT00639678|2484333|P3|Overall Study|Lack of Compliance|1
781252|NCT00639678|2484334|P2|Overall Study|Lack of Compliance|0
781253|NCT00639678|2484335|P1|Overall Study|Lack of Compliance|0
781254|NCT00639678|2484332|P4|Overall Study|Adverse Event|0
781255|NCT00639678|2484333|P3|Overall Study|Adverse Event|0
781256|NCT00639678|2484334|P2|Overall Study|Adverse Event|1
781257|NCT00639678|2484335|P1|Overall Study|Adverse Event|0
781258|NCT00639678|2484332|P4|Overall Study|Lost to Follow-up|0
781259|NCT00639678|2484333|P3|Overall Study|Lost to Follow-up|6
781260|NCT00639678|2484334|P2|Overall Study|Lost to Follow-up|0
781261|NCT00639678|2484335|P1|Overall Study|Lost to Follow-up|1
781262|NCT00639678|2484332|P4|Overall Study|Withdrawal by Subject|0
781263|NCT00639678|2484333|P3|Overall Study|Withdrawal by Subject|4
781264|NCT00639678|2484334|P2|Overall Study|Withdrawal by Subject|0
781265|NCT00639678|2484335|P1|Overall Study|Withdrawal by Subject|3
781266|NCT00639769|2484403|P1|Overall Study|Withdrawal by Subject|4
781267|NCT00639769|2484403|P1|Overall Study|Disease progression|26
781268|NCT00639769|2484403|P1|Overall Study|Lack of Efficacy|1
781269|NCT00639769|2484403|P1|Overall Study|Adverse Event|7
781270|NCT00639769|2484403|P1|Overall Study|Death|2
781271|NCT00640016|2484420|P4|Overall Study|Adverse Event|1
781272|NCT00640016|2484421|P3|Overall Study|Adverse Event|0
781273|NCT00640016|2484422|P2|Overall Study|Adverse Event|0
781274|NCT00640016|2484423|P1|Overall Study|Adverse Event|0
781275|NCT00640016|2484420|P4|Overall Study|Study termination|2
781276|NCT00640016|2484421|P3|Overall Study|Study termination|3
781277|NCT00640016|2484422|P2|Overall Study|Study termination|1
781278|NCT00640016|2484423|P1|Overall Study|Study termination|2
781279|NCT00640016|2484420|P4|Overall Study|Withdrawal by Subject|0
781280|NCT00640016|2484421|P3|Overall Study|Withdrawal by Subject|0
781281|NCT00640016|2484422|P2|Overall Study|Withdrawal by Subject|1
781282|NCT00640016|2484423|P1|Overall Study|Withdrawal by Subject|0
781283|NCT00640042|2484467|P1|Enrollment|Did not receive study drug|83
781284|NCT00640315|2484481|P2|Overall Study|Withdrawal by Subject|1
781285|NCT00640315|2484482|P1|Overall Study|Withdrawal by Subject|0
781286|NCT00640328|2484614|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
781287|NCT00640328|2484615|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
781288|NCT00640328|2484616|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
781289|NCT00640328|2484617|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
781290|NCT00640328|2484618|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
781291|NCT00640328|2484619|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
781292|NCT00640328|2484614|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
781293|NCT00640328|2484615|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
781294|NCT00640328|2484616|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
781295|NCT00640328|2484617|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
781296|NCT00640328|2484618|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
781297|NCT00640328|2484619|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
781298|NCT00640328|2484614|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
781299|NCT00640328|2484615|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
781300|NCT00640328|2484616|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
781301|NCT00640328|2484617|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
781302|NCT00640328|2484618|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
781303|NCT00640328|2484619|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
781304|NCT00640328|2484614|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
781305|NCT00640328|2484615|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
781306|NCT00640328|2484616|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
781307|NCT00640328|2484617|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
781308|NCT00640328|2484618|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
781309|NCT00640328|2484619|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
781310|NCT00640341|2484786|P3|Overall Study|Adverse event and positive slit lamp|0
781311|NCT00640341|2484787|P2|Overall Study|Adverse event and positive slit lamp|0
781312|NCT00640341|2484788|P1|Overall Study|Adverse event and positive slit lamp|1
781313|NCT00640341|2484786|P3|Overall Study|Ineligable at Baseline|2
781314|NCT00640341|2484787|P2|Overall Study|Ineligable at Baseline|3
781315|NCT00640341|2484788|P1|Overall Study|Ineligable at Baseline|5
781316|NCT00640341|2484786|P3|Overall Study|Poor fit/Uncomfortable|0
781317|NCT00640341|2484787|P2|Overall Study|Poor fit/Uncomfortable|0
781318|NCT00640341|2484788|P1|Overall Study|Poor fit/Uncomfortable|4
781319|NCT00640341|2484786|P3|Overall Study|Unacceptable Lens Movement|0
781320|NCT00640341|2484787|P2|Overall Study|Unacceptable Lens Movement|0
781321|NCT00640341|2484788|P1|Overall Study|Unacceptable Lens Movement|1
781322|NCT00640341|2484786|P3|Overall Study|Withdrawal by Subject|1
781323|NCT00640341|2484787|P2|Overall Study|Withdrawal by Subject|0
781324|NCT00640341|2484788|P1|Overall Study|Withdrawal by Subject|4
781325|NCT00640341|2484786|P3|Overall Study|Lost to Follow-up|0
781326|NCT00640341|2484787|P2|Overall Study|Lost to Follow-up|0
781327|NCT00640341|2484788|P1|Overall Study|Lost to Follow-up|2
781328|NCT00640341|2484786|P3|Overall Study|Failure to Follow Subject Instructions|0
781329|NCT00640341|2484787|P2|Overall Study|Failure to Follow Subject Instructions|0
781330|NCT00640341|2484788|P1|Overall Study|Failure to Follow Subject Instructions|1
781331|NCT00640341|2484786|P3|Overall Study|Inability to Maintain Wearing Schedule|0
781332|NCT00640341|2484787|P2|Overall Study|Inability to Maintain Wearing Schedule|1
781333|NCT00640341|2484788|P1|Overall Study|Inability to Maintain Wearing Schedule|1
781334|NCT00640341|2484786|P3|Overall Study|Study Related Symptoms/Complaints|2
781335|NCT00640341|2484787|P2|Overall Study|Study Related Symptoms/Complaints|1
781336|NCT00640341|2484788|P1|Overall Study|Study Related Symptoms/Complaints|2
781337|NCT00640341|2484786|P3|Overall Study|Positive Slit Lamp Findings|1
781338|NCT00640341|2484787|P2|Overall Study|Positive Slit Lamp Findings|0
781339|NCT00640341|2484788|P1|Overall Study|Positive Slit Lamp Findings|0
781340|NCT00640341|2484786|P3|Overall Study|Adverse Event|1
781341|NCT00640341|2484787|P2|Overall Study|Adverse Event|0
781342|NCT00640341|2484788|P1|Overall Study|Adverse Event|0
781343|NCT00640393|2484802|P3|Part 2|Adverse Event|0
781344|NCT00640393|2484803|P2|Part 2|Adverse Event|1
781345|NCT00640393|2484804|P1|Part 2|Adverse Event|0
781346|NCT00640393|2484802|P3|Part 2|Non-adherence|0
781347|NCT00640393|2484803|P2|Part 2|Non-adherence|1
781348|NCT00640393|2484804|P1|Part 2|Non-adherence|0
781349|NCT00640393|2484802|P3|Part 2|Withdrawal by Subject|1
781350|NCT00640393|2484803|P2|Part 2|Withdrawal by Subject|6
781351|NCT00640393|2484804|P1|Part 2|Withdrawal by Subject|0
781352|NCT00640393|2484802|P3|Part 2|Lost to Follow-up|2
781353|NCT00640393|2484803|P2|Part 2|Lost to Follow-up|2
781354|NCT00640393|2484804|P1|Part 2|Lost to Follow-up|0
781355|NCT00640393|2484802|P3|Randomization|Never randomized by site|0
781356|NCT00640393|2484803|P2|Randomization|Never randomized by site|0
781357|NCT00640393|2484804|P1|Randomization|Never randomized by site|2
781358|NCT00640393|2484802|P3|Randomization|Withdrawn per protocol|0
781359|NCT00640393|2484803|P2|Randomization|Withdrawn per protocol|0
781360|NCT00640393|2484804|P1|Randomization|Withdrawn per protocol|17
781361|NCT00640393|2484802|P3|Part 1|Withdrawal by Subject|0
781362|NCT00640393|2484803|P2|Part 1|Withdrawal by Subject|0
781363|NCT00640393|2484804|P1|Part 1|Withdrawal by Subject|3
781364|NCT00640393|2484802|P3|Part 1|Lost to Follow-up|0
781365|NCT00640393|2484803|P2|Part 1|Lost to Follow-up|0
781366|NCT00640393|2484804|P1|Part 1|Lost to Follow-up|2
781367|NCT00640510|2484868|P2|Overall Study|Physician Decision|1
781368|NCT00640510|2484869|P1|Overall Study|Physician Decision|0
781369|NCT00640510|2484868|P2|Overall Study|Protocol Violation|0
781370|NCT00640510|2484869|P1|Overall Study|Protocol Violation|1
781371|NCT00640510|2484868|P2|Overall Study|Lack of Efficacy|1
781372|NCT00640510|2484869|P1|Overall Study|Lack of Efficacy|0
781373|NCT00640562|2484883|P2|Overall Study|Glycosylated Hemoglobin >8|0
781374|NCT00640562|2484884|P1|Overall Study|Glycosylated Hemoglobin >8|1
781375|NCT00640562|2484883|P2|Overall Study|Low study drug dose|1
781376|NCT00640562|2484884|P1|Overall Study|Low study drug dose|0
781377|NCT00640562|2484883|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
781378|NCT00640562|2484884|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
781379|NCT00640562|2484883|P2|Overall Study|Known risperidone intolerance|1
781380|NCT00640562|2484884|P1|Overall Study|Known risperidone intolerance|0
781381|NCT00640562|2484883|P2|Overall Study|Withdrawal by Subject|10
781382|NCT00640562|2484884|P1|Overall Study|Withdrawal by Subject|6
781383|NCT00640562|2484883|P2|Overall Study|Protocol Violation|4
781384|NCT00640562|2484884|P1|Overall Study|Protocol Violation|2
781385|NCT00640562|2484883|P2|Overall Study|Lack of Efficacy|4
781386|NCT00640562|2484884|P1|Overall Study|Lack of Efficacy|1
781387|NCT00640562|2484883|P2|Overall Study|Adverse Event|5
781388|NCT00640562|2484884|P1|Overall Study|Adverse Event|8
781389|NCT00640601|2484910|P1|Overall Study|treatment naive, combination therapy|10
781390|NCT00640601|2484910|P1|Overall Study|Physician Decision|8
781391|NCT00640601|2484910|P1|Overall Study|Lost to Follow-up|9
781392|NCT00640601|2484910|P1|Overall Study|Lack of Efficacy|16
781393|NCT00640601|2484910|P1|Overall Study|Protocol Violation|6
781394|NCT00640601|2484910|P1|Overall Study|Withdrawal by Subject|20
781395|NCT00640601|2484910|P1|Overall Study|Adverse Event|43
781396|NCT00640614|2484926|P2|Overall Study|Lost to Follow-up|0
781397|NCT00640614|2484927|P1|Overall Study|Lost to Follow-up|1
781398|NCT00640835|2484984|P2|Overall Study|Other Reason|4
781399|NCT00640835|2484985|P1|Overall Study|Other Reason|19
781400|NCT00640835|2484984|P2|Overall Study|Lost to Follow-up|13
781401|NCT00640835|2484985|P1|Overall Study|Lost to Follow-up|17
781402|NCT00640835|2484984|P2|Overall Study|Protocol Violation|2
781403|NCT00640835|2484985|P1|Overall Study|Protocol Violation|2
781404|NCT00640835|2484984|P2|Overall Study|Sponsor's Decision|7
781405|NCT00640835|2484985|P1|Overall Study|Sponsor's Decision|11
781406|NCT00640835|2484984|P2|Overall Study|Physician Decision|14
781407|NCT00640835|2484985|P1|Overall Study|Physician Decision|10
781408|NCT00640835|2484984|P2|Overall Study|Withdrawal by Subject|14
781409|NCT00640835|2484985|P1|Overall Study|Withdrawal by Subject|12
781410|NCT00640835|2484984|P2|Overall Study|Adverse Event|3
781411|NCT00640835|2484985|P1|Overall Study|Adverse Event|5
781412|NCT00640926|2484996|P3|Overall Study|Withdrawal by Subject|1
781413|NCT00640926|2484997|P2|Overall Study|Withdrawal by Subject|0
781414|NCT00640926|2484998|P1|Overall Study|Withdrawal by Subject|1
781415|NCT00640926|2484996|P3|Overall Study|Lost to Follow-up|2
781416|NCT00640926|2484997|P2|Overall Study|Lost to Follow-up|1
781417|NCT00640926|2484998|P1|Overall Study|Lost to Follow-up|3
781418|NCT00640926|2484996|P3|Overall Study|Protocol Violation|2
781419|NCT00640926|2484997|P2|Overall Study|Protocol Violation|0
781420|NCT00640926|2484998|P1|Overall Study|Protocol Violation|2
781421|NCT00640926|2484996|P3|Overall Study|Lack of Efficacy|1
781422|NCT00640926|2484997|P2|Overall Study|Lack of Efficacy|2
781423|NCT00640926|2484998|P1|Overall Study|Lack of Efficacy|0
781424|NCT00640926|2484996|P3|Overall Study|Adverse Event|2
781425|NCT00640926|2484997|P2|Overall Study|Adverse Event|3
781426|NCT00640926|2484998|P1|Overall Study|Adverse Event|2
781427|NCT00641043|2485015|P2|Overall Study|Other incl. lack of efficacy|2
781428|NCT00641043|2485016|P1|Overall Study|Other incl. lack of efficacy|4
781429|NCT00641043|2485015|P2|Overall Study|Withdrawal by Subject|4
781430|NCT00641043|2485016|P1|Overall Study|Withdrawal by Subject|4
781431|NCT00641043|2485015|P2|Overall Study|Lost to Follow-up|2
781432|NCT00641043|2485016|P1|Overall Study|Lost to Follow-up|3
781433|NCT00641043|2485015|P2|Overall Study|Protocol Violation|3
781434|NCT00641043|2485016|P1|Overall Study|Protocol Violation|2
781435|NCT00641043|2485015|P2|Overall Study|Adverse Event|4
781436|NCT00641043|2485016|P1|Overall Study|Adverse Event|6
781437|NCT00641056|2485048|P2|Overall Study|Sponsor Decision|2
781438|NCT00641056|2485049|P1|Overall Study|Sponsor Decision|1
781439|NCT00641056|2485048|P2|Overall Study|Subject Decision|19
781440|NCT00641056|2485049|P1|Overall Study|Subject Decision|6
781441|NCT00641056|2485048|P2|Overall Study|Entry Criteria Not Met|0
781442|NCT00641056|2485049|P1|Overall Study|Entry Criteria Not Met|3
781443|NCT00641056|2485048|P2|Overall Study|Protocol Violation|0
781444|NCT00641056|2485049|P1|Overall Study|Protocol Violation|2
781445|NCT00641056|2485048|P2|Overall Study|Physician Decision|1
781446|NCT00641056|2485049|P1|Overall Study|Physician Decision|3
781447|NCT00641056|2485048|P2|Overall Study|Lost to Follow-up|1
781448|NCT00641056|2485049|P1|Overall Study|Lost to Follow-up|2
781449|NCT00641056|2485048|P2|Overall Study|Adverse Event|2
781450|NCT00641056|2485049|P1|Overall Study|Adverse Event|12
781451|NCT00641147|2485077|P2|Completed 16 Months.|Lost to Follow-up|0
781452|NCT00641147|2485078|P1|Completed 16 Months.|Lost to Follow-up|1
781453|NCT00641147|2485077|P2|Completed 16 Months.|Physician Decision|0
781454|NCT00641147|2485078|P1|Completed 16 Months.|Physician Decision|1
781455|NCT00641147|2485077|P2|Completed 12 Months.|Withdrawal by Subject|1
781456|NCT00641147|2485078|P1|Completed 12 Months.|Withdrawal by Subject|0
781457|NCT00641147|2485077|P2|Completed 12 Months.|Physician Decision|1
781458|NCT00641147|2485078|P1|Completed 12 Months.|Physician Decision|1
781459|NCT00641147|2485077|P2|Completed 8 Months.|Withdrawal by Subject|1
781460|NCT00641147|2485078|P1|Completed 8 Months.|Withdrawal by Subject|0
781461|NCT00641147|2485077|P2|Completed 8 Months.|non compliance|0
781462|NCT00641147|2485078|P1|Completed 8 Months.|non compliance|1
781463|NCT00641147|2485077|P2|Completed 8 Months.|Physician Decision|1
781464|NCT00641147|2485078|P1|Completed 8 Months.|Physician Decision|2
781465|NCT00641147|2485077|P2|Completed 4 Months.|Adverse Event|0
781466|NCT00641147|2485078|P1|Completed 4 Months.|Adverse Event|1
781467|NCT00641147|2485077|P2|Completed 4 Months.|Physician Decision|0
781468|NCT00641147|2485078|P1|Completed 4 Months.|Physician Decision|1
781469|NCT00635219|2485125|P5|Overall Study|Administrative or Other Reasons|1
781470|NCT00635219|2485126|P4|Overall Study|Administrative or Other Reasons|0
781471|NCT00635219|2485127|P3|Overall Study|Administrative or Other Reasons|1
781472|NCT00635219|2485128|P2|Overall Study|Administrative or Other Reasons|1
781473|NCT00635219|2485129|P1|Overall Study|Administrative or Other Reasons|0
781474|NCT00635219|2485125|P5|Overall Study|Lost to Follow-up|3
781475|NCT00635219|2485126|P4|Overall Study|Lost to Follow-up|0
781476|NCT00635219|2485127|P3|Overall Study|Lost to Follow-up|2
781477|NCT00635219|2485128|P2|Overall Study|Lost to Follow-up|0
781478|NCT00635219|2485129|P1|Overall Study|Lost to Follow-up|0
781479|NCT00635219|2485125|P5|Overall Study|Withdrawal of Consent|8
781480|NCT00635219|2485126|P4|Overall Study|Withdrawal of Consent|11
781481|NCT00635219|2485127|P3|Overall Study|Withdrawal of Consent|8
781482|NCT00635219|2485128|P2|Overall Study|Withdrawal of Consent|6
781483|NCT00635219|2485129|P1|Overall Study|Withdrawal of Consent|8
781484|NCT00635219|2485125|P5|Overall Study|Protocol Violation|4
781485|NCT00635219|2485126|P4|Overall Study|Protocol Violation|2
781486|NCT00635219|2485127|P3|Overall Study|Protocol Violation|3
781487|NCT00635219|2485128|P2|Overall Study|Protocol Violation|2
781488|NCT00635219|2485129|P1|Overall Study|Protocol Violation|0
781489|NCT00635219|2485125|P5|Overall Study|Non-compliance With Study Product|1
781490|NCT00635219|2485126|P4|Overall Study|Non-compliance With Study Product|2
781491|NCT00635219|2485127|P3|Overall Study|Non-compliance With Study Product|0
781492|NCT00635219|2485128|P2|Overall Study|Non-compliance With Study Product|0
781493|NCT00635219|2485129|P1|Overall Study|Non-compliance With Study Product|0
781494|NCT00635219|2485125|P5|Overall Study|Lack of Efficacy|6
781495|NCT00635219|2485126|P4|Overall Study|Lack of Efficacy|4
781496|NCT00635219|2485127|P3|Overall Study|Lack of Efficacy|3
781497|NCT00635219|2485128|P2|Overall Study|Lack of Efficacy|6
781498|NCT00635219|2485129|P1|Overall Study|Lack of Efficacy|5
781499|NCT00635219|2485125|P5|Overall Study|Adverse Event|19
781500|NCT00635219|2485126|P4|Overall Study|Adverse Event|15
781501|NCT00635219|2485127|P3|Overall Study|Adverse Event|18
781502|NCT00635219|2485128|P2|Overall Study|Adverse Event|10
781503|NCT00635219|2485129|P1|Overall Study|Adverse Event|12
781504|NCT00635349|2485219|P2|Overall Study|Adverse Event|9
781505|NCT00635349|2485220|P1|Overall Study|Adverse Event|11
781506|NCT00635349|2485219|P2|Overall Study|Lost to Follow-up|3
781507|NCT00635349|2485220|P1|Overall Study|Lost to Follow-up|4
781508|NCT00635349|2485219|P2|Overall Study|Withdrawal by Subject|8
781509|NCT00635349|2485220|P1|Overall Study|Withdrawal by Subject|3
781510|NCT00635349|2485219|P2|Overall Study|Protocol Violation|22
781511|NCT00635349|2485220|P1|Overall Study|Protocol Violation|18
781512|NCT00635349|2485219|P2|Overall Study|Unspecified|6
781513|NCT00635349|2485220|P1|Overall Study|Unspecified|8
781514|NCT00635427|2485260|P5|Overall Study|Withdrawal Of Consent|2
781515|NCT00635427|2485261|P4|Overall Study|Withdrawal Of Consent|2
781516|NCT00635427|2485262|P3|Overall Study|Withdrawal Of Consent|0
781517|NCT00635427|2485263|P2|Overall Study|Withdrawal Of Consent|0
781518|NCT00635427|2485264|P1|Overall Study|Withdrawal Of Consent|0
781519|NCT00635427|2485260|P5|Overall Study|Termination Of Study By Sponsor|6
781520|NCT00635427|2485261|P4|Overall Study|Termination Of Study By Sponsor|6
781521|NCT00635427|2485262|P3|Overall Study|Termination Of Study By Sponsor|10
781522|NCT00635427|2485263|P2|Overall Study|Termination Of Study By Sponsor|6
781523|NCT00635427|2485264|P1|Overall Study|Termination Of Study By Sponsor|12
781524|NCT00635427|2485260|P5|Overall Study|Death|0
781525|NCT00635427|2485261|P4|Overall Study|Death|1
781526|NCT00635427|2485262|P3|Overall Study|Death|0
781527|NCT00635427|2485263|P2|Overall Study|Death|0
781528|NCT00635427|2485264|P1|Overall Study|Death|0
781529|NCT00635427|2485260|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
781530|NCT00635427|2485261|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
781531|NCT00635427|2485262|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
781532|NCT00635427|2485263|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
781533|NCT00635427|2485264|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
781534|NCT00635492|2485295|P2|Overall Study|Withdrawal by Subject|45
781535|NCT00635492|2485296|P1|Overall Study|Withdrawal by Subject|82
781536|NCT00635492|2485295|P2|Overall Study|Sponsor decision|3
781537|NCT00635492|2485296|P1|Overall Study|Sponsor decision|2
781538|NCT00635492|2485295|P2|Overall Study|Physician Decision|22
781539|NCT00635492|2485296|P1|Overall Study|Physician Decision|32
781540|NCT00635492|2485295|P2|Overall Study|Lost to Follow-up|172
781541|NCT00635492|2485296|P1|Overall Study|Lost to Follow-up|151
781542|NCT00635492|2485295|P2|Overall Study|Death|40
781543|NCT00635492|2485296|P1|Overall Study|Death|12
781544|NCT00635570|2485342|P2|Overall Study|Early termination(No sexual activity)|1
781545|NCT00635570|2485343|P1|Overall Study|Early termination(No sexual activity)|1
781546|NCT00635570|2485342|P2|Overall Study|Did not complete survey|1
781547|NCT00635570|2485343|P1|Overall Study|Did not complete survey|2
781548|NCT00635570|2485342|P2|Overall Study|Physician Decision|0
781549|NCT00635570|2485343|P1|Overall Study|Physician Decision|1
781550|NCT00635570|2485342|P2|Overall Study|Adverse Event|0
781551|NCT00635570|2485343|P1|Overall Study|Adverse Event|2
781552|NCT00635570|2485342|P2|Overall Study|Withdrawal by Subject|1
781553|NCT00635570|2485343|P1|Overall Study|Withdrawal by Subject|1
781554|NCT00635570|2485342|P2|Overall Study|Lost to Follow-up|8
781555|NCT00635570|2485343|P1|Overall Study|Lost to Follow-up|8
781556|NCT00635648|2485368|P1|Overall Study|Other reason|2
781557|NCT00635648|2485368|P1|Overall Study|Noncompliance with protocol|1
781558|NCT00635648|2485368|P1|Overall Study|No improvement after 7-10 days treatment|4
781559|NCT00635648|2485368|P1|Overall Study|Use of other antifungal agent needed|1
781560|NCT00635648|2485368|P1|Overall Study|Rapid progression of baseline disease|4
781561|NCT00635648|2485368|P1|Overall Study|Physician Decision|4
781562|NCT00635648|2485368|P1|Overall Study|Withdrawal by Subject|9
781563|NCT00635648|2485368|P1|Overall Study|Adverse Event|12
781564|NCT00641537|2485380|P8|24-Week Supplemental Follow-up Period|Unspecified|1
781565|NCT00641537|2485381|P7|24-Week Supplemental Follow-up Period|Unspecified|1
781566|NCT00641537|2485382|P6|24-Week Supplemental Follow-up Period|Unspecified|0
781567|NCT00641537|2485383|P5|24-Week Supplemental Follow-up Period|Unspecified|3
781568|NCT00641537|2485384|P4|24-Week Supplemental Follow-up Period|Unspecified|1
781569|NCT00641537|2485385|P3|24-Week Supplemental Follow-up Period|Unspecified|2
781570|NCT00641537|2485386|P2|24-Week Supplemental Follow-up Period|Unspecified|2
781571|NCT00641537|2485387|P1|24-Week Supplemental Follow-up Period|Unspecified|0
781572|NCT00641537|2485380|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
781573|NCT00641537|2485381|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
781574|NCT00641537|2485382|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
781575|NCT00641537|2485383|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
781576|NCT00641537|2485384|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
781577|NCT00641537|2485385|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
781578|NCT00641537|2485386|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
781579|NCT00641537|2485387|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
781580|NCT00641537|2485380|P8|96-week Period|Unspecified|6
781581|NCT00641537|2485381|P7|96-week Period|Unspecified|4
781582|NCT00641537|2485382|P6|96-week Period|Unspecified|6
781583|NCT00641537|2485383|P5|96-week Period|Unspecified|12
781584|NCT00641537|2485384|P4|96-week Period|Unspecified|9
781585|NCT00641537|2485385|P3|96-week Period|Unspecified|14
781586|NCT00641537|2485386|P2|96-week Period|Unspecified|7
781587|NCT00641537|2485387|P1|96-week Period|Unspecified|4
781588|NCT00641537|2485380|P8|96-week Period|Death|0
781589|NCT00641537|2485381|P7|96-week Period|Death|0
781590|NCT00641537|2485382|P6|96-week Period|Death|0
781591|NCT00641537|2485383|P5|96-week Period|Death|0
781592|NCT00641537|2485384|P4|96-week Period|Death|0
781593|NCT00641537|2485385|P3|96-week Period|Death|1
781594|NCT00641537|2485386|P2|96-week Period|Death|0
781595|NCT00641537|2485387|P1|96-week Period|Death|2
781596|NCT00641537|2485380|P8|96-week Period|Protocol Violation|0
781597|NCT00641537|2485381|P7|96-week Period|Protocol Violation|0
781598|NCT00641537|2485382|P6|96-week Period|Protocol Violation|1
781599|NCT00641537|2485383|P5|96-week Period|Protocol Violation|0
781600|NCT00641537|2485384|P4|96-week Period|Protocol Violation|1
781601|NCT00641537|2485385|P3|96-week Period|Protocol Violation|0
781602|NCT00641537|2485386|P2|96-week Period|Protocol Violation|1
781603|NCT00641537|2485387|P1|96-week Period|Protocol Violation|0
781604|NCT00641537|2485380|P8|96-week Period|Lost to Follow-up|0
781605|NCT00641537|2485381|P7|96-week Period|Lost to Follow-up|1
781606|NCT00641537|2485382|P6|96-week Period|Lost to Follow-up|0
781607|NCT00641537|2485383|P5|96-week Period|Lost to Follow-up|4
781608|NCT00641537|2485384|P4|96-week Period|Lost to Follow-up|2
781609|NCT00641537|2485385|P3|96-week Period|Lost to Follow-up|2
781610|NCT00641537|2485386|P2|96-week Period|Lost to Follow-up|1
781611|NCT00641537|2485387|P1|96-week Period|Lost to Follow-up|3
781612|NCT00641537|2485380|P8|96-week Period|Adverse Event|0
781613|NCT00641537|2485381|P7|96-week Period|Adverse Event|0
781614|NCT00641537|2485382|P6|96-week Period|Adverse Event|0
781615|NCT00641537|2485383|P5|96-week Period|Adverse Event|2
781616|NCT00641537|2485384|P4|96-week Period|Adverse Event|0
781617|NCT00641537|2485385|P3|96-week Period|Adverse Event|3
781618|NCT00641537|2485386|P2|96-week Period|Adverse Event|1
781619|NCT00641537|2485387|P1|96-week Period|Adverse Event|0
781620|NCT00641667|2485453|P1|Overall Study|Worsening of underlying disease|3
781621|NCT00641667|2485453|P1|Overall Study|Physician Decision|1
781622|NCT00641667|2485453|P1|Overall Study|Adverse Event|1
781623|NCT00641667|2485453|P1|Overall Study|Withdrawal by Subject|1
781624|NCT00641706|2485465|P2|Overall Study|Lead Investigator Decision|1
781625|NCT00641706|2485466|P1|Overall Study|Lead Investigator Decision|0
781626|NCT00641706|2485465|P2|Overall Study|Clinical Decline|0
781627|NCT00641706|2485466|P1|Overall Study|Clinical Decline|1
781628|NCT00641706|2485465|P2|Overall Study|Withdrawal by Subject|1
781629|NCT00641706|2485466|P1|Overall Study|Withdrawal by Subject|6
781630|NCT00641706|2485465|P2|Overall Study|Adverse Event|1
781631|NCT00641706|2485466|P1|Overall Study|Adverse Event|2
781632|NCT00641719|2485480|P2|Overall Study|Reason Not Specified|2
781633|NCT00641719|2485481|P1|Overall Study|Reason Not Specified|1
781634|NCT00641719|2485480|P2|Overall Study|Withdrawal by Subject|4
781635|NCT00641719|2485481|P1|Overall Study|Withdrawal by Subject|4
781636|NCT00641719|2485480|P2|Overall Study|Adverse Event|29
781637|NCT00641719|2485481|P1|Overall Study|Adverse Event|24
781638|NCT00641719|2485480|P2|Overall Study|Lack of Efficacy|2
781639|NCT00641719|2485481|P1|Overall Study|Lack of Efficacy|1
781640|NCT00642473|2485514|P2|Overall Study|Unspecified|2
781641|NCT00642473|2485515|P1|Overall Study|Unspecified|2
781642|NCT00642473|2485514|P2|Overall Study|Progression or death|4
781643|NCT00642473|2485515|P1|Overall Study|Progression or death|2
781644|NCT00642473|2485514|P2|Overall Study|Withdrawal by Subject|5
781645|NCT00642473|2485515|P1|Overall Study|Withdrawal by Subject|0
781646|NCT00642616|2485540|P4|Overall Study|Physician Decision|1
781647|NCT00642616|2485541|P3|Overall Study|Physician Decision|1
781648|NCT00642616|2485542|P2|Overall Study|Physician Decision|0
781649|NCT00642616|2485543|P1|Overall Study|Physician Decision|0
781650|NCT00642616|2485540|P4|Overall Study|Protocol Violation|0
781651|NCT00642616|2485541|P3|Overall Study|Protocol Violation|2
781652|NCT00642616|2485542|P2|Overall Study|Protocol Violation|0
781653|NCT00642616|2485543|P1|Overall Study|Protocol Violation|0
781654|NCT00642616|2485540|P4|Overall Study|Withdrawal by Subject|1
781655|NCT00642616|2485541|P3|Overall Study|Withdrawal by Subject|1
781656|NCT00642616|2485542|P2|Overall Study|Withdrawal by Subject|1
781657|NCT00642616|2485543|P1|Overall Study|Withdrawal by Subject|0
781658|NCT00642616|2485540|P4|Overall Study|Study Terminated by Sponsor|5
781659|NCT00642616|2485541|P3|Overall Study|Study Terminated by Sponsor|4
781660|NCT00642616|2485542|P2|Overall Study|Study Terminated by Sponsor|6
781661|NCT00642616|2485543|P1|Overall Study|Study Terminated by Sponsor|7
781662|NCT00642616|2485540|P4|Overall Study|Adverse Event|0
781663|NCT00642616|2485541|P3|Overall Study|Adverse Event|1
781664|NCT00642616|2485542|P2|Overall Study|Adverse Event|0
781665|NCT00642616|2485543|P1|Overall Study|Adverse Event|2
781666|NCT00642642|2485565|P1|Treatment & Follow Up|Lost to Follow-up|10
781667|NCT00642642|2485565|P1|Treatment & Follow Up|Withdrawal by Subject|5
781668|NCT00642642|2485565|P1|Treatment & Follow Up|Adverse Event|2
781669|NCT00642668|2485578|P1|Overall Study|Blood Transfusion|2
781670|NCT00642668|2485578|P1|Overall Study|Dialysis Initiation|5
781671|NCT00642668|2485578|P1|Overall Study|Failure to Return|1
781672|NCT00642668|2485578|P1|Overall Study|Insufficient Therapeutic Response|1
781673|NCT00642668|2485578|P1|Overall Study|Death|2
781674|NCT00642668|2485578|P1|Overall Study|Adverse Event|2
781675|NCT00642668|2485578|P1|Overall Study|Lost to Follow-up|1
781676|NCT00642707|2485601|P4|Overall Study|Withdrawal by Subject|0
781677|NCT00642707|2485602|P3|Overall Study|Withdrawal by Subject|0
781678|NCT00642707|2485603|P2|Overall Study|Withdrawal by Subject|0
781679|NCT00642707|2485604|P1|Overall Study|Withdrawal by Subject|1
781680|NCT00642707|2485601|P4|Overall Study|Adverse Event|2
781681|NCT00642707|2485602|P3|Overall Study|Adverse Event|0
781682|NCT00642707|2485603|P2|Overall Study|Adverse Event|0
781683|NCT00642707|2485604|P1|Overall Study|Adverse Event|0
781684|NCT00642746|2485616|P2|Overall Study|Patient unevaluable|0
781685|NCT00642746|2485617|P1|Overall Study|Patient unevaluable|1
781686|NCT00642759|2485627|P1|Overall Study|Protocol Violation|1
781687|NCT00642772|2485634|P1|Overall Study|Withdrawal by Subject|7
781688|NCT00642772|2485634|P1|Overall Study|Lost to Follow-up|3
781689|NCT00642811|2485644|P6|Overall Study|Other|0
781690|NCT00642811|2485645|P5|Overall Study|Other|0
781691|NCT00642811|2485646|P4|Overall Study|Other|1
781692|NCT00642811|2485647|P3|Overall Study|Other|0
781693|NCT00642811|2485648|P2|Overall Study|Other|1
781694|NCT00642811|2485649|P1|Overall Study|Other|0
781695|NCT00642811|2485644|P6|Overall Study|Severe Non-compliance to protocol|0
781696|NCT00642811|2485645|P5|Overall Study|Severe Non-compliance to protocol|0
781697|NCT00642811|2485646|P4|Overall Study|Severe Non-compliance to protocol|0
781698|NCT00642811|2485647|P3|Overall Study|Severe Non-compliance to protocol|0
781699|NCT00642811|2485648|P2|Overall Study|Severe Non-compliance to protocol|0
781700|NCT00642811|2485649|P1|Overall Study|Severe Non-compliance to protocol|1
781701|NCT00642811|2485644|P6|Overall Study|Developement of discontinuation criteria|0
781702|NCT00642811|2485645|P5|Overall Study|Developement of discontinuation criteria|1
781703|NCT00642811|2485646|P4|Overall Study|Developement of discontinuation criteria|0
781704|NCT00642811|2485647|P3|Overall Study|Developement of discontinuation criteria|0
781705|NCT00642811|2485648|P2|Overall Study|Developement of discontinuation criteria|0
781706|NCT00642811|2485649|P1|Overall Study|Developement of discontinuation criteria|0
781707|NCT00642811|2485644|P6|Overall Study|Adverse Event|1
781708|NCT00642811|2485645|P5|Overall Study|Adverse Event|0
781709|NCT00642811|2485646|P4|Overall Study|Adverse Event|0
781710|NCT00642811|2485647|P3|Overall Study|Adverse Event|0
781711|NCT00642811|2485648|P2|Overall Study|Adverse Event|3
781712|NCT00642811|2485649|P1|Overall Study|Adverse Event|2
781713|NCT00642850|2485671|P1|Overall Study|Other reasons|7
781714|NCT00642850|2485671|P1|Overall Study|Blood transfusion|6
781715|NCT00642850|2485671|P1|Overall Study|Kidney transplantation|8
781716|NCT00642850|2485671|P1|Overall Study|Protocol Violation|2
781717|NCT00642850|2485671|P1|Overall Study|Lack of Efficacy|1
781718|NCT00642850|2485671|P1|Overall Study|Adverse Event|2
781719|NCT00642850|2485671|P1|Overall Study|Death|7
781720|NCT00642902|2485685|P4|Overall Study|Unspecified|4
781721|NCT00642902|2485686|P3|Overall Study|Unspecified|1
781722|NCT00642902|2485687|P2|Overall Study|Unspecified|5
781723|NCT00642902|2485688|P1|Overall Study|Unspecified|1
781724|NCT00642902|2485685|P4|Overall Study|Randomized, but not treated|0
781725|NCT00642902|2485686|P3|Overall Study|Randomized, but not treated|1
781726|NCT00642902|2485687|P2|Overall Study|Randomized, but not treated|0
781727|NCT00642902|2485688|P1|Overall Study|Randomized, but not treated|0
781728|NCT00642902|2485685|P4|Overall Study|Premature termination of clinical trial|35
781729|NCT00642902|2485686|P3|Overall Study|Premature termination of clinical trial|35
781730|NCT00642902|2485687|P2|Overall Study|Premature termination of clinical trial|32
781731|NCT00642902|2485688|P1|Overall Study|Premature termination of clinical trial|37
781732|NCT00642902|2485685|P4|Overall Study|Death|0
781733|NCT00642902|2485686|P3|Overall Study|Death|0
781734|NCT00642902|2485687|P2|Overall Study|Death|0
781735|NCT00642902|2485688|P1|Overall Study|Death|1
781736|NCT00642902|2485685|P4|Overall Study|Lack of Efficacy|0
781737|NCT00642902|2485686|P3|Overall Study|Lack of Efficacy|3
781738|NCT00642902|2485687|P2|Overall Study|Lack of Efficacy|3
781739|NCT00642902|2485688|P1|Overall Study|Lack of Efficacy|0
781740|NCT00642902|2485685|P4|Overall Study|Lost to Follow-up|0
781741|NCT00642902|2485686|P3|Overall Study|Lost to Follow-up|0
781742|NCT00642902|2485687|P2|Overall Study|Lost to Follow-up|1
781743|NCT00642902|2485688|P1|Overall Study|Lost to Follow-up|1
781744|NCT00642902|2485685|P4|Overall Study|Adverse Event|1
781745|NCT00642902|2485686|P3|Overall Study|Adverse Event|3
781746|NCT00642902|2485687|P2|Overall Study|Adverse Event|1
781747|NCT00642902|2485688|P1|Overall Study|Adverse Event|0
781748|NCT00642993|2485712|P2|Overall Study|Administrative|0
781749|NCT00642993|2485713|P1|Overall Study|Administrative|1
781750|NCT00642993|2485712|P2|Overall Study|Did not meet protocol eligibility|1
781751|NCT00642993|2485713|P1|Overall Study|Did not meet protocol eligibility|0
781752|NCT00642993|2485712|P2|Overall Study|Protocol Violation|4
781753|NCT00642993|2485713|P1|Overall Study|Protocol Violation|1
781754|NCT00642993|2485712|P2|Overall Study|Withdrew - reason unrelated to treatment|3
781755|NCT00642993|2485713|P1|Overall Study|Withdrew - reason unrelated to treatment|11
781756|NCT00642993|2485712|P2|Overall Study|Lost to Follow-up|4
781757|NCT00642993|2485713|P1|Overall Study|Lost to Follow-up|8
781758|NCT00642993|2485712|P2|Overall Study|Adverse Event|4
781759|NCT00642993|2485713|P1|Overall Study|Adverse Event|85
781760|NCT00643006|2485729|P2|Overall Study|Lost to Follow-up|4
781761|NCT00643006|2485730|P1|Overall Study|Lost to Follow-up|5
781762|NCT00643201|2485762|P2|Completed Study Follow Up|non-specified|0
781763|NCT00643201|2485763|P1|Completed Study Follow Up|non-specified|1
781764|NCT00643201|2485762|P2|Completed Study Follow Up|Lost to Follow-up|16
781765|NCT00643201|2485763|P1|Completed Study Follow Up|Lost to Follow-up|18
781766|NCT00643201|2485762|P2|Completed Study Follow Up|Withdrawal by Subject|29
781767|NCT00643201|2485763|P1|Completed Study Follow Up|Withdrawal by Subject|23
781768|NCT00643201|2485762|P2|Completed Study Follow Up|Death|34
781769|NCT00643201|2485763|P1|Completed Study Follow Up|Death|28
781770|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|not specified|107
781771|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|not specified|107
781772|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
781773|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
781774|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
781775|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
781776|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
781777|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
781778|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
781779|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
781780|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
781781|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
781782|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
781783|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
781784|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
781785|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
781786|NCT00643201|2485762|P2|Randomized, Completed 6 Months of Study|Death|26
781787|NCT00643201|2485763|P1|Randomized, Completed 6 Months of Study|Death|20
781788|NCT00643448|2485812|P3|Overall Study|QTcF>550 ms|0
781789|NCT00643448|2485813|P2|Overall Study|QTcF>550 ms|3
781790|NCT00643448|2485814|P1|Overall Study|QTcF>550 ms|0
781791|NCT00643448|2485812|P3|Overall Study|Adverse Event|2
781792|NCT00643448|2485813|P2|Overall Study|Adverse Event|2
781793|NCT00643448|2485814|P1|Overall Study|Adverse Event|2
781794|NCT00643448|2485812|P3|Overall Study|Lack of Efficacy|4
781795|NCT00643448|2485813|P2|Overall Study|Lack of Efficacy|0
781796|NCT00643448|2485814|P1|Overall Study|Lack of Efficacy|2
781797|NCT00643487|2485829|P1|Overall Study|Technical difficulty|3
891920|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Physician Decision|0
891921|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
891922|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
891923|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
891924|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
891925|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
781806|NCT00643604|2485867|P1|Overall Study|Death|1
781807|NCT00643682|2485886|P2|Overall Study|did not keep appointment|509
781808|NCT00643682|2485887|P1|Overall Study|did not keep appointment|522
781809|NCT00643760|2485904|P5|Overall Study|Withdrawal by Subject|1
781810|NCT00643760|2485905|P4|Overall Study|Withdrawal by Subject|4
781811|NCT00643760|2485906|P3|Overall Study|Withdrawal by Subject|2
781812|NCT00643760|2485907|P2|Overall Study|Withdrawal by Subject|1
781813|NCT00643760|2485908|P1|Overall Study|Withdrawal by Subject|3
781814|NCT00643760|2485904|P5|Overall Study|Investigator Discretion|0
781815|NCT00643760|2485905|P4|Overall Study|Investigator Discretion|2
781816|NCT00643760|2485906|P3|Overall Study|Investigator Discretion|0
781817|NCT00643760|2485907|P2|Overall Study|Investigator Discretion|0
781818|NCT00643760|2485908|P1|Overall Study|Investigator Discretion|0
781819|NCT00643760|2485904|P5|Overall Study|Lost to Follow-up|3
781820|NCT00643760|2485905|P4|Overall Study|Lost to Follow-up|3
781821|NCT00643760|2485906|P3|Overall Study|Lost to Follow-up|1
781822|NCT00643760|2485907|P2|Overall Study|Lost to Follow-up|2
781823|NCT00643760|2485908|P1|Overall Study|Lost to Follow-up|6
781824|NCT00643760|2485904|P5|Overall Study|Protocol Violation|6
781825|NCT00643760|2485905|P4|Overall Study|Protocol Violation|4
781826|NCT00643760|2485906|P3|Overall Study|Protocol Violation|4
781827|NCT00643760|2485907|P2|Overall Study|Protocol Violation|6
781828|NCT00643760|2485908|P1|Overall Study|Protocol Violation|7
781829|NCT00643760|2485904|P5|Overall Study|Lack of Efficacy|3
781830|NCT00643760|2485905|P4|Overall Study|Lack of Efficacy|4
781831|NCT00643760|2485906|P3|Overall Study|Lack of Efficacy|0
781832|NCT00643760|2485907|P2|Overall Study|Lack of Efficacy|1
781833|NCT00643760|2485908|P1|Overall Study|Lack of Efficacy|3
781834|NCT00643760|2485904|P5|Overall Study|Adverse Event|6
781835|NCT00643760|2485905|P4|Overall Study|Adverse Event|21
781836|NCT00643760|2485906|P3|Overall Study|Adverse Event|12
781837|NCT00643760|2485907|P2|Overall Study|Adverse Event|5
781838|NCT00643760|2485908|P1|Overall Study|Adverse Event|11
781839|NCT00643851|2486013|P3|Overall Study|Non-compl., not met criteria, etc.|6
781840|NCT00643851|2486014|P2|Overall Study|Non-compl., not met criteria, etc.|4
781841|NCT00643851|2486015|P1|Overall Study|Non-compl., not met criteria, etc.|3
781842|NCT00643851|2486013|P3|Overall Study|Withdrawal by Subject|9
781843|NCT00643851|2486014|P2|Overall Study|Withdrawal by Subject|15
781844|NCT00643851|2486015|P1|Overall Study|Withdrawal by Subject|8
781845|NCT00643851|2486013|P3|Overall Study|Lost to Follow-up|9
781846|NCT00643851|2486014|P2|Overall Study|Lost to Follow-up|6
781847|NCT00643851|2486015|P1|Overall Study|Lost to Follow-up|4
781848|NCT00643851|2486013|P3|Overall Study|Adverse Event|6
781849|NCT00643851|2486014|P2|Overall Study|Adverse Event|6
781850|NCT00643851|2486015|P1|Overall Study|Adverse Event|2
781851|NCT00643851|2486013|P3|Overall Study|Lack of Efficacy|0
781852|NCT00643851|2486014|P2|Overall Study|Lack of Efficacy|1
781853|NCT00643851|2486015|P1|Overall Study|Lack of Efficacy|0
781854|NCT00643851|2486013|P3|Overall Study|Death|0
781855|NCT00643851|2486014|P2|Overall Study|Death|1
781856|NCT00643851|2486015|P1|Overall Study|Death|0
781857|NCT00643916|2486044|P6|Overall Study|Not Vaccinated|0
781858|NCT00643916|2486045|P5|Overall Study|Not Vaccinated|2
781859|NCT00643916|2486046|P4|Overall Study|Not Vaccinated|0
781860|NCT00643916|2486047|P3|Overall Study|Not Vaccinated|3
781861|NCT00643916|2486048|P2|Overall Study|Not Vaccinated|2
781862|NCT00643916|2486049|P1|Overall Study|Not Vaccinated|2
781863|NCT00643916|2486044|P6|Overall Study|Withdrawal by Subject|1
781864|NCT00643916|2486045|P5|Overall Study|Withdrawal by Subject|0
781865|NCT00643916|2486046|P4|Overall Study|Withdrawal by Subject|1
781866|NCT00643916|2486047|P3|Overall Study|Withdrawal by Subject|2
781867|NCT00643916|2486048|P2|Overall Study|Withdrawal by Subject|2
781868|NCT00643916|2486049|P1|Overall Study|Withdrawal by Subject|2
781869|NCT00643916|2486044|P6|Overall Study|Lost to Follow-up|0
781870|NCT00643916|2486045|P5|Overall Study|Lost to Follow-up|0
781871|NCT00643916|2486046|P4|Overall Study|Lost to Follow-up|0
781872|NCT00643916|2486047|P3|Overall Study|Lost to Follow-up|0
781873|NCT00643916|2486048|P2|Overall Study|Lost to Follow-up|1
781874|NCT00643916|2486049|P1|Overall Study|Lost to Follow-up|0
781875|NCT00643916|2486044|P6|Overall Study|Protocol Violation|0
781876|NCT00643916|2486045|P5|Overall Study|Protocol Violation|0
781877|NCT00643916|2486046|P4|Overall Study|Protocol Violation|1
781878|NCT00643916|2486047|P3|Overall Study|Protocol Violation|1
781879|NCT00643916|2486048|P2|Overall Study|Protocol Violation|1
781880|NCT00643916|2486049|P1|Overall Study|Protocol Violation|0
781881|NCT00644059|2486072|P3|Overall Study|Unable to classify|3
781882|NCT00644059|2486073|P2|Overall Study|Unable to classify|2
781883|NCT00644059|2486074|P1|Overall Study|Unable to classify|6
781884|NCT00644059|2486072|P3|Overall Study|Protocol Deviation/violation|15
781885|NCT00644059|2486073|P2|Overall Study|Protocol Deviation/violation|19
781886|NCT00644059|2486074|P1|Overall Study|Protocol Deviation/violation|20
781887|NCT00644059|2486072|P3|Overall Study|Inappropriate Enrollment|0
781888|NCT00644059|2486073|P2|Overall Study|Inappropriate Enrollment|3
781889|NCT00644059|2486074|P1|Overall Study|Inappropriate Enrollment|1
781890|NCT00644059|2486072|P3|Overall Study|Adverse Event|1
781891|NCT00644059|2486073|P2|Overall Study|Adverse Event|5
781892|NCT00644059|2486074|P1|Overall Study|Adverse Event|8
781893|NCT00644059|2486072|P3|Overall Study|Withdrawal by Subject|30
781894|NCT00644059|2486073|P2|Overall Study|Withdrawal by Subject|60
781895|NCT00644059|2486074|P1|Overall Study|Withdrawal by Subject|52
781896|NCT00644059|2486072|P3|Overall Study|Lost to Follow-up|16
781897|NCT00644059|2486073|P2|Overall Study|Lost to Follow-up|34
781898|NCT00644059|2486074|P1|Overall Study|Lost to Follow-up|37
781899|NCT00644228|2486176|P2|Maintenance|On Treatment|40
781900|NCT00644228|2486177|P1|Maintenance|On Treatment|26
781901|NCT00644228|2486176|P2|Maintenance|Not Protocol-Specified|15
781902|NCT00644228|2486177|P1|Maintenance|Not Protocol-Specified|14
781903|NCT00644228|2486176|P2|Maintenance|Death|3
781904|NCT00644228|2486177|P1|Maintenance|Death|3
781905|NCT00644228|2486176|P2|Maintenance|Progression/Relapse|42
781906|NCT00644228|2486177|P1|Maintenance|Progression/Relapse|67
781907|NCT00644228|2486176|P2|Maintenance|Withdrawal by Subject|4
781908|NCT00644228|2486177|P1|Maintenance|Withdrawal by Subject|6
781909|NCT00644228|2486176|P2|Maintenance|Adverse Event|31
781910|NCT00644228|2486177|P1|Maintenance|Adverse Event|27
781911|NCT00644228|2486176|P2|Induction Therapy|Not Protocol-Specified|28
781912|NCT00644228|2486177|P1|Induction Therapy|Not Protocol-Specified|24
781913|NCT00644228|2486176|P2|Induction Therapy|Death|7
781914|NCT00644228|2486177|P1|Induction Therapy|Death|3
781915|NCT00644228|2486176|P2|Induction Therapy|Progression/Relapse|12
781916|NCT00644228|2486177|P1|Induction Therapy|Progression/Relapse|24
781917|NCT00644228|2486176|P2|Induction Therapy|Withdrawal by Subject|3
781918|NCT00644228|2486177|P1|Induction Therapy|Withdrawal by Subject|10
781919|NCT00644228|2486176|P2|Induction Therapy|Adverse Event|55
781920|NCT00644228|2486177|P1|Induction Therapy|Adverse Event|22
781921|NCT00644228|2486176|P2|Randomization & Eligibility|Invalid Consent|1
781922|NCT00644228|2486177|P1|Randomization & Eligibility|Invalid Consent|0
781923|NCT00644228|2486176|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
781924|NCT00644228|2486177|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
781925|NCT00644228|2486176|P2|Randomization & Eligibility|Ineligible|21
781926|NCT00644228|2486177|P1|Randomization & Eligibility|Ineligible|31
781927|NCT00644332|2486198|P1|Overall Study|Could Not Attend Scheduled Visits|1
781928|NCT00644332|2486198|P1|Overall Study|Did Not Meet Eligibility Requirements|1
781929|NCT00644332|2486198|P1|Overall Study|Completion Status Unknown|2
781930|NCT00644332|2486198|P1|Overall Study|Withdrawal by Subject|6
781931|NCT00644332|2486198|P1|Overall Study|Adverse Event|11
781932|NCT00644358|2486211|P1|Overall Study|Other Unspecified|11
781933|NCT00644358|2486211|P1|Overall Study|Noncompliance|14
781934|NCT00644358|2486211|P1|Overall Study|Protocol Violation|5
781935|NCT00644358|2486211|P1|Overall Study|Lack of Effectiveness|39
781936|NCT00644358|2486211|P1|Overall Study|Consent Withdrawal|64
781937|NCT00644358|2486211|P1|Overall Study|Lost to Follow-up|105
781938|NCT00644358|2486211|P1|Overall Study|Adverse Event|124
781939|NCT00644787|2486232|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
781940|NCT00644787|2486233|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
781941|NCT00644787|2486234|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
781942|NCT00644787|2486232|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
781943|NCT00644787|2486233|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
781944|NCT00644787|2486234|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
781945|NCT00644787|2486232|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
781946|NCT00644787|2486233|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
781947|NCT00644787|2486234|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
781948|NCT00644787|2486232|P3|Period 2: Double Blind Phase|Adverse Event|4
781949|NCT00644787|2486233|P2|Period 2: Double Blind Phase|Adverse Event|2
781950|NCT00644787|2486234|P1|Period 2: Double Blind Phase|Adverse Event|0
781951|NCT00644787|2486232|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
781952|NCT00644787|2486233|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
781953|NCT00644787|2486234|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
781954|NCT00644787|2486232|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
781955|NCT00644787|2486233|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
781956|NCT00644787|2486234|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
781957|NCT00644787|2486232|P3|Period 1: Titration Phase|Worsening of symptoms|0
781958|NCT00644787|2486233|P2|Period 1: Titration Phase|Worsening of symptoms|0
781959|NCT00644787|2486234|P1|Period 1: Titration Phase|Worsening of symptoms|1
781960|NCT00644787|2486232|P3|Period 1: Titration Phase|Worsening of complications|0
781961|NCT00644787|2486233|P2|Period 1: Titration Phase|Worsening of complications|0
781962|NCT00644787|2486234|P1|Period 1: Titration Phase|Worsening of complications|1
781963|NCT00644787|2486232|P3|Period 1: Titration Phase|Worsening of underlying disease|0
781964|NCT00644787|2486233|P2|Period 1: Titration Phase|Worsening of underlying disease|0
781965|NCT00644787|2486234|P1|Period 1: Titration Phase|Worsening of underlying disease|5
781966|NCT00644787|2486232|P3|Period 1: Titration Phase|Physician Decision|0
781967|NCT00644787|2486233|P2|Period 1: Titration Phase|Physician Decision|0
781968|NCT00644787|2486234|P1|Period 1: Titration Phase|Physician Decision|1
781969|NCT00644787|2486232|P3|Period 1: Titration Phase|Withdrawal by Subject|0
781970|NCT00644787|2486233|P2|Period 1: Titration Phase|Withdrawal by Subject|0
781971|NCT00644787|2486234|P1|Period 1: Titration Phase|Withdrawal by Subject|2
781972|NCT00644787|2486232|P3|Period 1: Titration Phase|Adverse Event|0
781973|NCT00644787|2486233|P2|Period 1: Titration Phase|Adverse Event|0
781974|NCT00644787|2486234|P1|Period 1: Titration Phase|Adverse Event|11
781975|NCT00644917|2486262|P1|Overall Study|Withdrawal by Subject|2
781976|NCT00638690|2486277|P2|Overall Study|Lost to Follow-up|2
781977|NCT00638690|2486278|P1|Overall Study|Lost to Follow-up|4
781978|NCT00638690|2486277|P2|Overall Study|Withdrawal by Subject|5
781979|NCT00638690|2486278|P1|Overall Study|Withdrawal by Subject|22
781980|NCT00638690|2486277|P2|Overall Study|Death|335
781981|NCT00638690|2486278|P1|Overall Study|Death|655
781982|NCT00638846|2486319|P2|Overall Study|lens issue|3
781983|NCT00638846|2486320|P1|Overall Study|lens issue|1
781984|NCT00638846|2486319|P2|Overall Study|Lost to Follow-up|2
781985|NCT00638846|2486320|P1|Overall Study|Lost to Follow-up|3
781986|NCT00638846|2486319|P2|Overall Study|Adverse Event|1
781987|NCT00638846|2486320|P1|Overall Study|Adverse Event|0
781988|NCT00644969|2486342|P2|Post Treatment Phase|Unspecified|0
781989|NCT00644969|2486343|P1|Post Treatment Phase|Unspecified|1
781990|NCT00644969|2486342|P2|Post Treatment Phase|Lost to Follow-up|1
781991|NCT00644969|2486343|P1|Post Treatment Phase|Lost to Follow-up|4
781992|NCT00644969|2486342|P2|Post Treatment Phase|Withdrawal by Subject|2
781993|NCT00644969|2486343|P1|Post Treatment Phase|Withdrawal by Subject|4
781994|NCT00644969|2486342|P2|Post Treatment Phase|Death|0
781995|NCT00644969|2486343|P1|Post Treatment Phase|Death|1
781996|NCT00644969|2486342|P2|Treatment Phase|Unspecified|1
781997|NCT00644969|2486343|P1|Treatment Phase|Unspecified|4
781998|NCT00644969|2486342|P2|Treatment Phase|Lost to Follow-up|2
781999|NCT00644969|2486343|P1|Treatment Phase|Lost to Follow-up|2
782000|NCT00644969|2486342|P2|Treatment Phase|Withdrawal by Subject|0
782001|NCT00644969|2486343|P1|Treatment Phase|Withdrawal by Subject|4
782002|NCT00644969|2486342|P2|Treatment Phase|Adverse Event|0
782003|NCT00644969|2486343|P1|Treatment Phase|Adverse Event|3
782004|NCT00644969|2486342|P2|Treatment Phase|Randomized, not treated|0
782005|NCT00644969|2486343|P1|Treatment Phase|Randomized, not treated|1
891926|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
891927|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
891928|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
891929|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
782010|NCT00645099|2486437|P2|Overall Study|Other|5
782011|NCT00645099|2486438|P1|Overall Study|Other|9
782012|NCT00645099|2486437|P2|Overall Study|Adverse Event|5
782013|NCT00645099|2486438|P1|Overall Study|Adverse Event|11
782014|NCT00645099|2486437|P2|Overall Study|Lost to Follow-up|4
782015|NCT00645099|2486438|P1|Overall Study|Lost to Follow-up|6
782016|NCT00645099|2486437|P2|Overall Study|Withdrawal by Subject|22
782017|NCT00645099|2486438|P1|Overall Study|Withdrawal by Subject|30
782018|NCT00645099|2486437|P2|Overall Study|Lack of Efficacy|6
782019|NCT00645099|2486438|P1|Overall Study|Lack of Efficacy|15
782020|NCT00645164|2486480|P1|Overall Study|Protocol Violation|1
782021|NCT00645164|2486480|P1|Overall Study|Withdrawal by Subject|4
782022|NCT00645164|2486480|P1|Overall Study|Lost to Follow-up|2
782023|NCT00645671|2486486|P2|Overall Study|Physician Decision|1
782024|NCT00645671|2486487|P1|Overall Study|Physician Decision|0
782025|NCT00645671|2486486|P2|Overall Study|Adverse Event|1
782026|NCT00645671|2486487|P1|Overall Study|Adverse Event|0
782027|NCT00645671|2486486|P2|Overall Study|Withdrawal by Subject|4
782028|NCT00645671|2486487|P1|Overall Study|Withdrawal by Subject|0
782029|NCT00645671|2486486|P2|Overall Study|Protocol Violation|0
782030|NCT00645671|2486487|P1|Overall Study|Protocol Violation|1
782031|NCT00645788|2486509|P4|Overall Study|Pulmonary exacerbation|9
782032|NCT00645788|2486510|P3|Overall Study|Pulmonary exacerbation|11
782033|NCT00645788|2486511|P2|Overall Study|Pulmonary exacerbation|16
782034|NCT00645788|2486512|P1|Overall Study|Pulmonary exacerbation|13
782035|NCT00645788|2486509|P4|Overall Study|Withdrawal by Subject|2
782036|NCT00645788|2486510|P3|Overall Study|Withdrawal by Subject|0
782037|NCT00645788|2486511|P2|Overall Study|Withdrawal by Subject|1
782038|NCT00645788|2486512|P1|Overall Study|Withdrawal by Subject|0
782039|NCT00645788|2486509|P4|Overall Study|Protocol Violation|0
782040|NCT00645788|2486510|P3|Overall Study|Protocol Violation|2
782041|NCT00645788|2486511|P2|Overall Study|Protocol Violation|0
782042|NCT00645788|2486512|P1|Overall Study|Protocol Violation|1
782043|NCT00645788|2486509|P4|Overall Study|Lost to Follow-up|0
782044|NCT00645788|2486510|P3|Overall Study|Lost to Follow-up|0
782045|NCT00645788|2486511|P2|Overall Study|Lost to Follow-up|0
782046|NCT00645788|2486512|P1|Overall Study|Lost to Follow-up|1
782047|NCT00645788|2486509|P4|Overall Study|Adverse Event|3
782048|NCT00645788|2486510|P3|Overall Study|Adverse Event|5
782049|NCT00645788|2486511|P2|Overall Study|Adverse Event|9
782050|NCT00645788|2486512|P1|Overall Study|Adverse Event|4
782051|NCT00645788|2486509|P4|Overall Study|Did not receive study drug|0
782052|NCT00645788|2486510|P3|Overall Study|Did not receive study drug|0
782053|NCT00645788|2486511|P2|Overall Study|Did not receive study drug|1
782054|NCT00645788|2486512|P1|Overall Study|Did not receive study drug|1
782055|NCT00645853|2486573|P2|Overall Study|recall of ICF, planned operation, death|4
782056|NCT00645853|2486574|P1|Overall Study|recall of ICF, planned operation, death|7
782057|NCT00645853|2486573|P2|Overall Study|Discontinuation criteria|2
782058|NCT00645853|2486574|P1|Overall Study|Discontinuation criteria|2
782059|NCT00645853|2486573|P2|Overall Study|Protocol Violation|2
782060|NCT00645853|2486574|P1|Overall Study|Protocol Violation|0
782061|NCT00645853|2486573|P2|Overall Study|Withdrawal by Subject|2
782062|NCT00645853|2486574|P1|Overall Study|Withdrawal by Subject|5
782063|NCT00645853|2486573|P2|Overall Study|AZ study closure in Hungary|40
782064|NCT00645853|2486574|P1|Overall Study|AZ study closure in Hungary|60
782065|NCT00645853|2486573|P2|Overall Study|Adverse Event|7
782066|NCT00645853|2486574|P1|Overall Study|Adverse Event|18
891930|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
891931|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
891932|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
891933|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
891934|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
891935|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
782077|NCT00646282|2486618|P2|Overall Study|Protocol terminated|4
782078|NCT00646282|2486619|P1|Overall Study|Protocol terminated|4
782079|NCT00646399|2486627|P2|Overall Study|Other Reason|11
782080|NCT00646399|2486628|P1|Overall Study|Other Reason|11
782081|NCT00646399|2486627|P2|Overall Study|Withdrawal by Subject|10
782082|NCT00646399|2486628|P1|Overall Study|Withdrawal by Subject|9
782083|NCT00646399|2486627|P2|Overall Study|Death|53
782084|NCT00646399|2486628|P1|Overall Study|Death|63
782085|NCT00646776|2486685|P2|Overall Study|Investigator discretion|4
782086|NCT00646776|2486686|P1|Overall Study|Investigator discretion|0
782087|NCT00646776|2486685|P2|Overall Study|Adverse Event|9
782088|NCT00646776|2486686|P1|Overall Study|Adverse Event|1
782089|NCT00646958|2486736|P3|Overall Study|Did not receive study drug|2
782090|NCT00646958|2486737|P2|Overall Study|Did not receive study drug|0
782091|NCT00646958|2486738|P1|Overall Study|Did not receive study drug|2
782092|NCT00646958|2486736|P3|Overall Study|Withdrawal by Subject|0
782093|NCT00646958|2486737|P2|Overall Study|Withdrawal by Subject|2
782094|NCT00646958|2486738|P1|Overall Study|Withdrawal by Subject|1
782095|NCT00646958|2486736|P3|Overall Study|Abnormal screening lab tests|0
782096|NCT00646958|2486737|P2|Overall Study|Abnormal screening lab tests|1
782097|NCT00646958|2486738|P1|Overall Study|Abnormal screening lab tests|1
782098|NCT00646958|2486736|P3|Overall Study|Protocol Violation|0
782099|NCT00646958|2486737|P2|Overall Study|Protocol Violation|1
782100|NCT00646958|2486738|P1|Overall Study|Protocol Violation|1
782101|NCT00646958|2486736|P3|Overall Study|Lost to Follow-up|7
782102|NCT00646958|2486737|P2|Overall Study|Lost to Follow-up|5
782103|NCT00646958|2486738|P1|Overall Study|Lost to Follow-up|1
782104|NCT00646958|2486736|P3|Overall Study|Adverse Event|0
782105|NCT00646958|2486737|P2|Overall Study|Adverse Event|0
782106|NCT00646958|2486738|P1|Overall Study|Adverse Event|4
782107|NCT00646958|2486736|P3|Overall Study|Lack of Efficacy|0
782108|NCT00646958|2486737|P2|Overall Study|Lack of Efficacy|0
782109|NCT00646958|2486738|P1|Overall Study|Lack of Efficacy|1
782110|NCT00647270|2486752|P3|Period 2, Placebo Switched to Adalimumab|Other|0
782111|NCT00647270|2486753|P2|Period 2, Placebo Switched to Adalimumab|Other|6
782112|NCT00647270|2486754|P1|Period 2, Placebo Switched to Adalimumab|Other|2
782113|NCT00647270|2486752|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
782114|NCT00647270|2486753|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
782115|NCT00647270|2486754|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
782116|NCT00647270|2486752|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
782117|NCT00647270|2486753|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
782118|NCT00647270|2486754|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
782119|NCT00647270|2486752|P3|Period 1, Placebo-control (12 Weeks)|Other|8
782120|NCT00647270|2486753|P2|Period 1, Placebo-control (12 Weeks)|Other|4
782121|NCT00647270|2486754|P1|Period 1, Placebo-control (12 Weeks)|Other|4
782122|NCT00647270|2486752|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
782123|NCT00647270|2486753|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
782124|NCT00647270|2486754|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
782125|NCT00647270|2486752|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
782126|NCT00647270|2486753|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
782127|NCT00647270|2486754|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
782128|NCT00647270|2486752|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
782129|NCT00647270|2486753|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
782130|NCT00647270|2486754|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
782131|NCT00647556|2486792|P2|Overall Study|Surgery for pre-existing neck pain|0
782132|NCT00647556|2486793|P1|Overall Study|Surgery for pre-existing neck pain|1
782133|NCT00647556|2486792|P2|Overall Study|Withdrawal by Subject|0
782134|NCT00647556|2486793|P1|Overall Study|Withdrawal by Subject|1
782135|NCT00647556|2486792|P2|Overall Study|Protocol Violation|1
782136|NCT00647556|2486793|P1|Overall Study|Protocol Violation|0
782137|NCT00647556|2486792|P2|Overall Study|Lost to Follow-up|0
782138|NCT00647556|2486793|P1|Overall Study|Lost to Follow-up|1
782139|NCT00647556|2486792|P2|Overall Study|Adverse Event|1
782140|NCT00647556|2486793|P1|Overall Study|Adverse Event|0
782145|NCT00648037|2486829|P1|Overall Study|Other|1
782146|NCT00648037|2486829|P1|Overall Study|Relapse|2
782147|NCT00648037|2486829|P1|Overall Study|Adverse Event|11
782148|NCT00648037|2486829|P1|Overall Study|Withdrawal by Subject|1
782149|NCT00648037|2486829|P1|Overall Study|Not Treated|1
782150|NCT00648167|2486849|P1|Overall Study|unable to swallow tablets|1
782151|NCT00648167|2486849|P1|Overall Study|Adverse Event|6
782152|NCT00642174|2486864|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
782153|NCT00642174|2486865|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
782154|NCT00642278|2486886|P7|Overall Study|Not specified|0
782155|NCT00642278|2486887|P6|Overall Study|Not specified|1
782156|NCT00642278|2486888|P5|Overall Study|Not specified|0
782157|NCT00642278|2486889|P4|Overall Study|Not specified|1
782158|NCT00642278|2486890|P3|Overall Study|Not specified|0
782159|NCT00642278|2486891|P2|Overall Study|Not specified|1
782160|NCT00642278|2486892|P1|Overall Study|Not specified|2
782161|NCT00642278|2486886|P7|Overall Study|Noncompliance with study drug regimen|0
782162|NCT00642278|2486887|P6|Overall Study|Noncompliance with study drug regimen|0
782163|NCT00642278|2486888|P5|Overall Study|Noncompliance with study drug regimen|0
782164|NCT00642278|2486889|P4|Overall Study|Noncompliance with study drug regimen|1
782165|NCT00642278|2486890|P3|Overall Study|Noncompliance with study drug regimen|0
782166|NCT00642278|2486891|P2|Overall Study|Noncompliance with study drug regimen|0
782167|NCT00642278|2486892|P1|Overall Study|Noncompliance with study drug regimen|0
782168|NCT00642278|2486886|P7|Overall Study|Withdrawal by Subject|2
782169|NCT00642278|2486887|P6|Overall Study|Withdrawal by Subject|2
782170|NCT00642278|2486888|P5|Overall Study|Withdrawal by Subject|6
782171|NCT00642278|2486889|P4|Overall Study|Withdrawal by Subject|3
782172|NCT00642278|2486890|P3|Overall Study|Withdrawal by Subject|1
782173|NCT00642278|2486891|P2|Overall Study|Withdrawal by Subject|1
782174|NCT00642278|2486892|P1|Overall Study|Withdrawal by Subject|1
782175|NCT00642278|2486886|P7|Overall Study|Protocol Violation|2
782176|NCT00642278|2486887|P6|Overall Study|Protocol Violation|1
782177|NCT00642278|2486888|P5|Overall Study|Protocol Violation|0
782178|NCT00642278|2486889|P4|Overall Study|Protocol Violation|1
782179|NCT00642278|2486890|P3|Overall Study|Protocol Violation|1
782180|NCT00642278|2486891|P2|Overall Study|Protocol Violation|0
782181|NCT00642278|2486892|P1|Overall Study|Protocol Violation|0
782182|NCT00642278|2486886|P7|Overall Study|Physician Decision|0
782183|NCT00642278|2486887|P6|Overall Study|Physician Decision|0
782184|NCT00642278|2486888|P5|Overall Study|Physician Decision|0
782185|NCT00642278|2486889|P4|Overall Study|Physician Decision|1
782186|NCT00642278|2486890|P3|Overall Study|Physician Decision|0
782187|NCT00642278|2486891|P2|Overall Study|Physician Decision|0
782188|NCT00642278|2486892|P1|Overall Study|Physician Decision|0
782189|NCT00642278|2486886|P7|Overall Study|Lost to Follow-up|1
782190|NCT00642278|2486887|P6|Overall Study|Lost to Follow-up|1
782191|NCT00642278|2486888|P5|Overall Study|Lost to Follow-up|0
782192|NCT00642278|2486889|P4|Overall Study|Lost to Follow-up|1
782193|NCT00642278|2486890|P3|Overall Study|Lost to Follow-up|0
782194|NCT00642278|2486891|P2|Overall Study|Lost to Follow-up|1
782195|NCT00642278|2486892|P1|Overall Study|Lost to Follow-up|5
782196|NCT00642278|2486886|P7|Overall Study|Lack of Efficacy|0
782197|NCT00642278|2486887|P6|Overall Study|Lack of Efficacy|0
782198|NCT00642278|2486888|P5|Overall Study|Lack of Efficacy|0
782199|NCT00642278|2486889|P4|Overall Study|Lack of Efficacy|0
782200|NCT00642278|2486890|P3|Overall Study|Lack of Efficacy|0
782201|NCT00642278|2486891|P2|Overall Study|Lack of Efficacy|1
782202|NCT00642278|2486892|P1|Overall Study|Lack of Efficacy|0
782203|NCT00642278|2486886|P7|Overall Study|Adverse Event|0
782204|NCT00642278|2486887|P6|Overall Study|Adverse Event|2
782205|NCT00642278|2486888|P5|Overall Study|Adverse Event|2
782206|NCT00642278|2486889|P4|Overall Study|Adverse Event|1
782207|NCT00642278|2486890|P3|Overall Study|Adverse Event|3
782208|NCT00642278|2486891|P2|Overall Study|Adverse Event|1
782209|NCT00642278|2486892|P1|Overall Study|Adverse Event|2
782210|NCT00642304|2486943|P1|Overall Study|Transplantation|1
782211|NCT00642304|2486943|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
782212|NCT00642304|2486943|P1|Overall Study|Blood transfusion|2
782213|NCT00642304|2486943|P1|Overall Study|Death|1
782214|NCT00642304|2486943|P1|Overall Study|Adverse Event|1
782215|NCT00642356|2486954|P2|Overall Study|Lack of Efficacy|0
782216|NCT00642356|2486955|P1|Overall Study|Lack of Efficacy|1
782217|NCT00642356|2486954|P2|Overall Study|Protocol Violation|3
782218|NCT00642356|2486955|P1|Overall Study|Protocol Violation|0
782219|NCT00642356|2486954|P2|Overall Study|Adverse Event|0
782220|NCT00642356|2486955|P1|Overall Study|Adverse Event|1
782221|NCT00642369|2486965|P2|Overall Study|Lack of Efficacy|2
782222|NCT00642369|2486966|P1|Overall Study|Lack of Efficacy|2
782223|NCT00642369|2486965|P2|Overall Study|misdiagnosis|1
782224|NCT00642369|2486966|P1|Overall Study|misdiagnosis|0
782225|NCT00642369|2486965|P2|Overall Study|Withdrawal by Subject|0
782226|NCT00642369|2486966|P1|Overall Study|Withdrawal by Subject|1
782227|NCT00642369|2486965|P2|Overall Study|Adverse Event|3
782228|NCT00642369|2486966|P1|Overall Study|Adverse Event|2
782229|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
782230|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
782231|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
782232|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
782233|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
782234|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
782235|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
782236|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
782237|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
782238|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
782239|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
782240|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
782241|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Death|3
782242|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Death|0
782243|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Death|0
782244|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Death|0
782245|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Death|0
782246|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Death|0
782247|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Unspecified|2
782248|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Unspecified|2
782249|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Unspecified|0
782250|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Unspecified|0
782251|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Unspecified|0
782252|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Unspecified|0
782253|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
782254|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
782255|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
782256|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
782257|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
782258|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
782259|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
782260|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
782261|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
782262|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
782263|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
782264|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
782265|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
782266|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
782267|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
782268|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
782269|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
782270|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
782271|NCT00642460|2486985|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
782272|NCT00642460|2486986|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
782273|NCT00642460|2486987|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
782274|NCT00642460|2486988|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
782275|NCT00642460|2486989|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
782276|NCT00642460|2486990|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
782277|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
782278|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
782279|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
782280|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
782281|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
782282|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
782283|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Failure to return|0
782284|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Failure to return|0
782285|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Failure to return|0
782286|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Failure to return|0
782287|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Failure to return|1
782288|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Failure to return|0
782289|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
782290|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
782291|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
782292|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
782293|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
782294|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
782295|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
782296|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
782297|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
782298|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
782299|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
782300|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
782301|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Death|0
782302|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Death|0
782303|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Death|2
782304|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Death|0
782305|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Death|1
782306|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Death|0
782307|NCT00642460|2486985|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
782308|NCT00642460|2486986|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
782309|NCT00642460|2486987|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
782310|NCT00642460|2486988|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
782311|NCT00642460|2486989|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
782312|NCT00642460|2486990|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
782313|NCT00642460|2486985|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
782314|NCT00642460|2486986|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
782315|NCT00642460|2486987|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
782316|NCT00642460|2486988|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
782317|NCT00642460|2486989|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
782318|NCT00642460|2486990|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
782319|NCT00642460|2486985|P6|Part I: 12 Week Double-Blind|Adverse Event|0
782320|NCT00642460|2486986|P5|Part I: 12 Week Double-Blind|Adverse Event|0
782321|NCT00642460|2486987|P4|Part I: 12 Week Double-Blind|Adverse Event|0
782322|NCT00642460|2486988|P3|Part I: 12 Week Double-Blind|Adverse Event|1
782323|NCT00642460|2486989|P2|Part I: 12 Week Double-Blind|Adverse Event|1
782324|NCT00642460|2486990|P1|Part I: 12 Week Double-Blind|Adverse Event|0
782325|NCT00649389|2487058|P4|Overall Study|Other|6
782326|NCT00649389|2487059|P3|Overall Study|Other|1
782327|NCT00649389|2487060|P2|Overall Study|Other|9
782328|NCT00649389|2487061|P1|Overall Study|Other|3
782329|NCT00649389|2487058|P4|Overall Study|Withdrawal by Subject|23
782330|NCT00649389|2487059|P3|Overall Study|Withdrawal by Subject|19
782331|NCT00649389|2487060|P2|Overall Study|Withdrawal by Subject|21
782332|NCT00649389|2487061|P1|Overall Study|Withdrawal by Subject|20
782333|NCT00649389|2487058|P4|Overall Study|Protocol Violation|8
782334|NCT00649389|2487059|P3|Overall Study|Protocol Violation|9
782335|NCT00649389|2487060|P2|Overall Study|Protocol Violation|13
782336|NCT00649389|2487061|P1|Overall Study|Protocol Violation|11
782337|NCT00649389|2487058|P4|Overall Study|Lost to Follow-up|26
782338|NCT00649389|2487059|P3|Overall Study|Lost to Follow-up|21
782339|NCT00649389|2487060|P2|Overall Study|Lost to Follow-up|17
782340|NCT00649389|2487061|P1|Overall Study|Lost to Follow-up|15
782341|NCT00649389|2487058|P4|Overall Study|Adverse Event|48
782342|NCT00649389|2487059|P3|Overall Study|Adverse Event|38
782343|NCT00649389|2487060|P2|Overall Study|Adverse Event|46
782344|NCT00649389|2487061|P1|Overall Study|Adverse Event|22
782345|NCT00649428|2487085|P2|Overall Study|Physician Decision|1
782346|NCT00649428|2487086|P1|Overall Study|Physician Decision|0
782347|NCT00649428|2487085|P2|Overall Study|Protocol Violation|2
782348|NCT00649428|2487086|P1|Overall Study|Protocol Violation|6
782349|NCT00649428|2487085|P2|Overall Study|Insufficient manufacturing yield|1
782350|NCT00649428|2487086|P1|Overall Study|Insufficient manufacturing yield|5
782351|NCT00649428|2487085|P2|Overall Study|Lost to Follow-up|3
782352|NCT00649428|2487086|P1|Overall Study|Lost to Follow-up|1
782353|NCT00649428|2487085|P2|Overall Study|Withdrawal by Subject|6
782354|NCT00649428|2487086|P1|Overall Study|Withdrawal by Subject|6
782355|NCT00649428|2487085|P2|Overall Study|Adverse Event|2
782356|NCT00649428|2487086|P1|Overall Study|Adverse Event|2
782357|NCT00650091|2487123|P3|Amended Study Design|Not specified|0
782358|NCT00650091|2487124|P2|Amended Study Design|Not specified|3
782359|NCT00650091|2487125|P1|Amended Study Design|Not specified|1
782360|NCT00650091|2487123|P3|Amended Study Design|Lung transplantation|0
782361|NCT00650091|2487124|P2|Amended Study Design|Lung transplantation|2
782362|NCT00650091|2487125|P1|Amended Study Design|Lung transplantation|4
782363|NCT00650091|2487123|P3|Amended Study Design|Adverse Event|0
782364|NCT00650091|2487124|P2|Amended Study Design|Adverse Event|4
782365|NCT00650091|2487125|P1|Amended Study Design|Adverse Event|1
782366|NCT00650091|2487123|P3|Amended Study Design|Physician Decision|0
782367|NCT00650091|2487124|P2|Amended Study Design|Physician Decision|0
782368|NCT00650091|2487125|P1|Amended Study Design|Physician Decision|5
782369|NCT00650091|2487123|P3|Amended Study Design|Withdrawal by Subject|0
782370|NCT00650091|2487124|P2|Amended Study Design|Withdrawal by Subject|11
782371|NCT00650091|2487125|P1|Amended Study Design|Withdrawal by Subject|12
782372|NCT00650104|2487143|P1|Overall Study|Sponsor Terminated Dosing|1
782373|NCT00650104|2487143|P1|Overall Study|Non-compliance|2
782374|NCT00650104|2487143|P1|Overall Study|Lost to Follow-up|1
782375|NCT00650104|2487143|P1|Overall Study|Physician Decision|7
782376|NCT00650104|2487143|P1|Overall Study|Withdrawal by Subject|11
782377|NCT00650104|2487143|P1|Overall Study|Death|2
782378|NCT00650104|2487143|P1|Overall Study|Adverse Event|17
782379|NCT00650585|2487182|P2|Overall Study|Excluded/ruled ineligible|129
782380|NCT00650585|2487183|P1|Overall Study|Excluded/ruled ineligible|357
782381|NCT00650585|2487182|P2|Overall Study|No parental consent|866
782382|NCT00650585|2487183|P1|Overall Study|No parental consent|935
782383|NCT00650585|2487182|P2|Overall Study|Lost to Follow-up|482
782384|NCT00650585|2487183|P1|Overall Study|Lost to Follow-up|505
782385|NCT00650767|2487207|P4|Overall Study|Other|0
782386|NCT00650767|2487208|P3|Overall Study|Other|0
782387|NCT00650767|2487209|P2|Overall Study|Other|1
782388|NCT00650767|2487210|P1|Overall Study|Other|1
782389|NCT00650767|2487207|P4|Overall Study|Lost to Follow-up|0
782390|NCT00650767|2487208|P3|Overall Study|Lost to Follow-up|1
782391|NCT00650767|2487209|P2|Overall Study|Lost to Follow-up|1
782392|NCT00650767|2487210|P1|Overall Study|Lost to Follow-up|1
782393|NCT00650767|2487207|P4|Overall Study|Withdrawal by Subject|3
782394|NCT00650767|2487208|P3|Overall Study|Withdrawal by Subject|3
782395|NCT00650767|2487209|P2|Overall Study|Withdrawal by Subject|4
782396|NCT00650767|2487210|P1|Overall Study|Withdrawal by Subject|2
782397|NCT00650767|2487207|P4|Overall Study|Death|0
782398|NCT00650767|2487208|P3|Overall Study|Death|0
782399|NCT00650767|2487209|P2|Overall Study|Death|0
782400|NCT00650767|2487210|P1|Overall Study|Death|1
782401|NCT00650767|2487207|P4|Overall Study|Adverse Event|8
782402|NCT00650767|2487208|P3|Overall Study|Adverse Event|10
782403|NCT00650767|2487209|P2|Overall Study|Adverse Event|3
782404|NCT00650767|2487210|P1|Overall Study|Adverse Event|0
782405|NCT00650806|2487716|P4|Overall Study|Not specified|0
782406|NCT00650806|2487717|P3|Overall Study|Not specified|2
782407|NCT00650806|2487718|P2|Overall Study|Not specified|1
782408|NCT00650806|2487719|P1|Overall Study|Not specified|1
782409|NCT00650806|2487716|P4|Overall Study|Study terminated by sponsor|4
782410|NCT00650806|2487717|P3|Overall Study|Study terminated by sponsor|5
782411|NCT00650806|2487718|P2|Overall Study|Study terminated by sponsor|3
782412|NCT00650806|2487719|P1|Overall Study|Study terminated by sponsor|2
782413|NCT00650806|2487716|P4|Overall Study|Noncompliance with study drug regimen|0
782414|NCT00650806|2487717|P3|Overall Study|Noncompliance with study drug regimen|0
782415|NCT00650806|2487718|P2|Overall Study|Noncompliance with study drug regimen|1
782416|NCT00650806|2487719|P1|Overall Study|Noncompliance with study drug regimen|1
782417|NCT00650806|2487716|P4|Overall Study|Withdrawal by Subject|6
782418|NCT00650806|2487717|P3|Overall Study|Withdrawal by Subject|8
782419|NCT00650806|2487718|P2|Overall Study|Withdrawal by Subject|5
782420|NCT00650806|2487719|P1|Overall Study|Withdrawal by Subject|7
782421|NCT00650806|2487716|P4|Overall Study|Pregnancy|1
782422|NCT00650806|2487717|P3|Overall Study|Pregnancy|0
782423|NCT00650806|2487718|P2|Overall Study|Pregnancy|0
782424|NCT00650806|2487719|P1|Overall Study|Pregnancy|0
782425|NCT00650806|2487716|P4|Overall Study|Protocol Violation|1
782426|NCT00650806|2487717|P3|Overall Study|Protocol Violation|0
782427|NCT00650806|2487718|P2|Overall Study|Protocol Violation|0
782428|NCT00650806|2487719|P1|Overall Study|Protocol Violation|0
782429|NCT00650806|2487716|P4|Overall Study|Lost to Follow-up|10
782430|NCT00650806|2487717|P3|Overall Study|Lost to Follow-up|11
782431|NCT00650806|2487718|P2|Overall Study|Lost to Follow-up|6
782432|NCT00650806|2487719|P1|Overall Study|Lost to Follow-up|7
782433|NCT00650806|2487716|P4|Overall Study|Adverse Event|4
782434|NCT00650806|2487717|P3|Overall Study|Adverse Event|3
782435|NCT00650806|2487718|P2|Overall Study|Adverse Event|5
782436|NCT00650806|2487719|P1|Overall Study|Adverse Event|0
782437|NCT00650845|2487759|P2|Overall Study|Protocol Violation|13
782438|NCT00650845|2487760|P1|Overall Study|Protocol Violation|0
782439|NCT00650845|2487759|P2|Overall Study|Withdrawal by Subject|0
782440|NCT00650845|2487760|P1|Overall Study|Withdrawal by Subject|5
782441|NCT00651118|2487808|P4|Overall Study|Withdrawal by Subject|1
782442|NCT00651118|2487809|P3|Overall Study|Withdrawal by Subject|1
782443|NCT00651118|2487810|P2|Overall Study|Withdrawal by Subject|1
782444|NCT00651118|2487811|P1|Overall Study|Withdrawal by Subject|0
782445|NCT00651118|2487808|P4|Overall Study|administrative|1
782446|NCT00651118|2487809|P3|Overall Study|administrative|2
782447|NCT00651118|2487810|P2|Overall Study|administrative|4
782448|NCT00651118|2487811|P1|Overall Study|administrative|1
782449|NCT00651118|2487808|P4|Overall Study|Lost to Follow-up|2
782450|NCT00651118|2487809|P3|Overall Study|Lost to Follow-up|1
782451|NCT00651118|2487810|P2|Overall Study|Lost to Follow-up|0
782452|NCT00651118|2487811|P1|Overall Study|Lost to Follow-up|2
782453|NCT00651118|2487808|P4|Overall Study|Protocol Violation|2
782454|NCT00651118|2487809|P3|Overall Study|Protocol Violation|6
782455|NCT00651118|2487810|P2|Overall Study|Protocol Violation|2
782456|NCT00651118|2487811|P1|Overall Study|Protocol Violation|2
782457|NCT00651118|2487808|P4|Overall Study|Adverse Event|1
782458|NCT00651118|2487809|P3|Overall Study|Adverse Event|1
782459|NCT00651118|2487810|P2|Overall Study|Adverse Event|0
782460|NCT00651118|2487811|P1|Overall Study|Adverse Event|4
782461|NCT00651157|2487829|P1|Overall Study|Protocol Violation|1
782462|NCT00651157|2487829|P1|Overall Study|Death|1
782463|NCT00651183|2487837|P2|Overall Study|missing|0
782464|NCT00651183|2487838|P1|Overall Study|missing|1
782465|NCT00651183|2487837|P2|Overall Study|Other reasons|2
782466|NCT00651183|2487838|P1|Overall Study|Other reasons|4
782467|NCT00651183|2487837|P2|Overall Study|Lost to Follow-up|1
782468|NCT00651183|2487838|P1|Overall Study|Lost to Follow-up|3
782469|NCT00651183|2487837|P2|Overall Study|Withdrawal by Subject|3
782470|NCT00651183|2487838|P1|Overall Study|Withdrawal by Subject|6
782471|NCT00651183|2487837|P2|Overall Study|Tolerability insufficient +Patients wish|1
782472|NCT00651183|2487838|P1|Overall Study|Tolerability insufficient +Patients wish|0
782473|NCT00651183|2487837|P2|Overall Study|Tolerability insufficient|2
782474|NCT00651183|2487838|P1|Overall Study|Tolerability insufficient|5
782475|NCT00651183|2487837|P2|Overall Study|Efficacy insufficient + patients wish|1
782476|NCT00651183|2487838|P1|Overall Study|Efficacy insufficient + patients wish|0
782477|NCT00651183|2487837|P2|Overall Study|Lack of Efficacy|0
782478|NCT00651183|2487838|P1|Overall Study|Lack of Efficacy|1
782479|NCT00651261|2487852|P2|Overall Study|Never treated|3
782480|NCT00651261|2487853|P1|Overall Study|Never treated|5
782481|NCT00651261|2487852|P2|Overall Study|Other disease or participant decisions|23
782482|NCT00651261|2487853|P1|Overall Study|Other disease or participant decisions|23
782483|NCT00651261|2487852|P2|Overall Study|Alternative therapy|107
782484|NCT00651261|2487853|P1|Overall Study|Alternative therapy|109
782485|NCT00651261|2487852|P2|Overall Study|Disease progression|58
782486|NCT00651261|2487853|P1|Overall Study|Disease progression|58
782487|NCT00651261|2487852|P2|Overall Study|Induction failure|35
782488|NCT00651261|2487853|P1|Overall Study|Induction failure|24
782489|NCT00651261|2487852|P2|Overall Study|Withdrawal by Subject|40
782490|NCT00651261|2487853|P1|Overall Study|Withdrawal by Subject|22
782491|NCT00651261|2487852|P2|Overall Study|Death|18
782492|NCT00651261|2487853|P1|Overall Study|Death|18
782493|NCT00651261|2487852|P2|Overall Study|Adverse Event|22
782494|NCT00651261|2487853|P1|Overall Study|Adverse Event|32
782495|NCT00651313|2487869|P2|Overall Study|Adminstrative Discontinuation|3
782496|NCT00651313|2487870|P1|Overall Study|Adminstrative Discontinuation|2
782497|NCT00651313|2487869|P2|Overall Study|Lost to Follow-up|1
782498|NCT00651313|2487870|P1|Overall Study|Lost to Follow-up|1
782499|NCT00651313|2487869|P2|Overall Study|Withdrawal by Subject|1
782500|NCT00651313|2487870|P1|Overall Study|Withdrawal by Subject|3
782501|NCT00651313|2487869|P2|Overall Study|Adverse Event|1
782502|NCT00651313|2487870|P1|Overall Study|Adverse Event|0
782503|NCT00651755|2487903|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
782504|NCT00651755|2487904|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
782505|NCT00651755|2487903|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
782506|NCT00651755|2487904|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
782507|NCT00645411|2487934|P4|Overall Study|Unable to classify|4
782508|NCT00645411|2487935|P3|Overall Study|Unable to classify|3
782509|NCT00645411|2487936|P2|Overall Study|Unable to classify|0
782510|NCT00645411|2487937|P1|Overall Study|Unable to classify|0
782511|NCT00645411|2487934|P4|Overall Study|Inappropriate enrollment|1
782512|NCT00645411|2487935|P3|Overall Study|Inappropriate enrollment|4
782513|NCT00645411|2487936|P2|Overall Study|Inappropriate enrollment|0
782514|NCT00645411|2487937|P1|Overall Study|Inappropriate enrollment|0
782515|NCT00645411|2487934|P4|Overall Study|Protocol Violation|0
782516|NCT00645411|2487935|P3|Overall Study|Protocol Violation|1
782517|NCT00645411|2487936|P2|Overall Study|Protocol Violation|0
782518|NCT00645411|2487937|P1|Overall Study|Protocol Violation|1
782519|NCT00645411|2487934|P4|Overall Study|Lost to Follow-up|75
782520|NCT00645411|2487935|P3|Overall Study|Lost to Follow-up|124
782521|NCT00645411|2487936|P2|Overall Study|Lost to Follow-up|5
782522|NCT00645411|2487937|P1|Overall Study|Lost to Follow-up|10
782523|NCT00645411|2487934|P4|Overall Study|Withdrawal by Subject|21
782524|NCT00645411|2487935|P3|Overall Study|Withdrawal by Subject|19
782525|NCT00645411|2487936|P2|Overall Study|Withdrawal by Subject|1
782526|NCT00645411|2487937|P1|Overall Study|Withdrawal by Subject|2
782527|NCT00645411|2487934|P4|Overall Study|Adverse Event|2
782528|NCT00645411|2487935|P3|Overall Study|Adverse Event|0
782529|NCT00645411|2487936|P2|Overall Study|Adverse Event|0
782530|NCT00645411|2487937|P1|Overall Study|Adverse Event|0
782531|NCT00645528|2487969|P1|Overall Study|Did not show up for Visit 2|7
782532|NCT00645567|2487978|P1|Overall Study|Adverse Event|1
782533|NCT00645593|2487988|P2|Overall Study|Later found to be ineligible|0
782534|NCT00645593|2487989|P1|Overall Study|Later found to be ineligible|1
782535|NCT00651820|2488001|P1|Overall Study|Lost to Follow-up|2
782536|NCT00651924|2488010|P2|Overall Study|Withdrawal by Subject|5
782537|NCT00651924|2488011|P1|Overall Study|Withdrawal by Subject|0
782538|NCT00651924|2488010|P2|Overall Study|Withdrawal by PI|2
782539|NCT00651924|2488011|P1|Overall Study|Withdrawal by PI|0
782540|NCT00652028|2488021|P4|Overall Study|Physician Decision|0
782541|NCT00652028|2488022|P3|Overall Study|Physician Decision|1
782542|NCT00652028|2488023|P2|Overall Study|Physician Decision|0
782543|NCT00652028|2488024|P1|Overall Study|Physician Decision|0
782544|NCT00652028|2488021|P4|Overall Study|No Longer Meets Entry Criteria|0
782545|NCT00652028|2488022|P3|Overall Study|No Longer Meets Entry Criteria|0
782546|NCT00652028|2488023|P2|Overall Study|No Longer Meets Entry Criteria|1
782547|NCT00652028|2488024|P1|Overall Study|No Longer Meets Entry Criteria|0
782548|NCT00652028|2488021|P4|Overall Study|Adverse Event|0
782549|NCT00652028|2488022|P3|Overall Study|Adverse Event|0
782550|NCT00652028|2488023|P2|Overall Study|Adverse Event|0
782551|NCT00652028|2488024|P1|Overall Study|Adverse Event|1
782552|NCT00652093|2488072|P6|Overall Study|Physician Decision|0
782553|NCT00652093|2488073|P5|Overall Study|Physician Decision|1
782554|NCT00652093|2488074|P4|Overall Study|Physician Decision|0
782555|NCT00652093|2488075|P3|Overall Study|Physician Decision|0
782556|NCT00652093|2488076|P2|Overall Study|Physician Decision|0
782557|NCT00652093|2488077|P1|Overall Study|Physician Decision|0
782558|NCT00652093|2488072|P6|Overall Study|Withdrawal by Subject|0
782559|NCT00652093|2488073|P5|Overall Study|Withdrawal by Subject|1
782560|NCT00652093|2488074|P4|Overall Study|Withdrawal by Subject|0
782561|NCT00652093|2488075|P3|Overall Study|Withdrawal by Subject|1
782562|NCT00652093|2488076|P2|Overall Study|Withdrawal by Subject|0
782563|NCT00652093|2488077|P1|Overall Study|Withdrawal by Subject|0
782564|NCT00652327|2488176|P2|Overall Study|Lost to Follow-up|3
782565|NCT00652327|2488177|P1|Overall Study|Lost to Follow-up|0
782566|NCT00652327|2488176|P2|Overall Study|Adverse Event|2
782567|NCT00652327|2488177|P1|Overall Study|Adverse Event|0
782568|NCT00652340|2488185|P2|Overall Study|Had not progressed.|3
782569|NCT00652340|2488186|P1|Overall Study|Had not progressed.|4
782570|NCT00652366|2488199|P5|Overall Study|Not specified|0
782571|NCT00652366|2488200|P4|Overall Study|Not specified|4
782572|NCT00652366|2488201|P3|Overall Study|Not specified|3
782573|NCT00652366|2488202|P2|Overall Study|Not specified|2
782574|NCT00652366|2488203|P1|Overall Study|Not specified|5
782575|NCT00652366|2488199|P5|Overall Study|Refused treatment|5
782576|NCT00652366|2488200|P4|Overall Study|Refused treatment|17
782577|NCT00652366|2488201|P3|Overall Study|Refused treatment|6
782578|NCT00652366|2488202|P2|Overall Study|Refused treatment|7
782579|NCT00652366|2488203|P1|Overall Study|Refused treatment|3
782580|NCT00652366|2488199|P5|Overall Study|Protocol Violation|0
782581|NCT00652366|2488200|P4|Overall Study|Protocol Violation|0
782582|NCT00652366|2488201|P3|Overall Study|Protocol Violation|0
782583|NCT00652366|2488202|P2|Overall Study|Protocol Violation|0
782584|NCT00652366|2488203|P1|Overall Study|Protocol Violation|1
782585|NCT00652366|2488199|P5|Overall Study|Violation of Selection Criteria|0
782586|NCT00652366|2488200|P4|Overall Study|Violation of Selection Criteria|0
782587|NCT00652366|2488201|P3|Overall Study|Violation of Selection Criteria|1
782588|NCT00652366|2488202|P2|Overall Study|Violation of Selection Criteria|0
782589|NCT00652366|2488203|P1|Overall Study|Violation of Selection Criteria|0
782590|NCT00652366|2488199|P5|Overall Study|Lack of Efficacy|13
782591|NCT00652366|2488200|P4|Overall Study|Lack of Efficacy|133
782592|NCT00652366|2488201|P3|Overall Study|Lack of Efficacy|53
782593|NCT00652366|2488202|P2|Overall Study|Lack of Efficacy|58
782594|NCT00652366|2488203|P1|Overall Study|Lack of Efficacy|84
782595|NCT00652366|2488199|P5|Overall Study|Death|5
782596|NCT00652366|2488200|P4|Overall Study|Death|8
782597|NCT00652366|2488201|P3|Overall Study|Death|1
782598|NCT00652366|2488202|P2|Overall Study|Death|4
782599|NCT00652366|2488203|P1|Overall Study|Death|5
782600|NCT00652366|2488199|P5|Overall Study|Adverse Event|13
782601|NCT00652366|2488200|P4|Overall Study|Adverse Event|17
782602|NCT00652366|2488201|P3|Overall Study|Adverse Event|7
782603|NCT00652366|2488202|P2|Overall Study|Adverse Event|4
782604|NCT00652366|2488203|P1|Overall Study|Adverse Event|8
782605|NCT00652626|2488243|P7|Extension Phase|Death|1
782606|NCT00652626|2488244|P6|Extension Phase|Death|1
782607|NCT00652626|2488245|P5|Extension Phase|Death|0
782608|NCT00652626|2488246|P4|Extension Phase|Death|0
782609|NCT00652626|2488247|P3|Extension Phase|Death|0
782610|NCT00652626|2488248|P2|Extension Phase|Death|0
782611|NCT00652626|2488249|P1|Extension Phase|Death|0
782612|NCT00652626|2488243|P7|Extension Phase|Physician Decision|1
782613|NCT00652626|2488244|P6|Extension Phase|Physician Decision|1
782614|NCT00652626|2488245|P5|Extension Phase|Physician Decision|0
782615|NCT00652626|2488246|P4|Extension Phase|Physician Decision|0
782616|NCT00652626|2488247|P3|Extension Phase|Physician Decision|0
782617|NCT00652626|2488248|P2|Extension Phase|Physician Decision|0
782618|NCT00652626|2488249|P1|Extension Phase|Physician Decision|0
782619|NCT00652626|2488243|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
782620|NCT00652626|2488244|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
782621|NCT00652626|2488245|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
782622|NCT00652626|2488246|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
782623|NCT00652626|2488247|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
782624|NCT00652626|2488248|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
782625|NCT00652626|2488249|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
782626|NCT00652626|2488243|P7|Extension Phase|Adverse Event|1
782627|NCT00652626|2488244|P6|Extension Phase|Adverse Event|2
782628|NCT00652626|2488245|P5|Extension Phase|Adverse Event|0
782629|NCT00652626|2488246|P4|Extension Phase|Adverse Event|0
782630|NCT00652626|2488247|P3|Extension Phase|Adverse Event|0
782631|NCT00652626|2488248|P2|Extension Phase|Adverse Event|0
782632|NCT00652626|2488249|P1|Extension Phase|Adverse Event|0
782633|NCT00652626|2488243|P7|Extension Phase|Withdrawal by Subject|0
782634|NCT00652626|2488244|P6|Extension Phase|Withdrawal by Subject|2
782635|NCT00652626|2488245|P5|Extension Phase|Withdrawal by Subject|0
782636|NCT00652626|2488246|P4|Extension Phase|Withdrawal by Subject|0
782637|NCT00652626|2488247|P3|Extension Phase|Withdrawal by Subject|0
782638|NCT00652626|2488248|P2|Extension Phase|Withdrawal by Subject|0
782639|NCT00652626|2488249|P1|Extension Phase|Withdrawal by Subject|0
782640|NCT00652626|2488243|P7|Initial Treatment Phase|Lost to Follow-up|0
782641|NCT00652626|2488244|P6|Initial Treatment Phase|Lost to Follow-up|0
782642|NCT00652626|2488245|P5|Initial Treatment Phase|Lost to Follow-up|1
782643|NCT00652626|2488246|P4|Initial Treatment Phase|Lost to Follow-up|0
782644|NCT00652626|2488247|P3|Initial Treatment Phase|Lost to Follow-up|0
782645|NCT00652626|2488248|P2|Initial Treatment Phase|Lost to Follow-up|0
782646|NCT00652626|2488249|P1|Initial Treatment Phase|Lost to Follow-up|0
782647|NCT00652626|2488243|P7|Initial Treatment Phase|Sponsor Request|0
782648|NCT00652626|2488244|P6|Initial Treatment Phase|Sponsor Request|0
782649|NCT00652626|2488245|P5|Initial Treatment Phase|Sponsor Request|0
782650|NCT00652626|2488246|P4|Initial Treatment Phase|Sponsor Request|0
782651|NCT00652626|2488247|P3|Initial Treatment Phase|Sponsor Request|1
782652|NCT00652626|2488248|P2|Initial Treatment Phase|Sponsor Request|0
782653|NCT00652626|2488249|P1|Initial Treatment Phase|Sponsor Request|0
782654|NCT00652626|2488243|P7|Initial Treatment Phase|Physician Decision|0
782655|NCT00652626|2488244|P6|Initial Treatment Phase|Physician Decision|0
782656|NCT00652626|2488245|P5|Initial Treatment Phase|Physician Decision|1
782657|NCT00652626|2488246|P4|Initial Treatment Phase|Physician Decision|0
782658|NCT00652626|2488247|P3|Initial Treatment Phase|Physician Decision|0
782659|NCT00652626|2488248|P2|Initial Treatment Phase|Physician Decision|0
782660|NCT00652626|2488249|P1|Initial Treatment Phase|Physician Decision|0
782661|NCT00652626|2488243|P7|Initial Treatment Phase|Protocol Violation|0
782662|NCT00652626|2488244|P6|Initial Treatment Phase|Protocol Violation|0
782663|NCT00652626|2488245|P5|Initial Treatment Phase|Protocol Violation|0
782664|NCT00652626|2488246|P4|Initial Treatment Phase|Protocol Violation|1
782665|NCT00652626|2488247|P3|Initial Treatment Phase|Protocol Violation|0
782666|NCT00652626|2488248|P2|Initial Treatment Phase|Protocol Violation|0
782667|NCT00652626|2488249|P1|Initial Treatment Phase|Protocol Violation|0
782668|NCT00652626|2488243|P7|Initial Treatment Phase|Adverse Event|0
782669|NCT00652626|2488244|P6|Initial Treatment Phase|Adverse Event|0
782670|NCT00652626|2488245|P5|Initial Treatment Phase|Adverse Event|1
782671|NCT00652626|2488246|P4|Initial Treatment Phase|Adverse Event|0
782672|NCT00652626|2488247|P3|Initial Treatment Phase|Adverse Event|0
782673|NCT00652626|2488248|P2|Initial Treatment Phase|Adverse Event|0
782674|NCT00652626|2488249|P1|Initial Treatment Phase|Adverse Event|0
782675|NCT00652834|2488313|P1|Overall Study|Lost to Follow-up|2
782676|NCT00652834|2488313|P1|Overall Study|Withdrawal by Subject|3
782677|NCT00652899|2488317|P1|Overall Study|Treating physician decision|1
782678|NCT00652899|2488317|P1|Overall Study|Death|1
782679|NCT00652938|2488330|P3|Overall Study|fear of blood sampling|0
782680|NCT00652938|2488331|P2|Overall Study|fear of blood sampling|1
782681|NCT00652938|2488332|P1|Overall Study|fear of blood sampling|0
782682|NCT00652938|2488330|P3|Overall Study|Lost to Follow-up|2
782683|NCT00652938|2488331|P2|Overall Study|Lost to Follow-up|0
782684|NCT00652938|2488332|P1|Overall Study|Lost to Follow-up|0
782685|NCT00652938|2488330|P3|Overall Study|Withdrawal by Subject|1
782686|NCT00652938|2488331|P2|Overall Study|Withdrawal by Subject|6
782687|NCT00652938|2488332|P1|Overall Study|Withdrawal by Subject|0
782688|NCT00652938|2488330|P3|Overall Study|Adverse Event|2
782689|NCT00652938|2488331|P2|Overall Study|Adverse Event|0
782690|NCT00652938|2488332|P1|Overall Study|Adverse Event|1
782691|NCT00653068|2488401|P1|Overall Study|Ineligible|2
782692|NCT00653068|2488401|P1|Overall Study|Withdrawal by Subject|1
782693|NCT00653068|2488401|P1|Overall Study|Physician Decision|4
782694|NCT00653068|2488401|P1|Overall Study|Lack of Efficacy|34
782695|NCT00653068|2488401|P1|Overall Study|Death|9
782696|NCT00653159|2488423|P2|Overall Study|Lost to Follow-up|2
782697|NCT00653159|2488424|P1|Overall Study|Lost to Follow-up|1
782698|NCT00653159|2488423|P2|Overall Study|Adverse Event|1
782699|NCT00653159|2488424|P1|Overall Study|Adverse Event|4
782700|NCT00653224|2488440|P2|Overall Study|Other|4
782701|NCT00653224|2488441|P1|Overall Study|Other|2
782702|NCT00653224|2488440|P2|Overall Study|Lost to Follow-up|0
782703|NCT00653224|2488441|P1|Overall Study|Lost to Follow-up|1
782704|NCT00653224|2488440|P2|Overall Study|Loss of efficacy|0
782705|NCT00653224|2488441|P1|Overall Study|Loss of efficacy|1
782706|NCT00653224|2488440|P2|Overall Study|Lack of Efficacy|2
782707|NCT00653224|2488441|P1|Overall Study|Lack of Efficacy|1
782708|NCT00653224|2488440|P2|Overall Study|Adverse Event|1
782709|NCT00653224|2488441|P1|Overall Study|Adverse Event|2
782710|NCT00653263|2488625|P1|Overall Study|Physician Decision|1
782711|NCT00653263|2488625|P1|Overall Study|Withdrawal by Subject|1
782712|NCT00653328|2488631|P1|Overall Study|Drug manufacturer no longing making drug|2
782713|NCT00653328|2488631|P1|Overall Study|Disease progression|10
782714|NCT00653328|2488631|P1|Overall Study|Adverse Event|2
782715|NCT00653328|2488631|P1|Overall Study|Withdrawal by Subject|1
782716|NCT00653523|2488638|P1|Overall Study|Adverse reaction did not improve (4)|1
782717|NCT00653523|2488638|P1|Overall Study|Elevated alanine aminotransferase (3)|2
782718|NCT00653523|2488638|P1|Overall Study|Withdrawal by Subject|6
782719|NCT00653523|2488638|P1|Overall Study|Adverse Event|7
782720|NCT00653523|2488638|P1|Overall Study|Elevated creatine phosphokinase (2)|1
782721|NCT00653523|2488638|P1|Overall Study|Drop in low density lipoprotein (1)|2
782722|NCT00653939|2488653|P2|Overall Study|Not Specified|6
782723|NCT00653939|2488654|P1|Overall Study|Not Specified|2
782724|NCT00653939|2488653|P2|Overall Study|Disease Progression|3
782725|NCT00653939|2488654|P1|Overall Study|Disease Progression|2
782726|NCT00653939|2488653|P2|Overall Study|Physician Decision|0
782727|NCT00653939|2488654|P1|Overall Study|Physician Decision|4
782728|NCT00653939|2488653|P2|Overall Study|Withdrawal by Subject|3
782729|NCT00653939|2488654|P1|Overall Study|Withdrawal by Subject|3
782730|NCT00653939|2488653|P2|Overall Study|Adverse Event|3
782731|NCT00653939|2488654|P1|Overall Study|Adverse Event|1
782732|NCT00654004|2488672|P2|Overall Study|Lost to Follow-up|0
782733|NCT00654004|2488673|P1|Overall Study|Lost to Follow-up|1
782734|NCT00654095|2488691|P1|Overall Study|Did not meet inclusion criteria|1
782735|NCT00654095|2488691|P1|Overall Study|Adverse reaction did not improve (5)|4
782736|NCT00654095|2488691|P1|Overall Study|Elevated alanine aminotransferase (4)|7
782737|NCT00654095|2488691|P1|Overall Study|Withdrawal by Subject|5
782738|NCT00654095|2488691|P1|Overall Study|Adverse Event|11
782739|NCT00654095|2488691|P1|Overall Study|Elevated alanine aminotransferase (3)|1
782740|NCT00654095|2488691|P1|Overall Study|Elevated triglyceride level (2)|1
782741|NCT00654095|2488691|P1|Overall Study|Drop in low density lipoprotein (1)|2
782742|NCT00654186|2488714|P1|Overall Study|Withdrawal by Subject|5
782745|NCT00654368|2488757|P3|Overall Study|Adverse Event|6
782746|NCT00654368|2488758|P2|Overall Study|Adverse Event|9
782747|NCT00654368|2488759|P1|Overall Study|Adverse Event|14
782748|NCT00654368|2488757|P3|Overall Study|Other|3
782749|NCT00654368|2488758|P2|Overall Study|Other|2
782750|NCT00654368|2488759|P1|Overall Study|Other|0
782751|NCT00654368|2488757|P3|Overall Study|Pregnancy|2
782752|NCT00654368|2488758|P2|Overall Study|Pregnancy|0
782753|NCT00654368|2488759|P1|Overall Study|Pregnancy|0
782754|NCT00654368|2488757|P3|Overall Study|Death|0
782755|NCT00654368|2488758|P2|Overall Study|Death|0
782756|NCT00654368|2488759|P1|Overall Study|Death|1
782757|NCT00654368|2488757|P3|Overall Study|Physician Decision|2
782758|NCT00654368|2488758|P2|Overall Study|Physician Decision|0
782759|NCT00654368|2488759|P1|Overall Study|Physician Decision|0
782760|NCT00654368|2488757|P3|Overall Study|Requirement for alternative therapy|1
782761|NCT00654368|2488758|P2|Overall Study|Requirement for alternative therapy|1
782762|NCT00654368|2488759|P1|Overall Study|Requirement for alternative therapy|1
782763|NCT00654368|2488757|P3|Overall Study|Disease progression|13
782764|NCT00654368|2488758|P2|Overall Study|Disease progression|31
782765|NCT00654368|2488759|P1|Overall Study|Disease progression|21
782766|NCT00654368|2488757|P3|Overall Study|Withdrawal by Subject|2
782767|NCT00654368|2488758|P2|Overall Study|Withdrawal by Subject|2
782768|NCT00654368|2488759|P1|Overall Study|Withdrawal by Subject|5
782769|NCT00654368|2488757|P3|Overall Study|Non-compliance|2
782770|NCT00654368|2488758|P2|Overall Study|Non-compliance|1
782771|NCT00654368|2488759|P1|Overall Study|Non-compliance|2
782772|NCT00654368|2488757|P3|Overall Study|Protocol deviation|1
782773|NCT00654368|2488758|P2|Overall Study|Protocol deviation|2
782774|NCT00654368|2488759|P1|Overall Study|Protocol deviation|3
782775|NCT00654368|2488757|P3|Overall Study|Ineligibility determined|0
782776|NCT00654368|2488758|P2|Overall Study|Ineligibility determined|0
782777|NCT00654368|2488759|P1|Overall Study|Ineligibility determined|6
782778|NCT00654381|2488794|P6|Extension Stage|Closure of the trial site|1
782779|NCT00654381|2488795|P5|Extension Stage|Closure of the trial site|1
782780|NCT00654381|2488796|P4|Extension Stage|Closure of the trial site|0
782781|NCT00654381|2488797|P3|Extension Stage|Closure of the trial site|0
782782|NCT00654381|2488798|P2|Extension Stage|Closure of the trial site|0
782783|NCT00654381|2488799|P1|Extension Stage|Closure of the trial site|0
782784|NCT00654381|2488794|P6|Extension Stage|Withdrawal by Subject|1
782785|NCT00654381|2488795|P5|Extension Stage|Withdrawal by Subject|1
782786|NCT00654381|2488796|P4|Extension Stage|Withdrawal by Subject|1
782787|NCT00654381|2488797|P3|Extension Stage|Withdrawal by Subject|1
782788|NCT00654381|2488798|P2|Extension Stage|Withdrawal by Subject|0
782789|NCT00654381|2488799|P1|Extension Stage|Withdrawal by Subject|0
782790|NCT00654381|2488794|P6|Extension Stage|Lack of Efficacy|0
782791|NCT00654381|2488795|P5|Extension Stage|Lack of Efficacy|0
782792|NCT00654381|2488796|P4|Extension Stage|Lack of Efficacy|0
782793|NCT00654381|2488797|P3|Extension Stage|Lack of Efficacy|1
782794|NCT00654381|2488798|P2|Extension Stage|Lack of Efficacy|0
782795|NCT00654381|2488799|P1|Extension Stage|Lack of Efficacy|0
782796|NCT00654381|2488794|P6|Extension Stage|Protocol Violation|0
782797|NCT00654381|2488795|P5|Extension Stage|Protocol Violation|0
782798|NCT00654381|2488796|P4|Extension Stage|Protocol Violation|1
782799|NCT00654381|2488797|P3|Extension Stage|Protocol Violation|0
782800|NCT00654381|2488798|P2|Extension Stage|Protocol Violation|0
782801|NCT00654381|2488799|P1|Extension Stage|Protocol Violation|0
782802|NCT00654381|2488794|P6|Extension Stage|Adverse Event|1
782803|NCT00654381|2488795|P5|Extension Stage|Adverse Event|1
782804|NCT00654381|2488796|P4|Extension Stage|Adverse Event|7
782805|NCT00654381|2488797|P3|Extension Stage|Adverse Event|9
782806|NCT00654381|2488798|P2|Extension Stage|Adverse Event|2
782807|NCT00654381|2488799|P1|Extension Stage|Adverse Event|1
782808|NCT00654381|2488794|P6|2nd Stage|Investigator's decision|0
782809|NCT00654381|2488795|P5|2nd Stage|Investigator's decision|0
782810|NCT00654381|2488796|P4|2nd Stage|Investigator's decision|1
782811|NCT00654381|2488797|P3|2nd Stage|Investigator's decision|1
782812|NCT00654381|2488798|P2|2nd Stage|Investigator's decision|0
782813|NCT00654381|2488799|P1|2nd Stage|Investigator's decision|0
782814|NCT00654381|2488794|P6|2nd Stage|Withdrawal by Subject|1
782815|NCT00654381|2488795|P5|2nd Stage|Withdrawal by Subject|1
782816|NCT00654381|2488796|P4|2nd Stage|Withdrawal by Subject|0
782817|NCT00654381|2488797|P3|2nd Stage|Withdrawal by Subject|0
782818|NCT00654381|2488798|P2|2nd Stage|Withdrawal by Subject|0
782819|NCT00654381|2488799|P1|2nd Stage|Withdrawal by Subject|0
782820|NCT00654381|2488794|P6|2nd Stage|Adverse Event|2
782821|NCT00654381|2488795|P5|2nd Stage|Adverse Event|7
782822|NCT00654381|2488796|P4|2nd Stage|Adverse Event|3
782823|NCT00654381|2488797|P3|2nd Stage|Adverse Event|2
782824|NCT00654381|2488798|P2|2nd Stage|Adverse Event|0
782825|NCT00654381|2488799|P1|2nd Stage|Adverse Event|2
782826|NCT00654381|2488794|P6|1st Stage|Investigator's decision|0
782827|NCT00654381|2488795|P5|1st Stage|Investigator's decision|0
782828|NCT00654381|2488796|P4|1st Stage|Investigator's decision|1
782829|NCT00654381|2488797|P3|1st Stage|Investigator's decision|0
782830|NCT00654381|2488798|P2|1st Stage|Investigator's decision|0
782831|NCT00654381|2488799|P1|1st Stage|Investigator's decision|0
782832|NCT00654381|2488794|P6|1st Stage|Withdrawal by Subject|1
782833|NCT00654381|2488795|P5|1st Stage|Withdrawal by Subject|0
782834|NCT00654381|2488796|P4|1st Stage|Withdrawal by Subject|1
782835|NCT00654381|2488797|P3|1st Stage|Withdrawal by Subject|0
782836|NCT00654381|2488798|P2|1st Stage|Withdrawal by Subject|0
782837|NCT00654381|2488799|P1|1st Stage|Withdrawal by Subject|0
782838|NCT00654381|2488794|P6|1st Stage|Adverse Event|1
782839|NCT00654381|2488795|P5|1st Stage|Adverse Event|2
782840|NCT00654381|2488796|P4|1st Stage|Adverse Event|3
782841|NCT00654381|2488797|P3|1st Stage|Adverse Event|3
782842|NCT00654381|2488798|P2|1st Stage|Adverse Event|3
782843|NCT00654381|2488799|P1|1st Stage|Adverse Event|3
782844|NCT00654420|2488837|P4|Phase II|Missing Disposition Record|0
782845|NCT00654420|2488838|P3|Phase II|Missing Disposition Record|1
782846|NCT00654420|2488839|P2|Phase II|Missing Disposition Record|0
782847|NCT00654420|2488840|P1|Phase II|Missing Disposition Record|0
782848|NCT00654420|2488837|P4|Phase II|Withdrawal by Subject|1
782849|NCT00654420|2488838|P3|Phase II|Withdrawal by Subject|4
782850|NCT00654420|2488839|P2|Phase II|Withdrawal by Subject|0
782851|NCT00654420|2488840|P1|Phase II|Withdrawal by Subject|0
782852|NCT00654420|2488837|P4|Phase II|Progressive Disease|29
782853|NCT00654420|2488838|P3|Phase II|Progressive Disease|29
782854|NCT00654420|2488839|P2|Phase II|Progressive Disease|0
782855|NCT00654420|2488840|P1|Phase II|Progressive Disease|0
782856|NCT00654420|2488837|P4|Phase II|Physician Decision|4
782857|NCT00654420|2488838|P3|Phase II|Physician Decision|0
782858|NCT00654420|2488839|P2|Phase II|Physician Decision|0
782859|NCT00654420|2488840|P1|Phase II|Physician Decision|0
782860|NCT00654420|2488837|P4|Phase II|Lost to Follow-up|1
782861|NCT00654420|2488838|P3|Phase II|Lost to Follow-up|0
782862|NCT00654420|2488839|P2|Phase II|Lost to Follow-up|0
782863|NCT00654420|2488840|P1|Phase II|Lost to Follow-up|0
782864|NCT00654420|2488837|P4|Phase II|Adverse Event|3
782865|NCT00654420|2488838|P3|Phase II|Adverse Event|3
782866|NCT00654420|2488839|P2|Phase II|Adverse Event|0
782867|NCT00654420|2488840|P1|Phase II|Adverse Event|0
782868|NCT00654420|2488837|P4|Phase I (Dose Escalation)|Progressive Disease|0
782869|NCT00654420|2488838|P3|Phase I (Dose Escalation)|Progressive Disease|0
782870|NCT00654420|2488839|P2|Phase I (Dose Escalation)|Progressive Disease|15
782871|NCT00654420|2488840|P1|Phase I (Dose Escalation)|Progressive Disease|4
782872|NCT00654420|2488837|P4|Phase I (Dose Escalation)|Adverse Event|0
782873|NCT00654420|2488838|P3|Phase I (Dose Escalation)|Adverse Event|0
782874|NCT00654420|2488839|P2|Phase I (Dose Escalation)|Adverse Event|1
782875|NCT00654420|2488840|P1|Phase I (Dose Escalation)|Adverse Event|0
782876|NCT00654498|2488864|P2|Overall Study|Other reason not defined above|5
782877|NCT00654498|2488865|P1|Overall Study|Other reason not defined above|4
782878|NCT00654498|2488864|P2|Overall Study|Withdrawal by Subject|0
782879|NCT00654498|2488865|P1|Overall Study|Withdrawal by Subject|1
782880|NCT00654498|2488864|P2|Overall Study|Lost to Follow-up|5
782881|NCT00654498|2488865|P1|Overall Study|Lost to Follow-up|1
782882|NCT00654498|2488864|P2|Overall Study|Protocol Violation|1
782883|NCT00654498|2488865|P1|Overall Study|Protocol Violation|1
782884|NCT00654498|2488864|P2|Overall Study|Adverse Event|1
782885|NCT00654498|2488865|P1|Overall Study|Adverse Event|6
782886|NCT00654498|2488864|P2|Overall Study|Not Treated|0
782887|NCT00654498|2488865|P1|Overall Study|Not Treated|1
782888|NCT00654628|2488914|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
782889|NCT00654628|2488914|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
782890|NCT00654628|2488914|P1|6-week Active Treatment Period|Out of window period|1
782891|NCT00654628|2488914|P1|6-week Active Treatment Period|Transferred to branch hospital|1
782892|NCT00654628|2488914|P1|6-week Active Treatment Period|Lost to Follow-up|10
782893|NCT00654628|2488914|P1|6-week Active Treatment Period|Adverse Event|9
782894|NCT00654641|2488931|P2|Overall Study|Lost to Follow-up|3
782895|NCT00654641|2488932|P1|Overall Study|Lost to Follow-up|2
782896|NCT00654745|2488943|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
782897|NCT00654745|2488943|P1|Overall Study|Withdrawal by Subject|10
782898|NCT00654745|2488943|P1|Overall Study|Protocol Violation|11
782899|NCT00654745|2488943|P1|Overall Study|Lost to Follow-up|7
782900|NCT00654745|2488943|P1|Overall Study|Adverse Event|12
782901|NCT00648895|2488992|P2|Overall Study|Lack of Efficacy|1
782902|NCT00648895|2488993|P1|Overall Study|Lack of Efficacy|0
782903|NCT00649220|2489007|P1|Overall Study|Withdrawal by Subject|1
782904|NCT00649220|2489007|P1|Overall Study|Adverse Event|2
782905|NCT00654875|2489026|P2|Overall Study|Administrative Problems|0
782906|NCT00654875|2489027|P1|Overall Study|Administrative Problems|1
782907|NCT00654875|2489026|P2|Overall Study|Abnormal Test Procedure Result(s)|0
782908|NCT00654875|2489027|P1|Overall Study|Abnormal Test Procedure Result(s)|1
782909|NCT00654875|2489026|P2|Overall Study|Lost to Follow-up|3
782910|NCT00654875|2489027|P1|Overall Study|Lost to Follow-up|1
782911|NCT00654875|2489026|P2|Overall Study|Lack of Efficacy|2
782912|NCT00654875|2489027|P1|Overall Study|Lack of Efficacy|2
782913|NCT00654875|2489026|P2|Overall Study|Protocol Violation|3
782914|NCT00654875|2489027|P1|Overall Study|Protocol Violation|3
782915|NCT00654875|2489026|P2|Overall Study|Withdrawal by Subject|4
782916|NCT00654875|2489027|P1|Overall Study|Withdrawal by Subject|4
782917|NCT00654875|2489026|P2|Overall Study|Adverse Event|5
782918|NCT00654875|2489027|P1|Overall Study|Adverse Event|5
782919|NCT00654901|2489049|P4|Overall Study|Withdrawal by Subject|0
782920|NCT00654901|2489050|P3|Overall Study|Withdrawal by Subject|1
782921|NCT00654901|2489051|P2|Overall Study|Withdrawal by Subject|0
782922|NCT00654901|2489052|P1|Overall Study|Withdrawal by Subject|3
782923|NCT00654901|2489049|P4|Overall Study|Lost to Follow-up|0
782924|NCT00654901|2489050|P3|Overall Study|Lost to Follow-up|1
782925|NCT00654901|2489051|P2|Overall Study|Lost to Follow-up|0
782926|NCT00654901|2489052|P1|Overall Study|Lost to Follow-up|1
782927|NCT00654940|2489080|P2|Period 1|Intolerable Pain Level|0
782928|NCT00654940|2489081|P1|Period 1|Intolerable Pain Level|1
782929|NCT00654940|2489080|P2|Period 1|Adverse Event|1
782930|NCT00654940|2489081|P1|Period 1|Adverse Event|0
782931|NCT00657267|2489130|P1|Overall Study|Adverse Event|9
782932|NCT00657267|2489130|P1|Overall Study|Progressive disease|45
782933|NCT00657358|2489142|P1|Overall Study|Lack of Efficacy|6
782934|NCT00657371|2489150|P1|Overall Study|Pre-existing medical condition|4
782935|NCT00657371|2489150|P1|Overall Study|Device- related reasons|13
782936|NCT00657371|2489150|P1|Overall Study|Protocol Violation|2
782937|NCT00657371|2489150|P1|Overall Study|Unable to intubate the cecum|5
782938|NCT00657371|2489150|P1|Overall Study|Poor bowel preparation|15
782939|NCT00657540|2489157|P2|Overall Study|Lost to Follow-up|4
782940|NCT00657540|2489158|P1|Overall Study|Lost to Follow-up|1
891936|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
891937|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
891938|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
891939|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
891940|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
891941|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
891942|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
891943|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
891944|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
891945|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
891946|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
891947|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
891948|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
891949|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
891950|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
891951|NCT01009463|2828581|P5|52-week, Double-blind Treatment Period|Adverse Event|31
891952|NCT01009463|2828582|P4|52-week, Double-blind Treatment Period|Adverse Event|29
782963|NCT00658320|2489250|P2|Extension Study: After Month 24|Subject withdrew consent|0
782964|NCT00658320|2489251|P1|Extension Study: After Month 24|Subject withdrew consent|2
782965|NCT00658320|2489250|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
782966|NCT00658320|2489251|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
782967|NCT00658320|2489250|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
782968|NCT00658320|2489251|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
782969|NCT00658320|2489250|P2|Core Study: 12 Months|Subject withdrew consent|3
782970|NCT00658320|2489251|P1|Core Study: 12 Months|Subject withdrew consent|5
782971|NCT00658333|2489276|P2|Overall Study|Adverse Event|1
782972|NCT00658333|2489277|P1|Overall Study|Adverse Event|2
782973|NCT00658528|2489299|P2|Overall Study|Not specified|4
782974|NCT00658528|2489300|P1|Overall Study|Not specified|8
782975|NCT00658528|2489299|P2|Overall Study|Withdrawal of consent|6
782976|NCT00658528|2489300|P1|Overall Study|Withdrawal of consent|5
782977|NCT00658528|2489299|P2|Overall Study|Withdrawal by Subject|6
782978|NCT00658528|2489300|P1|Overall Study|Withdrawal by Subject|8
782979|NCT00658528|2489299|P2|Overall Study|Lost to Follow-up|22
782980|NCT00658528|2489300|P1|Overall Study|Lost to Follow-up|14
782981|NCT00658528|2489299|P2|Overall Study|Adverse Event|7
782982|NCT00658528|2489300|P1|Overall Study|Adverse Event|5
782983|NCT00658541|2489310|P2|Washout Period of 7 Days|Withdrawal by Subject|1
782984|NCT00658541|2489311|P1|Washout Period of 7 Days|Withdrawal by Subject|0
782985|NCT00658541|2489310|P2|Washout Period of 7 Days|Withdrawal by Subject|1
782986|NCT00658541|2489311|P1|Washout Period of 7 Days|Withdrawal by Subject|1
782987|NCT00658567|2489324|P3|Overall Study|At Discretion of Sponsor|1
782988|NCT00658567|2489325|P2|Overall Study|At Discretion of Sponsor|1
782989|NCT00658567|2489326|P1|Overall Study|At Discretion of Sponsor|1
782990|NCT00658567|2489324|P3|Overall Study|Physician Decision|0
782991|NCT00658567|2489325|P2|Overall Study|Physician Decision|1
782992|NCT00658567|2489326|P1|Overall Study|Physician Decision|0
782993|NCT00658567|2489324|P3|Overall Study|Voluntary Withdrawal of Consent|2
782994|NCT00658567|2489325|P2|Overall Study|Voluntary Withdrawal of Consent|0
782995|NCT00658567|2489326|P1|Overall Study|Voluntary Withdrawal of Consent|2
782996|NCT00658567|2489324|P3|Overall Study|Adverse Event|3
782997|NCT00658567|2489325|P2|Overall Study|Adverse Event|2
782998|NCT00658567|2489326|P1|Overall Study|Adverse Event|5
782999|NCT00658606|2489339|P2|Overall Study|Lack of Compliance|3
783000|NCT00658606|2489340|P1|Overall Study|Lack of Compliance|0
783001|NCT00658606|2489339|P2|Overall Study|Withdrawal by Subject|16
783002|NCT00658606|2489340|P1|Overall Study|Withdrawal by Subject|7
783003|NCT00658606|2489339|P2|Overall Study|Lost to Follow-up|0
783004|NCT00658606|2489340|P1|Overall Study|Lost to Follow-up|1
783005|NCT00658606|2489339|P2|Overall Study|Lack of Efficacy|3
783006|NCT00658606|2489340|P1|Overall Study|Lack of Efficacy|6
783007|NCT00658606|2489339|P2|Overall Study|Adverse Event|1
783008|NCT00658606|2489340|P1|Overall Study|Adverse Event|2
783009|NCT00658632|2489397|P2|Overall Study|Not specified|8
783010|NCT00658632|2489398|P1|Overall Study|Not specified|7
783011|NCT00658632|2489397|P2|Overall Study|Pregnancy|1
783012|NCT00658632|2489398|P1|Overall Study|Pregnancy|1
783013|NCT00658632|2489397|P2|Overall Study|Withdrawal of consent|14
783014|NCT00658632|2489398|P1|Overall Study|Withdrawal of consent|8
783015|NCT00658632|2489397|P2|Overall Study|Lack of Efficacy|1
783016|NCT00658632|2489398|P1|Overall Study|Lack of Efficacy|0
783017|NCT00658632|2489397|P2|Overall Study|Withdrawal by Subject|7
783018|NCT00658632|2489398|P1|Overall Study|Withdrawal by Subject|10
783019|NCT00658632|2489397|P2|Overall Study|Lost to Follow-up|23
783020|NCT00658632|2489398|P1|Overall Study|Lost to Follow-up|25
783021|NCT00658632|2489397|P2|Overall Study|Adverse Event|11
783022|NCT00658632|2489398|P1|Overall Study|Adverse Event|13
783023|NCT00658658|2489413|P5|Overall Study|Other|1
783024|NCT00658658|2489414|P4|Overall Study|Other|0
783025|NCT00658658|2489415|P3|Overall Study|Other|0
783026|NCT00658658|2489416|P2|Overall Study|Other|0
783027|NCT00658658|2489417|P1|Overall Study|Other|0
783028|NCT00658658|2489413|P5|Overall Study|Protocol-specified Criteria|0
783029|NCT00658658|2489414|P4|Overall Study|Protocol-specified Criteria|0
783030|NCT00658658|2489415|P3|Overall Study|Protocol-specified Criteria|0
783031|NCT00658658|2489416|P2|Overall Study|Protocol-specified Criteria|0
783032|NCT00658658|2489417|P1|Overall Study|Protocol-specified Criteria|1
783033|NCT00658658|2489413|P5|Overall Study|Disease Progression|3
783034|NCT00658658|2489414|P4|Overall Study|Disease Progression|1
783035|NCT00658658|2489415|P3|Overall Study|Disease Progression|0
783036|NCT00658658|2489416|P2|Overall Study|Disease Progression|1
783037|NCT00658658|2489417|P1|Overall Study|Disease Progression|0
783038|NCT00658658|2489413|P5|Overall Study|Death|1
783039|NCT00658658|2489414|P4|Overall Study|Death|1
783040|NCT00658658|2489415|P3|Overall Study|Death|0
783041|NCT00658658|2489416|P2|Overall Study|Death|0
783042|NCT00658658|2489417|P1|Overall Study|Death|4
783043|NCT00658658|2489413|P5|Overall Study|Withdrawal by Subject|0
783044|NCT00658658|2489414|P4|Overall Study|Withdrawal by Subject|0
783045|NCT00658658|2489415|P3|Overall Study|Withdrawal by Subject|0
783046|NCT00658658|2489416|P2|Overall Study|Withdrawal by Subject|1
783047|NCT00658658|2489417|P1|Overall Study|Withdrawal by Subject|0
783048|NCT00658684|2489477|P4|Overall Study|Pregnancy|0
783049|NCT00658684|2489478|P3|Overall Study|Pregnancy|0
783050|NCT00658684|2489479|P2|Overall Study|Pregnancy|1
783051|NCT00658684|2489480|P1|Overall Study|Pregnancy|1
783052|NCT00658684|2489477|P4|Overall Study|Protocol Violation|0
783053|NCT00658684|2489478|P3|Overall Study|Protocol Violation|0
783054|NCT00658684|2489479|P2|Overall Study|Protocol Violation|1
783055|NCT00658684|2489480|P1|Overall Study|Protocol Violation|1
783056|NCT00658684|2489477|P4|Overall Study|Lack of Efficacy|0
783057|NCT00658684|2489478|P3|Overall Study|Lack of Efficacy|0
783058|NCT00658684|2489479|P2|Overall Study|Lack of Efficacy|1
783059|NCT00658684|2489480|P1|Overall Study|Lack of Efficacy|1
783060|NCT00658684|2489477|P4|Overall Study|Withdrawal by Subject|1
783061|NCT00658684|2489478|P3|Overall Study|Withdrawal by Subject|1
783062|NCT00658684|2489479|P2|Overall Study|Withdrawal by Subject|4
783063|NCT00658684|2489480|P1|Overall Study|Withdrawal by Subject|6
783064|NCT00658684|2489477|P4|Overall Study|Adverse Event|0
783065|NCT00658684|2489478|P3|Overall Study|Adverse Event|2
783066|NCT00658684|2489479|P2|Overall Study|Adverse Event|8
783067|NCT00658684|2489480|P1|Overall Study|Adverse Event|10
783068|NCT00658723|2489540|P3|Overall Study|Withdrawal by Subject|1
783069|NCT00658723|2489541|P2|Overall Study|Withdrawal by Subject|0
783070|NCT00658723|2489542|P1|Overall Study|Withdrawal by Subject|1
783071|NCT00658723|2489540|P3|Overall Study|Scheduling Issue|0
783072|NCT00658723|2489541|P2|Overall Study|Scheduling Issue|1
783073|NCT00658723|2489542|P1|Overall Study|Scheduling Issue|1
783074|NCT00658723|2489540|P3|Overall Study|Death|4
783075|NCT00658723|2489541|P2|Overall Study|Death|1
783076|NCT00658723|2489542|P1|Overall Study|Death|2
783077|NCT00658723|2489540|P3|Overall Study|Lost to Follow-up|2
783078|NCT00658723|2489541|P2|Overall Study|Lost to Follow-up|2
783079|NCT00658723|2489542|P1|Overall Study|Lost to Follow-up|0
783080|NCT00658775|2489582|P2|Overall Study|Not specified|8
783081|NCT00658775|2489583|P1|Overall Study|Not specified|7
783082|NCT00658775|2489582|P2|Overall Study|Withdrawal of consent|7
783083|NCT00658775|2489583|P1|Overall Study|Withdrawal of consent|8
783084|NCT00658775|2489582|P2|Overall Study|Withdrawal by Subject|4
783085|NCT00658775|2489583|P1|Overall Study|Withdrawal by Subject|6
783086|NCT00658775|2489582|P2|Overall Study|Lost to Follow-up|18
783087|NCT00658775|2489583|P1|Overall Study|Lost to Follow-up|17
783088|NCT00658775|2489582|P2|Overall Study|Adverse Event|6
783089|NCT00658775|2489583|P1|Overall Study|Adverse Event|4
783090|NCT00658788|2489593|P1|Overall Study|Treatment Discontinuation|32
783091|NCT00658788|2489593|P1|Overall Study|Lost to Follow-up|18
783092|NCT00658788|2489593|P1|Overall Study|Withdrawal by Subject|13
783093|NCT00658788|2489593|P1|Overall Study|Adverse Event|11
891953|NCT01009463|2828583|P3|52-week, Double-blind Treatment Period|Adverse Event|25
891954|NCT01009463|2828584|P2|52-week, Double-blind Treatment Period|Adverse Event|22
891955|NCT01009463|2828585|P1|52-week, Double-blind Treatment Period|Adverse Event|0
891956|NCT01009463|2828581|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
891957|NCT01009463|2828582|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
891958|NCT01009463|2828583|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
891959|NCT01009463|2828584|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
891960|NCT01009463|2828585|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
891961|NCT01009463|2828581|P5|4-week, Open-label Run-In Period|Physician Decision|0
891962|NCT01009463|2828582|P4|4-week, Open-label Run-In Period|Physician Decision|0
891963|NCT01009463|2828583|P3|4-week, Open-label Run-In Period|Physician Decision|0
891964|NCT01009463|2828584|P2|4-week, Open-label Run-In Period|Physician Decision|0
891965|NCT01009463|2828585|P1|4-week, Open-label Run-In Period|Physician Decision|10
891966|NCT01009463|2828581|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
891967|NCT01009463|2828582|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
891968|NCT01009463|2828583|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
891969|NCT01009463|2828584|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
891970|NCT01009463|2828585|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
891971|NCT01009463|2828581|P5|4-week, Open-label Run-In Period|Adverse Event|0
891972|NCT01009463|2828582|P4|4-week, Open-label Run-In Period|Adverse Event|0
783116|NCT00658996|2489663|P2|Second Intervention|Positive slit lamp finding|1
783117|NCT00658996|2489664|P1|Second Intervention|Positive slit lamp finding|0
783209|NCT00659529|2490154|P1|Overall Study|Protocol Violation|3
783118|NCT00658996|2489663|P2|Second Intervention|Developed a stye on upper lid|0
783119|NCT00658996|2489664|P1|Second Intervention|Developed a stye on upper lid|1
783120|NCT00658996|2489663|P2|Crossover Period|Ineligible|1
783121|NCT00658996|2489664|P1|Crossover Period|Ineligible|1
783122|NCT00658996|2489663|P2|Crossover Period|Physician Decision|0
783123|NCT00658996|2489664|P1|Crossover Period|Physician Decision|1
783124|NCT00658996|2489663|P2|First Intervention|Lack of lenses|1
783125|NCT00658996|2489664|P1|First Intervention|Lack of lenses|0
783126|NCT00658996|2489663|P2|First Intervention|Positive slit lamp finding|0
783127|NCT00658996|2489664|P1|First Intervention|Positive slit lamp finding|1
783128|NCT00659061|2489676|P2|Overall Study|Migration due to political unrest|15
783129|NCT00659061|2489677|P1|Overall Study|Migration due to political unrest|21
891973|NCT01009463|2828583|P3|4-week, Open-label Run-In Period|Adverse Event|0
891974|NCT01009463|2828584|P2|4-week, Open-label Run-In Period|Adverse Event|0
891975|NCT01009463|2828585|P1|4-week, Open-label Run-In Period|Adverse Event|10
891976|NCT01009463|2828581|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
891977|NCT01009463|2828582|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
783136|NCT00659269|2489721|P2|Overall Study|Physician Decision|1
783137|NCT00659269|2489722|P1|Overall Study|Physician Decision|1
783138|NCT00659334|2489766|P7|Overall Study|Screen Failure|1
783139|NCT00659334|2489767|P6|Overall Study|Screen Failure|0
783140|NCT00659334|2489768|P5|Overall Study|Screen Failure|0
783141|NCT00659334|2489769|P4|Overall Study|Screen Failure|0
783142|NCT00659334|2489770|P3|Overall Study|Screen Failure|0
783143|NCT00659334|2489771|P2|Overall Study|Screen Failure|5
783144|NCT00659334|2489772|P1|Overall Study|Screen Failure|8
783145|NCT00659373|2489798|P2|Overall Study|Assessment Missed|2
783146|NCT00659373|2489799|P1|Overall Study|Assessment Missed|2
783147|NCT00659373|2489798|P2|Overall Study|Withdrawal by Subject|5
783148|NCT00659373|2489799|P1|Overall Study|Withdrawal by Subject|3
783149|NCT00659425|2489815|P10|Overall Study|Unspecified|6
783150|NCT00659425|2489816|P9|Overall Study|Unspecified|0
783151|NCT00659425|2489817|P8|Overall Study|Unspecified|2
783152|NCT00659425|2489818|P7|Overall Study|Unspecified|3
783153|NCT00659425|2489819|P6|Overall Study|Unspecified|0
783154|NCT00659425|2489820|P5|Overall Study|Unspecified|4
783155|NCT00659425|2489821|P4|Overall Study|Unspecified|2
783156|NCT00659425|2489822|P3|Overall Study|Unspecified|1
783157|NCT00659425|2489823|P2|Overall Study|Unspecified|1
783158|NCT00659425|2489824|P1|Overall Study|Unspecified|0
783159|NCT00659425|2489815|P10|Overall Study|Investigator Discretion|0
783160|NCT00659425|2489816|P9|Overall Study|Investigator Discretion|0
783161|NCT00659425|2489817|P8|Overall Study|Investigator Discretion|3
783162|NCT00659425|2489818|P7|Overall Study|Investigator Discretion|0
783163|NCT00659425|2489819|P6|Overall Study|Investigator Discretion|1
783164|NCT00659425|2489820|P5|Overall Study|Investigator Discretion|0
783165|NCT00659425|2489821|P4|Overall Study|Investigator Discretion|0
783166|NCT00659425|2489822|P3|Overall Study|Investigator Discretion|0
783167|NCT00659425|2489823|P2|Overall Study|Investigator Discretion|0
783168|NCT00659425|2489824|P1|Overall Study|Investigator Discretion|0
783169|NCT00659425|2489815|P10|Overall Study|Adverse Event|4
783170|NCT00659425|2489816|P9|Overall Study|Adverse Event|1
783171|NCT00659425|2489817|P8|Overall Study|Adverse Event|3
783172|NCT00659425|2489818|P7|Overall Study|Adverse Event|0
783173|NCT00659425|2489819|P6|Overall Study|Adverse Event|1
783174|NCT00659425|2489820|P5|Overall Study|Adverse Event|0
783175|NCT00659425|2489821|P4|Overall Study|Adverse Event|0
783176|NCT00659425|2489822|P3|Overall Study|Adverse Event|0
783177|NCT00659425|2489823|P2|Overall Study|Adverse Event|0
783178|NCT00659425|2489824|P1|Overall Study|Adverse Event|0
783179|NCT00659425|2489815|P10|Overall Study|Death|0
783180|NCT00659425|2489816|P9|Overall Study|Death|0
783181|NCT00659425|2489817|P8|Overall Study|Death|0
783182|NCT00659425|2489818|P7|Overall Study|Death|1
783183|NCT00659425|2489819|P6|Overall Study|Death|0
783184|NCT00659425|2489820|P5|Overall Study|Death|0
783185|NCT00659425|2489821|P4|Overall Study|Death|1
783186|NCT00659425|2489822|P3|Overall Study|Death|0
783187|NCT00659425|2489823|P2|Overall Study|Death|0
783188|NCT00659425|2489824|P1|Overall Study|Death|0
783189|NCT00659425|2489815|P10|Overall Study|Disease progression|3
783190|NCT00659425|2489816|P9|Overall Study|Disease progression|5
783191|NCT00659425|2489817|P8|Overall Study|Disease progression|3
783192|NCT00659425|2489818|P7|Overall Study|Disease progression|4
783193|NCT00659425|2489819|P6|Overall Study|Disease progression|2
783194|NCT00659425|2489820|P5|Overall Study|Disease progression|0
783195|NCT00659425|2489821|P4|Overall Study|Disease progression|1
783196|NCT00659425|2489822|P3|Overall Study|Disease progression|0
783197|NCT00659425|2489823|P2|Overall Study|Disease progression|0
783198|NCT00659425|2489824|P1|Overall Study|Disease progression|1
783199|NCT00659438|2490055|P2|Overall Study|Lost to Follow-up|0
783200|NCT00659438|2490056|P1|Overall Study|Lost to Follow-up|1
783201|NCT00659438|2490055|P2|Overall Study|Death|6
783202|NCT00659438|2490056|P1|Overall Study|Death|11
783203|NCT00659438|2490055|P2|Overall Study|Withdrawal by Subject|2
783204|NCT00659438|2490056|P1|Overall Study|Withdrawal by Subject|2
783205|NCT00659490|2490081|P3|Overall Study|Lost to Follow-up|1
783206|NCT00659490|2490082|P2|Overall Study|Lost to Follow-up|0
783207|NCT00659490|2490083|P1|Overall Study|Lost to Follow-up|2
783208|NCT00659529|2490154|P1|Overall Study|Screen failure|9
783210|NCT00659529|2490154|P1|Overall Study|Withdrawal by Subject|4
783211|NCT00659581|2490158|P1|Overall Study|Other|6393
783212|NCT00659581|2490158|P1|Overall Study|Lack of Efficacy|1183
783213|NCT00659581|2490158|P1|Overall Study|Adverse Event|1006
783214|NCT00659607|2490170|P1|Overall Study|Inconsistent BP measuring date|2
783215|NCT00659607|2490170|P1|Overall Study|No recorded efficacy data|15
783216|NCT00659607|2490170|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
783217|NCT00659607|2490170|P1|Overall Study|Unknown measuring date of blood pressure|85
783218|NCT00659607|2490170|P1|Overall Study|No blood pressure recorded|147
783219|NCT00659815|2490253|P2|Overall Study|Withdrawal by Subject|1
783220|NCT00659815|2490254|P1|Overall Study|Withdrawal by Subject|1
783221|NCT00659815|2490253|P2|Overall Study|Inability to maintain wearing schedule|2
783222|NCT00659815|2490254|P1|Overall Study|Inability to maintain wearing schedule|1
783223|NCT00659815|2490253|P2|Overall Study|Study related symptoms and complaints|1
783224|NCT00659815|2490254|P1|Overall Study|Study related symptoms and complaints|2
783225|NCT00659880|2490264|P1|Overall Study|Lost to Follow-up|5
783226|NCT00659984|2490278|P1|Overall Study|Adverse Event|1
783227|NCT00660010|2490289|P1|Overall Study|Noncompliance with visit schedule|3
783228|NCT00660010|2490289|P1|Overall Study|Adverse Event|1
783229|NCT00660010|2490289|P1|Overall Study|Lost to Follow-up|3
783230|NCT00660010|2490289|P1|Overall Study|Withdrawal by Subject|2
783231|NCT00660023|2490303|P1|Overall Study|Other Screening Failure|9
783232|NCT00660023|2490303|P1|Overall Study|Missed Pregnancy Test|1
783233|NCT00660023|2490303|P1|Overall Study|Withdrawal by Subject|1
783234|NCT00660023|2490303|P1|Overall Study|Renal Transplantation|3
783235|NCT00660023|2490303|P1|Overall Study|Blood Transfusion|5
783236|NCT00660023|2490303|P1|Overall Study|Death|8
783237|NCT00660023|2490303|P1|Overall Study|Adverse Event|2
783238|NCT00666835|2490320|P2|Overall Study|Physician Decision|2
783239|NCT00666835|2490321|P1|Overall Study|Physician Decision|1
783240|NCT00666835|2490320|P2|Overall Study|Planned operation|0
783241|NCT00666835|2490321|P1|Overall Study|Planned operation|2
783242|NCT00666835|2490320|P2|Overall Study|Hemoglobulin concentration|3
783243|NCT00666835|2490321|P1|Overall Study|Hemoglobulin concentration|4
783244|NCT00666835|2490320|P2|Overall Study|Kidney Transplantation (NTX)|2
783245|NCT00666835|2490321|P1|Overall Study|Kidney Transplantation (NTX)|10
783246|NCT00666835|2490320|P2|Overall Study|Death|4
783247|NCT00666835|2490321|P1|Overall Study|Death|15
783248|NCT00666835|2490320|P2|Overall Study|Protocol Violation|0
783249|NCT00666835|2490321|P1|Overall Study|Protocol Violation|2
783250|NCT00666835|2490320|P2|Overall Study|Adverse Event|6
783251|NCT00666835|2490321|P1|Overall Study|Adverse Event|7
783252|NCT00666835|2490320|P2|Overall Study|Incl./excl. not fulfilled|2
783253|NCT00666835|2490321|P1|Overall Study|Incl./excl. not fulfilled|7
783254|NCT00666835|2490320|P2|Overall Study|Lack of Efficacy|1
783255|NCT00666835|2490321|P1|Overall Study|Lack of Efficacy|0
783256|NCT00666835|2490320|P2|Overall Study|Withdrawal by Subject|2
783257|NCT00666835|2490321|P1|Overall Study|Withdrawal by Subject|5
783258|NCT00666926|2490345|P16|Overall Study|Death|0
783259|NCT00666926|2490346|P15|Overall Study|Death|0
783260|NCT00666926|2490347|P14|Overall Study|Death|0
783261|NCT00666926|2490348|P13|Overall Study|Death|0
783262|NCT00666926|2490349|P12|Overall Study|Death|1
783263|NCT00666926|2490350|P11|Overall Study|Death|0
783264|NCT00666926|2490351|P10|Overall Study|Death|0
783265|NCT00666926|2490352|P9|Overall Study|Death|0
783266|NCT00666926|2490353|P8|Overall Study|Death|0
783267|NCT00666926|2490354|P7|Overall Study|Death|0
783268|NCT00666926|2490355|P6|Overall Study|Death|0
783269|NCT00666926|2490356|P5|Overall Study|Death|0
783270|NCT00666926|2490357|P4|Overall Study|Death|0
783271|NCT00666926|2490358|P3|Overall Study|Death|0
783272|NCT00666926|2490359|P2|Overall Study|Death|0
783273|NCT00666926|2490360|P1|Overall Study|Death|0
783274|NCT00666926|2490345|P16|Overall Study|Withdrawal by Subject|3
783275|NCT00666926|2490346|P15|Overall Study|Withdrawal by Subject|3
783276|NCT00666926|2490347|P14|Overall Study|Withdrawal by Subject|1
783277|NCT00666926|2490348|P13|Overall Study|Withdrawal by Subject|0
783278|NCT00666926|2490349|P12|Overall Study|Withdrawal by Subject|3
783279|NCT00666926|2490350|P11|Overall Study|Withdrawal by Subject|0
783280|NCT00666926|2490351|P10|Overall Study|Withdrawal by Subject|3
783281|NCT00666926|2490352|P9|Overall Study|Withdrawal by Subject|0
783282|NCT00666926|2490353|P8|Overall Study|Withdrawal by Subject|1
783283|NCT00666926|2490354|P7|Overall Study|Withdrawal by Subject|0
783284|NCT00666926|2490355|P6|Overall Study|Withdrawal by Subject|0
783285|NCT00666926|2490356|P5|Overall Study|Withdrawal by Subject|0
783286|NCT00666926|2490357|P4|Overall Study|Withdrawal by Subject|0
783287|NCT00666926|2490358|P3|Overall Study|Withdrawal by Subject|0
783288|NCT00666926|2490359|P2|Overall Study|Withdrawal by Subject|0
783289|NCT00666926|2490360|P1|Overall Study|Withdrawal by Subject|0
783290|NCT00666926|2490345|P16|Overall Study|Unspecified|4
783291|NCT00666926|2490346|P15|Overall Study|Unspecified|4
783292|NCT00666926|2490347|P14|Overall Study|Unspecified|2
783293|NCT00666926|2490348|P13|Overall Study|Unspecified|3
783294|NCT00666926|2490349|P12|Overall Study|Unspecified|26
783295|NCT00666926|2490350|P11|Overall Study|Unspecified|3
783296|NCT00666926|2490351|P10|Overall Study|Unspecified|5
783297|NCT00666926|2490352|P9|Overall Study|Unspecified|3
783298|NCT00666926|2490353|P8|Overall Study|Unspecified|0
783299|NCT00666926|2490354|P7|Overall Study|Unspecified|4
783300|NCT00666926|2490355|P6|Overall Study|Unspecified|3
783301|NCT00666926|2490356|P5|Overall Study|Unspecified|3
783302|NCT00666926|2490357|P4|Overall Study|Unspecified|3
783303|NCT00666926|2490358|P3|Overall Study|Unspecified|3
783304|NCT00666926|2490359|P2|Overall Study|Unspecified|4
783305|NCT00666926|2490360|P1|Overall Study|Unspecified|2
783306|NCT00666926|2490345|P16|Overall Study|Lost to Follow-up|0
783307|NCT00666926|2490346|P15|Overall Study|Lost to Follow-up|0
783308|NCT00666926|2490347|P14|Overall Study|Lost to Follow-up|0
783309|NCT00666926|2490348|P13|Overall Study|Lost to Follow-up|0
783310|NCT00666926|2490349|P12|Overall Study|Lost to Follow-up|0
783311|NCT00666926|2490350|P11|Overall Study|Lost to Follow-up|0
783312|NCT00666926|2490351|P10|Overall Study|Lost to Follow-up|0
783313|NCT00666926|2490352|P9|Overall Study|Lost to Follow-up|0
783314|NCT00666926|2490353|P8|Overall Study|Lost to Follow-up|0
783315|NCT00666926|2490354|P7|Overall Study|Lost to Follow-up|0
783316|NCT00666926|2490355|P6|Overall Study|Lost to Follow-up|0
783317|NCT00666926|2490356|P5|Overall Study|Lost to Follow-up|0
783318|NCT00666926|2490357|P4|Overall Study|Lost to Follow-up|1
783319|NCT00666926|2490358|P3|Overall Study|Lost to Follow-up|0
783320|NCT00666926|2490359|P2|Overall Study|Lost to Follow-up|0
783321|NCT00666926|2490360|P1|Overall Study|Lost to Follow-up|0
783322|NCT00666926|2490345|P16|Overall Study|Lack of Efficacy|0
783323|NCT00666926|2490346|P15|Overall Study|Lack of Efficacy|0
783324|NCT00666926|2490347|P14|Overall Study|Lack of Efficacy|0
783325|NCT00666926|2490348|P13|Overall Study|Lack of Efficacy|0
783326|NCT00666926|2490349|P12|Overall Study|Lack of Efficacy|1
783327|NCT00666926|2490350|P11|Overall Study|Lack of Efficacy|0
783328|NCT00666926|2490351|P10|Overall Study|Lack of Efficacy|0
783329|NCT00666926|2490352|P9|Overall Study|Lack of Efficacy|0
783330|NCT00666926|2490353|P8|Overall Study|Lack of Efficacy|0
783331|NCT00666926|2490354|P7|Overall Study|Lack of Efficacy|0
783332|NCT00666926|2490355|P6|Overall Study|Lack of Efficacy|1
783333|NCT00666926|2490356|P5|Overall Study|Lack of Efficacy|0
783334|NCT00666926|2490357|P4|Overall Study|Lack of Efficacy|0
783335|NCT00666926|2490358|P3|Overall Study|Lack of Efficacy|0
783336|NCT00666926|2490359|P2|Overall Study|Lack of Efficacy|0
783337|NCT00666926|2490360|P1|Overall Study|Lack of Efficacy|0
783338|NCT00666926|2490345|P16|Overall Study|Laboratory abnormality|1
783339|NCT00666926|2490346|P15|Overall Study|Laboratory abnormality|0
783340|NCT00666926|2490347|P14|Overall Study|Laboratory abnormality|0
783341|NCT00666926|2490348|P13|Overall Study|Laboratory abnormality|0
783342|NCT00666926|2490349|P12|Overall Study|Laboratory abnormality|0
783343|NCT00666926|2490350|P11|Overall Study|Laboratory abnormality|1
783344|NCT00666926|2490351|P10|Overall Study|Laboratory abnormality|0
783345|NCT00666926|2490352|P9|Overall Study|Laboratory abnormality|0
783346|NCT00666926|2490353|P8|Overall Study|Laboratory abnormality|0
783347|NCT00666926|2490354|P7|Overall Study|Laboratory abnormality|0
783348|NCT00666926|2490355|P6|Overall Study|Laboratory abnormality|0
783349|NCT00666926|2490356|P5|Overall Study|Laboratory abnormality|0
783350|NCT00666926|2490357|P4|Overall Study|Laboratory abnormality|0
783351|NCT00666926|2490358|P3|Overall Study|Laboratory abnormality|0
783352|NCT00666926|2490359|P2|Overall Study|Laboratory abnormality|0
783353|NCT00666926|2490360|P1|Overall Study|Laboratory abnormality|0
783354|NCT00666926|2490345|P16|Overall Study|Adverse Event|0
783355|NCT00666926|2490346|P15|Overall Study|Adverse Event|0
783356|NCT00666926|2490347|P14|Overall Study|Adverse Event|1
783357|NCT00666926|2490348|P13|Overall Study|Adverse Event|0
783358|NCT00666926|2490349|P12|Overall Study|Adverse Event|2
783359|NCT00666926|2490350|P11|Overall Study|Adverse Event|2
783360|NCT00666926|2490351|P10|Overall Study|Adverse Event|2
783361|NCT00666926|2490352|P9|Overall Study|Adverse Event|0
783362|NCT00666926|2490353|P8|Overall Study|Adverse Event|0
783363|NCT00666926|2490354|P7|Overall Study|Adverse Event|0
783364|NCT00666926|2490355|P6|Overall Study|Adverse Event|0
783365|NCT00666926|2490356|P5|Overall Study|Adverse Event|0
783366|NCT00666926|2490357|P4|Overall Study|Adverse Event|0
783367|NCT00666926|2490358|P3|Overall Study|Adverse Event|0
783368|NCT00666926|2490359|P2|Overall Study|Adverse Event|0
783369|NCT00666926|2490360|P1|Overall Study|Adverse Event|0
783370|NCT00666965|2490655|P4|Overall Study|Withdrawal by Subject|2
783371|NCT00666965|2490656|P3|Overall Study|Withdrawal by Subject|0
783372|NCT00666965|2490657|P2|Overall Study|Withdrawal by Subject|0
783373|NCT00666965|2490658|P1|Overall Study|Withdrawal by Subject|0
783374|NCT00666965|2490655|P4|Overall Study|Discontinuation criteria|2
783375|NCT00666965|2490656|P3|Overall Study|Discontinuation criteria|1
783376|NCT00666965|2490657|P2|Overall Study|Discontinuation criteria|1
783377|NCT00666965|2490658|P1|Overall Study|Discontinuation criteria|2
783378|NCT00666965|2490655|P4|Overall Study|Protocol Violation|2
783379|NCT00666965|2490656|P3|Overall Study|Protocol Violation|0
783380|NCT00666965|2490657|P2|Overall Study|Protocol Violation|0
783381|NCT00666965|2490658|P1|Overall Study|Protocol Violation|0
783382|NCT00666965|2490655|P4|Overall Study|Lack of Efficacy|0
783383|NCT00666965|2490656|P3|Overall Study|Lack of Efficacy|0
783384|NCT00666965|2490657|P2|Overall Study|Lack of Efficacy|1
783385|NCT00666965|2490658|P1|Overall Study|Lack of Efficacy|1
783386|NCT00666965|2490655|P4|Overall Study|Adverse Event|9
783387|NCT00666965|2490656|P3|Overall Study|Adverse Event|1
783388|NCT00666965|2490657|P2|Overall Study|Adverse Event|2
783389|NCT00666965|2490658|P1|Overall Study|Adverse Event|0
783390|NCT00667095|2490702|P2|Overall Study|Withdrawal by Subject|1
783391|NCT00667095|2490703|P1|Overall Study|Withdrawal by Subject|0
783392|NCT00667225|2490732|P2|Overall Study|Lost to Follow-up|1
783393|NCT00667225|2490733|P1|Overall Study|Lost to Follow-up|0
783394|NCT00667225|2490732|P2|Overall Study|Subject had no more lesions to treat.|0
783395|NCT00667225|2490733|P1|Overall Study|Subject had no more lesions to treat.|1
783396|NCT00667251|2490743|P2|Overall Study|Symptomatic progression|2
783397|NCT00667251|2490744|P1|Overall Study|Symptomatic progression|1
783398|NCT00667251|2490743|P2|Overall Study|Intercurrent Illness|3
783399|NCT00667251|2490744|P1|Overall Study|Intercurrent Illness|4
783400|NCT00667251|2490743|P2|Overall Study|Other/missing|84
783401|NCT00667251|2490744|P1|Overall Study|Other/missing|46
783402|NCT00667251|2490743|P2|Overall Study|Withdrawal by Subject|2
783403|NCT00667251|2490744|P1|Overall Study|Withdrawal by Subject|6
783404|NCT00667251|2490743|P2|Overall Study|Adverse Event|4
783405|NCT00667251|2490744|P1|Overall Study|Adverse Event|13
783406|NCT00667277|2490768|P1|Overall Study|Withdrawal by Subject|2
783407|NCT00667342|2490776|P3|Overall Study|Ineligible|1
783408|NCT00667342|2490777|P2|Overall Study|Ineligible|0
783409|NCT00667342|2490778|P1|Overall Study|Ineligible|0
783410|NCT00667342|2490776|P3|Overall Study|Adverse Event|1
783411|NCT00667342|2490777|P2|Overall Study|Adverse Event|0
783412|NCT00667342|2490778|P1|Overall Study|Adverse Event|0
783413|NCT00667342|2490776|P3|Overall Study|Relapse or tumor progression|7
783414|NCT00667342|2490777|P2|Overall Study|Relapse or tumor progression|0
783415|NCT00667342|2490778|P1|Overall Study|Relapse or tumor progression|9
783416|NCT00667342|2490776|P3|Overall Study|Physician Decision|0
783417|NCT00667342|2490777|P2|Overall Study|Physician Decision|0
783418|NCT00667342|2490778|P1|Overall Study|Physician Decision|3
783419|NCT00667342|2490776|P3|Overall Study|Withdrawal by Subject|0
783420|NCT00667342|2490777|P2|Overall Study|Withdrawal by Subject|0
783421|NCT00667342|2490778|P1|Overall Study|Withdrawal by Subject|1
783422|NCT00667342|2490776|P3|Overall Study|Protocol Violation|0
783423|NCT00667342|2490777|P2|Overall Study|Protocol Violation|0
783424|NCT00667342|2490778|P1|Overall Study|Protocol Violation|1
783425|NCT00667355|2490816|P1|Overall Study|Other reason was not specified|5
783426|NCT00667355|2490816|P1|Overall Study|Lost to Follow-up|1
783427|NCT00667355|2490816|P1|Overall Study|Adverse Event|5
783428|NCT00667368|2490840|P2|Overall Study|Discontinued early|17
783429|NCT00667368|2490841|P1|Overall Study|Discontinued early|24
783430|NCT00667368|2490840|P2|Overall Study|Lost to Follow-up|155
783431|NCT00667368|2490841|P1|Overall Study|Lost to Follow-up|176
783432|NCT00667394|2490868|P2|Overall Study|Progressive disease|0
783433|NCT00667394|2490869|P1|Overall Study|Progressive disease|1
783434|NCT00667394|2490868|P2|Overall Study|Adverse Event|0
783435|NCT00667394|2490869|P1|Overall Study|Adverse Event|3
783436|NCT00667420|2490877|P1|Overall Study|Withdrawal by Subject|2
783437|NCT00667420|2490877|P1|Overall Study|Physician Decision|1
783438|NCT00667420|2490877|P1|Overall Study|Lack of Efficacy|5
783439|NCT00667420|2490877|P1|Overall Study|Adverse Event|2
783440|NCT00667446|2490887|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
783441|NCT00667446|2490888|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
783442|NCT00667446|2490887|P2|Treatment Period (36 Months)|Therapeutic Failure|1
783443|NCT00667446|2490888|P1|Treatment Period (36 Months)|Therapeutic Failure|1
783444|NCT00667446|2490887|P2|Treatment Period (36 Months)|Protocol Violation|1
783445|NCT00667446|2490888|P1|Treatment Period (36 Months)|Protocol Violation|1
783446|NCT00667446|2490887|P2|Treatment Period (36 Months)|Lost to Follow-up|0
783447|NCT00667446|2490888|P1|Treatment Period (36 Months)|Lost to Follow-up|1
783448|NCT00667446|2490887|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
783449|NCT00667446|2490888|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
783450|NCT00667446|2490887|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
783451|NCT00667446|2490888|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
783452|NCT00667446|2490887|P2|Treatment Period (36 Months)|Personal reasons|2
783453|NCT00667446|2490888|P1|Treatment Period (36 Months)|Personal reasons|2
783454|NCT00667446|2490887|P2|Treatment Period (36 Months)|Other|2
783455|NCT00667446|2490888|P1|Treatment Period (36 Months)|Other|2
783456|NCT00667446|2490887|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
783457|NCT00667446|2490888|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
783458|NCT00667459|2490912|P2|Overall Study|Lost to Follow-up|43
783459|NCT00667459|2490913|P1|Overall Study|Lost to Follow-up|8
783460|NCT00667459|2490912|P2|Overall Study|Death|2
783461|NCT00667459|2490913|P1|Overall Study|Death|0
783462|NCT00667563|2490961|P1|Overall Study|Protocol Violation|24
783463|NCT00667576|2490976|P5|Overall Study|Missed Visit|0
783464|NCT00667576|2490977|P4|Overall Study|Missed Visit|1
783465|NCT00667576|2490978|P3|Overall Study|Missed Visit|0
783466|NCT00667576|2490979|P2|Overall Study|Missed Visit|0
783467|NCT00667576|2490980|P1|Overall Study|Missed Visit|0
783468|NCT00667576|2490976|P5|Overall Study|Physician Decision|0
783469|NCT00667576|2490977|P4|Overall Study|Physician Decision|1
783470|NCT00667576|2490978|P3|Overall Study|Physician Decision|0
783471|NCT00667576|2490979|P2|Overall Study|Physician Decision|0
783472|NCT00667576|2490980|P1|Overall Study|Physician Decision|0
783473|NCT00667576|2490976|P5|Overall Study|Protocol Violation|0
783474|NCT00667576|2490977|P4|Overall Study|Protocol Violation|1
783475|NCT00667576|2490978|P3|Overall Study|Protocol Violation|0
783476|NCT00667576|2490979|P2|Overall Study|Protocol Violation|0
783477|NCT00667576|2490980|P1|Overall Study|Protocol Violation|0
783478|NCT00667576|2490976|P5|Overall Study|Lost to Follow-up|0
783479|NCT00667576|2490977|P4|Overall Study|Lost to Follow-up|0
783480|NCT00667576|2490978|P3|Overall Study|Lost to Follow-up|1
783481|NCT00667576|2490979|P2|Overall Study|Lost to Follow-up|0
783482|NCT00667576|2490980|P1|Overall Study|Lost to Follow-up|0
783483|NCT00667576|2490976|P5|Overall Study|Adverse Event|0
783484|NCT00667576|2490977|P4|Overall Study|Adverse Event|0
783485|NCT00667576|2490978|P3|Overall Study|Adverse Event|0
783486|NCT00667576|2490979|P2|Overall Study|Adverse Event|1
783487|NCT00667576|2490980|P1|Overall Study|Adverse Event|1
783488|NCT00667576|2490976|P5|Overall Study|Withdrawal by Subject|1
783489|NCT00667576|2490977|P4|Overall Study|Withdrawal by Subject|1
783490|NCT00667576|2490978|P3|Overall Study|Withdrawal by Subject|1
783491|NCT00667576|2490979|P2|Overall Study|Withdrawal by Subject|0
783492|NCT00667576|2490980|P1|Overall Study|Withdrawal by Subject|1
783493|NCT00667602|2491047|P3|Overall Study|Protocol Violation|0
783494|NCT00667602|2491048|P2|Overall Study|Protocol Violation|1
783495|NCT00667602|2491049|P1|Overall Study|Protocol Violation|0
783496|NCT00667602|2491047|P3|Overall Study|Administrative reason|2
783497|NCT00667602|2491048|P2|Overall Study|Administrative reason|0
783498|NCT00667602|2491049|P1|Overall Study|Administrative reason|0
783499|NCT00667602|2491047|P3|Overall Study|Lost to Follow-up|6
783500|NCT00667602|2491048|P2|Overall Study|Lost to Follow-up|5
783501|NCT00667602|2491049|P1|Overall Study|Lost to Follow-up|4
783502|NCT00667602|2491047|P3|Overall Study|Withdrawal by Subject|10
783503|NCT00667602|2491048|P2|Overall Study|Withdrawal by Subject|9
783504|NCT00667602|2491049|P1|Overall Study|Withdrawal by Subject|4
783505|NCT00667732|2491106|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
783506|NCT00667732|2491107|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
783507|NCT00667732|2491108|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
783508|NCT00667732|2491106|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
783509|NCT00667732|2491107|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
783510|NCT00667732|2491108|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
783511|NCT00667732|2491106|P3|Run -In (8 Weeks)|Adverse Event|0
783512|NCT00667732|2491107|P2|Run -In (8 Weeks)|Adverse Event|0
783513|NCT00667732|2491108|P1|Run -In (8 Weeks)|Adverse Event|4
783514|NCT00667810|2491134|P4|Overall Study|Not specified|0
783515|NCT00667810|2491135|P3|Overall Study|Not specified|5
783516|NCT00667810|2491136|P2|Overall Study|Not specified|6
783517|NCT00667810|2491137|P1|Overall Study|Not specified|6
783518|NCT00667810|2491134|P4|Overall Study|Vasogenic Edema Recurrence|0
783519|NCT00667810|2491135|P3|Overall Study|Vasogenic Edema Recurrence|0
783520|NCT00667810|2491136|P2|Overall Study|Vasogenic Edema Recurrence|3
783521|NCT00667810|2491137|P1|Overall Study|Vasogenic Edema Recurrence|0
783522|NCT00667810|2491134|P4|Overall Study|Loss of Caregiver|0
783523|NCT00667810|2491135|P3|Overall Study|Loss of Caregiver|3
783524|NCT00667810|2491136|P2|Overall Study|Loss of Caregiver|1
783525|NCT00667810|2491137|P1|Overall Study|Loss of Caregiver|0
783526|NCT00667810|2491134|P4|Overall Study|Failed to Return|0
783527|NCT00667810|2491135|P3|Overall Study|Failed to Return|2
783528|NCT00667810|2491136|P2|Overall Study|Failed to Return|0
783529|NCT00667810|2491137|P1|Overall Study|Failed to Return|0
783530|NCT00667810|2491134|P4|Overall Study|Discontinuation of Study by Sponsor|0
783531|NCT00667810|2491135|P3|Overall Study|Discontinuation of Study by Sponsor|155
783532|NCT00667810|2491136|P2|Overall Study|Discontinuation of Study by Sponsor|118
783533|NCT00667810|2491137|P1|Overall Study|Discontinuation of Study by Sponsor|130
783534|NCT00667810|2491134|P4|Overall Study|Withdrawal by Subject|1
783535|NCT00667810|2491135|P3|Overall Study|Withdrawal by Subject|29
783536|NCT00667810|2491136|P2|Overall Study|Withdrawal by Subject|20
783537|NCT00667810|2491137|P1|Overall Study|Withdrawal by Subject|14
783538|NCT00667810|2491134|P4|Overall Study|Protocol Violation|0
783539|NCT00667810|2491135|P3|Overall Study|Protocol Violation|0
783540|NCT00667810|2491136|P2|Overall Study|Protocol Violation|2
783541|NCT00667810|2491137|P1|Overall Study|Protocol Violation|0
783542|NCT00667810|2491134|P4|Overall Study|Physician Decision|0
783543|NCT00667810|2491135|P3|Overall Study|Physician Decision|2
783544|NCT00667810|2491136|P2|Overall Study|Physician Decision|1
783545|NCT00667810|2491137|P1|Overall Study|Physician Decision|1
783546|NCT00667810|2491134|P4|Overall Study|Lost to Follow-up|0
783547|NCT00667810|2491135|P3|Overall Study|Lost to Follow-up|2
783548|NCT00667810|2491136|P2|Overall Study|Lost to Follow-up|4
783549|NCT00667810|2491137|P1|Overall Study|Lost to Follow-up|1
783550|NCT00667810|2491134|P4|Overall Study|Lack of Efficacy|0
783551|NCT00667810|2491135|P3|Overall Study|Lack of Efficacy|2
783552|NCT00667810|2491136|P2|Overall Study|Lack of Efficacy|0
783553|NCT00667810|2491137|P1|Overall Study|Lack of Efficacy|1
783554|NCT00667810|2491134|P4|Overall Study|Death|0
783555|NCT00667810|2491135|P3|Overall Study|Death|3
783556|NCT00667810|2491136|P2|Overall Study|Death|1
783557|NCT00667810|2491137|P1|Overall Study|Death|1
783558|NCT00667810|2491134|P4|Overall Study|Adverse Event|1
783559|NCT00667810|2491135|P3|Overall Study|Adverse Event|19
783560|NCT00667810|2491136|P2|Overall Study|Adverse Event|14
783561|NCT00667810|2491137|P1|Overall Study|Adverse Event|13
783562|NCT00667875|2491210|P3|Overall Study|Withdrawal by Subject|7
783563|NCT00667875|2491211|P2|Overall Study|Withdrawal by Subject|9
783564|NCT00667875|2491212|P1|Overall Study|Withdrawal by Subject|10
783565|NCT00667875|2491210|P3|Overall Study|Adverse Event|6
783566|NCT00667875|2491211|P2|Overall Study|Adverse Event|2
783567|NCT00667875|2491212|P1|Overall Study|Adverse Event|0
783568|NCT00667992|2491231|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
783569|NCT00667992|2491232|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
783570|NCT00667992|2491231|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
783571|NCT00667992|2491232|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
783572|NCT00667992|2491231|P2|Wash-out|Withdrawal by Subject|0
783573|NCT00667992|2491232|P1|Wash-out|Withdrawal by Subject|1
783574|NCT00667992|2491231|P2|Wash-out|Failure to wash-out|2
783575|NCT00667992|2491232|P1|Wash-out|Failure to wash-out|2
783576|NCT00667992|2491231|P2|Wash-out|Not within one doubling dilution|3
783577|NCT00667992|2491232|P1|Wash-out|Not within one doubling dilution|4
783578|NCT00667992|2491231|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
783579|NCT00667992|2491232|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
783580|NCT00667992|2491231|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
783581|NCT00667992|2491232|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
783582|NCT00667992|2491231|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
783583|NCT00667992|2491232|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
783584|NCT00667992|2491231|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
783585|NCT00667992|2491232|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
783586|NCT00667992|2491231|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
783587|NCT00667992|2491232|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
783588|NCT00667992|2491231|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
783589|NCT00667992|2491232|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
783590|NCT00667992|2491231|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
783591|NCT00667992|2491232|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
783592|NCT00667992|2491231|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
783593|NCT00667992|2491232|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
783594|NCT00668200|2491286|P1|Overall Study|Lost to Follow-up|1
783595|NCT00668200|2491286|P1|Overall Study|Withdrawal by Subject|2
783596|NCT00668317|2491303|P1|Overall Study|Adverse Event|2
783597|NCT00668395|2491314|P3|Overall Study|Physician Decision|0
783598|NCT00668395|2491315|P2|Overall Study|Physician Decision|1
783599|NCT00668395|2491316|P1|Overall Study|Physician Decision|1
783600|NCT00668395|2491314|P3|Overall Study|Adverse Event|0
783601|NCT00668395|2491315|P2|Overall Study|Adverse Event|1
783602|NCT00668395|2491316|P1|Overall Study|Adverse Event|1
783603|NCT00668395|2491314|P3|Overall Study|Withdrawal by Subject|1
783604|NCT00668395|2491315|P2|Overall Study|Withdrawal by Subject|4
783605|NCT00668395|2491316|P1|Overall Study|Withdrawal by Subject|4
783606|NCT00668733|2491362|P2|Overall Study|Withdrawal by Subject|4
783607|NCT00668733|2491363|P1|Overall Study|Withdrawal by Subject|0
783608|NCT00668733|2491362|P2|Overall Study|Lost to Follow-up|3
783609|NCT00668733|2491363|P1|Overall Study|Lost to Follow-up|2
783610|NCT00668746|2491371|P2|Overall Study|Lost to Follow-up|1
783611|NCT00668746|2491372|P1|Overall Study|Lost to Follow-up|2
783612|NCT00668863|2491394|P1|Overall Study|Physician Decision|1
783613|NCT00668863|2491394|P1|Overall Study|Subject’s work scheduling problem|1
783614|NCT00668863|2491394|P1|Overall Study|Surgery|1
783615|NCT00668863|2491394|P1|Overall Study|Withdrawal by Subject|1
783616|NCT00668863|2491394|P1|Overall Study|Global Deterioration of Health Status|4
783617|NCT00668863|2491394|P1|Overall Study|Study Terminated by Sponsor|8
783618|NCT00668863|2491394|P1|Overall Study|Adverse Event|13
783619|NCT00668863|2491394|P1|Overall Study|Objective Progression or Relapse|42
783620|NCT00669032|2491433|P2|Overall Study|No fulfilment of the selection criteria|5
783621|NCT00669032|2491434|P1|Overall Study|No fulfilment of the selection criteria|5
783622|NCT00669032|2491433|P2|Overall Study|Physician Decision|1
783623|NCT00669032|2491434|P1|Overall Study|Physician Decision|1
783624|NCT00669032|2491433|P2|Overall Study|Adverse Event|16
783625|NCT00669032|2491434|P1|Overall Study|Adverse Event|12
783626|NCT00669032|2491433|P2|Overall Study|Withdrawal by Subject|13
783627|NCT00669032|2491434|P1|Overall Study|Withdrawal by Subject|12
783628|NCT00669032|2491433|P2|Overall Study|Lack of Efficacy|19
783629|NCT00669032|2491434|P1|Overall Study|Lack of Efficacy|8
783630|NCT00669032|2491433|P2|Overall Study|Lost to Follow-up|5
783631|NCT00669032|2491434|P1|Overall Study|Lost to Follow-up|6
783632|NCT00669071|2491462|P1|Overall Study|Final visit 40 days out of window|1
783633|NCT00669071|2491462|P1|Overall Study|Lost to Follow-up|3
783634|NCT00669110|2491483|P2|Overall Study|Withdrawal by Subject|2
783635|NCT00669110|2491484|P1|Overall Study|Withdrawal by Subject|0
783636|NCT00669110|2491483|P2|Overall Study|Protocol Violation|5
783637|NCT00669110|2491484|P1|Overall Study|Protocol Violation|0
783638|NCT00669110|2491483|P2|Overall Study|Lost to Follow-up|0
783639|NCT00669110|2491484|P1|Overall Study|Lost to Follow-up|1
783640|NCT00669110|2491483|P2|Overall Study|Physician Decision|1
783641|NCT00669110|2491484|P1|Overall Study|Physician Decision|0
783642|NCT00669110|2491483|P2|Overall Study|Caregiver request|2
783643|NCT00669110|2491484|P1|Overall Study|Caregiver request|3
783644|NCT00669110|2491483|P2|Overall Study|Adverse Event|3
783645|NCT00669110|2491484|P1|Overall Study|Adverse Event|4
783646|NCT00669240|2491555|P1|Overall Study|Enrolled but no dosing record|1
783647|NCT00669240|2491555|P1|Overall Study|Enrolled but not treated|15
783648|NCT00669240|2491555|P1|Overall Study|Unspecified|19
783649|NCT00669240|2491555|P1|Overall Study|Adverse Event|21
783650|NCT00669240|2491555|P1|Overall Study|Lost to Follow-up|34
783651|NCT00669240|2491555|P1|Overall Study|Withdrawal by Subject|42
783652|NCT00669240|2491555|P1|Overall Study|Lack of Efficacy|33
783653|NCT00655356|2491571|P2|Overall Study|Other Reason|0
783654|NCT00655356|2491572|P1|Overall Study|Other Reason|1
783655|NCT00655356|2491571|P2|Overall Study|Protocol Violation|1
783656|NCT00655356|2491572|P1|Overall Study|Protocol Violation|2
783657|NCT00655356|2491571|P2|Overall Study|Adverse Event|1
783658|NCT00655356|2491572|P1|Overall Study|Adverse Event|1
783659|NCT00655356|2491571|P2|Overall Study|Sponsor Request|4
783660|NCT00655356|2491572|P1|Overall Study|Sponsor Request|10
783661|NCT00655356|2491571|P2|Overall Study|Withdrawal by Subject|4
783662|NCT00655356|2491572|P1|Overall Study|Withdrawal by Subject|3
783663|NCT00655486|2491584|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
783664|NCT00655486|2491584|P1|Overall Study|Other: Could not tolerate BID dosing|1
783665|NCT00655486|2491584|P1|Overall Study|Other: Pregnancy|1
783666|NCT00655486|2491584|P1|Overall Study|Unsatisfactory compliance|2
783667|NCT00655486|2491584|P1|Overall Study|Protocol Violation|1
783668|NCT00655486|2491584|P1|Overall Study|Withdrawal by Subject|4
783669|NCT00655486|2491584|P1|Overall Study|Lack of Efficacy|8
783670|NCT00655486|2491584|P1|Overall Study|Adverse Event|10
783671|NCT00655551|2491592|P3|Period 4 (up to 7 Days)|Adverse Event|0
783672|NCT00655551|2491593|P2|Period 4 (up to 7 Days)|Adverse Event|2
783673|NCT00655551|2491594|P1|Period 4 (up to 7 Days)|Adverse Event|0
783674|NCT00655551|2491592|P3|Period 3 (up to 7 Days)|Adverse Event|4
783675|NCT00655551|2491593|P2|Period 3 (up to 7 Days)|Adverse Event|0
783676|NCT00655551|2491594|P1|Period 3 (up to 7 Days)|Adverse Event|0
783677|NCT00655551|2491592|P3|Period 2 (up to 7 Days)|Adverse Event|0
783678|NCT00655551|2491593|P2|Period 2 (up to 7 Days)|Adverse Event|1
783679|NCT00655551|2491594|P1|Period 2 (up to 7 Days)|Adverse Event|0
783680|NCT00655551|2491592|P3|All Periods Combined|Adverse Event|4
783681|NCT00655551|2491593|P2|All Periods Combined|Adverse Event|3
783682|NCT00655551|2491594|P1|All Periods Combined|Adverse Event|0
783686|NCT00655629|2491615|P2|Overall Study|consent withdrawn|4
783687|NCT00655629|2491616|P1|Overall Study|consent withdrawn|6
783688|NCT00655629|2491615|P2|Overall Study|Protocol Violation|3
783689|NCT00655629|2491616|P1|Overall Study|Protocol Violation|5
783690|NCT00655629|2491615|P2|Overall Study|Lost to Follow-up|3
783691|NCT00655629|2491616|P1|Overall Study|Lost to Follow-up|4
783692|NCT00655629|2491615|P2|Overall Study|Lack of Efficacy|12
783693|NCT00655629|2491616|P1|Overall Study|Lack of Efficacy|2
783694|NCT00655629|2491615|P2|Overall Study|Adverse Event|1
783695|NCT00655629|2491616|P1|Overall Study|Adverse Event|4
783696|NCT00655668|2491669|P1|Overall Study|Withdrawal by Subject|2
783697|NCT00655668|2491669|P1|Overall Study|New Lymphoma Treatment Started|4
783698|NCT00655668|2491669|P1|Overall Study|Unspecified|1
783699|NCT00655668|2491669|P1|Overall Study|Study Terminated|9
783700|NCT00655668|2491669|P1|Overall Study|Disease Progression|27
783701|NCT00655668|2491669|P1|Overall Study|Death|5
783702|NCT00655668|2491669|P1|Overall Study|Adverse Event|6
783703|NCT00655733|2491679|P2|Overall Study|Physician Decision|1
783704|NCT00655733|2491680|P1|Overall Study|Physician Decision|0
783705|NCT00655733|2491679|P2|Overall Study|Withdrawal by Subject|3
783706|NCT00655733|2491680|P1|Overall Study|Withdrawal by Subject|3
783707|NCT00655733|2491679|P2|Overall Study|Adverse Event|2
783708|NCT00655733|2491680|P1|Overall Study|Adverse Event|2
783709|NCT00655733|2491679|P2|Overall Study|Lost to Follow-up|2
783710|NCT00655733|2491680|P1|Overall Study|Lost to Follow-up|2
783711|NCT00655746|2491686|P1|Overall Study|Withdrawal by Subject|1
783722|NCT00655850|2491761|P1|Overall Study|Withdrawal by Subject|1
783723|NCT00655850|2491761|P1|Overall Study|Death|2
783724|NCT00655863|2491771|P3|Overall Study|Lost to Follow-up|1
783725|NCT00655863|2491772|P2|Overall Study|Lost to Follow-up|0
783726|NCT00655863|2491773|P1|Overall Study|Lost to Follow-up|0
783727|NCT00655889|2491832|P1|Overall Study|Protocol Violation|1
783728|NCT00655889|2491832|P1|Overall Study|Inadequate cell growth|1
783729|NCT00656058|2491837|P1|Overall Study|Withdrawal by Subject|4
783730|NCT00656058|2491837|P1|Overall Study|Withdrawal by Subject|2
783731|NCT00656084|2491846|P1|Overall Study|Investigator Request|1
783732|NCT00656084|2491846|P1|Overall Study|Patient Request|1
783733|NCT00656084|2491846|P1|Overall Study|Withdrawal by Subject|1
783734|NCT00656084|2491846|P1|Overall Study|Adverse Event|4
783735|NCT00656136|2491855|P2|Overall Study|Unknown and others|4
783736|NCT00656136|2491856|P1|Overall Study|Unknown and others|4
783737|NCT00656136|2491855|P2|Overall Study|Patient refused to take study medication|10
783738|NCT00656136|2491856|P1|Overall Study|Patient refused to take study medication|7
783739|NCT00656136|2491855|P2|Overall Study|Protocol Violation|3
783740|NCT00656136|2491856|P1|Overall Study|Protocol Violation|2
783741|NCT00656136|2491855|P2|Overall Study|Other Adverse Event|51
783742|NCT00656136|2491856|P1|Overall Study|Other Adverse Event|5
783743|NCT00656136|2491855|P2|Overall Study|Progressive disease|322
783744|NCT00656136|2491856|P1|Overall Study|Progressive disease|177
783745|NCT00656175|2491868|P2|Overall Study|Transportation issues|1
783746|NCT00656175|2491869|P1|Overall Study|Transportation issues|0
783747|NCT00656175|2491868|P2|Overall Study|Adverse Event|0
783748|NCT00656175|2491869|P1|Overall Study|Adverse Event|1
783749|NCT00656292|2491886|P2|Overall Study|Screen failure|2
783750|NCT00656292|2491887|P1|Overall Study|Screen failure|1
783751|NCT00656292|2491886|P2|Overall Study|Withdrawal by Subject|3
783752|NCT00656292|2491887|P1|Overall Study|Withdrawal by Subject|2
783753|NCT00656370|2491903|P1|Overall Study|Alternates|3
783754|NCT00656370|2491903|P1|Overall Study|Screen Failures|7
783755|NCT00656474|2491920|P1|Overall Study|Other Reason|1
783756|NCT00656513|2491958|P3|Overall Study|Missing baseline form|5
783757|NCT00656513|2491959|P2|Overall Study|Missing baseline form|5
783758|NCT00656513|2491960|P1|Overall Study|Missing baseline form|0
783759|NCT00656513|2491958|P3|Overall Study|Treatment completed outside of timeframe|1
783760|NCT00656513|2491959|P2|Overall Study|Treatment completed outside of timeframe|3
783761|NCT00656513|2491960|P1|Overall Study|Treatment completed outside of timeframe|0
783762|NCT00656513|2491958|P3|Overall Study|Incomplete treatment|0
783763|NCT00656513|2491959|P2|Overall Study|Incomplete treatment|0
783764|NCT00656513|2491960|P1|Overall Study|Incomplete treatment|3
783765|NCT00656513|2491958|P3|Overall Study|Missing data|9
783766|NCT00656513|2491959|P2|Overall Study|Missing data|11
783767|NCT00656513|2491960|P1|Overall Study|Missing data|0
783768|NCT00656513|2491958|P3|Overall Study|Death|1
783769|NCT00656513|2491959|P2|Overall Study|Death|0
783770|NCT00656513|2491960|P1|Overall Study|Death|0
783771|NCT00656513|2491958|P3|Overall Study|Withdrawal by Subject|4
783772|NCT00656513|2491959|P2|Overall Study|Withdrawal by Subject|11
783773|NCT00656513|2491960|P1|Overall Study|Withdrawal by Subject|0
783774|NCT00656513|2491958|P3|Overall Study|Protocol Violation|2
783775|NCT00656513|2491959|P2|Overall Study|Protocol Violation|0
783776|NCT00656513|2491960|P1|Overall Study|Protocol Violation|1
783777|NCT00656617|2491979|P1|Overall Study|Move to different clinical trial|2
783778|NCT00656617|2491979|P1|Overall Study|Insurance Issues|2
783779|NCT00656617|2491979|P1|Overall Study|Death|2
783780|NCT00656617|2491979|P1|Overall Study|Adverse Event|1
783781|NCT00656669|2492015|P1|AC (Cycles 6-9)|Did not start segment 3|1
783782|NCT00656669|2492015|P1|AC (Cycles 6-9)|Adverse Event|1
783783|NCT00656669|2492015|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
783784|NCT00656669|2492015|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
783785|NCT00656799|2492024|P1|Overall Study|Death|2
783786|NCT00656851|2492048|P2|Overall Study|Withdrawal by Subject|4
783787|NCT00656851|2492049|P1|Overall Study|Withdrawal by Subject|0
783788|NCT00657020|2492091|P2|PERIOD 1|Adverse Event|1
783789|NCT00657020|2492092|P1|PERIOD 1|Adverse Event|0
783790|NCT00657046|2492123|P3|Overall Study|Surgery|1
783791|NCT00657046|2492124|P2|Overall Study|Surgery|0
783792|NCT00657046|2492125|P1|Overall Study|Surgery|0
783793|NCT00657046|2492123|P3|Overall Study|Death|1
783794|NCT00657046|2492124|P2|Overall Study|Death|0
783795|NCT00657046|2492125|P1|Overall Study|Death|0
783796|NCT00657046|2492123|P3|Overall Study|Withdrawal by Subject|0
783797|NCT00657046|2492124|P2|Overall Study|Withdrawal by Subject|0
783798|NCT00657046|2492125|P1|Overall Study|Withdrawal by Subject|1
783799|NCT00657046|2492123|P3|Overall Study|Protocol Violation|0
783800|NCT00657046|2492124|P2|Overall Study|Protocol Violation|2
783801|NCT00657046|2492125|P1|Overall Study|Protocol Violation|2
783802|NCT00657046|2492123|P3|Overall Study|Adverse Event|0
783803|NCT00657046|2492124|P2|Overall Study|Adverse Event|1
783804|NCT00657046|2492125|P1|Overall Study|Adverse Event|1
783805|NCT00657150|2492159|P2|Treatment|Not Specified|15
783806|NCT00657150|2492160|P1|Treatment|Not Specified|13
783807|NCT00657150|2492159|P2|Treatment|Withdrawal by Subject|20
783808|NCT00657150|2492160|P1|Treatment|Withdrawal by Subject|23
783809|NCT00657150|2492159|P2|Treatment|Lost to Follow-up|0
783810|NCT00657150|2492160|P1|Treatment|Lost to Follow-up|1
783811|NCT00657150|2492159|P2|Treatment|Non-compliant with protocol|9
783812|NCT00657150|2492160|P1|Treatment|Non-compliant with protocol|10
783813|NCT00657150|2492159|P2|Treatment|Adverse Event|53
783814|NCT00657150|2492160|P1|Treatment|Adverse Event|60
783815|NCT00657150|2492159|P2|Overall Study|Not Specified|38
783816|NCT00657150|2492160|P1|Overall Study|Not Specified|38
783817|NCT00657150|2492159|P2|Overall Study|Withdrawal by Subject|36
783818|NCT00657150|2492160|P1|Overall Study|Withdrawal by Subject|51
783819|NCT00657150|2492159|P2|Overall Study|Lost to Follow-up|0
783820|NCT00657150|2492160|P1|Overall Study|Lost to Follow-up|2
783821|NCT00657150|2492159|P2|Overall Study|Non-compliant with protocol|9
783822|NCT00657150|2492160|P1|Overall Study|Non-compliant with protocol|5
783823|NCT00657150|2492159|P2|Overall Study|Adverse Event|10
783824|NCT00657150|2492160|P1|Overall Study|Adverse Event|19
783825|NCT00669318|2492197|P1|Overall Study|Withdrawal by Subject|2
783826|NCT00669331|2492207|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
783827|NCT00669331|2492208|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
783828|NCT00669331|2492207|P2|Blinded Treatment Period|Physician Decision|3
783829|NCT00669331|2492208|P1|Blinded Treatment Period|Physician Decision|3
783830|NCT00669331|2492207|P2|Blinded Treatment Period|Death|2
783831|NCT00669331|2492208|P1|Blinded Treatment Period|Death|0
783832|NCT00669331|2492207|P2|Blinded Treatment Period|Lost to Follow-up|2
783833|NCT00669331|2492208|P1|Blinded Treatment Period|Lost to Follow-up|3
783834|NCT00669331|2492207|P2|Blinded Treatment Period|Withdrawal by Subject|19
783835|NCT00669331|2492208|P1|Blinded Treatment Period|Withdrawal by Subject|17
783836|NCT00669331|2492207|P2|Blinded Treatment Period|Protocol Violation|1
783837|NCT00669331|2492208|P1|Blinded Treatment Period|Protocol Violation|1
783838|NCT00669331|2492207|P2|Blinded Treatment Period|Adverse Event|10
783839|NCT00669331|2492208|P1|Blinded Treatment Period|Adverse Event|16
783840|NCT00669331|2492207|P2|Randomisation to First Dose|Randomised in error|10
783841|NCT00669331|2492208|P1|Randomisation to First Dose|Randomised in error|3
783842|NCT00669331|2492207|P2|Randomisation to First Dose|Sponsor decision|1
783843|NCT00669331|2492208|P1|Randomisation to First Dose|Sponsor decision|0
783844|NCT00669331|2492207|P2|Randomisation to First Dose|Death|0
783845|NCT00669331|2492208|P1|Randomisation to First Dose|Death|1
783846|NCT00669331|2492207|P2|Randomisation to First Dose|Lost to Follow-up|0
783847|NCT00669331|2492208|P1|Randomisation to First Dose|Lost to Follow-up|2
783848|NCT00669331|2492207|P2|Randomisation to First Dose|Withdrawal by Subject|2
783849|NCT00669331|2492208|P1|Randomisation to First Dose|Withdrawal by Subject|3
783850|NCT00669331|2492207|P2|Randomisation to First Dose|Protocol Violation|0
783851|NCT00669331|2492208|P1|Randomisation to First Dose|Protocol Violation|1
783852|NCT00669331|2492207|P2|Randomisation to First Dose|Adverse Event|0
783853|NCT00669331|2492208|P1|Randomisation to First Dose|Adverse Event|1
783854|NCT00669396|2492252|P2|Overall Study|Lost to Follow-up|12
783855|NCT00669396|2492253|P1|Overall Study|Lost to Follow-up|10
783856|NCT00670449|2492303|P4|Overall Study|Abnormal Laboratory Value(s)|0
783857|NCT00670449|2492304|P3|Overall Study|Abnormal Laboratory Value(s)|0
783858|NCT00670449|2492305|P2|Overall Study|Abnormal Laboratory Value(s)|2
783859|NCT00670449|2492306|P1|Overall Study|Abnormal Laboratory Value(s)|0
783860|NCT00670449|2492303|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
783861|NCT00670449|2492304|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
783862|NCT00670449|2492305|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
783863|NCT00670449|2492306|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
783864|NCT00670449|2492303|P4|Overall Study|Subject Withdrew Consent|1
783865|NCT00670449|2492304|P3|Overall Study|Subject Withdrew Consent|0
783866|NCT00670449|2492305|P2|Overall Study|Subject Withdrew Consent|2
783867|NCT00670449|2492306|P1|Overall Study|Subject Withdrew Consent|0
783868|NCT00670449|2492303|P4|Overall Study|Administrative Problems|1
783869|NCT00670449|2492304|P3|Overall Study|Administrative Problems|0
783870|NCT00670449|2492305|P2|Overall Study|Administrative Problems|2
783871|NCT00670449|2492306|P1|Overall Study|Administrative Problems|0
783872|NCT00670449|2492303|P4|Overall Study|Protocol Deviation|1
783873|NCT00670449|2492304|P3|Overall Study|Protocol Deviation|0
783874|NCT00670449|2492305|P2|Overall Study|Protocol Deviation|2
783875|NCT00670449|2492306|P1|Overall Study|Protocol Deviation|1
783876|NCT00670449|2492303|P4|Overall Study|Adverse Event|5
783877|NCT00670449|2492304|P3|Overall Study|Adverse Event|8
783878|NCT00670449|2492305|P2|Overall Study|Adverse Event|2
783879|NCT00670449|2492306|P1|Overall Study|Adverse Event|6
783880|NCT00670540|2492361|P1|Overall Study|missing information inclusion criteria|1
783881|NCT00670540|2492361|P1|Overall Study|controls randomised for no follow up|2770
783882|NCT00670540|2492361|P1|Overall Study|refused to participate|189
783883|NCT00670540|2492361|P1|Overall Study|not living in France|348
783884|NCT00670540|2492361|P1|Overall Study|ineligible|17
783885|NCT00670748|2492392|P4|Overall Study|Not off study|1
783886|NCT00670748|2492393|P3|Overall Study|Not off study|1
783887|NCT00670748|2492394|P2|Overall Study|Not off study|1
783888|NCT00670748|2492395|P1|Overall Study|Not off study|2
783889|NCT00670748|2492392|P4|Overall Study|Death during treatment|0
783890|NCT00670748|2492393|P3|Overall Study|Death during treatment|1
783891|NCT00670748|2492394|P2|Overall Study|Death during treatment|1
783892|NCT00670748|2492395|P1|Overall Study|Death during treatment|1
783893|NCT00670800|2492415|P2|Overall Study|2 controls were insulin resistant|2
783894|NCT00670800|2492416|P1|Overall Study|2 controls were insulin resistant|0
783895|NCT00670930|2492434|P2|Overall Study|Lost to Follow-up|0
783896|NCT00670930|2492435|P1|Overall Study|Lost to Follow-up|1
783897|NCT00670930|2492434|P2|Overall Study|Adminstrative Problem|1
783898|NCT00670930|2492435|P1|Overall Study|Adminstrative Problem|0
783899|NCT00671060|2492469|P2|Overall Study|Physician Decision|1
783900|NCT00671060|2492470|P1|Overall Study|Physician Decision|0
783901|NCT00671060|2492469|P2|Overall Study|Protocol Violation|0
783902|NCT00671060|2492470|P1|Overall Study|Protocol Violation|1
783903|NCT00671437|2492489|P1|Overall Study|Ineligible post-hoc|1
783904|NCT00671437|2492489|P1|Overall Study|Adverse Event|3
783905|NCT00671437|2492489|P1|Overall Study|Cutaneous SCC of head and neck|3
783906|NCT00671437|2492489|P1|Overall Study|Progressive disease before C1 week 8|8
783907|NCT00671554|2492542|P1|Overall Study|Disease progression|3
783908|NCT00671749|2492596|P1|Overall Study|Lost to Follow-up|1
783909|NCT00671749|2492596|P1|Overall Study|Protocol Violation|1
783910|NCT00671749|2492596|P1|Overall Study|Withdrawal by Subject|4
783911|NCT00671749|2492596|P1|Overall Study|Adverse Event|2
783912|NCT00671788|2492606|P1|Overall Study|Other|1
783913|NCT00671788|2492606|P1|Overall Study|MD Decision|1
783914|NCT00671788|2492606|P1|Overall Study|Ineligible|1
783915|NCT00671788|2492606|P1|Overall Study|Refused further treatment|3
783916|NCT00671788|2492606|P1|Overall Study|Adverse Event|8
783917|NCT00671853|2492615|P2|Overall Study|Non-adherence with study procedures|4
783918|NCT00671853|2492616|P1|Overall Study|Non-adherence with study procedures|1
783919|NCT00671853|2492615|P2|Overall Study|Physician Decision|2
783920|NCT00671853|2492616|P1|Overall Study|Physician Decision|0
783921|NCT00671853|2492615|P2|Overall Study|Lost to Follow-up|8
783922|NCT00671853|2492616|P1|Overall Study|Lost to Follow-up|8
783923|NCT00671853|2492615|P2|Overall Study|Withdrawal by Subject|5
783924|NCT00671853|2492616|P1|Overall Study|Withdrawal by Subject|1
783925|NCT00671853|2492615|P2|Overall Study|Adverse Event|1
783926|NCT00671853|2492616|P1|Overall Study|Adverse Event|7
783927|NCT00671853|2492615|P2|Overall Study|Lack of Efficacy|7
783928|NCT00671853|2492616|P1|Overall Study|Lack of Efficacy|3
783929|NCT00671879|2492635|P3|Overall Study|Withdrawal by Subject|6
783930|NCT00671879|2492636|P2|Overall Study|Withdrawal by Subject|4
783931|NCT00671879|2492637|P1|Overall Study|Withdrawal by Subject|0
783932|NCT00671931|2492658|P5|Overall Study|Physician Decision|1
783933|NCT00671931|2492659|P4|Overall Study|Physician Decision|2
783934|NCT00671931|2492660|P3|Overall Study|Physician Decision|0
783935|NCT00671931|2492661|P2|Overall Study|Physician Decision|0
783936|NCT00671931|2492662|P1|Overall Study|Physician Decision|1
783937|NCT00672256|2492736|P1|Overall Study|PI dropped, bad data|44
783938|NCT00672490|2492779|P2|Overall Study|No reason was provided|2
783939|NCT00672490|2492780|P1|Overall Study|No reason was provided|6
783940|NCT00672490|2492779|P2|Overall Study|Lost to Follow-up|5
783941|NCT00672490|2492780|P1|Overall Study|Lost to Follow-up|1
783942|NCT00672490|2492779|P2|Overall Study|Intolerance|2
783943|NCT00672490|2492780|P1|Overall Study|Intolerance|0
783944|NCT00672490|2492779|P2|Overall Study|Violation of Concomitant Medicine|0
783945|NCT00672490|2492780|P1|Overall Study|Violation of Concomitant Medicine|1
783946|NCT00672490|2492779|P2|Overall Study|Adverse Event|8
783947|NCT00672490|2492780|P1|Overall Study|Adverse Event|5
783948|NCT00672490|2492779|P2|Overall Study|Mismatch Include/Exclude Criteria|0
783949|NCT00672490|2492780|P1|Overall Study|Mismatch Include/Exclude Criteria|1
783950|NCT00672490|2492779|P2|Overall Study|Lack of Compliance|7
783951|NCT00672490|2492780|P1|Overall Study|Lack of Compliance|2
783952|NCT00672490|2492779|P2|Overall Study|Withdrawal by Subject|8
783953|NCT00672490|2492780|P1|Overall Study|Withdrawal by Subject|8
783954|NCT00672555|2492802|P1|Overall Study|Did not want to answer questionnaire|2
783955|NCT00672555|2492802|P1|Overall Study|Lost to Follow-up|4
783956|NCT00672620|2492826|P4|Overall Study|Reason not Specified|1
783957|NCT00672620|2492827|P3|Overall Study|Reason not Specified|2
783958|NCT00672620|2492828|P2|Overall Study|Reason not Specified|3
783959|NCT00672620|2492829|P1|Overall Study|Reason not Specified|3
783960|NCT00672620|2492826|P4|Overall Study|Lost to Follow-up|11
783961|NCT00672620|2492827|P3|Overall Study|Lost to Follow-up|8
783962|NCT00672620|2492828|P2|Overall Study|Lost to Follow-up|19
783963|NCT00672620|2492829|P1|Overall Study|Lost to Follow-up|8
783964|NCT00672620|2492826|P4|Overall Study|Withdrawal of Consent|6
783965|NCT00672620|2492827|P3|Overall Study|Withdrawal of Consent|5
783966|NCT00672620|2492828|P2|Overall Study|Withdrawal of Consent|12
783967|NCT00672620|2492829|P1|Overall Study|Withdrawal of Consent|6
783968|NCT00672620|2492826|P4|Overall Study|Protocol Deviations|5
783969|NCT00672620|2492827|P3|Overall Study|Protocol Deviations|2
783970|NCT00672620|2492828|P2|Overall Study|Protocol Deviations|7
783971|NCT00672620|2492829|P1|Overall Study|Protocol Deviations|5
783972|NCT00672620|2492826|P4|Overall Study|Noncompliance with Study Drug|2
783973|NCT00672620|2492827|P3|Overall Study|Noncompliance with Study Drug|0
783974|NCT00672620|2492828|P2|Overall Study|Noncompliance with Study Drug|4
783975|NCT00672620|2492829|P1|Overall Study|Noncompliance with Study Drug|3
783976|NCT00672620|2492826|P4|Overall Study|Lack of Efficacy|0
783977|NCT00672620|2492827|P3|Overall Study|Lack of Efficacy|2
783978|NCT00672620|2492828|P2|Overall Study|Lack of Efficacy|2
783979|NCT00672620|2492829|P1|Overall Study|Lack of Efficacy|1
783980|NCT00672620|2492826|P4|Overall Study|Adverse Event|17
783981|NCT00672620|2492827|P3|Overall Study|Adverse Event|12
783982|NCT00672620|2492828|P2|Overall Study|Adverse Event|7
783983|NCT00672620|2492829|P1|Overall Study|Adverse Event|7
783984|NCT00672633|2492885|P2|Overall Study|Withdrawal by Subject|1
783985|NCT00672633|2492886|P1|Overall Study|Withdrawal by Subject|0
783986|NCT00672646|2492899|P3|Overall Study|Withdrawal by Subject|1
783987|NCT00672646|2492900|P2|Overall Study|Withdrawal by Subject|0
783988|NCT00672646|2492901|P1|Overall Study|Withdrawal by Subject|0
783989|NCT00672646|2492899|P3|Overall Study|Lost to Follow-up|2
783990|NCT00672646|2492900|P2|Overall Study|Lost to Follow-up|1
783991|NCT00672646|2492901|P1|Overall Study|Lost to Follow-up|0
783992|NCT00672841|2492933|P2|Overall Study|Pregnancy|1
783993|NCT00672841|2492934|P1|Overall Study|Pregnancy|0
783994|NCT00672841|2492933|P2|Overall Study|Adverse Event|3
783995|NCT00672841|2492934|P1|Overall Study|Adverse Event|0
783996|NCT00672841|2492933|P2|Overall Study|Antifungal therapy, negative glucan|4
783997|NCT00672841|2492934|P1|Overall Study|Antifungal therapy, negative glucan|0
783998|NCT00672841|2492933|P2|Overall Study|icteric specimens|3
783999|NCT00672841|2492934|P1|Overall Study|icteric specimens|0
784000|NCT00672841|2492933|P2|Overall Study|Comfort care|4
784001|NCT00672841|2492934|P1|Overall Study|Comfort care|1
784002|NCT00672958|2492968|P2|Overall Study|Reason not specified|3
784003|NCT00672958|2492969|P1|Overall Study|Reason not specified|0
784004|NCT00672958|2492968|P2|Overall Study|Lost to Follow-up|17
784005|NCT00672958|2492969|P1|Overall Study|Lost to Follow-up|22
784006|NCT00672958|2492968|P2|Overall Study|Voluntary withdrawal|8
784007|NCT00672958|2492969|P1|Overall Study|Voluntary withdrawal|12
784008|NCT00672958|2492968|P2|Overall Study|Protocol deviations|5
784009|NCT00672958|2492969|P1|Overall Study|Protocol deviations|11
784010|NCT00672958|2492968|P2|Overall Study|Non-compliance with study drug|3
784011|NCT00672958|2492969|P1|Overall Study|Non-compliance with study drug|2
784012|NCT00672958|2492968|P2|Overall Study|Lack of Efficacy|11
784013|NCT00672958|2492969|P1|Overall Study|Lack of Efficacy|6
784014|NCT00672958|2492968|P2|Overall Study|Adverse Event|9
784015|NCT00672958|2492969|P1|Overall Study|Adverse Event|11
784016|NCT00660179|2493011|P3|Overall Study|Incorrect randomization|0
784017|NCT00660179|2493012|P2|Overall Study|Incorrect randomization|0
784018|NCT00660179|2493013|P1|Overall Study|Incorrect randomization|1
784019|NCT00660179|2493011|P3|Overall Study|Administrative reason|1
784020|NCT00660179|2493012|P2|Overall Study|Administrative reason|0
784021|NCT00660179|2493013|P1|Overall Study|Administrative reason|0
784022|NCT00660179|2493011|P3|Overall Study|Lost to Follow-up|2
784023|NCT00660179|2493012|P2|Overall Study|Lost to Follow-up|5
784024|NCT00660179|2493013|P1|Overall Study|Lost to Follow-up|7
784025|NCT00660179|2493011|P3|Overall Study|Withdrawal of consent|4
784026|NCT00660179|2493012|P2|Overall Study|Withdrawal of consent|6
784027|NCT00660179|2493013|P1|Overall Study|Withdrawal of consent|4
784028|NCT00660179|2493011|P3|Overall Study|Death|34
784029|NCT00660179|2493012|P2|Overall Study|Death|47
784030|NCT00660179|2493013|P1|Overall Study|Death|44
784031|NCT00660192|2493047|P2|Overall Study|Lost to Follow-up|3
784032|NCT00660192|2493048|P1|Overall Study|Lost to Follow-up|2
784033|NCT00660309|2493058|P2|Overall Study|Withdrawal by Subject|3
784034|NCT00660309|2493059|P1|Overall Study|Withdrawal by Subject|0
784035|NCT00660309|2493058|P2|Overall Study|Adverse Event|0
784036|NCT00660309|2493059|P1|Overall Study|Adverse Event|2
784037|NCT00660348|2493100|P2|Overall Study|Withdrawal by Subject|0
784038|NCT00660348|2493101|P1|Overall Study|Withdrawal by Subject|1
784039|NCT00660387|2493109|P2|Overall Study|Protocol Violation|0
784040|NCT00660387|2493110|P1|Overall Study|Protocol Violation|1
784041|NCT00660387|2493109|P2|Overall Study|Lack of Efficacy|1
784042|NCT00660387|2493110|P1|Overall Study|Lack of Efficacy|0
784043|NCT00660387|2493109|P2|Overall Study|Adverse Event|2
784044|NCT00660387|2493110|P1|Overall Study|Adverse Event|1
784045|NCT00660400|2493162|P1|Overall Study|Withdrawal by Subject|1
784046|NCT00660400|2493162|P1|Overall Study|Intracranial hemorrhage|1
784047|NCT00660400|2493162|P1|Overall Study|Suboptimal organ function|1
784048|NCT00660400|2493162|P1|Overall Study|Lack of insurance approval|1
784049|NCT00660595|2493220|P2|Overall Study|Non Specified reasons|0
784050|NCT00660595|2493221|P1|Overall Study|Non Specified reasons|5
784051|NCT00660595|2493220|P2|Overall Study|Participant left hospital|0
784052|NCT00660595|2493221|P1|Overall Study|Participant left hospital|1
784053|NCT00660595|2493220|P2|Overall Study|Did not consent to participate in study|8
784054|NCT00660595|2493221|P1|Overall Study|Did not consent to participate in study|12
784055|NCT00660595|2493220|P2|Overall Study|Lost to Follow-up|1
784056|NCT00660595|2493221|P1|Overall Study|Lost to Follow-up|0
784057|NCT00660660|2493235|P2|Overall Study|New medication after randomization|0
784058|NCT00660660|2493236|P1|Overall Study|New medication after randomization|1
784059|NCT00660660|2493235|P2|Overall Study|Incorrect enrollment and other|1
784060|NCT00660660|2493236|P1|Overall Study|Incorrect enrollment and other|0
784061|NCT00660660|2493235|P2|Overall Study|Withdrawal by Subject|0
784062|NCT00660660|2493236|P1|Overall Study|Withdrawal by Subject|3
784063|NCT00660660|2493235|P2|Overall Study|Lack of Efficacy|2
784064|NCT00660660|2493236|P1|Overall Study|Lack of Efficacy|0
784065|NCT00660660|2493235|P2|Overall Study|Lost to Follow-up|6
784066|NCT00660660|2493236|P1|Overall Study|Lost to Follow-up|0
784067|NCT00660660|2493235|P2|Overall Study|Adverse Event|0
784068|NCT00660660|2493236|P1|Overall Study|Adverse Event|1
784069|NCT00660699|2493334|P1|Overall Study|Withdrawal by Subject|2
784070|NCT00661193|2493350|P2|Overall Study|Not protocol specified|0
784071|NCT00661193|2493351|P1|Overall Study|Not protocol specified|1
784072|NCT00661193|2493350|P2|Overall Study|Progression|24
784073|NCT00661193|2493351|P1|Overall Study|Progression|27
784074|NCT00661193|2493350|P2|Overall Study|Withdrawal by Subject|1
784075|NCT00661193|2493351|P1|Overall Study|Withdrawal by Subject|3
784076|NCT00661193|2493350|P2|Overall Study|Adverse Event|1
784077|NCT00661193|2493351|P1|Overall Study|Adverse Event|2
784078|NCT00661258|2493361|P2|Overall Study|caught by police and in detox center|1
784079|NCT00661258|2493362|P1|Overall Study|caught by police and in detox center|2
784080|NCT00661258|2493361|P2|Overall Study|Death|0
784081|NCT00661258|2493362|P1|Overall Study|Death|1
784082|NCT00661362|2493372|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
784083|NCT00661362|2493373|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
784084|NCT00661362|2493372|P2|Overall Study|Safety reasons|0
784085|NCT00661362|2493373|P1|Overall Study|Safety reasons|1
784086|NCT00661362|2493372|P2|Overall Study|Severe non-compliance to protocol|1
784087|NCT00661362|2493373|P1|Overall Study|Severe non-compliance to protocol|0
784088|NCT00661362|2493372|P2|Overall Study|Lost to Follow-up|1
784089|NCT00661362|2493373|P1|Overall Study|Lost to Follow-up|3
784090|NCT00661362|2493372|P2|Overall Study|Withdrawal by Subject|23
784091|NCT00661362|2493373|P1|Overall Study|Withdrawal by Subject|13
784092|NCT00661362|2493372|P2|Overall Study|Study specific discontinuation criteria|11
784093|NCT00661362|2493373|P1|Overall Study|Study specific discontinuation criteria|4
784094|NCT00661362|2493372|P2|Overall Study|Incorrect enrollment|0
784095|NCT00661362|2493373|P1|Overall Study|Incorrect enrollment|2
784096|NCT00661362|2493372|P2|Overall Study|Adverse Event|4
784097|NCT00661362|2493373|P1|Overall Study|Adverse Event|5
784098|NCT00661388|2493389|P1|Overall Study|Administrative reasons|1
784099|NCT00661388|2493389|P1|Overall Study|Dialysis initiation|1
784100|NCT00661388|2493389|P1|Overall Study|Renal transplantation|1
784101|NCT00661388|2493389|P1|Overall Study|Protocol Violation|7
784102|NCT00661388|2493389|P1|Overall Study|Adverse Event|14
891978|NCT01009463|2828583|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
891979|NCT01009463|2828584|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
784107|NCT00661492|2493445|P2|Overall Study|Other|0
784108|NCT00661492|2493446|P1|Overall Study|Other|1
784109|NCT00661492|2493445|P2|Overall Study|Lost to Follow-up|1
784110|NCT00661492|2493446|P1|Overall Study|Lost to Follow-up|0
784111|NCT00661492|2493445|P2|Overall Study|Investigator Request|0
784112|NCT00661492|2493446|P1|Overall Study|Investigator Request|1
784113|NCT00661492|2493445|P2|Overall Study|Patient Request|1
784114|NCT00661492|2493446|P1|Overall Study|Patient Request|6
784115|NCT00661492|2493445|P2|Overall Study|Disease Progression|14
784116|NCT00661492|2493446|P1|Overall Study|Disease Progression|44
784117|NCT00661492|2493445|P2|Overall Study|Adverse Event|13
784118|NCT00661492|2493446|P1|Overall Study|Adverse Event|16
784124|NCT00661531|2493492|P1|Overall Study|Withdrawal by Subject|3
784125|NCT00661609|2493530|P1|Overall Study|Disease progression|3
784126|NCT00661609|2493530|P1|Overall Study|Survival follow up stage discontinued|11
784127|NCT00661609|2493530|P1|Overall Study|PI Decision|1
784128|NCT00661609|2493530|P1|Overall Study|Withdrawal by Subject|2
784129|NCT00661609|2493530|P1|Overall Study|Death|20
784130|NCT00661609|2493530|P1|Overall Study|Adverse Event|4
784131|NCT00661622|2493539|P2|Overall Study|Protocol Violation|0
784132|NCT00661622|2493540|P1|Overall Study|Protocol Violation|1
784133|NCT00661661|2493556|P2|Overall Study|Not assigned treatment|0
784134|NCT00661661|2493557|P1|Overall Study|Not assigned treatment|1
784135|NCT00661661|2493556|P2|Overall Study|Unspecified|7
784136|NCT00661661|2493557|P1|Overall Study|Unspecified|22
784137|NCT00661661|2493556|P2|Overall Study|Withdrawal by Subject|5
784138|NCT00661661|2493557|P1|Overall Study|Withdrawal by Subject|15
784139|NCT00661661|2493556|P2|Overall Study|Lost to Follow-up|1
784140|NCT00661661|2493557|P1|Overall Study|Lost to Follow-up|0
784141|NCT00661661|2493556|P2|Overall Study|Lack of Efficacy|2
784142|NCT00661661|2493557|P1|Overall Study|Lack of Efficacy|3
784143|NCT00661661|2493556|P2|Overall Study|Adverse Event|24
784144|NCT00661661|2493557|P1|Overall Study|Adverse Event|99
784145|NCT00661687|2493647|P1|Overall Study|Adverse Event|2
784146|NCT00661687|2493647|P1|Overall Study|Physician Decision|1
784147|NCT00661687|2493647|P1|Overall Study|Inability to maintain wearing schedule|3
784148|NCT00661687|2493647|P1|Overall Study|Positive slit lamp findings|4
784149|NCT00661687|2493647|P1|Overall Study|Study related symptoms and complaints|5
784150|NCT00661713|2493665|P8|Overall Study|Inappropriate Enrollment|0
784151|NCT00661713|2493666|P7|Overall Study|Inappropriate Enrollment|1
784152|NCT00661713|2493667|P6|Overall Study|Inappropriate Enrollment|0
784153|NCT00661713|2493668|P5|Overall Study|Inappropriate Enrollment|0
784154|NCT00661713|2493669|P4|Overall Study|Inappropriate Enrollment|0
784155|NCT00661713|2493670|P3|Overall Study|Inappropriate Enrollment|0
784156|NCT00661713|2493671|P2|Overall Study|Inappropriate Enrollment|0
784157|NCT00661713|2493672|P1|Overall Study|Inappropriate Enrollment|0
784158|NCT00661713|2493665|P8|Overall Study|Adverse Event|0
784159|NCT00661713|2493666|P7|Overall Study|Adverse Event|1
784160|NCT00661713|2493667|P6|Overall Study|Adverse Event|0
784161|NCT00661713|2493668|P5|Overall Study|Adverse Event|0
784162|NCT00661713|2493669|P4|Overall Study|Adverse Event|0
784163|NCT00661713|2493670|P3|Overall Study|Adverse Event|0
784164|NCT00661713|2493671|P2|Overall Study|Adverse Event|0
784165|NCT00661713|2493672|P1|Overall Study|Adverse Event|0
784166|NCT00661713|2493665|P8|Overall Study|Administrative Reason|0
784167|NCT00661713|2493666|P7|Overall Study|Administrative Reason|1
784168|NCT00661713|2493667|P6|Overall Study|Administrative Reason|2
784169|NCT00661713|2493668|P5|Overall Study|Administrative Reason|2
784170|NCT00661713|2493669|P4|Overall Study|Administrative Reason|2
784171|NCT00661713|2493670|P3|Overall Study|Administrative Reason|0
784172|NCT00661713|2493671|P2|Overall Study|Administrative Reason|1
784173|NCT00661713|2493672|P1|Overall Study|Administrative Reason|0
784174|NCT00661713|2493665|P8|Overall Study|Lost to Follow-up|1
784175|NCT00661713|2493666|P7|Overall Study|Lost to Follow-up|14
784176|NCT00661713|2493667|P6|Overall Study|Lost to Follow-up|7
784177|NCT00661713|2493668|P5|Overall Study|Lost to Follow-up|5
784178|NCT00661713|2493669|P4|Overall Study|Lost to Follow-up|2
784179|NCT00661713|2493670|P3|Overall Study|Lost to Follow-up|2
784180|NCT00661713|2493671|P2|Overall Study|Lost to Follow-up|7
784181|NCT00661713|2493672|P1|Overall Study|Lost to Follow-up|2
784182|NCT00661713|2493665|P8|Overall Study|Withdrawal by Subject|9
784183|NCT00661713|2493666|P7|Overall Study|Withdrawal by Subject|45
784184|NCT00661713|2493667|P6|Overall Study|Withdrawal by Subject|26
784185|NCT00661713|2493668|P5|Overall Study|Withdrawal by Subject|12
784186|NCT00661713|2493669|P4|Overall Study|Withdrawal by Subject|21
784187|NCT00661713|2493670|P3|Overall Study|Withdrawal by Subject|12
784188|NCT00661713|2493671|P2|Overall Study|Withdrawal by Subject|25
784189|NCT00661713|2493672|P1|Overall Study|Withdrawal by Subject|11
784190|NCT00661713|2493665|P8|Overall Study|Protocol Violation|1
784191|NCT00661713|2493666|P7|Overall Study|Protocol Violation|2
784192|NCT00661713|2493667|P6|Overall Study|Protocol Violation|2
784193|NCT00661713|2493668|P5|Overall Study|Protocol Violation|0
784194|NCT00661713|2493669|P4|Overall Study|Protocol Violation|3
784195|NCT00661713|2493670|P3|Overall Study|Protocol Violation|3
784196|NCT00661713|2493671|P2|Overall Study|Protocol Violation|6
784197|NCT00661713|2493672|P1|Overall Study|Protocol Violation|1
784198|NCT00661713|2493665|P8|Overall Study|Unable to Classify|0
784199|NCT00661713|2493666|P7|Overall Study|Unable to Classify|0
784200|NCT00661713|2493667|P6|Overall Study|Unable to Classify|0
784201|NCT00661713|2493668|P5|Overall Study|Unable to Classify|0
784202|NCT00661713|2493669|P4|Overall Study|Unable to Classify|0
784203|NCT00661713|2493670|P3|Overall Study|Unable to Classify|0
784204|NCT00661713|2493671|P2|Overall Study|Unable to Classify|0
784205|NCT00661713|2493672|P1|Overall Study|Unable to Classify|1
784206|NCT00661713|2493665|P8|Overall Study|Death|0
784207|NCT00661713|2493666|P7|Overall Study|Death|0
784208|NCT00661713|2493667|P6|Overall Study|Death|0
784209|NCT00661713|2493668|P5|Overall Study|Death|1
784210|NCT00661713|2493669|P4|Overall Study|Death|0
784211|NCT00661713|2493670|P3|Overall Study|Death|0
784212|NCT00661713|2493671|P2|Overall Study|Death|0
784213|NCT00661713|2493672|P1|Overall Study|Death|1
784214|NCT00661726|2493762|P1|Overall Study|Adverse Event|1
784215|NCT00661778|2493777|P1|Overall Study|Withdrawal of Consent|1
784216|NCT00661778|2493777|P1|Overall Study|Protocol Violation|2
784217|NCT00661778|2493777|P1|Overall Study|Reason not Specified|6
784218|NCT00661778|2493777|P1|Overall Study|Adverse Event|18
784219|NCT00661778|2493777|P1|Overall Study|Disease Progression|23
784220|NCT00661830|2493786|P2|Overall Study|Other reason|5
784221|NCT00661830|2493787|P1|Overall Study|Other reason|1
784222|NCT00661830|2493786|P2|Overall Study|Withdrawal by Subject|1
784223|NCT00661830|2493787|P1|Overall Study|Withdrawal by Subject|1
784224|NCT00661830|2493786|P2|Overall Study|Lost to Follow-up|3
784225|NCT00661830|2493787|P1|Overall Study|Lost to Follow-up|1
784226|NCT00661830|2493786|P2|Overall Study|Death|33
784227|NCT00661830|2493787|P1|Overall Study|Death|37
784228|NCT00661999|2493824|P3|Overall Study|Other Medical Problems|9
784229|NCT00661999|2493825|P2|Overall Study|Other Medical Problems|4
784230|NCT00661999|2493826|P1|Overall Study|Other Medical Problems|4
784231|NCT00661999|2493824|P3|Overall Study|Alternative Treatment|0
784232|NCT00661999|2493825|P2|Overall Study|Alternative Treatment|0
784233|NCT00661999|2493826|P1|Overall Study|Alternative Treatment|1
784234|NCT00661999|2493824|P3|Overall Study|Withdrawal by Subject|14
784235|NCT00661999|2493825|P2|Overall Study|Withdrawal by Subject|23
784236|NCT00661999|2493826|P1|Overall Study|Withdrawal by Subject|30
784237|NCT00661999|2493824|P3|Overall Study|Other Reasons|23
784238|NCT00661999|2493825|P2|Overall Study|Other Reasons|12
784239|NCT00661999|2493826|P1|Overall Study|Other Reasons|5
784240|NCT00661999|2493824|P3|Overall Study|Death|3
784241|NCT00661999|2493825|P2|Overall Study|Death|6
784242|NCT00661999|2493826|P1|Overall Study|Death|8
784243|NCT00661999|2493824|P3|Overall Study|Adverse Event|8
784244|NCT00661999|2493825|P2|Overall Study|Adverse Event|5
784245|NCT00661999|2493826|P1|Overall Study|Adverse Event|11
784246|NCT00662012|2493879|P1|Overall Study|Withdrawal by Subject|1
784247|NCT00662012|2493879|P1|Overall Study|Death|1
784248|NCT00662012|2493879|P1|Overall Study|Lost to Follow-up|85
784249|NCT00662025|2493884|P1|Overall Study|Domestic circumstances|1
784250|NCT00662025|2493884|P1|Overall Study|Target lesion cannot be evaluated|1
784251|NCT00662025|2493884|P1|Overall Study|Results of other clinical study|2
784252|NCT00662025|2493884|P1|Overall Study|Withdrawal by Subject|1
784253|NCT00662025|2493884|P1|Overall Study|Adverse Event|7
784254|NCT00662025|2493884|P1|Overall Study|Objective progression or relapse|51
784255|NCT00662038|2493904|P1|Overall Study|Continued treatment|5
784256|NCT00662038|2493904|P1|Overall Study|Adverse Event|358
784257|NCT00662038|2493904|P1|Overall Study|Death|95
784258|NCT00662038|2493904|P1|Overall Study|Lost to Follow-up|1
784259|NCT00662038|2493904|P1|Overall Study|Lung transplantation|44
784260|NCT00662038|2493904|P1|Overall Study|Physician Decision|19
784261|NCT00662038|2493904|P1|Overall Study|Sponsor decision|1
784262|NCT00662038|2493904|P1|Overall Study|Withdrawal by Subject|83
784263|NCT00662038|2493904|P1|Overall Study|Withdrawn consent|22
784264|NCT00662038|2493904|P1|Overall Study|Reason not specified|3
784265|NCT00662129|2493908|P1|Overall Study|Ineligible|1
784266|NCT00662129|2493908|P1|Overall Study|Cancel prior to beginning treatment|1
784267|NCT00662129|2493908|P1|Overall Study|Protocol Violation|1
784268|NCT00662311|2493949|P3|Overall Study|Respiratory Infection|0
784269|NCT00662311|2493950|P2|Overall Study|Respiratory Infection|0
784270|NCT00662311|2493951|P1|Overall Study|Respiratory Infection|1
784271|NCT00662363|2493976|P2|Overall Study|Protocol Violation|1
784272|NCT00662363|2493977|P1|Overall Study|Protocol Violation|1
784273|NCT00662363|2493976|P2|Overall Study|Discharged early from rehab|1
784274|NCT00662363|2493977|P1|Overall Study|Discharged early from rehab|4
784275|NCT00662363|2493976|P2|Overall Study|Adverse Event|3
784276|NCT00662363|2493977|P1|Overall Study|Adverse Event|0
784277|NCT00662363|2493976|P2|Overall Study|Withdrawal by Subject|5
784278|NCT00662363|2493977|P1|Overall Study|Withdrawal by Subject|6
784279|NCT00662532|2493990|P2|Overall Study|Lost to Follow-up|1
784280|NCT00662532|2493991|P1|Overall Study|Lost to Follow-up|0
784281|NCT00662532|2493990|P2|Overall Study|Adverse Event|1
784282|NCT00662532|2493991|P1|Overall Study|Adverse Event|0
784283|NCT00662558|2494020|P2|Overall Study|Randomized But Did Not Receive Treatment|8
784284|NCT00662558|2494021|P1|Overall Study|Randomized But Did Not Receive Treatment|2
784285|NCT00662558|2494020|P2|Overall Study|Withdrawal by Subject|12
784286|NCT00662558|2494021|P1|Overall Study|Withdrawal by Subject|7
784287|NCT00662558|2494020|P2|Overall Study|Other|14
784288|NCT00662558|2494021|P1|Overall Study|Other|9
784289|NCT00662558|2494020|P2|Overall Study|Lost to Follow-up|10
784290|NCT00662558|2494021|P1|Overall Study|Lost to Follow-up|13
784291|NCT00662558|2494020|P2|Overall Study|Lack of Efficacy|7
784292|NCT00662558|2494021|P1|Overall Study|Lack of Efficacy|4
784293|NCT00662558|2494020|P2|Overall Study|Adverse Event|59
784294|NCT00662558|2494021|P1|Overall Study|Adverse Event|21
784295|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
784296|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
784297|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
784298|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
784299|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
784300|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
784301|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
784302|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
784303|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
784304|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
784305|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
784306|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
784307|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
784308|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
784309|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
784310|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
784311|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
784312|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
784313|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
784314|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
784315|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
784316|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
784317|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
784318|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
784319|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
784320|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Adverse Event|10
784321|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Adverse Event|6
784322|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Adverse Event|0
784323|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Adverse Event|9
784324|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Adverse Event|6
784325|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Administrative problems|0
784326|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Administrative problems|1
784327|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Administrative problems|0
784328|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Administrative problems|0
784329|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Administrative problems|0
784330|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
784331|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
784332|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
784333|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
784334|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
784335|NCT00662649|2494057|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
784336|NCT00662649|2494058|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
784337|NCT00662649|2494059|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
784338|NCT00662649|2494060|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
784339|NCT00662649|2494061|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
784340|NCT00662649|2494057|P5|Core Study (24 Months)|Death|0
784341|NCT00662649|2494058|P4|Core Study (24 Months)|Death|0
784342|NCT00662649|2494059|P3|Core Study (24 Months)|Death|2
784343|NCT00662649|2494060|P2|Core Study (24 Months)|Death|0
784344|NCT00662649|2494061|P1|Core Study (24 Months)|Death|1
784345|NCT00662649|2494057|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
784346|NCT00662649|2494058|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
784347|NCT00662649|2494059|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
784348|NCT00662649|2494060|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
784349|NCT00662649|2494061|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
784350|NCT00662649|2494057|P5|Core Study (24 Months)|Protocol Violation|0
784351|NCT00662649|2494058|P4|Core Study (24 Months)|Protocol Violation|0
784352|NCT00662649|2494059|P3|Core Study (24 Months)|Protocol Violation|4
784353|NCT00662649|2494060|P2|Core Study (24 Months)|Protocol Violation|5
784354|NCT00662649|2494061|P1|Core Study (24 Months)|Protocol Violation|5
784355|NCT00662649|2494057|P5|Core Study (24 Months)|Lost to Follow-up|0
784356|NCT00662649|2494058|P4|Core Study (24 Months)|Lost to Follow-up|0
784357|NCT00662649|2494059|P3|Core Study (24 Months)|Lost to Follow-up|7
784358|NCT00662649|2494060|P2|Core Study (24 Months)|Lost to Follow-up|5
784359|NCT00662649|2494061|P1|Core Study (24 Months)|Lost to Follow-up|3
784360|NCT00662649|2494057|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
784361|NCT00662649|2494058|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
784362|NCT00662649|2494059|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
784363|NCT00662649|2494060|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
784364|NCT00662649|2494061|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
784365|NCT00662649|2494057|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
784366|NCT00662649|2494058|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
784367|NCT00662649|2494059|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
784368|NCT00662649|2494060|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
784369|NCT00662649|2494061|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
784370|NCT00662649|2494057|P5|Core Study (24 Months)|Adverse Event|0
784371|NCT00662649|2494058|P4|Core Study (24 Months)|Adverse Event|0
784372|NCT00662649|2494059|P3|Core Study (24 Months)|Adverse Event|18
784373|NCT00662649|2494060|P2|Core Study (24 Months)|Adverse Event|13
784374|NCT00662649|2494061|P1|Core Study (24 Months)|Adverse Event|22
784375|NCT00662649|2494057|P5|Core Study (24 Months)|Withdrawal by Subject|0
784376|NCT00662649|2494058|P4|Core Study (24 Months)|Withdrawal by Subject|0
784377|NCT00662649|2494059|P3|Core Study (24 Months)|Withdrawal by Subject|28
784378|NCT00662649|2494060|P2|Core Study (24 Months)|Withdrawal by Subject|17
784379|NCT00662649|2494061|P1|Core Study (24 Months)|Withdrawal by Subject|31
784380|NCT00662831|2494139|P2|Overall Study|Adverse Event|16
784381|NCT00662831|2494140|P1|Overall Study|Adverse Event|23
784382|NCT00662831|2494139|P2|Overall Study|Protocol Violation|4
784383|NCT00662831|2494140|P1|Overall Study|Protocol Violation|8
784384|NCT00662831|2494139|P2|Overall Study|Unspecified|31
784385|NCT00662831|2494140|P1|Overall Study|Unspecified|62
784386|NCT00662831|2494139|P2|Overall Study|Withdrawal by Subject|1
784387|NCT00662831|2494140|P1|Overall Study|Withdrawal by Subject|2
784388|NCT00662831|2494139|P2|Overall Study|Lost to Follow-up|0
784389|NCT00662831|2494140|P1|Overall Study|Lost to Follow-up|1
784390|NCT00662831|2494139|P2|Overall Study|Lack of Efficacy|6
784391|NCT00662831|2494140|P1|Overall Study|Lack of Efficacy|6
784392|NCT00662831|2494139|P2|Overall Study|Death|1
784393|NCT00662831|2494140|P1|Overall Study|Death|4
784394|NCT00662857|2494178|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
784395|NCT00662857|2494179|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
784396|NCT00662857|2494178|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
784397|NCT00662857|2494179|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
784398|NCT00662857|2494178|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
784399|NCT00662857|2494179|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
784427|NCT00663026|2494298|P3|Overall Study|Withdrawal by Subject|1
784428|NCT00663026|2494299|P2|Overall Study|Withdrawal by Subject|0
784429|NCT00663026|2494300|P1|Overall Study|Withdrawal by Subject|0
784430|NCT00663026|2494298|P3|Overall Study|Caregiver Request|0
784431|NCT00663026|2494299|P2|Overall Study|Caregiver Request|2
784432|NCT00663026|2494300|P1|Overall Study|Caregiver Request|0
784433|NCT00663026|2494298|P3|Overall Study|Adverse Event|3
784434|NCT00663026|2494299|P2|Overall Study|Adverse Event|2
784435|NCT00663026|2494300|P1|Overall Study|Adverse Event|0
784436|NCT00663026|2494298|P3|Overall Study|Unspecified|0
784437|NCT00663026|2494299|P2|Overall Study|Unspecified|2
784438|NCT00663026|2494300|P1|Overall Study|Unspecified|1
784439|NCT00663026|2494298|P3|Overall Study|Lost to Follow-up|0
784440|NCT00663026|2494299|P2|Overall Study|Lost to Follow-up|0
784441|NCT00663026|2494300|P1|Overall Study|Lost to Follow-up|1
784442|NCT00663052|2494322|P2|Overall Study|Unspecified|1
784443|NCT00663052|2494323|P1|Overall Study|Unspecified|0
784444|NCT00663052|2494322|P2|Overall Study|Unsatisfactory Response - Efficacy|1
784445|NCT00663052|2494323|P1|Overall Study|Unsatisfactory Response - Efficacy|1
784446|NCT00663052|2494322|P2|Overall Study|Withdrawal by Subject|5
784447|NCT00663052|2494323|P1|Overall Study|Withdrawal by Subject|2
784448|NCT00663052|2494322|P2|Overall Study|Protocol Violation|0
784449|NCT00663052|2494323|P1|Overall Study|Protocol Violation|1
784450|NCT00663052|2494322|P2|Overall Study|Discontinuation of Study by Sponsor|0
784451|NCT00663052|2494323|P1|Overall Study|Discontinuation of Study by Sponsor|2
784452|NCT00663052|2494322|P2|Overall Study|Adverse Event|3
784453|NCT00663052|2494323|P1|Overall Study|Adverse Event|6
784454|NCT00663117|2494405|P2|Overall Study|Lack of Efficacy|0
784455|NCT00663117|2494406|P1|Overall Study|Lack of Efficacy|1
784456|NCT00663208|2494451|P7|Follow-up Period|Other reason|1
784457|NCT00663208|2494452|P6|Follow-up Period|Other reason|0
784458|NCT00663208|2494453|P5|Follow-up Period|Other reason|0
784459|NCT00663208|2494454|P4|Follow-up Period|Other reason|0
784460|NCT00663208|2494455|P3|Follow-up Period|Other reason|0
784461|NCT00663208|2494456|P2|Follow-up Period|Other reason|0
784462|NCT00663208|2494457|P1|Follow-up Period|Other reason|1
784463|NCT00663208|2494451|P7|Follow-up Period|Lost to Follow-up|0
784464|NCT00663208|2494452|P6|Follow-up Period|Lost to Follow-up|0
784465|NCT00663208|2494453|P5|Follow-up Period|Lost to Follow-up|0
784466|NCT00663208|2494454|P4|Follow-up Period|Lost to Follow-up|2
784467|NCT00663208|2494455|P3|Follow-up Period|Lost to Follow-up|3
784468|NCT00663208|2494456|P2|Follow-up Period|Lost to Follow-up|0
784469|NCT00663208|2494457|P1|Follow-up Period|Lost to Follow-up|2
784470|NCT00663208|2494451|P7|Treatment Period|Lost to Follow-up|0
784471|NCT00663208|2494452|P6|Treatment Period|Lost to Follow-up|0
784472|NCT00663208|2494453|P5|Treatment Period|Lost to Follow-up|0
784473|NCT00663208|2494454|P4|Treatment Period|Lost to Follow-up|0
784474|NCT00663208|2494455|P3|Treatment Period|Lost to Follow-up|0
784475|NCT00663208|2494456|P2|Treatment Period|Lost to Follow-up|1
784476|NCT00663208|2494457|P1|Treatment Period|Lost to Follow-up|0
784477|NCT00663234|2494607|P1|Overall Study|Not willing to adhere to requirements|1
784478|NCT00663260|2494636|P3|Overall Study|non-compliance, not met criteria, etc.|3
784479|NCT00663260|2494637|P2|Overall Study|non-compliance, not met criteria, etc.|2
784480|NCT00663260|2494638|P1|Overall Study|non-compliance, not met criteria, etc.|3
784481|NCT00663260|2494636|P3|Overall Study|Lost to Follow-up|0
784482|NCT00663260|2494637|P2|Overall Study|Lost to Follow-up|1
784483|NCT00663260|2494638|P1|Overall Study|Lost to Follow-up|0
784484|NCT00663260|2494636|P3|Overall Study|Death|1
784485|NCT00663260|2494637|P2|Overall Study|Death|0
784486|NCT00663260|2494638|P1|Overall Study|Death|1
784487|NCT00663260|2494636|P3|Overall Study|Withdrawal by Subject|6
784488|NCT00663260|2494637|P2|Overall Study|Withdrawal by Subject|1
784489|NCT00663260|2494638|P1|Overall Study|Withdrawal by Subject|3
784490|NCT00663260|2494636|P3|Overall Study|Adverse Event|6
784491|NCT00663260|2494637|P2|Overall Study|Adverse Event|7
784492|NCT00663260|2494638|P1|Overall Study|Adverse Event|12
784493|NCT00663260|2494636|P3|Overall Study|Lack of Efficacy|0
784494|NCT00663260|2494637|P2|Overall Study|Lack of Efficacy|0
784495|NCT00663260|2494638|P1|Overall Study|Lack of Efficacy|2
784496|NCT00663702|2494664|P2|Overall Study|Lack of Efficacy|3
784497|NCT00663702|2494665|P1|Overall Study|Lack of Efficacy|3
784498|NCT00663702|2494664|P2|Overall Study|Death|1
784499|NCT00663702|2494665|P1|Overall Study|Death|1
784500|NCT00663702|2494664|P2|Overall Study|Lost to Follow-up|0
784501|NCT00663702|2494665|P1|Overall Study|Lost to Follow-up|3
784502|NCT00663702|2494664|P2|Overall Study|Pregnancy|1
784503|NCT00663702|2494665|P1|Overall Study|Pregnancy|0
784504|NCT00663702|2494664|P2|Overall Study|Withdrawal by Subject|1
784505|NCT00663702|2494665|P1|Overall Study|Withdrawal by Subject|3
784506|NCT00663702|2494664|P2|Overall Study|Adverse Event|4
784507|NCT00663702|2494665|P1|Overall Study|Adverse Event|8
784508|NCT00663858|2494713|P3|Overall Study|Other|4
784509|NCT00663858|2494714|P2|Overall Study|Other|2
784510|NCT00663858|2494715|P1|Overall Study|Other|8
784511|NCT00663858|2494713|P3|Overall Study|Protocol Violation|4
784512|NCT00663858|2494714|P2|Overall Study|Protocol Violation|3
784513|NCT00663858|2494715|P1|Overall Study|Protocol Violation|5
784514|NCT00663858|2494713|P3|Overall Study|Withdrawal by Subject|3
784515|NCT00663858|2494714|P2|Overall Study|Withdrawal by Subject|3
784516|NCT00663858|2494715|P1|Overall Study|Withdrawal by Subject|7
784517|NCT00663858|2494713|P3|Overall Study|Lack of Efficacy|3
784518|NCT00663858|2494714|P2|Overall Study|Lack of Efficacy|1
784519|NCT00663858|2494715|P1|Overall Study|Lack of Efficacy|5
784520|NCT00663858|2494713|P3|Overall Study|Adverse Event|6
784521|NCT00663858|2494714|P2|Overall Study|Adverse Event|1
784522|NCT00663858|2494715|P1|Overall Study|Adverse Event|9
784523|NCT00663923|2494723|P1|Overall Study|Lost to Follow-up|2
784524|NCT00663962|2494739|P2|Overall Study|somnolence|0
784525|NCT00663962|2494740|P1|Overall Study|somnolence|1
784526|NCT00664326|2494746|P1|Overall Study|ongoing with treatment|6
784527|NCT00664326|2494746|P1|Overall Study|Physician Decision|1
784528|NCT00664326|2494746|P1|Overall Study|Withdrawal by Subject|1
784529|NCT00664326|2494746|P1|Overall Study|Noncompliance with study medication|3
784530|NCT00664326|2494746|P1|Overall Study|Adverse Event|13
784531|NCT00664521|2494773|P2|Overall Study|Unspecified|0
784532|NCT00664521|2494774|P1|Overall Study|Unspecified|1
784533|NCT00664521|2494773|P2|Overall Study|Lost to Follow-up|0
784534|NCT00664521|2494774|P1|Overall Study|Lost to Follow-up|1
784535|NCT00664521|2494773|P2|Overall Study|Adverse Event|1
784536|NCT00664521|2494774|P1|Overall Study|Adverse Event|4
784537|NCT00664534|2494796|P2|Overall Study|Sponsor decision|6
784538|NCT00664534|2494797|P1|Overall Study|Sponsor decision|8
784539|NCT00664534|2494796|P2|Overall Study|Physician Decision|0
784540|NCT00664534|2494797|P1|Overall Study|Physician Decision|8
784541|NCT00664534|2494796|P2|Overall Study|Withdrawal by Subject|6
784542|NCT00664534|2494797|P1|Overall Study|Withdrawal by Subject|7
784543|NCT00664534|2494796|P2|Overall Study|Protocol Violation|8
784544|NCT00664534|2494797|P1|Overall Study|Protocol Violation|10
784545|NCT00664534|2494796|P2|Overall Study|Lost to Follow-up|10
784546|NCT00664534|2494797|P1|Overall Study|Lost to Follow-up|6
784547|NCT00664534|2494796|P2|Overall Study|Adverse Event|3
784548|NCT00664534|2494797|P1|Overall Study|Adverse Event|2
784549|NCT00664560|2494826|P3|Overall Study|Other|5
784550|NCT00664560|2494827|P2|Overall Study|Other|4
784551|NCT00664560|2494828|P1|Overall Study|Other|11
784552|NCT00664560|2494826|P3|Overall Study|Lost to Follow-up|0
784553|NCT00664560|2494827|P2|Overall Study|Lost to Follow-up|2
784554|NCT00664560|2494828|P1|Overall Study|Lost to Follow-up|0
784555|NCT00664560|2494826|P3|Overall Study|Withdrawal by Subject|7
784556|NCT00664560|2494827|P2|Overall Study|Withdrawal by Subject|13
784557|NCT00664560|2494828|P1|Overall Study|Withdrawal by Subject|9
784558|NCT00664560|2494826|P3|Overall Study|Adverse Event|7
784559|NCT00664560|2494827|P2|Overall Study|Adverse Event|16
784560|NCT00664560|2494828|P1|Overall Study|Adverse Event|19
784561|NCT00664742|2494869|P1|Overall Study|Lost to Follow-up|92
784562|NCT00664742|2494869|P1|Overall Study|Withdrawal by Subject|31
784563|NCT00664742|2494869|P1|Overall Study|Withdrawn due to adverse events|3
784564|NCT00665002|2494874|P1|Overall Study|Cytogenetic resistance|1
784565|NCT00665002|2494874|P1|Overall Study|Progression/relapse during treatment|11
784566|NCT00665353|2494886|P1|Study Step 2|Lack of Efficacy|12
784567|NCT00665353|2494886|P1|Study Step 2|Lost to Follow-up|2
784568|NCT00665353|2494886|P1|Study Step 1|Withdrawal by Subject|2
784569|NCT00665353|2494886|P1|Study Step 1|Adverse Event|1
784570|NCT00665366|2494898|P2|Overall Study|Other reasons|1
784571|NCT00665366|2494899|P1|Overall Study|Other reasons|4
784572|NCT00665366|2494898|P2|Overall Study|No longer meets study criteria|1
784573|NCT00665366|2494899|P1|Overall Study|No longer meets study criteria|0
784574|NCT00665366|2494898|P2|Overall Study|Pregnancy|0
784575|NCT00665366|2494899|P1|Overall Study|Pregnancy|1
784576|NCT00665366|2494898|P2|Overall Study|Poor compliance/noncompliance|5
784577|NCT00665366|2494899|P1|Overall Study|Poor compliance/noncompliance|3
784578|NCT00665366|2494898|P2|Overall Study|Lost to Follow-up|5
784579|NCT00665366|2494899|P1|Overall Study|Lost to Follow-up|3
784580|NCT00665366|2494898|P2|Overall Study|Withdrawal by Subject|14
784581|NCT00665366|2494899|P1|Overall Study|Withdrawal by Subject|11
784582|NCT00665366|2494898|P2|Overall Study|Adverse Event|23
784583|NCT00665366|2494899|P1|Overall Study|Adverse Event|25
784584|NCT00665366|2494898|P2|Overall Study|Lack of Efficacy|10
784585|NCT00665366|2494899|P1|Overall Study|Lack of Efficacy|11
784586|NCT00665431|2494930|P3|Overall Study|Other|2
784587|NCT00665431|2494931|P2|Overall Study|Other|7
784588|NCT00665431|2494932|P1|Overall Study|Other|4
784589|NCT00665431|2494930|P3|Overall Study|Lost to Follow-up|1
784590|NCT00665431|2494931|P2|Overall Study|Lost to Follow-up|3
784591|NCT00665431|2494932|P1|Overall Study|Lost to Follow-up|3
784592|NCT00665431|2494930|P3|Overall Study|Withdrawal by Subject|15
784593|NCT00665431|2494931|P2|Overall Study|Withdrawal by Subject|25
784594|NCT00665431|2494932|P1|Overall Study|Withdrawal by Subject|17
784595|NCT00665431|2494930|P3|Overall Study|Adverse Event|6
784596|NCT00665431|2494931|P2|Overall Study|Adverse Event|22
784597|NCT00665431|2494932|P1|Overall Study|Adverse Event|16
784600|NCT00665626|2494991|P2|Overall Study|Death|0
784601|NCT00665626|2494992|P1|Overall Study|Death|1
784602|NCT00665626|2494991|P2|Overall Study|Unably to comply with dosing regimen|1
784603|NCT00665626|2494992|P1|Overall Study|Unably to comply with dosing regimen|0
784604|NCT00665626|2494991|P2|Overall Study|Did not fulfil inclusion criteria|1
784605|NCT00665626|2494992|P1|Overall Study|Did not fulfil inclusion criteria|0
784606|NCT00665626|2494991|P2|Overall Study|Due to exclusion criteria|1
784607|NCT00665626|2494992|P1|Overall Study|Due to exclusion criteria|0
784608|NCT00665626|2494991|P2|Overall Study|Adverse Event|9
784609|NCT00665626|2494992|P1|Overall Study|Adverse Event|1
784610|NCT00665626|2494991|P2|Overall Study|Protocol Violation|2
784611|NCT00665626|2494992|P1|Overall Study|Protocol Violation|0
784612|NCT00665626|2494991|P2|Overall Study|Withdrawal by Subject|1
784613|NCT00665626|2494992|P1|Overall Study|Withdrawal by Subject|0
784614|NCT00665626|2494991|P2|Overall Study|Lost to Follow-up|2
784615|NCT00665626|2494992|P1|Overall Study|Lost to Follow-up|0
784616|NCT00665626|2494991|P2|Overall Study|Lack of Efficacy|5
784617|NCT00665626|2494992|P1|Overall Study|Lack of Efficacy|8
784618|NCT00665847|2495063|P1|Overall Study|Switch to Commercial Medication|1
784619|NCT00665847|2495063|P1|Overall Study|Subject ineligible to continue the trial|1
784620|NCT00665847|2495063|P1|Overall Study|Resistance to TMC125|1
784621|NCT00665847|2495063|P1|Overall Study|Subject reached a virologic endpoint|4
784622|NCT00665847|2495063|P1|Overall Study|Subject non-compliant|8
784623|NCT00665847|2495063|P1|Overall Study|Withdrawal by Subject|2
784624|NCT00665847|2495063|P1|Overall Study|Adverse Event|8
784625|NCT00665925|2495079|P4|Overall Study|Due to exclusion criteria|0
784626|NCT00665925|2495080|P3|Overall Study|Due to exclusion criteria|0
784627|NCT00665925|2495081|P2|Overall Study|Due to exclusion criteria|0
784628|NCT00665925|2495082|P1|Overall Study|Due to exclusion criteria|1
784629|NCT00665925|2495079|P4|Overall Study|Enrolled by mistake|1
784630|NCT00665925|2495080|P3|Overall Study|Enrolled by mistake|0
784631|NCT00665925|2495081|P2|Overall Study|Enrolled by mistake|0
784632|NCT00665925|2495082|P1|Overall Study|Enrolled by mistake|0
784633|NCT00665925|2495079|P4|Overall Study|Adverse Event|5
784634|NCT00665925|2495080|P3|Overall Study|Adverse Event|10
784635|NCT00665925|2495081|P2|Overall Study|Adverse Event|5
784636|NCT00665925|2495082|P1|Overall Study|Adverse Event|1
784637|NCT00665925|2495079|P4|Overall Study|Severe Non-Compliance to Protocol|1
784638|NCT00665925|2495080|P3|Overall Study|Severe Non-Compliance to Protocol|1
784639|NCT00665925|2495081|P2|Overall Study|Severe Non-Compliance to Protocol|0
784640|NCT00665925|2495082|P1|Overall Study|Severe Non-Compliance to Protocol|0
784641|NCT00665925|2495079|P4|Overall Study|Physician Decision|2
784642|NCT00665925|2495080|P3|Overall Study|Physician Decision|1
784643|NCT00665925|2495081|P2|Overall Study|Physician Decision|0
784644|NCT00665925|2495082|P1|Overall Study|Physician Decision|0
784645|NCT00665925|2495079|P4|Overall Study|Withdrawal by Subject|2
784646|NCT00665925|2495080|P3|Overall Study|Withdrawal by Subject|3
784647|NCT00665925|2495081|P2|Overall Study|Withdrawal by Subject|2
784648|NCT00665925|2495082|P1|Overall Study|Withdrawal by Subject|2
784649|NCT00665925|2495079|P4|Overall Study|Lost to Follow-up|2
784650|NCT00665925|2495080|P3|Overall Study|Lost to Follow-up|2
784651|NCT00665925|2495081|P2|Overall Study|Lost to Follow-up|2
784652|NCT00665925|2495082|P1|Overall Study|Lost to Follow-up|1
784653|NCT00665925|2495079|P4|Overall Study|Lack of Efficacy|8
784654|NCT00665925|2495080|P3|Overall Study|Lack of Efficacy|9
784655|NCT00665925|2495081|P2|Overall Study|Lack of Efficacy|8
784656|NCT00665925|2495082|P1|Overall Study|Lack of Efficacy|10
784657|NCT00666198|2495504|P1|Overall Study|No Drug Administration|4
784658|NCT00666198|2495504|P1|Overall Study|Safety Not Assessable|6
784659|NCT00666198|2495504|P1|Overall Study|No Visit After First Day of Treatment|13
784660|NCT00666198|2495504|P1|Overall Study|Protocol Violation|10
784661|NCT00666211|2495519|P2|Overall Study|Physician Decision|1
784662|NCT00666211|2495520|P1|Overall Study|Physician Decision|0
784663|NCT00666211|2495519|P2|Overall Study|off tx for other complicating disease|1
784664|NCT00666211|2495520|P1|Overall Study|off tx for other complicating disease|0
784665|NCT00666211|2495519|P2|Overall Study|Death|2
784666|NCT00666211|2495520|P1|Overall Study|Death|0
784667|NCT00666211|2495519|P2|Overall Study|hospital admission|5
784668|NCT00666211|2495520|P1|Overall Study|hospital admission|0
784669|NCT00666211|2495519|P2|Overall Study|toxicity|2
784670|NCT00666211|2495520|P1|Overall Study|toxicity|0
784671|NCT00666211|2495519|P2|Overall Study|Lost to Follow-up|0
784672|NCT00666211|2495520|P1|Overall Study|Lost to Follow-up|2
784673|NCT00666211|2495519|P2|Overall Study|disease progression|8
784674|NCT00666211|2495520|P1|Overall Study|disease progression|1
784675|NCT00666211|2495519|P2|Overall Study|patient non-compliant|6
784676|NCT00666211|2495520|P1|Overall Study|patient non-compliant|6
784677|NCT00666211|2495519|P2|Overall Study|went off medication, no more pain|0
784678|NCT00666211|2495520|P1|Overall Study|went off medication, no more pain|1
784679|NCT00666211|2495519|P2|Overall Study|Withdrawal by Subject|13
784680|NCT00666211|2495520|P1|Overall Study|Withdrawal by Subject|10
784681|NCT00666224|2495540|P2|Open-Label|Undefined/Unknown|1
784682|NCT00666224|2495541|P1|Open-Label|Undefined/Unknown|1
784683|NCT00666224|2495540|P2|Open-Label|Noncompliance|1
784684|NCT00666224|2495541|P1|Open-Label|Noncompliance|2
784685|NCT00666224|2495540|P2|Open-Label|Pregnancy|5
784686|NCT00666224|2495541|P1|Open-Label|Pregnancy|1
784687|NCT00666224|2495540|P2|Open-Label|Physician Decision|5
784688|NCT00666224|2495541|P1|Open-Label|Physician Decision|7
784689|NCT00666224|2495540|P2|Open-Label|Withdrawal by Subject|25
784690|NCT00666224|2495541|P1|Open-Label|Withdrawal by Subject|12
784691|NCT00666224|2495540|P2|Open-Label|Lost to Follow-up|5
784692|NCT00666224|2495541|P1|Open-Label|Lost to Follow-up|4
784693|NCT00666224|2495540|P2|Open-Label|Adverse Event|43
784694|NCT00666224|2495541|P1|Open-Label|Adverse Event|8
784695|NCT00666224|2495540|P2|Double-Blind|Undefined/Unknown|1
784696|NCT00666224|2495541|P1|Double-Blind|Undefined/Unknown|4
784697|NCT00666224|2495540|P2|Double-Blind|Death|0
784698|NCT00666224|2495541|P1|Double-Blind|Death|1
784699|NCT00666224|2495540|P2|Double-Blind|Noncompliance|0
784700|NCT00666224|2495541|P1|Double-Blind|Noncompliance|1
784701|NCT00666224|2495540|P2|Double-Blind|Pregnancy|2
784702|NCT00666224|2495541|P1|Double-Blind|Pregnancy|3
784703|NCT00666224|2495540|P2|Double-Blind|Sponsor decision|0
784704|NCT00666224|2495541|P1|Double-Blind|Sponsor decision|1
784705|NCT00666224|2495540|P2|Double-Blind|Physician Decision|3
784706|NCT00666224|2495541|P1|Double-Blind|Physician Decision|0
784707|NCT00666224|2495540|P2|Double-Blind|Withdrawal by Subject|14
784708|NCT00666224|2495541|P1|Double-Blind|Withdrawal by Subject|18
784709|NCT00666224|2495540|P2|Double-Blind|Lost to Follow-up|2
784710|NCT00666224|2495541|P1|Double-Blind|Lost to Follow-up|2
784711|NCT00666224|2495540|P2|Double-Blind|Adverse Event|5
784712|NCT00666224|2495541|P1|Double-Blind|Adverse Event|15
784719|NCT00666276|2495701|P1|Overall Study|Protocol Violation|34
784720|NCT00666328|2495725|P1|Overall Study|No longer met eligibility criteria|1
784721|NCT00666328|2495725|P1|Overall Study|Lost to Follow-up|2
784722|NCT00666328|2495725|P1|Overall Study|Death|2
784723|NCT00666458|2495816|P2|Overall Study|Medical history of anemia|0
784724|NCT00666458|2495817|P1|Overall Study|Medical history of anemia|1
784725|NCT00666458|2495816|P2|Overall Study|Safety reasons|0
784726|NCT00666458|2495817|P1|Overall Study|Safety reasons|1
784727|NCT00666458|2495816|P2|Overall Study|Severe non-compliance to the protocol|1
784728|NCT00666458|2495817|P1|Overall Study|Severe non-compliance to the protocol|1
784729|NCT00666458|2495816|P2|Overall Study|Study specific discontinuation criteria|7
784730|NCT00666458|2495817|P1|Overall Study|Study specific discontinuation criteria|14
784731|NCT00666458|2495816|P2|Overall Study|Incorrect enrollment|1
784732|NCT00666458|2495817|P1|Overall Study|Incorrect enrollment|7
784733|NCT00666458|2495816|P2|Overall Study|Administrative reason by sponsor|1
784734|NCT00666458|2495817|P1|Overall Study|Administrative reason by sponsor|1
784735|NCT00666458|2495816|P2|Overall Study|Lost to Follow-up|3
784736|NCT00666458|2495817|P1|Overall Study|Lost to Follow-up|0
784737|NCT00666458|2495816|P2|Overall Study|Withdrawal by Subject|4
784738|NCT00666458|2495817|P1|Overall Study|Withdrawal by Subject|5
784739|NCT00666458|2495816|P2|Overall Study|Adverse Event|7
784740|NCT00666458|2495817|P1|Overall Study|Adverse Event|8
784741|NCT00666536|2495831|P2|Overall Study|Lost to Follow-up|3
784742|NCT00666536|2495832|P1|Overall Study|Lost to Follow-up|4
784743|NCT00666536|2495831|P2|Overall Study|Withdrawal by Subject|9
784744|NCT00666536|2495832|P1|Overall Study|Withdrawal by Subject|10
784745|NCT00666536|2495831|P2|Overall Study|Protocol deviation(s)|6
784746|NCT00666536|2495832|P1|Overall Study|Protocol deviation(s)|8
784747|NCT00666536|2495831|P2|Overall Study|Unsatisfactory therapeutic effect|0
784748|NCT00666536|2495832|P1|Overall Study|Unsatisfactory therapeutic effect|2
784749|NCT00666536|2495831|P2|Overall Study|Adverse Event|19
784750|NCT00666536|2495832|P1|Overall Study|Adverse Event|9
784757|NCT00666588|2495902|P4|Overall Study|inevaluable|0
784758|NCT00666588|2495903|P3|Overall Study|inevaluable|0
784759|NCT00666588|2495904|P2|Overall Study|inevaluable|0
784760|NCT00666588|2495905|P1|Overall Study|inevaluable|2
784761|NCT00666588|2495902|P4|Overall Study|ineligible|2
784762|NCT00666588|2495903|P3|Overall Study|ineligible|0
784763|NCT00666588|2495904|P2|Overall Study|ineligible|0
784764|NCT00666588|2495905|P1|Overall Study|ineligible|2
784765|NCT00666679|2495927|P2|Second Intervention|Death|1
784766|NCT00666679|2495928|P1|Second Intervention|Death|0
784767|NCT00666679|2495927|P2|Second Intervention|Adverse Event|0
784768|NCT00666679|2495928|P1|Second Intervention|Adverse Event|1
784769|NCT00666679|2495927|P2|Washout Period of 1 Week|Protocol Violation|1
784770|NCT00666679|2495928|P1|Washout Period of 1 Week|Protocol Violation|0
784771|NCT00666679|2495927|P2|Washout Period of 1 Week|Lost to Follow-up|1
784772|NCT00666679|2495928|P1|Washout Period of 1 Week|Lost to Follow-up|0
784773|NCT00666679|2495927|P2|First Intervention|Randomized did not start treatment|1
784774|NCT00666679|2495928|P1|First Intervention|Randomized did not start treatment|1
784775|NCT00666679|2495927|P2|First Intervention|Withdrawal by Subject|0
784776|NCT00666679|2495928|P1|First Intervention|Withdrawal by Subject|1
784777|NCT00666679|2495927|P2|First Intervention|Protocol Violation|0
784778|NCT00666679|2495928|P1|First Intervention|Protocol Violation|1
784779|NCT00666679|2495927|P2|First Intervention|Lost to Follow-up|0
784780|NCT00666679|2495928|P1|First Intervention|Lost to Follow-up|1
784781|NCT00666705|2495948|P1|Overall Study|Withdrawal by Subject|1
784782|NCT00666718|2495967|P2|Overall Study|Physician Decision|2
784783|NCT00666718|2495968|P1|Overall Study|Physician Decision|0
784784|NCT00666718|2495967|P2|Overall Study|Withdrawal by Subject|12
784785|NCT00666718|2495968|P1|Overall Study|Withdrawal by Subject|7
784786|NCT00666718|2495967|P2|Overall Study|Protocol Violation|3
784787|NCT00666718|2495968|P1|Overall Study|Protocol Violation|1
784788|NCT00666718|2495967|P2|Overall Study|Entry Criteria Not Met|0
784789|NCT00666718|2495968|P1|Overall Study|Entry Criteria Not Met|2
784790|NCT00666718|2495967|P2|Overall Study|Lost to Follow-up|0
784791|NCT00666718|2495968|P1|Overall Study|Lost to Follow-up|1
784792|NCT00666718|2495967|P2|Overall Study|Death|0
784793|NCT00666718|2495968|P1|Overall Study|Death|1
784794|NCT00666718|2495967|P2|Overall Study|Adverse Event|1
784795|NCT00666718|2495968|P1|Overall Study|Adverse Event|0
784796|NCT00666757|2495996|P2|Overall Study|Sponsor decision|1
784797|NCT00666757|2495997|P1|Overall Study|Sponsor decision|0
784798|NCT00666757|2495996|P2|Overall Study|Physician Decision|2
784799|NCT00666757|2495997|P1|Overall Study|Physician Decision|0
784800|NCT00666757|2495996|P2|Overall Study|Lack of Efficacy|6
784801|NCT00666757|2495997|P1|Overall Study|Lack of Efficacy|3
784802|NCT00666757|2495996|P2|Overall Study|Withdrawal by Subject|17
784803|NCT00666757|2495997|P1|Overall Study|Withdrawal by Subject|13
784804|NCT00666757|2495996|P2|Overall Study|Adverse Event|12
784805|NCT00666757|2495997|P1|Overall Study|Adverse Event|22
784806|NCT00666757|2495996|P2|Overall Study|Protocol Violation|24
784807|NCT00666757|2495997|P1|Overall Study|Protocol Violation|23
784808|NCT00666757|2495996|P2|Overall Study|Lost to Follow-up|35
784809|NCT00666757|2495997|P1|Overall Study|Lost to Follow-up|39
784810|NCT00660816|2496056|P2|Overall Study|Complicating Disease|1
784811|NCT00660816|2496057|P1|Overall Study|Complicating Disease|0
784812|NCT00660816|2496056|P2|Overall Study|Disease Progression|12
784813|NCT00660816|2496057|P1|Overall Study|Disease Progression|16
784814|NCT00660816|2496056|P2|Overall Study|Protocol Violation|0
784815|NCT00660816|2496057|P1|Overall Study|Protocol Violation|1
784816|NCT00660816|2496056|P2|Overall Study|Physician Decision|2
784817|NCT00660816|2496057|P1|Overall Study|Physician Decision|0
784818|NCT00660816|2496056|P2|Overall Study|Lack of Efficacy|0
784819|NCT00660816|2496057|P1|Overall Study|Lack of Efficacy|1
784820|NCT00660816|2496056|P2|Overall Study|Death|2
784821|NCT00660816|2496057|P1|Overall Study|Death|0
784822|NCT00660816|2496056|P2|Overall Study|Withdrawal by Subject|0
784823|NCT00660816|2496057|P1|Overall Study|Withdrawal by Subject|1
784824|NCT00660816|2496056|P2|Overall Study|Adverse Event|2
784825|NCT00660816|2496057|P1|Overall Study|Adverse Event|1
784826|NCT00660829|2496071|P2|Overall Study|Other|4
784827|NCT00660829|2496072|P1|Overall Study|Other|9
784828|NCT00660829|2496071|P2|Overall Study|Lost to Follow-up|2
784829|NCT00660829|2496072|P1|Overall Study|Lost to Follow-up|3
784830|NCT00660829|2496071|P2|Overall Study|Withdrawal by Subject|2
784831|NCT00660829|2496072|P1|Overall Study|Withdrawal by Subject|1
784832|NCT00660829|2496071|P2|Overall Study|Non-Compliance|4
784833|NCT00660829|2496072|P1|Overall Study|Non-Compliance|0
784834|NCT00660829|2496071|P2|Overall Study|Lack of Efficacy|3
784835|NCT00660829|2496072|P1|Overall Study|Lack of Efficacy|2
784836|NCT00660829|2496071|P2|Overall Study|Adverse Event|4
784837|NCT00660829|2496072|P1|Overall Study|Adverse Event|3
784838|NCT00660907|2496090|P2|Overall Study|Various|8
784839|NCT00660907|2496091|P1|Overall Study|Various|11
784840|NCT00660907|2496090|P2|Overall Study|Death|3
784841|NCT00660907|2496091|P1|Overall Study|Death|1
784842|NCT00660907|2496090|P2|Overall Study|Safety|0
784843|NCT00660907|2496091|P1|Overall Study|Safety|1
784844|NCT00660907|2496090|P2|Overall Study|Poor/Non-Compliance|1
784845|NCT00660907|2496091|P1|Overall Study|Poor/Non-Compliance|5
784846|NCT00660907|2496090|P2|Overall Study|Lost to Follow-up|3
784847|NCT00660907|2496091|P1|Overall Study|Lost to Follow-up|3
784848|NCT00660907|2496090|P2|Overall Study|Withdrawal by Subject|32
784849|NCT00660907|2496091|P1|Overall Study|Withdrawal by Subject|23
784850|NCT00660907|2496090|P2|Overall Study|Subject No Longer Meets Study Criteria|27
784851|NCT00660907|2496091|P1|Overall Study|Subject No Longer Meets Study Criteria|6
784852|NCT00660907|2496090|P2|Overall Study|Adverse Event|19
784853|NCT00660907|2496091|P1|Overall Study|Adverse Event|33
784854|NCT00660907|2496090|P2|Overall Study|Incorrect Enrollment|1
784855|NCT00660907|2496091|P1|Overall Study|Incorrect Enrollment|1
784860|NCT00672984|2496370|P3|Third Intervention|Adverse Event|1
784861|NCT00672984|2496371|P2|Third Intervention|Adverse Event|0
784862|NCT00672984|2496372|P1|Third Intervention|Adverse Event|1
784863|NCT00672984|2496370|P3|Second Intervention|Protocol Violation|1
784864|NCT00672984|2496371|P2|Second Intervention|Protocol Violation|1
784865|NCT00672984|2496372|P1|Second Intervention|Protocol Violation|0
784866|NCT00672984|2496370|P3|Second Intervention|Withdrawal by Subject|0
784867|NCT00672984|2496371|P2|Second Intervention|Withdrawal by Subject|3
784868|NCT00672984|2496372|P1|Second Intervention|Withdrawal by Subject|0
784869|NCT00672984|2496370|P3|Second Intervention|Non-compliance with facility policies|0
784870|NCT00672984|2496371|P2|Second Intervention|Non-compliance with facility policies|2
784871|NCT00672984|2496372|P1|Second Intervention|Non-compliance with facility policies|0
784872|NCT00672984|2496370|P3|First Intervention|Sponsor decision|0
784873|NCT00672984|2496371|P2|First Intervention|Sponsor decision|0
784874|NCT00672984|2496372|P1|First Intervention|Sponsor decision|3
784875|NCT00672984|2496370|P3|First Intervention|Withdrawal by Subject|2
784876|NCT00672984|2496371|P2|First Intervention|Withdrawal by Subject|2
784877|NCT00672984|2496372|P1|First Intervention|Withdrawal by Subject|1
784878|NCT00672984|2496370|P3|First Intervention|Adverse Event|0
784879|NCT00672984|2496371|P2|First Intervention|Adverse Event|0
784880|NCT00672984|2496372|P1|First Intervention|Adverse Event|5
784881|NCT00673049|2496423|P4|After Progression on Erlotinib|study terminated by sponsor|4
784882|NCT00673049|2496424|P3|After Progression on Erlotinib|study terminated by sponsor|0
784883|NCT00673049|2496425|P2|After Progression on Erlotinib|study terminated by sponsor|0
784884|NCT00673049|2496426|P1|After Progression on Erlotinib|study terminated by sponsor|0
784885|NCT00673049|2496423|P4|After Progression on Erlotinib|Withdrawal by Subject|5
784886|NCT00673049|2496424|P3|After Progression on Erlotinib|Withdrawal by Subject|0
784887|NCT00673049|2496425|P2|After Progression on Erlotinib|Withdrawal by Subject|0
784888|NCT00673049|2496426|P1|After Progression on Erlotinib|Withdrawal by Subject|0
784889|NCT00673049|2496423|P4|After Progression on Erlotinib|Lost to Follow-up|3
784890|NCT00673049|2496424|P3|After Progression on Erlotinib|Lost to Follow-up|0
784891|NCT00673049|2496425|P2|After Progression on Erlotinib|Lost to Follow-up|0
784892|NCT00673049|2496426|P1|After Progression on Erlotinib|Lost to Follow-up|0
784893|NCT00673049|2496423|P4|After Progression on Erlotinib|Death|71
784894|NCT00673049|2496424|P3|After Progression on Erlotinib|Death|0
784895|NCT00673049|2496425|P2|After Progression on Erlotinib|Death|0
784896|NCT00673049|2496426|P1|After Progression on Erlotinib|Death|0
784897|NCT00673049|2496423|P4|Before Progression on Erlotinib|Switched to figitumumab|0
784898|NCT00673049|2496424|P3|Before Progression on Erlotinib|Switched to figitumumab|0
784899|NCT00673049|2496425|P2|Before Progression on Erlotinib|Switched to figitumumab|83
784900|NCT00673049|2496426|P1|Before Progression on Erlotinib|Switched to figitumumab|0
784901|NCT00673049|2496423|P4|Before Progression on Erlotinib|study terminated by sponsor|0
784902|NCT00673049|2496424|P3|Before Progression on Erlotinib|study terminated by sponsor|0
784903|NCT00673049|2496425|P2|Before Progression on Erlotinib|study terminated by sponsor|14
784904|NCT00673049|2496426|P1|Before Progression on Erlotinib|study terminated by sponsor|18
784905|NCT00673049|2496423|P4|Before Progression on Erlotinib|Unspecified|0
784906|NCT00673049|2496424|P3|Before Progression on Erlotinib|Unspecified|0
784907|NCT00673049|2496425|P2|Before Progression on Erlotinib|Unspecified|2
784908|NCT00673049|2496426|P1|Before Progression on Erlotinib|Unspecified|1
784909|NCT00673049|2496423|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
784910|NCT00673049|2496424|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
784911|NCT00673049|2496425|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
784912|NCT00673049|2496426|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
784913|NCT00673049|2496423|P4|Before Progression on Erlotinib|Lost to Follow-up|0
784914|NCT00673049|2496424|P3|Before Progression on Erlotinib|Lost to Follow-up|0
784915|NCT00673049|2496425|P2|Before Progression on Erlotinib|Lost to Follow-up|5
784916|NCT00673049|2496426|P1|Before Progression on Erlotinib|Lost to Follow-up|9
784917|NCT00673049|2496423|P4|Before Progression on Erlotinib|Death|0
784918|NCT00673049|2496424|P3|Before Progression on Erlotinib|Death|1
784919|NCT00673049|2496425|P2|Before Progression on Erlotinib|Death|167
784920|NCT00673049|2496426|P1|Before Progression on Erlotinib|Death|235
784921|NCT00673049|2496423|P4|Before Progression on Erlotinib|Randomized but not treated|0
784922|NCT00673049|2496424|P3|Before Progression on Erlotinib|Randomized but not treated|0
784923|NCT00673049|2496425|P2|Before Progression on Erlotinib|Randomized but not treated|1
784924|NCT00673049|2496426|P1|Before Progression on Erlotinib|Randomized but not treated|3
784925|NCT00673179|2496490|P2|Overall Study|Toxicity/Complications|0
784926|NCT00673179|2496491|P1|Overall Study|Toxicity/Complications|3
784927|NCT00673231|2496501|P4|Overall Study|Study criteria,compliance,safety, other|4
784928|NCT00673231|2496502|P3|Overall Study|Study criteria,compliance,safety, other|7
784929|NCT00673231|2496503|P2|Overall Study|Study criteria,compliance,safety, other|5
784930|NCT00673231|2496504|P1|Overall Study|Study criteria,compliance,safety, other|8
784931|NCT00673231|2496501|P4|Overall Study|Death|0
784932|NCT00673231|2496502|P3|Overall Study|Death|1
784933|NCT00673231|2496503|P2|Overall Study|Death|0
784934|NCT00673231|2496504|P1|Overall Study|Death|0
784935|NCT00673231|2496501|P4|Overall Study|Lost to Follow-up|2
784936|NCT00673231|2496502|P3|Overall Study|Lost to Follow-up|1
784937|NCT00673231|2496503|P2|Overall Study|Lost to Follow-up|2
784938|NCT00673231|2496504|P1|Overall Study|Lost to Follow-up|1
784939|NCT00673231|2496501|P4|Overall Study|Adverse Event|6
784940|NCT00673231|2496502|P3|Overall Study|Adverse Event|9
784941|NCT00673231|2496503|P2|Overall Study|Adverse Event|5
784942|NCT00673231|2496504|P1|Overall Study|Adverse Event|6
784943|NCT00673231|2496501|P4|Overall Study|Withdrawal by Subject|6
784944|NCT00673231|2496502|P3|Overall Study|Withdrawal by Subject|8
784945|NCT00673231|2496503|P2|Overall Study|Withdrawal by Subject|10
784946|NCT00673231|2496504|P1|Overall Study|Withdrawal by Subject|14
784947|NCT00673257|2496534|P1|Overall Study|Unable to obtain specimen|1
784948|NCT00673257|2496534|P1|Overall Study|Withdrawal by Subject|4
784949|NCT00673816|2496567|P1|Overall Study|Withdrawal by Subject|1
784950|NCT00673816|2496567|P1|Overall Study|Adverse Event|1
784951|NCT00673881|2496581|P1|Overall Study|Withdrawal by Subject|1
784952|NCT00673933|2496588|P1|Overall Study|Lost to Follow-up|1
784953|NCT00673933|2496588|P1|Overall Study|Withdrawal by Subject|2
784954|NCT00674128|2496625|P2|Overall Study|Withdrawal by Subject|23
784955|NCT00674128|2496626|P1|Overall Study|Withdrawal by Subject|25
784956|NCT00674154|2496634|P2|Overall Study|Did not want parathyroidectomy|2
784957|NCT00674154|2496635|P1|Overall Study|Did not want parathyroidectomy|0
784958|NCT00674154|2496634|P2|Overall Study|Withdrawal by Subject|1
784959|NCT00674154|2496635|P1|Overall Study|Withdrawal by Subject|3
784960|NCT00674323|2496649|P3|Overall Study|Protocol Violation|0
784961|NCT00674323|2496650|P2|Overall Study|Protocol Violation|0
784962|NCT00674323|2496651|P1|Overall Study|Protocol Violation|1
784963|NCT00674323|2496649|P3|Overall Study|Adverse Event|0
784964|NCT00674323|2496650|P2|Overall Study|Adverse Event|1
784965|NCT00674323|2496651|P1|Overall Study|Adverse Event|0
891980|NCT01009463|2828585|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
891985|NCT00911820|2828632|P2|Overall Study|Withdraw before Receive Treatment|2
891986|NCT00911820|2828633|P1|Overall Study|Withdraw before Receive Treatment|0
891987|NCT00911820|2828632|P2|Overall Study|Pathology Not Confirmed|0
891988|NCT00911820|2828633|P1|Overall Study|Pathology Not Confirmed|1
891989|NCT00911820|2828632|P2|Overall Study|Still on Therapy|2
891990|NCT00911820|2828633|P1|Overall Study|Still on Therapy|2
891991|NCT00911820|2828632|P2|Overall Study|Pursue Radiation|0
891992|NCT00911820|2828633|P1|Overall Study|Pursue Radiation|1
891993|NCT00911820|2828632|P2|Overall Study|Pursue surgery|1
891994|NCT00911820|2828633|P1|Overall Study|Pursue surgery|1
891995|NCT00911820|2828632|P2|Overall Study|Death|2
784988|NCT00674700|2496833|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
784989|NCT00674700|2496834|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
784990|NCT00674700|2496835|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
784991|NCT00674700|2496833|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
784992|NCT00674700|2496834|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
784993|NCT00674700|2496835|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
784994|NCT00674700|2496833|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
784995|NCT00674700|2496834|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
784996|NCT00674700|2496835|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
784997|NCT00674700|2496833|P3|Year 1|Any other reason not above-mentioned|6
784998|NCT00674700|2496834|P2|Year 1|Any other reason not above-mentioned|7
784999|NCT00674700|2496835|P1|Year 1|Any other reason not above-mentioned|7
785000|NCT00674700|2496833|P3|Year 1|Withdrawal by Subject|6
785001|NCT00674700|2496834|P2|Year 1|Withdrawal by Subject|7
785002|NCT00674700|2496835|P1|Year 1|Withdrawal by Subject|7
785003|NCT00674700|2496833|P3|Year 1|Adverse Event|5
785004|NCT00674700|2496834|P2|Year 1|Adverse Event|20
785005|NCT00674700|2496835|P1|Year 1|Adverse Event|17
785006|NCT00674817|2496874|P1|Period 4|Adverse Event|1
785007|NCT00674817|2496874|P1|Period 3|Protocol Violation|1
785008|NCT00674817|2496874|P1|Period 3|Adverse Event|1
785009|NCT00674817|2496874|P1|Period 1|Protocol Violation|1
785010|NCT00674817|2496874|P1|Period 1|Withdrawal by Subject|2
785011|NCT00674973|2497022|P2|Overall Study|Protocol Violation|1
785012|NCT00674973|2497023|P1|Overall Study|Protocol Violation|0
785013|NCT00674973|2497022|P2|Overall Study|Death|15
785014|NCT00674973|2497023|P1|Overall Study|Death|19
785015|NCT00674973|2497022|P2|Overall Study|Adverse Event|9
785016|NCT00674973|2497023|P1|Overall Study|Adverse Event|2
785017|NCT00674973|2497022|P2|Overall Study|Failure to Return|0
785018|NCT00674973|2497023|P1|Overall Study|Failure to Return|1
785019|NCT00674973|2497022|P2|Overall Study|Refused Treatment|5
785020|NCT00674973|2497023|P1|Overall Study|Refused Treatment|1
785021|NCT00674973|2497022|P2|Overall Study|Insufficient Therapeutic Response|72
785022|NCT00674973|2497023|P1|Overall Study|Insufficient Therapeutic Response|77
785023|NCT00674986|2497039|P2|Overall Study|Other reasons|8
785024|NCT00674986|2497040|P1|Overall Study|Other reasons|4
785025|NCT00674986|2497039|P2|Overall Study|Lost to Follow-up|53
785026|NCT00674986|2497040|P1|Overall Study|Lost to Follow-up|25
785027|NCT00674986|2497039|P2|Overall Study|Subject withdrew consent|19
785028|NCT00674986|2497040|P1|Overall Study|Subject withdrew consent|12
785029|NCT00674986|2497039|P2|Overall Study|Adverse Event|1
785030|NCT00674986|2497040|P1|Overall Study|Adverse Event|2
785031|NCT00675103|2497059|P1|Overall Study|Adverse Event|1
785032|NCT00675103|2497059|P1|Overall Study|Lack of Efficacy|2
785033|NCT00675428|2497084|P2|Overall Study|Physician Decision|0
785034|NCT00675428|2497085|P1|Overall Study|Physician Decision|1
785035|NCT00675428|2497084|P2|Overall Study|No Disease Response After Cycle 6|1
785036|NCT00675428|2497085|P1|Overall Study|No Disease Response After Cycle 6|0
785037|NCT00675428|2497084|P2|Overall Study|Disease Progression|2
785038|NCT00675428|2497085|P1|Overall Study|Disease Progression|2
785039|NCT00675441|2497103|P1|Overall Study|Death|1
785040|NCT00675441|2497103|P1|Overall Study|Withdrawal by Subject|2
785059|NCT00675597|2497150|P1|Overall Study|Withdrawal by Subject|3
785060|NCT00675766|2497158|P4|Overall Study|Lost to Follow-up|26
785061|NCT00675766|2497159|P3|Overall Study|Lost to Follow-up|21
785062|NCT00675766|2497160|P2|Overall Study|Lost to Follow-up|5
785063|NCT00675766|2497161|P1|Overall Study|Lost to Follow-up|6
785064|NCT00675948|2497210|P2|Overall Study|Patient feels unable to take medication|1
785065|NCT00675948|2497211|P1|Overall Study|Patient feels unable to take medication|0
785066|NCT00675948|2497210|P2|Overall Study|Patient unable to comply with diaries|0
785067|NCT00675948|2497211|P1|Overall Study|Patient unable to comply with diaries|1
785068|NCT00675948|2497210|P2|Overall Study|Patient died|0
785069|NCT00675948|2497211|P1|Overall Study|Patient died|1
785070|NCT00675948|2497210|P2|Overall Study|Sponsor decision|1
785071|NCT00675948|2497211|P1|Overall Study|Sponsor decision|0
785072|NCT00675948|2497210|P2|Overall Study|Pain under control|0
785073|NCT00675948|2497211|P1|Overall Study|Pain under control|1
785074|NCT00675948|2497210|P2|Overall Study|Protocol Violation|0
785075|NCT00675948|2497211|P1|Overall Study|Protocol Violation|1
785076|NCT00675948|2497210|P2|Overall Study|Lost to Follow-up|0
785077|NCT00675948|2497211|P1|Overall Study|Lost to Follow-up|2
785078|NCT00675948|2497210|P2|Overall Study|Withdrawal by Subject|0
785079|NCT00675948|2497211|P1|Overall Study|Withdrawal by Subject|7
785080|NCT00675948|2497210|P2|Overall Study|Lack of Efficacy|0
785081|NCT00675948|2497211|P1|Overall Study|Lack of Efficacy|3
785082|NCT00675948|2497210|P2|Overall Study|Adverse Event|1
785083|NCT00675948|2497211|P1|Overall Study|Adverse Event|23
891996|NCT00911820|2828633|P1|Overall Study|Death|1
891997|NCT00911820|2828632|P2|Overall Study|Withdrawal by Subject|4
891998|NCT00911820|2828633|P1|Overall Study|Withdrawal by Subject|3
891999|NCT00911820|2828632|P2|Overall Study|Decline in Performance Status|2
892000|NCT00911820|2828633|P1|Overall Study|Decline in Performance Status|4
892001|NCT00911820|2828632|P2|Overall Study|Physician Decision|9
892002|NCT00911820|2828633|P1|Overall Study|Physician Decision|5
892003|NCT00911820|2828632|P2|Overall Study|Clinical Progression|5
892004|NCT00911820|2828633|P1|Overall Study|Clinical Progression|7
892005|NCT00911820|2828632|P2|Overall Study|Adverse Event|8
892006|NCT00911820|2828633|P1|Overall Study|Adverse Event|8
892007|NCT00911820|2828632|P2|Overall Study|RECIST progression|8
892008|NCT00911820|2828633|P1|Overall Study|RECIST progression|12
892009|NCT00817063|2828649|P2|Overall Study|Abnormality of Laboratory Test|1
892010|NCT00817063|2828650|P1|Overall Study|Abnormality of Laboratory Test|2
892011|NCT00817063|2828649|P2|Overall Study|Administrative|4
892012|NCT00817063|2828650|P1|Overall Study|Administrative|10
892013|NCT00817063|2828649|P2|Overall Study|Early Improvement|4
892014|NCT00817063|2828650|P1|Overall Study|Early Improvement|19
892015|NCT00817063|2828649|P2|Overall Study|Withdrawal by Subject|37
892016|NCT00817063|2828650|P1|Overall Study|Withdrawal by Subject|17
892017|NCT00817063|2828649|P2|Overall Study|Protocol Violation|8
892018|NCT00817063|2828650|P1|Overall Study|Protocol Violation|3
892019|NCT00817063|2828649|P2|Overall Study|Violation of Selection at Entry|4
892020|NCT00817063|2828650|P1|Overall Study|Violation of Selection at Entry|7
892021|NCT00817063|2828649|P2|Overall Study|Failure to Return|12
892022|NCT00817063|2828650|P1|Overall Study|Failure to Return|13
892023|NCT00817063|2828649|P2|Overall Study|Lack of Efficacy|86
892024|NCT00817063|2828650|P1|Overall Study|Lack of Efficacy|33
892025|NCT00817063|2828649|P2|Overall Study|Death|1
892026|NCT00817063|2828650|P1|Overall Study|Death|1
892027|NCT00817063|2828649|P2|Overall Study|Adverse Event|13
892028|NCT00817063|2828650|P1|Overall Study|Adverse Event|32
892029|NCT00791700|2828696|P4|Overall Study|Blood sampling not done before Stage 1|1
892030|NCT00791700|2828697|P3|Overall Study|Blood sampling not done before Stage 1|0
785120|NCT00676091|2497300|P2|Toddler Dose|Parent or legal guardian request|0
785121|NCT00676091|2497301|P1|Toddler Dose|Parent or legal guardian request|1
785122|NCT00676091|2497300|P2|Toddler Dose|Failed to return|0
785123|NCT00676091|2497301|P1|Toddler Dose|Failed to return|2
785124|NCT00676091|2497300|P2|After Infant Series|Failed to return|1
785125|NCT00676091|2497301|P1|After Infant Series|Failed to return|1
785126|NCT00676091|2497300|P2|After Infant Series|Protocol Violation|1
785127|NCT00676091|2497301|P1|After Infant Series|Protocol Violation|0
785128|NCT00676091|2497300|P2|After Infant Series|Adverse Event|1
785129|NCT00676091|2497301|P1|After Infant Series|Adverse Event|0
785130|NCT00676091|2497300|P2|Infant Series|Died prior to receiving 7vPnC|1
785131|NCT00676091|2497301|P1|Infant Series|Died prior to receiving 7vPnC|0
785132|NCT00676091|2497300|P2|Infant Series|Lost to Follow-up|0
785133|NCT00676091|2497301|P1|Infant Series|Lost to Follow-up|1
785134|NCT00676091|2497300|P2|Infant Series|Failed to return|3
785135|NCT00676091|2497301|P1|Infant Series|Failed to return|1
785136|NCT00676091|2497300|P2|Infant Series|Adverse Event|3
785137|NCT00676091|2497301|P1|Infant Series|Adverse Event|2
785138|NCT00676091|2497300|P2|Infant Series|Protocol Violation|3
785139|NCT00676091|2497301|P1|Infant Series|Protocol Violation|6
785140|NCT00676091|2497300|P2|Infant Series|Parent or legal guardian request|8
785141|NCT00676091|2497301|P1|Infant Series|Parent or legal guardian request|10
785142|NCT00676130|2497335|P2|Overall Study|Withdrawal by Subject|1
785143|NCT00676130|2497336|P1|Overall Study|Withdrawal by Subject|0
785144|NCT00676130|2497335|P2|Overall Study|Found ineligible|2
785145|NCT00676130|2497336|P1|Overall Study|Found ineligible|3
785146|NCT00676130|2497335|P2|Overall Study|Lost to Follow-up|1
785147|NCT00676130|2497336|P1|Overall Study|Lost to Follow-up|0
785148|NCT00676143|2497346|P2|Overall Study|Vasogenic edema recurrence|3
785149|NCT00676143|2497347|P1|Overall Study|Vasogenic edema recurrence|1
785150|NCT00676143|2497346|P2|Overall Study|Participant participation unknown|4
785151|NCT00676143|2497347|P1|Overall Study|Participant participation unknown|1
785152|NCT00676143|2497346|P2|Overall Study|Not specified|20
785153|NCT00676143|2497347|P1|Overall Study|Not specified|11
785154|NCT00676143|2497346|P2|Overall Study|Loss of caregiver|3
785155|NCT00676143|2497347|P1|Overall Study|Loss of caregiver|5
785156|NCT00676143|2497346|P2|Overall Study|Failed to return|1
785157|NCT00676143|2497347|P1|Overall Study|Failed to return|2
785158|NCT00676143|2497346|P2|Overall Study|Discontinuation of study by sponsor|88
785159|NCT00676143|2497347|P1|Overall Study|Discontinuation of study by sponsor|65
785160|NCT00676143|2497346|P2|Overall Study|Withdrawal by Subject|42
785161|NCT00676143|2497347|P1|Overall Study|Withdrawal by Subject|24
785162|NCT00676143|2497346|P2|Overall Study|Protocol Violation|8
785163|NCT00676143|2497347|P1|Overall Study|Protocol Violation|4
785164|NCT00676143|2497346|P2|Overall Study|Physician Decision|8
785165|NCT00676143|2497347|P1|Overall Study|Physician Decision|5
785166|NCT00676143|2497346|P2|Overall Study|Lost to Follow-up|13
785167|NCT00676143|2497347|P1|Overall Study|Lost to Follow-up|0
785168|NCT00676143|2497346|P2|Overall Study|Lack of Efficacy|6
785169|NCT00676143|2497347|P1|Overall Study|Lack of Efficacy|0
785170|NCT00676143|2497346|P2|Overall Study|Death|4
785171|NCT00676143|2497347|P1|Overall Study|Death|4
785172|NCT00676143|2497346|P2|Overall Study|Adverse Event|60
785173|NCT00676143|2497347|P1|Overall Study|Adverse Event|34
785174|NCT00664066|2497385|P1|Overall Study|Study terminated|3
785175|NCT00664105|2497389|P1|Overall Study|Disease progression|7
785176|NCT00664105|2497389|P1|Overall Study|Adverse Event|9
785177|NCT00664105|2497389|P1|Overall Study|Withdrawal by Subject|5
785178|NCT00664105|2497389|P1|Overall Study|Death|3
785179|NCT00669617|2497396|P5|Period 3|Lost to Follow-up|0
785180|NCT00669617|2497397|P4|Period 3|Lost to Follow-up|0
785181|NCT00669617|2497398|P3|Period 3|Lost to Follow-up|0
785182|NCT00669617|2497399|P2|Period 3|Lost to Follow-up|0
785183|NCT00669617|2497400|P1|Period 3|Lost to Follow-up|1
785184|NCT00669617|2497396|P5|Period 1|Protocol Deviation|1
785185|NCT00669617|2497397|P4|Period 1|Protocol Deviation|0
785186|NCT00669617|2497398|P3|Period 1|Protocol Deviation|0
785187|NCT00669617|2497399|P2|Period 1|Protocol Deviation|0
785188|NCT00669617|2497400|P1|Period 1|Protocol Deviation|0
785189|NCT00669617|2497396|P5|Period 1|Withdrawal by Subject|0
785190|NCT00669617|2497397|P4|Period 1|Withdrawal by Subject|0
785191|NCT00669617|2497398|P3|Period 1|Withdrawal by Subject|1
785192|NCT00669617|2497399|P2|Period 1|Withdrawal by Subject|0
785193|NCT00669617|2497400|P1|Period 1|Withdrawal by Subject|0
785194|NCT00669864|2497417|P1|Overall Study|Other|2
785195|NCT00669864|2497417|P1|Overall Study|Withdrawal by Subject|3
785196|NCT00669864|2497417|P1|Overall Study|Protocol Violation|2
785197|NCT00669864|2497417|P1|Overall Study|Lost to Follow-up|2
785198|NCT00669903|2497430|P4|Overall Study|Protocol Violation|0
785199|NCT00669903|2497431|P3|Overall Study|Protocol Violation|0
785200|NCT00669903|2497432|P2|Overall Study|Protocol Violation|1
785201|NCT00669903|2497433|P1|Overall Study|Protocol Violation|0
785202|NCT00669903|2497430|P4|Overall Study|Lost to Follow-up|1
785203|NCT00669903|2497431|P3|Overall Study|Lost to Follow-up|0
785204|NCT00669903|2497432|P2|Overall Study|Lost to Follow-up|1
785205|NCT00669903|2497433|P1|Overall Study|Lost to Follow-up|1
785206|NCT00669903|2497430|P4|Overall Study|Withdrawal by Subject|2
785207|NCT00669903|2497431|P3|Overall Study|Withdrawal by Subject|2
785208|NCT00669903|2497432|P2|Overall Study|Withdrawal by Subject|2
785209|NCT00669903|2497433|P1|Overall Study|Withdrawal by Subject|0
785210|NCT00669903|2497430|P4|Overall Study|Adverse Event|1
785211|NCT00669903|2497431|P3|Overall Study|Adverse Event|3
785212|NCT00669903|2497432|P2|Overall Study|Adverse Event|1
785213|NCT00669903|2497433|P1|Overall Study|Adverse Event|0
785214|NCT00669942|2497492|P12|Parts 2 and 3|Protocol Violation|0
785215|NCT00669942|2497493|P11|Parts 2 and 3|Protocol Violation|0
785216|NCT00669942|2497494|P10|Parts 2 and 3|Protocol Violation|0
785217|NCT00669942|2497495|P9|Parts 2 and 3|Protocol Violation|0
785218|NCT00669942|2497496|P8|Parts 2 and 3|Protocol Violation|0
785219|NCT00669942|2497497|P7|Parts 2 and 3|Protocol Violation|0
785220|NCT00669942|2497498|P6|Parts 2 and 3|Protocol Violation|1
785221|NCT00669942|2497499|P5|Parts 2 and 3|Protocol Violation|0
785222|NCT00669942|2497500|P4|Parts 2 and 3|Protocol Violation|0
785223|NCT00669942|2497501|P3|Parts 2 and 3|Protocol Violation|0
785224|NCT00669942|2497502|P2|Parts 2 and 3|Protocol Violation|0
785225|NCT00669942|2497503|P1|Parts 2 and 3|Protocol Violation|0
785226|NCT00669942|2497492|P12|Parts 2 and 3|Withdrawal by Subject|0
785227|NCT00669942|2497493|P11|Parts 2 and 3|Withdrawal by Subject|0
785228|NCT00669942|2497494|P10|Parts 2 and 3|Withdrawal by Subject|0
785229|NCT00669942|2497495|P9|Parts 2 and 3|Withdrawal by Subject|2
785230|NCT00669942|2497496|P8|Parts 2 and 3|Withdrawal by Subject|0
785231|NCT00669942|2497497|P7|Parts 2 and 3|Withdrawal by Subject|0
785232|NCT00669942|2497498|P6|Parts 2 and 3|Withdrawal by Subject|1
785233|NCT00669942|2497499|P5|Parts 2 and 3|Withdrawal by Subject|0
785234|NCT00669942|2497500|P4|Parts 2 and 3|Withdrawal by Subject|0
785235|NCT00669942|2497501|P3|Parts 2 and 3|Withdrawal by Subject|0
785236|NCT00669942|2497502|P2|Parts 2 and 3|Withdrawal by Subject|0
785237|NCT00669942|2497503|P1|Parts 2 and 3|Withdrawal by Subject|0
785238|NCT00669942|2497492|P12|Parts 2 and 3|Adverse Event|0
785239|NCT00669942|2497493|P11|Parts 2 and 3|Adverse Event|0
785240|NCT00669942|2497494|P10|Parts 2 and 3|Adverse Event|0
785241|NCT00669942|2497495|P9|Parts 2 and 3|Adverse Event|1
785242|NCT00669942|2497496|P8|Parts 2 and 3|Adverse Event|2
785243|NCT00669942|2497497|P7|Parts 2 and 3|Adverse Event|0
785244|NCT00669942|2497498|P6|Parts 2 and 3|Adverse Event|0
785245|NCT00669942|2497499|P5|Parts 2 and 3|Adverse Event|0
785246|NCT00669942|2497500|P4|Parts 2 and 3|Adverse Event|0
785247|NCT00669942|2497501|P3|Parts 2 and 3|Adverse Event|0
785248|NCT00669942|2497502|P2|Parts 2 and 3|Adverse Event|0
785249|NCT00669942|2497503|P1|Parts 2 and 3|Adverse Event|0
785250|NCT00669955|2497567|P2|Overall Study|not compliant with study drug/visit|3
785251|NCT00669955|2497568|P1|Overall Study|not compliant with study drug/visit|2
785252|NCT00669955|2497567|P2|Overall Study|Investigator Sponsor Judgement|1
785253|NCT00669955|2497568|P1|Overall Study|Investigator Sponsor Judgement|0
785254|NCT00669955|2497567|P2|Overall Study|Protocol Violation|7
785255|NCT00669955|2497568|P1|Overall Study|Protocol Violation|2
785256|NCT00669955|2497567|P2|Overall Study|Lost to Follow-up|7
785257|NCT00669955|2497568|P1|Overall Study|Lost to Follow-up|5
785258|NCT00669955|2497567|P2|Overall Study|Withdrawal by Subject|3
785259|NCT00669955|2497568|P1|Overall Study|Withdrawal by Subject|2
785260|NCT00669955|2497567|P2|Overall Study|Death|1
785261|NCT00669955|2497568|P1|Overall Study|Death|0
785262|NCT00669955|2497567|P2|Overall Study|Adverse Event|5
785263|NCT00669955|2497568|P1|Overall Study|Adverse Event|3
785264|NCT00670007|2497586|P1|Overall Study|Withdrawal by Subject|4
785265|NCT00670007|2497586|P1|Overall Study|Adverse Event|1
785266|NCT00670007|2497586|P1|Overall Study|Adverse event, serious fatal|1
785267|NCT00670007|2497586|P1|Overall Study|Travel/Vacation|1
785268|NCT00670007|2497586|P1|Overall Study|Lung transplant|1
785269|NCT00670007|2497586|P1|Overall Study|Drug abuse|1
785270|NCT00670111|2497614|P3|Enrollment to One Month|Physician Decision|0
785271|NCT00670111|2497615|P2|Enrollment to One Month|Physician Decision|0
785272|NCT00670111|2497616|P1|Enrollment to One Month|Physician Decision|1
785273|NCT00670111|2497614|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
785274|NCT00670111|2497615|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
785275|NCT00670111|2497616|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
785276|NCT00670111|2497614|P3|Enrollment to One Month|Testing Failure|13
785277|NCT00670111|2497615|P2|Enrollment to One Month|Testing Failure|0
785278|NCT00670111|2497616|P1|Enrollment to One Month|Testing Failure|0
785279|NCT00670228|2497635|P2|Overall Study|Not meeting the selection criteria|0
785280|NCT00670228|2497636|P1|Overall Study|Not meeting the selection criteria|2
785281|NCT00670228|2497635|P2|Overall Study|Not treated|2
785282|NCT00670228|2497636|P1|Overall Study|Not treated|2
785283|NCT00670228|2497635|P2|Overall Study|Death or MACE|1
785284|NCT00670228|2497636|P1|Overall Study|Death or MACE|0
785285|NCT00670228|2497635|P2|Overall Study|Adverse Event|0
785286|NCT00670228|2497636|P1|Overall Study|Adverse Event|1
785287|NCT00670306|2497681|P1|Overall Study|incl/excl criterias did not meet|19
785288|NCT00670306|2497681|P1|Overall Study|Lost to Follow-up|8
785289|NCT00670306|2497681|P1|Overall Study|Physician Decision|1
785290|NCT00670306|2497681|P1|Overall Study|Withdrawal by Subject|9
785291|NCT00670306|2497681|P1|Overall Study|Lack of Efficacy|10
785292|NCT00670306|2497681|P1|Overall Study|Adverse Event|8
785293|NCT00676195|2497700|P1|Overall Study|Physician Decision|1
785294|NCT00676195|2497700|P1|Overall Study|Adverse Event|1
785295|NCT00676195|2497700|P1|Overall Study|Lost to Follow-up|1
785296|NCT00676208|2497710|P2|Overall Study|Incomplete data|4
785297|NCT00676208|2497711|P1|Overall Study|Incomplete data|2
785298|NCT00676208|2497710|P2|Overall Study|Lost to Follow-up|2
785299|NCT00676208|2497711|P1|Overall Study|Lost to Follow-up|0
785300|NCT00676338|2497723|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
785301|NCT00676338|2497724|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
785302|NCT00676338|2497725|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
785303|NCT00676338|2497726|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
785304|NCT00676338|2497723|P4|Overall Study|Entry Criteria Not Met|1
785305|NCT00676338|2497724|P3|Overall Study|Entry Criteria Not Met|1
785306|NCT00676338|2497725|P2|Overall Study|Entry Criteria Not Met|2
785307|NCT00676338|2497726|P1|Overall Study|Entry Criteria Not Met|0
785308|NCT00676338|2497723|P4|Overall Study|Withdrawal by Subject|6
785309|NCT00676338|2497724|P3|Overall Study|Withdrawal by Subject|12
785310|NCT00676338|2497725|P2|Overall Study|Withdrawal by Subject|9
785311|NCT00676338|2497726|P1|Overall Study|Withdrawal by Subject|17
785312|NCT00676338|2497723|P4|Overall Study|Protocol Violation|5
785313|NCT00676338|2497724|P3|Overall Study|Protocol Violation|2
785314|NCT00676338|2497725|P2|Overall Study|Protocol Violation|9
785315|NCT00676338|2497726|P1|Overall Study|Protocol Violation|5
785316|NCT00676338|2497723|P4|Overall Study|Physician Decision|3
785317|NCT00676338|2497724|P3|Overall Study|Physician Decision|2
785318|NCT00676338|2497725|P2|Overall Study|Physician Decision|3
785319|NCT00676338|2497726|P1|Overall Study|Physician Decision|3
785320|NCT00676338|2497723|P4|Overall Study|Lost to Follow-up|4
785321|NCT00676338|2497724|P3|Overall Study|Lost to Follow-up|3
785322|NCT00676338|2497725|P2|Overall Study|Lost to Follow-up|1
785323|NCT00676338|2497726|P1|Overall Study|Lost to Follow-up|4
785324|NCT00676338|2497723|P4|Overall Study|Adverse Event|1
785325|NCT00676338|2497724|P3|Overall Study|Adverse Event|5
785326|NCT00676338|2497725|P2|Overall Study|Adverse Event|6
785327|NCT00676338|2497726|P1|Overall Study|Adverse Event|6
785328|NCT00676403|2497793|P6|Overall Study|Withdrawal by Subject|1
785329|NCT00676403|2497794|P5|Overall Study|Withdrawal by Subject|0
785330|NCT00676403|2497795|P4|Overall Study|Withdrawal by Subject|0
785331|NCT00676403|2497796|P3|Overall Study|Withdrawal by Subject|0
785332|NCT00676403|2497797|P2|Overall Study|Withdrawal by Subject|0
785333|NCT00676403|2497798|P1|Overall Study|Withdrawal by Subject|0
785334|NCT00676403|2497793|P6|Overall Study|Reason Unspecified|1
785335|NCT00676403|2497794|P5|Overall Study|Reason Unspecified|0
785336|NCT00676403|2497795|P4|Overall Study|Reason Unspecified|0
785337|NCT00676403|2497796|P3|Overall Study|Reason Unspecified|1
785338|NCT00676403|2497797|P2|Overall Study|Reason Unspecified|0
785339|NCT00676403|2497798|P1|Overall Study|Reason Unspecified|1
785340|NCT00676403|2497793|P6|Overall Study|Lost to Follow-up|1
785341|NCT00676403|2497794|P5|Overall Study|Lost to Follow-up|0
785342|NCT00676403|2497795|P4|Overall Study|Lost to Follow-up|0
785343|NCT00676403|2497796|P3|Overall Study|Lost to Follow-up|0
785344|NCT00676403|2497797|P2|Overall Study|Lost to Follow-up|0
785345|NCT00676403|2497798|P1|Overall Study|Lost to Follow-up|0
785346|NCT00676403|2497793|P6|Overall Study|Adverse Event|2
785347|NCT00676403|2497794|P5|Overall Study|Adverse Event|1
785348|NCT00676403|2497795|P4|Overall Study|Adverse Event|5
785349|NCT00676403|2497796|P3|Overall Study|Adverse Event|0
785350|NCT00676403|2497797|P2|Overall Study|Adverse Event|2
785351|NCT00676403|2497798|P1|Overall Study|Adverse Event|1
785352|NCT00676494|2497931|P1|Overall Study|Withdrawal by Subject|6
785353|NCT00676494|2497931|P1|Overall Study|Missed Visit|8
785354|NCT00677014|2497975|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
785355|NCT00677014|2497976|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
785356|NCT00677014|2497977|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
785357|NCT00677014|2497975|P3|Overall Study|Death|7
785358|NCT00677014|2497976|P2|Overall Study|Death|15
785359|NCT00677014|2497977|P1|Overall Study|Death|6
785360|NCT00677014|2497975|P3|Overall Study|Lost to Follow-up|24
785361|NCT00677014|2497976|P2|Overall Study|Lost to Follow-up|12
785362|NCT00677014|2497977|P1|Overall Study|Lost to Follow-up|20
785363|NCT00677092|2497985|P1|Overall Study|Death Prior to Receiving Treatment|1
785364|NCT00677092|2497985|P1|Overall Study|Withdrawal by Subject|3
785365|NCT00677092|2497985|P1|Overall Study|Lost to Follow-up|1
785366|NCT00677092|2497985|P1|Overall Study|Adverse Event|1
785367|NCT00677235|2497996|P2|Overall Study|Adverse Experience|0
785368|NCT00677235|2497997|P1|Overall Study|Adverse Experience|1
785369|NCT00677235|2497996|P2|Overall Study|Death|36
785370|NCT00677235|2497997|P1|Overall Study|Death|37
785371|NCT00677235|2497996|P2|Overall Study|Lost to Follow-up|1
785372|NCT00677235|2497997|P1|Overall Study|Lost to Follow-up|2
785373|NCT00677235|2497996|P2|Overall Study|Withdrawal by Subject|1
785374|NCT00677235|2497997|P1|Overall Study|Withdrawal by Subject|1
785375|NCT00677352|2498039|P2|Tapering Phase|Job transfer|1
785376|NCT00677352|2498040|P1|Tapering Phase|Job transfer|0
785377|NCT00677352|2498039|P2|Tapering Phase|Pregnancy|1
785378|NCT00677352|2498040|P1|Tapering Phase|Pregnancy|0
785379|NCT00677352|2498039|P2|Tapering Phase|Withdrawal by Subject|3
785380|NCT00677352|2498040|P1|Tapering Phase|Withdrawal by Subject|5
785381|NCT00677352|2498039|P2|Tapering Phase|Adverse Event|5
785382|NCT00677352|2498040|P1|Tapering Phase|Adverse Event|1
785383|NCT00677352|2498039|P2|Treatment Phase|Not treated|2
785384|NCT00677352|2498040|P1|Treatment Phase|Not treated|0
785385|NCT00677352|2498039|P2|Treatment Phase|Transference or work related matter|5
785386|NCT00677352|2498040|P1|Treatment Phase|Transference or work related matter|0
785387|NCT00677352|2498039|P2|Treatment Phase|Protocol Violation|1
785388|NCT00677352|2498040|P1|Treatment Phase|Protocol Violation|1
785389|NCT00677352|2498039|P2|Treatment Phase|Pregnancy|1
785390|NCT00677352|2498040|P1|Treatment Phase|Pregnancy|0
785391|NCT00677352|2498039|P2|Treatment Phase|Physician Decision|0
785392|NCT00677352|2498040|P1|Treatment Phase|Physician Decision|1
785393|NCT00677352|2498039|P2|Treatment Phase|Withdrawal by Subject|7
785394|NCT00677352|2498040|P1|Treatment Phase|Withdrawal by Subject|7
785395|NCT00677352|2498039|P2|Treatment Phase|Lost to Follow-up|1
785396|NCT00677352|2498040|P1|Treatment Phase|Lost to Follow-up|0
785397|NCT00677352|2498039|P2|Treatment Phase|Lack of Efficacy|3
785398|NCT00677352|2498040|P1|Treatment Phase|Lack of Efficacy|2
785399|NCT00677352|2498039|P2|Treatment Phase|Adverse Event|22
785400|NCT00677352|2498040|P1|Treatment Phase|Adverse Event|14
785401|NCT00677365|2498062|P4|Overall Study|Other reason|1
785402|NCT00677365|2498063|P3|Overall Study|Other reason|0
785403|NCT00677365|2498064|P2|Overall Study|Other reason|0
785404|NCT00677365|2498065|P1|Overall Study|Other reason|0
785405|NCT00677365|2498062|P4|Overall Study|Withdrawal by Subject|0
785406|NCT00677365|2498063|P3|Overall Study|Withdrawal by Subject|1
785407|NCT00677365|2498064|P2|Overall Study|Withdrawal by Subject|0
785408|NCT00677365|2498065|P1|Overall Study|Withdrawal by Subject|0
785409|NCT00677365|2498062|P4|Overall Study|Adverse Event|2
785410|NCT00677365|2498063|P3|Overall Study|Adverse Event|1
785411|NCT00677365|2498064|P2|Overall Study|Adverse Event|1
785412|NCT00677365|2498065|P1|Overall Study|Adverse Event|2
785413|NCT00677534|2498095|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
785414|NCT00677534|2498095|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
785415|NCT00677534|2498095|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
785416|NCT00677807|2498119|P3|Overall Study|Protocol Deviation|0
785417|NCT00677807|2498120|P2|Overall Study|Protocol Deviation|3
785418|NCT00677807|2498121|P1|Overall Study|Protocol Deviation|1
785419|NCT00677807|2498119|P3|Overall Study|Death|1
785420|NCT00677807|2498120|P2|Overall Study|Death|1
785421|NCT00677807|2498121|P1|Overall Study|Death|0
785422|NCT00677807|2498119|P3|Overall Study|Administrative problems|2
785423|NCT00677807|2498120|P2|Overall Study|Administrative problems|1
785424|NCT00677807|2498121|P1|Overall Study|Administrative problems|1
785425|NCT00677807|2498119|P3|Overall Study|Lost to Follow-up|2
785426|NCT00677807|2498120|P2|Overall Study|Lost to Follow-up|2
785427|NCT00677807|2498121|P1|Overall Study|Lost to Follow-up|2
785428|NCT00677807|2498119|P3|Overall Study|Withdrawal by Subject|6
785429|NCT00677807|2498120|P2|Overall Study|Withdrawal by Subject|3
785430|NCT00677807|2498121|P1|Overall Study|Withdrawal by Subject|10
785431|NCT00677807|2498119|P3|Overall Study|Participant no longer needs study drug|1
785432|NCT00677807|2498120|P2|Overall Study|Participant no longer needs study drug|0
785433|NCT00677807|2498121|P1|Overall Study|Participant no longer needs study drug|0
785434|NCT00677807|2498119|P3|Overall Study|Lack of Efficacy|2
785435|NCT00677807|2498120|P2|Overall Study|Lack of Efficacy|0
785436|NCT00677807|2498121|P1|Overall Study|Lack of Efficacy|0
785437|NCT00677807|2498119|P3|Overall Study|Adverse Event|6
785438|NCT00677807|2498120|P2|Overall Study|Adverse Event|1
785439|NCT00677807|2498121|P1|Overall Study|Adverse Event|4
785440|NCT00677820|2498152|P2|Overall Study|Lost to Follow-up|0
785441|NCT00677820|2498153|P1|Overall Study|Lost to Follow-up|1
785442|NCT00677833|2498175|P4|Overall Study|Lost to Follow-up|0
785443|NCT00677833|2498176|P3|Overall Study|Lost to Follow-up|1
785444|NCT00677833|2498177|P2|Overall Study|Lost to Follow-up|0
785445|NCT00677833|2498178|P1|Overall Study|Lost to Follow-up|0
785446|NCT00677833|2498175|P4|Overall Study|Withdrawal by Subject|3
785447|NCT00677833|2498176|P3|Overall Study|Withdrawal by Subject|1
785448|NCT00677833|2498177|P2|Overall Study|Withdrawal by Subject|0
785449|NCT00677833|2498178|P1|Overall Study|Withdrawal by Subject|4
785450|NCT00678041|2498265|P2|Overall Study|Physician Decision|5
785451|NCT00678041|2498266|P1|Overall Study|Physician Decision|5
785452|NCT00678210|2498282|P4|Overall Study|Unspecified|0
785453|NCT00678210|2498283|P3|Overall Study|Unspecified|1
785454|NCT00678210|2498284|P2|Overall Study|Unspecified|0
785455|NCT00678210|2498285|P1|Overall Study|Unspecified|1
785456|NCT00678210|2498282|P4|Overall Study|Withdrawal by Subject|7
785457|NCT00678210|2498283|P3|Overall Study|Withdrawal by Subject|1
785458|NCT00678210|2498284|P2|Overall Study|Withdrawal by Subject|4
785459|NCT00678210|2498285|P1|Overall Study|Withdrawal by Subject|3
785460|NCT00678210|2498282|P4|Overall Study|Lost to Follow-up|1
785461|NCT00678210|2498283|P3|Overall Study|Lost to Follow-up|0
785462|NCT00678210|2498284|P2|Overall Study|Lost to Follow-up|2
785463|NCT00678210|2498285|P1|Overall Study|Lost to Follow-up|4
785464|NCT00678210|2498282|P4|Overall Study|Lack of Efficacy|9
785465|NCT00678210|2498283|P3|Overall Study|Lack of Efficacy|1
785466|NCT00678210|2498284|P2|Overall Study|Lack of Efficacy|3
785467|NCT00678210|2498285|P1|Overall Study|Lack of Efficacy|2
785468|NCT00678210|2498282|P4|Overall Study|Adverse Event|3
785469|NCT00678210|2498283|P3|Overall Study|Adverse Event|3
785470|NCT00678210|2498284|P2|Overall Study|Adverse Event|2
785471|NCT00678210|2498285|P1|Overall Study|Adverse Event|1
785472|NCT00678288|2498358|P2|Overall Study|Disease progression/recurrence/relapse|1
785473|NCT00678288|2498359|P1|Overall Study|Disease progression/recurrence/relapse|6
785474|NCT00678288|2498358|P2|Overall Study|Reason not reported|0
785475|NCT00678288|2498359|P1|Overall Study|Reason not reported|1
785476|NCT00678288|2498358|P2|Overall Study|Switch to commercial drug|1
785477|NCT00678288|2498359|P1|Overall Study|Switch to commercial drug|0
785478|NCT00678288|2498358|P2|Overall Study|Not compliant with study medication|1
785479|NCT00678288|2498359|P1|Overall Study|Not compliant with study medication|0
785480|NCT00678288|2498358|P2|Overall Study|Study terminated by the sponsor|0
785481|NCT00678288|2498359|P1|Overall Study|Study terminated by the sponsor|2
785482|NCT00678288|2498358|P2|Overall Study|Withdrawal by Subject|1
785483|NCT00678288|2498359|P1|Overall Study|Withdrawal by Subject|1
785484|NCT00678288|2498358|P2|Overall Study|Adverse Event|2
785485|NCT00678288|2498359|P1|Overall Study|Adverse Event|0
785486|NCT00678379|2498376|P3|Overall Study|Incomplete Data|3
785487|NCT00678379|2498377|P2|Overall Study|Incomplete Data|3
785488|NCT00678379|2498378|P1|Overall Study|Incomplete Data|4
785489|NCT00678379|2498376|P3|Overall Study|Injection performed after tonsillectomy|1
785490|NCT00678379|2498377|P2|Overall Study|Injection performed after tonsillectomy|0
785491|NCT00678379|2498378|P1|Overall Study|Injection performed after tonsillectomy|2
785492|NCT00678392|2498406|P2|Overall Study|Unspecified|53
785493|NCT00678392|2498407|P1|Overall Study|Unspecified|56
785494|NCT00678392|2498406|P2|Overall Study|Randomized But Not Treated|7
785495|NCT00678392|2498407|P1|Overall Study|Randomized But Not Treated|2
785496|NCT00678392|2498406|P2|Overall Study|Withdrawal by Subject|4
785497|NCT00678392|2498407|P1|Overall Study|Withdrawal by Subject|4
785498|NCT00678392|2498406|P2|Overall Study|Sponsor's Decision|2
785499|NCT00678392|2498407|P1|Overall Study|Sponsor's Decision|1
785500|NCT00678392|2498406|P2|Overall Study|Objective Progression or Relapse|8
785501|NCT00678392|2498407|P1|Overall Study|Objective Progression or Relapse|3
785502|NCT00678392|2498406|P2|Overall Study|Lost to Follow-up|13
785503|NCT00678392|2498407|P1|Overall Study|Lost to Follow-up|15
785504|NCT00678392|2498406|P2|Overall Study|Death|269
785505|NCT00678392|2498407|P1|Overall Study|Death|280
785506|NCT00678392|2498406|P2|Overall Study|Adverse Event|6
785507|NCT00678392|2498407|P1|Overall Study|Adverse Event|0
785508|NCT00678587|2498490|P2|Overall Study|Withdrew Consent|3
785509|NCT00678587|2498491|P1|Overall Study|Withdrew Consent|8
785510|NCT00678587|2498490|P2|Overall Study|Investigator Discretion|6
785511|NCT00678587|2498491|P1|Overall Study|Investigator Discretion|2
785512|NCT00678587|2498490|P2|Overall Study|Lost to Follow-up|5
785513|NCT00678587|2498491|P1|Overall Study|Lost to Follow-up|3
785514|NCT00678587|2498490|P2|Overall Study|Study Closed/Terminated|0
785515|NCT00678587|2498491|P1|Overall Study|Study Closed/Terminated|1
785516|NCT00678587|2498490|P2|Overall Study|Protocol Violation|1
785517|NCT00678587|2498491|P1|Overall Study|Protocol Violation|2
785518|NCT00678587|2498490|P2|Overall Study|Lack of Efficacy|0
785519|NCT00678587|2498491|P1|Overall Study|Lack of Efficacy|1
785520|NCT00678587|2498490|P2|Overall Study|Adverse Event|3
785521|NCT00678587|2498491|P1|Overall Study|Adverse Event|3
785522|NCT00678639|2498525|P2|Overall Study|Lost to Follow-up at 30 days|0
785523|NCT00678639|2498526|P1|Overall Study|Lost to Follow-up at 30 days|2
785524|NCT00678691|2498541|P2|Overall Study|Adverse Event|4
785525|NCT00678691|2498542|P1|Overall Study|Adverse Event|6
785526|NCT00678795|2498550|P2|Overall Study|Lack of Efficacy|1
785527|NCT00678795|2498551|P1|Overall Study|Lack of Efficacy|1
785528|NCT00678795|2498550|P2|Overall Study|Lost to Follow-up|1
785529|NCT00678795|2498551|P1|Overall Study|Lost to Follow-up|0
785530|NCT00678795|2498550|P2|Overall Study|Protocol Violation|1
785531|NCT00678795|2498551|P1|Overall Study|Protocol Violation|0
785532|NCT00678795|2498550|P2|Overall Study|Withdrawal by Subject|0
785533|NCT00678795|2498551|P1|Overall Study|Withdrawal by Subject|3
785534|NCT00678795|2498550|P2|Overall Study|Adverse Event|3
785535|NCT00678795|2498551|P1|Overall Study|Adverse Event|7
785536|NCT00678886|2498596|P4|Overall Study|Other|0
785537|NCT00678886|2498597|P3|Overall Study|Other|1
785538|NCT00678886|2498598|P2|Overall Study|Other|0
785539|NCT00678886|2498599|P1|Overall Study|Other|0
785540|NCT00678886|2498596|P4|Overall Study|Lost to Follow-up|2
785541|NCT00678886|2498597|P3|Overall Study|Lost to Follow-up|3
785542|NCT00678886|2498598|P2|Overall Study|Lost to Follow-up|0
785543|NCT00678886|2498599|P1|Overall Study|Lost to Follow-up|0
785544|NCT00678886|2498596|P4|Overall Study|Physician Decision|1
785545|NCT00678886|2498597|P3|Overall Study|Physician Decision|1
785546|NCT00678886|2498598|P2|Overall Study|Physician Decision|0
785547|NCT00678886|2498599|P1|Overall Study|Physician Decision|0
785548|NCT00678886|2498596|P4|Overall Study|Withdrawal by Subject|6
785549|NCT00678886|2498597|P3|Overall Study|Withdrawal by Subject|4
785550|NCT00678886|2498598|P2|Overall Study|Withdrawal by Subject|0
785551|NCT00678886|2498599|P1|Overall Study|Withdrawal by Subject|0
785552|NCT00678899|2498643|P1|Overall Study|Adverse Event|1
785553|NCT00679055|2498652|P2|Overall Study|Study Terminated|1
785554|NCT00679055|2498653|P1|Overall Study|Study Terminated|2
785555|NCT00679055|2498652|P2|Overall Study|Other|3
785556|NCT00679055|2498653|P1|Overall Study|Other|0
785557|NCT00679055|2498652|P2|Overall Study|Adverse Event|1
785558|NCT00679055|2498653|P1|Overall Study|Adverse Event|0
785559|NCT00679081|2498663|P1|Overall Study|Lost to Follow-up|1
785560|NCT00679172|2498676|P5|Overall Study|Other not specified|0
785561|NCT00679172|2498677|P4|Overall Study|Other not specified|0
785562|NCT00679172|2498678|P3|Overall Study|Other not specified|1
785563|NCT00679172|2498679|P2|Overall Study|Other not specified|0
785564|NCT00679172|2498680|P1|Overall Study|Other not specified|0
785565|NCT00679172|2498676|P5|Overall Study|Non-compliance|0
785566|NCT00679172|2498677|P4|Overall Study|Non-compliance|1
785567|NCT00679172|2498678|P3|Overall Study|Non-compliance|0
785568|NCT00679172|2498679|P2|Overall Study|Non-compliance|1
785569|NCT00679172|2498680|P1|Overall Study|Non-compliance|1
785570|NCT00679211|2498743|P1|Overall Study|Other|1
785571|NCT00679211|2498743|P1|Overall Study|Transferred to extension study TDM4529g|12
785572|NCT00679211|2498743|P1|Overall Study|Refused to undergo protocol procedures|1
785573|NCT00679211|2498743|P1|Overall Study|Physician Decision|5
785574|NCT00679211|2498743|P1|Overall Study|Withdrawal by Subject|2
785575|NCT00679211|2498743|P1|Overall Study|Adverse Event|7
785576|NCT00679211|2498743|P1|Overall Study|Progressive disease|82
785577|NCT00679263|2498758|P3|Visit 2/Dose 1|subject not compliance|0
785578|NCT00679263|2498759|P2|Visit 2/Dose 1|subject not compliance|1
785579|NCT00679263|2498760|P1|Visit 2/Dose 1|subject not compliance|1
785580|NCT00679263|2498758|P3|Visit 2/Dose 1|Adverse Event|0
785581|NCT00679263|2498759|P2|Visit 2/Dose 1|Adverse Event|0
785582|NCT00679263|2498760|P1|Visit 2/Dose 1|Adverse Event|1
785583|NCT00673361|2498771|P1|Overall Study|Screen Failure|2
785584|NCT00673387|2498783|P8|Overall Study|Lost to Follow-up|5
785585|NCT00673387|2498784|P7|Overall Study|Lost to Follow-up|8
785586|NCT00673387|2498785|P6|Overall Study|Lost to Follow-up|5
785587|NCT00673387|2498786|P5|Overall Study|Lost to Follow-up|6
785588|NCT00673387|2498787|P4|Overall Study|Lost to Follow-up|6
785589|NCT00673387|2498788|P3|Overall Study|Lost to Follow-up|5
785590|NCT00673387|2498789|P2|Overall Study|Lost to Follow-up|6
785591|NCT00673387|2498790|P1|Overall Study|Lost to Follow-up|8
785592|NCT00673387|2498783|P8|Overall Study|Protocol Violation|3
785593|NCT00673387|2498784|P7|Overall Study|Protocol Violation|1
785594|NCT00673387|2498785|P6|Overall Study|Protocol Violation|1
785595|NCT00673387|2498786|P5|Overall Study|Protocol Violation|0
785596|NCT00673387|2498787|P4|Overall Study|Protocol Violation|2
785597|NCT00673387|2498788|P3|Overall Study|Protocol Violation|1
785598|NCT00673387|2498789|P2|Overall Study|Protocol Violation|0
785599|NCT00673387|2498790|P1|Overall Study|Protocol Violation|3
785600|NCT00673387|2498783|P8|Overall Study|Physician Decision|1
785601|NCT00673387|2498784|P7|Overall Study|Physician Decision|1
785602|NCT00673387|2498785|P6|Overall Study|Physician Decision|5
785603|NCT00673387|2498786|P5|Overall Study|Physician Decision|0
785604|NCT00673387|2498787|P4|Overall Study|Physician Decision|0
785605|NCT00673387|2498788|P3|Overall Study|Physician Decision|0
785606|NCT00673387|2498789|P2|Overall Study|Physician Decision|0
785607|NCT00673387|2498790|P1|Overall Study|Physician Decision|0
785608|NCT00673387|2498783|P8|Overall Study|Adverse Event|5
785609|NCT00673387|2498784|P7|Overall Study|Adverse Event|5
785610|NCT00673387|2498785|P6|Overall Study|Adverse Event|2
785611|NCT00673387|2498786|P5|Overall Study|Adverse Event|6
785612|NCT00673387|2498787|P4|Overall Study|Adverse Event|2
785613|NCT00673387|2498788|P3|Overall Study|Adverse Event|5
785614|NCT00673387|2498789|P2|Overall Study|Adverse Event|1
785615|NCT00673387|2498790|P1|Overall Study|Adverse Event|3
785616|NCT00673387|2498783|P8|Overall Study|Withdrawal by Subject|21
785617|NCT00673387|2498784|P7|Overall Study|Withdrawal by Subject|15
785618|NCT00673387|2498785|P6|Overall Study|Withdrawal by Subject|21
785619|NCT00673387|2498786|P5|Overall Study|Withdrawal by Subject|18
785620|NCT00673387|2498787|P4|Overall Study|Withdrawal by Subject|16
785621|NCT00673387|2498788|P3|Overall Study|Withdrawal by Subject|20
785622|NCT00673387|2498789|P2|Overall Study|Withdrawal by Subject|16
785623|NCT00673387|2498790|P1|Overall Study|Withdrawal by Subject|15
785624|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
785625|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
785626|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Physician Decision|0
785627|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Physician Decision|2
785628|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Sponsor Decision|3
785629|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Sponsor Decision|0
785630|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Protocol Violation|3
785631|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Protocol Violation|2
785632|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
785633|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
785634|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
785635|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
785636|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
785637|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
785638|NCT00673452|2499029|P2|Continuation Double-Blind Phase|Adverse Event|13
785639|NCT00673452|2499030|P1|Continuation Double-Blind Phase|Adverse Event|5
785640|NCT00673452|2499029|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
785641|NCT00673452|2499030|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
785642|NCT00673452|2499029|P2|Acute Double-Blind Phase|Sponsor Decision|1
785643|NCT00673452|2499030|P1|Acute Double-Blind Phase|Sponsor Decision|0
785644|NCT00673452|2499029|P2|Acute Double-Blind Phase|Protocol Violation|3
785645|NCT00673452|2499030|P1|Acute Double-Blind Phase|Protocol Violation|5
785646|NCT00673452|2499029|P2|Acute Double-Blind Phase|Physician Decision|6
785647|NCT00673452|2499030|P1|Acute Double-Blind Phase|Physician Decision|0
785648|NCT00673452|2499029|P2|Acute Double-Blind Phase|Lost to Follow-up|19
785649|NCT00673452|2499030|P1|Acute Double-Blind Phase|Lost to Follow-up|16
785650|NCT00673452|2499029|P2|Acute Double-Blind Phase|Lack of Efficacy|14
785651|NCT00673452|2499030|P1|Acute Double-Blind Phase|Lack of Efficacy|9
785652|NCT00673452|2499029|P2|Acute Double-Blind Phase|Adverse Event|24
785653|NCT00673452|2499030|P1|Acute Double-Blind Phase|Adverse Event|41
785654|NCT00673465|2499064|P12|Part 1/Period 2 (United States)|Protocol Violation|0
785655|NCT00673465|2499065|P11|Part 1/Period 2 (United States)|Protocol Violation|0
785656|NCT00673465|2499066|P10|Part 1/Period 2 (United States)|Protocol Violation|0
785657|NCT00673465|2499067|P9|Part 1/Period 2 (United States)|Protocol Violation|0
785658|NCT00673465|2499068|P8|Part 1/Period 2 (United States)|Protocol Violation|0
785659|NCT00673465|2499069|P7|Part 1/Period 2 (United States)|Protocol Violation|0
785660|NCT00673465|2499070|P6|Part 1/Period 2 (United States)|Protocol Violation|0
785661|NCT00673465|2499071|P5|Part 1/Period 2 (United States)|Protocol Violation|1
785662|NCT00673465|2499072|P4|Part 1/Period 2 (United States)|Protocol Violation|0
785663|NCT00673465|2499073|P3|Part 1/Period 2 (United States)|Protocol Violation|0
785664|NCT00673465|2499074|P2|Part 1/Period 2 (United States)|Protocol Violation|0
785665|NCT00673465|2499075|P1|Part 1/Period 2 (United States)|Protocol Violation|0
785666|NCT00673465|2499064|P12|Part 1/Period 1 (United States)|Protocol Violation|0
785667|NCT00673465|2499065|P11|Part 1/Period 1 (United States)|Protocol Violation|0
785668|NCT00673465|2499066|P10|Part 1/Period 1 (United States)|Protocol Violation|0
785669|NCT00673465|2499067|P9|Part 1/Period 1 (United States)|Protocol Violation|0
785670|NCT00673465|2499068|P8|Part 1/Period 1 (United States)|Protocol Violation|0
785671|NCT00673465|2499069|P7|Part 1/Period 1 (United States)|Protocol Violation|0
785672|NCT00673465|2499070|P6|Part 1/Period 1 (United States)|Protocol Violation|1
785673|NCT00673465|2499071|P5|Part 1/Period 1 (United States)|Protocol Violation|1
785674|NCT00673465|2499072|P4|Part 1/Period 1 (United States)|Protocol Violation|0
785675|NCT00673465|2499073|P3|Part 1/Period 1 (United States)|Protocol Violation|0
785676|NCT00673465|2499074|P2|Part 1/Period 1 (United States)|Protocol Violation|0
785677|NCT00673465|2499075|P1|Part 1/Period 1 (United States)|Protocol Violation|0
785678|NCT00673660|2499133|P1|Overall Study|Lost to Follow-up|107
785679|NCT00673673|2499144|P1|Overall Study|Investigators' discretion|2
785680|NCT00673673|2499144|P1|Overall Study|Withdrawal by Subject|3
785681|NCT00673673|2499144|P1|Overall Study|Adverse Event|4
785682|NCT00673673|2499144|P1|Overall Study|Progressive disease|27
785683|NCT00679302|2499152|P2|Overall Study|Lost to Follow-up|4
785684|NCT00679302|2499153|P1|Overall Study|Lost to Follow-up|8
785685|NCT00679341|2499163|P2|Overall Study|Physician/patient decision to withdraw|6
785686|NCT00679341|2499164|P1|Overall Study|Physician/patient decision to withdraw|0
785687|NCT00679341|2499163|P2|Overall Study|Not treated|2
785688|NCT00679341|2499164|P1|Overall Study|Not treated|0
785689|NCT00679341|2499163|P2|Overall Study|Physician Decision|0
785690|NCT00679341|2499164|P1|Overall Study|Physician Decision|1
785691|NCT00679341|2499163|P2|Overall Study|Not specified|0
785692|NCT00679341|2499164|P1|Overall Study|Not specified|1
785693|NCT00679341|2499163|P2|Overall Study|Death|1
785694|NCT00679341|2499164|P1|Overall Study|Death|1
785695|NCT00679341|2499163|P2|Overall Study|Subject/guardian decision to discontinue|0
785696|NCT00679341|2499164|P1|Overall Study|Subject/guardian decision to discontinue|3
785697|NCT00679341|2499163|P2|Overall Study|Adverse Event|6
785698|NCT00679341|2499164|P1|Overall Study|Adverse Event|5
785699|NCT00679341|2499163|P2|Overall Study|Disease progression|36
785700|NCT00679341|2499164|P1|Overall Study|Disease progression|42
785701|NCT00679354|2499182|P1|Overall Study|Ineligible|1
785702|NCT00679354|2499182|P1|Overall Study|Physician Decision|4
785703|NCT00679354|2499182|P1|Overall Study|Lack of Efficacy|22
785704|NCT00679354|2499182|P1|Overall Study|Death|3
785705|NCT00679367|2499186|P1|Overall Study|Withdrawal by Subject|1
785706|NCT00679367|2499186|P1|Overall Study|Lack of Efficacy|3
785707|NCT00679367|2499186|P1|Overall Study|inability to swallow oral drugs|1
785708|NCT00679367|2499186|P1|Overall Study|Adverse Event|7
785709|NCT00679432|2499221|P4|Overall Study|Randomization error, return to prior Rx|0
785710|NCT00679432|2499222|P3|Overall Study|Randomization error, return to prior Rx|3
785711|NCT00679432|2499223|P2|Overall Study|Randomization error, return to prior Rx|0
785712|NCT00679432|2499224|P1|Overall Study|Randomization error, return to prior Rx|0
785713|NCT00679432|2499221|P4|Overall Study|Infectious colitis, normal histology|3
785714|NCT00679432|2499222|P3|Overall Study|Infectious colitis, normal histology|8
785715|NCT00679432|2499223|P2|Overall Study|Infectious colitis, normal histology|4
785716|NCT00679432|2499224|P1|Overall Study|Infectious colitis, normal histology|5
785717|NCT00679432|2499221|P4|Overall Study|Lack of Efficacy|8
785718|NCT00679432|2499222|P3|Overall Study|Lack of Efficacy|14
785719|NCT00679432|2499223|P2|Overall Study|Lack of Efficacy|9
785720|NCT00679432|2499224|P1|Overall Study|Lack of Efficacy|13
785721|NCT00679432|2499221|P4|Overall Study|Sponsor decision|0
785722|NCT00679432|2499222|P3|Overall Study|Sponsor decision|0
785723|NCT00679432|2499223|P2|Overall Study|Sponsor decision|0
785724|NCT00679432|2499224|P1|Overall Study|Sponsor decision|1
785725|NCT00679432|2499221|P4|Overall Study|Physician Decision|2
785726|NCT00679432|2499222|P3|Overall Study|Physician Decision|2
785727|NCT00679432|2499223|P2|Overall Study|Physician Decision|2
785728|NCT00679432|2499224|P1|Overall Study|Physician Decision|3
785729|NCT00679432|2499221|P4|Overall Study|Lost to Follow-up|2
785730|NCT00679432|2499222|P3|Overall Study|Lost to Follow-up|4
785731|NCT00679432|2499223|P2|Overall Study|Lost to Follow-up|5
785732|NCT00679432|2499224|P1|Overall Study|Lost to Follow-up|1
785733|NCT00679432|2499221|P4|Overall Study|Withdrawal by Subject|9
785734|NCT00679432|2499222|P3|Overall Study|Withdrawal by Subject|10
785735|NCT00679432|2499223|P2|Overall Study|Withdrawal by Subject|11
785736|NCT00679432|2499224|P1|Overall Study|Withdrawal by Subject|8
785737|NCT00679432|2499221|P4|Overall Study|Protocol Violation|1
785738|NCT00679432|2499222|P3|Overall Study|Protocol Violation|2
785739|NCT00679432|2499223|P2|Overall Study|Protocol Violation|1
785740|NCT00679432|2499224|P1|Overall Study|Protocol Violation|1
785741|NCT00679432|2499221|P4|Overall Study|Adverse Event|7
785742|NCT00679432|2499222|P3|Overall Study|Adverse Event|10
785743|NCT00679432|2499223|P2|Overall Study|Adverse Event|6
785744|NCT00679432|2499224|P1|Overall Study|Adverse Event|5
785745|NCT00679627|2499244|P2|Overall Study|Early Study Closure|405
785746|NCT00679627|2499245|P1|Overall Study|Early Study Closure|425
785747|NCT00679627|2499244|P2|Overall Study|Lost to Follow-up|26
785748|NCT00679627|2499245|P1|Overall Study|Lost to Follow-up|22
785749|NCT00679627|2499244|P2|Overall Study|Withdrawal by Subject|172
785750|NCT00679627|2499245|P1|Overall Study|Withdrawal by Subject|168
785751|NCT00679627|2499244|P2|Overall Study|Adverse Event|53
785752|NCT00679627|2499245|P1|Overall Study|Adverse Event|43
785753|NCT00679627|2499244|P2|Overall Study|Death|29
785754|NCT00679627|2499245|P1|Overall Study|Death|41
785755|NCT00681564|2499331|P2|Overall Study|Death|1
785756|NCT00681564|2499332|P1|Overall Study|Death|0
785757|NCT00681564|2499331|P2|Overall Study|Withdrawal by Subject|1
785758|NCT00681564|2499332|P1|Overall Study|Withdrawal by Subject|0
785759|NCT00681564|2499331|P2|Overall Study|Lost to Follow-up|6
785760|NCT00681564|2499332|P1|Overall Study|Lost to Follow-up|6
785761|NCT00681590|2499362|P2|Overall Study|Withdrawal by Subject|12
785762|NCT00681590|2499363|P1|Overall Study|Withdrawal by Subject|2
785763|NCT00681629|2499373|P2|Overall Study|Adverse Event|0
785764|NCT00681629|2499374|P1|Overall Study|Adverse Event|1
785765|NCT00681629|2499373|P2|Overall Study|Study termination|2
785766|NCT00681629|2499374|P1|Overall Study|Study termination|4
785767|NCT00681668|2499418|P1|Overall Study|Withdrawal by Subject|1
785768|NCT00681668|2499418|P1|Overall Study|Protocol Violation|1
785769|NCT00681811|2499427|P2|Overall Study|Non-compliance|1
785770|NCT00681811|2499428|P1|Overall Study|Non-compliance|0
785771|NCT00681811|2499427|P2|Overall Study|Withdrawal by Subject|2
785772|NCT00681811|2499428|P1|Overall Study|Withdrawal by Subject|2
785773|NCT00681811|2499427|P2|Overall Study|Adverse Event|1
785774|NCT00681811|2499428|P1|Overall Study|Adverse Event|1
785775|NCT00681824|2499459|P3|Overall Study|Death|0
785776|NCT00681824|2499460|P2|Overall Study|Death|1
785777|NCT00681824|2499461|P1|Overall Study|Death|0
785778|NCT00681824|2499459|P3|Overall Study|scheduling conflict|0
785779|NCT00681824|2499460|P2|Overall Study|scheduling conflict|0
785780|NCT00681824|2499461|P1|Overall Study|scheduling conflict|1
785781|NCT00681824|2499459|P3|Overall Study|withdrawn by investigator|1
785782|NCT00681824|2499460|P2|Overall Study|withdrawn by investigator|0
785783|NCT00681824|2499461|P1|Overall Study|withdrawn by investigator|0
785784|NCT00681863|2499477|P1|Overall Study|not specified|18
785785|NCT00681863|2499477|P1|Overall Study|Lack of Efficacy|2
785786|NCT00681863|2499477|P1|Overall Study|Lost to Follow-up|2
785787|NCT00681863|2499477|P1|Overall Study|Adverse Event|1
785788|NCT00682461|2499550|P2|Overall Study|Withdrawal by Subject|19
785789|NCT00682461|2499551|P1|Overall Study|Withdrawal by Subject|12
785790|NCT00682461|2499550|P2|Overall Study|Lost to Follow-up|5
785791|NCT00682461|2499551|P1|Overall Study|Lost to Follow-up|8
785792|NCT00682461|2499550|P2|Overall Study|Adverse Event|7
785793|NCT00682461|2499551|P1|Overall Study|Adverse Event|5
785794|NCT00682539|2499568|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
785795|NCT00682539|2499569|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
785796|NCT00682539|2499570|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
785797|NCT00682539|2499568|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
785798|NCT00682539|2499569|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
785799|NCT00682539|2499570|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
785800|NCT00682643|2499609|P2|Overall Study|Did Not Receive Study Drug|1
785801|NCT00682643|2499610|P1|Overall Study|Did Not Receive Study Drug|1
785802|NCT00682643|2499609|P2|Overall Study|Withdrawal by Subject|53
785803|NCT00682643|2499610|P1|Overall Study|Withdrawal by Subject|19
785804|NCT00682643|2499609|P2|Overall Study|Physician Decision|6
785805|NCT00682643|2499610|P1|Overall Study|Physician Decision|2
785806|NCT00682643|2499609|P2|Overall Study|Lost to Follow-up|6
785807|NCT00682643|2499610|P1|Overall Study|Lost to Follow-up|1
785808|NCT00682643|2499609|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
785809|NCT00682643|2499610|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
785810|NCT00682643|2499609|P2|Overall Study|Protocol Violation|76
785811|NCT00682643|2499610|P1|Overall Study|Protocol Violation|38
785812|NCT00682643|2499609|P2|Overall Study|Lack of Efficacy|0
785813|NCT00682643|2499610|P1|Overall Study|Lack of Efficacy|2
785814|NCT00682643|2499609|P2|Overall Study|Adverse Event|23
785815|NCT00682643|2499610|P1|Overall Study|Adverse Event|12
785816|NCT00682786|2499657|P2|Overall Study|Did not receive irinotecan|1
785817|NCT00682786|2499658|P1|Overall Study|Did not receive irinotecan|0
785818|NCT00682786|2499657|P2|Overall Study|Withdrawal by Subject|2
785819|NCT00682786|2499658|P1|Overall Study|Withdrawal by Subject|2
785820|NCT00682890|2499726|P2|Overall Study|heavy menstrual bleeding|0
785821|NCT00682890|2499727|P1|Overall Study|heavy menstrual bleeding|1
785822|NCT00682890|2499726|P2|Overall Study|subject moved away|1
785823|NCT00682890|2499727|P1|Overall Study|subject moved away|0
785824|NCT00682890|2499726|P2|Overall Study|Lost to Follow-up|1
785825|NCT00682890|2499727|P1|Overall Study|Lost to Follow-up|1
785826|NCT00683293|2499789|P2|Overall Study|Withdrawal by Subject|3
785827|NCT00683293|2499790|P1|Overall Study|Withdrawal by Subject|2
785828|NCT00683384|2499802|P1|Overall Study|Adverse Event|1
785829|NCT00683384|2499802|P1|Overall Study|Death|1
785830|NCT00683449|2499815|P5|Overall Study|Lost to Follow-up|0
785831|NCT00683449|2499816|P4|Overall Study|Lost to Follow-up|0
785832|NCT00683449|2499817|P3|Overall Study|Lost to Follow-up|0
785833|NCT00683449|2499818|P2|Overall Study|Lost to Follow-up|1
785834|NCT00683449|2499819|P1|Overall Study|Lost to Follow-up|0
785835|NCT00683475|2499843|P2|Overall Study|Never Treated: Progressive Disease|0
785836|NCT00683475|2499844|P1|Overall Study|Never Treated: Progressive Disease|1
785837|NCT00683475|2499843|P2|Overall Study|Never Treated: Adverse Event|3
785838|NCT00683475|2499844|P1|Overall Study|Never Treated: Adverse Event|2
785839|NCT00683475|2499843|P2|Overall Study|Withdrawal by Subject|0
785840|NCT00683475|2499844|P1|Overall Study|Withdrawal by Subject|1
785841|NCT00683592|2499876|P2|Overall Study|Other|1
785842|NCT00683592|2499877|P1|Overall Study|Other|1
785843|NCT00683592|2499876|P2|Overall Study|Non-compliance|5
785844|NCT00683592|2499877|P1|Overall Study|Non-compliance|3
785845|NCT00683592|2499876|P2|Overall Study|Physician Decision|1
785846|NCT00683592|2499877|P1|Overall Study|Physician Decision|0
785847|NCT00683592|2499876|P2|Overall Study|Lack of Efficacy|7
785848|NCT00683592|2499877|P1|Overall Study|Lack of Efficacy|3
785849|NCT00683592|2499876|P2|Overall Study|Lost to Follow-up|17
785850|NCT00683592|2499877|P1|Overall Study|Lost to Follow-up|17
785851|NCT00683592|2499876|P2|Overall Study|Withdrawal by Subject|11
785852|NCT00683592|2499877|P1|Overall Study|Withdrawal by Subject|11
785853|NCT00683592|2499876|P2|Overall Study|Adverse Event|4
785854|NCT00683592|2499877|P1|Overall Study|Adverse Event|12
785855|NCT00683618|2499896|P3|Extension Treatment Period|Protocol Violation|0
785856|NCT00683618|2499897|P2|Extension Treatment Period|Protocol Violation|0
785857|NCT00683618|2499898|P1|Extension Treatment Period|Protocol Violation|1
785858|NCT00683618|2499896|P3|Extension Treatment Period|Adverse Event|0
785859|NCT00683618|2499897|P2|Extension Treatment Period|Adverse Event|0
785860|NCT00683618|2499898|P1|Extension Treatment Period|Adverse Event|1
785861|NCT00683618|2499896|P3|Extension Treatment Period|Withdrawal by Subject|0
785862|NCT00683618|2499897|P2|Extension Treatment Period|Withdrawal by Subject|0
785863|NCT00683618|2499898|P1|Extension Treatment Period|Withdrawal by Subject|1
785864|NCT00683618|2499896|P3|Randomised Treatment Period|Reason not provided|2
785865|NCT00683618|2499897|P2|Randomised Treatment Period|Reason not provided|0
785866|NCT00683618|2499898|P1|Randomised Treatment Period|Reason not provided|0
785867|NCT00683618|2499896|P3|Randomised Treatment Period|Adverse Event|2
785868|NCT00683618|2499897|P2|Randomised Treatment Period|Adverse Event|0
785869|NCT00683618|2499898|P1|Randomised Treatment Period|Adverse Event|2
785870|NCT00683618|2499896|P3|Randomised Treatment Period|Protocol Violation|0
785871|NCT00683618|2499897|P2|Randomised Treatment Period|Protocol Violation|1
785872|NCT00683618|2499898|P1|Randomised Treatment Period|Protocol Violation|0
785873|NCT00683618|2499896|P3|Randomised Treatment Period|Withdrawal by Subject|2
785874|NCT00683618|2499897|P2|Randomised Treatment Period|Withdrawal by Subject|1
785875|NCT00683618|2499898|P1|Randomised Treatment Period|Withdrawal by Subject|4
785876|NCT00683657|2499948|P2|Overall Study|Subject Withdrew Consent|0
785877|NCT00683657|2499949|P1|Overall Study|Subject Withdrew Consent|1
785878|NCT00683657|2499948|P2|Overall Study|Adverse Event|1
785879|NCT00683657|2499949|P1|Overall Study|Adverse Event|0
785890|NCT00683774|2499975|P2|Overall Study|Physician Decision|0
785891|NCT00683774|2499976|P1|Overall Study|Physician Decision|3
785892|NCT00683774|2499975|P2|Overall Study|Withdrawal by Subject|1
785893|NCT00683774|2499976|P1|Overall Study|Withdrawal by Subject|0
785894|NCT00683787|2499987|P3|Overall Study|Adverse Event|2
785895|NCT00683787|2499988|P2|Overall Study|Adverse Event|0
785896|NCT00683787|2499989|P1|Overall Study|Adverse Event|0
785897|NCT00683787|2499987|P3|Overall Study|Progression|0
785898|NCT00683787|2499988|P2|Overall Study|Progression|3
785899|NCT00683787|2499989|P1|Overall Study|Progression|3
785900|NCT00676520|2500006|P1|Overall Study|Other Reason|18
785901|NCT00676520|2500006|P1|Overall Study|Ineligible for Randomization to DAPT|209
785902|NCT00676520|2500006|P1|Overall Study|Physician Decision|20
785903|NCT00676520|2500006|P1|Overall Study|Death|159
785904|NCT00676520|2500006|P1|Overall Study|Lost to Follow-up|162
785905|NCT00676520|2500006|P1|Overall Study|Withdrawal by Subject|163
785906|NCT00676650|2500078|P2|Overall Study|Randomized but not treated|4
785907|NCT00676650|2500079|P1|Overall Study|Randomized but not treated|3
785908|NCT00676650|2500078|P2|Overall Study|Withdrawal by Subject|24
785909|NCT00676650|2500079|P1|Overall Study|Withdrawal by Subject|48
785910|NCT00676650|2500078|P2|Overall Study|Study terminated by sponsor|43
785911|NCT00676650|2500079|P1|Overall Study|Study terminated by sponsor|57
785912|NCT00676650|2500078|P2|Overall Study|Protocol Violation|1
785913|NCT00676650|2500079|P1|Overall Study|Protocol Violation|3
785914|NCT00676650|2500078|P2|Overall Study|Unspecified|10
785915|NCT00676650|2500079|P1|Overall Study|Unspecified|14
785916|NCT00676650|2500078|P2|Overall Study|Objective progression or relapse|140
785917|NCT00676650|2500079|P1|Overall Study|Objective progression or relapse|189
785918|NCT00676650|2500078|P2|Overall Study|Lost to Follow-up|1
785919|NCT00676650|2500079|P1|Overall Study|Lost to Follow-up|0
785920|NCT00676650|2500078|P2|Overall Study|Global deterioration of health status|31
785921|NCT00676650|2500079|P1|Overall Study|Global deterioration of health status|66
785922|NCT00676650|2500078|P2|Overall Study|Adverse Event|21
785923|NCT00676650|2500079|P1|Overall Study|Adverse Event|159
785924|NCT00676650|2500078|P2|Overall Study|Death|14
785925|NCT00676650|2500079|P1|Overall Study|Death|45
785926|NCT00676689|2500101|P1|Overall Study|Continuing FU|49
785927|NCT00676689|2500101|P1|Overall Study|Withdrawal by Subject|3
785928|NCT00676689|2500101|P1|Overall Study|Physician Decision|1
785929|NCT00676689|2500101|P1|Overall Study|Lost to Follow-up|4
785930|NCT00676689|2500101|P1|Overall Study|Death|2
785931|NCT00676689|2500101|P1|Overall Study|Screen Failure|2
892031|NCT00791700|2828698|P2|Overall Study|Blood sampling not done before Stage 1|0
892032|NCT00791700|2828699|P1|Overall Study|Blood sampling not done before Stage 1|0
892033|NCT00791700|2828696|P4|Overall Study|Non-compliance with study treatment|2
892034|NCT00791700|2828697|P3|Overall Study|Non-compliance with study treatment|0
892035|NCT00791700|2828698|P2|Overall Study|Non-compliance with study treatment|0
892036|NCT00791700|2828699|P1|Overall Study|Non-compliance with study treatment|1
892037|NCT00791700|2828696|P4|Overall Study|No longer willing to participate|1
892038|NCT00791700|2828697|P3|Overall Study|No longer willing to participate|0
892039|NCT00791700|2828698|P2|Overall Study|No longer willing to participate|1
892040|NCT00791700|2828699|P1|Overall Study|No longer willing to participate|0
892041|NCT00791700|2828696|P4|Overall Study|Adverse Event|1
892042|NCT00791700|2828697|P3|Overall Study|Adverse Event|1
892043|NCT00791700|2828698|P2|Overall Study|Adverse Event|0
892044|NCT00791700|2828699|P1|Overall Study|Adverse Event|0
892045|NCT00791700|2828696|P4|Overall Study|Insufficient clinical response|13
892046|NCT00791700|2828697|P3|Overall Study|Insufficient clinical response|3
892047|NCT00791700|2828698|P2|Overall Study|Insufficient clinical response|4
892048|NCT00791700|2828699|P1|Overall Study|Insufficient clinical response|3
892049|NCT00777101|2828786|P2|Overall Study|Failed to Return|1
892050|NCT00777101|2828787|P1|Overall Study|Failed to Return|0
785956|NCT00683800|2500152|P2|Overall Study|Randomized, not treated|33
785957|NCT00683800|2500153|P1|Overall Study|Randomized, not treated|35
785958|NCT00683800|2500152|P2|Overall Study|Lack of Efficacy|104
785959|NCT00683800|2500153|P1|Overall Study|Lack of Efficacy|61
785960|NCT00683800|2500152|P2|Overall Study|Withdrawal by Subject|64
785961|NCT00683800|2500153|P1|Overall Study|Withdrawal by Subject|66
785962|NCT00683800|2500152|P2|Overall Study|Protocol Violation|16
785963|NCT00683800|2500153|P1|Overall Study|Protocol Violation|13
785964|NCT00683800|2500152|P2|Overall Study|Unspecified|2
785965|NCT00683800|2500153|P1|Overall Study|Unspecified|5
785966|NCT00683800|2500152|P2|Overall Study|Lost to Follow-up|44
785967|NCT00683800|2500153|P1|Overall Study|Lost to Follow-up|57
785968|NCT00683800|2500152|P2|Overall Study|Death|1
785969|NCT00683800|2500153|P1|Overall Study|Death|0
785970|NCT00683800|2500152|P2|Overall Study|Adverse Event|102
785971|NCT00683800|2500153|P1|Overall Study|Adverse Event|195
785972|NCT00683878|2500266|P3|Overall Study|Non-compliance, not met criteria etc.|0
785973|NCT00683878|2500267|P2|Overall Study|Non-compliance, not met criteria etc.|2
785974|NCT00683878|2500268|P1|Overall Study|Non-compliance, not met criteria etc.|3
785975|NCT00683878|2500266|P3|Overall Study|Lost to Follow-up|4
785976|NCT00683878|2500267|P2|Overall Study|Lost to Follow-up|2
785977|NCT00683878|2500268|P1|Overall Study|Lost to Follow-up|4
785978|NCT00683878|2500266|P3|Overall Study|Death|0
785979|NCT00683878|2500267|P2|Overall Study|Death|1
785980|NCT00683878|2500268|P1|Overall Study|Death|0
785981|NCT00683878|2500266|P3|Overall Study|Withdrawal by Subject|6
785982|NCT00683878|2500267|P2|Overall Study|Withdrawal by Subject|8
785983|NCT00683878|2500268|P1|Overall Study|Withdrawal by Subject|9
785984|NCT00683878|2500266|P3|Overall Study|Adverse Event|3
785985|NCT00683878|2500267|P2|Overall Study|Adverse Event|3
785986|NCT00683878|2500268|P1|Overall Study|Adverse Event|4
785987|NCT00683878|2500266|P3|Overall Study|Lack of Efficacy|1
785988|NCT00683878|2500267|P2|Overall Study|Lack of Efficacy|0
785989|NCT00683878|2500268|P1|Overall Study|Lack of Efficacy|3
785990|NCT00683904|2500296|P2|Dose Level 2|Adverse Event|2
785991|NCT00683904|2500297|P1|Dose Level 2|Adverse Event|0
785992|NCT00683904|2500296|P2|Dose Level 1|Adverse Event|0
785993|NCT00683904|2500297|P1|Dose Level 1|Adverse Event|1
785994|NCT00683904|2500296|P2|Dose Level 1|Disease progression|0
785995|NCT00683904|2500297|P1|Dose Level 1|Disease progression|2
785996|NCT00683917|2500333|P1|Overall Study|Study prematurely terminated|10
785997|NCT00684021|2500365|P4|Overall Study|Death|0
785998|NCT00684021|2500366|P3|Overall Study|Death|0
785999|NCT00684021|2500367|P2|Overall Study|Death|0
786000|NCT00684021|2500368|P1|Overall Study|Death|1
786001|NCT00684021|2500365|P4|Overall Study|MRI not performed|2
786002|NCT00684021|2500366|P3|Overall Study|MRI not performed|1
786003|NCT00684021|2500367|P2|Overall Study|MRI not performed|1
786004|NCT00684021|2500368|P1|Overall Study|MRI not performed|0
786005|NCT00684021|2500365|P4|Overall Study|MRI Contraindicated|0
786006|NCT00684021|2500366|P3|Overall Study|MRI Contraindicated|1
786007|NCT00684021|2500367|P2|Overall Study|MRI Contraindicated|1
786008|NCT00684021|2500368|P1|Overall Study|MRI Contraindicated|1
786009|NCT00684060|2500423|P2|Overall Study|Death|1
786010|NCT00684060|2500424|P1|Overall Study|Death|0
786011|NCT00684060|2500423|P2|Overall Study|Unable to collect MRI|2
786012|NCT00684060|2500424|P1|Overall Study|Unable to collect MRI|1
786013|NCT00684060|2500423|P2|Overall Study|New stenosis identified|0
786014|NCT00684060|2500424|P1|Overall Study|New stenosis identified|1
786015|NCT00684060|2500423|P2|Overall Study|Lost to Follow-up|0
786016|NCT00684060|2500424|P1|Overall Study|Lost to Follow-up|1
786017|NCT00684073|2500444|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
786018|NCT00684073|2500444|P1|Selection|request of the sponsor|1
786019|NCT00684073|2500444|P1|Selection|Lost to Follow-up|1
786020|NCT00684073|2500444|P1|Selection|noncompliance|1
786021|NCT00684073|2500444|P1|Selection|Death|1
786022|NCT00684073|2500444|P1|Selection|Selection/non-selection criteria|3
786023|NCT00684996|2500471|P1|Overall Study|Other reasons not protocol specified|1
786024|NCT00684996|2500471|P1|Overall Study|Progression/relapse|2
786025|NCT00684996|2500471|P1|Overall Study|Refusal unrelated to adverse event|1
786026|NCT00684996|2500471|P1|Overall Study|Adverse Event|1
786027|NCT00685035|2500484|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
786028|NCT00685035|2500485|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
786029|NCT00685165|2500518|P2|Washout Period of 14 Days|Adverse Event|0
786030|NCT00685165|2500519|P1|Washout Period of 14 Days|Adverse Event|1
786031|NCT00685178|2500533|P4|Overall Study|Pregnancy|1
786032|NCT00685178|2500534|P3|Overall Study|Pregnancy|0
786033|NCT00685178|2500535|P2|Overall Study|Pregnancy|0
786034|NCT00685178|2500536|P1|Overall Study|Pregnancy|0
786035|NCT00685178|2500533|P4|Overall Study|administrative (disciplinary) discharge|2
786036|NCT00685178|2500534|P3|Overall Study|administrative (disciplinary) discharge|0
786037|NCT00685178|2500535|P2|Overall Study|administrative (disciplinary) discharge|1
786038|NCT00685178|2500536|P1|Overall Study|administrative (disciplinary) discharge|0
786039|NCT00685178|2500533|P4|Overall Study|incarcerated|0
786040|NCT00685178|2500534|P3|Overall Study|incarcerated|7
786041|NCT00685178|2500535|P2|Overall Study|incarcerated|3
786042|NCT00685178|2500536|P1|Overall Study|incarcerated|1
786043|NCT00685178|2500533|P4|Overall Study|voluntary study discharge|1
786044|NCT00685178|2500534|P3|Overall Study|voluntary study discharge|1
786045|NCT00685178|2500535|P2|Overall Study|voluntary study discharge|5
786046|NCT00685178|2500536|P1|Overall Study|voluntary study discharge|4
786047|NCT00685178|2500533|P4|Overall Study|missed 3 consecutive methadone clin days|6
786048|NCT00685178|2500534|P3|Overall Study|missed 3 consecutive methadone clin days|2
786049|NCT00685178|2500535|P2|Overall Study|missed 3 consecutive methadone clin days|5
786050|NCT00685178|2500536|P1|Overall Study|missed 3 consecutive methadone clin days|7
786051|NCT00685178|2500533|P4|Overall Study|Adverse Event|4
786052|NCT00685178|2500534|P3|Overall Study|Adverse Event|2
786053|NCT00685178|2500535|P2|Overall Study|Adverse Event|5
786054|NCT00685178|2500536|P1|Overall Study|Adverse Event|1
786055|NCT00685334|2500565|P2|Overall Study|Chose to enter hospital|1
786056|NCT00685334|2500566|P1|Overall Study|Chose to enter hospital|1
786057|NCT00685334|2500565|P2|Overall Study|Lost to Follow-up|0
786058|NCT00685334|2500566|P1|Overall Study|Lost to Follow-up|4
786059|NCT00685334|2500565|P2|Overall Study|Withdrawal by Subject|6
786060|NCT00685334|2500566|P1|Overall Study|Withdrawal by Subject|5
786061|NCT00685373|2500574|P1|Overall Study|Protocol Violation|1
786062|NCT00685373|2500574|P1|Overall Study|Lost to Follow-up|2
786063|NCT00685373|2500574|P1|Overall Study|Condition no longer requires study drug|1
786064|NCT00685373|2500574|P1|Overall Study|Lack of Efficacy|3
786065|NCT00685373|2500574|P1|Overall Study|Withdrawal by Subject|5
786066|NCT00685373|2500574|P1|Overall Study|Adverse Event|3
786067|NCT00685399|2500588|P8|Extension|Adverse Event|0
786068|NCT00685399|2500589|P7|Extension|Adverse Event|0
786069|NCT00685399|2500590|P6|Extension|Adverse Event|0
786070|NCT00685399|2500591|P5|Extension|Adverse Event|0
786071|NCT00685399|2500592|P4|Extension|Adverse Event|2
786072|NCT00685399|2500593|P3|Extension|Adverse Event|0
786073|NCT00685399|2500594|P2|Extension|Adverse Event|0
786074|NCT00685399|2500595|P1|Extension|Adverse Event|0
786075|NCT00685399|2500588|P8|Extension|Lack of Efficacy|0
786076|NCT00685399|2500589|P7|Extension|Lack of Efficacy|0
786077|NCT00685399|2500590|P6|Extension|Lack of Efficacy|0
786078|NCT00685399|2500591|P5|Extension|Lack of Efficacy|0
786079|NCT00685399|2500592|P4|Extension|Lack of Efficacy|2
786080|NCT00685399|2500593|P3|Extension|Lack of Efficacy|0
786081|NCT00685399|2500594|P2|Extension|Lack of Efficacy|0
786082|NCT00685399|2500595|P1|Extension|Lack of Efficacy|0
786083|NCT00685399|2500588|P8|Extension|Protocol Violation|0
786084|NCT00685399|2500589|P7|Extension|Protocol Violation|0
786085|NCT00685399|2500590|P6|Extension|Protocol Violation|0
786086|NCT00685399|2500591|P5|Extension|Protocol Violation|0
786087|NCT00685399|2500592|P4|Extension|Protocol Violation|1
786088|NCT00685399|2500593|P3|Extension|Protocol Violation|0
786089|NCT00685399|2500594|P2|Extension|Protocol Violation|0
786090|NCT00685399|2500595|P1|Extension|Protocol Violation|0
786091|NCT00685399|2500588|P8|Extension|Withdrawal by Subject|0
786092|NCT00685399|2500589|P7|Extension|Withdrawal by Subject|0
786093|NCT00685399|2500590|P6|Extension|Withdrawal by Subject|0
786094|NCT00685399|2500591|P5|Extension|Withdrawal by Subject|0
786095|NCT00685399|2500592|P4|Extension|Withdrawal by Subject|1
786096|NCT00685399|2500593|P3|Extension|Withdrawal by Subject|0
786097|NCT00685399|2500594|P2|Extension|Withdrawal by Subject|0
786098|NCT00685399|2500595|P1|Extension|Withdrawal by Subject|0
786099|NCT00685399|2500588|P8|Extension|Administrative Issues|0
786100|NCT00685399|2500589|P7|Extension|Administrative Issues|0
786101|NCT00685399|2500590|P6|Extension|Administrative Issues|0
786102|NCT00685399|2500591|P5|Extension|Administrative Issues|0
786103|NCT00685399|2500592|P4|Extension|Administrative Issues|1
786104|NCT00685399|2500593|P3|Extension|Administrative Issues|0
786105|NCT00685399|2500594|P2|Extension|Administrative Issues|0
786106|NCT00685399|2500595|P1|Extension|Administrative Issues|0
786107|NCT00685399|2500588|P8|Treatment Period 2|Lack of Efficacy|0
786108|NCT00685399|2500589|P7|Treatment Period 2|Lack of Efficacy|0
786109|NCT00685399|2500590|P6|Treatment Period 2|Lack of Efficacy|1
786110|NCT00685399|2500591|P5|Treatment Period 2|Lack of Efficacy|0
786111|NCT00685399|2500592|P4|Treatment Period 2|Lack of Efficacy|0
786112|NCT00685399|2500593|P3|Treatment Period 2|Lack of Efficacy|2
786113|NCT00685399|2500594|P2|Treatment Period 2|Lack of Efficacy|10
786114|NCT00685399|2500595|P1|Treatment Period 2|Lack of Efficacy|0
786115|NCT00685399|2500588|P8|Treatment Period 2|Adverse Event|0
786116|NCT00685399|2500589|P7|Treatment Period 2|Adverse Event|0
786117|NCT00685399|2500590|P6|Treatment Period 2|Adverse Event|1
786118|NCT00685399|2500591|P5|Treatment Period 2|Adverse Event|0
786119|NCT00685399|2500592|P4|Treatment Period 2|Adverse Event|0
786120|NCT00685399|2500593|P3|Treatment Period 2|Adverse Event|0
786121|NCT00685399|2500594|P2|Treatment Period 2|Adverse Event|0
786122|NCT00685399|2500595|P1|Treatment Period 2|Adverse Event|0
786123|NCT00685399|2500588|P8|Treatment Period 2|Withdrawal by Subject|2
786124|NCT00685399|2500589|P7|Treatment Period 2|Withdrawal by Subject|0
786125|NCT00685399|2500590|P6|Treatment Period 2|Withdrawal by Subject|0
786126|NCT00685399|2500591|P5|Treatment Period 2|Withdrawal by Subject|0
786127|NCT00685399|2500592|P4|Treatment Period 2|Withdrawal by Subject|0
786128|NCT00685399|2500593|P3|Treatment Period 2|Withdrawal by Subject|0
786129|NCT00685399|2500594|P2|Treatment Period 2|Withdrawal by Subject|0
786130|NCT00685399|2500595|P1|Treatment Period 2|Withdrawal by Subject|0
786131|NCT00685399|2500588|P8|Treatment Period 2|Administrative Problems|0
786132|NCT00685399|2500589|P7|Treatment Period 2|Administrative Problems|0
786133|NCT00685399|2500590|P6|Treatment Period 2|Administrative Problems|0
786134|NCT00685399|2500591|P5|Treatment Period 2|Administrative Problems|0
786135|NCT00685399|2500592|P4|Treatment Period 2|Administrative Problems|0
786136|NCT00685399|2500593|P3|Treatment Period 2|Administrative Problems|1
786137|NCT00685399|2500594|P2|Treatment Period 2|Administrative Problems|2
786138|NCT00685399|2500595|P1|Treatment Period 2|Administrative Problems|0
786139|NCT00685399|2500588|P8|Treatment Period 1|Lack of Efficacy|0
786140|NCT00685399|2500589|P7|Treatment Period 1|Lack of Efficacy|0
786141|NCT00685399|2500590|P6|Treatment Period 1|Lack of Efficacy|0
786142|NCT00685399|2500591|P5|Treatment Period 1|Lack of Efficacy|0
786143|NCT00685399|2500592|P4|Treatment Period 1|Lack of Efficacy|0
786144|NCT00685399|2500593|P3|Treatment Period 1|Lack of Efficacy|0
786145|NCT00685399|2500594|P2|Treatment Period 1|Lack of Efficacy|0
786146|NCT00685399|2500595|P1|Treatment Period 1|Lack of Efficacy|1
786147|NCT00685399|2500588|P8|Treatment Period 1|Administrative|0
786148|NCT00685399|2500589|P7|Treatment Period 1|Administrative|0
786149|NCT00685399|2500590|P6|Treatment Period 1|Administrative|0
786150|NCT00685399|2500591|P5|Treatment Period 1|Administrative|0
786151|NCT00685399|2500592|P4|Treatment Period 1|Administrative|0
786152|NCT00685399|2500593|P3|Treatment Period 1|Administrative|0
786153|NCT00685399|2500594|P2|Treatment Period 1|Administrative|0
786154|NCT00685399|2500595|P1|Treatment Period 1|Administrative|2
786155|NCT00685399|2500588|P8|Treatment Period 1|Protocol Violation|0
786156|NCT00685399|2500589|P7|Treatment Period 1|Protocol Violation|0
786157|NCT00685399|2500590|P6|Treatment Period 1|Protocol Violation|0
786158|NCT00685399|2500591|P5|Treatment Period 1|Protocol Violation|0
786159|NCT00685399|2500592|P4|Treatment Period 1|Protocol Violation|0
786160|NCT00685399|2500593|P3|Treatment Period 1|Protocol Violation|0
786161|NCT00685399|2500594|P2|Treatment Period 1|Protocol Violation|0
786162|NCT00685399|2500595|P1|Treatment Period 1|Protocol Violation|1
786163|NCT00685399|2500588|P8|Treatment Period 1|Withdrawal by Subject|0
786164|NCT00685399|2500589|P7|Treatment Period 1|Withdrawal by Subject|0
786165|NCT00685399|2500590|P6|Treatment Period 1|Withdrawal by Subject|0
786166|NCT00685399|2500591|P5|Treatment Period 1|Withdrawal by Subject|0
786167|NCT00685399|2500592|P4|Treatment Period 1|Withdrawal by Subject|0
786168|NCT00685399|2500593|P3|Treatment Period 1|Withdrawal by Subject|0
786169|NCT00685399|2500594|P2|Treatment Period 1|Withdrawal by Subject|0
786170|NCT00685399|2500595|P1|Treatment Period 1|Withdrawal by Subject|2
786171|NCT00685685|2500764|P2|Washout Period of 7 Days|Withdrawal by Subject|1
786172|NCT00685685|2500765|P1|Washout Period of 7 Days|Withdrawal by Subject|0
786173|NCT00685685|2500764|P2|Washout Period of 7 Days|Adverse Event|0
786174|NCT00685685|2500765|P1|Washout Period of 7 Days|Adverse Event|2
786175|NCT00685698|2500775|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
786176|NCT00685698|2500775|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
786177|NCT00685698|2500775|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
786178|NCT00685698|2500775|P1|Overall Study|Adverse Event|3
786179|NCT00685698|2500775|P1|Overall Study|Protocol Violation|6
786180|NCT00685698|2500775|P1|Overall Study|Withdrawal by Subject|1
786181|NCT00685763|2500810|P1|Overall Study|Protocol Violation|1
786182|NCT00685763|2500810|P1|Overall Study|Intercurrent death-incomplete treatment|1
786183|NCT00685802|2500814|P2|Washout Period of 7 Days|Withdrawal by Subject|1
786184|NCT00685802|2500815|P1|Washout Period of 7 Days|Withdrawal by Subject|0
786185|NCT00685802|2500814|P2|Washout Period of 7 Days|Protocol Violation|0
786186|NCT00685802|2500815|P1|Washout Period of 7 Days|Protocol Violation|2
786187|NCT00685945|2500834|P1|L-NMMA + Bradykinin|Physician Decision|1
786188|NCT00686036|2500851|P2|Overall Study|Other reasons not identified|4
786189|NCT00686036|2500852|P1|Overall Study|Other reasons not identified|0
786190|NCT00686036|2500851|P2|Overall Study|PSA ≥ 10ng/mL|0
786191|NCT00686036|2500852|P1|Overall Study|PSA ≥ 10ng/mL|1
786192|NCT00686036|2500851|P2|Overall Study|Study terminated by AstraZeneca|1
786193|NCT00686036|2500852|P1|Overall Study|Study terminated by AstraZeneca|2
786194|NCT00686036|2500851|P2|Overall Study|Withdrawal by Subject|1
786195|NCT00686036|2500852|P1|Overall Study|Withdrawal by Subject|3
786196|NCT00686036|2500851|P2|Overall Study|Adverse Event|0
786197|NCT00686036|2500852|P1|Overall Study|Adverse Event|3
786198|NCT00686075|2500874|P10|Overall Study|unspecified|1
786199|NCT00686075|2500875|P9|Overall Study|unspecified|0
786200|NCT00686075|2500876|P8|Overall Study|unspecified|0
786201|NCT00686075|2500877|P7|Overall Study|unspecified|0
786202|NCT00686075|2500878|P6|Overall Study|unspecified|0
786203|NCT00686075|2500879|P5|Overall Study|unspecified|0
786204|NCT00686075|2500880|P4|Overall Study|unspecified|0
786205|NCT00686075|2500881|P3|Overall Study|unspecified|0
786206|NCT00686075|2500882|P2|Overall Study|unspecified|1
786207|NCT00686075|2500883|P1|Overall Study|unspecified|1
786208|NCT00686075|2500874|P10|Overall Study|Lost to Follow-up|3
786209|NCT00686075|2500875|P9|Overall Study|Lost to Follow-up|2
786210|NCT00686075|2500876|P8|Overall Study|Lost to Follow-up|0
786211|NCT00686075|2500877|P7|Overall Study|Lost to Follow-up|0
786212|NCT00686075|2500878|P6|Overall Study|Lost to Follow-up|3
786213|NCT00686075|2500879|P5|Overall Study|Lost to Follow-up|3
786214|NCT00686075|2500880|P4|Overall Study|Lost to Follow-up|2
786215|NCT00686075|2500881|P3|Overall Study|Lost to Follow-up|3
786216|NCT00686075|2500882|P2|Overall Study|Lost to Follow-up|6
786217|NCT00686075|2500883|P1|Overall Study|Lost to Follow-up|3
786218|NCT00686075|2500874|P10|Overall Study|Withdrawal by Subject|6
786219|NCT00686075|2500875|P9|Overall Study|Withdrawal by Subject|4
786220|NCT00686075|2500876|P8|Overall Study|Withdrawal by Subject|2
786221|NCT00686075|2500877|P7|Overall Study|Withdrawal by Subject|0
786222|NCT00686075|2500878|P6|Overall Study|Withdrawal by Subject|0
786223|NCT00686075|2500879|P5|Overall Study|Withdrawal by Subject|1
786224|NCT00686075|2500880|P4|Overall Study|Withdrawal by Subject|7
786225|NCT00686075|2500881|P3|Overall Study|Withdrawal by Subject|3
786226|NCT00686075|2500882|P2|Overall Study|Withdrawal by Subject|3
786227|NCT00686075|2500883|P1|Overall Study|Withdrawal by Subject|4
786228|NCT00686127|2501077|P2|Overall Study|Withdrawal by Subject|6
786229|NCT00686127|2501078|P1|Overall Study|Withdrawal by Subject|14
892051|NCT00777101|2828786|P2|Overall Study|Discontinuation of Study by Sponsor|0
892052|NCT00777101|2828787|P1|Overall Study|Discontinuation of Study by Sponsor|1
892053|NCT00777101|2828786|P2|Overall Study|Lost to Follow-up|1
892054|NCT00777101|2828787|P1|Overall Study|Lost to Follow-up|2
892055|NCT00777101|2828786|P2|Overall Study|Withdrawal by Subject|6
892056|NCT00777101|2828787|P1|Overall Study|Withdrawal by Subject|11
892057|NCT00777101|2828786|P2|Overall Study|Death|43
786237|NCT00686205|2501096|P2|Overall Study|Specimens not confirmed HIV positive|981
786238|NCT00686205|2501097|P1|Overall Study|Specimens not confirmed HIV positive|0
786239|NCT00686205|2501096|P2|Overall Study|Specimen handling procedure altered|0
786240|NCT00686205|2501097|P1|Overall Study|Specimen handling procedure altered|5878
786241|NCT00686205|2501096|P2|Overall Study|Withdrawal by Subject|0
786242|NCT00686205|2501097|P1|Overall Study|Withdrawal by Subject|2
786243|NCT00686205|2501096|P2|Overall Study|Protocol Violation|0
786244|NCT00686205|2501097|P1|Overall Study|Protocol Violation|127
786245|NCT00686335|2501125|P1|Run-in Period|violation of inclusion/exclusion criteri|3
786246|NCT00686335|2501125|P1|Run-in Period|asthma exacerbation|1
786247|NCT00686335|2501125|P1|Run-in Period|Adverse Event|1
786248|NCT00686517|2501134|P3|Treatment|Protocol Violation|0
786249|NCT00686517|2501135|P2|Treatment|Protocol Violation|1
786250|NCT00686517|2501136|P1|Treatment|Protocol Violation|2
786251|NCT00686517|2501134|P3|Treatment|Poor Protocol Compliance|0
786252|NCT00686517|2501135|P2|Treatment|Poor Protocol Compliance|0
786253|NCT00686517|2501136|P1|Treatment|Poor Protocol Compliance|1
786254|NCT00686517|2501134|P3|Treatment|Adverse Event|0
786255|NCT00686517|2501135|P2|Treatment|Adverse Event|0
786256|NCT00686517|2501136|P1|Treatment|Adverse Event|2
786257|NCT00686517|2501134|P3|Treatment|Serious Adverse Event|1
786258|NCT00686517|2501135|P2|Treatment|Serious Adverse Event|2
786259|NCT00686517|2501136|P1|Treatment|Serious Adverse Event|1
786260|NCT00686543|2501163|P4|Overall Study|Protocol Violation|1
786261|NCT00686543|2501164|P3|Overall Study|Protocol Violation|2
786262|NCT00686543|2501165|P2|Overall Study|Protocol Violation|0
786263|NCT00686543|2501166|P1|Overall Study|Protocol Violation|3
786264|NCT00686543|2501163|P4|Overall Study|Withdrawal by Subject|0
786265|NCT00686543|2501164|P3|Overall Study|Withdrawal by Subject|0
786266|NCT00686543|2501165|P2|Overall Study|Withdrawal by Subject|0
786267|NCT00686543|2501166|P1|Overall Study|Withdrawal by Subject|2
786268|NCT00686543|2501163|P4|Overall Study|Adverse Event|2
786269|NCT00686543|2501164|P3|Overall Study|Adverse Event|3
786270|NCT00686543|2501165|P2|Overall Study|Adverse Event|1
786271|NCT00686543|2501166|P1|Overall Study|Adverse Event|9
786272|NCT00686595|2501184|P1|Overall Study|Poor Compliance|1
786273|NCT00686595|2501184|P1|Overall Study|Lack of Efficacy|1
786274|NCT00686595|2501184|P1|Overall Study|Lost to Follow-up|1
786275|NCT00686595|2501184|P1|Overall Study|Protocol Violation|1
786276|NCT00686595|2501184|P1|Overall Study|Adverse Event|3
786277|NCT00686634|2501209|P1|Overall Study|Protocol Violation|6
786278|NCT00686647|2501216|P1|Overall Study|Death|1
786279|NCT00686647|2501216|P1|Overall Study|Lost to Follow-up|1
786280|NCT00686686|2501222|P1|Overall Study|Lost to Follow-up|3
786281|NCT00686686|2501222|P1|Overall Study|Adverse Event|2
786282|NCT00686686|2501222|P1|Overall Study|Non-compliance|1
786283|NCT00686699|2501232|P2|Treatment Period 1|Adverse Event|2
786284|NCT00686699|2501233|P1|Treatment Period 1|Adverse Event|0
786285|NCT00686712|2501260|P3|Overall Study|Adverse Event|0
786286|NCT00686712|2501261|P2|Overall Study|Adverse Event|1
786287|NCT00686712|2501262|P1|Overall Study|Adverse Event|1
786288|NCT00686712|2501260|P3|Overall Study|Lost to Follow-up|3
786289|NCT00686712|2501261|P2|Overall Study|Lost to Follow-up|2
786290|NCT00686712|2501262|P1|Overall Study|Lost to Follow-up|1
786291|NCT00686712|2501260|P3|Overall Study|Protocol Violation|10
786292|NCT00686712|2501261|P2|Overall Study|Protocol Violation|8
786293|NCT00686712|2501262|P1|Overall Study|Protocol Violation|8
892058|NCT00777101|2828787|P1|Overall Study|Death|48
892059|NCT00775593|2828805|P1|Overall Study|Death|1
892060|NCT00775593|2828805|P1|Overall Study|Unmet eligibility criteria|6
892061|NCT00741260|2828840|P7|Overall Study|Not Specified|1
892062|NCT00741260|2828841|P6|Overall Study|Not Specified|3
892063|NCT00741260|2828842|P5|Overall Study|Not Specified|1
892064|NCT00741260|2828843|P4|Overall Study|Not Specified|2
892065|NCT00741260|2828844|P3|Overall Study|Not Specified|1
892066|NCT00741260|2828845|P2|Overall Study|Not Specified|1
892067|NCT00741260|2828846|P1|Overall Study|Not Specified|2
892068|NCT00741260|2828840|P7|Overall Study|Physician Decision|0
892069|NCT00741260|2828841|P6|Overall Study|Physician Decision|0
892070|NCT00741260|2828842|P5|Overall Study|Physician Decision|0
892071|NCT00741260|2828843|P4|Overall Study|Physician Decision|0
786308|NCT00686777|2501313|P1|Overall Study|No Visit|1
786309|NCT00686777|2501313|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
786310|NCT00686777|2501313|P1|Overall Study|Withdrawal by Subject|2
786311|NCT00686777|2501313|P1|Overall Study|Pregnancy|1
786312|NCT00686777|2501313|P1|Overall Study|Adverse Event|2
786313|NCT00686790|2501319|P1|Overall Study|Lost to Follow-up|12
786314|NCT00686790|2501319|P1|Overall Study|Death|1
786315|NCT00686790|2501319|P1|Overall Study|Withdrawal by Subject|1
786316|NCT00686790|2501319|P1|Overall Study|Adverse Event|2
786317|NCT00686855|2501349|P2|Overall Study|Progressive GVHD|1
786318|NCT00686855|2501350|P1|Overall Study|Progressive GVHD|0
786319|NCT00686855|2501349|P2|Overall Study|Lost to Follow-up|0
786320|NCT00686855|2501350|P1|Overall Study|Lost to Follow-up|1
786321|NCT00686881|2501358|P2|Overall Study|Never received study drug|6
786322|NCT00686881|2501359|P1|Overall Study|Never received study drug|2
786323|NCT00686881|2501358|P2|Overall Study|Study discontinuation|32
786324|NCT00686881|2501359|P1|Overall Study|Study discontinuation|35
786325|NCT00686881|2501358|P2|Overall Study|Irregular visits|0
786326|NCT00686881|2501359|P1|Overall Study|Irregular visits|1
786327|NCT00686881|2501358|P2|Overall Study|Did not meet protocol eligibility|0
786328|NCT00686881|2501359|P1|Overall Study|Did not meet protocol eligibility|1
786329|NCT00686881|2501358|P2|Overall Study|Circumstances of site|1
786330|NCT00686881|2501359|P1|Overall Study|Circumstances of site|1
786331|NCT00686881|2501358|P2|Overall Study|Physician Decision|0
786332|NCT00686881|2501359|P1|Overall Study|Physician Decision|1
786333|NCT00686881|2501358|P2|Overall Study|Lack of Efficacy|3
786334|NCT00686881|2501359|P1|Overall Study|Lack of Efficacy|4
786335|NCT00686881|2501358|P2|Overall Study|Onset of malignant tumor|11
786336|NCT00686881|2501359|P1|Overall Study|Onset of malignant tumor|11
786337|NCT00686881|2501358|P2|Overall Study|Met discontinuation criteria|0
786338|NCT00686881|2501359|P1|Overall Study|Met discontinuation criteria|5
786339|NCT00686881|2501358|P2|Overall Study|Treatment-related adverse event|9
786340|NCT00686881|2501359|P1|Overall Study|Treatment-related adverse event|10
786341|NCT00686881|2501358|P2|Overall Study|Lost to Follow-up|1
786342|NCT00686881|2501359|P1|Overall Study|Lost to Follow-up|0
786343|NCT00686881|2501358|P2|Overall Study|Withdrawal by Subject|18
786344|NCT00686881|2501359|P1|Overall Study|Withdrawal by Subject|11
786345|NCT00686894|2501369|P1|Overall Study|Protocol Violation|4
786346|NCT00686894|2501369|P1|Overall Study|Relapse|2
786347|NCT00686959|2501375|P2|Overall Study|Participants censored (no death events)|117
786348|NCT00686959|2501376|P1|Overall Study|Participants censored (no death events)|124
786349|NCT00686972|2501394|P1|Overall Study|P.I, Left institution. Study terminated|51
786350|NCT00686998|2501401|P3|Overall Study|Safety Reasons|0
786351|NCT00686998|2501402|P2|Overall Study|Safety Reasons|0
786352|NCT00686998|2501403|P1|Overall Study|Safety Reasons|1
786353|NCT00686998|2501401|P3|Overall Study|Not specified|1
786354|NCT00686998|2501402|P2|Overall Study|Not specified|0
786355|NCT00686998|2501403|P1|Overall Study|Not specified|0
786356|NCT00686998|2501401|P3|Overall Study|Lack of Efficacy|0
786357|NCT00686998|2501402|P2|Overall Study|Lack of Efficacy|5
786358|NCT00686998|2501403|P1|Overall Study|Lack of Efficacy|7
786359|NCT00686998|2501401|P3|Overall Study|Withdrawal by Subject|2
786360|NCT00686998|2501402|P2|Overall Study|Withdrawal by Subject|1
786361|NCT00686998|2501403|P1|Overall Study|Withdrawal by Subject|2
786362|NCT00686998|2501401|P3|Overall Study|Adverse Event|1
786363|NCT00686998|2501402|P2|Overall Study|Adverse Event|2
786364|NCT00686998|2501403|P1|Overall Study|Adverse Event|3
786365|NCT00687193|2501437|P6|Overall Study|Protocol Violation|0
786366|NCT00687193|2501438|P5|Overall Study|Protocol Violation|2
786367|NCT00687193|2501439|P4|Overall Study|Protocol Violation|1
786368|NCT00687193|2501440|P3|Overall Study|Protocol Violation|0
786369|NCT00687193|2501441|P2|Overall Study|Protocol Violation|2
786370|NCT00687193|2501442|P1|Overall Study|Protocol Violation|1
786371|NCT00687193|2501437|P6|Overall Study|Lack of Efficacy|2
786372|NCT00687193|2501438|P5|Overall Study|Lack of Efficacy|0
786373|NCT00687193|2501439|P4|Overall Study|Lack of Efficacy|0
786374|NCT00687193|2501440|P3|Overall Study|Lack of Efficacy|0
786375|NCT00687193|2501441|P2|Overall Study|Lack of Efficacy|1
786376|NCT00687193|2501442|P1|Overall Study|Lack of Efficacy|1
786377|NCT00687193|2501437|P6|Overall Study|Adverse Event|2
786378|NCT00687193|2501438|P5|Overall Study|Adverse Event|0
786379|NCT00687193|2501439|P4|Overall Study|Adverse Event|3
786380|NCT00687193|2501440|P3|Overall Study|Adverse Event|2
786381|NCT00687193|2501441|P2|Overall Study|Adverse Event|1
786382|NCT00687193|2501442|P1|Overall Study|Adverse Event|0
786383|NCT00687219|2501606|P1|Overall Study|Lack of Efficacy|1
786384|NCT00687219|2501606|P1|Overall Study|Withdrawal by Subject|1
786385|NCT00687219|2501606|P1|Overall Study|HCV-RNA positive conversion|34
786386|NCT00687219|2501606|P1|Overall Study|Discontinuance criteria met|7
786387|NCT00687219|2501606|P1|Overall Study|Adverse Event|8
786388|NCT00687297|2501614|P2|Induction|Other|1
786389|NCT00687297|2501615|P1|Induction|Other|0
786390|NCT00687297|2501614|P2|Induction|Physician Decision|2
786391|NCT00687297|2501615|P1|Induction|Physician Decision|0
786392|NCT00687297|2501614|P2|Induction|Patient Noncompliance|0
786393|NCT00687297|2501615|P1|Induction|Patient Noncompliance|1
786394|NCT00687297|2501614|P2|Induction|Ineligible|1
786395|NCT00687297|2501615|P1|Induction|Ineligible|0
786396|NCT00687297|2501614|P2|Induction|Lack of Efficacy|21
786397|NCT00687297|2501615|P1|Induction|Lack of Efficacy|17
786398|NCT00687297|2501614|P2|Induction|Death|11
786399|NCT00687297|2501615|P1|Induction|Death|7
786400|NCT00687297|2501614|P2|Induction|Adverse Event|15
786401|NCT00687297|2501615|P1|Induction|Adverse Event|16
786402|NCT00687297|2501614|P2|Induction|Withdrawal by Subject|4
786403|NCT00687297|2501615|P1|Induction|Withdrawal by Subject|4
786404|NCT00687297|2501614|P2|Randomization|Withdrew before treatment, ineligible|1
786405|NCT00687297|2501615|P1|Randomization|Withdrew before treatment, ineligible|1
786406|NCT00687297|2501614|P2|Randomization|Withdrawal by Subject|0
786407|NCT00687297|2501615|P1|Randomization|Withdrawal by Subject|2
786408|NCT00687323|2501625|P1|Overall Study|Screen failure|148
786409|NCT00687323|2501625|P1|Overall Study|Excluded from efficacy evaluations|6
786410|NCT00687323|2501625|P1|Overall Study|Withdrawal by Subject|1
786411|NCT00687323|2501625|P1|Overall Study|Death|25
786412|NCT00687362|2501639|P1|Overall Study|Withdrawal by Subject|1
786413|NCT00687362|2501639|P1|Overall Study|Protocol Violation|2
786414|NCT00687401|2501643|P1|Overall Study|For reasons different from those above|4
786415|NCT00687401|2501643|P1|Overall Study|Did not return for visit|3
786416|NCT00687401|2501643|P1|Overall Study|Withdrawal by Subject|4
786417|NCT00687401|2501643|P1|Overall Study|Lack of Efficacy|6
786418|NCT00687401|2501643|P1|Overall Study|Adverse Event|6
786419|NCT00687401|2501643|P1|Overall Study|Protocol Violation|7
786420|NCT00687440|2501648|P1|Overall Study|Missing|1
786421|NCT00687440|2501648|P1|Overall Study|Not specified|1
786422|NCT00687440|2501648|P1|Overall Study|Death|2
786423|NCT00687440|2501648|P1|Overall Study|Lack of Efficacy|2
786424|NCT00687440|2501648|P1|Overall Study|Lost to Follow-up|3
786425|NCT00687440|2501648|P1|Overall Study|Adverse Event|3
786426|NCT00679783|2501659|P7|Overall Study|Ongoing at data cut-off|0
786427|NCT00679783|2501660|P6|Overall Study|Ongoing at data cut-off|0
786428|NCT00679783|2501661|P5|Overall Study|Ongoing at data cut-off|1
786429|NCT00679783|2501662|P4|Overall Study|Ongoing at data cut-off|9
786430|NCT00679783|2501663|P3|Overall Study|Ongoing at data cut-off|0
786431|NCT00679783|2501664|P2|Overall Study|Ongoing at data cut-off|2
786432|NCT00679783|2501665|P1|Overall Study|Ongoing at data cut-off|2
786433|NCT00679783|2501659|P7|Overall Study|Not Captured|0
786434|NCT00679783|2501660|P6|Overall Study|Not Captured|0
786435|NCT00679783|2501661|P5|Overall Study|Not Captured|0
786436|NCT00679783|2501662|P4|Overall Study|Not Captured|5
786437|NCT00679783|2501663|P3|Overall Study|Not Captured|0
786438|NCT00679783|2501664|P2|Overall Study|Not Captured|0
786439|NCT00679783|2501665|P1|Overall Study|Not Captured|0
786440|NCT00679783|2501659|P7|Overall Study|Withdrawal by Subject|0
786441|NCT00679783|2501660|P6|Overall Study|Withdrawal by Subject|0
786442|NCT00679783|2501661|P5|Overall Study|Withdrawal by Subject|0
786443|NCT00679783|2501662|P4|Overall Study|Withdrawal by Subject|1
786444|NCT00679783|2501663|P3|Overall Study|Withdrawal by Subject|1
786445|NCT00679783|2501664|P2|Overall Study|Withdrawal by Subject|0
786446|NCT00679783|2501665|P1|Overall Study|Withdrawal by Subject|0
786447|NCT00679783|2501659|P7|Overall Study|Lack of Efficacy|0
786448|NCT00679783|2501660|P6|Overall Study|Lack of Efficacy|0
786449|NCT00679783|2501661|P5|Overall Study|Lack of Efficacy|0
786450|NCT00679783|2501662|P4|Overall Study|Lack of Efficacy|2
786451|NCT00679783|2501663|P3|Overall Study|Lack of Efficacy|0
786452|NCT00679783|2501664|P2|Overall Study|Lack of Efficacy|1
786453|NCT00679783|2501665|P1|Overall Study|Lack of Efficacy|0
786454|NCT00679783|2501659|P7|Overall Study|Adverse Event|1
786455|NCT00679783|2501660|P6|Overall Study|Adverse Event|0
786456|NCT00679783|2501661|P5|Overall Study|Adverse Event|0
786457|NCT00679783|2501662|P4|Overall Study|Adverse Event|3
786458|NCT00679783|2501663|P3|Overall Study|Adverse Event|0
786459|NCT00679783|2501664|P2|Overall Study|Adverse Event|0
786460|NCT00679783|2501665|P1|Overall Study|Adverse Event|0
786461|NCT00679913|2501718|P2|Overall Study|Protocol Violation|13
786462|NCT00679913|2501719|P1|Overall Study|Protocol Violation|18
786463|NCT00679939|2501729|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
786464|NCT00679939|2501730|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
786465|NCT00679939|2501729|P2|24-Week Open-Label (OL) Period|Physician Decision|0
786466|NCT00679939|2501730|P1|24-Week Open-Label (OL) Period|Physician Decision|1
786467|NCT00679939|2501729|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
786468|NCT00679939|2501730|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
786469|NCT00679939|2501729|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
786470|NCT00679939|2501730|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
786471|NCT00679939|2501729|P2|24-Week Open-Label (OL) Period|Adverse Event|1
786472|NCT00679939|2501730|P1|24-Week Open-Label (OL) Period|Adverse Event|0
786473|NCT00679939|2501729|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
786474|NCT00679939|2501730|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
786475|NCT00679939|2501729|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
786476|NCT00679939|2501730|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
786477|NCT00679939|2501729|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
786478|NCT00679939|2501730|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
786479|NCT00679939|2501729|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
786480|NCT00679939|2501730|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
786481|NCT00679939|2501729|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
786482|NCT00679939|2501730|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
786483|NCT00680017|2501890|P2|Overall Study|Lost to Follow-up|0
786484|NCT00680017|2501891|P1|Overall Study|Lost to Follow-up|2
786485|NCT00680017|2501890|P2|Overall Study|Withdrawal by Subject|5
786486|NCT00680017|2501891|P1|Overall Study|Withdrawal by Subject|2
786487|NCT00680017|2501890|P2|Overall Study|Adverse Event|7
786488|NCT00680017|2501891|P1|Overall Study|Adverse Event|13
786489|NCT00680043|2501902|P3|Overall Study|Renal Transplant|4
786490|NCT00680043|2501903|P2|Overall Study|Renal Transplant|0
786491|NCT00680043|2501904|P1|Overall Study|Renal Transplant|1
786492|NCT00680043|2501902|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
786493|NCT00680043|2501903|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
786494|NCT00680043|2501904|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
786495|NCT00680043|2501902|P3|Overall Study|Withdrawal by Subject|0
786496|NCT00680043|2501903|P2|Overall Study|Withdrawal by Subject|0
786497|NCT00680043|2501904|P1|Overall Study|Withdrawal by Subject|1
786498|NCT00680056|2501920|P2|Second Intervention|Protocol Violation|1
786499|NCT00680056|2501921|P1|Second Intervention|Protocol Violation|3
786500|NCT00680056|2501920|P2|First Intervention|Mainly Exacerbation of COPD|2
786501|NCT00680056|2501921|P1|First Intervention|Mainly Exacerbation of COPD|1
786502|NCT00680121|2501931|P2|Overall Study|Lost to Follow-up|23
786503|NCT00680121|2501932|P1|Overall Study|Lost to Follow-up|27
786504|NCT00680186|2501946|P2|Overall Study|Other|1
786505|NCT00680186|2501947|P1|Overall Study|Other|4
786506|NCT00680186|2501946|P2|Overall Study|Withdrawal by Subject|39
786507|NCT00680186|2501947|P1|Overall Study|Withdrawal by Subject|32
786508|NCT00680186|2501946|P2|Overall Study|Lost to Follow-up|6
786509|NCT00680186|2501947|P1|Overall Study|Lost to Follow-up|11
786510|NCT00680186|2501946|P2|Overall Study|Protocol Violation|26
786511|NCT00680186|2501947|P1|Overall Study|Protocol Violation|31
786512|NCT00680186|2501946|P2|Overall Study|Adverse Event|44
786513|NCT00680186|2501947|P1|Overall Study|Adverse Event|47
786514|NCT00680368|2501991|P1|Overall Study|not supervised, not eligible|15
786515|NCT00680407|2502000|P3|Overall Study|Withdrawal by Subject|2
786516|NCT00680407|2502001|P2|Overall Study|Withdrawal by Subject|2
786517|NCT00680407|2502002|P1|Overall Study|Withdrawal by Subject|5
786518|NCT00680407|2502000|P3|Overall Study|Lost to Follow-up|1
786519|NCT00680407|2502001|P2|Overall Study|Lost to Follow-up|3
786520|NCT00680407|2502002|P1|Overall Study|Lost to Follow-up|3
786521|NCT00680745|2502061|P4|Overall Study|False Treatment|0
786522|NCT00680745|2502062|P3|Overall Study|False Treatment|3
786523|NCT00680745|2502063|P2|Overall Study|False Treatment|1
786524|NCT00680745|2502064|P1|Overall Study|False Treatment|0
786525|NCT00680745|2502061|P4|Overall Study|Subject No Longer Meets Study Criteria|2
786526|NCT00680745|2502062|P3|Overall Study|Subject No Longer Meets Study Criteria|0
786527|NCT00680745|2502063|P2|Overall Study|Subject No Longer Meets Study Criteria|2
786528|NCT00680745|2502064|P1|Overall Study|Subject No Longer Meets Study Criteria|0
786529|NCT00680745|2502061|P4|Overall Study|Poor/Non-compliance|0
786530|NCT00680745|2502062|P3|Overall Study|Poor/Non-compliance|0
786531|NCT00680745|2502063|P2|Overall Study|Poor/Non-compliance|3
786532|NCT00680745|2502064|P1|Overall Study|Poor/Non-compliance|0
786533|NCT00680745|2502061|P4|Overall Study|Adverse Event|3
786534|NCT00680745|2502062|P3|Overall Study|Adverse Event|3
786535|NCT00680745|2502063|P2|Overall Study|Adverse Event|3
786536|NCT00680745|2502064|P1|Overall Study|Adverse Event|5
786537|NCT00680745|2502061|P4|Overall Study|Death|0
786538|NCT00680745|2502062|P3|Overall Study|Death|1
786539|NCT00680745|2502063|P2|Overall Study|Death|0
786540|NCT00680745|2502064|P1|Overall Study|Death|1
786541|NCT00680745|2502061|P4|Overall Study|Lost to Follow-up|0
786542|NCT00680745|2502062|P3|Overall Study|Lost to Follow-up|1
786543|NCT00680745|2502063|P2|Overall Study|Lost to Follow-up|1
786544|NCT00680745|2502064|P1|Overall Study|Lost to Follow-up|0
786545|NCT00680745|2502061|P4|Overall Study|Withdrawal by Subject|8
786546|NCT00680745|2502062|P3|Overall Study|Withdrawal by Subject|2
786547|NCT00680745|2502063|P2|Overall Study|Withdrawal by Subject|3
786548|NCT00680745|2502064|P1|Overall Study|Withdrawal by Subject|8
786549|NCT00680771|2502096|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
786550|NCT00680771|2502097|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
786551|NCT00680771|2502096|P2|Overall Study|Sleep Apnea suspected after PSG|0
786552|NCT00680771|2502097|P1|Overall Study|Sleep Apnea suspected after PSG|1
786553|NCT00680771|2502096|P2|Overall Study|Withdrawal by Subject|0
786554|NCT00680771|2502097|P1|Overall Study|Withdrawal by Subject|1
786555|NCT00680836|2502122|P2|Overall Study|Physician Decision|1
786556|NCT00680836|2502123|P1|Overall Study|Physician Decision|2
786557|NCT00680836|2502122|P2|Overall Study|Lost to Follow-up|1
786558|NCT00680836|2502123|P1|Overall Study|Lost to Follow-up|3
786559|NCT00680836|2502122|P2|Overall Study|Withdrawal by Subject|0
786560|NCT00680836|2502123|P1|Overall Study|Withdrawal by Subject|3
786561|NCT00680901|2502145|P2|Overall Study|Ongoing: In Follow Up|41
786562|NCT00680901|2502146|P1|Overall Study|Ongoing: In Follow Up|45
786563|NCT00680901|2502145|P2|Overall Study|Ongoing: On Study Treatment|13
786564|NCT00680901|2502146|P1|Overall Study|Ongoing: On Study Treatment|16
786565|NCT00680901|2502145|P2|Overall Study|Physician Decision|1
786566|NCT00680901|2502146|P1|Overall Study|Physician Decision|0
786567|NCT00680901|2502145|P2|Overall Study|Withdrawal by Subject|13
786568|NCT00680901|2502146|P1|Overall Study|Withdrawal by Subject|4
786569|NCT00680901|2502145|P2|Overall Study|Lost to Follow-up|8
786570|NCT00680901|2502146|P1|Overall Study|Lost to Follow-up|8
786571|NCT00680914|2502180|P2|Overall Study|serious adverse event (SAE)|1
786572|NCT00680914|2502181|P1|Overall Study|serious adverse event (SAE)|0
786573|NCT00680914|2502180|P2|Overall Study|Lost to Follow-up|0
786574|NCT00680914|2502181|P1|Overall Study|Lost to Follow-up|4
786575|NCT00680914|2502180|P2|Overall Study|Consent withdrawal|3
786576|NCT00680914|2502181|P1|Overall Study|Consent withdrawal|6
892072|NCT00741260|2828844|P3|Overall Study|Physician Decision|0
892073|NCT00741260|2828845|P2|Overall Study|Physician Decision|1
892074|NCT00741260|2828846|P1|Overall Study|Physician Decision|1
786580|NCT00681187|2502259|P2|Overall Study|Adverse Event|1
786581|NCT00681187|2502260|P1|Overall Study|Adverse Event|0
786582|NCT00681187|2502259|P2|Overall Study|Death|1
786583|NCT00681187|2502260|P1|Overall Study|Death|0
786584|NCT00681187|2502259|P2|Overall Study|Withdrawal by Subject|0
786585|NCT00681187|2502260|P1|Overall Study|Withdrawal by Subject|1
786586|NCT00687531|2502301|P1|Overall Study|Lost to Follow-up|26
786587|NCT00687531|2502301|P1|Overall Study|Adverse Event|5
786588|NCT00687531|2502301|P1|Overall Study|Did not meet protocol eligibility|104
786589|NCT00687609|2502324|P1|Overall Study|Withdrawal by Subject|2
786590|NCT00687609|2502324|P1|Overall Study|Physician Decision|1
786591|NCT00687804|2502359|P3|Open-Label Extension Study|Death|3
786592|NCT00687804|2502360|P2|Open-Label Extension Study|Death|3
786593|NCT00687804|2502361|P1|Open-Label Extension Study|Death|2
786594|NCT00687804|2502359|P3|Open-Label Extension Study|Administrative problems|0
786595|NCT00687804|2502360|P2|Open-Label Extension Study|Administrative problems|1
786596|NCT00687804|2502361|P1|Open-Label Extension Study|Administrative problems|1
786597|NCT00687804|2502359|P3|Open-Label Extension Study|Lost to Follow-up|2
786598|NCT00687804|2502360|P2|Open-Label Extension Study|Lost to Follow-up|1
786599|NCT00687804|2502361|P1|Open-Label Extension Study|Lost to Follow-up|2
786600|NCT00687804|2502359|P3|Open-Label Extension Study|Subject withdrew consent|4
786601|NCT00687804|2502360|P2|Open-Label Extension Study|Subject withdrew consent|4
786602|NCT00687804|2502361|P1|Open-Label Extension Study|Subject withdrew consent|3
786603|NCT00687804|2502359|P3|Open-Label Extension Study|Adverse Event|2
786604|NCT00687804|2502360|P2|Open-Label Extension Study|Adverse Event|2
786605|NCT00687804|2502361|P1|Open-Label Extension Study|Adverse Event|2
786606|NCT00687804|2502359|P3|Core Study|Protocol Violation|0
786607|NCT00687804|2502360|P2|Core Study|Protocol Violation|1
786608|NCT00687804|2502361|P1|Core Study|Protocol Violation|1
786609|NCT00687804|2502359|P3|Core Study|Death|2
786610|NCT00687804|2502360|P2|Core Study|Death|2
786611|NCT00687804|2502361|P1|Core Study|Death|2
786612|NCT00687804|2502359|P3|Core Study|Lost to Follow-up|0
786613|NCT00687804|2502360|P2|Core Study|Lost to Follow-up|1
786614|NCT00687804|2502361|P1|Core Study|Lost to Follow-up|0
786615|NCT00687804|2502359|P3|Core Study|Withdrawal by Subject|7
786616|NCT00687804|2502360|P2|Core Study|Withdrawal by Subject|7
786617|NCT00687804|2502361|P1|Core Study|Withdrawal by Subject|4
786618|NCT00687804|2502359|P3|Core Study|Lack of Efficacy|1
786619|NCT00687804|2502360|P2|Core Study|Lack of Efficacy|1
786620|NCT00687804|2502361|P1|Core Study|Lack of Efficacy|1
786621|NCT00687804|2502359|P3|Core Study|Abnormal laboratory value(s)|0
786622|NCT00687804|2502360|P2|Core Study|Abnormal laboratory value(s)|0
786623|NCT00687804|2502361|P1|Core Study|Abnormal laboratory value(s)|1
786624|NCT00687804|2502359|P3|Core Study|Adverse Event|3
786625|NCT00687804|2502360|P2|Core Study|Adverse Event|3
786626|NCT00687804|2502361|P1|Core Study|Adverse Event|5
786627|NCT00688467|2502406|P2|Treatment Period 2|Adverse Event|1
786628|NCT00688467|2502407|P1|Treatment Period 2|Adverse Event|0
786629|NCT00688467|2502406|P2|Treatment Period 2|Protocol Violation|1
786630|NCT00688467|2502407|P1|Treatment Period 2|Protocol Violation|0
786631|NCT00688467|2502406|P2|Treatment Period 1|Did not meet protocol eligibility|1
786632|NCT00688467|2502407|P1|Treatment Period 1|Did not meet protocol eligibility|0
786633|NCT00688467|2502406|P2|Treatment Period 1|Adverse Event|1
786634|NCT00688467|2502407|P1|Treatment Period 1|Adverse Event|2
786635|NCT00688519|2502439|P2|Overall Study|Pregnancy|1
786636|NCT00688519|2502440|P1|Overall Study|Pregnancy|0
786637|NCT00688519|2502439|P2|Overall Study|Subject moved out of area|0
786638|NCT00688519|2502440|P1|Overall Study|Subject moved out of area|1
786639|NCT00688519|2502439|P2|Overall Study|Investigator decision|0
786640|NCT00688519|2502440|P1|Overall Study|Investigator decision|1
786641|NCT00688519|2502439|P2|Overall Study|Subject moved out of state|0
786642|NCT00688519|2502440|P1|Overall Study|Subject moved out of state|1
786643|NCT00688519|2502439|P2|Overall Study|Non-compliance|1
786644|NCT00688519|2502440|P1|Overall Study|Non-compliance|0
786645|NCT00688519|2502439|P2|Overall Study|Prohibited medication|0
786646|NCT00688519|2502440|P1|Overall Study|Prohibited medication|1
786647|NCT00688519|2502439|P2|Overall Study|Withdrawal by Subject|6
786648|NCT00688519|2502440|P1|Overall Study|Withdrawal by Subject|7
786649|NCT00688519|2502439|P2|Overall Study|Lack of Efficacy|1
786650|NCT00688519|2502440|P1|Overall Study|Lack of Efficacy|3
786651|NCT00688519|2502439|P2|Overall Study|Lost to Follow-up|3
786652|NCT00688519|2502440|P1|Overall Study|Lost to Follow-up|3
786653|NCT00688519|2502439|P2|Overall Study|Adverse Event|3
786654|NCT00688519|2502440|P1|Overall Study|Adverse Event|2
786655|NCT00688545|2502458|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
786656|NCT00688545|2502459|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
786657|NCT00688545|2502458|P2|Overall Study|Withdrawal by Subject|3
786658|NCT00688545|2502459|P1|Overall Study|Withdrawal by Subject|2
786659|NCT00688545|2502458|P2|Overall Study|Insurance/cost of drug|1
786660|NCT00688545|2502459|P1|Overall Study|Insurance/cost of drug|0
786661|NCT00688545|2502458|P2|Overall Study|Lost to Follow-up|4
786662|NCT00688545|2502459|P1|Overall Study|Lost to Follow-up|1
786663|NCT00688636|2502469|P2|Overall Study|Adverse Event|1
786664|NCT00688636|2502470|P1|Overall Study|Adverse Event|2
786698|NCT00688701|2502592|P4|Overall Study|Poor compliance to protocol|0
786699|NCT00688701|2502593|P3|Overall Study|Poor compliance to protocol|1
786700|NCT00688701|2502594|P2|Overall Study|Poor compliance to protocol|1
786701|NCT00688701|2502595|P1|Overall Study|Poor compliance to protocol|0
786702|NCT00688701|2502592|P4|Overall Study|Withdrawal by Subject|8
786703|NCT00688701|2502593|P3|Overall Study|Withdrawal by Subject|4
786704|NCT00688701|2502594|P2|Overall Study|Withdrawal by Subject|3
786705|NCT00688701|2502595|P1|Overall Study|Withdrawal by Subject|3
786706|NCT00688701|2502592|P4|Overall Study|Lack of Efficacy|0
786707|NCT00688701|2502593|P3|Overall Study|Lack of Efficacy|0
786708|NCT00688701|2502594|P2|Overall Study|Lack of Efficacy|1
786709|NCT00688701|2502595|P1|Overall Study|Lack of Efficacy|0
786710|NCT00688701|2502592|P4|Overall Study|Adverse Event|3
786711|NCT00688701|2502593|P3|Overall Study|Adverse Event|5
786712|NCT00688701|2502594|P2|Overall Study|Adverse Event|0
786713|NCT00688701|2502595|P1|Overall Study|Adverse Event|1
786714|NCT00688740|2502635|P2|Overall Study|Violation of Inclusion Criteria|3
786715|NCT00688740|2502636|P1|Overall Study|Violation of Inclusion Criteria|1
786716|NCT00688740|2502635|P2|Overall Study|Breast Cancer Relapse|4
786717|NCT00688740|2502636|P1|Overall Study|Breast Cancer Relapse|1
786718|NCT00688740|2502635|P2|Overall Study|Consent Withdrawn|17
786719|NCT00688740|2502636|P1|Overall Study|Consent Withdrawn|17
786720|NCT00688740|2502635|P2|Overall Study|Lost to Follow-up|1
786721|NCT00688740|2502636|P1|Overall Study|Lost to Follow-up|0
786722|NCT00688740|2502635|P2|Overall Study|Death|2
786723|NCT00688740|2502636|P1|Overall Study|Death|2
786724|NCT00688740|2502635|P2|Overall Study|Adverse Event|8
786725|NCT00688740|2502636|P1|Overall Study|Adverse Event|45
786726|NCT00688753|2502646|P1|Overall Study|Lost to Follow-up|3
786727|NCT00688753|2502646|P1|Overall Study|Protocol Violation|1
786728|NCT00688753|2502646|P1|Overall Study|Adverse Event|20
786729|NCT00688753|2502646|P1|Overall Study|Withdrawal by Subject|3
786730|NCT00688753|2502646|P1|Overall Study|Death|9
786731|NCT00688753|2502646|P1|Overall Study|Missing|1
786732|NCT00688753|2502646|P1|Overall Study|Disease progression|55
786733|NCT00688844|2502655|P1|Overall Study|Lost to Follow-up|10
786734|NCT00688870|2502667|P2|Infant Series|Parent or legal guardian request|0
786735|NCT00688870|2502668|P1|Infant Series|Parent or legal guardian request|4
786736|NCT00689026|2502702|P2|Overall Study|Withdrawal by Subject|6
786737|NCT00689026|2502703|P1|Overall Study|Withdrawal by Subject|13
786738|NCT00689052|2502711|P2|Overall Study|Early termination of the trial|24
786739|NCT00689052|2502712|P1|Overall Study|Early termination of the trial|22
786740|NCT00689052|2502711|P2|Overall Study|Withdrawal by Subject|0
786741|NCT00689052|2502712|P1|Overall Study|Withdrawal by Subject|2
786742|NCT00689052|2502711|P2|Overall Study|Lost to Follow-up|0
786743|NCT00689052|2502712|P1|Overall Study|Lost to Follow-up|2
786744|NCT00689052|2502711|P2|Overall Study|Protocol Violation|0
786745|NCT00689052|2502712|P1|Overall Study|Protocol Violation|1
786746|NCT00689052|2502711|P2|Overall Study|Adverse Event|6
786747|NCT00689052|2502712|P1|Overall Study|Adverse Event|4
786784|NCT00689117|2502892|P4|Overall Study|Dispensing Error|0
786785|NCT00689117|2502893|P3|Overall Study|Dispensing Error|0
786786|NCT00689117|2502894|P2|Overall Study|Dispensing Error|1
786787|NCT00689117|2502895|P1|Overall Study|Dispensing Error|0
786788|NCT00689117|2502892|P4|Overall Study|Personal Reason|0
786789|NCT00689117|2502893|P3|Overall Study|Personal Reason|0
786790|NCT00689117|2502894|P2|Overall Study|Personal Reason|1
786791|NCT00689117|2502895|P1|Overall Study|Personal Reason|0
786792|NCT00689117|2502892|P4|Overall Study|Patient Withdrew from Study|1
786793|NCT00689117|2502893|P3|Overall Study|Patient Withdrew from Study|0
786794|NCT00689117|2502894|P2|Overall Study|Patient Withdrew from Study|0
786795|NCT00689117|2502895|P1|Overall Study|Patient Withdrew from Study|0
786796|NCT00689117|2502892|P4|Overall Study|Transportation|0
786797|NCT00689117|2502893|P3|Overall Study|Transportation|0
786798|NCT00689117|2502894|P2|Overall Study|Transportation|0
786799|NCT00689117|2502895|P1|Overall Study|Transportation|1
786800|NCT00689117|2502892|P4|Overall Study|Fear of Birth Defects|0
786801|NCT00689117|2502893|P3|Overall Study|Fear of Birth Defects|1
786802|NCT00689117|2502894|P2|Overall Study|Fear of Birth Defects|0
786803|NCT00689117|2502895|P1|Overall Study|Fear of Birth Defects|0
786804|NCT00689117|2502892|P4|Overall Study|Incarceration|0
786805|NCT00689117|2502893|P3|Overall Study|Incarceration|0
786806|NCT00689117|2502894|P2|Overall Study|Incarceration|0
786807|NCT00689117|2502895|P1|Overall Study|Incarceration|2
786808|NCT00689117|2502892|P4|Overall Study|Pregnancy|2
786809|NCT00689117|2502893|P3|Overall Study|Pregnancy|0
786810|NCT00689117|2502894|P2|Overall Study|Pregnancy|2
786811|NCT00689117|2502895|P1|Overall Study|Pregnancy|0
786812|NCT00689117|2502892|P4|Overall Study|Use of Prohibitive Medication|0
786813|NCT00689117|2502893|P3|Overall Study|Use of Prohibitive Medication|3
786814|NCT00689117|2502894|P2|Overall Study|Use of Prohibitive Medication|1
786815|NCT00689117|2502895|P1|Overall Study|Use of Prohibitive Medication|2
786816|NCT00689117|2502892|P4|Overall Study|Change/Discontinuation of Birth Control|0
786817|NCT00689117|2502893|P3|Overall Study|Change/Discontinuation of Birth Control|1
786818|NCT00689117|2502894|P2|Overall Study|Change/Discontinuation of Birth Control|1
786819|NCT00689117|2502895|P1|Overall Study|Change/Discontinuation of Birth Control|1
786820|NCT00689117|2502892|P4|Overall Study|Non-compliance with Treatment Regimen|0
786821|NCT00689117|2502893|P3|Overall Study|Non-compliance with Treatment Regimen|0
786822|NCT00689117|2502894|P2|Overall Study|Non-compliance with Treatment Regimen|1
786823|NCT00689117|2502895|P1|Overall Study|Non-compliance with Treatment Regimen|0
786824|NCT00689117|2502892|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
786825|NCT00689117|2502893|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
786826|NCT00689117|2502894|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
786827|NCT00689117|2502895|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
786828|NCT00689117|2502892|P4|Overall Study|Unable to Comply with Visit Schedule|1
786829|NCT00689117|2502893|P3|Overall Study|Unable to Comply with Visit Schedule|1
786830|NCT00689117|2502894|P2|Overall Study|Unable to Comply with Visit Schedule|0
786831|NCT00689117|2502895|P1|Overall Study|Unable to Comply with Visit Schedule|0
786832|NCT00689117|2502892|P4|Overall Study|Withdrawal by Subject|13
786833|NCT00689117|2502893|P3|Overall Study|Withdrawal by Subject|26
786834|NCT00689117|2502894|P2|Overall Study|Withdrawal by Subject|18
786835|NCT00689117|2502895|P1|Overall Study|Withdrawal by Subject|19
786836|NCT00689117|2502892|P4|Overall Study|Non-Compliance with Study Treatment|1
786837|NCT00689117|2502893|P3|Overall Study|Non-Compliance with Study Treatment|3
786838|NCT00689117|2502894|P2|Overall Study|Non-Compliance with Study Treatment|3
786839|NCT00689117|2502895|P1|Overall Study|Non-Compliance with Study Treatment|3
786840|NCT00689117|2502892|P4|Overall Study|Lack of Efficacy|2
786841|NCT00689117|2502893|P3|Overall Study|Lack of Efficacy|2
786842|NCT00689117|2502894|P2|Overall Study|Lack of Efficacy|2
786843|NCT00689117|2502895|P1|Overall Study|Lack of Efficacy|1
786844|NCT00689117|2502892|P4|Overall Study|Lost to Follow-up|11
786845|NCT00689117|2502893|P3|Overall Study|Lost to Follow-up|17
786846|NCT00689117|2502894|P2|Overall Study|Lost to Follow-up|19
786847|NCT00689117|2502895|P1|Overall Study|Lost to Follow-up|26
786848|NCT00689117|2502892|P4|Overall Study|Adverse Event|0
786849|NCT00689117|2502893|P3|Overall Study|Adverse Event|5
786850|NCT00689117|2502894|P2|Overall Study|Adverse Event|0
786851|NCT00689117|2502895|P1|Overall Study|Adverse Event|6
786852|NCT00689221|2502923|P2|Overall Study|Ongoing at cut-off date|36
786853|NCT00689221|2502924|P1|Overall Study|Ongoing at cut-off date|39
786854|NCT00689299|2502971|P3|Overall Study|Protocol Violation|0
786855|NCT00689299|2502972|P2|Overall Study|Protocol Violation|0
786856|NCT00689299|2502973|P1|Overall Study|Protocol Violation|1
786857|NCT00689299|2502971|P3|Overall Study|Withdrawal by Subject|3
786858|NCT00689299|2502972|P2|Overall Study|Withdrawal by Subject|1
786859|NCT00689299|2502973|P1|Overall Study|Withdrawal by Subject|4
786860|NCT00689299|2502971|P3|Overall Study|Lost to Follow-up|1
786861|NCT00689299|2502972|P2|Overall Study|Lost to Follow-up|1
786862|NCT00689299|2502973|P1|Overall Study|Lost to Follow-up|0
786863|NCT00689299|2502971|P3|Overall Study|Adverse Event|1
786864|NCT00689299|2502972|P2|Overall Study|Adverse Event|1
786865|NCT00689299|2502973|P1|Overall Study|Adverse Event|2
786866|NCT00689338|2502981|P1|Overall Study|Protocol Violation|15
786867|NCT00689338|2502981|P1|Overall Study|Withdrawal by Subject|3
786868|NCT00689338|2502981|P1|Overall Study|Lost to Follow-up|5
786869|NCT00689338|2502981|P1|Overall Study|Did not Meet Entrance Criteria|27
786870|NCT00689338|2502981|P1|Overall Study|Unspecified|8
786871|NCT00689338|2502981|P1|Overall Study|Lack of Efficacy|6
786872|NCT00689338|2502981|P1|Overall Study|Insufficient Clinical Response|1
786873|NCT00689338|2502981|P1|Overall Study|Adverse Event|13
786874|NCT00689338|2502981|P1|Overall Study|Death|65
786875|NCT00689351|2502993|P2|After Infant Series|Parent/legal guardian request|0
786876|NCT00689351|2502994|P1|After Infant Series|Parent/legal guardian request|1
786877|NCT00689351|2502993|P2|Infant Series of Dosing|Lost to Follow-up|1
786878|NCT00689351|2502994|P1|Infant Series of Dosing|Lost to Follow-up|0
786879|NCT00689351|2502993|P2|Infant Series of Dosing|Adverse Event|0
786880|NCT00689351|2502994|P1|Infant Series of Dosing|Adverse Event|1
786881|NCT00689351|2502993|P2|Infant Series of Dosing|Parent/legal guardian request|0
786882|NCT00689351|2502994|P1|Infant Series of Dosing|Parent/legal guardian request|5
786883|NCT00689390|2503028|P2|Overall Study|Administrative|0
786884|NCT00689390|2503029|P1|Overall Study|Administrative|37
786885|NCT00689390|2503028|P2|Overall Study|Did Not Meet Protocol Eligibility|0
786886|NCT00689390|2503029|P1|Overall Study|Did Not Meet Protocol Eligibility|1
786887|NCT00689390|2503028|P2|Overall Study|Non-Compliance With Protocol|0
786888|NCT00689390|2503029|P1|Overall Study|Non-Compliance With Protocol|21
786889|NCT00689390|2503028|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
786890|NCT00689390|2503029|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
786891|NCT00689390|2503028|P2|Overall Study|Withdrawal by Subject|3
786892|NCT00689390|2503029|P1|Overall Study|Withdrawal by Subject|117
786893|NCT00689390|2503028|P2|Overall Study|Lost to Follow-up|7
786894|NCT00689390|2503029|P1|Overall Study|Lost to Follow-up|179
786895|NCT00689390|2503028|P2|Overall Study|Adverse Event|0
786896|NCT00689390|2503029|P1|Overall Study|Adverse Event|19
786897|NCT00689481|2503047|P2|Overall Study|Subject early term, left on vacation|1
786898|NCT00689481|2503048|P1|Overall Study|Subject early term, left on vacation|0
786899|NCT00689481|2503047|P2|Overall Study|Excluded medication started during study|1
786900|NCT00689481|2503048|P1|Overall Study|Excluded medication started during study|0
786901|NCT00689481|2503047|P2|Overall Study|Withdrawal by Subject|4
786902|NCT00689481|2503048|P1|Overall Study|Withdrawal by Subject|8
786903|NCT00689481|2503047|P2|Overall Study|Non-compliance with study treatment|1
786904|NCT00689481|2503048|P1|Overall Study|Non-compliance with study treatment|1
786905|NCT00689481|2503047|P2|Overall Study|Lack of Efficacy|3
786906|NCT00689481|2503048|P1|Overall Study|Lack of Efficacy|4
786907|NCT00689481|2503047|P2|Overall Study|Lost to Follow-up|3
786908|NCT00689481|2503048|P1|Overall Study|Lost to Follow-up|4
786909|NCT00689481|2503047|P2|Overall Study|Adverse Event|1
786910|NCT00689481|2503048|P1|Overall Study|Adverse Event|7
786911|NCT00689611|2503066|P2|Overall Study|Lost to Follow-up|28
786912|NCT00689611|2503067|P1|Overall Study|Lost to Follow-up|27
786913|NCT00689611|2503066|P2|Overall Study|Withdrawal by Subject|9
786914|NCT00689611|2503067|P1|Overall Study|Withdrawal by Subject|8
786915|NCT00689611|2503066|P2|Overall Study|Death|9
786916|NCT00689611|2503067|P1|Overall Study|Death|6
786917|NCT00689793|2503077|P2|Overall Study|Lost to Follow-up|5
786918|NCT00689793|2503078|P1|Overall Study|Lost to Follow-up|4
786919|NCT00689871|2503109|P4|Overall Study|Physician Decision|0
786920|NCT00689871|2503110|P3|Overall Study|Physician Decision|1
786921|NCT00689871|2503111|P2|Overall Study|Physician Decision|1
786922|NCT00689871|2503112|P1|Overall Study|Physician Decision|2
786923|NCT00689871|2503109|P4|Overall Study|Death|2
786924|NCT00689871|2503110|P3|Overall Study|Death|2
786925|NCT00689871|2503111|P2|Overall Study|Death|10
786926|NCT00689871|2503112|P1|Overall Study|Death|1
786927|NCT00689871|2503109|P4|Overall Study|Withdrawal by Subject|1
786928|NCT00689871|2503110|P3|Overall Study|Withdrawal by Subject|4
786929|NCT00689871|2503111|P2|Overall Study|Withdrawal by Subject|3
786930|NCT00689871|2503112|P1|Overall Study|Withdrawal by Subject|13
786931|NCT00689871|2503109|P4|Overall Study|Explanted of All Study Devices|3
786932|NCT00689871|2503110|P3|Overall Study|Explanted of All Study Devices|29
786933|NCT00689871|2503111|P2|Overall Study|Explanted of All Study Devices|25
786934|NCT00689871|2503112|P1|Overall Study|Explanted of All Study Devices|36
786935|NCT00689871|2503109|P4|Overall Study|Lost to Follow-up|1
786936|NCT00689871|2503110|P3|Overall Study|Lost to Follow-up|37
786937|NCT00689871|2503111|P2|Overall Study|Lost to Follow-up|13
786938|NCT00689871|2503112|P1|Overall Study|Lost to Follow-up|123
892075|NCT00741260|2828840|P7|Overall Study|Withdrawal by Subject|1
892076|NCT00741260|2828841|P6|Overall Study|Withdrawal by Subject|3
892077|NCT00741260|2828842|P5|Overall Study|Withdrawal by Subject|1
892078|NCT00741260|2828843|P4|Overall Study|Withdrawal by Subject|0
892079|NCT00741260|2828844|P3|Overall Study|Withdrawal by Subject|0
892080|NCT00741260|2828845|P2|Overall Study|Withdrawal by Subject|0
892081|NCT00741260|2828846|P1|Overall Study|Withdrawal by Subject|0
892082|NCT00741260|2828840|P7|Overall Study|Death|1
892083|NCT00741260|2828841|P6|Overall Study|Death|2
892084|NCT00741260|2828842|P5|Overall Study|Death|2
892085|NCT00741260|2828843|P4|Overall Study|Death|1
892086|NCT00741260|2828844|P3|Overall Study|Death|0
892087|NCT00741260|2828845|P2|Overall Study|Death|1
892088|NCT00741260|2828846|P1|Overall Study|Death|0
892089|NCT00741260|2828840|P7|Overall Study|Disease Progression|4
892090|NCT00741260|2828841|P6|Overall Study|Disease Progression|37
892091|NCT00741260|2828842|P5|Overall Study|Disease Progression|5
892092|NCT00741260|2828843|P4|Overall Study|Disease Progression|3
892093|NCT00741260|2828844|P3|Overall Study|Disease Progression|3
892094|NCT00741260|2828845|P2|Overall Study|Disease Progression|5
892095|NCT00741260|2828846|P1|Overall Study|Disease Progression|3
892096|NCT00529802|2828915|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
892097|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
892098|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
892099|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Death|1
892100|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Adverse Event|2
892101|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Worsening performance status|2
892102|NCT00529802|2828915|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
786966|NCT00690430|2503308|P3|Extension Phase|Early Termination|3
786967|NCT00690430|2503309|P2|Extension Phase|Early Termination|1
786968|NCT00690430|2503310|P1|Extension Phase|Early Termination|10
786969|NCT00690430|2503308|P3|Extension Phase|Withdrawal by Subject|2
786970|NCT00690430|2503309|P2|Extension Phase|Withdrawal by Subject|0
786971|NCT00690430|2503310|P1|Extension Phase|Withdrawal by Subject|0
786972|NCT00690430|2503308|P3|Extension Phase|Death|1
786973|NCT00690430|2503309|P2|Extension Phase|Death|1
786974|NCT00690430|2503310|P1|Extension Phase|Death|1
786975|NCT00690430|2503308|P3|Extension Phase|Adverse Event|2
786976|NCT00690430|2503309|P2|Extension Phase|Adverse Event|1
786977|NCT00690430|2503310|P1|Extension Phase|Adverse Event|2
786978|NCT00690430|2503308|P3|Extension Phase|Administrative Problems|1
786979|NCT00690430|2503309|P2|Extension Phase|Administrative Problems|1
786980|NCT00690430|2503310|P1|Extension Phase|Administrative Problems|0
786981|NCT00690430|2503308|P3|Extension Phase|Abnormal test procedure results|0
786982|NCT00690430|2503309|P2|Extension Phase|Abnormal test procedure results|0
786983|NCT00690430|2503310|P1|Extension Phase|Abnormal test procedure results|1
786984|NCT00690430|2503308|P3|Extension Phase|Abnormal Lab Values|0
786985|NCT00690430|2503309|P2|Extension Phase|Abnormal Lab Values|0
786986|NCT00690430|2503310|P1|Extension Phase|Abnormal Lab Values|1
786987|NCT00690430|2503308|P3|Extension Phase|Lack of Efficacy|4
786988|NCT00690430|2503309|P2|Extension Phase|Lack of Efficacy|1
786989|NCT00690430|2503310|P1|Extension Phase|Lack of Efficacy|3
786990|NCT00690430|2503308|P3|Core Phase|Early Termination|0
786991|NCT00690430|2503309|P2|Core Phase|Early Termination|5
786992|NCT00690430|2503310|P1|Core Phase|Early Termination|0
786993|NCT00690430|2503308|P3|Core Phase|Administrative Problems|0
786994|NCT00690430|2503309|P2|Core Phase|Administrative Problems|1
786995|NCT00690430|2503310|P1|Core Phase|Administrative Problems|0
786996|NCT00690430|2503308|P3|Core Phase|Lack of Efficacy|0
786997|NCT00690430|2503309|P2|Core Phase|Lack of Efficacy|10
786998|NCT00690430|2503310|P1|Core Phase|Lack of Efficacy|8
786999|NCT00690430|2503308|P3|Core Phase|Subject no longer requires study drug|0
787000|NCT00690430|2503309|P2|Core Phase|Subject no longer requires study drug|0
787001|NCT00690430|2503310|P1|Core Phase|Subject no longer requires study drug|1
787002|NCT00690430|2503308|P3|Core Phase|Withdrawal by Subject|0
787003|NCT00690430|2503309|P2|Core Phase|Withdrawal by Subject|3
787004|NCT00690430|2503310|P1|Core Phase|Withdrawal by Subject|3
787005|NCT00690430|2503308|P3|Core Phase|Protocol Violation|0
787006|NCT00690430|2503309|P2|Core Phase|Protocol Violation|0
787007|NCT00690430|2503310|P1|Core Phase|Protocol Violation|1
787008|NCT00690430|2503308|P3|Core Phase|Death|0
787009|NCT00690430|2503309|P2|Core Phase|Death|2
787010|NCT00690430|2503310|P1|Core Phase|Death|0
787011|NCT00690430|2503308|P3|Core Phase|Adverse Event|0
787012|NCT00690430|2503309|P2|Core Phase|Adverse Event|1
787013|NCT00690430|2503310|P1|Core Phase|Adverse Event|5
787014|NCT00690430|2503308|P3|Core Phase|Abnormal Laboratory value|0
787015|NCT00690430|2503309|P2|Core Phase|Abnormal Laboratory value|1
787016|NCT00690430|2503310|P1|Core Phase|Abnormal Laboratory value|0
787017|NCT00690443|2503339|P2|Overall Study|Adverse Event|2
787018|NCT00690443|2503340|P1|Overall Study|Adverse Event|1
787019|NCT00690482|2503350|P2|Overall Study|withdrew consent at rand.day|1
787020|NCT00690482|2503351|P1|Overall Study|withdrew consent at rand.day|0
787021|NCT00690482|2503350|P2|Overall Study|Intake of prohibited medicine|0
787022|NCT00690482|2503351|P1|Overall Study|Intake of prohibited medicine|1
787023|NCT00690482|2503350|P2|Overall Study|Study-specific discontinuation criteria|0
787024|NCT00690482|2503351|P1|Overall Study|Study-specific discontinuation criteria|1
787025|NCT00690482|2503350|P2|Overall Study|Incorrect enrolment|1
787026|NCT00690482|2503351|P1|Overall Study|Incorrect enrolment|0
787027|NCT00690482|2503350|P2|Overall Study|Adverse Event|1
787028|NCT00690482|2503351|P1|Overall Study|Adverse Event|2
787029|NCT00690573|2503392|P1|Overall Study|Withdrawal by Subject|1
787030|NCT00690573|2503392|P1|Overall Study|Lack of Efficacy|8
787031|NCT00690612|2503400|P1|Overall Study|Withdrawal by Subject|2
787032|NCT00690612|2503400|P1|Overall Study|Adverse Event|1
787033|NCT00684177|2503426|P2|Overall Study|Other|2
787034|NCT00684177|2503427|P1|Overall Study|Other|1
787035|NCT00684177|2503426|P2|Overall Study|Withdrawal by Subject|2
787036|NCT00684177|2503427|P1|Overall Study|Withdrawal by Subject|1
787037|NCT00684177|2503426|P2|Overall Study|Physician Decision|0
787038|NCT00684177|2503427|P1|Overall Study|Physician Decision|2
787039|NCT00684177|2503426|P2|Overall Study|Lost to Follow-up|1
787040|NCT00684177|2503427|P1|Overall Study|Lost to Follow-up|2
787041|NCT00684177|2503426|P2|Overall Study|Protocol Violation|0
787042|NCT00684177|2503427|P1|Overall Study|Protocol Violation|1
787043|NCT00684177|2503426|P2|Overall Study|Lack of Efficacy|15
787044|NCT00684177|2503427|P1|Overall Study|Lack of Efficacy|10
787045|NCT00684177|2503426|P2|Overall Study|Adverse Event|3
787046|NCT00684177|2503427|P1|Overall Study|Adverse Event|4
787047|NCT00684203|2503449|P6|Overall Study|Did not meet protocol eligibility|0
787048|NCT00684203|2503450|P5|Overall Study|Did not meet protocol eligibility|0
787049|NCT00684203|2503451|P4|Overall Study|Did not meet protocol eligibility|0
787050|NCT00684203|2503452|P3|Overall Study|Did not meet protocol eligibility|0
787051|NCT00684203|2503453|P2|Overall Study|Did not meet protocol eligibility|1
787052|NCT00684203|2503454|P1|Overall Study|Did not meet protocol eligibility|0
787053|NCT00684203|2503449|P6|Overall Study|Withdrawal by Subject|0
787054|NCT00684203|2503450|P5|Overall Study|Withdrawal by Subject|0
787055|NCT00684203|2503451|P4|Overall Study|Withdrawal by Subject|0
787056|NCT00684203|2503452|P3|Overall Study|Withdrawal by Subject|1
787057|NCT00684203|2503453|P2|Overall Study|Withdrawal by Subject|2
787058|NCT00684203|2503454|P1|Overall Study|Withdrawal by Subject|0
787059|NCT00684203|2503449|P6|Overall Study|Protocol-defined clinical event|0
787060|NCT00684203|2503450|P5|Overall Study|Protocol-defined clinical event|0
787061|NCT00684203|2503451|P4|Overall Study|Protocol-defined clinical event|0
787062|NCT00684203|2503452|P3|Overall Study|Protocol-defined clinical event|0
787063|NCT00684203|2503453|P2|Overall Study|Protocol-defined clinical event|1
787064|NCT00684203|2503454|P1|Overall Study|Protocol-defined clinical event|3
787065|NCT00684203|2503449|P6|Overall Study|Adverse Event|0
787066|NCT00684203|2503450|P5|Overall Study|Adverse Event|0
787067|NCT00684203|2503451|P4|Overall Study|Adverse Event|0
787068|NCT00684203|2503452|P3|Overall Study|Adverse Event|8
787069|NCT00684203|2503453|P2|Overall Study|Adverse Event|4
787070|NCT00684203|2503454|P1|Overall Study|Adverse Event|6
787071|NCT00684307|2503527|P5|Overall Study|Criteria from the CSR|3
787072|NCT00684307|2503528|P4|Overall Study|Criteria from the CSR|3
787073|NCT00684307|2503529|P3|Overall Study|Criteria from the CSR|1
787074|NCT00684307|2503530|P2|Overall Study|Criteria from the CSR|0
787075|NCT00684307|2503531|P1|Overall Study|Criteria from the CSR|0
787076|NCT00684307|2503527|P5|Overall Study|Participant not willing to continue|8
787077|NCT00684307|2503528|P4|Overall Study|Participant not willing to continue|5
787078|NCT00684307|2503529|P3|Overall Study|Participant not willing to continue|11
787079|NCT00684307|2503530|P2|Overall Study|Participant not willing to continue|10
787080|NCT00684307|2503531|P1|Overall Study|Participant not willing to continue|7
787081|NCT00684307|2503527|P5|Overall Study|Severe non compliance to protocol|2
787082|NCT00684307|2503528|P4|Overall Study|Severe non compliance to protocol|1
787083|NCT00684307|2503529|P3|Overall Study|Severe non compliance to protocol|0
787084|NCT00684307|2503530|P2|Overall Study|Severe non compliance to protocol|0
787085|NCT00684307|2503531|P1|Overall Study|Severe non compliance to protocol|1
787086|NCT00684307|2503527|P5|Overall Study|Interupted IP for more than 7 days|3
787087|NCT00684307|2503528|P4|Overall Study|Interupted IP for more than 7 days|3
787088|NCT00684307|2503529|P3|Overall Study|Interupted IP for more than 7 days|1
787089|NCT00684307|2503530|P2|Overall Study|Interupted IP for more than 7 days|4
787090|NCT00684307|2503531|P1|Overall Study|Interupted IP for more than 7 days|0
787091|NCT00684307|2503527|P5|Overall Study|Incorrect enrolment or randomization|0
787092|NCT00684307|2503528|P4|Overall Study|Incorrect enrolment or randomization|0
787093|NCT00684307|2503529|P3|Overall Study|Incorrect enrolment or randomization|0
787094|NCT00684307|2503530|P2|Overall Study|Incorrect enrolment or randomization|0
787095|NCT00684307|2503531|P1|Overall Study|Incorrect enrolment or randomization|4
787096|NCT00684307|2503527|P5|Overall Study|Fullfillment of exclusion criteria|1
787097|NCT00684307|2503528|P4|Overall Study|Fullfillment of exclusion criteria|3
787098|NCT00684307|2503529|P3|Overall Study|Fullfillment of exclusion criteria|0
787099|NCT00684307|2503530|P2|Overall Study|Fullfillment of exclusion criteria|0
787100|NCT00684307|2503531|P1|Overall Study|Fullfillment of exclusion criteria|1
787101|NCT00684307|2503527|P5|Overall Study|Development of increasing Liver Function|0
787102|NCT00684307|2503528|P4|Overall Study|Development of increasing Liver Function|1
787103|NCT00684307|2503529|P3|Overall Study|Development of increasing Liver Function|0
787104|NCT00684307|2503530|P2|Overall Study|Development of increasing Liver Function|2
787105|NCT00684307|2503531|P1|Overall Study|Development of increasing Liver Function|0
787106|NCT00684307|2503527|P5|Overall Study|Adverse Event|8
787107|NCT00684307|2503528|P4|Overall Study|Adverse Event|16
787108|NCT00684307|2503529|P3|Overall Study|Adverse Event|15
787109|NCT00684307|2503530|P2|Overall Study|Adverse Event|6
787110|NCT00684307|2503531|P1|Overall Study|Adverse Event|11
787111|NCT00684411|2503609|P1|Overall Study|Adverse Event|1
787112|NCT00684411|2503609|P1|Overall Study|Disease Progression|10
787113|NCT00684411|2503609|P1|Overall Study|New Primary Cancer|1
787114|NCT00684424|2503615|P1|Overall Study|Not Specified|2
787115|NCT00684424|2503615|P1|Overall Study|Lost to Follow-up|2
787116|NCT00684424|2503615|P1|Overall Study|Adverse Event|1
787117|NCT00684515|2503633|P3|Overall Study|Protocol-Defined Clinical Event|0
787118|NCT00684515|2503634|P2|Overall Study|Protocol-Defined Clinical Event|0
787119|NCT00684515|2503635|P1|Overall Study|Protocol-Defined Clinical Event|1
787120|NCT00684515|2503633|P3|Overall Study|Adverse Event|1
787121|NCT00684515|2503634|P2|Overall Study|Adverse Event|3
787122|NCT00684515|2503635|P1|Overall Study|Adverse Event|3
787123|NCT00684567|2503680|P1|Monotherapy Period|Progression of primary disease|11
787124|NCT00684567|2503680|P1|Monotherapy Period|Death|1
787125|NCT00684567|2503680|P1|Monotherapy Period|Adverse Event|2
787126|NCT00684567|2503680|P1|Concomitant Radiotherapy Period|Adverse Event|2
787127|NCT00684593|2503690|P2|Overall Study|Adverse Event|2
787128|NCT00684593|2503691|P1|Overall Study|Adverse Event|0
787129|NCT00684645|2503703|P1|Overall Study|Not specified|15
787130|NCT00684645|2503703|P1|Overall Study|Lost to Follow-up|3
787131|NCT00684645|2503703|P1|Overall Study|Adverse Event|27
787132|NCT00684645|2503703|P1|Overall Study|Progressive disease|67
787133|NCT00684645|2503703|P1|Overall Study|Death|2
787134|NCT00684671|2503724|P3|Overall Study|Alcoholic dependance|0
787135|NCT00684671|2503725|P2|Overall Study|Alcoholic dependance|0
787136|NCT00684671|2503726|P1|Overall Study|Alcoholic dependance|1
787137|NCT00684671|2503724|P3|Overall Study|Lost to Follow-up|0
787138|NCT00684671|2503725|P2|Overall Study|Lost to Follow-up|0
787139|NCT00684671|2503726|P1|Overall Study|Lost to Follow-up|1
787140|NCT00684671|2503724|P3|Overall Study|Adverse Event|0
787141|NCT00684671|2503725|P2|Overall Study|Adverse Event|0
787142|NCT00684671|2503726|P1|Overall Study|Adverse Event|1
787143|NCT00684762|2503770|P2|Washout Period of 7 Days|Withdrawal by Subject|2
787144|NCT00684762|2503771|P1|Washout Period of 7 Days|Withdrawal by Subject|2
787145|NCT00684814|2503781|P2|Second Intervention|Adverse Event|0
787146|NCT00684814|2503782|P1|Second Intervention|Adverse Event|1
787147|NCT00684814|2503781|P2|Washout Period of 7 Days|Withdrawal by Subject|2
787148|NCT00684814|2503782|P1|Washout Period of 7 Days|Withdrawal by Subject|1
787149|NCT00684814|2503781|P2|Washout Period of 7 Days|Adverse Event|2
787150|NCT00684814|2503782|P1|Washout Period of 7 Days|Adverse Event|1
787151|NCT00690755|2503799|P7|Overall Study|Physician Decision|0
787152|NCT00690755|2503800|P6|Overall Study|Physician Decision|4
787153|NCT00690755|2503801|P5|Overall Study|Physician Decision|0
787154|NCT00690755|2503802|P4|Overall Study|Physician Decision|5
787155|NCT00690755|2503803|P3|Overall Study|Physician Decision|46
787156|NCT00690755|2503804|P2|Overall Study|Physician Decision|0
787157|NCT00690755|2503805|P1|Overall Study|Physician Decision|2
787158|NCT00690794|2503823|P2|Overall Study|Other not specified|3
787159|NCT00690794|2503824|P1|Overall Study|Other not specified|1
787160|NCT00690794|2503823|P2|Overall Study|Noncompliance|2
787161|NCT00690794|2503824|P1|Overall Study|Noncompliance|1
787162|NCT00690794|2503823|P2|Overall Study|Protocol Violation|7
787163|NCT00690794|2503824|P1|Overall Study|Protocol Violation|6
787164|NCT00690794|2503823|P2|Overall Study|Withdrawal by Subject|9
787165|NCT00690794|2503824|P1|Overall Study|Withdrawal by Subject|0
787166|NCT00690794|2503823|P2|Overall Study|Lost to Follow-up|4
787167|NCT00690794|2503824|P1|Overall Study|Lost to Follow-up|1
787168|NCT00690794|2503823|P2|Overall Study|Adverse Event|10
787169|NCT00690794|2503824|P1|Overall Study|Adverse Event|12
787170|NCT00690820|2503834|P2|Period 1|Withdrawal by Subject|1
787171|NCT00690820|2503835|P1|Period 1|Withdrawal by Subject|0
787172|NCT00690898|2503859|P1|TREATMENT|Other (not otherwise specified)|1
787173|NCT00690898|2503859|P1|TREATMENT|Withdrawal by Subject|4
787174|NCT00690898|2503859|P1|TREATMENT|Lack of Efficacy|18
787175|NCT00690898|2503859|P1|TREATMENT|Adverse Event|3
787176|NCT00690898|2503859|P1|SCREENING|Screen failure|18
787177|NCT00691015|2503873|P1|Overall Study|Refused further treatment|1
787178|NCT00691028|2503887|P4|Double-blind Period|not come to a hospital.|0
787179|NCT00691028|2503888|P3|Double-blind Period|not come to a hospital.|0
787180|NCT00691028|2503889|P2|Double-blind Period|not come to a hospital.|1
787181|NCT00691028|2503890|P1|Double-blind Period|not come to a hospital.|0
787182|NCT00691028|2503887|P4|Double-blind Period|Withdrawal by Subject|0
787183|NCT00691028|2503888|P3|Double-blind Period|Withdrawal by Subject|1
787184|NCT00691028|2503889|P2|Double-blind Period|Withdrawal by Subject|0
787185|NCT00691028|2503890|P1|Double-blind Period|Withdrawal by Subject|1
787186|NCT00691028|2503887|P4|Double-blind Period|Lack of Efficacy|0
787187|NCT00691028|2503888|P3|Double-blind Period|Lack of Efficacy|2
787188|NCT00691028|2503889|P2|Double-blind Period|Lack of Efficacy|3
787189|NCT00691028|2503890|P1|Double-blind Period|Lack of Efficacy|4
787190|NCT00691028|2503887|P4|Double-blind Period|Adverse Event|0
787191|NCT00691028|2503888|P3|Double-blind Period|Adverse Event|6
787192|NCT00691028|2503889|P2|Double-blind Period|Adverse Event|9
787193|NCT00691028|2503890|P1|Double-blind Period|Adverse Event|8
787194|NCT00691028|2503887|P4|Open-label Period|not come to a hospital|1
787195|NCT00691028|2503888|P3|Open-label Period|not come to a hospital|0
787196|NCT00691028|2503889|P2|Open-label Period|not come to a hospital|0
787197|NCT00691028|2503890|P1|Open-label Period|not come to a hospital|0
787198|NCT00691028|2503887|P4|Open-label Period|Withdrawal by Subject|3
787199|NCT00691028|2503888|P3|Open-label Period|Withdrawal by Subject|0
787200|NCT00691028|2503889|P2|Open-label Period|Withdrawal by Subject|0
787201|NCT00691028|2503890|P1|Open-label Period|Withdrawal by Subject|0
787202|NCT00691028|2503887|P4|Open-label Period|Adverse Event|16
787203|NCT00691028|2503888|P3|Open-label Period|Adverse Event|0
787204|NCT00691028|2503889|P2|Open-label Period|Adverse Event|0
787205|NCT00691028|2503890|P1|Open-label Period|Adverse Event|0
787206|NCT00691704|2503942|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
787207|NCT00691704|2503942|P1|Two Years of Maintenance Therapy|Physician Decision|4
787208|NCT00691704|2503942|P1|Two Years of Maintenance Therapy|Disease Progression|8
787209|NCT00691704|2503942|P1|Induction Therapy|Active Hepatitis|1
787210|NCT00691704|2503942|P1|Induction Therapy|Disease Progression|1
787211|NCT00691938|2504003|P7|Overall Study|QTc prolongation|0
787212|NCT00691938|2504004|P6|Overall Study|QTc prolongation|0
787213|NCT00691938|2504005|P5|Overall Study|QTc prolongation|0
787214|NCT00691938|2504006|P4|Overall Study|QTc prolongation|0
787215|NCT00691938|2504007|P3|Overall Study|QTc prolongation|0
787216|NCT00691938|2504008|P2|Overall Study|QTc prolongation|0
787217|NCT00691938|2504009|P1|Overall Study|QTc prolongation|1
787218|NCT00692003|2504032|P2|Overall Study|Sponsor Decision|1
787219|NCT00692003|2504033|P1|Overall Study|Sponsor Decision|5
787220|NCT00692237|2504097|P2|Overall Study|Adverse Event|1
787221|NCT00692237|2504098|P1|Overall Study|Adverse Event|0
787222|NCT00692237|2504097|P2|Overall Study|Withdrawal by Subject|3
787223|NCT00692237|2504098|P1|Overall Study|Withdrawal by Subject|1
787224|NCT00692406|2504155|P1|Overall Study|PI dropped, bad data|57
892116|NCT00374556|2828933|P2|Overall Study|excluded at baseline due to medical cond|1
892117|NCT00374556|2828934|P1|Overall Study|excluded at baseline due to medical cond|0
892118|NCT00374556|2828933|P2|Overall Study|Lost to Follow-up|0
892119|NCT00374556|2828934|P1|Overall Study|Lost to Follow-up|1
787255|NCT00692913|2504209|P2|Overall Study|Withdrawal by Subject|20
787256|NCT00692913|2504210|P1|Overall Study|Withdrawal by Subject|15
787257|NCT00692913|2504209|P2|Overall Study|Protocol Violation|1
787258|NCT00692913|2504210|P1|Overall Study|Protocol Violation|1
787259|NCT00692913|2504209|P2|Overall Study|Physician Decision|0
787260|NCT00692913|2504210|P1|Overall Study|Physician Decision|2
787261|NCT00692913|2504209|P2|Overall Study|Lost to Follow-up|5
787262|NCT00692913|2504210|P1|Overall Study|Lost to Follow-up|3
787263|NCT00692913|2504209|P2|Overall Study|Adverse Event|4
787264|NCT00692913|2504210|P1|Overall Study|Adverse Event|8
787265|NCT00693017|2504232|P2|Overall Study|Death|1
787266|NCT00693017|2504233|P1|Overall Study|Death|0
787267|NCT00693017|2504232|P2|Overall Study|Sponsor Decision|1
787268|NCT00693017|2504233|P1|Overall Study|Sponsor Decision|2
787269|NCT00693225|2504254|P2|Overall Study|Adverse Event|3
787270|NCT00693225|2504255|P1|Overall Study|Adverse Event|1
787271|NCT00693225|2504254|P2|Overall Study|Lost to Follow-up|2
787272|NCT00693225|2504255|P1|Overall Study|Lost to Follow-up|1
787273|NCT00693420|2504280|P2|Overall Study|Personal Reasons|4
787274|NCT00693420|2504281|P1|Overall Study|Personal Reasons|1
787275|NCT00693420|2504280|P2|Overall Study|Sponsor Request - Conflict of Interest|2
787276|NCT00693420|2504281|P1|Overall Study|Sponsor Request - Conflict of Interest|0
787277|NCT00693420|2504280|P2|Overall Study|Protocol Violation|2
787278|NCT00693420|2504281|P1|Overall Study|Protocol Violation|0
787279|NCT00693420|2504280|P2|Overall Study|Withdrawal by Subject|0
787280|NCT00693420|2504281|P1|Overall Study|Withdrawal by Subject|1
787281|NCT00693420|2504280|P2|Overall Study|Lost to Follow-up|3
787282|NCT00693420|2504281|P1|Overall Study|Lost to Follow-up|0
787283|NCT00693420|2504280|P2|Overall Study|Adverse Event|4
787284|NCT00693420|2504281|P1|Overall Study|Adverse Event|4
787285|NCT00693472|2504309|P4|Part 2|Withdrew - reason unrelated to treatment|2
787286|NCT00693472|2504310|P3|Part 2|Withdrew - reason unrelated to treatment|1
787287|NCT00693472|2504311|P2|Part 2|Withdrew - reason unrelated to treatment|0
787288|NCT00693472|2504312|P1|Part 2|Withdrew - reason unrelated to treatment|0
787289|NCT00693472|2504309|P4|Part 2|Adverse Event|0
787290|NCT00693472|2504310|P3|Part 2|Adverse Event|1
787291|NCT00693472|2504311|P2|Part 2|Adverse Event|0
787292|NCT00693472|2504312|P1|Part 2|Adverse Event|0
787293|NCT00693472|2504309|P4|Part 1|Withdrew - reason unrelated to treatment|0
787294|NCT00693472|2504310|P3|Part 1|Withdrew - reason unrelated to treatment|0
787295|NCT00693472|2504311|P2|Part 1|Withdrew - reason unrelated to treatment|2
787296|NCT00693472|2504312|P1|Part 1|Withdrew - reason unrelated to treatment|5
787297|NCT00693472|2504309|P4|Part 1|Lost to Follow-up|0
787298|NCT00693472|2504310|P3|Part 1|Lost to Follow-up|0
787299|NCT00693472|2504311|P2|Part 1|Lost to Follow-up|1
787300|NCT00693472|2504312|P1|Part 1|Lost to Follow-up|0
787301|NCT00693472|2504309|P4|Part 1|Adverse Event|0
787302|NCT00693472|2504310|P3|Part 1|Adverse Event|0
787303|NCT00693472|2504311|P2|Part 1|Adverse Event|1
787304|NCT00693472|2504312|P1|Part 1|Adverse Event|1
787308|NCT00693706|2504390|P2|Overall Study|Protocol Violation|1
787309|NCT00693706|2504391|P1|Overall Study|Protocol Violation|0
787310|NCT00693784|2504420|P1|Overall Study|Withdrawal by Subject|2
787311|NCT00693784|2504420|P1|Overall Study|Lost to Follow-up|2
787312|NCT00687973|2504488|P2|Overall Study|Withdrawal by Subject|3
787313|NCT00687973|2504489|P1|Overall Study|Withdrawal by Subject|3
787314|NCT00687973|2504488|P2|Overall Study|Administrative Reasons|2
787315|NCT00687973|2504489|P1|Overall Study|Administrative Reasons|0
787316|NCT00687973|2504488|P2|Overall Study|Protocol Violation|2
787317|NCT00687973|2504489|P1|Overall Study|Protocol Violation|1
787318|NCT00687973|2504488|P2|Overall Study|Lack of Efficacy|3
787319|NCT00687973|2504489|P1|Overall Study|Lack of Efficacy|2
787320|NCT00687973|2504488|P2|Overall Study|Adverse Event|28
787321|NCT00687973|2504489|P1|Overall Study|Adverse Event|18
787322|NCT00688064|2504518|P2|Overall Study|Any other reasons|3
787323|NCT00688064|2504519|P1|Overall Study|Any other reasons|1
787324|NCT00688064|2504518|P2|Overall Study|Pregnancy|0
787325|NCT00688064|2504519|P1|Overall Study|Pregnancy|1
787326|NCT00688064|2504518|P2|Overall Study|Lack of Efficacy|1
787327|NCT00688064|2504519|P1|Overall Study|Lack of Efficacy|0
787328|NCT00688064|2504518|P2|Overall Study|Lost to Follow-up|10
787329|NCT00688064|2504519|P1|Overall Study|Lost to Follow-up|10
787330|NCT00688064|2504518|P2|Overall Study|Withdrawal by Subject|7
787331|NCT00688064|2504519|P1|Overall Study|Withdrawal by Subject|7
787332|NCT00688064|2504518|P2|Overall Study|Adverse Event|4
787333|NCT00688064|2504519|P1|Overall Study|Adverse Event|2
787334|NCT00688064|2504518|P2|Overall Study|Protocol Violation|1
787335|NCT00688064|2504519|P1|Overall Study|Protocol Violation|0
787336|NCT00688103|2504535|P2|Overall Study|complex reasons|9
787337|NCT00688103|2504536|P1|Overall Study|complex reasons|11
787338|NCT00688103|2504535|P2|Overall Study|Withdrawal by Subject|2
787339|NCT00688103|2504536|P1|Overall Study|Withdrawal by Subject|4
787340|NCT00688103|2504535|P2|Overall Study|Lack of Efficacy|1
787341|NCT00688103|2504536|P1|Overall Study|Lack of Efficacy|11
787342|NCT00688103|2504535|P2|Overall Study|Adverse Event|1
787343|NCT00688103|2504536|P1|Overall Study|Adverse Event|4
787344|NCT00694096|2504552|P1|Overall Study|Withdrawal by Subject|5
787345|NCT00694109|2504558|P1|Overall Study|Consented but no additional treatment|3
787346|NCT00694109|2504558|P1|Overall Study|Unspecified|2
787347|NCT00694109|2504558|P1|Overall Study|Enrolled but not treated|1
787348|NCT00694109|2504558|P1|Overall Study|Pregnancy|1
787349|NCT00694109|2504558|P1|Overall Study|Withdrawal by Subject|13
787350|NCT00694109|2504558|P1|Overall Study|Lack of Efficacy|2
787351|NCT00694109|2504558|P1|Overall Study|Not consent of more 2 years of treatment|18
787352|NCT00694109|2504558|P1|Overall Study|Adverse Event|74
787353|NCT00694109|2504558|P1|Overall Study|Physician Decision|3
787354|NCT00694122|2504582|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
787355|NCT00694122|2504583|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
787356|NCT00694122|2504582|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
787357|NCT00694122|2504583|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
787358|NCT00694122|2504582|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
787359|NCT00694122|2504583|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
787360|NCT00694161|2504599|P1|Part 2 (After Week 6 up to Month 12)|Death|1
787361|NCT00694161|2504599|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
787362|NCT00694161|2504599|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
787363|NCT00694304|2504638|P1|Overall Study|Administrative or Other Reasons|32
787364|NCT00694304|2504638|P1|Overall Study|Lost to Follow-up|15
787365|NCT00694304|2504638|P1|Overall Study|Withdrawal of Consent|61
787366|NCT00694304|2504638|P1|Overall Study|Protocol Violation|6
787367|NCT00694304|2504638|P1|Overall Study|Non-compliance With Study Product|16
787368|NCT00694304|2504638|P1|Overall Study|Lack of Efficacy|35
787369|NCT00694304|2504638|P1|Overall Study|Adverse Event|42
787370|NCT00694356|2504654|P3|Overall Study|Progressive Disease|6
787371|NCT00694356|2504655|P2|Overall Study|Progressive Disease|6
787372|NCT00694356|2504656|P1|Overall Study|Progressive Disease|2
787373|NCT00694356|2504654|P3|Overall Study|Adverse Event|0
787374|NCT00694356|2504655|P2|Overall Study|Adverse Event|0
787375|NCT00694356|2504656|P1|Overall Study|Adverse Event|1
787376|NCT00694369|2504696|P5|Overall Study|Withdrawal by Subject|2
787377|NCT00694369|2504697|P4|Overall Study|Withdrawal by Subject|1
787378|NCT00694369|2504698|P3|Overall Study|Withdrawal by Subject|1
787379|NCT00694369|2504699|P2|Overall Study|Withdrawal by Subject|1
787380|NCT00694369|2504700|P1|Overall Study|Withdrawal by Subject|1
787381|NCT00694369|2504696|P5|Overall Study|Protocol Violation|0
787382|NCT00694369|2504697|P4|Overall Study|Protocol Violation|0
787383|NCT00694369|2504698|P3|Overall Study|Protocol Violation|0
787384|NCT00694369|2504699|P2|Overall Study|Protocol Violation|1
787385|NCT00694369|2504700|P1|Overall Study|Protocol Violation|0
787386|NCT00694369|2504696|P5|Overall Study|Physician Decision|1
787387|NCT00694369|2504697|P4|Overall Study|Physician Decision|0
787388|NCT00694369|2504698|P3|Overall Study|Physician Decision|0
787389|NCT00694369|2504699|P2|Overall Study|Physician Decision|0
787390|NCT00694369|2504700|P1|Overall Study|Physician Decision|0
787391|NCT00694369|2504696|P5|Overall Study|Lost to Follow-up|0
787392|NCT00694369|2504697|P4|Overall Study|Lost to Follow-up|1
787393|NCT00694369|2504698|P3|Overall Study|Lost to Follow-up|1
787394|NCT00694369|2504699|P2|Overall Study|Lost to Follow-up|0
787395|NCT00694369|2504700|P1|Overall Study|Lost to Follow-up|0
787396|NCT00694369|2504696|P5|Overall Study|Adverse Event|3
787397|NCT00694369|2504697|P4|Overall Study|Adverse Event|1
787398|NCT00694369|2504698|P3|Overall Study|Adverse Event|0
787399|NCT00694369|2504699|P2|Overall Study|Adverse Event|1
787400|NCT00694369|2504700|P1|Overall Study|Adverse Event|0
787401|NCT00695864|2504717|P1|Placebo|Physician Decision|4
787402|NCT00695864|2504717|P1|Placebo|Withdrawal by Subject|1
787403|NCT00695903|2504725|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
787404|NCT00695903|2504726|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
787405|NCT00695903|2504725|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
787406|NCT00695903|2504726|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
787407|NCT00695903|2504725|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
787408|NCT00695903|2504726|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
787409|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
787410|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
787411|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
787412|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
787413|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
787414|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
787415|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
787416|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
787417|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
787418|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
787419|NCT00695903|2504725|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
787420|NCT00695903|2504726|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
787421|NCT00695955|2504738|P1|Cohort 2|Other|5
787422|NCT00695955|2504738|P1|Cohort 2|Lack of Efficacy|4
787423|NCT00695955|2504738|P1|Cohort 2|Withdrawal by Subject|28
787424|NCT00695955|2504738|P1|Cohort 2|Lost to Follow-up|38
787425|NCT00695955|2504738|P1|Cohort 2|Protocol Violation|5
787426|NCT00695955|2504738|P1|Cohort 2|Adverse Event|24
787427|NCT00695955|2504738|P1|Cohort 1|Other|16
787428|NCT00695955|2504738|P1|Cohort 1|Lack of Efficacy|3
787429|NCT00695955|2504738|P1|Cohort 1|Withdrawal by Subject|25
787430|NCT00695955|2504738|P1|Cohort 1|Lost to Follow-up|30
787431|NCT00695955|2504738|P1|Cohort 1|Protocol Violation|2
787432|NCT00695955|2504738|P1|Cohort 1|Adverse Event|26
787433|NCT00696020|2504752|P4|Overall Study|Other not stated above|1
787434|NCT00696020|2504753|P3|Overall Study|Other not stated above|1
787435|NCT00696020|2504754|P2|Overall Study|Other not stated above|0
787436|NCT00696020|2504755|P1|Overall Study|Other not stated above|0
787437|NCT00696020|2504752|P4|Overall Study|Withdrawal by Subject|1
787438|NCT00696020|2504753|P3|Overall Study|Withdrawal by Subject|0
787439|NCT00696020|2504754|P2|Overall Study|Withdrawal by Subject|1
787440|NCT00696020|2504755|P1|Overall Study|Withdrawal by Subject|0
787441|NCT00696020|2504752|P4|Overall Study|Protocol Violation|1
787442|NCT00696020|2504753|P3|Overall Study|Protocol Violation|0
787443|NCT00696020|2504754|P2|Overall Study|Protocol Violation|0
787444|NCT00696020|2504755|P1|Overall Study|Protocol Violation|0
787445|NCT00696020|2504752|P4|Overall Study|Lack of Efficacy|0
787446|NCT00696020|2504753|P3|Overall Study|Lack of Efficacy|0
787447|NCT00696020|2504754|P2|Overall Study|Lack of Efficacy|0
787448|NCT00696020|2504755|P1|Overall Study|Lack of Efficacy|1
787449|NCT00696020|2504752|P4|Overall Study|Adverse Event|1
787450|NCT00696020|2504753|P3|Overall Study|Adverse Event|2
787451|NCT00696020|2504754|P2|Overall Study|Adverse Event|1
787452|NCT00696020|2504755|P1|Overall Study|Adverse Event|3
787453|NCT00696072|2504865|P2|Overall Study|Non-specified|2
787454|NCT00696072|2504866|P1|Overall Study|Non-specified|1
787455|NCT00696072|2504865|P2|Overall Study|Disease Progression|30
787456|NCT00696072|2504866|P1|Overall Study|Disease Progression|32
787457|NCT00696072|2504865|P2|Overall Study|Sponsor Request|1
787458|NCT00696072|2504866|P1|Overall Study|Sponsor Request|0
787459|NCT00696072|2504865|P2|Overall Study|Investigator Request|4
787460|NCT00696072|2504866|P1|Overall Study|Investigator Request|1
787461|NCT00696072|2504865|P2|Overall Study|Patient Request|7
787462|NCT00696072|2504866|P1|Overall Study|Patient Request|3
787463|NCT00696072|2504865|P2|Overall Study|Adverse Event|6
787464|NCT00696072|2504866|P1|Overall Study|Adverse Event|10
787465|NCT00696072|2504865|P2|Overall Study|continuing active treatment|13
787466|NCT00696072|2504866|P1|Overall Study|continuing active treatment|10
787467|NCT00696241|2504888|P5|Overall Study|Other|1
787468|NCT00696241|2504889|P4|Overall Study|Other|2
787469|NCT00696241|2504890|P3|Overall Study|Other|5
787470|NCT00696241|2504891|P2|Overall Study|Other|1
787471|NCT00696241|2504892|P1|Overall Study|Other|6
787472|NCT00696241|2504888|P5|Overall Study|Lack of Efficacy|3
787473|NCT00696241|2504889|P4|Overall Study|Lack of Efficacy|5
787474|NCT00696241|2504890|P3|Overall Study|Lack of Efficacy|4
787475|NCT00696241|2504891|P2|Overall Study|Lack of Efficacy|5
787476|NCT00696241|2504892|P1|Overall Study|Lack of Efficacy|1
787477|NCT00696241|2504888|P5|Overall Study|Withdrawal by Subject|0
787478|NCT00696241|2504889|P4|Overall Study|Withdrawal by Subject|1
787479|NCT00696241|2504890|P3|Overall Study|Withdrawal by Subject|6
787480|NCT00696241|2504891|P2|Overall Study|Withdrawal by Subject|8
787481|NCT00696241|2504892|P1|Overall Study|Withdrawal by Subject|4
787482|NCT00696241|2504888|P5|Overall Study|Lost to Follow-up|0
787483|NCT00696241|2504889|P4|Overall Study|Lost to Follow-up|2
787484|NCT00696241|2504890|P3|Overall Study|Lost to Follow-up|1
787485|NCT00696241|2504891|P2|Overall Study|Lost to Follow-up|4
787486|NCT00696241|2504892|P1|Overall Study|Lost to Follow-up|1
787487|NCT00696241|2504888|P5|Overall Study|Protocol Violation|3
787488|NCT00696241|2504889|P4|Overall Study|Protocol Violation|0
787489|NCT00696241|2504890|P3|Overall Study|Protocol Violation|2
787490|NCT00696241|2504891|P2|Overall Study|Protocol Violation|1
787491|NCT00696241|2504892|P1|Overall Study|Protocol Violation|1
787492|NCT00696241|2504888|P5|Overall Study|Adverse Event|5
787493|NCT00696241|2504889|P4|Overall Study|Adverse Event|4
787494|NCT00696241|2504890|P3|Overall Study|Adverse Event|6
787495|NCT00696241|2504891|P2|Overall Study|Adverse Event|3
787496|NCT00696241|2504892|P1|Overall Study|Adverse Event|11
787497|NCT00696384|2504979|P3|Double Blind Phase|Physician Decision|0
787498|NCT00696384|2504980|P2|Double Blind Phase|Physician Decision|2
787499|NCT00696384|2504981|P1|Double Blind Phase|Physician Decision|0
787500|NCT00696384|2504979|P3|Double Blind Phase|Lack of Efficacy|0
787501|NCT00696384|2504980|P2|Double Blind Phase|Lack of Efficacy|1
787502|NCT00696384|2504981|P1|Double Blind Phase|Lack of Efficacy|0
787503|NCT00696384|2504979|P3|Double Blind Phase|Withdrawal by Subject|3
787504|NCT00696384|2504980|P2|Double Blind Phase|Withdrawal by Subject|4
787505|NCT00696384|2504981|P1|Double Blind Phase|Withdrawal by Subject|0
787506|NCT00696384|2504979|P3|Double Blind Phase|Lost to Follow-up|1
787507|NCT00696384|2504980|P2|Double Blind Phase|Lost to Follow-up|2
787508|NCT00696384|2504981|P1|Double Blind Phase|Lost to Follow-up|0
787509|NCT00696384|2504979|P3|Double Blind Phase|Adverse Event|2
787510|NCT00696384|2504980|P2|Double Blind Phase|Adverse Event|2
787511|NCT00696384|2504981|P1|Double Blind Phase|Adverse Event|0
787512|NCT00696384|2504979|P3|Open Label Phase|Physician Decision|0
787513|NCT00696384|2504980|P2|Open Label Phase|Physician Decision|0
787514|NCT00696384|2504981|P1|Open Label Phase|Physician Decision|4
787515|NCT00696384|2504979|P3|Open Label Phase|Lack of Efficacy|0
787516|NCT00696384|2504980|P2|Open Label Phase|Lack of Efficacy|0
787517|NCT00696384|2504981|P1|Open Label Phase|Lack of Efficacy|3
787518|NCT00696384|2504979|P3|Open Label Phase|Other|0
787519|NCT00696384|2504980|P2|Open Label Phase|Other|0
787520|NCT00696384|2504981|P1|Open Label Phase|Other|6
787521|NCT00696384|2504979|P3|Open Label Phase|Withdrawal by Subject|0
787522|NCT00696384|2504980|P2|Open Label Phase|Withdrawal by Subject|0
787523|NCT00696384|2504981|P1|Open Label Phase|Withdrawal by Subject|37
787524|NCT00696384|2504979|P3|Open Label Phase|Lost to Follow-up|0
787525|NCT00696384|2504980|P2|Open Label Phase|Lost to Follow-up|0
787526|NCT00696384|2504981|P1|Open Label Phase|Lost to Follow-up|24
787527|NCT00696384|2504979|P3|Open Label Phase|Protocol Violation|0
787528|NCT00696384|2504980|P2|Open Label Phase|Protocol Violation|0
787529|NCT00696384|2504981|P1|Open Label Phase|Protocol Violation|18
787530|NCT00696384|2504979|P3|Open Label Phase|Adverse Event|0
787531|NCT00696384|2504980|P2|Open Label Phase|Adverse Event|0
787532|NCT00696384|2504981|P1|Open Label Phase|Adverse Event|27
892120|NCT02760654|2828999|P2|Overall Study|Withdrawal by Subject|3
892121|NCT02760654|2829000|P1|Overall Study|Withdrawal by Subject|4
892122|NCT02760654|2828999|P2|Overall Study|Lost to Follow-up|3
892123|NCT02760654|2829000|P1|Overall Study|Lost to Follow-up|3
892124|NCT02667275|2829037|P2|Overall Study|Discontinued early without completing|1
892125|NCT02667275|2829038|P1|Overall Study|Discontinued early without completing|0
787539|NCT00696423|2505014|P2|Overall Study|Lost to Follow-up|5
787540|NCT00696423|2505015|P1|Overall Study|Lost to Follow-up|0
787541|NCT00696436|2505050|P5|Overall Study|Missing|0
787542|NCT00696436|2505051|P4|Overall Study|Missing|0
787543|NCT00696436|2505052|P3|Overall Study|Missing|1
787544|NCT00696436|2505053|P2|Overall Study|Missing|1
787545|NCT00696436|2505054|P1|Overall Study|Missing|0
787546|NCT00696436|2505050|P5|Overall Study|Administrative Decision|0
787547|NCT00696436|2505051|P4|Overall Study|Administrative Decision|0
787548|NCT00696436|2505052|P3|Overall Study|Administrative Decision|0
787549|NCT00696436|2505053|P2|Overall Study|Administrative Decision|0
787550|NCT00696436|2505054|P1|Overall Study|Administrative Decision|1
787551|NCT00696436|2505050|P5|Overall Study|Participant Non-compliance|0
787552|NCT00696436|2505051|P4|Overall Study|Participant Non-compliance|2
787553|NCT00696436|2505052|P3|Overall Study|Participant Non-compliance|1
787554|NCT00696436|2505053|P2|Overall Study|Participant Non-compliance|0
787555|NCT00696436|2505054|P1|Overall Study|Participant Non-compliance|0
787556|NCT00696436|2505050|P5|Overall Study|Administrative Error|0
787557|NCT00696436|2505051|P4|Overall Study|Administrative Error|0
787558|NCT00696436|2505052|P3|Overall Study|Administrative Error|2
787559|NCT00696436|2505053|P2|Overall Study|Administrative Error|0
787560|NCT00696436|2505054|P1|Overall Study|Administrative Error|2
787561|NCT00696436|2505050|P5|Overall Study|Participant Unavailability|0
787562|NCT00696436|2505051|P4|Overall Study|Participant Unavailability|1
787563|NCT00696436|2505052|P3|Overall Study|Participant Unavailability|2
787564|NCT00696436|2505053|P2|Overall Study|Participant Unavailability|0
787565|NCT00696436|2505054|P1|Overall Study|Participant Unavailability|2
787566|NCT00696436|2505050|P5|Overall Study|Lack of Efficacy|4
787567|NCT00696436|2505051|P4|Overall Study|Lack of Efficacy|2
787568|NCT00696436|2505052|P3|Overall Study|Lack of Efficacy|5
787569|NCT00696436|2505053|P2|Overall Study|Lack of Efficacy|1
787570|NCT00696436|2505054|P1|Overall Study|Lack of Efficacy|3
787571|NCT00696436|2505050|P5|Overall Study|Withdrawal by Subject|1
787572|NCT00696436|2505051|P4|Overall Study|Withdrawal by Subject|7
787573|NCT00696436|2505052|P3|Overall Study|Withdrawal by Subject|5
787574|NCT00696436|2505053|P2|Overall Study|Withdrawal by Subject|11
787575|NCT00696436|2505054|P1|Overall Study|Withdrawal by Subject|4
787576|NCT00696436|2505050|P5|Overall Study|Lost to Follow-up|3
787577|NCT00696436|2505051|P4|Overall Study|Lost to Follow-up|4
787578|NCT00696436|2505052|P3|Overall Study|Lost to Follow-up|2
787579|NCT00696436|2505053|P2|Overall Study|Lost to Follow-up|6
787580|NCT00696436|2505054|P1|Overall Study|Lost to Follow-up|1
787581|NCT00696436|2505050|P5|Overall Study|Protocol Violation|1
787582|NCT00696436|2505051|P4|Overall Study|Protocol Violation|0
787583|NCT00696436|2505052|P3|Overall Study|Protocol Violation|2
787584|NCT00696436|2505053|P2|Overall Study|Protocol Violation|2
787585|NCT00696436|2505054|P1|Overall Study|Protocol Violation|3
787586|NCT00696436|2505050|P5|Overall Study|Adverse Event|4
787587|NCT00696436|2505051|P4|Overall Study|Adverse Event|6
787588|NCT00696436|2505052|P3|Overall Study|Adverse Event|8
787589|NCT00696436|2505053|P2|Overall Study|Adverse Event|9
787590|NCT00696436|2505054|P1|Overall Study|Adverse Event|7
787591|NCT00696696|2505176|P1|Overall Study|Death|3
787592|NCT00696696|2505176|P1|Overall Study|Physician Decision|2
787593|NCT00696696|2505176|P1|Overall Study|Withdrawal by Subject|8
787594|NCT00696696|2505176|P1|Overall Study|Adverse Event|5
787595|NCT00696774|2505206|P3|Period III|Lack of Efficacy|0
787596|NCT00696774|2505207|P2|Period III|Lack of Efficacy|2
787597|NCT00696774|2505208|P1|Period III|Lack of Efficacy|0
787598|NCT00696774|2505206|P3|Period III|Sponsor Decision|0
787599|NCT00696774|2505207|P2|Period III|Sponsor Decision|0
787600|NCT00696774|2505208|P1|Period III|Sponsor Decision|2
787601|NCT00696774|2505206|P3|Period III|Withdrawal by Subject|0
787602|NCT00696774|2505207|P2|Period III|Withdrawal by Subject|2
787603|NCT00696774|2505208|P1|Period III|Withdrawal by Subject|1
787604|NCT00696774|2505206|P3|Period III|Protocol Violation|0
787605|NCT00696774|2505207|P2|Period III|Protocol Violation|1
787606|NCT00696774|2505208|P1|Period III|Protocol Violation|1
787607|NCT00696774|2505206|P3|Period III|Lost to Follow-up|0
787608|NCT00696774|2505207|P2|Period III|Lost to Follow-up|1
787609|NCT00696774|2505208|P1|Period III|Lost to Follow-up|2
787610|NCT00696774|2505206|P3|Period III|Adverse Event|0
787611|NCT00696774|2505207|P2|Period III|Adverse Event|1
787612|NCT00696774|2505208|P1|Period III|Adverse Event|1
787613|NCT00696774|2505206|P3|Period II|Lack of Efficacy|2
787614|NCT00696774|2505207|P2|Period II|Lack of Efficacy|0
787615|NCT00696774|2505208|P1|Period II|Lack of Efficacy|0
787616|NCT00696774|2505206|P3|Period II|Sponsor Decision|0
787617|NCT00696774|2505207|P2|Period II|Sponsor Decision|0
787618|NCT00696774|2505208|P1|Period II|Sponsor Decision|0
787619|NCT00696774|2505206|P3|Period II|Withdrawal by Subject|4
787620|NCT00696774|2505207|P2|Period II|Withdrawal by Subject|0
787621|NCT00696774|2505208|P1|Period II|Withdrawal by Subject|0
787622|NCT00696774|2505206|P3|Period II|Protocol Violation|11
787623|NCT00696774|2505207|P2|Period II|Protocol Violation|0
787624|NCT00696774|2505208|P1|Period II|Protocol Violation|0
787625|NCT00696774|2505206|P3|Period II|Lost to Follow-up|4
787626|NCT00696774|2505207|P2|Period II|Lost to Follow-up|0
787627|NCT00696774|2505208|P1|Period II|Lost to Follow-up|0
787628|NCT00696774|2505206|P3|Period II|Adverse Event|15
787629|NCT00696774|2505207|P2|Period II|Adverse Event|0
787630|NCT00696774|2505208|P1|Period II|Adverse Event|0
787631|NCT00696787|2505245|P3|Overall Study|Failed to return|1
787632|NCT00696787|2505246|P2|Overall Study|Failed to return|3
787633|NCT00696787|2505247|P1|Overall Study|Failed to return|1
787634|NCT00696787|2505245|P3|Overall Study|Withdrawal by Subject|2
787635|NCT00696787|2505246|P2|Overall Study|Withdrawal by Subject|3
787636|NCT00696787|2505247|P1|Overall Study|Withdrawal by Subject|0
787637|NCT00696787|2505245|P3|Overall Study|Lost to Follow-up|3
787638|NCT00696787|2505246|P2|Overall Study|Lost to Follow-up|0
787639|NCT00696787|2505247|P1|Overall Study|Lost to Follow-up|4
787640|NCT00696787|2505245|P3|Overall Study|Lack of Efficacy|0
787641|NCT00696787|2505246|P2|Overall Study|Lack of Efficacy|1
787642|NCT00696787|2505247|P1|Overall Study|Lack of Efficacy|0
787643|NCT00696787|2505245|P3|Overall Study|Discontinuation by Sponsor|14
787644|NCT00696787|2505246|P2|Overall Study|Discontinuation by Sponsor|13
787645|NCT00696787|2505247|P1|Overall Study|Discontinuation by Sponsor|9
787646|NCT00696787|2505245|P3|Overall Study|Adverse Event|6
787647|NCT00696787|2505246|P2|Overall Study|Adverse Event|0
787648|NCT00696787|2505247|P1|Overall Study|Adverse Event|1
787649|NCT00696800|2505260|P2|Overall Study|Not treated|2
787650|NCT00696800|2505261|P1|Overall Study|Not treated|1
787651|NCT00696800|2505260|P2|Overall Study|Other Reasons|3
787652|NCT00696800|2505261|P1|Overall Study|Other Reasons|5
787653|NCT00696800|2505260|P2|Overall Study|No/too few/bad quality embryos|18
787654|NCT00696800|2505261|P1|Overall Study|No/too few/bad quality embryos|24
787655|NCT00696800|2505260|P2|Overall Study|No/abnormal fertilization|13
787656|NCT00696800|2505261|P1|Overall Study|No/abnormal fertilization|11
787657|NCT00696800|2505260|P2|Overall Study|No/too few/bad quality oocytes|3
787658|NCT00696800|2505261|P1|Overall Study|No/too few/bad quality oocytes|4
787659|NCT00696800|2505260|P2|Overall Study|Too high ovarian response|1
787660|NCT00696800|2505261|P1|Overall Study|Too high ovarian response|6
787661|NCT00696800|2505260|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
787662|NCT00696800|2505261|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
787663|NCT00696800|2505260|P2|Overall Study|Insufficient ovarian response|1
787664|NCT00696800|2505261|P1|Overall Study|Insufficient ovarian response|4
787665|NCT00696800|2505260|P2|Overall Study|Insufficient ovarian response on Day 8|1
787666|NCT00696800|2505261|P1|Overall Study|Insufficient ovarian response on Day 8|4
787667|NCT00696800|2505260|P2|Overall Study|Insufficient compliance with medication|1
787668|NCT00696800|2505261|P1|Overall Study|Insufficient compliance with medication|2
787669|NCT00696800|2505260|P2|Overall Study|Adverse Event|3
787670|NCT00696800|2505261|P1|Overall Study|Adverse Event|16
787671|NCT00696878|2505311|P1|Overall Study|Other reason (not specified)|55
787672|NCT00696878|2505311|P1|Overall Study|Trial stopped|32
787673|NCT00696878|2505311|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
787674|NCT00696878|2505311|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
787675|NCT00696878|2505311|P1|Overall Study|Withdrawal by Subject|87
787676|NCT00696878|2505311|P1|Overall Study|Adverse Event|8
787677|NCT00697073|2505383|P1|Overall Study|non compliance and other|6
787678|NCT00697073|2505383|P1|Overall Study|Pregnancy|1
787679|NCT00697073|2505383|P1|Overall Study|Withdrawal by Subject|2
787680|NCT00697112|2505387|P1|Overall Study|Did not meet inclusion criteria|1
787681|NCT00697112|2505387|P1|Overall Study|Lost to Follow-up|1
787682|NCT00697112|2505387|P1|Overall Study|Adverse Event|8
787683|NCT00697255|2505448|P2|Stage 1b|Insufficient ovarian response|1
787684|NCT00697255|2505449|P1|Stage 1b|Insufficient ovarian response|0
787685|NCT00697255|2505448|P2|Stage 1b|Not growing of dominant follicle|1
787686|NCT00697255|2505449|P1|Stage 1b|Not growing of dominant follicle|0
787687|NCT00697255|2505448|P2|Stage 1a|Not growing of dominant follicle|0
787688|NCT00697255|2505449|P1|Stage 1a|Not growing of dominant follicle|1
787689|NCT00697255|2505448|P2|Stage 1a|Multifollicular growth|0
787690|NCT00697255|2505449|P1|Stage 1a|Multifollicular growth|1
787691|NCT00697255|2505448|P2|Stage 1a|Insufficient ovarian response|0
787692|NCT00697255|2505449|P1|Stage 1a|Insufficient ovarian response|1
787693|NCT00697515|2505465|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
787694|NCT00697515|2505466|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
787695|NCT00697515|2505465|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
787696|NCT00697515|2505466|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
787697|NCT00697515|2505465|P2|First Intervention (Crossover Period)|Adverse Event|2
787698|NCT00697515|2505466|P1|First Intervention (Crossover Period)|Adverse Event|0
787699|NCT00697515|2505465|P2|First Intervention (Crossover Period)|Natural disaster|9
787700|NCT00697515|2505466|P1|First Intervention (Crossover Period)|Natural disaster|8
787701|NCT00697515|2505465|P2|Dose Optimization Period|elevated QTc|0
787702|NCT00697515|2505466|P1|Dose Optimization Period|elevated QTc|1
787703|NCT00697515|2505465|P2|Dose Optimization Period|called to active duty|0
787704|NCT00697515|2505466|P1|Dose Optimization Period|called to active duty|1
787705|NCT00697515|2505465|P2|Dose Optimization Period|sponsor request|0
787706|NCT00697515|2505466|P1|Dose Optimization Period|sponsor request|2
787707|NCT00697515|2505465|P2|Dose Optimization Period|Lost to Follow-up|0
787708|NCT00697515|2505466|P1|Dose Optimization Period|Lost to Follow-up|2
787709|NCT00697515|2505465|P2|Dose Optimization Period|Withdrawal by Subject|0
787710|NCT00697515|2505466|P1|Dose Optimization Period|Withdrawal by Subject|5
787711|NCT00697515|2505465|P2|Dose Optimization Period|Adverse Event|0
787712|NCT00697515|2505466|P1|Dose Optimization Period|Adverse Event|4
787713|NCT00697593|2505507|P1|Overall Study|Suspension of the study by sponsor|12
787714|NCT00697593|2505507|P1|Overall Study|Lack of Efficacy|3
787715|NCT00697593|2505507|P1|Overall Study|Protocol Violation|1
787716|NCT00697593|2505507|P1|Overall Study|Adverse Event|3
787717|NCT00697619|2505540|P2|Overall Study|Adverse Event|6
787718|NCT00697619|2505541|P1|Overall Study|Adverse Event|4
787719|NCT00697619|2505540|P2|Overall Study|Lack of Efficacy|2
787720|NCT00697619|2505541|P1|Overall Study|Lack of Efficacy|2
787721|NCT00697788|2505558|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787722|NCT00697788|2505559|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787723|NCT00697788|2505560|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787724|NCT00697788|2505561|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
787725|NCT00697788|2505562|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787726|NCT00697788|2505563|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787727|NCT00697788|2505564|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787728|NCT00697788|2505565|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
787729|NCT00697788|2505558|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787730|NCT00697788|2505559|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787731|NCT00697788|2505560|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787732|NCT00697788|2505561|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787733|NCT00697788|2505562|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787734|NCT00697788|2505563|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787735|NCT00697788|2505564|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
787736|NCT00697788|2505565|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
787737|NCT00697827|2505628|P2|Overall Study|enrolled but not treated|1
787738|NCT00697827|2505629|P1|Overall Study|enrolled but not treated|2
787739|NCT00698009|2505637|P1|Overall Study|Withdrawal by Subject|1
787740|NCT00698204|2505695|P2|Overall Study|Withdrawal by Subject|0
787741|NCT00698204|2505696|P1|Overall Study|Withdrawal by Subject|1
787742|NCT00691054|2505704|P1|Overall Study|Withdrawal by Subject|1
787743|NCT00691093|2505713|P1|Overall Study|Ongoing at Date of Cut-Off|4
787744|NCT00691093|2505713|P1|Overall Study|Lack of Efficacy|1
787745|NCT00691093|2505713|P1|Overall Study|Lost to Follow-up|1
787746|NCT00691093|2505713|P1|Overall Study|Adverse Event|1
787747|NCT00691132|2505749|P2|Overall Study|Withdrawal by Subject|10
787748|NCT00691132|2505750|P1|Overall Study|Withdrawal by Subject|10
787749|NCT00691132|2505749|P2|Overall Study|Adverse Event|3
787750|NCT00691132|2505750|P1|Overall Study|Adverse Event|2
787751|NCT00691210|2505792|P8|Overall Study|Lack of Efficacy|0
787752|NCT00691210|2505793|P7|Overall Study|Lack of Efficacy|0
787753|NCT00691210|2505794|P6|Overall Study|Lack of Efficacy|1
787754|NCT00691210|2505795|P5|Overall Study|Lack of Efficacy|0
787755|NCT00691210|2505796|P4|Overall Study|Lack of Efficacy|1
787756|NCT00691210|2505797|P3|Overall Study|Lack of Efficacy|0
787757|NCT00691210|2505798|P2|Overall Study|Lack of Efficacy|0
787758|NCT00691210|2505799|P1|Overall Study|Lack of Efficacy|0
787759|NCT00691210|2505792|P8|Overall Study|Progression of Disease|0
787760|NCT00691210|2505793|P7|Overall Study|Progression of Disease|0
787761|NCT00691210|2505794|P6|Overall Study|Progression of Disease|0
787762|NCT00691210|2505795|P5|Overall Study|Progression of Disease|0
787763|NCT00691210|2505796|P4|Overall Study|Progression of Disease|2
787764|NCT00691210|2505797|P3|Overall Study|Progression of Disease|0
787765|NCT00691210|2505798|P2|Overall Study|Progression of Disease|0
787766|NCT00691210|2505799|P1|Overall Study|Progression of Disease|0
787767|NCT00691483|2505830|P2|Overall Study|Randomized by not treated|1
787768|NCT00691483|2505831|P1|Overall Study|Randomized by not treated|7
787769|NCT00691483|2505830|P2|Overall Study|Other known cause|1
787770|NCT00691483|2505831|P1|Overall Study|Other known cause|6
787771|NCT00691483|2505830|P2|Overall Study|Withdrawal by Subject|7
787772|NCT00691483|2505831|P1|Overall Study|Withdrawal by Subject|24
787773|NCT00691483|2505830|P2|Overall Study|Lost to Follow-up|10
787774|NCT00691483|2505831|P1|Overall Study|Lost to Follow-up|17
787775|NCT00691483|2505830|P2|Overall Study|Adverse Event|6
787776|NCT00691483|2505831|P1|Overall Study|Adverse Event|14
787777|NCT00698451|2505847|P1|Overall Study|Disease progression|3
787778|NCT00698451|2505847|P1|Overall Study|Withdrawal by Subject|6
787779|NCT00698451|2505847|P1|Overall Study|Protocol Violation|6
787780|NCT00698451|2505847|P1|Overall Study|Physician Decision|2
787781|NCT00698451|2505847|P1|Overall Study|Adverse Event|22
787782|NCT00698516|2505852|P1|Overall Study|Withdrawal by Subject|3
787783|NCT00698516|2505852|P1|Overall Study|Study Termination|2
787784|NCT00698581|2505872|P2|Overall Study|AE of unknown type|0
787785|NCT00698581|2505873|P1|Overall Study|AE of unknown type|1
787786|NCT00698581|2505872|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
787787|NCT00698581|2505873|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
787788|NCT00698581|2505872|P2|Overall Study|AE, non-serious non-fatal|0
787789|NCT00698581|2505873|P1|Overall Study|AE, non-serious non-fatal|4
787790|NCT00698581|2505872|P2|Overall Study|SAE, non-fatal|0
787791|NCT00698581|2505873|P1|Overall Study|SAE, non-fatal|1
787792|NCT00698581|2505872|P2|Overall Study|Other reason|1
787793|NCT00698581|2505873|P1|Overall Study|Other reason|9
787794|NCT00698581|2505872|P2|Overall Study|Withdrawal by Subject|0
787795|NCT00698581|2505873|P1|Overall Study|Withdrawal by Subject|6
787796|NCT00698581|2505872|P2|Overall Study|Lack of Efficacy|11
787797|NCT00698581|2505873|P1|Overall Study|Lack of Efficacy|23
892126|NCT02667275|2829037|P2|Overall Study|Withdrawal by Subject|5
892127|NCT02667275|2829038|P1|Overall Study|Withdrawal by Subject|0
787800|NCT00699842|2505906|P3|Overall Study|Death|0
787801|NCT00699842|2505907|P2|Overall Study|Death|1
787802|NCT00699842|2505908|P1|Overall Study|Death|0
787803|NCT00699972|2505922|P3|Overall Study|Randomized, Not Treated|1
787804|NCT00699972|2505923|P2|Overall Study|Randomized, Not Treated|0
787805|NCT00699972|2505924|P1|Overall Study|Randomized, Not Treated|1
787806|NCT00699972|2505922|P3|Overall Study|Administrative/Other|4
787807|NCT00699972|2505923|P2|Overall Study|Administrative/Other|1
787808|NCT00699972|2505924|P1|Overall Study|Administrative/Other|3
787809|NCT00699972|2505922|P3|Overall Study|Lack of Efficacy|2
787810|NCT00699972|2505923|P2|Overall Study|Lack of Efficacy|0
787811|NCT00699972|2505924|P1|Overall Study|Lack of Efficacy|2
787812|NCT00699972|2505922|P3|Overall Study|Withdrawal by Subject|4
787813|NCT00699972|2505923|P2|Overall Study|Withdrawal by Subject|7
787814|NCT00699972|2505924|P1|Overall Study|Withdrawal by Subject|3
787815|NCT00699972|2505922|P3|Overall Study|Lost to Follow-up|0
787816|NCT00699972|2505923|P2|Overall Study|Lost to Follow-up|2
787817|NCT00699972|2505924|P1|Overall Study|Lost to Follow-up|0
787818|NCT00699972|2505922|P3|Overall Study|Adverse Event|24
787819|NCT00699972|2505923|P2|Overall Study|Adverse Event|9
787820|NCT00699972|2505924|P1|Overall Study|Adverse Event|7
787821|NCT00699998|2505942|P4|Overall Study|Lost to Follow-up|1
787822|NCT00699998|2505943|P3|Overall Study|Lost to Follow-up|3
787823|NCT00699998|2505944|P2|Overall Study|Lost to Follow-up|1
787824|NCT00699998|2505945|P1|Overall Study|Lost to Follow-up|2
787825|NCT00699998|2505942|P4|Overall Study|Physician Decision|1
787826|NCT00699998|2505943|P3|Overall Study|Physician Decision|1
787827|NCT00699998|2505944|P2|Overall Study|Physician Decision|2
787828|NCT00699998|2505945|P1|Overall Study|Physician Decision|3
787829|NCT00699998|2505942|P4|Overall Study|Withdrawal by Subject|80
787830|NCT00699998|2505943|P3|Overall Study|Withdrawal by Subject|202
787831|NCT00699998|2505944|P2|Overall Study|Withdrawal by Subject|83
787832|NCT00699998|2505945|P1|Overall Study|Withdrawal by Subject|194
787833|NCT00700011|2505989|P2|Overall Study|Death|1
787834|NCT00700011|2505990|P1|Overall Study|Death|0
787835|NCT00700102|2506125|P2|Overall Study|Lost to Follow-up|10
787836|NCT00700102|2506126|P1|Overall Study|Lost to Follow-up|8
787837|NCT00700102|2506125|P2|Overall Study|Died|385
787838|NCT00700102|2506126|P1|Overall Study|Died|394
787839|NCT00700115|2506144|P2|Overall Study|Lost to Follow-up|1
787840|NCT00700115|2506145|P1|Overall Study|Lost to Follow-up|0
787841|NCT00700115|2506144|P2|Overall Study|Withdrawal by Subject|0
787842|NCT00700115|2506145|P1|Overall Study|Withdrawal by Subject|1
787843|NCT00700180|2506160|P2|Overall Study|Lost to Follow-up|5
787844|NCT00700180|2506161|P1|Overall Study|Lost to Follow-up|4
787845|NCT00700180|2506160|P2|Overall Study|Alive in follow-up|27
787846|NCT00700180|2506161|P1|Overall Study|Alive in follow-up|46
787847|NCT00700180|2506160|P2|Overall Study|Alive on treatment|3
787848|NCT00700180|2506161|P1|Overall Study|Alive on treatment|5
787849|NCT00700180|2506160|P2|Overall Study|Death|114
787850|NCT00700180|2506161|P1|Overall Study|Death|99
787851|NCT00700271|2506185|P2|Overall Study|Lost to Follow-up|2
787852|NCT00700271|2506186|P1|Overall Study|Lost to Follow-up|2
787853|NCT00700271|2506185|P2|Overall Study|Withdrawal by Subject|4
787854|NCT00700271|2506186|P1|Overall Study|Withdrawal by Subject|6
787855|NCT00700271|2506185|P2|Overall Study|Administrative Reasons|0
787856|NCT00700271|2506186|P1|Overall Study|Administrative Reasons|1
787857|NCT00700271|2506185|P2|Overall Study|Protocol Violation|0
787858|NCT00700271|2506186|P1|Overall Study|Protocol Violation|1
787859|NCT00700271|2506185|P2|Overall Study|Adverse Event|6
787860|NCT00700271|2506186|P1|Overall Study|Adverse Event|4
787861|NCT00700310|2506216|P4|Overall Study|Randomized, Not Treated|2
787862|NCT00700310|2506217|P3|Overall Study|Randomized, Not Treated|2
787863|NCT00700310|2506218|P2|Overall Study|Randomized, Not Treated|0
787864|NCT00700310|2506219|P1|Overall Study|Randomized, Not Treated|2
787865|NCT00700310|2506216|P4|Overall Study|Administrative/Other|3
787866|NCT00700310|2506217|P3|Overall Study|Administrative/Other|1
787867|NCT00700310|2506218|P2|Overall Study|Administrative/Other|3
787868|NCT00700310|2506219|P1|Overall Study|Administrative/Other|1
787869|NCT00700310|2506216|P4|Overall Study|Lack of Efficacy|1
787870|NCT00700310|2506217|P3|Overall Study|Lack of Efficacy|0
787871|NCT00700310|2506218|P2|Overall Study|Lack of Efficacy|3
787872|NCT00700310|2506219|P1|Overall Study|Lack of Efficacy|0
787873|NCT00700310|2506216|P4|Overall Study|Withdrawal by Subject|8
787874|NCT00700310|2506217|P3|Overall Study|Withdrawal by Subject|8
787875|NCT00700310|2506218|P2|Overall Study|Withdrawal by Subject|9
787876|NCT00700310|2506219|P1|Overall Study|Withdrawal by Subject|8
787877|NCT00700310|2506216|P4|Overall Study|Lost to Follow-up|1
787878|NCT00700310|2506217|P3|Overall Study|Lost to Follow-up|0
787879|NCT00700310|2506218|P2|Overall Study|Lost to Follow-up|1
787880|NCT00700310|2506219|P1|Overall Study|Lost to Follow-up|4
787881|NCT00700310|2506216|P4|Overall Study|Adverse Event|11
787882|NCT00700310|2506217|P3|Overall Study|Adverse Event|5
787883|NCT00700310|2506218|P2|Overall Study|Adverse Event|10
787884|NCT00700310|2506219|P1|Overall Study|Adverse Event|6
787885|NCT00700401|2506246|P1|Overall Study|Withdrawal by Subject|2
787886|NCT00700401|2506246|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
787887|NCT00700401|2506246|P1|Overall Study|Treatment never started|1
787888|NCT00700401|2506246|P1|Overall Study|Lost to Follow-up|1
787889|NCT00700401|2506246|P1|Overall Study|Refused Treatment|2
787890|NCT00700401|2506246|P1|Overall Study|Adverse Event|5
787891|NCT00700401|2506246|P1|Overall Study|Detectable HCV RNA after Week 4|82
787892|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
787893|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
787894|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
787895|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
787896|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
787897|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
787898|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
787899|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
787900|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
787901|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
787902|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
787903|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
787904|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
787905|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
787906|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
787907|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
787908|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
787909|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
787910|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
787911|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
787912|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
787913|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
787914|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
787915|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
787916|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
787917|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
787918|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
787919|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
787920|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
787921|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
787922|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
787923|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
787924|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
787925|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
787926|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
787927|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Death|1
787928|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Death|0
787929|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Death|0
787930|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Death|0
787931|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Death|0
787932|NCT00700427|2506257|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
787933|NCT00700427|2506258|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
787934|NCT00700427|2506259|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
787935|NCT00700427|2506260|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
787936|NCT00700427|2506261|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
787937|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Death|0
787938|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Death|0
787939|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Death|1
787940|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Death|0
787941|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Death|0
787942|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
787943|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
787944|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
787945|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
787946|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
787947|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
787948|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
787949|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
787950|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
787951|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
787952|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
787953|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
787954|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
787955|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
787956|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
787957|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
787958|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
787959|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
787960|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
787961|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
787962|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
787963|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
787964|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
787965|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
787966|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
787967|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
787968|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
787969|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
787970|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
787971|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
787972|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
787973|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
787974|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
787975|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
787976|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
787977|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
787978|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
787979|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
787980|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
787981|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
787982|NCT00700427|2506257|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
787983|NCT00700427|2506258|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
787984|NCT00700427|2506259|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
787985|NCT00700427|2506260|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
787986|NCT00700427|2506261|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
787987|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
787988|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
787989|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
787990|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
787991|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
787992|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
787993|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
787994|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
787995|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
787996|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
787997|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
787998|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
787999|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
788000|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
788001|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
788002|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
788003|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
788004|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
788005|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
788006|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
788007|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
788008|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
788009|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
788010|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
788011|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
788012|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
788013|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
788014|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
788015|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
788016|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
788017|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
788018|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
788019|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
788020|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
788021|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
788022|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
788023|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
788024|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
788025|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
788026|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
788027|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
788028|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
788029|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
788030|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
788031|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
788032|NCT00700427|2506257|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
788033|NCT00700427|2506258|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
788034|NCT00700427|2506259|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
788035|NCT00700427|2506260|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
788036|NCT00700427|2506261|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
788037|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
788038|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
788039|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
788040|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
788041|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
788042|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
788043|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
788044|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
788045|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
788046|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
788047|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
788048|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
788049|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
788050|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
788051|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
788052|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
788053|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
788054|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
788055|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
788056|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
788057|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
788058|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
788059|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
788060|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
788061|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
788062|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
788063|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
788064|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
788065|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
788066|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
788067|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
788068|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
788069|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
788070|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
788071|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
788072|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
788073|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
788074|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
788075|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
788076|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
788077|NCT00700427|2506257|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
788078|NCT00700427|2506258|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
788079|NCT00700427|2506259|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
788080|NCT00700427|2506260|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
788081|NCT00700427|2506261|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
788082|NCT00700570|2506289|P2|Overall Study|Withdrawal by Subject|6
788083|NCT00700570|2506290|P1|Overall Study|Withdrawal by Subject|1
788084|NCT00700570|2506289|P2|Overall Study|Disease Progression|11
788085|NCT00700570|2506290|P1|Overall Study|Disease Progression|8
788086|NCT00700570|2506289|P2|Overall Study|Discretion of Investigator or Sponsor|3
788087|NCT00700570|2506290|P1|Overall Study|Discretion of Investigator or Sponsor|0
788088|NCT00700570|2506289|P2|Overall Study|Adverse Event|6
788089|NCT00700570|2506290|P1|Overall Study|Adverse Event|2
788090|NCT00700622|2506304|P2|Overall Study|Other|1
788091|NCT00700622|2506305|P1|Overall Study|Other|3
788092|NCT00700622|2506304|P2|Overall Study|Withdrawal by Subject|1
788093|NCT00700622|2506305|P1|Overall Study|Withdrawal by Subject|4
788094|NCT00700622|2506304|P2|Overall Study|Protocol Violation|1
788095|NCT00700622|2506305|P1|Overall Study|Protocol Violation|0
788096|NCT00700622|2506304|P2|Overall Study|Physician Decision|1
788097|NCT00700622|2506305|P1|Overall Study|Physician Decision|2
788098|NCT00700622|2506304|P2|Overall Study|Lost to Follow-up|1
788099|NCT00700622|2506305|P1|Overall Study|Lost to Follow-up|0
788100|NCT00700622|2506304|P2|Overall Study|Adverse Event|0
788101|NCT00700622|2506305|P1|Overall Study|Adverse Event|4
892128|NCT02667275|2829037|P2|Overall Study|Lost to Follow-up|2
892129|NCT02667275|2829038|P1|Overall Study|Lost to Follow-up|0
892130|NCT02667275|2829037|P2|Overall Study|Protocol Violation|7
892131|NCT02667275|2829038|P1|Overall Study|Protocol Violation|11
892132|NCT02667236|2829048|P2|Overall Study|Withdrawal by Subject|0
892133|NCT02667236|2829049|P1|Overall Study|Withdrawal by Subject|2
892134|NCT02667236|2829048|P2|Overall Study|Adverse Event|1
892135|NCT02667236|2829049|P1|Overall Study|Adverse Event|1
892136|NCT02601573|2829062|P5|Overall Study|Withdrawal by Subject|0
892137|NCT02601573|2829063|P4|Overall Study|Withdrawal by Subject|1
892138|NCT02601573|2829064|P3|Overall Study|Withdrawal by Subject|0
892139|NCT02601573|2829065|P2|Overall Study|Withdrawal by Subject|1
788114|NCT00700713|2506339|P3|Overall Study|Withdrawal by Subject|1
788115|NCT00700713|2506340|P2|Overall Study|Withdrawal by Subject|0
788116|NCT00700713|2506341|P1|Overall Study|Withdrawal by Subject|0
788117|NCT00700713|2506339|P3|Overall Study|Protocol Violation|1
788118|NCT00700713|2506340|P2|Overall Study|Protocol Violation|0
788119|NCT00700713|2506341|P1|Overall Study|Protocol Violation|1
788120|NCT00700739|2506357|P2|Overall Study|Lost to Follow-up|4
788121|NCT00700739|2506358|P1|Overall Study|Lost to Follow-up|4
788122|NCT00700752|2506394|P2|First Intervention|Withdrawal by Subject|2
788123|NCT00700752|2506395|P1|First Intervention|Withdrawal by Subject|0
788124|NCT00700804|2506403|P2|Overall Study|Loose Stools|1
788125|NCT00700804|2506404|P1|Overall Study|Loose Stools|1
788126|NCT00700804|2506403|P2|Overall Study|Protocol Violation|1
788127|NCT00700804|2506404|P1|Overall Study|Protocol Violation|1
788128|NCT00700804|2506403|P2|Overall Study|Withdrawal by Subject|2
788129|NCT00700804|2506404|P1|Overall Study|Withdrawal by Subject|1
788130|NCT00700817|2506417|P5|Week 52-78 (Extension Period 2)|Unclassified|1
788131|NCT00700817|2506418|P4|Week 52-78 (Extension Period 2)|Unclassified|0
788132|NCT00700817|2506419|P3|Week 52-78 (Extension Period 2)|Unclassified|0
788133|NCT00700817|2506420|P2|Week 52-78 (Extension Period 2)|Unclassified|4
788134|NCT00700817|2506421|P1|Week 52-78 (Extension Period 2)|Unclassified|2
788135|NCT00700817|2506417|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
788136|NCT00700817|2506418|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
788137|NCT00700817|2506419|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
788138|NCT00700817|2506420|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
788139|NCT00700817|2506421|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
788140|NCT00700817|2506417|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
788141|NCT00700817|2506418|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
788142|NCT00700817|2506419|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
788143|NCT00700817|2506420|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
788144|NCT00700817|2506421|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
788145|NCT00700817|2506417|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
788146|NCT00700817|2506418|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
788147|NCT00700817|2506419|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
788148|NCT00700817|2506420|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
788149|NCT00700817|2506421|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
788150|NCT00700817|2506417|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
788151|NCT00700817|2506418|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
788152|NCT00700817|2506419|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
788153|NCT00700817|2506420|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
788154|NCT00700817|2506421|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
788155|NCT00700817|2506417|P5|Week 26-52 (Extension Period 1)|Unclassified|0
788156|NCT00700817|2506418|P4|Week 26-52 (Extension Period 1)|Unclassified|0
788157|NCT00700817|2506419|P3|Week 26-52 (Extension Period 1)|Unclassified|1
788158|NCT00700817|2506420|P2|Week 26-52 (Extension Period 1)|Unclassified|3
788159|NCT00700817|2506421|P1|Week 26-52 (Extension Period 1)|Unclassified|4
788160|NCT00700817|2506417|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
788161|NCT00700817|2506418|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
788162|NCT00700817|2506419|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
788163|NCT00700817|2506420|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
788164|NCT00700817|2506421|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
788165|NCT00700817|2506417|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
788166|NCT00700817|2506418|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
788167|NCT00700817|2506419|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
788168|NCT00700817|2506420|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
788169|NCT00700817|2506421|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
788170|NCT00700817|2506417|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
788171|NCT00700817|2506418|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
788172|NCT00700817|2506419|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
788173|NCT00700817|2506420|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
788174|NCT00700817|2506421|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
788175|NCT00700817|2506417|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
788176|NCT00700817|2506418|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
788177|NCT00700817|2506419|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
788178|NCT00700817|2506420|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
788179|NCT00700817|2506421|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
788180|NCT00700817|2506417|P5|Week 0-26 (Main Period)|Unclassified|0
788181|NCT00700817|2506418|P4|Week 0-26 (Main Period)|Unclassified|0
788182|NCT00700817|2506419|P3|Week 0-26 (Main Period)|Unclassified|8
788183|NCT00700817|2506420|P2|Week 0-26 (Main Period)|Unclassified|4
788184|NCT00700817|2506421|P1|Week 0-26 (Main Period)|Unclassified|14
788185|NCT00700817|2506417|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
788186|NCT00700817|2506418|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
788187|NCT00700817|2506419|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
788188|NCT00700817|2506420|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
788189|NCT00700817|2506421|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
788190|NCT00700817|2506417|P5|Week 0-26 (Main Period)|Protocol Violation|0
788191|NCT00700817|2506418|P4|Week 0-26 (Main Period)|Protocol Violation|0
788192|NCT00700817|2506419|P3|Week 0-26 (Main Period)|Protocol Violation|4
788193|NCT00700817|2506420|P2|Week 0-26 (Main Period)|Protocol Violation|4
788194|NCT00700817|2506421|P1|Week 0-26 (Main Period)|Protocol Violation|14
788195|NCT00700817|2506417|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
788196|NCT00700817|2506418|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
788197|NCT00700817|2506419|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
788198|NCT00700817|2506420|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
788199|NCT00700817|2506421|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
788200|NCT00700817|2506417|P5|Week 0-26 (Main Period)|Adverse Event|0
788201|NCT00700817|2506418|P4|Week 0-26 (Main Period)|Adverse Event|0
788202|NCT00700817|2506419|P3|Week 0-26 (Main Period)|Adverse Event|4
788203|NCT00700817|2506420|P2|Week 0-26 (Main Period)|Adverse Event|15
788204|NCT00700817|2506421|P1|Week 0-26 (Main Period)|Adverse Event|14
788205|NCT00700999|2506812|P2|Overall Study|Withdrawal by Subject|1
788206|NCT00700999|2506813|P1|Overall Study|Withdrawal by Subject|8
788207|NCT00700999|2506812|P2|Overall Study|Excluded - did not meet study criteria|1
788208|NCT00700999|2506813|P1|Overall Study|Excluded - did not meet study criteria|0
788209|NCT00700999|2506812|P2|Overall Study|Lost to Follow-up|7
788210|NCT00700999|2506813|P1|Overall Study|Lost to Follow-up|7
788211|NCT00701038|2506821|P2|Overall Study|study amended pilot group of patients|4
788212|NCT00701038|2506822|P1|Overall Study|study amended pilot group of patients|4
788213|NCT00701051|2506830|P3|Exercise Intervention|time conflict; non-study related illness|3
788214|NCT00701051|2506831|P2|Exercise Intervention|time conflict; non-study related illness|5
788215|NCT00701051|2506832|P1|Exercise Intervention|time conflict; non-study related illness|0
788216|NCT00701051|2506830|P3|Screening|Time conflicts|0
788217|NCT00701051|2506831|P2|Screening|Time conflicts|0
788218|NCT00701051|2506832|P1|Screening|Time conflicts|19
788219|NCT00701051|2506830|P3|Screening|Failed Screening|0
788220|NCT00701051|2506831|P2|Screening|Failed Screening|0
788221|NCT00701051|2506832|P1|Screening|Failed Screening|40
788222|NCT00701064|2506850|P2|Overall Study|initiated other PTSD treatment|2
788223|NCT00701064|2506851|P1|Overall Study|initiated other PTSD treatment|2
788224|NCT00701064|2506850|P2|Overall Study|Withdrawal by Subject|1
788225|NCT00701064|2506851|P1|Overall Study|Withdrawal by Subject|1
788226|NCT00701064|2506850|P2|Overall Study|Protocol Violation|1
788227|NCT00701064|2506851|P1|Overall Study|Protocol Violation|1
788228|NCT00701090|2506859|P2|Overall Study|Other|12
788229|NCT00701090|2506860|P1|Overall Study|Other|7
788230|NCT00701090|2506859|P2|Overall Study|Withdrawal by Subject|16
788231|NCT00701090|2506860|P1|Overall Study|Withdrawal by Subject|11
788232|NCT00701090|2506859|P2|Overall Study|Protocol Violation|3
788233|NCT00701090|2506860|P1|Overall Study|Protocol Violation|2
788234|NCT00701090|2506859|P2|Overall Study|Physician Decision|4
788235|NCT00701090|2506860|P1|Overall Study|Physician Decision|3
788236|NCT00701090|2506859|P2|Overall Study|Lost to Follow-up|9
788237|NCT00701090|2506860|P1|Overall Study|Lost to Follow-up|9
788238|NCT00701090|2506859|P2|Overall Study|Lack of Efficacy|4
788239|NCT00701090|2506860|P1|Overall Study|Lack of Efficacy|5
788240|NCT00701090|2506859|P2|Overall Study|Death|1
788241|NCT00701090|2506860|P1|Overall Study|Death|0
788242|NCT00701090|2506859|P2|Overall Study|Adverse Event|2
788243|NCT00701090|2506860|P1|Overall Study|Adverse Event|11
788244|NCT00701103|2506887|P11|Overall Study|Unspecified|0
788245|NCT00701103|2506888|P10|Overall Study|Unspecified|1
788246|NCT00701103|2506889|P9|Overall Study|Unspecified|1
788247|NCT00701103|2506890|P8|Overall Study|Unspecified|0
788248|NCT00701103|2506891|P7|Overall Study|Unspecified|0
788249|NCT00701103|2506892|P6|Overall Study|Unspecified|0
788250|NCT00701103|2506893|P5|Overall Study|Unspecified|0
788251|NCT00701103|2506894|P4|Overall Study|Unspecified|0
788252|NCT00701103|2506895|P3|Overall Study|Unspecified|0
788253|NCT00701103|2506896|P2|Overall Study|Unspecified|0
788254|NCT00701103|2506897|P1|Overall Study|Unspecified|0
788255|NCT00701103|2506887|P11|Overall Study|Withdrawal by Subject|0
788256|NCT00701103|2506888|P10|Overall Study|Withdrawal by Subject|0
788257|NCT00701103|2506889|P9|Overall Study|Withdrawal by Subject|0
788258|NCT00701103|2506890|P8|Overall Study|Withdrawal by Subject|0
788259|NCT00701103|2506891|P7|Overall Study|Withdrawal by Subject|0
788260|NCT00701103|2506892|P6|Overall Study|Withdrawal by Subject|0
788261|NCT00701103|2506893|P5|Overall Study|Withdrawal by Subject|0
788262|NCT00701103|2506894|P4|Overall Study|Withdrawal by Subject|0
788263|NCT00701103|2506895|P3|Overall Study|Withdrawal by Subject|1
788264|NCT00701103|2506896|P2|Overall Study|Withdrawal by Subject|1
788265|NCT00701103|2506897|P1|Overall Study|Withdrawal by Subject|0
788266|NCT00701103|2506887|P11|Overall Study|Progressive Disease|11
788267|NCT00701103|2506888|P10|Overall Study|Progressive Disease|8
788268|NCT00701103|2506889|P9|Overall Study|Progressive Disease|8
788269|NCT00701103|2506890|P8|Overall Study|Progressive Disease|7
788270|NCT00701103|2506891|P7|Overall Study|Progressive Disease|7
788271|NCT00701103|2506892|P6|Overall Study|Progressive Disease|5
788272|NCT00701103|2506893|P5|Overall Study|Progressive Disease|6
788273|NCT00701103|2506894|P4|Overall Study|Progressive Disease|5
788274|NCT00701103|2506895|P3|Overall Study|Progressive Disease|6
788275|NCT00701103|2506896|P2|Overall Study|Progressive Disease|2
788276|NCT00701103|2506897|P1|Overall Study|Progressive Disease|5
788277|NCT00701103|2506887|P11|Overall Study|Adverse Event|0
788278|NCT00701103|2506888|P10|Overall Study|Adverse Event|2
788279|NCT00701103|2506889|P9|Overall Study|Adverse Event|0
788280|NCT00701103|2506890|P8|Overall Study|Adverse Event|0
788281|NCT00701103|2506891|P7|Overall Study|Adverse Event|1
788282|NCT00701103|2506892|P6|Overall Study|Adverse Event|1
788283|NCT00701103|2506893|P5|Overall Study|Adverse Event|0
788284|NCT00701103|2506894|P4|Overall Study|Adverse Event|1
788285|NCT00701103|2506895|P3|Overall Study|Adverse Event|1
788286|NCT00701103|2506896|P2|Overall Study|Adverse Event|0
788287|NCT00701103|2506897|P1|Overall Study|Adverse Event|0
788288|NCT00701129|2507001|P1|Overall Study|Death|2
788289|NCT00701311|2507012|P1|Overall Study|Withdrawal by Subject|2
788290|NCT00701311|2507012|P1|Overall Study|Adverse Event|3
788291|NCT00701311|2507012|P1|Overall Study|Lack of Efficacy|3
788292|NCT00701363|2507020|P4|Treatment Phase 2|Withdrawal by Subject|0
788293|NCT00701363|2507021|P3|Treatment Phase 2|Withdrawal by Subject|1
788294|NCT00701363|2507022|P2|Treatment Phase 2|Withdrawal by Subject|0
788295|NCT00701363|2507023|P1|Treatment Phase 2|Withdrawal by Subject|0
788296|NCT00701363|2507020|P4|Treatment Phase 2|Adverse Event|0
788297|NCT00701363|2507021|P3|Treatment Phase 2|Adverse Event|1
788298|NCT00701363|2507022|P2|Treatment Phase 2|Adverse Event|0
788299|NCT00701363|2507023|P1|Treatment Phase 2|Adverse Event|0
788300|NCT00701363|2507020|P4|Treatment Phase 1|Lack of Efficacy|0
788301|NCT00701363|2507021|P3|Treatment Phase 1|Lack of Efficacy|0
788302|NCT00701363|2507022|P2|Treatment Phase 1|Lack of Efficacy|0
788303|NCT00701363|2507023|P1|Treatment Phase 1|Lack of Efficacy|1
788304|NCT00701363|2507020|P4|Treatment Phase 1|Withdrawal by Subject|0
788305|NCT00701363|2507021|P3|Treatment Phase 1|Withdrawal by Subject|0
788306|NCT00701363|2507022|P2|Treatment Phase 1|Withdrawal by Subject|0
788307|NCT00701363|2507023|P1|Treatment Phase 1|Withdrawal by Subject|5
788308|NCT00701363|2507020|P4|Treatment Phase 1|Protocol Violation|0
788309|NCT00701363|2507021|P3|Treatment Phase 1|Protocol Violation|0
788310|NCT00701363|2507022|P2|Treatment Phase 1|Protocol Violation|0
788311|NCT00701363|2507023|P1|Treatment Phase 1|Protocol Violation|1
788312|NCT00701363|2507020|P4|Treatment Phase 1|Adverse Event|0
788313|NCT00701363|2507021|P3|Treatment Phase 1|Adverse Event|0
788314|NCT00701363|2507022|P2|Treatment Phase 1|Adverse Event|0
788315|NCT00701363|2507023|P1|Treatment Phase 1|Adverse Event|7
788316|NCT00701363|2507020|P4|Treatment Phase 1|Does not meet entry Criteria|0
788317|NCT00701363|2507021|P3|Treatment Phase 1|Does not meet entry Criteria|0
788318|NCT00701363|2507022|P2|Treatment Phase 1|Does not meet entry Criteria|0
788319|NCT00701363|2507023|P1|Treatment Phase 1|Does not meet entry Criteria|1
788320|NCT00701363|2507020|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
788321|NCT00701363|2507021|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
788322|NCT00701363|2507022|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
788323|NCT00701363|2507023|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
788324|NCT00701415|2507086|P2|Overall Study|Social/family issues and needle phobia|0
788325|NCT00701415|2507087|P1|Overall Study|Social/family issues and needle phobia|1
788326|NCT00701415|2507086|P2|Overall Study|Adverse Event|1
788327|NCT00701415|2507087|P1|Overall Study|Adverse Event|0
788328|NCT00701441|2507099|P2|Overall Study|failure in cpap compliance|4
788329|NCT00701441|2507100|P1|Overall Study|failure in cpap compliance|0
788330|NCT00701558|2507110|P1|Overall Study|Lost to Follow-up|8
788331|NCT00701558|2507110|P1|Overall Study|Death|7
788332|NCT00701662|2507124|P1|Overall Study|Lack of Efficacy|1
788333|NCT00701727|2507154|P2|Second Treatment Period|Withdrawal by Subject|0
788334|NCT00701727|2507155|P1|Second Treatment Period|Withdrawal by Subject|2
788335|NCT00701727|2507154|P2|First Treatment Period|Lost to Follow-up|1
788336|NCT00701727|2507155|P1|First Treatment Period|Lost to Follow-up|0
788337|NCT00701727|2507154|P2|First Treatment Period|sponsor decision|1
788338|NCT00701727|2507155|P1|First Treatment Period|sponsor decision|0
788339|NCT00701727|2507154|P2|First Treatment Period|Withdrawal by Subject|0
788340|NCT00701727|2507155|P1|First Treatment Period|Withdrawal by Subject|1
788341|NCT00701727|2507154|P2|First Treatment Period|Adverse Event|0
788342|NCT00701727|2507155|P1|First Treatment Period|Adverse Event|0
788343|NCT00701779|2507173|P1|Overall Study|Withdrawal by Subject|2
788344|NCT00701779|2507173|P1|Overall Study|Lost to Follow-up|1
788345|NCT00701779|2507173|P1|Overall Study|Adverse Event|6
788346|NCT00701805|2507186|P4|Overall Study|Resumption criteria were not met|0
788347|NCT00701805|2507187|P3|Overall Study|Resumption criteria were not met|0
788348|NCT00701805|2507188|P2|Overall Study|Resumption criteria were not met|1
788349|NCT00701805|2507189|P1|Overall Study|Resumption criteria were not met|0
788350|NCT00701805|2507186|P4|Overall Study|Difficult to travel to dialysis site|0
788351|NCT00701805|2507187|P3|Overall Study|Difficult to travel to dialysis site|1
788352|NCT00701805|2507188|P2|Overall Study|Difficult to travel to dialysis site|0
788353|NCT00701805|2507189|P1|Overall Study|Difficult to travel to dialysis site|0
788354|NCT00701805|2507186|P4|Overall Study|Physician decision, change of therapy|1
788355|NCT00701805|2507187|P3|Overall Study|Physician decision, change of therapy|0
788356|NCT00701805|2507188|P2|Overall Study|Physician decision, change of therapy|0
788357|NCT00701805|2507189|P1|Overall Study|Physician decision, change of therapy|0
788358|NCT00701805|2507186|P4|Overall Study|Admitted to hospital for 2 weeks|0
788359|NCT00701805|2507187|P3|Overall Study|Admitted to hospital for 2 weeks|1
788360|NCT00701805|2507188|P2|Overall Study|Admitted to hospital for 2 weeks|0
788361|NCT00701805|2507189|P1|Overall Study|Admitted to hospital for 2 weeks|0
788362|NCT00701805|2507186|P4|Overall Study|Missed 7 consecutive doses|0
788363|NCT00701805|2507187|P3|Overall Study|Missed 7 consecutive doses|0
788364|NCT00701805|2507188|P2|Overall Study|Missed 7 consecutive doses|1
788365|NCT00701805|2507189|P1|Overall Study|Missed 7 consecutive doses|0
788366|NCT00701805|2507186|P4|Overall Study|Adverse Event|0
788367|NCT00701805|2507187|P3|Overall Study|Adverse Event|1
788368|NCT00701805|2507188|P2|Overall Study|Adverse Event|1
788369|NCT00701805|2507189|P1|Overall Study|Adverse Event|0
788370|NCT00701805|2507186|P4|Overall Study|Withdrawal by Subject|3
788371|NCT00701805|2507187|P3|Overall Study|Withdrawal by Subject|4
788372|NCT00701805|2507188|P2|Overall Study|Withdrawal by Subject|1
788373|NCT00701805|2507189|P1|Overall Study|Withdrawal by Subject|3
788374|NCT00702143|2507275|P3|Overall Study|Lost to Follow-up|1
788375|NCT00702143|2507276|P2|Overall Study|Lost to Follow-up|0
788376|NCT00702143|2507277|P1|Overall Study|Lost to Follow-up|0
788377|NCT00702208|2507289|P1|Overall Study|Unsatisfactory colposcopy|2
788378|NCT00702208|2507289|P1|Overall Study|Did not self-lavage|1
788379|NCT00702208|2507289|P1|Overall Study|Lost to Follow-up|28
788380|NCT00702221|2507297|P2|Overall Study|Adverse Event|3
788381|NCT00702221|2507298|P1|Overall Study|Adverse Event|4
892140|NCT02601573|2829066|P1|Overall Study|Withdrawal by Subject|0
892141|NCT02601573|2829062|P5|Overall Study|Lost to Follow-up|2
892142|NCT02601573|2829063|P4|Overall Study|Lost to Follow-up|0
788385|NCT00695019|2507376|P3|Overall Study|Various|4
788386|NCT00695019|2507377|P2|Overall Study|Various|5
788387|NCT00695019|2507378|P1|Overall Study|Various|4
788388|NCT00695019|2507376|P3|Overall Study|Lack of Efficacy|1
788389|NCT00695019|2507377|P2|Overall Study|Lack of Efficacy|0
788390|NCT00695019|2507378|P1|Overall Study|Lack of Efficacy|0
788391|NCT00695019|2507376|P3|Overall Study|Protocol Violation|1
788392|NCT00695019|2507377|P2|Overall Study|Protocol Violation|3
788393|NCT00695019|2507378|P1|Overall Study|Protocol Violation|1
788394|NCT00695019|2507376|P3|Overall Study|Withdrawal by Subject|4
788395|NCT00695019|2507377|P2|Overall Study|Withdrawal by Subject|6
788396|NCT00695019|2507378|P1|Overall Study|Withdrawal by Subject|8
788397|NCT00695136|2507416|P1|Overall Study|unrelated adverse event|1
788398|NCT00695136|2507416|P1|Overall Study|Withdrawal by Subject|1
788399|NCT00695318|2507436|P2|Overall Study|Study Terminated|0
788400|NCT00695318|2507437|P1|Overall Study|Study Terminated|1
788401|NCT00695318|2507436|P2|Overall Study|Death|1
788402|NCT00695318|2507437|P1|Overall Study|Death|1
788403|NCT00695318|2507436|P2|Overall Study|Withdrawal by Subject|0
788404|NCT00695318|2507437|P1|Overall Study|Withdrawal by Subject|2
788405|NCT00695318|2507436|P2|Overall Study|Lost to Follow-up|0
788406|NCT00695318|2507437|P1|Overall Study|Lost to Follow-up|1
788407|NCT00695396|2507451|P3|Overall Study|Withdrawal by Subject|0
788408|NCT00695396|2507452|P2|Overall Study|Withdrawal by Subject|2
788409|NCT00695396|2507453|P1|Overall Study|Withdrawal by Subject|2
788410|NCT00695396|2507451|P3|Overall Study|Study Closed Prematurely|8
788411|NCT00695396|2507452|P2|Overall Study|Study Closed Prematurely|6
788412|NCT00695396|2507453|P1|Overall Study|Study Closed Prematurely|5
788413|NCT00695565|2507495|P2|Overall Study|Subject did not follow instructions|1
788414|NCT00695565|2507496|P1|Overall Study|Subject did not follow instructions|1
788415|NCT00695565|2507495|P2|Overall Study|Lack of Efficacy|1
788416|NCT00695565|2507496|P1|Overall Study|Lack of Efficacy|1
788417|NCT00695565|2507495|P2|Overall Study|Withdrawal by Subject|1
788418|NCT00695565|2507496|P1|Overall Study|Withdrawal by Subject|1
788419|NCT00695565|2507495|P2|Overall Study|Protocol Violation|1
788420|NCT00695565|2507496|P1|Overall Study|Protocol Violation|3
788421|NCT00695565|2507495|P2|Overall Study|Adverse Event|1
788422|NCT00695565|2507496|P1|Overall Study|Adverse Event|3
788423|NCT00695565|2507495|P2|Overall Study|Lost to Follow-up|4
788424|NCT00695565|2507496|P1|Overall Study|Lost to Follow-up|4
788425|NCT00695669|2507532|P4|Overall Study|Lost to Follow-up|4
788426|NCT00695669|2507533|P3|Overall Study|Lost to Follow-up|1
788427|NCT00695669|2507534|P2|Overall Study|Lost to Follow-up|4
788428|NCT00695669|2507535|P1|Overall Study|Lost to Follow-up|4
788429|NCT00695669|2507532|P4|Overall Study|Adverse Event|0
788430|NCT00695669|2507533|P3|Overall Study|Adverse Event|2
788431|NCT00695669|2507534|P2|Overall Study|Adverse Event|0
788432|NCT00695669|2507535|P1|Overall Study|Adverse Event|0
788433|NCT00702325|2507622|P2|Overall Study|Incorrectly Discontinued|1
788434|NCT00702325|2507623|P1|Overall Study|Incorrectly Discontinued|0
788435|NCT00702325|2507622|P2|Overall Study|Withdrew consent|1
788436|NCT00702325|2507623|P1|Overall Study|Withdrew consent|0
788437|NCT00702325|2507622|P2|Overall Study|Didn't follow study medication dosage|2
788438|NCT00702325|2507623|P1|Overall Study|Didn't follow study medication dosage|0
788439|NCT00702325|2507622|P2|Overall Study|Termination due to lab results|0
788440|NCT00702325|2507623|P1|Overall Study|Termination due to lab results|1
788441|NCT00702325|2507622|P2|Overall Study|Severe noncompliance to protocol|3
788442|NCT00702325|2507623|P1|Overall Study|Severe noncompliance to protocol|3
788443|NCT00702325|2507622|P2|Overall Study|Developed study discontinuation criteria|28
788444|NCT00702325|2507623|P1|Overall Study|Developed study discontinuation criteria|18
788445|NCT00702325|2507622|P2|Overall Study|Incorrect enrollment|7
788446|NCT00702325|2507623|P1|Overall Study|Incorrect enrollment|5
788447|NCT00702325|2507622|P2|Overall Study|Lost to Follow-up|4
788448|NCT00702325|2507623|P1|Overall Study|Lost to Follow-up|3
788449|NCT00702325|2507622|P2|Overall Study|Withdrawal by Subject|7
788450|NCT00702325|2507623|P1|Overall Study|Withdrawal by Subject|7
788451|NCT00702325|2507622|P2|Overall Study|Adverse Event|0
788452|NCT00702325|2507623|P1|Overall Study|Adverse Event|1
788453|NCT00702403|2507719|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
788454|NCT00702403|2507719|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
788532|NCT00703534|2508263|P2|Overall Study|Severe Non Compliance|5
788455|NCT00702403|2507719|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
788456|NCT00702403|2507719|P1|From Engraftment to Study Completion|Suicide|1
788457|NCT00702403|2507719|P1|From Engraftment to Study Completion|Liver GVHD|1
788458|NCT00702403|2507719|P1|From Engraftment to Study Completion|Adenocarcinoma|1
788459|NCT00702403|2507719|P1|From Engraftment to Study Completion|Non-compliance|2
788460|NCT00702403|2507719|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
788461|NCT00702403|2507719|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
788462|NCT00702403|2507719|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
788463|NCT00702403|2507719|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
788464|NCT00702403|2507719|P1|From Consent to Engraftment|Myocardial infarction|1
788465|NCT00702403|2507719|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
788466|NCT00702403|2507719|P1|From Consent to Engraftment|Critically ill|2
788467|NCT00702403|2507719|P1|From Consent to Engraftment|Progressive leukemia|6
788468|NCT00702507|2507752|P1|Follow-up Phase|Late Enrollment|1
788469|NCT00702507|2507752|P1|Follow-up Phase|Lost to Follow-up|23
788470|NCT00702507|2507752|P1|Follow-up Phase|Protocol Violation|2
788471|NCT00702507|2507752|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
788472|NCT00702507|2507752|P1|Initial Treatment Phase|Negative Candida Culture|34
788473|NCT00702507|2507752|P1|Initial Treatment Phase|Lost to Follow-up|2
788474|NCT00702507|2507752|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
788475|NCT00702507|2507752|P1|Initial Treatment Phase|Adverse Event|2
788476|NCT00702520|2507766|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
788477|NCT00702520|2507767|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
788478|NCT00702520|2507768|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
788479|NCT00702520|2507769|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
788480|NCT00702520|2507766|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
788481|NCT00702520|2507767|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
788482|NCT00702520|2507768|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
788483|NCT00702520|2507769|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
788484|NCT00702520|2507766|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
788485|NCT00702520|2507767|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
788486|NCT00702520|2507768|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
788487|NCT00702520|2507769|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
788488|NCT00702923|2507827|P1|Overall Study|Adverse Event|1
788489|NCT00702949|2507839|P3|Overall Study|Other Medical Reason/unknown|3
788490|NCT00702949|2507840|P2|Overall Study|Other Medical Reason/unknown|1
788491|NCT00702949|2507841|P1|Overall Study|Other Medical Reason/unknown|1
788492|NCT00702949|2507839|P3|Overall Study|Adverse Event|3
788493|NCT00702949|2507840|P2|Overall Study|Adverse Event|6
788494|NCT00702949|2507841|P1|Overall Study|Adverse Event|1
788495|NCT00702949|2507839|P3|Overall Study|Refusal|2
788496|NCT00702949|2507840|P2|Overall Study|Refusal|2
788497|NCT00702949|2507841|P1|Overall Study|Refusal|3
788498|NCT00703014|2507868|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
788499|NCT00703014|2507869|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
788500|NCT00703014|2507870|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
788501|NCT00703014|2507871|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
788502|NCT00703014|2507868|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
788503|NCT00703014|2507869|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
788504|NCT00703014|2507870|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
788505|NCT00703014|2507871|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
892143|NCT02601573|2829064|P3|Overall Study|Lost to Follow-up|1
788507|NCT00703118|2508098|P3|Overall Study|Not specified|1
788508|NCT00703118|2508099|P2|Overall Study|Not specified|0
788509|NCT00703118|2508100|P1|Overall Study|Not specified|0
788510|NCT00703118|2508098|P3|Overall Study|Withdrawal by Subject|13
788511|NCT00703118|2508099|P2|Overall Study|Withdrawal by Subject|7
788512|NCT00703118|2508100|P1|Overall Study|Withdrawal by Subject|8
788513|NCT00703118|2508098|P3|Overall Study|Lost to Follow-up|4
788514|NCT00703118|2508099|P2|Overall Study|Lost to Follow-up|4
788515|NCT00703118|2508100|P1|Overall Study|Lost to Follow-up|6
788516|NCT00703118|2508098|P3|Overall Study|Subject Ineligible To Continue The Trial|2
788517|NCT00703118|2508099|P2|Overall Study|Subject Ineligible To Continue The Trial|3
788518|NCT00703118|2508100|P1|Overall Study|Subject Ineligible To Continue The Trial|6
788519|NCT00703118|2508098|P3|Overall Study|Adverse Event|2
788520|NCT00703118|2508099|P2|Overall Study|Adverse Event|2
788521|NCT00703118|2508100|P1|Overall Study|Adverse Event|1
788522|NCT00703157|2508133|P2|Overall Study|source data permanently lost/ other|1
788523|NCT00703157|2508134|P1|Overall Study|source data permanently lost/ other|4
788524|NCT00703157|2508133|P2|Overall Study|Lost to Follow-up|1
788525|NCT00703157|2508134|P1|Overall Study|Lost to Follow-up|0
788533|NCT00703534|2508264|P1|Overall Study|Severe Non Compliance|1
788534|NCT00703534|2508263|P2|Overall Study|Lost to Follow-up|4
788535|NCT00703534|2508264|P1|Overall Study|Lost to Follow-up|1
788536|NCT00703534|2508263|P2|Overall Study|Incorrect Enrollment|6
788537|NCT00703534|2508264|P1|Overall Study|Incorrect Enrollment|6
788538|NCT00703534|2508263|P2|Overall Study|Withdrawal by Subject|7
788539|NCT00703534|2508264|P1|Overall Study|Withdrawal by Subject|8
788540|NCT00703534|2508263|P2|Overall Study|Adverse Event|3
788541|NCT00703534|2508264|P1|Overall Study|Adverse Event|14
788542|NCT00703677|2508270|P1|Overall Study|Dropout-withdrawal not related to drug|3
788543|NCT00703781|2508322|P2|Overall Study|Cancelled surgery|0
788544|NCT00703781|2508323|P1|Overall Study|Cancelled surgery|1
788545|NCT00703781|2508322|P2|Overall Study|Withdrawal by Subject|2
788546|NCT00703781|2508323|P1|Overall Study|Withdrawal by Subject|1
788547|NCT00703846|2508331|P1|Overall Study|Did Not Receive Study Drug|2
788548|NCT00703846|2508331|P1|Overall Study|Other|14
788549|NCT00703846|2508331|P1|Overall Study|Death|1
788550|NCT00703846|2508331|P1|Overall Study|Withdrawal by Subject|40
788551|NCT00703846|2508331|P1|Overall Study|Noncompliance with Study Treatment|2
788552|NCT00703846|2508331|P1|Overall Study|Lack of Efficacy|15
788553|NCT00703846|2508331|P1|Overall Study|Lost to Follow-up|55
788554|NCT00703846|2508331|P1|Overall Study|Adverse Event|8
788555|NCT00703911|2508350|P1|Overall Study|Withdrawal by Subject|2
788556|NCT00703911|2508350|P1|Overall Study|Lost to Follow-up|1
788557|NCT00703911|2508350|P1|Overall Study|Physician Decision|6
788558|NCT00703911|2508350|P1|Overall Study|Death|1
788559|NCT00703924|2508380|P2|Overall Study|Withdrawal by Subject|1
788560|NCT00703924|2508381|P1|Overall Study|Withdrawal by Subject|1
788561|NCT00703963|2508408|P2|Overall Study|Physician Decision|1
788562|NCT00703963|2508409|P1|Overall Study|Physician Decision|0
788563|NCT00703963|2508408|P2|Overall Study|Withdrawal by Subject|13
788564|NCT00703963|2508409|P1|Overall Study|Withdrawal by Subject|7
788565|NCT00704132|2508441|P2|Overall Study|Withdrawal by Subject|1
788566|NCT00704132|2508442|P1|Overall Study|Withdrawal by Subject|0
788567|NCT00704132|2508441|P2|Overall Study|Lack of Efficacy|1
788568|NCT00704132|2508442|P1|Overall Study|Lack of Efficacy|0
788569|NCT00704132|2508441|P2|Overall Study|Clinical Adverse Experience|0
788570|NCT00704132|2508442|P1|Overall Study|Clinical Adverse Experience|1
788571|NCT00704171|2508450|P2|Overall Study|Withdrawal by Subject|0
788572|NCT00704171|2508451|P1|Overall Study|Withdrawal by Subject|1
788573|NCT00704184|2508472|P5|Open-Label Treatment|Withdrawal by Subject|0
788574|NCT00704184|2508473|P4|Open-Label Treatment|Withdrawal by Subject|3
788575|NCT00704184|2508474|P3|Open-Label Treatment|Withdrawal by Subject|0
788576|NCT00704184|2508475|P2|Open-Label Treatment|Withdrawal by Subject|0
788577|NCT00704184|2508476|P1|Open-Label Treatment|Withdrawal by Subject|1
788578|NCT00704184|2508472|P5|Open-Label Treatment|Physician Decision|1
788579|NCT00704184|2508473|P4|Open-Label Treatment|Physician Decision|0
788580|NCT00704184|2508474|P3|Open-Label Treatment|Physician Decision|0
788581|NCT00704184|2508475|P2|Open-Label Treatment|Physician Decision|0
788582|NCT00704184|2508476|P1|Open-Label Treatment|Physician Decision|0
788583|NCT00704184|2508472|P5|Open-Label Treatment|Lack of Efficacy|1
788584|NCT00704184|2508473|P4|Open-Label Treatment|Lack of Efficacy|2
788585|NCT00704184|2508474|P3|Open-Label Treatment|Lack of Efficacy|2
788586|NCT00704184|2508475|P2|Open-Label Treatment|Lack of Efficacy|2
788587|NCT00704184|2508476|P1|Open-Label Treatment|Lack of Efficacy|0
788588|NCT00704184|2508472|P5|Open-Label Treatment|Adverse Event|1
788589|NCT00704184|2508473|P4|Open-Label Treatment|Adverse Event|0
788590|NCT00704184|2508474|P3|Open-Label Treatment|Adverse Event|2
788591|NCT00704184|2508475|P2|Open-Label Treatment|Adverse Event|0
788592|NCT00704184|2508476|P1|Open-Label Treatment|Adverse Event|0
788593|NCT00704184|2508472|P5|Double-Blind Treatment|Withdrawal by Subject|0
788594|NCT00704184|2508473|P4|Double-Blind Treatment|Withdrawal by Subject|0
788595|NCT00704184|2508474|P3|Double-Blind Treatment|Withdrawal by Subject|0
788596|NCT00704184|2508475|P2|Double-Blind Treatment|Withdrawal by Subject|0
788597|NCT00704184|2508476|P1|Double-Blind Treatment|Withdrawal by Subject|1
788598|NCT00704340|2508515|P2|Overall Study|Death|1
788599|NCT00704340|2508516|P1|Overall Study|Death|0
788600|NCT00704340|2508515|P2|Overall Study|Lost to Follow-up|1
788601|NCT00704340|2508516|P1|Overall Study|Lost to Follow-up|2
788602|NCT00704405|2508559|P5|Overall Study (C Population)|Lost to Follow-up|0
788603|NCT00704405|2508560|P4|Overall Study (C Population)|Lost to Follow-up|0
788604|NCT00704405|2508561|P3|Overall Study (C Population)|Lost to Follow-up|0
788605|NCT00704405|2508562|P2|Overall Study (C Population)|Lost to Follow-up|2
788606|NCT00704405|2508563|P1|Overall Study (C Population)|Lost to Follow-up|0
788607|NCT00704405|2508559|P5|Overall Study (C Population)|Withdrawal by Subject|0
788608|NCT00704405|2508560|P4|Overall Study (C Population)|Withdrawal by Subject|1
788609|NCT00704405|2508561|P3|Overall Study (C Population)|Withdrawal by Subject|1
788610|NCT00704405|2508562|P2|Overall Study (C Population)|Withdrawal by Subject|1
788611|NCT00704405|2508563|P1|Overall Study (C Population)|Withdrawal by Subject|1
788612|NCT00704405|2508559|P5|Overall Study (NC Population)|Other|1
788613|NCT00704405|2508560|P4|Overall Study (NC Population)|Other|0
788614|NCT00704405|2508561|P3|Overall Study (NC Population)|Other|0
788615|NCT00704405|2508562|P2|Overall Study (NC Population)|Other|0
788616|NCT00704405|2508563|P1|Overall Study (NC Population)|Other|0
788617|NCT00704405|2508559|P5|Overall Study (NC Population)|Withdrawal by Subject|2
788618|NCT00704405|2508560|P4|Overall Study (NC Population)|Withdrawal by Subject|2
788619|NCT00704405|2508561|P3|Overall Study (NC Population)|Withdrawal by Subject|2
788620|NCT00704405|2508562|P2|Overall Study (NC Population)|Withdrawal by Subject|3
788621|NCT00704405|2508563|P1|Overall Study (NC Population)|Withdrawal by Subject|2
788622|NCT00704405|2508559|P5|Overall Study (NC Population)|Lost to Follow-up|2
788623|NCT00704405|2508560|P4|Overall Study (NC Population)|Lost to Follow-up|2
788624|NCT00704405|2508561|P3|Overall Study (NC Population)|Lost to Follow-up|1
788625|NCT00704405|2508562|P2|Overall Study (NC Population)|Lost to Follow-up|1
788626|NCT00704405|2508563|P1|Overall Study (NC Population)|Lost to Follow-up|2
788627|NCT00704405|2508559|P5|Overall Study (NC Population)|Adverse Event|0
788628|NCT00704405|2508560|P4|Overall Study (NC Population)|Adverse Event|0
788629|NCT00704405|2508561|P3|Overall Study (NC Population)|Adverse Event|0
788630|NCT00704405|2508562|P2|Overall Study (NC Population)|Adverse Event|0
788631|NCT00704405|2508563|P1|Overall Study (NC Population)|Adverse Event|1
788632|NCT00704418|2508593|P2|Overall Study|Over-enrolled/surgery postponed|6
788633|NCT00704418|2508594|P1|Overall Study|Over-enrolled/surgery postponed|3
788634|NCT00704418|2508593|P2|Overall Study|Withdrawal by Subject|0
788635|NCT00704418|2508594|P1|Overall Study|Withdrawal by Subject|2
788636|NCT00704522|2508604|P2|Overall Study|No information on therapy end|2
788637|NCT00704522|2508605|P1|Overall Study|No information on therapy end|27
788638|NCT00704522|2508604|P2|Overall Study|Undefined causes|7
788639|NCT00704522|2508605|P1|Overall Study|Undefined causes|9
788640|NCT00704522|2508604|P2|Overall Study|Adverse Event|1
788641|NCT00704522|2508605|P1|Overall Study|Adverse Event|9
788642|NCT00704522|2508604|P2|Overall Study|Withdrawal by Subject|8
788643|NCT00704522|2508605|P1|Overall Study|Withdrawal by Subject|17
788644|NCT00704522|2508604|P2|Overall Study|Failure to appear again at hospital|10
788645|NCT00704522|2508605|P1|Overall Study|Failure to appear again at hospital|56
788646|NCT00704522|2508604|P2|Overall Study|Lack of Efficacy|17
788647|NCT00704522|2508605|P1|Overall Study|Lack of Efficacy|65
788648|NCT00704535|2508612|P1|Overall Study|Completed status not on Case Report Form|124
788649|NCT00704535|2508612|P1|Overall Study|Protocol Violation|10
788650|NCT00704535|2508612|P1|Overall Study|Lost to Follow-up|8
788651|NCT00704535|2508612|P1|Overall Study|Death|2
788652|NCT00704535|2508612|P1|Overall Study|Adverse Event|2
788653|NCT00704730|2508629|P2|Overall Study|Withdrawal by Subject|13
788654|NCT00704730|2508630|P1|Overall Study|Withdrawal by Subject|9
788655|NCT00704730|2508629|P2|Overall Study|data unavailable|0
788656|NCT00704730|2508630|P1|Overall Study|data unavailable|1
788657|NCT00704730|2508629|P2|Overall Study|Disease progression per PI|67
788658|NCT00704730|2508630|P1|Overall Study|Disease progression per PI|58
788659|NCT00704730|2508629|P2|Overall Study|Did not receive drug|2
788660|NCT00704730|2508630|P1|Overall Study|Did not receive drug|5
788661|NCT00704730|2508629|P2|Overall Study|Physician Decision|0
788662|NCT00704730|2508630|P1|Overall Study|Physician Decision|2
788663|NCT00704730|2508629|P2|Overall Study|Death|5
788664|NCT00704730|2508630|P1|Overall Study|Death|11
788665|NCT00704730|2508629|P2|Overall Study|Adverse Event|9
788666|NCT00704730|2508630|P1|Overall Study|Adverse Event|35
788667|NCT00704808|2508651|P1|Overall Study|Treatment change|1
788668|NCT00704808|2508651|P1|Overall Study|Lost to Follow-up|1
788669|NCT00704808|2508651|P1|Overall Study|Adverse Event|1
788670|NCT00704808|2508651|P1|Overall Study|Early therapy discontinuation|16
788671|NCT00704808|2508651|P1|Overall Study|Patient's decision|11
788672|NCT00704808|2508651|P1|Overall Study|Tumor progression|80
788673|NCT00704808|2508651|P1|Overall Study|Death|7
788674|NCT00704808|2508651|P1|Overall Study|Discontinued prior to starting treatment|14
788675|NCT00704964|2508699|P1|Overall Study|Not completed on time|328
788676|NCT00705016|2508732|P3|Overall Study|Unspecified|6
788677|NCT00705016|2508733|P2|Overall Study|Unspecified|6
788678|NCT00705016|2508734|P1|Overall Study|Unspecified|9
788679|NCT00705016|2508732|P3|Overall Study|Symptomatic Deterioration|1
788680|NCT00705016|2508733|P2|Overall Study|Symptomatic Deterioration|1
788681|NCT00705016|2508734|P1|Overall Study|Symptomatic Deterioration|3
788682|NCT00705016|2508732|P3|Overall Study|Progressive Disease|33
788683|NCT00705016|2508733|P2|Overall Study|Progressive Disease|29
788684|NCT00705016|2508734|P1|Overall Study|Progressive Disease|33
788685|NCT00705016|2508732|P3|Overall Study|Withdrawal by Subject|2
788686|NCT00705016|2508733|P2|Overall Study|Withdrawal by Subject|3
788687|NCT00705016|2508734|P1|Overall Study|Withdrawal by Subject|4
788688|NCT00705016|2508732|P3|Overall Study|Protocol Violation|1
788689|NCT00705016|2508733|P2|Overall Study|Protocol Violation|1
788690|NCT00705016|2508734|P1|Overall Study|Protocol Violation|0
788691|NCT00705016|2508732|P3|Overall Study|Death|5
788692|NCT00705016|2508733|P2|Overall Study|Death|7
788693|NCT00705016|2508734|P1|Overall Study|Death|5
788694|NCT00705016|2508732|P3|Overall Study|Adverse Event|10
788695|NCT00705016|2508733|P2|Overall Study|Adverse Event|11
788696|NCT00705016|2508734|P1|Overall Study|Adverse Event|6
788697|NCT00705146|2508780|P2|Overall Study|Lost to Follow-up|1
788698|NCT00705146|2508781|P1|Overall Study|Lost to Follow-up|1
788699|NCT00705159|2508793|P4|Overall Study|Screen Failure|1
788700|NCT00705159|2508794|P3|Overall Study|Screen Failure|0
788701|NCT00705159|2508795|P2|Overall Study|Screen Failure|0
788702|NCT00705159|2508796|P1|Overall Study|Screen Failure|0
788703|NCT00705159|2508793|P4|Overall Study|Lost to Follow-up|2
788704|NCT00705159|2508794|P3|Overall Study|Lost to Follow-up|3
788705|NCT00705159|2508795|P2|Overall Study|Lost to Follow-up|0
788706|NCT00705159|2508796|P1|Overall Study|Lost to Follow-up|0
788707|NCT00705159|2508793|P4|Overall Study|Adverse Event|0
788708|NCT00705159|2508794|P3|Overall Study|Adverse Event|1
788709|NCT00705159|2508795|P2|Overall Study|Adverse Event|0
788710|NCT00705159|2508796|P1|Overall Study|Adverse Event|0
788711|NCT00705159|2508793|P4|Overall Study|Protocol Violation|0
788712|NCT00705159|2508794|P3|Overall Study|Protocol Violation|0
788713|NCT00705159|2508795|P2|Overall Study|Protocol Violation|1
788714|NCT00705159|2508796|P1|Overall Study|Protocol Violation|0
788715|NCT00705159|2508793|P4|Overall Study|Withdrawal by Subject|1
788716|NCT00705159|2508794|P3|Overall Study|Withdrawal by Subject|1
788717|NCT00705159|2508795|P2|Overall Study|Withdrawal by Subject|1
788718|NCT00705159|2508796|P1|Overall Study|Withdrawal by Subject|0
788719|NCT00705224|2508814|P1|Overall Study|Lost to Follow-up|5
788720|NCT00705224|2508814|P1|Overall Study|Withdrawal by Subject|3
788721|NCT00705224|2508814|P1|Overall Study|Lack of Efficacy|2
788722|NCT00705224|2508814|P1|Overall Study|Adverse Event|1
788723|NCT00705250|2508826|P1|Overall Study|Patient died in car accident|1
788724|NCT00705250|2508826|P1|Overall Study|Withdrawal by Subject|1
788725|NCT00705263|2508830|P1|Overall Study|Withdrawal by Subject|2
788726|NCT00705289|2508834|P1|Overall Study|Subject or treating physician's choice|131
788727|NCT00705341|2508860|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
788728|NCT00705341|2508861|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
788729|NCT00705341|2508862|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
788730|NCT00705341|2508863|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
788731|NCT00705341|2508860|P4|Phase 2: Trial|Withdrawal by Subject|4
788732|NCT00705341|2508861|P3|Phase 2: Trial|Withdrawal by Subject|6
788733|NCT00705341|2508862|P2|Phase 2: Trial|Withdrawal by Subject|0
788734|NCT00705341|2508863|P1|Phase 2: Trial|Withdrawal by Subject|0
788735|NCT00705367|2508873|P2|Long-term Extension Period|Administrative reason by sponsor|0
788736|NCT00705367|2508874|P1|Long-term Extension Period|Administrative reason by sponsor|3
788737|NCT00705367|2508873|P2|Long-term Extension Period|No longer met study criteria|0
788738|NCT00705367|2508874|P1|Long-term Extension Period|No longer met study criteria|1
788739|NCT00705367|2508873|P2|Long-term Extension Period|Lack of Efficacy|0
788740|NCT00705367|2508874|P1|Long-term Extension Period|Lack of Efficacy|1
788741|NCT00705367|2508873|P2|Long-term Extension Period|Withdrawal by Subject|0
788742|NCT00705367|2508874|P1|Long-term Extension Period|Withdrawal by Subject|2
788743|NCT00705367|2508873|P2|Long-term Extension Period|Adverse Event|0
788744|NCT00705367|2508874|P1|Long-term Extension Period|Adverse Event|2
788745|NCT00705406|2508901|P2|Overall Study|Did not receive study drug|2
788746|NCT00705406|2508902|P1|Overall Study|Did not receive study drug|1
788747|NCT00705406|2508901|P2|Overall Study|Lost to Follow-up|3
788748|NCT00705406|2508902|P1|Overall Study|Lost to Follow-up|3
788749|NCT00698646|2508927|P3|Overall Study|Administrative problems|1
788750|NCT00698646|2508928|P2|Overall Study|Administrative problems|0
788751|NCT00698646|2508929|P1|Overall Study|Administrative problems|1
788752|NCT00698646|2508927|P3|Overall Study|Lost to Follow-up|2
788753|NCT00698646|2508928|P2|Overall Study|Lost to Follow-up|0
788754|NCT00698646|2508929|P1|Overall Study|Lost to Follow-up|0
788755|NCT00698646|2508927|P3|Overall Study|Withdrawal by Subject|8
788756|NCT00698646|2508928|P2|Overall Study|Withdrawal by Subject|11
788757|NCT00698646|2508929|P1|Overall Study|Withdrawal by Subject|10
788758|NCT00698646|2508927|P3|Overall Study|Protocol Deviation|3
788759|NCT00698646|2508928|P2|Overall Study|Protocol Deviation|2
788760|NCT00698646|2508929|P1|Overall Study|Protocol Deviation|6
788761|NCT00698646|2508927|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
788762|NCT00698646|2508928|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
788763|NCT00698646|2508929|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
788764|NCT00698646|2508927|P3|Overall Study|Adverse Event|8
788765|NCT00698646|2508928|P2|Overall Study|Adverse Event|7
788766|NCT00698646|2508929|P1|Overall Study|Adverse Event|8
788767|NCT00698685|2508952|P1|Overall Study|Off study pre transplant by clinic MD|1
788768|NCT00698685|2508952|P1|Overall Study|Sister withdrew as donor|1
788769|NCT00698815|2508960|P3|Overall Study|Did not receive protocol treatment|2
788770|NCT00698815|2508961|P2|Overall Study|Did not receive protocol treatment|2
788771|NCT00698815|2508962|P1|Overall Study|Did not receive protocol treatment|1
788772|NCT00698815|2508960|P3|Overall Study|MD discretion|2
788773|NCT00698815|2508961|P2|Overall Study|MD discretion|7
788774|NCT00698815|2508962|P1|Overall Study|MD discretion|2
788775|NCT00698815|2508960|P3|Overall Study|Withdrawal by Subject|2
788776|NCT00698815|2508961|P2|Overall Study|Withdrawal by Subject|3
788777|NCT00698815|2508962|P1|Overall Study|Withdrawal by Subject|6
788778|NCT00698815|2508960|P3|Overall Study|Death|4
788779|NCT00698815|2508961|P2|Overall Study|Death|2
788780|NCT00698815|2508962|P1|Overall Study|Death|1
788781|NCT00698841|2508979|P1|Overall Study|Other|2
788782|NCT00698841|2508979|P1|Overall Study|Study drug toxicity|2
788783|NCT00698841|2508979|P1|Overall Study|Failure to meet eligibility criteria|2
788784|NCT00698841|2508979|P1|Overall Study|Disease progression|7
788785|NCT00698841|2508979|P1|Overall Study|Adverse Event|3
788786|NCT00698841|2508979|P1|Overall Study|Withdrawal by Subject|2
788787|NCT00698932|2509002|P2|Overall Study|Death|0
788788|NCT00698932|2509003|P1|Overall Study|Death|1
788789|NCT00698932|2509002|P2|Overall Study|Safety reasons|2
788790|NCT00698932|2509003|P1|Overall Study|Safety reasons|0
788791|NCT00698932|2509002|P2|Overall Study|Severe non-compliance to protocol|2
788792|NCT00698932|2509003|P1|Overall Study|Severe non-compliance to protocol|1
788793|NCT00698932|2509002|P2|Overall Study|Lost to Follow-up|1
788794|NCT00698932|2509003|P1|Overall Study|Lost to Follow-up|6
788795|NCT00698932|2509002|P2|Overall Study|Withdrawal by Subject|23
788796|NCT00698932|2509003|P1|Overall Study|Withdrawal by Subject|11
788797|NCT00698932|2509002|P2|Overall Study|Study specific discontinuation criteria|4
788798|NCT00698932|2509003|P1|Overall Study|Study specific discontinuation criteria|3
788799|NCT00698932|2509002|P2|Overall Study|Incorrect enrollment|2
788800|NCT00698932|2509003|P1|Overall Study|Incorrect enrollment|0
788801|NCT00698932|2509002|P2|Overall Study|Adverse Event|2
788802|NCT00698932|2509003|P1|Overall Study|Adverse Event|0
788803|NCT00699153|2509033|P2|Overall Study|Travel Problem|0
788804|NCT00699153|2509034|P1|Overall Study|Travel Problem|1
788805|NCT00699153|2509033|P2|Overall Study|Protocol Violation|0
788806|NCT00699153|2509034|P1|Overall Study|Protocol Violation|1
788807|NCT00699153|2509033|P2|Overall Study|Adverse Event|2
788808|NCT00699153|2509034|P1|Overall Study|Adverse Event|0
788809|NCT00699153|2509033|P2|Overall Study|Lost to Follow-up|0
788810|NCT00699153|2509034|P1|Overall Study|Lost to Follow-up|1
788811|NCT00699192|2509049|P3|Overall Study|Protocol Violation|0
788812|NCT00699192|2509050|P2|Overall Study|Protocol Violation|2
788813|NCT00699192|2509051|P1|Overall Study|Protocol Violation|2
788814|NCT00699192|2509049|P3|Overall Study|Administrative problems|1
788815|NCT00699192|2509050|P2|Overall Study|Administrative problems|3
788816|NCT00699192|2509051|P1|Overall Study|Administrative problems|1
788817|NCT00699192|2509049|P3|Overall Study|Withdrawal by Subject|4
788818|NCT00699192|2509050|P2|Overall Study|Withdrawal by Subject|2
788819|NCT00699192|2509051|P1|Overall Study|Withdrawal by Subject|3
788820|NCT00699192|2509049|P3|Overall Study|Lack of Efficacy|1
788821|NCT00699192|2509050|P2|Overall Study|Lack of Efficacy|0
788822|NCT00699192|2509051|P1|Overall Study|Lack of Efficacy|0
788823|NCT00699192|2509049|P3|Overall Study|Abnormal test procedure result(s)|1
788824|NCT00699192|2509050|P2|Overall Study|Abnormal test procedure result(s)|0
788825|NCT00699192|2509051|P1|Overall Study|Abnormal test procedure result(s)|0
788826|NCT00699192|2509049|P3|Overall Study|Adverse Event|3
788827|NCT00699192|2509050|P2|Overall Study|Adverse Event|4
788828|NCT00699192|2509051|P1|Overall Study|Adverse Event|9
788829|NCT00699192|2509049|P3|Overall Study|Missing|1
788830|NCT00699192|2509050|P2|Overall Study|Missing|1
788831|NCT00699192|2509051|P1|Overall Study|Missing|1
788832|NCT00699283|2509073|P2|Overall Study|AE of unknown type|0
788833|NCT00699283|2509074|P1|Overall Study|AE of unknown type|1
788834|NCT00699283|2509073|P2|Overall Study|AE, non-serious non-fatal|1
788835|NCT00699283|2509074|P1|Overall Study|AE, non-serious non-fatal|8
788836|NCT00699283|2509073|P2|Overall Study|SAE, non-fatal|1
788837|NCT00699283|2509074|P1|Overall Study|SAE, non-fatal|1
788838|NCT00699283|2509073|P2|Overall Study|Other Reason|1
788839|NCT00699283|2509074|P1|Overall Study|Other Reason|5
788840|NCT00699283|2509073|P2|Overall Study|Withdrawal by Subject|0
788841|NCT00699283|2509074|P1|Overall Study|Withdrawal by Subject|1
788842|NCT00699283|2509073|P2|Overall Study|Lost to Follow-up|0
788843|NCT00699283|2509074|P1|Overall Study|Lost to Follow-up|2
788844|NCT00699283|2509073|P2|Overall Study|Lack of Efficacy|5
788845|NCT00699283|2509074|P1|Overall Study|Lack of Efficacy|15
788846|NCT00699335|2509079|P1|Overall Study|Missing data|52
788847|NCT00699335|2509079|P1|Overall Study|Combination of multiple reasons|176
788848|NCT00699348|2509110|P1|Overall Study|Unspecified|5
788849|NCT00699348|2509110|P1|Overall Study|Renal transplantation|10
788850|NCT00699348|2509110|P1|Overall Study|Blood transfusion|24
788851|NCT00699348|2509110|P1|Overall Study|Failure to return|1
788852|NCT00699348|2509110|P1|Overall Study|Lack of Efficacy|8
788853|NCT00699348|2509110|P1|Overall Study|Protocol Violation|10
788854|NCT00699348|2509110|P1|Overall Study|Withdrawal by Subject|11
788855|NCT00699348|2509110|P1|Overall Study|Adverse Event|15
788856|NCT00699348|2509110|P1|Overall Study|Death|6
788857|NCT00699374|2509121|P2|Overall Study|Died 28 days after last dose|9
788858|NCT00699374|2509122|P1|Overall Study|Died 28 days after last dose|5
788859|NCT00699374|2509121|P2|Overall Study|Randomized but not treated|2
788860|NCT00699374|2509122|P1|Overall Study|Randomized but not treated|4
788861|NCT00699374|2509121|P2|Overall Study|Study terminated by sponsor|28
788862|NCT00699374|2509122|P1|Overall Study|Study terminated by sponsor|13
788863|NCT00699374|2509121|P2|Overall Study|Protocol Violation|6
788864|NCT00699374|2509122|P1|Overall Study|Protocol Violation|2
788865|NCT00699374|2509121|P2|Overall Study|Unspecified|15
788866|NCT00699374|2509122|P1|Overall Study|Unspecified|18
788867|NCT00699374|2509121|P2|Overall Study|Objective progression or relapse|277
788868|NCT00699374|2509122|P1|Overall Study|Objective progression or relapse|281
788869|NCT00699374|2509121|P2|Overall Study|Withdrawal by Subject|44
788870|NCT00699374|2509122|P1|Overall Study|Withdrawal by Subject|34
788871|NCT00699374|2509121|P2|Overall Study|Lost to Follow-up|5
788872|NCT00699374|2509122|P1|Overall Study|Lost to Follow-up|3
788873|NCT00699374|2509121|P2|Overall Study|Global deterioration of health status|8
788874|NCT00699374|2509122|P1|Overall Study|Global deterioration of health status|7
788875|NCT00699374|2509121|P2|Overall Study|Adverse Event|67
788876|NCT00699374|2509122|P1|Overall Study|Adverse Event|70
788877|NCT00699374|2509121|P2|Overall Study|Death|83
788878|NCT00699374|2509122|P1|Overall Study|Death|93
788879|NCT00699582|2509216|P3|Overall Study|Randomized, Not Treated|0
788880|NCT00699582|2509217|P2|Overall Study|Randomized, Not Treated|1
788881|NCT00699582|2509218|P1|Overall Study|Randomized, Not Treated|2
788882|NCT00699582|2509216|P3|Overall Study|Administrative/Other|0
788883|NCT00699582|2509217|P2|Overall Study|Administrative/Other|3
788884|NCT00699582|2509218|P1|Overall Study|Administrative/Other|4
788885|NCT00699582|2509216|P3|Overall Study|Progressive Disease|0
788886|NCT00699582|2509217|P2|Overall Study|Progressive Disease|0
788887|NCT00699582|2509218|P1|Overall Study|Progressive Disease|1
788888|NCT00699582|2509216|P3|Overall Study|Lack of Efficacy|1
788889|NCT00699582|2509217|P2|Overall Study|Lack of Efficacy|0
788890|NCT00699582|2509218|P1|Overall Study|Lack of Efficacy|1
788891|NCT00699582|2509216|P3|Overall Study|Withdrawal by Subject|4
788892|NCT00699582|2509217|P2|Overall Study|Withdrawal by Subject|7
788893|NCT00699582|2509218|P1|Overall Study|Withdrawal by Subject|6
788894|NCT00699582|2509216|P3|Overall Study|Adverse Event|23
788895|NCT00699582|2509217|P2|Overall Study|Adverse Event|11
788896|NCT00699582|2509218|P1|Overall Study|Adverse Event|4
788897|NCT00699608|2509232|P6|Second Intervention|Withdrawal by Subject|0
788898|NCT00699608|2509233|P5|Second Intervention|Withdrawal by Subject|0
788899|NCT00699608|2509234|P4|Second Intervention|Withdrawal by Subject|1
788900|NCT00699608|2509235|P3|Second Intervention|Withdrawal by Subject|0
788901|NCT00699608|2509236|P2|Second Intervention|Withdrawal by Subject|0
788902|NCT00699608|2509237|P1|Second Intervention|Withdrawal by Subject|0
788903|NCT00699608|2509232|P6|Second Intervention|Adverse Event|0
788904|NCT00699608|2509233|P5|Second Intervention|Adverse Event|0
788905|NCT00699608|2509234|P4|Second Intervention|Adverse Event|0
788906|NCT00699608|2509235|P3|Second Intervention|Adverse Event|1
788907|NCT00699608|2509236|P2|Second Intervention|Adverse Event|0
788908|NCT00699608|2509237|P1|Second Intervention|Adverse Event|0
788909|NCT00699608|2509232|P6|First Intervention|Protocol Violation|0
788910|NCT00699608|2509233|P5|First Intervention|Protocol Violation|1
788911|NCT00699608|2509234|P4|First Intervention|Protocol Violation|0
788912|NCT00699608|2509235|P3|First Intervention|Protocol Violation|0
788913|NCT00699608|2509236|P2|First Intervention|Protocol Violation|0
788914|NCT00699608|2509237|P1|First Intervention|Protocol Violation|0
788915|NCT00699608|2509232|P6|First Intervention|Withdrawal by Subject|0
788916|NCT00699608|2509233|P5|First Intervention|Withdrawal by Subject|0
788917|NCT00699608|2509234|P4|First Intervention|Withdrawal by Subject|0
788918|NCT00699608|2509235|P3|First Intervention|Withdrawal by Subject|1
788919|NCT00699608|2509236|P2|First Intervention|Withdrawal by Subject|0
788920|NCT00699608|2509237|P1|First Intervention|Withdrawal by Subject|0
788921|NCT00699660|2509289|P2|Overall Study|missing reports and recording failures|6
788922|NCT00699660|2509290|P1|Overall Study|missing reports and recording failures|10
788923|NCT00699660|2509289|P2|Overall Study|Lost to Follow-up|2
788924|NCT00699660|2509290|P1|Overall Study|Lost to Follow-up|4
788925|NCT00699699|2509302|P1|Overall Study|Individual different reasons|21
788926|NCT00699699|2509302|P1|Overall Study|Adverse Event|36
788927|NCT00699751|2509311|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
788928|NCT00699751|2509312|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
788929|NCT00699751|2509311|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
788930|NCT00699751|2509312|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
788931|NCT00699751|2509311|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
788932|NCT00699751|2509312|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
788933|NCT00699751|2509311|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
788934|NCT00699751|2509312|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
788935|NCT00699751|2509311|P2|Period 1: Without/Before Drug Switch|Unspecified|20
788936|NCT00699751|2509312|P1|Period 1: Without/Before Drug Switch|Unspecified|30
788937|NCT00699751|2509311|P2|Period 1: Without/Before Drug Switch|Subject Request|23
788938|NCT00699751|2509312|P1|Period 1: Without/Before Drug Switch|Subject Request|43
788939|NCT00699751|2509311|P2|Period 1: Without/Before Drug Switch|Death|29
788940|NCT00699751|2509312|P1|Period 1: Without/Before Drug Switch|Death|28
788941|NCT00699751|2509311|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
788942|NCT00699751|2509312|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
788943|NCT00705432|2509403|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
788944|NCT00705432|2509404|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
788945|NCT00705432|2509405|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
788946|NCT00705432|2509406|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
788947|NCT00705432|2509407|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
788948|NCT00705432|2509408|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
788949|NCT00705432|2509403|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
788950|NCT00705432|2509404|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
788951|NCT00705432|2509405|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
788952|NCT00705432|2509406|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
788953|NCT00705432|2509407|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
788954|NCT00705432|2509408|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
788955|NCT00705432|2509403|P6|Treatment Period|Non medical reason|7
788956|NCT00705432|2509404|P5|Treatment Period|Non medical reason|7
788957|NCT00705432|2509405|P4|Treatment Period|Non medical reason|4
788958|NCT00705432|2509406|P3|Treatment Period|Non medical reason|37
788959|NCT00705432|2509407|P2|Treatment Period|Non medical reason|32
788960|NCT00705432|2509408|P1|Treatment Period|Non medical reason|26
788961|NCT00705432|2509403|P6|Treatment Period|Treatment failure|14
788962|NCT00705432|2509404|P5|Treatment Period|Treatment failure|13
788963|NCT00705432|2509405|P4|Treatment Period|Treatment failure|25
788964|NCT00705432|2509406|P3|Treatment Period|Treatment failure|33
788965|NCT00705432|2509407|P2|Treatment Period|Treatment failure|42
788966|NCT00705432|2509408|P1|Treatment Period|Treatment failure|92
788967|NCT00705432|2509403|P6|Treatment Period|Adverse Event|9
788968|NCT00705432|2509404|P5|Treatment Period|Adverse Event|8
788969|NCT00705432|2509405|P4|Treatment Period|Adverse Event|12
788970|NCT00705432|2509406|P3|Treatment Period|Adverse Event|51
788971|NCT00705432|2509407|P2|Treatment Period|Adverse Event|37
788972|NCT00705432|2509408|P1|Treatment Period|Adverse Event|45
788973|NCT00705523|2509445|P2|Overall Study|Lost to Follow-up|3
788974|NCT00705523|2509446|P1|Overall Study|Lost to Follow-up|2
788975|NCT00705536|2509456|P4|Start Period 1|Withdrawal by Subject|1
788976|NCT00705536|2509457|P3|Start Period 1|Withdrawal by Subject|0
788977|NCT00705536|2509458|P2|Start Period 1|Withdrawal by Subject|0
788978|NCT00705536|2509459|P1|Start Period 1|Withdrawal by Subject|0
788979|NCT00705575|2509520|P2|Overall Study|Withdrawal by Subject|10
788980|NCT00705575|2509521|P1|Overall Study|Withdrawal by Subject|5
788981|NCT00705575|2509520|P2|Overall Study|Protocol Violation|2
788982|NCT00705575|2509521|P1|Overall Study|Protocol Violation|2
788983|NCT00705575|2509520|P2|Overall Study|Lost to Follow-up|4
788984|NCT00705575|2509521|P1|Overall Study|Lost to Follow-up|3
788985|NCT00705575|2509520|P2|Overall Study|Adverse Event|15
788986|NCT00705575|2509521|P1|Overall Study|Adverse Event|11
788987|NCT00705575|2509520|P2|Overall Study|Abnormal test procedure result(s)|12
788988|NCT00705575|2509521|P1|Overall Study|Abnormal test procedure result(s)|2
788989|NCT00705575|2509520|P2|Overall Study|Abnormal laboratory value(s)|3
788990|NCT00705575|2509521|P1|Overall Study|Abnormal laboratory value(s)|0
788991|NCT00705614|2509535|P2|Switch to Remicade|Administrative Reason|9
788992|NCT00705614|2509536|P1|Switch to Remicade|Administrative Reason|0
788993|NCT00705614|2509535|P2|Switch to Remicade|Withdrawal by Subject|12
788994|NCT00705614|2509536|P1|Switch to Remicade|Withdrawal by Subject|0
788995|NCT00705614|2509535|P2|Switch to Remicade|Lost to Follow-up|23
788996|NCT00705614|2509536|P1|Switch to Remicade|Lost to Follow-up|0
788997|NCT00705614|2509535|P2|Switch to Remicade|Adverse Event|5
788998|NCT00705614|2509536|P1|Switch to Remicade|Adverse Event|0
788999|NCT00705614|2509535|P2|Initial Intervention|Status completion unknown|0
789000|NCT00705614|2509536|P1|Initial Intervention|Status completion unknown|3
789001|NCT00705614|2509535|P2|Initial Intervention|Administrative Reason|38
789002|NCT00705614|2509536|P1|Initial Intervention|Administrative Reason|51
789003|NCT00705614|2509535|P2|Initial Intervention|Withdrawal by Subject|71
789004|NCT00705614|2509536|P1|Initial Intervention|Withdrawal by Subject|114
789005|NCT00705614|2509535|P2|Initial Intervention|Lost to Follow-up|191
789006|NCT00705614|2509536|P1|Initial Intervention|Lost to Follow-up|310
789007|NCT00705614|2509535|P2|Initial Intervention|Adverse Event|21
789008|NCT00705614|2509536|P1|Initial Intervention|Adverse Event|40
789009|NCT00705666|2509588|P1|Overall Study|Untreated|5
789010|NCT00705666|2509588|P1|Overall Study|Lack of data|3
789011|NCT00705666|2509588|P1|Overall Study|Other|2
789012|NCT00705666|2509588|P1|Overall Study|Not specified|12
789013|NCT00705666|2509588|P1|Overall Study|Adverse Event|4
789014|NCT00705666|2509588|P1|Overall Study|Death|1
789015|NCT00705666|2509588|P1|Overall Study|Lost to Follow-up|5
789016|NCT00705666|2509588|P1|Overall Study|Physician Decision|7
789017|NCT00705666|2509588|P1|Overall Study|Withdrawal by Subject|21
789018|NCT00705666|2509588|P1|Overall Study|No post-treatment questionnaire|279
789019|NCT00705679|2509597|P5|Overall Study|Withdrawal by Subject|33
789020|NCT00705679|2509598|P4|Overall Study|Withdrawal by Subject|47
789021|NCT00705679|2509599|P3|Overall Study|Withdrawal by Subject|68
789022|NCT00705679|2509600|P2|Overall Study|Withdrawal by Subject|77
789023|NCT00705679|2509601|P1|Overall Study|Withdrawal by Subject|32
789024|NCT00705679|2509597|P5|Overall Study|Physician Decision|0
789025|NCT00705679|2509598|P4|Overall Study|Physician Decision|1
789026|NCT00705679|2509599|P3|Overall Study|Physician Decision|0
789027|NCT00705679|2509600|P2|Overall Study|Physician Decision|1
789028|NCT00705679|2509601|P1|Overall Study|Physician Decision|0
789029|NCT00705679|2509597|P5|Overall Study|Lost to Follow-up|35
789030|NCT00705679|2509598|P4|Overall Study|Lost to Follow-up|30
789031|NCT00705679|2509599|P3|Overall Study|Lost to Follow-up|44
789032|NCT00705679|2509600|P2|Overall Study|Lost to Follow-up|60
789033|NCT00705679|2509601|P1|Overall Study|Lost to Follow-up|32
789034|NCT00705679|2509597|P5|Overall Study|Death|1
789035|NCT00705679|2509598|P4|Overall Study|Death|2
789036|NCT00705679|2509599|P3|Overall Study|Death|3
789037|NCT00705679|2509600|P2|Overall Study|Death|0
789038|NCT00705679|2509601|P1|Overall Study|Death|0
789039|NCT00705679|2509597|P5|Overall Study|Adverse Event|0
789040|NCT00705679|2509598|P4|Overall Study|Adverse Event|0
789041|NCT00705679|2509599|P3|Overall Study|Adverse Event|0
789042|NCT00705679|2509600|P2|Overall Study|Adverse Event|1
789043|NCT00705679|2509601|P1|Overall Study|Adverse Event|1
789044|NCT00705718|2509638|P2|Overall Study|Follow up not done|4
789045|NCT00705718|2509639|P1|Overall Study|Follow up not done|1
789046|NCT00705718|2509638|P2|Overall Study|Not due for Visit|12
789047|NCT00705718|2509639|P1|Overall Study|Not due for Visit|0
789048|NCT00705718|2509638|P2|Overall Study|Death|6
789049|NCT00705718|2509639|P1|Overall Study|Death|6
789050|NCT00705757|2509658|P3|Overall Study|Withdrawal by Subject|2
789051|NCT00705757|2509659|P2|Overall Study|Withdrawal by Subject|1
789052|NCT00705757|2509660|P1|Overall Study|Withdrawal by Subject|1
789053|NCT00705757|2509658|P3|Overall Study|Lost to Follow-up|6
789054|NCT00705757|2509659|P2|Overall Study|Lost to Follow-up|6
789055|NCT00705757|2509660|P1|Overall Study|Lost to Follow-up|7
789056|NCT00705757|2509658|P3|Overall Study|Lack of Efficacy|3
789057|NCT00705757|2509659|P2|Overall Study|Lack of Efficacy|1
789058|NCT00705757|2509660|P1|Overall Study|Lack of Efficacy|5
789059|NCT00708032|2509681|P2|Overall Study|Withdrawal by Subject|1
789060|NCT00708032|2509682|P1|Overall Study|Withdrawal by Subject|0
789061|NCT00708032|2509681|P2|Overall Study|Protocol Violation|1
789062|NCT00708032|2509682|P1|Overall Study|Protocol Violation|4
789063|NCT00708032|2509681|P2|Overall Study|Did not meet protocol criteria|2
789064|NCT00708032|2509682|P1|Overall Study|Did not meet protocol criteria|1
789065|NCT00708032|2509681|P2|Overall Study|Visit out of range at month 12|1
789066|NCT00708032|2509682|P1|Overall Study|Visit out of range at month 12|4
789067|NCT00708032|2509681|P2|Overall Study|Poor vision|6
789068|NCT00708032|2509682|P1|Overall Study|Poor vision|0
789069|NCT00708032|2509681|P2|Overall Study|Pregnancy|1
789070|NCT00708032|2509682|P1|Overall Study|Pregnancy|0
789071|NCT00708032|2509681|P2|Overall Study|Lost to Follow-up|2
789072|NCT00708032|2509682|P1|Overall Study|Lost to Follow-up|1
789073|NCT00708032|2509681|P2|Overall Study|Adverse Event|2
789074|NCT00708032|2509682|P1|Overall Study|Adverse Event|0
892144|NCT02601573|2829065|P2|Overall Study|Lost to Follow-up|3
892145|NCT02601573|2829066|P1|Overall Study|Lost to Follow-up|0
892170|NCT02550288|2829326|P5|Overall Study|Withdrawal by Subject|0
892171|NCT02550288|2829327|P4|Overall Study|Withdrawal by Subject|1
892172|NCT02550288|2829328|P3|Overall Study|Withdrawal by Subject|0
892173|NCT02550288|2829329|P2|Overall Study|Withdrawal by Subject|0
892174|NCT02550288|2829330|P1|Overall Study|Withdrawal by Subject|0
892175|NCT02550288|2829326|P5|Overall Study|Participant moved|0
892176|NCT02550288|2829327|P4|Overall Study|Participant moved|1
892177|NCT02550288|2829328|P3|Overall Study|Participant moved|0
892178|NCT02550288|2829329|P2|Overall Study|Participant moved|0
892179|NCT02550288|2829330|P1|Overall Study|Participant moved|0
892180|NCT02550288|2829326|P5|Overall Study|Protocol Violation|3
892181|NCT02550288|2829327|P4|Overall Study|Protocol Violation|0
892182|NCT02550288|2829328|P3|Overall Study|Protocol Violation|1
892183|NCT02550288|2829329|P2|Overall Study|Protocol Violation|2
892184|NCT02550288|2829330|P1|Overall Study|Protocol Violation|2
789120|NCT00708162|2509947|P2|Open-Label Phase|Other|0
789121|NCT00708162|2509948|P1|Open-Label Phase|Other|1
789122|NCT00708162|2509947|P2|Open-Label Phase|Adverse Event|2
789123|NCT00708162|2509948|P1|Open-Label Phase|Adverse Event|1
789124|NCT00708162|2509947|P2|Open-Label Phase|Death|1
789125|NCT00708162|2509948|P1|Open-Label Phase|Death|3
789126|NCT00708162|2509947|P2|Open-Label Phase|Investigator's Discretion|2
789127|NCT00708162|2509948|P1|Open-Label Phase|Investigator's Discretion|3
789128|NCT00708162|2509947|P2|Open-Label Phase|Lack of Efficacy|4
789129|NCT00708162|2509948|P1|Open-Label Phase|Lack of Efficacy|7
789130|NCT00708162|2509947|P2|Open-Label Phase|Participant Noncompliance|7
789131|NCT00708162|2509948|P1|Open-Label Phase|Participant Noncompliance|7
789132|NCT00708162|2509947|P2|Open-Label Phase|Withdrew Consent|6
789133|NCT00708162|2509948|P1|Open-Label Phase|Withdrew Consent|12
789134|NCT00708162|2509947|P2|Open-Label Phase|Lost to Follow-up|8
789135|NCT00708162|2509948|P1|Open-Label Phase|Lost to Follow-up|10
789136|NCT00708162|2509947|P2|Randomized Phase|Pregnancy|0
789137|NCT00708162|2509948|P1|Randomized Phase|Pregnancy|3
789138|NCT00708162|2509947|P2|Randomized Phase|Death|9
789139|NCT00708162|2509948|P1|Randomized Phase|Death|2
789140|NCT00708162|2509947|P2|Randomized Phase|Investigator’s Discretion|10
789141|NCT00708162|2509948|P1|Randomized Phase|Investigator’s Discretion|7
789142|NCT00708162|2509947|P2|Randomized Phase|Adverse Event|12
789143|NCT00708162|2509948|P1|Randomized Phase|Adverse Event|8
789144|NCT00708162|2509947|P2|Randomized Phase|Protocol Violation|11
789145|NCT00708162|2509948|P1|Randomized Phase|Protocol Violation|10
789146|NCT00708162|2509947|P2|Randomized Phase|Lack of Efficacy|19
789147|NCT00708162|2509948|P1|Randomized Phase|Lack of Efficacy|14
789148|NCT00708162|2509947|P2|Randomized Phase|Withdrew Consent|22
789149|NCT00708162|2509948|P1|Randomized Phase|Withdrew Consent|31
789150|NCT00708162|2509947|P2|Randomized Phase|Lost to Follow-up|34
789151|NCT00708162|2509948|P1|Randomized Phase|Lost to Follow-up|34
789152|NCT00708162|2509947|P2|Randomized Phase|Participant Noncompliance|32
789153|NCT00708162|2509948|P1|Randomized Phase|Participant Noncompliance|40
789154|NCT00708162|2509947|P2|Randomized Phase|Randomized but Not Treated|5
789155|NCT00708162|2509948|P1|Randomized Phase|Randomized but Not Treated|7
789156|NCT00708175|2509991|P2|Overall Study|BMD loss >7%|3
789157|NCT00708175|2509992|P1|Overall Study|BMD loss >7%|2
789158|NCT00708175|2509991|P2|Overall Study|Withdrawal by Subject|7
789159|NCT00708175|2509992|P1|Overall Study|Withdrawal by Subject|5
789160|NCT00708175|2509991|P2|Overall Study|Lost to Follow-up|3
789161|NCT00708175|2509992|P1|Overall Study|Lost to Follow-up|5
789162|NCT00708175|2509991|P2|Overall Study|Protocol Violation|3
789163|NCT00708175|2509992|P1|Overall Study|Protocol Violation|2
789164|NCT00708175|2509991|P2|Overall Study|Adverse Event|5
789165|NCT00708175|2509992|P1|Overall Study|Adverse Event|4
789166|NCT00708201|2510008|P2|Overall Study|Protocol Violation|1
789167|NCT00708201|2510009|P1|Overall Study|Protocol Violation|0
789168|NCT00708201|2510008|P2|Overall Study|Lost to Follow-up|0
789169|NCT00708201|2510009|P1|Overall Study|Lost to Follow-up|2
789170|NCT00708201|2510008|P2|Overall Study|Withdrawal by Subject|1
789171|NCT00708201|2510009|P1|Overall Study|Withdrawal by Subject|1
789172|NCT00708201|2510008|P2|Overall Study|Adverse Event|4
789173|NCT00708201|2510009|P1|Overall Study|Adverse Event|4
789174|NCT00708214|2510034|P3|Overall Study|Progressive Disease|5
789175|NCT00708214|2510035|P2|Overall Study|Progressive Disease|6
789176|NCT00708214|2510036|P1|Overall Study|Progressive Disease|4
789177|NCT00708214|2510034|P3|Overall Study|Other|1
789178|NCT00708214|2510035|P2|Overall Study|Other|1
789179|NCT00708214|2510036|P1|Overall Study|Other|0
789180|NCT00708214|2510034|P3|Overall Study|Other Adverse Event|2
789181|NCT00708214|2510035|P2|Overall Study|Other Adverse Event|6
789182|NCT00708214|2510036|P1|Overall Study|Other Adverse Event|3
892185|NCT02550288|2829326|P5|Overall Study|Physician Decision|0
892186|NCT02550288|2829327|P4|Overall Study|Physician Decision|1
892187|NCT02550288|2829328|P3|Overall Study|Physician Decision|0
892188|NCT02550288|2829329|P2|Overall Study|Physician Decision|0
892189|NCT02550288|2829330|P1|Overall Study|Physician Decision|0
892190|NCT02550288|2829326|P5|Overall Study|Adverse Event|0
892191|NCT02550288|2829327|P4|Overall Study|Adverse Event|0
892192|NCT02550288|2829328|P3|Overall Study|Adverse Event|0
892193|NCT02550288|2829329|P2|Overall Study|Adverse Event|1
892194|NCT02550288|2829330|P1|Overall Study|Adverse Event|0
892195|NCT02519855|2829429|P2|Overall Study|Lost to Follow-up|3
892196|NCT02519855|2829430|P1|Overall Study|Lost to Follow-up|3
892197|NCT02519855|2829429|P2|Overall Study|Adverse Event|1
892198|NCT02519855|2829430|P1|Overall Study|Adverse Event|0
892200|NCT02293395|2829452|P2|Overall Study|Withdrawal by Subject|7
892201|NCT02293395|2829453|P1|Overall Study|Withdrawal by Subject|8
892202|NCT02293395|2829452|P2|Overall Study|Lost to Follow-up|0
892203|NCT02293395|2829453|P1|Overall Study|Lost to Follow-up|1
892204|NCT02286193|2829459|P1|Overall Study|Referred: Declined service|38
892205|NCT02286193|2829459|P1|Overall Study|Referred: unable to reach/resource sent|104
892206|NCT02286193|2829459|P1|Overall Study|Referred: CRS unable to make contact|62
892209|NCT02186873|2829493|P2|Overall Study|Withdrawal by Subject|2
892210|NCT02186873|2829494|P1|Overall Study|Withdrawal by Subject|7
789211|NCT00708422|2510114|P2|Overall Study|Withdrawal by Subject|0
789212|NCT00708422|2510115|P1|Overall Study|Withdrawal by Subject|1
789213|NCT00708422|2510114|P2|Overall Study|Adverse Event|1
789214|NCT00708422|2510115|P1|Overall Study|Adverse Event|3
789215|NCT00708435|2510125|P2|Overall Study|Refused hospitalization|0
789216|NCT00708435|2510126|P1|Overall Study|Refused hospitalization|1
789217|NCT00708435|2510125|P2|Overall Study|Intervention by primary care physician|0
789218|NCT00708435|2510126|P1|Overall Study|Intervention by primary care physician|1
789219|NCT00708435|2510125|P2|Overall Study|Protocol Violation|1
789220|NCT00708435|2510126|P1|Overall Study|Protocol Violation|0
789221|NCT00708435|2510125|P2|Overall Study|Adverse Event|0
789222|NCT00708435|2510126|P1|Overall Study|Adverse Event|1
789223|NCT00708435|2510125|P2|Overall Study|Withdrawal by Subject|7
789224|NCT00708435|2510126|P1|Overall Study|Withdrawal by Subject|3
789225|NCT00708435|2510125|P2|Overall Study|Lost to Follow-up|4
789226|NCT00708435|2510126|P1|Overall Study|Lost to Follow-up|9
789227|NCT00708435|2510125|P2|Overall Study|Death / Serious Adverse Event|5
789228|NCT00708435|2510126|P1|Overall Study|Death / Serious Adverse Event|10
789229|NCT00708461|2510153|P2|Overall Study|left workforce|180
789230|NCT00708461|2510154|P1|Overall Study|left workforce|115
789231|NCT00708461|2510153|P2|Overall Study|Withdrawal by Subject|9
789232|NCT00708461|2510154|P1|Overall Study|Withdrawal by Subject|8
789233|NCT00708461|2510153|P2|Overall Study|Lost to Follow-up|11
789234|NCT00708461|2510154|P1|Overall Study|Lost to Follow-up|18
789235|NCT00708500|2510163|P3|FOLLOWUP|Non-compliance with protocol|1
789236|NCT00708500|2510164|P2|FOLLOWUP|Non-compliance with protocol|0
789237|NCT00708500|2510165|P1|FOLLOWUP|Non-compliance with protocol|5
789238|NCT00708500|2510163|P3|FOLLOWUP|Subject withdrew consent|5
789239|NCT00708500|2510164|P2|FOLLOWUP|Subject withdrew consent|4
789240|NCT00708500|2510165|P1|FOLLOWUP|Subject withdrew consent|31
789241|NCT00708500|2510163|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
789242|NCT00708500|2510164|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
789243|NCT00708500|2510165|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
789244|NCT00708500|2510163|P3|FOLLOWUP|Lost to Follow-up|4
789245|NCT00708500|2510164|P2|FOLLOWUP|Lost to Follow-up|6
789246|NCT00708500|2510165|P1|FOLLOWUP|Lost to Follow-up|1
789247|NCT00708500|2510163|P3|FOLLOWUP|Adverse Event|0
789248|NCT00708500|2510164|P2|FOLLOWUP|Adverse Event|1
789249|NCT00708500|2510165|P1|FOLLOWUP|Adverse Event|0
789250|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
789251|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
789252|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
789253|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
789254|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
789255|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
789256|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
789257|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
789258|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
789259|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
789260|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
789261|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
789262|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
789263|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
789264|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
789265|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
789266|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
789267|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
789268|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
789269|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
789270|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
789271|NCT00708500|2510163|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
789272|NCT00708500|2510164|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
789273|NCT00708500|2510165|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
789274|NCT00708500|2510163|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
789275|NCT00708500|2510164|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
789276|NCT00708500|2510165|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
789277|NCT00708500|2510163|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
789278|NCT00708500|2510164|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
789279|NCT00708500|2510165|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
789280|NCT00708500|2510163|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
789281|NCT00708500|2510164|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
789282|NCT00708500|2510165|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
789283|NCT00708500|2510163|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
789284|NCT00708500|2510164|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
789285|NCT00708500|2510165|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
789286|NCT00708500|2510163|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
789287|NCT00708500|2510164|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
789288|NCT00708500|2510165|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
789289|NCT00708643|2510195|P2|Overall Study|Adverse Event|1
789290|NCT00708643|2510196|P1|Overall Study|Adverse Event|0
789291|NCT00708682|2510212|P1|Toddler Dose|Failed to Return|4
789292|NCT00708682|2510212|P1|Toddler Dose|Lost to Follow-up|3
789293|NCT00708682|2510212|P1|Toddler Dose|Parent/Legal Guardian Request|1
789294|NCT00708682|2510212|P1|After Infant Series|Parent/Legal Guardian Request|1
789295|NCT00708682|2510212|P1|Infant Series|Not Specified|19
789296|NCT00708682|2510212|P1|Infant Series|Failed to return|2
789297|NCT00708682|2510212|P1|Infant Series|Parent/legal guardian request|6
789298|NCT00708682|2510212|P1|Infant Series|Protocol Violation|1
789299|NCT00708682|2510212|P1|Infant Series|Lost to Follow-up|4
789300|NCT00708682|2510212|P1|Infant Series|Adverse Event|1
789301|NCT00708708|2510231|P1|Overall Study|Missing values|392
789302|NCT00708708|2510231|P1|Overall Study|Adverse Event|3
789303|NCT00708708|2510231|P1|Overall Study|Pregnancy|3
789304|NCT00708708|2510231|P1|Overall Study|Lack of compliance|3
789305|NCT00708708|2510231|P1|Overall Study|Lack of effectiveness|4
789306|NCT00708708|2510231|P1|Overall Study|Administrative reasons|7
789307|NCT00708708|2510231|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
789308|NCT00708708|2510231|P1|Overall Study|Good effectiveness|9
789309|NCT00708708|2510231|P1|Overall Study|Other unspecified|11
789310|NCT00708708|2510231|P1|Overall Study|Another therapy along with Enbrel|15
789311|NCT00708708|2510231|P1|Overall Study|Intolerance|42
789312|NCT00708708|2510231|P1|Overall Study|Withdrawal by Subject|51
789313|NCT00708708|2510231|P1|Overall Study|Lost to Follow-up|52
789314|NCT00708708|2510231|P1|Overall Study|Another therapy instead of Enbrel|141
789315|NCT00708734|2510295|P1|Overall Study|leg fracture|1
789316|NCT00708734|2510295|P1|Overall Study|vertigo|1
789317|NCT00708734|2510295|P1|Overall Study|knee replacement|1
789318|NCT00708734|2510295|P1|Overall Study|leg injury|1
789319|NCT00708734|2510295|P1|Overall Study|moved|1
789320|NCT00708734|2510295|P1|Overall Study|scheduling conflict|2
789321|NCT00709059|2510342|P1|Overall Study|Serious side effects|11
789322|NCT00709059|2510342|P1|Overall Study|Side effects|20
789323|NCT00709059|2510342|P1|Overall Study|Disease complication|3
789324|NCT00709059|2510342|P1|Overall Study|Physician Decision|7
789325|NCT00709059|2510342|P1|Overall Study|Withdrawal by Subject|19
789326|NCT00709059|2510342|P1|Overall Study|Lost to Follow-up|34
789327|NCT00709098|2510349|P3|Open-label Period|Lost to Follow-up|1
789328|NCT00709098|2510350|P2|Open-label Period|Lost to Follow-up|0
789329|NCT00709098|2510351|P1|Open-label Period|Lost to Follow-up|0
789330|NCT00709098|2510349|P3|Open-label Period|Death|1
789331|NCT00709098|2510350|P2|Open-label Period|Death|0
789332|NCT00709098|2510351|P1|Open-label Period|Death|0
789333|NCT00709098|2510349|P3|Open-label Period|Administrative reason|5
789334|NCT00709098|2510350|P2|Open-label Period|Administrative reason|0
789335|NCT00709098|2510351|P1|Open-label Period|Administrative reason|0
789336|NCT00709098|2510349|P3|Open-label Period|Withdrawal of consent|7
789337|NCT00709098|2510350|P2|Open-label Period|Withdrawal of consent|0
789338|NCT00709098|2510351|P1|Open-label Period|Withdrawal of consent|0
789339|NCT00709098|2510349|P3|Double-blind Period|Lost to Follow-up|0
789340|NCT00709098|2510350|P2|Double-blind Period|Lost to Follow-up|1
789341|NCT00709098|2510351|P1|Double-blind Period|Lost to Follow-up|1
789342|NCT00709098|2510349|P3|Double-blind Period|Death|0
789343|NCT00709098|2510350|P2|Double-blind Period|Death|1
789344|NCT00709098|2510351|P1|Double-blind Period|Death|1
789345|NCT00709098|2510349|P3|Double-blind Period|Administrative reason|0
789346|NCT00709098|2510350|P2|Double-blind Period|Administrative reason|3
789347|NCT00709098|2510351|P1|Double-blind Period|Administrative reason|1
789348|NCT00709098|2510349|P3|Double-blind Period|Withdrawal of consent|0
789349|NCT00709098|2510350|P2|Double-blind Period|Withdrawal of consent|3
789350|NCT00709098|2510351|P1|Double-blind Period|Withdrawal of consent|3
789351|NCT00709111|2510370|P1|Overall Study|Unable to attend clinic visits|1
789352|NCT00709111|2510370|P1|Overall Study|Withdrawal by Subject|1
789353|NCT00709124|2510410|P2|Overall Study|encephalopathy; can't do assessment|0
789354|NCT00709124|2510411|P1|Overall Study|encephalopathy; can't do assessment|1
789355|NCT00709124|2510410|P2|Overall Study|Death|1
789356|NCT00709124|2510411|P1|Overall Study|Death|3
789357|NCT00709228|2510417|P1|Overall Study|Non-compliance|5
789358|NCT00709228|2510417|P1|Overall Study|Lost to Follow-up|6
789359|NCT00709228|2510417|P1|Overall Study|Disease progression|1
789360|NCT00709228|2510417|P1|Overall Study|Discontinued follow-up|5
789361|NCT00709228|2510417|P1|Overall Study|Did not enter follow-up|4
789362|NCT00709228|2510417|P1|Overall Study|Discontinued treatment|14
789363|NCT00709228|2510417|P1|Overall Study|Adverse events|2
789364|NCT00709228|2510417|P1|Overall Study|Eligibility criteria not met|281
789365|NCT00709228|2510417|P1|Overall Study|Not treated|14
789366|NCT00709319|2510421|P1|Overall Study|Withdrawal by Subject|2
789367|NCT00709319|2510421|P1|Overall Study|Death|4
789368|NCT00709592|2510431|P2|Overall Study|Unable to proceed to transplant|1
789369|NCT00709592|2510432|P1|Overall Study|Unable to proceed to transplant|0
789370|NCT00709618|2510452|P1|Overall Study|Study Closed/Terminated|25
789371|NCT00709618|2510452|P1|Overall Study|Lost to Follow-up|1
789372|NCT00709618|2510452|P1|Overall Study|Withdrawal by Subject|4
789373|NCT00709722|2510462|P1|Overall Study|Adverse Event|1
789374|NCT00709735|2510470|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
789375|NCT00709735|2510471|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
789376|NCT00709735|2510470|P2|Overall Study|Relapse into Opioid Abuse|1
789377|NCT00709735|2510471|P1|Overall Study|Relapse into Opioid Abuse|0
789378|NCT00709735|2510470|P2|Overall Study|Lost to Follow-up|1
789379|NCT00709735|2510471|P1|Overall Study|Lost to Follow-up|1
789380|NCT00709761|2510479|P1|Overall Study|Ongoing|40
789381|NCT00709761|2510479|P1|Overall Study|Withdrawal by Subject|7
789382|NCT00709852|2510499|P2|Period 2|No 72-hour follow-up|0
789383|NCT00709852|2510500|P1|Period 2|No 72-hour follow-up|3
789384|NCT00709852|2510499|P2|Period 2|Lost to Follow-up|0
789385|NCT00709852|2510500|P1|Period 2|Lost to Follow-up|1
789386|NCT00709852|2510499|P2|Period 2|Adverse Event|1
789387|NCT00709852|2510500|P1|Period 2|Adverse Event|1
789388|NCT00709852|2510499|P2|Period 2|Protocol Violation|1
789389|NCT00709852|2510500|P1|Period 2|Protocol Violation|4
789390|NCT00709852|2510499|P2|Period 1|Lost to Follow-up|0
789391|NCT00709852|2510500|P1|Period 1|Lost to Follow-up|1
789392|NCT00709852|2510499|P2|Period 1|Defective scanner|1
789393|NCT00709852|2510500|P1|Period 1|Defective scanner|0
789394|NCT00709852|2510499|P2|Period 1|Protocol Violation|0
789395|NCT00709852|2510500|P1|Period 1|Protocol Violation|1
789396|NCT00709852|2510499|P2|Period 1|Withdrawal by Subject|2
789397|NCT00709852|2510500|P1|Period 1|Withdrawal by Subject|4
789398|NCT00709852|2510499|P2|Period 1|Adverse Event|0
789399|NCT00709852|2510500|P1|Period 1|Adverse Event|2
789400|NCT00709956|2510677|P2|Overall Study|Inclusion/exclusion criteria violation|3
789401|NCT00709956|2510678|P1|Overall Study|Inclusion/exclusion criteria violation|2
789402|NCT00709956|2510677|P2|Overall Study|Withdrawal by Subject|1
789403|NCT00709956|2510678|P1|Overall Study|Withdrawal by Subject|1
789404|NCT00710021|2510689|P3|Overall Study|Physician Decision|0
789405|NCT00710021|2510690|P2|Overall Study|Physician Decision|1
789406|NCT00710021|2510691|P1|Overall Study|Physician Decision|0
789407|NCT00710021|2510689|P3|Overall Study|Subject misrandomized|1
789408|NCT00710021|2510690|P2|Overall Study|Subject misrandomized|1
789409|NCT00710021|2510691|P1|Overall Study|Subject misrandomized|0
789410|NCT00710021|2510689|P3|Overall Study|Subject's Decision|0
789411|NCT00710021|2510690|P2|Overall Study|Subject's Decision|1
789412|NCT00710021|2510691|P1|Overall Study|Subject's Decision|0
789413|NCT00710021|2510689|P3|Overall Study|Lost to Follow-up|0
789414|NCT00710021|2510690|P2|Overall Study|Lost to Follow-up|0
789415|NCT00710021|2510691|P1|Overall Study|Lost to Follow-up|1
789416|NCT00710385|2510830|P1|Overall Study|Undisclosed excessive methadone use|1
789417|NCT00710385|2510830|P1|Overall Study|Physician Decision|1
789418|NCT00710385|2510830|P1|Overall Study|Undisclosed back pain|1
789419|NCT00710385|2510830|P1|Overall Study|Withdrawal by Subject|1
789420|NCT00710385|2510830|P1|Overall Study|Did not qualify|1
789421|NCT00710424|2510849|P2|Overall Study|Felt good so stopped treatment|1
789422|NCT00710424|2510850|P1|Overall Study|Felt good so stopped treatment|0
789423|NCT00710424|2510849|P2|Overall Study|Subject preferred paracetamol|1
789424|NCT00710424|2510850|P1|Overall Study|Subject preferred paracetamol|0
789425|NCT00710424|2510849|P2|Overall Study|Ceased treatment due to travel|0
789426|NCT00710424|2510850|P1|Overall Study|Ceased treatment due to travel|1
789427|NCT00710424|2510849|P2|Overall Study|Subject thought medication changed|0
789428|NCT00710424|2510850|P1|Overall Study|Subject thought medication changed|1
789429|NCT00710424|2510849|P2|Overall Study|Did not meet entry criteria at visit 1|0
789430|NCT00710424|2510850|P1|Overall Study|Did not meet entry criteria at visit 1|1
789431|NCT00710424|2510849|P2|Overall Study|Non-compliance with stable analgesia|0
789432|NCT00710424|2510850|P1|Overall Study|Non-compliance with stable analgesia|1
789433|NCT00710424|2510849|P2|Overall Study|Refused medication, no side effects|0
789434|NCT00710424|2510850|P1|Overall Study|Refused medication, no side effects|1
789435|NCT00710424|2510849|P2|Overall Study|Lost to Follow-up|1
789436|NCT00710424|2510850|P1|Overall Study|Lost to Follow-up|0
789437|NCT00710424|2510849|P2|Overall Study|Withdrawal by Subject|3
789438|NCT00710424|2510850|P1|Overall Study|Withdrawal by Subject|5
789439|NCT00710424|2510849|P2|Overall Study|Lack of Efficacy|5
789440|NCT00710424|2510850|P1|Overall Study|Lack of Efficacy|4
789441|NCT00710424|2510849|P2|Overall Study|Adverse Event|12
789442|NCT00710424|2510850|P1|Overall Study|Adverse Event|30
789443|NCT00702650|2510874|P1|Overall Study|Adverse Event|3
789444|NCT00702650|2510874|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
789445|NCT00702650|2510874|P1|Overall Study|Sponsor Request|1
789446|NCT00702650|2510874|P1|Overall Study|Non-Compliance with Site Directives|1
789447|NCT00702650|2510874|P1|Overall Study|Lost to Follow-up|2
789448|NCT00702650|2510874|P1|Overall Study|Non-Compliance of Study Drug|3
789449|NCT00702650|2510874|P1|Overall Study|Withdrawal by Subject|9
789450|NCT00702689|2510892|P1|Overall Study|Adverse Event|1
789451|NCT00702689|2510892|P1|Overall Study|Recurrent malignancy|1
789452|NCT00702689|2510892|P1|Overall Study|Withdrawal by Subject|4
789453|NCT00702702|2510906|P1|Overall Study|Study prematurely terminated|56
789454|NCT00702715|2510916|P2|Overall Study|Lost to Follow-up|0
789455|NCT00702715|2510917|P1|Overall Study|Lost to Follow-up|1
789456|NCT00702845|2510951|P2|Overall Study|Not randomized|1
789457|NCT00702845|2510952|P1|Overall Study|Not randomized|0
789458|NCT00702845|2510951|P2|Overall Study|Patient's decision|1
789459|NCT00702845|2510952|P1|Overall Study|Patient's decision|2
789460|NCT00702845|2510951|P2|Overall Study|No or abnormal fertilization|2
789461|NCT00702845|2510952|P1|Overall Study|No or abnormal fertilization|4
789462|NCT00702845|2510951|P2|Overall Study|No/too few/bad quality embryos retrieved|1
789463|NCT00702845|2510952|P1|Overall Study|No/too few/bad quality embryos retrieved|7
789464|NCT00702845|2510951|P2|Overall Study|Insufficient ovarian response|0
789465|NCT00702845|2510952|P1|Overall Study|Insufficient ovarian response|1
789466|NCT00702845|2510951|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
789467|NCT00702845|2510952|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
789468|NCT00702845|2510951|P2|Overall Study|Too high ovarian response|1
789469|NCT00702845|2510952|P1|Overall Study|Too high ovarian response|5
789470|NCT00702845|2510951|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
789471|NCT00702845|2510952|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
789472|NCT00710554|2511004|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
789473|NCT00710554|2511005|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
789474|NCT00710554|2511004|P2|Overall Study|Lack of Efficacy|12
789475|NCT00710554|2511005|P1|Overall Study|Lack of Efficacy|11
789476|NCT00710554|2511004|P2|Overall Study|Lost to Follow-up|1
789477|NCT00710554|2511005|P1|Overall Study|Lost to Follow-up|7
789478|NCT00710554|2511004|P2|Overall Study|Withdrawal by Subject|3
789479|NCT00710554|2511005|P1|Overall Study|Withdrawal by Subject|7
789480|NCT00710554|2511004|P2|Overall Study|Adverse Event|7
789481|NCT00710554|2511005|P1|Overall Study|Adverse Event|24
789482|NCT00710593|2511033|P2|Overall Study|Prem disc vaccine, completed all visits|2
789483|NCT00710593|2511034|P1|Overall Study|Prem disc vaccine, completed all visits|6
789484|NCT00710593|2511033|P2|Overall Study|Protocol Violation|1
789485|NCT00710593|2511034|P1|Overall Study|Protocol Violation|1
789486|NCT00710593|2511033|P2|Overall Study|Failure to adhere or complete study eval|1
789487|NCT00710593|2511034|P1|Overall Study|Failure to adhere or complete study eval|1
789488|NCT00710593|2511033|P2|Overall Study|Moved out of area|0
789489|NCT00710593|2511034|P1|Overall Study|Moved out of area|1
789490|NCT00710593|2511033|P2|Overall Study|Lost to Follow-up|1
789491|NCT00710593|2511034|P1|Overall Study|Lost to Follow-up|3
789492|NCT00710593|2511033|P2|Overall Study|Unable to complete Wk 48 within window|0
789493|NCT00710593|2511034|P1|Overall Study|Unable to complete Wk 48 within window|2
789494|NCT00710593|2511033|P2|Overall Study|Incarceration|0
789495|NCT00710593|2511034|P1|Overall Study|Incarceration|1
789496|NCT00710606|2511077|P2|Overall Study|Adverse Event|2
789497|NCT00710606|2511078|P1|Overall Study|Adverse Event|0
789498|NCT00710749|2511088|P2|First Intervention|Withdrawal by Subject|0
789499|NCT00710749|2511089|P1|First Intervention|Withdrawal by Subject|1
789500|NCT00710762|2511099|P2|Overall Study|Reason other than listed above|2
789501|NCT00710762|2511100|P1|Overall Study|Reason other than listed above|2
789502|NCT00710762|2511099|P2|Overall Study|Lost to Follow-up|0
789503|NCT00710762|2511100|P1|Overall Study|Lost to Follow-up|1
789504|NCT00710762|2511099|P2|Overall Study|Other Adverse Event|7
789505|NCT00710762|2511100|P1|Overall Study|Other Adverse Event|7
789506|NCT00710762|2511099|P2|Overall Study|Adverse Event other disease worsening|1
789507|NCT00710762|2511100|P1|Overall Study|Adverse Event other disease worsening|2
789508|NCT00710762|2511099|P2|Overall Study|Progressive disease|30
789509|NCT00710762|2511100|P1|Overall Study|Progressive disease|27
789510|NCT00712725|2511148|P8|Overall Study|Protocol Specified Criteria|1
789511|NCT00712725|2511149|P7|Overall Study|Protocol Specified Criteria|2
789512|NCT00712725|2511150|P6|Overall Study|Protocol Specified Criteria|0
789513|NCT00712725|2511151|P5|Overall Study|Protocol Specified Criteria|1
789514|NCT00712725|2511152|P4|Overall Study|Protocol Specified Criteria|2
789515|NCT00712725|2511153|P3|Overall Study|Protocol Specified Criteria|1
789516|NCT00712725|2511154|P2|Overall Study|Protocol Specified Criteria|0
789517|NCT00712725|2511155|P1|Overall Study|Protocol Specified Criteria|3
789518|NCT00712725|2511148|P8|Overall Study|Lack of Qualifying Event|6
789519|NCT00712725|2511149|P7|Overall Study|Lack of Qualifying Event|11
789520|NCT00712725|2511150|P6|Overall Study|Lack of Qualifying Event|13
789521|NCT00712725|2511151|P5|Overall Study|Lack of Qualifying Event|11
789522|NCT00712725|2511152|P4|Overall Study|Lack of Qualifying Event|8
789523|NCT00712725|2511153|P3|Overall Study|Lack of Qualifying Event|6
789524|NCT00712725|2511154|P2|Overall Study|Lack of Qualifying Event|2
789525|NCT00712725|2511155|P1|Overall Study|Lack of Qualifying Event|16
789526|NCT00712725|2511148|P8|Overall Study|Withdrawal by Subject|2
789527|NCT00712725|2511149|P7|Overall Study|Withdrawal by Subject|1
789528|NCT00712725|2511150|P6|Overall Study|Withdrawal by Subject|1
789529|NCT00712725|2511151|P5|Overall Study|Withdrawal by Subject|1
789530|NCT00712725|2511152|P4|Overall Study|Withdrawal by Subject|2
789531|NCT00712725|2511153|P3|Overall Study|Withdrawal by Subject|1
789532|NCT00712725|2511154|P2|Overall Study|Withdrawal by Subject|1
789533|NCT00712725|2511155|P1|Overall Study|Withdrawal by Subject|2
789534|NCT00712725|2511148|P8|Overall Study|Protocol Violation|1
789535|NCT00712725|2511149|P7|Overall Study|Protocol Violation|1
789536|NCT00712725|2511150|P6|Overall Study|Protocol Violation|0
789537|NCT00712725|2511151|P5|Overall Study|Protocol Violation|2
789538|NCT00712725|2511152|P4|Overall Study|Protocol Violation|3
789539|NCT00712725|2511153|P3|Overall Study|Protocol Violation|1
789540|NCT00712725|2511154|P2|Overall Study|Protocol Violation|0
789541|NCT00712725|2511155|P1|Overall Study|Protocol Violation|2
789542|NCT00712725|2511148|P8|Overall Study|Pregnancy|0
789543|NCT00712725|2511149|P7|Overall Study|Pregnancy|2
789544|NCT00712725|2511150|P6|Overall Study|Pregnancy|0
789545|NCT00712725|2511151|P5|Overall Study|Pregnancy|1
789546|NCT00712725|2511152|P4|Overall Study|Pregnancy|0
789547|NCT00712725|2511153|P3|Overall Study|Pregnancy|0
789548|NCT00712725|2511154|P2|Overall Study|Pregnancy|1
789549|NCT00712725|2511155|P1|Overall Study|Pregnancy|0
789550|NCT00712725|2511148|P8|Overall Study|Physician Decision|0
789551|NCT00712725|2511149|P7|Overall Study|Physician Decision|2
789552|NCT00712725|2511150|P6|Overall Study|Physician Decision|0
789553|NCT00712725|2511151|P5|Overall Study|Physician Decision|1
789554|NCT00712725|2511152|P4|Overall Study|Physician Decision|0
789555|NCT00712725|2511153|P3|Overall Study|Physician Decision|0
789556|NCT00712725|2511154|P2|Overall Study|Physician Decision|0
789557|NCT00712725|2511155|P1|Overall Study|Physician Decision|2
789558|NCT00712725|2511148|P8|Overall Study|Lost to Follow-up|1
789559|NCT00712725|2511149|P7|Overall Study|Lost to Follow-up|3
789560|NCT00712725|2511150|P6|Overall Study|Lost to Follow-up|2
789561|NCT00712725|2511151|P5|Overall Study|Lost to Follow-up|2
789562|NCT00712725|2511152|P4|Overall Study|Lost to Follow-up|1
789563|NCT00712725|2511153|P3|Overall Study|Lost to Follow-up|1
789564|NCT00712725|2511154|P2|Overall Study|Lost to Follow-up|2
789565|NCT00712725|2511155|P1|Overall Study|Lost to Follow-up|3
789566|NCT00712725|2511148|P8|Overall Study|Adverse Event|0
789567|NCT00712725|2511149|P7|Overall Study|Adverse Event|0
789568|NCT00712725|2511150|P6|Overall Study|Adverse Event|0
789569|NCT00712725|2511151|P5|Overall Study|Adverse Event|0
789570|NCT00712725|2511152|P4|Overall Study|Adverse Event|1
789571|NCT00712725|2511153|P3|Overall Study|Adverse Event|0
789572|NCT00712725|2511154|P2|Overall Study|Adverse Event|0
789573|NCT00712725|2511155|P1|Overall Study|Adverse Event|1
789574|NCT00712920|2511216|P3|Overall Study|Non-compliance|0
789575|NCT00712920|2511217|P2|Overall Study|Non-compliance|0
789576|NCT00712920|2511218|P1|Overall Study|Non-compliance|3
789577|NCT00712920|2511216|P3|Overall Study|Other|3
789578|NCT00712920|2511217|P2|Overall Study|Other|7
789579|NCT00712920|2511218|P1|Overall Study|Other|5
789580|NCT00712920|2511216|P3|Overall Study|Lack of Efficacy|1
789581|NCT00712920|2511217|P2|Overall Study|Lack of Efficacy|0
789582|NCT00712920|2511218|P1|Overall Study|Lack of Efficacy|1
789583|NCT00712920|2511216|P3|Overall Study|Lost to Follow-up|0
789584|NCT00712920|2511217|P2|Overall Study|Lost to Follow-up|4
789585|NCT00712920|2511218|P1|Overall Study|Lost to Follow-up|1
789586|NCT00712920|2511216|P3|Overall Study|Withdrawal by Subject|1
789587|NCT00712920|2511217|P2|Overall Study|Withdrawal by Subject|2
789588|NCT00712920|2511218|P1|Overall Study|Withdrawal by Subject|4
789589|NCT00712920|2511216|P3|Overall Study|Adverse Event|7
789590|NCT00712920|2511217|P2|Overall Study|Adverse Event|4
789591|NCT00712920|2511218|P1|Overall Study|Adverse Event|3
789592|NCT00712959|2511240|P2|Overall Study|Withdrawal by Subject|0
789593|NCT00712959|2511241|P1|Overall Study|Withdrawal by Subject|3
789594|NCT00712959|2511240|P2|Overall Study|Lost to Follow-up|2
789595|NCT00712959|2511241|P1|Overall Study|Lost to Follow-up|13
789596|NCT00712959|2511240|P2|Overall Study|Protocol Violation|1
789597|NCT00712959|2511241|P1|Overall Study|Protocol Violation|3
789598|NCT00712985|2511259|P1|Overall Study|Lack of Efficacy|3
789599|NCT00712985|2511259|P1|Overall Study|1 patient moved out of state|1
789600|NCT00712985|2511259|P1|Overall Study|1 withdrew prior to start of drug|1
789601|NCT00713206|2511265|P2|Overall Study|Adverse Event|1
789602|NCT00713206|2511266|P1|Overall Study|Adverse Event|2
789603|NCT00713206|2511265|P2|Overall Study|Lost to Follow-up|2
789604|NCT00713206|2511266|P1|Overall Study|Lost to Follow-up|5
789605|NCT00713219|2511272|P1|Overall Study|Protocol Violation|1
789606|NCT00713219|2511272|P1|Overall Study|Death|1
789607|NCT00713258|2511278|P2|Overall Study|Other|1
789608|NCT00713258|2511279|P1|Overall Study|Other|1
789609|NCT00713258|2511278|P2|Overall Study|Non-Compliance|1
789610|NCT00713258|2511279|P1|Overall Study|Non-Compliance|2
789611|NCT00713258|2511278|P2|Overall Study|Adverse Event|4
789612|NCT00713258|2511279|P1|Overall Study|Adverse Event|2
789613|NCT00713310|2511289|P2|Overall Study|Withdrawal by Subject|2
789614|NCT00713310|2511290|P1|Overall Study|Withdrawal by Subject|0
789615|NCT00713310|2511289|P2|Overall Study|Lack of Efficacy|2
789616|NCT00713310|2511290|P1|Overall Study|Lack of Efficacy|0
789617|NCT00713310|2511289|P2|Overall Study|Adverse Event|2
789618|NCT00713310|2511290|P1|Overall Study|Adverse Event|5
789619|NCT00713323|2511298|P1|Overall Study|Treatment that may interact with Sativex|1
789620|NCT00713323|2511298|P1|Overall Study|Subject travelling to Dominica Republic|1
789621|NCT00713323|2511298|P1|Overall Study|Subject travelling to USA|1
789622|NCT00713323|2511298|P1|Overall Study|Pain resolved|1
789623|NCT00713323|2511298|P1|Overall Study|Non-compliance|1
789624|NCT00713323|2511298|P1|Overall Study|Pain free|1
789625|NCT00713323|2511298|P1|Overall Study|Surgery cured allodynic pain|1
789626|NCT00713323|2511298|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
789627|NCT00713323|2511298|P1|Overall Study|Low creatine clearance at screening|1
789628|NCT00713323|2511298|P1|Overall Study|Lack of Efficacy|36
789629|NCT00713323|2511298|P1|Overall Study|Lost to Follow-up|11
789630|NCT00713323|2511298|P1|Overall Study|Withdrawal by Subject|15
789631|NCT00713323|2511298|P1|Overall Study|Adverse Event|75
789632|NCT00713349|2511309|P1|Overall Study|Protocol Violation|1
789633|NCT00713544|2511334|P6|Overall Study|Hepatotoxicity - not an AE|0
789634|NCT00713544|2511335|P5|Overall Study|Hepatotoxicity - not an AE|1
789635|NCT00713544|2511336|P4|Overall Study|Hepatotoxicity - not an AE|0
789636|NCT00713544|2511337|P3|Overall Study|Hepatotoxicity - not an AE|0
789637|NCT00713544|2511338|P2|Overall Study|Hepatotoxicity - not an AE|0
789638|NCT00713544|2511339|P1|Overall Study|Hepatotoxicity - not an AE|0
789639|NCT00713544|2511334|P6|Overall Study|Incorrect enrollment|0
789640|NCT00713544|2511335|P5|Overall Study|Incorrect enrollment|0
789641|NCT00713544|2511336|P4|Overall Study|Incorrect enrollment|0
789642|NCT00713544|2511337|P3|Overall Study|Incorrect enrollment|0
789643|NCT00713544|2511338|P2|Overall Study|Incorrect enrollment|1
789644|NCT00713544|2511339|P1|Overall Study|Incorrect enrollment|0
789645|NCT00713544|2511334|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
789646|NCT00713544|2511335|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
789647|NCT00713544|2511336|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
789648|NCT00713544|2511337|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
789649|NCT00713544|2511338|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
789650|NCT00713544|2511339|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
789651|NCT00713544|2511334|P6|Overall Study|Lost to Follow-up|0
789652|NCT00713544|2511335|P5|Overall Study|Lost to Follow-up|0
789653|NCT00713544|2511336|P4|Overall Study|Lost to Follow-up|0
789654|NCT00713544|2511337|P3|Overall Study|Lost to Follow-up|1
789655|NCT00713544|2511338|P2|Overall Study|Lost to Follow-up|0
789656|NCT00713544|2511339|P1|Overall Study|Lost to Follow-up|0
789657|NCT00713544|2511334|P6|Overall Study|Lack of Efficacy|0
789658|NCT00713544|2511335|P5|Overall Study|Lack of Efficacy|1
789659|NCT00713544|2511336|P4|Overall Study|Lack of Efficacy|1
789660|NCT00713544|2511337|P3|Overall Study|Lack of Efficacy|0
789661|NCT00713544|2511338|P2|Overall Study|Lack of Efficacy|1
789662|NCT00713544|2511339|P1|Overall Study|Lack of Efficacy|0
789663|NCT00713544|2511334|P6|Overall Study|Physician Decision|2
789664|NCT00713544|2511335|P5|Overall Study|Physician Decision|0
789665|NCT00713544|2511336|P4|Overall Study|Physician Decision|0
789666|NCT00713544|2511337|P3|Overall Study|Physician Decision|0
789667|NCT00713544|2511338|P2|Overall Study|Physician Decision|0
789668|NCT00713544|2511339|P1|Overall Study|Physician Decision|0
789669|NCT00713544|2511334|P6|Overall Study|Protocol Violation|1
789670|NCT00713544|2511335|P5|Overall Study|Protocol Violation|0
789671|NCT00713544|2511336|P4|Overall Study|Protocol Violation|0
789672|NCT00713544|2511337|P3|Overall Study|Protocol Violation|0
789673|NCT00713544|2511338|P2|Overall Study|Protocol Violation|0
789674|NCT00713544|2511339|P1|Overall Study|Protocol Violation|0
789675|NCT00713544|2511334|P6|Overall Study|Withdrawal by Subject|1
789676|NCT00713544|2511335|P5|Overall Study|Withdrawal by Subject|3
789677|NCT00713544|2511336|P4|Overall Study|Withdrawal by Subject|2
789678|NCT00713544|2511337|P3|Overall Study|Withdrawal by Subject|3
789679|NCT00713544|2511338|P2|Overall Study|Withdrawal by Subject|0
789680|NCT00713544|2511339|P1|Overall Study|Withdrawal by Subject|2
789681|NCT00713544|2511334|P6|Overall Study|Adverse Event|5
789682|NCT00713544|2511335|P5|Overall Study|Adverse Event|3
789683|NCT00713544|2511336|P4|Overall Study|Adverse Event|7
789684|NCT00713544|2511337|P3|Overall Study|Adverse Event|7
789685|NCT00713544|2511338|P2|Overall Study|Adverse Event|3
789686|NCT00713544|2511339|P1|Overall Study|Adverse Event|5
789687|NCT00713596|2511380|P3|Overall Study|Study was terminated|2
789688|NCT00713596|2511381|P2|Overall Study|Study was terminated|3
789689|NCT00713596|2511382|P1|Overall Study|Study was terminated|2
789690|NCT00713609|2511399|P6|Overall Study|Protocol Violation|0
789691|NCT00713609|2511400|P5|Overall Study|Protocol Violation|2
789692|NCT00713609|2511401|P4|Overall Study|Protocol Violation|1
789693|NCT00713609|2511402|P3|Overall Study|Protocol Violation|1
789694|NCT00713609|2511403|P2|Overall Study|Protocol Violation|3
789695|NCT00713609|2511404|P1|Overall Study|Protocol Violation|6
789696|NCT00713609|2511399|P6|Overall Study|Withdrawal by Subject|7
789697|NCT00713609|2511400|P5|Overall Study|Withdrawal by Subject|5
789698|NCT00713609|2511401|P4|Overall Study|Withdrawal by Subject|1
789699|NCT00713609|2511402|P3|Overall Study|Withdrawal by Subject|5
789700|NCT00713609|2511403|P2|Overall Study|Withdrawal by Subject|1
789701|NCT00713609|2511404|P1|Overall Study|Withdrawal by Subject|6
789702|NCT00713609|2511399|P6|Overall Study|Non-Compliance with Study Treatment|0
789703|NCT00713609|2511400|P5|Overall Study|Non-Compliance with Study Treatment|1
789704|NCT00713609|2511401|P4|Overall Study|Non-Compliance with Study Treatment|0
789705|NCT00713609|2511402|P3|Overall Study|Non-Compliance with Study Treatment|2
789706|NCT00713609|2511403|P2|Overall Study|Non-Compliance with Study Treatment|1
789707|NCT00713609|2511404|P1|Overall Study|Non-Compliance with Study Treatment|1
789708|NCT00713609|2511399|P6|Overall Study|Lack of Efficacy|0
789709|NCT00713609|2511400|P5|Overall Study|Lack of Efficacy|1
789710|NCT00713609|2511401|P4|Overall Study|Lack of Efficacy|0
789711|NCT00713609|2511402|P3|Overall Study|Lack of Efficacy|0
789712|NCT00713609|2511403|P2|Overall Study|Lack of Efficacy|3
789713|NCT00713609|2511404|P1|Overall Study|Lack of Efficacy|1
789714|NCT00713609|2511399|P6|Overall Study|Lost to Follow-up|0
789715|NCT00713609|2511400|P5|Overall Study|Lost to Follow-up|7
789716|NCT00713609|2511401|P4|Overall Study|Lost to Follow-up|5
789717|NCT00713609|2511402|P3|Overall Study|Lost to Follow-up|5
789718|NCT00713609|2511403|P2|Overall Study|Lost to Follow-up|7
789719|NCT00713609|2511404|P1|Overall Study|Lost to Follow-up|5
789720|NCT00713609|2511399|P6|Overall Study|Adverse Event|1
789721|NCT00713609|2511400|P5|Overall Study|Adverse Event|3
789722|NCT00713609|2511401|P4|Overall Study|Adverse Event|2
789723|NCT00713609|2511402|P3|Overall Study|Adverse Event|2
789724|NCT00713609|2511403|P2|Overall Study|Adverse Event|0
789725|NCT00713609|2511404|P1|Overall Study|Adverse Event|2
789726|NCT00713648|2511436|P1|Overall Study|Development of antibodies|3
789727|NCT00713648|2511436|P1|Overall Study|According to Protocol|2
789728|NCT00713648|2511436|P1|Overall Study|Unclassified|2
789729|NCT00713648|2511436|P1|Overall Study|Adverse Event|1
789730|NCT00713700|2511464|P1|Overall Study|Withdrawal by Subject|1
789731|NCT00713700|2511464|P1|Overall Study|Lost to Follow-up|3
789732|NCT00713830|2511492|P2|Overall Study|Sponsor Decision|10
789733|NCT00713830|2511493|P1|Overall Study|Sponsor Decision|4
789734|NCT00713830|2511492|P2|Overall Study|Familial and Personal Reasons|34
789735|NCT00713830|2511493|P1|Overall Study|Familial and Personal Reasons|9
789736|NCT00713830|2511492|P2|Overall Study|Poor Compliance to Protocol|14
789737|NCT00713830|2511493|P1|Overall Study|Poor Compliance to Protocol|7
789738|NCT00713830|2511492|P2|Overall Study|Withdrawal by Subject|23
789739|NCT00713830|2511493|P1|Overall Study|Withdrawal by Subject|13
789740|NCT00713830|2511492|P2|Overall Study|Lost to Follow-up|9
789741|NCT00713830|2511493|P1|Overall Study|Lost to Follow-up|2
789742|NCT00713830|2511492|P2|Overall Study|Lack of Efficacy|16
789743|NCT00713830|2511493|P1|Overall Study|Lack of Efficacy|24
789744|NCT00713830|2511492|P2|Overall Study|Adverse Event|71
789745|NCT00713830|2511493|P1|Overall Study|Adverse Event|23
789746|NCT00714051|2511531|P2|Overall Study|Death|1
789747|NCT00714051|2511532|P1|Overall Study|Death|0
789748|NCT00714051|2511531|P2|Overall Study|Withdrawal by Subject|0
789749|NCT00714051|2511532|P1|Overall Study|Withdrawal by Subject|1
789750|NCT00714168|2511540|P2|Overall Study|Non-study medical condition|2
789751|NCT00714168|2511541|P1|Overall Study|Non-study medical condition|3
789752|NCT00714168|2511540|P2|Overall Study|Relocation|3
789753|NCT00714168|2511541|P1|Overall Study|Relocation|4
789754|NCT00714168|2511540|P2|Overall Study|Lost to Follow-up|50
789755|NCT00714168|2511541|P1|Overall Study|Lost to Follow-up|32
789756|NCT00714168|2511540|P2|Overall Study|Pregnancy|4
789757|NCT00714168|2511541|P1|Overall Study|Pregnancy|5
789758|NCT00714259|2511589|P1|Overall Study|Death|2
789759|NCT00714285|2511603|P4|Overall Study|Migrated/moved from study area|0
789760|NCT00714285|2511604|P3|Overall Study|Migrated/moved from study area|0
789761|NCT00714285|2511605|P2|Overall Study|Migrated/moved from study area|1
789762|NCT00714285|2511606|P1|Overall Study|Migrated/moved from study area|0
789763|NCT00714285|2511603|P4|Overall Study|Lost to Follow-up|1
789764|NCT00714285|2511604|P3|Overall Study|Lost to Follow-up|0
789765|NCT00714285|2511605|P2|Overall Study|Lost to Follow-up|2
789766|NCT00714285|2511606|P1|Overall Study|Lost to Follow-up|0
789767|NCT00714493|2511670|P1|Overall Study|OTHER|2
789768|NCT00714493|2511670|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
789769|NCT00714493|2511670|P1|Overall Study|Protocol Violation|12
789770|NCT00714493|2511670|P1|Overall Study|Lost to Follow-up|3
789771|NCT00714493|2511670|P1|Overall Study|Lack of Efficacy|10
789772|NCT00714493|2511670|P1|Overall Study|Death|3
789773|NCT00714493|2511670|P1|Overall Study|Adverse Event|11
789774|NCT00714688|2511708|P3|Overall Study|Other|5
789775|NCT00714688|2511709|P2|Overall Study|Other|6
789776|NCT00714688|2511710|P1|Overall Study|Other|1
789777|NCT00714688|2511708|P3|Overall Study|Sponsor's Decision|0
789778|NCT00714688|2511709|P2|Overall Study|Sponsor's Decision|2
789779|NCT00714688|2511710|P1|Overall Study|Sponsor's Decision|0
789780|NCT00714688|2511708|P3|Overall Study|Ineligible to Continue the Study|1
789781|NCT00714688|2511709|P2|Overall Study|Ineligible to Continue the Study|1
789782|NCT00714688|2511710|P1|Overall Study|Ineligible to Continue the Study|0
789783|NCT00714688|2511708|P3|Overall Study|Subject Non-compliant|5
789784|NCT00714688|2511709|P2|Overall Study|Subject Non-compliant|5
789785|NCT00714688|2511710|P1|Overall Study|Subject Non-compliant|3
789786|NCT00714688|2511708|P3|Overall Study|Adverse Event|19
789787|NCT00714688|2511709|P2|Overall Study|Adverse Event|15
789788|NCT00714688|2511710|P1|Overall Study|Adverse Event|2
789789|NCT00714688|2511708|P3|Overall Study|Lost to Follow-up|0
789790|NCT00714688|2511709|P2|Overall Study|Lost to Follow-up|2
789791|NCT00714688|2511710|P1|Overall Study|Lost to Follow-up|5
789792|NCT00714688|2511708|P3|Overall Study|Withdrawal by Subject|3
789793|NCT00714688|2511709|P2|Overall Study|Withdrawal by Subject|3
789794|NCT00714688|2511710|P1|Overall Study|Withdrawal by Subject|4
789795|NCT00714688|2511708|P3|Overall Study|Lack of Efficacy|4
789796|NCT00714688|2511709|P2|Overall Study|Lack of Efficacy|1
789797|NCT00714688|2511710|P1|Overall Study|Lack of Efficacy|14
789798|NCT00714714|2511727|P1|Overall Study|Adverse Event|1
789799|NCT00714870|2511744|P2|Overall Study|did not attend minimum of 4 sessions|0
789800|NCT00714870|2511745|P1|Overall Study|did not attend minimum of 4 sessions|4
789801|NCT00714870|2511744|P2|Overall Study|patient unable to come b/c back pain|0
789802|NCT00714870|2511745|P1|Overall Study|patient unable to come b/c back pain|1
789803|NCT00714870|2511744|P2|Overall Study|Lost to Follow-up|5
789804|NCT00714870|2511745|P1|Overall Study|Lost to Follow-up|22
789805|NCT00714948|2511751|P1|Overall Study|Adverse Event|2
789806|NCT00715026|2511755|P1|Overall Study|Surgery done on non-study consented hip|1
789807|NCT00715026|2511755|P1|Overall Study|Protocol Violation|1
789808|NCT00715026|2511755|P1|Overall Study|Lost to Follow-up|3
789809|NCT00715026|2511755|P1|Overall Study|Withdrawal by Subject|5
789810|NCT00715078|2511763|P3|Overall Study|Unable to start due to disease prog.|1
789811|NCT00715078|2511764|P2|Overall Study|Unable to start due to disease prog.|0
789812|NCT00715078|2511765|P1|Overall Study|Unable to start due to disease prog.|0
789813|NCT00715078|2511763|P3|Overall Study|Withdrawal by Subject|1
789814|NCT00715078|2511764|P2|Overall Study|Withdrawal by Subject|0
789815|NCT00715078|2511765|P1|Overall Study|Withdrawal by Subject|1
789816|NCT00715078|2511763|P3|Overall Study|Death|36
789817|NCT00715078|2511764|P2|Overall Study|Death|36
789818|NCT00715078|2511765|P1|Overall Study|Death|29
789819|NCT00715117|2511829|P2|Overall Study|Crohn's flare and rescue with steroids|1
789820|NCT00715117|2511830|P1|Overall Study|Crohn's flare and rescue with steroids|0
892211|NCT02186873|2829493|P2|Overall Study|Lost to Follow-up|2
892212|NCT02186873|2829494|P1|Overall Study|Lost to Follow-up|1
892213|NCT02186873|2829493|P2|Overall Study|Lack of Efficacy|1
892214|NCT02186873|2829494|P1|Overall Study|Lack of Efficacy|0
892215|NCT02186873|2829493|P2|Overall Study|Adverse Event|3
892216|NCT02186873|2829494|P1|Overall Study|Adverse Event|1
892217|NCT02158975|2829517|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
892218|NCT02062385|2829540|P4|Overall Study|Lost to Follow-up|0
892219|NCT02062385|2829541|P3|Overall Study|Lost to Follow-up|1
892220|NCT02062385|2829542|P2|Overall Study|Lost to Follow-up|0
892221|NCT02062385|2829543|P1|Overall Study|Lost to Follow-up|0
892222|NCT02062385|2829540|P4|Overall Study|Death|1
892223|NCT02062385|2829541|P3|Overall Study|Death|0
892224|NCT02062385|2829542|P2|Overall Study|Death|0
892225|NCT02062385|2829543|P1|Overall Study|Death|0
892226|NCT02062385|2829540|P4|Overall Study|Withdrawn by parent/guardian|8
892227|NCT02062385|2829541|P3|Overall Study|Withdrawn by parent/guardian|9
892228|NCT02062385|2829542|P2|Overall Study|Withdrawn by parent/guardian|41
892229|NCT02062385|2829543|P1|Overall Study|Withdrawn by parent/guardian|46
892230|NCT02062385|2829540|P4|Overall Study|Moved|0
892231|NCT02062385|2829541|P3|Overall Study|Moved|1
892232|NCT02062385|2829542|P2|Overall Study|Moved|11
892233|NCT02062385|2829543|P1|Overall Study|Moved|10
892234|NCT02062385|2829540|P4|Overall Study|Incomplete EPI by database lock|0
892235|NCT02062385|2829541|P3|Overall Study|Incomplete EPI by database lock|0
892236|NCT02062385|2829542|P2|Overall Study|Incomplete EPI by database lock|0
892237|NCT02062385|2829543|P1|Overall Study|Incomplete EPI by database lock|2
892238|NCT02062385|2829540|P4|Overall Study|Protocol Violation|0
892239|NCT02062385|2829541|P3|Overall Study|Protocol Violation|0
892240|NCT02062385|2829542|P2|Overall Study|Protocol Violation|0
892241|NCT02062385|2829543|P1|Overall Study|Protocol Violation|1
892242|NCT02062385|2829540|P4|Overall Study|Adverse Event|0
892243|NCT02062385|2829541|P3|Overall Study|Adverse Event|1
892244|NCT02062385|2829542|P2|Overall Study|Adverse Event|13
892245|NCT02062385|2829543|P1|Overall Study|Adverse Event|19
892262|NCT02036515|2829599|P3|Overall Study|Hyperglycemia|1
892263|NCT02036515|2829600|P2|Overall Study|Hyperglycemia|0
892264|NCT02036515|2829601|P1|Overall Study|Hyperglycemia|0
892265|NCT02036515|2829599|P3|Overall Study|Withdrawal by Subject|9
892266|NCT02036515|2829600|P2|Overall Study|Withdrawal by Subject|7
892267|NCT02036515|2829601|P1|Overall Study|Withdrawal by Subject|4
892268|NCT02036515|2829599|P3|Overall Study|Screen failure|0
892269|NCT02036515|2829600|P2|Overall Study|Screen failure|2
892270|NCT02036515|2829601|P1|Overall Study|Screen failure|0
892271|NCT02036515|2829599|P3|Overall Study|Non-compliance with study drug|2
892272|NCT02036515|2829600|P2|Overall Study|Non-compliance with study drug|0
892273|NCT02036515|2829601|P1|Overall Study|Non-compliance with study drug|0
892274|NCT02036515|2829599|P3|Overall Study|Lost to Follow-up|0
892275|NCT02036515|2829600|P2|Overall Study|Lost to Follow-up|2
892276|NCT02036515|2829601|P1|Overall Study|Lost to Follow-up|0
892277|NCT02036515|2829599|P3|Overall Study|Adverse Event|2
892278|NCT02036515|2829600|P2|Overall Study|Adverse Event|1
892279|NCT02036515|2829601|P1|Overall Study|Adverse Event|1
892280|NCT02023866|2829678|P1|Overall Study|Withdrawal by Subject|1
892281|NCT02023866|2829678|P1|Overall Study|Adverse Event|3
892282|NCT02023866|2829678|P1|Overall Study|Non-compliance|2
892307|NCT01769391|2829853|P2|Overall Study|On Treatment at Study Conclusion|0
892308|NCT01769391|2829854|P1|Overall Study|On Treatment at Study Conclusion|3
892309|NCT01769391|2829853|P2|Overall Study|Investigator Decision|0
892310|NCT01769391|2829854|P1|Overall Study|Investigator Decision|2
892311|NCT01769391|2829853|P2|Overall Study|Withdrawal by Subject|3
892312|NCT01769391|2829854|P1|Overall Study|Withdrawal by Subject|4
892313|NCT01769391|2829853|P2|Overall Study|Progressive Disease|2
892314|NCT01769391|2829854|P1|Overall Study|Progressive Disease|1
892315|NCT01769391|2829853|P2|Overall Study|Adverse Event|3
892316|NCT01769391|2829854|P1|Overall Study|Adverse Event|0
892317|NCT01769391|2829853|P2|Overall Study|Death|1
892318|NCT01769391|2829854|P1|Overall Study|Death|10
892325|NCT01709708|2829884|P2|Overall Study|Protocol Violation|2
789923|NCT00705939|2511904|P3|Overall Study|Physician Decision|0
789924|NCT00705939|2511905|P2|Overall Study|Physician Decision|1
789925|NCT00705939|2511906|P1|Overall Study|Physician Decision|0
789926|NCT00705939|2511904|P3|Overall Study|Withdrawal by Subject|3
789927|NCT00705939|2511905|P2|Overall Study|Withdrawal by Subject|1
789928|NCT00705939|2511906|P1|Overall Study|Withdrawal by Subject|0
789929|NCT00705939|2511904|P3|Overall Study|Protocol Violation|1
789930|NCT00705939|2511905|P2|Overall Study|Protocol Violation|0
789931|NCT00705939|2511906|P1|Overall Study|Protocol Violation|0
789932|NCT00706004|2511929|P1|Overall Study|Did not meet eligibility criteria|2
789933|NCT00706095|2511957|P3|Overall Study|Withdrawal by Subject|0
789934|NCT00706095|2511958|P2|Overall Study|Withdrawal by Subject|0
789935|NCT00706095|2511959|P1|Overall Study|Withdrawal by Subject|1
789936|NCT00706095|2511957|P3|Overall Study|Clinical Progression|2
789937|NCT00706095|2511958|P2|Overall Study|Clinical Progression|2
789938|NCT00706095|2511959|P1|Overall Study|Clinical Progression|1
789939|NCT00706095|2511957|P3|Overall Study|Progressive Disease|3
789940|NCT00706095|2511958|P2|Overall Study|Progressive Disease|5
789941|NCT00706095|2511959|P1|Overall Study|Progressive Disease|4
789942|NCT00706134|2512010|P4|Overall Study|Did not meet study criteria|0
789943|NCT00706134|2512011|P3|Overall Study|Did not meet study criteria|0
789944|NCT00706134|2512012|P2|Overall Study|Did not meet study criteria|0
789945|NCT00706134|2512013|P1|Overall Study|Did not meet study criteria|2
789946|NCT00706134|2512010|P4|Overall Study|Unsatisfactory therapeutic effect|5
789947|NCT00706134|2512011|P3|Overall Study|Unsatisfactory therapeutic effect|3
789948|NCT00706134|2512012|P2|Overall Study|Unsatisfactory therapeutic effect|3
789949|NCT00706134|2512013|P1|Overall Study|Unsatisfactory therapeutic effect|9
789950|NCT00706134|2512010|P4|Overall Study|Withdrawal by Subject|0
789951|NCT00706134|2512011|P3|Overall Study|Withdrawal by Subject|1
789952|NCT00706134|2512012|P2|Overall Study|Withdrawal by Subject|2
789953|NCT00706134|2512013|P1|Overall Study|Withdrawal by Subject|1
789954|NCT00706134|2512010|P4|Overall Study|Protocol Violation|3
789955|NCT00706134|2512011|P3|Overall Study|Protocol Violation|0
789956|NCT00706134|2512012|P2|Overall Study|Protocol Violation|6
789957|NCT00706134|2512013|P1|Overall Study|Protocol Violation|0
789958|NCT00706134|2512010|P4|Overall Study|Lost to Follow-up|0
789959|NCT00706134|2512011|P3|Overall Study|Lost to Follow-up|0
789960|NCT00706134|2512012|P2|Overall Study|Lost to Follow-up|1
789961|NCT00706134|2512013|P1|Overall Study|Lost to Follow-up|0
789962|NCT00706134|2512010|P4|Overall Study|Adverse Event|3
789963|NCT00706134|2512011|P3|Overall Study|Adverse Event|2
789964|NCT00706134|2512012|P2|Overall Study|Adverse Event|7
789965|NCT00706134|2512013|P1|Overall Study|Adverse Event|8
789966|NCT00706342|2512047|P1|Overall Study|WIthdrawal of consent|1
789967|NCT00706342|2512047|P1|Overall Study|Ongoing|6
789968|NCT00706342|2512047|P1|Overall Study|Non-responder Week 12|1
789969|NCT00706342|2512047|P1|Overall Study|Investigator discretion|2
789970|NCT00706342|2512047|P1|Overall Study|Withdrew from the study on his own.|1
789971|NCT00706342|2512047|P1|Overall Study|Death|1
789972|NCT00706342|2512047|P1|Overall Study|Withdrawn due to failure to respond|1
789973|NCT00706342|2512047|P1|Overall Study|Not responding to treatment|2
789974|NCT00706342|2512047|P1|Overall Study|Adverse Event|3
789975|NCT00706355|2512060|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
789976|NCT00706355|2512061|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
789977|NCT00706355|2512062|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
789978|NCT00706355|2512063|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
789979|NCT00706355|2512060|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
789980|NCT00706355|2512061|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
789981|NCT00706355|2512062|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
789982|NCT00706355|2512063|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
789983|NCT00706355|2512060|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
789984|NCT00706355|2512061|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
789985|NCT00706355|2512062|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
789986|NCT00706355|2512063|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
789987|NCT00706355|2512060|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
789988|NCT00706355|2512061|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
789989|NCT00706355|2512062|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
789990|NCT00706355|2512063|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
789991|NCT00706355|2512060|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
789992|NCT00706355|2512061|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
789993|NCT00706355|2512062|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
789994|NCT00706355|2512063|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
789995|NCT00706355|2512060|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
789996|NCT00706355|2512061|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
789997|NCT00706355|2512062|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
789998|NCT00706355|2512063|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
789999|NCT00706355|2512060|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
790000|NCT00706355|2512061|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
790001|NCT00706355|2512062|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
790002|NCT00706355|2512063|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
790003|NCT00706355|2512060|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
790004|NCT00706355|2512061|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
790005|NCT00706355|2512062|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
790006|NCT00706355|2512063|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
790007|NCT00706355|2512060|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
790008|NCT00706355|2512061|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
790009|NCT00706355|2512062|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
790010|NCT00706355|2512063|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
790011|NCT00706433|2512119|P4|Overall Study|new job|1
790012|NCT00706433|2512120|P3|Overall Study|new job|0
790013|NCT00706433|2512121|P2|Overall Study|new job|0
790014|NCT00706433|2512122|P1|Overall Study|new job|0
790015|NCT00706433|2512119|P4|Overall Study|Protocol Violation|0
790016|NCT00706433|2512120|P3|Overall Study|Protocol Violation|0
790017|NCT00706433|2512121|P2|Overall Study|Protocol Violation|0
790018|NCT00706433|2512122|P1|Overall Study|Protocol Violation|1
790019|NCT00706433|2512119|P4|Overall Study|Adverse Event|0
790020|NCT00706433|2512120|P3|Overall Study|Adverse Event|1
790021|NCT00706433|2512121|P2|Overall Study|Adverse Event|0
790022|NCT00706433|2512122|P1|Overall Study|Adverse Event|0
790023|NCT00706433|2512119|P4|Overall Study|Withdrawal by Subject|1
790024|NCT00706433|2512120|P3|Overall Study|Withdrawal by Subject|3
790025|NCT00706433|2512121|P2|Overall Study|Withdrawal by Subject|2
790026|NCT00706433|2512122|P1|Overall Study|Withdrawal by Subject|1
790027|NCT00706433|2512119|P4|Overall Study|Lost to Follow-up|0
790028|NCT00706433|2512120|P3|Overall Study|Lost to Follow-up|6
790029|NCT00706433|2512121|P2|Overall Study|Lost to Follow-up|1
790030|NCT00706433|2512122|P1|Overall Study|Lost to Follow-up|3
790031|NCT00706628|2512548|P4|Overall Study|Not treated|0
790032|NCT00706628|2512549|P3|Overall Study|Not treated|0
790033|NCT00706628|2512550|P2|Overall Study|Not treated|1
790034|NCT00706628|2512551|P1|Overall Study|Not treated|1
790035|NCT00706628|2512548|P4|Overall Study|Other than those stated above|0
790036|NCT00706628|2512549|P3|Overall Study|Other than those stated above|0
790037|NCT00706628|2512550|P2|Overall Study|Other than those stated above|0
790038|NCT00706628|2512551|P1|Overall Study|Other than those stated above|4
790039|NCT00706628|2512548|P4|Overall Study|Progressive disease|1
790040|NCT00706628|2512549|P3|Overall Study|Progressive disease|8
790041|NCT00706628|2512550|P2|Overall Study|Progressive disease|13
790042|NCT00706628|2512551|P1|Overall Study|Progressive disease|20
790043|NCT00706628|2512548|P4|Overall Study|Consent withdrawn|0
790044|NCT00706628|2512549|P3|Overall Study|Consent withdrawn|3
790045|NCT00706628|2512550|P2|Overall Study|Consent withdrawn|1
790046|NCT00706628|2512551|P1|Overall Study|Consent withdrawn|6
790047|NCT00706628|2512548|P4|Overall Study|Non compliant with protocol|0
790048|NCT00706628|2512549|P3|Overall Study|Non compliant with protocol|0
790049|NCT00706628|2512550|P2|Overall Study|Non compliant with protocol|1
790050|NCT00706628|2512551|P1|Overall Study|Non compliant with protocol|0
790051|NCT00706628|2512548|P4|Overall Study|Other Adverse Event|2
790052|NCT00706628|2512549|P3|Overall Study|Other Adverse Event|5
790053|NCT00706628|2512550|P2|Overall Study|Other Adverse Event|5
790054|NCT00706628|2512551|P1|Overall Study|Other Adverse Event|16
790055|NCT00706641|2512599|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
790056|NCT00706641|2512599|P1|Dasatinib Administration|Ineligible after start of therapy|1
790057|NCT00706641|2512599|P1|Dasatinib Administration|Withdrawal by Subject|1
790058|NCT00706654|2512612|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
790059|NCT00706654|2512613|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
790060|NCT00706654|2512614|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
790061|NCT00706654|2512615|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
790062|NCT00706654|2512612|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
790063|NCT00706654|2512613|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
790064|NCT00706654|2512614|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
790065|NCT00706654|2512615|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
790066|NCT00706654|2512612|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
790067|NCT00706654|2512613|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
790068|NCT00706654|2512614|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
790069|NCT00706654|2512615|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
790070|NCT00706654|2512612|P4|Depot Maintenance Phase|Protocol Deviation|1
790071|NCT00706654|2512613|P3|Depot Maintenance Phase|Protocol Deviation|3
790072|NCT00706654|2512614|P2|Depot Maintenance Phase|Protocol Deviation|2
790073|NCT00706654|2512615|P1|Depot Maintenance Phase|Protocol Deviation|0
790074|NCT00706654|2512612|P4|Depot Maintenance Phase|Withdrew Consent|14
790075|NCT00706654|2512613|P3|Depot Maintenance Phase|Withdrew Consent|29
790076|NCT00706654|2512614|P2|Depot Maintenance Phase|Withdrew Consent|21
790077|NCT00706654|2512615|P1|Depot Maintenance Phase|Withdrew Consent|0
790078|NCT00706654|2512612|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
790079|NCT00706654|2512613|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
790080|NCT00706654|2512614|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
790081|NCT00706654|2512615|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
790082|NCT00706654|2512612|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
790083|NCT00706654|2512613|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
790084|NCT00706654|2512614|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
790085|NCT00706654|2512615|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
790086|NCT00706654|2512612|P4|Depot Maintenance Phase|Lost to Follow-up|6
790087|NCT00706654|2512613|P3|Depot Maintenance Phase|Lost to Follow-up|10
790088|NCT00706654|2512614|P2|Depot Maintenance Phase|Lost to Follow-up|4
790089|NCT00706654|2512615|P1|Depot Maintenance Phase|Lost to Follow-up|0
790090|NCT00706654|2512612|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
790091|NCT00706654|2512613|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
790092|NCT00706654|2512614|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
790093|NCT00706654|2512615|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
790094|NCT00706654|2512612|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
790095|NCT00706654|2512613|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
790096|NCT00706654|2512614|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
790097|NCT00706654|2512615|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
790098|NCT00706654|2512612|P4|Oral Stabilization Phase|Adverse Event|0
790099|NCT00706654|2512613|P3|Oral Stabilization Phase|Adverse Event|0
790100|NCT00706654|2512614|P2|Oral Stabilization Phase|Adverse Event|0
790101|NCT00706654|2512615|P1|Oral Stabilization Phase|Adverse Event|21
790102|NCT00706654|2512612|P4|Oral Stabilization Phase|Protocol Deviation|0
790103|NCT00706654|2512613|P3|Oral Stabilization Phase|Protocol Deviation|0
790104|NCT00706654|2512614|P2|Oral Stabilization Phase|Protocol Deviation|0
790105|NCT00706654|2512615|P1|Oral Stabilization Phase|Protocol Deviation|2
790106|NCT00706654|2512612|P4|Oral Stabilization Phase|Withdrew consent|0
790107|NCT00706654|2512613|P3|Oral Stabilization Phase|Withdrew consent|0
790108|NCT00706654|2512614|P2|Oral Stabilization Phase|Withdrew consent|0
790109|NCT00706654|2512615|P1|Oral Stabilization Phase|Withdrew consent|55
790110|NCT00706654|2512612|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
790111|NCT00706654|2512613|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
790112|NCT00706654|2512614|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
790113|NCT00706654|2512615|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
790114|NCT00706654|2512612|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
790115|NCT00706654|2512613|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
790116|NCT00706654|2512614|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
790117|NCT00706654|2512615|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
790118|NCT00706654|2512612|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
790119|NCT00706654|2512613|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
790120|NCT00706654|2512614|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
790121|NCT00706654|2512615|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
790122|NCT00706654|2512612|P4|Oral Stabilization Phase|Lost to Follow-up|0
790123|NCT00706654|2512613|P3|Oral Stabilization Phase|Lost to Follow-up|0
790124|NCT00706654|2512614|P2|Oral Stabilization Phase|Lost to Follow-up|0
790125|NCT00706654|2512615|P1|Oral Stabilization Phase|Lost to Follow-up|17
790126|NCT00706654|2512612|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
790127|NCT00706654|2512613|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
790128|NCT00706654|2512614|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
790129|NCT00706654|2512615|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
790130|NCT00706654|2512612|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
790131|NCT00706654|2512613|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
790132|NCT00706654|2512614|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
790133|NCT00706654|2512615|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
790134|NCT00706654|2512612|P4|Conversion Phase|Adverse Event|0
790135|NCT00706654|2512613|P3|Conversion Phase|Adverse Event|0
790136|NCT00706654|2512614|P2|Conversion Phase|Adverse Event|0
790137|NCT00706654|2512615|P1|Conversion Phase|Adverse Event|18
790138|NCT00706654|2512612|P4|Conversion Phase|Withdrew Consent|0
790139|NCT00706654|2512613|P3|Conversion Phase|Withdrew Consent|0
790140|NCT00706654|2512614|P2|Conversion Phase|Withdrew Consent|0
790141|NCT00706654|2512615|P1|Conversion Phase|Withdrew Consent|38
790142|NCT00706654|2512612|P4|Conversion Phase|Withdrawn by Investigator|0
790143|NCT00706654|2512613|P3|Conversion Phase|Withdrawn by Investigator|0
790144|NCT00706654|2512614|P2|Conversion Phase|Withdrawn by Investigator|0
790145|NCT00706654|2512615|P1|Conversion Phase|Withdrawn by Investigator|14
790146|NCT00706654|2512612|P4|Conversion Phase|Met Withdrawal Criteria|0
790147|NCT00706654|2512613|P3|Conversion Phase|Met Withdrawal Criteria|0
790148|NCT00706654|2512614|P2|Conversion Phase|Met Withdrawal Criteria|0
790149|NCT00706654|2512615|P1|Conversion Phase|Met Withdrawal Criteria|2
790150|NCT00706654|2512612|P4|Conversion Phase|Sponsor Discontinued Trial|0
790151|NCT00706654|2512613|P3|Conversion Phase|Sponsor Discontinued Trial|0
790152|NCT00706654|2512614|P2|Conversion Phase|Sponsor Discontinued Trial|0
790153|NCT00706654|2512615|P1|Conversion Phase|Sponsor Discontinued Trial|8
790154|NCT00706654|2512612|P4|Conversion Phase|Lost to Follow-up|0
790155|NCT00706654|2512613|P3|Conversion Phase|Lost to Follow-up|0
790156|NCT00706654|2512614|P2|Conversion Phase|Lost to Follow-up|0
790157|NCT00706654|2512615|P1|Conversion Phase|Lost to Follow-up|4
790158|NCT00706706|2512634|P1|Overall Study|Study endpoint had reached|45
790159|NCT00706706|2512634|P1|Overall Study|Lost to Follow-up|7
790160|NCT00706706|2512634|P1|Overall Study|Death|53
790161|NCT00706797|2512672|P2|Overall Study|Unspecified|0
790162|NCT00706797|2512673|P1|Overall Study|Unspecified|1
790163|NCT00706797|2512672|P2|Overall Study|Lost to Follow-up|2
790164|NCT00706797|2512673|P1|Overall Study|Lost to Follow-up|1
790165|NCT00706797|2512672|P2|Overall Study|Protocol Violation|2
790166|NCT00706797|2512673|P1|Overall Study|Protocol Violation|3
790167|NCT00706797|2512672|P2|Overall Study|Discontinuation of study by sponsor|63
790168|NCT00706797|2512673|P1|Overall Study|Discontinuation of study by sponsor|52
790169|NCT00706797|2512672|P2|Overall Study|Death|0
790170|NCT00706797|2512673|P1|Overall Study|Death|1
790171|NCT00706797|2512672|P2|Overall Study|Withdrawal by Subject|1
790172|NCT00706797|2512673|P1|Overall Study|Withdrawal by Subject|8
790173|NCT00706797|2512672|P2|Overall Study|Adverse Event|3
790174|NCT00706797|2512673|P1|Overall Study|Adverse Event|0
790175|NCT00706797|2512672|P2|Overall Study|Lack of Efficacy|0
790176|NCT00706797|2512673|P1|Overall Study|Lack of Efficacy|3
790177|NCT00706849|2512747|P2|Follow-up Period|Protocol non-compliance|1
790178|NCT00706849|2512748|P1|Follow-up Period|Protocol non-compliance|0
790179|NCT00706849|2512747|P2|Follow-up Period|Withdrawal by Subject|2
790180|NCT00706849|2512748|P1|Follow-up Period|Withdrawal by Subject|0
790181|NCT00706849|2512747|P2|Treatment Period|Other|1
790182|NCT00706849|2512748|P1|Treatment Period|Other|0
790183|NCT00706849|2512747|P2|Treatment Period|Adverse Event|9
790184|NCT00706849|2512748|P1|Treatment Period|Adverse Event|0
790185|NCT00706901|2512795|P3|Overall Study|Death|0
790186|NCT00706901|2512796|P2|Overall Study|Death|0
790187|NCT00706901|2512797|P1|Overall Study|Death|1
790188|NCT00706901|2512795|P3|Overall Study|In Jail|1
790189|NCT00706901|2512796|P2|Overall Study|In Jail|0
790190|NCT00706901|2512797|P1|Overall Study|In Jail|1
790191|NCT00706901|2512795|P3|Overall Study|Withdrawal by Subject|5
790192|NCT00706901|2512796|P2|Overall Study|Withdrawal by Subject|2
790193|NCT00706901|2512797|P1|Overall Study|Withdrawal by Subject|4
790194|NCT00706901|2512795|P3|Overall Study|Lost to Follow-up|2
790195|NCT00706901|2512796|P2|Overall Study|Lost to Follow-up|3
790196|NCT00706901|2512797|P1|Overall Study|Lost to Follow-up|2
790197|NCT00706914|2512823|P3|Overall Study|Protocol Violation|1
790198|NCT00706914|2512824|P2|Overall Study|Protocol Violation|1
790199|NCT00706914|2512825|P1|Overall Study|Protocol Violation|3
790200|NCT00706914|2512823|P3|Overall Study|Adverse Event|0
790201|NCT00706914|2512824|P2|Overall Study|Adverse Event|2
790202|NCT00706914|2512825|P1|Overall Study|Adverse Event|2
790203|NCT00706914|2512823|P3|Overall Study|Lost to Follow-up|0
790204|NCT00706914|2512824|P2|Overall Study|Lost to Follow-up|0
790205|NCT00706914|2512825|P1|Overall Study|Lost to Follow-up|1
790206|NCT00706914|2512823|P3|Overall Study|Lack of Efficacy|0
790207|NCT00706914|2512824|P2|Overall Study|Lack of Efficacy|1
790208|NCT00706914|2512825|P1|Overall Study|Lack of Efficacy|0
790209|NCT00706966|2512845|P1|Overall Study|Adverse Event|1
790210|NCT00706992|2512900|P7|Overall Study|Disease progression before treatment|0
790211|NCT00706992|2512901|P6|Overall Study|Disease progression before treatment|0
790212|NCT00706992|2512902|P5|Overall Study|Disease progression before treatment|1
790213|NCT00706992|2512903|P4|Overall Study|Disease progression before treatment|0
790214|NCT00706992|2512904|P3|Overall Study|Disease progression before treatment|0
790215|NCT00706992|2512905|P2|Overall Study|Disease progression before treatment|0
790216|NCT00706992|2512906|P1|Overall Study|Disease progression before treatment|0
790217|NCT00706992|2512900|P7|Overall Study|Study termination|3
790218|NCT00706992|2512901|P6|Overall Study|Study termination|2
790219|NCT00706992|2512902|P5|Overall Study|Study termination|3
790220|NCT00706992|2512903|P4|Overall Study|Study termination|2
790221|NCT00706992|2512904|P3|Overall Study|Study termination|6
790222|NCT00706992|2512905|P2|Overall Study|Study termination|5
790223|NCT00706992|2512906|P1|Overall Study|Study termination|5
790224|NCT00707031|2512925|P2|Overall Study|Sponsor Decision|8
790225|NCT00707031|2512926|P1|Overall Study|Sponsor Decision|9
790226|NCT00707031|2512925|P2|Overall Study|Serious Noncompliance|3
790227|NCT00707031|2512926|P1|Overall Study|Serious Noncompliance|2
790228|NCT00707031|2512925|P2|Overall Study|Familial or Personal Reasons|15
790229|NCT00707031|2512926|P1|Overall Study|Familial or Personal Reasons|12
790230|NCT00707031|2512925|P2|Overall Study|Poor Compliance to Protocol|13
790231|NCT00707031|2512926|P1|Overall Study|Poor Compliance to Protocol|7
790232|NCT00707031|2512925|P2|Overall Study|Withdrawal by Subject|8
790233|NCT00707031|2512926|P1|Overall Study|Withdrawal by Subject|7
790234|NCT00707031|2512925|P2|Overall Study|Protocol Violation|0
790235|NCT00707031|2512926|P1|Overall Study|Protocol Violation|1
790236|NCT00707031|2512925|P2|Overall Study|Lost to Follow-up|1
790237|NCT00707031|2512926|P1|Overall Study|Lost to Follow-up|2
790238|NCT00707031|2512925|P2|Overall Study|Lack of Efficacy|6
790239|NCT00707031|2512926|P1|Overall Study|Lack of Efficacy|19
790240|NCT00707031|2512925|P2|Overall Study|Adverse Event|45
790241|NCT00707031|2512926|P1|Overall Study|Adverse Event|45
790242|NCT00707057|2512950|P2|Overall Study|Dosed incorrectly|1
790243|NCT00707057|2512951|P1|Overall Study|Dosed incorrectly|0
790244|NCT00707057|2512950|P2|Overall Study|Withdrawal by Subject|3
790245|NCT00707057|2512951|P1|Overall Study|Withdrawal by Subject|8
790246|NCT00707161|2512983|P1|Overall Study|Physician Decision|6
790247|NCT00707174|2512989|P2|Overall Study|Withdrawal by Subject|1
790248|NCT00707174|2512990|P1|Overall Study|Withdrawal by Subject|4
790249|NCT00707174|2512989|P2|Overall Study|Adverse Event|6
790250|NCT00707174|2512990|P1|Overall Study|Adverse Event|1
790251|NCT00707239|2512999|P3|Overall Study|Unspecified|5
790252|NCT00707239|2513000|P2|Overall Study|Unspecified|3
790253|NCT00707239|2513001|P1|Overall Study|Unspecified|8
790254|NCT00707239|2512999|P3|Overall Study|Randomized, but not treated|1
790255|NCT00707239|2513000|P2|Overall Study|Randomized, but not treated|1
790256|NCT00707239|2513001|P1|Overall Study|Randomized, but not treated|1
790257|NCT00707239|2512999|P3|Overall Study|Lack of Efficacy|0
790258|NCT00707239|2513000|P2|Overall Study|Lack of Efficacy|2
790259|NCT00707239|2513001|P1|Overall Study|Lack of Efficacy|1
790260|NCT00707239|2512999|P3|Overall Study|Protocol Violation|1
790261|NCT00707239|2513000|P2|Overall Study|Protocol Violation|0
790262|NCT00707239|2513001|P1|Overall Study|Protocol Violation|0
790263|NCT00707239|2512999|P3|Overall Study|Physician Decision|2
790264|NCT00707239|2513000|P2|Overall Study|Physician Decision|1
790265|NCT00707239|2513001|P1|Overall Study|Physician Decision|1
790266|NCT00707239|2512999|P3|Overall Study|Death|3
790267|NCT00707239|2513000|P2|Overall Study|Death|1
790268|NCT00707239|2513001|P1|Overall Study|Death|3
790269|NCT00707239|2512999|P3|Overall Study|Adverse Event|2
790270|NCT00707239|2513000|P2|Overall Study|Adverse Event|3
790271|NCT00707239|2513001|P1|Overall Study|Adverse Event|5
790272|NCT00707486|2513078|P1|Overall Study|Withdrawal by Subject|1
790273|NCT00707577|2513089|P2|Overall Study|Pregnancy|1
790274|NCT00707577|2513090|P1|Overall Study|Pregnancy|4
790275|NCT00707577|2513089|P2|Overall Study|Left employment|10
790276|NCT00707577|2513090|P1|Overall Study|Left employment|13
790277|NCT00707577|2513089|P2|Overall Study|Lost to Follow-up|25
790278|NCT00707577|2513090|P1|Overall Study|Lost to Follow-up|34
790279|NCT00707577|2513089|P2|Overall Study|Withdrawal by Subject|2
790280|NCT00707577|2513090|P1|Overall Study|Withdrawal by Subject|3
790281|NCT00707746|2513111|P2|Treatment Period|Ineligibility|1
790282|NCT00707746|2513112|P1|Treatment Period|Ineligibility|0
790283|NCT00707746|2513111|P2|Treatment Period|Adverse Event|4
790284|NCT00707746|2513112|P1|Treatment Period|Adverse Event|2
790285|NCT00707954|2513190|P5|Overall Study|Physician Decision|1
790286|NCT00707954|2513191|P4|Overall Study|Physician Decision|0
790287|NCT00707954|2513192|P3|Overall Study|Physician Decision|0
790288|NCT00707954|2513193|P2|Overall Study|Physician Decision|0
790289|NCT00707954|2513194|P1|Overall Study|Physician Decision|0
790290|NCT00707980|2513270|P1|Overall Study|Other|39
790291|NCT00707980|2513270|P1|Overall Study|Lost to Follow-up|59
790292|NCT00707980|2513270|P1|Overall Study|Withdrawal of Consent|81
790293|NCT00707980|2513270|P1|Overall Study|Protocol Deviations|19
790294|NCT00707980|2513270|P1|Overall Study|Non-Compliance with Study Drug|28
790295|NCT00707980|2513270|P1|Overall Study|Lack of Efficacy|35
790296|NCT00707980|2513270|P1|Overall Study|Adverse Event|49
790297|NCT00707993|2513287|P2|Overall Study|Other|0
790298|NCT00707993|2513288|P1|Overall Study|Other|2
790299|NCT00707993|2513287|P2|Overall Study|Hyperglycemic Rescue|47
790300|NCT00707993|2513288|P1|Overall Study|Hyperglycemic Rescue|55
790301|NCT00707993|2513287|P2|Overall Study|Withdrawal by Subject|16
790302|NCT00707993|2513288|P1|Overall Study|Withdrawal by Subject|12
790303|NCT00707993|2513287|P2|Overall Study|Lost to Follow-up|4
790304|NCT00707993|2513288|P1|Overall Study|Lost to Follow-up|0
790305|NCT00707993|2513287|P2|Overall Study|Protocol Violation|7
790306|NCT00707993|2513288|P1|Overall Study|Protocol Violation|4
790307|NCT00707993|2513287|P2|Overall Study|Adverse Event|20
790308|NCT00707993|2513288|P1|Overall Study|Adverse Event|16
790309|NCT00715208|2513332|P2|Overall Study|Lack of Efficacy|2
790310|NCT00715208|2513333|P1|Overall Study|Lack of Efficacy|0
790311|NCT00715208|2513332|P2|Overall Study|Adverse Event|6
790312|NCT00715208|2513333|P1|Overall Study|Adverse Event|0
790313|NCT00715208|2513332|P2|Overall Study|Withdrawal by Subject|1
790314|NCT00715208|2513333|P1|Overall Study|Withdrawal by Subject|1
790315|NCT00715299|2513347|P1|Overall Study|failed the pre-screen exercise test|2
790316|NCT00715299|2513347|P1|Overall Study|Adverse Event|3
790317|NCT00715299|2513347|P1|Overall Study|Withdrawal by Subject|1
790318|NCT00715403|2513362|P7|Overall Study|Other reason not defined above|0
790319|NCT00715403|2513363|P6|Overall Study|Other reason not defined above|1
790320|NCT00715403|2513364|P5|Overall Study|Other reason not defined above|1
790321|NCT00715403|2513365|P4|Overall Study|Other reason not defined above|0
790322|NCT00715403|2513366|P3|Overall Study|Other reason not defined above|1
790323|NCT00715403|2513367|P2|Overall Study|Other reason not defined above|0
790324|NCT00715403|2513368|P1|Overall Study|Other reason not defined above|0
790325|NCT00715403|2513362|P7|Overall Study|Protocol Violation|0
790326|NCT00715403|2513363|P6|Overall Study|Protocol Violation|1
790327|NCT00715403|2513364|P5|Overall Study|Protocol Violation|0
790328|NCT00715403|2513365|P4|Overall Study|Protocol Violation|0
790329|NCT00715403|2513366|P3|Overall Study|Protocol Violation|0
790330|NCT00715403|2513367|P2|Overall Study|Protocol Violation|0
790331|NCT00715403|2513368|P1|Overall Study|Protocol Violation|0
790332|NCT00715403|2513362|P7|Overall Study|Other Adverse Event than DLT|0
790333|NCT00715403|2513363|P6|Overall Study|Other Adverse Event than DLT|2
790334|NCT00715403|2513364|P5|Overall Study|Other Adverse Event than DLT|0
790335|NCT00715403|2513365|P4|Overall Study|Other Adverse Event than DLT|0
790336|NCT00715403|2513366|P3|Overall Study|Other Adverse Event than DLT|0
790337|NCT00715403|2513367|P2|Overall Study|Other Adverse Event than DLT|0
790338|NCT00715403|2513368|P1|Overall Study|Other Adverse Event than DLT|1
790339|NCT00715403|2513362|P7|Overall Study|Dose limiting Toxicity (DLT)|0
790340|NCT00715403|2513363|P6|Overall Study|Dose limiting Toxicity (DLT)|1
790341|NCT00715403|2513364|P5|Overall Study|Dose limiting Toxicity (DLT)|0
790342|NCT00715403|2513365|P4|Overall Study|Dose limiting Toxicity (DLT)|0
790343|NCT00715403|2513366|P3|Overall Study|Dose limiting Toxicity (DLT)|0
790344|NCT00715403|2513367|P2|Overall Study|Dose limiting Toxicity (DLT)|0
790345|NCT00715403|2513368|P1|Overall Study|Dose limiting Toxicity (DLT)|0
790346|NCT00715403|2513362|P7|Overall Study|Progressive disease|1
790347|NCT00715403|2513363|P6|Overall Study|Progressive disease|14
790348|NCT00715403|2513364|P5|Overall Study|Progressive disease|5
790349|NCT00715403|2513365|P4|Overall Study|Progressive disease|9
790350|NCT00715403|2513366|P3|Overall Study|Progressive disease|3
790351|NCT00715403|2513367|P2|Overall Study|Progressive disease|1
790352|NCT00715403|2513368|P1|Overall Study|Progressive disease|0
790353|NCT00715793|2513538|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
790354|NCT00715793|2513539|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
790355|NCT00715793|2513538|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
790356|NCT00715793|2513539|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
790357|NCT00715910|2513600|P6|Booster and ESFU Phase|Unspecified|0
790358|NCT00715910|2513601|P5|Booster and ESFU Phase|Unspecified|1
790359|NCT00715910|2513602|P4|Booster and ESFU Phase|Unspecified|5
790360|NCT00715910|2513603|P3|Booster and ESFU Phase|Unspecified|0
790361|NCT00715910|2513604|P2|Booster and ESFU Phase|Unspecified|0
790362|NCT00715910|2513605|P1|Booster and ESFU Phase|Unspecified|0
790363|NCT00715910|2513600|P6|Booster and ESFU Phase|Lost to Follow-up|13
790364|NCT00715910|2513601|P5|Booster and ESFU Phase|Lost to Follow-up|1
790365|NCT00715910|2513602|P4|Booster and ESFU Phase|Lost to Follow-up|6
790366|NCT00715910|2513603|P3|Booster and ESFU Phase|Lost to Follow-up|0
790367|NCT00715910|2513604|P2|Booster and ESFU Phase|Lost to Follow-up|0
790368|NCT00715910|2513605|P1|Booster and ESFU Phase|Lost to Follow-up|0
790369|NCT00715949|2513679|P1|Overall Study|could not finish first test|4
790370|NCT00716092|2513710|P3|Overall Study|Other incl. Lack of Efficacy|0
790371|NCT00716092|2513711|P2|Overall Study|Other incl. Lack of Efficacy|1
790372|NCT00716092|2513712|P1|Overall Study|Other incl. Lack of Efficacy|2
790373|NCT00716417|2513751|P10|Overall Study|On patient request due to toxicities|0
790374|NCT00716417|2513752|P9|Overall Study|On patient request due to toxicities|0
790375|NCT00716417|2513753|P8|Overall Study|On patient request due to toxicities|1
790376|NCT00716417|2513754|P7|Overall Study|On patient request due to toxicities|0
790377|NCT00716417|2513755|P6|Overall Study|On patient request due to toxicities|0
790378|NCT00716417|2513756|P5|Overall Study|On patient request due to toxicities|0
790379|NCT00716417|2513757|P4|Overall Study|On patient request due to toxicities|0
790380|NCT00716417|2513758|P3|Overall Study|On patient request due to toxicities|0
790381|NCT00716417|2513759|P2|Overall Study|On patient request due to toxicities|0
790382|NCT00716417|2513760|P1|Overall Study|On patient request due to toxicities|0
790383|NCT00716417|2513751|P10|Overall Study|Dose limiting toxicity (DLT)|0
790384|NCT00716417|2513752|P9|Overall Study|Dose limiting toxicity (DLT)|0
790385|NCT00716417|2513753|P8|Overall Study|Dose limiting toxicity (DLT)|0
790386|NCT00716417|2513754|P7|Overall Study|Dose limiting toxicity (DLT)|0
790387|NCT00716417|2513755|P6|Overall Study|Dose limiting toxicity (DLT)|0
790388|NCT00716417|2513756|P5|Overall Study|Dose limiting toxicity (DLT)|1
790389|NCT00716417|2513757|P4|Overall Study|Dose limiting toxicity (DLT)|0
790390|NCT00716417|2513758|P3|Overall Study|Dose limiting toxicity (DLT)|0
790391|NCT00716417|2513759|P2|Overall Study|Dose limiting toxicity (DLT)|0
790392|NCT00716417|2513760|P1|Overall Study|Dose limiting toxicity (DLT)|0
790393|NCT00716417|2513751|P10|Overall Study|Progressive disease|0
790394|NCT00716417|2513752|P9|Overall Study|Progressive disease|5
790395|NCT00716417|2513753|P8|Overall Study|Progressive disease|1
790396|NCT00716417|2513754|P7|Overall Study|Progressive disease|3
790397|NCT00716417|2513755|P6|Overall Study|Progressive disease|3
790398|NCT00716417|2513756|P5|Overall Study|Progressive disease|0
790399|NCT00716417|2513757|P4|Overall Study|Progressive disease|8
790400|NCT00716417|2513758|P3|Overall Study|Progressive disease|3
790401|NCT00716417|2513759|P2|Overall Study|Progressive disease|5
790402|NCT00716417|2513760|P1|Overall Study|Progressive disease|3
790403|NCT00716417|2513751|P10|Overall Study|Withdrawal by Subject|0
790404|NCT00716417|2513752|P9|Overall Study|Withdrawal by Subject|0
790405|NCT00716417|2513753|P8|Overall Study|Withdrawal by Subject|0
790406|NCT00716417|2513754|P7|Overall Study|Withdrawal by Subject|1
790407|NCT00716417|2513755|P6|Overall Study|Withdrawal by Subject|0
790408|NCT00716417|2513756|P5|Overall Study|Withdrawal by Subject|0
790409|NCT00716417|2513757|P4|Overall Study|Withdrawal by Subject|2
790410|NCT00716417|2513758|P3|Overall Study|Withdrawal by Subject|0
790411|NCT00716417|2513759|P2|Overall Study|Withdrawal by Subject|1
790412|NCT00716417|2513760|P1|Overall Study|Withdrawal by Subject|0
790413|NCT00716417|2513751|P10|Overall Study|Adverse Event|3
790414|NCT00716417|2513752|P9|Overall Study|Adverse Event|0
790415|NCT00716417|2513753|P8|Overall Study|Adverse Event|1
790416|NCT00716417|2513754|P7|Overall Study|Adverse Event|3
790417|NCT00716417|2513755|P6|Overall Study|Adverse Event|0
790418|NCT00716417|2513756|P5|Overall Study|Adverse Event|0
790419|NCT00716417|2513757|P4|Overall Study|Adverse Event|1
790420|NCT00716417|2513758|P3|Overall Study|Adverse Event|2
790421|NCT00716417|2513759|P2|Overall Study|Adverse Event|0
790422|NCT00716417|2513760|P1|Overall Study|Adverse Event|0
790423|NCT00716456|2513840|P3|Overall Study|Adverse Event|0
790424|NCT00716456|2513841|P2|Overall Study|Adverse Event|2
790425|NCT00716456|2513842|P1|Overall Study|Adverse Event|0
790426|NCT00716482|2513850|P1|Overall Study|inclusion/exclusion criteria not met|25
790427|NCT00716482|2513850|P1|Overall Study|technical/machine error|28
790428|NCT00716482|2513850|P1|Overall Study|no pathology obtained|10
790429|NCT00716482|2513850|P1|Overall Study|Inadequate acquisition or analysis|50
790430|NCT00716482|2513850|P1|Overall Study|Lost to Follow-up|6
790431|NCT00716625|2513860|P1|Overall Study|Safety was not Assessable|1
790432|NCT00716859|2513948|P2|Overall Study|Not treated|1
790433|NCT00716859|2513949|P1|Overall Study|Not treated|1
790434|NCT00716859|2513948|P2|Overall Study|Withdrawal by Subject|3
790435|NCT00716859|2513949|P1|Overall Study|Withdrawal by Subject|1
790436|NCT00716859|2513948|P2|Overall Study|Lack of Efficacy|0
790437|NCT00716859|2513949|P1|Overall Study|Lack of Efficacy|3
790438|NCT00716859|2513948|P2|Overall Study|Adverse Event|1
790439|NCT00716859|2513949|P1|Overall Study|Adverse Event|4
892326|NCT01709708|2829885|P1|Overall Study|Protocol Violation|1
892330|NCT01544153|2829927|P4|Overall Study|Non-smoker|0
892331|NCT01544153|2829928|P3|Overall Study|Non-smoker|1
892332|NCT01544153|2829929|P2|Overall Study|Non-smoker|0
892333|NCT01544153|2829930|P1|Overall Study|Non-smoker|0
892334|NCT01544153|2829927|P4|Overall Study|Under 18|0
892335|NCT01544153|2829928|P3|Overall Study|Under 18|0
892336|NCT01544153|2829929|P2|Overall Study|Under 18|1
892337|NCT01544153|2829930|P1|Overall Study|Under 18|0
892338|NCT01515306|2829955|P2|Overall Study|Ongoing receiving treatment|14
892339|NCT01515306|2829956|P1|Overall Study|Ongoing receiving treatment|9
790454|NCT00717067|2514040|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
790455|NCT00717067|2514041|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
790456|NCT00717067|2514042|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
790457|NCT00717067|2514043|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
790458|NCT00717067|2514044|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
790459|NCT00717093|2514128|P2|Overall Study|Randomized but not treated|0
790460|NCT00717093|2514129|P1|Overall Study|Randomized but not treated|1
790461|NCT00717093|2514128|P2|Overall Study|Unspecified|1
790462|NCT00717093|2514129|P1|Overall Study|Unspecified|0
790463|NCT00717093|2514128|P2|Overall Study|Withdrawal by Subject|19
790464|NCT00717093|2514129|P1|Overall Study|Withdrawal by Subject|12
790465|NCT00717093|2514128|P2|Overall Study|Lost to Follow-up|6
790466|NCT00717093|2514129|P1|Overall Study|Lost to Follow-up|9
790467|NCT00717093|2514128|P2|Overall Study|Lack of Efficacy|13
790468|NCT00717093|2514129|P1|Overall Study|Lack of Efficacy|3
790469|NCT00717093|2514128|P2|Overall Study|Adverse Event|9
790470|NCT00717093|2514129|P1|Overall Study|Adverse Event|19
790471|NCT00717197|2514141|P1|Overall Study|Physician Decision|1
790472|NCT00717197|2514141|P1|Overall Study|Tumor Progression|1
790473|NCT00717197|2514141|P1|Overall Study|Unable to purchase study drug|5
790474|NCT00717236|2514147|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
790475|NCT00717236|2514148|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
790476|NCT00717236|2514147|P2|Open-Label Period|Other: Completion Accidently Performed|0
790477|NCT00717236|2514148|P1|Open-Label Period|Other: Completion Accidently Performed|1
790478|NCT00717236|2514147|P2|Open-Label Period|Other: Administration of Golimumab|0
790479|NCT00717236|2514148|P1|Open-Label Period|Other: Administration of Golimumab|1
790480|NCT00717236|2514147|P2|Open-Label Period|Other: Cataract Surgery|0
790481|NCT00717236|2514148|P1|Open-Label Period|Other: Cataract Surgery|1
790482|NCT00717236|2514147|P2|Open-Label Period|Other: Sponsor Request|0
790483|NCT00717236|2514148|P1|Open-Label Period|Other: Sponsor Request|3
790484|NCT00717236|2514147|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
790485|NCT00717236|2514148|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
790486|NCT00717236|2514147|P2|Open-Label Period|Other: Investigator Decision|0
790487|NCT00717236|2514148|P1|Open-Label Period|Other: Investigator Decision|1
790488|NCT00717236|2514147|P2|Open-Label Period|Other: Moved|0
790489|NCT00717236|2514148|P1|Open-Label Period|Other: Moved|1
790490|NCT00717236|2514147|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
790491|NCT00717236|2514148|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
790492|NCT00717236|2514147|P2|Open-Label Period|Other: Lack of Compliance|1
790493|NCT00717236|2514148|P1|Open-Label Period|Other: Lack of Compliance|1
790494|NCT00717236|2514147|P2|Open-Label Period|Other: Peripheral Neuropathy|1
790495|NCT00717236|2514148|P1|Open-Label Period|Other: Peripheral Neuropathy|0
790496|NCT00717236|2514147|P2|Open-Label Period|Loss of Efficacy|1
790497|NCT00717236|2514148|P1|Open-Label Period|Loss of Efficacy|6
790498|NCT00717236|2514147|P2|Open-Label Period|Withdrawal by Subject|2
790499|NCT00717236|2514148|P1|Open-Label Period|Withdrawal by Subject|20
790500|NCT00717236|2514147|P2|Open-Label Period|Lost to Follow-up|4
790501|NCT00717236|2514148|P1|Open-Label Period|Lost to Follow-up|28
790502|NCT00717236|2514147|P2|Open-Label Period|Lack of Efficacy|8
790503|NCT00717236|2514148|P1|Open-Label Period|Lack of Efficacy|30
790504|NCT00717236|2514147|P2|Open-Label Period|Adverse Event|4
790505|NCT00717236|2514148|P1|Open-Label Period|Adverse Event|29
790506|NCT00717236|2514147|P2|Double-Blind Period|Other: Investigator Decision|1
790507|NCT00717236|2514148|P1|Double-Blind Period|Other: Investigator Decision|0
790508|NCT00717236|2514147|P2|Double-Blind Period|Other: Transportation problems|1
790509|NCT00717236|2514148|P1|Double-Blind Period|Other: Transportation problems|0
790510|NCT00717236|2514147|P2|Double-Blind Period|Other: Prohibited medication taken|2
790511|NCT00717236|2514148|P1|Double-Blind Period|Other: Prohibited medication taken|2
790512|NCT00717236|2514147|P2|Double-Blind Period|Other: Stopped taking DMARD|0
790513|NCT00717236|2514148|P1|Double-Blind Period|Other: Stopped taking DMARD|1
790514|NCT00717236|2514147|P2|Double-Blind Period|Other: Subject moved|1
790515|NCT00717236|2514148|P1|Double-Blind Period|Other: Subject moved|1
790516|NCT00717236|2514147|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
790517|NCT00717236|2514148|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
790518|NCT00717236|2514147|P2|Double-Blind Period|Other: Inappropriate randomization|0
790519|NCT00717236|2514148|P1|Double-Blind Period|Other: Inappropriate randomization|1
790520|NCT00717236|2514147|P2|Double-Blind Period|Other: Sponsor request|0
790521|NCT00717236|2514148|P1|Double-Blind Period|Other: Sponsor request|1
790522|NCT00717236|2514147|P2|Double-Blind Period|Other: History of cancer|0
790523|NCT00717236|2514148|P1|Double-Blind Period|Other: History of cancer|1
790524|NCT00717236|2514147|P2|Double-Blind Period|Other: History of adenoid grown|0
790525|NCT00717236|2514148|P1|Double-Blind Period|Other: History of adenoid grown|1
790526|NCT00717236|2514147|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
790527|NCT00717236|2514148|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
790528|NCT00717236|2514147|P2|Double-Blind Period|Other: subject withdrew consent|1
790529|NCT00717236|2514148|P1|Double-Blind Period|Other: subject withdrew consent|1
790530|NCT00717236|2514147|P2|Double-Blind Period|Other: Screening failure|0
790531|NCT00717236|2514148|P1|Double-Blind Period|Other: Screening failure|1
790532|NCT00717236|2514147|P2|Double-Blind Period|Other: Site withdrew|0
790533|NCT00717236|2514148|P1|Double-Blind Period|Other: Site withdrew|2
790534|NCT00717236|2514147|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
790535|NCT00717236|2514148|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
790536|NCT00717236|2514147|P2|Double-Blind Period|Other: Protocol Violation|0
790537|NCT00717236|2514148|P1|Double-Blind Period|Other: Protocol Violation|2
790538|NCT00717236|2514147|P2|Double-Blind Period|Other: Pregnancy|0
790539|NCT00717236|2514148|P1|Double-Blind Period|Other: Pregnancy|1
790540|NCT00717236|2514147|P2|Double-Blind Period|Other: Death|0
790541|NCT00717236|2514148|P1|Double-Blind Period|Other: Death|1
790542|NCT00717236|2514147|P2|Double-Blind Period|Loss of efficacy|0
790543|NCT00717236|2514148|P1|Double-Blind Period|Loss of efficacy|3
790544|NCT00717236|2514147|P2|Double-Blind Period|Withdrawal by Subject|2
790545|NCT00717236|2514148|P1|Double-Blind Period|Withdrawal by Subject|10
790546|NCT00717236|2514147|P2|Double-Blind Period|Lost to Follow-up|5
790547|NCT00717236|2514148|P1|Double-Blind Period|Lost to Follow-up|3
790548|NCT00717236|2514147|P2|Double-Blind Period|Lack of Efficacy|6
790549|NCT00717236|2514148|P1|Double-Blind Period|Lack of Efficacy|6
790550|NCT00717236|2514147|P2|Double-Blind Period|Adverse Event|6
790551|NCT00717236|2514148|P1|Double-Blind Period|Adverse Event|33
790552|NCT00717249|2514219|P2|Overall Study|Headaches|0
790553|NCT00717249|2514220|P1|Overall Study|Headaches|1
790554|NCT00717249|2514219|P2|Overall Study|Subject relocated|0
790555|NCT00717249|2514220|P1|Overall Study|Subject relocated|1
790556|NCT00717249|2514219|P2|Overall Study|Diagnosed with Multiple Scletosis|0
790557|NCT00717249|2514220|P1|Overall Study|Diagnosed with Multiple Scletosis|1
790558|NCT00717249|2514219|P2|Overall Study|Diagnosed with Diabetes|0
790559|NCT00717249|2514220|P1|Overall Study|Diagnosed with Diabetes|1
790560|NCT00717249|2514219|P2|Overall Study|Gastric Surgery|1
790561|NCT00717249|2514220|P1|Overall Study|Gastric Surgery|0
790562|NCT00717249|2514219|P2|Overall Study|Unsatisfactory Physiological Response|1
790563|NCT00717249|2514220|P1|Overall Study|Unsatisfactory Physiological Response|0
790564|NCT00717249|2514219|P2|Overall Study|Subject became Ineligible|1
790565|NCT00717249|2514220|P1|Overall Study|Subject became Ineligible|1
790566|NCT00717249|2514219|P2|Overall Study|Protocol Violation|2
790567|NCT00717249|2514220|P1|Overall Study|Protocol Violation|0
790568|NCT00717249|2514219|P2|Overall Study|Pregnancy|3
790569|NCT00717249|2514220|P1|Overall Study|Pregnancy|6
790570|NCT00717249|2514219|P2|Overall Study|Withdrawal by Subject|2
790571|NCT00717249|2514220|P1|Overall Study|Withdrawal by Subject|1
790572|NCT00717249|2514219|P2|Overall Study|Lost to Follow-up|0
790573|NCT00717249|2514220|P1|Overall Study|Lost to Follow-up|2
790574|NCT00717249|2514219|P2|Overall Study|Adverse Event|2
790575|NCT00717249|2514220|P1|Overall Study|Adverse Event|4
790576|NCT00717249|2514219|P2|Overall Study|Unsatisfactory visual Response|2
790577|NCT00717249|2514220|P1|Overall Study|Unsatisfactory visual Response|0
790578|NCT00717249|2514219|P2|Overall Study|Lens Discomfort|1
790579|NCT00717249|2514220|P1|Overall Study|Lens Discomfort|4
790580|NCT00717275|2514232|P1|Overall Study|Premature study termination.|3
790581|NCT00717314|2514257|P2|Overall Study|Withdrawal by Subject|3
790582|NCT00717314|2514258|P1|Overall Study|Withdrawal by Subject|1
790583|NCT00717314|2514257|P2|Overall Study|Lost to Follow-up|5
790584|NCT00717314|2514258|P1|Overall Study|Lost to Follow-up|1
790585|NCT00717314|2514257|P2|Overall Study|Protocol Violation|0
790586|NCT00717314|2514258|P1|Overall Study|Protocol Violation|1
790587|NCT00717314|2514257|P2|Overall Study|Adverse Event|2
790588|NCT00717314|2514258|P1|Overall Study|Adverse Event|3
790589|NCT00717366|2514278|P2|Extension Period (52 Weeks)|Withdrew consent|1
790590|NCT00717366|2514279|P1|Extension Period (52 Weeks)|Withdrew consent|1
790591|NCT00717366|2514278|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
790592|NCT00717366|2514279|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
790593|NCT00717366|2514278|P2|Extension Period (52 Weeks)|Renal transplant|13
790594|NCT00717366|2514279|P1|Extension Period (52 Weeks)|Renal transplant|3
790595|NCT00717366|2514278|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
790596|NCT00717366|2514279|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
790597|NCT00717366|2514278|P2|Core Study Period (20 Weeks)|Death|1
790598|NCT00717366|2514279|P1|Core Study Period (20 Weeks)|Death|0
790599|NCT00717366|2514278|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
790600|NCT00717366|2514279|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
790601|NCT00717366|2514278|P2|Core Study Period (20 Weeks)|Renal transplant|9
790602|NCT00717366|2514279|P1|Core Study Period (20 Weeks)|Renal transplant|4
790603|NCT00717522|2514330|P1|Overall Study|Death|1
790604|NCT00717522|2514330|P1|Overall Study|Adverse Event|1
790605|NCT00717522|2514330|P1|Overall Study|Disease Progression|5
790606|NCT00717756|2514344|P1|Overall Study|Withdrawal by Subject|1
790607|NCT00717860|2514350|P2|Overall Study|Withdrew consent|3
790608|NCT00717860|2514351|P1|Overall Study|Withdrew consent|7
790609|NCT00717860|2514350|P2|Overall Study|Discontinued for other reason|1
790610|NCT00717860|2514351|P1|Overall Study|Discontinued for other reason|6
790611|NCT00717860|2514350|P2|Overall Study|Lack of Efficacy|13
790612|NCT00717860|2514351|P1|Overall Study|Lack of Efficacy|7
790613|NCT00717860|2514350|P2|Overall Study|Laboratory adverse experience|2
790614|NCT00717860|2514351|P1|Overall Study|Laboratory adverse experience|2
790615|NCT00717860|2514350|P2|Overall Study|Clinical adverse experience|9
790616|NCT00717860|2514351|P1|Overall Study|Clinical adverse experience|5
790617|NCT00717886|2514370|P1|Overall Study|Treatment Failure|1
790618|NCT00717886|2514370|P1|Overall Study|Withdrawal by Subject|3
790619|NCT00718042|2514424|P6|Donor Follow-up|Lost to Follow-up|0
790620|NCT00718042|2514425|P5|Donor Follow-up|Lost to Follow-up|19
790621|NCT00718042|2514426|P4|Donor Follow-up|Lost to Follow-up|0
790622|NCT00718042|2514427|P3|Donor Follow-up|Lost to Follow-up|0
790623|NCT00718042|2514428|P2|Donor Follow-up|Lost to Follow-up|0
790624|NCT00718042|2514429|P1|Donor Follow-up|Lost to Follow-up|13
790625|NCT00718042|2514424|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
790626|NCT00718042|2514425|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
790627|NCT00718042|2514426|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
790628|NCT00718042|2514427|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
790629|NCT00718042|2514428|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
790630|NCT00718042|2514429|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
790631|NCT00718042|2514424|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
790632|NCT00718042|2514425|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
790633|NCT00718042|2514426|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
790634|NCT00718042|2514427|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
790635|NCT00718042|2514428|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
790636|NCT00718042|2514429|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
790637|NCT00718042|2514424|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
790638|NCT00718042|2514425|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
790639|NCT00718042|2514426|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
790640|NCT00718042|2514427|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
790641|NCT00718042|2514428|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
790642|NCT00718042|2514429|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
790643|NCT00718042|2514424|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
790644|NCT00718042|2514425|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
790645|NCT00718042|2514426|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
790646|NCT00718042|2514427|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
790647|NCT00718042|2514428|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
790648|NCT00718042|2514429|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
790649|NCT00718081|2514444|P3|Overall Study|Lack of Efficacy|21
790650|NCT00718081|2514445|P2|Overall Study|Lack of Efficacy|3
790651|NCT00718081|2514446|P1|Overall Study|Lack of Efficacy|7
790652|NCT00718081|2514444|P3|Overall Study|Adverse Event|0
790653|NCT00718081|2514445|P2|Overall Study|Adverse Event|1
790654|NCT00718081|2514446|P1|Overall Study|Adverse Event|0
790655|NCT00710866|2514480|P2|Overall Study|Failed to meet eligibility|1
790656|NCT00710866|2514481|P1|Overall Study|Failed to meet eligibility|1
790657|NCT00710866|2514480|P2|Overall Study|Lost to Follow-up|0
790658|NCT00710866|2514481|P1|Overall Study|Lost to Follow-up|1
790659|NCT00710866|2514480|P2|Overall Study|Withdrawal by Subject|1
790660|NCT00710866|2514481|P1|Overall Study|Withdrawal by Subject|2
790661|NCT00710866|2514480|P2|Overall Study|Protocol Violation|4
790662|NCT00710866|2514481|P1|Overall Study|Protocol Violation|5
790663|NCT00710879|2514503|P2|Overall Study|Protocol Violation|3
790664|NCT00710879|2514504|P1|Overall Study|Protocol Violation|0
790665|NCT00710879|2514503|P2|Overall Study|Lost to Follow-up|1
790666|NCT00710879|2514504|P1|Overall Study|Lost to Follow-up|2
790667|NCT00710970|2514535|P1|Overall Study|Never took drug|2
790668|NCT00710970|2514535|P1|Overall Study|Lost to Follow-up|8
790669|NCT00711009|2514554|P2|Overall Study|Dose adjustment|0
790670|NCT00711009|2514555|P1|Overall Study|Dose adjustment|1
790671|NCT00711009|2514554|P2|Overall Study|Site closing|1
790672|NCT00711009|2514555|P1|Overall Study|Site closing|0
790673|NCT00711009|2514554|P2|Overall Study|Pregnancy|0
790674|NCT00711009|2514555|P1|Overall Study|Pregnancy|1
790675|NCT00711009|2514554|P2|Overall Study|Virologic Failure|1
790676|NCT00711009|2514555|P1|Overall Study|Virologic Failure|2
790677|NCT00711009|2514554|P2|Overall Study|Participant Noncompliant|1
790678|NCT00711009|2514555|P1|Overall Study|Participant Noncompliant|0
790679|NCT00711009|2514554|P2|Overall Study|Lost to Follow-up|9
790680|NCT00711009|2514555|P1|Overall Study|Lost to Follow-up|3
790681|NCT00711009|2514554|P2|Overall Study|Withdrawal by Subject|2
790682|NCT00711009|2514555|P1|Overall Study|Withdrawal by Subject|4
790683|NCT00711009|2514554|P2|Overall Study|Adverse Event/HIV-Related Event|5
790684|NCT00711009|2514555|P1|Overall Study|Adverse Event/HIV-Related Event|4
790685|NCT00711087|2514729|P2|Overall Study|Lost to Follow-up|0
790686|NCT00711087|2514730|P1|Overall Study|Lost to Follow-up|1
790687|NCT00711100|2514736|P1|Overall Study|Withdrawal by Subject|8
790688|NCT00711100|2514736|P1|Overall Study|Lack of Efficacy|5
790689|NCT00711113|2514752|P1|Overall Study|Implant lost|2
790690|NCT00711113|2514752|P1|Overall Study|Lost to Follow-up|9
790691|NCT00711191|2514761|P3|Overall Study|Withdrawal by Subject|3
790692|NCT00711191|2514762|P2|Overall Study|Withdrawal by Subject|1
790693|NCT00711191|2514763|P1|Overall Study|Withdrawal by Subject|0
790694|NCT00711191|2514761|P3|Overall Study|Objective progression or relapse|7
790695|NCT00711191|2514762|P2|Overall Study|Objective progression or relapse|3
790696|NCT00711191|2514763|P1|Overall Study|Objective progression or relapse|2
790697|NCT00711191|2514761|P3|Overall Study|Adverse Event|2
790698|NCT00711191|2514762|P2|Overall Study|Adverse Event|1
790699|NCT00711191|2514763|P1|Overall Study|Adverse Event|1
790700|NCT00711425|2514819|P1|Overall Study|Lost to Follow-up|1
790701|NCT00711425|2514819|P1|Overall Study|Death|2
790702|NCT00711425|2514819|P1|Overall Study|Protocol Violation|1
790703|NCT00711477|2514845|P2|Overall Study|Noncompliance|1
790704|NCT00711477|2514846|P1|Overall Study|Noncompliance|0
790705|NCT00711477|2514845|P2|Overall Study|Lost to Follow-up|1
790706|NCT00711477|2514846|P1|Overall Study|Lost to Follow-up|0
790707|NCT00711477|2514845|P2|Overall Study|Adverse Event|1
790708|NCT00711477|2514846|P1|Overall Study|Adverse Event|3
790709|NCT00711516|2514887|P2|Overall Study|Protocol Violation|1
790710|NCT00711516|2514888|P1|Overall Study|Protocol Violation|0
790711|NCT00711516|2514887|P2|Overall Study|Withdrawal by Subject|1
790712|NCT00711516|2514888|P1|Overall Study|Withdrawal by Subject|0
790713|NCT00711516|2514887|P2|Overall Study|Adverse Event|1
790714|NCT00711516|2514888|P1|Overall Study|Adverse Event|1
790715|NCT00711529|2514984|P2|Overall Study|Withdrawal by Subject|6
790716|NCT00711529|2514985|P1|Overall Study|Withdrawal by Subject|2
790717|NCT00711529|2514984|P2|Overall Study|Protocol Violation|0
790718|NCT00711529|2514985|P1|Overall Study|Protocol Violation|2
790719|NCT00711555|2515007|P1|Overall Study|Adverse Event|3
790720|NCT00711594|2515018|P4|Overall Study|Withdrawal by Subject|2
790721|NCT00711594|2515019|P3|Overall Study|Withdrawal by Subject|0
790722|NCT00711594|2515020|P2|Overall Study|Withdrawal by Subject|1
790723|NCT00711594|2515021|P1|Overall Study|Withdrawal by Subject|0
790724|NCT00711594|2515018|P4|Overall Study|Other Adverse Event|16
790725|NCT00711594|2515019|P3|Overall Study|Other Adverse Event|0
790726|NCT00711594|2515020|P2|Overall Study|Other Adverse Event|0
790727|NCT00711594|2515021|P1|Overall Study|Other Adverse Event|1
790728|NCT00711594|2515018|P4|Overall Study|Progressive disease|44
790729|NCT00711594|2515019|P3|Overall Study|Progressive disease|6
790730|NCT00711594|2515020|P2|Overall Study|Progressive disease|2
790731|NCT00711594|2515021|P1|Overall Study|Progressive disease|2
790732|NCT00711646|2515060|P2|Overall Study|patient non-compliance|0
790733|NCT00711646|2515061|P1|Overall Study|patient non-compliance|1
790734|NCT00711646|2515060|P2|Overall Study|administrative decision|1
790735|NCT00711646|2515061|P1|Overall Study|administrative decision|0
790736|NCT00711646|2515060|P2|Overall Study|Lost to Follow-up|0
790737|NCT00711646|2515061|P1|Overall Study|Lost to Follow-up|1
790738|NCT00711646|2515060|P2|Overall Study|Protocol Violation|1
790739|NCT00711646|2515061|P1|Overall Study|Protocol Violation|0
790740|NCT00711646|2515060|P2|Overall Study|Withdrawal by Subject|0
790741|NCT00711646|2515061|P1|Overall Study|Withdrawal by Subject|4
790742|NCT00711646|2515060|P2|Overall Study|Adverse Event|1
790743|NCT00711646|2515061|P1|Overall Study|Adverse Event|6
790744|NCT00711802|2515087|P8|Overall Study|Reason not reported|0
790745|NCT00711802|2515088|P7|Overall Study|Reason not reported|1
790746|NCT00711802|2515089|P6|Overall Study|Reason not reported|0
790747|NCT00711802|2515090|P5|Overall Study|Reason not reported|1
790748|NCT00711802|2515091|P4|Overall Study|Reason not reported|0
790749|NCT00711802|2515092|P3|Overall Study|Reason not reported|1
790750|NCT00711802|2515093|P2|Overall Study|Reason not reported|1
790751|NCT00711802|2515094|P1|Overall Study|Reason not reported|0
790752|NCT00711802|2515087|P8|Overall Study|Lost to Follow-up|2
790753|NCT00711802|2515088|P7|Overall Study|Lost to Follow-up|4
790754|NCT00711802|2515089|P6|Overall Study|Lost to Follow-up|6
790755|NCT00711802|2515090|P5|Overall Study|Lost to Follow-up|10
790756|NCT00711802|2515091|P4|Overall Study|Lost to Follow-up|1
790757|NCT00711802|2515092|P3|Overall Study|Lost to Follow-up|3
790758|NCT00711802|2515093|P2|Overall Study|Lost to Follow-up|0
790759|NCT00711802|2515094|P1|Overall Study|Lost to Follow-up|0
790760|NCT00711802|2515087|P8|Overall Study|Withdrawal by Subject|0
790761|NCT00711802|2515088|P7|Overall Study|Withdrawal by Subject|0
790762|NCT00711802|2515089|P6|Overall Study|Withdrawal by Subject|0
790763|NCT00711802|2515090|P5|Overall Study|Withdrawal by Subject|0
790764|NCT00711802|2515091|P4|Overall Study|Withdrawal by Subject|1
790765|NCT00711802|2515092|P3|Overall Study|Withdrawal by Subject|0
790766|NCT00711802|2515093|P2|Overall Study|Withdrawal by Subject|1
790767|NCT00711802|2515094|P1|Overall Study|Withdrawal by Subject|0
790768|NCT00711802|2515087|P8|Overall Study|Physician Decision|0
790769|NCT00711802|2515088|P7|Overall Study|Physician Decision|0
790770|NCT00711802|2515089|P6|Overall Study|Physician Decision|0
790771|NCT00711802|2515090|P5|Overall Study|Physician Decision|0
790772|NCT00711802|2515091|P4|Overall Study|Physician Decision|0
790773|NCT00711802|2515092|P3|Overall Study|Physician Decision|0
790774|NCT00711802|2515093|P2|Overall Study|Physician Decision|2
790775|NCT00711802|2515094|P1|Overall Study|Physician Decision|0
790776|NCT00711802|2515087|P8|Overall Study|Protocol Violation|0
790777|NCT00711802|2515088|P7|Overall Study|Protocol Violation|0
790778|NCT00711802|2515089|P6|Overall Study|Protocol Violation|0
790779|NCT00711802|2515090|P5|Overall Study|Protocol Violation|0
790780|NCT00711802|2515091|P4|Overall Study|Protocol Violation|1
790781|NCT00711802|2515092|P3|Overall Study|Protocol Violation|0
790782|NCT00711802|2515093|P2|Overall Study|Protocol Violation|0
790783|NCT00711802|2515094|P1|Overall Study|Protocol Violation|0
790784|NCT00711802|2515087|P8|Overall Study|Microbiological failure|0
790785|NCT00711802|2515088|P7|Overall Study|Microbiological failure|0
790786|NCT00711802|2515089|P6|Overall Study|Microbiological failure|1
790787|NCT00711802|2515090|P5|Overall Study|Microbiological failure|0
790788|NCT00711802|2515091|P4|Overall Study|Microbiological failure|0
790789|NCT00711802|2515092|P3|Overall Study|Microbiological failure|0
790790|NCT00711802|2515093|P2|Overall Study|Microbiological failure|1
790791|NCT00711802|2515094|P1|Overall Study|Microbiological failure|0
790792|NCT00711802|2515087|P8|Overall Study|Adverse Event|0
790793|NCT00711802|2515088|P7|Overall Study|Adverse Event|0
790794|NCT00711802|2515089|P6|Overall Study|Adverse Event|1
790795|NCT00711802|2515090|P5|Overall Study|Adverse Event|1
790796|NCT00711802|2515091|P4|Overall Study|Adverse Event|0
790797|NCT00711802|2515092|P3|Overall Study|Adverse Event|0
790798|NCT00711802|2515093|P2|Overall Study|Adverse Event|0
790799|NCT00711802|2515094|P1|Overall Study|Adverse Event|0
790800|NCT00711802|2515087|P8|Overall Study|Not treated (no further detail)|0
790801|NCT00711802|2515088|P7|Overall Study|Not treated (no further detail)|0
790802|NCT00711802|2515089|P6|Overall Study|Not treated (no further detail)|0
790803|NCT00711802|2515090|P5|Overall Study|Not treated (no further detail)|2
790804|NCT00711802|2515091|P4|Overall Study|Not treated (no further detail)|0
790805|NCT00711802|2515092|P3|Overall Study|Not treated (no further detail)|2
790806|NCT00711802|2515093|P2|Overall Study|Not treated (no further detail)|1
790807|NCT00711802|2515094|P1|Overall Study|Not treated (no further detail)|2
790808|NCT00711880|2515144|P2|Overall Study|Lack of Efficacy|5
790809|NCT00711880|2515145|P1|Overall Study|Lack of Efficacy|1
790810|NCT00711880|2515144|P2|Overall Study|Patient non-compliance|0
790811|NCT00711880|2515145|P1|Overall Study|Patient non-compliance|1
790812|NCT00711880|2515144|P2|Overall Study|Adverse Event|2
790813|NCT00711880|2515145|P1|Overall Study|Adverse Event|11
790814|NCT00711958|2515183|P2|Overall Study|Progression of disease|0
790815|NCT00711958|2515184|P1|Overall Study|Progression of disease|1
790816|NCT00711958|2515183|P2|Overall Study|Death|5
790817|NCT00711958|2515184|P1|Overall Study|Death|10
790818|NCT00711958|2515183|P2|Overall Study|Lost to Follow-up|2
790819|NCT00711958|2515184|P1|Overall Study|Lost to Follow-up|2
790820|NCT00711958|2515183|P2|Overall Study|Protocol Violation|0
790821|NCT00711958|2515184|P1|Overall Study|Protocol Violation|1
790822|NCT00711958|2515183|P2|Overall Study|Adverse Event|7
790823|NCT00711958|2515184|P1|Overall Study|Adverse Event|9
790824|NCT00711958|2515183|P2|Overall Study|Clinical deterioration|0
790825|NCT00711958|2515184|P1|Overall Study|Clinical deterioration|1
790826|NCT00711958|2515183|P2|Overall Study|Lack of Efficacy|1
790827|NCT00711958|2515184|P1|Overall Study|Lack of Efficacy|3
790828|NCT00711958|2515183|P2|Overall Study|Withdrawal by Subject|8
790829|NCT00711958|2515184|P1|Overall Study|Withdrawal by Subject|6
790830|NCT00711971|2515193|P3|Overall Study|Lost to Follow-up|1
790831|NCT00711971|2515194|P2|Overall Study|Lost to Follow-up|4
790832|NCT00711971|2515195|P1|Overall Study|Lost to Follow-up|3
790833|NCT00712010|2515240|P1|Washout (7 Days)|Withdrawal by Subject|1
790834|NCT00712166|2515284|P2|Overall Study|Noncompliance|1
790835|NCT00712166|2515285|P1|Overall Study|Noncompliance|0
790836|NCT00712335|2515367|P5|Overall Study|Other Reason|0
790837|NCT00712335|2515368|P4|Overall Study|Other Reason|0
790838|NCT00712335|2515369|P3|Overall Study|Other Reason|1
790839|NCT00712335|2515370|P2|Overall Study|Other Reason|3
790840|NCT00712335|2515371|P1|Overall Study|Other Reason|0
790841|NCT00712335|2515367|P5|Overall Study|Lack of Efficacy|0
790842|NCT00712335|2515368|P4|Overall Study|Lack of Efficacy|1
790843|NCT00712335|2515369|P3|Overall Study|Lack of Efficacy|1
790844|NCT00712335|2515370|P2|Overall Study|Lack of Efficacy|0
790845|NCT00712335|2515371|P1|Overall Study|Lack of Efficacy|0
790846|NCT00712335|2515367|P5|Overall Study|Protocol Violation|0
790847|NCT00712335|2515368|P4|Overall Study|Protocol Violation|0
790848|NCT00712335|2515369|P3|Overall Study|Protocol Violation|1
790849|NCT00712335|2515370|P2|Overall Study|Protocol Violation|2
790850|NCT00712335|2515371|P1|Overall Study|Protocol Violation|1
790851|NCT00712335|2515367|P5|Overall Study|Lost to Follow-up|0
790852|NCT00712335|2515368|P4|Overall Study|Lost to Follow-up|1
790853|NCT00712335|2515369|P3|Overall Study|Lost to Follow-up|0
790854|NCT00712335|2515370|P2|Overall Study|Lost to Follow-up|5
790855|NCT00712335|2515371|P1|Overall Study|Lost to Follow-up|2
790856|NCT00712335|2515367|P5|Overall Study|Withdrawal by Subject|0
790857|NCT00712335|2515368|P4|Overall Study|Withdrawal by Subject|3
790858|NCT00712335|2515369|P3|Overall Study|Withdrawal by Subject|2
790859|NCT00712335|2515370|P2|Overall Study|Withdrawal by Subject|7
790860|NCT00712335|2515371|P1|Overall Study|Withdrawal by Subject|0
790861|NCT00712348|2515413|P1|Overall Study|Withdrawal by Subject|1
790862|NCT00712543|2515450|P2|Day 8-14|Lost to Follow-up|2
790863|NCT00712543|2515451|P1|Day 8-14|Lost to Follow-up|0
790864|NCT00712673|2515460|P4|Overall Study|Protocol Violation|0
790865|NCT00712673|2515461|P3|Overall Study|Protocol Violation|2
790866|NCT00712673|2515462|P2|Overall Study|Protocol Violation|0
790867|NCT00712673|2515463|P1|Overall Study|Protocol Violation|0
790868|NCT00712673|2515460|P4|Overall Study|Investigator's Decision|0
790869|NCT00712673|2515461|P3|Overall Study|Investigator's Decision|0
790870|NCT00712673|2515462|P2|Overall Study|Investigator's Decision|0
790871|NCT00712673|2515463|P1|Overall Study|Investigator's Decision|1
790872|NCT00712673|2515460|P4|Overall Study|Familial and Personal Reasons|2
790873|NCT00712673|2515461|P3|Overall Study|Familial and Personal Reasons|5
790874|NCT00712673|2515462|P2|Overall Study|Familial and Personal Reasons|0
790875|NCT00712673|2515463|P1|Overall Study|Familial and Personal Reasons|5
790876|NCT00712673|2515460|P4|Overall Study|Withdrawal by Subject|20
790877|NCT00712673|2515461|P3|Overall Study|Withdrawal by Subject|15
790878|NCT00712673|2515462|P2|Overall Study|Withdrawal by Subject|7
790879|NCT00712673|2515463|P1|Overall Study|Withdrawal by Subject|6
790880|NCT00712673|2515460|P4|Overall Study|Lost to Follow-up|0
790881|NCT00712673|2515461|P3|Overall Study|Lost to Follow-up|2
790882|NCT00712673|2515462|P2|Overall Study|Lost to Follow-up|0
790883|NCT00712673|2515463|P1|Overall Study|Lost to Follow-up|1
790884|NCT00712673|2515460|P4|Overall Study|Poor Compliance to Protocol|16
790885|NCT00712673|2515461|P3|Overall Study|Poor Compliance to Protocol|4
790886|NCT00712673|2515462|P2|Overall Study|Poor Compliance to Protocol|3
790887|NCT00712673|2515463|P1|Overall Study|Poor Compliance to Protocol|3
790888|NCT00712673|2515460|P4|Overall Study|Lack of Efficacy|6
790889|NCT00712673|2515461|P3|Overall Study|Lack of Efficacy|8
790890|NCT00712673|2515462|P2|Overall Study|Lack of Efficacy|8
790891|NCT00712673|2515463|P1|Overall Study|Lack of Efficacy|2
790892|NCT00712673|2515460|P4|Overall Study|Adverse Event|26
790893|NCT00712673|2515461|P3|Overall Study|Adverse Event|21
790894|NCT00712673|2515462|P2|Overall Study|Adverse Event|3
790895|NCT00712673|2515463|P1|Overall Study|Adverse Event|3
790896|NCT00718237|2515527|P2|Overall Study|Withdrawal by Subject|10
790897|NCT00718237|2515528|P1|Overall Study|Withdrawal by Subject|9
790898|NCT00718237|2515527|P2|Overall Study|Physician Decision|0
790899|NCT00718237|2515528|P1|Overall Study|Physician Decision|1
790900|NCT00718237|2515527|P2|Overall Study|Lost to Follow-up|2
790901|NCT00718237|2515528|P1|Overall Study|Lost to Follow-up|2
790902|NCT00718237|2515527|P2|Overall Study|Adverse Event|3
790903|NCT00718237|2515528|P1|Overall Study|Adverse Event|1
790904|NCT00718315|2515558|P3|Overall Study|Use of ATB and Corticoids|2
790905|NCT00718315|2515559|P2|Overall Study|Use of ATB and Corticoids|1
790906|NCT00718315|2515560|P1|Overall Study|Use of ATB and Corticoids|0
790907|NCT00718315|2515558|P3|Overall Study|Other|1
790908|NCT00718315|2515559|P2|Overall Study|Other|0
790909|NCT00718315|2515560|P1|Overall Study|Other|0
790910|NCT00718315|2515558|P3|Overall Study|Disease progression|1
790911|NCT00718315|2515559|P2|Overall Study|Disease progression|1
790912|NCT00718315|2515560|P1|Overall Study|Disease progression|0
790913|NCT00718315|2515558|P3|Overall Study|Use of Minocyclin|1
790914|NCT00718315|2515559|P2|Overall Study|Use of Minocyclin|1
790915|NCT00718315|2515560|P1|Overall Study|Use of Minocyclin|1
790916|NCT00718315|2515558|P3|Overall Study|Erlotinib dose decreased|1
790917|NCT00718315|2515559|P2|Overall Study|Erlotinib dose decreased|3
790918|NCT00718315|2515560|P1|Overall Study|Erlotinib dose decreased|4
790919|NCT00718315|2515558|P3|Overall Study|Protocol Violation|3
790920|NCT00718315|2515559|P2|Overall Study|Protocol Violation|5
790921|NCT00718315|2515560|P1|Overall Study|Protocol Violation|5
790922|NCT00718315|2515558|P3|Overall Study|Lost to Follow-up|4
790923|NCT00718315|2515559|P2|Overall Study|Lost to Follow-up|3
790924|NCT00718315|2515560|P1|Overall Study|Lost to Follow-up|2
790925|NCT00718315|2515558|P3|Overall Study|Death|5
790926|NCT00718315|2515559|P2|Overall Study|Death|6
790927|NCT00718315|2515560|P1|Overall Study|Death|6
790928|NCT00718315|2515558|P3|Overall Study|Adverse Event|3
790929|NCT00718315|2515559|P2|Overall Study|Adverse Event|2
790930|NCT00718315|2515560|P1|Overall Study|Adverse Event|1
892340|NCT01515306|2829955|P2|Overall Study|Progressive Disease|0
892341|NCT01515306|2829956|P1|Overall Study|Progressive Disease|1
790933|NCT00718770|2515601|P1|Overall Study|Adverse Event|1
790934|NCT00718770|2515601|P1|Overall Study|Lack of Efficacy|1
790935|NCT00718770|2515601|P1|Overall Study|Adverse Event|1
790936|NCT00718770|2515601|P1|Overall Study|Lack of Efficacy|1
790937|NCT00718770|2515601|P1|Overall Study|Adverse Event|1
790938|NCT00718770|2515601|P1|Overall Study|Lack of Efficacy|1
790939|NCT00718770|2515601|P1|Overall Study|Lack of Efficacy|1
790940|NCT00718770|2515601|P1|Overall Study|Adverse Event|1
790941|NCT00718809|2515607|P2|Overall Study|Noncompliance|0
790942|NCT00718809|2515608|P1|Overall Study|Noncompliance|1
790943|NCT00718809|2515607|P2|Overall Study|Lost to Follow-up|0
790944|NCT00718809|2515608|P1|Overall Study|Lost to Follow-up|1
790945|NCT00718809|2515607|P2|Overall Study|Withdrawal by Subject|1
790946|NCT00718809|2515608|P1|Overall Study|Withdrawal by Subject|0
790947|NCT00718809|2515607|P2|Overall Study|Adverse Event|1
790948|NCT00718809|2515608|P1|Overall Study|Adverse Event|1
790949|NCT00718809|2515607|P2|Overall Study|Disease progression|7
790950|NCT00718809|2515608|P1|Overall Study|Disease progression|9
790951|NCT00718861|2515624|P2|Overall Study|Death|5
790952|NCT00718861|2515625|P1|Overall Study|Death|1
790953|NCT00718861|2515624|P2|Overall Study|Administrative Problems|1
790954|NCT00718861|2515625|P1|Overall Study|Administrative Problems|1
790955|NCT00718861|2515624|P2|Overall Study|Lost to Follow-up|1
790956|NCT00718861|2515625|P1|Overall Study|Lost to Follow-up|2
790957|NCT00718861|2515624|P2|Overall Study|Adverse Event|1
790958|NCT00718861|2515625|P1|Overall Study|Adverse Event|2
790959|NCT00718861|2515624|P2|Overall Study|Withdrawal by Subject|10
790960|NCT00718861|2515625|P1|Overall Study|Withdrawal by Subject|15
790961|NCT00718887|2515653|P2|Overall Study|Not identified|7
790962|NCT00718887|2515654|P1|Overall Study|Not identified|2
790963|NCT00718887|2515653|P2|Overall Study|Withdrawal by Subject|2
790964|NCT00718887|2515654|P1|Overall Study|Withdrawal by Subject|3
790965|NCT00719043|2515683|P7|Overall Study|Withdrawal by Subject|14
790966|NCT00719043|2515684|P6|Overall Study|Withdrawal by Subject|18
790967|NCT00719043|2515685|P5|Overall Study|Withdrawal by Subject|16
790968|NCT00719043|2515686|P4|Overall Study|Withdrawal by Subject|10
790969|NCT00719043|2515687|P3|Overall Study|Withdrawal by Subject|9
790970|NCT00719043|2515688|P2|Overall Study|Withdrawal by Subject|14
790971|NCT00719043|2515689|P1|Overall Study|Withdrawal by Subject|12
790972|NCT00719043|2515683|P7|Overall Study|Unspecified|1
790973|NCT00719043|2515684|P6|Overall Study|Unspecified|2
790974|NCT00719043|2515685|P5|Overall Study|Unspecified|0
790975|NCT00719043|2515686|P4|Overall Study|Unspecified|2
790976|NCT00719043|2515687|P3|Overall Study|Unspecified|1
790977|NCT00719043|2515688|P2|Overall Study|Unspecified|0
790978|NCT00719043|2515689|P1|Overall Study|Unspecified|1
790979|NCT00719043|2515683|P7|Overall Study|Protocol Violation|0
790980|NCT00719043|2515684|P6|Overall Study|Protocol Violation|1
790981|NCT00719043|2515685|P5|Overall Study|Protocol Violation|0
790982|NCT00719043|2515686|P4|Overall Study|Protocol Violation|0
790983|NCT00719043|2515687|P3|Overall Study|Protocol Violation|0
790984|NCT00719043|2515688|P2|Overall Study|Protocol Violation|0
790985|NCT00719043|2515689|P1|Overall Study|Protocol Violation|0
790986|NCT00719043|2515683|P7|Overall Study|Lost to Follow-up|9
790987|NCT00719043|2515684|P6|Overall Study|Lost to Follow-up|9
790988|NCT00719043|2515685|P5|Overall Study|Lost to Follow-up|10
790989|NCT00719043|2515686|P4|Overall Study|Lost to Follow-up|9
790990|NCT00719043|2515687|P3|Overall Study|Lost to Follow-up|8
790991|NCT00719043|2515688|P2|Overall Study|Lost to Follow-up|10
790992|NCT00719043|2515689|P1|Overall Study|Lost to Follow-up|14
790993|NCT00719043|2515683|P7|Overall Study|Adverse Event|4
790994|NCT00719043|2515684|P6|Overall Study|Adverse Event|4
790995|NCT00719043|2515685|P5|Overall Study|Adverse Event|1
790996|NCT00719043|2515686|P4|Overall Study|Adverse Event|2
790997|NCT00719043|2515687|P3|Overall Study|Adverse Event|2
790998|NCT00719043|2515688|P2|Overall Study|Adverse Event|1
790999|NCT00719043|2515689|P1|Overall Study|Adverse Event|5
791000|NCT00719212|2515840|P1|Overall Study|Withdrawal by Subject|1
791001|NCT00719212|2515840|P1|Overall Study|Lost to Follow-up|2
791002|NCT00719212|2515840|P1|Overall Study|Death|41
791003|NCT00719264|2515852|P2|Overall Study|Disease Progression|107
791004|NCT00719264|2515853|P1|Overall Study|Disease Progression|104
791005|NCT00719264|2515852|P2|Overall Study|New Cancer Therapy|2
791006|NCT00719264|2515853|P1|Overall Study|New Cancer Therapy|4
791007|NCT00719264|2515852|P2|Overall Study|Protocol Deviation|3
791008|NCT00719264|2515853|P1|Overall Study|Protocol Deviation|1
791009|NCT00719264|2515852|P2|Overall Study|Withdrawal by Subject|7
791010|NCT00719264|2515853|P1|Overall Study|Withdrawal by Subject|12
791011|NCT00719264|2515852|P2|Overall Study|Lost to Follow-up|1
791012|NCT00719264|2515853|P1|Overall Study|Lost to Follow-up|1
791013|NCT00719264|2515852|P2|Overall Study|Administrative Problems|4
791014|NCT00719264|2515853|P1|Overall Study|Administrative Problems|6
791015|NCT00719264|2515852|P2|Overall Study|Death|10
791016|NCT00719264|2515853|P1|Overall Study|Death|13
791017|NCT00719264|2515852|P2|Overall Study|Adverse Event|49
791018|NCT00719264|2515853|P1|Overall Study|Adverse Event|41
791019|NCT00719355|2515893|P2|Overall Study|Moved|1
791020|NCT00719355|2515894|P1|Overall Study|Moved|0
791021|NCT00719355|2515893|P2|Overall Study|Compliance|6
791022|NCT00719355|2515894|P1|Overall Study|Compliance|4
791023|NCT00719355|2515893|P2|Overall Study|Medical|5
791024|NCT00719355|2515894|P1|Overall Study|Medical|14
791025|NCT00719355|2515893|P2|Overall Study|Death|1
791026|NCT00719355|2515894|P1|Overall Study|Death|0
791027|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Various Reasons|25
791028|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
791029|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
791030|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
791031|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Disease progression|3
791032|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Death|6
791033|NCT00719472|2515902|P1|Received Cycle 2 Treatment|Adverse Event|12
791034|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Various Reasons|13
791035|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
791036|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
791037|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
791038|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Death|5
791039|NCT00719472|2515902|P1|Received Cycle 1 Treatment|Adverse Event|8
791040|NCT00719472|2515902|P1|Enrolled in Study|Various Reasons|17
791041|NCT00719472|2515902|P1|Enrolled in Study|Subject decision to withdraw|8
791042|NCT00719472|2515902|P1|Enrolled in Study|Physician decision to withdraw patient|1
791043|NCT00719537|2515913|P2|Overall Study|Lost to Follow-up|1
791044|NCT00719537|2515914|P1|Overall Study|Lost to Follow-up|0
791045|NCT00719537|2515913|P2|Overall Study|Withdrawal by Subject|0
791046|NCT00719537|2515914|P1|Overall Study|Withdrawal by Subject|1
791047|NCT00719563|2515922|P2|Overall Study|Lost to Follow-up|3
791048|NCT00719563|2515923|P1|Overall Study|Lost to Follow-up|5
791049|NCT00719563|2515922|P2|Overall Study|Noncompliant|1
791050|NCT00719563|2515923|P1|Overall Study|Noncompliant|1
791051|NCT00719563|2515922|P2|Overall Study|Unknown reasons|6
791052|NCT00719563|2515923|P1|Overall Study|Unknown reasons|4
791053|NCT00719563|2515922|P2|Overall Study|Personal reasons|7
791054|NCT00719563|2515923|P1|Overall Study|Personal reasons|6
791055|NCT00719563|2515922|P2|Overall Study|Lack of Efficacy|7
791056|NCT00719563|2515923|P1|Overall Study|Lack of Efficacy|3
791057|NCT00719563|2515922|P2|Overall Study|Medical condition changed|5
791058|NCT00719563|2515923|P1|Overall Study|Medical condition changed|3
791059|NCT00719563|2515922|P2|Overall Study|Adverse Event|13
791060|NCT00719563|2515923|P1|Overall Study|Adverse Event|16
791061|NCT00719680|2515966|P1|Overall Study|Withdrawal by Subject|3
791062|NCT00719680|2515966|P1|Overall Study|Lost to Follow-up|1
791063|NCT00719680|2515966|P1|Overall Study|Adverse Event|1
791064|NCT00719706|2515988|P2|Overall Study|Protocol Violation|0
791065|NCT00719706|2515989|P1|Overall Study|Protocol Violation|3
791066|NCT00719706|2515988|P2|Overall Study|Withdrawal by Subject|2
791067|NCT00719706|2515989|P1|Overall Study|Withdrawal by Subject|1
791068|NCT00719706|2515988|P2|Overall Study|Adverse Event|4
791069|NCT00719706|2515989|P1|Overall Study|Adverse Event|5
791070|NCT00719732|2516003|P1|Overall Study|Illness not associated with device|1
791071|NCT00719732|2516003|P1|Overall Study|Unilateral (not bilateral) implantation|1
791072|NCT00719732|2516003|P1|Overall Study|Lost to Follow-up|20
791073|NCT00719810|2516010|P3|Overall Study|Withdrawal by Subject|2
791074|NCT00719810|2516011|P2|Overall Study|Withdrawal by Subject|1
791075|NCT00719810|2516012|P1|Overall Study|Withdrawal by Subject|1
791076|NCT00719810|2516010|P3|Overall Study|Physician Decision|0
791077|NCT00719810|2516011|P2|Overall Study|Physician Decision|1
791078|NCT00719810|2516012|P1|Overall Study|Physician Decision|0
791079|NCT00719810|2516010|P3|Overall Study|Lost to Follow-up|3
791080|NCT00719810|2516011|P2|Overall Study|Lost to Follow-up|0
791081|NCT00719810|2516012|P1|Overall Study|Lost to Follow-up|2
791082|NCT00719810|2516010|P3|Overall Study|Adverse Event|3
791083|NCT00719810|2516011|P2|Overall Study|Adverse Event|2
791084|NCT00719810|2516012|P1|Overall Study|Adverse Event|0
791085|NCT00719849|2516025|P2|Overall Study|Death|1
791086|NCT00719849|2516026|P1|Overall Study|Death|0
791087|NCT00719862|2516064|P2|Overall Study|Other|3
791088|NCT00719862|2516065|P1|Overall Study|Other|2
791089|NCT00719862|2516064|P2|Overall Study|Lost to Follow-up|1
791090|NCT00719862|2516065|P1|Overall Study|Lost to Follow-up|0
791091|NCT00719862|2516064|P2|Overall Study|Withdrawal by Subject|0
791092|NCT00719862|2516065|P1|Overall Study|Withdrawal by Subject|1
791093|NCT00719862|2516064|P2|Overall Study|Non-Compliance|0
791094|NCT00719862|2516065|P1|Overall Study|Non-Compliance|1
791095|NCT00719862|2516064|P2|Overall Study|Lack of Efficacy|0
791096|NCT00719862|2516065|P1|Overall Study|Lack of Efficacy|3
791097|NCT00719862|2516064|P2|Overall Study|Adverse Event|2
791098|NCT00719862|2516065|P1|Overall Study|Adverse Event|1
791099|NCT00719901|2516081|P1|Overall Study|Availability of Study Drug|1
791100|NCT00719901|2516081|P1|Overall Study|Disease Progression|3
791101|NCT00719901|2516081|P1|Overall Study|Alternate Treatment|1
791102|NCT00719901|2516081|P1|Overall Study|Withdrawal by Subject|1
791103|NCT00719901|2516081|P1|Overall Study|Adverse Event|5
791104|NCT00719953|2516100|P1|Overall Study|Adverse Event|4
791105|NCT00720057|2516106|P2|Overall Study|Withdrawal by Subject|1
791106|NCT00720057|2516107|P1|Overall Study|Withdrawal by Subject|0
791107|NCT00720057|2516106|P2|Overall Study|Protocol Violation|0
791108|NCT00720057|2516107|P1|Overall Study|Protocol Violation|1
791109|NCT00720057|2516106|P2|Overall Study|Lost to Follow-up|2
791110|NCT00720057|2516107|P1|Overall Study|Lost to Follow-up|0
791111|NCT00720083|2516125|P2|Overall Study|Ineligible|2
791112|NCT00720083|2516126|P1|Overall Study|Ineligible|1
892342|NCT01515306|2829955|P2|Overall Study|Adverse Event|0
892343|NCT01515306|2829956|P1|Overall Study|Adverse Event|2
791115|NCT00720109|2516145|P3|Risk Stratification Period|Development of second malignant neoplasm|0
791116|NCT00720109|2516146|P2|Risk Stratification Period|Development of second malignant neoplasm|1
791117|NCT00720109|2516147|P1|Risk Stratification Period|Development of second malignant neoplasm|0
791118|NCT00720109|2516145|P3|Risk Stratification Period|Disease progression or relapse|0
791119|NCT00720109|2516146|P2|Risk Stratification Period|Disease progression or relapse|2
791120|NCT00720109|2516147|P1|Risk Stratification Period|Disease progression or relapse|0
791121|NCT00720109|2516145|P3|Risk Stratification Period|Bone marrow transplant|7
791122|NCT00720109|2516146|P2|Risk Stratification Period|Bone marrow transplant|9
791123|NCT00720109|2516147|P1|Risk Stratification Period|Bone marrow transplant|0
791124|NCT00720109|2516145|P3|Risk Stratification Period|Physician Decision|1
791125|NCT00720109|2516146|P2|Risk Stratification Period|Physician Decision|2
791126|NCT00720109|2516147|P1|Risk Stratification Period|Physician Decision|0
791127|NCT00720109|2516145|P3|Risk Stratification Period|Adverse Event|0
791128|NCT00720109|2516146|P2|Risk Stratification Period|Adverse Event|1
791129|NCT00720109|2516147|P1|Risk Stratification Period|Adverse Event|0
791130|NCT00720109|2516145|P3|Induction Period|Physician Decision|0
791131|NCT00720109|2516146|P2|Induction Period|Physician Decision|0
791132|NCT00720109|2516147|P1|Induction Period|Physician Decision|1
791133|NCT00720109|2516145|P3|Induction Period|Bone Marrow Transplant|0
791134|NCT00720109|2516146|P2|Induction Period|Bone Marrow Transplant|0
791135|NCT00720109|2516147|P1|Induction Period|Bone Marrow Transplant|2
791136|NCT00720109|2516145|P3|Induction Period|Did not meet eligibility criteria|0
791137|NCT00720109|2516146|P2|Induction Period|Did not meet eligibility criteria|0
791138|NCT00720109|2516147|P1|Induction Period|Did not meet eligibility criteria|3
791139|NCT00720122|2516165|P1|Overall Study|Withdrawal by Subject|7
791140|NCT00720122|2516165|P1|Overall Study|Physician Decision|1
791141|NCT00720122|2516165|P1|Overall Study|Lost to Follow-up|1
791142|NCT00720226|2516171|P2|Overall Study|Withdrawal by Subject|4
791143|NCT00720226|2516172|P1|Overall Study|Withdrawal by Subject|7
791144|NCT00720278|2516183|P3|Overall Study|eligibility criteria violation|1
791145|NCT00720278|2516184|P2|Overall Study|eligibility criteria violation|0
791146|NCT00720278|2516185|P1|Overall Study|eligibility criteria violation|1
791147|NCT00720278|2516183|P3|Overall Study|Non-compliance|0
791148|NCT00720278|2516184|P2|Overall Study|Non-compliance|0
791149|NCT00720278|2516185|P1|Overall Study|Non-compliance|1
791150|NCT00720278|2516183|P3|Overall Study|Lost to Follow-up|1
791151|NCT00720278|2516184|P2|Overall Study|Lost to Follow-up|0
791152|NCT00720278|2516185|P1|Overall Study|Lost to Follow-up|0
791153|NCT00720278|2516183|P3|Overall Study|Withdrawal by Subject|0
791154|NCT00720278|2516184|P2|Overall Study|Withdrawal by Subject|1
791155|NCT00720278|2516185|P1|Overall Study|Withdrawal by Subject|0
791156|NCT00720278|2516183|P3|Overall Study|Adverse Event|4
791157|NCT00720278|2516184|P2|Overall Study|Adverse Event|3
791158|NCT00720278|2516185|P1|Overall Study|Adverse Event|5
791159|NCT00720343|2516230|P1|Overall Study|No data|3
791160|NCT00720343|2516230|P1|Overall Study|Physician Decision|3
791161|NCT00720382|2516249|P2|Overall Study|administrative|5
791162|NCT00720382|2516250|P1|Overall Study|administrative|14
791163|NCT00720382|2516249|P2|Overall Study|Lost to Follow-up|14
791164|NCT00720382|2516250|P1|Overall Study|Lost to Follow-up|28
791165|NCT00720382|2516249|P2|Overall Study|Withdrawal by Subject|11
791166|NCT00720382|2516250|P1|Overall Study|Withdrawal by Subject|47
791167|NCT00720382|2516249|P2|Overall Study|Non-Compliance|5
791168|NCT00720382|2516250|P1|Overall Study|Non-Compliance|15
791169|NCT00720382|2516249|P2|Overall Study|Lack of Efficacy|7
791170|NCT00720382|2516250|P1|Overall Study|Lack of Efficacy|18
791171|NCT00720382|2516249|P2|Overall Study|Adverse Event|17
791172|NCT00720382|2516250|P1|Overall Study|Adverse Event|54
791173|NCT00720434|2516262|P4|Open-Label Period (Week 5-72)|Unspecified|2
791174|NCT00720434|2516263|P3|Open-Label Period (Week 5-72)|Unspecified|3
791175|NCT00720434|2516264|P2|Open-Label Period (Week 5-72)|Unspecified|3
791176|NCT00720434|2516265|P1|Open-Label Period (Week 5-72)|Unspecified|4
791177|NCT00720434|2516262|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
791178|NCT00720434|2516263|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
791179|NCT00720434|2516264|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
791180|NCT00720434|2516265|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
791181|NCT00720434|2516262|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
892344|NCT01472965|2829980|P2|Overall Study|Withdrawal by Subject|0
791182|NCT00720434|2516263|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
791183|NCT00720434|2516264|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
791184|NCT00720434|2516265|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
791185|NCT00720434|2516262|P4|Open-Label Period (Week 5-72)|Adverse Event|2
791186|NCT00720434|2516263|P3|Open-Label Period (Week 5-72)|Adverse Event|0
791187|NCT00720434|2516264|P2|Open-Label Period (Week 5-72)|Adverse Event|0
791188|NCT00720434|2516265|P1|Open-Label Period (Week 5-72)|Adverse Event|0
791189|NCT00720434|2516262|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
791190|NCT00720434|2516263|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
791191|NCT00720434|2516264|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
791192|NCT00720434|2516265|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
791193|NCT00720499|2516314|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
791194|NCT00720499|2516315|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
791195|NCT00720499|2516314|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
791196|NCT00720499|2516315|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
791197|NCT00720499|2516314|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
791198|NCT00720499|2516315|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
791199|NCT00720759|2516391|P4|Overall Study|Lost to Follow-up|0
791200|NCT00720759|2516392|P3|Overall Study|Lost to Follow-up|1
791201|NCT00720759|2516393|P2|Overall Study|Lost to Follow-up|1
791202|NCT00720759|2516394|P1|Overall Study|Lost to Follow-up|0
791203|NCT00720798|2516404|P1|Overall Study|Reason not Specified|83
791204|NCT00720798|2516404|P1|Overall Study|Failure to Return|46
791205|NCT00720798|2516404|P1|Overall Study|Refused Treatment|151
791206|NCT00720798|2516404|P1|Overall Study|Protocol Violation|4
791207|NCT00720798|2516404|P1|Overall Study|Insufficient Therapeutic Response|129
791208|NCT00720798|2516404|P1|Overall Study|Death|39
791209|NCT00720798|2516404|P1|Overall Study|Adverse Event|304
791210|NCT00720941|2516425|P2|Overall Study|Ongoing|23
791211|NCT00720941|2516426|P1|Overall Study|Ongoing|34
791212|NCT00720941|2516425|P2|Overall Study|Withdrawal by Subject|35
791213|NCT00720941|2516426|P1|Overall Study|Withdrawal by Subject|27
791214|NCT00720941|2516425|P2|Overall Study|Physician Decision|5
791215|NCT00720941|2516426|P1|Overall Study|Physician Decision|1
791216|NCT00720941|2516425|P2|Overall Study|Lost to Follow-up|15
791217|NCT00720941|2516426|P1|Overall Study|Lost to Follow-up|17
791218|NCT00720941|2516425|P2|Overall Study|Protocol Violation|2
791219|NCT00720941|2516426|P1|Overall Study|Protocol Violation|0
791220|NCT00720941|2516425|P2|Overall Study|Death|335
791221|NCT00720941|2516426|P1|Overall Study|Death|334
791222|NCT00721110|2516470|P4|Overall Study|vertical incision|0
791223|NCT00721110|2516471|P3|Overall Study|vertical incision|1
791224|NCT00721110|2516472|P2|Overall Study|vertical incision|0
791225|NCT00721110|2516473|P1|Overall Study|vertical incision|0
791226|NCT00721110|2516470|P4|Overall Study|Ultram use|0
791227|NCT00721110|2516471|P3|Overall Study|Ultram use|0
791228|NCT00721110|2516472|P2|Overall Study|Ultram use|0
791229|NCT00721110|2516473|P1|Overall Study|Ultram use|1
791230|NCT00721123|2516499|P1|Overall Study|Withdrawal by Subject|5
791231|NCT00721123|2516499|P1|Overall Study|Failure to Return|9
791232|NCT00721123|2516499|P1|Overall Study|Refused Treatment|41
791233|NCT00721123|2516499|P1|Overall Study|Protocol Violation|1
791234|NCT00721123|2516499|P1|Overall Study|Insufficient Therapeutic Response|21
791235|NCT00721123|2516499|P1|Overall Study|Death|10
791236|NCT00721123|2516499|P1|Overall Study|Adverse Event|96
791237|NCT00721149|2516598|P1|Overall Study|Physician Decision|1
791238|NCT00715559|2516646|P1|Overall Study|medication not tolerated - nausea|1
791239|NCT00715624|2516655|P2|Overall Study|Other|1
791240|NCT00715624|2516656|P1|Overall Study|Other|0
791241|NCT00715624|2516655|P2|Overall Study|Incorrect randomization (not treated)|1
791242|NCT00715624|2516656|P1|Overall Study|Incorrect randomization (not treated)|0
791243|NCT00715624|2516655|P2|Overall Study|Sponsor decision|4
791244|NCT00715624|2516656|P1|Overall Study|Sponsor decision|0
791245|NCT00715624|2516655|P2|Overall Study|Poor compliance|13
791246|NCT00715624|2516656|P1|Overall Study|Poor compliance|6
791247|NCT00715624|2516655|P2|Overall Study|Familial and personal reasons|22
791248|NCT00715624|2516656|P1|Overall Study|Familial and personal reasons|10
791249|NCT00715624|2516655|P2|Overall Study|Withdrawal by Subject|25
791250|NCT00715624|2516656|P1|Overall Study|Withdrawal by Subject|11
791251|NCT00715624|2516655|P2|Overall Study|Protocol Violation|0
791252|NCT00715624|2516656|P1|Overall Study|Protocol Violation|1
791253|NCT00715624|2516655|P2|Overall Study|Lost to Follow-up|2
791254|NCT00715624|2516656|P1|Overall Study|Lost to Follow-up|1
791255|NCT00715624|2516655|P2|Overall Study|Lack of Efficacy|11
791256|NCT00715624|2516656|P1|Overall Study|Lack of Efficacy|11
791257|NCT00715624|2516655|P2|Overall Study|Adverse Event|37
791258|NCT00715624|2516656|P1|Overall Study|Adverse Event|12
791259|NCT00715676|2516702|P3|Overall Study|Elevated Blood Glucose|0
791260|NCT00715676|2516703|P2|Overall Study|Elevated Blood Glucose|1
791261|NCT00715676|2516704|P1|Overall Study|Elevated Blood Glucose|0
791262|NCT00715676|2516702|P3|Overall Study|Use of Exclusionary Medication|1
791263|NCT00715676|2516703|P2|Overall Study|Use of Exclusionary Medication|0
791264|NCT00715676|2516704|P1|Overall Study|Use of Exclusionary Medication|0
791265|NCT00715676|2516702|P3|Overall Study|Did Not Meet Entry Criteria|1
791266|NCT00715676|2516703|P2|Overall Study|Did Not Meet Entry Criteria|0
791267|NCT00715676|2516704|P1|Overall Study|Did Not Meet Entry Criteria|0
791268|NCT00715676|2516702|P3|Overall Study|Terminated by Sponsor|0
791269|NCT00715676|2516703|P2|Overall Study|Terminated by Sponsor|0
791270|NCT00715676|2516704|P1|Overall Study|Terminated by Sponsor|1
791271|NCT00715676|2516702|P3|Overall Study|Lost to Follow-up|1
791272|NCT00715676|2516703|P2|Overall Study|Lost to Follow-up|2
791273|NCT00715676|2516704|P1|Overall Study|Lost to Follow-up|1
791274|NCT00715676|2516702|P3|Overall Study|Withdrawal by Subject|8
791275|NCT00715676|2516703|P2|Overall Study|Withdrawal by Subject|3
791276|NCT00715676|2516704|P1|Overall Study|Withdrawal by Subject|1
791277|NCT00715676|2516702|P3|Overall Study|Adverse Event|21
791278|NCT00715676|2516703|P2|Overall Study|Adverse Event|5
791279|NCT00715676|2516704|P1|Overall Study|Adverse Event|3
791280|NCT00721214|2516730|P1|Overall Study|Death|3
791281|NCT00721214|2516730|P1|Overall Study|Chose another center for transplant|1
791282|NCT00721227|2516743|P2|Overall Study|Noncompliance with scheduled visits.|0
791283|NCT00721227|2516744|P1|Overall Study|Noncompliance with scheduled visits.|1
791284|NCT00721227|2516743|P2|Overall Study|Lost to Follow-up|0
791285|NCT00721227|2516744|P1|Overall Study|Lost to Follow-up|3
791286|NCT00721279|2516770|P2|Overall Study|Other|16
791287|NCT00721279|2516771|P1|Overall Study|Other|12
791288|NCT00721279|2516770|P2|Overall Study|Withdrawal by Subject|3
791289|NCT00721279|2516771|P1|Overall Study|Withdrawal by Subject|13
791290|NCT00721279|2516770|P2|Overall Study|Tolerability insufficient|2
791291|NCT00721279|2516771|P1|Overall Study|Tolerability insufficient|5
791292|NCT00721279|2516770|P2|Overall Study|Lack of Efficacy|3
791293|NCT00721279|2516771|P1|Overall Study|Lack of Efficacy|6
791294|NCT00721396|2516796|P4|Overall Study|Administrative reason|0
791295|NCT00721396|2516797|P3|Overall Study|Administrative reason|1
791296|NCT00721396|2516798|P2|Overall Study|Administrative reason|0
791297|NCT00721396|2516799|P1|Overall Study|Administrative reason|3
791298|NCT00721396|2516796|P4|Overall Study|Inappropriate enrollment|0
791299|NCT00721396|2516797|P3|Overall Study|Inappropriate enrollment|0
791300|NCT00721396|2516798|P2|Overall Study|Inappropriate enrollment|2
791301|NCT00721396|2516799|P1|Overall Study|Inappropriate enrollment|0
791302|NCT00721396|2516796|P4|Overall Study|Protocol Violation|0
791303|NCT00721396|2516797|P3|Overall Study|Protocol Violation|1
791304|NCT00721396|2516798|P2|Overall Study|Protocol Violation|3
791305|NCT00721396|2516799|P1|Overall Study|Protocol Violation|4
791306|NCT00721396|2516796|P4|Overall Study|Lost to Follow-up|3
791307|NCT00721396|2516797|P3|Overall Study|Lost to Follow-up|3
791308|NCT00721396|2516798|P2|Overall Study|Lost to Follow-up|9
791309|NCT00721396|2516799|P1|Overall Study|Lost to Follow-up|7
791310|NCT00721396|2516796|P4|Overall Study|Withdrawal by Subject|7
791311|NCT00721396|2516797|P3|Overall Study|Withdrawal by Subject|3
791312|NCT00721396|2516798|P2|Overall Study|Withdrawal by Subject|15
791313|NCT00721396|2516799|P1|Overall Study|Withdrawal by Subject|12
791314|NCT00721396|2516796|P4|Overall Study|Adverse Event|0
791315|NCT00721396|2516797|P3|Overall Study|Adverse Event|2
791316|NCT00721396|2516798|P2|Overall Study|Adverse Event|7
791317|NCT00721396|2516799|P1|Overall Study|Adverse Event|4
892345|NCT01472965|2829981|P1|Overall Study|Withdrawal by Subject|1
892346|NCT01390428|2830003|P6|Overall Study|Withdrawal by Subject|0
892347|NCT01390428|2830004|P5|Overall Study|Withdrawal by Subject|0
892348|NCT01390428|2830005|P4|Overall Study|Withdrawal by Subject|0
892349|NCT01390428|2830006|P3|Overall Study|Withdrawal by Subject|1
892350|NCT01390428|2830007|P2|Overall Study|Withdrawal by Subject|0
892351|NCT01390428|2830008|P1|Overall Study|Withdrawal by Subject|0
892352|NCT01390428|2830003|P6|Overall Study|Elective Surgery|0
892353|NCT01390428|2830004|P5|Overall Study|Elective Surgery|1
892354|NCT01390428|2830005|P4|Overall Study|Elective Surgery|0
892355|NCT01390428|2830006|P3|Overall Study|Elective Surgery|0
892356|NCT01390428|2830007|P2|Overall Study|Elective Surgery|0
892357|NCT01390428|2830008|P1|Overall Study|Elective Surgery|0
892358|NCT01251276|2830075|P2|Overall Study|Lost to Follow-up|1
892359|NCT01251276|2830076|P1|Overall Study|Lost to Follow-up|0
892360|NCT01251276|2830075|P2|Overall Study|Protocol Violation|0
892361|NCT01251276|2830076|P1|Overall Study|Protocol Violation|1
892362|NCT01141660|2830094|P2|Overall Study|Physician Decision|12
892363|NCT01141660|2830095|P1|Overall Study|Physician Decision|0
791339|NCT00721630|2516991|P1|Overall Study|Participant found to be ineligible|1
791340|NCT00721734|2517001|P5|Overall Study|Other|0
791341|NCT00721734|2517002|P4|Overall Study|Other|1
791342|NCT00721734|2517003|P3|Overall Study|Other|0
791343|NCT00721734|2517004|P2|Overall Study|Other|0
791344|NCT00721734|2517005|P1|Overall Study|Other|0
791345|NCT00721734|2517001|P5|Overall Study|Withdrawal by Subject|1
791346|NCT00721734|2517002|P4|Overall Study|Withdrawal by Subject|0
791347|NCT00721734|2517003|P3|Overall Study|Withdrawal by Subject|0
791348|NCT00721734|2517004|P2|Overall Study|Withdrawal by Subject|1
791349|NCT00721734|2517005|P1|Overall Study|Withdrawal by Subject|2
791350|NCT00721734|2517001|P5|Overall Study|Adverse Event|3
791351|NCT00721734|2517002|P4|Overall Study|Adverse Event|0
791352|NCT00721734|2517003|P3|Overall Study|Adverse Event|4
791353|NCT00721734|2517004|P2|Overall Study|Adverse Event|1
791354|NCT00721734|2517005|P1|Overall Study|Adverse Event|3
791355|NCT00721734|2517001|P5|Overall Study|Progressive Disease|2
791356|NCT00721734|2517002|P4|Overall Study|Progressive Disease|5
791357|NCT00721734|2517003|P3|Overall Study|Progressive Disease|4
791358|NCT00721734|2517004|P2|Overall Study|Progressive Disease|10
791359|NCT00721734|2517005|P1|Overall Study|Progressive Disease|3
791360|NCT00721799|2517117|P1|Overall Study|withdraw by subject after scan 1|1
791361|NCT00721799|2517117|P1|Overall Study|Withdrawal by Subject|7
791362|NCT00721955|2517155|P3|Overall Study|Adverse Event|2
791363|NCT00721955|2517156|P2|Overall Study|Adverse Event|0
791364|NCT00721955|2517157|P1|Overall Study|Adverse Event|0
791365|NCT00721968|2517173|P2|Overall Study|Lost to Follow-up|0
791366|NCT00721968|2517174|P1|Overall Study|Lost to Follow-up|2
791367|NCT00722137|2517212|P2|Overall Study|Randomized But Not Treated|2
791368|NCT00722137|2517213|P1|Overall Study|Randomized But Not Treated|3
791369|NCT00722137|2517212|P2|Overall Study|Other Reason Uknown|3
791370|NCT00722137|2517213|P1|Overall Study|Other Reason Uknown|4
791371|NCT00722137|2517212|P2|Overall Study|Withdrawal by Subject|6
791372|NCT00722137|2517213|P1|Overall Study|Withdrawal by Subject|9
791373|NCT00722137|2517212|P2|Overall Study|Death|12
791374|NCT00722137|2517213|P1|Overall Study|Death|7
791375|NCT00722137|2517212|P2|Overall Study|Adverse Event|17
791376|NCT00722137|2517213|P1|Overall Study|Adverse Event|21
791377|NCT00722137|2517212|P2|Overall Study|Overt Disease Progression|5
791378|NCT00722137|2517213|P1|Overall Study|Overt Disease Progression|4
791379|NCT00722371|2517244|P7|Overall Study|Withdrawal by Subject|26
791380|NCT00722371|2517245|P6|Overall Study|Withdrawal by Subject|18
791381|NCT00722371|2517246|P5|Overall Study|Withdrawal by Subject|19
791382|NCT00722371|2517247|P4|Overall Study|Withdrawal by Subject|23
791383|NCT00722371|2517248|P3|Overall Study|Withdrawal by Subject|19
791384|NCT00722371|2517249|P2|Overall Study|Withdrawal by Subject|27
791385|NCT00722371|2517250|P1|Overall Study|Withdrawal by Subject|18
791386|NCT00722371|2517244|P7|Overall Study|Protocol Violation|1
791387|NCT00722371|2517245|P6|Overall Study|Protocol Violation|2
791388|NCT00722371|2517246|P5|Overall Study|Protocol Violation|4
791389|NCT00722371|2517247|P4|Overall Study|Protocol Violation|1
791390|NCT00722371|2517248|P3|Overall Study|Protocol Violation|0
791391|NCT00722371|2517249|P2|Overall Study|Protocol Violation|1
791392|NCT00722371|2517250|P1|Overall Study|Protocol Violation|6
791393|NCT00722371|2517244|P7|Overall Study|Pregnancy|0
791394|NCT00722371|2517245|P6|Overall Study|Pregnancy|1
791395|NCT00722371|2517246|P5|Overall Study|Pregnancy|0
791396|NCT00722371|2517247|P4|Overall Study|Pregnancy|0
791397|NCT00722371|2517248|P3|Overall Study|Pregnancy|0
791398|NCT00722371|2517249|P2|Overall Study|Pregnancy|1
791399|NCT00722371|2517250|P1|Overall Study|Pregnancy|1
791400|NCT00722371|2517244|P7|Overall Study|Physician Decision|4
791401|NCT00722371|2517245|P6|Overall Study|Physician Decision|3
791402|NCT00722371|2517246|P5|Overall Study|Physician Decision|2
791403|NCT00722371|2517247|P4|Overall Study|Physician Decision|5
791404|NCT00722371|2517248|P3|Overall Study|Physician Decision|2
791405|NCT00722371|2517249|P2|Overall Study|Physician Decision|2
791406|NCT00722371|2517250|P1|Overall Study|Physician Decision|5
791407|NCT00722371|2517244|P7|Overall Study|Lost to Follow-up|13
791408|NCT00722371|2517245|P6|Overall Study|Lost to Follow-up|16
791409|NCT00722371|2517246|P5|Overall Study|Lost to Follow-up|8
791410|NCT00722371|2517247|P4|Overall Study|Lost to Follow-up|13
791411|NCT00722371|2517248|P3|Overall Study|Lost to Follow-up|21
791412|NCT00722371|2517249|P2|Overall Study|Lost to Follow-up|14
791413|NCT00722371|2517250|P1|Overall Study|Lost to Follow-up|11
791414|NCT00722371|2517244|P7|Overall Study|Lack of Efficacy|0
791415|NCT00722371|2517245|P6|Overall Study|Lack of Efficacy|3
791416|NCT00722371|2517246|P5|Overall Study|Lack of Efficacy|2
791417|NCT00722371|2517247|P4|Overall Study|Lack of Efficacy|6
791418|NCT00722371|2517248|P3|Overall Study|Lack of Efficacy|6
791419|NCT00722371|2517249|P2|Overall Study|Lack of Efficacy|6
791420|NCT00722371|2517250|P1|Overall Study|Lack of Efficacy|4
791421|NCT00722371|2517244|P7|Overall Study|Hypoglycemia|0
791422|NCT00722371|2517245|P6|Overall Study|Hypoglycemia|0
791423|NCT00722371|2517246|P5|Overall Study|Hypoglycemia|0
791424|NCT00722371|2517247|P4|Overall Study|Hypoglycemia|0
791425|NCT00722371|2517248|P3|Overall Study|Hypoglycemia|0
791426|NCT00722371|2517249|P2|Overall Study|Hypoglycemia|0
791427|NCT00722371|2517250|P1|Overall Study|Hypoglycemia|1
791428|NCT00722371|2517244|P7|Overall Study|Hyperglycemia|1
791429|NCT00722371|2517245|P6|Overall Study|Hyperglycemia|1
791430|NCT00722371|2517246|P5|Overall Study|Hyperglycemia|5
791431|NCT00722371|2517247|P4|Overall Study|Hyperglycemia|2
791432|NCT00722371|2517248|P3|Overall Study|Hyperglycemia|4
791433|NCT00722371|2517249|P2|Overall Study|Hyperglycemia|6
791434|NCT00722371|2517250|P1|Overall Study|Hyperglycemia|2
791435|NCT00722371|2517244|P7|Overall Study|Excluded medication|1
791436|NCT00722371|2517245|P6|Overall Study|Excluded medication|0
791437|NCT00722371|2517246|P5|Overall Study|Excluded medication|0
791438|NCT00722371|2517247|P4|Overall Study|Excluded medication|0
791439|NCT00722371|2517248|P3|Overall Study|Excluded medication|1
791440|NCT00722371|2517249|P2|Overall Study|Excluded medication|1
791441|NCT00722371|2517250|P1|Overall Study|Excluded medication|0
791442|NCT00722371|2517244|P7|Overall Study|Creatinine / Creatinine clearance|1
791443|NCT00722371|2517245|P6|Overall Study|Creatinine / Creatinine clearance|1
791444|NCT00722371|2517246|P5|Overall Study|Creatinine / Creatinine clearance|2
791445|NCT00722371|2517247|P4|Overall Study|Creatinine / Creatinine clearance|3
791446|NCT00722371|2517248|P3|Overall Study|Creatinine / Creatinine clearance|2
791447|NCT00722371|2517249|P2|Overall Study|Creatinine / Creatinine clearance|1
791448|NCT00722371|2517250|P1|Overall Study|Creatinine / Creatinine clearance|2
791449|NCT00722371|2517244|P7|Overall Study|Contraindication|0
791450|NCT00722371|2517245|P6|Overall Study|Contraindication|0
791451|NCT00722371|2517246|P5|Overall Study|Contraindication|0
791452|NCT00722371|2517247|P4|Overall Study|Contraindication|0
791453|NCT00722371|2517248|P3|Overall Study|Contraindication|1
791454|NCT00722371|2517249|P2|Overall Study|Contraindication|0
791455|NCT00722371|2517250|P1|Overall Study|Contraindication|0
791456|NCT00722371|2517244|P7|Overall Study|Adverse Event|4
791457|NCT00722371|2517245|P6|Overall Study|Adverse Event|8
791458|NCT00722371|2517246|P5|Overall Study|Adverse Event|6
791459|NCT00722371|2517247|P4|Overall Study|Adverse Event|10
791460|NCT00722371|2517248|P3|Overall Study|Adverse Event|9
791461|NCT00722371|2517249|P2|Overall Study|Adverse Event|13
791462|NCT00722371|2517250|P1|Overall Study|Adverse Event|6
791463|NCT00722423|2517303|P2|Overall Study|Protocol Violation|1
791464|NCT00722423|2517304|P1|Overall Study|Protocol Violation|0
791465|NCT00722761|2517361|P2|Overall Study|Withdrawal by Subject|2
791466|NCT00722761|2517362|P1|Overall Study|Withdrawal by Subject|5
791467|NCT00722761|2517361|P2|Overall Study|Lost to Follow-up|4
791468|NCT00722761|2517362|P1|Overall Study|Lost to Follow-up|1
791469|NCT00722800|2517372|P2|Overall Study|Physician Decision|0
791470|NCT00722800|2517373|P1|Overall Study|Physician Decision|1
791471|NCT00722800|2517372|P2|Overall Study|Withdrawal by Subject|0
791472|NCT00722800|2517373|P1|Overall Study|Withdrawal by Subject|1
791473|NCT00723008|2517393|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
791474|NCT00723008|2517394|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
791475|NCT00723008|2517393|P2|4-Week Unblinded Treatment|Adverse Event|0
791476|NCT00723008|2517394|P1|4-Week Unblinded Treatment|Adverse Event|1
791477|NCT00723008|2517393|P2|4-Week Double Blinded|Lost to Follow-up|3
791478|NCT00723008|2517394|P1|4-Week Double Blinded|Lost to Follow-up|4
791479|NCT00723008|2517393|P2|4-Week Double Blinded|Withdrawal by Subject|1
791480|NCT00723008|2517394|P1|4-Week Double Blinded|Withdrawal by Subject|1
791481|NCT00723008|2517393|P2|4-Week Double Blinded|Lack of Efficacy|1
791482|NCT00723008|2517394|P1|4-Week Double Blinded|Lack of Efficacy|0
791483|NCT00723008|2517393|P2|Enrollment|Lost to Follow-up|0
791484|NCT00723008|2517394|P1|Enrollment|Lost to Follow-up|1
791485|NCT00723021|2517416|P5|Intervention Period 4|Adverse Event|1
791486|NCT00723021|2517417|P4|Intervention Period 4|Adverse Event|0
791487|NCT00723021|2517418|P3|Intervention Period 4|Adverse Event|0
791488|NCT00723021|2517419|P2|Intervention Period 4|Adverse Event|0
791489|NCT00723021|2517420|P1|Intervention Period 4|Adverse Event|0
791490|NCT00723125|2517501|P2|Overall Study|Adverse Event|0
791491|NCT00723125|2517502|P1|Overall Study|Adverse Event|2
791492|NCT00723125|2517501|P2|Overall Study|Withdrawal by Subject|6
791493|NCT00723125|2517502|P1|Overall Study|Withdrawal by Subject|15
791494|NCT00723125|2517501|P2|Overall Study|Met Dx|0
791495|NCT00723125|2517502|P1|Overall Study|Met Dx|1
791496|NCT00723190|2517528|P1|Overall Study|Other-Not included in safety population|2
791497|NCT00723190|2517528|P1|Overall Study|Other-Premature Discontinuation|9
791498|NCT00723190|2517528|P1|Overall Study|Protocol Violation|15
791499|NCT00723190|2517528|P1|Overall Study|Lack of Efficacy|16
791500|NCT00723190|2517528|P1|Overall Study|Adverse Event|18
791501|NCT00723190|2517528|P1|Overall Study|Lost to Follow-up|37
791502|NCT00723190|2517528|P1|Overall Study|Withdrawal by Subject|45
791503|NCT00723203|2517543|P1|Overall Study|Withdrawal by Subject|3
791504|NCT00723229|2517549|P2|First Intervention|Lost to Follow-up|3
791505|NCT00723229|2517550|P1|First Intervention|Lost to Follow-up|7
791509|NCT00723294|2517581|P1|Overall Study|No treatment due to probe failure|1
791510|NCT00723294|2517581|P1|Overall Study|Withdrawal by Subject|1
791511|NCT00723294|2517581|P1|Overall Study|Benign lesion|1
791512|NCT00723294|2517581|P1|Overall Study|Treated by non-credentialed surgeon|1
791513|NCT00723294|2517581|P1|Overall Study|Treated prior to registration|1
791514|NCT00723294|2517581|P1|Overall Study|Did not undergo surgery|1
791515|NCT00723294|2517581|P1|Overall Study|No cryoabalation|2
791516|NCT00723294|2517581|P1|Overall Study|1.0-Tesla MRI|1
791517|NCT00723294|2517581|P1|Overall Study|No MRI tumor enhancement|1
791518|NCT00723294|2517581|P1|Overall Study|>25% intraductal component|1
791519|NCT00723294|2517581|P1|Overall Study|Lobular histology|2
791520|NCT00723450|2517588|P3|Randomized Phase|Withdrawal by Subject|22
791521|NCT00723450|2517589|P2|Randomized Phase|Withdrawal by Subject|14
791522|NCT00723450|2517590|P1|Randomized Phase|Withdrawal by Subject|0
791523|NCT00723450|2517588|P3|Randomized Phase|Physician Decision|1
791524|NCT00723450|2517589|P2|Randomized Phase|Physician Decision|3
791525|NCT00723450|2517590|P1|Randomized Phase|Physician Decision|0
791526|NCT00723450|2517588|P3|Randomized Phase|Lost to Follow-up|3
791527|NCT00723450|2517589|P2|Randomized Phase|Lost to Follow-up|2
791528|NCT00723450|2517590|P1|Randomized Phase|Lost to Follow-up|0
791529|NCT00723450|2517588|P3|Randomized Phase|Protocol Violation|13
791530|NCT00723450|2517589|P2|Randomized Phase|Protocol Violation|9
791531|NCT00723450|2517590|P1|Randomized Phase|Protocol Violation|0
791532|NCT00723450|2517588|P3|Randomized Phase|Lack of Efficacy|11
791533|NCT00723450|2517589|P2|Randomized Phase|Lack of Efficacy|11
791534|NCT00723450|2517590|P1|Randomized Phase|Lack of Efficacy|0
791535|NCT00723450|2517588|P3|Randomized Phase|Adverse Event|17
791536|NCT00723450|2517589|P2|Randomized Phase|Adverse Event|26
791537|NCT00723450|2517590|P1|Randomized Phase|Adverse Event|0
791538|NCT00723450|2517588|P3|Open-Label Phase|Withdrawal by Subject|0
791539|NCT00723450|2517589|P2|Open-Label Phase|Withdrawal by Subject|0
791540|NCT00723450|2517590|P1|Open-Label Phase|Withdrawal by Subject|37
791541|NCT00723450|2517588|P3|Open-Label Phase|Physician Decision|0
791542|NCT00723450|2517589|P2|Open-Label Phase|Physician Decision|0
791543|NCT00723450|2517590|P1|Open-Label Phase|Physician Decision|2
791544|NCT00723450|2517588|P3|Open-Label Phase|Lost to Follow-up|0
791545|NCT00723450|2517589|P2|Open-Label Phase|Lost to Follow-up|0
791546|NCT00723450|2517590|P1|Open-Label Phase|Lost to Follow-up|7
791547|NCT00723450|2517588|P3|Open-Label Phase|Protocol Violation|0
791548|NCT00723450|2517589|P2|Open-Label Phase|Protocol Violation|0
791549|NCT00723450|2517590|P1|Open-Label Phase|Protocol Violation|35
791550|NCT00723450|2517588|P3|Open-Label Phase|Lack of Efficacy|0
791551|NCT00723450|2517589|P2|Open-Label Phase|Lack of Efficacy|0
791552|NCT00723450|2517590|P1|Open-Label Phase|Lack of Efficacy|18
791553|NCT00723450|2517588|P3|Open-Label Phase|Adverse Event|0
791554|NCT00723450|2517589|P2|Open-Label Phase|Adverse Event|0
791555|NCT00723450|2517590|P1|Open-Label Phase|Adverse Event|26
791556|NCT00723489|2517635|P4|Overall Study|Samples Collected Out of Window|0
791557|NCT00723489|2517636|P3|Overall Study|Samples Collected Out of Window|0
791558|NCT00723489|2517637|P2|Overall Study|Samples Collected Out of Window|3
791559|NCT00723489|2517638|P1|Overall Study|Samples Collected Out of Window|0
791560|NCT00723489|2517635|P4|Overall Study|Prohibited Medication|1
791561|NCT00723489|2517636|P3|Overall Study|Prohibited Medication|0
791562|NCT00723489|2517637|P2|Overall Study|Prohibited Medication|0
791563|NCT00723489|2517638|P1|Overall Study|Prohibited Medication|0
791564|NCT00723489|2517635|P4|Overall Study|Seropositive at baseline|0
791565|NCT00723489|2517636|P3|Overall Study|Seropositive at baseline|0
791566|NCT00723489|2517637|P2|Overall Study|Seropositive at baseline|0
791567|NCT00723489|2517638|P1|Overall Study|Seropositive at baseline|1
791568|NCT00723489|2517635|P4|Overall Study|Withdrawal by Subject|1
791569|NCT00723489|2517636|P3|Overall Study|Withdrawal by Subject|0
791570|NCT00723489|2517637|P2|Overall Study|Withdrawal by Subject|0
791571|NCT00723489|2517638|P1|Overall Study|Withdrawal by Subject|0
791572|NCT00723489|2517635|P4|Overall Study|Pregnancy|1
791573|NCT00723489|2517636|P3|Overall Study|Pregnancy|0
791574|NCT00723489|2517637|P2|Overall Study|Pregnancy|0
791575|NCT00723489|2517638|P1|Overall Study|Pregnancy|0
791576|NCT00723489|2517635|P4|Overall Study|Physician Decision|0
791577|NCT00723489|2517636|P3|Overall Study|Physician Decision|0
791578|NCT00723489|2517637|P2|Overall Study|Physician Decision|1
791579|NCT00723489|2517638|P1|Overall Study|Physician Decision|0
791580|NCT00723528|2517667|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
791581|NCT00723528|2517668|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791582|NCT00723528|2517669|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791583|NCT00723528|2517670|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791584|NCT00723528|2517671|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791585|NCT00723528|2517672|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791586|NCT00723528|2517673|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
791587|NCT00723528|2517667|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
791588|NCT00723528|2517668|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791589|NCT00723528|2517669|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791590|NCT00723528|2517670|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791591|NCT00723528|2517671|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791592|NCT00723528|2517672|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791593|NCT00723528|2517673|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
791594|NCT00723528|2517667|P7|Period 2: After Controlled Period|Adverse Event|1
791595|NCT00723528|2517668|P6|Period 2: After Controlled Period|Adverse Event|0
791596|NCT00723528|2517669|P5|Period 2: After Controlled Period|Adverse Event|1
791597|NCT00723528|2517670|P4|Period 2: After Controlled Period|Adverse Event|0
791598|NCT00723528|2517671|P3|Period 2: After Controlled Period|Adverse Event|0
791599|NCT00723528|2517672|P2|Period 2: After Controlled Period|Adverse Event|0
791600|NCT00723528|2517673|P1|Period 2: After Controlled Period|Adverse Event|0
791601|NCT00723528|2517667|P7|Period 2: After Controlled Period|Unspecified|0
791602|NCT00723528|2517668|P6|Period 2: After Controlled Period|Unspecified|4
791603|NCT00723528|2517669|P5|Period 2: After Controlled Period|Unspecified|1
791604|NCT00723528|2517670|P4|Period 2: After Controlled Period|Unspecified|0
791605|NCT00723528|2517671|P3|Period 2: After Controlled Period|Unspecified|0
791606|NCT00723528|2517672|P2|Period 2: After Controlled Period|Unspecified|0
791607|NCT00723528|2517673|P1|Period 2: After Controlled Period|Unspecified|0
791608|NCT00723528|2517667|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791609|NCT00723528|2517668|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
791610|NCT00723528|2517669|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791687|NCT00723892|2517873|P2|Overall Study|Drug addiction|0
791611|NCT00723528|2517670|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791612|NCT00723528|2517671|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791613|NCT00723528|2517672|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791614|NCT00723528|2517673|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
791615|NCT00723528|2517667|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
791616|NCT00723528|2517668|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
791617|NCT00723528|2517669|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
791618|NCT00723528|2517670|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
791619|NCT00723528|2517671|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
791620|NCT00723528|2517672|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
791621|NCT00723528|2517673|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
791622|NCT00723528|2517667|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
791623|NCT00723528|2517668|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
791624|NCT00723528|2517669|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
791625|NCT00723528|2517670|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
791626|NCT00723528|2517671|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
791627|NCT00723528|2517672|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
791628|NCT00723528|2517673|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
791629|NCT00723528|2517667|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791630|NCT00723528|2517668|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791631|NCT00723528|2517669|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791632|NCT00723528|2517670|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791633|NCT00723528|2517671|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
791634|NCT00723528|2517672|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791635|NCT00723528|2517673|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
791636|NCT00723528|2517667|P7|Period 1: Controlled Period (CP)|Physician Decision|0
791637|NCT00723528|2517668|P6|Period 1: Controlled Period (CP)|Physician Decision|0
791638|NCT00723528|2517669|P5|Period 1: Controlled Period (CP)|Physician Decision|0
791639|NCT00723528|2517670|P4|Period 1: Controlled Period (CP)|Physician Decision|0
791640|NCT00723528|2517671|P3|Period 1: Controlled Period (CP)|Physician Decision|1
791641|NCT00723528|2517672|P2|Period 1: Controlled Period (CP)|Physician Decision|0
791642|NCT00723528|2517673|P1|Period 1: Controlled Period (CP)|Physician Decision|0
791643|NCT00723528|2517667|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791644|NCT00723528|2517668|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791645|NCT00723528|2517669|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791646|NCT00723528|2517670|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791647|NCT00723528|2517671|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791648|NCT00723528|2517672|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
791649|NCT00723528|2517673|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
791650|NCT00723528|2517667|P7|Period 1: Controlled Period (CP)|Adverse Event|0
791651|NCT00723528|2517668|P6|Period 1: Controlled Period (CP)|Adverse Event|0
791652|NCT00723528|2517669|P5|Period 1: Controlled Period (CP)|Adverse Event|0
791653|NCT00723528|2517670|P4|Period 1: Controlled Period (CP)|Adverse Event|0
791654|NCT00723528|2517671|P3|Period 1: Controlled Period (CP)|Adverse Event|1
791655|NCT00723528|2517672|P2|Period 1: Controlled Period (CP)|Adverse Event|0
791656|NCT00723528|2517673|P1|Period 1: Controlled Period (CP)|Adverse Event|0
791657|NCT00723554|2517731|P1|Overall Study|Non-compliance|1
791658|NCT00723554|2517731|P1|Overall Study|Lost to Follow-up|1
791659|NCT00723554|2517731|P1|Overall Study|Not specified|3
791660|NCT00723554|2517731|P1|Overall Study|Withdrawal of consent|3
791661|NCT00723554|2517731|P1|Overall Study|Inhaled medication other than iloprost|4
791662|NCT00723554|2517731|P1|Overall Study|Investigator's judgement|5
791663|NCT00723554|2517731|P1|Overall Study|Adverse Event|12
791664|NCT00723606|2517784|P2|Overall Study|Withdrawal by Subject|2
791665|NCT00723606|2517785|P1|Overall Study|Withdrawal by Subject|0
791666|NCT00723606|2517784|P2|Overall Study|Unspecified|0
791667|NCT00723606|2517785|P1|Overall Study|Unspecified|2
791668|NCT00723606|2517784|P2|Overall Study|Adverse Event|5
791669|NCT00723606|2517785|P1|Overall Study|Adverse Event|2
791670|NCT00723697|2517812|P1|Overall Study|Other exclusion criteria applied|6
791671|NCT00723697|2517812|P1|Overall Study|Missing Informed Consent Form|10
791672|NCT00723697|2517812|P1|Overall Study|Physician questionnaires not received|2
791673|NCT00723710|2517820|P1|Overall Study|Physician Decision|2
791674|NCT00723710|2517820|P1|Overall Study|Withdrawal by Subject|36
791675|NCT00723710|2517820|P1|Overall Study|Adverse Event|88
791676|NCT00723710|2517820|P1|Overall Study|Disease progression|48
791677|NCT00723801|2517843|P2|Overall Study|Protocol Violation|1
791678|NCT00723801|2517844|P1|Overall Study|Protocol Violation|2
791679|NCT00723801|2517843|P2|Overall Study|Lost to Follow-up|2
791680|NCT00723801|2517844|P1|Overall Study|Lost to Follow-up|1
791681|NCT00723840|2517860|P1|Overall Study|Unspecified reason|2
791682|NCT00723840|2517860|P1|Overall Study|Other Medical Event|2
791683|NCT00723840|2517860|P1|Overall Study|Serious Adverse Events|3
791684|NCT00723840|2517860|P1|Overall Study|Withdrawal by Subject|55
791685|NCT00723840|2517860|P1|Overall Study|Failure to return|18
791686|NCT00723840|2517860|P1|Overall Study|Lost to Follow-up|2
791688|NCT00723892|2517874|P1|Overall Study|Drug addiction|1
791689|NCT00723892|2517873|P2|Overall Study|Intercurrent infection|0
791690|NCT00723892|2517874|P1|Overall Study|Intercurrent infection|2
791691|NCT00723892|2517873|P2|Overall Study|Alcohol abuse|1
791692|NCT00723892|2517874|P1|Overall Study|Alcohol abuse|0
791693|NCT00723892|2517873|P2|Overall Study|Weight loss|3
791694|NCT00723892|2517874|P1|Overall Study|Weight loss|1
791695|NCT00723892|2517873|P2|Overall Study|Study end|3
791696|NCT00723892|2517874|P1|Overall Study|Study end|1
791697|NCT00723892|2517873|P2|Overall Study|Not specified|3
791698|NCT00723892|2517874|P1|Overall Study|Not specified|6
791699|NCT00723892|2517873|P2|Overall Study|Multiple reasons|12
791700|NCT00723892|2517874|P1|Overall Study|Multiple reasons|17
791701|NCT00723892|2517873|P2|Overall Study|Bad tolerance|5
791702|NCT00723892|2517874|P1|Overall Study|Bad tolerance|5
791703|NCT00723892|2517873|P2|Overall Study|End planned|7
791704|NCT00723892|2517874|P1|Overall Study|End planned|11
791705|NCT00723892|2517873|P2|Overall Study|Withdrawal by Subject|9
791706|NCT00723892|2517874|P1|Overall Study|Withdrawal by Subject|6
791707|NCT00723892|2517873|P2|Overall Study|Virological criterion|9
791708|NCT00723892|2517874|P1|Overall Study|Virological criterion|24
791709|NCT00723892|2517873|P2|Overall Study|Participant not tracked|35
791710|NCT00723892|2517874|P1|Overall Study|Participant not tracked|33
791711|NCT00723944|2517888|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
791712|NCT00723944|2517889|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
791713|NCT00723944|2517888|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
791714|NCT00723944|2517889|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
791715|NCT00723944|2517888|P2|Permanent Prosthesis Placement|Adverse Event|7
791716|NCT00723944|2517889|P1|Permanent Prosthesis Placement|Adverse Event|1
791717|NCT00723957|2517897|P2|Overall Study|Never received treatment|3
791718|NCT00723957|2517898|P1|Overall Study|Never received treatment|3
791719|NCT00723957|2517897|P2|Overall Study|Reason not analyzed|0
791720|NCT00723957|2517898|P1|Overall Study|Reason not analyzed|1
791721|NCT00723957|2517897|P2|Overall Study|Withdrawal by Subject|5
791722|NCT00723957|2517898|P1|Overall Study|Withdrawal by Subject|7
791723|NCT00723957|2517897|P2|Overall Study|Study drug toxicity|6
791724|NCT00723957|2517898|P1|Overall Study|Study drug toxicity|4
791725|NCT00723957|2517897|P2|Overall Study|Investigator decision|1
791726|NCT00723957|2517898|P1|Overall Study|Investigator decision|1
791727|NCT00723957|2517897|P2|Overall Study|Maximum clinical benefit|5
791728|NCT00723957|2517898|P1|Overall Study|Maximum clinical benefit|4
791729|NCT00723957|2517897|P2|Overall Study|Disease progression|25
791730|NCT00723957|2517898|P1|Overall Study|Disease progression|27
791731|NCT00723957|2517897|P2|Overall Study|Death|4
791732|NCT00723957|2517898|P1|Overall Study|Death|3
791733|NCT00723957|2517897|P2|Overall Study|Adverse event unrelated to study drug|4
791734|NCT00723957|2517898|P1|Overall Study|Adverse event unrelated to study drug|1
791735|NCT00724061|2517931|P1|Dose Escalation Phase|Disease Progression|3
791736|NCT00724061|2517931|P1|Dose Escalation Phase|Adverse Event|2
791737|NCT00724126|2517937|P2|Overall Study|Subject had to leave vicinity of site|1
791738|NCT00724126|2517938|P1|Overall Study|Subject had to leave vicinity of site|0
791739|NCT00724126|2517937|P2|Overall Study|Subject randomized although ineligible|1
791740|NCT00724126|2517938|P1|Overall Study|Subject randomized although ineligible|1
791741|NCT00724126|2517937|P2|Overall Study|Noncompliance|1
791742|NCT00724126|2517938|P1|Overall Study|Noncompliance|2
791743|NCT00724126|2517937|P2|Overall Study|Lost to Follow-up|6
791744|NCT00724126|2517938|P1|Overall Study|Lost to Follow-up|6
791745|NCT00724126|2517937|P2|Overall Study|Withdrawal by Subject|6
791746|NCT00724126|2517938|P1|Overall Study|Withdrawal by Subject|8
791747|NCT00724126|2517937|P2|Overall Study|Adverse Event|0
791748|NCT00724126|2517938|P1|Overall Study|Adverse Event|2
791749|NCT00724152|2517951|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
791750|NCT00724152|2517952|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
791751|NCT00724152|2517953|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
791752|NCT00724152|2517951|P3|Two-arm Study Period|Withdrawal by Subject|0
791753|NCT00724152|2517952|P2|Two-arm Study Period|Withdrawal by Subject|2
791754|NCT00724152|2517953|P1|Two-arm Study Period|Withdrawal by Subject|3
791755|NCT00718510|2517970|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
791756|NCT00718510|2517971|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
791757|NCT00718510|2517970|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
791758|NCT00718510|2517971|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
791759|NCT00718523|2517983|P2|Overall Study|Death|17
791760|NCT00718523|2517984|P1|Overall Study|Death|13
791761|NCT00718523|2517983|P2|Overall Study|Withdrawal by Subject|7
791762|NCT00718523|2517984|P1|Overall Study|Withdrawal by Subject|5
791763|NCT00718640|2517994|P1|Overall Study|Unresolved toxicity after 2 weeks|2
791764|NCT00718640|2517994|P1|Overall Study|Death|1
791765|NCT00718640|2517994|P1|Overall Study|Adverse Event|4
791766|NCT00724243|2518006|P1|Overall Study|Adverse Event|5
791767|NCT00724243|2518006|P1|Overall Study|Lack of Efficacy|10
791768|NCT00724282|2518011|P1|Overall Study|Physician Decision|1
791769|NCT00724282|2518011|P1|Overall Study|Withdrawal by Subject|3
791770|NCT00724373|2518028|P1|Overall Study|Tolerability|23
791771|NCT00724373|2518028|P1|Overall Study|Drug Relapse|1
791772|NCT00724373|2518028|P1|Overall Study|Acute HCV infection|1
791773|NCT00724373|2518028|P1|Overall Study|Viral Relapse|1
791774|NCT00724373|2518028|P1|Overall Study|Only to have 24 week regimen|1
791775|NCT00724373|2518028|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
791776|NCT00724373|2518028|P1|Overall Study|Participant moved away|1
791777|NCT00724373|2518028|P1|Overall Study|HCV RNA negative after 4 weeks|9
791778|NCT00724373|2518028|P1|Overall Study|Non-compliance|2
791779|NCT00724373|2518028|P1|Overall Study|Lost to Follow-up|7
791780|NCT00724373|2518028|P1|Overall Study|Lack of Efficacy|82
791781|NCT00724373|2518028|P1|Overall Study|Adverse Event|41
791782|NCT00724451|2518032|P1|Overall Study|Investigator + Participant Decision|13
791783|NCT00724451|2518032|P1|Overall Study|Withdrawal by Subject|45
791784|NCT00724451|2518032|P1|Overall Study|Physician Decision|116
791785|NCT00724451|2518032|P1|Overall Study|Unknown; No Data Sources Available|9
791786|NCT00724451|2518032|P1|Overall Study|Never Started Treatment|89
791787|NCT00724451|2518032|P1|Overall Study|Participant Refused Treatment|89
791788|NCT00724451|2518032|P1|Overall Study|Not Eligible for Treatment|431
791789|NCT00724451|2518032|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
791790|NCT00724451|2518032|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
791791|NCT00727272|2518054|P3|Washout Period B|Withdrawal by Subject|1
791792|NCT00727272|2518055|P2|Washout Period B|Withdrawal by Subject|0
791793|NCT00727272|2518056|P1|Washout Period B|Withdrawal by Subject|0
791794|NCT00727272|2518054|P3|Washout Period A|Adverse Event|1
791795|NCT00727272|2518055|P2|Washout Period A|Adverse Event|0
791796|NCT00727272|2518056|P1|Washout Period A|Adverse Event|0
791797|NCT00727311|2518079|P1|Overall Study|Multiple reasons|39
791798|NCT00727311|2518079|P1|Overall Study|not specified|97
791799|NCT00727311|2518079|P1|Overall Study|Withdrawal by Subject|77
791800|NCT00727311|2518079|P1|Overall Study|Lost to Follow-up|73
791801|NCT00727311|2518079|P1|Overall Study|Lack of Efficacy|242
791802|NCT00727311|2518079|P1|Overall Study|Adverse Event|58
791803|NCT00727311|2518079|P1|Overall Study|Missing end of therapy data|205
791804|NCT00727311|2518079|P1|Overall Study|Did not receive drug|316
791805|NCT00727402|2518103|P1|Overall Study|Physician Decision|116
791806|NCT00727506|2518113|P6|Overall Study|Other reason not described above|1
791807|NCT00727506|2518114|P5|Overall Study|Other reason not described above|1
791808|NCT00727506|2518115|P4|Overall Study|Other reason not described above|4
791809|NCT00727506|2518116|P3|Overall Study|Other reason not described above|1
791810|NCT00727506|2518117|P2|Overall Study|Other reason not described above|0
791811|NCT00727506|2518118|P1|Overall Study|Other reason not described above|0
791812|NCT00727506|2518113|P6|Overall Study|Refused to continue medication|2
791813|NCT00727506|2518114|P5|Overall Study|Refused to continue medication|1
791814|NCT00727506|2518115|P4|Overall Study|Refused to continue medication|3
791815|NCT00727506|2518116|P3|Overall Study|Refused to continue medication|2
791816|NCT00727506|2518117|P2|Overall Study|Refused to continue medication|1
791817|NCT00727506|2518118|P1|Overall Study|Refused to continue medication|0
791818|NCT00727506|2518113|P6|Overall Study|Progressive disease|28
791819|NCT00727506|2518114|P5|Overall Study|Progressive disease|38
791820|NCT00727506|2518115|P4|Overall Study|Progressive disease|28
791821|NCT00727506|2518116|P3|Overall Study|Progressive disease|9
791822|NCT00727506|2518117|P2|Overall Study|Progressive disease|7
791823|NCT00727506|2518118|P1|Overall Study|Progressive disease|4
791824|NCT00727506|2518113|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
791825|NCT00727506|2518114|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
791826|NCT00727506|2518115|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
791827|NCT00727506|2518116|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
791828|NCT00727506|2518117|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
791829|NCT00727506|2518118|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
791830|NCT00727506|2518113|P6|Overall Study|Adverse Event|8
791831|NCT00727506|2518114|P5|Overall Study|Adverse Event|1
791832|NCT00727506|2518115|P4|Overall Study|Adverse Event|4
791833|NCT00727506|2518116|P3|Overall Study|Adverse Event|4
791834|NCT00727506|2518117|P2|Overall Study|Adverse Event|0
791835|NCT00727506|2518118|P1|Overall Study|Adverse Event|0
791836|NCT00727558|2518213|P2|Overall Study|Lost to Follow-up|0
791837|NCT00727558|2518214|P1|Overall Study|Lost to Follow-up|1
791838|NCT00727558|2518213|P2|Overall Study|Subject unable to return for follow-up|1
791839|NCT00727558|2518214|P1|Overall Study|Subject unable to return for follow-up|1
791840|NCT00727558|2518213|P2|Overall Study|Adverse Event|1
791841|NCT00727558|2518214|P1|Overall Study|Adverse Event|0
791842|NCT00727558|2518213|P2|Overall Study|Lens issue|1
791843|NCT00727558|2518214|P1|Overall Study|Lens issue|0
791844|NCT00727571|2518236|P4|Overall Study|Other|0
791845|NCT00727571|2518237|P3|Overall Study|Other|6
791846|NCT00727571|2518238|P2|Overall Study|Other|4
791847|NCT00727571|2518239|P1|Overall Study|Other|0
791848|NCT00727571|2518236|P4|Overall Study|AE not leading to hospitalization|0
791849|NCT00727571|2518237|P3|Overall Study|AE not leading to hospitalization|2
791850|NCT00727571|2518238|P2|Overall Study|AE not leading to hospitalization|0
791851|NCT00727571|2518239|P1|Overall Study|AE not leading to hospitalization|0
791852|NCT00727571|2518236|P4|Overall Study|Hospitalization|1
791853|NCT00727571|2518237|P3|Overall Study|Hospitalization|0
791854|NCT00727571|2518238|P2|Overall Study|Hospitalization|1
791855|NCT00727571|2518239|P1|Overall Study|Hospitalization|0
791856|NCT00727571|2518236|P4|Overall Study|Dismissed from nursing home|0
791857|NCT00727571|2518237|P3|Overall Study|Dismissed from nursing home|5
791858|NCT00727571|2518238|P2|Overall Study|Dismissed from nursing home|9
791859|NCT00727571|2518239|P1|Overall Study|Dismissed from nursing home|0
791860|NCT00727571|2518236|P4|Overall Study|Subject Non Compliance|4
791861|NCT00727571|2518237|P3|Overall Study|Subject Non Compliance|0
791862|NCT00727571|2518238|P2|Overall Study|Subject Non Compliance|6
791863|NCT00727571|2518239|P1|Overall Study|Subject Non Compliance|0
791864|NCT00727571|2518236|P4|Overall Study|Withdrawal by Subject|0
791865|NCT00727571|2518237|P3|Overall Study|Withdrawal by Subject|11
791866|NCT00727571|2518238|P2|Overall Study|Withdrawal by Subject|10
791867|NCT00727571|2518239|P1|Overall Study|Withdrawal by Subject|0
791868|NCT00727571|2518236|P4|Overall Study|Physician Decision|0
791869|NCT00727571|2518237|P3|Overall Study|Physician Decision|0
791870|NCT00727571|2518238|P2|Overall Study|Physician Decision|5
791871|NCT00727571|2518239|P1|Overall Study|Physician Decision|0
791872|NCT00727571|2518236|P4|Overall Study|Death|1
791873|NCT00727571|2518237|P3|Overall Study|Death|5
791874|NCT00727571|2518238|P2|Overall Study|Death|19
791875|NCT00727571|2518239|P1|Overall Study|Death|0
791876|NCT00727571|2518236|P4|Overall Study|Ineligibility determined|0
791877|NCT00727571|2518237|P3|Overall Study|Ineligibility determined|1
791878|NCT00727571|2518238|P2|Overall Study|Ineligibility determined|1
791879|NCT00727571|2518239|P1|Overall Study|Ineligibility determined|1
791880|NCT00727649|2518292|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
791881|NCT00727649|2518293|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
791882|NCT00727649|2518292|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
791883|NCT00727649|2518293|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
791884|NCT00727649|2518292|P2|Second Intervention (4-weeks)|Death|0
791885|NCT00727649|2518293|P1|Second Intervention (4-weeks)|Death|1
791886|NCT00727649|2518292|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
791887|NCT00727649|2518293|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
791888|NCT00727649|2518292|P2|Wash-out (2-weeks)|Lost to Follow-up|1
791889|NCT00727649|2518293|P1|Wash-out (2-weeks)|Lost to Follow-up|3
791890|NCT00727649|2518292|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
791891|NCT00727649|2518293|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
791892|NCT00727649|2518292|P2|First Intervention (4-weeks)|Lost to Follow-up|2
791893|NCT00727649|2518293|P1|First Intervention (4-weeks)|Lost to Follow-up|1
791894|NCT00727714|2518305|P1|Overall Study|Lost to Follow-up|2
791895|NCT00727844|2518324|P4|Initial Randomization|Physician Decision|0
791896|NCT00727844|2518325|P3|Initial Randomization|Physician Decision|0
791897|NCT00727844|2518326|P2|Initial Randomization|Physician Decision|0
791898|NCT00727844|2518327|P1|Initial Randomization|Physician Decision|2
791899|NCT00727909|2518423|P4|Overall Study|Death|0
791900|NCT00727909|2518424|P3|Overall Study|Death|1
791901|NCT00727909|2518425|P2|Overall Study|Death|0
791902|NCT00727909|2518426|P1|Overall Study|Death|0
791903|NCT00727909|2518423|P4|Overall Study|Withdrawal by Subject|5
791904|NCT00727909|2518424|P3|Overall Study|Withdrawal by Subject|8
791905|NCT00727909|2518425|P2|Overall Study|Withdrawal by Subject|11
791906|NCT00727909|2518426|P1|Overall Study|Withdrawal by Subject|5
791907|NCT00727961|2518430|P1|Overall Study|Progression|30
791908|NCT00727961|2518430|P1|Overall Study|Patient's refusal|2
791909|NCT00727961|2518430|P1|Overall Study|Adverse Event|4
791910|NCT00727961|2518430|P1|Overall Study|Lost to Follow-up|1
791911|NCT00728130|2518440|P1|Overall Study|Physician Decision|1
791912|NCT00728130|2518440|P1|Overall Study|Paperwork not completed in time|1
791913|NCT00728130|2518440|P1|Overall Study|Withdrawal by Subject|1
791914|NCT00728182|2518447|P2|Overall Study|Protocol Noncompliance|1
791915|NCT00728182|2518448|P1|Overall Study|Protocol Noncompliance|0
791916|NCT00728182|2518447|P2|Overall Study|Death|2
791917|NCT00728182|2518448|P1|Overall Study|Death|0
791918|NCT00728182|2518447|P2|Overall Study|Lost to Follow-up|0
791919|NCT00728182|2518448|P1|Overall Study|Lost to Follow-up|2
791920|NCT00728182|2518447|P2|Overall Study|Adverse Event|0
791921|NCT00728182|2518448|P1|Overall Study|Adverse Event|1
791922|NCT00728416|2518484|P2|Overall Study|Withdrawal by Subject|0
791923|NCT00728416|2518485|P1|Overall Study|Withdrawal by Subject|1
791924|NCT00728416|2518484|P2|Overall Study|Treatment Failure|1
791925|NCT00728416|2518485|P1|Overall Study|Treatment Failure|0
791926|NCT00728416|2518484|P2|Overall Study|Adverse Event|1
791927|NCT00728416|2518485|P1|Overall Study|Adverse Event|1
791928|NCT00728468|2518493|P1|Overall Study|Study terminated by sponsor|1
791929|NCT00728468|2518493|P1|Overall Study|Objective progression or relapse|9
791930|NCT00728468|2518493|P1|Overall Study|Protocol Violation|4
791931|NCT00728468|2518493|P1|Overall Study|Death|1
791932|NCT00728468|2518493|P1|Overall Study|Enrolled but not treated|1
791933|NCT00728481|2518517|P2|Overall Study|Incorrectly assigned to opposite arm|0
791934|NCT00728481|2518518|P1|Overall Study|Incorrectly assigned to opposite arm|1
791935|NCT00728481|2518517|P2|Overall Study|Study medication non-compliance|2
791936|NCT00728481|2518518|P1|Overall Study|Study medication non-compliance|0
791937|NCT00728481|2518517|P2|Overall Study|Adverse Event|1
791938|NCT00728481|2518518|P1|Overall Study|Adverse Event|0
791939|NCT00728481|2518517|P2|Overall Study|Withdrawal by Subject|1
791940|NCT00728481|2518518|P1|Overall Study|Withdrawal by Subject|0
791941|NCT00728494|2518536|P2|Overall Study|No data available|1
791942|NCT00728494|2518537|P1|Overall Study|No data available|0
791943|NCT00728494|2518536|P2|Overall Study|Lack of Efficacy|4
791944|NCT00728494|2518537|P1|Overall Study|Lack of Efficacy|2
791945|NCT00728494|2518536|P2|Overall Study|Withdrawal by Subject|2
791946|NCT00728494|2518537|P1|Overall Study|Withdrawal by Subject|0
791947|NCT00728494|2518536|P2|Overall Study|Adverse Event|0
791948|NCT00728494|2518537|P1|Overall Study|Adverse Event|7
791949|NCT00728689|2518566|P2|Washout Period (Days 4 - 10)|Death in family|0
791950|NCT00728689|2518567|P1|Washout Period (Days 4 - 10)|Death in family|1
791951|NCT00728754|2518606|P2|One Year Post Placement Follow-up|Adverse Event|0
791952|NCT00728754|2518607|P1|One Year Post Placement Follow-up|Adverse Event|1
791953|NCT00728754|2518606|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
791954|NCT00728754|2518607|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
791955|NCT00728754|2518606|P2|Permanent Prosthesis Placement|Adverse Event|1
791956|NCT00728754|2518607|P1|Permanent Prosthesis Placement|Adverse Event|1
791957|NCT00728884|2518630|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
791958|NCT00728884|2518630|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
791959|NCT00728962|2518651|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
791960|NCT00728962|2518651|P1|Permanent Prosthesis Placement|Adverse Event|3
791961|NCT00728962|2518651|P1|Implant Placement Surgery|Protocol Violation|1
791962|NCT00728962|2518651|P1|Implant Placement Surgery|Lost to Follow-up|1
791963|NCT00728962|2518651|P1|Implant Placement Surgery|Adverse Event|8
791964|NCT00728988|2518657|P2|Overall Study|Withdrawal by Subject|6
791965|NCT00728988|2518658|P1|Overall Study|Withdrawal by Subject|2
791966|NCT00728988|2518657|P2|Overall Study|Unspecified|77
791967|NCT00728988|2518658|P1|Overall Study|Unspecified|85
791968|NCT00728988|2518657|P2|Overall Study|Adverse Event|2
791969|NCT00728988|2518658|P1|Overall Study|Adverse Event|3
791970|NCT00728988|2518657|P2|Overall Study|Death|1
791971|NCT00728988|2518658|P1|Overall Study|Death|1
791972|NCT00728988|2518657|P2|Overall Study|Not Treated|2
791973|NCT00728988|2518658|P1|Overall Study|Not Treated|2
791974|NCT00729157|2518676|P1|Overall Study|Withdrawal by Subject|1
791975|NCT00729183|2518686|P2|Overall Study|Withdrawal by Subject|7
791976|NCT00729183|2518687|P1|Overall Study|Withdrawal by Subject|9
791977|NCT00729183|2518686|P2|Overall Study|Protocol Violation|0
791978|NCT00729183|2518687|P1|Overall Study|Protocol Violation|1
791979|NCT00729183|2518686|P2|Overall Study|Physician Decision|1
791980|NCT00729183|2518687|P1|Overall Study|Physician Decision|1
791981|NCT00729183|2518686|P2|Overall Study|Lost to Follow-up|1
791982|NCT00729183|2518687|P1|Overall Study|Lost to Follow-up|3
791983|NCT00729183|2518686|P2|Overall Study|Lack of Efficacy|1
791984|NCT00729183|2518687|P1|Overall Study|Lack of Efficacy|0
791985|NCT00729183|2518686|P2|Overall Study|Adverse Event|5
791986|NCT00729183|2518687|P1|Overall Study|Adverse Event|11
791987|NCT00729248|2518719|P1|Overall Study|Physician Decision|2
791988|NCT00729326|2518726|P2|Overall Study|Sponsor Decision|2
791989|NCT00729326|2518727|P1|Overall Study|Sponsor Decision|1
791990|NCT00729326|2518726|P2|Overall Study|Subject Decision|4
791991|NCT00729326|2518727|P1|Overall Study|Subject Decision|4
791992|NCT00729326|2518726|P2|Overall Study|Protocol Violation|2
791993|NCT00729326|2518727|P1|Overall Study|Protocol Violation|3
791994|NCT00729326|2518726|P2|Overall Study|Physician Decision|1
791995|NCT00729326|2518727|P1|Overall Study|Physician Decision|0
791996|NCT00729326|2518726|P2|Overall Study|Lost to Follow-up|0
791997|NCT00729326|2518727|P1|Overall Study|Lost to Follow-up|2
791998|NCT00729365|2518772|P3|Overall Study|Physician Decision|7
791999|NCT00729365|2518773|P2|Overall Study|Physician Decision|6
792000|NCT00729365|2518774|P1|Overall Study|Physician Decision|33
792001|NCT00729469|2518802|P2|Overall Study|Other-Not mentioned|4
792002|NCT00729469|2518803|P1|Overall Study|Other-Not mentioned|9
792003|NCT00729469|2518802|P2|Overall Study|Withdrawal by Subject|8
792004|NCT00729469|2518803|P1|Overall Study|Withdrawal by Subject|19
792005|NCT00729469|2518802|P2|Overall Study|Protocol Violation|1
792006|NCT00729469|2518803|P1|Overall Study|Protocol Violation|2
792007|NCT00729469|2518802|P2|Overall Study|Lost to Follow-up|9
792008|NCT00729469|2518803|P1|Overall Study|Lost to Follow-up|9
792009|NCT00729469|2518802|P2|Overall Study|Adverse Event|25
792010|NCT00729469|2518803|P1|Overall Study|Adverse Event|14
792011|NCT00729560|2518859|P1|Overall Study|Withdrawal by Subject|3
792012|NCT00729612|2518863|P1|Overall Study|Non evaluable for response|10
792013|NCT00729651|2518872|P2|Overall Study|Subject’s private reason|0
792014|NCT00729651|2518873|P1|Overall Study|Subject’s private reason|2
792015|NCT00729651|2518872|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
792016|NCT00729651|2518873|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
792017|NCT00729651|2518872|P2|Overall Study|Adverse Event|3
792018|NCT00729651|2518873|P1|Overall Study|Adverse Event|7
792019|NCT00729651|2518872|P2|Overall Study|Protocol Violation|1
792020|NCT00729651|2518873|P1|Overall Study|Protocol Violation|0
792021|NCT00729651|2518872|P2|Overall Study|Lost to Follow-up|4
792022|NCT00729651|2518873|P1|Overall Study|Lost to Follow-up|5
792023|NCT00729651|2518872|P2|Overall Study|Withdrawal by Subject|6
792024|NCT00729651|2518873|P1|Overall Study|Withdrawal by Subject|5
792025|NCT00729690|2518899|P3|Overall Study|IT Catheter Malfunction|2
792026|NCT00729690|2518900|P2|Overall Study|IT Catheter Malfunction|2
792027|NCT00729690|2518901|P1|Overall Study|IT Catheter Malfunction|0
792028|NCT00721578|2518918|P2|Overall Study|Withdrawal by Subject|1
792029|NCT00721578|2518919|P1|Overall Study|Withdrawal by Subject|1
792030|NCT00721578|2518918|P2|Overall Study|Death|1
792031|NCT00721578|2518919|P1|Overall Study|Death|1
792032|NCT00729833|2518965|P4|Overall Study|Unspecified Reasons|1
792033|NCT00729833|2518966|P3|Overall Study|Unspecified Reasons|5
792034|NCT00729833|2518967|P2|Overall Study|Unspecified Reasons|5
792035|NCT00729833|2518968|P1|Overall Study|Unspecified Reasons|11
792036|NCT00729833|2518965|P4|Overall Study|Withdrawal by Subject|0
792037|NCT00729833|2518966|P3|Overall Study|Withdrawal by Subject|3
792038|NCT00729833|2518967|P2|Overall Study|Withdrawal by Subject|1
792039|NCT00729833|2518968|P1|Overall Study|Withdrawal by Subject|3
792040|NCT00729833|2518965|P4|Overall Study|Lost to Follow-up|0
792041|NCT00729833|2518966|P3|Overall Study|Lost to Follow-up|0
792042|NCT00729833|2518967|P2|Overall Study|Lost to Follow-up|0
792043|NCT00729833|2518968|P1|Overall Study|Lost to Follow-up|1
792044|NCT00729833|2518965|P4|Overall Study|Study Terminated by Sponsor|0
792045|NCT00729833|2518966|P3|Overall Study|Study Terminated by Sponsor|1
792046|NCT00729833|2518967|P2|Overall Study|Study Terminated by Sponsor|0
792047|NCT00729833|2518968|P1|Overall Study|Study Terminated by Sponsor|0
792048|NCT00729833|2518965|P4|Overall Study|Death|5
792049|NCT00729833|2518966|P3|Overall Study|Death|3
792050|NCT00729833|2518967|P2|Overall Study|Death|1
792051|NCT00729833|2518968|P1|Overall Study|Death|5
792052|NCT00729859|2519019|P3|Overall Study|Withdrawal by Subject|0
792053|NCT00729859|2519020|P2|Overall Study|Withdrawal by Subject|1
792054|NCT00729859|2519021|P1|Overall Study|Withdrawal by Subject|0
792055|NCT00729859|2519019|P3|Overall Study|Adverse Event|0
792056|NCT00729859|2519020|P2|Overall Study|Adverse Event|1
792057|NCT00729859|2519021|P1|Overall Study|Adverse Event|0
792058|NCT00729937|2519069|P6|Overall Study|Incarcerated|0
792059|NCT00729937|2519070|P5|Overall Study|Incarcerated|0
792060|NCT00729937|2519071|P4|Overall Study|Incarcerated|1
792061|NCT00729937|2519072|P3|Overall Study|Incarcerated|1
792062|NCT00729937|2519073|P2|Overall Study|Incarcerated|2
792063|NCT00729937|2519074|P1|Overall Study|Incarcerated|0
792064|NCT00729937|2519069|P6|Overall Study|Did not meet eligibility criteria|0
792065|NCT00729937|2519070|P5|Overall Study|Did not meet eligibility criteria|0
792066|NCT00729937|2519071|P4|Overall Study|Did not meet eligibility criteria|0
792067|NCT00729937|2519072|P3|Overall Study|Did not meet eligibility criteria|0
792068|NCT00729937|2519073|P2|Overall Study|Did not meet eligibility criteria|1
792069|NCT00729937|2519074|P1|Overall Study|Did not meet eligibility criteria|2
792070|NCT00729937|2519069|P6|Overall Study|Randomized but not treated|3
792071|NCT00729937|2519070|P5|Overall Study|Randomized but not treated|1
792072|NCT00729937|2519071|P4|Overall Study|Randomized but not treated|0
792073|NCT00729937|2519072|P3|Overall Study|Randomized but not treated|1
792074|NCT00729937|2519073|P2|Overall Study|Randomized but not treated|6
792075|NCT00729937|2519074|P1|Overall Study|Randomized but not treated|12
792076|NCT00729937|2519069|P6|Overall Study|Withdrawal by Subject|2
792077|NCT00729937|2519070|P5|Overall Study|Withdrawal by Subject|4
792078|NCT00729937|2519071|P4|Overall Study|Withdrawal by Subject|0
792079|NCT00729937|2519072|P3|Overall Study|Withdrawal by Subject|6
792080|NCT00729937|2519073|P2|Overall Study|Withdrawal by Subject|5
792081|NCT00729937|2519074|P1|Overall Study|Withdrawal by Subject|3
792082|NCT00729937|2519069|P6|Overall Study|Death|1
792083|NCT00729937|2519070|P5|Overall Study|Death|0
792084|NCT00729937|2519071|P4|Overall Study|Death|0
792085|NCT00729937|2519072|P3|Overall Study|Death|1
792086|NCT00729937|2519073|P2|Overall Study|Death|0
792087|NCT00729937|2519074|P1|Overall Study|Death|1
792088|NCT00729937|2519069|P6|Overall Study|Physician Decision|8
792089|NCT00729937|2519070|P5|Overall Study|Physician Decision|5
792090|NCT00729937|2519071|P4|Overall Study|Physician Decision|0
792091|NCT00729937|2519072|P3|Overall Study|Physician Decision|2
792092|NCT00729937|2519073|P2|Overall Study|Physician Decision|16
792093|NCT00729937|2519074|P1|Overall Study|Physician Decision|7
792094|NCT00729937|2519069|P6|Overall Study|Lost to Follow-up|23
792095|NCT00729937|2519070|P5|Overall Study|Lost to Follow-up|18
792096|NCT00729937|2519071|P4|Overall Study|Lost to Follow-up|33
792097|NCT00729937|2519072|P3|Overall Study|Lost to Follow-up|18
792098|NCT00729937|2519073|P2|Overall Study|Lost to Follow-up|58
792099|NCT00729937|2519074|P1|Overall Study|Lost to Follow-up|49
792100|NCT00730015|2519271|P3|Overall Study|Other Reason|1
792101|NCT00730015|2519272|P2|Overall Study|Other Reason|0
792102|NCT00730015|2519273|P1|Overall Study|Other Reason|1
792103|NCT00730015|2519271|P3|Overall Study|Lack of Efficacy|8
792104|NCT00730015|2519272|P2|Overall Study|Lack of Efficacy|2
792105|NCT00730015|2519273|P1|Overall Study|Lack of Efficacy|1
792106|NCT00730015|2519271|P3|Overall Study|Lost to Follow-up|3
792107|NCT00730015|2519272|P2|Overall Study|Lost to Follow-up|10
792108|NCT00730015|2519273|P1|Overall Study|Lost to Follow-up|4
792109|NCT00730015|2519271|P3|Overall Study|Withdrawal by Subject|8
792110|NCT00730015|2519272|P2|Overall Study|Withdrawal by Subject|12
792111|NCT00730015|2519273|P1|Overall Study|Withdrawal by Subject|12
792112|NCT00730015|2519271|P3|Overall Study|Protocol Violation|4
792113|NCT00730015|2519272|P2|Overall Study|Protocol Violation|6
792114|NCT00730015|2519273|P1|Overall Study|Protocol Violation|2
792115|NCT00730015|2519271|P3|Overall Study|Adverse Event|8
792116|NCT00730015|2519272|P2|Overall Study|Adverse Event|10
792117|NCT00730015|2519273|P1|Overall Study|Adverse Event|11
792118|NCT00730028|2519312|P5|Overall Study|Randomization Error|2
792119|NCT00730028|2519313|P4|Overall Study|Randomization Error|0
792120|NCT00730028|2519314|P3|Overall Study|Randomization Error|0
792121|NCT00730028|2519315|P2|Overall Study|Randomization Error|0
792122|NCT00730028|2519316|P1|Overall Study|Randomization Error|1
792123|NCT00730028|2519312|P5|Overall Study|Treatment Failure|1
792124|NCT00730028|2519313|P4|Overall Study|Treatment Failure|0
792125|NCT00730028|2519314|P3|Overall Study|Treatment Failure|0
792126|NCT00730028|2519315|P2|Overall Study|Treatment Failure|5
792127|NCT00730028|2519316|P1|Overall Study|Treatment Failure|5
792128|NCT00730028|2519312|P5|Overall Study|Physician Decision|2
792129|NCT00730028|2519313|P4|Overall Study|Physician Decision|3
792130|NCT00730028|2519314|P3|Overall Study|Physician Decision|2
792131|NCT00730028|2519315|P2|Overall Study|Physician Decision|3
792132|NCT00730028|2519316|P1|Overall Study|Physician Decision|3
792133|NCT00730028|2519312|P5|Overall Study|Withdrawal by Subject|9
792134|NCT00730028|2519313|P4|Overall Study|Withdrawal by Subject|5
792135|NCT00730028|2519314|P3|Overall Study|Withdrawal by Subject|4
792136|NCT00730028|2519315|P2|Overall Study|Withdrawal by Subject|5
792137|NCT00730028|2519316|P1|Overall Study|Withdrawal by Subject|9
792138|NCT00730028|2519312|P5|Overall Study|Protocol Violation|0
792139|NCT00730028|2519313|P4|Overall Study|Protocol Violation|2
792140|NCT00730028|2519314|P3|Overall Study|Protocol Violation|1
792141|NCT00730028|2519315|P2|Overall Study|Protocol Violation|1
792142|NCT00730028|2519316|P1|Overall Study|Protocol Violation|6
792143|NCT00730028|2519312|P5|Overall Study|Lost to Follow-up|25
792144|NCT00730028|2519313|P4|Overall Study|Lost to Follow-up|26
792145|NCT00730028|2519314|P3|Overall Study|Lost to Follow-up|22
792146|NCT00730028|2519315|P2|Overall Study|Lost to Follow-up|26
792147|NCT00730028|2519316|P1|Overall Study|Lost to Follow-up|13
792148|NCT00730028|2519312|P5|Overall Study|Adverse Event|43
792149|NCT00730028|2519313|P4|Overall Study|Adverse Event|20
792150|NCT00730028|2519314|P3|Overall Study|Adverse Event|16
792151|NCT00730028|2519315|P2|Overall Study|Adverse Event|26
792152|NCT00730028|2519316|P1|Overall Study|Adverse Event|23
792153|NCT00730041|2519365|P2|Overall Study|Lost to Follow-up|2
792154|NCT00730041|2519366|P1|Overall Study|Lost to Follow-up|0
792155|NCT00730756|2519393|P2|Overall Study|Withdrew Consent|1
792156|NCT00730756|2519394|P1|Overall Study|Withdrew Consent|0
792157|NCT00730756|2519393|P2|Overall Study|Lost to Follow-up|1
792158|NCT00730756|2519394|P1|Overall Study|Lost to Follow-up|0
792159|NCT00730756|2519393|P2|Overall Study|Protocol Deviation|2
792160|NCT00730756|2519394|P1|Overall Study|Protocol Deviation|1
792161|NCT00730756|2519393|P2|Overall Study|Lack of Efficacy|1
792162|NCT00730756|2519394|P1|Overall Study|Lack of Efficacy|1
792163|NCT00730756|2519393|P2|Overall Study|Adverse Event|0
792164|NCT00730756|2519394|P1|Overall Study|Adverse Event|2
792165|NCT00730847|2519416|P1|Overall Study|Unspecified|24
792166|NCT00730847|2519416|P1|Overall Study|Unknown completion status|21
792167|NCT00730847|2519416|P1|Overall Study|Lost to Follow-up|67
792168|NCT00730847|2519416|P1|Overall Study|Withdrawal by Subject|16
792169|NCT00730847|2519416|P1|Overall Study|Protocol Violation|2
792170|NCT00730847|2519416|P1|Overall Study|Adverse Event|1
792171|NCT00730912|2519426|P3|Overall Study|Discontinued|1
792172|NCT00730912|2519427|P2|Overall Study|Discontinued|0
792173|NCT00730912|2519428|P1|Overall Study|Discontinued|0
792174|NCT00730925|2519439|P1|Overall Study|Other|1
792175|NCT00730925|2519439|P1|Overall Study|Switch to combination therapy|8
792176|NCT00730925|2519439|P1|Overall Study|Withdrawal by Subject|1
792177|NCT00730925|2519439|P1|Overall Study|Protocol Violation|1
792178|NCT00730925|2519439|P1|Overall Study|Other Averse Event|7
792179|NCT00730925|2519439|P1|Overall Study|Dose reducing Event|2
792180|NCT00730925|2519439|P1|Overall Study|Progressive Disease|21
792181|NCT00731042|2519453|P2|Second Intervention|Did not meet inclusion criteria|2
792182|NCT00731042|2519454|P1|Second Intervention|Did not meet inclusion criteria|0
792183|NCT00731120|2519543|P3|Overall Study|Other|1
792184|NCT00731120|2519544|P2|Overall Study|Other|0
792185|NCT00731120|2519545|P1|Overall Study|Other|4
792186|NCT00731120|2519543|P3|Overall Study|Lost to Follow-up|17
792187|NCT00731120|2519544|P2|Overall Study|Lost to Follow-up|15
792188|NCT00731120|2519545|P1|Overall Study|Lost to Follow-up|10
792189|NCT00731120|2519543|P3|Overall Study|Withdrawal of Consent|4
792190|NCT00731120|2519544|P2|Overall Study|Withdrawal of Consent|8
792191|NCT00731120|2519545|P1|Overall Study|Withdrawal of Consent|13
792192|NCT00731120|2519543|P3|Overall Study|Protocol Deviations|1
792193|NCT00731120|2519544|P2|Overall Study|Protocol Deviations|6
792194|NCT00731120|2519545|P1|Overall Study|Protocol Deviations|1
792195|NCT00731120|2519543|P3|Overall Study|Noncompliance with Study Drug|1
792196|NCT00731120|2519544|P2|Overall Study|Noncompliance with Study Drug|3
792197|NCT00731120|2519545|P1|Overall Study|Noncompliance with Study Drug|3
792198|NCT00731120|2519543|P3|Overall Study|Lack of Efficacy|4
792199|NCT00731120|2519544|P2|Overall Study|Lack of Efficacy|5
792200|NCT00731120|2519545|P1|Overall Study|Lack of Efficacy|4
792201|NCT00731120|2519543|P3|Overall Study|Adverse Event|8
792202|NCT00731120|2519544|P2|Overall Study|Adverse Event|6
792203|NCT00731120|2519545|P1|Overall Study|Adverse Event|7
792204|NCT00731133|2519580|P1|Overall Study|Withdrawal by Subject|10
792205|NCT00731549|2519612|P1|Overall Study|Lack of efficacy without AE|6
792206|NCT00731549|2519612|P1|Overall Study|Lack of efficacy with AE|37
792207|NCT00731549|2519612|P1|Overall Study|Adverse Event|31
792208|NCT00731549|2519612|P1|Overall Study|Protocol deviation|1
792209|NCT00731549|2519612|P1|Overall Study|Withdrawal by Subject|89
792210|NCT00731549|2519612|P1|Overall Study|Physician Decision|16
792211|NCT00731549|2519612|P1|Overall Study|Met withdrawal criteria|24
792212|NCT00731549|2519612|P1|Overall Study|Lost to Follow-up|19
792213|NCT00731666|2519653|P1|Overall Study|Withdrawal by Subject|2
792214|NCT00731666|2519653|P1|Overall Study|Lost to Follow-up|8
792215|NCT00731666|2519653|P1|Overall Study|Adverse Event|2
792216|NCT00731679|2519661|P2|Overall Study|Pregnancy|1
792217|NCT00731679|2519662|P1|Overall Study|Pregnancy|0
792218|NCT00731679|2519661|P2|Overall Study|Noncompliance|1
792219|NCT00731679|2519662|P1|Overall Study|Noncompliance|0
792220|NCT00731679|2519661|P2|Overall Study|Lost to Follow-up|8
792221|NCT00731679|2519662|P1|Overall Study|Lost to Follow-up|7
792222|NCT00731679|2519661|P2|Overall Study|Withdrawal by Subject|8
792223|NCT00731679|2519662|P1|Overall Study|Withdrawal by Subject|8
792224|NCT00731679|2519661|P2|Overall Study|Adverse Event|8
792225|NCT00731679|2519662|P1|Overall Study|Adverse Event|7
792226|NCT00731692|2519673|P3|Extension Phase|Adverse Event|15
792227|NCT00731692|2519674|P2|Extension Phase|Adverse Event|1
792228|NCT00731692|2519675|P1|Extension Phase|Adverse Event|1
792229|NCT00731692|2519673|P3|Extension Phase|Withdrawal by Subject|3
792230|NCT00731692|2519674|P2|Extension Phase|Withdrawal by Subject|5
792231|NCT00731692|2519675|P1|Extension Phase|Withdrawal by Subject|4
792232|NCT00731692|2519673|P3|Extension Phase|Lost to Follow-up|4
792233|NCT00731692|2519674|P2|Extension Phase|Lost to Follow-up|1
792234|NCT00731692|2519675|P1|Extension Phase|Lost to Follow-up|0
792235|NCT00731692|2519673|P3|Extension Phase|Abnormal lab values|1
792236|NCT00731692|2519674|P2|Extension Phase|Abnormal lab values|0
792237|NCT00731692|2519675|P1|Extension Phase|Abnormal lab values|0
792238|NCT00731692|2519673|P3|Extension Phase|Abnormal test procedure|1
792239|NCT00731692|2519674|P2|Extension Phase|Abnormal test procedure|0
792240|NCT00731692|2519675|P1|Extension Phase|Abnormal test procedure|0
792241|NCT00731692|2519673|P3|Extension Phase|Admin Problems: Terminated # patients|277
792242|NCT00731692|2519674|P2|Extension Phase|Admin Problems: Terminated # patients|189
792243|NCT00731692|2519675|P1|Extension Phase|Admin Problems: Terminated # patients|69
792244|NCT00731692|2519673|P3|Core Study (36 Months)|Withdrawal by Subject|46
792245|NCT00731692|2519674|P2|Core Study (36 Months)|Withdrawal by Subject|32
792246|NCT00731692|2519675|P1|Core Study (36 Months)|Withdrawal by Subject|12
792247|NCT00731692|2519673|P3|Core Study (36 Months)|Adverse Event|29
792248|NCT00731692|2519674|P2|Core Study (36 Months)|Adverse Event|28
792249|NCT00731692|2519675|P1|Core Study (36 Months)|Adverse Event|25
792250|NCT00731692|2519673|P3|Core Study (36 Months)|Abnormal Lab values|5
792251|NCT00731692|2519674|P2|Core Study (36 Months)|Abnormal Lab values|19
792252|NCT00731692|2519675|P1|Core Study (36 Months)|Abnormal Lab values|6
792253|NCT00731692|2519673|P3|Core Study (36 Months)|Protocol Violation|8
792254|NCT00731692|2519674|P2|Core Study (36 Months)|Protocol Violation|5
792255|NCT00731692|2519675|P1|Core Study (36 Months)|Protocol Violation|4
792256|NCT00731692|2519673|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
792257|NCT00731692|2519674|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
792258|NCT00731692|2519675|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
792259|NCT00731692|2519673|P3|Core Study (36 Months)|Administrative|6
792260|NCT00731692|2519674|P2|Core Study (36 Months)|Administrative|2
792261|NCT00731692|2519675|P1|Core Study (36 Months)|Administrative|2
792262|NCT00731692|2519673|P3|Core Study (36 Months)|Lost to Follow-up|3
792263|NCT00731692|2519674|P2|Core Study (36 Months)|Lost to Follow-up|3
792264|NCT00731692|2519675|P1|Core Study (36 Months)|Lost to Follow-up|1
792265|NCT00731692|2519673|P3|Core Study (36 Months)|Death|2
792266|NCT00731692|2519674|P2|Core Study (36 Months)|Death|1
792267|NCT00731692|2519675|P1|Core Study (36 Months)|Death|2
792268|NCT00731692|2519673|P3|Core Study (36 Months)|Physician Decision|2
792269|NCT00731692|2519674|P2|Core Study (36 Months)|Physician Decision|0
792270|NCT00731692|2519675|P1|Core Study (36 Months)|Physician Decision|1
792271|NCT00731692|2519673|P3|Core Study (36 Months)|Lack of Efficacy|64
792272|NCT00731692|2519674|P2|Core Study (36 Months)|Lack of Efficacy|23
792273|NCT00731692|2519675|P1|Core Study (36 Months)|Lack of Efficacy|11
892370|NCT01075984|2830146|P5|Follow-up Phase|Treatment failure|4
892371|NCT01075984|2830147|P4|Follow-up Phase|Treatment failure|0
792280|NCT00731783|2519741|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
792281|NCT00731783|2519742|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
792282|NCT00731783|2519741|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
792283|NCT00731783|2519742|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
792284|NCT00731783|2519741|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
792285|NCT00731783|2519742|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
792286|NCT00731783|2519741|P2|One Month Follow-Up Visit|Lost to Follow-up|22
792287|NCT00731783|2519742|P1|One Month Follow-Up Visit|Lost to Follow-up|14
792288|NCT00731822|2519764|P2|Overall Study|Lost to Follow-up|0
792289|NCT00731822|2519765|P1|Overall Study|Lost to Follow-up|1
792290|NCT00731822|2519764|P2|Overall Study|Protocol Violation|0
792291|NCT00731822|2519765|P1|Overall Study|Protocol Violation|1
792292|NCT00731822|2519764|P2|Overall Study|Adverse Event|1
792293|NCT00731822|2519765|P1|Overall Study|Adverse Event|2
792294|NCT00731939|2519788|P1|Overall Study|Did not meet enrollment criteria|2
792295|NCT00731939|2519788|P1|Overall Study|Withdrawal by Subject|2
792296|NCT00731939|2519788|P1|Overall Study|Not implanted with study device|9
792297|NCT00731939|2519788|P1|Overall Study|Lost to Follow-up|15
792298|NCT00731939|2519788|P1|Overall Study|Adverse Event|6
792299|NCT00732069|2519843|P6|Washout After First Study Drug|Adverse Event|0
792300|NCT00732069|2519844|P5|Washout After First Study Drug|Adverse Event|0
792301|NCT00732069|2519845|P4|Washout After First Study Drug|Adverse Event|0
792302|NCT00732069|2519846|P3|Washout After First Study Drug|Adverse Event|0
792303|NCT00732069|2519847|P2|Washout After First Study Drug|Adverse Event|0
792304|NCT00732069|2519848|P1|Washout After First Study Drug|Adverse Event|1
792305|NCT00732160|2519863|P4|Overall Study|scheduling|1
792306|NCT00732160|2519864|P3|Overall Study|scheduling|2
792307|NCT00732160|2519865|P2|Overall Study|scheduling|4
792308|NCT00732160|2519866|P1|Overall Study|scheduling|4
792309|NCT00732160|2519863|P4|Overall Study|Adverse Event|1
792310|NCT00732160|2519864|P3|Overall Study|Adverse Event|1
792311|NCT00732160|2519865|P2|Overall Study|Adverse Event|0
792312|NCT00732160|2519866|P1|Overall Study|Adverse Event|1
792313|NCT00732199|2519882|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
792314|NCT00732199|2519883|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
792315|NCT00732199|2519882|P2|Overall Study|Withdrawal by Subject|18
792316|NCT00732199|2519883|P1|Overall Study|Withdrawal by Subject|25
792317|NCT00732238|2519987|P2|Overall Study|Asymptomatic bacteriuria|0
792318|NCT00732238|2519988|P1|Overall Study|Asymptomatic bacteriuria|1
792319|NCT00732238|2519987|P2|Overall Study|Bacteremia|1
792320|NCT00732238|2519988|P1|Overall Study|Bacteremia|4
792321|NCT00732303|2519996|P1|Overall Study|Study Terminated|2
792322|NCT00732381|2520004|P2|Overall Study|Treatment Failure|1
792323|NCT00732381|2520005|P1|Overall Study|Treatment Failure|1
792324|NCT00732381|2520004|P2|Overall Study|Adverse Event|0
792325|NCT00732381|2520005|P1|Overall Study|Adverse Event|1
792326|NCT00732472|2520017|P4|Overall Study|Withdrawal by Subject|1
792327|NCT00732472|2520018|P3|Overall Study|Withdrawal by Subject|0
792328|NCT00732472|2520019|P2|Overall Study|Withdrawal by Subject|2
792329|NCT00732472|2520020|P1|Overall Study|Withdrawal by Subject|0
792330|NCT00732472|2520017|P4|Overall Study|Protocol Violation|1
792331|NCT00732472|2520018|P3|Overall Study|Protocol Violation|0
792332|NCT00732472|2520019|P2|Overall Study|Protocol Violation|0
792333|NCT00732472|2520020|P1|Overall Study|Protocol Violation|0
792334|NCT00732472|2520017|P4|Overall Study|Adverse Event|1
792335|NCT00732472|2520018|P3|Overall Study|Adverse Event|1
792336|NCT00732472|2520019|P2|Overall Study|Adverse Event|1
792337|NCT00732472|2520020|P1|Overall Study|Adverse Event|0
792338|NCT00732615|2520120|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
792339|NCT00732615|2520121|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
792340|NCT00732615|2520120|P2|Overall Study|Physician Decision|0
792341|NCT00732615|2520121|P1|Overall Study|Physician Decision|3
792342|NCT00732615|2520120|P2|Overall Study|Adverse Event|2
792343|NCT00732615|2520121|P1|Overall Study|Adverse Event|0
792344|NCT00732615|2520120|P2|Overall Study|Lost to Follow-up|1
792345|NCT00732615|2520121|P1|Overall Study|Lost to Follow-up|0
792346|NCT00732615|2520120|P2|Overall Study|Withdrawal by Subject|1
792347|NCT00732615|2520121|P1|Overall Study|Withdrawal by Subject|3
792348|NCT00732641|2520135|P2|Overall Study|Not Specified|5
792349|NCT00732641|2520136|P1|Overall Study|Not Specified|18
792350|NCT00732641|2520135|P2|Overall Study|Unable to Complete|1
792351|NCT00732641|2520136|P1|Overall Study|Unable to Complete|1
792352|NCT00732641|2520135|P2|Overall Study|Withdrawal by Subject|2
792353|NCT00732641|2520136|P1|Overall Study|Withdrawal by Subject|4
792354|NCT00732641|2520135|P2|Overall Study|Physician Decision|0
792355|NCT00732641|2520136|P1|Overall Study|Physician Decision|6
792356|NCT00732641|2520135|P2|Overall Study|Serious Adverse Events|3
792357|NCT00732641|2520136|P1|Overall Study|Serious Adverse Events|12
792358|NCT00732641|2520135|P2|Overall Study|Relapse or Progressive Disease|101
792359|NCT00732641|2520136|P1|Overall Study|Relapse or Progressive Disease|65
792360|NCT00732758|2520182|P2|Overall Study|Lost to Follow-up|16
792361|NCT00732758|2520183|P1|Overall Study|Lost to Follow-up|8
792362|NCT00732875|2520195|P1|Overall Study|Lack of Efficacy|13
792363|NCT00732875|2520195|P1|Overall Study|Withdrawal by Subject|6
792364|NCT00732875|2520195|P1|Overall Study|Adverse Event|16
792365|NCT00732940|2520216|P2|Overall Study|Lost to Follow-up|0
792366|NCT00732940|2520217|P1|Overall Study|Lost to Follow-up|1
792367|NCT00732940|2520216|P2|Overall Study|Adverse Event|1
792368|NCT00732940|2520217|P1|Overall Study|Adverse Event|0
792369|NCT00732940|2520216|P2|Overall Study|Withdrawal by Subject|2
792370|NCT00732940|2520217|P1|Overall Study|Withdrawal by Subject|1
792371|NCT00732992|2520287|P2|Overall Study|Withdrawal by Subject|0
792372|NCT00732992|2520288|P1|Overall Study|Withdrawal by Subject|1
792373|NCT00732992|2520287|P2|Overall Study|Global Deterioration of Health Status|0
792374|NCT00732992|2520288|P1|Overall Study|Global Deterioration of Health Status|1
792375|NCT00732992|2520287|P2|Overall Study|Objective Progression or Relapse|5
792376|NCT00732992|2520288|P1|Overall Study|Objective Progression or Relapse|3
792377|NCT00732992|2520287|P2|Overall Study|Adverse Event|1
792378|NCT00732992|2520288|P1|Overall Study|Adverse Event|1
792379|NCT00733005|2520307|P2|Overall Study|Protocol Violation|0
792380|NCT00733005|2520308|P1|Overall Study|Protocol Violation|2
792381|NCT00733005|2520307|P2|Overall Study|Withdrawal by Subject|1
792382|NCT00733005|2520308|P1|Overall Study|Withdrawal by Subject|0
792383|NCT00733005|2520307|P2|Overall Study|Treatment Failure|1
792384|NCT00733005|2520308|P1|Overall Study|Treatment Failure|0
792385|NCT00733005|2520307|P2|Overall Study|Adverse Event|1
792386|NCT00733005|2520308|P1|Overall Study|Adverse Event|0
792387|NCT00724815|2520349|P2|Overall Study|Other Various|5
792388|NCT00724815|2520350|P1|Overall Study|Other Various|3
792389|NCT00724815|2520349|P2|Overall Study|Lost to Follow-up|1
792390|NCT00724815|2520350|P1|Overall Study|Lost to Follow-up|4
792391|NCT00724815|2520349|P2|Overall Study|Adverse Event|3
792392|NCT00724815|2520350|P1|Overall Study|Adverse Event|5
792393|NCT00724815|2520349|P2|Overall Study|Randomized, not treated|30
792394|NCT00724815|2520350|P1|Overall Study|Randomized, not treated|31
792395|NCT00724854|2520364|P2|Overall Study|Adverse event + lack of efficacy|1
792396|NCT00724854|2520365|P1|Overall Study|Adverse event + lack of efficacy|2
792397|NCT00724854|2520364|P2|Overall Study|Withdrawal by Subject|0
792398|NCT00724854|2520365|P1|Overall Study|Withdrawal by Subject|5
792399|NCT00724854|2520364|P2|Overall Study|Change of treatment|0
792400|NCT00724854|2520365|P1|Overall Study|Change of treatment|7
792401|NCT00724854|2520364|P2|Overall Study|Death|0
792402|NCT00724854|2520365|P1|Overall Study|Death|11
792403|NCT00724854|2520364|P2|Overall Study|Not specified|3
792404|NCT00724854|2520365|P1|Overall Study|Not specified|42
792405|NCT00724854|2520364|P2|Overall Study|Adverse Event|4
792406|NCT00724854|2520365|P1|Overall Study|Adverse Event|62
792407|NCT00724854|2520364|P2|Overall Study|Lost to Follow-up|10
792408|NCT00724854|2520365|P1|Overall Study|Lost to Follow-up|87
792409|NCT00724854|2520364|P2|Overall Study|Lack of Efficacy|13
792410|NCT00724854|2520365|P1|Overall Study|Lack of Efficacy|187
792411|NCT00724867|2520380|P1|Overall Study|Elected to exit due to site closure|2
792412|NCT00724867|2520380|P1|Overall Study|Subject moved out of state|1
792413|NCT00724867|2520380|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
792414|NCT00724867|2520380|P1|Overall Study|Subject incarcerated|1
792415|NCT00724867|2520380|P1|Overall Study|Sponsor decision to end study|14
792416|NCT00724867|2520380|P1|Overall Study|Withdrawal by Subject|31
792417|NCT00724867|2520380|P1|Overall Study|Protocol Violation|1
792418|NCT00724867|2520380|P1|Overall Study|Physician Decision|17
792419|NCT00724867|2520380|P1|Overall Study|Non-compliance with study drug|6
792420|NCT00724867|2520380|P1|Overall Study|Lost to Follow-up|12
792421|NCT00724867|2520380|P1|Overall Study|Lack of Efficacy|14
792422|NCT00724867|2520380|P1|Overall Study|Adverse Event|25
792423|NCT00724893|2520420|P2|Overall Study|Unknown, missing data|1
792424|NCT00724893|2520421|P1|Overall Study|Unknown, missing data|1
792425|NCT00724893|2520420|P2|Overall Study|Lost to Follow-up|52
792426|NCT00724893|2520421|P1|Overall Study|Lost to Follow-up|0
792427|NCT00724893|2520420|P2|Overall Study|Assigned shorter treatment|2
792428|NCT00724893|2520421|P1|Overall Study|Assigned shorter treatment|0
792429|NCT00724893|2520420|P2|Overall Study|Financial reasons|2
792430|NCT00724893|2520421|P1|Overall Study|Financial reasons|0
792431|NCT00724893|2520420|P2|Overall Study|Substance abuse|3
792432|NCT00724893|2520421|P1|Overall Study|Substance abuse|0
792433|NCT00724893|2520420|P2|Overall Study|Incarceration|9
792434|NCT00724893|2520421|P1|Overall Study|Incarceration|0
792435|NCT00724893|2520420|P2|Overall Study|Geographic reasons|11
792436|NCT00724893|2520421|P1|Overall Study|Geographic reasons|0
792437|NCT00724893|2520420|P2|Overall Study|Patient choice|26
792438|NCT00724893|2520421|P1|Overall Study|Patient choice|0
792439|NCT00724893|2520420|P2|Overall Study|Reason not specified|7
792440|NCT00724893|2520421|P1|Overall Study|Reason not specified|193
792441|NCT00724893|2520420|P2|Overall Study|Lack of virologic response|202
792442|NCT00724893|2520421|P1|Overall Study|Lack of virologic response|94
792443|NCT00724893|2520420|P2|Overall Study|Withdrawal by Subject|1
792444|NCT00724893|2520421|P1|Overall Study|Withdrawal by Subject|0
792445|NCT00724893|2520420|P2|Overall Study|Adverse Event|142
792446|NCT00724893|2520421|P1|Overall Study|Adverse Event|76
792447|NCT00724932|2520491|P2|Overall Study|Not treated|3
792448|NCT00724932|2520492|P1|Overall Study|Not treated|4
792449|NCT00724932|2520491|P2|Overall Study|Lost to Follow-up|0
792450|NCT00724932|2520492|P1|Overall Study|Lost to Follow-up|1
792451|NCT00724945|2520561|P2|Period 2|lens physiology issue|0
792452|NCT00724945|2520562|P1|Period 2|lens physiology issue|1
792453|NCT00724945|2520561|P2|Period 2|lens comfort issue|0
792454|NCT00724945|2520562|P1|Period 2|lens comfort issue|3
792455|NCT00724945|2520561|P2|Period 1|Lost to Follow-up|0
792456|NCT00724945|2520562|P1|Period 1|Lost to Follow-up|1
792457|NCT00724945|2520561|P2|Period 1|Adverse Event|1
792458|NCT00724945|2520562|P1|Period 1|Adverse Event|1
792459|NCT00724945|2520561|P2|Period 1|non-compliance|0
792460|NCT00724945|2520562|P1|Period 1|non-compliance|1
792461|NCT00724958|2520572|P1|Overall Study|No documentation for end of therapy|13
792462|NCT00724958|2520572|P1|Overall Study|Other Reason|76
792463|NCT00724958|2520572|P1|Overall Study|Remission|7
792464|NCT00724958|2520572|P1|Overall Study|No Response|18
792465|NCT00724958|2520572|P1|Overall Study|Loss of Response|40
792466|NCT00724958|2520572|P1|Overall Study|Adverse Event|28
792467|NCT00725010|2520606|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
792468|NCT00725010|2520606|P1|Overall Study|No further documentation|1
792469|NCT00725010|2520606|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
792470|NCT00725010|2520606|P1|Overall Study|Hepatopathy probably not Temodal-related|1
792471|NCT00725010|2520606|P1|Overall Study|Lost to Follow-up|1
792472|NCT00725010|2520606|P1|Overall Study|Death|1
792473|NCT00725010|2520606|P1|Overall Study|Withdrawal by Subject|2
792474|NCT00725010|2520606|P1|Overall Study|Tumor Progression|7
792475|NCT00725010|2520606|P1|Overall Study|Toxicity|9
792476|NCT00725075|2520626|P3|Overall Study|Other|0
792477|NCT00725075|2520627|P2|Overall Study|Other|0
792478|NCT00725075|2520628|P1|Overall Study|Other|1
792479|NCT00725075|2520626|P3|Overall Study|Inclusion/Exclusion Criteria|1
792480|NCT00725075|2520627|P2|Overall Study|Inclusion/Exclusion Criteria|0
792481|NCT00725075|2520628|P1|Overall Study|Inclusion/Exclusion Criteria|1
792482|NCT00725075|2520626|P3|Overall Study|Worsening of Disease|2
792483|NCT00725075|2520627|P2|Overall Study|Worsening of Disease|1
792484|NCT00725075|2520628|P1|Overall Study|Worsening of Disease|2
792485|NCT00725075|2520626|P3|Overall Study|Adverse Event|1
792486|NCT00725075|2520627|P2|Overall Study|Adverse Event|1
792487|NCT00725075|2520628|P1|Overall Study|Adverse Event|2
792488|NCT00725075|2520626|P3|Overall Study|Withdrawal by Subject|4
792489|NCT00725075|2520627|P2|Overall Study|Withdrawal by Subject|5
792490|NCT00725075|2520628|P1|Overall Study|Withdrawal by Subject|4
792491|NCT00725075|2520626|P3|Overall Study|Lost to Follow-up|0
792492|NCT00725075|2520627|P2|Overall Study|Lost to Follow-up|0
792493|NCT00725075|2520628|P1|Overall Study|Lost to Follow-up|1
792494|NCT00725075|2520626|P3|Overall Study|Protocol Violation|1
792495|NCT00725075|2520627|P2|Overall Study|Protocol Violation|0
792496|NCT00725075|2520628|P1|Overall Study|Protocol Violation|0
792497|NCT00725075|2520626|P3|Overall Study|Use of Excluded Medication|0
792498|NCT00725075|2520627|P2|Overall Study|Use of Excluded Medication|1
792499|NCT00725075|2520628|P1|Overall Study|Use of Excluded Medication|0
792500|NCT00725101|2520672|P1|Overall Study|not specified/no reason given|11
792501|NCT00725101|2520672|P1|Overall Study|Withdrawal by Subject|127
792502|NCT00725101|2520672|P1|Overall Study|Protocol Violation|1
792503|NCT00725101|2520672|P1|Overall Study|Lost to Follow-up|353
792504|NCT00725101|2520672|P1|Overall Study|Death|3
792505|NCT00725205|2520699|P1|Overall Study|Treatment Failure|41
792506|NCT00725205|2520699|P1|Overall Study|Protocol Defined Clinical Event|1
792507|NCT00725205|2520699|P1|Overall Study|Other|8
792508|NCT00725205|2520699|P1|Overall Study|Non-compliance With Protocol|14
792509|NCT00725205|2520699|P1|Overall Study|Investigator Discontinued|1
792510|NCT00725205|2520699|P1|Overall Study|Adverse Event|22
792511|NCT00725296|2520716|P1|Overall Study|Not Specified|38
792512|NCT00725296|2520716|P1|Overall Study|Lost to Follow-up|1
792513|NCT00725296|2520716|P1|Overall Study|Non-Compliance|2
792514|NCT00725296|2520716|P1|Overall Study|Withdrawal by Subject|3
792515|NCT00725296|2520716|P1|Overall Study|Lack of Efficacy|7
792516|NCT00725296|2520716|P1|Overall Study|Adverse Event|11
792517|NCT00725452|2520733|P1|Overall Study|Lost to Follow-up|1
792518|NCT00725452|2520733|P1|Overall Study|Withdrawal by Subject|3
792519|NCT00725452|2520733|P1|Overall Study|Physician Decision|1
792520|NCT00725452|2520733|P1|Overall Study|Reason not specified|1
792521|NCT00725452|2520733|P1|Overall Study|Lack of Efficacy|2
792522|NCT00725452|2520733|P1|Overall Study|Adverse Event|3
792523|NCT00725491|2520744|P2|Overall Study|No/too few embryos/ bad quality embryos|2
792524|NCT00725491|2520745|P1|Overall Study|No/too few embryos/ bad quality embryos|3
792525|NCT00725491|2520744|P2|Overall Study|Fertilization failure|1
792526|NCT00725491|2520745|P1|Overall Study|Fertilization failure|0
792527|NCT00725491|2520744|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
792528|NCT00725491|2520745|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
792529|NCT00725491|2520744|P2|Overall Study|Risk for hyperstimulation|9
792530|NCT00725491|2520745|P1|Overall Study|Risk for hyperstimulation|2
792531|NCT00725491|2520744|P2|Overall Study|Pregnancy|3
792532|NCT00725491|2520745|P1|Overall Study|Pregnancy|0
792533|NCT00725491|2520744|P2|Overall Study|Adverse Event|2
792534|NCT00725491|2520745|P1|Overall Study|Adverse Event|3
792535|NCT00725543|2520765|P1|Overall Study|Not specified|119
792536|NCT00725543|2520765|P1|Overall Study|Non-compliance|2
792537|NCT00725543|2520765|P1|Overall Study|Lost to Follow-up|4
792538|NCT00725543|2520765|P1|Overall Study|Physician Decision|5
792539|NCT00725543|2520765|P1|Overall Study|Withdrawal by Subject|10
792540|NCT00725543|2520765|P1|Overall Study|Lack of Efficacy|3
792541|NCT00725543|2520765|P1|Overall Study|Adverse Event|10
792542|NCT00725608|2520774|P1|Overall Study|Other|7
792543|NCT00725608|2520774|P1|Overall Study|Individual reasons|86
792544|NCT00725608|2520774|P1|Overall Study|Adverse Event|14
792545|NCT00725608|2520774|P1|Overall Study|Lost to Follow-up|60
792546|NCT00725621|2520780|P1|Overall Study|Reason not specified|55
792547|NCT00725621|2520780|P1|Overall Study|Prepared for elective surgery|1
792548|NCT00725621|2520780|P1|Overall Study|Switched to other drug|1
792549|NCT00725621|2520780|P1|Overall Study|Switched to other study|1
792550|NCT00725621|2520780|P1|Overall Study|Continued treatment by other physician|6
792551|NCT00725621|2520780|P1|Overall Study|Non-compliance|8
792552|NCT00725621|2520780|P1|Overall Study|Lost to Follow-up|52
792553|NCT00725621|2520780|P1|Overall Study|Physician Decision|19
792554|NCT00725621|2520780|P1|Overall Study|Withdrawal by Subject|57
792555|NCT00725621|2520780|P1|Overall Study|Lack of Efficacy|46
792556|NCT00725621|2520780|P1|Overall Study|Adverse Event|25
792557|NCT00725712|2520805|P2|Overall Study|Hospitalized, unable to continue|1
792558|NCT00725712|2520806|P1|Overall Study|Hospitalized, unable to continue|0
792559|NCT00725712|2520805|P2|Overall Study|Other: Death|0
792560|NCT00725712|2520806|P1|Overall Study|Other: Death|1
792561|NCT00725712|2520805|P2|Overall Study|Death|0
792562|NCT00725712|2520806|P1|Overall Study|Death|2
792563|NCT00725712|2520805|P2|Overall Study|Adverse Event|5
792564|NCT00725712|2520806|P1|Overall Study|Adverse Event|5
792565|NCT00725712|2520805|P2|Overall Study|Clinical progression not based on RECIST|3
792566|NCT00725712|2520806|P1|Overall Study|Clinical progression not based on RECIST|0
792567|NCT00725712|2520805|P2|Overall Study|Progressive disease|16
792568|NCT00725712|2520806|P1|Overall Study|Progressive disease|37
792569|NCT00725712|2520805|P2|Overall Study|Protocol Violation|0
792570|NCT00725712|2520806|P1|Overall Study|Protocol Violation|1
792571|NCT00725712|2520805|P2|Overall Study|Withdrawal by Subject|1
792572|NCT00725712|2520806|P1|Overall Study|Withdrawal by Subject|2
792573|NCT00725725|2520845|P3|Overall Study|Protocol Violation|0
792574|NCT00725725|2520846|P2|Overall Study|Protocol Violation|1
792575|NCT00725725|2520847|P1|Overall Study|Protocol Violation|0
792576|NCT00725725|2520845|P3|Overall Study|Withdrawal by Subject|1
792577|NCT00725725|2520846|P2|Overall Study|Withdrawal by Subject|0
792578|NCT00725725|2520847|P1|Overall Study|Withdrawal by Subject|1
792579|NCT00725725|2520845|P3|Overall Study|Lost to Follow-up|2
792580|NCT00725725|2520846|P2|Overall Study|Lost to Follow-up|0
792581|NCT00725725|2520847|P1|Overall Study|Lost to Follow-up|2
792582|NCT00725725|2520845|P3|Overall Study|Adverse Event|2
792583|NCT00725725|2520846|P2|Overall Study|Adverse Event|3
792584|NCT00725725|2520847|P1|Overall Study|Adverse Event|1
792585|NCT00725842|2520900|P1|Overall Study|No Visit 1 data|1
792586|NCT00725842|2520900|P1|Overall Study|Inclusion criterion not met|1
792587|NCT00725842|2520900|P1|Overall Study|Consent date prior to study start date|5
792588|NCT00725842|2520900|P1|Overall Study|Positive HCV-RNA at Visit 2|13
792589|NCT00725842|2520900|P1|Overall Study|Death|1
792590|NCT00725842|2520900|P1|Overall Study|Lost to Follow-up|19
792591|NCT00725920|2520909|P2|Overall Study|Lack of Efficacy|6
792592|NCT00725920|2520910|P1|Overall Study|Lack of Efficacy|3
792593|NCT00725985|2520919|P12|LTFU (No Cladribine Treatment)|Unspecified|14
792594|NCT00725985|2520920|P11|LTFU (No Cladribine Treatment)|Unspecified|36
792595|NCT00725985|2520921|P10|LTFU (No Cladribine Treatment)|Unspecified|34
792596|NCT00725985|2520922|P9|LTFU (No Cladribine Treatment)|Unspecified|0
792597|NCT00725985|2520923|P8|LTFU (No Cladribine Treatment)|Unspecified|0
792598|NCT00725985|2520924|P7|LTFU (No Cladribine Treatment)|Unspecified|0
792599|NCT00725985|2520925|P6|LTFU (No Cladribine Treatment)|Unspecified|0
792600|NCT00725985|2520926|P5|LTFU (No Cladribine Treatment)|Unspecified|0
792601|NCT00725985|2520927|P4|LTFU (No Cladribine Treatment)|Unspecified|0
792602|NCT00725985|2520928|P3|LTFU (No Cladribine Treatment)|Unspecified|0
792603|NCT00725985|2520929|P2|LTFU (No Cladribine Treatment)|Unspecified|0
792604|NCT00725985|2520930|P1|LTFU (No Cladribine Treatment)|Unspecified|0
792605|NCT00725985|2520919|P12|LTFU (With Cladribine Treatment)|Unspecified|0
792606|NCT00725985|2520920|P11|LTFU (With Cladribine Treatment)|Unspecified|0
792607|NCT00725985|2520921|P10|LTFU (With Cladribine Treatment)|Unspecified|0
792608|NCT00725985|2520922|P9|LTFU (With Cladribine Treatment)|Unspecified|16
792609|NCT00725985|2520923|P8|LTFU (With Cladribine Treatment)|Unspecified|8
792610|NCT00725985|2520924|P7|LTFU (With Cladribine Treatment)|Unspecified|9
792611|NCT00725985|2520925|P6|LTFU (With Cladribine Treatment)|Unspecified|0
792612|NCT00725985|2520926|P5|LTFU (With Cladribine Treatment)|Unspecified|0
792613|NCT00725985|2520927|P4|LTFU (With Cladribine Treatment)|Unspecified|0
792614|NCT00725985|2520928|P3|LTFU (With Cladribine Treatment)|Unspecified|0
792615|NCT00725985|2520929|P2|LTFU (With Cladribine Treatment)|Unspecified|0
792616|NCT00725985|2520930|P1|LTFU (With Cladribine Treatment)|Unspecified|0
792617|NCT00725985|2520919|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792618|NCT00725985|2520920|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792619|NCT00725985|2520921|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792620|NCT00725985|2520922|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
792621|NCT00725985|2520923|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792622|NCT00725985|2520924|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792623|NCT00725985|2520925|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792624|NCT00725985|2520926|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792625|NCT00725985|2520927|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792626|NCT00725985|2520928|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792627|NCT00725985|2520929|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792628|NCT00725985|2520930|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
792629|NCT00725985|2520919|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
792630|NCT00725985|2520920|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
792631|NCT00725985|2520921|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
792632|NCT00725985|2520922|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
792633|NCT00725985|2520923|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
792634|NCT00725985|2520924|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
792635|NCT00725985|2520925|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
792636|NCT00725985|2520926|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
792637|NCT00725985|2520927|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
792638|NCT00725985|2520928|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
792639|NCT00725985|2520929|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
792640|NCT00725985|2520930|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
792641|NCT00725985|2520919|P12|OLMP|Unspecified|0
792642|NCT00725985|2520920|P11|OLMP|Unspecified|0
792643|NCT00725985|2520921|P10|OLMP|Unspecified|0
792644|NCT00725985|2520922|P9|OLMP|Unspecified|0
792645|NCT00725985|2520923|P8|OLMP|Unspecified|0
792646|NCT00725985|2520924|P7|OLMP|Unspecified|0
792647|NCT00725985|2520925|P6|OLMP|Unspecified|44
792648|NCT00725985|2520926|P5|OLMP|Unspecified|20
792649|NCT00725985|2520927|P4|OLMP|Unspecified|15
792650|NCT00725985|2520928|P3|OLMP|Unspecified|0
792651|NCT00725985|2520929|P2|OLMP|Unspecified|0
792652|NCT00725985|2520930|P1|OLMP|Unspecified|0
792653|NCT00725985|2520919|P12|OLMP|Disease progression|0
792654|NCT00725985|2520920|P11|OLMP|Disease progression|0
792655|NCT00725985|2520921|P10|OLMP|Disease progression|0
792656|NCT00725985|2520922|P9|OLMP|Disease progression|0
792657|NCT00725985|2520923|P8|OLMP|Disease progression|0
792658|NCT00725985|2520924|P7|OLMP|Disease progression|0
792659|NCT00725985|2520925|P6|OLMP|Disease progression|4
792660|NCT00725985|2520926|P5|OLMP|Disease progression|0
792661|NCT00725985|2520927|P4|OLMP|Disease progression|0
792662|NCT00725985|2520928|P3|OLMP|Disease progression|0
792663|NCT00725985|2520929|P2|OLMP|Disease progression|0
792664|NCT00725985|2520930|P1|OLMP|Disease progression|0
792665|NCT00725985|2520919|P12|OLMP|Lost to Follow-up|0
792666|NCT00725985|2520920|P11|OLMP|Lost to Follow-up|0
792667|NCT00725985|2520921|P10|OLMP|Lost to Follow-up|0
792668|NCT00725985|2520922|P9|OLMP|Lost to Follow-up|0
792669|NCT00725985|2520923|P8|OLMP|Lost to Follow-up|0
792670|NCT00725985|2520924|P7|OLMP|Lost to Follow-up|0
792671|NCT00725985|2520925|P6|OLMP|Lost to Follow-up|0
792672|NCT00725985|2520926|P5|OLMP|Lost to Follow-up|0
792673|NCT00725985|2520927|P4|OLMP|Lost to Follow-up|1
792674|NCT00725985|2520928|P3|OLMP|Lost to Follow-up|0
792675|NCT00725985|2520929|P2|OLMP|Lost to Follow-up|0
792676|NCT00725985|2520930|P1|OLMP|Lost to Follow-up|0
792677|NCT00725985|2520919|P12|OLMP|Death|0
792678|NCT00725985|2520920|P11|OLMP|Death|0
792679|NCT00725985|2520921|P10|OLMP|Death|0
792680|NCT00725985|2520922|P9|OLMP|Death|0
792681|NCT00725985|2520923|P8|OLMP|Death|0
792682|NCT00725985|2520924|P7|OLMP|Death|0
792683|NCT00725985|2520925|P6|OLMP|Death|0
792684|NCT00725985|2520926|P5|OLMP|Death|1
792685|NCT00725985|2520927|P4|OLMP|Death|0
792686|NCT00725985|2520928|P3|OLMP|Death|0
792687|NCT00725985|2520929|P2|OLMP|Death|0
792688|NCT00725985|2520930|P1|OLMP|Death|0
792689|NCT00725985|2520919|P12|OLMP|Adverse Event|0
792690|NCT00725985|2520920|P11|OLMP|Adverse Event|0
792691|NCT00725985|2520921|P10|OLMP|Adverse Event|0
792692|NCT00725985|2520922|P9|OLMP|Adverse Event|0
792693|NCT00725985|2520923|P8|OLMP|Adverse Event|0
792694|NCT00725985|2520924|P7|OLMP|Adverse Event|0
792695|NCT00725985|2520925|P6|OLMP|Adverse Event|5
792696|NCT00725985|2520926|P5|OLMP|Adverse Event|2
792697|NCT00725985|2520927|P4|OLMP|Adverse Event|2
792698|NCT00725985|2520928|P3|OLMP|Adverse Event|0
792699|NCT00725985|2520929|P2|OLMP|Adverse Event|0
792700|NCT00725985|2520930|P1|OLMP|Adverse Event|0
792701|NCT00725985|2520919|P12|ITP (Up to 96 Weeks)|Unspecified|0
792702|NCT00725985|2520920|P11|ITP (Up to 96 Weeks)|Unspecified|0
792703|NCT00725985|2520921|P10|ITP (Up to 96 Weeks)|Unspecified|0
792704|NCT00725985|2520922|P9|ITP (Up to 96 Weeks)|Unspecified|0
792705|NCT00725985|2520923|P8|ITP (Up to 96 Weeks)|Unspecified|0
792706|NCT00725985|2520924|P7|ITP (Up to 96 Weeks)|Unspecified|0
792707|NCT00725985|2520925|P6|ITP (Up to 96 Weeks)|Unspecified|0
792708|NCT00725985|2520926|P5|ITP (Up to 96 Weeks)|Unspecified|0
792709|NCT00725985|2520927|P4|ITP (Up to 96 Weeks)|Unspecified|0
792710|NCT00725985|2520928|P3|ITP (Up to 96 Weeks)|Unspecified|24
792711|NCT00725985|2520929|P2|ITP (Up to 96 Weeks)|Unspecified|38
792712|NCT00725985|2520930|P1|ITP (Up to 96 Weeks)|Unspecified|50
792713|NCT00725985|2520919|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
792714|NCT00725985|2520920|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
792715|NCT00725985|2520921|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
792716|NCT00725985|2520922|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
792717|NCT00725985|2520923|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
792718|NCT00725985|2520924|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
792719|NCT00725985|2520925|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
792720|NCT00725985|2520926|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
792721|NCT00725985|2520927|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
792722|NCT00725985|2520928|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
792723|NCT00725985|2520929|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
792724|NCT00725985|2520930|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
792725|NCT00725985|2520919|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
792726|NCT00725985|2520920|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
792727|NCT00725985|2520921|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
792728|NCT00725985|2520922|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
792729|NCT00725985|2520923|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
792730|NCT00725985|2520924|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
792731|NCT00725985|2520925|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
792732|NCT00725985|2520926|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
792733|NCT00725985|2520927|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
792734|NCT00725985|2520928|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
792735|NCT00725985|2520929|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
792736|NCT00725985|2520930|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
792737|NCT00725985|2520919|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792738|NCT00725985|2520920|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792739|NCT00725985|2520921|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792740|NCT00725985|2520922|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792741|NCT00725985|2520923|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792742|NCT00725985|2520924|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792743|NCT00725985|2520925|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792744|NCT00725985|2520926|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792745|NCT00725985|2520927|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792746|NCT00725985|2520928|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
792747|NCT00725985|2520929|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792748|NCT00725985|2520930|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
792749|NCT00725985|2520919|P12|ITP (Up to 96 Weeks)|Adverse Event|0
792750|NCT00725985|2520920|P11|ITP (Up to 96 Weeks)|Adverse Event|0
792751|NCT00725985|2520921|P10|ITP (Up to 96 Weeks)|Adverse Event|0
792752|NCT00725985|2520922|P9|ITP (Up to 96 Weeks)|Adverse Event|0
792753|NCT00725985|2520923|P8|ITP (Up to 96 Weeks)|Adverse Event|0
792754|NCT00725985|2520924|P7|ITP (Up to 96 Weeks)|Adverse Event|0
792755|NCT00725985|2520925|P6|ITP (Up to 96 Weeks)|Adverse Event|0
792756|NCT00725985|2520926|P5|ITP (Up to 96 Weeks)|Adverse Event|0
792757|NCT00725985|2520927|P4|ITP (Up to 96 Weeks)|Adverse Event|0
792758|NCT00725985|2520928|P3|ITP (Up to 96 Weeks)|Adverse Event|5
792759|NCT00725985|2520929|P2|ITP (Up to 96 Weeks)|Adverse Event|10
792760|NCT00725985|2520930|P1|ITP (Up to 96 Weeks)|Adverse Event|20
792761|NCT00726063|2520963|P2|Overall Study|Adverse Event|7
792762|NCT00726063|2520964|P1|Overall Study|Adverse Event|9
792763|NCT00726232|2520980|P6|Overall Study|No response|1
792764|NCT00726232|2520981|P5|Overall Study|No response|3
792765|NCT00726232|2520982|P4|Overall Study|No response|0
792766|NCT00726232|2520983|P3|Overall Study|No response|0
792767|NCT00726232|2520984|P2|Overall Study|No response|0
792768|NCT00726232|2520985|P1|Overall Study|No response|1
792769|NCT00726232|2520980|P6|Overall Study|Disease progression|0
792770|NCT00726232|2520981|P5|Overall Study|Disease progression|0
792771|NCT00726232|2520982|P4|Overall Study|Disease progression|0
792772|NCT00726232|2520983|P3|Overall Study|Disease progression|0
792773|NCT00726232|2520984|P2|Overall Study|Disease progression|0
792774|NCT00726232|2520985|P1|Overall Study|Disease progression|1
792775|NCT00726232|2520980|P6|Overall Study|Adverse Event|1
792776|NCT00726232|2520981|P5|Overall Study|Adverse Event|2
792777|NCT00726232|2520982|P4|Overall Study|Adverse Event|1
792778|NCT00726232|2520983|P3|Overall Study|Adverse Event|0
792779|NCT00726232|2520984|P2|Overall Study|Adverse Event|1
792780|NCT00726232|2520985|P1|Overall Study|Adverse Event|1
792781|NCT00726232|2520980|P6|Overall Study|Withdrawal by Subject|2
792782|NCT00726232|2520981|P5|Overall Study|Withdrawal by Subject|0
792783|NCT00726232|2520982|P4|Overall Study|Withdrawal by Subject|0
792784|NCT00726232|2520983|P3|Overall Study|Withdrawal by Subject|0
792785|NCT00726232|2520984|P2|Overall Study|Withdrawal by Subject|0
792786|NCT00726232|2520985|P1|Overall Study|Withdrawal by Subject|2
792787|NCT00726453|2521047|P2|38 mm Length Group|Death|3
792788|NCT00726453|2521048|P1|38 mm Length Group|Death|0
792789|NCT00726453|2521047|P2|Primary Enrollment Group|Withdrawal by Subject|0
792790|NCT00726453|2521048|P1|Primary Enrollment Group|Withdrawal by Subject|13
792791|NCT00726453|2521047|P2|Primary Enrollment Group|Death|0
792792|NCT00726453|2521048|P1|Primary Enrollment Group|Death|18
792793|NCT00726557|2521058|P1|Overall Study|Inclusion criteria not met|15
792794|NCT00726557|2521058|P1|Overall Study|Treatment less than 3 months|17
792795|NCT00726557|2521058|P1|Overall Study|No follow-up documentation available|55
792796|NCT00726557|2521058|P1|Overall Study|No end of treatment documentation|37
792797|NCT00726557|2521058|P1|Overall Study|Screening failure|4
792798|NCT00726609|2521063|P1|Overall Study|Other|3
792799|NCT00726609|2521063|P1|Overall Study|Missing|42
792800|NCT00726609|2521063|P1|Overall Study|Not specified|16
792801|NCT00726609|2521063|P1|Overall Study|Lack of Efficacy|25
792802|NCT00726609|2521063|P1|Overall Study|Withdrawal by Subject|2
792803|NCT00726609|2521063|P1|Overall Study|Adverse Event|10
792804|NCT00726622|2521069|P2|Overall Study|Metastasis|0
792805|NCT00726622|2521070|P1|Overall Study|Metastasis|2
792806|NCT00726622|2521069|P2|Overall Study|Physician Decision|1
792807|NCT00726622|2521070|P1|Overall Study|Physician Decision|0
792808|NCT00726622|2521069|P2|Overall Study|Withdrawal by Subject|2
792809|NCT00726622|2521070|P1|Overall Study|Withdrawal by Subject|16
792810|NCT00726661|2521090|P2|Overall Study|Not specified|35
792811|NCT00726661|2521091|P1|Overall Study|Not specified|47
792812|NCT00726661|2521090|P2|Overall Study|Physician Decision|13
792813|NCT00726661|2521091|P1|Overall Study|Physician Decision|25
792814|NCT00726661|2521090|P2|Overall Study|Death|159
792815|NCT00726661|2521091|P1|Overall Study|Death|475
792816|NCT00726661|2521090|P2|Overall Study|Trial terminated by sponsor|187
792817|NCT00726661|2521091|P1|Overall Study|Trial terminated by sponsor|214
792818|NCT00726661|2521090|P2|Overall Study|Withdrawal by Subject|13
792819|NCT00726661|2521091|P1|Overall Study|Withdrawal by Subject|17
792820|NCT00726661|2521090|P2|Overall Study|Lost to Follow-up|11
792821|NCT00726661|2521091|P1|Overall Study|Lost to Follow-up|36
792822|NCT00726752|2521152|P1|Overall Study|Lack of Efficacy|6
792823|NCT00726882|2521175|P1|Overall Study|Not Specified|10
792824|NCT00726882|2521175|P1|Overall Study|Lost to Follow-up|7
792825|NCT00726882|2521175|P1|Overall Study|Withdrawal by Subject|5
792826|NCT00726895|2521181|P2|Washout Period of 7 Days|Withdrawal by Subject|1
792827|NCT00726895|2521182|P1|Washout Period of 7 Days|Withdrawal by Subject|0
792828|NCT00726986|2521195|P1|Maintenance Phase|Lack of Efficacy|2
792829|NCT00726986|2521195|P1|Maintenance Phase|Adverse Event|1
792830|NCT00726986|2521195|P1|Induction Phase|Secondary Disease|2
792831|NCT00726986|2521195|P1|Induction Phase|Lack of Efficacy|5
792832|NCT00726986|2521195|P1|Induction Phase|Death|2
792833|NCT00726986|2521195|P1|Induction Phase|Withdrawal by Subject|2
792834|NCT00726986|2521195|P1|Induction Phase|Adverse Event|4
792835|NCT00726999|2521204|P2|Overall Study|Protocol Violation|0
792836|NCT00726999|2521205|P1|Overall Study|Protocol Violation|1
792837|NCT00726999|2521204|P2|Overall Study|Withdrawal by Subject|0
792838|NCT00726999|2521205|P1|Overall Study|Withdrawal by Subject|2
792839|NCT00726999|2521204|P2|Overall Study|Physician Decision|1
792840|NCT00726999|2521205|P1|Overall Study|Physician Decision|0
792841|NCT00727025|2521215|P1|Overall Study|Physician Decision|23
792842|NCT00727194|2521263|P3|Treatment Period 2|Lack of Efficacy|0
792843|NCT00727194|2521264|P2|Treatment Period 2|Lack of Efficacy|1
792844|NCT00727194|2521265|P1|Treatment Period 2|Lack of Efficacy|0
792845|NCT00727194|2521263|P3|Screening Period|History of thymoma|1
792846|NCT00727194|2521264|P2|Screening Period|History of thymoma|0
792847|NCT00727194|2521265|P1|Screening Period|History of thymoma|0
792848|NCT00727194|2521263|P3|Screening Period|Severe infections|2
792849|NCT00727194|2521264|P2|Screening Period|Severe infections|0
792850|NCT00727194|2521265|P1|Screening Period|Severe infections|0
792851|NCT00727194|2521263|P3|Screening Period|Not stable on concomitant MG therapy|2
792852|NCT00727194|2521264|P2|Screening Period|Not stable on concomitant MG therapy|0
792853|NCT00727194|2521265|P1|Screening Period|Not stable on concomitant MG therapy|0
792854|NCT00727194|2521263|P3|Screening Period|Lacked AChR antibodies|5
792855|NCT00727194|2521264|P2|Screening Period|Lacked AChR antibodies|0
792856|NCT00727194|2521265|P1|Screening Period|Lacked AChR antibodies|0
792857|NCT00727194|2521263|P3|Screening Period|Low QMG scores|6
792858|NCT00727194|2521264|P2|Screening Period|Low QMG scores|0
792859|NCT00727194|2521265|P1|Screening Period|Low QMG scores|0
792860|NCT00727246|2521312|P4|Overall Study|withdrawn|0
792861|NCT00727246|2521313|P3|Overall Study|withdrawn|1
792862|NCT00727246|2521314|P2|Overall Study|withdrawn|0
792863|NCT00727246|2521315|P1|Overall Study|withdrawn|0
792864|NCT00727246|2521312|P4|Overall Study|incidental finding|1
792865|NCT00727246|2521313|P3|Overall Study|incidental finding|0
792866|NCT00727246|2521314|P2|Overall Study|incidental finding|0
792867|NCT00727246|2521315|P1|Overall Study|incidental finding|0
792868|NCT00727246|2521312|P4|Overall Study|could not complete MRI|1
792869|NCT00727246|2521313|P3|Overall Study|could not complete MRI|0
792870|NCT00727246|2521314|P2|Overall Study|could not complete MRI|1
792871|NCT00727246|2521315|P1|Overall Study|could not complete MRI|0
792872|NCT00727259|2521329|P1|Overall Study|Not all questionnaires completed|1055
792873|NCT00733226|2521336|P2|Overall Study|moved to another place|0
792874|NCT00733226|2521337|P1|Overall Study|moved to another place|2
792875|NCT00733226|2521336|P2|Overall Study|Lost to Follow-up|0
792876|NCT00733226|2521337|P1|Overall Study|Lost to Follow-up|2
792877|NCT00733226|2521336|P2|Overall Study|Withdrawal by Subject|0
792878|NCT00733226|2521337|P1|Overall Study|Withdrawal by Subject|1
792879|NCT00733291|2521360|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
792880|NCT00733291|2521361|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
792881|NCT00733291|2521362|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
792882|NCT00733291|2521363|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
792883|NCT00733369|2521472|P2|Overall Study|Protocol Violation|4
792884|NCT00733369|2521473|P1|Overall Study|Protocol Violation|4
792885|NCT00733369|2521472|P2|Overall Study|Adverse Event|4
792886|NCT00733369|2521473|P1|Overall Study|Adverse Event|4
792887|NCT00733369|2521472|P2|Overall Study|Lost to Follow-up|1
792888|NCT00733369|2521473|P1|Overall Study|Lost to Follow-up|2
792889|NCT00733421|2521591|P2|Overall Study|Withdrawal by Subject|1
792890|NCT00733421|2521592|P1|Overall Study|Withdrawal by Subject|1
792891|NCT00733499|2521616|P2|24 Months Follow-up|Death|1
792892|NCT00733499|2521617|P1|24 Months Follow-up|Death|0
792893|NCT00733499|2521616|P2|12 Months Follow-up|Death|1
792894|NCT00733499|2521617|P1|12 Months Follow-up|Death|2
792895|NCT00733499|2521616|P2|6 Months Follow-up|Adverse Event|1
792896|NCT00733499|2521617|P1|6 Months Follow-up|Adverse Event|0
792897|NCT00733499|2521616|P2|6 Months Follow-up|Death|2
792898|NCT00733499|2521617|P1|6 Months Follow-up|Death|0
792899|NCT00733499|2521616|P2|3 Months Follow-up|Death|2
792900|NCT00733499|2521617|P1|3 Months Follow-up|Death|1
792901|NCT00733499|2521616|P2|Pre-operative|Protocol Violation|1
792902|NCT00733499|2521617|P1|Pre-operative|Protocol Violation|0
792903|NCT00733746|2521628|P1|Overall Study|Ineligible|5
792904|NCT00733824|2521641|P5|Phase I|Withdrawal by Subject|0
792905|NCT00733824|2521642|P4|Phase I|Withdrawal by Subject|0
792906|NCT00733824|2521643|P3|Phase I|Withdrawal by Subject|0
792907|NCT00733824|2521644|P2|Phase I|Withdrawal by Subject|0
792908|NCT00733824|2521645|P1|Phase I|Withdrawal by Subject|1
792909|NCT00733954|2521666|P2|Overall Study|Withdrawal by Subject|0
792910|NCT00733954|2521667|P1|Overall Study|Withdrawal by Subject|2
792911|NCT00733954|2521666|P2|Overall Study|Protocol Violation|0
792912|NCT00733954|2521667|P1|Overall Study|Protocol Violation|1
792913|NCT00733954|2521666|P2|Overall Study|Lost to Follow-up|2
792914|NCT00733954|2521667|P1|Overall Study|Lost to Follow-up|5
792915|NCT00734071|2521747|P2|Overall Study|Other|2
792916|NCT00734071|2521748|P1|Overall Study|Other|1
792917|NCT00734071|2521747|P2|Overall Study|Lost to Follow-up|8
792918|NCT00734071|2521748|P1|Overall Study|Lost to Follow-up|16
792919|NCT00734071|2521747|P2|Overall Study|Voluntary Withdrawal|7
792920|NCT00734071|2521748|P1|Overall Study|Voluntary Withdrawal|9
792921|NCT00734071|2521747|P2|Overall Study|Protocol Deviations|4
792922|NCT00734071|2521748|P1|Overall Study|Protocol Deviations|3
792923|NCT00734071|2521747|P2|Overall Study|Noncompliance|2
792924|NCT00734071|2521748|P1|Overall Study|Noncompliance|2
792925|NCT00734071|2521747|P2|Overall Study|Lack of Efficacy|1
792926|NCT00734071|2521748|P1|Overall Study|Lack of Efficacy|3
792927|NCT00734071|2521747|P2|Overall Study|Adverse Event|3
792928|NCT00734071|2521748|P1|Overall Study|Adverse Event|4
792929|NCT00734097|2521802|P1|Open Label|Protocol Violation|4
792930|NCT00734097|2521802|P1|Open Label|Withdrawal by Subject|5
792931|NCT00734097|2521802|P1|Open Label|Lost to Follow-up|7
792932|NCT00734097|2521802|P1|Screening|Unconfirmed pregnancy|1
792933|NCT00734097|2521802|P1|Screening|Lost to Follow-up|2
792934|NCT00734097|2521802|P1|Screening|Withdrawal by Subject|5
792935|NCT00734097|2521802|P1|Screening|Protocol Violation|12
792936|NCT00734149|2521817|P1|Overall Study|Withdrawal by Subject|1
792937|NCT00734162|2521828|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
792938|NCT00734162|2521829|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
792939|NCT00734162|2521830|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
792940|NCT00734162|2521831|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
792941|NCT00734162|2521828|P4|Open-Label Phase|Lost to Follow-up|1
792942|NCT00734162|2521829|P3|Open-Label Phase|Lost to Follow-up|0
792943|NCT00734162|2521830|P2|Open-Label Phase|Lost to Follow-up|2
792944|NCT00734162|2521831|P1|Open-Label Phase|Lost to Follow-up|1
792945|NCT00734162|2521828|P4|Open-Label Phase|Withdrew Consent|1
792946|NCT00734162|2521829|P3|Open-Label Phase|Withdrew Consent|1
792947|NCT00734162|2521830|P2|Open-Label Phase|Withdrew Consent|0
792948|NCT00734162|2521831|P1|Open-Label Phase|Withdrew Consent|1
792949|NCT00734162|2521828|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
792950|NCT00734162|2521829|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
792951|NCT00734162|2521830|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
792952|NCT00734162|2521831|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
792953|NCT00734162|2521828|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
792954|NCT00734162|2521829|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
792955|NCT00734162|2521830|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
792956|NCT00734162|2521831|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
792957|NCT00734162|2521828|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
792958|NCT00734162|2521829|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
792959|NCT00734162|2521830|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
792960|NCT00734162|2521831|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
792961|NCT00734214|2522057|P2|Overall Study|MD withdrawal|0
792962|NCT00734214|2522058|P1|Overall Study|MD withdrawal|1
792963|NCT00734214|2522057|P2|Overall Study|Withdrawal by Subject|4
792964|NCT00734214|2522058|P1|Overall Study|Withdrawal by Subject|3
792965|NCT00734474|2522194|P9|Overall Study|Lack of Efficacy|6
792966|NCT00734474|2522195|P8|Overall Study|Lack of Efficacy|4
792967|NCT00734474|2522196|P7|Overall Study|Lack of Efficacy|0
792968|NCT00734474|2522197|P6|Overall Study|Lack of Efficacy|0
792969|NCT00734474|2522198|P5|Overall Study|Lack of Efficacy|0
792970|NCT00734474|2522199|P4|Overall Study|Lack of Efficacy|0
792971|NCT00734474|2522200|P3|Overall Study|Lack of Efficacy|4
792972|NCT00734474|2522201|P2|Overall Study|Lack of Efficacy|0
792973|NCT00734474|2522202|P1|Overall Study|Lack of Efficacy|0
792974|NCT00734474|2522194|P9|Overall Study|Death|1
792975|NCT00734474|2522195|P8|Overall Study|Death|2
792976|NCT00734474|2522196|P7|Overall Study|Death|0
792977|NCT00734474|2522197|P6|Overall Study|Death|0
792978|NCT00734474|2522198|P5|Overall Study|Death|0
792979|NCT00734474|2522199|P4|Overall Study|Death|0
792980|NCT00734474|2522200|P3|Overall Study|Death|1
792981|NCT00734474|2522201|P2|Overall Study|Death|0
792982|NCT00734474|2522202|P1|Overall Study|Death|0
792983|NCT00734474|2522194|P9|Overall Study|Sponsor Decision|0
792984|NCT00734474|2522195|P8|Overall Study|Sponsor Decision|0
792985|NCT00734474|2522196|P7|Overall Study|Sponsor Decision|0
792986|NCT00734474|2522197|P6|Overall Study|Sponsor Decision|0
792987|NCT00734474|2522198|P5|Overall Study|Sponsor Decision|2
792988|NCT00734474|2522199|P4|Overall Study|Sponsor Decision|0
792989|NCT00734474|2522200|P3|Overall Study|Sponsor Decision|0
792990|NCT00734474|2522201|P2|Overall Study|Sponsor Decision|0
792991|NCT00734474|2522202|P1|Overall Study|Sponsor Decision|0
792992|NCT00734474|2522194|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
792993|NCT00734474|2522195|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
792994|NCT00734474|2522196|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
792995|NCT00734474|2522197|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
792996|NCT00734474|2522198|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
792997|NCT00734474|2522199|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
792998|NCT00734474|2522200|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
792999|NCT00734474|2522201|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
793000|NCT00734474|2522202|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
793001|NCT00734474|2522194|P9|Overall Study|Protocol Violation|1
793002|NCT00734474|2522195|P8|Overall Study|Protocol Violation|3
793003|NCT00734474|2522196|P7|Overall Study|Protocol Violation|0
793004|NCT00734474|2522197|P6|Overall Study|Protocol Violation|0
793005|NCT00734474|2522198|P5|Overall Study|Protocol Violation|3
793006|NCT00734474|2522199|P4|Overall Study|Protocol Violation|0
793007|NCT00734474|2522200|P3|Overall Study|Protocol Violation|4
793008|NCT00734474|2522201|P2|Overall Study|Protocol Violation|0
793009|NCT00734474|2522202|P1|Overall Study|Protocol Violation|0
793010|NCT00734474|2522194|P9|Overall Study|Adverse Event|39
793011|NCT00734474|2522195|P8|Overall Study|Adverse Event|65
793012|NCT00734474|2522196|P7|Overall Study|Adverse Event|1
793013|NCT00734474|2522197|P6|Overall Study|Adverse Event|0
793014|NCT00734474|2522198|P5|Overall Study|Adverse Event|64
793015|NCT00734474|2522199|P4|Overall Study|Adverse Event|1
793016|NCT00734474|2522200|P3|Overall Study|Adverse Event|63
793017|NCT00734474|2522201|P2|Overall Study|Adverse Event|4
793018|NCT00734474|2522202|P1|Overall Study|Adverse Event|4
793019|NCT00734474|2522194|P9|Overall Study|Physician Decision|9
793020|NCT00734474|2522195|P8|Overall Study|Physician Decision|9
793021|NCT00734474|2522196|P7|Overall Study|Physician Decision|0
793022|NCT00734474|2522197|P6|Overall Study|Physician Decision|0
793023|NCT00734474|2522198|P5|Overall Study|Physician Decision|11
793024|NCT00734474|2522199|P4|Overall Study|Physician Decision|1
793025|NCT00734474|2522200|P3|Overall Study|Physician Decision|4
793026|NCT00734474|2522201|P2|Overall Study|Physician Decision|0
793027|NCT00734474|2522202|P1|Overall Study|Physician Decision|0
793028|NCT00734474|2522194|P9|Overall Study|Withdrawal by Subject|21
793029|NCT00734474|2522195|P8|Overall Study|Withdrawal by Subject|36
793030|NCT00734474|2522196|P7|Overall Study|Withdrawal by Subject|0
793031|NCT00734474|2522197|P6|Overall Study|Withdrawal by Subject|2
793032|NCT00734474|2522198|P5|Overall Study|Withdrawal by Subject|24
793033|NCT00734474|2522199|P4|Overall Study|Withdrawal by Subject|0
793034|NCT00734474|2522200|P3|Overall Study|Withdrawal by Subject|18
793035|NCT00734474|2522201|P2|Overall Study|Withdrawal by Subject|1
793036|NCT00734474|2522202|P1|Overall Study|Withdrawal by Subject|2
793037|NCT00734474|2522194|P9|Overall Study|Lost to Follow-up|4
793038|NCT00734474|2522195|P8|Overall Study|Lost to Follow-up|9
793039|NCT00734474|2522196|P7|Overall Study|Lost to Follow-up|0
793040|NCT00734474|2522197|P6|Overall Study|Lost to Follow-up|1
793041|NCT00734474|2522198|P5|Overall Study|Lost to Follow-up|11
793042|NCT00734474|2522199|P4|Overall Study|Lost to Follow-up|0
793043|NCT00734474|2522200|P3|Overall Study|Lost to Follow-up|13
793044|NCT00734474|2522201|P2|Overall Study|Lost to Follow-up|0
793045|NCT00734474|2522202|P1|Overall Study|Lost to Follow-up|1
793046|NCT00734474|2522194|P9|Overall Study|Entry Criteria Not Met|1
793047|NCT00734474|2522195|P8|Overall Study|Entry Criteria Not Met|1
793048|NCT00734474|2522196|P7|Overall Study|Entry Criteria Not Met|0
793049|NCT00734474|2522197|P6|Overall Study|Entry Criteria Not Met|1
793050|NCT00734474|2522198|P5|Overall Study|Entry Criteria Not Met|3
793051|NCT00734474|2522199|P4|Overall Study|Entry Criteria Not Met|0
793052|NCT00734474|2522200|P3|Overall Study|Entry Criteria Not Met|5
793053|NCT00734474|2522201|P2|Overall Study|Entry Criteria Not Met|0
793054|NCT00734474|2522202|P1|Overall Study|Entry Criteria Not Met|0
892372|NCT01075984|2830148|P3|Follow-up Phase|Treatment failure|0
892373|NCT01075984|2830149|P2|Follow-up Phase|Treatment failure|0
892374|NCT01075984|2830150|P1|Follow-up Phase|Treatment failure|0
892375|NCT01075984|2830146|P5|Follow-up Phase|Progression of disease|2
892376|NCT01075984|2830147|P4|Follow-up Phase|Progression of disease|0
892377|NCT01075984|2830148|P3|Follow-up Phase|Progression of disease|0
892378|NCT01075984|2830149|P2|Follow-up Phase|Progression of disease|0
793063|NCT00734578|2522408|P3|Overall Study|Exclusion criteria|0
793064|NCT00734578|2522409|P2|Overall Study|Exclusion criteria|0
793065|NCT00734578|2522410|P1|Overall Study|Exclusion criteria|1
793066|NCT00734578|2522408|P3|Overall Study|Randomized in error|0
793067|NCT00734578|2522409|P2|Overall Study|Randomized in error|0
793068|NCT00734578|2522410|P1|Overall Study|Randomized in error|1
793069|NCT00734578|2522408|P3|Overall Study|Lack of Efficacy|5
793070|NCT00734578|2522409|P2|Overall Study|Lack of Efficacy|2
793071|NCT00734578|2522410|P1|Overall Study|Lack of Efficacy|3
793072|NCT00734578|2522408|P3|Overall Study|Lost to Follow-up|5
793073|NCT00734578|2522409|P2|Overall Study|Lost to Follow-up|3
793074|NCT00734578|2522410|P1|Overall Study|Lost to Follow-up|9
793075|NCT00734578|2522408|P3|Overall Study|Withdrawal by Subject|11
793076|NCT00734578|2522409|P2|Overall Study|Withdrawal by Subject|8
793077|NCT00734578|2522410|P1|Overall Study|Withdrawal by Subject|7
793078|NCT00734578|2522408|P3|Overall Study|Protocol Violation|3
793079|NCT00734578|2522409|P2|Overall Study|Protocol Violation|6
793080|NCT00734578|2522410|P1|Overall Study|Protocol Violation|8
793081|NCT00734578|2522408|P3|Overall Study|Adverse Event|1
793082|NCT00734578|2522409|P2|Overall Study|Adverse Event|6
793083|NCT00734578|2522410|P1|Overall Study|Adverse Event|4
793084|NCT00734591|2522444|P2|Prospective Period|Unspecified|2
793085|NCT00734591|2522445|P1|Prospective Period|Unspecified|2
793086|NCT00734591|2522444|P2|Prospective Period|Study Terminated|0
793087|NCT00734591|2522445|P1|Prospective Period|Study Terminated|1
793088|NCT00734591|2522444|P2|Prospective Period|Lost to Follow-up|33
793089|NCT00734591|2522445|P1|Prospective Period|Lost to Follow-up|37
793090|NCT00734591|2522444|P2|Prospective Period|Withdrawal by Subject|9
793091|NCT00734591|2522445|P1|Prospective Period|Withdrawal by Subject|11
793092|NCT00734591|2522444|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
793093|NCT00734591|2522445|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
793094|NCT00734591|2522444|P2|Screening for Prospective Period|Site did not participate|1488
793095|NCT00734591|2522445|P1|Screening for Prospective Period|Site did not participate|1604
793096|NCT00734604|2522463|P6|Overall Study|Lack of Efficacy|0
793097|NCT00734604|2522464|P5|Overall Study|Lack of Efficacy|0
793098|NCT00734604|2522465|P4|Overall Study|Lack of Efficacy|0
793099|NCT00734604|2522466|P3|Overall Study|Lack of Efficacy|1
793100|NCT00734604|2522467|P2|Overall Study|Lack of Efficacy|1
793101|NCT00734604|2522468|P1|Overall Study|Lack of Efficacy|0
793102|NCT00734604|2522463|P6|Overall Study|Withdrawal by Subject|1
793103|NCT00734604|2522464|P5|Overall Study|Withdrawal by Subject|2
793104|NCT00734604|2522465|P4|Overall Study|Withdrawal by Subject|1
793105|NCT00734604|2522466|P3|Overall Study|Withdrawal by Subject|0
793106|NCT00734604|2522467|P2|Overall Study|Withdrawal by Subject|2
793107|NCT00734604|2522468|P1|Overall Study|Withdrawal by Subject|0
793108|NCT00734604|2522463|P6|Overall Study|Sponsor Decision|0
793109|NCT00734604|2522464|P5|Overall Study|Sponsor Decision|2
793110|NCT00734604|2522465|P4|Overall Study|Sponsor Decision|0
793111|NCT00734604|2522466|P3|Overall Study|Sponsor Decision|1
793112|NCT00734604|2522467|P2|Overall Study|Sponsor Decision|2
793113|NCT00734604|2522468|P1|Overall Study|Sponsor Decision|1
793114|NCT00734604|2522463|P6|Overall Study|Protocol Violation|0
793115|NCT00734604|2522464|P5|Overall Study|Protocol Violation|1
793116|NCT00734604|2522465|P4|Overall Study|Protocol Violation|0
793117|NCT00734604|2522466|P3|Overall Study|Protocol Violation|0
793118|NCT00734604|2522467|P2|Overall Study|Protocol Violation|2
793119|NCT00734604|2522468|P1|Overall Study|Protocol Violation|0
793120|NCT00734604|2522463|P6|Overall Study|Physician Decision|0
793121|NCT00734604|2522464|P5|Overall Study|Physician Decision|0
793122|NCT00734604|2522465|P4|Overall Study|Physician Decision|0
793123|NCT00734604|2522466|P3|Overall Study|Physician Decision|1
793124|NCT00734604|2522467|P2|Overall Study|Physician Decision|1
793125|NCT00734604|2522468|P1|Overall Study|Physician Decision|0
793126|NCT00734604|2522463|P6|Overall Study|Lost to Follow-up|3
793127|NCT00734604|2522464|P5|Overall Study|Lost to Follow-up|2
793128|NCT00734604|2522465|P4|Overall Study|Lost to Follow-up|4
793129|NCT00734604|2522466|P3|Overall Study|Lost to Follow-up|2
793130|NCT00734604|2522467|P2|Overall Study|Lost to Follow-up|2
793131|NCT00734604|2522468|P1|Overall Study|Lost to Follow-up|1
793132|NCT00734604|2522463|P6|Overall Study|Serious Adverse Event|1
793133|NCT00734604|2522464|P5|Overall Study|Serious Adverse Event|0
793134|NCT00734604|2522465|P4|Overall Study|Serious Adverse Event|2
793135|NCT00734604|2522466|P3|Overall Study|Serious Adverse Event|1
793136|NCT00734604|2522467|P2|Overall Study|Serious Adverse Event|0
793137|NCT00734604|2522468|P1|Overall Study|Serious Adverse Event|1
793138|NCT00734604|2522463|P6|Overall Study|Adverse Event|1
793139|NCT00734604|2522464|P5|Overall Study|Adverse Event|1
793140|NCT00734604|2522465|P4|Overall Study|Adverse Event|2
793141|NCT00734604|2522466|P3|Overall Study|Adverse Event|0
793142|NCT00734604|2522467|P2|Overall Study|Adverse Event|2
793143|NCT00734604|2522468|P1|Overall Study|Adverse Event|0
793144|NCT00734617|2522518|P2|Overall Study|Withdrawal by Subject|95
793145|NCT00734617|2522519|P1|Overall Study|Withdrawal by Subject|103
793146|NCT00734617|2522518|P2|Overall Study|Adverse Event|7
793147|NCT00734617|2522519|P1|Overall Study|Adverse Event|4
793148|NCT00734630|2522527|P2|Overall Study|Poor Compliance|1
793149|NCT00734630|2522528|P1|Overall Study|Poor Compliance|1
793150|NCT00734630|2522527|P2|Overall Study|Tested Positive for Illegal Drug Use|1
793151|NCT00734630|2522528|P1|Overall Study|Tested Positive for Illegal Drug Use|1
793152|NCT00734630|2522527|P2|Overall Study|Randomized in Error|1
793153|NCT00734630|2522528|P1|Overall Study|Randomized in Error|0
793154|NCT00734630|2522527|P2|Overall Study|Adverse Event|6
793155|NCT00734630|2522528|P1|Overall Study|Adverse Event|3
793156|NCT00734630|2522527|P2|Overall Study|Inclusion/Exclusion criteria not met|1
793157|NCT00734630|2522528|P1|Overall Study|Inclusion/Exclusion criteria not met|0
793158|NCT00734630|2522527|P2|Overall Study|Protocol Violation|3
793159|NCT00734630|2522528|P1|Overall Study|Protocol Violation|0
793160|NCT00734630|2522527|P2|Overall Study|Lost to Follow-up|7
793161|NCT00734630|2522528|P1|Overall Study|Lost to Follow-up|13
793162|NCT00734630|2522527|P2|Overall Study|Withdrawal by Subject|9
793163|NCT00734630|2522528|P1|Overall Study|Withdrawal by Subject|7
793164|NCT00734630|2522527|P2|Overall Study|Lack of Efficacy|4
793165|NCT00734630|2522528|P1|Overall Study|Lack of Efficacy|4
793166|NCT00734656|2522536|P4|Lab Session 4|Withdrawal by Subject|1
793167|NCT00734656|2522537|P3|Lab Session 4|Withdrawal by Subject|0
793168|NCT00734656|2522538|P2|Lab Session 4|Withdrawal by Subject|0
793169|NCT00734656|2522539|P1|Lab Session 4|Withdrawal by Subject|0
793170|NCT00734656|2522536|P4|Washout 3|Withdrawal by Subject|1
793171|NCT00734656|2522537|P3|Washout 3|Withdrawal by Subject|0
793172|NCT00734656|2522538|P2|Washout 3|Withdrawal by Subject|0
793173|NCT00734656|2522539|P1|Washout 3|Withdrawal by Subject|1
793174|NCT00734656|2522536|P4|Washout 2|Withdrawal by Subject|0
793175|NCT00734656|2522537|P3|Washout 2|Withdrawal by Subject|1
793176|NCT00734656|2522538|P2|Washout 2|Withdrawal by Subject|1
793177|NCT00734656|2522539|P1|Washout 2|Withdrawal by Subject|1
793178|NCT00734656|2522536|P4|Lab Session 2|Withdrawal by Subject|1
793179|NCT00734656|2522537|P3|Lab Session 2|Withdrawal by Subject|0
793180|NCT00734656|2522538|P2|Lab Session 2|Withdrawal by Subject|0
793181|NCT00734656|2522539|P1|Lab Session 2|Withdrawal by Subject|1
793182|NCT00734656|2522536|P4|Washout 1|Withdrawal by Subject|3
793183|NCT00734656|2522537|P3|Washout 1|Withdrawal by Subject|2
793184|NCT00734656|2522538|P2|Washout 1|Withdrawal by Subject|5
793185|NCT00734656|2522539|P1|Washout 1|Withdrawal by Subject|1
793186|NCT00734656|2522536|P4|Lab Session 1|Withdrawal by Subject|0
793187|NCT00734656|2522537|P3|Lab Session 1|Withdrawal by Subject|0
793188|NCT00734656|2522538|P2|Lab Session 1|Withdrawal by Subject|0
793189|NCT00734656|2522539|P1|Lab Session 1|Withdrawal by Subject|2
793190|NCT00734747|2522568|P1|6 Month Follow-up|Did not meet inclusion criteria|3
793191|NCT00734747|2522568|P1|SRS Procedure|No staples placed|3
793192|NCT00734851|2522586|P1|Overall Study|Physician Decision|18
793193|NCT00734851|2522586|P1|Overall Study|Lost to Follow-up|1
793194|NCT00734851|2522586|P1|Overall Study|Withdrawal by Subject|2
793195|NCT00734929|2522598|P2|Overall Study|No intervention/ screen fail|3
793196|NCT00734929|2522599|P1|Overall Study|No intervention/ screen fail|5
793197|NCT00734929|2522598|P2|Overall Study|Lost to Follow-up|2
793198|NCT00734929|2522599|P1|Overall Study|Lost to Follow-up|1
793199|NCT00734994|2522640|P1|Overall Study|Withdrawal by Subject|1
793200|NCT00735007|2522645|P1|Overall Study|Protocol Violation|1
793201|NCT00735007|2522645|P1|Overall Study|Adverse Event|4
793202|NCT00735072|2522672|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
793203|NCT00735072|2522673|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
793204|NCT00735072|2522672|P2|Overall Study|interrupted study med during ARV change|0
793205|NCT00735072|2522673|P1|Overall Study|interrupted study med during ARV change|1
793206|NCT00735371|2522689|P4|Overall Study|Exclusion criteria|0
793207|NCT00735371|2522690|P3|Overall Study|Exclusion criteria|0
793208|NCT00735371|2522691|P2|Overall Study|Exclusion criteria|0
793209|NCT00735371|2522692|P1|Overall Study|Exclusion criteria|1
793210|NCT00735371|2522689|P4|Overall Study|Prior Vyvanse Exposure|0
793211|NCT00735371|2522690|P3|Overall Study|Prior Vyvanse Exposure|0
793212|NCT00735371|2522691|P2|Overall Study|Prior Vyvanse Exposure|1
793213|NCT00735371|2522692|P1|Overall Study|Prior Vyvanse Exposure|1
793214|NCT00735371|2522689|P4|Overall Study|Protocol Violation|0
793215|NCT00735371|2522690|P3|Overall Study|Protocol Violation|2
793216|NCT00735371|2522691|P2|Overall Study|Protocol Violation|1
793217|NCT00735371|2522692|P1|Overall Study|Protocol Violation|0
793218|NCT00735371|2522689|P4|Overall Study|Sponsor Decision|1
793219|NCT00735371|2522690|P3|Overall Study|Sponsor Decision|0
793220|NCT00735371|2522691|P2|Overall Study|Sponsor Decision|1
793221|NCT00735371|2522692|P1|Overall Study|Sponsor Decision|3
793222|NCT00735371|2522689|P4|Overall Study|Lack of Efficacy|4
793223|NCT00735371|2522690|P3|Overall Study|Lack of Efficacy|0
793224|NCT00735371|2522691|P2|Overall Study|Lack of Efficacy|2
793225|NCT00735371|2522692|P1|Overall Study|Lack of Efficacy|4
793226|NCT00735371|2522689|P4|Overall Study|Lost to Follow-up|1
793227|NCT00735371|2522690|P3|Overall Study|Lost to Follow-up|3
793228|NCT00735371|2522691|P2|Overall Study|Lost to Follow-up|1
793229|NCT00735371|2522692|P1|Overall Study|Lost to Follow-up|1
793230|NCT00735371|2522689|P4|Overall Study|Withdrawal by Subject|0
793231|NCT00735371|2522690|P3|Overall Study|Withdrawal by Subject|2
793232|NCT00735371|2522691|P2|Overall Study|Withdrawal by Subject|2
793233|NCT00735371|2522692|P1|Overall Study|Withdrawal by Subject|0
793234|NCT00735371|2522689|P4|Overall Study|Protocol Violation|3
793235|NCT00735371|2522690|P3|Overall Study|Protocol Violation|0
793236|NCT00735371|2522691|P2|Overall Study|Protocol Violation|2
793237|NCT00735371|2522692|P1|Overall Study|Protocol Violation|2
793238|NCT00735371|2522689|P4|Overall Study|Adverse Event|1
793239|NCT00735371|2522690|P3|Overall Study|Adverse Event|4
793240|NCT00735371|2522691|P2|Overall Study|Adverse Event|3
793241|NCT00735371|2522692|P1|Overall Study|Adverse Event|3
793242|NCT00735397|2522710|P1|Overall Study|Administrative/Other|502
793243|NCT00735397|2522710|P1|Overall Study|Inadequate therapeutic effect|202
793244|NCT00735397|2522710|P1|Overall Study|Participant choice|252
793245|NCT00735397|2522710|P1|Overall Study|Lost to Follow-up|33
793246|NCT00735397|2522710|P1|Overall Study|Adverse Event|194
793257|NCT00735553|2522786|P1|Overall Study|Study prematurely terminated|77
793258|NCT00735644|2522803|P5|Overall Study|Withdrawal by Subject|0
793259|NCT00735644|2522804|P4|Overall Study|Withdrawal by Subject|1
793260|NCT00735644|2522805|P3|Overall Study|Withdrawal by Subject|1
793261|NCT00735644|2522806|P2|Overall Study|Withdrawal by Subject|1
793262|NCT00735644|2522807|P1|Overall Study|Withdrawal by Subject|0
793263|NCT00735644|2522803|P5|Overall Study|Did not receive study vaccine|0
793264|NCT00735644|2522804|P4|Overall Study|Did not receive study vaccine|0
793265|NCT00735644|2522805|P3|Overall Study|Did not receive study vaccine|0
793266|NCT00735644|2522806|P2|Overall Study|Did not receive study vaccine|1
793267|NCT00735644|2522807|P1|Overall Study|Did not receive study vaccine|0
793268|NCT00735696|2522855|P1|Overall Study|Enrolled but never Treated|1
793269|NCT00735696|2522855|P1|Overall Study|Withdrawal by Subject|1
793270|NCT00735709|2522871|P4|Overall Study|Excluded medication|1
793271|NCT00735709|2522872|P3|Overall Study|Excluded medication|0
793272|NCT00735709|2522873|P2|Overall Study|Excluded medication|0
793273|NCT00735709|2522874|P1|Overall Study|Excluded medication|1
793274|NCT00735709|2522871|P4|Overall Study|Lost to Follow-up|1
793275|NCT00735709|2522872|P3|Overall Study|Lost to Follow-up|1
793276|NCT00735709|2522873|P2|Overall Study|Lost to Follow-up|1
793277|NCT00735709|2522874|P1|Overall Study|Lost to Follow-up|0
793278|NCT00735709|2522871|P4|Overall Study|Voluntary Withdrawal|7
793279|NCT00735709|2522872|P3|Overall Study|Voluntary Withdrawal|5
793280|NCT00735709|2522873|P2|Overall Study|Voluntary Withdrawal|3
793281|NCT00735709|2522874|P1|Overall Study|Voluntary Withdrawal|1
793282|NCT00735709|2522871|P4|Overall Study|Protocol deviations|1
793283|NCT00735709|2522872|P3|Overall Study|Protocol deviations|1
793284|NCT00735709|2522873|P2|Overall Study|Protocol deviations|2
793285|NCT00735709|2522874|P1|Overall Study|Protocol deviations|1
793286|NCT00735709|2522871|P4|Overall Study|Noncompliance|0
793287|NCT00735709|2522872|P3|Overall Study|Noncompliance|1
793288|NCT00735709|2522873|P2|Overall Study|Noncompliance|0
793289|NCT00735709|2522874|P1|Overall Study|Noncompliance|0
793290|NCT00735709|2522871|P4|Overall Study|Lack of Efficacy|3
793291|NCT00735709|2522872|P3|Overall Study|Lack of Efficacy|2
793292|NCT00735709|2522873|P2|Overall Study|Lack of Efficacy|4
793293|NCT00735709|2522874|P1|Overall Study|Lack of Efficacy|8
793294|NCT00735709|2522871|P4|Overall Study|Adverse Event|5
793295|NCT00735709|2522872|P3|Overall Study|Adverse Event|1
793296|NCT00735709|2522873|P2|Overall Study|Adverse Event|3
793297|NCT00735709|2522874|P1|Overall Study|Adverse Event|2
793298|NCT00735904|2523042|P1|Overall Study|Unspecified|8
793299|NCT00735904|2523042|P1|Overall Study|Study Terminated by Sponsor|5
793300|NCT00735904|2523042|P1|Overall Study|Withdrawal by Subject|1
793301|NCT00735904|2523042|P1|Overall Study|Protocol Violation|1
793302|NCT00735904|2523042|P1|Overall Study|Death|20
793303|NCT00735904|2523042|P1|Overall Study|Adverse Event|3
793304|NCT00735943|2523057|P1|Overall Study|Adverse Event|1
793305|NCT00735943|2523057|P1|Overall Study|Lost to Follow-up|1
793306|NCT00736034|2523078|P1|Overall Study|Adverse Event|2
793307|NCT00736099|2523097|P2|Overall Study|Other reason|10
793308|NCT00736099|2523098|P1|Overall Study|Other reason|43
793309|NCT00736099|2523097|P2|Overall Study|Lack of Efficacy|8
793310|NCT00736099|2523098|P1|Overall Study|Lack of Efficacy|15
793311|NCT00736099|2523097|P2|Overall Study|Withdrawal by Subject|13
793312|NCT00736099|2523098|P1|Overall Study|Withdrawal by Subject|42
793313|NCT00736099|2523097|P2|Overall Study|Lost to Follow-up|5
793314|NCT00736099|2523098|P1|Overall Study|Lost to Follow-up|12
793315|NCT00736099|2523097|P2|Overall Study|Protocol Violation|4
793316|NCT00736099|2523098|P1|Overall Study|Protocol Violation|10
793317|NCT00736099|2523097|P2|Overall Study|Adverse Event|18
793318|NCT00736099|2523098|P1|Overall Study|Adverse Event|61
793319|NCT00724698|2523241|P1|Overall Study|No Info|25
793320|NCT00724698|2523241|P1|Overall Study|Lost to Follow-up|36
793321|NCT00724698|2523241|P1|Overall Study|Poor Compliance|16
793322|NCT00724698|2523241|P1|Overall Study|Failure of Therapy|4
793323|NCT00724698|2523241|P1|Overall Study|Adverse Event|9
793324|NCT00724711|2523246|P2|Overall Study|Protocol Violation|0
793325|NCT00724711|2523247|P1|Overall Study|Protocol Violation|1
793326|NCT00724711|2523246|P2|Overall Study|Lost to Follow-up|5
793327|NCT00724711|2523247|P1|Overall Study|Lost to Follow-up|4
793328|NCT00724711|2523246|P2|Overall Study|Withdrawal by Subject|4
793329|NCT00724711|2523247|P1|Overall Study|Withdrawal by Subject|5
793330|NCT00724711|2523246|P2|Overall Study|Physician Decision|3
793331|NCT00724711|2523247|P1|Overall Study|Physician Decision|0
793332|NCT00724711|2523246|P2|Overall Study|Lack of Efficacy|1
793333|NCT00724711|2523247|P1|Overall Study|Lack of Efficacy|0
793334|NCT00724711|2523246|P2|Overall Study|Pregnancy|1
793335|NCT00724711|2523247|P1|Overall Study|Pregnancy|0
793336|NCT00724711|2523246|P2|Overall Study|Adverse Event|3
793337|NCT00724711|2523247|P1|Overall Study|Adverse Event|7
793338|NCT00730132|2523298|P1|Overall Study|Death|1
793339|NCT00730132|2523298|P1|Overall Study|Protocol Violation|154
793340|NCT00730236|2523314|P1|Overall Study|Non-compliance|1
793341|NCT00730236|2523314|P1|Overall Study|Withdrawal by Subject|1
793342|NCT00730236|2523314|P1|Overall Study|Adverse Event|4
793343|NCT00730275|2523333|P4|Overall Study|Withdrawal by Subject|1
793344|NCT00730275|2523334|P3|Overall Study|Withdrawal by Subject|0
793345|NCT00730275|2523335|P2|Overall Study|Withdrawal by Subject|0
793346|NCT00730275|2523336|P1|Overall Study|Withdrawal by Subject|0
793347|NCT00730327|2523364|P2|Overall Study|Subject withdrew (reason not specified)|7
793348|NCT00730327|2523365|P1|Overall Study|Subject withdrew (reason not specified)|2
793349|NCT00730327|2523364|P2|Overall Study|Withdrawal by Subject|13
793350|NCT00730327|2523365|P1|Overall Study|Withdrawal by Subject|3
793351|NCT00730327|2523364|P2|Overall Study|Adverse Event|1
793352|NCT00730327|2523365|P1|Overall Study|Adverse Event|8
793353|NCT00730327|2523364|P2|Overall Study|Lost to Follow-up|16
793354|NCT00730327|2523365|P1|Overall Study|Lost to Follow-up|14
793400|NCT00730691|2523480|P5|Overall Study|Other|2
793401|NCT00730691|2523481|P4|Overall Study|Other|2
793402|NCT00730691|2523482|P3|Overall Study|Other|1
793403|NCT00730691|2523483|P2|Overall Study|Other|1
793404|NCT00730691|2523484|P1|Overall Study|Other|1
793405|NCT00730691|2523480|P5|Overall Study|Lost to Follow-up|13
793406|NCT00730691|2523481|P4|Overall Study|Lost to Follow-up|15
793407|NCT00730691|2523482|P3|Overall Study|Lost to Follow-up|13
793408|NCT00730691|2523483|P2|Overall Study|Lost to Follow-up|8
793409|NCT00730691|2523484|P1|Overall Study|Lost to Follow-up|11
793410|NCT00730691|2523480|P5|Overall Study|Withdrawal of Consent|3
793411|NCT00730691|2523481|P4|Overall Study|Withdrawal of Consent|6
793412|NCT00730691|2523482|P3|Overall Study|Withdrawal of Consent|3
793413|NCT00730691|2523483|P2|Overall Study|Withdrawal of Consent|9
793414|NCT00730691|2523484|P1|Overall Study|Withdrawal of Consent|7
793415|NCT00730691|2523480|P5|Overall Study|Protocol Deviations|5
793416|NCT00730691|2523481|P4|Overall Study|Protocol Deviations|7
793417|NCT00730691|2523482|P3|Overall Study|Protocol Deviations|3
793418|NCT00730691|2523483|P2|Overall Study|Protocol Deviations|5
793419|NCT00730691|2523484|P1|Overall Study|Protocol Deviations|3
793420|NCT00730691|2523480|P5|Overall Study|Non-compliance with Study Drug|3
793421|NCT00730691|2523481|P4|Overall Study|Non-compliance with Study Drug|3
793422|NCT00730691|2523482|P3|Overall Study|Non-compliance with Study Drug|6
793423|NCT00730691|2523483|P2|Overall Study|Non-compliance with Study Drug|1
793424|NCT00730691|2523484|P1|Overall Study|Non-compliance with Study Drug|6
793425|NCT00730691|2523480|P5|Overall Study|Lack of Efficacy|1
793426|NCT00730691|2523481|P4|Overall Study|Lack of Efficacy|1
793427|NCT00730691|2523482|P3|Overall Study|Lack of Efficacy|2
793428|NCT00730691|2523483|P2|Overall Study|Lack of Efficacy|4
793429|NCT00730691|2523484|P1|Overall Study|Lack of Efficacy|4
793430|NCT00730691|2523480|P5|Overall Study|Adverse Event|23
793431|NCT00730691|2523481|P4|Overall Study|Adverse Event|11
793432|NCT00730691|2523482|P3|Overall Study|Adverse Event|11
793433|NCT00730691|2523483|P2|Overall Study|Adverse Event|8
793434|NCT00730691|2523484|P1|Overall Study|Adverse Event|4
793435|NCT00736190|2523571|P1|Overall Study|Adverse Event|1
793436|NCT00736190|2523571|P1|Overall Study|Withdrawal by Subject|1
793437|NCT00736190|2523571|P1|Overall Study|Pregnancy|1
793438|NCT00736255|2523615|P2|Overall Study|Non-compliance|1
793439|NCT00736255|2523616|P1|Overall Study|Non-compliance|1
793440|NCT00736255|2523615|P2|Overall Study|Physician Decision|0
793441|NCT00736255|2523616|P1|Overall Study|Physician Decision|1
793442|NCT00736255|2523615|P2|Overall Study|Adverse Event|0
793443|NCT00736255|2523616|P1|Overall Study|Adverse Event|1
793444|NCT00736333|2523626|P1|Overall Study|Not Specified|4
793445|NCT00736333|2523626|P1|Overall Study|Death|7
793446|NCT00736333|2523626|P1|Overall Study|Withdrawal by Subject|10
793447|NCT00736333|2523626|P1|Overall Study|Toxicity|6
793448|NCT00736333|2523626|P1|Overall Study|Tumor Progression|75
793449|NCT00736333|2523626|P1|Overall Study|Data Missing|2
793450|NCT00736333|2523626|P1|Overall Study|Did Not Receive Drug or Not Documented|7
793451|NCT00736385|2523637|P2|Overall Study|Adverse Event|1
793452|NCT00736385|2523638|P1|Overall Study|Adverse Event|0
793453|NCT00736385|2523637|P2|Overall Study|Withdrawal by Subject|2
793454|NCT00736385|2523638|P1|Overall Study|Withdrawal by Subject|2
793455|NCT00736476|2523652|P2|Overall Study|Adverse Event|0
793456|NCT00736476|2523653|P1|Overall Study|Adverse Event|1
793457|NCT00736489|2523673|P6|Period 1|Withdrawal by Subject|1
793458|NCT00736489|2523674|P5|Period 1|Withdrawal by Subject|0
793459|NCT00736489|2523675|P4|Period 1|Withdrawal by Subject|0
793460|NCT00736489|2523676|P3|Period 1|Withdrawal by Subject|0
793461|NCT00736489|2523677|P2|Period 1|Withdrawal by Subject|0
793462|NCT00736489|2523678|P1|Period 1|Withdrawal by Subject|0
793463|NCT00736489|2523673|P6|Period 1|Lost to Follow-up|0
793464|NCT00736489|2523674|P5|Period 1|Lost to Follow-up|0
793465|NCT00736489|2523675|P4|Period 1|Lost to Follow-up|0
793466|NCT00736489|2523676|P3|Period 1|Lost to Follow-up|0
793467|NCT00736489|2523677|P2|Period 1|Lost to Follow-up|0
793468|NCT00736489|2523678|P1|Period 1|Lost to Follow-up|1
793469|NCT00736502|2523830|P1|Overall Study|Lost to Follow-up|27
793470|NCT00736502|2523830|P1|Overall Study|Lack of Efficacy|16
793471|NCT00736502|2523830|P1|Overall Study|Adverse Event|22
793472|NCT00738062|2523865|P3|Open-Label Extension|Study Terminated|0
793473|NCT00738062|2523866|P2|Open-Label Extension|Study Terminated|0
793474|NCT00738062|2523867|P1|Open-Label Extension|Study Terminated|2
793475|NCT00738062|2523865|P3|Open-Label Extension|Protocol Violation|0
793476|NCT00738062|2523866|P2|Open-Label Extension|Protocol Violation|0
793477|NCT00738062|2523867|P1|Open-Label Extension|Protocol Violation|1
793478|NCT00738062|2523865|P3|Open-Label Extension|Withdrawal by Subject|0
793479|NCT00738062|2523866|P2|Open-Label Extension|Withdrawal by Subject|0
793480|NCT00738062|2523867|P1|Open-Label Extension|Withdrawal by Subject|6
793481|NCT00738062|2523865|P3|Open-Label Extension|Lack of Efficacy|0
793482|NCT00738062|2523866|P2|Open-Label Extension|Lack of Efficacy|0
793483|NCT00738062|2523867|P1|Open-Label Extension|Lack of Efficacy|2
793484|NCT00738062|2523865|P3|Open-Label Extension|Physician Decision|0
793485|NCT00738062|2523866|P2|Open-Label Extension|Physician Decision|0
793486|NCT00738062|2523867|P1|Open-Label Extension|Physician Decision|1
793487|NCT00738062|2523865|P3|Open-Label Extension|Adverse Event|0
793488|NCT00738062|2523866|P2|Open-Label Extension|Adverse Event|0
793489|NCT00738062|2523867|P1|Open-Label Extension|Adverse Event|5
793490|NCT00738062|2523865|P3|Open Label Treatment|Investigator Decision|0
793491|NCT00738062|2523866|P2|Open Label Treatment|Investigator Decision|0
793492|NCT00738062|2523867|P1|Open Label Treatment|Investigator Decision|1
793493|NCT00738062|2523865|P3|Open Label Treatment|Withdrawal by Subject|0
793494|NCT00738062|2523866|P2|Open Label Treatment|Withdrawal by Subject|0
793495|NCT00738062|2523867|P1|Open Label Treatment|Withdrawal by Subject|9
793496|NCT00738062|2523865|P3|Open Label Treatment|Protocol Violation|0
793497|NCT00738062|2523866|P2|Open Label Treatment|Protocol Violation|0
793498|NCT00738062|2523867|P1|Open Label Treatment|Protocol Violation|2
793499|NCT00738062|2523865|P3|Open Label Treatment|Adverse Event|0
793500|NCT00738062|2523866|P2|Open Label Treatment|Adverse Event|0
793501|NCT00738062|2523867|P1|Open Label Treatment|Adverse Event|11
793502|NCT00738062|2523865|P3|Open Label Treatment|Lack of Efficacy|0
793503|NCT00738062|2523866|P2|Open Label Treatment|Lack of Efficacy|0
793504|NCT00738062|2523867|P1|Open Label Treatment|Lack of Efficacy|5
793505|NCT00738283|2523892|P1|Overall Study|Discharge home prior to end of study|1
793506|NCT00738283|2523892|P1|Overall Study|Transfer to another facility|2
793507|NCT00738283|2523892|P1|Overall Study|Death|1
793508|NCT00738374|2523905|P4|Maintenance Treatment/Observation Phase|Not Specified|0
793509|NCT00738374|2523906|P3|Maintenance Treatment/Observation Phase|Not Specified|0
793510|NCT00738374|2523907|P2|Maintenance Treatment/Observation Phase|Not Specified|1
793511|NCT00738374|2523908|P1|Maintenance Treatment/Observation Phase|Not Specified|0
793512|NCT00738374|2523905|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
793513|NCT00738374|2523906|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
793514|NCT00738374|2523907|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
793515|NCT00738374|2523908|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
793516|NCT00738374|2523905|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
793517|NCT00738374|2523906|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
793518|NCT00738374|2523907|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
793519|NCT00738374|2523908|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
793520|NCT00738374|2523905|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
793521|NCT00738374|2523906|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
793522|NCT00738374|2523907|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
793523|NCT00738374|2523908|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
793524|NCT00738374|2523905|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
793525|NCT00738374|2523906|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
793526|NCT00738374|2523907|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
793527|NCT00738374|2523908|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
793528|NCT00738374|2523905|P4|Induction Treatment Phase|Withdrawal by Subject|0
793529|NCT00738374|2523906|P3|Induction Treatment Phase|Withdrawal by Subject|0
793530|NCT00738374|2523907|P2|Induction Treatment Phase|Withdrawal by Subject|0
793531|NCT00738374|2523908|P1|Induction Treatment Phase|Withdrawal by Subject|1
793532|NCT00738374|2523905|P4|Induction Treatment Phase|Non-compliance|0
793533|NCT00738374|2523906|P3|Induction Treatment Phase|Non-compliance|0
793534|NCT00738374|2523907|P2|Induction Treatment Phase|Non-compliance|0
793535|NCT00738374|2523908|P1|Induction Treatment Phase|Non-compliance|1
793536|NCT00738374|2523905|P4|Induction Treatment Phase|Protocol Violation|0
793537|NCT00738374|2523906|P3|Induction Treatment Phase|Protocol Violation|0
793538|NCT00738374|2523907|P2|Induction Treatment Phase|Protocol Violation|0
793539|NCT00738374|2523908|P1|Induction Treatment Phase|Protocol Violation|2
793540|NCT00738374|2523905|P4|Induction Treatment Phase|Physician Decision|0
793541|NCT00738374|2523906|P3|Induction Treatment Phase|Physician Decision|0
793542|NCT00738374|2523907|P2|Induction Treatment Phase|Physician Decision|0
793543|NCT00738374|2523908|P1|Induction Treatment Phase|Physician Decision|2
793544|NCT00738374|2523905|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
793545|NCT00738374|2523906|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
793546|NCT00738374|2523907|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
793547|NCT00738374|2523908|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
793548|NCT00738374|2523905|P4|Induction Treatment Phase|Adverse Event|0
793549|NCT00738374|2523906|P3|Induction Treatment Phase|Adverse Event|0
793550|NCT00738374|2523907|P2|Induction Treatment Phase|Adverse Event|0
793551|NCT00738374|2523908|P1|Induction Treatment Phase|Adverse Event|14
793552|NCT00738400|2523942|P2|Overall Study|Non-compliant with study medication|1
793553|NCT00738400|2523943|P1|Overall Study|Non-compliant with study medication|0
793554|NCT00738400|2523942|P2|Overall Study|Protocol Violation|0
793555|NCT00738400|2523943|P1|Overall Study|Protocol Violation|1
793556|NCT00738400|2523942|P2|Overall Study|Lost to Follow-up|3
793557|NCT00738400|2523943|P1|Overall Study|Lost to Follow-up|0
793558|NCT00738400|2523942|P2|Overall Study|Lack of Efficacy|1
793559|NCT00738400|2523943|P1|Overall Study|Lack of Efficacy|0
793560|NCT00738400|2523942|P2|Overall Study|Withdrawal by Subject|1
793561|NCT00738400|2523943|P1|Overall Study|Withdrawal by Subject|0
793562|NCT00738400|2523942|P2|Overall Study|Adverse Event|1
793563|NCT00738400|2523943|P1|Overall Study|Adverse Event|3
793564|NCT00738530|2523972|P2|Overall Study|Withdrawal by Subject|8
793565|NCT00738530|2523973|P1|Overall Study|Withdrawal by Subject|6
793566|NCT00738530|2523972|P2|Overall Study|Lost to Follow-up|6
793567|NCT00738530|2523973|P1|Overall Study|Lost to Follow-up|8
793568|NCT00738530|2523972|P2|Overall Study|Death|224
793569|NCT00738530|2523973|P1|Overall Study|Death|220
793570|NCT00738673|2524007|P2|Overall Study|Withdrawal by Subject|1
793571|NCT00738673|2524008|P1|Overall Study|Withdrawal by Subject|3
793572|NCT00738673|2524007|P2|Overall Study|Protocol Violation|2
793573|NCT00738673|2524008|P1|Overall Study|Protocol Violation|1
793574|NCT00738673|2524007|P2|Overall Study|Lack of Efficacy|8
793575|NCT00738673|2524008|P1|Overall Study|Lack of Efficacy|19
793576|NCT00738673|2524007|P2|Overall Study|Adverse Event|0
793577|NCT00738673|2524008|P1|Overall Study|Adverse Event|1
793578|NCT00738699|2524038|P2|Overall Study|Not specified|0
793579|NCT00738699|2524039|P1|Overall Study|Not specified|2
793580|NCT00738699|2524038|P2|Overall Study|Discontinuation of study by Sponsor|72
793581|NCT00738699|2524039|P1|Overall Study|Discontinuation of study by Sponsor|123
793582|NCT00738699|2524038|P2|Overall Study|Death|68
793583|NCT00738699|2524039|P1|Overall Study|Death|144
793584|NCT00738699|2524038|P2|Overall Study|Lost to Follow-up|0
793585|NCT00738699|2524039|P1|Overall Study|Lost to Follow-up|1
793586|NCT00738699|2524038|P2|Overall Study|Withdrawal by Subject|0
793587|NCT00738699|2524039|P1|Overall Study|Withdrawal by Subject|5
793588|NCT00738881|2524057|P2|Overall Study|Withdrawal by Subject|2
793589|NCT00738881|2524058|P1|Overall Study|Withdrawal by Subject|0
793590|NCT00739063|2524109|P1|Overall Study|Screen failures|8
793591|NCT00739102|2524113|P1|Overall Study|Withdrawal by Subject|10
793592|NCT00739102|2524113|P1|Overall Study|Death|5
793593|NCT00739297|2524129|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
793594|NCT00739297|2524130|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
793595|NCT00739297|2524131|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
793596|NCT00739297|2524132|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
793597|NCT00739297|2524133|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
793598|NCT00739297|2524134|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
793599|NCT00739297|2524135|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
793600|NCT00739297|2524129|P7|First Washout Period of 4-7 Days|Adverse Event|2
793601|NCT00739297|2524130|P6|First Washout Period of 4-7 Days|Adverse Event|0
793602|NCT00739297|2524131|P5|First Washout Period of 4-7 Days|Adverse Event|0
793603|NCT00739297|2524132|P4|First Washout Period of 4-7 Days|Adverse Event|2
793604|NCT00739297|2524133|P3|First Washout Period of 4-7 Days|Adverse Event|0
793605|NCT00739297|2524134|P2|First Washout Period of 4-7 Days|Adverse Event|0
793606|NCT00739297|2524135|P1|First Washout Period of 4-7 Days|Adverse Event|0
793607|NCT00739310|2524163|P1|Overall Study|Lost to Follow-up|2
793608|NCT00739310|2524163|P1|Overall Study|Withdrawal by Subject|1
793609|NCT00739310|2524163|P1|Overall Study|Poor adherance to prescribed therapy|4
793610|NCT00739596|2524198|P2|Overall Study|Protocol Deviation|1
793611|NCT00739596|2524199|P1|Overall Study|Protocol Deviation|1
793612|NCT00739596|2524198|P2|Overall Study|Lost to Follow-up|2
793613|NCT00739596|2524199|P1|Overall Study|Lost to Follow-up|0
793614|NCT00739596|2524198|P2|Overall Study|Patient Withdrew Consent|8
793615|NCT00739596|2524199|P1|Overall Study|Patient Withdrew Consent|8
793616|NCT00739596|2524198|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
793617|NCT00739596|2524199|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
793618|NCT00739596|2524198|P2|Overall Study|Adverse Event|6
793619|NCT00739596|2524199|P1|Overall Study|Adverse Event|12
793620|NCT00739648|2524215|P2|Overall Study|Do not know|6
793621|NCT00739648|2524216|P1|Overall Study|Do not know|4
793622|NCT00739648|2524215|P2|Overall Study|Death|0
793623|NCT00739648|2524216|P1|Overall Study|Death|2
793624|NCT00739648|2524215|P2|Overall Study|Lost to Follow-up|7
793625|NCT00739648|2524216|P1|Overall Study|Lost to Follow-up|4
793626|NCT00739648|2524215|P2|Overall Study|Withdrawal by Subject|25
793627|NCT00739648|2524216|P1|Overall Study|Withdrawal by Subject|13
793628|NCT00739648|2524215|P2|Overall Study|Adverse Event|15
793629|NCT00739648|2524216|P1|Overall Study|Adverse Event|3
793630|NCT00739661|2524230|P2|Overall Study|Reason for discontinuation not available|1
793631|NCT00739661|2524231|P1|Overall Study|Reason for discontinuation not available|1
793632|NCT00739661|2524230|P2|Overall Study|Disease progression, radiographic|37
793633|NCT00739661|2524231|P1|Overall Study|Disease progression, radiographic|33
793634|NCT00739661|2524230|P2|Overall Study|Patient decision to withdraw|4
793635|NCT00739661|2524231|P1|Overall Study|Patient decision to withdraw|9
793636|NCT00739661|2524230|P2|Overall Study|Physician decision to withdraw patient|0
793637|NCT00739661|2524231|P1|Overall Study|Physician decision to withdraw patient|1
793638|NCT00739661|2524230|P2|Overall Study|Adverse Event|0
793639|NCT00739661|2524231|P1|Overall Study|Adverse Event|2
793640|NCT00739674|2524243|P2|Overall Study|Erectile dysfunction|1
793641|NCT00739674|2524244|P1|Overall Study|Erectile dysfunction|0
793642|NCT00739674|2524243|P2|Overall Study|Home monitoring off meds|0
793643|NCT00739674|2524244|P1|Overall Study|Home monitoring off meds|1
793644|NCT00739674|2524243|P2|Overall Study|Unable to attend visit|1
793645|NCT00739674|2524244|P1|Overall Study|Unable to attend visit|3
793646|NCT00739674|2524243|P2|Overall Study|Non compliant|0
793647|NCT00739674|2524244|P1|Overall Study|Non compliant|4
793648|NCT00739674|2524243|P2|Overall Study|Patient moved|2
793649|NCT00739674|2524244|P1|Overall Study|Patient moved|3
793650|NCT00739674|2524243|P2|Overall Study|Clinic closed|4
793651|NCT00739674|2524244|P1|Overall Study|Clinic closed|6
793652|NCT00739674|2524243|P2|Overall Study|Reason missing|0
793653|NCT00739674|2524244|P1|Overall Study|Reason missing|2
793654|NCT00739674|2524243|P2|Overall Study|Withdrawal by Subject|9
793655|NCT00739674|2524244|P1|Overall Study|Withdrawal by Subject|9
793656|NCT00739674|2524243|P2|Overall Study|Protocol Violation|5
793657|NCT00739674|2524244|P1|Overall Study|Protocol Violation|5
793658|NCT00739674|2524243|P2|Overall Study|Lost to Follow-up|30
793659|NCT00739674|2524244|P1|Overall Study|Lost to Follow-up|52
793660|NCT00739674|2524243|P2|Overall Study|Lack of Efficacy|0
793661|NCT00739674|2524244|P1|Overall Study|Lack of Efficacy|1
793662|NCT00739674|2524243|P2|Overall Study|Death|0
793663|NCT00739674|2524244|P1|Overall Study|Death|1
793664|NCT00739674|2524243|P2|Overall Study|Adverse Event|13
793665|NCT00739674|2524244|P1|Overall Study|Adverse Event|22
793666|NCT00739674|2524243|P2|Overall Study|Dietician consultation >30 days|9
793667|NCT00739674|2524244|P1|Overall Study|Dietician consultation >30 days|1
793668|NCT00739674|2524243|P2|Overall Study|No follow-up data|18
793669|NCT00739674|2524244|P1|Overall Study|No follow-up data|33
793670|NCT00739674|2524243|P2|Overall Study|Site 212 removal|13
793671|NCT00739674|2524244|P1|Overall Study|Site 212 removal|19
793672|NCT00739674|2524243|P2|Overall Study|Screening failures|17
793673|NCT00739674|2524244|P1|Overall Study|Screening failures|19
793674|NCT00739882|2524288|P2|Open-label Period|Other|5
793675|NCT00739882|2524289|P1|Open-label Period|Other|9
793676|NCT00739882|2524288|P2|Open-label Period|Adverse Event|0
793677|NCT00739882|2524289|P1|Open-label Period|Adverse Event|1
793678|NCT00739882|2524288|P2|Double-blind Period|Not specified|8
793679|NCT00739882|2524289|P1|Double-blind Period|Not specified|16
793680|NCT00739882|2524288|P2|Double-blind Period|Lack of Efficacy|1
793681|NCT00739882|2524289|P1|Double-blind Period|Lack of Efficacy|1
793682|NCT00739882|2524288|P2|Double-blind Period|Protocol Violation|0
793683|NCT00739882|2524289|P1|Double-blind Period|Protocol Violation|1
793684|NCT00739882|2524288|P2|Double-blind Period|Adverse Event|2
793685|NCT00739882|2524289|P1|Double-blind Period|Adverse Event|1
793686|NCT00739908|2524309|P2|Overall Study|Relocation|1
793687|NCT00739908|2524310|P1|Overall Study|Relocation|0
793688|NCT00739908|2524309|P2|Overall Study|Lack of Efficacy|1
793689|NCT00739908|2524310|P1|Overall Study|Lack of Efficacy|0
793690|NCT00739908|2524309|P2|Overall Study|Non-Compliance With Study Medication|3
793691|NCT00739908|2524310|P1|Overall Study|Non-Compliance With Study Medication|0
793692|NCT00739908|2524309|P2|Overall Study|Non-Compliance With Study Procedures|3
793693|NCT00739908|2524310|P1|Overall Study|Non-Compliance With Study Procedures|2
793694|NCT00739908|2524309|P2|Overall Study|Lost to Follow-up|9
793695|NCT00739908|2524310|P1|Overall Study|Lost to Follow-up|14
793696|NCT00739908|2524309|P2|Overall Study|Withdrawal by Subject|2
793697|NCT00739908|2524310|P1|Overall Study|Withdrawal by Subject|4
793698|NCT00739908|2524309|P2|Overall Study|Adverse Event|6
793699|NCT00739908|2524310|P1|Overall Study|Adverse Event|5
793700|NCT00739934|2524328|P1|Voriconazole Oral|unspecified|3
793701|NCT00739934|2524328|P1|Voriconazole IV|Adverse Event|6
793702|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793703|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793704|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
793705|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793706|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793707|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793708|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793709|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
793710|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
793711|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
793712|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
793713|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
793714|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
793715|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
793716|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
793717|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
793718|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
793719|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
793720|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793721|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793722|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
793723|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793724|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793725|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793726|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793727|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793728|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
793729|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
793730|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
793731|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
793732|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
793733|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
793734|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
793735|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
793736|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
793737|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
793738|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
793739|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
793740|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
793741|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
793742|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
793743|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
793744|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
793745|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
793746|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
793747|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793748|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793749|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793750|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793751|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793752|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793753|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
793754|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793755|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
793756|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
793757|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
793758|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
793759|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
793760|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
793761|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
793762|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
793763|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
793764|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
793765|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793766|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793767|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793768|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793769|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793770|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793771|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
793772|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
793773|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
793774|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793775|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
793776|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793777|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793778|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
793779|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793780|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793781|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793782|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
793783|NCT00739973|2524357|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
793784|NCT00739973|2524358|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
793785|NCT00739973|2524359|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
793786|NCT00739973|2524360|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
793787|NCT00739973|2524361|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
793788|NCT00739973|2524362|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
793789|NCT00739973|2524363|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
793790|NCT00739973|2524364|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
793791|NCT00739973|2524365|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
793792|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793793|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793794|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793795|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793796|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793797|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793798|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793799|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
793800|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
793801|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793802|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793803|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793804|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793805|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793806|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793807|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793808|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
793809|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
793810|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793811|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793812|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793813|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793814|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793815|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793816|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793817|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
793818|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
793819|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793820|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793821|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793822|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793823|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793824|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793825|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793826|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
793827|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
793828|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793829|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793830|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793831|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793832|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793833|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793834|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793835|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
793836|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
793837|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793838|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793839|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793840|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793841|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793842|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793843|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793844|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
793845|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
793846|NCT00739973|2524357|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793847|NCT00739973|2524358|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793848|NCT00739973|2524359|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793849|NCT00739973|2524360|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793850|NCT00739973|2524361|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793851|NCT00739973|2524362|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793852|NCT00739973|2524363|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793853|NCT00739973|2524364|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
793854|NCT00739973|2524365|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
793855|NCT00740051|2524527|P2|Overall Study|Other reason (not specified)|1
793856|NCT00740051|2524528|P1|Overall Study|Other reason (not specified)|4
793857|NCT00740051|2524527|P2|Overall Study|Withdrawal by Subject|8
793858|NCT00740051|2524528|P1|Overall Study|Withdrawal by Subject|6
793859|NCT00740051|2524527|P2|Overall Study|Lost to Follow-up|8
793860|NCT00740051|2524528|P1|Overall Study|Lost to Follow-up|3
793861|NCT00740051|2524527|P2|Overall Study|Protocol Violation|6
793862|NCT00740051|2524528|P1|Overall Study|Protocol Violation|2
793863|NCT00740051|2524527|P2|Overall Study|Adverse Event|4
793864|NCT00740051|2524528|P1|Overall Study|Adverse Event|1
793865|NCT00740051|2524527|P2|Overall Study|Lack of Efficacy|5
793866|NCT00740051|2524528|P1|Overall Study|Lack of Efficacy|2
793868|NCT00740480|2524571|P1|Overall Study|Physician Decision|1
793869|NCT00740480|2524571|P1|Overall Study|Adverse Event|1
793870|NCT00740584|2524575|P1|Overall Study|Withdrawal by Subject|1
793871|NCT00740597|2524579|P1|Overall Study|insurance would not cover treatment|1
793872|NCT00740636|2524585|P2|Overall Study|Death|0
793873|NCT00740636|2524586|P1|Overall Study|Death|1
793874|NCT00740636|2524585|P2|Overall Study|Progressive Disease|0
793875|NCT00740636|2524586|P1|Overall Study|Progressive Disease|1
793876|NCT00740636|2524585|P2|Overall Study|Patient Not Treated|1
793877|NCT00740636|2524586|P1|Overall Study|Patient Not Treated|0
793878|NCT00740636|2524585|P2|Overall Study|Patient Ineligible|1
793879|NCT00740636|2524586|P1|Overall Study|Patient Ineligible|0
793880|NCT00740636|2524585|P2|Overall Study|Adverse Event|2
793881|NCT00740636|2524586|P1|Overall Study|Adverse Event|0
793882|NCT00740714|2524595|P3|Overall Study|Withdrawal by Subject|29
793883|NCT00740714|2524596|P2|Overall Study|Withdrawal by Subject|19
793884|NCT00740714|2524597|P1|Overall Study|Withdrawal by Subject|17
793885|NCT00740779|2524680|P3|Overall Study|Lost to Follow-up|5
793886|NCT00740779|2524681|P2|Overall Study|Lost to Follow-up|3
793887|NCT00740779|2524682|P1|Overall Study|Lost to Follow-up|2
793888|NCT00740779|2524680|P3|Overall Study|Withdrawal by Subject|2
793889|NCT00740779|2524681|P2|Overall Study|Withdrawal by Subject|4
793890|NCT00740779|2524682|P1|Overall Study|Withdrawal by Subject|2
793891|NCT00740779|2524680|P3|Overall Study|Lack of Efficacy|2
793892|NCT00740779|2524681|P2|Overall Study|Lack of Efficacy|0
793893|NCT00740779|2524682|P1|Overall Study|Lack of Efficacy|0
793894|NCT00740779|2524680|P3|Overall Study|Protocol Violation|1
793895|NCT00740779|2524681|P2|Overall Study|Protocol Violation|1
793896|NCT00740779|2524682|P1|Overall Study|Protocol Violation|1
793897|NCT00740779|2524680|P3|Overall Study|Adverse Event|3
793898|NCT00740779|2524681|P2|Overall Study|Adverse Event|6
793899|NCT00740779|2524682|P1|Overall Study|Adverse Event|4
793900|NCT00740792|2524694|P4|Overall Study|administrative|2
793901|NCT00740792|2524695|P3|Overall Study|administrative|8
793902|NCT00740792|2524696|P2|Overall Study|administrative|3
793903|NCT00740792|2524697|P1|Overall Study|administrative|3
793904|NCT00740792|2524694|P4|Overall Study|Withdrawal by Subject|0
793905|NCT00740792|2524695|P3|Overall Study|Withdrawal by Subject|0
793906|NCT00740792|2524696|P2|Overall Study|Withdrawal by Subject|1
793907|NCT00740792|2524697|P1|Overall Study|Withdrawal by Subject|1
793908|NCT00740792|2524694|P4|Overall Study|Protocol Violation|2
793909|NCT00740792|2524695|P3|Overall Study|Protocol Violation|0
793910|NCT00740792|2524696|P2|Overall Study|Protocol Violation|1
793911|NCT00740792|2524697|P1|Overall Study|Protocol Violation|0
793912|NCT00740792|2524694|P4|Overall Study|Lost to Follow-up|0
793913|NCT00740792|2524695|P3|Overall Study|Lost to Follow-up|0
793914|NCT00740792|2524696|P2|Overall Study|Lost to Follow-up|1
793915|NCT00740792|2524697|P1|Overall Study|Lost to Follow-up|2
793916|NCT00740792|2524694|P4|Overall Study|Lack of Efficacy|3
793917|NCT00740792|2524695|P3|Overall Study|Lack of Efficacy|0
793918|NCT00740792|2524696|P2|Overall Study|Lack of Efficacy|1
793919|NCT00740792|2524697|P1|Overall Study|Lack of Efficacy|1
793920|NCT00740792|2524694|P4|Overall Study|Adverse Event|3
793921|NCT00740792|2524695|P3|Overall Study|Adverse Event|1
793922|NCT00740792|2524696|P2|Overall Study|Adverse Event|1
793923|NCT00740792|2524697|P1|Overall Study|Adverse Event|3
793924|NCT00740857|2524740|P3|Overall Study|Withdrawal by Subject|0
793925|NCT00740857|2524741|P2|Overall Study|Withdrawal by Subject|0
793926|NCT00740857|2524742|P1|Overall Study|Withdrawal by Subject|1
892379|NCT01075984|2830150|P1|Follow-up Phase|Progression of disease|0
892380|NCT01075984|2830146|P5|Follow-up Phase|Withdrawal by Subject|10
793929|NCT00741013|2524786|P3|Overall Study|Discovered failed screen after enrolled|0
793930|NCT00741013|2524787|P2|Overall Study|Discovered failed screen after enrolled|2
793931|NCT00741013|2524788|P1|Overall Study|Discovered failed screen after enrolled|0
793932|NCT00741013|2524786|P3|Overall Study|Withdrawal by Subject|1
793933|NCT00741013|2524787|P2|Overall Study|Withdrawal by Subject|0
793934|NCT00741013|2524788|P1|Overall Study|Withdrawal by Subject|0
793935|NCT00741013|2524786|P3|Overall Study|Adverse Event|0
793936|NCT00741013|2524787|P2|Overall Study|Adverse Event|0
793937|NCT00741013|2524788|P1|Overall Study|Adverse Event|1
793938|NCT00741039|2524829|P2|Overall Study|Patient non-compliance|0
793939|NCT00741039|2524830|P1|Overall Study|Patient non-compliance|2
793940|NCT00741091|2524836|P1|Overall Study|Missed Visit|22
793941|NCT00741091|2524836|P1|Overall Study|Withdrawal by Subject|6
793942|NCT00741091|2524836|P1|Overall Study|Lost to Follow-up|16
793943|NCT00741091|2524836|P1|Overall Study|Death|13
793944|NCT00741286|2524887|P2|Overall Study|Primary Outcome|1
793945|NCT00741286|2524888|P1|Overall Study|Primary Outcome|1
793946|NCT00741286|2524887|P2|Overall Study|Protocol Violation|2
793947|NCT00741286|2524888|P1|Overall Study|Protocol Violation|3
793948|NCT00741286|2524887|P2|Overall Study|Adverse Event|6
793949|NCT00741286|2524888|P1|Overall Study|Adverse Event|1
793950|NCT00741286|2524887|P2|Overall Study|Lost to Follow-up|10
793951|NCT00741286|2524888|P1|Overall Study|Lost to Follow-up|15
793952|NCT00741338|2524898|P2|Overall Study|Adverse Event|1
793953|NCT00741338|2524899|P1|Overall Study|Adverse Event|0
793954|NCT00741598|2524939|P2|Overall Study|Withdrawal by Subject|2
793955|NCT00741598|2524940|P1|Overall Study|Withdrawal by Subject|3
793956|NCT00741598|2524939|P2|Overall Study|Pregnancy|0
793957|NCT00741598|2524940|P1|Overall Study|Pregnancy|1
793958|NCT00741598|2524939|P2|Overall Study|Physician Decision|1
793959|NCT00741598|2524940|P1|Overall Study|Physician Decision|1
793960|NCT00741598|2524939|P2|Overall Study|Lack of Efficacy|2
793961|NCT00741598|2524940|P1|Overall Study|Lack of Efficacy|1
793962|NCT00741598|2524939|P2|Overall Study|Lost to Follow-up|4
793963|NCT00741598|2524940|P1|Overall Study|Lost to Follow-up|3
793964|NCT00741611|2524957|P3|Overall Study|Withdrawal by Subject|2
793965|NCT00741611|2524958|P2|Overall Study|Withdrawal by Subject|2
793966|NCT00741611|2524959|P1|Overall Study|Withdrawal by Subject|0
793967|NCT00741611|2524957|P3|Overall Study|Death|1
793968|NCT00741611|2524958|P2|Overall Study|Death|0
793969|NCT00741611|2524959|P1|Overall Study|Death|0
793970|NCT00741819|2524976|P1|Overall Study|Disease progression|1
793971|NCT00741819|2524976|P1|Overall Study|Death|1
793972|NCT00741819|2524976|P1|Overall Study|Withdrawal by Subject|3
793973|NCT00741819|2524976|P1|Overall Study|Adverse Event|3
793974|NCT00741936|2524998|P2|Overall Study|Low compliance|0
793975|NCT00741936|2524999|P1|Overall Study|Low compliance|3
793976|NCT00741936|2524998|P2|Overall Study|Lack of Efficacy|2
793977|NCT00741936|2524999|P1|Overall Study|Lack of Efficacy|0
793978|NCT00741936|2524998|P2|Overall Study|Protocol Violation|0
793979|NCT00741936|2524999|P1|Overall Study|Protocol Violation|2
793980|NCT00741936|2524998|P2|Overall Study|Pregnancy|1
793981|NCT00741936|2524999|P1|Overall Study|Pregnancy|0
793982|NCT00741936|2524998|P2|Overall Study|Adverse Event|4
793983|NCT00741936|2524999|P1|Overall Study|Adverse Event|3
793984|NCT00741936|2524998|P2|Overall Study|Lost to Follow-up|1
793985|NCT00741936|2524999|P1|Overall Study|Lost to Follow-up|1
793986|NCT00741988|2525027|P2|Overall Study|Lack of Efficacy|0
793987|NCT00741988|2525028|P1|Overall Study|Lack of Efficacy|2
793988|NCT00741988|2525027|P2|Overall Study|Adverse Event|4
793989|NCT00741988|2525028|P1|Overall Study|Adverse Event|2
793990|NCT00742079|2525044|P2|Overall Study|Lost to Follow-up|1
793991|NCT00742079|2525045|P1|Overall Study|Lost to Follow-up|0
794006|NCT00742209|2525076|P5|Overall Study|Investigator Discretion|1
794007|NCT00742209|2525077|P4|Overall Study|Investigator Discretion|1
794008|NCT00742209|2525078|P3|Overall Study|Investigator Discretion|5
794009|NCT00742209|2525079|P2|Overall Study|Investigator Discretion|0
794010|NCT00742209|2525080|P1|Overall Study|Investigator Discretion|0
794011|NCT00742209|2525076|P5|Overall Study|Lack of Efficacy|1
794012|NCT00742209|2525077|P4|Overall Study|Lack of Efficacy|3
794013|NCT00742209|2525078|P3|Overall Study|Lack of Efficacy|1
794014|NCT00742209|2525079|P2|Overall Study|Lack of Efficacy|1
794015|NCT00742209|2525080|P1|Overall Study|Lack of Efficacy|6
794016|NCT00742209|2525076|P5|Overall Study|Lost to Follow-up|3
794017|NCT00742209|2525077|P4|Overall Study|Lost to Follow-up|5
794018|NCT00742209|2525078|P3|Overall Study|Lost to Follow-up|5
794019|NCT00742209|2525079|P2|Overall Study|Lost to Follow-up|4
794020|NCT00742209|2525080|P1|Overall Study|Lost to Follow-up|3
794021|NCT00742209|2525076|P5|Overall Study|Protocol Violation|3
794022|NCT00742209|2525077|P4|Overall Study|Protocol Violation|5
794023|NCT00742209|2525078|P3|Overall Study|Protocol Violation|4
794024|NCT00742209|2525079|P2|Overall Study|Protocol Violation|5
794025|NCT00742209|2525080|P1|Overall Study|Protocol Violation|6
794026|NCT00742209|2525076|P5|Overall Study|Participant Withdrew Consent|4
794027|NCT00742209|2525077|P4|Overall Study|Participant Withdrew Consent|7
794028|NCT00742209|2525078|P3|Overall Study|Participant Withdrew Consent|14
794029|NCT00742209|2525079|P2|Overall Study|Participant Withdrew Consent|4
794030|NCT00742209|2525080|P1|Overall Study|Participant Withdrew Consent|8
794031|NCT00742209|2525076|P5|Overall Study|Adverse Event|13
794032|NCT00742209|2525077|P4|Overall Study|Adverse Event|16
794033|NCT00742209|2525078|P3|Overall Study|Adverse Event|17
794034|NCT00742209|2525079|P2|Overall Study|Adverse Event|4
794035|NCT00742209|2525080|P1|Overall Study|Adverse Event|11
794036|NCT00742235|2525183|P2|Overall Study|Lost to Follow-up|31
794037|NCT00742235|2525184|P1|Overall Study|Lost to Follow-up|0
794038|NCT00742274|2525194|P2|Overall Study|Removed for medical reasons|1
794039|NCT00742274|2525195|P1|Overall Study|Removed for medical reasons|1
794040|NCT00742274|2525194|P2|Overall Study|Withdrawal by Subject|2
794041|NCT00742274|2525195|P1|Overall Study|Withdrawal by Subject|1
794042|NCT00742274|2525194|P2|Overall Study|Death|0
794043|NCT00742274|2525195|P1|Overall Study|Death|1
794044|NCT00742326|2525212|P2|Overall Study|Physician Decision|1
794045|NCT00742326|2525213|P1|Overall Study|Physician Decision|0
794046|NCT00742391|2525223|P2|Overall Study|Protocol Violation|0
794047|NCT00742391|2525224|P1|Overall Study|Protocol Violation|1
794048|NCT00742391|2525223|P2|Overall Study|Lost to Follow-up|0
794049|NCT00742391|2525224|P1|Overall Study|Lost to Follow-up|1
794050|NCT00742391|2525223|P2|Overall Study|Adverse Event|1
794051|NCT00742391|2525224|P1|Overall Study|Adverse Event|2
794052|NCT00742417|2525234|P2|Intensive Period|Adverse Event|0
794053|NCT00742417|2525235|P1|Intensive Period|Adverse Event|2
794054|NCT00742417|2525234|P2|Intensive Period|Withdrawal by Subject|1
794055|NCT00742417|2525235|P1|Intensive Period|Withdrawal by Subject|1
794056|NCT00742417|2525234|P2|Randomized|Physician Decision|0
794057|NCT00742417|2525235|P1|Randomized|Physician Decision|1
794058|NCT00742417|2525234|P2|Randomized|Withdrawal by Subject|0
794059|NCT00742417|2525235|P1|Randomized|Withdrawal by Subject|1
794060|NCT00742417|2525234|P2|Randomized|Withdrawal by legal representative|1
794061|NCT00742417|2525235|P1|Randomized|Withdrawal by legal representative|0
794062|NCT00742508|2525259|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
794063|NCT00742508|2525260|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
794064|NCT00742508|2525259|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
794065|NCT00742508|2525260|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
794066|NCT00742508|2525259|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
794067|NCT00742508|2525260|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
794068|NCT00742508|2525259|P2|8-Week Primary Evaluation Period|Protocol Violation|0
794069|NCT00742508|2525260|P1|8-Week Primary Evaluation Period|Protocol Violation|1
794070|NCT00742508|2525259|P2|8-Week Primary Evaluation Period|Adverse Event|4
794071|NCT00742508|2525260|P1|8-Week Primary Evaluation Period|Adverse Event|2
794072|NCT00742625|2525322|P1|Consolidation|Non protocol therapy|13
794073|NCT00742625|2525322|P1|Consolidation|Refused|1
794074|NCT00742625|2525322|P1|Consolidation|Death|1
794075|NCT00742625|2525322|P1|Consolidation|Adverse Event|1
794076|NCT00742625|2525322|P1|Consolidation|Progression|5
794077|NCT00742625|2525322|P1|Remission Induction|Other, not specified|5
794078|NCT00742625|2525322|P1|Remission Induction|Non protocol treatment|17
794079|NCT00742625|2525322|P1|Remission Induction|Refusal|5
794080|NCT00742625|2525322|P1|Remission Induction|Death|10
794081|NCT00742625|2525322|P1|Remission Induction|Adverse Event|3
794082|NCT00742625|2525322|P1|Remission Induction|Failed induction|8
794083|NCT00742625|2525322|P1|Remission Induction|Progression|6
794084|NCT00742781|2525331|P1|Overall Study|Withdrawal by Subject|3
892381|NCT01075984|2830147|P4|Follow-up Phase|Withdrawal by Subject|0
892382|NCT01075984|2830148|P3|Follow-up Phase|Withdrawal by Subject|0
892383|NCT01075984|2830149|P2|Follow-up Phase|Withdrawal by Subject|0
892384|NCT01075984|2830150|P1|Follow-up Phase|Withdrawal by Subject|0
892385|NCT01075984|2830146|P5|Follow-up Phase|Administrative|1
892386|NCT01075984|2830147|P4|Follow-up Phase|Administrative|0
892387|NCT01075984|2830148|P3|Follow-up Phase|Administrative|0
892388|NCT01075984|2830149|P2|Follow-up Phase|Administrative|0
892389|NCT01075984|2830150|P1|Follow-up Phase|Administrative|0
892390|NCT01075984|2830146|P5|Follow-up Phase|Adverse Event|27
892391|NCT01075984|2830147|P4|Follow-up Phase|Adverse Event|2
892392|NCT01075984|2830148|P3|Follow-up Phase|Adverse Event|0
892393|NCT01075984|2830149|P2|Follow-up Phase|Adverse Event|0
892394|NCT01075984|2830150|P1|Follow-up Phase|Adverse Event|0
892395|NCT01075984|2830146|P5|Follow-up Phase|Protocol Violation|3
892396|NCT01075984|2830147|P4|Follow-up Phase|Protocol Violation|0
892397|NCT01075984|2830148|P3|Follow-up Phase|Protocol Violation|1
892398|NCT01075984|2830149|P2|Follow-up Phase|Protocol Violation|0
892399|NCT01075984|2830150|P1|Follow-up Phase|Protocol Violation|0
892400|NCT01075984|2830146|P5|Treatment Phase|Progression of disease|2
892401|NCT01075984|2830147|P4|Treatment Phase|Progression of disease|0
892402|NCT01075984|2830148|P3|Treatment Phase|Progression of disease|0
892403|NCT01075984|2830149|P2|Treatment Phase|Progression of disease|0
892404|NCT01075984|2830150|P1|Treatment Phase|Progression of disease|0
892405|NCT01075984|2830146|P5|Treatment Phase|Treatment Failure|5
892406|NCT01075984|2830147|P4|Treatment Phase|Treatment Failure|0
892407|NCT01075984|2830148|P3|Treatment Phase|Treatment Failure|1
892408|NCT01075984|2830149|P2|Treatment Phase|Treatment Failure|0
892409|NCT01075984|2830150|P1|Treatment Phase|Treatment Failure|0
892410|NCT01075984|2830146|P5|Treatment Phase|Withdrawal by Subject|15
892411|NCT01075984|2830147|P4|Treatment Phase|Withdrawal by Subject|0
892412|NCT01075984|2830148|P3|Treatment Phase|Withdrawal by Subject|2
892413|NCT01075984|2830149|P2|Treatment Phase|Withdrawal by Subject|0
892414|NCT01075984|2830150|P1|Treatment Phase|Withdrawal by Subject|0
892415|NCT01075984|2830146|P5|Treatment Phase|Protocol Violation|3
794121|NCT00742885|2525372|P2|Overall Study|Lost to Follow-up|0
794122|NCT00742885|2525373|P1|Overall Study|Lost to Follow-up|1
794123|NCT00742924|2525423|P4|Overall Study|Withdrawal by Subject|0
794124|NCT00742924|2525424|P3|Overall Study|Withdrawal by Subject|1
794125|NCT00742924|2525425|P2|Overall Study|Withdrawal by Subject|1
794126|NCT00742924|2525426|P1|Overall Study|Withdrawal by Subject|0
794127|NCT00742924|2525423|P4|Overall Study|Physician Decision|1
794128|NCT00742924|2525424|P3|Overall Study|Physician Decision|0
794129|NCT00742924|2525425|P2|Overall Study|Physician Decision|0
794130|NCT00742924|2525426|P1|Overall Study|Physician Decision|0
794131|NCT00742924|2525423|P4|Overall Study|Lack of Efficacy|4
794132|NCT00742924|2525424|P3|Overall Study|Lack of Efficacy|2
794133|NCT00742924|2525425|P2|Overall Study|Lack of Efficacy|1
794134|NCT00742924|2525426|P1|Overall Study|Lack of Efficacy|5
794135|NCT00742924|2525423|P4|Overall Study|Adverse Event|1
794136|NCT00742924|2525424|P3|Overall Study|Adverse Event|1
794137|NCT00742924|2525425|P2|Overall Study|Adverse Event|0
794138|NCT00742924|2525426|P1|Overall Study|Adverse Event|0
794141|NCT00743197|2525462|P2|Overall Study|Study terminated due to departure of PI.|2
794142|NCT00743197|2525463|P1|Overall Study|Study terminated due to departure of PI.|1
794143|NCT00736723|2525480|P2|Overall Study|Withdrawal by Subject|3
794144|NCT00736723|2525481|P1|Overall Study|Withdrawal by Subject|4
794145|NCT00736840|2525487|P1|Overall Study|Lost to Follow-up|13
794146|NCT00736853|2525492|P3|Double-Blind Period|Ineligible to participate the study|0
794147|NCT00736853|2525493|P2|Double-Blind Period|Ineligible to participate the study|1
794148|NCT00736853|2525494|P1|Double-Blind Period|Ineligible to participate the study|0
794149|NCT00736853|2525492|P3|Double-Blind Period|Withdrawal by Subject|4
794150|NCT00736853|2525493|P2|Double-Blind Period|Withdrawal by Subject|1
794151|NCT00736853|2525494|P1|Double-Blind Period|Withdrawal by Subject|0
794152|NCT00736853|2525492|P3|Double-Blind Period|Adverse Event|2
794153|NCT00736853|2525493|P2|Double-Blind Period|Adverse Event|3
794154|NCT00736853|2525494|P1|Double-Blind Period|Adverse Event|0
794155|NCT00736853|2525492|P3|Double-Blind Period|Lack of Efficacy|42
794156|NCT00736853|2525493|P2|Double-Blind Period|Lack of Efficacy|19
794157|NCT00736853|2525494|P1|Double-Blind Period|Lack of Efficacy|0
794158|NCT00736853|2525492|P3|Open-Label Period|Unable to attend hospital appointments|0
794159|NCT00736853|2525493|P2|Open-Label Period|Unable to attend hospital appointments|0
794160|NCT00736853|2525494|P1|Open-Label Period|Unable to attend hospital appointments|1
794161|NCT00736853|2525492|P3|Open-Label Period|Failed to meet the transfer criteria|0
794162|NCT00736853|2525493|P2|Open-Label Period|Failed to meet the transfer criteria|0
794163|NCT00736853|2525494|P1|Open-Label Period|Failed to meet the transfer criteria|40
794164|NCT00736853|2525492|P3|Open-Label Period|Started but not treated|0
794165|NCT00736853|2525493|P2|Open-Label Period|Started but not treated|0
794166|NCT00736853|2525494|P1|Open-Label Period|Started but not treated|42
794167|NCT00736853|2525492|P3|Open-Label Period|Withdrawal by Subject|0
794168|NCT00736853|2525493|P2|Open-Label Period|Withdrawal by Subject|0
794169|NCT00736853|2525494|P1|Open-Label Period|Withdrawal by Subject|16
794170|NCT00736853|2525492|P3|Open-Label Period|Adverse Event|0
794171|NCT00736853|2525493|P2|Open-Label Period|Adverse Event|0
794172|NCT00736853|2525494|P1|Open-Label Period|Adverse Event|31
794173|NCT00736853|2525492|P3|Open-Label Period|Physician Decision|0
794174|NCT00736853|2525493|P2|Open-Label Period|Physician Decision|0
794175|NCT00736853|2525494|P1|Open-Label Period|Physician Decision|2
794176|NCT00736879|2525538|P4|Follow up Period - No Drug Treatment|non-specified|0
794177|NCT00736879|2525539|P3|Follow up Period - No Drug Treatment|non-specified|0
794178|NCT00736879|2525540|P2|Follow up Period - No Drug Treatment|non-specified|2
794179|NCT00736879|2525541|P1|Follow up Period - No Drug Treatment|non-specified|1
794180|NCT00736879|2525538|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
794181|NCT00736879|2525539|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
794182|NCT00736879|2525540|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
794183|NCT00736879|2525541|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
794184|NCT00736879|2525538|P4|Double Blind Treatment Period|non-specified|0
794185|NCT00736879|2525539|P3|Double Blind Treatment Period|non-specified|0
794186|NCT00736879|2525540|P2|Double Blind Treatment Period|non-specified|1
794187|NCT00736879|2525541|P1|Double Blind Treatment Period|non-specified|0
794188|NCT00736879|2525538|P4|Double Blind Treatment Period|No longer met criteria|0
794189|NCT00736879|2525539|P3|Double Blind Treatment Period|No longer met criteria|0
794190|NCT00736879|2525540|P2|Double Blind Treatment Period|No longer met criteria|1
794191|NCT00736879|2525541|P1|Double Blind Treatment Period|No longer met criteria|0
794192|NCT00736879|2525538|P4|Double Blind Treatment Period|Poor non-compliance|1
794193|NCT00736879|2525539|P3|Double Blind Treatment Period|Poor non-compliance|1
794194|NCT00736879|2525540|P2|Double Blind Treatment Period|Poor non-compliance|0
794195|NCT00736879|2525541|P1|Double Blind Treatment Period|Poor non-compliance|0
794196|NCT00736879|2525538|P4|Double Blind Treatment Period|Lost to Follow-up|1
794197|NCT00736879|2525539|P3|Double Blind Treatment Period|Lost to Follow-up|2
794198|NCT00736879|2525540|P2|Double Blind Treatment Period|Lost to Follow-up|0
794199|NCT00736879|2525541|P1|Double Blind Treatment Period|Lost to Follow-up|0
794200|NCT00736879|2525538|P4|Double Blind Treatment Period|Withdrawal by Subject|3
794201|NCT00736879|2525539|P3|Double Blind Treatment Period|Withdrawal by Subject|3
794202|NCT00736879|2525540|P2|Double Blind Treatment Period|Withdrawal by Subject|1
794203|NCT00736879|2525541|P1|Double Blind Treatment Period|Withdrawal by Subject|2
794204|NCT00736879|2525538|P4|Double Blind Treatment Period|Adverse Event|0
794205|NCT00736879|2525539|P3|Double Blind Treatment Period|Adverse Event|1
794206|NCT00736879|2525540|P2|Double Blind Treatment Period|Adverse Event|1
794207|NCT00736879|2525541|P1|Double Blind Treatment Period|Adverse Event|0
794208|NCT00736879|2525538|P4|Double Blind Treatment Period|Lack of Efficacy|0
794209|NCT00736879|2525539|P3|Double Blind Treatment Period|Lack of Efficacy|0
794210|NCT00736879|2525540|P2|Double Blind Treatment Period|Lack of Efficacy|0
794211|NCT00736879|2525541|P1|Double Blind Treatment Period|Lack of Efficacy|1
794212|NCT00736944|2525595|P1|Definitive Treatment|Physician Decision|1
794213|NCT00736944|2525595|P1|Induction|Death|1
794214|NCT00736957|2525622|P1|Overall Study|Physician Decision|5
794215|NCT00736957|2525622|P1|Overall Study|not eligible for Treatment Period I|22
794216|NCT00736957|2525622|P1|Overall Study|did not attend hospital appointments|1
794217|NCT00736957|2525622|P1|Overall Study|violation of eligibility criteria|2
794218|NCT00736957|2525622|P1|Overall Study|Withdrawal by Subject|49
794219|NCT00736957|2525622|P1|Overall Study|Adverse Event|43
794220|NCT00736996|2525635|P3|Overall Study|Lost to Follow-up|2
794221|NCT00736996|2525636|P2|Overall Study|Lost to Follow-up|9
794222|NCT00736996|2525637|P1|Overall Study|Lost to Follow-up|1
794223|NCT00737048|2525654|P3|Overall Study|Worsening of the symptoms|3
794224|NCT00737048|2525655|P2|Overall Study|Worsening of the symptoms|5
794225|NCT00737048|2525656|P1|Overall Study|Worsening of the symptoms|3
794226|NCT00737048|2525654|P3|Overall Study|Adverse Event|0
794227|NCT00737048|2525655|P2|Overall Study|Adverse Event|1
794228|NCT00737048|2525656|P1|Overall Study|Adverse Event|0
794229|NCT00737048|2525654|P3|Overall Study|Physician Decision|1
794230|NCT00737048|2525655|P2|Overall Study|Physician Decision|0
794231|NCT00737048|2525656|P1|Overall Study|Physician Decision|0
794232|NCT00737061|2525697|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
794233|NCT00737061|2525697|P1|1 Year Wearing Period|Discontinued reilance|3
794234|NCT00737061|2525697|P1|1 Year Wearing Period|Withdrawal by Subject|2
794235|NCT00737061|2525697|P1|1 Year Wearing Period|Lost to Follow-up|11
794236|NCT00737061|2525697|P1|Waiting Period|Elected surgical tubal ligation|5
794237|NCT00737061|2525697|P1|Waiting Period|Alternative contraception failure|3
794238|NCT00737061|2525697|P1|Waiting Period|Deemed patent following HSG|26
794239|NCT00737061|2525697|P1|Waiting Period|Bilateral placement failure|34
794240|NCT00737061|2525697|P1|Waiting Period|Withdrawal by Subject|1
794241|NCT00737061|2525697|P1|Waiting Period|Lost to Follow-up|6
794242|NCT00737100|2525714|P3|Overall Study|Reason discontinued not explained above|1
794243|NCT00737100|2525715|P2|Overall Study|Reason discontinued not explained above|1
794244|NCT00737100|2525716|P1|Overall Study|Reason discontinued not explained above|1
794245|NCT00737100|2525714|P3|Overall Study|Withdrawal by Subject|3
794246|NCT00737100|2525715|P2|Overall Study|Withdrawal by Subject|0
794247|NCT00737100|2525716|P1|Overall Study|Withdrawal by Subject|0
794248|NCT00737100|2525714|P3|Overall Study|Lost to Follow-up|0
794249|NCT00737100|2525715|P2|Overall Study|Lost to Follow-up|1
794250|NCT00737100|2525716|P1|Overall Study|Lost to Follow-up|0
794251|NCT00737100|2525714|P3|Overall Study|Adverse Event|3
794252|NCT00737100|2525715|P2|Overall Study|Adverse Event|5
794253|NCT00737100|2525716|P1|Overall Study|Adverse Event|6
794254|NCT00737282|2525796|P1|Overall Study|Study prematurely terminated|175
794255|NCT00737438|2525809|P1|Overall Study|Patient ineligible|1
794256|NCT00737438|2525809|P1|Overall Study|Withdrawal by Subject|2
794262|NCT00737477|2525834|P1|Overall Study|Not Specified|4
794263|NCT00737477|2525834|P1|Overall Study|Renal Transplantation|10
794264|NCT00737477|2525834|P1|Overall Study|Withdrawal by Subject|1
794265|NCT00737477|2525834|P1|Overall Study|Treatment Refusal|1
794266|NCT00737477|2525834|P1|Overall Study|Death|9
794267|NCT00737477|2525834|P1|Overall Study|Adverse Event|9
794274|NCT00737568|2525866|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
794275|NCT00737568|2525867|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
794276|NCT00737568|2525866|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
794277|NCT00737568|2525867|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
794278|NCT00737568|2525866|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
794279|NCT00737568|2525867|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
794280|NCT00737568|2525866|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
794281|NCT00737568|2525867|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
794282|NCT00737568|2525866|P2|Treatment Period Through Week 240|Protocol Violation|3
794283|NCT00737568|2525867|P1|Treatment Period Through Week 240|Protocol Violation|2
794284|NCT00737568|2525866|P2|Treatment Period Through Week 240|Lost to Follow-up|3
794285|NCT00737568|2525867|P1|Treatment Period Through Week 240|Lost to Follow-up|3
794286|NCT00737568|2525866|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
794287|NCT00737568|2525867|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
794288|NCT00737568|2525866|P2|Treatment Period Through Week 240|Withdrew Consent|6
794289|NCT00737568|2525867|P1|Treatment Period Through Week 240|Withdrew Consent|5
794290|NCT00737568|2525866|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
794291|NCT00737568|2525867|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
794292|NCT00737633|2525912|P2|Overall Study|protocol non-compliance|1
794293|NCT00737633|2525913|P1|Overall Study|protocol non-compliance|0
794294|NCT00737633|2525912|P2|Overall Study|Lost to Follow-up|1
794295|NCT00737633|2525913|P1|Overall Study|Lost to Follow-up|0
794296|NCT00737633|2525912|P2|Overall Study|Study terminated by sponsor|55
794297|NCT00737633|2525913|P1|Overall Study|Study terminated by sponsor|44
892416|NCT01075984|2830147|P4|Treatment Phase|Protocol Violation|0
892417|NCT01075984|2830148|P3|Treatment Phase|Protocol Violation|1
892418|NCT01075984|2830149|P2|Treatment Phase|Protocol Violation|0
892419|NCT01075984|2830150|P1|Treatment Phase|Protocol Violation|0
892420|NCT01075984|2830146|P5|Treatment Phase|Adverse Event|35
892421|NCT01075984|2830147|P4|Treatment Phase|Adverse Event|7
892422|NCT01075984|2830148|P3|Treatment Phase|Adverse Event|3
892423|NCT01075984|2830149|P2|Treatment Phase|Adverse Event|1
892424|NCT01075984|2830150|P1|Treatment Phase|Adverse Event|0
892425|NCT01066923|2830208|P4|Overall Study|Withdrawal by Subject|8
892426|NCT01066923|2830209|P3|Overall Study|Withdrawal by Subject|8
892427|NCT01066923|2830210|P2|Overall Study|Withdrawal by Subject|3
794310|NCT00737711|2525960|P1|Overall Study|Other|5
794311|NCT00737711|2525960|P1|Overall Study|Blood transfusion|6
794312|NCT00737711|2525960|P1|Overall Study|Withdrawal by Subject|5
794313|NCT00737711|2525960|P1|Overall Study|Protocol Violation|1
794314|NCT00737711|2525960|P1|Overall Study|Failure to return|4
794315|NCT00737711|2525960|P1|Overall Study|Death|8
794316|NCT00737711|2525960|P1|Overall Study|Adverse Event|2
794317|NCT00743249|2526004|P2|Overall Study|Unsuccessful insertion of stent|1
794318|NCT00743249|2526005|P1|Overall Study|Unsuccessful insertion of stent|2
794319|NCT00743249|2526004|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
794320|NCT00743249|2526005|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
794321|NCT00743249|2526004|P2|Overall Study|Adverse Event|4
794322|NCT00743249|2526005|P1|Overall Study|Adverse Event|0
794323|NCT00743275|2526021|P2|Overall Study|Protocol Violation|1
794324|NCT00743275|2526022|P1|Overall Study|Protocol Violation|0
794325|NCT00743288|2526034|P7|Overall Study|Worsening of condition (Not PD)|0
794326|NCT00743288|2526035|P6|Overall Study|Worsening of condition (Not PD)|0
794327|NCT00743288|2526036|P5|Overall Study|Worsening of condition (Not PD)|0
794328|NCT00743288|2526037|P4|Overall Study|Worsening of condition (Not PD)|1
794329|NCT00743288|2526038|P3|Overall Study|Worsening of condition (Not PD)|1
794330|NCT00743288|2526039|P2|Overall Study|Worsening of condition (Not PD)|2
794331|NCT00743288|2526040|P1|Overall Study|Worsening of condition (Not PD)|0
794332|NCT00743288|2526034|P7|Overall Study|Progressive disease (PD)|6
794333|NCT00743288|2526035|P6|Overall Study|Progressive disease (PD)|3
794334|NCT00743288|2526036|P5|Overall Study|Progressive disease (PD)|5
794335|NCT00743288|2526037|P4|Overall Study|Progressive disease (PD)|4
794336|NCT00743288|2526038|P3|Overall Study|Progressive disease (PD)|1
794337|NCT00743288|2526039|P2|Overall Study|Progressive disease (PD)|0
794338|NCT00743288|2526040|P1|Overall Study|Progressive disease (PD)|2
794339|NCT00743288|2526034|P7|Overall Study|Withdrawal by Subject|1
794340|NCT00743288|2526035|P6|Overall Study|Withdrawal by Subject|1
794341|NCT00743288|2526036|P5|Overall Study|Withdrawal by Subject|0
794342|NCT00743288|2526037|P4|Overall Study|Withdrawal by Subject|0
794343|NCT00743288|2526038|P3|Overall Study|Withdrawal by Subject|1
794344|NCT00743288|2526039|P2|Overall Study|Withdrawal by Subject|0
794345|NCT00743288|2526040|P1|Overall Study|Withdrawal by Subject|0
794346|NCT00743288|2526034|P7|Overall Study|Adverse Event|2
794347|NCT00743288|2526035|P6|Overall Study|Adverse Event|1
794348|NCT00743288|2526036|P5|Overall Study|Adverse Event|1
794349|NCT00743288|2526037|P4|Overall Study|Adverse Event|2
794350|NCT00743288|2526038|P3|Overall Study|Adverse Event|2
794351|NCT00743288|2526039|P2|Overall Study|Adverse Event|1
794352|NCT00743288|2526040|P1|Overall Study|Adverse Event|1
794353|NCT00743366|2526052|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
794354|NCT00743366|2526053|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
794355|NCT00743431|2526059|P1|Overall Study|No documentation available|13
794356|NCT00743431|2526059|P1|Overall Study|Reason for discontinuation not specified|29
794357|NCT00743431|2526059|P1|Overall Study|Death|9
794358|NCT00743431|2526059|P1|Overall Study|Withdrawal by Subject|13
794359|NCT00743431|2526059|P1|Overall Study|Tumor progression|56
794360|NCT00743431|2526059|P1|Overall Study|Toxicity|6
794361|NCT00743444|2526063|P2|Washout Period|Adverse Event|1
794362|NCT00743444|2526064|P1|Washout Period|Adverse Event|0
794363|NCT00743444|2526063|P2|First Intervention|Catheter placement problems|1
794364|NCT00743444|2526064|P1|First Intervention|Catheter placement problems|0
794365|NCT00743483|2526073|P1|Treatment Period|Adverse Event|1
794366|NCT00743483|2526073|P1|Baseline Period|Physician Decision|1
794367|NCT00743509|2526077|P1|Overall Study|Withdrawal by Subject|2
794368|NCT00744653|2526082|P1|Overall Study|Physician Decision|3
794369|NCT00744653|2526082|P1|Overall Study|Lost to Follow-up|1
794370|NCT00744653|2526082|P1|Overall Study|Death|1
794371|NCT00744653|2526082|P1|Overall Study|antineoplastic treatment|11
794372|NCT00744757|2526100|P1|Overall Study|Adverse Event|2
794373|NCT00744757|2526100|P1|Overall Study|Death|6
794374|NCT00744757|2526100|P1|Overall Study|Withdrawal by Subject|1
794375|NCT00744757|2526100|P1|Overall Study|Physician Decision|5
794376|NCT00744757|2526100|P1|Overall Study|Objective disease progression|7
794377|NCT00744874|2526122|P1|Overall Study|Unable to accomodate schedule|1
794378|NCT00744874|2526122|P1|Overall Study|Study Device not available at procedure|1
794379|NCT00744874|2526122|P1|Overall Study|Withdrawal by Subject|1
794380|NCT00744874|2526122|P1|Overall Study|Lost to Follow-up|1
794381|NCT00744939|2526142|P1|Overall Study|incorrect race|1
794382|NCT00744939|2526142|P1|Overall Study|coma|1
794383|NCT00744939|2526142|P1|Overall Study|Failed inclusion/exclusion criteria|19
794384|NCT00744939|2526142|P1|Overall Study|Did not receive Magnevist|7
794385|NCT00744939|2526142|P1|Overall Study|Medical history exclusionary|1
794386|NCT00744939|2526142|P1|Overall Study|Lost to Follow-up|12
794387|NCT00744939|2526142|P1|Overall Study|distance|4
794388|NCT00744939|2526142|P1|Overall Study|Death|24
794389|NCT00744939|2526142|P1|Overall Study|Protocol Violation|13
794390|NCT00744939|2526142|P1|Overall Study|Withdrawal by Subject|9
794391|NCT00744978|2526180|P2|Period 2|Adverse Event|1
794392|NCT00744978|2526181|P1|Period 2|Adverse Event|0
794393|NCT00744978|2526180|P2|Period 1|Randomized but not Treated|1
794394|NCT00744978|2526181|P1|Period 1|Randomized but not Treated|1
794395|NCT00744978|2526180|P2|Period 1|Adverse Event|0
794396|NCT00744978|2526181|P1|Period 1|Adverse Event|4
794397|NCT00744978|2526180|P2|Period 1|Unspecified|2
794398|NCT00744978|2526181|P1|Period 1|Unspecified|0
794399|NCT00744978|2526180|P2|Period 1|Withdrawal by Subject|2
794400|NCT00744978|2526181|P1|Period 1|Withdrawal by Subject|0
794401|NCT00744978|2526180|P2|Period 1|Lost to Follow-up|0
794402|NCT00744978|2526181|P1|Period 1|Lost to Follow-up|1
794403|NCT00745095|2526244|P6|Overall Study|Ineligible due to GFR criteria|28
794404|NCT00745095|2526245|P5|Overall Study|Ineligible due to GFR criteria|30
794405|NCT00745095|2526246|P4|Overall Study|Ineligible due to GFR criteria|3
794406|NCT00745095|2526247|P3|Overall Study|Ineligible due to GFR criteria|3
794407|NCT00745095|2526248|P2|Overall Study|Ineligible due to GFR criteria|2
794408|NCT00745095|2526249|P1|Overall Study|Ineligible due to GFR criteria|0
794409|NCT00745095|2526244|P6|Overall Study|Declined to participate|95
794410|NCT00745095|2526245|P5|Overall Study|Declined to participate|92
794411|NCT00745095|2526246|P4|Overall Study|Declined to participate|0
794412|NCT00745095|2526247|P3|Overall Study|Declined to participate|0
794413|NCT00745095|2526248|P2|Overall Study|Declined to participate|0
794414|NCT00745095|2526249|P1|Overall Study|Declined to participate|1
794415|NCT00745251|2526271|P2|Overall Study|Withdrawal by Subject|1
794416|NCT00745251|2526272|P1|Overall Study|Withdrawal by Subject|1
794417|NCT00745251|2526271|P2|Overall Study|Adverse Event|2
794418|NCT00745251|2526272|P1|Overall Study|Adverse Event|1
794419|NCT00745368|2526289|P1|Overall Study|Unable to provide sample|3
794420|NCT00745498|2526303|P3|Overall Study|Edophthalmitis after preoperative IVB|0
794421|NCT00745498|2526304|P2|Overall Study|Edophthalmitis after preoperative IVB|0
794422|NCT00745498|2526305|P1|Overall Study|Edophthalmitis after preoperative IVB|1
794423|NCT00745498|2526303|P3|Overall Study|Non-PDR related VH|1
794424|NCT00745498|2526304|P2|Overall Study|Non-PDR related VH|1
794425|NCT00745498|2526305|P1|Overall Study|Non-PDR related VH|0
794426|NCT00745498|2526303|P3|Overall Study|Injection of intravitreal silicone oil o|4
794427|NCT00745498|2526304|P2|Overall Study|Injection of intravitreal silicone oil o|4
794428|NCT00745498|2526305|P1|Overall Study|Injection of intravitreal silicone oil o|3
794429|NCT00745498|2526303|P3|Overall Study|Lost to Follow-up|3
794430|NCT00745498|2526304|P2|Overall Study|Lost to Follow-up|1
794431|NCT00745498|2526305|P1|Overall Study|Lost to Follow-up|1
892428|NCT01066923|2830211|P1|Overall Study|Withdrawal by Subject|3
892433|NCT00948675|2830246|P2|Overall Study|Treatment ongoing|4
892434|NCT00948675|2830247|P1|Overall Study|Treatment ongoing|5
892435|NCT00948675|2830246|P2|Overall Study|Lost to Follow-up|0
892436|NCT00948675|2830247|P1|Overall Study|Lost to Follow-up|2
892437|NCT00816556|2830279|P3|Overall Study|Lost to Follow-up|1
892438|NCT00816556|2830280|P2|Overall Study|Lost to Follow-up|0
892439|NCT00816556|2830281|P1|Overall Study|Lost to Follow-up|0
892440|NCT00816556|2830279|P3|Overall Study|Withdrawal by Subject|1
892441|NCT00816556|2830280|P2|Overall Study|Withdrawal by Subject|1
794446|NCT00745875|2526348|P2|Overall Study|Continuing study treatment|4
794447|NCT00745875|2526349|P1|Overall Study|Continuing study treatment|4
794448|NCT00745901|2526359|P2|Overall Study|Patient didn't take any study medication|3
794449|NCT00745901|2526360|P1|Overall Study|Patient didn't take any study medication|7
794450|NCT00745901|2526359|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
794451|NCT00745901|2526360|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
794452|NCT00745901|2526359|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
794453|NCT00745901|2526360|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
794454|NCT00745901|2526359|P2|Overall Study|Patient's next menses did not start with|0
794455|NCT00745901|2526360|P1|Overall Study|Patient's next menses did not start with|1
794456|NCT00745901|2526359|P2|Overall Study|Lack of compliance|2
794457|NCT00745901|2526360|P1|Overall Study|Lack of compliance|2
794458|NCT00745901|2526359|P2|Overall Study|Pregnancy|4
794459|NCT00745901|2526360|P1|Overall Study|Pregnancy|2
794460|NCT00745901|2526359|P2|Overall Study|Lost to Follow-up|4
794461|NCT00745901|2526360|P1|Overall Study|Lost to Follow-up|7
794462|NCT00745901|2526359|P2|Overall Study|Withdrawal by Subject|0
794463|NCT00745901|2526360|P1|Overall Study|Withdrawal by Subject|1
794464|NCT00745901|2526359|P2|Overall Study|Protocol Violation|1
794465|NCT00745901|2526360|P1|Overall Study|Protocol Violation|0
794466|NCT00745901|2526359|P2|Overall Study|Adverse Event|4
794467|NCT00745901|2526360|P1|Overall Study|Adverse Event|3
794468|NCT00746096|2526423|P2|Overall Study|No study drug treatment|1
794469|NCT00746096|2526424|P1|Overall Study|No study drug treatment|1
794470|NCT00746096|2526423|P2|Overall Study|Protocol Violation|0
794471|NCT00746096|2526424|P1|Overall Study|Protocol Violation|1
794472|NCT00746096|2526423|P2|Overall Study|Lost to Follow-up|1
794473|NCT00746096|2526424|P1|Overall Study|Lost to Follow-up|2
794474|NCT00746096|2526423|P2|Overall Study|Withdrawal by Subject|1
794475|NCT00746096|2526424|P1|Overall Study|Withdrawal by Subject|5
794476|NCT00746096|2526423|P2|Overall Study|Adverse Event|0
794477|NCT00746096|2526424|P1|Overall Study|Adverse Event|1
794478|NCT00746330|2526449|P4|Period 1|Abnormal test procedure result|0
794479|NCT00746330|2526450|P3|Period 1|Abnormal test procedure result|1
794480|NCT00746330|2526451|P2|Period 1|Abnormal test procedure result|0
794481|NCT00746330|2526452|P1|Period 1|Abnormal test procedure result|0
794482|NCT00746356|2526480|P2|Overall Study|Patient relocated|0
794483|NCT00746356|2526481|P1|Overall Study|Patient relocated|1
794484|NCT00746356|2526480|P2|Overall Study|Removal of Device|1
794485|NCT00746356|2526481|P1|Overall Study|Removal of Device|0
794486|NCT00746356|2526480|P2|Overall Study|Lost to Follow-up|0
794487|NCT00746356|2526481|P1|Overall Study|Lost to Follow-up|1
794488|NCT00746356|2526480|P2|Overall Study|Death|3
794489|NCT00746356|2526481|P1|Overall Study|Death|7
794490|NCT00746356|2526480|P2|Overall Study|Withdrawal by Subject|3
794491|NCT00746356|2526481|P1|Overall Study|Withdrawal by Subject|2
794492|NCT00746551|2526534|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
794493|NCT00746551|2526535|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
794494|NCT00746551|2526534|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
794495|NCT00746551|2526535|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
794496|NCT00746551|2526534|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
794497|NCT00746551|2526535|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
794498|NCT00746564|2526543|P1|Overall Study|Required Pacemaker/ICD Implant|2
794499|NCT00746590|2526556|P1|Overall Study|Death|1
794500|NCT00746733|2526584|P2|Third Intervention|Withdrawal by Subject|1
794501|NCT00746733|2526585|P1|Third Intervention|Withdrawal by Subject|1
794502|NCT00746733|2526584|P2|Second Intervention|Adverse Event|0
794503|NCT00746733|2526585|P1|Second Intervention|Adverse Event|1
794504|NCT00746785|2526648|P3|Overall Study|Lost to Follow-up|27
794505|NCT00746785|2526649|P2|Overall Study|Lost to Follow-up|25
794506|NCT00746785|2526650|P1|Overall Study|Lost to Follow-up|29
794507|NCT00746798|2526662|P4|Overall Study|Participant unable to return for visit|0
794508|NCT00746798|2526663|P3|Overall Study|Participant unable to return for visit|0
794509|NCT00746798|2526664|P2|Overall Study|Participant unable to return for visit|0
794510|NCT00746798|2526665|P1|Overall Study|Participant unable to return for visit|1
794511|NCT00746798|2526662|P4|Overall Study|Death|0
794512|NCT00746798|2526663|P3|Overall Study|Death|2
794513|NCT00746798|2526664|P2|Overall Study|Death|0
794514|NCT00746798|2526665|P1|Overall Study|Death|0
794515|NCT00746798|2526662|P4|Overall Study|Withdrawal by Subject|0
794516|NCT00746798|2526663|P3|Overall Study|Withdrawal by Subject|1
794517|NCT00746798|2526664|P2|Overall Study|Withdrawal by Subject|1
794518|NCT00746798|2526665|P1|Overall Study|Withdrawal by Subject|0
794519|NCT00746798|2526662|P4|Overall Study|Protocol Violation|0
794520|NCT00746798|2526663|P3|Overall Study|Protocol Violation|0
794521|NCT00746798|2526664|P2|Overall Study|Protocol Violation|1
794522|NCT00746798|2526665|P1|Overall Study|Protocol Violation|0
794523|NCT00746941|2526719|P4|Overall Study|Adverse Event|1
794524|NCT00746941|2526720|P3|Overall Study|Adverse Event|0
794525|NCT00746941|2526721|P2|Overall Study|Adverse Event|0
794526|NCT00746941|2526722|P1|Overall Study|Adverse Event|0
794527|NCT00746941|2526719|P4|Overall Study|Other, reason not provided|4
794528|NCT00746941|2526720|P3|Overall Study|Other, reason not provided|0
794529|NCT00746941|2526721|P2|Overall Study|Other, reason not provided|4
794530|NCT00746941|2526722|P1|Overall Study|Other, reason not provided|2
794531|NCT00746941|2526719|P4|Overall Study|Withdrawal by Subject|2
794532|NCT00746941|2526720|P3|Overall Study|Withdrawal by Subject|0
794533|NCT00746941|2526721|P2|Overall Study|Withdrawal by Subject|0
794534|NCT00746941|2526722|P1|Overall Study|Withdrawal by Subject|3
794535|NCT00746941|2526719|P4|Overall Study|Physician Decision|0
794536|NCT00746941|2526720|P3|Overall Study|Physician Decision|2
794537|NCT00746941|2526721|P2|Overall Study|Physician Decision|0
794538|NCT00746941|2526722|P1|Overall Study|Physician Decision|0
794539|NCT00746941|2526719|P4|Overall Study|Death|6
794540|NCT00746941|2526720|P3|Overall Study|Death|0
794541|NCT00746941|2526721|P2|Overall Study|Death|0
794542|NCT00746941|2526722|P1|Overall Study|Death|2
794543|NCT00747006|2526759|P3|Overall Study|Physician Decision|1
794544|NCT00747006|2526760|P2|Overall Study|Physician Decision|0
794545|NCT00747006|2526761|P1|Overall Study|Physician Decision|2
794546|NCT00747006|2526759|P3|Overall Study|Lost to Follow-up|0
794547|NCT00747006|2526760|P2|Overall Study|Lost to Follow-up|1
794548|NCT00747006|2526761|P1|Overall Study|Lost to Follow-up|0
794549|NCT00747006|2526759|P3|Overall Study|Adverse Event|0
794550|NCT00747006|2526760|P2|Overall Study|Adverse Event|0
794551|NCT00747006|2526761|P1|Overall Study|Adverse Event|1
794552|NCT00747149|2526829|P2|Overall Study|Not reported|4
794553|NCT00747149|2526830|P1|Overall Study|Not reported|1
794554|NCT00747149|2526829|P2|Overall Study|Severe non-compliance to protocol|1
794555|NCT00747149|2526830|P1|Overall Study|Severe non-compliance to protocol|0
794556|NCT00747149|2526829|P2|Overall Study|Incorrect enrollment|6
794557|NCT00747149|2526830|P1|Overall Study|Incorrect enrollment|0
794558|NCT00747149|2526829|P2|Overall Study|Did not receive treatment|1
794559|NCT00747149|2526830|P1|Overall Study|Did not receive treatment|0
794560|NCT00747149|2526829|P2|Overall Study|Withdrawal by Subject|6
794561|NCT00747149|2526830|P1|Overall Study|Withdrawal by Subject|0
794562|NCT00747149|2526829|P2|Overall Study|Lost to Follow-up|10
794563|NCT00747149|2526830|P1|Overall Study|Lost to Follow-up|0
794564|NCT00747149|2526829|P2|Overall Study|Adverse Event|15
794565|NCT00747149|2526830|P1|Overall Study|Adverse Event|0
794566|NCT00747227|2526859|P2|Overall Study|Illness|1
794567|NCT00747227|2526860|P1|Overall Study|Illness|1
794568|NCT00747227|2526859|P2|Overall Study|Lost to Follow-up|2
794569|NCT00747227|2526860|P1|Overall Study|Lost to Follow-up|1
794570|NCT00747227|2526859|P2|Overall Study|Withdrawal by Subject|0
794571|NCT00747227|2526860|P1|Overall Study|Withdrawal by Subject|1
794572|NCT00747227|2526859|P2|Overall Study|Death|1
794573|NCT00747227|2526860|P1|Overall Study|Death|3
794574|NCT00747344|2526874|P4|After Controlled Period|Adverse Event|1
794575|NCT00747344|2526875|P3|After Controlled Period|Adverse Event|0
794576|NCT00747344|2526876|P2|After Controlled Period|Adverse Event|0
794577|NCT00747344|2526877|P1|After Controlled Period|Adverse Event|0
794578|NCT00747344|2526874|P4|Controlled Period|Other|0
794579|NCT00747344|2526875|P3|Controlled Period|Other|0
794580|NCT00747344|2526876|P2|Controlled Period|Other|3
794581|NCT00747344|2526877|P1|Controlled Period|Other|0
794582|NCT00747344|2526874|P4|Controlled Period|Lack of Efficacy|0
794583|NCT00747344|2526875|P3|Controlled Period|Lack of Efficacy|0
794584|NCT00747344|2526876|P2|Controlled Period|Lack of Efficacy|1
794585|NCT00747344|2526877|P1|Controlled Period|Lack of Efficacy|2
794586|NCT00747344|2526874|P4|Controlled Period|Adverse Event|0
794587|NCT00747344|2526875|P3|Controlled Period|Adverse Event|0
794588|NCT00747344|2526876|P2|Controlled Period|Adverse Event|0
794589|NCT00747344|2526877|P1|Controlled Period|Adverse Event|3
794590|NCT00747435|2526889|P1|Overall Study|Still undergoing follow up|1
794591|NCT00747435|2526889|P1|Overall Study|Withdrawal by Subject|3
794592|NCT00747435|2526889|P1|Overall Study|Lost to Follow-up|2
794593|NCT00747461|2526897|P1|Overall Study|study terminated by sponsor|5
794594|NCT00747474|2526902|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794595|NCT00747474|2526903|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794596|NCT00747474|2526904|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794597|NCT00747474|2526905|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794598|NCT00747474|2526906|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
794599|NCT00747474|2526907|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794600|NCT00747474|2526908|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794601|NCT00747474|2526909|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794602|NCT00747474|2526910|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794603|NCT00747474|2526911|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794604|NCT00747474|2526912|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794605|NCT00747474|2526913|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
794606|NCT00747565|2526946|P2|Overall Study|Lost to Follow-up|1
794607|NCT00747565|2526947|P1|Overall Study|Lost to Follow-up|4
794608|NCT00747565|2526946|P2|Overall Study|Withdrawal by Subject|6
794609|NCT00747565|2526947|P1|Overall Study|Withdrawal by Subject|10
794610|NCT00747617|2526957|P2|Overall Study|Lost to Follow-up|1
794611|NCT00747617|2526958|P1|Overall Study|Lost to Follow-up|3
794612|NCT00747643|2526966|P2|Overall Study|Withdrawal by Subject|27
794613|NCT00747643|2526967|P1|Overall Study|Withdrawal by Subject|36
794614|NCT00747812|2527009|P2|Overall Study|Research Site Staff Relocation|3
794615|NCT00747812|2527010|P1|Overall Study|Research Site Staff Relocation|5
794616|NCT00748098|2527037|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
794617|NCT00748098|2527038|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
794618|NCT00748098|2527037|P2|Second Treatment Intervention Period|Lost to Follow-up|1
794619|NCT00748098|2527038|P1|Second Treatment Intervention Period|Lost to Follow-up|1
794620|NCT00748098|2527037|P2|Second Treatment Intervention Period|Adverse Event|1
794621|NCT00748098|2527038|P1|Second Treatment Intervention Period|Adverse Event|4
794622|NCT00748098|2527037|P2|1-Week Washout Period|Withdrawal by Subject|0
794623|NCT00748098|2527038|P1|1-Week Washout Period|Withdrawal by Subject|2
794624|NCT00748098|2527037|P2|1-Week Washout Period|Adverse Event|1
794625|NCT00748098|2527038|P1|1-Week Washout Period|Adverse Event|0
794626|NCT00748098|2527037|P2|First Taper Period|Protocol Stopping Criteria Met|1
794627|NCT00748098|2527038|P1|First Taper Period|Protocol Stopping Criteria Met|0
794628|NCT00748098|2527037|P2|First Taper Period|Withdrawal by Subject|0
794629|NCT00748098|2527038|P1|First Taper Period|Withdrawal by Subject|2
794630|NCT00748098|2527037|P2|First Taper Period|Protocol Violation|0
794631|NCT00748098|2527038|P1|First Taper Period|Protocol Violation|1
794632|NCT00748098|2527037|P2|First Treatment Intervention Period|Withdrawal by Subject|0
794633|NCT00748098|2527038|P1|First Treatment Intervention Period|Withdrawal by Subject|2
794634|NCT00748098|2527037|P2|First Treatment Intervention Period|Lost to Follow-up|0
794635|NCT00748098|2527038|P1|First Treatment Intervention Period|Lost to Follow-up|1
794636|NCT00748098|2527037|P2|First Treatment Intervention Period|Protocol Violation|0
794637|NCT00748098|2527038|P1|First Treatment Intervention Period|Protocol Violation|1
794638|NCT00748098|2527037|P2|First Treatment Intervention Period|Adverse Event|1
794639|NCT00748098|2527038|P1|First Treatment Intervention Period|Adverse Event|1
794640|NCT00748189|2527100|P2|Overall Study|Ongoing|162
794641|NCT00748189|2527101|P1|Overall Study|Ongoing|155
794642|NCT00748189|2527100|P2|Overall Study|Study terminated by Sponsor|1
794643|NCT00748189|2527101|P1|Overall Study|Study terminated by Sponsor|0
794644|NCT00748189|2527100|P2|Overall Study|Lost to Follow-up|4
794645|NCT00748189|2527101|P1|Overall Study|Lost to Follow-up|2
794646|NCT00748189|2527100|P2|Overall Study|Physician Decision|4
794647|NCT00748189|2527101|P1|Overall Study|Physician Decision|13
794648|NCT00748189|2527100|P2|Overall Study|Withdrawal by Subject|16
794649|NCT00748189|2527101|P1|Overall Study|Withdrawal by Subject|15
794650|NCT00748189|2527100|P2|Overall Study|Death|34
794651|NCT00748189|2527101|P1|Overall Study|Death|40
794652|NCT00748241|2527155|P1|Overall Study|Death|2
794653|NCT00748241|2527155|P1|Overall Study|Lost to Follow-up|5
794654|NCT00748241|2527155|P1|Overall Study|Implant failure|1
794655|NCT00748553|2527165|P2|Overall Study|noncompliance|0
794656|NCT00748553|2527166|P1|Overall Study|noncompliance|1
794657|NCT00748553|2527165|P2|Overall Study|disease progression|0
794658|NCT00748553|2527166|P1|Overall Study|disease progression|2
794659|NCT00748553|2527165|P2|Overall Study|Adverse Event|1
794660|NCT00748553|2527166|P1|Overall Study|Adverse Event|0
794661|NCT00748566|2527173|P1|Overall Study|Unspecified|9
794662|NCT00748566|2527173|P1|Overall Study|Study terminated by sponsor|5
794663|NCT00748566|2527173|P1|Overall Study|Withdrawal by Subject|22
794664|NCT00748566|2527173|P1|Overall Study|Protocol Violation|13
794665|NCT00748566|2527173|P1|Overall Study|Lost to Follow-up|1
794666|NCT00748566|2527173|P1|Overall Study|Lack of Efficacy|12
794667|NCT00748566|2527173|P1|Overall Study|Death|1
794668|NCT00748566|2527173|P1|Overall Study|Adverse Event|49
794669|NCT00748709|2527216|P1|Overall Study|Other Reasons|1
794670|NCT00748709|2527216|P1|Overall Study|Withdrawal by Subject|1
794671|NCT00748709|2527216|P1|Overall Study|Other Adverse Event|1
794672|NCT00748709|2527216|P1|Overall Study|Drug reducing Toxity|2
794673|NCT00748709|2527216|P1|Overall Study|Progressive disease|15
794674|NCT00749190|2527307|P7|Overall Study|Other reason not defined above|0
794675|NCT00749190|2527308|P6|Overall Study|Other reason not defined above|0
794676|NCT00749190|2527309|P5|Overall Study|Other reason not defined above|0
794677|NCT00749190|2527310|P4|Overall Study|Other reason not defined above|1
794678|NCT00749190|2527311|P3|Overall Study|Other reason not defined above|0
794679|NCT00749190|2527312|P2|Overall Study|Other reason not defined above|0
794680|NCT00749190|2527313|P1|Overall Study|Other reason not defined above|0
794681|NCT00749190|2527307|P7|Overall Study|Protocol Violation|1
794682|NCT00749190|2527308|P6|Overall Study|Protocol Violation|0
794683|NCT00749190|2527309|P5|Overall Study|Protocol Violation|0
794684|NCT00749190|2527310|P4|Overall Study|Protocol Violation|0
794685|NCT00749190|2527311|P3|Overall Study|Protocol Violation|0
794686|NCT00749190|2527312|P2|Overall Study|Protocol Violation|1
794687|NCT00749190|2527313|P1|Overall Study|Protocol Violation|0
794688|NCT00749190|2527307|P7|Overall Study|Withdrawal by Subject|0
794689|NCT00749190|2527308|P6|Overall Study|Withdrawal by Subject|1
794690|NCT00749190|2527309|P5|Overall Study|Withdrawal by Subject|0
794691|NCT00749190|2527310|P4|Overall Study|Withdrawal by Subject|0
794692|NCT00749190|2527311|P3|Overall Study|Withdrawal by Subject|0
794693|NCT00749190|2527312|P2|Overall Study|Withdrawal by Subject|1
794694|NCT00749190|2527313|P1|Overall Study|Withdrawal by Subject|2
794695|NCT00749190|2527307|P7|Overall Study|Lack of Efficacy|0
794696|NCT00749190|2527308|P6|Overall Study|Lack of Efficacy|1
794697|NCT00749190|2527309|P5|Overall Study|Lack of Efficacy|0
794698|NCT00749190|2527310|P4|Overall Study|Lack of Efficacy|0
794699|NCT00749190|2527311|P3|Overall Study|Lack of Efficacy|1
794700|NCT00749190|2527312|P2|Overall Study|Lack of Efficacy|1
794701|NCT00749190|2527313|P1|Overall Study|Lack of Efficacy|3
794702|NCT00749190|2527307|P7|Overall Study|Adverse Event|0
794703|NCT00749190|2527308|P6|Overall Study|Adverse Event|3
794704|NCT00749190|2527309|P5|Overall Study|Adverse Event|0
794705|NCT00749190|2527310|P4|Overall Study|Adverse Event|4
794706|NCT00749190|2527311|P3|Overall Study|Adverse Event|0
794707|NCT00749190|2527312|P2|Overall Study|Adverse Event|2
794708|NCT00749190|2527313|P1|Overall Study|Adverse Event|0
794709|NCT00749398|2527417|P1|Overall Study|Unknown reason|1
794710|NCT00749398|2527417|P1|Overall Study|Reason not specified|2
794711|NCT00749398|2527417|P1|Overall Study|Lost to Follow-up|11
794712|NCT00749398|2527417|P1|Overall Study|Withdrawal by Subject|17
794713|NCT00749398|2527417|P1|Overall Study|Serious adverse event|11
794714|NCT00749398|2527417|P1|Overall Study|Adverse Event|4
794715|NCT00749398|2527417|P1|Overall Study|Lack of Efficacy|7
794716|NCT00749463|2527434|P3|Overall Study|Withdrawal by Subject|0
794717|NCT00749463|2527435|P2|Overall Study|Withdrawal by Subject|0
794718|NCT00749463|2527436|P1|Overall Study|Withdrawal by Subject|1
794719|NCT00749463|2527434|P3|Overall Study|Adverse Event|1
794720|NCT00749463|2527435|P2|Overall Study|Adverse Event|4
794721|NCT00749463|2527436|P1|Overall Study|Adverse Event|0
794722|NCT00749580|2527468|P2|Overall Study|Adverse Event|1
794723|NCT00749580|2527469|P1|Overall Study|Adverse Event|0
794724|NCT00749580|2527468|P2|Overall Study|Lost to Follow-up|8
794725|NCT00749580|2527469|P1|Overall Study|Lost to Follow-up|4
794726|NCT00749684|2527488|P1|Overall Study|Missing|9
794727|NCT00749684|2527488|P1|Overall Study|AE+discontinuation on participants wish|1
794728|NCT00749684|2527488|P1|Overall Study|Therapy according to protocol + AE|2
794729|NCT00749684|2527488|P1|Overall Study|Progressive Desease|31
794730|NCT00749684|2527488|P1|Overall Study|Not Documented|1
794731|NCT00749684|2527488|P1|Overall Study|Participant's Wish|10
794732|NCT00749684|2527488|P1|Overall Study|Adverse Event|27
794733|NCT00749684|2527488|P1|Overall Study|Death|1
794734|NCT00749775|2527493|P1|Overall Study|No drug administration|3
794735|NCT00749775|2527493|P1|Overall Study|No visit after first day of treatment|44
794736|NCT00749775|2527493|P1|Overall Study|Lost to Follow-up|36
794737|NCT00749775|2527493|P1|Overall Study|Protocol Violation|24
794738|NCT00749944|2527524|P2|Overall Study|Withdrawal by Subject|0
794739|NCT00749944|2527525|P1|Overall Study|Withdrawal by Subject|2
794740|NCT00749944|2527524|P2|Overall Study|Not specified|0
794741|NCT00749944|2527525|P1|Overall Study|Not specified|1
794742|NCT00749944|2527524|P2|Overall Study|Lost to Follow-up|1
794743|NCT00749944|2527525|P1|Overall Study|Lost to Follow-up|2
794744|NCT00743652|2527618|P5|Overall Study|Lost to Follow-up|0
794745|NCT00743652|2527619|P4|Overall Study|Lost to Follow-up|0
794746|NCT00743652|2527620|P3|Overall Study|Lost to Follow-up|0
794747|NCT00743652|2527621|P2|Overall Study|Lost to Follow-up|0
794748|NCT00743652|2527622|P1|Overall Study|Lost to Follow-up|1
794749|NCT00743652|2527618|P5|Overall Study|Unspecified|0
794750|NCT00743652|2527619|P4|Overall Study|Unspecified|0
794751|NCT00743652|2527620|P3|Overall Study|Unspecified|0
794752|NCT00743652|2527621|P2|Overall Study|Unspecified|1
794753|NCT00743652|2527622|P1|Overall Study|Unspecified|1
794754|NCT00743652|2527618|P5|Overall Study|Investigator Request|0
794755|NCT00743652|2527619|P4|Overall Study|Investigator Request|2
794756|NCT00743652|2527620|P3|Overall Study|Investigator Request|0
794757|NCT00743652|2527621|P2|Overall Study|Investigator Request|0
794758|NCT00743652|2527622|P1|Overall Study|Investigator Request|0
794759|NCT00743652|2527618|P5|Overall Study|Death|0
794760|NCT00743652|2527619|P4|Overall Study|Death|0
794761|NCT00743652|2527620|P3|Overall Study|Death|0
794762|NCT00743652|2527621|P2|Overall Study|Death|0
794763|NCT00743652|2527622|P1|Overall Study|Death|2
794764|NCT00743652|2527618|P5|Overall Study|Adverse Event|0
794765|NCT00743652|2527619|P4|Overall Study|Adverse Event|0
794766|NCT00743652|2527620|P3|Overall Study|Adverse Event|0
794767|NCT00743652|2527621|P2|Overall Study|Adverse Event|0
794768|NCT00743652|2527622|P1|Overall Study|Adverse Event|3
794769|NCT00743652|2527618|P5|Overall Study|Parent/Legal Guardian Request|0
794770|NCT00743652|2527619|P4|Overall Study|Parent/Legal Guardian Request|2
794771|NCT00743652|2527620|P3|Overall Study|Parent/Legal Guardian Request|2
794772|NCT00743652|2527621|P2|Overall Study|Parent/Legal Guardian Request|2
794773|NCT00743652|2527622|P1|Overall Study|Parent/Legal Guardian Request|3
794774|NCT00744042|2527722|P1|Overall Study|Withdrawal by Subject|1
794775|NCT00744055|2527737|P2|Overall Study|Lost to Follow-up|1
794776|NCT00744055|2527738|P1|Overall Study|Lost to Follow-up|0
794777|NCT00744055|2527737|P2|Overall Study|Protocol Violation|1
794778|NCT00744055|2527738|P1|Overall Study|Protocol Violation|1
794779|NCT00744055|2527737|P2|Overall Study|Physician Decision|2
794780|NCT00744055|2527738|P1|Overall Study|Physician Decision|0
794781|NCT00744055|2527737|P2|Overall Study|Lack of Efficacy|1
794782|NCT00744055|2527738|P1|Overall Study|Lack of Efficacy|0
794783|NCT00744055|2527737|P2|Overall Study|Withdrawal by Subject|9
794784|NCT00744055|2527738|P1|Overall Study|Withdrawal by Subject|6
794785|NCT00744237|2527749|P3|Overall Study|Adverse Event|5
794786|NCT00744237|2527750|P2|Overall Study|Adverse Event|13
794787|NCT00744237|2527751|P1|Overall Study|Adverse Event|9
794788|NCT00744237|2527749|P3|Overall Study|Administrative. Site Closed|1
794789|NCT00744237|2527750|P2|Overall Study|Administrative. Site Closed|1
794790|NCT00744237|2527751|P1|Overall Study|Administrative. Site Closed|1
794791|NCT00744237|2527749|P3|Overall Study|Poor Compliance|0
794792|NCT00744237|2527750|P2|Overall Study|Poor Compliance|2
794793|NCT00744237|2527751|P1|Overall Study|Poor Compliance|0
794794|NCT00744237|2527749|P3|Overall Study|Prohibited Concomitant Medication|1
794795|NCT00744237|2527750|P2|Overall Study|Prohibited Concomitant Medication|0
794796|NCT00744237|2527751|P1|Overall Study|Prohibited Concomitant Medication|0
794797|NCT00744237|2527749|P3|Overall Study|Study Drug Error|0
794798|NCT00744237|2527750|P2|Overall Study|Study Drug Error|0
794799|NCT00744237|2527751|P1|Overall Study|Study Drug Error|1
794800|NCT00744237|2527749|P3|Overall Study|Dosing Error|1
794801|NCT00744237|2527750|P2|Overall Study|Dosing Error|0
794802|NCT00744237|2527751|P1|Overall Study|Dosing Error|1
794803|NCT00744237|2527749|P3|Overall Study|Inclusion/Exclusion criteria not met|0
794804|NCT00744237|2527750|P2|Overall Study|Inclusion/Exclusion criteria not met|0
794805|NCT00744237|2527751|P1|Overall Study|Inclusion/Exclusion criteria not met|1
794806|NCT00744237|2527749|P3|Overall Study|Protocol Violation|3
794807|NCT00744237|2527750|P2|Overall Study|Protocol Violation|4
794808|NCT00744237|2527751|P1|Overall Study|Protocol Violation|3
794809|NCT00744237|2527749|P3|Overall Study|Lost to Follow-up|1
794810|NCT00744237|2527750|P2|Overall Study|Lost to Follow-up|1
794811|NCT00744237|2527751|P1|Overall Study|Lost to Follow-up|1
794812|NCT00744237|2527749|P3|Overall Study|Withdrawal by Subject|3
794813|NCT00744237|2527750|P2|Overall Study|Withdrawal by Subject|5
794814|NCT00744237|2527751|P1|Overall Study|Withdrawal by Subject|9
794815|NCT00744237|2527749|P3|Overall Study|Lack of Efficacy|0
794816|NCT00744237|2527750|P2|Overall Study|Lack of Efficacy|1
794817|NCT00744237|2527751|P1|Overall Study|Lack of Efficacy|1
794818|NCT00744263|2527764|P2|Overall Study|Unspecified|2
794819|NCT00744263|2527765|P1|Overall Study|Unspecified|2
794820|NCT00744263|2527764|P2|Overall Study|Adverse Event|0
794821|NCT00744263|2527765|P1|Overall Study|Adverse Event|1
794822|NCT00744263|2527764|P2|Overall Study|Protocol Violation|5
794823|NCT00744263|2527765|P1|Overall Study|Protocol Violation|3
794824|NCT00744263|2527764|P2|Overall Study|Physician Decision|23
794825|NCT00744263|2527765|P1|Overall Study|Physician Decision|20
794826|NCT00744263|2527764|P2|Overall Study|Withdrawal by Subject|150
794827|NCT00744263|2527765|P1|Overall Study|Withdrawal by Subject|166
794828|NCT00744263|2527764|P2|Overall Study|Lost to Follow-up|2135
794829|NCT00744263|2527765|P1|Overall Study|Lost to Follow-up|2038
794830|NCT00744263|2527764|P2|Overall Study|Death|3005
794831|NCT00744263|2527765|P1|Overall Study|Death|3006
794832|NCT00744328|2527788|P3|Overall Study|Found ineligible after randomization|1
794833|NCT00744328|2527789|P2|Overall Study|Found ineligible after randomization|0
794834|NCT00744328|2527790|P1|Overall Study|Found ineligible after randomization|0
794835|NCT00744328|2527788|P3|Overall Study|Withdrawal by Subject|4
794836|NCT00744328|2527789|P2|Overall Study|Withdrawal by Subject|3
794837|NCT00744328|2527790|P1|Overall Study|Withdrawal by Subject|5
794838|NCT00744328|2527788|P3|Overall Study|Lost to Follow-up|3
794839|NCT00744328|2527789|P2|Overall Study|Lost to Follow-up|5
794840|NCT00744328|2527790|P1|Overall Study|Lost to Follow-up|2
794841|NCT00744497|2527823|P2|Overall Study|Not defined|13
794842|NCT00744497|2527824|P1|Overall Study|Not defined|19
794843|NCT00744497|2527823|P2|Overall Study|Maximum clinical benefit|142
794844|NCT00744497|2527824|P1|Overall Study|Maximum clinical benefit|141
794845|NCT00744497|2527823|P2|Overall Study|Patient requested to stop study drug|80
794846|NCT00744497|2527824|P1|Overall Study|Patient requested to stop study drug|65
794847|NCT00744497|2527823|P2|Overall Study|Adverse event unrelated to study drug|122
794848|NCT00744497|2527824|P1|Overall Study|Adverse event unrelated to study drug|78
794849|NCT00744497|2527823|P2|Overall Study|Study drug toxicity|141
794850|NCT00744497|2527824|P1|Overall Study|Study drug toxicity|68
794851|NCT00744497|2527823|P2|Overall Study|Disease progression|219
794852|NCT00744497|2527824|P1|Overall Study|Disease progression|312
794853|NCT00744497|2527823|P2|Overall Study|Administrative Reason By Sponsor|8
794854|NCT00744497|2527824|P1|Overall Study|Administrative Reason By Sponsor|25
794855|NCT00744497|2527823|P2|Overall Study|No longer meets study criteria|3
794856|NCT00744497|2527824|P1|Overall Study|No longer meets study criteria|7
794857|NCT00744497|2527823|P2|Overall Study|Poor compliance/noncompliance|5
794858|NCT00744497|2527824|P1|Overall Study|Poor compliance/noncompliance|9
794859|NCT00744497|2527823|P2|Overall Study|Lost to Follow-up|2
794860|NCT00744497|2527824|P1|Overall Study|Lost to Follow-up|4
794861|NCT00744497|2527823|P2|Overall Study|Death|9
794862|NCT00744497|2527824|P1|Overall Study|Death|11
794863|NCT00744497|2527823|P2|Overall Study|Withdrawal by Subject|18
794864|NCT00744497|2527824|P1|Overall Study|Withdrawal by Subject|21
794865|NCT00744523|2527860|P2|30 Days After the Procedure|Insufficient follow-up|5
794866|NCT00744523|2527861|P1|30 Days After the Procedure|Insufficient follow-up|0
794867|NCT00744627|2527881|P2|Overall Study|Other|0
794868|NCT00744627|2527882|P1|Overall Study|Other|1
794869|NCT00744627|2527881|P2|Overall Study|Lost to Follow-up|1
794870|NCT00744627|2527882|P1|Overall Study|Lost to Follow-up|2
794871|NCT00744627|2527881|P2|Overall Study|Voluntary Withdrawal|6
794872|NCT00744627|2527882|P1|Overall Study|Voluntary Withdrawal|9
794873|NCT00744627|2527881|P2|Overall Study|Protocol Deviations|2
794874|NCT00744627|2527882|P1|Overall Study|Protocol Deviations|0
794875|NCT00744627|2527881|P2|Overall Study|Noncompliance|1
794876|NCT00744627|2527882|P1|Overall Study|Noncompliance|0
794877|NCT00744627|2527881|P2|Overall Study|Lack of Efficacy|3
794878|NCT00744627|2527882|P1|Overall Study|Lack of Efficacy|7
794879|NCT00744627|2527881|P2|Overall Study|Adverse Event|9
794880|NCT00744627|2527882|P1|Overall Study|Adverse Event|6
794881|NCT00749996|2527938|P2|Overall Study|Death|0
794882|NCT00749996|2527939|P1|Overall Study|Death|1
794883|NCT00749996|2527938|P2|Overall Study|Adverse Event|0
794884|NCT00749996|2527939|P1|Overall Study|Adverse Event|1
794885|NCT00749996|2527938|P2|Overall Study|Pregnancy|2
794886|NCT00749996|2527939|P1|Overall Study|Pregnancy|0
794887|NCT00749996|2527938|P2|Overall Study|Physician Decision|0
794888|NCT00749996|2527939|P1|Overall Study|Physician Decision|2
794889|NCT00749996|2527938|P2|Overall Study|Protocol Violation|3
794890|NCT00749996|2527939|P1|Overall Study|Protocol Violation|2
794891|NCT00749996|2527938|P2|Overall Study|Withdrawal by Subject|4
794892|NCT00749996|2527939|P1|Overall Study|Withdrawal by Subject|5
794893|NCT00749996|2527938|P2|Overall Study|Lost to Follow-up|4
794894|NCT00749996|2527939|P1|Overall Study|Lost to Follow-up|7
794895|NCT00750061|2527949|P2|Overall Study|Physician Decision|1
794896|NCT00750061|2527950|P1|Overall Study|Physician Decision|0
794897|NCT00750061|2527949|P2|Overall Study|Withdrawal by Subject|1
794898|NCT00750061|2527950|P1|Overall Study|Withdrawal by Subject|0
794899|NCT00750061|2527949|P2|Overall Study|Adverse Event|0
794900|NCT00750061|2527950|P1|Overall Study|Adverse Event|2
794901|NCT00750139|2527962|P4|Overall Study|Non-specific|33
794902|NCT00750139|2527963|P3|Overall Study|Non-specific|79
794903|NCT00750139|2527964|P2|Overall Study|Non-specific|42
794904|NCT00750139|2527965|P1|Overall Study|Non-specific|62
794905|NCT00750139|2527962|P4|Overall Study|Termination by sponsor|1
794906|NCT00750139|2527963|P3|Overall Study|Termination by sponsor|0
794907|NCT00750139|2527964|P2|Overall Study|Termination by sponsor|0
794908|NCT00750139|2527965|P1|Overall Study|Termination by sponsor|4
794909|NCT00750139|2527962|P4|Overall Study|Non-compliance|3
794910|NCT00750139|2527963|P3|Overall Study|Non-compliance|1
794911|NCT00750139|2527964|P2|Overall Study|Non-compliance|0
794912|NCT00750139|2527965|P1|Overall Study|Non-compliance|1
794913|NCT00750139|2527962|P4|Overall Study|Physician Decision|0
794914|NCT00750139|2527963|P3|Overall Study|Physician Decision|0
794915|NCT00750139|2527964|P2|Overall Study|Physician Decision|1
794916|NCT00750139|2527965|P1|Overall Study|Physician Decision|1
794917|NCT00750139|2527962|P4|Overall Study|Withdrawal by Subject|2
794918|NCT00750139|2527963|P3|Overall Study|Withdrawal by Subject|6
794919|NCT00750139|2527964|P2|Overall Study|Withdrawal by Subject|2
794920|NCT00750139|2527965|P1|Overall Study|Withdrawal by Subject|3
794921|NCT00750139|2527962|P4|Overall Study|Lost to Follow-up|6
794922|NCT00750139|2527963|P3|Overall Study|Lost to Follow-up|15
794923|NCT00750139|2527964|P2|Overall Study|Lost to Follow-up|12
794924|NCT00750139|2527965|P1|Overall Study|Lost to Follow-up|17
794925|NCT00750139|2527962|P4|Overall Study|Adverse Event|1
794926|NCT00750139|2527963|P3|Overall Study|Adverse Event|0
794927|NCT00750139|2527964|P2|Overall Study|Adverse Event|2
794928|NCT00750139|2527965|P1|Overall Study|Adverse Event|1
794929|NCT00750152|2527981|P2|Overall Study|Not specified|8
794930|NCT00750152|2527982|P1|Overall Study|Not specified|7
794931|NCT00750152|2527981|P2|Overall Study|Termination by sponsor|0
794932|NCT00750152|2527982|P1|Overall Study|Termination by sponsor|1
794933|NCT00750152|2527981|P2|Overall Study|Non-compliance|1
794934|NCT00750152|2527982|P1|Overall Study|Non-compliance|0
794935|NCT00750152|2527981|P2|Overall Study|Physician Decision|1
794936|NCT00750152|2527982|P1|Overall Study|Physician Decision|1
794937|NCT00750152|2527981|P2|Overall Study|Withdrawal by Subject|3
794938|NCT00750152|2527982|P1|Overall Study|Withdrawal by Subject|3
794939|NCT00750152|2527981|P2|Overall Study|Lost to Follow-up|13
794940|NCT00750152|2527982|P1|Overall Study|Lost to Follow-up|8
794941|NCT00750152|2527981|P2|Overall Study|Adverse Event|1
794942|NCT00750152|2527982|P1|Overall Study|Adverse Event|2
794943|NCT00750204|2528007|P2|Overall Study|study halted prematurely|1
794944|NCT00750204|2528008|P1|Overall Study|study halted prematurely|1
794945|NCT00750269|2528019|P5|Overall Study|Fiducials could not be placed|1
794946|NCT00750269|2528020|P4|Overall Study|Fiducials could not be placed|0
794947|NCT00750269|2528021|P3|Overall Study|Fiducials could not be placed|0
794948|NCT00750269|2528022|P2|Overall Study|Fiducials could not be placed|0
794949|NCT00750269|2528023|P1|Overall Study|Fiducials could not be placed|0
794950|NCT00750269|2528019|P5|Overall Study|SBRT plan could not be drawn|1
794951|NCT00750269|2528020|P4|Overall Study|SBRT plan could not be drawn|0
794952|NCT00750269|2528021|P3|Overall Study|SBRT plan could not be drawn|0
794953|NCT00750269|2528022|P2|Overall Study|SBRT plan could not be drawn|0
794954|NCT00750269|2528023|P1|Overall Study|SBRT plan could not be drawn|0
794955|NCT00750269|2528019|P5|Overall Study|Site error|0
794956|NCT00750269|2528020|P4|Overall Study|Site error|1
794957|NCT00750269|2528021|P3|Overall Study|Site error|0
794958|NCT00750269|2528022|P2|Overall Study|Site error|0
794959|NCT00750269|2528023|P1|Overall Study|Site error|0
794960|NCT00750269|2528019|P5|Overall Study|Patient too large for positioning|0
794961|NCT00750269|2528020|P4|Overall Study|Patient too large for positioning|0
794962|NCT00750269|2528021|P3|Overall Study|Patient too large for positioning|1
794963|NCT00750269|2528022|P2|Overall Study|Patient too large for positioning|0
794964|NCT00750269|2528023|P1|Overall Study|Patient too large for positioning|0
794965|NCT00750269|2528019|P5|Overall Study|Physician Decision|2
794966|NCT00750269|2528020|P4|Overall Study|Physician Decision|0
794967|NCT00750269|2528021|P3|Overall Study|Physician Decision|0
794968|NCT00750269|2528022|P2|Overall Study|Physician Decision|0
794969|NCT00750269|2528023|P1|Overall Study|Physician Decision|0
794970|NCT00750269|2528019|P5|Overall Study|Withdrawal by Subject|2
794971|NCT00750269|2528020|P4|Overall Study|Withdrawal by Subject|2
794972|NCT00750269|2528021|P3|Overall Study|Withdrawal by Subject|2
794973|NCT00750269|2528022|P2|Overall Study|Withdrawal by Subject|0
794974|NCT00750269|2528023|P1|Overall Study|Withdrawal by Subject|0
794975|NCT00750269|2528019|P5|Overall Study|Protocol Violation|4
794976|NCT00750269|2528020|P4|Overall Study|Protocol Violation|2
794977|NCT00750269|2528021|P3|Overall Study|Protocol Violation|1
794978|NCT00750269|2528022|P2|Overall Study|Protocol Violation|1
794979|NCT00750269|2528023|P1|Overall Study|Protocol Violation|0
794980|NCT00750308|2528099|P12|Third Treatment|Withdrawal by Subject|0
794981|NCT00750308|2528100|P11|Third Treatment|Withdrawal by Subject|0
794982|NCT00750308|2528101|P10|Third Treatment|Withdrawal by Subject|0
794983|NCT00750308|2528102|P9|Third Treatment|Withdrawal by Subject|0
794984|NCT00750308|2528103|P8|Third Treatment|Withdrawal by Subject|0
794985|NCT00750308|2528104|P7|Third Treatment|Withdrawal by Subject|0
794986|NCT00750308|2528105|P6|Third Treatment|Withdrawal by Subject|0
794987|NCT00750308|2528106|P5|Third Treatment|Withdrawal by Subject|0
794988|NCT00750308|2528107|P4|Third Treatment|Withdrawal by Subject|0
794989|NCT00750308|2528108|P3|Third Treatment|Withdrawal by Subject|0
794990|NCT00750308|2528109|P2|Third Treatment|Withdrawal by Subject|1
794991|NCT00750308|2528110|P1|Third Treatment|Withdrawal by Subject|0
794992|NCT00750308|2528099|P12|Second Treatment|Withdrawal by Subject|0
794993|NCT00750308|2528100|P11|Second Treatment|Withdrawal by Subject|0
794994|NCT00750308|2528101|P10|Second Treatment|Withdrawal by Subject|0
794995|NCT00750308|2528102|P9|Second Treatment|Withdrawal by Subject|0
794996|NCT00750308|2528103|P8|Second Treatment|Withdrawal by Subject|0
794997|NCT00750308|2528104|P7|Second Treatment|Withdrawal by Subject|0
794998|NCT00750308|2528105|P6|Second Treatment|Withdrawal by Subject|0
794999|NCT00750308|2528106|P5|Second Treatment|Withdrawal by Subject|1
795000|NCT00750308|2528107|P4|Second Treatment|Withdrawal by Subject|0
795001|NCT00750308|2528108|P3|Second Treatment|Withdrawal by Subject|0
795002|NCT00750308|2528109|P2|Second Treatment|Withdrawal by Subject|0
795003|NCT00750308|2528110|P1|Second Treatment|Withdrawal by Subject|0
795004|NCT00750308|2528099|P12|Second Treatment|Adverse Event|0
795005|NCT00750308|2528100|P11|Second Treatment|Adverse Event|0
795006|NCT00750308|2528101|P10|Second Treatment|Adverse Event|0
795007|NCT00750308|2528102|P9|Second Treatment|Adverse Event|1
795008|NCT00750308|2528103|P8|Second Treatment|Adverse Event|0
795009|NCT00750308|2528104|P7|Second Treatment|Adverse Event|0
795010|NCT00750308|2528105|P6|Second Treatment|Adverse Event|1
795011|NCT00750308|2528106|P5|Second Treatment|Adverse Event|0
795012|NCT00750308|2528107|P4|Second Treatment|Adverse Event|0
795013|NCT00750308|2528108|P3|Second Treatment|Adverse Event|0
795014|NCT00750308|2528109|P2|Second Treatment|Adverse Event|0
795015|NCT00750308|2528110|P1|Second Treatment|Adverse Event|0
795016|NCT00750308|2528099|P12|First Treatment|Withdrawal by Subject|0
795017|NCT00750308|2528100|P11|First Treatment|Withdrawal by Subject|0
795018|NCT00750308|2528101|P10|First Treatment|Withdrawal by Subject|0
795019|NCT00750308|2528102|P9|First Treatment|Withdrawal by Subject|0
795020|NCT00750308|2528103|P8|First Treatment|Withdrawal by Subject|1
795021|NCT00750308|2528104|P7|First Treatment|Withdrawal by Subject|0
795022|NCT00750308|2528105|P6|First Treatment|Withdrawal by Subject|0
795023|NCT00750308|2528106|P5|First Treatment|Withdrawal by Subject|0
795024|NCT00750308|2528107|P4|First Treatment|Withdrawal by Subject|1
795025|NCT00750308|2528108|P3|First Treatment|Withdrawal by Subject|0
795026|NCT00750308|2528109|P2|First Treatment|Withdrawal by Subject|0
795027|NCT00750308|2528110|P1|First Treatment|Withdrawal by Subject|0
795028|NCT00750308|2528099|P12|First Treatment|Adverse Event|1
795029|NCT00750308|2528100|P11|First Treatment|Adverse Event|1
795030|NCT00750308|2528101|P10|First Treatment|Adverse Event|0
795031|NCT00750308|2528102|P9|First Treatment|Adverse Event|0
795032|NCT00750308|2528103|P8|First Treatment|Adverse Event|0
795033|NCT00750308|2528104|P7|First Treatment|Adverse Event|0
795034|NCT00750308|2528105|P6|First Treatment|Adverse Event|0
795035|NCT00750308|2528106|P5|First Treatment|Adverse Event|0
795036|NCT00750308|2528107|P4|First Treatment|Adverse Event|0
795037|NCT00750308|2528108|P3|First Treatment|Adverse Event|0
795038|NCT00750308|2528109|P2|First Treatment|Adverse Event|1
795039|NCT00750308|2528110|P1|First Treatment|Adverse Event|0
795040|NCT00751114|2528126|P2|Overall Study|Move to another city|0
795041|NCT00751114|2528127|P1|Overall Study|Move to another city|1
795042|NCT00751114|2528126|P2|Overall Study|Out of country for 2 months|0
795043|NCT00751114|2528127|P1|Overall Study|Out of country for 2 months|1
795044|NCT00751114|2528126|P2|Overall Study|Not Treated|1
795045|NCT00751114|2528127|P1|Overall Study|Not Treated|13
795046|NCT00751114|2528126|P2|Overall Study|Lack of Efficacy|7
795047|NCT00751114|2528127|P1|Overall Study|Lack of Efficacy|0
795048|NCT00751114|2528126|P2|Overall Study|Lost to Follow-up|7
795049|NCT00751114|2528127|P1|Overall Study|Lost to Follow-up|4
795050|NCT00751114|2528126|P2|Overall Study|Withdrawal by Subject|4
795051|NCT00751114|2528127|P1|Overall Study|Withdrawal by Subject|9
795052|NCT00751114|2528126|P2|Overall Study|Protocol Violation|9
795053|NCT00751114|2528127|P1|Overall Study|Protocol Violation|8
795054|NCT00751114|2528126|P2|Overall Study|Adverse Event|4
795055|NCT00751114|2528127|P1|Overall Study|Adverse Event|2
795056|NCT00751140|2528150|P1|Overall Study|benign angioma excluded from analysis|1
795057|NCT00751296|2528181|P1|Overall Study|Adverse Event|2
795058|NCT00751348|2528188|P2|Overall Study|Migration from study area|0
795059|NCT00751348|2528189|P1|Overall Study|Migration from study area|1
795060|NCT00751348|2528188|P2|Overall Study|Withdrawal by Subject|2
795061|NCT00751348|2528189|P1|Overall Study|Withdrawal by Subject|5
795062|NCT00751400|2528211|P1|Overall Study|Lost to Follow-up|10
795063|NCT00751621|2528241|P1|Overall Study|Poor adherence to asthma treatment|1
795064|NCT00751621|2528241|P1|Overall Study|Subject moved to another country|1
795065|NCT00751621|2528241|P1|Overall Study|Withdrawal by Subject|1
795066|NCT00751621|2528241|P1|Overall Study|Adverse Event|1
795067|NCT00751790|2528279|P1|Overall Study|Withdrawal by Subject|1
795068|NCT00751790|2528279|P1|Overall Study|Death|3
795069|NCT00751790|2528279|P1|Overall Study|Lost to Follow-up|1
795070|NCT00751881|2528286|P3|Extension Study Period|Other than specified above|18
795071|NCT00751881|2528287|P2|Extension Study Period|Other than specified above|30
795072|NCT00751881|2528288|P1|Extension Study Period|Other than specified above|26
795073|NCT00751881|2528286|P3|Extension Study Period|Poor Compliance to Protocol|1
795074|NCT00751881|2528287|P2|Extension Study Period|Poor Compliance to Protocol|2
795075|NCT00751881|2528288|P1|Extension Study Period|Poor Compliance to Protocol|3
795076|NCT00751881|2528286|P3|Extension Study Period|Lost to Follow-up|6
795077|NCT00751881|2528287|P2|Extension Study Period|Lost to Follow-up|9
795078|NCT00751881|2528288|P1|Extension Study Period|Lost to Follow-up|4
795079|NCT00751881|2528286|P3|Extension Study Period|Lack of Efficacy|20
795080|NCT00751881|2528287|P2|Extension Study Period|Lack of Efficacy|10
795081|NCT00751881|2528288|P1|Extension Study Period|Lack of Efficacy|14
795082|NCT00751881|2528286|P3|Extension Study Period|Adverse Event|21
795083|NCT00751881|2528287|P2|Extension Study Period|Adverse Event|20
795084|NCT00751881|2528288|P1|Extension Study Period|Adverse Event|18
795085|NCT00751881|2528286|P3|Core Treatment Period|Other:participant's decision/unspecified|16
795086|NCT00751881|2528287|P2|Core Treatment Period|Other:participant's decision/unspecified|22
795087|NCT00751881|2528288|P1|Core Treatment Period|Other:participant's decision/unspecified|19
795088|NCT00751881|2528286|P3|Core Treatment Period|Other: tolerability complaints|0
795089|NCT00751881|2528287|P2|Core Treatment Period|Other: tolerability complaints|0
795090|NCT00751881|2528288|P1|Core Treatment Period|Other: tolerability complaints|2
795091|NCT00751881|2528286|P3|Core Treatment Period|Other: MS treatment change|4
795092|NCT00751881|2528287|P2|Core Treatment Period|Other: MS treatment change|4
795093|NCT00751881|2528288|P1|Core Treatment Period|Other: MS treatment change|6
795094|NCT00751881|2528286|P3|Core Treatment Period|Other: personal/family constraints|10
795095|NCT00751881|2528287|P2|Core Treatment Period|Other: personal/family constraints|7
795096|NCT00751881|2528288|P1|Core Treatment Period|Other: personal/family constraints|6
795097|NCT00751881|2528286|P3|Core Treatment Period|Other: wish to parent|4
795098|NCT00751881|2528287|P2|Core Treatment Period|Other: wish to parent|7
795099|NCT00751881|2528288|P1|Core Treatment Period|Other: wish to parent|5
795100|NCT00751881|2528286|P3|Core Treatment Period|Other: protocol deviation|7
795101|NCT00751881|2528287|P2|Core Treatment Period|Other: protocol deviation|3
795102|NCT00751881|2528288|P1|Core Treatment Period|Other: protocol deviation|3
795103|NCT00751881|2528286|P3|Core Treatment Period|Lost to Follow-up|3
795104|NCT00751881|2528287|P2|Core Treatment Period|Lost to Follow-up|4
795105|NCT00751881|2528288|P1|Core Treatment Period|Lost to Follow-up|6
795106|NCT00751881|2528286|P3|Core Treatment Period|Poor compliance to protocol|4
795107|NCT00751881|2528287|P2|Core Treatment Period|Poor compliance to protocol|3
795108|NCT00751881|2528288|P1|Core Treatment Period|Poor compliance to protocol|15
795109|NCT00751881|2528286|P3|Core Treatment Period|Lack of Efficacy|20
795110|NCT00751881|2528287|P2|Core Treatment Period|Lack of Efficacy|30
795111|NCT00751881|2528288|P1|Core Treatment Period|Lack of Efficacy|37
795112|NCT00751881|2528286|P3|Core Treatment Period|Adverse Event|58
795113|NCT00751881|2528287|P2|Core Treatment Period|Adverse Event|54
795114|NCT00751881|2528288|P1|Core Treatment Period|Adverse Event|26
795115|NCT00751881|2528286|P3|Core Treatment Period|Not treated|2
795116|NCT00751881|2528287|P2|Core Treatment Period|Not treated|1
795117|NCT00751881|2528288|P1|Core Treatment Period|Not treated|1
795118|NCT00751933|2528335|P4|Overall Study|Physician Decision|1
795119|NCT00751933|2528336|P3|Overall Study|Physician Decision|1
795120|NCT00751933|2528337|P2|Overall Study|Physician Decision|0
795121|NCT00751933|2528338|P1|Overall Study|Physician Decision|0
795122|NCT00751933|2528335|P4|Overall Study|Withdrawal by Subject|0
795123|NCT00751933|2528336|P3|Overall Study|Withdrawal by Subject|0
795124|NCT00751933|2528337|P2|Overall Study|Withdrawal by Subject|1
795125|NCT00751933|2528338|P1|Overall Study|Withdrawal by Subject|0
795126|NCT00751998|2528358|P1|Overall Study|Withdrawal by Subject|2
795127|NCT00751998|2528358|P1|Overall Study|Death|11
795128|NCT00751998|2528358|P1|Overall Study|Lost to Follow-up|7
892442|NCT00816556|2830281|P1|Overall Study|Withdrawal by Subject|1
892443|NCT00816556|2830279|P3|Overall Study|Adverse Event|1
892444|NCT00816556|2830280|P2|Overall Study|Adverse Event|1
892445|NCT00816556|2830281|P1|Overall Study|Adverse Event|1
892446|NCT00771810|2830298|P3|Overall Study|Other|1
795134|NCT00752128|2528376|P1|Overall Study|Withdrawal by Subject|4
795135|NCT00752232|2528388|P7|Overall Study|Caregiver could not attend the subject|0
795136|NCT00752232|2528389|P6|Overall Study|Caregiver could not attend the subject|0
795137|NCT00752232|2528390|P5|Overall Study|Caregiver could not attend the subject|1
795138|NCT00752232|2528391|P4|Overall Study|Caregiver could not attend the subject|0
795139|NCT00752232|2528392|P3|Overall Study|Caregiver could not attend the subject|0
795140|NCT00752232|2528393|P2|Overall Study|Caregiver could not attend the subject|0
795141|NCT00752232|2528394|P1|Overall Study|Caregiver could not attend the subject|0
795142|NCT00752232|2528388|P7|Overall Study|Group home admission|0
795143|NCT00752232|2528389|P6|Overall Study|Group home admission|0
795144|NCT00752232|2528390|P5|Overall Study|Group home admission|0
795145|NCT00752232|2528391|P4|Overall Study|Group home admission|1
795146|NCT00752232|2528392|P3|Overall Study|Group home admission|0
795147|NCT00752232|2528393|P2|Overall Study|Group home admission|0
795148|NCT00752232|2528394|P1|Overall Study|Group home admission|0
795149|NCT00752232|2528388|P7|Overall Study|Subject request|0
795150|NCT00752232|2528389|P6|Overall Study|Subject request|0
795151|NCT00752232|2528390|P5|Overall Study|Subject request|0
795152|NCT00752232|2528391|P4|Overall Study|Subject request|0
795153|NCT00752232|2528392|P3|Overall Study|Subject request|1
795154|NCT00752232|2528393|P2|Overall Study|Subject request|0
795155|NCT00752232|2528394|P1|Overall Study|Subject request|0
795156|NCT00752232|2528388|P7|Overall Study|Investigator request|0
795157|NCT00752232|2528389|P6|Overall Study|Investigator request|0
795158|NCT00752232|2528390|P5|Overall Study|Investigator request|1
795159|NCT00752232|2528391|P4|Overall Study|Investigator request|0
795160|NCT00752232|2528392|P3|Overall Study|Investigator request|0
795161|NCT00752232|2528393|P2|Overall Study|Investigator request|0
795162|NCT00752232|2528394|P1|Overall Study|Investigator request|0
795163|NCT00752232|2528388|P7|Overall Study|Caregiver request|0
795164|NCT00752232|2528389|P6|Overall Study|Caregiver request|0
795165|NCT00752232|2528390|P5|Overall Study|Caregiver request|1
795166|NCT00752232|2528391|P4|Overall Study|Caregiver request|0
795167|NCT00752232|2528392|P3|Overall Study|Caregiver request|0
795168|NCT00752232|2528393|P2|Overall Study|Caregiver request|0
795169|NCT00752232|2528394|P1|Overall Study|Caregiver request|2
795170|NCT00752232|2528388|P7|Overall Study|Protocol Violation|0
795171|NCT00752232|2528389|P6|Overall Study|Protocol Violation|1
795172|NCT00752232|2528390|P5|Overall Study|Protocol Violation|0
795173|NCT00752232|2528391|P4|Overall Study|Protocol Violation|0
795174|NCT00752232|2528392|P3|Overall Study|Protocol Violation|0
795175|NCT00752232|2528393|P2|Overall Study|Protocol Violation|0
795176|NCT00752232|2528394|P1|Overall Study|Protocol Violation|0
795177|NCT00752609|2528468|P2|Overall Study|Received Aranesp in error|0
795178|NCT00752609|2528469|P1|Overall Study|Received Aranesp in error|1
795179|NCT00752609|2528468|P2|Overall Study|Met exclusion criteria|0
795180|NCT00752609|2528469|P1|Overall Study|Met exclusion criteria|1
795181|NCT00752609|2528468|P2|Overall Study|Death|0
795182|NCT00752609|2528469|P1|Overall Study|Death|1
795183|NCT00752609|2528468|P2|Overall Study|Physician Decision|0
795184|NCT00752609|2528469|P1|Overall Study|Physician Decision|1
795185|NCT00752609|2528468|P2|Overall Study|Withdrawal by Subject|0
795186|NCT00752609|2528469|P1|Overall Study|Withdrawal by Subject|3
795187|NCT00752609|2528468|P2|Overall Study|Adverse Event|2
795188|NCT00752609|2528469|P1|Overall Study|Adverse Event|2
795189|NCT00752622|2528488|P1|Interventional Phase|Premature Study Termination|5
795190|NCT00752622|2528488|P1|Interventional Phase|Physician Decision|1
795191|NCT00752622|2528488|P1|Interventional Phase|Non-responder|2
795192|NCT00752622|2528488|P1|Observational Phase|Unspecified|2
795193|NCT00752622|2528488|P1|Observational Phase|Adverse Event|1
795194|NCT00752622|2528488|P1|Observational Phase|Withdrawal by Subject|2
795195|NCT00752622|2528488|P1|Observational Phase|Non-responder|2
795196|NCT00752622|2528488|P1|Observational Phase|Premature Study Termination|36
795197|NCT00752622|2528488|P1|Induction Phase|Premature study termination|14
795198|NCT00752622|2528488|P1|Induction Phase|Withdrawal by Subject|1
795199|NCT00752622|2528488|P1|Induction Phase|Non-responder|14
795200|NCT00752622|2528488|P1|Induction Phase|Unspecified|3
795201|NCT00752622|2528488|P1|Induction Phase|Adverse Event|3
795202|NCT00752726|2528501|P2|Overall Study|Other Reason|2
795203|NCT00752726|2528502|P1|Overall Study|Other Reason|1
795204|NCT00752726|2528501|P2|Overall Study|Withdrawal by Subject|10
795205|NCT00752726|2528502|P1|Overall Study|Withdrawal by Subject|5
795206|NCT00752726|2528501|P2|Overall Study|Adverse Event|0
795207|NCT00752726|2528502|P1|Overall Study|Adverse Event|3
795208|NCT00752726|2528501|P2|Overall Study|Lost to Follow-up|1
795209|NCT00752726|2528502|P1|Overall Study|Lost to Follow-up|2
795210|NCT00752791|2528527|P1|Overall Study|Protocol deviation|1
795211|NCT00752791|2528527|P1|Overall Study|Switched to hemodialysis|2
795212|NCT00752791|2528527|P1|Overall Study|Renal transplant|3
795213|NCT00752791|2528527|P1|Overall Study|Death|1
795214|NCT00752791|2528527|P1|Overall Study|Physician Decision|1
795215|NCT00752791|2528527|P1|Overall Study|Withdrawal by Subject|1
795216|NCT00752791|2528527|P1|Overall Study|Adverse Event|7
795217|NCT00752895|2528539|P2|Overall Study|Withdrawal by Subject|3
795218|NCT00752895|2528540|P1|Overall Study|Withdrawal by Subject|8
795219|NCT00752986|2528561|P3|Overall Study|Protocol Violation|0
795220|NCT00752986|2528562|P2|Overall Study|Protocol Violation|0
795221|NCT00752986|2528563|P1|Overall Study|Protocol Violation|3
795222|NCT00752986|2528561|P3|Overall Study|Withdrawal by Subject|2
795223|NCT00752986|2528562|P2|Overall Study|Withdrawal by Subject|1
795224|NCT00752986|2528563|P1|Overall Study|Withdrawal by Subject|2
795225|NCT00753012|2528582|P2|Overall Study|Confounded endpoint data|0
795226|NCT00753012|2528583|P1|Overall Study|Confounded endpoint data|1
795227|NCT00753012|2528582|P2|Overall Study|Lost to Follow-up|0
795228|NCT00753012|2528583|P1|Overall Study|Lost to Follow-up|4
795229|NCT00753012|2528582|P2|Overall Study|Withdrawal by Subject|1
795230|NCT00753012|2528583|P1|Overall Study|Withdrawal by Subject|0
795231|NCT00753012|2528582|P2|Overall Study|Adverse Event|0
795232|NCT00753012|2528583|P1|Overall Study|Adverse Event|2
795233|NCT00753012|2528582|P2|Overall Study|Ineligible, abnormal cardiac histo|0
795234|NCT00753012|2528583|P1|Overall Study|Ineligible, abnormal cardiac histo|1
795235|NCT00753272|2528612|P2|Overall Study|Unspecified|1088
795236|NCT00753272|2528613|P1|Overall Study|Unspecified|1104
795237|NCT00753272|2528612|P2|Overall Study|Lost to Follow-up|497
795238|NCT00753272|2528613|P1|Overall Study|Lost to Follow-up|491
795239|NCT00753272|2528612|P2|Overall Study|Withdrawal by Subject|2407
795240|NCT00753272|2528613|P1|Overall Study|Withdrawal by Subject|2481
795241|NCT00753272|2528612|P2|Overall Study|Protocol Violation|46
795242|NCT00753272|2528613|P1|Overall Study|Protocol Violation|28
795243|NCT00753272|2528612|P2|Overall Study|Adverse Event|869
795244|NCT00753272|2528613|P1|Overall Study|Adverse Event|878
795245|NCT00753415|2528730|P10|Part B|Disease progression|1
795246|NCT00753415|2528731|P9|Part B|Disease progression|2
795247|NCT00753415|2528732|P8|Part B|Disease progression|0
795248|NCT00753415|2528733|P7|Part B|Disease progression|0
795249|NCT00753415|2528734|P6|Part B|Disease progression|0
795250|NCT00753415|2528735|P5|Part B|Disease progression|0
795251|NCT00753415|2528736|P4|Part B|Disease progression|0
795252|NCT00753415|2528737|P3|Part B|Disease progression|0
795253|NCT00753415|2528738|P2|Part B|Disease progression|0
795254|NCT00753415|2528739|P1|Part B|Disease progression|0
795255|NCT00753415|2528730|P10|Part B|Lost to Follow-up|0
795256|NCT00753415|2528731|P9|Part B|Lost to Follow-up|1
795257|NCT00753415|2528732|P8|Part B|Lost to Follow-up|1
795258|NCT00753415|2528733|P7|Part B|Lost to Follow-up|0
795259|NCT00753415|2528734|P6|Part B|Lost to Follow-up|0
795260|NCT00753415|2528735|P5|Part B|Lost to Follow-up|0
795261|NCT00753415|2528736|P4|Part B|Lost to Follow-up|0
795262|NCT00753415|2528737|P3|Part B|Lost to Follow-up|0
795263|NCT00753415|2528738|P2|Part B|Lost to Follow-up|0
795264|NCT00753415|2528739|P1|Part B|Lost to Follow-up|0
795265|NCT00753415|2528730|P10|Part A|Withdrawal by Subject|0
795266|NCT00753415|2528731|P9|Part A|Withdrawal by Subject|0
795267|NCT00753415|2528732|P8|Part A|Withdrawal by Subject|0
795268|NCT00753415|2528733|P7|Part A|Withdrawal by Subject|0
795269|NCT00753415|2528734|P6|Part A|Withdrawal by Subject|0
795270|NCT00753415|2528735|P5|Part A|Withdrawal by Subject|0
795271|NCT00753415|2528736|P4|Part A|Withdrawal by Subject|0
795272|NCT00753415|2528737|P3|Part A|Withdrawal by Subject|1
795273|NCT00753415|2528738|P2|Part A|Withdrawal by Subject|0
795274|NCT00753415|2528739|P1|Part A|Withdrawal by Subject|0
795275|NCT00753415|2528730|P10|Part A|Disease progression|0
795276|NCT00753415|2528731|P9|Part A|Disease progression|0
795277|NCT00753415|2528732|P8|Part A|Disease progression|0
795278|NCT00753415|2528733|P7|Part A|Disease progression|0
795279|NCT00753415|2528734|P6|Part A|Disease progression|0
795280|NCT00753415|2528735|P5|Part A|Disease progression|0
795281|NCT00753415|2528736|P4|Part A|Disease progression|2
795282|NCT00753415|2528737|P3|Part A|Disease progression|1
795283|NCT00753415|2528738|P2|Part A|Disease progression|0
795284|NCT00753415|2528739|P1|Part A|Disease progression|1
795285|NCT00753454|2528781|P1|Overall Study|Investigator Decision|1
795286|NCT00753454|2528781|P1|Overall Study|Withdrawal by Subject|5
795287|NCT00753454|2528781|P1|Overall Study|Lost to Follow-up|3
795288|NCT00753454|2528781|P1|Overall Study|Lack of Efficacy|1
795289|NCT00753454|2528781|P1|Overall Study|Adverse Event|4
795290|NCT00753506|2528812|P2|Overall Study|Other reason|1
795291|NCT00753506|2528813|P1|Overall Study|Other reason|1
795292|NCT00753506|2528812|P2|Overall Study|Lost to Follow-up|0
795293|NCT00753506|2528813|P1|Overall Study|Lost to Follow-up|2
795294|NCT00753506|2528812|P2|Overall Study|Withdrawal by Subject|1
795295|NCT00753506|2528813|P1|Overall Study|Withdrawal by Subject|4
795296|NCT00753519|2528821|P2|Overall Study|Withdrawal by Subject|2
795297|NCT00753519|2528822|P1|Overall Study|Withdrawal by Subject|0
795306|NCT00753623|2528883|P2|Phase II (14 Days)|Physician Decision|1
795307|NCT00753623|2528884|P1|Phase II (14 Days)|Physician Decision|0
795308|NCT00753623|2528883|P2|Washout (7 Days)|Physician Decision|0
795309|NCT00753623|2528884|P1|Washout (7 Days)|Physician Decision|1
795310|NCT00753623|2528883|P2|Phase I (14 Days)|Adverse Event|1
795311|NCT00753623|2528884|P1|Phase I (14 Days)|Adverse Event|0
795312|NCT00753623|2528883|P2|Phase I (14 Days)|Physician Decision|2
795313|NCT00753623|2528884|P1|Phase I (14 Days)|Physician Decision|1
795314|NCT00753623|2528883|P2|Phase I (14 Days)|Withdrawal by Subject|1
795315|NCT00753623|2528884|P1|Phase I (14 Days)|Withdrawal by Subject|1
795316|NCT00753649|2528902|P2|Overall Study|Protocol Violation|0
795317|NCT00753649|2528903|P1|Overall Study|Protocol Violation|2
795318|NCT00753649|2528902|P2|Overall Study|Lost to follow-up-complete vaccination|0
795319|NCT00753649|2528903|P1|Overall Study|Lost to follow-up-complete vaccination|1
795320|NCT00753649|2528902|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
795321|NCT00753649|2528903|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
795322|NCT00753649|2528902|P2|Overall Study|Migrated/moved from study area|0
795323|NCT00753649|2528903|P1|Overall Study|Migrated/moved from study area|1
795324|NCT00753675|2528926|P3|Overall Study|Lost to Follow-up|0
795325|NCT00753675|2528927|P2|Overall Study|Lost to Follow-up|0
795326|NCT00753675|2528928|P1|Overall Study|Lost to Follow-up|1
795327|NCT00753675|2528926|P3|Overall Study|Withdrawal by Subject|0
795328|NCT00753675|2528927|P2|Overall Study|Withdrawal by Subject|1
795329|NCT00753675|2528928|P1|Overall Study|Withdrawal by Subject|0
795330|NCT00753675|2528926|P3|Overall Study|Objective progression of disease|35
795331|NCT00753675|2528927|P2|Overall Study|Objective progression of disease|35
795332|NCT00753675|2528928|P1|Overall Study|Objective progression of disease|35
795333|NCT00753675|2528926|P3|Overall Study|Adverse Event|4
795334|NCT00753675|2528927|P2|Overall Study|Adverse Event|9
795335|NCT00753675|2528928|P1|Overall Study|Adverse Event|11
795336|NCT00753675|2528926|P3|Overall Study|Death|4
795337|NCT00753675|2528927|P2|Overall Study|Death|2
795338|NCT00753675|2528928|P1|Overall Study|Death|1
795339|NCT00753675|2528926|P3|Overall Study|other reason|13
795340|NCT00753675|2528927|P2|Overall Study|other reason|12
795341|NCT00753675|2528928|P1|Overall Study|other reason|11
795342|NCT00753688|2528950|P2|Overall Study|Adverse Event|1
795343|NCT00753688|2528951|P1|Overall Study|Adverse Event|0
795344|NCT00753688|2528950|P2|Overall Study|Ongoing - in Follow-up|31
795345|NCT00753688|2528951|P1|Overall Study|Ongoing - in Follow-up|15
795346|NCT00753688|2528950|P2|Overall Study|Participant Withdrew Consent|2
795347|NCT00753688|2528951|P1|Overall Study|Participant Withdrew Consent|2
795348|NCT00753688|2528950|P2|Overall Study|Missing|9
795349|NCT00753688|2528951|P1|Overall Study|Missing|4
795350|NCT00753688|2528950|P2|Overall Study|Death|203
795351|NCT00753688|2528951|P1|Overall Study|Death|102
795352|NCT00753714|2528979|P2|Overall Study|not specified|5
795353|NCT00753714|2528980|P1|Overall Study|not specified|7
795354|NCT00753714|2528979|P2|Overall Study|Death|3
795355|NCT00753714|2528980|P1|Overall Study|Death|3
795356|NCT00753714|2528979|P2|Overall Study|Withdrawal by Subject|1
795357|NCT00753714|2528980|P1|Overall Study|Withdrawal by Subject|2
795358|NCT00753714|2528979|P2|Overall Study|Lost to Follow-up|1
795359|NCT00753714|2528980|P1|Overall Study|Lost to Follow-up|0
795360|NCT00753714|2528979|P2|Overall Study|Protocol Violation|0
795361|NCT00753714|2528980|P1|Overall Study|Protocol Violation|1
795362|NCT00753714|2528979|P2|Overall Study|Adverse Event|18
795363|NCT00753714|2528980|P1|Overall Study|Adverse Event|26
795364|NCT00753714|2528979|P2|Overall Study|Lack of Efficacy|34
795365|NCT00753714|2528980|P1|Overall Study|Lack of Efficacy|21
795366|NCT00753766|2528996|P2|Overall Study|Physician Decision|0
795367|NCT00753766|2528997|P1|Overall Study|Physician Decision|1
795368|NCT00753896|2529005|P1|Overall Study|Entry Criteria Not Met|4
795369|NCT00753896|2529005|P1|Overall Study|Withdrawal by Subject|4
795370|NCT00753896|2529005|P1|Overall Study|Protocol Violation|1
795371|NCT00753896|2529005|P1|Overall Study|Lost to Follow-up|2
795372|NCT00753896|2529005|P1|Overall Study|Death|1
795373|NCT00753896|2529005|P1|Overall Study|Adverse Event|4
795374|NCT00753922|2529023|P4|Overall Study|Discontinuation Due to Explantation|4
795375|NCT00753922|2529024|P3|Overall Study|Discontinuation Due to Explantation|14
795376|NCT00753922|2529025|P2|Overall Study|Discontinuation Due to Explantation|14
795377|NCT00753922|2529026|P1|Overall Study|Discontinuation Due to Explantation|14
795378|NCT00753922|2529023|P4|Overall Study|Death|1
795379|NCT00753922|2529024|P3|Overall Study|Death|2
795380|NCT00753922|2529025|P2|Overall Study|Death|23
795381|NCT00753922|2529026|P1|Overall Study|Death|2
795382|NCT00753922|2529023|P4|Overall Study|Patients Not Completing Visit|0
795383|NCT00753922|2529024|P3|Overall Study|Patients Not Completing Visit|1
795384|NCT00753922|2529025|P2|Overall Study|Patients Not Completing Visit|0
795385|NCT00753922|2529026|P1|Overall Study|Patients Not Completing Visit|11
795386|NCT00753922|2529023|P4|Overall Study|Patient Non-compliance|11
795387|NCT00753922|2529024|P3|Overall Study|Patient Non-compliance|14
795388|NCT00753922|2529025|P2|Overall Study|Patient Non-compliance|22
795389|NCT00753922|2529026|P1|Overall Study|Patient Non-compliance|55
795390|NCT00753922|2529023|P4|Overall Study|Withdrawal by Subject|2
795391|NCT00753922|2529024|P3|Overall Study|Withdrawal by Subject|4
795392|NCT00753922|2529025|P2|Overall Study|Withdrawal by Subject|11
795393|NCT00753922|2529026|P1|Overall Study|Withdrawal by Subject|9
795394|NCT00753922|2529023|P4|Overall Study|Lost to Follow-up|5
795395|NCT00753922|2529024|P3|Overall Study|Lost to Follow-up|28
795396|NCT00753922|2529025|P2|Overall Study|Lost to Follow-up|24
795397|NCT00753922|2529026|P1|Overall Study|Lost to Follow-up|155
795398|NCT00754234|2529056|P1|Overall Study|Withdrawal by Subject|3
795399|NCT00754325|2529062|P2|Initial Treatment|Disease Progression|35
795400|NCT00754325|2529063|P1|Initial Treatment|Disease Progression|35
795401|NCT00754325|2529062|P2|Initial Treatment|Sponsor Request|1
795402|NCT00754325|2529063|P1|Initial Treatment|Sponsor Request|0
795403|NCT00754325|2529062|P2|Initial Treatment|Physician Decision|0
795404|NCT00754325|2529063|P1|Initial Treatment|Physician Decision|2
795405|NCT00754325|2529062|P2|Initial Treatment|Withdrawal by Subject|2
795406|NCT00754325|2529063|P1|Initial Treatment|Withdrawal by Subject|2
795407|NCT00754325|2529062|P2|Initial Treatment|Adverse Event|6
795408|NCT00754325|2529063|P1|Initial Treatment|Adverse Event|7
795409|NCT00754325|2529062|P2|Initial Treatment|Continuing Active Treatment|5
795410|NCT00754325|2529063|P1|Initial Treatment|Continuing Active Treatment|4
795411|NCT00754338|2529086|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
795412|NCT00754338|2529087|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
795413|NCT00754338|2529088|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
795414|NCT00754338|2529089|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
795415|NCT00754338|2529086|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
795416|NCT00754338|2529087|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
795417|NCT00754338|2529088|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
795418|NCT00754338|2529089|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
795419|NCT00754390|2529130|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
795420|NCT00754390|2529130|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
795421|NCT00754390|2529130|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
795422|NCT00754390|2529130|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
795423|NCT00754442|2529139|P2|Overall Study|Withdrawal by Subject|3
795424|NCT00754442|2529140|P1|Overall Study|Withdrawal by Subject|5
795425|NCT00754559|2529221|P1|Overall Study|Withdrawal by Subject|3
795426|NCT00754559|2529221|P1|Overall Study|Other|5
795427|NCT00754559|2529221|P1|Overall Study|Administrative reason|1
795428|NCT00754559|2529221|P1|Overall Study|Lost to Follow-up|2
795429|NCT00754559|2529221|P1|Overall Study|Lack of Efficacy|10
795430|NCT00754559|2529221|P1|Overall Study|Protocol Violation|11
795431|NCT00754559|2529221|P1|Overall Study|Adverse Event|15
795432|NCT00754572|2529245|P1|Overall Study|Lost to Follow-up|1
795433|NCT00754572|2529245|P1|Overall Study|Administrative Reason|3
795434|NCT00754572|2529245|P1|Overall Study|Death|1
795435|NCT00754572|2529245|P1|Overall Study|Lack of Efficacy|2
795436|NCT00754572|2529245|P1|Overall Study|Withdrawal by Subject|3
795437|NCT00754572|2529245|P1|Overall Study|Protocol Violation|3
795438|NCT00754572|2529245|P1|Overall Study|Unspecified|39
795439|NCT00754572|2529245|P1|Overall Study|Adverse Event|19
795440|NCT00754624|2529272|P1|Overall Study|Lost to Follow-up|3
795441|NCT00754624|2529272|P1|Overall Study|Various|12
795442|NCT00754624|2529272|P1|Overall Study|Withdrawal by Subject|28
795443|NCT00754624|2529272|P1|Overall Study|Protocol Violation|1
795444|NCT00754624|2529272|P1|Overall Study|Physician Decision|8
795445|NCT00754624|2529272|P1|Overall Study|Death|1
795446|NCT00754624|2529272|P1|Overall Study|Adverse Event|16
795447|NCT00754650|2529282|P1|Overall Study|Disease Progression|2
795448|NCT00754741|2529290|P3|Overall Study|Died or disenrolled|54
795449|NCT00754741|2529291|P2|Overall Study|Died or disenrolled|69
795450|NCT00754741|2529292|P1|Overall Study|Died or disenrolled|57
795451|NCT00754793|2529350|P2|Overall Study|voluntary withdrawn from study|1
795452|NCT00754793|2529351|P1|Overall Study|voluntary withdrawn from study|0
795453|NCT00755079|2529386|P2|Overall Study|Withdrawal by Subject|2
795454|NCT00755079|2529387|P1|Overall Study|Withdrawal by Subject|0
795455|NCT00755079|2529386|P2|Overall Study|Adverse Event|1
795456|NCT00755079|2529387|P1|Overall Study|Adverse Event|0
795457|NCT00755079|2529386|P2|Overall Study|Lost to Follow-up|3
795458|NCT00755079|2529387|P1|Overall Study|Lost to Follow-up|1
795459|NCT00755105|2529398|P3|Overall Study|Withdrawal by Subject|4
795460|NCT00755105|2529399|P2|Overall Study|Withdrawal by Subject|11
795461|NCT00755105|2529400|P1|Overall Study|Withdrawal by Subject|9
795462|NCT00755196|2529421|P1|Overall Study|Lack of Efficiency|1
795463|NCT00755196|2529421|P1|Overall Study|Lost to Follow-up|1
795464|NCT00755222|2529428|P2|Overall Study|Protocol Violation|0
795465|NCT00755222|2529429|P1|Overall Study|Protocol Violation|2
795466|NCT00755222|2529428|P2|Overall Study|Adverse Event|0
795467|NCT00755222|2529429|P1|Overall Study|Adverse Event|2
795468|NCT00755222|2529428|P2|Overall Study|Withdrawal by Subject|2
795469|NCT00755222|2529429|P1|Overall Study|Withdrawal by Subject|4
795470|NCT00755417|2529484|P3|Overall Study|Not specified or missing data|12
795471|NCT00755417|2529485|P2|Overall Study|Not specified or missing data|18
795472|NCT00755417|2529486|P1|Overall Study|Not specified or missing data|9
795473|NCT00755417|2529484|P3|Overall Study|Withdrawal by Subject|12
795474|NCT00755417|2529485|P2|Overall Study|Withdrawal by Subject|12
795475|NCT00755417|2529486|P1|Overall Study|Withdrawal by Subject|12
795476|NCT00755417|2529484|P3|Overall Study|Lost to Follow-up|1
795477|NCT00755417|2529485|P2|Overall Study|Lost to Follow-up|0
795478|NCT00755417|2529486|P1|Overall Study|Lost to Follow-up|3
795479|NCT00755417|2529484|P3|Overall Study|Protocol Violation|1
795480|NCT00755417|2529485|P2|Overall Study|Protocol Violation|1
795481|NCT00755417|2529486|P1|Overall Study|Protocol Violation|2
795482|NCT00755417|2529484|P3|Overall Study|Lack of Efficacy|9
795483|NCT00755417|2529485|P2|Overall Study|Lack of Efficacy|4
795484|NCT00755417|2529486|P1|Overall Study|Lack of Efficacy|8
795485|NCT00755417|2529484|P3|Overall Study|Adverse Event|7
795486|NCT00755417|2529485|P2|Overall Study|Adverse Event|20
795487|NCT00755417|2529486|P1|Overall Study|Adverse Event|28
892447|NCT00771810|2830299|P2|Overall Study|Other|0
892448|NCT00771810|2830300|P1|Overall Study|Other|0
892449|NCT00771810|2830298|P3|Overall Study|Withdrawal by Subject|0
892450|NCT00771810|2830299|P2|Overall Study|Withdrawal by Subject|2
892451|NCT00771810|2830300|P1|Overall Study|Withdrawal by Subject|1
892452|NCT00771810|2830298|P3|Overall Study|Protocol Violation|1
892453|NCT00771810|2830299|P2|Overall Study|Protocol Violation|1
892454|NCT00771810|2830300|P1|Overall Study|Protocol Violation|0
892455|NCT00771810|2830298|P3|Overall Study|Physician Decision|2
892456|NCT00771810|2830299|P2|Overall Study|Physician Decision|2
892457|NCT00771810|2830300|P1|Overall Study|Physician Decision|1
892458|NCT00771810|2830298|P3|Overall Study|Lost to Follow-up|1
795500|NCT00755807|2529537|P2|Open-label Extension Phase|Sponsor Decision|1
795501|NCT00755807|2529538|P1|Open-label Extension Phase|Sponsor Decision|0
795502|NCT00755807|2529537|P2|Open-label Extension Phase|Lost to Follow-up|0
795503|NCT00755807|2529538|P1|Open-label Extension Phase|Lost to Follow-up|2
795504|NCT00755807|2529537|P2|Open-label Extension Phase|Withdrawal by Subject|3
795505|NCT00755807|2529538|P1|Open-label Extension Phase|Withdrawal by Subject|1
795506|NCT00755807|2529537|P2|Open-label Extension Phase|Lack of Efficacy|3
795507|NCT00755807|2529538|P1|Open-label Extension Phase|Lack of Efficacy|3
795508|NCT00755807|2529537|P2|Open-label Extension Phase|Protocol Violation|2
795509|NCT00755807|2529538|P1|Open-label Extension Phase|Protocol Violation|5
795510|NCT00755807|2529537|P2|Open-label Extension Phase|Adverse Event|7
795511|NCT00755807|2529538|P1|Open-label Extension Phase|Adverse Event|7
795512|NCT00755807|2529537|P2|Acute Phase|Physician Decision|1
795513|NCT00755807|2529538|P1|Acute Phase|Physician Decision|0
795514|NCT00755807|2529537|P2|Acute Phase|Lack of Efficacy|1
795515|NCT00755807|2529538|P1|Acute Phase|Lack of Efficacy|0
795516|NCT00755807|2529537|P2|Acute Phase|Withdrawal by Subject|2
795517|NCT00755807|2529538|P1|Acute Phase|Withdrawal by Subject|1
795518|NCT00755807|2529537|P2|Acute Phase|Protocol Violation|3
795519|NCT00755807|2529538|P1|Acute Phase|Protocol Violation|1
795520|NCT00755807|2529537|P2|Acute Phase|Adverse Event|5
795521|NCT00755807|2529538|P1|Acute Phase|Adverse Event|16
795522|NCT00755846|2529605|P6|Overall Study|Participant Non-compliance|0
795523|NCT00755846|2529606|P5|Overall Study|Participant Non-compliance|1
795524|NCT00755846|2529607|P4|Overall Study|Participant Non-compliance|0
795525|NCT00755846|2529608|P3|Overall Study|Participant Non-compliance|0
795526|NCT00755846|2529609|P2|Overall Study|Participant Non-compliance|0
795527|NCT00755846|2529610|P1|Overall Study|Participant Non-compliance|0
795528|NCT00755846|2529605|P6|Overall Study|Administrative Error|0
795529|NCT00755846|2529606|P5|Overall Study|Administrative Error|0
795530|NCT00755846|2529607|P4|Overall Study|Administrative Error|0
795531|NCT00755846|2529608|P3|Overall Study|Administrative Error|0
795532|NCT00755846|2529609|P2|Overall Study|Administrative Error|1
795533|NCT00755846|2529610|P1|Overall Study|Administrative Error|0
795534|NCT00755846|2529605|P6|Overall Study|Physician Decision|1
795535|NCT00755846|2529606|P5|Overall Study|Physician Decision|0
795536|NCT00755846|2529607|P4|Overall Study|Physician Decision|1
795537|NCT00755846|2529608|P3|Overall Study|Physician Decision|0
795538|NCT00755846|2529609|P2|Overall Study|Physician Decision|3
795539|NCT00755846|2529610|P1|Overall Study|Physician Decision|1
795540|NCT00755846|2529605|P6|Overall Study|Hyperglycemic Rescue|7
795541|NCT00755846|2529606|P5|Overall Study|Hyperglycemic Rescue|8
795542|NCT00755846|2529607|P4|Overall Study|Hyperglycemic Rescue|8
795543|NCT00755846|2529608|P3|Overall Study|Hyperglycemic Rescue|5
795544|NCT00755846|2529609|P2|Overall Study|Hyperglycemic Rescue|7
795545|NCT00755846|2529610|P1|Overall Study|Hyperglycemic Rescue|21
795546|NCT00755846|2529605|P6|Overall Study|Withdrawal by Subject|1
795547|NCT00755846|2529606|P5|Overall Study|Withdrawal by Subject|0
795548|NCT00755846|2529607|P4|Overall Study|Withdrawal by Subject|2
795549|NCT00755846|2529608|P3|Overall Study|Withdrawal by Subject|5
795550|NCT00755846|2529609|P2|Overall Study|Withdrawal by Subject|3
795551|NCT00755846|2529610|P1|Overall Study|Withdrawal by Subject|2
795552|NCT00755846|2529605|P6|Overall Study|Lost to Follow-up|2
795553|NCT00755846|2529606|P5|Overall Study|Lost to Follow-up|4
795554|NCT00755846|2529607|P4|Overall Study|Lost to Follow-up|0
795555|NCT00755846|2529608|P3|Overall Study|Lost to Follow-up|1
795556|NCT00755846|2529609|P2|Overall Study|Lost to Follow-up|2
795557|NCT00755846|2529610|P1|Overall Study|Lost to Follow-up|0
795558|NCT00755846|2529605|P6|Overall Study|Protocol Violation|1
795559|NCT00755846|2529606|P5|Overall Study|Protocol Violation|1
795560|NCT00755846|2529607|P4|Overall Study|Protocol Violation|1
795561|NCT00755846|2529608|P3|Overall Study|Protocol Violation|1
795562|NCT00755846|2529609|P2|Overall Study|Protocol Violation|1
795563|NCT00755846|2529610|P1|Overall Study|Protocol Violation|1
795564|NCT00755846|2529605|P6|Overall Study|Adverse Event|2
795565|NCT00755846|2529606|P5|Overall Study|Adverse Event|3
795566|NCT00755846|2529607|P4|Overall Study|Adverse Event|1
795567|NCT00755846|2529608|P3|Overall Study|Adverse Event|0
795568|NCT00755846|2529609|P2|Overall Study|Adverse Event|0
795569|NCT00755846|2529610|P1|Overall Study|Adverse Event|0
795570|NCT00755937|2529719|P1|Observational Follow-up|Lost to Follow-up|148
795571|NCT00755937|2529719|P1|Recruitment|Unknown if infliximab received|164
795572|NCT00756002|2529731|P2|Double-Blind Treatment Period|Not Specified|2
795573|NCT00756002|2529732|P1|Double-Blind Treatment Period|Not Specified|2
795574|NCT00756002|2529731|P2|Double-Blind Treatment Period|Protocol Violation|5
795575|NCT00756002|2529732|P1|Double-Blind Treatment Period|Protocol Violation|6
795576|NCT00756002|2529731|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
795577|NCT00756002|2529732|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
795578|NCT00756002|2529731|P2|Double-Blind Treatment Period|Lost to Follow-up|1
795579|NCT00756002|2529732|P1|Double-Blind Treatment Period|Lost to Follow-up|0
795580|NCT00756002|2529731|P2|Double-Blind Treatment Period|Lack of Efficacy|1
795581|NCT00756002|2529732|P1|Double-Blind Treatment Period|Lack of Efficacy|1
795582|NCT00756314|2529854|P2|Overall Study|Lost to Follow-up|59
795583|NCT00756314|2529855|P1|Overall Study|Lost to Follow-up|2
795584|NCT00756444|2529871|P2|Overall Study|Ineligibility Determined|0
795585|NCT00756444|2529872|P1|Overall Study|Ineligibility Determined|1
795586|NCT00756444|2529871|P2|Overall Study|Disease Progression|7
795587|NCT00756444|2529872|P1|Overall Study|Disease Progression|2
795588|NCT00756444|2529871|P2|Overall Study|Death|4
795589|NCT00756444|2529872|P1|Overall Study|Death|5
795590|NCT00756444|2529871|P2|Overall Study|Lost to Follow-up|1
795591|NCT00756444|2529872|P1|Overall Study|Lost to Follow-up|0
795592|NCT00756444|2529871|P2|Overall Study|Withdrawal by Subject|8
795593|NCT00756444|2529872|P1|Overall Study|Withdrawal by Subject|6
795594|NCT00756444|2529871|P2|Overall Study|Adverse Event|1
795595|NCT00756444|2529872|P1|Overall Study|Adverse Event|1
795596|NCT00756457|2529883|P2|Overall Study|Lost to Follow-up|2
795597|NCT00756457|2529884|P1|Overall Study|Lost to Follow-up|1
795598|NCT00756470|2529912|P1|Overall Study|Adverse Event|4
795599|NCT00756470|2529912|P1|Overall Study|Withdrawal by Subject|1
795600|NCT00756574|2529953|P2|Overall Study|Lost to Follow-up|4
795601|NCT00756574|2529954|P1|Overall Study|Lost to Follow-up|4
795602|NCT00756574|2529953|P2|Overall Study|Withdrawal by Subject|7
795603|NCT00756574|2529954|P1|Overall Study|Withdrawal by Subject|9
795604|NCT00750737|2530029|P2|Overall Study|Withdrawal by Subject|3
795605|NCT00750737|2530030|P1|Overall Study|Withdrawal by Subject|3
795606|NCT00750867|2530052|P1|Overall Study|Adverse Event|2
795607|NCT00750880|2530057|P1|Overall Study|Administrative|11
795608|NCT00750880|2530057|P1|Overall Study|Physician Decision|20
795609|NCT00750880|2530057|P1|Overall Study|Withdrawal by Subject|33
795610|NCT00750880|2530057|P1|Overall Study|Protocol Violation|15
795611|NCT00750880|2530057|P1|Overall Study|Lost to Follow-up|10
795612|NCT00750880|2530057|P1|Overall Study|Lack of Efficacy|46
795613|NCT00750880|2530057|P1|Overall Study|Death|4
795614|NCT00750880|2530057|P1|Overall Study|Adverse Event|76
795615|NCT00750893|2530080|P1|Overall Study|Unspecified|17
795616|NCT00750893|2530080|P1|Overall Study|Lost to Follow-up|510
795617|NCT00750893|2530080|P1|Overall Study|Withdrawal by Subject|10
795618|NCT00750893|2530080|P1|Overall Study|Adverse Event|5
795619|NCT00750919|2530095|P1|Overall Study|Unspecified|36
795620|NCT00750919|2530095|P1|Overall Study|Could not cooperate, unrelated to trial|4
795621|NCT00750919|2530095|P1|Overall Study|Lack of Efficacy|8
795622|NCT00750919|2530095|P1|Overall Study|Withdrawal by Subject|1
795623|NCT00750919|2530095|P1|Overall Study|Adverse Event|9
795624|NCT00751036|2530105|P2|Overall Study|Missing end of Treatment Page|3
795625|NCT00751036|2530106|P1|Overall Study|Missing end of Treatment Page|2
795626|NCT00751036|2530105|P2|Overall Study|Protocol Violation|0
795627|NCT00751036|2530106|P1|Overall Study|Protocol Violation|1
795628|NCT00751036|2530105|P2|Overall Study|Lost to Follow-up|1
795629|NCT00751036|2530106|P1|Overall Study|Lost to Follow-up|0
795630|NCT00751036|2530105|P2|Overall Study|Death|3
795631|NCT00751036|2530106|P1|Overall Study|Death|3
795632|NCT00751036|2530105|P2|Overall Study|Withdrawal by Subject|2
795633|NCT00751036|2530106|P1|Overall Study|Withdrawal by Subject|5
795634|NCT00751036|2530105|P2|Overall Study|Administrative Problems|4
795635|NCT00751036|2530106|P1|Overall Study|Administrative Problems|3
795636|NCT00751036|2530105|P2|Overall Study|Adverse Event|4
795637|NCT00751036|2530106|P1|Overall Study|Adverse Event|6
795638|NCT00751036|2530105|P2|Overall Study|Disease Progression|29
795639|NCT00751036|2530106|P1|Overall Study|Disease Progression|28
795640|NCT00756730|2530120|P2|Overall Study|persistent low-level viremmia|1
795641|NCT00756730|2530121|P1|Overall Study|persistent low-level viremmia|0
795642|NCT00756730|2530120|P2|Overall Study|discontinued due to rash prior to week 4|1
795643|NCT00756730|2530121|P1|Overall Study|discontinued due to rash prior to week 4|0
795644|NCT00756886|2530143|P2|Overall Study|Ineligible|4
795645|NCT00756886|2530144|P1|Overall Study|Ineligible|9
795646|NCT00756886|2530143|P2|Overall Study|Lack of Efficacy|0
795647|NCT00756886|2530144|P1|Overall Study|Lack of Efficacy|1
795648|NCT00756886|2530143|P2|Overall Study|Adverse Event|3
795649|NCT00756886|2530144|P1|Overall Study|Adverse Event|0
795650|NCT00756886|2530143|P2|Overall Study|Lost to Follow-up|0
795651|NCT00756886|2530144|P1|Overall Study|Lost to Follow-up|1
892459|NCT00771810|2830299|P2|Overall Study|Lost to Follow-up|0
892460|NCT00771810|2830300|P1|Overall Study|Lost to Follow-up|0
892461|NCT00771810|2830298|P3|Overall Study|Adverse Event|2
892462|NCT00771810|2830299|P2|Overall Study|Adverse Event|0
892463|NCT00771810|2830300|P1|Overall Study|Adverse Event|3
892470|NCT00703326|2830369|P2|Overall Study|Withdrawal by Subject|20
892471|NCT00703326|2830370|P1|Overall Study|Withdrawal by Subject|42
892472|NCT00703326|2830369|P2|Overall Study|Lost to Follow-up|8
892473|NCT00703326|2830370|P1|Overall Study|Lost to Follow-up|25
892474|NCT00703326|2830369|P2|Overall Study|Still on study|197
892475|NCT00703326|2830370|P1|Overall Study|Still on study|380
892476|NCT00570674|2830440|P7|Overall Study|Withdrawal by Subject|0
892477|NCT00570674|2830441|P6|Overall Study|Withdrawal by Subject|0
892478|NCT00570674|2830442|P5|Overall Study|Withdrawal by Subject|0
892479|NCT00570674|2830443|P4|Overall Study|Withdrawal by Subject|0
892480|NCT00570674|2830444|P3|Overall Study|Withdrawal by Subject|1
892481|NCT00570674|2830445|P2|Overall Study|Withdrawal by Subject|0
892482|NCT00570674|2830446|P1|Overall Study|Withdrawal by Subject|0
892483|NCT00543543|2830467|P4|Extension Study|Withdrawal by Subject|120
892484|NCT00543543|2830468|P3|Extension Study|Withdrawal by Subject|0
892485|NCT00543543|2830469|P2|Extension Study|Withdrawal by Subject|0
892486|NCT00543543|2830470|P1|Extension Study|Withdrawal by Subject|0
892487|NCT00543543|2830467|P4|Extension Study|Protocol Violation|11
892488|NCT00543543|2830468|P3|Extension Study|Protocol Violation|0
892489|NCT00543543|2830469|P2|Extension Study|Protocol Violation|0
892490|NCT00543543|2830470|P1|Extension Study|Protocol Violation|0
892491|NCT00543543|2830467|P4|Extension Study|Pregnancy|6
892492|NCT00543543|2830468|P3|Extension Study|Pregnancy|0
892493|NCT00543543|2830469|P2|Extension Study|Pregnancy|0
892494|NCT00543543|2830470|P1|Extension Study|Pregnancy|0
892495|NCT00543543|2830467|P4|Extension Study|Physician Decision|7
892496|NCT00543543|2830468|P3|Extension Study|Physician Decision|0
892497|NCT00543543|2830469|P2|Extension Study|Physician Decision|0
892498|NCT00543543|2830470|P1|Extension Study|Physician Decision|0
892499|NCT00543543|2830467|P4|Extension Study|Lost to Follow-up|77
892500|NCT00543543|2830468|P3|Extension Study|Lost to Follow-up|0
892501|NCT00543543|2830469|P2|Extension Study|Lost to Follow-up|0
892502|NCT00543543|2830470|P1|Extension Study|Lost to Follow-up|0
795696|NCT00757003|2530220|P1|Overall Study|Not implanted|1
795697|NCT00757003|2530220|P1|Overall Study|Surgically explanted|2
795698|NCT00757003|2530220|P1|Overall Study|Withdrawal by Subject|4
795699|NCT00757003|2530220|P1|Overall Study|Lost to Follow-up|9
795700|NCT00757003|2530220|P1|Overall Study|Death|33
795701|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Not specified|0
795702|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Not specified|1
795703|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
795704|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
795705|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
795706|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
795707|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
795708|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
795709|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
795710|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
795711|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
795712|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
795713|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
795714|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
795715|NCT00757588|2530235|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
795716|NCT00757588|2530236|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
795717|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Not specified|1
892503|NCT00543543|2830467|P4|Extension Study|Adverse Event|5
892504|NCT00543543|2830468|P3|Extension Study|Adverse Event|0
892505|NCT00543543|2830469|P2|Extension Study|Adverse Event|0
892506|NCT00543543|2830470|P1|Extension Study|Adverse Event|0
795718|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Not specified|0
795719|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
795720|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
795721|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
795722|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
795723|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
795724|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
795725|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Death|0
795726|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Death|1
795727|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
795728|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
795729|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
795730|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
795731|NCT00757588|2530235|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
795732|NCT00757588|2530236|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
795733|NCT00757627|2530388|P1|Overall Study|Unspecified|1
795734|NCT00757627|2530388|P1|Overall Study|Withdrawal by Subject|27
795735|NCT00757627|2530388|P1|Overall Study|Lost to Follow-up|28
795736|NCT00757627|2530388|P1|Overall Study|Lack of Efficacy|10
795737|NCT00757627|2530388|P1|Overall Study|Adverse Event|15
795738|NCT00757705|2530418|P1|Overall Study|Unspecified|18
795739|NCT00757705|2530418|P1|Overall Study|Non-compliant|9
795740|NCT00757705|2530418|P1|Overall Study|Ineligible to continue|8
795741|NCT00757705|2530418|P1|Overall Study|Insufficient Response|26
795742|NCT00757705|2530418|P1|Overall Study|Withdrawal by Subject|25
795743|NCT00757705|2530418|P1|Overall Study|Lost to Follow-up|16
795744|NCT00757705|2530418|P1|Overall Study|Adverse Event|19
795745|NCT00757783|2530432|P2|Overall Study|Unspecified|2
795746|NCT00757783|2530433|P1|Overall Study|Unspecified|1
795747|NCT00757783|2530432|P2|Overall Study|Withdrawal by Subject|1
795748|NCT00757783|2530433|P1|Overall Study|Withdrawal by Subject|2
795749|NCT00757783|2530432|P2|Overall Study|Protocol Violation|0
795750|NCT00757783|2530433|P1|Overall Study|Protocol Violation|1
795751|NCT00757783|2530432|P2|Overall Study|Lost to Follow-up|1
795752|NCT00757783|2530433|P1|Overall Study|Lost to Follow-up|1
795753|NCT00757783|2530432|P2|Overall Study|Adverse Event|2
795754|NCT00757783|2530433|P1|Overall Study|Adverse Event|0
795755|NCT00757848|2530494|P2|Overall Study|Incorrect enrolment|0
795756|NCT00757848|2530495|P1|Overall Study|Incorrect enrolment|1
795757|NCT00757848|2530494|P2|Overall Study|Adverse Event|2
795758|NCT00757848|2530495|P1|Overall Study|Adverse Event|1
795759|NCT00757848|2530494|P2|Overall Study|Voluntary discontinuation|0
795760|NCT00757848|2530495|P1|Overall Study|Voluntary discontinuation|1
795761|NCT00758043|2530543|P4|Overall Study|Other Reasons|5
795762|NCT00758043|2530544|P3|Overall Study|Other Reasons|0
795763|NCT00758043|2530545|P2|Overall Study|Other Reasons|1
795764|NCT00758043|2530546|P1|Overall Study|Other Reasons|0
795765|NCT00758043|2530543|P4|Overall Study|Non-Compliant With study Drug|1
795766|NCT00758043|2530544|P3|Overall Study|Non-Compliant With study Drug|0
795767|NCT00758043|2530545|P2|Overall Study|Non-Compliant With study Drug|0
795768|NCT00758043|2530546|P1|Overall Study|Non-Compliant With study Drug|0
795769|NCT00758043|2530543|P4|Overall Study|Required Prohibited Medication|3
795770|NCT00758043|2530544|P3|Overall Study|Required Prohibited Medication|1
795771|NCT00758043|2530545|P2|Overall Study|Required Prohibited Medication|0
795772|NCT00758043|2530546|P1|Overall Study|Required Prohibited Medication|0
795773|NCT00758043|2530543|P4|Overall Study|Withdrawal by Subject|4
795774|NCT00758043|2530544|P3|Overall Study|Withdrawal by Subject|1
795775|NCT00758043|2530545|P2|Overall Study|Withdrawal by Subject|1
795776|NCT00758043|2530546|P1|Overall Study|Withdrawal by Subject|0
795777|NCT00758043|2530543|P4|Overall Study|Lost to Follow-up|5
795778|NCT00758043|2530544|P3|Overall Study|Lost to Follow-up|2
795779|NCT00758043|2530545|P2|Overall Study|Lost to Follow-up|2
795780|NCT00758043|2530546|P1|Overall Study|Lost to Follow-up|0
795781|NCT00758043|2530543|P4|Overall Study|Refused Further Treatment|8
795782|NCT00758043|2530544|P3|Overall Study|Refused Further Treatment|5
795783|NCT00758043|2530545|P2|Overall Study|Refused Further Treatment|11
795784|NCT00758043|2530546|P1|Overall Study|Refused Further Treatment|0
795785|NCT00758043|2530543|P4|Overall Study|Lack of Efficacy|12
795786|NCT00758043|2530544|P3|Overall Study|Lack of Efficacy|18
795787|NCT00758043|2530545|P2|Overall Study|Lack of Efficacy|6
795788|NCT00758043|2530546|P1|Overall Study|Lack of Efficacy|0
795789|NCT00758043|2530543|P4|Overall Study|Adverse Event|62
795790|NCT00758043|2530544|P3|Overall Study|Adverse Event|12
795791|NCT00758043|2530545|P2|Overall Study|Adverse Event|20
795792|NCT00758043|2530546|P1|Overall Study|Adverse Event|1
795793|NCT00758069|2530575|P3|Overall Study|Incorrect Study Drug|0
795794|NCT00758069|2530576|P2|Overall Study|Incorrect Study Drug|0
795795|NCT00758069|2530577|P1|Overall Study|Incorrect Study Drug|1
795796|NCT00758069|2530575|P3|Overall Study|Lack of Efficacy|1
795797|NCT00758069|2530576|P2|Overall Study|Lack of Efficacy|0
795798|NCT00758069|2530577|P1|Overall Study|Lack of Efficacy|0
795799|NCT00758160|2530588|P1|Overall Study|Withdrawal by Subject|8
795800|NCT00758160|2530588|P1|Overall Study|Protocol Violation|12
795801|NCT00758160|2530588|P1|Overall Study|Lost to Follow-up|14
795802|NCT00758160|2530588|P1|Overall Study|Lack of Efficacy|10
795803|NCT00758160|2530588|P1|Overall Study|Adverse Event|15
795804|NCT00758160|2530588|P1|Overall Study|Administration Problems|3
795805|NCT00758160|2530588|P1|Overall Study|No Longer Requires Study Medication|4
795806|NCT00758394|2530626|P4|3rd Intervention|Lost to Follow-up|1
795807|NCT00758394|2530627|P3|3rd Intervention|Lost to Follow-up|0
795808|NCT00758394|2530628|P2|3rd Intervention|Lost to Follow-up|0
795809|NCT00758394|2530629|P1|3rd Intervention|Lost to Follow-up|1
795810|NCT00758394|2530626|P4|2nd Intervention Order|Lost to Follow-up|0
795811|NCT00758394|2530627|P3|2nd Intervention Order|Lost to Follow-up|0
795812|NCT00758394|2530628|P2|2nd Intervention Order|Lost to Follow-up|1
795813|NCT00758394|2530629|P1|2nd Intervention Order|Lost to Follow-up|0
795814|NCT00758459|2530650|P2|Overall Study|Withdrawal by Subject|1
795815|NCT00758459|2530651|P1|Overall Study|Withdrawal by Subject|0
795816|NCT00758459|2530650|P2|Overall Study|Protocol Violation|1
795817|NCT00758459|2530651|P1|Overall Study|Protocol Violation|0
795818|NCT00758459|2530650|P2|Overall Study|Adverse Event|2
795819|NCT00758459|2530651|P1|Overall Study|Adverse Event|3
795820|NCT00758485|2530685|P2|Overall Study|Not Treated|2
795821|NCT00758485|2530686|P1|Overall Study|Not Treated|1
795822|NCT00758485|2530685|P2|Overall Study|Lost to Follow-up|1
795823|NCT00758485|2530686|P1|Overall Study|Lost to Follow-up|0
795824|NCT00758498|2530699|P3|Overall Study|Noncompliance to study procedures|1
795825|NCT00758498|2530700|P2|Overall Study|Noncompliance to study procedures|0
795826|NCT00758498|2530701|P1|Overall Study|Noncompliance to study procedures|0
795827|NCT00758498|2530699|P3|Overall Study|Withdrawal by Subject|1
795828|NCT00758498|2530700|P2|Overall Study|Withdrawal by Subject|0
795829|NCT00758498|2530701|P1|Overall Study|Withdrawal by Subject|0
795830|NCT00758498|2530699|P3|Overall Study|Subject legally detained out of state|0
795831|NCT00758498|2530700|P2|Overall Study|Subject legally detained out of state|0
795832|NCT00758498|2530701|P1|Overall Study|Subject legally detained out of state|1
795833|NCT00758498|2530699|P3|Overall Study|Adverse Event|3
795834|NCT00758498|2530700|P2|Overall Study|Adverse Event|2
795835|NCT00758498|2530701|P1|Overall Study|Adverse Event|2
795836|NCT00758589|2530812|P4|Overall Study|Palm stopped to work|1
795837|NCT00758589|2530813|P3|Overall Study|Palm stopped to work|0
795838|NCT00758589|2530814|P2|Overall Study|Palm stopped to work|0
795839|NCT00758589|2530815|P1|Overall Study|Palm stopped to work|0
795840|NCT00758589|2530812|P4|Overall Study|Withdrawal by Subject|1
795841|NCT00758589|2530813|P3|Overall Study|Withdrawal by Subject|1
795842|NCT00758589|2530814|P2|Overall Study|Withdrawal by Subject|1
795843|NCT00758589|2530815|P1|Overall Study|Withdrawal by Subject|0
795844|NCT00758589|2530812|P4|Overall Study|Adverse Event|4
795845|NCT00758589|2530813|P3|Overall Study|Adverse Event|5
795846|NCT00758589|2530814|P2|Overall Study|Adverse Event|2
795847|NCT00758589|2530815|P1|Overall Study|Adverse Event|3
795848|NCT00758602|2530883|P2|Overall Study|Reason not specified|3
795849|NCT00758602|2530884|P1|Overall Study|Reason not specified|3
795850|NCT00758602|2530883|P2|Overall Study|Death|1
795851|NCT00758602|2530884|P1|Overall Study|Death|0
795852|NCT00758602|2530883|P2|Overall Study|Protocol Violation|2
795853|NCT00758602|2530884|P1|Overall Study|Protocol Violation|0
795854|NCT00758602|2530883|P2|Overall Study|Withdrawal by Subject|3
795855|NCT00758602|2530884|P1|Overall Study|Withdrawal by Subject|1
795856|NCT00758602|2530883|P2|Overall Study|Lost to Follow-up|3
795857|NCT00758602|2530884|P1|Overall Study|Lost to Follow-up|4
795858|NCT00758602|2530883|P2|Overall Study|Adverse Event|10
795859|NCT00758602|2530884|P1|Overall Study|Adverse Event|11
795860|NCT00758680|2530917|P10|Overall Study|Withdrawal by Subject|0
795861|NCT00758680|2530918|P9|Overall Study|Withdrawal by Subject|1
795862|NCT00758680|2530919|P8|Overall Study|Withdrawal by Subject|0
795863|NCT00758680|2530920|P7|Overall Study|Withdrawal by Subject|1
795864|NCT00758680|2530921|P6|Overall Study|Withdrawal by Subject|0
795865|NCT00758680|2530922|P5|Overall Study|Withdrawal by Subject|0
795866|NCT00758680|2530923|P4|Overall Study|Withdrawal by Subject|0
795867|NCT00758680|2530924|P3|Overall Study|Withdrawal by Subject|0
795868|NCT00758680|2530925|P2|Overall Study|Withdrawal by Subject|0
795869|NCT00758680|2530926|P1|Overall Study|Withdrawal by Subject|0
795870|NCT00758680|2530917|P10|Overall Study|Laboratory Adverse Event|0
795871|NCT00758680|2530918|P9|Overall Study|Laboratory Adverse Event|1
795872|NCT00758680|2530919|P8|Overall Study|Laboratory Adverse Event|0
795873|NCT00758680|2530920|P7|Overall Study|Laboratory Adverse Event|0
795874|NCT00758680|2530921|P6|Overall Study|Laboratory Adverse Event|0
795875|NCT00758680|2530922|P5|Overall Study|Laboratory Adverse Event|0
795876|NCT00758680|2530923|P4|Overall Study|Laboratory Adverse Event|0
795877|NCT00758680|2530924|P3|Overall Study|Laboratory Adverse Event|0
795878|NCT00758680|2530925|P2|Overall Study|Laboratory Adverse Event|0
795879|NCT00758680|2530926|P1|Overall Study|Laboratory Adverse Event|0
795880|NCT00758680|2530917|P10|Overall Study|Adverse Event|1
795881|NCT00758680|2530918|P9|Overall Study|Adverse Event|0
795882|NCT00758680|2530919|P8|Overall Study|Adverse Event|1
795883|NCT00758680|2530920|P7|Overall Study|Adverse Event|0
795884|NCT00758680|2530921|P6|Overall Study|Adverse Event|0
795885|NCT00758680|2530922|P5|Overall Study|Adverse Event|0
795886|NCT00758680|2530923|P4|Overall Study|Adverse Event|0
795887|NCT00758680|2530924|P3|Overall Study|Adverse Event|0
795888|NCT00758680|2530925|P2|Overall Study|Adverse Event|0
795889|NCT00758680|2530926|P1|Overall Study|Adverse Event|0
795890|NCT00758706|2530968|P2|Overall Study|Adverse Event|4
795891|NCT00758706|2530969|P1|Overall Study|Adverse Event|4
795892|NCT00758771|2531057|P2|Overall Study|Did not meet eligibility criteria|4
795893|NCT00758771|2531058|P1|Overall Study|Did not meet eligibility criteria|2
795894|NCT00758771|2531057|P2|Overall Study|Withdrawal by Subject|1
795895|NCT00758771|2531058|P1|Overall Study|Withdrawal by Subject|1
795896|NCT00759031|2531095|P2|First Intervention (1 Day)|Screening failure|0
795897|NCT00759031|2531096|P1|First Intervention (1 Day)|Screening failure|1
795898|NCT00759031|2531095|P2|First Intervention (1 Day)|Withdrawal by Subject|1
795899|NCT00759031|2531096|P1|First Intervention (1 Day)|Withdrawal by Subject|0
795900|NCT00759031|2531095|P2|First Intervention (1 Day)|Physician Decision|0
795901|NCT00759031|2531096|P1|First Intervention (1 Day)|Physician Decision|1
892507|NCT00543543|2830467|P4|Base Study|Withdrawal by Subject|503
892508|NCT00543543|2830468|P3|Base Study|Withdrawal by Subject|5
892509|NCT00543543|2830469|P2|Base Study|Withdrawal by Subject|482
892510|NCT00543543|2830470|P1|Base Study|Withdrawal by Subject|7
892511|NCT00543543|2830467|P4|Base Study|Protocol Violation|6
892512|NCT00543543|2830468|P3|Base Study|Protocol Violation|0
892513|NCT00543543|2830469|P2|Base Study|Protocol Violation|6
892514|NCT00543543|2830470|P1|Base Study|Protocol Violation|0
892515|NCT00543543|2830467|P4|Base Study|Physician Decision|7
892516|NCT00543543|2830468|P3|Base Study|Physician Decision|0
892517|NCT00543543|2830469|P2|Base Study|Physician Decision|4
892518|NCT00543543|2830470|P1|Base Study|Physician Decision|0
892519|NCT00543543|2830467|P4|Base Study|Lost to Follow-up|701
892520|NCT00543543|2830468|P3|Base Study|Lost to Follow-up|9
892521|NCT00543543|2830469|P2|Base Study|Lost to Follow-up|749
892522|NCT00543543|2830470|P1|Base Study|Lost to Follow-up|12
892523|NCT00543543|2830467|P4|Base Study|Adverse Event|5
892524|NCT00543543|2830468|P3|Base Study|Adverse Event|0
892525|NCT00543543|2830469|P2|Base Study|Adverse Event|11
892526|NCT00543543|2830470|P1|Base Study|Adverse Event|1
795922|NCT00759174|2531151|P2|Overall Study|Unspecified|2
795923|NCT00759174|2531152|P1|Overall Study|Unspecified|0
795924|NCT00759356|2531229|P2|Overall Study|Subject was unable to return|0
795925|NCT00759356|2531230|P1|Overall Study|Subject was unable to return|1
795926|NCT00759356|2531229|P2|Overall Study|Withdrawal by Subject|2
795927|NCT00759356|2531230|P1|Overall Study|Withdrawal by Subject|0
795928|NCT00759356|2531229|P2|Overall Study|Adverse Event|1
795929|NCT00759356|2531230|P1|Overall Study|Adverse Event|0
795930|NCT00759395|2531244|P2|Overall Study|Lack of Efficacy|2
795931|NCT00759395|2531245|P1|Overall Study|Lack of Efficacy|0
795932|NCT00759395|2531244|P2|Overall Study|Withdrawal by Subject|0
795933|NCT00759395|2531245|P1|Overall Study|Withdrawal by Subject|1
795934|NCT00759395|2531244|P2|Overall Study|Adverse Event|0
795935|NCT00759395|2531245|P1|Overall Study|Adverse Event|1
795936|NCT00759564|2531292|P5|Washout Period (at Least 14 Days)|Adverse Event|1
795937|NCT00759564|2531293|P4|Washout Period (at Least 14 Days)|Adverse Event|0
795938|NCT00759564|2531294|P3|Washout Period (at Least 14 Days)|Adverse Event|0
795939|NCT00759564|2531295|P2|Washout Period (at Least 14 Days)|Adverse Event|0
795940|NCT00759564|2531296|P1|Washout Period (at Least 14 Days)|Adverse Event|0
795941|NCT00759655|2531448|P1|Overall Study|Termination of the study by sponsor|1
795942|NCT00759681|2531480|P2|Overall Study|Lost to Follow-up|5
795943|NCT00759681|2531481|P1|Overall Study|Lost to Follow-up|8
795944|NCT00759681|2531480|P2|Overall Study|Death|5
795945|NCT00759681|2531481|P1|Overall Study|Death|2
795946|NCT00759759|2531495|P2|Overall Study|Withdrawal by Subject|1
795947|NCT00759759|2531496|P1|Overall Study|Withdrawal by Subject|2
795948|NCT00759759|2531495|P2|Overall Study|Didn't receive drug in period 2|0
795949|NCT00759759|2531496|P1|Overall Study|Didn't receive drug in period 2|1
795950|NCT00759759|2531495|P2|Overall Study|didn't return for period 2|0
795951|NCT00759759|2531496|P1|Overall Study|didn't return for period 2|1
795952|NCT00754013|2531523|P2|Overall Study|didn't return after study termed|4
795953|NCT00754013|2531524|P1|Overall Study|didn't return after study termed|3
795954|NCT00754013|2531523|P2|Overall Study|Lost to Follow-up|1
795955|NCT00754013|2531524|P1|Overall Study|Lost to Follow-up|1
795956|NCT00754065|2531534|P2|Overall Study|Reason not specified or unknown, etc.|27
795957|NCT00754065|2531535|P1|Overall Study|Reason not specified or unknown, etc.|21
795958|NCT00754065|2531534|P2|Overall Study|Pregnancy|0
795959|NCT00754065|2531535|P1|Overall Study|Pregnancy|6
795960|NCT00754065|2531534|P2|Overall Study|Withdrawal by Subject|5
795961|NCT00754065|2531535|P1|Overall Study|Withdrawal by Subject|4
795962|NCT00754065|2531534|P2|Overall Study|Protocol Violation|10
795963|NCT00754065|2531535|P1|Overall Study|Protocol Violation|12
795964|NCT00754065|2531534|P2|Overall Study|Lost to Follow-up|11
795965|NCT00754065|2531535|P1|Overall Study|Lost to Follow-up|7
795966|NCT00754065|2531534|P2|Overall Study|Adverse Event|25
795967|NCT00754065|2531535|P1|Overall Study|Adverse Event|19
795968|NCT00754065|2531534|P2|Overall Study|Never received treatment|2
795969|NCT00754065|2531535|P1|Overall Study|Never received treatment|12
795970|NCT00759785|2531857|P2|Overall Study|Withdrawal by Subject|1
795971|NCT00759785|2531858|P1|Overall Study|Withdrawal by Subject|0
795972|NCT00759785|2531857|P2|Overall Study|Physician Decision|1
795973|NCT00759785|2531858|P1|Overall Study|Physician Decision|0
795974|NCT00759785|2531857|P2|Overall Study|Protocol Violation|0
795975|NCT00759785|2531858|P1|Overall Study|Protocol Violation|1
795976|NCT00759785|2531857|P2|Overall Study|Participant sample lost|1
795977|NCT00759785|2531858|P1|Overall Study|Participant sample lost|0
795978|NCT00759785|2531857|P2|Overall Study|Participant sample not evaluable|2
795979|NCT00759785|2531858|P1|Overall Study|Participant sample not evaluable|11
795980|NCT00759863|2531881|P2|Overall Study|Death, moved, or lost contact|18
795981|NCT00759863|2531882|P1|Overall Study|Death, moved, or lost contact|20
795982|NCT00759902|2531894|P2|Overall Study|Adverse Event|1
795983|NCT00759902|2531895|P1|Overall Study|Adverse Event|0
795984|NCT00759915|2531909|P2|Overall Study|Adverse Event|1
795985|NCT00759915|2531910|P1|Overall Study|Adverse Event|0
795986|NCT00759915|2531909|P2|Overall Study|Withdrawal by Subject|0
795987|NCT00759915|2531910|P1|Overall Study|Withdrawal by Subject|1
795988|NCT00759941|2531924|P2|Overall Study|Exited in error by site|1
795989|NCT00759941|2531925|P1|Overall Study|Exited in error by site|1
795990|NCT00759941|2531924|P2|Overall Study|Adverse Event|0
795991|NCT00759941|2531925|P1|Overall Study|Adverse Event|1
795992|NCT00759941|2531924|P2|Overall Study|Use of medication|0
795993|NCT00759941|2531925|P1|Overall Study|Use of medication|1
795994|NCT00759954|2531939|P2|Overall Study|Adverse Event|2
795995|NCT00759954|2531940|P1|Overall Study|Adverse Event|1
795996|NCT00759954|2531939|P2|Overall Study|Personal reason|0
795997|NCT00759954|2531940|P1|Overall Study|Personal reason|1
795998|NCT00760084|2531980|P1|Overall Study|Progressive Disease|3
795999|NCT00760084|2531980|P1|Overall Study|Withdrawal by Subject|2
796000|NCT00760084|2531980|P1|Overall Study|Physician Decision|5
796001|NCT00761150|2532027|P3|Double-blind Period|Not specified|3
796002|NCT00761150|2532028|P2|Double-blind Period|Not specified|3
796003|NCT00761150|2532029|P1|Double-blind Period|Not specified|0
796004|NCT00761150|2532027|P3|Double-blind Period|Noncompliance|0
796005|NCT00761150|2532028|P2|Double-blind Period|Noncompliance|1
796006|NCT00761150|2532029|P1|Double-blind Period|Noncompliance|0
796007|NCT00761150|2532027|P3|Double-blind Period|Did not meet DB randomization criteria|1
796008|NCT00761150|2532028|P2|Double-blind Period|Did not meet DB randomization criteria|0
796009|NCT00761150|2532029|P1|Double-blind Period|Did not meet DB randomization criteria|0
796010|NCT00761150|2532027|P3|Double-blind Period|Lost to Follow-up|1
796011|NCT00761150|2532028|P2|Double-blind Period|Lost to Follow-up|2
796012|NCT00761150|2532029|P1|Double-blind Period|Lost to Follow-up|0
796013|NCT00761150|2532027|P3|Double-blind Period|Withdrawal by Subject|2
796014|NCT00761150|2532028|P2|Double-blind Period|Withdrawal by Subject|3
796015|NCT00761150|2532029|P1|Double-blind Period|Withdrawal by Subject|0
796016|NCT00761150|2532027|P3|Double-blind Period|Adverse Event|3
796017|NCT00761150|2532028|P2|Double-blind Period|Adverse Event|3
796018|NCT00761150|2532029|P1|Double-blind Period|Adverse Event|0
796019|NCT00761150|2532027|P3|Double-blind Period|Lack of Efficacy|19
796020|NCT00761150|2532028|P2|Double-blind Period|Lack of Efficacy|2
796021|NCT00761150|2532029|P1|Double-blind Period|Lack of Efficacy|0
796022|NCT00761150|2532027|P3|Open-label Period|Not specified|0
796023|NCT00761150|2532028|P2|Open-label Period|Not specified|0
796024|NCT00761150|2532029|P1|Open-label Period|Not specified|5
796025|NCT00761150|2532027|P3|Open-label Period|Noncompliance|0
796026|NCT00761150|2532028|P2|Open-label Period|Noncompliance|0
796027|NCT00761150|2532029|P1|Open-label Period|Noncompliance|2
796028|NCT00761150|2532027|P3|Open-label Period|Withdrawal by Subject|0
796029|NCT00761150|2532028|P2|Open-label Period|Withdrawal by Subject|0
796030|NCT00761150|2532029|P1|Open-label Period|Withdrawal by Subject|5
796031|NCT00761150|2532027|P3|Open-label Period|Lack of Efficacy|0
796032|NCT00761150|2532028|P2|Open-label Period|Lack of Efficacy|0
796033|NCT00761150|2532029|P1|Open-label Period|Lack of Efficacy|4
796034|NCT00761150|2532027|P3|Open-label Period|Lost to Follow-up|0
796035|NCT00761150|2532028|P2|Open-label Period|Lost to Follow-up|0
796036|NCT00761150|2532029|P1|Open-label Period|Lost to Follow-up|7
796037|NCT00761150|2532027|P3|Open-label Period|Did not meet DB randomization criteria|0
796038|NCT00761150|2532028|P2|Open-label Period|Did not meet DB randomization criteria|0
796039|NCT00761150|2532029|P1|Open-label Period|Did not meet DB randomization criteria|11
796040|NCT00761150|2532027|P3|Open-label Period|Adverse Event|0
796041|NCT00761150|2532028|P2|Open-label Period|Adverse Event|0
796042|NCT00761150|2532029|P1|Open-label Period|Adverse Event|36
796043|NCT00761176|2532040|P2|Overall Study|Withdrawal by Subject|1
796044|NCT00761176|2532041|P1|Overall Study|Withdrawal by Subject|1
796045|NCT00761176|2532040|P2|Overall Study|Death|0
796046|NCT00761176|2532041|P1|Overall Study|Death|1
796047|NCT00761189|2532047|P1|Overall Study|Unspecified|13
796048|NCT00761189|2532047|P1|Overall Study|Withdrawal by Subject|49
796049|NCT00761189|2532047|P1|Overall Study|Lost to Follow-up|36
796050|NCT00761189|2532047|P1|Overall Study|Lack of Efficacy|45
796051|NCT00761189|2532047|P1|Overall Study|Adverse Event|42
796052|NCT00761215|2532084|P3|Overall Study|Bacteremia|0
796053|NCT00761215|2532085|P2|Overall Study|Bacteremia|0
796054|NCT00761215|2532086|P1|Overall Study|Bacteremia|1
796055|NCT00761215|2532084|P3|Overall Study|Withdrawal by Subject|0
796056|NCT00761215|2532085|P2|Overall Study|Withdrawal by Subject|0
796057|NCT00761215|2532086|P1|Overall Study|Withdrawal by Subject|1
796058|NCT00761215|2532084|P3|Overall Study|Lost to Follow-up|6
796059|NCT00761215|2532085|P2|Overall Study|Lost to Follow-up|3
796060|NCT00761215|2532086|P1|Overall Study|Lost to Follow-up|6
796061|NCT00761215|2532084|P3|Overall Study|Randomized but didn't receive drug|2
796062|NCT00761215|2532085|P2|Overall Study|Randomized but didn't receive drug|1
796063|NCT00761215|2532086|P1|Overall Study|Randomized but didn't receive drug|1
892528|NCT00490568|2830516|P1|Overall Study|Participant withdrawal due to surgery|1
892529|NCT00490568|2830516|P1|Overall Study|Participant died|1
892530|NCT00490568|2830516|P1|Overall Study|Efficacy related|3
892531|NCT00490568|2830516|P1|Overall Study|Non-Compliance|7
892532|NCT00490568|2830516|P1|Overall Study|Investigator decision|3
892533|NCT00490568|2830516|P1|Overall Study|Unmet inclusion-exclusion criteria|5
892534|NCT00490568|2830516|P1|Overall Study|Disease progression|4
892535|NCT00490568|2830516|P1|Overall Study|Legal representative withdrew consent|1
892536|NCT00490568|2830516|P1|Overall Study|Participant refused follow-up|9
892537|NCT00490568|2830516|P1|Overall Study|Abnormal ECG|25
892538|NCT00490568|2830516|P1|Overall Study|Caregiver related|20
892539|NCT00490568|2830516|P1|Overall Study|Exclusion criteria met|1
892540|NCT00490568|2830516|P1|Overall Study|Other|1
892541|NCT00490568|2830516|P1|Overall Study|Still in the study at termination|974
892542|NCT00490568|2830516|P1|Overall Study|Withdrawal by Subject|135
796080|NCT00761306|2532140|P1|Overall Study|Administrative or Other Reasons|5
796081|NCT00761306|2532140|P1|Overall Study|Lost to Follow-up|1
796082|NCT00761306|2532140|P1|Overall Study|Withdrawal of Consent|3
796083|NCT00761306|2532140|P1|Overall Study|Protocol Violation|2
796084|NCT00761306|2532140|P1|Overall Study|Lack of Efficacy|4
796085|NCT00761306|2532140|P1|Overall Study|Adverse Event|5
796086|NCT00761319|2532151|P2|Overall Study|Missing|0
796087|NCT00761319|2532152|P1|Overall Study|Missing|1
796088|NCT00761319|2532151|P2|Overall Study|Nonspecified|2
796089|NCT00761319|2532152|P1|Overall Study|Nonspecified|2
796090|NCT00761319|2532151|P2|Overall Study|Lost to Follow-up|1
796091|NCT00761319|2532152|P1|Overall Study|Lost to Follow-up|1
796092|NCT00761319|2532151|P2|Overall Study|Noncompliance|3
796093|NCT00761319|2532152|P1|Overall Study|Noncompliance|4
796094|NCT00761319|2532151|P2|Overall Study|Withdrawal by Subject|7
796095|NCT00761319|2532152|P1|Overall Study|Withdrawal by Subject|8
796096|NCT00761319|2532151|P2|Overall Study|Adverse Event|7
796097|NCT00761319|2532152|P1|Overall Study|Adverse Event|11
796098|NCT00761319|2532151|P2|Overall Study|Protocol Violation|14
796099|NCT00761319|2532152|P1|Overall Study|Protocol Violation|21
796100|NCT00761462|2532166|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
796101|NCT00761462|2532167|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
796102|NCT00761462|2532166|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
796103|NCT00761462|2532167|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
796104|NCT00761462|2532166|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
796105|NCT00761462|2532167|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
796106|NCT00761462|2532166|P2|Treatment|Subjects never received study medication|12
796107|NCT00761462|2532167|P1|Treatment|Subjects never received study medication|23
796108|NCT00761514|2532175|P1|Overall Study|Unable to pay for medications|1
796109|NCT00761514|2532175|P1|Overall Study|Problem complying with study visit|1
796110|NCT00761514|2532175|P1|Overall Study|Health insurance didn't cover study drug|1
796111|NCT00761514|2532175|P1|Overall Study|Lost to Follow-up|1
796112|NCT00761514|2532175|P1|Overall Study|Withdrawal by Subject|2
796113|NCT00761514|2532175|P1|Overall Study|Adverse Event|1
796114|NCT00761527|2532180|P1|Overall Study|Unknown reason|2
796115|NCT00761527|2532180|P1|Overall Study|Lost to Follow-up|9
796116|NCT00761527|2532180|P1|Overall Study|Poor Compliance|8
796117|NCT00761527|2532180|P1|Overall Study|Adverse Event|3
796118|NCT00761579|2532187|P1|Overall Study|Intake of prohibited concomitant drug|1
796119|NCT00761579|2532187|P1|Overall Study|Lost survey form|1
796120|NCT00761579|2532187|P1|Overall Study|Aggravation of symptoms by changing drug|1
796121|NCT00761579|2532187|P1|Overall Study|Aggravation of depression|1
796122|NCT00761579|2532187|P1|Overall Study|Drug overdose|1
796123|NCT00761579|2532187|P1|Overall Study|Protocol deviation|1
796124|NCT00761579|2532187|P1|Overall Study|Lack of compliance|2
796125|NCT00761579|2532187|P1|Overall Study|Withdrawal by Subject|34
796126|NCT00761579|2532187|P1|Overall Study|Pregnancy|1
796127|NCT00761579|2532187|P1|Overall Study|Lost to Follow-up|16
796128|NCT00761579|2532187|P1|Overall Study|Lack of Efficacy|21
796129|NCT00761579|2532187|P1|Overall Study|Death|2
796130|NCT00761579|2532187|P1|Overall Study|Adverse Event|10
796131|NCT00761605|2532237|P1|Overall Study|Unspecified|21
796132|NCT00761605|2532237|P1|Overall Study|Withdrawal by Subject|37
796133|NCT00761605|2532237|P1|Overall Study|Lost to Follow-up|29
796134|NCT00761605|2532237|P1|Overall Study|Lack of Efficacy|26
796135|NCT00761605|2532237|P1|Overall Study|Death|2
796136|NCT00761605|2532237|P1|Overall Study|Adverse Event|26
796137|NCT00761631|2532268|P6|Overall Study|Unspecified|1
796138|NCT00761631|2532269|P5|Overall Study|Unspecified|1
796139|NCT00761631|2532270|P4|Overall Study|Unspecified|0
796140|NCT00761631|2532271|P3|Overall Study|Unspecified|0
796141|NCT00761631|2532272|P2|Overall Study|Unspecified|0
796142|NCT00761631|2532273|P1|Overall Study|Unspecified|0
796143|NCT00761631|2532268|P6|Overall Study|Physician Decision|0
796144|NCT00761631|2532269|P5|Overall Study|Physician Decision|0
796145|NCT00761631|2532270|P4|Overall Study|Physician Decision|0
796146|NCT00761631|2532271|P3|Overall Study|Physician Decision|0
796147|NCT00761631|2532272|P2|Overall Study|Physician Decision|0
796148|NCT00761631|2532273|P1|Overall Study|Physician Decision|1
892543|NCT00490568|2830516|P1|Overall Study|Protocol Violation|45
796149|NCT00761631|2532268|P6|Overall Study|Failed to return|2
796150|NCT00761631|2532269|P5|Overall Study|Failed to return|5
796151|NCT00761631|2532270|P4|Overall Study|Failed to return|1
796152|NCT00761631|2532271|P3|Overall Study|Failed to return|1
796153|NCT00761631|2532272|P2|Overall Study|Failed to return|0
796154|NCT00761631|2532273|P1|Overall Study|Failed to return|1
796155|NCT00761631|2532268|P6|Overall Study|Randomized, not treated|0
796156|NCT00761631|2532269|P5|Overall Study|Randomized, not treated|0
796157|NCT00761631|2532270|P4|Overall Study|Randomized, not treated|0
796158|NCT00761631|2532271|P3|Overall Study|Randomized, not treated|0
796159|NCT00761631|2532272|P2|Overall Study|Randomized, not treated|0
796160|NCT00761631|2532273|P1|Overall Study|Randomized, not treated|1
796161|NCT00761631|2532268|P6|Overall Study|Protocol Violation|1
796162|NCT00761631|2532269|P5|Overall Study|Protocol Violation|5
796163|NCT00761631|2532270|P4|Overall Study|Protocol Violation|1
796164|NCT00761631|2532271|P3|Overall Study|Protocol Violation|0
796165|NCT00761631|2532272|P2|Overall Study|Protocol Violation|0
796166|NCT00761631|2532273|P1|Overall Study|Protocol Violation|2
796167|NCT00761631|2532268|P6|Overall Study|Lost to Follow-up|1
796168|NCT00761631|2532269|P5|Overall Study|Lost to Follow-up|6
796169|NCT00761631|2532270|P4|Overall Study|Lost to Follow-up|1
796170|NCT00761631|2532271|P3|Overall Study|Lost to Follow-up|7
796171|NCT00761631|2532272|P2|Overall Study|Lost to Follow-up|4
796172|NCT00761631|2532273|P1|Overall Study|Lost to Follow-up|2
796173|NCT00761631|2532268|P6|Overall Study|Parent/legal guardian request|0
796174|NCT00761631|2532269|P5|Overall Study|Parent/legal guardian request|5
796175|NCT00761631|2532270|P4|Overall Study|Parent/legal guardian request|0
796176|NCT00761631|2532271|P3|Overall Study|Parent/legal guardian request|8
796177|NCT00761631|2532272|P2|Overall Study|Parent/legal guardian request|3
796178|NCT00761631|2532273|P1|Overall Study|Parent/legal guardian request|8
796179|NCT00761735|2532308|P1|Overall Study|Administrative|1
796180|NCT00761735|2532308|P1|Overall Study|Non-compliance with protocol|1
796181|NCT00761735|2532308|P1|Overall Study|Withdrawal by Subject|6
796182|NCT00761735|2532308|P1|Overall Study|Lost to Follow-up|6
796183|NCT00761748|2532320|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
796184|NCT00761748|2532321|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
796185|NCT00761748|2532320|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
796186|NCT00761748|2532321|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
796187|NCT00761761|2532329|P2|Overall Study|Withdrawal by Subject|0
796188|NCT00761761|2532330|P1|Overall Study|Withdrawal by Subject|3
796189|NCT00761761|2532329|P2|Overall Study|Lost to Follow-up|1
796190|NCT00761761|2532330|P1|Overall Study|Lost to Follow-up|3
796191|NCT00761865|2532344|P2|Overall Study|Lost to Follow-up|7
796192|NCT00761865|2532345|P1|Overall Study|Lost to Follow-up|8
796193|NCT00761956|2532374|P2|Overall Study|Adverse Event|34
796194|NCT00761956|2532375|P1|Overall Study|Adverse Event|26
796195|NCT00761956|2532374|P2|Overall Study|Death|1
796196|NCT00761956|2532375|P1|Overall Study|Death|0
796197|NCT00761956|2532374|P2|Overall Study|Withdrawal by Subject|8
796198|NCT00761956|2532375|P1|Overall Study|Withdrawal by Subject|3
796199|NCT00761956|2532374|P2|Overall Study|Lost to Follow-up|11
796200|NCT00761956|2532375|P1|Overall Study|Lost to Follow-up|6
796201|NCT00761969|2532385|P2|Overall Study|Lost to Follow-up|93
796202|NCT00761969|2532386|P1|Overall Study|Lost to Follow-up|88
796203|NCT00761969|2532385|P2|Overall Study|Death|47
796204|NCT00761969|2532386|P1|Overall Study|Death|112
796205|NCT00762034|2532409|P2|Maintenance Period|Other|1
796206|NCT00762034|2532410|P1|Maintenance Period|Other|1
796207|NCT00762034|2532409|P2|Maintenance Period|Death due to study disease|3
796208|NCT00762034|2532410|P1|Maintenance Period|Death due to study disease|3
796209|NCT00762034|2532409|P2|Maintenance Period|Death not due to study disease|5
796210|NCT00762034|2532410|P1|Maintenance Period|Death not due to study disease|2
796211|NCT00762034|2532409|P2|Maintenance Period|Withdrawal by Subject|14
796212|NCT00762034|2532410|P1|Maintenance Period|Withdrawal by Subject|34
796213|NCT00762034|2532409|P2|Maintenance Period|Physician Decision|20
796214|NCT00762034|2532410|P1|Maintenance Period|Physician Decision|25
796215|NCT00762034|2532409|P2|Maintenance Period|Progressive Disease|224
796216|NCT00762034|2532410|P1|Maintenance Period|Progressive Disease|186
796217|NCT00762034|2532409|P2|Maintenance Period|Adverse Event|26
796218|NCT00762034|2532410|P1|Maintenance Period|Adverse Event|42
796219|NCT00762034|2532409|P2|Maintenance Period|Entry Criterion Not Met|2
796220|NCT00762034|2532410|P1|Maintenance Period|Entry Criterion Not Met|0
796221|NCT00762034|2532409|P2|Maintenance Period|Protocol Violation|3
796222|NCT00762034|2532410|P1|Maintenance Period|Protocol Violation|1
796223|NCT00762034|2532409|P2|Induction Period|Deaths Due to Study Disease|9
796224|NCT00762034|2532410|P1|Induction Period|Deaths Due to Study Disease|9
796225|NCT00762034|2532409|P2|Induction Period|Deaths Not Due to Study Disease|14
796226|NCT00762034|2532410|P1|Induction Period|Deaths Not Due to Study Disease|19
796227|NCT00762034|2532409|P2|Induction Period|Withdrawal by Subject|19
796228|NCT00762034|2532410|P1|Induction Period|Withdrawal by Subject|15
796229|NCT00762034|2532409|P2|Induction Period|Physician Decision|20
796230|NCT00762034|2532410|P1|Induction Period|Physician Decision|21
796231|NCT00762034|2532409|P2|Induction Period|Progressive Disease|55
796232|NCT00762034|2532410|P1|Induction Period|Progressive Disease|73
796233|NCT00762034|2532409|P2|Induction Period|Lost to Follow-up|1
796234|NCT00762034|2532410|P1|Induction Period|Lost to Follow-up|1
796235|NCT00762034|2532409|P2|Induction Period|Adverse Event|38
796236|NCT00762034|2532410|P1|Induction Period|Adverse Event|27
796237|NCT00762034|2532409|P2|Induction Period|Entry Criterion Not Met|11
796238|NCT00762034|2532410|P1|Induction Period|Entry Criterion Not Met|12
796239|NCT00762034|2532409|P2|Induction Period|Protocol Violation|2
796240|NCT00762034|2532410|P1|Induction Period|Protocol Violation|1
796241|NCT00762073|2532471|P4|Overall Study|Not on treatment for >/= 77 days|0
796242|NCT00762073|2532472|P3|Overall Study|Not on treatment for >/= 77 days|0
796243|NCT00762073|2532473|P2|Overall Study|Not on treatment for >/= 77 days|0
796244|NCT00762073|2532474|P1|Overall Study|Not on treatment for >/= 77 days|1
796245|NCT00762073|2532471|P4|Overall Study|Withdrawal by Subject|1
796246|NCT00762073|2532472|P3|Overall Study|Withdrawal by Subject|1
796247|NCT00762073|2532473|P2|Overall Study|Withdrawal by Subject|2
796248|NCT00762073|2532474|P1|Overall Study|Withdrawal by Subject|1
796249|NCT00762073|2532471|P4|Overall Study|Significant Subject Noncompliance|1
796250|NCT00762073|2532472|P3|Overall Study|Significant Subject Noncompliance|0
796251|NCT00762073|2532473|P2|Overall Study|Significant Subject Noncompliance|1
796252|NCT00762073|2532474|P1|Overall Study|Significant Subject Noncompliance|0
796253|NCT00762073|2532471|P4|Overall Study|Adverse Event|1
796254|NCT00762073|2532472|P3|Overall Study|Adverse Event|1
796255|NCT00762073|2532473|P2|Overall Study|Adverse Event|0
796256|NCT00762073|2532474|P1|Overall Study|Adverse Event|1
796257|NCT00762073|2532471|P4|Overall Study|Lack of Efficacy|0
796258|NCT00762073|2532472|P3|Overall Study|Lack of Efficacy|0
796259|NCT00762073|2532473|P2|Overall Study|Lack of Efficacy|1
796260|NCT00762073|2532474|P1|Overall Study|Lack of Efficacy|1
796261|NCT00762086|2532538|P2|Overall Study|Ineligible to participate in the study|0
796262|NCT00762086|2532539|P1|Overall Study|Ineligible to participate in the study|1
796263|NCT00762086|2532538|P2|Overall Study|Withdrawal by Subject|2
796264|NCT00762086|2532539|P1|Overall Study|Withdrawal by Subject|2
796265|NCT00762086|2532538|P2|Overall Study|Non compliance|0
796266|NCT00762086|2532539|P1|Overall Study|Non compliance|1
796267|NCT00762086|2532538|P2|Overall Study|Lost to Follow-up|2
796268|NCT00762086|2532539|P1|Overall Study|Lost to Follow-up|0
796269|NCT00762086|2532538|P2|Overall Study|Adverse Event|0
796270|NCT00762086|2532539|P1|Overall Study|Adverse Event|2
796271|NCT00762164|2532547|P2|Overall Study|Withdrawal by Subject|1
796272|NCT00762164|2532548|P1|Overall Study|Withdrawal by Subject|0
796273|NCT00762164|2532547|P2|Overall Study|Discontinued medication|0
796274|NCT00762164|2532548|P1|Overall Study|Discontinued medication|2
796275|NCT00762164|2532547|P2|Overall Study|Lost to Follow-up|1
796276|NCT00762164|2532548|P1|Overall Study|Lost to Follow-up|1
796277|NCT00762229|2532645|P2|Overall Study|did not recveive intervention|1
796278|NCT00762229|2532646|P1|Overall Study|did not recveive intervention|0
796279|NCT00762229|2532645|P2|Overall Study|Lost to Follow-up|1
796280|NCT00762229|2532646|P1|Overall Study|Lost to Follow-up|1
796281|NCT00762268|2532656|P2|Overall Study|Protocol Violation|2
796282|NCT00762268|2532657|P1|Overall Study|Protocol Violation|1
796283|NCT00762359|2532680|P2|Overall Study|Withdrew consent|0
796284|NCT00762359|2532681|P1|Overall Study|Withdrew consent|1
796285|NCT00762359|2532680|P2|Overall Study|Removal|1
796286|NCT00762359|2532681|P1|Overall Study|Removal|0
796287|NCT00762359|2532680|P2|Overall Study|Physician Decision|3
796288|NCT00762359|2532681|P1|Overall Study|Physician Decision|2
796289|NCT00762359|2532680|P2|Overall Study|Institution closed|3
796290|NCT00762359|2532681|P1|Overall Study|Institution closed|2
796291|NCT00762359|2532680|P2|Overall Study|Lack of Efficacy|4
796292|NCT00762359|2532681|P1|Overall Study|Lack of Efficacy|0
796293|NCT00762359|2532680|P2|Overall Study|Withdrawal by Subject|10
796294|NCT00762359|2532681|P1|Overall Study|Withdrawal by Subject|13
796295|NCT00762359|2532680|P2|Overall Study|Protocol Violation|13
796296|NCT00762359|2532681|P1|Overall Study|Protocol Violation|21
796297|NCT00762359|2532680|P2|Overall Study|Adverse Event|23
796298|NCT00762359|2532681|P1|Overall Study|Adverse Event|20
796299|NCT00762385|2532781|P2|Second Intervention|Protocol Violation|3
796300|NCT00762385|2532782|P1|Second Intervention|Protocol Violation|3
796301|NCT00762385|2532781|P2|First Intervention|Protocol Violation|1
796302|NCT00762385|2532782|P1|First Intervention|Protocol Violation|0
796303|NCT00762385|2532781|P2|First Intervention|Ineligible|0
796304|NCT00762385|2532782|P1|First Intervention|Ineligible|1
796305|NCT00762385|2532781|P2|First Intervention|Lost to Follow-up|2
796306|NCT00762385|2532782|P1|First Intervention|Lost to Follow-up|0
796307|NCT00762385|2532781|P2|First Intervention|Lens Issue|1
796308|NCT00762385|2532782|P1|First Intervention|Lens Issue|1
796309|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
796310|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
796311|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
796312|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
796313|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
796314|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
796315|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
796316|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
796317|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
796318|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
796319|NCT00762411|2532794|P2|Safety Follow Up (SFU)-Optional|Death|8
796320|NCT00762411|2532795|P1|Safety Follow Up (SFU)-Optional|Death|1
796321|NCT00762411|2532794|P2|Delayed Start|Caregiver Decision|1
796322|NCT00762411|2532795|P1|Delayed Start|Caregiver Decision|1
796323|NCT00762411|2532794|P2|Delayed Start|Sponsor Decision|20
796324|NCT00762411|2532795|P1|Delayed Start|Sponsor Decision|16
796325|NCT00762411|2532794|P2|Delayed Start|Protocol Violation|1
796326|NCT00762411|2532795|P1|Delayed Start|Protocol Violation|0
796327|NCT00762411|2532794|P2|Delayed Start|Adverse Event|4
796328|NCT00762411|2532795|P1|Delayed Start|Adverse Event|0
796329|NCT00762411|2532794|P2|Initial Treatment|Entry Criteria Exclusion|1
796330|NCT00762411|2532795|P1|Initial Treatment|Entry Criteria Exclusion|0
796331|NCT00762411|2532794|P2|Initial Treatment|Abnormal Lab/ECG Result|4
796332|NCT00762411|2532795|P1|Initial Treatment|Abnormal Lab/ECG Result|6
796333|NCT00762411|2532794|P2|Initial Treatment|Caregiver Decision|16
796334|NCT00762411|2532795|P1|Initial Treatment|Caregiver Decision|21
796335|NCT00762411|2532794|P2|Initial Treatment|Lost to Follow-up|0
796336|NCT00762411|2532795|P1|Initial Treatment|Lost to Follow-up|5
796337|NCT00762411|2532794|P2|Initial Treatment|Sponsor Decision|401
796338|NCT00762411|2532795|P1|Initial Treatment|Sponsor Decision|293
796339|NCT00762411|2532794|P2|Initial Treatment|Physician Decision|0
796340|NCT00762411|2532795|P1|Initial Treatment|Physician Decision|1
796341|NCT00762411|2532794|P2|Initial Treatment|Withdrawal by Subject|52
796342|NCT00762411|2532795|P1|Initial Treatment|Withdrawal by Subject|65
796343|NCT00762411|2532794|P2|Initial Treatment|Protocol Violation|1
796344|NCT00762411|2532795|P1|Initial Treatment|Protocol Violation|4
796345|NCT00762411|2532794|P2|Initial Treatment|Adverse Event|40
796346|NCT00762411|2532795|P1|Initial Treatment|Adverse Event|132
796347|NCT00762411|2532794|P2|Initial Treatment|Death|6
796348|NCT00762411|2532795|P1|Initial Treatment|Death|7
796349|NCT00762463|2532883|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
796350|NCT00762463|2532884|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
796351|NCT00762463|2532885|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
796352|NCT00762463|2532886|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
796353|NCT00762463|2532883|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
796354|NCT00762463|2532884|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
796355|NCT00762463|2532885|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
796356|NCT00762463|2532886|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
796357|NCT00762463|2532883|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
796358|NCT00762463|2532884|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
796359|NCT00762463|2532885|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
796360|NCT00762463|2532886|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
796361|NCT00762463|2532883|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
796362|NCT00762463|2532884|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
796363|NCT00762463|2532885|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
796364|NCT00762463|2532886|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
796365|NCT00762463|2532883|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
796366|NCT00762463|2532884|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
796367|NCT00762463|2532885|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
796368|NCT00762463|2532886|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
796369|NCT00762463|2532883|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
796370|NCT00762463|2532884|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
796371|NCT00762463|2532885|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
796372|NCT00762463|2532886|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
796373|NCT00762463|2532883|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
796374|NCT00762463|2532884|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
796375|NCT00762463|2532885|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
796376|NCT00762463|2532886|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
796377|NCT00762463|2532883|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
796378|NCT00762463|2532884|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
796379|NCT00762463|2532885|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
796380|NCT00762463|2532886|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
796381|NCT00762476|2532970|P2|Overall Study|Seasonal allergies|0
796382|NCT00762476|2532971|P1|Overall Study|Seasonal allergies|1
796383|NCT00762476|2532970|P2|Overall Study|non-compliance with study visits|2
796384|NCT00762476|2532971|P1|Overall Study|non-compliance with study visits|0
796385|NCT00762476|2532970|P2|Overall Study|antibiotic use|1
796386|NCT00762476|2532971|P1|Overall Study|antibiotic use|0
796387|NCT00762476|2532970|P2|Overall Study|Withdrawal by Subject|12
796388|NCT00762476|2532971|P1|Overall Study|Withdrawal by Subject|6
796389|NCT00762476|2532970|P2|Overall Study|Physician Decision|14
796390|NCT00762476|2532971|P1|Overall Study|Physician Decision|2
796391|NCT00762476|2532970|P2|Overall Study|Protocol Violation|6
796392|NCT00762476|2532971|P1|Overall Study|Protocol Violation|5
796393|NCT00762476|2532970|P2|Overall Study|Lost to Follow-up|0
796394|NCT00762476|2532971|P1|Overall Study|Lost to Follow-up|2
796395|NCT00762476|2532970|P2|Overall Study|Adverse Event|1
796396|NCT00762476|2532971|P1|Overall Study|Adverse Event|7
796397|NCT00762502|2532984|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
796398|NCT00762502|2532985|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
796399|NCT00762502|2532986|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
796400|NCT00762502|2532984|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
796401|NCT00762502|2532985|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
796402|NCT00762502|2532986|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
796403|NCT00762502|2532984|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
796404|NCT00762502|2532985|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
796405|NCT00762502|2532986|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
796406|NCT00762606|2533034|P2|Overall Study|Lost to Follow-up|13
796407|NCT00762606|2533035|P1|Overall Study|Lost to Follow-up|18
796408|NCT00762723|2533200|P3|Overall Study|Study Terminated slow enrollement|3
796409|NCT00762723|2533201|P2|Overall Study|Study Terminated slow enrollement|5
796410|NCT00762723|2533202|P1|Overall Study|Study Terminated slow enrollement|5
796411|NCT00762762|2533212|P2|Overall Study|Did not report for appointments|10
796412|NCT00762762|2533213|P1|Overall Study|Did not report for appointments|8
796413|NCT00762788|2533233|P6|Overall Study|Lost to Follow-up|21
796414|NCT00762788|2533234|P5|Overall Study|Lost to Follow-up|13
796415|NCT00762788|2533235|P4|Overall Study|Lost to Follow-up|26
796416|NCT00762788|2533236|P3|Overall Study|Lost to Follow-up|21
796417|NCT00762788|2533237|P2|Overall Study|Lost to Follow-up|37
796418|NCT00762788|2533238|P1|Overall Study|Lost to Follow-up|26
796419|NCT00762892|2533269|P2|Overall Study|Incarceration|0
796420|NCT00762892|2533270|P1|Overall Study|Incarceration|1
796421|NCT00762892|2533269|P2|Overall Study|Pregnancy|0
796422|NCT00762892|2533270|P1|Overall Study|Pregnancy|1
796423|NCT00762892|2533269|P2|Overall Study|Death|0
796424|NCT00762892|2533270|P1|Overall Study|Death|1
796425|NCT00762892|2533269|P2|Overall Study|Withdrawal by Subject|1
796426|NCT00762892|2533270|P1|Overall Study|Withdrawal by Subject|0
796427|NCT00762892|2533269|P2|Overall Study|Lost to Follow-up|5
796428|NCT00762892|2533270|P1|Overall Study|Lost to Follow-up|2
796429|NCT00762970|2533287|P3|Overall Study|Difficulty of handling lens|0
796430|NCT00762970|2533288|P2|Overall Study|Difficulty of handling lens|2
796431|NCT00762970|2533289|P1|Overall Study|Difficulty of handling lens|1
796432|NCT00762970|2533287|P3|Overall Study|Lost to Follow-up|0
796433|NCT00762970|2533288|P2|Overall Study|Lost to Follow-up|2
796434|NCT00762970|2533289|P1|Overall Study|Lost to Follow-up|1
796435|NCT00762970|2533287|P3|Overall Study|Protocol Violation|1
796436|NCT00762970|2533288|P2|Overall Study|Protocol Violation|1
796437|NCT00762970|2533289|P1|Overall Study|Protocol Violation|3
796438|NCT00762970|2533287|P3|Overall Study|Withdrawal by Subject|0
796439|NCT00762970|2533288|P2|Overall Study|Withdrawal by Subject|4
796440|NCT00762970|2533289|P1|Overall Study|Withdrawal by Subject|7
796441|NCT00762996|2533300|P4|Period One|Withdrawal by Subject|0
796442|NCT00762996|2533301|P3|Period One|Withdrawal by Subject|1
796443|NCT00762996|2533302|P2|Period One|Withdrawal by Subject|0
796444|NCT00762996|2533303|P1|Period One|Withdrawal by Subject|0
796445|NCT00762996|2533300|P4|Period One|Adverse Event|0
796446|NCT00762996|2533301|P3|Period One|Adverse Event|1
796447|NCT00762996|2533302|P2|Period One|Adverse Event|0
796448|NCT00762996|2533303|P1|Period One|Adverse Event|0
796449|NCT00762996|2533300|P4|Period One|ineligible|1
796450|NCT00762996|2533301|P3|Period One|ineligible|1
796451|NCT00762996|2533302|P2|Period One|ineligible|0
796452|NCT00762996|2533303|P1|Period One|ineligible|0
796453|NCT00762996|2533300|P4|Period One|Protocol Violation|0
796454|NCT00762996|2533301|P3|Period One|Protocol Violation|1
796455|NCT00762996|2533302|P2|Period One|Protocol Violation|0
796456|NCT00762996|2533303|P1|Period One|Protocol Violation|0
796457|NCT00763009|2533313|P1|Overall Study|Coronary Anatomy unsuitable|1
796458|NCT00763139|2533359|P2|Overall Study|med change not allowed by protocol|0
796459|NCT00763139|2533360|P1|Overall Study|med change not allowed by protocol|1
796460|NCT00763139|2533359|P2|Overall Study|Withdrawal by Subject|1
796461|NCT00763139|2533360|P1|Overall Study|Withdrawal by Subject|0
796462|NCT00763139|2533359|P2|Overall Study|Adverse Event|2
796463|NCT00763139|2533360|P1|Overall Study|Adverse Event|4
796464|NCT00763256|2533404|P2|Overall Study|Didn't return for appointments|10
796465|NCT00763256|2533405|P1|Overall Study|Didn't return for appointments|7
796466|NCT00763269|2533421|P2|Overall Study|Lost to Follow-up|13
796467|NCT00763269|2533422|P1|Overall Study|Lost to Follow-up|12
796468|NCT00763282|2533436|P2|Overall Study|Lost to Follow-up|26
796469|NCT00763282|2533437|P1|Overall Study|Lost to Follow-up|22
796470|NCT00763282|2533436|P2|Overall Study|Death|3
796471|NCT00763282|2533437|P1|Overall Study|Death|4
796472|NCT00763282|2533436|P2|Overall Study|Withdrawal by Subject|5
796473|NCT00763282|2533437|P1|Overall Study|Withdrawal by Subject|6
796474|NCT00763321|2533454|P3|Double-blind Period|Not specified|3
796475|NCT00763321|2533455|P2|Double-blind Period|Not specified|2
796476|NCT00763321|2533456|P1|Double-blind Period|Not specified|0
796477|NCT00763321|2533454|P3|Double-blind Period|Withdrawal by Subject|3
796478|NCT00763321|2533455|P2|Double-blind Period|Withdrawal by Subject|2
796479|NCT00763321|2533456|P1|Double-blind Period|Withdrawal by Subject|0
796480|NCT00763321|2533454|P3|Double-blind Period|Lost to Follow-up|2
796481|NCT00763321|2533455|P2|Double-blind Period|Lost to Follow-up|4
796482|NCT00763321|2533456|P1|Double-blind Period|Lost to Follow-up|0
796483|NCT00763321|2533454|P3|Double-blind Period|Adverse Event|4
796484|NCT00763321|2533455|P2|Double-blind Period|Adverse Event|4
796485|NCT00763321|2533456|P1|Double-blind Period|Adverse Event|0
796486|NCT00763321|2533454|P3|Double-blind Period|Lack of Efficacy|17
796487|NCT00763321|2533455|P2|Double-blind Period|Lack of Efficacy|9
796488|NCT00763321|2533456|P1|Double-blind Period|Lack of Efficacy|0
796489|NCT00763321|2533454|P3|Open-label Period|Not specified|0
796490|NCT00763321|2533455|P2|Open-label Period|Not specified|0
796491|NCT00763321|2533456|P1|Open-label Period|Not specified|4
796492|NCT00763321|2533454|P3|Open-label Period|Lack of Efficacy|0
796493|NCT00763321|2533455|P2|Open-label Period|Lack of Efficacy|0
796494|NCT00763321|2533456|P1|Open-label Period|Lack of Efficacy|2
796495|NCT00763321|2533454|P3|Open-label Period|Did not meet DB randomization criteria|0
796496|NCT00763321|2533455|P2|Open-label Period|Did not meet DB randomization criteria|0
796497|NCT00763321|2533456|P1|Open-label Period|Did not meet DB randomization criteria|5
796498|NCT00763321|2533454|P3|Open-label Period|Subject noncompliant|0
796499|NCT00763321|2533455|P2|Open-label Period|Subject noncompliant|0
796500|NCT00763321|2533456|P1|Open-label Period|Subject noncompliant|7
796501|NCT00763321|2533454|P3|Open-label Period|Withdrawal by Subject|0
796502|NCT00763321|2533455|P2|Open-label Period|Withdrawal by Subject|0
796503|NCT00763321|2533456|P1|Open-label Period|Withdrawal by Subject|7
796504|NCT00763321|2533454|P3|Open-label Period|Lost to Follow-up|0
796505|NCT00763321|2533455|P2|Open-label Period|Lost to Follow-up|0
796506|NCT00763321|2533456|P1|Open-label Period|Lost to Follow-up|14
796507|NCT00763321|2533454|P3|Open-label Period|Adverse Event|0
796508|NCT00763321|2533455|P2|Open-label Period|Adverse Event|0
796509|NCT00763321|2533456|P1|Open-label Period|Adverse Event|24
796510|NCT00763386|2533489|P2|Overall Study|Study Prosthesis Removed|0
796511|NCT00763386|2533490|P1|Overall Study|Study Prosthesis Removed|1
796512|NCT00763386|2533489|P2|Overall Study|CRF missing|1
796513|NCT00763386|2533490|P1|Overall Study|CRF missing|0
796514|NCT00763386|2533489|P2|Overall Study|Withdrawal by Subject|1
796515|NCT00763386|2533490|P1|Overall Study|Withdrawal by Subject|0
796516|NCT00763386|2533489|P2|Overall Study|Lost to Follow-up|3
796517|NCT00763386|2533490|P1|Overall Study|Lost to Follow-up|3
796518|NCT00763386|2533489|P2|Overall Study|Death|2
796519|NCT00763386|2533490|P1|Overall Study|Death|1
796520|NCT00763386|2533489|P2|Overall Study|Adverse Event|33
796521|NCT00763386|2533490|P1|Overall Study|Adverse Event|43
796522|NCT00757172|2533523|P1|Overall Study|Progression|4
796523|NCT00757172|2533523|P1|Overall Study|Physician Decision|3
796524|NCT00757172|2533523|P1|Overall Study|Withdrawal by Subject|4
796525|NCT00757237|2533533|P2|Overall Study|Other|2
796526|NCT00757237|2533534|P1|Overall Study|Other|0
796527|NCT00757237|2533533|P2|Overall Study|Safety or Tolerability|5
796528|NCT00757237|2533534|P1|Overall Study|Safety or Tolerability|3
796529|NCT00757237|2533533|P2|Overall Study|Withdrawal by Subject|12
796530|NCT00757237|2533534|P1|Overall Study|Withdrawal by Subject|8
796531|NCT00757237|2533533|P2|Overall Study|Physician Decision|3
796532|NCT00757237|2533534|P1|Overall Study|Physician Decision|2
796533|NCT00757237|2533533|P2|Overall Study|Protocol Violation|2
796534|NCT00757237|2533534|P1|Overall Study|Protocol Violation|0
796535|NCT00757237|2533533|P2|Overall Study|Lost to Follow-up|1
796536|NCT00757237|2533534|P1|Overall Study|Lost to Follow-up|0
796537|NCT00763451|2533566|P4|Overall Study|Study Site Reason|1
796538|NCT00763451|2533567|P3|Overall Study|Study Site Reason|1
796539|NCT00763451|2533568|P2|Overall Study|Study Site Reason|1
796540|NCT00763451|2533569|P1|Overall Study|Study Site Reason|0
796541|NCT00763451|2533566|P4|Overall Study|Randomized but not Treated|0
796542|NCT00763451|2533567|P3|Overall Study|Randomized but not Treated|0
796543|NCT00763451|2533568|P2|Overall Study|Randomized but not Treated|1
796544|NCT00763451|2533569|P1|Overall Study|Randomized but not Treated|1
796545|NCT00763451|2533566|P4|Overall Study|Familial and Personal Reasons|4
796546|NCT00763451|2533567|P3|Overall Study|Familial and Personal Reasons|5
796547|NCT00763451|2533568|P2|Overall Study|Familial and Personal Reasons|3
796548|NCT00763451|2533569|P1|Overall Study|Familial and Personal Reasons|5
796549|NCT00763451|2533566|P4|Overall Study|Poor Compliance to Protocol|2
796550|NCT00763451|2533567|P3|Overall Study|Poor Compliance to Protocol|2
796551|NCT00763451|2533568|P2|Overall Study|Poor Compliance to Protocol|1
796552|NCT00763451|2533569|P1|Overall Study|Poor Compliance to Protocol|1
796553|NCT00763451|2533566|P4|Overall Study|Protocol Violation|0
796554|NCT00763451|2533567|P3|Overall Study|Protocol Violation|1
796555|NCT00763451|2533568|P2|Overall Study|Protocol Violation|0
796556|NCT00763451|2533569|P1|Overall Study|Protocol Violation|0
796557|NCT00763451|2533566|P4|Overall Study|Withdrawal by Subject|7
796558|NCT00763451|2533567|P3|Overall Study|Withdrawal by Subject|9
796559|NCT00763451|2533568|P2|Overall Study|Withdrawal by Subject|6
796560|NCT00763451|2533569|P1|Overall Study|Withdrawal by Subject|1
796561|NCT00763451|2533566|P4|Overall Study|Lack of Efficacy|2
796562|NCT00763451|2533567|P3|Overall Study|Lack of Efficacy|3
796563|NCT00763451|2533568|P2|Overall Study|Lack of Efficacy|4
796564|NCT00763451|2533569|P1|Overall Study|Lack of Efficacy|1
796565|NCT00763451|2533566|P4|Overall Study|Adverse Event|14
796566|NCT00763451|2533567|P3|Overall Study|Adverse Event|19
796567|NCT00763451|2533568|P2|Overall Study|Adverse Event|6
796568|NCT00763451|2533569|P1|Overall Study|Adverse Event|4
796569|NCT00763698|2533608|P1|Overall Study|Withdrawal by Subject|1
796570|NCT00763698|2533608|P1|Overall Study|Death|4
796571|NCT00763698|2533608|P1|Overall Study|Unsuccessful Implant|5
796572|NCT00766415|2533620|P2|Overall Study|Withdrawal by Subject|1
796573|NCT00766415|2533621|P1|Overall Study|Withdrawal by Subject|0
796574|NCT00766467|2533671|P2|Overall Study|Physician Decision|0
796575|NCT00766467|2533672|P1|Overall Study|Physician Decision|1
796576|NCT00766467|2533671|P2|Overall Study|Tumor Progression on Study|1
796577|NCT00766467|2533672|P1|Overall Study|Tumor Progression on Study|0
796578|NCT00766467|2533671|P2|Overall Study|Protocol Violation|4
796579|NCT00766467|2533672|P1|Overall Study|Protocol Violation|2
796580|NCT00766467|2533671|P2|Overall Study|Adverse Event|1
796581|NCT00766467|2533672|P1|Overall Study|Adverse Event|1
796582|NCT00766467|2533671|P2|Overall Study|Withdrawal by Subject|2
796583|NCT00766467|2533672|P1|Overall Study|Withdrawal by Subject|7
796584|NCT00766493|2533682|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
796585|NCT00766493|2533682|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
796586|NCT00766493|2533682|P1|30 Days Post-Procedure|Discontinued|7
796587|NCT00766506|2533692|P2|Overall Study|Unspecified|2
796588|NCT00766506|2533693|P1|Overall Study|Unspecified|2
796589|NCT00766506|2533692|P2|Overall Study|Use rescue medication after 3 hours|0
796590|NCT00766506|2533693|P1|Overall Study|Use rescue medication after 3 hours|3
796591|NCT00766532|2533717|P1|Overall Study|Protocol Violation|2
796592|NCT00766597|2533721|P1|Overall Study|Without CCR5-tropic virus|5
796593|NCT00766597|2533721|P1|Overall Study|Unexpected closure of study|4
796594|NCT00766636|2533735|P2|Overall Study|Disease Progression|0
796595|NCT00766636|2533736|P1|Overall Study|Disease Progression|1
796596|NCT00766636|2533735|P2|Overall Study|Adverse Event|0
796597|NCT00766636|2533736|P1|Overall Study|Adverse Event|1
796598|NCT00766636|2533735|P2|Overall Study|Incomplete Treatment|1
796599|NCT00766636|2533736|P1|Overall Study|Incomplete Treatment|0
796600|NCT00766636|2533735|P2|Overall Study|Withdrawal by Subject|1
796601|NCT00766636|2533736|P1|Overall Study|Withdrawal by Subject|1
796602|NCT00766675|2533754|P1|Overall Study|Insufficient therapy|1
796603|NCT00766675|2533754|P1|Overall Study|Receive other anti-neoplastic treatment|1
796604|NCT00766675|2533754|P1|Overall Study|Participant took prohibited medication|1
796605|NCT00766675|2533754|P1|Overall Study|Protocol Violation|8
796606|NCT00766675|2533754|P1|Overall Study|Withdrawal by Subject|11
796607|NCT00766675|2533754|P1|Overall Study|Lost to Follow-up|2
796608|NCT00766675|2533754|P1|Overall Study|Adverse Event|16
796609|NCT00766831|2533781|P1|Overall Study|Not specified|28
796610|NCT00766831|2533781|P1|Overall Study|Non cooperation by participants|14
796611|NCT00766831|2533781|P1|Overall Study|Withdrawal of consent|26
796612|NCT00766831|2533781|P1|Overall Study|Physician Decision|5
796613|NCT00766831|2533781|P1|Overall Study|Protocol Violation|15
796614|NCT00766831|2533781|P1|Overall Study|Adverse Event|20
796615|NCT00766831|2533781|P1|Overall Study|Lost to Follow-up|3
796616|NCT00766831|2533781|P1|Overall Study|Withdrawal by Subject|4
796617|NCT00767000|2533802|P5|Optional 104-week Extension|Study terminated by sponsor|4
796618|NCT00767000|2533803|P4|Optional 104-week Extension|Study terminated by sponsor|2
796619|NCT00767000|2533804|P3|Optional 104-week Extension|Study terminated by sponsor|7
796620|NCT00767000|2533805|P2|Optional 104-week Extension|Study terminated by sponsor|3
796621|NCT00767000|2533806|P1|Optional 104-week Extension|Study terminated by sponsor|7
796622|NCT00767000|2533802|P5|54-week Study|Reason not reported|0
796623|NCT00767000|2533803|P4|54-week Study|Reason not reported|1
796624|NCT00767000|2533804|P3|54-week Study|Reason not reported|0
796625|NCT00767000|2533805|P2|54-week Study|Reason not reported|0
796626|NCT00767000|2533806|P1|54-week Study|Reason not reported|0
796627|NCT00767000|2533802|P5|54-week Study|Study terminated by sponsor|194
796628|NCT00767000|2533803|P4|54-week Study|Study terminated by sponsor|196
796629|NCT00767000|2533804|P3|54-week Study|Study terminated by sponsor|89
796630|NCT00767000|2533805|P2|54-week Study|Study terminated by sponsor|102
796631|NCT00767000|2533806|P1|54-week Study|Study terminated by sponsor|90
796632|NCT00767000|2533802|P5|54-week Study|Withdrawal by Subject|13
796633|NCT00767000|2533803|P4|54-week Study|Withdrawal by Subject|11
796634|NCT00767000|2533804|P3|54-week Study|Withdrawal by Subject|5
796635|NCT00767000|2533805|P2|54-week Study|Withdrawal by Subject|3
796636|NCT00767000|2533806|P1|54-week Study|Withdrawal by Subject|2
796637|NCT00767000|2533802|P5|54-week Study|Protocol Violation|0
796638|NCT00767000|2533803|P4|54-week Study|Protocol Violation|2
796639|NCT00767000|2533804|P3|54-week Study|Protocol Violation|1
796640|NCT00767000|2533805|P2|54-week Study|Protocol Violation|0
796641|NCT00767000|2533806|P1|54-week Study|Protocol Violation|0
796642|NCT00767000|2533802|P5|54-week Study|Progressive disease|0
796643|NCT00767000|2533803|P4|54-week Study|Progressive disease|0
796644|NCT00767000|2533804|P3|54-week Study|Progressive disease|1
796645|NCT00767000|2533805|P2|54-week Study|Progressive disease|0
796646|NCT00767000|2533806|P1|54-week Study|Progressive disease|0
796647|NCT00767000|2533802|P5|54-week Study|Physician Decision|1
796648|NCT00767000|2533803|P4|54-week Study|Physician Decision|1
796649|NCT00767000|2533804|P3|54-week Study|Physician Decision|1
796650|NCT00767000|2533805|P2|54-week Study|Physician Decision|0
796651|NCT00767000|2533806|P1|54-week Study|Physician Decision|4
796652|NCT00767000|2533802|P5|54-week Study|Lost to Follow-up|2
796653|NCT00767000|2533803|P4|54-week Study|Lost to Follow-up|4
796654|NCT00767000|2533804|P3|54-week Study|Lost to Follow-up|1
796655|NCT00767000|2533805|P2|54-week Study|Lost to Follow-up|0
796656|NCT00767000|2533806|P1|54-week Study|Lost to Follow-up|4
796657|NCT00767000|2533802|P5|54-week Study|Lack of Efficacy|5
796658|NCT00767000|2533803|P4|54-week Study|Lack of Efficacy|0
796659|NCT00767000|2533804|P3|54-week Study|Lack of Efficacy|1
796660|NCT00767000|2533805|P2|54-week Study|Lack of Efficacy|0
796661|NCT00767000|2533806|P1|54-week Study|Lack of Efficacy|2
796662|NCT00767000|2533802|P5|54-week Study|Interruption of study medication|0
796663|NCT00767000|2533803|P4|54-week Study|Interruption of study medication|0
796664|NCT00767000|2533804|P3|54-week Study|Interruption of study medication|1
796665|NCT00767000|2533805|P2|54-week Study|Interruption of study medication|0
796666|NCT00767000|2533806|P1|54-week Study|Interruption of study medication|0
796667|NCT00767000|2533802|P5|54-week Study|Hypoglycemia|0
796668|NCT00767000|2533803|P4|54-week Study|Hypoglycemia|0
796669|NCT00767000|2533804|P3|54-week Study|Hypoglycemia|0
796670|NCT00767000|2533805|P2|54-week Study|Hypoglycemia|1
796671|NCT00767000|2533806|P1|54-week Study|Hypoglycemia|0
796672|NCT00767000|2533802|P5|54-week Study|Hyperglycemia|1
796673|NCT00767000|2533803|P4|54-week Study|Hyperglycemia|0
796674|NCT00767000|2533804|P3|54-week Study|Hyperglycemia|1
796675|NCT00767000|2533805|P2|54-week Study|Hyperglycemia|0
796676|NCT00767000|2533806|P1|54-week Study|Hyperglycemia|0
796677|NCT00767000|2533802|P5|54-week Study|Creaninine/creatinine clearance|4
796678|NCT00767000|2533803|P4|54-week Study|Creaninine/creatinine clearance|2
796679|NCT00767000|2533804|P3|54-week Study|Creaninine/creatinine clearance|2
796680|NCT00767000|2533805|P2|54-week Study|Creaninine/creatinine clearance|1
796681|NCT00767000|2533806|P1|54-week Study|Creaninine/creatinine clearance|2
796682|NCT00767000|2533802|P5|54-week Study|Adverse Event|4
796683|NCT00767000|2533803|P4|54-week Study|Adverse Event|8
796684|NCT00767000|2533804|P3|54-week Study|Adverse Event|6
796685|NCT00767000|2533805|P2|54-week Study|Adverse Event|6
796686|NCT00767000|2533806|P1|54-week Study|Adverse Event|4
796687|NCT00767039|2533850|P2|Overall Study|Death|2
796688|NCT00767039|2533851|P1|Overall Study|Death|5
796689|NCT00767104|2533879|P2|Overall Study|Lost to Follow-up|2
796690|NCT00767104|2533880|P1|Overall Study|Lost to Follow-up|1
796691|NCT00767325|2533888|P1|Overall Study|Missed visit due to family reasons|1
796692|NCT00767325|2533888|P1|Overall Study|No longer met study criteria|2
796693|NCT00767325|2533888|P1|Overall Study|Lost to Follow-up|3
796694|NCT00767325|2533888|P1|Overall Study|Adverse Event|7
796695|NCT00767325|2533888|P1|Overall Study|Lack of Efficacy|2
796696|NCT00767455|2533925|P1|Overall Study|Investigator error|19
796697|NCT00767520|2533964|P2|Overall Study|Randomized in error and Never treated|2
796698|NCT00767520|2533965|P1|Overall Study|Randomized in error and Never treated|0
796699|NCT00767520|2533964|P2|Overall Study|Participants still on treatment|15
796700|NCT00767520|2533965|P1|Overall Study|Participants still on treatment|11
796701|NCT00767676|2534004|P1|Overall Study|Investigator error|54
796702|NCT00767806|2534031|P2|Overall Study|Sponsor Decision|1
796703|NCT00767806|2534032|P1|Overall Study|Sponsor Decision|0
796704|NCT00767806|2534031|P2|Overall Study|Entry Criteria Not Met|1
796705|NCT00767806|2534032|P1|Overall Study|Entry Criteria Not Met|1
796706|NCT00767806|2534031|P2|Overall Study|Lost to Follow-up|4
796707|NCT00767806|2534032|P1|Overall Study|Lost to Follow-up|1
796708|NCT00767806|2534031|P2|Overall Study|Physician Decision|3
796709|NCT00767806|2534032|P1|Overall Study|Physician Decision|4
796710|NCT00767806|2534031|P2|Overall Study|Lack of Efficacy|9
796711|NCT00767806|2534032|P1|Overall Study|Lack of Efficacy|1
796712|NCT00767806|2534031|P2|Overall Study|Protocol Violation|5
796713|NCT00767806|2534032|P1|Overall Study|Protocol Violation|6
796714|NCT00767806|2534031|P2|Overall Study|Withdrawal by Subject|13
796715|NCT00767806|2534032|P1|Overall Study|Withdrawal by Subject|8
796716|NCT00767806|2534031|P2|Overall Study|Adverse Event|11
796717|NCT00767806|2534032|P1|Overall Study|Adverse Event|30
796718|NCT00768040|2534090|P2|Overall Study|Abnormal laboratory value|1
796719|NCT00768040|2534091|P1|Overall Study|Abnormal laboratory value|1
796720|NCT00768040|2534090|P2|Overall Study|Adverse Event|2
796721|NCT00768040|2534091|P1|Overall Study|Adverse Event|3
796722|NCT00768053|2534097|P1|Overall Study|Lost to Follow-up|1
796723|NCT00768053|2534097|P1|Overall Study|Adverse Event|10
796724|NCT00768066|2534129|P3|Overall Study|Did not receive study product injection.|0
796725|NCT00768066|2534130|P2|Overall Study|Did not receive study product injection.|3
796726|NCT00768066|2534131|P1|Overall Study|Did not receive study product injection.|3
796727|NCT00768144|2534167|P1|Overall Study|Pt Withdrew Consent|1
796728|NCT00768144|2534167|P1|Overall Study|Patient or MD Decision to End Treatment|1
796729|NCT00768144|2534167|P1|Overall Study|Progressive Disease|21
796730|NCT00768144|2534167|P1|Overall Study|Adverse Event|13
796731|NCT00768222|2534175|P2|Overall Study|Protocol Violation|2
796732|NCT00768222|2534176|P1|Overall Study|Protocol Violation|0
796733|NCT00768222|2534175|P2|Overall Study|Withdrawal by Subject|1
796734|NCT00768222|2534176|P1|Overall Study|Withdrawal by Subject|3
796735|NCT00768222|2534175|P2|Overall Study|Lost to Follow-up|1
796736|NCT00768222|2534176|P1|Overall Study|Lost to Follow-up|1
796737|NCT00768300|2534200|P2|Overall Study|Missing data|0
796738|NCT00768300|2534201|P1|Overall Study|Missing data|1
796739|NCT00768300|2534200|P2|Overall Study|Treated but never dosed with Study drug|0
796740|NCT00768300|2534201|P1|Overall Study|Treated but never dosed with Study drug|1
796741|NCT00768300|2534200|P2|Overall Study|Began prohibited concomitant medication|1
796742|NCT00768300|2534201|P1|Overall Study|Began prohibited concomitant medication|0
796743|NCT00768300|2534200|P2|Overall Study|Lost to Follow-up|1
796744|NCT00768300|2534201|P1|Overall Study|Lost to Follow-up|0
796745|NCT00768300|2534200|P2|Overall Study|Received lung transplant|1
796746|NCT00768300|2534201|P1|Overall Study|Received lung transplant|1
796747|NCT00768300|2534200|P2|Overall Study|Screen failure following randomization|0
796748|NCT00768300|2534201|P1|Overall Study|Screen failure following randomization|1
796749|NCT00768300|2534200|P2|Overall Study|Subject moved to pursue lung transplant|1
796750|NCT00768300|2534201|P1|Overall Study|Subject moved to pursue lung transplant|1
796751|NCT00768300|2534200|P2|Overall Study|Death|5
796752|NCT00768300|2534201|P1|Overall Study|Death|21
796753|NCT00768300|2534200|P2|Overall Study|Study discontinued by Sponsor|140
796754|NCT00768300|2534201|P1|Overall Study|Study discontinued by Sponsor|271
796755|NCT00768300|2534200|P2|Overall Study|Physician Decision|3
796756|NCT00768300|2534201|P1|Overall Study|Physician Decision|2
796757|NCT00768300|2534200|P2|Overall Study|Withdrawal by Subject|7
796758|NCT00768300|2534201|P1|Overall Study|Withdrawal by Subject|13
796759|NCT00768300|2534200|P2|Overall Study|Protocol Violation|1
796760|NCT00768300|2534201|P1|Overall Study|Protocol Violation|6
796761|NCT00768300|2534200|P2|Overall Study|Adverse Event|2
796762|NCT00768300|2534201|P1|Overall Study|Adverse Event|10
796763|NCT00768300|2534200|P2|Overall Study|Randomized but not treated|1
796764|NCT00768300|2534201|P1|Overall Study|Randomized but not treated|1
796765|NCT00768430|2534225|P2|7 Day Endpoint|Withdrawal by Subject|3
796766|NCT00768430|2534226|P1|7 Day Endpoint|Withdrawal by Subject|2
796767|NCT00768560|2534247|P6|Intervention Set 1|Adverse Event|0
796768|NCT00768560|2534248|P5|Intervention Set 1|Adverse Event|0
796769|NCT00768560|2534249|P4|Intervention Set 1|Adverse Event|0
796770|NCT00768560|2534250|P3|Intervention Set 1|Adverse Event|0
796771|NCT00768560|2534251|P2|Intervention Set 1|Adverse Event|1
796772|NCT00768560|2534252|P1|Intervention Set 1|Adverse Event|0
796773|NCT00768651|2534306|P1|Overall Study|Withdrawal by Subject|1
796774|NCT00768755|2534315|P4|Phase 2|Randomized but not treated|2
796775|NCT00768755|2534316|P3|Phase 2|Randomized but not treated|0
796776|NCT00768755|2534317|P2|Phase 2|Randomized but not treated|0
796777|NCT00768755|2534318|P1|Phase 2|Randomized but not treated|0
796778|NCT00768755|2534315|P4|Phase 2|Study Terminated by Sponsor|14
796779|NCT00768755|2534316|P3|Phase 2|Study Terminated by Sponsor|7
796780|NCT00768755|2534317|P2|Phase 2|Study Terminated by Sponsor|13
796781|NCT00768755|2534318|P1|Phase 2|Study Terminated by Sponsor|0
796782|NCT00768755|2534315|P4|Phase 2|Unspecified|4
796783|NCT00768755|2534316|P3|Phase 2|Unspecified|2
796784|NCT00768755|2534317|P2|Phase 2|Unspecified|1
796785|NCT00768755|2534318|P1|Phase 2|Unspecified|0
796786|NCT00768755|2534315|P4|Phase 2|Withdrawal by Subject|1
796787|NCT00768755|2534316|P3|Phase 2|Withdrawal by Subject|0
796788|NCT00768755|2534317|P2|Phase 2|Withdrawal by Subject|1
796789|NCT00768755|2534318|P1|Phase 2|Withdrawal by Subject|0
796790|NCT00768755|2534315|P4|Phase 2|Lost to Follow-up|4
796791|NCT00768755|2534316|P3|Phase 2|Lost to Follow-up|1
796792|NCT00768755|2534317|P2|Phase 2|Lost to Follow-up|1
796793|NCT00768755|2534318|P1|Phase 2|Lost to Follow-up|0
796794|NCT00768755|2534315|P4|Phase 2|Protocol Violation|1
796795|NCT00768755|2534316|P3|Phase 2|Protocol Violation|0
796796|NCT00768755|2534317|P2|Phase 2|Protocol Violation|2
796797|NCT00768755|2534318|P1|Phase 2|Protocol Violation|0
796798|NCT00768755|2534315|P4|Phase 2|Death|31
796799|NCT00768755|2534316|P3|Phase 2|Death|48
796800|NCT00768755|2534317|P2|Phase 2|Death|37
796801|NCT00768755|2534318|P1|Phase 2|Death|0
796802|NCT00768755|2534315|P4|Phase 1|Unspecified|0
796803|NCT00768755|2534316|P3|Phase 1|Unspecified|0
796804|NCT00768755|2534317|P2|Phase 1|Unspecified|0
796805|NCT00768755|2534318|P1|Phase 1|Unspecified|4
796806|NCT00768755|2534315|P4|Phase 1|Death|0
796807|NCT00768755|2534316|P3|Phase 1|Death|0
796808|NCT00768755|2534317|P2|Phase 1|Death|0
796809|NCT00768755|2534318|P1|Phase 1|Death|6
796810|NCT00768898|2534342|P1|Overall Study|Headache|1
796811|NCT00768898|2534342|P1|Overall Study|Unrelated injury|1
796812|NCT00760214|2534365|P3|Overall Study|Other|6
796813|NCT00760214|2534366|P2|Overall Study|Other|4
796814|NCT00760214|2534367|P1|Overall Study|Other|3
796815|NCT00760214|2534365|P3|Overall Study|Physician Decision|1
796816|NCT00760214|2534366|P2|Overall Study|Physician Decision|1
796817|NCT00760214|2534367|P1|Overall Study|Physician Decision|1
796818|NCT00760214|2534365|P3|Overall Study|Pregnancy|1
796819|NCT00760214|2534366|P2|Overall Study|Pregnancy|0
796820|NCT00760214|2534367|P1|Overall Study|Pregnancy|0
796821|NCT00760214|2534365|P3|Overall Study|Lack of Efficacy|4
796822|NCT00760214|2534366|P2|Overall Study|Lack of Efficacy|2
796823|NCT00760214|2534367|P1|Overall Study|Lack of Efficacy|3
796824|NCT00760214|2534365|P3|Overall Study|Withdrawal by Subject|13
796825|NCT00760214|2534366|P2|Overall Study|Withdrawal by Subject|14
796826|NCT00760214|2534367|P1|Overall Study|Withdrawal by Subject|12
796827|NCT00760214|2534365|P3|Overall Study|Lost to Follow-up|1
796828|NCT00760214|2534366|P2|Overall Study|Lost to Follow-up|0
796829|NCT00760214|2534367|P1|Overall Study|Lost to Follow-up|0
796830|NCT00760214|2534365|P3|Overall Study|Protocol Violation|3
796831|NCT00760214|2534366|P2|Overall Study|Protocol Violation|0
796832|NCT00760214|2534367|P1|Overall Study|Protocol Violation|3
796833|NCT00760214|2534365|P3|Overall Study|Adverse Event|12
796834|NCT00760214|2534366|P2|Overall Study|Adverse Event|9
796835|NCT00760214|2534367|P1|Overall Study|Adverse Event|8
796836|NCT00760266|2534410|P2|Overall Study|Administrative Problems|1
796837|NCT00760266|2534411|P1|Overall Study|Administrative Problems|0
796838|NCT00760266|2534410|P2|Overall Study|Lost to Follow-up|1
796839|NCT00760266|2534411|P1|Overall Study|Lost to Follow-up|2
796840|NCT00760266|2534410|P2|Overall Study|Patient withdrew consent|3
796841|NCT00760266|2534411|P1|Overall Study|Patient withdrew consent|3
796842|NCT00760266|2534410|P2|Overall Study|Protocol deviation|4
796843|NCT00760266|2534411|P1|Overall Study|Protocol deviation|2
796844|NCT00760266|2534410|P2|Overall Study|Lack of Efficacy|2
796845|NCT00760266|2534411|P1|Overall Study|Lack of Efficacy|2
796846|NCT00760266|2534410|P2|Overall Study|Abnormal test procedure result(s)|0
796847|NCT00760266|2534411|P1|Overall Study|Abnormal test procedure result(s)|1
796848|NCT00760266|2534410|P2|Overall Study|Abnormal laboratory value(s)|0
796849|NCT00760266|2534411|P1|Overall Study|Abnormal laboratory value(s)|1
796850|NCT00760266|2534410|P2|Overall Study|Adverse Event|7
796851|NCT00760266|2534411|P1|Overall Study|Adverse Event|13
796852|NCT00760383|2534427|P2|Overall Study|moved away; withdrew; medical reasons|7
796853|NCT00760383|2534428|P1|Overall Study|moved away; withdrew; medical reasons|5
796854|NCT00760474|2534457|P2|Period 2 (P2)|Adverse Event|1
796855|NCT00760474|2534458|P1|Period 2 (P2)|Adverse Event|0
796856|NCT00760474|2534457|P2|Period 2 (P2)|Lost to Follow-up|0
796857|NCT00760474|2534458|P1|Period 2 (P2)|Lost to Follow-up|1
796858|NCT00760474|2534457|P2|Placebo Washout Period|Unspecified|1
796859|NCT00760474|2534458|P1|Placebo Washout Period|Unspecified|0
796860|NCT00760474|2534457|P2|Period 1 (P1)|Discontinued then re-entered|1
796861|NCT00760474|2534458|P1|Period 1 (P1)|Discontinued then re-entered|1
796862|NCT00760487|2534494|P1|Overall Study|Unilateral implantation|3
796863|NCT00760552|2534530|P2|Overall Study|Lost to Follow-up|10
796864|NCT00760552|2534531|P1|Overall Study|Lost to Follow-up|11
796865|NCT00760552|2534530|P2|Overall Study|Death|0
796866|NCT00760552|2534531|P1|Overall Study|Death|2
796867|NCT00760617|2534581|P3|Overall Study|Lost to Follow-up|5
796868|NCT00760617|2534582|P2|Overall Study|Lost to Follow-up|0
796869|NCT00760617|2534583|P1|Overall Study|Lost to Follow-up|0
796870|NCT00760617|2534581|P3|Overall Study|Adverse Event|0
796871|NCT00760617|2534582|P2|Overall Study|Adverse Event|2
796872|NCT00760617|2534583|P1|Overall Study|Adverse Event|5
796873|NCT00760669|2534654|P1|Overall Study|Took drug before entering in contract|5
796874|NCT00760669|2534654|P1|Overall Study|Participants with overlapping cases|1
796875|NCT00760669|2534654|P1|Overall Study|Participants missing efficacy assessment|6
796876|NCT00760669|2534654|P1|Overall Study|Not assessed for overall improvement|18
796877|NCT00760747|2534670|P2|Study Period III|Physician Decision|1
796878|NCT00760747|2534671|P1|Study Period III|Physician Decision|0
796879|NCT00760747|2534670|P2|Study Period III|Protocol Violation|1
796880|NCT00760747|2534671|P1|Study Period III|Protocol Violation|1
796881|NCT00760747|2534670|P2|Study Period III|Parent/Caregiver Decision|1
796882|NCT00760747|2534671|P1|Study Period III|Parent/Caregiver Decision|0
796883|NCT00760747|2534670|P2|Study Period III|Lack of Efficacy|0
796884|NCT00760747|2534671|P1|Study Period III|Lack of Efficacy|1
796885|NCT00760747|2534670|P2|Study Period III|Adverse Event|0
796886|NCT00760747|2534671|P1|Study Period III|Adverse Event|1
796887|NCT00760747|2534670|P2|Study Period II|No drug administered|1
796888|NCT00760747|2534671|P1|Study Period II|No drug administered|0
796889|NCT00760747|2534670|P2|Study Period II|Withdrawal by Subject|0
796890|NCT00760747|2534671|P1|Study Period II|Withdrawal by Subject|1
796891|NCT00760747|2534670|P2|Study Period II|Protocol Violation|3
796892|NCT00760747|2534671|P1|Study Period II|Protocol Violation|6
796893|NCT00760747|2534670|P2|Study Period II|Parent/Caregiver Decision|0
796894|NCT00760747|2534671|P1|Study Period II|Parent/Caregiver Decision|3
796895|NCT00760747|2534670|P2|Study Period II|Lack of Efficacy|6
796896|NCT00760747|2534671|P1|Study Period II|Lack of Efficacy|0
796897|NCT00760747|2534670|P2|Study Period II|Adverse Event|4
796898|NCT00760747|2534671|P1|Study Period II|Adverse Event|3
796899|NCT00760838|2534701|P2|Overall Study|Withdrawal by Subject|1
796900|NCT00760838|2534702|P1|Overall Study|Withdrawal by Subject|1
796901|NCT00760838|2534701|P2|Overall Study|Lost to Follow-up|0
796902|NCT00760838|2534702|P1|Overall Study|Lost to Follow-up|2
796903|NCT00760838|2534701|P2|Overall Study|Lack of Efficacy|0
796904|NCT00760838|2534702|P1|Overall Study|Lack of Efficacy|1
796905|NCT00760838|2534701|P2|Overall Study|Adverse Event|1
796906|NCT00760838|2534702|P1|Overall Study|Adverse Event|1
796907|NCT00760877|2534720|P2|Overall Study|Treatment failure|0
796908|NCT00760877|2534721|P1|Overall Study|Treatment failure|1
796909|NCT00760877|2534720|P2|Overall Study|Participants transferred to AMN107A2408|1
796910|NCT00760877|2534721|P1|Overall Study|Participants transferred to AMN107A2408|11
796911|NCT00760877|2534720|P2|Overall Study|Physician Decision|2
796912|NCT00760877|2534721|P1|Overall Study|Physician Decision|1
796913|NCT00760877|2534720|P2|Overall Study|Participant not eligible to cross-over|1
796914|NCT00760877|2534721|P1|Overall Study|Participant not eligible to cross-over|0
796915|NCT00760877|2534720|P2|Overall Study|Participant diagnosed with AML|1
796916|NCT00760877|2534721|P1|Overall Study|Participant diagnosed with AML|0
796917|NCT00760877|2534720|P2|Overall Study|Adverse Event|12
796918|NCT00760877|2534721|P1|Overall Study|Adverse Event|19
796919|NCT00760877|2534720|P2|Overall Study|Withdrawal by Subject|3
796920|NCT00760877|2534721|P1|Overall Study|Withdrawal by Subject|7
796921|NCT00760877|2534720|P2|Overall Study|Death|1
796922|NCT00760877|2534721|P1|Overall Study|Death|2
796923|NCT00760877|2534720|P2|Overall Study|Pregnancy|4
796924|NCT00760877|2534721|P1|Overall Study|Pregnancy|1
796925|NCT00760877|2534720|P2|Overall Study|Non-compliance with protocol treatment|1
796926|NCT00760877|2534721|P1|Overall Study|Non-compliance with protocol treatment|2
796927|NCT00760877|2534720|P2|Overall Study|Protocol Violation|0
796928|NCT00760877|2534721|P1|Overall Study|Protocol Violation|1
796929|NCT00768989|2534739|P2|On or After Week 36|Sponsor Termination|26
796930|NCT00768989|2534740|P1|On or After Week 36|Sponsor Termination|45
796931|NCT00768989|2534739|P2|On or After Week 36|Did not attend termination visit|0
796932|NCT00768989|2534740|P1|On or After Week 36|Did not attend termination visit|2
796933|NCT00768989|2534739|P2|On or After Week 36|Protocol Violation|0
796934|NCT00768989|2534740|P1|On or After Week 36|Protocol Violation|1
796935|NCT00768989|2534739|P2|On or After Week 36|Poor Compliance|0
796936|NCT00768989|2534740|P1|On or After Week 36|Poor Compliance|1
796937|NCT00768989|2534739|P2|On or After Week 36|Lost to Follow-up|0
796938|NCT00768989|2534740|P1|On or After Week 36|Lost to Follow-up|1
796939|NCT00768989|2534739|P2|On or After Week 36|Adverse Event|1
796940|NCT00768989|2534740|P1|On or After Week 36|Adverse Event|0
796941|NCT00768989|2534739|P2|On or After Week 36|Lack of Efficacy|0
796942|NCT00768989|2534740|P1|On or After Week 36|Lack of Efficacy|1
796943|NCT00768989|2534739|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
796944|NCT00768989|2534740|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
796945|NCT00768989|2534739|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
796946|NCT00768989|2534740|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
796947|NCT00768989|2534739|P2|Week 24 to Prior to Week 36|Adverse Event|0
796948|NCT00768989|2534740|P1|Week 24 to Prior to Week 36|Adverse Event|1
796949|NCT00768989|2534739|P2|Prior to Week 24|Protocol Violation|2
796950|NCT00768989|2534740|P1|Prior to Week 24|Protocol Violation|0
796951|NCT00768989|2534739|P2|Prior to Week 24|Lost to Follow-up|1
796952|NCT00768989|2534740|P1|Prior to Week 24|Lost to Follow-up|0
796953|NCT00768989|2534739|P2|Prior to Week 24|Adverse Event|0
796954|NCT00768989|2534740|P1|Prior to Week 24|Adverse Event|3
796955|NCT00768989|2534739|P2|Prior to Week 24|Withdrawal by Subject|0
796956|NCT00768989|2534740|P1|Prior to Week 24|Withdrawal by Subject|1
796957|NCT00769067|2534811|P2|Overall Study|Withdrawal by Subject|1
796958|NCT00769067|2534812|P1|Overall Study|Withdrawal by Subject|0
796959|NCT00769067|2534811|P2|Overall Study|Unspecified|3
796960|NCT00769067|2534812|P1|Overall Study|Unspecified|1
796961|NCT00769067|2534811|P2|Overall Study|Study terminated by sponsor|3
796962|NCT00769067|2534812|P1|Overall Study|Study terminated by sponsor|1
796963|NCT00769067|2534811|P2|Overall Study|Lost to Follow-up|1
796964|NCT00769067|2534812|P1|Overall Study|Lost to Follow-up|3
796965|NCT00769067|2534811|P2|Overall Study|Death|86
796966|NCT00769067|2534812|P1|Overall Study|Death|89
796967|NCT00769119|2534839|P2|Overall Study|Disallowed medication|0
796968|NCT00769119|2534840|P1|Overall Study|Disallowed medication|1
796969|NCT00769119|2534839|P2|Overall Study|Adverse Event|1
796970|NCT00769119|2534840|P1|Overall Study|Adverse Event|1
796971|NCT00769119|2534839|P2|Overall Study|Voluntary discontinuation|2
796972|NCT00769119|2534840|P1|Overall Study|Voluntary discontinuation|0
796973|NCT00769132|2534884|P4|Period 4|Withdrawal by Subject|0
796974|NCT00769132|2534885|P3|Period 4|Withdrawal by Subject|0
796975|NCT00769132|2534886|P2|Period 4|Withdrawal by Subject|1
796976|NCT00769132|2534887|P1|Period 4|Withdrawal by Subject|0
796977|NCT00769132|2534884|P4|Period 3|Withdrawal by Subject|0
796978|NCT00769132|2534885|P3|Period 3|Withdrawal by Subject|0
796979|NCT00769132|2534886|P2|Period 3|Withdrawal by Subject|0
796980|NCT00769132|2534887|P1|Period 3|Withdrawal by Subject|1
796981|NCT00769132|2534884|P4|Period 2|Withdrawal by Subject|1
796982|NCT00769132|2534885|P3|Period 2|Withdrawal by Subject|0
796983|NCT00769132|2534886|P2|Period 2|Withdrawal by Subject|0
796984|NCT00769132|2534887|P1|Period 2|Withdrawal by Subject|0
796985|NCT00769132|2534884|P4|Period 1|Adverse Event|1
796986|NCT00769132|2534885|P3|Period 1|Adverse Event|0
796987|NCT00769132|2534886|P2|Period 1|Adverse Event|0
796988|NCT00769132|2534887|P1|Period 1|Adverse Event|1
796989|NCT00769184|2534901|P2|No Treatment (6 Weeks)|Adverse Event|1
796990|NCT00769184|2534902|P1|No Treatment (6 Weeks)|Adverse Event|1
796991|NCT00769184|2534901|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
796992|NCT00769184|2534902|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
796993|NCT00769184|2534901|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
796994|NCT00769184|2534902|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
796995|NCT00769561|2534912|P2|Overall Study|Lost to Follow-up|3
796996|NCT00769561|2534913|P1|Overall Study|Lost to Follow-up|1
796997|NCT00769561|2534912|P2|Overall Study|Withdrawal by Subject|2
796998|NCT00769561|2534913|P1|Overall Study|Withdrawal by Subject|2
796999|NCT00769704|2534948|P2|Overall Study|Other|2
797000|NCT00769704|2534949|P1|Overall Study|Other|1
797001|NCT00769704|2534948|P2|Overall Study|Withdrawal by Subject|5
797002|NCT00769704|2534949|P1|Overall Study|Withdrawal by Subject|12
797003|NCT00769704|2534948|P2|Overall Study|Death|190
797004|NCT00769704|2534949|P1|Overall Study|Death|95
797005|NCT00769704|2534948|P2|Overall Study|Lost to Follow-up|2
797006|NCT00769704|2534949|P1|Overall Study|Lost to Follow-up|3
797007|NCT00769860|2534969|P2|Overall Study|Withdrawal by Subject|0
797008|NCT00769860|2534970|P1|Overall Study|Withdrawal by Subject|2
797009|NCT00770029|2534998|P2|Overall Study|Adverse Event|0
797010|NCT00770029|2534999|P1|Overall Study|Adverse Event|1
797011|NCT00770029|2534998|P2|Overall Study|Withdrawal by Subject|3
797012|NCT00770029|2534999|P1|Overall Study|Withdrawal by Subject|3
797013|NCT00770029|2534998|P2|Overall Study|Lost to Follow-up|0
797014|NCT00770029|2534999|P1|Overall Study|Lost to Follow-up|2
797015|NCT00770120|2535013|P1|Overall Study|Reason under Review|1
797016|NCT00770120|2535013|P1|Overall Study|Never Received Treatment/Not Analyzable|1
797017|NCT00770120|2535013|P1|Overall Study|Ineligible|1
797018|NCT00770120|2535013|P1|Overall Study|Withdrawal by Subject|2
797019|NCT00770120|2535013|P1|Overall Study|Death|3
797020|NCT00770120|2535013|P1|Overall Study|Not Protocol Specified|11
797021|NCT00770120|2535013|P1|Overall Study|Adverse Event|11
797022|NCT00770120|2535013|P1|Overall Study|Progression|31
797023|NCT00770146|2535022|P2|Follow-up Period|Other|5
797024|NCT00770146|2535023|P1|Follow-up Period|Other|4
797025|NCT00770146|2535022|P2|Follow-up Period|Adverse Event|2
797026|NCT00770146|2535023|P1|Follow-up Period|Adverse Event|0
797027|NCT00770146|2535022|P2|Follow-up Period|Withdrawal by Subject|13
797028|NCT00770146|2535023|P1|Follow-up Period|Withdrawal by Subject|7
797029|NCT00770146|2535022|P2|Treatment Period|Protocol non-compliance|1
797030|NCT00770146|2535023|P1|Treatment Period|Protocol non-compliance|0
797031|NCT00770146|2535022|P2|Treatment Period|Other|5
797032|NCT00770146|2535023|P1|Treatment Period|Other|1
797033|NCT00770146|2535022|P2|Treatment Period|Adverse Event|26
797034|NCT00770146|2535023|P1|Treatment Period|Adverse Event|2
797035|NCT00770146|2535022|P2|Treatment Period|Withdrawal by Subject|13
797036|NCT00770146|2535023|P1|Treatment Period|Withdrawal by Subject|6
797037|NCT00770211|2535069|P2|Overall Study|Withdrawal by Subject|2
797038|NCT00770211|2535070|P1|Overall Study|Withdrawal by Subject|0
797039|NCT00770211|2535069|P2|Overall Study|Lost to Follow-up|0
797040|NCT00770211|2535070|P1|Overall Study|Lost to Follow-up|1
797041|NCT00770289|2535084|P1|Overall Study|Unspecified|6
797042|NCT00770315|2535097|P4|Overall Study|Noncompliance with Protocol|9
797043|NCT00770315|2535098|P3|Overall Study|Noncompliance with Protocol|7
797044|NCT00770315|2535099|P2|Overall Study|Noncompliance with Protocol|4
797045|NCT00770315|2535100|P1|Overall Study|Noncompliance with Protocol|7
797046|NCT00770315|2535097|P4|Overall Study|Withdrawal by Subject|20
797047|NCT00770315|2535098|P3|Overall Study|Withdrawal by Subject|24
797048|NCT00770315|2535099|P2|Overall Study|Withdrawal by Subject|17
797049|NCT00770315|2535100|P1|Overall Study|Withdrawal by Subject|13
797050|NCT00770315|2535097|P4|Overall Study|Lost to Follow-up|3
797051|NCT00770315|2535098|P3|Overall Study|Lost to Follow-up|10
797052|NCT00770315|2535099|P2|Overall Study|Lost to Follow-up|5
797053|NCT00770315|2535100|P1|Overall Study|Lost to Follow-up|9
797054|NCT00770315|2535097|P4|Overall Study|Adverse Event|6
797055|NCT00770315|2535098|P3|Overall Study|Adverse Event|16
797056|NCT00770315|2535099|P2|Overall Study|Adverse Event|17
797057|NCT00770315|2535100|P1|Overall Study|Adverse Event|11
892544|NCT00490568|2830516|P1|Overall Study|Lost to Follow-up|13
892545|NCT00490568|2830516|P1|Overall Study|Adverse Event|116
892546|NCT00451321|2830544|P8|Overall Study|Sponsor decision to amend protocol|3
892547|NCT00451321|2830545|P7|Overall Study|Sponsor decision to amend protocol|1
892548|NCT00451321|2830546|P6|Overall Study|Sponsor decision to amend protocol|1
892549|NCT00451321|2830547|P5|Overall Study|Sponsor decision to amend protocol|0
892550|NCT00451321|2830548|P4|Overall Study|Sponsor decision to amend protocol|0
892551|NCT00451321|2830549|P3|Overall Study|Sponsor decision to amend protocol|0
892552|NCT00451321|2830550|P2|Overall Study|Sponsor decision to amend protocol|0
892553|NCT00451321|2830551|P1|Overall Study|Sponsor decision to amend protocol|0
892554|NCT00451321|2830544|P8|Overall Study|Study closed/terminated|3
892555|NCT00451321|2830545|P7|Overall Study|Study closed/terminated|5
892556|NCT00451321|2830546|P6|Overall Study|Study closed/terminated|7
892557|NCT00451321|2830547|P5|Overall Study|Study closed/terminated|7
892558|NCT00451321|2830548|P4|Overall Study|Study closed/terminated|5
892559|NCT00451321|2830549|P3|Overall Study|Study closed/terminated|17
892560|NCT00451321|2830550|P2|Overall Study|Study closed/terminated|1
892561|NCT00451321|2830551|P1|Overall Study|Study closed/terminated|1
892562|NCT00451321|2830544|P8|Overall Study|Withdrawal by Subject|0
797079|NCT00770367|2535157|P2|Second Intervention|Lost to Follow-up|0
797080|NCT00770367|2535158|P1|Second Intervention|Lost to Follow-up|2
797081|NCT00770367|2535157|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
797082|NCT00770367|2535158|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
797083|NCT00770367|2535157|P2|First Intervention|Withdrawal by Subject|2
797084|NCT00770367|2535158|P1|First Intervention|Withdrawal by Subject|0
797085|NCT00770432|2535166|P2|Overall Study|Non-compliance|1
797086|NCT00770432|2535167|P1|Overall Study|Non-compliance|0
797087|NCT00770432|2535166|P2|Overall Study|Not specified|6
797088|NCT00770432|2535167|P1|Overall Study|Not specified|4
797089|NCT00770484|2535175|P2|Overall Study|Withdrawal by Subject|0
797090|NCT00770484|2535176|P1|Overall Study|Withdrawal by Subject|1
797091|NCT00770510|2535182|P1|Overall Study|Withdrawal by Subject|2
797092|NCT00770510|2535182|P1|Overall Study|Pregnancy|1
797093|NCT00770510|2535182|P1|Overall Study|Lost to Follow-up|2
797094|NCT00770562|2535221|P2|Overall Study|Did not take treatment|1
797095|NCT00770562|2535222|P1|Overall Study|Did not take treatment|1
797096|NCT00770588|2535235|P2|Overall Study|Withdrawal by Subject|1
797097|NCT00770588|2535236|P1|Overall Study|Withdrawal by Subject|1
797098|NCT00770588|2535235|P2|Overall Study|Lost to Follow-up|1
797099|NCT00770588|2535236|P1|Overall Study|Lost to Follow-up|1
797100|NCT00770588|2535235|P2|Overall Study|Death caused by progression of disease|91
797101|NCT00770588|2535236|P1|Overall Study|Death caused by progression of disease|70
797102|NCT00770588|2535235|P2|Overall Study|Adverse Event|2
797103|NCT00770588|2535236|P1|Overall Study|Adverse Event|9
797104|NCT00770653|2535252|P2|Overall Study|Physician Decision|0
797105|NCT00770653|2535253|P1|Overall Study|Physician Decision|1
797106|NCT00770653|2535252|P2|Overall Study|Lost to Follow-up|2
797107|NCT00770653|2535253|P1|Overall Study|Lost to Follow-up|1
797108|NCT00770653|2535252|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
797109|NCT00770653|2535253|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
797110|NCT00770653|2535252|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
797111|NCT00770653|2535253|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
797112|NCT00770653|2535252|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
797113|NCT00770653|2535253|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
797114|NCT00770653|2535252|P2|Overall Study|Lack of Compliance|4
797115|NCT00770653|2535253|P1|Overall Study|Lack of Compliance|1
797116|NCT00770653|2535252|P2|Overall Study|Withdrawal by Subject|7
797117|NCT00770653|2535253|P1|Overall Study|Withdrawal by Subject|4
797118|NCT00770653|2535252|P2|Overall Study|Protocol Violation|6
797119|NCT00770653|2535253|P1|Overall Study|Protocol Violation|8
797120|NCT00770653|2535252|P2|Overall Study|Adverse Event|5
797121|NCT00770653|2535253|P1|Overall Study|Adverse Event|13
797122|NCT00770679|2535321|P1|Overall Study|Follow-up LDL measurement not collected|3
797123|NCT00770679|2535321|P1|Overall Study|Lost to Follow-up|3
797124|NCT00770692|2535331|P4|Overall Study|Investigator judgment|1
797125|NCT00770692|2535332|P3|Overall Study|Investigator judgment|1
797126|NCT00770692|2535333|P2|Overall Study|Investigator judgment|0
797127|NCT00770692|2535334|P1|Overall Study|Investigator judgment|2
797128|NCT00770692|2535331|P4|Overall Study|Adverse Event|4
797129|NCT00770692|2535332|P3|Overall Study|Adverse Event|4
797130|NCT00770692|2535333|P2|Overall Study|Adverse Event|0
797131|NCT00770692|2535334|P1|Overall Study|Adverse Event|3
797132|NCT00770692|2535331|P4|Overall Study|Withdrawal by Subject|6
797133|NCT00770692|2535332|P3|Overall Study|Withdrawal by Subject|9
797134|NCT00770692|2535333|P2|Overall Study|Withdrawal by Subject|9
797135|NCT00770692|2535334|P1|Overall Study|Withdrawal by Subject|7
797136|NCT00770770|2535370|P2|Overall Study|Study Terminated|0
797137|NCT00770770|2535371|P1|Overall Study|Study Terminated|8
797138|NCT00770770|2535370|P2|Overall Study|Death|1
797139|NCT00770770|2535371|P1|Overall Study|Death|0
797140|NCT00770770|2535370|P2|Overall Study|Withdrawal by Subject|0
797141|NCT00770770|2535371|P1|Overall Study|Withdrawal by Subject|1
797142|NCT00770770|2535370|P2|Overall Study|Lost to Follow-up|0
797143|NCT00770770|2535371|P1|Overall Study|Lost to Follow-up|1
797144|NCT00770809|2535380|P3|Overall Study|Other Medical Reasons|3
797145|NCT00770809|2535381|P2|Overall Study|Other Medical Reasons|4
797146|NCT00770809|2535382|P1|Overall Study|Other Medical Reasons|2
797147|NCT00770809|2535380|P3|Overall Study|Complicating illness|1
797148|NCT00770809|2535381|P2|Overall Study|Complicating illness|0
797149|NCT00770809|2535382|P1|Overall Study|Complicating illness|0
797150|NCT00770809|2535380|P3|Overall Study|Progression|0
797151|NCT00770809|2535381|P2|Overall Study|Progression|2
797152|NCT00770809|2535382|P1|Overall Study|Progression|2
797153|NCT00770809|2535380|P3|Overall Study|Withdrawal by Subject|7
797154|NCT00770809|2535381|P2|Overall Study|Withdrawal by Subject|3
797155|NCT00770809|2535382|P1|Overall Study|Withdrawal by Subject|3
797156|NCT00770809|2535380|P3|Overall Study|Death|0
797157|NCT00770809|2535381|P2|Overall Study|Death|0
797158|NCT00770809|2535382|P1|Overall Study|Death|1
797159|NCT00770809|2535380|P3|Overall Study|Adverse Event|12
797160|NCT00770809|2535381|P2|Overall Study|Adverse Event|1
797161|NCT00770809|2535382|P1|Overall Study|Adverse Event|9
797162|NCT00770913|2535404|P3|Overall Study|Incorrect drug was allocated|0
797163|NCT00770913|2535405|P2|Overall Study|Incorrect drug was allocated|0
797164|NCT00770913|2535406|P1|Overall Study|Incorrect drug was allocated|1
797165|NCT00770913|2535404|P3|Overall Study|Protocol Violation|1
797166|NCT00770913|2535405|P2|Overall Study|Protocol Violation|0
797167|NCT00770913|2535406|P1|Overall Study|Protocol Violation|3
797168|NCT00770913|2535404|P3|Overall Study|Physician Decision|1
797169|NCT00770913|2535405|P2|Overall Study|Physician Decision|1
797170|NCT00770913|2535406|P1|Overall Study|Physician Decision|0
797171|NCT00770913|2535404|P3|Overall Study|Refusal to continue participation|5
797172|NCT00770913|2535405|P2|Overall Study|Refusal to continue participation|4
797173|NCT00770913|2535406|P1|Overall Study|Refusal to continue participation|6
797174|NCT00770913|2535404|P3|Overall Study|Adverse Event|6
797175|NCT00770913|2535405|P2|Overall Study|Adverse Event|3
797176|NCT00770913|2535406|P1|Overall Study|Adverse Event|1
797177|NCT00770965|2535418|P4|Excluded Set|Withdrawal by Subject|3
797178|NCT00770965|2535419|P3|Excluded Set|Withdrawal by Subject|2
797179|NCT00770965|2535420|P2|Excluded Set|Withdrawal by Subject|1
797180|NCT00770965|2535421|P1|Excluded Set|Withdrawal by Subject|1
797181|NCT00770965|2535418|P4|Excluded Set|Administrative problems|10
797182|NCT00770965|2535419|P3|Excluded Set|Administrative problems|12
797183|NCT00770965|2535420|P2|Excluded Set|Administrative problems|12
797184|NCT00770965|2535421|P1|Excluded Set|Administrative problems|14
797185|NCT00770965|2535418|P4|Safety Set|Protocol deviation|0
797186|NCT00770965|2535419|P3|Safety Set|Protocol deviation|1
797187|NCT00770965|2535420|P2|Safety Set|Protocol deviation|0
797188|NCT00770965|2535421|P1|Safety Set|Protocol deviation|0
797189|NCT00770965|2535418|P4|Safety Set|Withdrawal by Subject|1
797190|NCT00770965|2535419|P3|Safety Set|Withdrawal by Subject|0
797191|NCT00770965|2535420|P2|Safety Set|Withdrawal by Subject|0
797192|NCT00770965|2535421|P1|Safety Set|Withdrawal by Subject|0
797193|NCT00770991|2535441|P2|Overall Study|Pregnancy|0
797194|NCT00770991|2535442|P1|Overall Study|Pregnancy|1
797195|NCT00770991|2535441|P2|Overall Study|Adverse Event|5
797196|NCT00770991|2535442|P1|Overall Study|Adverse Event|1
797197|NCT00770991|2535441|P2|Overall Study|Withdrawal by Subject|0
797198|NCT00770991|2535442|P1|Overall Study|Withdrawal by Subject|1
797199|NCT00770991|2535441|P2|Overall Study|Physician Decision|0
797200|NCT00770991|2535442|P1|Overall Study|Physician Decision|2
797201|NCT00771316|2535496|P2|Overall Study|Discontinued due to early termination|0
797202|NCT00771316|2535497|P1|Overall Study|Discontinued due to early termination|1
797203|NCT00771316|2535496|P2|Overall Study|Patient withdrew consent|0
797204|NCT00771316|2535497|P1|Overall Study|Patient withdrew consent|1
797205|NCT00771316|2535496|P2|Overall Study|Adverse Event|1
797206|NCT00771316|2535497|P1|Overall Study|Adverse Event|0
797207|NCT00771472|2535516|P2|Overall Study|Protocol Violation|0
797208|NCT00771472|2535517|P1|Overall Study|Protocol Violation|1
797209|NCT00771472|2535516|P2|Overall Study|Progressive Disease|1
797210|NCT00771472|2535517|P1|Overall Study|Progressive Disease|3
797211|NCT00771472|2535516|P2|Overall Study|Physician Decision|3
797212|NCT00771472|2535517|P1|Overall Study|Physician Decision|2
797213|NCT00771615|2535605|P9|Overall Study|Lost to Follow-up|0
797214|NCT00771615|2535606|P8|Overall Study|Lost to Follow-up|0
797215|NCT00771615|2535607|P7|Overall Study|Lost to Follow-up|1
797216|NCT00771615|2535608|P6|Overall Study|Lost to Follow-up|1
797217|NCT00771615|2535609|P5|Overall Study|Lost to Follow-up|0
797218|NCT00771615|2535610|P4|Overall Study|Lost to Follow-up|1
797219|NCT00771615|2535611|P3|Overall Study|Lost to Follow-up|1
797220|NCT00771615|2535612|P2|Overall Study|Lost to Follow-up|1
797221|NCT00771615|2535613|P1|Overall Study|Lost to Follow-up|1
797222|NCT00771615|2535605|P9|Overall Study|Withdrawal by Subject|0
797223|NCT00771615|2535606|P8|Overall Study|Withdrawal by Subject|1
797224|NCT00771615|2535607|P7|Overall Study|Withdrawal by Subject|0
797225|NCT00771615|2535608|P6|Overall Study|Withdrawal by Subject|0
797226|NCT00771615|2535609|P5|Overall Study|Withdrawal by Subject|0
797227|NCT00771615|2535610|P4|Overall Study|Withdrawal by Subject|0
797228|NCT00771615|2535611|P3|Overall Study|Withdrawal by Subject|0
797229|NCT00771615|2535612|P2|Overall Study|Withdrawal by Subject|1
797230|NCT00771615|2535613|P1|Overall Study|Withdrawal by Subject|0
892563|NCT00451321|2830545|P7|Overall Study|Withdrawal by Subject|0
892564|NCT00451321|2830546|P6|Overall Study|Withdrawal by Subject|0
892565|NCT00451321|2830547|P5|Overall Study|Withdrawal by Subject|0
892566|NCT00451321|2830548|P4|Overall Study|Withdrawal by Subject|4
892567|NCT00451321|2830549|P3|Overall Study|Withdrawal by Subject|0
892568|NCT00451321|2830550|P2|Overall Study|Withdrawal by Subject|1
892569|NCT00451321|2830551|P1|Overall Study|Withdrawal by Subject|3
892570|NCT00451321|2830544|P8|Overall Study|Lost to Follow-up|0
892571|NCT00451321|2830545|P7|Overall Study|Lost to Follow-up|0
892572|NCT00451321|2830546|P6|Overall Study|Lost to Follow-up|1
892573|NCT00451321|2830547|P5|Overall Study|Lost to Follow-up|0
892574|NCT00451321|2830548|P4|Overall Study|Lost to Follow-up|3
892575|NCT00451321|2830549|P3|Overall Study|Lost to Follow-up|1
892576|NCT00451321|2830550|P2|Overall Study|Lost to Follow-up|3
892577|NCT00451321|2830551|P1|Overall Study|Lost to Follow-up|3
892578|NCT00432965|2830723|P2|Overall Study|Incomplete Data|3
892579|NCT00432965|2830724|P1|Overall Study|Incomplete Data|4
892580|NCT00432965|2830723|P2|Overall Study|Exclusionary Methods|2
892581|NCT00432965|2830724|P1|Overall Study|Exclusionary Methods|1
892582|NCT00432965|2830723|P2|Overall Study|Death|4
892583|NCT00432965|2830724|P1|Overall Study|Death|3
892584|NCT00432965|2830723|P2|Overall Study|Adverse Event|19
892585|NCT00432965|2830724|P1|Overall Study|Adverse Event|22
892586|NCT00432965|2830723|P2|Overall Study|Non-compliance|0
892587|NCT00432965|2830724|P1|Overall Study|Non-compliance|7
892588|NCT00432965|2830723|P2|Overall Study|Lack of Efficacy|13
892589|NCT00432965|2830724|P1|Overall Study|Lack of Efficacy|8
892590|NCT00432965|2830723|P2|Overall Study|Physician Decision|13
892591|NCT00432965|2830724|P1|Overall Study|Physician Decision|14
892592|NCT00432965|2830723|P2|Overall Study|Withdrawal by Subject|13
892593|NCT00432965|2830724|P1|Overall Study|Withdrawal by Subject|13
892594|NCT00432965|2830723|P2|Overall Study|Lost to Follow-up|19
892595|NCT00432965|2830724|P1|Overall Study|Lost to Follow-up|22
892597|NCT00004259|2830765|P4|Overall Study|Withdrawal by Subject|0
892598|NCT00004259|2830766|P3|Overall Study|Withdrawal by Subject|0
892599|NCT00004259|2830767|P2|Overall Study|Withdrawal by Subject|2
892600|NCT00004259|2830768|P1|Overall Study|Withdrawal by Subject|0
892601|NCT00004259|2830765|P4|Overall Study|Protocol Violation|0
892602|NCT00004259|2830766|P3|Overall Study|Protocol Violation|0
892603|NCT00004259|2830767|P2|Overall Study|Protocol Violation|2
892604|NCT00004259|2830768|P1|Overall Study|Protocol Violation|1
797301|NCT00771758|2535865|P3|Overall Study|Other|0
797302|NCT00771758|2535866|P2|Overall Study|Other|2
797303|NCT00771758|2535867|P1|Overall Study|Other|3
797304|NCT00771758|2535865|P3|Overall Study|Withdrawal by Subject|0
797305|NCT00771758|2535866|P2|Overall Study|Withdrawal by Subject|0
797306|NCT00771758|2535867|P1|Overall Study|Withdrawal by Subject|1
797307|NCT00771758|2535865|P3|Overall Study|Protocol Violation|0
797308|NCT00771758|2535866|P2|Overall Study|Protocol Violation|0
797309|NCT00771758|2535867|P1|Overall Study|Protocol Violation|1
797310|NCT00771758|2535865|P3|Overall Study|Lost to Follow-up|0
797311|NCT00771758|2535866|P2|Overall Study|Lost to Follow-up|0
797312|NCT00771758|2535867|P1|Overall Study|Lost to Follow-up|1
797313|NCT00771758|2535865|P3|Overall Study|Lack of Efficacy|1
797314|NCT00771758|2535866|P2|Overall Study|Lack of Efficacy|2
797315|NCT00771758|2535867|P1|Overall Study|Lack of Efficacy|0
797316|NCT00771758|2535865|P3|Overall Study|Adverse Event|1
797317|NCT00771758|2535866|P2|Overall Study|Adverse Event|8
797318|NCT00771758|2535867|P1|Overall Study|Adverse Event|2
797337|NCT00771849|2536057|P2|Overall Study|Not vaccinated|1
797338|NCT00771849|2536058|P1|Overall Study|Not vaccinated|0
797339|NCT00771849|2536057|P2|Overall Study|Withdrawal by Subject|1
797340|NCT00771849|2536058|P1|Overall Study|Withdrawal by Subject|1
797341|NCT00771849|2536057|P2|Overall Study|Lost to Follow-up|2
797342|NCT00771849|2536058|P1|Overall Study|Lost to Follow-up|1
797343|NCT00771914|2536101|P4|Overall Study|Lost to Follow-up|1
797344|NCT00771914|2536102|P3|Overall Study|Lost to Follow-up|0
797345|NCT00771914|2536103|P2|Overall Study|Lost to Follow-up|0
797346|NCT00771914|2536104|P1|Overall Study|Lost to Follow-up|0
797347|NCT00771914|2536101|P4|Overall Study|Physician Decision|1
797348|NCT00771914|2536102|P3|Overall Study|Physician Decision|0
797349|NCT00771914|2536103|P2|Overall Study|Physician Decision|0
797350|NCT00771914|2536104|P1|Overall Study|Physician Decision|0
797351|NCT00771927|2536116|P2|Overall Study|Other reason|27
797352|NCT00771927|2536117|P1|Overall Study|Other reason|23
797353|NCT00771927|2536116|P2|Overall Study|Withdrawal by Subject|17
797354|NCT00771927|2536117|P1|Overall Study|Withdrawal by Subject|16
797355|NCT00771927|2536116|P2|Overall Study|Lost to Follow-up|46
797356|NCT00771927|2536117|P1|Overall Study|Lost to Follow-up|46
797357|NCT00771927|2536116|P2|Overall Study|Lack of Efficacy|42
797358|NCT00771927|2536117|P1|Overall Study|Lack of Efficacy|70
797359|NCT00771927|2536116|P2|Overall Study|Adverse Event|105
797360|NCT00771927|2536117|P1|Overall Study|Adverse Event|100
797361|NCT00771953|2536127|P2|Overall Study|Withdrawal by Subject|3
797362|NCT00771953|2536128|P1|Overall Study|Withdrawal by Subject|0
797363|NCT00771953|2536127|P2|Overall Study|Other complicating disease|0
797364|NCT00771953|2536128|P1|Overall Study|Other complicating disease|1
797365|NCT00771953|2536127|P2|Overall Study|Sponsor decision|0
797366|NCT00771953|2536128|P1|Overall Study|Sponsor decision|1
797367|NCT00771953|2536127|P2|Overall Study|Progression before active Tx|2
797368|NCT00771953|2536128|P1|Overall Study|Progression before active Tx|1
797369|NCT00771953|2536127|P2|Overall Study|Death|2
797370|NCT00771953|2536128|P1|Overall Study|Death|2
797371|NCT00771953|2536127|P2|Overall Study|Adverse Event|3
797372|NCT00771953|2536128|P1|Overall Study|Adverse Event|5
797373|NCT00763815|2536138|P2|Overall Study|Sponsor's Decision|1
797374|NCT00763815|2536139|P1|Overall Study|Sponsor's Decision|0
797375|NCT00763815|2536138|P2|Overall Study|Protocol Violation|5
797376|NCT00763815|2536139|P1|Overall Study|Protocol Violation|2
797377|NCT00763815|2536138|P2|Overall Study|Withdrawal by Subject|12
797378|NCT00763815|2536139|P1|Overall Study|Withdrawal by Subject|7
797379|NCT00763815|2536138|P2|Overall Study|Physician Decision|0
797380|NCT00763815|2536139|P1|Overall Study|Physician Decision|1
797381|NCT00763815|2536138|P2|Overall Study|Familial and Personal Reasons|16
797382|NCT00763815|2536139|P1|Overall Study|Familial and Personal Reasons|9
797383|NCT00763815|2536138|P2|Overall Study|Early Termination|0
797384|NCT00763815|2536139|P1|Overall Study|Early Termination|1
797385|NCT00763815|2536138|P2|Overall Study|Lost to Follow-up|4
797386|NCT00763815|2536139|P1|Overall Study|Lost to Follow-up|2
797387|NCT00763815|2536138|P2|Overall Study|Poor Compliance to Protocol|6
797388|NCT00763815|2536139|P1|Overall Study|Poor Compliance to Protocol|6
797389|NCT00763815|2536138|P2|Overall Study|Lack of Efficacy|11
797390|NCT00763815|2536139|P1|Overall Study|Lack of Efficacy|10
797391|NCT00763815|2536138|P2|Overall Study|Adverse Event|29
797392|NCT00763815|2536139|P1|Overall Study|Adverse Event|14
797393|NCT00763958|2536288|P2|Overall Study|Believed they were receiving placebo|5
797394|NCT00763958|2536289|P1|Overall Study|Believed they were receiving placebo|0
797395|NCT00763958|2536288|P2|Overall Study|Lost to Follow-up|2
797396|NCT00763958|2536289|P1|Overall Study|Lost to Follow-up|10
797397|NCT00763958|2536288|P2|Overall Study|did not meet final criteria|4
797398|NCT00763958|2536289|P1|Overall Study|did not meet final criteria|4
797399|NCT00763971|2536302|P3|Overall Study|Participation in 489-326 required|0
797400|NCT00763971|2536303|P2|Overall Study|Participation in 489-326 required|0
797401|NCT00763971|2536304|P1|Overall Study|Participation in 489-326 required|1
797402|NCT00763971|2536302|P3|Overall Study|Performed final visit on phone|0
797403|NCT00763971|2536303|P2|Overall Study|Performed final visit on phone|1
797404|NCT00763971|2536304|P1|Overall Study|Performed final visit on phone|0
797405|NCT00763971|2536302|P3|Overall Study|Lack of availability|0
797406|NCT00763971|2536303|P2|Overall Study|Lack of availability|1
797407|NCT00763971|2536304|P1|Overall Study|Lack of availability|0
797408|NCT00763971|2536302|P3|Overall Study|Subject wanted dose reduction|0
797409|NCT00763971|2536303|P2|Overall Study|Subject wanted dose reduction|1
797410|NCT00763971|2536304|P1|Overall Study|Subject wanted dose reduction|0
797411|NCT00763971|2536302|P3|Overall Study|Moved to another country|0
797412|NCT00763971|2536303|P2|Overall Study|Moved to another country|1
797413|NCT00763971|2536304|P1|Overall Study|Moved to another country|0
797414|NCT00763971|2536302|P3|Overall Study|Medical monitor decision|1
797415|NCT00763971|2536303|P2|Overall Study|Medical monitor decision|0
797416|NCT00763971|2536304|P1|Overall Study|Medical monitor decision|0
797417|NCT00763971|2536302|P3|Overall Study|Randomization error|1
797418|NCT00763971|2536303|P2|Overall Study|Randomization error|0
797419|NCT00763971|2536304|P1|Overall Study|Randomization error|0
797420|NCT00763971|2536302|P3|Overall Study|Due to holiday season|1
797421|NCT00763971|2536303|P2|Overall Study|Due to holiday season|0
797422|NCT00763971|2536304|P1|Overall Study|Due to holiday season|2
797423|NCT00763971|2536302|P3|Overall Study|Sponsor decision|0
797424|NCT00763971|2536303|P2|Overall Study|Sponsor decision|0
797425|NCT00763971|2536304|P1|Overall Study|Sponsor decision|1
797426|NCT00763971|2536302|P3|Overall Study|Exclusion criteria met|0
797427|NCT00763971|2536303|P2|Overall Study|Exclusion criteria met|0
797428|NCT00763971|2536304|P1|Overall Study|Exclusion criteria met|1
797429|NCT00763971|2536302|P3|Overall Study|Personal reason|0
797430|NCT00763971|2536303|P2|Overall Study|Personal reason|0
797431|NCT00763971|2536304|P1|Overall Study|Personal reason|3
797432|NCT00763971|2536302|P3|Overall Study|Unable to swallow capsule|1
797433|NCT00763971|2536303|P2|Overall Study|Unable to swallow capsule|1
797434|NCT00763971|2536304|P1|Overall Study|Unable to swallow capsule|2
797435|NCT00763971|2536302|P3|Overall Study|Lack of Efficacy|54
797436|NCT00763971|2536303|P2|Overall Study|Lack of Efficacy|22
797437|NCT00763971|2536304|P1|Overall Study|Lack of Efficacy|11
797438|NCT00763971|2536302|P3|Overall Study|Lost to Follow-up|0
797439|NCT00763971|2536303|P2|Overall Study|Lost to Follow-up|1
797440|NCT00763971|2536304|P1|Overall Study|Lost to Follow-up|0
797441|NCT00763971|2536302|P3|Overall Study|Withdrawal by Subject|5
797442|NCT00763971|2536303|P2|Overall Study|Withdrawal by Subject|5
797443|NCT00763971|2536304|P1|Overall Study|Withdrawal by Subject|4
797444|NCT00763971|2536302|P3|Overall Study|Protocol Violation|2
797445|NCT00763971|2536303|P2|Overall Study|Protocol Violation|3
797446|NCT00763971|2536304|P1|Overall Study|Protocol Violation|3
797447|NCT00763971|2536302|P3|Overall Study|Adverse Event|4
797448|NCT00763971|2536303|P2|Overall Study|Adverse Event|2
797449|NCT00763971|2536304|P1|Overall Study|Adverse Event|5
797450|NCT00764322|2536342|P1|Overall Study|No CYP2D6 genotyping|9
797451|NCT00764322|2536342|P1|Overall Study|Withdrawal by Subject|11
797452|NCT00764361|2536361|P2|Overall Study|Adverse Event|1
797453|NCT00764361|2536362|P1|Overall Study|Adverse Event|0
797454|NCT00764361|2536361|P2|Overall Study|Withdrawal by Subject|3
797455|NCT00764361|2536362|P1|Overall Study|Withdrawal by Subject|2
797456|NCT00764465|2536374|P6|Overall Study|Withdrawal by Subject|0
797457|NCT00764465|2536375|P5|Overall Study|Withdrawal by Subject|0
797458|NCT00764465|2536376|P4|Overall Study|Withdrawal by Subject|0
797459|NCT00764465|2536377|P3|Overall Study|Withdrawal by Subject|1
797460|NCT00764465|2536378|P2|Overall Study|Withdrawal by Subject|1
797461|NCT00764465|2536379|P1|Overall Study|Withdrawal by Subject|0
797462|NCT00764465|2536374|P6|Overall Study|Adverse Event|1
797463|NCT00764465|2536375|P5|Overall Study|Adverse Event|1
797464|NCT00764465|2536376|P4|Overall Study|Adverse Event|1
797465|NCT00764465|2536377|P3|Overall Study|Adverse Event|0
797466|NCT00764465|2536378|P2|Overall Study|Adverse Event|0
797467|NCT00764465|2536379|P1|Overall Study|Adverse Event|2
797468|NCT00764478|2536408|P3|Overall Study|Protocol Violation|1
797469|NCT00764478|2536409|P2|Overall Study|Protocol Violation|1
797470|NCT00764478|2536410|P1|Overall Study|Protocol Violation|0
797471|NCT00764478|2536408|P3|Overall Study|Lost to Follow-up|5
797472|NCT00764478|2536409|P2|Overall Study|Lost to Follow-up|8
797473|NCT00764478|2536410|P1|Overall Study|Lost to Follow-up|7
797474|NCT00764478|2536408|P3|Overall Study|Withdrawal by Subject|1
797475|NCT00764478|2536409|P2|Overall Study|Withdrawal by Subject|12
797476|NCT00764478|2536410|P1|Overall Study|Withdrawal by Subject|7
797477|NCT00764478|2536408|P3|Overall Study|Adverse Event|1
797478|NCT00764478|2536409|P2|Overall Study|Adverse Event|1
797479|NCT00764478|2536410|P1|Overall Study|Adverse Event|1
797480|NCT00764504|2536487|P3|Overall Study|Lost to Follow-up|72
797481|NCT00764504|2536488|P2|Overall Study|Lost to Follow-up|34
797482|NCT00764504|2536489|P1|Overall Study|Lost to Follow-up|40
797483|NCT00764504|2536487|P3|Overall Study|Withdrawal by Subject|4
797484|NCT00764504|2536488|P2|Overall Study|Withdrawal by Subject|7
797485|NCT00764504|2536489|P1|Overall Study|Withdrawal by Subject|1
797486|NCT00764504|2536487|P3|Overall Study|Physician Decision|0
797487|NCT00764504|2536488|P2|Overall Study|Physician Decision|0
797488|NCT00764504|2536489|P1|Overall Study|Physician Decision|1
797489|NCT00764504|2536487|P3|Overall Study|Revision of Device|14
797490|NCT00764504|2536488|P2|Overall Study|Revision of Device|23
797491|NCT00764504|2536489|P1|Overall Study|Revision of Device|12
797492|NCT00764504|2536487|P3|Overall Study|Death|13
797493|NCT00764504|2536488|P2|Overall Study|Death|6
797494|NCT00764504|2536489|P1|Overall Study|Death|12
797495|NCT00764660|2536517|P2|Overall Study|Did Not Meet Protocol Eligibility|0
797496|NCT00764660|2536518|P1|Overall Study|Did Not Meet Protocol Eligibility|1
797497|NCT00764660|2536517|P2|Overall Study|Noncompliance With Protocol|1
797498|NCT00764660|2536518|P1|Overall Study|Noncompliance With Protocol|5
797499|NCT00764660|2536517|P2|Overall Study|Withdrawal by Subject|3
797500|NCT00764660|2536518|P1|Overall Study|Withdrawal by Subject|7
797501|NCT00764660|2536517|P2|Overall Study|Lost to Follow-up|4
797502|NCT00764660|2536518|P1|Overall Study|Lost to Follow-up|3
797503|NCT00764660|2536517|P2|Overall Study|Adverse Event|3
797504|NCT00764660|2536518|P1|Overall Study|Adverse Event|6
797505|NCT00764673|2536550|P1|Overall Study|Revision of Device|2
797506|NCT00764673|2536550|P1|Overall Study|Withdrawal by Subject|6
797507|NCT00764673|2536550|P1|Overall Study|Lost to Follow-up|3
797508|NCT00764673|2536550|P1|Overall Study|Death|1
797509|NCT00764790|2536561|P3|Overall Study|Lost to Follow-up|23
797510|NCT00764790|2536562|P2|Overall Study|Lost to Follow-up|29
797511|NCT00764790|2536563|P1|Overall Study|Lost to Follow-up|28
797512|NCT00764790|2536561|P3|Overall Study|Withdrawal by Subject|6
797513|NCT00764790|2536562|P2|Overall Study|Withdrawal by Subject|12
797514|NCT00764790|2536563|P1|Overall Study|Withdrawal by Subject|10
797515|NCT00764790|2536561|P3|Overall Study|Protocol Violation|1
797516|NCT00764790|2536562|P2|Overall Study|Protocol Violation|0
797517|NCT00764790|2536563|P1|Overall Study|Protocol Violation|0
797518|NCT00764868|2536595|P1|Overall Study|Sponsor requested withdrawal|1
797519|NCT00764868|2536595|P1|Overall Study|Positive drug screen|2
797520|NCT00764868|2536595|P1|Overall Study|Met an exclusion criteria|1
797521|NCT00764868|2536595|P1|Overall Study|Subject sent to boarding school|1
797522|NCT00764868|2536595|P1|Overall Study|Misuse and compliance of study drug|1
797523|NCT00764868|2536595|P1|Overall Study|Out of town|1
797524|NCT00764868|2536595|P1|Overall Study|Prohibited medication|1
797525|NCT00764868|2536595|P1|Overall Study|Pregnancy|3
797526|NCT00764868|2536595|P1|Overall Study|Subject moved|7
797527|NCT00764868|2536595|P1|Overall Study|Lack of Efficacy|5
797528|NCT00764868|2536595|P1|Overall Study|Lost to Follow-up|25
797529|NCT00764868|2536595|P1|Overall Study|Non-compliance|16
797530|NCT00764868|2536595|P1|Overall Study|Withdrawal by Subject|31
797531|NCT00764868|2536595|P1|Overall Study|Adverse Event|18
797532|NCT00764881|2536603|P2|Overall Study|no treatment or no observation|2
797533|NCT00764881|2536604|P1|Overall Study|no treatment or no observation|2
797534|NCT00764881|2536603|P2|Overall Study|Possibly noncompliant (study drug)|2
797535|NCT00764881|2536604|P1|Overall Study|Possibly noncompliant (study drug)|0
797536|NCT00764881|2536603|P2|Overall Study|Carcinoma detected|0
797537|NCT00764881|2536604|P1|Overall Study|Carcinoma detected|1
797538|NCT00764881|2536603|P2|Overall Study|Wished to become pregnant|0
797539|NCT00764881|2536604|P1|Overall Study|Wished to become pregnant|1
797540|NCT00764881|2536603|P2|Overall Study|Accidentally discontinued study drug|0
797541|NCT00764881|2536604|P1|Overall Study|Accidentally discontinued study drug|1
797542|NCT00764881|2536603|P2|Overall Study|Noncompliant|0
797543|NCT00764881|2536604|P1|Overall Study|Noncompliant|1
797544|NCT00764881|2536603|P2|Overall Study|Lost to Follow-up|0
797545|NCT00764881|2536604|P1|Overall Study|Lost to Follow-up|2
797546|NCT00764881|2536603|P2|Overall Study|Protocol Violation|2
797547|NCT00764881|2536604|P1|Overall Study|Protocol Violation|2
797548|NCT00764881|2536603|P2|Overall Study|Withdrawal by Subject|3
797549|NCT00764881|2536604|P1|Overall Study|Withdrawal by Subject|1
797550|NCT00764881|2536603|P2|Overall Study|Adverse Event|1
797551|NCT00764881|2536604|P1|Overall Study|Adverse Event|5
797552|NCT00764946|2536831|P3|Overall Study|Never Treated|1
797553|NCT00764946|2536832|P2|Overall Study|Never Treated|1
797554|NCT00764946|2536833|P1|Overall Study|Never Treated|1
797555|NCT00764946|2536831|P3|Overall Study|Withdrawal by Subject|2
797556|NCT00764946|2536832|P2|Overall Study|Withdrawal by Subject|6
797557|NCT00764946|2536833|P1|Overall Study|Withdrawal by Subject|3
797558|NCT00764946|2536831|P3|Overall Study|Adverse Event|1
797559|NCT00764946|2536832|P2|Overall Study|Adverse Event|2
797560|NCT00764946|2536833|P1|Overall Study|Adverse Event|3
797561|NCT00764946|2536831|P3|Overall Study|Physician Decision|0
797562|NCT00764946|2536832|P2|Overall Study|Physician Decision|4
797563|NCT00764946|2536833|P1|Overall Study|Physician Decision|2
797564|NCT00764946|2536831|P3|Overall Study|Lost to Follow-up|0
797565|NCT00764946|2536832|P2|Overall Study|Lost to Follow-up|4
797566|NCT00764946|2536833|P1|Overall Study|Lost to Follow-up|3
797567|NCT00764946|2536831|P3|Overall Study|Lack of Efficacy|0
797568|NCT00764946|2536832|P2|Overall Study|Lack of Efficacy|0
797569|NCT00764946|2536833|P1|Overall Study|Lack of Efficacy|1
797570|NCT00765037|2536859|P1|Overall Study|Adverse Event|1
797571|NCT00765037|2536859|P1|Overall Study|Lost to Follow-up|5
797572|NCT00765063|2536863|P1|Overall Study|Adverse Event|4
797573|NCT00765063|2536863|P1|Overall Study|Protocol Violation|6
797574|NCT00765063|2536863|P1|Overall Study|Unspecified|16
797575|NCT00765063|2536863|P1|Overall Study|Withdrawal by Subject|1
797576|NCT00765063|2536863|P1|Overall Study|Lack of Efficacy|5
797577|NCT00765076|2536882|P3|Overall Study|Withdrawal by Subject|1
797578|NCT00765076|2536883|P2|Overall Study|Withdrawal by Subject|0
797579|NCT00765076|2536884|P1|Overall Study|Withdrawal by Subject|0
797580|NCT00765076|2536882|P3|Overall Study|Adverse Event|0
797581|NCT00765076|2536883|P2|Overall Study|Adverse Event|0
797582|NCT00765076|2536884|P1|Overall Study|Adverse Event|1
797583|NCT00765102|2536937|P1|Overall Study|Protocol Violation|1
797584|NCT00765102|2536937|P1|Overall Study|Withdrawal by Subject|2
797585|NCT00765102|2536937|P1|Overall Study|Physician Decision|4
797586|NCT00765102|2536937|P1|Overall Study|Adverse Event|6
797587|NCT00765102|2536937|P1|Overall Study|Progressive disease|18
797588|NCT00765245|2536997|P2|Overall Study|Death|0
797589|NCT00765245|2536998|P1|Overall Study|Death|1
797590|NCT00765245|2536997|P2|Overall Study|Physician Decision|0
797591|NCT00765245|2536998|P1|Overall Study|Physician Decision|1
797592|NCT00765245|2536997|P2|Overall Study|Adverse Event|0
797593|NCT00765245|2536998|P1|Overall Study|Adverse Event|5
797594|NCT00765245|2536997|P2|Overall Study|Withdrawal by Subject|0
797595|NCT00765245|2536998|P1|Overall Study|Withdrawal by Subject|3
797596|NCT00765245|2536997|P2|Overall Study|disease progression|2
797597|NCT00765245|2536998|P1|Overall Study|disease progression|3
797598|NCT00765336|2537010|P2|Overall Study|Adverse Event|1
797599|NCT00765336|2537011|P1|Overall Study|Adverse Event|2
797600|NCT00765336|2537010|P2|Overall Study|Lost to Follow-up|9
797601|NCT00765336|2537011|P1|Overall Study|Lost to Follow-up|7
797602|NCT00765336|2537010|P2|Overall Study|Withdrawal by Subject|4
797603|NCT00765336|2537011|P1|Overall Study|Withdrawal by Subject|6
797604|NCT00765336|2537010|P2|Overall Study|Protocol Violation|2
797605|NCT00765336|2537011|P1|Overall Study|Protocol Violation|4
797606|NCT00765362|2537017|P1|Overall Study|Lost to Follow-up|95
797607|NCT00765362|2537017|P1|Overall Study|Withdrawal by Subject|13
797608|NCT00765362|2537017|P1|Overall Study|Protocol Violation|18
797609|NCT00765362|2537017|P1|Overall Study|Adverse Event|2
797610|NCT00765362|2537017|P1|Overall Study|Death|9
797611|NCT00765388|2537029|P2|Period 1|Hip operation|1
797612|NCT00765388|2537030|P1|Period 1|Hip operation|0
797613|NCT00765388|2537029|P2|Period 1|Herpes Zoster|1
797614|NCT00765388|2537030|P1|Period 1|Herpes Zoster|0
797615|NCT00765388|2537029|P2|Period 1|Lost to Follow-up|1
797616|NCT00765388|2537030|P1|Period 1|Lost to Follow-up|0
797617|NCT00765388|2537029|P2|Period 1|Lack of Efficacy|2
797618|NCT00765388|2537030|P1|Period 1|Lack of Efficacy|1
797619|NCT00765674|2537107|P4|Overall Study|Randomized in Error - No Study Drug|1
797620|NCT00765674|2537108|P3|Overall Study|Randomized in Error - No Study Drug|0
797621|NCT00765674|2537109|P2|Overall Study|Randomized in Error - No Study Drug|1
797622|NCT00765674|2537110|P1|Overall Study|Randomized in Error - No Study Drug|0
797623|NCT00765674|2537107|P4|Overall Study|Lost to Follow-up|1
797624|NCT00765674|2537108|P3|Overall Study|Lost to Follow-up|2
797625|NCT00765674|2537109|P2|Overall Study|Lost to Follow-up|6
797626|NCT00765674|2537110|P1|Overall Study|Lost to Follow-up|4
797627|NCT00765674|2537107|P4|Overall Study|Withdrawal by Subject|8
797628|NCT00765674|2537108|P3|Overall Study|Withdrawal by Subject|3
797629|NCT00765674|2537109|P2|Overall Study|Withdrawal by Subject|7
797630|NCT00765674|2537110|P1|Overall Study|Withdrawal by Subject|5
797631|NCT00765674|2537107|P4|Overall Study|Protocol Violation|0
797632|NCT00765674|2537108|P3|Overall Study|Protocol Violation|1
797633|NCT00765674|2537109|P2|Overall Study|Protocol Violation|0
797634|NCT00765674|2537110|P1|Overall Study|Protocol Violation|2
797635|NCT00765674|2537107|P4|Overall Study|Lack of Efficacy|2
797636|NCT00765674|2537108|P3|Overall Study|Lack of Efficacy|1
797637|NCT00765674|2537109|P2|Overall Study|Lack of Efficacy|3
797638|NCT00765674|2537110|P1|Overall Study|Lack of Efficacy|2
797639|NCT00765674|2537107|P4|Overall Study|Abnormal Test Procedure Result(s)|2
797640|NCT00765674|2537108|P3|Overall Study|Abnormal Test Procedure Result(s)|1
797641|NCT00765674|2537109|P2|Overall Study|Abnormal Test Procedure Result(s)|3
797642|NCT00765674|2537110|P1|Overall Study|Abnormal Test Procedure Result(s)|1
797643|NCT00765674|2537107|P4|Overall Study|Abnormal Laboratory Value(s)|0
797644|NCT00765674|2537108|P3|Overall Study|Abnormal Laboratory Value(s)|1
797645|NCT00765674|2537109|P2|Overall Study|Abnormal Laboratory Value(s)|0
797646|NCT00765674|2537110|P1|Overall Study|Abnormal Laboratory Value(s)|0
797647|NCT00765674|2537107|P4|Overall Study|Adverse Event|11
797648|NCT00765674|2537108|P3|Overall Study|Adverse Event|8
797649|NCT00765674|2537109|P2|Overall Study|Adverse Event|2
797650|NCT00765674|2537110|P1|Overall Study|Adverse Event|7
797651|NCT00765726|2537132|P1|Overall Study|Discontinuation of study by sponsor|8
797652|NCT00765726|2537132|P1|Overall Study|Withdrawal by Subject|1
797653|NCT00765817|2537148|P2|Overall Study|Subject decision|11
797654|NCT00765817|2537149|P1|Overall Study|Subject decision|7
797655|NCT00765817|2537148|P2|Overall Study|Protocol Violation|1
797656|NCT00765817|2537149|P1|Overall Study|Protocol Violation|1
797657|NCT00765817|2537148|P2|Overall Study|Physician Decision|1
797658|NCT00765817|2537149|P1|Overall Study|Physician Decision|2
797659|NCT00765817|2537148|P2|Overall Study|Lost to Follow-up|3
797660|NCT00765817|2537149|P1|Overall Study|Lost to Follow-up|1
797661|NCT00765817|2537148|P2|Overall Study|Loss of glucose control|2
797662|NCT00765817|2537149|P1|Overall Study|Loss of glucose control|0
797663|NCT00765817|2537148|P2|Overall Study|Entry criteria not met|2
797664|NCT00765817|2537149|P1|Overall Study|Entry criteria not met|2
797665|NCT00765817|2537148|P2|Overall Study|Death|1
797666|NCT00765817|2537149|P1|Overall Study|Death|0
797667|NCT00765817|2537148|P2|Overall Study|Adverse Event|1
797668|NCT00765817|2537149|P1|Overall Study|Adverse Event|13
797669|NCT00765843|2537190|P3|Overall Study|Adverse Event|1
797670|NCT00765843|2537191|P2|Overall Study|Adverse Event|0
797671|NCT00765843|2537192|P1|Overall Study|Adverse Event|0
797672|NCT00765843|2537190|P3|Overall Study|did not return to receive intervention|0
797673|NCT00765843|2537191|P2|Overall Study|did not return to receive intervention|1
797674|NCT00765843|2537192|P1|Overall Study|did not return to receive intervention|0
797675|NCT00765843|2537190|P3|Overall Study|Lost to Follow-up|2
797676|NCT00765843|2537191|P2|Overall Study|Lost to Follow-up|3
797677|NCT00765843|2537192|P1|Overall Study|Lost to Follow-up|1
797678|NCT00765882|2537203|P3|Overall Study|Other Reason|2
797679|NCT00765882|2537204|P2|Overall Study|Other Reason|1
797680|NCT00765882|2537205|P1|Overall Study|Other Reason|3
797681|NCT00765882|2537203|P3|Overall Study|Lost to Follow-up|6
797682|NCT00765882|2537204|P2|Overall Study|Lost to Follow-up|9
797683|NCT00765882|2537205|P1|Overall Study|Lost to Follow-up|1
797684|NCT00765882|2537203|P3|Overall Study|Withdrawal by Subject|6
797685|NCT00765882|2537204|P2|Overall Study|Withdrawal by Subject|6
797686|NCT00765882|2537205|P1|Overall Study|Withdrawal by Subject|2
797687|NCT00765882|2537203|P3|Overall Study|Protocol Violation|1
797688|NCT00765882|2537204|P2|Overall Study|Protocol Violation|3
797689|NCT00765882|2537205|P1|Overall Study|Protocol Violation|4
797690|NCT00765882|2537203|P3|Overall Study|Lack of Efficacy|1
797691|NCT00765882|2537204|P2|Overall Study|Lack of Efficacy|0
797692|NCT00765882|2537205|P1|Overall Study|Lack of Efficacy|4
797693|NCT00765882|2537203|P3|Overall Study|Adverse Event|20
797694|NCT00765882|2537204|P2|Overall Study|Adverse Event|21
797695|NCT00765882|2537205|P1|Overall Study|Adverse Event|10
797696|NCT00766051|2537254|P2|Overall Study|Withdrawal by Subject|0
797697|NCT00766051|2537255|P1|Overall Study|Withdrawal by Subject|2
797698|NCT00766090|2537267|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797699|NCT00766090|2537268|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797700|NCT00766090|2537269|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797701|NCT00766090|2537270|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797702|NCT00766090|2537271|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797703|NCT00766090|2537272|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797704|NCT00766090|2537273|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797705|NCT00766090|2537274|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
797706|NCT00766090|2537275|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797707|NCT00766090|2537276|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797708|NCT00766090|2537277|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797709|NCT00766090|2537278|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
797710|NCT00766090|2537267|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
797711|NCT00766090|2537268|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797712|NCT00766090|2537269|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797713|NCT00766090|2537270|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797714|NCT00766090|2537271|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797715|NCT00766090|2537272|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797716|NCT00766090|2537273|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797717|NCT00766090|2537274|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797718|NCT00766090|2537275|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
797719|NCT00766090|2537276|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797720|NCT00766090|2537277|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
797721|NCT00766090|2537278|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
797722|NCT00766090|2537267|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
797723|NCT00766090|2537268|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
797724|NCT00766090|2537269|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
797725|NCT00766090|2537270|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
797726|NCT00766090|2537271|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
797727|NCT00766090|2537272|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
797728|NCT00766090|2537273|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
797729|NCT00766090|2537274|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
797730|NCT00766090|2537275|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
797731|NCT00766090|2537276|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
797732|NCT00766090|2537277|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
797733|NCT00766090|2537278|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
797734|NCT00766090|2537267|P12|Washout Period 2 (14 Days)|Physician Decision|0
797735|NCT00766090|2537268|P11|Washout Period 2 (14 Days)|Physician Decision|0
797736|NCT00766090|2537269|P10|Washout Period 2 (14 Days)|Physician Decision|0
797737|NCT00766090|2537270|P9|Washout Period 2 (14 Days)|Physician Decision|0
797738|NCT00766090|2537271|P8|Washout Period 2 (14 Days)|Physician Decision|0
797739|NCT00766090|2537272|P7|Washout Period 2 (14 Days)|Physician Decision|0
797740|NCT00766090|2537273|P6|Washout Period 2 (14 Days)|Physician Decision|0
797741|NCT00766090|2537274|P5|Washout Period 2 (14 Days)|Physician Decision|0
797742|NCT00766090|2537275|P4|Washout Period 2 (14 Days)|Physician Decision|0
797743|NCT00766090|2537276|P3|Washout Period 2 (14 Days)|Physician Decision|1
797744|NCT00766090|2537277|P2|Washout Period 2 (14 Days)|Physician Decision|0
797745|NCT00766090|2537278|P1|Washout Period 2 (14 Days)|Physician Decision|0
797746|NCT00766090|2537267|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797747|NCT00766090|2537268|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797748|NCT00766090|2537269|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797749|NCT00766090|2537270|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797750|NCT00766090|2537271|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797751|NCT00766090|2537272|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797752|NCT00766090|2537273|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797753|NCT00766090|2537274|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797754|NCT00766090|2537275|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797755|NCT00766090|2537276|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
797756|NCT00766090|2537277|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797757|NCT00766090|2537278|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
797758|NCT00766090|2537267|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797759|NCT00766090|2537268|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797760|NCT00766090|2537269|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797761|NCT00766090|2537270|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797762|NCT00766090|2537271|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797763|NCT00766090|2537272|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797764|NCT00766090|2537273|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797765|NCT00766090|2537274|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
797766|NCT00766090|2537275|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797767|NCT00766090|2537276|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797768|NCT00766090|2537277|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797769|NCT00766090|2537278|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
797770|NCT00766090|2537267|P12|Washout Period 1 (14 Days)|Protocol Violation|0
797771|NCT00766090|2537268|P11|Washout Period 1 (14 Days)|Protocol Violation|0
797772|NCT00766090|2537269|P10|Washout Period 1 (14 Days)|Protocol Violation|0
797773|NCT00766090|2537270|P9|Washout Period 1 (14 Days)|Protocol Violation|0
797774|NCT00766090|2537271|P8|Washout Period 1 (14 Days)|Protocol Violation|0
797775|NCT00766090|2537272|P7|Washout Period 1 (14 Days)|Protocol Violation|0
797776|NCT00766090|2537273|P6|Washout Period 1 (14 Days)|Protocol Violation|0
797777|NCT00766090|2537274|P5|Washout Period 1 (14 Days)|Protocol Violation|0
797778|NCT00766090|2537275|P4|Washout Period 1 (14 Days)|Protocol Violation|0
797779|NCT00766090|2537276|P3|Washout Period 1 (14 Days)|Protocol Violation|1
797780|NCT00766090|2537277|P2|Washout Period 1 (14 Days)|Protocol Violation|0
797781|NCT00766090|2537278|P1|Washout Period 1 (14 Days)|Protocol Violation|0
797782|NCT00766090|2537267|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797783|NCT00766090|2537268|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797784|NCT00766090|2537269|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797785|NCT00766090|2537270|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797786|NCT00766090|2537271|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797787|NCT00766090|2537272|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797788|NCT00766090|2537273|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797789|NCT00766090|2537274|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797790|NCT00766090|2537275|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
797791|NCT00766090|2537276|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797792|NCT00766090|2537277|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
797793|NCT00766090|2537278|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
797794|NCT00766090|2537267|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797795|NCT00766090|2537268|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797796|NCT00766090|2537269|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797797|NCT00766090|2537270|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797798|NCT00766090|2537271|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797799|NCT00766090|2537272|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797800|NCT00766090|2537273|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797801|NCT00766090|2537274|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797802|NCT00766090|2537275|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797803|NCT00766090|2537276|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797804|NCT00766090|2537277|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
797805|NCT00766090|2537278|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
797806|NCT00766090|2537267|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797807|NCT00766090|2537268|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797808|NCT00766090|2537269|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797809|NCT00766090|2537270|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
797810|NCT00766090|2537271|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797811|NCT00766090|2537272|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797812|NCT00766090|2537273|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797813|NCT00766090|2537274|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797814|NCT00766090|2537275|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797815|NCT00766090|2537276|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797816|NCT00766090|2537277|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797817|NCT00766090|2537278|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
797818|NCT00766363|2537321|P4|Overall Study|Adverse Event Prior to Randomization|0
797819|NCT00766363|2537322|P3|Overall Study|Adverse Event Prior to Randomization|0
797820|NCT00766363|2537323|P2|Overall Study|Adverse Event Prior to Randomization|1
797821|NCT00766363|2537324|P1|Overall Study|Adverse Event Prior to Randomization|0
797822|NCT00766363|2537321|P4|Overall Study|Withdrawal by Subject|0
797823|NCT00766363|2537322|P3|Overall Study|Withdrawal by Subject|0
797824|NCT00766363|2537323|P2|Overall Study|Withdrawal by Subject|0
797825|NCT00766363|2537324|P1|Overall Study|Withdrawal by Subject|1
797826|NCT00766376|2537361|P1|Overall Study|Withdrawal by Subject|27
797827|NCT00772005|2537370|P4|Overall Study|Non-compliance with drug administration|1
797828|NCT00772005|2537371|P3|Overall Study|Non-compliance with drug administration|1
797829|NCT00772005|2537372|P2|Overall Study|Non-compliance with drug administration|0
797830|NCT00772005|2537373|P1|Overall Study|Non-compliance with drug administration|3
797831|NCT00772005|2537370|P4|Overall Study|Non-compliance with study procedures|1
797832|NCT00772005|2537371|P3|Overall Study|Non-compliance with study procedures|0
797833|NCT00772005|2537372|P2|Overall Study|Non-compliance with study procedures|1
797834|NCT00772005|2537373|P1|Overall Study|Non-compliance with study procedures|1
797835|NCT00772005|2537370|P4|Overall Study|Lost to Follow-up|3
797836|NCT00772005|2537371|P3|Overall Study|Lost to Follow-up|6
797837|NCT00772005|2537372|P2|Overall Study|Lost to Follow-up|3
797838|NCT00772005|2537373|P1|Overall Study|Lost to Follow-up|7
797839|NCT00772005|2537370|P4|Overall Study|Protocol Violation|6
797840|NCT00772005|2537371|P3|Overall Study|Protocol Violation|1
797841|NCT00772005|2537372|P2|Overall Study|Protocol Violation|4
797842|NCT00772005|2537373|P1|Overall Study|Protocol Violation|2
797843|NCT00772005|2537370|P4|Overall Study|Withdrawal by Subject|2
797844|NCT00772005|2537371|P3|Overall Study|Withdrawal by Subject|10
797845|NCT00772005|2537372|P2|Overall Study|Withdrawal by Subject|7
797846|NCT00772005|2537373|P1|Overall Study|Withdrawal by Subject|3
797847|NCT00772005|2537370|P4|Overall Study|Lack of Efficacy|0
797848|NCT00772005|2537371|P3|Overall Study|Lack of Efficacy|0
797849|NCT00772005|2537372|P2|Overall Study|Lack of Efficacy|1
797850|NCT00772005|2537373|P1|Overall Study|Lack of Efficacy|0
797851|NCT00772005|2537370|P4|Overall Study|Adverse Event|13
797852|NCT00772005|2537371|P3|Overall Study|Adverse Event|10
797853|NCT00772005|2537372|P2|Overall Study|Adverse Event|14
797854|NCT00772005|2537373|P1|Overall Study|Adverse Event|9
797855|NCT00772031|2538061|P2|Overall Study|Lost to Follow-up|33
797856|NCT00772031|2538062|P1|Overall Study|Lost to Follow-up|20
797857|NCT00772031|2538061|P2|Overall Study|Early termination of trial|10
797858|NCT00772031|2538062|P1|Overall Study|Early termination of trial|12
797859|NCT00772070|2538086|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
797860|NCT00772070|2538087|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
797861|NCT00772070|2538086|P2|Overall Study|Withdrawal by Subject|2
797862|NCT00772070|2538087|P1|Overall Study|Withdrawal by Subject|0
797863|NCT00772070|2538086|P2|Overall Study|Lost to Follow-up|8
797864|NCT00772070|2538087|P1|Overall Study|Lost to Follow-up|0
797865|NCT00772109|2538101|P4|Overall Study|Withdrawal by Subject|16
797866|NCT00772109|2538102|P3|Overall Study|Withdrawal by Subject|6
797867|NCT00772109|2538103|P2|Overall Study|Withdrawal by Subject|8
797868|NCT00772109|2538104|P1|Overall Study|Withdrawal by Subject|8
797869|NCT00772109|2538101|P4|Overall Study|Lost to Follow-up|9
797870|NCT00772109|2538102|P3|Overall Study|Lost to Follow-up|5
797871|NCT00772109|2538103|P2|Overall Study|Lost to Follow-up|3
797872|NCT00772109|2538104|P1|Overall Study|Lost to Follow-up|7
797873|NCT00772109|2538101|P4|Overall Study|Protocol Violation|6
797874|NCT00772109|2538102|P3|Overall Study|Protocol Violation|7
797875|NCT00772109|2538103|P2|Overall Study|Protocol Violation|8
797876|NCT00772109|2538104|P1|Overall Study|Protocol Violation|5
797877|NCT00772109|2538101|P4|Overall Study|Serious adverse event|0
797878|NCT00772109|2538102|P3|Overall Study|Serious adverse event|1
797879|NCT00772109|2538103|P2|Overall Study|Serious adverse event|0
797880|NCT00772109|2538104|P1|Overall Study|Serious adverse event|1
797881|NCT00772148|2538128|P2|Maintenance Phase (Week 52)|Administrative/other|2
797882|NCT00772148|2538129|P1|Maintenance Phase (Week 52)|Administrative/other|1
797883|NCT00772148|2538128|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
797884|NCT00772148|2538129|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
797885|NCT00772148|2538128|P2|Maintenance Phase (Week 52)|Adverse Event|0
797886|NCT00772148|2538129|P1|Maintenance Phase (Week 52)|Adverse Event|1
797887|NCT00772148|2538128|P2|Maintenance Phase (Week 52)|Death|2
797888|NCT00772148|2538129|P1|Maintenance Phase (Week 52)|Death|2
797889|NCT00772148|2538128|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
797890|NCT00772148|2538129|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
797891|NCT00772148|2538128|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
797892|NCT00772148|2538129|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
797893|NCT00772148|2538128|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
797894|NCT00772148|2538129|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
797895|NCT00772538|2538147|P2|Overall Study|Other|7
797896|NCT00772538|2538148|P1|Overall Study|Other|7
797897|NCT00772538|2538147|P2|Overall Study|Lack of Efficacy|1
797898|NCT00772538|2538148|P1|Overall Study|Lack of Efficacy|0
797899|NCT00772538|2538147|P2|Overall Study|Withdrawal by Subject|8
797900|NCT00772538|2538148|P1|Overall Study|Withdrawal by Subject|3
797901|NCT00772538|2538147|P2|Overall Study|Lost to Follow-up|1
797902|NCT00772538|2538148|P1|Overall Study|Lost to Follow-up|1
797903|NCT00772538|2538147|P2|Overall Study|Protocol Violation|3
797904|NCT00772538|2538148|P1|Overall Study|Protocol Violation|3
797905|NCT00772538|2538147|P2|Overall Study|Adverse Event|6
797906|NCT00772538|2538148|P1|Overall Study|Adverse Event|6
797907|NCT00772577|2538220|P2|Overall Study|Protocol Deviation|2
797908|NCT00772577|2538221|P1|Overall Study|Protocol Deviation|3
797909|NCT00772577|2538220|P2|Overall Study|Administrative problems|1
797910|NCT00772577|2538221|P1|Overall Study|Administrative problems|2
797911|NCT00772577|2538220|P2|Overall Study|Lost to Follow-up|3
797912|NCT00772577|2538221|P1|Overall Study|Lost to Follow-up|4
797913|NCT00772577|2538220|P2|Overall Study|Patient withdrew consent|5
797914|NCT00772577|2538221|P1|Overall Study|Patient withdrew consent|8
797915|NCT00772577|2538220|P2|Overall Study|Unsatisfactory therapeutic effect|8
797916|NCT00772577|2538221|P1|Overall Study|Unsatisfactory therapeutic effect|0
797917|NCT00772577|2538220|P2|Overall Study|Abnormal laboratory values|1
797918|NCT00772577|2538221|P1|Overall Study|Abnormal laboratory values|0
797919|NCT00772577|2538220|P2|Overall Study|Adverse Event|3
797920|NCT00772577|2538221|P1|Overall Study|Adverse Event|6
797921|NCT00772603|2538255|P3|Overall Study|Other|2
797922|NCT00772603|2538256|P2|Overall Study|Other|0
797923|NCT00772603|2538257|P1|Overall Study|Other|2
797924|NCT00772603|2538255|P3|Overall Study|Physician Decision|1
797925|NCT00772603|2538256|P2|Overall Study|Physician Decision|0
797926|NCT00772603|2538257|P1|Overall Study|Physician Decision|0
797927|NCT00772603|2538255|P3|Overall Study|Lost to Follow-up|2
797928|NCT00772603|2538256|P2|Overall Study|Lost to Follow-up|5
797929|NCT00772603|2538257|P1|Overall Study|Lost to Follow-up|1
797930|NCT00772603|2538255|P3|Overall Study|Protocol Violation|1
797931|NCT00772603|2538256|P2|Overall Study|Protocol Violation|1
797932|NCT00772603|2538257|P1|Overall Study|Protocol Violation|0
797933|NCT00772603|2538255|P3|Overall Study|Subject Non-compliance|4
797934|NCT00772603|2538256|P2|Overall Study|Subject Non-compliance|6
797935|NCT00772603|2538257|P1|Overall Study|Subject Non-compliance|1
797936|NCT00772603|2538255|P3|Overall Study|Adverse Event|10
797937|NCT00772603|2538256|P2|Overall Study|Adverse Event|18
797938|NCT00772603|2538257|P1|Overall Study|Adverse Event|37
797939|NCT00772603|2538255|P3|Overall Study|Withdrawal by Subject|6
797940|NCT00772603|2538256|P2|Overall Study|Withdrawal by Subject|10
797941|NCT00772603|2538257|P1|Overall Study|Withdrawal by Subject|11
797942|NCT00772629|2538279|P2|Overall Study|Subject was not vaccinated|0
797943|NCT00772629|2538280|P1|Overall Study|Subject was not vaccinated|1
797945|NCT00772707|2538290|P1|Overall Study|Withdrawn|3
797946|NCT00772889|2538303|P3|Overall Study|Lost to Follow-up|7
797947|NCT00772889|2538304|P2|Overall Study|Lost to Follow-up|6
797948|NCT00772889|2538305|P1|Overall Study|Lost to Follow-up|6
797949|NCT00772889|2538303|P3|Overall Study|Withdrawal by Subject|9
797950|NCT00772889|2538304|P2|Overall Study|Withdrawal by Subject|8
797951|NCT00772889|2538305|P1|Overall Study|Withdrawal by Subject|9
797952|NCT00772889|2538303|P3|Overall Study|Adverse Event|0
797953|NCT00772889|2538304|P2|Overall Study|Adverse Event|4
797954|NCT00772889|2538305|P1|Overall Study|Adverse Event|7
797955|NCT00772928|2538364|P2|Overall Study|Did not receive vaccine|1
797956|NCT00772928|2538365|P1|Overall Study|Did not receive vaccine|0
797957|NCT00772928|2538364|P2|Overall Study|Withdrawal by Subject|22
797958|NCT00772928|2538365|P1|Overall Study|Withdrawal by Subject|25
797959|NCT00772928|2538364|P2|Overall Study|Protocol Violation|12
797960|NCT00772928|2538365|P1|Overall Study|Protocol Violation|10
797961|NCT00772928|2538364|P2|Overall Study|Lost to Follow-up|6
797962|NCT00772928|2538365|P1|Overall Study|Lost to Follow-up|9
797963|NCT00772941|2538375|P1|Overall Study|GPSP Violation|90
797964|NCT00772941|2538375|P1|Overall Study|Poor Compliance|7
797965|NCT00772941|2538375|P1|Overall Study|Missed Visits|374
797966|NCT00772941|2538375|P1|Overall Study|Study not completed|16
797967|NCT00772941|2538375|P1|Overall Study|CRFs not available|195
797968|NCT00772954|2538407|P3|Overall Study|Adverse Event|1
797969|NCT00772954|2538408|P2|Overall Study|Adverse Event|0
797970|NCT00772954|2538409|P1|Overall Study|Adverse Event|0
797971|NCT00772967|2538417|P6|Crossover Treatment 3|Adverse Event|0
797972|NCT00772967|2538418|P5|Crossover Treatment 3|Adverse Event|1
797973|NCT00772967|2538419|P4|Crossover Treatment 3|Adverse Event|0
797974|NCT00772967|2538420|P3|Crossover Treatment 3|Adverse Event|0
797975|NCT00772967|2538421|P2|Crossover Treatment 3|Adverse Event|0
797976|NCT00772967|2538422|P1|Crossover Treatment 3|Adverse Event|0
797977|NCT00772967|2538417|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
797978|NCT00772967|2538418|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
797979|NCT00772967|2538419|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
797980|NCT00772967|2538420|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
797981|NCT00772967|2538421|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
797982|NCT00772967|2538422|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
797983|NCT00772967|2538417|P6|Crossover Treatment 1|Adverse Event (Pain)|0
797984|NCT00772967|2538418|P5|Crossover Treatment 1|Adverse Event (Pain)|0
797985|NCT00772967|2538419|P4|Crossover Treatment 1|Adverse Event (Pain)|1
797986|NCT00772967|2538420|P3|Crossover Treatment 1|Adverse Event (Pain)|0
797987|NCT00772967|2538421|P2|Crossover Treatment 1|Adverse Event (Pain)|0
797988|NCT00772967|2538422|P1|Crossover Treatment 1|Adverse Event (Pain)|0
797989|NCT00773097|2538439|P1|Overall Study|Physician Decision|6
797990|NCT00773097|2538439|P1|Overall Study|Withdrawal by Subject|1
797991|NCT00773136|2538445|P1|Overall Study|Physician Decision|2
797992|NCT00773253|2538452|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
797993|NCT00773253|2538453|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
797994|NCT00773279|2538459|P2|Period 2|Unclassified|2
797995|NCT00773279|2538460|P1|Period 2|Unclassified|2
797996|NCT00773279|2538459|P2|Period 2|Protocol Violation|3
797997|NCT00773279|2538460|P1|Period 2|Protocol Violation|0
797998|NCT00773279|2538459|P2|Period 2|Lack of Efficacy|0
797999|NCT00773279|2538460|P1|Period 2|Lack of Efficacy|1
798000|NCT00773279|2538459|P2|Period 2|Adverse Event|1
798001|NCT00773279|2538460|P1|Period 2|Adverse Event|0
798002|NCT00773279|2538459|P2|Period 1|Unclassified|1
798003|NCT00773279|2538460|P1|Period 1|Unclassified|5
798004|NCT00773279|2538459|P2|Period 1|Lack of Efficacy|2
798005|NCT00773279|2538460|P1|Period 1|Lack of Efficacy|0
798006|NCT00773279|2538459|P2|Period 1|Adverse Event|1
798007|NCT00773279|2538460|P1|Period 1|Adverse Event|2
798008|NCT00773383|2538494|P1|Overall Study|No study dose received|1
798009|NCT00773383|2538494|P1|Overall Study|not specified|2
798010|NCT00773383|2538494|P1|Overall Study|Progression of Disease|23
798011|NCT00773383|2538494|P1|Overall Study|Death|1
798012|NCT00773383|2538494|P1|Overall Study|Adverse Event|4
798013|NCT00773461|2538516|P2|Overall Study|Withdrawal by Subject|1
798014|NCT00773461|2538517|P1|Overall Study|Withdrawal by Subject|4
798015|NCT00773461|2538516|P2|Overall Study|Adverse Event|3
798016|NCT00773461|2538517|P1|Overall Study|Adverse Event|1
798017|NCT00773734|2538566|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
798018|NCT00773734|2538567|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
798019|NCT00773734|2538568|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
798020|NCT00773734|2538569|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
798021|NCT00773734|2538570|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
798022|NCT00773734|2538571|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
798023|NCT00773734|2538566|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
798024|NCT00773734|2538567|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
798025|NCT00773734|2538568|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
798026|NCT00773734|2538569|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
798027|NCT00773734|2538570|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
798028|NCT00773734|2538571|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
798029|NCT00773734|2538566|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
798030|NCT00773734|2538567|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
798031|NCT00773734|2538568|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
798032|NCT00773734|2538569|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
798033|NCT00773734|2538570|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
798034|NCT00773734|2538571|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
798035|NCT00773734|2538566|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
798036|NCT00773734|2538567|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
798037|NCT00773734|2538568|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
798038|NCT00773734|2538569|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
798039|NCT00773734|2538570|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
798040|NCT00773734|2538571|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
798041|NCT00773734|2538566|P6|Extension: Active Treatment Week 24-52|Unspecified|1
798042|NCT00773734|2538567|P5|Extension: Active Treatment Week 24-52|Unspecified|0
798043|NCT00773734|2538568|P4|Extension: Active Treatment Week 24-52|Unspecified|2
798044|NCT00773734|2538569|P3|Extension: Active Treatment Week 24-52|Unspecified|1
798045|NCT00773734|2538570|P2|Extension: Active Treatment Week 24-52|Unspecified|0
798046|NCT00773734|2538571|P1|Extension: Active Treatment Week 24-52|Unspecified|0
798047|NCT00773734|2538566|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
798048|NCT00773734|2538567|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
798049|NCT00773734|2538568|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
798050|NCT00773734|2538569|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
798051|NCT00773734|2538570|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
798052|NCT00773734|2538571|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
798053|NCT00773734|2538566|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
798054|NCT00773734|2538567|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
798055|NCT00773734|2538568|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
798056|NCT00773734|2538569|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
798057|NCT00773734|2538570|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
798058|NCT00773734|2538571|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
798059|NCT00773734|2538566|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
798060|NCT00773734|2538567|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
798061|NCT00773734|2538568|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
798062|NCT00773734|2538569|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
798063|NCT00773734|2538570|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
798064|NCT00773734|2538571|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
798065|NCT00773734|2538566|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
798066|NCT00773734|2538567|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
798067|NCT00773734|2538568|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
798068|NCT00773734|2538569|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
798069|NCT00773734|2538570|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
798070|NCT00773734|2538571|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
798071|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Unspecified|0
798072|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Unspecified|0
798073|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Unspecified|0
798074|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Unspecified|0
798075|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Unspecified|1
798076|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Unspecified|0
798077|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
798078|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
798079|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
798080|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
798081|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
798082|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
798083|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
798084|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
798085|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
798086|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
798087|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
798088|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
798089|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
798090|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
798091|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
798092|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
798093|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
798094|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
798095|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
798096|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
798097|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
798098|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
798099|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
798100|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
798101|NCT00773734|2538566|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
798102|NCT00773734|2538567|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
798103|NCT00773734|2538568|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
798104|NCT00773734|2538569|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
798105|NCT00773734|2538570|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
798106|NCT00773734|2538571|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
798107|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
798108|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
798109|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
798110|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
798111|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
798112|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
798113|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
798114|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
798115|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
798116|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
798117|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
798118|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
798119|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
798120|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
798121|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
798122|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
798123|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
798124|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
798125|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
798126|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
798127|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
798128|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
798129|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
798130|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
798131|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
798132|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
798133|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
798134|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
798135|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
798136|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
798137|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
798138|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
798139|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
798140|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
798141|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
798142|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
798143|NCT00773734|2538566|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
798144|NCT00773734|2538567|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
798145|NCT00773734|2538568|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
798146|NCT00773734|2538569|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
798147|NCT00773734|2538570|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
798148|NCT00773734|2538571|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
798149|NCT00773968|2539151|P1|Overall Study|Unspecified|8
798150|NCT00773968|2539151|P1|Overall Study|Screen Failure|17
798151|NCT00773968|2539151|P1|Overall Study|Withdrawal by Subject|11
798152|NCT00773968|2539151|P1|Overall Study|Protocol Violation|1
798153|NCT00773968|2539151|P1|Overall Study|Lack of Efficacy|3
798154|NCT00773968|2539151|P1|Overall Study|Failure to Return|2
798155|NCT00773968|2539151|P1|Overall Study|Death|1
798156|NCT00773968|2539151|P1|Overall Study|Adverse Event|2
798157|NCT00774046|2539160|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
798158|NCT00774046|2539160|P1|Enrollment|Desired other therapy/refused|28
798159|NCT00774046|2539160|P1|Screening|Not eligible|56
798160|NCT00774306|2539232|P4|Overall Study|Death|0
798161|NCT00774306|2539233|P3|Overall Study|Death|0
798162|NCT00774306|2539234|P2|Overall Study|Death|1
798163|NCT00774306|2539235|P1|Overall Study|Death|1
798164|NCT00774306|2539232|P4|Overall Study|Lost to Follow-up|5
798165|NCT00774306|2539233|P3|Overall Study|Lost to Follow-up|4
798166|NCT00774306|2539234|P2|Overall Study|Lost to Follow-up|0
798167|NCT00774306|2539235|P1|Overall Study|Lost to Follow-up|6
798168|NCT00774306|2539232|P4|Overall Study|Withdrawal by Subject|0
798169|NCT00774306|2539233|P3|Overall Study|Withdrawal by Subject|1
798170|NCT00774306|2539234|P2|Overall Study|Withdrawal by Subject|1
798171|NCT00774306|2539235|P1|Overall Study|Withdrawal by Subject|6
798172|NCT00774306|2539232|P4|Overall Study|Protocol Violation|0
798173|NCT00774306|2539233|P3|Overall Study|Protocol Violation|3
798174|NCT00774306|2539234|P2|Overall Study|Protocol Violation|0
798175|NCT00774306|2539235|P1|Overall Study|Protocol Violation|2
798176|NCT00774306|2539232|P4|Overall Study|Adverse Event|0
798177|NCT00774306|2539233|P3|Overall Study|Adverse Event|0
798178|NCT00774306|2539234|P2|Overall Study|Adverse Event|0
798179|NCT00774306|2539235|P1|Overall Study|Adverse Event|3
798180|NCT00774397|2539252|P7|Overall Study|Other than those stated above|1
798181|NCT00774397|2539253|P6|Overall Study|Other than those stated above|0
798182|NCT00774397|2539254|P5|Overall Study|Other than those stated above|2
798183|NCT00774397|2539255|P4|Overall Study|Other than those stated above|2
798184|NCT00774397|2539256|P3|Overall Study|Other than those stated above|3
798185|NCT00774397|2539257|P2|Overall Study|Other than those stated above|1
798186|NCT00774397|2539258|P1|Overall Study|Other than those stated above|1
798187|NCT00774397|2539252|P7|Overall Study|Not treated|1
798188|NCT00774397|2539253|P6|Overall Study|Not treated|0
798189|NCT00774397|2539254|P5|Overall Study|Not treated|1
798190|NCT00774397|2539255|P4|Overall Study|Not treated|0
798191|NCT00774397|2539256|P3|Overall Study|Not treated|0
798192|NCT00774397|2539257|P2|Overall Study|Not treated|0
798193|NCT00774397|2539258|P1|Overall Study|Not treated|0
798194|NCT00774397|2539252|P7|Overall Study|Refused to continue trial medication|3
798195|NCT00774397|2539253|P6|Overall Study|Refused to continue trial medication|2
798196|NCT00774397|2539254|P5|Overall Study|Refused to continue trial medication|6
798197|NCT00774397|2539255|P4|Overall Study|Refused to continue trial medication|2
798198|NCT00774397|2539256|P3|Overall Study|Refused to continue trial medication|2
798199|NCT00774397|2539257|P2|Overall Study|Refused to continue trial medication|3
798200|NCT00774397|2539258|P1|Overall Study|Refused to continue trial medication|1
798201|NCT00774397|2539252|P7|Overall Study|Lost to Follow-up|0
798202|NCT00774397|2539253|P6|Overall Study|Lost to Follow-up|1
798203|NCT00774397|2539254|P5|Overall Study|Lost to Follow-up|0
798204|NCT00774397|2539255|P4|Overall Study|Lost to Follow-up|1
798205|NCT00774397|2539256|P3|Overall Study|Lost to Follow-up|1
798206|NCT00774397|2539257|P2|Overall Study|Lost to Follow-up|1
798207|NCT00774397|2539258|P1|Overall Study|Lost to Follow-up|0
798208|NCT00774397|2539252|P7|Overall Study|Protocol Violation|0
798209|NCT00774397|2539253|P6|Overall Study|Protocol Violation|1
798210|NCT00774397|2539254|P5|Overall Study|Protocol Violation|2
798211|NCT00774397|2539255|P4|Overall Study|Protocol Violation|1
798212|NCT00774397|2539256|P3|Overall Study|Protocol Violation|3
798213|NCT00774397|2539257|P2|Overall Study|Protocol Violation|1
798214|NCT00774397|2539258|P1|Overall Study|Protocol Violation|0
798215|NCT00774397|2539252|P7|Overall Study|Lack of Efficacy|9
798216|NCT00774397|2539253|P6|Overall Study|Lack of Efficacy|15
798217|NCT00774397|2539254|P5|Overall Study|Lack of Efficacy|27
798218|NCT00774397|2539255|P4|Overall Study|Lack of Efficacy|3
798219|NCT00774397|2539256|P3|Overall Study|Lack of Efficacy|5
798220|NCT00774397|2539257|P2|Overall Study|Lack of Efficacy|4
798221|NCT00774397|2539258|P1|Overall Study|Lack of Efficacy|11
798222|NCT00774397|2539252|P7|Overall Study|Adverse Event|16
798223|NCT00774397|2539253|P6|Overall Study|Adverse Event|3
798224|NCT00774397|2539254|P5|Overall Study|Adverse Event|8
798225|NCT00774397|2539255|P4|Overall Study|Adverse Event|8
798226|NCT00774397|2539256|P3|Overall Study|Adverse Event|16
798227|NCT00774397|2539257|P2|Overall Study|Adverse Event|3
798228|NCT00774397|2539258|P1|Overall Study|Adverse Event|1
798229|NCT00774748|2539490|P1|Overall Study|Lost to Follow-up|3
798230|NCT00774787|2539498|P1|Overall Study|Lost to Follow-up|1
798231|NCT00774800|2539505|P1|Intervention 4|Withdrawal by Subject|1
798232|NCT00774852|2539529|P2|Overall Study|Subject received prohibited medication|0
798233|NCT00774852|2539530|P1|Overall Study|Subject received prohibited medication|1
798234|NCT00774852|2539529|P2|Overall Study|Protocol Violation|0
798235|NCT00774852|2539530|P1|Overall Study|Protocol Violation|1
798236|NCT00774852|2539529|P2|Overall Study|Subject non-compliance|1
798237|NCT00774852|2539530|P1|Overall Study|Subject non-compliance|0
798238|NCT00774852|2539529|P2|Overall Study|Non-responder|11
798239|NCT00774852|2539530|P1|Overall Study|Non-responder|15
798240|NCT00774852|2539529|P2|Overall Study|Withdrawal by Subject|2
798241|NCT00774852|2539530|P1|Overall Study|Withdrawal by Subject|2
798242|NCT00774852|2539529|P2|Overall Study|Pregnancy|2
798243|NCT00774852|2539530|P1|Overall Study|Pregnancy|1
798244|NCT00774852|2539529|P2|Overall Study|Physician Decision|6
798245|NCT00774852|2539530|P1|Overall Study|Physician Decision|2
798246|NCT00774852|2539529|P2|Overall Study|Lost to Follow-up|5
798247|NCT00774852|2539530|P1|Overall Study|Lost to Follow-up|9
798248|NCT00774852|2539529|P2|Overall Study|Lack of Efficacy|7
798249|NCT00774852|2539530|P1|Overall Study|Lack of Efficacy|3
798250|NCT00774852|2539529|P2|Overall Study|Death|1
798251|NCT00774852|2539530|P1|Overall Study|Death|2
798252|NCT00774852|2539529|P2|Overall Study|Adverse Event|6
798253|NCT00774852|2539530|P1|Overall Study|Adverse Event|9
798254|NCT00774930|2539580|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
798255|NCT00774930|2539581|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
798256|NCT00774930|2539580|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
798257|NCT00774930|2539581|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
798258|NCT00774930|2539580|P2|LTOLE Phase|Disease Progression|5
798259|NCT00774930|2539581|P1|LTOLE Phase|Disease Progression|2
798260|NCT00774930|2539580|P2|LTOLE Phase|Sponsor decision|1
798261|NCT00774930|2539581|P1|LTOLE Phase|Sponsor decision|2
798262|NCT00774930|2539580|P2|LTOLE Phase|Physician Decision|1
798263|NCT00774930|2539581|P1|LTOLE Phase|Physician Decision|4
798264|NCT00774930|2539580|P2|LTOLE Phase|Subject decision|5
798265|NCT00774930|2539581|P1|LTOLE Phase|Subject decision|0
798266|NCT00774930|2539580|P2|LTOLE Phase|Adverse Event|3
798267|NCT00774930|2539581|P1|LTOLE Phase|Adverse Event|7
798268|NCT00774930|2539580|P2|IOL Phase|Brain radiation|1
798269|NCT00774930|2539581|P1|IOL Phase|Brain radiation|0
798270|NCT00774930|2539580|P2|IOL Phase|Unspecified|0
798271|NCT00774930|2539581|P1|IOL Phase|Unspecified|1
798272|NCT00774930|2539580|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
798273|NCT00774930|2539581|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
798274|NCT00774930|2539580|P2|IOL Phase|Subject Consumed Prohibited Medication|0
798275|NCT00774930|2539581|P1|IOL Phase|Subject Consumed Prohibited Medication|1
798276|NCT00774930|2539580|P2|IOL Phase|Disease Progression|1
798277|NCT00774930|2539581|P1|IOL Phase|Disease Progression|2
798278|NCT00774930|2539580|P2|IOL Phase|Sponsor Decision|0
798279|NCT00774930|2539581|P1|IOL Phase|Sponsor Decision|1
798280|NCT00774930|2539580|P2|IOL Phase|Physician Decision|2
798281|NCT00774930|2539581|P1|IOL Phase|Physician Decision|3
798282|NCT00774930|2539580|P2|IOL Phase|Subject Decision|3
798283|NCT00774930|2539581|P1|IOL Phase|Subject Decision|4
798284|NCT00774930|2539580|P2|IOL Phase|Adverse Event|1
798285|NCT00774930|2539581|P1|IOL Phase|Adverse Event|1
798286|NCT00774930|2539580|P2|DB Phase|Started Nonprotocol Radiation therapy|1
798287|NCT00774930|2539581|P1|DB Phase|Started Nonprotocol Radiation therapy|0
798288|NCT00774930|2539580|P2|DB Phase|Disease Progression|1
798289|NCT00774930|2539581|P1|DB Phase|Disease Progression|1
798290|NCT00774930|2539580|P2|DB Phase|Sponsor Decision|1
798291|NCT00774930|2539581|P1|DB Phase|Sponsor Decision|0
798292|NCT00774930|2539580|P2|DB Phase|Subject Decision|5
798293|NCT00774930|2539581|P1|DB Phase|Subject Decision|1
798294|NCT00774930|2539580|P2|DB Phase|Adverse Event|2
798295|NCT00774930|2539581|P1|DB Phase|Adverse Event|1
798296|NCT00774930|2539580|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
798297|NCT00774930|2539581|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
798298|NCT00774995|2539640|P4|Overall Study|Protocol Violation|0
798299|NCT00774995|2539641|P3|Overall Study|Protocol Violation|1
798300|NCT00774995|2539642|P2|Overall Study|Protocol Violation|0
798301|NCT00774995|2539643|P1|Overall Study|Protocol Violation|0
798302|NCT00775021|2539681|P2|Second Intervention|Adverse Event|1
798303|NCT00775021|2539682|P1|Second Intervention|Adverse Event|0
798304|NCT00775021|2539681|P2|First Intervention|Lost to Follow-up|0
798305|NCT00775021|2539682|P1|First Intervention|Lost to Follow-up|1
798306|NCT00775190|2539698|P2|Overall Study|Protocol Violation|0
798307|NCT00775190|2539699|P1|Overall Study|Protocol Violation|1
798308|NCT00775190|2539698|P2|Overall Study|Withdrawal by Subject|2
798309|NCT00775190|2539699|P1|Overall Study|Withdrawal by Subject|1
798310|NCT00775190|2539698|P2|Overall Study|Lost to Follow-up|3
798311|NCT00775190|2539699|P1|Overall Study|Lost to Follow-up|2
798312|NCT00775203|2539723|P2|Overall Study|Physician Decision|1
798313|NCT00775203|2539724|P1|Overall Study|Physician Decision|0
798314|NCT00775203|2539723|P2|Overall Study|Entered other study|0
798315|NCT00775203|2539724|P1|Overall Study|Entered other study|1
798316|NCT00775203|2539723|P2|Overall Study|Protocol Violation|1
798317|NCT00775203|2539724|P1|Overall Study|Protocol Violation|0
798318|NCT00775203|2539723|P2|Overall Study|Noncompliance|2
798319|NCT00775203|2539724|P1|Overall Study|Noncompliance|4
798320|NCT00775203|2539723|P2|Overall Study|Administrative reason|0
798321|NCT00775203|2539724|P1|Overall Study|Administrative reason|2
798322|NCT00775203|2539723|P2|Overall Study|Lost to Follow-up|15
798323|NCT00775203|2539724|P1|Overall Study|Lost to Follow-up|11
798324|NCT00775203|2539723|P2|Overall Study|Withdrawal by Subject|9
798325|NCT00775203|2539724|P1|Overall Study|Withdrawal by Subject|11
798326|NCT00775203|2539723|P2|Overall Study|Lack of Efficacy|9
798327|NCT00775203|2539724|P1|Overall Study|Lack of Efficacy|8
798328|NCT00775203|2539723|P2|Overall Study|Adverse Event|6
798329|NCT00775203|2539724|P1|Overall Study|Adverse Event|25
798330|NCT00775983|2539804|P2|Overall Study|Protocol Violation|2
798331|NCT00775983|2539805|P1|Overall Study|Protocol Violation|1
798332|NCT00776009|2539819|P6|Period 3: Third Intervention|Withdrawal by Subject|0
798333|NCT00776009|2539820|P5|Period 3: Third Intervention|Withdrawal by Subject|0
798334|NCT00776009|2539821|P4|Period 3: Third Intervention|Withdrawal by Subject|0
798335|NCT00776009|2539822|P3|Period 3: Third Intervention|Withdrawal by Subject|0
798336|NCT00776009|2539823|P2|Period 3: Third Intervention|Withdrawal by Subject|0
798337|NCT00776009|2539824|P1|Period 3: Third Intervention|Withdrawal by Subject|1
798338|NCT00776009|2539819|P6|Period 2: Second Intervention|Protocol Violation|0
798339|NCT00776009|2539820|P5|Period 2: Second Intervention|Protocol Violation|0
798340|NCT00776009|2539821|P4|Period 2: Second Intervention|Protocol Violation|0
798341|NCT00776009|2539822|P3|Period 2: Second Intervention|Protocol Violation|1
798342|NCT00776009|2539823|P2|Period 2: Second Intervention|Protocol Violation|0
798343|NCT00776009|2539824|P1|Period 2: Second Intervention|Protocol Violation|1
798344|NCT00776009|2539819|P6|Period 2: Second Intervention|Withdrawal by Subject|1
798345|NCT00776009|2539820|P5|Period 2: Second Intervention|Withdrawal by Subject|0
798346|NCT00776009|2539821|P4|Period 2: Second Intervention|Withdrawal by Subject|0
798347|NCT00776009|2539822|P3|Period 2: Second Intervention|Withdrawal by Subject|0
798348|NCT00776009|2539823|P2|Period 2: Second Intervention|Withdrawal by Subject|0
798349|NCT00776009|2539824|P1|Period 2: Second Intervention|Withdrawal by Subject|0
798350|NCT00776009|2539819|P6|Period 1: First Intervention|Protocol Violation|0
798351|NCT00776009|2539820|P5|Period 1: First Intervention|Protocol Violation|1
798352|NCT00776009|2539821|P4|Period 1: First Intervention|Protocol Violation|0
798353|NCT00776009|2539822|P3|Period 1: First Intervention|Protocol Violation|0
798354|NCT00776009|2539823|P2|Period 1: First Intervention|Protocol Violation|1
798355|NCT00776009|2539824|P1|Period 1: First Intervention|Protocol Violation|0
798356|NCT00776009|2539819|P6|Period 1: First Intervention|Withdrawal by Subject|0
798357|NCT00776009|2539820|P5|Period 1: First Intervention|Withdrawal by Subject|1
798358|NCT00776009|2539821|P4|Period 1: First Intervention|Withdrawal by Subject|0
798359|NCT00776009|2539822|P3|Period 1: First Intervention|Withdrawal by Subject|1
798360|NCT00776009|2539823|P2|Period 1: First Intervention|Withdrawal by Subject|0
798361|NCT00776009|2539824|P1|Period 1: First Intervention|Withdrawal by Subject|0
798362|NCT00776100|2539846|P2|Overall Study|Disease Progression|0
798363|NCT00776100|2539847|P1|Overall Study|Disease Progression|1
798364|NCT00776230|2539866|P3|Overall Study|Subject missed Visit 4|0
798365|NCT00776230|2539867|P2|Overall Study|Subject missed Visit 4|1
798366|NCT00776230|2539868|P1|Overall Study|Subject missed Visit 4|0
798367|NCT00776230|2539866|P3|Overall Study|Withdrawal by Subject|0
798368|NCT00776230|2539867|P2|Overall Study|Withdrawal by Subject|1
798369|NCT00776230|2539868|P1|Overall Study|Withdrawal by Subject|0
798370|NCT00776230|2539866|P3|Overall Study|Not vaccinated at Day 0|0
798371|NCT00776230|2539867|P2|Overall Study|Not vaccinated at Day 0|0
798372|NCT00776230|2539868|P1|Overall Study|Not vaccinated at Day 0|1
798373|NCT00776230|2539866|P3|Overall Study|Lost to Follow-up|5
798374|NCT00776230|2539867|P2|Overall Study|Lost to Follow-up|1
798375|NCT00776230|2539868|P1|Overall Study|Lost to Follow-up|2
798376|NCT00776555|2539883|P2|Overall Study|Study terminated|0
798377|NCT00776555|2539884|P1|Overall Study|Study terminated|3
798378|NCT00776659|2539909|P1|Overall Study|Study Terminated by Sponsor|1
798379|NCT00776659|2539909|P1|Overall Study|Withdrawal by Subject|10
798380|NCT00776659|2539909|P1|Overall Study|Lost to Follow-up|15
798381|NCT00776789|2539921|P2|Overall Study|Poor quality video|1
798382|NCT00776789|2539922|P1|Overall Study|Poor quality video|1
798383|NCT00776789|2539921|P2|Overall Study|Consent refusal|2
798384|NCT00776789|2539922|P1|Overall Study|Consent refusal|2
798385|NCT00776919|2539938|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
798386|NCT00776919|2539939|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
798387|NCT00776919|2539940|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
798388|NCT00776919|2539941|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
798389|NCT00776919|2539938|P4|Overall Study|Protocol Violation|1
798390|NCT00776919|2539939|P3|Overall Study|Protocol Violation|0
798391|NCT00776919|2539940|P2|Overall Study|Protocol Violation|2
798392|NCT00776919|2539941|P1|Overall Study|Protocol Violation|1
798393|NCT00776919|2539938|P4|Overall Study|Adverse Event|2
798394|NCT00776919|2539939|P3|Overall Study|Adverse Event|2
798395|NCT00776919|2539940|P2|Overall Study|Adverse Event|0
798396|NCT00776919|2539941|P1|Overall Study|Adverse Event|1
798397|NCT00776919|2539938|P4|Overall Study|Lost to Follow-up|8
798398|NCT00776919|2539939|P3|Overall Study|Lost to Follow-up|11
798399|NCT00776919|2539940|P2|Overall Study|Lost to Follow-up|12
798400|NCT00776919|2539941|P1|Overall Study|Lost to Follow-up|8
798401|NCT00776919|2539938|P4|Overall Study|Withdrawal by Subject|26
798402|NCT00776919|2539939|P3|Overall Study|Withdrawal by Subject|15
798403|NCT00776919|2539940|P2|Overall Study|Withdrawal by Subject|14
798404|NCT00776919|2539941|P1|Overall Study|Withdrawal by Subject|16
798405|NCT00776984|2540005|P2|Overall Study|Other|9
798406|NCT00776984|2540006|P1|Overall Study|Other|5
798407|NCT00776984|2540005|P2|Overall Study|Lack of Efficacy|1
798408|NCT00776984|2540006|P1|Overall Study|Lack of Efficacy|0
798409|NCT00776984|2540005|P2|Overall Study|Withdrawal by Subject|7
798410|NCT00776984|2540006|P1|Overall Study|Withdrawal by Subject|12
798411|NCT00776984|2540005|P2|Overall Study|Lost to Follow-up|0
798412|NCT00776984|2540006|P1|Overall Study|Lost to Follow-up|2
798413|NCT00776984|2540005|P2|Overall Study|Protocol Violation|2
798414|NCT00776984|2540006|P1|Overall Study|Protocol Violation|4
798415|NCT00776984|2540005|P2|Overall Study|Adverse Event|2
798416|NCT00776984|2540006|P1|Overall Study|Adverse Event|8
798417|NCT00776997|2540076|P1|Overall Study|Adverse Event|2
798418|NCT00777023|2540086|P3|Overall Study|Last dose date unknown|1
798419|NCT00777023|2540087|P2|Overall Study|Last dose date unknown|3
798420|NCT00777023|2540088|P1|Overall Study|Last dose date unknown|3
798421|NCT00777023|2540086|P3|Overall Study|Reasons not specified|2
798422|NCT00777023|2540087|P2|Overall Study|Reasons not specified|4
798423|NCT00777023|2540088|P1|Overall Study|Reasons not specified|4
798424|NCT00777023|2540086|P3|Overall Study|Missing data|0
798425|NCT00777023|2540087|P2|Overall Study|Missing data|1
798426|NCT00777023|2540088|P1|Overall Study|Missing data|1
798427|NCT00777023|2540086|P3|Overall Study|Withdrawal by Subject|8
798428|NCT00777023|2540087|P2|Overall Study|Withdrawal by Subject|7
798429|NCT00777023|2540088|P1|Overall Study|Withdrawal by Subject|7
798430|NCT00777023|2540086|P3|Overall Study|Death|0
798431|NCT00777023|2540087|P2|Overall Study|Death|1
798432|NCT00777023|2540088|P1|Overall Study|Death|0
798433|NCT00777023|2540086|P3|Overall Study|Lost to Follow-up|3
798434|NCT00777023|2540087|P2|Overall Study|Lost to Follow-up|3
798435|NCT00777023|2540088|P1|Overall Study|Lost to Follow-up|2
798436|NCT00777023|2540086|P3|Overall Study|Protocol Violation|1
798437|NCT00777023|2540087|P2|Overall Study|Protocol Violation|1
798438|NCT00777023|2540088|P1|Overall Study|Protocol Violation|2
798439|NCT00777023|2540086|P3|Overall Study|Lack of Efficacy|14
798440|NCT00777023|2540087|P2|Overall Study|Lack of Efficacy|0
798441|NCT00777023|2540088|P1|Overall Study|Lack of Efficacy|1
798442|NCT00777023|2540086|P3|Overall Study|Adverse Event|8
798443|NCT00777023|2540087|P2|Overall Study|Adverse Event|21
798444|NCT00777023|2540088|P1|Overall Study|Adverse Event|15
798445|NCT00777049|2540107|P2|Overall Study|No treatment (elevated liver enzymes)|1
798446|NCT00777049|2540108|P1|Overall Study|No treatment (elevated liver enzymes)|0
798447|NCT00777049|2540107|P2|Overall Study|Withdrawal by Subject|0
798448|NCT00777049|2540108|P1|Overall Study|Withdrawal by Subject|1
798449|NCT00777153|2540128|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
798450|NCT00777153|2540129|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
798451|NCT00777153|2540130|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
798452|NCT00777153|2540128|P3|Overall Study|Withdrawal by Subject|3
798453|NCT00777153|2540129|P2|Overall Study|Withdrawal by Subject|4
798454|NCT00777153|2540130|P1|Overall Study|Withdrawal by Subject|3
798455|NCT00777153|2540128|P3|Overall Study|Death|33
798456|NCT00777153|2540129|P2|Overall Study|Death|73
798457|NCT00777153|2540130|P1|Overall Study|Death|85
798458|NCT00777153|2540128|P3|Overall Study|Lost to Follow-up|0
798459|NCT00777153|2540129|P2|Overall Study|Lost to Follow-up|1
798460|NCT00777153|2540130|P1|Overall Study|Lost to Follow-up|1
798461|NCT00777205|2540172|P2|Overall Study|Protocol Violation|56
798462|NCT00777205|2540173|P1|Overall Study|Protocol Violation|0
798463|NCT00777205|2540172|P2|Overall Study|Death|2
798464|NCT00777205|2540173|P1|Overall Study|Death|0
798465|NCT00777205|2540172|P2|Overall Study|Withdrawal by Subject|4
798466|NCT00777205|2540173|P1|Overall Study|Withdrawal by Subject|6
798467|NCT00777205|2540172|P2|Overall Study|Lost to Follow-up|9
798468|NCT00777205|2540173|P1|Overall Study|Lost to Follow-up|25
798469|NCT00777257|2540190|P3|Overall Study|Withdrawal by Subject|5
798470|NCT00777257|2540191|P2|Overall Study|Withdrawal by Subject|6
798471|NCT00777257|2540192|P1|Overall Study|Withdrawal by Subject|3
798472|NCT00777257|2540190|P3|Overall Study|Protocol Violation|2
798473|NCT00777257|2540191|P2|Overall Study|Protocol Violation|2
798474|NCT00777257|2540192|P1|Overall Study|Protocol Violation|2
798475|NCT00777257|2540190|P3|Overall Study|Lost to Follow-up|2
798476|NCT00777257|2540191|P2|Overall Study|Lost to Follow-up|3
798477|NCT00777257|2540192|P1|Overall Study|Lost to Follow-up|3
798478|NCT00777257|2540190|P3|Overall Study|Adverse Event|0
798479|NCT00777257|2540191|P2|Overall Study|Adverse Event|1
798480|NCT00777257|2540192|P1|Overall Study|Adverse Event|3
798481|NCT00777556|2540220|P1|Overall Study|Did not complete all 3 follow-up visits|20
798482|NCT00777556|2540220|P1|Overall Study|Dispensed but did not use product|12
798483|NCT00777556|2540220|P1|Overall Study|Inappropriate self-selection|34
798484|NCT00777608|2540229|P2|Overall Study|Investigator Decision|2
798485|NCT00777608|2540230|P1|Overall Study|Investigator Decision|1
798486|NCT00777608|2540229|P2|Overall Study|Protocol Violation|0
798487|NCT00777608|2540230|P1|Overall Study|Protocol Violation|1
798488|NCT00777608|2540229|P2|Overall Study|Withdrawal by Subject|3
798489|NCT00777608|2540230|P1|Overall Study|Withdrawal by Subject|1
798490|NCT00777608|2540229|P2|Overall Study|Lost to Follow-up|1
798491|NCT00777608|2540230|P1|Overall Study|Lost to Follow-up|1
798492|NCT00777803|2540287|P2|Overall Study|Non-compliance|2
798493|NCT00777803|2540288|P1|Overall Study|Non-compliance|2
798494|NCT00777803|2540287|P2|Overall Study|Adverse Event|0
798495|NCT00777803|2540288|P1|Overall Study|Adverse Event|1
798496|NCT00777803|2540287|P2|Overall Study|Lost to Follow-up|5
798497|NCT00777803|2540288|P1|Overall Study|Lost to Follow-up|12
798498|NCT00777946|2540333|P3|Overall Study|Randomized in error|0
798499|NCT00777946|2540334|P2|Overall Study|Randomized in error|1
798500|NCT00777946|2540335|P1|Overall Study|Randomized in error|1
798501|NCT00777946|2540333|P3|Overall Study|Protocol deviation|1
798502|NCT00777946|2540334|P2|Overall Study|Protocol deviation|1
798503|NCT00777946|2540335|P1|Overall Study|Protocol deviation|2
798504|NCT00777946|2540333|P3|Overall Study|Lost to Follow-up|0
798505|NCT00777946|2540334|P2|Overall Study|Lost to Follow-up|1
798506|NCT00777946|2540335|P1|Overall Study|Lost to Follow-up|3
798507|NCT00777946|2540333|P3|Overall Study|Patient withdrew consent|3
798508|NCT00777946|2540334|P2|Overall Study|Patient withdrew consent|2
798509|NCT00777946|2540335|P1|Overall Study|Patient withdrew consent|3
798510|NCT00777946|2540333|P3|Overall Study|Condition no longer required study drug|0
798511|NCT00777946|2540334|P2|Overall Study|Condition no longer required study drug|0
798512|NCT00777946|2540335|P1|Overall Study|Condition no longer required study drug|1
798513|NCT00777946|2540333|P3|Overall Study|Lack of Efficacy|9
798514|NCT00777946|2540334|P2|Overall Study|Lack of Efficacy|0
798515|NCT00777946|2540335|P1|Overall Study|Lack of Efficacy|0
798516|NCT00777946|2540333|P3|Overall Study|Adverse Event|3
798517|NCT00777946|2540334|P2|Overall Study|Adverse Event|1
798518|NCT00777946|2540335|P1|Overall Study|Adverse Event|11
798519|NCT00778102|2540360|P2|Overall Study|Administrative Reason|10
798520|NCT00778102|2540361|P1|Overall Study|Administrative Reason|7
798521|NCT00778102|2540360|P2|Overall Study|Withdrawal by Subject|1
798522|NCT00778102|2540361|P1|Overall Study|Withdrawal by Subject|1
798523|NCT00778102|2540360|P2|Overall Study|Refused Treatment|3
798524|NCT00778102|2540361|P1|Overall Study|Refused Treatment|2
798525|NCT00778102|2540360|P2|Overall Study|Protocol Violation|1
798526|NCT00778102|2540361|P1|Overall Study|Protocol Violation|0
798527|NCT00778102|2540360|P2|Overall Study|Violation of Selection Criteria|1
798528|NCT00778102|2540361|P1|Overall Study|Violation of Selection Criteria|1
798529|NCT00778102|2540360|P2|Overall Study|Lost to Follow-up|0
798530|NCT00778102|2540361|P1|Overall Study|Lost to Follow-up|1
798531|NCT00778102|2540360|P2|Overall Study|Death|1
798532|NCT00778102|2540361|P1|Overall Study|Death|1
798533|NCT00778102|2540360|P2|Overall Study|Adverse Event|5
798534|NCT00778102|2540361|P1|Overall Study|Adverse Event|8
798535|NCT00778258|2540415|P9|Overall Study|Unspecified|0
798536|NCT00778258|2540416|P8|Overall Study|Unspecified|0
798537|NCT00778258|2540417|P7|Overall Study|Unspecified|1
798538|NCT00778258|2540418|P6|Overall Study|Unspecified|0
798539|NCT00778258|2540419|P5|Overall Study|Unspecified|0
798540|NCT00778258|2540420|P4|Overall Study|Unspecified|0
798541|NCT00778258|2540421|P3|Overall Study|Unspecified|0
798542|NCT00778258|2540422|P2|Overall Study|Unspecified|0
798543|NCT00778258|2540423|P1|Overall Study|Unspecified|0
798544|NCT00778258|2540415|P9|Overall Study|Non-compliance|0
798545|NCT00778258|2540416|P8|Overall Study|Non-compliance|0
798546|NCT00778258|2540417|P7|Overall Study|Non-compliance|0
798547|NCT00778258|2540418|P6|Overall Study|Non-compliance|0
798548|NCT00778258|2540419|P5|Overall Study|Non-compliance|0
798549|NCT00778258|2540420|P4|Overall Study|Non-compliance|1
798550|NCT00778258|2540421|P3|Overall Study|Non-compliance|0
798551|NCT00778258|2540422|P2|Overall Study|Non-compliance|0
798552|NCT00778258|2540423|P1|Overall Study|Non-compliance|0
798553|NCT00778258|2540415|P9|Overall Study|New Contraindication|0
798554|NCT00778258|2540416|P8|Overall Study|New Contraindication|1
798555|NCT00778258|2540417|P7|Overall Study|New Contraindication|0
798556|NCT00778258|2540418|P6|Overall Study|New Contraindication|0
798557|NCT00778258|2540419|P5|Overall Study|New Contraindication|0
798558|NCT00778258|2540420|P4|Overall Study|New Contraindication|0
798559|NCT00778258|2540421|P3|Overall Study|New Contraindication|0
798560|NCT00778258|2540422|P2|Overall Study|New Contraindication|0
798561|NCT00778258|2540423|P1|Overall Study|New Contraindication|0
798562|NCT00778258|2540415|P9|Overall Study|Withdrawal by Subject|4
798563|NCT00778258|2540416|P8|Overall Study|Withdrawal by Subject|12
798564|NCT00778258|2540417|P7|Overall Study|Withdrawal by Subject|12
798565|NCT00778258|2540418|P6|Overall Study|Withdrawal by Subject|6
798566|NCT00778258|2540419|P5|Overall Study|Withdrawal by Subject|0
798567|NCT00778258|2540420|P4|Overall Study|Withdrawal by Subject|2
798568|NCT00778258|2540421|P3|Overall Study|Withdrawal by Subject|8
798569|NCT00778258|2540422|P2|Overall Study|Withdrawal by Subject|2
798570|NCT00778258|2540423|P1|Overall Study|Withdrawal by Subject|6
798571|NCT00778258|2540415|P9|Overall Study|Lost to Follow-up|0
798572|NCT00778258|2540416|P8|Overall Study|Lost to Follow-up|2
798573|NCT00778258|2540417|P7|Overall Study|Lost to Follow-up|2
798574|NCT00778258|2540418|P6|Overall Study|Lost to Follow-up|3
798575|NCT00778258|2540419|P5|Overall Study|Lost to Follow-up|0
798576|NCT00778258|2540420|P4|Overall Study|Lost to Follow-up|0
798577|NCT00778258|2540421|P3|Overall Study|Lost to Follow-up|2
798578|NCT00778258|2540422|P2|Overall Study|Lost to Follow-up|0
798579|NCT00778258|2540423|P1|Overall Study|Lost to Follow-up|0
798580|NCT00778258|2540415|P9|Overall Study|Adverse Event|0
798581|NCT00778258|2540416|P8|Overall Study|Adverse Event|0
798582|NCT00778258|2540417|P7|Overall Study|Adverse Event|0
798583|NCT00778258|2540418|P6|Overall Study|Adverse Event|1
798584|NCT00778258|2540419|P5|Overall Study|Adverse Event|0
798585|NCT00778258|2540420|P4|Overall Study|Adverse Event|0
798586|NCT00778258|2540421|P3|Overall Study|Adverse Event|0
798587|NCT00778258|2540422|P2|Overall Study|Adverse Event|0
798588|NCT00778258|2540423|P1|Overall Study|Adverse Event|1
798589|NCT00778336|2540490|P4|3 Month Follow Up|Death|0
798590|NCT00778336|2540491|P3|3 Month Follow Up|Death|2
798591|NCT00778336|2540492|P2|3 Month Follow Up|Death|3
798592|NCT00778336|2540493|P1|3 Month Follow Up|Death|8
798593|NCT00778336|2540490|P4|3 Month Follow Up|Lost to Follow-up|0
798594|NCT00778336|2540491|P3|3 Month Follow Up|Lost to Follow-up|3
798595|NCT00778336|2540492|P2|3 Month Follow Up|Lost to Follow-up|20
798596|NCT00778336|2540493|P1|3 Month Follow Up|Lost to Follow-up|15
798597|NCT00778336|2540490|P4|Index Procedure-Discharge|Death|0
798598|NCT00778336|2540491|P3|Index Procedure-Discharge|Death|2
798599|NCT00778336|2540492|P2|Index Procedure-Discharge|Death|3
798600|NCT00778336|2540493|P1|Index Procedure-Discharge|Death|6
798601|NCT00778375|2540511|P1|Overall Study|Ineligible|3
798602|NCT00772369|2540525|P1|Overall Study|Did not return record release form|1
798603|NCT00772382|2540530|P1|Overall Study|Other Reasons|10
798604|NCT00772382|2540530|P1|Overall Study|Withdrawal by Subject|10
798605|NCT00772382|2540530|P1|Overall Study|Protocol Violation|1
798606|NCT00772382|2540530|P1|Overall Study|Physician Decision|5
798607|NCT00772382|2540530|P1|Overall Study|Lack of Efficacy|4
798608|NCT00772382|2540530|P1|Overall Study|Death|6
798609|NCT00772382|2540530|P1|Overall Study|Adverse Event|19
798610|NCT00772447|2540537|P2|Overall Study|all others|2
798611|NCT00772447|2540538|P1|Overall Study|all others|2
798612|NCT00772447|2540537|P2|Overall Study|Protocol Violation|1
798613|NCT00772447|2540538|P1|Overall Study|Protocol Violation|0
798614|NCT00772447|2540537|P2|Overall Study|incorrect enrolment|4
798615|NCT00772447|2540538|P1|Overall Study|incorrect enrolment|3
798616|NCT00772447|2540537|P2|Overall Study|Lost to Follow-up|4
798617|NCT00772447|2540538|P1|Overall Study|Lost to Follow-up|2
798618|NCT00772447|2540537|P2|Overall Study|Physician Decision|8
798619|NCT00772447|2540538|P1|Overall Study|Physician Decision|4
798620|NCT00772447|2540537|P2|Overall Study|Withdrawal by Subject|5
798621|NCT00772447|2540538|P1|Overall Study|Withdrawal by Subject|9
798622|NCT00778622|2540569|P3|Overall Study|unspecified|1
798623|NCT00778622|2540570|P2|Overall Study|unspecified|0
798624|NCT00778622|2540571|P1|Overall Study|unspecified|1
798625|NCT00778622|2540569|P3|Overall Study|immigration|0
798626|NCT00778622|2540570|P2|Overall Study|immigration|0
798627|NCT00778622|2540571|P1|Overall Study|immigration|1
798628|NCT00778622|2540569|P3|Overall Study|Lack of Efficacy|0
798629|NCT00778622|2540570|P2|Overall Study|Lack of Efficacy|0
798630|NCT00778622|2540571|P1|Overall Study|Lack of Efficacy|2
798631|NCT00778622|2540569|P3|Overall Study|Protocol Violation|0
798632|NCT00778622|2540570|P2|Overall Study|Protocol Violation|3
798633|NCT00778622|2540571|P1|Overall Study|Protocol Violation|0
798634|NCT00778622|2540569|P3|Overall Study|Lost to Follow-up|2
798635|NCT00778622|2540570|P2|Overall Study|Lost to Follow-up|3
798636|NCT00778622|2540571|P1|Overall Study|Lost to Follow-up|3
798637|NCT00778622|2540569|P3|Overall Study|Withdrawal by Subject|5
798638|NCT00778622|2540570|P2|Overall Study|Withdrawal by Subject|5
798639|NCT00778622|2540571|P1|Overall Study|Withdrawal by Subject|4
798640|NCT00778622|2540569|P3|Overall Study|Adverse Event|7
798641|NCT00778622|2540570|P2|Overall Study|Adverse Event|4
798642|NCT00778622|2540571|P1|Overall Study|Adverse Event|5
798643|NCT00780910|2540672|P1|Overall Study|Adverse Event|2
798644|NCT00781274|2540687|P1|Overall Study|Withdrawal by Subject|2
798645|NCT00781326|2540691|P1|Phase I|Physician Decision|2
798646|NCT00781326|2540691|P1|Phase I|Withdrawal by Subject|1
798647|NCT00781326|2540691|P1|Phase I|Adverse Event|1
798648|NCT00781365|2540697|P2|Overall Study|Language barrier|0
798649|NCT00781365|2540698|P1|Overall Study|Language barrier|1
798650|NCT00781365|2540697|P2|Overall Study|Did Not Attend Visit|28
798651|NCT00781365|2540698|P1|Overall Study|Did Not Attend Visit|20
798652|NCT00781365|2540697|P2|Overall Study|Withdrawal by Subject|8
798653|NCT00781365|2540698|P1|Overall Study|Withdrawal by Subject|13
798654|NCT00781391|2540711|P3|Overall Study|Lost to Follow-up|1
798655|NCT00781391|2540712|P2|Overall Study|Lost to Follow-up|0
798656|NCT00781391|2540713|P1|Overall Study|Lost to Follow-up|0
798657|NCT00781391|2540711|P3|Overall Study|Withdrawal by Subject|25
798658|NCT00781391|2540712|P2|Overall Study|Withdrawal by Subject|37
798659|NCT00781391|2540713|P1|Overall Study|Withdrawal by Subject|47
798660|NCT00781391|2540711|P3|Overall Study|Death|706
798661|NCT00781391|2540712|P2|Overall Study|Death|730
798662|NCT00781391|2540713|P1|Overall Study|Death|789
798663|NCT00781391|2540711|P3|Overall Study|Protocol Violation|20
798664|NCT00781391|2540712|P2|Overall Study|Protocol Violation|17
798665|NCT00781391|2540713|P1|Overall Study|Protocol Violation|19
798666|NCT00781391|2540711|P3|Overall Study|never received study drug|32
798667|NCT00781391|2540712|P2|Overall Study|never received study drug|23
798668|NCT00781391|2540713|P1|Overall Study|never received study drug|24
798669|NCT00781456|2540747|P2|Overall Study|Other Reason, Unknown|1
798670|NCT00781456|2540748|P1|Overall Study|Other Reason, Unknown|0
798671|NCT00781456|2540747|P2|Overall Study|Lost to Follow-up|5
798672|NCT00781456|2540748|P1|Overall Study|Lost to Follow-up|10
798673|NCT00781456|2540747|P2|Overall Study|Noncompliance With Protocol|1
798674|NCT00781456|2540748|P1|Overall Study|Noncompliance With Protocol|1
798675|NCT00781456|2540747|P2|Overall Study|Protocol Violation|1
798676|NCT00781456|2540748|P1|Overall Study|Protocol Violation|4
798677|NCT00781456|2540747|P2|Overall Study|Withdrawal by Subject|5
798678|NCT00781456|2540748|P1|Overall Study|Withdrawal by Subject|3
798679|NCT00781456|2540747|P2|Overall Study|Adverse Event|3
798680|NCT00781456|2540748|P1|Overall Study|Adverse Event|3
798681|NCT00781599|2540781|P2|Overall Study|Lost to Follow-up|4
798682|NCT00781599|2540782|P1|Overall Study|Lost to Follow-up|7
798683|NCT00781859|2540796|P2|Overall Study|Death|0
798684|NCT00781859|2540797|P1|Overall Study|Death|3
798685|NCT00781859|2540796|P2|Overall Study|Lost to Follow-up|3
798686|NCT00781859|2540797|P1|Overall Study|Lost to Follow-up|6
798687|NCT00781859|2540796|P2|Overall Study|Withdrawal by Subject|4
798688|NCT00781859|2540797|P1|Overall Study|Withdrawal by Subject|8
798689|NCT00781859|2540796|P2|Overall Study|Adverse Event|2
798690|NCT00781859|2540797|P1|Overall Study|Adverse Event|2
798705|NCT00781963|2540878|P3|Overall Study|Refused follow-up|0
798706|NCT00781963|2540879|P2|Overall Study|Refused follow-up|5
798707|NCT00781963|2540880|P1|Overall Study|Refused follow-up|4
798708|NCT00781963|2540878|P3|Overall Study|Withdrawal by Subject|1
798709|NCT00781963|2540879|P2|Overall Study|Withdrawal by Subject|3
798710|NCT00781963|2540880|P1|Overall Study|Withdrawal by Subject|0
798711|NCT00781963|2540878|P3|Overall Study|Lost to Follow-up|1
798712|NCT00781963|2540879|P2|Overall Study|Lost to Follow-up|1
798713|NCT00781963|2540880|P1|Overall Study|Lost to Follow-up|1
798714|NCT00781963|2540878|P3|Overall Study|Death|0
798715|NCT00781963|2540879|P2|Overall Study|Death|0
798716|NCT00781963|2540880|P1|Overall Study|Death|3
798717|NCT00782067|2540888|P1|Overall Study|Disease progression|44
798718|NCT00782067|2540888|P1|Overall Study|Withdrawal by Subject|10
798719|NCT00782067|2540888|P1|Overall Study|Adverse Event|28
798720|NCT00782067|2540888|P1|Overall Study|Death|8
798721|NCT00782067|2540888|P1|Overall Study|Protocol deviation|2
798722|NCT00782067|2540888|P1|Overall Study|Lost to Follow-up|1
798723|NCT00782067|2540888|P1|Overall Study|Administrative problems|1
798724|NCT00782067|2540888|P1|Overall Study|Abnormal procedure results|1
798725|NCT00782171|2540897|P2|Overall Study|not eligible|6
798726|NCT00782171|2540898|P1|Overall Study|not eligible|8
798727|NCT00782171|2540897|P2|Overall Study|others|9
798728|NCT00782171|2540898|P1|Overall Study|others|7
798729|NCT00782171|2540897|P2|Overall Study|complications|1
798730|NCT00782171|2540898|P1|Overall Study|complications|3
798731|NCT00782171|2540897|P2|Overall Study|Withdrawal by Subject|1
798732|NCT00782171|2540898|P1|Overall Study|Withdrawal by Subject|2
798733|NCT00782171|2540897|P2|Overall Study|Lost to Follow-up|2
798734|NCT00782171|2540898|P1|Overall Study|Lost to Follow-up|2
798735|NCT00782184|2540932|P2|Overall Study|Withdrawal by Subject|2
798736|NCT00782184|2540933|P1|Overall Study|Withdrawal by Subject|3
798737|NCT00782184|2540932|P2|Overall Study|Protocol Violation|1
798738|NCT00782184|2540933|P1|Overall Study|Protocol Violation|0
798739|NCT00782184|2540932|P2|Overall Study|Adverse Event|2
798740|NCT00782184|2540933|P1|Overall Study|Adverse Event|1
798741|NCT00782210|2540971|P3|Overall Study|Other reason not described above|3
798742|NCT00782210|2540972|P2|Overall Study|Other reason not described above|2
798743|NCT00782210|2540973|P1|Overall Study|Other reason not described above|3
798744|NCT00782210|2540971|P3|Overall Study|Lack of Efficacy|1
798745|NCT00782210|2540972|P2|Overall Study|Lack of Efficacy|4
798746|NCT00782210|2540973|P1|Overall Study|Lack of Efficacy|13
798747|NCT00782210|2540971|P3|Overall Study|Non compliance with protocol|2
798748|NCT00782210|2540972|P2|Overall Study|Non compliance with protocol|3
798749|NCT00782210|2540973|P1|Overall Study|Non compliance with protocol|0
798750|NCT00782210|2540971|P3|Overall Study|Withdrawal by Subject|11
798751|NCT00782210|2540972|P2|Overall Study|Withdrawal by Subject|8
798752|NCT00782210|2540973|P1|Overall Study|Withdrawal by Subject|11
798753|NCT00782210|2540971|P3|Overall Study|Lost to Follow-up|2
798754|NCT00782210|2540972|P2|Overall Study|Lost to Follow-up|1
798755|NCT00782210|2540973|P1|Overall Study|Lost to Follow-up|2
798756|NCT00782210|2540971|P3|Overall Study|Adverse Event|16
798757|NCT00782210|2540972|P2|Overall Study|Adverse Event|17
798758|NCT00782210|2540973|P1|Overall Study|Adverse Event|21
798759|NCT00782340|2541214|P3|Open Label Titration|Randomized in error|0
798760|NCT00782340|2541215|P2|Open Label Titration|Randomized in error|0
798761|NCT00782340|2541216|P1|Open Label Titration|Randomized in error|6
798762|NCT00782340|2541214|P3|Open Label Titration|Lost to Follow-up|0
798763|NCT00782340|2541215|P2|Open Label Titration|Lost to Follow-up|0
798764|NCT00782340|2541216|P1|Open Label Titration|Lost to Follow-up|5
798765|NCT00782340|2541214|P3|Open Label Titration|Did not meet responder criteria|0
798766|NCT00782340|2541215|P2|Open Label Titration|Did not meet responder criteria|0
798767|NCT00782340|2541216|P1|Open Label Titration|Did not meet responder criteria|2
798768|NCT00782340|2541214|P3|Open Label Titration|Enrollment capped|0
798769|NCT00782340|2541215|P2|Open Label Titration|Enrollment capped|0
798770|NCT00782340|2541216|P1|Open Label Titration|Enrollment capped|16
798771|NCT00782340|2541214|P3|Open Label Titration|Withdrawal by Subject|0
798772|NCT00782340|2541215|P2|Open Label Titration|Withdrawal by Subject|0
798773|NCT00782340|2541216|P1|Open Label Titration|Withdrawal by Subject|5
798774|NCT00782340|2541214|P3|Open Label Titration|Protocol Violation|0
798775|NCT00782340|2541215|P2|Open Label Titration|Protocol Violation|0
798776|NCT00782340|2541216|P1|Open Label Titration|Protocol Violation|5
798777|NCT00782340|2541214|P3|Open Label Titration|Treatment failure|0
798778|NCT00782340|2541215|P2|Open Label Titration|Treatment failure|0
798779|NCT00782340|2541216|P1|Open Label Titration|Treatment failure|50
798780|NCT00782340|2541214|P3|Open Label Titration|Adverse Event|0
798781|NCT00782340|2541215|P2|Open Label Titration|Adverse Event|0
798782|NCT00782340|2541216|P1|Open Label Titration|Adverse Event|12
798783|NCT00782418|2541253|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
798784|NCT00782418|2541254|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
798785|NCT00782418|2541255|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
798786|NCT00782418|2541256|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
798787|NCT00782418|2541257|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
798788|NCT00782418|2541258|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
798789|NCT00782418|2541259|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
798790|NCT00782418|2541253|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
798791|NCT00782418|2541254|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
798792|NCT00782418|2541255|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
798793|NCT00782418|2541256|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
798794|NCT00782418|2541257|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
798795|NCT00782418|2541258|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
798796|NCT00782418|2541259|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
798797|NCT00782483|2541279|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
798798|NCT00782496|2541285|P2|Overall Study|Lost to Follow-up|15
798799|NCT00782496|2541286|P1|Overall Study|Lost to Follow-up|14
798800|NCT00782509|2541296|P3|Overall Study|Lack of Efficacy|2
798801|NCT00782509|2541297|P2|Overall Study|Lack of Efficacy|5
798802|NCT00782509|2541298|P1|Overall Study|Lack of Efficacy|10
798803|NCT00782509|2541296|P3|Overall Study|Other reasons not stated above|3
798804|NCT00782509|2541297|P2|Overall Study|Other reasons not stated above|2
798805|NCT00782509|2541298|P1|Overall Study|Other reasons not stated above|5
798806|NCT00782509|2541296|P3|Overall Study|Non compliance with protocol|0
798807|NCT00782509|2541297|P2|Overall Study|Non compliance with protocol|0
798808|NCT00782509|2541298|P1|Overall Study|Non compliance with protocol|2
798809|NCT00782509|2541296|P3|Overall Study|Withdrawal by Subject|8
798810|NCT00782509|2541297|P2|Overall Study|Withdrawal by Subject|5
798811|NCT00782509|2541298|P1|Overall Study|Withdrawal by Subject|3
798812|NCT00782509|2541296|P3|Overall Study|Lost to Follow-up|3
798813|NCT00782509|2541297|P2|Overall Study|Lost to Follow-up|2
798814|NCT00782509|2541298|P1|Overall Study|Lost to Follow-up|1
798815|NCT00782509|2541296|P3|Overall Study|Adverse Event|20
798816|NCT00782509|2541297|P2|Overall Study|Adverse Event|10
798817|NCT00782509|2541298|P1|Overall Study|Adverse Event|20
798818|NCT00782626|2541489|P1|Overall Study|Other Complicating Disease|1
798819|NCT00782626|2541489|P1|Overall Study|Progressive Disease|5
798820|NCT00782626|2541489|P1|Overall Study|Adverse Event|1
798821|NCT00782717|2541514|P2|Overall Study|Exited in error|2
798822|NCT00782717|2541515|P1|Overall Study|Exited in error|0
798823|NCT00782717|2541514|P2|Overall Study|Did not meet entrance criteria|3
798824|NCT00782717|2541515|P1|Overall Study|Did not meet entrance criteria|1
798825|NCT00782717|2541514|P2|Overall Study|Enrollment close prior to surgery|0
798826|NCT00782717|2541515|P1|Overall Study|Enrollment close prior to surgery|1
798827|NCT00782717|2541514|P2|Overall Study|Treatment failure|14
798828|NCT00782717|2541515|P1|Overall Study|Treatment failure|3
798829|NCT00782717|2541514|P2|Overall Study|Noncompliance|1
798830|NCT00782717|2541515|P1|Overall Study|Noncompliance|2
798831|NCT00782717|2541514|P2|Overall Study|Patient decision unrelated to AE|3
798832|NCT00782717|2541515|P1|Overall Study|Patient decision unrelated to AE|6
798833|NCT00782717|2541514|P2|Overall Study|Adverse Event|5
798834|NCT00782717|2541515|P1|Overall Study|Adverse Event|2
798835|NCT00782834|2541556|P1|Treatment Phase|fibrous tumor not GIST|1
798836|NCT00775437|2541571|P1|Overall Study|Lost to Follow-up|1
798837|NCT00775437|2541571|P1|Overall Study|Withdrawal by Subject|3
798838|NCT00775437|2541571|P1|Overall Study|Loss of efficacy|2
798839|NCT00775450|2541626|P5|Overall Study|Withdrawal by Subject|1
798840|NCT00775450|2541627|P4|Overall Study|Withdrawal by Subject|0
798841|NCT00775450|2541628|P3|Overall Study|Withdrawal by Subject|0
798842|NCT00775450|2541629|P2|Overall Study|Withdrawal by Subject|0
798843|NCT00775450|2541630|P1|Overall Study|Withdrawal by Subject|1
798844|NCT00775450|2541626|P5|Overall Study|Protocol Violation|1
798845|NCT00775450|2541627|P4|Overall Study|Protocol Violation|0
798846|NCT00775450|2541628|P3|Overall Study|Protocol Violation|0
798847|NCT00775450|2541629|P2|Overall Study|Protocol Violation|0
798848|NCT00775450|2541630|P1|Overall Study|Protocol Violation|0
798849|NCT00775450|2541626|P5|Overall Study|Serious Adverse Event|0
798850|NCT00775450|2541627|P4|Overall Study|Serious Adverse Event|0
798851|NCT00775450|2541628|P3|Overall Study|Serious Adverse Event|0
798852|NCT00775450|2541629|P2|Overall Study|Serious Adverse Event|0
798853|NCT00775450|2541630|P1|Overall Study|Serious Adverse Event|2
798854|NCT00775463|2541659|P2|Overall Study|Lack of Efficacy|1
798855|NCT00775463|2541660|P1|Overall Study|Lack of Efficacy|1
798856|NCT00775463|2541659|P2|Overall Study|Lost to Follow-up|0
798857|NCT00775463|2541660|P1|Overall Study|Lost to Follow-up|1
798858|NCT00775463|2541659|P2|Overall Study|Protocol Violation|2
798859|NCT00775463|2541660|P1|Overall Study|Protocol Violation|2
798860|NCT00775463|2541659|P2|Overall Study|Adverse Event|9
798861|NCT00775463|2541660|P1|Overall Study|Adverse Event|7
798862|NCT00775463|2541659|P2|Overall Study|Withdrawal by Subject|1
798863|NCT00775463|2541660|P1|Overall Study|Withdrawal by Subject|0
798864|NCT00775528|2541692|P1|Overall Study|Protocol Violation|1
798867|NCT00775606|2541708|P2|Overall Study|Study sponsor terminated funding|0
798868|NCT00775606|2541709|P1|Overall Study|Study sponsor terminated funding|3
798869|NCT00783094|2541765|P3|Open-Label Extension Period|Lack of Efficacy|0
798870|NCT00783094|2541766|P2|Open-Label Extension Period|Lack of Efficacy|4
798871|NCT00783094|2541767|P1|Open-Label Extension Period|Lack of Efficacy|1
798872|NCT00783094|2541765|P3|Open-Label Extension Period|Physician Decision|3
798873|NCT00783094|2541766|P2|Open-Label Extension Period|Physician Decision|2
798874|NCT00783094|2541767|P1|Open-Label Extension Period|Physician Decision|4
798875|NCT00783094|2541765|P3|Open-Label Extension Period|Withdrawal by Subject|3
798876|NCT00783094|2541766|P2|Open-Label Extension Period|Withdrawal by Subject|1
798877|NCT00783094|2541767|P1|Open-Label Extension Period|Withdrawal by Subject|1
798878|NCT00783094|2541765|P3|Open-Label Extension Period|Protocol Violation|7
798879|NCT00783094|2541766|P2|Open-Label Extension Period|Protocol Violation|5
798880|NCT00783094|2541767|P1|Open-Label Extension Period|Protocol Violation|4
798881|NCT00783094|2541765|P3|Open-Label Extension Period|Death|1
798882|NCT00783094|2541766|P2|Open-Label Extension Period|Death|0
798883|NCT00783094|2541767|P1|Open-Label Extension Period|Death|0
798884|NCT00783094|2541765|P3|Open-Label Extension Period|Adverse Event|16
798885|NCT00783094|2541766|P2|Open-Label Extension Period|Adverse Event|7
798886|NCT00783094|2541767|P1|Open-Label Extension Period|Adverse Event|12
798887|NCT00783094|2541765|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
798888|NCT00783094|2541766|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
798889|NCT00783094|2541767|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
798890|NCT00783094|2541765|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
798891|NCT00783094|2541766|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
798892|NCT00783094|2541767|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
798893|NCT00783094|2541765|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
798894|NCT00783094|2541766|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
798895|NCT00783094|2541767|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
798896|NCT00783094|2541765|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
798897|NCT00783094|2541766|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
798898|NCT00783094|2541767|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
798899|NCT00783094|2541765|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
798900|NCT00783094|2541766|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
798901|NCT00783094|2541767|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
798902|NCT00783198|2541846|P3|Overall Study|Administrative|2
798903|NCT00783198|2541847|P2|Overall Study|Administrative|1
798904|NCT00783198|2541848|P1|Overall Study|Administrative|2
798905|NCT00783198|2541846|P3|Overall Study|Did not meet protocol eligibility|0
798906|NCT00783198|2541847|P2|Overall Study|Did not meet protocol eligibility|1
798907|NCT00783198|2541848|P1|Overall Study|Did not meet protocol eligibility|0
798908|NCT00783198|2541846|P3|Overall Study|Noncompliance with protocol|10
798909|NCT00783198|2541847|P2|Overall Study|Noncompliance with protocol|7
798910|NCT00783198|2541848|P1|Overall Study|Noncompliance with protocol|7
798911|NCT00783198|2541846|P3|Overall Study|Withdrawal by Subject|20
798912|NCT00783198|2541847|P2|Overall Study|Withdrawal by Subject|14
798913|NCT00783198|2541848|P1|Overall Study|Withdrawal by Subject|22
798914|NCT00783198|2541846|P3|Overall Study|Lost to Follow-up|7
798915|NCT00783198|2541847|P2|Overall Study|Lost to Follow-up|1
798916|NCT00783198|2541848|P1|Overall Study|Lost to Follow-up|11
798917|NCT00783198|2541846|P3|Overall Study|Adverse Event|3
798918|NCT00783198|2541847|P2|Overall Study|Adverse Event|19
798919|NCT00783198|2541848|P1|Overall Study|Adverse Event|15
798920|NCT00783224|2541872|P4|Overall Study|Inappropriate as a study subject|1
798921|NCT00783224|2541873|P3|Overall Study|Inappropriate as a study subject|0
798922|NCT00783224|2541874|P2|Overall Study|Inappropriate as a study subject|0
798923|NCT00783224|2541875|P1|Overall Study|Inappropriate as a study subject|0
798924|NCT00783224|2541872|P4|Overall Study|Discarded the Investigational Drug Used|1
798925|NCT00783224|2541873|P3|Overall Study|Discarded the Investigational Drug Used|0
798926|NCT00783224|2541874|P2|Overall Study|Discarded the Investigational Drug Used|0
798927|NCT00783224|2541875|P1|Overall Study|Discarded the Investigational Drug Used|0
798928|NCT00783224|2541872|P4|Overall Study|Adverse Event|0
798929|NCT00783224|2541873|P3|Overall Study|Adverse Event|1
798930|NCT00783224|2541874|P2|Overall Study|Adverse Event|0
798931|NCT00783224|2541875|P1|Overall Study|Adverse Event|0
798944|NCT00783302|2541917|P1|Overall Study|Withdrawal by Subject|3
798945|NCT00783302|2541917|P1|Overall Study|Physician Decision|1
798946|NCT00783302|2541917|P1|Overall Study|Protocol Violation|3
798947|NCT00783302|2541917|P1|Overall Study|Technical Problems|11
798948|NCT00783302|2541917|P1|Overall Study|Lost to Follow-up|17
798949|NCT00785291|2541938|P3|Overall Study|Other Medical Reasons|15
798950|NCT00785291|2541939|P2|Overall Study|Other Medical Reasons|25
798951|NCT00785291|2541940|P1|Overall Study|Other Medical Reasons|29
798952|NCT00785291|2541938|P3|Overall Study|Complicating illness|4
798953|NCT00785291|2541939|P2|Overall Study|Complicating illness|4
798954|NCT00785291|2541940|P1|Overall Study|Complicating illness|6
798955|NCT00785291|2541938|P3|Overall Study|Alternative Therapy|7
798956|NCT00785291|2541939|P2|Overall Study|Alternative Therapy|6
798957|NCT00785291|2541940|P1|Overall Study|Alternative Therapy|12
798958|NCT00785291|2541938|P3|Overall Study|Withdrawal by Subject|17
798959|NCT00785291|2541939|P2|Overall Study|Withdrawal by Subject|36
798960|NCT00785291|2541940|P1|Overall Study|Withdrawal by Subject|35
798961|NCT00785291|2541938|P3|Overall Study|Death|3
798962|NCT00785291|2541939|P2|Overall Study|Death|4
798963|NCT00785291|2541940|P1|Overall Study|Death|7
798964|NCT00785291|2541938|P3|Overall Study|Adverse Event|56
798965|NCT00785291|2541939|P2|Overall Study|Adverse Event|70
798966|NCT00785291|2541940|P1|Overall Study|Adverse Event|39
798967|NCT00785291|2541938|P3|Overall Study|Never began treatment|4
798968|NCT00785291|2541939|P2|Overall Study|Never began treatment|4
798969|NCT00785291|2541940|P1|Overall Study|Never began treatment|8
798970|NCT00785356|2541963|P1|Overall Study|Study prematurely terminated|8
798971|NCT00785486|2541971|P1|Midazolam Alone|Withdrawal by Subject|1
798972|NCT00785512|2541994|P2|Overall Study|Lack of compliance|1
798973|NCT00785512|2541995|P1|Overall Study|Lack of compliance|0
798974|NCT00785512|2541994|P2|Overall Study|Physician Decision|0
798975|NCT00785512|2541995|P1|Overall Study|Physician Decision|0
798976|NCT00785512|2541994|P2|Overall Study|IVRS Programing Error|0
798977|NCT00785512|2541995|P1|Overall Study|IVRS Programing Error|0
798978|NCT00785512|2541994|P2|Overall Study|Precedure Refused|0
798979|NCT00785512|2541995|P1|Overall Study|Precedure Refused|0
798980|NCT00785512|2541994|P2|Overall Study|Lost to Follow-up|0
798981|NCT00785512|2541995|P1|Overall Study|Lost to Follow-up|3
798982|NCT00785512|2541994|P2|Overall Study|Withdrawal by Subject|1
798983|NCT00785512|2541995|P1|Overall Study|Withdrawal by Subject|0
798984|NCT00785512|2541994|P2|Overall Study|Lack of Efficacy|2
798985|NCT00785512|2541995|P1|Overall Study|Lack of Efficacy|0
798986|NCT00785512|2541994|P2|Overall Study|Adverse Event|0
798987|NCT00785512|2541995|P1|Overall Study|Adverse Event|0
798988|NCT00785512|2541994|P2|Overall Study|Inclusion/Exclusion not meet|0
798989|NCT00785512|2541995|P1|Overall Study|Inclusion/Exclusion not meet|0
798990|NCT00785577|2542009|P5|Study Period 3: 1-Week Washout Phase|Death|1
798991|NCT00785577|2542010|P4|Study Period 3: 1-Week Washout Phase|Death|0
798992|NCT00785577|2542011|P3|Study Period 3: 1-Week Washout Phase|Death|0
798993|NCT00785577|2542012|P2|Study Period 3: 1-Week Washout Phase|Death|0
798994|NCT00785577|2542013|P1|Study Period 3: 1-Week Washout Phase|Death|0
798995|NCT00785577|2542009|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
798996|NCT00785577|2542010|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
798997|NCT00785577|2542011|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
798998|NCT00785577|2542012|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
798999|NCT00785577|2542013|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
799000|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
799001|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
799002|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
799003|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
799004|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
799005|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
799006|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
799007|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
799008|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
799009|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
799010|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
799011|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
799012|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
799013|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
799014|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
799015|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Protocol Violation|1
799016|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Protocol Violation|0
799017|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Protocol Violation|1
799018|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Protocol Violation|1
799019|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Protocol Violation|1
799020|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Physician Decision|0
799021|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Physician Decision|0
799022|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Physician Decision|0
799023|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Physician Decision|0
799024|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Physician Decision|1
799025|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
799026|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
799027|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
799028|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
799029|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
799030|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
799031|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
799032|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
799033|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
799034|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
799035|NCT00785577|2542009|P5|Study Period 2: Therapy Phase|Adverse Event|17
799036|NCT00785577|2542010|P4|Study Period 2: Therapy Phase|Adverse Event|10
799037|NCT00785577|2542011|P3|Study Period 2: Therapy Phase|Adverse Event|14
799038|NCT00785577|2542012|P2|Study Period 2: Therapy Phase|Adverse Event|7
799039|NCT00785577|2542013|P1|Study Period 2: Therapy Phase|Adverse Event|5
799040|NCT00785629|2542153|P4|Overall Study|Withdrawal by Subject|2
799041|NCT00785629|2542154|P3|Overall Study|Withdrawal by Subject|2
799042|NCT00785629|2542155|P2|Overall Study|Withdrawal by Subject|1
799043|NCT00785629|2542156|P1|Overall Study|Withdrawal by Subject|0
799044|NCT00785629|2542153|P4|Overall Study|administrative decision|4
799045|NCT00785629|2542154|P3|Overall Study|administrative decision|3
799046|NCT00785629|2542155|P2|Overall Study|administrative decision|1
799047|NCT00785629|2542156|P1|Overall Study|administrative decision|5
799048|NCT00785629|2542153|P4|Overall Study|Protocol Violation|5
799049|NCT00785629|2542154|P3|Overall Study|Protocol Violation|4
799050|NCT00785629|2542155|P2|Overall Study|Protocol Violation|2
799051|NCT00785629|2542156|P1|Overall Study|Protocol Violation|1
799052|NCT00785629|2542153|P4|Overall Study|Adverse Event|5
799053|NCT00785629|2542154|P3|Overall Study|Adverse Event|1
799054|NCT00785629|2542155|P2|Overall Study|Adverse Event|1
799055|NCT00785629|2542156|P1|Overall Study|Adverse Event|2
799056|NCT00785707|2542164|P1|Overall Study|Lost to Follow-up|7
799057|NCT00785785|2542177|P2|Optional Extension Phase|Study terminated by sponsor|37
799058|NCT00785785|2542178|P1|Optional Extension Phase|Study terminated by sponsor|3
799059|NCT00785785|2542177|P2|Optional Extension Phase|Protocol deviation|2
799060|NCT00785785|2542178|P1|Optional Extension Phase|Protocol deviation|0
799061|NCT00785785|2542177|P2|Optional Extension Phase|Disease progression|70
799062|NCT00785785|2542178|P1|Optional Extension Phase|Disease progression|22
799063|NCT00785785|2542177|P2|Optional Extension Phase|Death|5
799064|NCT00785785|2542178|P1|Optional Extension Phase|Death|1
799065|NCT00785785|2542177|P2|Optional Extension Phase|Administrative problems|0
799066|NCT00785785|2542178|P1|Optional Extension Phase|Administrative problems|2
799067|NCT00785785|2542177|P2|Optional Extension Phase|Lost to Follow-up|0
799068|NCT00785785|2542178|P1|Optional Extension Phase|Lost to Follow-up|1
799069|NCT00785785|2542177|P2|Optional Extension Phase|Withdrawal by Subject|6
799070|NCT00785785|2542178|P1|Optional Extension Phase|Withdrawal by Subject|6
799071|NCT00785785|2542177|P2|Optional Extension Phase|Adverse Event|5
799072|NCT00785785|2542178|P1|Optional Extension Phase|Adverse Event|4
799073|NCT00785785|2542177|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
799074|NCT00785785|2542178|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
799075|NCT00785785|2542177|P2|Core Phase up to 36 Months|Protocol deviation|6
799076|NCT00785785|2542178|P1|Core Phase up to 36 Months|Protocol deviation|5
799077|NCT00785785|2542177|P2|Core Phase up to 36 Months|Disease progression|119
799078|NCT00785785|2542178|P1|Core Phase up to 36 Months|Disease progression|139
799079|NCT00785785|2542177|P2|Core Phase up to 36 Months|Death|8
799080|NCT00785785|2542178|P1|Core Phase up to 36 Months|Death|5
799081|NCT00785785|2542177|P2|Core Phase up to 36 Months|Administrative problems|3
799082|NCT00785785|2542178|P1|Core Phase up to 36 Months|Administrative problems|3
799083|NCT00785785|2542177|P2|Core Phase up to 36 Months|Lost to Follow-up|7
799084|NCT00785785|2542178|P1|Core Phase up to 36 Months|Lost to Follow-up|3
799085|NCT00785785|2542177|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
799086|NCT00785785|2542178|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
799087|NCT00785785|2542177|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
799088|NCT00785785|2542178|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
799089|NCT00785785|2542177|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
799090|NCT00785785|2542178|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
799091|NCT00785785|2542177|P2|Core Phase up to 36 Months|Adverse Event|21
799092|NCT00785785|2542178|P1|Core Phase up to 36 Months|Adverse Event|31
799093|NCT00785785|2542177|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
799094|NCT00785785|2542178|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
799095|NCT00785980|2542191|P1|7 Day Washout Period|Protocol Violation|3
799096|NCT00786032|2542202|P1|Overall Study|Did not complete in the timeframe|6
799097|NCT00786032|2542202|P1|Overall Study|Withdrawal by Subject|14
799098|NCT00786032|2542202|P1|Overall Study|Death|4
799099|NCT00786188|2542214|P2|Overall Study|Withdrawal by Subject|0
799100|NCT00786188|2542215|P1|Overall Study|Withdrawal by Subject|2
799101|NCT00786188|2542214|P2|Overall Study|Adverse Event|1
799102|NCT00786188|2542215|P1|Overall Study|Adverse Event|3
799103|NCT00786422|2542241|P1|Follow-up Period|End-of-study done up to 4 days early|2
799104|NCT00786422|2542241|P1|Follow-up Period|Death|1
799105|NCT00786422|2542241|P1|Rivaroxaban Treatment|Adverse Event|2
799106|NCT00786422|2542241|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
799107|NCT00786422|2542241|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
799108|NCT00786422|2542241|P1|Rivaroxaban Treatment|Physician Decision|1
799109|NCT00786422|2542241|P1|Rivaroxaban Treatment|Lack of Efficacy|1
799110|NCT00786422|2542241|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
799111|NCT00786422|2542241|P1|Rivaroxaban Treatment|Death|2
799112|NCT00786474|2542259|P2|Overall Study|Not Specified|4
799113|NCT00786474|2542260|P1|Overall Study|Not Specified|4
799114|NCT00786474|2542259|P2|Overall Study|Physician Decision|1
799115|NCT00786474|2542260|P1|Overall Study|Physician Decision|2
799116|NCT00786474|2542259|P2|Overall Study|Lost to Follow-up|3
799117|NCT00786474|2542260|P1|Overall Study|Lost to Follow-up|3
799118|NCT00786474|2542259|P2|Overall Study|Withdrawal by Subject|31
799119|NCT00786474|2542260|P1|Overall Study|Withdrawal by Subject|23
799120|NCT00786474|2542259|P2|Overall Study|Death|4
799121|NCT00786474|2542260|P1|Overall Study|Death|5
799122|NCT00786565|2542289|P1|Post Surgery|Adapt AO implanted posterior side up|1
799123|NCT00786565|2542289|P1|Post Surgery|Abnormal macular pucker|1
799124|NCT00786565|2542289|P1|Enrollment Prior to Surgery|Protocol Violation|3
799125|NCT00786565|2542289|P1|Enrollment Prior to Surgery|Site Closed|3
799126|NCT00786799|2542348|P2|Overall Study|Lost to Follow-up|1
799127|NCT00786799|2542349|P1|Overall Study|Lost to Follow-up|1
799128|NCT00786838|2542360|P1|Overall Study|Withdrawal by Subject|4
799129|NCT00786838|2542360|P1|Overall Study|Progressive disease|31
799130|NCT00786838|2542360|P1|Overall Study|Adverse Event|6
799131|NCT00786838|2542360|P1|Overall Study|Death|4
799132|NCT00786838|2542360|P1|Overall Study|Physician Decision|4
799133|NCT00786864|2542387|P2|Overall Study|Sustained serious back injury|0
799134|NCT00786864|2542388|P1|Overall Study|Sustained serious back injury|1
799135|NCT00786864|2542387|P2|Overall Study|Lost to Follow-up|1
799136|NCT00786864|2542388|P1|Overall Study|Lost to Follow-up|0
799137|NCT00787137|2542456|P3|Overall Study|Study Termination|1
799138|NCT00787137|2542457|P2|Overall Study|Study Termination|0
799139|NCT00787137|2542458|P1|Overall Study|Study Termination|0
799140|NCT00787150|2542481|P3|Overall Study|Dosing incorrect study durg|0
799141|NCT00787150|2542482|P2|Overall Study|Dosing incorrect study durg|0
799142|NCT00787150|2542483|P1|Overall Study|Dosing incorrect study durg|2
799143|NCT00787150|2542481|P3|Overall Study|Withdrawal by Subject|0
799144|NCT00787150|2542482|P2|Overall Study|Withdrawal by Subject|1
799145|NCT00787150|2542483|P1|Overall Study|Withdrawal by Subject|2
799146|NCT00787150|2542481|P3|Overall Study|Physician Decision|1
799147|NCT00787150|2542482|P2|Overall Study|Physician Decision|2
799148|NCT00787150|2542483|P1|Overall Study|Physician Decision|1
799149|NCT00787150|2542481|P3|Overall Study|Adverse Event|4
799150|NCT00787150|2542482|P2|Overall Study|Adverse Event|4
799151|NCT00787150|2542483|P1|Overall Study|Adverse Event|4
799152|NCT00787189|2542527|P2|Overall Study|Lost to Follow-up|2
799153|NCT00787189|2542528|P1|Overall Study|Lost to Follow-up|2
799154|NCT00787202|2542539|P5|Overall Study|Randomized, not treated|0
799155|NCT00787202|2542540|P4|Overall Study|Randomized, not treated|0
799156|NCT00787202|2542541|P3|Overall Study|Randomized, not treated|0
799157|NCT00787202|2542542|P2|Overall Study|Randomized, not treated|0
799158|NCT00787202|2542543|P1|Overall Study|Randomized, not treated|1
799159|NCT00787202|2542539|P5|Overall Study|Protocol Violation|1
799160|NCT00787202|2542540|P4|Overall Study|Protocol Violation|0
799161|NCT00787202|2542541|P3|Overall Study|Protocol Violation|0
799162|NCT00787202|2542542|P2|Overall Study|Protocol Violation|1
799163|NCT00787202|2542543|P1|Overall Study|Protocol Violation|2
799164|NCT00787202|2542539|P5|Overall Study|Withdrawal by Subject|0
799165|NCT00787202|2542540|P4|Overall Study|Withdrawal by Subject|0
799166|NCT00787202|2542541|P3|Overall Study|Withdrawal by Subject|2
799167|NCT00787202|2542542|P2|Overall Study|Withdrawal by Subject|2
799168|NCT00787202|2542543|P1|Overall Study|Withdrawal by Subject|2
799169|NCT00787202|2542539|P5|Overall Study|Lost to Follow-up|0
799170|NCT00787202|2542540|P4|Overall Study|Lost to Follow-up|0
799171|NCT00787202|2542541|P3|Overall Study|Lost to Follow-up|0
799172|NCT00787202|2542542|P2|Overall Study|Lost to Follow-up|0
799173|NCT00787202|2542543|P1|Overall Study|Lost to Follow-up|1
799174|NCT00787202|2542539|P5|Overall Study|Lack of Efficacy|1
799175|NCT00787202|2542540|P4|Overall Study|Lack of Efficacy|2
799176|NCT00787202|2542541|P3|Overall Study|Lack of Efficacy|5
799177|NCT00787202|2542542|P2|Overall Study|Lack of Efficacy|6
799178|NCT00787202|2542543|P1|Overall Study|Lack of Efficacy|5
799179|NCT00787202|2542539|P5|Overall Study|Adverse Event|2
799180|NCT00787202|2542540|P4|Overall Study|Adverse Event|0
799181|NCT00787202|2542541|P3|Overall Study|Adverse Event|0
799182|NCT00787202|2542542|P2|Overall Study|Adverse Event|2
799183|NCT00787202|2542543|P1|Overall Study|Adverse Event|3
799184|NCT00787254|2542615|P2|Overall Study|Physician Decision|8
799185|NCT00787254|2542616|P1|Overall Study|Physician Decision|4
799186|NCT00787254|2542615|P2|Overall Study|Institution closed|0
799187|NCT00787254|2542616|P1|Overall Study|Institution closed|1
799188|NCT00787254|2542615|P2|Overall Study|NSAIDs discontinuation|2
799189|NCT00787254|2542616|P1|Overall Study|NSAIDs discontinuation|1
799190|NCT00787254|2542615|P2|Overall Study|Lack of Efficacy|15
799191|NCT00787254|2542616|P1|Overall Study|Lack of Efficacy|4
799192|NCT00787254|2542615|P2|Overall Study|Withdrawal by Subject|11
799193|NCT00787254|2542616|P1|Overall Study|Withdrawal by Subject|16
799194|NCT00787254|2542615|P2|Overall Study|Protocol Violation|23
799195|NCT00787254|2542616|P1|Overall Study|Protocol Violation|26
799196|NCT00787254|2542615|P2|Overall Study|Adverse Event|23
799197|NCT00787254|2542616|P1|Overall Study|Adverse Event|24
799198|NCT00787267|2542716|P1|Overall Study|Withdrawal by Subject|1
799199|NCT00787267|2542716|P1|Overall Study|No Reason Provided|1
799200|NCT00787267|2542716|P1|Overall Study|Screen failure/Ineligible|10
799201|NCT00787319|2542724|P1|Overall Study|Inactive disease|5
799202|NCT00787319|2542724|P1|Overall Study|Stabilized disease findings|3
799203|NCT00787319|2542724|P1|Overall Study|No health insurance reimbursement|2
799204|NCT00787319|2542724|P1|Overall Study|Unresponsiveness to visit invitation|1
799205|NCT00787319|2542724|P1|Overall Study|Budget exhausted/exceeded|1
799206|NCT00787319|2542724|P1|Overall Study|Lack of Efficacy|1
799207|NCT00787319|2542724|P1|Overall Study|Objective progression or relapse|30
799208|NCT00787319|2542724|P1|Overall Study|Adverse Event|3
799209|NCT00787319|2542724|P1|Overall Study|Withdrawal by Subject|15
799210|NCT00787319|2542724|P1|Overall Study|Lost to Follow-up|2
799211|NCT00787527|2542745|P1|Overall Study|Toxicity|3
799212|NCT00787566|2542756|P3|Overall Study|AE related to chemotherapy|0
799213|NCT00787566|2542757|P2|Overall Study|AE related to chemotherapy|1
799214|NCT00787566|2542758|P1|Overall Study|AE related to chemotherapy|0
799215|NCT00787605|2542768|P2|Overall Study|Lack of Efficacy|9
799216|NCT00787605|2542769|P1|Overall Study|Lack of Efficacy|13
799217|NCT00787605|2542768|P2|Overall Study|Withdrawal by Subject|13
799218|NCT00787605|2542769|P1|Overall Study|Withdrawal by Subject|6
799219|NCT00787605|2542768|P2|Overall Study|Protocol Violation|3
799220|NCT00787605|2542769|P1|Overall Study|Protocol Violation|7
799221|NCT00787605|2542768|P2|Overall Study|Lost to Follow-up|6
799222|NCT00787605|2542769|P1|Overall Study|Lost to Follow-up|3
799223|NCT00787605|2542768|P2|Overall Study|Adverse Event|25
799224|NCT00787605|2542769|P1|Overall Study|Adverse Event|14
799225|NCT00787605|2542768|P2|Overall Study|Administrative Problems|0
799226|NCT00787605|2542769|P1|Overall Study|Administrative Problems|3
799227|NCT00787644|2542800|P2|Overall Study|Withdrawal by Subject|1
799228|NCT00787644|2542801|P1|Overall Study|Withdrawal by Subject|1
799229|NCT00787644|2542800|P2|Overall Study|Lost to Follow-up|1
799230|NCT00787644|2542801|P1|Overall Study|Lost to Follow-up|1
799231|NCT00778817|2542807|P1|Overall Study|Withdrawal by Subject|2
799232|NCT00778817|2542807|P1|Overall Study|Adverse Event|2
799233|NCT00778830|2542824|P2|Overall Study|Ongoing at data cut-off|1
799234|NCT00778830|2542825|P1|Overall Study|Ongoing at data cut-off|0
799235|NCT00778895|2542844|P3|ESFU Phase|Unspecified|0
799236|NCT00778895|2542845|P2|ESFU Phase|Unspecified|0
799237|NCT00778895|2542846|P1|ESFU Phase|Unspecified|2
799238|NCT00778895|2542844|P3|ESFU Phase|Lost to Follow-up|2
799239|NCT00778895|2542845|P2|ESFU Phase|Lost to Follow-up|7
799240|NCT00778895|2542846|P1|ESFU Phase|Lost to Follow-up|6
799241|NCT00778895|2542844|P3|ESFU Phase|Withdrawal by Subject|0
799242|NCT00778895|2542845|P2|ESFU Phase|Withdrawal by Subject|4
799243|NCT00778895|2542846|P1|ESFU Phase|Withdrawal by Subject|1
799244|NCT00778895|2542844|P3|ESFU Phase|Adverse Event|0
799245|NCT00778895|2542845|P2|ESFU Phase|Adverse Event|1
799246|NCT00778895|2542846|P1|ESFU Phase|Adverse Event|2
799247|NCT00778895|2542844|P3|Active Phase|Unspecified|0
799248|NCT00778895|2542845|P2|Active Phase|Unspecified|0
799249|NCT00778895|2542846|P1|Active Phase|Unspecified|2
799250|NCT00778895|2542844|P3|Active Phase|Lost to Follow-up|0
799251|NCT00778895|2542845|P2|Active Phase|Lost to Follow-up|1
799252|NCT00778895|2542846|P1|Active Phase|Lost to Follow-up|1
799253|NCT00778895|2542844|P3|Active Phase|Withdrawal by Subject|0
799254|NCT00778895|2542845|P2|Active Phase|Withdrawal by Subject|4
799255|NCT00778895|2542846|P1|Active Phase|Withdrawal by Subject|1
799256|NCT00778895|2542844|P3|Active Phase|Adverse Event|0
799257|NCT00778895|2542845|P2|Active Phase|Adverse Event|1
799258|NCT00778895|2542846|P1|Active Phase|Adverse Event|3
799259|NCT00778921|2542887|P3|Overall Study|Not treated|2
799260|NCT00778921|2542888|P2|Overall Study|Not treated|2
799261|NCT00778921|2542889|P1|Overall Study|Not treated|0
799262|NCT00778921|2542887|P3|Overall Study|Protocol Violation|2
799263|NCT00778921|2542888|P2|Overall Study|Protocol Violation|0
799264|NCT00778921|2542889|P1|Overall Study|Protocol Violation|3
799265|NCT00778921|2542887|P3|Overall Study|Administrative Problems|0
799266|NCT00778921|2542888|P2|Overall Study|Administrative Problems|2
799267|NCT00778921|2542889|P1|Overall Study|Administrative Problems|1
799268|NCT00778921|2542887|P3|Overall Study|Lost to Follow-up|1
799269|NCT00778921|2542888|P2|Overall Study|Lost to Follow-up|2
799270|NCT00778921|2542889|P1|Overall Study|Lost to Follow-up|0
799271|NCT00778921|2542887|P3|Overall Study|Patient withdrew request|6
799272|NCT00778921|2542888|P2|Overall Study|Patient withdrew request|1
799273|NCT00778921|2542889|P1|Overall Study|Patient withdrew request|3
799274|NCT00778921|2542887|P3|Overall Study|Patient No Longer Requires Study Drug|0
799275|NCT00778921|2542888|P2|Overall Study|Patient No Longer Requires Study Drug|1
799276|NCT00778921|2542889|P1|Overall Study|Patient No Longer Requires Study Drug|0
799277|NCT00778921|2542887|P3|Overall Study|Unsatisfactory therapeutic response|1
799278|NCT00778921|2542888|P2|Overall Study|Unsatisfactory therapeutic response|1
799279|NCT00778921|2542889|P1|Overall Study|Unsatisfactory therapeutic response|1
799280|NCT00778921|2542887|P3|Overall Study|Abnormal Test Procedure Result(s)|2
799281|NCT00778921|2542888|P2|Overall Study|Abnormal Test Procedure Result(s)|0
799282|NCT00778921|2542889|P1|Overall Study|Abnormal Test Procedure Result(s)|0
799283|NCT00778921|2542887|P3|Overall Study|Abnormal Laboratory Value(s)|0
799284|NCT00778921|2542888|P2|Overall Study|Abnormal Laboratory Value(s)|0
799285|NCT00778921|2542889|P1|Overall Study|Abnormal Laboratory Value(s)|1
799286|NCT00778921|2542887|P3|Overall Study|Adverse Event|14
799287|NCT00778921|2542888|P2|Overall Study|Adverse Event|10
799288|NCT00778921|2542889|P1|Overall Study|Adverse Event|9
799289|NCT00778999|2542905|P2|Overall Study|Did not receive recFSH|20
799290|NCT00778999|2542906|P1|Overall Study|Did not receive recFSH|14
799291|NCT00778999|2542905|P2|Overall Study|Discontinuation: no embryo transfer|14
799292|NCT00778999|2542906|P1|Overall Study|Discontinuation: no embryo transfer|14
799293|NCT00779025|2542912|P1|Overall Study|Withdrawal by Subject|1
799294|NCT00779038|2542921|P1|Overall Study|Study Prematurely Terminated|13
799296|NCT00779246|2542953|P2|Overall Study|Missing sufficient data for analysis|53
799297|NCT00779246|2542954|P1|Overall Study|Missing sufficient data for analysis|33
799298|NCT00779259|2542960|P1|Quinine Alone|Adverse Event|2
799319|NCT00779506|2543059|P1|Overall Study|Lost to Follow-up|1
799320|NCT00779506|2543059|P1|Overall Study|Withdrawal by Subject|6
799321|NCT00779506|2543059|P1|Overall Study|Protocol Violation|5
799322|NCT00779506|2543059|P1|Overall Study|Lack of Efficacy|11
799323|NCT00779506|2543059|P1|Overall Study|Adverse Event|4
799324|NCT00779506|2543059|P1|Overall Study|Screening Failed|2
799325|NCT00779584|2543095|P9|Overall Study|Ongoing in Study|0
799326|NCT00779584|2543096|P8|Overall Study|Ongoing in Study|0
799327|NCT00779584|2543097|P7|Overall Study|Ongoing in Study|0
799328|NCT00779584|2543098|P6|Overall Study|Ongoing in Study|1
799329|NCT00779584|2543099|P5|Overall Study|Ongoing in Study|1
799330|NCT00779584|2543100|P4|Overall Study|Ongoing in Study|0
799331|NCT00779584|2543101|P3|Overall Study|Ongoing in Study|0
799332|NCT00779584|2543102|P2|Overall Study|Ongoing in Study|0
799333|NCT00779584|2543103|P1|Overall Study|Ongoing in Study|0
799334|NCT00779584|2543095|P9|Overall Study|Symptomatic Deterioration|0
799335|NCT00779584|2543096|P8|Overall Study|Symptomatic Deterioration|0
799336|NCT00779584|2543097|P7|Overall Study|Symptomatic Deterioration|1
799337|NCT00779584|2543098|P6|Overall Study|Symptomatic Deterioration|1
799338|NCT00779584|2543099|P5|Overall Study|Symptomatic Deterioration|0
799339|NCT00779584|2543100|P4|Overall Study|Symptomatic Deterioration|0
799340|NCT00779584|2543101|P3|Overall Study|Symptomatic Deterioration|1
799341|NCT00779584|2543102|P2|Overall Study|Symptomatic Deterioration|1
799342|NCT00779584|2543103|P1|Overall Study|Symptomatic Deterioration|1
799343|NCT00779584|2543095|P9|Overall Study|Adverse Event|1
799344|NCT00779584|2543096|P8|Overall Study|Adverse Event|1
799345|NCT00779584|2543097|P7|Overall Study|Adverse Event|2
799346|NCT00779584|2543098|P6|Overall Study|Adverse Event|0
799347|NCT00779584|2543099|P5|Overall Study|Adverse Event|0
799348|NCT00779584|2543100|P4|Overall Study|Adverse Event|0
799349|NCT00779584|2543101|P3|Overall Study|Adverse Event|2
799350|NCT00779584|2543102|P2|Overall Study|Adverse Event|0
799351|NCT00779584|2543103|P1|Overall Study|Adverse Event|1
799352|NCT00779584|2543095|P9|Overall Study|Progression of Disease|1
799353|NCT00779584|2543096|P8|Overall Study|Progression of Disease|2
799354|NCT00779584|2543097|P7|Overall Study|Progression of Disease|4
799355|NCT00779584|2543098|P6|Overall Study|Progression of Disease|1
799356|NCT00779584|2543099|P5|Overall Study|Progression of Disease|5
799357|NCT00779584|2543100|P4|Overall Study|Progression of Disease|6
799358|NCT00779584|2543101|P3|Overall Study|Progression of Disease|2
799359|NCT00779584|2543102|P2|Overall Study|Progression of Disease|1
799360|NCT00779584|2543103|P1|Overall Study|Progression of Disease|0
799361|NCT00779584|2543095|P9|Overall Study|Lost to Follow-up|0
799362|NCT00779584|2543096|P8|Overall Study|Lost to Follow-up|0
799363|NCT00779584|2543097|P7|Overall Study|Lost to Follow-up|0
799364|NCT00779584|2543098|P6|Overall Study|Lost to Follow-up|0
799365|NCT00779584|2543099|P5|Overall Study|Lost to Follow-up|1
799366|NCT00779584|2543100|P4|Overall Study|Lost to Follow-up|0
799367|NCT00779584|2543101|P3|Overall Study|Lost to Follow-up|0
799368|NCT00779584|2543102|P2|Overall Study|Lost to Follow-up|0
799369|NCT00779584|2543103|P1|Overall Study|Lost to Follow-up|0
799370|NCT00779584|2543095|P9|Overall Study|Withdrawal by Subject|0
799371|NCT00779584|2543096|P8|Overall Study|Withdrawal by Subject|0
799372|NCT00779584|2543097|P7|Overall Study|Withdrawal by Subject|1
799373|NCT00779584|2543098|P6|Overall Study|Withdrawal by Subject|2
799374|NCT00779584|2543099|P5|Overall Study|Withdrawal by Subject|0
799375|NCT00779584|2543100|P4|Overall Study|Withdrawal by Subject|0
799376|NCT00779584|2543101|P3|Overall Study|Withdrawal by Subject|2
799377|NCT00779584|2543102|P2|Overall Study|Withdrawal by Subject|1
799378|NCT00779584|2543103|P1|Overall Study|Withdrawal by Subject|1
799379|NCT00779584|2543095|P9|Overall Study|Protocol Violation|0
799380|NCT00779584|2543096|P8|Overall Study|Protocol Violation|0
799381|NCT00779584|2543097|P7|Overall Study|Protocol Violation|0
799382|NCT00779584|2543098|P6|Overall Study|Protocol Violation|1
799383|NCT00779584|2543099|P5|Overall Study|Protocol Violation|0
799384|NCT00779584|2543100|P4|Overall Study|Protocol Violation|0
799385|NCT00779584|2543101|P3|Overall Study|Protocol Violation|0
799386|NCT00779584|2543102|P2|Overall Study|Protocol Violation|0
799387|NCT00779584|2543103|P1|Overall Study|Protocol Violation|0
799388|NCT00779675|2543177|P1|Extended Treatment Period|Lost to Follow-up|6
799389|NCT00779675|2543177|P1|Extended Treatment Period|Protocol defined clinical event|1
799390|NCT00779675|2543177|P1|Extended Treatment Period|Treatment Failure|11
799391|NCT00779675|2543177|P1|Extended Treatment Period|Adverse Event|6
799392|NCT00779675|2543177|P1|Extended Treatment Period|Protocol Violation|13
799393|NCT00779675|2543177|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
799394|NCT00779675|2543177|P1|Treatment Period|Administrative|3
799395|NCT00779675|2543177|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
799396|NCT00779675|2543177|P1|Treatment Period|Protocol Violation|54
799397|NCT00779675|2543177|P1|Treatment Period|Withdrawal by Subject|46
799398|NCT00779675|2543177|P1|Treatment Period|Lost to Follow-up|23
799399|NCT00779675|2543177|P1|Treatment Period|Transferred to Another Study|38
799400|NCT00779675|2543177|P1|Treatment Period|Treatment Failure|80
799401|NCT00779675|2543177|P1|Treatment Period|Adverse Event|87
799402|NCT00779766|2543202|P2|Overall Study|Withdrawal by Subject|67
799403|NCT00779766|2543203|P1|Overall Study|Withdrawal by Subject|84
799404|NCT00779766|2543202|P2|Overall Study|Protocol Violation|1
799405|NCT00779766|2543203|P1|Overall Study|Protocol Violation|1
799406|NCT00779779|2543281|P1|Overall Study|Lost to Follow-up|5
799407|NCT00779779|2543281|P1|Overall Study|Withdrawal by Subject|4
799408|NCT00779779|2543281|P1|Overall Study|Protocol Violation|14
799409|NCT00779779|2543281|P1|Overall Study|Adverse Event|1
799410|NCT00779857|2543288|P1|Overall Study|Missed Visit|2
799411|NCT00779857|2543288|P1|Overall Study|Withdrawal by Subject|3
799412|NCT00779857|2543288|P1|Overall Study|Death|1
799413|NCT00779909|2543297|P4|Overall Study|Withdrawal by Subject|0
799414|NCT00779909|2543298|P3|Overall Study|Withdrawal by Subject|0
799415|NCT00779909|2543299|P2|Overall Study|Withdrawal by Subject|1
799416|NCT00779909|2543300|P1|Overall Study|Withdrawal by Subject|0
799417|NCT00779909|2543297|P4|Overall Study|Lost to Follow-up|1
799418|NCT00779909|2543298|P3|Overall Study|Lost to Follow-up|0
799419|NCT00779909|2543299|P2|Overall Study|Lost to Follow-up|0
799420|NCT00779909|2543300|P1|Overall Study|Lost to Follow-up|1
799421|NCT00780273|2543342|P1|Overall Study|Lost to Follow-up|1
799422|NCT00780273|2543342|P1|Overall Study|Death|1
799423|NCT00780416|2543392|P2|Overall Study|Withdrawal by Subject|6
799424|NCT00780416|2543393|P1|Overall Study|Withdrawal by Subject|8
799425|NCT00780416|2543392|P2|Overall Study|Protocol Violation|0
799426|NCT00780416|2543393|P1|Overall Study|Protocol Violation|1
799427|NCT00780416|2543392|P2|Overall Study|Physician Decision|3
799428|NCT00780416|2543393|P1|Overall Study|Physician Decision|3
799429|NCT00787787|2543444|P1|Overall Study|Adverse Event|3
799430|NCT00787787|2543444|P1|Overall Study|Lack of Efficacy|4
799431|NCT00787800|2543452|P2|Overall Study|Death|2
799432|NCT00787800|2543453|P1|Overall Study|Death|0
799433|NCT00787800|2543452|P2|Overall Study|Withdrawal by Subject|5
799434|NCT00787800|2543453|P1|Overall Study|Withdrawal by Subject|3
799435|NCT00787839|2543469|P1|Overall Study|Failure to have the OGTT was most common|404
799436|NCT00787891|2543501|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
799437|NCT00787891|2543502|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
799438|NCT00787891|2543501|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
799439|NCT00787891|2543502|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
799440|NCT00787891|2543501|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
799441|NCT00787891|2543502|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
799442|NCT00787891|2543501|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
799443|NCT00787891|2543502|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
799444|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
799445|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
799446|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
799447|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
799448|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
799449|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
799450|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
799451|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
799452|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
799453|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
799454|NCT00787891|2543501|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
799455|NCT00787891|2543502|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
799456|NCT00787917|2543533|P2|Open Label|Administrative problems|0
799457|NCT00787917|2543534|P1|Open Label|Administrative problems|3
799458|NCT00787917|2543533|P2|Open Label|Unsatisfactory therapeutic effect|0
799459|NCT00787917|2543534|P1|Open Label|Unsatisfactory therapeutic effect|1
799460|NCT00787917|2543533|P2|Blinded Treatment|Administrative problems|2
799461|NCT00787917|2543534|P1|Blinded Treatment|Administrative problems|3
799462|NCT00787917|2543533|P2|Blinded Treatment|Lack of Efficacy|0
799463|NCT00787917|2543534|P1|Blinded Treatment|Lack of Efficacy|1
799464|NCT00787917|2543533|P2|Blinded Treatment|Adverse Event|0
799465|NCT00787917|2543534|P1|Blinded Treatment|Adverse Event|1
799466|NCT00787930|2543551|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
799467|NCT00788073|2543583|P2|Placebo Then STX209|Protocol Violation|1
799468|NCT00788073|2543584|P1|Placebo Then STX209|Protocol Violation|0
799469|NCT00788073|2543583|P2|Placebo Then STX209|Adverse Event|0
799470|NCT00788073|2543584|P1|Placebo Then STX209|Adverse Event|2
799471|NCT00788073|2543583|P2|STX209 Then Placebo|unable to return due to travel|1
799472|NCT00788073|2543584|P1|STX209 Then Placebo|unable to return due to travel|0
799473|NCT00788073|2543583|P2|STX209 Then Placebo|Withdrawal by Subject|1
799474|NCT00788073|2543584|P1|STX209 Then Placebo|Withdrawal by Subject|0
799475|NCT00788073|2543583|P2|STX209 Then Placebo|Lost to Follow-up|1
799476|NCT00788073|2543584|P1|STX209 Then Placebo|Lost to Follow-up|0
799477|NCT00788073|2543583|P2|STX209 Then Placebo|Adverse Event|0
799478|NCT00788073|2543584|P1|STX209 Then Placebo|Adverse Event|1
799479|NCT00791479|2543598|P6|Overall Study|Withdrawal by Subject|1
799480|NCT00791479|2543599|P5|Overall Study|Withdrawal by Subject|0
799481|NCT00791479|2543600|P4|Overall Study|Withdrawal by Subject|1
799482|NCT00791479|2543601|P3|Overall Study|Withdrawal by Subject|0
799483|NCT00791479|2543602|P2|Overall Study|Withdrawal by Subject|0
799484|NCT00791479|2543603|P1|Overall Study|Withdrawal by Subject|0
799485|NCT00791479|2543598|P6|Overall Study|Protocol Violation|0
799486|NCT00791479|2543599|P5|Overall Study|Protocol Violation|0
799487|NCT00791479|2543600|P4|Overall Study|Protocol Violation|1
799488|NCT00791479|2543601|P3|Overall Study|Protocol Violation|0
799489|NCT00791479|2543602|P2|Overall Study|Protocol Violation|1
799490|NCT00791479|2543603|P1|Overall Study|Protocol Violation|2
799491|NCT00791479|2543598|P6|Overall Study|Lost to Follow-up|1
799492|NCT00791479|2543599|P5|Overall Study|Lost to Follow-up|0
799493|NCT00791479|2543600|P4|Overall Study|Lost to Follow-up|0
799494|NCT00791479|2543601|P3|Overall Study|Lost to Follow-up|0
799495|NCT00791479|2543602|P2|Overall Study|Lost to Follow-up|1
799496|NCT00791479|2543603|P1|Overall Study|Lost to Follow-up|0
799497|NCT00791479|2543598|P6|Overall Study|Adverse Event|1
799498|NCT00791479|2543599|P5|Overall Study|Adverse Event|0
799499|NCT00791479|2543600|P4|Overall Study|Adverse Event|2
799500|NCT00791479|2543601|P3|Overall Study|Adverse Event|0
799501|NCT00791479|2543602|P2|Overall Study|Adverse Event|1
799502|NCT00791479|2543603|P1|Overall Study|Adverse Event|0
799503|NCT00791479|2543598|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
799504|NCT00791479|2543599|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
799505|NCT00791479|2543600|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
799506|NCT00791479|2543601|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
799507|NCT00791479|2543602|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
799508|NCT00791479|2543603|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
799509|NCT00791492|2543699|P2|Overall Study|Liver transplantation|1
799510|NCT00791492|2543700|P1|Overall Study|Liver transplantation|5
799511|NCT00791492|2543699|P2|Overall Study|Withdrawal by Subject|2
799512|NCT00791492|2543700|P1|Overall Study|Withdrawal by Subject|1
799513|NCT00791518|2543742|P1|Overall Study|Protocol Violation|93
799514|NCT00791557|2543768|P1|Overall Study|Adverse Event|1
799519|NCT00791661|2543794|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
799520|NCT00791661|2543795|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
799521|NCT00791661|2543796|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
799522|NCT00791661|2543794|P3|7 Day Wash-out|Adverse Event|1
799523|NCT00791661|2543795|P2|7 Day Wash-out|Adverse Event|0
799524|NCT00791661|2543796|P1|7 Day Wash-out|Adverse Event|0
799545|NCT00791765|2543981|P2|Weeks 13 to 24|Other|1
799546|NCT00791765|2543982|P1|Weeks 13 to 24|Other|0
799547|NCT00791765|2543981|P2|Weeks 13 to 24|Lost to Follow-up|2
799548|NCT00791765|2543982|P1|Weeks 13 to 24|Lost to Follow-up|1
799549|NCT00791765|2543981|P2|Weeks 13 to 24|Disease progression|1
799550|NCT00791765|2543982|P1|Weeks 13 to 24|Disease progression|0
799551|NCT00791765|2543981|P2|Weeks 13 to 24|Withdrawal by Subject|1
799552|NCT00791765|2543982|P1|Weeks 13 to 24|Withdrawal by Subject|2
799553|NCT00791765|2543981|P2|Weeks 13 to 24|Adverse Event|3
799554|NCT00791765|2543982|P1|Weeks 13 to 24|Adverse Event|0
799555|NCT00791765|2543981|P2|Weeks 13 to 24|Protocol deviation|0
799556|NCT00791765|2543982|P1|Weeks 13 to 24|Protocol deviation|2
799557|NCT00791765|2543981|P2|Weeks 1 to 12|Ineligibility determined|3
799558|NCT00791765|2543982|P1|Weeks 1 to 12|Ineligibility determined|0
799559|NCT00791765|2543981|P2|Weeks 1 to 12|Disease progression|0
799560|NCT00791765|2543982|P1|Weeks 1 to 12|Disease progression|3
799561|NCT00791765|2543981|P2|Weeks 1 to 12|Physician Decision|0
799562|NCT00791765|2543982|P1|Weeks 1 to 12|Physician Decision|1
799563|NCT00791765|2543981|P2|Weeks 1 to 12|Withdrawal by Subject|0
799564|NCT00791765|2543982|P1|Weeks 1 to 12|Withdrawal by Subject|3
799565|NCT00791765|2543981|P2|Weeks 1 to 12|Lost to Follow-up|0
799566|NCT00791765|2543982|P1|Weeks 1 to 12|Lost to Follow-up|1
799567|NCT00791765|2543981|P2|Weeks 1 to 12|Adverse Event|1
799568|NCT00791765|2543982|P1|Weeks 1 to 12|Adverse Event|0
799569|NCT00791778|2543995|P2|Follow-up|Lost to Follow-up|1
799570|NCT00791778|2543996|P1|Follow-up|Lost to Follow-up|2
799571|NCT00791778|2543995|P2|Follow-up|Withdrawal by Subject|0
799572|NCT00791778|2543996|P1|Follow-up|Withdrawal by Subject|3
799573|NCT00791778|2543995|P2|Double-blind Treatment|Non-compliant with study medication|0
799574|NCT00791778|2543996|P1|Double-blind Treatment|Non-compliant with study medication|2
799575|NCT00791778|2543995|P2|Double-blind Treatment|Withdrawal by Subject|9
799576|NCT00791778|2543996|P1|Double-blind Treatment|Withdrawal by Subject|20
799577|NCT00791778|2543995|P2|Double-blind Treatment|Protocol Violation|4
799578|NCT00791778|2543996|P1|Double-blind Treatment|Protocol Violation|0
799579|NCT00791778|2543995|P2|Double-blind Treatment|Physician Decision|26
799580|NCT00791778|2543996|P1|Double-blind Treatment|Physician Decision|6
799581|NCT00791778|2543995|P2|Double-blind Treatment|Adverse Event|9
799582|NCT00791778|2543996|P1|Double-blind Treatment|Adverse Event|49
799583|NCT00791921|2544067|P2|Overall Study|Reason other than those above|1
799584|NCT00791921|2544068|P1|Overall Study|Reason other than those above|0
799585|NCT00791921|2544067|P2|Overall Study|Lack of study drug administration|1
799586|NCT00791921|2544068|P1|Overall Study|Lack of study drug administration|1
799587|NCT00791921|2544067|P2|Overall Study|Lack of Efficacy|2
799588|NCT00791921|2544068|P1|Overall Study|Lack of Efficacy|0
799589|NCT00791921|2544067|P2|Overall Study|Adverse Event|2
799590|NCT00791921|2544068|P1|Overall Study|Adverse Event|8
799591|NCT00791921|2544067|P2|Overall Study|Withdrawal by Subject|2
799592|NCT00791921|2544068|P1|Overall Study|Withdrawal by Subject|1
799593|NCT00791921|2544067|P2|Overall Study|Protocol planed|88
799594|NCT00791921|2544068|P1|Overall Study|Protocol planed|24
799595|NCT00791934|2544076|P1|Overall Study|Did not consent for extended follow-up|13
799596|NCT00791934|2544076|P1|Overall Study|Withdrawal by Subject|2
799597|NCT00791999|2544099|P4|Overall Study|Reason other than those above|0
799598|NCT00791999|2544100|P3|Overall Study|Reason other than those above|1
799599|NCT00791999|2544101|P2|Overall Study|Reason other than those above|0
799600|NCT00791999|2544102|P1|Overall Study|Reason other than those above|1
799601|NCT00791999|2544099|P4|Overall Study|Lack of Efficacy|2
799602|NCT00791999|2544100|P3|Overall Study|Lack of Efficacy|0
799603|NCT00791999|2544101|P2|Overall Study|Lack of Efficacy|1
799604|NCT00791999|2544102|P1|Overall Study|Lack of Efficacy|0
799605|NCT00791999|2544099|P4|Overall Study|Adverse Event|3
799606|NCT00791999|2544100|P3|Overall Study|Adverse Event|7
799607|NCT00791999|2544101|P2|Overall Study|Adverse Event|3
799608|NCT00791999|2544102|P1|Overall Study|Adverse Event|3
799609|NCT00791999|2544099|P4|Overall Study|Protocol Violation|0
799610|NCT00791999|2544100|P3|Overall Study|Protocol Violation|1
799611|NCT00791999|2544101|P2|Overall Study|Protocol Violation|0
799612|NCT00791999|2544102|P1|Overall Study|Protocol Violation|3
799613|NCT00791999|2544099|P4|Overall Study|Withdrawal by Subject|2
799614|NCT00791999|2544100|P3|Overall Study|Withdrawal by Subject|0
799615|NCT00791999|2544101|P2|Overall Study|Withdrawal by Subject|1
799616|NCT00791999|2544102|P1|Overall Study|Withdrawal by Subject|0
799617|NCT00791999|2544099|P4|Overall Study|Protocol planed withdrawal|45
799618|NCT00791999|2544100|P3|Overall Study|Protocol planed withdrawal|11
799619|NCT00791999|2544101|P2|Overall Study|Protocol planed withdrawal|11
799620|NCT00791999|2544102|P1|Overall Study|Protocol planed withdrawal|14
799621|NCT00792103|2544116|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
799622|NCT00792103|2544116|P1|Overall Study|Protocol Violation|10
799623|NCT00792103|2544116|P1|Overall Study|Withdrawal by Subject|52
799624|NCT00792103|2544116|P1|Overall Study|Adverse Event|25
799625|NCT00792103|2544116|P1|Overall Study|Lost to Follow-up|17
799626|NCT00792103|2544116|P1|Overall Study|Enrolled, not treated|15
799627|NCT00792116|2544126|P2|Overall Study|Discontnued intervention|0
799628|NCT00792116|2544127|P1|Overall Study|Discontnued intervention|1
799629|NCT00792116|2544126|P2|Overall Study|Lost to Follow-up|1
799630|NCT00792116|2544127|P1|Overall Study|Lost to Follow-up|0
799631|NCT00792259|2544140|P3|Overall Study|Poor Quality Scans|0
799632|NCT00792259|2544141|P2|Overall Study|Poor Quality Scans|0
799633|NCT00792259|2544142|P1|Overall Study|Poor Quality Scans|1
799634|NCT00792298|2544150|P8|Treatment Period 2|Withdrawal by Subject|2
799635|NCT00792298|2544151|P7|Treatment Period 2|Withdrawal by Subject|0
799636|NCT00792298|2544152|P6|Treatment Period 2|Withdrawal by Subject|0
799637|NCT00792298|2544153|P5|Treatment Period 2|Withdrawal by Subject|1
799638|NCT00792298|2544154|P4|Treatment Period 2|Withdrawal by Subject|2
799639|NCT00792298|2544155|P3|Treatment Period 2|Withdrawal by Subject|0
799640|NCT00792298|2544156|P2|Treatment Period 2|Withdrawal by Subject|1
799641|NCT00792298|2544157|P1|Treatment Period 2|Withdrawal by Subject|1
799642|NCT00792298|2544150|P8|Treatment Period 2|Pregnancy|0
799643|NCT00792298|2544151|P7|Treatment Period 2|Pregnancy|0
799644|NCT00792298|2544152|P6|Treatment Period 2|Pregnancy|0
799645|NCT00792298|2544153|P5|Treatment Period 2|Pregnancy|0
799646|NCT00792298|2544154|P4|Treatment Period 2|Pregnancy|0
799647|NCT00792298|2544155|P3|Treatment Period 2|Pregnancy|1
799648|NCT00792298|2544156|P2|Treatment Period 2|Pregnancy|0
799649|NCT00792298|2544157|P1|Treatment Period 2|Pregnancy|0
799650|NCT00792298|2544150|P8|Treatment Period 2|Physician Decision|0
799651|NCT00792298|2544151|P7|Treatment Period 2|Physician Decision|1
799652|NCT00792298|2544152|P6|Treatment Period 2|Physician Decision|0
799653|NCT00792298|2544153|P5|Treatment Period 2|Physician Decision|0
799654|NCT00792298|2544154|P4|Treatment Period 2|Physician Decision|0
799655|NCT00792298|2544155|P3|Treatment Period 2|Physician Decision|0
799656|NCT00792298|2544156|P2|Treatment Period 2|Physician Decision|0
799657|NCT00792298|2544157|P1|Treatment Period 2|Physician Decision|0
799658|NCT00792298|2544150|P8|Treatment Period 2|Lack of Efficacy|0
799659|NCT00792298|2544151|P7|Treatment Period 2|Lack of Efficacy|0
799660|NCT00792298|2544152|P6|Treatment Period 2|Lack of Efficacy|0
799661|NCT00792298|2544153|P5|Treatment Period 2|Lack of Efficacy|1
799662|NCT00792298|2544154|P4|Treatment Period 2|Lack of Efficacy|0
799663|NCT00792298|2544155|P3|Treatment Period 2|Lack of Efficacy|0
799664|NCT00792298|2544156|P2|Treatment Period 2|Lack of Efficacy|0
799665|NCT00792298|2544157|P1|Treatment Period 2|Lack of Efficacy|0
799666|NCT00792298|2544150|P8|Washout|Withdrawal by Subject|0
799667|NCT00792298|2544151|P7|Washout|Withdrawal by Subject|0
799668|NCT00792298|2544152|P6|Washout|Withdrawal by Subject|1
799669|NCT00792298|2544153|P5|Washout|Withdrawal by Subject|0
799670|NCT00792298|2544154|P4|Washout|Withdrawal by Subject|0
799671|NCT00792298|2544155|P3|Washout|Withdrawal by Subject|1
799672|NCT00792298|2544156|P2|Washout|Withdrawal by Subject|0
799673|NCT00792298|2544157|P1|Washout|Withdrawal by Subject|0
799674|NCT00792298|2544150|P8|Washout|Adverse Event|0
799675|NCT00792298|2544151|P7|Washout|Adverse Event|0
799676|NCT00792298|2544152|P6|Washout|Adverse Event|1
799677|NCT00792298|2544153|P5|Washout|Adverse Event|0
799678|NCT00792298|2544154|P4|Washout|Adverse Event|0
799679|NCT00792298|2544155|P3|Washout|Adverse Event|0
799680|NCT00792298|2544156|P2|Washout|Adverse Event|0
799681|NCT00792298|2544157|P1|Washout|Adverse Event|0
799682|NCT00792298|2544150|P8|Treatment Period 1|Protocol Violation|1
799683|NCT00792298|2544151|P7|Treatment Period 1|Protocol Violation|0
799684|NCT00792298|2544152|P6|Treatment Period 1|Protocol Violation|0
799685|NCT00792298|2544153|P5|Treatment Period 1|Protocol Violation|0
799686|NCT00792298|2544154|P4|Treatment Period 1|Protocol Violation|0
799687|NCT00792298|2544155|P3|Treatment Period 1|Protocol Violation|0
799688|NCT00792298|2544156|P2|Treatment Period 1|Protocol Violation|0
799689|NCT00792298|2544157|P1|Treatment Period 1|Protocol Violation|0
799690|NCT00792298|2544150|P8|Treatment Period 1|Physician Decision|0
799691|NCT00792298|2544151|P7|Treatment Period 1|Physician Decision|1
799692|NCT00792298|2544152|P6|Treatment Period 1|Physician Decision|0
799693|NCT00792298|2544153|P5|Treatment Period 1|Physician Decision|0
799694|NCT00792298|2544154|P4|Treatment Period 1|Physician Decision|1
799695|NCT00792298|2544155|P3|Treatment Period 1|Physician Decision|0
799696|NCT00792298|2544156|P2|Treatment Period 1|Physician Decision|0
799697|NCT00792298|2544157|P1|Treatment Period 1|Physician Decision|0
799698|NCT00792298|2544150|P8|Treatment Period 1|Lost to Follow-up|0
799699|NCT00792298|2544151|P7|Treatment Period 1|Lost to Follow-up|1
799700|NCT00792298|2544152|P6|Treatment Period 1|Lost to Follow-up|0
799701|NCT00792298|2544153|P5|Treatment Period 1|Lost to Follow-up|0
799702|NCT00792298|2544154|P4|Treatment Period 1|Lost to Follow-up|0
799703|NCT00792298|2544155|P3|Treatment Period 1|Lost to Follow-up|0
799704|NCT00792298|2544156|P2|Treatment Period 1|Lost to Follow-up|0
799705|NCT00792298|2544157|P1|Treatment Period 1|Lost to Follow-up|0
799706|NCT00792298|2544150|P8|Treatment Period 1|Withdrawal by Subject|0
799707|NCT00792298|2544151|P7|Treatment Period 1|Withdrawal by Subject|1
799708|NCT00792298|2544152|P6|Treatment Period 1|Withdrawal by Subject|2
799709|NCT00792298|2544153|P5|Treatment Period 1|Withdrawal by Subject|0
799710|NCT00792298|2544154|P4|Treatment Period 1|Withdrawal by Subject|2
799711|NCT00792298|2544155|P3|Treatment Period 1|Withdrawal by Subject|1
799712|NCT00792298|2544156|P2|Treatment Period 1|Withdrawal by Subject|0
799713|NCT00792298|2544157|P1|Treatment Period 1|Withdrawal by Subject|1
799714|NCT00792298|2544150|P8|Treatment Period 1|Lack of Efficacy|0
799715|NCT00792298|2544151|P7|Treatment Period 1|Lack of Efficacy|0
799716|NCT00792298|2544152|P6|Treatment Period 1|Lack of Efficacy|0
799717|NCT00792298|2544153|P5|Treatment Period 1|Lack of Efficacy|0
799718|NCT00792298|2544154|P4|Treatment Period 1|Lack of Efficacy|0
799719|NCT00792298|2544155|P3|Treatment Period 1|Lack of Efficacy|1
799720|NCT00792298|2544156|P2|Treatment Period 1|Lack of Efficacy|0
799721|NCT00792298|2544157|P1|Treatment Period 1|Lack of Efficacy|0
799722|NCT00792298|2544150|P8|Treatment Period 1|Adverse Event|0
799723|NCT00792298|2544151|P7|Treatment Period 1|Adverse Event|1
799724|NCT00792298|2544152|P6|Treatment Period 1|Adverse Event|1
799725|NCT00792298|2544153|P5|Treatment Period 1|Adverse Event|0
799726|NCT00792298|2544154|P4|Treatment Period 1|Adverse Event|1
799727|NCT00792298|2544155|P3|Treatment Period 1|Adverse Event|0
799728|NCT00792298|2544156|P2|Treatment Period 1|Adverse Event|1
799729|NCT00792298|2544157|P1|Treatment Period 1|Adverse Event|0
799730|NCT00792623|2544199|P1|Overall Study|Withdrawal by Subject|5
799731|NCT00792623|2544199|P1|Overall Study|Adverse Event|2
799732|NCT00792636|2544215|P3|Overall Study|Investigator Discretion|2
799733|NCT00792636|2544216|P2|Overall Study|Investigator Discretion|0
799734|NCT00792636|2544217|P1|Overall Study|Investigator Discretion|2
799735|NCT00792636|2544215|P3|Overall Study|Adverse Event|3
799736|NCT00792636|2544216|P2|Overall Study|Adverse Event|2
799737|NCT00792636|2544217|P1|Overall Study|Adverse Event|4
799738|NCT00792636|2544215|P3|Overall Study|Lack of Efficacy|13
799739|NCT00792636|2544216|P2|Overall Study|Lack of Efficacy|4
799740|NCT00792636|2544217|P1|Overall Study|Lack of Efficacy|3
799741|NCT00792636|2544215|P3|Overall Study|Withdrew Consent|9
799742|NCT00792636|2544216|P2|Overall Study|Withdrew Consent|13
799743|NCT00792636|2544217|P1|Overall Study|Withdrew Consent|10
799744|NCT00792636|2544215|P3|Overall Study|Lost to Follow-up|14
799745|NCT00792636|2544216|P2|Overall Study|Lost to Follow-up|19
799746|NCT00792636|2544217|P1|Overall Study|Lost to Follow-up|13
799747|NCT00792636|2544215|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
799748|NCT00792636|2544216|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
799749|NCT00792636|2544217|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
799750|NCT00792636|2544215|P3|Overall Study|Protocol Violation|20
799751|NCT00792636|2544216|P2|Overall Study|Protocol Violation|23
799752|NCT00792636|2544217|P1|Overall Study|Protocol Violation|17
799753|NCT00792701|2544272|P2|Overall Study|Not protocol specified|0
799754|NCT00792701|2544273|P1|Overall Study|Not protocol specified|17
799755|NCT00792701|2544272|P2|Overall Study|Withdrawal by Subject|19
799756|NCT00792701|2544273|P1|Overall Study|Withdrawal by Subject|1
799757|NCT00792701|2544272|P2|Overall Study|Ineligible|3
799758|NCT00792701|2544273|P1|Overall Study|Ineligible|1
799759|NCT00792701|2544272|P2|Overall Study|Adverse Event|22
799760|NCT00792701|2544273|P1|Overall Study|Adverse Event|0
799761|NCT00792805|2544287|P3|Overall Study|Protocol deviation|1
799762|NCT00792805|2544288|P2|Overall Study|Protocol deviation|1
799763|NCT00792805|2544289|P1|Overall Study|Protocol deviation|0
799764|NCT00792805|2544287|P3|Overall Study|Abnormal laboratory value(s)|1
799765|NCT00792805|2544288|P2|Overall Study|Abnormal laboratory value(s)|0
799766|NCT00792805|2544289|P1|Overall Study|Abnormal laboratory value(s)|0
799767|NCT00792805|2544287|P3|Overall Study|Lost to Follow-up|6
799768|NCT00792805|2544288|P2|Overall Study|Lost to Follow-up|1
799769|NCT00792805|2544289|P1|Overall Study|Lost to Follow-up|1
799770|NCT00792805|2544287|P3|Overall Study|Unsatisfactory therapeutic effect|6
799771|NCT00792805|2544288|P2|Overall Study|Unsatisfactory therapeutic effect|6
799772|NCT00792805|2544289|P1|Overall Study|Unsatisfactory therapeutic effect|1
799773|NCT00792805|2544287|P3|Overall Study|Abnormal test procedure result(s)|0
799774|NCT00792805|2544288|P2|Overall Study|Abnormal test procedure result(s)|2
799775|NCT00792805|2544289|P1|Overall Study|Abnormal test procedure result(s)|1
799776|NCT00792805|2544287|P3|Overall Study|Administrative problems|4
799777|NCT00792805|2544288|P2|Overall Study|Administrative problems|0
799778|NCT00792805|2544289|P1|Overall Study|Administrative problems|2
799779|NCT00792805|2544287|P3|Overall Study|Subject withdrew consent|5
799780|NCT00792805|2544288|P2|Overall Study|Subject withdrew consent|6
799781|NCT00792805|2544289|P1|Overall Study|Subject withdrew consent|5
799782|NCT00792805|2544287|P3|Overall Study|Adverse Event|10
799783|NCT00792805|2544288|P2|Overall Study|Adverse Event|10
799784|NCT00792805|2544289|P1|Overall Study|Adverse Event|12
799785|NCT00792935|2544320|P2|Overall Study|Withdrawal by Subject|1
799786|NCT00792935|2544321|P1|Overall Study|Withdrawal by Subject|0
799787|NCT00792935|2544320|P2|Overall Study|Protocol Violation|0
799788|NCT00792935|2544321|P1|Overall Study|Protocol Violation|2
799789|NCT00792935|2544320|P2|Overall Study|Lost to Follow-up|1
799790|NCT00792935|2544321|P1|Overall Study|Lost to Follow-up|0
799791|NCT00792935|2544320|P2|Overall Study|Adverse Event|1
799792|NCT00792935|2544321|P1|Overall Study|Adverse Event|2
799800|NCT00793104|2544338|P1|Overall Study|Lost to Follow-up|1
799801|NCT00793325|2544354|P1|Overall Study|Lost to Follow-up|1
799802|NCT00793325|2544354|P1|Overall Study|Protocol Violation|18
799803|NCT00793403|2544378|P1|Overall Study|Unspecified|73
799804|NCT00793546|2544449|P2|Overall Study|Unspecified|0
799805|NCT00793546|2544450|P1|Overall Study|Unspecified|1
799806|NCT00793546|2544449|P2|Overall Study|Study Terminated by Sponsor|27
799807|NCT00793546|2544450|P1|Overall Study|Study Terminated by Sponsor|8
799808|NCT00793546|2544449|P2|Overall Study|Withdrawal by Subject|1
799809|NCT00793546|2544450|P1|Overall Study|Withdrawal by Subject|1
799810|NCT00793546|2544449|P2|Overall Study|Lost to Follow-up|0
799811|NCT00793546|2544450|P1|Overall Study|Lost to Follow-up|1
799812|NCT00793546|2544449|P2|Overall Study|Death|0
799813|NCT00793546|2544450|P1|Overall Study|Death|3
799814|NCT00793585|2544489|P2|Overall Study|Protocol Violation|2
799815|NCT00793585|2544490|P1|Overall Study|Protocol Violation|1
799816|NCT00793585|2544489|P2|Overall Study|Adverse Event|1
799817|NCT00793585|2544490|P1|Overall Study|Adverse Event|1
799818|NCT00793624|2544515|P4|Overall Study|Other reason not described above|3
799819|NCT00793624|2544516|P3|Overall Study|Other reason not described above|6
799820|NCT00793624|2544517|P2|Overall Study|Other reason not described above|4
799821|NCT00793624|2544518|P1|Overall Study|Other reason not described above|6
799822|NCT00793624|2544515|P4|Overall Study|Non compliance with protocol|3
799823|NCT00793624|2544516|P3|Overall Study|Non compliance with protocol|2
799824|NCT00793624|2544517|P2|Overall Study|Non compliance with protocol|3
799825|NCT00793624|2544518|P1|Overall Study|Non compliance with protocol|2
799826|NCT00793624|2544515|P4|Overall Study|Lack of Efficacy|3
799827|NCT00793624|2544516|P3|Overall Study|Lack of Efficacy|1
799828|NCT00793624|2544517|P2|Overall Study|Lack of Efficacy|2
799829|NCT00793624|2544518|P1|Overall Study|Lack of Efficacy|9
799830|NCT00793624|2544515|P4|Overall Study|Withdrawal by Subject|14
799831|NCT00793624|2544516|P3|Overall Study|Withdrawal by Subject|11
799832|NCT00793624|2544517|P2|Overall Study|Withdrawal by Subject|9
799833|NCT00793624|2544518|P1|Overall Study|Withdrawal by Subject|20
799834|NCT00793624|2544515|P4|Overall Study|Lost to Follow-up|0
799835|NCT00793624|2544516|P3|Overall Study|Lost to Follow-up|4
799836|NCT00793624|2544517|P2|Overall Study|Lost to Follow-up|2
799837|NCT00793624|2544518|P1|Overall Study|Lost to Follow-up|2
799838|NCT00793624|2544515|P4|Overall Study|Adverse Event|20
799839|NCT00793624|2544516|P3|Overall Study|Adverse Event|15
799840|NCT00793624|2544517|P2|Overall Study|Adverse Event|16
799841|NCT00793624|2544518|P1|Overall Study|Adverse Event|18
799844|NCT00793793|2544826|P12|Overall Study|reason not specified|4
799845|NCT00793793|2544827|P11|Overall Study|reason not specified|2
799846|NCT00793793|2544828|P10|Overall Study|reason not specified|6
799847|NCT00793793|2544829|P9|Overall Study|reason not specified|7
799848|NCT00793793|2544830|P8|Overall Study|reason not specified|0
799849|NCT00793793|2544831|P7|Overall Study|reason not specified|2
799850|NCT00793793|2544832|P6|Overall Study|reason not specified|1
799851|NCT00793793|2544833|P5|Overall Study|reason not specified|1
799852|NCT00793793|2544834|P4|Overall Study|reason not specified|1
799853|NCT00793793|2544835|P3|Overall Study|reason not specified|0
799854|NCT00793793|2544836|P2|Overall Study|reason not specified|1
799855|NCT00793793|2544837|P1|Overall Study|reason not specified|0
799856|NCT00793793|2544826|P12|Overall Study|Withdrawal by Subject|0
799857|NCT00793793|2544827|P11|Overall Study|Withdrawal by Subject|0
799858|NCT00793793|2544828|P10|Overall Study|Withdrawal by Subject|0
799859|NCT00793793|2544829|P9|Overall Study|Withdrawal by Subject|1
799860|NCT00793793|2544830|P8|Overall Study|Withdrawal by Subject|0
799861|NCT00793793|2544831|P7|Overall Study|Withdrawal by Subject|0
799862|NCT00793793|2544832|P6|Overall Study|Withdrawal by Subject|0
799863|NCT00793793|2544833|P5|Overall Study|Withdrawal by Subject|1
799864|NCT00793793|2544834|P4|Overall Study|Withdrawal by Subject|0
799865|NCT00793793|2544835|P3|Overall Study|Withdrawal by Subject|0
799866|NCT00793793|2544836|P2|Overall Study|Withdrawal by Subject|0
799867|NCT00793793|2544837|P1|Overall Study|Withdrawal by Subject|0
799868|NCT00793793|2544826|P12|Overall Study|Lost to Follow-up|0
799869|NCT00793793|2544827|P11|Overall Study|Lost to Follow-up|1
799870|NCT00793793|2544828|P10|Overall Study|Lost to Follow-up|3
799871|NCT00793793|2544829|P9|Overall Study|Lost to Follow-up|1
799872|NCT00793793|2544830|P8|Overall Study|Lost to Follow-up|0
799873|NCT00793793|2544831|P7|Overall Study|Lost to Follow-up|0
799874|NCT00793793|2544832|P6|Overall Study|Lost to Follow-up|0
799875|NCT00793793|2544833|P5|Overall Study|Lost to Follow-up|0
799876|NCT00793793|2544834|P4|Overall Study|Lost to Follow-up|0
799877|NCT00793793|2544835|P3|Overall Study|Lost to Follow-up|1
799878|NCT00793793|2544836|P2|Overall Study|Lost to Follow-up|0
799879|NCT00793793|2544837|P1|Overall Study|Lost to Follow-up|0
799880|NCT00793793|2544826|P12|Overall Study|Protocol Violation|0
799881|NCT00793793|2544827|P11|Overall Study|Protocol Violation|0
799882|NCT00793793|2544828|P10|Overall Study|Protocol Violation|0
799883|NCT00793793|2544829|P9|Overall Study|Protocol Violation|0
799884|NCT00793793|2544830|P8|Overall Study|Protocol Violation|0
799885|NCT00793793|2544831|P7|Overall Study|Protocol Violation|0
799886|NCT00793793|2544832|P6|Overall Study|Protocol Violation|0
799887|NCT00793793|2544833|P5|Overall Study|Protocol Violation|0
799888|NCT00793793|2544834|P4|Overall Study|Protocol Violation|1
799889|NCT00793793|2544835|P3|Overall Study|Protocol Violation|0
799890|NCT00793793|2544836|P2|Overall Study|Protocol Violation|0
799891|NCT00793793|2544837|P1|Overall Study|Protocol Violation|0
799892|NCT00793793|2544826|P12|Overall Study|Adverse Event|2
799893|NCT00793793|2544827|P11|Overall Study|Adverse Event|0
799894|NCT00793793|2544828|P10|Overall Study|Adverse Event|0
799895|NCT00793793|2544829|P9|Overall Study|Adverse Event|0
799896|NCT00793793|2544830|P8|Overall Study|Adverse Event|0
799897|NCT00793793|2544831|P7|Overall Study|Adverse Event|2
799898|NCT00793793|2544832|P6|Overall Study|Adverse Event|1
799899|NCT00793793|2544833|P5|Overall Study|Adverse Event|0
799900|NCT00793793|2544834|P4|Overall Study|Adverse Event|1
799901|NCT00793793|2544835|P3|Overall Study|Adverse Event|1
799902|NCT00793793|2544836|P2|Overall Study|Adverse Event|0
799903|NCT00793793|2544837|P1|Overall Study|Adverse Event|0
799904|NCT00793819|2545212|P2|Overall Study|Lost to Follow-up|1
799905|NCT00793819|2545213|P1|Overall Study|Lost to Follow-up|1
799906|NCT00793819|2545212|P2|Overall Study|Withdrawal by Subject|3
799907|NCT00793819|2545213|P1|Overall Study|Withdrawal by Subject|4
799908|NCT00793819|2545212|P2|Overall Study|Lack of Efficacy|1
799909|NCT00793819|2545213|P1|Overall Study|Lack of Efficacy|1
799910|NCT00793819|2545212|P2|Overall Study|Adverse Event|4
799911|NCT00793819|2545213|P1|Overall Study|Adverse Event|8
800000|NCT00783692|2545281|P7|Induction Phase|Lack of Efficacy|0
799912|NCT00793871|2545219|P1|Overall Study|Study terminated by the Sponsor|7
799913|NCT00793871|2545219|P1|Overall Study|Lost to Follow-up|3
799914|NCT00793871|2545219|P1|Overall Study|Death|50
799915|NCT00793910|2545233|P2|Overall Study|Withdrawal by Subject|1
799916|NCT00793910|2545234|P1|Overall Study|Withdrawal by Subject|0
799917|NCT00793910|2545233|P2|Overall Study|decided to undergo LASIK instead of PRK|1
799918|NCT00793910|2545234|P1|Overall Study|decided to undergo LASIK instead of PRK|2
799919|NCT00793910|2545233|P2|Overall Study|ineligible based on entry criteria|3
799920|NCT00793910|2545234|P1|Overall Study|ineligible based on entry criteria|2
799921|NCT00793910|2545233|P2|Overall Study|did not pick up medications|1
799922|NCT00793910|2545234|P1|Overall Study|did not pick up medications|1
799923|NCT00793910|2545233|P2|Overall Study|discarded study pills|1
799924|NCT00793910|2545234|P1|Overall Study|discarded study pills|0
799925|NCT00783432|2545250|P2|Overall Study|Protocol Violation|9
799926|NCT00783432|2545251|P1|Overall Study|Protocol Violation|6
799927|NCT00783432|2545250|P2|Overall Study|subject moved|5
799928|NCT00783432|2545251|P1|Overall Study|subject moved|3
799929|NCT00783432|2545250|P2|Overall Study|Withdrawal by Subject|20
799930|NCT00783432|2545251|P1|Overall Study|Withdrawal by Subject|23
799931|NCT00783432|2545250|P2|Overall Study|Lost to Follow-up|6
799932|NCT00783432|2545251|P1|Overall Study|Lost to Follow-up|11
799933|NCT00783432|2545250|P2|Overall Study|Lack of Efficacy|21
799934|NCT00783432|2545251|P1|Overall Study|Lack of Efficacy|20
799935|NCT00783432|2545250|P2|Overall Study|Adverse Event|17
799936|NCT00783432|2545251|P1|Overall Study|Adverse Event|22
799937|NCT00783692|2545281|P7|Maintenance Phase|Other|1
799938|NCT00783692|2545282|P6|Maintenance Phase|Other|1
799939|NCT00783692|2545283|P5|Maintenance Phase|Other|0
799940|NCT00783692|2545284|P4|Maintenance Phase|Other|1
799941|NCT00783692|2545285|P3|Maintenance Phase|Other|0
799942|NCT00783692|2545286|P2|Maintenance Phase|Other|0
799943|NCT00783692|2545287|P1|Maintenance Phase|Other|0
799944|NCT00783692|2545281|P7|Maintenance Phase|Lost to Follow-up|5
799945|NCT00783692|2545282|P6|Maintenance Phase|Lost to Follow-up|2
799946|NCT00783692|2545283|P5|Maintenance Phase|Lost to Follow-up|3
799947|NCT00783692|2545284|P4|Maintenance Phase|Lost to Follow-up|1
799948|NCT00783692|2545285|P3|Maintenance Phase|Lost to Follow-up|0
799949|NCT00783692|2545286|P2|Maintenance Phase|Lost to Follow-up|0
799950|NCT00783692|2545287|P1|Maintenance Phase|Lost to Follow-up|2
799951|NCT00783692|2545281|P7|Maintenance Phase|Withdrawal by Subject|24
799952|NCT00783692|2545282|P6|Maintenance Phase|Withdrawal by Subject|9
799953|NCT00783692|2545283|P5|Maintenance Phase|Withdrawal by Subject|6
799954|NCT00783692|2545284|P4|Maintenance Phase|Withdrawal by Subject|7
799955|NCT00783692|2545285|P3|Maintenance Phase|Withdrawal by Subject|0
799956|NCT00783692|2545286|P2|Maintenance Phase|Withdrawal by Subject|0
799957|NCT00783692|2545287|P1|Maintenance Phase|Withdrawal by Subject|7
799958|NCT00783692|2545281|P7|Maintenance Phase|Lack of Efficacy|177
799959|NCT00783692|2545282|P6|Maintenance Phase|Lack of Efficacy|48
799960|NCT00783692|2545283|P5|Maintenance Phase|Lack of Efficacy|58
799961|NCT00783692|2545284|P4|Maintenance Phase|Lack of Efficacy|64
799962|NCT00783692|2545285|P3|Maintenance Phase|Lack of Efficacy|0
799963|NCT00783692|2545286|P2|Maintenance Phase|Lack of Efficacy|0
799964|NCT00783692|2545287|P1|Maintenance Phase|Lack of Efficacy|79
799965|NCT00783692|2545281|P7|Maintenance Phase|Protocol Violation|4
799966|NCT00783692|2545282|P6|Maintenance Phase|Protocol Violation|3
799967|NCT00783692|2545283|P5|Maintenance Phase|Protocol Violation|2
799968|NCT00783692|2545284|P4|Maintenance Phase|Protocol Violation|1
799969|NCT00783692|2545285|P3|Maintenance Phase|Protocol Violation|0
799970|NCT00783692|2545286|P2|Maintenance Phase|Protocol Violation|0
799971|NCT00783692|2545287|P1|Maintenance Phase|Protocol Violation|0
799972|NCT00783692|2545281|P7|Maintenance Phase|Adverse Event|38
799973|NCT00783692|2545282|P6|Maintenance Phase|Adverse Event|9
799974|NCT00783692|2545283|P5|Maintenance Phase|Adverse Event|12
799975|NCT00783692|2545284|P4|Maintenance Phase|Adverse Event|15
799976|NCT00783692|2545285|P3|Maintenance Phase|Adverse Event|0
799977|NCT00783692|2545286|P2|Maintenance Phase|Adverse Event|0
799978|NCT00783692|2545287|P1|Maintenance Phase|Adverse Event|7
799979|NCT00783692|2545281|P7|Induction Phase|Other|0
799980|NCT00783692|2545282|P6|Induction Phase|Other|0
799981|NCT00783692|2545283|P5|Induction Phase|Other|0
799982|NCT00783692|2545284|P4|Induction Phase|Other|0
799983|NCT00783692|2545285|P3|Induction Phase|Other|2
799984|NCT00783692|2545286|P2|Induction Phase|Other|0
799985|NCT00783692|2545287|P1|Induction Phase|Other|0
799986|NCT00783692|2545281|P7|Induction Phase|Lost to Follow-up|0
799987|NCT00783692|2545282|P6|Induction Phase|Lost to Follow-up|0
799988|NCT00783692|2545283|P5|Induction Phase|Lost to Follow-up|0
799989|NCT00783692|2545284|P4|Induction Phase|Lost to Follow-up|0
799990|NCT00783692|2545285|P3|Induction Phase|Lost to Follow-up|3
799991|NCT00783692|2545286|P2|Induction Phase|Lost to Follow-up|0
799992|NCT00783692|2545287|P1|Induction Phase|Lost to Follow-up|0
799993|NCT00783692|2545281|P7|Induction Phase|Withdrawal by Subject|0
799994|NCT00783692|2545282|P6|Induction Phase|Withdrawal by Subject|0
799995|NCT00783692|2545283|P5|Induction Phase|Withdrawal by Subject|0
799996|NCT00783692|2545284|P4|Induction Phase|Withdrawal by Subject|0
799997|NCT00783692|2545285|P3|Induction Phase|Withdrawal by Subject|16
799998|NCT00783692|2545286|P2|Induction Phase|Withdrawal by Subject|9
799999|NCT00783692|2545287|P1|Induction Phase|Withdrawal by Subject|3
800001|NCT00783692|2545282|P6|Induction Phase|Lack of Efficacy|0
800002|NCT00783692|2545283|P5|Induction Phase|Lack of Efficacy|0
800003|NCT00783692|2545284|P4|Induction Phase|Lack of Efficacy|0
800004|NCT00783692|2545285|P3|Induction Phase|Lack of Efficacy|28
800005|NCT00783692|2545286|P2|Induction Phase|Lack of Efficacy|3
800006|NCT00783692|2545287|P1|Induction Phase|Lack of Efficacy|1
800007|NCT00783692|2545281|P7|Induction Phase|Protocol Violation|0
800008|NCT00783692|2545282|P6|Induction Phase|Protocol Violation|0
800009|NCT00783692|2545283|P5|Induction Phase|Protocol Violation|0
800010|NCT00783692|2545284|P4|Induction Phase|Protocol Violation|0
800011|NCT00783692|2545285|P3|Induction Phase|Protocol Violation|1
800012|NCT00783692|2545286|P2|Induction Phase|Protocol Violation|0
800013|NCT00783692|2545287|P1|Induction Phase|Protocol Violation|0
800014|NCT00783692|2545281|P7|Induction Phase|Adverse Event|0
800015|NCT00783692|2545282|P6|Induction Phase|Adverse Event|0
800016|NCT00783692|2545283|P5|Induction Phase|Adverse Event|0
800017|NCT00783692|2545284|P4|Induction Phase|Adverse Event|0
800018|NCT00783692|2545285|P3|Induction Phase|Adverse Event|24
800019|NCT00783692|2545286|P2|Induction Phase|Adverse Event|9
800020|NCT00783692|2545287|P1|Induction Phase|Adverse Event|7
800027|NCT00783718|2545358|P7|Maintenance Phase|Lost to Follow-up|2
800028|NCT00783718|2545359|P6|Maintenance Phase|Lost to Follow-up|0
800029|NCT00783718|2545360|P5|Maintenance Phase|Lost to Follow-up|2
800030|NCT00783718|2545361|P4|Maintenance Phase|Lost to Follow-up|0
800031|NCT00783718|2545362|P3|Maintenance Phase|Lost to Follow-up|0
800032|NCT00783718|2545363|P2|Maintenance Phase|Lost to Follow-up|0
800033|NCT00783718|2545364|P1|Maintenance Phase|Lost to Follow-up|3
800034|NCT00783718|2545358|P7|Maintenance Phase|Withdrawal by Subject|20
800035|NCT00783718|2545359|P6|Maintenance Phase|Withdrawal by Subject|2
800036|NCT00783718|2545360|P5|Maintenance Phase|Withdrawal by Subject|5
800037|NCT00783718|2545361|P4|Maintenance Phase|Withdrawal by Subject|2
800038|NCT00783718|2545362|P3|Maintenance Phase|Withdrawal by Subject|0
800039|NCT00783718|2545363|P2|Maintenance Phase|Withdrawal by Subject|0
800040|NCT00783718|2545364|P1|Maintenance Phase|Withdrawal by Subject|6
800041|NCT00783718|2545358|P7|Maintenance Phase|Lack of Efficacy|155
800042|NCT00783718|2545359|P6|Maintenance Phase|Lack of Efficacy|33
800043|NCT00783718|2545360|P5|Maintenance Phase|Lack of Efficacy|31
800044|NCT00783718|2545361|P4|Maintenance Phase|Lack of Efficacy|61
800045|NCT00783718|2545362|P3|Maintenance Phase|Lack of Efficacy|0
800046|NCT00783718|2545363|P2|Maintenance Phase|Lack of Efficacy|0
800047|NCT00783718|2545364|P1|Maintenance Phase|Lack of Efficacy|83
800048|NCT00783718|2545358|P7|Maintenance Phase|Protocol Violation|2
800049|NCT00783718|2545359|P6|Maintenance Phase|Protocol Violation|0
800050|NCT00783718|2545360|P5|Maintenance Phase|Protocol Violation|0
800051|NCT00783718|2545361|P4|Maintenance Phase|Protocol Violation|0
800052|NCT00783718|2545362|P3|Maintenance Phase|Protocol Violation|0
800053|NCT00783718|2545363|P2|Maintenance Phase|Protocol Violation|0
800054|NCT00783718|2545364|P1|Maintenance Phase|Protocol Violation|1
800055|NCT00783718|2545358|P7|Maintenance Phase|Adverse Event|16
800056|NCT00783718|2545359|P6|Maintenance Phase|Adverse Event|6
800057|NCT00783718|2545360|P5|Maintenance Phase|Adverse Event|7
800058|NCT00783718|2545361|P4|Maintenance Phase|Adverse Event|15
800059|NCT00783718|2545362|P3|Maintenance Phase|Adverse Event|0
800060|NCT00783718|2545363|P2|Maintenance Phase|Adverse Event|0
800061|NCT00783718|2545364|P1|Maintenance Phase|Adverse Event|12
800062|NCT00783718|2545358|P7|Induction Phase|Lost to Follow-up|0
800063|NCT00783718|2545359|P6|Induction Phase|Lost to Follow-up|0
800064|NCT00783718|2545360|P5|Induction Phase|Lost to Follow-up|0
800065|NCT00783718|2545361|P4|Induction Phase|Lost to Follow-up|0
800066|NCT00783718|2545362|P3|Induction Phase|Lost to Follow-up|1
800067|NCT00783718|2545363|P2|Induction Phase|Lost to Follow-up|0
800068|NCT00783718|2545364|P1|Induction Phase|Lost to Follow-up|1
800069|NCT00783718|2545358|P7|Induction Phase|Withdrawal by Subject|0
800070|NCT00783718|2545359|P6|Induction Phase|Withdrawal by Subject|0
800071|NCT00783718|2545360|P5|Induction Phase|Withdrawal by Subject|0
800072|NCT00783718|2545361|P4|Induction Phase|Withdrawal by Subject|0
800073|NCT00783718|2545362|P3|Induction Phase|Withdrawal by Subject|8
800074|NCT00783718|2545363|P2|Induction Phase|Withdrawal by Subject|4
800075|NCT00783718|2545364|P1|Induction Phase|Withdrawal by Subject|3
800076|NCT00783718|2545358|P7|Induction Phase|Lack of Efficacy|0
800077|NCT00783718|2545359|P6|Induction Phase|Lack of Efficacy|0
800078|NCT00783718|2545360|P5|Induction Phase|Lack of Efficacy|0
800079|NCT00783718|2545361|P4|Induction Phase|Lack of Efficacy|0
800080|NCT00783718|2545362|P3|Induction Phase|Lack of Efficacy|14
800081|NCT00783718|2545363|P2|Induction Phase|Lack of Efficacy|2
800082|NCT00783718|2545364|P1|Induction Phase|Lack of Efficacy|5
800083|NCT00783718|2545358|P7|Induction Phase|Protocol Violation|0
800084|NCT00783718|2545359|P6|Induction Phase|Protocol Violation|0
800085|NCT00783718|2545360|P5|Induction Phase|Protocol Violation|0
800086|NCT00783718|2545361|P4|Induction Phase|Protocol Violation|0
800087|NCT00783718|2545362|P3|Induction Phase|Protocol Violation|6
800088|NCT00783718|2545363|P2|Induction Phase|Protocol Violation|1
800089|NCT00783718|2545364|P1|Induction Phase|Protocol Violation|1
800090|NCT00783718|2545358|P7|Induction Phase|Adverse Event|0
800091|NCT00783718|2545359|P6|Induction Phase|Adverse Event|0
800092|NCT00783718|2545360|P5|Induction Phase|Adverse Event|0
800093|NCT00783718|2545361|P4|Induction Phase|Adverse Event|0
800094|NCT00783718|2545362|P3|Induction Phase|Adverse Event|7
800095|NCT00783718|2545363|P2|Induction Phase|Adverse Event|0
800096|NCT00783718|2545364|P1|Induction Phase|Adverse Event|4
800097|NCT00783796|2545390|P1|Overall Study|Received commercial XIENCE V stent|1
800098|NCT00783796|2545390|P1|Overall Study|Received non-XIENCE V stent|1
800099|NCT00783796|2545390|P1|Overall Study|Did not receive any stent|4
800100|NCT00783835|2545492|P1|Overall Study|Participant not Adherent|3
800101|NCT00783835|2545492|P1|Overall Study|Lost to Follow-up|1
800102|NCT00783835|2545492|P1|Overall Study|Withdrawal by Subject|2
800103|NCT00783835|2545492|P1|Overall Study|Medical Criteria|1
800104|NCT00783835|2545492|P1|Overall Study|Adverse Event|3
800105|NCT00784134|2545556|P2|Overall Study|Lost to Follow-up|6
800106|NCT00784134|2545557|P1|Overall Study|Lost to Follow-up|3
800107|NCT00784147|2545655|P2|Overall Study|Death|0
800108|NCT00784147|2545656|P1|Overall Study|Death|2
800109|NCT00784147|2545655|P2|Overall Study|Protocol Violation|1
800110|NCT00784147|2545656|P1|Overall Study|Protocol Violation|1
800111|NCT00784147|2545655|P2|Overall Study|Physician Decision|1
800112|NCT00784147|2545656|P1|Overall Study|Physician Decision|2
800113|NCT00784147|2545655|P2|Overall Study|Withdrawal by Subject|3
800114|NCT00784147|2545656|P1|Overall Study|Withdrawal by Subject|1
800115|NCT00784147|2545655|P2|Overall Study|Lost to Follow-up|4
800116|NCT00784147|2545656|P1|Overall Study|Lost to Follow-up|2
800117|NCT00784238|2545674|P1|Overall Study|Unspecified|14
800118|NCT00784238|2545674|P1|Overall Study|Withdrawal by Subject|26
800119|NCT00784238|2545674|P1|Overall Study|Pregnancy|1
800120|NCT00784238|2545674|P1|Overall Study|Lost to Follow-up|29
800121|NCT00784238|2545674|P1|Overall Study|Lack of Efficacy|33
800122|NCT00784238|2545674|P1|Overall Study|Death|2
800123|NCT00784238|2545674|P1|Overall Study|Adverse Event|14
800124|NCT00784277|2545719|P7|ER Treatment|Other|2
800125|NCT00784277|2545720|P6|ER Treatment|Other|3
800126|NCT00784277|2545721|P5|ER Treatment|Other|1
800127|NCT00784277|2545722|P4|ER Treatment|Other|0
800128|NCT00784277|2545723|P3|ER Treatment|Other|0
800129|NCT00784277|2545724|P2|ER Treatment|Other|0
800130|NCT00784277|2545725|P1|ER Treatment|Other|0
800131|NCT00784277|2545719|P7|ER Treatment|Study Medication Non-Compliant|3
800132|NCT00784277|2545720|P6|ER Treatment|Study Medication Non-Compliant|3
800133|NCT00784277|2545721|P5|ER Treatment|Study Medication Non-Compliant|2
800134|NCT00784277|2545722|P4|ER Treatment|Study Medication Non-Compliant|0
800135|NCT00784277|2545723|P3|ER Treatment|Study Medication Non-Compliant|0
800136|NCT00784277|2545724|P2|ER Treatment|Study Medication Non-Compliant|0
800137|NCT00784277|2545725|P1|ER Treatment|Study Medication Non-Compliant|0
800138|NCT00784277|2545719|P7|ER Treatment|Withdrawal by Subject|3
800139|NCT00784277|2545720|P6|ER Treatment|Withdrawal by Subject|5
800140|NCT00784277|2545721|P5|ER Treatment|Withdrawal by Subject|2
800141|NCT00784277|2545722|P4|ER Treatment|Withdrawal by Subject|0
800142|NCT00784277|2545723|P3|ER Treatment|Withdrawal by Subject|0
800143|NCT00784277|2545724|P2|ER Treatment|Withdrawal by Subject|0
800144|NCT00784277|2545725|P1|ER Treatment|Withdrawal by Subject|0
800145|NCT00784277|2545719|P7|ER Treatment|Lost to Follow-up|0
800146|NCT00784277|2545720|P6|ER Treatment|Lost to Follow-up|2
800147|NCT00784277|2545721|P5|ER Treatment|Lost to Follow-up|0
800148|NCT00784277|2545722|P4|ER Treatment|Lost to Follow-up|0
800149|NCT00784277|2545723|P3|ER Treatment|Lost to Follow-up|0
800150|NCT00784277|2545724|P2|ER Treatment|Lost to Follow-up|0
800151|NCT00784277|2545725|P1|ER Treatment|Lost to Follow-up|0
800152|NCT00784277|2545719|P7|ER Treatment|Lack of Efficacy|0
800153|NCT00784277|2545720|P6|ER Treatment|Lack of Efficacy|4
800154|NCT00784277|2545721|P5|ER Treatment|Lack of Efficacy|3
800155|NCT00784277|2545722|P4|ER Treatment|Lack of Efficacy|0
800156|NCT00784277|2545723|P3|ER Treatment|Lack of Efficacy|0
800157|NCT00784277|2545724|P2|ER Treatment|Lack of Efficacy|0
800158|NCT00784277|2545725|P1|ER Treatment|Lack of Efficacy|0
800159|NCT00784277|2545719|P7|ER Treatment|Adverse Event|7
800160|NCT00784277|2545720|P6|ER Treatment|Adverse Event|7
800161|NCT00784277|2545721|P5|ER Treatment|Adverse Event|1
800162|NCT00784277|2545722|P4|ER Treatment|Adverse Event|0
800163|NCT00784277|2545723|P3|ER Treatment|Adverse Event|0
800164|NCT00784277|2545724|P2|ER Treatment|Adverse Event|0
800165|NCT00784277|2545725|P1|ER Treatment|Adverse Event|0
800166|NCT00784277|2545719|P7|IR Treatment|Other|0
800167|NCT00784277|2545720|P6|IR Treatment|Other|0
800168|NCT00784277|2545721|P5|IR Treatment|Other|0
800169|NCT00784277|2545722|P4|IR Treatment|Other|2
800170|NCT00784277|2545723|P3|IR Treatment|Other|3
800171|NCT00784277|2545724|P2|IR Treatment|Other|3
800172|NCT00784277|2545725|P1|IR Treatment|Other|2
800173|NCT00784277|2545719|P7|IR Treatment|Resolution Of Pain|0
800174|NCT00784277|2545720|P6|IR Treatment|Resolution Of Pain|0
800175|NCT00784277|2545721|P5|IR Treatment|Resolution Of Pain|0
800176|NCT00784277|2545722|P4|IR Treatment|Resolution Of Pain|0
800177|NCT00784277|2545723|P3|IR Treatment|Resolution Of Pain|0
800178|NCT00784277|2545724|P2|IR Treatment|Resolution Of Pain|1
800179|NCT00784277|2545725|P1|IR Treatment|Resolution Of Pain|0
800180|NCT00784277|2545719|P7|IR Treatment|Withdrawal by Subject|0
800181|NCT00784277|2545720|P6|IR Treatment|Withdrawal by Subject|0
800182|NCT00784277|2545721|P5|IR Treatment|Withdrawal by Subject|0
800183|NCT00784277|2545722|P4|IR Treatment|Withdrawal by Subject|6
800184|NCT00784277|2545723|P3|IR Treatment|Withdrawal by Subject|4
800185|NCT00784277|2545724|P2|IR Treatment|Withdrawal by Subject|1
800186|NCT00784277|2545725|P1|IR Treatment|Withdrawal by Subject|5
800187|NCT00784277|2545719|P7|IR Treatment|Lost to Follow-up|0
800188|NCT00784277|2545720|P6|IR Treatment|Lost to Follow-up|0
800189|NCT00784277|2545721|P5|IR Treatment|Lost to Follow-up|0
800190|NCT00784277|2545722|P4|IR Treatment|Lost to Follow-up|0
800191|NCT00784277|2545723|P3|IR Treatment|Lost to Follow-up|1
800192|NCT00784277|2545724|P2|IR Treatment|Lost to Follow-up|0
800193|NCT00784277|2545725|P1|IR Treatment|Lost to Follow-up|1
800194|NCT00784277|2545719|P7|IR Treatment|Lack of Efficacy|0
800195|NCT00784277|2545720|P6|IR Treatment|Lack of Efficacy|0
800196|NCT00784277|2545721|P5|IR Treatment|Lack of Efficacy|0
800197|NCT00784277|2545722|P4|IR Treatment|Lack of Efficacy|0
800198|NCT00784277|2545723|P3|IR Treatment|Lack of Efficacy|1
800199|NCT00784277|2545724|P2|IR Treatment|Lack of Efficacy|4
800200|NCT00784277|2545725|P1|IR Treatment|Lack of Efficacy|4
800201|NCT00784277|2545719|P7|IR Treatment|Adverse Event|0
800202|NCT00784277|2545720|P6|IR Treatment|Adverse Event|0
800203|NCT00784277|2545721|P5|IR Treatment|Adverse Event|0
800204|NCT00784277|2545722|P4|IR Treatment|Adverse Event|35
800205|NCT00784277|2545723|P3|IR Treatment|Adverse Event|19
800206|NCT00784277|2545724|P2|IR Treatment|Adverse Event|8
800207|NCT00784277|2545725|P1|IR Treatment|Adverse Event|4
800208|NCT00784368|2545745|P3|Overall Study|Withdrawal of informed consent|0
800209|NCT00784368|2545746|P2|Overall Study|Withdrawal of informed consent|1
800210|NCT00784368|2545747|P1|Overall Study|Withdrawal of informed consent|0
800211|NCT00784368|2545745|P3|Overall Study|Worsening of symptoms|0
800212|NCT00784368|2545746|P2|Overall Study|Worsening of symptoms|1
800213|NCT00784368|2545747|P1|Overall Study|Worsening of symptoms|0
800214|NCT00784368|2545745|P3|Overall Study|Worsening of complications|1
800215|NCT00784368|2545746|P2|Overall Study|Worsening of complications|0
800216|NCT00784368|2545747|P1|Overall Study|Worsening of complications|0
800217|NCT00784368|2545745|P3|Overall Study|Diagnosis of fever|1
800218|NCT00784368|2545746|P2|Overall Study|Diagnosis of fever|0
800219|NCT00784368|2545747|P1|Overall Study|Diagnosis of fever|0
800220|NCT00784368|2545745|P3|Overall Study|Adverse Event|2
800221|NCT00784368|2545746|P2|Overall Study|Adverse Event|9
800222|NCT00784368|2545747|P1|Overall Study|Adverse Event|6
800223|NCT00784368|2545745|P3|Overall Study|Lack of Efficacy|1
800224|NCT00784368|2545746|P2|Overall Study|Lack of Efficacy|0
800225|NCT00784368|2545747|P1|Overall Study|Lack of Efficacy|2
800226|NCT00784368|2545745|P3|Overall Study|Physician Decision|6
800227|NCT00784368|2545746|P2|Overall Study|Physician Decision|0
800228|NCT00784368|2545747|P1|Overall Study|Physician Decision|0
800229|NCT00784459|2545783|P2|Overall Study|Adverse Event|2
800230|NCT00784459|2545784|P1|Overall Study|Adverse Event|0
800231|NCT00784550|2545794|P2|Overall Study|Withdrawal by Subject|13
800232|NCT00784550|2545795|P1|Overall Study|Withdrawal by Subject|4
800233|NCT00784550|2545794|P2|Overall Study|Physician Decision|3
800234|NCT00784550|2545795|P1|Overall Study|Physician Decision|2
800235|NCT00784550|2545794|P2|Overall Study|Lost to Follow-up|5
800236|NCT00784550|2545795|P1|Overall Study|Lost to Follow-up|8
800237|NCT00784550|2545794|P2|Overall Study|Protocol Violation|10
800238|NCT00784550|2545795|P1|Overall Study|Protocol Violation|10
800239|NCT00784550|2545794|P2|Overall Study|Lack of Efficacy|1
800240|NCT00784550|2545795|P1|Overall Study|Lack of Efficacy|0
800241|NCT00784550|2545794|P2|Overall Study|Adverse Event|10
800242|NCT00784550|2545795|P1|Overall Study|Adverse Event|12
800243|NCT00784563|2545814|P3|Year 3|Adverse Event|1
800244|NCT00784563|2545815|P2|Year 3|Adverse Event|0
800245|NCT00784563|2545816|P1|Year 3|Adverse Event|0
800246|NCT00784563|2545814|P3|Year 3|Withdrawal by Subject|2
800247|NCT00784563|2545815|P2|Year 3|Withdrawal by Subject|0
800248|NCT00784563|2545816|P1|Year 3|Withdrawal by Subject|0
800249|NCT00784563|2545814|P3|Years 1 & 2|Adverse Event|0
800250|NCT00784563|2545815|P2|Years 1 & 2|Adverse Event|3
800251|NCT00784563|2545816|P1|Years 1 & 2|Adverse Event|0
800252|NCT00784563|2545814|P3|Years 1 & 2|Withdrawal by Subject|0
800253|NCT00784563|2545815|P2|Years 1 & 2|Withdrawal by Subject|2
800254|NCT00784563|2545816|P1|Years 1 & 2|Withdrawal by Subject|3
800255|NCT00784654|2545832|P3|Randomized Withdrawal Period|Family reasons|1
800256|NCT00784654|2545833|P2|Randomized Withdrawal Period|Family reasons|0
800257|NCT00784654|2545834|P1|Randomized Withdrawal Period|Family reasons|0
800258|NCT00784654|2545832|P3|Randomized Withdrawal Period|Did not complete a visit|0
800259|NCT00784654|2545833|P2|Randomized Withdrawal Period|Did not complete a visit|1
800260|NCT00784654|2545834|P1|Randomized Withdrawal Period|Did not complete a visit|0
800261|NCT00784654|2545832|P3|Randomized Withdrawal Period|Adverse Event|1
800262|NCT00784654|2545833|P2|Randomized Withdrawal Period|Adverse Event|1
800263|NCT00784654|2545834|P1|Randomized Withdrawal Period|Adverse Event|0
800264|NCT00784654|2545832|P3|Randomized Withdrawal Period|Protocol Violation|1
800265|NCT00784654|2545833|P2|Randomized Withdrawal Period|Protocol Violation|2
800266|NCT00784654|2545834|P1|Randomized Withdrawal Period|Protocol Violation|0
800267|NCT00784654|2545832|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
800268|NCT00784654|2545833|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
800269|NCT00784654|2545834|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
800270|NCT00784654|2545832|P3|Randomized Withdrawal Period|Lack of Efficacy|18
800271|NCT00784654|2545833|P2|Randomized Withdrawal Period|Lack of Efficacy|5
800272|NCT00784654|2545834|P1|Randomized Withdrawal Period|Lack of Efficacy|0
800273|NCT00784654|2545832|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
800274|NCT00784654|2545833|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
800275|NCT00784654|2545834|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
800276|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
800277|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
800278|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
800279|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
800280|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
800281|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
800282|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
800283|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
800284|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
800285|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
800286|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
800287|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
800288|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
800289|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
800290|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
800291|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
800292|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
800293|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
800294|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
800295|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
800296|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
800297|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
800298|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
800299|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
800300|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
800301|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
800302|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
800303|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
800304|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
800305|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
800306|NCT00784654|2545832|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
800307|NCT00784654|2545833|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
800308|NCT00784654|2545834|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
800309|NCT00784719|2545873|P7|Overall Study|Withdrawal by Subject|1
800310|NCT00784719|2545874|P6|Overall Study|Withdrawal by Subject|0
800311|NCT00784719|2545875|P5|Overall Study|Withdrawal by Subject|2
800312|NCT00784719|2545876|P4|Overall Study|Withdrawal by Subject|0
800313|NCT00784719|2545877|P3|Overall Study|Withdrawal by Subject|0
800314|NCT00784719|2545878|P2|Overall Study|Withdrawal by Subject|0
800315|NCT00784719|2545879|P1|Overall Study|Withdrawal by Subject|1
800316|NCT00784719|2545873|P7|Overall Study|Unspecified|3
800317|NCT00784719|2545874|P6|Overall Study|Unspecified|1
800318|NCT00784719|2545875|P5|Overall Study|Unspecified|2
800319|NCT00784719|2545876|P4|Overall Study|Unspecified|0
800320|NCT00784719|2545877|P3|Overall Study|Unspecified|1
800321|NCT00784719|2545878|P2|Overall Study|Unspecified|1
800322|NCT00784719|2545879|P1|Overall Study|Unspecified|2
800323|NCT00784719|2545873|P7|Overall Study|Lost to Follow-up|0
800324|NCT00784719|2545874|P6|Overall Study|Lost to Follow-up|1
800325|NCT00784719|2545875|P5|Overall Study|Lost to Follow-up|1
800326|NCT00784719|2545876|P4|Overall Study|Lost to Follow-up|0
800327|NCT00784719|2545877|P3|Overall Study|Lost to Follow-up|0
800328|NCT00784719|2545878|P2|Overall Study|Lost to Follow-up|0
800329|NCT00784719|2545879|P1|Overall Study|Lost to Follow-up|0
800330|NCT00784719|2545873|P7|Overall Study|Adverse Event|1
800331|NCT00784719|2545874|P6|Overall Study|Adverse Event|1
800332|NCT00784719|2545875|P5|Overall Study|Adverse Event|1
800333|NCT00784719|2545876|P4|Overall Study|Adverse Event|0
800334|NCT00784719|2545877|P3|Overall Study|Adverse Event|0
800335|NCT00784719|2545878|P2|Overall Study|Adverse Event|2
800336|NCT00784719|2545879|P1|Overall Study|Adverse Event|0
800337|NCT00784784|2546051|P2|Overall Study|Withdrawal by Subject|2
800338|NCT00784784|2546052|P1|Overall Study|Withdrawal by Subject|2
800339|NCT00784810|2546062|P2|Overall Study|Lost to Follow-up|1
800340|NCT00784810|2546063|P1|Overall Study|Lost to Follow-up|1
800341|NCT00784810|2546062|P2|Overall Study|Administrative|8
800342|NCT00784810|2546063|P1|Overall Study|Administrative|5
800343|NCT00784810|2546062|P2|Overall Study|Withdrawal by Subject|9
800344|NCT00784810|2546063|P1|Overall Study|Withdrawal by Subject|11
800345|NCT00784810|2546062|P2|Overall Study|Lack of Efficacy|11
800346|NCT00784810|2546063|P1|Overall Study|Lack of Efficacy|14
800347|NCT00784810|2546062|P2|Overall Study|Adverse Event|20
800348|NCT00784810|2546063|P1|Overall Study|Adverse Event|32
800349|NCT00784836|2546071|P1|Overall Study|Early Study Termination|3
800350|NCT00784875|2546086|P4|Period D|Lost to Follow-up|1
800351|NCT00784875|2546087|P3|Period D|Lost to Follow-up|1
800352|NCT00784875|2546088|P2|Period D|Lost to Follow-up|0
800353|NCT00784875|2546089|P1|Period D|Lost to Follow-up|1
800354|NCT00784875|2546086|P4|Period D|Sponsor Decision|0
800355|NCT00784875|2546087|P3|Period D|Sponsor Decision|1
800356|NCT00784875|2546088|P2|Period D|Sponsor Decision|1
800357|NCT00784875|2546089|P1|Period D|Sponsor Decision|1
800358|NCT00784875|2546086|P4|Period D|Physician Decision|0
800359|NCT00784875|2546087|P3|Period D|Physician Decision|0
800360|NCT00784875|2546088|P2|Period D|Physician Decision|1
800361|NCT00784875|2546089|P1|Period D|Physician Decision|0
800362|NCT00784875|2546086|P4|Period D|Withdrawal by Subject|0
800363|NCT00784875|2546087|P3|Period D|Withdrawal by Subject|2
800364|NCT00784875|2546088|P2|Period D|Withdrawal by Subject|0
800365|NCT00784875|2546089|P1|Period D|Withdrawal by Subject|2
800366|NCT00784875|2546086|P4|Period D|Protocol Violation|0
800367|NCT00784875|2546087|P3|Period D|Protocol Violation|0
800368|NCT00784875|2546088|P2|Period D|Protocol Violation|0
800369|NCT00784875|2546089|P1|Period D|Protocol Violation|1
800370|NCT00784875|2546086|P4|Period D|Adverse Event|0
800371|NCT00784875|2546087|P3|Period D|Adverse Event|2
800372|NCT00784875|2546088|P2|Period D|Adverse Event|2
800373|NCT00784875|2546089|P1|Period D|Adverse Event|0
800374|NCT00784875|2546086|P4|Period C|Sponsor Decision|2
800375|NCT00784875|2546087|P3|Period C|Sponsor Decision|4
800376|NCT00784875|2546088|P2|Period C|Sponsor Decision|5
800377|NCT00784875|2546089|P1|Period C|Sponsor Decision|5
800378|NCT00784875|2546086|P4|Period C|Physician Decision|1
800379|NCT00784875|2546087|P3|Period C|Physician Decision|1
800380|NCT00784875|2546088|P2|Period C|Physician Decision|0
800381|NCT00784875|2546089|P1|Period C|Physician Decision|0
800382|NCT00784875|2546086|P4|Period C|Withdrawal by Subject|0
800383|NCT00784875|2546087|P3|Period C|Withdrawal by Subject|2
800384|NCT00784875|2546088|P2|Period C|Withdrawal by Subject|1
800385|NCT00784875|2546089|P1|Period C|Withdrawal by Subject|1
800386|NCT00784875|2546086|P4|Period C|Lack of Efficacy|0
800387|NCT00784875|2546087|P3|Period C|Lack of Efficacy|1
800388|NCT00784875|2546088|P2|Period C|Lack of Efficacy|0
800389|NCT00784875|2546089|P1|Period C|Lack of Efficacy|0
800390|NCT00784875|2546086|P4|Period C|Protocol Violation|2
800391|NCT00784875|2546087|P3|Period C|Protocol Violation|1
800392|NCT00784875|2546088|P2|Period C|Protocol Violation|0
800393|NCT00784875|2546089|P1|Period C|Protocol Violation|0
800394|NCT00784875|2546086|P4|Period C|Adverse Event|2
800395|NCT00784875|2546087|P3|Period C|Adverse Event|4
800396|NCT00784875|2546088|P2|Period C|Adverse Event|0
800397|NCT00784875|2546089|P1|Period C|Adverse Event|1
800398|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
800399|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
800400|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
800401|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
800402|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
800403|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
800404|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
800405|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
800406|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Physician Decision|0
800407|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Physician Decision|1
800408|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Physician Decision|0
800409|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Physician Decision|0
800410|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
800411|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
800412|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
800413|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
800414|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
800415|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
800416|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
800417|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
800418|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Protocol Violation|3
800419|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Protocol Violation|2
800420|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Protocol Violation|1
800421|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Protocol Violation|1
800422|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Adverse Event|1
800423|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Adverse Event|2
800424|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Adverse Event|3
800425|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Adverse Event|0
800426|NCT00784875|2546086|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
800427|NCT00784875|2546087|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
800428|NCT00784875|2546088|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
800429|NCT00784875|2546089|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
800430|NCT00784875|2546086|P4|Period A - Baseline|Lost to Follow-up|2
800431|NCT00784875|2546087|P3|Period A - Baseline|Lost to Follow-up|0
800432|NCT00784875|2546088|P2|Period A - Baseline|Lost to Follow-up|0
800433|NCT00784875|2546089|P1|Period A - Baseline|Lost to Follow-up|0
800434|NCT00784875|2546086|P4|Period A - Baseline|Sponsor Decision|113
800435|NCT00784875|2546087|P3|Period A - Baseline|Sponsor Decision|0
800436|NCT00784875|2546088|P2|Period A - Baseline|Sponsor Decision|0
800437|NCT00784875|2546089|P1|Period A - Baseline|Sponsor Decision|0
800438|NCT00784875|2546086|P4|Period A - Baseline|Physician Decision|2
800439|NCT00784875|2546087|P3|Period A - Baseline|Physician Decision|0
800440|NCT00784875|2546088|P2|Period A - Baseline|Physician Decision|0
800441|NCT00784875|2546089|P1|Period A - Baseline|Physician Decision|0
800442|NCT00784875|2546086|P4|Period A - Baseline|Withdrawal by Subject|27
800443|NCT00784875|2546087|P3|Period A - Baseline|Withdrawal by Subject|0
800444|NCT00784875|2546088|P2|Period A - Baseline|Withdrawal by Subject|0
800445|NCT00784875|2546089|P1|Period A - Baseline|Withdrawal by Subject|0
800446|NCT00784875|2546086|P4|Period A - Baseline|Protocol Violation|25
800447|NCT00784875|2546087|P3|Period A - Baseline|Protocol Violation|0
800448|NCT00784875|2546088|P2|Period A - Baseline|Protocol Violation|0
800449|NCT00784875|2546089|P1|Period A - Baseline|Protocol Violation|0
800450|NCT00784875|2546086|P4|Period A - Baseline|Adverse Event|8
800451|NCT00784875|2546087|P3|Period A - Baseline|Adverse Event|0
800452|NCT00784875|2546088|P2|Period A - Baseline|Adverse Event|0
800453|NCT00784875|2546089|P1|Period A - Baseline|Adverse Event|0
800454|NCT00784875|2546086|P4|Period A - Baseline|Entry Criteria Not Met|5
800455|NCT00784875|2546087|P3|Period A - Baseline|Entry Criteria Not Met|0
800456|NCT00784875|2546088|P2|Period A - Baseline|Entry Criteria Not Met|0
800457|NCT00784875|2546089|P1|Period A - Baseline|Entry Criteria Not Met|0
800458|NCT00784927|2546203|P1|Overall Study|Ineligible|1
800459|NCT00784927|2546203|P1|Overall Study|Protocol Violation|1
800460|NCT00784927|2546203|P1|Overall Study|Cancel Prior to Initiating Treatment|1
800461|NCT00784979|2546211|P1|Overall Study|incomplete data|6
800462|NCT00785044|2546215|P1|Overall Study|Withdrawal by Subject|1
800463|NCT00785044|2546215|P1|Overall Study|Lost to Follow-up|266
800464|NCT00785044|2546215|P1|Overall Study|Death|77
800465|NCT00785044|2546215|P1|Overall Study|Dosed at non-participating sites|152
800466|NCT00785213|2546220|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
800467|NCT00785213|2546220|P1|Quinine Sulfate Alone|Adverse Event|4
800468|NCT00794118|2546231|P1|Overall Study|Changed hospital center|2
800469|NCT00794118|2546231|P1|Overall Study|Withdrawal by Subject|9
800470|NCT00794118|2546231|P1|Overall Study|Lost to Follow-up|16
800471|NCT00794157|2546299|P3|Overall Study|Protocol deviation|1
800472|NCT00794157|2546300|P2|Overall Study|Protocol deviation|1
800473|NCT00794157|2546301|P1|Overall Study|Protocol deviation|0
800474|NCT00794157|2546299|P3|Overall Study|Abnormal test procedure result(s)|0
800475|NCT00794157|2546300|P2|Overall Study|Abnormal test procedure result(s)|1
800476|NCT00794157|2546301|P1|Overall Study|Abnormal test procedure result(s)|0
800477|NCT00794157|2546299|P3|Overall Study|Administrative problems|4
800478|NCT00794157|2546300|P2|Overall Study|Administrative problems|7
800479|NCT00794157|2546301|P1|Overall Study|Administrative problems|1
800480|NCT00794157|2546299|P3|Overall Study|Unsatisfactory therapeutic effect|2
800481|NCT00794157|2546300|P2|Overall Study|Unsatisfactory therapeutic effect|0
800482|NCT00794157|2546301|P1|Overall Study|Unsatisfactory therapeutic effect|1
800483|NCT00794157|2546299|P3|Overall Study|Lost to Follow-up|1
800484|NCT00794157|2546300|P2|Overall Study|Lost to Follow-up|0
800485|NCT00794157|2546301|P1|Overall Study|Lost to Follow-up|2
800486|NCT00794157|2546299|P3|Overall Study|Subject withdrew consent|3
800487|NCT00794157|2546300|P2|Overall Study|Subject withdrew consent|0
800488|NCT00794157|2546301|P1|Overall Study|Subject withdrew consent|2
800489|NCT00794157|2546299|P3|Overall Study|Adverse Event|8
800490|NCT00794157|2546300|P2|Overall Study|Adverse Event|1
800491|NCT00794157|2546301|P1|Overall Study|Adverse Event|4
800492|NCT00794196|2546332|P2|Overall Study|Lost to Follow-up|23
800493|NCT00794196|2546333|P1|Overall Study|Lost to Follow-up|5
800494|NCT00801632|2546354|P1|Overall Study|Re-transplant|1
800495|NCT00801983|2546407|P2|Period 2|Withdrawal by Subject|1
800496|NCT00801983|2546408|P1|Period 2|Withdrawal by Subject|2
800497|NCT00801983|2546407|P2|Period 1|Withdrawal by Subject|8
800498|NCT00801983|2546408|P1|Period 1|Withdrawal by Subject|2
800499|NCT00801983|2546407|P2|Period 1|Lost to Follow-up|0
800500|NCT00801983|2546408|P1|Period 1|Lost to Follow-up|2
800501|NCT00802074|2546420|P6|Overall Study|Withdrawal by Subject|0
800502|NCT00802074|2546421|P5|Overall Study|Withdrawal by Subject|0
800503|NCT00802074|2546422|P4|Overall Study|Withdrawal by Subject|0
800504|NCT00802074|2546423|P3|Overall Study|Withdrawal by Subject|0
800505|NCT00802074|2546424|P2|Overall Study|Withdrawal by Subject|0
800506|NCT00802074|2546425|P1|Overall Study|Withdrawal by Subject|1
800507|NCT00802074|2546420|P6|Overall Study|Adverse Event|0
800508|NCT00802074|2546421|P5|Overall Study|Adverse Event|0
800509|NCT00802074|2546422|P4|Overall Study|Adverse Event|0
800510|NCT00802074|2546423|P3|Overall Study|Adverse Event|1
800511|NCT00802074|2546424|P2|Overall Study|Adverse Event|1
800512|NCT00802074|2546425|P1|Overall Study|Adverse Event|1
800513|NCT00802178|2546471|P1|Overall Study|Patients wish and other reason|1
800514|NCT00802178|2546471|P1|Overall Study|IT and patient wish|8
800515|NCT00802178|2546471|P1|Overall Study|Lack of efficacy and patient wish|1
800516|NCT00802178|2546471|P1|Overall Study|Other|32
800517|NCT00802178|2546471|P1|Overall Study|Withdrawal by Subject|18
800518|NCT00802178|2546471|P1|Overall Study|Insufficient tolerability (IT)|17
800519|NCT00802178|2546471|P1|Overall Study|Lack of Efficacy|36
800520|NCT00802360|2546509|P4|Overall Study|Unspecified|3
800521|NCT00802360|2546510|P3|Overall Study|Unspecified|6
800522|NCT00802360|2546511|P2|Overall Study|Unspecified|3
800523|NCT00802360|2546512|P1|Overall Study|Unspecified|2
800524|NCT00802360|2546509|P4|Overall Study|Pregnancy loss/miscarriage|3
800525|NCT00802360|2546510|P3|Overall Study|Pregnancy loss/miscarriage|0
800526|NCT00802360|2546511|P2|Overall Study|Pregnancy loss/miscarriage|2
800527|NCT00802360|2546512|P1|Overall Study|Pregnancy loss/miscarriage|0
800528|NCT00802360|2546509|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
800529|NCT00802360|2546510|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
800530|NCT00802360|2546511|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
800531|NCT00802360|2546512|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
800532|NCT00802360|2546509|P4|Overall Study|No positive serum pregnancy|10
800533|NCT00802360|2546510|P3|Overall Study|No positive serum pregnancy|14
800534|NCT00802360|2546511|P2|Overall Study|No positive serum pregnancy|20
800535|NCT00802360|2546512|P1|Overall Study|No positive serum pregnancy|17
800536|NCT00802360|2546509|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
800537|NCT00802360|2546510|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
800538|NCT00802360|2546511|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
800539|NCT00802360|2546512|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
800540|NCT00802360|2546509|P4|Overall Study|Cycle cancelled|1
800541|NCT00802360|2546510|P3|Overall Study|Cycle cancelled|1
800542|NCT00802360|2546511|P2|Overall Study|Cycle cancelled|1
800543|NCT00802360|2546512|P1|Overall Study|Cycle cancelled|0
800544|NCT00802360|2546509|P4|Overall Study|Inadequate number of oocytes retrieved|1
800545|NCT00802360|2546510|P3|Overall Study|Inadequate number of oocytes retrieved|0
800546|NCT00802360|2546511|P2|Overall Study|Inadequate number of oocytes retrieved|0
800547|NCT00802360|2546512|P1|Overall Study|Inadequate number of oocytes retrieved|0
800548|NCT00802360|2546509|P4|Overall Study|Stimulation failure|3
800549|NCT00802360|2546510|P3|Overall Study|Stimulation failure|3
800550|NCT00802360|2546511|P2|Overall Study|Stimulation failure|0
800551|NCT00802360|2546512|P1|Overall Study|Stimulation failure|4
800552|NCT00802529|2546590|P2|Overall Study|Lost to Follow-up|1
800553|NCT00802529|2546591|P1|Overall Study|Lost to Follow-up|0
800554|NCT00802659|2546616|P4|Overall Study|Physician Decision|0
800555|NCT00802659|2546617|P3|Overall Study|Physician Decision|0
800556|NCT00802659|2546618|P2|Overall Study|Physician Decision|1
800557|NCT00802659|2546619|P1|Overall Study|Physician Decision|0
800558|NCT00802672|2546648|P3|Overall Study|other|2
800559|NCT00802672|2546649|P2|Overall Study|other|1
800560|NCT00802672|2546650|P1|Overall Study|other|3
800561|NCT00802672|2546648|P3|Overall Study|Withdrawal by Subject|2
800562|NCT00802672|2546649|P2|Overall Study|Withdrawal by Subject|1
800563|NCT00802672|2546650|P1|Overall Study|Withdrawal by Subject|1
800564|NCT00802672|2546648|P3|Overall Study|Lost to Follow-up|3
800565|NCT00802672|2546649|P2|Overall Study|Lost to Follow-up|5
800566|NCT00802672|2546650|P1|Overall Study|Lost to Follow-up|5
800567|NCT00802672|2546648|P3|Overall Study|Protocol Violation|1
800568|NCT00802672|2546649|P2|Overall Study|Protocol Violation|1
800569|NCT00802672|2546650|P1|Overall Study|Protocol Violation|2
800570|NCT00802672|2546648|P3|Overall Study|Adverse Event|1
800571|NCT00802672|2546649|P2|Overall Study|Adverse Event|1
800572|NCT00802672|2546650|P1|Overall Study|Adverse Event|1
800573|NCT00802672|2546648|P3|Overall Study|Lack of fungal pathogen at baseline|25
800574|NCT00802672|2546649|P2|Overall Study|Lack of fungal pathogen at baseline|43
800575|NCT00802672|2546650|P1|Overall Study|Lack of fungal pathogen at baseline|56
800576|NCT00802737|2546678|P3|Overall Study|Participant too Unwell|0
800577|NCT00802737|2546679|P2|Overall Study|Participant too Unwell|2
800578|NCT00802737|2546680|P1|Overall Study|Participant too Unwell|0
800579|NCT00802737|2546678|P3|Overall Study|Ongoing CLL-Treatment|0
800580|NCT00802737|2546679|P2|Overall Study|Ongoing CLL-Treatment|1
800581|NCT00802737|2546680|P1|Overall Study|Ongoing CLL-Treatment|0
800582|NCT00802737|2546678|P3|Overall Study|Received Prohibited Therapy|0
800583|NCT00802737|2546679|P2|Overall Study|Received Prohibited Therapy|0
800584|NCT00802737|2546680|P1|Overall Study|Received Prohibited Therapy|1
800585|NCT00802737|2546678|P3|Overall Study|Adverse Event|0
800586|NCT00802737|2546679|P2|Overall Study|Adverse Event|0
800587|NCT00802737|2546680|P1|Overall Study|Adverse Event|1
800588|NCT00802737|2546678|P3|Overall Study|Death|1
800589|NCT00802737|2546679|P2|Overall Study|Death|5
800590|NCT00802737|2546680|P1|Overall Study|Death|6
800591|NCT00802737|2546678|P3|Overall Study|Withdrawn due to Disease Progression|0
800592|NCT00802737|2546679|P2|Overall Study|Withdrawn due to Disease Progression|3
800593|NCT00802737|2546680|P1|Overall Study|Withdrawn due to Disease Progression|9
800594|NCT00802841|2546728|P2|Overall Study|Treatment duration completed|76
800595|NCT00802841|2546729|P1|Overall Study|Treatment duration completed|66
800596|NCT00802841|2546728|P2|Overall Study|Protocol deviation|6
800597|NCT00802841|2546729|P1|Overall Study|Protocol deviation|2
800598|NCT00802841|2546728|P2|Overall Study|Withdrawal by Subject|5
800599|NCT00802841|2546729|P1|Overall Study|Withdrawal by Subject|9
800600|NCT00802841|2546728|P2|Overall Study|Disease progression|3
800601|NCT00802841|2546729|P1|Overall Study|Disease progression|7
800602|NCT00802841|2546728|P2|Overall Study|Adverse Event|2
800603|NCT00802841|2546729|P1|Overall Study|Adverse Event|8
800604|NCT00802841|2546728|P2|Overall Study|Death|2
800605|NCT00802841|2546729|P1|Overall Study|Death|1
800606|NCT00802841|2546728|P2|Overall Study|Lost to Follow-up|1
800607|NCT00802841|2546729|P1|Overall Study|Lost to Follow-up|2
800608|NCT00802841|2546728|P2|Overall Study|Administrative problems|0
800609|NCT00802841|2546729|P1|Overall Study|Administrative problems|1
800610|NCT00802867|2546751|P1|Overall Study|Withdrawal by Subject|1
800611|NCT00802867|2546751|P1|Overall Study|Protocol Violation|6
800612|NCT00802867|2546751|P1|Overall Study|Lost to Follow-up|6
800613|NCT00802893|2546778|P1|Overall Study|study terminated|3
800614|NCT00803023|2546813|P4|Overall Study|Lack of Efficacy|1
800615|NCT00803023|2546814|P3|Overall Study|Lack of Efficacy|1
800616|NCT00803023|2546815|P2|Overall Study|Lack of Efficacy|1
800617|NCT00803023|2546816|P1|Overall Study|Lack of Efficacy|0
800618|NCT00803023|2546813|P4|Overall Study|Lost to Follow-up|1
800619|NCT00803023|2546814|P3|Overall Study|Lost to Follow-up|2
800620|NCT00803023|2546815|P2|Overall Study|Lost to Follow-up|1
800621|NCT00803023|2546816|P1|Overall Study|Lost to Follow-up|0
800622|NCT00803023|2546813|P4|Overall Study|Withdrawal by Subject|0
800623|NCT00803023|2546814|P3|Overall Study|Withdrawal by Subject|0
800624|NCT00803023|2546815|P2|Overall Study|Withdrawal by Subject|2
800625|NCT00803023|2546816|P1|Overall Study|Withdrawal by Subject|0
800626|NCT00803023|2546813|P4|Overall Study|Adverse Event|6
800627|NCT00803023|2546814|P3|Overall Study|Adverse Event|8
800628|NCT00803023|2546815|P2|Overall Study|Adverse Event|4
800629|NCT00803023|2546816|P1|Overall Study|Adverse Event|5
800630|NCT00803049|2546830|P4|Overall Study|Other than Specified Above|5
800631|NCT00803049|2546831|P3|Overall Study|Other than Specified Above|2
800632|NCT00803049|2546832|P2|Overall Study|Other than Specified Above|9
800633|NCT00803049|2546833|P1|Overall Study|Other than Specified Above|3
800634|NCT00803049|2546830|P4|Overall Study|Randomized and Not Treated|2
800635|NCT00803049|2546831|P3|Overall Study|Randomized and Not Treated|0
800636|NCT00803049|2546832|P2|Overall Study|Randomized and Not Treated|0
800637|NCT00803049|2546833|P1|Overall Study|Randomized and Not Treated|0
800638|NCT00803049|2546830|P4|Overall Study|Protocol Violation|0
800639|NCT00803049|2546831|P3|Overall Study|Protocol Violation|1
800640|NCT00803049|2546832|P2|Overall Study|Protocol Violation|1
800641|NCT00803049|2546833|P1|Overall Study|Protocol Violation|0
800642|NCT00803049|2546830|P4|Overall Study|Withdrawal by Subject|44
800643|NCT00803049|2546831|P3|Overall Study|Withdrawal by Subject|16
800644|NCT00803049|2546832|P2|Overall Study|Withdrawal by Subject|43
800645|NCT00803049|2546833|P1|Overall Study|Withdrawal by Subject|19
800646|NCT00803049|2546830|P4|Overall Study|Progressive Disease|6
800647|NCT00803049|2546831|P3|Overall Study|Progressive Disease|6
800648|NCT00803049|2546832|P2|Overall Study|Progressive Disease|10
800649|NCT00803049|2546833|P1|Overall Study|Progressive Disease|6
800650|NCT00803049|2546830|P4|Overall Study|Death|2
800651|NCT00803049|2546831|P3|Overall Study|Death|0
800652|NCT00803049|2546832|P2|Overall Study|Death|1
800653|NCT00803049|2546833|P1|Overall Study|Death|2
800654|NCT00803049|2546830|P4|Overall Study|Lost to Follow-up|3
800655|NCT00803049|2546831|P3|Overall Study|Lost to Follow-up|0
800656|NCT00803049|2546832|P2|Overall Study|Lost to Follow-up|2
800657|NCT00803049|2546833|P1|Overall Study|Lost to Follow-up|0
800658|NCT00803049|2546830|P4|Overall Study|Lack of Efficacy|13
800659|NCT00803049|2546831|P3|Overall Study|Lack of Efficacy|6
800660|NCT00803049|2546832|P2|Overall Study|Lack of Efficacy|19
800661|NCT00803049|2546833|P1|Overall Study|Lack of Efficacy|10
800662|NCT00803049|2546830|P4|Overall Study|Adverse Event|27
800663|NCT00803049|2546831|P3|Overall Study|Adverse Event|13
800664|NCT00803049|2546832|P2|Overall Study|Adverse Event|33
800665|NCT00803049|2546833|P1|Overall Study|Adverse Event|21
800666|NCT00803101|2546890|P2|Overall Study|Patient did not have surgery|1
800667|NCT00803101|2546891|P1|Overall Study|Patient did not have surgery|1
800668|NCT00803101|2546890|P2|Overall Study|Patient did not attend scheduled visit|1
800669|NCT00803101|2546891|P1|Overall Study|Patient did not attend scheduled visit|2
800670|NCT00803101|2546890|P2|Overall Study|Patient died outside SAE report period|0
800671|NCT00803101|2546891|P1|Overall Study|Patient died outside SAE report period|1
800672|NCT00803101|2546890|P2|Overall Study|Surgery finished outside protocol window|1
800673|NCT00803101|2546891|P1|Overall Study|Surgery finished outside protocol window|1
800674|NCT00803101|2546890|P2|Overall Study|Protocol Violation|7
800675|NCT00803101|2546891|P1|Overall Study|Protocol Violation|1
800676|NCT00803101|2546890|P2|Overall Study|Lost to Follow-up|2
800677|NCT00803101|2546891|P1|Overall Study|Lost to Follow-up|2
800678|NCT00803101|2546890|P2|Overall Study|Withdrawal by Subject|4
800679|NCT00803101|2546891|P1|Overall Study|Withdrawal by Subject|6
800680|NCT00803101|2546890|P2|Overall Study|Death / Serious Adverse Event|6
800681|NCT00803101|2546891|P1|Overall Study|Death / Serious Adverse Event|4
800682|NCT00803179|2546922|P1|Overall Study|Lost to Follow-up|3
800683|NCT00803244|2546928|P2|Overall Study|Any other reason not above-mentioned|10
800684|NCT00803244|2546929|P1|Overall Study|Any other reason not above-mentioned|4
800685|NCT00803244|2546928|P2|Overall Study|Withdrawal by Subject|3
800686|NCT00803244|2546929|P1|Overall Study|Withdrawal by Subject|2
800687|NCT00803244|2546928|P2|Overall Study|Adverse Event|2
800688|NCT00803244|2546929|P1|Overall Study|Adverse Event|1
800689|NCT00803270|2546939|P2|Overall Study|Lost to Follow-up|2
800690|NCT00803270|2546940|P1|Overall Study|Lost to Follow-up|1
800691|NCT00803361|2546977|P2|Overall Study|Withdrawal by Subject|6
800692|NCT00803361|2546978|P1|Overall Study|Withdrawal by Subject|5
800693|NCT00803361|2546977|P2|Overall Study|Protocol Violation|4
800694|NCT00803361|2546978|P1|Overall Study|Protocol Violation|2
800695|NCT00803361|2546977|P2|Overall Study|Physician Decision|0
800696|NCT00803361|2546978|P1|Overall Study|Physician Decision|1
800697|NCT00803361|2546977|P2|Overall Study|Lost to Follow-up|2
800698|NCT00803361|2546978|P1|Overall Study|Lost to Follow-up|1
800699|NCT00803361|2546977|P2|Overall Study|Lack of Efficacy|13
800700|NCT00803361|2546978|P1|Overall Study|Lack of Efficacy|4
800701|NCT00803361|2546977|P2|Overall Study|Adverse Event|3
800702|NCT00803361|2546978|P1|Overall Study|Adverse Event|13
800703|NCT00803595|2547053|P3|Overall Study|Withdrawal by Subject|3
800704|NCT00803595|2547054|P2|Overall Study|Withdrawal by Subject|2
800705|NCT00803595|2547055|P1|Overall Study|Withdrawal by Subject|5
800706|NCT00803595|2547053|P3|Overall Study|Protocol Violation|12
800707|NCT00803595|2547054|P2|Overall Study|Protocol Violation|2
800708|NCT00803595|2547055|P1|Overall Study|Protocol Violation|7
800709|NCT00803595|2547053|P3|Overall Study|Adverse Event|1
800710|NCT00803595|2547054|P2|Overall Study|Adverse Event|4
800711|NCT00803595|2547055|P1|Overall Study|Adverse Event|3
800712|NCT00803634|2547068|P2|Overall Study|Death|2
800713|NCT00803634|2547069|P1|Overall Study|Death|3
800714|NCT00803634|2547068|P2|Overall Study|Lost to Follow-up|3
800715|NCT00803634|2547069|P1|Overall Study|Lost to Follow-up|2
800716|NCT00803634|2547068|P2|Overall Study|Withdrew Consent|0
800717|NCT00803634|2547069|P1|Overall Study|Withdrew Consent|1
800718|NCT00803712|2547129|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
800719|NCT00803712|2547130|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
800720|NCT00803712|2547129|P2|Overall Study|Administrative decision|3
800721|NCT00803712|2547130|P1|Overall Study|Administrative decision|2
800722|NCT00803712|2547129|P2|Overall Study|Protocol criteria (renal transplant)|8
800723|NCT00803712|2547130|P1|Overall Study|Protocol criteria (renal transplant)|12
800724|NCT00803712|2547129|P2|Overall Study|Protocol criteria (other)|2
800725|NCT00803712|2547130|P1|Overall Study|Protocol criteria (other)|0
800726|NCT00803712|2547129|P2|Overall Study|"Other in electronic Case Report Form"|1
800727|NCT00803712|2547130|P1|Overall Study|"Other in electronic Case Report Form"|0
800728|NCT00803712|2547129|P2|Overall Study|Withdrawal by Subject|4
800729|NCT00803712|2547130|P1|Overall Study|Withdrawal by Subject|2
800730|NCT00803712|2547129|P2|Overall Study|Lost to Follow-up|1
800731|NCT00803712|2547130|P1|Overall Study|Lost to Follow-up|3
800732|NCT00803712|2547129|P2|Overall Study|Death|7
800733|NCT00803712|2547130|P1|Overall Study|Death|8
800734|NCT00803712|2547129|P2|Overall Study|Adverse Event|0
800735|NCT00803712|2547130|P1|Overall Study|Adverse Event|5
800736|NCT00803712|2547129|P2|Overall Study|Noncompliance|0
800737|NCT00803712|2547130|P1|Overall Study|Noncompliance|3
800738|NCT00803738|2547196|P2|Overall Study|Positive Results for STD or abnormal PAP|8
800739|NCT00803738|2547197|P1|Overall Study|Positive Results for STD or abnormal PAP|2
800740|NCT00803738|2547196|P2|Overall Study|Negative Baseline Culture of Candida|63
800741|NCT00803738|2547197|P1|Overall Study|Negative Baseline Culture of Candida|56
800742|NCT00803738|2547196|P2|Overall Study|Lack of Efficacy|16
800743|NCT00803738|2547197|P1|Overall Study|Lack of Efficacy|10
800744|NCT00803738|2547196|P2|Overall Study|Withdrawal by Subject|4
800745|NCT00803738|2547197|P1|Overall Study|Withdrawal by Subject|1
800746|NCT00803738|2547196|P2|Overall Study|Protocol Violation|10
800747|NCT00803738|2547197|P1|Overall Study|Protocol Violation|18
800748|NCT00803738|2547196|P2|Overall Study|Lost to Follow-up|4
800749|NCT00803738|2547197|P1|Overall Study|Lost to Follow-up|4
800750|NCT00803738|2547196|P2|Overall Study|Adverse Event|5
800751|NCT00803738|2547197|P1|Overall Study|Adverse Event|3
800752|NCT00803790|2547236|P4|Period 2|Positive Drug Screen or Personal Reasons|0
800753|NCT00803790|2547237|P3|Period 2|Positive Drug Screen or Personal Reasons|0
800754|NCT00803790|2547238|P2|Period 2|Positive Drug Screen or Personal Reasons|0
800755|NCT00803790|2547239|P1|Period 2|Positive Drug Screen or Personal Reasons|1
800756|NCT00803790|2547236|P4|Period 2|Withdrawal by Subject|0
800757|NCT00803790|2547237|P3|Period 2|Withdrawal by Subject|0
800758|NCT00803790|2547238|P2|Period 2|Withdrawal by Subject|0
800759|NCT00803790|2547239|P1|Period 2|Withdrawal by Subject|1
800760|NCT00803790|2547236|P4|Period 2|Adverse Event|1
800761|NCT00803790|2547237|P3|Period 2|Adverse Event|1
800762|NCT00803790|2547238|P2|Period 2|Adverse Event|0
800763|NCT00803790|2547239|P1|Period 2|Adverse Event|0
800764|NCT00803790|2547236|P4|Period 1|Protocol Violation|0
800765|NCT00803790|2547237|P3|Period 1|Protocol Violation|1
800766|NCT00803790|2547238|P2|Period 1|Protocol Violation|0
800767|NCT00803790|2547239|P1|Period 1|Protocol Violation|0
800768|NCT00803790|2547236|P4|Period 1|positive drug screen or personal reasons|4
800769|NCT00803790|2547237|P3|Period 1|positive drug screen or personal reasons|0
800770|NCT00803790|2547238|P2|Period 1|positive drug screen or personal reasons|3
800771|NCT00803790|2547239|P1|Period 1|positive drug screen or personal reasons|0
800772|NCT00803790|2547236|P4|Period 1|Withdrawal by Subject|0
800773|NCT00803790|2547237|P3|Period 1|Withdrawal by Subject|0
800774|NCT00803790|2547238|P2|Period 1|Withdrawal by Subject|6
800775|NCT00803790|2547239|P1|Period 1|Withdrawal by Subject|8
800776|NCT00803790|2547236|P4|Period 1|Lost to Follow-up|0
800777|NCT00803790|2547237|P3|Period 1|Lost to Follow-up|0
800778|NCT00803790|2547238|P2|Period 1|Lost to Follow-up|2
800779|NCT00803790|2547239|P1|Period 1|Lost to Follow-up|1
800780|NCT00803790|2547236|P4|Period 1|Adverse Event|0
800781|NCT00803790|2547237|P3|Period 1|Adverse Event|0
800782|NCT00803790|2547238|P2|Period 1|Adverse Event|1
800783|NCT00803790|2547239|P1|Period 1|Adverse Event|0
800784|NCT00789035|2547288|P5|Overall Study|Other reason not defined above|1
800785|NCT00789035|2547289|P4|Overall Study|Other reason not defined above|0
800786|NCT00789035|2547290|P3|Overall Study|Other reason not defined above|1
800787|NCT00789035|2547291|P2|Overall Study|Other reason not defined above|3
800788|NCT00789035|2547292|P1|Overall Study|Other reason not defined above|2
800789|NCT00789035|2547288|P5|Overall Study|Withdrawal by Subject|0
800790|NCT00789035|2547289|P4|Overall Study|Withdrawal by Subject|0
800791|NCT00789035|2547290|P3|Overall Study|Withdrawal by Subject|0
800792|NCT00789035|2547291|P2|Overall Study|Withdrawal by Subject|2
800793|NCT00789035|2547292|P1|Overall Study|Withdrawal by Subject|0
800794|NCT00789035|2547288|P5|Overall Study|Protocol Violation|0
800795|NCT00789035|2547289|P4|Overall Study|Protocol Violation|0
800796|NCT00789035|2547290|P3|Overall Study|Protocol Violation|0
800797|NCT00789035|2547291|P2|Overall Study|Protocol Violation|0
800798|NCT00789035|2547292|P1|Overall Study|Protocol Violation|1
800799|NCT00789035|2547288|P5|Overall Study|Lack of Efficacy|2
800800|NCT00789035|2547289|P4|Overall Study|Lack of Efficacy|0
800801|NCT00789035|2547290|P3|Overall Study|Lack of Efficacy|0
800802|NCT00789035|2547291|P2|Overall Study|Lack of Efficacy|0
800803|NCT00789035|2547292|P1|Overall Study|Lack of Efficacy|3
800804|NCT00789035|2547288|P5|Overall Study|Adverse Event|3
800805|NCT00789035|2547289|P4|Overall Study|Adverse Event|1
800806|NCT00789035|2547290|P3|Overall Study|Adverse Event|0
800807|NCT00789035|2547291|P2|Overall Study|Adverse Event|2
800808|NCT00789035|2547292|P1|Overall Study|Adverse Event|0
800809|NCT00789191|2547373|P2|Overall Study|Unclassified|3
800810|NCT00789191|2547374|P1|Overall Study|Unclassified|5
800811|NCT00789191|2547373|P2|Overall Study|Withdrawal Criteria|4
800812|NCT00789191|2547374|P1|Overall Study|Withdrawal Criteria|2
800813|NCT00789191|2547373|P2|Overall Study|Protocol Violation|3
800814|NCT00789191|2547374|P1|Overall Study|Protocol Violation|5
800815|NCT00789191|2547373|P2|Overall Study|Lack of Efficacy|5
800816|NCT00789191|2547374|P1|Overall Study|Lack of Efficacy|0
800817|NCT00789191|2547373|P2|Overall Study|Adverse Event|4
800818|NCT00789191|2547374|P1|Overall Study|Adverse Event|2
800819|NCT00789321|2547413|P2|Overall Study|Adverse Event|1
800820|NCT00789321|2547414|P1|Overall Study|Adverse Event|0
800821|NCT00789373|2547422|P3|Maintenance|Participants On-Going at Data Cut-Off|0
800822|NCT00789373|2547423|P2|Maintenance|Participants On-Going at Data Cut-Off|4
800823|NCT00789373|2547424|P1|Maintenance|Participants On-Going at Data Cut-Off|0
800824|NCT00789373|2547422|P3|Maintenance|Sponsor Decision|2
800825|NCT00789373|2547423|P2|Maintenance|Sponsor Decision|0
800826|NCT00789373|2547424|P1|Maintenance|Sponsor Decision|0
800827|NCT00789373|2547422|P3|Maintenance|Withdrawal by Subject|8
800828|NCT00789373|2547423|P2|Maintenance|Withdrawal by Subject|21
800829|NCT00789373|2547424|P1|Maintenance|Withdrawal by Subject|0
800830|NCT00789373|2547422|P3|Maintenance|Progressive Disease|152
800831|NCT00789373|2547423|P2|Maintenance|Progressive Disease|253
800832|NCT00789373|2547424|P1|Maintenance|Progressive Disease|0
800833|NCT00789373|2547422|P3|Maintenance|Lost to Follow-up|0
800834|NCT00789373|2547423|P2|Maintenance|Lost to Follow-up|2
800835|NCT00789373|2547424|P1|Maintenance|Lost to Follow-up|0
800836|NCT00789373|2547422|P3|Maintenance|Protocol entry criteria not met|0
800837|NCT00789373|2547423|P2|Maintenance|Protocol entry criteria not met|2
800838|NCT00789373|2547424|P1|Maintenance|Protocol entry criteria not met|0
800839|NCT00789373|2547422|P3|Maintenance|Investigator Decision|2
800840|NCT00789373|2547423|P2|Maintenance|Investigator Decision|4
800841|NCT00789373|2547424|P1|Maintenance|Investigator Decision|0
800842|NCT00789373|2547422|P3|Maintenance|Death due to toxicity|2
800843|NCT00789373|2547423|P2|Maintenance|Death due to toxicity|1
800844|NCT00789373|2547424|P1|Maintenance|Death due to toxicity|0
800845|NCT00789373|2547422|P3|Maintenance|Death due to adverse event|1
800846|NCT00789373|2547423|P2|Maintenance|Death due to adverse event|4
800847|NCT00789373|2547424|P1|Maintenance|Death due to adverse event|0
800848|NCT00789373|2547422|P3|Maintenance|Death due to study disease|1
800849|NCT00789373|2547423|P2|Maintenance|Death due to study disease|3
800850|NCT00789373|2547424|P1|Maintenance|Death due to study disease|0
800851|NCT00789373|2547422|P3|Maintenance|Adverse Event|12
800852|NCT00789373|2547423|P2|Maintenance|Adverse Event|65
800853|NCT00789373|2547424|P1|Maintenance|Adverse Event|0
800854|NCT00789373|2547422|P3|Induction|Withdrawal by Subject|0
800855|NCT00789373|2547423|P2|Induction|Withdrawal by Subject|0
800856|NCT00789373|2547424|P1|Induction|Withdrawal by Subject|37
800857|NCT00789373|2547422|P3|Induction|Progressive Disease|0
800858|NCT00789373|2547423|P2|Induction|Progressive Disease|0
800859|NCT00789373|2547424|P1|Induction|Progressive Disease|220
800860|NCT00789373|2547422|P3|Induction|Protocol Violation|0
800861|NCT00789373|2547423|P2|Induction|Protocol Violation|0
800862|NCT00789373|2547424|P1|Induction|Protocol Violation|1
800863|NCT00789373|2547422|P3|Induction|Lost to Follow-up|0
800864|NCT00789373|2547423|P2|Induction|Lost to Follow-up|0
800865|NCT00789373|2547424|P1|Induction|Lost to Follow-up|6
800866|NCT00789373|2547422|P3|Induction|Protocol entry criteria not met|0
800867|NCT00789373|2547423|P2|Induction|Protocol entry criteria not met|0
800868|NCT00789373|2547424|P1|Induction|Protocol entry criteria not met|9
800869|NCT00789373|2547422|P3|Induction|Investigator decision|0
800870|NCT00789373|2547423|P2|Induction|Investigator decision|0
800871|NCT00789373|2547424|P1|Induction|Investigator decision|7
800872|NCT00789373|2547422|P3|Induction|Death due to procedure|0
800873|NCT00789373|2547423|P2|Induction|Death due to procedure|0
800874|NCT00789373|2547424|P1|Induction|Death due to procedure|1
800875|NCT00789373|2547422|P3|Induction|Death due to toxicity|0
800876|NCT00789373|2547423|P2|Induction|Death due to toxicity|0
800877|NCT00789373|2547424|P1|Induction|Death due to toxicity|11
800878|NCT00789373|2547422|P3|Induction|Death due to adverse event|0
800879|NCT00789373|2547423|P2|Induction|Death due to adverse event|0
800880|NCT00789373|2547424|P1|Induction|Death due to adverse event|19
800881|NCT00789373|2547422|P3|Induction|Death Due to study disease|0
800882|NCT00789373|2547423|P2|Induction|Death Due to study disease|0
800883|NCT00789373|2547424|P1|Induction|Death Due to study disease|24
800884|NCT00789373|2547422|P3|Induction|Adverse Event|0
800885|NCT00789373|2547423|P2|Induction|Adverse Event|0
800886|NCT00789373|2547424|P1|Induction|Adverse Event|64
800887|NCT00789477|2547467|P5|Overall Study|Other|0
800888|NCT00789477|2547468|P4|Overall Study|Other|3
800889|NCT00789477|2547469|P3|Overall Study|Other|1
800890|NCT00789477|2547470|P2|Overall Study|Other|0
800891|NCT00789477|2547471|P1|Overall Study|Other|2
800892|NCT00789477|2547467|P5|Overall Study|Lack of Efficacy|0
800893|NCT00789477|2547468|P4|Overall Study|Lack of Efficacy|0
800894|NCT00789477|2547469|P3|Overall Study|Lack of Efficacy|0
800895|NCT00789477|2547470|P2|Overall Study|Lack of Efficacy|0
800896|NCT00789477|2547471|P1|Overall Study|Lack of Efficacy|2
800897|NCT00789477|2547467|P5|Overall Study|Lost to Follow-up|4
800898|NCT00789477|2547468|P4|Overall Study|Lost to Follow-up|2
800899|NCT00789477|2547469|P3|Overall Study|Lost to Follow-up|4
800900|NCT00789477|2547470|P2|Overall Study|Lost to Follow-up|1
800901|NCT00789477|2547471|P1|Overall Study|Lost to Follow-up|0
800902|NCT00789477|2547467|P5|Overall Study|Death|0
800903|NCT00789477|2547468|P4|Overall Study|Death|2
800904|NCT00789477|2547469|P3|Overall Study|Death|2
800905|NCT00789477|2547470|P2|Overall Study|Death|1
800906|NCT00789477|2547471|P1|Overall Study|Death|1
800907|NCT00789477|2547467|P5|Overall Study|Adverse Event|0
800908|NCT00789477|2547468|P4|Overall Study|Adverse Event|0
800909|NCT00789477|2547469|P3|Overall Study|Adverse Event|1
800910|NCT00789477|2547470|P2|Overall Study|Adverse Event|3
800911|NCT00789477|2547471|P1|Overall Study|Adverse Event|3
800912|NCT00789477|2547467|P5|Overall Study|Protocol Violation|0
800913|NCT00789477|2547468|P4|Overall Study|Protocol Violation|1
800914|NCT00789477|2547469|P3|Overall Study|Protocol Violation|0
800915|NCT00789477|2547470|P2|Overall Study|Protocol Violation|0
800916|NCT00789477|2547471|P1|Overall Study|Protocol Violation|1
800917|NCT00789477|2547467|P5|Overall Study|Withdrawal by Subject|3
800918|NCT00789477|2547468|P4|Overall Study|Withdrawal by Subject|2
800919|NCT00789477|2547469|P3|Overall Study|Withdrawal by Subject|3
800920|NCT00789477|2547470|P2|Overall Study|Withdrawal by Subject|1
800921|NCT00789477|2547471|P1|Overall Study|Withdrawal by Subject|2
800922|NCT00789529|2547505|P2|Overall Study|Other Reason|0
800923|NCT00789529|2547506|P1|Overall Study|Other Reason|1
800924|NCT00789529|2547505|P2|Overall Study|Withdrawal by Subject|1
800925|NCT00789529|2547506|P1|Overall Study|Withdrawal by Subject|0
800926|NCT00789555|2547517|P3|Overall Study|Protocol Violation|13
800927|NCT00789555|2547518|P2|Overall Study|Protocol Violation|9
800928|NCT00789555|2547519|P1|Overall Study|Protocol Violation|6
800929|NCT00789555|2547517|P3|Overall Study|Treatment failure|12
800930|NCT00789555|2547518|P2|Overall Study|Treatment failure|8
800931|NCT00789555|2547519|P1|Overall Study|Treatment failure|11
800932|NCT00789555|2547517|P3|Overall Study|Patient decision unnrelated to adv event|26
800933|NCT00789555|2547518|P2|Overall Study|Patient decision unnrelated to adv event|29
800934|NCT00789555|2547519|P1|Overall Study|Patient decision unnrelated to adv event|38
800935|NCT00789555|2547517|P3|Overall Study|Lost to Follow-up|18
800936|NCT00789555|2547518|P2|Overall Study|Lost to Follow-up|10
800937|NCT00789555|2547519|P1|Overall Study|Lost to Follow-up|9
800938|NCT00789555|2547517|P3|Overall Study|Adverse Event|10
800939|NCT00789555|2547518|P2|Overall Study|Adverse Event|7
800940|NCT00789555|2547519|P1|Overall Study|Adverse Event|17
800941|NCT00789555|2547517|P3|Overall Study|Protocol Amendment|80
800942|NCT00789555|2547518|P2|Overall Study|Protocol Amendment|76
800943|NCT00789555|2547519|P1|Overall Study|Protocol Amendment|78
800944|NCT00789581|2547544|P2|Adjuvant Therapy|Not Specified|1
800945|NCT00789581|2547545|P1|Adjuvant Therapy|Not Specified|0
800946|NCT00789581|2547544|P2|Adjuvant Therapy|Protocol Violation|1
800947|NCT00789581|2547545|P1|Adjuvant Therapy|Protocol Violation|1
800948|NCT00789581|2547544|P2|Adjuvant Therapy|Intercurrent Illness|3
800949|NCT00789581|2547545|P1|Adjuvant Therapy|Intercurrent Illness|1
800950|NCT00789581|2547544|P2|Adjuvant Therapy|Disease recurrence|1
800951|NCT00789581|2547545|P1|Adjuvant Therapy|Disease recurrence|2
800952|NCT00789581|2547544|P2|Adjuvant Therapy|Withdrawal by Subject|5
800953|NCT00789581|2547545|P1|Adjuvant Therapy|Withdrawal by Subject|14
800954|NCT00789581|2547544|P2|Adjuvant Therapy|Adverse Event|44
800955|NCT00789581|2547545|P1|Adjuvant Therapy|Adverse Event|20
800956|NCT00789581|2547544|P2|Adjuvant Therapy|Never treated|2
800957|NCT00789581|2547545|P1|Adjuvant Therapy|Never treated|2
800958|NCT00789581|2547544|P2|AC Therapy|Not specified|2
800959|NCT00789581|2547545|P1|AC Therapy|Not specified|0
800960|NCT00789581|2547544|P2|AC Therapy|Never Treated|4
800961|NCT00789581|2547545|P1|AC Therapy|Never Treated|1
800962|NCT00789581|2547544|P2|AC Therapy|Intercurrent Illness|0
800963|NCT00789581|2547545|P1|AC Therapy|Intercurrent Illness|1
800964|NCT00789581|2547544|P2|AC Therapy|Disease recurrence|1
800965|NCT00789581|2547545|P1|AC Therapy|Disease recurrence|3
800966|NCT00789581|2547544|P2|AC Therapy|Withdrawal by Subject|7
800967|NCT00789581|2547545|P1|AC Therapy|Withdrawal by Subject|4
800968|NCT00789581|2547544|P2|AC Therapy|Adverse Event|3
800969|NCT00789581|2547545|P1|AC Therapy|Adverse Event|2
800970|NCT00789698|2547596|P4|Overall Study|Administrative|1
800971|NCT00789698|2547597|P3|Overall Study|Administrative|3
800972|NCT00789698|2547598|P2|Overall Study|Administrative|3
800973|NCT00789698|2547599|P1|Overall Study|Administrative|0
800974|NCT00789698|2547596|P4|Overall Study|Withdrawal by Subject|19
800975|NCT00789698|2547597|P3|Overall Study|Withdrawal by Subject|12
800976|NCT00789698|2547598|P2|Overall Study|Withdrawal by Subject|15
800977|NCT00789698|2547599|P1|Overall Study|Withdrawal by Subject|14
800978|NCT00789698|2547596|P4|Overall Study|Protocol Violation|1
800979|NCT00789698|2547597|P3|Overall Study|Protocol Violation|2
800980|NCT00789698|2547598|P2|Overall Study|Protocol Violation|1
800981|NCT00789698|2547599|P1|Overall Study|Protocol Violation|6
800982|NCT00789698|2547596|P4|Overall Study|Lost to Follow-up|9
800983|NCT00789698|2547597|P3|Overall Study|Lost to Follow-up|2
800984|NCT00789698|2547598|P2|Overall Study|Lost to Follow-up|5
800985|NCT00789698|2547599|P1|Overall Study|Lost to Follow-up|5
800986|NCT00789698|2547596|P4|Overall Study|Adverse Event|4
800987|NCT00789698|2547597|P3|Overall Study|Adverse Event|3
800988|NCT00789698|2547598|P2|Overall Study|Adverse Event|5
800989|NCT00789698|2547599|P1|Overall Study|Adverse Event|5
800990|NCT00789698|2547596|P4|Overall Study|Lack of Efficacy|18
800991|NCT00789698|2547597|P3|Overall Study|Lack of Efficacy|5
800992|NCT00789698|2547598|P2|Overall Study|Lack of Efficacy|4
800993|NCT00789698|2547599|P1|Overall Study|Lack of Efficacy|10
800994|NCT00789737|2547624|P2|Overall Study|not specified|7
800995|NCT00789737|2547625|P1|Overall Study|not specified|11
800996|NCT00789737|2547624|P2|Overall Study|hyperglycemia that met protocol-specifie|4
800997|NCT00789737|2547625|P1|Overall Study|hyperglycemia that met protocol-specifie|0
800998|NCT00789737|2547624|P2|Overall Study|Lack of Efficacy|0
800999|NCT00789737|2547625|P1|Overall Study|Lack of Efficacy|3
801000|NCT00789737|2547624|P2|Overall Study|Protocol Violation|0
801001|NCT00789737|2547625|P1|Overall Study|Protocol Violation|3
801002|NCT00789737|2547624|P2|Overall Study|Adverse Event|8
801003|NCT00789737|2547625|P1|Overall Study|Adverse Event|8
801004|NCT00789737|2547624|P2|Overall Study|Lost to Follow-up|14
801005|NCT00789737|2547625|P1|Overall Study|Lost to Follow-up|10
801006|NCT00789737|2547624|P2|Overall Study|Withdrawal by Subject|22
801007|NCT00789737|2547625|P1|Overall Study|Withdrawal by Subject|13
801008|NCT00789815|2547715|P2|Overall Study|Intubation due to massive bleeding|0
801009|NCT00789815|2547716|P1|Overall Study|Intubation due to massive bleeding|1
801010|NCT00789815|2547715|P2|Overall Study|Protocol Violation|1
801011|NCT00789815|2547716|P1|Overall Study|Protocol Violation|6
801012|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
801013|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
801014|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Disease progression|0
801015|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Disease progression|1
801016|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Death|0
801017|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Death|1
801018|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Administrative problems|0
801019|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Administrative problems|7
801020|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
801021|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
801022|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
801023|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
801024|NCT00789828|2547738|P2|Open-label Extension Period (4 Years)|Adverse Event|0
801025|NCT00789828|2547739|P1|Open-label Extension Period (4 Years)|Adverse Event|10
801026|NCT00789828|2547738|P2|Core Period (48 Weeks)|Lost to Follow-up|1
801027|NCT00789828|2547739|P1|Core Period (48 Weeks)|Lost to Follow-up|0
801028|NCT00789828|2547738|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
801029|NCT00789828|2547739|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
801030|NCT00789828|2547738|P2|Core Period (48 Weeks)|Administrative problems|1
801031|NCT00789828|2547739|P1|Core Period (48 Weeks)|Administrative problems|0
801032|NCT00789854|2547774|P3|Overall Study|Other|5
801033|NCT00789854|2547775|P2|Overall Study|Other|0
801034|NCT00789854|2547776|P1|Overall Study|Other|6
801035|NCT00789854|2547774|P3|Overall Study|Safety reasons|2
801036|NCT00789854|2547775|P2|Overall Study|Safety reasons|0
801037|NCT00789854|2547776|P1|Overall Study|Safety reasons|0
801038|NCT00789854|2547774|P3|Overall Study|Severe non-compliance to the protocol|0
801039|NCT00789854|2547775|P2|Overall Study|Severe non-compliance to the protocol|0
801040|NCT00789854|2547776|P1|Overall Study|Severe non-compliance to the protocol|3
801041|NCT00789854|2547774|P3|Overall Study|Eligibility criteria not fulfilled|1
801042|NCT00789854|2547775|P2|Overall Study|Eligibility criteria not fulfilled|5
801043|NCT00789854|2547776|P1|Overall Study|Eligibility criteria not fulfilled|2
801044|NCT00789854|2547774|P3|Overall Study|Withdrawal by Subject|17
801045|NCT00789854|2547775|P2|Overall Study|Withdrawal by Subject|6
801046|NCT00789854|2547776|P1|Overall Study|Withdrawal by Subject|9
801047|NCT00789854|2547774|P3|Overall Study|Lost to Follow-up|4
801048|NCT00789854|2547775|P2|Overall Study|Lost to Follow-up|1
801049|NCT00789854|2547776|P1|Overall Study|Lost to Follow-up|1
801050|NCT00789854|2547774|P3|Overall Study|Adverse Event|18
801051|NCT00789854|2547775|P2|Overall Study|Adverse Event|23
801052|NCT00789854|2547776|P1|Overall Study|Adverse Event|28
801053|NCT00789880|2547877|P6|Overall Study|Withdrawal by Subject|0
801054|NCT00789880|2547878|P5|Overall Study|Withdrawal by Subject|2
801055|NCT00789880|2547879|P4|Overall Study|Withdrawal by Subject|0
801056|NCT00789880|2547880|P3|Overall Study|Withdrawal by Subject|0
801057|NCT00789880|2547881|P2|Overall Study|Withdrawal by Subject|0
801058|NCT00789880|2547882|P1|Overall Study|Withdrawal by Subject|1
801059|NCT00789880|2547877|P6|Overall Study|Protocol Violation|0
801060|NCT00789880|2547878|P5|Overall Study|Protocol Violation|0
801061|NCT00789880|2547879|P4|Overall Study|Protocol Violation|1
801062|NCT00789880|2547880|P3|Overall Study|Protocol Violation|0
801063|NCT00789880|2547881|P2|Overall Study|Protocol Violation|1
801064|NCT00789880|2547882|P1|Overall Study|Protocol Violation|0
801065|NCT00789880|2547877|P6|Overall Study|Adverse Event|0
801066|NCT00789880|2547878|P5|Overall Study|Adverse Event|1
801067|NCT00789880|2547879|P4|Overall Study|Adverse Event|0
801068|NCT00789880|2547880|P3|Overall Study|Adverse Event|0
801069|NCT00789880|2547881|P2|Overall Study|Adverse Event|0
801070|NCT00789880|2547882|P1|Overall Study|Adverse Event|0
801071|NCT00789958|2547908|P1|Overall Study|Not eligible/not analyzable|26
801072|NCT00789958|2547908|P1|Overall Study|not protocol specified|1
801073|NCT00789958|2547908|P1|Overall Study|Progression|3
801074|NCT00789958|2547908|P1|Overall Study|Withdrawal by Subject|4
801075|NCT00789958|2547908|P1|Overall Study|Adverse Event|3
801076|NCT00790023|2547935|P3|Overall Study|Not specified|8
801077|NCT00790023|2547936|P2|Overall Study|Not specified|5
801078|NCT00790023|2547937|P1|Overall Study|Not specified|5
801079|NCT00790023|2547935|P3|Overall Study|Lost to Follow-up|1
801080|NCT00790023|2547936|P2|Overall Study|Lost to Follow-up|0
801081|NCT00790023|2547937|P1|Overall Study|Lost to Follow-up|0
801082|NCT00790023|2547935|P3|Overall Study|Withdrawal by Subject|6
801083|NCT00790023|2547936|P2|Overall Study|Withdrawal by Subject|0
801084|NCT00790023|2547937|P1|Overall Study|Withdrawal by Subject|2
801085|NCT00790023|2547935|P3|Overall Study|Protocol Violation|2
801086|NCT00790023|2547936|P2|Overall Study|Protocol Violation|4
801087|NCT00790023|2547937|P1|Overall Study|Protocol Violation|2
801088|NCT00790023|2547935|P3|Overall Study|Adverse Event|4
801089|NCT00790023|2547936|P2|Overall Study|Adverse Event|1
801090|NCT00790023|2547937|P1|Overall Study|Adverse Event|2
801091|NCT00790036|2548027|P2|Overall Study|Subject/guardian decision|7
801092|NCT00790036|2548028|P1|Overall Study|Subject/guardian decision|20
801093|NCT00790036|2548027|P2|Overall Study|Withdrawal by Subject|7
801094|NCT00790036|2548028|P1|Overall Study|Withdrawal by Subject|18
801095|NCT00790036|2548027|P2|Overall Study|Protocol Violation|2
801096|NCT00790036|2548028|P1|Overall Study|Protocol Violation|10
801097|NCT00790036|2548027|P2|Overall Study|Lost to Follow-up|2
801098|NCT00790036|2548028|P1|Overall Study|Lost to Follow-up|1
801099|NCT00790036|2548027|P2|Overall Study|Disease progression|48
801100|NCT00790036|2548028|P1|Overall Study|Disease progression|24
801101|NCT00790036|2548027|P2|Overall Study|Death|0
801102|NCT00790036|2548028|P1|Overall Study|Death|1
801103|NCT00790036|2548027|P2|Overall Study|Adverse Event|44
801104|NCT00790036|2548028|P1|Overall Study|Adverse Event|113
801105|NCT00790036|2548027|P2|Overall Study|Administrative problems|9
801106|NCT00790036|2548028|P1|Overall Study|Administrative problems|5
801107|NCT00790036|2548027|P2|Overall Study|Abnormal lab values|2
801108|NCT00790036|2548028|P1|Overall Study|Abnormal lab values|3
801109|NCT00790205|2548096|P2|Overall Study|Withdrawal by Subject|363
801110|NCT00790205|2548097|P1|Overall Study|Withdrawal by Subject|299
801111|NCT00790205|2548096|P2|Overall Study|Lost to Follow-up|71
801112|NCT00790205|2548097|P1|Overall Study|Lost to Follow-up|61
801113|NCT00790218|2548137|P3|Overall Study|Death|0
801114|NCT00790218|2548138|P2|Overall Study|Death|0
801115|NCT00790218|2548139|P1|Overall Study|Death|1
801116|NCT00790296|2548165|P2|Overall Study|Adverse Event|1
801117|NCT00790296|2548166|P1|Overall Study|Adverse Event|0
801118|NCT00790296|2548165|P2|Overall Study|Did not meet study eligibility criteria|1
801119|NCT00790296|2548166|P1|Overall Study|Did not meet study eligibility criteria|1
801120|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|New treatment|0
801121|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|New treatment|2
801122|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
801123|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
801124|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Disease progression|0
801125|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Disease progression|5
801126|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Death|0
801127|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Death|1
801128|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Administrative problems|0
801289|NCT00808132|2548613|P4|Overall Study|Unsatisfactory response|4
801129|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Administrative problems|2
801130|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
801131|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
801132|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
801133|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
801134|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
801135|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
801136|NCT00790400|2548174|P2|Everolimus Period (Core or Extension)|Adverse Event|0
801137|NCT00790400|2548175|P1|Everolimus Period (Core or Extension)|Adverse Event|9
801138|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Death|0
801139|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Death|1
801140|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Administrative problems|0
801141|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Administrative problems|1
801142|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
801143|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
801144|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
801145|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
801146|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Adverse Event|4
801147|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Adverse Event|2
801148|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Progressive disease|9
801149|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Progressive disease|0
801150|NCT00790400|2548174|P2|Double-blind Period (Core Phase)|Protocol Violation|0
801151|NCT00790400|2548175|P1|Double-blind Period (Core Phase)|Protocol Violation|1
801152|NCT00790452|2548204|P2|Overall Study|Drug supply issue|0
801153|NCT00790452|2548205|P1|Overall Study|Drug supply issue|1
801154|NCT00790556|2548211|P2|Treatment Period 1|Withdrawal by Subject|0
801155|NCT00790556|2548212|P1|Treatment Period 1|Withdrawal by Subject|1
801156|NCT00790556|2548211|P2|Treatment Period 1|Physician Decision|0
801157|NCT00790556|2548212|P1|Treatment Period 1|Physician Decision|1
801176|NCT00790647|2548250|P1|Overall Study|Adverse Event|1
801177|NCT00790751|2548291|P4|Overall Study|Physician Decision|1
801178|NCT00790751|2548292|P3|Overall Study|Physician Decision|0
801179|NCT00790751|2548293|P2|Overall Study|Physician Decision|0
801180|NCT00790751|2548294|P1|Overall Study|Physician Decision|0
801181|NCT00790751|2548291|P4|Overall Study|Death|0
801182|NCT00790751|2548292|P3|Overall Study|Death|1
801183|NCT00790751|2548293|P2|Overall Study|Death|0
801184|NCT00790751|2548294|P1|Overall Study|Death|0
801185|NCT00790751|2548291|P4|Overall Study|Requirement for restricted medication|0
801186|NCT00790751|2548292|P3|Overall Study|Requirement for restricted medication|0
801187|NCT00790751|2548293|P2|Overall Study|Requirement for restricted medication|2
801188|NCT00790751|2548294|P1|Overall Study|Requirement for restricted medication|0
801189|NCT00790751|2548291|P4|Overall Study|Adverse Event|4
801190|NCT00790751|2548292|P3|Overall Study|Adverse Event|5
801191|NCT00790751|2548293|P2|Overall Study|Adverse Event|3
801192|NCT00790751|2548294|P1|Overall Study|Adverse Event|5
801193|NCT00790751|2548291|P4|Overall Study|Lost to Follow-up|5
801194|NCT00790751|2548292|P3|Overall Study|Lost to Follow-up|4
801195|NCT00790751|2548293|P2|Overall Study|Lost to Follow-up|9
801196|NCT00790751|2548294|P1|Overall Study|Lost to Follow-up|4
801197|NCT00790751|2548291|P4|Overall Study|Protocol non-compliance|11
801198|NCT00790751|2548292|P3|Overall Study|Protocol non-compliance|10
801199|NCT00790751|2548293|P2|Overall Study|Protocol non-compliance|16
801200|NCT00790751|2548294|P1|Overall Study|Protocol non-compliance|16
801201|NCT00790790|2548315|P3|Study Period 2: Therapy Phase|Physician Decision|0
801202|NCT00790790|2548316|P2|Study Period 2: Therapy Phase|Physician Decision|1
801203|NCT00790790|2548317|P1|Study Period 2: Therapy Phase|Physician Decision|0
801204|NCT00790790|2548315|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
801205|NCT00790790|2548316|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
801206|NCT00790790|2548317|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
801207|NCT00790790|2548315|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
801208|NCT00790790|2548316|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
801209|NCT00790790|2548317|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
801210|NCT00790790|2548315|P3|Study Period 2: Therapy Phase|Protocol Violation|0
801211|NCT00790790|2548316|P2|Study Period 2: Therapy Phase|Protocol Violation|1
801212|NCT00790790|2548317|P1|Study Period 2: Therapy Phase|Protocol Violation|1
801213|NCT00790790|2548315|P3|Study Period 2: Therapy Phase|Adverse Event|16
801214|NCT00790790|2548316|P2|Study Period 2: Therapy Phase|Adverse Event|16
801215|NCT00790790|2548317|P1|Study Period 2: Therapy Phase|Adverse Event|3
801216|NCT00790907|2548406|P3|Overall Study|Did Not Receive Study Drug|0
801217|NCT00790907|2548407|P2|Overall Study|Did Not Receive Study Drug|0
801218|NCT00790907|2548408|P1|Overall Study|Did Not Receive Study Drug|10
801219|NCT00790907|2548406|P3|Overall Study|Verbatim Reason on the Case Report Form|29
801220|NCT00790907|2548407|P2|Overall Study|Verbatim Reason on the Case Report Form|20
801221|NCT00790907|2548408|P1|Overall Study|Verbatim Reason on the Case Report Form|74
801222|NCT00790907|2548406|P3|Overall Study|Qualifying Condition Not Present|16
801223|NCT00790907|2548407|P2|Overall Study|Qualifying Condition Not Present|14
801224|NCT00790907|2548408|P1|Overall Study|Qualifying Condition Not Present|29
801225|NCT00790907|2548406|P3|Overall Study|Required Protocol-prohibited Therapy|7
801226|NCT00790907|2548407|P2|Overall Study|Required Protocol-prohibited Therapy|5
801227|NCT00790907|2548408|P1|Overall Study|Required Protocol-prohibited Therapy|17
801228|NCT00790907|2548406|P3|Overall Study|Bleeding Event|21
801229|NCT00790907|2548407|P2|Overall Study|Bleeding Event|16
801230|NCT00790907|2548408|P1|Overall Study|Bleeding Event|11
801231|NCT00790907|2548406|P3|Overall Study|Withdrawal by Subject|5
801232|NCT00790907|2548407|P2|Overall Study|Withdrawal by Subject|7
801233|NCT00790907|2548408|P1|Overall Study|Withdrawal by Subject|1
801234|NCT00790907|2548406|P3|Overall Study|Physician Decision|255
801235|NCT00790907|2548407|P2|Overall Study|Physician Decision|271
801236|NCT00790907|2548408|P1|Overall Study|Physician Decision|304
801237|NCT00790907|2548406|P3|Overall Study|Adverse Event|6
801238|NCT00790907|2548407|P2|Overall Study|Adverse Event|7
801239|NCT00790907|2548408|P1|Overall Study|Adverse Event|9
801240|NCT00791076|2548436|P1|Overall Study|Study was terminated,PI left institution|8
801241|NCT00791128|2548470|P1|Overall Study|abdominal tumor, unrelated to device|1
801242|NCT00791128|2548470|P1|Overall Study|non-compliance by subject|2
801243|NCT00791128|2548470|P1|Overall Study|Device migration|2
801244|NCT00791128|2548470|P1|Overall Study|Adverse Event|4
801245|NCT00791258|2548475|P1|Overall Study|Lack of Efficacy|1
801246|NCT00791258|2548475|P1|Overall Study|Subject required restricted medication|1
801247|NCT00791258|2548475|P1|Overall Study|Subject incarcerated|1
801248|NCT00791258|2548475|P1|Overall Study|non-compliance|3
801249|NCT00791258|2548475|P1|Overall Study|subject left area|2
801250|NCT00791258|2548475|P1|Overall Study|Did not take medication for >3 days|1
801251|NCT00791258|2548475|P1|Overall Study|Withdrawal by Subject|40
801252|NCT00791258|2548475|P1|Overall Study|Protocol Violation|109
801253|NCT00791258|2548475|P1|Overall Study|Lost to Follow-up|18
801254|NCT00791258|2548475|P1|Overall Study|Adverse Event|87
801255|NCT00791388|2548557|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
801256|NCT00791388|2548558|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
801257|NCT00791388|2548559|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
801258|NCT00791388|2548560|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
801259|NCT00791388|2548561|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
801260|NCT00791388|2548557|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
801261|NCT00791388|2548558|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
801262|NCT00791388|2548559|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
801263|NCT00791388|2548560|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
801264|NCT00791388|2548561|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
801265|NCT00791388|2548557|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
801266|NCT00791388|2548558|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
801267|NCT00791388|2548559|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
801268|NCT00791388|2548560|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
801269|NCT00791388|2548561|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
801270|NCT00804193|2548591|P3|Overall Study|Withdrawal by Subject|2
801271|NCT00804193|2548592|P2|Overall Study|Withdrawal by Subject|1
801272|NCT00804193|2548593|P1|Overall Study|Withdrawal by Subject|3
801273|NCT00804193|2548591|P3|Overall Study|Lost to Follow-up|4
801274|NCT00804193|2548592|P2|Overall Study|Lost to Follow-up|3
801275|NCT00804193|2548593|P1|Overall Study|Lost to Follow-up|3
801276|NCT00804193|2548591|P3|Overall Study|Protocol Violation|2
801277|NCT00804193|2548592|P2|Overall Study|Protocol Violation|8
801278|NCT00804193|2548593|P1|Overall Study|Protocol Violation|0
801279|NCT00804193|2548591|P3|Overall Study|Lack of Efficacy|3
801280|NCT00804193|2548592|P2|Overall Study|Lack of Efficacy|1
801281|NCT00804193|2548593|P1|Overall Study|Lack of Efficacy|1
801282|NCT00804193|2548591|P3|Overall Study|Adverse Event|2
801283|NCT00804193|2548592|P2|Overall Study|Adverse Event|0
801284|NCT00804193|2548593|P1|Overall Study|Adverse Event|0
801285|NCT00804193|2548591|P3|Overall Study|Lack of baseline fungus|19
801286|NCT00804193|2548592|P2|Overall Study|Lack of baseline fungus|31
801287|NCT00804193|2548593|P1|Overall Study|Lack of baseline fungus|32
801288|NCT00808132|2548612|P5|Overall Study|Unsatisfactory response|12
801290|NCT00808132|2548614|P3|Overall Study|Unsatisfactory response|6
801291|NCT00808132|2548615|P2|Overall Study|Unsatisfactory response|6
801292|NCT00808132|2548616|P1|Overall Study|Unsatisfactory response|5
801293|NCT00808132|2548612|P5|Overall Study|Randomized, but not treated|9
801294|NCT00808132|2548613|P4|Overall Study|Randomized, but not treated|8
801295|NCT00808132|2548614|P3|Overall Study|Randomized, but not treated|9
801296|NCT00808132|2548615|P2|Overall Study|Randomized, but not treated|7
801297|NCT00808132|2548616|P1|Overall Study|Randomized, but not treated|10
801298|NCT00808132|2548612|P5|Overall Study|Unspecified|15
801299|NCT00808132|2548613|P4|Overall Study|Unspecified|2
801300|NCT00808132|2548614|P3|Overall Study|Unspecified|6
801301|NCT00808132|2548615|P2|Overall Study|Unspecified|4
801302|NCT00808132|2548616|P1|Overall Study|Unspecified|6
801303|NCT00808132|2548612|P5|Overall Study|Withdrawal by Subject|16
801304|NCT00808132|2548613|P4|Overall Study|Withdrawal by Subject|7
801305|NCT00808132|2548614|P3|Overall Study|Withdrawal by Subject|2
801306|NCT00808132|2548615|P2|Overall Study|Withdrawal by Subject|18
801307|NCT00808132|2548616|P1|Overall Study|Withdrawal by Subject|27
801308|NCT00808132|2548612|P5|Overall Study|Protocol Violation|5
801309|NCT00808132|2548613|P4|Overall Study|Protocol Violation|9
801310|NCT00808132|2548614|P3|Overall Study|Protocol Violation|4
801311|NCT00808132|2548615|P2|Overall Study|Protocol Violation|9
801312|NCT00808132|2548616|P1|Overall Study|Protocol Violation|8
801313|NCT00808132|2548612|P5|Overall Study|Lost to Follow-up|9
801314|NCT00808132|2548613|P4|Overall Study|Lost to Follow-up|8
801315|NCT00808132|2548614|P3|Overall Study|Lost to Follow-up|11
801316|NCT00808132|2548615|P2|Overall Study|Lost to Follow-up|10
801317|NCT00808132|2548616|P1|Overall Study|Lost to Follow-up|8
801318|NCT00808132|2548612|P5|Overall Study|Physician Decision|0
801319|NCT00808132|2548613|P4|Overall Study|Physician Decision|0
801320|NCT00808132|2548614|P3|Overall Study|Physician Decision|0
801321|NCT00808132|2548615|P2|Overall Study|Physician Decision|1
801322|NCT00808132|2548616|P1|Overall Study|Physician Decision|0
801323|NCT00808132|2548612|P5|Overall Study|Death|1
801324|NCT00808132|2548613|P4|Overall Study|Death|0
801325|NCT00808132|2548614|P3|Overall Study|Death|0
801326|NCT00808132|2548615|P2|Overall Study|Death|0
801327|NCT00808132|2548616|P1|Overall Study|Death|0
801328|NCT00808132|2548612|P5|Overall Study|Adverse Event|33
801329|NCT00808132|2548613|P4|Overall Study|Adverse Event|31
801330|NCT00808132|2548614|P3|Overall Study|Adverse Event|16
801331|NCT00808132|2548615|P2|Overall Study|Adverse Event|33
801332|NCT00808132|2548616|P1|Overall Study|Adverse Event|34
801333|NCT00808236|2548690|P2|Overall Study|Death|30
801334|NCT00808236|2548691|P1|Overall Study|Death|18
801335|NCT00808236|2548690|P2|Overall Study|Physician Decision|1
801336|NCT00808236|2548691|P1|Overall Study|Physician Decision|0
801337|NCT00808236|2548690|P2|Overall Study|Lost to Follow-up|1
801338|NCT00808236|2548691|P1|Overall Study|Lost to Follow-up|1
801339|NCT00808236|2548690|P2|Overall Study|Pre-defined exclusion|3
801340|NCT00808236|2548691|P1|Overall Study|Pre-defined exclusion|13
801341|NCT00808236|2548690|P2|Overall Study|Was not resuscitated|56
801342|NCT00808236|2548691|P1|Overall Study|Was not resuscitated|50
801343|NCT00808249|2548723|P4|Overall Study|All other reasons|1
801344|NCT00808249|2548724|P3|Overall Study|All other reasons|3
801345|NCT00808249|2548725|P2|Overall Study|All other reasons|1
801346|NCT00808249|2548726|P1|Overall Study|All other reasons|2
801347|NCT00808249|2548723|P4|Overall Study|study specific discontinuation criteria|0
801348|NCT00808249|2548724|P3|Overall Study|study specific discontinuation criteria|1
801349|NCT00808249|2548725|P2|Overall Study|study specific discontinuation criteria|0
801350|NCT00808249|2548726|P1|Overall Study|study specific discontinuation criteria|1
801351|NCT00808249|2548723|P4|Overall Study|Lack of Efficacy|0
801352|NCT00808249|2548724|P3|Overall Study|Lack of Efficacy|0
801353|NCT00808249|2548725|P2|Overall Study|Lack of Efficacy|1
801354|NCT00808249|2548726|P1|Overall Study|Lack of Efficacy|1
801355|NCT00808249|2548723|P4|Overall Study|Protocol Violation|0
801356|NCT00808249|2548724|P3|Overall Study|Protocol Violation|3
801357|NCT00808249|2548725|P2|Overall Study|Protocol Violation|3
801358|NCT00808249|2548726|P1|Overall Study|Protocol Violation|3
801359|NCT00808249|2548723|P4|Overall Study|Withdrawal by Subject|4
801360|NCT00808249|2548724|P3|Overall Study|Withdrawal by Subject|2
801361|NCT00808249|2548725|P2|Overall Study|Withdrawal by Subject|0
801362|NCT00808249|2548726|P1|Overall Study|Withdrawal by Subject|4
801363|NCT00808249|2548723|P4|Overall Study|Lost to Follow-up|5
801364|NCT00808249|2548724|P3|Overall Study|Lost to Follow-up|3
801365|NCT00808249|2548725|P2|Overall Study|Lost to Follow-up|3
801366|NCT00808249|2548726|P1|Overall Study|Lost to Follow-up|2
801367|NCT00808249|2548723|P4|Overall Study|Adverse Event|6
801368|NCT00808249|2548724|P3|Overall Study|Adverse Event|10
801369|NCT00808249|2548725|P2|Overall Study|Adverse Event|7
801370|NCT00808249|2548726|P1|Overall Study|Adverse Event|4
801371|NCT00808444|2548787|P2|Overall Study|Lost to Follow-up|1
801372|NCT00808444|2548788|P1|Overall Study|Lost to Follow-up|0
801373|NCT00808444|2548787|P2|Overall Study|Withdrawal by Subject|0
801374|NCT00808444|2548788|P1|Overall Study|Withdrawal by Subject|1
801375|NCT00808483|2548843|P2|From 5 Months to 12 Months|Lack of Efficacy|0
801376|NCT00808483|2548844|P1|From 5 Months to 12 Months|Lack of Efficacy|1
801377|NCT00808483|2548843|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
801462|NCT00809133|2549088|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
801378|NCT00808483|2548844|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
801379|NCT00808483|2548843|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
801380|NCT00808483|2548844|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
801381|NCT00808509|2548866|P2|Randomized Phase|Patient refused rescue therapy|3
801382|NCT00808509|2548867|P1|Randomized Phase|Patient refused rescue therapy|0
801383|NCT00808509|2548866|P2|Randomized Phase|Reduced methotrexate dose|2
801384|NCT00808509|2548867|P1|Randomized Phase|Reduced methotrexate dose|1
801385|NCT00808509|2548866|P2|Randomized Phase|Did not meet eligibility criteria|0
801386|NCT00808509|2548867|P1|Randomized Phase|Did not meet eligibility criteria|1
801387|NCT00808639|2548963|P1|Overall Study|Disease progression before surgery.|1
801388|NCT00808808|2548979|P3|Overall Study|Employee was not vaccinated.|2255
801389|NCT00808808|2548980|P2|Overall Study|Employee was not vaccinated.|2268
801390|NCT00808808|2548981|P1|Overall Study|Employee was not vaccinated.|2686
801391|NCT00808808|2548979|P3|Overall Study|Vaccinated; survey not completed|302
801392|NCT00808808|2548980|P2|Overall Study|Vaccinated; survey not completed|169
801393|NCT00808808|2548981|P1|Overall Study|Vaccinated; survey not completed|131
801394|NCT00808899|2549014|P1|Overall Study|Physician Decision|3
801395|NCT00808899|2549014|P1|Overall Study|Death|1
801396|NCT00809094|2549047|P2|Overall Study|Lost to Follow-up|1
801397|NCT00809094|2549048|P1|Overall Study|Lost to Follow-up|0
801398|NCT00809133|2549080|P14|Overall Study|Other not mentioned above|0
801399|NCT00809133|2549081|P13|Overall Study|Other not mentioned above|0
801400|NCT00809133|2549082|P12|Overall Study|Other not mentioned above|0
801401|NCT00809133|2549083|P11|Overall Study|Other not mentioned above|0
801402|NCT00809133|2549084|P10|Overall Study|Other not mentioned above|0
801403|NCT00809133|2549085|P9|Overall Study|Other not mentioned above|0
801404|NCT00809133|2549086|P8|Overall Study|Other not mentioned above|0
801405|NCT00809133|2549087|P7|Overall Study|Other not mentioned above|0
801406|NCT00809133|2549088|P6|Overall Study|Other not mentioned above|1
801407|NCT00809133|2549089|P5|Overall Study|Other not mentioned above|0
801408|NCT00809133|2549090|P4|Overall Study|Other not mentioned above|0
801409|NCT00809133|2549091|P3|Overall Study|Other not mentioned above|0
801410|NCT00809133|2549092|P2|Overall Study|Other not mentioned above|1
801411|NCT00809133|2549093|P1|Overall Study|Other not mentioned above|0
801412|NCT00809133|2549080|P14|Overall Study|Consent withdrawn|0
801413|NCT00809133|2549081|P13|Overall Study|Consent withdrawn|0
801414|NCT00809133|2549082|P12|Overall Study|Consent withdrawn|0
801415|NCT00809133|2549083|P11|Overall Study|Consent withdrawn|0
801416|NCT00809133|2549084|P10|Overall Study|Consent withdrawn|0
801417|NCT00809133|2549085|P9|Overall Study|Consent withdrawn|0
801418|NCT00809133|2549086|P8|Overall Study|Consent withdrawn|0
801419|NCT00809133|2549087|P7|Overall Study|Consent withdrawn|0
801420|NCT00809133|2549088|P6|Overall Study|Consent withdrawn|0
801421|NCT00809133|2549089|P5|Overall Study|Consent withdrawn|1
801422|NCT00809133|2549090|P4|Overall Study|Consent withdrawn|0
801423|NCT00809133|2549091|P3|Overall Study|Consent withdrawn|0
801424|NCT00809133|2549092|P2|Overall Study|Consent withdrawn|0
801425|NCT00809133|2549093|P1|Overall Study|Consent withdrawn|0
801426|NCT00809133|2549080|P14|Overall Study|Lost to Follow-up|0
801427|NCT00809133|2549081|P13|Overall Study|Lost to Follow-up|0
801428|NCT00809133|2549082|P12|Overall Study|Lost to Follow-up|0
801429|NCT00809133|2549083|P11|Overall Study|Lost to Follow-up|0
801430|NCT00809133|2549084|P10|Overall Study|Lost to Follow-up|0
801431|NCT00809133|2549085|P9|Overall Study|Lost to Follow-up|0
801432|NCT00809133|2549086|P8|Overall Study|Lost to Follow-up|0
801433|NCT00809133|2549087|P7|Overall Study|Lost to Follow-up|0
801434|NCT00809133|2549088|P6|Overall Study|Lost to Follow-up|1
801435|NCT00809133|2549089|P5|Overall Study|Lost to Follow-up|0
801436|NCT00809133|2549090|P4|Overall Study|Lost to Follow-up|0
801437|NCT00809133|2549091|P3|Overall Study|Lost to Follow-up|0
801438|NCT00809133|2549092|P2|Overall Study|Lost to Follow-up|0
801439|NCT00809133|2549093|P1|Overall Study|Lost to Follow-up|0
801440|NCT00809133|2549080|P14|Overall Study|Other adverse event|1
801441|NCT00809133|2549081|P13|Overall Study|Other adverse event|0
801442|NCT00809133|2549082|P12|Overall Study|Other adverse event|1
801443|NCT00809133|2549083|P11|Overall Study|Other adverse event|1
801444|NCT00809133|2549084|P10|Overall Study|Other adverse event|0
801445|NCT00809133|2549085|P9|Overall Study|Other adverse event|0
801446|NCT00809133|2549086|P8|Overall Study|Other adverse event|4
801447|NCT00809133|2549087|P7|Overall Study|Other adverse event|2
801448|NCT00809133|2549088|P6|Overall Study|Other adverse event|3
801449|NCT00809133|2549089|P5|Overall Study|Other adverse event|0
801450|NCT00809133|2549090|P4|Overall Study|Other adverse event|0
801451|NCT00809133|2549091|P3|Overall Study|Other adverse event|1
801452|NCT00809133|2549092|P2|Overall Study|Other adverse event|1
801453|NCT00809133|2549093|P1|Overall Study|Other adverse event|1
801454|NCT00809133|2549080|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
801455|NCT00809133|2549081|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
801456|NCT00809133|2549082|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
801457|NCT00809133|2549083|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
801458|NCT00809133|2549084|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
801459|NCT00809133|2549085|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
801460|NCT00809133|2549086|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
801461|NCT00809133|2549087|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
801463|NCT00809133|2549089|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
801464|NCT00809133|2549090|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
801465|NCT00809133|2549091|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
801466|NCT00809133|2549092|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
801467|NCT00809133|2549093|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
801468|NCT00809133|2549080|P14|Overall Study|Progressive disease|4
801469|NCT00809133|2549081|P13|Overall Study|Progressive disease|5
801470|NCT00809133|2549082|P12|Overall Study|Progressive disease|7
801471|NCT00809133|2549083|P11|Overall Study|Progressive disease|5
801472|NCT00809133|2549084|P10|Overall Study|Progressive disease|9
801473|NCT00809133|2549085|P9|Overall Study|Progressive disease|3
801474|NCT00809133|2549086|P8|Overall Study|Progressive disease|3
801475|NCT00809133|2549087|P7|Overall Study|Progressive disease|3
801476|NCT00809133|2549088|P6|Overall Study|Progressive disease|1
801477|NCT00809133|2549089|P5|Overall Study|Progressive disease|4
801478|NCT00809133|2549090|P4|Overall Study|Progressive disease|3
801479|NCT00809133|2549091|P3|Overall Study|Progressive disease|5
801480|NCT00809133|2549092|P2|Overall Study|Progressive disease|5
801481|NCT00809133|2549093|P1|Overall Study|Progressive disease|2
801482|NCT00809159|2549276|P6|Part 1 and 2|Withdrawal by Subject|1
801483|NCT00809159|2549277|P5|Part 1 and 2|Withdrawal by Subject|0
801484|NCT00809159|2549278|P4|Part 1 and 2|Withdrawal by Subject|0
801485|NCT00809159|2549279|P3|Part 1 and 2|Withdrawal by Subject|4
801486|NCT00809159|2549280|P2|Part 1 and 2|Withdrawal by Subject|0
801487|NCT00809159|2549281|P1|Part 1 and 2|Withdrawal by Subject|0
801488|NCT00809159|2549276|P6|Part 1 and 2|Lost to Follow-up|0
801489|NCT00809159|2549277|P5|Part 1 and 2|Lost to Follow-up|0
801490|NCT00809159|2549278|P4|Part 1 and 2|Lost to Follow-up|1
801491|NCT00809159|2549279|P3|Part 1 and 2|Lost to Follow-up|1
801492|NCT00809159|2549280|P2|Part 1 and 2|Lost to Follow-up|0
801493|NCT00809159|2549281|P1|Part 1 and 2|Lost to Follow-up|0
801494|NCT00809159|2549276|P6|Part 1 and 2|Adverse Event|1
801495|NCT00809159|2549277|P5|Part 1 and 2|Adverse Event|1
801496|NCT00809159|2549278|P4|Part 1 and 2|Adverse Event|0
801497|NCT00809159|2549279|P3|Part 1 and 2|Adverse Event|1
801498|NCT00809159|2549280|P2|Part 1 and 2|Adverse Event|0
801499|NCT00809159|2549281|P1|Part 1 and 2|Adverse Event|0
801500|NCT00809159|2549276|P6|Part 1 and 2|Administrative problems|0
801501|NCT00809159|2549277|P5|Part 1 and 2|Administrative problems|0
801502|NCT00809159|2549278|P4|Part 1 and 2|Administrative problems|1
801503|NCT00809159|2549279|P3|Part 1 and 2|Administrative problems|0
801504|NCT00809159|2549280|P2|Part 1 and 2|Administrative problems|0
801505|NCT00809159|2549281|P1|Part 1 and 2|Administrative problems|0
801506|NCT00809159|2549276|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
801507|NCT00809159|2549277|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
801508|NCT00809159|2549278|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
801509|NCT00809159|2549279|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
801510|NCT00809159|2549280|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
801511|NCT00809159|2549281|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
801512|NCT00809159|2549276|P6|Part 1|Unsatisfactory therapeutic effect|0
801513|NCT00809159|2549277|P5|Part 1|Unsatisfactory therapeutic effect|0
801514|NCT00809159|2549278|P4|Part 1|Unsatisfactory therapeutic effect|0
801515|NCT00809159|2549279|P3|Part 1|Unsatisfactory therapeutic effect|0
801516|NCT00809159|2549280|P2|Part 1|Unsatisfactory therapeutic effect|1
801517|NCT00809159|2549281|P1|Part 1|Unsatisfactory therapeutic effect|3
801518|NCT00809159|2549276|P6|Part 1|Withdrawal by Subject|0
801519|NCT00809159|2549277|P5|Part 1|Withdrawal by Subject|0
801520|NCT00809159|2549278|P4|Part 1|Withdrawal by Subject|0
801521|NCT00809159|2549279|P3|Part 1|Withdrawal by Subject|0
801522|NCT00809159|2549280|P2|Part 1|Withdrawal by Subject|1
801523|NCT00809159|2549281|P1|Part 1|Withdrawal by Subject|3
801524|NCT00809159|2549276|P6|Part 1|Lost to Follow-up|0
801525|NCT00809159|2549277|P5|Part 1|Lost to Follow-up|0
801526|NCT00809159|2549278|P4|Part 1|Lost to Follow-up|0
801527|NCT00809159|2549279|P3|Part 1|Lost to Follow-up|0
801528|NCT00809159|2549280|P2|Part 1|Lost to Follow-up|0
801529|NCT00809159|2549281|P1|Part 1|Lost to Follow-up|1
801530|NCT00809159|2549276|P6|Part 1|Adverse Event|0
801531|NCT00809159|2549277|P5|Part 1|Adverse Event|0
801532|NCT00809159|2549278|P4|Part 1|Adverse Event|0
801533|NCT00809159|2549279|P3|Part 1|Adverse Event|0
801534|NCT00809159|2549280|P2|Part 1|Adverse Event|1
801535|NCT00809159|2549281|P1|Part 1|Adverse Event|1
801536|NCT00809328|2549353|P1|Overall Study|Withdrawal by Subject|2
801537|NCT00809328|2549353|P1|Overall Study|Protocol Violation|3
801538|NCT00809328|2549353|P1|Overall Study|Adverse Event|6
801539|NCT00809328|2549353|P1|Overall Study|Lack of Efficacy|18
801540|NCT00809445|2549364|P3|6 Month Follow-up|Withdrew consent|1
801541|NCT00809445|2549365|P2|6 Month Follow-up|Withdrew consent|0
801542|NCT00809445|2549366|P1|6 Month Follow-up|Withdrew consent|0
801543|NCT00809445|2549364|P3|6 Month Follow-up|Incarcerated|8
801544|NCT00809445|2549365|P2|6 Month Follow-up|Incarcerated|8
801545|NCT00809445|2549366|P1|6 Month Follow-up|Incarcerated|6
801546|NCT00809445|2549364|P3|6 Month Follow-up|Death|1
801547|NCT00809445|2549365|P2|6 Month Follow-up|Death|1
801548|NCT00809445|2549366|P1|6 Month Follow-up|Death|2
801549|NCT00809445|2549364|P3|6 Month Follow-up|Lost contact|14
801550|NCT00809445|2549365|P2|6 Month Follow-up|Lost contact|14
801551|NCT00809445|2549366|P1|6 Month Follow-up|Lost contact|16
801552|NCT00809445|2549364|P3|1 Month Follow-up|Incarcerated|1
801553|NCT00809445|2549365|P2|1 Month Follow-up|Incarcerated|0
801554|NCT00809445|2549366|P1|1 Month Follow-up|Incarcerated|0
801555|NCT00809445|2549364|P3|1 Month Follow-up|Death|1
801556|NCT00809445|2549365|P2|1 Month Follow-up|Death|1
801557|NCT00809445|2549366|P1|1 Month Follow-up|Death|0
801558|NCT00809445|2549364|P3|1 Month Follow-up|Withdrew consent|1
801559|NCT00809445|2549365|P2|1 Month Follow-up|Withdrew consent|1
801560|NCT00809445|2549366|P1|1 Month Follow-up|Withdrew consent|1
801561|NCT00809445|2549364|P3|1 Month Follow-up|Lost contact|1
801562|NCT00809445|2549365|P2|1 Month Follow-up|Lost contact|2
801563|NCT00809445|2549366|P1|1 Month Follow-up|Lost contact|1
801564|NCT00809471|2549399|P3|Overall Study|Requirement for restricted medication|0
801565|NCT00809471|2549400|P2|Overall Study|Requirement for restricted medication|1
801566|NCT00809471|2549401|P1|Overall Study|Requirement for restricted medication|1
801567|NCT00809471|2549399|P3|Overall Study|Adverse Event|2
801568|NCT00809471|2549400|P2|Overall Study|Adverse Event|2
801569|NCT00809471|2549401|P1|Overall Study|Adverse Event|0
801570|NCT00809471|2549399|P3|Overall Study|Lost to Follow-up|9
801571|NCT00809471|2549400|P2|Overall Study|Lost to Follow-up|2
801572|NCT00809471|2549401|P1|Overall Study|Lost to Follow-up|4
801573|NCT00809471|2549399|P3|Overall Study|Protocol non-compliance|6
801574|NCT00809471|2549400|P2|Overall Study|Protocol non-compliance|15
801575|NCT00809471|2549401|P1|Overall Study|Protocol non-compliance|15
801576|NCT00809614|2549430|P2|Overall Study|Withdrawal by Subject|1
801577|NCT00809614|2549431|P1|Overall Study|Withdrawal by Subject|1
801578|NCT00809614|2549430|P2|Overall Study|Lack of Efficacy|3
801579|NCT00809614|2549431|P1|Overall Study|Lack of Efficacy|2
801580|NCT00809757|2549462|P3|Overall Study|Noncompliance with Medication|1
801581|NCT00809757|2549463|P2|Overall Study|Noncompliance with Medication|0
801582|NCT00809757|2549464|P1|Overall Study|Noncompliance with Medication|0
801583|NCT00809757|2549462|P3|Overall Study|Subject Uncooperative|2
801584|NCT00809757|2549463|P2|Overall Study|Subject Uncooperative|0
801585|NCT00809757|2549464|P1|Overall Study|Subject Uncooperative|1
801586|NCT00809757|2549462|P3|Overall Study|Withdrawal by Subject|3
801587|NCT00809757|2549463|P2|Overall Study|Withdrawal by Subject|1
801588|NCT00809757|2549464|P1|Overall Study|Withdrawal by Subject|2
801589|NCT00809757|2549462|P3|Overall Study|Protocol Violation|1
801590|NCT00809757|2549463|P2|Overall Study|Protocol Violation|1
801591|NCT00809757|2549464|P1|Overall Study|Protocol Violation|1
801592|NCT00809757|2549462|P3|Overall Study|Lost to Follow-up|1
801593|NCT00809757|2549463|P2|Overall Study|Lost to Follow-up|0
801594|NCT00809757|2549464|P1|Overall Study|Lost to Follow-up|0
801595|NCT00809757|2549462|P3|Overall Study|Adverse Event|3
801596|NCT00809757|2549463|P2|Overall Study|Adverse Event|3
801597|NCT00809757|2549464|P1|Overall Study|Adverse Event|2
801598|NCT00809835|2549560|P4|Overall Study|Withdrawal by Subject|0
801599|NCT00809835|2549561|P3|Overall Study|Withdrawal by Subject|1
801600|NCT00809835|2549562|P2|Overall Study|Withdrawal by Subject|1
801601|NCT00809835|2549563|P1|Overall Study|Withdrawal by Subject|1
801602|NCT00809835|2549560|P4|Overall Study|Lost to Follow-up|2
801603|NCT00809835|2549561|P3|Overall Study|Lost to Follow-up|10
801604|NCT00809835|2549562|P2|Overall Study|Lost to Follow-up|6
801605|NCT00809835|2549563|P1|Overall Study|Lost to Follow-up|7
801606|NCT00809926|2549609|P2|Overall Study|Protocol deviation|2
801607|NCT00809926|2549610|P1|Overall Study|Protocol deviation|0
801608|NCT00809926|2549609|P2|Overall Study|Administrative Problems|1
801609|NCT00809926|2549610|P1|Overall Study|Administrative Problems|0
801610|NCT00809926|2549609|P2|Overall Study|Lost to Follow-up|1
801611|NCT00809926|2549610|P1|Overall Study|Lost to Follow-up|2
801612|NCT00809926|2549609|P2|Overall Study|Patient withdrew consent|6
801613|NCT00809926|2549610|P1|Overall Study|Patient withdrew consent|8
801614|NCT00809926|2549609|P2|Overall Study|Unsatisfactory therapeutic effect|3
801615|NCT00809926|2549610|P1|Overall Study|Unsatisfactory therapeutic effect|3
801616|NCT00809926|2549609|P2|Overall Study|Adverse Event|10
801617|NCT00809926|2549610|P1|Overall Study|Adverse Event|18
801618|NCT00809965|2549637|P3|Overall Study|Other Reason|189
801619|NCT00809965|2549638|P2|Overall Study|Other Reason|170
801620|NCT00809965|2549639|P1|Overall Study|Other Reason|167
801621|NCT00809965|2549637|P3|Overall Study|Withdrawal by Subject|441
801622|NCT00809965|2549638|P2|Overall Study|Withdrawal by Subject|448
801623|NCT00809965|2549639|P1|Overall Study|Withdrawal by Subject|405
801624|NCT00809965|2549637|P3|Overall Study|Lost to Follow-up|18
801625|NCT00809965|2549638|P2|Overall Study|Lost to Follow-up|10
801626|NCT00809965|2549639|P1|Overall Study|Lost to Follow-up|17
801627|NCT00809965|2549637|P3|Overall Study|Death|196
801628|NCT00809965|2549638|P2|Overall Study|Death|147
801629|NCT00809965|2549639|P1|Overall Study|Death|194
801651|NCT00810069|2549684|P3|Double-Blind Period II|Protocol Violation|6
801652|NCT00810069|2549685|P2|Double-Blind Period II|Protocol Violation|7
801653|NCT00810069|2549686|P1|Double-Blind Period II|Protocol Violation|0
801654|NCT00810069|2549684|P3|Double-Blind Period II|Clinical relapse|0
801655|NCT00810069|2549685|P2|Double-Blind Period II|Clinical relapse|3
801656|NCT00810069|2549686|P1|Double-Blind Period II|Clinical relapse|0
801657|NCT00810069|2549684|P3|Double-Blind Period II|Protocol entry criterion not met|1
801658|NCT00810069|2549685|P2|Double-Blind Period II|Protocol entry criterion not met|0
801659|NCT00810069|2549686|P1|Double-Blind Period II|Protocol entry criterion not met|0
801660|NCT00810069|2549684|P3|Double-Blind Period II|Withdrawal by Subject|35
801661|NCT00810069|2549685|P2|Double-Blind Period II|Withdrawal by Subject|21
801662|NCT00810069|2549686|P1|Double-Blind Period II|Withdrawal by Subject|0
801663|NCT00810069|2549684|P3|Double-Blind Period II|Physician Decision|1
801664|NCT00810069|2549685|P2|Double-Blind Period II|Physician Decision|0
801665|NCT00810069|2549686|P1|Double-Blind Period II|Physician Decision|0
801666|NCT00810069|2549684|P3|Double-Blind Period II|Lost to Follow-up|9
801667|NCT00810069|2549685|P2|Double-Blind Period II|Lost to Follow-up|9
801668|NCT00810069|2549686|P1|Double-Blind Period II|Lost to Follow-up|0
801669|NCT00810069|2549684|P3|Double-Blind Period II|Lack of Efficacy|12
801670|NCT00810069|2549685|P2|Double-Blind Period II|Lack of Efficacy|7
801671|NCT00810069|2549686|P1|Double-Blind Period II|Lack of Efficacy|0
801672|NCT00810069|2549684|P3|Double-Blind Period II|Adverse Event|8
801673|NCT00810069|2549685|P2|Double-Blind Period II|Adverse Event|9
801674|NCT00810069|2549686|P1|Double-Blind Period II|Adverse Event|0
801675|NCT00810069|2549684|P3|Lead-in Period I|Randomization criteria not met|0
801676|NCT00810069|2549685|P2|Lead-in Period I|Randomization criteria not met|0
801677|NCT00810069|2549686|P1|Lead-in Period I|Randomization criteria not met|158
801678|NCT00810069|2549684|P3|Lead-in Period I|Protocol entry criterion not met|0
801679|NCT00810069|2549685|P2|Lead-in Period I|Protocol entry criterion not met|0
801680|NCT00810069|2549686|P1|Lead-in Period I|Protocol entry criterion not met|5
801681|NCT00810069|2549684|P3|Lead-in Period I|Withdrawal by Subject|0
801682|NCT00810069|2549685|P2|Lead-in Period I|Withdrawal by Subject|0
801683|NCT00810069|2549686|P1|Lead-in Period I|Withdrawal by Subject|46
801684|NCT00810069|2549684|P3|Lead-in Period I|Protocol Violation|0
801685|NCT00810069|2549685|P2|Lead-in Period I|Protocol Violation|0
801686|NCT00810069|2549686|P1|Lead-in Period I|Protocol Violation|1
801687|NCT00810069|2549684|P3|Lead-in Period I|Physician Decision|0
801688|NCT00810069|2549685|P2|Lead-in Period I|Physician Decision|0
801689|NCT00810069|2549686|P1|Lead-in Period I|Physician Decision|1
801690|NCT00810069|2549684|P3|Lead-in Period I|Lost to Follow-up|0
801691|NCT00810069|2549685|P2|Lead-in Period I|Lost to Follow-up|0
801692|NCT00810069|2549686|P1|Lead-in Period I|Lost to Follow-up|19
801693|NCT00810069|2549684|P3|Lead-in Period I|Lack of Efficacy|0
801694|NCT00810069|2549685|P2|Lead-in Period I|Lack of Efficacy|0
801695|NCT00810069|2549686|P1|Lead-in Period I|Lack of Efficacy|1
801696|NCT00810069|2549684|P3|Lead-in Period I|Adverse Event|0
801697|NCT00810069|2549685|P2|Lead-in Period I|Adverse Event|0
801698|NCT00810069|2549686|P1|Lead-in Period I|Adverse Event|43
801699|NCT00810082|2549731|P2|Overall Study|Lost to Follow-up|4
801700|NCT00810082|2549732|P1|Overall Study|Lost to Follow-up|0
801701|NCT00810108|2549747|P2|Overall Study|Withdrawal by Subject|0
801702|NCT00810108|2549748|P1|Overall Study|Withdrawal by Subject|1
801703|NCT00810199|2549755|P2|Overall Study|Did not receive study drug|1
801704|NCT00810199|2549756|P1|Overall Study|Did not receive study drug|2
801705|NCT00810199|2549755|P2|Overall Study|Failure to return|4
801706|NCT00810199|2549756|P1|Overall Study|Failure to return|1
801707|NCT00810199|2549755|P2|Overall Study|Protocol Violation|6
801708|NCT00810199|2549756|P1|Overall Study|Protocol Violation|2
801709|NCT00810199|2549755|P2|Overall Study|Administrative/Other|6
801710|NCT00810199|2549756|P1|Overall Study|Administrative/Other|5
801711|NCT00810199|2549755|P2|Overall Study|Refused treatment/Did not cooperate|7
801712|NCT00810199|2549756|P1|Overall Study|Refused treatment/Did not cooperate|7
801713|NCT00810199|2549755|P2|Overall Study|Insufficient therapeutic response|14
801714|NCT00810199|2549756|P1|Overall Study|Insufficient therapeutic response|5
801715|NCT00810199|2549755|P2|Overall Study|Withdrew consent|12
801716|NCT00810199|2549756|P1|Overall Study|Withdrew consent|9
801717|NCT00810199|2549755|P2|Overall Study|Death|6
801718|NCT00810199|2549756|P1|Overall Study|Death|4
801719|NCT00810199|2549755|P2|Overall Study|Adverse Event|26
801720|NCT00810199|2549756|P1|Overall Study|Adverse Event|24
801721|NCT00810277|2549832|P1|Overall Study|Adverse Event|1
801722|NCT00810342|2549872|P2|12-month Followup|Lost to Follow-up|1
801723|NCT00810342|2549873|P1|12-month Followup|Lost to Follow-up|3
801724|NCT00810342|2549872|P2|12-month Followup|Pregnancy|10
801725|NCT00810342|2549873|P1|12-month Followup|Pregnancy|9
801726|NCT00810342|2549872|P2|6-month Follow-up|Pregnancy|2
801727|NCT00810342|2549873|P1|6-month Follow-up|Pregnancy|6
801728|NCT00810342|2549872|P2|6-month Follow-up|Lost to Follow-up|6
801729|NCT00810342|2549873|P1|6-month Follow-up|Lost to Follow-up|18
801730|NCT00810342|2549872|P2|Month 1 Follow-up|Pregnancy|0
801731|NCT00810342|2549873|P1|Month 1 Follow-up|Pregnancy|1
801732|NCT00810342|2549872|P2|Month 1 Follow-up|Lost to Follow-up|2
801733|NCT00810342|2549873|P1|Month 1 Follow-up|Lost to Follow-up|4
801734|NCT00810355|2549884|P3|Overall Study|Withdrawal by Subject|0
801735|NCT00810355|2549885|P2|Overall Study|Withdrawal by Subject|0
801736|NCT00810355|2549886|P1|Overall Study|Withdrawal by Subject|1
801737|NCT00810355|2549884|P3|Overall Study|Lost to Follow-up|11
801738|NCT00810355|2549885|P2|Overall Study|Lost to Follow-up|17
801739|NCT00810355|2549886|P1|Overall Study|Lost to Follow-up|13
801740|NCT00810368|2549902|P2|Overall Study|Lack of Efficacy|0
801741|NCT00810368|2549903|P1|Overall Study|Lack of Efficacy|2
801742|NCT00810368|2549902|P2|Overall Study|Lost to Follow-up|2
801743|NCT00810368|2549903|P1|Overall Study|Lost to Follow-up|4
801744|NCT00810394|2549921|P1|Overall Study|Withdrawal by Subject|3
801745|NCT00810511|2549929|P2|Overall Study|deposits on contact lens|1
801746|NCT00810511|2549930|P1|Overall Study|deposits on contact lens|0
801747|NCT00810511|2549929|P2|Overall Study|Lost to Follow-up|0
801748|NCT00810511|2549930|P1|Overall Study|Lost to Follow-up|1
801749|NCT00810511|2549929|P2|Overall Study|death in the family|1
801750|NCT00810511|2549930|P1|Overall Study|death in the family|0
801751|NCT00810511|2549929|P2|Overall Study|Lack of Efficacy|1
801752|NCT00810511|2549930|P1|Overall Study|Lack of Efficacy|9
801753|NCT00810511|2549929|P2|Overall Study|Protocol Violation|1
801754|NCT00810511|2549930|P1|Overall Study|Protocol Violation|0
801755|NCT00810602|2549940|P2|Overall Study|Withdrawal by Subject|3
801756|NCT00810602|2549941|P1|Overall Study|Withdrawal by Subject|8
801757|NCT00788372|2549961|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
801758|NCT00788372|2549961|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
801759|NCT00788372|2549961|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
801760|NCT00788372|2549961|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
801761|NCT00788372|2549961|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
801762|NCT00788372|2549961|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
801763|NCT00788372|2549961|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
801764|NCT00788593|2549975|P3|Second Intervention Period|Unspecified|1
801765|NCT00788593|2549976|P2|Second Intervention Period|Unspecified|0
801766|NCT00788593|2549977|P1|Second Intervention Period|Unspecified|0
801767|NCT00788593|2549975|P3|Second Intervention Period|Lost to Follow-up|0
801768|NCT00788593|2549976|P2|Second Intervention Period|Lost to Follow-up|1
801769|NCT00788593|2549977|P1|Second Intervention Period|Lost to Follow-up|0
801770|NCT00788593|2549975|P3|First Intervention Period|Adverse Event|0
801771|NCT00788593|2549976|P2|First Intervention Period|Adverse Event|1
801772|NCT00788593|2549977|P1|First Intervention Period|Adverse Event|0
801773|NCT00788593|2549975|P3|Placebo Run-in Phase|Protocol Violation|0
801774|NCT00788593|2549976|P2|Placebo Run-in Phase|Protocol Violation|0
801775|NCT00788593|2549977|P1|Placebo Run-in Phase|Protocol Violation|2
801776|NCT00788593|2549975|P3|Placebo Run-in Phase|Withdrawal by Subject|0
801777|NCT00788593|2549976|P2|Placebo Run-in Phase|Withdrawal by Subject|0
801778|NCT00788593|2549977|P1|Placebo Run-in Phase|Withdrawal by Subject|2
801779|NCT00788593|2549975|P3|Placebo Run-in Phase|Adverse Event|0
801780|NCT00788593|2549976|P2|Placebo Run-in Phase|Adverse Event|0
801781|NCT00788593|2549977|P1|Placebo Run-in Phase|Adverse Event|2
801787|NCT00788710|2550044|P3|Overall Study|Withdrawal by Subject|0
801788|NCT00788710|2550045|P2|Overall Study|Withdrawal by Subject|2
801789|NCT00788710|2550046|P1|Overall Study|Withdrawal by Subject|2
801790|NCT00788710|2550044|P3|Overall Study|Protocol Violation|1
801791|NCT00788710|2550045|P2|Overall Study|Protocol Violation|1
801792|NCT00788710|2550046|P1|Overall Study|Protocol Violation|0
801793|NCT00788710|2550044|P3|Overall Study|Physician Decision|0
801794|NCT00788710|2550045|P2|Overall Study|Physician Decision|1
801795|NCT00788710|2550046|P1|Overall Study|Physician Decision|2
801796|NCT00788710|2550044|P3|Overall Study|Lost to Follow-up|0
801797|NCT00788710|2550045|P2|Overall Study|Lost to Follow-up|1
801798|NCT00788710|2550046|P1|Overall Study|Lost to Follow-up|0
801799|NCT00788710|2550044|P3|Overall Study|Lack of Efficacy|1
801800|NCT00788710|2550045|P2|Overall Study|Lack of Efficacy|0
801801|NCT00788710|2550046|P1|Overall Study|Lack of Efficacy|0
801802|NCT00788710|2550044|P3|Overall Study|Adverse Event|4
801803|NCT00788710|2550045|P2|Overall Study|Adverse Event|3
801804|NCT00788710|2550046|P1|Overall Study|Adverse Event|1
801805|NCT00788775|2550062|P2|Overall Study|Patient's measurable disease resected.|0
801806|NCT00788775|2550063|P1|Overall Study|Patient's measurable disease resected.|1
801807|NCT00788775|2550062|P2|Overall Study|Patient Non-Compliance|0
801808|NCT00788775|2550063|P1|Overall Study|Patient Non-Compliance|1
801809|NCT00788775|2550062|P2|Overall Study|Withdrawal by Subject|2
801810|NCT00788775|2550063|P1|Overall Study|Withdrawal by Subject|0
801811|NCT00788775|2550062|P2|Overall Study|Progressive Disease|6
801812|NCT00788775|2550063|P1|Overall Study|Progressive Disease|8
801813|NCT00788957|2550079|P6|Part 3|On-study at time of data cut-off|0
801814|NCT00788957|2550080|P5|Part 3|On-study at time of data cut-off|1
801815|NCT00788957|2550081|P4|Part 3|On-study at time of data cut-off|0
801816|NCT00788957|2550082|P3|Part 3|On-study at time of data cut-off|0
801817|NCT00788957|2550083|P2|Part 3|On-study at time of data cut-off|0
801818|NCT00788957|2550084|P1|Part 3|On-study at time of data cut-off|0
801819|NCT00788957|2550079|P6|Part 3|Death|9
801820|NCT00788957|2550080|P5|Part 3|Death|8
801821|NCT00788957|2550081|P4|Part 3|Death|0
801822|NCT00788957|2550082|P3|Part 3|Death|0
801823|NCT00788957|2550083|P2|Part 3|Death|0
801824|NCT00788957|2550084|P1|Part 3|Death|0
801825|NCT00788957|2550079|P6|Part 3|Withdrawal by Subject|2
801826|NCT00788957|2550080|P5|Part 3|Withdrawal by Subject|0
801827|NCT00788957|2550081|P4|Part 3|Withdrawal by Subject|0
801828|NCT00788957|2550082|P3|Part 3|Withdrawal by Subject|0
801829|NCT00788957|2550083|P2|Part 3|Withdrawal by Subject|0
801830|NCT00788957|2550084|P1|Part 3|Withdrawal by Subject|0
801831|NCT00788957|2550079|P6|Part 2|On-study at time of data cut-off|0
801832|NCT00788957|2550080|P5|Part 2|On-study at time of data cut-off|0
801833|NCT00788957|2550081|P4|Part 2|On-study at time of data cut-off|1
801834|NCT00788957|2550082|P3|Part 2|On-study at time of data cut-off|1
801835|NCT00788957|2550083|P2|Part 2|On-study at time of data cut-off|1
801836|NCT00788957|2550084|P1|Part 2|On-study at time of data cut-off|0
801837|NCT00788957|2550079|P6|Part 2|Lost to Follow-up|0
801838|NCT00788957|2550080|P5|Part 2|Lost to Follow-up|0
801839|NCT00788957|2550081|P4|Part 2|Lost to Follow-up|0
801840|NCT00788957|2550082|P3|Part 2|Lost to Follow-up|3
801841|NCT00788957|2550083|P2|Part 2|Lost to Follow-up|0
801842|NCT00788957|2550084|P1|Part 2|Lost to Follow-up|0
801843|NCT00788957|2550079|P6|Part 2|Death|0
801844|NCT00788957|2550080|P5|Part 2|Death|0
801845|NCT00788957|2550081|P4|Part 2|Death|37
801846|NCT00788957|2550082|P3|Part 2|Death|35
801847|NCT00788957|2550083|P2|Part 2|Death|32
801848|NCT00788957|2550084|P1|Part 2|Death|0
801849|NCT00788957|2550079|P6|Part 2|Withdrawal by Subject|0
801850|NCT00788957|2550080|P5|Part 2|Withdrawal by Subject|0
801851|NCT00788957|2550081|P4|Part 2|Withdrawal by Subject|3
801852|NCT00788957|2550082|P3|Part 2|Withdrawal by Subject|5
801853|NCT00788957|2550083|P2|Part 2|Withdrawal by Subject|9
801854|NCT00788957|2550084|P1|Part 2|Withdrawal by Subject|0
801855|NCT00788957|2550079|P6|Part 1|Lost to Follow-up|0
801856|NCT00788957|2550080|P5|Part 1|Lost to Follow-up|0
801857|NCT00788957|2550081|P4|Part 1|Lost to Follow-up|0
801858|NCT00788957|2550082|P3|Part 1|Lost to Follow-up|0
801859|NCT00788957|2550083|P2|Part 1|Lost to Follow-up|0
801860|NCT00788957|2550084|P1|Part 1|Lost to Follow-up|1
801861|NCT00788957|2550079|P6|Part 1|Death|0
801862|NCT00788957|2550080|P5|Part 1|Death|0
801863|NCT00788957|2550081|P4|Part 1|Death|0
801864|NCT00788957|2550082|P3|Part 1|Death|0
801865|NCT00788957|2550083|P2|Part 1|Death|0
801866|NCT00788957|2550084|P1|Part 1|Death|8
801867|NCT00794365|2550138|P1|Overall Study|Lack of Efficacy|3
801868|NCT00794365|2550138|P1|Overall Study|Adverse Event|10
801869|NCT00794365|2550138|P1|Overall Study|Poor Compliance|11
801870|NCT00794365|2550138|P1|Overall Study|Unspecified|17
801871|NCT00794365|2550138|P1|Overall Study|Lost to Follow-up|38
801872|NCT00794664|2550186|P2|Follow-up Period|Protocol non-compliance|1
801873|NCT00794664|2550187|P1|Follow-up Period|Protocol non-compliance|0
801874|NCT00794664|2550186|P2|Follow-up Period|Withdrawal by Subject|2
801875|NCT00794664|2550187|P1|Follow-up Period|Withdrawal by Subject|0
801876|NCT00794664|2550186|P2|Follow-up Period|Not specified|2
801877|NCT00794664|2550187|P1|Follow-up Period|Not specified|1
801878|NCT00794664|2550186|P2|Treatment Period|Adverse Event|8
801879|NCT00794664|2550187|P1|Treatment Period|Adverse Event|1
801880|NCT00794664|2550186|P2|Treatment Period|Not specified|1
801881|NCT00794664|2550187|P1|Treatment Period|Not specified|0
801882|NCT00794664|2550186|P2|Treatment Period|Protocol non-compliance|1
801883|NCT00794664|2550187|P1|Treatment Period|Protocol non-compliance|0
801884|NCT00794664|2550186|P2|Treatment Period|Withdrawal by Subject|2
801885|NCT00794664|2550187|P1|Treatment Period|Withdrawal by Subject|0
801886|NCT00794677|2550233|P2|First Intervention|Withdrawal by Subject|0
801887|NCT00794677|2550234|P1|First Intervention|Withdrawal by Subject|2
801888|NCT00794820|2550254|P1|Overall Study|Ineligible/Screen Failure|1
801889|NCT00794820|2550254|P1|Overall Study|Resistant Disease|2
801890|NCT00794820|2550254|P1|Overall Study|Secondary Malignancies|2
801891|NCT00794820|2550254|P1|Overall Study|Adverse Event|11
801892|NCT00794924|2550262|P2|Overall Study|Adverse Event|2
801893|NCT00794924|2550263|P1|Overall Study|Adverse Event|6
801894|NCT00794924|2550262|P2|Overall Study|Withdrawal by Subject|60
801895|NCT00794924|2550263|P1|Overall Study|Withdrawal by Subject|48
801896|NCT00794924|2550262|P2|Overall Study|Lost to Follow-up|8
801897|NCT00794924|2550263|P1|Overall Study|Lost to Follow-up|6
801898|NCT00794963|2550269|P2|Overall Study|Withdrawal by Subject|4
801899|NCT00794963|2550270|P1|Overall Study|Withdrawal by Subject|1
801900|NCT00795132|2550285|P1|Overall Study|Relapse|2
801901|NCT00795132|2550285|P1|Overall Study|Death|1
801902|NCT00795184|2550349|P2|Overall Study|Tissue sampling incomplete/conclusive|13
801992|NCT00796367|2550729|P2|Overall Study|Lack of Efficacy|1
801903|NCT00795184|2550350|P1|Overall Study|Tissue sampling incomplete/conclusive|8
801904|NCT00795509|2550410|P1|Overall Study|Protocol Violation|31
801905|NCT00795535|2550415|P1|Overall Study|incomplete data and technical problems|20
801906|NCT00795600|2550424|P2|Overall Study|Unclassified|1
801907|NCT00795600|2550425|P1|Overall Study|Unclassified|1
801908|NCT00795600|2550424|P2|Overall Study|Withdrawal by Subject|0
801909|NCT00795600|2550425|P1|Overall Study|Withdrawal by Subject|1
801910|NCT00795600|2550424|P2|Overall Study|Protocol Violation|2
801911|NCT00795600|2550425|P1|Overall Study|Protocol Violation|1
801912|NCT00795600|2550424|P2|Overall Study|Adverse Event|1
801913|NCT00795600|2550425|P1|Overall Study|Adverse Event|1
801914|NCT00795639|2550547|P2|Overall Study|Randomized and not treated|1
801915|NCT00795639|2550548|P1|Overall Study|Randomized and not treated|0
801916|NCT00795639|2550547|P2|Overall Study|Terminated by sponsor|12
801917|NCT00795639|2550548|P1|Overall Study|Terminated by sponsor|13
801918|NCT00795639|2550547|P2|Overall Study|Unspecified|2
801919|NCT00795639|2550548|P1|Overall Study|Unspecified|0
801920|NCT00795639|2550547|P2|Overall Study|Adverse Event|2
801921|NCT00795639|2550548|P1|Overall Study|Adverse Event|5
801922|NCT00795639|2550547|P2|Overall Study|Pregnancy|0
801923|NCT00795639|2550548|P1|Overall Study|Pregnancy|1
801924|NCT00795639|2550547|P2|Overall Study|Withdrawal by Subject|3
801925|NCT00795639|2550548|P1|Overall Study|Withdrawal by Subject|1
801926|NCT00795639|2550547|P2|Overall Study|Death|6
801927|NCT00795639|2550548|P1|Overall Study|Death|1
801928|NCT00795704|2550560|P2|Overall Study|Adverse Event|1
801929|NCT00795704|2550561|P1|Overall Study|Adverse Event|1
801930|NCT00795704|2550560|P2|Overall Study|Withdrawal by Subject|2
801931|NCT00795704|2550561|P1|Overall Study|Withdrawal by Subject|3
801932|NCT00795717|2550573|P2|Phase II|too busy|1
801933|NCT00795717|2550574|P1|Phase II|too busy|0
801934|NCT00795717|2550573|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
801935|NCT00795717|2550574|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
801936|NCT00795717|2550573|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
801937|NCT00795717|2550574|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
801938|NCT00795717|2550573|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
801939|NCT00795717|2550574|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
801940|NCT00795886|2550588|P1|Overall Study|Death|10
801941|NCT00795951|2550594|P1|Overall Study|Withdrawal by Subject|1
801942|NCT00795951|2550594|P1|Overall Study|Lost to Follow-up|1
801943|NCT00796003|2550633|P2|Overall Study|Participants Not treated|2
801944|NCT00796003|2550634|P1|Overall Study|Participants Not treated|0
801945|NCT00796003|2550633|P2|Overall Study|Unspecified|1
801946|NCT00796003|2550634|P1|Overall Study|Unspecified|0
801947|NCT00796003|2550633|P2|Overall Study|Withdrawal by Subject|1
801948|NCT00796003|2550634|P1|Overall Study|Withdrawal by Subject|0
801949|NCT00796003|2550633|P2|Overall Study|Physician Decision|4
801950|NCT00796003|2550634|P1|Overall Study|Physician Decision|0
801951|NCT00796003|2550633|P2|Overall Study|Specified organ function not met|1
801952|NCT00796003|2550634|P1|Overall Study|Specified organ function not met|0
801953|NCT00796003|2550633|P2|Overall Study|Adverse Event|7
801954|NCT00796003|2550634|P1|Overall Study|Adverse Event|1
801955|NCT00796003|2550633|P2|Overall Study|Disease Progression|13
801956|NCT00796003|2550634|P1|Overall Study|Disease Progression|2
801957|NCT00796120|2550657|P2|Overall Study|Randomized but not treated|3
801958|NCT00796120|2550658|P1|Overall Study|Randomized but not treated|0
801959|NCT00796120|2550657|P2|Overall Study|Physician Decision|17
801960|NCT00796120|2550658|P1|Overall Study|Physician Decision|16
801961|NCT00796120|2550657|P2|Overall Study|unspecified|17
801962|NCT00796120|2550658|P1|Overall Study|unspecified|6
801963|NCT00796120|2550657|P2|Overall Study|Participant refusal|4
801964|NCT00796120|2550658|P1|Overall Study|Participant refusal|3
801965|NCT00796120|2550657|P2|Overall Study|Progressive disease|13
801966|NCT00796120|2550658|P1|Overall Study|Progressive disease|22
801967|NCT00796120|2550657|P2|Overall Study|Adverse Event|6
801968|NCT00796120|2550658|P1|Overall Study|Adverse Event|11
801969|NCT00796120|2550657|P2|Overall Study|Death|0
801970|NCT00796120|2550658|P1|Overall Study|Death|3
801971|NCT00796224|2550674|P2|Overall Study|Protocol Violation|1
801972|NCT00796224|2550675|P1|Overall Study|Protocol Violation|0
801973|NCT00796224|2550674|P2|Overall Study|Adverse Event|0
801974|NCT00796224|2550675|P1|Overall Study|Adverse Event|1
801975|NCT00796315|2550708|P3|Overall Study|Protocol Violation|0
801976|NCT00796315|2550709|P2|Overall Study|Protocol Violation|1
801977|NCT00796315|2550710|P1|Overall Study|Protocol Violation|0
801978|NCT00796328|2550721|P1|Overall Study|experienced hypotension requiring tx|6
801979|NCT00796367|2550728|P3|Overall Study|other|3
801980|NCT00796367|2550729|P2|Overall Study|other|4
801981|NCT00796367|2550730|P1|Overall Study|other|2
801982|NCT00796367|2550728|P3|Overall Study|Requirement for restricted medication|2
801983|NCT00796367|2550729|P2|Overall Study|Requirement for restricted medication|0
801984|NCT00796367|2550730|P1|Overall Study|Requirement for restricted medication|2
801985|NCT00796367|2550728|P3|Overall Study|Pregnancy|1
801986|NCT00796367|2550729|P2|Overall Study|Pregnancy|0
801987|NCT00796367|2550730|P1|Overall Study|Pregnancy|1
801988|NCT00796367|2550728|P3|Overall Study|non compliance|1
801989|NCT00796367|2550729|P2|Overall Study|non compliance|1
801990|NCT00796367|2550730|P1|Overall Study|non compliance|3
801991|NCT00796367|2550728|P3|Overall Study|Lack of Efficacy|0
801993|NCT00796367|2550730|P1|Overall Study|Lack of Efficacy|2
801994|NCT00796367|2550728|P3|Overall Study|Withdrawal by Subject|12
801995|NCT00796367|2550729|P2|Overall Study|Withdrawal by Subject|11
801996|NCT00796367|2550730|P1|Overall Study|Withdrawal by Subject|9
801997|NCT00796367|2550728|P3|Overall Study|Lost to Follow-up|21
801998|NCT00796367|2550729|P2|Overall Study|Lost to Follow-up|4
801999|NCT00796367|2550730|P1|Overall Study|Lost to Follow-up|5
802000|NCT00796367|2550728|P3|Overall Study|Adverse Event|7
802001|NCT00796367|2550729|P2|Overall Study|Adverse Event|4
802002|NCT00796367|2550730|P1|Overall Study|Adverse Event|6
802003|NCT00796419|2550743|P2|Overall Study|Death|1
802004|NCT00796419|2550744|P1|Overall Study|Death|0
802005|NCT00796510|2550756|P2|Overall Study|Study Terminated|0
802006|NCT00796510|2550757|P1|Overall Study|Study Terminated|2
802007|NCT00796510|2550756|P2|Overall Study|Death|0
802008|NCT00796510|2550757|P1|Overall Study|Death|1
802009|NCT00796523|2550769|P2|Overall Study|Lost to Follow-up|7
802010|NCT00796523|2550770|P1|Overall Study|Lost to Follow-up|9
802011|NCT00796549|2550778|P1|Overall Study|Progressive disease|56
802012|NCT00796549|2550778|P1|Overall Study|Other|2
802013|NCT00796549|2550778|P1|Overall Study|not entered|149
802014|NCT00796549|2550778|P1|Overall Study|Adverse Event|11
802015|NCT00796614|2550797|P4|Overall Study|Other than stated|0
802016|NCT00796614|2550798|P3|Overall Study|Other than stated|0
802017|NCT00796614|2550799|P2|Overall Study|Other than stated|0
802018|NCT00796614|2550800|P1|Overall Study|Other than stated|1
802019|NCT00796614|2550797|P4|Overall Study|Withdrawal by Subject|1
802020|NCT00796614|2550798|P3|Overall Study|Withdrawal by Subject|0
802021|NCT00796614|2550799|P2|Overall Study|Withdrawal by Subject|0
802022|NCT00796614|2550800|P1|Overall Study|Withdrawal by Subject|1
802023|NCT00796614|2550797|P4|Overall Study|Lost to Follow-up|0
802024|NCT00796614|2550798|P3|Overall Study|Lost to Follow-up|1
802025|NCT00796614|2550799|P2|Overall Study|Lost to Follow-up|2
802026|NCT00796614|2550800|P1|Overall Study|Lost to Follow-up|2
802027|NCT00796614|2550797|P4|Overall Study|Protocol Violation|0
802028|NCT00796614|2550798|P3|Overall Study|Protocol Violation|2
802029|NCT00796614|2550799|P2|Overall Study|Protocol Violation|0
802030|NCT00796614|2550800|P1|Overall Study|Protocol Violation|0
802031|NCT00796614|2550797|P4|Overall Study|Adverse Event|0
802032|NCT00796614|2550798|P3|Overall Study|Adverse Event|0
802033|NCT00796614|2550799|P2|Overall Study|Adverse Event|2
802034|NCT00796614|2550800|P1|Overall Study|Adverse Event|1
802035|NCT00796653|2550861|P4|Overall Study|Other reason not described above|4
802036|NCT00796653|2550862|P3|Overall Study|Other reason not described above|7
802037|NCT00796653|2550863|P2|Overall Study|Other reason not described above|9
802038|NCT00796653|2550864|P1|Overall Study|Other reason not described above|4
802039|NCT00796653|2550861|P4|Overall Study|Non compliance with protocol|2
802040|NCT00796653|2550862|P3|Overall Study|Non compliance with protocol|0
802041|NCT00796653|2550863|P2|Overall Study|Non compliance with protocol|2
802042|NCT00796653|2550864|P1|Overall Study|Non compliance with protocol|2
802043|NCT00796653|2550861|P4|Overall Study|Lack of Efficacy|2
802044|NCT00796653|2550862|P3|Overall Study|Lack of Efficacy|3
802045|NCT00796653|2550863|P2|Overall Study|Lack of Efficacy|1
802046|NCT00796653|2550864|P1|Overall Study|Lack of Efficacy|8
802047|NCT00796653|2550861|P4|Overall Study|Withdrawal by Subject|13
802048|NCT00796653|2550862|P3|Overall Study|Withdrawal by Subject|8
802049|NCT00796653|2550863|P2|Overall Study|Withdrawal by Subject|8
802050|NCT00796653|2550864|P1|Overall Study|Withdrawal by Subject|16
802051|NCT00796653|2550861|P4|Overall Study|Lost to Follow-up|3
802052|NCT00796653|2550862|P3|Overall Study|Lost to Follow-up|2
802053|NCT00796653|2550863|P2|Overall Study|Lost to Follow-up|1
802054|NCT00796653|2550864|P1|Overall Study|Lost to Follow-up|2
802055|NCT00796653|2550861|P4|Overall Study|Adverse Event|16
802056|NCT00796653|2550862|P3|Overall Study|Adverse Event|16
802057|NCT00796653|2550863|P2|Overall Study|Adverse Event|16
802058|NCT00796653|2550864|P1|Overall Study|Adverse Event|19
802059|NCT00796666|2551132|P2|Overall Study|Randomized and not treated|0
802060|NCT00796666|2551133|P1|Overall Study|Randomized and not treated|1
802061|NCT00796666|2551132|P2|Overall Study|Terminated by sponsor|55
802062|NCT00796666|2551133|P1|Overall Study|Terminated by sponsor|53
802063|NCT00796666|2551132|P2|Overall Study|Unspecified|0
802064|NCT00796666|2551133|P1|Overall Study|Unspecified|1
802065|NCT00796666|2551132|P2|Overall Study|Protocol Violation|0
802066|NCT00796666|2551133|P1|Overall Study|Protocol Violation|1
802067|NCT00796666|2551132|P2|Overall Study|Adverse Event|5
802068|NCT00796666|2551133|P1|Overall Study|Adverse Event|7
802069|NCT00796666|2551132|P2|Overall Study|Withdrawal by Subject|0
802070|NCT00796666|2551133|P1|Overall Study|Withdrawal by Subject|2
802071|NCT00796666|2551132|P2|Overall Study|Death|4
802072|NCT00796666|2551133|P1|Overall Study|Death|2
802073|NCT00796718|2551206|P1|Overall Study|Withdrawal by Informed Consent|1
802074|NCT00796718|2551206|P1|Overall Study|Lost to Follow-up|5
802075|NCT00796718|2551206|P1|Overall Study|Exclusion Criteria|1
802076|NCT00796718|2551206|P1|Overall Study|Adverse Event|2
802077|NCT00796757|2551235|P1|Overall Study|Not specified|7
802078|NCT00796757|2551235|P1|Overall Study|Investigator's decision|2
802079|NCT00796757|2551235|P1|Overall Study|Participant noncompliance|1
802080|NCT00796757|2551235|P1|Overall Study|Protocol Violation|1
802081|NCT00796757|2551235|P1|Overall Study|Death|61
802082|NCT00796757|2551235|P1|Overall Study|Withdrawal by Subject|14
802087|NCT00796991|2551268|P3|Overall Study|Withdrawal by Subject|1
802088|NCT00796991|2551269|P2|Overall Study|Withdrawal by Subject|0
802089|NCT00796991|2551270|P1|Overall Study|Withdrawal by Subject|0
802090|NCT00796991|2551268|P3|Overall Study|Study Drug Toxicity|5
802091|NCT00796991|2551269|P2|Overall Study|Study Drug Toxicity|3
802092|NCT00796991|2551270|P1|Overall Study|Study Drug Toxicity|3
802093|NCT00796991|2551268|P3|Overall Study|Disease Progression|7
802094|NCT00796991|2551269|P2|Overall Study|Disease Progression|9
802095|NCT00796991|2551270|P1|Overall Study|Disease Progression|10
802096|NCT00796991|2551268|P3|Overall Study|Death|0
802097|NCT00796991|2551269|P2|Overall Study|Death|0
802098|NCT00796991|2551270|P1|Overall Study|Death|2
802099|NCT00796991|2551268|P3|Overall Study|Adverse Event|1
802100|NCT00796991|2551269|P2|Overall Study|Adverse Event|0
802101|NCT00796991|2551270|P1|Overall Study|Adverse Event|0
802102|NCT00797108|2551371|P3|Overall Study|Randomized but not Treated|0
802103|NCT00797108|2551372|P2|Overall Study|Randomized but not Treated|0
802104|NCT00797108|2551373|P1|Overall Study|Randomized but not Treated|2
802105|NCT00797108|2551371|P3|Overall Study|Unspecified|2
802106|NCT00797108|2551372|P2|Overall Study|Unspecified|0
802107|NCT00797108|2551373|P1|Overall Study|Unspecified|0
802108|NCT00797108|2551371|P3|Overall Study|Lack of Efficacy|1
802109|NCT00797108|2551372|P2|Overall Study|Lack of Efficacy|0
802110|NCT00797108|2551373|P1|Overall Study|Lack of Efficacy|1
802111|NCT00797108|2551371|P3|Overall Study|Global Deterioration of Health Status|0
802112|NCT00797108|2551372|P2|Overall Study|Global Deterioration of Health Status|1
802113|NCT00797108|2551373|P1|Overall Study|Global Deterioration of Health Status|0
802114|NCT00797108|2551371|P3|Overall Study|Did Not Meet Entrance Criteria|0
802115|NCT00797108|2551372|P2|Overall Study|Did Not Meet Entrance Criteria|1
802116|NCT00797108|2551373|P1|Overall Study|Did Not Meet Entrance Criteria|0
802117|NCT00797108|2551371|P3|Overall Study|Adverse Event|3
802118|NCT00797108|2551372|P2|Overall Study|Adverse Event|0
802119|NCT00797108|2551373|P1|Overall Study|Adverse Event|1
802120|NCT00797316|2551424|P2|Overall Study|Unsatisfactory therapeutic effect|13
802121|NCT00797316|2551425|P1|Overall Study|Unsatisfactory therapeutic effect|0
802122|NCT00797316|2551424|P2|Overall Study|Patient withdrew consent|6
802123|NCT00797316|2551425|P1|Overall Study|Patient withdrew consent|12
802124|NCT00797316|2551424|P2|Overall Study|Protocol Deviation|2
802125|NCT00797316|2551425|P1|Overall Study|Protocol Deviation|1
802126|NCT00797316|2551424|P2|Overall Study|Lost to Follow-up|8
802127|NCT00797316|2551425|P1|Overall Study|Lost to Follow-up|4
802128|NCT00797316|2551424|P2|Overall Study|Adverse Event|3
802129|NCT00797316|2551425|P1|Overall Study|Adverse Event|5
802130|NCT00797316|2551424|P2|Overall Study|Administrative problems|0
802131|NCT00797316|2551425|P1|Overall Study|Administrative problems|1
802132|NCT00797511|2551447|P1|Overall Study|Withdrawal by Subject|1
802133|NCT00797563|2551455|P1|Overall Study|Adverse Event|1
802134|NCT00799396|2551475|P1|Clopidogrel Plus Aspirin|Physician Decision|4
802135|NCT00799396|2551475|P1|Clopidogrel Plus Aspirin|Adverse Event|2
802136|NCT00799396|2551475|P1|Clopidogrel Treatment|Withdrawal by Subject|2
802137|NCT00799396|2551475|P1|Clopidogrel Treatment|Physician Decision|5
802138|NCT00799396|2551475|P1|Clopidogrel Treatment|Adverse Event|6
802139|NCT00799409|2551483|P3|Overall Study|medication compliance|0
802140|NCT00799409|2551484|P2|Overall Study|medication compliance|0
802141|NCT00799409|2551485|P1|Overall Study|medication compliance|1
802142|NCT00799409|2551483|P3|Overall Study|Did not attend lab school day 1|0
802143|NCT00799409|2551484|P2|Overall Study|Did not attend lab school day 1|0
802144|NCT00799409|2551485|P1|Overall Study|Did not attend lab school day 1|1
802145|NCT00799409|2551483|P3|Overall Study|Failure to follow study protocol)|0
802146|NCT00799409|2551484|P2|Overall Study|Failure to follow study protocol)|0
802147|NCT00799409|2551485|P1|Overall Study|Failure to follow study protocol)|1
802148|NCT00799409|2551483|P3|Overall Study|Optimal Dose Not Achieved|0
802149|NCT00799409|2551484|P2|Overall Study|Optimal Dose Not Achieved|0
802150|NCT00799409|2551485|P1|Overall Study|Optimal Dose Not Achieved|2
802151|NCT00799409|2551483|P3|Overall Study|Lost to Follow-up|0
802152|NCT00799409|2551484|P2|Overall Study|Lost to Follow-up|0
802153|NCT00799409|2551485|P1|Overall Study|Lost to Follow-up|1
802154|NCT00799409|2551483|P3|Overall Study|Withdrawal by Subject|0
802155|NCT00799409|2551484|P2|Overall Study|Withdrawal by Subject|0
802156|NCT00799409|2551485|P1|Overall Study|Withdrawal by Subject|1
802157|NCT00799422|2551565|P6|First Week of Wear|Adverse Event|0
802158|NCT00799422|2551566|P5|First Week of Wear|Adverse Event|0
802159|NCT00799422|2551567|P4|First Week of Wear|Adverse Event|1
802160|NCT00799422|2551568|P3|First Week of Wear|Adverse Event|0
802161|NCT00799422|2551569|P2|First Week of Wear|Adverse Event|0
802162|NCT00799422|2551570|P1|First Week of Wear|Adverse Event|0
802163|NCT00799422|2551565|P6|First Week of Wear|Lost to Follow-up|0
802164|NCT00799422|2551566|P5|First Week of Wear|Lost to Follow-up|0
802165|NCT00799422|2551567|P4|First Week of Wear|Lost to Follow-up|0
802166|NCT00799422|2551568|P3|First Week of Wear|Lost to Follow-up|1
802167|NCT00799422|2551569|P2|First Week of Wear|Lost to Follow-up|0
802168|NCT00799422|2551570|P1|First Week of Wear|Lost to Follow-up|0
802248|NCT00799903|2551875|P1|Overall Study|Investigator Site Closed|25
802169|NCT00799487|2551602|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
802170|NCT00799487|2551603|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
802171|NCT00799487|2551604|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
802172|NCT00799487|2551602|P3|Double-Blind Assessment Period|Subject was out of the state|1
802173|NCT00799487|2551603|P2|Double-Blind Assessment Period|Subject was out of the state|0
802174|NCT00799487|2551604|P1|Double-Blind Assessment Period|Subject was out of the state|0
802175|NCT00799487|2551602|P3|Double-Blind Assessment Period|Lost to Follow-up|1
802176|NCT00799487|2551603|P2|Double-Blind Assessment Period|Lost to Follow-up|0
802177|NCT00799487|2551604|P1|Double-Blind Assessment Period|Lost to Follow-up|0
802178|NCT00799487|2551602|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
802179|NCT00799487|2551603|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
802180|NCT00799487|2551604|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
802181|NCT00799487|2551602|P3|Dose Adjustment Period|Missed laboratory day 1|0
802182|NCT00799487|2551603|P2|Dose Adjustment Period|Missed laboratory day 1|0
802183|NCT00799487|2551604|P1|Dose Adjustment Period|Missed laboratory day 1|1
802184|NCT00799487|2551602|P3|Dose Adjustment Period|Child too young (exclusion)|0
802185|NCT00799487|2551603|P2|Dose Adjustment Period|Child too young (exclusion)|0
802186|NCT00799487|2551604|P1|Dose Adjustment Period|Child too young (exclusion)|1
802187|NCT00799487|2551602|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
802188|NCT00799487|2551603|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
802189|NCT00799487|2551604|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
802190|NCT00799487|2551602|P3|Dose Adjustment Period|Withdrawal by Subject|0
802191|NCT00799487|2551603|P2|Dose Adjustment Period|Withdrawal by Subject|0
802192|NCT00799487|2551604|P1|Dose Adjustment Period|Withdrawal by Subject|3
802193|NCT00799487|2551602|P3|Dose Adjustment Period|Investigator Discretion|0
802194|NCT00799487|2551603|P2|Dose Adjustment Period|Investigator Discretion|0
802195|NCT00799487|2551604|P1|Dose Adjustment Period|Investigator Discretion|2
802196|NCT00799487|2551602|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
802197|NCT00799487|2551603|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
802198|NCT00799487|2551604|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
802199|NCT00799487|2551602|P3|Dose Adjustment Period|Adverse Event|0
802200|NCT00799487|2551603|P2|Dose Adjustment Period|Adverse Event|0
802201|NCT00799487|2551604|P1|Dose Adjustment Period|Adverse Event|2
802202|NCT00799487|2551602|P3|Dose Adjustment Period|Lost to Follow-up|0
802203|NCT00799487|2551603|P2|Dose Adjustment Period|Lost to Follow-up|0
802204|NCT00799487|2551604|P1|Dose Adjustment Period|Lost to Follow-up|1
802205|NCT00799591|2551688|P1|Overall Study|Infectious origin not probable|1
802206|NCT00799591|2551688|P1|Overall Study|Antibiotic changed, no apparent reason|1
802207|NCT00799591|2551688|P1|Overall Study|Persistance of fever undetermined origin|1
802208|NCT00799591|2551688|P1|Overall Study|Resistance germ and technical failure|2
802209|NCT00799591|2551688|P1|Overall Study|New infection|4
802210|NCT00799591|2551688|P1|Overall Study|Resistant germ|11
802211|NCT00799591|2551688|P1|Overall Study|Technical failure|12
802212|NCT00799591|2551688|P1|Overall Study|Death|14
802213|NCT00799591|2551688|P1|Overall Study|De-escalation of doses|20
802236|NCT00799708|2551823|P3|Overall Study|non-compliance|0
802237|NCT00799708|2551824|P2|Overall Study|non-compliance|0
802238|NCT00799708|2551825|P1|Overall Study|non-compliance|1
802239|NCT00799825|2551866|P1|Overall Study|Pregnancy|3
802240|NCT00799825|2551866|P1|Overall Study|Lost to Follow-up|38
802241|NCT00799825|2551866|P1|Overall Study|Withdrawal by Subject|6
802242|NCT00799825|2551866|P1|Overall Study|Adverse Event|1
802243|NCT00799903|2551874|P2|Overall Study|Lost to Follow-up|80
802244|NCT00799903|2551875|P1|Overall Study|Lost to Follow-up|69
802245|NCT00799903|2551874|P2|Overall Study|Withdrawal by Subject|175
802246|NCT00799903|2551875|P1|Overall Study|Withdrawal by Subject|179
802247|NCT00799903|2551874|P2|Overall Study|Investigator Site Closed|23
802249|NCT00800202|2551897|P2|Overall Study|Disease Progression|18
802250|NCT00800202|2551898|P1|Overall Study|Disease Progression|54
802251|NCT00800202|2551897|P2|Overall Study|Unspecified|0
802252|NCT00800202|2551898|P1|Overall Study|Unspecified|5
802253|NCT00800202|2551897|P2|Overall Study|Death|0
802254|NCT00800202|2551898|P1|Overall Study|Death|1
802255|NCT00800202|2551897|P2|Overall Study|Adverse Event|6
802256|NCT00800202|2551898|P1|Overall Study|Adverse Event|7
802257|NCT00800384|2551946|P2|Overall Study|Lost to Follow-up|26
802258|NCT00800384|2551947|P1|Overall Study|Lost to Follow-up|17
802259|NCT00800384|2551946|P2|Overall Study|Withdrawal by Subject|17
802260|NCT00800384|2551947|P1|Overall Study|Withdrawal by Subject|24
802261|NCT00800436|2551962|P7|Overall Study|Withdrawal by Subject|0
802262|NCT00800436|2551963|P6|Overall Study|Withdrawal by Subject|0
802263|NCT00800436|2551964|P5|Overall Study|Withdrawal by Subject|0
802264|NCT00800436|2551965|P4|Overall Study|Withdrawal by Subject|1
802265|NCT00800436|2551966|P3|Overall Study|Withdrawal by Subject|1
802266|NCT00800436|2551967|P2|Overall Study|Withdrawal by Subject|0
802267|NCT00800436|2551968|P1|Overall Study|Withdrawal by Subject|0
802268|NCT00800540|2552012|P2|Period 2: 6 Weeks|Adverse Event|1
802269|NCT00800540|2552013|P1|Period 2: 6 Weeks|Adverse Event|0
802270|NCT00800540|2552012|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
802271|NCT00800540|2552013|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
802272|NCT00800540|2552012|P2|Period One: 6 Weeks|Noncompliance|0
802273|NCT00800540|2552013|P1|Period One: 6 Weeks|Noncompliance|1
802274|NCT00800683|2552043|P2|Overall Study|Not specified|2
802275|NCT00800683|2552044|P1|Overall Study|Not specified|1
802276|NCT00800683|2552043|P2|Overall Study|Lack of Efficacy|1
802277|NCT00800683|2552044|P1|Overall Study|Lack of Efficacy|1
802278|NCT00800683|2552043|P2|Overall Study|Withdrawal by Subject|7
802279|NCT00800683|2552044|P1|Overall Study|Withdrawal by Subject|1
802280|NCT00800683|2552043|P2|Overall Study|Lost to Follow-up|1
802281|NCT00800683|2552044|P1|Overall Study|Lost to Follow-up|3
802282|NCT00800683|2552043|P2|Overall Study|Adverse Event|8
802283|NCT00800683|2552044|P1|Overall Study|Adverse Event|11
802284|NCT00800735|2552090|P1|Overall Study|Withdrew Consent|3
802285|NCT00800735|2552090|P1|Overall Study|Violation of Selection Criteria at Entry|7
802286|NCT00800735|2552090|P1|Overall Study|Insufficient Therapeutic Response|2
802287|NCT00800735|2552090|P1|Overall Study|Administrative/Other|2
802288|NCT00800982|2552116|P2|Overall Study|Patient moved out of state|0
802289|NCT00800982|2552117|P1|Overall Study|Patient moved out of state|1
802290|NCT00800982|2552116|P2|Overall Study|Withdrawal by Subject|1
802291|NCT00800982|2552117|P1|Overall Study|Withdrawal by Subject|0
802292|NCT00800982|2552116|P2|Overall Study|Lost to Follow-up|2
802293|NCT00800982|2552117|P1|Overall Study|Lost to Follow-up|1
802294|NCT00801099|2552123|P1|Overall Study|Lost to Follow-up|101
802295|NCT00801229|2552158|P2|Received Study Drug/Placebo|Adverse Event|1
802296|NCT00801229|2552159|P1|Received Study Drug/Placebo|Adverse Event|1
802297|NCT00801229|2552158|P2|Received Study Drug/Placebo|Lost to Follow-up|1
802298|NCT00801229|2552159|P1|Received Study Drug/Placebo|Lost to Follow-up|0
802299|NCT00801229|2552158|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
802300|NCT00801229|2552159|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
802301|NCT00801229|2552158|P2|Received Study Drug/Placebo|Simulator sickness|1
802302|NCT00801229|2552159|P1|Received Study Drug/Placebo|Simulator sickness|1
802303|NCT00801229|2552158|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
802304|NCT00801229|2552159|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
802305|NCT00801229|2552158|P2|Received Study Drug/Placebo|Elevated SGOT level|0
802306|NCT00801229|2552159|P1|Received Study Drug/Placebo|Elevated SGOT level|1
802307|NCT00801229|2552158|P2|Signed Consent|Found Ineligible|1
802308|NCT00801229|2552159|P1|Signed Consent|Found Ineligible|1
802309|NCT00801229|2552158|P2|Signed Consent|Withdrawal by Subject|2
802310|NCT00801229|2552159|P1|Signed Consent|Withdrawal by Subject|2
802311|NCT00801242|2552165|P1|Overall Study|Miscellaneous reasons|20
802312|NCT00801242|2552165|P1|Overall Study|Lost to Follow-up|1
802313|NCT00801242|2552165|P1|Overall Study|Physician Decision|3
802314|NCT00801242|2552165|P1|Overall Study|Protocol Violation|5
802315|NCT00801242|2552165|P1|Overall Study|Withdrawal by Subject|13
802316|NCT00801242|2552165|P1|Overall Study|Adverse Event|10
802317|NCT00810641|2552179|P3|Overall Study|Withdrawal by Subject|2
802318|NCT00810641|2552180|P2|Overall Study|Withdrawal by Subject|1
802319|NCT00810641|2552181|P1|Overall Study|Withdrawal by Subject|0
802320|NCT00810693|2552192|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
802321|NCT00810693|2552193|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
802322|NCT00810693|2552194|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
802323|NCT00810693|2552192|P3|Follow-up Period (FUP)|Protocol Violation|0
802324|NCT00810693|2552193|P2|Follow-up Period (FUP)|Protocol Violation|1
802325|NCT00810693|2552194|P1|Follow-up Period (FUP)|Protocol Violation|0
802326|NCT00810693|2552192|P3|Follow-up Period (FUP)|Lost to Follow-up|2
802327|NCT00810693|2552193|P2|Follow-up Period (FUP)|Lost to Follow-up|0
802328|NCT00810693|2552194|P1|Follow-up Period (FUP)|Lost to Follow-up|1
802329|NCT00810693|2552192|P3|Follow-up Period (FUP)|Death|1
802330|NCT00810693|2552193|P2|Follow-up Period (FUP)|Death|0
802331|NCT00810693|2552194|P1|Follow-up Period (FUP)|Death|2
802332|NCT00810693|2552192|P3|Follow-up Period (FUP)|Adverse Event|1
802333|NCT00810693|2552193|P2|Follow-up Period (FUP)|Adverse Event|1
802334|NCT00810693|2552194|P1|Follow-up Period (FUP)|Adverse Event|3
802335|NCT00810693|2552192|P3|Treatment Period|Not treated|1
802336|NCT00810693|2552193|P2|Treatment Period|Not treated|1
802337|NCT00810693|2552194|P1|Treatment Period|Not treated|0
802338|NCT00810693|2552192|P3|Treatment Period|Withdrawal by Subject|3
802339|NCT00810693|2552193|P2|Treatment Period|Withdrawal by Subject|2
802340|NCT00810693|2552194|P1|Treatment Period|Withdrawal by Subject|6
802341|NCT00810693|2552192|P3|Treatment Period|Protocol Violation|2
802342|NCT00810693|2552193|P2|Treatment Period|Protocol Violation|2
802343|NCT00810693|2552194|P1|Treatment Period|Protocol Violation|1
802344|NCT00810693|2552192|P3|Treatment Period|Non-compliance|0
802345|NCT00810693|2552193|P2|Treatment Period|Non-compliance|0
802346|NCT00810693|2552194|P1|Treatment Period|Non-compliance|1
802347|NCT00810693|2552192|P3|Treatment Period|Lost to Follow-up|0
802348|NCT00810693|2552193|P2|Treatment Period|Lost to Follow-up|0
802349|NCT00810693|2552194|P1|Treatment Period|Lost to Follow-up|1
802350|NCT00810693|2552192|P3|Treatment Period|Lack of Efficacy|1
802351|NCT00810693|2552193|P2|Treatment Period|Lack of Efficacy|0
802352|NCT00810693|2552194|P1|Treatment Period|Lack of Efficacy|0
802353|NCT00810693|2552192|P3|Treatment Period|Death|2
802354|NCT00810693|2552193|P2|Treatment Period|Death|1
802355|NCT00810693|2552194|P1|Treatment Period|Death|0
802356|NCT00810693|2552192|P3|Treatment Period|Adverse Event|7
802357|NCT00810693|2552193|P2|Treatment Period|Adverse Event|1
802358|NCT00810693|2552194|P1|Treatment Period|Adverse Event|8
802359|NCT00810901|2552256|P2|Overall Study|Lost to Follow-up|58
802360|NCT00810901|2552257|P1|Overall Study|Lost to Follow-up|88
802361|NCT00811395|2552286|P6|Extension Treatment|Other than above|0
802362|NCT00811395|2552287|P5|Extension Treatment|Other than above|0
802363|NCT00811395|2552288|P4|Extension Treatment|Other than above|0
802364|NCT00811395|2552289|P3|Extension Treatment|Other than above|1
802365|NCT00811395|2552290|P2|Extension Treatment|Other than above|0
802366|NCT00811395|2552291|P1|Extension Treatment|Other than above|0
802367|NCT00811395|2552286|P6|Extension Treatment|Participant did not wish to continue|1
802368|NCT00811395|2552287|P5|Extension Treatment|Participant did not wish to continue|0
802369|NCT00811395|2552288|P4|Extension Treatment|Participant did not wish to continue|1
802370|NCT00811395|2552289|P3|Extension Treatment|Participant did not wish to continue|0
802371|NCT00811395|2552290|P2|Extension Treatment|Participant did not wish to continue|3
802372|NCT00811395|2552291|P1|Extension Treatment|Participant did not wish to continue|0
802373|NCT00811395|2552286|P6|Extension Treatment|Progressive disease|0
802374|NCT00811395|2552287|P5|Extension Treatment|Progressive disease|0
802375|NCT00811395|2552288|P4|Extension Treatment|Progressive disease|0
802376|NCT00811395|2552289|P3|Extension Treatment|Progressive disease|0
802377|NCT00811395|2552290|P2|Extension Treatment|Progressive disease|1
802378|NCT00811395|2552291|P1|Extension Treatment|Progressive disease|1
802379|NCT00811395|2552286|P6|Extension Treatment|Adverse Event|1
802380|NCT00811395|2552287|P5|Extension Treatment|Adverse Event|0
802381|NCT00811395|2552288|P4|Extension Treatment|Adverse Event|2
802382|NCT00811395|2552289|P3|Extension Treatment|Adverse Event|2
802383|NCT00811395|2552290|P2|Extension Treatment|Adverse Event|2
802384|NCT00811395|2552291|P1|Extension Treatment|Adverse Event|1
802385|NCT00811473|2552364|P2|Overall Study|Safety Reasons|0
802386|NCT00811473|2552365|P1|Overall Study|Safety Reasons|1
802387|NCT00811473|2552364|P2|Overall Study|Incorrect Enrollment|0
802388|NCT00811473|2552365|P1|Overall Study|Incorrect Enrollment|1
802389|NCT00811473|2552364|P2|Overall Study|Other 2|1
802390|NCT00811473|2552365|P1|Overall Study|Other 2|4
802391|NCT00811473|2552364|P2|Overall Study|Condition under investigation worsened|3
802392|NCT00811473|2552365|P1|Overall Study|Condition under investigation worsened|1
802393|NCT00811473|2552364|P2|Overall Study|Lack of therapeutic response|1
802394|NCT00811473|2552365|P1|Overall Study|Lack of therapeutic response|4
802395|NCT00811473|2552364|P2|Overall Study|Severe non-compliance to protocol|4
802396|NCT00811473|2552365|P1|Overall Study|Severe non-compliance to protocol|2
802397|NCT00811473|2552364|P2|Overall Study|Withdrawal by Subject|4
802398|NCT00811473|2552365|P1|Overall Study|Withdrawal by Subject|2
802399|NCT00811473|2552364|P2|Overall Study|Lost to Follow-up|1
802400|NCT00811473|2552365|P1|Overall Study|Lost to Follow-up|5
802401|NCT00811473|2552364|P2|Overall Study|Adverse Event|12
802402|NCT00811473|2552365|P1|Overall Study|Adverse Event|3
802403|NCT00811577|2552392|P2|Overall Study|Withdrawal by Subject|0
802404|NCT00811577|2552393|P1|Overall Study|Withdrawal by Subject|3
802405|NCT00811577|2552392|P2|Overall Study|Lost to Follow-up|1
802406|NCT00811577|2552393|P1|Overall Study|Lost to Follow-up|7
802407|NCT00811642|2552446|P1|Overall Study|Cumulative use of antifungal agent|2
802408|NCT00811642|2552446|P1|Overall Study|Withdrawal by Subject|7
802409|NCT00811642|2552446|P1|Overall Study|Death|2
802410|NCT00811642|2552446|P1|Overall Study|Protocol Violation|1
802411|NCT00811642|2552446|P1|Overall Study|Adverse Event|3
802412|NCT00811655|2552456|P1|Overall Study|Physician Decision|1
802413|NCT00811720|2552470|P2|All Treated Patients|Other Reason|4
802414|NCT00811720|2552471|P1|All Treated Patients|Other Reason|7
802415|NCT00811720|2552470|P2|All Treated Patients|Lost to Follow-up|16
802416|NCT00811720|2552471|P1|All Treated Patients|Lost to Follow-up|10
802417|NCT00811720|2552470|P2|All Treated Patients|Withdrawal by Subject|34
802418|NCT00811720|2552471|P1|All Treated Patients|Withdrawal by Subject|28
802419|NCT00811720|2552470|P2|All Treated Patients|Protocol Violation|16
802420|NCT00811720|2552471|P1|All Treated Patients|Protocol Violation|9
802421|NCT00811720|2552470|P2|All Treated Patients|Non-compliance|14
802422|NCT00811720|2552471|P1|All Treated Patients|Non-compliance|0
802423|NCT00811720|2552470|P2|All Treated Patients|Lack of Efficacy|18
802424|NCT00811720|2552471|P1|All Treated Patients|Lack of Efficacy|22
802425|NCT00811720|2552470|P2|All Treated Patients|Adverse Event|62
802426|NCT00811720|2552471|P1|All Treated Patients|Adverse Event|20
802427|NCT00811720|2552470|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
802428|NCT00811720|2552471|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
802429|NCT00811733|2552491|P2|Overall Study|Withdrawal by Subject|2
802430|NCT00811733|2552492|P1|Overall Study|Withdrawal by Subject|1
802431|NCT00811733|2552491|P2|Overall Study|Investigator Discretion|8
802432|NCT00811733|2552492|P1|Overall Study|Investigator Discretion|10
802445|NCT00811941|2552585|P2|All Treated Patients|Other Reason|14
802446|NCT00811941|2552586|P1|All Treated Patients|Other Reason|4
802447|NCT00811941|2552585|P2|All Treated Patients|Lost to Follow-up|12
802448|NCT00811941|2552586|P1|All Treated Patients|Lost to Follow-up|3
802449|NCT00811941|2552585|P2|All Treated Patients|Withdrawal by Subject|94
802450|NCT00811941|2552586|P1|All Treated Patients|Withdrawal by Subject|35
802451|NCT00811941|2552585|P2|All Treated Patients|Protocol Violation|17
802452|NCT00811941|2552586|P1|All Treated Patients|Protocol Violation|5
802453|NCT00811941|2552585|P2|All Treated Patients|Non-compliance|8
802454|NCT00811941|2552586|P1|All Treated Patients|Non-compliance|1
802455|NCT00811941|2552585|P2|All Treated Patients|Lack of Efficacy|3
802456|NCT00811941|2552586|P1|All Treated Patients|Lack of Efficacy|2
802457|NCT00811941|2552585|P2|All Treated Patients|Adverse Event|43
802458|NCT00811941|2552586|P1|All Treated Patients|Adverse Event|2
802459|NCT00811941|2552585|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
802460|NCT00811941|2552586|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
802461|NCT00811954|2552625|P3|Overall Study|Complete Protocol: No follow-up|1
802462|NCT00811954|2552626|P2|Overall Study|Complete Protocol: No follow-up|0
802463|NCT00811954|2552627|P1|Overall Study|Complete Protocol: No follow-up|0
802464|NCT00811954|2552625|P3|Overall Study|Severe Debilitation|1
802465|NCT00811954|2552626|P2|Overall Study|Severe Debilitation|0
802466|NCT00811954|2552627|P1|Overall Study|Severe Debilitation|2
802467|NCT00811954|2552625|P3|Overall Study|Site Closure|1
802468|NCT00811954|2552626|P2|Overall Study|Site Closure|0
802469|NCT00811954|2552627|P1|Overall Study|Site Closure|4
802470|NCT00811954|2552625|P3|Overall Study|Withdraw consent prior study completion|5
802471|NCT00811954|2552626|P2|Overall Study|Withdraw consent prior study completion|6
802472|NCT00811954|2552627|P1|Overall Study|Withdraw consent prior study completion|4
802473|NCT00811954|2552625|P3|Overall Study|Not willing to adhere to requirements|16
802474|NCT00811954|2552626|P2|Overall Study|Not willing to adhere to requirements|2
802475|NCT00811954|2552627|P1|Overall Study|Not willing to adhere to requirements|12
802476|NCT00811954|2552625|P3|Overall Study|Not able to get to clinic|30
802477|NCT00811954|2552626|P2|Overall Study|Not able to get to clinic|35
802478|NCT00811954|2552627|P1|Overall Study|Not able to get to clinic|28
802479|NCT00811954|2552625|P3|Overall Study|Lost to Follow-up|34
802480|NCT00811954|2552626|P2|Overall Study|Lost to Follow-up|23
802481|NCT00811954|2552627|P1|Overall Study|Lost to Follow-up|29
802482|NCT00811954|2552625|P3|Overall Study|Death|13
802483|NCT00811954|2552626|P2|Overall Study|Death|6
802484|NCT00811954|2552627|P1|Overall Study|Death|10
802485|NCT00812006|2552692|P3|Overall Study|Lack of Qualifying Event|2
802486|NCT00812006|2552693|P2|Overall Study|Lack of Qualifying Event|2
802487|NCT00812006|2552694|P1|Overall Study|Lack of Qualifying Event|4
802488|NCT00812006|2552692|P3|Overall Study|Withdrawal by Subject|1
802489|NCT00812006|2552693|P2|Overall Study|Withdrawal by Subject|1
802490|NCT00812006|2552694|P1|Overall Study|Withdrawal by Subject|2
802491|NCT00812006|2552692|P3|Overall Study|Physician Decision|1
802492|NCT00812006|2552693|P2|Overall Study|Physician Decision|0
802493|NCT00812006|2552694|P1|Overall Study|Physician Decision|0
802494|NCT00812006|2552692|P3|Overall Study|Lost to Follow-up|2
802495|NCT00812006|2552693|P2|Overall Study|Lost to Follow-up|0
802496|NCT00812006|2552694|P1|Overall Study|Lost to Follow-up|0
802497|NCT00812097|2552712|P4|Overall Study|Unknown reasons and patient/doctor moves|5
802498|NCT00812097|2552713|P3|Overall Study|Unknown reasons and patient/doctor moves|15
802499|NCT00812097|2552714|P2|Overall Study|Unknown reasons and patient/doctor moves|24
802500|NCT00812097|2552715|P1|Overall Study|Unknown reasons and patient/doctor moves|111
802501|NCT00812097|2552712|P4|Overall Study|Explantation of study device(s)|20
802502|NCT00812097|2552713|P3|Overall Study|Explantation of study device(s)|14
802503|NCT00812097|2552714|P2|Overall Study|Explantation of study device(s)|29
802504|NCT00812097|2552715|P1|Overall Study|Explantation of study device(s)|27
802505|NCT00812097|2552712|P4|Overall Study|Lost to Follow-up|5
802506|NCT00812097|2552713|P3|Overall Study|Lost to Follow-up|17
802507|NCT00812097|2552714|P2|Overall Study|Lost to Follow-up|14
802508|NCT00812097|2552715|P1|Overall Study|Lost to Follow-up|90
802509|NCT00812097|2552712|P4|Overall Study|Withdrawal by Subject|2
802510|NCT00812097|2552713|P3|Overall Study|Withdrawal by Subject|8
802511|NCT00812097|2552714|P2|Overall Study|Withdrawal by Subject|12
802512|NCT00812097|2552715|P1|Overall Study|Withdrawal by Subject|14
802513|NCT00812097|2552712|P4|Overall Study|Death|3
802514|NCT00812097|2552713|P3|Overall Study|Death|3
802515|NCT00812097|2552714|P2|Overall Study|Death|10
802516|NCT00812097|2552715|P1|Overall Study|Death|3
802517|NCT00812253|2552748|P2|Overall Study|Lost to Follow-up|0
802518|NCT00812253|2552749|P1|Overall Study|Lost to Follow-up|2
802519|NCT00812253|2552748|P2|Overall Study|Protocol Violation|1
802520|NCT00812253|2552749|P1|Overall Study|Protocol Violation|1
802521|NCT00812253|2552748|P2|Overall Study|Withdrawal by Subject|2
802522|NCT00812253|2552749|P1|Overall Study|Withdrawal by Subject|3
802523|NCT00812331|2552764|P5|Overall Study|Adverse Event|0
802524|NCT00812331|2552765|P4|Overall Study|Adverse Event|0
802525|NCT00812331|2552766|P3|Overall Study|Adverse Event|0
802526|NCT00812331|2552767|P2|Overall Study|Adverse Event|0
802527|NCT00812331|2552768|P1|Overall Study|Adverse Event|1
802528|NCT00812461|2552843|P2|All Treated Patients|Other Reason|21
802529|NCT00812461|2552844|P1|All Treated Patients|Other Reason|13
802530|NCT00812461|2552843|P2|All Treated Patients|Lost to Follow-up|14
802531|NCT00812461|2552844|P1|All Treated Patients|Lost to Follow-up|11
802532|NCT00812461|2552843|P2|All Treated Patients|Withdrawal by Subject|54
802533|NCT00812461|2552844|P1|All Treated Patients|Withdrawal by Subject|45
802534|NCT00812461|2552843|P2|All Treated Patients|Protocol Violation|27
802535|NCT00812461|2552844|P1|All Treated Patients|Protocol Violation|36
802536|NCT00812461|2552843|P2|All Treated Patients|Non-compliance|9
802537|NCT00812461|2552844|P1|All Treated Patients|Non-compliance|6
802538|NCT00812461|2552843|P2|All Treated Patients|Lack of Efficacy|7
802539|NCT00812461|2552844|P1|All Treated Patients|Lack of Efficacy|13
802540|NCT00812461|2552843|P2|All Treated Patients|Adverse Event|15
802541|NCT00812461|2552844|P1|All Treated Patients|Adverse Event|8
802542|NCT00812461|2552843|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
802543|NCT00812461|2552844|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
802544|NCT00812487|2552864|P2|Overall Study|Protocol Violation|1
802545|NCT00812487|2552865|P1|Overall Study|Protocol Violation|0
802546|NCT00812487|2552864|P2|Overall Study|Transfer to ICU prior to intervention|0
802547|NCT00812487|2552865|P1|Overall Study|Transfer to ICU prior to intervention|1
802548|NCT00812487|2552864|P2|Overall Study|Withdrawal by Subject|2
802549|NCT00812487|2552865|P1|Overall Study|Withdrawal by Subject|3
802550|NCT00812487|2552864|P2|Overall Study|Lost to Follow-up|0
802551|NCT00812487|2552865|P1|Overall Study|Lost to Follow-up|2
802552|NCT00812565|2552897|P8|Overall Study|Reason Not Specified|0
802553|NCT00812565|2552898|P7|Overall Study|Reason Not Specified|0
802554|NCT00812565|2552899|P6|Overall Study|Reason Not Specified|1
802555|NCT00812565|2552900|P5|Overall Study|Reason Not Specified|0
802556|NCT00812565|2552901|P4|Overall Study|Reason Not Specified|0
802557|NCT00812565|2552902|P3|Overall Study|Reason Not Specified|0
802558|NCT00812565|2552903|P2|Overall Study|Reason Not Specified|0
802559|NCT00812565|2552904|P1|Overall Study|Reason Not Specified|0
802560|NCT00812565|2552897|P8|Overall Study|Withdrawal of Consent|0
802561|NCT00812565|2552898|P7|Overall Study|Withdrawal of Consent|0
802562|NCT00812565|2552899|P6|Overall Study|Withdrawal of Consent|0
802563|NCT00812565|2552900|P5|Overall Study|Withdrawal of Consent|1
802564|NCT00812565|2552901|P4|Overall Study|Withdrawal of Consent|0
802565|NCT00812565|2552902|P3|Overall Study|Withdrawal of Consent|0
802566|NCT00812565|2552903|P2|Overall Study|Withdrawal of Consent|0
802567|NCT00812565|2552904|P1|Overall Study|Withdrawal of Consent|1
802568|NCT00812565|2552897|P8|Overall Study|Did Not Come to Study Visit|0
802569|NCT00812565|2552898|P7|Overall Study|Did Not Come to Study Visit|0
802570|NCT00812565|2552899|P6|Overall Study|Did Not Come to Study Visit|0
802571|NCT00812565|2552900|P5|Overall Study|Did Not Come to Study Visit|0
802572|NCT00812565|2552901|P4|Overall Study|Did Not Come to Study Visit|0
802573|NCT00812565|2552902|P3|Overall Study|Did Not Come to Study Visit|0
802574|NCT00812565|2552903|P2|Overall Study|Did Not Come to Study Visit|0
802575|NCT00812565|2552904|P1|Overall Study|Did Not Come to Study Visit|1
802576|NCT00812565|2552897|P8|Overall Study|Adverse Event|1
802577|NCT00812565|2552898|P7|Overall Study|Adverse Event|0
802578|NCT00812565|2552899|P6|Overall Study|Adverse Event|0
802579|NCT00812565|2552900|P5|Overall Study|Adverse Event|0
802580|NCT00812565|2552901|P4|Overall Study|Adverse Event|2
802581|NCT00812565|2552902|P3|Overall Study|Adverse Event|0
802582|NCT00812565|2552903|P2|Overall Study|Adverse Event|0
802583|NCT00812565|2552904|P1|Overall Study|Adverse Event|0
802584|NCT00812565|2552897|P8|Overall Study|Did Not Receive Study Medication|0
802585|NCT00812565|2552898|P7|Overall Study|Did Not Receive Study Medication|0
802586|NCT00812565|2552899|P6|Overall Study|Did Not Receive Study Medication|0
802587|NCT00812565|2552900|P5|Overall Study|Did Not Receive Study Medication|0
802588|NCT00812565|2552901|P4|Overall Study|Did Not Receive Study Medication|0
802673|NCT00813150|2553336|P2|Long Term Follow-up|Progression/Relapse|24
802589|NCT00812565|2552902|P3|Overall Study|Did Not Receive Study Medication|0
802590|NCT00812565|2552903|P2|Overall Study|Did Not Receive Study Medication|1
802591|NCT00812565|2552904|P1|Overall Study|Did Not Receive Study Medication|1
802592|NCT00812812|2553039|P2|Overall Study|Withdrawal by Subject|2
802593|NCT00812812|2553040|P1|Overall Study|Withdrawal by Subject|0
802594|NCT00812812|2553039|P2|Overall Study|Lost to Follow-up|1
802595|NCT00812812|2553040|P1|Overall Study|Lost to Follow-up|0
802596|NCT00812812|2553039|P2|Overall Study|Lack of Efficacy|0
802597|NCT00812812|2553040|P1|Overall Study|Lack of Efficacy|1
802598|NCT00812812|2553039|P2|Overall Study|Adverse Event|1
802599|NCT00812812|2553040|P1|Overall Study|Adverse Event|2
802600|NCT00812929|2553073|P10|Washout Period 3 (7 Days)|Adverse Event|0
802601|NCT00812929|2553074|P9|Washout Period 3 (7 Days)|Adverse Event|0
802602|NCT00812929|2553075|P8|Washout Period 3 (7 Days)|Adverse Event|0
802603|NCT00812929|2553076|P7|Washout Period 3 (7 Days)|Adverse Event|0
802604|NCT00812929|2553077|P6|Washout Period 3 (7 Days)|Adverse Event|1
802605|NCT00812929|2553078|P5|Washout Period 3 (7 Days)|Adverse Event|0
802606|NCT00812929|2553079|P4|Washout Period 3 (7 Days)|Adverse Event|0
802607|NCT00812929|2553080|P3|Washout Period 3 (7 Days)|Adverse Event|0
802608|NCT00812929|2553081|P2|Washout Period 3 (7 Days)|Adverse Event|0
802609|NCT00812929|2553082|P1|Washout Period 3 (7 Days)|Adverse Event|0
802610|NCT00812929|2553073|P10|Washout Period 2 (7 Days)|Physician Decision|1
802611|NCT00812929|2553074|P9|Washout Period 2 (7 Days)|Physician Decision|0
802612|NCT00812929|2553075|P8|Washout Period 2 (7 Days)|Physician Decision|0
802613|NCT00812929|2553076|P7|Washout Period 2 (7 Days)|Physician Decision|0
802614|NCT00812929|2553077|P6|Washout Period 2 (7 Days)|Physician Decision|0
802615|NCT00812929|2553078|P5|Washout Period 2 (7 Days)|Physician Decision|0
802616|NCT00812929|2553079|P4|Washout Period 2 (7 Days)|Physician Decision|0
802617|NCT00812929|2553080|P3|Washout Period 2 (7 Days)|Physician Decision|0
802618|NCT00812929|2553081|P2|Washout Period 2 (7 Days)|Physician Decision|0
802619|NCT00812929|2553082|P1|Washout Period 2 (7 Days)|Physician Decision|0
802620|NCT00812929|2553073|P10|Washout Period 1 (7 Days)|Physician Decision|0
802621|NCT00812929|2553074|P9|Washout Period 1 (7 Days)|Physician Decision|0
802622|NCT00812929|2553075|P8|Washout Period 1 (7 Days)|Physician Decision|0
802623|NCT00812929|2553076|P7|Washout Period 1 (7 Days)|Physician Decision|0
802624|NCT00812929|2553077|P6|Washout Period 1 (7 Days)|Physician Decision|0
802625|NCT00812929|2553078|P5|Washout Period 1 (7 Days)|Physician Decision|0
802626|NCT00812929|2553079|P4|Washout Period 1 (7 Days)|Physician Decision|0
802627|NCT00812929|2553080|P3|Washout Period 1 (7 Days)|Physician Decision|1
802628|NCT00812929|2553081|P2|Washout Period 1 (7 Days)|Physician Decision|0
802629|NCT00812929|2553082|P1|Washout Period 1 (7 Days)|Physician Decision|0
802630|NCT00812955|2553202|P4|Overall Study|randomized in error|0
802631|NCT00812955|2553203|P3|Overall Study|randomized in error|1
802632|NCT00812955|2553204|P2|Overall Study|randomized in error|0
802633|NCT00812955|2553205|P1|Overall Study|randomized in error|0
802634|NCT00812955|2553202|P4|Overall Study|Withdrawal by Subject|2
802635|NCT00812955|2553203|P3|Overall Study|Withdrawal by Subject|1
802636|NCT00812955|2553204|P2|Overall Study|Withdrawal by Subject|0
802637|NCT00812955|2553205|P1|Overall Study|Withdrawal by Subject|1
802638|NCT00812955|2553202|P4|Overall Study|Lost to Follow-up|2
802639|NCT00812955|2553203|P3|Overall Study|Lost to Follow-up|1
802640|NCT00812955|2553204|P2|Overall Study|Lost to Follow-up|1
802641|NCT00812955|2553205|P1|Overall Study|Lost to Follow-up|2
802642|NCT00812955|2553202|P4|Overall Study|Adverse Event|4
802643|NCT00812955|2553203|P3|Overall Study|Adverse Event|3
802644|NCT00812955|2553204|P2|Overall Study|Adverse Event|6
802645|NCT00812955|2553205|P1|Overall Study|Adverse Event|7
802646|NCT00812968|2553225|P1|Overall Study|Study closed due to marketing approval|3
802647|NCT00812968|2553225|P1|Overall Study|No further treatment required|1
802648|NCT00812968|2553225|P1|Overall Study|Disease progression|1
802649|NCT00812968|2553225|P1|Overall Study|Relapse after erythroid response|6
802650|NCT00812981|2553258|P2|Overall Study|Unspecified|1
802651|NCT00812981|2553259|P1|Overall Study|Unspecified|0
802652|NCT00813098|2553300|P3|Overall Study|Withdrew Consent|0
802653|NCT00813098|2553301|P2|Overall Study|Withdrew Consent|1
802654|NCT00813098|2553302|P1|Overall Study|Withdrew Consent|0
802655|NCT00813098|2553300|P3|Overall Study|Principal Investigator decision|0
802656|NCT00813098|2553301|P2|Overall Study|Principal Investigator decision|1
802657|NCT00813098|2553302|P1|Overall Study|Principal Investigator decision|0
802658|NCT00813098|2553300|P3|Overall Study|Protocol Violation|1
802659|NCT00813098|2553301|P2|Overall Study|Protocol Violation|0
802660|NCT00813098|2553302|P1|Overall Study|Protocol Violation|0
802661|NCT00813098|2553300|P3|Overall Study|Lost to Follow-up|0
802662|NCT00813098|2553301|P2|Overall Study|Lost to Follow-up|1
802663|NCT00813098|2553302|P1|Overall Study|Lost to Follow-up|0
802664|NCT00813098|2553300|P3|Overall Study|Inability to complete study procedures|0
802665|NCT00813098|2553301|P2|Overall Study|Inability to complete study procedures|0
802666|NCT00813098|2553302|P1|Overall Study|Inability to complete study procedures|1
802667|NCT00813098|2553300|P3|Overall Study|Withdrawal by Subject|0
802668|NCT00813098|2553301|P2|Overall Study|Withdrawal by Subject|1
802669|NCT00813098|2553302|P1|Overall Study|Withdrawal by Subject|0
802670|NCT00813098|2553300|P3|Overall Study|Adverse Event|1
802671|NCT00813098|2553301|P2|Overall Study|Adverse Event|4
802672|NCT00813098|2553302|P1|Overall Study|Adverse Event|2
802674|NCT00813150|2553337|P1|Long Term Follow-up|Progression/Relapse|22
802675|NCT00813150|2553336|P2|Long Term Follow-up|Lost to Follow-up|0
802676|NCT00813150|2553337|P1|Long Term Follow-up|Lost to Follow-up|2
802677|NCT00813150|2553336|P2|Long Term Follow-up|Not specified|3
802678|NCT00813150|2553337|P1|Long Term Follow-up|Not specified|0
802679|NCT00813150|2553336|P2|Long Term Follow-up|Death|4
802680|NCT00813150|2553337|P1|Long Term Follow-up|Death|0
802681|NCT00813150|2553336|P2|Treatment Period|Data not available|2
802682|NCT00813150|2553337|P1|Treatment Period|Data not available|1
802683|NCT00813150|2553336|P2|Treatment Period|Reason not specified|4
802684|NCT00813150|2553337|P1|Treatment Period|Reason not specified|3
802685|NCT00813150|2553336|P2|Treatment Period|Non compliance|1
802686|NCT00813150|2553337|P1|Treatment Period|Non compliance|0
802687|NCT00813150|2553336|P2|Treatment Period|Withdrawal by Subject|3
802688|NCT00813150|2553337|P1|Treatment Period|Withdrawal by Subject|5
802689|NCT00813150|2553336|P2|Treatment Period|Protocol Violation|4
802690|NCT00813150|2553337|P1|Treatment Period|Protocol Violation|3
802691|NCT00813150|2553336|P2|Treatment Period|Stable disease|2
802692|NCT00813150|2553337|P1|Treatment Period|Stable disease|1
802693|NCT00813150|2553336|P2|Treatment Period|Complete response|1
802694|NCT00813150|2553337|P1|Treatment Period|Complete response|0
802695|NCT00813150|2553336|P2|Treatment Period|Progressive disease|0
802696|NCT00813150|2553337|P1|Treatment Period|Progressive disease|1
802697|NCT00813150|2553336|P2|Treatment Period|Death|0
802698|NCT00813150|2553337|P1|Treatment Period|Death|2
802699|NCT00813150|2553336|P2|Treatment Period|Adverse Event|15
802700|NCT00813150|2553337|P1|Treatment Period|Adverse Event|16
802701|NCT00813488|2553362|P2|Open-label Extension|Not specified|0
802702|NCT00813488|2553363|P1|Open-label Extension|Not specified|1
802703|NCT00813488|2553362|P2|Open-label Extension|Non-compliance study procedures|1
802704|NCT00813488|2553363|P1|Open-label Extension|Non-compliance study procedures|2
802705|NCT00813488|2553362|P2|Open-label Extension|Non-compliance study medication|0
802706|NCT00813488|2553363|P1|Open-label Extension|Non-compliance study medication|4
802707|NCT00813488|2553362|P2|Open-label Extension|Protocol Violation|2
802708|NCT00813488|2553363|P1|Open-label Extension|Protocol Violation|1
802709|NCT00813488|2553362|P2|Open-label Extension|Withdrawal by Subject|2
802710|NCT00813488|2553363|P1|Open-label Extension|Withdrawal by Subject|0
802711|NCT00813488|2553362|P2|Open-label Extension|Lack of Efficacy|0
802712|NCT00813488|2553363|P1|Open-label Extension|Lack of Efficacy|3
802713|NCT00813488|2553362|P2|Open-label Extension|Adverse Event|2
802714|NCT00813488|2553363|P1|Open-label Extension|Adverse Event|1
802715|NCT00813488|2553362|P2|Double-blind Treatment Period 2|Not Specified|0
802716|NCT00813488|2553363|P1|Double-blind Treatment Period 2|Not Specified|1
802717|NCT00813488|2553362|P2|Double-blind Treatment Period 2|Protocol Violation|0
802718|NCT00813488|2553363|P1|Double-blind Treatment Period 2|Protocol Violation|2
802719|NCT00813488|2553362|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
802720|NCT00813488|2553363|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
802721|NCT00813488|2553362|P2|Double-blind Treatment Period 2|Adverse Event|0
802722|NCT00813488|2553363|P1|Double-blind Treatment Period 2|Adverse Event|1
802723|NCT00813488|2553362|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
802724|NCT00813488|2553363|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
802725|NCT00813488|2553362|P2|Double-blind Treatment Period 1|Protocol Violation|2
802726|NCT00813488|2553363|P1|Double-blind Treatment Period 1|Protocol Violation|0
802727|NCT00813488|2553362|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
802728|NCT00813488|2553363|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
802729|NCT00813488|2553362|P2|Double-blind Treatment Period 1|Adverse Event|1
802730|NCT00813488|2553363|P1|Double-blind Treatment Period 1|Adverse Event|1
802731|NCT00813488|2553362|P2|Titration Period 2|Non-compliance with study procedures|1
802732|NCT00813488|2553363|P1|Titration Period 2|Non-compliance with study procedures|2
802733|NCT00813488|2553362|P2|Titration Period 2|Lost to Follow-up|0
802734|NCT00813488|2553363|P1|Titration Period 2|Lost to Follow-up|1
802735|NCT00813488|2553362|P2|Titration Period 2|Protocol Violation|2
802736|NCT00813488|2553363|P1|Titration Period 2|Protocol Violation|3
802737|NCT00813488|2553362|P2|Titration Period 2|Lack of Efficacy|4
802738|NCT00813488|2553363|P1|Titration Period 2|Lack of Efficacy|8
802739|NCT00813488|2553362|P2|Titration Period 2|Adverse Event|3
802740|NCT00813488|2553363|P1|Titration Period 2|Adverse Event|2
802741|NCT00813488|2553362|P2|Titration Period 1|Technical Difficulties|1
802742|NCT00813488|2553363|P1|Titration Period 1|Technical Difficulties|0
802743|NCT00813488|2553362|P2|Titration Period 1|Non-compliance to study procedures|2
802744|NCT00813488|2553363|P1|Titration Period 1|Non-compliance to study procedures|2
802745|NCT00813488|2553362|P2|Titration Period 1|Non-compliance to study medication|1
802746|NCT00813488|2553363|P1|Titration Period 1|Non-compliance to study medication|4
802747|NCT00813488|2553362|P2|Titration Period 1|Protocol Violation|3
802748|NCT00813488|2553363|P1|Titration Period 1|Protocol Violation|4
802749|NCT00813488|2553362|P2|Titration Period 1|Withdrawal by Subject|2
802750|NCT00813488|2553363|P1|Titration Period 1|Withdrawal by Subject|2
802751|NCT00813488|2553362|P2|Titration Period 1|Lack of Efficacy|7
802752|NCT00813488|2553363|P1|Titration Period 1|Lack of Efficacy|9
802753|NCT00813488|2553362|P2|Titration Period 1|Adverse Event|1
802754|NCT00813488|2553363|P1|Titration Period 1|Adverse Event|6
802755|NCT00813592|2553459|P1|Overall Study|Disease assessment was not completed per|2
802756|NCT00813709|2553471|P6|Open Label Period|Unspecified|6
802757|NCT00813709|2553472|P5|Open Label Period|Unspecified|5
802758|NCT00813709|2553473|P4|Open Label Period|Unspecified|11
802759|NCT00813709|2553474|P3|Open Label Period|Unspecified|0
802760|NCT00813709|2553475|P2|Open Label Period|Unspecified|0
802761|NCT00813709|2553476|P1|Open Label Period|Unspecified|0
802762|NCT00813709|2553471|P6|Open Label Period|Randomized but not treated|1
802763|NCT00813709|2553472|P5|Open Label Period|Randomized but not treated|0
802764|NCT00813709|2553473|P4|Open Label Period|Randomized but not treated|1
802765|NCT00813709|2553474|P3|Open Label Period|Randomized but not treated|0
802766|NCT00813709|2553475|P2|Open Label Period|Randomized but not treated|0
802767|NCT00813709|2553476|P1|Open Label Period|Randomized but not treated|0
802768|NCT00813709|2553471|P6|Open Label Period|Lack of Efficacy|1
802769|NCT00813709|2553472|P5|Open Label Period|Lack of Efficacy|1
802770|NCT00813709|2553473|P4|Open Label Period|Lack of Efficacy|3
802771|NCT00813709|2553474|P3|Open Label Period|Lack of Efficacy|0
802772|NCT00813709|2553475|P2|Open Label Period|Lack of Efficacy|0
802773|NCT00813709|2553476|P1|Open Label Period|Lack of Efficacy|0
802774|NCT00813709|2553471|P6|Open Label Period|Adverse Event|3
802775|NCT00813709|2553472|P5|Open Label Period|Adverse Event|4
802776|NCT00813709|2553473|P4|Open Label Period|Adverse Event|5
802777|NCT00813709|2553474|P3|Open Label Period|Adverse Event|0
802778|NCT00813709|2553475|P2|Open Label Period|Adverse Event|0
802779|NCT00813709|2553476|P1|Open Label Period|Adverse Event|0
802780|NCT00813709|2553471|P6|Double Blind Period|Unspecified|0
802781|NCT00813709|2553472|P5|Double Blind Period|Unspecified|0
802782|NCT00813709|2553473|P4|Double Blind Period|Unspecified|0
802783|NCT00813709|2553474|P3|Double Blind Period|Unspecified|6
802784|NCT00813709|2553475|P2|Double Blind Period|Unspecified|9
802785|NCT00813709|2553476|P1|Double Blind Period|Unspecified|14
802786|NCT00813709|2553471|P6|Double Blind Period|Randomized but not treated|0
802787|NCT00813709|2553472|P5|Double Blind Period|Randomized but not treated|0
802788|NCT00813709|2553473|P4|Double Blind Period|Randomized but not treated|0
802789|NCT00813709|2553474|P3|Double Blind Period|Randomized but not treated|1
802790|NCT00813709|2553475|P2|Double Blind Period|Randomized but not treated|3
802791|NCT00813709|2553476|P1|Double Blind Period|Randomized but not treated|1
802792|NCT00813709|2553471|P6|Double Blind Period|Switched to open label phase|0
802793|NCT00813709|2553472|P5|Double Blind Period|Switched to open label phase|0
802794|NCT00813709|2553473|P4|Double Blind Period|Switched to open label phase|0
802795|NCT00813709|2553474|P3|Double Blind Period|Switched to open label phase|18
802796|NCT00813709|2553475|P2|Double Blind Period|Switched to open label phase|26
802797|NCT00813709|2553476|P1|Double Blind Period|Switched to open label phase|9
802798|NCT00813709|2553471|P6|Double Blind Period|Lost to Follow-up|0
802799|NCT00813709|2553472|P5|Double Blind Period|Lost to Follow-up|0
802800|NCT00813709|2553473|P4|Double Blind Period|Lost to Follow-up|0
802801|NCT00813709|2553474|P3|Double Blind Period|Lost to Follow-up|2
802802|NCT00813709|2553475|P2|Double Blind Period|Lost to Follow-up|2
802803|NCT00813709|2553476|P1|Double Blind Period|Lost to Follow-up|3
802804|NCT00813709|2553471|P6|Double Blind Period|Adverse Event|0
802805|NCT00813709|2553472|P5|Double Blind Period|Adverse Event|0
802806|NCT00813709|2553473|P4|Double Blind Period|Adverse Event|0
802807|NCT00813709|2553474|P3|Double Blind Period|Adverse Event|4
802808|NCT00813709|2553475|P2|Double Blind Period|Adverse Event|1
802809|NCT00813709|2553476|P1|Double Blind Period|Adverse Event|4
802810|NCT00813748|2553558|P2|Skin Test Substudy|Physician Decision|1
802811|NCT00813748|2553559|P1|Skin Test Substudy|Physician Decision|0
802812|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
802813|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
802814|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
802815|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
802816|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
802817|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
802818|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
802819|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
802820|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
802821|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
802822|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
802823|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
802824|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
802825|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
802826|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
802827|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
802828|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
802829|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
802830|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
802831|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
802832|NCT00813761|2553587|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
802833|NCT00813761|2553588|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
802834|NCT00813761|2553589|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
802835|NCT00813761|2553590|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
802836|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
802837|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
802838|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
802839|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
802840|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
802841|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
802842|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
802843|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
802844|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
802845|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
802846|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
802847|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
802848|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
802849|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
802850|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
802851|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
802852|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
802853|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
802854|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
802855|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
802856|NCT00813761|2553587|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
802857|NCT00813761|2553588|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
802858|NCT00813761|2553589|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
802859|NCT00813761|2553590|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
802860|NCT00805545|2553640|P2|Overall Study|Protocol Violation|1
802861|NCT00805545|2553641|P1|Overall Study|Protocol Violation|3
802862|NCT00805545|2553640|P2|Overall Study|Protocol Violation|2
802863|NCT00805545|2553641|P1|Overall Study|Protocol Violation|3
802864|NCT00805675|2553650|P3|Overall Study|Adverse Event|1
802865|NCT00805675|2553651|P2|Overall Study|Adverse Event|0
802866|NCT00805675|2553652|P1|Overall Study|Adverse Event|0
802867|NCT00805740|2553686|P2|Overall Study|Randomized, but not treated|0
802868|NCT00805740|2553687|P1|Overall Study|Randomized, but not treated|2
802869|NCT00805740|2553686|P2|Overall Study|Lost to Follow-up|0
802870|NCT00805740|2553687|P1|Overall Study|Lost to Follow-up|1
802871|NCT00805740|2553686|P2|Overall Study|Withdrawal by Subject|0
802872|NCT00805740|2553687|P1|Overall Study|Withdrawal by Subject|1
802873|NCT00805740|2553686|P2|Overall Study|Death|4
802874|NCT00805740|2553687|P1|Overall Study|Death|7
802883|NCT00805792|2553716|P1|Overall Study|Lost to Follow-up|2
802884|NCT00805792|2553716|P1|Overall Study|Death|3
802885|NCT00805935|2553743|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
802886|NCT00805935|2553744|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
802887|NCT00805935|2553745|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
802888|NCT00805935|2553746|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
802889|NCT00805935|2553743|P4|Overall Study|Ectopic pregnancy|0
802890|NCT00805935|2553744|P3|Overall Study|Ectopic pregnancy|1
802891|NCT00805935|2553745|P2|Overall Study|Ectopic pregnancy|0
802892|NCT00805935|2553746|P1|Overall Study|Ectopic pregnancy|0
802893|NCT00805935|2553743|P4|Overall Study|Chemical pregnancy|2
802894|NCT00805935|2553744|P3|Overall Study|Chemical pregnancy|3
802895|NCT00805935|2553745|P2|Overall Study|Chemical pregnancy|5
802896|NCT00805935|2553746|P1|Overall Study|Chemical pregnancy|0
802897|NCT00805935|2553743|P4|Overall Study|Biochemical pregnancy|0
802898|NCT00805935|2553744|P3|Overall Study|Biochemical pregnancy|0
802899|NCT00805935|2553745|P2|Overall Study|Biochemical pregnancy|1
802900|NCT00805935|2553746|P1|Overall Study|Biochemical pregnancy|0
802901|NCT00805935|2553743|P4|Overall Study|Pregnancy loss/miscarriage|0
802902|NCT00805935|2553744|P3|Overall Study|Pregnancy loss/miscarriage|0
802903|NCT00805935|2553745|P2|Overall Study|Pregnancy loss/miscarriage|0
802904|NCT00805935|2553746|P1|Overall Study|Pregnancy loss/miscarriage|2
802905|NCT00805935|2553743|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
802906|NCT00805935|2553744|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
802907|NCT00805935|2553745|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
802908|NCT00805935|2553746|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
802909|NCT00805935|2553743|P4|Overall Study|No positive serum pregnancy|5
802910|NCT00805935|2553744|P3|Overall Study|No positive serum pregnancy|6
802911|NCT00805935|2553745|P2|Overall Study|No positive serum pregnancy|7
802912|NCT00805935|2553746|P1|Overall Study|No positive serum pregnancy|8
802913|NCT00805935|2553743|P4|Overall Study|Lost to Follow-up|0
802914|NCT00805935|2553744|P3|Overall Study|Lost to Follow-up|0
802915|NCT00805935|2553745|P2|Overall Study|Lost to Follow-up|0
802916|NCT00805935|2553746|P1|Overall Study|Lost to Follow-up|1
802917|NCT00805935|2553743|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
802918|NCT00805935|2553744|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
802919|NCT00805935|2553745|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
802920|NCT00805935|2553746|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
802921|NCT00805935|2553743|P4|Overall Study|Cycle cancellation for risk of OHSS|0
802922|NCT00805935|2553744|P3|Overall Study|Cycle cancellation for risk of OHSS|1
802923|NCT00805935|2553745|P2|Overall Study|Cycle cancellation for risk of OHSS|0
802924|NCT00805935|2553746|P1|Overall Study|Cycle cancellation for risk of OHSS|1
802925|NCT00805935|2553743|P4|Overall Study|Cycle cancelled|0
802926|NCT00805935|2553744|P3|Overall Study|Cycle cancelled|2
802927|NCT00805935|2553745|P2|Overall Study|Cycle cancelled|0
802928|NCT00805935|2553746|P1|Overall Study|Cycle cancelled|0
802929|NCT00805935|2553743|P4|Overall Study|Stimulation Failure|2
802930|NCT00805935|2553744|P3|Overall Study|Stimulation Failure|2
802931|NCT00805935|2553745|P2|Overall Study|Stimulation Failure|5
802932|NCT00805935|2553746|P1|Overall Study|Stimulation Failure|1
802933|NCT00805961|2553798|P1|Maintenance Treatment|Withdrawn Consent|1
802934|NCT00805961|2553798|P1|Maintenance Treatment|Symptomatic Deterioration|2
802935|NCT00805961|2553798|P1|Maintenance Treatment|Withdrawal by Subject|5
802936|NCT00805961|2553798|P1|Maintenance Treatment|Adverse Event|6
802937|NCT00805961|2553798|P1|Maintenance Treatment|Intercurrent Illness|7
802938|NCT00805961|2553798|P1|Maintenance Treatment|Lack of Efficacy|13
802939|NCT00805961|2553798|P1|Treatment-Free Interval|Lack of Efficacy|1
802940|NCT00805961|2553798|P1|Treatment-Free Interval|Physician Decision|1
802941|NCT00805961|2553798|P1|Treatment-Free Interval|Intercurrent Illness|2
802942|NCT00805961|2553798|P1|Treatment-Free Interval|Adverse Event|3
802943|NCT00805961|2553798|P1|Modality Therapy|Disease Progression|2
802944|NCT00805961|2553798|P1|Modality Therapy|Adverse Event|1
802945|NCT00805961|2553798|P1|Modality Therapy|Withdrawal by Subject|1
802946|NCT00806026|2553810|P6|Overall Study|Adverse Event|9
802947|NCT00806026|2553811|P5|Overall Study|Adverse Event|9
802948|NCT00806026|2553812|P4|Overall Study|Adverse Event|17
802949|NCT00806026|2553813|P3|Overall Study|Adverse Event|44
802950|NCT00806026|2553814|P2|Overall Study|Adverse Event|35
802951|NCT00806026|2553815|P1|Overall Study|Adverse Event|52
802952|NCT00806026|2553810|P6|Overall Study|Protocol Violation|3
802953|NCT00806026|2553811|P5|Overall Study|Protocol Violation|2
802954|NCT00806026|2553812|P4|Overall Study|Protocol Violation|0
802955|NCT00806026|2553813|P3|Overall Study|Protocol Violation|9
802956|NCT00806026|2553814|P2|Overall Study|Protocol Violation|9
802957|NCT00806026|2553815|P1|Overall Study|Protocol Violation|6
802958|NCT00806026|2553810|P6|Overall Study|Unspecified|4
802959|NCT00806026|2553811|P5|Overall Study|Unspecified|0
802960|NCT00806026|2553812|P4|Overall Study|Unspecified|2
802961|NCT00806026|2553813|P3|Overall Study|Unspecified|8
802962|NCT00806026|2553814|P2|Overall Study|Unspecified|6
802963|NCT00806026|2553815|P1|Overall Study|Unspecified|3
802964|NCT00806026|2553810|P6|Overall Study|Withdrawal by Subject|3
802965|NCT00806026|2553811|P5|Overall Study|Withdrawal by Subject|5
802966|NCT00806026|2553812|P4|Overall Study|Withdrawal by Subject|2
802967|NCT00806026|2553813|P3|Overall Study|Withdrawal by Subject|9
802968|NCT00806026|2553814|P2|Overall Study|Withdrawal by Subject|17
802969|NCT00806026|2553815|P1|Overall Study|Withdrawal by Subject|14
802970|NCT00806026|2553810|P6|Overall Study|Lost to Follow-up|6
802971|NCT00806026|2553811|P5|Overall Study|Lost to Follow-up|6
802972|NCT00806026|2553812|P4|Overall Study|Lost to Follow-up|2
802973|NCT00806026|2553813|P3|Overall Study|Lost to Follow-up|8
802974|NCT00806026|2553814|P2|Overall Study|Lost to Follow-up|15
802975|NCT00806026|2553815|P1|Overall Study|Lost to Follow-up|8
802976|NCT00806026|2553810|P6|Overall Study|Lack of Efficacy|7
802977|NCT00806026|2553811|P5|Overall Study|Lack of Efficacy|8
802978|NCT00806026|2553812|P4|Overall Study|Lack of Efficacy|4
802979|NCT00806026|2553813|P3|Overall Study|Lack of Efficacy|13
802980|NCT00806026|2553814|P2|Overall Study|Lack of Efficacy|18
802981|NCT00806026|2553815|P1|Overall Study|Lack of Efficacy|5
802982|NCT00806026|2553810|P6|Overall Study|Did not meet entrance criteria|0
802983|NCT00806026|2553811|P5|Overall Study|Did not meet entrance criteria|0
802984|NCT00806026|2553812|P4|Overall Study|Did not meet entrance criteria|1
802985|NCT00806026|2553813|P3|Overall Study|Did not meet entrance criteria|2
802986|NCT00806026|2553814|P2|Overall Study|Did not meet entrance criteria|1
802987|NCT00806026|2553815|P1|Overall Study|Did not meet entrance criteria|4
802988|NCT00806026|2553810|P6|Overall Study|Death|0
802989|NCT00806026|2553811|P5|Overall Study|Death|0
802990|NCT00806026|2553812|P4|Overall Study|Death|1
802991|NCT00806026|2553813|P3|Overall Study|Death|0
802992|NCT00806026|2553814|P2|Overall Study|Death|0
802993|NCT00806026|2553815|P1|Overall Study|Death|0
802994|NCT00806195|2553927|P4|Overall Study|Protocol Violation|9
802995|NCT00806195|2553928|P3|Overall Study|Protocol Violation|26
802996|NCT00806195|2553929|P2|Overall Study|Protocol Violation|24
802997|NCT00806195|2553930|P1|Overall Study|Protocol Violation|34
802998|NCT00806195|2553927|P4|Overall Study|Administrative Reason|26
802999|NCT00806195|2553928|P3|Overall Study|Administrative Reason|66
803000|NCT00806195|2553929|P2|Overall Study|Administrative Reason|35
803001|NCT00806195|2553930|P1|Overall Study|Administrative Reason|113
803002|NCT00806195|2553927|P4|Overall Study|Inappropriate Enrollment|0
803003|NCT00806195|2553928|P3|Overall Study|Inappropriate Enrollment|0
803004|NCT00806195|2553929|P2|Overall Study|Inappropriate Enrollment|1
803005|NCT00806195|2553930|P1|Overall Study|Inappropriate Enrollment|0
803006|NCT00806195|2553927|P4|Overall Study|Lost to Follow-up|34
803007|NCT00806195|2553928|P3|Overall Study|Lost to Follow-up|90
803008|NCT00806195|2553929|P2|Overall Study|Lost to Follow-up|66
803009|NCT00806195|2553930|P1|Overall Study|Lost to Follow-up|217
803010|NCT00806195|2553927|P4|Overall Study|Withdrawal by Subject|35
803011|NCT00806195|2553928|P3|Overall Study|Withdrawal by Subject|76
803012|NCT00806195|2553929|P2|Overall Study|Withdrawal by Subject|31
803013|NCT00806195|2553930|P1|Overall Study|Withdrawal by Subject|119
803014|NCT00806195|2553927|P4|Overall Study|Adverse Event|2
803015|NCT00806195|2553928|P3|Overall Study|Adverse Event|11
803016|NCT00806195|2553929|P2|Overall Study|Adverse Event|5
803017|NCT00806195|2553930|P1|Overall Study|Adverse Event|25
803018|NCT00806195|2553927|P4|Overall Study|Death|0
803019|NCT00806195|2553928|P3|Overall Study|Death|1
803020|NCT00806195|2553929|P2|Overall Study|Death|0
803021|NCT00806195|2553930|P1|Overall Study|Death|6
803022|NCT00806260|2553977|P6|Period 3|Pregnancy|0
803023|NCT00806260|2553978|P5|Period 3|Pregnancy|0
803024|NCT00806260|2553979|P4|Period 3|Pregnancy|0
803025|NCT00806260|2553980|P3|Period 3|Pregnancy|0
803026|NCT00806260|2553981|P2|Period 3|Pregnancy|0
803027|NCT00806260|2553982|P1|Period 3|Pregnancy|1
803028|NCT00806260|2553977|P6|Period 3|Protocol Violation|0
803029|NCT00806260|2553978|P5|Period 3|Protocol Violation|0
803030|NCT00806260|2553979|P4|Period 3|Protocol Violation|0
803031|NCT00806260|2553980|P3|Period 3|Protocol Violation|1
803032|NCT00806260|2553981|P2|Period 3|Protocol Violation|1
803033|NCT00806260|2553982|P1|Period 3|Protocol Violation|0
803034|NCT00806260|2553977|P6|Period 2|sponsor request|0
803035|NCT00806260|2553978|P5|Period 2|sponsor request|0
803036|NCT00806260|2553979|P4|Period 2|sponsor request|1
803037|NCT00806260|2553980|P3|Period 2|sponsor request|1
803038|NCT00806260|2553981|P2|Period 2|sponsor request|0
803039|NCT00806260|2553982|P1|Period 2|sponsor request|0
803040|NCT00806260|2553977|P6|Period 2|Need to take concomitant medication|0
803041|NCT00806260|2553978|P5|Period 2|Need to take concomitant medication|0
803042|NCT00806260|2553979|P4|Period 2|Need to take concomitant medication|0
803043|NCT00806260|2553980|P3|Period 2|Need to take concomitant medication|0
803044|NCT00806260|2553981|P2|Period 2|Need to take concomitant medication|0
803045|NCT00806260|2553982|P1|Period 2|Need to take concomitant medication|1
803046|NCT00806260|2553977|P6|Period 2|Protocol Violation|0
803047|NCT00806260|2553978|P5|Period 2|Protocol Violation|0
803048|NCT00806260|2553979|P4|Period 2|Protocol Violation|0
803049|NCT00806260|2553980|P3|Period 2|Protocol Violation|1
803050|NCT00806260|2553981|P2|Period 2|Protocol Violation|0
803051|NCT00806260|2553982|P1|Period 2|Protocol Violation|1
803052|NCT00806260|2553977|P6|Period 2|Adverse Event|0
803053|NCT00806260|2553978|P5|Period 2|Adverse Event|0
803054|NCT00806260|2553979|P4|Period 2|Adverse Event|1
803055|NCT00806260|2553980|P3|Period 2|Adverse Event|0
803056|NCT00806260|2553981|P2|Period 2|Adverse Event|0
803057|NCT00806260|2553982|P1|Period 2|Adverse Event|0
803058|NCT00806260|2553977|P6|Period 1 (1 Day)|Adverse Event|0
803059|NCT00806260|2553978|P5|Period 1 (1 Day)|Adverse Event|3
803060|NCT00806260|2553979|P4|Period 1 (1 Day)|Adverse Event|0
803061|NCT00806260|2553980|P3|Period 1 (1 Day)|Adverse Event|0
803062|NCT00806260|2553981|P2|Period 1 (1 Day)|Adverse Event|0
803063|NCT00806260|2553982|P1|Period 1 (1 Day)|Adverse Event|0
803066|NCT00806403|2554039|P2|Overall Study|Death|3
803067|NCT00806403|2554040|P1|Overall Study|Death|4
803068|NCT00806416|2554054|P4|Period 1 - Part II|Withdrawal by Subject|2
803069|NCT00806416|2554055|P3|Period 1 - Part II|Withdrawal by Subject|0
803070|NCT00806416|2554056|P2|Period 1 - Part II|Withdrawal by Subject|0
803071|NCT00806416|2554057|P1|Period 1 - Part II|Withdrawal by Subject|0
803072|NCT00806416|2554054|P4|Period 1 - Part I|Withdrawal by Subject|0
803073|NCT00806416|2554055|P3|Period 1 - Part I|Withdrawal by Subject|0
803074|NCT00806416|2554056|P2|Period 1 - Part I|Withdrawal by Subject|1
803075|NCT00806416|2554057|P1|Period 1 - Part I|Withdrawal by Subject|3
803076|NCT00806416|2554054|P4|Period 1 - Part I|Lost to Follow-up|0
803077|NCT00806416|2554055|P3|Period 1 - Part I|Lost to Follow-up|0
803078|NCT00806416|2554056|P2|Period 1 - Part I|Lost to Follow-up|2
803079|NCT00806416|2554057|P1|Period 1 - Part I|Lost to Follow-up|0
803080|NCT00806416|2554054|P4|Period 1 - Part I|Adverse Event|0
803081|NCT00806416|2554055|P3|Period 1 - Part I|Adverse Event|0
803082|NCT00806416|2554056|P2|Period 1 - Part I|Adverse Event|1
803083|NCT00806416|2554057|P1|Period 1 - Part I|Adverse Event|0
803084|NCT00806442|2554068|P2|Overall Study|Withdrawal by Subject|5
803085|NCT00806442|2554069|P1|Overall Study|Withdrawal by Subject|1
803086|NCT00806442|2554068|P2|Overall Study|Lost to Follow-up|2
803087|NCT00806442|2554069|P1|Overall Study|Lost to Follow-up|3
803088|NCT00806494|2554089|P1|Overall Study|Withdrawal by Subject|5
803089|NCT00806494|2554089|P1|Overall Study|Unspecified|30
803090|NCT00806494|2554089|P1|Overall Study|Lost to Follow-up|10
803091|NCT00806494|2554089|P1|Overall Study|Lack of Efficacy|6
803092|NCT00806494|2554089|P1|Overall Study|Adverse Event|29
803093|NCT00806546|2554113|P1|Overall Study|Various|42
803094|NCT00806546|2554113|P1|Overall Study|Protocol Violation|49
803095|NCT00806546|2554113|P1|Overall Study|Withdrawal by Subject|75
803096|NCT00806546|2554113|P1|Overall Study|Adverse Event|74
803097|NCT00806546|2554113|P1|Overall Study|Lost to Follow-up|32
803098|NCT00806546|2554113|P1|Overall Study|Enrolled, not treated|35
803099|NCT00806585|2554122|P5|Overall Study|Completion status unknown|12
803100|NCT00806585|2554123|P4|Overall Study|Completion status unknown|4
803101|NCT00806585|2554124|P3|Overall Study|Completion status unknown|12
803102|NCT00806585|2554125|P2|Overall Study|Completion status unknown|14
803103|NCT00806585|2554126|P1|Overall Study|Completion status unknown|15
803104|NCT00806585|2554122|P5|Overall Study|Withdrawal by Subject|11
803105|NCT00806585|2554123|P4|Overall Study|Withdrawal by Subject|3
803106|NCT00806585|2554124|P3|Overall Study|Withdrawal by Subject|9
803107|NCT00806585|2554125|P2|Overall Study|Withdrawal by Subject|8
803108|NCT00806585|2554126|P1|Overall Study|Withdrawal by Subject|10
803109|NCT00806585|2554122|P5|Overall Study|Adverse Event|2
803110|NCT00806585|2554123|P4|Overall Study|Adverse Event|4
803111|NCT00806585|2554124|P3|Overall Study|Adverse Event|3
803112|NCT00806585|2554125|P2|Overall Study|Adverse Event|5
803113|NCT00806585|2554126|P1|Overall Study|Adverse Event|1
803114|NCT00806585|2554122|P5|Overall Study|Lack of Efficacy|0
803115|NCT00806585|2554123|P4|Overall Study|Lack of Efficacy|0
803116|NCT00806585|2554124|P3|Overall Study|Lack of Efficacy|0
803117|NCT00806585|2554125|P2|Overall Study|Lack of Efficacy|0
803118|NCT00806585|2554126|P1|Overall Study|Lack of Efficacy|1
803119|NCT00806585|2554122|P5|Overall Study|Lost to Follow-up|5
803120|NCT00806585|2554123|P4|Overall Study|Lost to Follow-up|2
803121|NCT00806585|2554124|P3|Overall Study|Lost to Follow-up|2
803122|NCT00806585|2554125|P2|Overall Study|Lost to Follow-up|1
803123|NCT00806585|2554126|P1|Overall Study|Lost to Follow-up|2
803124|NCT00806585|2554122|P5|Overall Study|Physician Decision|1
803125|NCT00806585|2554123|P4|Overall Study|Physician Decision|0
803126|NCT00806585|2554124|P3|Overall Study|Physician Decision|3
803127|NCT00806585|2554125|P2|Overall Study|Physician Decision|2
803128|NCT00806585|2554126|P1|Overall Study|Physician Decision|0
803129|NCT00806585|2554122|P5|Overall Study|Protocol Violation|0
803130|NCT00806585|2554123|P4|Overall Study|Protocol Violation|0
803131|NCT00806585|2554124|P3|Overall Study|Protocol Violation|2
803132|NCT00806585|2554125|P2|Overall Study|Protocol Violation|1
803133|NCT00806585|2554126|P1|Overall Study|Protocol Violation|3
803134|NCT00806585|2554122|P5|Overall Study|Study terminated by Sponsor|0
803135|NCT00806585|2554123|P4|Overall Study|Study terminated by Sponsor|2
803136|NCT00806585|2554124|P3|Overall Study|Study terminated by Sponsor|1
803137|NCT00806585|2554125|P2|Overall Study|Study terminated by Sponsor|0
803138|NCT00806585|2554126|P1|Overall Study|Study terminated by Sponsor|0
803139|NCT00806624|2554165|P3|Overall Study|discontinued before start of treatment|1
803140|NCT00806624|2554166|P2|Overall Study|discontinued before start of treatment|0
803141|NCT00806624|2554167|P1|Overall Study|discontinued before start of treatment|0
803142|NCT00806624|2554165|P3|Overall Study|Withdrawal by Subject|3
803143|NCT00806624|2554166|P2|Overall Study|Withdrawal by Subject|3
803144|NCT00806624|2554167|P1|Overall Study|Withdrawal by Subject|6
803145|NCT00806624|2554165|P3|Overall Study|Lost to Follow-up|1
803146|NCT00806624|2554166|P2|Overall Study|Lost to Follow-up|0
803147|NCT00806624|2554167|P1|Overall Study|Lost to Follow-up|1
803148|NCT00806624|2554165|P3|Overall Study|Death|1
803149|NCT00806624|2554166|P2|Overall Study|Death|1
803150|NCT00806624|2554167|P1|Overall Study|Death|0
803151|NCT00806624|2554165|P3|Overall Study|Adverse Event|0
803152|NCT00806624|2554166|P2|Overall Study|Adverse Event|8
803153|NCT00806624|2554167|P1|Overall Study|Adverse Event|2
803154|NCT00806819|2554211|P2|Overall Study|Reasons other than stated above|41
803155|NCT00806819|2554212|P1|Overall Study|Reasons other than stated above|25
803156|NCT00806819|2554211|P2|Overall Study|Not treated|3
803157|NCT00806819|2554212|P1|Overall Study|Not treated|6
803158|NCT00806819|2554211|P2|Overall Study|Withdrawal by Subject|29
803159|NCT00806819|2554212|P1|Overall Study|Withdrawal by Subject|32
803160|NCT00806819|2554211|P2|Overall Study|Lost to Follow-up|0
803161|NCT00806819|2554212|P1|Overall Study|Lost to Follow-up|1
803162|NCT00806819|2554211|P2|Overall Study|Protocol Violation|4
803163|NCT00806819|2554212|P1|Overall Study|Protocol Violation|9
803164|NCT00806819|2554211|P2|Overall Study|Other AE|40
803165|NCT00806819|2554212|P1|Overall Study|Other AE|38
803166|NCT00806819|2554211|P2|Overall Study|Worsening or AE of underlying disease|25
803167|NCT00806819|2554212|P1|Overall Study|Worsening or AE of underlying disease|18
803168|NCT00806819|2554211|P2|Overall Study|progressive disease (modified RECIST )|216
803169|NCT00806819|2554212|P1|Overall Study|progressive disease (modified RECIST )|217
803170|NCT00806988|2554246|P2|Overall Study|Lost to Follow-up|19
803171|NCT00806988|2554247|P1|Overall Study|Lost to Follow-up|4
803172|NCT00806988|2554246|P2|Overall Study|Withdrawal by Subject|8
803173|NCT00806988|2554247|P1|Overall Study|Withdrawal by Subject|8
803174|NCT00806988|2554246|P2|Overall Study|Death|16
803175|NCT00806988|2554247|P1|Overall Study|Death|15
803176|NCT00807001|2554260|P5|Overall Study|Non-compliance|0
803177|NCT00807001|2554261|P4|Overall Study|Non-compliance|0
803178|NCT00807001|2554262|P3|Overall Study|Non-compliance|0
803179|NCT00807001|2554263|P2|Overall Study|Non-compliance|1
803180|NCT00807001|2554264|P1|Overall Study|Non-compliance|0
803181|NCT00807014|2554283|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
803182|NCT00807014|2554284|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
803183|NCT00807014|2554283|P2|Overall Study|Recovery|0
803184|NCT00807014|2554284|P1|Overall Study|Recovery|1
803185|NCT00807014|2554283|P2|Overall Study|Lost to Follow-up|7
803186|NCT00807014|2554284|P1|Overall Study|Lost to Follow-up|9
803187|NCT00807014|2554283|P2|Overall Study|Adverse Event|2
803188|NCT00807014|2554284|P1|Overall Study|Adverse Event|0
803189|NCT00807014|2554283|P2|Overall Study|Protocol Violation|8
803190|NCT00807014|2554284|P1|Overall Study|Protocol Violation|2
803191|NCT00807014|2554283|P2|Overall Study|Participant Considered Disease Not Cured|7
803192|NCT00807014|2554284|P1|Overall Study|Participant Considered Disease Not Cured|2
803193|NCT00807014|2554283|P2|Overall Study|Participant Considered Disease Cured|2
803194|NCT00807014|2554284|P1|Overall Study|Participant Considered Disease Cured|13
803195|NCT00807040|2554312|P2|Overall Study|Lost to Follow-up|6
803196|NCT00807040|2554313|P1|Overall Study|Lost to Follow-up|4
803197|NCT00807040|2554312|P2|Overall Study|Withdrawal by Subject|6
803198|NCT00807040|2554313|P1|Overall Study|Withdrawal by Subject|8
803199|NCT00807040|2554312|P2|Overall Study|Death|29
803200|NCT00807040|2554313|P1|Overall Study|Death|24
803201|NCT00807092|2554323|P2|Overall Study|CGMS data collection failed|1
803202|NCT00807092|2554324|P1|Overall Study|CGMS data collection failed|0
803203|NCT00807092|2554323|P2|Overall Study|Withdrawal by Subject|0
803204|NCT00807092|2554324|P1|Overall Study|Withdrawal by Subject|1
803205|NCT00807092|2554323|P2|Overall Study|Protocol Violation|2
803206|NCT00807092|2554324|P1|Overall Study|Protocol Violation|0
803207|NCT00807092|2554323|P2|Overall Study|Adverse Event|1
803208|NCT00807092|2554324|P1|Overall Study|Adverse Event|0
803209|NCT00807235|2554367|P2|Overall Study|Adverse Event|0
803210|NCT00807235|2554368|P1|Overall Study|Adverse Event|1
803211|NCT00807248|2554402|P4|Overall Study|Other Reason|0
803212|NCT00807248|2554403|P3|Overall Study|Other Reason|2
803213|NCT00807248|2554404|P2|Overall Study|Other Reason|0
803214|NCT00807248|2554405|P1|Overall Study|Other Reason|0
803215|NCT00807248|2554402|P4|Overall Study|Lost to Follow-up|0
803216|NCT00807248|2554403|P3|Overall Study|Lost to Follow-up|0
803217|NCT00807248|2554404|P2|Overall Study|Lost to Follow-up|0
803218|NCT00807248|2554405|P1|Overall Study|Lost to Follow-up|1
803219|NCT00807248|2554402|P4|Overall Study|Withdrawal of Consent|5
803220|NCT00807248|2554403|P3|Overall Study|Withdrawal of Consent|5
803221|NCT00807248|2554404|P2|Overall Study|Withdrawal of Consent|5
803222|NCT00807248|2554405|P1|Overall Study|Withdrawal of Consent|5
803223|NCT00807248|2554402|P4|Overall Study|Protocol Violation|0
803224|NCT00807248|2554403|P3|Overall Study|Protocol Violation|1
803225|NCT00807248|2554404|P2|Overall Study|Protocol Violation|1
803226|NCT00807248|2554405|P1|Overall Study|Protocol Violation|0
803227|NCT00807248|2554402|P4|Overall Study|Lack of Efficacy|3
803228|NCT00807248|2554403|P3|Overall Study|Lack of Efficacy|8
803229|NCT00807248|2554404|P2|Overall Study|Lack of Efficacy|4
803230|NCT00807248|2554405|P1|Overall Study|Lack of Efficacy|14
803231|NCT00807248|2554402|P4|Overall Study|Adverse Event|6
803232|NCT00807248|2554403|P3|Overall Study|Adverse Event|2
803233|NCT00807248|2554404|P2|Overall Study|Adverse Event|2
803234|NCT00807248|2554405|P1|Overall Study|Adverse Event|1
803235|NCT00807365|2554447|P1|Overall Study|Study Terminated|5
803236|NCT00807573|2554492|P1|Overall Study|Adverse Event|1
803237|NCT00807573|2554492|P1|Overall Study|Withdrawal by Subject|1
803238|NCT00807846|2554498|P2|Overall Study|Not Specified|2
803239|NCT00807846|2554499|P1|Overall Study|Not Specified|1
803240|NCT00807846|2554498|P2|Overall Study|Withdrawal by Subject|1
803241|NCT00807846|2554499|P1|Overall Study|Withdrawal by Subject|2
803242|NCT00807846|2554498|P2|Overall Study|Protocol Violation|1
803243|NCT00807846|2554499|P1|Overall Study|Protocol Violation|2
803244|NCT00807846|2554498|P2|Overall Study|Lack of Efficacy|0
803245|NCT00807846|2554499|P1|Overall Study|Lack of Efficacy|2
803246|NCT00807846|2554498|P2|Overall Study|Adverse Event|0
803247|NCT00807846|2554499|P1|Overall Study|Adverse Event|5
803248|NCT00807885|2554540|P9|Overall Study|Lost to Follow-up|0
803249|NCT00807885|2554541|P8|Overall Study|Lost to Follow-up|0
803250|NCT00807885|2554542|P7|Overall Study|Lost to Follow-up|0
803251|NCT00807885|2554543|P6|Overall Study|Lost to Follow-up|1
803252|NCT00807885|2554544|P5|Overall Study|Lost to Follow-up|0
803253|NCT00807885|2554545|P4|Overall Study|Lost to Follow-up|0
803254|NCT00807885|2554546|P3|Overall Study|Lost to Follow-up|0
803255|NCT00807885|2554547|P2|Overall Study|Lost to Follow-up|0
803256|NCT00807885|2554548|P1|Overall Study|Lost to Follow-up|0
803257|NCT00807937|2554599|P4|Overall Study|All other reasons (not provided)|1
803258|NCT00807937|2554600|P3|Overall Study|All other reasons (not provided)|0
803259|NCT00807937|2554601|P2|Overall Study|All other reasons (not provided)|4
803260|NCT00807937|2554602|P1|Overall Study|All other reasons (not provided)|2
803261|NCT00807937|2554599|P4|Overall Study|Intake of prohibited medicine|0
803262|NCT00807937|2554600|P3|Overall Study|Intake of prohibited medicine|2
803263|NCT00807937|2554601|P2|Overall Study|Intake of prohibited medicine|0
803264|NCT00807937|2554602|P1|Overall Study|Intake of prohibited medicine|0
803265|NCT00807937|2554599|P4|Overall Study|Lack of Efficacy|2
803266|NCT00807937|2554600|P3|Overall Study|Lack of Efficacy|1
803267|NCT00807937|2554601|P2|Overall Study|Lack of Efficacy|0
803268|NCT00807937|2554602|P1|Overall Study|Lack of Efficacy|0
803269|NCT00807937|2554599|P4|Overall Study|Lost to Follow-up|1
803270|NCT00807937|2554600|P3|Overall Study|Lost to Follow-up|2
803271|NCT00807937|2554601|P2|Overall Study|Lost to Follow-up|0
803272|NCT00807937|2554602|P1|Overall Study|Lost to Follow-up|4
803273|NCT00807937|2554599|P4|Overall Study|Withdrawal by Subject|4
803274|NCT00807937|2554600|P3|Overall Study|Withdrawal by Subject|1
803275|NCT00807937|2554601|P2|Overall Study|Withdrawal by Subject|4
803276|NCT00807937|2554602|P1|Overall Study|Withdrawal by Subject|5
803277|NCT00807937|2554599|P4|Overall Study|Protocol Violation|3
803278|NCT00807937|2554600|P3|Overall Study|Protocol Violation|3
803279|NCT00807937|2554601|P2|Overall Study|Protocol Violation|5
803280|NCT00807937|2554602|P1|Overall Study|Protocol Violation|4
803281|NCT00807937|2554599|P4|Overall Study|Adverse Event|4
803282|NCT00807937|2554600|P3|Overall Study|Adverse Event|5
803283|NCT00807937|2554601|P2|Overall Study|Adverse Event|12
803284|NCT00807937|2554602|P1|Overall Study|Adverse Event|12
803285|NCT00808015|2554641|P1|Overall Study|Enrolled but not treated|4
803286|NCT00808015|2554641|P1|Overall Study|Unspecified|25
803287|NCT00808015|2554641|P1|Overall Study|Adverse Event|22
803288|NCT00808015|2554641|P1|Overall Study|Participants not willing to participate|158
803289|NCT00808015|2554641|P1|Overall Study|Lost to Follow-up|76
803290|NCT00808015|2554641|P1|Overall Study|Lack of Efficacy|58
803291|NCT00808015|2554641|P1|Overall Study|Death|1
803292|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
803293|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
803294|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
803295|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
803296|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Death|0
803297|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Death|1
803298|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Death|0
803299|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Death|0
803300|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
803301|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
803302|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
803303|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
803304|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Unspecified|1
803305|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Unspecified|1
803306|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Unspecified|0
803307|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Unspecified|0
803308|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
803309|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
803310|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
803311|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
803312|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
803313|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
803314|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
803315|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
803316|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
803317|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
803318|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
803319|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
803320|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
803321|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
803322|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
803323|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
803324|NCT00808028|2554657|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
803325|NCT00808028|2554658|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
803326|NCT00808028|2554659|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
803327|NCT00808028|2554660|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
803328|NCT00808028|2554657|P4|Stage 1 (6 Months)|Protocol Violation|1
803329|NCT00808028|2554658|P3|Stage 1 (6 Months)|Protocol Violation|0
803330|NCT00808028|2554659|P2|Stage 1 (6 Months)|Protocol Violation|0
803331|NCT00808028|2554660|P1|Stage 1 (6 Months)|Protocol Violation|0
803332|NCT00808028|2554657|P4|Stage 1 (6 Months)|Lost to Follow-up|0
803333|NCT00808028|2554658|P3|Stage 1 (6 Months)|Lost to Follow-up|1
803334|NCT00808028|2554659|P2|Stage 1 (6 Months)|Lost to Follow-up|0
803335|NCT00808028|2554660|P1|Stage 1 (6 Months)|Lost to Follow-up|1
803336|NCT00808028|2554657|P4|Stage 1 (6 Months)|Adverse Event|2
803337|NCT00808028|2554658|P3|Stage 1 (6 Months)|Adverse Event|1
803338|NCT00808028|2554659|P2|Stage 1 (6 Months)|Adverse Event|0
803339|NCT00808028|2554660|P1|Stage 1 (6 Months)|Adverse Event|0
803340|NCT00808028|2554657|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
803341|NCT00808028|2554658|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
803342|NCT00808028|2554659|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
803343|NCT00808028|2554660|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
803344|NCT00808028|2554657|P4|Stage 1 (6 Months)|Unspecified|4
803345|NCT00808028|2554658|P3|Stage 1 (6 Months)|Unspecified|2
803346|NCT00808028|2554659|P2|Stage 1 (6 Months)|Unspecified|0
803347|NCT00808028|2554660|P1|Stage 1 (6 Months)|Unspecified|1
803348|NCT00808028|2554657|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
803349|NCT00808028|2554658|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
803350|NCT00808028|2554659|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
803351|NCT00808028|2554660|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
803352|NCT00808067|2554698|P2|Overall Study|Excluded from analysis|19
803353|NCT00808067|2554699|P1|Overall Study|Excluded from analysis|13
803354|NCT00808067|2554698|P2|Overall Study|Other reason not defined above|5
803355|NCT00808067|2554699|P1|Overall Study|Other reason not defined above|5
803356|NCT00808067|2554698|P2|Overall Study|Site closed for cause|19
803357|NCT00808067|2554699|P1|Overall Study|Site closed for cause|19
803358|NCT00808067|2554698|P2|Overall Study|Patient elected|9
803359|NCT00808067|2554699|P1|Overall Study|Patient elected|7
803360|NCT00808067|2554698|P2|Overall Study|Protocol Violation|11
803361|NCT00808067|2554699|P1|Overall Study|Protocol Violation|3
803362|NCT00808067|2554698|P2|Overall Study|Physician Decision|38
803363|NCT00808067|2554699|P1|Overall Study|Physician Decision|47
803364|NCT00808067|2554698|P2|Overall Study|Site closed|3
803365|NCT00808067|2554699|P1|Overall Study|Site closed|4
803366|NCT00808067|2554698|P2|Overall Study|Withdrawal by Subject|25
803367|NCT00808067|2554699|P1|Overall Study|Withdrawal by Subject|21
803368|NCT00808067|2554698|P2|Overall Study|Procedure|7
803369|NCT00808067|2554699|P1|Overall Study|Procedure|6
803370|NCT00808067|2554698|P2|Overall Study|Death|1
803371|NCT00808067|2554699|P1|Overall Study|Death|1
803372|NCT00808067|2554698|P2|Overall Study|Missing|0
803373|NCT00808067|2554699|P1|Overall Study|Missing|1
803374|NCT00808067|2554698|P2|Overall Study|Patient refused to take study medication|76
803375|NCT00808067|2554699|P1|Overall Study|Patient refused to take study medication|65
803376|NCT00808067|2554698|P2|Overall Study|Elevated LFT results|3
803377|NCT00808067|2554699|P1|Overall Study|Elevated LFT results|7
803378|NCT00808067|2554698|P2|Overall Study|Reduced creatinine clearance|55
803379|NCT00808067|2554699|P1|Overall Study|Reduced creatinine clearance|53
803380|NCT00808067|2554698|P2|Overall Study|Hospitalization due to surgery|40
803381|NCT00808067|2554699|P1|Overall Study|Hospitalization due to surgery|37
803382|NCT00808067|2554698|P2|Overall Study|Hospitalization (not including surgery)|17
803383|NCT00808067|2554699|P1|Overall Study|Hospitalization (not including surgery)|18
803384|NCT00808067|2554698|P2|Overall Study|Adverse Event|121
803385|NCT00808067|2554699|P1|Overall Study|Adverse Event|111
803386|NCT00808067|2554698|P2|Overall Study|Outcome event - other|25
803387|NCT00808067|2554699|P1|Overall Study|Outcome event - other|33
803388|NCT00808067|2554698|P2|Overall Study|Major/minor bleed|44
803389|NCT00808067|2554699|P1|Overall Study|Major/minor bleed|30
803390|NCT00808080|2554731|P1|Overall Study|Patients Became Ineligible for infusion|6
803391|NCT00813800|2554735|P1|Overall Study|Physician Decision|1
803392|NCT00813800|2554735|P1|Overall Study|Worsening of depression|2
803393|NCT00813800|2554735|P1|Overall Study|Adverse Event|1
803394|NCT00813800|2554735|P1|Overall Study|Screen Failure after Consent|2
803395|NCT00813813|2554743|P2|Overall Study|Other|1
803396|NCT00813813|2554744|P1|Overall Study|Other|0
803397|NCT00813813|2554743|P2|Overall Study|Lost to Follow-up|7
803398|NCT00813813|2554744|P1|Overall Study|Lost to Follow-up|2
803399|NCT00813813|2554743|P2|Overall Study|Withdrawal by Subject|1
803400|NCT00813813|2554744|P1|Overall Study|Withdrawal by Subject|1
803401|NCT00813904|2554760|P1|Overall Study|Death|1
803402|NCT00813917|2554768|P2|Overall Study|Lost to Follow-up|1
803403|NCT00813917|2554769|P1|Overall Study|Lost to Follow-up|3
803404|NCT00813917|2554768|P2|Overall Study|Withdrawal by Subject|4
803405|NCT00813917|2554769|P1|Overall Study|Withdrawal by Subject|3
803406|NCT00813917|2554768|P2|Overall Study|Adverse Event|1
803407|NCT00813917|2554769|P1|Overall Study|Adverse Event|0
803408|NCT00813943|2554778|P3|Overall Study|Ongoing at cut-off date|3
803409|NCT00813943|2554779|P2|Overall Study|Ongoing at cut-off date|5
803410|NCT00813943|2554780|P1|Overall Study|Ongoing at cut-off date|5
803411|NCT00813995|2554816|P2|Overall Study|Withdrawal by Subject|5
803412|NCT00813995|2554817|P1|Overall Study|Withdrawal by Subject|0
803413|NCT00813995|2554816|P2|Overall Study|Subject moved|0
803414|NCT00813995|2554817|P1|Overall Study|Subject moved|4
803415|NCT00813995|2554816|P2|Overall Study|Protocol Violation|2
803416|NCT00813995|2554817|P1|Overall Study|Protocol Violation|3
803417|NCT00813995|2554816|P2|Overall Study|Other reason|2
803418|NCT00813995|2554817|P1|Overall Study|Other reason|2
803419|NCT00813995|2554816|P2|Overall Study|Lost to Follow-up|2
803420|NCT00813995|2554817|P1|Overall Study|Lost to Follow-up|4
803421|NCT00813995|2554816|P2|Overall Study|Lack of Efficacy|0
803422|NCT00813995|2554817|P1|Overall Study|Lack of Efficacy|1
803423|NCT00813995|2554816|P2|Overall Study|Laboratory adverse event|2
803424|NCT00813995|2554817|P1|Overall Study|Laboratory adverse event|0
803425|NCT00813995|2554816|P2|Overall Study|Clinical adverse event|3
803426|NCT00813995|2554817|P1|Overall Study|Clinical adverse event|9
803427|NCT00814710|2554833|P2|Overall Study|Lost to Follow-up|3
803428|NCT00814710|2554834|P1|Overall Study|Lost to Follow-up|7
803429|NCT00814710|2554833|P2|Overall Study|Adverse Event|0
803430|NCT00814710|2554834|P1|Overall Study|Adverse Event|1
803431|NCT00814801|2554892|P3|Overall Study|Not specified|4
803432|NCT00814801|2554893|P2|Overall Study|Not specified|6
803433|NCT00814801|2554894|P1|Overall Study|Not specified|2
803434|NCT00814801|2554892|P3|Overall Study|Non-compliance|1
803435|NCT00814801|2554893|P2|Overall Study|Non-compliance|1
803436|NCT00814801|2554894|P1|Overall Study|Non-compliance|0
803437|NCT00814801|2554892|P3|Overall Study|Missing or change of caregiver|4
803438|NCT00814801|2554893|P2|Overall Study|Missing or change of caregiver|2
803439|NCT00814801|2554894|P1|Overall Study|Missing or change of caregiver|6
803440|NCT00814801|2554892|P3|Overall Study|Change of patients for CIBIC plus-J|0
803441|NCT00814801|2554893|P2|Overall Study|Change of patients for CIBIC plus-J|1
803442|NCT00814801|2554894|P1|Overall Study|Change of patients for CIBIC plus-J|1
803443|NCT00814801|2554892|P3|Overall Study|Inappropriate as a subject|1
803444|NCT00814801|2554893|P2|Overall Study|Inappropriate as a subject|1
803445|NCT00814801|2554894|P1|Overall Study|Inappropriate as a subject|1
803446|NCT00814801|2554892|P3|Overall Study|Withdrawal by Subject|14
803447|NCT00814801|2554893|P2|Overall Study|Withdrawal by Subject|11
803448|NCT00814801|2554894|P1|Overall Study|Withdrawal by Subject|9
803449|NCT00814801|2554892|P3|Overall Study|Adverse Event|19
803450|NCT00814801|2554893|P2|Overall Study|Adverse Event|16
803451|NCT00814801|2554894|P1|Overall Study|Adverse Event|15
803452|NCT00814879|2554916|P2|By Week 48|Death|1
803453|NCT00814879|2554917|P1|By Week 48|Death|0
803454|NCT00814879|2554916|P2|By Week 48|Lost to Follow-up|2
803455|NCT00814879|2554917|P1|By Week 48|Lost to Follow-up|2
803456|NCT00814879|2554916|P2|By Week 24|Incarceration|1
803457|NCT00814879|2554917|P1|By Week 24|Incarceration|0
803458|NCT00814879|2554916|P2|By Week 24|Cancer Diagnosis|0
803459|NCT00814879|2554917|P1|By Week 24|Cancer Diagnosis|1
803460|NCT00814892|2554933|P1|Overall Study|Study Termination|1
803461|NCT00814892|2554933|P1|Overall Study|Disease Progression|1
803462|NCT00814983|2554966|P2|Overall Study|Graft failure|0
803463|NCT00814983|2554967|P1|Overall Study|Graft failure|1
803464|NCT00814983|2554966|P2|Overall Study|Withdrawal by Subject|0
803465|NCT00814983|2554967|P1|Overall Study|Withdrawal by Subject|1
803466|NCT00814983|2554966|P2|Overall Study|Screen failure|0
803467|NCT00814983|2554967|P1|Overall Study|Screen failure|1
803468|NCT00815191|2555008|P2|Overall Study|Protocol Violation|1
803469|NCT00815191|2555009|P1|Overall Study|Protocol Violation|1
803470|NCT00815295|2555018|P3|Overall Study|Cetuximab hypersensitivity reaction|3
803471|NCT00815295|2555019|P2|Overall Study|Cetuximab hypersensitivity reaction|1
803472|NCT00815295|2555020|P1|Overall Study|Cetuximab hypersensitivity reaction|0
803473|NCT00815308|2555030|P1|Overall Study|Protocol Violation|6
803474|NCT00815308|2555030|P1|Overall Study|Withdrawal by Subject|0
803475|NCT00815308|2555030|P1|Overall Study|Adverse Event|4
803476|NCT00815516|2555074|P2|Overall Study|Physician Decision|0
803477|NCT00815516|2555075|P1|Overall Study|Physician Decision|1
803478|NCT00815516|2555074|P2|Overall Study|Death|1
803479|NCT00815516|2555075|P1|Overall Study|Death|3
803480|NCT00815659|2555104|P1|Overall Study|Protocol Violation|1
803481|NCT00815659|2555104|P1|Overall Study|Lost to Follow-up|4
803482|NCT00815659|2555104|P1|Overall Study|Withdrawal by Subject|9
803483|NCT00815659|2555104|P1|Overall Study|Adverse Event|9
803484|NCT00815919|2555182|P1|Overall Study|Lack of Efficacy|2
803485|NCT00815919|2555182|P1|Overall Study|AML Relapse|1
803486|NCT00815919|2555182|P1|Overall Study|Unrelated Fungal Infection|1
803487|NCT00816023|2555194|P4|Overall Study|Randomized Not Treated|11
803488|NCT00816023|2555195|P3|Overall Study|Randomized Not Treated|6
803489|NCT00816023|2555196|P2|Overall Study|Randomized Not Treated|4
803490|NCT00816023|2555197|P1|Overall Study|Randomized Not Treated|6
803491|NCT00816023|2555194|P4|Overall Study|assessments complete prior to window|1
803492|NCT00816023|2555195|P3|Overall Study|assessments complete prior to window|2
803493|NCT00816023|2555196|P2|Overall Study|assessments complete prior to window|1
803494|NCT00816023|2555197|P1|Overall Study|assessments complete prior to window|1
803495|NCT00816023|2555194|P4|Overall Study|Physician Decision|0
803496|NCT00816023|2555195|P3|Overall Study|Physician Decision|1
803497|NCT00816023|2555196|P2|Overall Study|Physician Decision|0
803498|NCT00816023|2555197|P1|Overall Study|Physician Decision|0
803499|NCT00816023|2555194|P4|Overall Study|Withdrawal by Subject|0
803500|NCT00816023|2555195|P3|Overall Study|Withdrawal by Subject|0
803501|NCT00816023|2555196|P2|Overall Study|Withdrawal by Subject|0
803502|NCT00816023|2555197|P1|Overall Study|Withdrawal by Subject|1
803503|NCT00816023|2555194|P4|Overall Study|Lost to Follow-up|0
803504|NCT00816023|2555195|P3|Overall Study|Lost to Follow-up|0
803505|NCT00816023|2555196|P2|Overall Study|Lost to Follow-up|1
803506|NCT00816023|2555197|P1|Overall Study|Lost to Follow-up|1
803507|NCT00816036|2555213|P2|Overall Study|Withdrawal by Subject|23
803508|NCT00816036|2555214|P1|Overall Study|Withdrawal by Subject|54
803509|NCT00816036|2555213|P2|Overall Study|Lost to Follow-up|57
803510|NCT00816036|2555214|P1|Overall Study|Lost to Follow-up|75
803511|NCT00816036|2555213|P2|Overall Study|Death|28
803512|NCT00816036|2555214|P1|Overall Study|Death|47
803513|NCT00816166|2555245|P2|Overall Study|Death|2
803514|NCT00816166|2555246|P1|Overall Study|Death|4
803515|NCT00816166|2555245|P2|Overall Study|Lost to Follow-up|10
803516|NCT00816166|2555246|P1|Overall Study|Lost to Follow-up|6
803517|NCT00816400|2555265|P9|Overall Study|In hospice care at the end of the study|0
803518|NCT00816400|2555266|P8|Overall Study|In hospice care at the end of the study|0
803519|NCT00816400|2555267|P7|Overall Study|In hospice care at the end of the study|0
803520|NCT00816400|2555268|P6|Overall Study|In hospice care at the end of the study|0
803521|NCT00816400|2555269|P5|Overall Study|In hospice care at the end of the study|0
803522|NCT00816400|2555270|P4|Overall Study|In hospice care at the end of the study|0
803523|NCT00816400|2555271|P3|Overall Study|In hospice care at the end of the study|2
803524|NCT00816400|2555272|P2|Overall Study|In hospice care at the end of the study|0
803525|NCT00816400|2555273|P1|Overall Study|In hospice care at the end of the study|0
803526|NCT00816400|2555265|P9|Overall Study|Death|6
803527|NCT00816400|2555266|P8|Overall Study|Death|5
803528|NCT00816400|2555267|P7|Overall Study|Death|2
803529|NCT00816400|2555268|P6|Overall Study|Death|3
803530|NCT00816400|2555269|P5|Overall Study|Death|2
803531|NCT00816400|2555270|P4|Overall Study|Death|3
803532|NCT00816400|2555271|P3|Overall Study|Death|3
803533|NCT00816400|2555272|P2|Overall Study|Death|3
803534|NCT00816400|2555273|P1|Overall Study|Death|2
803544|NCT00816595|2555478|P2|Overall Study|Withdrawal by Subject|0
803545|NCT00816595|2555479|P1|Overall Study|Withdrawal by Subject|2
803546|NCT00798096|2555548|P1|Overall Study|Ongoing|2
803547|NCT00798135|2555555|P1|Overall Study|Physician Decision|1
803548|NCT00798135|2555555|P1|Overall Study|Disease progression, refractory|1
803549|NCT00798135|2555555|P1|Overall Study|Disease progression, relapse|11
803550|NCT00798161|2555568|P7|Overall Study|Other reason (incl. lack of efficacy)|5
803551|NCT00798161|2555569|P6|Overall Study|Other reason (incl. lack of efficacy)|4
803552|NCT00798161|2555570|P5|Overall Study|Other reason (incl. lack of efficacy)|2
803553|NCT00798161|2555571|P4|Overall Study|Other reason (incl. lack of efficacy)|5
803554|NCT00798161|2555572|P3|Overall Study|Other reason (incl. lack of efficacy)|3
803555|NCT00798161|2555573|P2|Overall Study|Other reason (incl. lack of efficacy)|5
803556|NCT00798161|2555574|P1|Overall Study|Other reason (incl. lack of efficacy)|7
803557|NCT00798161|2555568|P7|Overall Study|Withdrawal by Subject|1
803558|NCT00798161|2555569|P6|Overall Study|Withdrawal by Subject|3
803559|NCT00798161|2555570|P5|Overall Study|Withdrawal by Subject|2
803560|NCT00798161|2555571|P4|Overall Study|Withdrawal by Subject|4
803561|NCT00798161|2555572|P3|Overall Study|Withdrawal by Subject|5
803562|NCT00798161|2555573|P2|Overall Study|Withdrawal by Subject|4
803563|NCT00798161|2555574|P1|Overall Study|Withdrawal by Subject|5
803564|NCT00798161|2555568|P7|Overall Study|Lost to Follow-up|0
803565|NCT00798161|2555569|P6|Overall Study|Lost to Follow-up|0
803566|NCT00798161|2555570|P5|Overall Study|Lost to Follow-up|4
803567|NCT00798161|2555571|P4|Overall Study|Lost to Follow-up|3
803568|NCT00798161|2555572|P3|Overall Study|Lost to Follow-up|4
803569|NCT00798161|2555573|P2|Overall Study|Lost to Follow-up|3
803570|NCT00798161|2555574|P1|Overall Study|Lost to Follow-up|1
803571|NCT00798161|2555568|P7|Overall Study|Protocol Violation|0
803572|NCT00798161|2555569|P6|Overall Study|Protocol Violation|2
803573|NCT00798161|2555570|P5|Overall Study|Protocol Violation|3
803574|NCT00798161|2555571|P4|Overall Study|Protocol Violation|3
803575|NCT00798161|2555572|P3|Overall Study|Protocol Violation|3
803576|NCT00798161|2555573|P2|Overall Study|Protocol Violation|1
803577|NCT00798161|2555574|P1|Overall Study|Protocol Violation|2
803578|NCT00798161|2555568|P7|Overall Study|Adverse Event|4
803579|NCT00798161|2555569|P6|Overall Study|Adverse Event|2
803580|NCT00798161|2555570|P5|Overall Study|Adverse Event|5
803581|NCT00798161|2555571|P4|Overall Study|Adverse Event|6
803582|NCT00798161|2555572|P3|Overall Study|Adverse Event|6
803583|NCT00798161|2555573|P2|Overall Study|Adverse Event|4
803584|NCT00798161|2555574|P1|Overall Study|Adverse Event|3
803585|NCT00798304|2555684|P3|Overall Study|Discontinuation by Sponsor|9
803586|NCT00798304|2555685|P2|Overall Study|Discontinuation by Sponsor|21
803587|NCT00798304|2555686|P1|Overall Study|Discontinuation by Sponsor|14
803588|NCT00798304|2555684|P3|Overall Study|Adverse Event|1
803589|NCT00798304|2555685|P2|Overall Study|Adverse Event|1
803590|NCT00798304|2555686|P1|Overall Study|Adverse Event|0
803591|NCT00798317|2555714|P2|Overall Study|Death|0
803592|NCT00798317|2555715|P1|Overall Study|Death|1
803593|NCT00798317|2555714|P2|Overall Study|Adverse Event|0
803594|NCT00798317|2555715|P1|Overall Study|Adverse Event|2
803595|NCT00798317|2555714|P2|Overall Study|Lost to Follow-up|2
803596|NCT00798317|2555715|P1|Overall Study|Lost to Follow-up|2
803597|NCT00798317|2555714|P2|Overall Study|Withdrawal by Subject|4
803598|NCT00798317|2555715|P1|Overall Study|Withdrawal by Subject|5
803599|NCT00798317|2555714|P2|Overall Study|Physician Decision|1
803600|NCT00798317|2555715|P1|Overall Study|Physician Decision|0
803601|NCT00798369|2555729|P6|Overall Study|Adminstrative problems|1
803602|NCT00798369|2555730|P5|Overall Study|Adminstrative problems|0
803603|NCT00798369|2555731|P4|Overall Study|Adminstrative problems|0
803604|NCT00798369|2555732|P3|Overall Study|Adminstrative problems|0
803605|NCT00798369|2555733|P2|Overall Study|Adminstrative problems|0
803606|NCT00798369|2555734|P1|Overall Study|Adminstrative problems|0
803607|NCT00798369|2555729|P6|Overall Study|Lost to Follow-up|0
803608|NCT00798369|2555730|P5|Overall Study|Lost to Follow-up|1
803609|NCT00798369|2555731|P4|Overall Study|Lost to Follow-up|0
803610|NCT00798369|2555732|P3|Overall Study|Lost to Follow-up|1
803611|NCT00798369|2555733|P2|Overall Study|Lost to Follow-up|1
803612|NCT00798369|2555734|P1|Overall Study|Lost to Follow-up|1
803613|NCT00798369|2555729|P6|Overall Study|Subject withdrew consent|2
803614|NCT00798369|2555730|P5|Overall Study|Subject withdrew consent|0
803615|NCT00798369|2555731|P4|Overall Study|Subject withdrew consent|1
803616|NCT00798369|2555732|P3|Overall Study|Subject withdrew consent|1
803617|NCT00798369|2555733|P2|Overall Study|Subject withdrew consent|0
803618|NCT00798369|2555734|P1|Overall Study|Subject withdrew consent|0
803619|NCT00798434|2555781|P2|Open-Label|Not Treated|1
803620|NCT00798434|2555782|P1|Open-Label|Not Treated|0
803621|NCT00798434|2555781|P2|Open-Label|Not Specified|2
803622|NCT00798434|2555782|P1|Open-Label|Not Specified|1
803623|NCT00798434|2555781|P2|Open-Label|Protocol Violation|0
803624|NCT00798434|2555782|P1|Open-Label|Protocol Violation|1
803625|NCT00798434|2555781|P2|Open-Label|Withdrawal by Subject|7
803626|NCT00798434|2555782|P1|Open-Label|Withdrawal by Subject|2
803627|NCT00798434|2555781|P2|Open-Label|Lack of Efficacy|11
803628|NCT00798434|2555782|P1|Open-Label|Lack of Efficacy|5
803629|NCT00798434|2555781|P2|Open-Label|Adverse Event|11
803630|NCT00798434|2555782|P1|Open-Label|Adverse Event|33
803631|NCT00798434|2555781|P2|Double-Blind|Not Treated|6
803632|NCT00798434|2555782|P1|Double-Blind|Not Treated|3
803633|NCT00798434|2555781|P2|Double-Blind|Not Specified|0
803634|NCT00798434|2555782|P1|Double-Blind|Not Specified|1
803635|NCT00798434|2555781|P2|Double-Blind|Did Not Meet Entrance Criteria|1
803636|NCT00798434|2555782|P1|Double-Blind|Did Not Meet Entrance Criteria|2
803637|NCT00798434|2555781|P2|Double-Blind|Protocol Violation|4
803638|NCT00798434|2555782|P1|Double-Blind|Protocol Violation|1
803639|NCT00798434|2555781|P2|Double-Blind|Withdrawal by Subject|14
803640|NCT00798434|2555782|P1|Double-Blind|Withdrawal by Subject|17
803641|NCT00798434|2555781|P2|Double-Blind|Lack of Efficacy|12
803642|NCT00798434|2555782|P1|Double-Blind|Lack of Efficacy|8
803643|NCT00798434|2555781|P2|Double-Blind|Lost to Follow-up|0
803644|NCT00798434|2555782|P1|Double-Blind|Lost to Follow-up|1
803645|NCT00798434|2555781|P2|Double-Blind|Death|1
803646|NCT00798434|2555782|P1|Double-Blind|Death|0
803647|NCT00798434|2555781|P2|Double-Blind|Adverse Event|46
803648|NCT00798434|2555782|P1|Double-Blind|Adverse Event|22
803649|NCT00798590|2555888|P2|Overall Study|P.I, Left institution. Study terminated|8
803650|NCT00798590|2555889|P1|Overall Study|P.I, Left institution. Study terminated|11
803651|NCT00798603|2555897|P1|Overall Study|Lack of insurance coverage|1
803652|NCT00798603|2555897|P1|Overall Study|Physician Decision|1
803653|NCT00798603|2555897|P1|Overall Study|Adverse Event|22
803654|NCT00798603|2555897|P1|Overall Study|Withdrawal by Subject|10
803655|NCT00798603|2555897|P1|Overall Study|Still on treatment as of 11/6/2012|1
803656|NCT00798655|2555917|P1|Overall Study|Did not receive at least one dose of pan|2
803657|NCT00798707|2555925|P3|Overall Study|Randomized not treated|1
803658|NCT00798707|2555926|P2|Overall Study|Randomized not treated|5
803659|NCT00798707|2555927|P1|Overall Study|Randomized not treated|4
803660|NCT00798707|2555925|P3|Overall Study|Withdrawal by Subject|2
803661|NCT00798707|2555926|P2|Overall Study|Withdrawal by Subject|8
803662|NCT00798707|2555927|P1|Overall Study|Withdrawal by Subject|3
803663|NCT00798707|2555925|P3|Overall Study|Protocol Violation|2
803664|NCT00798707|2555926|P2|Overall Study|Protocol Violation|0
803665|NCT00798707|2555927|P1|Overall Study|Protocol Violation|4
803666|NCT00798707|2555925|P3|Overall Study|Unspecified|0
803667|NCT00798707|2555926|P2|Overall Study|Unspecified|1
803668|NCT00798707|2555927|P1|Overall Study|Unspecified|0
803669|NCT00798707|2555925|P3|Overall Study|Lost to Follow-up|6
803670|NCT00798707|2555926|P2|Overall Study|Lost to Follow-up|6
803671|NCT00798707|2555927|P1|Overall Study|Lost to Follow-up|5
803672|NCT00798707|2555925|P3|Overall Study|Lack of Efficacy|1
803673|NCT00798707|2555926|P2|Overall Study|Lack of Efficacy|2
803674|NCT00798707|2555927|P1|Overall Study|Lack of Efficacy|2
803675|NCT00798707|2555925|P3|Overall Study|Investigator|2
803676|NCT00798707|2555926|P2|Overall Study|Investigator|1
803677|NCT00798707|2555927|P1|Overall Study|Investigator|0
803678|NCT00798707|2555925|P3|Overall Study|Failed to return|0
803679|NCT00798707|2555926|P2|Overall Study|Failed to return|2
803680|NCT00798707|2555927|P1|Overall Study|Failed to return|2
803681|NCT00798707|2555925|P3|Overall Study|Adverse Event|8
803682|NCT00798707|2555926|P2|Overall Study|Adverse Event|8
803683|NCT00798707|2555927|P1|Overall Study|Adverse Event|6
803684|NCT00798759|2555986|P2|Overall Study|Not specified|1
803685|NCT00798759|2555987|P1|Overall Study|Not specified|0
803686|NCT00798759|2555986|P2|Overall Study|Protocol Violation|8
803687|NCT00798759|2555987|P1|Overall Study|Protocol Violation|4
803688|NCT00798759|2555986|P2|Overall Study|Lost to Follow-up|1
803689|NCT00798759|2555987|P1|Overall Study|Lost to Follow-up|1
803690|NCT00798759|2555986|P2|Overall Study|Adverse Event|3
803691|NCT00798759|2555987|P1|Overall Study|Adverse Event|3
803692|NCT00798889|2555995|P1|Overall Study|Enrolled, Not treated|3
803693|NCT00798889|2555995|P1|Overall Study|Decision of Sponsor|11
803694|NCT00798889|2555995|P1|Overall Study|Lack of Efficacy|213
803695|NCT00798889|2555995|P1|Overall Study|Lost to Follow-up|1
803696|NCT00798889|2555995|P1|Overall Study|Withdrawal by Subject|31
803697|NCT00798889|2555995|P1|Overall Study|Protocol Violation|2
803698|NCT00798889|2555995|P1|Overall Study|Adverse Event|53
803699|NCT00798967|2556001|P2|Overall Study|Randomized in error by site|0
803700|NCT00798967|2556002|P1|Overall Study|Randomized in error by site|1
803701|NCT00798967|2556001|P2|Overall Study|Physician Decision|0
803702|NCT00798967|2556002|P1|Overall Study|Physician Decision|1
803703|NCT00798967|2556001|P2|Overall Study|Withdrawal by Subject|1
803704|NCT00798967|2556002|P1|Overall Study|Withdrawal by Subject|0
803705|NCT00798967|2556001|P2|Overall Study|Adverse Event|3
803706|NCT00798967|2556002|P1|Overall Study|Adverse Event|2
803707|NCT00804570|2556012|P2|Overall Study|Withdrawal by Subject|38
803708|NCT00804570|2556013|P1|Overall Study|Withdrawal by Subject|21
803709|NCT00804570|2556012|P2|Overall Study|Sponsor decision|4
803710|NCT00804570|2556013|P1|Overall Study|Sponsor decision|1
803711|NCT00804570|2556012|P2|Overall Study|Physician Decision|2
803712|NCT00804570|2556013|P1|Overall Study|Physician Decision|1
803713|NCT00804570|2556012|P2|Overall Study|Protocol Violation|16
803714|NCT00804570|2556013|P1|Overall Study|Protocol Violation|12
803715|NCT00804570|2556012|P2|Overall Study|Entry criteria not met|5
803716|NCT00804570|2556013|P1|Overall Study|Entry criteria not met|5
803717|NCT00804570|2556012|P2|Overall Study|Lost to Follow-up|21
803718|NCT00804570|2556013|P1|Overall Study|Lost to Follow-up|18
803719|NCT00804570|2556012|P2|Overall Study|Lack of Efficacy|1
803720|NCT00804570|2556013|P1|Overall Study|Lack of Efficacy|0
803721|NCT00804570|2556012|P2|Overall Study|Adverse Event|7
803722|NCT00804570|2556013|P1|Overall Study|Adverse Event|14
803723|NCT00804687|2556129|P6|Period 5: Treatment Period|Positive drug test|0
803724|NCT00804687|2556130|P5|Period 5: Treatment Period|Positive drug test|0
803725|NCT00804687|2556131|P4|Period 5: Treatment Period|Positive drug test|0
803726|NCT00804687|2556132|P3|Period 5: Treatment Period|Positive drug test|0
803727|NCT00804687|2556133|P2|Period 5: Treatment Period|Positive drug test|0
803728|NCT00804687|2556134|P1|Period 5: Treatment Period|Positive drug test|1
803729|NCT00804687|2556129|P6|Period 5: Treatment Period|Positive drugs of abuse|0
803730|NCT00804687|2556130|P5|Period 5: Treatment Period|Positive drugs of abuse|0
803731|NCT00804687|2556131|P4|Period 5: Treatment Period|Positive drugs of abuse|0
803732|NCT00804687|2556132|P3|Period 5: Treatment Period|Positive drugs of abuse|1
803733|NCT00804687|2556133|P2|Period 5: Treatment Period|Positive drugs of abuse|0
803734|NCT00804687|2556134|P1|Period 5: Treatment Period|Positive drugs of abuse|0
803735|NCT00804687|2556129|P6|Period 5: Treatment Period|Withdrawal by Subject|0
803736|NCT00804687|2556130|P5|Period 5: Treatment Period|Withdrawal by Subject|1
803737|NCT00804687|2556131|P4|Period 5: Treatment Period|Withdrawal by Subject|0
803738|NCT00804687|2556132|P3|Period 5: Treatment Period|Withdrawal by Subject|0
803739|NCT00804687|2556133|P2|Period 5: Treatment Period|Withdrawal by Subject|0
803740|NCT00804687|2556134|P1|Period 5: Treatment Period|Withdrawal by Subject|0
803741|NCT00804687|2556129|P6|Period 3: Treatment Period|Positive Drug screen|0
803742|NCT00804687|2556130|P5|Period 3: Treatment Period|Positive Drug screen|0
803743|NCT00804687|2556131|P4|Period 3: Treatment Period|Positive Drug screen|1
803744|NCT00804687|2556132|P3|Period 3: Treatment Period|Positive Drug screen|0
803745|NCT00804687|2556133|P2|Period 3: Treatment Period|Positive Drug screen|0
803746|NCT00804687|2556134|P1|Period 3: Treatment Period|Positive Drug screen|0
803753|NCT00804908|2556175|P3|Overall Study|Not specified|114
803754|NCT00804908|2556176|P2|Overall Study|Not specified|116
803755|NCT00804908|2556177|P1|Overall Study|Not specified|115
803756|NCT00804986|2556212|P6|Overall Study|Physician Decision|0
803757|NCT00804986|2556213|P5|Overall Study|Physician Decision|0
803758|NCT00804986|2556214|P4|Overall Study|Physician Decision|0
803759|NCT00804986|2556215|P3|Overall Study|Physician Decision|0
803760|NCT00804986|2556216|P2|Overall Study|Physician Decision|0
803761|NCT00804986|2556217|P1|Overall Study|Physician Decision|1
803762|NCT00804986|2556212|P6|Overall Study|Sponsor Decision|0
803763|NCT00804986|2556213|P5|Overall Study|Sponsor Decision|0
803764|NCT00804986|2556214|P4|Overall Study|Sponsor Decision|0
803765|NCT00804986|2556215|P3|Overall Study|Sponsor Decision|0
803766|NCT00804986|2556216|P2|Overall Study|Sponsor Decision|1
803767|NCT00804986|2556217|P1|Overall Study|Sponsor Decision|0
803768|NCT00804986|2556212|P6|Overall Study|Inclusion/Exclusion criteria not met|1
803769|NCT00804986|2556213|P5|Overall Study|Inclusion/Exclusion criteria not met|0
803770|NCT00804986|2556214|P4|Overall Study|Inclusion/Exclusion criteria not met|1
803771|NCT00804986|2556215|P3|Overall Study|Inclusion/Exclusion criteria not met|0
803772|NCT00804986|2556216|P2|Overall Study|Inclusion/Exclusion criteria not met|2
803773|NCT00804986|2556217|P1|Overall Study|Inclusion/Exclusion criteria not met|0
803774|NCT00804986|2556212|P6|Overall Study|Withdrawal by Subject|3
803775|NCT00804986|2556213|P5|Overall Study|Withdrawal by Subject|5
803776|NCT00804986|2556214|P4|Overall Study|Withdrawal by Subject|3
803777|NCT00804986|2556215|P3|Overall Study|Withdrawal by Subject|0
803778|NCT00804986|2556216|P2|Overall Study|Withdrawal by Subject|3
803779|NCT00804986|2556217|P1|Overall Study|Withdrawal by Subject|0
803780|NCT00804986|2556212|P6|Overall Study|Protocol Violation|0
803781|NCT00804986|2556213|P5|Overall Study|Protocol Violation|0
803782|NCT00804986|2556214|P4|Overall Study|Protocol Violation|1
803783|NCT00804986|2556215|P3|Overall Study|Protocol Violation|0
803784|NCT00804986|2556216|P2|Overall Study|Protocol Violation|1
803785|NCT00804986|2556217|P1|Overall Study|Protocol Violation|0
803786|NCT00804986|2556212|P6|Overall Study|Lost to Follow-up|3
803787|NCT00804986|2556213|P5|Overall Study|Lost to Follow-up|1
803788|NCT00804986|2556214|P4|Overall Study|Lost to Follow-up|1
803789|NCT00804986|2556215|P3|Overall Study|Lost to Follow-up|0
803790|NCT00804986|2556216|P2|Overall Study|Lost to Follow-up|0
803791|NCT00804986|2556217|P1|Overall Study|Lost to Follow-up|0
803792|NCT00804986|2556212|P6|Overall Study|Lack of Efficacy|3
803793|NCT00804986|2556213|P5|Overall Study|Lack of Efficacy|0
803794|NCT00804986|2556214|P4|Overall Study|Lack of Efficacy|1
803795|NCT00804986|2556215|P3|Overall Study|Lack of Efficacy|0
803796|NCT00804986|2556216|P2|Overall Study|Lack of Efficacy|0
803797|NCT00804986|2556217|P1|Overall Study|Lack of Efficacy|0
803798|NCT00804986|2556212|P6|Overall Study|Adverse Event|0
803799|NCT00804986|2556213|P5|Overall Study|Adverse Event|3
803800|NCT00804986|2556214|P4|Overall Study|Adverse Event|1
803801|NCT00804986|2556215|P3|Overall Study|Adverse Event|2
803802|NCT00804986|2556216|P2|Overall Study|Adverse Event|1
803803|NCT00804986|2556217|P1|Overall Study|Adverse Event|0
803804|NCT00805025|2556309|P1|Overall Study|Physician Decision|1
803805|NCT00805025|2556309|P1|Overall Study|Withdrawal by Subject|2
803806|NCT00805025|2556309|P1|Overall Study|Adverse Event|4
803807|NCT00805025|2556309|P1|Overall Study|Screened but not enrolled/treated|42
803808|NCT00805142|2556326|P2|Maintenance Period|Unspecified|1
803809|NCT00805142|2556327|P1|Maintenance Period|Unspecified|0
803810|NCT00805142|2556326|P2|Maintenance Period|Adverse Event|1
803811|NCT00805142|2556327|P1|Maintenance Period|Adverse Event|0
803812|NCT00805142|2556326|P2|Titration Period|Unspecified|3
803813|NCT00805142|2556327|P1|Titration Period|Unspecified|0
803814|NCT00805142|2556326|P2|Titration Period|Withdrawal of consent|1
803815|NCT00805142|2556327|P1|Titration Period|Withdrawal of consent|0
803816|NCT00805142|2556326|P2|Titration Period|Disease Progression|1
803817|NCT00805142|2556327|P1|Titration Period|Disease Progression|2
803818|NCT00805142|2556326|P2|Titration Period|Lost to Follow-up|1
803819|NCT00805142|2556327|P1|Titration Period|Lost to Follow-up|0
803820|NCT00805142|2556326|P2|Titration Period|Lack of Efficacy|1
803821|NCT00805142|2556327|P1|Titration Period|Lack of Efficacy|1
803822|NCT00805142|2556326|P2|Titration Period|Adverse Event|3
803823|NCT00805142|2556327|P1|Titration Period|Adverse Event|3
803840|NCT00805285|2556386|P1|Overall Study|Lack of Efficacy|1
803841|NCT00805389|2556399|P5|Overall Study|Withdrawal by Subject|4
803842|NCT00805389|2556400|P4|Overall Study|Withdrawal by Subject|5
803843|NCT00805389|2556401|P3|Overall Study|Withdrawal by Subject|4
803844|NCT00805389|2556402|P2|Overall Study|Withdrawal by Subject|2
803845|NCT00805389|2556403|P1|Overall Study|Withdrawal by Subject|3
803846|NCT00805389|2556399|P5|Overall Study|Protocol Violation|0
803847|NCT00805389|2556400|P4|Overall Study|Protocol Violation|0
803848|NCT00805389|2556401|P3|Overall Study|Protocol Violation|1
803849|NCT00805389|2556402|P2|Overall Study|Protocol Violation|0
803850|NCT00805389|2556403|P1|Overall Study|Protocol Violation|0
803851|NCT00805389|2556399|P5|Overall Study|Lost to Follow-up|9
803852|NCT00805389|2556400|P4|Overall Study|Lost to Follow-up|10
803853|NCT00805389|2556401|P3|Overall Study|Lost to Follow-up|6
803854|NCT00805389|2556402|P2|Overall Study|Lost to Follow-up|3
803855|NCT00805389|2556403|P1|Overall Study|Lost to Follow-up|4
803856|NCT00805389|2556399|P5|Overall Study|Adverse Event|0
803857|NCT00805389|2556400|P4|Overall Study|Adverse Event|2
803858|NCT00805389|2556401|P3|Overall Study|Adverse Event|1
803859|NCT00805389|2556402|P2|Overall Study|Adverse Event|0
803860|NCT00805389|2556403|P1|Overall Study|Adverse Event|0
803861|NCT00805467|2556649|P4|Overall Study|Not reported|7
803862|NCT00805467|2556650|P3|Overall Study|Not reported|3
803863|NCT00805467|2556651|P2|Overall Study|Not reported|0
803864|NCT00805467|2556652|P1|Overall Study|Not reported|0
803865|NCT00805467|2556649|P4|Overall Study|Physician Decision|6
803866|NCT00805467|2556650|P3|Overall Study|Physician Decision|2
803867|NCT00805467|2556651|P2|Overall Study|Physician Decision|1
803868|NCT00805467|2556652|P1|Overall Study|Physician Decision|0
803869|NCT00805467|2556649|P4|Overall Study|Death|5
803870|NCT00805467|2556650|P3|Overall Study|Death|7
803871|NCT00805467|2556651|P2|Overall Study|Death|2
803872|NCT00805467|2556652|P1|Overall Study|Death|0
803873|NCT00805467|2556649|P4|Overall Study|Adverse Event|57
803874|NCT00805467|2556650|P3|Overall Study|Adverse Event|26
803875|NCT00805467|2556651|P2|Overall Study|Adverse Event|13
803876|NCT00805467|2556652|P1|Overall Study|Adverse Event|0
803877|NCT00805467|2556649|P4|Overall Study|Protocol Violation|5
803878|NCT00805467|2556650|P3|Overall Study|Protocol Violation|0
803879|NCT00805467|2556651|P2|Overall Study|Protocol Violation|3
803880|NCT00805467|2556652|P1|Overall Study|Protocol Violation|0
803881|NCT00805467|2556649|P4|Overall Study|Withdrawal by Subject|50
803882|NCT00805467|2556650|P3|Overall Study|Withdrawal by Subject|45
803883|NCT00805467|2556651|P2|Overall Study|Withdrawal by Subject|6
803884|NCT00805467|2556652|P1|Overall Study|Withdrawal by Subject|0
803885|NCT00805467|2556649|P4|Overall Study|Lost to Follow-up|21
803886|NCT00805467|2556650|P3|Overall Study|Lost to Follow-up|7
803887|NCT00805467|2556651|P2|Overall Study|Lost to Follow-up|1
803888|NCT00805467|2556652|P1|Overall Study|Lost to Follow-up|0
803889|NCT00805467|2556649|P4|Overall Study|Lack of Efficacy|86
803890|NCT00805467|2556650|P3|Overall Study|Lack of Efficacy|13
803891|NCT00805467|2556651|P2|Overall Study|Lack of Efficacy|8
803892|NCT00805467|2556652|P1|Overall Study|Lack of Efficacy|0
803893|NCT00805480|2556674|P4|Overall Study|Adverse Event|0
803894|NCT00805480|2556675|P3|Overall Study|Adverse Event|1
803895|NCT00805480|2556676|P2|Overall Study|Adverse Event|0
803896|NCT00805480|2556677|P1|Overall Study|Adverse Event|0
803897|NCT00805480|2556674|P4|Overall Study|Lost to Follow-up|0
803898|NCT00805480|2556675|P3|Overall Study|Lost to Follow-up|0
803899|NCT00805480|2556676|P2|Overall Study|Lost to Follow-up|2
803900|NCT00805480|2556677|P1|Overall Study|Lost to Follow-up|1
803901|NCT00805480|2556674|P4|Overall Study|Withdrawal by Subject|5
803902|NCT00805480|2556675|P3|Overall Study|Withdrawal by Subject|11
803903|NCT00805480|2556676|P2|Overall Study|Withdrawal by Subject|5
803904|NCT00805480|2556677|P1|Overall Study|Withdrawal by Subject|13
803905|NCT00811018|2556718|P1|Overall Study|Unspecified|26
803906|NCT00811018|2556718|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
803907|NCT00811018|2556718|P1|Overall Study|Withdrawal by Subject|70
803908|NCT00811018|2556718|P1|Overall Study|Sponsor Decision|450
803909|NCT00811018|2556718|P1|Overall Study|Pregnancy|6
803910|NCT00811018|2556718|P1|Overall Study|Lost to Follow-up|19
803911|NCT00811018|2556718|P1|Overall Study|Investigator Decision|57
803912|NCT00811018|2556718|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
803913|NCT00811018|2556718|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
803914|NCT00811018|2556718|P1|Overall Study|Death|147
803915|NCT00811018|2556718|P1|Overall Study|Adverse Event|79
803916|NCT00811018|2556718|P1|Overall Study|Additional Chronic Treatment|31
803917|NCT00811057|2556737|P3|Overall Study|Protocol Violation|10
803918|NCT00811057|2556738|P2|Overall Study|Protocol Violation|10
803919|NCT00811057|2556739|P1|Overall Study|Protocol Violation|5
803920|NCT00811070|2556756|P6|Overall Study|Physician Decision|1
803921|NCT00811070|2556757|P5|Overall Study|Physician Decision|0
803922|NCT00811070|2556758|P4|Overall Study|Physician Decision|0
803923|NCT00811070|2556759|P3|Overall Study|Physician Decision|0
803924|NCT00811070|2556760|P2|Overall Study|Physician Decision|0
803925|NCT00811070|2556761|P1|Overall Study|Physician Decision|0
803926|NCT00811070|2556756|P6|Overall Study|Withdrawal by Subject|0
803927|NCT00811070|2556757|P5|Overall Study|Withdrawal by Subject|0
803928|NCT00811070|2556758|P4|Overall Study|Withdrawal by Subject|0
803929|NCT00811070|2556759|P3|Overall Study|Withdrawal by Subject|0
803930|NCT00811070|2556760|P2|Overall Study|Withdrawal by Subject|1
803931|NCT00811070|2556761|P1|Overall Study|Withdrawal by Subject|0
803932|NCT00811070|2556756|P6|Overall Study|Unspecified|0
803933|NCT00811070|2556757|P5|Overall Study|Unspecified|0
803934|NCT00811070|2556758|P4|Overall Study|Unspecified|0
803935|NCT00811070|2556759|P3|Overall Study|Unspecified|0
803936|NCT00811070|2556760|P2|Overall Study|Unspecified|0
803937|NCT00811070|2556761|P1|Overall Study|Unspecified|1
803938|NCT00811070|2556756|P6|Overall Study|Death|0
803939|NCT00811070|2556757|P5|Overall Study|Death|5
803940|NCT00811070|2556758|P4|Overall Study|Death|2
803941|NCT00811070|2556759|P3|Overall Study|Death|0
803942|NCT00811070|2556760|P2|Overall Study|Death|0
803943|NCT00811070|2556761|P1|Overall Study|Death|0
803944|NCT00811135|2556818|P1|Overall Study|Ongoing|59
803945|NCT00811135|2556818|P1|Overall Study|Administrative/Other Unspecified|11
803946|NCT00811135|2556818|P1|Overall Study|Withdrawal by Subject|3
803947|NCT00811135|2556818|P1|Overall Study|Refused Treatment|1
803948|NCT00811135|2556818|P1|Overall Study|Violation of Selection Criteria|1
803949|NCT00811135|2556818|P1|Overall Study|Protocol Violation|2
803950|NCT00811135|2556818|P1|Overall Study|Death|3
803951|NCT00811135|2556818|P1|Overall Study|Adverse Event/Intercurrent Illness|8
803952|NCT00811174|2556830|P1|Overall Study|Sponsors Decision|1
803953|NCT00811174|2556830|P1|Overall Study|Protocol Violation|2
803954|NCT00811252|2556844|P3|Overall Study|Administrative or Other Reasons|2
803955|NCT00811252|2556845|P2|Overall Study|Administrative or Other Reasons|3
803956|NCT00811252|2556846|P1|Overall Study|Administrative or Other Reasons|0
803957|NCT00811252|2556844|P3|Overall Study|Lost to Follow-up|2
803958|NCT00811252|2556845|P2|Overall Study|Lost to Follow-up|0
803959|NCT00811252|2556846|P1|Overall Study|Lost to Follow-up|0
803960|NCT00811252|2556844|P3|Overall Study|Withdrawal of Consent|2
803961|NCT00811252|2556845|P2|Overall Study|Withdrawal of Consent|2
803962|NCT00811252|2556846|P1|Overall Study|Withdrawal of Consent|1
803963|NCT00811252|2556844|P3|Overall Study|Protocol Violation|2
803964|NCT00811252|2556845|P2|Overall Study|Protocol Violation|3
803965|NCT00811252|2556846|P1|Overall Study|Protocol Violation|3
803966|NCT00811252|2556844|P3|Overall Study|Lack of Efficacy|0
803967|NCT00811252|2556845|P2|Overall Study|Lack of Efficacy|2
803968|NCT00811252|2556846|P1|Overall Study|Lack of Efficacy|7
803969|NCT00811252|2556844|P3|Overall Study|Adverse Event|15
803970|NCT00811252|2556845|P2|Overall Study|Adverse Event|10
803971|NCT00811252|2556846|P1|Overall Study|Adverse Event|6
803972|NCT00817206|2556892|P2|Overall Study|Physician Decision|0
803973|NCT00817206|2556893|P1|Overall Study|Physician Decision|2
803974|NCT00817206|2556892|P2|Overall Study|Withdrawal by Subject|3
803975|NCT00817206|2556893|P1|Overall Study|Withdrawal by Subject|7
803976|NCT00817206|2556892|P2|Overall Study|Death|0
803977|NCT00817206|2556893|P1|Overall Study|Death|2
803978|NCT00817206|2556892|P2|Overall Study|Lost to Follow-up|1
803979|NCT00817206|2556893|P1|Overall Study|Lost to Follow-up|0
803980|NCT00817206|2556892|P2|Overall Study|Protocol Violation|2
803981|NCT00817206|2556893|P1|Overall Study|Protocol Violation|0
803982|NCT00817206|2556892|P2|Overall Study|Adverse Event|3
803983|NCT00817206|2556893|P1|Overall Study|Adverse Event|10
803984|NCT00817336|2556914|P2|Overall Study|Withdrawal by Subject|1
803985|NCT00817336|2556915|P1|Overall Study|Withdrawal by Subject|1
803986|NCT00817479|2556928|P2|Overall Study|Physician Decision|1
803987|NCT00817479|2556929|P1|Overall Study|Physician Decision|1
803988|NCT00818441|2556939|P2|Overall Study|Study terminated by sponsor|2
803989|NCT00818441|2556940|P1|Overall Study|Study terminated by sponsor|11
803990|NCT00818441|2556939|P2|Overall Study|Adverse Event|1
803991|NCT00818441|2556940|P1|Overall Study|Adverse Event|0
803992|NCT00818441|2556939|P2|Overall Study|Withdrawal by Subject|0
803993|NCT00818441|2556940|P1|Overall Study|Withdrawal by Subject|2
803994|NCT00818441|2556939|P2|Overall Study|Lost to Follow-up|1
803995|NCT00818441|2556940|P1|Overall Study|Lost to Follow-up|2
803996|NCT00818441|2556939|P2|Overall Study|Unspecified|0
803997|NCT00818441|2556940|P1|Overall Study|Unspecified|5
803998|NCT00818441|2556939|P2|Overall Study|Death|26
803999|NCT00818441|2556940|P1|Overall Study|Death|69
804000|NCT00818454|2556960|P4|Treatment Period 3|Adverse Event|1
804001|NCT00818454|2556961|P3|Treatment Period 3|Adverse Event|0
804002|NCT00818454|2556962|P2|Treatment Period 3|Adverse Event|0
804003|NCT00818454|2556963|P1|Treatment Period 3|Adverse Event|0
804004|NCT00818454|2556960|P4|Treatment Period 2|not specified|0
804005|NCT00818454|2556961|P3|Treatment Period 2|not specified|0
804006|NCT00818454|2556962|P2|Treatment Period 2|not specified|1
804007|NCT00818454|2556963|P1|Treatment Period 2|not specified|2
804008|NCT00818454|2556960|P4|Washout Period of 1 Week|not specified|0
804009|NCT00818454|2556961|P3|Washout Period of 1 Week|not specified|0
804010|NCT00818454|2556962|P2|Washout Period of 1 Week|not specified|2
804011|NCT00818454|2556963|P1|Washout Period of 1 Week|not specified|1
804012|NCT00818454|2556960|P4|Washout Period of 1 Week|Protocol Violation|0
804013|NCT00818454|2556961|P3|Washout Period of 1 Week|Protocol Violation|0
804014|NCT00818454|2556962|P2|Washout Period of 1 Week|Protocol Violation|0
804015|NCT00818454|2556963|P1|Washout Period of 1 Week|Protocol Violation|2
804016|NCT00818454|2556960|P4|Washout Period of 1 Week|Adverse Event|0
804017|NCT00818454|2556961|P3|Washout Period of 1 Week|Adverse Event|0
804018|NCT00818454|2556962|P2|Washout Period of 1 Week|Adverse Event|1
804019|NCT00818454|2556963|P1|Washout Period of 1 Week|Adverse Event|1
804020|NCT00818454|2556960|P4|Treatment Period 1|not specified|0
804021|NCT00818454|2556961|P3|Treatment Period 1|not specified|0
804022|NCT00818454|2556962|P2|Treatment Period 1|not specified|0
804023|NCT00818454|2556963|P1|Treatment Period 1|not specified|3
804024|NCT00818454|2556960|P4|Treatment Period 1|Adverse Event|0
804025|NCT00818454|2556961|P3|Treatment Period 1|Adverse Event|0
804026|NCT00818454|2556962|P2|Treatment Period 1|Adverse Event|1
804027|NCT00818454|2556963|P1|Treatment Period 1|Adverse Event|0
804028|NCT00818519|2556991|P2|Overall Study|participant will leave for long tme|0
804029|NCT00818519|2556992|P1|Overall Study|participant will leave for long tme|1
804030|NCT00818519|2556991|P2|Overall Study|participant recovered completely|0
804031|NCT00818519|2556992|P1|Overall Study|participant recovered completely|1
804032|NCT00818519|2556991|P2|Overall Study|Withdrawal by Subject|9
804033|NCT00818519|2556992|P1|Overall Study|Withdrawal by Subject|4
804034|NCT00818519|2556991|P2|Overall Study|Pregnancy|1
804035|NCT00818519|2556992|P1|Overall Study|Pregnancy|0
804036|NCT00818519|2556991|P2|Overall Study|Protocol Violation|1
804037|NCT00818519|2556992|P1|Overall Study|Protocol Violation|2
804038|NCT00818519|2556991|P2|Overall Study|Lost to Follow-up|6
804039|NCT00818519|2556992|P1|Overall Study|Lost to Follow-up|4
804040|NCT00818519|2556991|P2|Overall Study|Adverse Event|2
804041|NCT00818519|2556992|P1|Overall Study|Adverse Event|2
804042|NCT00818623|2557030|P8|Overall Study|Disease progression|0
804043|NCT00818623|2557031|P7|Overall Study|Disease progression|1
804044|NCT00818623|2557032|P6|Overall Study|Disease progression|0
804045|NCT00818623|2557033|P5|Overall Study|Disease progression|0
804046|NCT00818623|2557034|P4|Overall Study|Disease progression|0
804047|NCT00818623|2557035|P3|Overall Study|Disease progression|0
804048|NCT00818623|2557036|P2|Overall Study|Disease progression|0
804049|NCT00818623|2557037|P1|Overall Study|Disease progression|0
804050|NCT00818623|2557030|P8|Overall Study|Lack of trial drug at site|0
804051|NCT00818623|2557031|P7|Overall Study|Lack of trial drug at site|1
804052|NCT00818623|2557032|P6|Overall Study|Lack of trial drug at site|0
804053|NCT00818623|2557033|P5|Overall Study|Lack of trial drug at site|2
804054|NCT00818623|2557034|P4|Overall Study|Lack of trial drug at site|0
804055|NCT00818623|2557035|P3|Overall Study|Lack of trial drug at site|0
804056|NCT00818623|2557036|P2|Overall Study|Lack of trial drug at site|0
804057|NCT00818623|2557037|P1|Overall Study|Lack of trial drug at site|0
804058|NCT00818623|2557030|P8|Overall Study|Need of additional treatment|0
804059|NCT00818623|2557031|P7|Overall Study|Need of additional treatment|0
804060|NCT00818623|2557032|P6|Overall Study|Need of additional treatment|0
804061|NCT00818623|2557033|P5|Overall Study|Need of additional treatment|1
804062|NCT00818623|2557034|P4|Overall Study|Need of additional treatment|0
804063|NCT00818623|2557035|P3|Overall Study|Need of additional treatment|0
804064|NCT00818623|2557036|P2|Overall Study|Need of additional treatment|0
804065|NCT00818623|2557037|P1|Overall Study|Need of additional treatment|0
804066|NCT00818623|2557030|P8|Overall Study|Protocol Violation|0
804067|NCT00818623|2557031|P7|Overall Study|Protocol Violation|1
804068|NCT00818623|2557032|P6|Overall Study|Protocol Violation|0
804069|NCT00818623|2557033|P5|Overall Study|Protocol Violation|1
804070|NCT00818623|2557034|P4|Overall Study|Protocol Violation|0
804071|NCT00818623|2557035|P3|Overall Study|Protocol Violation|0
804072|NCT00818623|2557036|P2|Overall Study|Protocol Violation|0
804073|NCT00818623|2557037|P1|Overall Study|Protocol Violation|1
804074|NCT00818623|2557030|P8|Overall Study|Withdrawal by Subject|1
804075|NCT00818623|2557031|P7|Overall Study|Withdrawal by Subject|1
804076|NCT00818623|2557032|P6|Overall Study|Withdrawal by Subject|1
804077|NCT00818623|2557033|P5|Overall Study|Withdrawal by Subject|0
804078|NCT00818623|2557034|P4|Overall Study|Withdrawal by Subject|0
804079|NCT00818623|2557035|P3|Overall Study|Withdrawal by Subject|1
804080|NCT00818623|2557036|P2|Overall Study|Withdrawal by Subject|1
804081|NCT00818623|2557037|P1|Overall Study|Withdrawal by Subject|0
804082|NCT00818623|2557030|P8|Overall Study|Bad prostate specific antigen response|0
804083|NCT00818623|2557031|P7|Overall Study|Bad prostate specific antigen response|0
804084|NCT00818623|2557032|P6|Overall Study|Bad prostate specific antigen response|1
804085|NCT00818623|2557033|P5|Overall Study|Bad prostate specific antigen response|0
804086|NCT00818623|2557034|P4|Overall Study|Bad prostate specific antigen response|5
804087|NCT00818623|2557035|P3|Overall Study|Bad prostate specific antigen response|2
804088|NCT00818623|2557036|P2|Overall Study|Bad prostate specific antigen response|3
804089|NCT00818623|2557037|P1|Overall Study|Bad prostate specific antigen response|0
804090|NCT00818623|2557030|P8|Overall Study|Adverse Event|0
804091|NCT00818623|2557031|P7|Overall Study|Adverse Event|0
804092|NCT00818623|2557032|P6|Overall Study|Adverse Event|1
804093|NCT00818623|2557033|P5|Overall Study|Adverse Event|0
804094|NCT00818623|2557034|P4|Overall Study|Adverse Event|0
804095|NCT00818623|2557035|P3|Overall Study|Adverse Event|1
804096|NCT00818623|2557036|P2|Overall Study|Adverse Event|0
804097|NCT00818623|2557037|P1|Overall Study|Adverse Event|1
804098|NCT00818649|2557111|P1|Overall Study|Adverse Event|1
804099|NCT00818649|2557111|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
804100|NCT00818649|2557111|P1|Overall Study|Declining performance status|2
804169|NCT00818753|2557213|P3|Overall Study|Randomised and not treated|0
804170|NCT00818753|2557214|P2|Overall Study|Randomised and not treated|0
804171|NCT00818753|2557215|P1|Overall Study|Randomised and not treated|2
804172|NCT00818753|2557213|P3|Overall Study|Other reason (not specified)|1
804173|NCT00818753|2557214|P2|Overall Study|Other reason (not specified)|0
804174|NCT00818753|2557215|P1|Overall Study|Other reason (not specified)|0
804175|NCT00818753|2557213|P3|Overall Study|Protocol Violation|0
804176|NCT00818753|2557214|P2|Overall Study|Protocol Violation|0
804177|NCT00818753|2557215|P1|Overall Study|Protocol Violation|1
804178|NCT00818766|2557237|P2|Overall Study|Did not Receive Allocated Intervention|0
804179|NCT00818766|2557238|P1|Overall Study|Did not Receive Allocated Intervention|3
804180|NCT00818766|2557237|P2|Overall Study|Death|0
804181|NCT00818766|2557238|P1|Overall Study|Death|1
804182|NCT00818766|2557237|P2|Overall Study|Could not be Contacted on Day 28|10
804183|NCT00818766|2557238|P1|Overall Study|Could not be Contacted on Day 28|11
804190|NCT00818883|2557286|P2|Overall Study|Other|7
804191|NCT00818883|2557287|P1|Overall Study|Other|2
804192|NCT00818883|2557286|P2|Overall Study|Lack of Efficacy|2
804193|NCT00818883|2557287|P1|Overall Study|Lack of Efficacy|0
804194|NCT00818883|2557286|P2|Overall Study|Withdrawal by Subject|14
804195|NCT00818883|2557287|P1|Overall Study|Withdrawal by Subject|16
804196|NCT00818883|2557286|P2|Overall Study|Lost to Follow-up|2
804197|NCT00818883|2557287|P1|Overall Study|Lost to Follow-up|3
804198|NCT00818883|2557286|P2|Overall Study|Protocol Violation|2
804199|NCT00818883|2557287|P1|Overall Study|Protocol Violation|2
804200|NCT00818883|2557286|P2|Overall Study|Adverse Event|19
804201|NCT00818883|2557287|P1|Overall Study|Adverse Event|28
804202|NCT00819013|2557339|P4|Overall Study|Death|1
804203|NCT00819013|2557340|P3|Overall Study|Death|0
804204|NCT00819013|2557341|P2|Overall Study|Death|0
804205|NCT00819013|2557342|P1|Overall Study|Death|0
804206|NCT00819013|2557339|P4|Overall Study|Lost to Follow-up|2
804207|NCT00819013|2557340|P3|Overall Study|Lost to Follow-up|1
804208|NCT00819013|2557341|P2|Overall Study|Lost to Follow-up|0
804209|NCT00819013|2557342|P1|Overall Study|Lost to Follow-up|0
804210|NCT00819013|2557339|P4|Overall Study|Withdrawal by Subject|0
804211|NCT00819013|2557340|P3|Overall Study|Withdrawal by Subject|1
804212|NCT00819013|2557341|P2|Overall Study|Withdrawal by Subject|0
804213|NCT00819013|2557342|P1|Overall Study|Withdrawal by Subject|1
804214|NCT00819013|2557339|P4|Overall Study|Adverse Event|0
804215|NCT00819013|2557340|P3|Overall Study|Adverse Event|1
804216|NCT00819013|2557341|P2|Overall Study|Adverse Event|0
804217|NCT00819013|2557342|P1|Overall Study|Adverse Event|0
804218|NCT00819013|2557339|P4|Overall Study|Not meeting continuing study eligibility|1
804219|NCT00819013|2557340|P3|Overall Study|Not meeting continuing study eligibility|2
804220|NCT00819013|2557341|P2|Overall Study|Not meeting continuing study eligibility|1
804221|NCT00819013|2557342|P1|Overall Study|Not meeting continuing study eligibility|2
804222|NCT00819039|2557395|P3|Overall Study|Protocol Violation|0
804223|NCT00819039|2557396|P2|Overall Study|Protocol Violation|0
804224|NCT00819039|2557397|P1|Overall Study|Protocol Violation|1
804225|NCT00819039|2557395|P3|Overall Study|Physician Decision|1
804226|NCT00819039|2557396|P2|Overall Study|Physician Decision|0
804227|NCT00819039|2557397|P1|Overall Study|Physician Decision|1
804228|NCT00819052|2557425|P2|Overall Study|Death or events leading to death|0
804229|NCT00819052|2557426|P1|Overall Study|Death or events leading to death|1
804230|NCT00819052|2557425|P2|Overall Study|Pregnancy|2
804231|NCT00819052|2557426|P1|Overall Study|Pregnancy|1
804232|NCT00819052|2557425|P2|Overall Study|Lack of Efficacy|1
804233|NCT00819052|2557426|P1|Overall Study|Lack of Efficacy|1
804234|NCT00819052|2557425|P2|Overall Study|Withdrawal by Subject|2
804235|NCT00819052|2557426|P1|Overall Study|Withdrawal by Subject|1
804236|NCT00819052|2557425|P2|Overall Study|Lost to Follow-up|2
804237|NCT00819052|2557426|P1|Overall Study|Lost to Follow-up|1
804238|NCT00819052|2557425|P2|Overall Study|Protocol Violation|2
804239|NCT00819052|2557426|P1|Overall Study|Protocol Violation|1
804240|NCT00819052|2557425|P2|Overall Study|Adverse Event|5
804241|NCT00819052|2557426|P1|Overall Study|Adverse Event|0
804242|NCT00819091|2557540|P2|Overall Study|Not Specified|2
804243|NCT00819091|2557541|P1|Overall Study|Not Specified|1
804244|NCT00819091|2557540|P2|Overall Study|Withdrawal by Subject|2
804245|NCT00819091|2557541|P1|Overall Study|Withdrawal by Subject|1
804246|NCT00819091|2557540|P2|Overall Study|Lost to Follow-up|0
804247|NCT00819091|2557541|P1|Overall Study|Lost to Follow-up|2
804248|NCT00819091|2557540|P2|Overall Study|Protocol Violation|1
804249|NCT00819091|2557541|P1|Overall Study|Protocol Violation|0
804250|NCT00819091|2557540|P2|Overall Study|Adverse Event|5
804251|NCT00819091|2557541|P1|Overall Study|Adverse Event|3
804252|NCT00819156|2557571|P6|Overall Study|Prostate-specific antigen progression|0
804253|NCT00819156|2557572|P5|Overall Study|Prostate-specific antigen progression|1
804254|NCT00819156|2557573|P4|Overall Study|Prostate-specific antigen progression|0
804255|NCT00819156|2557574|P3|Overall Study|Prostate-specific antigen progression|0
804256|NCT00819156|2557575|P2|Overall Study|Prostate-specific antigen progression|0
804257|NCT00819156|2557576|P1|Overall Study|Prostate-specific antigen progression|0
804258|NCT00819156|2557571|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
804259|NCT00819156|2557572|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
804260|NCT00819156|2557573|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
804261|NCT00819156|2557574|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
804262|NCT00819156|2557575|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
804263|NCT00819156|2557576|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
804264|NCT00819156|2557571|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
804265|NCT00819156|2557572|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
804266|NCT00819156|2557573|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
804267|NCT00819156|2557574|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
804268|NCT00819156|2557575|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
804269|NCT00819156|2557576|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
804270|NCT00819156|2557571|P6|Overall Study|Lost to Follow-up|2
804271|NCT00819156|2557572|P5|Overall Study|Lost to Follow-up|0
804272|NCT00819156|2557573|P4|Overall Study|Lost to Follow-up|0
804273|NCT00819156|2557574|P3|Overall Study|Lost to Follow-up|0
804274|NCT00819156|2557575|P2|Overall Study|Lost to Follow-up|1
804275|NCT00819156|2557576|P1|Overall Study|Lost to Follow-up|0
804276|NCT00819156|2557571|P6|Overall Study|Protocol Violation|1
804277|NCT00819156|2557572|P5|Overall Study|Protocol Violation|0
804278|NCT00819156|2557573|P4|Overall Study|Protocol Violation|0
804279|NCT00819156|2557574|P3|Overall Study|Protocol Violation|1
804280|NCT00819156|2557575|P2|Overall Study|Protocol Violation|0
804281|NCT00819156|2557576|P1|Overall Study|Protocol Violation|1
804282|NCT00819156|2557571|P6|Overall Study|Withdrawal by Subject|0
804283|NCT00819156|2557572|P5|Overall Study|Withdrawal by Subject|1
804284|NCT00819156|2557573|P4|Overall Study|Withdrawal by Subject|0
804285|NCT00819156|2557574|P3|Overall Study|Withdrawal by Subject|2
804286|NCT00819156|2557575|P2|Overall Study|Withdrawal by Subject|3
804287|NCT00819156|2557576|P1|Overall Study|Withdrawal by Subject|0
804288|NCT00819156|2557571|P6|Overall Study|Adverse Event|3
804289|NCT00819156|2557572|P5|Overall Study|Adverse Event|2
804290|NCT00819156|2557573|P4|Overall Study|Adverse Event|1
804291|NCT00819156|2557574|P3|Overall Study|Adverse Event|2
804292|NCT00819156|2557575|P2|Overall Study|Adverse Event|4
804293|NCT00819156|2557576|P1|Overall Study|Adverse Event|1
804294|NCT00819234|2557699|P10|Overall Study|Lost to Follow-up|2
804295|NCT00819234|2557700|P9|Overall Study|Lost to Follow-up|1
804296|NCT00819234|2557701|P8|Overall Study|Lost to Follow-up|1
804297|NCT00819234|2557702|P7|Overall Study|Lost to Follow-up|1
804298|NCT00819234|2557703|P6|Overall Study|Lost to Follow-up|1
804299|NCT00819234|2557704|P5|Overall Study|Lost to Follow-up|1
804300|NCT00819234|2557705|P4|Overall Study|Lost to Follow-up|2
804301|NCT00819234|2557706|P3|Overall Study|Lost to Follow-up|0
804302|NCT00819234|2557707|P2|Overall Study|Lost to Follow-up|2
804303|NCT00819234|2557708|P1|Overall Study|Lost to Follow-up|2
804304|NCT00819234|2557699|P10|Overall Study|Protocol Violation|0
804305|NCT00819234|2557700|P9|Overall Study|Protocol Violation|0
804306|NCT00819234|2557701|P8|Overall Study|Protocol Violation|0
804307|NCT00819234|2557702|P7|Overall Study|Protocol Violation|0
804308|NCT00819234|2557703|P6|Overall Study|Protocol Violation|0
804309|NCT00819234|2557704|P5|Overall Study|Protocol Violation|0
804310|NCT00819234|2557705|P4|Overall Study|Protocol Violation|0
804311|NCT00819234|2557706|P3|Overall Study|Protocol Violation|1
804312|NCT00819234|2557707|P2|Overall Study|Protocol Violation|0
804313|NCT00819234|2557708|P1|Overall Study|Protocol Violation|0
804314|NCT00819234|2557699|P10|Overall Study|Physician Decision|2
804315|NCT00819234|2557700|P9|Overall Study|Physician Decision|0
804316|NCT00819234|2557701|P8|Overall Study|Physician Decision|0
804317|NCT00819234|2557702|P7|Overall Study|Physician Decision|0
804318|NCT00819234|2557703|P6|Overall Study|Physician Decision|0
804319|NCT00819234|2557704|P5|Overall Study|Physician Decision|0
804320|NCT00819234|2557705|P4|Overall Study|Physician Decision|1
804321|NCT00819234|2557706|P3|Overall Study|Physician Decision|0
804322|NCT00819234|2557707|P2|Overall Study|Physician Decision|0
804323|NCT00819234|2557708|P1|Overall Study|Physician Decision|0
804324|NCT00819234|2557699|P10|Overall Study|Adverse Event|0
804325|NCT00819234|2557700|P9|Overall Study|Adverse Event|0
804326|NCT00819234|2557701|P8|Overall Study|Adverse Event|0
804327|NCT00819234|2557702|P7|Overall Study|Adverse Event|0
804328|NCT00819234|2557703|P6|Overall Study|Adverse Event|2
804329|NCT00819234|2557704|P5|Overall Study|Adverse Event|0
804330|NCT00819234|2557705|P4|Overall Study|Adverse Event|0
804331|NCT00819234|2557706|P3|Overall Study|Adverse Event|1
804332|NCT00819234|2557707|P2|Overall Study|Adverse Event|0
804333|NCT00819234|2557708|P1|Overall Study|Adverse Event|0
804334|NCT00819234|2557699|P10|Overall Study|Withdrawal by Subject|3
804335|NCT00819234|2557700|P9|Overall Study|Withdrawal by Subject|5
804336|NCT00819234|2557701|P8|Overall Study|Withdrawal by Subject|8
804337|NCT00819234|2557702|P7|Overall Study|Withdrawal by Subject|4
804338|NCT00819234|2557703|P6|Overall Study|Withdrawal by Subject|4
804339|NCT00819234|2557704|P5|Overall Study|Withdrawal by Subject|0
804340|NCT00819234|2557705|P4|Overall Study|Withdrawal by Subject|3
804341|NCT00819234|2557706|P3|Overall Study|Withdrawal by Subject|6
804342|NCT00819234|2557707|P2|Overall Study|Withdrawal by Subject|13
804343|NCT00819234|2557708|P1|Overall Study|Withdrawal by Subject|8
804344|NCT00819247|2557869|P3|Overall Study|not specified|0
804345|NCT00819247|2557870|P2|Overall Study|not specified|0
804346|NCT00819247|2557871|P1|Overall Study|not specified|1
804347|NCT00819247|2557869|P3|Overall Study|Bad prostate-specific antigen response|0
804348|NCT00819247|2557870|P2|Overall Study|Bad prostate-specific antigen response|2
804349|NCT00819247|2557871|P1|Overall Study|Bad prostate-specific antigen response|3
804350|NCT00819247|2557869|P3|Overall Study|Mistakenly withdrawn|0
804351|NCT00819247|2557870|P2|Overall Study|Mistakenly withdrawn|1
804352|NCT00819247|2557871|P1|Overall Study|Mistakenly withdrawn|0
804353|NCT00819247|2557869|P3|Overall Study|Protocol Violation|1
804354|NCT00819247|2557870|P2|Overall Study|Protocol Violation|0
804355|NCT00819247|2557871|P1|Overall Study|Protocol Violation|1
804356|NCT00819247|2557869|P3|Overall Study|Withdrawal by Subject|0
804357|NCT00819247|2557870|P2|Overall Study|Withdrawal by Subject|0
804358|NCT00819247|2557871|P1|Overall Study|Withdrawal by Subject|1
804359|NCT00819247|2557869|P3|Overall Study|Insufficient testosterone response|10
804360|NCT00819247|2557870|P2|Overall Study|Insufficient testosterone response|8
804361|NCT00819247|2557871|P1|Overall Study|Insufficient testosterone response|5
804362|NCT00819247|2557869|P3|Overall Study|Adverse Event|3
804363|NCT00819247|2557870|P2|Overall Study|Adverse Event|5
804364|NCT00819247|2557871|P1|Overall Study|Adverse Event|0
804377|NCT00819585|2558060|P7|Overall Study|Protocol Violation|3
804378|NCT00819585|2558061|P6|Overall Study|Protocol Violation|1
804379|NCT00819585|2558062|P5|Overall Study|Protocol Violation|0
804380|NCT00819585|2558063|P4|Overall Study|Protocol Violation|0
804381|NCT00819585|2558064|P3|Overall Study|Protocol Violation|1
804382|NCT00819585|2558065|P2|Overall Study|Protocol Violation|0
804383|NCT00819585|2558066|P1|Overall Study|Protocol Violation|0
804384|NCT00819585|2558060|P7|Overall Study|Death|1
804385|NCT00819585|2558061|P6|Overall Study|Death|0
804386|NCT00819585|2558062|P5|Overall Study|Death|0
804387|NCT00819585|2558063|P4|Overall Study|Death|0
804388|NCT00819585|2558064|P3|Overall Study|Death|0
804389|NCT00819585|2558065|P2|Overall Study|Death|0
804390|NCT00819585|2558066|P1|Overall Study|Death|0
804391|NCT00819585|2558060|P7|Overall Study|Administrative problems|2
804392|NCT00819585|2558061|P6|Overall Study|Administrative problems|0
804393|NCT00819585|2558062|P5|Overall Study|Administrative problems|0
804394|NCT00819585|2558063|P4|Overall Study|Administrative problems|0
804395|NCT00819585|2558064|P3|Overall Study|Administrative problems|0
804396|NCT00819585|2558065|P2|Overall Study|Administrative problems|0
804397|NCT00819585|2558066|P1|Overall Study|Administrative problems|0
804398|NCT00819585|2558060|P7|Overall Study|Lost to Follow-up|1
804399|NCT00819585|2558061|P6|Overall Study|Lost to Follow-up|1
804400|NCT00819585|2558062|P5|Overall Study|Lost to Follow-up|1
804401|NCT00819585|2558063|P4|Overall Study|Lost to Follow-up|0
804402|NCT00819585|2558064|P3|Overall Study|Lost to Follow-up|2
804403|NCT00819585|2558065|P2|Overall Study|Lost to Follow-up|1
804404|NCT00819585|2558066|P1|Overall Study|Lost to Follow-up|2
804405|NCT00819585|2558060|P7|Overall Study|Subject withdrew consent|3
804406|NCT00819585|2558061|P6|Overall Study|Subject withdrew consent|0
804407|NCT00819585|2558062|P5|Overall Study|Subject withdrew consent|0
804408|NCT00819585|2558063|P4|Overall Study|Subject withdrew consent|1
804409|NCT00819585|2558064|P3|Overall Study|Subject withdrew consent|2
804410|NCT00819585|2558065|P2|Overall Study|Subject withdrew consent|3
804411|NCT00819585|2558066|P1|Overall Study|Subject withdrew consent|0
804412|NCT00819585|2558060|P7|Overall Study|Subject no longer requires study drug|0
804413|NCT00819585|2558061|P6|Overall Study|Subject no longer requires study drug|0
804414|NCT00819585|2558062|P5|Overall Study|Subject no longer requires study drug|1
804415|NCT00819585|2558063|P4|Overall Study|Subject no longer requires study drug|0
804416|NCT00819585|2558064|P3|Overall Study|Subject no longer requires study drug|0
804417|NCT00819585|2558065|P2|Overall Study|Subject no longer requires study drug|0
804418|NCT00819585|2558066|P1|Overall Study|Subject no longer requires study drug|0
804419|NCT00819585|2558060|P7|Overall Study|Unsatisfactory therapeutic effect|1
804420|NCT00819585|2558061|P6|Overall Study|Unsatisfactory therapeutic effect|0
804421|NCT00819585|2558062|P5|Overall Study|Unsatisfactory therapeutic effect|0
804422|NCT00819585|2558063|P4|Overall Study|Unsatisfactory therapeutic effect|0
804423|NCT00819585|2558064|P3|Overall Study|Unsatisfactory therapeutic effect|0
804424|NCT00819585|2558065|P2|Overall Study|Unsatisfactory therapeutic effect|1
804425|NCT00819585|2558066|P1|Overall Study|Unsatisfactory therapeutic effect|0
804426|NCT00819585|2558060|P7|Overall Study|Abnormal laboratory value(s)|0
804427|NCT00819585|2558061|P6|Overall Study|Abnormal laboratory value(s)|0
804428|NCT00819585|2558062|P5|Overall Study|Abnormal laboratory value(s)|0
804429|NCT00819585|2558063|P4|Overall Study|Abnormal laboratory value(s)|0
804430|NCT00819585|2558064|P3|Overall Study|Abnormal laboratory value(s)|0
804431|NCT00819585|2558065|P2|Overall Study|Abnormal laboratory value(s)|0
804432|NCT00819585|2558066|P1|Overall Study|Abnormal laboratory value(s)|2
804433|NCT00819585|2558060|P7|Overall Study|Adverse Event|2
804434|NCT00819585|2558061|P6|Overall Study|Adverse Event|0
804435|NCT00819585|2558062|P5|Overall Study|Adverse Event|1
804436|NCT00819585|2558063|P4|Overall Study|Adverse Event|4
804437|NCT00819585|2558064|P3|Overall Study|Adverse Event|1
804438|NCT00819585|2558065|P2|Overall Study|Adverse Event|1
804439|NCT00819585|2558066|P1|Overall Study|Adverse Event|2
804440|NCT00819741|2558138|P2|Overall Study|Reasons unknown|3
804441|NCT00819741|2558139|P1|Overall Study|Reasons unknown|3
804442|NCT00819741|2558138|P2|Overall Study|Unclassified|0
804443|NCT00819741|2558139|P1|Overall Study|Unclassified|6
804444|NCT00819741|2558138|P2|Overall Study|Withdrawal by Subject|2
804445|NCT00819741|2558139|P1|Overall Study|Withdrawal by Subject|2
804446|NCT00819741|2558138|P2|Overall Study|Protocol Violation|4
804447|NCT00819741|2558139|P1|Overall Study|Protocol Violation|3
804448|NCT00819741|2558138|P2|Overall Study|Lost to Follow-up|1
804449|NCT00819741|2558139|P1|Overall Study|Lost to Follow-up|3
804450|NCT00819741|2558138|P2|Overall Study|Lack of Efficacy|2
804451|NCT00819741|2558139|P1|Overall Study|Lack of Efficacy|0
804452|NCT00819741|2558138|P2|Overall Study|Adverse Event|2
804453|NCT00819741|2558139|P1|Overall Study|Adverse Event|5
804454|NCT00819767|2558175|P2|Overall Study|Unsatisfactory therapeutic effect|2
804455|NCT00819767|2558176|P1|Overall Study|Unsatisfactory therapeutic effect|1
804460|NCT00819832|2558227|P6|Overall Study|Sponsor Termination of Study|0
804461|NCT00819832|2558228|P5|Overall Study|Sponsor Termination of Study|0
804462|NCT00819832|2558229|P4|Overall Study|Sponsor Termination of Study|0
804463|NCT00819832|2558230|P3|Overall Study|Sponsor Termination of Study|0
804464|NCT00819832|2558231|P2|Overall Study|Sponsor Termination of Study|0
804465|NCT00819832|2558232|P1|Overall Study|Sponsor Termination of Study|3
804466|NCT00819910|2558250|P4|Overall Study|Lost to Follow-up|0
804467|NCT00819910|2558251|P3|Overall Study|Lost to Follow-up|0
804468|NCT00819910|2558252|P2|Overall Study|Lost to Follow-up|0
804469|NCT00819910|2558253|P1|Overall Study|Lost to Follow-up|1
804470|NCT00819910|2558250|P4|Overall Study|Withdrawal by Subject|0
804471|NCT00819910|2558251|P3|Overall Study|Withdrawal by Subject|1
804472|NCT00819910|2558252|P2|Overall Study|Withdrawal by Subject|1
804473|NCT00819910|2558253|P1|Overall Study|Withdrawal by Subject|1
804474|NCT00819910|2558250|P4|Overall Study|Adverse Event|1
804475|NCT00819910|2558251|P3|Overall Study|Adverse Event|2
804476|NCT00819910|2558252|P2|Overall Study|Adverse Event|0
804477|NCT00819910|2558253|P1|Overall Study|Adverse Event|0
804478|NCT00820222|2558281|P2|Overall Study|Ongoing|191
804479|NCT00820222|2558282|P1|Overall Study|Ongoing|185
804480|NCT00820222|2558281|P2|Overall Study|Sponsor Terminated Study|1
804481|NCT00820222|2558282|P1|Overall Study|Sponsor Terminated Study|0
804482|NCT00820222|2558281|P2|Overall Study|Physician Decision|6
804483|NCT00820222|2558282|P1|Overall Study|Physician Decision|4
804484|NCT00820222|2558281|P2|Overall Study|Withdrawal by Subject|9
804485|NCT00820222|2558282|P1|Overall Study|Withdrawal by Subject|8
804486|NCT00820222|2558281|P2|Overall Study|Lost to Follow-up|4
804487|NCT00820222|2558282|P1|Overall Study|Lost to Follow-up|4
804488|NCT00820248|2558310|P2|Overall Study|No treated|1
804489|NCT00820248|2558311|P1|Overall Study|No treated|4
804490|NCT00820755|2558389|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
804491|NCT00820755|2558390|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
804492|NCT00820755|2558391|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
804493|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Unspecified|0
804494|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Unspecified|0
804495|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Unspecified|11
804496|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
804497|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
804498|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
804499|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Progressive disease|0
804500|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Progressive disease|0
804501|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Progressive disease|114
804502|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
804503|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
804504|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
804505|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
804506|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
804507|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
804508|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
804509|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
804510|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
804511|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Death|0
804512|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Death|0
804513|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Death|28
804514|NCT00820755|2558389|P3|Period 1: Combination Therapy Phase|Adverse Event|0
804515|NCT00820755|2558390|P2|Period 1: Combination Therapy Phase|Adverse Event|0
804516|NCT00820755|2558391|P1|Period 1: Combination Therapy Phase|Adverse Event|77
804517|NCT00797667|2558419|P3|Overall Study|Adverse Event|8
804518|NCT00797667|2558420|P2|Overall Study|Adverse Event|8
804519|NCT00797667|2558421|P1|Overall Study|Adverse Event|19
804520|NCT00797667|2558419|P3|Overall Study|Withdrawal by Subject|2
804521|NCT00797667|2558420|P2|Overall Study|Withdrawal by Subject|14
804522|NCT00797667|2558421|P1|Overall Study|Withdrawal by Subject|9
804523|NCT00797667|2558419|P3|Overall Study|Study Terminated by Sponsor|115
804524|NCT00797667|2558420|P2|Overall Study|Study Terminated by Sponsor|216
804525|NCT00797667|2558421|P1|Overall Study|Study Terminated by Sponsor|217
804526|NCT00797667|2558419|P3|Overall Study|Protocol Violation|0
804527|NCT00797667|2558420|P2|Overall Study|Protocol Violation|7
804528|NCT00797667|2558421|P1|Overall Study|Protocol Violation|2
804529|NCT00797667|2558419|P3|Overall Study|Pregnancy|0
804530|NCT00797667|2558420|P2|Overall Study|Pregnancy|0
804531|NCT00797667|2558421|P1|Overall Study|Pregnancy|2
804532|NCT00797667|2558419|P3|Overall Study|Physician Decision|0
804533|NCT00797667|2558420|P2|Overall Study|Physician Decision|1
804534|NCT00797667|2558421|P1|Overall Study|Physician Decision|3
804535|NCT00797667|2558419|P3|Overall Study|Lost to Follow-up|2
804536|NCT00797667|2558420|P2|Overall Study|Lost to Follow-up|12
804537|NCT00797667|2558421|P1|Overall Study|Lost to Follow-up|8
804538|NCT00797667|2558419|P3|Overall Study|Lack of Efficacy|0
804539|NCT00797667|2558420|P2|Overall Study|Lack of Efficacy|1
804540|NCT00797667|2558421|P1|Overall Study|Lack of Efficacy|0
804541|NCT00797823|2558461|P3|First Period (Initial Randomization)|Physician Decision|0
804542|NCT00797823|2558462|P2|First Period (Initial Randomization)|Physician Decision|0
804543|NCT00797823|2558463|P1|First Period (Initial Randomization)|Physician Decision|1
804544|NCT00797862|2558475|P3|Overall Study|Mis-randomized|1
804545|NCT00797862|2558476|P2|Overall Study|Mis-randomized|3
804546|NCT00797862|2558477|P1|Overall Study|Mis-randomized|3
804547|NCT00797862|2558475|P3|Overall Study|Protocol Violation|8
804548|NCT00797862|2558476|P2|Overall Study|Protocol Violation|6
804549|NCT00797862|2558477|P1|Overall Study|Protocol Violation|4
804550|NCT00797862|2558475|P3|Overall Study|Administrative Problem|0
804551|NCT00797862|2558476|P2|Overall Study|Administrative Problem|0
804552|NCT00797862|2558477|P1|Overall Study|Administrative Problem|4
804553|NCT00797862|2558475|P3|Overall Study|Lost to Follow-up|5
804554|NCT00797862|2558476|P2|Overall Study|Lost to Follow-up|0
804555|NCT00797862|2558477|P1|Overall Study|Lost to Follow-up|11
804556|NCT00797862|2558475|P3|Overall Study|Withdrawal by Subject|7
804557|NCT00797862|2558476|P2|Overall Study|Withdrawal by Subject|7
804558|NCT00797862|2558477|P1|Overall Study|Withdrawal by Subject|14
804559|NCT00797862|2558475|P3|Overall Study|No longer required study medication|0
804560|NCT00797862|2558476|P2|Overall Study|No longer required study medication|0
804561|NCT00797862|2558477|P1|Overall Study|No longer required study medication|1
804562|NCT00797862|2558475|P3|Overall Study|Lack of Efficacy|6
804563|NCT00797862|2558476|P2|Overall Study|Lack of Efficacy|7
804564|NCT00797862|2558477|P1|Overall Study|Lack of Efficacy|1
804565|NCT00797862|2558475|P3|Overall Study|Abnormal Test Procedure Result|1
804566|NCT00797862|2558476|P2|Overall Study|Abnormal Test Procedure Result|1
804567|NCT00797862|2558477|P1|Overall Study|Abnormal Test Procedure Result|0
804568|NCT00797862|2558475|P3|Overall Study|Adverse Event|58
804569|NCT00797862|2558476|P2|Overall Study|Adverse Event|44
804570|NCT00797862|2558477|P1|Overall Study|Adverse Event|86
804571|NCT00797966|2558507|P6|Phase A+|Protocol deviation|4
804572|NCT00797966|2558508|P5|Phase A+|Protocol deviation|0
804573|NCT00797966|2558509|P4|Phase A+|Protocol deviation|0
804574|NCT00797966|2558510|P3|Phase A+|Protocol deviation|0
804575|NCT00797966|2558511|P2|Phase A+|Protocol deviation|0
804576|NCT00797966|2558512|P1|Phase A+|Protocol deviation|0
804577|NCT00797966|2558507|P6|Phase A+|Adverse Event|4
804578|NCT00797966|2558508|P5|Phase A+|Adverse Event|0
804579|NCT00797966|2558509|P4|Phase A+|Adverse Event|0
804580|NCT00797966|2558510|P3|Phase A+|Adverse Event|0
804581|NCT00797966|2558511|P2|Phase A+|Adverse Event|0
804582|NCT00797966|2558512|P1|Phase A+|Adverse Event|0
804583|NCT00797966|2558507|P6|Phase A+|Withdrawal by Subject|6
804584|NCT00797966|2558508|P5|Phase A+|Withdrawal by Subject|0
804585|NCT00797966|2558509|P4|Phase A+|Withdrawal by Subject|0
804586|NCT00797966|2558510|P3|Phase A+|Withdrawal by Subject|0
804587|NCT00797966|2558511|P2|Phase A+|Withdrawal by Subject|0
804588|NCT00797966|2558512|P1|Phase A+|Withdrawal by Subject|0
804589|NCT00797966|2558507|P6|Phase A+|Met withdrawal criteria|5
804590|NCT00797966|2558508|P5|Phase A+|Met withdrawal criteria|0
804591|NCT00797966|2558509|P4|Phase A+|Met withdrawal criteria|0
804592|NCT00797966|2558510|P3|Phase A+|Met withdrawal criteria|0
804593|NCT00797966|2558511|P2|Phase A+|Met withdrawal criteria|0
804594|NCT00797966|2558512|P1|Phase A+|Met withdrawal criteria|0
804595|NCT00797966|2558507|P6|Phase A+|Lost to Follow-up|9
804596|NCT00797966|2558508|P5|Phase A+|Lost to Follow-up|0
804597|NCT00797966|2558509|P4|Phase A+|Lost to Follow-up|0
804598|NCT00797966|2558510|P3|Phase A+|Lost to Follow-up|0
804599|NCT00797966|2558511|P2|Phase A+|Lost to Follow-up|0
804600|NCT00797966|2558512|P1|Phase A+|Lost to Follow-up|0
804601|NCT00797966|2558507|P6|Phase B|Lack of Efficacy|0
804602|NCT00797966|2558508|P5|Phase B|Lack of Efficacy|0
804603|NCT00797966|2558509|P4|Phase B|Lack of Efficacy|4
804604|NCT00797966|2558510|P3|Phase B|Lack of Efficacy|1
804605|NCT00797966|2558511|P2|Phase B|Lack of Efficacy|1
804606|NCT00797966|2558512|P1|Phase B|Lack of Efficacy|0
804607|NCT00797966|2558507|P6|Phase B|Protocol Deviation|0
804608|NCT00797966|2558508|P5|Phase B|Protocol Deviation|0
804609|NCT00797966|2558509|P4|Phase B|Protocol Deviation|6
804610|NCT00797966|2558510|P3|Phase B|Protocol Deviation|2
804611|NCT00797966|2558511|P2|Phase B|Protocol Deviation|8
804612|NCT00797966|2558512|P1|Phase B|Protocol Deviation|4
804613|NCT00797966|2558507|P6|Phase B|Withdrawal by Subject|0
804614|NCT00797966|2558508|P5|Phase B|Withdrawal by Subject|0
804615|NCT00797966|2558509|P4|Phase B|Withdrawal by Subject|3
804616|NCT00797966|2558510|P3|Phase B|Withdrawal by Subject|3
804617|NCT00797966|2558511|P2|Phase B|Withdrawal by Subject|4
804618|NCT00797966|2558512|P1|Phase B|Withdrawal by Subject|1
804619|NCT00797966|2558507|P6|Phase B|Physician Decision|0
804620|NCT00797966|2558508|P5|Phase B|Physician Decision|0
804621|NCT00797966|2558509|P4|Phase B|Physician Decision|1
804622|NCT00797966|2558510|P3|Phase B|Physician Decision|3
804623|NCT00797966|2558511|P2|Phase B|Physician Decision|0
804624|NCT00797966|2558512|P1|Phase B|Physician Decision|1
804625|NCT00797966|2558507|P6|Phase B|Met Withdrawal Criteria|0
804626|NCT00797966|2558508|P5|Phase B|Met Withdrawal Criteria|0
804627|NCT00797966|2558509|P4|Phase B|Met Withdrawal Criteria|1
804628|NCT00797966|2558510|P3|Phase B|Met Withdrawal Criteria|6
804629|NCT00797966|2558511|P2|Phase B|Met Withdrawal Criteria|3
804630|NCT00797966|2558512|P1|Phase B|Met Withdrawal Criteria|3
804631|NCT00797966|2558507|P6|Phase B|Adverse Event|0
804632|NCT00797966|2558508|P5|Phase B|Adverse Event|0
804633|NCT00797966|2558509|P4|Phase B|Adverse Event|1
804634|NCT00797966|2558510|P3|Phase B|Adverse Event|3
804635|NCT00797966|2558511|P2|Phase B|Adverse Event|1
804636|NCT00797966|2558512|P1|Phase B|Adverse Event|2
804637|NCT00797966|2558507|P6|Phase B|Lost to Follow-up|0
804638|NCT00797966|2558508|P5|Phase B|Lost to Follow-up|0
804639|NCT00797966|2558509|P4|Phase B|Lost to Follow-up|0
804640|NCT00797966|2558510|P3|Phase B|Lost to Follow-up|3
804641|NCT00797966|2558511|P2|Phase B|Lost to Follow-up|1
804642|NCT00797966|2558512|P1|Phase B|Lost to Follow-up|0
804643|NCT00797966|2558507|P6|Phase A|Protocol deviation|0
804644|NCT00797966|2558508|P5|Phase A|Protocol deviation|56
804645|NCT00797966|2558509|P4|Phase A|Protocol deviation|0
804646|NCT00797966|2558510|P3|Phase A|Protocol deviation|0
804647|NCT00797966|2558511|P2|Phase A|Protocol deviation|0
804648|NCT00797966|2558512|P1|Phase A|Protocol deviation|0
804649|NCT00797966|2558507|P6|Phase A|Withdrawal by Subject|0
804650|NCT00797966|2558508|P5|Phase A|Withdrawal by Subject|33
804651|NCT00797966|2558509|P4|Phase A|Withdrawal by Subject|0
804652|NCT00797966|2558510|P3|Phase A|Withdrawal by Subject|0
804653|NCT00797966|2558511|P2|Phase A|Withdrawal by Subject|0
804654|NCT00797966|2558512|P1|Phase A|Withdrawal by Subject|0
804655|NCT00797966|2558507|P6|Phase A|Physician Decision|0
804656|NCT00797966|2558508|P5|Phase A|Physician Decision|13
804657|NCT00797966|2558509|P4|Phase A|Physician Decision|0
804658|NCT00797966|2558510|P3|Phase A|Physician Decision|0
804659|NCT00797966|2558511|P2|Phase A|Physician Decision|0
804660|NCT00797966|2558512|P1|Phase A|Physician Decision|0
804661|NCT00797966|2558507|P6|Phase A|Met withdrawal criteria|0
804662|NCT00797966|2558508|P5|Phase A|Met withdrawal criteria|4
804663|NCT00797966|2558509|P4|Phase A|Met withdrawal criteria|0
804664|NCT00797966|2558510|P3|Phase A|Met withdrawal criteria|0
804665|NCT00797966|2558511|P2|Phase A|Met withdrawal criteria|0
804666|NCT00797966|2558512|P1|Phase A|Met withdrawal criteria|0
804667|NCT00797966|2558507|P6|Phase A|Adverse Event|0
804668|NCT00797966|2558508|P5|Phase A|Adverse Event|46
804669|NCT00797966|2558509|P4|Phase A|Adverse Event|0
804670|NCT00797966|2558510|P3|Phase A|Adverse Event|0
804671|NCT00797966|2558511|P2|Phase A|Adverse Event|0
804672|NCT00797966|2558512|P1|Phase A|Adverse Event|0
804673|NCT00797966|2558507|P6|Phase A|Lost to Follow-up|0
804674|NCT00797966|2558508|P5|Phase A|Lost to Follow-up|33
804675|NCT00797966|2558509|P4|Phase A|Lost to Follow-up|0
804676|NCT00797966|2558510|P3|Phase A|Lost to Follow-up|0
804677|NCT00797966|2558511|P2|Phase A|Lost to Follow-up|0
804678|NCT00797966|2558512|P1|Phase A|Lost to Follow-up|0
804679|NCT00814164|2558612|P1|Overall Study|Death|5
804680|NCT00814164|2558612|P1|Overall Study|not stated|7
804681|NCT00814164|2558612|P1|Overall Study|Progression|7
804682|NCT00814307|2558661|P4|Overall Study|Death|0
804683|NCT00814307|2558662|P3|Overall Study|Death|0
804684|NCT00814307|2558663|P2|Overall Study|Death|1
804685|NCT00814307|2558664|P1|Overall Study|Death|0
804686|NCT00814307|2558661|P4|Overall Study|Withdrawal by Subject|2
804687|NCT00814307|2558662|P3|Overall Study|Withdrawal by Subject|0
804688|NCT00814307|2558663|P2|Overall Study|Withdrawal by Subject|6
804689|NCT00814307|2558664|P1|Overall Study|Withdrawal by Subject|4
804690|NCT00814307|2558661|P4|Overall Study|Protocol Violation|1
804691|NCT00814307|2558662|P3|Overall Study|Protocol Violation|1
804692|NCT00814307|2558663|P2|Overall Study|Protocol Violation|8
804693|NCT00814307|2558664|P1|Overall Study|Protocol Violation|2
804694|NCT00814307|2558661|P4|Overall Study|Unspecified|1
804695|NCT00814307|2558662|P3|Overall Study|Unspecified|0
804696|NCT00814307|2558663|P2|Overall Study|Unspecified|2
804697|NCT00814307|2558664|P1|Overall Study|Unspecified|1
804698|NCT00814307|2558661|P4|Overall Study|Lack of Efficacy|4
804699|NCT00814307|2558662|P3|Overall Study|Lack of Efficacy|3
804700|NCT00814307|2558663|P2|Overall Study|Lack of Efficacy|1
804701|NCT00814307|2558664|P1|Overall Study|Lack of Efficacy|1
804702|NCT00814307|2558661|P4|Overall Study|Adverse Event|2
804703|NCT00814307|2558662|P3|Overall Study|Adverse Event|3
804704|NCT00814307|2558663|P2|Overall Study|Adverse Event|9
804705|NCT00814307|2558664|P1|Overall Study|Adverse Event|3
804706|NCT00814307|2558661|P4|Overall Study|Randomized but not treated|0
804707|NCT00814307|2558662|P3|Overall Study|Randomized but not treated|0
804708|NCT00814307|2558663|P2|Overall Study|Randomized but not treated|0
804709|NCT00814307|2558664|P1|Overall Study|Randomized but not treated|1
804730|NCT00814333|2558959|P2|Enrollment|Lost to Follow-up|0
804731|NCT00814333|2558960|P1|Enrollment|Lost to Follow-up|1
804732|NCT00814346|2558968|P2|Open Phase (17 Months)|Not otherwise specified|0
804733|NCT00814346|2558969|P1|Open Phase (17 Months)|Not otherwise specified|1
804734|NCT00814346|2558968|P2|Open Phase (17 Months)|Lost to Follow-up|0
804735|NCT00814346|2558969|P1|Open Phase (17 Months)|Lost to Follow-up|2
804736|NCT00814346|2558968|P2|Open Phase (17 Months)|Consent|0
804737|NCT00814346|2558969|P1|Open Phase (17 Months)|Consent|2
804738|NCT00814346|2558968|P2|Open Phase (17 Months)|Adverse Event|0
804739|NCT00814346|2558969|P1|Open Phase (17 Months)|Adverse Event|5
804740|NCT00814346|2558968|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
804741|NCT00814346|2558969|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
804742|NCT00814346|2558968|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
804743|NCT00814346|2558969|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
804744|NCT00814463|2559033|P1|Overall Study|Lost to Follow-up|1
804745|NCT00814489|2559040|P3|Overall Study|Unspecified|1
804746|NCT00814489|2559041|P2|Overall Study|Unspecified|0
804747|NCT00814489|2559042|P1|Overall Study|Unspecified|2
804748|NCT00814502|2559076|P2|Overall Study|Withdrawal by Subject|2
804749|NCT00814502|2559077|P1|Overall Study|Withdrawal by Subject|0
804750|NCT00814502|2559076|P2|Overall Study|Adverse Event|0
804751|NCT00814502|2559077|P1|Overall Study|Adverse Event|1
804752|NCT00814580|2559089|P2|Overall Study|Did Not Take Drug|2
804753|NCT00814580|2559090|P1|Overall Study|Did Not Take Drug|2
804754|NCT00814580|2559089|P2|Overall Study|Other|3
804755|NCT00814580|2559090|P1|Overall Study|Other|1
804756|NCT00814580|2559089|P2|Overall Study|Withdrawal by Subject|2
804757|NCT00814580|2559090|P1|Overall Study|Withdrawal by Subject|2
804758|NCT00814580|2559089|P2|Overall Study|Protocol Violation|0
804759|NCT00814580|2559090|P1|Overall Study|Protocol Violation|2
804760|NCT00814580|2559089|P2|Overall Study|Lack of Efficacy|25
804761|NCT00814580|2559090|P1|Overall Study|Lack of Efficacy|18
804762|NCT00814580|2559089|P2|Overall Study|Adverse Event|15
804763|NCT00814580|2559090|P1|Overall Study|Adverse Event|6
804764|NCT00814632|2559218|P1|Overall Study|Lack of Efficacy|2
804765|NCT00814658|2559224|P2|Overall Study|Adverse Event|3
804766|NCT00814658|2559225|P1|Overall Study|Adverse Event|3
804767|NCT00814658|2559224|P2|Overall Study|Physician Decision|0
804768|NCT00814658|2559225|P1|Overall Study|Physician Decision|1
804769|NCT00814658|2559224|P2|Overall Study|Lost to Follow-up|1
804770|NCT00814658|2559225|P1|Overall Study|Lost to Follow-up|0
804771|NCT00821093|2559324|P2|Overall Study|Administrative problems|2
804772|NCT00821093|2559325|P1|Overall Study|Administrative problems|1
804773|NCT00821093|2559324|P2|Overall Study|Abnormal test procedure result(s)|1
804774|NCT00821093|2559325|P1|Overall Study|Abnormal test procedure result(s)|1
804775|NCT00821093|2559324|P2|Overall Study|Death|1
804776|NCT00821093|2559325|P1|Overall Study|Death|2
804777|NCT00821093|2559324|P2|Overall Study|Lack of Efficacy|2
804778|NCT00821093|2559325|P1|Overall Study|Lack of Efficacy|2
804779|NCT00821093|2559324|P2|Overall Study|Abnormal laboratory value(s)|0
804780|NCT00821093|2559325|P1|Overall Study|Abnormal laboratory value(s)|2
804781|NCT00821093|2559324|P2|Overall Study|Protocol deviation|6
804782|NCT00821093|2559325|P1|Overall Study|Protocol deviation|3
804783|NCT00821093|2559324|P2|Overall Study|Lost to Follow-up|3
804784|NCT00821093|2559325|P1|Overall Study|Lost to Follow-up|9
804785|NCT00821093|2559324|P2|Overall Study|Withdrawal by Subject|13
804786|NCT00821093|2559325|P1|Overall Study|Withdrawal by Subject|9
804787|NCT00821093|2559324|P2|Overall Study|Adverse Event|12
804788|NCT00821093|2559325|P1|Overall Study|Adverse Event|20
804789|NCT00821236|2559358|P1|Overall Study|Lost to Follow-up|3
804790|NCT00822172|2559393|P2|Overall Study|Other|1
804791|NCT00822172|2559394|P1|Overall Study|Other|0
804792|NCT00822172|2559393|P2|Overall Study|site closed|1
804793|NCT00822172|2559394|P1|Overall Study|site closed|0
804794|NCT00822172|2559393|P2|Overall Study|Withdrawal by Subject|4
804795|NCT00822172|2559394|P1|Overall Study|Withdrawal by Subject|1
804796|NCT00822172|2559393|P2|Overall Study|Lost to Follow-up|1
804797|NCT00822172|2559394|P1|Overall Study|Lost to Follow-up|3
804798|NCT00822172|2559393|P2|Overall Study|Death|0
804799|NCT00822172|2559394|P1|Overall Study|Death|1
804800|NCT00822172|2559393|P2|Overall Study|Adverse Event|12
804801|NCT00822172|2559394|P1|Overall Study|Adverse Event|10
804802|NCT00822237|2559476|P2|Dose 2 Vaccination|Lost to Follow-up|9
804803|NCT00822237|2559477|P1|Dose 2 Vaccination|Lost to Follow-up|2
804804|NCT00822237|2559476|P2|Dose 2 Vaccination|Withdrawal by Subject|2
804805|NCT00822237|2559477|P1|Dose 2 Vaccination|Withdrawal by Subject|2
804806|NCT00822237|2559476|P2|Dose 1 Vaccination|Lost to Follow-up|12
804807|NCT00822237|2559477|P1|Dose 1 Vaccination|Lost to Follow-up|9
804808|NCT00822237|2559476|P2|Dose 1 Vaccination|Withdrawal by Subject|14
804809|NCT00822237|2559477|P1|Dose 1 Vaccination|Withdrawal by Subject|13
804810|NCT00822237|2559476|P2|Dose 1 Vaccination|Not vaccinated|0
804811|NCT00822237|2559477|P1|Dose 1 Vaccination|Not vaccinated|3
804812|NCT00822692|2559614|P2|Overall Study|Lost to Follow-up|25
804813|NCT00822692|2559615|P1|Overall Study|Lost to Follow-up|17
804814|NCT00822900|2559640|P2|Overall Study|Became a ward of the state|1
804815|NCT00822900|2559641|P1|Overall Study|Became a ward of the state|2
804816|NCT00822900|2559640|P2|Overall Study|Death|69
804817|NCT00822900|2559641|P1|Overall Study|Death|83
804818|NCT00822900|2559640|P2|Overall Study|Lost to Follow-up|9
804819|NCT00822900|2559641|P1|Overall Study|Lost to Follow-up|9
804820|NCT00822900|2559640|P2|Overall Study|Withdrawal by Subject|14
804821|NCT00822900|2559641|P1|Overall Study|Withdrawal by Subject|14
804822|NCT00822926|2559671|P2|Second Injection Visit|Withdrawal by Subject|1
804823|NCT00822926|2559672|P1|Second Injection Visit|Withdrawal by Subject|0
804824|NCT00822926|2559671|P2|Second Injection Visit|Lost to Follow-up|0
804825|NCT00822926|2559672|P1|Second Injection Visit|Lost to Follow-up|1
804826|NCT00823199|2559745|P1|Overall Study|Withdrawal by Subject|2
804827|NCT00823212|2559753|P2|Overall Study|Missed 12-month visit|21
804828|NCT00823212|2559754|P1|Overall Study|Missed 12-month visit|21
804829|NCT00823212|2559753|P2|Overall Study|Incarcerated|1
804830|NCT00823212|2559754|P1|Overall Study|Incarcerated|0
804831|NCT00823212|2559753|P2|Overall Study|Withdrawal by Subject|1
804832|NCT00823212|2559754|P1|Overall Study|Withdrawal by Subject|6
804833|NCT00823212|2559753|P2|Overall Study|Death|10
804834|NCT00823212|2559754|P1|Overall Study|Death|8
804835|NCT00823264|2559838|P2|Overall Study|Protocol Violation|0
804836|NCT00823264|2559839|P1|Overall Study|Protocol Violation|2
804837|NCT00823472|2559856|P2|Overall Study|Physician Decision|28
804838|NCT00823472|2559857|P1|Overall Study|Physician Decision|24
804839|NCT00823615|2559865|P2|Period 2|Time/Job Conflict|2
804840|NCT00823615|2559866|P1|Period 2|Time/Job Conflict|1
804841|NCT00823615|2559865|P2|Period 2|Lost to Follow-up|0
804842|NCT00823615|2559866|P1|Period 2|Lost to Follow-up|2
804843|NCT00823719|2559876|P2|Overall Study|Disease Progression|4
804844|NCT00823719|2559877|P1|Overall Study|Disease Progression|4
804845|NCT00823719|2559876|P2|Overall Study|Withdrawal by Subject|1
804846|NCT00823719|2559877|P1|Overall Study|Withdrawal by Subject|0
804847|NCT00823719|2559876|P2|Overall Study|Physician Decision|4
804848|NCT00823719|2559877|P1|Overall Study|Physician Decision|1
804849|NCT00823719|2559876|P2|Overall Study|Adverse Event|2
804850|NCT00823719|2559877|P1|Overall Study|Adverse Event|1
804851|NCT00823823|2559946|P2|Overall Study|Protocol Violation|5
804852|NCT00823823|2559947|P1|Overall Study|Protocol Violation|5
804853|NCT00823823|2559946|P2|Overall Study|Lost to Follow-up|1
804854|NCT00823823|2559947|P1|Overall Study|Lost to Follow-up|3
804855|NCT00823836|2559957|P2|Long-term Phase|Withdrawal by Subject|1
804856|NCT00823836|2559958|P1|Long-term Phase|Withdrawal by Subject|1
804857|NCT00823836|2559957|P2|Long-term Phase|Physician Decision|2
804858|NCT00823836|2559958|P1|Long-term Phase|Physician Decision|1
804859|NCT00823836|2559957|P2|Long-term Phase|Adverse Event|2
804860|NCT00823836|2559958|P1|Long-term Phase|Adverse Event|3
804861|NCT00823836|2559957|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
804862|NCT00823836|2559958|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
804863|NCT00823836|2559957|P2|NV and PR/XR Switching Phases|Physician Decision|2
804864|NCT00823836|2559958|P1|NV and PR/XR Switching Phases|Physician Decision|5
804865|NCT00823836|2559957|P2|NV and PR/XR Switching Phases|Protocol Violation|1
804866|NCT00823836|2559958|P1|NV and PR/XR Switching Phases|Protocol Violation|1
804867|NCT00823836|2559957|P2|NV and PR/XR Switching Phases|Adverse Event|21
804868|NCT00823836|2559958|P1|NV and PR/XR Switching Phases|Adverse Event|22
804869|NCT00823901|2560064|P2|Overall Study|Lost to Follow-up|1
804870|NCT00823901|2560065|P1|Overall Study|Lost to Follow-up|2
804871|NCT00823901|2560064|P2|Overall Study|Lack of Efficacy|0
804872|NCT00823901|2560065|P1|Overall Study|Lack of Efficacy|1
804873|NCT00823901|2560064|P2|Overall Study|Adverse Event|1
804874|NCT00823901|2560065|P1|Overall Study|Adverse Event|1
804875|NCT00823979|2560079|P3|Overall Study|Study Terminated by Sponsor|7
804876|NCT00823979|2560080|P2|Overall Study|Study Terminated by Sponsor|5
804877|NCT00823979|2560081|P1|Overall Study|Study Terminated by Sponsor|5
804878|NCT00823979|2560079|P3|Overall Study|Randomized but not Treated|1
804879|NCT00823979|2560080|P2|Overall Study|Randomized but not Treated|3
804880|NCT00823979|2560081|P1|Overall Study|Randomized but not Treated|4
804881|NCT00823979|2560079|P3|Overall Study|Unspecified|1
804882|NCT00823979|2560080|P2|Overall Study|Unspecified|0
804883|NCT00823979|2560081|P1|Overall Study|Unspecified|2
804884|NCT00823979|2560079|P3|Overall Study|Adverse Event|4
804885|NCT00823979|2560080|P2|Overall Study|Adverse Event|2
804886|NCT00823979|2560081|P1|Overall Study|Adverse Event|0
804887|NCT00823979|2560079|P3|Overall Study|Pregnancy|0
804888|NCT00823979|2560080|P2|Overall Study|Pregnancy|1
804889|NCT00823979|2560081|P1|Overall Study|Pregnancy|0
804890|NCT00823979|2560079|P3|Overall Study|Protocol Violation|0
804891|NCT00823979|2560080|P2|Overall Study|Protocol Violation|1
804892|NCT00823979|2560081|P1|Overall Study|Protocol Violation|1
804893|NCT00823979|2560079|P3|Overall Study|Withdrawal by Subject|2
804894|NCT00823979|2560080|P2|Overall Study|Withdrawal by Subject|3
804895|NCT00823979|2560081|P1|Overall Study|Withdrawal by Subject|2
804896|NCT00823979|2560079|P3|Overall Study|Lost to Follow-up|0
804897|NCT00823979|2560080|P2|Overall Study|Lost to Follow-up|1
804898|NCT00823979|2560081|P1|Overall Study|Lost to Follow-up|2
804899|NCT00823979|2560079|P3|Overall Study|Lack of Efficacy|9
804900|NCT00823979|2560080|P2|Overall Study|Lack of Efficacy|16
804901|NCT00823979|2560081|P1|Overall Study|Lack of Efficacy|13
804902|NCT00824005|2560121|P2|Overall Study|Lost to Follow-up|1
804903|NCT00824005|2560122|P1|Overall Study|Lost to Follow-up|0
804904|NCT00824005|2560121|P2|Overall Study|Death|1
804905|NCT00824005|2560122|P1|Overall Study|Death|0
804906|NCT00824161|2560176|P1|Overall Study|Screen Failure|1
804907|NCT00824161|2560176|P1|Overall Study|Withdrawal by Subject|1
804908|NCT00824265|2560184|P2|Overall Study|Withdrawal by Subject|15
804909|NCT00824265|2560185|P1|Overall Study|Withdrawal by Subject|6
804910|NCT00824265|2560184|P2|Overall Study|Physician Decision|12
804911|NCT00824265|2560185|P1|Overall Study|Physician Decision|6
804912|NCT00824265|2560184|P2|Overall Study|Lost to Follow-up|1
804913|NCT00824265|2560185|P1|Overall Study|Lost to Follow-up|1
804914|NCT00824265|2560184|P2|Overall Study|Protocol Violation|0
804915|NCT00824265|2560185|P1|Overall Study|Protocol Violation|1
804916|NCT00824265|2560184|P2|Overall Study|Adverse Event,non-fatal|52
804917|NCT00824265|2560185|P1|Overall Study|Adverse Event,non-fatal|50
804918|NCT00824291|2560246|P2|Overall Study|Participant on prohibited medication|0
804919|NCT00824291|2560247|P1|Overall Study|Participant on prohibited medication|1
804920|NCT00824291|2560246|P2|Overall Study|Lack of Efficacy|8
804921|NCT00824291|2560247|P1|Overall Study|Lack of Efficacy|7
804922|NCT00824291|2560246|P2|Overall Study|Withdrawal by Subject|8
804923|NCT00824291|2560247|P1|Overall Study|Withdrawal by Subject|14
804924|NCT00824291|2560246|P2|Overall Study|Protocol Violation|1
804925|NCT00824291|2560247|P1|Overall Study|Protocol Violation|4
804926|NCT00824291|2560246|P2|Overall Study|Non-compliance|1
804927|NCT00824291|2560247|P1|Overall Study|Non-compliance|1
804928|NCT00824291|2560246|P2|Overall Study|Lost to Follow-up|9
804929|NCT00824291|2560247|P1|Overall Study|Lost to Follow-up|11
804930|NCT00824291|2560246|P2|Overall Study|Discontinuation of Study by Sponsor|2
804931|NCT00824291|2560247|P1|Overall Study|Discontinuation of Study by Sponsor|1
804932|NCT00824291|2560246|P2|Overall Study|Adverse Event|6
804933|NCT00824291|2560247|P1|Overall Study|Adverse Event|15
804934|NCT00824369|2560273|P6|Overall Study|Lost to Follow-up|0
804935|NCT00824369|2560274|P5|Overall Study|Lost to Follow-up|1
804936|NCT00824369|2560275|P4|Overall Study|Lost to Follow-up|0
804937|NCT00824369|2560276|P3|Overall Study|Lost to Follow-up|0
804938|NCT00824369|2560277|P2|Overall Study|Lost to Follow-up|0
804939|NCT00824369|2560278|P1|Overall Study|Lost to Follow-up|0
804940|NCT00824369|2560273|P6|Overall Study|Nolonger willing to participate in study|1
804941|NCT00824369|2560274|P5|Overall Study|Nolonger willing to participate in study|0
804942|NCT00824369|2560275|P4|Overall Study|Nolonger willing to participate in study|2
804943|NCT00824369|2560276|P3|Overall Study|Nolonger willing to participate in study|1
804944|NCT00824369|2560277|P2|Overall Study|Nolonger willing to participate in study|0
804945|NCT00824369|2560278|P1|Overall Study|Nolonger willing to participate in study|1
804946|NCT00824382|2560320|P4|Overall Study|Investigator's decision|0
804947|NCT00824382|2560321|P3|Overall Study|Investigator's decision|2
804948|NCT00824382|2560322|P2|Overall Study|Investigator's decision|1
804949|NCT00824382|2560323|P1|Overall Study|Investigator's decision|0
804950|NCT00824382|2560320|P4|Overall Study|Protocol Violation|1
804951|NCT00824382|2560321|P3|Overall Study|Protocol Violation|0
804952|NCT00824382|2560322|P2|Overall Study|Protocol Violation|0
804953|NCT00824382|2560323|P1|Overall Study|Protocol Violation|1
804954|NCT00824382|2560320|P4|Overall Study|Adverse Event|4
804955|NCT00824382|2560321|P3|Overall Study|Adverse Event|1
804956|NCT00824382|2560322|P2|Overall Study|Adverse Event|1
804957|NCT00824382|2560323|P1|Overall Study|Adverse Event|4
804958|NCT00824408|2560398|P5|Randomized Phase|Other reason not defined above|4
804959|NCT00824408|2560399|P4|Randomized Phase|Other reason not defined above|2
804960|NCT00824408|2560400|P3|Randomized Phase|Other reason not defined above|4
804961|NCT00824408|2560401|P2|Randomized Phase|Other reason not defined above|0
804962|NCT00824408|2560402|P1|Randomized Phase|Other reason not defined above|0
804963|NCT00824408|2560398|P5|Randomized Phase|Refused to continue medication|2
804964|NCT00824408|2560399|P4|Randomized Phase|Refused to continue medication|2
804965|NCT00824408|2560400|P3|Randomized Phase|Refused to continue medication|2
804966|NCT00824408|2560401|P2|Randomized Phase|Refused to continue medication|0
804967|NCT00824408|2560402|P1|Randomized Phase|Refused to continue medication|0
804968|NCT00824408|2560398|P5|Randomized Phase|Adverse Event|5
804969|NCT00824408|2560399|P4|Randomized Phase|Adverse Event|5
804970|NCT00824408|2560400|P3|Randomized Phase|Adverse Event|4
804971|NCT00824408|2560401|P2|Randomized Phase|Adverse Event|0
804972|NCT00824408|2560402|P1|Randomized Phase|Adverse Event|0
804973|NCT00824408|2560398|P5|Randomized Phase|Progressive disease|34
804974|NCT00824408|2560399|P4|Randomized Phase|Progressive disease|36
804975|NCT00824408|2560400|P3|Randomized Phase|Progressive disease|25
804976|NCT00824408|2560401|P2|Randomized Phase|Progressive disease|0
804977|NCT00824408|2560402|P1|Randomized Phase|Progressive disease|0
804978|NCT00824408|2560398|P5|Randomized Phase|Not treated|1
804979|NCT00824408|2560399|P4|Randomized Phase|Not treated|1
804980|NCT00824408|2560400|P3|Randomized Phase|Not treated|1
804981|NCT00824408|2560401|P2|Randomized Phase|Not treated|0
804982|NCT00824408|2560402|P1|Randomized Phase|Not treated|0
804983|NCT00824408|2560398|P5|Run-in Phase|Other reason not defined above|0
804984|NCT00824408|2560399|P4|Run-in Phase|Other reason not defined above|0
804985|NCT00824408|2560400|P3|Run-in Phase|Other reason not defined above|0
804986|NCT00824408|2560401|P2|Run-in Phase|Other reason not defined above|1
804987|NCT00824408|2560402|P1|Run-in Phase|Other reason not defined above|0
804988|NCT00824408|2560398|P5|Run-in Phase|Refused to continue medication|0
804989|NCT00824408|2560399|P4|Run-in Phase|Refused to continue medication|0
804990|NCT00824408|2560400|P3|Run-in Phase|Refused to continue medication|0
804991|NCT00824408|2560401|P2|Run-in Phase|Refused to continue medication|0
804992|NCT00824408|2560402|P1|Run-in Phase|Refused to continue medication|1
804993|NCT00824408|2560398|P5|Run-in Phase|Adverse Event|0
804994|NCT00824408|2560399|P4|Run-in Phase|Adverse Event|0
804995|NCT00824408|2560400|P3|Run-in Phase|Adverse Event|0
804996|NCT00824408|2560401|P2|Run-in Phase|Adverse Event|1
804997|NCT00824408|2560402|P1|Run-in Phase|Adverse Event|1
804998|NCT00824408|2560398|P5|Run-in Phase|Progressive disease|0
804999|NCT00824408|2560399|P4|Run-in Phase|Progressive disease|0
805000|NCT00824408|2560400|P3|Run-in Phase|Progressive disease|0
805001|NCT00824408|2560401|P2|Run-in Phase|Progressive disease|4
805002|NCT00824408|2560402|P1|Run-in Phase|Progressive disease|4
805003|NCT00824421|2560453|P3|Overall Study|Unspecified|0
805004|NCT00824421|2560454|P2|Overall Study|Unspecified|1
805005|NCT00824421|2560455|P1|Overall Study|Unspecified|0
805006|NCT00824421|2560453|P3|Overall Study|Randomized but not Treated|0
805007|NCT00824421|2560454|P2|Overall Study|Randomized but not Treated|1
805008|NCT00824421|2560455|P1|Overall Study|Randomized but not Treated|1
805009|NCT00824421|2560453|P3|Overall Study|Withdrawal by Subject|3
805010|NCT00824421|2560454|P2|Overall Study|Withdrawal by Subject|3
805011|NCT00824421|2560455|P1|Overall Study|Withdrawal by Subject|2
805012|NCT00824421|2560453|P3|Overall Study|Pregnancy|1
805013|NCT00824421|2560454|P2|Overall Study|Pregnancy|0
805014|NCT00824421|2560455|P1|Overall Study|Pregnancy|1
805015|NCT00824421|2560453|P3|Overall Study|Lost to Follow-up|0
805016|NCT00824421|2560454|P2|Overall Study|Lost to Follow-up|3
805017|NCT00824421|2560455|P1|Overall Study|Lost to Follow-up|2
805018|NCT00824421|2560453|P3|Overall Study|Lack of Efficacy|4
805019|NCT00824421|2560454|P2|Overall Study|Lack of Efficacy|7
805020|NCT00824421|2560455|P1|Overall Study|Lack of Efficacy|5
805021|NCT00824421|2560453|P3|Overall Study|Death|0
805022|NCT00824421|2560454|P2|Overall Study|Death|1
805023|NCT00824421|2560455|P1|Overall Study|Death|0
805024|NCT00824421|2560453|P3|Overall Study|Adverse Event|6
805025|NCT00824421|2560454|P2|Overall Study|Adverse Event|6
805026|NCT00824421|2560455|P1|Overall Study|Adverse Event|6
805027|NCT00824473|2560565|P2|Overall Study|Other|1
805028|NCT00824473|2560566|P1|Overall Study|Other|1
805029|NCT00824473|2560565|P2|Overall Study|Withdrawal by Subject|3
805030|NCT00824473|2560566|P1|Overall Study|Withdrawal by Subject|2
805031|NCT00824473|2560565|P2|Overall Study|Non-Compliance|2
805032|NCT00824473|2560566|P1|Overall Study|Non-Compliance|4
805033|NCT00824473|2560565|P2|Overall Study|Protocol Violation|0
805034|NCT00824473|2560566|P1|Overall Study|Protocol Violation|2
805035|NCT00824473|2560565|P2|Overall Study|Lack of Efficacy|2
805036|NCT00824473|2560566|P1|Overall Study|Lack of Efficacy|2
805037|NCT00824473|2560565|P2|Overall Study|Adverse Event|5
805038|NCT00824473|2560566|P1|Overall Study|Adverse Event|4
805039|NCT00817531|2560582|P1|Overall Study|Lack of Efficacy|1
805040|NCT00817531|2560582|P1|Overall Study|Adverse Event|1
805041|NCT00817778|2560592|P2|Overall Study|Poor venous access|0
805042|NCT00817778|2560593|P1|Overall Study|Poor venous access|1
805043|NCT00817778|2560592|P2|Overall Study|Study-specific discontinuation criteria|1
805044|NCT00817778|2560593|P1|Overall Study|Study-specific discontinuation criteria|0
805045|NCT00817778|2560592|P2|Overall Study|Protocol Violation|1
805046|NCT00817778|2560593|P1|Overall Study|Protocol Violation|0
805047|NCT00817778|2560592|P2|Overall Study|Withdrawal by Subject|1
805048|NCT00817778|2560593|P1|Overall Study|Withdrawal by Subject|1
805049|NCT00817778|2560592|P2|Overall Study|Adverse Event|0
805050|NCT00817778|2560593|P1|Overall Study|Adverse Event|1
805051|NCT00818168|2560648|P1|Overall Study|Participant Moved|2
805052|NCT00818168|2560648|P1|Overall Study|Reason for Non-completion Not reported|6
805053|NCT00818168|2560648|P1|Overall Study|Adverse Event|19
805054|NCT00818168|2560648|P1|Overall Study|Lost to Follow-up|7
805055|NCT00818168|2560648|P1|Overall Study|Withdrawal by Subject|16
805056|NCT00818168|2560648|P1|Overall Study|Pregnancy|2
805057|NCT00818168|2560648|P1|Overall Study|Lack of Efficacy|18
805058|NCT00818207|2560658|P2|Overall Study|Death|5
805059|NCT00818207|2560659|P1|Overall Study|Death|3
805060|NCT00818207|2560658|P2|Overall Study|Withdrawal by Subject|104
805061|NCT00818207|2560659|P1|Overall Study|Withdrawal by Subject|42
805062|NCT00818207|2560658|P2|Overall Study|Multiple reasons|12
805063|NCT00818207|2560659|P1|Overall Study|Multiple reasons|11
805064|NCT00818207|2560658|P2|Overall Study|Lost to Follow-up|146
805065|NCT00818207|2560659|P1|Overall Study|Lost to Follow-up|160
805066|NCT00818207|2560658|P2|Overall Study|Adverse Event|0
805067|NCT00818207|2560659|P1|Overall Study|Adverse Event|6
805068|NCT00818246|2560673|P1|Overall Study|Impossible to match pictures|5
805069|NCT00818259|2560687|P9|Part V|Adverse Event|0
805070|NCT00818259|2560688|P8|Part V|Adverse Event|1
805071|NCT00818259|2560689|P7|Part V|Adverse Event|0
805072|NCT00818259|2560690|P6|Part V|Adverse Event|0
805073|NCT00818259|2560691|P5|Part V|Adverse Event|0
805074|NCT00818259|2560692|P4|Part V|Adverse Event|0
805075|NCT00818259|2560693|P3|Part V|Adverse Event|0
805076|NCT00818259|2560694|P2|Part V|Adverse Event|0
805077|NCT00818259|2560695|P1|Part V|Adverse Event|0
805078|NCT00818259|2560687|P9|Part IV|Physician Decision|0
805079|NCT00818259|2560688|P8|Part IV|Physician Decision|0
805080|NCT00818259|2560689|P7|Part IV|Physician Decision|0
805081|NCT00818259|2560690|P6|Part IV|Physician Decision|1
805082|NCT00818259|2560691|P5|Part IV|Physician Decision|0
805083|NCT00818259|2560692|P4|Part IV|Physician Decision|0
805084|NCT00818259|2560693|P3|Part IV|Physician Decision|0
805085|NCT00818259|2560694|P2|Part IV|Physician Decision|0
805086|NCT00818259|2560695|P1|Part IV|Physician Decision|0
805087|NCT00818259|2560687|P9|Part II|Not Treated|0
805088|NCT00818259|2560688|P8|Part II|Not Treated|0
805089|NCT00818259|2560689|P7|Part II|Not Treated|0
805090|NCT00818259|2560690|P6|Part II|Not Treated|0
805091|NCT00818259|2560691|P5|Part II|Not Treated|0
805092|NCT00818259|2560692|P4|Part II|Not Treated|1
805093|NCT00818259|2560693|P3|Part II|Not Treated|0
805094|NCT00818259|2560694|P2|Part II|Not Treated|0
805095|NCT00818259|2560695|P1|Part II|Not Treated|0
805096|NCT00818259|2560687|P9|Part II|Lack of Efficacy|0
805097|NCT00818259|2560688|P8|Part II|Lack of Efficacy|0
805098|NCT00818259|2560689|P7|Part II|Lack of Efficacy|0
805099|NCT00818259|2560690|P6|Part II|Lack of Efficacy|0
805100|NCT00818259|2560691|P5|Part II|Lack of Efficacy|0
805101|NCT00818259|2560692|P4|Part II|Lack of Efficacy|1
805102|NCT00818259|2560693|P3|Part II|Lack of Efficacy|0
805103|NCT00818259|2560694|P2|Part II|Lack of Efficacy|0
805104|NCT00818259|2560695|P1|Part II|Lack of Efficacy|0
805105|NCT00818259|2560687|P9|Part II|Physician Decision|0
805106|NCT00818259|2560688|P8|Part II|Physician Decision|0
805107|NCT00818259|2560689|P7|Part II|Physician Decision|0
805108|NCT00818259|2560690|P6|Part II|Physician Decision|0
805109|NCT00818259|2560691|P5|Part II|Physician Decision|0
805110|NCT00818259|2560692|P4|Part II|Physician Decision|0
805111|NCT00818259|2560693|P3|Part II|Physician Decision|1
805112|NCT00818259|2560694|P2|Part II|Physician Decision|0
805113|NCT00818259|2560695|P1|Part II|Physician Decision|0
805114|NCT00818259|2560687|P9|Part I|Withdrawal by Subject|0
805115|NCT00818259|2560688|P8|Part I|Withdrawal by Subject|0
805116|NCT00818259|2560689|P7|Part I|Withdrawal by Subject|0
805117|NCT00818259|2560690|P6|Part I|Withdrawal by Subject|0
805118|NCT00818259|2560691|P5|Part I|Withdrawal by Subject|0
805119|NCT00818259|2560692|P4|Part I|Withdrawal by Subject|0
805120|NCT00818259|2560693|P3|Part I|Withdrawal by Subject|0
805121|NCT00818259|2560694|P2|Part I|Withdrawal by Subject|0
805122|NCT00818259|2560695|P1|Part I|Withdrawal by Subject|1
805123|NCT00818389|2560787|P2|Overall Study|Adverse Event|1
805124|NCT00818389|2560788|P1|Overall Study|Adverse Event|0
805125|NCT00818389|2560787|P2|Overall Study|Withdrawal by Subject|2
805126|NCT00818389|2560788|P1|Overall Study|Withdrawal by Subject|2
805127|NCT00818389|2560787|P2|Overall Study|ALS Disease Progression|0
805128|NCT00818389|2560788|P1|Overall Study|ALS Disease Progression|1
805129|NCT00818389|2560787|P2|Overall Study|Death|3
805130|NCT00818389|2560788|P1|Overall Study|Death|1
805131|NCT00824564|2560857|P2|Overall Study|Randomized, but not treated|0
805132|NCT00824564|2560858|P1|Overall Study|Randomized, but not treated|1
805133|NCT00824564|2560857|P2|Overall Study|Unspecified|2
805134|NCT00824564|2560858|P1|Overall Study|Unspecified|1
805135|NCT00824564|2560857|P2|Overall Study|Withdrawal by Subject|1
805136|NCT00824564|2560858|P1|Overall Study|Withdrawal by Subject|1
805137|NCT00824564|2560857|P2|Overall Study|Lost to Follow-up|7
805138|NCT00824564|2560858|P1|Overall Study|Lost to Follow-up|5
805139|NCT00824616|2560878|P2|Overall Study|Withdrawal by Subject|1
805140|NCT00824616|2560879|P1|Overall Study|Withdrawal by Subject|1
805141|NCT00824616|2560878|P2|Overall Study|Lost to Follow-up|1
805142|NCT00824616|2560879|P1|Overall Study|Lost to Follow-up|0
805143|NCT00824616|2560878|P2|Overall Study|Lack of Efficacy|1
805144|NCT00824616|2560879|P1|Overall Study|Lack of Efficacy|2
805145|NCT00824616|2560878|P2|Overall Study|Hyperglycemia|1
805146|NCT00824616|2560879|P1|Overall Study|Hyperglycemia|1
805147|NCT00824616|2560878|P2|Overall Study|Creatinine/Creatinine Clearance|2
805148|NCT00824616|2560879|P1|Overall Study|Creatinine/Creatinine Clearance|0
805149|NCT00824616|2560878|P2|Overall Study|Adverse Event|1
805150|NCT00824616|2560879|P1|Overall Study|Adverse Event|2
805151|NCT00824655|2560889|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
805152|NCT00824655|2560890|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
805153|NCT00824655|2560889|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
805154|NCT00824655|2560890|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
805155|NCT00824720|2560911|P3|Overall Study|Protocol Violation|1
805156|NCT00824720|2560912|P2|Overall Study|Protocol Violation|0
805157|NCT00824720|2560913|P1|Overall Study|Protocol Violation|0
805158|NCT00824720|2560911|P3|Overall Study|failed plug insertion|0
805159|NCT00824720|2560912|P2|Overall Study|failed plug insertion|1
805160|NCT00824720|2560913|P1|Overall Study|failed plug insertion|3
805161|NCT00824772|2560939|P1|Overall Study|Withdrawal by Subject|8
805162|NCT00826176|2560955|P2|Overall Study|Administrative|0
805163|NCT00826176|2560956|P1|Overall Study|Administrative|9
805164|NCT00826176|2560955|P2|Overall Study|Subject Withdrew Consent|0
805165|NCT00826176|2560956|P1|Overall Study|Subject Withdrew Consent|3
805166|NCT00826176|2560955|P2|Overall Study|Lost to Follow-up|0
805167|NCT00826176|2560956|P1|Overall Study|Lost to Follow-up|1
805168|NCT00826228|2560981|P1|Overall Study|Withdrawal by Subject|1
805169|NCT00826267|2560989|P3|Overall Study|Other Adverse Event|0
805170|NCT00826267|2560990|P2|Overall Study|Other Adverse Event|0
805171|NCT00826267|2560991|P1|Overall Study|Other Adverse Event|1
805172|NCT00826280|2561012|P3|Overall Study|One or more non-interpretable scan|1
805173|NCT00826280|2561013|P2|Overall Study|One or more non-interpretable scan|1
805174|NCT00826280|2561014|P1|Overall Study|One or more non-interpretable scan|0
805175|NCT00826280|2561012|P3|Overall Study|Machine Failure|0
805176|NCT00826280|2561013|P2|Overall Study|Machine Failure|1
805177|NCT00826280|2561014|P1|Overall Study|Machine Failure|1
805178|NCT00826280|2561012|P3|Overall Study|Interpretation Failure|0
805179|NCT00826280|2561013|P2|Overall Study|Interpretation Failure|0
805180|NCT00826280|2561014|P1|Overall Study|Interpretation Failure|1
805181|NCT00826280|2561012|P3|Overall Study|Reversible ischemic defect not present|44
805182|NCT00826280|2561013|P2|Overall Study|Reversible ischemic defect not present|40
805183|NCT00826280|2561014|P1|Overall Study|Reversible ischemic defect not present|43
805184|NCT00826280|2561012|P3|Overall Study|Sponsor discontinued subject or study|0
805185|NCT00826280|2561013|P2|Overall Study|Sponsor discontinued subject or study|0
805186|NCT00826280|2561014|P1|Overall Study|Sponsor discontinued subject or study|1
805187|NCT00826280|2561012|P3|Overall Study|Lost to Follow-up|0
805188|NCT00826280|2561013|P2|Overall Study|Lost to Follow-up|1
805189|NCT00826280|2561014|P1|Overall Study|Lost to Follow-up|0
805190|NCT00826280|2561012|P3|Overall Study|Adverse Event|0
805191|NCT00826280|2561013|P2|Overall Study|Adverse Event|3
805192|NCT00826280|2561014|P1|Overall Study|Adverse Event|1
805193|NCT00826280|2561012|P3|Overall Study|Randomized but drug not received|1
805194|NCT00826280|2561013|P2|Overall Study|Randomized but drug not received|0
805195|NCT00826280|2561014|P1|Overall Study|Randomized but drug not received|1
805196|NCT00826449|2561042|P1|Overall Study|Withdrawal by Subject|1
805197|NCT00826449|2561042|P1|Overall Study|Disease Progression|4
805198|NCT00826540|2561048|P1|Overall Study|Withdrawal by Subject|1
805199|NCT00826540|2561048|P1|Overall Study|ineligible|3
805200|NCT00826618|2561052|P1|Overall Study|Withdrawal by Subject|1
805201|NCT00826943|2561060|P6|Overall Study|Withdrawal by Subject|0
805202|NCT00826943|2561061|P5|Overall Study|Withdrawal by Subject|1
805203|NCT00826943|2561062|P4|Overall Study|Withdrawal by Subject|0
805204|NCT00826943|2561063|P3|Overall Study|Withdrawal by Subject|0
805205|NCT00826943|2561064|P2|Overall Study|Withdrawal by Subject|0
805206|NCT00826943|2561065|P1|Overall Study|Withdrawal by Subject|0
805207|NCT00827112|2561101|P2|Overall Study|Unspecified|3
805208|NCT00827112|2561102|P1|Overall Study|Unspecified|1
805209|NCT00827112|2561101|P2|Overall Study|Randomized but not treated|3
805210|NCT00827112|2561102|P1|Overall Study|Randomized but not treated|5
805211|NCT00827112|2561101|P2|Overall Study|Withdrawal by Subject|1
805212|NCT00827112|2561102|P1|Overall Study|Withdrawal by Subject|2
805213|NCT00827112|2561101|P2|Overall Study|Protocol Violation|2
805214|NCT00827112|2561102|P1|Overall Study|Protocol Violation|0
805215|NCT00827112|2561101|P2|Overall Study|Pregnancy|1
805216|NCT00827112|2561102|P1|Overall Study|Pregnancy|0
805217|NCT00827112|2561101|P2|Overall Study|Lost to Follow-up|2
805218|NCT00827112|2561102|P1|Overall Study|Lost to Follow-up|3
805219|NCT00827112|2561101|P2|Overall Study|Lack of Efficacy|0
805220|NCT00827112|2561102|P1|Overall Study|Lack of Efficacy|2
805221|NCT00827112|2561101|P2|Overall Study|Adverse Event|0
805222|NCT00827112|2561102|P1|Overall Study|Adverse Event|2
805223|NCT00827242|2561137|P2|Overall Study|Lack of Efficacy|0
805224|NCT00827242|2561138|P1|Overall Study|Lack of Efficacy|1
805225|NCT00827242|2561137|P2|Overall Study|Death|0
805226|NCT00827242|2561138|P1|Overall Study|Death|1
805227|NCT00827242|2561137|P2|Overall Study|Physician Decision|0
805228|NCT00827242|2561138|P1|Overall Study|Physician Decision|2
805229|NCT00827242|2561137|P2|Overall Study|Entry Criteria Not Met|1
805230|NCT00827242|2561138|P1|Overall Study|Entry Criteria Not Met|4
805231|NCT00827242|2561137|P2|Overall Study|Adverse Event Excluding Death|1
805232|NCT00827242|2561138|P1|Overall Study|Adverse Event Excluding Death|2
805233|NCT00827242|2561137|P2|Overall Study|Lost to Follow-up|3
805234|NCT00827242|2561138|P1|Overall Study|Lost to Follow-up|0
805235|NCT00827242|2561137|P2|Overall Study|Protocol Violation|3
805236|NCT00827242|2561138|P1|Overall Study|Protocol Violation|1
805237|NCT00827242|2561137|P2|Overall Study|Withdrawal by Subject|4
805238|NCT00827242|2561138|P1|Overall Study|Withdrawal by Subject|2
805239|NCT00827372|2561179|P1|Overall Study|Lack of Efficacy|3
805240|NCT00827372|2561179|P1|Overall Study|Adverse Event|5
805241|NCT00827502|2561187|P1|Overall Study|Withdrawal by Subject|5
805242|NCT00827502|2561187|P1|Overall Study|Lost to Follow-up|4
805243|NCT00827502|2561187|P1|Overall Study|Adverse Event|1
805244|NCT00827502|2561187|P1|Overall Study|randomized but not treated|11
805245|NCT00827541|2561195|P2|Overall Study|Lack of effectiveness|0
805246|NCT00827541|2561196|P1|Overall Study|Lack of effectiveness|1
805247|NCT00827541|2561195|P2|Overall Study|Pathogen not susceptible|0
805248|NCT00827541|2561196|P1|Overall Study|Pathogen not susceptible|1
805249|NCT00827541|2561195|P2|Overall Study|Unspecified|3
805250|NCT00827541|2561196|P1|Overall Study|Unspecified|1
805251|NCT00827541|2561195|P2|Overall Study|Exitus|8
805252|NCT00827541|2561196|P1|Overall Study|Exitus|1
805253|NCT00827567|2561208|P1|Overall Study|Progression of Disease/Screen Failure|4
805254|NCT00827606|2561214|P2|Overall Study|Adverse Event|2
805255|NCT00827606|2561215|P1|Overall Study|Adverse Event|4
805256|NCT00827606|2561214|P2|Overall Study|LDL below 2.59 mmol/L|12
805257|NCT00827606|2561215|P1|Overall Study|LDL below 2.59 mmol/L|4
805258|NCT00827606|2561214|P2|Overall Study|Not specified|13
805259|NCT00827606|2561215|P1|Overall Study|Not specified|5
805260|NCT00827606|2561214|P2|Overall Study|Pregnancy|1
805261|NCT00827606|2561215|P1|Overall Study|Pregnancy|0
805262|NCT00827606|2561214|P2|Overall Study|Withdrawal by Subject|6
805263|NCT00827606|2561215|P1|Overall Study|Withdrawal by Subject|7
805264|NCT00827606|2561214|P2|Overall Study|Lost to Follow-up|1
805265|NCT00827606|2561215|P1|Overall Study|Lost to Follow-up|3
805266|NCT00827606|2561214|P2|Overall Study|Protocol Violation|3
805267|NCT00827606|2561215|P1|Overall Study|Protocol Violation|4
805268|NCT00827632|2561278|P2|Overall Study|Early withdrawal|11
805269|NCT00827632|2561279|P1|Overall Study|Early withdrawal|14
805270|NCT00827632|2561278|P2|Overall Study|Lost to Follow-up|12
805271|NCT00827632|2561279|P1|Overall Study|Lost to Follow-up|8
805272|NCT00827827|2561287|P2|Overall Study|Burned with water at home|0
805273|NCT00827827|2561288|P1|Overall Study|Burned with water at home|1
805274|NCT00827827|2561287|P2|Overall Study|Transportation issues|0
805275|NCT00827827|2561288|P1|Overall Study|Transportation issues|1
805276|NCT00827827|2561287|P2|Overall Study|Gout|0
805277|NCT00827827|2561288|P1|Overall Study|Gout|1
805278|NCT00827827|2561287|P2|Overall Study|Another cerebrovascular accident (CVA)|0
805279|NCT00827827|2561288|P1|Overall Study|Another cerebrovascular accident (CVA)|1
805280|NCT00827827|2561287|P2|Overall Study|Fall at home- hospitalization|0
805281|NCT00827827|2561288|P1|Overall Study|Fall at home- hospitalization|1
805282|NCT00827827|2561287|P2|Overall Study|Lost to Follow-up|0
805283|NCT00827827|2561288|P1|Overall Study|Lost to Follow-up|3
805284|NCT00827918|2561333|P3|Overall Study|Withdrawal by Subject|6
805285|NCT00827918|2561334|P2|Overall Study|Withdrawal by Subject|2
805286|NCT00827918|2561335|P1|Overall Study|Withdrawal by Subject|6
805287|NCT00827918|2561333|P3|Overall Study|Protocol Violation|0
805288|NCT00827918|2561334|P2|Overall Study|Protocol Violation|1
805289|NCT00827918|2561335|P1|Overall Study|Protocol Violation|0
805290|NCT00827918|2561333|P3|Overall Study|Progressive Disease|0
805291|NCT00827918|2561334|P2|Overall Study|Progressive Disease|1
805292|NCT00827918|2561335|P1|Overall Study|Progressive Disease|1
805293|NCT00827918|2561333|P3|Overall Study|Pregnancy|0
805294|NCT00827918|2561334|P2|Overall Study|Pregnancy|1
805295|NCT00827918|2561335|P1|Overall Study|Pregnancy|0
805296|NCT00827918|2561333|P3|Overall Study|Physician Decision|0
805297|NCT00827918|2561334|P2|Overall Study|Physician Decision|0
805298|NCT00827918|2561335|P1|Overall Study|Physician Decision|1
805299|NCT00827918|2561333|P3|Overall Study|Lack of Efficacy|15
805300|NCT00827918|2561334|P2|Overall Study|Lack of Efficacy|4
805301|NCT00827918|2561335|P1|Overall Study|Lack of Efficacy|16
805302|NCT00827918|2561333|P3|Overall Study|Adverse Event|0
805303|NCT00827918|2561334|P2|Overall Study|Adverse Event|0
805304|NCT00827918|2561335|P1|Overall Study|Adverse Event|4
805305|NCT00827931|2561363|P2|Overall Study|Unspecified|0
805306|NCT00827931|2561364|P1|Overall Study|Unspecified|1
805307|NCT00827931|2561363|P2|Overall Study|Withdrawal by Subject|1
805308|NCT00827931|2561364|P1|Overall Study|Withdrawal by Subject|0
805309|NCT00827931|2561363|P2|Overall Study|Lost to Follow-up|0
805310|NCT00827931|2561364|P1|Overall Study|Lost to Follow-up|1
805311|NCT00827931|2561363|P2|Overall Study|Adverse Event|0
805312|NCT00827931|2561364|P1|Overall Study|Adverse Event|1
805313|NCT00827931|2561363|P2|Overall Study|Death|5
805314|NCT00827931|2561364|P1|Overall Study|Death|3
805315|NCT00828113|2561450|P2|Overall Study|Lost to Follow-up|5
805316|NCT00828113|2561451|P1|Overall Study|Lost to Follow-up|3
805317|NCT00828113|2561450|P2|Overall Study|Withdrawal by Subject|26
805318|NCT00828113|2561451|P1|Overall Study|Withdrawal by Subject|27
805319|NCT00828139|2561461|P4|Overall Study|Not specified|2
805320|NCT00828139|2561462|P3|Overall Study|Not specified|5
805321|NCT00828139|2561463|P2|Overall Study|Not specified|2
805322|NCT00828139|2561464|P1|Overall Study|Not specified|4
805323|NCT00828139|2561461|P4|Overall Study|Disease Progression|39
805324|NCT00828139|2561462|P3|Overall Study|Disease Progression|35
805325|NCT00828139|2561463|P2|Overall Study|Disease Progression|33
805326|NCT00828139|2561464|P1|Overall Study|Disease Progression|24
805327|NCT00828139|2561461|P4|Overall Study|Refusal unrelated to toxicity|3
805328|NCT00828139|2561462|P3|Overall Study|Refusal unrelated to toxicity|5
805329|NCT00828139|2561463|P2|Overall Study|Refusal unrelated to toxicity|4
805330|NCT00828139|2561464|P1|Overall Study|Refusal unrelated to toxicity|3
805331|NCT00828139|2561461|P4|Overall Study|Death|2
805332|NCT00828139|2561462|P3|Overall Study|Death|0
805333|NCT00828139|2561463|P2|Overall Study|Death|1
805334|NCT00828139|2561464|P1|Overall Study|Death|2
805335|NCT00828139|2561461|P4|Overall Study|Adverse Event|5
805336|NCT00828139|2561462|P3|Overall Study|Adverse Event|10
805337|NCT00828139|2561463|P2|Overall Study|Adverse Event|1
805338|NCT00828139|2561464|P1|Overall Study|Adverse Event|8
805339|NCT00828204|2561510|P2|Extension Study|Physician Decision|2
805340|NCT00828204|2561511|P1|Extension Study|Physician Decision|0
805341|NCT00828204|2561510|P2|Extension Study|Lost to Follow-up|1
805342|NCT00828204|2561511|P1|Extension Study|Lost to Follow-up|0
805343|NCT00828204|2561510|P2|Main Study: After Study Restart|Noncompliance|1
805344|NCT00828204|2561511|P1|Main Study: After Study Restart|Noncompliance|0
805345|NCT00828204|2561510|P2|Main Study: After Study Restart|Adverse Event|2
805346|NCT00828204|2561511|P1|Main Study: After Study Restart|Adverse Event|0
805347|NCT00828204|2561510|P2|Main Study: Prior to Study Suspension|Study Suspension|0
805348|NCT00828204|2561511|P1|Main Study: Prior to Study Suspension|Study Suspension|11
805349|NCT00828204|2561510|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
805350|NCT00828204|2561511|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
805351|NCT00828204|2561510|P2|Main Study: Prior to Study Suspension|Adverse Event|0
805352|NCT00828204|2561511|P1|Main Study: Prior to Study Suspension|Adverse Event|1
805353|NCT00828321|2561545|P2|Second Intervention|Protocol Violation|1
805354|NCT00828321|2561546|P1|Second Intervention|Protocol Violation|0
805355|NCT00828321|2561545|P2|Washout of 42 Days|Withdrawal by Subject|0
805356|NCT00828321|2561546|P1|Washout of 42 Days|Withdrawal by Subject|2
805357|NCT00828464|2561576|P1|Overall Study|Withdrawal by Subject|1
805358|NCT00828516|2561593|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
805359|NCT00828568|2561610|P3|Treated - Received at Least One Dose|Protocol Violation|3
805360|NCT00828568|2561611|P2|Treated - Received at Least One Dose|Protocol Violation|5
805361|NCT00828568|2561612|P1|Treated - Received at Least One Dose|Protocol Violation|9
805362|NCT00828568|2561610|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
805363|NCT00828568|2561611|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
805364|NCT00828568|2561612|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
805365|NCT00828568|2561610|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
805366|NCT00828568|2561611|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
805367|NCT00828568|2561612|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
805368|NCT00828568|2561610|P3|Treated - Received at Least One Dose|Adverse Event|1
805369|NCT00828568|2561611|P2|Treated - Received at Least One Dose|Adverse Event|8
805370|NCT00828568|2561612|P1|Treated - Received at Least One Dose|Adverse Event|11
805371|NCT00828568|2561610|P3|Randomized|Withdrawal by Subject|2
805372|NCT00828568|2561611|P2|Randomized|Withdrawal by Subject|0
805373|NCT00828568|2561612|P1|Randomized|Withdrawal by Subject|1
805374|NCT00821327|2561625|P1|Overall Study|Other/Unknown|5
805375|NCT00821327|2561625|P1|Overall Study|Disease Progression|13
805376|NCT00821327|2561625|P1|Overall Study|Sponsor Request|1
805377|NCT00821327|2561625|P1|Overall Study|Investigator Request|2
805378|NCT00821327|2561625|P1|Overall Study|Patient Request|1
805379|NCT00821327|2561625|P1|Overall Study|Adverse Event|13
805380|NCT00821431|2561633|P2|Overall Study|Physician Decision|1
805381|NCT00821431|2561634|P1|Overall Study|Physician Decision|0
805382|NCT00821431|2561633|P2|Overall Study|Protocol Violation|1
805383|NCT00821431|2561634|P1|Overall Study|Protocol Violation|3
805384|NCT00821431|2561633|P2|Overall Study|Lost to Follow-up|0
805385|NCT00821431|2561634|P1|Overall Study|Lost to Follow-up|1
805386|NCT00821431|2561633|P2|Overall Study|Withdrawal by Subject|0
805387|NCT00821431|2561634|P1|Overall Study|Withdrawal by Subject|5
805388|NCT00821431|2561633|P2|Overall Study|Adverse Event|3
805389|NCT00821431|2561634|P1|Overall Study|Adverse Event|6
805390|NCT00821509|2561645|P3|Overall Study|Withdrawal by Subject|34
805391|NCT00821509|2561646|P2|Overall Study|Withdrawal by Subject|11
805392|NCT00821509|2561647|P1|Overall Study|Withdrawal by Subject|12
805393|NCT00821587|2561660|P2|Overall Study|Physician Decision|1
805394|NCT00821587|2561661|P1|Overall Study|Physician Decision|0
805395|NCT00821678|2561669|P2|Overall Study|Death|2
805396|NCT00821678|2561670|P1|Overall Study|Death|0
805397|NCT00821678|2561669|P2|Overall Study|Lost to Follow-up|12
805398|NCT00821678|2561670|P1|Overall Study|Lost to Follow-up|13
805399|NCT00821678|2561669|P2|Overall Study|Withdrawal by Subject|0
805400|NCT00821678|2561670|P1|Overall Study|Withdrawal by Subject|8
805401|NCT00821873|2561701|P1|Overall Study|Lost to Follow-up|4
805402|NCT00828711|2561725|P3|Overall Study|Lost to Follow-up|0
805403|NCT00828711|2561726|P2|Overall Study|Lost to Follow-up|0
805404|NCT00828711|2561727|P1|Overall Study|Lost to Follow-up|1
805405|NCT00828750|2561756|P1|Overall Study|Normal PC Remained While No Treatment|1
805406|NCT00828750|2561756|P1|Overall Study|Lack of Efficacy|3
805407|NCT00833755|2561789|P4|Overall Study|Subject had scheduling issues|0
805408|NCT00833755|2561790|P3|Overall Study|Subject had scheduling issues|0
805409|NCT00833755|2561791|P2|Overall Study|Subject had scheduling issues|1
805410|NCT00833755|2561792|P1|Overall Study|Subject had scheduling issues|0
805411|NCT00833755|2561789|P4|Overall Study|Physician Decision|6
805412|NCT00833755|2561790|P3|Overall Study|Physician Decision|2
805413|NCT00833755|2561791|P2|Overall Study|Physician Decision|4
805414|NCT00833755|2561792|P1|Overall Study|Physician Decision|4
805415|NCT00833794|2561826|P2|Double-blind Phase|Administrative reason|3
805416|NCT00833794|2561827|P1|Double-blind Phase|Administrative reason|1
805417|NCT00833794|2561826|P2|Double-blind Phase|Physician Decision|7
805418|NCT00833794|2561827|P1|Double-blind Phase|Physician Decision|4
805419|NCT00833794|2561826|P2|Double-blind Phase|Withdrawal by Subject|6
805420|NCT00833794|2561827|P1|Double-blind Phase|Withdrawal by Subject|23
805421|NCT00833794|2561826|P2|Double-blind Phase|Lack of Efficacy|22
805422|NCT00833794|2561827|P1|Double-blind Phase|Lack of Efficacy|34
805423|NCT00833794|2561826|P2|Double-blind Phase|Adverse Event|11
805424|NCT00833794|2561827|P1|Double-blind Phase|Adverse Event|44
805425|NCT00833794|2561826|P2|Open-label Phase|enrolled in error (immediately D/C)|0
805426|NCT00833794|2561827|P1|Open-label Phase|enrolled in error (immediately D/C)|1
805427|NCT00833794|2561826|P2|Open-label Phase|Did not complete wash-out period|0
805428|NCT00833794|2561827|P1|Open-label Phase|Did not complete wash-out period|12
805429|NCT00833794|2561826|P2|Open-label Phase|Protocol Violation|0
805430|NCT00833794|2561827|P1|Open-label Phase|Protocol Violation|47
805431|NCT00833794|2561826|P2|Open-label Phase|Administrative reason|0
805432|NCT00833794|2561827|P1|Open-label Phase|Administrative reason|1
805433|NCT00833794|2561826|P2|Open-label Phase|Physician Decision|0
805434|NCT00833794|2561827|P1|Open-label Phase|Physician Decision|20
805435|NCT00833794|2561826|P2|Open-label Phase|Withdrawal by Subject|0
805436|NCT00833794|2561827|P1|Open-label Phase|Withdrawal by Subject|48
805437|NCT00833794|2561826|P2|Open-label Phase|Lack of Efficacy|0
805438|NCT00833794|2561827|P1|Open-label Phase|Lack of Efficacy|28
805439|NCT00833794|2561826|P2|Open-label Phase|Adverse Event|0
805440|NCT00833794|2561827|P1|Open-label Phase|Adverse Event|225
805441|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
805442|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
805443|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
805444|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
805445|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
805446|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
805447|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Unspecified|3
805448|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Unspecified|4
805449|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Unspecified|0
805450|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Unspecified|0
805451|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Unspecified|0
805452|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Unspecified|0
805453|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
805454|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
805455|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
805456|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
805457|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
805458|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
805459|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
805460|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
805461|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
805462|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
805463|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
805464|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
805465|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Death|9
805466|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Death|8
805467|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Death|0
805468|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Death|0
805469|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Death|0
805470|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Death|0
805471|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
805472|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
805473|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
805474|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
805475|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
805476|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
805477|NCT00833833|2561859|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
805478|NCT00833833|2561860|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
805479|NCT00833833|2561861|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
805480|NCT00833833|2561862|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
805481|NCT00833833|2561863|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
805482|NCT00833833|2561864|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
805483|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Unspecified|0
805484|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Unspecified|0
805485|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Unspecified|1
805486|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Unspecified|0
805487|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Unspecified|3
805488|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Unspecified|1
805489|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
805490|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
805491|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
805492|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
805493|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
805494|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
805495|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Death|0
805496|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Death|0
805497|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Death|0
805498|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Death|2
805499|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Death|1
805500|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Death|0
805501|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
805502|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
805503|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
805504|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
805505|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
805506|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
805507|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
805508|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
805509|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
805510|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
805511|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
805512|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
805513|NCT00833833|2561859|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
805514|NCT00833833|2561860|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
805515|NCT00833833|2561861|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
805516|NCT00833833|2561862|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
805517|NCT00833833|2561863|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
805518|NCT00833833|2561864|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
805519|NCT00833898|2561911|P2|Overall Study|Patient did not receive transplant|2
805520|NCT00833898|2561912|P1|Overall Study|Patient did not receive transplant|0
805521|NCT00833898|2561911|P2|Overall Study|Lost to Follow-up|7
805522|NCT00833898|2561912|P1|Overall Study|Lost to Follow-up|7
805523|NCT00833898|2561911|P2|Overall Study|Withdrawal by Subject|27
805524|NCT00833898|2561912|P1|Overall Study|Withdrawal by Subject|33
805525|NCT00833911|2561958|P1|Maintenance Phase II|Lack of Efficacy|1
805526|NCT00833911|2561958|P1|Maintenance Phase II|Withdrawal by Subject|1
805527|NCT00833911|2561958|P1|Maintenance Phase II|Physician Decision|2
805528|NCT00833911|2561958|P1|Maintenance Phase II|Adverse Event|6
805529|NCT00833911|2561958|P1|Maintenance Phase I|Lack of Efficacy|4
805530|NCT00833911|2561958|P1|Maintenance Phase I|Physician Decision|10
805531|NCT00833911|2561958|P1|Maintenance Phase I|Withdrawal by Subject|11
805532|NCT00833911|2561958|P1|Maintenance Phase I|Adverse Event|73
805533|NCT00833911|2561958|P1|Titration|Withdrawal by Subject|3
805534|NCT00833911|2561958|P1|Titration|Adverse Event|18
805535|NCT00833924|2561966|P1|Overall Study|In study follow-up|71
805536|NCT00833924|2561966|P1|Overall Study|Withdrawal by Subject|13
805537|NCT00833924|2561966|P1|Overall Study|Lost to Follow-up|2
805538|NCT00833924|2561966|P1|Overall Study|Conversion|2
805539|NCT00833924|2561966|P1|Overall Study|Death|21
805540|NCT00833937|2561973|P2|Washout|Withdrawal by Subject|0
805541|NCT00833937|2561974|P1|Washout|Withdrawal by Subject|1
805542|NCT00833976|2561982|P1|Overall Study|Physician Decision|1
805543|NCT00833976|2561982|P1|Overall Study|Did not meet eligibility criteria|41
805544|NCT00833976|2561982|P1|Overall Study|Lost to Follow-up|4
805545|NCT00833976|2561982|P1|Overall Study|Withdrawal by Subject|5
805546|NCT00834041|2561990|P2|Overall Study|Lost to Follow-up|1
805547|NCT00834041|2561991|P1|Overall Study|Lost to Follow-up|0
805548|NCT00834041|2561990|P2|Overall Study|Withdrawal by Subject|0
805549|NCT00834041|2561991|P1|Overall Study|Withdrawal by Subject|1
805550|NCT00834067|2562007|P2|Washout of 21 Days|Protocol Violation|1
805551|NCT00834067|2562008|P1|Washout of 21 Days|Protocol Violation|0
805552|NCT00834080|2562028|P1|Overall Study|Subject Relocated|1
805553|NCT00834080|2562028|P1|Overall Study|Physician Decision|1
805554|NCT00834080|2562028|P1|Overall Study|Other - False positive tests of the UDS|1
805555|NCT00834080|2562028|P1|Overall Study|Other - Pregnancy|1
805556|NCT00834080|2562028|P1|Overall Study|Withdrawal by Subject|5
805557|NCT00834080|2562028|P1|Overall Study|Lost to Follow-up|7
805558|NCT00834080|2562028|P1|Overall Study|Adverse Event|7
805559|NCT00834249|2562089|P2|Second Intervention|Adverse Event|0
805560|NCT00834249|2562090|P1|Second Intervention|Adverse Event|1
805561|NCT00834249|2562089|P2|Washout: 7 Days|Withdrawal by Subject|1
805562|NCT00834249|2562090|P1|Washout: 7 Days|Withdrawal by Subject|1
805563|NCT00834340|2562140|P2|Washout|Withdrawal by Subject|0
805564|NCT00834340|2562141|P1|Washout|Withdrawal by Subject|1
805565|NCT00834340|2562140|P2|Washout|Adverse Event|0
805566|NCT00834340|2562141|P1|Washout|Adverse Event|1
805567|NCT00834366|2562151|P2|Treatment Period 1|Adverse Event|1
805568|NCT00834366|2562152|P1|Treatment Period 1|Adverse Event|1
805569|NCT00834418|2562177|P2|Overall Study|Adverse Event|2
805570|NCT00834418|2562178|P1|Overall Study|Adverse Event|0
805571|NCT00834431|2562186|P2|Washout of 7 Days|Withdrawal by Subject|1
805572|NCT00834431|2562187|P1|Washout of 7 Days|Withdrawal by Subject|0
805573|NCT00834431|2562186|P2|First Intervention|Adverse Event|1
805574|NCT00834431|2562187|P1|First Intervention|Adverse Event|0
805575|NCT00834444|2562197|P2|Second Intervention|Adverse Event|0
805576|NCT00834444|2562198|P1|Second Intervention|Adverse Event|1
805577|NCT00834444|2562197|P2|Washout of 7 Days|Withdrawal by Subject|1
805578|NCT00834444|2562198|P1|Washout of 7 Days|Withdrawal by Subject|0
805579|NCT00834444|2562197|P2|First Intervention|Intolerance to Venopuncture|1
805580|NCT00834444|2562198|P1|First Intervention|Intolerance to Venopuncture|0
805581|NCT00834444|2562197|P2|First Intervention|Adverse Event|0
805582|NCT00834444|2562198|P1|First Intervention|Adverse Event|1
805583|NCT00834522|2562221|P2|Washout|Withdrawal by Subject|1
805584|NCT00834522|2562222|P1|Washout|Withdrawal by Subject|2
805585|NCT00834522|2562221|P2|Washout|Adverse Event|0
805586|NCT00834522|2562222|P1|Washout|Adverse Event|1
805587|NCT00834587|2562265|P2|Washout: 7 Days|Withdrawal by Subject|0
805588|NCT00834587|2562266|P1|Washout: 7 Days|Withdrawal by Subject|1
805589|NCT00834613|2562282|P2|First Intervention|Protocol Violation|0
805590|NCT00834613|2562283|P1|First Intervention|Protocol Violation|1
805591|NCT00834639|2562300|P2|Second Intervention|Physician Decision|2
805592|NCT00834639|2562301|P1|Second Intervention|Physician Decision|0
805593|NCT00834717|2562322|P2|First Intervention|Withdrawal by Subject|1
805594|NCT00834717|2562323|P1|First Intervention|Withdrawal by Subject|0
805595|NCT00834717|2562322|P2|First Intervention|Adverse Event|0
805596|NCT00834717|2562323|P1|First Intervention|Adverse Event|1
805597|NCT00834743|2562333|P2|Second Intervention|Withdrawal by Subject|0
805598|NCT00834743|2562334|P1|Second Intervention|Withdrawal by Subject|1
805599|NCT00834756|2562344|P2|Washout: 21 Days|Withdrawal by Subject|0
805600|NCT00834756|2562345|P1|Washout: 21 Days|Withdrawal by Subject|1
805601|NCT00834756|2562344|P2|First Intervention|Adverse Event|0
805602|NCT00834756|2562345|P1|First Intervention|Adverse Event|1
805603|NCT00834795|2562355|P2|Second Intervention|Adverse Event|0
805604|NCT00834795|2562356|P1|Second Intervention|Adverse Event|1
805605|NCT00834795|2562355|P2|Washout: 7 Days|Withdrawal by Subject|1
805606|NCT00834795|2562356|P1|Washout: 7 Days|Withdrawal by Subject|0
805607|NCT00834834|2562391|P2|Overall Study|Withdrawal by Subject|3
805608|NCT00834834|2562392|P1|Overall Study|Withdrawal by Subject|4
805609|NCT00834873|2562402|P2|First Intervention|Adverse Event|1
805610|NCT00834873|2562403|P1|First Intervention|Adverse Event|0
805611|NCT00834899|2562438|P2|Overall Study|Withdrawal by Subject|1
805612|NCT00834899|2562439|P1|Overall Study|Withdrawal by Subject|1
805613|NCT00834912|2562457|P6|Treatment Period 2|Withdrawal by Subject|0
805614|NCT00834912|2562458|P5|Treatment Period 2|Withdrawal by Subject|1
805615|NCT00834912|2562459|P4|Treatment Period 2|Withdrawal by Subject|0
805616|NCT00834912|2562460|P3|Treatment Period 2|Withdrawal by Subject|1
805617|NCT00834912|2562461|P2|Treatment Period 2|Withdrawal by Subject|0
805618|NCT00834912|2562462|P1|Treatment Period 2|Withdrawal by Subject|0
805619|NCT00834912|2562457|P6|Treatment Period 1|Adverse Event|0
805620|NCT00834912|2562458|P5|Treatment Period 1|Adverse Event|0
805621|NCT00834912|2562459|P4|Treatment Period 1|Adverse Event|1
805622|NCT00834912|2562460|P3|Treatment Period 1|Adverse Event|0
805623|NCT00834912|2562461|P2|Treatment Period 1|Adverse Event|1
805624|NCT00834912|2562462|P1|Treatment Period 1|Adverse Event|0
805625|NCT00835042|2562544|P2|Washout of 21 Days|Withdrawal by Subject|2
805626|NCT00835042|2562545|P1|Washout of 21 Days|Withdrawal by Subject|0
805627|NCT00835042|2562544|P2|First Intervention|Adverse Event|2
805628|NCT00835042|2562545|P1|First Intervention|Adverse Event|1
805629|NCT00835042|2562544|P2|First Intervention|Withdrawal by Subject|0
805630|NCT00835042|2562545|P1|First Intervention|Withdrawal by Subject|3
805631|NCT00835068|2562567|P2|Overall Study|Withdrawal by Subject|0
805632|NCT00835068|2562568|P1|Overall Study|Withdrawal by Subject|1
805633|NCT00835068|2562567|P2|Overall Study|Unspecified|0
805634|NCT00835068|2562568|P1|Overall Study|Unspecified|8
805635|NCT00835068|2562567|P2|Overall Study|Adverse Event|1
805636|NCT00835068|2562568|P1|Overall Study|Adverse Event|0
805637|NCT00835068|2562567|P2|Overall Study|Death|0
805638|NCT00835068|2562568|P1|Overall Study|Death|1
805639|NCT00835081|2562588|P2|Washout of 7 Days|Withdrawal by Subject|0
805640|NCT00835081|2562589|P1|Washout of 7 Days|Withdrawal by Subject|1
805641|NCT00835120|2562597|P1|Overall Study|Withdrawal by Subject|2
805642|NCT00835120|2562597|P1|Overall Study|Adverse Event|2
805643|NCT00835120|2562597|P1|Overall Study|Lost to Follow-up|3
805644|NCT00835120|2562597|P1|Overall Study|Lack of Efficacy|1
805645|NCT00835172|2562625|P2|Washout|Protocol Violation|1
805646|NCT00835172|2562626|P1|Washout|Protocol Violation|0
805647|NCT00835211|2562672|P2|Washout: 7 Days|Withdrawal by Subject|0
805648|NCT00835211|2562673|P1|Washout: 7 Days|Withdrawal by Subject|1
805649|NCT00835211|2562672|P2|Washout: 7 Days|Adverse Event|1
805650|NCT00835211|2562673|P1|Washout: 7 Days|Adverse Event|2
805651|NCT00835211|2562672|P2|First Intervention|Withdrawal by Subject|1
805652|NCT00835211|2562673|P1|First Intervention|Withdrawal by Subject|0
805653|NCT00835237|2562697|P2|Overall Study|Withdrawal by Subject|0
805654|NCT00835237|2562698|P1|Overall Study|Withdrawal by Subject|2
805655|NCT00835237|2562697|P2|Overall Study|Lost to Follow-up|0
805656|NCT00835237|2562698|P1|Overall Study|Lost to Follow-up|4
805657|NCT00835263|2562724|P2|Second Intervention|Adverse Event|0
805658|NCT00835263|2562725|P1|Second Intervention|Adverse Event|1
805659|NCT00835341|2562746|P2|Overall Study|Lost to Follow-up|12
805660|NCT00835341|2562747|P1|Overall Study|Lost to Follow-up|3
805661|NCT00835354|2562755|P2|First Intervention|Adverse Event|1
805662|NCT00835354|2562756|P1|First Intervention|Adverse Event|0
805663|NCT00835367|2562766|P2|Second Intervention|Adverse Event|1
805664|NCT00835367|2562767|P1|Second Intervention|Adverse Event|1
805665|NCT00835367|2562766|P2|Washout|Withdrawal by Subject|0
805666|NCT00835367|2562767|P1|Washout|Withdrawal by Subject|1
805667|NCT00835367|2562766|P2|Washout|Adverse Event|0
805668|NCT00835367|2562767|P1|Washout|Adverse Event|2
805669|NCT00835380|2562787|P1|Overall Study|Withdrawal by Subject|2
805670|NCT00835406|2562794|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
805671|NCT00835406|2562795|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
805672|NCT00835406|2562794|P2|Period: First Intervention|Withdrawal by Subject|0
805673|NCT00835406|2562795|P1|Period: First Intervention|Withdrawal by Subject|2
805674|NCT00835406|2562794|P2|Period: First Intervention|Adverse Event|1
805675|NCT00835406|2562795|P1|Period: First Intervention|Adverse Event|0
805676|NCT00835536|2562856|P2|Washout of 5 Weeks|Withdrawal by Subject|0
805677|NCT00835536|2562857|P1|Washout of 5 Weeks|Withdrawal by Subject|1
805678|NCT00835549|2562865|P2|Washout of 7 Days|Withdrawal by Subject|0
805679|NCT00835549|2562866|P1|Washout of 7 Days|Withdrawal by Subject|2
805680|NCT00835575|2562876|P2|Washout of 14 Days|Withdrawal by Subject|0
805681|NCT00835575|2562877|P1|Washout of 14 Days|Withdrawal by Subject|1
805682|NCT00835640|2562909|P2|Second Intervention|Protocol Violation|0
805683|NCT00835640|2562910|P1|Second Intervention|Protocol Violation|1
805684|NCT00835666|2562920|P2|Washout|Withdrawal by Subject|0
805685|NCT00835666|2562921|P1|Washout|Withdrawal by Subject|1
805686|NCT00835666|2562920|P2|Washout|Protocol Violation|0
805687|NCT00835666|2562921|P1|Washout|Protocol Violation|1
805688|NCT00835679|2562933|P4|Overall Study|Withdrawal by Subject|0
805689|NCT00835679|2562934|P3|Overall Study|Withdrawal by Subject|0
805690|NCT00835679|2562935|P2|Overall Study|Withdrawal by Subject|0
805691|NCT00835679|2562936|P1|Overall Study|Withdrawal by Subject|1
805692|NCT00835692|2562960|P2|First Intervention|Withdrawal by Subject|0
805693|NCT00835692|2562961|P1|First Intervention|Withdrawal by Subject|1
805694|NCT00835705|2562971|P2|Second Intervention|Difficulty with vein|0
805695|NCT00835705|2562972|P1|Second Intervention|Difficulty with vein|1
805696|NCT00835705|2562971|P2|First Intervention|Difficulty with vein|0
805697|NCT00835705|2562972|P1|First Intervention|Difficulty with vein|1
805702|NCT00835796|2563005|P2|First Intervention|Withdrawal by Subject|1
805703|NCT00835796|2563006|P1|First Intervention|Withdrawal by Subject|0
805704|NCT00835978|2563069|P4|Overall Study|Study terminated by sponsor|0
805705|NCT00835978|2563070|P3|Overall Study|Study terminated by sponsor|30
805706|NCT00835978|2563071|P2|Overall Study|Study terminated by sponsor|8
805707|NCT00835978|2563072|P1|Overall Study|Study terminated by sponsor|12
805708|NCT00835978|2563069|P4|Overall Study|Withdrawal by Subject|5
805709|NCT00835978|2563070|P3|Overall Study|Withdrawal by Subject|0
805710|NCT00835978|2563071|P2|Overall Study|Withdrawal by Subject|3
805711|NCT00835978|2563072|P1|Overall Study|Withdrawal by Subject|0
805712|NCT00835978|2563069|P4|Overall Study|Adverse Event|0
805713|NCT00835978|2563070|P3|Overall Study|Adverse Event|1
805714|NCT00835978|2563071|P2|Overall Study|Adverse Event|0
805715|NCT00835978|2563072|P1|Overall Study|Adverse Event|1
805716|NCT00835978|2563069|P4|Overall Study|Objective progression or relapse|0
805717|NCT00835978|2563070|P3|Overall Study|Objective progression or relapse|1
805718|NCT00835978|2563071|P2|Overall Study|Objective progression or relapse|0
805719|NCT00835978|2563072|P1|Overall Study|Objective progression or relapse|2
805720|NCT00835978|2563069|P4|Overall Study|Not Specified|0
805721|NCT00835978|2563070|P3|Overall Study|Not Specified|8
805722|NCT00835978|2563071|P2|Overall Study|Not Specified|1
805723|NCT00835978|2563072|P1|Overall Study|Not Specified|5
805724|NCT00835978|2563069|P4|Overall Study|Lost to Follow-up|1
805725|NCT00835978|2563070|P3|Overall Study|Lost to Follow-up|2
805726|NCT00835978|2563071|P2|Overall Study|Lost to Follow-up|4
805727|NCT00835978|2563072|P1|Overall Study|Lost to Follow-up|3
805728|NCT00835978|2563069|P4|Overall Study|Death|4
805729|NCT00835978|2563070|P3|Overall Study|Death|49
805730|NCT00835978|2563071|P2|Overall Study|Death|40
805731|NCT00835978|2563072|P1|Overall Study|Death|33
805732|NCT00835991|2563132|P2|Washout|Withdrawal by Subject|1
805733|NCT00835991|2563133|P1|Washout|Withdrawal by Subject|3
805734|NCT00835991|2563132|P2|Washout|Protocol Violation|2
805735|NCT00835991|2563133|P1|Washout|Protocol Violation|0
805736|NCT00835991|2563132|P2|First Intervention|Adverse Event|1
805737|NCT00835991|2563133|P1|First Intervention|Adverse Event|0
805738|NCT00836056|2563168|P2|First Intervention|Adverse Event|0
805739|NCT00836056|2563169|P1|First Intervention|Adverse Event|1
805740|NCT00836095|2563179|P2|Overall Study|Physician Decision|3
805741|NCT00836095|2563180|P1|Overall Study|Physician Decision|0
805742|NCT00824850|2563190|P2|Overall Study|Withdrawal by Subject|1
805743|NCT00824850|2563191|P1|Overall Study|Withdrawal by Subject|0
805761|NCT00825305|2563297|P2|Overall Study|Can not be classified|1
805762|NCT00825305|2563298|P1|Overall Study|Can not be classified|0
805763|NCT00825305|2563297|P2|Overall Study|Protocol Violation|9
805764|NCT00825305|2563298|P1|Overall Study|Protocol Violation|9
805765|NCT00825305|2563297|P2|Overall Study|Inappropriate inclusion|0
805766|NCT00825305|2563298|P1|Overall Study|Inappropriate inclusion|1
805767|NCT00825305|2563297|P2|Overall Study|Withdrawal by Subject|12
805768|NCT00825305|2563298|P1|Overall Study|Withdrawal by Subject|6
805769|NCT00825305|2563297|P2|Overall Study|Adverse Event|1
805770|NCT00825305|2563298|P1|Overall Study|Adverse Event|1
805771|NCT00825682|2563371|P2|Overall Study|personal reasons/ inconvenience|5
805772|NCT00825682|2563372|P1|Overall Study|personal reasons/ inconvenience|13
805773|NCT00825812|2563417|P4|Overall Study|Administrative|5
805774|NCT00825812|2563418|P3|Overall Study|Administrative|3
805775|NCT00825812|2563419|P2|Overall Study|Administrative|1
805776|NCT00825812|2563420|P1|Overall Study|Administrative|0
805777|NCT00825812|2563417|P4|Overall Study|Non-compliance with protocol|1
805778|NCT00825812|2563418|P3|Overall Study|Non-compliance with protocol|0
805779|NCT00825812|2563419|P2|Overall Study|Non-compliance with protocol|0
805780|NCT00825812|2563420|P1|Overall Study|Non-compliance with protocol|0
805781|NCT00825812|2563417|P4|Overall Study|Subject withdrew consent|2
805782|NCT00825812|2563418|P3|Overall Study|Subject withdrew consent|3
805783|NCT00825812|2563419|P2|Overall Study|Subject withdrew consent|0
805784|NCT00825812|2563420|P1|Overall Study|Subject withdrew consent|0
805785|NCT00825812|2563417|P4|Overall Study|Adverse Event|1
805786|NCT00825812|2563418|P3|Overall Study|Adverse Event|0
805787|NCT00825812|2563419|P2|Overall Study|Adverse Event|0
805788|NCT00825812|2563420|P1|Overall Study|Adverse Event|0
805789|NCT00825812|2563417|P4|Overall Study|Never entered follow up|1
805790|NCT00825812|2563418|P3|Overall Study|Never entered follow up|0
805791|NCT00825812|2563419|P2|Overall Study|Never entered follow up|0
805792|NCT00825812|2563420|P1|Overall Study|Never entered follow up|0
805793|NCT00825825|2563434|P6|Third Medication Period (14 Days)|poor data quality|0
805794|NCT00825825|2563435|P5|Third Medication Period (14 Days)|poor data quality|0
805795|NCT00825825|2563436|P4|Third Medication Period (14 Days)|poor data quality|0
805796|NCT00825825|2563437|P3|Third Medication Period (14 Days)|poor data quality|0
805797|NCT00825825|2563438|P2|Third Medication Period (14 Days)|poor data quality|1
805798|NCT00825825|2563439|P1|Third Medication Period (14 Days)|poor data quality|0
805799|NCT00825825|2563434|P6|Third Medication Period (14 Days)|Protocol Violation|2
805800|NCT00825825|2563435|P5|Third Medication Period (14 Days)|Protocol Violation|0
805801|NCT00825825|2563436|P4|Third Medication Period (14 Days)|Protocol Violation|0
805802|NCT00825825|2563437|P3|Third Medication Period (14 Days)|Protocol Violation|0
805803|NCT00825825|2563438|P2|Third Medication Period (14 Days)|Protocol Violation|0
805804|NCT00825825|2563439|P1|Third Medication Period (14 Days)|Protocol Violation|0
805805|NCT00825825|2563434|P6|Third Medication Period (14 Days)|Adverse Event|0
805806|NCT00825825|2563435|P5|Third Medication Period (14 Days)|Adverse Event|0
805807|NCT00825825|2563436|P4|Third Medication Period (14 Days)|Adverse Event|0
805808|NCT00825825|2563437|P3|Third Medication Period (14 Days)|Adverse Event|0
805809|NCT00825825|2563438|P2|Third Medication Period (14 Days)|Adverse Event|1
805810|NCT00825825|2563439|P1|Third Medication Period (14 Days)|Adverse Event|0
805811|NCT00825825|2563434|P6|Second Medication Period (14 Days)|Protocol Violation|0
805812|NCT00825825|2563435|P5|Second Medication Period (14 Days)|Protocol Violation|1
805813|NCT00825825|2563436|P4|Second Medication Period (14 Days)|Protocol Violation|0
805814|NCT00825825|2563437|P3|Second Medication Period (14 Days)|Protocol Violation|0
805815|NCT00825825|2563438|P2|Second Medication Period (14 Days)|Protocol Violation|0
805816|NCT00825825|2563439|P1|Second Medication Period (14 Days)|Protocol Violation|1
805817|NCT00825825|2563434|P6|Second Medication Period (14 Days)|Physician Decision|0
805818|NCT00825825|2563435|P5|Second Medication Period (14 Days)|Physician Decision|0
805819|NCT00825825|2563436|P4|Second Medication Period (14 Days)|Physician Decision|2
805820|NCT00825825|2563437|P3|Second Medication Period (14 Days)|Physician Decision|0
805821|NCT00825825|2563438|P2|Second Medication Period (14 Days)|Physician Decision|0
805822|NCT00825825|2563439|P1|Second Medication Period (14 Days)|Physician Decision|1
805823|NCT00825825|2563434|P6|First Medication Period (14 Days)|Physician Decision|1
805824|NCT00825825|2563435|P5|First Medication Period (14 Days)|Physician Decision|0
805825|NCT00825825|2563436|P4|First Medication Period (14 Days)|Physician Decision|0
805826|NCT00825825|2563437|P3|First Medication Period (14 Days)|Physician Decision|1
805827|NCT00825825|2563438|P2|First Medication Period (14 Days)|Physician Decision|0
805828|NCT00825825|2563439|P1|First Medication Period (14 Days)|Physician Decision|2
805829|NCT00825825|2563434|P6|First Medication Period (14 Days)|Adverse Event|1
805830|NCT00825825|2563435|P5|First Medication Period (14 Days)|Adverse Event|0
805831|NCT00825825|2563436|P4|First Medication Period (14 Days)|Adverse Event|0
805832|NCT00825825|2563437|P3|First Medication Period (14 Days)|Adverse Event|0
805833|NCT00825825|2563438|P2|First Medication Period (14 Days)|Adverse Event|0
805834|NCT00825825|2563439|P1|First Medication Period (14 Days)|Adverse Event|1
805835|NCT00825916|2563454|P3|Overall Study|Lost to Follow-up|1
805836|NCT00825916|2563455|P2|Overall Study|Lost to Follow-up|2
805837|NCT00825916|2563456|P1|Overall Study|Lost to Follow-up|4
805838|NCT00825994|2563497|P1|Overall Study|Placebo Responder at V2|1
805839|NCT00825994|2563497|P1|Overall Study|Protocol Violation|1
805840|NCT00825994|2563497|P1|Overall Study|Lost to Follow-up|1
805841|NCT00825994|2563497|P1|Overall Study|Withdrawal by Subject|2
805842|NCT00826111|2563512|P2|Overall Study|Physician Decision|1
805843|NCT00826111|2563513|P1|Overall Study|Physician Decision|1
805844|NCT00826111|2563512|P2|Overall Study|Withdrawal by Subject|0
805845|NCT00826111|2563513|P1|Overall Study|Withdrawal by Subject|5
805846|NCT00826111|2563512|P2|Overall Study|Protocol Violation|0
805847|NCT00826111|2563513|P1|Overall Study|Protocol Violation|1
805848|NCT00826111|2563512|P2|Overall Study|Lost to Follow-up|1
805849|NCT00826111|2563513|P1|Overall Study|Lost to Follow-up|0
805850|NCT00836277|2563535|P1|Overall Study|Not evaluable for response|6
805851|NCT00836472|2563608|P2|Washout|Withdrawal by Subject|1
805852|NCT00836472|2563609|P1|Washout|Withdrawal by Subject|1
805853|NCT00836472|2563608|P2|Washout|Adverse Event|2
805854|NCT00836472|2563609|P1|Washout|Adverse Event|1
805855|NCT00836498|2563625|P2|Overall Study|Withdrawal by Subject|1
805856|NCT00836498|2563626|P1|Overall Study|Withdrawal by Subject|2
805857|NCT00836498|2563625|P2|Overall Study|Lost to Follow-up|0
805858|NCT00836498|2563626|P1|Overall Study|Lost to Follow-up|1
805859|NCT00836498|2563625|P2|Overall Study|Adverse Event|0
805860|NCT00836498|2563626|P1|Overall Study|Adverse Event|1
805861|NCT00836693|2563668|P2|Overall Study|Lost to Follow-up|0
805862|NCT00836693|2563669|P1|Overall Study|Lost to Follow-up|1
805863|NCT00836693|2563668|P2|Overall Study|Protocol Violation|0
805864|NCT00836693|2563669|P1|Overall Study|Protocol Violation|1
805865|NCT00836693|2563668|P2|Overall Study|Withdrawal by Subject|4
805866|NCT00836693|2563669|P1|Overall Study|Withdrawal by Subject|9
805867|NCT00836693|2563668|P2|Overall Study|Physician Decision|0
805868|NCT00836693|2563669|P1|Overall Study|Physician Decision|2
805869|NCT00836693|2563668|P2|Overall Study|Sponsor Decision|1
805870|NCT00836693|2563669|P1|Overall Study|Sponsor Decision|0
805871|NCT00836693|2563668|P2|Overall Study|Adverse Event|1
805872|NCT00836693|2563669|P1|Overall Study|Adverse Event|4
805873|NCT00836706|2563711|P2|Washout: 7 Days|Withdrawal by Subject|1
805874|NCT00836706|2563712|P1|Washout: 7 Days|Withdrawal by Subject|0
805875|NCT00836745|2563725|P1|Overall Study|Unspecified|2
805876|NCT00836745|2563725|P1|Overall Study|Objective progression or relapse|4
805877|NCT00836745|2563725|P1|Overall Study|Adverse Event|3
805878|NCT00836745|2563725|P1|Overall Study|Lost to Follow-up|10
805879|NCT00836745|2563725|P1|Overall Study|Death|2
805880|NCT00836875|2563734|P2|Overall Study|Withdrawal by Subject|1
805881|NCT00836875|2563735|P1|Overall Study|Withdrawal by Subject|0
805882|NCT00836875|2563734|P2|Overall Study|Death|2
805883|NCT00836875|2563735|P1|Overall Study|Death|3
805884|NCT00836901|2563751|P2|First Intervention|Withdrawal by Subject|0
805885|NCT00836901|2563752|P1|First Intervention|Withdrawal by Subject|1
805886|NCT00836953|2563766|P1|Overall Study|Lost to Follow-up|1
805887|NCT00836953|2563766|P1|Overall Study|Withdrawal by Subject|1
805888|NCT00837148|2563778|P1|Overall Study|Death|1
805889|NCT00837148|2563778|P1|Overall Study|Adverse Event|1
805890|NCT00837161|2563782|P1|Overall Study|refused hysterectomy|2
805891|NCT00837213|2563798|P2|Overall Study|not stated|1
805892|NCT00837213|2563799|P1|Overall Study|not stated|1
805893|NCT00837213|2563798|P2|Overall Study|Withdrawal by Subject|2
805894|NCT00837213|2563799|P1|Overall Study|Withdrawal by Subject|2
805895|NCT00837213|2563798|P2|Overall Study|Lost to Follow-up|2
805896|NCT00837213|2563799|P1|Overall Study|Lost to Follow-up|3
805897|NCT00837330|2563836|P2|Overall Study|Lost to Follow-up|3
805898|NCT00837330|2563837|P1|Overall Study|Lost to Follow-up|1
805911|NCT00837486|2563871|P2|Long-term Follow-up Phase - Open Label|Death|0
805912|NCT00837486|2563872|P1|Long-term Follow-up Phase - Open Label|Death|1
805913|NCT00837486|2563871|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
805914|NCT00837486|2563872|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
805915|NCT00837486|2563871|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
805916|NCT00837486|2563872|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
805917|NCT00837486|2563871|P2|Blinded-treatment Phase|Physician Decision|0
805918|NCT00837486|2563872|P1|Blinded-treatment Phase|Physician Decision|1
805919|NCT00837577|2563893|P2|Open-label Period|Other Reason|1
805920|NCT00837577|2563894|P1|Open-label Period|Other Reason|1
805921|NCT00837577|2563893|P2|Open-label Period|Withdrawal by Subject|2
805922|NCT00837577|2563894|P1|Open-label Period|Withdrawal by Subject|1
805923|NCT00837577|2563893|P2|Open-label Period|Lack of Efficacy|3
805924|NCT00837577|2563894|P1|Open-label Period|Lack of Efficacy|4
805925|NCT00837577|2563893|P2|Open-label Period|Laboratory Adverse Event|1
805926|NCT00837577|2563894|P1|Open-label Period|Laboratory Adverse Event|0
805927|NCT00837577|2563893|P2|Open-label Period|Clinical Adverse Event|2
805928|NCT00837577|2563894|P1|Open-label Period|Clinical Adverse Event|2
805929|NCT00837577|2563893|P2|Double-blind Period|Withdrawal by Subject|0
805930|NCT00837577|2563894|P1|Double-blind Period|Withdrawal by Subject|1
805931|NCT00837577|2563893|P2|Double-blind Period|Clinical Adverse Event|0
805932|NCT00837577|2563894|P1|Double-blind Period|Clinical Adverse Event|1
805933|NCT00837616|2563907|P2|Overall Study|Withdrawal by Subject|1
805934|NCT00837616|2563908|P1|Overall Study|Withdrawal by Subject|0
805935|NCT00837759|2563932|P1|Overall Study|Lost to Follow-up|1
805936|NCT00837759|2563932|P1|Overall Study|Protocol Violation|3
805937|NCT00837876|2563953|P1|Overall Study|disease progression|24
805938|NCT00837876|2563953|P1|Overall Study|Withdrawal by Subject|3
805939|NCT00837876|2563953|P1|Overall Study|Physician Decision|1
805940|NCT00837876|2563953|P1|Overall Study|Adverse Event|7
805941|NCT00837876|2563953|P1|Overall Study|Death|2
805942|NCT00837967|2563960|P2|Washout Period of 7 - 14 Days|Adverse Event|0
805943|NCT00837967|2563961|P1|Washout Period of 7 - 14 Days|Adverse Event|2
805944|NCT00838097|2563977|P1|Overall Study|Protocol-specified criteria|142
805945|NCT00838097|2563977|P1|Overall Study|Death|6
805946|NCT00838097|2563977|P1|Overall Study|Lost to Follow-up|11
805947|NCT00838097|2563977|P1|Overall Study|Physician Decision|4
805948|NCT00838097|2563977|P1|Overall Study|Requirement for alternative therapy|2
805949|NCT00838097|2563977|P1|Overall Study|Withdrawal by Subject|3
805950|NCT00838097|2563977|P1|Overall Study|Adverse Event|2
805951|NCT00838097|2563977|P1|Overall Study|Ineligibility determined|6
805952|NCT00838110|2563987|P4|Overall Study|Randomized but not treated|0
805953|NCT00838110|2563988|P3|Overall Study|Randomized but not treated|0
805954|NCT00838110|2563989|P2|Overall Study|Randomized but not treated|1
805955|NCT00838110|2563990|P1|Overall Study|Randomized but not treated|0
805956|NCT00838110|2563987|P4|Overall Study|Did not meet eligibility criteria|2
805957|NCT00838110|2563988|P3|Overall Study|Did not meet eligibility criteria|1
805958|NCT00838110|2563989|P2|Overall Study|Did not meet eligibility criteria|0
805959|NCT00838110|2563990|P1|Overall Study|Did not meet eligibility criteria|0
805960|NCT00838110|2563987|P4|Overall Study|Lost to Follow-up|0
805961|NCT00838110|2563988|P3|Overall Study|Lost to Follow-up|0
805962|NCT00838110|2563989|P2|Overall Study|Lost to Follow-up|0
805963|NCT00838110|2563990|P1|Overall Study|Lost to Follow-up|3
805964|NCT00838110|2563987|P4|Overall Study|Protocol Violation|1
805965|NCT00838110|2563988|P3|Overall Study|Protocol Violation|1
805966|NCT00838110|2563989|P2|Overall Study|Protocol Violation|2
805967|NCT00838110|2563990|P1|Overall Study|Protocol Violation|0
805968|NCT00838110|2563987|P4|Overall Study|Unspecified|2
805969|NCT00838110|2563988|P3|Overall Study|Unspecified|3
805970|NCT00838110|2563989|P2|Overall Study|Unspecified|3
805971|NCT00838110|2563990|P1|Overall Study|Unspecified|3
805972|NCT00838110|2563987|P4|Overall Study|Withdrawal by Subject|4
805973|NCT00838110|2563988|P3|Overall Study|Withdrawal by Subject|3
805974|NCT00838110|2563989|P2|Overall Study|Withdrawal by Subject|6
805975|NCT00838110|2563990|P1|Overall Study|Withdrawal by Subject|5
805976|NCT00838110|2563987|P4|Overall Study|Adverse Event|7
805977|NCT00838110|2563988|P3|Overall Study|Adverse Event|8
805978|NCT00838110|2563989|P2|Overall Study|Adverse Event|10
805979|NCT00838110|2563990|P1|Overall Study|Adverse Event|11
805980|NCT00838110|2563987|P4|Overall Study|Death|2
805981|NCT00838110|2563988|P3|Overall Study|Death|1
805982|NCT00838110|2563989|P2|Overall Study|Death|0
805983|NCT00838110|2563990|P1|Overall Study|Death|0
805984|NCT00838201|2564072|P2|Overall Study|Death|13
805985|NCT00838201|2564073|P1|Overall Study|Death|11
805986|NCT00838201|2564072|P2|Overall Study|Adverse Event|9
805987|NCT00838201|2564073|P1|Overall Study|Adverse Event|5
805988|NCT00838201|2564072|P2|Overall Study|Lost to Follow-up|3
805989|NCT00838201|2564073|P1|Overall Study|Lost to Follow-up|4
805990|NCT00838201|2564072|P2|Overall Study|Consetn withdrawn|19
805991|NCT00838201|2564073|P1|Overall Study|Consetn withdrawn|16
805992|NCT00838201|2564072|P2|Overall Study|Disease progression|3
805993|NCT00838201|2564073|P1|Overall Study|Disease progression|3
805994|NCT00838201|2564072|P2|Overall Study|Administrative decision|2
805995|NCT00838201|2564073|P1|Overall Study|Administrative decision|1
805996|NCT00838201|2564072|P2|Overall Study|Noncompliance|1
805997|NCT00838201|2564073|P1|Overall Study|Noncompliance|0
805998|NCT00838201|2564072|P2|Overall Study|Investigator decision, or other reasons|3
805999|NCT00838201|2564073|P1|Overall Study|Investigator decision, or other reasons|2
806000|NCT00838279|2564081|P2|Washout|Withdrawal by Subject|1
806001|NCT00838279|2564082|P1|Washout|Withdrawal by Subject|0
806002|NCT00838279|2564081|P2|Washout|Protocol Violation|0
806003|NCT00838279|2564082|P1|Washout|Protocol Violation|1
806004|NCT00838331|2564090|P1|Aged Blood Transfusion|Withdrawal by Subject|9
806005|NCT00838513|2564094|P1|Post Treatment Period (Patients Who Disc|Death|1
806006|NCT00838513|2564094|P1|Extension Treatment Period|Death|1
806007|NCT00838513|2564094|P1|Screening Period|Screen Failure|3
806008|NCT00838526|2564112|P2|Overall Study|Not specified|7
806009|NCT00838526|2564113|P1|Overall Study|Not specified|11
806010|NCT00838526|2564112|P2|Overall Study|Lack of Efficacy|3
806011|NCT00838526|2564113|P1|Overall Study|Lack of Efficacy|2
806012|NCT00838526|2564112|P2|Overall Study|Withdrawal by Subject|5
806013|NCT00838526|2564113|P1|Overall Study|Withdrawal by Subject|4
806014|NCT00838526|2564112|P2|Overall Study|Lost to Follow-up|12
806015|NCT00838526|2564113|P1|Overall Study|Lost to Follow-up|4
806016|NCT00838526|2564112|P2|Overall Study|Adverse Event|12
806017|NCT00838526|2564113|P1|Overall Study|Adverse Event|3
806018|NCT00838578|2564121|P1|Overall Study|Protocol Violation|2
806019|NCT00838630|2564131|P2|Washout: 7 Days|Protocol Violation|0
806020|NCT00838630|2564132|P1|Washout: 7 Days|Protocol Violation|1
806021|NCT00838630|2564131|P2|First Intervention|Adverse Event|0
806022|NCT00838630|2564132|P1|First Intervention|Adverse Event|1
806023|NCT00838682|2564142|P2|Overall Study|Withdrawal by Subject|1
806024|NCT00838682|2564143|P1|Overall Study|Withdrawal by Subject|0
806025|NCT00838682|2564142|P2|Overall Study|Protocol Violation|1
806026|NCT00838682|2564143|P1|Overall Study|Protocol Violation|0
806027|NCT00838682|2564142|P2|Overall Study|detection of exclusion criteria|3
806028|NCT00838682|2564143|P1|Overall Study|detection of exclusion criteria|4
806029|NCT00838682|2564142|P2|Overall Study|Lost to Follow-up|14
806030|NCT00838682|2564143|P1|Overall Study|Lost to Follow-up|21
806031|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Missing|1
806032|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Missing|1
806033|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Missing|2
806034|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Missing|1
806035|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
806036|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
806037|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
806038|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
806039|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
806040|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
806041|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
806042|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
806043|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
806044|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
806045|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
806046|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
806047|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
806048|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
806049|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
806050|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
806051|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Physician Decision|1
806052|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Physician Decision|1
806053|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Physician Decision|1
806054|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Physician Decision|1
806055|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
806056|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
806057|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
806058|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
806059|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
806060|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
806061|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
806062|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
806063|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
806064|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
806065|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
806066|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
806067|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Noncompliance|5
806068|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Noncompliance|5
806069|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Noncompliance|8
806070|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Noncompliance|2
806071|NCT00838903|2564163|P4|Follow-up Period (8 Weeks)|Adverse Event|1
806072|NCT00838903|2564164|P3|Follow-up Period (8 Weeks)|Adverse Event|3
806073|NCT00838903|2564165|P2|Follow-up Period (8 Weeks)|Adverse Event|0
806074|NCT00838903|2564166|P1|Follow-up Period (8 Weeks)|Adverse Event|0
806075|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
806076|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
806077|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
806078|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
806079|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
806080|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
806081|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
806082|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
806083|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
806084|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
806085|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
806086|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
806087|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Site closed|0
806088|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Site closed|1
806089|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Site closed|0
806090|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Site closed|0
806091|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
806092|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
806093|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
806094|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
806095|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Pregnancy|0
806096|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Pregnancy|1
806097|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Pregnancy|0
806098|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Pregnancy|0
806099|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
806100|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
806101|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
806102|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
806103|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
806104|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
806105|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
806106|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
806107|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
806108|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
806109|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
806110|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
806111|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
806112|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
806113|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
806114|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
806115|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Physician Decision|2
806116|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Physician Decision|1
806117|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Physician Decision|2
806118|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Physician Decision|1
806119|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
806120|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
806121|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
806122|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
806123|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
806124|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
806125|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
806126|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
806127|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
806128|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
806129|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
806130|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
806131|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Noncompliance|6
806132|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Noncompliance|12
806133|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Noncompliance|13
806134|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Noncompliance|9
806135|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Protocol Violation|5
806136|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Protocol Violation|6
806137|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Protocol Violation|6
806138|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Protocol Violation|1
806139|NCT00838903|2564163|P4|Treatment Period (156 Weeks)|Adverse Event|25
806140|NCT00838903|2564164|P3|Treatment Period (156 Weeks)|Adverse Event|17
806141|NCT00838903|2564165|P2|Treatment Period (156 Weeks)|Adverse Event|13
806142|NCT00838903|2564166|P1|Treatment Period (156 Weeks)|Adverse Event|5
806143|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Missing|0
806144|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Missing|3
806145|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
806146|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
806147|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
806148|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
806149|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Physician Decision|0
806150|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Physician Decision|2
806151|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
806152|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
806153|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
806154|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
806155|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
806156|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
806157|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Noncompliance|5
806158|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Noncompliance|6
806159|NCT00838916|2564210|P2|Follow-up Period (8 Weeks)|Adverse Event|5
806160|NCT00838916|2564211|P1|Follow-up Period (8 Weeks)|Adverse Event|10
806161|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Pregnancy|0
806162|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Pregnancy|2
806163|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Missing|1
806164|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Missing|3
806165|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
806166|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
806167|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Physician Decision|1
806168|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Physician Decision|6
806169|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
806170|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
806171|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
806172|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
806173|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
806174|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
806175|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Noncompliance|14
806176|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Noncompliance|21
806177|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Protocol Violation|3
806178|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Protocol Violation|12
806179|NCT00838916|2564210|P2|Treatment Period (156 Weeks)|Adverse Event|11
806180|NCT00838916|2564211|P1|Treatment Period (156 Weeks)|Adverse Event|50
806181|NCT00838929|2564239|P3|Overall Study|Disease progression|1
806182|NCT00838929|2564240|P2|Overall Study|Disease progression|2
806183|NCT00838929|2564241|P1|Overall Study|Disease progression|0
806184|NCT00838929|2564239|P3|Overall Study|Protocol Violation|0
806185|NCT00838929|2564240|P2|Overall Study|Protocol Violation|1
806186|NCT00838929|2564241|P1|Overall Study|Protocol Violation|0
806187|NCT00839072|2564272|P2|Second Intervention Period|Withdrawal by Subject|0
806188|NCT00839072|2564273|P1|Second Intervention Period|Withdrawal by Subject|1
806189|NCT00839072|2564272|P2|First Intervention Period|Adverse Event|1
806190|NCT00839072|2564273|P1|First Intervention Period|Adverse Event|1
806191|NCT00839072|2564272|P2|First Intervention Period|Withdrawal by Subject|0
806281|NCT00829387|2564671|P1|Overall Study|Withdrawal by Subject|2
806192|NCT00839072|2564273|P1|First Intervention Period|Withdrawal by Subject|1
806193|NCT00839098|2564292|P3|Overall Study|Withdrawal by Subject|7
806194|NCT00839098|2564293|P2|Overall Study|Withdrawal by Subject|1
806195|NCT00839098|2564294|P1|Overall Study|Withdrawal by Subject|2
806196|NCT00828945|2564320|P1|Overall Study|Unspecified|36
806197|NCT00828945|2564320|P1|Overall Study|Participant was missing|1
806198|NCT00828945|2564320|P1|Overall Study|Death|4
806199|NCT00828984|2564337|P3|Overall Study|ConMed|1
806200|NCT00828984|2564338|P2|Overall Study|ConMed|1
806201|NCT00828984|2564339|P1|Overall Study|ConMed|1
806202|NCT00828984|2564337|P3|Overall Study|Noncompliant|3
806203|NCT00828984|2564338|P2|Overall Study|Noncompliant|2
806204|NCT00828984|2564339|P1|Overall Study|Noncompliant|1
806205|NCT00828984|2564337|P3|Overall Study|Medical Contraindication|0
806206|NCT00828984|2564338|P2|Overall Study|Medical Contraindication|1
806207|NCT00828984|2564339|P1|Overall Study|Medical Contraindication|0
806208|NCT00828984|2564337|P3|Overall Study|Ineligable|0
806209|NCT00828984|2564338|P2|Overall Study|Ineligable|2
806210|NCT00828984|2564339|P1|Overall Study|Ineligable|1
806211|NCT00828984|2564337|P3|Overall Study|Withdrawal by Subject|4
806212|NCT00828984|2564338|P2|Overall Study|Withdrawal by Subject|4
806213|NCT00828984|2564339|P1|Overall Study|Withdrawal by Subject|4
806214|NCT00828984|2564337|P3|Overall Study|Lost to Follow-up|1
806215|NCT00828984|2564338|P2|Overall Study|Lost to Follow-up|3
806216|NCT00828984|2564339|P1|Overall Study|Lost to Follow-up|5
806217|NCT00828984|2564337|P3|Overall Study|Adverse Event|0
806218|NCT00828984|2564338|P2|Overall Study|Adverse Event|3
806219|NCT00828984|2564339|P1|Overall Study|Adverse Event|2
806245|NCT00829166|2564554|P2|Overall Study|Reason Not Specified|3
806246|NCT00829166|2564555|P1|Overall Study|Reason Not Specified|3
806247|NCT00829166|2564554|P2|Overall Study|Sponsor’s Decision|98
806248|NCT00829166|2564555|P1|Overall Study|Sponsor’s Decision|137
806249|NCT00829166|2564554|P2|Overall Study|Subject's Decision|55
806250|NCT00829166|2564555|P1|Overall Study|Subject's Decision|41
806251|NCT00829166|2564554|P2|Overall Study|Physician's Decision|3
806252|NCT00829166|2564555|P1|Overall Study|Physician's Decision|4
806253|NCT00829166|2564554|P2|Overall Study|Lost to Follow-up|4
806254|NCT00829166|2564555|P1|Overall Study|Lost to Follow-up|5
806255|NCT00829166|2564554|P2|Overall Study|Death|333
806256|NCT00829166|2564555|P1|Overall Study|Death|305
806257|NCT00829179|2564594|P1|Overall Study|Withdrawal by Subject|1
806258|NCT00829244|2564600|P2|Overall Study|No embryo cleavage|2
806259|NCT00829244|2564601|P1|Overall Study|No embryo cleavage|0
806260|NCT00829244|2564600|P2|Overall Study|All embryos discarded|3
806261|NCT00829244|2564601|P1|Overall Study|All embryos discarded|0
806262|NCT00829244|2564600|P2|Overall Study|No fertilization|2
806263|NCT00829244|2564601|P1|Overall Study|No fertilization|2
806264|NCT00829244|2564600|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
806265|NCT00829244|2564601|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
806266|NCT00829244|2564600|P2|Overall Study|Lack of ovarian response to stimulation|5
806267|NCT00829244|2564601|P1|Overall Study|Lack of ovarian response to stimulation|9
806268|NCT00829244|2564600|P2|Overall Study|Protocol Violation|0
806269|NCT00829244|2564601|P1|Overall Study|Protocol Violation|1
806270|NCT00829244|2564600|P2|Overall Study|Adverse Event|3
806271|NCT00829244|2564601|P1|Overall Study|Adverse Event|1
806272|NCT00829283|2564633|P2|Overall Study|Lost to Follow-up|25
806273|NCT00829283|2564634|P1|Overall Study|Lost to Follow-up|7
806274|NCT00829296|2564644|P2|Overall Study|Adverse Event|4
806275|NCT00829296|2564645|P1|Overall Study|Adverse Event|5
806276|NCT00829309|2564659|P2|Washout: 7 Days|Protocol Violation|0
806277|NCT00829309|2564660|P1|Washout: 7 Days|Protocol Violation|1
806278|NCT00829387|2564670|P2|Overall Study|Disqualified by PI|0
806279|NCT00829387|2564671|P1|Overall Study|Disqualified by PI|1
806280|NCT00829387|2564670|P2|Overall Study|Withdrawal by Subject|3
806282|NCT00829426|2564689|P2|Washout: 7 Days|Withdrawal by Subject|0
806283|NCT00829426|2564690|P1|Washout: 7 Days|Withdrawal by Subject|1
806284|NCT00829439|2564698|P4|Overall Study|Adverse Event|0
806285|NCT00829439|2564699|P3|Overall Study|Adverse Event|1
806286|NCT00829439|2564700|P2|Overall Study|Adverse Event|0
806287|NCT00829439|2564701|P1|Overall Study|Adverse Event|0
806288|NCT00829452|2564707|P2|Second Intervention|Physician Decision|1
806289|NCT00829452|2564708|P1|Second Intervention|Physician Decision|0
806290|NCT00829452|2564707|P2|Washout of 42 Days|Withdrawal by Subject|1
806291|NCT00829452|2564708|P1|Washout of 42 Days|Withdrawal by Subject|0
806292|NCT00829452|2564707|P2|First Intervention|Withdrawal by Subject|1
806293|NCT00829452|2564708|P1|First Intervention|Withdrawal by Subject|0
806294|NCT00829504|2564722|P2|Second Intervention|Physician Decision|0
806295|NCT00829504|2564723|P1|Second Intervention|Physician Decision|1
806296|NCT00829504|2564722|P2|Washout of 7 Days|Withdrawal by Subject|0
806297|NCT00829504|2564723|P1|Washout of 7 Days|Withdrawal by Subject|1
806298|NCT00829504|2564722|P2|First Intervention|Adverse Event|0
806299|NCT00829504|2564723|P1|First Intervention|Adverse Event|1
806300|NCT00829530|2564733|P2|Second Intervention|Intolerance to Venopuncture|0
806301|NCT00829530|2564734|P1|Second Intervention|Intolerance to Venopuncture|1
806302|NCT00829530|2564733|P2|First Intervention|Intolerance to Venopuncture|1
806303|NCT00829530|2564734|P1|First Intervention|Intolerance to Venopuncture|0
806304|NCT00829530|2564733|P2|First Intervention|Adverse Event|1
806305|NCT00829530|2564734|P1|First Intervention|Adverse Event|0
806306|NCT00829621|2564748|P2|Overall Study|Lost to Follow-up|4
806307|NCT00829621|2564749|P1|Overall Study|Lost to Follow-up|3
806308|NCT00829621|2564748|P2|Overall Study|Death|0
806309|NCT00829621|2564749|P1|Overall Study|Death|1
806310|NCT00829673|2564757|P2|Washout of 7 Days|Withdrawal by Subject|0
806311|NCT00829673|2564758|P1|Washout of 7 Days|Withdrawal by Subject|1
806312|NCT00829712|2564777|P2|Washout of 7 Days|Withdrawal by Subject|1
806313|NCT00829712|2564778|P1|Washout of 7 Days|Withdrawal by Subject|0
806314|NCT00829764|2564804|P2|First Intervention|Withdrawal by Subject|1
806315|NCT00829764|2564805|P1|First Intervention|Withdrawal by Subject|1
806316|NCT00829764|2564804|P2|First Intervention|Adverse Event|0
806317|NCT00829764|2564805|P1|First Intervention|Adverse Event|1
806318|NCT00829790|2564815|P2|Washout of 14 Days|Withdrawal by Subject|1
806319|NCT00829790|2564816|P1|Washout of 14 Days|Withdrawal by Subject|0
806320|NCT00829829|2564827|P3|Overall Study|Other than specified above|1
806321|NCT00829829|2564828|P2|Overall Study|Other than specified above|2
806322|NCT00829829|2564829|P1|Overall Study|Other than specified above|2
806323|NCT00829829|2564827|P3|Overall Study|Lost to Follow-up|3
806324|NCT00829829|2564828|P2|Overall Study|Lost to Follow-up|3
806325|NCT00829829|2564829|P1|Overall Study|Lost to Follow-up|7
806326|NCT00829829|2564827|P3|Overall Study|Decision by the Sponsor|2
806327|NCT00829829|2564828|P2|Overall Study|Decision by the Sponsor|0
806328|NCT00829829|2564829|P1|Overall Study|Decision by the Sponsor|1
806329|NCT00829829|2564827|P3|Overall Study|Withdrawal by Subject|2
806330|NCT00829829|2564828|P2|Overall Study|Withdrawal by Subject|4
806331|NCT00829829|2564829|P1|Overall Study|Withdrawal by Subject|8
806332|NCT00829829|2564827|P3|Overall Study|Adverse Event|3
806333|NCT00829829|2564828|P2|Overall Study|Adverse Event|4
806334|NCT00829829|2564829|P1|Overall Study|Adverse Event|4
806335|NCT00829829|2564827|P3|Overall Study|Protocol Violation|0
806336|NCT00829829|2564828|P2|Overall Study|Protocol Violation|3
806337|NCT00829829|2564829|P1|Overall Study|Protocol Violation|0
806338|NCT00829868|2564854|P2|Washout|Physician Decision|0
806339|NCT00829868|2564855|P1|Washout|Physician Decision|1
806340|NCT00829933|2564867|P4|Overall Study|withdrew before treatment started|9
806341|NCT00829933|2564868|P3|Overall Study|withdrew before treatment started|2
806342|NCT00829933|2564869|P2|Overall Study|withdrew before treatment started|1
806343|NCT00829933|2564870|P1|Overall Study|withdrew before treatment started|5
806344|NCT00829933|2564867|P4|Overall Study|Protocol Violation|0
806345|NCT00829933|2564868|P3|Overall Study|Protocol Violation|0
806346|NCT00829933|2564869|P2|Overall Study|Protocol Violation|1
806347|NCT00829933|2564870|P1|Overall Study|Protocol Violation|2
806348|NCT00829933|2564867|P4|Overall Study|Pregnancy|2
806349|NCT00829933|2564868|P3|Overall Study|Pregnancy|0
806350|NCT00829933|2564869|P2|Overall Study|Pregnancy|0
806351|NCT00829933|2564870|P1|Overall Study|Pregnancy|0
806352|NCT00829933|2564867|P4|Overall Study|Physician Decision|1
806353|NCT00829933|2564868|P3|Overall Study|Physician Decision|8
806354|NCT00829933|2564869|P2|Overall Study|Physician Decision|7
806355|NCT00829933|2564870|P1|Overall Study|Physician Decision|5
806356|NCT00829933|2564867|P4|Overall Study|Lack of Efficacy|0
806357|NCT00829933|2564868|P3|Overall Study|Lack of Efficacy|0
806358|NCT00829933|2564869|P2|Overall Study|Lack of Efficacy|1
806359|NCT00829933|2564870|P1|Overall Study|Lack of Efficacy|0
806360|NCT00829933|2564867|P4|Overall Study|Death|1
806361|NCT00829933|2564868|P3|Overall Study|Death|1
806362|NCT00829933|2564869|P2|Overall Study|Death|0
806363|NCT00829933|2564870|P1|Overall Study|Death|0
806364|NCT00829933|2564867|P4|Overall Study|Adverse Event|1
806365|NCT00829933|2564868|P3|Overall Study|Adverse Event|2
806366|NCT00829933|2564869|P2|Overall Study|Adverse Event|3
806367|NCT00829933|2564870|P1|Overall Study|Adverse Event|2
806368|NCT00829998|2564899|P2|Washout|Adverse Event|1
806369|NCT00829998|2564900|P1|Washout|Adverse Event|0
806370|NCT00830024|2564910|P2|Washout: 7 Days|Withdrawal by Subject|0
806371|NCT00830024|2564911|P1|Washout: 7 Days|Withdrawal by Subject|1
806372|NCT00830037|2564921|P2|Overall Study|Active when terminated by DSMB|14
806373|NCT00830037|2564922|P1|Overall Study|Active when terminated by DSMB|15
806374|NCT00830037|2564921|P2|Overall Study|Lost to Follow-up|2
806375|NCT00830037|2564922|P1|Overall Study|Lost to Follow-up|1
806376|NCT00830037|2564921|P2|Overall Study|Withdrawal by Subject|3
806377|NCT00830037|2564922|P1|Overall Study|Withdrawal by Subject|2
806378|NCT00830115|2564939|P1|Overall Study|Improvement/recovery|1
806379|NCT00830115|2564939|P1|Overall Study|Adverse Event|2
806380|NCT00830128|2564955|P1|Overall Study|Operating a vehicle|1
806381|NCT00830128|2564955|P1|Overall Study|Work obligation|1
806382|NCT00830128|2564955|P1|Overall Study|Relocation|1
806383|NCT00830128|2564955|P1|Overall Study|Family obligation|1
806384|NCT00830128|2564955|P1|Overall Study|Withdrawal by Subject|2
806385|NCT00830128|2564955|P1|Overall Study|Protocol Violation|1
806386|NCT00830128|2564955|P1|Overall Study|Lack of Efficacy|7
806387|NCT00830128|2564955|P1|Overall Study|Adverse Event|5
806388|NCT00830167|2564972|P2|Overall Study|Other|2
806389|NCT00830167|2564973|P1|Overall Study|Other|2
806390|NCT00830167|2564972|P2|Overall Study|Protocol Violation|1
806391|NCT00830167|2564973|P1|Overall Study|Protocol Violation|0
806392|NCT00830167|2564972|P2|Overall Study|Lost to Follow-up|1
806393|NCT00830167|2564973|P1|Overall Study|Lost to Follow-up|0
806394|NCT00830167|2564972|P2|Overall Study|Withdrawal by Subject|0
806395|NCT00830167|2564973|P1|Overall Study|Withdrawal by Subject|2
806396|NCT00830167|2564972|P2|Overall Study|Not meeting entrance criteria|5
806397|NCT00830167|2564973|P1|Overall Study|Not meeting entrance criteria|2
806398|NCT00830167|2564972|P2|Overall Study|Adverse Event|24
806399|NCT00830167|2564973|P1|Overall Study|Adverse Event|8
806400|NCT00830167|2564972|P2|Overall Study|Lack of Efficacy|10
806401|NCT00830167|2564973|P1|Overall Study|Lack of Efficacy|26
806402|NCT00830206|2565045|P2|Washout: 21 Days|Withdrawal by Subject|1
806403|NCT00830206|2565046|P1|Washout: 21 Days|Withdrawal by Subject|1
806404|NCT00830219|2565056|P2|Washout of 7 Days|Withdrawal by Subject|1
806405|NCT00830219|2565057|P1|Washout of 7 Days|Withdrawal by Subject|1
806406|NCT00830258|2565076|P2|Washout: 7 Days|Protocol Violation|0
806407|NCT00830258|2565077|P1|Washout: 7 Days|Protocol Violation|1
806408|NCT00830258|2565076|P2|First Intervention|Adverse Event|0
806409|NCT00830258|2565077|P1|First Intervention|Adverse Event|1
806410|NCT00830336|2565104|P2|Washout: 21 Days|Withdrawal by Subject|0
806411|NCT00830336|2565105|P1|Washout: 21 Days|Withdrawal by Subject|1
806412|NCT00830375|2565122|P1|Overall Study|Lost to Follow-up|1
806413|NCT00830440|2565133|P2|Overall Study|Adverse Event|0
806414|NCT00830440|2565134|P1|Overall Study|Adverse Event|2
806415|NCT00830440|2565133|P2|Overall Study|unsuccessful procedure|0
806416|NCT00830440|2565134|P1|Overall Study|unsuccessful procedure|4
806417|NCT00830440|2565133|P2|Overall Study|Withdrawal by Subject|0
806418|NCT00830440|2565134|P1|Overall Study|Withdrawal by Subject|1
806419|NCT00830440|2565133|P2|Overall Study|Protocol Violation|0
806420|NCT00830440|2565134|P1|Overall Study|Protocol Violation|1
806421|NCT00830765|2565171|P2|Overall Study|Protocol Violation|2
806422|NCT00830765|2565172|P1|Overall Study|Protocol Violation|3
806423|NCT00831233|2565180|P2|Overall Study|Selection Criteria Not Met|0
806424|NCT00831233|2565181|P1|Overall Study|Selection Criteria Not Met|2
806425|NCT00831233|2565180|P2|Overall Study|Protocol Violation|0
806426|NCT00831233|2565181|P1|Overall Study|Protocol Violation|1
806427|NCT00831233|2565180|P2|Overall Study|Adverse Event|1
806428|NCT00831233|2565181|P1|Overall Study|Adverse Event|0
806429|NCT00831311|2565224|P2|Overall Study|Withdrawal by Subject|4
806430|NCT00831311|2565225|P1|Overall Study|Withdrawal by Subject|6
806431|NCT00831311|2565224|P2|Overall Study|Physician Decision|1
806432|NCT00831311|2565225|P1|Overall Study|Physician Decision|0
806433|NCT00831311|2565224|P2|Overall Study|Lost to Follow-up|0
806434|NCT00831311|2565225|P1|Overall Study|Lost to Follow-up|3
806435|NCT00831311|2565224|P2|Overall Study|Definitive Contraindication|3
806436|NCT00831311|2565225|P1|Overall Study|Definitive Contraindication|3
806438|NCT00831415|2565267|P1|Overall Study|Death|1
806439|NCT00831415|2565267|P1|Overall Study|Unsatisfactory response - Efficacy|4
806440|NCT00831415|2565267|P1|Overall Study|Withdrawal by Subject|35
806441|NCT00831415|2565267|P1|Overall Study|Protocol Violation|3
806442|NCT00831415|2565267|P1|Overall Study|Lost to Follow-up|9
806443|NCT00831415|2565267|P1|Overall Study|Physician Decision|6
806444|NCT00831415|2565267|P1|Overall Study|Failed to return|3
806445|NCT00831415|2565267|P1|Overall Study|Adverse Event|14
806446|NCT00831441|2565280|P2|Follow Up (30 Days)|missing end of study status|1
806447|NCT00831441|2565281|P1|Follow Up (30 Days)|missing end of study status|0
806448|NCT00831441|2565280|P2|Follow Up (30 Days)|non-specified|26
806449|NCT00831441|2565281|P1|Follow Up (30 Days)|non-specified|16
806450|NCT00831441|2565280|P2|Follow Up (30 Days)|Death|86
806451|NCT00831441|2565281|P1|Follow Up (30 Days)|Death|63
806452|NCT00831441|2565280|P2|Follow Up (30 Days)|Lost to Follow-up|27
806453|NCT00831441|2565281|P1|Follow Up (30 Days)|Lost to Follow-up|13
806454|NCT00831441|2565280|P2|Follow Up (30 Days)|Withdrawal by Subject|34
806455|NCT00831441|2565281|P1|Follow Up (30 Days)|Withdrawal by Subject|41
806456|NCT00831441|2565280|P2|Randomized|non-specified|266
806457|NCT00831441|2565281|P1|Randomized|non-specified|276
806458|NCT00831441|2565280|P2|Randomized|poor/non-compliance|38
806459|NCT00831441|2565281|P1|Randomized|poor/non-compliance|30
806460|NCT00831441|2565280|P2|Randomized|Administrative reason by sponsor|2671
806461|NCT00831441|2565281|P1|Randomized|Administrative reason by sponsor|2780
806462|NCT00831441|2565280|P2|Randomized|Lost to Follow-up|35
806463|NCT00831441|2565281|P1|Randomized|Lost to Follow-up|26
806464|NCT00831441|2565280|P2|Randomized|Withdrawal by Subject|212
806465|NCT00831441|2565281|P1|Randomized|Withdrawal by Subject|178
806466|NCT00831441|2565280|P2|Randomized|No longer met criteria|19
806467|NCT00831441|2565281|P1|Randomized|No longer met criteria|13
806468|NCT00831441|2565280|P2|Randomized|Physician Decision|35
806469|NCT00831441|2565281|P1|Randomized|Physician Decision|26
806470|NCT00831441|2565280|P2|Randomized|Elective procedure|25
806471|NCT00831441|2565281|P1|Randomized|Elective procedure|26
806472|NCT00831441|2565280|P2|Randomized|Emergency procedure|2
806473|NCT00831441|2565281|P1|Randomized|Emergency procedure|2
806474|NCT00831441|2565280|P2|Randomized|Adverse Event|321
806475|NCT00831441|2565281|P1|Randomized|Adverse Event|248
806476|NCT00831441|2565280|P2|Randomized|Death|81
806477|NCT00831441|2565281|P1|Randomized|Death|82
806478|NCT00831493|2565313|P1|Overall Study|Intractable nausea and vomiting|1
806479|NCT00831701|2565334|P2|Overall Study|Lost to Follow-up|3
806480|NCT00831701|2565335|P1|Overall Study|Lost to Follow-up|1
806481|NCT00831701|2565334|P2|Overall Study|Stone expulsion before first medication|2
806482|NCT00831701|2565335|P1|Overall Study|Stone expulsion before first medication|2
806483|NCT00831701|2565334|P2|Overall Study|Withdrawal by Subject|0
806484|NCT00831701|2565335|P1|Overall Study|Withdrawal by Subject|2
806485|NCT00831779|2565375|P2|Overall Study|No longer met criteria|1
806486|NCT00831779|2565376|P1|Overall Study|No longer met criteria|0
806487|NCT00831779|2565375|P2|Overall Study|Lost to Follow-up|0
806488|NCT00831779|2565376|P1|Overall Study|Lost to Follow-up|1
806489|NCT00831844|2565394|P10|Overall Study|Ineligible|0
806490|NCT00831844|2565395|P9|Overall Study|Ineligible|0
806491|NCT00831844|2565396|P8|Overall Study|Ineligible|0
806492|NCT00831844|2565397|P7|Overall Study|Ineligible|0
806493|NCT00831844|2565398|P6|Overall Study|Ineligible|0
806494|NCT00831844|2565399|P5|Overall Study|Ineligible|1
806495|NCT00831844|2565400|P4|Overall Study|Ineligible|0
806496|NCT00831844|2565401|P3|Overall Study|Ineligible|1
806497|NCT00831844|2565402|P2|Overall Study|Ineligible|1
806498|NCT00831844|2565403|P1|Overall Study|Ineligible|0
806499|NCT00831844|2565394|P10|Overall Study|Withdrawal by Subject|0
806500|NCT00831844|2565395|P9|Overall Study|Withdrawal by Subject|1
806501|NCT00831844|2565396|P8|Overall Study|Withdrawal by Subject|1
806502|NCT00831844|2565397|P7|Overall Study|Withdrawal by Subject|0
806503|NCT00831844|2565398|P6|Overall Study|Withdrawal by Subject|0
806504|NCT00831844|2565399|P5|Overall Study|Withdrawal by Subject|0
806505|NCT00831844|2565400|P4|Overall Study|Withdrawal by Subject|0
806506|NCT00831844|2565401|P3|Overall Study|Withdrawal by Subject|1
806507|NCT00831844|2565402|P2|Overall Study|Withdrawal by Subject|0
806508|NCT00831844|2565403|P1|Overall Study|Withdrawal by Subject|0
806509|NCT00831844|2565394|P10|Overall Study|Physician Decision|0
806510|NCT00831844|2565395|P9|Overall Study|Physician Decision|1
806511|NCT00831844|2565396|P8|Overall Study|Physician Decision|0
806512|NCT00831844|2565397|P7|Overall Study|Physician Decision|0
806513|NCT00831844|2565398|P6|Overall Study|Physician Decision|1
806514|NCT00831844|2565399|P5|Overall Study|Physician Decision|1
806515|NCT00831844|2565400|P4|Overall Study|Physician Decision|1
806516|NCT00831844|2565401|P3|Overall Study|Physician Decision|3
806517|NCT00831844|2565402|P2|Overall Study|Physician Decision|1
806518|NCT00831844|2565403|P1|Overall Study|Physician Decision|0
806519|NCT00831844|2565394|P10|Overall Study|Lack of Efficacy|0
806520|NCT00831844|2565395|P9|Overall Study|Lack of Efficacy|7
806521|NCT00831844|2565396|P8|Overall Study|Lack of Efficacy|9
806522|NCT00831844|2565397|P7|Overall Study|Lack of Efficacy|8
806523|NCT00831844|2565398|P6|Overall Study|Lack of Efficacy|17
806524|NCT00831844|2565399|P5|Overall Study|Lack of Efficacy|11
806525|NCT00831844|2565400|P4|Overall Study|Lack of Efficacy|8
806526|NCT00831844|2565401|P3|Overall Study|Lack of Efficacy|15
806527|NCT00831844|2565402|P2|Overall Study|Lack of Efficacy|10
806528|NCT00831844|2565403|P1|Overall Study|Lack of Efficacy|8
806529|NCT00831844|2565394|P10|Overall Study|Death|0
806530|NCT00831844|2565395|P9|Overall Study|Death|0
806531|NCT00831844|2565396|P8|Overall Study|Death|0
806532|NCT00831844|2565397|P7|Overall Study|Death|0
806533|NCT00831844|2565398|P6|Overall Study|Death|0
806534|NCT00831844|2565399|P5|Overall Study|Death|0
806535|NCT00831844|2565400|P4|Overall Study|Death|1
806536|NCT00831844|2565401|P3|Overall Study|Death|0
806537|NCT00831844|2565402|P2|Overall Study|Death|0
806538|NCT00831844|2565403|P1|Overall Study|Death|0
806539|NCT00831844|2565394|P10|Overall Study|Adverse Event|0
806540|NCT00831844|2565395|P9|Overall Study|Adverse Event|0
806541|NCT00831844|2565396|P8|Overall Study|Adverse Event|0
806542|NCT00831844|2565397|P7|Overall Study|Adverse Event|2
806543|NCT00831844|2565398|P6|Overall Study|Adverse Event|1
806544|NCT00831844|2565399|P5|Overall Study|Adverse Event|1
806545|NCT00831844|2565400|P4|Overall Study|Adverse Event|0
806546|NCT00831844|2565401|P3|Overall Study|Adverse Event|0
806547|NCT00831844|2565402|P2|Overall Study|Adverse Event|0
806548|NCT00831844|2565403|P1|Overall Study|Adverse Event|2
806549|NCT00832000|2565440|P2|Overall Study|No calls to IVR in period 2|0
806550|NCT00832000|2565441|P1|Overall Study|No calls to IVR in period 2|2
806551|NCT00832000|2565440|P2|Overall Study|No calls to IVR in either period|1
806552|NCT00832000|2565441|P1|Overall Study|No calls to IVR in either period|1
806553|NCT00832000|2565440|P2|Overall Study|Withdrawal by Subject|0
806554|NCT00832000|2565441|P1|Overall Study|Withdrawal by Subject|1
806555|NCT00832000|2565440|P2|Overall Study|Adverse Event|0
806556|NCT00832000|2565441|P1|Overall Study|Adverse Event|2
806557|NCT00832078|2565477|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
806558|NCT00832078|2565478|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
806559|NCT00832078|2565477|P2|Test Day 1-2 Period|Lack of Efficacy|2
806560|NCT00832078|2565478|P1|Test Day 1-2 Period|Lack of Efficacy|0
806561|NCT00832091|2565486|P2|Overall Study|Prohibited Medication|0
806562|NCT00832091|2565487|P1|Overall Study|Prohibited Medication|1
806563|NCT00832091|2565486|P2|Overall Study|Withdrawal by Subject|1
806564|NCT00832091|2565487|P1|Overall Study|Withdrawal by Subject|2
806565|NCT00832091|2565486|P2|Overall Study|Protocol Violation|0
806566|NCT00832091|2565487|P1|Overall Study|Protocol Violation|1
806567|NCT00832091|2565486|P2|Overall Study|Adverse Event|1
806568|NCT00832091|2565487|P1|Overall Study|Adverse Event|1
806569|NCT00832117|2565497|P1|Overall Study|Disease Progression|11
806570|NCT00832117|2565497|P1|Overall Study|Death|1
806571|NCT00832377|2565550|P1|Overall Study|Protocol Violation|1
806572|NCT00832416|2565574|P4|Overall Study|Death|0
806573|NCT00832416|2565575|P3|Overall Study|Death|0
806574|NCT00832416|2565576|P2|Overall Study|Death|0
806575|NCT00832416|2565577|P1|Overall Study|Death|1
806576|NCT00832416|2565574|P4|Overall Study|Adverse Event|10
806577|NCT00832416|2565575|P3|Overall Study|Adverse Event|41
806578|NCT00832416|2565576|P2|Overall Study|Adverse Event|19
806579|NCT00832416|2565577|P1|Overall Study|Adverse Event|21
806580|NCT00832416|2565574|P4|Overall Study|Administrative|1
806581|NCT00832416|2565575|P3|Overall Study|Administrative|0
806582|NCT00832416|2565576|P2|Overall Study|Administrative|0
806583|NCT00832416|2565577|P1|Overall Study|Administrative|0
806584|NCT00832416|2565574|P4|Overall Study|Physician Decision|10
806585|NCT00832416|2565575|P3|Overall Study|Physician Decision|5
806586|NCT00832416|2565576|P2|Overall Study|Physician Decision|12
806587|NCT00832416|2565577|P1|Overall Study|Physician Decision|2
806588|NCT00832416|2565574|P4|Overall Study|Withdrawal by Subject|10
806589|NCT00832416|2565575|P3|Overall Study|Withdrawal by Subject|2
806590|NCT00832416|2565576|P2|Overall Study|Withdrawal by Subject|7
806591|NCT00832416|2565577|P1|Overall Study|Withdrawal by Subject|5
806592|NCT00832416|2565574|P4|Overall Study|Lack of Efficacy|52
806593|NCT00832416|2565575|P3|Overall Study|Lack of Efficacy|13
806594|NCT00832416|2565576|P2|Overall Study|Lack of Efficacy|15
806595|NCT00832416|2565577|P1|Overall Study|Lack of Efficacy|17
806596|NCT00832455|2565615|P1|Overall Study|Patient moved|1
806597|NCT00832455|2565615|P1|Overall Study|No improvement|3
806598|NCT00832455|2565615|P1|Overall Study|Parent dissatisfied|1
806599|NCT00832455|2565615|P1|Overall Study|Parent misunderstood study|1
806600|NCT00832455|2565615|P1|Overall Study|Stopped Medication|4
806601|NCT00832455|2565615|P1|Overall Study|Screening Failure|2
806602|NCT00832455|2565615|P1|Overall Study|Withdrawal by Subject|17
806603|NCT00832455|2565615|P1|Overall Study|Protocol Violation|4
806604|NCT00832455|2565615|P1|Overall Study|Lost to Follow-up|26
806605|NCT00832455|2565615|P1|Overall Study|Adverse Event|13
806606|NCT00832585|2565654|P1|Overall Study|Lost to Follow-up|1
806607|NCT00832585|2565654|P1|Overall Study|Withdrawal by Subject|1
806608|NCT00832624|2565659|P1|Overall Study|Study Terminated|10
806609|NCT00832650|2565674|P3|Overall Study|Randomized but not treated|1
806610|NCT00832650|2565675|P2|Overall Study|Randomized but not treated|0
806611|NCT00832650|2565676|P1|Overall Study|Randomized but not treated|0
806612|NCT00832819|2565711|P3|Overall Study|Protocol Violation|1
806613|NCT00832819|2565712|P2|Overall Study|Protocol Violation|0
806614|NCT00832819|2565713|P1|Overall Study|Protocol Violation|0
806615|NCT00832819|2565711|P3|Overall Study|Adverse Event|0
806616|NCT00832819|2565712|P2|Overall Study|Adverse Event|1
806617|NCT00832819|2565713|P1|Overall Study|Adverse Event|0
806618|NCT00832975|2565725|P1|Overall Study|Other reasons|14
806619|NCT00832975|2565725|P1|Overall Study|Withdrawal by Subject|3
806620|NCT00832975|2565725|P1|Overall Study|Physician Decision|4
806621|NCT00832975|2565725|P1|Overall Study|Death|5
806622|NCT00832975|2565725|P1|Overall Study|Protocol Violation|6
806623|NCT00832975|2565725|P1|Overall Study|Lost to Follow-up|7
806624|NCT00833027|2565730|P1|Overall Study|Missing|10
806625|NCT00833027|2565730|P1|Overall Study|Withdrawal by Subject|16
806626|NCT00833027|2565730|P1|Overall Study|Protocol Violation|115
806627|NCT00833027|2565730|P1|Overall Study|Lost to Follow-up|24
806628|NCT00833027|2565730|P1|Overall Study|Lack of Efficacy|12
806629|NCT00833027|2565730|P1|Overall Study|Death|1
806630|NCT00833027|2565730|P1|Overall Study|Adverse Event|33
806631|NCT00833040|2565735|P6|Overall Study|Adverse Event|1
806632|NCT00833040|2565736|P5|Overall Study|Adverse Event|0
806633|NCT00833040|2565737|P4|Overall Study|Adverse Event|0
806634|NCT00833040|2565738|P3|Overall Study|Adverse Event|0
806635|NCT00833040|2565739|P2|Overall Study|Adverse Event|0
806636|NCT00833040|2565740|P1|Overall Study|Adverse Event|0
806637|NCT00833053|2565747|P2|Overall Study|Protocol Violation|1
806638|NCT00833053|2565748|P1|Overall Study|Protocol Violation|2
806639|NCT00833053|2565747|P2|Overall Study|Withdrawal by Subject|1
806640|NCT00833053|2565748|P1|Overall Study|Withdrawal by Subject|0
806641|NCT00833053|2565747|P2|Overall Study|Treatment Failure|1
806642|NCT00833053|2565748|P1|Overall Study|Treatment Failure|3
806643|NCT00833053|2565747|P2|Overall Study|Adverse Event|0
806644|NCT00833053|2565748|P1|Overall Study|Adverse Event|4
806645|NCT00833092|2565768|P2|Overall Study|constipation|1
806646|NCT00833092|2565769|P1|Overall Study|constipation|0
806647|NCT00833092|2565768|P2|Overall Study|Diarrhea|2
806648|NCT00833092|2565769|P1|Overall Study|Diarrhea|0
806649|NCT00833092|2565768|P2|Overall Study|Protocol Violation|1
806650|NCT00833092|2565769|P1|Overall Study|Protocol Violation|2
806651|NCT00833092|2565768|P2|Overall Study|Withdrawal by Subject|3
806652|NCT00833092|2565769|P1|Overall Study|Withdrawal by Subject|2
806653|NCT00833248|2565777|P2|Overall Study|Withdrawal by Subject|1
806654|NCT00833248|2565778|P1|Overall Study|Withdrawal by Subject|0
806655|NCT00833248|2565777|P2|Overall Study|Protocol Violation|2
806656|NCT00833248|2565778|P1|Overall Study|Protocol Violation|1
806657|NCT00833248|2565777|P2|Overall Study|Adverse Event|0
806658|NCT00833248|2565778|P1|Overall Study|Adverse Event|3
806659|NCT00833417|2565813|P2|Overall Study|Reason Not Specified|1
806660|NCT00833417|2565814|P1|Overall Study|Reason Not Specified|0
806661|NCT00833417|2565813|P2|Overall Study|Disease Progression|17
806662|NCT00833417|2565814|P1|Overall Study|Disease Progression|18
806663|NCT00833417|2565813|P2|Overall Study|Sponsor Decision to Terminate Study|2
806664|NCT00833417|2565814|P1|Overall Study|Sponsor Decision to Terminate Study|1
806665|NCT00833417|2565813|P2|Overall Study|Patient Decision to Withdraw|23
806666|NCT00833417|2565814|P1|Overall Study|Patient Decision to Withdraw|4
806667|NCT00833417|2565813|P2|Overall Study|Physician Decision to Withdraw Patient|7
806668|NCT00833417|2565814|P1|Overall Study|Physician Decision to Withdraw Patient|3
806669|NCT00833417|2565813|P2|Overall Study|Lost to Follow-up|2
806670|NCT00833417|2565814|P1|Overall Study|Lost to Follow-up|1
806671|NCT00833417|2565813|P2|Overall Study|Death|3
806672|NCT00833417|2565814|P1|Overall Study|Death|1
806673|NCT00833417|2565813|P2|Overall Study|Adverse Event|16
806674|NCT00833417|2565814|P1|Overall Study|Adverse Event|5
806675|NCT00833469|2565842|P1|Overall Study|Lost to Follow-up|1
806676|NCT00833469|2565842|P1|Overall Study|Withdrawal by Subject|1
806677|NCT00833482|2565850|P6|Days 21-30|Withdrawal by Subject|0
806678|NCT00833482|2565851|P5|Days 21-30|Withdrawal by Subject|1
806679|NCT00833482|2565852|P4|Days 21-30|Withdrawal by Subject|0
806680|NCT00833482|2565853|P3|Days 21-30|Withdrawal by Subject|0
806681|NCT00833482|2565854|P2|Days 21-30|Withdrawal by Subject|0
806682|NCT00833482|2565855|P1|Days 21-30|Withdrawal by Subject|0
806683|NCT00833482|2565850|P6|Days 21-30|Adverse Event|0
806684|NCT00833482|2565851|P5|Days 21-30|Adverse Event|0
806685|NCT00833482|2565852|P4|Days 21-30|Adverse Event|0
806686|NCT00833482|2565853|P3|Days 21-30|Adverse Event|1
806687|NCT00833482|2565854|P2|Days 21-30|Adverse Event|0
806688|NCT00833482|2565855|P1|Days 21-30|Adverse Event|0
806689|NCT00833482|2565850|P6|Days 11-20|Withdrawal by Subject|0
806690|NCT00833482|2565851|P5|Days 11-20|Withdrawal by Subject|0
806691|NCT00833482|2565852|P4|Days 11-20|Withdrawal by Subject|0
806692|NCT00833482|2565853|P3|Days 11-20|Withdrawal by Subject|0
806693|NCT00833482|2565854|P2|Days 11-20|Withdrawal by Subject|1
806694|NCT00833482|2565855|P1|Days 11-20|Withdrawal by Subject|0
806695|NCT00833482|2565850|P6|Days 11-20|Adverse Event|0
806696|NCT00833482|2565851|P5|Days 11-20|Adverse Event|0
806697|NCT00833482|2565852|P4|Days 11-20|Adverse Event|0
806698|NCT00833482|2565853|P3|Days 11-20|Adverse Event|0
806699|NCT00833482|2565854|P2|Days 11-20|Adverse Event|2
806700|NCT00833482|2565855|P1|Days 11-20|Adverse Event|0
806701|NCT00833547|2565924|P2|Overall Study|Withdrawal by Subject|2
806702|NCT00833547|2565925|P1|Overall Study|Withdrawal by Subject|2
806703|NCT00833560|2565933|P1|Overall Study|Not specified|5
806704|NCT00833560|2565933|P1|Overall Study|Pregression of other disease|1
806705|NCT00833560|2565933|P1|Overall Study|Death|2
806706|NCT00833560|2565933|P1|Overall Study|Lack of Efficacy|4
806707|NCT00833560|2565933|P1|Overall Study|Protocol Violation|6
806708|NCT00833560|2565933|P1|Overall Study|Adverse Event|11
806709|NCT00833560|2565933|P1|Overall Study|Toxicity|13
806710|NCT00833638|2565954|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
806711|NCT00833638|2565955|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
806712|NCT00833638|2565956|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
806713|NCT00833638|2565954|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
806714|NCT00833638|2565955|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
806715|NCT00833638|2565956|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
806716|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
806717|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
806718|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
806719|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
806720|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
806721|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
806722|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
806723|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
806724|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
806725|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
806726|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
806727|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
806728|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
806729|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
806730|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
806731|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
806732|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
806733|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
806734|NCT00833638|2565954|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
806735|NCT00833638|2565955|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
806736|NCT00833638|2565956|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
806737|NCT00833690|2566010|P3|Overall Study|Discontinued study drug|0
806738|NCT00833690|2566011|P2|Overall Study|Discontinued study drug|2
806739|NCT00833690|2566012|P1|Overall Study|Discontinued study drug|3
806740|NCT00833690|2566010|P3|Overall Study|Withdrawal by Subject|0
806741|NCT00833690|2566011|P2|Overall Study|Withdrawal by Subject|0
806742|NCT00833690|2566012|P1|Overall Study|Withdrawal by Subject|1
806743|NCT00833703|2566136|P2|Overall Study|Parent(s)/guardian(s)'s request|1
806744|NCT00833703|2566137|P1|Overall Study|Parent(s)/guardian(s)'s request|0
806745|NCT00839306|2566236|P2|Overall Study|Not specified|18
806746|NCT00839306|2566237|P1|Overall Study|Not specified|6
806747|NCT00839306|2566236|P2|Overall Study|Lack of Efficacy|4
806748|NCT00839306|2566237|P1|Overall Study|Lack of Efficacy|5
806749|NCT00839306|2566236|P2|Overall Study|Withdrawal by Subject|7
806750|NCT00839306|2566237|P1|Overall Study|Withdrawal by Subject|5
806751|NCT00839306|2566236|P2|Overall Study|Lost to Follow-up|9
806752|NCT00839306|2566237|P1|Overall Study|Lost to Follow-up|6
806753|NCT00839306|2566236|P2|Overall Study|Adverse Event|5
806754|NCT00839306|2566237|P1|Overall Study|Adverse Event|3
806755|NCT00839423|2566285|P4|Overall Study|Administrative or other reasons|0
806756|NCT00839423|2566286|P3|Overall Study|Administrative or other reasons|1
806757|NCT00839423|2566287|P2|Overall Study|Administrative or other reasons|0
806758|NCT00839423|2566288|P1|Overall Study|Administrative or other reasons|3
806759|NCT00839423|2566285|P4|Overall Study|Lost to Follow-up|0
806760|NCT00839423|2566286|P3|Overall Study|Lost to Follow-up|1
806761|NCT00839423|2566287|P2|Overall Study|Lost to Follow-up|0
806762|NCT00839423|2566288|P1|Overall Study|Lost to Follow-up|1
806763|NCT00839423|2566285|P4|Overall Study|Withdrawal of consent|1
806764|NCT00839423|2566286|P3|Overall Study|Withdrawal of consent|4
806765|NCT00839423|2566287|P2|Overall Study|Withdrawal of consent|0
806766|NCT00839423|2566288|P1|Overall Study|Withdrawal of consent|4
806767|NCT00839423|2566285|P4|Overall Study|Protocol Violation|0
806768|NCT00839423|2566286|P3|Overall Study|Protocol Violation|2
806769|NCT00839423|2566287|P2|Overall Study|Protocol Violation|1
806770|NCT00839423|2566288|P1|Overall Study|Protocol Violation|0
806771|NCT00839423|2566285|P4|Overall Study|Non-compliance|1
806772|NCT00839423|2566286|P3|Overall Study|Non-compliance|0
806773|NCT00839423|2566287|P2|Overall Study|Non-compliance|0
806774|NCT00839423|2566288|P1|Overall Study|Non-compliance|0
806775|NCT00839423|2566285|P4|Overall Study|Lack of Efficacy|2
806776|NCT00839423|2566286|P3|Overall Study|Lack of Efficacy|3
806777|NCT00839423|2566287|P2|Overall Study|Lack of Efficacy|6
806778|NCT00839423|2566288|P1|Overall Study|Lack of Efficacy|6
806779|NCT00839423|2566285|P4|Overall Study|Adverse Event|16
806780|NCT00839423|2566286|P3|Overall Study|Adverse Event|7
806781|NCT00839423|2566287|P2|Overall Study|Adverse Event|3
806782|NCT00839423|2566288|P1|Overall Study|Adverse Event|4
806783|NCT00839436|2566329|P3|Overall Study|Study drug no longer available|1
806784|NCT00839436|2566330|P2|Overall Study|Study drug no longer available|0
806785|NCT00839436|2566331|P1|Overall Study|Study drug no longer available|0
806786|NCT00839436|2566329|P3|Overall Study|Withdrawal by Subject|0
806787|NCT00839436|2566330|P2|Overall Study|Withdrawal by Subject|1
806788|NCT00839436|2566331|P1|Overall Study|Withdrawal by Subject|0
806789|NCT00839436|2566329|P3|Overall Study|Developed exclusionary condition|0
806790|NCT00839436|2566330|P2|Overall Study|Developed exclusionary condition|0
806791|NCT00839436|2566331|P1|Overall Study|Developed exclusionary condition|1
806792|NCT00841321|2566345|P2|Overall Study|Adverse Event|2
806793|NCT00841321|2566346|P1|Overall Study|Adverse Event|0
806794|NCT00841321|2566345|P2|Overall Study|Lost to Follow-up|1
806795|NCT00841321|2566346|P1|Overall Study|Lost to Follow-up|1
806796|NCT00841542|2566365|P2|Period 1|Adverse Event|0
806797|NCT00841542|2566366|P1|Period 1|Adverse Event|1
806798|NCT00841659|2566389|P2|Washout: 2 Weeks|Protocol Violation|0
806799|NCT00841659|2566390|P1|Washout: 2 Weeks|Protocol Violation|1
806800|NCT00841672|2566400|P2|Overall Study|Protocol Deviation|1
806801|NCT00841672|2566401|P1|Overall Study|Protocol Deviation|0
806802|NCT00841672|2566400|P2|Overall Study|Misrandomized|0
806803|NCT00841672|2566401|P1|Overall Study|Misrandomized|1
806804|NCT00841672|2566400|P2|Overall Study|Administrative problems|9
806805|NCT00841672|2566401|P1|Overall Study|Administrative problems|9
806806|NCT00841672|2566400|P2|Overall Study|Lost to Follow-up|1
806807|NCT00841672|2566401|P1|Overall Study|Lost to Follow-up|1
806808|NCT00841672|2566400|P2|Overall Study|Subject withdrew consent|4
806809|NCT00841672|2566401|P1|Overall Study|Subject withdrew consent|2
806810|NCT00841672|2566400|P2|Overall Study|Abnormal test procedure result(s)|1
806811|NCT00841672|2566401|P1|Overall Study|Abnormal test procedure result(s)|0
806812|NCT00841672|2566400|P2|Overall Study|Adverse Event|16
806813|NCT00841672|2566401|P1|Overall Study|Adverse Event|7
806814|NCT00841698|2566417|P2|First Intervention|Withdrawal by Subject|0
806815|NCT00841698|2566418|P1|First Intervention|Withdrawal by Subject|1
806816|NCT00841763|2566428|P4|Overall Study|Unable to Classify|0
806817|NCT00841763|2566429|P3|Overall Study|Unable to Classify|0
806818|NCT00841763|2566430|P2|Overall Study|Unable to Classify|1
806819|NCT00841763|2566431|P1|Overall Study|Unable to Classify|7
806820|NCT00841763|2566428|P4|Overall Study|Administrative Reasons|0
806821|NCT00841763|2566429|P3|Overall Study|Administrative Reasons|0
806822|NCT00841763|2566430|P2|Overall Study|Administrative Reasons|1
806823|NCT00841763|2566431|P1|Overall Study|Administrative Reasons|3
806824|NCT00841763|2566428|P4|Overall Study|Protocol Violation|0
806825|NCT00841763|2566429|P3|Overall Study|Protocol Violation|1
806826|NCT00841763|2566430|P2|Overall Study|Protocol Violation|3
806827|NCT00841763|2566431|P1|Overall Study|Protocol Violation|20
806828|NCT00841763|2566428|P4|Overall Study|Lost to Follow-up|0
806829|NCT00841763|2566429|P3|Overall Study|Lost to Follow-up|0
806830|NCT00841763|2566430|P2|Overall Study|Lost to Follow-up|25
806831|NCT00841763|2566431|P1|Overall Study|Lost to Follow-up|63
806832|NCT00841763|2566428|P4|Overall Study|Adverse Event|2
806833|NCT00841763|2566429|P3|Overall Study|Adverse Event|3
806834|NCT00841763|2566430|P2|Overall Study|Adverse Event|10
806835|NCT00841763|2566431|P1|Overall Study|Adverse Event|9
806836|NCT00841763|2566428|P4|Overall Study|Withdrawal by Subject|1
806837|NCT00841763|2566429|P3|Overall Study|Withdrawal by Subject|4
806838|NCT00841763|2566430|P2|Overall Study|Withdrawal by Subject|17
806839|NCT00841763|2566431|P1|Overall Study|Withdrawal by Subject|60
806840|NCT00841776|2566493|P2|Overall Study|Withdrawal by Subject|1
806841|NCT00841776|2566494|P1|Overall Study|Withdrawal by Subject|0
806842|NCT00841776|2566493|P2|Overall Study|Lost to Follow-up|1
806843|NCT00841776|2566494|P1|Overall Study|Lost to Follow-up|2
806844|NCT00841776|2566493|P2|Overall Study|Lack of Efficacy|1
806845|NCT00841776|2566494|P1|Overall Study|Lack of Efficacy|0
806846|NCT00841815|2566512|P2|Washout|Withdrawal by Subject|1
806847|NCT00841815|2566513|P1|Washout|Withdrawal by Subject|0
806848|NCT00841906|2566523|P2|Overall Study|Withdrawal by Subject|0
806849|NCT00841906|2566524|P1|Overall Study|Withdrawal by Subject|2
806854|NCT00842244|2566618|P1|Overall Study|Unspecified|17
806855|NCT00842244|2566618|P1|Overall Study|Withdrawal by Subject|1
806856|NCT00842244|2566618|P1|Overall Study|Death|3
806857|NCT00842257|2566637|P1|Overall Study|Adverse Event|1
806858|NCT00842348|2566653|P2|Study 729|Surgical resection|0
806859|NCT00842348|2566654|P1|Study 729|Surgical resection|1
806860|NCT00842348|2566653|P2|Study 729|Sponsor's decision|0
806861|NCT00842348|2566654|P1|Study 729|Sponsor's decision|1
806862|NCT00842348|2566653|P2|Study 729|Due to non-availability of IP|1
806863|NCT00842348|2566654|P1|Study 729|Due to non-availability of IP|0
806864|NCT00842348|2566653|P2|Study 729|Due to Sponsor stopping the study|1
806865|NCT00842348|2566654|P1|Study 729|Due to Sponsor stopping the study|1
806866|NCT00842348|2566653|P2|Study 729|Withdrawal by Subject|4
806867|NCT00842348|2566654|P1|Study 729|Withdrawal by Subject|2
806868|NCT00842348|2566653|P2|Study 729|Protocol Violation|1
806869|NCT00842348|2566654|P1|Study 729|Protocol Violation|1
806870|NCT00842348|2566653|P2|Study 729|Adverse Event|1
806871|NCT00842348|2566654|P1|Study 729|Adverse Event|1
806872|NCT00842348|2566653|P2|Study 729|Disease progression/death|30
806873|NCT00842348|2566654|P1|Study 729|Disease progression/death|19
806874|NCT00842348|2566653|P2|Patients Randomised in Study 726|Did not enter Study 729|56
806875|NCT00842348|2566654|P1|Patients Randomised in Study 726|Did not enter Study 729|59
806876|NCT00842361|2566666|P2|Overall Study|Unclassified|2
806877|NCT00842361|2566667|P1|Overall Study|Unclassified|0
806878|NCT00842361|2566666|P2|Overall Study|Protocol Violation|0
806879|NCT00842361|2566667|P1|Overall Study|Protocol Violation|1
806880|NCT00842543|2566689|P4|Overall Study|Withdrawal by Subject|4
806881|NCT00842543|2566690|P3|Overall Study|Withdrawal by Subject|3
806882|NCT00842543|2566691|P2|Overall Study|Withdrawal by Subject|0
806883|NCT00842543|2566692|P1|Overall Study|Withdrawal by Subject|2
806884|NCT00842712|2566736|P7|Randomized Part|Ongoing at cut-off date|2
806885|NCT00842712|2566737|P6|Randomized Part|Ongoing at cut-off date|0
806886|NCT00842712|2566738|P5|Randomized Part|Ongoing at cut-off date|0
806887|NCT00842712|2566739|P4|Randomized Part|Ongoing at cut-off date|0
806888|NCT00842712|2566740|P3|Randomized Part|Ongoing at cut-off date|0
806889|NCT00842712|2566741|P2|Randomized Part|Ongoing at cut-off date|0
806890|NCT00842712|2566742|P1|Randomized Part|Ongoing at cut-off date|0
806891|NCT00842712|2566736|P7|Randomized Part|Randomized but not treated|4
806892|NCT00842712|2566737|P6|Randomized Part|Randomized but not treated|1
806893|NCT00842712|2566738|P5|Randomized Part|Randomized but not treated|0
806894|NCT00842712|2566739|P4|Randomized Part|Randomized but not treated|0
806895|NCT00842712|2566740|P3|Randomized Part|Randomized but not treated|0
806896|NCT00842712|2566741|P2|Randomized Part|Randomized but not treated|0
806897|NCT00842712|2566742|P1|Randomized Part|Randomized but not treated|0
806898|NCT00842712|2566736|P7|Safety Run-in Part|Progressive disease|0
806899|NCT00842712|2566737|P6|Safety Run-in Part|Progressive disease|0
806900|NCT00842712|2566738|P5|Safety Run-in Part|Progressive disease|0
806901|NCT00842712|2566739|P4|Safety Run-in Part|Progressive disease|1
806902|NCT00842712|2566740|P3|Safety Run-in Part|Progressive disease|0
806903|NCT00842712|2566741|P2|Safety Run-in Part|Progressive disease|1
806904|NCT00842712|2566742|P1|Safety Run-in Part|Progressive disease|3
806905|NCT00842712|2566736|P7|Safety Run-in Part|Adverse Event|0
806906|NCT00842712|2566737|P6|Safety Run-in Part|Adverse Event|0
806907|NCT00842712|2566738|P5|Safety Run-in Part|Adverse Event|0
806908|NCT00842712|2566739|P4|Safety Run-in Part|Adverse Event|0
806909|NCT00842712|2566740|P3|Safety Run-in Part|Adverse Event|0
806910|NCT00842712|2566741|P2|Safety Run-in Part|Adverse Event|1
806911|NCT00842712|2566742|P1|Safety Run-in Part|Adverse Event|0
806912|NCT00842829|2566786|P3|Continuation Period|Non-compliance to study drug|1
806913|NCT00842829|2566787|P2|Continuation Period|Non-compliance to study drug|0
806914|NCT00842829|2566788|P1|Continuation Period|Non-compliance to study drug|0
806915|NCT00842829|2566786|P3|Continuation Period|Non-compliance to study procedures|2
806916|NCT00842829|2566787|P2|Continuation Period|Non-compliance to study procedures|0
806917|NCT00842829|2566788|P1|Continuation Period|Non-compliance to study procedures|0
806918|NCT00842829|2566786|P3|Continuation Period|Not specified|7
806919|NCT00842829|2566787|P2|Continuation Period|Not specified|0
806920|NCT00842829|2566788|P1|Continuation Period|Not specified|0
806921|NCT00842829|2566786|P3|Continuation Period|Withdrawal by Subject|10
806922|NCT00842829|2566787|P2|Continuation Period|Withdrawal by Subject|0
806923|NCT00842829|2566788|P1|Continuation Period|Withdrawal by Subject|0
806924|NCT00842829|2566786|P3|Continuation Period|Unstable persistent cancer pain|3
806925|NCT00842829|2566787|P2|Continuation Period|Unstable persistent cancer pain|0
806926|NCT00842829|2566788|P1|Continuation Period|Unstable persistent cancer pain|0
806927|NCT00842829|2566786|P3|Continuation Period|Lack of Efficacy|6
806928|NCT00842829|2566787|P2|Continuation Period|Lack of Efficacy|0
806929|NCT00842829|2566788|P1|Continuation Period|Lack of Efficacy|0
806930|NCT00842829|2566786|P3|Continuation Period|Adverse Event|32
806931|NCT00842829|2566787|P2|Continuation Period|Adverse Event|0
806932|NCT00842829|2566788|P1|Continuation Period|Adverse Event|0
806933|NCT00842829|2566786|P3|Treatment Period|Unclear completion status|1
806934|NCT00842829|2566787|P2|Treatment Period|Unclear completion status|0
806935|NCT00842829|2566788|P1|Treatment Period|Unclear completion status|0
806936|NCT00842829|2566786|P3|Treatment Period|Non-compliance to study procedures|4
806937|NCT00842829|2566787|P2|Treatment Period|Non-compliance to study procedures|0
806938|NCT00842829|2566788|P1|Treatment Period|Non-compliance to study procedures|0
806939|NCT00842829|2566786|P3|Treatment Period|Not specified|18
806940|NCT00842829|2566787|P2|Treatment Period|Not specified|0
806941|NCT00842829|2566788|P1|Treatment Period|Not specified|0
806942|NCT00842829|2566786|P3|Treatment Period|Protocol Violation|2
806943|NCT00842829|2566787|P2|Treatment Period|Protocol Violation|0
806944|NCT00842829|2566788|P1|Treatment Period|Protocol Violation|0
806945|NCT00842829|2566786|P3|Treatment Period|Consistently >4 BTP episodes daily|1
806946|NCT00842829|2566787|P2|Treatment Period|Consistently >4 BTP episodes daily|0
806947|NCT00842829|2566788|P1|Treatment Period|Consistently >4 BTP episodes daily|0
806948|NCT00842829|2566786|P3|Treatment Period|Withdrawal by Subject|11
806949|NCT00842829|2566787|P2|Treatment Period|Withdrawal by Subject|0
806950|NCT00842829|2566788|P1|Treatment Period|Withdrawal by Subject|0
806951|NCT00842829|2566786|P3|Treatment Period|Unstable persistent cancer pain|5
806952|NCT00842829|2566787|P2|Treatment Period|Unstable persistent cancer pain|0
806953|NCT00842829|2566788|P1|Treatment Period|Unstable persistent cancer pain|0
806954|NCT00842829|2566786|P3|Treatment Period|Lack of Efficacy|6
806955|NCT00842829|2566787|P2|Treatment Period|Lack of Efficacy|0
806956|NCT00842829|2566788|P1|Treatment Period|Lack of Efficacy|0
806957|NCT00842829|2566786|P3|Treatment Period|Adverse Event|15
806958|NCT00842829|2566787|P2|Treatment Period|Adverse Event|0
806959|NCT00842829|2566788|P1|Treatment Period|Adverse Event|0
806960|NCT00842829|2566786|P3|Dose Titration Period|Non-compliance to study drug|0
806961|NCT00842829|2566787|P2|Dose Titration Period|Non-compliance to study drug|1
806962|NCT00842829|2566788|P1|Dose Titration Period|Non-compliance to study drug|2
806963|NCT00842829|2566786|P3|Dose Titration Period|Non-compliance to study procedures|0
806964|NCT00842829|2566787|P2|Dose Titration Period|Non-compliance to study procedures|1
806965|NCT00842829|2566788|P1|Dose Titration Period|Non-compliance to study procedures|1
806966|NCT00842829|2566786|P3|Dose Titration Period|Not specified|0
806967|NCT00842829|2566787|P2|Dose Titration Period|Not specified|4
806968|NCT00842829|2566788|P1|Dose Titration Period|Not specified|5
806969|NCT00842829|2566786|P3|Dose Titration Period|Withdrawal by Subject|0
806970|NCT00842829|2566787|P2|Dose Titration Period|Withdrawal by Subject|6
806971|NCT00842829|2566788|P1|Dose Titration Period|Withdrawal by Subject|2
806972|NCT00842829|2566786|P3|Dose Titration Period|Unstable persistent cancer pain|0
806973|NCT00842829|2566787|P2|Dose Titration Period|Unstable persistent cancer pain|0
806974|NCT00842829|2566788|P1|Dose Titration Period|Unstable persistent cancer pain|1
806975|NCT00842829|2566786|P3|Dose Titration Period|Lack of Efficacy|0
806976|NCT00842829|2566787|P2|Dose Titration Period|Lack of Efficacy|1
806977|NCT00842829|2566788|P1|Dose Titration Period|Lack of Efficacy|4
806978|NCT00842829|2566786|P3|Dose Titration Period|Adverse Event|0
806979|NCT00842829|2566787|P2|Dose Titration Period|Adverse Event|10
806980|NCT00842829|2566788|P1|Dose Titration Period|Adverse Event|11
806981|NCT00842985|2566831|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
806982|NCT00842985|2566831|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
806983|NCT00842985|2566831|P1|First Intervention|Protocol Violation|3
806984|NCT00842985|2566831|P1|First Intervention|Withdrawal by Subject|3
806985|NCT00842985|2566831|P1|Screening|Did not meet entrance requirements|27
806986|NCT00843024|2566842|P6|Double-blind Treatment Phase|Lack of Efficacy|0
806987|NCT00843024|2566843|P5|Double-blind Treatment Phase|Lack of Efficacy|1
806988|NCT00843024|2566844|P4|Double-blind Treatment Phase|Lack of Efficacy|0
806989|NCT00843024|2566845|P3|Double-blind Treatment Phase|Lack of Efficacy|0
806990|NCT00843024|2566846|P2|Double-blind Treatment Phase|Lack of Efficacy|0
806991|NCT00843024|2566847|P1|Double-blind Treatment Phase|Lack of Efficacy|0
806992|NCT00843024|2566842|P6|Double-blind Treatment Phase|Adverse Event|1
806993|NCT00843024|2566843|P5|Double-blind Treatment Phase|Adverse Event|1
806994|NCT00843024|2566844|P4|Double-blind Treatment Phase|Adverse Event|0
806995|NCT00843024|2566845|P3|Double-blind Treatment Phase|Adverse Event|0
806996|NCT00843024|2566846|P2|Double-blind Treatment Phase|Adverse Event|0
806997|NCT00843024|2566847|P1|Double-blind Treatment Phase|Adverse Event|0
806998|NCT00843024|2566842|P6|Double-blind Treatment Phase|Physician Decision|1
806999|NCT00843024|2566843|P5|Double-blind Treatment Phase|Physician Decision|1
807000|NCT00843024|2566844|P4|Double-blind Treatment Phase|Physician Decision|3
807001|NCT00843024|2566845|P3|Double-blind Treatment Phase|Physician Decision|0
807002|NCT00843024|2566846|P2|Double-blind Treatment Phase|Physician Decision|0
807003|NCT00843024|2566847|P1|Double-blind Treatment Phase|Physician Decision|0
807004|NCT00843024|2566842|P6|Double-blind Treatment Phase|Protocol Violation|3
807005|NCT00843024|2566843|P5|Double-blind Treatment Phase|Protocol Violation|0
807006|NCT00843024|2566844|P4|Double-blind Treatment Phase|Protocol Violation|0
807007|NCT00843024|2566845|P3|Double-blind Treatment Phase|Protocol Violation|3
807008|NCT00843024|2566846|P2|Double-blind Treatment Phase|Protocol Violation|0
807009|NCT00843024|2566847|P1|Double-blind Treatment Phase|Protocol Violation|0
807010|NCT00843024|2566842|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
807011|NCT00843024|2566843|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
807012|NCT00843024|2566844|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
807013|NCT00843024|2566845|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
807014|NCT00843024|2566846|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
807015|NCT00843024|2566847|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
807016|NCT00843024|2566842|P6|Double-blind Treatment Phase|Lost to Follow-up|4
807017|NCT00843024|2566843|P5|Double-blind Treatment Phase|Lost to Follow-up|4
807018|NCT00843024|2566844|P4|Double-blind Treatment Phase|Lost to Follow-up|4
807019|NCT00843024|2566845|P3|Double-blind Treatment Phase|Lost to Follow-up|8
807020|NCT00843024|2566846|P2|Double-blind Treatment Phase|Lost to Follow-up|0
807021|NCT00843024|2566847|P1|Double-blind Treatment Phase|Lost to Follow-up|0
807022|NCT00843024|2566842|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
807023|NCT00843024|2566843|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
807024|NCT00843024|2566844|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
807025|NCT00843024|2566845|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
807026|NCT00843024|2566846|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
807027|NCT00843024|2566847|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
807028|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Other|0
807029|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Other|0
807030|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Other|0
807031|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Other|0
807032|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Other|1
807033|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Other|0
807034|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
807035|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
807036|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
807037|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
807038|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
807039|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
807040|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
807041|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
807042|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
807043|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
807044|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
807045|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
807046|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
807047|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
807048|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
807049|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
807050|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
807051|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
807052|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
807053|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
807054|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
807055|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
807056|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
807057|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
807058|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
807059|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
807060|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
807061|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
807062|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
807063|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
807064|NCT00843024|2566842|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
807065|NCT00843024|2566843|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
807066|NCT00843024|2566844|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
807067|NCT00843024|2566845|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
807068|NCT00843024|2566846|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
807069|NCT00843024|2566847|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
807070|NCT00843115|2566918|P1|Overall Study|Syndrome De Glissement|1
807071|NCT00843115|2566918|P1|Overall Study|week 12 not done|1
807072|NCT00843115|2566918|P1|Overall Study|hospitalized due to deterioration|1
807073|NCT00843115|2566918|P1|Overall Study|patient never took the medication|1
807074|NCT00843115|2566918|P1|Overall Study|patient took for 2 days then stopped|1
807075|NCT00843115|2566918|P1|Overall Study|Family discontinued meds|1
807076|NCT00843115|2566918|P1|Overall Study|Physician Decision|1
807077|NCT00843115|2566918|P1|Overall Study|Does not meet entrance criteria|1
807078|NCT00843115|2566918|P1|Overall Study|Patient forgot to take meds|1
807079|NCT00843115|2566918|P1|Overall Study|Family does not want continuation|1
807080|NCT00843115|2566918|P1|Overall Study|Family wanted meds stopped|1
807081|NCT00843115|2566918|P1|Overall Study|Withdrawal by Subject|17
807082|NCT00843115|2566918|P1|Overall Study|Lost to Follow-up|4
807083|NCT00843115|2566918|P1|Overall Study|Adverse Event|30
807084|NCT00843115|2566918|P1|Overall Study|Death|4
807085|NCT00843167|2566966|P2|Treatment Period|Withdrawal by Subject|3
807086|NCT00843167|2566967|P1|Treatment Period|Withdrawal by Subject|2
807087|NCT00843167|2566966|P2|Treatment Period|Adverse Event|5
807088|NCT00843167|2566967|P1|Treatment Period|Adverse Event|1
807089|NCT00843284|2566995|P1|Overall Study|Death|3
807090|NCT00843284|2566995|P1|Overall Study|Withdrawal by Subject|4
807091|NCT00843284|2566995|P1|Overall Study|Other|10
807092|NCT00843284|2566995|P1|Overall Study|Lost to Follow-up|11
807093|NCT00843284|2566995|P1|Overall Study|Lack of Efficacy|5
807094|NCT00843284|2566995|P1|Overall Study|Adverse Event|39
807095|NCT00843492|2567058|P2|Overall Study|Deep-vein Thrombosis|0
807096|NCT00843492|2567059|P1|Overall Study|Deep-vein Thrombosis|1
807097|NCT00843492|2567058|P2|Overall Study|Visit Not Performed|0
807098|NCT00843492|2567059|P1|Overall Study|Visit Not Performed|1
807099|NCT00843492|2567058|P2|Overall Study|Orthopedic Surgery|2
807100|NCT00843492|2567059|P1|Overall Study|Orthopedic Surgery|0
807101|NCT00843492|2567058|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
807102|NCT00843492|2567059|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
807103|NCT00843492|2567058|P2|Overall Study|Immobilization Stopped|0
807104|NCT00843492|2567059|P1|Overall Study|Immobilization Stopped|1
807105|NCT00843492|2567058|P2|Overall Study|Withdrawal by Subject|4
807106|NCT00843492|2567059|P1|Overall Study|Withdrawal by Subject|0
807107|NCT00843492|2567058|P2|Overall Study|Lost to Follow-up|4
807108|NCT00843492|2567059|P1|Overall Study|Lost to Follow-up|4
807109|NCT00843492|2567058|P2|Overall Study|Adverse Event|3
807110|NCT00843492|2567059|P1|Overall Study|Adverse Event|0
807111|NCT00843635|2567089|P3|Overall Study|Adverse Event|0
807112|NCT00843635|2567090|P2|Overall Study|Adverse Event|2
807113|NCT00843635|2567091|P1|Overall Study|Adverse Event|2
807114|NCT00843778|2567118|P1|Overall Study|Withdrawal by Subject|4
807115|NCT00843778|2567118|P1|Overall Study|Loss of efficacy|2
807116|NCT00843778|2567118|P1|Overall Study|Lack of Efficacy|14
807117|NCT00843778|2567118|P1|Overall Study|Adverse Event|15
807118|NCT00830804|2567209|P1|Overall Study|Unwilling to adhere to study requirement|1
807119|NCT00830804|2567209|P1|Overall Study|Consent withdrawn|2
807120|NCT00830804|2567209|P1|Overall Study|Unable to get to clinic|7
807121|NCT00830804|2567209|P1|Overall Study|Death|1
807122|NCT00830804|2567209|P1|Overall Study|Lost to Follow-up|4
807123|NCT00830947|2567231|P2|Overall Study|Lost to Follow-up|4
807124|NCT00830947|2567232|P1|Overall Study|Lost to Follow-up|4
807125|NCT00830960|2567244|P6|Overall Study|No study drug received|7
807126|NCT00830960|2567245|P5|Overall Study|No study drug received|5
807127|NCT00830960|2567246|P4|Overall Study|No study drug received|3
807128|NCT00830960|2567247|P3|Overall Study|No study drug received|4
807129|NCT00830960|2567248|P2|Overall Study|No study drug received|2
807130|NCT00830960|2567249|P1|Overall Study|No study drug received|7
807131|NCT00830960|2567244|P6|Overall Study|Sponsor Decision|7
807132|NCT00830960|2567245|P5|Overall Study|Sponsor Decision|5
807133|NCT00830960|2567246|P4|Overall Study|Sponsor Decision|4
807134|NCT00830960|2567247|P3|Overall Study|Sponsor Decision|3
807135|NCT00830960|2567248|P2|Overall Study|Sponsor Decision|2
807136|NCT00830960|2567249|P1|Overall Study|Sponsor Decision|1
807137|NCT00830960|2567244|P6|Overall Study|Withdrawal by Subject|21
807138|NCT00830960|2567245|P5|Overall Study|Withdrawal by Subject|16
807139|NCT00830960|2567246|P4|Overall Study|Withdrawal by Subject|23
807140|NCT00830960|2567247|P3|Overall Study|Withdrawal by Subject|18
807141|NCT00830960|2567248|P2|Overall Study|Withdrawal by Subject|19
807142|NCT00830960|2567249|P1|Overall Study|Withdrawal by Subject|19
807143|NCT00830960|2567244|P6|Overall Study|Lost to Follow-up|1
807144|NCT00830960|2567245|P5|Overall Study|Lost to Follow-up|0
807145|NCT00830960|2567246|P4|Overall Study|Lost to Follow-up|0
807146|NCT00830960|2567247|P3|Overall Study|Lost to Follow-up|1
807147|NCT00830960|2567248|P2|Overall Study|Lost to Follow-up|1
807148|NCT00830960|2567249|P1|Overall Study|Lost to Follow-up|1
807149|NCT00830960|2567244|P6|Overall Study|Death|1
807150|NCT00830960|2567245|P5|Overall Study|Death|6
807151|NCT00830960|2567246|P4|Overall Study|Death|2
807152|NCT00830960|2567247|P3|Overall Study|Death|3
807153|NCT00830960|2567248|P2|Overall Study|Death|4
807154|NCT00830960|2567249|P1|Overall Study|Death|5
807155|NCT00831129|2567365|P2|Overall Study|9 lost to follow-up reasons uknown|9
807156|NCT00831129|2567366|P1|Overall Study|9 lost to follow-up reasons uknown|0
807157|NCT00831129|2567365|P2|Overall Study|Adverse Event|1
807158|NCT00831129|2567366|P1|Overall Study|Adverse Event|0
807159|NCT00843843|2567409|P2|Overall Study|Protocol Violation|1
807160|NCT00843843|2567410|P1|Overall Study|Protocol Violation|1
807161|NCT00843843|2567409|P2|Overall Study|Physician Decision|1
807162|NCT00843843|2567410|P1|Overall Study|Physician Decision|1
807163|NCT00845897|2567470|P3|Overall Study|Too ill to participate|0
807164|NCT00845897|2567471|P2|Overall Study|Too ill to participate|1
807165|NCT00845897|2567472|P1|Overall Study|Too ill to participate|0
807166|NCT00845897|2567470|P3|Overall Study|Ulcer did not heal|1
807167|NCT00845897|2567471|P2|Overall Study|Ulcer did not heal|0
807168|NCT00845897|2567472|P1|Overall Study|Ulcer did not heal|1
807169|NCT00845897|2567470|P3|Overall Study|Withdrawal by Subject|2
807170|NCT00845897|2567471|P2|Overall Study|Withdrawal by Subject|3
807171|NCT00845897|2567472|P1|Overall Study|Withdrawal by Subject|0
807172|NCT00845897|2567470|P3|Overall Study|Lost to Follow-up|0
807173|NCT00845897|2567471|P2|Overall Study|Lost to Follow-up|1
807174|NCT00845897|2567472|P1|Overall Study|Lost to Follow-up|1
807175|NCT00846027|2567496|P1|Overall Study|Subject Not Treated|7
807176|NCT00846027|2567496|P1|Overall Study|Protocol Violation|2
807177|NCT00846027|2567496|P1|Overall Study|Investigator Discretion|29
807178|NCT00846027|2567496|P1|Overall Study|Patient Decision|7
807179|NCT00846027|2567496|P1|Overall Study|Toxicity|12
807180|NCT00846027|2567496|P1|Overall Study|Disease Progression|30
807181|NCT00846027|2567496|P1|Overall Study|Death|3
807182|NCT00846365|2567532|P3|Overall Study|Other|6
807183|NCT00846365|2567533|P2|Overall Study|Other|1
807184|NCT00846365|2567534|P1|Overall Study|Other|9
807185|NCT00846365|2567532|P3|Overall Study|Lack of Efficacy|2
807186|NCT00846365|2567533|P2|Overall Study|Lack of Efficacy|1
807187|NCT00846365|2567534|P1|Overall Study|Lack of Efficacy|1
807188|NCT00846365|2567532|P3|Overall Study|Pregnancy|0
807189|NCT00846365|2567533|P2|Overall Study|Pregnancy|0
807190|NCT00846365|2567534|P1|Overall Study|Pregnancy|1
807191|NCT00846365|2567532|P3|Overall Study|Withdrawal by Subject|9
807192|NCT00846365|2567533|P2|Overall Study|Withdrawal by Subject|11
807193|NCT00846365|2567534|P1|Overall Study|Withdrawal by Subject|11
807194|NCT00846365|2567532|P3|Overall Study|Lost to Follow-up|5
807195|NCT00846365|2567533|P2|Overall Study|Lost to Follow-up|2
807196|NCT00846365|2567534|P1|Overall Study|Lost to Follow-up|8
807197|NCT00846365|2567532|P3|Overall Study|Protocol Violation|0
807198|NCT00846365|2567533|P2|Overall Study|Protocol Violation|4
807199|NCT00846365|2567534|P1|Overall Study|Protocol Violation|5
807200|NCT00846365|2567532|P3|Overall Study|Adverse Event|11
807201|NCT00846365|2567533|P2|Overall Study|Adverse Event|30
807202|NCT00846365|2567534|P1|Overall Study|Adverse Event|20
807203|NCT00846391|2567590|P3|Overall Study|Study Terminated by Sponsor|2
807204|NCT00846391|2567591|P2|Overall Study|Study Terminated by Sponsor|2
807205|NCT00846391|2567592|P1|Overall Study|Study Terminated by Sponsor|1
807206|NCT00846391|2567590|P3|Overall Study|Physician Decision|1
807207|NCT00846391|2567591|P2|Overall Study|Physician Decision|0
807208|NCT00846391|2567592|P1|Overall Study|Physician Decision|0
807209|NCT00846495|2567602|P2|Overall Study|Physician Decision|0
807210|NCT00846495|2567603|P1|Overall Study|Physician Decision|1
807211|NCT00846495|2567602|P2|Overall Study|Lack of Efficacy|2
807212|NCT00846495|2567603|P1|Overall Study|Lack of Efficacy|1
807213|NCT00846495|2567602|P2|Overall Study|Adverse Event|1
807214|NCT00846495|2567603|P1|Overall Study|Adverse Event|5
807215|NCT00846495|2567602|P2|Overall Study|Lost to Follow-up|0
807216|NCT00846495|2567603|P1|Overall Study|Lost to Follow-up|1
807217|NCT00846521|2567623|P1|Overall Study|Protocol Violation|1
807218|NCT00846521|2567623|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
807219|NCT00846521|2567623|P1|Overall Study|Withdrawal by Subject|5
807220|NCT00846586|2567648|P2|Overall Study|Unsatisfactory therapeutic effect|1
807221|NCT00846586|2567649|P1|Overall Study|Unsatisfactory therapeutic effect|0
807222|NCT00846586|2567648|P2|Overall Study|Lost to Follow-up|4
807223|NCT00846586|2567649|P1|Overall Study|Lost to Follow-up|1
807224|NCT00846586|2567648|P2|Overall Study|Abnormal test procedure result(s)|0
807225|NCT00846586|2567649|P1|Overall Study|Abnormal test procedure result(s)|1
807226|NCT00846586|2567648|P2|Overall Study|Protocol deviation|6
807227|NCT00846586|2567649|P1|Overall Study|Protocol deviation|2
807228|NCT00846586|2567648|P2|Overall Study|Death|0
807229|NCT00846586|2567649|P1|Overall Study|Death|2
807230|NCT00846586|2567648|P2|Overall Study|Administrative problems|4
807231|NCT00846586|2567649|P1|Overall Study|Administrative problems|5
807232|NCT00846586|2567648|P2|Overall Study|Subject withdrew consent|10
807233|NCT00846586|2567649|P1|Overall Study|Subject withdrew consent|8
807234|NCT00846586|2567648|P2|Overall Study|Adverse Event|10
807235|NCT00846586|2567649|P1|Overall Study|Adverse Event|20
807236|NCT00846768|2567682|P4|Overall Study|Adverse Event|0
807237|NCT00846768|2567683|P3|Overall Study|Adverse Event|0
807238|NCT00846768|2567684|P2|Overall Study|Adverse Event|1
807239|NCT00846768|2567685|P1|Overall Study|Adverse Event|0
807240|NCT00846807|2567755|P1|Overall Study|Other|60
807241|NCT00846807|2567755|P1|Overall Study|No prescription after hospital discharge|56
807242|NCT00846807|2567755|P1|Overall Study|Switch to other anticoagulants|89
807243|NCT00846807|2567755|P1|Overall Study|Non compliant with European label|7
807244|NCT00846807|2567755|P1|Overall Study|Withdrawal by Subject|56
807245|NCT00846807|2567755|P1|Overall Study|Lost to Follow-up|94
807246|NCT00846807|2567755|P1|Overall Study|Adverse Event|270
807247|NCT00846846|2567763|P1|Overall Study|Withdrawal by Subject|19
807248|NCT00846846|2567763|P1|Overall Study|Death|56
807249|NCT00847015|2567790|P1|Overall Study|partial cystectomy vs radical cystectomy|1
807250|NCT00847015|2567790|P1|Overall Study|declined any surgery|1
807251|NCT00847015|2567790|P1|Overall Study|Withdrawal by Subject|1
807252|NCT00847132|2567798|P2|Overall Study|Death|1
807253|NCT00847132|2567799|P1|Overall Study|Death|1
807254|NCT00847145|2567815|P8|Overall Study|Protocol Violation|1
807255|NCT00847145|2567816|P7|Overall Study|Protocol Violation|0
807256|NCT00847145|2567817|P6|Overall Study|Protocol Violation|0
807257|NCT00847145|2567818|P5|Overall Study|Protocol Violation|1
807258|NCT00847145|2567819|P4|Overall Study|Protocol Violation|0
807259|NCT00847145|2567820|P3|Overall Study|Protocol Violation|3
807260|NCT00847145|2567821|P2|Overall Study|Protocol Violation|0
807261|NCT00847145|2567822|P1|Overall Study|Protocol Violation|0
807262|NCT00847145|2567815|P8|Overall Study|Inappropriate enrollment|0
807263|NCT00847145|2567816|P7|Overall Study|Inappropriate enrollment|0
807264|NCT00847145|2567817|P6|Overall Study|Inappropriate enrollment|0
807265|NCT00847145|2567818|P5|Overall Study|Inappropriate enrollment|1
807266|NCT00847145|2567819|P4|Overall Study|Inappropriate enrollment|0
807267|NCT00847145|2567820|P3|Overall Study|Inappropriate enrollment|0
807268|NCT00847145|2567821|P2|Overall Study|Inappropriate enrollment|0
807269|NCT00847145|2567822|P1|Overall Study|Inappropriate enrollment|0
807270|NCT00847145|2567815|P8|Overall Study|Lost to Follow-up|2
807271|NCT00847145|2567816|P7|Overall Study|Lost to Follow-up|8
807272|NCT00847145|2567817|P6|Overall Study|Lost to Follow-up|4
807273|NCT00847145|2567818|P5|Overall Study|Lost to Follow-up|4
807274|NCT00847145|2567819|P4|Overall Study|Lost to Follow-up|0
807275|NCT00847145|2567820|P3|Overall Study|Lost to Follow-up|1
807276|NCT00847145|2567821|P2|Overall Study|Lost to Follow-up|1
807277|NCT00847145|2567822|P1|Overall Study|Lost to Follow-up|3
807278|NCT00847145|2567815|P8|Overall Study|Withdrawal by Subject|1
807279|NCT00847145|2567816|P7|Overall Study|Withdrawal by Subject|1
807280|NCT00847145|2567817|P6|Overall Study|Withdrawal by Subject|0
807281|NCT00847145|2567818|P5|Overall Study|Withdrawal by Subject|0
807282|NCT00847145|2567819|P4|Overall Study|Withdrawal by Subject|1
807283|NCT00847145|2567820|P3|Overall Study|Withdrawal by Subject|6
807284|NCT00847145|2567821|P2|Overall Study|Withdrawal by Subject|4
807285|NCT00847145|2567822|P1|Overall Study|Withdrawal by Subject|3
807286|NCT00847145|2567815|P8|Overall Study|AE or Death|0
807287|NCT00847145|2567816|P7|Overall Study|AE or Death|0
807288|NCT00847145|2567817|P6|Overall Study|AE or Death|0
807289|NCT00847145|2567818|P5|Overall Study|AE or Death|0
807290|NCT00847145|2567819|P4|Overall Study|AE or Death|0
807291|NCT00847145|2567820|P3|Overall Study|AE or Death|1
807292|NCT00847145|2567821|P2|Overall Study|AE or Death|1
807293|NCT00847145|2567822|P1|Overall Study|AE or Death|0
807294|NCT00847197|2567872|P2|Overall Study|Withdrawal by Subject|1
807295|NCT00847197|2567873|P1|Overall Study|Withdrawal by Subject|3
807296|NCT00847197|2567872|P2|Overall Study|Protocol Violation|1
807297|NCT00847197|2567873|P1|Overall Study|Protocol Violation|0
807298|NCT00847197|2567872|P2|Overall Study|Adverse Event|3
807299|NCT00847197|2567873|P1|Overall Study|Adverse Event|21
807300|NCT00847301|2567921|P1|Overall Study|Other reason not defined above|1
807301|NCT00847301|2567921|P1|Overall Study|No prescription after hospital discharge|1
807302|NCT00847301|2567921|P1|Overall Study|Lost to Follow-up|1
807303|NCT00847301|2567921|P1|Overall Study|Switch to other anticoagulants|16
807304|NCT00847301|2567921|P1|Overall Study|Adverse Event|35
807305|NCT00847405|2567931|P2|Washout of 7 Days|Withdrawal by Subject|0
807306|NCT00847405|2567932|P1|Washout of 7 Days|Withdrawal by Subject|1
807307|NCT00847405|2567931|P2|First Intervention|Adverse Event|1
807308|NCT00847405|2567932|P1|First Intervention|Adverse Event|0
807309|NCT00847535|2567944|P3|Overall Study|Lost to Follow-up|0
807310|NCT00847535|2567945|P2|Overall Study|Lost to Follow-up|1
807311|NCT00847535|2567946|P1|Overall Study|Lost to Follow-up|0
807312|NCT00847535|2567944|P3|Overall Study|Withdrawal by Subject|1
807313|NCT00847535|2567945|P2|Overall Study|Withdrawal by Subject|1
807314|NCT00847535|2567946|P1|Overall Study|Withdrawal by Subject|2
807315|NCT00847561|2567956|P2|Overall Study|Unable to schedule|1
807316|NCT00847561|2567957|P1|Overall Study|Unable to schedule|9
807317|NCT00847561|2567956|P2|Overall Study|Withdrawal by Subject|3
807318|NCT00847561|2567957|P1|Overall Study|Withdrawal by Subject|4
807319|NCT00847613|2567978|P4|Overall Study|Unspecified|0
807320|NCT00847613|2567979|P3|Overall Study|Unspecified|2
807321|NCT00847613|2567980|P2|Overall Study|Unspecified|1
807322|NCT00847613|2567981|P1|Overall Study|Unspecified|1
807323|NCT00847613|2567978|P4|Overall Study|Randomized, but not treated|0
807324|NCT00847613|2567979|P3|Overall Study|Randomized, but not treated|0
807325|NCT00847613|2567980|P2|Overall Study|Randomized, but not treated|3
807326|NCT00847613|2567981|P1|Overall Study|Randomized, but not treated|0
807327|NCT00847613|2567978|P4|Overall Study|Sponsor request|0
807328|NCT00847613|2567979|P3|Overall Study|Sponsor request|0
807329|NCT00847613|2567980|P2|Overall Study|Sponsor request|1
807330|NCT00847613|2567981|P1|Overall Study|Sponsor request|0
807331|NCT00847613|2567978|P4|Overall Study|Participant moved|0
807332|NCT00847613|2567979|P3|Overall Study|Participant moved|0
807333|NCT00847613|2567980|P2|Overall Study|Participant moved|1
807334|NCT00847613|2567981|P1|Overall Study|Participant moved|4
807335|NCT00847613|2567978|P4|Overall Study|Withdrawal by Subject|2
807336|NCT00847613|2567979|P3|Overall Study|Withdrawal by Subject|2
807337|NCT00847613|2567980|P2|Overall Study|Withdrawal by Subject|11
807338|NCT00847613|2567981|P1|Overall Study|Withdrawal by Subject|8
807339|NCT00847613|2567978|P4|Overall Study|Site closure|1
807340|NCT00847613|2567979|P3|Overall Study|Site closure|0
807341|NCT00847613|2567980|P2|Overall Study|Site closure|0
807342|NCT00847613|2567981|P1|Overall Study|Site closure|1
807343|NCT00847613|2567978|P4|Overall Study|Pregnancy|0
807344|NCT00847613|2567979|P3|Overall Study|Pregnancy|0
807345|NCT00847613|2567980|P2|Overall Study|Pregnancy|1
807346|NCT00847613|2567981|P1|Overall Study|Pregnancy|1
807347|NCT00847613|2567978|P4|Overall Study|Protocol Violation|1
807348|NCT00847613|2567979|P3|Overall Study|Protocol Violation|3
807349|NCT00847613|2567980|P2|Overall Study|Protocol Violation|6
807350|NCT00847613|2567981|P1|Overall Study|Protocol Violation|6
807351|NCT00847613|2567978|P4|Overall Study|Lost to Follow-up|3
807352|NCT00847613|2567979|P3|Overall Study|Lost to Follow-up|0
807353|NCT00847613|2567980|P2|Overall Study|Lost to Follow-up|0
807354|NCT00847613|2567981|P1|Overall Study|Lost to Follow-up|5
807355|NCT00847613|2567978|P4|Overall Study|Study terminated by Sponsor|1
807356|NCT00847613|2567979|P3|Overall Study|Study terminated by Sponsor|2
807357|NCT00847613|2567980|P2|Overall Study|Study terminated by Sponsor|0
807358|NCT00847613|2567981|P1|Overall Study|Study terminated by Sponsor|1
807359|NCT00847613|2567978|P4|Overall Study|Lack of Efficacy|1
807360|NCT00847613|2567979|P3|Overall Study|Lack of Efficacy|3
807361|NCT00847613|2567980|P2|Overall Study|Lack of Efficacy|3
807362|NCT00847613|2567981|P1|Overall Study|Lack of Efficacy|7
807363|NCT00847613|2567978|P4|Overall Study|Adverse Event|6
807364|NCT00847613|2567979|P3|Overall Study|Adverse Event|5
807365|NCT00847613|2567980|P2|Overall Study|Adverse Event|26
807366|NCT00847613|2567981|P1|Overall Study|Adverse Event|36
807367|NCT00847613|2567978|P4|Overall Study|Death|0
807368|NCT00847613|2567979|P3|Overall Study|Death|0
807369|NCT00847613|2567980|P2|Overall Study|Death|1
807370|NCT00847613|2567981|P1|Overall Study|Death|1
807371|NCT00847613|2567978|P4|Overall Study|Ongoing at cut-off date|64
807372|NCT00847613|2567979|P3|Overall Study|Ongoing at cut-off date|64
807373|NCT00847613|2567980|P2|Overall Study|Ongoing at cut-off date|265
807374|NCT00847613|2567981|P1|Overall Study|Ongoing at cut-off date|250
807375|NCT00847626|2568230|P11|Overall Study|Other|3
807376|NCT00847626|2568231|P10|Overall Study|Other|1
807377|NCT00847626|2568232|P9|Overall Study|Other|1
807378|NCT00847626|2568233|P8|Overall Study|Other|3
807379|NCT00847626|2568234|P7|Overall Study|Other|2
807380|NCT00847626|2568235|P6|Overall Study|Other|2
807381|NCT00847626|2568236|P5|Overall Study|Other|2
807382|NCT00847626|2568237|P4|Overall Study|Other|1
807383|NCT00847626|2568238|P3|Overall Study|Other|4
807384|NCT00847626|2568239|P2|Overall Study|Other|5
807385|NCT00847626|2568240|P1|Overall Study|Other|1
807386|NCT00847626|2568230|P11|Overall Study|Lack of Efficacy|7
807387|NCT00847626|2568231|P10|Overall Study|Lack of Efficacy|1
807388|NCT00847626|2568232|P9|Overall Study|Lack of Efficacy|5
807389|NCT00847626|2568233|P8|Overall Study|Lack of Efficacy|2
807390|NCT00847626|2568234|P7|Overall Study|Lack of Efficacy|6
807391|NCT00847626|2568235|P6|Overall Study|Lack of Efficacy|0
807392|NCT00847626|2568236|P5|Overall Study|Lack of Efficacy|2
807393|NCT00847626|2568237|P4|Overall Study|Lack of Efficacy|1
807394|NCT00847626|2568238|P3|Overall Study|Lack of Efficacy|0
807395|NCT00847626|2568239|P2|Overall Study|Lack of Efficacy|1
807396|NCT00847626|2568240|P1|Overall Study|Lack of Efficacy|3
807397|NCT00847626|2568230|P11|Overall Study|Withdrawal by Subject|2
807398|NCT00847626|2568231|P10|Overall Study|Withdrawal by Subject|5
807399|NCT00847626|2568232|P9|Overall Study|Withdrawal by Subject|4
807400|NCT00847626|2568233|P8|Overall Study|Withdrawal by Subject|4
807401|NCT00847626|2568234|P7|Overall Study|Withdrawal by Subject|8
807402|NCT00847626|2568235|P6|Overall Study|Withdrawal by Subject|9
807403|NCT00847626|2568236|P5|Overall Study|Withdrawal by Subject|12
807404|NCT00847626|2568237|P4|Overall Study|Withdrawal by Subject|8
807405|NCT00847626|2568238|P3|Overall Study|Withdrawal by Subject|3
807406|NCT00847626|2568239|P2|Overall Study|Withdrawal by Subject|5
807407|NCT00847626|2568240|P1|Overall Study|Withdrawal by Subject|5
807408|NCT00847626|2568230|P11|Overall Study|Lost to Follow-up|1
807409|NCT00847626|2568231|P10|Overall Study|Lost to Follow-up|0
807410|NCT00847626|2568232|P9|Overall Study|Lost to Follow-up|1
807411|NCT00847626|2568233|P8|Overall Study|Lost to Follow-up|3
807412|NCT00847626|2568234|P7|Overall Study|Lost to Follow-up|1
807413|NCT00847626|2568235|P6|Overall Study|Lost to Follow-up|3
807414|NCT00847626|2568236|P5|Overall Study|Lost to Follow-up|0
807415|NCT00847626|2568237|P4|Overall Study|Lost to Follow-up|1
807416|NCT00847626|2568238|P3|Overall Study|Lost to Follow-up|1
807417|NCT00847626|2568239|P2|Overall Study|Lost to Follow-up|1
807418|NCT00847626|2568240|P1|Overall Study|Lost to Follow-up|0
807419|NCT00847626|2568230|P11|Overall Study|Protocol Violation|1
807420|NCT00847626|2568231|P10|Overall Study|Protocol Violation|1
807421|NCT00847626|2568232|P9|Overall Study|Protocol Violation|0
807422|NCT00847626|2568233|P8|Overall Study|Protocol Violation|1
807423|NCT00847626|2568234|P7|Overall Study|Protocol Violation|1
807424|NCT00847626|2568235|P6|Overall Study|Protocol Violation|1
807425|NCT00847626|2568236|P5|Overall Study|Protocol Violation|1
807426|NCT00847626|2568237|P4|Overall Study|Protocol Violation|1
807427|NCT00847626|2568238|P3|Overall Study|Protocol Violation|2
807428|NCT00847626|2568239|P2|Overall Study|Protocol Violation|1
807429|NCT00847626|2568240|P1|Overall Study|Protocol Violation|2
807430|NCT00847626|2568230|P11|Overall Study|Adverse Event|6
807431|NCT00847626|2568231|P10|Overall Study|Adverse Event|6
807432|NCT00847626|2568232|P9|Overall Study|Adverse Event|3
807433|NCT00847626|2568233|P8|Overall Study|Adverse Event|6
807434|NCT00847626|2568234|P7|Overall Study|Adverse Event|4
807435|NCT00847626|2568235|P6|Overall Study|Adverse Event|22
807436|NCT00847626|2568236|P5|Overall Study|Adverse Event|11
807437|NCT00847626|2568237|P4|Overall Study|Adverse Event|19
807438|NCT00847626|2568238|P3|Overall Study|Adverse Event|6
807439|NCT00847626|2568239|P2|Overall Study|Adverse Event|10
807440|NCT00847626|2568240|P1|Overall Study|Adverse Event|10
807441|NCT00847665|2568437|P2|Overall Study|Withdrawal by Subject|0
807442|NCT00847665|2568438|P1|Overall Study|Withdrawal by Subject|1
807443|NCT00847704|2568450|P1|Overall Study|Withdrawal by Subject|1
807444|NCT00847808|2568459|P1|Overall Study|Participant Took Excluded Medication|1
807445|NCT00847808|2568459|P1|Overall Study|Participant Reported Lack of Efficacy|1
807446|NCT00847808|2568459|P1|Overall Study|Withdrawal by Subject|4
807447|NCT00847808|2568459|P1|Overall Study|Lost to Follow-up|1
807448|NCT00847808|2568459|P1|Overall Study|Protocol Violation|1
807449|NCT00847808|2568459|P1|Overall Study|Adverse Event|7
807450|NCT00847886|2568478|P2|Overall Study|Adverse Event|1
807451|NCT00847886|2568479|P1|Overall Study|Adverse Event|0
807456|NCT00848042|2568525|P3|Overall Study|Other Therapy|0
807457|NCT00848042|2568526|P2|Overall Study|Other Therapy|0
807458|NCT00848042|2568527|P1|Overall Study|Other Therapy|3
807459|NCT00848042|2568525|P3|Overall Study|Death|0
807460|NCT00848042|2568526|P2|Overall Study|Death|2
807461|NCT00848042|2568527|P1|Overall Study|Death|1
807462|NCT00848081|2568540|P2|Overall Study|Withdrawal by Subject|3
807463|NCT00848081|2568541|P1|Overall Study|Withdrawal by Subject|5
807464|NCT00848081|2568540|P2|Overall Study|Physician Decision|3
807465|NCT00848081|2568541|P1|Overall Study|Physician Decision|0
807466|NCT00848081|2568540|P2|Overall Study|Lost to Follow-up|0
807467|NCT00848081|2568541|P1|Overall Study|Lost to Follow-up|1
807468|NCT00848081|2568540|P2|Overall Study|Protocol Violation|5
807469|NCT00848081|2568541|P1|Overall Study|Protocol Violation|8
807470|NCT00848081|2568540|P2|Overall Study|Adverse Event|7
807471|NCT00848081|2568541|P1|Overall Study|Adverse Event|6
807472|NCT00848107|2568555|P1|Overall Study|Pregnancy|1
807473|NCT00848107|2568555|P1|Overall Study|Death|1
807474|NCT00848107|2568555|P1|Overall Study|Adverse Event|9
807475|NCT00848107|2568555|P1|Overall Study|Withdrawal by Subject|8
807476|NCT00848107|2568555|P1|Overall Study|Lost to Follow-up|2
807477|NCT00848120|2568563|P1|Overall Study|Adverse Event|1
807478|NCT00848198|2568602|P1|Overall Study|Incomplete Case Report Forms|15
807479|NCT00848211|2568644|P4|Overall Study|Adverse Event|0
807480|NCT00848211|2568645|P3|Overall Study|Adverse Event|0
807481|NCT00848211|2568646|P2|Overall Study|Adverse Event|0
807482|NCT00848211|2568647|P1|Overall Study|Adverse Event|0
807483|NCT00848211|2568644|P4|Overall Study|Protocol Violation|0
807484|NCT00848211|2568645|P3|Overall Study|Protocol Violation|1
807485|NCT00848211|2568646|P2|Overall Study|Protocol Violation|1
807486|NCT00848211|2568647|P1|Overall Study|Protocol Violation|0
807487|NCT00848250|2568676|P2|Overall Study|surgery was completed without cardiopulm|1
807488|NCT00848250|2568677|P1|Overall Study|surgery was completed without cardiopulm|0
807489|NCT00848354|2568697|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
807490|NCT00848354|2568698|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
807491|NCT00848354|2568697|P2|Phase 2 Year 2|Subject Request|1
807492|NCT00848354|2568698|P1|Phase 2 Year 2|Subject Request|1
807493|NCT00848354|2568697|P2|Phase 2 Year 2|Protocol Violation|1
807494|NCT00848354|2568698|P1|Phase 2 Year 2|Protocol Violation|1
807495|NCT00848354|2568697|P2|Phase 2 Year 2|Unspecified Reason|0
807496|NCT00848354|2568698|P1|Phase 2 Year 2|Unspecified Reason|1
807497|NCT00848354|2568697|P2|Phase 2 Year 2|Lost to Follow-up|3
807498|NCT00848354|2568698|P1|Phase 2 Year 2|Lost to Follow-up|1
807499|NCT00848354|2568697|P2|Phase 2 Year 2|Failed to return|0
807500|NCT00848354|2568698|P1|Phase 2 Year 2|Failed to return|3
807501|NCT00848354|2568697|P2|Phase 2 Year 2|Death|0
807502|NCT00848354|2568698|P1|Phase 2 Year 2|Death|2
807503|NCT00848354|2568697|P2|Phase 2 Year 2|Adverse Event|2
807504|NCT00848354|2568698|P1|Phase 2 Year 2|Adverse Event|12
807505|NCT00848354|2568697|P2|Phase 2 Year 1|Subject Request|2
807506|NCT00848354|2568698|P1|Phase 2 Year 1|Subject Request|1
807507|NCT00848354|2568697|P2|Phase 2 Year 1|Protocol Violation|1
807508|NCT00848354|2568698|P1|Phase 2 Year 1|Protocol Violation|4
807509|NCT00848354|2568697|P2|Phase 2 Year 1|Unspecified Reason|0
807510|NCT00848354|2568698|P1|Phase 2 Year 1|Unspecified Reason|3
807511|NCT00848354|2568697|P2|Phase 2 Year 1|Lost to Follow-up|0
807512|NCT00848354|2568698|P1|Phase 2 Year 1|Lost to Follow-up|1
807513|NCT00848354|2568697|P2|Phase 2 Year 1|Failed to Return|1
807514|NCT00848354|2568698|P1|Phase 2 Year 1|Failed to Return|1
807515|NCT00848354|2568697|P2|Phase 2 Year 1|Death|0
807516|NCT00848354|2568698|P1|Phase 2 Year 1|Death|1
807517|NCT00848354|2568697|P2|Phase 2 Year 1|Adverse Event|2
807518|NCT00848354|2568698|P1|Phase 2 Year 1|Adverse Event|7
807519|NCT00848354|2568697|P2|Phase 1|Lack of Efficacy|1
807520|NCT00848354|2568698|P1|Phase 1|Lack of Efficacy|0
807521|NCT00848354|2568697|P2|Phase 1|Withdrawal by Subject|4
807522|NCT00848354|2568698|P1|Phase 1|Withdrawal by Subject|2
807523|NCT00848354|2568697|P2|Phase 1|Protocol Violation|1
807524|NCT00848354|2568698|P1|Phase 1|Protocol Violation|1
807525|NCT00848354|2568697|P2|Phase 1|Unspecified Reason|1
807526|NCT00848354|2568698|P1|Phase 1|Unspecified Reason|1
807527|NCT00848354|2568697|P2|Phase 1|Lost to Follow-up|1
807528|NCT00848354|2568698|P1|Phase 1|Lost to Follow-up|1
807529|NCT00848354|2568697|P2|Phase 1|Failed to return|1
807530|NCT00848354|2568698|P1|Phase 1|Failed to return|0
807531|NCT00848354|2568697|P2|Phase 1|Discontinuation of study by sponsor|1
807532|NCT00848354|2568698|P1|Phase 1|Discontinuation of study by sponsor|2
807533|NCT00848354|2568697|P2|Phase 1|Adverse Event|4
807534|NCT00848354|2568698|P1|Phase 1|Adverse Event|5
807535|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
807536|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
807537|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
807538|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
807539|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
807540|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
807541|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
807542|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
807543|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
807544|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
807545|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
807546|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
807547|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
807548|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
807549|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
807550|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
807551|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
807552|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
807553|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
807554|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
807555|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
807556|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
807557|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
807558|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
807559|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
807560|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
807561|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
807562|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
807563|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
807564|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
807565|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
807566|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
807567|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
807568|NCT00839527|2568862|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
807569|NCT00839527|2568863|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
807570|NCT00839527|2568864|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
807571|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
807572|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
807573|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
807574|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
807575|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
807576|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
807577|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
807578|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
807579|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
807580|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
807581|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
807582|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
807583|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Missing|0
807584|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Missing|1
807585|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Missing|0
807586|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
807587|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
807588|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
807589|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
807590|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
807591|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
807592|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
807593|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
807594|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
807595|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
807596|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
807597|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
807598|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
807599|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
807600|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
807601|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
807602|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
807603|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
807604|NCT00839527|2568862|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
807605|NCT00839527|2568863|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
807606|NCT00839527|2568864|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
807607|NCT00839800|2568911|P2|Overall Study|Severe Non-Compliance to Protocol|7
807608|NCT00839800|2568912|P1|Overall Study|Severe Non-Compliance to Protocol|7
807609|NCT00839800|2568911|P2|Overall Study|Not Specified|14
807610|NCT00839800|2568912|P1|Overall Study|Not Specified|8
807611|NCT00839800|2568911|P2|Overall Study|Safety Reasons|1
807612|NCT00839800|2568912|P1|Overall Study|Safety Reasons|2
807613|NCT00839800|2568911|P2|Overall Study|Study-Specific Discontinuation Criteria|13
807614|NCT00839800|2568912|P1|Overall Study|Study-Specific Discontinuation Criteria|6
807615|NCT00839800|2568911|P2|Overall Study|Incorrect Enrolment|3
807616|NCT00839800|2568912|P1|Overall Study|Incorrect Enrolment|3
807617|NCT00839800|2568911|P2|Overall Study|Withdrawal by Subject|34
807618|NCT00839800|2568912|P1|Overall Study|Withdrawal by Subject|28
807619|NCT00839800|2568911|P2|Overall Study|Lost to Follow-up|26
807620|NCT00839800|2568912|P1|Overall Study|Lost to Follow-up|31
807621|NCT00839800|2568911|P2|Overall Study|Adverse Event|12
807622|NCT00839800|2568912|P1|Overall Study|Adverse Event|8
807623|NCT00839917|2568944|P2|Overall Study|Did not receive vaccine|1
807624|NCT00839917|2568945|P1|Overall Study|Did not receive vaccine|0
807625|NCT00839917|2568944|P2|Overall Study|Lost to Follow-up|0
807626|NCT00839917|2568945|P1|Overall Study|Lost to Follow-up|1
807627|NCT00839956|2568992|P1|Overall Study|Withdrawal by Subject|3
807628|NCT00839956|2568992|P1|Overall Study|Physician Decision|1
807629|NCT00839956|2568992|P1|Overall Study|Lack of Efficacy|6
807630|NCT00839956|2568992|P1|Overall Study|Adverse Event|2
807631|NCT00840060|2569018|P2|Overall Study|Change in emotional/behavioral status|1
807632|NCT00840060|2569019|P1|Overall Study|Change in emotional/behavioral status|0
807633|NCT00840060|2569018|P2|Overall Study|Withdrawal by Subject|0
807634|NCT00840060|2569019|P1|Overall Study|Withdrawal by Subject|1
807635|NCT00840073|2569029|P2|Second Intervention|Missed 72 hour blood draw|1
807636|NCT00840073|2569030|P1|Second Intervention|Missed 72 hour blood draw|1
807637|NCT00840086|2569042|P1|Overall Study|Lost to Follow-up|1
807638|NCT00840086|2569042|P1|Overall Study|Protocol Violation|2
807639|NCT00840086|2569042|P1|Overall Study|Adverse Event|1
807640|NCT00840203|2569068|P2|Washout|Protocol Violation|0
807641|NCT00840203|2569069|P1|Washout|Protocol Violation|1
807642|NCT00840203|2569068|P2|First Intervention|Protocol Violation|1
807643|NCT00840203|2569069|P1|First Intervention|Protocol Violation|1
807644|NCT00840216|2569085|P2|Washout: 7 Days|Withdrawal by Subject|0
807645|NCT00840216|2569086|P1|Washout: 7 Days|Withdrawal by Subject|1
807646|NCT00840294|2569107|P2|Overall Study|Illness|1
807647|NCT00840294|2569108|P1|Overall Study|Illness|0
807648|NCT00840294|2569107|P2|Overall Study|Protocol Violation|3
807649|NCT00840294|2569108|P1|Overall Study|Protocol Violation|1
807650|NCT00840294|2569107|P2|Overall Study|Withdrawal by Subject|1
807651|NCT00840294|2569108|P1|Overall Study|Withdrawal by Subject|2
807652|NCT00840411|2569118|P2|Washout|Withdrawal by Subject|0
807653|NCT00840411|2569119|P1|Washout|Withdrawal by Subject|1
807654|NCT00840411|2569118|P2|First Intervention|Adverse Event|0
807655|NCT00840411|2569119|P1|First Intervention|Adverse Event|1
807656|NCT00840450|2569127|P1|Overall Study|Lack of Efficacy|2
807657|NCT00840450|2569127|P1|Overall Study|Adverse Event|1
807658|NCT00840632|2569146|P2|Washout|Withdrawal by Subject|1
807659|NCT00840632|2569147|P1|Washout|Withdrawal by Subject|1
807660|NCT00840632|2569146|P2|First Intervention|Withdrawal by Subject|1
807661|NCT00840632|2569147|P1|First Intervention|Withdrawal by Subject|0
807662|NCT00840658|2569165|P4|Overall Study|Lost to Follow-up|1
807663|NCT00840658|2569166|P3|Overall Study|Lost to Follow-up|2
807664|NCT00840658|2569167|P2|Overall Study|Lost to Follow-up|1
807665|NCT00840658|2569168|P1|Overall Study|Lost to Follow-up|3
807666|NCT00840658|2569165|P4|Overall Study|Death|3
807667|NCT00840658|2569166|P3|Overall Study|Death|3
807668|NCT00840658|2569167|P2|Overall Study|Death|2
807669|NCT00840658|2569168|P1|Overall Study|Death|2
807670|NCT00840879|2569208|P2|Second Intervention|Withdrawal by Subject|0
807671|NCT00840879|2569209|P1|Second Intervention|Withdrawal by Subject|1
807672|NCT00840996|2569219|P2|Overall Study|Withdrawal by Subject|0
807673|NCT00840996|2569220|P1|Overall Study|Withdrawal by Subject|1
807674|NCT00841035|2569238|P1|Phase 1 Overall Study|Physician Decision|13
807675|NCT00848484|2569279|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
807676|NCT00848484|2569280|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
807677|NCT00848484|2569279|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
807678|NCT00848484|2569280|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
807679|NCT00848484|2569279|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
807680|NCT00848484|2569280|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
807681|NCT00848484|2569279|P2|First Intervention (Treatment Period 1)|Physician Decision|1
807682|NCT00848484|2569280|P1|First Intervention (Treatment Period 1)|Physician Decision|0
807683|NCT00848484|2569279|P2|First Intervention (Treatment Period 1)|Adverse Event|1
807684|NCT00848484|2569280|P1|First Intervention (Treatment Period 1)|Adverse Event|2
807685|NCT00848497|2569298|P2|Overall Study|Withdrawal by Subject|1
807686|NCT00848497|2569299|P1|Overall Study|Withdrawal by Subject|0
807687|NCT00848497|2569298|P2|Overall Study|Screen failure|0
807688|NCT00848497|2569299|P1|Overall Study|Screen failure|2
807689|NCT00848536|2569366|P2|Overall Study|Patient Moved|2
807690|NCT00848536|2569367|P1|Overall Study|Patient Moved|0
807691|NCT00848536|2569366|P2|Overall Study|Inadequate Control of IOP|1
807692|NCT00848536|2569367|P1|Overall Study|Inadequate Control of IOP|1
807693|NCT00848536|2569366|P2|Overall Study|Noncompliance|0
807694|NCT00848536|2569367|P1|Overall Study|Noncompliance|1
807695|NCT00848536|2569366|P2|Overall Study|Protocol Violation|1
807696|NCT00848536|2569367|P1|Overall Study|Protocol Violation|0
807697|NCT00848536|2569366|P2|Overall Study|Withdrawal by Subject|1
807698|NCT00848536|2569367|P1|Overall Study|Withdrawal by Subject|0
807699|NCT00848536|2569366|P2|Overall Study|Adverse Event|2
807700|NCT00848536|2569367|P1|Overall Study|Adverse Event|2
807701|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Not Specified|6
807702|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Not Specified|5
807703|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
807704|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
807705|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
807706|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
807707|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
807708|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
807709|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
807710|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
807711|NCT00848549|2569379|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
807712|NCT00848549|2569380|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
807713|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
807714|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
807715|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
807716|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
807717|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
807718|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
807719|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
807720|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
807721|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
807722|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
807723|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
807724|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
807725|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
807726|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
807727|NCT00848549|2569379|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
807728|NCT00848549|2569380|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
807729|NCT00848926|2569396|P1|Follow-up Period|Not specified|2
807730|NCT00848926|2569396|P1|Follow-up Period|Withdrawal by Subject|3
807731|NCT00848926|2569396|P1|Follow-up Period|Lost to Follow-up|7
807732|NCT00848926|2569396|P1|Treatment Period|Withdrawal by Subject|7
807733|NCT00848926|2569396|P1|Treatment Period|Physician Decision|12
807734|NCT00848926|2569396|P1|Treatment Period|Adverse Event|20
807735|NCT00848926|2569396|P1|Treatment Period|Progressive disease|45
807736|NCT00848965|2569412|P1|Overall Study|Withdrawal by Subject|1
807737|NCT00848965|2569412|P1|Overall Study|Adverse Event|1
807738|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
807739|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
807740|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
807741|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
807742|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
807743|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
807744|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Physician Decision|1
807745|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Physician Decision|1
807746|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Physician Decision|0
807747|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
807748|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
807749|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
807750|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
807751|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
807752|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
807753|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
807754|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
807755|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
807756|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Noncompliance|0
807757|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Noncompliance|1
807758|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Noncompliance|2
807759|NCT00849017|2569457|P3|Follow-up Period (8 Weeks)|Adverse Event|0
807760|NCT00849017|2569458|P2|Follow-up Period (8 Weeks)|Adverse Event|0
807761|NCT00849017|2569459|P1|Follow-up Period (8 Weeks)|Adverse Event|1
807762|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
807763|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
807764|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
807765|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Pregnancy|1
807766|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Pregnancy|0
807767|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Pregnancy|1
807768|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
807769|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
807770|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
807771|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
807772|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
807773|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
807774|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
807775|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
807776|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
807777|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
807778|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
807779|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
807780|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Physician Decision|1
807781|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Physician Decision|2
807782|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Physician Decision|0
807783|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
807784|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
807785|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
807786|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
807787|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
807788|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
807789|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Noncompliance|4
807790|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Noncompliance|3
807791|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Noncompliance|3
807792|NCT00849017|2569457|P3|Treatment Period (156 Weeks)|Adverse Event|15
807793|NCT00849017|2569458|P2|Treatment Period (156 Weeks)|Adverse Event|6
807794|NCT00849017|2569459|P1|Treatment Period (156 Weeks)|Adverse Event|5
807795|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
807796|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
807797|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
807798|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
807799|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
807800|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
807801|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
807802|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
807803|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
807804|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
807805|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
807806|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
807807|NCT00849056|2569504|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
807808|NCT00849056|2569505|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
807809|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
807810|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
807811|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
807812|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
807813|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
807814|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
807815|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
807816|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
807817|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
807818|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
807819|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
807820|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
807821|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
807822|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
807823|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
807824|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
807825|NCT00849056|2569504|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
807826|NCT00849056|2569505|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
807827|NCT00849108|2569530|P2|Cohort 2 Efficacy|Not specified|9
807828|NCT00849108|2569531|P1|Cohort 2 Efficacy|Not specified|0
807829|NCT00849108|2569530|P2|Cohort 2 Efficacy|Adverse Event|1
807830|NCT00849108|2569531|P1|Cohort 2 Efficacy|Adverse Event|0
807831|NCT00849108|2569530|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
807832|NCT00849108|2569531|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
807833|NCT00849147|2569554|P1|Overall Study|Disease Relapse/Progression|2
807834|NCT00849147|2569554|P1|Overall Study|Protocol Violation|2
807835|NCT00849147|2569554|P1|Overall Study|Withdrawal by Subject|1
807836|NCT00849186|2569569|P1|Overall Study|Other|1
807837|NCT00849186|2569569|P1|Overall Study|not treated|6
807838|NCT00849186|2569569|P1|Overall Study|Withdrawal by Subject|1
807839|NCT00849186|2569569|P1|Overall Study|Adverse Event|2
807840|NCT00849212|2569575|P1|Overall Study|Miscellaneous|1
807841|NCT00849212|2569575|P1|Overall Study|Adverse Event|2
807842|NCT00849212|2569575|P1|Overall Study|Withdrawal by Subject|3
807843|NCT00849212|2569575|P1|Overall Study|Lack of Efficacy|1
807844|NCT00849290|2569587|P1|Overall Study|Disease Progression|20
807845|NCT00849290|2569587|P1|Overall Study|Protocol Violation|5
807846|NCT00849290|2569587|P1|Overall Study|Lost to Follow-up|2
807847|NCT00849290|2569587|P1|Overall Study|Withdrawal by Subject|11
807848|NCT00849290|2569587|P1|Overall Study|Death|14
807849|NCT00849290|2569587|P1|Overall Study|Adverse Event|3
807850|NCT00849381|2569591|P1|Overall Study|Unspecified|4
807851|NCT00849381|2569591|P1|Overall Study|Withdrawal by Subject|6
807852|NCT00849381|2569591|P1|Overall Study|Protocol Violation|5
807853|NCT00849381|2569591|P1|Overall Study|Lost to Follow-up|129
807854|NCT00849381|2569591|P1|Overall Study|Adverse Event|1
807855|NCT00849472|2569597|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
807856|NCT00849472|2569597|P1|Pazopanib Postsurgery Treatment|Moved|1
807857|NCT00849472|2569597|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
807858|NCT00849472|2569597|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
807859|NCT00849472|2569597|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
807860|NCT00849472|2569597|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
807861|NCT00849472|2569597|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
807862|NCT00849472|2569597|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
807863|NCT00849472|2569597|P1|Weekly Paclitaxel|Physician Decision|3
807864|NCT00849472|2569597|P1|Weekly Paclitaxel|Withdrawal by Subject|1
807865|NCT00849472|2569597|P1|Weekly Paclitaxel|Adverse Event|11
807866|NCT00849472|2569597|P1|Weekly Paclitaxel|Disease Progression|1
807867|NCT00849472|2569597|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
807868|NCT00849472|2569597|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
807869|NCT00849472|2569597|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
807870|NCT00849472|2569597|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
807871|NCT00849472|2569597|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
807872|NCT00849524|2569622|P1|Overall Study|Lack of Efficacy|3
807873|NCT00849680|2569636|P8|Overall Study|Subject unable to comply with protocol|0
807874|NCT00849680|2569637|P7|Overall Study|Subject unable to comply with protocol|0
807875|NCT00849680|2569638|P6|Overall Study|Subject unable to comply with protocol|0
807876|NCT00849680|2569639|P5|Overall Study|Subject unable to comply with protocol|0
807877|NCT00849680|2569640|P4|Overall Study|Subject unable to comply with protocol|0
807878|NCT00849680|2569641|P3|Overall Study|Subject unable to comply with protocol|0
807879|NCT00849680|2569642|P2|Overall Study|Subject unable to comply with protocol|0
807880|NCT00849680|2569643|P1|Overall Study|Subject unable to comply with protocol|1
807881|NCT00849680|2569636|P8|Overall Study|Withdrawal by Subject|1
807882|NCT00849680|2569637|P7|Overall Study|Withdrawal by Subject|1
807883|NCT00849680|2569638|P6|Overall Study|Withdrawal by Subject|2
807884|NCT00849680|2569639|P5|Overall Study|Withdrawal by Subject|2
807885|NCT00849680|2569640|P4|Overall Study|Withdrawal by Subject|2
807886|NCT00849680|2569641|P3|Overall Study|Withdrawal by Subject|0
807887|NCT00849680|2569642|P2|Overall Study|Withdrawal by Subject|0
807888|NCT00849680|2569643|P1|Overall Study|Withdrawal by Subject|2
807889|NCT00849680|2569636|P8|Overall Study|Subject moved|2
807890|NCT00849680|2569637|P7|Overall Study|Subject moved|2
807891|NCT00849680|2569638|P6|Overall Study|Subject moved|2
807892|NCT00849680|2569639|P5|Overall Study|Subject moved|0
807893|NCT00849680|2569640|P4|Overall Study|Subject moved|1
807894|NCT00849680|2569641|P3|Overall Study|Subject moved|3
807895|NCT00849680|2569642|P2|Overall Study|Subject moved|0
807896|NCT00849680|2569643|P1|Overall Study|Subject moved|1
807897|NCT00849680|2569636|P8|Overall Study|Lost to Follow-up|5
807898|NCT00849680|2569637|P7|Overall Study|Lost to Follow-up|12
807899|NCT00849680|2569638|P6|Overall Study|Lost to Follow-up|11
807900|NCT00849680|2569639|P5|Overall Study|Lost to Follow-up|8
807901|NCT00849680|2569640|P4|Overall Study|Lost to Follow-up|11
807902|NCT00849680|2569641|P3|Overall Study|Lost to Follow-up|12
807903|NCT00849680|2569642|P2|Overall Study|Lost to Follow-up|3
807904|NCT00849680|2569643|P1|Overall Study|Lost to Follow-up|7
807905|NCT00849680|2569636|P8|Overall Study|Adverse Event|0
807906|NCT00849680|2569637|P7|Overall Study|Adverse Event|2
807907|NCT00849680|2569638|P6|Overall Study|Adverse Event|0
807908|NCT00849680|2569639|P5|Overall Study|Adverse Event|0
807909|NCT00849680|2569640|P4|Overall Study|Adverse Event|0
807910|NCT00849680|2569641|P3|Overall Study|Adverse Event|0
807911|NCT00849680|2569642|P2|Overall Study|Adverse Event|0
807912|NCT00849680|2569643|P1|Overall Study|Adverse Event|0
807913|NCT00849693|2569689|P4|Extension Phase|Lack of Efficacy|1
807914|NCT00849693|2569690|P3|Extension Phase|Lack of Efficacy|2
807915|NCT00849693|2569691|P2|Extension Phase|Lack of Efficacy|2
807916|NCT00849693|2569692|P1|Extension Phase|Lack of Efficacy|2
807917|NCT00849693|2569689|P4|Extension Phase|Sponsor decision|1
807918|NCT00849693|2569690|P3|Extension Phase|Sponsor decision|0
807919|NCT00849693|2569691|P2|Extension Phase|Sponsor decision|0
807920|NCT00849693|2569692|P1|Extension Phase|Sponsor decision|1
807921|NCT00849693|2569689|P4|Extension Phase|Physician Decision|0
807922|NCT00849693|2569690|P3|Extension Phase|Physician Decision|2
807923|NCT00849693|2569691|P2|Extension Phase|Physician Decision|1
807924|NCT00849693|2569692|P1|Extension Phase|Physician Decision|1
807925|NCT00849693|2569689|P4|Extension Phase|Parent or caregiver decision|5
807926|NCT00849693|2569690|P3|Extension Phase|Parent or caregiver decision|10
807927|NCT00849693|2569691|P2|Extension Phase|Parent or caregiver decision|4
807928|NCT00849693|2569692|P1|Extension Phase|Parent or caregiver decision|9
807929|NCT00849693|2569689|P4|Extension Phase|Withdrawal by Subject|15
807930|NCT00849693|2569690|P3|Extension Phase|Withdrawal by Subject|10
807931|NCT00849693|2569691|P2|Extension Phase|Withdrawal by Subject|9
807932|NCT00849693|2569692|P1|Extension Phase|Withdrawal by Subject|6
807933|NCT00849693|2569689|P4|Extension Phase|Protocol Violation|3
807934|NCT00849693|2569690|P3|Extension Phase|Protocol Violation|2
807935|NCT00849693|2569691|P2|Extension Phase|Protocol Violation|3
807936|NCT00849693|2569692|P1|Extension Phase|Protocol Violation|0
807937|NCT00849693|2569689|P4|Extension Phase|Lost to Follow-up|6
807938|NCT00849693|2569690|P3|Extension Phase|Lost to Follow-up|6
807939|NCT00849693|2569691|P2|Extension Phase|Lost to Follow-up|5
807940|NCT00849693|2569692|P1|Extension Phase|Lost to Follow-up|7
807941|NCT00849693|2569689|P4|Extension Phase|Adverse Event|7
807942|NCT00849693|2569690|P3|Extension Phase|Adverse Event|3
807943|NCT00849693|2569691|P2|Extension Phase|Adverse Event|6
807944|NCT00849693|2569692|P1|Extension Phase|Adverse Event|4
807945|NCT00849693|2569689|P4|Acute Treatment Phase|Lack of Efficacy|2
807946|NCT00849693|2569690|P3|Acute Treatment Phase|Lack of Efficacy|1
807947|NCT00849693|2569691|P2|Acute Treatment Phase|Lack of Efficacy|3
807948|NCT00849693|2569692|P1|Acute Treatment Phase|Lack of Efficacy|1
807949|NCT00849693|2569689|P4|Acute Treatment Phase|Sponsor decision|0
807950|NCT00849693|2569690|P3|Acute Treatment Phase|Sponsor decision|1
807951|NCT00849693|2569691|P2|Acute Treatment Phase|Sponsor decision|0
807952|NCT00849693|2569692|P1|Acute Treatment Phase|Sponsor decision|0
807953|NCT00849693|2569689|P4|Acute Treatment Phase|Physician Decision|1
807954|NCT00849693|2569690|P3|Acute Treatment Phase|Physician Decision|2
807955|NCT00849693|2569691|P2|Acute Treatment Phase|Physician Decision|1
807956|NCT00849693|2569692|P1|Acute Treatment Phase|Physician Decision|2
807957|NCT00849693|2569689|P4|Acute Treatment Phase|Parent or caregiver decision|7
807958|NCT00849693|2569690|P3|Acute Treatment Phase|Parent or caregiver decision|7
807959|NCT00849693|2569691|P2|Acute Treatment Phase|Parent or caregiver decision|6
807960|NCT00849693|2569692|P1|Acute Treatment Phase|Parent or caregiver decision|7
807961|NCT00849693|2569689|P4|Acute Treatment Phase|Withdrawal by Subject|8
807962|NCT00849693|2569690|P3|Acute Treatment Phase|Withdrawal by Subject|3
807963|NCT00849693|2569691|P2|Acute Treatment Phase|Withdrawal by Subject|5
807964|NCT00849693|2569692|P1|Acute Treatment Phase|Withdrawal by Subject|5
807965|NCT00849693|2569689|P4|Acute Treatment Phase|Protocol Violation|6
807966|NCT00849693|2569690|P3|Acute Treatment Phase|Protocol Violation|2
807967|NCT00849693|2569691|P2|Acute Treatment Phase|Protocol Violation|5
807968|NCT00849693|2569692|P1|Acute Treatment Phase|Protocol Violation|1
807969|NCT00849693|2569689|P4|Acute Treatment Phase|Lost to Follow-up|9
807970|NCT00849693|2569690|P3|Acute Treatment Phase|Lost to Follow-up|11
807971|NCT00849693|2569691|P2|Acute Treatment Phase|Lost to Follow-up|8
807972|NCT00849693|2569692|P1|Acute Treatment Phase|Lost to Follow-up|5
807973|NCT00849693|2569689|P4|Acute Treatment Phase|Adverse Event|4
807974|NCT00849693|2569690|P3|Acute Treatment Phase|Adverse Event|6
807975|NCT00849693|2569691|P2|Acute Treatment Phase|Adverse Event|7
807976|NCT00849693|2569692|P1|Acute Treatment Phase|Adverse Event|12
807977|NCT00849797|2569753|P2|Washout: One Week|Withdrawal by Subject|2
807978|NCT00849797|2569754|P1|Washout: One Week|Withdrawal by Subject|0
807979|NCT00849797|2569753|P2|First Intervention|Adverse Event|1
807980|NCT00849797|2569754|P1|First Intervention|Adverse Event|0
807981|NCT00849797|2569753|P2|First Intervention|bad veins|0
807982|NCT00849797|2569754|P1|First Intervention|bad veins|1
807983|NCT00849875|2569786|P1|Overall Study|Lost to Follow-up|2
807984|NCT00849875|2569786|P1|Overall Study|Others|6
807985|NCT00849875|2569786|P1|Overall Study|Ongoing (unknown completion status)|11
807986|NCT00849875|2569786|P1|Overall Study|Death|28
807987|NCT00849901|2569869|P3|Extension Phase|Lack of Efficacy|1
807988|NCT00849901|2569870|P2|Extension Phase|Lack of Efficacy|4
807989|NCT00849901|2569871|P1|Extension Phase|Lack of Efficacy|2
807990|NCT00849901|2569869|P3|Extension Phase|Physician Decision|0
807991|NCT00849901|2569870|P2|Extension Phase|Physician Decision|2
807992|NCT00849901|2569871|P1|Extension Phase|Physician Decision|1
807993|NCT00849901|2569869|P3|Extension Phase|Parent or Caregiver Decision|4
807994|NCT00849901|2569870|P2|Extension Phase|Parent or Caregiver Decision|4
807995|NCT00849901|2569871|P1|Extension Phase|Parent or Caregiver Decision|10
807996|NCT00849901|2569869|P3|Extension Phase|Withdrawal by Subject|3
807997|NCT00849901|2569870|P2|Extension Phase|Withdrawal by Subject|6
807998|NCT00849901|2569871|P1|Extension Phase|Withdrawal by Subject|7
807999|NCT00849901|2569869|P3|Extension Phase|Protocol Violation|4
808000|NCT00849901|2569870|P2|Extension Phase|Protocol Violation|2
808001|NCT00849901|2569871|P1|Extension Phase|Protocol Violation|2
808002|NCT00849901|2569869|P3|Extension Phase|Lost to Follow-up|1
808003|NCT00849901|2569870|P2|Extension Phase|Lost to Follow-up|0
808004|NCT00849901|2569871|P1|Extension Phase|Lost to Follow-up|3
808005|NCT00849901|2569869|P3|Extension Phase|Adverse Event|4
808006|NCT00849901|2569870|P2|Extension Phase|Adverse Event|8
808007|NCT00849901|2569871|P1|Extension Phase|Adverse Event|2
808008|NCT00849901|2569869|P3|Acute Treatment Phase|Lack of Efficacy|2
808009|NCT00849901|2569870|P2|Acute Treatment Phase|Lack of Efficacy|3
808010|NCT00849901|2569871|P1|Acute Treatment Phase|Lack of Efficacy|2
808011|NCT00849901|2569869|P3|Acute Treatment Phase|Sponsor Decision|0
808012|NCT00849901|2569870|P2|Acute Treatment Phase|Sponsor Decision|0
808013|NCT00849901|2569871|P1|Acute Treatment Phase|Sponsor Decision|1
808014|NCT00849901|2569869|P3|Acute Treatment Phase|Physician Decision|1
808015|NCT00849901|2569870|P2|Acute Treatment Phase|Physician Decision|1
808016|NCT00849901|2569871|P1|Acute Treatment Phase|Physician Decision|1
808017|NCT00849901|2569869|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
808018|NCT00849901|2569870|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
808019|NCT00849901|2569871|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
808020|NCT00849901|2569869|P3|Acute Treatment Phase|Withdrawal by Subject|4
808021|NCT00849901|2569870|P2|Acute Treatment Phase|Withdrawal by Subject|10
808022|NCT00849901|2569871|P1|Acute Treatment Phase|Withdrawal by Subject|4
808023|NCT00849901|2569869|P3|Acute Treatment Phase|Protocol Violation|1
808024|NCT00849901|2569870|P2|Acute Treatment Phase|Protocol Violation|2
808025|NCT00849901|2569871|P1|Acute Treatment Phase|Protocol Violation|0
808026|NCT00849901|2569869|P3|Acute Treatment Phase|Lost to Follow-up|1
808027|NCT00849901|2569870|P2|Acute Treatment Phase|Lost to Follow-up|4
808028|NCT00849901|2569871|P1|Acute Treatment Phase|Lost to Follow-up|2
808029|NCT00849901|2569869|P3|Acute Treatment Phase|Adverse Event|3
808030|NCT00849901|2569870|P2|Acute Treatment Phase|Adverse Event|1
808031|NCT00849901|2569871|P1|Acute Treatment Phase|Adverse Event|9
808032|NCT00849940|2569915|P1|Overall Study|Physician Decision|4
808033|NCT00850070|2569930|P2|Overall Study|Adverse Event|0
808034|NCT00850070|2569931|P1|Overall Study|Adverse Event|2
808035|NCT00850070|2569930|P2|Overall Study|Lack of Efficacy|1
808036|NCT00850070|2569931|P1|Overall Study|Lack of Efficacy|1
808037|NCT00850135|2569958|P1|Overall Study|Physician Decision|1
808038|NCT00850174|2569966|P2|Second Intervention|Withdrawal by Subject|0
808039|NCT00850174|2569967|P1|Second Intervention|Withdrawal by Subject|1
808040|NCT00850174|2569966|P2|Washout: One Week|Withdrawal by Subject|2
808041|NCT00850174|2569967|P1|Washout: One Week|Withdrawal by Subject|0
808042|NCT00850200|2569981|P1|Overall Study|Withdrawal by Subject|1
808043|NCT00850343|2569991|P4|Overall Study|Physician Decision|1
808044|NCT00850343|2569992|P3|Overall Study|Physician Decision|1
808045|NCT00850343|2569993|P2|Overall Study|Physician Decision|1
808046|NCT00850343|2569994|P1|Overall Study|Physician Decision|2
808047|NCT00850343|2569991|P4|Overall Study|Non-compliance with Study Procedures|1
808048|NCT00850343|2569992|P3|Overall Study|Non-compliance with Study Procedures|1
808049|NCT00850343|2569993|P2|Overall Study|Non-compliance with Study Procedures|0
808050|NCT00850343|2569994|P1|Overall Study|Non-compliance with Study Procedures|1
808051|NCT00850343|2569991|P4|Overall Study|Lack of Efficacy|2
808052|NCT00850343|2569992|P3|Overall Study|Lack of Efficacy|3
808053|NCT00850343|2569993|P2|Overall Study|Lack of Efficacy|0
808054|NCT00850343|2569994|P1|Overall Study|Lack of Efficacy|17
808055|NCT00850343|2569991|P4|Overall Study|Pregnancy|1
808056|NCT00850343|2569992|P3|Overall Study|Pregnancy|0
808057|NCT00850343|2569993|P2|Overall Study|Pregnancy|0
808058|NCT00850343|2569994|P1|Overall Study|Pregnancy|0
808059|NCT00850343|2569991|P4|Overall Study|Adverse Event|6
808060|NCT00850343|2569992|P3|Overall Study|Adverse Event|6
808061|NCT00850343|2569993|P2|Overall Study|Adverse Event|2
808062|NCT00850343|2569994|P1|Overall Study|Adverse Event|15
808063|NCT00850343|2569991|P4|Overall Study|Withdrawal by Subject|2
808064|NCT00850343|2569992|P3|Overall Study|Withdrawal by Subject|3
808065|NCT00850343|2569993|P2|Overall Study|Withdrawal by Subject|0
808066|NCT00850343|2569994|P1|Overall Study|Withdrawal by Subject|11
808067|NCT00850395|2570024|P1|Overall Study|Unspecified|5
808068|NCT00850395|2570024|P1|Overall Study|Insufficient clinical response|3
808069|NCT00850395|2570024|P1|Overall Study|Adverse Event|1
808070|NCT00850395|2570024|P1|Overall Study|Death|1
808071|NCT00850460|2570046|P2|Overall Study|Lost to Follow-up|4
808072|NCT00850460|2570047|P1|Overall Study|Lost to Follow-up|4
808073|NCT00850499|2570057|P2|Overall Study|Lack of Efficacy|1
808074|NCT00850499|2570058|P1|Overall Study|Lack of Efficacy|0
808075|NCT00850499|2570057|P2|Overall Study|Adverse Event|1
808076|NCT00850499|2570058|P1|Overall Study|Adverse Event|3
808077|NCT00850538|2570066|P1|Overall Study|Protocol Violation|2
808078|NCT00850538|2570066|P1|Overall Study|radiology error|2
808079|NCT00850538|2570066|P1|Overall Study|Withdrawal by Subject|3
808080|NCT00850538|2570066|P1|Overall Study|specimen unusable|7
808081|NCT00850538|2570066|P1|Overall Study|specimen missed due to scheduling error|14
808082|NCT00850538|2570066|P1|Overall Study|unable/unwilling to complete MRI|13
808083|NCT00850564|2570070|P1|Overall Study|Withdrawal by Subject|2
808084|NCT00850759|2570114|P4|Overall Study|Lost to Follow-up|3
808085|NCT00850759|2570115|P3|Overall Study|Lost to Follow-up|5
808086|NCT00850759|2570116|P2|Overall Study|Lost to Follow-up|5
808087|NCT00850759|2570117|P1|Overall Study|Lost to Follow-up|7
808088|NCT00851084|2570169|P2|Overall Study|Not specified|1
808089|NCT00851084|2570170|P1|Overall Study|Not specified|7
808090|NCT00851084|2570169|P2|Overall Study|Metastatic surgery|6
808091|NCT00851084|2570170|P1|Overall Study|Metastatic surgery|6
808092|NCT00851084|2570169|P2|Overall Study|Withdrawal by Subject|12
808093|NCT00851084|2570170|P1|Overall Study|Withdrawal by Subject|11
808094|NCT00851084|2570169|P2|Overall Study|Consent withdrawn|2
808095|NCT00851084|2570170|P1|Overall Study|Consent withdrawn|0
808096|NCT00851084|2570169|P2|Overall Study|Physician Decision|14
808097|NCT00851084|2570170|P1|Overall Study|Physician Decision|13
808098|NCT00851084|2570169|P2|Overall Study|Poor compliance to protocol|1
808099|NCT00851084|2570170|P1|Overall Study|Poor compliance to protocol|1
808100|NCT00851084|2570169|P2|Overall Study|Disease progression|47
808101|NCT00851084|2570170|P1|Overall Study|Disease progression|52
808102|NCT00851084|2570169|P2|Overall Study|Adverse Event|36
808103|NCT00851084|2570170|P1|Overall Study|Adverse Event|26
808104|NCT00851084|2570169|P2|Overall Study|Randomized but not treated|0
808105|NCT00851084|2570170|P1|Overall Study|Randomized but not treated|1
808106|NCT00851318|2570194|P4|Overall Study|Physician Decision|1
808107|NCT00851318|2570195|P3|Overall Study|Physician Decision|1
808108|NCT00851318|2570196|P2|Overall Study|Physician Decision|0
808109|NCT00851318|2570197|P1|Overall Study|Physician Decision|0
808110|NCT00851318|2570194|P4|Overall Study|Non-compliance with Study Procedures|0
808111|NCT00851318|2570195|P3|Overall Study|Non-compliance with Study Procedures|1
808112|NCT00851318|2570196|P2|Overall Study|Non-compliance with Study Procedures|0
808113|NCT00851318|2570197|P1|Overall Study|Non-compliance with Study Procedures|2
808114|NCT00851318|2570194|P4|Overall Study|Lack of Efficacy|2
808115|NCT00851318|2570195|P3|Overall Study|Lack of Efficacy|4
808116|NCT00851318|2570196|P2|Overall Study|Lack of Efficacy|2
808117|NCT00851318|2570197|P1|Overall Study|Lack of Efficacy|8
808118|NCT00851318|2570194|P4|Overall Study|Pregnancy|1
808119|NCT00851318|2570195|P3|Overall Study|Pregnancy|1
808120|NCT00851318|2570196|P2|Overall Study|Pregnancy|0
808121|NCT00851318|2570197|P1|Overall Study|Pregnancy|0
808122|NCT00851318|2570194|P4|Overall Study|Adverse Event|12
808123|NCT00851318|2570195|P3|Overall Study|Adverse Event|9
808124|NCT00851318|2570196|P2|Overall Study|Adverse Event|2
808125|NCT00851318|2570197|P1|Overall Study|Adverse Event|13
808126|NCT00851318|2570194|P4|Overall Study|Withdrawal by Subject|3
808127|NCT00851318|2570195|P3|Overall Study|Withdrawal by Subject|5
808128|NCT00851318|2570196|P2|Overall Study|Withdrawal by Subject|1
808129|NCT00851318|2570197|P1|Overall Study|Withdrawal by Subject|7
808130|NCT00844194|2570234|P2|Overall Study|Other reason (not specified)|0
808131|NCT00844194|2570235|P1|Overall Study|Other reason (not specified)|1
808132|NCT00844194|2570234|P2|Overall Study|Lack of Efficacy|0
808133|NCT00844194|2570235|P1|Overall Study|Lack of Efficacy|3
808134|NCT00844194|2570234|P2|Overall Study|Withdrawal by Subject|1
808135|NCT00844194|2570235|P1|Overall Study|Withdrawal by Subject|2
808136|NCT00844194|2570234|P2|Overall Study|Lost to Follow-up|1
808137|NCT00844194|2570235|P1|Overall Study|Lost to Follow-up|1
808138|NCT00844194|2570234|P2|Overall Study|Protocol Violation|1
808139|NCT00844194|2570235|P1|Overall Study|Protocol Violation|1
808140|NCT00844194|2570234|P2|Overall Study|Adverse Event|5
808141|NCT00844194|2570235|P1|Overall Study|Adverse Event|17
808142|NCT00844376|2570443|P2|Period 1: First Intervention|Withdrawal by Subject|0
808143|NCT00844376|2570444|P1|Period 1: First Intervention|Withdrawal by Subject|1
808144|NCT00844415|2570462|P1|Overall Study|Withdrawal by Subject|1
808145|NCT00844428|2570476|P1|Post Treatment Period (Patients Who Disc|Death|1
808146|NCT00844428|2570476|P1|Extension Treatment Period|Death|1
808147|NCT00844428|2570476|P1|Screening Period|Screen Failure|3
808148|NCT00844480|2570494|P2|Overall Study|Withdrawal by Subject|3
808149|NCT00844480|2570495|P1|Overall Study|Withdrawal by Subject|2
808150|NCT00844519|2570505|P2|Overall Study|Adverse Event|0
808151|NCT00844519|2570506|P1|Overall Study|Adverse Event|1
808152|NCT00844519|2570505|P2|Overall Study|Withdrawal by Subject|1
808153|NCT00844519|2570506|P1|Overall Study|Withdrawal by Subject|1
808154|NCT00844532|2570512|P1|Overall Study|Lost to Follow-up|7
808155|NCT00844532|2570512|P1|Overall Study|Withdrawal by Subject|16
808156|NCT00844532|2570512|P1|Overall Study|Death|16
808157|NCT00844545|2570596|P1|Post Treatment Period|Withdrawal by Subject|1
808158|NCT00844545|2570596|P1|Extension Treatment Period|Adverse Event|2
808159|NCT00844545|2570596|P1|Treatment Period (26 Weeks)|Protocol Violation|1
808160|NCT00844545|2570596|P1|Treatment Period (26 Weeks)|Adverse Event|1
808161|NCT00844558|2570612|P2|Overall Study|Physician Decision|0
808162|NCT00844558|2570613|P1|Overall Study|Physician Decision|1
808163|NCT00844558|2570612|P2|Overall Study|Lost to Follow-up|1
808164|NCT00844558|2570613|P1|Overall Study|Lost to Follow-up|0
808165|NCT00844558|2570612|P2|Overall Study|Protocol Violation|1
808166|NCT00844558|2570613|P1|Overall Study|Protocol Violation|1
808167|NCT00844558|2570612|P2|Overall Study|Death|0
808168|NCT00844558|2570613|P1|Overall Study|Death|1
808169|NCT00844558|2570612|P2|Overall Study|Withdrawal by Subject|2
808170|NCT00844558|2570613|P1|Overall Study|Withdrawal by Subject|9
808171|NCT00844597|2570635|P6|Overall Study|Adverse Event|0
808172|NCT00844597|2570636|P5|Overall Study|Adverse Event|0
808173|NCT00844597|2570637|P4|Overall Study|Adverse Event|1
808174|NCT00844597|2570638|P3|Overall Study|Adverse Event|0
808175|NCT00844597|2570639|P2|Overall Study|Adverse Event|0
808176|NCT00844597|2570640|P1|Overall Study|Adverse Event|0
808177|NCT00844649|2570660|P2|Overall Study|Withdrew prior to starting treatment|27
808178|NCT00844649|2570661|P1|Overall Study|Withdrew prior to starting treatment|11
808179|NCT00844649|2570660|P2|Overall Study|Unspecified|10
808180|NCT00844649|2570661|P1|Overall Study|Unspecified|7
808181|NCT00844649|2570660|P2|Overall Study|Withdrawal by Subject|39
808182|NCT00844649|2570661|P1|Overall Study|Withdrawal by Subject|28
808183|NCT00844649|2570660|P2|Overall Study|Protocol Violation|6
808184|NCT00844649|2570661|P1|Overall Study|Protocol Violation|10
808185|NCT00844649|2570660|P2|Overall Study|Physician Decision|18
808186|NCT00844649|2570661|P1|Overall Study|Physician Decision|25
808187|NCT00844649|2570660|P2|Overall Study|Adverse Event|73
808188|NCT00844649|2570661|P1|Overall Study|Adverse Event|128
808189|NCT00844649|2570660|P2|Overall Study|Progressive Disease|245
808190|NCT00844649|2570661|P1|Overall Study|Progressive Disease|196
808191|NCT00844753|2570687|P4|Overall Study|Withdrawal by Subject|3
808192|NCT00844753|2570688|P3|Overall Study|Withdrawal by Subject|0
808193|NCT00844753|2570689|P2|Overall Study|Withdrawal by Subject|0
808194|NCT00844753|2570690|P1|Overall Study|Withdrawal by Subject|1
808195|NCT00844753|2570687|P4|Overall Study|could not swallow medication|0
808196|NCT00844753|2570688|P3|Overall Study|could not swallow medication|0
808197|NCT00844753|2570689|P2|Overall Study|could not swallow medication|0
808198|NCT00844753|2570690|P1|Overall Study|could not swallow medication|2
808199|NCT00844753|2570687|P4|Overall Study|Lost to Follow-up|1
808200|NCT00844753|2570688|P3|Overall Study|Lost to Follow-up|0
808201|NCT00844753|2570689|P2|Overall Study|Lost to Follow-up|1
808202|NCT00844753|2570690|P1|Overall Study|Lost to Follow-up|1
808203|NCT00844753|2570687|P4|Overall Study|Adverse Event|5
808204|NCT00844753|2570688|P3|Overall Study|Adverse Event|5
808205|NCT00844753|2570689|P2|Overall Study|Adverse Event|2
808206|NCT00844753|2570690|P1|Overall Study|Adverse Event|3
808207|NCT00844753|2570687|P4|Overall Study|Lack of Efficacy|2
808208|NCT00844753|2570688|P3|Overall Study|Lack of Efficacy|2
808209|NCT00844753|2570689|P2|Overall Study|Lack of Efficacy|0
808210|NCT00844753|2570690|P1|Overall Study|Lack of Efficacy|1
808211|NCT00844805|2570704|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
808212|NCT00844805|2570705|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
808213|NCT00844805|2570706|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
808214|NCT00844805|2570707|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
808215|NCT00844805|2570704|P4|Follow-Up Phase|Relapse/Recurrence|4
808216|NCT00844805|2570705|P3|Follow-Up Phase|Relapse/Recurrence|2
808217|NCT00844805|2570706|P2|Follow-Up Phase|Relapse/Recurrence|0
808218|NCT00844805|2570707|P1|Follow-Up Phase|Relapse/Recurrence|0
808219|NCT00844805|2570704|P4|Follow-Up Phase|Noncompliance With Protocol|1
808220|NCT00844805|2570705|P3|Follow-Up Phase|Noncompliance With Protocol|0
808221|NCT00844805|2570706|P2|Follow-Up Phase|Noncompliance With Protocol|0
808222|NCT00844805|2570707|P1|Follow-Up Phase|Noncompliance With Protocol|0
808223|NCT00844805|2570704|P4|Follow-Up Phase|Withdrawal by Subject|3
808224|NCT00844805|2570705|P3|Follow-Up Phase|Withdrawal by Subject|6
808225|NCT00844805|2570706|P2|Follow-Up Phase|Withdrawal by Subject|0
808226|NCT00844805|2570707|P1|Follow-Up Phase|Withdrawal by Subject|0
808227|NCT00844805|2570704|P4|Follow-Up Phase|Adverse Event|0
808228|NCT00844805|2570705|P3|Follow-Up Phase|Adverse Event|1
808229|NCT00844805|2570706|P2|Follow-Up Phase|Adverse Event|0
808230|NCT00844805|2570707|P1|Follow-Up Phase|Adverse Event|0
808231|NCT00844805|2570704|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
808232|NCT00844805|2570705|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
808233|NCT00844805|2570706|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
808234|NCT00844805|2570707|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
808235|NCT00844805|2570704|P4|Treatment Phase|Noncompliance With Protocol|0
808236|NCT00844805|2570705|P3|Treatment Phase|Noncompliance With Protocol|0
808237|NCT00844805|2570706|P2|Treatment Phase|Noncompliance With Protocol|0
808238|NCT00844805|2570707|P1|Treatment Phase|Noncompliance With Protocol|1
808239|NCT00844805|2570704|P4|Treatment Phase|Withdrawal by Subject|0
808240|NCT00844805|2570705|P3|Treatment Phase|Withdrawal by Subject|0
808241|NCT00844805|2570706|P2|Treatment Phase|Withdrawal by Subject|4
808242|NCT00844805|2570707|P1|Treatment Phase|Withdrawal by Subject|3
808243|NCT00844805|2570704|P4|Treatment Phase|Adverse Event|0
808244|NCT00844805|2570705|P3|Treatment Phase|Adverse Event|0
808245|NCT00844805|2570706|P2|Treatment Phase|Adverse Event|1
808246|NCT00844805|2570707|P1|Treatment Phase|Adverse Event|5
808247|NCT00844831|2570747|P1|Overall Study|Physician Decision|1
808248|NCT00844831|2570747|P1|Overall Study|Adverse Event|1
808249|NCT00844831|2570747|P1|Overall Study|Withdrawal by Subject|4
808250|NCT00844844|2570755|P1|Post Treatment Period|Withdrawal by Subject|1
808251|NCT00844844|2570755|P1|Extension Treatment Period|Adverse Event|2
808252|NCT00844844|2570755|P1|Treatment Period (26 Weeks)|Protocol Violation|1
808253|NCT00844844|2570755|P1|Treatment Period (26 Weeks)|Adverse Event|1
808254|NCT00844857|2570771|P2|Overall Study|Good Clinical Practice Violations|11
808255|NCT00844857|2570772|P1|Overall Study|Good Clinical Practice Violations|21
808256|NCT00844857|2570771|P2|Overall Study|Did Not Take Study Drug|1
808257|NCT00844857|2570772|P1|Overall Study|Did Not Take Study Drug|3
808258|NCT00844857|2570771|P2|Overall Study|Lost to Follow-up|3
808259|NCT00844857|2570772|P1|Overall Study|Lost to Follow-up|2
808260|NCT00844857|2570771|P2|Overall Study|Entry Criteria Not Met|1
808261|NCT00844857|2570772|P1|Overall Study|Entry Criteria Not Met|0
808262|NCT00844857|2570771|P2|Overall Study|Clinical Relapse|1
808263|NCT00844857|2570772|P1|Overall Study|Clinical Relapse|0
808264|NCT00844857|2570771|P2|Overall Study|Lack of Efficacy|5
808265|NCT00844857|2570772|P1|Overall Study|Lack of Efficacy|5
808266|NCT00844857|2570771|P2|Overall Study|Protocol Violation|0
808267|NCT00844857|2570772|P1|Overall Study|Protocol Violation|6
808268|NCT00844857|2570771|P2|Overall Study|Withdrawal by Subject|7
808269|NCT00844857|2570772|P1|Overall Study|Withdrawal by Subject|8
808270|NCT00844857|2570771|P2|Overall Study|Parent/Caregiver Decision|2
808271|NCT00844857|2570772|P1|Overall Study|Parent/Caregiver Decision|6
808272|NCT00844857|2570771|P2|Overall Study|Physician Decision|0
808273|NCT00844857|2570772|P1|Overall Study|Physician Decision|2
808274|NCT00844857|2570771|P2|Overall Study|Sponsor Decision|1
808275|NCT00844857|2570772|P1|Overall Study|Sponsor Decision|1
808276|NCT00844857|2570771|P2|Overall Study|Adverse Event|5
808277|NCT00844857|2570772|P1|Overall Study|Adverse Event|24
808278|NCT00844883|2570816|P1|Overall Study|Bridged to resection|1
808279|NCT00844883|2570816|P1|Overall Study|Bridged to liver transplant|3
808280|NCT00844896|2570828|P2|Overall Study|Parents did not have time to complete|1
808281|NCT00844896|2570829|P1|Overall Study|Parents did not have time to complete|0
808282|NCT00844896|2570828|P2|Overall Study|Lost to Follow-up|16
808283|NCT00844896|2570829|P1|Overall Study|Lost to Follow-up|12
808284|NCT00845065|2570881|P2|Overall Study|Non-Medical Reasons|11
808285|NCT00845065|2570882|P1|Overall Study|Non-Medical Reasons|1
808286|NCT00845065|2570881|P2|Overall Study|Lack of Efficacy|21
808287|NCT00845065|2570882|P1|Overall Study|Lack of Efficacy|43
808288|NCT00845065|2570881|P2|Overall Study|Adverse Event|23
808289|NCT00845065|2570882|P1|Overall Study|Adverse Event|3
808299|NCT00845429|2570941|P3|Overall Study|Serious adverse event|1
808300|NCT00845429|2570942|P2|Overall Study|Serious adverse event|0
808301|NCT00845429|2570943|P1|Overall Study|Serious adverse event|0
808302|NCT00845429|2570941|P3|Overall Study|Withdrawal by Subject|2
808303|NCT00845429|2570942|P2|Overall Study|Withdrawal by Subject|2
808304|NCT00845429|2570943|P1|Overall Study|Withdrawal by Subject|2
808305|NCT00845429|2570941|P3|Overall Study|Lost to Follow-up|10
808306|NCT00845429|2570942|P2|Overall Study|Lost to Follow-up|9
808307|NCT00845429|2570943|P1|Overall Study|Lost to Follow-up|7
808308|NCT00845429|2570941|P3|Overall Study|Protocol Violation|7
808309|NCT00845429|2570942|P2|Overall Study|Protocol Violation|4
808310|NCT00845429|2570943|P1|Overall Study|Protocol Violation|5
808311|NCT00845676|2571020|P1|Overall Study|Adverse Event|1
808312|NCT00845676|2571020|P1|Overall Study|Virologic breakthrough at week 20|1
808313|NCT00845728|2571032|P2|Overall Study|Withdrawal by Subject|108
808314|NCT00845728|2571033|P1|Overall Study|Withdrawal by Subject|105
808315|NCT00845728|2571032|P2|Overall Study|Adverse Event|96
808316|NCT00845728|2571033|P1|Overall Study|Adverse Event|101
808317|NCT00845728|2571032|P2|Overall Study|Lack of Efficacy|39
808318|NCT00845728|2571033|P1|Overall Study|Lack of Efficacy|51
808319|NCT00845728|2571032|P2|Overall Study|Protocol Violation|24
808320|NCT00845728|2571033|P1|Overall Study|Protocol Violation|36
808321|NCT00845728|2571032|P2|Overall Study|Administrative Problems|26
808322|NCT00845728|2571033|P1|Overall Study|Administrative Problems|34
808323|NCT00845728|2571032|P2|Overall Study|Death|26
808324|NCT00845728|2571033|P1|Overall Study|Death|24
808325|NCT00845728|2571032|P2|Overall Study|Lost to Follow-up|13
808326|NCT00845728|2571033|P1|Overall Study|Lost to Follow-up|22
808327|NCT00845728|2571032|P2|Overall Study|Abnormal test procedure result (s)|2
808328|NCT00845728|2571033|P1|Overall Study|Abnormal test procedure result (s)|7
808329|NCT00845728|2571032|P2|Overall Study|Patient's inability to use the device|6
808330|NCT00845728|2571033|P1|Overall Study|Patient's inability to use the device|4
808331|NCT00845728|2571032|P2|Overall Study|Abnormal laboratory value (s)|2
808332|NCT00845728|2571033|P1|Overall Study|Abnormal laboratory value (s)|2
808333|NCT00845832|2571044|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
808334|NCT00845832|2571045|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
808335|NCT00845832|2571046|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
808336|NCT00845832|2571044|P3|Safety Follow-Up|Withdrawal by Subject|0
808337|NCT00845832|2571045|P2|Safety Follow-Up|Withdrawal by Subject|0
808338|NCT00845832|2571046|P1|Safety Follow-Up|Withdrawal by Subject|1
808339|NCT00845832|2571044|P3|Treatment Period|Protocol Violation|0
808340|NCT00845832|2571045|P2|Treatment Period|Protocol Violation|1
808341|NCT00845832|2571046|P1|Treatment Period|Protocol Violation|1
808342|NCT00845832|2571044|P3|Treatment Period|Adverse Event|0
808343|NCT00845832|2571045|P2|Treatment Period|Adverse Event|2
808344|NCT00845832|2571046|P1|Treatment Period|Adverse Event|0
808345|NCT00845845|2571092|P2|Overall Study|Lost to Follow-up|4
808346|NCT00845845|2571093|P1|Overall Study|Lost to Follow-up|0
808347|NCT00845858|2571104|P3|Overall Study|not eligible|2
808348|NCT00845858|2571105|P2|Overall Study|not eligible|3
808349|NCT00845858|2571106|P1|Overall Study|not eligible|0
808350|NCT00845858|2571104|P3|Overall Study|Protocol Violation|1
808351|NCT00845858|2571105|P2|Overall Study|Protocol Violation|0
808352|NCT00845858|2571106|P1|Overall Study|Protocol Violation|0
808353|NCT00845858|2571104|P3|Overall Study|Adverse Event|4
808354|NCT00845858|2571105|P2|Overall Study|Adverse Event|8
808355|NCT00845858|2571106|P1|Overall Study|Adverse Event|3
808356|NCT00845858|2571104|P3|Overall Study|Withdrawal by Subject|1
808357|NCT00845858|2571105|P2|Overall Study|Withdrawal by Subject|1
808358|NCT00845858|2571106|P1|Overall Study|Withdrawal by Subject|5
808359|NCT00851552|2571117|P1|Overall Study|Disease Progression|4
808360|NCT00851552|2571117|P1|Overall Study|Adverse Event|1
808361|NCT00851552|2571117|P1|Overall Study|Death|2
808364|NCT00851630|2571133|P2|Overall Study|Clinical failure|1
808365|NCT00851630|2571134|P1|Overall Study|Clinical failure|0
808366|NCT00851630|2571133|P2|Overall Study|Death|1
808367|NCT00851630|2571134|P1|Overall Study|Death|2
808368|NCT00851643|2571152|P6|Extension Study (Up to 36 Months)|Moved|1
808369|NCT00851643|2571153|P5|Extension Study (Up to 36 Months)|Moved|0
808370|NCT00851643|2571154|P4|Extension Study (Up to 36 Months)|Moved|1
808371|NCT00851643|2571155|P3|Extension Study (Up to 36 Months)|Moved|1
808372|NCT00851643|2571156|P2|Extension Study (Up to 36 Months)|Moved|2
808373|NCT00851643|2571157|P1|Extension Study (Up to 36 Months)|Moved|0
808374|NCT00851643|2571152|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
808375|NCT00851643|2571153|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
808376|NCT00851643|2571154|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
808377|NCT00851643|2571155|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
808378|NCT00851643|2571156|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
808379|NCT00851643|2571157|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
808380|NCT00851643|2571152|P6|Base Study (Up to 12 Months)|Unspecified|1
808381|NCT00851643|2571153|P5|Base Study (Up to 12 Months)|Unspecified|0
808382|NCT00851643|2571154|P4|Base Study (Up to 12 Months)|Unspecified|0
808383|NCT00851643|2571155|P3|Base Study (Up to 12 Months)|Unspecified|0
808384|NCT00851643|2571156|P2|Base Study (Up to 12 Months)|Unspecified|0
808385|NCT00851643|2571157|P1|Base Study (Up to 12 Months)|Unspecified|0
808386|NCT00851643|2571152|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
808387|NCT00851643|2571153|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
808388|NCT00851643|2571154|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
808389|NCT00851643|2571155|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
808390|NCT00851643|2571156|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
808391|NCT00851643|2571157|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
808392|NCT00851682|2571178|P2|Overall Study|screen failure|0
808393|NCT00851682|2571179|P1|Overall Study|screen failure|5
808400|NCT00851786|2571280|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
808401|NCT00851786|2571281|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
808402|NCT00851786|2571280|P2|Overall Study|Site Closure|0
808403|NCT00851786|2571281|P1|Overall Study|Site Closure|1
808404|NCT00851786|2571280|P2|Overall Study|Incarceration|0
808405|NCT00851786|2571281|P1|Overall Study|Incarceration|1
808406|NCT00851786|2571280|P2|Overall Study|Lost to Follow-up|0
808407|NCT00851786|2571281|P1|Overall Study|Lost to Follow-up|1
808408|NCT00851786|2571280|P2|Overall Study|Protocol Violation|1
808409|NCT00851786|2571281|P1|Overall Study|Protocol Violation|0
808410|NCT00851786|2571280|P2|Overall Study|Withdrawal by Subject|1
808411|NCT00851786|2571281|P1|Overall Study|Withdrawal by Subject|0
808412|NCT00851799|2571292|P3|Overall Study|Completed protocol due to pregnancy|1
808413|NCT00851799|2571293|P2|Overall Study|Completed protocol due to pregnancy|0
808414|NCT00851799|2571294|P1|Overall Study|Completed protocol due to pregnancy|0
808415|NCT00851799|2571292|P3|Overall Study|Severe Debilitation|0
808416|NCT00851799|2571293|P2|Overall Study|Severe Debilitation|1
808417|NCT00851799|2571294|P1|Overall Study|Severe Debilitation|0
808418|NCT00851799|2571292|P3|Overall Study|Withdrew consent prior study completion|1
808419|NCT00851799|2571293|P2|Overall Study|Withdrew consent prior study completion|2
808420|NCT00851799|2571294|P1|Overall Study|Withdrew consent prior study completion|1
808421|NCT00851799|2571292|P3|Overall Study|Not willing to adhere to requirements|2
808422|NCT00851799|2571293|P2|Overall Study|Not willing to adhere to requirements|2
808423|NCT00851799|2571294|P1|Overall Study|Not willing to adhere to requirements|1
808424|NCT00851799|2571292|P3|Overall Study|Not able to get to clinic|9
808425|NCT00851799|2571293|P2|Overall Study|Not able to get to clinic|5
808426|NCT00851799|2571294|P1|Overall Study|Not able to get to clinic|8
808427|NCT00851799|2571292|P3|Overall Study|Lost to Follow-up|10
808428|NCT00851799|2571293|P2|Overall Study|Lost to Follow-up|3
808429|NCT00851799|2571294|P1|Overall Study|Lost to Follow-up|5
808430|NCT00851799|2571292|P3|Overall Study|Death|1
808431|NCT00851799|2571293|P2|Overall Study|Death|0
808432|NCT00851799|2571294|P1|Overall Study|Death|1
808433|NCT00854308|2571382|P2|Overall Study|Sponsor's decision to terminate study|1
808434|NCT00854308|2571383|P1|Overall Study|Sponsor's decision to terminate study|0
808435|NCT00854308|2571382|P2|Overall Study|Withdrawal by Subject|2
808436|NCT00854308|2571383|P1|Overall Study|Withdrawal by Subject|4
808437|NCT00854308|2571382|P2|Overall Study|Physician Decision|6
808438|NCT00854308|2571383|P1|Overall Study|Physician Decision|6
808439|NCT00854308|2571382|P2|Overall Study|Death|5
808440|NCT00854308|2571383|P1|Overall Study|Death|2
808441|NCT00854308|2571382|P2|Overall Study|Adverse Event|3
808442|NCT00854308|2571383|P1|Overall Study|Adverse Event|8
808443|NCT00854308|2571382|P2|Overall Study|Disease progression|50
808444|NCT00854308|2571383|P1|Overall Study|Disease progression|42
808445|NCT00854360|2571401|P4|Overall Study|Other|3
808446|NCT00854360|2571402|P3|Overall Study|Other|0
808447|NCT00854360|2571403|P2|Overall Study|Other|0
808448|NCT00854360|2571404|P1|Overall Study|Other|0
808449|NCT00854360|2571401|P4|Overall Study|Lack of Efficacy|0
808450|NCT00854360|2571402|P3|Overall Study|Lack of Efficacy|0
808451|NCT00854360|2571403|P2|Overall Study|Lack of Efficacy|1
808452|NCT00854360|2571404|P1|Overall Study|Lack of Efficacy|2
808453|NCT00854360|2571401|P4|Overall Study|Pregnancy|0
808454|NCT00854360|2571402|P3|Overall Study|Pregnancy|0
808455|NCT00854360|2571403|P2|Overall Study|Pregnancy|1
808456|NCT00854360|2571404|P1|Overall Study|Pregnancy|0
808457|NCT00854360|2571401|P4|Overall Study|Withdrawal by Subject|1
808458|NCT00854360|2571402|P3|Overall Study|Withdrawal by Subject|0
808459|NCT00854360|2571403|P2|Overall Study|Withdrawal by Subject|0
808460|NCT00854360|2571404|P1|Overall Study|Withdrawal by Subject|0
808461|NCT00854360|2571401|P4|Overall Study|Adverse Event|6
808462|NCT00854360|2571402|P3|Overall Study|Adverse Event|2
808463|NCT00854360|2571403|P2|Overall Study|Adverse Event|1
808464|NCT00854360|2571404|P1|Overall Study|Adverse Event|0
808465|NCT00854373|2571436|P2|Overall Study|Forgot to take study drug|1
808466|NCT00854373|2571437|P1|Overall Study|Forgot to take study drug|1
808467|NCT00854373|2571436|P2|Overall Study|Withdrawal by Subject|3
808468|NCT00854373|2571437|P1|Overall Study|Withdrawal by Subject|1
808469|NCT00854607|2571467|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
808470|NCT00854620|2571500|P1|Overall Study|Adverse Event|1
808471|NCT00854724|2571506|P2|Second Intervention|Physician Decision|1
808472|NCT00854724|2571507|P1|Second Intervention|Physician Decision|0
808473|NCT00854724|2571506|P2|Second Intervention|Protocol Violation|0
808474|NCT00854724|2571507|P1|Second Intervention|Protocol Violation|1
808475|NCT00854724|2571506|P2|Washout|Withdrawal by Subject|1
808476|NCT00854724|2571507|P1|Washout|Withdrawal by Subject|0
808477|NCT00854724|2571506|P2|Washout|Protocol Violation|0
808478|NCT00854724|2571507|P1|Washout|Protocol Violation|1
808479|NCT00854724|2571506|P2|First Intervention|Withdrawal by Subject|1
808480|NCT00854724|2571507|P1|First Intervention|Withdrawal by Subject|1
808481|NCT00854906|2571513|P1|Overall Study|One person had no ocular history|1
808482|NCT00855062|2571522|P2|Step2|Initiation of antiretroviral therapy/ART|1
808483|NCT00855062|2571523|P1|Step2|Initiation of antiretroviral therapy/ART|0
808484|NCT00855062|2571522|P2|Step2|Adverse Event|3
808485|NCT00855062|2571523|P1|Step2|Adverse Event|0
808486|NCT00855062|2571522|P2|Step2|Early Study Closure|2
808487|NCT00855062|2571523|P1|Step2|Early Study Closure|6
808488|NCT00855062|2571522|P2|Step1|Withdrawal by Subject|3
808489|NCT00855062|2571523|P1|Step1|Withdrawal by Subject|2
808490|NCT00855062|2571522|P2|Step1|Pregnancy|0
808491|NCT00855062|2571523|P1|Step1|Pregnancy|1
808492|NCT00855062|2571522|P2|Step1|Protocol Violation|0
808493|NCT00855062|2571523|P1|Step1|Protocol Violation|1
808494|NCT00855062|2571522|P2|Step1|Adverse Event|1
808495|NCT00855062|2571523|P1|Step1|Adverse Event|1
808496|NCT00855062|2571522|P2|Step1|Early Study Closure|7
808497|NCT00855062|2571523|P1|Step1|Early Study Closure|5
808498|NCT00855166|2571549|P2|Overall Study|Subject no longer meets study criteria|1
808499|NCT00855166|2571550|P1|Overall Study|Subject no longer meets study criteria|1
808500|NCT00855166|2571549|P2|Overall Study|Administrative reasons by sponsor|0
808501|NCT00855166|2571550|P1|Overall Study|Administrative reasons by sponsor|1
808502|NCT00855166|2571549|P2|Overall Study|Poor/non-compliance|0
808503|NCT00855166|2571550|P1|Overall Study|Poor/non-compliance|2
808504|NCT00855166|2571549|P2|Overall Study|Withdrawal by Subject|4
808505|NCT00855166|2571550|P1|Overall Study|Withdrawal by Subject|1
808506|NCT00855166|2571549|P2|Overall Study|Death|1
808507|NCT00855166|2571550|P1|Overall Study|Death|0
808508|NCT00855166|2571549|P2|Overall Study|Adverse Event|2
808509|NCT00855166|2571550|P1|Overall Study|Adverse Event|0
808510|NCT00855218|2571570|P2|Overall Study|Clinical endpoint reached|13
808511|NCT00855218|2571571|P1|Overall Study|Clinical endpoint reached|10
808512|NCT00855218|2571570|P2|Overall Study|Progression measurement proven|15
808513|NCT00855218|2571571|P1|Overall Study|Progression measurement proven|7
808514|NCT00855218|2571570|P2|Overall Study|Second malignancy|1
808515|NCT00855218|2571571|P1|Overall Study|Second malignancy|0
808516|NCT00855218|2571570|P2|Overall Study|Untreatable disease progression|67
808517|NCT00855218|2571571|P1|Overall Study|Untreatable disease progression|54
808518|NCT00855218|2571570|P2|Overall Study|Still treated with study medication|1
808519|NCT00855218|2571571|P1|Overall Study|Still treated with study medication|0
808520|NCT00855218|2571570|P2|Overall Study|technical problems|1
808521|NCT00855218|2571571|P1|Overall Study|technical problems|2
808522|NCT00855218|2571570|P2|Overall Study|patient convenience|0
808523|NCT00855218|2571571|P1|Overall Study|patient convenience|2
808524|NCT00855218|2571570|P2|Overall Study|non-compliant with study drug|1
808525|NCT00855218|2571571|P1|Overall Study|non-compliant with study drug|3
808526|NCT00855218|2571570|P2|Overall Study|Protocol Violation|9
808527|NCT00855218|2571571|P1|Overall Study|Protocol Violation|5
808528|NCT00855218|2571570|P2|Overall Study|Lost to Follow-up|1
808529|NCT00855218|2571571|P1|Overall Study|Lost to Follow-up|0
808530|NCT00855218|2571570|P2|Overall Study|Physician Decision|11
808531|NCT00855218|2571571|P1|Overall Study|Physician Decision|18
808532|NCT00855218|2571570|P2|Overall Study|Withdrawal by Subject|6
808533|NCT00855218|2571571|P1|Overall Study|Withdrawal by Subject|10
808534|NCT00855218|2571570|P2|Overall Study|Adverse Event|27
808535|NCT00855218|2571571|P1|Overall Study|Adverse Event|43
808536|NCT00855309|2571589|P2|Overall Study|patient never recieved drug|0
808537|NCT00855309|2571590|P1|Overall Study|patient never recieved drug|1
808558|NCT00855439|2571671|P2|Overall Study|Pregnancy|0
808559|NCT00855439|2571672|P1|Overall Study|Pregnancy|1
808560|NCT00855439|2571671|P2|Overall Study|Withdrawal by Subject|0
808561|NCT00855439|2571672|P1|Overall Study|Withdrawal by Subject|2
808562|NCT00855465|2571686|P2|Follow-up Period (FUP)|Missing|0
808563|NCT00855465|2571687|P1|Follow-up Period (FUP)|Missing|1
808564|NCT00855465|2571686|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
808565|NCT00855465|2571687|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
808566|NCT00855465|2571686|P2|Follow-up Period (FUP)|Lost to Follow-up|0
808567|NCT00855465|2571687|P1|Follow-up Period (FUP)|Lost to Follow-up|3
808568|NCT00855465|2571686|P2|Follow-up Period (FUP)|Death|1
808569|NCT00855465|2571687|P1|Follow-up Period (FUP)|Death|0
808570|NCT00855465|2571686|P2|Follow-up Period (FUP)|Adverse Event|1
808571|NCT00855465|2571687|P1|Follow-up Period (FUP)|Adverse Event|0
808572|NCT00855465|2571686|P2|Treatment Period|Not treated|0
808573|NCT00855465|2571687|P1|Treatment Period|Not treated|1
808574|NCT00855465|2571686|P2|Treatment Period|Withdrawal by Subject|0
808575|NCT00855465|2571687|P1|Treatment Period|Withdrawal by Subject|2
808576|NCT00855465|2571686|P2|Treatment Period|Protocol Violation|0
808577|NCT00855465|2571687|P1|Treatment Period|Protocol Violation|2
808578|NCT00855465|2571686|P2|Treatment Period|Non-compliance|0
808579|NCT00855465|2571687|P1|Treatment Period|Non-compliance|1
808580|NCT00855465|2571686|P2|Treatment Period|Lack of Efficacy|1
808581|NCT00855465|2571687|P1|Treatment Period|Lack of Efficacy|2
808582|NCT00855465|2571686|P2|Treatment Period|Death|2
808583|NCT00855465|2571687|P1|Treatment Period|Death|2
808584|NCT00855465|2571686|P2|Treatment Period|Adverse Event|2
808585|NCT00855465|2571687|P1|Treatment Period|Adverse Event|4
808586|NCT00855582|2571778|P3|Overall Study|Withdrawal by Subject|8
808587|NCT00855582|2571779|P2|Overall Study|Withdrawal by Subject|4
808588|NCT00855582|2571780|P1|Overall Study|Withdrawal by Subject|7
808589|NCT00855582|2571778|P3|Overall Study|Entry Criteria Not Met|3
808590|NCT00855582|2571779|P2|Overall Study|Entry Criteria Not Met|6
808591|NCT00855582|2571780|P1|Overall Study|Entry Criteria Not Met|8
808592|NCT00855582|2571778|P3|Overall Study|Protocol Violation|6
808593|NCT00855582|2571779|P2|Overall Study|Protocol Violation|2
808594|NCT00855582|2571780|P1|Overall Study|Protocol Violation|6
808595|NCT00855582|2571778|P3|Overall Study|Physician Decision|1
808596|NCT00855582|2571779|P2|Overall Study|Physician Decision|0
808597|NCT00855582|2571780|P1|Overall Study|Physician Decision|0
808598|NCT00855582|2571778|P3|Overall Study|Lost to Follow-up|1
808599|NCT00855582|2571779|P2|Overall Study|Lost to Follow-up|3
808600|NCT00855582|2571780|P1|Overall Study|Lost to Follow-up|1
808601|NCT00855582|2571778|P3|Overall Study|Lack of Efficacy|8
808602|NCT00855582|2571779|P2|Overall Study|Lack of Efficacy|3
808603|NCT00855582|2571780|P1|Overall Study|Lack of Efficacy|1
808604|NCT00855582|2571778|P3|Overall Study|Death|0
808605|NCT00855582|2571779|P2|Overall Study|Death|0
808606|NCT00855582|2571780|P1|Overall Study|Death|1
808607|NCT00855582|2571778|P3|Overall Study|Adverse Event|3
808608|NCT00855582|2571779|P2|Overall Study|Adverse Event|6
808609|NCT00855582|2571780|P1|Overall Study|Adverse Event|2
808610|NCT00855595|2571869|P2|Overall Study|patient left country|1
808611|NCT00855595|2571870|P1|Overall Study|patient left country|0
808612|NCT00855595|2571869|P2|Overall Study|patient moved out of state|0
808613|NCT00855595|2571870|P1|Overall Study|patient moved out of state|1
808614|NCT00855595|2571869|P2|Overall Study|Adverse Event|1
808615|NCT00855595|2571870|P1|Overall Study|Adverse Event|1
808616|NCT00855595|2571869|P2|Overall Study|Lost to Follow-up|3
808617|NCT00855595|2571870|P1|Overall Study|Lost to Follow-up|3
808618|NCT00855595|2571869|P2|Overall Study|Withdrawal by Subject|2
808619|NCT00855595|2571870|P1|Overall Study|Withdrawal by Subject|1
808620|NCT00855738|2571906|P1|Overall Study|Death|1
808621|NCT00855738|2571906|P1|Overall Study|Subject Defaulted|1
808622|NCT00855738|2571906|P1|Overall Study|Adverse Event|1
808623|NCT00855738|2571906|P1|Overall Study|Lost to Follow-up|2
808624|NCT00855816|2571934|P2|Overall Study|Became ineligible|1
808625|NCT00855816|2571935|P1|Overall Study|Became ineligible|0
808626|NCT00855816|2571934|P2|Overall Study|Death|0
808627|NCT00855816|2571935|P1|Overall Study|Death|1
808628|NCT00855816|2571934|P2|Overall Study|Lost to Follow-up|5
808629|NCT00855816|2571935|P1|Overall Study|Lost to Follow-up|3
808630|NCT00855816|2571934|P2|Overall Study|Withdrawal by Subject|15
808631|NCT00855816|2571935|P1|Overall Study|Withdrawal by Subject|22
808632|NCT00855894|2571954|P1|Overall Study|Disease progression|1
808633|NCT00855894|2571954|P1|Overall Study|Patient's decision|1
808634|NCT00855894|2571954|P1|Overall Study|Death|31
808635|NCT00855920|2571965|P3|Overall Study|Other than specified above|1
808636|NCT00855920|2571966|P2|Overall Study|Other than specified above|1
808637|NCT00855920|2571967|P1|Overall Study|Other than specified above|1
808638|NCT00855920|2571965|P3|Overall Study|Decision by the sponsor|1
808639|NCT00855920|2571966|P2|Overall Study|Decision by the sponsor|1
808640|NCT00855920|2571967|P1|Overall Study|Decision by the sponsor|0
808641|NCT00855920|2571965|P3|Overall Study|Death|0
808642|NCT00855920|2571966|P2|Overall Study|Death|1
808643|NCT00855920|2571967|P1|Overall Study|Death|0
808644|NCT00855920|2571965|P3|Overall Study|Lost to Follow-up|2
808645|NCT00855920|2571966|P2|Overall Study|Lost to Follow-up|0
808646|NCT00855920|2571967|P1|Overall Study|Lost to Follow-up|1
808647|NCT00855920|2571965|P3|Overall Study|Withdrawal by Subject|2
808648|NCT00855920|2571966|P2|Overall Study|Withdrawal by Subject|3
808649|NCT00855920|2571967|P1|Overall Study|Withdrawal by Subject|2
808650|NCT00855920|2571965|P3|Overall Study|Lack of Efficacy|2
808651|NCT00855920|2571966|P2|Overall Study|Lack of Efficacy|2
808652|NCT00855920|2571967|P1|Overall Study|Lack of Efficacy|2
808653|NCT00855920|2571965|P3|Overall Study|Adverse Event|1
808654|NCT00855920|2571966|P2|Overall Study|Adverse Event|1
808655|NCT00855920|2571967|P1|Overall Study|Adverse Event|2
808656|NCT00855920|2571965|P3|Overall Study|Protocol Violation|2
808657|NCT00855920|2571966|P2|Overall Study|Protocol Violation|0
808658|NCT00855920|2571967|P1|Overall Study|Protocol Violation|0
808659|NCT00855933|2571986|P2|Overall Study|Withdrawal by Subject|1
808660|NCT00855933|2571987|P1|Overall Study|Withdrawal by Subject|0
808661|NCT00855959|2571993|P1|Overall Study|Incorrect enrolment|1
808662|NCT00855959|2571993|P1|Overall Study|Pregnancy|1
808663|NCT00855959|2571993|P1|Overall Study|Withdrawal by Subject|3
808664|NCT00855959|2571993|P1|Overall Study|Lost to Follow-up|2
808665|NCT00855959|2571993|P1|Overall Study|Adverse Event|2
808666|NCT00856180|2572024|P1|Overall Study|Progressive Disease|16
808667|NCT00856180|2572024|P1|Overall Study|Adverse Event|4
808668|NCT00856193|2572033|P2|Period 2|Lost to Follow-up|1
808669|NCT00856193|2572034|P1|Period 2|Lost to Follow-up|0
808670|NCT00856193|2572033|P2|Period 2|Abnormal test procedure results|1
808671|NCT00856193|2572034|P1|Period 2|Abnormal test procedure results|0
808672|NCT00856206|2572048|P2|Overall Study|Other than specified above|10
808673|NCT00856206|2572049|P1|Overall Study|Other than specified above|3
808674|NCT00856206|2572048|P2|Overall Study|Decision by the Sponsor|8
808675|NCT00856206|2572049|P1|Overall Study|Decision by the Sponsor|4
808676|NCT00856206|2572048|P2|Overall Study|Death|2
808677|NCT00856206|2572049|P1|Overall Study|Death|2
808678|NCT00856206|2572048|P2|Overall Study|Lost to Follow-up|39
808679|NCT00856206|2572049|P1|Overall Study|Lost to Follow-up|13
808680|NCT00856206|2572048|P2|Overall Study|Withdrawal by Subject|36
808681|NCT00856206|2572049|P1|Overall Study|Withdrawal by Subject|15
808682|NCT00856206|2572048|P2|Overall Study|Lack of Efficacy|2
808683|NCT00856206|2572049|P1|Overall Study|Lack of Efficacy|1
808684|NCT00856206|2572048|P2|Overall Study|Adverse Event|46
808685|NCT00856206|2572049|P1|Overall Study|Adverse Event|10
808686|NCT00856206|2572048|P2|Overall Study|Protocol Violation|18
808687|NCT00856206|2572049|P1|Overall Study|Protocol Violation|6
808688|NCT00856245|2572079|P1|Overall Study|Was not transplanted|5
808716|NCT00856297|2572120|P5|Overall Study|Unable to classify|0
808717|NCT00856297|2572121|P4|Overall Study|Unable to classify|0
808718|NCT00856297|2572122|P3|Overall Study|Unable to classify|0
808719|NCT00856297|2572123|P2|Overall Study|Unable to classify|0
808720|NCT00856297|2572124|P1|Overall Study|Unable to classify|2
808721|NCT00856323|2572154|P1|Overall Study|Withdrawal by Subject|2
808722|NCT00856349|2572161|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
808723|NCT00856349|2572161|P1|Overall Study|Site closure|78
808724|NCT00856349|2572161|P1|Overall Study|Device explant|33
808725|NCT00856349|2572161|P1|Overall Study|Subject relocation|104
808726|NCT00856349|2572161|P1|Overall Study|Physician Decision|13
808727|NCT00856349|2572161|P1|Overall Study|Protocol Violation|38
808728|NCT00856349|2572161|P1|Overall Study|Lost to Follow-up|91
808729|NCT00856349|2572161|P1|Overall Study|Withdrawal by Subject|116
808730|NCT00856349|2572161|P1|Overall Study|Death|418
808731|NCT00856388|2572170|P1|Overall Study|Not Specified|1
808732|NCT00856492|2572192|P3|Overall Study|Ineligible or withdrew consent|2
808733|NCT00856492|2572193|P2|Overall Study|Ineligible or withdrew consent|1
808734|NCT00856492|2572194|P1|Overall Study|Ineligible or withdrew consent|1
808735|NCT00856518|2572210|P2|Overall Study|Lost to Follow-up|2
808736|NCT00856518|2572211|P1|Overall Study|Lost to Follow-up|4
808737|NCT00856544|2572225|P4|Overall Study|Withdrawal by Subject|1
808738|NCT00856544|2572226|P3|Overall Study|Withdrawal by Subject|0
808739|NCT00856544|2572227|P2|Overall Study|Withdrawal by Subject|5
808740|NCT00856544|2572228|P1|Overall Study|Withdrawal by Subject|8
808741|NCT00856544|2572225|P4|Overall Study|Lost to Follow-up|0
808742|NCT00856544|2572226|P3|Overall Study|Lost to Follow-up|2
808743|NCT00856544|2572227|P2|Overall Study|Lost to Follow-up|2
808744|NCT00856544|2572228|P1|Overall Study|Lost to Follow-up|1
808745|NCT00856544|2572225|P4|Overall Study|Unspecified|6
808746|NCT00856544|2572226|P3|Overall Study|Unspecified|1
808747|NCT00856544|2572227|P2|Overall Study|Unspecified|16
808748|NCT00856544|2572228|P1|Overall Study|Unspecified|9
808749|NCT00856544|2572225|P4|Overall Study|Lack of Efficacy|3
808750|NCT00856544|2572226|P3|Overall Study|Lack of Efficacy|3
808751|NCT00856544|2572227|P2|Overall Study|Lack of Efficacy|12
808752|NCT00856544|2572228|P1|Overall Study|Lack of Efficacy|16
808753|NCT00856544|2572225|P4|Overall Study|Adverse Event|3
808754|NCT00856544|2572226|P3|Overall Study|Adverse Event|2
808755|NCT00856544|2572227|P2|Overall Study|Adverse Event|29
808756|NCT00856544|2572228|P1|Overall Study|Adverse Event|20
808757|NCT00856544|2572225|P4|Overall Study|Death|0
808758|NCT00856544|2572226|P3|Overall Study|Death|0
808759|NCT00856544|2572227|P2|Overall Study|Death|2
808760|NCT00856544|2572228|P1|Overall Study|Death|0
808761|NCT00856544|2572225|P4|Overall Study|Randomized but not treated|0
808762|NCT00856544|2572226|P3|Overall Study|Randomized but not treated|0
808763|NCT00856544|2572227|P2|Overall Study|Randomized but not treated|0
808764|NCT00856544|2572228|P1|Overall Study|Randomized but not treated|3
808765|NCT00856557|2572407|P2|Overall Study|No patients with contextual flags|16
808766|NCT00856557|2572408|P1|Overall Study|No patients with contextual flags|12
808767|NCT00856583|2572420|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
808768|NCT00856583|2572421|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
808769|NCT00856583|2572420|P2|Overall Study|Other|104
808770|NCT00856583|2572421|P1|Overall Study|Other|92
808771|NCT00856583|2572420|P2|Overall Study|Pregnancy|5
808772|NCT00856583|2572421|P1|Overall Study|Pregnancy|14
808773|NCT00856583|2572420|P2|Overall Study|Physician Decision|82
808774|NCT00856583|2572421|P1|Overall Study|Physician Decision|59
808775|NCT00856583|2572420|P2|Overall Study|Withdrawal by Subject|919
808776|NCT00856583|2572421|P1|Overall Study|Withdrawal by Subject|1092
808777|NCT00856583|2572420|P2|Overall Study|Non-compliance|262
808778|NCT00856583|2572421|P1|Overall Study|Non-compliance|305
808779|NCT00856583|2572420|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
808780|NCT00856583|2572421|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
808781|NCT00856583|2572420|P2|Overall Study|Serious Adverse Event (SAE)|65
808782|NCT00856583|2572421|P1|Overall Study|Serious Adverse Event (SAE)|99
808783|NCT00856583|2572420|P2|Overall Study|Lack of Efficacy|377
808784|NCT00856583|2572421|P1|Overall Study|Lack of Efficacy|389
808785|NCT00856635|2572451|P2|Overall Study|Discontinued at Randomization|2
808786|NCT00856635|2572452|P1|Overall Study|Discontinued at Randomization|2
808787|NCT00856635|2572451|P2|Overall Study|Other|0
808788|NCT00856635|2572452|P1|Overall Study|Other|1
808789|NCT00856635|2572451|P2|Overall Study|Serious Adverse Event|0
808790|NCT00856635|2572452|P1|Overall Study|Serious Adverse Event|1
808791|NCT00856635|2572451|P2|Overall Study|Withdrawal by Subject|1
808792|NCT00856635|2572452|P1|Overall Study|Withdrawal by Subject|3
808793|NCT00856635|2572451|P2|Overall Study|Pregnancy|0
808794|NCT00856635|2572452|P1|Overall Study|Pregnancy|1
808795|NCT00856635|2572451|P2|Overall Study|Lost to Follow-up|5
808796|NCT00856635|2572452|P1|Overall Study|Lost to Follow-up|2
808797|NCT00856661|2572460|P2|Overall Study|Physician Judgement|5
808798|NCT00856661|2572461|P1|Overall Study|Physician Judgement|8
808799|NCT00856661|2572460|P2|Overall Study|Lost to Follow-up|3
808800|NCT00856661|2572461|P1|Overall Study|Lost to Follow-up|1
808801|NCT00856661|2572460|P2|Overall Study|Withdrawal by Subject|2
808802|NCT00856661|2572461|P1|Overall Study|Withdrawal by Subject|1
808803|NCT00856661|2572460|P2|Overall Study|Protocol Violation|1
808804|NCT00856661|2572461|P1|Overall Study|Protocol Violation|2
808805|NCT00856661|2572460|P2|Overall Study|Death|18
808806|NCT00856661|2572461|P1|Overall Study|Death|15
808807|NCT00856778|2572514|P1|Overall Study|Lost to Follow-up|5
808808|NCT00856778|2572514|P1|Overall Study|Study deviation|2
808809|NCT00856778|2572514|P1|Overall Study|Withdrawal by Subject|10
808810|NCT00856778|2572514|P1|Overall Study|Adverse Event|7
808811|NCT00856830|2572539|P4|Irinotecan & Bendamustine|Physician Decision|1
808812|NCT00856830|2572540|P3|Irinotecan & Bendamustine|Physician Decision|0
808813|NCT00856830|2572541|P2|Irinotecan & Bendamustine|Physician Decision|0
808814|NCT00856830|2572542|P1|Irinotecan & Bendamustine|Physician Decision|0
808815|NCT00856830|2572539|P4|Irinotecan & Bendamustine|Death|2
808816|NCT00856830|2572540|P3|Irinotecan & Bendamustine|Death|0
808817|NCT00856830|2572541|P2|Irinotecan & Bendamustine|Death|0
808818|NCT00856830|2572542|P1|Irinotecan & Bendamustine|Death|0
808819|NCT00856843|2572550|P2|Overall Study|Lack of Efficacy|0
808820|NCT00856843|2572551|P1|Overall Study|Lack of Efficacy|1
808821|NCT00856843|2572550|P2|Overall Study|Withdrawal by Subject|5
808822|NCT00856843|2572551|P1|Overall Study|Withdrawal by Subject|1
808823|NCT00856908|2572585|P2|Overall Study|Lost to Follow-up|0
808824|NCT00856908|2572586|P1|Overall Study|Lost to Follow-up|1
808825|NCT00856973|2572627|P3|Overall Study|Other|13
808826|NCT00856973|2572628|P2|Overall Study|Other|12
808827|NCT00856973|2572629|P1|Overall Study|Other|11
808828|NCT00856973|2572627|P3|Overall Study|Withdrawal by Subject|15
808829|NCT00856973|2572628|P2|Overall Study|Withdrawal by Subject|16
808830|NCT00856973|2572629|P1|Overall Study|Withdrawal by Subject|13
808831|NCT00856973|2572627|P3|Overall Study|Protocol Violation|1
808832|NCT00856973|2572628|P2|Overall Study|Protocol Violation|2
808833|NCT00856973|2572629|P1|Overall Study|Protocol Violation|1
808834|NCT00856973|2572627|P3|Overall Study|Physician Decision|1
808835|NCT00856973|2572628|P2|Overall Study|Physician Decision|3
808836|NCT00856973|2572629|P1|Overall Study|Physician Decision|0
808837|NCT00856973|2572627|P3|Overall Study|Lost to Follow-up|5
808838|NCT00856973|2572628|P2|Overall Study|Lost to Follow-up|3
808839|NCT00856973|2572629|P1|Overall Study|Lost to Follow-up|6
808840|NCT00856973|2572627|P3|Overall Study|Adverse Event|3
808841|NCT00856973|2572628|P2|Overall Study|Adverse Event|5
808842|NCT00856973|2572629|P1|Overall Study|Adverse Event|5
808843|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Unclassified|0
808844|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Unclassified|0
808845|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Unclassified|11
808846|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Unclassified|2
808847|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Unclassified|4
808848|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
808849|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
808850|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
808851|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
808852|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
808853|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
808854|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
808855|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
808856|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
808857|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
808858|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
808859|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
808860|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
808861|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
808862|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
808863|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Protocol Violation|0
808864|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Protocol Violation|0
808865|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Protocol Violation|5
808866|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Protocol Violation|2
808867|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Protocol Violation|6
808868|NCT00856986|2572699|P5|Extension Period, Weeks 26-52|Adverse Event|0
808869|NCT00856986|2572700|P4|Extension Period, Weeks 26-52|Adverse Event|0
808870|NCT00856986|2572701|P3|Extension Period, Weeks 26-52|Adverse Event|10
808871|NCT00856986|2572702|P2|Extension Period, Weeks 26-52|Adverse Event|3
808872|NCT00856986|2572703|P1|Extension Period, Weeks 26-52|Adverse Event|3
808873|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Unclassified|0
808874|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Unclassified|0
808875|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Unclassified|7
808876|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Unclassified|6
808877|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Unclassified|7
808878|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
808879|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
808880|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
808881|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
808882|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
808883|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
808884|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
808885|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
808886|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
808887|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
808888|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
808889|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
808890|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
808891|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
808892|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
808893|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Protocol Violation|0
808894|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Protocol Violation|0
808895|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Protocol Violation|7
808896|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Protocol Violation|5
808897|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Protocol Violation|4
808898|NCT00856986|2572699|P5|Main Period, Weeks 0-26|Adverse Event|0
808899|NCT00856986|2572700|P4|Main Period, Weeks 0-26|Adverse Event|0
808900|NCT00856986|2572701|P3|Main Period, Weeks 0-26|Adverse Event|9
808901|NCT00856986|2572702|P2|Main Period, Weeks 0-26|Adverse Event|4
808902|NCT00856986|2572703|P1|Main Period, Weeks 0-26|Adverse Event|6
808903|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Unclassified|0
808904|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Unclassified|24
808905|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Unclassified|0
808906|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Unclassified|0
808907|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Unclassified|0
808908|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
808909|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
808910|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
808911|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
808912|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
808913|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
808914|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
808915|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
808916|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
808917|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
808918|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
808919|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
808920|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
808921|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
808922|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
808923|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
808924|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
808925|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
808926|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
808927|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
808928|NCT00856986|2572699|P5|Run-in Period, Weeks -12-0|Adverse Event|0
808929|NCT00856986|2572700|P4|Run-in Period, Weeks -12-0|Adverse Event|92
808930|NCT00856986|2572701|P3|Run-in Period, Weeks -12-0|Adverse Event|0
808931|NCT00856986|2572702|P2|Run-in Period, Weeks -12-0|Adverse Event|0
808932|NCT00856986|2572703|P1|Run-in Period, Weeks -12-0|Adverse Event|0
808943|NCT00857233|2572887|P1|Overall Study|Other Reasons|2
808944|NCT00857233|2572887|P1|Overall Study|Nursing Home Placement|14
808945|NCT00857233|2572887|P1|Overall Study|Lost to Follow-up|4
808946|NCT00857233|2572887|P1|Overall Study|Withdrawal of Consent|9
808947|NCT00857233|2572887|P1|Overall Study|Non-compliance|1
808948|NCT00857233|2572887|P1|Overall Study|Lack of Efficacy|1
808949|NCT00857233|2572887|P1|Overall Study|Adverse Event|24
808950|NCT00857246|2572896|P1|ChemoRT|Adverse Event|2
808951|NCT00857246|2572896|P1|ChemoRT|Withdrawal by Subject|1
808952|NCT00857246|2572896|P1|Surgery (Curative)|disease progression|6
808953|NCT00857246|2572896|P1|Induction Regimen|Withdrawal by Subject|1
808954|NCT00857246|2572896|P1|Induction Regimen|disease-related complications|1
808955|NCT00857246|2572896|P1|Induction Regimen|Adverse Event|1
808956|NCT00857259|2572909|P3|Overall Study|Protocol Violation|1
808957|NCT00857259|2572910|P2|Overall Study|Protocol Violation|0
808958|NCT00857259|2572911|P1|Overall Study|Protocol Violation|1
808959|NCT00857285|2572932|P2|Overall Study|Randomization criteria not met|1
808960|NCT00857285|2572933|P1|Overall Study|Randomization criteria not met|1
808961|NCT00857285|2572932|P2|Overall Study|Withdrawal by Subject|0
808962|NCT00857285|2572933|P1|Overall Study|Withdrawal by Subject|4
808963|NCT00857285|2572932|P2|Overall Study|Protocol Violation|1
808964|NCT00857285|2572933|P1|Overall Study|Protocol Violation|3
808965|NCT00857285|2572932|P2|Overall Study|Lack of Efficacy|2
808966|NCT00857285|2572933|P1|Overall Study|Lack of Efficacy|0
808967|NCT00857285|2572932|P2|Overall Study|Adverse Event|2
808968|NCT00857285|2572933|P1|Overall Study|Adverse Event|4
808969|NCT00857311|2572941|P4|Overall Study|Lost to Follow-up|0
808970|NCT00857311|2572942|P3|Overall Study|Lost to Follow-up|0
808971|NCT00857311|2572943|P2|Overall Study|Lost to Follow-up|0
808972|NCT00857311|2572944|P1|Overall Study|Lost to Follow-up|1
808973|NCT00857415|2572956|P2|Overall Study|Deceased with no autopsy|0
808974|NCT00857415|2572957|P1|Overall Study|Deceased with no autopsy|2
808975|NCT00857415|2572956|P2|Overall Study|Subject still living at end of study|0
808976|NCT00857415|2572957|P1|Overall Study|Subject still living at end of study|110
808977|NCT00857415|2572956|P2|Overall Study|Invalid image or not imaged|0
808978|NCT00857415|2572957|P1|Overall Study|Invalid image or not imaged|3
808979|NCT00857415|2572956|P2|Overall Study|Image acquisition failure|0
808980|NCT00857415|2572957|P1|Overall Study|Image acquisition failure|2
808981|NCT00857454|2572964|P1|Overall Study|MTE09 enrollment criteria not met|6
808982|NCT00857454|2572964|P1|Overall Study|Total Testosterone <300 ng/dL|8
808983|NCT00857454|2572964|P1|Overall Study|Total Testosterone >1050 ng/dL|1
808984|NCT00857454|2572964|P1|Overall Study|Adverse Event|2
808985|NCT00857454|2572964|P1|Overall Study|Lost to Follow-up|1
808986|NCT00857454|2572964|P1|Overall Study|Withdrawal by Subject|2
808987|NCT00857584|2573029|P2|Overall Study|Physician Decision|1
808988|NCT00857584|2573030|P1|Overall Study|Physician Decision|1
808989|NCT00857584|2573029|P2|Overall Study|Adverse Event|2
808990|NCT00857584|2573030|P1|Overall Study|Adverse Event|2
808991|NCT00857584|2573029|P2|Overall Study|Lack of Efficacy|2
808992|NCT00857584|2573030|P1|Overall Study|Lack of Efficacy|1
808993|NCT00857623|2573072|P2|Overall Study|Positive for HEP C|1
808994|NCT00857623|2573073|P1|Overall Study|Positive for HEP C|0
808995|NCT00857623|2573072|P2|Overall Study|Intake of prohibited medication|1
808996|NCT00857623|2573073|P1|Overall Study|Intake of prohibited medication|0
808997|NCT00857623|2573072|P2|Overall Study|Severe non-compliance to protocol|1
808998|NCT00857623|2573073|P1|Overall Study|Severe non-compliance to protocol|1
808999|NCT00857623|2573072|P2|Overall Study|Lack of Efficacy|1
809000|NCT00857623|2573073|P1|Overall Study|Lack of Efficacy|1
809001|NCT00857623|2573072|P2|Overall Study|Withdrawal by Subject|1
809002|NCT00857623|2573073|P1|Overall Study|Withdrawal by Subject|2
809003|NCT00857623|2573072|P2|Overall Study|Study-specific discontinuation criteria|3
809004|NCT00857623|2573073|P1|Overall Study|Study-specific discontinuation criteria|5
809005|NCT00857623|2573072|P2|Overall Study|Adverse Event|2
809006|NCT00857623|2573073|P1|Overall Study|Adverse Event|5
809007|NCT00857649|2573097|P2|Overall Study|Other Reasons|3
809008|NCT00857649|2573098|P1|Overall Study|Other Reasons|1
809009|NCT00857649|2573097|P2|Overall Study|Nursing Home Placement|9
809010|NCT00857649|2573098|P1|Overall Study|Nursing Home Placement|2
809011|NCT00857649|2573097|P2|Overall Study|Withdrawal of Consent|7
809012|NCT00857649|2573098|P1|Overall Study|Withdrawal of Consent|10
809013|NCT00857649|2573097|P2|Overall Study|Protocol Violation|2
809014|NCT00857649|2573098|P1|Overall Study|Protocol Violation|2
809015|NCT00857649|2573097|P2|Overall Study|Non-compliance|1
809016|NCT00857649|2573098|P1|Overall Study|Non-compliance|1
809017|NCT00857649|2573097|P2|Overall Study|Adverse Event|10
809018|NCT00857649|2573098|P1|Overall Study|Adverse Event|15
809019|NCT00857766|2573119|P2|Overall Study|Participant Withdrew Consent|4
809020|NCT00857766|2573120|P1|Overall Study|Participant Withdrew Consent|4
809021|NCT00857766|2573119|P2|Overall Study|Investigator Discretion|3
809022|NCT00857766|2573120|P1|Overall Study|Investigator Discretion|2
809023|NCT00857766|2573119|P2|Overall Study|Lost to Follow-up|0
809024|NCT00857766|2573120|P1|Overall Study|Lost to Follow-up|1
809025|NCT00857766|2573119|P2|Overall Study|Protocol Violation|11
809026|NCT00857766|2573120|P1|Overall Study|Protocol Violation|11
809027|NCT00857766|2573119|P2|Overall Study|Adverse Event|12
809028|NCT00857766|2573120|P1|Overall Study|Adverse Event|13
809029|NCT00857792|2573130|P1|Overall Study|inadequate image quality for analysis|12
809030|NCT00857818|2573136|P2|Overall Study|Investigator decision|0
809031|NCT00857818|2573137|P1|Overall Study|Investigator decision|1
809032|NCT00857818|2573136|P2|Overall Study|Sponsor terminated study|4
809033|NCT00857818|2573137|P1|Overall Study|Sponsor terminated study|6
809034|NCT00857818|2573136|P2|Overall Study|Withdrawal by Subject|4
809035|NCT00857818|2573137|P1|Overall Study|Withdrawal by Subject|0
809036|NCT00857818|2573136|P2|Overall Study|Adverse Event|0
809037|NCT00857818|2573137|P1|Overall Study|Adverse Event|3
809038|NCT00857818|2573136|P2|Overall Study|Lack of Efficacy|0
809039|NCT00857818|2573137|P1|Overall Study|Lack of Efficacy|1
809040|NCT00857896|2573165|P1|Baseline to Week 4|Withdrawal by Subject|1
809041|NCT00857948|2573181|P4|Overall Study|Protocol Violation|0
809042|NCT00857948|2573182|P3|Overall Study|Protocol Violation|1
809043|NCT00857948|2573183|P2|Overall Study|Protocol Violation|0
809044|NCT00857948|2573184|P1|Overall Study|Protocol Violation|1
809045|NCT00857948|2573181|P4|Overall Study|Withdrawal by Subject|0
809046|NCT00857948|2573182|P3|Overall Study|Withdrawal by Subject|0
809047|NCT00857948|2573183|P2|Overall Study|Withdrawal by Subject|0
809048|NCT00857948|2573184|P1|Overall Study|Withdrawal by Subject|2
809049|NCT00858143|2573257|P1|Overall Study|Other|23
809050|NCT00858143|2573257|P1|Overall Study|Death|7
809051|NCT00858143|2573257|P1|Overall Study|Lack of Efficacy|4
809052|NCT00858143|2573257|P1|Overall Study|Adverse Event|16
809053|NCT00858208|2573306|P1|Overall Study|Unspecified|10
809054|NCT00858208|2573306|P1|Overall Study|Participant refused|40
809055|NCT00858208|2573306|P1|Overall Study|Lost to Follow-up|26
809056|NCT00858208|2573306|P1|Overall Study|Adverse Event|3
809057|NCT00858247|2573325|P2|Week 12 Follow-up|Withdrawal by Subject|1
809058|NCT00858247|2573326|P1|Week 12 Follow-up|Withdrawal by Subject|0
809059|NCT00858247|2573325|P2|Baseline Assessment|Protocol Violation|1
809060|NCT00858247|2573326|P1|Baseline Assessment|Protocol Violation|0
809061|NCT00858247|2573325|P2|Baseline Assessment|Poor IV access|0
809062|NCT00858247|2573326|P1|Baseline Assessment|Poor IV access|1
809063|NCT00858247|2573325|P2|Baseline Assessment|Withdrawal by Subject|1
809064|NCT00858247|2573326|P1|Baseline Assessment|Withdrawal by Subject|1
809065|NCT00858403|2573351|P1|Overall Study|Disease Progression|1
809066|NCT00858403|2573351|P1|Overall Study|Death|3
809067|NCT00858403|2573351|P1|Overall Study|Withdrawal by Subject|1
809068|NCT00858442|2573363|P2|Compression:Start to Finish|Lost to Follow-up|3
809069|NCT00858442|2573364|P1|Compression:Start to Finish|Lost to Follow-up|1
809070|NCT00858637|2573405|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
809071|NCT00858637|2573406|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
809072|NCT00858637|2573407|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
809073|NCT00858637|2573408|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
809074|NCT00858637|2573409|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
809075|NCT00858637|2573410|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
809076|NCT00858637|2573405|P6|Placebo-controlled Withdrawal Phase|Death|0
809077|NCT00858637|2573406|P5|Placebo-controlled Withdrawal Phase|Death|1
809078|NCT00858637|2573407|P4|Placebo-controlled Withdrawal Phase|Death|0
809079|NCT00858637|2573408|P3|Placebo-controlled Withdrawal Phase|Death|1
809080|NCT00858637|2573409|P2|Placebo-controlled Withdrawal Phase|Death|0
809081|NCT00858637|2573410|P1|Placebo-controlled Withdrawal Phase|Death|0
809082|NCT00858637|2573405|P6|Active Comparison Phase|Other Reasons|0
809083|NCT00858637|2573406|P5|Active Comparison Phase|Other Reasons|0
809084|NCT00858637|2573407|P4|Active Comparison Phase|Other Reasons|1
809085|NCT00858637|2573408|P3|Active Comparison Phase|Other Reasons|0
809086|NCT00858637|2573409|P2|Active Comparison Phase|Other Reasons|0
809087|NCT00858637|2573410|P1|Active Comparison Phase|Other Reasons|1
809088|NCT00858637|2573405|P6|Active Comparison Phase|Withdrawal by Subject|0
809089|NCT00858637|2573406|P5|Active Comparison Phase|Withdrawal by Subject|0
809090|NCT00858637|2573407|P4|Active Comparison Phase|Withdrawal by Subject|6
809091|NCT00858637|2573408|P3|Active Comparison Phase|Withdrawal by Subject|0
809092|NCT00858637|2573409|P2|Active Comparison Phase|Withdrawal by Subject|0
809093|NCT00858637|2573410|P1|Active Comparison Phase|Withdrawal by Subject|7
809094|NCT00858637|2573405|P6|Active Comparison Phase|Physician Decision|0
809095|NCT00858637|2573406|P5|Active Comparison Phase|Physician Decision|0
809096|NCT00858637|2573407|P4|Active Comparison Phase|Physician Decision|1
809097|NCT00858637|2573408|P3|Active Comparison Phase|Physician Decision|0
809098|NCT00858637|2573409|P2|Active Comparison Phase|Physician Decision|0
809099|NCT00858637|2573410|P1|Active Comparison Phase|Physician Decision|1
809100|NCT00858637|2573405|P6|Active Comparison Phase|Death|0
809101|NCT00858637|2573406|P5|Active Comparison Phase|Death|0
809102|NCT00858637|2573407|P4|Active Comparison Phase|Death|1
809103|NCT00858637|2573408|P3|Active Comparison Phase|Death|0
809104|NCT00858637|2573409|P2|Active Comparison Phase|Death|0
809105|NCT00858637|2573410|P1|Active Comparison Phase|Death|1
809106|NCT00858637|2573405|P6|Active Comparison Phase|Adverse Event|0
809107|NCT00858637|2573406|P5|Active Comparison Phase|Adverse Event|0
809108|NCT00858637|2573407|P4|Active Comparison Phase|Adverse Event|9
809109|NCT00858637|2573408|P3|Active Comparison Phase|Adverse Event|0
809110|NCT00858637|2573409|P2|Active Comparison Phase|Adverse Event|0
809111|NCT00858637|2573410|P1|Active Comparison Phase|Adverse Event|14
809120|NCT00858780|2573438|P5|OL Re-Treatment (Failure to Week 48)|Unspecified|1
809121|NCT00858780|2573439|P4|OL Re-Treatment (Failure to Week 48)|Unspecified|0
809122|NCT00858780|2573440|P3|OL Re-Treatment (Failure to Week 48)|Unspecified|0
809123|NCT00858780|2573441|P2|OL Re-Treatment (Failure to Week 48)|Unspecified|0
809124|NCT00858780|2573442|P1|OL Re-Treatment (Failure to Week 48)|Unspecified|0
809125|NCT00858780|2573438|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
809126|NCT00858780|2573439|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
809127|NCT00858780|2573440|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
809128|NCT00858780|2573441|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
809129|NCT00858780|2573442|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
809130|NCT00858780|2573438|P5|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
809131|NCT00858780|2573439|P4|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
809132|NCT00858780|2573440|P3|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
809133|NCT00858780|2573441|P2|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|1
809134|NCT00858780|2573442|P1|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
809135|NCT00858780|2573438|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
809136|NCT00858780|2573439|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
809137|NCT00858780|2573440|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
809138|NCT00858780|2573441|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
809139|NCT00858780|2573442|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
809140|NCT00858780|2573438|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
809141|NCT00858780|2573439|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
809142|NCT00858780|2573440|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
809143|NCT00858780|2573441|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
809144|NCT00858780|2573442|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
809145|NCT00858780|2573438|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
809146|NCT00858780|2573439|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
809147|NCT00858780|2573440|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
809148|NCT00858780|2573441|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
809149|NCT00858780|2573442|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
809150|NCT00858832|2573517|P2|Overall Study|Adverse Event|1
809151|NCT00858832|2573518|P1|Overall Study|Adverse Event|0
809152|NCT00858832|2573517|P2|Overall Study|became ineligible: delivered vaginally|0
809153|NCT00858832|2573518|P1|Overall Study|became ineligible: delivered vaginally|1
809154|NCT00858845|2573524|P1|Overall Study|Patient underwent heart transplant.|1
809155|NCT00859014|2573536|P1|Overall Study|Lost to Follow-up|1
809156|NCT00859014|2573536|P1|Overall Study|Death|4
809157|NCT00859222|2573638|P5|Overall Study|DLT|0
809158|NCT00859222|2573639|P4|Overall Study|DLT|0
809159|NCT00859222|2573640|P3|Overall Study|DLT|0
809160|NCT00859222|2573641|P2|Overall Study|DLT|0
809161|NCT00859222|2573642|P1|Overall Study|DLT|1
809162|NCT00859222|2573638|P5|Overall Study|Adverse Event|15
809163|NCT00859222|2573639|P4|Overall Study|Adverse Event|24
809164|NCT00859222|2573640|P3|Overall Study|Adverse Event|6
809165|NCT00859222|2573641|P2|Overall Study|Adverse Event|3
809166|NCT00859222|2573642|P1|Overall Study|Adverse Event|2
809167|NCT00859313|2573667|P1|Overall Study|staff error|1
809168|NCT00859313|2573667|P1|Overall Study|Adverse Event|1
809169|NCT00859313|2573667|P1|Overall Study|Lack of Efficacy|2
809170|NCT00859430|2573681|P2|First Intervention|Withdrawal by Subject|1
809171|NCT00859430|2573682|P1|First Intervention|Withdrawal by Subject|0
809172|NCT00859469|2573690|P1|Overall Study|Death|16
809173|NCT00859469|2573690|P1|Overall Study|Withdrawal by Subject|1
809174|NCT00859469|2573690|P1|Overall Study|Lack of Efficacy|9
809175|NCT00859469|2573690|P1|Overall Study|Adverse Event|2
809176|NCT00859521|2573707|P2|Washout|Withdrawal by Subject|1
809177|NCT00859521|2573708|P1|Washout|Withdrawal by Subject|0
809178|NCT00859547|2573716|P1|Overall Study|Parent withdrew consent|1
809179|NCT00859547|2573716|P1|Overall Study|Lost to Follow-up|1
809184|NCT00859586|2573736|P1|Overall Study|Donors|4
809185|NCT00859638|2573742|P2|Overall Study|Ill health|1
809186|NCT00859638|2573743|P1|Overall Study|Ill health|1
809187|NCT00859638|2573742|P2|Overall Study|Withdrawal by Subject|2
809188|NCT00859638|2573743|P1|Overall Study|Withdrawal by Subject|3
809189|NCT00859638|2573742|P2|Overall Study|Lost to Follow-up|1
809190|NCT00859638|2573743|P1|Overall Study|Lost to Follow-up|6
809191|NCT00851890|2573764|P4|Overall Study|Lost to Follow-up|1
809192|NCT00851890|2573765|P3|Overall Study|Lost to Follow-up|0
809193|NCT00851890|2573766|P2|Overall Study|Lost to Follow-up|1
809194|NCT00851890|2573767|P1|Overall Study|Lost to Follow-up|0
809195|NCT00851903|2573824|P1|Overall Study|Withdrawal by Subject|2
809196|NCT00852397|2573868|P3|Overall Study|Protocol Violation|1
809197|NCT00852397|2573869|P2|Overall Study|Protocol Violation|0
809198|NCT00852397|2573870|P1|Overall Study|Protocol Violation|0
809199|NCT00852397|2573868|P3|Overall Study|Difficulty in study site visit|0
809200|NCT00852397|2573869|P2|Overall Study|Difficulty in study site visit|0
809201|NCT00852397|2573870|P1|Overall Study|Difficulty in study site visit|1
809202|NCT00852397|2573868|P3|Overall Study|Study terminated by sponsor|6
809203|NCT00852397|2573869|P2|Overall Study|Study terminated by sponsor|1
809204|NCT00852397|2573870|P1|Overall Study|Study terminated by sponsor|2
809205|NCT00852397|2573868|P3|Overall Study|Withdrawal by Subject|2
809206|NCT00852397|2573869|P2|Overall Study|Withdrawal by Subject|1
809207|NCT00852397|2573870|P1|Overall Study|Withdrawal by Subject|4
809208|NCT00852397|2573868|P3|Overall Study|Death|1
809209|NCT00852397|2573869|P2|Overall Study|Death|0
809210|NCT00852397|2573870|P1|Overall Study|Death|0
809211|NCT00852397|2573868|P3|Overall Study|Adverse Event|4
809212|NCT00852397|2573869|P2|Overall Study|Adverse Event|6
809213|NCT00852397|2573870|P1|Overall Study|Adverse Event|4
809214|NCT00852475|2573901|P2|Overall Study|Lost to Follow-up|4
809215|NCT00852475|2573902|P1|Overall Study|Lost to Follow-up|3
809216|NCT00852540|2573918|P2|Overall Study|Did Not Receive Study Drug|3
809217|NCT00852540|2573919|P1|Overall Study|Did Not Receive Study Drug|3
809218|NCT00852540|2573918|P2|Overall Study|Withdrawal by Subject|1
809219|NCT00852540|2573919|P1|Overall Study|Withdrawal by Subject|3
809220|NCT00852540|2573918|P2|Overall Study|Investigator Discretion|3
809221|NCT00852540|2573919|P1|Overall Study|Investigator Discretion|2
809222|NCT00852540|2573918|P2|Overall Study|Lost to Follow-up|3
809223|NCT00852540|2573919|P1|Overall Study|Lost to Follow-up|2
809224|NCT00852540|2573918|P2|Overall Study|Protocol Violation|2
809225|NCT00852540|2573919|P1|Overall Study|Protocol Violation|1
809226|NCT00852540|2573918|P2|Overall Study|Lack of Efficacy|3
809227|NCT00852540|2573919|P1|Overall Study|Lack of Efficacy|15
809228|NCT00852540|2573918|P2|Overall Study|Adverse Event|3
809229|NCT00852540|2573919|P1|Overall Study|Adverse Event|10
809230|NCT00852917|2574011|P4|Overall Study|Death|1
809231|NCT00852917|2574012|P3|Overall Study|Death|0
809232|NCT00852917|2574013|P2|Overall Study|Death|0
809233|NCT00852917|2574014|P1|Overall Study|Death|0
809234|NCT00852917|2574011|P4|Overall Study|Physician Decision|19
809235|NCT00852917|2574012|P3|Overall Study|Physician Decision|2
809236|NCT00852917|2574013|P2|Overall Study|Physician Decision|7
809237|NCT00852917|2574014|P1|Overall Study|Physician Decision|6
809238|NCT00852917|2574011|P4|Overall Study|Withdrawal by Subject|9
809239|NCT00852917|2574012|P3|Overall Study|Withdrawal by Subject|10
809240|NCT00852917|2574013|P2|Overall Study|Withdrawal by Subject|8
809241|NCT00852917|2574014|P1|Overall Study|Withdrawal by Subject|4
809242|NCT00852917|2574011|P4|Overall Study|Lack of Efficacy|47
809243|NCT00852917|2574012|P3|Overall Study|Lack of Efficacy|11
809244|NCT00852917|2574013|P2|Overall Study|Lack of Efficacy|11
809245|NCT00852917|2574014|P1|Overall Study|Lack of Efficacy|21
809246|NCT00852917|2574011|P4|Overall Study|Adverse Event|17
809247|NCT00852917|2574012|P3|Overall Study|Adverse Event|35
809248|NCT00852917|2574013|P2|Overall Study|Adverse Event|20
809249|NCT00852917|2574014|P1|Overall Study|Adverse Event|13
809250|NCT00852930|2574055|P3|Overall Study|Physician Decision|1
809251|NCT00852930|2574056|P2|Overall Study|Physician Decision|0
809252|NCT00852930|2574057|P1|Overall Study|Physician Decision|0
809253|NCT00852930|2574055|P3|Overall Study|Withdrawal by Subject|1
809254|NCT00852930|2574056|P2|Overall Study|Withdrawal by Subject|1
809255|NCT00852930|2574057|P1|Overall Study|Withdrawal by Subject|1
809256|NCT00852969|2574076|P2|Overall Study|Lost to Follow-up|1
809257|NCT00852969|2574077|P1|Overall Study|Lost to Follow-up|0
809258|NCT00852969|2574076|P2|Overall Study|Adverse Event|1
809259|NCT00852969|2574077|P1|Overall Study|Adverse Event|0
809260|NCT00852995|2574090|P5|Overall Study|Moved Out of Area|0
809261|NCT00852995|2574091|P4|Overall Study|Moved Out of Area|0
809262|NCT00852995|2574092|P3|Overall Study|Moved Out of Area|0
809263|NCT00852995|2574093|P2|Overall Study|Moved Out of Area|0
809264|NCT00852995|2574094|P1|Overall Study|Moved Out of Area|1
809265|NCT00852995|2574090|P5|Overall Study|Protocol Violation|1
809266|NCT00852995|2574091|P4|Overall Study|Protocol Violation|0
809267|NCT00852995|2574092|P3|Overall Study|Protocol Violation|0
809268|NCT00852995|2574093|P2|Overall Study|Protocol Violation|0
809269|NCT00852995|2574094|P1|Overall Study|Protocol Violation|0
809270|NCT00852995|2574090|P5|Overall Study|Physician Decision|0
809271|NCT00852995|2574091|P4|Overall Study|Physician Decision|0
809272|NCT00852995|2574092|P3|Overall Study|Physician Decision|0
809273|NCT00852995|2574093|P2|Overall Study|Physician Decision|0
809274|NCT00852995|2574094|P1|Overall Study|Physician Decision|1
809275|NCT00852995|2574090|P5|Overall Study|Progressive Disease|1
809276|NCT00852995|2574091|P4|Overall Study|Progressive Disease|2
809277|NCT00852995|2574092|P3|Overall Study|Progressive Disease|0
809278|NCT00852995|2574093|P2|Overall Study|Progressive Disease|0
809279|NCT00852995|2574094|P1|Overall Study|Progressive Disease|1
809280|NCT00852995|2574090|P5|Overall Study|Non-Compliance|0
809281|NCT00852995|2574091|P4|Overall Study|Non-Compliance|2
809282|NCT00852995|2574092|P3|Overall Study|Non-Compliance|0
809283|NCT00852995|2574093|P2|Overall Study|Non-Compliance|0
809284|NCT00852995|2574094|P1|Overall Study|Non-Compliance|0
809285|NCT00852995|2574090|P5|Overall Study|Withdrawal by Subject|2
809286|NCT00852995|2574091|P4|Overall Study|Withdrawal by Subject|1
809287|NCT00852995|2574092|P3|Overall Study|Withdrawal by Subject|0
809288|NCT00852995|2574093|P2|Overall Study|Withdrawal by Subject|0
809289|NCT00852995|2574094|P1|Overall Study|Withdrawal by Subject|4
809290|NCT00852995|2574090|P5|Overall Study|Lost to Follow-up|0
809291|NCT00852995|2574091|P4|Overall Study|Lost to Follow-up|0
809292|NCT00852995|2574092|P3|Overall Study|Lost to Follow-up|1
809293|NCT00852995|2574093|P2|Overall Study|Lost to Follow-up|1
809294|NCT00852995|2574094|P1|Overall Study|Lost to Follow-up|0
809295|NCT00852995|2574090|P5|Overall Study|Adverse Event|0
809296|NCT00852995|2574091|P4|Overall Study|Adverse Event|0
809297|NCT00852995|2574092|P3|Overall Study|Adverse Event|4
809298|NCT00852995|2574093|P2|Overall Study|Adverse Event|0
809299|NCT00852995|2574094|P1|Overall Study|Adverse Event|1
809300|NCT00853021|2574136|P1|Overall Study|Death|1
809301|NCT00853021|2574136|P1|Overall Study|Withdrawal by Subject|2
809302|NCT00853021|2574136|P1|Overall Study|Adverse Event|2
809303|NCT00853073|2574145|P2|Overall Study|Withdrawal by Subject|2
809304|NCT00853073|2574146|P1|Overall Study|Withdrawal by Subject|3
809305|NCT00853099|2574155|P4|Double-blind + Open-label Periods|Not Specified|6
809306|NCT00853099|2574156|P3|Double-blind + Open-label Periods|Not Specified|0
809307|NCT00853099|2574157|P2|Double-blind + Open-label Periods|Not Specified|0
809308|NCT00853099|2574158|P1|Double-blind + Open-label Periods|Not Specified|0
809309|NCT00853099|2574155|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
809310|NCT00853099|2574156|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
809311|NCT00853099|2574157|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
809312|NCT00853099|2574158|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
809313|NCT00853099|2574155|P4|Double-blind + Open-label Periods|Adverse Event|47
809314|NCT00853099|2574156|P3|Double-blind + Open-label Periods|Adverse Event|0
809315|NCT00853099|2574157|P2|Double-blind + Open-label Periods|Adverse Event|0
809316|NCT00853099|2574158|P1|Double-blind + Open-label Periods|Adverse Event|0
809317|NCT00853099|2574155|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
809318|NCT00853099|2574156|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
809319|NCT00853099|2574157|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
809320|NCT00853099|2574158|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
809321|NCT00853099|2574155|P4|Double-blind Period|Mistreated with rescue study drug|0
809322|NCT00853099|2574156|P3|Double-blind Period|Mistreated with rescue study drug|1
809323|NCT00853099|2574157|P2|Double-blind Period|Mistreated with rescue study drug|0
809324|NCT00853099|2574158|P1|Double-blind Period|Mistreated with rescue study drug|0
809325|NCT00853099|2574155|P4|Double-blind Period|Not Specified|0
809326|NCT00853099|2574156|P3|Double-blind Period|Not Specified|1
809327|NCT00853099|2574157|P2|Double-blind Period|Not Specified|0
809328|NCT00853099|2574158|P1|Double-blind Period|Not Specified|0
809329|NCT00853099|2574155|P4|Double-blind Period|Lack of Efficacy|0
809330|NCT00853099|2574156|P3|Double-blind Period|Lack of Efficacy|16
809331|NCT00853099|2574157|P2|Double-blind Period|Lack of Efficacy|17
809332|NCT00853099|2574158|P1|Double-blind Period|Lack of Efficacy|14
809333|NCT00853099|2574155|P4|Double-blind Period|Withdrawal by Subject|0
809334|NCT00853099|2574156|P3|Double-blind Period|Withdrawal by Subject|0
809335|NCT00853099|2574157|P2|Double-blind Period|Withdrawal by Subject|3
809336|NCT00853099|2574158|P1|Double-blind Period|Withdrawal by Subject|2
809337|NCT00853099|2574155|P4|Double-blind Period|Adverse Event|0
809338|NCT00853099|2574156|P3|Double-blind Period|Adverse Event|13
809339|NCT00853099|2574157|P2|Double-blind Period|Adverse Event|9
809340|NCT00853099|2574158|P1|Double-blind Period|Adverse Event|7
809341|NCT00853151|2574202|P4|Overall Study|Sponsor Decision|0
809342|NCT00853151|2574203|P3|Overall Study|Sponsor Decision|0
809343|NCT00853151|2574204|P2|Overall Study|Sponsor Decision|3
809344|NCT00853151|2574205|P1|Overall Study|Sponsor Decision|0
809345|NCT00853151|2574202|P4|Overall Study|Physician Decision|0
809346|NCT00853151|2574203|P3|Overall Study|Physician Decision|1
809347|NCT00853151|2574204|P2|Overall Study|Physician Decision|2
809348|NCT00853151|2574205|P1|Overall Study|Physician Decision|0
809349|NCT00853151|2574202|P4|Overall Study|Withdrawal by Subject|1
809350|NCT00853151|2574203|P3|Overall Study|Withdrawal by Subject|2
809351|NCT00853151|2574204|P2|Overall Study|Withdrawal by Subject|4
809352|NCT00853151|2574205|P1|Overall Study|Withdrawal by Subject|5
809353|NCT00853151|2574202|P4|Overall Study|Protocol Violation|1
809354|NCT00853151|2574203|P3|Overall Study|Protocol Violation|0
809355|NCT00853151|2574204|P2|Overall Study|Protocol Violation|0
809356|NCT00853151|2574205|P1|Overall Study|Protocol Violation|0
809357|NCT00853151|2574202|P4|Overall Study|Death|1
809358|NCT00853151|2574203|P3|Overall Study|Death|0
809359|NCT00853151|2574204|P2|Overall Study|Death|0
809360|NCT00853151|2574205|P1|Overall Study|Death|1
809361|NCT00853151|2574202|P4|Overall Study|Lost to Follow-up|0
809362|NCT00853151|2574203|P3|Overall Study|Lost to Follow-up|3
809363|NCT00853151|2574204|P2|Overall Study|Lost to Follow-up|0
809364|NCT00853151|2574205|P1|Overall Study|Lost to Follow-up|2
809365|NCT00853151|2574202|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
809366|NCT00853151|2574203|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
809367|NCT00853151|2574204|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
809368|NCT00853151|2574205|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
809369|NCT00853151|2574202|P4|Overall Study|Adverse Event|0
809370|NCT00853151|2574203|P3|Overall Study|Adverse Event|2
809371|NCT00853151|2574204|P2|Overall Study|Adverse Event|4
809372|NCT00853151|2574205|P1|Overall Study|Adverse Event|1
809373|NCT00853229|2574349|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
809374|NCT00853229|2574350|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
809375|NCT00853242|2574363|P7|Overall Study|Unspecified|2
809376|NCT00853242|2574364|P6|Overall Study|Unspecified|1
809377|NCT00853242|2574365|P5|Overall Study|Unspecified|0
809378|NCT00853242|2574366|P4|Overall Study|Unspecified|0
809379|NCT00853242|2574367|P3|Overall Study|Unspecified|2
809380|NCT00853242|2574368|P2|Overall Study|Unspecified|0
809381|NCT00853242|2574369|P1|Overall Study|Unspecified|2
809382|NCT00853242|2574363|P7|Overall Study|Withdrawal by Subject|2
809383|NCT00853242|2574364|P6|Overall Study|Withdrawal by Subject|0
809384|NCT00853242|2574365|P5|Overall Study|Withdrawal by Subject|0
809385|NCT00853242|2574366|P4|Overall Study|Withdrawal by Subject|4
809386|NCT00853242|2574367|P3|Overall Study|Withdrawal by Subject|0
809387|NCT00853242|2574368|P2|Overall Study|Withdrawal by Subject|2
809388|NCT00853242|2574369|P1|Overall Study|Withdrawal by Subject|1
809389|NCT00853242|2574363|P7|Overall Study|Noncompliant|0
809390|NCT00853242|2574364|P6|Overall Study|Noncompliant|0
809391|NCT00853242|2574365|P5|Overall Study|Noncompliant|1
809392|NCT00853242|2574366|P4|Overall Study|Noncompliant|0
809393|NCT00853242|2574367|P3|Overall Study|Noncompliant|0
809394|NCT00853242|2574368|P2|Overall Study|Noncompliant|0
809395|NCT00853242|2574369|P1|Overall Study|Noncompliant|0
809396|NCT00853242|2574363|P7|Overall Study|Adverse Event|1
809397|NCT00853242|2574364|P6|Overall Study|Adverse Event|1
809398|NCT00853242|2574365|P5|Overall Study|Adverse Event|3
809399|NCT00853242|2574366|P4|Overall Study|Adverse Event|0
809400|NCT00853242|2574367|P3|Overall Study|Adverse Event|1
809401|NCT00853242|2574368|P2|Overall Study|Adverse Event|1
809402|NCT00853242|2574369|P1|Overall Study|Adverse Event|0
809403|NCT00853385|2574427|P5|Overall Study|Unspecified|12
809404|NCT00853385|2574428|P4|Overall Study|Unspecified|4
809405|NCT00853385|2574429|P3|Overall Study|Unspecified|4
809406|NCT00853385|2574430|P2|Overall Study|Unspecified|9
809407|NCT00853385|2574431|P1|Overall Study|Unspecified|18
809408|NCT00853385|2574427|P5|Overall Study|Withdrawal by Subject|1
809409|NCT00853385|2574428|P4|Overall Study|Withdrawal by Subject|1
809410|NCT00853385|2574429|P3|Overall Study|Withdrawal by Subject|0
809411|NCT00853385|2574430|P2|Overall Study|Withdrawal by Subject|2
809412|NCT00853385|2574431|P1|Overall Study|Withdrawal by Subject|4
809413|NCT00853385|2574427|P5|Overall Study|Lost to Follow-up|0
809414|NCT00853385|2574428|P4|Overall Study|Lost to Follow-up|0
809415|NCT00853385|2574429|P3|Overall Study|Lost to Follow-up|0
809416|NCT00853385|2574430|P2|Overall Study|Lost to Follow-up|1
809417|NCT00853385|2574431|P1|Overall Study|Lost to Follow-up|2
809418|NCT00853385|2574427|P5|Overall Study|Lack of Efficacy|6
809419|NCT00853385|2574428|P4|Overall Study|Lack of Efficacy|3
809420|NCT00853385|2574429|P3|Overall Study|Lack of Efficacy|3
809421|NCT00853385|2574430|P2|Overall Study|Lack of Efficacy|7
809422|NCT00853385|2574431|P1|Overall Study|Lack of Efficacy|6
809423|NCT00853385|2574427|P5|Overall Study|Adverse Event|22
809424|NCT00853385|2574428|P4|Overall Study|Adverse Event|5
809425|NCT00853385|2574429|P3|Overall Study|Adverse Event|2
809426|NCT00853385|2574430|P2|Overall Study|Adverse Event|24
809427|NCT00853385|2574431|P1|Overall Study|Adverse Event|24
809428|NCT00853385|2574427|P5|Overall Study|Death|1
809429|NCT00853385|2574428|P4|Overall Study|Death|0
809430|NCT00853385|2574429|P3|Overall Study|Death|0
809431|NCT00853385|2574430|P2|Overall Study|Death|0
809432|NCT00853385|2574431|P1|Overall Study|Death|0
809433|NCT00853567|2574647|P1|Overall Study|Study prematurely terminated|71
809434|NCT00853593|2574655|P1|Overall Study|Implant not attempted|4
809435|NCT00853593|2574655|P1|Overall Study|Model 4396 lead not attempted|29
809436|NCT00853593|2574655|P1|Overall Study|Subjects did not receive a 4396 lead|12
809437|NCT00853658|2574689|P3|Overall Study|Missing study completion information|6
809438|NCT00853658|2574690|P2|Overall Study|Missing study completion information|4
809439|NCT00853658|2574691|P1|Overall Study|Missing study completion information|5
809440|NCT00853658|2574689|P3|Overall Study|Patient's request|11
809441|NCT00853658|2574690|P2|Overall Study|Patient's request|17
809442|NCT00853658|2574691|P1|Overall Study|Patient's request|21
809443|NCT00853658|2574689|P3|Overall Study|Vital Status at study end N/A|10
809444|NCT00853658|2574690|P2|Overall Study|Vital Status at study end N/A|10
809445|NCT00853658|2574691|P1|Overall Study|Vital Status at study end N/A|8
809446|NCT00853658|2574689|P3|Overall Study|Vital Status unknown at study end|0
809447|NCT00853658|2574690|P2|Overall Study|Vital Status unknown at study end|1
809448|NCT00853658|2574691|P1|Overall Study|Vital Status unknown at study end|1
809449|NCT00853658|2574689|P3|Overall Study|Vital Status known (alive) at study end|3
809450|NCT00853658|2574690|P2|Overall Study|Vital Status known (alive) at study end|3
809451|NCT00853658|2574691|P1|Overall Study|Vital Status known (alive) at study end|2
809452|NCT00853658|2574689|P3|Overall Study|IRB request|2
809453|NCT00853658|2574690|P2|Overall Study|IRB request|0
809454|NCT00853658|2574691|P1|Overall Study|IRB request|0
809455|NCT00853658|2574689|P3|Overall Study|H.A. Request|19
809456|NCT00853658|2574690|P2|Overall Study|H.A. Request|23
809457|NCT00853658|2574691|P1|Overall Study|H.A. Request|26
809458|NCT00853658|2574689|P3|Overall Study|Lost to Follow-up|11
809459|NCT00853658|2574690|P2|Overall Study|Lost to Follow-up|6
809460|NCT00853658|2574691|P1|Overall Study|Lost to Follow-up|11
809461|NCT00853658|2574689|P3|Overall Study|Death|753
809462|NCT00853658|2574690|P2|Overall Study|Death|768
809463|NCT00853658|2574691|P1|Overall Study|Death|713
809464|NCT00853723|2574708|P3|Overall Study|Protocol Violation|1
809465|NCT00853723|2574709|P2|Overall Study|Protocol Violation|2
809466|NCT00853723|2574710|P1|Overall Study|Protocol Violation|1
809467|NCT00853723|2574708|P3|Overall Study|Withdrawal by Subject|0
809468|NCT00853723|2574709|P2|Overall Study|Withdrawal by Subject|1
809469|NCT00853723|2574710|P1|Overall Study|Withdrawal by Subject|2
809470|NCT00853723|2574708|P3|Overall Study|Adverse Event|1
809471|NCT00853723|2574709|P2|Overall Study|Adverse Event|4
809472|NCT00853723|2574710|P1|Overall Study|Adverse Event|3
809473|NCT00853749|2574756|P2|Overall Study|Lost to Follow-up|1
809474|NCT00853749|2574757|P1|Overall Study|Lost to Follow-up|0
809475|NCT00853762|2574779|P4|Overall Study|Randomised but not Treated|0
809476|NCT00853762|2574780|P3|Overall Study|Randomised but not Treated|2
809477|NCT00853762|2574781|P2|Overall Study|Randomised but not Treated|2
809478|NCT00853762|2574782|P1|Overall Study|Randomised but not Treated|0
809479|NCT00853762|2574779|P4|Overall Study|Unspecified|0
809480|NCT00853762|2574780|P3|Overall Study|Unspecified|0
809481|NCT00853762|2574781|P2|Overall Study|Unspecified|2
809482|NCT00853762|2574782|P1|Overall Study|Unspecified|0
809483|NCT00853762|2574779|P4|Overall Study|Withdrawal by Subject|0
809484|NCT00853762|2574780|P3|Overall Study|Withdrawal by Subject|1
809485|NCT00853762|2574781|P2|Overall Study|Withdrawal by Subject|0
809486|NCT00853762|2574782|P1|Overall Study|Withdrawal by Subject|0
809487|NCT00853762|2574779|P4|Overall Study|Protocol Violation|1
809488|NCT00853762|2574780|P3|Overall Study|Protocol Violation|0
809489|NCT00853762|2574781|P2|Overall Study|Protocol Violation|0
809490|NCT00853762|2574782|P1|Overall Study|Protocol Violation|0
809491|NCT00853762|2574779|P4|Overall Study|Premature Termination|21
809492|NCT00853762|2574780|P3|Overall Study|Premature Termination|14
809493|NCT00853762|2574781|P2|Overall Study|Premature Termination|15
809494|NCT00853762|2574782|P1|Overall Study|Premature Termination|16
809495|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Death|6
809496|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Death|1
809497|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Administrative problems|56
809498|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Administrative problems|45
809499|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
809500|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
809501|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
809502|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
809503|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
809504|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
809505|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
809506|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
809507|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
809508|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
809509|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
809510|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
809511|NCT00853827|2574850|P2|Double Blind Period (103 Weeks)|Adverse Event|14
809512|NCT00853827|2574851|P1|Double Blind Period (103 Weeks)|Adverse Event|25
809513|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Protocol Violation|0
809514|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Protocol Violation|12
809515|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
809516|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
809517|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
809518|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
809519|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
809520|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
809521|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
809522|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
809523|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Adverse Event|0
809524|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Adverse Event|9
809525|NCT00853827|2574850|P2|Single Blind Period (1 Week)|Other|0
809526|NCT00853827|2574851|P1|Single Blind Period (1 Week)|Other|4
809527|NCT00853905|2574881|P2|Overall Study|never had surgery|0
809528|NCT00853905|2574882|P1|Overall Study|never had surgery|1
809529|NCT00853905|2574881|P2|Overall Study|Withdrawal by Subject|1
809530|NCT00853905|2574882|P1|Overall Study|Withdrawal by Subject|0
809531|NCT00853905|2574881|P2|Overall Study|Lost to Follow-up|3
809532|NCT00853905|2574882|P1|Overall Study|Lost to Follow-up|1
809533|NCT00853957|2574890|P2|Overall Study|Protocol deviation|3
809534|NCT00853957|2574891|P1|Overall Study|Protocol deviation|0
809535|NCT00853957|2574890|P2|Overall Study|Lost to Follow-up|6
809536|NCT00853957|2574891|P1|Overall Study|Lost to Follow-up|1
809537|NCT00853957|2574890|P2|Overall Study|Subject withdrew consent|5
809538|NCT00853957|2574891|P1|Overall Study|Subject withdrew consent|4
809539|NCT00853957|2574890|P2|Overall Study|Unsatisfactory therapeutic effect|2
809540|NCT00853957|2574891|P1|Overall Study|Unsatisfactory therapeutic effect|0
809541|NCT00853957|2574890|P2|Overall Study|Adverse Event|3
809542|NCT00853957|2574891|P1|Overall Study|Adverse Event|9
809543|NCT00853970|2574909|P2|Overall Study|Cancelled surgery|2
809544|NCT00853970|2574910|P1|Overall Study|Cancelled surgery|4
809545|NCT00853970|2574909|P2|Overall Study|Withdrawal by Subject|1
809546|NCT00853970|2574910|P1|Overall Study|Withdrawal by Subject|2
809547|NCT00854113|2574948|P11|Overall Study|Withdrawal by Subject|0
809548|NCT00854113|2574949|P10|Overall Study|Withdrawal by Subject|0
809549|NCT00854113|2574950|P9|Overall Study|Withdrawal by Subject|1
809550|NCT00854113|2574951|P8|Overall Study|Withdrawal by Subject|1
809551|NCT00854113|2574952|P7|Overall Study|Withdrawal by Subject|0
809552|NCT00854113|2574953|P6|Overall Study|Withdrawal by Subject|0
809553|NCT00854113|2574954|P5|Overall Study|Withdrawal by Subject|0
809554|NCT00854113|2574955|P4|Overall Study|Withdrawal by Subject|0
809555|NCT00854113|2574956|P3|Overall Study|Withdrawal by Subject|0
809556|NCT00854113|2574957|P2|Overall Study|Withdrawal by Subject|0
809557|NCT00854113|2574958|P1|Overall Study|Withdrawal by Subject|0
809558|NCT00854113|2574948|P11|Overall Study|Adverse Event|0
809559|NCT00854113|2574949|P10|Overall Study|Adverse Event|0
809560|NCT00854113|2574950|P9|Overall Study|Adverse Event|0
809561|NCT00854113|2574951|P8|Overall Study|Adverse Event|2
809562|NCT00854113|2574952|P7|Overall Study|Adverse Event|0
809563|NCT00854113|2574953|P6|Overall Study|Adverse Event|0
809564|NCT00854113|2574954|P5|Overall Study|Adverse Event|0
809565|NCT00854113|2574955|P4|Overall Study|Adverse Event|0
809566|NCT00854113|2574956|P3|Overall Study|Adverse Event|0
809567|NCT00854113|2574957|P2|Overall Study|Adverse Event|0
809568|NCT00854113|2574958|P1|Overall Study|Adverse Event|0
809569|NCT00859898|2575067|P3|Overall Study|non-specified|1
809570|NCT00859898|2575068|P2|Overall Study|non-specified|1
809571|NCT00859898|2575069|P1|Overall Study|non-specified|1
809572|NCT00859898|2575067|P3|Overall Study|No longer meets criteria|0
809573|NCT00859898|2575068|P2|Overall Study|No longer meets criteria|1
809574|NCT00859898|2575069|P1|Overall Study|No longer meets criteria|0
809575|NCT00859898|2575067|P3|Overall Study|poor/non-compliance|0
809576|NCT00859898|2575068|P2|Overall Study|poor/non-compliance|0
809577|NCT00859898|2575069|P1|Overall Study|poor/non-compliance|2
809578|NCT00859898|2575067|P3|Overall Study|Lost to Follow-up|5
809579|NCT00859898|2575068|P2|Overall Study|Lost to Follow-up|11
809580|NCT00859898|2575069|P1|Overall Study|Lost to Follow-up|10
809581|NCT00859898|2575067|P3|Overall Study|Death|1
809582|NCT00859898|2575068|P2|Overall Study|Death|0
809583|NCT00859898|2575069|P1|Overall Study|Death|0
809584|NCT00859898|2575067|P3|Overall Study|Withdrawal by Subject|11
809585|NCT00859898|2575068|P2|Overall Study|Withdrawal by Subject|8
809586|NCT00859898|2575069|P1|Overall Study|Withdrawal by Subject|11
809587|NCT00859898|2575067|P3|Overall Study|Adverse Event|8
809588|NCT00859898|2575068|P2|Overall Study|Adverse Event|9
809589|NCT00859898|2575069|P1|Overall Study|Adverse Event|4
809590|NCT00859898|2575067|P3|Overall Study|Lack of Efficacy|1
809591|NCT00859898|2575068|P2|Overall Study|Lack of Efficacy|1
809592|NCT00859898|2575069|P1|Overall Study|Lack of Efficacy|0
809593|NCT00859937|2575112|P2|Overall Study|Protocol Violation|0
809594|NCT00859937|2575113|P1|Overall Study|Protocol Violation|1
809595|NCT00860028|2575136|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
809596|NCT00860028|2575137|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
809597|NCT00860067|2575150|P3|Overall Study|Pregnancy|0
809598|NCT00860067|2575151|P2|Overall Study|Pregnancy|0
809599|NCT00860067|2575152|P1|Overall Study|Pregnancy|1
809600|NCT00860067|2575150|P3|Overall Study|Withdrawal by Subject|0
809601|NCT00860067|2575151|P2|Overall Study|Withdrawal by Subject|0
809602|NCT00860067|2575152|P1|Overall Study|Withdrawal by Subject|4
809603|NCT00860067|2575150|P3|Overall Study|Lost to Follow-up|9
809604|NCT00860067|2575151|P2|Overall Study|Lost to Follow-up|9
809605|NCT00860067|2575152|P1|Overall Study|Lost to Follow-up|46
809606|NCT00860470|2575216|P2|Overall Study|Lost to Follow-up|39
809607|NCT00860470|2575217|P1|Overall Study|Lost to Follow-up|34
809608|NCT00860470|2575216|P2|Overall Study|Moved away|10
809609|NCT00860470|2575217|P1|Overall Study|Moved away|8
809610|NCT00860470|2575216|P2|Overall Study|Death|10
809611|NCT00860470|2575217|P1|Overall Study|Death|6
809614|NCT00860951|2575289|P1|Overall Study|Lost to Follow-up|5
809615|NCT00860951|2575289|P1|Overall Study|Withdrawal by Subject|2
809616|NCT00861198|2575308|P1|Overall Study|SpyGlass Failed|5
809617|NCT00861341|2575316|P1|Overall Study|Withdrawal by Subject|2
809618|NCT00861471|2575321|P1|Overall Study|Physician Decision|2
809619|NCT00861471|2575321|P1|Overall Study|treatment for lumbar laminectomy|1
809620|NCT00861471|2575321|P1|Overall Study|Lack of Efficacy|3
809621|NCT00861471|2575321|P1|Overall Study|Adverse Event|2
809622|NCT00861471|2575321|P1|Overall Study|Withdrawal by Subject|1
809623|NCT00861614|2575386|P2|Overall Study|Unspecified|22
809624|NCT00861614|2575387|P1|Overall Study|Unspecified|17
809625|NCT00861614|2575386|P2|Overall Study|Withdrawal by Subject|35
809626|NCT00861614|2575387|P1|Overall Study|Withdrawal by Subject|34
809627|NCT00861614|2575386|P2|Overall Study|Adverse Event|23
809628|NCT00861614|2575387|P1|Overall Study|Adverse Event|27
809629|NCT00861614|2575386|P2|Overall Study|Death|19
809630|NCT00861614|2575387|P1|Overall Study|Death|32
809631|NCT00861614|2575386|P2|Overall Study|Study Drug Toxicity|6
809632|NCT00861614|2575387|P1|Overall Study|Study Drug Toxicity|79
809633|NCT00861614|2575386|P2|Overall Study|Disease Progression|263
809634|NCT00861614|2575387|P1|Overall Study|Disease Progression|182
809635|NCT00861692|2575417|P1|Overall Study|Death|6
809636|NCT00861705|2575431|P4|Overall Study|Never Began Treatment|1
809637|NCT00861705|2575432|P3|Overall Study|Never Began Treatment|0
809638|NCT00861705|2575433|P2|Overall Study|Never Began Treatment|3
809639|NCT00861705|2575434|P1|Overall Study|Never Began Treatment|7
809640|NCT00861744|2575454|P4|Overall Study|Blood draws|1
809641|NCT00861744|2575455|P3|Overall Study|Blood draws|0
809642|NCT00861744|2575456|P2|Overall Study|Blood draws|0
809643|NCT00861744|2575457|P1|Overall Study|Blood draws|0
809644|NCT00861744|2575454|P4|Overall Study|Migration from study area|0
809645|NCT00861744|2575455|P3|Overall Study|Migration from study area|1
809646|NCT00861744|2575456|P2|Overall Study|Migration from study area|3
809647|NCT00861744|2575457|P1|Overall Study|Migration from study area|0
809648|NCT00861744|2575454|P4|Overall Study|Protocol Violation|0
809649|NCT00861744|2575455|P3|Overall Study|Protocol Violation|0
809650|NCT00861744|2575456|P2|Overall Study|Protocol Violation|1
809651|NCT00861744|2575457|P1|Overall Study|Protocol Violation|0
809652|NCT00861744|2575454|P4|Overall Study|Withdrawal by Subject|19
809653|NCT00861744|2575455|P3|Overall Study|Withdrawal by Subject|6
809654|NCT00861744|2575456|P2|Overall Study|Withdrawal by Subject|6
809655|NCT00861744|2575457|P1|Overall Study|Withdrawal by Subject|10
809656|NCT00861744|2575454|P4|Overall Study|Lost to Follow-up|12
809657|NCT00861744|2575455|P3|Overall Study|Lost to Follow-up|17
809658|NCT00861744|2575456|P2|Overall Study|Lost to Follow-up|19
809659|NCT00861744|2575457|P1|Overall Study|Lost to Follow-up|7
809660|NCT00861744|2575454|P4|Overall Study|Adverse Event|1
809661|NCT00861744|2575455|P3|Overall Study|Adverse Event|0
809662|NCT00861744|2575456|P2|Overall Study|Adverse Event|0
809663|NCT00861744|2575457|P1|Overall Study|Adverse Event|0
809664|NCT00861757|2575639|P4|Overall Study|Withdrawal by Subject|2
809665|NCT00861757|2575640|P3|Overall Study|Withdrawal by Subject|5
809666|NCT00861757|2575641|P2|Overall Study|Withdrawal by Subject|5
809667|NCT00861757|2575642|P1|Overall Study|Withdrawal by Subject|1
809668|NCT00861757|2575639|P4|Overall Study|Protocol Violation|1
809669|NCT00861757|2575640|P3|Overall Study|Protocol Violation|4
809670|NCT00861757|2575641|P2|Overall Study|Protocol Violation|2
809671|NCT00861757|2575642|P1|Overall Study|Protocol Violation|2
809672|NCT00861757|2575639|P4|Overall Study|Physician Decision|1
809673|NCT00861757|2575640|P3|Overall Study|Physician Decision|0
809674|NCT00861757|2575641|P2|Overall Study|Physician Decision|0
809675|NCT00861757|2575642|P1|Overall Study|Physician Decision|0
809676|NCT00861757|2575639|P4|Overall Study|Lost to Follow-up|1
809677|NCT00861757|2575640|P3|Overall Study|Lost to Follow-up|1
809678|NCT00861757|2575641|P2|Overall Study|Lost to Follow-up|0
809679|NCT00861757|2575642|P1|Overall Study|Lost to Follow-up|1
809680|NCT00861757|2575639|P4|Overall Study|Lack of Efficacy|1
809681|NCT00861757|2575640|P3|Overall Study|Lack of Efficacy|0
809682|NCT00861757|2575641|P2|Overall Study|Lack of Efficacy|1
809683|NCT00861757|2575642|P1|Overall Study|Lack of Efficacy|3
809684|NCT00861757|2575639|P4|Overall Study|Entry Criteria Not Met|1
809685|NCT00861757|2575640|P3|Overall Study|Entry Criteria Not Met|1
809686|NCT00861757|2575641|P2|Overall Study|Entry Criteria Not Met|2
809687|NCT00861757|2575642|P1|Overall Study|Entry Criteria Not Met|1
809688|NCT00861757|2575639|P4|Overall Study|Adverse Event|2
809689|NCT00861757|2575640|P3|Overall Study|Adverse Event|7
809690|NCT00861757|2575641|P2|Overall Study|Adverse Event|5
809691|NCT00861757|2575642|P1|Overall Study|Adverse Event|1
809692|NCT00862082|2575706|P2|Overall Study|Withdrawal by Subject|1
809693|NCT00862082|2575707|P1|Overall Study|Withdrawal by Subject|0
809694|NCT00862082|2575706|P2|Overall Study|Sponsor decision to terminate the study|0
809695|NCT00862082|2575707|P1|Overall Study|Sponsor decision to terminate the study|5
809696|NCT00862121|2575752|P2|Overall Study|Incorrect randomisation|1
809697|NCT00862121|2575753|P1|Overall Study|Incorrect randomisation|0
809698|NCT00862121|2575752|P2|Overall Study|Exclusion criterion violation|1
809699|NCT00862121|2575753|P1|Overall Study|Exclusion criterion violation|0
809700|NCT00862121|2575752|P2|Overall Study|Protocol Violation|1
809701|NCT00862121|2575753|P1|Overall Study|Protocol Violation|0
809702|NCT00862121|2575752|P2|Overall Study|Lack of Efficacy|3
809703|NCT00862121|2575753|P1|Overall Study|Lack of Efficacy|0
809704|NCT00862121|2575752|P2|Overall Study|Adverse Event|2
809705|NCT00862121|2575753|P1|Overall Study|Adverse Event|1
809706|NCT00862134|2575771|P2|Overall Study|Withdrew prior to dosing|0
809707|NCT00862134|2575772|P1|Overall Study|Withdrew prior to dosing|2
809708|NCT00862134|2575771|P2|Overall Study|Adverse Event|2
809709|NCT00862134|2575772|P1|Overall Study|Adverse Event|2
809710|NCT00862134|2575771|P2|Overall Study|Sponsor terminated study|7
809711|NCT00862134|2575772|P1|Overall Study|Sponsor terminated study|5
809712|NCT00862134|2575771|P2|Overall Study|Withdrawal by Subject|2
809713|NCT00862134|2575772|P1|Overall Study|Withdrawal by Subject|1
809714|NCT00862134|2575771|P2|Overall Study|Physician Decision|1
809715|NCT00862134|2575772|P1|Overall Study|Physician Decision|0
809716|NCT00862134|2575771|P2|Overall Study|Death|0
809717|NCT00862134|2575772|P1|Overall Study|Death|1
809718|NCT00862251|2575790|P3|Overall Study|Withdrawal by Subject|6
809719|NCT00862251|2575791|P2|Overall Study|Withdrawal by Subject|2
809720|NCT00862251|2575792|P1|Overall Study|Withdrawal by Subject|9
809721|NCT00862251|2575790|P3|Overall Study|Protocol Violation|1
809722|NCT00862251|2575791|P2|Overall Study|Protocol Violation|0
809723|NCT00862251|2575792|P1|Overall Study|Protocol Violation|2
809724|NCT00862251|2575790|P3|Overall Study|Lost to Follow-up|1
809725|NCT00862251|2575791|P2|Overall Study|Lost to Follow-up|0
809726|NCT00862251|2575792|P1|Overall Study|Lost to Follow-up|0
809727|NCT00862251|2575790|P3|Overall Study|Adverse Event|1
809728|NCT00862251|2575791|P2|Overall Study|Adverse Event|3
809729|NCT00862251|2575792|P1|Overall Study|Adverse Event|8
809730|NCT00862277|2575848|P3|Overall Study|Protocol Violation|5
809731|NCT00862277|2575849|P2|Overall Study|Protocol Violation|2
809732|NCT00862277|2575850|P1|Overall Study|Protocol Violation|1
809733|NCT00862459|2575864|P3|Overall Study|Administrative problems|0
809734|NCT00862459|2575865|P2|Overall Study|Administrative problems|1
809735|NCT00862459|2575866|P1|Overall Study|Administrative problems|0
809736|NCT00862459|2575864|P3|Overall Study|Inclusion/exclusion criteria not met|0
809737|NCT00862459|2575865|P2|Overall Study|Inclusion/exclusion criteria not met|1
809738|NCT00862459|2575866|P1|Overall Study|Inclusion/exclusion criteria not met|0
809739|NCT00862459|2575864|P3|Overall Study|Unable to hold still for imaging|0
809740|NCT00862459|2575865|P2|Overall Study|Unable to hold still for imaging|1
809741|NCT00862459|2575866|P1|Overall Study|Unable to hold still for imaging|0
809742|NCT00862459|2575864|P3|Overall Study|Intravenous (IV) site problems|1
809743|NCT00862459|2575865|P2|Overall Study|Intravenous (IV) site problems|0
809744|NCT00862459|2575866|P1|Overall Study|Intravenous (IV) site problems|1
809745|NCT00862459|2575864|P3|Overall Study|Operation|0
809746|NCT00862459|2575865|P2|Overall Study|Operation|1
809747|NCT00862459|2575866|P1|Overall Study|Operation|1
809748|NCT00862459|2575864|P3|Overall Study|Personal reasons|0
809749|NCT00862459|2575865|P2|Overall Study|Personal reasons|0
809750|NCT00862459|2575866|P1|Overall Study|Personal reasons|1
809751|NCT00862459|2575864|P3|Overall Study|Adverse Event|0
809752|NCT00862459|2575865|P2|Overall Study|Adverse Event|1
809753|NCT00862459|2575866|P1|Overall Study|Adverse Event|0
809754|NCT00862459|2575864|P3|Overall Study|Withdrawal by Subject|3
809755|NCT00862459|2575865|P2|Overall Study|Withdrawal by Subject|1
809756|NCT00862459|2575866|P1|Overall Study|Withdrawal by Subject|1
809757|NCT00862459|2575864|P3|Overall Study|Protocol Violation|0
809758|NCT00862459|2575865|P2|Overall Study|Protocol Violation|0
809759|NCT00862459|2575866|P1|Overall Study|Protocol Violation|1
809760|NCT00862459|2575864|P3|Overall Study|Lost to Follow-up|2
809761|NCT00862459|2575865|P2|Overall Study|Lost to Follow-up|2
809762|NCT00862459|2575866|P1|Overall Study|Lost to Follow-up|1
809763|NCT00862641|2576063|P4|Overall Study|Randomized, but drug not received|4
809764|NCT00862641|2576064|P3|Overall Study|Randomized, but drug not received|1
809765|NCT00862641|2576065|P2|Overall Study|Randomized, but drug not received|4
809766|NCT00862641|2576066|P1|Overall Study|Randomized, but drug not received|1
809767|NCT00862654|2576112|P4|Overall Study|Included after end of inclusions|0
809768|NCT00862654|2576113|P3|Overall Study|Included after end of inclusions|1
809769|NCT00862654|2576114|P2|Overall Study|Included after end of inclusions|0
809770|NCT00862654|2576115|P1|Overall Study|Included after end of inclusions|0
809771|NCT00862654|2576112|P4|Overall Study|Never used study drugs|0
809772|NCT00862654|2576113|P3|Overall Study|Never used study drugs|0
809773|NCT00862654|2576114|P2|Overall Study|Never used study drugs|0
809774|NCT00862654|2576115|P1|Overall Study|Never used study drugs|1
809775|NCT00862654|2576112|P4|Overall Study|Familly constraint|0
809776|NCT00862654|2576113|P3|Overall Study|Familly constraint|0
809777|NCT00862654|2576114|P2|Overall Study|Familly constraint|1
809778|NCT00862654|2576115|P1|Overall Study|Familly constraint|0
809779|NCT00862654|2576112|P4|Overall Study|Subject mistake|0
809780|NCT00862654|2576113|P3|Overall Study|Subject mistake|0
809781|NCT00862654|2576114|P2|Overall Study|Subject mistake|1
809782|NCT00862654|2576115|P1|Overall Study|Subject mistake|0
809783|NCT00862654|2576112|P4|Overall Study|Withdrawal by Subject|3
809784|NCT00862654|2576113|P3|Overall Study|Withdrawal by Subject|2
809785|NCT00862654|2576114|P2|Overall Study|Withdrawal by Subject|2
809786|NCT00862654|2576115|P1|Overall Study|Withdrawal by Subject|2
809787|NCT00862654|2576112|P4|Overall Study|Pregnancy|0
809788|NCT00862654|2576113|P3|Overall Study|Pregnancy|0
809789|NCT00862654|2576114|P2|Overall Study|Pregnancy|1
809790|NCT00862654|2576115|P1|Overall Study|Pregnancy|1
809791|NCT00862654|2576112|P4|Overall Study|Adverse Event|0
809792|NCT00862654|2576113|P3|Overall Study|Adverse Event|1
809793|NCT00862654|2576114|P2|Overall Study|Adverse Event|1
809794|NCT00862654|2576115|P1|Overall Study|Adverse Event|0
809795|NCT00862654|2576112|P4|Overall Study|Lost to Follow-up|3
809796|NCT00862654|2576113|P3|Overall Study|Lost to Follow-up|1
809797|NCT00862654|2576114|P2|Overall Study|Lost to Follow-up|2
809798|NCT00862654|2576115|P1|Overall Study|Lost to Follow-up|1
809799|NCT00862654|2576112|P4|Overall Study|Lack of Efficacy|0
809800|NCT00862654|2576113|P3|Overall Study|Lack of Efficacy|1
809801|NCT00862654|2576114|P2|Overall Study|Lack of Efficacy|0
809802|NCT00862654|2576115|P1|Overall Study|Lack of Efficacy|1
809803|NCT00862719|2576129|P4|Overall Study|Veno-Occlusive Disease|0
809804|NCT00862719|2576130|P3|Overall Study|Veno-Occlusive Disease|1
809805|NCT00862719|2576131|P2|Overall Study|Veno-Occlusive Disease|0
809806|NCT00862719|2576132|P1|Overall Study|Veno-Occlusive Disease|0
809807|NCT00862719|2576129|P4|Overall Study|Engraftment failure|0
809808|NCT00862719|2576130|P3|Overall Study|Engraftment failure|1
809809|NCT00862719|2576131|P2|Overall Study|Engraftment failure|0
809810|NCT00862719|2576132|P1|Overall Study|Engraftment failure|0
809811|NCT00862719|2576129|P4|Overall Study|Death|1
809812|NCT00862719|2576130|P3|Overall Study|Death|1
809813|NCT00862719|2576131|P2|Overall Study|Death|6
809814|NCT00862719|2576132|P1|Overall Study|Death|5
809815|NCT00862719|2576129|P4|Overall Study|Disease Progression|0
809816|NCT00862719|2576130|P3|Overall Study|Disease Progression|1
809817|NCT00862719|2576131|P2|Overall Study|Disease Progression|0
809818|NCT00862719|2576132|P1|Overall Study|Disease Progression|5
809819|NCT00862823|2576189|P2|First Intervention|Withdrawal by Subject|1
809820|NCT00862823|2576190|P1|First Intervention|Withdrawal by Subject|1
809821|NCT00862836|2576197|P1|Overall Study|Withdrawal by Subject|1
809822|NCT00862849|2576208|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
809823|NCT00862849|2576209|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
809824|NCT00862849|2576210|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
809825|NCT00862849|2576211|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
809826|NCT00862849|2576212|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
809827|NCT00862849|2576213|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
809828|NCT00862849|2576208|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
809829|NCT00862849|2576209|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
809830|NCT00862849|2576210|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
809831|NCT00862849|2576211|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
809832|NCT00862849|2576212|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
809833|NCT00862849|2576213|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
809834|NCT00862940|2576238|P2|Overall Study|Administrative or other reason(s)|3
809835|NCT00862940|2576239|P1|Overall Study|Administrative or other reason(s)|4
809836|NCT00862940|2576238|P2|Overall Study|Lost to Follow-up|1
809837|NCT00862940|2576239|P1|Overall Study|Lost to Follow-up|0
809838|NCT00862940|2576238|P2|Overall Study|Non-compliance|0
809839|NCT00862940|2576239|P1|Overall Study|Non-compliance|4
809840|NCT00862940|2576238|P2|Overall Study|Withdrawal by Subject|6
809841|NCT00862940|2576239|P1|Overall Study|Withdrawal by Subject|4
809842|NCT00862940|2576238|P2|Overall Study|Protocol Violation|5
809843|NCT00862940|2576239|P1|Overall Study|Protocol Violation|2
809844|NCT00862940|2576238|P2|Overall Study|Lack of Efficacy|3
809845|NCT00862940|2576239|P1|Overall Study|Lack of Efficacy|1
809846|NCT00862940|2576238|P2|Overall Study|Adverse Event|12
809847|NCT00862940|2576239|P1|Overall Study|Adverse Event|15
809864|NCT00864682|2576314|P3|Overall Study|Protocol Violation|2
809865|NCT00864682|2576315|P2|Overall Study|Protocol Violation|1
809866|NCT00864682|2576316|P1|Overall Study|Protocol Violation|2
809867|NCT00864851|2576342|P3|Overall Study|Patient uncooperative|0
809868|NCT00864851|2576343|P2|Overall Study|Patient uncooperative|0
809869|NCT00864851|2576344|P1|Overall Study|Patient uncooperative|1
809870|NCT00864851|2576342|P3|Overall Study|Death|0
809871|NCT00864851|2576343|P2|Overall Study|Death|0
809872|NCT00864851|2576344|P1|Overall Study|Death|1
809873|NCT00864851|2576342|P3|Overall Study|Physician Decision|0
809874|NCT00864851|2576343|P2|Overall Study|Physician Decision|0
809875|NCT00864851|2576344|P1|Overall Study|Physician Decision|1
809876|NCT00864851|2576342|P3|Overall Study|Withdrawal by Subject|0
809877|NCT00864851|2576343|P2|Overall Study|Withdrawal by Subject|1
809878|NCT00864851|2576344|P1|Overall Study|Withdrawal by Subject|0
809879|NCT00864916|2576380|P2|Overall Study|Withdrawal by Subject|0
809880|NCT00864916|2576381|P1|Overall Study|Withdrawal by Subject|1
809881|NCT00864916|2576380|P2|Overall Study|Protocol Violation|0
809882|NCT00864916|2576381|P1|Overall Study|Protocol Violation|1
809883|NCT00864916|2576380|P2|Overall Study|Lost to Follow-up|4
809884|NCT00864916|2576381|P1|Overall Study|Lost to Follow-up|4
809885|NCT00865020|2576389|P2|Overall Study|Randomized but discontinued|4
809886|NCT00865020|2576390|P1|Overall Study|Randomized but discontinued|2
809887|NCT00865020|2576389|P2|Overall Study|Death|1
809888|NCT00865020|2576390|P1|Overall Study|Death|0
809889|NCT00865020|2576389|P2|Overall Study|Abnormal laboratory value(s)|1
809890|NCT00865020|2576390|P1|Overall Study|Abnormal laboratory value(s)|0
809891|NCT00865020|2576389|P2|Overall Study|Administrative problems|2
809892|NCT00865020|2576390|P1|Overall Study|Administrative problems|0
809893|NCT00865020|2576389|P2|Overall Study|Protocol deviation|1
809894|NCT00865020|2576390|P1|Overall Study|Protocol deviation|4
809895|NCT00865020|2576389|P2|Overall Study|Lost to Follow-up|4
809896|NCT00865020|2576390|P1|Overall Study|Lost to Follow-up|6
809897|NCT00865020|2576389|P2|Overall Study|Abnormal test procedure result(s)|8
809898|NCT00865020|2576390|P1|Overall Study|Abnormal test procedure result(s)|6
809899|NCT00865020|2576389|P2|Overall Study|Adverse Event|14
809900|NCT00865020|2576390|P1|Overall Study|Adverse Event|9
809901|NCT00865020|2576389|P2|Overall Study|Withdrawal by Subject|16
809902|NCT00865020|2576390|P1|Overall Study|Withdrawal by Subject|22
809903|NCT00865046|2576407|P3|Overall Study|Withdrawal by Subject|0
809904|NCT00865046|2576408|P2|Overall Study|Withdrawal by Subject|0
809905|NCT00865046|2576409|P1|Overall Study|Withdrawal by Subject|5
809906|NCT00865046|2576407|P3|Overall Study|Death|1
809907|NCT00865046|2576408|P2|Overall Study|Death|1
809908|NCT00865046|2576409|P1|Overall Study|Death|0
809909|NCT00865046|2576407|P3|Overall Study|Lost to Follow-up|0
809910|NCT00865046|2576408|P2|Overall Study|Lost to Follow-up|4
809911|NCT00865046|2576409|P1|Overall Study|Lost to Follow-up|1
809912|NCT00865098|2576417|P1|Overall Study|Progressive disease|1
809913|NCT00865124|2576429|P3|Overall Study|Withdrawn consent|0
809914|NCT00865124|2576430|P2|Overall Study|Withdrawn consent|0
809915|NCT00865124|2576431|P1|Overall Study|Withdrawn consent|2
809916|NCT00865124|2576429|P3|Overall Study|Physician Decision|0
809917|NCT00865124|2576430|P2|Overall Study|Physician Decision|1
809918|NCT00865124|2576431|P1|Overall Study|Physician Decision|2
809919|NCT00865189|2576450|P2|Overall Study|Withdrawal by Subject|0
809920|NCT00865189|2576451|P1|Overall Study|Withdrawal by Subject|1
809921|NCT00865189|2576450|P2|Overall Study|Lost to Follow-up|6
809922|NCT00865189|2576451|P1|Overall Study|Lost to Follow-up|6
809923|NCT00865189|2576450|P2|Overall Study|Death|11
809924|NCT00865189|2576451|P1|Overall Study|Death|4
809925|NCT00865189|2576450|P2|Overall Study|Unspecified|2
809926|NCT00865189|2576451|P1|Overall Study|Unspecified|1
809927|NCT00865306|2576495|P2|Controlled Trial|Withdrawal by Subject|1
809928|NCT00865306|2576496|P1|Controlled Trial|Withdrawal by Subject|0
809929|NCT00865306|2576495|P2|Controlled Trial|Sought treatment for conduct disorder|0
809930|NCT00865306|2576496|P1|Controlled Trial|Sought treatment for conduct disorder|1
809931|NCT00865306|2576495|P2|Controlled Trial|Improved btw baseline and first session|0
809932|NCT00865306|2576496|P1|Controlled Trial|Improved btw baseline and first session|1
809933|NCT00865306|2576495|P2|Controlled Trial|Difficulty commuting|0
809934|NCT00865306|2576496|P1|Controlled Trial|Difficulty commuting|2
809935|NCT00865306|2576495|P2|Controlled Trial|Lost to Follow-up|1
809936|NCT00865306|2576496|P1|Controlled Trial|Lost to Follow-up|1
809937|NCT00865345|2576506|P1|Overall Study|Withdrawal by Subject|2
809938|NCT00865514|2576511|P1|Overall Study|Infusion cost exceeded funding|2
809939|NCT00865709|2576518|P2|Treatment|Surgery|3
809940|NCT00865709|2576519|P1|Treatment|Surgery|8
809941|NCT00865709|2576518|P2|Treatment|Physician Decision|2
809942|NCT00865709|2576519|P1|Treatment|Physician Decision|3
809943|NCT00865709|2576518|P2|Treatment|Withdrawal by Subject|7
809944|NCT00865709|2576519|P1|Treatment|Withdrawal by Subject|10
809945|NCT00865709|2576518|P2|Treatment|Adverse Event|6
809946|NCT00865709|2576519|P1|Treatment|Adverse Event|9
809947|NCT00865904|2576540|P5|Overall Study|Randomized but not Treated|1
809948|NCT00865904|2576541|P4|Overall Study|Randomized but not Treated|1
809949|NCT00865904|2576542|P3|Overall Study|Randomized but not Treated|0
809950|NCT00865904|2576543|P2|Overall Study|Randomized but not Treated|0
809951|NCT00865904|2576544|P1|Overall Study|Randomized but not Treated|2
809952|NCT00866047|2576610|P1|Follow-up Period|Lost to Follow-up|5
809953|NCT00866047|2576610|P1|Treatment Period|Withdrawal by Subject|5
809954|NCT00866047|2576610|P1|Treatment Period|Physician Decision|14
809955|NCT00866047|2576610|P1|Treatment Period|Adverse Event|16
809956|NCT00866047|2576610|P1|Treatment Period|Progressive disease|13
809957|NCT00866177|2576626|P1|Overall Study|Not Treated|151
809958|NCT00866177|2576626|P1|Overall Study|Withdrawal by Subject|1
809959|NCT00866281|2576632|P2|Overall Study|New cancer therapy|4
809960|NCT00866281|2576633|P1|Overall Study|New cancer therapy|0
809961|NCT00866281|2576632|P2|Overall Study|Disease progression|11
809962|NCT00866281|2576633|P1|Overall Study|Disease progression|3
809963|NCT00866281|2576632|P2|Overall Study|Withdrawal by participants|0
809964|NCT00866281|2576633|P1|Overall Study|Withdrawal by participants|3
809965|NCT00866281|2576632|P2|Overall Study|Adverse Event|0
809966|NCT00866281|2576633|P1|Overall Study|Adverse Event|1
809967|NCT00866294|2576652|P3|Overall Study|Physician Decision|1
809968|NCT00866294|2576653|P2|Overall Study|Physician Decision|2
809969|NCT00866294|2576654|P1|Overall Study|Physician Decision|6
809970|NCT00866294|2576652|P3|Overall Study|Lost to Follow-up|0
809971|NCT00866294|2576653|P2|Overall Study|Lost to Follow-up|3
809972|NCT00866294|2576654|P1|Overall Study|Lost to Follow-up|1
809973|NCT00866294|2576652|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
809974|NCT00866294|2576653|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
809975|NCT00866294|2576654|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
809976|NCT00866294|2576652|P3|Overall Study|Protocol Violation|0
809977|NCT00866294|2576653|P2|Overall Study|Protocol Violation|0
809978|NCT00866294|2576654|P1|Overall Study|Protocol Violation|2
809979|NCT00866294|2576652|P3|Overall Study|Lack of Efficacy|0
809980|NCT00866294|2576653|P2|Overall Study|Lack of Efficacy|1
809981|NCT00866294|2576654|P1|Overall Study|Lack of Efficacy|7
809982|NCT00866294|2576652|P3|Overall Study|Adverse Event|9
809983|NCT00866294|2576653|P2|Overall Study|Adverse Event|13
809984|NCT00866294|2576654|P1|Overall Study|Adverse Event|12
809985|NCT00866307|2576681|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
809986|NCT00866307|2576682|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
809987|NCT00866307|2576683|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
809988|NCT00866307|2576681|P3|Consolidation/Maintenance|Non-compliance|1
809989|NCT00866307|2576682|P2|Consolidation/Maintenance|Non-compliance|0
809990|NCT00866307|2576683|P1|Consolidation/Maintenance|Non-compliance|0
809991|NCT00866307|2576681|P3|Consolidation/Maintenance|Therapy error|0
809992|NCT00866307|2576682|P2|Consolidation/Maintenance|Therapy error|1
809993|NCT00866307|2576683|P1|Consolidation/Maintenance|Therapy error|0
809994|NCT00866307|2576681|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
809995|NCT00866307|2576682|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
809996|NCT00866307|2576683|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
809997|NCT00866307|2576681|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
809998|NCT00866307|2576682|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
809999|NCT00866307|2576683|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
810000|NCT00866307|2576681|P3|Consolidation/Maintenance|Withdrawal by Subject|1
810001|NCT00866307|2576682|P2|Consolidation/Maintenance|Withdrawal by Subject|1
810002|NCT00866307|2576683|P1|Consolidation/Maintenance|Withdrawal by Subject|0
810003|NCT00866307|2576681|P3|Consolidation/Maintenance|Physician Decision|2
810004|NCT00866307|2576682|P2|Consolidation/Maintenance|Physician Decision|3
810005|NCT00866307|2576683|P1|Consolidation/Maintenance|Physician Decision|0
810006|NCT00866307|2576681|P3|Consolidation/Maintenance|Death|1
810007|NCT00866307|2576682|P2|Consolidation/Maintenance|Death|0
810008|NCT00866307|2576683|P1|Consolidation/Maintenance|Death|0
810009|NCT00866307|2576681|P3|Consolidation/Maintenance|Adverse Event|8
810010|NCT00866307|2576682|P2|Consolidation/Maintenance|Adverse Event|0
810011|NCT00866307|2576683|P1|Consolidation/Maintenance|Adverse Event|0
810012|NCT00866307|2576681|P3|Induction|Study was closed at the time|0
810013|NCT00866307|2576682|P2|Induction|Study was closed at the time|0
810014|NCT00866307|2576683|P1|Induction|Study was closed at the time|1
810015|NCT00866307|2576681|P3|Induction|Improper post-induction consent|0
810016|NCT00866307|2576682|P2|Induction|Improper post-induction consent|0
810017|NCT00866307|2576683|P1|Induction|Improper post-induction consent|2
810018|NCT00866307|2576681|P3|Induction|Inadequate cytognetic samples th|0
810019|NCT00866307|2576682|P2|Induction|Inadequate cytognetic samples th|0
810020|NCT00866307|2576683|P1|Induction|Inadequate cytognetic samples th|1
810021|NCT00866307|2576681|P3|Induction|Identification of Patients with Day 29 M|0
810022|NCT00866307|2576682|P2|Induction|Identification of Patients with Day 29 M|0
810023|NCT00866307|2576683|P1|Induction|Identification of Patients with Day 29 M|3
810024|NCT00866307|2576681|P3|Induction|Progressive Disease|0
810025|NCT00866307|2576682|P2|Induction|Progressive Disease|0
810026|NCT00866307|2576683|P1|Induction|Progressive Disease|1
810027|NCT00866307|2576681|P3|Induction|Physician Decision|0
810028|NCT00866307|2576682|P2|Induction|Physician Decision|0
810029|NCT00866307|2576683|P1|Induction|Physician Decision|5
810030|NCT00866307|2576681|P3|Induction|Death|0
810031|NCT00866307|2576682|P2|Induction|Death|0
810032|NCT00866307|2576683|P1|Induction|Death|2
810033|NCT00866307|2576681|P3|Induction|Adverse Event|0
810034|NCT00866307|2576682|P2|Induction|Adverse Event|0
810035|NCT00866307|2576683|P1|Induction|Adverse Event|5
810036|NCT00866320|2576690|P1|Overall Study|Death|2
810037|NCT00866320|2576690|P1|Overall Study|Withdrawal by Subject|4
810062|NCT00866606|2576755|P1|Overall Study|Adverse Event|1
810063|NCT00866606|2576755|P1|Overall Study|Lost to Follow-up|3
810064|NCT00866658|2576769|P2|Overall Study|Familial and Personal Reasons|5
810065|NCT00866658|2576770|P1|Overall Study|Familial and Personal Reasons|4
810066|NCT00866658|2576769|P2|Overall Study|Protocol Violation|1
810067|NCT00866658|2576770|P1|Overall Study|Protocol Violation|1
810068|NCT00866658|2576769|P2|Overall Study|Withdrawal by Subject|0
810069|NCT00866658|2576770|P1|Overall Study|Withdrawal by Subject|1
810070|NCT00866658|2576769|P2|Overall Study|Lack of Efficacy|1
810071|NCT00866658|2576770|P1|Overall Study|Lack of Efficacy|2
810072|NCT00866658|2576769|P2|Overall Study|Adverse Event|14
810073|NCT00866658|2576770|P1|Overall Study|Adverse Event|5
810074|NCT00866697|2576800|P2|Overall Study|Ongoing|312
810075|NCT00866697|2576801|P1|Overall Study|Ongoing|335
810076|NCT00866697|2576800|P2|Overall Study|Withdrawal by Subject|53
810077|NCT00866697|2576801|P1|Overall Study|Withdrawal by Subject|28
810078|NCT00866697|2576800|P2|Overall Study|Physician Decision|4
810079|NCT00866697|2576801|P1|Overall Study|Physician Decision|3
810080|NCT00866697|2576800|P2|Overall Study|Lost to Follow-up|8
810081|NCT00866697|2576801|P1|Overall Study|Lost to Follow-up|7
810082|NCT00866723|2576843|P1|Overall Study|Disease Progression|4
810083|NCT00866723|2576843|P1|Overall Study|Withdrawal by Subject|1
810084|NCT00866775|2576850|P2|Overall Study|discontinued due to communication error|1
810085|NCT00866775|2576851|P1|Overall Study|discontinued due to communication error|0
810086|NCT00866775|2576850|P2|Overall Study|met exit criteria|17
810087|NCT00866775|2576851|P1|Overall Study|met exit criteria|23
810088|NCT00866775|2576850|P2|Overall Study|Withdrawal by Subject|4
810089|NCT00866775|2576851|P1|Overall Study|Withdrawal by Subject|4
810090|NCT00866775|2576850|P2|Overall Study|Protocol Violation|4
810091|NCT00866775|2576851|P1|Overall Study|Protocol Violation|3
810092|NCT00866775|2576850|P2|Overall Study|Physician Decision|3
810093|NCT00866775|2576851|P1|Overall Study|Physician Decision|0
810094|NCT00866775|2576850|P2|Overall Study|Lost to Follow-up|4
810095|NCT00866775|2576851|P1|Overall Study|Lost to Follow-up|0
810096|NCT00866775|2576850|P2|Overall Study|Death|0
810097|NCT00866775|2576851|P1|Overall Study|Death|1
810098|NCT00866775|2576850|P2|Overall Study|Adverse Event|19
810099|NCT00866775|2576851|P1|Overall Study|Adverse Event|5
810100|NCT00866788|2576891|P4|Overall Study|Physician Decision|1
810101|NCT00866788|2576892|P3|Overall Study|Physician Decision|1
810102|NCT00866788|2576893|P2|Overall Study|Physician Decision|0
810103|NCT00866788|2576894|P1|Overall Study|Physician Decision|0
810104|NCT00866788|2576891|P4|Overall Study|Disease progression|0
810105|NCT00866788|2576892|P3|Overall Study|Disease progression|1
810106|NCT00866788|2576893|P2|Overall Study|Disease progression|1
810107|NCT00866788|2576894|P1|Overall Study|Disease progression|3
810108|NCT00866788|2576891|P4|Overall Study|Pregnancy|0
810109|NCT00866788|2576892|P3|Overall Study|Pregnancy|0
810110|NCT00866788|2576893|P2|Overall Study|Pregnancy|1
810111|NCT00866788|2576894|P1|Overall Study|Pregnancy|0
810112|NCT00866788|2576891|P4|Overall Study|Withdrawal by Subject|1
810113|NCT00866788|2576892|P3|Overall Study|Withdrawal by Subject|0
810114|NCT00866788|2576893|P2|Overall Study|Withdrawal by Subject|1
810115|NCT00866788|2576894|P1|Overall Study|Withdrawal by Subject|2
810116|NCT00866788|2576891|P4|Overall Study|Lost to Follow-up|2
810117|NCT00866788|2576892|P3|Overall Study|Lost to Follow-up|0
810118|NCT00866788|2576893|P2|Overall Study|Lost to Follow-up|1
810119|NCT00866788|2576894|P1|Overall Study|Lost to Follow-up|1
810120|NCT00866788|2576891|P4|Overall Study|Adverse Event|1
810121|NCT00866788|2576892|P3|Overall Study|Adverse Event|0
810122|NCT00866788|2576893|P2|Overall Study|Adverse Event|2
810123|NCT00866788|2576894|P1|Overall Study|Adverse Event|0
810124|NCT00866814|2576940|P1|Overall Study|Moved to area without study site|1
810125|NCT00866814|2576940|P1|Overall Study|Unable to meet follow-up requirements|2
810126|NCT00866814|2576940|P1|Overall Study|No longer wished to participate|1
810127|NCT00866814|2576940|P1|Overall Study|Death|1
810128|NCT00866814|2576940|P1|Overall Study|Physician Decision|1
810129|NCT00866814|2576940|P1|Overall Study|Adverse Event|2
810130|NCT00866814|2576940|P1|Overall Study|Lost to Follow-up|12
810131|NCT00866918|2576956|P2|Overall Study|Secondary malignancy|0
810132|NCT00866918|2576957|P1|Overall Study|Secondary malignancy|1
810133|NCT00866918|2576956|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
810134|NCT00866918|2576957|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
810135|NCT00866918|2576956|P2|Overall Study|Ineligible|4
810136|NCT00866918|2576957|P1|Overall Study|Ineligible|2
810137|NCT00866918|2576956|P2|Overall Study|Physician Decision|2
810138|NCT00866918|2576957|P1|Overall Study|Physician Decision|10
810139|NCT00866918|2576956|P2|Overall Study|Lack of Efficacy|1
810140|NCT00866918|2576957|P1|Overall Study|Lack of Efficacy|1
810141|NCT00866918|2576956|P2|Overall Study|Death|5
810142|NCT00866918|2576957|P1|Overall Study|Death|1
810143|NCT00867009|2576969|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
810144|NCT00867009|2576969|P1|Induction Period|Progressive Disease (PD)|25
810145|NCT00867009|2576969|P1|Induction Period|Physician Decision|3
810146|NCT00867009|2576969|P1|Induction Period|Withdrawal by Subject|8
810147|NCT00867009|2576969|P1|Induction Period|Protocol Violation|1
810148|NCT00867009|2576969|P1|Induction Period|Death due to Study Disease|4
810149|NCT00867009|2576969|P1|Induction Period|Death due to serious adverse event|6
810150|NCT00867009|2576969|P1|Induction Period|Serious Adverse Event|10
810151|NCT00867009|2576969|P1|Induction Period|Nonserious Adverse Event|5
810152|NCT00867035|2576978|P2|Baseline to 1 Week|Withdrawal by Subject|0
810153|NCT00867035|2576979|P1|Baseline to 1 Week|Withdrawal by Subject|1
810154|NCT00867035|2576978|P2|Baseline to 1 Hour|Withdrawal by Subject|1
810155|NCT00867035|2576979|P1|Baseline to 1 Hour|Withdrawal by Subject|1
810159|NCT00860158|2577019|P1|Overall Study|Study Terminated|1
810160|NCT00860249|2577030|P3|Overall Study|trial was terminated prior to completion|21
810161|NCT00860249|2577031|P2|Overall Study|trial was terminated prior to completion|18
810162|NCT00860249|2577032|P1|Overall Study|trial was terminated prior to completion|21
810163|NCT00860262|2577046|P3|Overall Study|Not Specified|1
810164|NCT00860262|2577047|P2|Overall Study|Not Specified|3
810165|NCT00860262|2577048|P1|Overall Study|Not Specified|5
810166|NCT00860262|2577046|P3|Overall Study|Lack of Efficacy|3
810167|NCT00860262|2577047|P2|Overall Study|Lack of Efficacy|4
810168|NCT00860262|2577048|P1|Overall Study|Lack of Efficacy|0
810169|NCT00860262|2577046|P3|Overall Study|Withdrawal by Subject|6
810170|NCT00860262|2577047|P2|Overall Study|Withdrawal by Subject|8
810171|NCT00860262|2577048|P1|Overall Study|Withdrawal by Subject|4
810172|NCT00860262|2577046|P3|Overall Study|Lost to Follow-up|1
810173|NCT00860262|2577047|P2|Overall Study|Lost to Follow-up|0
810174|NCT00860262|2577048|P1|Overall Study|Lost to Follow-up|2
810175|NCT00860262|2577046|P3|Overall Study|Protocol Violation|0
810176|NCT00860262|2577047|P2|Overall Study|Protocol Violation|1
810177|NCT00860262|2577048|P1|Overall Study|Protocol Violation|0
810178|NCT00860262|2577046|P3|Overall Study|Adverse Event|7
810179|NCT00860262|2577047|P2|Overall Study|Adverse Event|6
810180|NCT00860262|2577048|P1|Overall Study|Adverse Event|9
810181|NCT00860405|2577175|P2|Overall Study|Main reason: Follow-up data not complete|4
810182|NCT00860405|2577176|P1|Overall Study|Main reason: Follow-up data not complete|5
810183|NCT00867165|2577246|P2|Overall Study|Withdrawal by Subject|0
810184|NCT00867165|2577247|P1|Overall Study|Withdrawal by Subject|1
810185|NCT00867165|2577246|P2|Overall Study|Adverse Event|0
810186|NCT00867165|2577247|P1|Overall Study|Adverse Event|3
810187|NCT00867360|2577377|P2|Overall Study|Physician Decision|1
810188|NCT00867360|2577378|P1|Overall Study|Physician Decision|0
810189|NCT00867360|2577377|P2|Overall Study|Withdrawal by Subject|0
810190|NCT00867360|2577378|P1|Overall Study|Withdrawal by Subject|1
810191|NCT00867568|2577393|P1|Overall Study|Withdrawal by Subject|1
810192|NCT00867568|2577393|P1|Overall Study|Adverse Event|4
810193|NCT00867568|2577393|P1|Overall Study|Lack of Efficacy|10
810194|NCT00868192|2577441|P1|Overall Study|Ineligible|4
810195|NCT00868231|2577481|P6|Treatment Period 3|Adverse Event|0
810196|NCT00868231|2577482|P5|Treatment Period 3|Adverse Event|0
810197|NCT00868231|2577483|P4|Treatment Period 3|Adverse Event|0
810198|NCT00868231|2577484|P3|Treatment Period 3|Adverse Event|1
810199|NCT00868231|2577485|P2|Treatment Period 3|Adverse Event|0
810200|NCT00868231|2577486|P1|Treatment Period 3|Adverse Event|0
810201|NCT00868231|2577481|P6|Treatment Period 2|Adverse Event|0
810202|NCT00868231|2577482|P5|Treatment Period 2|Adverse Event|0
810203|NCT00868231|2577483|P4|Treatment Period 2|Adverse Event|0
810204|NCT00868231|2577484|P3|Treatment Period 2|Adverse Event|0
810205|NCT00868231|2577485|P2|Treatment Period 2|Adverse Event|0
810206|NCT00868231|2577486|P1|Treatment Period 2|Adverse Event|1
810207|NCT00868231|2577481|P6|Treatment Period 1|Adverse Event|0
810208|NCT00868231|2577482|P5|Treatment Period 1|Adverse Event|1
810209|NCT00868231|2577483|P4|Treatment Period 1|Adverse Event|0
810210|NCT00868231|2577484|P3|Treatment Period 1|Adverse Event|0
810211|NCT00868231|2577485|P2|Treatment Period 1|Adverse Event|0
810212|NCT00868231|2577486|P1|Treatment Period 1|Adverse Event|0
810213|NCT00868296|2577529|P2|Overall Study|Withdrawal by Subject|1
810214|NCT00868296|2577530|P1|Overall Study|Withdrawal by Subject|0
810215|NCT00868296|2577529|P2|Overall Study|Adverse Event|2
810216|NCT00868296|2577530|P1|Overall Study|Adverse Event|0
810217|NCT00868439|2577579|P2|Overall Study|Withdrawal by Subject|1
810218|NCT00868439|2577580|P1|Overall Study|Withdrawal by Subject|0
810219|NCT00868439|2577579|P2|Overall Study|Physician Decision|0
810220|NCT00868439|2577580|P1|Overall Study|Physician Decision|1
810221|NCT00868439|2577579|P2|Overall Study|Protocol Violation|1
810222|NCT00868439|2577580|P1|Overall Study|Protocol Violation|1
810223|NCT00868439|2577579|P2|Overall Study|Death|1
810224|NCT00868439|2577580|P1|Overall Study|Death|0
810225|NCT00868439|2577579|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
810226|NCT00868439|2577580|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
810227|NCT00868439|2577579|P2|Overall Study|Adverse Event|3
810228|NCT00868439|2577580|P1|Overall Study|Adverse Event|4
810229|NCT00868517|2577612|P3|Overall Study|Protocol Violation|0
810230|NCT00868517|2577613|P2|Overall Study|Protocol Violation|1
810231|NCT00868517|2577614|P1|Overall Study|Protocol Violation|1
810232|NCT00868517|2577612|P3|Overall Study|Withdrawal by Subject|2
810233|NCT00868517|2577613|P2|Overall Study|Withdrawal by Subject|3
810234|NCT00868517|2577614|P1|Overall Study|Withdrawal by Subject|3
810235|NCT00868530|2577637|P1|Overall Study|Lost to Follow-up|1
810236|NCT00868530|2577637|P1|Overall Study|Adverse Event|3
810237|NCT00868790|2577692|P14|Post-study|Excluded Medication|0
810238|NCT00868790|2577693|P13|Post-study|Excluded Medication|0
810239|NCT00868790|2577694|P12|Post-study|Excluded Medication|0
810240|NCT00868790|2577695|P11|Post-study|Excluded Medication|0
810241|NCT00868790|2577696|P10|Post-study|Excluded Medication|1
810242|NCT00868790|2577697|P9|Post-study|Excluded Medication|0
810243|NCT00868790|2577698|P8|Post-study|Excluded Medication|2
810244|NCT00868790|2577699|P7|Post-study|Excluded Medication|0
810245|NCT00868790|2577700|P6|Post-study|Excluded Medication|0
810246|NCT00868790|2577701|P5|Post-study|Excluded Medication|0
810247|NCT00868790|2577702|P4|Post-study|Excluded Medication|0
810248|NCT00868790|2577703|P3|Post-study|Excluded Medication|0
810249|NCT00868790|2577704|P2|Post-study|Excluded Medication|0
810250|NCT00868790|2577705|P1|Post-study|Excluded Medication|0
810251|NCT00868790|2577692|P14|Post-study|Withdrawal by Subject|0
810252|NCT00868790|2577693|P13|Post-study|Withdrawal by Subject|0
810253|NCT00868790|2577694|P12|Post-study|Withdrawal by Subject|0
810254|NCT00868790|2577695|P11|Post-study|Withdrawal by Subject|0
810255|NCT00868790|2577696|P10|Post-study|Withdrawal by Subject|0
810256|NCT00868790|2577697|P9|Post-study|Withdrawal by Subject|0
810257|NCT00868790|2577698|P8|Post-study|Withdrawal by Subject|0
810258|NCT00868790|2577699|P7|Post-study|Withdrawal by Subject|0
810259|NCT00868790|2577700|P6|Post-study|Withdrawal by Subject|0
810260|NCT00868790|2577701|P5|Post-study|Withdrawal by Subject|1
810261|NCT00868790|2577702|P4|Post-study|Withdrawal by Subject|0
810262|NCT00868790|2577703|P3|Post-study|Withdrawal by Subject|0
810263|NCT00868790|2577704|P2|Post-study|Withdrawal by Subject|0
810264|NCT00868790|2577705|P1|Post-study|Withdrawal by Subject|0
810265|NCT00868790|2577692|P14|Period 4|Abnormal ALT/AST|0
810266|NCT00868790|2577693|P13|Period 4|Abnormal ALT/AST|0
810267|NCT00868790|2577694|P12|Period 4|Abnormal ALT/AST|0
810268|NCT00868790|2577695|P11|Period 4|Abnormal ALT/AST|0
810269|NCT00868790|2577696|P10|Period 4|Abnormal ALT/AST|0
810270|NCT00868790|2577697|P9|Period 4|Abnormal ALT/AST|0
810271|NCT00868790|2577698|P8|Period 4|Abnormal ALT/AST|0
810272|NCT00868790|2577699|P7|Period 4|Abnormal ALT/AST|0
810273|NCT00868790|2577700|P6|Period 4|Abnormal ALT/AST|0
810274|NCT00868790|2577701|P5|Period 4|Abnormal ALT/AST|0
810275|NCT00868790|2577702|P4|Period 4|Abnormal ALT/AST|0
810276|NCT00868790|2577703|P3|Period 4|Abnormal ALT/AST|1
810277|NCT00868790|2577704|P2|Period 4|Abnormal ALT/AST|0
810278|NCT00868790|2577705|P1|Period 4|Abnormal ALT/AST|0
810279|NCT00868790|2577692|P14|Period 4|Study Terminated by Sponsor|1
810280|NCT00868790|2577693|P13|Period 4|Study Terminated by Sponsor|0
810281|NCT00868790|2577694|P12|Period 4|Study Terminated by Sponsor|1
810282|NCT00868790|2577695|P11|Period 4|Study Terminated by Sponsor|2
810283|NCT00868790|2577696|P10|Period 4|Study Terminated by Sponsor|0
810284|NCT00868790|2577697|P9|Period 4|Study Terminated by Sponsor|2
810285|NCT00868790|2577698|P8|Period 4|Study Terminated by Sponsor|1
810286|NCT00868790|2577699|P7|Period 4|Study Terminated by Sponsor|0
810287|NCT00868790|2577700|P6|Period 4|Study Terminated by Sponsor|0
810288|NCT00868790|2577701|P5|Period 4|Study Terminated by Sponsor|0
810289|NCT00868790|2577702|P4|Period 4|Study Terminated by Sponsor|0
810290|NCT00868790|2577703|P3|Period 4|Study Terminated by Sponsor|0
810291|NCT00868790|2577704|P2|Period 4|Study Terminated by Sponsor|0
810292|NCT00868790|2577705|P1|Period 4|Study Terminated by Sponsor|2
810293|NCT00868790|2577692|P14|Period 4|Lost to Follow-up|0
810294|NCT00868790|2577693|P13|Period 4|Lost to Follow-up|0
810295|NCT00868790|2577694|P12|Period 4|Lost to Follow-up|0
810296|NCT00868790|2577695|P11|Period 4|Lost to Follow-up|0
810297|NCT00868790|2577696|P10|Period 4|Lost to Follow-up|0
810298|NCT00868790|2577697|P9|Period 4|Lost to Follow-up|0
810299|NCT00868790|2577698|P8|Period 4|Lost to Follow-up|1
810300|NCT00868790|2577699|P7|Period 4|Lost to Follow-up|0
810301|NCT00868790|2577700|P6|Period 4|Lost to Follow-up|0
810302|NCT00868790|2577701|P5|Period 4|Lost to Follow-up|0
810303|NCT00868790|2577702|P4|Period 4|Lost to Follow-up|0
810304|NCT00868790|2577703|P3|Period 4|Lost to Follow-up|0
810305|NCT00868790|2577704|P2|Period 4|Lost to Follow-up|0
810306|NCT00868790|2577705|P1|Period 4|Lost to Follow-up|0
810307|NCT00868790|2577692|P14|Period 4|Adverse Event|0
810308|NCT00868790|2577693|P13|Period 4|Adverse Event|1
810309|NCT00868790|2577694|P12|Period 4|Adverse Event|0
810310|NCT00868790|2577695|P11|Period 4|Adverse Event|1
810311|NCT00868790|2577696|P10|Period 4|Adverse Event|0
810312|NCT00868790|2577697|P9|Period 4|Adverse Event|0
810313|NCT00868790|2577698|P8|Period 4|Adverse Event|1
810314|NCT00868790|2577699|P7|Period 4|Adverse Event|0
810315|NCT00868790|2577700|P6|Period 4|Adverse Event|0
810316|NCT00868790|2577701|P5|Period 4|Adverse Event|0
810317|NCT00868790|2577702|P4|Period 4|Adverse Event|0
810318|NCT00868790|2577703|P3|Period 4|Adverse Event|0
810319|NCT00868790|2577704|P2|Period 4|Adverse Event|0
810320|NCT00868790|2577705|P1|Period 4|Adverse Event|0
810321|NCT00868790|2577692|P14|Period 3|Study Terminated by Sponsor|0
810322|NCT00868790|2577693|P13|Period 3|Study Terminated by Sponsor|0
810323|NCT00868790|2577694|P12|Period 3|Study Terminated by Sponsor|0
810324|NCT00868790|2577695|P11|Period 3|Study Terminated by Sponsor|0
810325|NCT00868790|2577696|P10|Period 3|Study Terminated by Sponsor|0
810326|NCT00868790|2577697|P9|Period 3|Study Terminated by Sponsor|0
810327|NCT00868790|2577698|P8|Period 3|Study Terminated by Sponsor|0
810328|NCT00868790|2577699|P7|Period 3|Study Terminated by Sponsor|0
810329|NCT00868790|2577700|P6|Period 3|Study Terminated by Sponsor|0
810330|NCT00868790|2577701|P5|Period 3|Study Terminated by Sponsor|0
810331|NCT00868790|2577702|P4|Period 3|Study Terminated by Sponsor|1
810332|NCT00868790|2577703|P3|Period 3|Study Terminated by Sponsor|0
810333|NCT00868790|2577704|P2|Period 3|Study Terminated by Sponsor|0
810334|NCT00868790|2577705|P1|Period 3|Study Terminated by Sponsor|0
810335|NCT00868790|2577692|P14|Period 3|Protocol Violation|0
810336|NCT00868790|2577693|P13|Period 3|Protocol Violation|0
810337|NCT00868790|2577694|P12|Period 3|Protocol Violation|0
810338|NCT00868790|2577695|P11|Period 3|Protocol Violation|1
810339|NCT00868790|2577696|P10|Period 3|Protocol Violation|0
810340|NCT00868790|2577697|P9|Period 3|Protocol Violation|0
810341|NCT00868790|2577698|P8|Period 3|Protocol Violation|0
810342|NCT00868790|2577699|P7|Period 3|Protocol Violation|0
810343|NCT00868790|2577700|P6|Period 3|Protocol Violation|0
810344|NCT00868790|2577701|P5|Period 3|Protocol Violation|0
810345|NCT00868790|2577702|P4|Period 3|Protocol Violation|0
810346|NCT00868790|2577703|P3|Period 3|Protocol Violation|0
810347|NCT00868790|2577704|P2|Period 3|Protocol Violation|0
810348|NCT00868790|2577705|P1|Period 3|Protocol Violation|0
810349|NCT00868790|2577692|P14|Period 3|Adverse Event|0
810350|NCT00868790|2577693|P13|Period 3|Adverse Event|0
810351|NCT00868790|2577694|P12|Period 3|Adverse Event|0
810352|NCT00868790|2577695|P11|Period 3|Adverse Event|0
810353|NCT00868790|2577696|P10|Period 3|Adverse Event|1
810354|NCT00868790|2577697|P9|Period 3|Adverse Event|0
810355|NCT00868790|2577698|P8|Period 3|Adverse Event|0
810356|NCT00868790|2577699|P7|Period 3|Adverse Event|0
810357|NCT00868790|2577700|P6|Period 3|Adverse Event|0
810358|NCT00868790|2577701|P5|Period 3|Adverse Event|0
810359|NCT00868790|2577702|P4|Period 3|Adverse Event|0
810360|NCT00868790|2577703|P3|Period 3|Adverse Event|0
810361|NCT00868790|2577704|P2|Period 3|Adverse Event|0
810362|NCT00868790|2577705|P1|Period 3|Adverse Event|0
810363|NCT00868790|2577692|P14|Period 2|Withdrawal by Subject|1
810364|NCT00868790|2577693|P13|Period 2|Withdrawal by Subject|0
810365|NCT00868790|2577694|P12|Period 2|Withdrawal by Subject|0
810366|NCT00868790|2577695|P11|Period 2|Withdrawal by Subject|0
810367|NCT00868790|2577696|P10|Period 2|Withdrawal by Subject|0
810368|NCT00868790|2577697|P9|Period 2|Withdrawal by Subject|1
810369|NCT00868790|2577698|P8|Period 2|Withdrawal by Subject|0
810370|NCT00868790|2577699|P7|Period 2|Withdrawal by Subject|0
810371|NCT00868790|2577700|P6|Period 2|Withdrawal by Subject|0
810372|NCT00868790|2577701|P5|Period 2|Withdrawal by Subject|0
810373|NCT00868790|2577702|P4|Period 2|Withdrawal by Subject|0
810374|NCT00868790|2577703|P3|Period 2|Withdrawal by Subject|0
810375|NCT00868790|2577704|P2|Period 2|Withdrawal by Subject|0
810376|NCT00868790|2577705|P1|Period 2|Withdrawal by Subject|0
810377|NCT00868790|2577692|P14|Period 2|Lost to Follow-up|0
810378|NCT00868790|2577693|P13|Period 2|Lost to Follow-up|0
810379|NCT00868790|2577694|P12|Period 2|Lost to Follow-up|0
810380|NCT00868790|2577695|P11|Period 2|Lost to Follow-up|0
810381|NCT00868790|2577696|P10|Period 2|Lost to Follow-up|0
810382|NCT00868790|2577697|P9|Period 2|Lost to Follow-up|0
810383|NCT00868790|2577698|P8|Period 2|Lost to Follow-up|0
810384|NCT00868790|2577699|P7|Period 2|Lost to Follow-up|0
810385|NCT00868790|2577700|P6|Period 2|Lost to Follow-up|1
810386|NCT00868790|2577701|P5|Period 2|Lost to Follow-up|0
810387|NCT00868790|2577702|P4|Period 2|Lost to Follow-up|0
810388|NCT00868790|2577703|P3|Period 2|Lost to Follow-up|0
810389|NCT00868790|2577704|P2|Period 2|Lost to Follow-up|1
810390|NCT00868790|2577705|P1|Period 2|Lost to Follow-up|0
810391|NCT00868790|2577692|P14|Period 2|Adverse Event|0
810392|NCT00868790|2577693|P13|Period 2|Adverse Event|0
810393|NCT00868790|2577694|P12|Period 2|Adverse Event|0
810394|NCT00868790|2577695|P11|Period 2|Adverse Event|0
810395|NCT00868790|2577696|P10|Period 2|Adverse Event|0
810396|NCT00868790|2577697|P9|Period 2|Adverse Event|1
810397|NCT00868790|2577698|P8|Period 2|Adverse Event|0
810398|NCT00868790|2577699|P7|Period 2|Adverse Event|0
810399|NCT00868790|2577700|P6|Period 2|Adverse Event|0
810400|NCT00868790|2577701|P5|Period 2|Adverse Event|0
810401|NCT00868790|2577702|P4|Period 2|Adverse Event|0
810402|NCT00868790|2577703|P3|Period 2|Adverse Event|0
810403|NCT00868790|2577704|P2|Period 2|Adverse Event|0
810404|NCT00868790|2577705|P1|Period 2|Adverse Event|0
810405|NCT00868790|2577692|P14|Period 1|Lost to Follow-up|0
810406|NCT00868790|2577693|P13|Period 1|Lost to Follow-up|0
810407|NCT00868790|2577694|P12|Period 1|Lost to Follow-up|0
810408|NCT00868790|2577695|P11|Period 1|Lost to Follow-up|0
810409|NCT00868790|2577696|P10|Period 1|Lost to Follow-up|0
810410|NCT00868790|2577697|P9|Period 1|Lost to Follow-up|0
810411|NCT00868790|2577698|P8|Period 1|Lost to Follow-up|0
810412|NCT00868790|2577699|P7|Period 1|Lost to Follow-up|0
810413|NCT00868790|2577700|P6|Period 1|Lost to Follow-up|1
810414|NCT00868790|2577701|P5|Period 1|Lost to Follow-up|0
810415|NCT00868790|2577702|P4|Period 1|Lost to Follow-up|0
810416|NCT00868790|2577703|P3|Period 1|Lost to Follow-up|0
810417|NCT00868790|2577704|P2|Period 1|Lost to Follow-up|0
810418|NCT00868790|2577705|P1|Period 1|Lost to Follow-up|0
810419|NCT00868790|2577692|P14|Period 1|Abnormal Triglycerides|0
810420|NCT00868790|2577693|P13|Period 1|Abnormal Triglycerides|0
810421|NCT00868790|2577694|P12|Period 1|Abnormal Triglycerides|0
810422|NCT00868790|2577695|P11|Period 1|Abnormal Triglycerides|0
810423|NCT00868790|2577696|P10|Period 1|Abnormal Triglycerides|0
810424|NCT00868790|2577697|P9|Period 1|Abnormal Triglycerides|0
810425|NCT00868790|2577698|P8|Period 1|Abnormal Triglycerides|0
810426|NCT00868790|2577699|P7|Period 1|Abnormal Triglycerides|0
810427|NCT00868790|2577700|P6|Period 1|Abnormal Triglycerides|0
810428|NCT00868790|2577701|P5|Period 1|Abnormal Triglycerides|1
810429|NCT00868790|2577702|P4|Period 1|Abnormal Triglycerides|0
810430|NCT00868790|2577703|P3|Period 1|Abnormal Triglycerides|0
810431|NCT00868790|2577704|P2|Period 1|Abnormal Triglycerides|0
810432|NCT00868790|2577705|P1|Period 1|Abnormal Triglycerides|0
810433|NCT00868790|2577692|P14|Period 1|Withdrawal by Subject|1
810434|NCT00868790|2577693|P13|Period 1|Withdrawal by Subject|0
810435|NCT00868790|2577694|P12|Period 1|Withdrawal by Subject|0
810436|NCT00868790|2577695|P11|Period 1|Withdrawal by Subject|0
810437|NCT00868790|2577696|P10|Period 1|Withdrawal by Subject|0
810438|NCT00868790|2577697|P9|Period 1|Withdrawal by Subject|0
810439|NCT00868790|2577698|P8|Period 1|Withdrawal by Subject|0
810440|NCT00868790|2577699|P7|Period 1|Withdrawal by Subject|0
810441|NCT00868790|2577700|P6|Period 1|Withdrawal by Subject|0
810442|NCT00868790|2577701|P5|Period 1|Withdrawal by Subject|0
810443|NCT00868790|2577702|P4|Period 1|Withdrawal by Subject|0
810444|NCT00868790|2577703|P3|Period 1|Withdrawal by Subject|0
810445|NCT00868790|2577704|P2|Period 1|Withdrawal by Subject|1
810446|NCT00868790|2577705|P1|Period 1|Withdrawal by Subject|0
810447|NCT00868790|2577692|P14|Period 1|Protocol Violation|0
810448|NCT00868790|2577693|P13|Period 1|Protocol Violation|0
810449|NCT00868790|2577694|P12|Period 1|Protocol Violation|0
810450|NCT00868790|2577695|P11|Period 1|Protocol Violation|0
810451|NCT00868790|2577696|P10|Period 1|Protocol Violation|0
810452|NCT00868790|2577697|P9|Period 1|Protocol Violation|0
810453|NCT00868790|2577698|P8|Period 1|Protocol Violation|0
810454|NCT00868790|2577699|P7|Period 1|Protocol Violation|0
810455|NCT00868790|2577700|P6|Period 1|Protocol Violation|0
810456|NCT00868790|2577701|P5|Period 1|Protocol Violation|0
810457|NCT00868790|2577702|P4|Period 1|Protocol Violation|0
810458|NCT00868790|2577703|P3|Period 1|Protocol Violation|0
810459|NCT00868790|2577704|P2|Period 1|Protocol Violation|0
810460|NCT00868790|2577705|P1|Period 1|Protocol Violation|1
810461|NCT00868790|2577692|P14|Period 1|Adverse Event|1
810462|NCT00868790|2577693|P13|Period 1|Adverse Event|0
810463|NCT00868790|2577694|P12|Period 1|Adverse Event|0
810464|NCT00868790|2577695|P11|Period 1|Adverse Event|0
810465|NCT00868790|2577696|P10|Period 1|Adverse Event|0
810466|NCT00868790|2577697|P9|Period 1|Adverse Event|1
810467|NCT00868790|2577698|P8|Period 1|Adverse Event|3
810468|NCT00868790|2577699|P7|Period 1|Adverse Event|0
810469|NCT00868790|2577700|P6|Period 1|Adverse Event|0
810470|NCT00868790|2577701|P5|Period 1|Adverse Event|0
810471|NCT00868790|2577702|P4|Period 1|Adverse Event|0
810472|NCT00868790|2577703|P3|Period 1|Adverse Event|0
810473|NCT00868790|2577704|P2|Period 1|Adverse Event|0
810474|NCT00868790|2577705|P1|Period 1|Adverse Event|1
810475|NCT00868998|2577748|P1|Overall Study|Death|1
810476|NCT00868998|2577748|P1|Overall Study|Progression of disease|2
810477|NCT00868998|2577748|P1|Overall Study|Withdrawal by Subject|1
810478|NCT00868998|2577748|P1|Overall Study|Screen Failure|1
810479|NCT00869050|2577753|P1|Overall Study|Screen Failure|3
810480|NCT00869089|2577758|P1|Overall Study|Screen Fail|1
810481|NCT00869089|2577758|P1|Overall Study|Withdrawal by Subject|1
810482|NCT00869089|2577758|P1|Overall Study|Lost to Follow-up|1
810483|NCT00869128|2577762|P2|Overall Study|lack of Compliance|6
810484|NCT00869128|2577763|P1|Overall Study|lack of Compliance|6
810485|NCT00869258|2577797|P1|Overall Study|Physician Decision|1
810487|NCT00869362|2577824|P2|Overall Study|Lost to Follow-up|3
810488|NCT00869362|2577825|P1|Overall Study|Lost to Follow-up|1
810489|NCT00869362|2577824|P2|Overall Study|Death|2
810490|NCT00869362|2577825|P1|Overall Study|Death|0
810491|NCT00869401|2577847|P5|Overall Study|Withdrawal by Subject|3
810492|NCT00869401|2577848|P4|Overall Study|Withdrawal by Subject|5
810493|NCT00869401|2577849|P3|Overall Study|Withdrawal by Subject|0
810494|NCT00869401|2577850|P2|Overall Study|Withdrawal by Subject|0
810495|NCT00869401|2577851|P1|Overall Study|Withdrawal by Subject|0
810496|NCT00869518|2577882|P2|Overall Study|Lost to Follow-up|1
810497|NCT00869518|2577883|P1|Overall Study|Lost to Follow-up|1
810498|NCT00869557|2577897|P2|Extension Phase|Withdrew Consent|0
810499|NCT00869557|2577898|P1|Extension Phase|Withdrew Consent|2
810500|NCT00869557|2577897|P2|Extension Phase|Investigator's Discretion|0
810501|NCT00869557|2577898|P1|Extension Phase|Investigator's Discretion|2
810502|NCT00869557|2577897|P2|Extension Phase|Lost to Follow-up|1
810503|NCT00869557|2577898|P1|Extension Phase|Lost to Follow-up|3
810504|NCT00869557|2577897|P2|Extension Phase|Lack of Efficacy|0
810505|NCT00869557|2577898|P1|Extension Phase|Lack of Efficacy|1
810506|NCT00869557|2577897|P2|Extension Phase|Adverse Event|2
810507|NCT00869557|2577898|P1|Extension Phase|Adverse Event|2
810508|NCT00869557|2577897|P2|Randomized Phase|Withdrew Consent|1
810509|NCT00869557|2577898|P1|Randomized Phase|Withdrew Consent|0
810510|NCT00869557|2577897|P2|Randomized Phase|Investigator's Discretion|0
810511|NCT00869557|2577898|P1|Randomized Phase|Investigator's Discretion|1
810512|NCT00869557|2577897|P2|Randomized Phase|Lost to Follow-up|1
810513|NCT00869557|2577898|P1|Randomized Phase|Lost to Follow-up|2
810514|NCT00869778|2577956|P3|Overall Study|Unblinding|0
810515|NCT00869778|2577957|P2|Overall Study|Unblinding|0
810516|NCT00869778|2577958|P1|Overall Study|Unblinding|1
810517|NCT00869778|2577956|P3|Overall Study|Protocol Violation|5
810518|NCT00869778|2577957|P2|Overall Study|Protocol Violation|3
810519|NCT00869778|2577958|P1|Overall Study|Protocol Violation|5
810520|NCT00869778|2577956|P3|Overall Study|Pregnancy|0
810521|NCT00869778|2577957|P2|Overall Study|Pregnancy|0
810522|NCT00869778|2577958|P1|Overall Study|Pregnancy|1
810523|NCT00869778|2577956|P3|Overall Study|Withdrawal by Subject|5
810524|NCT00869778|2577957|P2|Overall Study|Withdrawal by Subject|4
810525|NCT00869778|2577958|P1|Overall Study|Withdrawal by Subject|3
810526|NCT00869778|2577956|P3|Overall Study|Adverse Event|0
810527|NCT00869778|2577957|P2|Overall Study|Adverse Event|0
810528|NCT00869778|2577958|P1|Overall Study|Adverse Event|2
810529|NCT00869960|2578028|P1|Overall Study|Lost to Follow-up|2
810530|NCT00863317|2578041|P2|Overall Study|Lost to Follow-up|9
810531|NCT00863317|2578042|P1|Overall Study|Lost to Follow-up|8
810532|NCT00863330|2578048|P1|Overall Study|study terminated early due to administra|6
810533|NCT00863512|2578079|P2|Overall Study|Physician Decision|0
810534|NCT00863512|2578080|P1|Overall Study|Physician Decision|1
810535|NCT00863512|2578079|P2|Overall Study|Withdrawal by Subject|0
810536|NCT00863512|2578080|P1|Overall Study|Withdrawal by Subject|11
810537|NCT00863512|2578079|P2|Overall Study|Adverse Event|0
810538|NCT00863512|2578080|P1|Overall Study|Adverse Event|2
810539|NCT00863655|2578096|P2|Overall Study|Treatment completed as per protocol|1
810540|NCT00863655|2578097|P1|Overall Study|Treatment completed as per protocol|5
810541|NCT00863655|2578096|P2|Overall Study|Disease progression|221
810542|NCT00863655|2578097|P1|Overall Study|Disease progression|364
810543|NCT00863655|2578096|P2|Overall Study|New cancer therapy|1
810544|NCT00863655|2578097|P1|Overall Study|New cancer therapy|5
810545|NCT00863655|2578096|P2|Overall Study|Death|1
810546|NCT00863655|2578097|P1|Overall Study|Death|7
810547|NCT00863655|2578096|P2|Overall Study|Administrative problems|0
810548|NCT00863655|2578097|P1|Overall Study|Administrative problems|1
810549|NCT00863655|2578096|P2|Overall Study|Withdrawal by Subject|7
810550|NCT00863655|2578097|P1|Overall Study|Withdrawal by Subject|47
810551|NCT00863655|2578096|P2|Overall Study|Adverse Event|8
810552|NCT00863655|2578097|P1|Overall Study|Adverse Event|52
810553|NCT00863655|2578096|P2|Overall Study|Protocol Violation|0
810554|NCT00863655|2578097|P1|Overall Study|Protocol Violation|4
810555|NCT00863707|2578126|P2|Overall Study|Randomized, but drug not received|3
810556|NCT00863707|2578127|P1|Overall Study|Randomized, but drug not received|4
810557|NCT00863746|2578135|P2|Survival Follow up|Consent Withdrawn|8
810558|NCT00863746|2578136|P1|Survival Follow up|Consent Withdrawn|7
810559|NCT00863746|2578135|P2|Survival Follow up|Lost to Follow-up|1
810560|NCT00863746|2578136|P1|Survival Follow up|Lost to Follow-up|2
810561|NCT00863746|2578135|P2|Survival Follow up|Death|271
810562|NCT00863746|2578136|P1|Survival Follow up|Death|244
810563|NCT00863746|2578135|P2|Treatment|not available|0
810564|NCT00863746|2578136|P1|Treatment|not available|1
810565|NCT00863746|2578135|P2|Treatment|Protocol Violation|3
810566|NCT00863746|2578136|P1|Treatment|Protocol Violation|5
810567|NCT00863746|2578135|P2|Treatment|Lost to Follow-up|0
810568|NCT00863746|2578136|P1|Treatment|Lost to Follow-up|1
810569|NCT00863746|2578135|P2|Treatment|Consent withdrawn|14
810570|NCT00863746|2578136|P1|Treatment|Consent withdrawn|15
810571|NCT00863746|2578135|P2|Treatment|non-compliant with study medication|0
810572|NCT00863746|2578136|P1|Treatment|non-compliant with study medication|4
810573|NCT00863746|2578135|P2|Treatment|Adverse Event|16
810574|NCT00863746|2578136|P1|Treatment|Adverse Event|41
810575|NCT00863746|2578135|P2|Treatment|Not treated|2
810576|NCT00863746|2578136|P1|Treatment|Not treated|4
810577|NCT00863798|2578163|P3|Overall Study|Randomized not treated|3
810578|NCT00863798|2578164|P2|Overall Study|Randomized not treated|2
810579|NCT00863798|2578165|P1|Overall Study|Randomized not treated|4
810580|NCT00863798|2578163|P3|Overall Study|Withdrawal by Subject|4
810581|NCT00863798|2578164|P2|Overall Study|Withdrawal by Subject|7
810582|NCT00863798|2578165|P1|Overall Study|Withdrawal by Subject|8
810583|NCT00863798|2578163|P3|Overall Study|Protocol Violation|1
810584|NCT00863798|2578164|P2|Overall Study|Protocol Violation|1
810585|NCT00863798|2578165|P1|Overall Study|Protocol Violation|0
810586|NCT00863798|2578163|P3|Overall Study|Unspecified|1
810587|NCT00863798|2578164|P2|Overall Study|Unspecified|3
810588|NCT00863798|2578165|P1|Overall Study|Unspecified|2
810589|NCT00863798|2578163|P3|Overall Study|Lost to Follow-up|5
810590|NCT00863798|2578164|P2|Overall Study|Lost to Follow-up|9
810591|NCT00863798|2578165|P1|Overall Study|Lost to Follow-up|6
810592|NCT00863798|2578163|P3|Overall Study|Lack of Efficacy|6
810593|NCT00863798|2578164|P2|Overall Study|Lack of Efficacy|3
810594|NCT00863798|2578165|P1|Overall Study|Lack of Efficacy|4
810595|NCT00863798|2578163|P3|Overall Study|Investigator request|1
810596|NCT00863798|2578164|P2|Overall Study|Investigator request|2
810597|NCT00863798|2578165|P1|Overall Study|Investigator request|1
810598|NCT00863798|2578163|P3|Overall Study|Participant failed to return|0
810599|NCT00863798|2578164|P2|Overall Study|Participant failed to return|1
810600|NCT00863798|2578165|P1|Overall Study|Participant failed to return|2
810601|NCT00863798|2578163|P3|Overall Study|Adverse Event|4
810602|NCT00863798|2578164|P2|Overall Study|Adverse Event|2
810603|NCT00863798|2578165|P1|Overall Study|Adverse Event|5
810606|NCT00864253|2578276|P2|Overall Study|Untreated|7
810607|NCT00864253|2578277|P1|Overall Study|Untreated|7
810608|NCT00864253|2578276|P2|Overall Study|Ongoing|3
810609|NCT00864253|2578277|P1|Overall Study|Ongoing|2
810610|NCT00864253|2578276|P2|Overall Study|Death|0
810611|NCT00864253|2578277|P1|Overall Study|Death|1
810612|NCT00864253|2578276|P2|Overall Study|Withdrawal by Subject|18
810613|NCT00864253|2578277|P1|Overall Study|Withdrawal by Subject|18
810614|NCT00864253|2578276|P2|Overall Study|Lost to Follow-up|1
810615|NCT00864253|2578277|P1|Overall Study|Lost to Follow-up|1
810616|NCT00864253|2578276|P2|Overall Study|Protocol Violation|2
810617|NCT00864253|2578277|P1|Overall Study|Protocol Violation|0
810618|NCT00864253|2578276|P2|Overall Study|Physician Decision|15
810619|NCT00864253|2578277|P1|Overall Study|Physician Decision|11
810620|NCT00864253|2578276|P2|Overall Study|Unrelated Adverse Event|1
810621|NCT00864253|2578277|P1|Overall Study|Unrelated Adverse Event|3
810622|NCT00864253|2578276|P2|Overall Study|Adverse Event|11
810623|NCT00864253|2578277|P1|Overall Study|Adverse Event|56
810624|NCT00864513|2578344|P1|Overall Study|Withdrawal by Subject|3
810625|NCT00869999|2578376|P1|Overall Study|removed prior to starting therapy|1
810626|NCT00869999|2578376|P1|Overall Study|Withdrawal by Subject|1
810627|NCT00870103|2578382|P1|Overall Study|Lost to Follow-up|2
810628|NCT00870103|2578382|P1|Overall Study|Physician Decision|2
810629|NCT00870194|2578389|P2|Overall Study|Subject Decision|2
810630|NCT00870194|2578390|P1|Overall Study|Subject Decision|7
810631|NCT00870194|2578389|P2|Overall Study|Entry Criteria Not Met|2
810632|NCT00870194|2578390|P1|Overall Study|Entry Criteria Not Met|1
810633|NCT00870194|2578389|P2|Overall Study|Protocol Violation|3
810634|NCT00870194|2578390|P1|Overall Study|Protocol Violation|3
810635|NCT00870194|2578389|P2|Overall Study|Physician Decision|1
810636|NCT00870194|2578390|P1|Overall Study|Physician Decision|3
810637|NCT00870194|2578389|P2|Overall Study|Lost to Follow-up|0
810638|NCT00870194|2578390|P1|Overall Study|Lost to Follow-up|2
810639|NCT00870194|2578389|P2|Overall Study|Lack of Efficacy|1
810640|NCT00870194|2578390|P1|Overall Study|Lack of Efficacy|0
810641|NCT00870194|2578389|P2|Overall Study|Adverse Event|5
810642|NCT00870194|2578390|P1|Overall Study|Adverse Event|10
810643|NCT00870584|2578490|P2|Overall Study|Protocol Deviation|2
810644|NCT00870584|2578491|P1|Overall Study|Protocol Deviation|2
810645|NCT00870584|2578490|P2|Overall Study|Lost to Follow-up|1
810646|NCT00870584|2578491|P1|Overall Study|Lost to Follow-up|5
810647|NCT00870584|2578490|P2|Overall Study|Withdrawal by Subject|7
810648|NCT00870584|2578491|P1|Overall Study|Withdrawal by Subject|6
810649|NCT00870584|2578490|P2|Overall Study|Adverse Event|3
810650|NCT00870584|2578491|P1|Overall Study|Adverse Event|3
810651|NCT00870688|2578499|P1|Overall Study|Granules in the Stools|1
810652|NCT00870688|2578499|P1|Overall Study|Death, Unrelated|1
810653|NCT00870688|2578499|P1|Overall Study|Lost to Follow-up|2
810654|NCT00870740|2578508|P6|Overall Study|Not Specified|5
810655|NCT00870740|2578509|P5|Overall Study|Not Specified|3
810656|NCT00870740|2578510|P4|Overall Study|Not Specified|4
810657|NCT00870740|2578511|P3|Overall Study|Not Specified|2
810658|NCT00870740|2578512|P2|Overall Study|Not Specified|5
810659|NCT00870740|2578513|P1|Overall Study|Not Specified|2
810660|NCT00870740|2578508|P6|Overall Study|Death|0
810661|NCT00870740|2578509|P5|Overall Study|Death|1
810662|NCT00870740|2578510|P4|Overall Study|Death|0
810663|NCT00870740|2578511|P3|Overall Study|Death|0
810664|NCT00870740|2578512|P2|Overall Study|Death|0
810665|NCT00870740|2578513|P1|Overall Study|Death|0
810666|NCT00870740|2578508|P6|Overall Study|Subject Non-compliance|1
810667|NCT00870740|2578509|P5|Overall Study|Subject Non-compliance|0
810668|NCT00870740|2578510|P4|Overall Study|Subject Non-compliance|0
810669|NCT00870740|2578511|P3|Overall Study|Subject Non-compliance|0
810670|NCT00870740|2578512|P2|Overall Study|Subject Non-compliance|0
810671|NCT00870740|2578513|P1|Overall Study|Subject Non-compliance|0
810672|NCT00870740|2578508|P6|Overall Study|Investigator Decision|0
810673|NCT00870740|2578509|P5|Overall Study|Investigator Decision|0
810674|NCT00870740|2578510|P4|Overall Study|Investigator Decision|0
810675|NCT00870740|2578511|P3|Overall Study|Investigator Decision|1
810676|NCT00870740|2578512|P2|Overall Study|Investigator Decision|0
810677|NCT00870740|2578513|P1|Overall Study|Investigator Decision|2
810678|NCT00870740|2578508|P6|Overall Study|Consent Withdrawn|5
810679|NCT00870740|2578509|P5|Overall Study|Consent Withdrawn|6
810680|NCT00870740|2578510|P4|Overall Study|Consent Withdrawn|6
810681|NCT00870740|2578511|P3|Overall Study|Consent Withdrawn|4
810682|NCT00870740|2578512|P2|Overall Study|Consent Withdrawn|3
810683|NCT00870740|2578513|P1|Overall Study|Consent Withdrawn|6
810684|NCT00870740|2578508|P6|Overall Study|Adverse Event|6
810685|NCT00870740|2578509|P5|Overall Study|Adverse Event|1
810686|NCT00870740|2578510|P4|Overall Study|Adverse Event|2
810687|NCT00870740|2578511|P3|Overall Study|Adverse Event|3
810688|NCT00870740|2578512|P2|Overall Study|Adverse Event|1
810689|NCT00870740|2578513|P1|Overall Study|Adverse Event|2
810690|NCT00871000|2578595|P2|Overall Study|Withdrawal by Subject|0
810691|NCT00871000|2578596|P1|Overall Study|Withdrawal by Subject|1
810692|NCT00871117|2578640|P2|Overall Study|Lost to Follow-up|10
810693|NCT00871117|2578641|P1|Overall Study|Lost to Follow-up|5
810694|NCT00871169|2578692|P1|Overall Study|Patient did not receive study treatment|2
810695|NCT00871169|2578692|P1|Overall Study|Protocol Violation|1
810696|NCT00871234|2578697|P1|Overall Study|Lost to Follow-up|3
810697|NCT00871234|2578697|P1|Overall Study|Adverse Event|2
810698|NCT00871338|2578714|P2|Prior to Booster|Lost to Follow-up|0
810699|NCT00871338|2578715|P1|Prior to Booster|Lost to Follow-up|1
810700|NCT00871338|2578714|P2|Prior to Booster|Withdrawal by Subject|3
810701|NCT00871338|2578715|P1|Prior to Booster|Withdrawal by Subject|1
810702|NCT00871351|2578796|P3|Overall Study|Adverse Event|0
810703|NCT00871351|2578797|P2|Overall Study|Adverse Event|1
810704|NCT00871351|2578798|P1|Overall Study|Adverse Event|3
810705|NCT00871351|2578796|P3|Overall Study|Withdrawal by Subject|0
810706|NCT00871351|2578797|P2|Overall Study|Withdrawal by Subject|0
810707|NCT00871351|2578798|P1|Overall Study|Withdrawal by Subject|1
810708|NCT00871377|2578818|P6|Third Intervention (10 Weeks)|Death|0
810709|NCT00871377|2578819|P5|Third Intervention (10 Weeks)|Death|0
810710|NCT00871377|2578820|P4|Third Intervention (10 Weeks)|Death|1
810711|NCT00871377|2578821|P3|Third Intervention (10 Weeks)|Death|0
810712|NCT00871377|2578822|P2|Third Intervention (10 Weeks)|Death|0
810713|NCT00871377|2578823|P1|Third Intervention (10 Weeks)|Death|0
810714|NCT00871377|2578818|P6|Washout (6 Weeks)|Withdrawal by Subject|1
810715|NCT00871377|2578819|P5|Washout (6 Weeks)|Withdrawal by Subject|0
810716|NCT00871377|2578820|P4|Washout (6 Weeks)|Withdrawal by Subject|0
810717|NCT00871377|2578821|P3|Washout (6 Weeks)|Withdrawal by Subject|0
810718|NCT00871377|2578822|P2|Washout (6 Weeks)|Withdrawal by Subject|0
810719|NCT00871377|2578823|P1|Washout (6 Weeks)|Withdrawal by Subject|0
810720|NCT00871377|2578818|P6|Washout (6 Weeks)|Withdrawal by Subject|0
810721|NCT00871377|2578819|P5|Washout (6 Weeks)|Withdrawal by Subject|0
810722|NCT00871377|2578820|P4|Washout (6 Weeks)|Withdrawal by Subject|0
810723|NCT00871377|2578821|P3|Washout (6 Weeks)|Withdrawal by Subject|0
810724|NCT00871377|2578822|P2|Washout (6 Weeks)|Withdrawal by Subject|0
810725|NCT00871377|2578823|P1|Washout (6 Weeks)|Withdrawal by Subject|1
810726|NCT00871377|2578818|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
810727|NCT00871377|2578819|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
810728|NCT00871377|2578820|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
810729|NCT00871377|2578821|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
810730|NCT00871377|2578822|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
810731|NCT00871377|2578823|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
810732|NCT00871377|2578818|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
810733|NCT00871377|2578819|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
810734|NCT00871377|2578820|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
810735|NCT00871377|2578821|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
810736|NCT00871377|2578822|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
810737|NCT00871377|2578823|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
810738|NCT00871403|2578834|P3|Monotherapy Treatment Phase|Adverse Event|0
810739|NCT00871403|2578835|P2|Monotherapy Treatment Phase|Adverse Event|4
810740|NCT00871403|2578836|P1|Monotherapy Treatment Phase|Adverse Event|0
810741|NCT00871403|2578834|P3|Monotherapy Treatment Phase|Disease Progression|1
810742|NCT00871403|2578835|P2|Monotherapy Treatment Phase|Disease Progression|9
810743|NCT00871403|2578836|P1|Monotherapy Treatment Phase|Disease Progression|0
810744|NCT00871403|2578834|P3|Combination Treatment Phase|Physician Decision|3
810745|NCT00871403|2578835|P2|Combination Treatment Phase|Physician Decision|1
810746|NCT00871403|2578836|P1|Combination Treatment Phase|Physician Decision|0
810747|NCT00871403|2578834|P3|Combination Treatment Phase|Withdrawal by Subject|1
810748|NCT00871403|2578835|P2|Combination Treatment Phase|Withdrawal by Subject|3
810749|NCT00871403|2578836|P1|Combination Treatment Phase|Withdrawal by Subject|0
810750|NCT00871403|2578834|P3|Combination Treatment Phase|Disease Progression|5
810751|NCT00871403|2578835|P2|Combination Treatment Phase|Disease Progression|8
810752|NCT00871403|2578836|P1|Combination Treatment Phase|Disease Progression|0
810753|NCT00871403|2578834|P3|Combination Treatment Phase|Adverse Event|2
810754|NCT00871403|2578835|P2|Combination Treatment Phase|Adverse Event|17
810755|NCT00871403|2578836|P1|Combination Treatment Phase|Adverse Event|0
810756|NCT00871403|2578834|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
810757|NCT00871403|2578835|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
810758|NCT00871403|2578836|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
810759|NCT00871403|2578834|P3|Combination Treatment Phase|Randomized but Not Treated|1
810760|NCT00871403|2578835|P2|Combination Treatment Phase|Randomized but Not Treated|1
810761|NCT00871403|2578836|P1|Combination Treatment Phase|Randomized but Not Treated|1
810762|NCT00871429|2578849|P1|Overall Study|Questionnaire not completed|1
810763|NCT00871429|2578849|P1|Overall Study|Withdrawal by Subject|17
810764|NCT00871429|2578849|P1|Overall Study|Lost to Follow-up|6
810765|NCT00871494|2578857|P1|Overall Study|Lost to Follow-up|1
810766|NCT00871494|2578857|P1|Overall Study|Adverse Event|4
810767|NCT00871494|2578857|P1|Overall Study|Lack of Efficacy|4
810768|NCT00871494|2578857|P1|Overall Study|Protocol Violation|5
810769|NCT00871715|2578887|P3|Overall Study|Lost to Follow-up|9
810770|NCT00871715|2578888|P2|Overall Study|Lost to Follow-up|6
810771|NCT00871715|2578889|P1|Overall Study|Lost to Follow-up|3
810772|NCT00871715|2578887|P3|Overall Study|Physician Decision|2
810773|NCT00871715|2578888|P2|Overall Study|Physician Decision|0
810774|NCT00871715|2578889|P1|Overall Study|Physician Decision|6
810775|NCT00871715|2578887|P3|Overall Study|Withdrawal by Subject|15
810776|NCT00871715|2578888|P2|Overall Study|Withdrawal by Subject|10
810777|NCT00871715|2578889|P1|Overall Study|Withdrawal by Subject|6
810778|NCT00871728|2578907|P1|Overall Study|Withdrawal of Informed Consent|5
810779|NCT00871728|2578907|P1|Overall Study|Participant Non-compliance|1
810780|NCT00871728|2578907|P1|Overall Study|Failed to Visit Hospital|4
810781|NCT00871728|2578907|P1|Overall Study|Lost to Follow-up|2
810782|NCT00871728|2578907|P1|Overall Study|Protocol Violation|7
810783|NCT00871728|2578907|P1|Overall Study|Adverse Event|1
810784|NCT00871741|2578919|P2|Overall Study|Premature study termination|7
810785|NCT00871741|2578920|P1|Overall Study|Premature study termination|9
810786|NCT00871780|2578934|P1|Overall Study|Physician Decision|1
810787|NCT00871780|2578934|P1|Overall Study|Death|1
810788|NCT00871780|2578934|P1|Overall Study|Voluntary Discontinuation|4
810789|NCT00871780|2578934|P1|Overall Study|Adverse Event|6
810790|NCT00871780|2578934|P1|Overall Study|Withdrawal by Subject|9
810791|NCT00871780|2578934|P1|Overall Study|Enrolled But Not Treated|6
810792|NCT00871871|2578958|P4|Part II|Protocol Violation|1
810793|NCT00871871|2578959|P3|Part II|Protocol Violation|0
810794|NCT00871871|2578960|P2|Part II|Protocol Violation|0
810795|NCT00871871|2578961|P1|Part II|Protocol Violation|0
810796|NCT00871871|2578958|P4|Part II|Adverse Event|2
810797|NCT00871871|2578959|P3|Part II|Adverse Event|1
810798|NCT00871871|2578960|P2|Part II|Adverse Event|0
810799|NCT00871871|2578961|P1|Part II|Adverse Event|0
810800|NCT00871871|2578958|P4|Part II|Withdrawal by Subject|1
810801|NCT00871871|2578959|P3|Part II|Withdrawal by Subject|2
810802|NCT00871871|2578960|P2|Part II|Withdrawal by Subject|0
810803|NCT00871871|2578961|P1|Part II|Withdrawal by Subject|0
810804|NCT00871871|2578958|P4|Part II|Lack of Efficacy|0
810805|NCT00871871|2578959|P3|Part II|Lack of Efficacy|1
810806|NCT00871871|2578960|P2|Part II|Lack of Efficacy|0
810807|NCT00871871|2578961|P1|Part II|Lack of Efficacy|0
810808|NCT00871871|2578958|P4|Part I|Laboratory abnormality|0
810809|NCT00871871|2578959|P3|Part I|Laboratory abnormality|0
810810|NCT00871871|2578960|P2|Part I|Laboratory abnormality|1
810811|NCT00871871|2578961|P1|Part I|Laboratory abnormality|0
810812|NCT00871871|2578958|P4|Part I|Withdrawal by Subject|0
810813|NCT00871871|2578959|P3|Part I|Withdrawal by Subject|0
810814|NCT00871871|2578960|P2|Part I|Withdrawal by Subject|0
810815|NCT00871871|2578961|P1|Part I|Withdrawal by Subject|3
810816|NCT00871871|2578958|P4|Part I|Adverse Event|0
810817|NCT00871871|2578959|P3|Part I|Adverse Event|0
810818|NCT00871871|2578960|P2|Part I|Adverse Event|2
810819|NCT00871871|2578961|P1|Part I|Adverse Event|0
810820|NCT00871975|2578981|P1|Overall Study|Motion artifact, tracing uninterpretable|5
810821|NCT00871975|2578981|P1|Overall Study|Patient unable to void/insufficient vol|13
810822|NCT00871975|2578981|P1|Overall Study|Catheters could not be inserted|1
810823|NCT00871975|2578981|P1|Overall Study|Technical difficulty w155-1ith equipment|3
810824|NCT00872001|2578987|P2|Overall Study|Administrative|15
810825|NCT00872001|2578988|P1|Overall Study|Administrative|23
810826|NCT00872001|2578987|P2|Overall Study|Did Not Meet Protocol Eligibility|36
810827|NCT00872001|2578988|P1|Overall Study|Did Not Meet Protocol Eligibility|38
810828|NCT00872001|2578987|P2|Overall Study|Protocol Violation|8
810829|NCT00872001|2578988|P1|Overall Study|Protocol Violation|5
810830|NCT00872001|2578987|P2|Overall Study|Withdrawal by Subject|30
810831|NCT00872001|2578988|P1|Overall Study|Withdrawal by Subject|18
810832|NCT00872001|2578987|P2|Overall Study|Lost to Follow-up|12
810833|NCT00872001|2578988|P1|Overall Study|Lost to Follow-up|13
810834|NCT00872001|2578987|P2|Overall Study|Protocol Defined Clinical Event|7
810835|NCT00872001|2578988|P1|Overall Study|Protocol Defined Clinical Event|5
810836|NCT00872001|2578987|P2|Overall Study|Adverse Event|23
810837|NCT00872001|2578988|P1|Overall Study|Adverse Event|34
810838|NCT00872170|2579011|P2|Overall Study|Adverse Event|0
810839|NCT00872170|2579012|P1|Overall Study|Adverse Event|1
810840|NCT00872521|2579053|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
810841|NCT00872521|2579054|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
810842|NCT00872521|2579055|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
810843|NCT00872521|2579053|P3|Completed 3-month Follow up|Physician Decision|0
810844|NCT00872521|2579054|P2|Completed 3-month Follow up|Physician Decision|1
810845|NCT00872521|2579055|P1|Completed 3-month Follow up|Physician Decision|0
810846|NCT00872521|2579053|P3|Completed 3-month Follow up|Not specified|0
810847|NCT00872521|2579054|P2|Completed 3-month Follow up|Not specified|2
810848|NCT00872521|2579055|P1|Completed 3-month Follow up|Not specified|0
810849|NCT00872521|2579053|P3|Primary Endpoint Analysis|Patient response missing|1
810850|NCT00872521|2579054|P2|Primary Endpoint Analysis|Patient response missing|0
810851|NCT00872521|2579055|P1|Primary Endpoint Analysis|Patient response missing|0
810852|NCT00872521|2579053|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
810853|NCT00872521|2579054|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
810854|NCT00872521|2579055|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
810855|NCT00872521|2579053|P3|Primary Endpoint Analysis|Patient choice|0
810856|NCT00872521|2579054|P2|Primary Endpoint Analysis|Patient choice|1
810857|NCT00872521|2579055|P1|Primary Endpoint Analysis|Patient choice|0
810858|NCT00872521|2579053|P3|Primary Endpoint Analysis|Not specified|0
810859|NCT00872521|2579054|P2|Primary Endpoint Analysis|Not specified|2
810860|NCT00872521|2579055|P1|Primary Endpoint Analysis|Not specified|1
810861|NCT00872521|2579053|P3|Completed PAD Induction|Death|0
810862|NCT00872521|2579054|P2|Completed PAD Induction|Death|1
810863|NCT00872521|2579055|P1|Completed PAD Induction|Death|1
810864|NCT00872521|2579053|P3|Completed PAD Induction|Adverse Event|0
810865|NCT00872521|2579054|P2|Completed PAD Induction|Adverse Event|0
810866|NCT00872521|2579055|P1|Completed PAD Induction|Adverse Event|4
810867|NCT00872521|2579053|P3|Completed PAD Induction|Disease progression|0
810868|NCT00872521|2579054|P2|Completed PAD Induction|Disease progression|2
810869|NCT00872521|2579055|P1|Completed PAD Induction|Disease progression|0
810870|NCT00872521|2579053|P3|Completed PAD Induction|Patient choice|0
810871|NCT00872521|2579054|P2|Completed PAD Induction|Patient choice|1
810872|NCT00872521|2579055|P1|Completed PAD Induction|Patient choice|0
810873|NCT00872599|2579110|P2|Second Washout Period|Adverse Event|1
810874|NCT00872599|2579111|P1|Second Washout Period|Adverse Event|1
810875|NCT00872898|2579162|P2|Part Two - Double Blind|Other reasons|0
810876|NCT00872898|2579163|P1|Part Two - Double Blind|Other reasons|2
810877|NCT00872898|2579162|P2|Part Two - Double Blind|Lost to Follow-up|2
810878|NCT00872898|2579163|P1|Part Two - Double Blind|Lost to Follow-up|0
810879|NCT00872898|2579162|P2|Part Two - Double Blind|Withdrawal by Subject|1
810880|NCT00872898|2579163|P1|Part Two - Double Blind|Withdrawal by Subject|3
810881|NCT00872898|2579162|P2|Part Two - Double Blind|Protocol Violation|0
810882|NCT00872898|2579163|P1|Part Two - Double Blind|Protocol Violation|1
810883|NCT00872898|2579162|P2|Part Two - Double Blind|Lack of Efficacy|0
810884|NCT00872898|2579163|P1|Part Two - Double Blind|Lack of Efficacy|1
810885|NCT00872898|2579162|P2|Part Two - Double Blind|Adverse Event|3
810886|NCT00872898|2579163|P1|Part Two - Double Blind|Adverse Event|4
810887|NCT00867490|2579220|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
810888|NCT00867490|2579220|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
810889|NCT00867490|2579220|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
810890|NCT00867490|2579220|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
810891|NCT00867490|2579220|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
810892|NCT00867503|2579237|P1|Overall Study|Withdrawal by Subject|1
810893|NCT00872989|2579245|P2|Overall Study|Not protocol specified|8
810894|NCT00872989|2579246|P1|Overall Study|Not protocol specified|3
810895|NCT00872989|2579245|P2|Overall Study|Progression/relapse|35
810896|NCT00872989|2579246|P1|Overall Study|Progression/relapse|47
810897|NCT00872989|2579245|P2|Overall Study|Withdrawal by Subject|5
810898|NCT00872989|2579246|P1|Overall Study|Withdrawal by Subject|8
810899|NCT00872989|2579245|P2|Overall Study|Adverse Event|15
810900|NCT00872989|2579246|P1|Overall Study|Adverse Event|7
810901|NCT00873015|2579266|P4|Overall Study|Withdrawal by Subject|0
810902|NCT00873015|2579267|P3|Overall Study|Withdrawal by Subject|0
810903|NCT00873015|2579268|P2|Overall Study|Withdrawal by Subject|1
810904|NCT00873015|2579269|P1|Overall Study|Withdrawal by Subject|0
810905|NCT00873041|2579279|P3|Extension Study|Administrative reasons|1
810906|NCT00873041|2579280|P2|Extension Study|Administrative reasons|0
810907|NCT00873041|2579281|P1|Extension Study|Administrative reasons|0
810908|NCT00873041|2579279|P3|Extension Study|Adverse Event|1
810909|NCT00873041|2579280|P2|Extension Study|Adverse Event|0
810910|NCT00873041|2579281|P1|Extension Study|Adverse Event|1
810911|NCT00873041|2579279|P3|Core Study|Protocol deviation|1
810912|NCT00873041|2579280|P2|Core Study|Protocol deviation|0
810913|NCT00873041|2579281|P1|Core Study|Protocol deviation|1
810914|NCT00873041|2579279|P3|Core Study|Abnormal laboratory value|1
810915|NCT00873041|2579280|P2|Core Study|Abnormal laboratory value|0
810916|NCT00873041|2579281|P1|Core Study|Abnormal laboratory value|0
810917|NCT00873041|2579279|P3|Core Study|Lost to Follow-up|0
810918|NCT00873041|2579280|P2|Core Study|Lost to Follow-up|1
810919|NCT00873041|2579281|P1|Core Study|Lost to Follow-up|3
810920|NCT00873041|2579279|P3|Core Study|Withdrawal by Subject|2
810921|NCT00873041|2579280|P2|Core Study|Withdrawal by Subject|2
810922|NCT00873041|2579281|P1|Core Study|Withdrawal by Subject|1
810923|NCT00873041|2579279|P3|Core Study|Adverse Event|1
810924|NCT00873041|2579280|P2|Core Study|Adverse Event|3
810925|NCT00873041|2579281|P1|Core Study|Adverse Event|2
810926|NCT00873093|2579340|P5|Overall Study|Ineligible|0
810927|NCT00873093|2579341|P4|Overall Study|Ineligible|1
810928|NCT00873093|2579342|P3|Overall Study|Ineligible|0
810929|NCT00873093|2579343|P2|Overall Study|Ineligible|1
810930|NCT00873093|2579344|P1|Overall Study|Ineligible|0
810931|NCT00873093|2579340|P5|Overall Study|Withdrawal by Subject|0
810932|NCT00873093|2579341|P4|Overall Study|Withdrawal by Subject|0
810933|NCT00873093|2579342|P3|Overall Study|Withdrawal by Subject|4
810934|NCT00873093|2579343|P2|Overall Study|Withdrawal by Subject|4
810935|NCT00873093|2579344|P1|Overall Study|Withdrawal by Subject|1
810936|NCT00873093|2579340|P5|Overall Study|Physician Decision|2
810937|NCT00873093|2579341|P4|Overall Study|Physician Decision|10
810938|NCT00873093|2579342|P3|Overall Study|Physician Decision|10
810939|NCT00873093|2579343|P2|Overall Study|Physician Decision|17
810940|NCT00873093|2579344|P1|Overall Study|Physician Decision|0
810941|NCT00873093|2579340|P5|Overall Study|Death|0
810942|NCT00873093|2579341|P4|Overall Study|Death|0
810943|NCT00873093|2579342|P3|Overall Study|Death|2
810944|NCT00873093|2579343|P2|Overall Study|Death|3
810945|NCT00873093|2579344|P1|Overall Study|Death|0
810946|NCT00873093|2579340|P5|Overall Study|Adverse Event|0
810947|NCT00873093|2579341|P4|Overall Study|Adverse Event|0
810948|NCT00873093|2579342|P3|Overall Study|Adverse Event|0
810949|NCT00873093|2579343|P2|Overall Study|Adverse Event|2
810950|NCT00873093|2579344|P1|Overall Study|Adverse Event|0
810951|NCT00873119|2579400|P2|Overall Study|Not treated|0
810952|NCT00873119|2579401|P1|Overall Study|Not treated|2
810953|NCT00873119|2579400|P2|Overall Study|Other|5
810954|NCT00873119|2579401|P1|Overall Study|Other|2
810955|NCT00873119|2579400|P2|Overall Study|Death|1
810956|NCT00873119|2579401|P1|Overall Study|Death|2
810957|NCT00873119|2579400|P2|Overall Study|Progressive disease|18
810958|NCT00873119|2579401|P1|Overall Study|Progressive disease|26
810959|NCT00873119|2579400|P2|Overall Study|Adverse Event|0
810960|NCT00873119|2579401|P1|Overall Study|Adverse Event|8
810961|NCT00873119|2579400|P2|Overall Study|Patient request|2
810962|NCT00873119|2579401|P1|Overall Study|Patient request|4
810963|NCT00875563|2579436|P1|Overall Study|Still be eligible for follow-up|7
810964|NCT00875563|2579436|P1|Overall Study|No long-term (3-5 year) consent|6
810965|NCT00875563|2579436|P1|Overall Study|Withdrawal by Subject|7
810966|NCT00875563|2579436|P1|Overall Study|Death|4
810967|NCT00875615|2579449|P1|Overall Study|Withdrawal by Subject|1
810968|NCT00875706|2579457|P3|Overall Study|Withdrawal by Subject|0
810969|NCT00875706|2579458|P2|Overall Study|Withdrawal by Subject|0
810970|NCT00875706|2579459|P1|Overall Study|Withdrawal by Subject|1
810971|NCT00875797|2579478|P2|Overall Study|Protocol Violation|3
810972|NCT00875797|2579479|P1|Overall Study|Protocol Violation|6
810973|NCT00875810|2579489|P1|Overall Study|Device explanted|1
810974|NCT00875810|2579489|P1|Overall Study|Patient enroled but not implanted|2
810975|NCT00875810|2579489|P1|Overall Study|Lost to Follow-up|39
810976|NCT00875810|2579489|P1|Overall Study|Physician Decision|3
810977|NCT00875810|2579489|P1|Overall Study|Withdrawal by Subject|1
810978|NCT00875979|2579511|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
810979|NCT00875979|2579512|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
810980|NCT00875979|2579511|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
810981|NCT00875979|2579512|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
810982|NCT00875979|2579511|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
810983|NCT00875979|2579512|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
810984|NCT00875979|2579511|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
810985|NCT00875979|2579512|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
810986|NCT00875979|2579511|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
810987|NCT00875979|2579512|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
810988|NCT00875979|2579511|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
810989|NCT00875979|2579512|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
810990|NCT00875979|2579511|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
810991|NCT00875979|2579512|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
810992|NCT00875979|2579511|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
810993|NCT00875979|2579512|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
810994|NCT00875979|2579511|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
810995|NCT00875979|2579512|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
810996|NCT00876018|2579525|P3|Overall Study|Withdrew Consent due to Adverse Event|2
810997|NCT00876018|2579526|P2|Overall Study|Withdrew Consent due to Adverse Event|4
810998|NCT00876018|2579527|P1|Overall Study|Withdrew Consent due to Adverse Event|5
810999|NCT00876018|2579525|P3|Overall Study|Lost to Follow-up|1
811000|NCT00876018|2579526|P2|Overall Study|Lost to Follow-up|1
811001|NCT00876018|2579527|P1|Overall Study|Lost to Follow-up|0
811002|NCT00876265|2579580|P1|Overall Study|Withdrawal by Subject|2
811003|NCT00876265|2579580|P1|Overall Study|Lost to Follow-up|6
811004|NCT00876265|2579580|P1|Overall Study|Miscellaneous reasons|4
811005|NCT00876343|2579589|P3|Overall Study|Change of residence or other commitments|3
811006|NCT00876343|2579590|P2|Overall Study|Change of residence or other commitments|2
811007|NCT00876343|2579591|P1|Overall Study|Change of residence or other commitments|2
811008|NCT00876343|2579589|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
811009|NCT00876343|2579590|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
811010|NCT00876343|2579591|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
811011|NCT00876343|2579589|P3|Overall Study|Physician Decision|1
811012|NCT00876343|2579590|P2|Overall Study|Physician Decision|1
811013|NCT00876343|2579591|P1|Overall Study|Physician Decision|0
811014|NCT00876343|2579589|P3|Overall Study|Protocol Violation|1
811015|NCT00876343|2579590|P2|Overall Study|Protocol Violation|1
811016|NCT00876343|2579591|P1|Overall Study|Protocol Violation|4
811017|NCT00876343|2579589|P3|Overall Study|Lack of Efficacy|1
811018|NCT00876343|2579590|P2|Overall Study|Lack of Efficacy|0
811019|NCT00876343|2579591|P1|Overall Study|Lack of Efficacy|0
811020|NCT00876343|2579589|P3|Overall Study|Withdrawal by Subject|3
811021|NCT00876343|2579590|P2|Overall Study|Withdrawal by Subject|4
811022|NCT00876343|2579591|P1|Overall Study|Withdrawal by Subject|4
811023|NCT00876343|2579589|P3|Overall Study|Adverse Event|2
811024|NCT00876343|2579590|P2|Overall Study|Adverse Event|8
811025|NCT00876343|2579591|P1|Overall Study|Adverse Event|7
811026|NCT00876447|2579607|P2|Overall Study|Adverse Event|8
811027|NCT00876447|2579608|P1|Overall Study|Adverse Event|4
811028|NCT00876447|2579607|P2|Overall Study|Lack of Efficacy|3
811029|NCT00876447|2579608|P1|Overall Study|Lack of Efficacy|5
811030|NCT00876447|2579607|P2|Overall Study|Pregnancy|2
811031|NCT00876447|2579608|P1|Overall Study|Pregnancy|4
811032|NCT00876447|2579607|P2|Overall Study|Lost to Follow-up|15
811033|NCT00876447|2579608|P1|Overall Study|Lost to Follow-up|6
811034|NCT00876447|2579607|P2|Overall Study|Personal reasons|28
811035|NCT00876447|2579608|P1|Overall Study|Personal reasons|30
811036|NCT00876447|2579607|P2|Overall Study|Protocol Violation|3
811037|NCT00876447|2579608|P1|Overall Study|Protocol Violation|9
811038|NCT00876447|2579607|P2|Overall Study|Site closure|14
811039|NCT00876447|2579608|P1|Overall Study|Site closure|19
811040|NCT00876447|2579607|P2|Overall Study|Other miscellaneous reasons|8
811041|NCT00876447|2579608|P1|Overall Study|Other miscellaneous reasons|3
811042|NCT00876460|2579674|P8|Mono Therapy Phase|Adverse Event|0
811043|NCT00876460|2579675|P7|Mono Therapy Phase|Adverse Event|0
811044|NCT00876460|2579676|P6|Mono Therapy Phase|Adverse Event|0
811045|NCT00876460|2579677|P5|Mono Therapy Phase|Adverse Event|0
811046|NCT00876460|2579678|P4|Mono Therapy Phase|Adverse Event|1
811047|NCT00876460|2579679|P3|Mono Therapy Phase|Adverse Event|0
811048|NCT00876460|2579680|P2|Mono Therapy Phase|Adverse Event|0
811049|NCT00876460|2579681|P1|Mono Therapy Phase|Adverse Event|0
811050|NCT00876460|2579674|P8|Mono Therapy Phase|Withdrawal by Subject|0
811051|NCT00876460|2579675|P7|Mono Therapy Phase|Withdrawal by Subject|0
811052|NCT00876460|2579676|P6|Mono Therapy Phase|Withdrawal by Subject|0
811053|NCT00876460|2579677|P5|Mono Therapy Phase|Withdrawal by Subject|0
811054|NCT00876460|2579678|P4|Mono Therapy Phase|Withdrawal by Subject|0
811055|NCT00876460|2579679|P3|Mono Therapy Phase|Withdrawal by Subject|0
811056|NCT00876460|2579680|P2|Mono Therapy Phase|Withdrawal by Subject|1
811057|NCT00876460|2579681|P1|Mono Therapy Phase|Withdrawal by Subject|0
811058|NCT00876460|2579674|P8|Mono Therapy Phase|Progressive disease|3
811059|NCT00876460|2579675|P7|Mono Therapy Phase|Progressive disease|1
811060|NCT00876460|2579676|P6|Mono Therapy Phase|Progressive disease|0
811061|NCT00876460|2579677|P5|Mono Therapy Phase|Progressive disease|2
811062|NCT00876460|2579678|P4|Mono Therapy Phase|Progressive disease|0
811063|NCT00876460|2579679|P3|Mono Therapy Phase|Progressive disease|0
811064|NCT00876460|2579680|P2|Mono Therapy Phase|Progressive disease|0
811065|NCT00876460|2579681|P1|Mono Therapy Phase|Progressive disease|0
811066|NCT00876460|2579674|P8|Combination Therapy Phase|Not treated|0
811067|NCT00876460|2579675|P7|Combination Therapy Phase|Not treated|1
811068|NCT00876460|2579676|P6|Combination Therapy Phase|Not treated|0
811069|NCT00876460|2579677|P5|Combination Therapy Phase|Not treated|0
811070|NCT00876460|2579678|P4|Combination Therapy Phase|Not treated|0
811071|NCT00876460|2579679|P3|Combination Therapy Phase|Not treated|0
811072|NCT00876460|2579680|P2|Combination Therapy Phase|Not treated|0
811073|NCT00876460|2579681|P1|Combination Therapy Phase|Not treated|0
811074|NCT00876460|2579674|P8|Combination Therapy Phase|Other reason not defined above|2
811075|NCT00876460|2579675|P7|Combination Therapy Phase|Other reason not defined above|1
811076|NCT00876460|2579676|P6|Combination Therapy Phase|Other reason not defined above|0
811077|NCT00876460|2579677|P5|Combination Therapy Phase|Other reason not defined above|0
811078|NCT00876460|2579678|P4|Combination Therapy Phase|Other reason not defined above|0
811079|NCT00876460|2579679|P3|Combination Therapy Phase|Other reason not defined above|0
811080|NCT00876460|2579680|P2|Combination Therapy Phase|Other reason not defined above|0
811081|NCT00876460|2579681|P1|Combination Therapy Phase|Other reason not defined above|0
811082|NCT00876460|2579674|P8|Combination Therapy Phase|Withdrawal by Subject|0
811083|NCT00876460|2579675|P7|Combination Therapy Phase|Withdrawal by Subject|0
811084|NCT00876460|2579676|P6|Combination Therapy Phase|Withdrawal by Subject|0
811085|NCT00876460|2579677|P5|Combination Therapy Phase|Withdrawal by Subject|1
811086|NCT00876460|2579678|P4|Combination Therapy Phase|Withdrawal by Subject|0
811087|NCT00876460|2579679|P3|Combination Therapy Phase|Withdrawal by Subject|0
811088|NCT00876460|2579680|P2|Combination Therapy Phase|Withdrawal by Subject|1
811089|NCT00876460|2579681|P1|Combination Therapy Phase|Withdrawal by Subject|1
811090|NCT00876460|2579674|P8|Combination Therapy Phase|Adverse Event|2
811091|NCT00876460|2579675|P7|Combination Therapy Phase|Adverse Event|3
811092|NCT00876460|2579676|P6|Combination Therapy Phase|Adverse Event|0
811093|NCT00876460|2579677|P5|Combination Therapy Phase|Adverse Event|2
811094|NCT00876460|2579678|P4|Combination Therapy Phase|Adverse Event|2
811095|NCT00876460|2579679|P3|Combination Therapy Phase|Adverse Event|0
811096|NCT00876460|2579680|P2|Combination Therapy Phase|Adverse Event|2
811097|NCT00876460|2579681|P1|Combination Therapy Phase|Adverse Event|0
811098|NCT00876460|2579674|P8|Combination Therapy Phase|Dose limiting toxicity|1
811099|NCT00876460|2579675|P7|Combination Therapy Phase|Dose limiting toxicity|2
811100|NCT00876460|2579676|P6|Combination Therapy Phase|Dose limiting toxicity|2
811101|NCT00876460|2579677|P5|Combination Therapy Phase|Dose limiting toxicity|1
811102|NCT00876460|2579678|P4|Combination Therapy Phase|Dose limiting toxicity|1
811103|NCT00876460|2579679|P3|Combination Therapy Phase|Dose limiting toxicity|0
811104|NCT00876460|2579680|P2|Combination Therapy Phase|Dose limiting toxicity|1
811105|NCT00876460|2579681|P1|Combination Therapy Phase|Dose limiting toxicity|0
811106|NCT00876460|2579674|P8|Combination Therapy Phase|Progressive disease|1
811107|NCT00876460|2579675|P7|Combination Therapy Phase|Progressive disease|1
811108|NCT00876460|2579676|P6|Combination Therapy Phase|Progressive disease|1
811109|NCT00876460|2579677|P5|Combination Therapy Phase|Progressive disease|3
811110|NCT00876460|2579678|P4|Combination Therapy Phase|Progressive disease|3
811111|NCT00876460|2579679|P3|Combination Therapy Phase|Progressive disease|3
811112|NCT00876460|2579680|P2|Combination Therapy Phase|Progressive disease|3
811113|NCT00876460|2579681|P1|Combination Therapy Phase|Progressive disease|2
811114|NCT00876694|2579753|P2|Overall Study|Death|0
811115|NCT00876694|2579754|P1|Overall Study|Death|1
811116|NCT00876694|2579753|P2|Overall Study|Administrative problems|1
811117|NCT00876694|2579754|P1|Overall Study|Administrative problems|1
811118|NCT00876694|2579753|P2|Overall Study|Abnormal test procedure result(s)|0
811119|NCT00876694|2579754|P1|Overall Study|Abnormal test procedure result(s)|1
811120|NCT00876694|2579753|P2|Overall Study|Unsatisfactory therapeutic effect|0
811121|NCT00876694|2579754|P1|Overall Study|Unsatisfactory therapeutic effect|2
811122|NCT00876694|2579753|P2|Overall Study|Subject withdrew consent|4
811123|NCT00876694|2579754|P1|Overall Study|Subject withdrew consent|6
811124|NCT00876694|2579753|P2|Overall Study|Adverse Event|7
811125|NCT00876694|2579754|P1|Overall Study|Adverse Event|10
811126|NCT00876733|2579776|P4|Overall Study|Data not available|1
811127|NCT00876733|2579777|P3|Overall Study|Data not available|7
811128|NCT00876733|2579778|P2|Overall Study|Data not available|3
811129|NCT00876733|2579779|P1|Overall Study|Data not available|14
811130|NCT00876733|2579776|P4|Overall Study|Lost to Follow-up|2
811131|NCT00876733|2579777|P3|Overall Study|Lost to Follow-up|3
811132|NCT00876733|2579778|P2|Overall Study|Lost to Follow-up|10
811133|NCT00876733|2579779|P1|Overall Study|Lost to Follow-up|26
811134|NCT00876733|2579776|P4|Overall Study|Lack of Efficacy|1
811135|NCT00876733|2579777|P3|Overall Study|Lack of Efficacy|10
811136|NCT00876733|2579778|P2|Overall Study|Lack of Efficacy|9
811137|NCT00876733|2579779|P1|Overall Study|Lack of Efficacy|17
811138|NCT00876733|2579776|P4|Overall Study|Adverse Event|3
811139|NCT00876733|2579777|P3|Overall Study|Adverse Event|10
811140|NCT00876733|2579778|P2|Overall Study|Adverse Event|20
811141|NCT00876733|2579779|P1|Overall Study|Adverse Event|34
811142|NCT00876928|2579912|P2|Overall Study|Hypokalemia-affects insulin secretion|0
811143|NCT00876928|2579913|P1|Overall Study|Hypokalemia-affects insulin secretion|1
811144|NCT00876928|2579912|P2|Overall Study|Lost to Follow-up|5
811145|NCT00876928|2579913|P1|Overall Study|Lost to Follow-up|2
811146|NCT00877006|2579923|P2|Treatment Period|Randomized but Not Treated|8
811147|NCT00877006|2579924|P1|Treatment Period|Randomized but Not Treated|3
811148|NCT00877006|2579923|P2|Treatment Period|Not Specified|4
811149|NCT00877006|2579924|P1|Treatment Period|Not Specified|4
811150|NCT00877006|2579923|P2|Treatment Period|Started New Treatment Regimen|5
811151|NCT00877006|2579924|P1|Treatment Period|Started New Treatment Regimen|1
811152|NCT00877006|2579923|P2|Treatment Period|Disease Progression|2
811153|NCT00877006|2579924|P1|Treatment Period|Disease Progression|0
811154|NCT00877006|2579923|P2|Treatment Period|Lost to Follow-up|1
811155|NCT00877006|2579924|P1|Treatment Period|Lost to Follow-up|0
811156|NCT00877006|2579923|P2|Treatment Period|Protocol Violation|0
811157|NCT00877006|2579924|P1|Treatment Period|Protocol Violation|1
811158|NCT00877006|2579923|P2|Treatment Period|Withdrawal by Subject|3
811159|NCT00877006|2579924|P1|Treatment Period|Withdrawal by Subject|2
811160|NCT00877006|2579923|P2|Treatment Period|Adverse Event|3
811161|NCT00877006|2579924|P1|Treatment Period|Adverse Event|9
811162|NCT00877006|2579923|P2|Treatment Period|Death|1
811163|NCT00877006|2579924|P1|Treatment Period|Death|1
811164|NCT00877032|2579957|P7|Overall Study|Did not meet entrance criteria|2
811165|NCT00877032|2579958|P6|Overall Study|Did not meet entrance criteria|0
811166|NCT00877032|2579959|P5|Overall Study|Did not meet entrance criteria|0
811167|NCT00877032|2579960|P4|Overall Study|Did not meet entrance criteria|1
811168|NCT00877032|2579961|P3|Overall Study|Did not meet entrance criteria|0
811169|NCT00877032|2579962|P2|Overall Study|Did not meet entrance criteria|0
811170|NCT00877032|2579963|P1|Overall Study|Did not meet entrance criteria|0
811171|NCT00877071|2580081|P1|Overall Study|disease progression|2
811172|NCT00877383|2580094|P2|Overall Study|Death|2
811173|NCT00877383|2580095|P1|Overall Study|Death|1
811174|NCT00877383|2580094|P2|Overall Study|Unsatisfactory therapeutic effect|0
811175|NCT00877383|2580095|P1|Overall Study|Unsatisfactory therapeutic effect|1
811176|NCT00877383|2580094|P2|Overall Study|Protocol deviation|6
811177|NCT00877383|2580095|P1|Overall Study|Protocol deviation|2
811178|NCT00877383|2580094|P2|Overall Study|Administrative problems|0
811179|NCT00877383|2580095|P1|Overall Study|Administrative problems|2
811180|NCT00877383|2580094|P2|Overall Study|Subject no longer requires study drug|0
811181|NCT00877383|2580095|P1|Overall Study|Subject no longer requires study drug|2
811182|NCT00877383|2580094|P2|Overall Study|Subject withdrew consent|12
811183|NCT00877383|2580095|P1|Overall Study|Subject withdrew consent|3
811184|NCT00877383|2580094|P2|Overall Study|Lost to Follow-up|3
811185|NCT00877383|2580095|P1|Overall Study|Lost to Follow-up|5
811186|NCT00877383|2580094|P2|Overall Study|Adverse Event|14
811187|NCT00877383|2580095|P1|Overall Study|Adverse Event|13
811188|NCT00877487|2580147|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
811189|NCT00877487|2580148|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
811190|NCT00877487|2580147|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
811191|NCT00877487|2580148|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
811192|NCT00877487|2580147|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
811193|NCT00877487|2580148|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
811194|NCT00877487|2580147|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
811195|NCT00877487|2580148|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
811196|NCT00877487|2580147|P2|Open-label Treatment Phase|Out of country for business|0
811197|NCT00877487|2580148|P1|Open-label Treatment Phase|Out of country for business|1
811198|NCT00877487|2580147|P2|Open-label Treatment Phase|Lost to Follow-up|0
811199|NCT00877487|2580148|P1|Open-label Treatment Phase|Lost to Follow-up|1
811200|NCT00877487|2580147|P2|Open-label Treatment Phase|Withdrawal by Subject|0
811201|NCT00877487|2580148|P1|Open-label Treatment Phase|Withdrawal by Subject|1
811202|NCT00877487|2580147|P2|Open-label Treatment Phase|Protocol Violation|0
811203|NCT00877487|2580148|P1|Open-label Treatment Phase|Protocol Violation|3
811204|NCT00877487|2580147|P2|Open-label Treatment Phase|Adverse Event|0
811205|NCT00877487|2580148|P1|Open-label Treatment Phase|Adverse Event|1
811206|NCT00877773|2580167|P1|Overall Study|Disease Progression|44
811207|NCT00877799|2580176|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
811208|NCT00877799|2580177|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
811209|NCT00877799|2580178|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
811210|NCT00877799|2580179|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
811211|NCT00877799|2580180|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
811212|NCT00877799|2580176|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
811213|NCT00877799|2580177|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
811214|NCT00877799|2580178|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
811215|NCT00877799|2580179|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
811216|NCT00877799|2580180|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
811217|NCT00877799|2580176|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
811218|NCT00877799|2580177|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
811219|NCT00877799|2580178|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
811220|NCT00877799|2580179|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
811221|NCT00877799|2580180|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
811222|NCT00877799|2580176|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
811223|NCT00877799|2580177|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
811224|NCT00877799|2580178|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
811225|NCT00877799|2580179|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
811226|NCT00877799|2580180|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
811227|NCT00877799|2580176|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
811228|NCT00877799|2580177|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
811229|NCT00877799|2580178|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
811230|NCT00877799|2580179|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
811231|NCT00877799|2580180|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
811232|NCT00877890|2580223|P2|Overall Study|Loss of Glucose Control|4
811233|NCT00877890|2580224|P1|Overall Study|Loss of Glucose Control|3
811234|NCT00877890|2580223|P2|Overall Study|Investigator Decision|2
811235|NCT00877890|2580224|P1|Overall Study|Investigator Decision|0
811236|NCT00877890|2580223|P2|Overall Study|Withdrawal of Consent|12
811237|NCT00877890|2580224|P1|Overall Study|Withdrawal of Consent|6
811238|NCT00877890|2580223|P2|Overall Study|Protocol Violation|1
811239|NCT00877890|2580224|P1|Overall Study|Protocol Violation|0
811240|NCT00877890|2580223|P2|Overall Study|Lost to Follow-up|5
811241|NCT00877890|2580224|P1|Overall Study|Lost to Follow-up|5
811242|NCT00877890|2580223|P2|Overall Study|Adverse Event|6
811243|NCT00877890|2580224|P1|Overall Study|Adverse Event|6
811244|NCT00877929|2580260|P2|Overall Study|Other reason (not specified)|6
811245|NCT00877929|2580261|P1|Overall Study|Other reason (not specified)|2
811246|NCT00877929|2580260|P2|Overall Study|Lack of Efficacy|1
811247|NCT00877929|2580261|P1|Overall Study|Lack of Efficacy|0
811248|NCT00877929|2580260|P2|Overall Study|Withdrawal by Subject|4
811249|NCT00877929|2580261|P1|Overall Study|Withdrawal by Subject|4
811250|NCT00877929|2580260|P2|Overall Study|Lost to Follow-up|1
811251|NCT00877929|2580261|P1|Overall Study|Lost to Follow-up|0
811252|NCT00877929|2580260|P2|Overall Study|Protocol Violation|3
811253|NCT00877929|2580261|P1|Overall Study|Protocol Violation|3
811254|NCT00877929|2580260|P2|Overall Study|Adverse Event|20
811255|NCT00877929|2580261|P1|Overall Study|Adverse Event|11
811256|NCT00881959|2580403|P2|Overall Study|Lost to Follow-up|4
811257|NCT00881959|2580404|P1|Overall Study|Lost to Follow-up|2
811258|NCT00882310|2580421|P1|Overall Study|Adverse Event|1
811259|NCT00882310|2580421|P1|Overall Study|Progression of disease|4
811260|NCT00882310|2580421|P1|Overall Study|Death|6
811261|NCT00882310|2580421|P1|Overall Study|Never received treatment|1
811262|NCT00882310|2580421|P1|Overall Study|Screen Failure|10
811263|NCT00882362|2580429|P2|Overall Study|change of residence or other commitments|0
811264|NCT00882362|2580430|P1|Overall Study|change of residence or other commitments|5
811265|NCT00882362|2580429|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
811266|NCT00882362|2580430|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
811267|NCT00882362|2580429|P2|Overall Study|Physician Decision|1
811268|NCT00882362|2580430|P1|Overall Study|Physician Decision|5
811269|NCT00882362|2580429|P2|Overall Study|Pregnancy|0
811270|NCT00882362|2580430|P1|Overall Study|Pregnancy|1
811271|NCT00882362|2580429|P2|Overall Study|Protocol Violation|2
811272|NCT00882362|2580430|P1|Overall Study|Protocol Violation|7
811273|NCT00882362|2580429|P2|Overall Study|Lack of Efficacy|0
811274|NCT00882362|2580430|P1|Overall Study|Lack of Efficacy|3
811275|NCT00882362|2580429|P2|Overall Study|Withdrawal by Subject|10
811276|NCT00882362|2580430|P1|Overall Study|Withdrawal by Subject|13
811277|NCT00882362|2580429|P2|Overall Study|Adverse Event|10
811278|NCT00882362|2580430|P1|Overall Study|Adverse Event|13
811279|NCT00882440|2580443|P7|Overall Study|Patient Uncooperative|0
811280|NCT00882440|2580444|P6|Overall Study|Patient Uncooperative|0
811281|NCT00882440|2580445|P5|Overall Study|Patient Uncooperative|1
811282|NCT00882440|2580446|P4|Overall Study|Patient Uncooperative|0
811283|NCT00882440|2580447|P3|Overall Study|Patient Uncooperative|0
811284|NCT00882440|2580448|P2|Overall Study|Patient Uncooperative|0
811285|NCT00882440|2580449|P1|Overall Study|Patient Uncooperative|2
811286|NCT00882440|2580443|P7|Overall Study|Withdrawal by Subject|1
811287|NCT00882440|2580444|P6|Overall Study|Withdrawal by Subject|0
811288|NCT00882440|2580445|P5|Overall Study|Withdrawal by Subject|6
811289|NCT00882440|2580446|P4|Overall Study|Withdrawal by Subject|0
811290|NCT00882440|2580447|P3|Overall Study|Withdrawal by Subject|1
811291|NCT00882440|2580448|P2|Overall Study|Withdrawal by Subject|1
811292|NCT00882440|2580449|P1|Overall Study|Withdrawal by Subject|2
811293|NCT00882440|2580443|P7|Overall Study|Protocol Violation|0
811294|NCT00882440|2580444|P6|Overall Study|Protocol Violation|0
811295|NCT00882440|2580445|P5|Overall Study|Protocol Violation|1
811296|NCT00882440|2580446|P4|Overall Study|Protocol Violation|1
811297|NCT00882440|2580447|P3|Overall Study|Protocol Violation|1
811298|NCT00882440|2580448|P2|Overall Study|Protocol Violation|0
811299|NCT00882440|2580449|P1|Overall Study|Protocol Violation|0
811300|NCT00882440|2580443|P7|Overall Study|Lost to Follow-up|1
811301|NCT00882440|2580444|P6|Overall Study|Lost to Follow-up|0
811302|NCT00882440|2580445|P5|Overall Study|Lost to Follow-up|1
811303|NCT00882440|2580446|P4|Overall Study|Lost to Follow-up|1
811304|NCT00882440|2580447|P3|Overall Study|Lost to Follow-up|1
811305|NCT00882440|2580448|P2|Overall Study|Lost to Follow-up|0
811306|NCT00882440|2580449|P1|Overall Study|Lost to Follow-up|2
811307|NCT00882440|2580443|P7|Overall Study|Lack of Efficacy|0
811308|NCT00882440|2580444|P6|Overall Study|Lack of Efficacy|3
811309|NCT00882440|2580445|P5|Overall Study|Lack of Efficacy|0
811310|NCT00882440|2580446|P4|Overall Study|Lack of Efficacy|0
811311|NCT00882440|2580447|P3|Overall Study|Lack of Efficacy|2
811312|NCT00882440|2580448|P2|Overall Study|Lack of Efficacy|5
811313|NCT00882440|2580449|P1|Overall Study|Lack of Efficacy|3
811314|NCT00882440|2580443|P7|Overall Study|Adverse Event|2
811315|NCT00882440|2580444|P6|Overall Study|Adverse Event|4
811316|NCT00882440|2580445|P5|Overall Study|Adverse Event|1
811317|NCT00882440|2580446|P4|Overall Study|Adverse Event|1
811318|NCT00882440|2580447|P3|Overall Study|Adverse Event|2
811319|NCT00882440|2580448|P2|Overall Study|Adverse Event|2
811320|NCT00882440|2580449|P1|Overall Study|Adverse Event|2
811321|NCT00882518|2580474|P2|Overall Study|Allocating random number by mistake|1
811322|NCT00882518|2580475|P1|Overall Study|Allocating random number by mistake|0
811323|NCT00882518|2580474|P2|Overall Study|Central lab closure for National day|0
811324|NCT00882518|2580475|P1|Overall Study|Central lab closure for National day|1
811325|NCT00882518|2580474|P2|Overall Study|Incorrect enrolment|2
811326|NCT00882518|2580475|P1|Overall Study|Incorrect enrolment|4
811327|NCT00882518|2580474|P2|Overall Study|Severe non-compliance to protocol|1
811328|NCT00882518|2580475|P1|Overall Study|Severe non-compliance to protocol|3
811329|NCT00882518|2580474|P2|Overall Study|Lack of Efficacy|9
811330|NCT00882518|2580475|P1|Overall Study|Lack of Efficacy|12
811331|NCT00882518|2580474|P2|Overall Study|Withdrawal by Subject|13
811332|NCT00882518|2580475|P1|Overall Study|Withdrawal by Subject|9
811333|NCT00882518|2580474|P2|Overall Study|Adverse Event|18
811334|NCT00882518|2580475|P1|Overall Study|Adverse Event|9
811341|NCT00882583|2580520|P2|Overall Study|Adverse Event|1
811342|NCT00882583|2580521|P1|Overall Study|Adverse Event|0
811343|NCT00882583|2580520|P2|Overall Study|Physician Decision|0
811344|NCT00882583|2580521|P1|Overall Study|Physician Decision|1
811345|NCT00882713|2580596|P1|Overall Study|Other - Reasons|2
811346|NCT00882713|2580596|P1|Overall Study|Failure to return|2
811347|NCT00882713|2580596|P1|Overall Study|Insufficient therapeutic response|3
811348|NCT00882713|2580596|P1|Overall Study|Blood transfusion|2
811349|NCT00882713|2580596|P1|Overall Study|refused treatment/withdrew consent|4
811350|NCT00882713|2580596|P1|Overall Study|Administrative reasons|4
811351|NCT00882713|2580596|P1|Overall Study|Death|3
811352|NCT00882713|2580596|P1|Overall Study|Adverse Event|2
811353|NCT00882908|2580654|P5|Overall Study|Study terminated in error|0
811354|NCT00882908|2580655|P4|Overall Study|Study terminated in error|1
811355|NCT00882908|2580656|P3|Overall Study|Study terminated in error|0
811356|NCT00882908|2580657|P2|Overall Study|Study terminated in error|0
811357|NCT00882908|2580658|P1|Overall Study|Study terminated in error|0
811358|NCT00882908|2580654|P5|Overall Study|Subject reached a virologic endpoint|1
811359|NCT00882908|2580655|P4|Overall Study|Subject reached a virologic endpoint|0
811360|NCT00882908|2580656|P3|Overall Study|Subject reached a virologic endpoint|0
811361|NCT00882908|2580657|P2|Overall Study|Subject reached a virologic endpoint|0
811362|NCT00882908|2580658|P1|Overall Study|Subject reached a virologic endpoint|0
811363|NCT00882908|2580654|P5|Overall Study|Withdrawal by Subject|2
811364|NCT00882908|2580655|P4|Overall Study|Withdrawal by Subject|5
811365|NCT00882908|2580656|P3|Overall Study|Withdrawal by Subject|3
811366|NCT00882908|2580657|P2|Overall Study|Withdrawal by Subject|0
811367|NCT00882908|2580658|P1|Overall Study|Withdrawal by Subject|0
811368|NCT00882908|2580654|P5|Overall Study|Protocol Violation|0
811369|NCT00882908|2580655|P4|Overall Study|Protocol Violation|0
811370|NCT00882908|2580656|P3|Overall Study|Protocol Violation|0
811371|NCT00882908|2580657|P2|Overall Study|Protocol Violation|1
811372|NCT00882908|2580658|P1|Overall Study|Protocol Violation|0
811373|NCT00882908|2580654|P5|Overall Study|Lost to Follow-up|2
811374|NCT00882908|2580655|P4|Overall Study|Lost to Follow-up|1
811375|NCT00882908|2580656|P3|Overall Study|Lost to Follow-up|3
811376|NCT00882908|2580657|P2|Overall Study|Lost to Follow-up|5
811377|NCT00882908|2580658|P1|Overall Study|Lost to Follow-up|3
811378|NCT00882908|2580654|P5|Overall Study|Adverse Event|1
811379|NCT00882908|2580655|P4|Overall Study|Adverse Event|0
811380|NCT00882908|2580656|P3|Overall Study|Adverse Event|1
811381|NCT00882908|2580657|P2|Overall Study|Adverse Event|0
811382|NCT00882908|2580658|P1|Overall Study|Adverse Event|0
811383|NCT00882921|2580733|P1|Overall Study|Withdrawal Of Consent|1
811384|NCT00882921|2580733|P1|Overall Study|Termination By Investigator|3
811385|NCT00882921|2580733|P1|Overall Study|Lost to Follow-up|2
811386|NCT00882921|2580733|P1|Overall Study|Not specified|3
811387|NCT00882921|2580733|P1|Overall Study|Death|2
811388|NCT00883090|2580738|P1|Overall Study|Withdrawal by Subject|1
811389|NCT00883090|2580738|P1|Overall Study|Sponsor's decision|1
811390|NCT00883116|2580764|P2|Overall Study|No longer meets study criteria|2
811391|NCT00883116|2580765|P1|Overall Study|No longer meets study criteria|2
811392|NCT00883116|2580764|P2|Overall Study|Withdrawal by Subject|8
811393|NCT00883116|2580765|P1|Overall Study|Withdrawal by Subject|14
811394|NCT00883116|2580764|P2|Overall Study|Study drug toxicity|16
811395|NCT00883116|2580765|P1|Overall Study|Study drug toxicity|36
811396|NCT00883116|2580764|P2|Overall Study|Not identified|6
811397|NCT00883116|2580765|P1|Overall Study|Not identified|3
811398|NCT00883116|2580764|P2|Overall Study|Maximum clinical benefit|46
811399|NCT00883116|2580765|P1|Overall Study|Maximum clinical benefit|13
811400|NCT00883116|2580764|P2|Overall Study|Lost to Follow-up|1
811401|NCT00883116|2580765|P1|Overall Study|Lost to Follow-up|0
811402|NCT00883116|2580764|P2|Overall Study|Disease progression|128
811403|NCT00883116|2580765|P1|Overall Study|Disease progression|130
811404|NCT00883116|2580764|P2|Overall Study|Death|2
811405|NCT00883116|2580765|P1|Overall Study|Death|6
811406|NCT00883116|2580764|P2|Overall Study|Adverse event unrelated to study drug|10
811407|NCT00883116|2580765|P1|Overall Study|Adverse event unrelated to study drug|5
811408|NCT00883129|2580780|P2|Overall Study|Defined Treatment Failure|2
811409|NCT00883129|2580781|P1|Overall Study|Defined Treatment Failure|0
811410|NCT00883129|2580780|P2|Overall Study|Death|2
811411|NCT00883129|2580781|P1|Overall Study|Death|1
811412|NCT00883129|2580780|P2|Overall Study|Lost to Follow-up|2
811413|NCT00883129|2580781|P1|Overall Study|Lost to Follow-up|1
811414|NCT00883129|2580780|P2|Overall Study|Non-compliance|6
811415|NCT00883129|2580781|P1|Overall Study|Non-compliance|3
811416|NCT00883129|2580780|P2|Overall Study|Withdrawal by Subject|9
811417|NCT00883129|2580781|P1|Overall Study|Withdrawal by Subject|8
811418|NCT00883129|2580780|P2|Overall Study|Adverse Event|15
811419|NCT00883129|2580781|P1|Overall Study|Adverse Event|7
811420|NCT00883181|2580828|P1|Overall Study|Noncompliance|3
811421|NCT00883181|2580828|P1|Overall Study|Protocol Deviation|3
811422|NCT00883181|2580828|P1|Overall Study|Other|38
811423|NCT00883181|2580828|P1|Overall Study|Death|31
811424|NCT00883181|2580828|P1|Overall Study|Withdrawal by Subject|4
811425|NCT00883181|2580828|P1|Overall Study|Administrative Reason|24
811426|NCT00883181|2580828|P1|Overall Study|Disease Progression|94
811427|NCT00883181|2580828|P1|Overall Study|Non-hematological Adverse Event|55
811428|NCT00883181|2580828|P1|Overall Study|Hematological Adverse Event|26
811429|NCT00883337|2581075|P3|Extension Treatment Period|Other than above|5
811430|NCT00883337|2581076|P2|Extension Treatment Period|Other than above|9
811431|NCT00883337|2581077|P1|Extension Treatment Period|Other than above|10
811432|NCT00883337|2581075|P3|Extension Treatment Period|Lost to Follow-up|0
811433|NCT00883337|2581076|P2|Extension Treatment Period|Lost to Follow-up|0
811434|NCT00883337|2581077|P1|Extension Treatment Period|Lost to Follow-up|1
811435|NCT00883337|2581075|P3|Extension Treatment Period|Poor compliance to protocol|1
811436|NCT00883337|2581076|P2|Extension Treatment Period|Poor compliance to protocol|1
811437|NCT00883337|2581077|P1|Extension Treatment Period|Poor compliance to protocol|1
811438|NCT00883337|2581075|P3|Extension Treatment Period|Lack of Efficacy|8
811439|NCT00883337|2581076|P2|Extension Treatment Period|Lack of Efficacy|8
811440|NCT00883337|2581077|P1|Extension Treatment Period|Lack of Efficacy|8
811441|NCT00883337|2581075|P3|Extension Treatment Period|Adverse Event|5
811442|NCT00883337|2581076|P2|Extension Treatment Period|Adverse Event|5
811443|NCT00883337|2581077|P1|Extension Treatment Period|Adverse Event|8
811444|NCT00883337|2581075|P3|Core Treatment Period|Other than above|1
811445|NCT00883337|2581076|P2|Core Treatment Period|Other than above|1
811446|NCT00883337|2581077|P1|Core Treatment Period|Other than above|0
811447|NCT00883337|2581075|P3|Core Treatment Period|Poor compliance to protocol|1
811448|NCT00883337|2581076|P2|Core Treatment Period|Poor compliance to protocol|0
811449|NCT00883337|2581077|P1|Core Treatment Period|Poor compliance to protocol|0
811450|NCT00883337|2581075|P3|Core Treatment Period|Wish to be pregnant|1
811451|NCT00883337|2581076|P2|Core Treatment Period|Wish to be pregnant|2
811452|NCT00883337|2581077|P1|Core Treatment Period|Wish to be pregnant|1
811453|NCT00883337|2581075|P3|Core Treatment Period|Withdrawal by Subject|6
811454|NCT00883337|2581076|P2|Core Treatment Period|Withdrawal by Subject|2
811455|NCT00883337|2581077|P1|Core Treatment Period|Withdrawal by Subject|2
811456|NCT00883337|2581075|P3|Core Treatment Period|Lost to Follow-up|0
811457|NCT00883337|2581076|P2|Core Treatment Period|Lost to Follow-up|1
811458|NCT00883337|2581077|P1|Core Treatment Period|Lost to Follow-up|1
811459|NCT00883337|2581075|P3|Core Treatment Period|Lack of Efficacy|2
811460|NCT00883337|2581076|P2|Core Treatment Period|Lack of Efficacy|4
811461|NCT00883337|2581077|P1|Core Treatment Period|Lack of Efficacy|7
811462|NCT00883337|2581075|P3|Core Treatment Period|Adverse Event|22
811463|NCT00883337|2581076|P2|Core Treatment Period|Adverse Event|12
811464|NCT00883337|2581077|P1|Core Treatment Period|Adverse Event|9
811465|NCT00883493|2581115|P2|Overall Study|Not specified|3
811466|NCT00883493|2581116|P1|Overall Study|Not specified|5
811467|NCT00883493|2581115|P2|Overall Study|Study specific disc. criteria|0
811468|NCT00883493|2581116|P1|Overall Study|Study specific disc. criteria|2
811469|NCT00883493|2581115|P2|Overall Study|Eligibility Criteria not fullfilled|6
811470|NCT00883493|2581116|P1|Overall Study|Eligibility Criteria not fullfilled|6
811471|NCT00883493|2581115|P2|Overall Study|Withdrawal by Subject|20
811472|NCT00883493|2581116|P1|Overall Study|Withdrawal by Subject|11
811473|NCT00883493|2581115|P2|Overall Study|Lost to Follow-up|6
811474|NCT00883493|2581116|P1|Overall Study|Lost to Follow-up|7
811475|NCT00883493|2581115|P2|Overall Study|Lack of Efficacy|3
811476|NCT00883493|2581116|P1|Overall Study|Lack of Efficacy|4
811477|NCT00883493|2581115|P2|Overall Study|Adverse Event|12
811478|NCT00883493|2581116|P1|Overall Study|Adverse Event|11
811479|NCT00883558|2581140|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
811480|NCT00883558|2581141|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
811481|NCT00883558|2581142|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
811482|NCT00883558|2581140|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
811483|NCT00883558|2581141|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
811484|NCT00883558|2581142|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
811485|NCT00883558|2581140|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
811486|NCT00883558|2581141|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
811487|NCT00883558|2581142|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
811488|NCT00883558|2581140|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
811489|NCT00883558|2581141|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
811490|NCT00883558|2581142|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
811491|NCT00883558|2581140|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
811492|NCT00883558|2581141|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
811493|NCT00883558|2581142|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
811494|NCT00883740|2581156|P2|Second Intervention|No longer willing to participate|1
811495|NCT00883740|2581157|P1|Second Intervention|No longer willing to participate|0
811496|NCT00883740|2581156|P2|Second Intervention|Protocol Violation|0
811497|NCT00883740|2581157|P1|Second Intervention|Protocol Violation|1
811498|NCT00883740|2581156|P2|First Intervention|Adverse Event|2
811499|NCT00883740|2581157|P1|First Intervention|Adverse Event|1
811500|NCT00883740|2581156|P2|First Intervention|Protocol Violation|6
811501|NCT00883740|2581157|P1|First Intervention|Protocol Violation|3
811502|NCT00883740|2581156|P2|First Intervention|No longer willing to participate|0
811503|NCT00883740|2581157|P1|First Intervention|No longer willing to participate|2
811504|NCT00883740|2581156|P2|First Intervention|Lost to Follow-up|0
811505|NCT00883740|2581157|P1|First Intervention|Lost to Follow-up|1
811506|NCT00883753|2581197|P1|Overall Study|Administrative/Other|8
811507|NCT00883753|2581197|P1|Overall Study|Investigator's decision|17
811508|NCT00883753|2581197|P1|Overall Study|Withdrew consent|10
811509|NCT00883753|2581197|P1|Overall Study|Refused treatment|4
811510|NCT00883753|2581197|P1|Overall Study|Protocol Violation|2
811511|NCT00883753|2581197|P1|Overall Study|Violation of selection criteria at entry|7
811512|NCT00883753|2581197|P1|Overall Study|Lost to Follow-up|4
811513|NCT00883753|2581197|P1|Overall Study|Insufficient therapeutic response|16
811514|NCT00883753|2581197|P1|Overall Study|Death|2
811515|NCT00883753|2581197|P1|Overall Study|Adverse Event|37
811516|NCT00883779|2581239|P2|Off-study Phase|Unspecified|21
811517|NCT00883779|2581240|P1|Off-study Phase|Unspecified|18
811518|NCT00883779|2581239|P2|Off-study Phase|Failure to return|6
811519|NCT00883779|2581240|P1|Off-study Phase|Failure to return|5
811520|NCT00883779|2581239|P2|Off-study Phase|Refused treatment|1
811521|NCT00883779|2581240|P1|Off-study Phase|Refused treatment|1
811522|NCT00883779|2581239|P2|Off-study Phase|Death|174
811523|NCT00883779|2581240|P1|Off-study Phase|Death|185
811524|NCT00883779|2581239|P2|Post-Study Treatment Phase|Ongoing in the study|6
811525|NCT00883779|2581240|P1|Post-Study Treatment Phase|Ongoing in the study|0
811526|NCT00883779|2581239|P2|Post-Study Treatment Phase|Unspecified|0
811527|NCT00883779|2581240|P1|Post-Study Treatment Phase|Unspecified|3
811528|NCT00883779|2581239|P2|Post-Study Treatment Phase|Disease progression|122
811529|NCT00883779|2581240|P1|Post-Study Treatment Phase|Disease progression|103
811530|NCT00883779|2581239|P2|Post-Study Treatment Phase|Refused Treatment|0
811531|NCT00883779|2581240|P1|Post-Study Treatment Phase|Refused Treatment|3
811532|NCT00883779|2581239|P2|Post-Study Treatment Phase|Protocol Violation|1
811533|NCT00883779|2581240|P1|Post-Study Treatment Phase|Protocol Violation|0
811534|NCT00883779|2581239|P2|Post-Study Treatment Phase|Death|3
811535|NCT00883779|2581240|P1|Post-Study Treatment Phase|Death|1
811536|NCT00883779|2581239|P2|Post-Study Treatment Phase|Adverse Event|3
811537|NCT00883779|2581240|P1|Post-Study Treatment Phase|Adverse Event|2
811538|NCT00883779|2581239|P2|Primary Study Treatment Phase|Unspecified|0
811539|NCT00883779|2581240|P1|Primary Study Treatment Phase|Unspecified|3
811540|NCT00883779|2581239|P2|Primary Study Treatment Phase|Refused Treatment|4
811541|NCT00883779|2581240|P1|Primary Study Treatment Phase|Refused Treatment|5
811542|NCT00883779|2581239|P2|Primary Study Treatment Phase|Death|3
811543|NCT00883779|2581240|P1|Primary Study Treatment Phase|Death|2
811544|NCT00883779|2581239|P2|Primary Study Treatment Phase|Adverse Event|16
811545|NCT00883779|2581240|P1|Primary Study Treatment Phase|Adverse Event|16
811546|NCT00883779|2581239|P2|Primary Study Treatment Phase|Disease progression|59
811547|NCT00883779|2581240|P1|Primary Study Treatment Phase|Disease progression|75
811548|NCT00883779|2581239|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
811549|NCT00883779|2581240|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
811550|NCT00884039|2581278|P2|Overall Study|Lack of Efficacy|0
811551|NCT00884039|2581279|P1|Overall Study|Lack of Efficacy|2
811552|NCT00884039|2581278|P2|Overall Study|Withdrawal by Subject|1
811553|NCT00884039|2581279|P1|Overall Study|Withdrawal by Subject|0
811554|NCT00884117|2581304|P1|Overall Study|Not Specified|12
811555|NCT00884117|2581304|P1|Overall Study|Lost to Follow-up|143
811556|NCT00884117|2581304|P1|Overall Study|Death|3
811557|NCT00884117|2581304|P1|Overall Study|Withdrawal by Subject|89
811558|NCT00884117|2581304|P1|Overall Study|Adverse Event|2
811559|NCT00884221|2581348|P2|Overall Study|Cancellation of Cycle and Other Reason|13
811560|NCT00884221|2581349|P1|Overall Study|Cancellation of Cycle and Other Reason|12
811561|NCT00884221|2581348|P2|Overall Study|Protocol Violation|13
811562|NCT00884221|2581349|P1|Overall Study|Protocol Violation|16
811563|NCT00884221|2581348|P2|Overall Study|Adverse Event|3
811564|NCT00884221|2581349|P1|Overall Study|Adverse Event|6
811565|NCT00884221|2581348|P2|Overall Study|Withdrawal by Subject|3
811566|NCT00884221|2581349|P1|Overall Study|Withdrawal by Subject|0
811567|NCT00884273|2581387|P2|Overall Study|Practical reasons|0
811568|NCT00884273|2581388|P1|Overall Study|Practical reasons|1
811569|NCT00884273|2581387|P2|Overall Study|Protocol Violation|3
811570|NCT00884273|2581388|P1|Overall Study|Protocol Violation|1
811571|NCT00884273|2581387|P2|Overall Study|Adverse Event|2
811572|NCT00884273|2581388|P1|Overall Study|Adverse Event|0
811573|NCT00884325|2581414|P2|Overall Study|Not provided|0
811574|NCT00884325|2581415|P1|Overall Study|Not provided|1
811575|NCT00884325|2581414|P2|Overall Study|Withdrawal by Subject|1
811576|NCT00884325|2581415|P1|Overall Study|Withdrawal by Subject|1
811577|NCT00884325|2581414|P2|Overall Study|Lack of Efficacy|1
811578|NCT00884325|2581415|P1|Overall Study|Lack of Efficacy|0
811579|NCT00884325|2581414|P2|Overall Study|Lost to Follow-up|2
811580|NCT00884325|2581415|P1|Overall Study|Lost to Follow-up|1
811581|NCT00884377|2581425|P2|Overall Study|Physician Decision|1
811582|NCT00884377|2581426|P1|Overall Study|Physician Decision|0
811583|NCT00884377|2581425|P2|Overall Study|Could not confirm diagnosis|0
811584|NCT00884377|2581426|P1|Overall Study|Could not confirm diagnosis|1
811585|NCT00884377|2581425|P2|Overall Study|Withdrawal by Subject|0
811586|NCT00884377|2581426|P1|Overall Study|Withdrawal by Subject|1
811587|NCT00884390|2581448|P2|Overall Study|Not specified|1
811588|NCT00884390|2581449|P1|Overall Study|Not specified|11
811589|NCT00884390|2581448|P2|Overall Study|Discontinuation of Study by Sponsor|2
811590|NCT00884390|2581449|P1|Overall Study|Discontinuation of Study by Sponsor|2
811591|NCT00884390|2581448|P2|Overall Study|Withdrawal by Subject|1
811592|NCT00884390|2581449|P1|Overall Study|Withdrawal by Subject|4
811593|NCT00884390|2581448|P2|Overall Study|Protocol Violation|1
811594|NCT00884390|2581449|P1|Overall Study|Protocol Violation|4
811595|NCT00884390|2581448|P2|Overall Study|Physician Decision|1
811596|NCT00884390|2581449|P1|Overall Study|Physician Decision|2
811597|NCT00884390|2581448|P2|Overall Study|Lost to Follow-up|1
811598|NCT00884390|2581449|P1|Overall Study|Lost to Follow-up|0
811599|NCT00884390|2581448|P2|Overall Study|Adverse Event|1
811600|NCT00884390|2581449|P1|Overall Study|Adverse Event|0
811601|NCT00873730|2581478|P2|Overall Study|Sponsor decision|0
811602|NCT00873730|2581479|P1|Overall Study|Sponsor decision|1
811603|NCT00873730|2581478|P2|Overall Study|Withdrawal by Subject|1
811604|NCT00873730|2581479|P1|Overall Study|Withdrawal by Subject|0
811605|NCT00873730|2581478|P2|Overall Study|Adverse Event|2
811606|NCT00873730|2581479|P1|Overall Study|Adverse Event|0
811607|NCT00873730|2581478|P2|Overall Study|Protocol Deviation|2
811608|NCT00873730|2581479|P1|Overall Study|Protocol Deviation|5
811609|NCT00873860|2581536|P4|Overall Study|Unspecified|0
811610|NCT00873860|2581537|P3|Overall Study|Unspecified|1
811611|NCT00873860|2581538|P2|Overall Study|Unspecified|0
811612|NCT00873860|2581539|P1|Overall Study|Unspecified|1
811613|NCT00873860|2581536|P4|Overall Study|Death|0
811614|NCT00873860|2581537|P3|Overall Study|Death|0
811615|NCT00873860|2581538|P2|Overall Study|Death|0
811616|NCT00873860|2581539|P1|Overall Study|Death|1
811617|NCT00873860|2581536|P4|Overall Study|Withdrawal by Subject|0
811618|NCT00873860|2581537|P3|Overall Study|Withdrawal by Subject|2
811619|NCT00873860|2581538|P2|Overall Study|Withdrawal by Subject|0
811620|NCT00873860|2581539|P1|Overall Study|Withdrawal by Subject|1
811621|NCT00873860|2581536|P4|Overall Study|Lost to Follow-up|1
811622|NCT00873860|2581537|P3|Overall Study|Lost to Follow-up|0
811623|NCT00873860|2581538|P2|Overall Study|Lost to Follow-up|0
811624|NCT00873860|2581539|P1|Overall Study|Lost to Follow-up|1
811625|NCT00873912|2581631|P2|Overall Study|Lost to Follow-up|0
811626|NCT00873912|2581632|P1|Overall Study|Lost to Follow-up|2
811627|NCT00873912|2581631|P2|Overall Study|Withdrawal by Subject|0
811628|NCT00873912|2581632|P1|Overall Study|Withdrawal by Subject|1
811629|NCT00874029|2581646|P1|Overall Study|Lost to Follow-up|5
811630|NCT00874029|2581646|P1|Overall Study|Adverse Event|1
811631|NCT00874029|2581646|P1|Overall Study|Physician Decision|1
811632|NCT00874029|2581646|P1|Overall Study|Pregnancy|4
811633|NCT00874029|2581646|P1|Overall Study|Withdrawal by Subject|10
811648|NCT00874276|2581690|P2|Overall Study|Withdrawal by Subject|1
811649|NCT00874276|2581691|P1|Overall Study|Withdrawal by Subject|1
811650|NCT00874497|2581701|P2|Overall Study|Withdrawal by Subject|4
811651|NCT00874497|2581702|P1|Overall Study|Withdrawal by Subject|5
811652|NCT00874497|2581701|P2|Overall Study|Physician Decision|1
811653|NCT00874497|2581702|P1|Overall Study|Physician Decision|1
811654|NCT00874497|2581701|P2|Overall Study|Met Withdrawal Criteria|2
811655|NCT00874497|2581702|P1|Overall Study|Met Withdrawal Criteria|4
811656|NCT00874497|2581701|P2|Overall Study|Sponsor Discontinued Trial|3
811657|NCT00874497|2581702|P1|Overall Study|Sponsor Discontinued Trial|7
811658|NCT00874497|2581701|P2|Overall Study|Adverse Event|4
811659|NCT00874497|2581702|P1|Overall Study|Adverse Event|9
811660|NCT00874497|2581701|P2|Overall Study|Lost to Follow-up|4
811661|NCT00874497|2581702|P1|Overall Study|Lost to Follow-up|2
811662|NCT00874549|2581753|P4|Overall Study|Withdrawal by Subject|1
811663|NCT00874549|2581754|P3|Overall Study|Withdrawal by Subject|0
811664|NCT00874549|2581755|P2|Overall Study|Withdrawal by Subject|1
811665|NCT00874549|2581756|P1|Overall Study|Withdrawal by Subject|0
811666|NCT00874549|2581753|P4|Overall Study|Lost to Follow-up|0
811667|NCT00874549|2581754|P3|Overall Study|Lost to Follow-up|1
811668|NCT00874549|2581755|P2|Overall Study|Lost to Follow-up|0
811669|NCT00874549|2581756|P1|Overall Study|Lost to Follow-up|0
811670|NCT00874549|2581753|P4|Overall Study|Protocol Violation|1
811671|NCT00874549|2581754|P3|Overall Study|Protocol Violation|2
811672|NCT00874549|2581755|P2|Overall Study|Protocol Violation|0
811673|NCT00874549|2581756|P1|Overall Study|Protocol Violation|1
811674|NCT00874549|2581753|P4|Overall Study|Adverse Event|0
811675|NCT00874549|2581754|P3|Overall Study|Adverse Event|1
811676|NCT00874549|2581755|P2|Overall Study|Adverse Event|0
811677|NCT00874549|2581756|P1|Overall Study|Adverse Event|0
811678|NCT00874770|2581826|P4|Overall Study|Subject no Longer Meets Study Criteria|0
811679|NCT00874770|2581827|P3|Overall Study|Subject no Longer Meets Study Criteria|0
811680|NCT00874770|2581828|P2|Overall Study|Subject no Longer Meets Study Criteria|0
811681|NCT00874770|2581829|P1|Overall Study|Subject no Longer Meets Study Criteria|1
811682|NCT00874770|2581826|P4|Overall Study|Lost to Follow-up|1
811683|NCT00874770|2581827|P3|Overall Study|Lost to Follow-up|0
811684|NCT00874770|2581828|P2|Overall Study|Lost to Follow-up|0
811685|NCT00874770|2581829|P1|Overall Study|Lost to Follow-up|1
811686|NCT00874770|2581826|P4|Overall Study|Adverse Event|2
811687|NCT00874770|2581827|P3|Overall Study|Adverse Event|4
811688|NCT00874770|2581828|P2|Overall Study|Adverse Event|1
811689|NCT00874770|2581829|P1|Overall Study|Adverse Event|1
811690|NCT00874770|2581826|P4|Overall Study|Lack of Efficacy|2
811691|NCT00874770|2581827|P3|Overall Study|Lack of Efficacy|0
811692|NCT00874770|2581828|P2|Overall Study|Lack of Efficacy|0
811693|NCT00874770|2581829|P1|Overall Study|Lack of Efficacy|2
811694|NCT00874822|2581863|P1|Overall Study|excluded by criteria|8
811695|NCT00874848|2581869|P2|Overall Study|Physician Decision|2
811696|NCT00874848|2581870|P1|Overall Study|Physician Decision|0
811697|NCT00874848|2581869|P2|Overall Study|Failure to comply with protocol|1
811698|NCT00874848|2581870|P1|Overall Study|Failure to comply with protocol|0
811699|NCT00874848|2581869|P2|Overall Study|Noncompliance|1
811700|NCT00874848|2581870|P1|Overall Study|Noncompliance|1
811701|NCT00874848|2581869|P2|Overall Study|Withdrawal by Subject|4
811702|NCT00874848|2581870|P1|Overall Study|Withdrawal by Subject|7
811703|NCT00874848|2581869|P2|Overall Study|Progressive neoplastic disease|18
811704|NCT00874848|2581870|P1|Overall Study|Progressive neoplastic disease|38
811705|NCT00874848|2581869|P2|Overall Study|Adverse Event|2
811706|NCT00874848|2581870|P1|Overall Study|Adverse Event|13
811707|NCT00874939|2581903|P1|Overall Study|Study terminated|4
811708|NCT00875017|2581923|P6|Fourth Intervention|Inability to comply with fasting|1
811709|NCT00875017|2581924|P5|Fourth Intervention|Inability to comply with fasting|0
811710|NCT00875017|2581925|P4|Fourth Intervention|Inability to comply with fasting|0
811711|NCT00875017|2581926|P3|Fourth Intervention|Inability to comply with fasting|0
811712|NCT00875017|2581927|P2|Fourth Intervention|Inability to comply with fasting|0
811713|NCT00875017|2581928|P1|Fourth Intervention|Inability to comply with fasting|0
811714|NCT00875017|2581923|P6|Washout|Withdrawal by Subject|0
811715|NCT00875017|2581924|P5|Washout|Withdrawal by Subject|1
811716|NCT00875017|2581925|P4|Washout|Withdrawal by Subject|0
811717|NCT00875017|2581926|P3|Washout|Withdrawal by Subject|0
811718|NCT00875017|2581927|P2|Washout|Withdrawal by Subject|0
811719|NCT00875017|2581928|P1|Washout|Withdrawal by Subject|0
811720|NCT00875017|2581923|P6|Third Intervention|Adverse Event|0
811721|NCT00875017|2581924|P5|Third Intervention|Adverse Event|0
811722|NCT00875017|2581925|P4|Third Intervention|Adverse Event|0
811723|NCT00875017|2581926|P3|Third Intervention|Adverse Event|1
811724|NCT00875017|2581927|P2|Third Intervention|Adverse Event|1
811725|NCT00875017|2581928|P1|Third Intervention|Adverse Event|0
811726|NCT00875017|2581923|P6|Washout|Problems collecting rectal effluent|0
811727|NCT00875017|2581924|P5|Washout|Problems collecting rectal effluent|0
811728|NCT00875017|2581925|P4|Washout|Problems collecting rectal effluent|0
811729|NCT00875017|2581926|P3|Washout|Problems collecting rectal effluent|0
811730|NCT00875017|2581927|P2|Washout|Problems collecting rectal effluent|1
811731|NCT00875017|2581928|P1|Washout|Problems collecting rectal effluent|0
811732|NCT00875017|2581923|P6|Second Intervention|Adverse Event|0
811733|NCT00875017|2581924|P5|Second Intervention|Adverse Event|0
811734|NCT00875017|2581925|P4|Second Intervention|Adverse Event|1
811735|NCT00875017|2581926|P3|Second Intervention|Adverse Event|0
811736|NCT00875017|2581927|P2|Second Intervention|Adverse Event|0
811737|NCT00875017|2581928|P1|Second Intervention|Adverse Event|0
811738|NCT00875017|2581923|P6|Washout|Problem collecting rectal effluent|0
811739|NCT00875017|2581924|P5|Washout|Problem collecting rectal effluent|0
811740|NCT00875017|2581925|P4|Washout|Problem collecting rectal effluent|0
811741|NCT00875017|2581926|P3|Washout|Problem collecting rectal effluent|1
811742|NCT00875017|2581927|P2|Washout|Problem collecting rectal effluent|0
811743|NCT00875017|2581928|P1|Washout|Problem collecting rectal effluent|0
811744|NCT00875017|2581923|P6|First Intervention|Intolerance to nasogastric tube|0
811745|NCT00875017|2581924|P5|First Intervention|Intolerance to nasogastric tube|1
811746|NCT00875017|2581925|P4|First Intervention|Intolerance to nasogastric tube|0
811747|NCT00875017|2581926|P3|First Intervention|Intolerance to nasogastric tube|0
811748|NCT00875017|2581927|P2|First Intervention|Intolerance to nasogastric tube|0
811749|NCT00875017|2581928|P1|First Intervention|Intolerance to nasogastric tube|0
811750|NCT00875017|2581923|P6|First Intervention|Problems collecting rectal effluent|0
811751|NCT00875017|2581924|P5|First Intervention|Problems collecting rectal effluent|0
811752|NCT00875017|2581925|P4|First Intervention|Problems collecting rectal effluent|0
811753|NCT00875017|2581926|P3|First Intervention|Problems collecting rectal effluent|0
811754|NCT00875017|2581927|P2|First Intervention|Problems collecting rectal effluent|0
811755|NCT00875017|2581928|P1|First Intervention|Problems collecting rectal effluent|1
811756|NCT00875017|2581923|P6|First Intervention|Adverse Event|0
811757|NCT00875017|2581924|P5|First Intervention|Adverse Event|0
811758|NCT00875017|2581925|P4|First Intervention|Adverse Event|1
811759|NCT00875017|2581926|P3|First Intervention|Adverse Event|0
811760|NCT00875017|2581927|P2|First Intervention|Adverse Event|0
811761|NCT00875017|2581928|P1|First Intervention|Adverse Event|0
811762|NCT00875017|2581923|P6|First Intervention|Withdrawal by Subject|0
811763|NCT00875017|2581924|P5|First Intervention|Withdrawal by Subject|0
811764|NCT00875017|2581925|P4|First Intervention|Withdrawal by Subject|0
811765|NCT00875017|2581926|P3|First Intervention|Withdrawal by Subject|1
811766|NCT00875017|2581927|P2|First Intervention|Withdrawal by Subject|0
811767|NCT00875017|2581928|P1|First Intervention|Withdrawal by Subject|1
811768|NCT00875420|2581975|P5|Overall Study|Withdrawal by Subject|0
811769|NCT00875420|2581976|P4|Overall Study|Withdrawal by Subject|0
811770|NCT00875420|2581977|P3|Overall Study|Withdrawal by Subject|1
811771|NCT00875420|2581978|P2|Overall Study|Withdrawal by Subject|0
811772|NCT00875420|2581979|P1|Overall Study|Withdrawal by Subject|0
811773|NCT00875420|2581975|P5|Overall Study|Sponsor decision|0
811774|NCT00875420|2581976|P4|Overall Study|Sponsor decision|0
811775|NCT00875420|2581977|P3|Overall Study|Sponsor decision|0
811776|NCT00875420|2581978|P2|Overall Study|Sponsor decision|1
811777|NCT00875420|2581979|P1|Overall Study|Sponsor decision|0
811778|NCT00875420|2581975|P5|Overall Study|Prohibited medication|0
811779|NCT00875420|2581976|P4|Overall Study|Prohibited medication|1
811780|NCT00875420|2581977|P3|Overall Study|Prohibited medication|0
811781|NCT00875420|2581978|P2|Overall Study|Prohibited medication|0
811782|NCT00875420|2581979|P1|Overall Study|Prohibited medication|0
811783|NCT00875420|2581975|P5|Overall Study|Personal reason|1
811784|NCT00875420|2581976|P4|Overall Study|Personal reason|0
811785|NCT00875420|2581977|P3|Overall Study|Personal reason|0
811786|NCT00875420|2581978|P2|Overall Study|Personal reason|0
811787|NCT00875420|2581979|P1|Overall Study|Personal reason|0
811788|NCT00875420|2581975|P5|Overall Study|Lost to Follow-up|0
811789|NCT00875420|2581976|P4|Overall Study|Lost to Follow-up|0
811790|NCT00875420|2581977|P3|Overall Study|Lost to Follow-up|0
811791|NCT00875420|2581978|P2|Overall Study|Lost to Follow-up|0
811792|NCT00875420|2581979|P1|Overall Study|Lost to Follow-up|1
811793|NCT00875420|2581975|P5|Overall Study|Inability to complete study procedures|1
811794|NCT00875420|2581976|P4|Overall Study|Inability to complete study procedures|1
811795|NCT00875420|2581977|P3|Overall Study|Inability to complete study procedures|1
811796|NCT00875420|2581978|P2|Overall Study|Inability to complete study procedures|0
811797|NCT00875420|2581979|P1|Overall Study|Inability to complete study procedures|1
811798|NCT00875420|2581975|P5|Overall Study|Adverse Event|0
811799|NCT00875420|2581976|P4|Overall Study|Adverse Event|0
811800|NCT00875420|2581977|P3|Overall Study|Adverse Event|1
811801|NCT00875420|2581978|P2|Overall Study|Adverse Event|1
811802|NCT00875420|2581979|P1|Overall Study|Adverse Event|0
811803|NCT00875433|2582006|P1|Overall Study|Not specified|3
811804|NCT00875433|2582006|P1|Overall Study|Withdrawal by Subject|2
811805|NCT00875433|2582006|P1|Overall Study|Other Adverse Event|14
811806|NCT00875433|2582006|P1|Overall Study|Progressive disease|41
811807|NCT00875485|2582033|P2|Challenge Dose Epoch|Pregnancy|0
811808|NCT00875485|2582034|P1|Challenge Dose Epoch|Pregnancy|1
811857|NCT00884832|2582108|P2|Overall Study|Withdrawal by Subject|1
811858|NCT00884832|2582109|P1|Overall Study|Withdrawal by Subject|0
811859|NCT00884949|2582155|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
811860|NCT00884949|2582155|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
811861|NCT00885105|2582198|P2|Overall Study|Protocol Violation|2
811862|NCT00885105|2582199|P1|Overall Study|Protocol Violation|0
811863|NCT00885105|2582198|P2|Overall Study|Adverse Event|0
811864|NCT00885105|2582199|P1|Overall Study|Adverse Event|1
811865|NCT00885105|2582198|P2|Overall Study|Withdrawal by Subject|8
811866|NCT00885105|2582199|P1|Overall Study|Withdrawal by Subject|0
811867|NCT00885118|2582220|P5|Overall Study|Other reason not defined above|0
811868|NCT00885118|2582221|P4|Overall Study|Other reason not defined above|0
811869|NCT00885118|2582222|P3|Overall Study|Other reason not defined above|1
811870|NCT00885118|2582223|P2|Overall Study|Other reason not defined above|0
811871|NCT00885118|2582224|P1|Overall Study|Other reason not defined above|0
811872|NCT00885118|2582220|P5|Overall Study|Withdrawal by Subject|1
811873|NCT00885118|2582221|P4|Overall Study|Withdrawal by Subject|0
811874|NCT00885118|2582222|P3|Overall Study|Withdrawal by Subject|0
811875|NCT00885118|2582223|P2|Overall Study|Withdrawal by Subject|0
811876|NCT00885118|2582224|P1|Overall Study|Withdrawal by Subject|0
811877|NCT00885118|2582220|P5|Overall Study|Adverse Event|0
811878|NCT00885118|2582221|P4|Overall Study|Adverse Event|0
811879|NCT00885118|2582222|P3|Overall Study|Adverse Event|0
811880|NCT00885118|2582223|P2|Overall Study|Adverse Event|0
811881|NCT00885118|2582224|P1|Overall Study|Adverse Event|1
811882|NCT00885170|2582363|P2|Overall Study|Withdrawal by Subject|13
811883|NCT00885170|2582364|P1|Overall Study|Withdrawal by Subject|13
811884|NCT00885170|2582363|P2|Overall Study|Protocol Violation|1
811885|NCT00885170|2582364|P1|Overall Study|Protocol Violation|3
811886|NCT00885170|2582363|P2|Overall Study|Physician Decision|1
811887|NCT00885170|2582364|P1|Overall Study|Physician Decision|2
811888|NCT00885170|2582363|P2|Overall Study|Lost to Follow-up|1
811889|NCT00885170|2582364|P1|Overall Study|Lost to Follow-up|2
811890|NCT00885170|2582363|P2|Overall Study|Excessive bone loss|3
811891|NCT00885170|2582364|P1|Overall Study|Excessive bone loss|6
811892|NCT00885170|2582363|P2|Overall Study|Adverse Event|4
811893|NCT00885170|2582364|P1|Overall Study|Adverse Event|12
811894|NCT00885352|2582420|P2|Overall Study|Lab abnormalities|1
811895|NCT00885352|2582421|P1|Overall Study|Lab abnormalities|1
811896|NCT00885352|2582420|P2|Overall Study|Excluded medication|2
811897|NCT00885352|2582421|P1|Overall Study|Excluded medication|2
811898|NCT00885352|2582420|P2|Overall Study|Contradiction to study medication|2
811899|NCT00885352|2582421|P1|Overall Study|Contradiction to study medication|0
811900|NCT00885352|2582420|P2|Overall Study|Withdrawal by Subject|5
811901|NCT00885352|2582421|P1|Overall Study|Withdrawal by Subject|1
811902|NCT00885352|2582420|P2|Overall Study|Protocol Violation|2
811903|NCT00885352|2582421|P1|Overall Study|Protocol Violation|0
811904|NCT00885352|2582420|P2|Overall Study|Physician Decision|3
811905|NCT00885352|2582421|P1|Overall Study|Physician Decision|0
811906|NCT00885352|2582420|P2|Overall Study|Lost to Follow-up|2
811907|NCT00885352|2582421|P1|Overall Study|Lost to Follow-up|2
811908|NCT00885352|2582420|P2|Overall Study|Adverse Event|3
811909|NCT00885352|2582421|P1|Overall Study|Adverse Event|2
811910|NCT00885365|2582433|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
811911|NCT00885365|2582434|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
811912|NCT00885365|2582433|P2|4 Weeks ON Treatment|Protocol Violation|2
811913|NCT00885365|2582434|P1|4 Weeks ON Treatment|Protocol Violation|1
811914|NCT00885365|2582433|P2|4 Weeks ON Treatment|Adverse Event|4
811915|NCT00885365|2582434|P1|4 Weeks ON Treatment|Adverse Event|2
811916|NCT00885378|2582470|P2|Overall Study|Protocol Violation|0
811917|NCT00885378|2582471|P1|Overall Study|Protocol Violation|2
811918|NCT00885378|2582470|P2|Overall Study|Poor/Noncompliance|2
811919|NCT00885378|2582471|P1|Overall Study|Poor/Noncompliance|2
811920|NCT00885378|2582470|P2|Overall Study|Lost to Follow-up|2
811921|NCT00885378|2582471|P1|Overall Study|Lost to Follow-up|1
811922|NCT00885378|2582470|P2|Overall Study|Withdrawal by Subject|2
811923|NCT00885378|2582471|P1|Overall Study|Withdrawal by Subject|1
811924|NCT00885378|2582470|P2|Overall Study|Lack of Efficacy|2
811925|NCT00885378|2582471|P1|Overall Study|Lack of Efficacy|2
811926|NCT00885482|2582499|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
811927|NCT00885482|2582499|P1|Overall Study|Death|1
811928|NCT00885482|2582499|P1|Overall Study|Lack of Efficacy|1
811929|NCT00885482|2582499|P1|Overall Study|Pregnancy|1
811930|NCT00885534|2582503|P1|Overall Study|Patient deemed ineligible|1
811931|NCT00885677|2582517|P2|Overall Study|Inclusion/exclusion not met|27
811932|NCT00885677|2582518|P1|Overall Study|Inclusion/exclusion not met|25
811933|NCT00885677|2582517|P2|Overall Study|Heart transplantation|0
811934|NCT00885677|2582518|P1|Overall Study|Heart transplantation|1
811935|NCT00885677|2582517|P2|Overall Study|device/lead revision or replacement|6
811936|NCT00885677|2582518|P1|Overall Study|device/lead revision or replacement|7
811937|NCT00885677|2582517|P2|Overall Study|premature study closure|44
811938|NCT00885677|2582518|P1|Overall Study|premature study closure|41
811939|NCT00885677|2582517|P2|Overall Study|Protocol Violation|54
811940|NCT00885677|2582518|P1|Overall Study|Protocol Violation|54
811941|NCT00885677|2582517|P2|Overall Study|Lost to Follow-up|13
811942|NCT00885677|2582518|P1|Overall Study|Lost to Follow-up|15
811943|NCT00885677|2582517|P2|Overall Study|Death|34
811944|NCT00885677|2582518|P1|Overall Study|Death|40
811945|NCT00885755|2582540|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
811946|NCT00885755|2582541|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
811947|NCT00885755|2582542|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
811948|NCT00885755|2582540|P3|Part I: Trastuzumab+Taxane|Death|1
811949|NCT00885755|2582541|P2|Part I: Trastuzumab+Taxane|Death|0
811950|NCT00885755|2582542|P1|Part I: Trastuzumab+Taxane|Death|0
811951|NCT00885755|2582540|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
811952|NCT00885755|2582541|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
811953|NCT00885755|2582542|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
811954|NCT00885755|2582540|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
811955|NCT00885755|2582541|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
811956|NCT00885755|2582542|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
811957|NCT00885755|2582540|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
811958|NCT00885755|2582541|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
811959|NCT00885755|2582542|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
811960|NCT00885846|2582574|P3|Overall Study|Withdrawal by Subject|2
811961|NCT00885846|2582575|P2|Overall Study|Withdrawal by Subject|5
811962|NCT00885846|2582576|P1|Overall Study|Withdrawal by Subject|2
811963|NCT00886015|2582586|P2|Overall Study|Death|2
811964|NCT00886015|2582587|P1|Overall Study|Death|0
811965|NCT00886119|2582603|P2|Period 1|Did not meet inclusion criteria|0
811966|NCT00886119|2582604|P1|Period 1|Did not meet inclusion criteria|1
811967|NCT00886288|2582618|P2|Overall Study|Lost to Follow-up|0
811968|NCT00886288|2582619|P1|Overall Study|Lost to Follow-up|86
811969|NCT00886288|2582618|P2|Overall Study|no respect of the 12 weeks period|227
811970|NCT00886288|2582619|P1|Overall Study|no respect of the 12 weeks period|657
811971|NCT00886340|2582637|P2|Overall Study|Withdrawal by Subject|7
811972|NCT00886340|2582638|P1|Overall Study|Withdrawal by Subject|0
811973|NCT00886483|2582646|P2|Overall Study|Distance to center, poor grades|0
811974|NCT00886483|2582647|P1|Overall Study|Distance to center, poor grades|1
811975|NCT00886483|2582646|P2|Overall Study|Pursue medications|2
811976|NCT00886483|2582647|P1|Overall Study|Pursue medications|1
811977|NCT00886483|2582646|P2|Overall Study|Lost to Follow-up|1
811978|NCT00886483|2582647|P1|Overall Study|Lost to Follow-up|0
811979|NCT00886587|2582665|P2|Overall Study|Withdrawal by Subject|1
811980|NCT00886587|2582666|P1|Overall Study|Withdrawal by Subject|0
811981|NCT00886587|2582665|P2|Overall Study|Protocol Violation|0
811982|NCT00886587|2582666|P1|Overall Study|Protocol Violation|2
811983|NCT00886587|2582665|P2|Overall Study|Adverse Event|1
811984|NCT00886587|2582666|P1|Overall Study|Adverse Event|2
811985|NCT00886600|2582682|P4|Combination Therapy Period|Protocol Violation|0
811986|NCT00886600|2582683|P3|Combination Therapy Period|Protocol Violation|1
811987|NCT00886600|2582684|P2|Combination Therapy Period|Protocol Violation|0
811988|NCT00886600|2582685|P1|Combination Therapy Period|Protocol Violation|0
811989|NCT00886600|2582682|P4|Combination Therapy Period|Adverse Event|0
811990|NCT00886600|2582683|P3|Combination Therapy Period|Adverse Event|1
811991|NCT00886600|2582684|P2|Combination Therapy Period|Adverse Event|0
811992|NCT00886600|2582685|P1|Combination Therapy Period|Adverse Event|0
811993|NCT00886600|2582682|P4|Double-blind Monotherapy|Withdrawal by Subject|0
811994|NCT00886600|2582683|P3|Double-blind Monotherapy|Withdrawal by Subject|0
811995|NCT00886600|2582684|P2|Double-blind Monotherapy|Withdrawal by Subject|0
811996|NCT00886600|2582685|P1|Double-blind Monotherapy|Withdrawal by Subject|1
811997|NCT00886600|2582682|P4|Double-blind Monotherapy|Protocol Violation|1
811998|NCT00886600|2582683|P3|Double-blind Monotherapy|Protocol Violation|0
811999|NCT00886600|2582684|P2|Double-blind Monotherapy|Protocol Violation|0
812000|NCT00886600|2582685|P1|Double-blind Monotherapy|Protocol Violation|0
812001|NCT00886600|2582682|P4|Double-blind Monotherapy|Adverse Event|1
812002|NCT00886600|2582683|P3|Double-blind Monotherapy|Adverse Event|1
812003|NCT00886600|2582684|P2|Double-blind Monotherapy|Adverse Event|1
812004|NCT00886600|2582685|P1|Double-blind Monotherapy|Adverse Event|1
812005|NCT00886613|2582710|P3|Overall Study|Subject withdrew consent (Part A)|2
812006|NCT00886613|2582711|P2|Overall Study|Subject withdrew consent (Part A)|0
812007|NCT00886613|2582712|P1|Overall Study|Subject withdrew consent (Part A)|0
812008|NCT00886613|2582710|P3|Overall Study|Lost to follow-up (Part B)|1
812009|NCT00886613|2582711|P2|Overall Study|Lost to follow-up (Part B)|0
812010|NCT00886613|2582712|P1|Overall Study|Lost to follow-up (Part B)|1
812011|NCT00886613|2582710|P3|Overall Study|Protocol deviation (Part B)|0
812012|NCT00886613|2582711|P2|Overall Study|Protocol deviation (Part B)|0
812013|NCT00886613|2582712|P1|Overall Study|Protocol deviation (Part B)|1
812014|NCT00886639|2582737|P1|Overall Study|non-compliance|2
812015|NCT00886639|2582737|P1|Overall Study|acute exacerbation|14
812016|NCT00886743|2582752|P1|Overall Study|Unspecified|1
812017|NCT00886743|2582752|P1|Overall Study|Adverse Event|3
812018|NCT00886769|2582762|P2|Overall Study|Unsatisfactory therapeutic effect|37
812019|NCT00886769|2582763|P1|Overall Study|Unsatisfactory therapeutic effect|6
812020|NCT00886795|2582787|P1|Overall Study|Lack of Efficacy|1
812021|NCT00886821|2582806|P14|Stage 2|Lost to Follow-up|1
812022|NCT00886821|2582807|P13|Stage 2|Lost to Follow-up|2
812023|NCT00886821|2582808|P12|Stage 2|Lost to Follow-up|0
812024|NCT00886821|2582809|P11|Stage 2|Lost to Follow-up|0
812025|NCT00886821|2582810|P10|Stage 2|Lost to Follow-up|0
812026|NCT00886821|2582811|P9|Stage 2|Lost to Follow-up|0
812027|NCT00886821|2582812|P8|Stage 2|Lost to Follow-up|0
812028|NCT00886821|2582813|P7|Stage 2|Lost to Follow-up|0
812029|NCT00886821|2582814|P6|Stage 2|Lost to Follow-up|0
812030|NCT00886821|2582815|P5|Stage 2|Lost to Follow-up|0
812031|NCT00886821|2582816|P4|Stage 2|Lost to Follow-up|0
812032|NCT00886821|2582817|P3|Stage 2|Lost to Follow-up|0
812033|NCT00886821|2582818|P2|Stage 2|Lost to Follow-up|0
812034|NCT00886821|2582819|P1|Stage 2|Lost to Follow-up|0
812035|NCT00886821|2582806|P14|Stage 2|Adverse Event|0
812036|NCT00886821|2582807|P13|Stage 2|Adverse Event|3
812037|NCT00886821|2582808|P12|Stage 2|Adverse Event|1
812038|NCT00886821|2582809|P11|Stage 2|Adverse Event|0
812039|NCT00886821|2582810|P10|Stage 2|Adverse Event|0
812040|NCT00886821|2582811|P9|Stage 2|Adverse Event|0
812041|NCT00886821|2582812|P8|Stage 2|Adverse Event|0
812042|NCT00886821|2582813|P7|Stage 2|Adverse Event|0
812043|NCT00886821|2582814|P6|Stage 2|Adverse Event|0
812044|NCT00886821|2582815|P5|Stage 2|Adverse Event|0
812045|NCT00886821|2582816|P4|Stage 2|Adverse Event|0
812046|NCT00886821|2582817|P3|Stage 2|Adverse Event|0
812047|NCT00886821|2582818|P2|Stage 2|Adverse Event|0
812048|NCT00886821|2582819|P1|Stage 2|Adverse Event|0
812049|NCT00886834|2583046|P2|Overall Study|Protocol Violation|3
812050|NCT00886834|2583047|P1|Overall Study|Protocol Violation|0
812051|NCT00886938|2583062|P1|Overall Study|Withdrawal by Subject|1
812052|NCT00886938|2583062|P1|Overall Study|Adverse Event|1
812053|NCT00887159|2583069|P3|Overall Study|Never started assigned therapy|4
812054|NCT00887159|2583070|P2|Overall Study|Never started assigned therapy|3
812055|NCT00887159|2583071|P1|Overall Study|Never started assigned therapy|3
812056|NCT00887159|2583069|P3|Overall Study|Ineligible|0
812057|NCT00887159|2583070|P2|Overall Study|Ineligible|1
812058|NCT00887159|2583071|P1|Overall Study|Ineligible|5
812059|NCT00887159|2583069|P3|Overall Study|Received more tx instead of observation|0
812060|NCT00887159|2583070|P2|Overall Study|Received more tx instead of observation|0
812061|NCT00887159|2583071|P1|Overall Study|Received more tx instead of observation|1
812062|NCT00887159|2583069|P3|Overall Study|Pt had PD but was SD when re-measured|0
812063|NCT00887159|2583070|P2|Overall Study|Pt had PD but was SD when re-measured|1
812064|NCT00887159|2583071|P1|Overall Study|Pt had PD but was SD when re-measured|0
812065|NCT00887159|2583069|P3|Overall Study|Treatment delayed|0
812066|NCT00887159|2583070|P2|Overall Study|Treatment delayed|1
812067|NCT00887159|2583071|P1|Overall Study|Treatment delayed|1
812068|NCT00887159|2583069|P3|Overall Study|Sympomatic deterioration|0
812069|NCT00887159|2583070|P2|Overall Study|Sympomatic deterioration|0
812070|NCT00887159|2583071|P1|Overall Study|Sympomatic deterioration|1
812071|NCT00887159|2583069|P3|Overall Study|Physician Decision|0
812072|NCT00887159|2583070|P2|Overall Study|Physician Decision|1
812073|NCT00887159|2583071|P1|Overall Study|Physician Decision|1
812074|NCT00887159|2583069|P3|Overall Study|Alternative therapy|0
812075|NCT00887159|2583070|P2|Overall Study|Alternative therapy|0
812076|NCT00887159|2583071|P1|Overall Study|Alternative therapy|2
812077|NCT00887159|2583069|P3|Overall Study|Withdrawal by Subject|2
812078|NCT00887159|2583070|P2|Overall Study|Withdrawal by Subject|4
812079|NCT00887159|2583071|P1|Overall Study|Withdrawal by Subject|4
812080|NCT00887159|2583069|P3|Overall Study|Death|0
812081|NCT00887159|2583070|P2|Overall Study|Death|2
812082|NCT00887159|2583071|P1|Overall Study|Death|2
812083|NCT00887159|2583069|P3|Overall Study|Adverse Event|17
812084|NCT00887159|2583070|P2|Overall Study|Adverse Event|4
812085|NCT00887159|2583071|P1|Overall Study|Adverse Event|3
812086|NCT00887159|2583069|P3|Overall Study|Disease progression|33
812087|NCT00887159|2583070|P2|Overall Study|Disease progression|39
812088|NCT00887159|2583071|P1|Overall Study|Disease progression|6
812089|NCT00887198|2583089|P2|Overall Study|Lost to Follow-up|3
812090|NCT00887198|2583090|P1|Overall Study|Lost to Follow-up|4
812091|NCT00887198|2583089|P2|Overall Study|Withdrawal by Subject|41
812092|NCT00887198|2583090|P1|Overall Study|Withdrawal by Subject|28
812093|NCT00887198|2583089|P2|Overall Study|Death|387
812094|NCT00887198|2583090|P1|Overall Study|Death|352
812095|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
812096|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
812097|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
812098|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
812099|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
812100|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
812101|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Unspecified|12
812102|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Unspecified|11
812103|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Unspecified|0
812104|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
812105|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
812106|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
812107|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
812108|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
812109|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
812110|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
812111|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
812112|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
812113|NCT00887224|2583121|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
812114|NCT00887224|2583122|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
812115|NCT00887224|2583123|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
812116|NCT00887224|2583121|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
812117|NCT00887224|2583122|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
812118|NCT00887224|2583123|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
812119|NCT00887224|2583121|P3|Double-blind (DB) Phase|Protocol Violation|5
812120|NCT00887224|2583122|P2|Double-blind (DB) Phase|Protocol Violation|8
812121|NCT00887224|2583123|P1|Double-blind (DB) Phase|Protocol Violation|0
812122|NCT00887224|2583121|P3|Double-blind (DB) Phase|Unspecified|0
812123|NCT00887224|2583122|P2|Double-blind (DB) Phase|Unspecified|2
812124|NCT00887224|2583123|P1|Double-blind (DB) Phase|Unspecified|0
812125|NCT00887224|2583121|P3|Double-blind (DB) Phase|Lost to Follow-up|8
812126|NCT00887224|2583122|P2|Double-blind (DB) Phase|Lost to Follow-up|8
812127|NCT00887224|2583123|P1|Double-blind (DB) Phase|Lost to Follow-up|0
812128|NCT00887224|2583121|P3|Double-blind (DB) Phase|Lack of Efficacy|33
812129|NCT00887224|2583122|P2|Double-blind (DB) Phase|Lack of Efficacy|67
812130|NCT00887224|2583123|P1|Double-blind (DB) Phase|Lack of Efficacy|0
812131|NCT00887224|2583121|P3|Double-blind (DB) Phase|Failed to return|2
812132|NCT00887224|2583122|P2|Double-blind (DB) Phase|Failed to return|2
812133|NCT00887224|2583123|P1|Double-blind (DB) Phase|Failed to return|0
812134|NCT00887224|2583121|P3|Double-blind (DB) Phase|Adverse Event|2
812135|NCT00887224|2583122|P2|Double-blind (DB) Phase|Adverse Event|7
812136|NCT00887224|2583123|P1|Double-blind (DB) Phase|Adverse Event|0
812137|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
812138|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
812139|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
812140|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
812141|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
812142|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
812143|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Unspecified|0
812144|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Unspecified|0
812145|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Unspecified|30
812146|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
812147|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
812148|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
812149|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
812150|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
812151|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
812152|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Failed to return|0
812153|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Failed to return|0
812154|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Failed to return|17
812155|NCT00887224|2583121|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
812156|NCT00887224|2583122|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
812157|NCT00887224|2583123|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
812158|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
812159|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
812160|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
812161|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
812162|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
812163|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
812164|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Unspecified|0
812165|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Unspecified|0
812166|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Unspecified|1
812167|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
812168|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
812169|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
812170|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
812171|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
812172|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
812173|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Failed to return|0
812174|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Failed to return|0
812175|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Failed to return|3
812176|NCT00887224|2583121|P3|Open-label Stability (OLS) Phase|Adverse Event|0
812177|NCT00887224|2583122|P2|Open-label Stability (OLS) Phase|Adverse Event|0
812178|NCT00887224|2583123|P1|Open-label Stability (OLS) Phase|Adverse Event|22
812179|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
812180|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
812181|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
812182|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Protocol Violation|0
812183|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Protocol Violation|0
812184|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Protocol Violation|12
812185|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Unspecified|0
812186|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Unspecified|0
812187|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Unspecified|1
812188|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
812189|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
812190|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
812191|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
812192|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
812193|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
812194|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Failed to return|0
812195|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Failed to return|0
812196|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Failed to return|6
812197|NCT00887224|2583121|P3|Open-label Response (OLR) Phase|Adverse Event|0
812198|NCT00887224|2583122|P2|Open-label Response (OLR) Phase|Adverse Event|0
812199|NCT00887224|2583123|P1|Open-label Response (OLR) Phase|Adverse Event|46
812200|NCT00887250|2583151|P3|Overall Study|Patient uncooperative|1
812201|NCT00887250|2583152|P2|Overall Study|Patient uncooperative|0
812202|NCT00887250|2583153|P1|Overall Study|Patient uncooperative|0
812203|NCT00887250|2583151|P3|Overall Study|Withdrawal by Subject|2
812204|NCT00887250|2583152|P2|Overall Study|Withdrawal by Subject|1
812205|NCT00887250|2583153|P1|Overall Study|Withdrawal by Subject|2
812206|NCT00887250|2583151|P3|Overall Study|Protocol Violation|1
812207|NCT00887250|2583152|P2|Overall Study|Protocol Violation|2
812208|NCT00887250|2583153|P1|Overall Study|Protocol Violation|2
812209|NCT00887250|2583151|P3|Overall Study|Lost to Follow-up|1
812210|NCT00887250|2583152|P2|Overall Study|Lost to Follow-up|3
812211|NCT00887250|2583153|P1|Overall Study|Lost to Follow-up|2
812212|NCT00887250|2583151|P3|Overall Study|Lack of Efficacy|1
812213|NCT00887250|2583152|P2|Overall Study|Lack of Efficacy|6
812214|NCT00887250|2583153|P1|Overall Study|Lack of Efficacy|9
812215|NCT00887250|2583151|P3|Overall Study|Adverse Event|7
812216|NCT00887250|2583152|P2|Overall Study|Adverse Event|0
812217|NCT00887250|2583153|P1|Overall Study|Adverse Event|3
812218|NCT00887289|2583173|P1|Overall Study|not specified|20
812219|NCT00887289|2583173|P1|Overall Study|Lost to Follow-up|8
812220|NCT00887289|2583173|P1|Overall Study|Withdrawal by Subject|26
812221|NCT00887289|2583173|P1|Overall Study|Adverse Event|27
812222|NCT00887289|2583173|P1|Overall Study|Lack of Efficacy|14
812223|NCT00887315|2583184|P2|Overall Study|Study termination|4
812224|NCT00887315|2583185|P1|Overall Study|Study termination|7
812225|NCT00878501|2583196|P3|Overall Study|Administrative|1
812226|NCT00878501|2583197|P2|Overall Study|Administrative|0
812227|NCT00878501|2583198|P1|Overall Study|Administrative|0
812228|NCT00878501|2583196|P3|Overall Study|Mis-randomisation of patient|0
812229|NCT00878501|2583197|P2|Overall Study|Mis-randomisation of patient|0
812230|NCT00878501|2583198|P1|Overall Study|Mis-randomisation of patient|1
812231|NCT00878501|2583196|P3|Overall Study|Intake of prohibited concom. medication|1
812232|NCT00878501|2583197|P2|Overall Study|Intake of prohibited concom. medication|0
812233|NCT00878501|2583198|P1|Overall Study|Intake of prohibited concom. medication|0
812234|NCT00878501|2583196|P3|Overall Study|Incorrect enrolment|0
812235|NCT00878501|2583197|P2|Overall Study|Incorrect enrolment|2
812236|NCT00878501|2583198|P1|Overall Study|Incorrect enrolment|1
812237|NCT00878501|2583196|P3|Overall Study|Protocol Violation|1
812238|NCT00878501|2583197|P2|Overall Study|Protocol Violation|0
812239|NCT00878501|2583198|P1|Overall Study|Protocol Violation|0
812240|NCT00878501|2583196|P3|Overall Study|Withdrawal by Subject|2
812241|NCT00878501|2583197|P2|Overall Study|Withdrawal by Subject|1
812242|NCT00878501|2583198|P1|Overall Study|Withdrawal by Subject|2
812243|NCT00878501|2583196|P3|Overall Study|Lack of Efficacy|0
812244|NCT00878501|2583197|P2|Overall Study|Lack of Efficacy|1
812245|NCT00878501|2583198|P1|Overall Study|Lack of Efficacy|2
812246|NCT00878501|2583196|P3|Overall Study|Adverse Event|3
812247|NCT00878501|2583197|P2|Overall Study|Adverse Event|3
812248|NCT00878501|2583198|P1|Overall Study|Adverse Event|11
812249|NCT00878553|2583219|P5|PK Study|Withdrawal by Subject|0
812250|NCT00878553|2583220|P4|PK Study|Withdrawal by Subject|1
812251|NCT00878553|2583221|P3|PK Study|Withdrawal by Subject|0
812252|NCT00878553|2583222|P2|PK Study|Withdrawal by Subject|0
812253|NCT00878553|2583223|P1|PK Study|Withdrawal by Subject|0
812254|NCT00878553|2583219|P5|Sleep Study|family emergency|0
812255|NCT00878553|2583220|P4|Sleep Study|family emergency|0
812256|NCT00878553|2583221|P3|Sleep Study|family emergency|0
812257|NCT00878553|2583222|P2|Sleep Study|family emergency|0
812258|NCT00878553|2583223|P1|Sleep Study|family emergency|1
812259|NCT00878553|2583219|P5|Sleep Study|car accident|0
812260|NCT00878553|2583220|P4|Sleep Study|car accident|0
812261|NCT00878553|2583221|P3|Sleep Study|car accident|0
812262|NCT00878553|2583222|P2|Sleep Study|car accident|0
812263|NCT00878553|2583223|P1|Sleep Study|car accident|1
812264|NCT00878553|2583219|P5|Sleep Study|Lost to Follow-up|0
812265|NCT00878553|2583220|P4|Sleep Study|Lost to Follow-up|0
812266|NCT00878553|2583221|P3|Sleep Study|Lost to Follow-up|0
812267|NCT00878553|2583222|P2|Sleep Study|Lost to Follow-up|0
812268|NCT00878553|2583223|P1|Sleep Study|Lost to Follow-up|1
812269|NCT00878553|2583219|P5|Sleep Study|Withdrawal by Subject|0
812270|NCT00878553|2583220|P4|Sleep Study|Withdrawal by Subject|0
812271|NCT00878553|2583221|P3|Sleep Study|Withdrawal by Subject|0
812272|NCT00878553|2583222|P2|Sleep Study|Withdrawal by Subject|0
812273|NCT00878553|2583223|P1|Sleep Study|Withdrawal by Subject|2
812280|NCT00878722|2583346|P8|Overall Study|Relapse|0
812281|NCT00878722|2583347|P7|Overall Study|Relapse|0
812282|NCT00878722|2583348|P6|Overall Study|Relapse|0
812283|NCT00878722|2583349|P5|Overall Study|Relapse|0
812284|NCT00878722|2583350|P4|Overall Study|Relapse|1
812285|NCT00878722|2583351|P3|Overall Study|Relapse|0
812286|NCT00878722|2583352|P2|Overall Study|Relapse|0
812287|NCT00878722|2583353|P1|Overall Study|Relapse|0
812288|NCT00878722|2583346|P8|Overall Study|Withdrawal by Subject|2
812289|NCT00878722|2583347|P7|Overall Study|Withdrawal by Subject|0
812290|NCT00878722|2583348|P6|Overall Study|Withdrawal by Subject|0
812291|NCT00878722|2583349|P5|Overall Study|Withdrawal by Subject|0
812292|NCT00878722|2583350|P4|Overall Study|Withdrawal by Subject|0
812293|NCT00878722|2583351|P3|Overall Study|Withdrawal by Subject|0
812294|NCT00878722|2583352|P2|Overall Study|Withdrawal by Subject|0
812295|NCT00878722|2583353|P1|Overall Study|Withdrawal by Subject|0
812296|NCT00878722|2583346|P8|Overall Study|Adverse Event|0
812297|NCT00878722|2583347|P7|Overall Study|Adverse Event|2
812298|NCT00878722|2583348|P6|Overall Study|Adverse Event|0
812299|NCT00878722|2583349|P5|Overall Study|Adverse Event|0
812300|NCT00878722|2583350|P4|Overall Study|Adverse Event|0
812301|NCT00878722|2583351|P3|Overall Study|Adverse Event|0
812302|NCT00878722|2583352|P2|Overall Study|Adverse Event|0
812303|NCT00878722|2583353|P1|Overall Study|Adverse Event|0
812304|NCT00878722|2583346|P8|Overall Study|Death|2
812305|NCT00878722|2583347|P7|Overall Study|Death|0
812306|NCT00878722|2583348|P6|Overall Study|Death|1
812307|NCT00878722|2583349|P5|Overall Study|Death|0
812308|NCT00878722|2583350|P4|Overall Study|Death|1
812309|NCT00878722|2583351|P3|Overall Study|Death|0
812310|NCT00878722|2583352|P2|Overall Study|Death|0
812311|NCT00878722|2583353|P1|Overall Study|Death|0
812312|NCT00878722|2583346|P8|Overall Study|Progressive disease|3
812313|NCT00878722|2583347|P7|Overall Study|Progressive disease|4
812314|NCT00878722|2583348|P6|Overall Study|Progressive disease|1
812315|NCT00878722|2583349|P5|Overall Study|Progressive disease|7
812316|NCT00878722|2583350|P4|Overall Study|Progressive disease|7
812317|NCT00878722|2583351|P3|Overall Study|Progressive disease|3
812318|NCT00878722|2583352|P2|Overall Study|Progressive disease|3
812319|NCT00878722|2583353|P1|Overall Study|Progressive disease|3
812320|NCT00878800|2583441|P5|Overall Study|Other|1
812321|NCT00878800|2583442|P4|Overall Study|Other|0
812322|NCT00878800|2583443|P3|Overall Study|Other|0
812323|NCT00878800|2583444|P2|Overall Study|Other|1
812324|NCT00878800|2583445|P1|Overall Study|Other|1
812325|NCT00878800|2583441|P5|Overall Study|Death|0
812326|NCT00878800|2583442|P4|Overall Study|Death|0
812327|NCT00878800|2583443|P3|Overall Study|Death|1
812328|NCT00878800|2583444|P2|Overall Study|Death|0
812329|NCT00878800|2583445|P1|Overall Study|Death|0
812330|NCT00878800|2583441|P5|Overall Study|Withdrew consent|1
812331|NCT00878800|2583442|P4|Overall Study|Withdrew consent|1
812332|NCT00878800|2583443|P3|Overall Study|Withdrew consent|0
812333|NCT00878800|2583444|P2|Overall Study|Withdrew consent|1
812334|NCT00878800|2583445|P1|Overall Study|Withdrew consent|1
812335|NCT00878800|2583441|P5|Overall Study|Progressive disease|13
812336|NCT00878800|2583442|P4|Overall Study|Progressive disease|5
812337|NCT00878800|2583443|P3|Overall Study|Progressive disease|6
812338|NCT00878800|2583444|P2|Overall Study|Progressive disease|5
812339|NCT00878800|2583445|P1|Overall Study|Progressive disease|1
812340|NCT00878800|2583441|P5|Overall Study|Adverse Event|1
812341|NCT00878800|2583442|P4|Overall Study|Adverse Event|0
812342|NCT00878800|2583443|P3|Overall Study|Adverse Event|2
812343|NCT00878800|2583444|P2|Overall Study|Adverse Event|0
812344|NCT00878800|2583445|P1|Overall Study|Adverse Event|0
812345|NCT00879398|2583507|P1|Overall Study|Other Reasons|171
812346|NCT00879398|2583507|P1|Overall Study|Adverse Event|41
812347|NCT00879398|2583507|P1|Overall Study|Lack of Efficacy|64
812348|NCT00879398|2583507|P1|Overall Study|Visit Stop|399
812349|NCT00879411|2583517|P1|Overall Study|lost to follow-up (non-AE)|162
812350|NCT00879645|2583536|P4|Overall Study|Adverse Event|0
812351|NCT00879645|2583537|P3|Overall Study|Adverse Event|0
812352|NCT00879645|2583538|P2|Overall Study|Adverse Event|0
812353|NCT00879645|2583539|P1|Overall Study|Adverse Event|1
812354|NCT00879684|2583557|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
812355|NCT00879684|2583558|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
812356|NCT00879684|2583559|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
812357|NCT00879684|2583560|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
812358|NCT00879684|2583561|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
812359|NCT00879684|2583562|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
812360|NCT00879684|2583563|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
812361|NCT00879684|2583557|P7|Stage 2: Expanded Cohort|Progressive Disease|11
812362|NCT00879684|2583558|P6|Stage 2: Expanded Cohort|Progressive Disease|0
812363|NCT00879684|2583559|P5|Stage 2: Expanded Cohort|Progressive Disease|0
812364|NCT00879684|2583560|P4|Stage 2: Expanded Cohort|Progressive Disease|0
812365|NCT00879684|2583561|P3|Stage 2: Expanded Cohort|Progressive Disease|0
812366|NCT00879684|2583562|P2|Stage 2: Expanded Cohort|Progressive Disease|0
812367|NCT00879684|2583563|P1|Stage 2: Expanded Cohort|Progressive Disease|0
812368|NCT00879684|2583557|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
812369|NCT00879684|2583558|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
812370|NCT00879684|2583559|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
812371|NCT00879684|2583560|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
812372|NCT00879684|2583561|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
812373|NCT00879684|2583562|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
812374|NCT00879684|2583563|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
812375|NCT00879684|2583557|P7|Stage 1: Dose Escalation|Death|0
812376|NCT00879684|2583558|P6|Stage 1: Dose Escalation|Death|0
812377|NCT00879684|2583559|P5|Stage 1: Dose Escalation|Death|0
812378|NCT00879684|2583560|P4|Stage 1: Dose Escalation|Death|0
812379|NCT00879684|2583561|P3|Stage 1: Dose Escalation|Death|1
812380|NCT00879684|2583562|P2|Stage 1: Dose Escalation|Death|0
812381|NCT00879684|2583563|P1|Stage 1: Dose Escalation|Death|0
812382|NCT00879684|2583557|P7|Stage 1: Dose Escalation|Investigator declined participation|0
812383|NCT00879684|2583558|P6|Stage 1: Dose Escalation|Investigator declined participation|0
812384|NCT00879684|2583559|P5|Stage 1: Dose Escalation|Investigator declined participation|0
812385|NCT00879684|2583560|P4|Stage 1: Dose Escalation|Investigator declined participation|2
812386|NCT00879684|2583561|P3|Stage 1: Dose Escalation|Investigator declined participation|2
812387|NCT00879684|2583562|P2|Stage 1: Dose Escalation|Investigator declined participation|0
812388|NCT00879684|2583563|P1|Stage 1: Dose Escalation|Investigator declined participation|0
812389|NCT00879684|2583557|P7|Stage 1: Dose Escalation|Progressive Disease|0
812390|NCT00879684|2583558|P6|Stage 1: Dose Escalation|Progressive Disease|3
812391|NCT00879684|2583559|P5|Stage 1: Dose Escalation|Progressive Disease|3
812392|NCT00879684|2583560|P4|Stage 1: Dose Escalation|Progressive Disease|4
812393|NCT00879684|2583561|P3|Stage 1: Dose Escalation|Progressive Disease|0
812394|NCT00879684|2583562|P2|Stage 1: Dose Escalation|Progressive Disease|3
812395|NCT00879684|2583563|P1|Stage 1: Dose Escalation|Progressive Disease|2
812396|NCT00879684|2583557|P7|Stage 1: Dose Escalation|Adverse Event|0
812397|NCT00879684|2583558|P6|Stage 1: Dose Escalation|Adverse Event|0
812398|NCT00879684|2583559|P5|Stage 1: Dose Escalation|Adverse Event|0
812399|NCT00879684|2583560|P4|Stage 1: Dose Escalation|Adverse Event|0
812400|NCT00879684|2583561|P3|Stage 1: Dose Escalation|Adverse Event|0
812401|NCT00879684|2583562|P2|Stage 1: Dose Escalation|Adverse Event|0
812402|NCT00879684|2583563|P1|Stage 1: Dose Escalation|Adverse Event|1
812403|NCT00879697|2583627|P2|Overall Study|Physician Decision|2
812404|NCT00879697|2583628|P1|Overall Study|Physician Decision|2
812405|NCT00879710|2583636|P4|Phase 1 - 6 Weeks|Adverse Event|0
812406|NCT00879710|2583637|P3|Phase 1 - 6 Weeks|Adverse Event|1
812407|NCT00879710|2583638|P2|Phase 1 - 6 Weeks|Adverse Event|0
812408|NCT00879710|2583639|P1|Phase 1 - 6 Weeks|Adverse Event|0
812409|NCT00879710|2583636|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
812410|NCT00879710|2583637|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
812411|NCT00879710|2583638|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
812412|NCT00879710|2583639|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
812413|NCT00879775|2583649|P2|Overall Study|Lost to Follow-up|1
812414|NCT00879775|2583650|P1|Overall Study|Lost to Follow-up|2
812415|NCT00879814|2583668|P4|Overall Study|Unspecified|0
812416|NCT00879814|2583669|P3|Overall Study|Unspecified|1
812417|NCT00879814|2583670|P2|Overall Study|Unspecified|0
812418|NCT00879814|2583671|P1|Overall Study|Unspecified|0
812419|NCT00879814|2583668|P4|Overall Study|Physician Decision|0
812420|NCT00879814|2583669|P3|Overall Study|Physician Decision|1
812421|NCT00879814|2583670|P2|Overall Study|Physician Decision|0
812422|NCT00879814|2583671|P1|Overall Study|Physician Decision|0
812423|NCT00879814|2583668|P4|Overall Study|Withdrawal by Subject|2
812424|NCT00879814|2583669|P3|Overall Study|Withdrawal by Subject|1
812425|NCT00879814|2583670|P2|Overall Study|Withdrawal by Subject|1
812426|NCT00879814|2583671|P1|Overall Study|Withdrawal by Subject|3
812427|NCT00879814|2583668|P4|Overall Study|Participant Failed to Return|1
812428|NCT00879814|2583669|P3|Overall Study|Participant Failed to Return|0
812429|NCT00879814|2583670|P2|Overall Study|Participant Failed to Return|0
812430|NCT00879814|2583671|P1|Overall Study|Participant Failed to Return|0
812431|NCT00879814|2583668|P4|Overall Study|Lost to Follow-up|2
812432|NCT00879814|2583669|P3|Overall Study|Lost to Follow-up|0
812433|NCT00879814|2583670|P2|Overall Study|Lost to Follow-up|0
812434|NCT00879814|2583671|P1|Overall Study|Lost to Follow-up|1
812435|NCT00879814|2583668|P4|Overall Study|Adverse Event|0
812436|NCT00879814|2583669|P3|Overall Study|Adverse Event|0
812437|NCT00879814|2583670|P2|Overall Study|Adverse Event|1
812438|NCT00879814|2583671|P1|Overall Study|Adverse Event|0
812439|NCT00879879|2583777|P1|Overall Study|Physician Decision|1
812440|NCT00879879|2583777|P1|Overall Study|Withdrawal by Subject|1
812441|NCT00879879|2583777|P1|Overall Study|Death|1
812442|NCT00879970|2583784|P5|Period 2 Vitamin D Randomization|Death|0
812443|NCT00879970|2583785|P4|Period 2 Vitamin D Randomization|Death|2
812444|NCT00879970|2583786|P3|Period 2 Vitamin D Randomization|Death|0
812445|NCT00879970|2583787|P2|Period 2 Vitamin D Randomization|Death|0
812446|NCT00879970|2583788|P1|Period 2 Vitamin D Randomization|Death|0
812447|NCT00879970|2583784|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
812448|NCT00879970|2583785|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
812449|NCT00879970|2583786|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
812450|NCT00879970|2583787|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
812451|NCT00879970|2583788|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
812452|NCT00879970|2583784|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
812453|NCT00879970|2583785|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
812454|NCT00879970|2583786|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
812455|NCT00879970|2583787|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
812456|NCT00879970|2583788|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
812457|NCT00879970|2583784|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
812458|NCT00879970|2583785|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
812459|NCT00879970|2583786|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
812460|NCT00879970|2583787|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
812461|NCT00879970|2583788|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
812462|NCT00879970|2583784|P5|Period 1 TZD Randomization|Death|0
812463|NCT00879970|2583785|P4|Period 1 TZD Randomization|Death|0
812464|NCT00879970|2583786|P3|Period 1 TZD Randomization|Death|0
812465|NCT00879970|2583787|P2|Period 1 TZD Randomization|Death|1
812466|NCT00879970|2583788|P1|Period 1 TZD Randomization|Death|2
812467|NCT00879970|2583784|P5|Period 1 TZD Randomization|Lost to Follow-up|0
812468|NCT00879970|2583785|P4|Period 1 TZD Randomization|Lost to Follow-up|0
812469|NCT00879970|2583786|P3|Period 1 TZD Randomization|Lost to Follow-up|1
812470|NCT00879970|2583787|P2|Period 1 TZD Randomization|Lost to Follow-up|0
812471|NCT00879970|2583788|P1|Period 1 TZD Randomization|Lost to Follow-up|1
812472|NCT00879970|2583784|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
812473|NCT00879970|2583785|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
812474|NCT00879970|2583786|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
812475|NCT00879970|2583787|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
812476|NCT00879970|2583788|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
812477|NCT00879996|2583872|P2|Overall Study|put on parole|0
812478|NCT00879996|2583873|P1|Overall Study|put on parole|1
812479|NCT00879996|2583872|P2|Overall Study|psychiatric problem|1
812480|NCT00879996|2583873|P1|Overall Study|psychiatric problem|0
812481|NCT00879996|2583872|P2|Overall Study|Physician Decision|2
812482|NCT00879996|2583873|P1|Overall Study|Physician Decision|1
812483|NCT00879996|2583872|P2|Overall Study|non-compliance|4
812484|NCT00879996|2583873|P1|Overall Study|non-compliance|6
812485|NCT00879996|2583872|P2|Overall Study|Lost to Follow-up|6
812486|NCT00879996|2583873|P1|Overall Study|Lost to Follow-up|7
812487|NCT00880009|2583885|P1|Overall Study|Protocol Violation|1
812488|NCT00880009|2583885|P1|Overall Study|Withdrawal by Subject|1
812489|NCT00880009|2583885|P1|Overall Study|Study terminated by sponsor|14
812490|NCT00880100|2583916|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
812491|NCT00880100|2583916|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
812492|NCT00880100|2583916|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
812493|NCT00880165|2583929|P2|Overall Study|Lost to follow|15
812494|NCT00880165|2583930|P1|Overall Study|Lost to follow|9
812495|NCT00880165|2583929|P2|Overall Study|Required BIPAP or oxygen treatment|4
812496|NCT00880165|2583930|P1|Overall Study|Required BIPAP or oxygen treatment|12
812497|NCT00880165|2583929|P2|Overall Study|Not diagnosed with OSA|8
812498|NCT00880165|2583930|P1|Overall Study|Not diagnosed with OSA|14
812499|NCT00880165|2583929|P2|Overall Study|Withdrawal by Subject|23
812500|NCT00880165|2583930|P1|Overall Study|Withdrawal by Subject|27
812501|NCT00880191|2583942|P2|Overall Study|Hospitalization/efficacy|1
812502|NCT00880191|2583943|P1|Overall Study|Hospitalization/efficacy|1
812503|NCT00880191|2583942|P2|Overall Study|Adverse Event|6
812504|NCT00880191|2583943|P1|Overall Study|Adverse Event|8
812505|NCT00880191|2583942|P2|Overall Study|Refused further treatment|1
812506|NCT00880191|2583943|P1|Overall Study|Refused further treatment|4
812507|NCT00880256|2583981|P1|Overall Study|Lost to Follow-up|28
812508|NCT00880269|2583988|P2|Overall Study|Adverse Event|9
812509|NCT00880269|2583989|P1|Overall Study|Adverse Event|10
812510|NCT00880269|2583988|P2|Overall Study|Withdrawal by Subject|4
812511|NCT00880269|2583989|P1|Overall Study|Withdrawal by Subject|3
812512|NCT00880269|2583988|P2|Overall Study|Lost to Follow-up|1
812513|NCT00880269|2583989|P1|Overall Study|Lost to Follow-up|0
812514|NCT00880269|2583988|P2|Overall Study|Death|2
812515|NCT00880269|2583989|P1|Overall Study|Death|4
812516|NCT00880269|2583988|P2|Overall Study|New Cancer Therapy|0
812517|NCT00880269|2583989|P1|Overall Study|New Cancer Therapy|1
812518|NCT00880269|2583988|P2|Overall Study|Disease Progression|11
812519|NCT00880269|2583989|P1|Overall Study|Disease Progression|13
812520|NCT00880269|2583988|P2|Overall Study|Protocol Violation|0
812521|NCT00880269|2583989|P1|Overall Study|Protocol Violation|1
812522|NCT00880334|2584007|P2|Overall Study|Brain Metastasis|1
812523|NCT00880334|2584008|P1|Overall Study|Brain Metastasis|0
812524|NCT00880334|2584007|P2|Overall Study|Inadequate Labs|1
812525|NCT00880334|2584008|P1|Overall Study|Inadequate Labs|1
812526|NCT00880334|2584007|P2|Overall Study|Withdrawal by Subject|1
812527|NCT00880334|2584008|P1|Overall Study|Withdrawal by Subject|2
812528|NCT00880334|2584007|P2|Overall Study|Physician Decision|0
812529|NCT00880334|2584008|P1|Overall Study|Physician Decision|1
812530|NCT00880399|2584029|P3|Overall Study|Withdrawal by Subject|3
812531|NCT00880399|2584030|P2|Overall Study|Withdrawal by Subject|3
812532|NCT00880399|2584031|P1|Overall Study|Withdrawal by Subject|6
812533|NCT00880399|2584029|P3|Overall Study|Physician Decision|3
812534|NCT00880399|2584030|P2|Overall Study|Physician Decision|0
812535|NCT00880399|2584031|P1|Overall Study|Physician Decision|5
812536|NCT00880399|2584029|P3|Overall Study|Lost to Follow-up|3
812537|NCT00880399|2584030|P2|Overall Study|Lost to Follow-up|5
812538|NCT00880399|2584031|P1|Overall Study|Lost to Follow-up|8
812539|NCT00880399|2584029|P3|Overall Study|Study closed/terminated|4
812540|NCT00880399|2584030|P2|Overall Study|Study closed/terminated|7
812541|NCT00880399|2584031|P1|Overall Study|Study closed/terminated|3
812542|NCT00880399|2584029|P3|Overall Study|Protocol Violation|6
812543|NCT00880399|2584030|P2|Overall Study|Protocol Violation|4
812544|NCT00880399|2584031|P1|Overall Study|Protocol Violation|4
812545|NCT00880399|2584029|P3|Overall Study|Lack of Efficacy|2
812546|NCT00880399|2584030|P2|Overall Study|Lack of Efficacy|4
812547|NCT00880399|2584031|P1|Overall Study|Lack of Efficacy|1
812548|NCT00880399|2584029|P3|Overall Study|Adverse Event|5
812549|NCT00880399|2584030|P2|Overall Study|Adverse Event|6
812550|NCT00880399|2584031|P1|Overall Study|Adverse Event|4
812551|NCT00880542|2584096|P1|REP: Surgical Resection|progressive disease|1
812552|NCT00880542|2584096|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
812553|NCT00880542|2584096|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
812554|NCT00880555|2584104|P6|Overall Study|Lost to Follow-up|0
812555|NCT00880555|2584105|P5|Overall Study|Lost to Follow-up|0
812556|NCT00880555|2584106|P4|Overall Study|Lost to Follow-up|0
812557|NCT00880555|2584107|P3|Overall Study|Lost to Follow-up|0
812558|NCT00880555|2584108|P2|Overall Study|Lost to Follow-up|1
812559|NCT00880555|2584109|P1|Overall Study|Lost to Follow-up|0
812560|NCT00880555|2584104|P6|Overall Study|Death|1
812561|NCT00880555|2584105|P5|Overall Study|Death|0
812562|NCT00880555|2584106|P4|Overall Study|Death|0
812563|NCT00880555|2584107|P3|Overall Study|Death|0
812564|NCT00880555|2584108|P2|Overall Study|Death|0
812565|NCT00880555|2584109|P1|Overall Study|Death|0
812566|NCT00880555|2584104|P6|Overall Study|Lack of resources (hired rater)|0
812567|NCT00880555|2584105|P5|Overall Study|Lack of resources (hired rater)|0
812568|NCT00880555|2584106|P4|Overall Study|Lack of resources (hired rater)|0
812569|NCT00880555|2584107|P3|Overall Study|Lack of resources (hired rater)|5
812570|NCT00880555|2584108|P2|Overall Study|Lack of resources (hired rater)|7
812571|NCT00880555|2584109|P1|Overall Study|Lack of resources (hired rater)|9
812572|NCT00880555|2584104|P6|Overall Study|Withdrawal by Subject|0
812573|NCT00880555|2584105|P5|Overall Study|Withdrawal by Subject|0
812574|NCT00880555|2584106|P4|Overall Study|Withdrawal by Subject|0
812575|NCT00880555|2584107|P3|Overall Study|Withdrawal by Subject|0
812576|NCT00880555|2584108|P2|Overall Study|Withdrawal by Subject|1
812577|NCT00880555|2584109|P1|Overall Study|Withdrawal by Subject|1
812578|NCT00880555|2584104|P6|Overall Study|Physician Decision|0
812579|NCT00880555|2584105|P5|Overall Study|Physician Decision|1
812580|NCT00880555|2584106|P4|Overall Study|Physician Decision|2
812581|NCT00880555|2584107|P3|Overall Study|Physician Decision|0
812582|NCT00880555|2584108|P2|Overall Study|Physician Decision|8
812583|NCT00880555|2584109|P1|Overall Study|Physician Decision|0
812584|NCT00880568|2584129|P9|Overall Study|Withdrawal by Subject|0
812585|NCT00880568|2584130|P8|Overall Study|Withdrawal by Subject|1
812586|NCT00880568|2584131|P7|Overall Study|Withdrawal by Subject|0
812587|NCT00880568|2584132|P6|Overall Study|Withdrawal by Subject|0
812588|NCT00880568|2584133|P5|Overall Study|Withdrawal by Subject|0
812589|NCT00880568|2584134|P4|Overall Study|Withdrawal by Subject|0
812590|NCT00880568|2584135|P3|Overall Study|Withdrawal by Subject|0
812591|NCT00880568|2584136|P2|Overall Study|Withdrawal by Subject|0
812592|NCT00880568|2584137|P1|Overall Study|Withdrawal by Subject|0
812593|NCT00880568|2584129|P9|Overall Study|Adverse Event|0
812594|NCT00880568|2584130|P8|Overall Study|Adverse Event|1
812595|NCT00880568|2584131|P7|Overall Study|Adverse Event|1
812596|NCT00880568|2584132|P6|Overall Study|Adverse Event|0
812597|NCT00880568|2584133|P5|Overall Study|Adverse Event|0
812598|NCT00880568|2584134|P4|Overall Study|Adverse Event|0
812599|NCT00880568|2584135|P3|Overall Study|Adverse Event|0
812600|NCT00880568|2584136|P2|Overall Study|Adverse Event|0
812601|NCT00880568|2584137|P1|Overall Study|Adverse Event|0
812602|NCT00880568|2584129|P9|Overall Study|Disease progression|3
812603|NCT00880568|2584130|P8|Overall Study|Disease progression|0
812604|NCT00880568|2584131|P7|Overall Study|Disease progression|5
812605|NCT00880568|2584132|P6|Overall Study|Disease progression|3
812606|NCT00880568|2584133|P5|Overall Study|Disease progression|3
812607|NCT00880568|2584134|P4|Overall Study|Disease progression|1
812608|NCT00880568|2584135|P3|Overall Study|Disease progression|3
812609|NCT00880568|2584136|P2|Overall Study|Disease progression|3
812610|NCT00880568|2584137|P1|Overall Study|Disease progression|3
812611|NCT00880620|2584189|P4|Overall Study|Not specified|2
812612|NCT00880620|2584190|P3|Overall Study|Not specified|2
812613|NCT00880620|2584191|P2|Overall Study|Not specified|1
812614|NCT00880620|2584192|P1|Overall Study|Not specified|1
812615|NCT00880620|2584189|P4|Overall Study|Noncompliance|1
812616|NCT00880620|2584190|P3|Overall Study|Noncompliance|1
812617|NCT00880620|2584191|P2|Overall Study|Noncompliance|0
812618|NCT00880620|2584192|P1|Overall Study|Noncompliance|0
812619|NCT00880620|2584189|P4|Overall Study|Withdrawal by Subject|3
812620|NCT00880620|2584190|P3|Overall Study|Withdrawal by Subject|1
812621|NCT00880620|2584191|P2|Overall Study|Withdrawal by Subject|3
812622|NCT00880620|2584192|P1|Overall Study|Withdrawal by Subject|4
812623|NCT00880620|2584189|P4|Overall Study|Protocol Violation|2
812624|NCT00880620|2584190|P3|Overall Study|Protocol Violation|0
812625|NCT00880620|2584191|P2|Overall Study|Protocol Violation|1
812626|NCT00880620|2584192|P1|Overall Study|Protocol Violation|0
812627|NCT00880620|2584189|P4|Overall Study|Lost to Follow-up|0
812628|NCT00880620|2584190|P3|Overall Study|Lost to Follow-up|1
812629|NCT00880620|2584191|P2|Overall Study|Lost to Follow-up|1
812630|NCT00880620|2584192|P1|Overall Study|Lost to Follow-up|0
812631|NCT00880620|2584189|P4|Overall Study|Lack of Efficacy|1
812632|NCT00880620|2584190|P3|Overall Study|Lack of Efficacy|0
812633|NCT00880620|2584191|P2|Overall Study|Lack of Efficacy|4
812634|NCT00880620|2584192|P1|Overall Study|Lack of Efficacy|12
812635|NCT00880620|2584189|P4|Overall Study|Death|0
812636|NCT00880620|2584190|P3|Overall Study|Death|1
812637|NCT00880620|2584191|P2|Overall Study|Death|0
812638|NCT00880620|2584192|P1|Overall Study|Death|0
812639|NCT00880620|2584189|P4|Overall Study|Adverse Event|15
812640|NCT00880620|2584190|P3|Overall Study|Adverse Event|15
812641|NCT00880620|2584191|P2|Overall Study|Adverse Event|5
812642|NCT00880620|2584192|P1|Overall Study|Adverse Event|4
812643|NCT00880685|2584206|P1|Memantine 20mg|Withdrawal by Subject|1
812644|NCT00880685|2584206|P1|Memantine 10mg|Lost to Follow-up|2
812653|NCT00880750|2584249|P2|Second Intervention|Unable to collect urine|0
812654|NCT00880750|2584250|P1|Second Intervention|Unable to collect urine|1
812655|NCT00880750|2584249|P2|Second Intervention|Protocol Violation|0
812656|NCT00880750|2584250|P1|Second Intervention|Protocol Violation|1
812657|NCT00880750|2584249|P2|Second Intervention|Withdrawal by Subject|2
812658|NCT00880750|2584250|P1|Second Intervention|Withdrawal by Subject|2
812659|NCT00880750|2584249|P2|First Intervention|Lost to Follow-up|0
812660|NCT00880750|2584250|P1|First Intervention|Lost to Follow-up|2
812661|NCT00880750|2584249|P2|First Intervention|Withdrawal by Subject|0
812662|NCT00880750|2584250|P1|First Intervention|Withdrawal by Subject|2
812663|NCT00880750|2584249|P2|First Intervention|Non-compliance with meals|1
812664|NCT00880750|2584250|P1|First Intervention|Non-compliance with meals|0
812665|NCT00880750|2584249|P2|First Intervention|Unable to collect urine|0
812666|NCT00880750|2584250|P1|First Intervention|Unable to collect urine|4
812667|NCT00880750|2584249|P2|First Intervention|Adverse Event|0
812668|NCT00880750|2584250|P1|First Intervention|Adverse Event|1
812669|NCT00880763|2584268|P4|Extension Period (Part 2)|Lack of Efficacy|1
812670|NCT00880763|2584269|P3|Extension Period (Part 2)|Lack of Efficacy|0
812671|NCT00880763|2584270|P2|Extension Period (Part 2)|Lack of Efficacy|0
812672|NCT00880763|2584271|P1|Extension Period (Part 2)|Lack of Efficacy|0
812673|NCT00880763|2584268|P4|Extension Period (Part 2)|Physician Decision|0
812674|NCT00880763|2584269|P3|Extension Period (Part 2)|Physician Decision|1
812675|NCT00880763|2584270|P2|Extension Period (Part 2)|Physician Decision|1
812676|NCT00880763|2584271|P1|Extension Period (Part 2)|Physician Decision|0
812677|NCT00880763|2584268|P4|Extension Period (Part 2)|Withdrawal by Subject|1
812678|NCT00880763|2584269|P3|Extension Period (Part 2)|Withdrawal by Subject|1
812679|NCT00880763|2584270|P2|Extension Period (Part 2)|Withdrawal by Subject|2
812680|NCT00880763|2584271|P1|Extension Period (Part 2)|Withdrawal by Subject|0
812681|NCT00880763|2584268|P4|Extension Period (Part 2)|Adverse Event|1
812682|NCT00880763|2584269|P3|Extension Period (Part 2)|Adverse Event|1
812683|NCT00880763|2584270|P2|Extension Period (Part 2)|Adverse Event|0
812684|NCT00880763|2584271|P1|Extension Period (Part 2)|Adverse Event|0
812689|NCT00881205|2584349|P2|Overall Study|Condition no longer requires drug|0
812690|NCT00881205|2584350|P1|Overall Study|Condition no longer requires drug|1
812691|NCT00881205|2584349|P2|Overall Study|Administrative problems|1
812692|NCT00881205|2584350|P1|Overall Study|Administrative problems|1
812693|NCT00881205|2584349|P2|Overall Study|Lost to Follow-up|1
812694|NCT00881205|2584350|P1|Overall Study|Lost to Follow-up|0
812695|NCT00881205|2584349|P2|Overall Study|Withdrawal by Subject|2
812696|NCT00881205|2584350|P1|Overall Study|Withdrawal by Subject|1
812697|NCT00881205|2584349|P2|Overall Study|Adverse Event|3
812698|NCT00881205|2584350|P1|Overall Study|Adverse Event|8
812699|NCT00881335|2584359|P2|Overall Study|Lost to Follow-up|2
812700|NCT00881335|2584360|P1|Overall Study|Lost to Follow-up|3
812701|NCT00881504|2584391|P1|Overall Study|Withdrawal by Subject|1
812702|NCT00881530|2584402|P6|Overall Study|Other reason not defined above|2
812703|NCT00881530|2584403|P5|Overall Study|Other reason not defined above|0
812704|NCT00881530|2584404|P4|Overall Study|Other reason not defined above|0
812705|NCT00881530|2584405|P3|Overall Study|Other reason not defined above|2
812706|NCT00881530|2584406|P2|Overall Study|Other reason not defined above|1
812707|NCT00881530|2584407|P1|Overall Study|Other reason not defined above|1
812708|NCT00881530|2584402|P6|Overall Study|Refused to continue medication|0
812709|NCT00881530|2584403|P5|Overall Study|Refused to continue medication|0
812710|NCT00881530|2584404|P4|Overall Study|Refused to continue medication|2
812711|NCT00881530|2584405|P3|Overall Study|Refused to continue medication|1
812712|NCT00881530|2584406|P2|Overall Study|Refused to continue medication|2
812713|NCT00881530|2584407|P1|Overall Study|Refused to continue medication|7
812714|NCT00881530|2584402|P6|Overall Study|Lost to Follow-up|0
812715|NCT00881530|2584403|P5|Overall Study|Lost to Follow-up|1
812716|NCT00881530|2584404|P4|Overall Study|Lost to Follow-up|3
812717|NCT00881530|2584405|P3|Overall Study|Lost to Follow-up|1
812718|NCT00881530|2584406|P2|Overall Study|Lost to Follow-up|1
812719|NCT00881530|2584407|P1|Overall Study|Lost to Follow-up|0
812720|NCT00881530|2584402|P6|Overall Study|Not compliant with the protocol|0
812721|NCT00881530|2584403|P5|Overall Study|Not compliant with the protocol|2
812722|NCT00881530|2584404|P4|Overall Study|Not compliant with the protocol|0
812723|NCT00881530|2584405|P3|Overall Study|Not compliant with the protocol|0
812724|NCT00881530|2584406|P2|Overall Study|Not compliant with the protocol|0
812725|NCT00881530|2584407|P1|Overall Study|Not compliant with the protocol|0
812726|NCT00881530|2584402|P6|Overall Study|Lack of Efficacy|1
812727|NCT00881530|2584403|P5|Overall Study|Lack of Efficacy|1
812728|NCT00881530|2584404|P4|Overall Study|Lack of Efficacy|0
812729|NCT00881530|2584405|P3|Overall Study|Lack of Efficacy|0
812730|NCT00881530|2584406|P2|Overall Study|Lack of Efficacy|0
812731|NCT00881530|2584407|P1|Overall Study|Lack of Efficacy|1
812732|NCT00881530|2584402|P6|Overall Study|Adverse Event|2
812733|NCT00881530|2584403|P5|Overall Study|Adverse Event|10
812734|NCT00881530|2584404|P4|Overall Study|Adverse Event|4
812735|NCT00881530|2584405|P3|Overall Study|Adverse Event|1
812736|NCT00881530|2584406|P2|Overall Study|Adverse Event|1
812737|NCT00881530|2584407|P1|Overall Study|Adverse Event|5
812738|NCT00881608|2584468|P1|Overall Study|Study prematurely terminated|11
812739|NCT00881621|2584485|P1|Overall Study|Physician Decision|34
812740|NCT00881712|2584508|P3|Overall Study|Withdrawal by Subject|0
812741|NCT00881712|2584509|P2|Overall Study|Withdrawal by Subject|0
812742|NCT00881712|2584510|P1|Overall Study|Withdrawal by Subject|1
812743|NCT00881712|2584508|P3|Overall Study|Death|0
812744|NCT00881712|2584509|P2|Overall Study|Death|0
812745|NCT00881712|2584510|P1|Overall Study|Death|1
812746|NCT00881751|2584532|P2|Overall Study|Withdrawal by Subject|2
812747|NCT00881751|2584533|P1|Overall Study|Withdrawal by Subject|0
812748|NCT00881751|2584532|P2|Overall Study|Adverse Event|2
812749|NCT00881751|2584533|P1|Overall Study|Adverse Event|0
812750|NCT00881751|2584532|P2|Overall Study|Physician Decision|1
812751|NCT00881751|2584533|P1|Overall Study|Physician Decision|0
812752|NCT00881868|2584547|P2|Overall Study|Protocol Violation|0
812753|NCT00881868|2584548|P1|Overall Study|Protocol Violation|2
812754|NCT00881868|2584547|P2|Overall Study|Physician Decision|0
812755|NCT00881868|2584548|P1|Overall Study|Physician Decision|4
812756|NCT00881868|2584547|P2|Overall Study|Lost to Follow-up|1
812757|NCT00881868|2584548|P1|Overall Study|Lost to Follow-up|2
812758|NCT00881868|2584547|P2|Overall Study|Adverse Event|1
812759|NCT00881868|2584548|P1|Overall Study|Adverse Event|0
812760|NCT00881894|2584562|P2|Overall Study|Other reasons for premature termination|2
812761|NCT00881894|2584563|P1|Overall Study|Other reasons for premature termination|1
812762|NCT00881894|2584562|P2|Overall Study|Consent withdrawn|1
812763|NCT00881894|2584563|P1|Overall Study|Consent withdrawn|0
812764|NCT00887341|2584595|P2|Overall Study|Lost to Follow-up|1
812765|NCT00887341|2584596|P1|Overall Study|Lost to Follow-up|0
812766|NCT00887341|2584595|P2|Overall Study|Adverse Event|1
812767|NCT00887341|2584596|P1|Overall Study|Adverse Event|0
812768|NCT00887341|2584595|P2|Overall Study|Withdrawal by Subject|1
812769|NCT00887341|2584596|P1|Overall Study|Withdrawal by Subject|1
812770|NCT00887341|2584595|P2|Overall Study|Refused treatment|0
812771|NCT00887341|2584596|P1|Overall Study|Refused treatment|1
812772|NCT00887354|2584632|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
812773|NCT00887354|2584633|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
812774|NCT00887354|2584632|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
812775|NCT00887354|2584633|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
812776|NCT00887354|2584632|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
812777|NCT00887354|2584633|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
812778|NCT00887354|2584632|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
812779|NCT00887354|2584633|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
812780|NCT00887354|2584632|P2|Open Label Phase (Week 26 to Week 78)|Death|2
812781|NCT00887354|2584633|P1|Open Label Phase (Week 26 to Week 78)|Death|0
812782|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
812783|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
812784|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
812785|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
812786|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
812787|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
812788|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
812789|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
812790|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
812791|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
812792|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
812793|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
812794|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
812795|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
812796|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
812797|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
812798|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
812799|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
812800|NCT00887354|2584632|P2|Treatment Phase (Week 0 to Week 26)|Death|1
812801|NCT00887354|2584633|P1|Treatment Phase (Week 0 to Week 26)|Death|0
812802|NCT00887484|2584671|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
812803|NCT00887484|2584671|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
812804|NCT00887484|2584671|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
812805|NCT00887549|2584746|P1|Maintenance Therapy|Death due to adverse event|1
812806|NCT00887549|2584746|P1|Maintenance Therapy|Progressive Disease|25
812807|NCT00887549|2584746|P1|Maintenance Therapy|Physician Decision|1
812808|NCT00887549|2584746|P1|Maintenance Therapy|Adverse Event|16
812809|NCT00887549|2584746|P1|Induction Therapy|Death due to Study Drug Toxicity|1
812810|NCT00887549|2584746|P1|Induction Therapy|Death due to Study Disease|4
812811|NCT00887549|2584746|P1|Induction Therapy|Progressive Disease|13
812812|NCT00887549|2584746|P1|Induction Therapy|Physician Decision|1
812813|NCT00887549|2584746|P1|Induction Therapy|Adverse Event|8
812814|NCT00887588|2584784|P2|Extension Period|Lost to Follow-up|0
812815|NCT00887588|2584785|P1|Extension Period|Lost to Follow-up|1
812816|NCT00887588|2584784|P2|Extension Period|Protocol deviation|0
812817|NCT00887588|2584785|P1|Extension Period|Protocol deviation|1
812818|NCT00887588|2584784|P2|Extension Period|Death|1
812819|NCT00887588|2584785|P1|Extension Period|Death|0
812820|NCT00887588|2584784|P2|Extension Period|Adverse Event|4
812821|NCT00887588|2584785|P1|Extension Period|Adverse Event|4
812822|NCT00887588|2584784|P2|Core Period|Adverse Event|11
812823|NCT00887588|2584785|P1|Core Period|Adverse Event|9
812824|NCT00887588|2584784|P2|Core Period|Withdrawal by Subject|8
812825|NCT00887588|2584785|P1|Core Period|Withdrawal by Subject|6
812826|NCT00887588|2584784|P2|Core Period|Lost to Follow-up|1
812827|NCT00887588|2584785|P1|Core Period|Lost to Follow-up|3
812828|NCT00887588|2584784|P2|Core Period|Death|1
812829|NCT00887588|2584785|P1|Core Period|Death|1
812830|NCT00888654|2584862|P1|Overall Study|Stopped meds due to headaches|1
812831|NCT00888654|2584862|P1|Overall Study|Change in surg date|1
812832|NCT00888654|2584862|P1|Overall Study|Inelig. due to contraindication of med|1
812833|NCT00888654|2584862|P1|Overall Study|Withdrawal by Subject|1
812834|NCT00888654|2584862|P1|Overall Study|Surgery aborted|2
812835|NCT00888654|2584862|P1|Overall Study|Not enough oral meds before surgery|3
812836|NCT00888654|2584862|P1|Overall Study|Problems swallowing oral meds.|1
812837|NCT00888849|2584868|P2|Overall Study|Lost to Follow-up|2
812838|NCT00888849|2584869|P1|Overall Study|Lost to Follow-up|1
812839|NCT00888849|2584868|P2|Overall Study|Death|7
812840|NCT00888849|2584869|P1|Overall Study|Death|4
812841|NCT00888940|2584881|P2|Overall Study|Randomized Not Treated|13
812842|NCT00888940|2584882|P1|Overall Study|Randomized Not Treated|11
812843|NCT00888940|2584881|P2|Overall Study|Lost to Follow-up|5
812844|NCT00888940|2584882|P1|Overall Study|Lost to Follow-up|5
812845|NCT00888940|2584881|P2|Overall Study|Adverse Event|3
812846|NCT00888940|2584882|P1|Overall Study|Adverse Event|12
812847|NCT00889252|2584915|P2|Overall Study|Protocol Violation|0
812848|NCT00889252|2584916|P1|Overall Study|Protocol Violation|2
812849|NCT00889252|2584915|P2|Overall Study|Withdrawal by Subject|0
812850|NCT00889252|2584916|P1|Overall Study|Withdrawal by Subject|3
812851|NCT00889252|2584915|P2|Overall Study|Adverse Event|4
812852|NCT00889252|2584916|P1|Overall Study|Adverse Event|2
812853|NCT00889265|2584958|P1|Overall Study|Protocol Violation|1
812854|NCT00889265|2584958|P1|Overall Study|Lost to Follow-up|5
812855|NCT00889265|2584958|P1|Overall Study|Adverse Event|1
812856|NCT00889421|2584996|P1|Overall Study|Lack of Efficacy|3
812857|NCT00889603|2585013|P1|Overall Study|Not Specified|4
812858|NCT00889603|2585013|P1|Overall Study|No longer willing to participant in stud|4
812859|NCT00889603|2585013|P1|Overall Study|Lost to Follow-up|19
812860|NCT00889603|2585013|P1|Overall Study|Death|3
812861|NCT00889603|2585013|P1|Overall Study|Adverse Event|7
812862|NCT00889681|2585026|P1|Overall Study|Insurance disapproval|1
812863|NCT00889681|2585026|P1|Overall Study|Not meeting qualification Criteria|2
812864|NCT00889707|2585035|P2|Overall Study|Lack of Efficacy|5
812865|NCT00889707|2585036|P1|Overall Study|Lack of Efficacy|2
812866|NCT00889707|2585035|P2|Overall Study|Lost to Follow-up|2
812867|NCT00889707|2585036|P1|Overall Study|Lost to Follow-up|0
812868|NCT00889707|2585035|P2|Overall Study|Withdrawal by Subject|3
812869|NCT00889707|2585036|P1|Overall Study|Withdrawal by Subject|4
812870|NCT00889707|2585035|P2|Overall Study|Adverse Event|0
812871|NCT00889707|2585036|P1|Overall Study|Adverse Event|1
812872|NCT00889720|2585044|P1|Overall Study|Unspecified|4
812873|NCT00889720|2585044|P1|Overall Study|Withdrawal by Subject|4
812874|NCT00889863|2585073|P2|Part II: Randomized Double Blind|Protocol deviation|1
812875|NCT00889863|2585074|P1|Part II: Randomized Double Blind|Protocol deviation|0
812876|NCT00889863|2585073|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
812877|NCT00889863|2585074|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
812878|NCT00889863|2585073|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
812879|NCT00889863|2585074|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
812880|NCT00889863|2585073|P2|Part II: Randomized Double Blind|Adverse Event|4
812881|NCT00889863|2585074|P1|Part II: Randomized Double Blind|Adverse Event|0
812882|NCT00889863|2585073|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
812883|NCT00889863|2585074|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
812884|NCT00889863|2585073|P2|Part I: Open Label|Adverse Event|0
812885|NCT00889863|2585074|P1|Part I: Open Label|Adverse Event|4
812886|NCT00889863|2585073|P2|Part I: Open Label|Death|0
812887|NCT00889863|2585074|P1|Part I: Open Label|Death|1
812888|NCT00890084|2585125|P1|Overall Study|Lost to Follow-up|126
812889|NCT00890084|2585125|P1|Overall Study|Adverse Event|16
812890|NCT00890097|2585139|P3|Overall Study|Protocol Deviation|1
812891|NCT00890097|2585140|P2|Overall Study|Protocol Deviation|1
812892|NCT00890097|2585141|P1|Overall Study|Protocol Deviation|1
812893|NCT00890097|2585139|P3|Overall Study|Subject Moved|0
812894|NCT00890097|2585140|P2|Overall Study|Subject Moved|4
812895|NCT00890097|2585141|P1|Overall Study|Subject Moved|0
812896|NCT00890097|2585139|P3|Overall Study|Transportation|0
812897|NCT00890097|2585140|P2|Overall Study|Transportation|2
812898|NCT00890097|2585141|P1|Overall Study|Transportation|0
812899|NCT00890097|2585139|P3|Overall Study|Failed inclusion criteria|0
812900|NCT00890097|2585140|P2|Overall Study|Failed inclusion criteria|4
812901|NCT00890097|2585141|P1|Overall Study|Failed inclusion criteria|3
812902|NCT00890097|2585139|P3|Overall Study|Randomization Error|0
812903|NCT00890097|2585140|P2|Overall Study|Randomization Error|0
812904|NCT00890097|2585141|P1|Overall Study|Randomization Error|2
812905|NCT00890097|2585139|P3|Overall Study|Subject Decision|6
812906|NCT00890097|2585140|P2|Overall Study|Subject Decision|2
812907|NCT00890097|2585141|P1|Overall Study|Subject Decision|3
812908|NCT00890097|2585139|P3|Overall Study|Did not attend final visit|0
812909|NCT00890097|2585140|P2|Overall Study|Did not attend final visit|3
812910|NCT00890097|2585141|P1|Overall Study|Did not attend final visit|2
812911|NCT00890097|2585139|P3|Overall Study|Sponsor Decision|7
812912|NCT00890097|2585140|P2|Overall Study|Sponsor Decision|11
812913|NCT00890097|2585141|P1|Overall Study|Sponsor Decision|7
812914|NCT00890097|2585139|P3|Overall Study|Noncompliance|4
812915|NCT00890097|2585140|P2|Overall Study|Noncompliance|4
812916|NCT00890097|2585141|P1|Overall Study|Noncompliance|0
812917|NCT00890097|2585139|P3|Overall Study|Lost to Follow-up|5
812918|NCT00890097|2585140|P2|Overall Study|Lost to Follow-up|5
812919|NCT00890097|2585141|P1|Overall Study|Lost to Follow-up|5
812920|NCT00890097|2585139|P3|Overall Study|Withdrew Consent|9
812921|NCT00890097|2585140|P2|Overall Study|Withdrew Consent|6
812922|NCT00890097|2585141|P1|Overall Study|Withdrew Consent|9
812923|NCT00890097|2585139|P3|Overall Study|Decision Unrelated to an Adverse Event|17
812924|NCT00890097|2585140|P2|Overall Study|Decision Unrelated to an Adverse Event|12
812925|NCT00890097|2585141|P1|Overall Study|Decision Unrelated to an Adverse Event|15
812926|NCT00890097|2585139|P3|Overall Study|Adverse Event|28
812927|NCT00890097|2585140|P2|Overall Study|Adverse Event|32
812928|NCT00890097|2585141|P1|Overall Study|Adverse Event|21
812929|NCT00890201|2585151|P2|Overall Study|Protocol Violation|56
812930|NCT00890201|2585152|P1|Overall Study|Protocol Violation|5
812931|NCT00890409|2585160|P2|Overall Study|Lost to Follow-up|21
812932|NCT00890409|2585161|P1|Overall Study|Lost to Follow-up|20
812933|NCT00890552|2585169|P1|On-treatment|Early prog disease/ death|10
812934|NCT00890552|2585169|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
812935|NCT00890591|2585176|P1|Overall Study|Lack of Efficacy|20
812936|NCT00890695|2585197|P2|Overall Study|Protocol Violation|0
812937|NCT00890695|2585198|P1|Overall Study|Protocol Violation|1
812938|NCT00890929|2585227|P1|Overall Study|Physician Decision|1
812939|NCT00890929|2585227|P1|Overall Study|Withdrawal by Subject|3
812940|NCT00890929|2585227|P1|Overall Study|Death before treatment|2
812941|NCT00891020|2585275|P3|Long-term Extension Period|Administrative|2
812942|NCT00891020|2585276|P2|Long-term Extension Period|Administrative|2
812943|NCT00891020|2585277|P1|Long-term Extension Period|Administrative|1
812944|NCT00891020|2585275|P3|Long-term Extension Period|Failure to return|3
812945|NCT00891020|2585276|P2|Long-term Extension Period|Failure to return|2
812946|NCT00891020|2585277|P1|Long-term Extension Period|Failure to return|0
812947|NCT00891020|2585275|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
812948|NCT00891020|2585276|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
812949|NCT00891020|2585277|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
812950|NCT00891020|2585275|P3|Long-term Extension Period|Protocol Violation|1
812951|NCT00891020|2585276|P2|Long-term Extension Period|Protocol Violation|1
812952|NCT00891020|2585277|P1|Long-term Extension Period|Protocol Violation|0
812953|NCT00891020|2585275|P3|Long-term Extension Period|Insufficient therapeutic response|2
812954|NCT00891020|2585276|P2|Long-term Extension Period|Insufficient therapeutic response|2
812955|NCT00891020|2585277|P1|Long-term Extension Period|Insufficient therapeutic response|3
812956|NCT00891020|2585275|P3|Long-term Extension Period|Death|1
812957|NCT00891020|2585276|P2|Long-term Extension Period|Death|0
812958|NCT00891020|2585277|P1|Long-term Extension Period|Death|0
812959|NCT00891020|2585275|P3|Long-term Extension Period|Adverse Event|10
812960|NCT00891020|2585276|P2|Long-term Extension Period|Adverse Event|11
812961|NCT00891020|2585277|P1|Long-term Extension Period|Adverse Event|1
812962|NCT00891020|2585275|P3|24 Week Treatment Period|Administrative/Other|1
812963|NCT00891020|2585276|P2|24 Week Treatment Period|Administrative/Other|6
812964|NCT00891020|2585277|P1|24 Week Treatment Period|Administrative/Other|5
812965|NCT00891020|2585275|P3|24 Week Treatment Period|Withdrew consent|15
812966|NCT00891020|2585276|P2|24 Week Treatment Period|Withdrew consent|3
812967|NCT00891020|2585277|P1|24 Week Treatment Period|Withdrew consent|6
812968|NCT00891020|2585275|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
812969|NCT00891020|2585276|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
812970|NCT00891020|2585277|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
812971|NCT00891020|2585275|P3|24 Week Treatment Period|Other protocol violation|2
812972|NCT00891020|2585276|P2|24 Week Treatment Period|Other protocol violation|1
812973|NCT00891020|2585277|P1|24 Week Treatment Period|Other protocol violation|1
812974|NCT00891020|2585275|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
812975|NCT00891020|2585276|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
812976|NCT00891020|2585277|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
812977|NCT00891020|2585275|P3|24 Week Treatment Period|Failure to return|5
812978|NCT00891020|2585276|P2|24 Week Treatment Period|Failure to return|5
812979|NCT00891020|2585277|P1|24 Week Treatment Period|Failure to return|4
812980|NCT00891020|2585275|P3|24 Week Treatment Period|Insufficient therapeutic response|15
812981|NCT00891020|2585276|P2|24 Week Treatment Period|Insufficient therapeutic response|9
812982|NCT00891020|2585277|P1|24 Week Treatment Period|Insufficient therapeutic response|6
812983|NCT00891020|2585275|P3|24 Week Treatment Period|Death|0
812984|NCT00891020|2585276|P2|24 Week Treatment Period|Death|2
812985|NCT00891020|2585277|P1|24 Week Treatment Period|Death|0
812986|NCT00891020|2585275|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
812987|NCT00891020|2585276|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
812988|NCT00891020|2585277|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
812989|NCT00878969|2585311|P3|Overall Study|Pregnancy|0
812990|NCT00878969|2585312|P2|Overall Study|Pregnancy|1
812991|NCT00878969|2585313|P1|Overall Study|Pregnancy|0
812992|NCT00878969|2585311|P3|Overall Study|Death|2
812993|NCT00878969|2585312|P2|Overall Study|Death|0
812994|NCT00878969|2585313|P1|Overall Study|Death|0
812995|NCT00878969|2585311|P3|Overall Study|Protocol Violation|0
812996|NCT00878969|2585312|P2|Overall Study|Protocol Violation|0
812997|NCT00878969|2585313|P1|Overall Study|Protocol Violation|2
812998|NCT00878969|2585311|P3|Overall Study|Lost to Follow-up|0
812999|NCT00878969|2585312|P2|Overall Study|Lost to Follow-up|1
813000|NCT00878969|2585313|P1|Overall Study|Lost to Follow-up|2
813001|NCT00878969|2585311|P3|Overall Study|Adverse Event|2
813002|NCT00878969|2585312|P2|Overall Study|Adverse Event|1
813003|NCT00878969|2585313|P1|Overall Study|Adverse Event|3
813004|NCT00878969|2585311|P3|Overall Study|kidney transplant|2
813005|NCT00878969|2585312|P2|Overall Study|kidney transplant|3
813006|NCT00878969|2585313|P1|Overall Study|kidney transplant|2
813007|NCT00878969|2585311|P3|Overall Study|Withdrawal by Subject|3
813008|NCT00878969|2585312|P2|Overall Study|Withdrawal by Subject|6
813009|NCT00878969|2585313|P1|Overall Study|Withdrawal by Subject|1
813010|NCT00878969|2585311|P3|Overall Study|Physician Decision|2
813011|NCT00878969|2585312|P2|Overall Study|Physician Decision|3
813012|NCT00878969|2585313|P1|Overall Study|Physician Decision|5
813013|NCT00879229|2585345|P2|Overall Study|Other|0
813014|NCT00879229|2585346|P1|Overall Study|Other|1
813015|NCT00879229|2585345|P2|Overall Study|Clinical status did not improve|0
813016|NCT00879229|2585346|P1|Overall Study|Clinical status did not improve|1
813017|NCT00879229|2585345|P2|Overall Study|Withdrawal by Subject|0
813018|NCT00879229|2585346|P1|Overall Study|Withdrawal by Subject|1
813019|NCT00879229|2585345|P2|Overall Study|Adverse Event|0
813020|NCT00879229|2585346|P1|Overall Study|Adverse Event|2
813021|NCT00879229|2585345|P2|Overall Study|Death|2
813022|NCT00879229|2585346|P1|Overall Study|Death|4
813023|NCT00879229|2585345|P2|Overall Study|Study terminated by Sponsor|12
813024|NCT00879229|2585346|P1|Overall Study|Study terminated by Sponsor|13
813025|NCT00879333|2585385|P2|Overall Study|Protocol Violation|1
813026|NCT00879333|2585386|P1|Overall Study|Protocol Violation|1
813027|NCT00879333|2585385|P2|Overall Study|Disease Progression|169
813028|NCT00879333|2585386|P1|Overall Study|Disease Progression|292
813029|NCT00879333|2585385|P2|Overall Study|Death|5
813030|NCT00879333|2585386|P1|Overall Study|Death|16
813031|NCT00879333|2585385|P2|Overall Study|Administrative Problems|0
813032|NCT00879333|2585386|P1|Overall Study|Administrative Problems|2
813033|NCT00879333|2585385|P2|Overall Study|Lost to Follow-up|1
813034|NCT00879333|2585386|P1|Overall Study|Lost to Follow-up|2
813035|NCT00879333|2585385|P2|Overall Study|Withdrawal by Subject|7
813036|NCT00879333|2585386|P1|Overall Study|Withdrawal by Subject|20
813037|NCT00879333|2585385|P2|Overall Study|Abnormal Laboratory Value|0
813038|NCT00879333|2585386|P1|Overall Study|Abnormal Laboratory Value|1
813039|NCT00879333|2585385|P2|Overall Study|Adverse Event|34
813040|NCT00879333|2585386|P1|Overall Study|Adverse Event|94
813041|NCT00884793|2585419|P1|Overall Study|Withdrawal by Subject|1
813042|NCT00891046|2585436|P5|Overall Study|Lost to Follow-up|1
813043|NCT00891046|2585437|P4|Overall Study|Lost to Follow-up|0
813044|NCT00891046|2585438|P3|Overall Study|Lost to Follow-up|0
813045|NCT00891046|2585439|P2|Overall Study|Lost to Follow-up|0
813046|NCT00891046|2585440|P1|Overall Study|Lost to Follow-up|0
813047|NCT00891046|2585436|P5|Overall Study|Withdrawal by Subject|1
813048|NCT00891046|2585437|P4|Overall Study|Withdrawal by Subject|1
813049|NCT00891046|2585438|P3|Overall Study|Withdrawal by Subject|2
813050|NCT00891046|2585439|P2|Overall Study|Withdrawal by Subject|1
813051|NCT00891046|2585440|P1|Overall Study|Withdrawal by Subject|2
813052|NCT00891046|2585436|P5|Overall Study|Adverse Event|14
813053|NCT00891046|2585437|P4|Overall Study|Adverse Event|0
813054|NCT00891046|2585438|P3|Overall Study|Adverse Event|2
813055|NCT00891046|2585439|P2|Overall Study|Adverse Event|3
813056|NCT00891046|2585440|P1|Overall Study|Adverse Event|4
813057|NCT00891046|2585436|P5|Overall Study|Participant no longer required drug|1
813058|NCT00891046|2585437|P4|Overall Study|Participant no longer required drug|0
813059|NCT00891046|2585438|P3|Overall Study|Participant no longer required drug|0
813060|NCT00891046|2585439|P2|Overall Study|Participant no longer required drug|2
813061|NCT00891046|2585440|P1|Overall Study|Participant no longer required drug|0
813062|NCT00891046|2585436|P5|Overall Study|Administrative problems|1
813063|NCT00891046|2585437|P4|Overall Study|Administrative problems|0
813064|NCT00891046|2585438|P3|Overall Study|Administrative problems|0
813065|NCT00891046|2585439|P2|Overall Study|Administrative problems|0
813066|NCT00891046|2585440|P1|Overall Study|Administrative problems|0
813067|NCT00891046|2585436|P5|Overall Study|Unsatisfactory therapeutic effect|20
813068|NCT00891046|2585437|P4|Overall Study|Unsatisfactory therapeutic effect|2
813069|NCT00891046|2585438|P3|Overall Study|Unsatisfactory therapeutic effect|19
813070|NCT00891046|2585439|P2|Overall Study|Unsatisfactory therapeutic effect|2
813071|NCT00891046|2585440|P1|Overall Study|Unsatisfactory therapeutic effect|5
813072|NCT00891046|2585436|P5|Overall Study|Protocol Violation|1
813073|NCT00891046|2585437|P4|Overall Study|Protocol Violation|0
813074|NCT00891046|2585438|P3|Overall Study|Protocol Violation|0
813075|NCT00891046|2585439|P2|Overall Study|Protocol Violation|1
813076|NCT00891046|2585440|P1|Overall Study|Protocol Violation|1
813077|NCT00891202|2585648|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
813078|NCT00891202|2585649|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
813079|NCT00891202|2585650|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
813080|NCT00891202|2585651|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
813081|NCT00891202|2585648|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
813082|NCT00891202|2585649|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
813083|NCT00891202|2585650|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
813084|NCT00891202|2585651|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
813085|NCT00891202|2585648|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
813086|NCT00891202|2585649|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
813087|NCT00891202|2585650|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
813088|NCT00891202|2585651|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
813089|NCT00891202|2585648|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
813090|NCT00891202|2585649|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
813091|NCT00891202|2585650|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
813092|NCT00891202|2585651|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
813093|NCT00891293|2585673|P1|Overall Study|Sponsor termination|62
813094|NCT00891293|2585673|P1|Overall Study|Subject withdrew consent|7
813095|NCT00891293|2585673|P1|Overall Study|Lost to Follow-up|7
813096|NCT00891293|2585673|P1|Overall Study|Laboratory abnormality|4
813097|NCT00891293|2585673|P1|Overall Study|Protocol Violation|2
813098|NCT00891293|2585673|P1|Overall Study|Adverse Event|2
813099|NCT00891371|2585685|P1|Treatment|Lost to Follow-up|1
813100|NCT00891371|2585685|P1|Treatment|Death|1
813101|NCT00891371|2585685|P1|Treatment|Adverse Event|2
813102|NCT00891371|2585685|P1|Treatment|Lack of Efficacy|5
813103|NCT00891371|2585685|P1|Pre-assignment|Consent withdrawal|1
813104|NCT00891371|2585685|P1|Pre-assignment|Inclusion/exclusion|5
813105|NCT00891618|2585694|P1|Overall Study|Withdrawal by Subject|1
813106|NCT00891657|2585700|P2|Overall Study|Withdrawal by Subject|1
813107|NCT00891657|2585701|P1|Overall Study|Withdrawal by Subject|1
813108|NCT00891735|2585717|P4|Overall Study|Patient's decision to withdraw|8
813109|NCT00891735|2585718|P3|Overall Study|Patient's decision to withdraw|4
813110|NCT00891735|2585719|P2|Overall Study|Patient's decision to withdraw|9
813111|NCT00891735|2585720|P1|Overall Study|Patient's decision to withdraw|4
813112|NCT00891735|2585717|P4|Overall Study|Physician's decision to withdraw patient|0
813113|NCT00891735|2585718|P3|Overall Study|Physician's decision to withdraw patient|0
813114|NCT00891735|2585719|P2|Overall Study|Physician's decision to withdraw patient|0
813115|NCT00891735|2585720|P1|Overall Study|Physician's decision to withdraw patient|1
813116|NCT00891735|2585717|P4|Overall Study|Lost to Follow-up|2
813117|NCT00891735|2585718|P3|Overall Study|Lost to Follow-up|2
813118|NCT00891735|2585719|P2|Overall Study|Lost to Follow-up|2
813119|NCT00891735|2585720|P1|Overall Study|Lost to Follow-up|2
813120|NCT00891735|2585717|P4|Overall Study|Death|5
813121|NCT00891735|2585718|P3|Overall Study|Death|4
813122|NCT00891735|2585719|P2|Overall Study|Death|5
813123|NCT00891735|2585720|P1|Overall Study|Death|8
813124|NCT00891735|2585717|P4|Overall Study|Adverse Event|0
813125|NCT00891735|2585718|P3|Overall Study|Adverse Event|2
813126|NCT00891735|2585719|P2|Overall Study|Adverse Event|0
813127|NCT00891735|2585720|P1|Overall Study|Adverse Event|2
813128|NCT00891774|2585758|P1|Overall Study|Protocol Violation|4
813129|NCT00891774|2585758|P1|Overall Study|Withdrawal by Subject|2
813130|NCT00891774|2585758|P1|Overall Study|Illness (Self/Mother)|3
813131|NCT00891774|2585758|P1|Overall Study|Lost to Follow-up|5
813132|NCT00891813|2585762|P1|Overall Study|Protocol Violation|2
813133|NCT00891813|2585762|P1|Overall Study|Patient Noncompliance|6
813134|NCT00891813|2585762|P1|Overall Study|Withdrawal by Subject|1
813135|NCT00891813|2585762|P1|Overall Study|Adverse Event|3
813139|NCT00891904|2585777|P1|Overall Study|Adverse Event|1
813140|NCT00891904|2585777|P1|Overall Study|Death|1
813141|NCT00891930|2585784|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
813142|NCT00891930|2585784|P1|Part 2: Panitumumab + Ganitumab|Death|30
813143|NCT00891930|2585784|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
813144|NCT00891930|2585784|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
813145|NCT00891930|2585784|P1|Part 1: Panitumumab +Irinotecan|Death|38
813146|NCT00892008|2585877|P1|Overall Study|Adverse Event|37
813147|NCT00892008|2585877|P1|Overall Study|unspecified|378
813148|NCT00892008|2585877|P1|Overall Study|Lost to Follow-up|142
813149|NCT00892008|2585877|P1|Overall Study|Lack of Efficacy|3
813150|NCT00892008|2585877|P1|Overall Study|Death|5
813151|NCT00892047|2585893|P2|Overall Study|Lack of Efficacy|2
813152|NCT00892047|2585894|P1|Overall Study|Lack of Efficacy|0
813153|NCT00892047|2585893|P2|Overall Study|subject burden|3
813154|NCT00892047|2585894|P1|Overall Study|subject burden|2
813155|NCT00892047|2585893|P2|Overall Study|Adverse Event|2
813156|NCT00892047|2585894|P1|Overall Study|Adverse Event|2
813181|NCT00892151|2585923|P1|Overall Study|Protocol Violation|1
813182|NCT00892177|2585932|P6|Phase II|Withdrawal by Subject|1
813183|NCT00892177|2585933|P5|Phase II|Withdrawal by Subject|4
813184|NCT00892177|2585934|P4|Phase II|Withdrawal by Subject|0
813185|NCT00892177|2585935|P3|Phase II|Withdrawal by Subject|0
813186|NCT00892177|2585936|P2|Phase II|Withdrawal by Subject|0
813187|NCT00892177|2585937|P1|Phase II|Withdrawal by Subject|0
813188|NCT00892177|2585932|P6|Phase II|Ineligible|1
813189|NCT00892177|2585933|P5|Phase II|Ineligible|1
813190|NCT00892177|2585934|P4|Phase II|Ineligible|0
813191|NCT00892177|2585935|P3|Phase II|Ineligible|0
813192|NCT00892177|2585936|P2|Phase II|Ineligible|0
813193|NCT00892177|2585937|P1|Phase II|Ineligible|0
813194|NCT00892281|2585964|P2|Overall Study|Visit 4 date out of window|0
813195|NCT00892281|2585965|P1|Overall Study|Visit 4 date out of window|1
813196|NCT00892281|2585964|P2|Overall Study|Rash on hand|0
813197|NCT00892281|2585965|P1|Overall Study|Rash on hand|1
813198|NCT00892281|2585964|P2|Overall Study|Subject had history of drug abuse|0
813199|NCT00892281|2585965|P1|Overall Study|Subject had history of drug abuse|1
813200|NCT00892281|2585964|P2|Overall Study|Non-compliant with visits as scheduled|0
813201|NCT00892281|2585965|P1|Overall Study|Non-compliant with visits as scheduled|1
813202|NCT00892281|2585964|P2|Overall Study|Missed visits rescheduled out of window|0
813203|NCT00892281|2585965|P1|Overall Study|Missed visits rescheduled out of window|1
813204|NCT00892281|2585964|P2|Overall Study|Missed multiple visits|0
813205|NCT00892281|2585965|P1|Overall Study|Missed multiple visits|1
813206|NCT00892281|2585964|P2|Overall Study|No show Visit 2; prescription not filled|0
813207|NCT00892281|2585965|P1|Overall Study|No show Visit 2; prescription not filled|1
813208|NCT00892281|2585964|P2|Overall Study|Subject not seen by PI at final visit|0
813209|NCT00892281|2585965|P1|Overall Study|Subject not seen by PI at final visit|1
813210|NCT00892281|2585964|P2|Overall Study|Lack of efficacy of study product|0
813211|NCT00892281|2585965|P1|Overall Study|Lack of efficacy of study product|2
813212|NCT00892281|2585964|P2|Overall Study|Death in family|0
813213|NCT00892281|2585965|P1|Overall Study|Death in family|1
813214|NCT00892281|2585964|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
813215|NCT00892281|2585965|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
813216|NCT00892281|2585964|P2|Overall Study|Subject lost interest in program|1
813217|NCT00892281|2585965|P1|Overall Study|Subject lost interest in program|0
813218|NCT00892281|2585964|P2|Overall Study|PI complained of inadequate compensation|0
813219|NCT00892281|2585965|P1|Overall Study|PI complained of inadequate compensation|3
813220|NCT00892281|2585964|P2|Overall Study|Scheduled for knee replacement|1
813221|NCT00892281|2585965|P1|Overall Study|Scheduled for knee replacement|0
813222|NCT00892281|2585964|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
813223|NCT00892281|2585965|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
813224|NCT00892281|2585964|P2|Overall Study|Subject missed several visits/lost meds|0
813225|NCT00892281|2585965|P1|Overall Study|Subject missed several visits/lost meds|1
813226|NCT00892281|2585964|P2|Overall Study|Subject did not return for any visits|0
813227|NCT00892281|2585965|P1|Overall Study|Subject did not return for any visits|1
813228|NCT00892281|2585964|P2|Overall Study|Subject not good candidate for study|0
813229|NCT00892281|2585965|P1|Overall Study|Subject not good candidate for study|1
813230|NCT00892281|2585964|P2|Overall Study|Unable to redeem the drug voucher|0
813231|NCT00892281|2585965|P1|Overall Study|Unable to redeem the drug voucher|1
813232|NCT00892281|2585964|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
813233|NCT00892281|2585965|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
813234|NCT00892281|2585964|P2|Overall Study|Did not meet incl/excl criteria|0
813235|NCT00892281|2585965|P1|Overall Study|Did not meet incl/excl criteria|1
813236|NCT00892281|2585964|P2|Overall Study|Last visit not done - death in family|0
813237|NCT00892281|2585965|P1|Overall Study|Last visit not done - death in family|1
813238|NCT00892281|2585964|P2|Overall Study|Family emergency|0
813239|NCT00892281|2585965|P1|Overall Study|Family emergency|1
813240|NCT00892281|2585964|P2|Overall Study|Subject completed day after study closed|0
813241|NCT00892281|2585965|P1|Overall Study|Subject completed day after study closed|1
813242|NCT00892281|2585964|P2|Overall Study|Final visit completed 4 weeks late|1
813243|NCT00892281|2585965|P1|Overall Study|Final visit completed 4 weeks late|0
813244|NCT00892281|2585964|P2|Overall Study|Subject unable to keep follow-up visits|0
813245|NCT00892281|2585965|P1|Overall Study|Subject unable to keep follow-up visits|1
813246|NCT00892281|2585964|P2|Overall Study|Subject failed to return for final visit|0
813247|NCT00892281|2585965|P1|Overall Study|Subject failed to return for final visit|2
813248|NCT00892281|2585964|P2|Overall Study|Withdrawal by Subject|14
813249|NCT00892281|2585965|P1|Overall Study|Withdrawal by Subject|86
813250|NCT00892281|2585964|P2|Overall Study|Protocol Violation|2
813251|NCT00892281|2585965|P1|Overall Study|Protocol Violation|7
813252|NCT00892281|2585964|P2|Overall Study|Pregnancy|0
813253|NCT00892281|2585965|P1|Overall Study|Pregnancy|1
813254|NCT00892281|2585964|P2|Overall Study|Lost to Follow-up|8
813255|NCT00892281|2585965|P1|Overall Study|Lost to Follow-up|81
813256|NCT00892281|2585964|P2|Overall Study|Adverse Event|8
813257|NCT00892281|2585965|P1|Overall Study|Adverse Event|65
813258|NCT00892437|2585977|P2|Open-Label Extension Phase|Withdrew Consent|1
813259|NCT00892437|2585978|P1|Open-Label Extension Phase|Withdrew Consent|3
813260|NCT00892437|2585977|P2|Open-Label Extension Phase|Investigator's Discretion|0
813261|NCT00892437|2585978|P1|Open-Label Extension Phase|Investigator's Discretion|1
813262|NCT00892437|2585977|P2|Open-Label Extension Phase|Lost to Follow-up|1
813263|NCT00892437|2585978|P1|Open-Label Extension Phase|Lost to Follow-up|3
813264|NCT00892437|2585977|P2|Open-Label Extension Phase|Lack of Efficacy|0
813265|NCT00892437|2585978|P1|Open-Label Extension Phase|Lack of Efficacy|1
813266|NCT00892437|2585977|P2|Open-Label Extension Phase|Adverse Event|2
813267|NCT00892437|2585978|P1|Open-Label Extension Phase|Adverse Event|4
813268|NCT00892437|2585977|P2|Randomized Phase|Withdrew Consent|0
813269|NCT00892437|2585978|P1|Randomized Phase|Withdrew Consent|1
813270|NCT00892437|2585977|P2|Randomized Phase|Investigator’s Discretion|0
813271|NCT00892437|2585978|P1|Randomized Phase|Investigator’s Discretion|1
813272|NCT00892437|2585977|P2|Randomized Phase|Lost to Follow-up|3
813273|NCT00892437|2585978|P1|Randomized Phase|Lost to Follow-up|1
813274|NCT00892437|2585977|P2|Randomized Phase|Adverse Event|2
813275|NCT00892437|2585978|P1|Randomized Phase|Adverse Event|2
813276|NCT00892437|2585977|P2|Randomized Phase|Randomized but not treated|0
813277|NCT00892437|2585978|P1|Randomized Phase|Randomized but not treated|6
813278|NCT00892723|2586044|P3|Overall Study|Withdrawal by Subject|1
813279|NCT00892723|2586045|P2|Overall Study|Withdrawal by Subject|1
813280|NCT00892723|2586046|P1|Overall Study|Withdrawal by Subject|1
813281|NCT00892723|2586044|P3|Overall Study|Lost to Follow-up|1
813282|NCT00892723|2586045|P2|Overall Study|Lost to Follow-up|3
813283|NCT00892723|2586046|P1|Overall Study|Lost to Follow-up|1
813296|NCT00892957|2586116|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
813297|NCT00892957|2586117|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
813298|NCT00892957|2586116|P2|Between Postoperative Day 1 and Day 14|Death|2
813299|NCT00892957|2586117|P1|Between Postoperative Day 1 and Day 14|Death|0
813300|NCT00893113|2586223|P2|Overall Study|Withdrew Consent|7
813301|NCT00893113|2586224|P1|Overall Study|Withdrew Consent|8
813302|NCT00893113|2586223|P2|Overall Study|Early Termination|1
813303|NCT00893113|2586224|P1|Overall Study|Early Termination|1
813304|NCT00893113|2586223|P2|Overall Study|Lost to Follow-up|8
813305|NCT00893113|2586224|P1|Overall Study|Lost to Follow-up|4
813306|NCT00893464|2586251|P8|Overall Study|Did not complete therapy/experience PD|2
813307|NCT00893464|2586252|P7|Overall Study|Did not complete therapy/experience PD|2
813308|NCT00893464|2586253|P6|Overall Study|Did not complete therapy/experience PD|0
813309|NCT00893464|2586254|P5|Overall Study|Did not complete therapy/experience PD|0
813310|NCT00893464|2586255|P4|Overall Study|Did not complete therapy/experience PD|0
813311|NCT00893464|2586256|P3|Overall Study|Did not complete therapy/experience PD|0
813312|NCT00893464|2586257|P2|Overall Study|Did not complete therapy/experience PD|0
813313|NCT00893464|2586258|P1|Overall Study|Did not complete therapy/experience PD|0
813314|NCT00893737|2586374|P1|Overall Study|Lost to Follow-up|6
813315|NCT00893737|2586374|P1|Overall Study|Withdrawal by Subject|2
813316|NCT00893737|2586374|P1|Overall Study|Adverse Event|4
813317|NCT00893763|2586382|P2|Overall Study|extubated|110
813318|NCT00893763|2586383|P1|Overall Study|extubated|110
813319|NCT00893789|2586395|P4|Overall Study|Lost to Follow-up|1
813320|NCT00893789|2586396|P3|Overall Study|Lost to Follow-up|0
813321|NCT00893789|2586397|P2|Overall Study|Lost to Follow-up|0
813322|NCT00893789|2586398|P1|Overall Study|Lost to Follow-up|0
813323|NCT00893789|2586395|P4|Overall Study|Protocol Violation|4
813324|NCT00893789|2586396|P3|Overall Study|Protocol Violation|1
813325|NCT00893789|2586397|P2|Overall Study|Protocol Violation|1
813326|NCT00893789|2586398|P1|Overall Study|Protocol Violation|0
813327|NCT00893789|2586395|P4|Overall Study|Adverse Event|5
813328|NCT00893789|2586396|P3|Overall Study|Adverse Event|1
813329|NCT00893789|2586397|P2|Overall Study|Adverse Event|2
813330|NCT00893789|2586398|P1|Overall Study|Adverse Event|0
813331|NCT00893789|2586395|P4|Overall Study|Taking Excluded Concomitant Medication|0
813332|NCT00893789|2586396|P3|Overall Study|Taking Excluded Concomitant Medication|1
813333|NCT00893789|2586397|P2|Overall Study|Taking Excluded Concomitant Medication|0
813334|NCT00893789|2586398|P1|Overall Study|Taking Excluded Concomitant Medication|1
813335|NCT00893789|2586395|P4|Overall Study|Noncompliance With Study Procedures|0
813336|NCT00893789|2586396|P3|Overall Study|Noncompliance With Study Procedures|0
813337|NCT00893789|2586397|P2|Overall Study|Noncompliance With Study Procedures|0
813338|NCT00893789|2586398|P1|Overall Study|Noncompliance With Study Procedures|1
813339|NCT00893789|2586395|P4|Overall Study|Noncompliance With Study Drug|2
813340|NCT00893789|2586396|P3|Overall Study|Noncompliance With Study Drug|1
813341|NCT00893789|2586397|P2|Overall Study|Noncompliance With Study Drug|0
813342|NCT00893789|2586398|P1|Overall Study|Noncompliance With Study Drug|1
813343|NCT00893789|2586395|P4|Overall Study|Withdrawal by Subject|1
813344|NCT00893789|2586396|P3|Overall Study|Withdrawal by Subject|3
813345|NCT00893789|2586397|P2|Overall Study|Withdrawal by Subject|1
813346|NCT00893789|2586398|P1|Overall Study|Withdrawal by Subject|3
813347|NCT00893971|2586480|P1|Overall Study|Physician Decision|3
813348|NCT00887679|2586603|P1|Overall Study|Physician Decision|5
813349|NCT00887679|2586603|P1|Overall Study|Lost to Follow-up|4
813350|NCT00887679|2586603|P1|Overall Study|Withdrawal by Subject|1
813351|NCT00887744|2586612|P1|Overall Study|Various reasons|9
813352|NCT00887744|2586612|P1|Overall Study|Withdrawal by Subject|18
813353|NCT00887744|2586612|P1|Overall Study|Lost to Follow-up|3
813354|NCT00887744|2586612|P1|Overall Study|Death|1
813355|NCT00887744|2586612|P1|Overall Study|Adverse Event|3
813356|NCT00887809|2586623|P2|Overall Study|Death|0
813357|NCT00887809|2586624|P1|Overall Study|Death|1
813358|NCT00887809|2586623|P2|Overall Study|Patient Not Treated|0
813359|NCT00887809|2586624|P1|Overall Study|Patient Not Treated|3
813360|NCT00887822|2586632|P2|Overall Study|Randomized but not treated|1
813361|NCT00887822|2586633|P1|Overall Study|Randomized but not treated|0
813362|NCT00887822|2586632|P2|Overall Study|Protocol Violation|1
813363|NCT00887822|2586633|P1|Overall Study|Protocol Violation|0
813364|NCT00887822|2586632|P2|Overall Study|Death|3
813365|NCT00887822|2586633|P1|Overall Study|Death|2
813366|NCT00887822|2586632|P2|Overall Study|Administrative/Other than specified|4
813367|NCT00887822|2586633|P1|Overall Study|Administrative/Other than specified|5
813368|NCT00887822|2586632|P2|Overall Study|Refused treatment/Did not cooperate|10
813369|NCT00887822|2586633|P1|Overall Study|Refused treatment/Did not cooperate|12
813370|NCT00887822|2586632|P2|Overall Study|Failure to return|11
813371|NCT00887822|2586633|P1|Overall Study|Failure to return|11
813372|NCT00887822|2586632|P2|Overall Study|Adverse Event|17
813373|NCT00887822|2586633|P1|Overall Study|Adverse Event|14
813374|NCT00887822|2586632|P2|Overall Study|Insufficient therapeutic response|55
813375|NCT00887822|2586633|P1|Overall Study|Insufficient therapeutic response|53
813376|NCT00887913|2586663|P1|Overall Study|Withdrawal by Subject|6
813377|NCT00887978|2586701|P2|Overall Study|Lost to Follow-up|1
813378|NCT00887978|2586702|P1|Overall Study|Lost to Follow-up|0
813379|NCT00887978|2586701|P2|Overall Study|Withdrawal by Subject|2
813380|NCT00887978|2586702|P1|Overall Study|Withdrawal by Subject|1
813381|NCT00887978|2586701|P2|Overall Study|Death|3
813382|NCT00887978|2586702|P1|Overall Study|Death|2
813383|NCT00887978|2586701|P2|Overall Study|Clinical Worsening|4
813384|NCT00887978|2586702|P1|Overall Study|Clinical Worsening|4
813385|NCT00887978|2586701|P2|Overall Study|Adverse Event|5
813386|NCT00887978|2586702|P1|Overall Study|Adverse Event|18
813387|NCT00888134|2586738|P1|Follow-up|being followed for long-term survival|1
813388|NCT00888134|2586738|P1|Treatment With Study Drug|Withdrawal by Subject|1
813389|NCT00888238|2586746|P3|Washout Period After Period 2|Adverse Event|1
813390|NCT00888238|2586747|P2|Washout Period After Period 2|Adverse Event|0
813391|NCT00888238|2586748|P1|Washout Period After Period 2|Adverse Event|0
813392|NCT00888329|2586758|P2|Overall Study|Physician Decision|9
813393|NCT00888329|2586759|P1|Overall Study|Physician Decision|6
813394|NCT00888355|2586769|P4|Overall Study|Withdrawal by Subject|3
813395|NCT00888355|2586770|P3|Overall Study|Withdrawal by Subject|1
813396|NCT00888355|2586771|P2|Overall Study|Withdrawal by Subject|3
813397|NCT00888355|2586772|P1|Overall Study|Withdrawal by Subject|0
813398|NCT00888355|2586769|P4|Overall Study|Protocol Violation|2
813399|NCT00888355|2586770|P3|Overall Study|Protocol Violation|1
813400|NCT00888355|2586771|P2|Overall Study|Protocol Violation|2
813401|NCT00888355|2586772|P1|Overall Study|Protocol Violation|3
813402|NCT00888355|2586769|P4|Overall Study|Lost to Follow-up|0
813403|NCT00888355|2586770|P3|Overall Study|Lost to Follow-up|2
813404|NCT00888355|2586771|P2|Overall Study|Lost to Follow-up|2
813405|NCT00888355|2586772|P1|Overall Study|Lost to Follow-up|0
813406|NCT00888355|2586769|P4|Overall Study|Lack of Efficacy|2
813407|NCT00888355|2586770|P3|Overall Study|Lack of Efficacy|5
813408|NCT00888355|2586771|P2|Overall Study|Lack of Efficacy|2
813409|NCT00888355|2586772|P1|Overall Study|Lack of Efficacy|9
813410|NCT00888355|2586769|P4|Overall Study|Adverse Event|3
813411|NCT00888355|2586770|P3|Overall Study|Adverse Event|3
813412|NCT00888355|2586771|P2|Overall Study|Adverse Event|0
813413|NCT00888355|2586772|P1|Overall Study|Adverse Event|10
813416|NCT00888433|2586847|P2|Overall Study|Missed Visit|1
813417|NCT00888433|2586848|P1|Overall Study|Missed Visit|2
813418|NCT00888433|2586847|P2|Overall Study|Withdrawal by Subject|2
813419|NCT00888433|2586848|P1|Overall Study|Withdrawal by Subject|1
813420|NCT00894166|2586871|P8|Overall Study|Death|0
813421|NCT00894166|2586872|P7|Overall Study|Death|0
813422|NCT00894166|2586873|P6|Overall Study|Death|0
813423|NCT00894166|2586874|P5|Overall Study|Death|0
813424|NCT00894166|2586875|P4|Overall Study|Death|1
813425|NCT00894166|2586876|P3|Overall Study|Death|0
813426|NCT00894166|2586877|P2|Overall Study|Death|0
813427|NCT00894166|2586878|P1|Overall Study|Death|0
813428|NCT00894166|2586871|P8|Overall Study|Withdrew or Lost to Follow-Up|34
813429|NCT00894166|2586872|P7|Overall Study|Withdrew or Lost to Follow-Up|16
813430|NCT00894166|2586873|P6|Overall Study|Withdrew or Lost to Follow-Up|16
813431|NCT00894166|2586874|P5|Overall Study|Withdrew or Lost to Follow-Up|24
813432|NCT00894166|2586875|P4|Overall Study|Withdrew or Lost to Follow-Up|68
813433|NCT00894166|2586876|P3|Overall Study|Withdrew or Lost to Follow-Up|62
813434|NCT00894166|2586877|P2|Overall Study|Withdrew or Lost to Follow-Up|63
813435|NCT00894166|2586878|P1|Overall Study|Withdrew or Lost to Follow-Up|61
813436|NCT00894322|2586915|P3|Overall Study|Withdrawal by Subject|0
813437|NCT00894322|2586916|P2|Overall Study|Withdrawal by Subject|0
813438|NCT00894322|2586917|P1|Overall Study|Withdrawal by Subject|1
813439|NCT00894361|2586958|P2|Overall Study|deaths and less than 2 yr followup|64
813440|NCT00894361|2586959|P1|Overall Study|deaths and less than 2 yr followup|24
813441|NCT00894387|2586967|P2|Overall Study|GCP non-compliance|2
813442|NCT00894387|2586968|P1|Overall Study|GCP non-compliance|0
813443|NCT00894387|2586967|P2|Overall Study|Mis-randomized|9
813444|NCT00894387|2586968|P1|Overall Study|Mis-randomized|13
813445|NCT00894387|2586967|P2|Overall Study|Other (Missing)|3
813446|NCT00894387|2586968|P1|Overall Study|Other (Missing)|5
813447|NCT00894387|2586967|P2|Overall Study|Patient's request|30
813448|NCT00894387|2586968|P1|Overall Study|Patient's request|25
813449|NCT00894387|2586967|P2|Overall Study|Protocol Deviation|0
813450|NCT00894387|2586968|P1|Overall Study|Protocol Deviation|4
813451|NCT00894387|2586967|P2|Overall Study|Death|76
813452|NCT00894387|2586968|P1|Overall Study|Death|77
813453|NCT00894387|2586967|P2|Overall Study|Administrative problems|2
813454|NCT00894387|2586968|P1|Overall Study|Administrative problems|2
813455|NCT00894387|2586967|P2|Overall Study|Lost to Follow-up|5
813456|NCT00894387|2586968|P1|Overall Study|Lost to Follow-up|3
813457|NCT00894387|2586967|P2|Overall Study|Unsatisfactory therapeutic effect|1
813458|NCT00894387|2586968|P1|Overall Study|Unsatisfactory therapeutic effect|0
813459|NCT00894387|2586967|P2|Overall Study|Abnormal Laboratory values|2
813460|NCT00894387|2586968|P1|Overall Study|Abnormal Laboratory values|2
813461|NCT00894387|2586967|P2|Overall Study|Adverse Event|45
813462|NCT00894387|2586968|P1|Overall Study|Adverse Event|44
813463|NCT00896233|2586997|P1|Overall Study|Claustrophobia during MRI|1
813464|NCT00896337|2587008|P1|Overall Study|Lost to Follow-up|11
813465|NCT00896337|2587008|P1|Overall Study|Withdrawal by Subject|7
813466|NCT00896337|2587008|P1|Overall Study|Death|7
813467|NCT00896454|2587075|P1|Overall Study|Withdrawal by Subject|1
813468|NCT00896454|2587075|P1|Overall Study|Ongoing in study|2
813469|NCT00896454|2587075|P1|Overall Study|Requirement for alternative therapy|3
813470|NCT00896454|2587075|P1|Overall Study|Other|4
813471|NCT00896454|2587075|P1|Overall Study|Disease Progression|5
813472|NCT00896454|2587075|P1|Overall Study|Adverse Event|8
813473|NCT00896454|2587075|P1|Overall Study|Death|10
813474|NCT00896649|2587087|P1|Overall Study|technical difficulties|2
813475|NCT00896649|2587087|P1|Overall Study|missing documentation|1
813476|NCT00896649|2587087|P1|Overall Study|Pregnancy|1
813477|NCT00896649|2587087|P1|Overall Study|Physician Decision|1
813478|NCT00897104|2587104|P3|Overall Study|Withdrawal by Subject|1
813479|NCT00897104|2587105|P2|Overall Study|Withdrawal by Subject|0
813480|NCT00897104|2587106|P1|Overall Study|Withdrawal by Subject|0
813481|NCT00897104|2587104|P3|Overall Study|Protocol Violation|0
813482|NCT00897104|2587105|P2|Overall Study|Protocol Violation|0
813483|NCT00897104|2587106|P1|Overall Study|Protocol Violation|1
813484|NCT00897104|2587104|P3|Overall Study|Not Specified|0
813485|NCT00897104|2587105|P2|Overall Study|Not Specified|0
813486|NCT00897104|2587106|P1|Overall Study|Not Specified|3
813487|NCT00897104|2587104|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
813488|NCT00897104|2587105|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
813489|NCT00897104|2587106|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
813490|NCT00897104|2587104|P3|Overall Study|Lack of Migraine Attack|1
813491|NCT00897104|2587105|P2|Overall Study|Lack of Migraine Attack|22
813492|NCT00897104|2587106|P1|Overall Study|Lack of Migraine Attack|20
813493|NCT00897104|2587104|P3|Overall Study|Need for Concom. Med.|1
813494|NCT00897104|2587105|P2|Overall Study|Need for Concom. Med.|1
813495|NCT00897104|2587106|P1|Overall Study|Need for Concom. Med.|0
813496|NCT00897104|2587104|P3|Overall Study|Abnormal Baseline ECG|0
813497|NCT00897104|2587105|P2|Overall Study|Abnormal Baseline ECG|2
813498|NCT00897104|2587106|P1|Overall Study|Abnormal Baseline ECG|2
813499|NCT00897104|2587104|P3|Overall Study|Abnormal Prestudy Labs|0
813500|NCT00897104|2587105|P2|Overall Study|Abnormal Prestudy Labs|0
813501|NCT00897104|2587106|P1|Overall Study|Abnormal Prestudy Labs|2
813502|NCT00897104|2587104|P3|Overall Study|Withdrawal by Subject|3
813503|NCT00897104|2587105|P2|Overall Study|Withdrawal by Subject|27
813504|NCT00897104|2587106|P1|Overall Study|Withdrawal by Subject|23
813505|NCT00897104|2587104|P3|Overall Study|Protocol Violation|0
813506|NCT00897104|2587105|P2|Overall Study|Protocol Violation|1
813507|NCT00897104|2587106|P1|Overall Study|Protocol Violation|0
813508|NCT00897104|2587104|P3|Overall Study|Pregnancy|0
813509|NCT00897104|2587105|P2|Overall Study|Pregnancy|1
813510|NCT00897104|2587106|P1|Overall Study|Pregnancy|0
813511|NCT00897104|2587104|P3|Overall Study|Lost to Follow-up|2
813512|NCT00897104|2587105|P2|Overall Study|Lost to Follow-up|17
813513|NCT00897104|2587106|P1|Overall Study|Lost to Follow-up|12
813514|NCT00897390|2587132|P1|Overall Study|Did not Return for the Clinic Visit|2
813515|NCT00897390|2587132|P1|Overall Study|Personal Reasons|1
813516|NCT00897390|2587132|P1|Overall Study|No Longer Met Study Criteria|1
813517|NCT00897390|2587132|P1|Overall Study|Adverse Event|2
813518|NCT00897715|2587221|P2|Overall Study|increased risk of infection|0
813519|NCT00897715|2587222|P1|Overall Study|increased risk of infection|1
813520|NCT00897715|2587221|P2|Overall Study|Physician Decision|0
813521|NCT00897715|2587222|P1|Overall Study|Physician Decision|1
813522|NCT00897715|2587221|P2|Overall Study|Lost to Follow-up|1
813523|NCT00897715|2587222|P1|Overall Study|Lost to Follow-up|0
813524|NCT00897949|2587242|P3|Overall Study|Did not take study drug|4
813525|NCT00897949|2587243|P2|Overall Study|Did not take study drug|3
813526|NCT00897949|2587244|P1|Overall Study|Did not take study drug|9
813527|NCT00897949|2587242|P3|Overall Study|Lack of Migraine Attack|19
813528|NCT00897949|2587243|P2|Overall Study|Lack of Migraine Attack|30
813529|NCT00897949|2587244|P1|Overall Study|Lack of Migraine Attack|29
813530|NCT00897949|2587242|P3|Overall Study|Need for Concom. Med.|1
813531|NCT00897949|2587243|P2|Overall Study|Need for Concom. Med.|1
813532|NCT00897949|2587244|P1|Overall Study|Need for Concom. Med.|0
813533|NCT00897949|2587242|P3|Overall Study|Abnormal Baseline ECG|4
813534|NCT00897949|2587243|P2|Overall Study|Abnormal Baseline ECG|2
813535|NCT00897949|2587244|P1|Overall Study|Abnormal Baseline ECG|2
813536|NCT00897949|2587242|P3|Overall Study|Abnormal Prestudy Labs|4
813537|NCT00897949|2587243|P2|Overall Study|Abnormal Prestudy Labs|3
813538|NCT00897949|2587244|P1|Overall Study|Abnormal Prestudy Labs|2
813539|NCT00897949|2587242|P3|Overall Study|Withdrawal by Subject|17
813540|NCT00897949|2587243|P2|Overall Study|Withdrawal by Subject|31
813541|NCT00897949|2587244|P1|Overall Study|Withdrawal by Subject|24
813542|NCT00897949|2587242|P3|Overall Study|Lost to Follow-up|17
813543|NCT00897949|2587243|P2|Overall Study|Lost to Follow-up|23
813544|NCT00897949|2587244|P1|Overall Study|Lost to Follow-up|30
813545|NCT00897949|2587242|P3|Overall Study|Patient Uncoorperative|1
813546|NCT00897949|2587243|P2|Overall Study|Patient Uncoorperative|2
813547|NCT00897949|2587244|P1|Overall Study|Patient Uncoorperative|0
813548|NCT00897949|2587242|P3|Overall Study|Withdrawal by Subject|0
813549|NCT00897949|2587243|P2|Overall Study|Withdrawal by Subject|2
813550|NCT00897949|2587244|P1|Overall Study|Withdrawal by Subject|1
813551|NCT00897949|2587242|P3|Overall Study|Protocol Violation|1
813552|NCT00897949|2587243|P2|Overall Study|Protocol Violation|3
813553|NCT00897949|2587244|P1|Overall Study|Protocol Violation|6
813554|NCT00897949|2587242|P3|Overall Study|Lost to Follow-up|1
813555|NCT00897949|2587243|P2|Overall Study|Lost to Follow-up|2
813556|NCT00897949|2587244|P1|Overall Study|Lost to Follow-up|0
813557|NCT00897949|2587242|P3|Overall Study|Adverse Event|0
813558|NCT00897949|2587243|P2|Overall Study|Adverse Event|1
813559|NCT00897949|2587244|P1|Overall Study|Adverse Event|1
813560|NCT00898443|2587273|P2|Overall Study|Withdrawal by Subject|0
813561|NCT00898443|2587274|P1|Overall Study|Withdrawal by Subject|1
813562|NCT00898677|2587296|P4|Overall Study|Not Treated: Other (Not Specified)|0
813563|NCT00898677|2587297|P3|Overall Study|Not Treated: Other (Not Specified)|2
813564|NCT00898677|2587298|P2|Overall Study|Not Treated: Other (Not Specified)|0
813565|NCT00898677|2587299|P1|Overall Study|Not Treated: Other (Not Specified)|0
813566|NCT00898677|2587296|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
813567|NCT00898677|2587297|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
813568|NCT00898677|2587298|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
813569|NCT00898677|2587299|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
813570|NCT00898677|2587296|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
813571|NCT00898677|2587297|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
813572|NCT00898677|2587298|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
813573|NCT00898677|2587299|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
813574|NCT00898677|2587296|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
813575|NCT00898677|2587297|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
813576|NCT00898677|2587298|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
813577|NCT00898677|2587299|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
813578|NCT00898677|2587296|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
813579|NCT00898677|2587297|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
813580|NCT00898677|2587298|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
813581|NCT00898677|2587299|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
813582|NCT00898677|2587296|P4|Overall Study|Not Treated: Patient uncooperative|0
813583|NCT00898677|2587297|P3|Overall Study|Not Treated: Patient uncooperative|1
813584|NCT00898677|2587298|P2|Overall Study|Not Treated: Patient uncooperative|3
813585|NCT00898677|2587299|P1|Overall Study|Not Treated: Patient uncooperative|2
813586|NCT00898677|2587296|P4|Overall Study|Not Treated: Withdraw by Subject|3
813587|NCT00898677|2587297|P3|Overall Study|Not Treated: Withdraw by Subject|11
813588|NCT00898677|2587298|P2|Overall Study|Not Treated: Withdraw by Subject|16
813589|NCT00898677|2587299|P1|Overall Study|Not Treated: Withdraw by Subject|2
813590|NCT00898677|2587296|P4|Overall Study|Not Treated: Protocol Violation|0
813591|NCT00898677|2587297|P3|Overall Study|Not Treated: Protocol Violation|2
813592|NCT00898677|2587298|P2|Overall Study|Not Treated: Protocol Violation|0
813593|NCT00898677|2587299|P1|Overall Study|Not Treated: Protocol Violation|2
813594|NCT00898677|2587296|P4|Overall Study|Not Treated: Pregnancy|0
813595|NCT00898677|2587297|P3|Overall Study|Not Treated: Pregnancy|1
813596|NCT00898677|2587298|P2|Overall Study|Not Treated: Pregnancy|0
813597|NCT00898677|2587299|P1|Overall Study|Not Treated: Pregnancy|0
813598|NCT00898677|2587296|P4|Overall Study|Not Treated: Lost to Follow-Up|2
813599|NCT00898677|2587297|P3|Overall Study|Not Treated: Lost to Follow-Up|5
813600|NCT00898677|2587298|P2|Overall Study|Not Treated: Lost to Follow-Up|5
813601|NCT00898677|2587299|P1|Overall Study|Not Treated: Lost to Follow-Up|0
813602|NCT00898677|2587296|P4|Overall Study|Not Treated: Adverse Event|0
813603|NCT00898677|2587297|P3|Overall Study|Not Treated: Adverse Event|1
813604|NCT00898677|2587298|P2|Overall Study|Not Treated: Adverse Event|2
813605|NCT00898677|2587299|P1|Overall Study|Not Treated: Adverse Event|0
813606|NCT00898677|2587296|P4|Overall Study|Withdrawal by Subject|1
813607|NCT00898677|2587297|P3|Overall Study|Withdrawal by Subject|0
813608|NCT00898677|2587298|P2|Overall Study|Withdrawal by Subject|0
813609|NCT00898677|2587299|P1|Overall Study|Withdrawal by Subject|0
813610|NCT00898677|2587296|P4|Overall Study|Protocol Violation|0
813611|NCT00898677|2587297|P3|Overall Study|Protocol Violation|2
813612|NCT00898677|2587298|P2|Overall Study|Protocol Violation|1
813613|NCT00898677|2587299|P1|Overall Study|Protocol Violation|1
813614|NCT00898677|2587296|P4|Overall Study|Lost to Follow-up|0
813615|NCT00898677|2587297|P3|Overall Study|Lost to Follow-up|2
813616|NCT00898677|2587298|P2|Overall Study|Lost to Follow-up|0
813617|NCT00898677|2587299|P1|Overall Study|Lost to Follow-up|0
813618|NCT00898677|2587296|P4|Overall Study|Adverse Event|0
813619|NCT00898677|2587297|P3|Overall Study|Adverse Event|1
813620|NCT00898677|2587298|P2|Overall Study|Adverse Event|0
813621|NCT00898677|2587299|P1|Overall Study|Adverse Event|0
813622|NCT00898807|2587327|P2|Overall Study|Death|1
813623|NCT00898807|2587328|P1|Overall Study|Death|0
813624|NCT00898807|2587327|P2|Overall Study|Lost to Follow-up|3
813625|NCT00898807|2587328|P1|Overall Study|Lost to Follow-up|1
813626|NCT00898807|2587327|P2|Overall Study|Family pressure to discontinue|2
813627|NCT00898807|2587328|P1|Overall Study|Family pressure to discontinue|2
813628|NCT00898807|2587327|P2|Overall Study|Withdrawal by Subject|3
813629|NCT00898807|2587328|P1|Overall Study|Withdrawal by Subject|5
813630|NCT00891462|2587354|P3|Overall Study|Lost to Follow-up|0
813631|NCT00891462|2587355|P2|Overall Study|Lost to Follow-up|2
813632|NCT00891462|2587356|P1|Overall Study|Lost to Follow-up|0
813633|NCT00891462|2587354|P3|Overall Study|Inclusion/exclusion criteria|2
813634|NCT00891462|2587355|P2|Overall Study|Inclusion/exclusion criteria|2
813635|NCT00891462|2587356|P1|Overall Study|Inclusion/exclusion criteria|0
813636|NCT00891462|2587354|P3|Overall Study|Protocol Violation|3
813637|NCT00891462|2587355|P2|Overall Study|Protocol Violation|1
813638|NCT00891462|2587356|P1|Overall Study|Protocol Violation|2
813639|NCT00891462|2587354|P3|Overall Study|Other Reason|3
813640|NCT00891462|2587355|P2|Overall Study|Other Reason|5
813641|NCT00891462|2587356|P1|Overall Study|Other Reason|2
813642|NCT00891462|2587354|P3|Overall Study|COPD exacerbation|1
813643|NCT00891462|2587355|P2|Overall Study|COPD exacerbation|4
813644|NCT00891462|2587356|P1|Overall Study|COPD exacerbation|7
813645|NCT00891462|2587354|P3|Overall Study|Lack of Efficacy|1
813646|NCT00891462|2587355|P2|Overall Study|Lack of Efficacy|5
813647|NCT00891462|2587356|P1|Overall Study|Lack of Efficacy|10
813648|NCT00891462|2587354|P3|Overall Study|Adverse Event|7
813649|NCT00891462|2587355|P2|Overall Study|Adverse Event|8
813650|NCT00891462|2587356|P1|Overall Study|Adverse Event|7
813651|NCT00891462|2587354|P3|Overall Study|Withdrawal by Subject|7
813652|NCT00891462|2587355|P2|Overall Study|Withdrawal by Subject|6
813653|NCT00891462|2587356|P1|Overall Study|Withdrawal by Subject|9
813655|NCT00899353|2587373|P1|Overall Study|Withdrawal by Subject|2
813656|NCT00899353|2587373|P1|Overall Study|Lost to Follow-up|1
813657|NCT00899353|2587373|P1|Overall Study|Adverse Event|2
813658|NCT00899379|2587399|P5|Overall Study|Inc/Exc Criteria Not Met|0
813659|NCT00899379|2587400|P4|Overall Study|Inc/Exc Criteria Not Met|0
813660|NCT00899379|2587401|P3|Overall Study|Inc/Exc Criteria Not Met|1
813661|NCT00899379|2587402|P2|Overall Study|Inc/Exc Criteria Not Met|0
813662|NCT00899379|2587403|P1|Overall Study|Inc/Exc Criteria Not Met|0
813663|NCT00899379|2587399|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
813664|NCT00899379|2587400|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
813665|NCT00899379|2587401|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
813666|NCT00899379|2587402|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
813667|NCT00899379|2587403|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
813668|NCT00899379|2587399|P5|Overall Study|No Attack Pretreatment|4
813669|NCT00899379|2587400|P4|Overall Study|No Attack Pretreatment|6
813670|NCT00899379|2587401|P3|Overall Study|No Attack Pretreatment|5
813671|NCT00899379|2587402|P2|Overall Study|No Attack Pretreatment|5
813672|NCT00899379|2587403|P1|Overall Study|No Attack Pretreatment|3
813673|NCT00899379|2587399|P5|Overall Study|Abnormal Baseline ECG|0
813674|NCT00899379|2587400|P4|Overall Study|Abnormal Baseline ECG|1
813675|NCT00899379|2587401|P3|Overall Study|Abnormal Baseline ECG|1
813676|NCT00899379|2587402|P2|Overall Study|Abnormal Baseline ECG|0
813677|NCT00899379|2587403|P1|Overall Study|Abnormal Baseline ECG|0
813678|NCT00899379|2587399|P5|Overall Study|Abnormal Prestudy Labs|2
813679|NCT00899379|2587400|P4|Overall Study|Abnormal Prestudy Labs|0
813680|NCT00899379|2587401|P3|Overall Study|Abnormal Prestudy Labs|0
813681|NCT00899379|2587402|P2|Overall Study|Abnormal Prestudy Labs|0
813682|NCT00899379|2587403|P1|Overall Study|Abnormal Prestudy Labs|0
813683|NCT00899379|2587399|P5|Overall Study|Patient Uncooperative|0
813684|NCT00899379|2587400|P4|Overall Study|Patient Uncooperative|1
813685|NCT00899379|2587401|P3|Overall Study|Patient Uncooperative|0
813686|NCT00899379|2587402|P2|Overall Study|Patient Uncooperative|0
813687|NCT00899379|2587403|P1|Overall Study|Patient Uncooperative|0
813688|NCT00899379|2587399|P5|Overall Study|Pregnancy|0
813689|NCT00899379|2587400|P4|Overall Study|Pregnancy|0
813690|NCT00899379|2587401|P3|Overall Study|Pregnancy|0
813691|NCT00899379|2587402|P2|Overall Study|Pregnancy|0
813692|NCT00899379|2587403|P1|Overall Study|Pregnancy|1
813693|NCT00899379|2587399|P5|Overall Study|Withdrawal by Subject|2
813694|NCT00899379|2587400|P4|Overall Study|Withdrawal by Subject|7
813695|NCT00899379|2587401|P3|Overall Study|Withdrawal by Subject|4
813696|NCT00899379|2587402|P2|Overall Study|Withdrawal by Subject|7
813697|NCT00899379|2587403|P1|Overall Study|Withdrawal by Subject|4
813698|NCT00899379|2587399|P5|Overall Study|Lost to Follow-up|5
813699|NCT00899379|2587400|P4|Overall Study|Lost to Follow-up|2
813700|NCT00899379|2587401|P3|Overall Study|Lost to Follow-up|0
813701|NCT00899379|2587402|P2|Overall Study|Lost to Follow-up|1
813702|NCT00899379|2587403|P1|Overall Study|Lost to Follow-up|3
813703|NCT00899379|2587399|P5|Overall Study|Study Terminated|1
813704|NCT00899379|2587400|P4|Overall Study|Study Terminated|3
813705|NCT00899379|2587401|P3|Overall Study|Study Terminated|3
813706|NCT00899379|2587402|P2|Overall Study|Study Terminated|0
813707|NCT00899379|2587403|P1|Overall Study|Study Terminated|3
813708|NCT00899379|2587399|P5|Overall Study|Not Completed/Entered Extn|3
813709|NCT00899379|2587400|P4|Overall Study|Not Completed/Entered Extn|4
813710|NCT00899379|2587401|P3|Overall Study|Not Completed/Entered Extn|6
813711|NCT00899379|2587402|P2|Overall Study|Not Completed/Entered Extn|1
813712|NCT00899379|2587403|P1|Overall Study|Not Completed/Entered Extn|5
813713|NCT00899379|2587399|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
813714|NCT00899379|2587400|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
813715|NCT00899379|2587401|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
813716|NCT00899379|2587402|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
813717|NCT00899379|2587403|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
813718|NCT00899379|2587399|P5|Overall Study|Abnormal Baseline ECG|0
813719|NCT00899379|2587400|P4|Overall Study|Abnormal Baseline ECG|1
813720|NCT00899379|2587401|P3|Overall Study|Abnormal Baseline ECG|0
813721|NCT00899379|2587402|P2|Overall Study|Abnormal Baseline ECG|0
813722|NCT00899379|2587403|P1|Overall Study|Abnormal Baseline ECG|0
813723|NCT00899379|2587399|P5|Overall Study|Patient Uncooperative|2
813724|NCT00899379|2587400|P4|Overall Study|Patient Uncooperative|1
813725|NCT00899379|2587401|P3|Overall Study|Patient Uncooperative|0
813726|NCT00899379|2587402|P2|Overall Study|Patient Uncooperative|1
813727|NCT00899379|2587403|P1|Overall Study|Patient Uncooperative|0
813728|NCT00899379|2587399|P5|Overall Study|Pregnancy|1
813729|NCT00899379|2587400|P4|Overall Study|Pregnancy|0
813730|NCT00899379|2587401|P3|Overall Study|Pregnancy|1
813731|NCT00899379|2587402|P2|Overall Study|Pregnancy|0
813732|NCT00899379|2587403|P1|Overall Study|Pregnancy|0
813733|NCT00899379|2587399|P5|Overall Study|Withdrawal by Subject|6
813734|NCT00899379|2587400|P4|Overall Study|Withdrawal by Subject|3
813735|NCT00899379|2587401|P3|Overall Study|Withdrawal by Subject|2
813736|NCT00899379|2587402|P2|Overall Study|Withdrawal by Subject|4
813737|NCT00899379|2587403|P1|Overall Study|Withdrawal by Subject|2
813738|NCT00899379|2587399|P5|Overall Study|Protocol Violation|0
813739|NCT00899379|2587400|P4|Overall Study|Protocol Violation|1
813740|NCT00899379|2587401|P3|Overall Study|Protocol Violation|1
813741|NCT00899379|2587402|P2|Overall Study|Protocol Violation|0
813742|NCT00899379|2587403|P1|Overall Study|Protocol Violation|0
813743|NCT00899379|2587399|P5|Overall Study|Lost to Follow-up|2
813744|NCT00899379|2587400|P4|Overall Study|Lost to Follow-up|6
813745|NCT00899379|2587401|P3|Overall Study|Lost to Follow-up|0
813746|NCT00899379|2587402|P2|Overall Study|Lost to Follow-up|3
813747|NCT00899379|2587403|P1|Overall Study|Lost to Follow-up|9
813748|NCT00899379|2587399|P5|Overall Study|Lack of Efficacy|1
813749|NCT00899379|2587400|P4|Overall Study|Lack of Efficacy|0
813750|NCT00899379|2587401|P3|Overall Study|Lack of Efficacy|3
813751|NCT00899379|2587402|P2|Overall Study|Lack of Efficacy|4
813752|NCT00899379|2587403|P1|Overall Study|Lack of Efficacy|0
813753|NCT00899379|2587399|P5|Overall Study|Adverse Event|2
813754|NCT00899379|2587400|P4|Overall Study|Adverse Event|1
813755|NCT00899379|2587401|P3|Overall Study|Adverse Event|1
813756|NCT00899379|2587402|P2|Overall Study|Adverse Event|2
813757|NCT00899379|2587403|P1|Overall Study|Adverse Event|2
813758|NCT00899392|2587417|P2|Overall Study|Subject didn't finish/partial pilot data|24
813759|NCT00899392|2587418|P1|Overall Study|Subject didn't finish/partial pilot data|21
813760|NCT00899678|2587526|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
813761|NCT00899678|2587527|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
813762|NCT00899678|2587528|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
813763|NCT00899678|2587526|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
813764|NCT00899678|2587527|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
813765|NCT00899678|2587528|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
813766|NCT00899678|2587526|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
813767|NCT00899678|2587527|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
813768|NCT00899678|2587528|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
813769|NCT00899678|2587526|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
813770|NCT00899678|2587527|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
813771|NCT00899678|2587528|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
813772|NCT00899678|2587526|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
813773|NCT00899678|2587527|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
813774|NCT00899678|2587528|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
813775|NCT00899678|2587526|P3|Induction Period (Weeks 0 to 6)|Other reason|0
813776|NCT00899678|2587527|P2|Induction Period (Weeks 0 to 6)|Other reason|0
813777|NCT00899678|2587528|P1|Induction Period (Weeks 0 to 6)|Other reason|1
813778|NCT00899678|2587526|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
813779|NCT00899678|2587527|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
813780|NCT00899678|2587528|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
813781|NCT00899678|2587526|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
813782|NCT00899678|2587527|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
813783|NCT00899678|2587528|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
813784|NCT00899678|2587526|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
813785|NCT00899678|2587527|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
813786|NCT00899678|2587528|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
813787|NCT00900029|2587578|P5|Overall Study|Death|0
813788|NCT00900029|2587579|P4|Overall Study|Death|1
813789|NCT00900029|2587580|P3|Overall Study|Death|0
813790|NCT00900029|2587581|P2|Overall Study|Death|0
813791|NCT00900029|2587582|P1|Overall Study|Death|1
813792|NCT00900029|2587578|P5|Overall Study|Adverse Event|1
813793|NCT00900029|2587579|P4|Overall Study|Adverse Event|1
813794|NCT00900029|2587580|P3|Overall Study|Adverse Event|1
813795|NCT00900029|2587581|P2|Overall Study|Adverse Event|0
813796|NCT00900029|2587582|P1|Overall Study|Adverse Event|0
813797|NCT00900029|2587578|P5|Overall Study|Withdrawal by Subject|1
813798|NCT00900029|2587579|P4|Overall Study|Withdrawal by Subject|1
813799|NCT00900029|2587580|P3|Overall Study|Withdrawal by Subject|1
813800|NCT00900029|2587581|P2|Overall Study|Withdrawal by Subject|2
813801|NCT00900029|2587582|P1|Overall Study|Withdrawal by Subject|2
813802|NCT00900029|2587578|P5|Overall Study|Lost to Follow-up|4
813803|NCT00900029|2587579|P4|Overall Study|Lost to Follow-up|4
813804|NCT00900029|2587580|P3|Overall Study|Lost to Follow-up|1
813805|NCT00900029|2587581|P2|Overall Study|Lost to Follow-up|2
813806|NCT00900029|2587582|P1|Overall Study|Lost to Follow-up|0
813807|NCT00900146|2587604|P5|Intermediate: Period III|Administrative problems|163
813808|NCT00900146|2587605|P4|Intermediate: Period III|Administrative problems|90
813809|NCT00900146|2587606|P3|Intermediate: Period III|Administrative problems|84
813810|NCT00900146|2587607|P2|Intermediate: Period III|Administrative problems|92
813811|NCT00900146|2587608|P1|Intermediate: Period III|Administrative problems|85
813812|NCT00900146|2587604|P5|Intermediate: Period III|Lost to Follow-up|1
813813|NCT00900146|2587605|P4|Intermediate: Period III|Lost to Follow-up|0
813814|NCT00900146|2587606|P3|Intermediate: Period III|Lost to Follow-up|0
813815|NCT00900146|2587607|P2|Intermediate: Period III|Lost to Follow-up|0
813816|NCT00900146|2587608|P1|Intermediate: Period III|Lost to Follow-up|2
813817|NCT00900146|2587604|P5|Intermediate: Period III|Withdrawal by Subject|3
813818|NCT00900146|2587605|P4|Intermediate: Period III|Withdrawal by Subject|0
813819|NCT00900146|2587606|P3|Intermediate: Period III|Withdrawal by Subject|0
813820|NCT00900146|2587607|P2|Intermediate: Period III|Withdrawal by Subject|1
813821|NCT00900146|2587608|P1|Intermediate: Period III|Withdrawal by Subject|0
813822|NCT00900146|2587604|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
813823|NCT00900146|2587605|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
813824|NCT00900146|2587606|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
813825|NCT00900146|2587607|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
813826|NCT00900146|2587608|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
813827|NCT00900146|2587604|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
813828|NCT00900146|2587605|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
813829|NCT00900146|2587606|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
813830|NCT00900146|2587607|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
813831|NCT00900146|2587608|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
813832|NCT00900146|2587604|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
813833|NCT00900146|2587605|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
813834|NCT00900146|2587606|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
813835|NCT00900146|2587607|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
813836|NCT00900146|2587608|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
813837|NCT00900159|2587722|P2|Second Intervention|disempanelled for inappropriate behavior|0
813838|NCT00900159|2587723|P1|Second Intervention|disempanelled for inappropriate behavior|1
813839|NCT00900627|2587754|P6|Overall Study|Death|24
813840|NCT00900627|2587755|P5|Overall Study|Death|28
813841|NCT00900627|2587756|P4|Overall Study|Death|0
813842|NCT00900627|2587757|P3|Overall Study|Death|0
813843|NCT00900627|2587758|P2|Overall Study|Death|0
813844|NCT00900627|2587759|P1|Overall Study|Death|0
813845|NCT00900627|2587754|P6|Overall Study|Adverse Event|0
813846|NCT00900627|2587755|P5|Overall Study|Adverse Event|0
813847|NCT00900627|2587756|P4|Overall Study|Adverse Event|3
813848|NCT00900627|2587757|P3|Overall Study|Adverse Event|0
813849|NCT00900627|2587758|P2|Overall Study|Adverse Event|2
813850|NCT00900627|2587759|P1|Overall Study|Adverse Event|1
813851|NCT00900627|2587754|P6|Overall Study|Withdrawal by Subject|2
813852|NCT00900627|2587755|P5|Overall Study|Withdrawal by Subject|1
813853|NCT00900627|2587756|P4|Overall Study|Withdrawal by Subject|0
813854|NCT00900627|2587757|P3|Overall Study|Withdrawal by Subject|1
813855|NCT00900627|2587758|P2|Overall Study|Withdrawal by Subject|0
813856|NCT00900627|2587759|P1|Overall Study|Withdrawal by Subject|1
813857|NCT00900627|2587754|P6|Overall Study|Condition under investigation worsened|0
813858|NCT00900627|2587755|P5|Overall Study|Condition under investigation worsened|0
813859|NCT00900627|2587756|P4|Overall Study|Condition under investigation worsened|3
813860|NCT00900627|2587757|P3|Overall Study|Condition under investigation worsened|5
813861|NCT00900627|2587758|P2|Overall Study|Condition under investigation worsened|0
813862|NCT00900627|2587759|P1|Overall Study|Condition under investigation worsened|4
813863|NCT00900731|2587790|P2|Overall Study|Death|2
813864|NCT00900731|2587791|P1|Overall Study|Death|0
813865|NCT00900731|2587790|P2|Overall Study|Lack of Efficacy|3
813866|NCT00900731|2587791|P1|Overall Study|Lack of Efficacy|1
813867|NCT00900731|2587790|P2|Overall Study|Lost to Follow-up|3
813868|NCT00900731|2587791|P1|Overall Study|Lost to Follow-up|2
813869|NCT00900731|2587790|P2|Overall Study|Abnormal Laboratory Value(s)|4
813870|NCT00900731|2587791|P1|Overall Study|Abnormal Laboratory Value(s)|2
813871|NCT00900731|2587790|P2|Overall Study|Abnormal Test Procedure Result(s)|0
813872|NCT00900731|2587791|P1|Overall Study|Abnormal Test Procedure Result(s)|3
813873|NCT00900731|2587790|P2|Overall Study|Administrative Problems|4
813874|NCT00900731|2587791|P1|Overall Study|Administrative Problems|5
813875|NCT00900731|2587790|P2|Overall Study|Protocol Deviation|11
813876|NCT00900731|2587791|P1|Overall Study|Protocol Deviation|8
813877|NCT00900731|2587790|P2|Overall Study|Withdrawal by Subject|7
813878|NCT00900731|2587791|P1|Overall Study|Withdrawal by Subject|8
813879|NCT00900731|2587790|P2|Overall Study|Adverse Event|27
813880|NCT00900731|2587791|P1|Overall Study|Adverse Event|31
813881|NCT00900757|2587811|P1|Overall Study|screen failure|19
813882|NCT00900796|2587819|P1|Phase 2|Lost to Follow-up|5
813883|NCT00900796|2587819|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
813884|NCT00900796|2587819|P1|Phase 1|Missing information at Week 16|7
813885|NCT00900796|2587819|P1|Phase 1|Lacked sufficient information|4
813886|NCT00901186|2587855|P2|Overall Study|Protocol deviations|4
813887|NCT00901186|2587856|P1|Overall Study|Protocol deviations|5
813888|NCT00901186|2587855|P2|Overall Study|Administration problems|1
813889|NCT00901186|2587856|P1|Overall Study|Administration problems|0
813890|NCT00901186|2587855|P2|Overall Study|Adverse Event|4
813891|NCT00901186|2587856|P1|Overall Study|Adverse Event|2
813892|NCT00901186|2587855|P2|Overall Study|Lost to Follow-up|0
813893|NCT00901186|2587856|P1|Overall Study|Lost to Follow-up|2
813894|NCT00901186|2587855|P2|Overall Study|Abnormal laboratory values|1
813895|NCT00901186|2587856|P1|Overall Study|Abnormal laboratory values|0
813896|NCT00901186|2587855|P2|Overall Study|Lack of Efficacy|1
813897|NCT00901186|2587856|P1|Overall Study|Lack of Efficacy|0
813898|NCT00901342|2587890|P1|Overall Study|Withdrawal by Subject|9
813899|NCT00901342|2587890|P1|Overall Study|Disease progression|1
813900|NCT00901342|2587890|P1|Overall Study|Death|4
813901|NCT00901342|2587890|P1|Overall Study|Adverse Event|1
813902|NCT00901459|2587894|P1|Overall Study|Withdrawal by Subject|6
813903|NCT00901576|2587911|P6|Second Intervention|Physician Decision|0
813904|NCT00901576|2587912|P5|Second Intervention|Physician Decision|0
813905|NCT00901576|2587913|P4|Second Intervention|Physician Decision|0
813906|NCT00901576|2587914|P3|Second Intervention|Physician Decision|0
813907|NCT00901576|2587915|P2|Second Intervention|Physician Decision|0
813908|NCT00901576|2587916|P1|Second Intervention|Physician Decision|1
813909|NCT00901576|2587911|P6|Second Intervention|Withdrawal by Subject|1
813910|NCT00901576|2587912|P5|Second Intervention|Withdrawal by Subject|0
813911|NCT00901576|2587913|P4|Second Intervention|Withdrawal by Subject|1
813912|NCT00901576|2587914|P3|Second Intervention|Withdrawal by Subject|0
813913|NCT00901576|2587915|P2|Second Intervention|Withdrawal by Subject|0
813914|NCT00901576|2587916|P1|Second Intervention|Withdrawal by Subject|0
813915|NCT00901628|2587939|P2|Overall Study|peroneal nerve palsy|1
813916|NCT00901628|2587940|P1|Overall Study|peroneal nerve palsy|0
813917|NCT00901628|2587939|P2|Overall Study|disconnection of drain|1
813918|NCT00901628|2587940|P1|Overall Study|disconnection of drain|0
813919|NCT00901628|2587939|P2|Overall Study|disconnection of catheter|8
813920|NCT00901628|2587940|P1|Overall Study|disconnection of catheter|4
813945|NCT00894543|2588012|P2|Week 4 to Week 8|No diary or lost or withdrew|2
813946|NCT00894543|2588013|P1|Week 4 to Week 8|No diary or lost or withdrew|4
813947|NCT00894543|2588012|P2|Baseline to Week 4|No diary or lost or withdrew|2
813948|NCT00894543|2588013|P1|Baseline to Week 4|No diary or lost or withdrew|3
813949|NCT00894556|2588038|P4|Treatment Phase|Lack of Qualifying Event|0
813950|NCT00894556|2588039|P3|Treatment Phase|Lack of Qualifying Event|0
813951|NCT00894556|2588040|P2|Treatment Phase|Lack of Qualifying Event|1
813952|NCT00894556|2588041|P1|Treatment Phase|Lack of Qualifying Event|2
813953|NCT00894556|2588038|P4|Treatment Phase|Lost to Follow-up|0
813954|NCT00894556|2588039|P3|Treatment Phase|Lost to Follow-up|1
813955|NCT00894556|2588040|P2|Treatment Phase|Lost to Follow-up|3
813956|NCT00894556|2588041|P1|Treatment Phase|Lost to Follow-up|2
813957|NCT00894556|2588038|P4|Baseline Phase|Did not meet Randomization Criteria|85
813958|NCT00894556|2588039|P3|Baseline Phase|Did not meet Randomization Criteria|0
813959|NCT00894556|2588040|P2|Baseline Phase|Did not meet Randomization Criteria|0
813960|NCT00894556|2588041|P1|Baseline Phase|Did not meet Randomization Criteria|0
813961|NCT00894647|2588052|P2|Overall Study|Other, not due to AE|2
813962|NCT00894647|2588053|P1|Overall Study|Other, not due to AE|1
813963|NCT00894647|2588052|P2|Overall Study|Non-compliance with study procedures|2
813964|NCT00894647|2588053|P1|Overall Study|Non-compliance with study procedures|0
813965|NCT00894647|2588052|P2|Overall Study|Lost to Follow-up|2
813966|NCT00894647|2588053|P1|Overall Study|Lost to Follow-up|0
813967|NCT00894647|2588052|P2|Overall Study|Withdrawal by Subject|4
813968|NCT00894647|2588053|P1|Overall Study|Withdrawal by Subject|4
813969|NCT00894647|2588052|P2|Overall Study|Adverse Event|4
813970|NCT00894647|2588053|P1|Overall Study|Adverse Event|5
813971|NCT00894790|2588074|P2|Overall Study|Did not meet entrance criteria|0
813972|NCT00894790|2588075|P1|Overall Study|Did not meet entrance criteria|1
813973|NCT00894790|2588074|P2|Overall Study|Lost to Follow-up|1
813974|NCT00894790|2588075|P1|Overall Study|Lost to Follow-up|0
813975|NCT00894790|2588074|P2|Overall Study|Protocol Violation|1
813976|NCT00894790|2588075|P1|Overall Study|Protocol Violation|0
813977|NCT00894803|2588099|P2|Overall Study|Lost to Follow-up|1
813978|NCT00894803|2588100|P1|Overall Study|Lost to Follow-up|0
813979|NCT00894803|2588099|P2|Overall Study|Death|4
813980|NCT00894803|2588100|P1|Overall Study|Death|20
813981|NCT00894933|2588134|P1|Overall Study|Did not meeting incl/excl criteria|1
813982|NCT00894933|2588134|P1|Overall Study|Cancelled Procedure|1
813983|NCT00894933|2588134|P1|Overall Study|Lost to Follow-up|2
813984|NCT00895011|2588153|P3|Overall Study|schedule conflict|0
813985|NCT00895011|2588154|P2|Overall Study|schedule conflict|0
813986|NCT00895011|2588155|P1|Overall Study|schedule conflict|1
813987|NCT00895011|2588153|P3|Overall Study|Adverse Event|2
813988|NCT00895011|2588154|P2|Overall Study|Adverse Event|2
813989|NCT00895011|2588155|P1|Overall Study|Adverse Event|1
813990|NCT00895011|2588153|P3|Overall Study|Protocol Violation|3
813991|NCT00895011|2588154|P2|Overall Study|Protocol Violation|1
813992|NCT00895011|2588155|P1|Overall Study|Protocol Violation|3
813993|NCT00895011|2588153|P3|Overall Study|Lost to Follow-up|1
813994|NCT00895011|2588154|P2|Overall Study|Lost to Follow-up|4
813995|NCT00895011|2588155|P1|Overall Study|Lost to Follow-up|5
813996|NCT00895011|2588153|P3|Overall Study|Withdrawal by Subject|2
813997|NCT00895011|2588154|P2|Overall Study|Withdrawal by Subject|7
813998|NCT00895011|2588155|P1|Overall Study|Withdrawal by Subject|14
813999|NCT00895245|2588238|P1|Overall Study|Lack of Efficacy|6
814000|NCT00895310|2588254|P1|Overall Study|Withdrawal by Subject|1
814001|NCT00895453|2588264|P3|Overall Study|Lost to Follow-up|23
814002|NCT00895453|2588265|P2|Overall Study|Lost to Follow-up|25
814003|NCT00895453|2588266|P1|Overall Study|Lost to Follow-up|25
814004|NCT00895583|2588285|P2|Overall Study|Not specified|1
814005|NCT00895583|2588286|P1|Overall Study|Not specified|0
814006|NCT00895583|2588285|P2|Overall Study|Lack of Efficacy|0
814007|NCT00895583|2588286|P1|Overall Study|Lack of Efficacy|5
814008|NCT00895583|2588285|P2|Overall Study|Withdrawal by Subject|2
814009|NCT00895583|2588286|P1|Overall Study|Withdrawal by Subject|4
814010|NCT00895583|2588285|P2|Overall Study|Protocol Violation|0
814011|NCT00895583|2588286|P1|Overall Study|Protocol Violation|1
814012|NCT00895583|2588285|P2|Overall Study|Lost to Follow-up|3
814013|NCT00895583|2588286|P1|Overall Study|Lost to Follow-up|1
814014|NCT00895583|2588285|P2|Overall Study|Physician Decision|1
814015|NCT00895583|2588286|P1|Overall Study|Physician Decision|3
814016|NCT00895583|2588285|P2|Overall Study|Death|1
814017|NCT00895583|2588286|P1|Overall Study|Death|2
814018|NCT00895583|2588285|P2|Overall Study|Adverse Event|4
814019|NCT00895583|2588286|P1|Overall Study|Adverse Event|28
814020|NCT00895661|2588364|P1|Overall Study|reason unknown|2
814021|NCT00895661|2588364|P1|Overall Study|Death|1
814022|NCT00895843|2588414|P2|Overall Study|Protocol Violation|12
814023|NCT00895843|2588415|P1|Overall Study|Protocol Violation|12
814024|NCT00895895|2588426|P5|Period 2|unsatisfactory response-efficacy|0
814025|NCT00895895|2588427|P4|Period 2|unsatisfactory response-efficacy|0
814026|NCT00895895|2588428|P3|Period 2|unsatisfactory response-efficacy|0
814027|NCT00895895|2588429|P2|Period 2|unsatisfactory response-efficacy|1
814028|NCT00895895|2588430|P1|Period 2|unsatisfactory response-efficacy|2
814029|NCT00895895|2588426|P5|Period 2|Withdrawal by Subject|5
814030|NCT00895895|2588427|P4|Period 2|Withdrawal by Subject|3
814031|NCT00895895|2588428|P3|Period 2|Withdrawal by Subject|0
814032|NCT00895895|2588429|P2|Period 2|Withdrawal by Subject|2
814033|NCT00895895|2588430|P1|Period 2|Withdrawal by Subject|0
814034|NCT00895895|2588426|P5|Period 2|Protocol Violation|1
814035|NCT00895895|2588427|P4|Period 2|Protocol Violation|1
814036|NCT00895895|2588428|P3|Period 2|Protocol Violation|1
814037|NCT00895895|2588429|P2|Period 2|Protocol Violation|0
814038|NCT00895895|2588430|P1|Period 2|Protocol Violation|1
814039|NCT00895895|2588426|P5|Period 2|unspecified|1
814040|NCT00895895|2588427|P4|Period 2|unspecified|1
814041|NCT00895895|2588428|P3|Period 2|unspecified|3
814042|NCT00895895|2588429|P2|Period 2|unspecified|1
814043|NCT00895895|2588430|P1|Period 2|unspecified|1
814044|NCT00895895|2588426|P5|Period 2|Lost to Follow-up|0
814045|NCT00895895|2588427|P4|Period 2|Lost to Follow-up|1
814046|NCT00895895|2588428|P3|Period 2|Lost to Follow-up|1
814047|NCT00895895|2588429|P2|Period 2|Lost to Follow-up|2
814048|NCT00895895|2588430|P1|Period 2|Lost to Follow-up|1
814049|NCT00895895|2588426|P5|Period 2|investigator request|0
814050|NCT00895895|2588427|P4|Period 2|investigator request|0
814051|NCT00895895|2588428|P3|Period 2|investigator request|0
814052|NCT00895895|2588429|P2|Period 2|investigator request|0
814053|NCT00895895|2588430|P1|Period 2|investigator request|2
814054|NCT00895895|2588426|P5|Period 2|failed to return|0
814055|NCT00895895|2588427|P4|Period 2|failed to return|0
814056|NCT00895895|2588428|P3|Period 2|failed to return|0
814057|NCT00895895|2588429|P2|Period 2|failed to return|0
814058|NCT00895895|2588430|P1|Period 2|failed to return|2
814059|NCT00895895|2588426|P5|Period 2|discontinued by sponsor|37
814060|NCT00895895|2588427|P4|Period 2|discontinued by sponsor|46
814061|NCT00895895|2588428|P3|Period 2|discontinued by sponsor|38
814062|NCT00895895|2588429|P2|Period 2|discontinued by sponsor|44
814063|NCT00895895|2588430|P1|Period 2|discontinued by sponsor|44
814064|NCT00895895|2588426|P5|Period 2|Death|0
814065|NCT00895895|2588427|P4|Period 2|Death|0
814066|NCT00895895|2588428|P3|Period 2|Death|1
814067|NCT00895895|2588429|P2|Period 2|Death|0
814068|NCT00895895|2588430|P1|Period 2|Death|0
814069|NCT00895895|2588426|P5|Period 2|Adverse Event|5
814070|NCT00895895|2588427|P4|Period 2|Adverse Event|2
814071|NCT00895895|2588428|P3|Period 2|Adverse Event|5
814072|NCT00895895|2588429|P2|Period 2|Adverse Event|3
814073|NCT00895895|2588430|P1|Period 2|Adverse Event|3
814074|NCT00895895|2588426|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
814075|NCT00895895|2588427|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
814076|NCT00895895|2588428|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
814077|NCT00895895|2588429|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
814078|NCT00895895|2588430|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
814079|NCT00895895|2588426|P5|After Period 1, Prior to Period 2|Protocol Violation|1
814080|NCT00895895|2588427|P4|After Period 1, Prior to Period 2|Protocol Violation|0
814081|NCT00895895|2588428|P3|After Period 1, Prior to Period 2|Protocol Violation|0
814082|NCT00895895|2588429|P2|After Period 1, Prior to Period 2|Protocol Violation|0
814083|NCT00895895|2588430|P1|After Period 1, Prior to Period 2|Protocol Violation|0
814084|NCT00895895|2588426|P5|After Period 1, Prior to Period 2|unspecified|0
814085|NCT00895895|2588427|P4|After Period 1, Prior to Period 2|unspecified|0
814086|NCT00895895|2588428|P3|After Period 1, Prior to Period 2|unspecified|1
814087|NCT00895895|2588429|P2|After Period 1, Prior to Period 2|unspecified|0
814088|NCT00895895|2588430|P1|After Period 1, Prior to Period 2|unspecified|0
814089|NCT00895895|2588426|P5|After Period 1, Prior to Period 2|Adverse Event|0
814090|NCT00895895|2588427|P4|After Period 1, Prior to Period 2|Adverse Event|0
814091|NCT00895895|2588428|P3|After Period 1, Prior to Period 2|Adverse Event|1
814092|NCT00895895|2588429|P2|After Period 1, Prior to Period 2|Adverse Event|0
814093|NCT00895895|2588430|P1|After Period 1, Prior to Period 2|Adverse Event|0
814094|NCT00895895|2588426|P5|Period 1|randomized and not treated|2
814095|NCT00895895|2588427|P4|Period 1|randomized and not treated|1
814096|NCT00895895|2588428|P3|Period 1|randomized and not treated|1
814097|NCT00895895|2588429|P2|Period 1|randomized and not treated|3
814098|NCT00895895|2588430|P1|Period 1|randomized and not treated|1
814099|NCT00895895|2588426|P5|Period 1|unsatisfactory response-efficacy|0
814100|NCT00895895|2588427|P4|Period 1|unsatisfactory response-efficacy|0
814101|NCT00895895|2588428|P3|Period 1|unsatisfactory response-efficacy|0
814102|NCT00895895|2588429|P2|Period 1|unsatisfactory response-efficacy|0
814103|NCT00895895|2588430|P1|Period 1|unsatisfactory response-efficacy|2
814104|NCT00895895|2588426|P5|Period 1|Withdrawal by Subject|4
814105|NCT00895895|2588427|P4|Period 1|Withdrawal by Subject|2
814106|NCT00895895|2588428|P3|Period 1|Withdrawal by Subject|8
814107|NCT00895895|2588429|P2|Period 1|Withdrawal by Subject|6
814108|NCT00895895|2588430|P1|Period 1|Withdrawal by Subject|6
814109|NCT00895895|2588426|P5|Period 1|Protocol Violation|0
814110|NCT00895895|2588427|P4|Period 1|Protocol Violation|0
814111|NCT00895895|2588428|P3|Period 1|Protocol Violation|0
814112|NCT00895895|2588429|P2|Period 1|Protocol Violation|1
814113|NCT00895895|2588430|P1|Period 1|Protocol Violation|0
814114|NCT00895895|2588426|P5|Period 1|unspecified|1
814115|NCT00895895|2588427|P4|Period 1|unspecified|1
814116|NCT00895895|2588428|P3|Period 1|unspecified|1
814117|NCT00895895|2588429|P2|Period 1|unspecified|2
814118|NCT00895895|2588430|P1|Period 1|unspecified|1
814119|NCT00895895|2588426|P5|Period 1|Lost to Follow-up|3
814120|NCT00895895|2588427|P4|Period 1|Lost to Follow-up|2
814121|NCT00895895|2588428|P3|Period 1|Lost to Follow-up|3
814122|NCT00895895|2588429|P2|Period 1|Lost to Follow-up|1
814123|NCT00895895|2588430|P1|Period 1|Lost to Follow-up|2
814124|NCT00895895|2588426|P5|Period 1|investigator request|0
814125|NCT00895895|2588427|P4|Period 1|investigator request|0
814126|NCT00895895|2588428|P3|Period 1|investigator request|0
814127|NCT00895895|2588429|P2|Period 1|investigator request|1
814128|NCT00895895|2588430|P1|Period 1|investigator request|0
814129|NCT00895895|2588426|P5|Period 1|failed to return|1
814130|NCT00895895|2588427|P4|Period 1|failed to return|0
814131|NCT00895895|2588428|P3|Period 1|failed to return|1
814132|NCT00895895|2588429|P2|Period 1|failed to return|0
814133|NCT00895895|2588430|P1|Period 1|failed to return|0
814134|NCT00895895|2588426|P5|Period 1|discontinued by sponsor|1
814135|NCT00895895|2588427|P4|Period 1|discontinued by sponsor|1
814136|NCT00895895|2588428|P3|Period 1|discontinued by sponsor|2
814137|NCT00895895|2588429|P2|Period 1|discontinued by sponsor|1
814138|NCT00895895|2588430|P1|Period 1|discontinued by sponsor|2
814139|NCT00895895|2588426|P5|Period 1|Death|1
814140|NCT00895895|2588427|P4|Period 1|Death|0
814141|NCT00895895|2588428|P3|Period 1|Death|0
814142|NCT00895895|2588429|P2|Period 1|Death|0
814143|NCT00895895|2588430|P1|Period 1|Death|0
814144|NCT00895895|2588426|P5|Period 1|Adverse Event|7
814145|NCT00895895|2588427|P4|Period 1|Adverse Event|6
814146|NCT00895895|2588428|P3|Period 1|Adverse Event|4
814147|NCT00895895|2588429|P2|Period 1|Adverse Event|6
814148|NCT00895895|2588430|P1|Period 1|Adverse Event|7
814149|NCT00895934|2588544|P2|Overall Study|ineligible|0
814150|NCT00895934|2588545|P1|Overall Study|ineligible|1
814151|NCT00895934|2588544|P2|Overall Study|Death|1
814152|NCT00895934|2588545|P1|Overall Study|Death|0
814153|NCT00895934|2588544|P2|Overall Study|Lack of Efficacy|24
814154|NCT00895934|2588545|P1|Overall Study|Lack of Efficacy|5
814155|NCT00895947|2588553|P2|Overall Study|Withdrawal by Subject|0
814156|NCT00895947|2588554|P1|Overall Study|Withdrawal by Subject|2
814157|NCT00895947|2588553|P2|Overall Study|Protocol Violation|2
814158|NCT00895947|2588554|P1|Overall Study|Protocol Violation|4
814159|NCT00895947|2588553|P2|Overall Study|Lost to Follow-up|4
814160|NCT00895947|2588554|P1|Overall Study|Lost to Follow-up|3
814161|NCT00895947|2588553|P2|Overall Study|Adverse Event|4
814162|NCT00895947|2588554|P1|Overall Study|Adverse Event|3
814163|NCT00896051|2588617|P2|Overall Study|Not specified|1
814164|NCT00896051|2588618|P1|Overall Study|Not specified|1
814165|NCT00896051|2588617|P2|Overall Study|Subject noncompliant|3
814166|NCT00896051|2588618|P1|Overall Study|Subject noncompliant|1
814167|NCT00896051|2588617|P2|Overall Study|Withdrawal by Subject|2
814168|NCT00896051|2588618|P1|Overall Study|Withdrawal by Subject|3
814169|NCT00896051|2588617|P2|Overall Study|Lost to Follow-up|2
814170|NCT00896051|2588618|P1|Overall Study|Lost to Follow-up|3
814171|NCT00896051|2588617|P2|Overall Study|Adverse Event|1
814172|NCT00896051|2588618|P1|Overall Study|Adverse Event|2
814173|NCT00896168|2588691|P2|Overall Study|Unspecified|1
814174|NCT00896168|2588692|P1|Overall Study|Unspecified|1
814175|NCT00896168|2588691|P2|Overall Study|Lost to Follow-up|1
814176|NCT00896168|2588692|P1|Overall Study|Lost to Follow-up|1
814177|NCT00896168|2588691|P2|Overall Study|Treatment failure|10
814178|NCT00896168|2588692|P1|Overall Study|Treatment failure|8
814179|NCT00896168|2588691|P2|Overall Study|Adverse Event|7
814180|NCT00896168|2588692|P1|Overall Study|Adverse Event|4
814181|NCT00902174|2588741|P2|Overall Study|Administration problem|1
814182|NCT00902174|2588742|P1|Overall Study|Administration problem|0
814183|NCT00902174|2588741|P2|Overall Study|Protocol Violation|1
814184|NCT00902174|2588742|P1|Overall Study|Protocol Violation|1
814185|NCT00902174|2588741|P2|Overall Study|Abnormal labs|1
814186|NCT00902174|2588742|P1|Overall Study|Abnormal labs|1
814187|NCT00902174|2588741|P2|Overall Study|Withdrawal by Subject|1
814188|NCT00902174|2588742|P1|Overall Study|Withdrawal by Subject|2
814189|NCT00902174|2588741|P2|Overall Study|Death|2
814190|NCT00902174|2588742|P1|Overall Study|Death|2
814191|NCT00902174|2588741|P2|Overall Study|Lack of Efficacy|5
814192|NCT00902174|2588742|P1|Overall Study|Lack of Efficacy|1
814193|NCT00902174|2588741|P2|Overall Study|Adverse Event|7
814194|NCT00902174|2588742|P1|Overall Study|Adverse Event|27
814195|NCT00902265|2588788|P1|Overall Study|Protocol Violation|1
814196|NCT00902265|2588788|P1|Overall Study|Lack of Efficacy|2
814197|NCT00902265|2588788|P1|Overall Study|Adverse Event|2
814198|NCT00902265|2588788|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
814199|NCT00902668|2588800|P1|Overall Study|Protocol stopped due to slow accrual.|3
814200|NCT00902746|2588804|P1|Overall Study|Physician Decision|2
814201|NCT00902746|2588804|P1|Overall Study|Lost to Follow-up|3
814202|NCT00902746|2588804|P1|Overall Study|Adverse Event|8
814203|NCT00902746|2588804|P1|Overall Study|Withdrawal by Subject|16
814204|NCT00902746|2588804|P1|Overall Study|Protocol Violation|7
814205|NCT00902850|2588811|P2|Overall Study|Physician Decision|2
814206|NCT00902850|2588812|P1|Overall Study|Physician Decision|2
814207|NCT00903006|2588822|P4|Overall Study|Progressive Disease|0
814208|NCT00903006|2588823|P3|Overall Study|Progressive Disease|1
814209|NCT00903006|2588824|P2|Overall Study|Progressive Disease|3
814210|NCT00903006|2588825|P1|Overall Study|Progressive Disease|0
814211|NCT00903006|2588822|P4|Overall Study|Withdrawal by Subject|0
814212|NCT00903006|2588823|P3|Overall Study|Withdrawal by Subject|0
814213|NCT00903006|2588824|P2|Overall Study|Withdrawal by Subject|0
814214|NCT00903006|2588825|P1|Overall Study|Withdrawal by Subject|2
814215|NCT00903032|2588837|P2|Overall Study|Lost to Follow-up|2
814216|NCT00903032|2588838|P1|Overall Study|Lost to Follow-up|2
814217|NCT00903032|2588837|P2|Overall Study|Withdrawal by Subject|3
814218|NCT00903032|2588838|P1|Overall Study|Withdrawal by Subject|5
814219|NCT00903175|2588852|P2|Period 2 - Second Line|Death|2
814220|NCT00903175|2588853|P1|Period 2 - Second Line|Death|5
814221|NCT00903175|2588852|P2|Period 2 - Second Line|Administrative problems|9
814222|NCT00903175|2588853|P1|Period 2 - Second Line|Administrative problems|19
814223|NCT00903175|2588852|P2|Period 2 - Second Line|Lost to Follow-up|0
814224|NCT00903175|2588853|P1|Period 2 - Second Line|Lost to Follow-up|1
814225|NCT00903175|2588852|P2|Period 2 - Second Line|Withdrawal by Subject|5
814226|NCT00903175|2588853|P1|Period 2 - Second Line|Withdrawal by Subject|7
814227|NCT00903175|2588852|P2|Period 2 - Second Line|Adverse Event|20
814228|NCT00903175|2588853|P1|Period 2 - Second Line|Adverse Event|16
814229|NCT00903175|2588852|P2|Period 2 - Second Line|Missing|0
814230|NCT00903175|2588853|P1|Period 2 - Second Line|Missing|1
814231|NCT00903175|2588852|P2|Period 1 - First Line|Death|10
814232|NCT00903175|2588853|P1|Period 1 - First Line|Death|17
814233|NCT00903175|2588852|P2|Period 1 - First Line|Administrative problems|13
814234|NCT00903175|2588853|P1|Period 1 - First Line|Administrative problems|12
814235|NCT00903175|2588852|P2|Period 1 - First Line|Withdrawal by Subject|12
814236|NCT00903175|2588853|P1|Period 1 - First Line|Withdrawal by Subject|8
814237|NCT00903175|2588852|P2|Period 1 - First Line|Protocol Violation|3
814238|NCT00903175|2588853|P1|Period 1 - First Line|Protocol Violation|3
814239|NCT00903175|2588852|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
814240|NCT00903175|2588853|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
814241|NCT00903175|2588852|P2|Period 1 - First Line|Abnormal lab value(s)|1
814242|NCT00903175|2588853|P1|Period 1 - First Line|Abnormal lab value(s)|0
814243|NCT00903175|2588852|P2|Period 1 - First Line|Adverse Event|50
814244|NCT00903175|2588853|P1|Period 1 - First Line|Adverse Event|36
814245|NCT00903331|2588885|P2|Overall Study|Lung transplant|2
814246|NCT00903331|2588886|P1|Overall Study|Lung transplant|0
814247|NCT00903331|2588885|P2|Overall Study|Withdrawal of consent|8
814248|NCT00903331|2588886|P1|Overall Study|Withdrawal of consent|1
814249|NCT00903331|2588885|P2|Overall Study|Death|8
814250|NCT00903331|2588886|P1|Overall Study|Death|4
814251|NCT00903344|2588896|P2|Overall Study|Lost to Follow-up|0
814252|NCT00903344|2588897|P1|Overall Study|Lost to Follow-up|3
814253|NCT00903344|2588896|P2|Overall Study|Pregnancy|3
814254|NCT00903344|2588897|P1|Overall Study|Pregnancy|2
814255|NCT00903357|2588913|P2|Second Intervention|Lost to Follow-up|0
814256|NCT00903357|2588914|P1|Second Intervention|Lost to Follow-up|1
814257|NCT00903357|2588913|P2|Wash Out Period of 2 Weeks|Flu|1
814258|NCT00903357|2588914|P1|Wash Out Period of 2 Weeks|Flu|0
814259|NCT00903357|2588913|P2|First Intervention|Flu|1
814260|NCT00903357|2588914|P1|First Intervention|Flu|0
814261|NCT00903357|2588913|P2|First Intervention|Withdrawal by Subject|3
814262|NCT00903357|2588914|P1|First Intervention|Withdrawal by Subject|5
814263|NCT00903370|2588926|P2|Overall Study|Lost to Follow-up|8
814264|NCT00903370|2588927|P1|Overall Study|Lost to Follow-up|6
814265|NCT00903370|2588926|P2|Overall Study|Withdrawal by Subject|6
814266|NCT00903370|2588927|P1|Overall Study|Withdrawal by Subject|9
814267|NCT00903370|2588926|P2|Overall Study|Death|10
814268|NCT00903370|2588927|P1|Overall Study|Death|13
814269|NCT00903383|2588939|P4|Overall Study|Patient Decision|1
814270|NCT00903383|2588940|P3|Overall Study|Patient Decision|0
814271|NCT00903383|2588941|P2|Overall Study|Patient Decision|0
814272|NCT00903383|2588942|P1|Overall Study|Patient Decision|0
814273|NCT00903383|2588939|P4|Overall Study|Patient Decision - Lack of Efficacy|0
814274|NCT00903383|2588940|P3|Overall Study|Patient Decision - Lack of Efficacy|0
814275|NCT00903383|2588941|P2|Overall Study|Patient Decision - Lack of Efficacy|1
814276|NCT00903383|2588942|P1|Overall Study|Patient Decision - Lack of Efficacy|0
814277|NCT00903383|2588939|P4|Overall Study|Withdrawal by Subject|2
814278|NCT00903383|2588940|P3|Overall Study|Withdrawal by Subject|0
814279|NCT00903383|2588941|P2|Overall Study|Withdrawal by Subject|1
814280|NCT00903383|2588942|P1|Overall Study|Withdrawal by Subject|4
814281|NCT00903383|2588939|P4|Overall Study|Decision of Sponsor|0
814282|NCT00903383|2588940|P3|Overall Study|Decision of Sponsor|0
814283|NCT00903383|2588941|P2|Overall Study|Decision of Sponsor|0
814284|NCT00903383|2588942|P1|Overall Study|Decision of Sponsor|1
814285|NCT00903383|2588939|P4|Overall Study|Lost to Follow-up|1
814286|NCT00903383|2588940|P3|Overall Study|Lost to Follow-up|0
814287|NCT00903383|2588941|P2|Overall Study|Lost to Follow-up|0
814288|NCT00903383|2588942|P1|Overall Study|Lost to Follow-up|0
814289|NCT00903383|2588939|P4|Overall Study|Physician Decision|0
814290|NCT00903383|2588940|P3|Overall Study|Physician Decision|0
814291|NCT00903383|2588941|P2|Overall Study|Physician Decision|2
814292|NCT00903383|2588942|P1|Overall Study|Physician Decision|1
814293|NCT00903383|2588939|P4|Overall Study|Adverse Event|1
814294|NCT00903383|2588940|P3|Overall Study|Adverse Event|3
814295|NCT00903383|2588941|P2|Overall Study|Adverse Event|2
814296|NCT00903383|2588942|P1|Overall Study|Adverse Event|1
814309|NCT00903617|2589033|P4|Overall Study|Withdrawal by Subject|0
814310|NCT00903617|2589034|P3|Overall Study|Withdrawal by Subject|3
814311|NCT00903617|2589035|P2|Overall Study|Withdrawal by Subject|2
814312|NCT00903617|2589036|P1|Overall Study|Withdrawal by Subject|1
814313|NCT00903617|2589033|P4|Overall Study|Lost to Follow-up|1
814314|NCT00903617|2589034|P3|Overall Study|Lost to Follow-up|1
814315|NCT00903617|2589035|P2|Overall Study|Lost to Follow-up|0
814316|NCT00903617|2589036|P1|Overall Study|Lost to Follow-up|2
814317|NCT00903617|2589033|P4|Overall Study|Protocol-defined stopping criteria|0
814318|NCT00903617|2589034|P3|Overall Study|Protocol-defined stopping criteria|0
814319|NCT00903617|2589035|P2|Overall Study|Protocol-defined stopping criteria|2
814320|NCT00903617|2589036|P1|Overall Study|Protocol-defined stopping criteria|0
814321|NCT00903617|2589033|P4|Overall Study|Adverse Event|0
814322|NCT00903617|2589034|P3|Overall Study|Adverse Event|1
814323|NCT00903617|2589035|P2|Overall Study|Adverse Event|1
814324|NCT00903617|2589036|P1|Overall Study|Adverse Event|0
814325|NCT00903630|2589133|P3|Phase 2|Adverse Event|1
814326|NCT00903630|2589134|P2|Phase 2|Adverse Event|0
814327|NCT00903630|2589135|P1|Phase 2|Adverse Event|0
814328|NCT00903682|2589151|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
814329|NCT00903682|2589152|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
814330|NCT00903682|2589151|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
814331|NCT00903682|2589152|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
814332|NCT00903682|2589151|P2|Overall Study|Subject Non-Compliant|0
814333|NCT00903682|2589152|P1|Overall Study|Subject Non-Compliant|1
814334|NCT00903682|2589151|P2|Overall Study|Subject Reached A Virologic Endpoint|1
814335|NCT00903682|2589152|P1|Overall Study|Subject Reached A Virologic Endpoint|1
814336|NCT00903682|2589151|P2|Overall Study|Pregnancy|1
814337|NCT00903682|2589152|P1|Overall Study|Pregnancy|0
814338|NCT00903682|2589151|P2|Overall Study|Withdrawal by Subject|0
814339|NCT00903682|2589152|P1|Overall Study|Withdrawal by Subject|5
814340|NCT00903682|2589151|P2|Overall Study|Lost to Follow-up|0
814341|NCT00903682|2589152|P1|Overall Study|Lost to Follow-up|1
814342|NCT00903682|2589151|P2|Overall Study|Adverse Event|13
814343|NCT00903682|2589152|P1|Overall Study|Adverse Event|6
814344|NCT00903695|2589172|P2|Overall Study|lung cancer|0
814345|NCT00903695|2589173|P1|Overall Study|lung cancer|1
814346|NCT00903695|2589172|P2|Overall Study|medical exclusion after 1st testing|0
814347|NCT00903695|2589173|P1|Overall Study|medical exclusion after 1st testing|1
814348|NCT00903877|2589193|P1|Overall Study|Participation put on hold|4
814349|NCT00903877|2589193|P1|Overall Study|Lost to Follow-up|1
814350|NCT00903877|2589193|P1|Overall Study|Adverse Event|2
814351|NCT00903877|2589193|P1|Overall Study|Withdrawal by Subject|3
814352|NCT00903877|2589193|P1|Overall Study|Did not meet study criteria|33
814353|NCT00903929|2589197|P4|Overall Study|Adverse Event|1
814354|NCT00903929|2589198|P3|Overall Study|Adverse Event|0
814355|NCT00903929|2589199|P2|Overall Study|Adverse Event|0
814356|NCT00903929|2589200|P1|Overall Study|Adverse Event|0
814357|NCT00903929|2589197|P4|Overall Study|Withdrawal by Subject|2
814358|NCT00903929|2589198|P3|Overall Study|Withdrawal by Subject|1
814359|NCT00903929|2589199|P2|Overall Study|Withdrawal by Subject|0
814360|NCT00903929|2589200|P1|Overall Study|Withdrawal by Subject|0
814417|NCT00904150|2589256|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
814418|NCT00904150|2589257|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
814419|NCT00904150|2589256|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
814420|NCT00904150|2589257|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
814421|NCT00904215|2589280|P1|Overall Study|Other|28
814422|NCT00904215|2589280|P1|Overall Study|Withdrawal by Subject|9
814423|NCT00904215|2589280|P1|Overall Study|Lost to Follow-up|63
814424|NCT00904215|2589280|P1|Overall Study|Protocol Violation|10
814425|NCT00904215|2589280|P1|Overall Study|Adverse Event|25
814426|NCT00904371|2589287|P1|Overall Study|Continued with Tritace|1
814427|NCT00904371|2589287|P1|Overall Study|Discontinued at target blood pressure|2
814428|NCT00904371|2589287|P1|Overall Study|Lost to Follow-up|4
814429|NCT00904371|2589287|P1|Overall Study|Adverse Event|2
814430|NCT00904670|2589317|P2|Open Label Phase|Lost to Follow-up|0
814431|NCT00904670|2589318|P1|Open Label Phase|Lost to Follow-up|1
814432|NCT00904670|2589317|P2|Open Label Phase|Lack of Efficacy|0
814433|NCT00904670|2589318|P1|Open Label Phase|Lack of Efficacy|1
814434|NCT00904670|2589317|P2|Open Label Phase|Adverse Event|0
814435|NCT00904670|2589318|P1|Open Label Phase|Adverse Event|2
814436|NCT00904670|2589317|P2|Open Label Phase|Withdrawal by Subject|0
814437|NCT00904670|2589318|P1|Open Label Phase|Withdrawal by Subject|2
814438|NCT00904722|2589339|P1|Overall Study|Physician Decision|1
814439|NCT00904748|2589344|P6|Overall Study|Adverse Event|0
814440|NCT00904748|2589345|P5|Overall Study|Adverse Event|1
814441|NCT00904748|2589346|P4|Overall Study|Adverse Event|0
814442|NCT00904748|2589347|P3|Overall Study|Adverse Event|0
814443|NCT00904748|2589348|P2|Overall Study|Adverse Event|0
814444|NCT00904748|2589349|P1|Overall Study|Adverse Event|0
814445|NCT00904748|2589344|P6|Overall Study|Withdrawal by Subject|0
814446|NCT00904748|2589345|P5|Overall Study|Withdrawal by Subject|0
814447|NCT00904748|2589346|P4|Overall Study|Withdrawal by Subject|2
814448|NCT00904748|2589347|P3|Overall Study|Withdrawal by Subject|1
814449|NCT00904748|2589348|P2|Overall Study|Withdrawal by Subject|1
814450|NCT00904748|2589349|P1|Overall Study|Withdrawal by Subject|1
814451|NCT00904839|2589387|P3|Overall Study|Other than above|7
814452|NCT00904839|2589388|P2|Overall Study|Other than above|9
814453|NCT00904839|2589389|P1|Overall Study|Other than above|0
814454|NCT00904839|2589387|P3|Overall Study|Not treated|1
814455|NCT00904839|2589388|P2|Overall Study|Not treated|0
814456|NCT00904839|2589389|P1|Overall Study|Not treated|1
814457|NCT00904839|2589387|P3|Overall Study|Withdrawal by Subject|0
814458|NCT00904839|2589388|P2|Overall Study|Withdrawal by Subject|2
814459|NCT00904839|2589389|P1|Overall Study|Withdrawal by Subject|0
814460|NCT00904839|2589387|P3|Overall Study|Lost to Follow-up|2
814461|NCT00904839|2589388|P2|Overall Study|Lost to Follow-up|1
814462|NCT00904839|2589389|P1|Overall Study|Lost to Follow-up|0
814463|NCT00904839|2589387|P3|Overall Study|Protocol Violation|1
814464|NCT00904839|2589388|P2|Overall Study|Protocol Violation|1
814465|NCT00904839|2589389|P1|Overall Study|Protocol Violation|0
814466|NCT00904839|2589387|P3|Overall Study|Adverse Event|4
814467|NCT00904839|2589388|P2|Overall Study|Adverse Event|5
814468|NCT00904839|2589389|P1|Overall Study|Adverse Event|0
814469|NCT00904917|2589427|P4|Overall Study|Lost to Follow-up|2
814470|NCT00904917|2589428|P3|Overall Study|Lost to Follow-up|2
814471|NCT00904917|2589429|P2|Overall Study|Lost to Follow-up|2
814472|NCT00904917|2589430|P1|Overall Study|Lost to Follow-up|2
814473|NCT00904982|2589461|P4|Overall Study|Withdrawal by Subject|0
814474|NCT00904982|2589462|P3|Overall Study|Withdrawal by Subject|0
814475|NCT00904982|2589463|P2|Overall Study|Withdrawal by Subject|0
814476|NCT00904982|2589464|P1|Overall Study|Withdrawal by Subject|2
814477|NCT00905021|2589483|P1|Overall Study|Adverse Event|2
814478|NCT00905034|2589488|P1|Overall Study|Withdrawal by Subject|1
814479|NCT00905164|2589533|P2|Period 1|Protocol Violation|1
814480|NCT00905164|2589534|P1|Period 1|Protocol Violation|0
814481|NCT00905255|2589544|P2|Overall Study|Familial and Personal Reasons|0
814482|NCT00905255|2589545|P1|Overall Study|Familial and Personal Reasons|1
814483|NCT00905255|2589544|P2|Overall Study|Withdrawal by Subject|4
814484|NCT00905255|2589545|P1|Overall Study|Withdrawal by Subject|5
814485|NCT00905255|2589544|P2|Overall Study|Adverse Event|5
814486|NCT00905255|2589545|P1|Overall Study|Adverse Event|7
814487|NCT00905307|2589604|P6|Overall Study|Lack of Efficacy|8
814488|NCT00905307|2589605|P5|Overall Study|Lack of Efficacy|4
814489|NCT00905307|2589606|P4|Overall Study|Lack of Efficacy|4
814490|NCT00905307|2589607|P3|Overall Study|Lack of Efficacy|5
814491|NCT00905307|2589608|P2|Overall Study|Lack of Efficacy|3
814492|NCT00905307|2589609|P1|Overall Study|Lack of Efficacy|6
814493|NCT00905307|2589604|P6|Overall Study|Protocol Violation|0
814494|NCT00905307|2589605|P5|Overall Study|Protocol Violation|0
814495|NCT00905307|2589606|P4|Overall Study|Protocol Violation|0
814496|NCT00905307|2589607|P3|Overall Study|Protocol Violation|1
814497|NCT00905307|2589608|P2|Overall Study|Protocol Violation|0
814498|NCT00905307|2589609|P1|Overall Study|Protocol Violation|1
814499|NCT00905307|2589604|P6|Overall Study|Withdrawal by Subject|13
814500|NCT00905307|2589605|P5|Overall Study|Withdrawal by Subject|4
814501|NCT00905307|2589606|P4|Overall Study|Withdrawal by Subject|11
814502|NCT00905307|2589607|P3|Overall Study|Withdrawal by Subject|15
814503|NCT00905307|2589608|P2|Overall Study|Withdrawal by Subject|13
814504|NCT00905307|2589609|P1|Overall Study|Withdrawal by Subject|5
814505|NCT00905307|2589604|P6|Overall Study|Adverse Event|5
814506|NCT00905307|2589605|P5|Overall Study|Adverse Event|3
814507|NCT00905307|2589606|P4|Overall Study|Adverse Event|11
814508|NCT00905307|2589607|P3|Overall Study|Adverse Event|5
814509|NCT00905307|2589608|P2|Overall Study|Adverse Event|4
814510|NCT00905307|2589609|P1|Overall Study|Adverse Event|3
814511|NCT00905307|2589604|P6|Overall Study|Lost to Follow-up|1
814512|NCT00905307|2589605|P5|Overall Study|Lost to Follow-up|1
814513|NCT00905307|2589606|P4|Overall Study|Lost to Follow-up|0
814514|NCT00905307|2589607|P3|Overall Study|Lost to Follow-up|0
814515|NCT00905307|2589608|P2|Overall Study|Lost to Follow-up|0
814516|NCT00905307|2589609|P1|Overall Study|Lost to Follow-up|0
814517|NCT00905307|2589604|P6|Overall Study|Switched to Open Label Rescue|15
814518|NCT00905307|2589605|P5|Overall Study|Switched to Open Label Rescue|4
814519|NCT00905307|2589606|P4|Overall Study|Switched to Open Label Rescue|11
814520|NCT00905307|2589607|P3|Overall Study|Switched to Open Label Rescue|11
814521|NCT00905307|2589608|P2|Overall Study|Switched to Open Label Rescue|17
814522|NCT00905307|2589609|P1|Overall Study|Switched to Open Label Rescue|7
814523|NCT00905346|2589667|P2|Period 1|Withdrawal by Subject|0
814524|NCT00905346|2589668|P1|Period 1|Withdrawal by Subject|1
814525|NCT00905359|2589678|P2|Overall Study|Withdrawal consent|6
814526|NCT00905359|2589679|P1|Overall Study|Withdrawal consent|5
814527|NCT00905359|2589678|P2|Overall Study|Death|0
814528|NCT00905359|2589679|P1|Overall Study|Death|2
814529|NCT00905359|2589678|P2|Overall Study|Lost to Follow-up|10
814530|NCT00905359|2589679|P1|Overall Study|Lost to Follow-up|17
814531|NCT00905424|2589715|P2|Overall Study|Non-adherence to visit schedule|1
814532|NCT00905424|2589716|P1|Overall Study|Non-adherence to visit schedule|0
814533|NCT00905424|2589715|P2|Overall Study|Positive urine drug screen|1
814534|NCT00905424|2589716|P1|Overall Study|Positive urine drug screen|0
814535|NCT00905424|2589715|P2|Overall Study|Sponsor decision|0
814536|NCT00905424|2589716|P1|Overall Study|Sponsor decision|1
814537|NCT00905424|2589715|P2|Overall Study|Non-compliance with study medication|0
814538|NCT00905424|2589716|P1|Overall Study|Non-compliance with study medication|2
814539|NCT00905424|2589715|P2|Overall Study|Adverse Event|2
814540|NCT00905424|2589716|P1|Overall Study|Adverse Event|4
814541|NCT00905424|2589715|P2|Overall Study|Withdrawal by Subject|2
814542|NCT00905424|2589716|P1|Overall Study|Withdrawal by Subject|1
814543|NCT00905424|2589715|P2|Overall Study|Lost to Follow-up|3
814544|NCT00905424|2589716|P1|Overall Study|Lost to Follow-up|3
814545|NCT00905437|2589758|P2|Overall Study|Unspecified|6
814546|NCT00905437|2589759|P1|Overall Study|Unspecified|5
814547|NCT00905437|2589758|P2|Overall Study|Withdrawal by Subject|1
814548|NCT00905437|2589759|P1|Overall Study|Withdrawal by Subject|0
814549|NCT00905437|2589758|P2|Overall Study|Lost to Follow-up|1
814550|NCT00905437|2589759|P1|Overall Study|Lost to Follow-up|0
814551|NCT00905437|2589758|P2|Overall Study|Adverse Event|2
814552|NCT00905437|2589759|P1|Overall Study|Adverse Event|3
814553|NCT00905489|2589777|P1|Optional Extension Phase (OEP)|Adverse Event|1
814554|NCT00905489|2589777|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
814555|NCT00905489|2589777|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
814556|NCT00907335|2589826|P2|Overall Study|Lost to Follow-up|0
814557|NCT00907335|2589827|P1|Overall Study|Lost to Follow-up|2
814558|NCT00907335|2589826|P2|Overall Study|Adverse Event|1
814559|NCT00907335|2589827|P1|Overall Study|Adverse Event|4
814560|NCT00907335|2589826|P2|Overall Study|Withdrawal by Subject|0
814561|NCT00907335|2589827|P1|Overall Study|Withdrawal by Subject|2
814562|NCT00907374|2589845|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
814563|NCT00907374|2589846|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
814564|NCT00907478|2589881|P3|Overall Study|Other|1
814565|NCT00907478|2589882|P2|Overall Study|Other|0
814566|NCT00907478|2589883|P1|Overall Study|Other|3
814567|NCT00907478|2589881|P3|Overall Study|Lost to Follow-up|0
814568|NCT00907478|2589882|P2|Overall Study|Lost to Follow-up|0
814569|NCT00907478|2589883|P1|Overall Study|Lost to Follow-up|1
814570|NCT00907478|2589881|P3|Overall Study|Pregnancy|1
814571|NCT00907478|2589882|P2|Overall Study|Pregnancy|1
814572|NCT00907478|2589883|P1|Overall Study|Pregnancy|0
814573|NCT00907478|2589881|P3|Overall Study|Protocol-specified criteria|3
814574|NCT00907478|2589882|P2|Overall Study|Protocol-specified criteria|2
814575|NCT00907478|2589883|P1|Overall Study|Protocol-specified criteria|5
814576|NCT00907478|2589881|P3|Overall Study|Death|1
814577|NCT00907478|2589882|P2|Overall Study|Death|2
814578|NCT00907478|2589883|P1|Overall Study|Death|4
814579|NCT00907478|2589881|P3|Overall Study|Physician Decision|3
814580|NCT00907478|2589882|P2|Overall Study|Physician Decision|0
814581|NCT00907478|2589883|P1|Overall Study|Physician Decision|2
814582|NCT00907478|2589881|P3|Overall Study|Requirement for alternative therapy|3
814583|NCT00907478|2589882|P2|Overall Study|Requirement for alternative therapy|2
814584|NCT00907478|2589883|P1|Overall Study|Requirement for alternative therapy|1
814585|NCT00907478|2589881|P3|Overall Study|Withdrawal by Subject|6
814586|NCT00907478|2589882|P2|Overall Study|Withdrawal by Subject|9
814587|NCT00907478|2589883|P1|Overall Study|Withdrawal by Subject|8
814588|NCT00907478|2589881|P3|Overall Study|Adverse Event|2
814589|NCT00907478|2589882|P2|Overall Study|Adverse Event|1
814590|NCT00907478|2589883|P1|Overall Study|Adverse Event|3
814591|NCT00907478|2589881|P3|Overall Study|Noncompliance|1
814592|NCT00907478|2589882|P2|Overall Study|Noncompliance|0
814593|NCT00907478|2589883|P1|Overall Study|Noncompliance|0
814594|NCT00907478|2589881|P3|Overall Study|Ineligibility determined|1
814595|NCT00907478|2589882|P2|Overall Study|Ineligibility determined|0
814596|NCT00907478|2589883|P1|Overall Study|Ineligibility determined|0
814597|NCT00907517|2589916|P5|Overall Study|Symptomatic Deterioration|1
814598|NCT00907517|2589917|P4|Overall Study|Symptomatic Deterioration|0
814599|NCT00907517|2589918|P3|Overall Study|Symptomatic Deterioration|0
814600|NCT00907517|2589919|P2|Overall Study|Symptomatic Deterioration|0
814601|NCT00907517|2589920|P1|Overall Study|Symptomatic Deterioration|0
814602|NCT00907517|2589916|P5|Overall Study|Progressive Disease|4
814603|NCT00907517|2589917|P4|Overall Study|Progressive Disease|4
814604|NCT00907517|2589918|P3|Overall Study|Progressive Disease|4
814605|NCT00907517|2589919|P2|Overall Study|Progressive Disease|3
814606|NCT00907517|2589920|P1|Overall Study|Progressive Disease|3
814607|NCT00907621|2589944|P2|Overall Study|intercurrent febrile illness|1
814608|NCT00907621|2589945|P1|Overall Study|intercurrent febrile illness|1
814609|NCT00907621|2589944|P2|Overall Study|Lost to Follow-up|3
814610|NCT00907621|2589945|P1|Overall Study|Lost to Follow-up|6
814611|NCT00907738|2589958|P5|Overall Study|Disease progression|2
814612|NCT00907738|2589959|P4|Overall Study|Disease progression|4
814613|NCT00907738|2589960|P3|Overall Study|Disease progression|6
814614|NCT00907738|2589961|P2|Overall Study|Disease progression|1
814615|NCT00907738|2589962|P1|Overall Study|Disease progression|8
814616|NCT00907738|2589958|P5|Overall Study|not specified or withdrew consent|0
814617|NCT00907738|2589959|P4|Overall Study|not specified or withdrew consent|0
814618|NCT00907738|2589960|P3|Overall Study|not specified or withdrew consent|0
814619|NCT00907738|2589961|P2|Overall Study|not specified or withdrew consent|0
814620|NCT00907738|2589962|P1|Overall Study|not specified or withdrew consent|3
814621|NCT00907738|2589958|P5|Overall Study|Adverse Event|0
814622|NCT00907738|2589959|P4|Overall Study|Adverse Event|0
814623|NCT00907738|2589960|P3|Overall Study|Adverse Event|1
814624|NCT00907738|2589961|P2|Overall Study|Adverse Event|0
814625|NCT00907738|2589962|P1|Overall Study|Adverse Event|2
814626|NCT00907777|2589980|P2|Overall Study|Withdrawal by Subject|1
814627|NCT00907777|2589981|P1|Overall Study|Withdrawal by Subject|0
814628|NCT00907803|2590006|P3|Overall Study|Protocol Violation|0
814629|NCT00907803|2590007|P2|Overall Study|Protocol Violation|1
814630|NCT00907803|2590008|P1|Overall Study|Protocol Violation|0
814631|NCT00907803|2590006|P3|Overall Study|Lost to Follow-up|0
814632|NCT00907803|2590007|P2|Overall Study|Lost to Follow-up|1
814633|NCT00907803|2590008|P1|Overall Study|Lost to Follow-up|0
814634|NCT00907803|2590006|P3|Overall Study|Withdrawal by Subject|0
814635|NCT00907803|2590007|P2|Overall Study|Withdrawal by Subject|1
814636|NCT00907803|2590008|P1|Overall Study|Withdrawal by Subject|0
814637|NCT00907803|2590006|P3|Overall Study|Adverse Event|0
814638|NCT00907803|2590007|P2|Overall Study|Adverse Event|0
814639|NCT00907803|2590008|P1|Overall Study|Adverse Event|2
814640|NCT00907803|2590006|P3|Overall Study|Withdrawal of consent - long commute|0
814641|NCT00907803|2590007|P2|Overall Study|Withdrawal of consent - long commute|0
814642|NCT00907803|2590008|P1|Overall Study|Withdrawal of consent - long commute|1
814643|NCT00907881|2590037|P1|Overall Study|Missing discontinuation information|15
814644|NCT00907881|2590037|P1|Overall Study|Protocol Violation|1
814645|NCT00907881|2590037|P1|Overall Study|Withdrawal by Subject|5
814646|NCT00907881|2590037|P1|Overall Study|Noncompliance|5
814647|NCT00907881|2590037|P1|Overall Study|Lost to Follow-up|59
814648|NCT00908011|2590057|P2|Overall Study|Withdrawal by Subject|2
814649|NCT00908011|2590058|P1|Overall Study|Withdrawal by Subject|2
814650|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814651|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
814652|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814653|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814654|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814655|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814656|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814657|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814658|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814659|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814660|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814661|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
814662|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814663|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814664|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
814665|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814666|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814667|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814668|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814669|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814670|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814671|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814672|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814673|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
814674|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814675|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
814676|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814677|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814678|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814679|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814680|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814681|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814682|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814683|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814684|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814685|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
814686|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814687|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814688|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
814689|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814690|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814691|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814692|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814693|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814694|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814695|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814696|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814697|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
814698|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
814699|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814700|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
814701|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814702|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814703|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814704|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814705|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814706|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814707|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814708|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814709|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
814710|NCT00908037|2590071|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
814711|NCT00908037|2590072|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814712|NCT00908037|2590073|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814713|NCT00908037|2590074|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814714|NCT00908037|2590075|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814715|NCT00908037|2590076|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814716|NCT00908037|2590077|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814717|NCT00908037|2590078|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814718|NCT00908037|2590079|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814719|NCT00908037|2590080|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814720|NCT00908037|2590081|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814721|NCT00908037|2590082|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
814722|NCT00908037|2590071|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814723|NCT00908037|2590072|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814724|NCT00908037|2590073|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814725|NCT00908037|2590074|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814726|NCT00908037|2590075|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814727|NCT00908037|2590076|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
814728|NCT00908037|2590077|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814729|NCT00908037|2590078|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814730|NCT00908037|2590079|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
814731|NCT00908037|2590080|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814732|NCT00908037|2590081|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814733|NCT00908037|2590082|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
814734|NCT00908037|2590071|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814735|NCT00908037|2590072|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814736|NCT00908037|2590073|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814737|NCT00908037|2590074|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
814738|NCT00908037|2590075|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814739|NCT00908037|2590076|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814740|NCT00908037|2590077|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814741|NCT00908037|2590078|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
814742|NCT00908037|2590079|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814743|NCT00908037|2590080|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814744|NCT00908037|2590081|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814745|NCT00908037|2590082|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
814746|NCT00908037|2590071|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814747|NCT00908037|2590072|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814748|NCT00908037|2590073|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814749|NCT00908037|2590074|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
814750|NCT00908037|2590075|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814751|NCT00908037|2590076|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
814752|NCT00908037|2590077|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814753|NCT00908037|2590078|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
814754|NCT00908037|2590079|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814755|NCT00908037|2590080|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814756|NCT00908037|2590081|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814757|NCT00908037|2590082|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
814758|NCT00908076|2590231|P2|Overall Study|Lack of Efficacy|1
814759|NCT00908076|2590232|P1|Overall Study|Lack of Efficacy|1
814760|NCT00908115|2590238|P1|Overall Study|Unspecified|14
814761|NCT00908141|2590257|P2|Overall Study|Withdrawal by Subject|1
814762|NCT00908141|2590258|P1|Overall Study|Withdrawal by Subject|0
814763|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
814764|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
814765|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
814766|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
814767|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Other|0
814768|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Other|0
814769|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Other|1
814770|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Other|3
814771|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
814772|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
814773|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
814774|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
814775|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
814776|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
814777|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
814778|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
814779|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
814780|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
814781|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
814782|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
814783|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Death|0
814784|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Death|0
814785|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Death|0
814786|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Death|2
814787|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
814788|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
814789|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
814790|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
814791|NCT00908232|2590264|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
814792|NCT00908232|2590265|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
814793|NCT00908232|2590266|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
814794|NCT00908232|2590267|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
814795|NCT00908232|2590264|P4|Cycle 1 to 4|not specified|0
814796|NCT00908232|2590265|P3|Cycle 1 to 4|not specified|0
814797|NCT00908232|2590266|P2|Cycle 1 to 4|not specified|0
814798|NCT00908232|2590267|P1|Cycle 1 to 4|not specified|1
814799|NCT00908232|2590264|P4|Cycle 1 to 4|Adverse Event|0
814800|NCT00908232|2590265|P3|Cycle 1 to 4|Adverse Event|0
814801|NCT00908232|2590266|P2|Cycle 1 to 4|Adverse Event|0
814802|NCT00908232|2590267|P1|Cycle 1 to 4|Adverse Event|12
814803|NCT00908232|2590264|P4|Cycle 1 to 4|Progressive Disease|0
814804|NCT00908232|2590265|P3|Cycle 1 to 4|Progressive Disease|0
814805|NCT00908232|2590266|P2|Cycle 1 to 4|Progressive Disease|0
814806|NCT00908232|2590267|P1|Cycle 1 to 4|Progressive Disease|6
814807|NCT00908232|2590264|P4|Cycle 1 to 4|Withdrawal by Subject|0
814808|NCT00908232|2590265|P3|Cycle 1 to 4|Withdrawal by Subject|0
814809|NCT00908232|2590266|P2|Cycle 1 to 4|Withdrawal by Subject|0
814810|NCT00908232|2590267|P1|Cycle 1 to 4|Withdrawal by Subject|4
814811|NCT00908232|2590264|P4|Cycle 1 to 4|Death|0
814812|NCT00908232|2590265|P3|Cycle 1 to 4|Death|0
814813|NCT00908232|2590266|P2|Cycle 1 to 4|Death|0
814814|NCT00908232|2590267|P1|Cycle 1 to 4|Death|5
814815|NCT00908310|2590283|P1|Overall Study|Other reasons|4
814816|NCT00908310|2590283|P1|Overall Study|Screening failure|5
814817|NCT00908310|2590283|P1|Overall Study|Lost to Follow-up|7
814818|NCT00908310|2590283|P1|Overall Study|Withdrawal by Subject|7
814819|NCT00908310|2590283|P1|Overall Study|Death|37
814820|NCT00908349|2590287|P1|Overall Study|Various|6
814821|NCT00908349|2590287|P1|Overall Study|Lost to Follow-up|5
814822|NCT00908349|2590287|P1|Overall Study|Physician Decision|5
814823|NCT00908349|2590287|P1|Overall Study|Withdrawal by Subject|9
814824|NCT00908349|2590287|P1|Overall Study|Adverse Event|10
814825|NCT00908375|2590293|P2|Overall Study|Lost to Follow-up|6
814826|NCT00908375|2590294|P1|Overall Study|Lost to Follow-up|8
814827|NCT00908375|2590293|P2|Overall Study|Withdrawal by Subject|4
814828|NCT00908375|2590294|P1|Overall Study|Withdrawal by Subject|2
814829|NCT00908583|2590312|P1|Phase 5|Adverse Event|3
814830|NCT00908583|2590312|P1|Phase 4|Physician Decision|1
814831|NCT00908583|2590312|P1|Phase 4|Adverse Event|1
814832|NCT00908583|2590312|P1|Phase 3|Adverse Event|2
814833|NCT00908583|2590312|P1|Phase 2|Adverse Event|1
814834|NCT00908583|2590312|P1|Phase 2|Physician Decision|1
814835|NCT00908583|2590312|P1|Phase 1|Adverse Event|4
814836|NCT00908583|2590312|P1|Phase 1|Withdrawal by Subject|1
814837|NCT00908596|2590334|P4|Overall Study|Withdrawal by Subject|1
814838|NCT00908596|2590335|P3|Overall Study|Withdrawal by Subject|3
814839|NCT00908596|2590336|P2|Overall Study|Withdrawal by Subject|1
814840|NCT00908596|2590337|P1|Overall Study|Withdrawal by Subject|0
814841|NCT00908596|2590334|P4|Overall Study|Protocol Violation|0
814842|NCT00908596|2590335|P3|Overall Study|Protocol Violation|0
814843|NCT00908596|2590336|P2|Overall Study|Protocol Violation|0
814844|NCT00908596|2590337|P1|Overall Study|Protocol Violation|1
814845|NCT00908596|2590334|P4|Overall Study|Death|32
814846|NCT00908596|2590335|P3|Overall Study|Death|57
814847|NCT00908596|2590336|P2|Overall Study|Death|5
814848|NCT00908596|2590337|P1|Overall Study|Death|0
814849|NCT00908596|2590334|P4|Overall Study|Lost to Follow-up|4
814850|NCT00908596|2590335|P3|Overall Study|Lost to Follow-up|12
814851|NCT00908596|2590336|P2|Overall Study|Lost to Follow-up|1
814852|NCT00908596|2590337|P1|Overall Study|Lost to Follow-up|0
814853|NCT00908596|2590334|P4|Overall Study|Other reasons|0
814854|NCT00908596|2590335|P3|Overall Study|Other reasons|2
814855|NCT00908596|2590336|P2|Overall Study|Other reasons|6
814856|NCT00908596|2590337|P1|Overall Study|Other reasons|46
814857|NCT00908895|2590430|P2|Overall Study|Adverse Event|1
814858|NCT00908895|2590431|P1|Overall Study|Adverse Event|1
814859|NCT00908895|2590430|P2|Overall Study|algodystrophy|2
814860|NCT00908895|2590431|P1|Overall Study|algodystrophy|2
814861|NCT00908895|2590430|P2|Overall Study|Lost to Follow-up|3
814862|NCT00908895|2590431|P1|Overall Study|Lost to Follow-up|1
814863|NCT00908960|2590448|P3|Overall Study|excluded from analysis|2
814864|NCT00908960|2590449|P2|Overall Study|excluded from analysis|1
814865|NCT00908960|2590450|P1|Overall Study|excluded from analysis|1
814866|NCT00909038|2590458|P1|Overall Study|Non-evaluable Subjects|230
814867|NCT00909038|2590458|P1|Overall Study|Protocol Violation|187
814868|NCT00909181|2590489|P3|Overall Study|Lost to Follow-up|33
814869|NCT00909181|2590490|P2|Overall Study|Lost to Follow-up|18
814870|NCT00909181|2590491|P1|Overall Study|Lost to Follow-up|39
814871|NCT00909389|2590512|P1|Overall Study|No Information|103
814872|NCT00909389|2590512|P1|Overall Study|Lost to Follow-up|4
814873|NCT00909389|2590512|P1|Overall Study|Poor Compliance|16
814874|NCT00909389|2590512|P1|Overall Study|Death|4
814875|NCT00909389|2590512|P1|Overall Study|Adverse Event|6
814876|NCT00909428|2590519|P3|Overall Study|Lost to Follow-up|9
814877|NCT00909428|2590520|P2|Overall Study|Lost to Follow-up|10
814878|NCT00909428|2590521|P1|Overall Study|Lost to Follow-up|13
814879|NCT00909480|2590530|P2|Overall Study|Unclassified|19
814880|NCT00909480|2590531|P1|Overall Study|Unclassified|18
814881|NCT00909480|2590530|P2|Overall Study|Withdrawal criteria|11
814882|NCT00909480|2590531|P1|Overall Study|Withdrawal criteria|9
814883|NCT00909480|2590530|P2|Overall Study|Protocol Violation|8
814884|NCT00909480|2590531|P1|Overall Study|Protocol Violation|6
814885|NCT00909480|2590530|P2|Overall Study|Adverse Event|3
814886|NCT00909480|2590531|P1|Overall Study|Adverse Event|5
814887|NCT00909532|2590565|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
814888|NCT00909532|2590566|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
814889|NCT00909532|2590565|P2|Overall Study|Wrong Genotype|0
814890|NCT00909532|2590566|P1|Overall Study|Wrong Genotype|1
814891|NCT00909532|2590565|P2|Overall Study|Physician Decision|0
814892|NCT00909532|2590566|P1|Overall Study|Physician Decision|1
814893|NCT00909532|2590565|P2|Overall Study|Noncompliance with Study Requirements|2
814894|NCT00909532|2590566|P1|Overall Study|Noncompliance with Study Requirements|0
814895|NCT00909532|2590565|P2|Overall Study|Withdrawal of Consent|1
814896|NCT00909532|2590566|P1|Overall Study|Withdrawal of Consent|1
814897|NCT00909532|2590565|P2|Overall Study|Prohibited Medication|1
814898|NCT00909532|2590566|P1|Overall Study|Prohibited Medication|2
814899|NCT00909532|2590565|P2|Overall Study|Pregnancy|1
814900|NCT00909532|2590566|P1|Overall Study|Pregnancy|0
814901|NCT00909532|2590565|P2|Overall Study|Adverse Event|1
814902|NCT00909532|2590566|P1|Overall Study|Adverse Event|4
814903|NCT00909610|2590725|P2|Period: Second Intervention|Adverse Event|0
814904|NCT00909610|2590726|P1|Period: Second Intervention|Adverse Event|1
814905|NCT00909610|2590725|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
814906|NCT00909610|2590726|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
814907|NCT00909610|2590725|P2|Period: First Intervention|Adverse Event|1
814908|NCT00909610|2590726|P1|Period: First Intervention|Adverse Event|0
814909|NCT00909727|2590753|P2|Overall Study|Prohibited Medication|0
814910|NCT00909727|2590754|P1|Overall Study|Prohibited Medication|1
814911|NCT00909727|2590753|P2|Overall Study|Withdrawal of Consent|0
814912|NCT00909727|2590754|P1|Overall Study|Withdrawal of Consent|1
814913|NCT00909727|2590753|P2|Overall Study|Wrong Genotype|0
814914|NCT00909727|2590754|P1|Overall Study|Wrong Genotype|1
814915|NCT00909727|2590753|P2|Overall Study|Adverse Event|0
814916|NCT00909727|2590754|P1|Overall Study|Adverse Event|1
814917|NCT00909753|2590770|P2|Period: Second Intervention|Protocol Violation|0
814918|NCT00909753|2590771|P1|Period: Second Intervention|Protocol Violation|1
814919|NCT00909753|2590770|P2|Period: Washout of 28 Days|Protocol Violation|3
815160|NCT00910624|2591284|P4|Follow-Up Phase|Adverse Event|0
814920|NCT00909753|2590771|P1|Period: Washout of 28 Days|Protocol Violation|2
814921|NCT00909779|2590791|P2|Overall Study|Randomized in error|1
814922|NCT00909779|2590792|P1|Overall Study|Randomized in error|1
814923|NCT00909779|2590791|P2|Overall Study|Noncompliance|1
814924|NCT00909779|2590792|P1|Overall Study|Noncompliance|1
814925|NCT00909779|2590791|P2|Overall Study|Medical Monitor Decision|0
814926|NCT00909779|2590792|P1|Overall Study|Medical Monitor Decision|1
814927|NCT00909779|2590791|P2|Overall Study|Site Ceasing Operation|2
814928|NCT00909779|2590792|P1|Overall Study|Site Ceasing Operation|2
814929|NCT00909779|2590791|P2|Overall Study|Withdrawal by Subject|80
814930|NCT00909779|2590792|P1|Overall Study|Withdrawal by Subject|116
814931|NCT00909779|2590791|P2|Overall Study|Protocol Violation|5
814932|NCT00909779|2590792|P1|Overall Study|Protocol Violation|2
814933|NCT00909779|2590791|P2|Overall Study|Physician Decision|2
814934|NCT00909779|2590792|P1|Overall Study|Physician Decision|8
814935|NCT00909779|2590791|P2|Overall Study|Lost to Follow-up|15
814936|NCT00909779|2590792|P1|Overall Study|Lost to Follow-up|19
814937|NCT00909779|2590791|P2|Overall Study|Lack of Efficacy|4
814938|NCT00909779|2590792|P1|Overall Study|Lack of Efficacy|7
814939|NCT00909779|2590791|P2|Overall Study|Adverse Event|55
814940|NCT00909779|2590792|P1|Overall Study|Adverse Event|53
814941|NCT00909792|2590814|P2|Period 2|Lost to Follow-up|1
814942|NCT00909792|2590815|P1|Period 2|Lost to Follow-up|0
814943|NCT00909792|2590814|P2|Period 2|Biomicroscopy|0
814944|NCT00909792|2590815|P1|Period 2|Biomicroscopy|1
814945|NCT00909792|2590814|P2|Period 1|Did not meet inclusion criteria|1
814946|NCT00909792|2590815|P1|Period 1|Did not meet inclusion criteria|0
814947|NCT00909844|2590821|P1|Overall Study|Lost to Follow-up|2
814948|NCT00909844|2590821|P1|Overall Study|Withdrawal by Subject|1
814949|NCT00909844|2590821|P1|Overall Study|Adverse Event|1
814950|NCT00902304|2590842|P3|Overall Study|includes pregnancy|2
814951|NCT00902304|2590843|P2|Overall Study|includes pregnancy|9
814952|NCT00902304|2590844|P1|Overall Study|includes pregnancy|3
814953|NCT00902304|2590842|P3|Overall Study|Withdrawal by Subject|43
814954|NCT00902304|2590843|P2|Overall Study|Withdrawal by Subject|22
814955|NCT00902304|2590844|P1|Overall Study|Withdrawal by Subject|32
814956|NCT00902304|2590842|P3|Overall Study|Protocol Violation|20
814957|NCT00902304|2590843|P2|Overall Study|Protocol Violation|18
814958|NCT00902304|2590844|P1|Overall Study|Protocol Violation|9
814959|NCT00902304|2590842|P3|Overall Study|Lost to Follow-up|7
814960|NCT00902304|2590843|P2|Overall Study|Lost to Follow-up|7
814961|NCT00902304|2590844|P1|Overall Study|Lost to Follow-up|7
814962|NCT00902304|2590842|P3|Overall Study|Investigator discretion|13
814963|NCT00902304|2590843|P2|Overall Study|Investigator discretion|5
814964|NCT00902304|2590844|P1|Overall Study|Investigator discretion|3
814965|NCT00902304|2590842|P3|Overall Study|Adverse Event|25
814966|NCT00902304|2590843|P2|Overall Study|Adverse Event|10
814967|NCT00902304|2590844|P1|Overall Study|Adverse Event|4
814968|NCT00902330|2590891|P2|Overall Study|No post baseline data|0
814969|NCT00902330|2590892|P1|Overall Study|No post baseline data|1
814970|NCT00902330|2590891|P2|Overall Study|Adverse Event|0
814971|NCT00902330|2590892|P1|Overall Study|Adverse Event|1
814972|NCT00902330|2590891|P2|Overall Study|Too overwhelmed by treatment|5
814973|NCT00902330|2590892|P1|Overall Study|Too overwhelmed by treatment|2
814974|NCT00902538|2590929|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
814975|NCT00902538|2590930|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
814976|NCT00902538|2590931|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
814977|NCT00902538|2590932|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
814978|NCT00902538|2590933|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
814979|NCT00902538|2590934|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
814980|NCT00902538|2590929|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
814981|NCT00902538|2590930|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
814982|NCT00902538|2590931|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
814983|NCT00902538|2590932|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
814984|NCT00902538|2590933|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
814985|NCT00902538|2590934|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
814986|NCT00902538|2590929|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
814987|NCT00902538|2590930|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
814988|NCT00902538|2590931|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
814989|NCT00902538|2590932|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
814990|NCT00902538|2590933|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
814991|NCT00902538|2590934|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
814992|NCT00902538|2590929|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
814993|NCT00902538|2590930|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
814994|NCT00902538|2590931|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
814995|NCT00902538|2590932|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
814996|NCT00902538|2590933|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
814997|NCT00902538|2590934|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
814998|NCT00902538|2590929|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
814999|NCT00902538|2590930|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
815000|NCT00902538|2590931|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
815001|NCT00902538|2590932|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
815002|NCT00902538|2590933|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
815003|NCT00902538|2590934|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
815004|NCT00902538|2590929|P6|3-Single-blind, Single Treatment|Protocol Violation|0
815005|NCT00902538|2590930|P5|3-Single-blind, Single Treatment|Protocol Violation|0
815006|NCT00902538|2590931|P4|3-Single-blind, Single Treatment|Protocol Violation|0
815007|NCT00902538|2590932|P3|3-Single-blind, Single Treatment|Protocol Violation|0
815008|NCT00902538|2590933|P2|3-Single-blind, Single Treatment|Protocol Violation|5
815009|NCT00902538|2590934|P1|3-Single-blind, Single Treatment|Protocol Violation|0
815010|NCT00902538|2590929|P6|3-Single-blind, Single Treatment|Adverse Event|0
815011|NCT00902538|2590930|P5|3-Single-blind, Single Treatment|Adverse Event|0
815012|NCT00902538|2590931|P4|3-Single-blind, Single Treatment|Adverse Event|0
815013|NCT00902538|2590932|P3|3-Single-blind, Single Treatment|Adverse Event|0
815014|NCT00902538|2590933|P2|3-Single-blind, Single Treatment|Adverse Event|5
815015|NCT00902538|2590934|P1|3-Single-blind, Single Treatment|Adverse Event|0
815016|NCT00902538|2590929|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
815017|NCT00902538|2590930|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
815018|NCT00902538|2590931|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
815019|NCT00902538|2590932|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
815020|NCT00902538|2590933|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
815021|NCT00902538|2590934|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
815022|NCT00902538|2590929|P6|2-Randomized Double-blind 3 Treatments|Other|0
815023|NCT00902538|2590930|P5|2-Randomized Double-blind 3 Treatments|Other|0
815024|NCT00902538|2590931|P4|2-Randomized Double-blind 3 Treatments|Other|0
815025|NCT00902538|2590932|P3|2-Randomized Double-blind 3 Treatments|Other|0
815026|NCT00902538|2590933|P2|2-Randomized Double-blind 3 Treatments|Other|1
815027|NCT00902538|2590934|P1|2-Randomized Double-blind 3 Treatments|Other|2
815028|NCT00902538|2590929|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
815029|NCT00902538|2590930|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
815030|NCT00902538|2590931|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
815031|NCT00902538|2590932|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
815032|NCT00902538|2590933|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
815033|NCT00902538|2590934|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
815034|NCT00902538|2590929|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
815035|NCT00902538|2590930|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
815036|NCT00902538|2590931|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
815037|NCT00902538|2590932|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
815038|NCT00902538|2590933|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
815039|NCT00902538|2590934|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
815040|NCT00902538|2590929|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
815041|NCT00902538|2590930|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
815042|NCT00902538|2590931|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
815043|NCT00902538|2590932|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
815044|NCT00902538|2590933|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
815045|NCT00902538|2590934|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
815046|NCT00902538|2590929|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
815047|NCT00902538|2590930|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
815048|NCT00902538|2590931|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
815049|NCT00902538|2590932|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
815050|NCT00902538|2590933|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
815051|NCT00902538|2590934|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
815052|NCT00902538|2590929|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
815053|NCT00902538|2590930|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
815054|NCT00902538|2590931|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
815055|NCT00902538|2590932|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
815056|NCT00902538|2590933|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
815057|NCT00902538|2590934|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
815058|NCT00902538|2590929|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
815059|NCT00902538|2590930|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
815060|NCT00902538|2590931|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
815061|NCT00902538|2590932|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
815062|NCT00902538|2590933|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
815063|NCT00902538|2590934|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
815064|NCT00902538|2590929|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
815065|NCT00902538|2590930|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
815066|NCT00902538|2590931|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
815067|NCT00902538|2590932|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
815068|NCT00902538|2590933|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
815069|NCT00902538|2590934|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
815070|NCT00902538|2590929|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
815071|NCT00902538|2590930|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
815072|NCT00902538|2590931|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
815073|NCT00902538|2590932|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
815074|NCT00902538|2590933|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
815075|NCT00902538|2590934|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
815076|NCT00902564|2590964|P1|Overall Study|Withdrawal by Subject|2
815077|NCT00909857|2590978|P2|Overall Study|Did not receive study medication|24
815078|NCT00909857|2590979|P1|Overall Study|Did not receive study medication|19
815079|NCT00909857|2590978|P2|Overall Study|Other|0
815080|NCT00909857|2590979|P1|Overall Study|Other|1
815081|NCT00909857|2590978|P2|Overall Study|Pregnancy|0
815082|NCT00909857|2590979|P1|Overall Study|Pregnancy|1
815083|NCT00909857|2590978|P2|Overall Study|Protocol Violation|1
815084|NCT00909857|2590979|P1|Overall Study|Protocol Violation|2
815085|NCT00909857|2590978|P2|Overall Study|Lost to Follow-up|5
815086|NCT00909857|2590979|P1|Overall Study|Lost to Follow-up|2
815087|NCT00909857|2590978|P2|Overall Study|Adverse Event|5
815088|NCT00909857|2590979|P1|Overall Study|Adverse Event|5
815089|NCT00909857|2590978|P2|Overall Study|Withdrawal by Subject|10
815090|NCT00909857|2590979|P1|Overall Study|Withdrawal by Subject|6
815103|NCT00910000|2591138|P6|Overall Study|Withdrawal by Subject|0
815104|NCT00910000|2591139|P5|Overall Study|Withdrawal by Subject|1
815105|NCT00910000|2591140|P4|Overall Study|Withdrawal by Subject|0
815106|NCT00910000|2591141|P3|Overall Study|Withdrawal by Subject|1
815107|NCT00910000|2591142|P2|Overall Study|Withdrawal by Subject|0
815108|NCT00910000|2591143|P1|Overall Study|Withdrawal by Subject|0
815109|NCT00910000|2591138|P6|Overall Study|Adverse Event|1
815110|NCT00910000|2591139|P5|Overall Study|Adverse Event|0
815111|NCT00910000|2591140|P4|Overall Study|Adverse Event|2
815112|NCT00910000|2591141|P3|Overall Study|Adverse Event|2
815113|NCT00910000|2591142|P2|Overall Study|Adverse Event|3
815114|NCT00910000|2591143|P1|Overall Study|Adverse Event|0
815115|NCT00910039|2591159|P1|Overall Study|Physician Decision|1
815116|NCT00910091|2591172|P2|Treatment and Survival|Adverse Event|0
815117|NCT00910091|2591173|P1|Treatment and Survival|Adverse Event|1
815118|NCT00910091|2591172|P2|Treatment and Survival|Withdrawal by Subject|4
815119|NCT00910091|2591173|P1|Treatment and Survival|Withdrawal by Subject|3
815120|NCT00910091|2591172|P2|Pre-assignment|Withdrawal by Subject|2
815121|NCT00910091|2591173|P1|Pre-assignment|Withdrawal by Subject|0
815122|NCT00910273|2591203|P2|Overall Study|Lost to Follow-up|1
815123|NCT00910273|2591204|P1|Overall Study|Lost to Follow-up|1
815124|NCT00910273|2591203|P2|Overall Study|Protocol Violation|0
815125|NCT00910273|2591204|P1|Overall Study|Protocol Violation|1
815126|NCT00910273|2591203|P2|Overall Study|Discontinuation of study by sponsor|2
815127|NCT00910273|2591204|P1|Overall Study|Discontinuation of study by sponsor|8
815128|NCT00910273|2591203|P2|Overall Study|Withdrawal by Subject|0
815129|NCT00910273|2591204|P1|Overall Study|Withdrawal by Subject|1
815130|NCT00910273|2591203|P2|Overall Study|Adverse Event|1
815131|NCT00910273|2591204|P1|Overall Study|Adverse Event|1
815132|NCT00910273|2591203|P2|Overall Study|Lack of Efficacy|9
815133|NCT00910273|2591204|P1|Overall Study|Lack of Efficacy|6
815134|NCT00910299|2591256|P2|Overall Study|Didn't receive any study drug|1
815135|NCT00910299|2591257|P1|Overall Study|Didn't receive any study drug|2
815136|NCT00910299|2591256|P2|Overall Study|Sponsor Decision|60
815137|NCT00910299|2591257|P1|Overall Study|Sponsor Decision|58
815138|NCT00910299|2591256|P2|Overall Study|Withdrawal by Subject|13
815139|NCT00910299|2591257|P1|Overall Study|Withdrawal by Subject|16
815140|NCT00910624|2591284|P4|Follow-Up Phase|Administrative|0
815141|NCT00910624|2591285|P3|Follow-Up Phase|Administrative|1
815142|NCT00910624|2591286|P2|Follow-Up Phase|Administrative|1
815143|NCT00910624|2591287|P1|Follow-Up Phase|Administrative|0
815144|NCT00910624|2591284|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
815145|NCT00910624|2591285|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
815146|NCT00910624|2591286|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
815147|NCT00910624|2591287|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
815148|NCT00910624|2591284|P4|Follow-Up Phase|Withdrawal by Subject|0
815149|NCT00910624|2591285|P3|Follow-Up Phase|Withdrawal by Subject|0
815150|NCT00910624|2591286|P2|Follow-Up Phase|Withdrawal by Subject|0
815151|NCT00910624|2591287|P1|Follow-Up Phase|Withdrawal by Subject|1
815152|NCT00910624|2591284|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
815153|NCT00910624|2591285|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
815154|NCT00910624|2591286|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
815155|NCT00910624|2591287|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
815156|NCT00910624|2591284|P4|Follow-Up Phase|Lost to Follow-up|0
815157|NCT00910624|2591285|P3|Follow-Up Phase|Lost to Follow-up|2
815158|NCT00910624|2591286|P2|Follow-Up Phase|Lost to Follow-up|1
815159|NCT00910624|2591287|P1|Follow-Up Phase|Lost to Follow-up|3
815161|NCT00910624|2591285|P3|Follow-Up Phase|Adverse Event|1
815162|NCT00910624|2591286|P2|Follow-Up Phase|Adverse Event|0
815163|NCT00910624|2591287|P1|Follow-Up Phase|Adverse Event|0
815164|NCT00910624|2591284|P4|Treatment Phase|Non-Compliance With Protocol|0
815165|NCT00910624|2591285|P3|Treatment Phase|Non-Compliance With Protocol|1
815166|NCT00910624|2591286|P2|Treatment Phase|Non-Compliance With Protocol|1
815167|NCT00910624|2591287|P1|Treatment Phase|Non-Compliance With Protocol|0
815168|NCT00910624|2591284|P4|Treatment Phase|Withdrawal by Subject|0
815169|NCT00910624|2591285|P3|Treatment Phase|Withdrawal by Subject|0
815170|NCT00910624|2591286|P2|Treatment Phase|Withdrawal by Subject|1
815171|NCT00910624|2591287|P1|Treatment Phase|Withdrawal by Subject|2
815172|NCT00910624|2591284|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
815173|NCT00910624|2591285|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
815174|NCT00910624|2591286|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
815175|NCT00910624|2591287|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
815176|NCT00910624|2591284|P4|Treatment Phase|Lost to Follow-up|0
815177|NCT00910624|2591285|P3|Treatment Phase|Lost to Follow-up|1
815178|NCT00910624|2591286|P2|Treatment Phase|Lost to Follow-up|0
815179|NCT00910624|2591287|P1|Treatment Phase|Lost to Follow-up|0
815180|NCT00910624|2591284|P4|Treatment Phase|Treatment Failure|0
815181|NCT00910624|2591285|P3|Treatment Phase|Treatment Failure|0
815182|NCT00910624|2591286|P2|Treatment Phase|Treatment Failure|10
815183|NCT00910624|2591287|P1|Treatment Phase|Treatment Failure|23
815184|NCT00910624|2591284|P4|Treatment Phase|Adverse Event|0
815185|NCT00910624|2591285|P3|Treatment Phase|Adverse Event|6
815186|NCT00910624|2591286|P2|Treatment Phase|Adverse Event|6
815187|NCT00910624|2591287|P1|Treatment Phase|Adverse Event|2
815188|NCT00910663|2591301|P2|Period 1|Withdrawal by Subject|1
815189|NCT00910663|2591302|P1|Period 1|Withdrawal by Subject|0
815190|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
815191|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
815192|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
815193|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
815194|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
815195|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
815196|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
815197|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
815198|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Time Demands|0
815199|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Time Demands|0
815200|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Time Demands|1
815201|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Time Demands|2
815202|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
815203|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
815204|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
815205|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
815206|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
815207|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
815208|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
815209|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
815210|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
815211|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
815212|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
815213|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
815214|NCT00910689|2591316|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
815215|NCT00910689|2591317|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
815216|NCT00910689|2591318|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
815217|NCT00910689|2591319|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
815218|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
815219|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
815220|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
815221|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
815222|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
815223|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
815224|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
815225|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
815226|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
815227|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
815228|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
815229|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
815230|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
815231|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
815232|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
815233|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
815234|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
815235|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
815236|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
815237|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
815238|NCT00910689|2591316|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
815239|NCT00910689|2591317|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
815240|NCT00910689|2591318|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
815241|NCT00910689|2591319|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
815242|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Protocol Violation|0
815243|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Protocol Violation|0
815244|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Protocol Violation|0
815245|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Protocol Violation|1
815246|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Pregnancy|0
815247|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Pregnancy|0
815248|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Pregnancy|2
815249|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Pregnancy|0
815250|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
815251|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
815252|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
815253|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
815254|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
815255|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
815256|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
815257|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
815258|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Time Demands|8
815259|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Time Demands|4
815260|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Time Demands|0
815261|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Time Demands|1
815262|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Adverse Event|0
815263|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Adverse Event|2
815264|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Adverse Event|3
815265|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Adverse Event|2
815266|NCT00910689|2591316|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
815267|NCT00910689|2591317|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
815268|NCT00910689|2591318|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
815269|NCT00910689|2591319|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
815270|NCT00910689|2591316|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
815271|NCT00910689|2591317|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
815272|NCT00910689|2591318|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
815273|NCT00910689|2591319|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
815274|NCT00910715|2591352|P3|Overall Study|Lost to Follow-up|0
815275|NCT00910715|2591353|P2|Overall Study|Lost to Follow-up|26
815276|NCT00910715|2591354|P1|Overall Study|Lost to Follow-up|22
815277|NCT00910728|2591373|P9|Overall Study|Adverse Event|1
815278|NCT00910728|2591374|P8|Overall Study|Adverse Event|1
815279|NCT00910728|2591375|P7|Overall Study|Adverse Event|2
815280|NCT00910728|2591376|P6|Overall Study|Adverse Event|0
815281|NCT00910728|2591377|P5|Overall Study|Adverse Event|0
815282|NCT00910728|2591378|P4|Overall Study|Adverse Event|1
815283|NCT00910728|2591379|P3|Overall Study|Adverse Event|1
815284|NCT00910728|2591380|P2|Overall Study|Adverse Event|0
815285|NCT00910728|2591381|P1|Overall Study|Adverse Event|2
815286|NCT00910728|2591373|P9|Overall Study|(not specified)|0
815287|NCT00910728|2591374|P8|Overall Study|(not specified)|0
815288|NCT00910728|2591375|P7|Overall Study|(not specified)|0
815289|NCT00910728|2591376|P6|Overall Study|(not specified)|0
815290|NCT00910728|2591377|P5|Overall Study|(not specified)|1
815291|NCT00910728|2591378|P4|Overall Study|(not specified)|0
815292|NCT00910728|2591379|P3|Overall Study|(not specified)|1
815293|NCT00910728|2591380|P2|Overall Study|(not specified)|0
815294|NCT00910728|2591381|P1|Overall Study|(not specified)|2
815295|NCT00910728|2591373|P9|Overall Study|Withdrawal by Subject|0
815296|NCT00910728|2591374|P8|Overall Study|Withdrawal by Subject|0
815297|NCT00910728|2591375|P7|Overall Study|Withdrawal by Subject|2
815298|NCT00910728|2591376|P6|Overall Study|Withdrawal by Subject|1
815299|NCT00910728|2591377|P5|Overall Study|Withdrawal by Subject|3
815300|NCT00910728|2591378|P4|Overall Study|Withdrawal by Subject|0
815301|NCT00910728|2591379|P3|Overall Study|Withdrawal by Subject|0
815302|NCT00910728|2591380|P2|Overall Study|Withdrawal by Subject|0
815303|NCT00910728|2591381|P1|Overall Study|Withdrawal by Subject|0
815304|NCT00910728|2591373|P9|Overall Study|Lack of Efficacy|2
815305|NCT00910728|2591374|P8|Overall Study|Lack of Efficacy|2
815306|NCT00910728|2591375|P7|Overall Study|Lack of Efficacy|2
815307|NCT00910728|2591376|P6|Overall Study|Lack of Efficacy|0
815308|NCT00910728|2591377|P5|Overall Study|Lack of Efficacy|1
815309|NCT00910728|2591378|P4|Overall Study|Lack of Efficacy|2
815310|NCT00910728|2591379|P3|Overall Study|Lack of Efficacy|1
815311|NCT00910728|2591380|P2|Overall Study|Lack of Efficacy|3
815312|NCT00910728|2591381|P1|Overall Study|Lack of Efficacy|2
815313|NCT00910858|2591516|P3|Combined Treatment Phase|Other|1
815314|NCT00910858|2591517|P2|Combined Treatment Phase|Other|2
815315|NCT00910858|2591518|P1|Combined Treatment Phase|Other|0
815316|NCT00910858|2591516|P3|Combined Treatment Phase|Protocol Violation|0
815317|NCT00910858|2591517|P2|Combined Treatment Phase|Protocol Violation|0
815318|NCT00910858|2591518|P1|Combined Treatment Phase|Protocol Violation|1
815319|NCT00910858|2591516|P3|Combined Treatment Phase|Withdrawal by Subject|0
815320|NCT00910858|2591517|P2|Combined Treatment Phase|Withdrawal by Subject|2
815321|NCT00910858|2591518|P1|Combined Treatment Phase|Withdrawal by Subject|0
815322|NCT00910858|2591516|P3|Combined Treatment Phase|Lack of therapeutic effect|3
815323|NCT00910858|2591517|P2|Combined Treatment Phase|Lack of therapeutic effect|6
815324|NCT00910858|2591518|P1|Combined Treatment Phase|Lack of therapeutic effect|8
815325|NCT00910858|2591516|P3|Monotherapy Phase|Other|2
815326|NCT00910858|2591517|P2|Monotherapy Phase|Other|4
815327|NCT00910858|2591518|P1|Monotherapy Phase|Other|3
815328|NCT00910858|2591516|P3|Monotherapy Phase|Protocol Violation|0
815329|NCT00910858|2591517|P2|Monotherapy Phase|Protocol Violation|0
815330|NCT00910858|2591518|P1|Monotherapy Phase|Protocol Violation|1
815331|NCT00910858|2591516|P3|Monotherapy Phase|Withdrawal by Subject|1
815332|NCT00910858|2591517|P2|Monotherapy Phase|Withdrawal by Subject|3
815333|NCT00910858|2591518|P1|Monotherapy Phase|Withdrawal by Subject|1
815334|NCT00910858|2591516|P3|Monotherapy Phase|Lack of therapeutic effect|4
815335|NCT00910858|2591517|P2|Monotherapy Phase|Lack of therapeutic effect|6
815336|NCT00910858|2591518|P1|Monotherapy Phase|Lack of therapeutic effect|9
815337|NCT00910858|2591516|P3|Monotherapy Phase|Adverse Event|0
815338|NCT00910858|2591517|P2|Monotherapy Phase|Adverse Event|2
815339|NCT00910858|2591518|P1|Monotherapy Phase|Adverse Event|3
815340|NCT00910858|2591516|P3|Pharmacokinetic Phase|Adverse Event|0
815341|NCT00910858|2591517|P2|Pharmacokinetic Phase|Adverse Event|0
815342|NCT00910858|2591518|P1|Pharmacokinetic Phase|Adverse Event|1
815343|NCT00910871|2591541|P1|Overall Study|Undefined|1
815344|NCT00910871|2591541|P1|Overall Study|Subject didn’t meet eligibility criteria|5
815345|NCT00910871|2591541|P1|Overall Study|Withdrawal by Subject|12
815346|NCT00910871|2591541|P1|Overall Study|Protocol Violation|11
815347|NCT00910871|2591541|P1|Overall Study|Lost to Follow-up|8
815348|NCT00910871|2591541|P1|Overall Study|Death|12
815349|NCT00910871|2591541|P1|Overall Study|Adverse Event|5
815350|NCT00910910|2591548|P2|Overall Study|Untreated before cycle 1|2
815351|NCT00910910|2591549|P1|Overall Study|Untreated before cycle 1|1
815352|NCT00910910|2591548|P2|Overall Study|Unspecified|32
815353|NCT00910910|2591549|P1|Overall Study|Unspecified|114
815354|NCT00910910|2591548|P2|Overall Study|Completed 13 cycles of treatment|118
815355|NCT00910910|2591549|P1|Overall Study|Completed 13 cycles of treatment|0
815356|NCT00910910|2591548|P2|Overall Study|Protocol Violation|2
815357|NCT00910910|2591549|P1|Overall Study|Protocol Violation|2
815358|NCT00910910|2591548|P2|Overall Study|Death|3
815359|NCT00910910|2591549|P1|Overall Study|Death|9
815360|NCT00910910|2591548|P2|Overall Study|Lost to Follow-up|2
815361|NCT00910910|2591549|P1|Overall Study|Lost to Follow-up|2
815362|NCT00910910|2591548|P2|Overall Study|Withdrawal by Subject|5
815363|NCT00910910|2591549|P1|Overall Study|Withdrawal by Subject|7
815364|NCT00910910|2591548|P2|Overall Study|PD with histologic change|2
815365|NCT00910910|2591549|P1|Overall Study|PD with histologic change|0
815366|NCT00910910|2591548|P2|Overall Study|PD without histologic change|23
815367|NCT00910910|2591549|P1|Overall Study|PD without histologic change|27
815368|NCT00910910|2591548|P2|Overall Study|Adverse Event|35
815369|NCT00910910|2591549|P1|Overall Study|Adverse Event|63
815370|NCT00910988|2591587|P4|Overall Study|Lost to Follow-up|0
815371|NCT00910988|2591588|P3|Overall Study|Lost to Follow-up|3
815372|NCT00910988|2591589|P2|Overall Study|Lost to Follow-up|4
815373|NCT00910988|2591590|P1|Overall Study|Lost to Follow-up|2
815374|NCT00911144|2591634|P2|Overall Study|Withdrawal by Subject|5
815375|NCT00911144|2591635|P1|Overall Study|Withdrawal by Subject|16
815376|NCT00911157|2591661|P2|Overall Study|Need to treat for lung cancer|0
815377|NCT00911157|2591662|P1|Overall Study|Need to treat for lung cancer|1
815378|NCT00911157|2591661|P2|Overall Study|Need for prohibited drug (heparin)|0
815379|NCT00911157|2591662|P1|Overall Study|Need for prohibited drug (heparin)|1
815380|NCT00911157|2591661|P2|Overall Study|Withdrawal by Subject|1
815381|NCT00911157|2591662|P1|Overall Study|Withdrawal by Subject|1
815382|NCT00911157|2591661|P2|Overall Study|Adverse Event|1
815383|NCT00911157|2591662|P1|Overall Study|Adverse Event|4
815384|NCT00911170|2591678|P2|Long Term Follow-Up|Death|121
815385|NCT00911170|2591679|P1|Long Term Follow-Up|Death|116
815386|NCT00911170|2591678|P2|Long Term Follow-Up|Lost to Follow-up|7
815387|NCT00911170|2591679|P1|Long Term Follow-Up|Lost to Follow-up|8
815388|NCT00911170|2591678|P2|Long Term Follow-Up|Physician Decision|4
815389|NCT00911170|2591679|P1|Long Term Follow-Up|Physician Decision|5
815390|NCT00911170|2591678|P2|Long Term Follow-Up|Withdrawal by Subject|21
815391|NCT00911170|2591679|P1|Long Term Follow-Up|Withdrawal by Subject|20
815392|NCT00911170|2591678|P2|Long Term Follow-Up|Continuing in study|269
815393|NCT00911170|2591679|P1|Long Term Follow-Up|Continuing in study|274
815394|NCT00911170|2591678|P2|Treatment Period|Death|9
815395|NCT00911170|2591679|P1|Treatment Period|Death|6
815396|NCT00911170|2591678|P2|Treatment Period|Lost to Follow-up|1
815397|NCT00911170|2591679|P1|Treatment Period|Lost to Follow-up|0
815398|NCT00911170|2591678|P2|Treatment Period|Physician Decision|5
815399|NCT00911170|2591679|P1|Treatment Period|Physician Decision|5
815400|NCT00911170|2591678|P2|Treatment Period|Disease progression|2
815401|NCT00911170|2591679|P1|Treatment Period|Disease progression|0
815402|NCT00911170|2591678|P2|Treatment Period|Withdrawal by Subject|4
815403|NCT00911170|2591679|P1|Treatment Period|Withdrawal by Subject|4
815404|NCT00911170|2591678|P2|Treatment Period|Adverse Event|10
815405|NCT00911170|2591679|P1|Treatment Period|Adverse Event|9
815406|NCT00911170|2591678|P2|Treatment Period|Protocol deviation|2
815407|NCT00911170|2591679|P1|Treatment Period|Protocol deviation|1
815408|NCT00911170|2591678|P2|Treatment Period|Ineligibility determined|3
815409|NCT00911170|2591679|P1|Treatment Period|Ineligibility determined|1
815410|NCT00911170|2591678|P2|Treatment Period|Randomized in error|1
815411|NCT00911170|2591679|P1|Treatment Period|Randomized in error|1
815412|NCT00911300|2591714|P2|Overall Study|Randomized; No Study Medication Received|2
815413|NCT00911300|2591715|P1|Overall Study|Randomized; No Study Medication Received|0
815414|NCT00911300|2591714|P2|Overall Study|Treatment Stopped by Mistake|1
815415|NCT00911300|2591715|P1|Overall Study|Treatment Stopped by Mistake|0
815416|NCT00911300|2591714|P2|Overall Study|Physician Decision|1
815417|NCT00911300|2591715|P1|Overall Study|Physician Decision|0
815418|NCT00911300|2591714|P2|Overall Study|Underlying Disease (Myocarditis)|1
815419|NCT00911300|2591715|P1|Overall Study|Underlying Disease (Myocarditis)|0
815420|NCT00911300|2591714|P2|Overall Study|Participant Refused Hospital Consulation|1
815421|NCT00911300|2591715|P1|Overall Study|Participant Refused Hospital Consulation|0
815422|NCT00911300|2591714|P2|Overall Study|International Normalized Ratio Too High|1
815423|NCT00911300|2591715|P1|Overall Study|International Normalized Ratio Too High|0
815424|NCT00911300|2591714|P2|Overall Study|Investigator's Decision; New AF Episode|1
815425|NCT00911300|2591715|P1|Overall Study|Investigator's Decision; New AF Episode|0
815426|NCT00911300|2591714|P2|Overall Study|Participant Could Not Stay in Hospital|1
815427|NCT00911300|2591715|P1|Overall Study|Participant Could Not Stay in Hospital|0
815428|NCT00911300|2591714|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
815429|NCT00911300|2591715|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
815430|NCT00911300|2591714|P2|Overall Study|Nurse Unavailable in Participant's City|0
815431|NCT00911300|2591715|P1|Overall Study|Nurse Unavailable in Participant's City|1
815432|NCT00911300|2591714|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
815433|NCT00911300|2591715|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
815434|NCT00911300|2591714|P2|Overall Study|Recurrent Tachyarrhythmia|1
815435|NCT00911300|2591715|P1|Overall Study|Recurrent Tachyarrhythmia|1
815436|NCT00911300|2591714|P2|Overall Study|Received Commercial Treatment|0
815437|NCT00911300|2591715|P1|Overall Study|Received Commercial Treatment|1
815438|NCT00911300|2591714|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
815439|NCT00911300|2591715|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
815440|NCT00911300|2591714|P2|Overall Study|Coronary Angiography Performed|0
815441|NCT00911300|2591715|P1|Overall Study|Coronary Angiography Performed|1
815442|NCT00911300|2591714|P2|Overall Study|Consent Withdrawn|12
815443|NCT00911300|2591715|P1|Overall Study|Consent Withdrawn|4
815444|NCT00911300|2591714|P2|Overall Study|Protocol Violation|2
815445|NCT00911300|2591715|P1|Overall Study|Protocol Violation|3
815446|NCT00911300|2591714|P2|Overall Study|Adverse Event|6
815447|NCT00911300|2591715|P1|Overall Study|Adverse Event|14
815448|NCT00911300|2591714|P2|Overall Study|Thrombus Persistant in Second TEE|7
815449|NCT00911300|2591715|P1|Overall Study|Thrombus Persistant in Second TEE|3
815450|NCT00911300|2591714|P2|Overall Study|Death|0
815451|NCT00911300|2591715|P1|Overall Study|Death|1
815452|NCT00911300|2591714|P2|Overall Study|Primary Endpoint Component Occurred|2
815453|NCT00911300|2591715|P1|Overall Study|Primary Endpoint Component Occurred|1
815454|NCT00911534|2591782|P2|Overall Study|Not specified|2
815455|NCT00911534|2591783|P1|Overall Study|Not specified|2
815456|NCT00911534|2591782|P2|Overall Study|Withdrawal of consent|4
815457|NCT00911534|2591783|P1|Overall Study|Withdrawal of consent|1
815458|NCT00911534|2591782|P2|Overall Study|Lack of Efficacy|1
815459|NCT00911534|2591783|P1|Overall Study|Lack of Efficacy|4
815460|NCT00911534|2591782|P2|Overall Study|Withdrawal by Subject|1
815461|NCT00911534|2591783|P1|Overall Study|Withdrawal by Subject|2
815462|NCT00911534|2591782|P2|Overall Study|Lost to Follow-up|4
815463|NCT00911534|2591783|P1|Overall Study|Lost to Follow-up|2
815464|NCT00911534|2591782|P2|Overall Study|Adverse Event|4
815465|NCT00911534|2591783|P1|Overall Study|Adverse Event|4
815466|NCT00911547|2591799|P4|Overall Study|Withdrawal by Subject|8
815467|NCT00911547|2591800|P3|Overall Study|Withdrawal by Subject|4
815468|NCT00911547|2591801|P2|Overall Study|Withdrawal by Subject|10
815469|NCT00911547|2591802|P1|Overall Study|Withdrawal by Subject|3
815470|NCT00911547|2591799|P4|Overall Study|Protocol Violation|1
815471|NCT00911547|2591800|P3|Overall Study|Protocol Violation|5
815472|NCT00911547|2591801|P2|Overall Study|Protocol Violation|5
815473|NCT00911547|2591802|P1|Overall Study|Protocol Violation|0
815474|NCT00911547|2591799|P4|Overall Study|Lost to Follow-up|1
815475|NCT00911547|2591800|P3|Overall Study|Lost to Follow-up|2
815476|NCT00911547|2591801|P2|Overall Study|Lost to Follow-up|0
815477|NCT00911547|2591802|P1|Overall Study|Lost to Follow-up|0
815478|NCT00911547|2591799|P4|Overall Study|Adverse Event|6
815479|NCT00911547|2591800|P3|Overall Study|Adverse Event|11
815480|NCT00911547|2591801|P2|Overall Study|Adverse Event|27
815481|NCT00911547|2591802|P1|Overall Study|Adverse Event|8
815482|NCT00911625|2591847|P2|Overall Study|Lost to Follow-up|0
815483|NCT00911625|2591848|P1|Overall Study|Lost to Follow-up|7
815484|NCT00911768|2591875|P2|Overall Study|Withdrawal by Subject|0
815485|NCT00911768|2591876|P1|Overall Study|Withdrawal by Subject|1
815486|NCT00911768|2591875|P2|Overall Study|Protocol Violation|4
815487|NCT00911768|2591876|P1|Overall Study|Protocol Violation|5
815488|NCT00911807|2591889|P3|Overall Study|Organizational reasons|1
815489|NCT00911807|2591890|P2|Overall Study|Organizational reasons|3
815490|NCT00911807|2591891|P1|Overall Study|Organizational reasons|1
815491|NCT00911807|2591889|P3|Overall Study|Withdrawal by Subject|7
815492|NCT00911807|2591890|P2|Overall Study|Withdrawal by Subject|10
815493|NCT00911807|2591891|P1|Overall Study|Withdrawal by Subject|8
815494|NCT00911807|2591889|P3|Overall Study|Protocol Violation|9
815495|NCT00911807|2591890|P2|Overall Study|Protocol Violation|4
815496|NCT00911807|2591891|P1|Overall Study|Protocol Violation|6
815497|NCT00911807|2591889|P3|Overall Study|Death|1
815498|NCT00911807|2591890|P2|Overall Study|Death|0
815499|NCT00911807|2591891|P1|Overall Study|Death|0
815500|NCT00911807|2591889|P3|Overall Study|Adverse Event|5
815501|NCT00911807|2591890|P2|Overall Study|Adverse Event|1
815502|NCT00911807|2591891|P1|Overall Study|Adverse Event|2
815503|NCT00911859|2591902|P3|Follow-up Period|Study terminated by sponsor|27
815504|NCT00911859|2591903|P2|Follow-up Period|Study terminated by sponsor|33
815505|NCT00911859|2591904|P1|Follow-up Period|Study terminated by sponsor|5
815506|NCT00911859|2591902|P3|Follow-up Period|Withdrawal by Subject|4
815507|NCT00911859|2591903|P2|Follow-up Period|Withdrawal by Subject|4
815508|NCT00911859|2591904|P1|Follow-up Period|Withdrawal by Subject|0
815509|NCT00911859|2591902|P3|Follow-up Period|Lost to Follow-up|0
815510|NCT00911859|2591903|P2|Follow-up Period|Lost to Follow-up|1
815511|NCT00911859|2591904|P1|Follow-up Period|Lost to Follow-up|1
815512|NCT00911859|2591902|P3|Follow-up Period|Death|10
815513|NCT00911859|2591903|P2|Follow-up Period|Death|8
815514|NCT00911859|2591904|P1|Follow-up Period|Death|5
815515|NCT00911859|2591902|P3|Maintainance Period|Withdrawal by Subject|3
815516|NCT00911859|2591903|P2|Maintainance Period|Withdrawal by Subject|0
815517|NCT00911859|2591904|P1|Maintainance Period|Withdrawal by Subject|0
815518|NCT00911859|2591902|P3|Maintainance Period|Physician Decision|9
815519|NCT00911859|2591903|P2|Maintainance Period|Physician Decision|0
815520|NCT00911859|2591904|P1|Maintainance Period|Physician Decision|0
815521|NCT00911859|2591902|P3|Maintainance Period|Lack of Efficacy|9
815522|NCT00911859|2591903|P2|Maintainance Period|Lack of Efficacy|0
815523|NCT00911859|2591904|P1|Maintainance Period|Lack of Efficacy|0
815524|NCT00911859|2591902|P3|Treatment Period|Did not receive study treatment|0
815525|NCT00911859|2591903|P2|Treatment Period|Did not receive study treatment|1
815526|NCT00911859|2591904|P1|Treatment Period|Did not receive study treatment|0
815527|NCT00911859|2591902|P3|Treatment Period|Withdrawal by Subject|5
815528|NCT00911859|2591903|P2|Treatment Period|Withdrawal by Subject|4
815529|NCT00911859|2591904|P1|Treatment Period|Withdrawal by Subject|0
815530|NCT00911859|2591902|P3|Treatment Period|Physician Decision|3
815531|NCT00911859|2591903|P2|Treatment Period|Physician Decision|3
815532|NCT00911859|2591904|P1|Treatment Period|Physician Decision|3
815533|NCT00911859|2591902|P3|Treatment Period|Lack of Efficacy|5
815534|NCT00911859|2591903|P2|Treatment Period|Lack of Efficacy|7
815535|NCT00911859|2591904|P1|Treatment Period|Lack of Efficacy|1
815536|NCT00911859|2591902|P3|Treatment Period|Death|5
815537|NCT00911859|2591903|P2|Treatment Period|Death|3
815538|NCT00911859|2591904|P1|Treatment Period|Death|1
815539|NCT00911859|2591902|P3|Treatment Period|Adverse Event|7
815540|NCT00911859|2591903|P2|Treatment Period|Adverse Event|3
815541|NCT00911859|2591904|P1|Treatment Period|Adverse Event|3
815542|NCT00911937|2591934|P2|Overall Study|Unspecified|5
815543|NCT00911937|2591935|P1|Overall Study|Unspecified|9
815544|NCT00911937|2591934|P2|Overall Study|Randomized but not treated|13
815545|NCT00911937|2591935|P1|Overall Study|Randomized but not treated|13
815546|NCT00911937|2591934|P2|Overall Study|Protocol Violation|23
815547|NCT00911937|2591935|P1|Overall Study|Protocol Violation|14
815548|NCT00911937|2591934|P2|Overall Study|Did not meet inclusion criteria|11
815549|NCT00911937|2591935|P1|Overall Study|Did not meet inclusion criteria|9
815550|NCT00911937|2591934|P2|Overall Study|Lack of Efficacy|6
815551|NCT00911937|2591935|P1|Overall Study|Lack of Efficacy|11
815552|NCT00911937|2591934|P2|Overall Study|Adverse Event|25
815553|NCT00911937|2591935|P1|Overall Study|Adverse Event|11
815554|NCT00911937|2591934|P2|Overall Study|Withdrawn due to pregnancy|0
815555|NCT00911937|2591935|P1|Overall Study|Withdrawn due to pregnancy|1
815556|NCT00911937|2591934|P2|Overall Study|Withdrawal by Subject|7
815557|NCT00911937|2591935|P1|Overall Study|Withdrawal by Subject|10
815558|NCT00911937|2591934|P2|Overall Study|Lost to Follow-up|5
815559|NCT00911937|2591935|P1|Overall Study|Lost to Follow-up|8
815560|NCT00911937|2591934|P2|Overall Study|Death|0
815561|NCT00911937|2591935|P1|Overall Study|Death|1
815562|NCT00911989|2591995|P1|Overall Study|Adverse Event|1
815563|NCT00912015|2592009|P4|Overall Study|Adverse Event|1
815564|NCT00912015|2592010|P3|Overall Study|Adverse Event|0
815565|NCT00912015|2592011|P2|Overall Study|Adverse Event|0
815566|NCT00912015|2592012|P1|Overall Study|Adverse Event|6
815567|NCT00912015|2592009|P4|Overall Study|Protocol Violation|1
815568|NCT00912015|2592010|P3|Overall Study|Protocol Violation|0
815569|NCT00912015|2592011|P2|Overall Study|Protocol Violation|0
815570|NCT00912015|2592012|P1|Overall Study|Protocol Violation|1
815571|NCT00912015|2592009|P4|Overall Study|Withdrawal by Subject|0
815572|NCT00912015|2592010|P3|Overall Study|Withdrawal by Subject|3
815573|NCT00912015|2592011|P2|Overall Study|Withdrawal by Subject|8
815574|NCT00912015|2592012|P1|Overall Study|Withdrawal by Subject|8
815575|NCT00912015|2592009|P4|Overall Study|Lack of Efficacy|0
815576|NCT00912015|2592010|P3|Overall Study|Lack of Efficacy|0
815577|NCT00912015|2592011|P2|Overall Study|Lack of Efficacy|0
815578|NCT00912015|2592012|P1|Overall Study|Lack of Efficacy|1
815579|NCT00912028|2592025|P5|Overall Study|Withdrawal by Subject|0
815580|NCT00912028|2592026|P4|Overall Study|Withdrawal by Subject|0
815581|NCT00912028|2592027|P3|Overall Study|Withdrawal by Subject|0
815582|NCT00912028|2592028|P2|Overall Study|Withdrawal by Subject|0
815583|NCT00912028|2592029|P1|Overall Study|Withdrawal by Subject|3
815584|NCT00912028|2592025|P5|Overall Study|Lost to Follow-up|3
815585|NCT00912028|2592026|P4|Overall Study|Lost to Follow-up|1
815586|NCT00912028|2592027|P3|Overall Study|Lost to Follow-up|0
815587|NCT00912028|2592028|P2|Overall Study|Lost to Follow-up|3
815588|NCT00912028|2592029|P1|Overall Study|Lost to Follow-up|2
815589|NCT00912093|2592059|P5|The Controlled Phase|Lost to Follow-up|1
815590|NCT00912093|2592060|P4|The Controlled Phase|Lost to Follow-up|0
815591|NCT00912093|2592061|P3|The Controlled Phase|Lost to Follow-up|0
815592|NCT00912093|2592062|P2|The Controlled Phase|Lost to Follow-up|0
815593|NCT00912093|2592063|P1|The Controlled Phase|Lost to Follow-up|0
815594|NCT00912093|2592059|P5|The Controlled Phase|Medical Condition|0
815595|NCT00912093|2592060|P4|The Controlled Phase|Medical Condition|0
815596|NCT00912093|2592061|P3|The Controlled Phase|Medical Condition|0
815597|NCT00912093|2592062|P2|The Controlled Phase|Medical Condition|1
815598|NCT00912093|2592063|P1|The Controlled Phase|Medical Condition|0
815599|NCT00912093|2592059|P5|The Controlled Phase|Death|0
815600|NCT00912093|2592060|P4|The Controlled Phase|Death|0
815601|NCT00912093|2592061|P3|The Controlled Phase|Death|0
815602|NCT00912093|2592062|P2|The Controlled Phase|Death|1
815603|NCT00912093|2592063|P1|The Controlled Phase|Death|0
815607|NCT00912288|2592107|P2|Overall Study|Unspecified|0
815608|NCT00912288|2592108|P1|Overall Study|Unspecified|1
815609|NCT00912288|2592107|P2|Overall Study|Study terminated by sponsor|35
815610|NCT00912288|2592108|P1|Overall Study|Study terminated by sponsor|34
815611|NCT00912288|2592107|P2|Overall Study|Withdrawal by Subject|3
815612|NCT00912288|2592108|P1|Overall Study|Withdrawal by Subject|3
815613|NCT00912288|2592107|P2|Overall Study|Protocol Violation|0
815614|NCT00912288|2592108|P1|Overall Study|Protocol Violation|1
815615|NCT00912288|2592107|P2|Overall Study|Lost to Follow-up|0
815616|NCT00912288|2592108|P1|Overall Study|Lost to Follow-up|1
815617|NCT00912288|2592107|P2|Overall Study|Adverse Event|1
815618|NCT00912288|2592108|P1|Overall Study|Adverse Event|1
815619|NCT00912288|2592107|P2|Overall Study|Death|1
815620|NCT00912288|2592108|P1|Overall Study|Death|0
815621|NCT00912405|2592155|P1|Overall Study|Lost to Follow-up|5
815626|NCT00905567|2592197|P2|Washout|Withdrawal by Subject|1
815627|NCT00905567|2592198|P1|Washout|Withdrawal by Subject|0
815628|NCT00905606|2592223|P2|Washout|Withdrawal by Subject|0
815629|NCT00905606|2592224|P1|Washout|Withdrawal by Subject|1
815630|NCT00905606|2592223|P2|Period 1|Adverse Event|1
815631|NCT00905606|2592224|P1|Period 1|Adverse Event|0
815632|NCT00905632|2592239|P7|Overall Study|Adverse Event|4
815633|NCT00905632|2592240|P6|Overall Study|Adverse Event|1
815634|NCT00905632|2592241|P5|Overall Study|Adverse Event|0
815635|NCT00905632|2592242|P4|Overall Study|Adverse Event|0
815636|NCT00905632|2592243|P3|Overall Study|Adverse Event|0
815637|NCT00905632|2592244|P2|Overall Study|Adverse Event|0
815638|NCT00905632|2592245|P1|Overall Study|Adverse Event|0
815639|NCT00905840|2592396|P1|Overall Study|Adverse Event|1
815640|NCT00905840|2592396|P1|Overall Study|Withdrawal by Subject|1
815641|NCT00905840|2592396|P1|Overall Study|Death|3
815642|NCT00905840|2592396|P1|Overall Study|Lost to Follow-up|11
815643|NCT00906035|2592408|P3|Overall Study|Withdrawal by Subject|0
815644|NCT00906035|2592409|P2|Overall Study|Withdrawal by Subject|3
815645|NCT00906035|2592410|P1|Overall Study|Withdrawal by Subject|2
815646|NCT00906087|2592451|P1|Initial Washout|Physician Decision|1
815647|NCT00906087|2592451|P1|Initial Washout|Withdrawal by Subject|1
815648|NCT00906204|2592475|P2|Secondary Endpoints (Long-term Safety)|Death|1
815649|NCT00906204|2592476|P1|Secondary Endpoints (Long-term Safety)|Death|0
815650|NCT00906204|2592475|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
815651|NCT00906204|2592476|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
815652|NCT00906204|2592475|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
815653|NCT00906204|2592476|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
815654|NCT00906204|2592475|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
815655|NCT00906204|2592476|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
815656|NCT00906204|2592475|P2|Primary Endpoint (Early Safety)|Physician Decision|0
815657|NCT00906204|2592476|P1|Primary Endpoint (Early Safety)|Physician Decision|1
815658|NCT00906282|2592496|P1|Preoperative Chemotherapy|Toxicity|1
815659|NCT00906282|2592496|P1|Preoperative Chemotherapy|Progressive disease|6
815660|NCT00906282|2592496|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
815661|NCT00906282|2592496|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
815662|NCT00906347|2592506|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
815663|NCT00906347|2592507|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
815664|NCT00906347|2592506|P2|Received Study Drug|Refused study drug|0
815665|NCT00906347|2592507|P1|Received Study Drug|Refused study drug|1
815666|NCT00906347|2592506|P2|Received Study Drug|Nonreassuring fetal heart rate|1
815667|NCT00906347|2592507|P1|Received Study Drug|Nonreassuring fetal heart rate|13
815668|NCT00906347|2592506|P2|Received Study Drug|8 cm prior to initiation of study drug|30
815669|NCT00906347|2592507|P1|Received Study Drug|8 cm prior to initiation of study drug|18
815670|NCT00906399|2592530|P7|Year 2|Not specified|0
815671|NCT00906399|2592531|P6|Year 2|Not specified|1
815672|NCT00906399|2592532|P5|Year 2|Not specified|3
815673|NCT00906399|2592533|P4|Year 2|Not specified|2
815674|NCT00906399|2592534|P3|Year 2|Not specified|0
815675|NCT00906399|2592535|P2|Year 2|Not specified|0
815676|NCT00906399|2592536|P1|Year 2|Not specified|0
815677|NCT00906399|2592530|P7|Year 2|Death|3
815678|NCT00906399|2592531|P6|Year 2|Death|0
815679|NCT00906399|2592532|P5|Year 2|Death|0
815680|NCT00906399|2592533|P4|Year 2|Death|1
815681|NCT00906399|2592534|P3|Year 2|Death|0
815682|NCT00906399|2592535|P2|Year 2|Death|0
815683|NCT00906399|2592536|P1|Year 2|Death|0
815684|NCT00906399|2592530|P7|Year 2|Physician Decision|3
815685|NCT00906399|2592531|P6|Year 2|Physician Decision|6
815686|NCT00906399|2592532|P5|Year 2|Physician Decision|2
815687|NCT00906399|2592533|P4|Year 2|Physician Decision|0
815688|NCT00906399|2592534|P3|Year 2|Physician Decision|0
815689|NCT00906399|2592535|P2|Year 2|Physician Decision|0
815690|NCT00906399|2592536|P1|Year 2|Physician Decision|0
815691|NCT00906399|2592530|P7|Year 2|Withdrawal by Subject|13
815692|NCT00906399|2592531|P6|Year 2|Withdrawal by Subject|27
815693|NCT00906399|2592532|P5|Year 2|Withdrawal by Subject|18
815694|NCT00906399|2592533|P4|Year 2|Withdrawal by Subject|17
815695|NCT00906399|2592534|P3|Year 2|Withdrawal by Subject|0
815696|NCT00906399|2592535|P2|Year 2|Withdrawal by Subject|0
815697|NCT00906399|2592536|P1|Year 2|Withdrawal by Subject|0
815698|NCT00906399|2592530|P7|Year 2|Lost to Follow-up|4
815699|NCT00906399|2592531|P6|Year 2|Lost to Follow-up|2
815700|NCT00906399|2592532|P5|Year 2|Lost to Follow-up|4
815701|NCT00906399|2592533|P4|Year 2|Lost to Follow-up|1
815702|NCT00906399|2592534|P3|Year 2|Lost to Follow-up|0
815703|NCT00906399|2592535|P2|Year 2|Lost to Follow-up|0
815704|NCT00906399|2592536|P1|Year 2|Lost to Follow-up|0
815705|NCT00906399|2592530|P7|Year 2|Adverse Event|6
815706|NCT00906399|2592531|P6|Year 2|Adverse Event|11
815707|NCT00906399|2592532|P5|Year 2|Adverse Event|8
815708|NCT00906399|2592533|P4|Year 2|Adverse Event|9
815709|NCT00906399|2592534|P3|Year 2|Adverse Event|0
815710|NCT00906399|2592535|P2|Year 2|Adverse Event|0
815711|NCT00906399|2592536|P1|Year 2|Adverse Event|0
815712|NCT00906399|2592530|P7|Year 1|Not specified|0
815713|NCT00906399|2592531|P6|Year 1|Not specified|0
815714|NCT00906399|2592532|P5|Year 1|Not specified|0
815715|NCT00906399|2592533|P4|Year 1|Not specified|0
815716|NCT00906399|2592534|P3|Year 1|Not specified|7
815717|NCT00906399|2592535|P2|Year 1|Not specified|2
815718|NCT00906399|2592536|P1|Year 1|Not specified|4
815719|NCT00906399|2592530|P7|Year 1|Death|0
815720|NCT00906399|2592531|P6|Year 1|Death|0
815721|NCT00906399|2592532|P5|Year 1|Death|0
815722|NCT00906399|2592533|P4|Year 1|Death|0
815723|NCT00906399|2592534|P3|Year 1|Death|1
815724|NCT00906399|2592535|P2|Year 1|Death|1
815725|NCT00906399|2592536|P1|Year 1|Death|2
815726|NCT00906399|2592530|P7|Year 1|Physician Decision|0
815727|NCT00906399|2592531|P6|Year 1|Physician Decision|0
815728|NCT00906399|2592532|P5|Year 1|Physician Decision|0
815729|NCT00906399|2592533|P4|Year 1|Physician Decision|0
815730|NCT00906399|2592534|P3|Year 1|Physician Decision|3
815731|NCT00906399|2592535|P2|Year 1|Physician Decision|1
815732|NCT00906399|2592536|P1|Year 1|Physician Decision|0
815733|NCT00906399|2592530|P7|Year 1|Withdrawal by Subject|0
815734|NCT00906399|2592531|P6|Year 1|Withdrawal by Subject|0
815735|NCT00906399|2592532|P5|Year 1|Withdrawal by Subject|0
815736|NCT00906399|2592533|P4|Year 1|Withdrawal by Subject|0
815737|NCT00906399|2592534|P3|Year 1|Withdrawal by Subject|36
815738|NCT00906399|2592535|P2|Year 1|Withdrawal by Subject|32
815739|NCT00906399|2592536|P1|Year 1|Withdrawal by Subject|30
815740|NCT00906399|2592530|P7|Year 1|Lost to Follow-up|0
815741|NCT00906399|2592531|P6|Year 1|Lost to Follow-up|0
815742|NCT00906399|2592532|P5|Year 1|Lost to Follow-up|0
815743|NCT00906399|2592533|P4|Year 1|Lost to Follow-up|0
815744|NCT00906399|2592534|P3|Year 1|Lost to Follow-up|2
815745|NCT00906399|2592535|P2|Year 1|Lost to Follow-up|4
815746|NCT00906399|2592536|P1|Year 1|Lost to Follow-up|4
815747|NCT00906399|2592530|P7|Year 1|Adverse Event|0
815748|NCT00906399|2592531|P6|Year 1|Adverse Event|0
815749|NCT00906399|2592532|P5|Year 1|Adverse Event|0
815750|NCT00906399|2592533|P4|Year 1|Adverse Event|0
815751|NCT00906399|2592534|P3|Year 1|Adverse Event|24
815752|NCT00906399|2592535|P2|Year 1|Adverse Event|22
815753|NCT00906399|2592536|P1|Year 1|Adverse Event|4
815754|NCT00906399|2592530|P7|Year 1|Randomized But Not Treated|0
815755|NCT00906399|2592531|P6|Year 1|Randomized But Not Treated|0
815756|NCT00906399|2592532|P5|Year 1|Randomized But Not Treated|0
815757|NCT00906399|2592533|P4|Year 1|Randomized But Not Treated|0
815758|NCT00906399|2592534|P3|Year 1|Randomized But Not Treated|3
815759|NCT00906399|2592535|P2|Year 1|Randomized But Not Treated|1
815760|NCT00906399|2592536|P1|Year 1|Randomized But Not Treated|0
815761|NCT00906698|2592580|P6|Overall Study|incl. non compliance, lost to follow-up|0
815762|NCT00906698|2592581|P5|Overall Study|incl. non compliance, lost to follow-up|0
815763|NCT00906698|2592582|P4|Overall Study|incl. non compliance, lost to follow-up|0
815764|NCT00906698|2592583|P3|Overall Study|incl. non compliance, lost to follow-up|0
815765|NCT00906698|2592584|P2|Overall Study|incl. non compliance, lost to follow-up|1
815766|NCT00906698|2592585|P1|Overall Study|incl. non compliance, lost to follow-up|0
815767|NCT00906698|2592580|P6|Overall Study|Withdrawal by Subject|0
815768|NCT00906698|2592581|P5|Overall Study|Withdrawal by Subject|1
815769|NCT00906698|2592582|P4|Overall Study|Withdrawal by Subject|0
815770|NCT00906698|2592583|P3|Overall Study|Withdrawal by Subject|0
815771|NCT00906698|2592584|P2|Overall Study|Withdrawal by Subject|0
815772|NCT00906698|2592585|P1|Overall Study|Withdrawal by Subject|0
815773|NCT00906698|2592580|P6|Overall Study|Disease progression|4
815774|NCT00906698|2592581|P5|Overall Study|Disease progression|12
815775|NCT00906698|2592582|P4|Overall Study|Disease progression|4
815776|NCT00906698|2592583|P3|Overall Study|Disease progression|4
815777|NCT00906698|2592584|P2|Overall Study|Disease progression|12
815778|NCT00906698|2592585|P1|Overall Study|Disease progression|3
815779|NCT00906698|2592580|P6|Overall Study|Adverse Event|1
815780|NCT00906698|2592581|P5|Overall Study|Adverse Event|4
815781|NCT00906698|2592582|P4|Overall Study|Adverse Event|0
815782|NCT00906698|2592583|P3|Overall Study|Adverse Event|2
815783|NCT00906698|2592584|P2|Overall Study|Adverse Event|0
815784|NCT00906698|2592585|P1|Overall Study|Adverse Event|0
815785|NCT00906698|2592580|P6|Overall Study|Dose-limiting toxicity (DLT)|0
815786|NCT00906698|2592581|P5|Overall Study|Dose-limiting toxicity (DLT)|1
815787|NCT00906698|2592582|P4|Overall Study|Dose-limiting toxicity (DLT)|0
815788|NCT00906698|2592583|P3|Overall Study|Dose-limiting toxicity (DLT)|0
815789|NCT00906698|2592584|P2|Overall Study|Dose-limiting toxicity (DLT)|6
815790|NCT00906698|2592585|P1|Overall Study|Dose-limiting toxicity (DLT)|0
815791|NCT00906945|2592699|P6|Overall Study|Physician Decision|1
815792|NCT00906945|2592700|P5|Overall Study|Physician Decision|0
815793|NCT00906945|2592701|P4|Overall Study|Physician Decision|0
815794|NCT00906945|2592702|P3|Overall Study|Physician Decision|0
815795|NCT00906945|2592703|P2|Overall Study|Physician Decision|0
815796|NCT00906945|2592704|P1|Overall Study|Physician Decision|0
815797|NCT00906945|2592699|P6|Overall Study|Found to be not eligible|1
815798|NCT00906945|2592700|P5|Overall Study|Found to be not eligible|1
815799|NCT00906945|2592701|P4|Overall Study|Found to be not eligible|1
815800|NCT00906945|2592702|P3|Overall Study|Found to be not eligible|0
815801|NCT00906945|2592703|P2|Overall Study|Found to be not eligible|0
815802|NCT00906945|2592704|P1|Overall Study|Found to be not eligible|0
815803|NCT00906971|2592733|P2|Overall Study|Lost to Follow-up|1
815804|NCT00906971|2592734|P1|Overall Study|Lost to Follow-up|0
815805|NCT00906971|2592733|P2|Overall Study|Withdrawal by Subject|2
815806|NCT00906971|2592734|P1|Overall Study|Withdrawal by Subject|8
815807|NCT00907257|2592765|P2|Overall Study|Personal Reasons|1
815808|NCT00907257|2592766|P1|Overall Study|Personal Reasons|6
815809|NCT00907257|2592765|P2|Overall Study|Moved|0
815810|NCT00907257|2592766|P1|Overall Study|Moved|1
815811|NCT00907257|2592765|P2|Overall Study|Per IRB-Subject became vulnerable|0
815812|NCT00907257|2592766|P1|Overall Study|Per IRB-Subject became vulnerable|1
815813|NCT00907257|2592765|P2|Overall Study|Withdrawal by Subject|2
815814|NCT00907257|2592766|P1|Overall Study|Withdrawal by Subject|1
815815|NCT00907257|2592765|P2|Overall Study|Lost to Follow-up|3
815816|NCT00907257|2592766|P1|Overall Study|Lost to Follow-up|3
815817|NCT00907257|2592765|P2|Overall Study|Protocol Violation|2
815818|NCT00907257|2592766|P1|Overall Study|Protocol Violation|1
815819|NCT00907257|2592765|P2|Overall Study|Adverse Event|4
815820|NCT00907257|2592766|P1|Overall Study|Adverse Event|0
815821|NCT00912743|2592778|P2|Overall Study|End of treatment form was not collected|0
815822|NCT00912743|2592779|P1|Overall Study|End of treatment form was not collected|1
815823|NCT00912743|2592778|P2|Overall Study|Toxicity|1
815824|NCT00912743|2592779|P1|Overall Study|Toxicity|0
815825|NCT00912743|2592778|P2|Overall Study|Lack of Efficacy|18
815826|NCT00912743|2592779|P1|Overall Study|Lack of Efficacy|9
815827|NCT00912743|2592778|P2|Overall Study|Adverse Event|1
815828|NCT00912743|2592779|P1|Overall Study|Adverse Event|3
815829|NCT00912782|2592791|P2|Overall Study|Relocated before study completion|1
815830|NCT00912782|2592792|P1|Overall Study|Relocated before study completion|0
815831|NCT00912782|2592791|P2|Overall Study|Did not receive vascular access type|2
815832|NCT00912782|2592792|P1|Overall Study|Did not receive vascular access type|1
815833|NCT00912782|2592791|P2|Overall Study|Lost to Follow-up|1
815834|NCT00912782|2592792|P1|Overall Study|Lost to Follow-up|0
815835|NCT00912782|2592791|P2|Overall Study|Death|1
815836|NCT00912782|2592792|P1|Overall Study|Death|2
815837|NCT00912912|2592826|P1|Overall Study|Disease Progression|3
815838|NCT00912912|2592826|P1|Overall Study|Withdrawal by Subject|1
815872|NCT00915278|2593002|P6|Overall Study|Admission to hospice|0
815873|NCT00915278|2593003|P5|Overall Study|Admission to hospice|0
815874|NCT00915278|2593004|P4|Overall Study|Admission to hospice|0
815875|NCT00915278|2593005|P3|Overall Study|Admission to hospice|1
815876|NCT00915278|2593006|P2|Overall Study|Admission to hospice|0
815877|NCT00915278|2593007|P1|Overall Study|Admission to hospice|0
815878|NCT00915278|2593002|P6|Overall Study|Infusion related AEs|2
815879|NCT00915278|2593003|P5|Overall Study|Infusion related AEs|0
815880|NCT00915278|2593004|P4|Overall Study|Infusion related AEs|0
815881|NCT00915278|2593005|P3|Overall Study|Infusion related AEs|0
815882|NCT00915278|2593006|P2|Overall Study|Infusion related AEs|0
815883|NCT00915278|2593007|P1|Overall Study|Infusion related AEs|0
815884|NCT00915278|2593002|P6|Overall Study|Progressive disease/clinical progression|2
815885|NCT00915278|2593003|P5|Overall Study|Progressive disease/clinical progression|1
815886|NCT00915278|2593004|P4|Overall Study|Progressive disease/clinical progression|3
815887|NCT00915278|2593005|P3|Overall Study|Progressive disease/clinical progression|0
815888|NCT00915278|2593006|P2|Overall Study|Progressive disease/clinical progression|0
815889|NCT00915278|2593007|P1|Overall Study|Progressive disease/clinical progression|0
815890|NCT00915278|2593002|P6|Overall Study|Adverse Event|0
815891|NCT00915278|2593003|P5|Overall Study|Adverse Event|0
815892|NCT00915278|2593004|P4|Overall Study|Adverse Event|0
815893|NCT00915278|2593005|P3|Overall Study|Adverse Event|0
815894|NCT00915278|2593006|P2|Overall Study|Adverse Event|1
815895|NCT00915278|2593007|P1|Overall Study|Adverse Event|4
815896|NCT00915278|2593002|P6|Overall Study|Withdrawal by Subject|4
815897|NCT00915278|2593003|P5|Overall Study|Withdrawal by Subject|1
815898|NCT00915278|2593004|P4|Overall Study|Withdrawal by Subject|0
815899|NCT00915278|2593005|P3|Overall Study|Withdrawal by Subject|0
815900|NCT00915278|2593006|P2|Overall Study|Withdrawal by Subject|1
815901|NCT00915278|2593007|P1|Overall Study|Withdrawal by Subject|0
815902|NCT00915278|2593002|P6|Overall Study|Lost to Follow-up|0
815903|NCT00915278|2593003|P5|Overall Study|Lost to Follow-up|0
815904|NCT00915278|2593004|P4|Overall Study|Lost to Follow-up|0
815905|NCT00915278|2593005|P3|Overall Study|Lost to Follow-up|0
815906|NCT00915278|2593006|P2|Overall Study|Lost to Follow-up|1
815907|NCT00915278|2593007|P1|Overall Study|Lost to Follow-up|0
815908|NCT00915278|2593002|P6|Overall Study|Death|0
815909|NCT00915278|2593003|P5|Overall Study|Death|0
815910|NCT00915278|2593004|P4|Overall Study|Death|0
815911|NCT00915278|2593005|P3|Overall Study|Death|0
815912|NCT00915278|2593006|P2|Overall Study|Death|0
815913|NCT00915278|2593007|P1|Overall Study|Death|1
815914|NCT00915343|2593153|P3|Part B - Open Label Period|Did not attend the last visit|1
815915|NCT00915343|2593154|P2|Part B - Open Label Period|Did not attend the last visit|0
815916|NCT00915343|2593155|P1|Part B - Open Label Period|Did not attend the last visit|0
815917|NCT00915343|2593153|P3|Part B - Open Label Period|Treatment switch|1
815918|NCT00915343|2593154|P2|Part B - Open Label Period|Treatment switch|0
815919|NCT00915343|2593155|P1|Part B - Open Label Period|Treatment switch|0
815920|NCT00915356|2593239|P5|Overall Study|Withdrawal by Subject|0
815921|NCT00915356|2593240|P4|Overall Study|Withdrawal by Subject|0
815922|NCT00915356|2593241|P3|Overall Study|Withdrawal by Subject|0
815923|NCT00915356|2593242|P2|Overall Study|Withdrawal by Subject|0
815924|NCT00915356|2593243|P1|Overall Study|Withdrawal by Subject|1
815925|NCT00915473|2593307|P2|4-week Follow Up|Lost to Follow-up|5
815926|NCT00915473|2593308|P1|4-week Follow Up|Lost to Follow-up|1
815927|NCT00915473|2593307|P2|Screening|Withdrawal by Subject|0
815928|NCT00915473|2593308|P1|Screening|Withdrawal by Subject|1
815929|NCT00915525|2593333|P2|Overall Study|Patient Moved|9
815930|NCT00915525|2593334|P1|Overall Study|Patient Moved|15
815931|NCT00915525|2593333|P2|Overall Study|Non-Compliance|1
815932|NCT00915525|2593334|P1|Overall Study|Non-Compliance|3
815933|NCT00915525|2593333|P2|Overall Study|Study Burden|12
815934|NCT00915525|2593334|P1|Overall Study|Study Burden|28
815935|NCT00915525|2593333|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
815936|NCT00915525|2593334|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
815937|NCT00915525|2593333|P2|Overall Study|Site Closed|9
815938|NCT00915525|2593334|P1|Overall Study|Site Closed|27
815939|NCT00915525|2593333|P2|Overall Study|Other Reason|12
815940|NCT00915525|2593334|P1|Overall Study|Other Reason|35
815941|NCT00915525|2593333|P2|Overall Study|Missing|1
815942|NCT00915525|2593334|P1|Overall Study|Missing|12
815943|NCT00915525|2593333|P2|Overall Study|Adverse Event|13
815944|NCT00915525|2593334|P1|Overall Study|Adverse Event|29
815945|NCT00915525|2593333|P2|Overall Study|Lack of Efficacy|32
815946|NCT00915525|2593334|P1|Overall Study|Lack of Efficacy|15
815947|NCT00915525|2593333|P2|Overall Study|Pregnancy|0
815948|NCT00915525|2593334|P1|Overall Study|Pregnancy|2
815949|NCT00915525|2593333|P2|Overall Study|Lost to Follow-up|16
815950|NCT00915525|2593334|P1|Overall Study|Lost to Follow-up|27
815951|NCT00915525|2593333|P2|Overall Study|Withdrawal by Subject|21
815952|NCT00915525|2593334|P1|Overall Study|Withdrawal by Subject|59
815953|NCT00915525|2593333|P2|Overall Study|Protocol Violation|4
815954|NCT00915525|2593334|P1|Overall Study|Protocol Violation|9
815955|NCT00915551|2593437|P2|Overall Study|Withdrawal by Subject|1
815956|NCT00915551|2593438|P1|Overall Study|Withdrawal by Subject|0
815957|NCT00915772|2593501|P3|Overall Study|Any other reason|7
815958|NCT00915772|2593502|P2|Overall Study|Any other reason|7
815959|NCT00915772|2593503|P1|Overall Study|Any other reason|4
815960|NCT00915772|2593501|P3|Overall Study|Refused to continue trial medication|4
815961|NCT00915772|2593502|P2|Overall Study|Refused to continue trial medication|8
815962|NCT00915772|2593503|P1|Overall Study|Refused to continue trial medication|6
815963|NCT00915772|2593501|P3|Overall Study|Lack of Efficacy|3
815964|NCT00915772|2593502|P2|Overall Study|Lack of Efficacy|15
815965|NCT00915772|2593503|P1|Overall Study|Lack of Efficacy|9
815966|NCT00915772|2593501|P3|Overall Study|Lost to Follow-up|2
815967|NCT00915772|2593502|P2|Overall Study|Lost to Follow-up|2
815968|NCT00915772|2593503|P1|Overall Study|Lost to Follow-up|1
815969|NCT00915772|2593501|P3|Overall Study|Protocol Violation|2
815970|NCT00915772|2593502|P2|Overall Study|Protocol Violation|1
815971|NCT00915772|2593503|P1|Overall Study|Protocol Violation|4
815972|NCT00915772|2593501|P3|Overall Study|Adverse Event|11
815973|NCT00915772|2593502|P2|Overall Study|Adverse Event|13
815974|NCT00915772|2593503|P1|Overall Study|Adverse Event|12
815975|NCT00915876|2593577|P2|Overall Study|Adverse Event|1
815976|NCT00915876|2593578|P1|Overall Study|Adverse Event|0
815977|NCT00916006|2593597|P2|Overall Study|Protocol Violation|1
815978|NCT00916006|2593598|P1|Overall Study|Protocol Violation|0
815979|NCT00916006|2593597|P2|Overall Study|Withdrawal by Subject|5
815980|NCT00916006|2593598|P1|Overall Study|Withdrawal by Subject|2
815981|NCT00916006|2593597|P2|Overall Study|Adverse Event|1
815982|NCT00916006|2593598|P1|Overall Study|Adverse Event|1
815983|NCT00916279|2593658|P1|Overall Study|Lost to Follow-up|2
815984|NCT00916279|2593658|P1|Overall Study|Death|2
815985|NCT00916305|2593668|P2|Overall Study|Withdrawal by Subject|1
815986|NCT00916305|2593669|P1|Overall Study|Withdrawal by Subject|0
815987|NCT00916305|2593668|P2|Overall Study|Lost to Follow-up|27
815988|NCT00916305|2593669|P1|Overall Study|Lost to Follow-up|21
815989|NCT00916344|2593677|P1|Overall Study|Drop-out|5
815990|NCT00916344|2593677|P1|Overall Study|ICD upgrade|1
815991|NCT00916344|2593677|P1|Overall Study|Death|2
815992|NCT00916357|2593682|P6|Period 2|Weight loss > 3 kilograms (kg)|0
815993|NCT00916357|2593683|P5|Period 2|Weight loss > 3 kilograms (kg)|0
815994|NCT00916357|2593684|P4|Period 2|Weight loss > 3 kilograms (kg)|1
815995|NCT00916357|2593685|P3|Period 2|Weight loss > 3 kilograms (kg)|0
815996|NCT00916357|2593686|P2|Period 2|Weight loss > 3 kilograms (kg)|0
815997|NCT00916357|2593687|P1|Period 2|Weight loss > 3 kilograms (kg)|0
815998|NCT00916357|2593682|P6|Period 1|Withdrawal by Subject|0
815999|NCT00916357|2593683|P5|Period 1|Withdrawal by Subject|0
816000|NCT00916357|2593684|P4|Period 1|Withdrawal by Subject|0
816001|NCT00916357|2593685|P3|Period 1|Withdrawal by Subject|0
816002|NCT00916357|2593686|P2|Period 1|Withdrawal by Subject|0
816003|NCT00916357|2593687|P1|Period 1|Withdrawal by Subject|1
816004|NCT00916370|2593727|P2|Overall Study|Physician Decision|1
816005|NCT00916370|2593728|P1|Overall Study|Physician Decision|0
816006|NCT00916370|2593727|P2|Overall Study|Withdrawal by Subject|0
816007|NCT00916370|2593728|P1|Overall Study|Withdrawal by Subject|2
816008|NCT00916370|2593727|P2|Overall Study|Death|1
816009|NCT00916370|2593728|P1|Overall Study|Death|3
816010|NCT00916383|2593902|P1|Overall Study|Protocol Violation|1
816011|NCT00916383|2593902|P1|Overall Study|Death|1
816012|NCT00916383|2593902|P1|Overall Study|Adverse Event|1
816013|NCT00916617|2593957|P4|Overall Study|Not specified|2
816014|NCT00916617|2593958|P3|Overall Study|Not specified|0
816015|NCT00916617|2593959|P2|Overall Study|Not specified|0
816016|NCT00916617|2593960|P1|Overall Study|Not specified|2
816017|NCT00916617|2593957|P4|Overall Study|Lack of Efficacy|0
816018|NCT00916617|2593958|P3|Overall Study|Lack of Efficacy|0
816019|NCT00916617|2593959|P2|Overall Study|Lack of Efficacy|0
816020|NCT00916617|2593960|P1|Overall Study|Lack of Efficacy|1
816021|NCT00916617|2593957|P4|Overall Study|Lost to Follow-up|0
816022|NCT00916617|2593958|P3|Overall Study|Lost to Follow-up|0
816023|NCT00916617|2593959|P2|Overall Study|Lost to Follow-up|1
816024|NCT00916617|2593960|P1|Overall Study|Lost to Follow-up|2
816025|NCT00916617|2593957|P4|Overall Study|Discontinuation of Study by Sponsor|1
816026|NCT00916617|2593958|P3|Overall Study|Discontinuation of Study by Sponsor|3
816027|NCT00916617|2593959|P2|Overall Study|Discontinuation of Study by Sponsor|13
816028|NCT00916617|2593960|P1|Overall Study|Discontinuation of Study by Sponsor|8
816029|NCT00916617|2593957|P4|Overall Study|Physician Decision|0
816030|NCT00916617|2593958|P3|Overall Study|Physician Decision|0
816031|NCT00916617|2593959|P2|Overall Study|Physician Decision|1
816032|NCT00916617|2593960|P1|Overall Study|Physician Decision|1
816033|NCT00916617|2593957|P4|Overall Study|Caregiver Request|0
816034|NCT00916617|2593958|P3|Overall Study|Caregiver Request|1
816035|NCT00916617|2593959|P2|Overall Study|Caregiver Request|2
816036|NCT00916617|2593960|P1|Overall Study|Caregiver Request|3
816037|NCT00916617|2593957|P4|Overall Study|Withdrawal by Subject|1
816038|NCT00916617|2593958|P3|Overall Study|Withdrawal by Subject|0
816039|NCT00916617|2593959|P2|Overall Study|Withdrawal by Subject|2
816040|NCT00916617|2593960|P1|Overall Study|Withdrawal by Subject|3
816041|NCT00916617|2593957|P4|Overall Study|Adverse Event|3
816042|NCT00916617|2593958|P3|Overall Study|Adverse Event|6
816043|NCT00916617|2593959|P2|Overall Study|Adverse Event|2
816044|NCT00916617|2593960|P1|Overall Study|Adverse Event|3
816045|NCT00916721|2593983|P2|Overall Study|Protocol Violation|4
816046|NCT00916721|2593984|P1|Overall Study|Protocol Violation|2
816047|NCT00916721|2593983|P2|Overall Study|Withdrawal by Subject|2
816048|NCT00916721|2593984|P1|Overall Study|Withdrawal by Subject|2
816049|NCT00916721|2593983|P2|Overall Study|Adverse Event|3
816050|NCT00916721|2593984|P1|Overall Study|Adverse Event|6
816051|NCT00916721|2593983|P2|Overall Study|Lost to Follow-up|1
816052|NCT00916721|2593984|P1|Overall Study|Lost to Follow-up|0
816053|NCT00916929|2593998|P2|Overall Study|Device unable to process impedance data|7
816054|NCT00916929|2593999|P1|Overall Study|Device unable to process impedance data|0
816055|NCT00916929|2593998|P2|Overall Study|Moved to another state|1
816056|NCT00916929|2593999|P1|Overall Study|Moved to another state|0
816057|NCT00916929|2593998|P2|Overall Study|System explant|0
816058|NCT00916929|2593999|P1|Overall Study|System explant|1
816059|NCT00916929|2593998|P2|Overall Study|Transferred to hospice care|1
816060|NCT00916929|2593999|P1|Overall Study|Transferred to hospice care|1
816061|NCT00916929|2593998|P2|Overall Study|Left ventricular epicardial lead|2
816062|NCT00916929|2593999|P1|Overall Study|Left ventricular epicardial lead|1
816063|NCT00916929|2593998|P2|Overall Study|Withdrawal by Subject|5
816064|NCT00916929|2593999|P1|Overall Study|Withdrawal by Subject|1
816065|NCT00916929|2593998|P2|Overall Study|Death|10
816066|NCT00916929|2593999|P1|Overall Study|Death|5
816067|NCT00916929|2593998|P2|Overall Study|Lost to Follow-up|3
816068|NCT00916929|2593999|P1|Overall Study|Lost to Follow-up|1
816069|NCT00917124|2594009|P2|Overall Study|Protocol Violation|6
816070|NCT00917124|2594010|P1|Overall Study|Protocol Violation|4
816071|NCT00917267|2594020|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
816072|NCT00917267|2594021|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
816073|NCT00917267|2594020|P2|Overall Study|Sponsor Decision|5
816074|NCT00917267|2594021|P1|Overall Study|Sponsor Decision|5
816075|NCT00917267|2594020|P2|Overall Study|Entry Criteria Not Met|0
816076|NCT00917267|2594021|P1|Overall Study|Entry Criteria Not Met|1
816077|NCT00917267|2594020|P2|Overall Study|Lost to follow up|2
816078|NCT00917267|2594021|P1|Overall Study|Lost to follow up|0
816079|NCT00917267|2594020|P2|Overall Study|Withdrawal by Subject|12
816080|NCT00917267|2594021|P1|Overall Study|Withdrawal by Subject|5
816081|NCT00917267|2594020|P2|Overall Study|Protocol Violation|18
816082|NCT00917267|2594021|P1|Overall Study|Protocol Violation|9
816083|NCT00917267|2594020|P2|Overall Study|Physician Decision|4
816084|NCT00917267|2594021|P1|Overall Study|Physician Decision|2
816085|NCT00917267|2594020|P2|Overall Study|Adverse Event|36
816086|NCT00917267|2594021|P1|Overall Study|Adverse Event|15
816087|NCT00917384|2594049|P2|Overall Study|Withdrawal by Subject|2
816088|NCT00917384|2594050|P1|Overall Study|Withdrawal by Subject|10
816089|NCT00917384|2594049|P2|Overall Study|Lost to Follow-up|2
816090|NCT00917384|2594050|P1|Overall Study|Lost to Follow-up|4
816091|NCT00917501|2594074|P2|Overall Study|trouble swollowing capsules|1
816092|NCT00917501|2594075|P1|Overall Study|trouble swollowing capsules|0
816093|NCT00917501|2594074|P2|Overall Study|Lack of Efficacy|2
816094|NCT00917501|2594075|P1|Overall Study|Lack of Efficacy|1
816095|NCT00917501|2594074|P2|Overall Study|Withdrawal by Subject|1
816096|NCT00917501|2594075|P1|Overall Study|Withdrawal by Subject|3
816097|NCT00917501|2594074|P2|Overall Study|Lost to Follow-up|1
816098|NCT00917501|2594075|P1|Overall Study|Lost to Follow-up|4
816099|NCT00917579|2594081|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
816100|NCT00917579|2594082|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
816101|NCT00917579|2594081|P2|Washout >= 2 Weeks|Adverse Event|0
816102|NCT00917579|2594082|P1|Washout >= 2 Weeks|Adverse Event|1
816103|NCT00917644|2594096|P2|Period 2: Second Intervention|family emergency|0
816104|NCT00917644|2594097|P1|Period 2: Second Intervention|family emergency|1
816105|NCT00917644|2594096|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
816106|NCT00917644|2594097|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
816107|NCT00917644|2594096|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
816108|NCT00917644|2594097|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
816109|NCT00917852|2594124|P1|Overall Study|Death|6
816110|NCT00920621|2594144|P4|Overall Study|Blood sample not collected|0
816111|NCT00920621|2594145|P3|Overall Study|Blood sample not collected|0
816112|NCT00920621|2594146|P2|Overall Study|Blood sample not collected|14
816113|NCT00920621|2594147|P1|Overall Study|Blood sample not collected|22
816114|NCT00920621|2594144|P4|Overall Study|Fetal/neonatal deaths|14
816115|NCT00920621|2594145|P3|Overall Study|Fetal/neonatal deaths|16
816116|NCT00920621|2594146|P2|Overall Study|Fetal/neonatal deaths|14
816117|NCT00920621|2594147|P1|Overall Study|Fetal/neonatal deaths|16
816118|NCT00920621|2594144|P4|Overall Study|Lost to Follow-up|21
816119|NCT00920621|2594145|P3|Overall Study|Lost to Follow-up|19
816120|NCT00920621|2594146|P2|Overall Study|Lost to Follow-up|17
816121|NCT00920621|2594147|P1|Overall Study|Lost to Follow-up|16
816122|NCT00920686|2594229|P3|Overall Study|Study drug dosing criteria not met|12
816123|NCT00920686|2594230|P2|Overall Study|Study drug dosing criteria not met|19
816124|NCT00920686|2594231|P1|Overall Study|Study drug dosing criteria not met|17
816125|NCT00920686|2594229|P3|Overall Study|Lost to Follow-up|1
816126|NCT00920686|2594230|P2|Overall Study|Lost to Follow-up|3
816127|NCT00920686|2594231|P1|Overall Study|Lost to Follow-up|2
816128|NCT00920699|2594254|P3|Overall Study|Lost to Follow-up|2
816129|NCT00920699|2594255|P2|Overall Study|Lost to Follow-up|0
816130|NCT00920699|2594256|P1|Overall Study|Lost to Follow-up|0
816131|NCT00920699|2594254|P3|Overall Study|no longer met eligibility|0
816132|NCT00920699|2594255|P2|Overall Study|no longer met eligibility|1
816133|NCT00920699|2594256|P1|Overall Study|no longer met eligibility|0
816134|NCT00920699|2594254|P3|Overall Study|Withdrawal by Subject|2
816135|NCT00920699|2594255|P2|Overall Study|Withdrawal by Subject|0
816136|NCT00920699|2594256|P1|Overall Study|Withdrawal by Subject|2
816137|NCT00920790|2594270|P1|Overall Study|aggravation of general condition|14
816138|NCT00920816|2594283|P4|Overall Study|Ongoing|36
816139|NCT00920816|2594284|P3|Overall Study|Ongoing|70
816140|NCT00920816|2594285|P2|Overall Study|Ongoing|56
816141|NCT00920816|2594286|P1|Overall Study|Ongoing|106
816142|NCT00920816|2594283|P4|Overall Study|Withdrawal by Subject|1
816143|NCT00920816|2594284|P3|Overall Study|Withdrawal by Subject|1
816144|NCT00920816|2594285|P2|Overall Study|Withdrawal by Subject|2
816145|NCT00920816|2594286|P1|Overall Study|Withdrawal by Subject|7
816146|NCT00920816|2594283|P4|Overall Study|Objective progression or relapse|0
816147|NCT00920816|2594284|P3|Overall Study|Objective progression or relapse|2
816148|NCT00920816|2594285|P2|Overall Study|Objective progression or relapse|0
816149|NCT00920816|2594286|P1|Overall Study|Objective progression or relapse|0
816150|NCT00920816|2594283|P4|Overall Study|Lost to Follow-up|4
816151|NCT00920816|2594284|P3|Overall Study|Lost to Follow-up|3
816152|NCT00920816|2594285|P2|Overall Study|Lost to Follow-up|2
816153|NCT00920816|2594286|P1|Overall Study|Lost to Follow-up|1
816154|NCT00920816|2594283|P4|Overall Study|Adverse Event|0
816155|NCT00920816|2594284|P3|Overall Study|Adverse Event|1
816156|NCT00920816|2594285|P2|Overall Study|Adverse Event|0
816157|NCT00920816|2594286|P1|Overall Study|Adverse Event|1
816158|NCT00920816|2594283|P4|Overall Study|Death|28
816159|NCT00920816|2594284|P3|Overall Study|Death|58
816160|NCT00920816|2594285|P2|Overall Study|Death|36
816161|NCT00920816|2594286|P1|Overall Study|Death|77
816162|NCT00920855|2594327|P3|Overall Study|Response plateau; started maintenance|1
816163|NCT00920855|2594328|P2|Overall Study|Response plateau; started maintenance|0
816164|NCT00920855|2594329|P1|Overall Study|Response plateau; started maintenance|0
816165|NCT00920855|2594327|P3|Overall Study|Noncompliance to study medication|1
816166|NCT00920855|2594328|P2|Overall Study|Noncompliance to study medication|0
816167|NCT00920855|2594329|P1|Overall Study|Noncompliance to study medication|0
816168|NCT00920855|2594327|P3|Overall Study|Disease progression|10
816169|NCT00920855|2594328|P2|Overall Study|Disease progression|1
816170|NCT00920855|2594329|P1|Overall Study|Disease progression|2
816171|NCT00920855|2594327|P3|Overall Study|Withdrawal by Subject|6
816172|NCT00920855|2594328|P2|Overall Study|Withdrawal by Subject|1
816173|NCT00920855|2594329|P1|Overall Study|Withdrawal by Subject|2
816174|NCT00920855|2594327|P3|Overall Study|Adverse Event|4
816175|NCT00920855|2594328|P2|Overall Study|Adverse Event|1
816176|NCT00920855|2594329|P1|Overall Study|Adverse Event|1
816177|NCT00920907|2594353|P2|Maintenance Period|Adverse Event|1
816178|NCT00920907|2594354|P1|Maintenance Period|Adverse Event|0
816179|NCT00920907|2594353|P2|Maintenance Period|Withdrawal by Subject|0
816180|NCT00920907|2594354|P1|Maintenance Period|Withdrawal by Subject|1
816181|NCT00920907|2594353|P2|Maintenance Period|Death|1
816182|NCT00920907|2594354|P1|Maintenance Period|Death|1
816183|NCT00920907|2594353|P2|Maintenance Period|Study Drug Toxicity|2
816184|NCT00920907|2594354|P1|Maintenance Period|Study Drug Toxicity|0
816185|NCT00920907|2594353|P2|Maintenance Period|Administrative (study closure)|2
816186|NCT00920907|2594354|P1|Maintenance Period|Administrative (study closure)|7
816187|NCT00920907|2594353|P2|Maintenance Period|Disease Progression|7
816188|NCT00920907|2594354|P1|Maintenance Period|Disease Progression|3
816189|NCT00920907|2594353|P2|Induction Period|Withdrawal by Subject|1
816190|NCT00920907|2594354|P1|Induction Period|Withdrawal by Subject|1
816191|NCT00920907|2594353|P2|Induction Period|No longer meets study criteria|1
816192|NCT00920907|2594354|P1|Induction Period|No longer meets study criteria|0
816193|NCT00920907|2594353|P2|Induction Period|Study Drug Toxicity|6
816194|NCT00920907|2594354|P1|Induction Period|Study Drug Toxicity|8
816195|NCT00920907|2594353|P2|Induction Period|Disease Progression|11
816196|NCT00920907|2594354|P1|Induction Period|Disease Progression|12
816197|NCT00920907|2594353|P2|Induction Period|Death|1
816198|NCT00920907|2594354|P1|Induction Period|Death|1
816199|NCT00920907|2594353|P2|Induction Period|Adverse Event|2
816200|NCT00920907|2594354|P1|Induction Period|Adverse Event|0
816201|NCT00921024|2594394|P2|Overall Study|Withdrawal by Subject|3
816202|NCT00921024|2594395|P1|Overall Study|Withdrawal by Subject|0
816203|NCT00921024|2594394|P2|Overall Study|Received concomittant therapy|0
816204|NCT00921024|2594395|P1|Overall Study|Received concomittant therapy|2
816205|NCT00921024|2594394|P2|Overall Study|Lost to Follow-up|0
816206|NCT00921024|2594395|P1|Overall Study|Lost to Follow-up|2
816207|NCT00921557|2594448|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
816208|NCT00921557|2594449|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
816209|NCT00921557|2594450|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
816210|NCT00921557|2594448|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
816211|NCT00921557|2594449|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
816212|NCT00921557|2594450|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
816213|NCT00921557|2594448|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
816214|NCT00921557|2594449|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
816215|NCT00921557|2594450|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
816216|NCT00921557|2594448|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
816217|NCT00921557|2594449|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
816218|NCT00921557|2594450|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
816219|NCT00921557|2594448|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
816220|NCT00921557|2594449|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
816221|NCT00921557|2594450|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
816222|NCT00922116|2594541|P1|Overall Study|Unspecified|5
816223|NCT00922116|2594541|P1|Overall Study|Withdrawal by Subject|4
816224|NCT00922116|2594541|P1|Overall Study|Lost to Follow-up|1
816225|NCT00922116|2594541|P1|Overall Study|Death|1
816226|NCT00922116|2594541|P1|Overall Study|Adverse Event|4
816227|NCT00922207|2594563|P3|Overall Study|Abnormality of Laboratory Test|1
816228|NCT00922207|2594564|P2|Overall Study|Abnormality of Laboratory Test|1
816229|NCT00922207|2594565|P1|Overall Study|Abnormality of Laboratory Test|0
816230|NCT00922207|2594563|P3|Overall Study|Withdrew Consent|2
816231|NCT00922207|2594564|P2|Overall Study|Withdrew Consent|5
816232|NCT00922207|2594565|P1|Overall Study|Withdrew Consent|2
816233|NCT00922207|2594563|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
816234|NCT00922207|2594564|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
816235|NCT00922207|2594565|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
816236|NCT00922207|2594563|P3|Overall Study|Violation of Selection Criteria at Entry|0
816237|NCT00922207|2594564|P2|Overall Study|Violation of Selection Criteria at Entry|1
816238|NCT00922207|2594565|P1|Overall Study|Violation of Selection Criteria at Entry|0
816239|NCT00922207|2594563|P3|Overall Study|Insufficient Therapeutic Response|1
816240|NCT00922207|2594564|P2|Overall Study|Insufficient Therapeutic Response|0
816241|NCT00922207|2594565|P1|Overall Study|Insufficient Therapeutic Response|0
816242|NCT00922207|2594563|P3|Overall Study|Adverse Event/Intercurrent Illness|0
816243|NCT00922207|2594564|P2|Overall Study|Adverse Event/Intercurrent Illness|0
816244|NCT00922207|2594565|P1|Overall Study|Adverse Event/Intercurrent Illness|3
816245|NCT00922272|2594597|P2|Double-blind Phase|Positive urine drug screen|1
816246|NCT00922272|2594598|P1|Double-blind Phase|Positive urine drug screen|1
816247|NCT00922272|2594597|P2|Double-blind Phase|Noncompliance|1
816248|NCT00922272|2594598|P1|Double-blind Phase|Noncompliance|1
816249|NCT00922272|2594597|P2|Double-blind Phase|Withdrawal criteria met|1
816250|NCT00922272|2594598|P1|Double-blind Phase|Withdrawal criteria met|1
816251|NCT00922272|2594597|P2|Double-blind Phase|Lost to Follow-up|1
816252|NCT00922272|2594598|P1|Double-blind Phase|Lost to Follow-up|2
816253|NCT00922272|2594597|P2|Double-blind Phase|Withdrawal by Subject|1
816254|NCT00922272|2594598|P1|Double-blind Phase|Withdrawal by Subject|1
816255|NCT00922272|2594597|P2|Double-blind Phase|Adverse Event|1
816256|NCT00922272|2594598|P1|Double-blind Phase|Adverse Event|1
816257|NCT00922272|2594597|P2|Open-label Phase|Withdrawal criteria met|0
816258|NCT00922272|2594598|P1|Open-label Phase|Withdrawal criteria met|5
816259|NCT00922272|2594597|P2|Open-label Phase|Failure to meet randomization criteria|0
816260|NCT00922272|2594598|P1|Open-label Phase|Failure to meet randomization criteria|1
816261|NCT00922272|2594597|P2|Open-label Phase|Withdrawal by Subject|0
816262|NCT00922272|2594598|P1|Open-label Phase|Withdrawal by Subject|11
816263|NCT00922272|2594597|P2|Open-label Phase|Protocol Violation|0
816264|NCT00922272|2594598|P1|Open-label Phase|Protocol Violation|1
816265|NCT00922272|2594597|P2|Open-label Phase|Adverse Event|0
816266|NCT00922272|2594598|P1|Open-label Phase|Adverse Event|5
816267|NCT00922428|2594654|P1|Overall Study|no medication use or questionable use|13
816268|NCT00922428|2594654|P1|Overall Study|retrospective/extremely implausible data|2
816269|NCT00922623|2594683|P1|Overall Study|Lost to Follow-up|1
816270|NCT00922623|2594683|P1|Overall Study|Other|4
816271|NCT00922636|2594694|P5|Overall Study|Lost to Follow-up|4
816272|NCT00922636|2594695|P4|Overall Study|Lost to Follow-up|2
816273|NCT00922636|2594696|P3|Overall Study|Lost to Follow-up|2
816274|NCT00922636|2594697|P2|Overall Study|Lost to Follow-up|2
816275|NCT00922636|2594698|P1|Overall Study|Lost to Follow-up|1
816276|NCT00922636|2594694|P5|Overall Study|Parent/Caregiver Decision|2
816277|NCT00922636|2594695|P4|Overall Study|Parent/Caregiver Decision|5
816278|NCT00922636|2594696|P3|Overall Study|Parent/Caregiver Decision|3
816279|NCT00922636|2594697|P2|Overall Study|Parent/Caregiver Decision|4
816280|NCT00922636|2594698|P1|Overall Study|Parent/Caregiver Decision|2
816281|NCT00922636|2594694|P5|Overall Study|Entry Criteria Not Met|0
816282|NCT00922636|2594695|P4|Overall Study|Entry Criteria Not Met|1
816283|NCT00922636|2594696|P3|Overall Study|Entry Criteria Not Met|1
816284|NCT00922636|2594697|P2|Overall Study|Entry Criteria Not Met|0
816285|NCT00922636|2594698|P1|Overall Study|Entry Criteria Not Met|0
816286|NCT00922636|2594694|P5|Overall Study|Protocol Violation|0
816287|NCT00922636|2594695|P4|Overall Study|Protocol Violation|2
816288|NCT00922636|2594696|P3|Overall Study|Protocol Violation|2
816289|NCT00922636|2594697|P2|Overall Study|Protocol Violation|0
816290|NCT00922636|2594698|P1|Overall Study|Protocol Violation|0
816291|NCT00922636|2594694|P5|Overall Study|Withdrawal by Subject|4
816292|NCT00922636|2594695|P4|Overall Study|Withdrawal by Subject|2
816293|NCT00922636|2594696|P3|Overall Study|Withdrawal by Subject|5
816294|NCT00922636|2594697|P2|Overall Study|Withdrawal by Subject|0
816295|NCT00922636|2594698|P1|Overall Study|Withdrawal by Subject|0
816296|NCT00922636|2594694|P5|Overall Study|Sponsor Decision|0
816297|NCT00922636|2594695|P4|Overall Study|Sponsor Decision|0
816298|NCT00922636|2594696|P3|Overall Study|Sponsor Decision|2
816299|NCT00922636|2594697|P2|Overall Study|Sponsor Decision|0
816300|NCT00922636|2594698|P1|Overall Study|Sponsor Decision|0
816301|NCT00922636|2594694|P5|Overall Study|Lack of Efficacy|4
816302|NCT00922636|2594695|P4|Overall Study|Lack of Efficacy|2
816303|NCT00922636|2594696|P3|Overall Study|Lack of Efficacy|3
816304|NCT00922636|2594697|P2|Overall Study|Lack of Efficacy|7
816305|NCT00922636|2594698|P1|Overall Study|Lack of Efficacy|1
816306|NCT00922636|2594694|P5|Overall Study|Adverse Event|2
816307|NCT00922636|2594695|P4|Overall Study|Adverse Event|3
816308|NCT00922636|2594696|P3|Overall Study|Adverse Event|2
816309|NCT00922636|2594697|P2|Overall Study|Adverse Event|3
816310|NCT00922636|2594698|P1|Overall Study|Adverse Event|3
816311|NCT00922766|2594849|P1|Overall Study|Adverse Event|1
816312|NCT00922766|2594849|P1|Overall Study|Unspecified|1
816313|NCT00922766|2594849|P1|Overall Study|Withdrawal by Subject|2
816314|NCT00922766|2594849|P1|Overall Study|Death|3
816315|NCT00922779|2594858|P1|Overall Study|Missing|1874
816316|NCT00922779|2594858|P1|Overall Study|Unspecified|27
816317|NCT00922779|2594858|P1|Overall Study|Lost to Follow-up|44
816318|NCT00922779|2594858|P1|Overall Study|Withdrawal by Subject|308
816319|NCT00922779|2594858|P1|Overall Study|Pregnancy|7
816320|NCT00922779|2594858|P1|Overall Study|Adverse Event|67
816321|NCT00913380|2594891|P2|Clinical Outcomes|Lost to Follow-up|6
816322|NCT00913380|2594892|P1|Clinical Outcomes|Lost to Follow-up|6
816323|NCT00913458|2594918|P7|Phase 3|Unsatisfactory Response per Investigator|4
816324|NCT00913458|2594919|P6|Phase 3|Unsatisfactory Response per Investigator|11
816325|NCT00913458|2594920|P5|Phase 3|Unsatisfactory Response per Investigator|14
816326|NCT00913458|2594921|P4|Phase 3|Unsatisfactory Response per Investigator|0
816327|NCT00913458|2594922|P3|Phase 3|Unsatisfactory Response per Investigator|0
816328|NCT00913458|2594923|P2|Phase 3|Unsatisfactory Response per Investigator|0
816329|NCT00913458|2594924|P1|Phase 3|Unsatisfactory Response per Investigator|0
816330|NCT00913458|2594918|P7|Phase 3|Withdrawal by Subject|0
816331|NCT00913458|2594919|P6|Phase 3|Withdrawal by Subject|2
816332|NCT00913458|2594920|P5|Phase 3|Withdrawal by Subject|1
816333|NCT00913458|2594921|P4|Phase 3|Withdrawal by Subject|0
816334|NCT00913458|2594922|P3|Phase 3|Withdrawal by Subject|0
816335|NCT00913458|2594923|P2|Phase 3|Withdrawal by Subject|0
816336|NCT00913458|2594924|P1|Phase 3|Withdrawal by Subject|0
816337|NCT00913458|2594918|P7|Phase 3|Non-Responder|3
816338|NCT00913458|2594919|P6|Phase 3|Non-Responder|1
816339|NCT00913458|2594920|P5|Phase 3|Non-Responder|0
816340|NCT00913458|2594921|P4|Phase 3|Non-Responder|0
816341|NCT00913458|2594922|P3|Phase 3|Non-Responder|0
816342|NCT00913458|2594923|P2|Phase 3|Non-Responder|0
816343|NCT00913458|2594924|P1|Phase 3|Non-Responder|0
816344|NCT00913458|2594918|P7|Phase 3|Lost to Follow-up|0
816345|NCT00913458|2594919|P6|Phase 3|Lost to Follow-up|0
816346|NCT00913458|2594920|P5|Phase 3|Lost to Follow-up|2
816347|NCT00913458|2594921|P4|Phase 3|Lost to Follow-up|0
816348|NCT00913458|2594922|P3|Phase 3|Lost to Follow-up|0
816349|NCT00913458|2594923|P2|Phase 3|Lost to Follow-up|0
816350|NCT00913458|2594924|P1|Phase 3|Lost to Follow-up|0
816351|NCT00913458|2594918|P7|Phase 3|Adverse Event|1
816352|NCT00913458|2594919|P6|Phase 3|Adverse Event|4
816353|NCT00913458|2594920|P5|Phase 3|Adverse Event|5
816354|NCT00913458|2594921|P4|Phase 3|Adverse Event|0
816355|NCT00913458|2594922|P3|Phase 3|Adverse Event|0
816356|NCT00913458|2594923|P2|Phase 3|Adverse Event|0
816357|NCT00913458|2594924|P1|Phase 3|Adverse Event|0
816358|NCT00913458|2594918|P7|Phase 2|Unsatisfactory Response per Investigator|0
816359|NCT00913458|2594919|P6|Phase 2|Unsatisfactory Response per Investigator|0
816360|NCT00913458|2594920|P5|Phase 2|Unsatisfactory Response per Investigator|0
816361|NCT00913458|2594921|P4|Phase 2|Unsatisfactory Response per Investigator|17
816362|NCT00913458|2594922|P3|Phase 2|Unsatisfactory Response per Investigator|11
816363|NCT00913458|2594923|P2|Phase 2|Unsatisfactory Response per Investigator|0
816364|NCT00913458|2594924|P1|Phase 2|Unsatisfactory Response per Investigator|0
816365|NCT00913458|2594918|P7|Phase 2|Protocol Violation|0
816366|NCT00913458|2594919|P6|Phase 2|Protocol Violation|0
816367|NCT00913458|2594920|P5|Phase 2|Protocol Violation|0
816368|NCT00913458|2594921|P4|Phase 2|Protocol Violation|0
816369|NCT00913458|2594922|P3|Phase 2|Protocol Violation|0
816370|NCT00913458|2594923|P2|Phase 2|Protocol Violation|2
816371|NCT00913458|2594924|P1|Phase 2|Protocol Violation|0
816372|NCT00913458|2594918|P7|Phase 2|Lost to Follow-up|0
816373|NCT00913458|2594919|P6|Phase 2|Lost to Follow-up|0
816374|NCT00913458|2594920|P5|Phase 2|Lost to Follow-up|0
816375|NCT00913458|2594921|P4|Phase 2|Lost to Follow-up|1
816376|NCT00913458|2594922|P3|Phase 2|Lost to Follow-up|0
816377|NCT00913458|2594923|P2|Phase 2|Lost to Follow-up|0
816378|NCT00913458|2594924|P1|Phase 2|Lost to Follow-up|0
816379|NCT00913458|2594918|P7|Phase 2|Adverse Event|0
816380|NCT00913458|2594919|P6|Phase 2|Adverse Event|0
816381|NCT00913458|2594920|P5|Phase 2|Adverse Event|0
816382|NCT00913458|2594921|P4|Phase 2|Adverse Event|1
816383|NCT00913458|2594922|P3|Phase 2|Adverse Event|0
816384|NCT00913458|2594923|P2|Phase 2|Adverse Event|3
816385|NCT00913458|2594924|P1|Phase 2|Adverse Event|0
816386|NCT00913458|2594918|P7|Phase 2|Subject Request|0
816387|NCT00913458|2594919|P6|Phase 2|Subject Request|0
816388|NCT00913458|2594920|P5|Phase 2|Subject Request|0
816389|NCT00913458|2594921|P4|Phase 2|Subject Request|2
816390|NCT00913458|2594922|P3|Phase 2|Subject Request|1
816391|NCT00913458|2594923|P2|Phase 2|Subject Request|0
816392|NCT00913458|2594924|P1|Phase 2|Subject Request|0
816393|NCT00913458|2594918|P7|Phase 2|Non-Responder|0
816394|NCT00913458|2594919|P6|Phase 2|Non-Responder|0
816395|NCT00913458|2594920|P5|Phase 2|Non-Responder|0
816396|NCT00913458|2594921|P4|Phase 2|Non-Responder|12
816397|NCT00913458|2594922|P3|Phase 2|Non-Responder|7
816398|NCT00913458|2594923|P2|Phase 2|Non-Responder|5
816399|NCT00913458|2594924|P1|Phase 2|Non-Responder|0
816400|NCT00913458|2594918|P7|Phase 1|Unsatisfactory Response per Investigator|0
816401|NCT00913458|2594919|P6|Phase 1|Unsatisfactory Response per Investigator|0
816402|NCT00913458|2594920|P5|Phase 1|Unsatisfactory Response per Investigator|0
816403|NCT00913458|2594921|P4|Phase 1|Unsatisfactory Response per Investigator|0
816404|NCT00913458|2594922|P3|Phase 1|Unsatisfactory Response per Investigator|0
816405|NCT00913458|2594923|P2|Phase 1|Unsatisfactory Response per Investigator|0
816406|NCT00913458|2594924|P1|Phase 1|Unsatisfactory Response per Investigator|7
816407|NCT00913458|2594918|P7|Phase 1|Sponsor|0
816408|NCT00913458|2594919|P6|Phase 1|Sponsor|0
816409|NCT00913458|2594920|P5|Phase 1|Sponsor|0
816410|NCT00913458|2594921|P4|Phase 1|Sponsor|0
816411|NCT00913458|2594922|P3|Phase 1|Sponsor|0
816412|NCT00913458|2594923|P2|Phase 1|Sponsor|0
816413|NCT00913458|2594924|P1|Phase 1|Sponsor|2
816414|NCT00913458|2594918|P7|Phase 1|Protocol Violation|0
816415|NCT00913458|2594919|P6|Phase 1|Protocol Violation|0
816416|NCT00913458|2594920|P5|Phase 1|Protocol Violation|0
816417|NCT00913458|2594921|P4|Phase 1|Protocol Violation|0
816418|NCT00913458|2594922|P3|Phase 1|Protocol Violation|0
816419|NCT00913458|2594923|P2|Phase 1|Protocol Violation|0
816420|NCT00913458|2594924|P1|Phase 1|Protocol Violation|10
816421|NCT00913458|2594918|P7|Phase 1|Lost to Follow-up|0
816422|NCT00913458|2594919|P6|Phase 1|Lost to Follow-up|0
816423|NCT00913458|2594920|P5|Phase 1|Lost to Follow-up|0
816424|NCT00913458|2594921|P4|Phase 1|Lost to Follow-up|0
816425|NCT00913458|2594922|P3|Phase 1|Lost to Follow-up|0
816426|NCT00913458|2594923|P2|Phase 1|Lost to Follow-up|0
816427|NCT00913458|2594924|P1|Phase 1|Lost to Follow-up|2
816428|NCT00913458|2594918|P7|Phase 1|Adverse Event|0
816429|NCT00913458|2594919|P6|Phase 1|Adverse Event|0
816430|NCT00913458|2594920|P5|Phase 1|Adverse Event|0
816431|NCT00913458|2594921|P4|Phase 1|Adverse Event|0
816432|NCT00913458|2594922|P3|Phase 1|Adverse Event|0
816433|NCT00913458|2594923|P2|Phase 1|Adverse Event|0
816434|NCT00913458|2594924|P1|Phase 1|Adverse Event|20
816435|NCT00913458|2594918|P7|Phase 1|Subject Request|0
816436|NCT00913458|2594919|P6|Phase 1|Subject Request|0
816437|NCT00913458|2594920|P5|Phase 1|Subject Request|0
816438|NCT00913458|2594921|P4|Phase 1|Subject Request|0
816439|NCT00913458|2594922|P3|Phase 1|Subject Request|0
816440|NCT00913458|2594923|P2|Phase 1|Subject Request|0
816441|NCT00913458|2594924|P1|Phase 1|Subject Request|17
816442|NCT00913458|2594918|P7|Phase 1|Non-Responder|0
816443|NCT00913458|2594919|P6|Phase 1|Non-Responder|0
816444|NCT00913458|2594920|P5|Phase 1|Non-Responder|0
816445|NCT00913458|2594921|P4|Phase 1|Non-Responder|0
816446|NCT00913458|2594922|P3|Phase 1|Non-Responder|0
816447|NCT00913458|2594923|P2|Phase 1|Non-Responder|0
816448|NCT00913458|2594924|P1|Phase 1|Non-Responder|54
816449|NCT00913523|2595027|P3|Overall Study|Inadequate Number of Tampons Used|3
816450|NCT00913523|2595028|P2|Overall Study|Inadequate Number of Tampons Used|2
816451|NCT00913523|2595029|P1|Overall Study|Inadequate Number of Tampons Used|7
816452|NCT00913523|2595027|P3|Overall Study|Pregnancy|0
816453|NCT00913523|2595028|P2|Overall Study|Pregnancy|3
816454|NCT00913523|2595029|P1|Overall Study|Pregnancy|1
816455|NCT00913523|2595027|P3|Overall Study|Protocol Violation|8
816456|NCT00913523|2595028|P2|Overall Study|Protocol Violation|8
816457|NCT00913523|2595029|P1|Overall Study|Protocol Violation|5
816458|NCT00913523|2595027|P3|Overall Study|Adverse Event|0
816459|NCT00913523|2595028|P2|Overall Study|Adverse Event|0
816460|NCT00913523|2595029|P1|Overall Study|Adverse Event|1
816461|NCT00913523|2595027|P3|Overall Study|Lost to Follow-up|1
816462|NCT00913523|2595028|P2|Overall Study|Lost to Follow-up|1
816463|NCT00913523|2595029|P1|Overall Study|Lost to Follow-up|1
816464|NCT00913523|2595027|P3|Overall Study|Withdrawal by Subject|2
816465|NCT00913523|2595028|P2|Overall Study|Withdrawal by Subject|2
816466|NCT00913523|2595029|P1|Overall Study|Withdrawal by Subject|3
816467|NCT00913692|2595052|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
816468|NCT00913692|2595052|P1|Screening (4 Months)|Not eligible after screening phase.|6
816469|NCT00913692|2595052|P1|Screening (4 Months)|Physician Decision|3
816470|NCT00913744|2595064|P2|Overall Study|Death|0
816471|NCT00913744|2595065|P1|Overall Study|Death|1
816472|NCT00913744|2595064|P2|Overall Study|Withdrawal by Subject|1
816473|NCT00913744|2595065|P1|Overall Study|Withdrawal by Subject|2
816474|NCT00913744|2595064|P2|Overall Study|Adverse Event|0
816475|NCT00913744|2595065|P1|Overall Study|Adverse Event|2
816476|NCT00913770|2595074|P3|Overall Study|Refused|8
816477|NCT00913770|2595075|P2|Overall Study|Refused|10
816478|NCT00913770|2595076|P1|Overall Study|Refused|11
816479|NCT00913770|2595074|P3|Overall Study|Unable to contact|13
816480|NCT00913770|2595075|P2|Overall Study|Unable to contact|19
816481|NCT00913770|2595076|P1|Overall Study|Unable to contact|24
816482|NCT00913835|2595089|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
816483|NCT00913835|2595090|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
816484|NCT00913835|2595089|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
816485|NCT00913835|2595090|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
816486|NCT00913835|2595089|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
816487|NCT00913835|2595090|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
816488|NCT00913835|2595089|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
816489|NCT00913835|2595090|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
816490|NCT00913835|2595089|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
816491|NCT00913835|2595090|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
816492|NCT00914316|2595193|P4|Phase 2|Withdrawal by Subject|0
816493|NCT00914316|2595194|P3|Phase 2|Withdrawal by Subject|1
816494|NCT00914316|2595195|P2|Phase 2|Withdrawal by Subject|0
816495|NCT00914316|2595196|P1|Phase 2|Withdrawal by Subject|1
816496|NCT00914316|2595193|P4|Phase 1|Adverse Event|0
816497|NCT00914316|2595194|P3|Phase 1|Adverse Event|0
816498|NCT00914316|2595195|P2|Phase 1|Adverse Event|0
816499|NCT00914316|2595196|P1|Phase 1|Adverse Event|1
816500|NCT00914316|2595193|P4|Phase 1|Withdrawal by Subject|0
816501|NCT00914316|2595194|P3|Phase 1|Withdrawal by Subject|4
816502|NCT00914316|2595195|P2|Phase 1|Withdrawal by Subject|2
816503|NCT00914316|2595196|P1|Phase 1|Withdrawal by Subject|0
816504|NCT00914316|2595193|P4|Phase 1|Physician Decision|2
816505|NCT00914316|2595194|P3|Phase 1|Physician Decision|1
816506|NCT00914316|2595195|P2|Phase 1|Physician Decision|0
816507|NCT00914316|2595196|P1|Phase 1|Physician Decision|4
816508|NCT00914459|2595212|P2|Overall Study|Parent/Legal guardian request|0
816509|NCT00914459|2595213|P1|Overall Study|Parent/Legal guardian request|1
816510|NCT00914459|2595212|P2|Overall Study|Protocol Violation|1
816511|NCT00914459|2595213|P1|Overall Study|Protocol Violation|0
816512|NCT00914589|2595246|P3|Overall Study|Death|1
816513|NCT00914589|2595247|P2|Overall Study|Death|1
816514|NCT00914589|2595248|P1|Overall Study|Death|0
816515|NCT00914589|2595246|P3|Overall Study|unclassified|7
816516|NCT00914589|2595247|P2|Overall Study|unclassified|9
816517|NCT00914589|2595248|P1|Overall Study|unclassified|16
816518|NCT00914589|2595246|P3|Overall Study|Protocol Violation|3
816519|NCT00914589|2595247|P2|Overall Study|Protocol Violation|6
816520|NCT00914589|2595248|P1|Overall Study|Protocol Violation|8
816521|NCT00914589|2595246|P3|Overall Study|Adverse Event|1
816522|NCT00914589|2595247|P2|Overall Study|Adverse Event|0
816523|NCT00914589|2595248|P1|Overall Study|Adverse Event|1
816524|NCT00914810|2595270|P2|Overall Study|Hospitalized and unable to follow up.|1
816525|NCT00914810|2595271|P1|Overall Study|Hospitalized and unable to follow up.|0
816526|NCT00914810|2595270|P2|Overall Study|Relocated out of state|0
816527|NCT00914810|2595271|P1|Overall Study|Relocated out of state|1
816528|NCT00914810|2595270|P2|Overall Study|Withdrawal by Subject|0
816529|NCT00914810|2595271|P1|Overall Study|Withdrawal by Subject|1
816530|NCT00914849|2595281|P2|Overall Study|Not eligible|1
816531|NCT00914849|2595282|P1|Overall Study|Not eligible|0
816532|NCT00914849|2595281|P2|Overall Study|Withdrawal by Subject|0
816533|NCT00914849|2595282|P1|Overall Study|Withdrawal by Subject|1
816534|NCT00914966|2595395|P1|Step 2: 2000 Units|Withdrawal by Subject|1
816535|NCT00914966|2595395|P1|Step 1: 1500 Units|Physician Decision|1
816536|NCT00914966|2595395|P1|Step 1: 1500 Units|Withdrawal by Subject|1
816537|NCT00922935|2595410|P3|Overall Study|Lost to Follow-up|0
816538|NCT00922935|2595411|P2|Overall Study|Lost to Follow-up|1
816539|NCT00922935|2595412|P1|Overall Study|Lost to Follow-up|0
816540|NCT00922935|2595410|P3|Overall Study|Physician Decision|0
816541|NCT00922935|2595411|P2|Overall Study|Physician Decision|1
816542|NCT00922935|2595412|P1|Overall Study|Physician Decision|1
816543|NCT00922935|2595410|P3|Overall Study|Protocol Violation|0
816544|NCT00922935|2595411|P2|Overall Study|Protocol Violation|3
816545|NCT00922935|2595412|P1|Overall Study|Protocol Violation|0
816546|NCT00922987|2595420|P1|Overall Study|Adverse Event|1
816547|NCT00922987|2595420|P1|Overall Study|Protocol Violation|2
816548|NCT00922987|2595420|P1|Overall Study|Insufficient clinical response|1
816549|NCT00923091|2595440|P13|Period VI (Open-Label)|Other Reason|0
816550|NCT00923091|2595441|P12|Period VI (Open-Label)|Other Reason|0
816551|NCT00923091|2595442|P11|Period VI (Open-Label)|Other Reason|0
816552|NCT00923091|2595443|P10|Period VI (Open-Label)|Other Reason|0
816553|NCT00923091|2595444|P9|Period VI (Open-Label)|Other Reason|0
816554|NCT00923091|2595445|P8|Period VI (Open-Label)|Other Reason|0
816555|NCT00923091|2595446|P7|Period VI (Open-Label)|Other Reason|0
816556|NCT00923091|2595447|P6|Period VI (Open-Label)|Other Reason|0
816557|NCT00923091|2595448|P5|Period VI (Open-Label)|Other Reason|1
816558|NCT00923091|2595449|P4|Period VI (Open-Label)|Other Reason|1
816559|NCT00923091|2595450|P3|Period VI (Open-Label)|Other Reason|0
816560|NCT00923091|2595451|P2|Period VI (Open-Label)|Other Reason|0
816561|NCT00923091|2595452|P1|Period VI (Open-Label)|Other Reason|0
816562|NCT00923091|2595440|P13|Period VI (Open-Label)|Lost to Follow-up|0
816563|NCT00923091|2595441|P12|Period VI (Open-Label)|Lost to Follow-up|0
816564|NCT00923091|2595442|P11|Period VI (Open-Label)|Lost to Follow-up|0
816565|NCT00923091|2595443|P10|Period VI (Open-Label)|Lost to Follow-up|0
816566|NCT00923091|2595444|P9|Period VI (Open-Label)|Lost to Follow-up|0
816567|NCT00923091|2595445|P8|Period VI (Open-Label)|Lost to Follow-up|0
816568|NCT00923091|2595446|P7|Period VI (Open-Label)|Lost to Follow-up|0
816569|NCT00923091|2595447|P6|Period VI (Open-Label)|Lost to Follow-up|0
816570|NCT00923091|2595448|P5|Period VI (Open-Label)|Lost to Follow-up|0
816571|NCT00923091|2595449|P4|Period VI (Open-Label)|Lost to Follow-up|0
816572|NCT00923091|2595450|P3|Period VI (Open-Label)|Lost to Follow-up|1
816573|NCT00923091|2595451|P2|Period VI (Open-Label)|Lost to Follow-up|0
816574|NCT00923091|2595452|P1|Period VI (Open-Label)|Lost to Follow-up|1
816575|NCT00923091|2595440|P13|Period VI (Open-Label)|Protocol Violation|0
816576|NCT00923091|2595441|P12|Period VI (Open-Label)|Protocol Violation|0
816577|NCT00923091|2595442|P11|Period VI (Open-Label)|Protocol Violation|0
816578|NCT00923091|2595443|P10|Period VI (Open-Label)|Protocol Violation|0
816579|NCT00923091|2595444|P9|Period VI (Open-Label)|Protocol Violation|0
816580|NCT00923091|2595445|P8|Period VI (Open-Label)|Protocol Violation|0
816581|NCT00923091|2595446|P7|Period VI (Open-Label)|Protocol Violation|0
816582|NCT00923091|2595447|P6|Period VI (Open-Label)|Protocol Violation|0
816583|NCT00923091|2595448|P5|Period VI (Open-Label)|Protocol Violation|4
816584|NCT00923091|2595449|P4|Period VI (Open-Label)|Protocol Violation|1
816585|NCT00923091|2595450|P3|Period VI (Open-Label)|Protocol Violation|3
816586|NCT00923091|2595451|P2|Period VI (Open-Label)|Protocol Violation|1
816587|NCT00923091|2595452|P1|Period VI (Open-Label)|Protocol Violation|6
816588|NCT00923091|2595440|P13|Period VI (Open-Label)|Withdrawal by Subject|0
816589|NCT00923091|2595441|P12|Period VI (Open-Label)|Withdrawal by Subject|0
816590|NCT00923091|2595442|P11|Period VI (Open-Label)|Withdrawal by Subject|0
816591|NCT00923091|2595443|P10|Period VI (Open-Label)|Withdrawal by Subject|0
816592|NCT00923091|2595444|P9|Period VI (Open-Label)|Withdrawal by Subject|0
816593|NCT00923091|2595445|P8|Period VI (Open-Label)|Withdrawal by Subject|0
816594|NCT00923091|2595446|P7|Period VI (Open-Label)|Withdrawal by Subject|0
816595|NCT00923091|2595447|P6|Period VI (Open-Label)|Withdrawal by Subject|0
816596|NCT00923091|2595448|P5|Period VI (Open-Label)|Withdrawal by Subject|1
816597|NCT00923091|2595449|P4|Period VI (Open-Label)|Withdrawal by Subject|0
816598|NCT00923091|2595450|P3|Period VI (Open-Label)|Withdrawal by Subject|5
816599|NCT00923091|2595451|P2|Period VI (Open-Label)|Withdrawal by Subject|7
816600|NCT00923091|2595452|P1|Period VI (Open-Label)|Withdrawal by Subject|15
816601|NCT00923091|2595440|P13|Period VI (Open-Label)|Adverse Event|0
816602|NCT00923091|2595441|P12|Period VI (Open-Label)|Adverse Event|0
816603|NCT00923091|2595442|P11|Period VI (Open-Label)|Adverse Event|0
816604|NCT00923091|2595443|P10|Period VI (Open-Label)|Adverse Event|0
816605|NCT00923091|2595444|P9|Period VI (Open-Label)|Adverse Event|0
816606|NCT00923091|2595445|P8|Period VI (Open-Label)|Adverse Event|0
816607|NCT00923091|2595446|P7|Period VI (Open-Label)|Adverse Event|0
816608|NCT00923091|2595447|P6|Period VI (Open-Label)|Adverse Event|0
816609|NCT00923091|2595448|P5|Period VI (Open-Label)|Adverse Event|1
816610|NCT00923091|2595449|P4|Period VI (Open-Label)|Adverse Event|1
816611|NCT00923091|2595450|P3|Period VI (Open-Label)|Adverse Event|4
816612|NCT00923091|2595451|P2|Period VI (Open-Label)|Adverse Event|0
816613|NCT00923091|2595452|P1|Period VI (Open-Label)|Adverse Event|17
816614|NCT00923091|2595440|P13|Period V (Double -Blind)|Lost to Follow-up|0
816615|NCT00923091|2595441|P12|Period V (Double -Blind)|Lost to Follow-up|0
816616|NCT00923091|2595442|P11|Period V (Double -Blind)|Lost to Follow-up|1
816617|NCT00923091|2595443|P10|Period V (Double -Blind)|Lost to Follow-up|0
816618|NCT00923091|2595444|P9|Period V (Double -Blind)|Lost to Follow-up|0
816619|NCT00923091|2595445|P8|Period V (Double -Blind)|Lost to Follow-up|0
816620|NCT00923091|2595446|P7|Period V (Double -Blind)|Lost to Follow-up|0
816621|NCT00923091|2595447|P6|Period V (Double -Blind)|Lost to Follow-up|0
816622|NCT00923091|2595448|P5|Period V (Double -Blind)|Lost to Follow-up|0
816623|NCT00923091|2595449|P4|Period V (Double -Blind)|Lost to Follow-up|0
816624|NCT00923091|2595450|P3|Period V (Double -Blind)|Lost to Follow-up|0
816625|NCT00923091|2595451|P2|Period V (Double -Blind)|Lost to Follow-up|0
816626|NCT00923091|2595452|P1|Period V (Double -Blind)|Lost to Follow-up|0
816627|NCT00923091|2595440|P13|Period V (Double -Blind)|Protocol Violation|1
816628|NCT00923091|2595441|P12|Period V (Double -Blind)|Protocol Violation|0
816629|NCT00923091|2595442|P11|Period V (Double -Blind)|Protocol Violation|0
816630|NCT00923091|2595443|P10|Period V (Double -Blind)|Protocol Violation|0
816631|NCT00923091|2595444|P9|Period V (Double -Blind)|Protocol Violation|0
816632|NCT00923091|2595445|P8|Period V (Double -Blind)|Protocol Violation|0
816633|NCT00923091|2595446|P7|Period V (Double -Blind)|Protocol Violation|0
816634|NCT00923091|2595447|P6|Period V (Double -Blind)|Protocol Violation|0
816635|NCT00923091|2595448|P5|Period V (Double -Blind)|Protocol Violation|0
816636|NCT00923091|2595449|P4|Period V (Double -Blind)|Protocol Violation|0
816637|NCT00923091|2595450|P3|Period V (Double -Blind)|Protocol Violation|0
816638|NCT00923091|2595451|P2|Period V (Double -Blind)|Protocol Violation|0
816639|NCT00923091|2595452|P1|Period V (Double -Blind)|Protocol Violation|0
816640|NCT00923091|2595440|P13|Period V (Double -Blind)|Withdrawal by Subject|1
816641|NCT00923091|2595441|P12|Period V (Double -Blind)|Withdrawal by Subject|0
816642|NCT00923091|2595442|P11|Period V (Double -Blind)|Withdrawal by Subject|0
816643|NCT00923091|2595443|P10|Period V (Double -Blind)|Withdrawal by Subject|0
816644|NCT00923091|2595444|P9|Period V (Double -Blind)|Withdrawal by Subject|1
816645|NCT00923091|2595445|P8|Period V (Double -Blind)|Withdrawal by Subject|0
816646|NCT00923091|2595446|P7|Period V (Double -Blind)|Withdrawal by Subject|0
816647|NCT00923091|2595447|P6|Period V (Double -Blind)|Withdrawal by Subject|0
816648|NCT00923091|2595448|P5|Period V (Double -Blind)|Withdrawal by Subject|0
816649|NCT00923091|2595449|P4|Period V (Double -Blind)|Withdrawal by Subject|0
816650|NCT00923091|2595450|P3|Period V (Double -Blind)|Withdrawal by Subject|0
816651|NCT00923091|2595451|P2|Period V (Double -Blind)|Withdrawal by Subject|0
816652|NCT00923091|2595452|P1|Period V (Double -Blind)|Withdrawal by Subject|0
816653|NCT00923091|2595440|P13|Period IV (Double-Blind)|Protocol Violation|0
816654|NCT00923091|2595441|P12|Period IV (Double-Blind)|Protocol Violation|0
816655|NCT00923091|2595442|P11|Period IV (Double-Blind)|Protocol Violation|0
816656|NCT00923091|2595443|P10|Period IV (Double-Blind)|Protocol Violation|0
816657|NCT00923091|2595444|P9|Period IV (Double-Blind)|Protocol Violation|0
816658|NCT00923091|2595445|P8|Period IV (Double-Blind)|Protocol Violation|0
816659|NCT00923091|2595446|P7|Period IV (Double-Blind)|Protocol Violation|0
816660|NCT00923091|2595447|P6|Period IV (Double-Blind)|Protocol Violation|0
816661|NCT00923091|2595448|P5|Period IV (Double-Blind)|Protocol Violation|0
816662|NCT00923091|2595449|P4|Period IV (Double-Blind)|Protocol Violation|0
816663|NCT00923091|2595450|P3|Period IV (Double-Blind)|Protocol Violation|0
816664|NCT00923091|2595451|P2|Period IV (Double-Blind)|Protocol Violation|1
816665|NCT00923091|2595452|P1|Period IV (Double-Blind)|Protocol Violation|0
816666|NCT00923091|2595440|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
816667|NCT00923091|2595441|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
816668|NCT00923091|2595442|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
816669|NCT00923091|2595443|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
816670|NCT00923091|2595444|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
816671|NCT00923091|2595445|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
816672|NCT00923091|2595446|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
816673|NCT00923091|2595447|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
816674|NCT00923091|2595448|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
816675|NCT00923091|2595449|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
816676|NCT00923091|2595450|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
816677|NCT00923091|2595451|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
816678|NCT00923091|2595452|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
816679|NCT00923091|2595440|P13|Period IV (Double-Blind)|Adverse Event|0
816680|NCT00923091|2595441|P12|Period IV (Double-Blind)|Adverse Event|0
816681|NCT00923091|2595442|P11|Period IV (Double-Blind)|Adverse Event|0
816682|NCT00923091|2595443|P10|Period IV (Double-Blind)|Adverse Event|0
816683|NCT00923091|2595444|P9|Period IV (Double-Blind)|Adverse Event|0
816684|NCT00923091|2595445|P8|Period IV (Double-Blind)|Adverse Event|0
816685|NCT00923091|2595446|P7|Period IV (Double-Blind)|Adverse Event|0
816686|NCT00923091|2595447|P6|Period IV (Double-Blind)|Adverse Event|0
816687|NCT00923091|2595448|P5|Period IV (Double-Blind)|Adverse Event|0
816688|NCT00923091|2595449|P4|Period IV (Double-Blind)|Adverse Event|0
816689|NCT00923091|2595450|P3|Period IV (Double-Blind)|Adverse Event|0
816690|NCT00923091|2595451|P2|Period IV (Double-Blind)|Adverse Event|0
816691|NCT00923091|2595452|P1|Period IV (Double-Blind)|Adverse Event|2
816692|NCT00923091|2595440|P13|Period III (Single-Blind)|Lost to Follow-up|0
816693|NCT00923091|2595441|P12|Period III (Single-Blind)|Lost to Follow-up|0
816694|NCT00923091|2595442|P11|Period III (Single-Blind)|Lost to Follow-up|0
816695|NCT00923091|2595443|P10|Period III (Single-Blind)|Lost to Follow-up|0
816696|NCT00923091|2595444|P9|Period III (Single-Blind)|Lost to Follow-up|0
816697|NCT00923091|2595445|P8|Period III (Single-Blind)|Lost to Follow-up|0
816698|NCT00923091|2595446|P7|Period III (Single-Blind)|Lost to Follow-up|0
816699|NCT00923091|2595447|P6|Period III (Single-Blind)|Lost to Follow-up|0
816700|NCT00923091|2595448|P5|Period III (Single-Blind)|Lost to Follow-up|0
816701|NCT00923091|2595449|P4|Period III (Single-Blind)|Lost to Follow-up|0
816702|NCT00923091|2595450|P3|Period III (Single-Blind)|Lost to Follow-up|0
816703|NCT00923091|2595451|P2|Period III (Single-Blind)|Lost to Follow-up|0
816704|NCT00923091|2595452|P1|Period III (Single-Blind)|Lost to Follow-up|2
816705|NCT00923091|2595440|P13|Period III (Single-Blind)|Protocol Violation|0
816706|NCT00923091|2595441|P12|Period III (Single-Blind)|Protocol Violation|0
816707|NCT00923091|2595442|P11|Period III (Single-Blind)|Protocol Violation|0
816708|NCT00923091|2595443|P10|Period III (Single-Blind)|Protocol Violation|0
816709|NCT00923091|2595444|P9|Period III (Single-Blind)|Protocol Violation|0
816710|NCT00923091|2595445|P8|Period III (Single-Blind)|Protocol Violation|0
816711|NCT00923091|2595446|P7|Period III (Single-Blind)|Protocol Violation|0
816712|NCT00923091|2595447|P6|Period III (Single-Blind)|Protocol Violation|0
816713|NCT00923091|2595448|P5|Period III (Single-Blind)|Protocol Violation|0
816714|NCT00923091|2595449|P4|Period III (Single-Blind)|Protocol Violation|0
816715|NCT00923091|2595450|P3|Period III (Single-Blind)|Protocol Violation|0
816716|NCT00923091|2595451|P2|Period III (Single-Blind)|Protocol Violation|0
816717|NCT00923091|2595452|P1|Period III (Single-Blind)|Protocol Violation|3
816718|NCT00923091|2595440|P13|Period III (Single-Blind)|Withdrawal by Subject|0
816719|NCT00923091|2595441|P12|Period III (Single-Blind)|Withdrawal by Subject|0
816720|NCT00923091|2595442|P11|Period III (Single-Blind)|Withdrawal by Subject|0
816721|NCT00923091|2595443|P10|Period III (Single-Blind)|Withdrawal by Subject|0
816722|NCT00923091|2595444|P9|Period III (Single-Blind)|Withdrawal by Subject|0
816723|NCT00923091|2595445|P8|Period III (Single-Blind)|Withdrawal by Subject|0
816724|NCT00923091|2595446|P7|Period III (Single-Blind)|Withdrawal by Subject|0
816725|NCT00923091|2595447|P6|Period III (Single-Blind)|Withdrawal by Subject|0
816726|NCT00923091|2595448|P5|Period III (Single-Blind)|Withdrawal by Subject|0
816727|NCT00923091|2595449|P4|Period III (Single-Blind)|Withdrawal by Subject|0
816728|NCT00923091|2595450|P3|Period III (Single-Blind)|Withdrawal by Subject|0
816729|NCT00923091|2595451|P2|Period III (Single-Blind)|Withdrawal by Subject|0
816730|NCT00923091|2595452|P1|Period III (Single-Blind)|Withdrawal by Subject|10
816731|NCT00923091|2595440|P13|Period III (Single-Blind)|Adverse Event|0
816732|NCT00923091|2595441|P12|Period III (Single-Blind)|Adverse Event|0
816733|NCT00923091|2595442|P11|Period III (Single-Blind)|Adverse Event|0
816734|NCT00923091|2595443|P10|Period III (Single-Blind)|Adverse Event|0
816735|NCT00923091|2595444|P9|Period III (Single-Blind)|Adverse Event|0
816736|NCT00923091|2595445|P8|Period III (Single-Blind)|Adverse Event|0
816737|NCT00923091|2595446|P7|Period III (Single-Blind)|Adverse Event|0
816738|NCT00923091|2595447|P6|Period III (Single-Blind)|Adverse Event|0
816739|NCT00923091|2595448|P5|Period III (Single-Blind)|Adverse Event|0
816740|NCT00923091|2595449|P4|Period III (Single-Blind)|Adverse Event|0
816741|NCT00923091|2595450|P3|Period III (Single-Blind)|Adverse Event|0
816742|NCT00923091|2595451|P2|Period III (Single-Blind)|Adverse Event|0
816743|NCT00923091|2595452|P1|Period III (Single-Blind)|Adverse Event|5
816744|NCT00923091|2595440|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816745|NCT00923091|2595441|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816746|NCT00923091|2595442|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816747|NCT00923091|2595443|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816748|NCT00923091|2595444|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816749|NCT00923091|2595445|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816750|NCT00923091|2595446|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816751|NCT00923091|2595447|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
816752|NCT00923091|2595448|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816753|NCT00923091|2595449|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
816754|NCT00923091|2595450|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816755|NCT00923091|2595451|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
816756|NCT00923091|2595452|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
816757|NCT00923091|2595440|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816758|NCT00923091|2595441|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816759|NCT00923091|2595442|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816760|NCT00923091|2595443|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816761|NCT00923091|2595444|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816762|NCT00923091|2595445|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816763|NCT00923091|2595446|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816764|NCT00923091|2595447|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
816765|NCT00923091|2595448|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816766|NCT00923091|2595449|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816767|NCT00923091|2595450|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816768|NCT00923091|2595451|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816769|NCT00923091|2595452|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
816770|NCT00923091|2595440|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
816771|NCT00923091|2595441|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
816772|NCT00923091|2595442|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
816773|NCT00923091|2595443|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
816774|NCT00923091|2595444|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
816775|NCT00923091|2595445|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
816776|NCT00923091|2595446|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
816777|NCT00923091|2595447|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
816778|NCT00923091|2595448|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
816779|NCT00923091|2595449|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
816780|NCT00923091|2595450|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
816781|NCT00923091|2595451|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
816782|NCT00923091|2595452|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
816783|NCT00923091|2595440|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
816784|NCT00923091|2595441|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
816785|NCT00923091|2595442|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
816786|NCT00923091|2595443|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
816787|NCT00923091|2595444|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
816788|NCT00923091|2595445|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
816789|NCT00923091|2595446|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
816790|NCT00923091|2595447|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
816791|NCT00923091|2595448|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
816792|NCT00923091|2595449|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
816793|NCT00923091|2595450|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
816794|NCT00923091|2595451|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
816795|NCT00923091|2595452|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
816796|NCT00923091|2595440|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
816797|NCT00923091|2595441|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
816798|NCT00923091|2595442|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
816799|NCT00923091|2595443|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
816800|NCT00923091|2595444|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
816801|NCT00923091|2595445|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
816802|NCT00923091|2595446|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
816803|NCT00923091|2595447|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
816804|NCT00923091|2595448|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
816805|NCT00923091|2595449|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
816806|NCT00923091|2595450|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
816807|NCT00923091|2595451|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
816808|NCT00923091|2595452|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
816809|NCT00923130|2595510|P1|Overall Study|Refused further treatment|2
816810|NCT00923130|2595510|P1|Overall Study|Switched to alternative treatment|2
816811|NCT00923130|2595510|P1|Overall Study|Discontinued treatment due to toxicities|3
816812|NCT00923130|2595510|P1|Overall Study|Death|1
816813|NCT00923130|2595510|P1|Overall Study|Stopped treatment due to progression|17
816814|NCT00923156|2595529|P3|Overall Study|Lack of Efficacy|1
816815|NCT00923156|2595530|P2|Overall Study|Lack of Efficacy|0
816816|NCT00923156|2595531|P1|Overall Study|Lack of Efficacy|0
816817|NCT00923156|2595529|P3|Overall Study|Death|0
816818|NCT00923156|2595530|P2|Overall Study|Death|1
816819|NCT00923156|2595531|P1|Overall Study|Death|0
816820|NCT00923156|2595529|P3|Overall Study|Withdrawal by Subject|0
816821|NCT00923156|2595530|P2|Overall Study|Withdrawal by Subject|1
816822|NCT00923156|2595531|P1|Overall Study|Withdrawal by Subject|0
816823|NCT00923156|2595529|P3|Overall Study|Abnormal laboratory values|1
816824|NCT00923156|2595530|P2|Overall Study|Abnormal laboratory values|0
816825|NCT00923156|2595531|P1|Overall Study|Abnormal laboratory values|0
816826|NCT00923156|2595529|P3|Overall Study|Adverse Event|1
816827|NCT00923156|2595530|P2|Overall Study|Adverse Event|2
816828|NCT00923156|2595531|P1|Overall Study|Adverse Event|0
816829|NCT00923195|2595559|P2|Overall Study|Death|1
816830|NCT00923195|2595560|P1|Overall Study|Death|0
816831|NCT00923260|2595599|P2|Overall Study|Lost to Follow-up|1
816832|NCT00923260|2595600|P1|Overall Study|Lost to Follow-up|1
816833|NCT00923845|2595734|P2|Induction Therapy|Poor performance status|2
816834|NCT00923845|2595735|P1|Induction Therapy|Poor performance status|0
816835|NCT00923936|2595771|P2|Overall Study|Continuing in follow up period|1
816836|NCT00923936|2595772|P1|Overall Study|Continuing in follow up period|2
816837|NCT00923936|2595771|P2|Overall Study|Lost to follow up|0
816838|NCT00923936|2595772|P1|Overall Study|Lost to follow up|2
816839|NCT00923936|2595771|P2|Overall Study|Adverse Event|1
816840|NCT00923936|2595772|P1|Overall Study|Adverse Event|2
816841|NCT00923936|2595771|P2|Overall Study|progressive disease on study|1
816842|NCT00923936|2595772|P1|Overall Study|progressive disease on study|2
816843|NCT00923975|2595796|P1|Overall Study|Did not meet inclusion criteria|1
816844|NCT00924170|2595892|P2|Overall Study|Death|0
816845|NCT00924170|2595893|P1|Overall Study|Death|1
816846|NCT00924170|2595892|P2|Overall Study|Stopped due to neutralizing antibodies|0
816847|NCT00924170|2595893|P1|Overall Study|Stopped due to neutralizing antibodies|3
816848|NCT00924170|2595892|P2|Overall Study|Progressive disease|6
816849|NCT00924170|2595893|P1|Overall Study|Progressive disease|3
816850|NCT00924170|2595892|P2|Overall Study|Physician Decision|1
816851|NCT00924170|2595893|P1|Overall Study|Physician Decision|0
816852|NCT00924170|2595892|P2|Overall Study|Refused further treatment|1
816853|NCT00924170|2595893|P1|Overall Study|Refused further treatment|0
816854|NCT00924287|2595936|P1|Overall Study|Death|1
816855|NCT00924313|2595942|P1|Overall Study|not imaged due to failed tracer imaging|1
816856|NCT00924404|2595970|P2|Overall Study|Lost to Follow-up|4
816857|NCT00924404|2595971|P1|Overall Study|Lost to Follow-up|6
816858|NCT00924443|2595977|P1|Overall Study|Protocol Violation|1
816859|NCT00924443|2595977|P1|Overall Study|Physician Decision|2
816860|NCT00924469|2595987|P2|Overall Study|Lost to Follow-up|1
816861|NCT00924469|2595988|P1|Overall Study|Lost to Follow-up|0
816862|NCT00924469|2595987|P2|Overall Study|Withdrawal by Subject|1
816863|NCT00924469|2595988|P1|Overall Study|Withdrawal by Subject|0
816864|NCT00924469|2595987|P2|Overall Study|Adverse Event|0
816865|NCT00924469|2595988|P1|Overall Study|Adverse Event|2
816866|NCT00924508|2596015|P1|Overall Study|Withdrawal by Subject|3
816867|NCT00924560|2596025|P3|Overall Study|Miscellaneous Reasons|10
816868|NCT00924560|2596026|P2|Overall Study|Miscellaneous Reasons|10
816869|NCT00924560|2596027|P1|Overall Study|Miscellaneous Reasons|13
816870|NCT00924560|2596025|P3|Overall Study|Lost to Follow-up|45
816871|NCT00924560|2596026|P2|Overall Study|Lost to Follow-up|94
816872|NCT00924560|2596027|P1|Overall Study|Lost to Follow-up|78
816873|NCT00924560|2596025|P3|Overall Study|Pregnancy|1
816874|NCT00924560|2596026|P2|Overall Study|Pregnancy|7
816875|NCT00924560|2596027|P1|Overall Study|Pregnancy|5
816876|NCT00924560|2596025|P3|Overall Study|Adverse Event|0
816877|NCT00924560|2596026|P2|Overall Study|Adverse Event|33
816878|NCT00924560|2596027|P1|Overall Study|Adverse Event|39
816879|NCT00924560|2596025|P3|Overall Study|Withdrawal by Subject|18
816880|NCT00924560|2596026|P2|Overall Study|Withdrawal by Subject|44
816881|NCT00924560|2596027|P1|Overall Study|Withdrawal by Subject|50
816882|NCT00924560|2596025|P3|Overall Study|Physician Decision|4
816883|NCT00924560|2596026|P2|Overall Study|Physician Decision|3
816884|NCT00924560|2596027|P1|Overall Study|Physician Decision|2
816885|NCT00924560|2596025|P3|Overall Study|Non Compliance with the Protocol|4
816886|NCT00924560|2596026|P2|Overall Study|Non Compliance with the Protocol|15
816887|NCT00924560|2596027|P1|Overall Study|Non Compliance with the Protocol|20
816888|NCT00924560|2596025|P3|Overall Study|Did Not Meet Protocol Requirements|1
816889|NCT00924560|2596026|P2|Overall Study|Did Not Meet Protocol Requirements|2
816890|NCT00924560|2596027|P1|Overall Study|Did Not Meet Protocol Requirements|4
816891|NCT00924638|2596073|P2|Overall Study|Physician Decision|3
816892|NCT00924638|2596074|P1|Overall Study|Physician Decision|3
816893|NCT00924638|2596073|P2|Overall Study|Withdrawal by Subject|7
816894|NCT00924638|2596074|P1|Overall Study|Withdrawal by Subject|5
816895|NCT00924638|2596073|P2|Overall Study|Lost to Follow-up|1
816896|NCT00924638|2596074|P1|Overall Study|Lost to Follow-up|1
816897|NCT00924638|2596073|P2|Overall Study|Death|2
816898|NCT00924638|2596074|P1|Overall Study|Death|3
816899|NCT00924651|2596095|P2|Overall Study|Incomplete Form|1
816900|NCT00924651|2596096|P1|Overall Study|Incomplete Form|2
816901|NCT00924651|2596095|P2|Overall Study|Changed Mind|1
816902|NCT00924651|2596096|P1|Overall Study|Changed Mind|10
816903|NCT00924651|2596095|P2|Overall Study|Medical|3
816904|NCT00924651|2596096|P1|Overall Study|Medical|1
816905|NCT00924651|2596095|P2|Overall Study|Noncompliant|4
816906|NCT00924651|2596096|P1|Overall Study|Noncompliant|1
816907|NCT00924651|2596095|P2|Overall Study|Overwhelmed|6
816908|NCT00924651|2596096|P1|Overall Study|Overwhelmed|6
816909|NCT00924651|2596095|P2|Overall Study|No Reason|7
816910|NCT00924651|2596096|P1|Overall Study|No Reason|3
816911|NCT00924651|2596095|P2|Overall Study|Chemo started too soon|3
816912|NCT00924651|2596096|P1|Overall Study|Chemo started too soon|2
816917|NCT00924781|2596115|P2|Overall Study|Study terminated by sponsor|10
816918|NCT00924781|2596116|P1|Overall Study|Study terminated by sponsor|12
816919|NCT00924898|2596171|P1|Overall Study|Withdrawal by Subject|2
816920|NCT00924950|2596180|P1|Overall Study|Lost to Follow-up|2
816921|NCT00925015|2596188|P3|Overall Study|Withdrawal by Subject|1
816922|NCT00925015|2596189|P2|Overall Study|Withdrawal by Subject|0
816923|NCT00925015|2596190|P1|Overall Study|Withdrawal by Subject|0
816924|NCT00925015|2596188|P3|Overall Study|Progressive Disease|4
816925|NCT00925015|2596189|P2|Overall Study|Progressive Disease|3
816926|NCT00925015|2596190|P1|Overall Study|Progressive Disease|7
816927|NCT00925015|2596188|P3|Overall Study|Physician Decision|0
816928|NCT00925015|2596189|P2|Overall Study|Physician Decision|1
816929|NCT00925015|2596190|P1|Overall Study|Physician Decision|0
816930|NCT00925015|2596188|P3|Overall Study|Adverse Event|1
816931|NCT00925015|2596189|P2|Overall Study|Adverse Event|2
816932|NCT00925015|2596190|P1|Overall Study|Adverse Event|1
816933|NCT00925132|2596246|P5|Overall Study|Removed due to disease progression|4
816934|NCT00925132|2596247|P4|Overall Study|Removed due to disease progression|0
816935|NCT00925132|2596248|P3|Overall Study|Removed due to disease progression|0
816936|NCT00925132|2596249|P2|Overall Study|Removed due to disease progression|0
816937|NCT00925132|2596250|P1|Overall Study|Removed due to disease progression|0
816938|NCT00925132|2596246|P5|Overall Study|Withdrawal by Subject|1
816939|NCT00925132|2596247|P4|Overall Study|Withdrawal by Subject|0
816940|NCT00925132|2596248|P3|Overall Study|Withdrawal by Subject|0
816941|NCT00925132|2596249|P2|Overall Study|Withdrawal by Subject|0
816942|NCT00925132|2596250|P1|Overall Study|Withdrawal by Subject|2
816943|NCT00925288|2596258|P2|Overall Study|Lost to Follow-up|7
816944|NCT00925288|2596259|P1|Overall Study|Lost to Follow-up|9
816945|NCT00925353|2596271|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
816946|NCT00925548|2596281|P2|Overall Study|Discontinuation of trial by sponsor|5
816947|NCT00925548|2596282|P1|Overall Study|Discontinuation of trial by sponsor|10
816948|NCT00925587|2596310|P2|Overall Study|Lost to Follow-up|1
816949|NCT00925587|2596311|P1|Overall Study|Lost to Follow-up|0
816950|NCT00925587|2596310|P2|Overall Study|Adverse Event|2
816951|NCT00925587|2596311|P1|Overall Study|Adverse Event|6
816952|NCT00925587|2596310|P2|Overall Study|Death|5
816953|NCT00925587|2596311|P1|Overall Study|Death|5
816954|NCT00925587|2596310|P2|Overall Study|Withdrawal by Subject|6
816955|NCT00925587|2596311|P1|Overall Study|Withdrawal by Subject|9
816956|NCT00925587|2596310|P2|Overall Study|Protocol Violation|4
816957|NCT00925587|2596311|P1|Overall Study|Protocol Violation|6
816958|NCT00925587|2596310|P2|Overall Study|Physician Decision|1
816959|NCT00925587|2596311|P1|Overall Study|Physician Decision|4
816960|NCT00925587|2596310|P2|Overall Study|Protocol Specified Criteria|6
816961|NCT00925587|2596311|P1|Overall Study|Protocol Specified Criteria|6
816962|NCT00925600|2596425|P2|Overall Study|Adverse Event|2
816963|NCT00925600|2596426|P1|Overall Study|Adverse Event|1
816964|NCT00925600|2596425|P2|Overall Study|Other|1
816965|NCT00925600|2596426|P1|Overall Study|Other|3
816966|NCT00925600|2596425|P2|Overall Study|Requirement for Alternative Therapy|1
816967|NCT00925600|2596426|P1|Overall Study|Requirement for Alternative Therapy|0
816968|NCT00925600|2596425|P2|Overall Study|Protocol Deviation|1
816969|NCT00925600|2596426|P1|Overall Study|Protocol Deviation|0
816970|NCT00925600|2596425|P2|Overall Study|Ineligibility Determined|0
816971|NCT00925600|2596426|P1|Overall Study|Ineligibility Determined|2
816972|NCT00925600|2596425|P2|Overall Study|Noncompliance|0
816973|NCT00925600|2596426|P1|Overall Study|Noncompliance|2
816974|NCT00925600|2596425|P2|Overall Study|Administrative Decision|1
816975|NCT00925600|2596426|P1|Overall Study|Administrative Decision|1
816976|NCT00925600|2596425|P2|Overall Study|Disease Progression|3
816977|NCT00925600|2596426|P1|Overall Study|Disease Progression|1
816978|NCT00925600|2596425|P2|Overall Study|Lost to Follow-up|2
816979|NCT00925600|2596426|P1|Overall Study|Lost to Follow-up|2
816980|NCT00925600|2596425|P2|Overall Study|Death|3
816981|NCT00925600|2596426|P1|Overall Study|Death|4
816982|NCT00925600|2596425|P2|Overall Study|Withdrawal by Subject|14
816983|NCT00925600|2596426|P1|Overall Study|Withdrawal by Subject|16
816984|NCT00925704|2596452|P6|Third Intervention|Withdrew consent|1
816985|NCT00925704|2596453|P5|Third Intervention|Withdrew consent|0
816986|NCT00925704|2596454|P4|Third Intervention|Withdrew consent|0
816987|NCT00925704|2596455|P3|Third Intervention|Withdrew consent|0
816988|NCT00925704|2596456|P2|Third Intervention|Withdrew consent|0
816989|NCT00925704|2596457|P1|Third Intervention|Withdrew consent|0
816990|NCT00925704|2596452|P6|Second Intervention|Withdrawal by Subject|0
816991|NCT00925704|2596453|P5|Second Intervention|Withdrawal by Subject|1
816992|NCT00925704|2596454|P4|Second Intervention|Withdrawal by Subject|0
816993|NCT00925704|2596455|P3|Second Intervention|Withdrawal by Subject|0
816994|NCT00925704|2596456|P2|Second Intervention|Withdrawal by Subject|0
816995|NCT00925704|2596457|P1|Second Intervention|Withdrawal by Subject|1
816996|NCT00925704|2596452|P6|First Intervention|Withdrew consent|0
816997|NCT00925704|2596453|P5|First Intervention|Withdrew consent|1
816998|NCT00925704|2596454|P4|First Intervention|Withdrew consent|1
816999|NCT00925704|2596455|P3|First Intervention|Withdrew consent|0
817000|NCT00925704|2596456|P2|First Intervention|Withdrew consent|0
817001|NCT00925704|2596457|P1|First Intervention|Withdrew consent|0
817002|NCT00925769|2596468|P6|Overall Study|Adverse Event|0
817003|NCT00925769|2596469|P5|Overall Study|Adverse Event|1
817004|NCT00925769|2596470|P4|Overall Study|Adverse Event|0
817005|NCT00925769|2596471|P3|Overall Study|Adverse Event|0
817006|NCT00925769|2596472|P2|Overall Study|Adverse Event|0
817007|NCT00925769|2596473|P1|Overall Study|Adverse Event|0
817008|NCT00925769|2596468|P6|Overall Study|Participant is unable to swallow drug|0
817009|NCT00925769|2596469|P5|Overall Study|Participant is unable to swallow drug|0
817010|NCT00925769|2596470|P4|Overall Study|Participant is unable to swallow drug|1
817011|NCT00925769|2596471|P3|Overall Study|Participant is unable to swallow drug|0
817012|NCT00925769|2596472|P2|Overall Study|Participant is unable to swallow drug|0
817013|NCT00925769|2596473|P1|Overall Study|Participant is unable to swallow drug|0
817014|NCT00925769|2596468|P6|Overall Study|End of study visit not done|0
817015|NCT00925769|2596469|P5|Overall Study|End of study visit not done|0
817016|NCT00925769|2596470|P4|Overall Study|End of study visit not done|0
817017|NCT00925769|2596471|P3|Overall Study|End of study visit not done|1
817018|NCT00925769|2596472|P2|Overall Study|End of study visit not done|0
817019|NCT00925769|2596473|P1|Overall Study|End of study visit not done|0
817020|NCT00925769|2596468|P6|Overall Study|Missing documentation|0
817021|NCT00925769|2596469|P5|Overall Study|Missing documentation|0
817022|NCT00925769|2596470|P4|Overall Study|Missing documentation|0
817023|NCT00925769|2596471|P3|Overall Study|Missing documentation|0
817024|NCT00925769|2596472|P2|Overall Study|Missing documentation|1
817025|NCT00925769|2596473|P1|Overall Study|Missing documentation|0
817026|NCT00925769|2596468|P6|Overall Study|Physician Decision|0
817027|NCT00925769|2596469|P5|Overall Study|Physician Decision|0
817028|NCT00925769|2596470|P4|Overall Study|Physician Decision|0
817029|NCT00925769|2596471|P3|Overall Study|Physician Decision|0
817030|NCT00925769|2596472|P2|Overall Study|Physician Decision|0
817031|NCT00925769|2596473|P1|Overall Study|Physician Decision|1
817032|NCT00925769|2596468|P6|Overall Study|Death|0
817033|NCT00925769|2596469|P5|Overall Study|Death|0
817034|NCT00925769|2596470|P4|Overall Study|Death|0
817035|NCT00925769|2596471|P3|Overall Study|Death|1
817036|NCT00925769|2596472|P2|Overall Study|Death|0
817037|NCT00925769|2596473|P1|Overall Study|Death|0
817038|NCT00925769|2596468|P6|Overall Study|Disease progression|3
817039|NCT00925769|2596469|P5|Overall Study|Disease progression|2
817040|NCT00925769|2596470|P4|Overall Study|Disease progression|4
817041|NCT00925769|2596471|P3|Overall Study|Disease progression|3
817042|NCT00925769|2596472|P2|Overall Study|Disease progression|5
817043|NCT00925769|2596473|P1|Overall Study|Disease progression|4
817044|NCT00925769|2596468|P6|Overall Study|Major toxicity|0
817045|NCT00925769|2596469|P5|Overall Study|Major toxicity|0
817046|NCT00925769|2596470|P4|Overall Study|Major toxicity|1
817047|NCT00925769|2596471|P3|Overall Study|Major toxicity|1
817048|NCT00925769|2596472|P2|Overall Study|Major toxicity|0
817049|NCT00925769|2596473|P1|Overall Study|Major toxicity|1
817050|NCT00925899|2596547|P2|Part 1|Withdrawal by Subject|9
817051|NCT00925899|2596548|P1|Part 1|Withdrawal by Subject|10
817052|NCT00925899|2596547|P2|Part 1|Death|2
817053|NCT00925899|2596548|P1|Part 1|Death|1
817054|NCT00925990|2596593|P2|Overall Study|moved out of state, missed medication|2
817055|NCT00925990|2596594|P1|Overall Study|moved out of state, missed medication|0
817056|NCT00925990|2596593|P2|Overall Study|Physician Decision|1
817057|NCT00925990|2596594|P1|Overall Study|Physician Decision|1
817058|NCT00925990|2596593|P2|Overall Study|Lost to Follow-up|3
817059|NCT00925990|2596594|P1|Overall Study|Lost to Follow-up|1
817060|NCT00925990|2596593|P2|Overall Study|Withdrawal by Subject|2
817061|NCT00925990|2596594|P1|Overall Study|Withdrawal by Subject|2
817062|NCT00925990|2596593|P2|Overall Study|Adverse Event|3
817063|NCT00925990|2596594|P1|Overall Study|Adverse Event|1
817064|NCT00926029|2596605|P3|Overall Study|Lost to Follow-up|1
817065|NCT00926029|2596606|P2|Overall Study|Lost to Follow-up|1
817066|NCT00926029|2596607|P1|Overall Study|Lost to Follow-up|2
817067|NCT00926211|2596639|P1|Overall Study|Lost to Follow-up|1
817068|NCT00926289|2596682|P2|Overall Study|not specified|3
817069|NCT00926289|2596683|P1|Overall Study|not specified|1
817070|NCT00926289|2596682|P2|Overall Study|Withdrawal by Subject|4
817071|NCT00926289|2596683|P1|Overall Study|Withdrawal by Subject|4
817072|NCT00926289|2596682|P2|Overall Study|Lost to Follow-up|6
817073|NCT00926289|2596683|P1|Overall Study|Lost to Follow-up|3
817074|NCT00926289|2596682|P2|Overall Study|Protocol Violation|12
817075|NCT00926289|2596683|P1|Overall Study|Protocol Violation|8
817076|NCT00926289|2596682|P2|Overall Study|Adverse Event|11
817077|NCT00926289|2596683|P1|Overall Study|Adverse Event|9
817078|NCT00918138|2596733|P2|Overall Study|Death|0
817079|NCT00918138|2596734|P1|Overall Study|Death|1
817080|NCT00918138|2596733|P2|Overall Study|Subject withdrew consent|1
817081|NCT00918138|2596734|P1|Overall Study|Subject withdrew consent|1
817082|NCT00918203|2596750|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
817083|NCT00918203|2596751|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
817084|NCT00918203|2596752|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
817085|NCT00918203|2596750|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
817086|NCT00918203|2596751|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
817087|NCT00918203|2596752|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
817088|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|On Treatment|0
817089|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|On Treatment|0
817090|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|On Treatment|1
817091|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Physician Decision|0
817092|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Physician Decision|1
817093|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Physician Decision|0
817094|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
817095|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
817096|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
817097|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Never Treated|0
817098|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Never Treated|1
817099|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Never Treated|2
817100|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Adverse Event|0
817101|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Adverse Event|1
817102|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Adverse Event|1
817103|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
817104|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
817105|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
817106|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
817107|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
817108|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
817109|NCT00918203|2596750|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
817110|NCT00918203|2596751|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
817111|NCT00918203|2596752|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
817112|NCT00918255|2596784|P3|Overall Study|Investigator discretion|0
817113|NCT00918255|2596785|P2|Overall Study|Investigator discretion|0
817114|NCT00918255|2596786|P1|Overall Study|Investigator discretion|1
817115|NCT00918255|2596784|P3|Overall Study|Non-compliance|0
817116|NCT00918255|2596785|P2|Overall Study|Non-compliance|0
817117|NCT00918255|2596786|P1|Overall Study|Non-compliance|1
817118|NCT00918255|2596784|P3|Overall Study|Exceeded allowed number of interventions|1
817119|NCT00918255|2596785|P2|Overall Study|Exceeded allowed number of interventions|0
817120|NCT00918255|2596786|P1|Overall Study|Exceeded allowed number of interventions|0
817121|NCT00918255|2596784|P3|Overall Study|Lost to Follow-up|2
817122|NCT00918255|2596785|P2|Overall Study|Lost to Follow-up|0
817123|NCT00918255|2596786|P1|Overall Study|Lost to Follow-up|1
817124|NCT00918255|2596784|P3|Overall Study|Lack of Efficacy|0
817125|NCT00918255|2596785|P2|Overall Study|Lack of Efficacy|0
817126|NCT00918255|2596786|P1|Overall Study|Lack of Efficacy|1
817127|NCT00918255|2596784|P3|Overall Study|Withdrawal by Subject|2
817128|NCT00918255|2596785|P2|Overall Study|Withdrawal by Subject|0
817129|NCT00918255|2596786|P1|Overall Study|Withdrawal by Subject|1
817130|NCT00918255|2596784|P3|Overall Study|Adverse Event|0
817131|NCT00918255|2596785|P2|Overall Study|Adverse Event|0
817132|NCT00918255|2596786|P1|Overall Study|Adverse Event|1
817133|NCT00918281|2596812|P1|Overall Study|Physician Decision|29
817134|NCT00918346|2596819|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
817135|NCT00918346|2596820|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
817136|NCT00918385|2596836|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
817137|NCT00918385|2596837|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
817138|NCT00918385|2596836|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
817139|NCT00918385|2596837|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
817140|NCT00918385|2596836|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
817141|NCT00918385|2596837|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
817142|NCT00918385|2596836|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
817143|NCT00918385|2596837|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
817144|NCT00918385|2596836|P2|Monotherapy|Complicating illness|0
817145|NCT00918385|2596837|P1|Monotherapy|Complicating illness|1
817146|NCT00918385|2596836|P2|Monotherapy|Adverse Event|6
817147|NCT00918385|2596837|P1|Monotherapy|Adverse Event|1
817148|NCT00918580|2596846|P1|After 6-month FU to 1-year FU|Failed to Return|2
817149|NCT00918580|2596846|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
817150|NCT00918580|2596846|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
817151|NCT00918580|2596846|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
817152|NCT00918580|2596846|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
817153|NCT00918580|2596846|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
817154|NCT00918580|2596846|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
817155|NCT00918684|2596869|P1|Treatment Phase|Withdrawal by Subject|8
817156|NCT00918684|2596869|P1|Treatment Phase|Protocol Violation|1
817157|NCT00918684|2596869|P1|Treatment Phase|Physician Decision|8
817158|NCT00918684|2596869|P1|Treatment Phase|Lost to Follow-up|2
817159|NCT00918684|2596869|P1|Treatment Phase|Lack of Efficacy|6
817160|NCT00918684|2596869|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
817161|NCT00918736|2596875|P1|Overall Study|Withdrawal by Subject|4
817162|NCT00918749|2596882|P3|Overall Study|No Study Medication Taken|0
817163|NCT00918749|2596883|P2|Overall Study|No Study Medication Taken|0
817164|NCT00918749|2596884|P1|Overall Study|No Study Medication Taken|1
817165|NCT00918749|2596882|P3|Overall Study|Withdrawal by Subject|5
817166|NCT00918749|2596883|P2|Overall Study|Withdrawal by Subject|3
817167|NCT00918749|2596884|P1|Overall Study|Withdrawal by Subject|5
817168|NCT00918749|2596882|P3|Overall Study|Lost to Follow-up|1
817169|NCT00918749|2596883|P2|Overall Study|Lost to Follow-up|0
817170|NCT00918749|2596884|P1|Overall Study|Lost to Follow-up|0
817171|NCT00918749|2596882|P3|Overall Study|Adverse Event|1
817172|NCT00918749|2596883|P2|Overall Study|Adverse Event|0
817173|NCT00918749|2596884|P1|Overall Study|Adverse Event|1
817174|NCT00918879|2596935|P2|Overall Study|Severe non-compliance to protocol|1
817175|NCT00918879|2596936|P1|Overall Study|Severe non-compliance to protocol|1
817176|NCT00918879|2596935|P2|Overall Study|Lost to Follow-up|1
817177|NCT00918879|2596936|P1|Overall Study|Lost to Follow-up|1
817178|NCT00918879|2596935|P2|Overall Study|Withdrawal by Subject|4
817179|NCT00918879|2596936|P1|Overall Study|Withdrawal by Subject|4
817180|NCT00918957|2596954|P2|Overall Study|Withdrawal by Subject|0
817181|NCT00918957|2596955|P1|Overall Study|Withdrawal by Subject|1
817182|NCT00918957|2596954|P2|Overall Study|Adverse Event|0
817183|NCT00918957|2596955|P1|Overall Study|Adverse Event|2
817184|NCT00919061|2596988|P1|Overall Study|Withdrawal by Subject|1
817185|NCT00919061|2596988|P1|Overall Study|Adverse Event|1
817186|NCT00919633|2597064|P4|Overall Study|Viral rebound outside protocol timepoint|0
817187|NCT00919633|2597065|P3|Overall Study|Viral rebound outside protocol timepoint|1
817188|NCT00919633|2597066|P2|Overall Study|Viral rebound outside protocol timepoint|0
817189|NCT00919633|2597067|P1|Overall Study|Viral rebound outside protocol timepoint|0
817190|NCT00919633|2597064|P4|Overall Study|Request of withdrawal w/o future contact|0
817191|NCT00919633|2597065|P3|Overall Study|Request of withdrawal w/o future contact|1
817192|NCT00919633|2597066|P2|Overall Study|Request of withdrawal w/o future contact|0
817193|NCT00919633|2597067|P1|Overall Study|Request of withdrawal w/o future contact|0
817194|NCT00919633|2597064|P4|Overall Study|Physician Decision|1
817195|NCT00919633|2597065|P3|Overall Study|Physician Decision|0
817196|NCT00919633|2597066|P2|Overall Study|Physician Decision|0
817197|NCT00919633|2597067|P1|Overall Study|Physician Decision|0
817198|NCT00919633|2597064|P4|Overall Study|Protocol Violation|1
817199|NCT00919633|2597065|P3|Overall Study|Protocol Violation|0
817200|NCT00919633|2597066|P2|Overall Study|Protocol Violation|0
817201|NCT00919633|2597067|P1|Overall Study|Protocol Violation|0
817202|NCT00919633|2597064|P4|Overall Study|Withdraw consent post transition to SOC|1
817203|NCT00919633|2597065|P3|Overall Study|Withdraw consent post transition to SOC|1
817204|NCT00919633|2597066|P2|Overall Study|Withdraw consent post transition to SOC|0
817205|NCT00919633|2597067|P1|Overall Study|Withdraw consent post transition to SOC|0
817206|NCT00919633|2597064|P4|Overall Study|Lost to Follow-up|2
817207|NCT00919633|2597065|P3|Overall Study|Lost to Follow-up|0
817208|NCT00919633|2597066|P2|Overall Study|Lost to Follow-up|1
817209|NCT00919633|2597067|P1|Overall Study|Lost to Follow-up|3
817210|NCT00919633|2597064|P4|Overall Study|Withdrawal by Subject|3
817211|NCT00919633|2597065|P3|Overall Study|Withdrawal by Subject|4
817212|NCT00919633|2597066|P2|Overall Study|Withdrawal by Subject|2
817213|NCT00919633|2597067|P1|Overall Study|Withdrawal by Subject|1
817214|NCT00919633|2597064|P4|Overall Study|Lack of Efficacy|3
817215|NCT00919633|2597065|P3|Overall Study|Lack of Efficacy|2
817216|NCT00919633|2597066|P2|Overall Study|Lack of Efficacy|3
817217|NCT00919633|2597067|P1|Overall Study|Lack of Efficacy|17
817218|NCT00919633|2597064|P4|Overall Study|Death|0
817219|NCT00919633|2597065|P3|Overall Study|Death|2
817220|NCT00919633|2597066|P2|Overall Study|Death|0
817221|NCT00919633|2597067|P1|Overall Study|Death|0
817222|NCT00919633|2597064|P4|Overall Study|Adverse Event|10
817223|NCT00919633|2597065|P3|Overall Study|Adverse Event|12
817224|NCT00919633|2597066|P2|Overall Study|Adverse Event|9
817225|NCT00919633|2597067|P1|Overall Study|Adverse Event|1
817226|NCT00919711|2597087|P2|Overall Study|Noncompliance|0
817227|NCT00919711|2597088|P1|Overall Study|Noncompliance|1
817228|NCT00919711|2597087|P2|Overall Study|Death|0
817229|NCT00919711|2597088|P1|Overall Study|Death|1
817230|NCT00919711|2597087|P2|Overall Study|Lost to Follow-up|0
817231|NCT00919711|2597088|P1|Overall Study|Lost to Follow-up|2
817232|NCT00919711|2597087|P2|Overall Study|Administrative Decision|1
817233|NCT00919711|2597088|P1|Overall Study|Administrative Decision|0
817234|NCT00919711|2597087|P2|Overall Study|Other|2
817235|NCT00919711|2597088|P1|Overall Study|Other|1
817236|NCT00919711|2597087|P2|Overall Study|Adverse Event|3
817237|NCT00919711|2597088|P1|Overall Study|Adverse Event|13
817238|NCT00919711|2597087|P2|Overall Study|Withdrawal by Subject|7
817239|NCT00919711|2597088|P1|Overall Study|Withdrawal by Subject|15
817240|NCT00919854|2597127|P1|Overall Study|Adverse Event|1
817241|NCT00919867|2597142|P6|First Intervention|Physician Decision|1
817242|NCT00919867|2597143|P5|First Intervention|Physician Decision|0
817243|NCT00919867|2597144|P4|First Intervention|Physician Decision|0
817244|NCT00919867|2597145|P3|First Intervention|Physician Decision|0
817245|NCT00919867|2597146|P2|First Intervention|Physician Decision|0
817246|NCT00919867|2597147|P1|First Intervention|Physician Decision|0
817247|NCT00919867|2597142|P6|First Intervention|Withdrawal by Subject|0
817248|NCT00919867|2597143|P5|First Intervention|Withdrawal by Subject|0
817249|NCT00919867|2597144|P4|First Intervention|Withdrawal by Subject|0
817250|NCT00919867|2597145|P3|First Intervention|Withdrawal by Subject|1
817251|NCT00919867|2597146|P2|First Intervention|Withdrawal by Subject|0
817252|NCT00919867|2597147|P1|First Intervention|Withdrawal by Subject|0
817253|NCT00919893|2597170|P2|Overall Study|Protocol Violation|9
817254|NCT00919893|2597171|P1|Overall Study|Protocol Violation|19
817255|NCT00920140|2597204|P5|Phase 2|Withdrawal by Subject|1
817256|NCT00920140|2597205|P4|Phase 2|Withdrawal by Subject|2
817257|NCT00920140|2597206|P3|Phase 2|Withdrawal by Subject|4
817258|NCT00920140|2597207|P2|Phase 2|Withdrawal by Subject|0
817259|NCT00920140|2597208|P1|Phase 2|Withdrawal by Subject|0
817260|NCT00920140|2597204|P5|Phase 2|Physician Decision|2
817261|NCT00920140|2597205|P4|Phase 2|Physician Decision|3
817262|NCT00920140|2597206|P3|Phase 2|Physician Decision|3
817263|NCT00920140|2597207|P2|Phase 2|Physician Decision|0
817264|NCT00920140|2597208|P1|Phase 2|Physician Decision|0
817265|NCT00920140|2597204|P5|Phase 2|Lost to Follow-up|0
817266|NCT00920140|2597205|P4|Phase 2|Lost to Follow-up|1
817267|NCT00920140|2597206|P3|Phase 2|Lost to Follow-up|0
817268|NCT00920140|2597207|P2|Phase 2|Lost to Follow-up|0
817269|NCT00920140|2597208|P1|Phase 2|Lost to Follow-up|0
817270|NCT00920140|2597204|P5|Phase 2|Lack of Efficacy|5
817271|NCT00920140|2597205|P4|Phase 2|Lack of Efficacy|14
817272|NCT00920140|2597206|P3|Phase 2|Lack of Efficacy|29
817273|NCT00920140|2597207|P2|Phase 2|Lack of Efficacy|0
817274|NCT00920140|2597208|P1|Phase 2|Lack of Efficacy|0
817275|NCT00920140|2597204|P5|Phase 2|Adverse Event|3
817276|NCT00920140|2597205|P4|Phase 2|Adverse Event|2
817277|NCT00920140|2597206|P3|Phase 2|Adverse Event|14
817278|NCT00920140|2597207|P2|Phase 2|Adverse Event|0
817279|NCT00920140|2597208|P1|Phase 2|Adverse Event|0
817280|NCT00920140|2597204|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
817281|NCT00920140|2597205|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
817282|NCT00920140|2597206|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
817283|NCT00920140|2597207|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
817284|NCT00920140|2597208|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
817285|NCT00920140|2597204|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
817286|NCT00920140|2597205|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
817287|NCT00920140|2597206|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
817288|NCT00920140|2597207|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
817289|NCT00920140|2597208|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
817290|NCT00920140|2597204|P5|Phase 1 (Dose Escalation)|Adverse Event|0
817291|NCT00920140|2597205|P4|Phase 1 (Dose Escalation)|Adverse Event|0
817292|NCT00920140|2597206|P3|Phase 1 (Dose Escalation)|Adverse Event|0
817293|NCT00920140|2597207|P2|Phase 1 (Dose Escalation)|Adverse Event|3
817294|NCT00920140|2597208|P1|Phase 1 (Dose Escalation)|Adverse Event|3
817295|NCT00926328|2597297|P2|Overall Study|Lost to Follow-up|14
817296|NCT00926328|2597298|P1|Overall Study|Lost to Follow-up|12
817297|NCT00926367|2597308|P2|Overall Study|Skin Irritation|2
817298|NCT00926367|2597309|P1|Overall Study|Skin Irritation|1
817299|NCT00926367|2597308|P2|Overall Study|Lost to Follow-up|0
817300|NCT00926367|2597309|P1|Overall Study|Lost to Follow-up|1
817301|NCT00926367|2597308|P2|Overall Study|Withdrawal by Subject|1
817302|NCT00926367|2597309|P1|Overall Study|Withdrawal by Subject|0
817303|NCT00926393|2597351|P2|Overall Study|Adverse Event|1
817304|NCT00926393|2597352|P1|Overall Study|Adverse Event|1
817305|NCT00926393|2597351|P2|Overall Study|Withdrawal by Subject|2
817306|NCT00926393|2597352|P1|Overall Study|Withdrawal by Subject|1
817307|NCT00926536|2597395|P2|Overall Study|Physician Decision|2
817308|NCT00926536|2597396|P1|Overall Study|Physician Decision|1
817309|NCT00926575|2597406|P2|Overall Study|Withdrawal by Subject|9
817310|NCT00926575|2597407|P1|Overall Study|Withdrawal by Subject|8
817311|NCT00926575|2597406|P2|Overall Study|Protocol Violation|0
817312|NCT00926575|2597407|P1|Overall Study|Protocol Violation|1
817313|NCT00926575|2597406|P2|Overall Study|Physician Decision|2
817314|NCT00926575|2597407|P1|Overall Study|Physician Decision|1
817315|NCT00926575|2597406|P2|Overall Study|Lost to Follow-up|1
817316|NCT00926575|2597407|P1|Overall Study|Lost to Follow-up|1
817317|NCT00926575|2597406|P2|Overall Study|Death|4
817318|NCT00926575|2597407|P1|Overall Study|Death|4
817319|NCT00926575|2597406|P2|Overall Study|Adverse Event|1
817320|NCT00926575|2597407|P1|Overall Study|Adverse Event|1
817321|NCT00927069|2597428|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
817322|NCT00927069|2597429|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
817323|NCT00927069|2597430|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
817324|NCT00927069|2597431|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
817325|NCT00927069|2597428|P4|Week 12 to Week 24|Withdrawal by Subject|0
817326|NCT00927069|2597429|P3|Week 12 to Week 24|Withdrawal by Subject|0
817327|NCT00927069|2597430|P2|Week 12 to Week 24|Withdrawal by Subject|0
817328|NCT00927069|2597431|P1|Week 12 to Week 24|Withdrawal by Subject|1
817329|NCT00927069|2597428|P4|Week 12 to Week 24|Lost to Follow-up|0
817330|NCT00927069|2597429|P3|Week 12 to Week 24|Lost to Follow-up|1
817331|NCT00927069|2597430|P2|Week 12 to Week 24|Lost to Follow-up|0
817332|NCT00927069|2597431|P1|Week 12 to Week 24|Lost to Follow-up|0
817333|NCT00927069|2597428|P4|Week 12 to Week 24|Lack of Efficacy|3
817334|NCT00927069|2597429|P3|Week 12 to Week 24|Lack of Efficacy|2
817335|NCT00927069|2597430|P2|Week 12 to Week 24|Lack of Efficacy|0
817336|NCT00927069|2597431|P1|Week 12 to Week 24|Lack of Efficacy|0
817337|NCT00927069|2597428|P4|Week 0 to Week 12|Worsening of psoriasis|0
817338|NCT00927069|2597429|P3|Week 0 to Week 12|Worsening of psoriasis|0
817339|NCT00927069|2597430|P2|Week 0 to Week 12|Worsening of psoriasis|1
817340|NCT00927069|2597431|P1|Week 0 to Week 12|Worsening of psoriasis|1
817341|NCT00927082|2597445|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
817342|NCT00927082|2597446|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
817343|NCT00927082|2597447|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
817344|NCT00927082|2597448|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
817345|NCT00927082|2597445|P4|Overall Study|Death|0
817346|NCT00927082|2597446|P3|Overall Study|Death|1
817347|NCT00927082|2597447|P2|Overall Study|Death|0
817348|NCT00927082|2597448|P1|Overall Study|Death|0
817349|NCT00927082|2597445|P4|Overall Study|Withdrawal by Subject|2
817350|NCT00927082|2597446|P3|Overall Study|Withdrawal by Subject|7
817351|NCT00927082|2597447|P2|Overall Study|Withdrawal by Subject|2
817352|NCT00927082|2597448|P1|Overall Study|Withdrawal by Subject|3
817353|NCT00927082|2597445|P4|Overall Study|Lost to Follow-up|16
817354|NCT00927082|2597446|P3|Overall Study|Lost to Follow-up|12
817355|NCT00927082|2597447|P2|Overall Study|Lost to Follow-up|8
817356|NCT00927082|2597448|P1|Overall Study|Lost to Follow-up|9
817357|NCT00927095|2597513|P3|Overall Study|Physician Decision|1
817358|NCT00927095|2597514|P2|Overall Study|Physician Decision|2
817359|NCT00927095|2597515|P1|Overall Study|Physician Decision|1
817360|NCT00927095|2597513|P3|Overall Study|Withdrawal by Subject|1
817361|NCT00927095|2597514|P2|Overall Study|Withdrawal by Subject|1
817362|NCT00927095|2597515|P1|Overall Study|Withdrawal by Subject|2
817363|NCT00927095|2597513|P3|Overall Study|Adverse Event|0
817364|NCT00927095|2597514|P2|Overall Study|Adverse Event|1
817365|NCT00927095|2597515|P1|Overall Study|Adverse Event|3
817366|NCT00927186|2597536|P2|12 Months Primary Study|Withdrawal by Subject|1
817367|NCT00927186|2597537|P1|12 Months Primary Study|Withdrawal by Subject|1
817368|NCT00927186|2597536|P2|12 Months Primary Study|Protocol Violation|1
817369|NCT00927186|2597537|P1|12 Months Primary Study|Protocol Violation|0
817370|NCT00927186|2597536|P2|12 Months Primary Study|Lost to Follow-up|0
817371|NCT00927186|2597537|P1|12 Months Primary Study|Lost to Follow-up|1
817372|NCT00927186|2597536|P2|12 Months Primary Study|Adverse Event|2
817373|NCT00927186|2597537|P1|12 Months Primary Study|Adverse Event|5
817374|NCT00927251|2597653|P1|Overall Study|Patients not implanted with 4296 lead|8
817375|NCT00927355|2597676|P2|Overall Study|Adverse Event|1
817376|NCT00927355|2597677|P1|Overall Study|Adverse Event|1
817377|NCT00927368|2597698|P3|Overall Study|cancellation of surgery|2
817378|NCT00927368|2597699|P2|Overall Study|cancellation of surgery|1
817379|NCT00927368|2597700|P1|Overall Study|cancellation of surgery|0
817380|NCT00927368|2597698|P3|Overall Study|ineligible post randomization|1
817381|NCT00927368|2597699|P2|Overall Study|ineligible post randomization|3
817382|NCT00927368|2597700|P1|Overall Study|ineligible post randomization|0
817383|NCT00927368|2597698|P3|Overall Study|equipment failure|0
817384|NCT00927368|2597699|P2|Overall Study|equipment failure|0
817385|NCT00927368|2597700|P1|Overall Study|equipment failure|1
817386|NCT00927368|2597698|P3|Overall Study|Lost to Follow-up|0
817387|NCT00927368|2597699|P2|Overall Study|Lost to Follow-up|0
817388|NCT00927368|2597700|P1|Overall Study|Lost to Follow-up|4
817389|NCT00927368|2597698|P3|Overall Study|enrollment in another study|2
817390|NCT00927368|2597699|P2|Overall Study|enrollment in another study|1
817391|NCT00927368|2597700|P1|Overall Study|enrollment in another study|1
817392|NCT00927394|2597719|P2|Overall Study|Randomized in error|1
817393|NCT00927394|2597720|P1|Overall Study|Randomized in error|0
817394|NCT00927394|2597719|P2|Overall Study|Protocol deviation|13
817395|NCT00927394|2597720|P1|Overall Study|Protocol deviation|16
817396|NCT00927394|2597719|P2|Overall Study|Death|1
817397|NCT00927394|2597720|P1|Overall Study|Death|1
817398|NCT00927394|2597719|P2|Overall Study|Administrative Problem|0
817399|NCT00927394|2597720|P1|Overall Study|Administrative Problem|1
817400|NCT00927394|2597719|P2|Overall Study|Lost to Follow-up|14
817401|NCT00927394|2597720|P1|Overall Study|Lost to Follow-up|8
817402|NCT00927394|2597719|P2|Overall Study|Withdrawal by Subject|24
817403|NCT00927394|2597720|P1|Overall Study|Withdrawal by Subject|20
817404|NCT00927394|2597719|P2|Overall Study|Unsatisfactory therapeutic effect|23
817405|NCT00927394|2597720|P1|Overall Study|Unsatisfactory therapeutic effect|17
817406|NCT00927394|2597719|P2|Overall Study|Adverse Event|9
817407|NCT00927394|2597720|P1|Overall Study|Adverse Event|14
817408|NCT00927472|2597750|P2|Overall Study|Post treatment Assessment out of window|4
817409|NCT00927472|2597751|P1|Overall Study|Post treatment Assessment out of window|0
817410|NCT00927472|2597750|P2|Overall Study|Protocol Violation|1
817411|NCT00927472|2597751|P1|Overall Study|Protocol Violation|0
817412|NCT00927472|2597750|P2|Overall Study|Lost to Follow-up|6
817413|NCT00927472|2597751|P1|Overall Study|Lost to Follow-up|1
817414|NCT00927472|2597750|P2|Overall Study|Withdrawal by Subject|11
817415|NCT00927472|2597751|P1|Overall Study|Withdrawal by Subject|10
817416|NCT00927563|2597775|P1|Overall Study|Withdrawal by Subject|1
817417|NCT00927563|2597775|P1|Overall Study|Lost to Follow-up|1
817418|NCT00927589|2597789|P1|Overall Study|Non-compliance|1
817419|NCT00927589|2597789|P1|Overall Study|Disease Progression|8
817420|NCT00927589|2597789|P1|Overall Study|Adverse Event|2
817421|NCT00927589|2597789|P1|Overall Study|Withdrawal by Subject|3
817422|NCT00927589|2597789|P1|Overall Study|Physician Decision|1
817423|NCT00927589|2597789|P1|Overall Study|Death|1
817424|NCT00927758|2597811|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
817425|NCT00927758|2597812|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
817426|NCT00927758|2597813|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
817427|NCT00927758|2597814|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
817428|NCT00927758|2597815|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
817429|NCT00927758|2597816|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
817430|NCT00927758|2597811|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
817431|NCT00927758|2597812|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
817432|NCT00927758|2597813|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
817433|NCT00927758|2597814|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
817434|NCT00927758|2597815|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
817435|NCT00927758|2597816|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
817436|NCT00927823|2597824|P4|Continuous Dosing Period|Unspecified|3
817437|NCT00927823|2597825|P3|Continuous Dosing Period|Unspecified|9
817438|NCT00927823|2597826|P2|Continuous Dosing Period|Unspecified|2
817439|NCT00927823|2597827|P1|Continuous Dosing Period|Unspecified|1
817440|NCT00927823|2597824|P4|Continuous Dosing Period|Withdrawal by Subject|2
817441|NCT00927823|2597825|P3|Continuous Dosing Period|Withdrawal by Subject|2
817442|NCT00927823|2597826|P2|Continuous Dosing Period|Withdrawal by Subject|0
817443|NCT00927823|2597827|P1|Continuous Dosing Period|Withdrawal by Subject|1
817444|NCT00927823|2597824|P4|Continuous Dosing Period|Lost to Follow-up|0
817445|NCT00927823|2597825|P3|Continuous Dosing Period|Lost to Follow-up|9
817446|NCT00927823|2597826|P2|Continuous Dosing Period|Lost to Follow-up|1
817447|NCT00927823|2597827|P1|Continuous Dosing Period|Lost to Follow-up|1
817448|NCT00927823|2597824|P4|Continuous Dosing Period|Death|0
817449|NCT00927823|2597825|P3|Continuous Dosing Period|Death|6
817450|NCT00927823|2597826|P2|Continuous Dosing Period|Death|0
817451|NCT00927823|2597827|P1|Continuous Dosing Period|Death|0
817452|NCT00927862|2597906|P2|Overall Study|Missing data needed for endpt analyses|45
817453|NCT00927862|2597907|P1|Overall Study|Missing data needed for endpt analyses|27
817454|NCT00927901|2597940|P4|Treatment Period 4|Subject withdrew consent|0
817455|NCT00927901|2597941|P3|Treatment Period 4|Subject withdrew consent|1
817456|NCT00927901|2597942|P2|Treatment Period 4|Subject withdrew consent|0
817457|NCT00927901|2597943|P1|Treatment Period 4|Subject withdrew consent|0
817458|NCT00927901|2597940|P4|Treatment Period 4|Adverse Event|1
817459|NCT00927901|2597941|P3|Treatment Period 4|Adverse Event|0
817460|NCT00927901|2597942|P2|Treatment Period 4|Adverse Event|0
817461|NCT00927901|2597943|P1|Treatment Period 4|Adverse Event|0
817462|NCT00927901|2597940|P4|Treatment Period 1|Subject withdrew consent|0
817463|NCT00927901|2597941|P3|Treatment Period 1|Subject withdrew consent|1
817464|NCT00927901|2597942|P2|Treatment Period 1|Subject withdrew consent|0
817465|NCT00927901|2597943|P1|Treatment Period 1|Subject withdrew consent|0
817466|NCT00927927|2597986|P15|Overall Study|Withdrawal by Subject|0
817467|NCT00927927|2597987|P14|Overall Study|Withdrawal by Subject|0
817468|NCT00927927|2597988|P13|Overall Study|Withdrawal by Subject|0
817469|NCT00927927|2597989|P12|Overall Study|Withdrawal by Subject|2
817470|NCT00927927|2597990|P11|Overall Study|Withdrawal by Subject|0
817471|NCT00927927|2597991|P10|Overall Study|Withdrawal by Subject|0
817472|NCT00927927|2597992|P9|Overall Study|Withdrawal by Subject|0
817473|NCT00927927|2597993|P8|Overall Study|Withdrawal by Subject|2
817474|NCT00927927|2597994|P7|Overall Study|Withdrawal by Subject|0
817475|NCT00927927|2597995|P6|Overall Study|Withdrawal by Subject|0
817476|NCT00927927|2597996|P5|Overall Study|Withdrawal by Subject|0
817477|NCT00927927|2597997|P4|Overall Study|Withdrawal by Subject|0
817478|NCT00927927|2597998|P3|Overall Study|Withdrawal by Subject|0
817479|NCT00927927|2597999|P2|Overall Study|Withdrawal by Subject|0
817480|NCT00927927|2598000|P1|Overall Study|Withdrawal by Subject|0
817481|NCT00927940|2598047|P1|Overall Study|Death|1
817482|NCT00927953|2598054|P2|Overall Study|Death|1
817483|NCT00927953|2598055|P1|Overall Study|Death|2
817484|NCT00928018|2598081|P2|Overall Study|Withdrawal by Subject|0
817485|NCT00928018|2598082|P1|Overall Study|Withdrawal by Subject|1
817486|NCT00928057|2598102|P2|Overall Study|Protocol Violation|1
817487|NCT00928057|2598103|P1|Overall Study|Protocol Violation|0
817488|NCT00928057|2598102|P2|Overall Study|Lost to Follow-up|1
817489|NCT00928057|2598103|P1|Overall Study|Lost to Follow-up|0
817490|NCT00928057|2598102|P2|Overall Study|Withdrawal by Subject|0
817491|NCT00928057|2598103|P1|Overall Study|Withdrawal by Subject|1
817492|NCT00928057|2598102|P2|Overall Study|Adverse Event|2
817493|NCT00928057|2598103|P1|Overall Study|Adverse Event|1
817494|NCT00928070|2598128|P2|Overall Study|Unspecified|5
817495|NCT00928070|2598129|P1|Overall Study|Unspecified|5
817496|NCT00928070|2598128|P2|Overall Study|Randomized but not treated|2
817497|NCT00928070|2598129|P1|Overall Study|Randomized but not treated|2
817498|NCT00928070|2598128|P2|Overall Study|Protocol Violation|5
817499|NCT00928070|2598129|P1|Overall Study|Protocol Violation|6
817500|NCT00928070|2598128|P2|Overall Study|Did not meet entrance criteria|9
817501|NCT00928070|2598129|P1|Overall Study|Did not meet entrance criteria|16
817502|NCT00928070|2598128|P2|Overall Study|Lack of Efficacy|5
817503|NCT00928070|2598129|P1|Overall Study|Lack of Efficacy|9
817504|NCT00928070|2598128|P2|Overall Study|Adverse Event|26
817505|NCT00928070|2598129|P1|Overall Study|Adverse Event|14
817506|NCT00928070|2598128|P2|Overall Study|Withdrawal by Subject|3
817507|NCT00928070|2598129|P1|Overall Study|Withdrawal by Subject|10
817508|NCT00928070|2598128|P2|Overall Study|Lost to Follow-up|2
817509|NCT00928070|2598129|P1|Overall Study|Lost to Follow-up|1
817510|NCT00928187|2598312|P3|Overall Study|Protocol Violation|0
817511|NCT00928187|2598313|P2|Overall Study|Protocol Violation|1
817512|NCT00928187|2598314|P1|Overall Study|Protocol Violation|0
817513|NCT00928187|2598312|P3|Overall Study|Withdrawal by Subject|1
817514|NCT00928187|2598313|P2|Overall Study|Withdrawal by Subject|1
817515|NCT00928187|2598314|P1|Overall Study|Withdrawal by Subject|0
817516|NCT00928187|2598312|P3|Overall Study|Lost to Follow-up|1
817517|NCT00928187|2598313|P2|Overall Study|Lost to Follow-up|2
817518|NCT00928187|2598314|P1|Overall Study|Lost to Follow-up|1
817519|NCT00928187|2598312|P3|Overall Study|Death|3
817520|NCT00928187|2598313|P2|Overall Study|Death|2
817521|NCT00928187|2598314|P1|Overall Study|Death|1
817522|NCT00928252|2598358|P1|Overall Study|Physician Decision|3
817523|NCT00928408|2598381|P1|Overall Study|Lost to Follow-up|12
817524|NCT00928408|2598381|P1|Overall Study|Death|5
817525|NCT00928408|2598381|P1|Overall Study|Withdrawal by Subject|4
817526|NCT00928408|2598381|P1|Overall Study|Other|2
817527|NCT00928434|2598417|P3|Overall Study|Other (not meeting above criteria)|2
817528|NCT00928434|2598418|P2|Overall Study|Other (not meeting above criteria)|1
817529|NCT00928434|2598419|P1|Overall Study|Other (not meeting above criteria)|5
817530|NCT00928434|2598417|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
817531|NCT00928434|2598418|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
817532|NCT00928434|2598419|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
817533|NCT00928434|2598417|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
817534|NCT00928434|2598418|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
817535|NCT00928434|2598419|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
817536|NCT00928434|2598417|P3|Overall Study|Withdrawal by Subject|2
817537|NCT00928434|2598418|P2|Overall Study|Withdrawal by Subject|3
817538|NCT00928434|2598419|P1|Overall Study|Withdrawal by Subject|5
817539|NCT00928434|2598417|P3|Overall Study|Lost to Follow-up|3
817540|NCT00928434|2598418|P2|Overall Study|Lost to Follow-up|0
817541|NCT00928434|2598419|P1|Overall Study|Lost to Follow-up|1
817542|NCT00928434|2598417|P3|Overall Study|Physician Decision|3
817543|NCT00928434|2598418|P2|Overall Study|Physician Decision|0
817544|NCT00928434|2598419|P1|Overall Study|Physician Decision|2
817545|NCT00928434|2598417|P3|Overall Study|Protocol Violation|8
817546|NCT00928434|2598418|P2|Overall Study|Protocol Violation|0
817547|NCT00928434|2598419|P1|Overall Study|Protocol Violation|5
817548|NCT00928434|2598417|P3|Overall Study|Adverse Event|18
817549|NCT00928434|2598418|P2|Overall Study|Adverse Event|5
817550|NCT00928434|2598419|P1|Overall Study|Adverse Event|14
817551|NCT00928486|2598491|P1|Overall Study|Withdrawal by Subject|1
817552|NCT00928486|2598491|P1|Overall Study|Disease Progression|7
817553|NCT00928486|2598491|P1|Overall Study|Adverse Event|2
817554|NCT00928512|2598502|P5|Overall Study|Administrative Problems|0
817555|NCT00928512|2598503|P4|Overall Study|Administrative Problems|0
817556|NCT00928512|2598504|P3|Overall Study|Administrative Problems|0
817557|NCT00928512|2598505|P2|Overall Study|Administrative Problems|1
817558|NCT00928512|2598506|P1|Overall Study|Administrative Problems|0
817559|NCT00928512|2598502|P5|Overall Study|Lost to Follow-up|3
817560|NCT00928512|2598503|P4|Overall Study|Lost to Follow-up|1
817561|NCT00928512|2598504|P3|Overall Study|Lost to Follow-up|2
817562|NCT00928512|2598505|P2|Overall Study|Lost to Follow-up|1
817563|NCT00928512|2598506|P1|Overall Study|Lost to Follow-up|1
817564|NCT00928512|2598502|P5|Overall Study|Withdrawal by Subject|0
817565|NCT00928512|2598503|P4|Overall Study|Withdrawal by Subject|4
817566|NCT00928512|2598504|P3|Overall Study|Withdrawal by Subject|3
817567|NCT00928512|2598505|P2|Overall Study|Withdrawal by Subject|0
817568|NCT00928512|2598506|P1|Overall Study|Withdrawal by Subject|3
817569|NCT00928512|2598502|P5|Overall Study|Protocol Violation|3
817570|NCT00928512|2598503|P4|Overall Study|Protocol Violation|1
817571|NCT00928512|2598504|P3|Overall Study|Protocol Violation|0
817572|NCT00928512|2598505|P2|Overall Study|Protocol Violation|1
817573|NCT00928512|2598506|P1|Overall Study|Protocol Violation|0
817574|NCT00928512|2598502|P5|Overall Study|Lack of Efficacy|3
817575|NCT00928512|2598503|P4|Overall Study|Lack of Efficacy|7
817576|NCT00928512|2598504|P3|Overall Study|Lack of Efficacy|4
817577|NCT00928512|2598505|P2|Overall Study|Lack of Efficacy|0
817578|NCT00928512|2598506|P1|Overall Study|Lack of Efficacy|2
817579|NCT00928512|2598502|P5|Overall Study|Adverse Event|6
817580|NCT00928512|2598503|P4|Overall Study|Adverse Event|8
817581|NCT00928512|2598504|P3|Overall Study|Adverse Event|2
817582|NCT00928512|2598505|P2|Overall Study|Adverse Event|3
817583|NCT00928512|2598506|P1|Overall Study|Adverse Event|4
817584|NCT00928668|2598616|P5|Overall Study|Other reasons not listed above|0
817585|NCT00928668|2598617|P4|Overall Study|Other reasons not listed above|1
817586|NCT00928668|2598618|P3|Overall Study|Other reasons not listed above|0
817587|NCT00928668|2598619|P2|Overall Study|Other reasons not listed above|0
817588|NCT00928668|2598620|P1|Overall Study|Other reasons not listed above|0
817589|NCT00928668|2598616|P5|Overall Study|Withdrawal by Subject|0
817590|NCT00928668|2598617|P4|Overall Study|Withdrawal by Subject|0
817591|NCT00928668|2598618|P3|Overall Study|Withdrawal by Subject|1
817592|NCT00928668|2598619|P2|Overall Study|Withdrawal by Subject|1
817593|NCT00928668|2598620|P1|Overall Study|Withdrawal by Subject|0
817594|NCT00928668|2598616|P5|Overall Study|Protocol Violation|1
817595|NCT00928668|2598617|P4|Overall Study|Protocol Violation|0
817596|NCT00928668|2598618|P3|Overall Study|Protocol Violation|0
817597|NCT00928668|2598619|P2|Overall Study|Protocol Violation|0
817598|NCT00928668|2598620|P1|Overall Study|Protocol Violation|0
817599|NCT00928668|2598616|P5|Overall Study|Adverse Event|0
817600|NCT00928668|2598617|P4|Overall Study|Adverse Event|0
817601|NCT00928668|2598618|P3|Overall Study|Adverse Event|0
817602|NCT00928668|2598619|P2|Overall Study|Adverse Event|0
817603|NCT00928668|2598620|P1|Overall Study|Adverse Event|1
817604|NCT00928746|2598684|P1|Overall Study|Other|2
817605|NCT00928746|2598684|P1|Overall Study|Withdrawal by Subject|1
817606|NCT00928746|2598684|P1|Overall Study|Protocol Violation|1
817607|NCT00928746|2598684|P1|Overall Study|Adverse Event|2
817608|NCT00928889|2598728|P2|Overall Study|Other|0
817609|NCT00928889|2598729|P1|Overall Study|Other|1
817610|NCT00928889|2598728|P2|Overall Study|Adverse Event|0
817611|NCT00928889|2598729|P1|Overall Study|Adverse Event|1
817612|NCT00928889|2598728|P2|Overall Study|Protocol Violation|1
817613|NCT00928889|2598729|P1|Overall Study|Protocol Violation|0
817614|NCT00928889|2598728|P2|Overall Study|Lost to Follow-up|1
817615|NCT00928889|2598729|P1|Overall Study|Lost to Follow-up|3
817616|NCT00929110|2598772|P3|Overall Study|Patient inability to use the device|0
817617|NCT00929110|2598773|P2|Overall Study|Patient inability to use the device|1
817618|NCT00929110|2598774|P1|Overall Study|Patient inability to use the device|0
817619|NCT00929110|2598772|P3|Overall Study|Abnormal test procedure result(s)|1
817620|NCT00929110|2598773|P2|Overall Study|Abnormal test procedure result(s)|1
817621|NCT00929110|2598774|P1|Overall Study|Abnormal test procedure result(s)|0
817622|NCT00929110|2598772|P3|Overall Study|Abnormal laboratory value(s)|0
817623|NCT00929110|2598773|P2|Overall Study|Abnormal laboratory value(s)|1
817624|NCT00929110|2598774|P1|Overall Study|Abnormal laboratory value(s)|0
817625|NCT00929110|2598772|P3|Overall Study|Death|2
817626|NCT00929110|2598773|P2|Overall Study|Death|2
817627|NCT00929110|2598774|P1|Overall Study|Death|2
817628|NCT00929110|2598772|P3|Overall Study|Administrative problems|2
817629|NCT00929110|2598773|P2|Overall Study|Administrative problems|1
817630|NCT00929110|2598774|P1|Overall Study|Administrative problems|4
817631|NCT00929110|2598772|P3|Overall Study|Protocol deviation|4
817632|NCT00929110|2598773|P2|Overall Study|Protocol deviation|2
817633|NCT00929110|2598774|P1|Overall Study|Protocol deviation|5
817634|NCT00929110|2598772|P3|Overall Study|Lost to Follow-up|3
817635|NCT00929110|2598773|P2|Overall Study|Lost to Follow-up|7
817636|NCT00929110|2598774|P1|Overall Study|Lost to Follow-up|7
817637|NCT00929110|2598772|P3|Overall Study|Unsatisfactory therapeutic effect|6
817638|NCT00929110|2598773|P2|Overall Study|Unsatisfactory therapeutic effect|9
817639|NCT00929110|2598774|P1|Overall Study|Unsatisfactory therapeutic effect|20
817640|NCT00929110|2598772|P3|Overall Study|Subject withdrew consent|26
817641|NCT00929110|2598773|P2|Overall Study|Subject withdrew consent|23
817642|NCT00929110|2598774|P1|Overall Study|Subject withdrew consent|40
817643|NCT00929110|2598772|P3|Overall Study|Adverse Event|18
817644|NCT00929110|2598773|P2|Overall Study|Adverse Event|29
817645|NCT00929110|2598774|P1|Overall Study|Adverse Event|40
817646|NCT00929162|2598841|P2|Overall Study|Other termination reason|6
817647|NCT00929162|2598842|P1|Overall Study|Other termination reason|5
817648|NCT00929162|2598841|P2|Overall Study|Protocol Violation|30
817649|NCT00929162|2598842|P1|Overall Study|Protocol Violation|32
817650|NCT00929162|2598841|P2|Overall Study|Withdrawal by Subject|1
817651|NCT00929162|2598842|P1|Overall Study|Withdrawal by Subject|3
817652|NCT00929162|2598841|P2|Overall Study|Adverse Event|5
817653|NCT00929162|2598842|P1|Overall Study|Adverse Event|8
817654|NCT00929201|2598852|P2|Period 1|Withdrawal by Subject|1
817655|NCT00929201|2598853|P1|Period 1|Withdrawal by Subject|0
817656|NCT00929240|2598861|P3|Maintenance Phase|Participant not treated|0
817657|NCT00929240|2598862|P2|Maintenance Phase|Participant not treated|2
817658|NCT00929240|2598863|P1|Maintenance Phase|Participant not treated|0
817659|NCT00929240|2598861|P3|Maintenance Phase|Treatment ongoing at study closure|10
817660|NCT00929240|2598862|P2|Maintenance Phase|Treatment ongoing at study closure|0
817661|NCT00929240|2598863|P1|Maintenance Phase|Treatment ongoing at study closure|0
817662|NCT00929240|2598861|P3|Maintenance Phase|Change of treatment|0
817663|NCT00929240|2598862|P2|Maintenance Phase|Change of treatment|4
817664|NCT00929240|2598863|P1|Maintenance Phase|Change of treatment|0
817665|NCT00929240|2598861|P3|Maintenance Phase|Physician Decision|1
817666|NCT00929240|2598862|P2|Maintenance Phase|Physician Decision|2
817667|NCT00929240|2598863|P1|Maintenance Phase|Physician Decision|0
817668|NCT00929240|2598861|P3|Maintenance Phase|Health authority/Study termination|2
817669|NCT00929240|2598862|P2|Maintenance Phase|Health authority/Study termination|1
817670|NCT00929240|2598863|P1|Maintenance Phase|Health authority/Study termination|0
817671|NCT00929240|2598861|P3|Maintenance Phase|Protocol Violation|0
817672|NCT00929240|2598862|P2|Maintenance Phase|Protocol Violation|1
817673|NCT00929240|2598863|P1|Maintenance Phase|Protocol Violation|0
817674|NCT00929240|2598861|P3|Maintenance Phase|Withdrawal by Subject|6
817675|NCT00929240|2598862|P2|Maintenance Phase|Withdrawal by Subject|2
817676|NCT00929240|2598863|P1|Maintenance Phase|Withdrawal by Subject|0
817677|NCT00929240|2598861|P3|Maintenance Phase|Adverse Event|12
817678|NCT00929240|2598862|P2|Maintenance Phase|Adverse Event|9
817679|NCT00929240|2598863|P1|Maintenance Phase|Adverse Event|0
817680|NCT00929240|2598861|P3|Maintenance Phase|Disease progression|60
817681|NCT00929240|2598862|P2|Maintenance Phase|Disease progression|73
817682|NCT00929240|2598863|P1|Maintenance Phase|Disease progression|0
817683|NCT00929240|2598861|P3|Initial Treatment Phase|Physician Decision|0
817684|NCT00929240|2598862|P2|Initial Treatment Phase|Physician Decision|0
817685|NCT00929240|2598863|P1|Initial Treatment Phase|Physician Decision|4
817686|NCT00929240|2598861|P3|Initial Treatment Phase|Health authority/Study termination|0
817687|NCT00929240|2598862|P2|Initial Treatment Phase|Health authority/Study termination|0
817688|NCT00929240|2598863|P1|Initial Treatment Phase|Health authority/Study termination|3
817689|NCT00929240|2598861|P3|Initial Treatment Phase|Death|0
817690|NCT00929240|2598862|P2|Initial Treatment Phase|Death|0
817691|NCT00929240|2598863|P1|Initial Treatment Phase|Death|2
817692|NCT00929240|2598861|P3|Initial Treatment Phase|Protocol Violation|0
817693|NCT00929240|2598862|P2|Initial Treatment Phase|Protocol Violation|0
817694|NCT00929240|2598863|P1|Initial Treatment Phase|Protocol Violation|5
817695|NCT00929240|2598861|P3|Initial Treatment Phase|Withdrawal by Subject|0
817696|NCT00929240|2598862|P2|Initial Treatment Phase|Withdrawal by Subject|0
817697|NCT00929240|2598863|P1|Initial Treatment Phase|Withdrawal by Subject|13
817698|NCT00929240|2598861|P3|Initial Treatment Phase|Disease progression|0
817699|NCT00929240|2598862|P2|Initial Treatment Phase|Disease progression|0
817700|NCT00929240|2598863|P1|Initial Treatment Phase|Disease progression|41
817701|NCT00929240|2598861|P3|Initial Treatment Phase|Adverse Event|0
817702|NCT00929240|2598862|P2|Initial Treatment Phase|Adverse Event|0
817703|NCT00929240|2598863|P1|Initial Treatment Phase|Adverse Event|31
817704|NCT00923273|2598991|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
817705|NCT00923273|2598992|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
817706|NCT00923273|2598993|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
817707|NCT00923273|2598994|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
817708|NCT00923273|2598995|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
817709|NCT00923273|2598991|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
817710|NCT00923273|2598992|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
817711|NCT00923273|2598993|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
817712|NCT00923273|2598994|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
817713|NCT00923273|2598995|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
817717|NCT00929526|2599061|P2|Overall Study|Unspecified|6
817718|NCT00929526|2599062|P1|Overall Study|Unspecified|8
817719|NCT00929526|2599061|P2|Overall Study|Lost to Follow-up|12
817720|NCT00929526|2599062|P1|Overall Study|Lost to Follow-up|8
817721|NCT00929526|2599061|P2|Overall Study|Withdrawal by Subject|11
817722|NCT00929526|2599062|P1|Overall Study|Withdrawal by Subject|1
817723|NCT00929643|2599107|P1|Overall Study|Protocol Violation|2
817724|NCT00929656|2599118|P2|Overall Study|Lost to Follow-up|1
817725|NCT00929656|2599119|P1|Overall Study|Lost to Follow-up|0
817726|NCT00929695|2599135|P2|Overall Study|incorrect stratification|0
817727|NCT00929695|2599136|P1|Overall Study|incorrect stratification|2
817728|NCT00929695|2599135|P2|Overall Study|discharge home|3
817729|NCT00929695|2599136|P1|Overall Study|discharge home|4
817730|NCT00929695|2599135|P2|Overall Study|Withdrawal by Subject|2
817731|NCT00929695|2599136|P1|Overall Study|Withdrawal by Subject|0
817732|NCT00929695|2599135|P2|Overall Study|Death|1
817733|NCT00929695|2599136|P1|Overall Study|Death|2
817734|NCT00929708|2599171|P5|Overall Study|Lost to Follow-up|0
817735|NCT00929708|2599172|P4|Overall Study|Lost to Follow-up|1
817736|NCT00929708|2599173|P3|Overall Study|Lost to Follow-up|0
817737|NCT00929708|2599174|P2|Overall Study|Lost to Follow-up|0
817738|NCT00929708|2599175|P1|Overall Study|Lost to Follow-up|0
817739|NCT00929708|2599171|P5|Overall Study|Physician Decision|1
817740|NCT00929708|2599172|P4|Overall Study|Physician Decision|2
817741|NCT00929708|2599173|P3|Overall Study|Physician Decision|2
817742|NCT00929708|2599174|P2|Overall Study|Physician Decision|2
817743|NCT00929708|2599175|P1|Overall Study|Physician Decision|0
817744|NCT00929708|2599171|P5|Overall Study|Adverse Event|3
817745|NCT00929708|2599172|P4|Overall Study|Adverse Event|0
817746|NCT00929708|2599173|P3|Overall Study|Adverse Event|0
817747|NCT00929708|2599174|P2|Overall Study|Adverse Event|0
817748|NCT00929708|2599175|P1|Overall Study|Adverse Event|0
817749|NCT00929708|2599171|P5|Overall Study|Withdrawal by Subject|1
817750|NCT00929708|2599172|P4|Overall Study|Withdrawal by Subject|2
817751|NCT00929708|2599173|P3|Overall Study|Withdrawal by Subject|0
817752|NCT00929708|2599174|P2|Overall Study|Withdrawal by Subject|0
817753|NCT00929708|2599175|P1|Overall Study|Withdrawal by Subject|2
817754|NCT00929708|2599171|P5|Overall Study|Protocol Violation|1
817755|NCT00929708|2599172|P4|Overall Study|Protocol Violation|1
817756|NCT00929708|2599173|P3|Overall Study|Protocol Violation|1
817757|NCT00929708|2599174|P2|Overall Study|Protocol Violation|1
817758|NCT00929708|2599175|P1|Overall Study|Protocol Violation|2
817759|NCT00929734|2599229|P2|Overall Study|Withdrawal by Subject|2
817760|NCT00929734|2599230|P1|Overall Study|Withdrawal by Subject|0
817761|NCT00929734|2599229|P2|Overall Study|Lost to Follow-up|1
817762|NCT00929734|2599230|P1|Overall Study|Lost to Follow-up|2
817763|NCT00932165|2599268|P1|Overall Study|Lost to Follow-up|1
817764|NCT00932373|2599318|P11|Overall Study|Lack of Efficacy|0
817765|NCT00932373|2599319|P10|Overall Study|Lack of Efficacy|1
817766|NCT00932373|2599320|P9|Overall Study|Lack of Efficacy|0
817767|NCT00932373|2599321|P8|Overall Study|Lack of Efficacy|0
817768|NCT00932373|2599322|P7|Overall Study|Lack of Efficacy|0
817769|NCT00932373|2599323|P6|Overall Study|Lack of Efficacy|0
817770|NCT00932373|2599324|P5|Overall Study|Lack of Efficacy|0
817771|NCT00932373|2599325|P4|Overall Study|Lack of Efficacy|0
817772|NCT00932373|2599326|P3|Overall Study|Lack of Efficacy|0
817773|NCT00932373|2599327|P2|Overall Study|Lack of Efficacy|0
817774|NCT00932373|2599328|P1|Overall Study|Lack of Efficacy|0
817775|NCT00932373|2599318|P11|Overall Study|Clinical progression|0
817776|NCT00932373|2599319|P10|Overall Study|Clinical progression|0
817777|NCT00932373|2599320|P9|Overall Study|Clinical progression|0
817778|NCT00932373|2599321|P8|Overall Study|Clinical progression|0
817779|NCT00932373|2599322|P7|Overall Study|Clinical progression|1
817780|NCT00932373|2599323|P6|Overall Study|Clinical progression|0
817781|NCT00932373|2599324|P5|Overall Study|Clinical progression|0
817782|NCT00932373|2599325|P4|Overall Study|Clinical progression|0
817783|NCT00932373|2599326|P3|Overall Study|Clinical progression|0
817784|NCT00932373|2599327|P2|Overall Study|Clinical progression|0
817785|NCT00932373|2599328|P1|Overall Study|Clinical progression|0
817786|NCT00932373|2599318|P11|Overall Study|Withdrawal by Subject|0
817787|NCT00932373|2599319|P10|Overall Study|Withdrawal by Subject|0
817788|NCT00932373|2599320|P9|Overall Study|Withdrawal by Subject|1
817789|NCT00932373|2599321|P8|Overall Study|Withdrawal by Subject|0
817790|NCT00932373|2599322|P7|Overall Study|Withdrawal by Subject|0
817791|NCT00932373|2599323|P6|Overall Study|Withdrawal by Subject|0
817792|NCT00932373|2599324|P5|Overall Study|Withdrawal by Subject|0
817793|NCT00932373|2599325|P4|Overall Study|Withdrawal by Subject|0
817794|NCT00932373|2599326|P3|Overall Study|Withdrawal by Subject|0
817795|NCT00932373|2599327|P2|Overall Study|Withdrawal by Subject|0
817796|NCT00932373|2599328|P1|Overall Study|Withdrawal by Subject|0
817797|NCT00932373|2599318|P11|Overall Study|Dose limiting toxicity|0
817798|NCT00932373|2599319|P10|Overall Study|Dose limiting toxicity|0
817799|NCT00932373|2599320|P9|Overall Study|Dose limiting toxicity|0
817800|NCT00932373|2599321|P8|Overall Study|Dose limiting toxicity|0
817801|NCT00932373|2599322|P7|Overall Study|Dose limiting toxicity|0
817802|NCT00932373|2599323|P6|Overall Study|Dose limiting toxicity|1
817803|NCT00932373|2599324|P5|Overall Study|Dose limiting toxicity|0
817804|NCT00932373|2599325|P4|Overall Study|Dose limiting toxicity|0
817805|NCT00932373|2599326|P3|Overall Study|Dose limiting toxicity|0
817806|NCT00932373|2599327|P2|Overall Study|Dose limiting toxicity|0
817807|NCT00932373|2599328|P1|Overall Study|Dose limiting toxicity|0
817808|NCT00932373|2599318|P11|Overall Study|Physician Decision|0
817809|NCT00932373|2599319|P10|Overall Study|Physician Decision|1
817810|NCT00932373|2599320|P9|Overall Study|Physician Decision|0
817811|NCT00932373|2599321|P8|Overall Study|Physician Decision|0
817812|NCT00932373|2599322|P7|Overall Study|Physician Decision|0
817813|NCT00932373|2599323|P6|Overall Study|Physician Decision|0
817814|NCT00932373|2599324|P5|Overall Study|Physician Decision|2
817815|NCT00932373|2599325|P4|Overall Study|Physician Decision|0
817816|NCT00932373|2599326|P3|Overall Study|Physician Decision|1
817817|NCT00932373|2599327|P2|Overall Study|Physician Decision|0
817818|NCT00932373|2599328|P1|Overall Study|Physician Decision|0
817819|NCT00932373|2599318|P11|Overall Study|Adverse Event|1
817820|NCT00932373|2599319|P10|Overall Study|Adverse Event|2
817821|NCT00932373|2599320|P9|Overall Study|Adverse Event|0
817822|NCT00932373|2599321|P8|Overall Study|Adverse Event|1
817823|NCT00932373|2599322|P7|Overall Study|Adverse Event|0
817824|NCT00932373|2599323|P6|Overall Study|Adverse Event|1
817825|NCT00932373|2599324|P5|Overall Study|Adverse Event|2
817826|NCT00932373|2599325|P4|Overall Study|Adverse Event|0
817827|NCT00932373|2599326|P3|Overall Study|Adverse Event|0
817828|NCT00932373|2599327|P2|Overall Study|Adverse Event|0
817829|NCT00932373|2599328|P1|Overall Study|Adverse Event|0
817830|NCT00932373|2599318|P11|Overall Study|Progressive disease|2
817831|NCT00932373|2599319|P10|Overall Study|Progressive disease|9
817832|NCT00932373|2599320|P9|Overall Study|Progressive disease|1
817833|NCT00932373|2599321|P8|Overall Study|Progressive disease|2
817834|NCT00932373|2599322|P7|Overall Study|Progressive disease|0
817835|NCT00932373|2599323|P6|Overall Study|Progressive disease|1
817836|NCT00932373|2599324|P5|Overall Study|Progressive disease|10
817837|NCT00932373|2599325|P4|Overall Study|Progressive disease|0
817838|NCT00932373|2599326|P3|Overall Study|Progressive disease|0
817839|NCT00932373|2599327|P2|Overall Study|Progressive disease|1
817840|NCT00932373|2599328|P1|Overall Study|Progressive disease|3
817841|NCT00932425|2599439|P2|Overall Study|Withdrawal by Subject|1
817842|NCT00932425|2599440|P1|Overall Study|Withdrawal by Subject|0
817843|NCT00932425|2599439|P2|Overall Study|Lost to Follow-up|1
817844|NCT00932425|2599440|P1|Overall Study|Lost to Follow-up|0
817845|NCT00932451|2599453|P1|Overall Study|Other reasons|5
817846|NCT00932451|2599453|P1|Overall Study|Death|726
817847|NCT00932451|2599453|P1|Overall Study|Lost to Follow-up|22
817848|NCT00932451|2599453|P1|Overall Study|Withdrawal by Subject|69
817849|NCT00932646|2599508|P4|Overall Study|Withdrawal by Subject|0
817850|NCT00932646|2599509|P3|Overall Study|Withdrawal by Subject|3
817851|NCT00932646|2599510|P2|Overall Study|Withdrawal by Subject|1
817852|NCT00932646|2599511|P1|Overall Study|Withdrawal by Subject|1
817853|NCT00932646|2599508|P4|Overall Study|Lost to Follow-up|0
817854|NCT00932646|2599509|P3|Overall Study|Lost to Follow-up|0
817855|NCT00932646|2599510|P2|Overall Study|Lost to Follow-up|1
817856|NCT00932646|2599511|P1|Overall Study|Lost to Follow-up|2
817857|NCT00932646|2599508|P4|Overall Study|Adverse Event|1
817858|NCT00932646|2599509|P3|Overall Study|Adverse Event|1
817859|NCT00932646|2599510|P2|Overall Study|Adverse Event|1
817860|NCT00932646|2599511|P1|Overall Study|Adverse Event|2
817861|NCT00932893|2599572|P2|Overall Study|Unspecified|144
817862|NCT00932893|2599573|P1|Overall Study|Unspecified|5
817863|NCT00932893|2599572|P2|Overall Study|Withdrawal by Subject|2
817864|NCT00932893|2599573|P1|Overall Study|Withdrawal by Subject|5
817865|NCT00932893|2599572|P2|Overall Study|Lost to Follow-up|0
817866|NCT00932893|2599573|P1|Overall Study|Lost to Follow-up|8
817867|NCT00932893|2599572|P2|Overall Study|Death|24
817868|NCT00932893|2599573|P1|Overall Study|Death|115
817869|NCT00933166|2599604|P1|Overall Study|Withdrawal by Subject|1
817870|NCT00933166|2599604|P1|Overall Study|Unavailable|4
817871|NCT00933166|2599604|P1|Overall Study|Lack of Efficacy|9
817872|NCT00933166|2599604|P1|Overall Study|Lost to Follow-up|4
817873|NCT00933244|2599611|P3|Overall Study|Withdrawal by Subject|3
817874|NCT00933244|2599612|P2|Overall Study|Withdrawal by Subject|1
817875|NCT00933244|2599613|P1|Overall Study|Withdrawal by Subject|5
817876|NCT00933270|2599630|P1|Overall Study|Moved or would not return|10
817877|NCT00933270|2599630|P1|Overall Study|Death|24
817878|NCT00933270|2599630|P1|Overall Study|Missed Visit|2
817879|NCT00933270|2599630|P1|Overall Study|Adverse Event|1
817880|NCT00933270|2599630|P1|Overall Study|Lost to Follow-up|14
817881|NCT00933270|2599630|P1|Overall Study|Insufficient Follow-up|10
817882|NCT00933270|2599630|P1|Overall Study|Withdrawal by Subject|26
817883|NCT00933335|2599723|P2|Overall Study|Co-morbid Illness|0
817884|NCT00933335|2599724|P1|Overall Study|Co-morbid Illness|1
817885|NCT00933335|2599723|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
817886|NCT00933335|2599724|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
817887|NCT00933335|2599723|P2|Overall Study|Progressive Disease|11
817888|NCT00933335|2599724|P1|Overall Study|Progressive Disease|0
817889|NCT00933335|2599723|P2|Overall Study|Withdrawal by Subject|1
817890|NCT00933335|2599724|P1|Overall Study|Withdrawal by Subject|0
817891|NCT00933335|2599723|P2|Overall Study|Lost to Follow-up|3
817892|NCT00933335|2599724|P1|Overall Study|Lost to Follow-up|1
817893|NCT00933543|2599807|P2|Overall Study|Not known|1
817894|NCT00933543|2599808|P1|Overall Study|Not known|1
817895|NCT00933543|2599807|P2|Overall Study|Lack of Efficacy|3
817896|NCT00933543|2599808|P1|Overall Study|Lack of Efficacy|0
817897|NCT00933543|2599807|P2|Overall Study|Withdrawal by Subject|1
817898|NCT00933543|2599808|P1|Overall Study|Withdrawal by Subject|0
817899|NCT00933543|2599807|P2|Overall Study|Lost to Follow-up|1
817900|NCT00933543|2599808|P1|Overall Study|Lost to Follow-up|0
817901|NCT00933543|2599807|P2|Overall Study|Adverse Event|1
817902|NCT00933543|2599808|P1|Overall Study|Adverse Event|2
817903|NCT00933608|2599866|P2|Overall Study|Physician Decision|0
817904|NCT00933608|2599867|P1|Overall Study|Physician Decision|1
817905|NCT00933608|2599866|P2|Overall Study|Adverse Event|2
817906|NCT00933608|2599867|P1|Overall Study|Adverse Event|4
817907|NCT00933686|2599875|P2|Overall Study|Failure to show up at endpoint visits|2
817908|NCT00933686|2599876|P1|Overall Study|Failure to show up at endpoint visits|0
817909|NCT00933686|2599875|P2|Overall Study|Physician Decision|0
817910|NCT00933686|2599876|P1|Overall Study|Physician Decision|1
817911|NCT00933686|2599875|P2|Overall Study|Adverse Event|1
817912|NCT00933686|2599876|P1|Overall Study|Adverse Event|1
817913|NCT00933686|2599875|P2|Overall Study|Withdrawal by Subject|5
817914|NCT00933686|2599876|P1|Overall Study|Withdrawal by Subject|6
817915|NCT00933686|2599875|P2|Overall Study|Lost to Follow-up|2
817916|NCT00933686|2599876|P1|Overall Study|Lost to Follow-up|2
817917|NCT00933686|2599875|P2|Overall Study|Protocol Violation|1
817918|NCT00933686|2599876|P1|Overall Study|Protocol Violation|0
817919|NCT00933933|2599899|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
817920|NCT00933933|2599900|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
817921|NCT00933933|2599901|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
817922|NCT00933933|2599899|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
817923|NCT00933933|2599900|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
817924|NCT00933933|2599901|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
817925|NCT00934050|2599923|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
817926|NCT00934050|2599924|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
817927|NCT00934050|2599925|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
817928|NCT00934050|2599926|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
817929|NCT00934050|2599927|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
817930|NCT00934050|2599928|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
817931|NCT00934050|2599923|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
817932|NCT00934050|2599924|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
817933|NCT00934050|2599925|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
817934|NCT00934050|2599926|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
817935|NCT00934050|2599927|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
817936|NCT00934050|2599928|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
817937|NCT00934050|2599923|P6|Enrolled After 15 Dec 2009|Death|1
817938|NCT00934050|2599924|P5|Enrolled After 15 Dec 2009|Death|0
817939|NCT00934050|2599925|P4|Enrolled After 15 Dec 2009|Death|0
817940|NCT00934050|2599926|P3|Enrolled After 15 Dec 2009|Death|0
817941|NCT00934050|2599927|P2|Enrolled After 15 Dec 2009|Death|0
817942|NCT00934050|2599928|P1|Enrolled After 15 Dec 2009|Death|0
817943|NCT00934050|2599923|P6|Enrolled After 15 Dec 2009|Adverse Event|0
817944|NCT00934050|2599924|P5|Enrolled After 15 Dec 2009|Adverse Event|3
817945|NCT00934050|2599925|P4|Enrolled After 15 Dec 2009|Adverse Event|0
817946|NCT00934050|2599926|P3|Enrolled After 15 Dec 2009|Adverse Event|0
817947|NCT00934050|2599927|P2|Enrolled After 15 Dec 2009|Adverse Event|0
817948|NCT00934050|2599928|P1|Enrolled After 15 Dec 2009|Adverse Event|0
817949|NCT00934050|2599923|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
817950|NCT00934050|2599924|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
817951|NCT00934050|2599925|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
817952|NCT00934050|2599926|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
817953|NCT00934050|2599927|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
817954|NCT00934050|2599928|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
817955|NCT00934050|2599923|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
817956|NCT00934050|2599924|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
817957|NCT00934050|2599925|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
817958|NCT00934050|2599926|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
817959|NCT00934050|2599927|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
817960|NCT00934050|2599928|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
817961|NCT00934050|2599923|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
817962|NCT00934050|2599924|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
817963|NCT00934050|2599925|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
817964|NCT00934050|2599926|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
817965|NCT00934050|2599927|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
817966|NCT00934050|2599928|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
817967|NCT00934102|2599938|P3|Period 1, One Night of Wear|Personal Reasons|0
817968|NCT00934102|2599939|P2|Period 1, One Night of Wear|Personal Reasons|0
817969|NCT00934102|2599940|P1|Period 1, One Night of Wear|Personal Reasons|1
817970|NCT00934128|2599950|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
817971|NCT00934128|2599951|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
817972|NCT00934128|2599950|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
817973|NCT00934128|2599951|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
817974|NCT00934128|2599950|P2|Washout Period (1 Hour)|Too tired|0
817975|NCT00934128|2599951|P1|Washout Period (1 Hour)|Too tired|1
817976|NCT00934128|2599950|P2|Washout Period (1 Hour)|Pain|0
817977|NCT00934128|2599951|P1|Washout Period (1 Hour)|Pain|1
817978|NCT00934128|2599950|P2|Washout Period (1 Hour)|Patient preference|3
817979|NCT00934128|2599951|P1|Washout Period (1 Hour)|Patient preference|1
817980|NCT00934128|2599950|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
818066|NCT00934856|2600220|P5|Feasibility Part|Progressive disease|0
817981|NCT00934128|2599951|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
817982|NCT00934128|2599950|P2|First Intervention (2 Hours)|Adverse Event|1
817983|NCT00934128|2599951|P1|First Intervention (2 Hours)|Adverse Event|4
817984|NCT00934128|2599950|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
817985|NCT00934128|2599951|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
817986|NCT00934362|2600001|P2|Overall Study|Adverse Event|0
817987|NCT00934362|2600002|P1|Overall Study|Adverse Event|1
817988|NCT00934440|2600019|P1|Overall Study|Lost to Follow-up|1
817989|NCT00934544|2600026|P2|Overall Study|Entered Extension phase INC424|18
817990|NCT00934544|2600027|P1|Overall Study|Entered Extension phase INC424|29
817991|NCT00934544|2600026|P2|Overall Study|Other Reasons|7
817992|NCT00934544|2600027|P1|Overall Study|Other Reasons|7
817993|NCT00934544|2600026|P2|Overall Study|Non-compliance with study procedures|1
817994|NCT00934544|2600027|P1|Overall Study|Non-compliance with study procedures|0
817995|NCT00934544|2600026|P2|Overall Study|Non-compliance with study Medication|0
817996|NCT00934544|2600027|P1|Overall Study|Non-compliance with study Medication|2
817997|NCT00934544|2600026|P2|Overall Study|Disease Progression|3
817998|NCT00934544|2600027|P1|Overall Study|Disease Progression|1
817999|NCT00934544|2600026|P2|Overall Study|Protocol Violation|0
818000|NCT00934544|2600027|P1|Overall Study|Protocol Violation|2
818001|NCT00934544|2600026|P2|Overall Study|Withdrawal by Subject|9
818002|NCT00934544|2600027|P1|Overall Study|Withdrawal by Subject|2
818003|NCT00934544|2600026|P2|Overall Study|Adverse Event|4
818004|NCT00934544|2600027|P1|Overall Study|Adverse Event|12
818005|NCT00934622|2600072|P1|Overall Study|2nd Intraoperative exclusion criteria|1
818006|NCT00934622|2600072|P1|Overall Study|Lost to Follow-up|7
818007|NCT00926783|2600116|P2|Overall Study|Incomplete CFAE Procedures|3
818008|NCT00926783|2600117|P1|Overall Study|Incomplete CFAE Procedures|3
818009|NCT00926796|2600135|P2|Overall Study|Withdrawal by Subject|0
818010|NCT00926796|2600136|P1|Overall Study|Withdrawal by Subject|1
818011|NCT00926796|2600135|P2|Overall Study|Protocol Violation|11
818012|NCT00926796|2600136|P1|Overall Study|Protocol Violation|15
818013|NCT00926796|2600135|P2|Overall Study|Lost to Follow-up|13
818014|NCT00926796|2600136|P1|Overall Study|Lost to Follow-up|22
818015|NCT00926796|2600135|P2|Overall Study|Adverse Event|14
818016|NCT00926796|2600136|P1|Overall Study|Adverse Event|7
818017|NCT00926796|2600135|P2|Overall Study|Ineligible, but positive for gonorrhea|1
818018|NCT00926796|2600136|P1|Overall Study|Ineligible, but positive for gonorrhea|1
818019|NCT00926796|2600135|P2|Overall Study|Ineligible, negative for gonorrhea|60
818020|NCT00926796|2600136|P1|Overall Study|Ineligible, negative for gonorrhea|57
818021|NCT00926796|2600135|P2|Overall Study|Did not receive randomized treatment|7
818022|NCT00926796|2600136|P1|Overall Study|Did not receive randomized treatment|4
818023|NCT00934648|2600180|P1|Overall Study|Withdrawal by Subject|1
818024|NCT00934648|2600180|P1|Overall Study|Failure to return|8
818025|NCT00934791|2600189|P2|Overall Study|Withdrawal by Subject|0
818026|NCT00934791|2600190|P1|Overall Study|Withdrawal by Subject|1
818027|NCT00934843|2600198|P2|Overall Study|Protocol Violation|1
818028|NCT00934843|2600199|P1|Overall Study|Protocol Violation|0
818029|NCT00934856|2600219|P6|Extension Part|Non-compliance with drug|1
818030|NCT00934856|2600220|P5|Extension Part|Non-compliance with drug|0
818031|NCT00934856|2600221|P4|Extension Part|Non-compliance with drug|0
818032|NCT00934856|2600222|P3|Extension Part|Non-compliance with drug|0
818033|NCT00934856|2600223|P2|Extension Part|Non-compliance with drug|0
818034|NCT00934856|2600224|P1|Extension Part|Non-compliance with drug|0
818035|NCT00934856|2600219|P6|Extension Part|Progressive disease|0
818036|NCT00934856|2600220|P5|Extension Part|Progressive disease|0
818037|NCT00934856|2600221|P4|Extension Part|Progressive disease|1
818038|NCT00934856|2600222|P3|Extension Part|Progressive disease|0
818039|NCT00934856|2600223|P2|Extension Part|Progressive disease|0
818040|NCT00934856|2600224|P1|Extension Part|Progressive disease|0
818041|NCT00934856|2600219|P6|Extension Part|Adverse Event|4
818042|NCT00934856|2600220|P5|Extension Part|Adverse Event|4
818043|NCT00934856|2600221|P4|Extension Part|Adverse Event|1
818044|NCT00934856|2600222|P3|Extension Part|Adverse Event|0
818045|NCT00934856|2600223|P2|Extension Part|Adverse Event|0
818046|NCT00934856|2600224|P1|Extension Part|Adverse Event|0
818047|NCT00934856|2600219|P6|Feasibility Part|Withdrawal by Subject|1
818048|NCT00934856|2600220|P5|Feasibility Part|Withdrawal by Subject|0
818049|NCT00934856|2600221|P4|Feasibility Part|Withdrawal by Subject|1
818050|NCT00934856|2600222|P3|Feasibility Part|Withdrawal by Subject|0
818051|NCT00934856|2600223|P2|Feasibility Part|Withdrawal by Subject|0
818052|NCT00934856|2600224|P1|Feasibility Part|Withdrawal by Subject|0
818053|NCT00934856|2600219|P6|Feasibility Part|Adverse Event|2
818054|NCT00934856|2600220|P5|Feasibility Part|Adverse Event|0
818055|NCT00934856|2600221|P4|Feasibility Part|Adverse Event|1
818056|NCT00934856|2600222|P3|Feasibility Part|Adverse Event|0
818057|NCT00934856|2600223|P2|Feasibility Part|Adverse Event|1
818058|NCT00934856|2600224|P1|Feasibility Part|Adverse Event|1
818059|NCT00934856|2600219|P6|Feasibility Part|Physician Decision|0
818060|NCT00934856|2600220|P5|Feasibility Part|Physician Decision|0
818061|NCT00934856|2600221|P4|Feasibility Part|Physician Decision|0
818062|NCT00934856|2600222|P3|Feasibility Part|Physician Decision|1
818063|NCT00934856|2600223|P2|Feasibility Part|Physician Decision|0
818064|NCT00934856|2600224|P1|Feasibility Part|Physician Decision|0
818065|NCT00934856|2600219|P6|Feasibility Part|Progressive disease|0
818067|NCT00934856|2600221|P4|Feasibility Part|Progressive disease|3
818068|NCT00934856|2600222|P3|Feasibility Part|Progressive disease|2
818069|NCT00934856|2600223|P2|Feasibility Part|Progressive disease|4
818070|NCT00934856|2600224|P1|Feasibility Part|Progressive disease|4
818073|NCT00935493|2600343|P3|Overall Study|Treatment Discontinued|0
818074|NCT00935493|2600344|P2|Overall Study|Treatment Discontinued|1
818075|NCT00935493|2600345|P1|Overall Study|Treatment Discontinued|0
818076|NCT00935493|2600343|P3|Overall Study|Lost to Follow-up|1
818077|NCT00935493|2600344|P2|Overall Study|Lost to Follow-up|1
818078|NCT00935493|2600345|P1|Overall Study|Lost to Follow-up|1
818079|NCT00935532|2600361|P2|Overall Study|Loss Glucose Control|0
818080|NCT00935532|2600362|P1|Overall Study|Loss Glucose Control|4
818081|NCT00935532|2600361|P2|Overall Study|Sponsor Decision|1
818082|NCT00935532|2600362|P1|Overall Study|Sponsor Decision|0
818083|NCT00935532|2600361|P2|Overall Study|Subject Decision|1
818084|NCT00935532|2600362|P1|Overall Study|Subject Decision|2
818085|NCT00935532|2600361|P2|Overall Study|Protocol Violation|1
818086|NCT00935532|2600362|P1|Overall Study|Protocol Violation|2
818087|NCT00935532|2600361|P2|Overall Study|Physician Decision|2
818088|NCT00935532|2600362|P1|Overall Study|Physician Decision|1
818089|NCT00935532|2600361|P2|Overall Study|Lost to Follow-up|0
818090|NCT00935532|2600362|P1|Overall Study|Lost to Follow-up|1
818091|NCT00935532|2600361|P2|Overall Study|Death|0
818092|NCT00935532|2600362|P1|Overall Study|Death|1
818093|NCT00935532|2600361|P2|Overall Study|Adverse Event|6
818094|NCT00935532|2600362|P1|Overall Study|Adverse Event|11
818095|NCT00935584|2600390|P2|Overall Study|Provider dropped out of study|4
818096|NCT00935584|2600391|P1|Overall Study|Provider dropped out of study|14
818097|NCT00935584|2600390|P2|Overall Study|Patient changed provider|0
818098|NCT00935584|2600391|P1|Overall Study|Patient changed provider|3
818099|NCT00935584|2600390|P2|Overall Study|Relocated|0
818100|NCT00935584|2600391|P1|Overall Study|Relocated|3
818101|NCT00935584|2600390|P2|Overall Study|No show|0
818102|NCT00935584|2600391|P1|Overall Study|No show|9
818103|NCT00935584|2600390|P2|Overall Study|Lost to Follow-up|0
818104|NCT00935584|2600391|P1|Overall Study|Lost to Follow-up|8
818105|NCT00935584|2600390|P2|Overall Study|Death|0
818106|NCT00935584|2600391|P1|Overall Study|Death|3
818107|NCT00935584|2600390|P2|Overall Study|Withdrawal by Subject|0
818108|NCT00935584|2600391|P1|Overall Study|Withdrawal by Subject|9
818109|NCT00935701|2600409|P1|Overall Study|Failure to Transition to Acupuncture|1
818110|NCT00935818|2600451|P2|Overall Study|Physician Decision|1
818111|NCT00935818|2600452|P1|Overall Study|Physician Decision|0
818112|NCT00935818|2600451|P2|Overall Study|Adverse Event|7
818113|NCT00935818|2600452|P1|Overall Study|Adverse Event|6
818114|NCT00935818|2600451|P2|Overall Study|Lost to Follow-up|42
818115|NCT00935818|2600452|P1|Overall Study|Lost to Follow-up|40
818116|NCT00935818|2600451|P2|Overall Study|Withdrawal by Subject|50
818117|NCT00935818|2600452|P1|Overall Study|Withdrawal by Subject|45
818118|NCT00935883|2600485|P2|Treatment Period|Withdrawal by Subject|2
818119|NCT00935883|2600486|P1|Treatment Period|Withdrawal by Subject|0
818120|NCT00935883|2600485|P2|Treatment Period|Physician Decision|0
818121|NCT00935883|2600486|P1|Treatment Period|Physician Decision|1
818122|NCT00936065|2600501|P3|Overall Study|Withdrawal by Subject|4
818123|NCT00936065|2600502|P2|Overall Study|Withdrawal by Subject|2
818124|NCT00936065|2600503|P1|Overall Study|Withdrawal by Subject|0
818125|NCT00936065|2600501|P3|Overall Study|Protocol Violation|1
818126|NCT00936065|2600502|P2|Overall Study|Protocol Violation|2
818127|NCT00936065|2600503|P1|Overall Study|Protocol Violation|1
818128|NCT00936065|2600501|P3|Overall Study|Lost to Follow-up|0
818129|NCT00936065|2600502|P2|Overall Study|Lost to Follow-up|0
818130|NCT00936065|2600503|P1|Overall Study|Lost to Follow-up|1
818131|NCT00936065|2600501|P3|Overall Study|Lack of Efficacy|1
818132|NCT00936065|2600502|P2|Overall Study|Lack of Efficacy|0
818133|NCT00936065|2600503|P1|Overall Study|Lack of Efficacy|1
818134|NCT00936065|2600501|P3|Overall Study|Adverse Event|1
818135|NCT00936065|2600502|P2|Overall Study|Adverse Event|0
818136|NCT00936065|2600503|P1|Overall Study|Adverse Event|1
818137|NCT00936117|2600607|P1|Overall Study|Unable to continue oral medication|3
818138|NCT00936117|2600607|P1|Overall Study|Adverse Event|7
818139|NCT00936208|2600614|P2|Overall Study|Protocol Violation|22
818140|NCT00936208|2600615|P1|Overall Study|Protocol Violation|37
818141|NCT00936221|2600635|P2|Overall Study|Withdrawal by Subject|1
818142|NCT00936221|2600636|P1|Overall Study|Withdrawal by Subject|1
818143|NCT00936598|2600727|P2|Overall Study|Ineligible after consent|0
818144|NCT00936598|2600728|P1|Overall Study|Ineligible after consent|1
818145|NCT00936598|2600727|P2|Overall Study|Withdrawal by Subject|0
818146|NCT00936598|2600728|P1|Overall Study|Withdrawal by Subject|1
818147|NCT00936702|2600738|P1|Overall Study|Unspecified|1
818148|NCT00936702|2600738|P1|Overall Study|Alternative Treatment|1
818149|NCT00936702|2600738|P1|Overall Study|Withdrawal by Subject|2
818150|NCT00936702|2600738|P1|Overall Study|Adverse Event|8
818151|NCT00936702|2600738|P1|Overall Study|Disease progression|34
818152|NCT00936715|2600746|P1|Overall Study|Safety or Tolerability Reasons|4
818153|NCT00936715|2600746|P1|Overall Study|Protocol Violation|1
818154|NCT00936715|2600746|P1|Overall Study|Investigators Discretion|1
818155|NCT00936897|2600757|P2|Overall Study|Death|1
818156|NCT00936897|2600758|P1|Overall Study|Death|0
818157|NCT00936897|2600757|P2|Overall Study|Noncompliance|2
818158|NCT00936897|2600758|P1|Overall Study|Noncompliance|0
818159|NCT00936897|2600757|P2|Overall Study|Ineligibility Determined|3
818160|NCT00936897|2600758|P1|Overall Study|Ineligibility Determined|0
818161|NCT00936897|2600757|P2|Overall Study|Protocol Violation|1
818162|NCT00936897|2600758|P1|Overall Study|Protocol Violation|1
818163|NCT00936897|2600757|P2|Overall Study|Administrative Decision|2
818164|NCT00936897|2600758|P1|Overall Study|Administrative Decision|1
818165|NCT00936897|2600757|P2|Overall Study|Lost to Follow-up|10
818166|NCT00936897|2600758|P1|Overall Study|Lost to Follow-up|1
818167|NCT00936897|2600757|P2|Overall Study|Other|9
818168|NCT00936897|2600758|P1|Overall Study|Other|3
818169|NCT00936897|2600757|P2|Overall Study|Adverse Event|13
818170|NCT00936897|2600758|P1|Overall Study|Adverse Event|4
818171|NCT00936897|2600757|P2|Overall Study|Withdrawal by Subject|19
818172|NCT00936897|2600758|P1|Overall Study|Withdrawal by Subject|9
818174|NCT00936975|2600777|P1|Overall Study|Post-Tx scan uninterpretable|2
818175|NCT00936975|2600777|P1|Overall Study|Disease progression|3
818176|NCT00936975|2600777|P1|Overall Study|Withdrawal by Subject|1
818177|NCT00937040|2600788|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
818178|NCT00937040|2600789|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
818179|NCT00937040|2600788|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
818180|NCT00937040|2600789|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
818181|NCT00937040|2600788|P2|Overall Study|Withdrawal by Subject|7
818182|NCT00937040|2600789|P1|Overall Study|Withdrawal by Subject|13
818183|NCT00937040|2600788|P2|Overall Study|Protocol Violation|0
818184|NCT00937040|2600789|P1|Overall Study|Protocol Violation|3
818185|NCT00937040|2600788|P2|Overall Study|Lost to Follow-up|12
818186|NCT00937040|2600789|P1|Overall Study|Lost to Follow-up|12
818187|NCT00937040|2600788|P2|Overall Study|Adverse Event|8
818188|NCT00937040|2600789|P1|Overall Study|Adverse Event|5
818189|NCT00937157|2600856|P1|Overall Study|Lost to Follow-up|3
818190|NCT00937157|2600856|P1|Overall Study|Pregnancy|1
818191|NCT00937391|2600885|P1|Stage 2|Withdrawal by Subject|1
818192|NCT00937495|2600936|P1|Overall Study|Protocol Violation|2
818193|NCT00937521|2600950|P8|Booster Phase|Protocol Deviation|0
818194|NCT00937521|2600951|P7|Booster Phase|Protocol Deviation|1
818195|NCT00937521|2600952|P6|Booster Phase|Protocol Deviation|0
818196|NCT00937521|2600953|P5|Booster Phase|Protocol Deviation|0
818197|NCT00937521|2600954|P4|Booster Phase|Protocol Deviation|0
818198|NCT00937521|2600955|P3|Booster Phase|Protocol Deviation|0
818199|NCT00937521|2600956|P2|Booster Phase|Protocol Deviation|0
818200|NCT00937521|2600957|P1|Booster Phase|Protocol Deviation|0
818201|NCT00937521|2600950|P8|Booster Phase|Administrative Reason|0
818202|NCT00937521|2600951|P7|Booster Phase|Administrative Reason|0
818203|NCT00937521|2600952|P6|Booster Phase|Administrative Reason|1
818204|NCT00937521|2600953|P5|Booster Phase|Administrative Reason|1
818205|NCT00937521|2600954|P4|Booster Phase|Administrative Reason|0
818206|NCT00937521|2600955|P3|Booster Phase|Administrative Reason|1
818207|NCT00937521|2600956|P2|Booster Phase|Administrative Reason|0
818208|NCT00937521|2600957|P1|Booster Phase|Administrative Reason|0
818209|NCT00937521|2600950|P8|Booster Phase|Lost to Follow-up|0
818210|NCT00937521|2600951|P7|Booster Phase|Lost to Follow-up|3
818211|NCT00937521|2600952|P6|Booster Phase|Lost to Follow-up|4
818212|NCT00937521|2600953|P5|Booster Phase|Lost to Follow-up|4
818213|NCT00937521|2600954|P4|Booster Phase|Lost to Follow-up|2
818214|NCT00937521|2600955|P3|Booster Phase|Lost to Follow-up|4
818215|NCT00937521|2600956|P2|Booster Phase|Lost to Follow-up|2
818216|NCT00937521|2600957|P1|Booster Phase|Lost to Follow-up|2
818217|NCT00937521|2600950|P8|Booster Phase|Withdrawal by Subject|2
818218|NCT00937521|2600951|P7|Booster Phase|Withdrawal by Subject|0
818219|NCT00937521|2600952|P6|Booster Phase|Withdrawal by Subject|0
818220|NCT00937521|2600953|P5|Booster Phase|Withdrawal by Subject|0
818221|NCT00937521|2600954|P4|Booster Phase|Withdrawal by Subject|1
818222|NCT00937521|2600955|P3|Booster Phase|Withdrawal by Subject|0
818223|NCT00937521|2600956|P2|Booster Phase|Withdrawal by Subject|0
818224|NCT00937521|2600957|P1|Booster Phase|Withdrawal by Subject|1
818225|NCT00937521|2600950|P8|Booster Phase|Adverse Event|0
818226|NCT00937521|2600951|P7|Booster Phase|Adverse Event|1
818227|NCT00937521|2600952|P6|Booster Phase|Adverse Event|0
818228|NCT00937521|2600953|P5|Booster Phase|Adverse Event|0
818229|NCT00937521|2600954|P4|Booster Phase|Adverse Event|0
818230|NCT00937521|2600955|P3|Booster Phase|Adverse Event|0
818231|NCT00937521|2600956|P2|Booster Phase|Adverse Event|0
818232|NCT00937521|2600957|P1|Booster Phase|Adverse Event|0
818233|NCT00937521|2600950|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818234|NCT00937521|2600951|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
818235|NCT00937521|2600952|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818236|NCT00937521|2600953|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818237|NCT00937521|2600954|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818238|NCT00937521|2600955|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818239|NCT00937521|2600956|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
818240|NCT00937521|2600957|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
818241|NCT00937521|2600950|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
818242|NCT00937521|2600951|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
818243|NCT00937521|2600952|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
818244|NCT00937521|2600953|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
818245|NCT00937521|2600954|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
818246|NCT00937521|2600955|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
818247|NCT00937521|2600956|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
818248|NCT00937521|2600957|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
818249|NCT00937521|2600950|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818250|NCT00937521|2600951|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818251|NCT00937521|2600952|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818252|NCT00937521|2600953|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818253|NCT00937521|2600954|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
818254|NCT00937521|2600955|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
818255|NCT00937521|2600956|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818256|NCT00937521|2600957|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
818257|NCT00937521|2600950|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
818258|NCT00937521|2600951|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
818259|NCT00937521|2600952|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
818260|NCT00937521|2600953|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
818261|NCT00937521|2600954|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
818262|NCT00937521|2600955|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
818263|NCT00937521|2600956|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
818264|NCT00937521|2600957|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
818265|NCT00937521|2600950|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
818266|NCT00937521|2600951|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
818267|NCT00937521|2600952|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
818268|NCT00937521|2600953|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
818269|NCT00937521|2600954|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
818270|NCT00937521|2600955|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
818271|NCT00937521|2600956|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
818272|NCT00937521|2600957|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
818273|NCT00937547|2601066|P3|Overall Study|misdiagnosis|7
818274|NCT00937547|2601067|P2|Overall Study|misdiagnosis|6
818275|NCT00937547|2601068|P1|Overall Study|misdiagnosis|1
818284|NCT00937768|2601107|P2|Overall Study|No Further Funding|4
818285|NCT00937768|2601108|P1|Overall Study|No Further Funding|4
818286|NCT00937768|2601107|P2|Overall Study|Alternate Treatment|1
818287|NCT00937768|2601108|P1|Overall Study|Alternate Treatment|0
818288|NCT00937768|2601107|P2|Overall Study|Disease Progression|1
818289|NCT00937768|2601108|P1|Overall Study|Disease Progression|1
818290|NCT00937768|2601107|P2|Overall Study|Refused Further Treatment|2
818291|NCT00937768|2601108|P1|Overall Study|Refused Further Treatment|3
818292|NCT00937833|2601121|P2|Overall Study|Withdrawal by Subject|6
818293|NCT00937833|2601122|P1|Overall Study|Withdrawal by Subject|4
818294|NCT00937833|2601121|P2|Overall Study|Lost to Follow-up|8
818295|NCT00937833|2601122|P1|Overall Study|Lost to Follow-up|10
818296|NCT00937833|2601121|P2|Overall Study|Procedure delayed; enrollment closed|1
818297|NCT00937833|2601122|P1|Overall Study|Procedure delayed; enrollment closed|0
818298|NCT00937833|2601121|P2|Overall Study|Protocol Violation|2
818299|NCT00937833|2601122|P1|Overall Study|Protocol Violation|1
818300|NCT00929864|2601130|P2|Overall Study|Non-specified|7
818301|NCT00929864|2601131|P1|Overall Study|Non-specified|2
818302|NCT00929864|2601130|P2|Overall Study|Administrative reason by Sponsor|1
818303|NCT00929864|2601131|P1|Overall Study|Administrative reason by Sponsor|1
818304|NCT00929864|2601130|P2|Overall Study|Pregnancy|3
818305|NCT00929864|2601131|P1|Overall Study|Pregnancy|0
818306|NCT00929864|2601130|P2|Overall Study|Poor or non-compliance|3
818307|NCT00929864|2601131|P1|Overall Study|Poor or non-compliance|3
818308|NCT00929864|2601130|P2|Overall Study|No longer met criteria|1
818309|NCT00929864|2601131|P1|Overall Study|No longer met criteria|2
818310|NCT00929864|2601130|P2|Overall Study|Withdrawal by Subject|9
818311|NCT00929864|2601131|P1|Overall Study|Withdrawal by Subject|20
818312|NCT00929864|2601130|P2|Overall Study|Lost to Follow-up|12
818313|NCT00929864|2601131|P1|Overall Study|Lost to Follow-up|7
818314|NCT00929864|2601130|P2|Overall Study|Lack of Efficacy|16
818315|NCT00929864|2601131|P1|Overall Study|Lack of Efficacy|19
818316|NCT00929864|2601130|P2|Overall Study|Adverse Event|30
818317|NCT00929864|2601131|P1|Overall Study|Adverse Event|11
818318|NCT00929864|2601130|P2|Overall Study|Death|1
818319|NCT00929864|2601131|P1|Overall Study|Death|1
818320|NCT00930176|2601159|P1|Overall Study|Death|1
818321|NCT00930553|2601175|P1|Overall Study|Other than specified above|28
818322|NCT00930553|2601175|P1|Overall Study|Study terminated by sponsor|24
818323|NCT00930553|2601175|P1|Overall Study|Death|9
818324|NCT00930553|2601175|P1|Overall Study|Lost to Follow-up|25
818325|NCT00930553|2601175|P1|Overall Study|Withdrawal by Subject|88
818326|NCT00930553|2601175|P1|Overall Study|Pregnancy|1
818327|NCT00930553|2601175|P1|Overall Study|Protocol Violation|1
818328|NCT00930553|2601175|P1|Overall Study|Physician Decision|39
818329|NCT00930553|2601175|P1|Overall Study|Lack of Efficacy|7
818330|NCT00930553|2601175|P1|Overall Study|Adverse Event|1
818331|NCT00930644|2601241|P1|Overall Study|Adverse Event|16
818332|NCT00930644|2601241|P1|Overall Study|Death|1
818333|NCT00930644|2601241|P1|Overall Study|Physician Decision|2
818334|NCT00930644|2601241|P1|Overall Study|Withdrawal by Subject|4
818335|NCT00930722|2601254|P1|Overall Study|Study terminated by sponsor|2
818336|NCT00930722|2601254|P1|Overall Study|No longer willing to participate|9
818337|NCT00930722|2601254|P1|Overall Study|Lost to Follow-up|16
818338|NCT00930761|2601271|P2|Overall Study|less than 3 music therapy sessions|3
818339|NCT00930761|2601272|P1|Overall Study|less than 3 music therapy sessions|0
818340|NCT00930761|2601271|P2|Overall Study|3 newborns died; 1 mother quit the study|0
818341|NCT00930761|2601272|P1|Overall Study|3 newborns died; 1 mother quit the study|4
818342|NCT00930774|2601288|P4|Overall Study|Withdrawal by Subject|0
818343|NCT00930774|2601289|P3|Overall Study|Withdrawal by Subject|2
818344|NCT00930774|2601290|P2|Overall Study|Withdrawal by Subject|9
818345|NCT00930774|2601291|P1|Overall Study|Withdrawal by Subject|1
818346|NCT00930813|2601340|P2|Overall Study|Lost to Follow-up|4
818347|NCT00930813|2601341|P1|Overall Study|Lost to Follow-up|2
818348|NCT00930813|2601340|P2|Overall Study|Withdrawal by Subject|5
818349|NCT00930813|2601341|P1|Overall Study|Withdrawal by Subject|2
818350|NCT00930813|2601340|P2|Overall Study|Death|5
818351|NCT00930813|2601341|P1|Overall Study|Death|4
818352|NCT00930930|2601351|P2|Overall Study|patients not compliant|1
818353|NCT00930930|2601352|P1|Overall Study|patients not compliant|1
818354|NCT00930930|2601351|P2|Overall Study|excessive lapse btw txs, not eligible|1
818355|NCT00930930|2601352|P1|Overall Study|excessive lapse btw txs, not eligible|0
818356|NCT00930930|2601351|P2|Overall Study|Disease progression|3
818357|NCT00930930|2601352|P1|Overall Study|Disease progression|2
818358|NCT00930930|2601351|P2|Overall Study|Withdrawal by Subject|1
818359|NCT00930930|2601352|P1|Overall Study|Withdrawal by Subject|3
818360|NCT00930930|2601351|P2|Overall Study|Adverse Event|3
818361|NCT00930930|2601352|P1|Overall Study|Adverse Event|13
818362|NCT00930930|2601351|P2|Overall Study|Physician Decision|0
818363|NCT00930930|2601352|P1|Overall Study|Physician Decision|1
818364|NCT00930930|2601351|P2|Overall Study|Death|0
818365|NCT00930930|2601352|P1|Overall Study|Death|1
818366|NCT00930969|2601364|P1|Overall Study|Withdrawal by Subject|19
818367|NCT00930969|2601364|P1|Overall Study|Physician Decision|13
818368|NCT00930969|2601364|P1|Overall Study|Lost to Follow-up|1
818369|NCT00930969|2601364|P1|Overall Study|Death|5
818370|NCT00930982|2601374|P2|Overall Study|Withdrawal by Subject|1
818371|NCT00930982|2601375|P1|Overall Study|Withdrawal by Subject|1
818372|NCT00930982|2601374|P2|Overall Study|Protocol Violation|5
818373|NCT00930982|2601375|P1|Overall Study|Protocol Violation|1
818374|NCT00930982|2601374|P2|Overall Study|Adverse Event|23
818375|NCT00930982|2601375|P1|Overall Study|Adverse Event|19
818376|NCT00931268|2601422|P1|Overall Study|Lost to Follow-up|6
818377|NCT00931307|2601432|P1|Overall Study|Biomicroscopy|1
818378|NCT00931307|2601432|P1|Overall Study|Lack of Efficacy|12
818379|NCT00931385|2601451|P4|Overall Study|Lost to Follow-up|1
818380|NCT00931385|2601452|P3|Overall Study|Lost to Follow-up|0
818381|NCT00931385|2601453|P2|Overall Study|Lost to Follow-up|0
818382|NCT00931385|2601454|P1|Overall Study|Lost to Follow-up|0
818383|NCT00931385|2601451|P4|Overall Study|Withdrawal by Subject|1
818384|NCT00931385|2601452|P3|Overall Study|Withdrawal by Subject|0
818385|NCT00931385|2601453|P2|Overall Study|Withdrawal by Subject|1
818386|NCT00931385|2601454|P1|Overall Study|Withdrawal by Subject|0
818387|NCT00931385|2601451|P4|Overall Study|Protocol Violation|0
818388|NCT00931385|2601452|P3|Overall Study|Protocol Violation|1
818389|NCT00931385|2601453|P2|Overall Study|Protocol Violation|0
818390|NCT00931385|2601454|P1|Overall Study|Protocol Violation|0
818391|NCT00931385|2601451|P4|Overall Study|Adverse Event|3
818392|NCT00931385|2601452|P3|Overall Study|Adverse Event|0
818393|NCT00931385|2601453|P2|Overall Study|Adverse Event|1
818394|NCT00931385|2601454|P1|Overall Study|Adverse Event|2
818395|NCT00931411|2601510|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
818396|NCT00931411|2601511|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
818397|NCT00931411|2601510|P2|First Intervention - 42 Days|Lost to Follow-up|0
818398|NCT00931411|2601511|P1|First Intervention - 42 Days|Lost to Follow-up|2
818399|NCT00931411|2601510|P2|First Intervention - 42 Days|Adverse Event|3
818400|NCT00931411|2601511|P1|First Intervention - 42 Days|Adverse Event|2
818401|NCT00931463|2601534|P2|Overall Study|Lost to Follow-up|1
818402|NCT00931463|2601535|P1|Overall Study|Lost to Follow-up|4
818403|NCT00931463|2601534|P2|Overall Study|Withdrawal by Subject|0
818404|NCT00931463|2601535|P1|Overall Study|Withdrawal by Subject|5
818405|NCT00931463|2601534|P2|Overall Study|Death|4
818406|NCT00931463|2601535|P1|Overall Study|Death|8
818407|NCT00931515|2601573|P2|Overall Study|Lost to Follow-up|5
818408|NCT00931515|2601574|P1|Overall Study|Lost to Follow-up|2
818409|NCT00931528|2601582|P2|Overall Study|Assessment outside of Time Frame|23
818410|NCT00931528|2601583|P1|Overall Study|Assessment outside of Time Frame|22
818411|NCT00931528|2601582|P2|Overall Study|Lost to Follow-up|13
818412|NCT00931528|2601583|P1|Overall Study|Lost to Follow-up|6
818413|NCT00931528|2601582|P2|Overall Study|Withdrawal by Subject|12
818414|NCT00931528|2601583|P1|Overall Study|Withdrawal by Subject|4
818415|NCT00931528|2601582|P2|Overall Study|Protocol Violation|12
818416|NCT00931528|2601583|P1|Overall Study|Protocol Violation|9
818421|NCT00931710|2601600|P2|Overall Study|Protocol deviation|2
818422|NCT00931710|2601601|P1|Overall Study|Protocol deviation|1
818423|NCT00931710|2601600|P2|Overall Study|Lost to Follow-up|5
818424|NCT00931710|2601601|P1|Overall Study|Lost to Follow-up|6
818425|NCT00931710|2601600|P2|Overall Study|Patient withdrew consent|9
818426|NCT00931710|2601601|P1|Overall Study|Patient withdrew consent|4
818427|NCT00931710|2601600|P2|Overall Study|Unsatisfactory therapeutic effects|12
818428|NCT00931710|2601601|P1|Overall Study|Unsatisfactory therapeutic effects|5
818429|NCT00931710|2601600|P2|Overall Study|Abnormal test procedure results|0
818430|NCT00931710|2601601|P1|Overall Study|Abnormal test procedure results|2
818431|NCT00931710|2601600|P2|Overall Study|Adverse Event|10
818432|NCT00931710|2601601|P1|Overall Study|Adverse Event|16
818433|NCT00931723|2601619|P2|Overall Study|Late hospital discharge|0
818434|NCT00931723|2601620|P1|Overall Study|Late hospital discharge|1
818435|NCT00931723|2601619|P2|Overall Study|Sponsor decision|0
818436|NCT00931723|2601620|P1|Overall Study|Sponsor decision|1
818437|NCT00931723|2601619|P2|Overall Study|Lack or insufficient theraputic response|5
818438|NCT00931723|2601620|P1|Overall Study|Lack or insufficient theraputic response|2
818439|NCT00931723|2601619|P2|Overall Study|Took prohibited concomitant medication|1
818440|NCT00931723|2601620|P1|Overall Study|Took prohibited concomitant medication|0
818441|NCT00931723|2601619|P2|Overall Study|Safety reasons|1
818442|NCT00931723|2601620|P1|Overall Study|Safety reasons|0
818443|NCT00931723|2601619|P2|Overall Study|Severe non-compliance to protocol|0
818444|NCT00931723|2601620|P1|Overall Study|Severe non-compliance to protocol|2
818445|NCT00931723|2601619|P2|Overall Study|Study-specific discontinuation criteria|1
818446|NCT00931723|2601620|P1|Overall Study|Study-specific discontinuation criteria|1
818447|NCT00931723|2601619|P2|Overall Study|Lost to Follow-up|2
818448|NCT00931723|2601620|P1|Overall Study|Lost to Follow-up|1
818449|NCT00931723|2601619|P2|Overall Study|Condition under investigation worsened|2
818450|NCT00931723|2601620|P1|Overall Study|Condition under investigation worsened|1
818451|NCT00931723|2601619|P2|Overall Study|Lithium found in blood|1
818452|NCT00931723|2601620|P1|Overall Study|Lithium found in blood|0
818453|NCT00931723|2601619|P2|Overall Study|Adverse Event|13
818454|NCT00931723|2601620|P1|Overall Study|Adverse Event|6
818455|NCT00931723|2601619|P2|Overall Study|Withdrawal by Subject|13
818456|NCT00931723|2601620|P1|Overall Study|Withdrawal by Subject|11
818457|NCT00931801|2601669|P3|Overall Study|Confirmed Virologic Failure|3
818458|NCT00931801|2601670|P2|Overall Study|Confirmed Virologic Failure|0
818459|NCT00931801|2601671|P1|Overall Study|Confirmed Virologic Failure|0
818460|NCT00931801|2601669|P3|Overall Study|Withdrawal by Subject|0
818461|NCT00931801|2601670|P2|Overall Study|Withdrawal by Subject|0
818462|NCT00931801|2601671|P1|Overall Study|Withdrawal by Subject|1
818463|NCT00931801|2601669|P3|Overall Study|Lost to Follow-up|0
818464|NCT00931801|2601670|P2|Overall Study|Lost to Follow-up|1
818465|NCT00931801|2601671|P1|Overall Study|Lost to Follow-up|0
818466|NCT00931801|2601669|P3|Overall Study|Adverse Event|1
818467|NCT00931801|2601670|P2|Overall Study|Adverse Event|0
818468|NCT00931801|2601671|P1|Overall Study|Adverse Event|0
818469|NCT00931918|2601719|P2|Overall Study|Did not receive study drug|2
818470|NCT00931918|2601720|P1|Overall Study|Did not receive study drug|3
818471|NCT00931918|2601719|P2|Overall Study|Other Reason not Specified|4
818472|NCT00931918|2601720|P1|Overall Study|Other Reason not Specified|4
818473|NCT00931918|2601719|P2|Overall Study|Withdrawal by Patient|4
818474|NCT00931918|2601720|P1|Overall Study|Withdrawal by Patient|3
818475|NCT00931918|2601719|P2|Overall Study|Symptomatic Deterioration|0
818476|NCT00931918|2601720|P1|Overall Study|Symptomatic Deterioration|1
818477|NCT00931918|2601719|P2|Overall Study|Progressive Disease|1
818478|NCT00931918|2601720|P1|Overall Study|Progressive Disease|2
818479|NCT00931918|2601719|P2|Overall Study|Adverse Event|6
818480|NCT00931918|2601720|P1|Overall Study|Adverse Event|4
818481|NCT00932113|2601780|P2|Overall Study|Lost to Follow-up|0
818482|NCT00932113|2601781|P1|Overall Study|Lost to Follow-up|1
818483|NCT00932126|2601797|P8|Overall Study|Other|2
818484|NCT00932126|2601798|P7|Overall Study|Other|1
818485|NCT00932126|2601799|P6|Overall Study|Other|0
818486|NCT00932126|2601800|P5|Overall Study|Other|1
818487|NCT00932126|2601801|P4|Overall Study|Other|0
818488|NCT00932126|2601802|P3|Overall Study|Other|0
818489|NCT00932126|2601803|P2|Overall Study|Other|0
818490|NCT00932126|2601804|P1|Overall Study|Other|0
818491|NCT00932126|2601797|P8|Overall Study|Objective progression or relapse|5
818492|NCT00932126|2601798|P7|Overall Study|Objective progression or relapse|3
818493|NCT00932126|2601799|P6|Overall Study|Objective progression or relapse|3
818494|NCT00932126|2601800|P5|Overall Study|Objective progression or relapse|3
818495|NCT00932126|2601801|P4|Overall Study|Objective progression or relapse|3
818496|NCT00932126|2601802|P3|Overall Study|Objective progression or relapse|2
818497|NCT00932126|2601803|P2|Overall Study|Objective progression or relapse|3
818498|NCT00932126|2601804|P1|Overall Study|Objective progression or relapse|3
818499|NCT00932126|2601797|P8|Overall Study|Withdrawal by Subject|1
818500|NCT00932126|2601798|P7|Overall Study|Withdrawal by Subject|0
818501|NCT00932126|2601799|P6|Overall Study|Withdrawal by Subject|0
818502|NCT00932126|2601800|P5|Overall Study|Withdrawal by Subject|0
818503|NCT00932126|2601801|P4|Overall Study|Withdrawal by Subject|0
818504|NCT00932126|2601802|P3|Overall Study|Withdrawal by Subject|1
818505|NCT00932126|2601803|P2|Overall Study|Withdrawal by Subject|0
818506|NCT00932126|2601804|P1|Overall Study|Withdrawal by Subject|0
818507|NCT00932126|2601797|P8|Overall Study|Protocol Violation|0
818508|NCT00932126|2601798|P7|Overall Study|Protocol Violation|0
818509|NCT00932126|2601799|P6|Overall Study|Protocol Violation|0
818510|NCT00932126|2601800|P5|Overall Study|Protocol Violation|1
818511|NCT00932126|2601801|P4|Overall Study|Protocol Violation|0
818512|NCT00932126|2601802|P3|Overall Study|Protocol Violation|0
818513|NCT00932126|2601803|P2|Overall Study|Protocol Violation|0
818514|NCT00932126|2601804|P1|Overall Study|Protocol Violation|0
818515|NCT00932126|2601797|P8|Overall Study|Adverse Event|2
818516|NCT00932126|2601798|P7|Overall Study|Adverse Event|1
818517|NCT00932126|2601799|P6|Overall Study|Adverse Event|0
818518|NCT00932126|2601800|P5|Overall Study|Adverse Event|0
818519|NCT00932126|2601801|P4|Overall Study|Adverse Event|0
818520|NCT00932126|2601802|P3|Overall Study|Adverse Event|0
818521|NCT00932126|2601803|P2|Overall Study|Adverse Event|0
818522|NCT00932126|2601804|P1|Overall Study|Adverse Event|0
818528|NCT00937950|2601847|P1|Overall Study|Others|18
818529|NCT00937950|2601847|P1|Overall Study|Missing confirmed|4
818530|NCT00937950|2601847|P1|Overall Study|Lost to Follow-up|144
818531|NCT00937950|2601847|P1|Overall Study|Migrated/moved from study area|27
818532|NCT00937950|2601847|P1|Overall Study|Withdrawal by Subject|23
818533|NCT00938015|2601863|P1|Overall Study|Reason not related to Etanercept|29
818534|NCT00938015|2601863|P1|Overall Study|Non-responder|52
818535|NCT00938015|2601863|P1|Overall Study|Adverse Event|32
818536|NCT00938015|2601863|P1|Overall Study|Lost to Follow-up|32
818537|NCT00938015|2601863|P1|Overall Study|Death|2
818538|NCT00938041|2601879|P1|Overall Study|Adrenal Insufficiency|3
818539|NCT00938041|2601879|P1|Overall Study|Death|12
818540|NCT00938041|2601879|P1|Overall Study|Progressive Disease|5
818541|NCT00938041|2601879|P1|Overall Study|Received Alternative Therapy|1
818542|NCT00938041|2601879|P1|Overall Study|Lost to Follow-up|6
818543|NCT00940875|2601890|P2|Post-Study Treatment|Disease Progression|2
818544|NCT00940875|2601891|P1|Post-Study Treatment|Disease Progression|0
818545|NCT00940875|2601890|P2|Post-Study Treatment|Death|1
818546|NCT00940875|2601891|P1|Post-Study Treatment|Death|0
818547|NCT00940875|2601890|P2|Treatment Phase|Physician Decision|0
818548|NCT00940875|2601891|P1|Treatment Phase|Physician Decision|1
818549|NCT00940875|2601890|P2|Treatment Phase|Disease progression|11
818550|NCT00940875|2601891|P1|Treatment Phase|Disease progression|9
818551|NCT00940875|2601890|P2|Treatment Phase|Withdrawal by Subject|0
818552|NCT00940875|2601891|P1|Treatment Phase|Withdrawal by Subject|3
818553|NCT00940875|2601890|P2|Treatment Phase|Lack of Efficacy|0
818554|NCT00940875|2601891|P1|Treatment Phase|Lack of Efficacy|1
818555|NCT00940875|2601890|P2|Treatment Phase|Death|5
818556|NCT00940875|2601891|P1|Treatment Phase|Death|3
818557|NCT00940875|2601890|P2|Treatment Phase|Adverse Event|3
818558|NCT00940875|2601891|P1|Treatment Phase|Adverse Event|9
818563|NCT00940992|2601935|P3|Overall Study|Lost to Follow-up|1
818564|NCT00940992|2601936|P2|Overall Study|Lost to Follow-up|1
818565|NCT00940992|2601937|P1|Overall Study|Lost to Follow-up|0
818566|NCT00940992|2601935|P3|Overall Study|subject request|0
818567|NCT00940992|2601936|P2|Overall Study|subject request|1
818568|NCT00940992|2601937|P1|Overall Study|subject request|2
818569|NCT00940992|2601935|P3|Overall Study|Adverse Event|1
818570|NCT00940992|2601936|P2|Overall Study|Adverse Event|0
818571|NCT00940992|2601937|P1|Overall Study|Adverse Event|2
818572|NCT00941031|2601952|P7|Maintenance Period|Lack of Efficacy|13
818573|NCT00941031|2601953|P6|Maintenance Period|Lack of Efficacy|0
818574|NCT00941031|2601954|P5|Maintenance Period|Lack of Efficacy|0
818575|NCT00941031|2601955|P4|Maintenance Period|Lack of Efficacy|0
818576|NCT00941031|2601956|P3|Maintenance Period|Lack of Efficacy|0
818577|NCT00941031|2601957|P2|Maintenance Period|Lack of Efficacy|0
818578|NCT00941031|2601958|P1|Maintenance Period|Lack of Efficacy|0
818579|NCT00941031|2601952|P7|Maintenance Period|Lost to Follow-up|7
818580|NCT00941031|2601953|P6|Maintenance Period|Lost to Follow-up|2
818581|NCT00941031|2601954|P5|Maintenance Period|Lost to Follow-up|2
818582|NCT00941031|2601955|P4|Maintenance Period|Lost to Follow-up|0
818583|NCT00941031|2601956|P3|Maintenance Period|Lost to Follow-up|0
818584|NCT00941031|2601957|P2|Maintenance Period|Lost to Follow-up|0
818585|NCT00941031|2601958|P1|Maintenance Period|Lost to Follow-up|0
818586|NCT00941031|2601952|P7|Maintenance Period|Adverse Event|8
818587|NCT00941031|2601953|P6|Maintenance Period|Adverse Event|2
818588|NCT00941031|2601954|P5|Maintenance Period|Adverse Event|0
818589|NCT00941031|2601955|P4|Maintenance Period|Adverse Event|0
818590|NCT00941031|2601956|P3|Maintenance Period|Adverse Event|0
818591|NCT00941031|2601957|P2|Maintenance Period|Adverse Event|0
818592|NCT00941031|2601958|P1|Maintenance Period|Adverse Event|0
818593|NCT00941031|2601952|P7|Maintenance Period|Protocol Violation|1
818594|NCT00941031|2601953|P6|Maintenance Period|Protocol Violation|0
818595|NCT00941031|2601954|P5|Maintenance Period|Protocol Violation|0
818596|NCT00941031|2601955|P4|Maintenance Period|Protocol Violation|0
818597|NCT00941031|2601956|P3|Maintenance Period|Protocol Violation|0
818598|NCT00941031|2601957|P2|Maintenance Period|Protocol Violation|0
818599|NCT00941031|2601958|P1|Maintenance Period|Protocol Violation|0
818600|NCT00941031|2601952|P7|Maintenance Period|Administrative Problems|1
818601|NCT00941031|2601953|P6|Maintenance Period|Administrative Problems|0
818602|NCT00941031|2601954|P5|Maintenance Period|Administrative Problems|1
818603|NCT00941031|2601955|P4|Maintenance Period|Administrative Problems|0
818604|NCT00941031|2601956|P3|Maintenance Period|Administrative Problems|0
818605|NCT00941031|2601957|P2|Maintenance Period|Administrative Problems|0
818606|NCT00941031|2601958|P1|Maintenance Period|Administrative Problems|0
818607|NCT00941031|2601952|P7|Maintenance Period|Withdrawal by Subject|13
818608|NCT00941031|2601953|P6|Maintenance Period|Withdrawal by Subject|2
818609|NCT00941031|2601954|P5|Maintenance Period|Withdrawal by Subject|6
818610|NCT00941031|2601955|P4|Maintenance Period|Withdrawal by Subject|0
818611|NCT00941031|2601956|P3|Maintenance Period|Withdrawal by Subject|0
818612|NCT00941031|2601957|P2|Maintenance Period|Withdrawal by Subject|0
818613|NCT00941031|2601958|P1|Maintenance Period|Withdrawal by Subject|0
818614|NCT00941031|2601952|P7|Induction Period|Adverse Event|0
818615|NCT00941031|2601953|P6|Induction Period|Adverse Event|0
818616|NCT00941031|2601954|P5|Induction Period|Adverse Event|0
818617|NCT00941031|2601955|P4|Induction Period|Adverse Event|2
818618|NCT00941031|2601956|P3|Induction Period|Adverse Event|3
818619|NCT00941031|2601957|P2|Induction Period|Adverse Event|0
818620|NCT00941031|2601958|P1|Induction Period|Adverse Event|1
818621|NCT00941031|2601952|P7|Induction Period|Adminstative Problems|0
818622|NCT00941031|2601953|P6|Induction Period|Adminstative Problems|0
818623|NCT00941031|2601954|P5|Induction Period|Adminstative Problems|0
818624|NCT00941031|2601955|P4|Induction Period|Adminstative Problems|0
818625|NCT00941031|2601956|P3|Induction Period|Adminstative Problems|1
818626|NCT00941031|2601957|P2|Induction Period|Adminstative Problems|1
818627|NCT00941031|2601958|P1|Induction Period|Adminstative Problems|1
818628|NCT00941031|2601952|P7|Induction Period|Withdrawal by Subject|0
818629|NCT00941031|2601953|P6|Induction Period|Withdrawal by Subject|0
818630|NCT00941031|2601954|P5|Induction Period|Withdrawal by Subject|0
818631|NCT00941031|2601955|P4|Induction Period|Withdrawal by Subject|2
818632|NCT00941031|2601956|P3|Induction Period|Withdrawal by Subject|2
818633|NCT00941031|2601957|P2|Induction Period|Withdrawal by Subject|2
818634|NCT00941031|2601958|P1|Induction Period|Withdrawal by Subject|1
818635|NCT00941031|2601952|P7|Induction Period|Lack of Efficacy|0
818636|NCT00941031|2601953|P6|Induction Period|Lack of Efficacy|0
818637|NCT00941031|2601954|P5|Induction Period|Lack of Efficacy|0
818638|NCT00941031|2601955|P4|Induction Period|Lack of Efficacy|5
818639|NCT00941031|2601956|P3|Induction Period|Lack of Efficacy|0
818640|NCT00941031|2601957|P2|Induction Period|Lack of Efficacy|1
818641|NCT00941031|2601958|P1|Induction Period|Lack of Efficacy|2
818643|NCT00941304|2602000|P5|Overall Study|Lost to Follow-up|0
818644|NCT00941304|2602001|P4|Overall Study|Lost to Follow-up|0
818645|NCT00941304|2602002|P3|Overall Study|Lost to Follow-up|0
818646|NCT00941304|2602003|P2|Overall Study|Lost to Follow-up|0
818647|NCT00941304|2602004|P1|Overall Study|Lost to Follow-up|1
818652|NCT00941603|2602083|P6|Overall Study|Did not meet protocol eligibility|0
818653|NCT00941603|2602084|P5|Overall Study|Did not meet protocol eligibility|0
818654|NCT00941603|2602085|P4|Overall Study|Did not meet protocol eligibility|0
818655|NCT00941603|2602086|P3|Overall Study|Did not meet protocol eligibility|0
818656|NCT00941603|2602087|P2|Overall Study|Did not meet protocol eligibility|0
818657|NCT00941603|2602088|P1|Overall Study|Did not meet protocol eligibility|1
818658|NCT00941603|2602083|P6|Overall Study|Protocol Violation|0
818659|NCT00941603|2602084|P5|Overall Study|Protocol Violation|0
818660|NCT00941603|2602085|P4|Overall Study|Protocol Violation|0
818661|NCT00941603|2602086|P3|Overall Study|Protocol Violation|0
818662|NCT00941603|2602087|P2|Overall Study|Protocol Violation|1
818663|NCT00941603|2602088|P1|Overall Study|Protocol Violation|0
818664|NCT00941603|2602083|P6|Overall Study|Withdrawal by Subject|1
818665|NCT00941603|2602084|P5|Overall Study|Withdrawal by Subject|0
818666|NCT00941603|2602085|P4|Overall Study|Withdrawal by Subject|2
818667|NCT00941603|2602086|P3|Overall Study|Withdrawal by Subject|0
818668|NCT00941603|2602087|P2|Overall Study|Withdrawal by Subject|0
818669|NCT00941603|2602088|P1|Overall Study|Withdrawal by Subject|0
818670|NCT00941603|2602083|P6|Overall Study|Lost to Follow-up|2
818671|NCT00941603|2602084|P5|Overall Study|Lost to Follow-up|0
818672|NCT00941603|2602085|P4|Overall Study|Lost to Follow-up|1
818673|NCT00941603|2602086|P3|Overall Study|Lost to Follow-up|0
818674|NCT00941603|2602087|P2|Overall Study|Lost to Follow-up|0
818675|NCT00941603|2602088|P1|Overall Study|Lost to Follow-up|0
818676|NCT00941603|2602083|P6|Overall Study|Adverse Event|0
818677|NCT00941603|2602084|P5|Overall Study|Adverse Event|4
818678|NCT00941603|2602085|P4|Overall Study|Adverse Event|1
818679|NCT00941603|2602086|P3|Overall Study|Adverse Event|5
818680|NCT00941603|2602087|P2|Overall Study|Adverse Event|15
818681|NCT00941603|2602088|P1|Overall Study|Adverse Event|10
818682|NCT00941655|2602110|P2|Overall Study|non-compliant|1
818683|NCT00941655|2602111|P1|Overall Study|non-compliant|0
818684|NCT00941655|2602110|P2|Overall Study|withdrew consent|1
818685|NCT00941655|2602111|P1|Overall Study|withdrew consent|0
818686|NCT00941655|2602110|P2|Overall Study|refused further treatment|1
818687|NCT00941655|2602111|P1|Overall Study|refused further treatment|0
818688|NCT00941655|2602110|P2|Overall Study|progressed while on chemo|2
818689|NCT00941655|2602111|P1|Overall Study|progressed while on chemo|0
818690|NCT00941655|2602110|P2|Overall Study|not meet criteria for chemo foll surgery|0
818691|NCT00941655|2602111|P1|Overall Study|not meet criteria for chemo foll surgery|4
818692|NCT00941655|2602110|P2|Overall Study|received some chemo, 4 and 9 cycles|0
818693|NCT00941655|2602111|P1|Overall Study|received some chemo, 4 and 9 cycles|1
818694|NCT00941720|2602169|P1|Overall Study|ineligible|2
818695|NCT00941720|2602169|P1|Overall Study|Insurance denied participation|11
818696|NCT00941720|2602169|P1|Overall Study|Withdrawal by Subject|1
818697|NCT00941733|2602177|P2|Overall Study|Protocol Violation|6
818698|NCT00941733|2602178|P1|Overall Study|Protocol Violation|15
818699|NCT00941733|2602177|P2|Overall Study|Lost to Follow-up|2
818700|NCT00941733|2602178|P1|Overall Study|Lost to Follow-up|1
818701|NCT00941733|2602177|P2|Overall Study|Adverse Event|4
818702|NCT00941733|2602178|P1|Overall Study|Adverse Event|20
818703|NCT00941733|2602177|P2|Overall Study|Withdrawal by Subject|6
818704|NCT00941733|2602178|P1|Overall Study|Withdrawal by Subject|14
818705|NCT00941733|2602177|P2|Overall Study|Death|10
818706|NCT00941733|2602178|P1|Overall Study|Death|24
818707|NCT00941798|2602220|P2|Overall Study|Death|1
818708|NCT00941798|2602221|P1|Overall Study|Death|0
818709|NCT00941798|2602220|P2|Overall Study|Abnormal laboratory values|2
818710|NCT00941798|2602221|P1|Overall Study|Abnormal laboratory values|1
818711|NCT00941798|2602220|P2|Overall Study|Abnormal test procedure results|1
818712|NCT00941798|2602221|P1|Overall Study|Abnormal test procedure results|3
818713|NCT00941798|2602220|P2|Overall Study|Patient's inability to use device|1
818714|NCT00941798|2602221|P1|Overall Study|Patient's inability to use device|6
818715|NCT00941798|2602220|P2|Overall Study|Lack of Efficacy|17
818716|NCT00941798|2602221|P1|Overall Study|Lack of Efficacy|10
818717|NCT00941798|2602220|P2|Overall Study|Administrative problems|23
818718|NCT00941798|2602221|P1|Overall Study|Administrative problems|13
818719|NCT00941798|2602220|P2|Overall Study|Protocol Violation|20
818720|NCT00941798|2602221|P1|Overall Study|Protocol Violation|17
818721|NCT00941798|2602220|P2|Overall Study|Lost to Follow-up|23
818722|NCT00941798|2602221|P1|Overall Study|Lost to Follow-up|29
818723|NCT00941798|2602220|P2|Overall Study|Adverse Event|23
818724|NCT00941798|2602221|P1|Overall Study|Adverse Event|43
818725|NCT00941798|2602220|P2|Overall Study|Withdrawal by Subject|74
818726|NCT00941798|2602221|P1|Overall Study|Withdrawal by Subject|72
818727|NCT00941863|2602254|P5|Continued After PCD|Disease progression, recurrence, relapse|18
818728|NCT00941863|2602255|P4|Continued After PCD|Disease progression, recurrence, relapse|0
818729|NCT00941863|2602256|P3|Continued After PCD|Disease progression, recurrence, relapse|0
818730|NCT00941863|2602257|P2|Continued After PCD|Disease progression, recurrence, relapse|0
818731|NCT00941863|2602258|P1|Continued After PCD|Disease progression, recurrence, relapse|0
818732|NCT00941863|2602254|P5|Continued After PCD|Withdrawal by Subject|1
818733|NCT00941863|2602255|P4|Continued After PCD|Withdrawal by Subject|0
818734|NCT00941863|2602256|P3|Continued After PCD|Withdrawal by Subject|0
818735|NCT00941863|2602257|P2|Continued After PCD|Withdrawal by Subject|0
818736|NCT00941863|2602258|P1|Continued After PCD|Withdrawal by Subject|0
818737|NCT00941863|2602254|P5|Until Primary Completion Date (PCD)|Disease progression|73
818738|NCT00941863|2602255|P4|Until Primary Completion Date (PCD)|Disease progression|14
818739|NCT00941863|2602256|P3|Until Primary Completion Date (PCD)|Disease progression|8
818740|NCT00941863|2602257|P2|Until Primary Completion Date (PCD)|Disease progression|1
818741|NCT00941863|2602258|P1|Until Primary Completion Date (PCD)|Disease progression|6
818742|NCT00941863|2602254|P5|Until Primary Completion Date (PCD)|Death|7
818743|NCT00941863|2602255|P4|Until Primary Completion Date (PCD)|Death|2
818744|NCT00941863|2602256|P3|Until Primary Completion Date (PCD)|Death|1
818745|NCT00941863|2602257|P2|Until Primary Completion Date (PCD)|Death|0
818746|NCT00941863|2602258|P1|Until Primary Completion Date (PCD)|Death|0
818747|NCT00941863|2602254|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
818748|NCT00941863|2602255|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
818749|NCT00941863|2602256|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
818750|NCT00941863|2602257|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
818751|NCT00941863|2602258|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
818752|NCT00941863|2602254|P5|Until Primary Completion Date (PCD)|Physician Decision|1
818753|NCT00941863|2602255|P4|Until Primary Completion Date (PCD)|Physician Decision|0
818754|NCT00941863|2602256|P3|Until Primary Completion Date (PCD)|Physician Decision|0
818755|NCT00941863|2602257|P2|Until Primary Completion Date (PCD)|Physician Decision|0
818756|NCT00941863|2602258|P1|Until Primary Completion Date (PCD)|Physician Decision|0
818757|NCT00941863|2602254|P5|Until Primary Completion Date (PCD)|Adverse Event|5
818758|NCT00941863|2602255|P4|Until Primary Completion Date (PCD)|Adverse Event|1
818759|NCT00941863|2602256|P3|Until Primary Completion Date (PCD)|Adverse Event|2
818760|NCT00941863|2602257|P2|Until Primary Completion Date (PCD)|Adverse Event|2
818761|NCT00941863|2602258|P1|Until Primary Completion Date (PCD)|Adverse Event|1
818762|NCT00941928|2602292|P1|Overall Study|Disease Progression|1
818763|NCT00941928|2602292|P1|Overall Study|Withdrawal by Subject|1
818764|NCT00942084|2602304|P1|Overall Study|Death|2
818765|NCT00942175|2602321|P4|Overall Study|Low Platelet Count|0
818766|NCT00942175|2602322|P3|Overall Study|Low Platelet Count|0
818767|NCT00942175|2602323|P2|Overall Study|Low Platelet Count|2
818768|NCT00942175|2602324|P1|Overall Study|Low Platelet Count|0
818769|NCT00942175|2602321|P4|Overall Study|Elevated Alanine Amino Transferase|1
818770|NCT00942175|2602322|P3|Overall Study|Elevated Alanine Amino Transferase|0
818771|NCT00942175|2602323|P2|Overall Study|Elevated Alanine Amino Transferase|0
818772|NCT00942175|2602324|P1|Overall Study|Elevated Alanine Amino Transferase|0
818773|NCT00942175|2602321|P4|Overall Study|Pregnancy|1
818774|NCT00942175|2602322|P3|Overall Study|Pregnancy|0
818775|NCT00942175|2602323|P2|Overall Study|Pregnancy|0
818776|NCT00942175|2602324|P1|Overall Study|Pregnancy|0
818777|NCT00942175|2602321|P4|Overall Study|Protocol Violation|0
818778|NCT00942175|2602322|P3|Overall Study|Protocol Violation|2
818779|NCT00942175|2602323|P2|Overall Study|Protocol Violation|1
818780|NCT00942175|2602324|P1|Overall Study|Protocol Violation|0
818781|NCT00942175|2602321|P4|Overall Study|Adverse Event|0
818782|NCT00942175|2602322|P3|Overall Study|Adverse Event|0
818783|NCT00942175|2602323|P2|Overall Study|Adverse Event|1
818784|NCT00942175|2602324|P1|Overall Study|Adverse Event|2
818785|NCT00942266|2602376|P2|Overall Study|medical deterioration (pneumonia)|1
818786|NCT00942266|2602377|P1|Overall Study|medical deterioration (pneumonia)|0
818787|NCT00942266|2602376|P2|Overall Study|Physician Decision|0
818788|NCT00942266|2602377|P1|Overall Study|Physician Decision|2
818789|NCT00942266|2602376|P2|Overall Study|Intercurrent illness|1
818790|NCT00942266|2602377|P1|Overall Study|Intercurrent illness|0
818791|NCT00942266|2602376|P2|Overall Study|Failure to thrive and pt withdrawal|1
818792|NCT00942266|2602377|P1|Overall Study|Failure to thrive and pt withdrawal|0
818793|NCT00942266|2602376|P2|Overall Study|Disease Progression|11
818794|NCT00942266|2602377|P1|Overall Study|Disease Progression|38
818795|NCT00942266|2602376|P2|Overall Study|Adverse Event|1
818796|NCT00942266|2602377|P1|Overall Study|Adverse Event|2
818797|NCT00942266|2602376|P2|Overall Study|Withdrawal by Subject|0
818798|NCT00942266|2602377|P1|Overall Study|Withdrawal by Subject|1
818799|NCT00942409|2602395|P1|Overall Study|study drug unavailable|2
818800|NCT00942409|2602395|P1|Overall Study|Lack of Efficacy|1
818801|NCT00942422|2602399|P1|Overall Study|Progressive diease|1
818802|NCT00942422|2602399|P1|Overall Study|Death|1
818803|NCT00942422|2602399|P1|Overall Study|Withdrawal by Subject|1
818804|NCT00942604|2602474|P2|Overall Study|Patient relocation|1
818805|NCT00942604|2602475|P1|Overall Study|Patient relocation|1
818806|NCT00942604|2602474|P2|Overall Study|Withdrawal by Subject|1
818807|NCT00942604|2602475|P1|Overall Study|Withdrawal by Subject|0
818808|NCT00942604|2602474|P2|Overall Study|Adverse Event|1
818809|NCT00942604|2602475|P1|Overall Study|Adverse Event|0
818810|NCT00942604|2602474|P2|Overall Study|Protocol Violation|1
818811|NCT00942604|2602475|P1|Overall Study|Protocol Violation|1
818812|NCT00942734|2602483|P1|Overall Study|Physician Decision|1
818813|NCT00942734|2602483|P1|Overall Study|Disease Progression|2
818814|NCT00942734|2602483|P1|Overall Study|Protocol Violation|3
818815|NCT00942734|2602483|P1|Overall Study|Adverse Event|2
818816|NCT00942968|2602521|P1|Overall Study|Deep vein thrombosis (DVT)|2
818817|NCT00942968|2602521|P1|Overall Study|Participant required pancreatic biopsy|1
818818|NCT00942968|2602521|P1|Overall Study|Pulmonary embolism (PE)|1
818819|NCT00942968|2602521|P1|Overall Study|Inferior vena cava filter placement|4
818820|NCT00942968|2602521|P1|Overall Study|Progression of disease|12
818821|NCT00942968|2602521|P1|Overall Study|Physician Decision|11
818822|NCT00942968|2602521|P1|Overall Study|Sponsor request|5
818823|NCT00942968|2602521|P1|Overall Study|Withdrawal by Subject|44
818824|NCT00942968|2602521|P1|Overall Study|Lost to Follow-up|4
818825|NCT00942968|2602521|P1|Overall Study|Protocol Violation|9
818826|NCT00942968|2602521|P1|Overall Study|Death|76
818827|NCT00942968|2602521|P1|Overall Study|Adverse Event|60
818828|NCT00942994|2602544|P2|Overall Study|Protocol deviation|2
818829|NCT00942994|2602545|P1|Overall Study|Protocol deviation|1
818830|NCT00942994|2602544|P2|Overall Study|Lost to Follow-up|4
818831|NCT00942994|2602545|P1|Overall Study|Lost to Follow-up|1
818832|NCT00942994|2602544|P2|Overall Study|Patient withdrew consent|8
818833|NCT00942994|2602545|P1|Overall Study|Patient withdrew consent|5
818834|NCT00942994|2602544|P2|Overall Study|Unsatisfactory therapeutic effect|1
818835|NCT00942994|2602545|P1|Overall Study|Unsatisfactory therapeutic effect|1
818836|NCT00942994|2602544|P2|Overall Study|Abnormal laboratory value(s)|0
818837|NCT00942994|2602545|P1|Overall Study|Abnormal laboratory value(s)|1
818838|NCT00942994|2602544|P2|Overall Study|Adverse Event|4
818839|NCT00942994|2602545|P1|Overall Study|Adverse Event|7
818840|NCT00943072|2602563|P2|Overall Study|Other|1
818841|NCT00943072|2602564|P1|Overall Study|Other|1
818842|NCT00943072|2602563|P2|Overall Study|Lack of Efficacy|4
818843|NCT00943072|2602564|P1|Overall Study|Lack of Efficacy|0
818844|NCT00943072|2602563|P2|Overall Study|Lost to Follow-up|2
818845|NCT00943072|2602564|P1|Overall Study|Lost to Follow-up|1
818846|NCT00943072|2602563|P2|Overall Study|Protocol Violation|1
818847|NCT00943072|2602564|P1|Overall Study|Protocol Violation|0
818848|NCT00943072|2602563|P2|Overall Study|Withdrawal by Subject|1
818849|NCT00943072|2602564|P1|Overall Study|Withdrawal by Subject|3
818850|NCT00943072|2602563|P2|Overall Study|Death|2
818851|NCT00943072|2602564|P1|Overall Study|Death|0
818852|NCT00943072|2602563|P2|Overall Study|Adverse Event|3
818853|NCT00943072|2602564|P1|Overall Study|Adverse Event|0
818854|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Other than specified above|2
818855|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Other than specified above|0
818856|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Other than specified above|0
818857|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
818858|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
818859|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
818860|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Pregnancy|4
818861|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Pregnancy|0
818862|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Pregnancy|0
818863|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
818864|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
818865|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
818866|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Adverse Event|9
818867|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Adverse Event|0
818868|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Adverse Event|0
818869|NCT00943111|2602617|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
818870|NCT00943111|2602618|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
818871|NCT00943111|2602619|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
818872|NCT00943111|2602617|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
818873|NCT00943111|2602618|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
818874|NCT00943111|2602619|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
818875|NCT00943111|2602617|P3|52-Weeks Primary Analysis Period|Adverse Event|0
818876|NCT00943111|2602618|P2|52-Weeks Primary Analysis Period|Adverse Event|1
818877|NCT00943111|2602619|P1|52-Weeks Primary Analysis Period|Adverse Event|2
818878|NCT00943124|2602650|P2|Period 1|Personal Reasons|1
818879|NCT00943124|2602651|P1|Period 1|Personal Reasons|0
818880|NCT00943124|2602650|P2|Period 1|Did Not Follow Study Procedures|0
818881|NCT00943124|2602651|P1|Period 1|Did Not Follow Study Procedures|1
818882|NCT00943124|2602650|P2|Period 1|Withdrawal by Subject|1
818883|NCT00943124|2602651|P1|Period 1|Withdrawal by Subject|1
818884|NCT00935220|2602933|P1|Overall Study|Other reason (not specified)|1
818885|NCT00935220|2602933|P1|Overall Study|Adverse Event|1
818886|NCT00935259|2602945|P2|Period 1|Administrative (scheduling conflict)|1
818887|NCT00935259|2602946|P1|Period 1|Administrative (scheduling conflict)|1
818888|NCT00935272|2602962|P2|Overall Study|Protocol Violation|1
818889|NCT00935272|2602963|P1|Overall Study|Protocol Violation|0
818890|NCT00935272|2602962|P2|Overall Study|Physician Decision|0
818891|NCT00935272|2602963|P1|Overall Study|Physician Decision|1
818892|NCT00935272|2602962|P2|Overall Study|Withdrawal by Subject|2
818893|NCT00935272|2602963|P1|Overall Study|Withdrawal by Subject|8
818894|NCT00935272|2602962|P2|Overall Study|Lost to Follow-up|3
818895|NCT00935272|2602963|P1|Overall Study|Lost to Follow-up|10
818896|NCT00943384|2602994|P1|Overall Study|Withdrawal by Subject|5
818897|NCT00943384|2602994|P1|Overall Study|Lost to Follow-up|16
818898|NCT00943384|2602994|P1|Overall Study|Treated off protocol-protocol violation|5
818899|NCT00943384|2602994|P1|Overall Study|Dispositioned prior to treatment|23
818900|NCT00943397|2603010|P2|Overall Study|Site terminated and other|56
818901|NCT00943397|2603011|P1|Overall Study|Site terminated and other|12
818902|NCT00943397|2603010|P2|Overall Study|Withdrawal by Subject|1
818903|NCT00943397|2603011|P1|Overall Study|Withdrawal by Subject|1
818904|NCT00943397|2603010|P2|Overall Study|Protocol Violation|5
818905|NCT00943397|2603011|P1|Overall Study|Protocol Violation|2
818906|NCT00943397|2603010|P2|Overall Study|Lost to Follow-up|4
818907|NCT00943397|2603011|P1|Overall Study|Lost to Follow-up|0
818908|NCT00943397|2603010|P2|Overall Study|Adverse Event|6
818909|NCT00943397|2603011|P1|Overall Study|Adverse Event|0
818910|NCT00943579|2603099|P2|Overall Study|Lack of Efficacy|2
818911|NCT00943579|2603100|P1|Overall Study|Lack of Efficacy|2
818912|NCT00943579|2603099|P2|Overall Study|Adverse Event|3
818913|NCT00943579|2603100|P1|Overall Study|Adverse Event|4
818914|NCT00943592|2603112|P1|Overall Study|Death|3
818915|NCT00943605|2603125|P2|Overall Study|Study termination|30
818916|NCT00943605|2603126|P1|Overall Study|Study termination|30
818917|NCT00943670|2603189|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
818918|NCT00943670|2603189|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
818919|NCT00943670|2603189|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
818920|NCT00943670|2603189|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
818921|NCT00943670|2603189|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
818922|NCT00943670|2603189|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
818923|NCT00943670|2603189|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
818924|NCT00943670|2603189|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
818925|NCT00943670|2603189|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
818926|NCT00943670|2603189|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
818927|NCT00943761|2603225|P2|Overall Study|Withdrawal by Subject|1
818928|NCT00943761|2603226|P1|Overall Study|Withdrawal by Subject|2
818929|NCT00943761|2603225|P2|Overall Study|Lost to Follow-up|0
818930|NCT00943761|2603226|P1|Overall Study|Lost to Follow-up|2
818931|NCT00943787|2603238|P1|Overall Study|Withdrawal by Subject|3
818932|NCT00943787|2603238|P1|Overall Study|Physician Decision|4
818933|NCT00943826|2603245|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
818934|NCT00943826|2603246|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
818935|NCT00943826|2603245|P2|After Primary Overall Survival Analysis|Progression of Disease|4
818936|NCT00943826|2603246|P1|After Primary Overall Survival Analysis|Progression of Disease|2
818937|NCT00943826|2603245|P2|After Primary Overall Survival Analysis|Administrative reasons|16
818938|NCT00943826|2603246|P1|After Primary Overall Survival Analysis|Administrative reasons|10
818939|NCT00943826|2603245|P2|After Primary Overall Survival Analysis|Adverse Event|0
818940|NCT00943826|2603246|P1|After Primary Overall Survival Analysis|Adverse Event|11
818941|NCT00943826|2603245|P2|Monotherapy Phase|Failure to return|1
818942|NCT00943826|2603246|P1|Monotherapy Phase|Failure to return|2
818943|NCT00943826|2603245|P2|Monotherapy Phase|Withdrew Consent|3
818944|NCT00943826|2603246|P1|Monotherapy Phase|Withdrew Consent|2
818945|NCT00943826|2603245|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
818946|NCT00943826|2603246|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
818947|NCT00943826|2603245|P2|Monotherapy Phase|Administrative reasons|5
818948|NCT00943826|2603246|P1|Monotherapy Phase|Administrative reasons|11
818949|NCT00943826|2603245|P2|Monotherapy Phase|Adverse Event|5
818950|NCT00943826|2603246|P1|Monotherapy Phase|Adverse Event|42
818951|NCT00943826|2603245|P2|Maintenance Phase|Failure to return|1
818952|NCT00943826|2603246|P1|Maintenance Phase|Failure to return|0
818953|NCT00943826|2603245|P2|Maintenance Phase|Administrative reasons|1
818954|NCT00943826|2603246|P1|Maintenance Phase|Administrative reasons|4
818955|NCT00943826|2603245|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
818956|NCT00943826|2603246|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
818957|NCT00943826|2603245|P2|Maintenance Phase|Withdrew consent|4
818958|NCT00943826|2603246|P1|Maintenance Phase|Withdrew consent|2
818959|NCT00943826|2603245|P2|Maintenance Phase|Adverse Event|30
818960|NCT00943826|2603246|P1|Maintenance Phase|Adverse Event|31
818961|NCT00943826|2603245|P2|Concurrent Phase|Protocol Violation|0
818962|NCT00943826|2603246|P1|Concurrent Phase|Protocol Violation|1
818963|NCT00943826|2603245|P2|Concurrent Phase|Administrative reasons|1
818964|NCT00943826|2603246|P1|Concurrent Phase|Administrative reasons|2
818965|NCT00943826|2603245|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
818966|NCT00943826|2603246|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
818967|NCT00943826|2603245|P2|Concurrent Phase|Withdrew consent|7
818968|NCT00943826|2603246|P1|Concurrent Phase|Withdrew consent|3
818969|NCT00943826|2603245|P2|Concurrent Phase|Adverse Event|27
818970|NCT00943826|2603246|P1|Concurrent Phase|Adverse Event|50
818971|NCT00943852|2603264|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
818972|NCT00943852|2603265|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
818973|NCT00943852|2603266|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
818974|NCT00943852|2603267|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
818975|NCT00943852|2603268|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
818976|NCT00943852|2603269|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
818977|NCT00943852|2603270|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
818978|NCT00943852|2603271|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
818979|NCT00943852|2603272|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
818980|NCT00943852|2603273|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
818981|NCT00943852|2603264|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818982|NCT00943852|2603265|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818983|NCT00943852|2603266|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
818984|NCT00943852|2603267|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818985|NCT00943852|2603268|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818986|NCT00943852|2603269|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818987|NCT00943852|2603270|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818988|NCT00943852|2603271|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818989|NCT00943852|2603272|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818990|NCT00943852|2603273|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
818991|NCT00943852|2603264|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818992|NCT00943852|2603265|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818993|NCT00943852|2603266|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818994|NCT00943852|2603267|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
818995|NCT00943852|2603268|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818996|NCT00943852|2603269|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818997|NCT00943852|2603270|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818998|NCT00943852|2603271|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
818999|NCT00943852|2603272|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
819000|NCT00943852|2603273|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
819001|NCT00943852|2603264|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
819002|NCT00943852|2603265|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
819003|NCT00943852|2603266|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
819004|NCT00943852|2603267|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
819005|NCT00943852|2603268|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
819006|NCT00943852|2603269|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
819007|NCT00943852|2603270|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
819008|NCT00943852|2603271|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
819009|NCT00943852|2603272|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
819010|NCT00943852|2603273|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
819011|NCT00943852|2603264|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819012|NCT00943852|2603265|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819013|NCT00943852|2603266|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819014|NCT00943852|2603267|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819015|NCT00943852|2603268|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819016|NCT00943852|2603269|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819017|NCT00943852|2603270|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
819018|NCT00943852|2603271|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819019|NCT00943852|2603272|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819020|NCT00943852|2603273|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
819021|NCT00943917|2603428|P15|Stage II Continuation|A1C elevation|0
819022|NCT00943917|2603429|P14|Stage II Continuation|A1C elevation|1
819023|NCT00943917|2603430|P13|Stage II Continuation|A1C elevation|0
819024|NCT00943917|2603431|P12|Stage II Continuation|A1C elevation|0
819025|NCT00943917|2603432|P11|Stage II Continuation|A1C elevation|0
819026|NCT00943917|2603433|P10|Stage II Continuation|A1C elevation|0
819027|NCT00943917|2603434|P9|Stage II Continuation|A1C elevation|0
819028|NCT00943917|2603435|P8|Stage II Continuation|A1C elevation|0
819029|NCT00943917|2603436|P7|Stage II Continuation|A1C elevation|0
819030|NCT00943917|2603437|P6|Stage II Continuation|A1C elevation|0
819031|NCT00943917|2603438|P5|Stage II Continuation|A1C elevation|0
819032|NCT00943917|2603439|P4|Stage II Continuation|A1C elevation|0
819033|NCT00943917|2603440|P3|Stage II Continuation|A1C elevation|0
819034|NCT00943917|2603441|P2|Stage II Continuation|A1C elevation|0
819035|NCT00943917|2603442|P1|Stage II Continuation|A1C elevation|0
819036|NCT00943917|2603428|P15|Stage II Continuation|hypoglycemia|0
819037|NCT00943917|2603429|P14|Stage II Continuation|hypoglycemia|0
819038|NCT00943917|2603430|P13|Stage II Continuation|hypoglycemia|1
819039|NCT00943917|2603431|P12|Stage II Continuation|hypoglycemia|0
819040|NCT00943917|2603432|P11|Stage II Continuation|hypoglycemia|0
819041|NCT00943917|2603433|P10|Stage II Continuation|hypoglycemia|0
819042|NCT00943917|2603434|P9|Stage II Continuation|hypoglycemia|0
819043|NCT00943917|2603435|P8|Stage II Continuation|hypoglycemia|0
819044|NCT00943917|2603436|P7|Stage II Continuation|hypoglycemia|0
819045|NCT00943917|2603437|P6|Stage II Continuation|hypoglycemia|0
819046|NCT00943917|2603438|P5|Stage II Continuation|hypoglycemia|0
819047|NCT00943917|2603439|P4|Stage II Continuation|hypoglycemia|0
819048|NCT00943917|2603440|P3|Stage II Continuation|hypoglycemia|0
819049|NCT00943917|2603441|P2|Stage II Continuation|hypoglycemia|0
819050|NCT00943917|2603442|P1|Stage II Continuation|hypoglycemia|0
819051|NCT00943917|2603428|P15|Stage II Continuation|Protocol Violation|0
819052|NCT00943917|2603429|P14|Stage II Continuation|Protocol Violation|0
819053|NCT00943917|2603430|P13|Stage II Continuation|Protocol Violation|0
819054|NCT00943917|2603431|P12|Stage II Continuation|Protocol Violation|1
819055|NCT00943917|2603432|P11|Stage II Continuation|Protocol Violation|0
819056|NCT00943917|2603433|P10|Stage II Continuation|Protocol Violation|1
819057|NCT00943917|2603434|P9|Stage II Continuation|Protocol Violation|0
819058|NCT00943917|2603435|P8|Stage II Continuation|Protocol Violation|0
819059|NCT00943917|2603436|P7|Stage II Continuation|Protocol Violation|0
819060|NCT00943917|2603437|P6|Stage II Continuation|Protocol Violation|0
819061|NCT00943917|2603438|P5|Stage II Continuation|Protocol Violation|0
819062|NCT00943917|2603439|P4|Stage II Continuation|Protocol Violation|0
819063|NCT00943917|2603440|P3|Stage II Continuation|Protocol Violation|0
819064|NCT00943917|2603441|P2|Stage II Continuation|Protocol Violation|0
819065|NCT00943917|2603442|P1|Stage II Continuation|Protocol Violation|0
819066|NCT00943917|2603428|P15|Stage II Continuation|Withdrawal by Subject|3
819067|NCT00943917|2603429|P14|Stage II Continuation|Withdrawal by Subject|1
819068|NCT00943917|2603430|P13|Stage II Continuation|Withdrawal by Subject|0
819069|NCT00943917|2603431|P12|Stage II Continuation|Withdrawal by Subject|0
819070|NCT00943917|2603432|P11|Stage II Continuation|Withdrawal by Subject|0
819071|NCT00943917|2603433|P10|Stage II Continuation|Withdrawal by Subject|0
819072|NCT00943917|2603434|P9|Stage II Continuation|Withdrawal by Subject|0
819073|NCT00943917|2603435|P8|Stage II Continuation|Withdrawal by Subject|0
819074|NCT00943917|2603436|P7|Stage II Continuation|Withdrawal by Subject|0
819075|NCT00943917|2603437|P6|Stage II Continuation|Withdrawal by Subject|0
819076|NCT00943917|2603438|P5|Stage II Continuation|Withdrawal by Subject|0
819077|NCT00943917|2603439|P4|Stage II Continuation|Withdrawal by Subject|0
819078|NCT00943917|2603440|P3|Stage II Continuation|Withdrawal by Subject|0
819079|NCT00943917|2603441|P2|Stage II Continuation|Withdrawal by Subject|0
819080|NCT00943917|2603442|P1|Stage II Continuation|Withdrawal by Subject|0
819081|NCT00943917|2603428|P15|Stage II Continuation|Adverse Event|1
819082|NCT00943917|2603429|P14|Stage II Continuation|Adverse Event|1
819083|NCT00943917|2603430|P13|Stage II Continuation|Adverse Event|2
819084|NCT00943917|2603431|P12|Stage II Continuation|Adverse Event|1
819085|NCT00943917|2603432|P11|Stage II Continuation|Adverse Event|0
819086|NCT00943917|2603433|P10|Stage II Continuation|Adverse Event|0
819087|NCT00943917|2603434|P9|Stage II Continuation|Adverse Event|0
819088|NCT00943917|2603435|P8|Stage II Continuation|Adverse Event|0
819089|NCT00943917|2603436|P7|Stage II Continuation|Adverse Event|0
819090|NCT00943917|2603437|P6|Stage II Continuation|Adverse Event|0
819091|NCT00943917|2603438|P5|Stage II Continuation|Adverse Event|0
819092|NCT00943917|2603439|P4|Stage II Continuation|Adverse Event|0
819093|NCT00943917|2603440|P3|Stage II Continuation|Adverse Event|0
819094|NCT00943917|2603441|P2|Stage II Continuation|Adverse Event|0
819095|NCT00943917|2603442|P1|Stage II Continuation|Adverse Event|0
819096|NCT00943917|2603428|P15|Stage II|Pregnancy|0
819097|NCT00943917|2603429|P14|Stage II|Pregnancy|0
819098|NCT00943917|2603430|P13|Stage II|Pregnancy|0
819099|NCT00943917|2603431|P12|Stage II|Pregnancy|0
819100|NCT00943917|2603432|P11|Stage II|Pregnancy|0
819101|NCT00943917|2603433|P10|Stage II|Pregnancy|0
819102|NCT00943917|2603434|P9|Stage II|Pregnancy|0
819103|NCT00943917|2603435|P8|Stage II|Pregnancy|0
819104|NCT00943917|2603436|P7|Stage II|Pregnancy|0
819105|NCT00943917|2603437|P6|Stage II|Pregnancy|1
819106|NCT00943917|2603438|P5|Stage II|Pregnancy|0
819107|NCT00943917|2603439|P4|Stage II|Pregnancy|0
819108|NCT00943917|2603440|P3|Stage II|Pregnancy|0
819109|NCT00943917|2603441|P2|Stage II|Pregnancy|0
819110|NCT00943917|2603442|P1|Stage II|Pregnancy|0
819111|NCT00943917|2603428|P15|Stage II|Withdrawal by Subject|0
819112|NCT00943917|2603429|P14|Stage II|Withdrawal by Subject|0
819113|NCT00943917|2603430|P13|Stage II|Withdrawal by Subject|0
819114|NCT00943917|2603431|P12|Stage II|Withdrawal by Subject|0
819115|NCT00943917|2603432|P11|Stage II|Withdrawal by Subject|0
819116|NCT00943917|2603433|P10|Stage II|Withdrawal by Subject|0
819117|NCT00943917|2603434|P9|Stage II|Withdrawal by Subject|0
819118|NCT00943917|2603435|P8|Stage II|Withdrawal by Subject|0
819119|NCT00943917|2603436|P7|Stage II|Withdrawal by Subject|0
819120|NCT00943917|2603437|P6|Stage II|Withdrawal by Subject|1
819121|NCT00943917|2603438|P5|Stage II|Withdrawal by Subject|0
819122|NCT00943917|2603439|P4|Stage II|Withdrawal by Subject|0
819123|NCT00943917|2603440|P3|Stage II|Withdrawal by Subject|0
819124|NCT00943917|2603441|P2|Stage II|Withdrawal by Subject|0
819125|NCT00943917|2603442|P1|Stage II|Withdrawal by Subject|0
819126|NCT00943917|2603428|P15|Stage II|Adverse Event|0
819127|NCT00943917|2603429|P14|Stage II|Adverse Event|0
819128|NCT00943917|2603430|P13|Stage II|Adverse Event|0
819129|NCT00943917|2603431|P12|Stage II|Adverse Event|0
819130|NCT00943917|2603432|P11|Stage II|Adverse Event|0
819131|NCT00943917|2603433|P10|Stage II|Adverse Event|0
819132|NCT00943917|2603434|P9|Stage II|Adverse Event|1
819133|NCT00943917|2603435|P8|Stage II|Adverse Event|0
819134|NCT00943917|2603436|P7|Stage II|Adverse Event|3
819135|NCT00943917|2603437|P6|Stage II|Adverse Event|1
819136|NCT00943917|2603438|P5|Stage II|Adverse Event|0
819137|NCT00943917|2603439|P4|Stage II|Adverse Event|0
819138|NCT00943917|2603440|P3|Stage II|Adverse Event|0
819139|NCT00943917|2603441|P2|Stage II|Adverse Event|0
819140|NCT00943917|2603442|P1|Stage II|Adverse Event|0
819141|NCT00943917|2603428|P15|Stage I|Withdrawal by Subject|0
819142|NCT00943917|2603429|P14|Stage I|Withdrawal by Subject|0
819143|NCT00943917|2603430|P13|Stage I|Withdrawal by Subject|0
819144|NCT00943917|2603431|P12|Stage I|Withdrawal by Subject|0
819145|NCT00943917|2603432|P11|Stage I|Withdrawal by Subject|0
819146|NCT00943917|2603433|P10|Stage I|Withdrawal by Subject|0
819147|NCT00943917|2603434|P9|Stage I|Withdrawal by Subject|0
819148|NCT00943917|2603435|P8|Stage I|Withdrawal by Subject|0
819149|NCT00943917|2603436|P7|Stage I|Withdrawal by Subject|0
819150|NCT00943917|2603437|P6|Stage I|Withdrawal by Subject|0
819151|NCT00943917|2603438|P5|Stage I|Withdrawal by Subject|0
819152|NCT00943917|2603439|P4|Stage I|Withdrawal by Subject|0
819153|NCT00943917|2603440|P3|Stage I|Withdrawal by Subject|2
819154|NCT00943917|2603441|P2|Stage I|Withdrawal by Subject|1
819155|NCT00943917|2603442|P1|Stage I|Withdrawal by Subject|2
819156|NCT00943917|2603428|P15|Stage I|A1C elevation|0
819157|NCT00943917|2603429|P14|Stage I|A1C elevation|0
819158|NCT00943917|2603430|P13|Stage I|A1C elevation|0
819159|NCT00943917|2603431|P12|Stage I|A1C elevation|0
819160|NCT00943917|2603432|P11|Stage I|A1C elevation|0
819161|NCT00943917|2603433|P10|Stage I|A1C elevation|0
819162|NCT00943917|2603434|P9|Stage I|A1C elevation|0
819163|NCT00943917|2603435|P8|Stage I|A1C elevation|0
819164|NCT00943917|2603436|P7|Stage I|A1C elevation|0
819165|NCT00943917|2603437|P6|Stage I|A1C elevation|0
819166|NCT00943917|2603438|P5|Stage I|A1C elevation|0
819167|NCT00943917|2603439|P4|Stage I|A1C elevation|0
819168|NCT00943917|2603440|P3|Stage I|A1C elevation|0
819169|NCT00943917|2603441|P2|Stage I|A1C elevation|0
819170|NCT00943917|2603442|P1|Stage I|A1C elevation|1
819171|NCT00943917|2603428|P15|Stage I|hyperglycemia|0
819172|NCT00943917|2603429|P14|Stage I|hyperglycemia|0
819173|NCT00943917|2603430|P13|Stage I|hyperglycemia|0
819174|NCT00943917|2603431|P12|Stage I|hyperglycemia|0
819175|NCT00943917|2603432|P11|Stage I|hyperglycemia|0
819176|NCT00943917|2603433|P10|Stage I|hyperglycemia|0
819177|NCT00943917|2603434|P9|Stage I|hyperglycemia|0
819178|NCT00943917|2603435|P8|Stage I|hyperglycemia|0
819179|NCT00943917|2603436|P7|Stage I|hyperglycemia|0
819180|NCT00943917|2603437|P6|Stage I|hyperglycemia|0
819181|NCT00943917|2603438|P5|Stage I|hyperglycemia|0
819182|NCT00943917|2603439|P4|Stage I|hyperglycemia|0
819183|NCT00943917|2603440|P3|Stage I|hyperglycemia|1
819184|NCT00943917|2603441|P2|Stage I|hyperglycemia|0
819185|NCT00943917|2603442|P1|Stage I|hyperglycemia|0
819186|NCT00943917|2603428|P15|Stage I|Lost to Follow-up|0
819187|NCT00943917|2603429|P14|Stage I|Lost to Follow-up|0
819188|NCT00943917|2603430|P13|Stage I|Lost to Follow-up|0
819189|NCT00943917|2603431|P12|Stage I|Lost to Follow-up|0
819190|NCT00943917|2603432|P11|Stage I|Lost to Follow-up|0
819191|NCT00943917|2603433|P10|Stage I|Lost to Follow-up|0
819192|NCT00943917|2603434|P9|Stage I|Lost to Follow-up|0
819193|NCT00943917|2603435|P8|Stage I|Lost to Follow-up|0
819194|NCT00943917|2603436|P7|Stage I|Lost to Follow-up|0
819195|NCT00943917|2603437|P6|Stage I|Lost to Follow-up|0
819196|NCT00943917|2603438|P5|Stage I|Lost to Follow-up|0
819197|NCT00943917|2603439|P4|Stage I|Lost to Follow-up|0
819198|NCT00943917|2603440|P3|Stage I|Lost to Follow-up|1
819199|NCT00943917|2603441|P2|Stage I|Lost to Follow-up|0
819200|NCT00943917|2603442|P1|Stage I|Lost to Follow-up|0
819201|NCT00943917|2603428|P15|Stage I|Adverse Event|0
819202|NCT00943917|2603429|P14|Stage I|Adverse Event|0
819203|NCT00943917|2603430|P13|Stage I|Adverse Event|0
819204|NCT00943917|2603431|P12|Stage I|Adverse Event|0
819205|NCT00943917|2603432|P11|Stage I|Adverse Event|0
819206|NCT00943917|2603433|P10|Stage I|Adverse Event|0
819207|NCT00943917|2603434|P9|Stage I|Adverse Event|0
819208|NCT00943917|2603435|P8|Stage I|Adverse Event|0
819209|NCT00943917|2603436|P7|Stage I|Adverse Event|0
819210|NCT00943917|2603437|P6|Stage I|Adverse Event|0
819211|NCT00943917|2603438|P5|Stage I|Adverse Event|0
819212|NCT00943917|2603439|P4|Stage I|Adverse Event|0
819213|NCT00943917|2603440|P3|Stage I|Adverse Event|2
819214|NCT00943917|2603441|P2|Stage I|Adverse Event|2
819215|NCT00943917|2603442|P1|Stage I|Adverse Event|1
819216|NCT00944034|2603567|P12|Overall Study|Administrative reason|0
819217|NCT00944034|2603568|P11|Overall Study|Administrative reason|0
819218|NCT00944034|2603569|P10|Overall Study|Administrative reason|0
819219|NCT00944034|2603570|P9|Overall Study|Administrative reason|0
819220|NCT00944034|2603571|P8|Overall Study|Administrative reason|0
819221|NCT00944034|2603572|P7|Overall Study|Administrative reason|1
819222|NCT00944034|2603573|P6|Overall Study|Administrative reason|0
819223|NCT00944034|2603574|P5|Overall Study|Administrative reason|0
819224|NCT00944034|2603575|P4|Overall Study|Administrative reason|0
819225|NCT00944034|2603576|P3|Overall Study|Administrative reason|0
819226|NCT00944034|2603577|P2|Overall Study|Administrative reason|0
819227|NCT00944034|2603578|P1|Overall Study|Administrative reason|0
819228|NCT00944034|2603567|P12|Overall Study|Unable to classify|0
819229|NCT00944034|2603568|P11|Overall Study|Unable to classify|0
819230|NCT00944034|2603569|P10|Overall Study|Unable to classify|0
819231|NCT00944034|2603570|P9|Overall Study|Unable to classify|0
819232|NCT00944034|2603571|P8|Overall Study|Unable to classify|1
819233|NCT00944034|2603572|P7|Overall Study|Unable to classify|1
819234|NCT00944034|2603573|P6|Overall Study|Unable to classify|1
819235|NCT00944034|2603574|P5|Overall Study|Unable to classify|0
819236|NCT00944034|2603575|P4|Overall Study|Unable to classify|0
819237|NCT00944034|2603576|P3|Overall Study|Unable to classify|0
819238|NCT00944034|2603577|P2|Overall Study|Unable to classify|0
819239|NCT00944034|2603578|P1|Overall Study|Unable to classify|0
819240|NCT00944034|2603567|P12|Overall Study|Protocol Violation|0
819241|NCT00944034|2603568|P11|Overall Study|Protocol Violation|0
819242|NCT00944034|2603569|P10|Overall Study|Protocol Violation|4
819243|NCT00944034|2603570|P9|Overall Study|Protocol Violation|1
819244|NCT00944034|2603571|P8|Overall Study|Protocol Violation|1
819245|NCT00944034|2603572|P7|Overall Study|Protocol Violation|0
819246|NCT00944034|2603573|P6|Overall Study|Protocol Violation|3
819247|NCT00944034|2603574|P5|Overall Study|Protocol Violation|2
819248|NCT00944034|2603575|P4|Overall Study|Protocol Violation|1
819249|NCT00944034|2603576|P3|Overall Study|Protocol Violation|0
819250|NCT00944034|2603577|P2|Overall Study|Protocol Violation|0
819251|NCT00944034|2603578|P1|Overall Study|Protocol Violation|2
819252|NCT00944034|2603567|P12|Overall Study|Death|0
819253|NCT00944034|2603568|P11|Overall Study|Death|0
819254|NCT00944034|2603569|P10|Overall Study|Death|0
819255|NCT00944034|2603570|P9|Overall Study|Death|0
819256|NCT00944034|2603571|P8|Overall Study|Death|0
819257|NCT00944034|2603572|P7|Overall Study|Death|0
819258|NCT00944034|2603573|P6|Overall Study|Death|0
819259|NCT00944034|2603574|P5|Overall Study|Death|0
819260|NCT00944034|2603575|P4|Overall Study|Death|0
819261|NCT00944034|2603576|P3|Overall Study|Death|1
819262|NCT00944034|2603577|P2|Overall Study|Death|0
819263|NCT00944034|2603578|P1|Overall Study|Death|0
819264|NCT00944034|2603567|P12|Overall Study|Lost to Follow-up|0
819265|NCT00944034|2603568|P11|Overall Study|Lost to Follow-up|1
819266|NCT00944034|2603569|P10|Overall Study|Lost to Follow-up|1
819267|NCT00944034|2603570|P9|Overall Study|Lost to Follow-up|5
819268|NCT00944034|2603571|P8|Overall Study|Lost to Follow-up|1
819269|NCT00944034|2603572|P7|Overall Study|Lost to Follow-up|0
819270|NCT00944034|2603573|P6|Overall Study|Lost to Follow-up|7
819271|NCT00944034|2603574|P5|Overall Study|Lost to Follow-up|5
819272|NCT00944034|2603575|P4|Overall Study|Lost to Follow-up|0
819273|NCT00944034|2603576|P3|Overall Study|Lost to Follow-up|2
819274|NCT00944034|2603577|P2|Overall Study|Lost to Follow-up|4
819275|NCT00944034|2603578|P1|Overall Study|Lost to Follow-up|0
819276|NCT00944034|2603567|P12|Overall Study|Withdrawal by Subject|4
819277|NCT00944034|2603568|P11|Overall Study|Withdrawal by Subject|0
819278|NCT00944034|2603569|P10|Overall Study|Withdrawal by Subject|4
819279|NCT00944034|2603570|P9|Overall Study|Withdrawal by Subject|3
819280|NCT00944034|2603571|P8|Overall Study|Withdrawal by Subject|2
819281|NCT00944034|2603572|P7|Overall Study|Withdrawal by Subject|2
819282|NCT00944034|2603573|P6|Overall Study|Withdrawal by Subject|8
819283|NCT00944034|2603574|P5|Overall Study|Withdrawal by Subject|5
819284|NCT00944034|2603575|P4|Overall Study|Withdrawal by Subject|2
819285|NCT00944034|2603576|P3|Overall Study|Withdrawal by Subject|6
819286|NCT00944034|2603577|P2|Overall Study|Withdrawal by Subject|2
819287|NCT00944034|2603578|P1|Overall Study|Withdrawal by Subject|3
819288|NCT00944034|2603567|P12|Overall Study|Inappropriate enrollment|0
819289|NCT00944034|2603568|P11|Overall Study|Inappropriate enrollment|0
819290|NCT00944034|2603569|P10|Overall Study|Inappropriate enrollment|1
819291|NCT00944034|2603570|P9|Overall Study|Inappropriate enrollment|1
819292|NCT00944034|2603571|P8|Overall Study|Inappropriate enrollment|0
819293|NCT00944034|2603572|P7|Overall Study|Inappropriate enrollment|0
819294|NCT00944034|2603573|P6|Overall Study|Inappropriate enrollment|1
819295|NCT00944034|2603574|P5|Overall Study|Inappropriate enrollment|2
819296|NCT00944034|2603575|P4|Overall Study|Inappropriate enrollment|1
819297|NCT00944034|2603576|P3|Overall Study|Inappropriate enrollment|0
819298|NCT00944034|2603577|P2|Overall Study|Inappropriate enrollment|1
819299|NCT00944034|2603578|P1|Overall Study|Inappropriate enrollment|0
819300|NCT00944125|2603724|P2|6 Months to Study Completion|Withdrawal by Subject|2
819301|NCT00944125|2603725|P1|6 Months to Study Completion|Withdrawal by Subject|0
819302|NCT00944125|2603724|P2|3 to 6 Months|Withdrawal by Subject|2
819303|NCT00944125|2603725|P1|3 to 6 Months|Withdrawal by Subject|0
819304|NCT00944229|2603731|P1|Overall Study|Physician Decision|14
819305|NCT00944229|2603731|P1|Overall Study|Withdrawal by Subject|11
819306|NCT00944645|2603755|P2|Period 2|Withdrawal by Subject|6
819307|NCT00944645|2603756|P1|Period 2|Withdrawal by Subject|7
819308|NCT00944645|2603755|P2|Period 2|Lost to Follow-up|3
819309|NCT00944645|2603756|P1|Period 2|Lost to Follow-up|0
819310|NCT00944645|2603755|P2|Period 2|Adverse Event|0
819311|NCT00944645|2603756|P1|Period 2|Adverse Event|1
819312|NCT00944697|2603794|P2|Overall Study|Administrative|1
819313|NCT00944697|2603795|P1|Overall Study|Administrative|1
819314|NCT00944697|2603794|P2|Overall Study|Adverse Event|3
819315|NCT00944697|2603795|P1|Overall Study|Adverse Event|0
819316|NCT00944697|2603794|P2|Overall Study|Withdrawal by Subject|1
819317|NCT00944697|2603795|P1|Overall Study|Withdrawal by Subject|1
819319|NCT00945321|2603988|P6|Period 4|Lost to Follow-up|1
819320|NCT00945321|2603989|P5|Period 4|Lost to Follow-up|0
819321|NCT00945321|2603990|P4|Period 4|Lost to Follow-up|0
819322|NCT00945321|2603991|P3|Period 4|Lost to Follow-up|0
819323|NCT00945321|2603992|P2|Period 4|Lost to Follow-up|0
819324|NCT00945321|2603993|P1|Period 4|Lost to Follow-up|0
819325|NCT00945321|2603988|P6|Period 1|Adverse Event|0
819326|NCT00945321|2603989|P5|Period 1|Adverse Event|1
819327|NCT00945321|2603990|P4|Period 1|Adverse Event|0
819328|NCT00945321|2603991|P3|Period 1|Adverse Event|0
819329|NCT00945321|2603992|P2|Period 1|Adverse Event|0
819330|NCT00945321|2603993|P1|Period 1|Adverse Event|0
819331|NCT00945477|2604024|P1|Overall Study|Withdrawal by Subject|1
819332|NCT00945477|2604024|P1|Overall Study|Lack of Efficacy|2
819333|NCT00945477|2604024|P1|Overall Study|Adverse Event|3
819334|NCT00945555|2604029|P1|Overall Study|Other|1
819335|NCT00945555|2604029|P1|Overall Study|Death|18
819336|NCT00945555|2604029|P1|Overall Study|Participant continued treatment at home|1
819337|NCT00945555|2604029|P1|Overall Study|Withdrawal by Subject|2
819338|NCT00945555|2604029|P1|Overall Study|Worsening condition, intensive care unit|1
819339|NCT00945555|2604029|P1|Overall Study|Referred to another hospital|5
819344|NCT00945893|2604084|P2|Overall Study|Withdrawal of consent|2
819345|NCT00945893|2604085|P1|Overall Study|Withdrawal of consent|1
819346|NCT00945893|2604084|P2|Overall Study|Lost to Follow-up|8
819347|NCT00945893|2604085|P1|Overall Study|Lost to Follow-up|2
819348|NCT00945906|2604149|P1|Overall Study|Moved to another country|2
819349|NCT00945906|2604149|P1|Overall Study|Unable to return for last visit|2
819350|NCT00945906|2604149|P1|Overall Study|Did not want to return for last visit|2
819351|NCT00945906|2604149|P1|Overall Study|Withdrawal by Subject|1
819352|NCT00945945|2604160|P2|Overall Study|Entry Criteria Not Met|1
819353|NCT00945945|2604161|P1|Overall Study|Entry Criteria Not Met|0
819354|NCT00945945|2604160|P2|Overall Study|Protocol Violation|2
819355|NCT00945945|2604161|P1|Overall Study|Protocol Violation|4
819356|NCT00945945|2604160|P2|Overall Study|Lack of Efficacy|2
819357|NCT00945945|2604161|P1|Overall Study|Lack of Efficacy|6
819358|NCT00945945|2604160|P2|Overall Study|Lost to Follow-up|5
819359|NCT00945945|2604161|P1|Overall Study|Lost to Follow-up|4
819360|NCT00945945|2604160|P2|Overall Study|Withdrawal by Subject|10
819361|NCT00945945|2604161|P1|Overall Study|Withdrawal by Subject|7
819362|NCT00945945|2604160|P2|Overall Study|Adverse Event|35
819363|NCT00945945|2604161|P1|Overall Study|Adverse Event|15
819364|NCT00946088|2604194|P2|Overall Study|Withdrawal by Subject|1
819365|NCT00946088|2604195|P1|Overall Study|Withdrawal by Subject|0
819366|NCT00946101|2604219|P2|Overall Study|Physician Decision|1
819367|NCT00946101|2604220|P1|Overall Study|Physician Decision|0
819368|NCT00946101|2604219|P2|Overall Study|Withdrawal of consent|0
819369|NCT00946101|2604220|P1|Overall Study|Withdrawal of consent|2
819370|NCT00946101|2604219|P2|Overall Study|Lost to Follow-up|1
819371|NCT00946101|2604220|P1|Overall Study|Lost to Follow-up|2
819372|NCT00946114|2604286|P2|Overall Study|Withdrawal by Subject|0
819373|NCT00946114|2604287|P1|Overall Study|Withdrawal by Subject|2
819374|NCT00946114|2604286|P2|Overall Study|Unspecified|0
819375|NCT00946114|2604287|P1|Overall Study|Unspecified|1
819376|NCT00946114|2604286|P2|Overall Study|Death|2
819377|NCT00946114|2604287|P1|Overall Study|Death|5
819378|NCT00938366|2604295|P2|Overall Study|Withdrawal by Subject|0
819379|NCT00938366|2604296|P1|Overall Study|Withdrawal by Subject|1
819380|NCT00938392|2604318|P2|Overall Study|Lost to Follow-up|2
819381|NCT00938392|2604319|P1|Overall Study|Lost to Follow-up|2
819382|NCT00938392|2604318|P2|Overall Study|Withdrawal by Subject|1
819383|NCT00938392|2604319|P1|Overall Study|Withdrawal by Subject|0
819384|NCT00938392|2604318|P2|Overall Study|Adverse Event|1
819385|NCT00938392|2604319|P1|Overall Study|Adverse Event|0
819386|NCT00938431|2604346|P3|Overall Study|Reached maximum dose early|1
819387|NCT00938431|2604347|P2|Overall Study|Reached maximum dose early|0
819388|NCT00938431|2604348|P1|Overall Study|Reached maximum dose early|0
819389|NCT00938431|2604346|P3|Overall Study|Dosing compliance issue|1
819390|NCT00938431|2604347|P2|Overall Study|Dosing compliance issue|0
819391|NCT00938431|2604348|P1|Overall Study|Dosing compliance issue|0
819392|NCT00938431|2604346|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
819393|NCT00938431|2604347|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
819394|NCT00938431|2604348|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
819395|NCT00938431|2604346|P3|Overall Study|Lack of Efficacy|0
819396|NCT00938431|2604347|P2|Overall Study|Lack of Efficacy|1
819397|NCT00938431|2604348|P1|Overall Study|Lack of Efficacy|0
819398|NCT00938431|2604346|P3|Overall Study|Adverse Event|6
819399|NCT00938431|2604347|P2|Overall Study|Adverse Event|8
819400|NCT00938431|2604348|P1|Overall Study|Adverse Event|5
819401|NCT00938470|2604388|P2|Overall Study|Other Reason|1
819402|NCT00938470|2604389|P1|Overall Study|Other Reason|0
819403|NCT00938470|2604388|P2|Overall Study|Death|2
819404|NCT00938470|2604389|P1|Overall Study|Death|3
819405|NCT00938470|2604388|P2|Overall Study|Alternate Treatment|0
819406|NCT00938470|2604389|P1|Overall Study|Alternate Treatment|1
819407|NCT00938470|2604388|P2|Overall Study|Disease Progression|0
819408|NCT00938470|2604389|P1|Overall Study|Disease Progression|3
819417|NCT00938717|2604506|P2|Overall Study|Other reason|2
819418|NCT00938717|2604507|P1|Overall Study|Other reason|5
819419|NCT00938717|2604506|P2|Overall Study|Lack of Efficacy|15
819420|NCT00938717|2604507|P1|Overall Study|Lack of Efficacy|33
819421|NCT00938717|2604506|P2|Overall Study|Lost to Follow-up|18
819422|NCT00938717|2604507|P1|Overall Study|Lost to Follow-up|13
819423|NCT00938717|2604506|P2|Overall Study|Withdrawal by Subject|24
819424|NCT00938717|2604507|P1|Overall Study|Withdrawal by Subject|26
819425|NCT00938717|2604506|P2|Overall Study|Protocol Violation|8
819426|NCT00938717|2604507|P1|Overall Study|Protocol Violation|11
819427|NCT00938717|2604506|P2|Overall Study|Adverse Event|41
819428|NCT00938717|2604507|P1|Overall Study|Adverse Event|10
819429|NCT00938860|2604550|P2|Overall Study|Protocol Violation|1
819430|NCT00938860|2604551|P1|Overall Study|Protocol Violation|3
819431|NCT00938860|2604550|P2|Overall Study|Death|1
819432|NCT00938860|2604551|P1|Overall Study|Death|1
819433|NCT00938860|2604550|P2|Overall Study|Administration problems|0
819434|NCT00938860|2604551|P1|Overall Study|Administration problems|2
819435|NCT00938860|2604550|P2|Overall Study|Lost to Follow-up|4
819436|NCT00938860|2604551|P1|Overall Study|Lost to Follow-up|4
819437|NCT00938860|2604550|P2|Overall Study|Withdrawal by Subject|8
819438|NCT00938860|2604551|P1|Overall Study|Withdrawal by Subject|11
819439|NCT00938860|2604550|P2|Overall Study|Abnormal laboratory values|2
819440|NCT00938860|2604551|P1|Overall Study|Abnormal laboratory values|2
819441|NCT00938860|2604550|P2|Overall Study|Adverse Event|1
819442|NCT00938860|2604551|P1|Overall Study|Adverse Event|2
819443|NCT00938886|2604575|P2|Overall Study|Lost to Follow-up|2
819444|NCT00938886|2604576|P1|Overall Study|Lost to Follow-up|3
819445|NCT00938886|2604575|P2|Overall Study|Withdrawal by Subject|7
819446|NCT00938886|2604576|P1|Overall Study|Withdrawal by Subject|4
819447|NCT00938886|2604575|P2|Overall Study|Death|1
819448|NCT00938886|2604576|P1|Overall Study|Death|0
819449|NCT00938964|2604586|P2|Overall Study|Found to Meet Exclusion Criteria|4
819450|NCT00938964|2604587|P1|Overall Study|Found to Meet Exclusion Criteria|3
819451|NCT00938964|2604586|P2|Overall Study|Withdrawal by Subject|18
819452|NCT00938964|2604587|P1|Overall Study|Withdrawal by Subject|22
819453|NCT00938964|2604586|P2|Overall Study|Lost to Follow-up|3
819454|NCT00938964|2604587|P1|Overall Study|Lost to Follow-up|2
819455|NCT00938964|2604586|P2|Overall Study|Death|3
819456|NCT00938964|2604587|P1|Overall Study|Death|3
819457|NCT00939003|2604627|P2|Open-label Treatment Period|Site Closure|4
819458|NCT00939003|2604628|P1|Open-label Treatment Period|Site Closure|3
819459|NCT00939003|2604627|P2|Open-label Treatment Period|Exclusion Criteria|0
819460|NCT00939003|2604628|P1|Open-label Treatment Period|Exclusion Criteria|1
819461|NCT00939003|2604627|P2|Open-label Treatment Period|Pregnancy|1
819462|NCT00939003|2604628|P1|Open-label Treatment Period|Pregnancy|1
819463|NCT00939003|2604627|P2|Open-label Treatment Period|Lack of Efficacy|9
819464|NCT00939003|2604628|P1|Open-label Treatment Period|Lack of Efficacy|6
819465|NCT00939003|2604627|P2|Open-label Treatment Period|Withdrawal by Subject|7
819466|NCT00939003|2604628|P1|Open-label Treatment Period|Withdrawal by Subject|14
819467|NCT00939003|2604627|P2|Open-label Treatment Period|Adverse Event|8
819468|NCT00939003|2604628|P1|Open-label Treatment Period|Adverse Event|4
819469|NCT00939003|2604627|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
819470|NCT00939003|2604628|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
819471|NCT00939003|2604627|P2|Double-blind Treatment Period|Pregnancy|1
819472|NCT00939003|2604628|P1|Double-blind Treatment Period|Pregnancy|0
819473|NCT00939003|2604627|P2|Double-blind Treatment Period|Lack of Efficacy|1
819474|NCT00939003|2604628|P1|Double-blind Treatment Period|Lack of Efficacy|0
819475|NCT00939003|2604627|P2|Double-blind Treatment Period|Adverse Event|1
819476|NCT00939003|2604628|P1|Double-blind Treatment Period|Adverse Event|1
819477|NCT00939029|2604665|P2|Overall Study|Adverse Event|1
819478|NCT00939029|2604666|P1|Overall Study|Adverse Event|0
819479|NCT00939029|2604665|P2|Overall Study|Lost to Follow-up|4
819480|NCT00939029|2604666|P1|Overall Study|Lost to Follow-up|3
819481|NCT00939029|2604665|P2|Overall Study|Withdrawal by Subject|7
819482|NCT00939029|2604666|P1|Overall Study|Withdrawal by Subject|3
819483|NCT00939055|2604678|P2|Overall Study|Discontinuation prior to procedure|0
819484|NCT00939055|2604679|P1|Overall Study|Discontinuation prior to procedure|4
819485|NCT00939094|2604689|P2|Overall Study|Abnormal ECG findings|0
819486|NCT00939094|2604690|P1|Overall Study|Abnormal ECG findings|1
819487|NCT00939094|2604689|P2|Overall Study|Study stopped by sponsor|2
819488|NCT00939094|2604690|P1|Overall Study|Study stopped by sponsor|0
819489|NCT00939094|2604689|P2|Overall Study|Severe non-compliance to protocol|1
819490|NCT00939094|2604690|P1|Overall Study|Severe non-compliance to protocol|0
819491|NCT00939094|2604689|P2|Overall Study|Eligibility criteria not fulfilled|0
819492|NCT00939094|2604690|P1|Overall Study|Eligibility criteria not fulfilled|2
819493|NCT00939094|2604689|P2|Overall Study|Lost to Follow-up|1
819494|NCT00939094|2604690|P1|Overall Study|Lost to Follow-up|1
819495|NCT00939094|2604689|P2|Overall Study|Withdrawal by Subject|6
819496|NCT00939094|2604690|P1|Overall Study|Withdrawal by Subject|1
819497|NCT00939094|2604689|P2|Overall Study|Adverse Event|0
819498|NCT00939094|2604690|P1|Overall Study|Adverse Event|9
819499|NCT00939107|2604712|P2|Overall Study|Lost to Follow-up|12
819500|NCT00939107|2604713|P1|Overall Study|Lost to Follow-up|14
819501|NCT00939185|2604754|P1|Overall Study|Randomized But Did Not Receive Treatment|10
819502|NCT00939185|2604754|P1|Overall Study|Withdrawal by Subject|2
819503|NCT00939185|2604754|P1|Overall Study|Unspecified|3
819504|NCT00939185|2604754|P1|Overall Study|Lost to Follow-up|6
819505|NCT00939185|2604754|P1|Overall Study|Lack of Efficacy|1
819506|NCT00939185|2604754|P1|Overall Study|Adverse Event|3
819507|NCT00939341|2604823|P1|Overall Study|Incorrect enrolment|8
819508|NCT00939341|2604823|P1|Overall Study|Protocol Violation|6
819509|NCT00939341|2604823|P1|Overall Study|Withdrawal by Subject|13
819510|NCT00939341|2604823|P1|Overall Study|Lost to Follow-up|23
819511|NCT00939341|2604823|P1|Overall Study|Pregnancy|1
819512|NCT00939341|2604823|P1|Overall Study|Adverse Event|15
819517|NCT00939484|2604891|P3|Overall Study|Progression/Relapse|3
819518|NCT00939484|2604892|P2|Overall Study|Progression/Relapse|20
819519|NCT00939484|2604893|P1|Overall Study|Progression/Relapse|8
819520|NCT00939510|2604906|P1|Overall Study|Withdrawal by Subject|1
819542|NCT00939692|2604954|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
819543|NCT00939692|2604955|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
819544|NCT00939692|2604954|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
819545|NCT00939692|2604955|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
819546|NCT00939783|2604997|P1|Overall Study|Enrolled but not treated|1
819547|NCT00939783|2604997|P1|Overall Study|Protocol Violation|3
819548|NCT00939783|2604997|P1|Overall Study|Lost to Follow-up|8
819549|NCT00939783|2604997|P1|Overall Study|Unspecified|16
819550|NCT00939783|2604997|P1|Overall Study|Withdrawal by Subject|78
819551|NCT00939783|2604997|P1|Overall Study|Study Terminated by Sponsor|498
819552|NCT00939783|2604997|P1|Overall Study|Adverse Event|39
819553|NCT00939783|2604997|P1|Overall Study|Death|6
819554|NCT00939809|2605010|P1|Overall Study|Death|1
819555|NCT00939809|2605010|P1|Overall Study|Adverse Event|2
819556|NCT00940017|2605055|P1|Overall Study|Adverse Event|1
819557|NCT00940017|2605055|P1|Overall Study|did not meet entrance criteria|3
819586|NCT00940485|2605150|P2|Overall Study|Others|1
819587|NCT00940485|2605151|P1|Overall Study|Others|1
819588|NCT00940485|2605150|P2|Overall Study|Withdrawal by Subject|1
819589|NCT00940485|2605151|P1|Overall Study|Withdrawal by Subject|1
819590|NCT00940485|2605150|P2|Overall Study|Adverse Event|0
819591|NCT00940485|2605151|P1|Overall Study|Adverse Event|8
819592|NCT00940485|2605150|P2|Overall Study|Lost to Follow-up|3
819593|NCT00940485|2605151|P1|Overall Study|Lost to Follow-up|2
819594|NCT00940485|2605150|P2|Overall Study|HBeAb positive at Baseline|2
819595|NCT00940485|2605151|P1|Overall Study|HBeAb positive at Baseline|3
819596|NCT00946296|2605197|P2|Overall Study|Physician Decision|0
819597|NCT00946296|2605198|P1|Overall Study|Physician Decision|3
819598|NCT00946309|2605206|P2|Overall Study|Procedure cancelled/discontinued|3
819599|NCT00946309|2605207|P1|Overall Study|Procedure cancelled/discontinued|0
819600|NCT00946309|2605206|P2|Overall Study|Lost to Follow-up|1
819601|NCT00946309|2605207|P1|Overall Study|Lost to Follow-up|0
819602|NCT00946309|2605206|P2|Overall Study|Protocol Violation|0
819603|NCT00946309|2605207|P1|Overall Study|Protocol Violation|1
819604|NCT00946322|2605223|P1|Post-treatment|participant failure to follow up|2
819605|NCT00946322|2605223|P1|Pre-treatment|participant failure to follow up|1
819606|NCT00946530|2605256|P4|Overall Study|Physician Decision|1
819607|NCT00946530|2605257|P3|Overall Study|Physician Decision|1
819608|NCT00946530|2605258|P2|Overall Study|Physician Decision|1
819609|NCT00946530|2605259|P1|Overall Study|Physician Decision|1
819610|NCT00946530|2605256|P4|Overall Study|Withdrawal by Subject|3
819611|NCT00946530|2605257|P3|Overall Study|Withdrawal by Subject|0
819612|NCT00946530|2605258|P2|Overall Study|Withdrawal by Subject|3
819613|NCT00946530|2605259|P1|Overall Study|Withdrawal by Subject|0
819614|NCT00948389|2605278|P5|Overall Study|Both Progression and Toxicity|0
819615|NCT00948389|2605279|P4|Overall Study|Both Progression and Toxicity|0
819616|NCT00948389|2605280|P3|Overall Study|Both Progression and Toxicity|0
819617|NCT00948389|2605281|P2|Overall Study|Both Progression and Toxicity|0
819618|NCT00948389|2605282|P1|Overall Study|Both Progression and Toxicity|1
819619|NCT00948389|2605278|P5|Overall Study|Thrombocytopenia, Grade 4|0
819620|NCT00948389|2605279|P4|Overall Study|Thrombocytopenia, Grade 4|1
819621|NCT00948389|2605280|P3|Overall Study|Thrombocytopenia, Grade 4|0
819622|NCT00948389|2605281|P2|Overall Study|Thrombocytopenia, Grade 4|0
819623|NCT00948389|2605282|P1|Overall Study|Thrombocytopenia, Grade 4|2
819624|NCT00948389|2605278|P5|Overall Study|Disease Progression/Relapse/Death|1
819625|NCT00948389|2605279|P4|Overall Study|Disease Progression/Relapse/Death|8
819626|NCT00948389|2605280|P3|Overall Study|Disease Progression/Relapse/Death|7
819627|NCT00948389|2605281|P2|Overall Study|Disease Progression/Relapse/Death|3
819628|NCT00948389|2605282|P1|Overall Study|Disease Progression/Relapse/Death|3
819629|NCT00948441|2605321|P2|Overall Study|no longer meet inclusion criteria|4
819630|NCT00948441|2605322|P1|Overall Study|no longer meet inclusion criteria|1
819631|NCT00948506|2605332|P2|Overall Study|Withdrawal by Subject|1
819632|NCT00948506|2605333|P1|Overall Study|Withdrawal by Subject|3
819637|NCT00948688|2605370|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
819638|NCT00948688|2605371|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
819639|NCT00948688|2605370|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
819640|NCT00948688|2605371|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
819641|NCT00948688|2605370|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
819642|NCT00948688|2605371|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
819643|NCT00948766|2605385|P2|Extension Study|Death|0
819644|NCT00948766|2605386|P1|Extension Study|Death|4
819645|NCT00948766|2605385|P2|Extension Study|Administrative Problems|0
819646|NCT00948766|2605386|P1|Extension Study|Administrative Problems|1
819647|NCT00948766|2605385|P2|Extension Study|Lost to Follow-up|0
819648|NCT00948766|2605386|P1|Extension Study|Lost to Follow-up|8
819649|NCT00948766|2605385|P2|Extension Study|Patient Withdrew Consent|0
819650|NCT00948766|2605386|P1|Extension Study|Patient Withdrew Consent|32
819651|NCT00948766|2605385|P2|Extension Study|Study Drug No Longer Required|0
819652|NCT00948766|2605386|P1|Extension Study|Study Drug No Longer Required|1
819653|NCT00948766|2605385|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
819654|NCT00948766|2605386|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
819655|NCT00948766|2605385|P2|Extension Study|Adverse Event|0
819656|NCT00948766|2605386|P1|Extension Study|Adverse Event|43
819657|NCT00948766|2605385|P2|Core Study|Protocol Deviation|10
819658|NCT00948766|2605386|P1|Core Study|Protocol Deviation|8
819659|NCT00948766|2605385|P2|Core Study|Death|1
819660|NCT00948766|2605386|P1|Core Study|Death|1
819661|NCT00948766|2605385|P2|Core Study|Administrative Problems|2
819662|NCT00948766|2605386|P1|Core Study|Administrative Problems|2
819663|NCT00948766|2605385|P2|Core Study|Lost to Follow-up|2
819664|NCT00948766|2605386|P1|Core Study|Lost to Follow-up|3
819665|NCT00948766|2605385|P2|Core Study|Patient Withdrew Consent|46
819666|NCT00948766|2605386|P1|Core Study|Patient Withdrew Consent|27
819667|NCT00948766|2605385|P2|Core Study|Unsatisfactory Therapeutic Effect|14
819668|NCT00948766|2605386|P1|Core Study|Unsatisfactory Therapeutic Effect|13
819669|NCT00948766|2605385|P2|Core Study|Adverse Event|51
819670|NCT00948766|2605386|P1|Core Study|Adverse Event|73
819671|NCT00948818|2605414|P2|Overall Study|Other Reason|5
819672|NCT00948818|2605415|P1|Overall Study|Other Reason|4
819673|NCT00948818|2605414|P2|Overall Study|Lack of Efficacy|5
819674|NCT00948818|2605415|P1|Overall Study|Lack of Efficacy|4
819675|NCT00948818|2605414|P2|Overall Study|Lost to Follow-up|17
819676|NCT00948818|2605415|P1|Overall Study|Lost to Follow-up|10
819677|NCT00948818|2605414|P2|Overall Study|Withdrawal by Subject|25
819678|NCT00948818|2605415|P1|Overall Study|Withdrawal by Subject|25
819679|NCT00948818|2605414|P2|Overall Study|Protocol Violation|10
819680|NCT00948818|2605415|P1|Overall Study|Protocol Violation|9
819681|NCT00948818|2605414|P2|Overall Study|Adverse Event|32
819682|NCT00948818|2605415|P1|Overall Study|Adverse Event|10
819683|NCT00948857|2605452|P2|Overall Study|Lost to Follow-up|0
819684|NCT00948857|2605453|P1|Overall Study|Lost to Follow-up|1
819685|NCT00948896|2605467|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819686|NCT00948896|2605468|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819687|NCT00948896|2605469|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819688|NCT00948896|2605470|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819689|NCT00948896|2605471|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
819690|NCT00948896|2605472|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819691|NCT00948896|2605473|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819692|NCT00948896|2605474|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
819693|NCT00948896|2605467|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
819694|NCT00948896|2605468|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
819695|NCT00948896|2605469|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
819696|NCT00948896|2605470|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
819697|NCT00948896|2605471|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
819698|NCT00948896|2605472|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
819699|NCT00948896|2605473|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
819700|NCT00948896|2605474|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
819701|NCT00948896|2605467|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
819702|NCT00948896|2605468|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
819703|NCT00948896|2605469|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
819704|NCT00948896|2605470|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
819705|NCT00948896|2605471|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
819706|NCT00948896|2605472|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
819707|NCT00948896|2605473|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
819708|NCT00948896|2605474|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
819709|NCT00948896|2605467|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
819710|NCT00948896|2605468|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
819711|NCT00948896|2605469|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
819712|NCT00948896|2605470|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
819713|NCT00948896|2605471|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
819714|NCT00948896|2605472|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
819715|NCT00948896|2605473|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
819716|NCT00948896|2605474|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
819717|NCT00948896|2605467|P8|24 Months of Age to 36 Months of Age|Death|0
819718|NCT00948896|2605468|P7|24 Months of Age to 36 Months of Age|Death|0
819719|NCT00948896|2605469|P6|24 Months of Age to 36 Months of Age|Death|1
819720|NCT00948896|2605470|P5|24 Months of Age to 36 Months of Age|Death|0
819721|NCT00948896|2605471|P4|24 Months of Age to 36 Months of Age|Death|0
819722|NCT00948896|2605472|P3|24 Months of Age to 36 Months of Age|Death|2
819723|NCT00948896|2605473|P2|24 Months of Age to 36 Months of Age|Death|2
819724|NCT00948896|2605474|P1|24 Months of Age to 36 Months of Age|Death|0
819725|NCT00948896|2605467|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
819726|NCT00948896|2605468|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
819727|NCT00948896|2605469|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
819728|NCT00948896|2605470|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
819729|NCT00948896|2605471|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
819730|NCT00948896|2605472|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
819731|NCT00948896|2605473|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
819732|NCT00948896|2605474|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
819733|NCT00948896|2605467|P8|Randomization to 24 Months of Age|Protocol Violation|1
819734|NCT00948896|2605468|P7|Randomization to 24 Months of Age|Protocol Violation|1
819735|NCT00948896|2605469|P6|Randomization to 24 Months of Age|Protocol Violation|0
819736|NCT00948896|2605470|P5|Randomization to 24 Months of Age|Protocol Violation|0
819737|NCT00948896|2605471|P4|Randomization to 24 Months of Age|Protocol Violation|1
819738|NCT00948896|2605472|P3|Randomization to 24 Months of Age|Protocol Violation|0
819739|NCT00948896|2605473|P2|Randomization to 24 Months of Age|Protocol Violation|1
819740|NCT00948896|2605474|P1|Randomization to 24 Months of Age|Protocol Violation|0
819741|NCT00948896|2605467|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
819742|NCT00948896|2605468|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
819743|NCT00948896|2605469|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
819744|NCT00948896|2605470|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
819745|NCT00948896|2605471|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
819746|NCT00948896|2605472|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
819747|NCT00948896|2605473|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
819748|NCT00948896|2605474|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
819749|NCT00948896|2605467|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
819750|NCT00948896|2605468|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
819751|NCT00948896|2605469|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
819752|NCT00948896|2605470|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
819753|NCT00948896|2605471|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
819754|NCT00948896|2605472|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
819755|NCT00948896|2605473|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
819756|NCT00948896|2605474|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
819757|NCT00948896|2605467|P8|Randomization to 24 Months of Age|Death|1
819758|NCT00948896|2605468|P7|Randomization to 24 Months of Age|Death|2
819759|NCT00948896|2605469|P6|Randomization to 24 Months of Age|Death|1
819760|NCT00948896|2605470|P5|Randomization to 24 Months of Age|Death|2
819761|NCT00948896|2605471|P4|Randomization to 24 Months of Age|Death|0
819762|NCT00948896|2605472|P3|Randomization to 24 Months of Age|Death|0
819763|NCT00948896|2605473|P2|Randomization to 24 Months of Age|Death|0
819764|NCT00948896|2605474|P1|Randomization to 24 Months of Age|Death|1
819765|NCT00949117|2605535|P2|Overall Study|Adverse Event|1
819766|NCT00949117|2605536|P1|Overall Study|Adverse Event|0
819767|NCT00949117|2605535|P2|Overall Study|Protocol Violation|1
819768|NCT00949117|2605536|P1|Overall Study|Protocol Violation|1
819769|NCT00949117|2605535|P2|Overall Study|Lack of Efficacy|3
819770|NCT00949117|2605536|P1|Overall Study|Lack of Efficacy|2
819771|NCT00949533|2605552|P2|Overall Study|Lost to Follow-up|1
819772|NCT00949533|2605553|P1|Overall Study|Lost to Follow-up|0
819773|NCT00949650|2605567|P2|Overall Study|Other|0
819774|NCT00949650|2605568|P1|Overall Study|Other|1
819775|NCT00949650|2605567|P2|Overall Study|Not treated|4
819776|NCT00949650|2605568|P1|Overall Study|Not treated|1
819777|NCT00949650|2605567|P2|Overall Study|Withdrawal by Subject|11
819778|NCT00949650|2605568|P1|Overall Study|Withdrawal by Subject|6
819779|NCT00949650|2605567|P2|Overall Study|Protocol Violation|4
819780|NCT00949650|2605568|P1|Overall Study|Protocol Violation|1
819781|NCT00949650|2605567|P2|Overall Study|Other Adverse Event|17
819782|NCT00949650|2605568|P1|Overall Study|Other Adverse Event|23
819783|NCT00949650|2605567|P2|Overall Study|Progressive disease|19
819784|NCT00949650|2605568|P1|Overall Study|Progressive disease|133
819785|NCT00949702|2605604|P1|Overall Study|Withdrawal of consent|1
819786|NCT00949702|2605604|P1|Overall Study|Disease progression|7
819787|NCT00949702|2605604|P1|Overall Study|Death|40
819788|NCT00949715|2605621|P2|Overall Study|Missing 24 month LVEF measurement|0
819789|NCT00949715|2605622|P1|Overall Study|Missing 24 month LVEF measurement|2
819790|NCT00949715|2605621|P2|Overall Study|Lost to Follow-up|0
819791|NCT00949715|2605622|P1|Overall Study|Lost to Follow-up|1
819792|NCT00949715|2605621|P2|Overall Study|Physician Decision|0
819793|NCT00949715|2605622|P1|Overall Study|Physician Decision|1
819794|NCT00949884|2605636|P3|Overall Study|Study terminated by sponsor|1
819795|NCT00949884|2605637|P2|Overall Study|Study terminated by sponsor|0
819796|NCT00949884|2605638|P1|Overall Study|Study terminated by sponsor|0
819797|NCT00949884|2605636|P3|Overall Study|Lack of Efficacy|7
819798|NCT00949884|2605637|P2|Overall Study|Lack of Efficacy|2
819799|NCT00949884|2605638|P1|Overall Study|Lack of Efficacy|4
819800|NCT00949884|2605636|P3|Overall Study|Withdrawal by Subject|16
819801|NCT00949884|2605637|P2|Overall Study|Withdrawal by Subject|4
819802|NCT00949884|2605638|P1|Overall Study|Withdrawal by Subject|13
819803|NCT00949884|2605636|P3|Overall Study|Treatment non-compliance|8
819804|NCT00949884|2605637|P2|Overall Study|Treatment non-compliance|0
819805|NCT00949884|2605638|P1|Overall Study|Treatment non-compliance|5
819806|NCT00949884|2605636|P3|Overall Study|Physician Decision|6
819807|NCT00949884|2605637|P2|Overall Study|Physician Decision|0
819808|NCT00949884|2605638|P1|Overall Study|Physician Decision|5
819809|NCT00949884|2605636|P3|Overall Study|Lost to Follow-up|5
819810|NCT00949884|2605637|P2|Overall Study|Lost to Follow-up|5
819811|NCT00949884|2605638|P1|Overall Study|Lost to Follow-up|7
819812|NCT00949884|2605636|P3|Overall Study|Did not meet inclusion/exclusion|3
819813|NCT00949884|2605637|P2|Overall Study|Did not meet inclusion/exclusion|1
819814|NCT00949884|2605638|P1|Overall Study|Did not meet inclusion/exclusion|2
819815|NCT00949884|2605636|P3|Overall Study|Adverse Event|12
819816|NCT00949884|2605637|P2|Overall Study|Adverse Event|3
819817|NCT00949884|2605638|P1|Overall Study|Adverse Event|14
819818|NCT00949910|2605691|P1|Overall Study|No Data|9
819819|NCT00949910|2605691|P1|Overall Study|Other|4
819820|NCT00949910|2605691|P1|Overall Study|Physician/Participant Decision|7
819821|NCT00949910|2605691|P1|Overall Study|Serious Adverse Event|6
819822|NCT00949910|2605691|P1|Overall Study|Adverse Event|83
819823|NCT00949910|2605691|P1|Overall Study|Prolonged Dosing Interruption|4
819824|NCT00949910|2605691|P1|Overall Study|Non-Compliance|10
819825|NCT00949910|2605691|P1|Overall Study|Logistical Reasons|13
819826|NCT00949910|2605691|P1|Overall Study|Violation of Eligibility|23
819827|NCT00949910|2605691|P1|Overall Study|Switched to Commercial Treatment|4
819828|NCT00949910|2605691|P1|Overall Study|Switched to Compassionate/Other Use|174
819829|NCT00949910|2605691|P1|Overall Study|Unspecified Progression/Deterioration|13
819830|NCT00949910|2605691|P1|Overall Study|Death from Unknown Cause|5
819831|NCT00949910|2605691|P1|Overall Study|Death Due to Toxicity|3
819832|NCT00949910|2605691|P1|Overall Study|Death Due to Adverse Event|115
819833|NCT00949910|2605691|P1|Overall Study|Death Due to Progression/Deterioration|4
819834|NCT00949910|2605691|P1|Overall Study|Death Due to Malignant Disease|456
819835|NCT00949910|2605691|P1|Overall Study|Participant Refusal|390
819836|NCT00949910|2605691|P1|Overall Study|Study Drug-Related Adverse Event|315
819837|NCT00949910|2605691|P1|Overall Study|Lost to Follow-up|100
819838|NCT00949910|2605691|P1|Overall Study|Symptomatic Deterioration|1088
819839|NCT00949910|2605691|P1|Overall Study|Progressive Disease|3750
819840|NCT00949975|2605705|P4|Overall Study|Other|0
819841|NCT00949975|2605706|P3|Overall Study|Other|0
819842|NCT00949975|2605707|P2|Overall Study|Other|0
819843|NCT00949975|2605708|P1|Overall Study|Other|1
819844|NCT00949975|2605705|P4|Overall Study|Lost to Follow-up|3
819845|NCT00949975|2605706|P3|Overall Study|Lost to Follow-up|1
819846|NCT00949975|2605707|P2|Overall Study|Lost to Follow-up|0
819847|NCT00949975|2605708|P1|Overall Study|Lost to Follow-up|1
819848|NCT00949975|2605705|P4|Overall Study|Severe non-compliance|2
819849|NCT00949975|2605706|P3|Overall Study|Severe non-compliance|0
819850|NCT00949975|2605707|P2|Overall Study|Severe non-compliance|1
819851|NCT00949975|2605708|P1|Overall Study|Severe non-compliance|3
819852|NCT00949975|2605705|P4|Overall Study|Incorrect enrolment|7
819853|NCT00949975|2605706|P3|Overall Study|Incorrect enrolment|4
819854|NCT00949975|2605707|P2|Overall Study|Incorrect enrolment|10
819855|NCT00949975|2605708|P1|Overall Study|Incorrect enrolment|5
819856|NCT00949975|2605705|P4|Overall Study|Study-specific criteria|0
819857|NCT00949975|2605706|P3|Overall Study|Study-specific criteria|1
819858|NCT00949975|2605707|P2|Overall Study|Study-specific criteria|1
819859|NCT00949975|2605708|P1|Overall Study|Study-specific criteria|0
819860|NCT00949975|2605705|P4|Overall Study|Safety reason|0
819861|NCT00949975|2605706|P3|Overall Study|Safety reason|0
819862|NCT00949975|2605707|P2|Overall Study|Safety reason|1
819863|NCT00949975|2605708|P1|Overall Study|Safety reason|0
819864|NCT00949975|2605705|P4|Overall Study|Adverse Event|10
819865|NCT00949975|2605706|P3|Overall Study|Adverse Event|10
819866|NCT00949975|2605707|P2|Overall Study|Adverse Event|11
819867|NCT00949975|2605708|P1|Overall Study|Adverse Event|11
819868|NCT00949975|2605705|P4|Overall Study|Voluntary discontinuation|6
819869|NCT00949975|2605706|P3|Overall Study|Voluntary discontinuation|3
819870|NCT00949975|2605707|P2|Overall Study|Voluntary discontinuation|5
819871|NCT00949975|2605708|P1|Overall Study|Voluntary discontinuation|6
819914|NCT00950599|2605920|P10|Follow-Up Period|Subject withdrew Consent|1
819915|NCT00950599|2605921|P9|Follow-Up Period|Subject withdrew Consent|2
819916|NCT00950599|2605922|P8|Follow-Up Period|Subject withdrew Consent|0
819917|NCT00950599|2605923|P7|Follow-Up Period|Subject withdrew Consent|0
819918|NCT00950599|2605924|P6|Follow-Up Period|Subject withdrew Consent|0
819919|NCT00950599|2605925|P5|Follow-Up Period|Subject withdrew Consent|0
819920|NCT00950599|2605926|P4|Follow-Up Period|Subject withdrew Consent|0
819921|NCT00950599|2605927|P3|Follow-Up Period|Subject withdrew Consent|0
819922|NCT00950599|2605928|P2|Follow-Up Period|Subject withdrew Consent|0
819923|NCT00950599|2605929|P1|Follow-Up Period|Subject withdrew Consent|0
819924|NCT00950599|2605920|P10|Follow-Up Period|Poor/Noncompliance|0
819925|NCT00950599|2605921|P9|Follow-Up Period|Poor/Noncompliance|1
819926|NCT00950599|2605922|P8|Follow-Up Period|Poor/Noncompliance|0
819927|NCT00950599|2605923|P7|Follow-Up Period|Poor/Noncompliance|0
819928|NCT00950599|2605924|P6|Follow-Up Period|Poor/Noncompliance|0
819929|NCT00950599|2605925|P5|Follow-Up Period|Poor/Noncompliance|0
819930|NCT00950599|2605926|P4|Follow-Up Period|Poor/Noncompliance|0
819931|NCT00950599|2605927|P3|Follow-Up Period|Poor/Noncompliance|0
819932|NCT00950599|2605928|P2|Follow-Up Period|Poor/Noncompliance|0
819933|NCT00950599|2605929|P1|Follow-Up Period|Poor/Noncompliance|0
819934|NCT00950599|2605920|P10|Follow-Up Period|Physician Decision|0
819935|NCT00950599|2605921|P9|Follow-Up Period|Physician Decision|1
819936|NCT00950599|2605922|P8|Follow-Up Period|Physician Decision|0
819937|NCT00950599|2605923|P7|Follow-Up Period|Physician Decision|0
819938|NCT00950599|2605924|P6|Follow-Up Period|Physician Decision|0
819939|NCT00950599|2605925|P5|Follow-Up Period|Physician Decision|0
819940|NCT00950599|2605926|P4|Follow-Up Period|Physician Decision|0
819941|NCT00950599|2605927|P3|Follow-Up Period|Physician Decision|0
819942|NCT00950599|2605928|P2|Follow-Up Period|Physician Decision|0
819943|NCT00950599|2605929|P1|Follow-Up Period|Physician Decision|0
819944|NCT00950599|2605920|P10|Follow-Up Period|Lost to Follow-up|1
819945|NCT00950599|2605921|P9|Follow-Up Period|Lost to Follow-up|5
819946|NCT00950599|2605922|P8|Follow-Up Period|Lost to Follow-up|0
819947|NCT00950599|2605923|P7|Follow-Up Period|Lost to Follow-up|0
819948|NCT00950599|2605924|P6|Follow-Up Period|Lost to Follow-up|0
819949|NCT00950599|2605925|P5|Follow-Up Period|Lost to Follow-up|0
819950|NCT00950599|2605926|P4|Follow-Up Period|Lost to Follow-up|0
819951|NCT00950599|2605927|P3|Follow-Up Period|Lost to Follow-up|0
819952|NCT00950599|2605928|P2|Follow-Up Period|Lost to Follow-up|0
819953|NCT00950599|2605929|P1|Follow-Up Period|Lost to Follow-up|0
819954|NCT00950599|2605920|P10|Follow-Up Period|Lack of Efficacy|0
819955|NCT00950599|2605921|P9|Follow-Up Period|Lack of Efficacy|3
819956|NCT00950599|2605922|P8|Follow-Up Period|Lack of Efficacy|0
819957|NCT00950599|2605923|P7|Follow-Up Period|Lack of Efficacy|0
819958|NCT00950599|2605924|P6|Follow-Up Period|Lack of Efficacy|0
819959|NCT00950599|2605925|P5|Follow-Up Period|Lack of Efficacy|0
819960|NCT00950599|2605926|P4|Follow-Up Period|Lack of Efficacy|0
819961|NCT00950599|2605927|P3|Follow-Up Period|Lack of Efficacy|0
819962|NCT00950599|2605928|P2|Follow-Up Period|Lack of Efficacy|0
819963|NCT00950599|2605929|P1|Follow-Up Period|Lack of Efficacy|0
819964|NCT00950599|2605920|P10|Follow-Up Period|Adverse Event|0
819965|NCT00950599|2605921|P9|Follow-Up Period|Adverse Event|1
819966|NCT00950599|2605922|P8|Follow-Up Period|Adverse Event|0
819967|NCT00950599|2605923|P7|Follow-Up Period|Adverse Event|0
819968|NCT00950599|2605924|P6|Follow-Up Period|Adverse Event|0
819969|NCT00950599|2605925|P5|Follow-Up Period|Adverse Event|0
819970|NCT00950599|2605926|P4|Follow-Up Period|Adverse Event|0
819971|NCT00950599|2605927|P3|Follow-Up Period|Adverse Event|0
819972|NCT00950599|2605928|P2|Follow-Up Period|Adverse Event|0
819973|NCT00950599|2605929|P1|Follow-Up Period|Adverse Event|0
819974|NCT00950599|2605920|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
819975|NCT00950599|2605921|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
819976|NCT00950599|2605922|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
819977|NCT00950599|2605923|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
819978|NCT00950599|2605924|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
819979|NCT00950599|2605925|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
819980|NCT00950599|2605926|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
819981|NCT00950599|2605927|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
819982|NCT00950599|2605928|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
819983|NCT00950599|2605929|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
819984|NCT00950599|2605920|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819985|NCT00950599|2605921|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819986|NCT00950599|2605922|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819987|NCT00950599|2605923|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819988|NCT00950599|2605924|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
819989|NCT00950599|2605925|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
819990|NCT00950599|2605926|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819991|NCT00950599|2605927|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819992|NCT00950599|2605928|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819993|NCT00950599|2605929|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
819994|NCT00950599|2605920|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
819995|NCT00950599|2605921|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
819996|NCT00950599|2605922|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
819997|NCT00950599|2605923|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
819998|NCT00950599|2605924|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
819999|NCT00950599|2605925|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
820000|NCT00950599|2605926|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
820001|NCT00950599|2605927|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
820002|NCT00950599|2605928|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
820003|NCT00950599|2605929|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
820004|NCT00950599|2605920|P10|Double-Blind Treatment Period|Lost to Follow-up|0
820005|NCT00950599|2605921|P9|Double-Blind Treatment Period|Lost to Follow-up|0
820006|NCT00950599|2605922|P8|Double-Blind Treatment Period|Lost to Follow-up|1
820007|NCT00950599|2605923|P7|Double-Blind Treatment Period|Lost to Follow-up|0
820008|NCT00950599|2605924|P6|Double-Blind Treatment Period|Lost to Follow-up|2
820009|NCT00950599|2605925|P5|Double-Blind Treatment Period|Lost to Follow-up|1
820010|NCT00950599|2605926|P4|Double-Blind Treatment Period|Lost to Follow-up|1
820011|NCT00950599|2605927|P3|Double-Blind Treatment Period|Lost to Follow-up|0
820012|NCT00950599|2605928|P2|Double-Blind Treatment Period|Lost to Follow-up|0
820013|NCT00950599|2605929|P1|Double-Blind Treatment Period|Lost to Follow-up|0
820014|NCT00950599|2605920|P10|Double-Blind Treatment Period|Lack of Efficacy|0
820015|NCT00950599|2605921|P9|Double-Blind Treatment Period|Lack of Efficacy|0
820016|NCT00950599|2605922|P8|Double-Blind Treatment Period|Lack of Efficacy|1
820017|NCT00950599|2605923|P7|Double-Blind Treatment Period|Lack of Efficacy|0
820018|NCT00950599|2605924|P6|Double-Blind Treatment Period|Lack of Efficacy|6
820019|NCT00950599|2605925|P5|Double-Blind Treatment Period|Lack of Efficacy|3
820020|NCT00950599|2605926|P4|Double-Blind Treatment Period|Lack of Efficacy|7
820021|NCT00950599|2605927|P3|Double-Blind Treatment Period|Lack of Efficacy|5
820022|NCT00950599|2605928|P2|Double-Blind Treatment Period|Lack of Efficacy|5
820023|NCT00950599|2605929|P1|Double-Blind Treatment Period|Lack of Efficacy|2
820024|NCT00950599|2605920|P10|Double-Blind Treatment Period|Adverse Event|0
820025|NCT00950599|2605921|P9|Double-Blind Treatment Period|Adverse Event|0
820026|NCT00950599|2605922|P8|Double-Blind Treatment Period|Adverse Event|0
820027|NCT00950599|2605923|P7|Double-Blind Treatment Period|Adverse Event|0
820028|NCT00950599|2605924|P6|Double-Blind Treatment Period|Adverse Event|1
820029|NCT00950599|2605925|P5|Double-Blind Treatment Period|Adverse Event|1
820030|NCT00950599|2605926|P4|Double-Blind Treatment Period|Adverse Event|1
820031|NCT00950599|2605927|P3|Double-Blind Treatment Period|Adverse Event|1
820032|NCT00950599|2605928|P2|Double-Blind Treatment Period|Adverse Event|1
820033|NCT00950599|2605929|P1|Double-Blind Treatment Period|Adverse Event|0
820034|NCT00950599|2605920|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
820035|NCT00950599|2605921|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
820036|NCT00950599|2605922|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
820037|NCT00950599|2605923|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
820038|NCT00950599|2605924|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
820039|NCT00950599|2605925|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
820040|NCT00950599|2605926|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
820041|NCT00950599|2605927|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
820042|NCT00950599|2605928|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
820043|NCT00950599|2605929|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
820044|NCT00950651|2606532|P2|Overall Study|Withdrawal by Subject|9
820045|NCT00950651|2606533|P1|Overall Study|Withdrawal by Subject|8
820046|NCT00950651|2606532|P2|Overall Study|Protocol Violation|4
820047|NCT00950651|2606533|P1|Overall Study|Protocol Violation|3
820048|NCT00950651|2606532|P2|Overall Study|Lack of Efficacy|2
820049|NCT00950651|2606533|P1|Overall Study|Lack of Efficacy|2
820050|NCT00950651|2606532|P2|Overall Study|Death|0
820051|NCT00950651|2606533|P1|Overall Study|Death|1
820052|NCT00950651|2606532|P2|Overall Study|Adverse Event|20
820053|NCT00950651|2606533|P1|Overall Study|Adverse Event|17
820054|NCT00950664|2606581|P2|First Intervention|Withdrawal by Subject|2
820055|NCT00950664|2606582|P1|First Intervention|Withdrawal by Subject|2
820056|NCT00950664|2606581|P2|First Intervention|Lost to Follow-up|3
820057|NCT00950664|2606582|P1|First Intervention|Lost to Follow-up|1
820058|NCT00950690|2606600|P1|Overall Study|Not known|163
820059|NCT00950690|2606600|P1|Overall Study|Lost to Follow-up|40
820060|NCT00950690|2606600|P1|Overall Study|Lack of Efficacy|22
820061|NCT00950690|2606600|P1|Overall Study|Adverse Event|15
820062|NCT00950690|2606600|P1|Overall Study|Death|4
820063|NCT00950742|2606612|P2|Overall Study|Dose limiting toxicity|0
820064|NCT00950742|2606613|P1|Overall Study|Dose limiting toxicity|6
820065|NCT00950742|2606612|P2|Overall Study|Progressive Disease|2
820066|NCT00950742|2606613|P1|Overall Study|Progressive Disease|6
820067|NCT00950742|2606612|P2|Overall Study|Withdrawal by Subject|0
820068|NCT00950742|2606613|P1|Overall Study|Withdrawal by Subject|3
820069|NCT00950742|2606612|P2|Overall Study|Other Adverse Event|0
820070|NCT00950742|2606613|P1|Overall Study|Other Adverse Event|1
820071|NCT00950755|2606629|P1|Long-Term Follow-Up|Death|8
820072|NCT00950755|2606629|P1|Long-Term Follow-Up|Lost to Follow-up|1
820073|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
820074|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
820075|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
820076|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
820077|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Death|1
820078|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
820079|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
820080|NCT00950755|2606629|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
893161|NCT02685202|2833211|P1|Overall Study|Lost to Follow-up|9
893172|NCT02668783|2833252|P2|Overall Study|Withdrawal by Subject|0
893173|NCT02668783|2833253|P1|Overall Study|Withdrawal by Subject|1
893174|NCT02668783|2833252|P2|Overall Study|Subject moved|0
893175|NCT02668783|2833253|P1|Overall Study|Subject moved|1
893176|NCT02668783|2833252|P2|Overall Study|Study terminated by sponsor|10
893177|NCT02668783|2833253|P1|Overall Study|Study terminated by sponsor|9
893178|NCT02668783|2833252|P2|Overall Study|Protocol Violation|1
893179|NCT02668783|2833253|P1|Overall Study|Protocol Violation|2
893180|NCT02668783|2833252|P2|Overall Study|Pregnancy|1
893181|NCT02668783|2833253|P1|Overall Study|Pregnancy|0
893182|NCT02639338|2833275|P2|Overall Study|Randomized but Not Treated|1
893183|NCT02639338|2833276|P1|Overall Study|Randomized but Not Treated|0
893184|NCT02639338|2833275|P2|Overall Study|Death|0
893185|NCT02639338|2833276|P1|Overall Study|Death|1
893186|NCT02639338|2833275|P2|Overall Study|Withdrew Consent|2
893187|NCT02639338|2833276|P1|Overall Study|Withdrew Consent|1
893188|NCT02639338|2833275|P2|Overall Study|Lost to Follow-up|2
893189|NCT02639338|2833276|P1|Overall Study|Lost to Follow-up|2
893190|NCT02564042|2833298|P6|Overall Study|Withdrawal by Subject|12
893191|NCT02564042|2833299|P5|Overall Study|Withdrawal by Subject|10
893192|NCT02564042|2833300|P4|Overall Study|Withdrawal by Subject|2
893193|NCT02564042|2833301|P3|Overall Study|Withdrawal by Subject|2
893194|NCT02564042|2833302|P2|Overall Study|Withdrawal by Subject|3
893195|NCT02564042|2833303|P1|Overall Study|Withdrawal by Subject|5
893196|NCT02564042|2833298|P6|Overall Study|Physician Decision|0
893197|NCT02564042|2833299|P5|Overall Study|Physician Decision|0
893198|NCT02564042|2833300|P4|Overall Study|Physician Decision|1
893199|NCT02564042|2833301|P3|Overall Study|Physician Decision|0
893200|NCT02564042|2833302|P2|Overall Study|Physician Decision|0
893201|NCT02564042|2833303|P1|Overall Study|Physician Decision|1
893202|NCT02564042|2833298|P6|Overall Study|Lost to Follow-up|1
893203|NCT02564042|2833299|P5|Overall Study|Lost to Follow-up|1
893204|NCT02564042|2833300|P4|Overall Study|Lost to Follow-up|0
893205|NCT02564042|2833301|P3|Overall Study|Lost to Follow-up|1
893206|NCT02564042|2833302|P2|Overall Study|Lost to Follow-up|1
893207|NCT02564042|2833303|P1|Overall Study|Lost to Follow-up|1
893208|NCT02564042|2833298|P6|Overall Study|Adverse Event|1
893209|NCT02564042|2833299|P5|Overall Study|Adverse Event|0
893210|NCT02564042|2833300|P4|Overall Study|Adverse Event|0
893211|NCT02564042|2833301|P3|Overall Study|Adverse Event|3
893212|NCT02564042|2833302|P2|Overall Study|Adverse Event|4
893213|NCT02564042|2833303|P1|Overall Study|Adverse Event|4
893214|NCT02355028|2833521|P2|Overall Study|Deemed ineligible after randomization|4
893215|NCT02355028|2833522|P1|Overall Study|Deemed ineligible after randomization|8
893216|NCT02355028|2833521|P2|Overall Study|Withdrawal by Subject|1
893217|NCT02355028|2833522|P1|Overall Study|Withdrawal by Subject|1
893218|NCT02355028|2833521|P2|Overall Study|Adverse Event|0
893219|NCT02355028|2833522|P1|Overall Study|Adverse Event|2
893220|NCT02348723|2833557|P2|Overall Study|Adverse Event|1
893221|NCT02348723|2833558|P1|Overall Study|Adverse Event|3
893222|NCT02348723|2833557|P2|Overall Study|Reason other than specified|1
893223|NCT02348723|2833558|P1|Overall Study|Reason other than specified|1
893224|NCT02348723|2833557|P2|Overall Study|Consent withdrawn|3
893225|NCT02348723|2833558|P1|Overall Study|Consent withdrawn|1
893226|NCT02348723|2833557|P2|Overall Study|Lost to Follow-up|1
893227|NCT02348723|2833558|P1|Overall Study|Lost to Follow-up|1
893228|NCT02348723|2833557|P2|Overall Study|Non-compliant with Protocol|0
893229|NCT02348723|2833558|P1|Overall Study|Non-compliant with Protocol|1
893230|NCT02348723|2833557|P2|Overall Study|No ablation|20
893231|NCT02348723|2833558|P1|Overall Study|No ablation|21
893235|NCT02157883|2833574|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
893236|NCT02157883|2833574|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
893237|NCT02157883|2833574|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
893238|NCT02157883|2833574|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
893239|NCT02157883|2833574|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
893240|NCT02100514|2833605|P2|Overall Study|Other|11
893241|NCT02100514|2833606|P1|Overall Study|Other|9
893242|NCT02100514|2833605|P2|Overall Study|Withdrawal by Subject|37
893243|NCT02100514|2833606|P1|Overall Study|Withdrawal by Subject|12
893244|NCT02100514|2833605|P2|Overall Study|Protocol Violation|1
893245|NCT02100514|2833606|P1|Overall Study|Protocol Violation|1
893246|NCT02100514|2833605|P2|Overall Study|Did Not Meet Entrance Criteria|1
893247|NCT02100514|2833606|P1|Overall Study|Did Not Meet Entrance Criteria|0
893248|NCT02100514|2833605|P2|Overall Study|Lost to Follow-up|17
893249|NCT02100514|2833606|P1|Overall Study|Lost to Follow-up|5
893250|NCT02100514|2833605|P2|Overall Study|Death|2
893251|NCT02100514|2833606|P1|Overall Study|Death|2
893252|NCT02100514|2833605|P2|Overall Study|Adverse Event|5
893253|NCT02100514|2833606|P1|Overall Study|Adverse Event|0
893254|NCT02010567|2833669|P5|Overall Study|Adverse Event|1
893255|NCT02010567|2833670|P4|Overall Study|Adverse Event|0
893256|NCT02010567|2833671|P3|Overall Study|Adverse Event|1
893257|NCT02010567|2833672|P2|Overall Study|Adverse Event|0
893258|NCT02010567|2833673|P1|Overall Study|Adverse Event|0
893259|NCT01977222|2833680|P1|Overall Study|Withdrawal by Subject|1
820271|NCT00938327|2606765|P1|Overall Study|Vaccine not received as out of stock|9
820272|NCT00938327|2606765|P1|Overall Study|2nd dose received outside of the study|7
820273|NCT00938327|2606765|P1|Overall Study|Lost to Follow-up|37
820274|NCT00938327|2606765|P1|Overall Study|Withdrawal by Subject|4
820275|NCT00938327|2606765|P1|Overall Study|Protocol Violation|1
820276|NCT00938327|2606765|P1|Overall Study|Adverse Event|2
820277|NCT00943683|2606774|P2|Overall Study|Patient Moved|0
820278|NCT00943683|2606775|P1|Overall Study|Patient Moved|1
820279|NCT00943683|2606774|P2|Overall Study|Withdrawal by Subject|0
820280|NCT00943683|2606775|P1|Overall Study|Withdrawal by Subject|1
820281|NCT00943683|2606774|P2|Overall Study|Protocol Violation|2
820282|NCT00943683|2606775|P1|Overall Study|Protocol Violation|1
820283|NCT00943683|2606774|P2|Overall Study|Lost to Follow-up|1
820284|NCT00943683|2606775|P1|Overall Study|Lost to Follow-up|1
820285|NCT00943683|2606774|P2|Overall Study|Adverse Event|3
820286|NCT00943683|2606775|P1|Overall Study|Adverse Event|3
893262|NCT01910181|2833732|P1|Overall Study|Alive in Follow-Up|12
893263|NCT01910181|2833732|P1|Overall Study|Alive on Treatment|14
893264|NCT01910181|2833732|P1|Overall Study|Death|20
893265|NCT01853280|2833759|P2|Overall Study|Ineligible|1
893266|NCT01853280|2833760|P1|Overall Study|Ineligible|0
893267|NCT01853280|2833759|P2|Overall Study|Withdrawal by Subject|1
893268|NCT01853280|2833760|P1|Overall Study|Withdrawal by Subject|0
893269|NCT01853280|2833759|P2|Overall Study|Physician Decision|1
893270|NCT01853280|2833760|P1|Overall Study|Physician Decision|0
893271|NCT01853280|2833759|P2|Overall Study|Lost to Follow-up|1
893272|NCT01853280|2833760|P1|Overall Study|Lost to Follow-up|0
893273|NCT01853280|2833759|P2|Overall Study|Lack of Efficacy|2
893274|NCT01853280|2833760|P1|Overall Study|Lack of Efficacy|2
893275|NCT01780545|2833768|P2|Overall Study|Lost to Follow-up|1
893276|NCT01780545|2833769|P1|Overall Study|Lost to Follow-up|1
893277|NCT01780545|2833768|P2|Overall Study|Withdrawal by Subject|1
893278|NCT01780545|2833769|P1|Overall Study|Withdrawal by Subject|3
893279|NCT01765673|2833785|P1|Overall Study|No transportation for 2nd/3rd visits|1
893280|NCT01748162|2833822|P2|Overall Study|reasons not available|2
893281|NCT01748162|2833823|P1|Overall Study|reasons not available|3
893282|NCT01748162|2833822|P2|Overall Study|participant consented but did not begin|1
893283|NCT01748162|2833823|P1|Overall Study|participant consented but did not begin|0
893284|NCT01748162|2833822|P2|Overall Study|no additional croup episodes to evaluate|2
893285|NCT01748162|2833823|P1|Overall Study|no additional croup episodes to evaluate|2
893286|NCT01632904|2833833|P2|Overall Study|Reason for discontinuation not available|1
893287|NCT01632904|2833834|P1|Overall Study|Reason for discontinuation not available|0
820317|NCT00943735|2606818|P1|Overall Study|Other|3
820318|NCT00943735|2606818|P1|Overall Study|Unspecified|8
820319|NCT00943735|2606818|P1|Overall Study|Death|1
820320|NCT00943735|2606818|P1|Overall Study|Withdrawal by Subject|8
820321|NCT00943735|2606818|P1|Overall Study|Adverse Event|12
820322|NCT00950859|2606912|P2|Overall Study|Lost to Follow-up|3
820323|NCT00950859|2606913|P1|Overall Study|Lost to Follow-up|0
820324|NCT00950859|2606912|P2|Overall Study|Protocol Violation|1
820325|NCT00950859|2606913|P1|Overall Study|Protocol Violation|1
820326|NCT00950859|2606912|P2|Overall Study|Insufficient Viral Load Response|3
820327|NCT00950859|2606913|P1|Overall Study|Insufficient Viral Load Response|12
820328|NCT00950859|2606912|P2|Overall Study|Adverse Event|3
820329|NCT00950859|2606913|P1|Overall Study|Adverse Event|3
820330|NCT00950872|2606953|P1|Overall Study|Did not have surgery|2
820331|NCT00950872|2606953|P1|Overall Study|Withdrawal by Subject|1
820332|NCT00950911|2606962|P2|Overall Study|Poor performance status|1
820333|NCT00950911|2606963|P1|Overall Study|Poor performance status|0
820334|NCT00950911|2606962|P2|Overall Study|Noncompliance|0
820335|NCT00950911|2606963|P1|Overall Study|Noncompliance|1
820336|NCT00950911|2606962|P2|Overall Study|Ineligibility determined|0
820337|NCT00950911|2606963|P1|Overall Study|Ineligibility determined|1
820338|NCT00950911|2606962|P2|Overall Study|Administrative decision|1
820339|NCT00950911|2606963|P1|Overall Study|Administrative decision|3
820340|NCT00950911|2606962|P2|Overall Study|Consent withdrawn|3
820341|NCT00950911|2606963|P1|Overall Study|Consent withdrawn|1
820342|NCT00950911|2606962|P2|Overall Study|Disease progression|2
820343|NCT00950911|2606963|P1|Overall Study|Disease progression|2
820344|NCT00950911|2606962|P2|Overall Study|Death|6
820345|NCT00950911|2606963|P1|Overall Study|Death|4
820346|NCT00950911|2606962|P2|Overall Study|Adverse Event|2
820347|NCT00950911|2606963|P1|Overall Study|Adverse Event|0
820348|NCT00950963|2606990|P2|Overall Study|Lost to Follow-up|24
820349|NCT00950963|2606991|P1|Overall Study|Lost to Follow-up|29
820350|NCT00951015|2607009|P4|Overall Study|Ongoing|8
820351|NCT00951015|2607010|P3|Overall Study|Ongoing|46
820352|NCT00951015|2607011|P2|Overall Study|Ongoing|45
820353|NCT00951015|2607012|P1|Overall Study|Ongoing|47
820354|NCT00951015|2607009|P4|Overall Study|Withdrawal by Subject|2
820355|NCT00951015|2607010|P3|Overall Study|Withdrawal by Subject|1
820356|NCT00951015|2607011|P2|Overall Study|Withdrawal by Subject|1
820357|NCT00951015|2607012|P1|Overall Study|Withdrawal by Subject|3
820358|NCT00951015|2607009|P4|Overall Study|Lost to Follow-up|2
820359|NCT00951015|2607010|P3|Overall Study|Lost to Follow-up|1
820360|NCT00951015|2607011|P2|Overall Study|Lost to Follow-up|2
820361|NCT00951015|2607012|P1|Overall Study|Lost to Follow-up|0
820362|NCT00951015|2607009|P4|Overall Study|Protocol-Defined Stopping Criteria|1
820363|NCT00951015|2607010|P3|Overall Study|Protocol-Defined Stopping Criteria|0
820364|NCT00951015|2607011|P2|Overall Study|Protocol-Defined Stopping Criteria|0
820365|NCT00951015|2607012|P1|Overall Study|Protocol-Defined Stopping Criteria|0
820366|NCT00951015|2607009|P4|Overall Study|Protocol Violation|0
820367|NCT00951015|2607010|P3|Overall Study|Protocol Violation|1
820368|NCT00951015|2607011|P2|Overall Study|Protocol Violation|1
820369|NCT00951015|2607012|P1|Overall Study|Protocol Violation|1
820370|NCT00951015|2607009|P4|Overall Study|Lack of Efficacy|0
820371|NCT00951015|2607010|P3|Overall Study|Lack of Efficacy|0
820372|NCT00951015|2607011|P2|Overall Study|Lack of Efficacy|1
820373|NCT00951015|2607012|P1|Overall Study|Lack of Efficacy|1
820374|NCT00951015|2607009|P4|Overall Study|Adverse Event|5
820375|NCT00951015|2607010|P3|Overall Study|Adverse Event|2
820376|NCT00951015|2607011|P2|Overall Study|Adverse Event|1
820377|NCT00951015|2607012|P1|Overall Study|Adverse Event|1
820378|NCT00951275|2607130|P1|Overall Study|Protocol Violation|1
820379|NCT00951275|2607130|P1|Overall Study|Withdrawal by Subject|4
820380|NCT00951275|2607130|P1|Overall Study|Adverse Event|7
820381|NCT00951275|2607130|P1|Overall Study|Administrative Reason|1
820382|NCT00951379|2607162|P2|Overall Study|Disease Progression|1
820383|NCT00951379|2607163|P1|Overall Study|Disease Progression|0
820384|NCT00951379|2607162|P2|Overall Study|Noncompliance|0
820385|NCT00951379|2607163|P1|Overall Study|Noncompliance|1
820386|NCT00951379|2607162|P2|Overall Study|Withdrawal by Subject|0
820387|NCT00951379|2607163|P1|Overall Study|Withdrawal by Subject|1
820388|NCT00951379|2607162|P2|Overall Study|Adverse Event|1
820389|NCT00951379|2607163|P1|Overall Study|Adverse Event|4
820390|NCT00951483|2607207|P2|Overall Study|Withdrawal by Subject|0
820391|NCT00951483|2607208|P1|Overall Study|Withdrawal by Subject|15
820392|NCT00951483|2607207|P2|Overall Study|Physician Decision|0
820393|NCT00951483|2607208|P1|Overall Study|Physician Decision|4
820394|NCT00951509|2607226|P1|Overall Study|Withdrawal by Subject|2
820395|NCT00951665|2607248|P6|Phase 2a|Disease Progression|5
820396|NCT00951665|2607249|P5|Phase 2a|Disease Progression|6
820397|NCT00951665|2607250|P4|Phase 2a|Disease Progression|0
820398|NCT00951665|2607251|P3|Phase 2a|Disease Progression|0
820399|NCT00951665|2607252|P2|Phase 2a|Disease Progression|0
820400|NCT00951665|2607253|P1|Phase 2a|Disease Progression|0
820401|NCT00951665|2607248|P6|Phase 2a|Withdrawal by Subject|0
820402|NCT00951665|2607249|P5|Phase 2a|Withdrawal by Subject|2
820403|NCT00951665|2607250|P4|Phase 2a|Withdrawal by Subject|0
820404|NCT00951665|2607251|P3|Phase 2a|Withdrawal by Subject|0
820405|NCT00951665|2607252|P2|Phase 2a|Withdrawal by Subject|0
820406|NCT00951665|2607253|P1|Phase 2a|Withdrawal by Subject|0
820407|NCT00951665|2607248|P6|Phase 2a|Physician Decision|1
820408|NCT00951665|2607249|P5|Phase 2a|Physician Decision|0
820409|NCT00951665|2607250|P4|Phase 2a|Physician Decision|0
820410|NCT00951665|2607251|P3|Phase 2a|Physician Decision|0
820411|NCT00951665|2607252|P2|Phase 2a|Physician Decision|0
820412|NCT00951665|2607253|P1|Phase 2a|Physician Decision|0
820413|NCT00951665|2607248|P6|Phase 2a|Lost to Follow-up|0
820414|NCT00951665|2607249|P5|Phase 2a|Lost to Follow-up|1
820415|NCT00951665|2607250|P4|Phase 2a|Lost to Follow-up|0
820416|NCT00951665|2607251|P3|Phase 2a|Lost to Follow-up|0
820417|NCT00951665|2607252|P2|Phase 2a|Lost to Follow-up|0
820418|NCT00951665|2607253|P1|Phase 2a|Lost to Follow-up|0
820419|NCT00951665|2607248|P6|Phase 2a|Death|1
820420|NCT00951665|2607249|P5|Phase 2a|Death|1
820421|NCT00951665|2607250|P4|Phase 2a|Death|0
820422|NCT00951665|2607251|P3|Phase 2a|Death|0
820423|NCT00951665|2607252|P2|Phase 2a|Death|0
820424|NCT00951665|2607253|P1|Phase 2a|Death|0
820425|NCT00951665|2607248|P6|Phase 2a|Adverse Event|0
820426|NCT00951665|2607249|P5|Phase 2a|Adverse Event|2
820427|NCT00951665|2607250|P4|Phase 2a|Adverse Event|0
820428|NCT00951665|2607251|P3|Phase 2a|Adverse Event|0
820429|NCT00951665|2607252|P2|Phase 2a|Adverse Event|0
820430|NCT00951665|2607253|P1|Phase 2a|Adverse Event|0
820431|NCT00951665|2607248|P6|Phase 1b|Protocol Violation|0
820432|NCT00951665|2607249|P5|Phase 1b|Protocol Violation|0
820433|NCT00951665|2607250|P4|Phase 1b|Protocol Violation|0
820434|NCT00951665|2607251|P3|Phase 1b|Protocol Violation|0
820435|NCT00951665|2607252|P2|Phase 1b|Protocol Violation|0
820436|NCT00951665|2607253|P1|Phase 1b|Protocol Violation|2
820437|NCT00951665|2607248|P6|Phase 1b|Disease Progression|0
820438|NCT00951665|2607249|P5|Phase 1b|Disease Progression|0
820439|NCT00951665|2607250|P4|Phase 1b|Disease Progression|0
820440|NCT00951665|2607251|P3|Phase 1b|Disease Progression|14
820441|NCT00951665|2607252|P2|Phase 1b|Disease Progression|2
820442|NCT00951665|2607253|P1|Phase 1b|Disease Progression|13
820443|NCT00951665|2607248|P6|Phase 1b|Withdrawal by Subject|0
820444|NCT00951665|2607249|P5|Phase 1b|Withdrawal by Subject|0
820445|NCT00951665|2607250|P4|Phase 1b|Withdrawal by Subject|0
820446|NCT00951665|2607251|P3|Phase 1b|Withdrawal by Subject|0
820447|NCT00951665|2607252|P2|Phase 1b|Withdrawal by Subject|1
820448|NCT00951665|2607253|P1|Phase 1b|Withdrawal by Subject|0
820449|NCT00951665|2607248|P6|Phase 1b|Physician Decision|0
820450|NCT00951665|2607249|P5|Phase 1b|Physician Decision|0
820451|NCT00951665|2607250|P4|Phase 1b|Physician Decision|0
820452|NCT00951665|2607251|P3|Phase 1b|Physician Decision|1
820453|NCT00951665|2607252|P2|Phase 1b|Physician Decision|0
820454|NCT00951665|2607253|P1|Phase 1b|Physician Decision|4
820455|NCT00951665|2607248|P6|Phase 1b|Death|0
820456|NCT00951665|2607249|P5|Phase 1b|Death|0
820457|NCT00951665|2607250|P4|Phase 1b|Death|0
820458|NCT00951665|2607251|P3|Phase 1b|Death|2
820459|NCT00951665|2607252|P2|Phase 1b|Death|0
820460|NCT00951665|2607253|P1|Phase 1b|Death|1
820461|NCT00951665|2607248|P6|Phase 1b|Adverse Event|0
820462|NCT00951665|2607249|P5|Phase 1b|Adverse Event|0
820463|NCT00951665|2607250|P4|Phase 1b|Adverse Event|1
820464|NCT00951665|2607251|P3|Phase 1b|Adverse Event|0
820465|NCT00951665|2607252|P2|Phase 1b|Adverse Event|1
820466|NCT00951665|2607253|P1|Phase 1b|Adverse Event|2
820467|NCT00951912|2607401|P3|Overall Study|Other: Stroke|0
820468|NCT00951912|2607402|P2|Overall Study|Other: Stroke|1
820469|NCT00951912|2607403|P1|Overall Study|Other: Stroke|0
820470|NCT00951912|2607401|P3|Overall Study|Other: Colon cancer|0
820471|NCT00951912|2607402|P2|Overall Study|Other: Colon cancer|0
820472|NCT00951912|2607403|P1|Overall Study|Other: Colon cancer|1
820473|NCT00951912|2607401|P3|Overall Study|Other:Depression|0
820474|NCT00951912|2607402|P2|Overall Study|Other:Depression|0
820475|NCT00951912|2607403|P1|Overall Study|Other:Depression|1
820476|NCT00951912|2607401|P3|Overall Study|Withdrawal by Subject|0
820477|NCT00951912|2607402|P2|Overall Study|Withdrawal by Subject|1
820478|NCT00951912|2607403|P1|Overall Study|Withdrawal by Subject|1
820479|NCT00951912|2607401|P3|Overall Study|Physician Decision|1
820480|NCT00951912|2607402|P2|Overall Study|Physician Decision|0
820481|NCT00951912|2607403|P1|Overall Study|Physician Decision|1
820482|NCT00951912|2607401|P3|Overall Study|Lost to Follow-up|0
820483|NCT00951912|2607402|P2|Overall Study|Lost to Follow-up|2
820484|NCT00951912|2607403|P1|Overall Study|Lost to Follow-up|2
820485|NCT00951912|2607401|P3|Overall Study|Adverse Event|1
820486|NCT00951912|2607402|P2|Overall Study|Adverse Event|1
820487|NCT00951912|2607403|P1|Overall Study|Adverse Event|0
820488|NCT00951912|2607401|P3|Overall Study|Lack of Efficacy|0
820489|NCT00951912|2607402|P2|Overall Study|Lack of Efficacy|0
820490|NCT00951912|2607403|P1|Overall Study|Lack of Efficacy|1
820491|NCT00952068|2607453|P1|Overall Study|Withdrawal by Subject|4
820492|NCT00952068|2607453|P1|Overall Study|Adverse Event|3
820493|NCT00952276|2607505|P5|Overall Study|Withdrawal by Subject|0
820494|NCT00952276|2607506|P4|Overall Study|Withdrawal by Subject|1
820495|NCT00952276|2607507|P3|Overall Study|Withdrawal by Subject|0
820496|NCT00952276|2607508|P2|Overall Study|Withdrawal by Subject|0
820497|NCT00952276|2607509|P1|Overall Study|Withdrawal by Subject|1
820498|NCT00952289|2607558|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
820499|NCT00952289|2607559|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
820500|NCT00952289|2607558|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
820501|NCT00952289|2607559|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
820502|NCT00952289|2607558|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
820503|NCT00952289|2607559|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
820504|NCT00952289|2607558|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
820505|NCT00952289|2607559|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
820506|NCT00952289|2607558|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
820507|NCT00952289|2607559|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
820508|NCT00952289|2607558|P2|All Participants|Data lost during site relocation|1
820509|NCT00952289|2607559|P1|All Participants|Data lost during site relocation|0
820510|NCT00952289|2607558|P2|All Participants|Withdrawal by Subject|10
820511|NCT00952289|2607559|P1|All Participants|Withdrawal by Subject|1
820512|NCT00952289|2607558|P2|All Participants|Disease progression|12
820513|NCT00952289|2607559|P1|All Participants|Disease progression|3
820514|NCT00952289|2607558|P2|All Participants|Adverse Event|8
820515|NCT00952289|2607559|P1|All Participants|Adverse Event|8
820516|NCT00952289|2607558|P2|All Participants|Death|9
820517|NCT00952289|2607559|P1|All Participants|Death|9
893288|NCT01632904|2833833|P2|Overall Study|Disease Progression|1
893289|NCT01632904|2833834|P1|Overall Study|Disease Progression|0
893290|NCT01632904|2833833|P2|Overall Study|Subject decision|2
893291|NCT01632904|2833834|P1|Overall Study|Subject decision|3
893292|NCT01632904|2833833|P2|Overall Study|Physician Decision|1
893293|NCT01632904|2833834|P1|Overall Study|Physician Decision|0
893294|NCT01632904|2833833|P2|Overall Study|Adverse Event|1
893295|NCT01632904|2833834|P1|Overall Study|Adverse Event|4
893296|NCT01587924|2833847|P4|Overall Study|Withdrawal by Subject|0
893297|NCT01587924|2833848|P3|Overall Study|Withdrawal by Subject|1
893298|NCT01587924|2833849|P2|Overall Study|Withdrawal by Subject|1
893299|NCT01587924|2833850|P1|Overall Study|Withdrawal by Subject|0
893300|NCT01587924|2833847|P4|Overall Study|Met Hemoglobin stopping criteria|0
893301|NCT01587924|2833848|P3|Overall Study|Met Hemoglobin stopping criteria|1
893302|NCT01587924|2833849|P2|Overall Study|Met Hemoglobin stopping criteria|0
893303|NCT01587924|2833850|P1|Overall Study|Met Hemoglobin stopping criteria|2
893304|NCT01587924|2833847|P4|Overall Study|Protocol Violation|1
893305|NCT01587924|2833848|P3|Overall Study|Protocol Violation|2
820538|NCT00952367|2607606|P1|Overall Study|Protocol Violation|3
820539|NCT00952367|2607606|P1|Overall Study|Noncoordination|1
820540|NCT00952367|2607606|P1|Overall Study|Withdrawal by Subject|2
820541|NCT00952419|2607626|P3|Overall Study|Withdrawal by Subject|0
820542|NCT00952419|2607627|P2|Overall Study|Withdrawal by Subject|3
820543|NCT00952419|2607628|P1|Overall Study|Withdrawal by Subject|1
820544|NCT00952419|2607626|P3|Overall Study|Protocol Violation|0
820545|NCT00952419|2607627|P2|Overall Study|Protocol Violation|7
820546|NCT00952419|2607628|P1|Overall Study|Protocol Violation|3
820547|NCT00952419|2607626|P3|Overall Study|Adverse Event|0
820548|NCT00952419|2607627|P2|Overall Study|Adverse Event|0
820549|NCT00952419|2607628|P1|Overall Study|Adverse Event|2
820550|NCT00952484|2607663|P3|Overall Study|Withdrawal by Subject|0
820551|NCT00952484|2607664|P2|Overall Study|Withdrawal by Subject|1
820552|NCT00952484|2607665|P1|Overall Study|Withdrawal by Subject|0
820553|NCT00952523|2607689|P1|Overall Study|Withdrawal by Subject|7
820554|NCT00952588|2607697|P2|Overall Study|Lack of Efficacy|2
820555|NCT00952588|2607698|P1|Overall Study|Lack of Efficacy|2
820556|NCT00952588|2607697|P2|Overall Study|Physician Decision|1
820557|NCT00952588|2607698|P1|Overall Study|Physician Decision|0
820558|NCT00952588|2607697|P2|Overall Study|Lost to Follow-up|0
820559|NCT00952588|2607698|P1|Overall Study|Lost to Follow-up|2
820560|NCT00952588|2607697|P2|Overall Study|Adverse Event|3
820561|NCT00952588|2607698|P1|Overall Study|Adverse Event|2
820562|NCT00952588|2607697|P2|Overall Study|Withdrawal by Subject|5
820563|NCT00952588|2607698|P1|Overall Study|Withdrawal by Subject|2
820564|NCT00952588|2607697|P2|Overall Study|Death|13
820565|NCT00952588|2607698|P1|Overall Study|Death|28
820566|NCT00952614|2607716|P1|Overall Study|other reason|1
820567|NCT00952614|2607716|P1|Overall Study|Lost to Follow-up|3
820568|NCT00952614|2607716|P1|Overall Study|Death|3
820569|NCT00952705|2607749|P3|Overall Study|Exclusion criteria not met pre dose|0
820570|NCT00952705|2607750|P2|Overall Study|Exclusion criteria not met pre dose|1
820571|NCT00952705|2607751|P1|Overall Study|Exclusion criteria not met pre dose|0
820572|NCT00952705|2607749|P3|Overall Study|Incarcerated post dose|0
820573|NCT00952705|2607750|P2|Overall Study|Incarcerated post dose|0
820574|NCT00952705|2607751|P1|Overall Study|Incarcerated post dose|5
820575|NCT00952705|2607749|P3|Overall Study|Death|0
820576|NCT00952705|2607750|P2|Overall Study|Death|0
820577|NCT00952705|2607751|P1|Overall Study|Death|2
820578|NCT00952705|2607749|P3|Overall Study|Withdrawal by Subject|1
820579|NCT00952705|2607750|P2|Overall Study|Withdrawal by Subject|1
820580|NCT00952705|2607751|P1|Overall Study|Withdrawal by Subject|2
820581|NCT00952705|2607749|P3|Overall Study|Lost to Follow-up|9
820582|NCT00952705|2607750|P2|Overall Study|Lost to Follow-up|8
820583|NCT00952705|2607751|P1|Overall Study|Lost to Follow-up|24
820584|NCT00952731|2607815|P2|Overall Study|Drug supply expired|0
820585|NCT00952731|2607816|P1|Overall Study|Drug supply expired|1
820594|NCT00952848|2607865|P1|Overall Study|Withdrawal by Subject|4
820595|NCT00953017|2607876|P4|Overall Study|Brown stool prior to procedure|0
820596|NCT00953017|2607877|P3|Overall Study|Brown stool prior to procedure|1
820597|NCT00953017|2607878|P2|Overall Study|Brown stool prior to procedure|0
820598|NCT00953017|2607879|P1|Overall Study|Brown stool prior to procedure|0
820599|NCT00953017|2607876|P4|Overall Study|Procedure incomplete due to pain/looping|1
820600|NCT00953017|2607877|P3|Overall Study|Procedure incomplete due to pain/looping|0
820601|NCT00953017|2607878|P2|Overall Study|Procedure incomplete due to pain/looping|1
820602|NCT00953017|2607879|P1|Overall Study|Procedure incomplete due to pain/looping|0
820603|NCT00953017|2607876|P4|Overall Study|Incomplete data|0
820604|NCT00953017|2607877|P3|Overall Study|Incomplete data|0
820605|NCT00953017|2607878|P2|Overall Study|Incomplete data|1
820606|NCT00953017|2607879|P1|Overall Study|Incomplete data|1
820607|NCT00953017|2607876|P4|Overall Study|DId not show up for colonoscopy|4
820608|NCT00953017|2607877|P3|Overall Study|DId not show up for colonoscopy|5
820609|NCT00953017|2607878|P2|Overall Study|DId not show up for colonoscopy|4
820610|NCT00953017|2607879|P1|Overall Study|DId not show up for colonoscopy|4
820611|NCT00953043|2607903|P2|Overall Study|Physician Decision|2
820612|NCT00953043|2607904|P1|Overall Study|Physician Decision|0
820613|NCT00953043|2607903|P2|Overall Study|Withdrawal by Subject|0
820614|NCT00953043|2607904|P1|Overall Study|Withdrawal by Subject|4
820615|NCT00953056|2607930|P6|Overall Study|Serious Adverse Event|1
820616|NCT00953056|2607931|P5|Overall Study|Serious Adverse Event|0
820617|NCT00953056|2607932|P4|Overall Study|Serious Adverse Event|0
820618|NCT00953056|2607933|P3|Overall Study|Serious Adverse Event|0
820619|NCT00953056|2607934|P2|Overall Study|Serious Adverse Event|0
820620|NCT00953056|2607935|P1|Overall Study|Serious Adverse Event|0
820621|NCT00953056|2607930|P6|Overall Study|Withdrew Consent|3
820622|NCT00953056|2607931|P5|Overall Study|Withdrew Consent|2
820623|NCT00953056|2607932|P4|Overall Study|Withdrew Consent|0
820624|NCT00953056|2607933|P3|Overall Study|Withdrew Consent|0
820625|NCT00953056|2607934|P2|Overall Study|Withdrew Consent|0
820626|NCT00953056|2607935|P1|Overall Study|Withdrew Consent|0
820627|NCT00953147|2607985|P3|Overall Study|Other|13
820628|NCT00953147|2607986|P2|Overall Study|Other|11
820629|NCT00953147|2607987|P1|Overall Study|Other|4
820630|NCT00953147|2607985|P3|Overall Study|Physician Decision|3
820631|NCT00953147|2607986|P2|Overall Study|Physician Decision|7
820632|NCT00953147|2607987|P1|Overall Study|Physician Decision|2
820633|NCT00953147|2607985|P3|Overall Study|Lost to Follow-up|4
820634|NCT00953147|2607986|P2|Overall Study|Lost to Follow-up|9
820635|NCT00953147|2607987|P1|Overall Study|Lost to Follow-up|8
820636|NCT00953147|2607985|P3|Overall Study|Withdrawal by Subject|12
820637|NCT00953147|2607986|P2|Overall Study|Withdrawal by Subject|15
820638|NCT00953147|2607987|P1|Overall Study|Withdrawal by Subject|13
820639|NCT00953147|2607985|P3|Overall Study|Protocol Violation|4
820640|NCT00953147|2607986|P2|Overall Study|Protocol Violation|8
820641|NCT00953147|2607987|P1|Overall Study|Protocol Violation|2
820642|NCT00953147|2607985|P3|Overall Study|Adverse Event|6
820643|NCT00953147|2607986|P2|Overall Study|Adverse Event|16
820644|NCT00953147|2607987|P1|Overall Study|Adverse Event|8
820645|NCT00953160|2608034|P1|Overall Study|Withdrawal by Subject|4
820646|NCT00953160|2608034|P1|Overall Study|Lost to Follow-up|23
893306|NCT01587924|2833849|P2|Overall Study|Protocol Violation|1
893307|NCT01587924|2833850|P1|Overall Study|Protocol Violation|2
820649|NCT00953329|2608069|P1|Overall Study|Lack of Efficacy|1
820650|NCT00953407|2608078|P5|Overall Study|Lost to Follow-up|0
820651|NCT00953407|2608079|P4|Overall Study|Lost to Follow-up|1
820652|NCT00953407|2608080|P3|Overall Study|Lost to Follow-up|0
820653|NCT00953407|2608081|P2|Overall Study|Lost to Follow-up|0
820654|NCT00953407|2608082|P1|Overall Study|Lost to Follow-up|0
820655|NCT00953407|2608078|P5|Overall Study|Failed inclusion criteria|1
820656|NCT00953407|2608079|P4|Overall Study|Failed inclusion criteria|1
820657|NCT00953407|2608080|P3|Overall Study|Failed inclusion criteria|1
820658|NCT00953407|2608081|P2|Overall Study|Failed inclusion criteria|1
820659|NCT00953407|2608082|P1|Overall Study|Failed inclusion criteria|1
820660|NCT00953524|2608098|P4|Overall Study|Withdrawal by Subject|0
820661|NCT00953524|2608099|P3|Overall Study|Withdrawal by Subject|1
820662|NCT00953524|2608100|P2|Overall Study|Withdrawal by Subject|4
820663|NCT00953524|2608101|P1|Overall Study|Withdrawal by Subject|2
820664|NCT00953524|2608098|P4|Overall Study|Lost to Follow-up|0
820665|NCT00953524|2608099|P3|Overall Study|Lost to Follow-up|1
820666|NCT00953524|2608100|P2|Overall Study|Lost to Follow-up|1
820667|NCT00953524|2608101|P1|Overall Study|Lost to Follow-up|0
820668|NCT00953524|2608098|P4|Overall Study|Protocol Violation|6
820669|NCT00953524|2608099|P3|Overall Study|Protocol Violation|11
820670|NCT00953524|2608100|P2|Overall Study|Protocol Violation|10
820671|NCT00953524|2608101|P1|Overall Study|Protocol Violation|18
820672|NCT00953524|2608098|P4|Overall Study|Adverse Event|2
820673|NCT00953524|2608099|P3|Overall Study|Adverse Event|1
820674|NCT00953524|2608100|P2|Overall Study|Adverse Event|0
820675|NCT00953524|2608101|P1|Overall Study|Adverse Event|2
820676|NCT00953615|2608139|P1|Overall Study|Adverse Event|1
820677|NCT00953667|2608162|P1|Overall Study|poor venous access,unable to draw blood|4
820678|NCT00953667|2608162|P1|Overall Study|Adverse Event|10
820679|NCT00953667|2608162|P1|Overall Study|Withdrawal by Subject|63
820680|NCT00953667|2608162|P1|Overall Study|Physician Decision|35
820681|NCT00953667|2608162|P1|Overall Study|Lost to Follow-up|11
820682|NCT00953680|2608167|P2|Period 1|Withdrawal by Subject|1
820683|NCT00953680|2608168|P1|Period 1|Withdrawal by Subject|0
820684|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Unspecified|2
820685|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Unspecified|0
820686|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Unspecified|0
820687|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Unspecified|0
820688|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
820689|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
820690|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
820691|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
820692|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
820693|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
820694|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
820695|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
820696|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
820697|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
820698|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
820699|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
820700|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
820701|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
820702|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
820703|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
820704|NCT00953706|2608182|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
820705|NCT00953706|2608183|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
820706|NCT00953706|2608184|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
820707|NCT00953706|2608185|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
820708|NCT00953706|2608182|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
820709|NCT00953706|2608183|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
820710|NCT00953706|2608184|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
820711|NCT00953706|2608185|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
820712|NCT00953706|2608182|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
820713|NCT00953706|2608183|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
820714|NCT00953706|2608184|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
820715|NCT00953706|2608185|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
820716|NCT00953706|2608182|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
820717|NCT00953706|2608183|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
820718|NCT00953706|2608184|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
820719|NCT00953706|2608185|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
820720|NCT00953706|2608182|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
820721|NCT00953706|2608183|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
820722|NCT00953706|2608184|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
820723|NCT00953706|2608185|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
820724|NCT00953706|2608182|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
820725|NCT00953706|2608183|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
820726|NCT00953706|2608184|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
820727|NCT00953706|2608185|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
820728|NCT00946920|2608242|P2|Overall Study|Miscellaneous reasons|3
820729|NCT00946920|2608243|P1|Overall Study|Miscellaneous reasons|18
820730|NCT00946920|2608242|P2|Overall Study|Protocol Violation|8
820731|NCT00946920|2608243|P1|Overall Study|Protocol Violation|16
820732|NCT00946920|2608242|P2|Overall Study|Adverse Event|14
820733|NCT00946920|2608243|P1|Overall Study|Adverse Event|41
820734|NCT00946920|2608242|P2|Overall Study|Physician Decision|2
820735|NCT00946920|2608243|P1|Overall Study|Physician Decision|5
820736|NCT00946920|2608242|P2|Overall Study|Lost to Follow-up|2
820737|NCT00946920|2608243|P1|Overall Study|Lost to Follow-up|2
820738|NCT00946920|2608242|P2|Overall Study|Withdrawal by Subject|15
820739|NCT00946920|2608243|P1|Overall Study|Withdrawal by Subject|28
820740|NCT00946985|2608258|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
820741|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
820742|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
820743|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
820744|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
820745|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
820746|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
820747|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
820748|NCT00946985|2608258|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
820749|NCT00947011|2608262|P1|Overall Study|Study was terminated,PI left institution|12
820750|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
820751|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
820752|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
820753|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
820754|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
820755|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
820756|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
820757|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
820758|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
820759|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
820760|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
820761|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
820762|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
820763|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
820764|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
820765|NCT00947115|2608273|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
820766|NCT00947115|2608274|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
820767|NCT00947115|2608275|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
820768|NCT00947154|2608337|P1|Overall Study|Lost to Follow-up|1
820769|NCT00947349|2608430|P4|Overall Study Standard of Care|not specified|1
820770|NCT00947349|2608431|P3|Overall Study Standard of Care|not specified|0
820771|NCT00947349|2608432|P2|Overall Study Standard of Care|not specified|0
820772|NCT00947349|2608433|P1|Overall Study Standard of Care|not specified|0
820773|NCT00947349|2608430|P4|Overall Study Standard of Care|Withdrawal by Subject|0
820774|NCT00947349|2608431|P3|Overall Study Standard of Care|Withdrawal by Subject|1
820775|NCT00947349|2608432|P2|Overall Study Standard of Care|Withdrawal by Subject|0
820776|NCT00947349|2608433|P1|Overall Study Standard of Care|Withdrawal by Subject|0
820777|NCT00947349|2608430|P4|Overall Study Standard of Care|Lack of Efficacy|1
820778|NCT00947349|2608431|P3|Overall Study Standard of Care|Lack of Efficacy|1
820779|NCT00947349|2608432|P2|Overall Study Standard of Care|Lack of Efficacy|0
820780|NCT00947349|2608433|P1|Overall Study Standard of Care|Lack of Efficacy|0
820781|NCT00947349|2608430|P4|Triple Treatment Combination Period|Adverse Event|0
820782|NCT00947349|2608431|P3|Triple Treatment Combination Period|Adverse Event|0
820783|NCT00947349|2608432|P2|Triple Treatment Combination Period|Adverse Event|1
820784|NCT00947349|2608433|P1|Triple Treatment Combination Period|Adverse Event|0
820785|NCT00947427|2608567|P2|Overall Study|Protocol Violation|1
820786|NCT00947427|2608568|P1|Overall Study|Protocol Violation|0
820787|NCT00947427|2608567|P2|Overall Study|Withdrawal by Subject|3
820788|NCT00947427|2608568|P1|Overall Study|Withdrawal by Subject|1
820789|NCT00947531|2608601|P2|Overall Study|Other|1
820790|NCT00947531|2608602|P1|Overall Study|Other|1
820791|NCT00947531|2608601|P2|Overall Study|Lack of Efficacy|0
820792|NCT00947531|2608602|P1|Overall Study|Lack of Efficacy|1
820793|NCT00947531|2608601|P2|Overall Study|Adverse Event|2
820794|NCT00947531|2608602|P1|Overall Study|Adverse Event|2
820795|NCT00947531|2608601|P2|Overall Study|Administrative Reason|1
820796|NCT00947531|2608602|P1|Overall Study|Administrative Reason|0
820797|NCT00947531|2608601|P2|Overall Study|Withdrawal by Subject|7
820798|NCT00947531|2608602|P1|Overall Study|Withdrawal by Subject|10
820799|NCT00947544|2608608|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
820800|NCT00947544|2608609|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
820801|NCT00947856|2608697|P2|Follow-up Period|Withdrawal by Subject|0
820802|NCT00947856|2608698|P1|Follow-up Period|Withdrawal by Subject|1
820803|NCT00947856|2608697|P2|Follow-up Period|Patient unavailable for site visits|0
820804|NCT00947856|2608698|P1|Follow-up Period|Patient unavailable for site visits|1
820805|NCT00947856|2608697|P2|Follow-up Period|Lost to Follow-up|0
820806|NCT00947856|2608698|P1|Follow-up Period|Lost to Follow-up|7
820807|NCT00947856|2608697|P2|Follow-up Period|Re-enrolled for Retreatment|3
820808|NCT00947856|2608698|P1|Follow-up Period|Re-enrolled for Retreatment|2
820809|NCT00947856|2608697|P2|Follow-up Period|Study Stopped by Sponsor|20
820810|NCT00947856|2608698|P1|Follow-up Period|Study Stopped by Sponsor|40
820811|NCT00947856|2608697|P2|Treatment Period|Withdrawal by Subject|1
820812|NCT00947856|2608698|P1|Treatment Period|Withdrawal by Subject|12
820813|NCT00947856|2608697|P2|Treatment Period|Study Stopped by Sponsor|4
820814|NCT00947856|2608698|P1|Treatment Period|Study Stopped by Sponsor|4
820815|NCT00947856|2608697|P2|Treatment Period|Physician Decision|6
820816|NCT00947856|2608698|P1|Treatment Period|Physician Decision|14
820817|NCT00947856|2608697|P2|Treatment Period|Adverse Event|9
820818|NCT00947856|2608698|P1|Treatment Period|Adverse Event|15
820819|NCT00947856|2608697|P2|Treatment Period|Progressive Disease|12
820820|NCT00947856|2608698|P1|Treatment Period|Progressive Disease|33
820821|NCT00947882|2608729|P4|Overall Study|Trial Terminated by Sponsor|70
820822|NCT00947882|2608730|P3|Overall Study|Trial Terminated by Sponsor|62
820823|NCT00947882|2608731|P2|Overall Study|Trial Terminated by Sponsor|61
820824|NCT00947882|2608732|P1|Overall Study|Trial Terminated by Sponsor|62
820825|NCT00947882|2608729|P4|Overall Study|Other/Unknown|6
820826|NCT00947882|2608730|P3|Overall Study|Other/Unknown|3
820827|NCT00947882|2608731|P2|Overall Study|Other/Unknown|13
820828|NCT00947882|2608732|P1|Overall Study|Other/Unknown|10
820829|NCT00947882|2608729|P4|Overall Study|Lost to Follow-up|0
820830|NCT00947882|2608730|P3|Overall Study|Lost to Follow-up|1
820831|NCT00947882|2608731|P2|Overall Study|Lost to Follow-up|2
820832|NCT00947882|2608732|P1|Overall Study|Lost to Follow-up|0
820833|NCT00947882|2608729|P4|Overall Study|Protocol Violation|0
820834|NCT00947882|2608730|P3|Overall Study|Protocol Violation|1
820835|NCT00947882|2608731|P2|Overall Study|Protocol Violation|0
820836|NCT00947882|2608732|P1|Overall Study|Protocol Violation|0
820837|NCT00947882|2608729|P4|Overall Study|Withdrawal by Subject|2
820838|NCT00947882|2608730|P3|Overall Study|Withdrawal by Subject|8
820839|NCT00947882|2608731|P2|Overall Study|Withdrawal by Subject|0
820840|NCT00947882|2608732|P1|Overall Study|Withdrawal by Subject|2
820841|NCT00947882|2608729|P4|Overall Study|Adverse Event|4
820842|NCT00947882|2608730|P3|Overall Study|Adverse Event|4
820843|NCT00947882|2608731|P2|Overall Study|Adverse Event|1
820844|NCT00947882|2608732|P1|Overall Study|Adverse Event|0
820845|NCT00948064|2608761|P3|Phase II|Withdrawal by Subject|0
820846|NCT00948064|2608762|P2|Phase II|Withdrawal by Subject|1
820847|NCT00948064|2608763|P1|Phase II|Withdrawal by Subject|0
820848|NCT00948064|2608761|P3|Phase II|Physician Decision|1
820849|NCT00948064|2608762|P2|Phase II|Physician Decision|0
820850|NCT00948064|2608763|P1|Phase II|Physician Decision|0
820851|NCT00948064|2608761|P3|Phase I|No treatment received|0
820852|NCT00948064|2608762|P2|Phase I|No treatment received|0
820853|NCT00948064|2608763|P1|Phase I|No treatment received|1
820854|NCT00948155|2608800|P2|Washout 14 Days|Lost to Follow-up|2
820855|NCT00948155|2608801|P1|Washout 14 Days|Lost to Follow-up|1
820856|NCT00948155|2608800|P2|First Intervention 21 Days|Lost to Follow-up|2
820857|NCT00948155|2608801|P1|First Intervention 21 Days|Lost to Follow-up|2
820858|NCT00948246|2608821|P1|Overall Study|Withdrawal by Subject|1
820859|NCT00948246|2608821|P1|Overall Study|Death|1
820860|NCT00948246|2608821|P1|Overall Study|Adverse Event|11
820861|NCT00948246|2608821|P1|Overall Study|Lost to Follow-up|11
820862|NCT00953927|2608865|P2|Overall Study|Other study discontinuation|1
820863|NCT00953927|2608866|P1|Overall Study|Other study discontinuation|1
820864|NCT00953927|2608865|P2|Overall Study|Death|4
820865|NCT00953927|2608866|P1|Overall Study|Death|7
820866|NCT00953927|2608865|P2|Overall Study|Withdrawal by Subject|25
820867|NCT00953927|2608866|P1|Overall Study|Withdrawal by Subject|36
820868|NCT00953927|2608865|P2|Overall Study|Lost to Follow-up|65
820869|NCT00953927|2608866|P1|Overall Study|Lost to Follow-up|61
820870|NCT00954122|2608889|P1|Overall Study|Safety Reason|1
820871|NCT00954122|2608889|P1|Overall Study|Adverse Event|1
820872|NCT00954122|2608889|P1|Overall Study|Withdrawal by Subject|5
820873|NCT00956943|2608901|P2|Overall Study|Lost to Follow-up|10
820874|NCT00956943|2608902|P1|Overall Study|Lost to Follow-up|9
820891|NCT00957021|2608931|P1|Overall Study|Termination due to language issue|2
820892|NCT00957021|2608931|P1|Overall Study|Surgery Cancelled|9
820893|NCT00957021|2608931|P1|Overall Study|Site Termination by the 2 yr visit|16
820894|NCT00957021|2608931|P1|Overall Study|Revised study component by 2 yr visit|8
820895|NCT00957021|2608931|P1|Overall Study|No 2 yr ROM data|35
820896|NCT00957021|2608931|P1|Overall Study|Withdrawal by Subject|34
820897|NCT00957021|2608931|P1|Overall Study|Lost to Follow-up|8
820898|NCT00957021|2608931|P1|Overall Study|Death|5
820899|NCT00957034|2608943|P3|Overall Study|Withdrawal by Subject|0
820900|NCT00957034|2608944|P2|Overall Study|Withdrawal by Subject|2
820901|NCT00957034|2608945|P1|Overall Study|Withdrawal by Subject|0
820902|NCT00957034|2608943|P3|Overall Study|Sponsor Terminated Study|5
820903|NCT00957034|2608944|P2|Overall Study|Sponsor Terminated Study|1
820904|NCT00957034|2608945|P1|Overall Study|Sponsor Terminated Study|6
820905|NCT00957034|2608943|P3|Overall Study|Adverse Event|1
820906|NCT00957034|2608944|P2|Overall Study|Adverse Event|1
820907|NCT00957034|2608945|P1|Overall Study|Adverse Event|0
820908|NCT00957268|2609030|P5|Overall Study|Voluntary Withdrawal|0
820909|NCT00957268|2609031|P4|Overall Study|Voluntary Withdrawal|0
820910|NCT00957268|2609032|P3|Overall Study|Voluntary Withdrawal|1
820911|NCT00957268|2609033|P2|Overall Study|Voluntary Withdrawal|0
820912|NCT00957268|2609034|P1|Overall Study|Voluntary Withdrawal|0
820913|NCT00957372|2609103|P4|PART II|Patient non-compliance|4
820914|NCT00957372|2609104|P3|PART II|Patient non-compliance|0
820915|NCT00957372|2609105|P2|PART II|Patient non-compliance|0
820916|NCT00957372|2609106|P1|PART II|Patient non-compliance|0
820917|NCT00957372|2609103|P4|PART II|Adverse Event|10
820918|NCT00957372|2609104|P3|PART II|Adverse Event|0
820919|NCT00957372|2609105|P2|PART II|Adverse Event|0
820920|NCT00957372|2609106|P1|PART II|Adverse Event|0
820921|NCT00957372|2609103|P4|PART II|Not Know|20
820922|NCT00957372|2609104|P3|PART II|Not Know|0
820923|NCT00957372|2609105|P2|PART II|Not Know|0
820924|NCT00957372|2609106|P1|PART II|Not Know|0
820925|NCT00957372|2609103|P4|PART II|Pregnancy|1
820926|NCT00957372|2609104|P3|PART II|Pregnancy|0
820927|NCT00957372|2609105|P2|PART II|Pregnancy|0
820928|NCT00957372|2609106|P1|PART II|Pregnancy|0
820929|NCT00957372|2609103|P4|PART II|Physician Decision|1
820930|NCT00957372|2609104|P3|PART II|Physician Decision|0
820931|NCT00957372|2609105|P2|PART II|Physician Decision|0
820932|NCT00957372|2609106|P1|PART II|Physician Decision|0
820933|NCT00957372|2609103|P4|PART II|Withdrawal by Subject|8
820934|NCT00957372|2609104|P3|PART II|Withdrawal by Subject|0
820935|NCT00957372|2609105|P2|PART II|Withdrawal by Subject|0
820936|NCT00957372|2609106|P1|PART II|Withdrawal by Subject|0
820937|NCT00957372|2609103|P4|PART I|Lost to Follow-up|0
820938|NCT00957372|2609104|P3|PART I|Lost to Follow-up|1
820939|NCT00957372|2609105|P2|PART I|Lost to Follow-up|0
820940|NCT00957372|2609106|P1|PART I|Lost to Follow-up|0
820941|NCT00957424|2609122|P1|Overall Study|Withdrawal by Subject|1
820942|NCT00957424|2609122|P1|Overall Study|Protocol Violation|3
820943|NCT00957424|2609122|P1|Overall Study|Lost to Follow-up|19
820944|NCT00957528|2609132|P3|Overall Study|Withdrawal by Subject|1
820945|NCT00957528|2609133|P2|Overall Study|Withdrawal by Subject|0
820946|NCT00957528|2609134|P1|Overall Study|Withdrawal by Subject|0
820947|NCT00957528|2609132|P3|Overall Study|Protocol Violation|0
820948|NCT00957528|2609133|P2|Overall Study|Protocol Violation|1
820949|NCT00957528|2609134|P1|Overall Study|Protocol Violation|0
820950|NCT00957580|2609160|P3|Overall Study|Enrolled but not treated|0
820951|NCT00957580|2609161|P2|Overall Study|Enrolled but not treated|1
820952|NCT00957580|2609162|P1|Overall Study|Enrolled but not treated|0
820953|NCT00957580|2609160|P3|Overall Study|Ongoing at data cut-off|0
820954|NCT00957580|2609161|P2|Overall Study|Ongoing at data cut-off|1
820955|NCT00957580|2609162|P1|Overall Study|Ongoing at data cut-off|0
820956|NCT00957658|2609315|P1|Overall Study|Protocol Violation|5
820957|NCT00957658|2609315|P1|Overall Study|surgery cancelled|2
820958|NCT00957658|2609315|P1|Overall Study|unwilling/unable to return|2
820959|NCT00957658|2609315|P1|Overall Study|Site termination|10
820960|NCT00957658|2609315|P1|Overall Study|Incomplete 2 yr data|28
820961|NCT00957658|2609315|P1|Overall Study|Revision|1
820962|NCT00957658|2609315|P1|Overall Study|Withdrawal by Subject|12
820963|NCT00957658|2609315|P1|Overall Study|Lost to Follow-up|4
820964|NCT00957658|2609315|P1|Overall Study|Death|1
893308|NCT01587924|2833847|P4|Overall Study|Adverse Event|0
893309|NCT01587924|2833848|P3|Overall Study|Adverse Event|0
893310|NCT01587924|2833849|P2|Overall Study|Adverse Event|2
893311|NCT01587924|2833850|P1|Overall Study|Adverse Event|0
893312|NCT01585428|2833949|P2|Overall Study|Death during treatment|0
893313|NCT01585428|2833950|P1|Overall Study|Death during treatment|1
893314|NCT01371825|2833985|P1|Primary Efficacy Analysis Period|Death|3
893315|NCT01282424|2833997|P1|Overall Study|Investigator Request|7
820973|NCT00957905|2609359|P2|Part B|Protocol Violation|1
820974|NCT00957905|2609360|P1|Part B|Protocol Violation|0
820975|NCT00957905|2609359|P2|Part B|Death|1
820976|NCT00957905|2609360|P1|Part B|Death|0
820977|NCT00957905|2609359|P2|Part B|Physician Decision|1
820978|NCT00957905|2609360|P1|Part B|Physician Decision|0
820979|NCT00957905|2609359|P2|Part B|Not Treated|1
820980|NCT00957905|2609360|P1|Part B|Not Treated|0
820981|NCT00957944|2609368|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
820982|NCT00957944|2609369|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
820983|NCT00957996|2609405|P2|Overall Study|Noncompliance; Protocol Deviations|6
820984|NCT00957996|2609406|P1|Overall Study|Noncompliance; Protocol Deviations|5
820985|NCT00957996|2609405|P2|Overall Study|Missing|0
820986|NCT00957996|2609406|P1|Overall Study|Missing|1
820987|NCT00957996|2609405|P2|Overall Study|Influenza-related complication|1
820988|NCT00957996|2609406|P1|Overall Study|Influenza-related complication|0
820989|NCT00957996|2609405|P2|Overall Study|Physician Decision|1
820990|NCT00957996|2609406|P1|Overall Study|Physician Decision|1
820991|NCT00957996|2609405|P2|Overall Study|Adverse Event|1
820992|NCT00957996|2609406|P1|Overall Study|Adverse Event|2
820993|NCT00957996|2609405|P2|Overall Study|Withdrawal by Subject|2
820994|NCT00957996|2609406|P1|Overall Study|Withdrawal by Subject|9
820995|NCT00957996|2609405|P2|Overall Study|Lost to Follow-up|7
820996|NCT00957996|2609406|P1|Overall Study|Lost to Follow-up|4
820997|NCT00957996|2609405|P2|Overall Study|Death|10
820998|NCT00957996|2609406|P1|Overall Study|Death|4
820999|NCT00958009|2609436|P1|Overall Study|Subject found device difficult to use|1
821000|NCT00958009|2609436|P1|Overall Study|Adverse Event|1
821001|NCT00958074|2609452|P2|Overall Study|Withdrawal by Subject|1
821002|NCT00958074|2609453|P1|Overall Study|Withdrawal by Subject|0
821051|NCT00958165|2609544|P1|Overall Study|Not eligible|9
821052|NCT00958165|2609544|P1|Overall Study|Lost to Follow-up|5
821053|NCT00958191|2609548|P1|Overall Study|No 5 yr x-rays|56
821054|NCT00958191|2609548|P1|Overall Study|Site termination|11
821055|NCT00958191|2609548|P1|Overall Study|Revision of study device|4
821056|NCT00958191|2609548|P1|Overall Study|Did not receive study device|1
821057|NCT00958191|2609548|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
821058|NCT00958191|2609548|P1|Overall Study|Inadequate 5 yr x-ray quality|10
821059|NCT00958191|2609548|P1|Overall Study|Lost to Follow-up|5
821060|NCT00958191|2609548|P1|Overall Study|Death|4
821061|NCT00958217|2609563|P2|Overall Study|Inpatient hospitalization|1
821062|NCT00958217|2609564|P1|Overall Study|Inpatient hospitalization|0
821063|NCT00958217|2609563|P2|Overall Study|Moved out of area|1
821064|NCT00958217|2609564|P1|Overall Study|Moved out of area|1
821065|NCT00958217|2609563|P2|Overall Study|Lost to Follow-up|19
821066|NCT00958217|2609564|P1|Overall Study|Lost to Follow-up|17
821067|NCT00958217|2609563|P2|Overall Study|Withdrawal by Subject|3
821068|NCT00958217|2609564|P1|Overall Study|Withdrawal by Subject|4
821069|NCT00958217|2609563|P2|Overall Study|Death|1
821070|NCT00958217|2609564|P1|Overall Study|Death|2
821083|NCT00958256|2609642|P1|Overall Study|Adverse Event|3
821084|NCT00958347|2609683|P1|Overall Study|study termination|135
821085|NCT00958347|2609683|P1|Overall Study|revision/removal|10
821086|NCT00958347|2609683|P1|Overall Study|Lost to Follow-up|15
821087|NCT00958347|2609683|P1|Overall Study|Withdrawal by Subject|23
821088|NCT00958347|2609683|P1|Overall Study|Death|43
821089|NCT00958360|2609689|P2|Overall Study|Lost to Follow-up|1
821090|NCT00958360|2609690|P1|Overall Study|Lost to Follow-up|0
821091|NCT00958360|2609689|P2|Overall Study|Physician Decision|1
821092|NCT00958360|2609690|P1|Overall Study|Physician Decision|2
821093|NCT00958360|2609689|P2|Overall Study|Death|7
821094|NCT00958360|2609690|P1|Overall Study|Death|6
821095|NCT00958360|2609689|P2|Overall Study|Withdrawal by Subject|1
821096|NCT00958360|2609690|P1|Overall Study|Withdrawal by Subject|3
821097|NCT00958438|2609707|P3|Overall Study|Other than specified above|2
821098|NCT00958438|2609708|P2|Overall Study|Other than specified above|3
821099|NCT00958438|2609709|P1|Overall Study|Other than specified above|2
821100|NCT00958438|2609707|P3|Overall Study|Physician Decision|1
821101|NCT00958438|2609708|P2|Overall Study|Physician Decision|0
821102|NCT00958438|2609709|P1|Overall Study|Physician Decision|1
821103|NCT00958438|2609707|P3|Overall Study|Adverse Event|0
821104|NCT00958438|2609708|P2|Overall Study|Adverse Event|3
821105|NCT00958438|2609709|P1|Overall Study|Adverse Event|0
821106|NCT00958438|2609707|P3|Overall Study|Withdrawal by Subject|1
821107|NCT00958438|2609708|P2|Overall Study|Withdrawal by Subject|2
821108|NCT00958438|2609709|P1|Overall Study|Withdrawal by Subject|4
821109|NCT00958438|2609707|P3|Overall Study|Protocol Violation|2
821110|NCT00958438|2609708|P2|Overall Study|Protocol Violation|2
821111|NCT00958438|2609709|P1|Overall Study|Protocol Violation|3
821112|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
821113|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
821114|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
821115|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
821116|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
821117|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
821118|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
821119|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
821120|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
821121|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
821122|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
821123|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
821124|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
821125|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
821126|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
821127|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
821128|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
821129|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
821130|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
821131|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
821132|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
821133|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
821134|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
821135|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
821136|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
821137|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
821138|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
821139|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
821140|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
821141|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
821142|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
821143|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
821144|NCT00958568|2609885|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
821145|NCT00958568|2609886|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
821146|NCT00958568|2609887|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
821147|NCT00958568|2609888|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
821148|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
821149|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
821150|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
821151|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
821152|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
821153|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
821154|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
821155|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
821156|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
821157|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
821158|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
821159|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
821160|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
821161|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
821162|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
821163|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
821164|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
821165|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
821166|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
821167|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
821168|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
821169|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
821170|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
821171|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
821172|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
821173|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
821174|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
821175|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
821176|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
821177|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
821178|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
821179|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
821180|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
821181|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
821182|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
821183|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
821184|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
821185|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
821186|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
821187|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
821188|NCT00958568|2609885|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
821189|NCT00958568|2609886|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
821190|NCT00958568|2609887|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
821191|NCT00958568|2609888|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
821192|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
821193|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
821194|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
821195|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
821196|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
821197|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
821198|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
821199|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
821200|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
821201|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
821202|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
821203|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
821204|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
821205|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
821206|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
821207|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
821208|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
821209|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
821210|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
821211|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
821212|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
821213|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
821214|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
821215|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
821216|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
821217|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
821218|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
821219|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
821220|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
821221|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
821222|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
821223|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
821224|NCT00958568|2609885|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
821225|NCT00958568|2609886|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
821226|NCT00958568|2609887|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
821227|NCT00958568|2609888|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
821228|NCT00958776|2609971|P2|Overall Study|Missing|1
821229|NCT00958776|2609972|P1|Overall Study|Missing|1
821230|NCT00958776|2609971|P2|Overall Study|Noncompliance; Protocol Deviations|3
821231|NCT00958776|2609972|P1|Overall Study|Noncompliance; Protocol Deviations|2
821232|NCT00958776|2609971|P2|Overall Study|Death|1
821233|NCT00958776|2609972|P1|Overall Study|Death|2
821234|NCT00958776|2609971|P2|Overall Study|Protocol Violation|1
821235|NCT00958776|2609972|P1|Overall Study|Protocol Violation|1
821236|NCT00958776|2609971|P2|Overall Study|Withdrawal by Subject|16
821237|NCT00958776|2609972|P1|Overall Study|Withdrawal by Subject|7
821238|NCT00958776|2609971|P2|Overall Study|Lost to Follow-up|6
821239|NCT00958776|2609972|P1|Overall Study|Lost to Follow-up|2
821240|NCT00958776|2609971|P2|Overall Study|Physician Decision|0
821241|NCT00958776|2609972|P1|Overall Study|Physician Decision|1
821242|NCT00958776|2609971|P2|Overall Study|Adverse Event|1
821243|NCT00958776|2609972|P1|Overall Study|Adverse Event|0
821244|NCT00958789|2610002|P1|Overall Study|Revision|8
821245|NCT00958789|2610002|P1|Overall Study|Subject terminated|3
821246|NCT00958789|2610002|P1|Overall Study|2 yr. Knee Society Score not calculable|2
821247|NCT00958789|2610002|P1|Overall Study|No 2 yr. Knee Society Score data|12
821248|NCT00958789|2610002|P1|Overall Study|Withdrawal by Subject|16
821249|NCT00958789|2610002|P1|Overall Study|Lost to Follow-up|7
821250|NCT00958789|2610002|P1|Overall Study|Death|3
821251|NCT00958828|2610006|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
821252|NCT00958828|2610007|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
821253|NCT00958828|2610006|P2|Period 1, 1 Week of Wear|Randomization break|1
821254|NCT00958828|2610007|P1|Period 1, 1 Week of Wear|Randomization break|0
821255|NCT00958841|2610013|P1|Overall Study|Discontinued prior to M*|28
821256|NCT00958841|2610013|P1|Overall Study|Completed M6/did not enter extension|27
821257|NCT00958841|2610013|P1|Overall Study|Unsatisfactory therapeutic effect|22
821258|NCT00958841|2610013|P1|Overall Study|Withdrawal by Subject|1
821259|NCT00958841|2610013|P1|Overall Study|New cancer therapy|5
821260|NCT00958841|2610013|P1|Overall Study|Adverse Event|8
821261|NCT00958841|2610013|P1|Overall Study|Administrative problems|1
821262|NCT00958841|2610013|P1|Overall Study|Abnormal test procedure result(s)|3
821263|NCT00958841|2610013|P1|Overall Study|Abnormal laboratory value(s)|1
821264|NCT00958880|2610033|P2|Overall Study|Lost to Follow-up|2
821265|NCT00958880|2610034|P1|Overall Study|Lost to Follow-up|2
821266|NCT00958893|2610042|P1|Overall Study|Study prematurely terminated|4
821267|NCT00959049|2610067|P6|Overall Study|Withdrawal by Subject|0
821268|NCT00959049|2610068|P5|Overall Study|Withdrawal by Subject|0
821269|NCT00959049|2610069|P4|Overall Study|Withdrawal by Subject|0
821270|NCT00959049|2610070|P3|Overall Study|Withdrawal by Subject|0
821271|NCT00959049|2610071|P2|Overall Study|Withdrawal by Subject|2
821272|NCT00959049|2610072|P1|Overall Study|Withdrawal by Subject|0
821273|NCT00959049|2610067|P6|Overall Study|Contraindicated medication|0
821274|NCT00959049|2610068|P5|Overall Study|Contraindicated medication|0
821275|NCT00959049|2610069|P4|Overall Study|Contraindicated medication|1
821276|NCT00959049|2610070|P3|Overall Study|Contraindicated medication|0
821277|NCT00959049|2610071|P2|Overall Study|Contraindicated medication|0
821278|NCT00959049|2610072|P1|Overall Study|Contraindicated medication|0
821279|NCT00959049|2610067|P6|Overall Study|Lost to Follow-up|1
821280|NCT00959049|2610068|P5|Overall Study|Lost to Follow-up|9
821281|NCT00959049|2610069|P4|Overall Study|Lost to Follow-up|10
821282|NCT00959049|2610070|P3|Overall Study|Lost to Follow-up|1
821283|NCT00959049|2610071|P2|Overall Study|Lost to Follow-up|5
821284|NCT00959049|2610072|P1|Overall Study|Lost to Follow-up|17
821285|NCT00959049|2610067|P6|Overall Study|Adverse Event|0
821286|NCT00959049|2610068|P5|Overall Study|Adverse Event|0
821287|NCT00959049|2610069|P4|Overall Study|Adverse Event|0
821288|NCT00959049|2610070|P3|Overall Study|Adverse Event|0
821289|NCT00959049|2610071|P2|Overall Study|Adverse Event|0
821290|NCT00959049|2610072|P1|Overall Study|Adverse Event|1
821291|NCT00959192|2610126|P4|Overall Study|Caregiver Request|1
821292|NCT00959192|2610127|P3|Overall Study|Caregiver Request|2
821293|NCT00959192|2610128|P2|Overall Study|Caregiver Request|0
821294|NCT00959192|2610129|P1|Overall Study|Caregiver Request|0
821295|NCT00959192|2610126|P4|Overall Study|Investigator Request|0
821296|NCT00959192|2610127|P3|Overall Study|Investigator Request|0
821297|NCT00959192|2610128|P2|Overall Study|Investigator Request|0
821298|NCT00959192|2610129|P1|Overall Study|Investigator Request|1
821299|NCT00959192|2610126|P4|Overall Study|Adverse Event|0
821300|NCT00959192|2610127|P3|Overall Study|Adverse Event|1
821301|NCT00959192|2610128|P2|Overall Study|Adverse Event|1
821302|NCT00959192|2610129|P1|Overall Study|Adverse Event|1
821303|NCT00959374|2610171|P1|Overall Study|Physician Decision|1
821304|NCT00959374|2610171|P1|Overall Study|Implant Removed/Not Replaced|4
821305|NCT00959374|2610171|P1|Overall Study|Protocol Violation|1
821306|NCT00959374|2610171|P1|Overall Study|Death|1
821307|NCT00959374|2610171|P1|Overall Study|Lost to Follow-up|14
821308|NCT00959374|2610171|P1|Overall Study|Withdrawal by Subject|2
821309|NCT00951171|2610183|P2|Overall Study|Adverse Event|0
821310|NCT00951171|2610184|P1|Overall Study|Adverse Event|2
821311|NCT00959647|2610190|P1|Overall Study|Withdrawal by Subject|7
821312|NCT00959647|2610190|P1|Overall Study|Study terminated by sponsor|4
821313|NCT00959647|2610190|P1|Overall Study|Progressive disease|6
821314|NCT00959647|2610190|P1|Overall Study|Adverse Event|2
821315|NCT00959699|2610197|P2|Follow-up Period|Withdrawal by Subject|4
821316|NCT00959699|2610198|P1|Follow-up Period|Withdrawal by Subject|3
821317|NCT00959699|2610197|P2|Follow-up Period|Lost to Follow-up|2
821318|NCT00959699|2610198|P1|Follow-up Period|Lost to Follow-up|3
821319|NCT00959699|2610197|P2|Treatment Period|Futility/crossover to boceprevir|0
821320|NCT00959699|2610198|P1|Treatment Period|Futility/crossover to boceprevir|4
821321|NCT00959699|2610197|P2|Treatment Period|Did not receive treatment|1
821322|NCT00959699|2610198|P1|Treatment Period|Did not receive treatment|0
821323|NCT00959699|2610197|P2|Treatment Period|Non-Compliance with Protocol|1
821324|NCT00959699|2610198|P1|Treatment Period|Non-Compliance with Protocol|0
821325|NCT00959699|2610197|P2|Treatment Period|Withdrawal by Subject|3
821326|NCT00959699|2610198|P1|Treatment Period|Withdrawal by Subject|1
821327|NCT00959699|2610197|P2|Treatment Period|Lost to Follow-up|1
821328|NCT00959699|2610198|P1|Treatment Period|Lost to Follow-up|0
821329|NCT00959699|2610197|P2|Treatment Period|Lack of Efficacy|6
821330|NCT00959699|2610198|P1|Treatment Period|Lack of Efficacy|15
821331|NCT00959699|2610197|P2|Treatment Period|Adverse Event|13
821332|NCT00959699|2610198|P1|Treatment Period|Adverse Event|3
821333|NCT00959751|2610217|P2|Overall Study|No migraine headache without aura|7
821334|NCT00959751|2610218|P1|Overall Study|No migraine headache without aura|7
821335|NCT00959751|2610217|P2|Overall Study|Non-compliance to Study Procedures|1
821336|NCT00959751|2610218|P1|Overall Study|Non-compliance to Study Procedures|0
821337|NCT00959751|2610217|P2|Overall Study|Consent Withdrawn|1
821338|NCT00959751|2610218|P1|Overall Study|Consent Withdrawn|0
821339|NCT00959751|2610217|P2|Overall Study|Lost to Follow-up|3
821340|NCT00959751|2610218|P1|Overall Study|Lost to Follow-up|2
821341|NCT00961116|2610257|P2|Washout Period of 7 Days|Protocol Violation|1
821342|NCT00961116|2610258|P1|Washout Period of 7 Days|Protocol Violation|0
821343|NCT00961116|2610257|P2|Washout Period of 7 Days|Withdrawal by Subject|1
821344|NCT00961116|2610258|P1|Washout Period of 7 Days|Withdrawal by Subject|1
821345|NCT00961116|2610257|P2|Washout Period of 7 Days|Adverse Event|1
821346|NCT00961116|2610258|P1|Washout Period of 7 Days|Adverse Event|1
821347|NCT00961181|2610268|P1|Overall Study|Lost to Follow-up|1
821348|NCT00961181|2610268|P1|Overall Study|Withdrawal by Subject|2
821349|NCT00961181|2610268|P1|Overall Study|Death|2
821350|NCT00961220|2610281|P1|Overall Study|Complete Response prior to 12 courses|1
821351|NCT00961220|2610281|P1|Overall Study|O6BG no longer supplied|1
821352|NCT00961220|2610281|P1|Overall Study|No IV access for O6BG|1
821353|NCT00961220|2610281|P1|Overall Study|Lack of Efficacy|1
821354|NCT00961220|2610281|P1|Overall Study|Adverse Event|3
821355|NCT00961259|2610308|P3|Washout Period of 7 Days|due to concomitant medication used|0
821356|NCT00961259|2610309|P2|Washout Period of 7 Days|due to concomitant medication used|1
821357|NCT00961259|2610310|P1|Washout Period of 7 Days|due to concomitant medication used|0
821358|NCT00961298|2610327|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
821359|NCT00961298|2610327|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
821360|NCT00961298|2610327|P1|Two Week Placebo Run in|Withdrawal by Subject|1
821361|NCT00961350|2610343|P2|Overall Study|Misc|21
821362|NCT00961350|2610344|P1|Overall Study|Misc|16
821363|NCT00961350|2610343|P2|Overall Study|Lost to Follow-up|3
821364|NCT00961350|2610344|P1|Overall Study|Lost to Follow-up|3
821365|NCT00961350|2610343|P2|Overall Study|Withdrawal by Subject|10
821366|NCT00961350|2610344|P1|Overall Study|Withdrawal by Subject|10
821367|NCT00961350|2610343|P2|Overall Study|Adverse Event|33
821368|NCT00961350|2610344|P1|Overall Study|Adverse Event|18
821369|NCT00961415|2610375|P3|Maintenance Treatment Phase|Other reason|3
821370|NCT00961415|2610376|P2|Maintenance Treatment Phase|Other reason|1
821371|NCT00961415|2610377|P1|Maintenance Treatment Phase|Other reason|0
821372|NCT00961415|2610375|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
821373|NCT00961415|2610376|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
821374|NCT00961415|2610377|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
821375|NCT00961415|2610375|P3|Maintenance Treatment Phase|Investigators decision|0
821376|NCT00961415|2610376|P2|Maintenance Treatment Phase|Investigators decision|2
821377|NCT00961415|2610377|P1|Maintenance Treatment Phase|Investigators decision|0
821378|NCT00961415|2610375|P3|Maintenance Treatment Phase|Death|34
821379|NCT00961415|2610376|P2|Maintenance Treatment Phase|Death|42
821380|NCT00961415|2610377|P1|Maintenance Treatment Phase|Death|0
821381|NCT00961415|2610375|P3|Induction Treatment Phase|Other Reason|0
821382|NCT00961415|2610376|P2|Induction Treatment Phase|Other Reason|0
821383|NCT00961415|2610377|P1|Induction Treatment Phase|Other Reason|5
821384|NCT00961415|2610375|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
821385|NCT00961415|2610376|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
821386|NCT00961415|2610377|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
821387|NCT00961415|2610375|P3|Induction Treatment Phase|Physician Decision|0
821388|NCT00961415|2610376|P2|Induction Treatment Phase|Physician Decision|0
821389|NCT00961415|2610377|P1|Induction Treatment Phase|Physician Decision|2
821390|NCT00961415|2610375|P3|Induction Treatment Phase|Protocol Violation|0
821391|NCT00961415|2610376|P2|Induction Treatment Phase|Protocol Violation|0
821392|NCT00961415|2610377|P1|Induction Treatment Phase|Protocol Violation|1
821393|NCT00961415|2610375|P3|Induction Treatment Phase|Death|0
821394|NCT00961415|2610376|P2|Induction Treatment Phase|Death|0
821395|NCT00961415|2610377|P1|Induction Treatment Phase|Death|77
821396|NCT00961415|2610375|P3|Induction Treatment Phase|Withdrawal by Subject|0
821397|NCT00961415|2610376|P2|Induction Treatment Phase|Withdrawal by Subject|0
821398|NCT00961415|2610377|P1|Induction Treatment Phase|Withdrawal by Subject|11
821399|NCT00961571|2610422|P1|Overall Study|Physician Decision|39
821400|NCT00961636|2610429|P3|Overall Study|Withdrawal by Subject|13
821401|NCT00961636|2610430|P2|Overall Study|Withdrawal by Subject|22
821402|NCT00961636|2610431|P1|Overall Study|Withdrawal by Subject|29
821403|NCT00961636|2610429|P3|Overall Study|Protocol Violation|1
821404|NCT00961636|2610430|P2|Overall Study|Protocol Violation|5
821405|NCT00961636|2610431|P1|Overall Study|Protocol Violation|9
821406|NCT00961636|2610429|P3|Overall Study|Physician Decision|1
821407|NCT00961636|2610430|P2|Overall Study|Physician Decision|1
821408|NCT00961636|2610431|P1|Overall Study|Physician Decision|3
821409|NCT00961636|2610429|P3|Overall Study|Lost to Follow-up|1
821410|NCT00961636|2610430|P2|Overall Study|Lost to Follow-up|3
821411|NCT00961636|2610431|P1|Overall Study|Lost to Follow-up|2
821412|NCT00961636|2610429|P3|Overall Study|Flushing Symptoms|3
821413|NCT00961636|2610430|P2|Overall Study|Flushing Symptoms|46
821414|NCT00961636|2610431|P1|Overall Study|Flushing Symptoms|29
821415|NCT00961636|2610429|P3|Overall Study|Adverse Event|13
821416|NCT00961636|2610430|P2|Overall Study|Adverse Event|54
821417|NCT00961636|2610431|P1|Overall Study|Adverse Event|35
821418|NCT00961649|2610446|P4|Overall Study|Study terminated by sponsor|1
821419|NCT00961649|2610447|P3|Overall Study|Study terminated by sponsor|4
821420|NCT00961649|2610448|P2|Overall Study|Study terminated by sponsor|4
821421|NCT00961649|2610449|P1|Overall Study|Study terminated by sponsor|4
821422|NCT00961649|2610446|P4|Overall Study|Patient left to Mexico-family emergency|0
821423|NCT00961649|2610447|P3|Overall Study|Patient left to Mexico-family emergency|0
821424|NCT00961649|2610448|P2|Overall Study|Patient left to Mexico-family emergency|0
821425|NCT00961649|2610449|P1|Overall Study|Patient left to Mexico-family emergency|1
821426|NCT00961649|2610446|P4|Overall Study|Patient has travel plans during holidays|0
821427|NCT00961649|2610447|P3|Overall Study|Patient has travel plans during holidays|1
821428|NCT00961649|2610448|P2|Overall Study|Patient has travel plans during holidays|0
821429|NCT00961649|2610449|P1|Overall Study|Patient has travel plans during holidays|0
821430|NCT00961649|2610446|P4|Overall Study|Inadequate control of IOP|1
821431|NCT00961649|2610447|P3|Overall Study|Inadequate control of IOP|0
821432|NCT00961649|2610448|P2|Overall Study|Inadequate control of IOP|0
821433|NCT00961649|2610449|P1|Overall Study|Inadequate control of IOP|0
821434|NCT00961649|2610446|P4|Overall Study|Adverse Event|2
821435|NCT00961649|2610447|P3|Overall Study|Adverse Event|0
821436|NCT00961649|2610448|P2|Overall Study|Adverse Event|0
821437|NCT00961649|2610449|P1|Overall Study|Adverse Event|4
821438|NCT00961896|2610507|P3|Overall Study|Abnormal laboratory value|1
821439|NCT00961896|2610508|P2|Overall Study|Abnormal laboratory value|0
821440|NCT00961896|2610509|P1|Overall Study|Abnormal laboratory value|0
821441|NCT00962013|2610539|P1|Overall Study|No 5 year evaluation|6
821442|NCT00962013|2610539|P1|Overall Study|Site Termination|24
821443|NCT00962013|2610539|P1|Overall Study|Removal of study device|3
821444|NCT00962013|2610539|P1|Overall Study|Withdrawal by Subject|8
821445|NCT00962013|2610539|P1|Overall Study|Unable/Unwilling to return|6
821446|NCT00962013|2610539|P1|Overall Study|Lost to Follow-up|12
821447|NCT00962013|2610539|P1|Overall Study|Death|8
821448|NCT00962013|2610539|P1|Overall Study|Did not have surgery|1
821449|NCT00962104|2610578|P2|Overall Study|Other|0
821450|NCT00962104|2610579|P1|Overall Study|Other|2
821451|NCT00962104|2610578|P2|Overall Study|Withdrawal by Subject|6
821452|NCT00962104|2610579|P1|Overall Study|Withdrawal by Subject|10
821453|NCT00962104|2610578|P2|Overall Study|Sponsor Decision|1
821454|NCT00962104|2610579|P1|Overall Study|Sponsor Decision|0
821455|NCT00962104|2610578|P2|Overall Study|Protocol Violation|8
821456|NCT00962104|2610579|P1|Overall Study|Protocol Violation|6
821457|NCT00962104|2610578|P2|Overall Study|Physician Decision|0
821458|NCT00962104|2610579|P1|Overall Study|Physician Decision|1
821459|NCT00962104|2610578|P2|Overall Study|Lost to Follow-up|4
821460|NCT00962104|2610579|P1|Overall Study|Lost to Follow-up|10
821461|NCT00962104|2610578|P2|Overall Study|Lack of Efficacy|1
821462|NCT00962104|2610579|P1|Overall Study|Lack of Efficacy|0
821463|NCT00962104|2610578|P2|Overall Study|Entry Criteria Not Met|2
821464|NCT00962104|2610579|P1|Overall Study|Entry Criteria Not Met|1
821465|NCT00962104|2610578|P2|Overall Study|Adverse Event|3
821466|NCT00962104|2610579|P1|Overall Study|Adverse Event|10
821467|NCT00962208|2610607|P2|Overall Study|Lost to Follow-up|9
821468|NCT00962208|2610608|P1|Overall Study|Lost to Follow-up|0
821469|NCT00962208|2610607|P2|Overall Study|Contraindicated to continue study|1
821470|NCT00962208|2610608|P1|Overall Study|Contraindicated to continue study|5
821471|NCT00962208|2610607|P2|Overall Study|Could not achieve good vision|0
821472|NCT00962208|2610608|P1|Overall Study|Could not achieve good vision|9
821473|NCT00962247|2610614|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
821474|NCT00962247|2610614|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
821475|NCT00962247|2610614|P1|Usual Sedentary|Withdrawal by Subject|5
821476|NCT00962247|2610614|P1|Usual Sedentary|Protocol Violation|13
821477|NCT00962390|2610627|P4|Overall Study|Withdrawal by Subject|0
821478|NCT00962390|2610628|P3|Overall Study|Withdrawal by Subject|1
821479|NCT00962390|2610629|P2|Overall Study|Withdrawal by Subject|1
821480|NCT00962390|2610630|P1|Overall Study|Withdrawal by Subject|1
821481|NCT00962390|2610627|P4|Overall Study|Protocol Violation|0
821482|NCT00962390|2610628|P3|Overall Study|Protocol Violation|0
821483|NCT00962390|2610629|P2|Overall Study|Protocol Violation|0
821484|NCT00962390|2610630|P1|Overall Study|Protocol Violation|1
821485|NCT00962390|2610627|P4|Overall Study|Lost to Follow-up|0
821486|NCT00962390|2610628|P3|Overall Study|Lost to Follow-up|0
821487|NCT00962390|2610629|P2|Overall Study|Lost to Follow-up|2
821488|NCT00962390|2610630|P1|Overall Study|Lost to Follow-up|2
821489|NCT00962390|2610627|P4|Overall Study|Adverse Event|1
821490|NCT00962390|2610628|P3|Overall Study|Adverse Event|3
821491|NCT00962390|2610629|P2|Overall Study|Adverse Event|0
821492|NCT00962390|2610630|P1|Overall Study|Adverse Event|0
821493|NCT00962585|2610696|P4|Overall Study|Withdrew Consent|0
821494|NCT00962585|2610697|P3|Overall Study|Withdrew Consent|0
821495|NCT00962585|2610698|P2|Overall Study|Withdrew Consent|0
821496|NCT00962585|2610699|P1|Overall Study|Withdrew Consent|2
821497|NCT00962585|2610696|P4|Overall Study|Withdrawal by Subject|0
821498|NCT00962585|2610697|P3|Overall Study|Withdrawal by Subject|0
821499|NCT00962585|2610698|P2|Overall Study|Withdrawal by Subject|0
821500|NCT00962585|2610699|P1|Overall Study|Withdrawal by Subject|1
821501|NCT00962585|2610696|P4|Overall Study|Protocol Violation|0
821502|NCT00962585|2610697|P3|Overall Study|Protocol Violation|1
821503|NCT00962585|2610698|P2|Overall Study|Protocol Violation|0
821504|NCT00962585|2610699|P1|Overall Study|Protocol Violation|0
821505|NCT00962585|2610696|P4|Overall Study|Lost to Follow-up|0
821506|NCT00962585|2610697|P3|Overall Study|Lost to Follow-up|1
821507|NCT00962585|2610698|P2|Overall Study|Lost to Follow-up|0
821508|NCT00962585|2610699|P1|Overall Study|Lost to Follow-up|3
821509|NCT00962585|2610696|P4|Overall Study|Adverse Event|0
821510|NCT00962585|2610697|P3|Overall Study|Adverse Event|1
821511|NCT00962585|2610698|P2|Overall Study|Adverse Event|2
821512|NCT00962585|2610699|P1|Overall Study|Adverse Event|0
821513|NCT00962598|2610759|P2|Overall Study|discontinued prior to getting treatment|3
821514|NCT00962598|2610760|P1|Overall Study|discontinued prior to getting treatment|0
821515|NCT00962598|2610759|P2|Overall Study|Pregnancy|0
821516|NCT00962598|2610760|P1|Overall Study|Pregnancy|1
821517|NCT00962598|2610759|P2|Overall Study|Withdrawal by Subject|3
821518|NCT00962598|2610760|P1|Overall Study|Withdrawal by Subject|1
821519|NCT00962598|2610759|P2|Overall Study|Physician Decision|0
821520|NCT00962598|2610760|P1|Overall Study|Physician Decision|1
821521|NCT00962598|2610759|P2|Overall Study|Lost to Follow-up|0
821522|NCT00962598|2610760|P1|Overall Study|Lost to Follow-up|2
821523|NCT00962598|2610759|P2|Overall Study|Adverse Event|0
821524|NCT00962598|2610760|P1|Overall Study|Adverse Event|1
821525|NCT00962650|2610768|P1|Overall Study|Transgastric DP was not completed|2
821526|NCT00962741|2610772|P1|Overall Study|drug ineffective+prohibited drug taken|1
821527|NCT00962741|2610772|P1|Overall Study|Lack of Efficacy|1
821528|NCT00962741|2610772|P1|Overall Study|Withdrawal by Subject|1
821529|NCT00962741|2610772|P1|Overall Study|Lost to Follow-up|2
821530|NCT00962741|2610772|P1|Overall Study|Failed to return|3
821531|NCT00962780|2610878|P2|Overall Study|Unspecified|1
821532|NCT00962780|2610879|P1|Overall Study|Unspecified|0
821533|NCT00962780|2610878|P2|Overall Study|Withdrawal by Subject|8
821534|NCT00962780|2610879|P1|Overall Study|Withdrawal by Subject|1
821535|NCT00962780|2610878|P2|Overall Study|Protocol Violation|4
821536|NCT00962780|2610879|P1|Overall Study|Protocol Violation|9
821537|NCT00962780|2610878|P2|Overall Study|Death|1
821538|NCT00962780|2610879|P1|Overall Study|Death|0
821539|NCT00963235|2611163|P1|Overall Study|Unspecified|1
821540|NCT00963235|2611163|P1|Overall Study|Physician Decision|2
821541|NCT00963235|2611163|P1|Overall Study|Adverse Event|5
821542|NCT00963235|2611163|P1|Overall Study|Protocol Violation|7
821543|NCT00963235|2611163|P1|Overall Study|Failed to return|9
821544|NCT00963235|2611163|P1|Overall Study|Lost to Follow-up|14
821545|NCT00963235|2611163|P1|Overall Study|Withdrawal by Subject|22
821546|NCT00963469|2611226|P3|Overall Study|Site closed (local pollen Season ended)|3
821547|NCT00963469|2611227|P2|Overall Study|Site closed (local pollen Season ended)|1
821548|NCT00963469|2611228|P1|Overall Study|Site closed (local pollen Season ended)|4
821549|NCT00963469|2611226|P3|Overall Study|Moved|0
821550|NCT00963469|2611227|P2|Overall Study|Moved|0
821551|NCT00963469|2611228|P1|Overall Study|Moved|1
821552|NCT00963469|2611226|P3|Overall Study|Pre-randomization Adverse Event|0
821553|NCT00963469|2611227|P2|Overall Study|Pre-randomization Adverse Event|2
821554|NCT00963469|2611228|P1|Overall Study|Pre-randomization Adverse Event|1
821555|NCT00963469|2611226|P3|Overall Study|Withdrawal by Subject|1
821556|NCT00963469|2611227|P2|Overall Study|Withdrawal by Subject|1
821557|NCT00963469|2611228|P1|Overall Study|Withdrawal by Subject|4
821558|NCT00963469|2611226|P3|Overall Study|Protocol Violation|3
821559|NCT00963469|2611227|P2|Overall Study|Protocol Violation|5
821560|NCT00963469|2611228|P1|Overall Study|Protocol Violation|5
821561|NCT00963469|2611226|P3|Overall Study|Lost to Follow-up|0
821562|NCT00963469|2611227|P2|Overall Study|Lost to Follow-up|1
821563|NCT00963469|2611228|P1|Overall Study|Lost to Follow-up|1
821564|NCT00963469|2611226|P3|Overall Study|Lack of Efficacy|2
821565|NCT00963469|2611227|P2|Overall Study|Lack of Efficacy|7
821566|NCT00963469|2611228|P1|Overall Study|Lack of Efficacy|10
821567|NCT00963469|2611226|P3|Overall Study|Adverse Event|1
821568|NCT00963469|2611227|P2|Overall Study|Adverse Event|11
821569|NCT00963469|2611228|P1|Overall Study|Adverse Event|15
821570|NCT00963599|2611291|P4|Overall Study|Withdrawal by Subject|3
821571|NCT00963599|2611292|P3|Overall Study|Withdrawal by Subject|3
821572|NCT00963599|2611293|P2|Overall Study|Withdrawal by Subject|1
821573|NCT00963599|2611294|P1|Overall Study|Withdrawal by Subject|2
821574|NCT00963599|2611291|P4|Overall Study|Protocol Violation|4
821575|NCT00963599|2611292|P3|Overall Study|Protocol Violation|3
821576|NCT00963599|2611293|P2|Overall Study|Protocol Violation|2
821577|NCT00963599|2611294|P1|Overall Study|Protocol Violation|2
821578|NCT00963599|2611291|P4|Overall Study|Lost to Follow-up|1
821579|NCT00963599|2611292|P3|Overall Study|Lost to Follow-up|1
821580|NCT00963599|2611293|P2|Overall Study|Lost to Follow-up|1
821581|NCT00963599|2611294|P1|Overall Study|Lost to Follow-up|0
821582|NCT00963599|2611291|P4|Overall Study|Lack of Efficacy|4
821583|NCT00963599|2611292|P3|Overall Study|Lack of Efficacy|1
821584|NCT00963599|2611293|P2|Overall Study|Lack of Efficacy|2
821585|NCT00963599|2611294|P1|Overall Study|Lack of Efficacy|0
821586|NCT00963599|2611291|P4|Overall Study|Adverse Event|2
821587|NCT00963599|2611292|P3|Overall Study|Adverse Event|1
821588|NCT00963599|2611293|P2|Overall Study|Adverse Event|0
821589|NCT00963599|2611294|P1|Overall Study|Adverse Event|2
821590|NCT00954447|2611350|P2|Overall Study|Other|18
821591|NCT00954447|2611351|P1|Overall Study|Other|21
821592|NCT00954447|2611350|P2|Overall Study|Withdrawal by Subject|21
821593|NCT00954447|2611351|P1|Overall Study|Withdrawal by Subject|26
821594|NCT00954447|2611350|P2|Overall Study|Lost to Follow-up|14
821595|NCT00954447|2611351|P1|Overall Study|Lost to Follow-up|8
821596|NCT00954447|2611350|P2|Overall Study|Protocol Violation|7
821597|NCT00954447|2611351|P1|Overall Study|Protocol Violation|5
821598|NCT00954447|2611350|P2|Overall Study|Lack of Efficacy|3
821599|NCT00954447|2611351|P1|Overall Study|Lack of Efficacy|17
821600|NCT00954447|2611350|P2|Overall Study|Adverse Event|25
821601|NCT00954447|2611351|P1|Overall Study|Adverse Event|33
821602|NCT00954512|2611393|P6|Overall Study|Progression of Disease|1
821603|NCT00954512|2611394|P5|Overall Study|Progression of Disease|1
821604|NCT00954512|2611395|P4|Overall Study|Progression of Disease|1
821605|NCT00954512|2611396|P3|Overall Study|Progression of Disease|0
821606|NCT00954512|2611397|P2|Overall Study|Progression of Disease|1
821607|NCT00954512|2611398|P1|Overall Study|Progression of Disease|2
821608|NCT00954512|2611393|P6|Overall Study|Symptomatic Deterioration|0
821609|NCT00954512|2611394|P5|Overall Study|Symptomatic Deterioration|2
821610|NCT00954512|2611395|P4|Overall Study|Symptomatic Deterioration|0
821611|NCT00954512|2611396|P3|Overall Study|Symptomatic Deterioration|0
821612|NCT00954512|2611397|P2|Overall Study|Symptomatic Deterioration|1
821613|NCT00954512|2611398|P1|Overall Study|Symptomatic Deterioration|0
821614|NCT00954512|2611393|P6|Overall Study|Physician Decision|0
821615|NCT00954512|2611394|P5|Overall Study|Physician Decision|0
821616|NCT00954512|2611395|P4|Overall Study|Physician Decision|1
821617|NCT00954512|2611396|P3|Overall Study|Physician Decision|0
821618|NCT00954512|2611397|P2|Overall Study|Physician Decision|1
821619|NCT00954512|2611398|P1|Overall Study|Physician Decision|0
821620|NCT00954512|2611393|P6|Overall Study|Adverse Event|2
821621|NCT00954512|2611394|P5|Overall Study|Adverse Event|1
821622|NCT00954512|2611395|P4|Overall Study|Adverse Event|0
821623|NCT00954512|2611396|P3|Overall Study|Adverse Event|0
821624|NCT00954512|2611397|P2|Overall Study|Adverse Event|0
821625|NCT00954512|2611398|P1|Overall Study|Adverse Event|0
821626|NCT00954512|2611393|P6|Overall Study|Withdrawal by Subject|1
821627|NCT00954512|2611394|P5|Overall Study|Withdrawal by Subject|0
821628|NCT00954512|2611395|P4|Overall Study|Withdrawal by Subject|0
821629|NCT00954512|2611396|P3|Overall Study|Withdrawal by Subject|0
821630|NCT00954512|2611397|P2|Overall Study|Withdrawal by Subject|0
821631|NCT00954512|2611398|P1|Overall Study|Withdrawal by Subject|0
821632|NCT00954538|2611419|P6|Part III|Withdrawal by Subject|0
821633|NCT00954538|2611420|P5|Part III|Withdrawal by Subject|1
821634|NCT00954538|2611421|P4|Part III|Withdrawal by Subject|0
821635|NCT00954538|2611422|P3|Part III|Withdrawal by Subject|0
821636|NCT00954538|2611423|P2|Part III|Withdrawal by Subject|0
821637|NCT00954538|2611424|P1|Part III|Withdrawal by Subject|0
821638|NCT00954707|2611439|P1|Overall Study|Lost to Follow-up|33
821639|NCT00954707|2611439|P1|Overall Study|Withdrawal by Subject|100
821640|NCT00954707|2611439|P1|Overall Study|Death|34
821641|NCT00954733|2611455|P1|Overall Study|blood gas machine did not work|1
821642|NCT00954941|2611469|P2|Overall Study|Adverse Event|1
821643|NCT00954941|2611470|P1|Overall Study|Adverse Event|0
821644|NCT00954941|2611469|P2|Overall Study|Ineligible|2
821645|NCT00954941|2611470|P1|Overall Study|Ineligible|2
821646|NCT00954941|2611469|P2|Overall Study|Physician Decision|2
821647|NCT00954941|2611470|P1|Overall Study|Physician Decision|2
821648|NCT00954941|2611469|P2|Overall Study|Insurance Denial|2
821649|NCT00954941|2611470|P1|Overall Study|Insurance Denial|2
821650|NCT00954941|2611469|P2|Overall Study|Withdrawal by Subject|0
821651|NCT00954941|2611470|P1|Overall Study|Withdrawal by Subject|1
821652|NCT00954941|2611469|P2|Overall Study|Received treatment at home|0
821653|NCT00954941|2611470|P1|Overall Study|Received treatment at home|1
821654|NCT00955110|2611511|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
821655|NCT00955110|2611511|P1|Treatment Phase|Non-compliance with study restrictions|1
821656|NCT00955110|2611511|P1|Treatment Phase|Administrative reasons|2
821657|NCT00955110|2611511|P1|Treatment Phase|Adverse Event|2
821658|NCT00955110|2611511|P1|Qualification Phase|Did not meet eligibility criteria|24
821659|NCT00955279|2611543|P3|Overall Study|Withdrawal by Subject|3
821660|NCT00955279|2611544|P2|Overall Study|Withdrawal by Subject|0
821661|NCT00955279|2611545|P1|Overall Study|Withdrawal by Subject|2
821662|NCT00955279|2611543|P3|Overall Study|Lost to Follow-up|1
821663|NCT00955279|2611544|P2|Overall Study|Lost to Follow-up|3
821664|NCT00955279|2611545|P1|Overall Study|Lost to Follow-up|0
821665|NCT00955279|2611543|P3|Overall Study|Death|1
821666|NCT00955279|2611544|P2|Overall Study|Death|1
821667|NCT00955279|2611545|P1|Overall Study|Death|1
821668|NCT00955279|2611543|P3|Overall Study|Unspecified|3
821669|NCT00955279|2611544|P2|Overall Study|Unspecified|0
821670|NCT00955279|2611545|P1|Overall Study|Unspecified|0
821671|NCT00955305|2611567|P2|Overall Study|Ineligible|7
821672|NCT00955305|2611568|P1|Overall Study|Ineligible|5
821673|NCT00955305|2611567|P2|Overall Study|Never started protocol treatment|5
821674|NCT00955305|2611568|P1|Overall Study|Never started protocol treatment|5
821675|NCT00955305|2611567|P2|Overall Study|No off-treatment reason submitted|0
821676|NCT00955305|2611568|P1|Overall Study|No off-treatment reason submitted|1
821677|NCT00955305|2611567|P2|Overall Study|Lost to Follow-up|1
821678|NCT00955305|2611568|P1|Overall Study|Lost to Follow-up|0
821679|NCT00955305|2611567|P2|Overall Study|Maximum response achieved|1
821680|NCT00955305|2611568|P1|Overall Study|Maximum response achieved|0
821681|NCT00955305|2611567|P2|Overall Study|Functional decline|0
821682|NCT00955305|2611568|P1|Overall Study|Functional decline|2
821683|NCT00955305|2611567|P2|Overall Study|Continued presence of residual disease|1
821684|NCT00955305|2611568|P1|Overall Study|Continued presence of residual disease|0
821685|NCT00955305|2611567|P2|Overall Study|Physician Decision|0
821686|NCT00955305|2611568|P1|Overall Study|Physician Decision|1
821687|NCT00955305|2611567|P2|Overall Study|Other complicating disease|4
821688|NCT00955305|2611568|P1|Overall Study|Other complicating disease|2
821689|NCT00955305|2611567|P2|Overall Study|Alternative therapy|0
821690|NCT00955305|2611568|P1|Overall Study|Alternative therapy|4
821691|NCT00955305|2611567|P2|Overall Study|Withdrawal by Subject|4
821692|NCT00955305|2611568|P1|Overall Study|Withdrawal by Subject|5
821693|NCT00955305|2611567|P2|Overall Study|Death|1
821694|NCT00955305|2611568|P1|Overall Study|Death|2
821695|NCT00955305|2611567|P2|Overall Study|Adverse Event|22
821696|NCT00955305|2611568|P1|Overall Study|Adverse Event|22
821697|NCT00955305|2611567|P2|Overall Study|Disease progression|41
821698|NCT00955305|2611568|P1|Overall Study|Disease progression|39
821699|NCT00955357|2611580|P2|Maintenance Phase|Non compliance to study procedures|0
821700|NCT00955357|2611581|P1|Maintenance Phase|Non compliance to study procedures|1
821701|NCT00955357|2611580|P2|Maintenance Phase|Patient moving out of area|1
821702|NCT00955357|2611581|P1|Maintenance Phase|Patient moving out of area|0
821703|NCT00955357|2611580|P2|Maintenance Phase|Withdrawal by Subject|4
821704|NCT00955357|2611581|P1|Maintenance Phase|Withdrawal by Subject|4
821705|NCT00955357|2611580|P2|Maintenance Phase|Lost to Follow-up|7
821706|NCT00955357|2611581|P1|Maintenance Phase|Lost to Follow-up|2
821707|NCT00955357|2611580|P2|Maintenance Phase|Protocol Violation|6
821708|NCT00955357|2611581|P1|Maintenance Phase|Protocol Violation|2
821709|NCT00955357|2611580|P2|Maintenance Phase|Lack of Efficacy|4
821710|NCT00955357|2611581|P1|Maintenance Phase|Lack of Efficacy|0
821711|NCT00955357|2611580|P2|Maintenance Phase|Adverse Event|23
821712|NCT00955357|2611581|P1|Maintenance Phase|Adverse Event|3
821713|NCT00955357|2611580|P2|Titration Phase|Non compliance to study procedures|1
821714|NCT00955357|2611581|P1|Titration Phase|Non compliance to study procedures|0
821715|NCT00955357|2611580|P2|Titration Phase|Study medication not tolerated|1
821716|NCT00955357|2611581|P1|Titration Phase|Study medication not tolerated|0
821717|NCT00955357|2611580|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
821718|NCT00955357|2611581|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
821719|NCT00955357|2611580|P2|Titration Phase|Withdrawal by Subject|5
821720|NCT00955357|2611581|P1|Titration Phase|Withdrawal by Subject|3
821721|NCT00955357|2611580|P2|Titration Phase|Lost to Follow-up|3
821722|NCT00955357|2611581|P1|Titration Phase|Lost to Follow-up|1
821723|NCT00955357|2611580|P2|Titration Phase|Protocol Violation|7
821724|NCT00955357|2611581|P1|Titration Phase|Protocol Violation|3
821725|NCT00955357|2611580|P2|Titration Phase|Lack of Efficacy|2
821726|NCT00955357|2611581|P1|Titration Phase|Lack of Efficacy|0
821727|NCT00955357|2611580|P2|Titration Phase|Adverse Event|46
821728|NCT00955357|2611581|P1|Titration Phase|Adverse Event|9
821729|NCT00955474|2611589|P2|Overall Study|Physician Decision|5
821730|NCT00955474|2611590|P1|Overall Study|Physician Decision|7
821731|NCT00955617|2611676|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
821732|NCT00955617|2611677|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
821733|NCT00955617|2611676|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
821734|NCT00955617|2611677|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
821735|NCT00955617|2611676|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
821736|NCT00955617|2611677|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
821737|NCT00955617|2611676|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
821738|NCT00955617|2611677|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
821739|NCT00955721|2611689|P2|Overall Study|Withdrawal by Subject|0
821740|NCT00955721|2611690|P1|Overall Study|Withdrawal by Subject|1
821741|NCT00955721|2611689|P2|Overall Study|Death|0
821742|NCT00955721|2611690|P1|Overall Study|Death|1
821743|NCT00955721|2611689|P2|Overall Study|Physician Decision|0
821744|NCT00955721|2611690|P1|Overall Study|Physician Decision|1
821745|NCT00955825|2611709|P2|Overall Study|Any other reason not above-mentioned|9
821746|NCT00955825|2611710|P1|Overall Study|Any other reason not above-mentioned|7
821747|NCT00955825|2611709|P2|Overall Study|Withdrawal by Subject|6
821748|NCT00955825|2611710|P1|Overall Study|Withdrawal by Subject|4
821749|NCT00955825|2611709|P2|Overall Study|Adverse Event|2
821750|NCT00955825|2611710|P1|Overall Study|Adverse Event|15
821751|NCT00955955|2611744|P3|Overall Study|Lost to Follow-up|0
821752|NCT00955955|2611745|P2|Overall Study|Lost to Follow-up|0
821753|NCT00955955|2611746|P1|Overall Study|Lost to Follow-up|2
821754|NCT00956293|2611791|P3|Follow-up Period|Follow-up period was terminated.|0
821755|NCT00956293|2611792|P2|Follow-up Period|Follow-up period was terminated.|32
821756|NCT00956293|2611793|P1|Follow-up Period|Follow-up period was terminated.|20
821757|NCT00956293|2611791|P3|Main Period (Randomization)|Adverse Event|0
821758|NCT00956293|2611792|P2|Main Period (Randomization)|Adverse Event|15
821759|NCT00956293|2611793|P1|Main Period (Randomization)|Adverse Event|0
821760|NCT00956293|2611791|P3|Main Period (Randomization)|Lack of Efficacy|0
821761|NCT00956293|2611792|P2|Main Period (Randomization)|Lack of Efficacy|10
821762|NCT00956293|2611793|P1|Main Period (Randomization)|Lack of Efficacy|1
821763|NCT00956293|2611791|P3|Main Period (Randomization)|Abnormal laboratory value|0
821764|NCT00956293|2611792|P2|Main Period (Randomization)|Abnormal laboratory value|2
821765|NCT00956293|2611793|P1|Main Period (Randomization)|Abnormal laboratory value|0
821766|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
821767|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
821768|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
821769|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Adverse Event|36
821770|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Adverse Event|0
821771|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Adverse Event|0
821772|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
821773|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
821774|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
821775|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
821776|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
821777|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
821778|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Graft loss|7
821779|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Graft loss|0
821780|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Graft loss|0
821781|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Administrative problems|6
821782|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Administrative problems|0
821783|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Administrative problems|0
821784|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
821785|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
821786|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
821787|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Protocol Violation|1
821788|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Protocol Violation|0
821789|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Protocol Violation|0
821790|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Death|1
821791|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Death|0
821792|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Death|0
821793|NCT00956293|2611791|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
821794|NCT00956293|2611792|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
821795|NCT00956293|2611793|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
821796|NCT00956592|2611836|P2|Overall Study|Protocol Violation|3
821797|NCT00956592|2611837|P1|Overall Study|Protocol Violation|1
821798|NCT00956813|2611880|P2|Flaxseed and Placebo|Ineligible|1
821799|NCT00956813|2611881|P1|Flaxseed and Placebo|Ineligible|3
821800|NCT00956813|2611880|P2|Flaxseed and Placebo|Withdrawal by Subject|4
821801|NCT00956813|2611881|P1|Flaxseed and Placebo|Withdrawal by Subject|5
821802|NCT00956839|2611899|P3|Overall Study|Lost to Follow-up|3
821803|NCT00956839|2611900|P2|Overall Study|Lost to Follow-up|0
821804|NCT00956839|2611901|P1|Overall Study|Lost to Follow-up|3
821805|NCT00963807|2611932|P1|Overall Study|Disease progression|15
821806|NCT00963807|2611932|P1|Overall Study|Reaction to study chemotherapy regimen|1
821807|NCT00963807|2611932|P1|Overall Study|Physician Decision|2
821808|NCT00963820|2611941|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
821809|NCT00963820|2611942|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
821810|NCT00963820|2611943|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
821811|NCT00963820|2611944|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
821812|NCT00963820|2611945|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
821813|NCT00963820|2611946|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
821814|NCT00963820|2611947|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
821815|NCT00963820|2611948|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
821816|NCT00963820|2611949|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
821817|NCT00963820|2611950|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
821818|NCT00963820|2611951|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
821819|NCT00963820|2611952|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
821820|NCT00963820|2611941|P12|Expansion Phase|Withdrawal by Subject|1
821821|NCT00963820|2611942|P11|Expansion Phase|Withdrawal by Subject|1
821822|NCT00963820|2611943|P10|Expansion Phase|Withdrawal by Subject|0
821823|NCT00963820|2611944|P9|Expansion Phase|Withdrawal by Subject|1
821824|NCT00963820|2611945|P8|Expansion Phase|Withdrawal by Subject|0
821825|NCT00963820|2611946|P7|Expansion Phase|Withdrawal by Subject|0
821826|NCT00963820|2611947|P6|Expansion Phase|Withdrawal by Subject|0
821827|NCT00963820|2611948|P5|Expansion Phase|Withdrawal by Subject|0
821828|NCT00963820|2611949|P4|Expansion Phase|Withdrawal by Subject|0
821829|NCT00963820|2611950|P3|Expansion Phase|Withdrawal by Subject|0
821830|NCT00963820|2611951|P2|Expansion Phase|Withdrawal by Subject|0
821831|NCT00963820|2611952|P1|Expansion Phase|Withdrawal by Subject|0
821832|NCT00963820|2611941|P12|Expansion Phase|Adverse Event|0
821833|NCT00963820|2611942|P11|Expansion Phase|Adverse Event|0
821834|NCT00963820|2611943|P10|Expansion Phase|Adverse Event|3
821835|NCT00963820|2611944|P9|Expansion Phase|Adverse Event|1
821836|NCT00963820|2611945|P8|Expansion Phase|Adverse Event|0
821837|NCT00963820|2611946|P7|Expansion Phase|Adverse Event|0
821838|NCT00963820|2611947|P6|Expansion Phase|Adverse Event|0
821839|NCT00963820|2611948|P5|Expansion Phase|Adverse Event|0
821840|NCT00963820|2611949|P4|Expansion Phase|Adverse Event|0
821841|NCT00963820|2611950|P3|Expansion Phase|Adverse Event|0
821842|NCT00963820|2611951|P2|Expansion Phase|Adverse Event|0
821843|NCT00963820|2611952|P1|Expansion Phase|Adverse Event|0
821844|NCT00963820|2611941|P12|Expansion Phase|Progressive Disease|2
821845|NCT00963820|2611942|P11|Expansion Phase|Progressive Disease|4
821846|NCT00963820|2611943|P10|Expansion Phase|Progressive Disease|6
821847|NCT00963820|2611944|P9|Expansion Phase|Progressive Disease|8
821848|NCT00963820|2611945|P8|Expansion Phase|Progressive Disease|0
821849|NCT00963820|2611946|P7|Expansion Phase|Progressive Disease|0
821850|NCT00963820|2611947|P6|Expansion Phase|Progressive Disease|0
821851|NCT00963820|2611948|P5|Expansion Phase|Progressive Disease|0
821852|NCT00963820|2611949|P4|Expansion Phase|Progressive Disease|0
821853|NCT00963820|2611950|P3|Expansion Phase|Progressive Disease|0
821854|NCT00963820|2611951|P2|Expansion Phase|Progressive Disease|0
821855|NCT00963820|2611952|P1|Expansion Phase|Progressive Disease|0
821856|NCT00963820|2611941|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821857|NCT00963820|2611942|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821858|NCT00963820|2611943|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821859|NCT00963820|2611944|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821860|NCT00963820|2611945|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821861|NCT00963820|2611946|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
821862|NCT00963820|2611947|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821863|NCT00963820|2611948|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821864|NCT00963820|2611949|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821865|NCT00963820|2611950|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821866|NCT00963820|2611951|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821867|NCT00963820|2611952|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
821868|NCT00963820|2611941|P12|Dose Escalation Phase|Withdrawal by Subject|0
821869|NCT00963820|2611942|P11|Dose Escalation Phase|Withdrawal by Subject|0
821870|NCT00963820|2611943|P10|Dose Escalation Phase|Withdrawal by Subject|0
821871|NCT00963820|2611944|P9|Dose Escalation Phase|Withdrawal by Subject|0
821872|NCT00963820|2611945|P8|Dose Escalation Phase|Withdrawal by Subject|2
821873|NCT00963820|2611946|P7|Dose Escalation Phase|Withdrawal by Subject|1
821874|NCT00963820|2611947|P6|Dose Escalation Phase|Withdrawal by Subject|0
821875|NCT00963820|2611948|P5|Dose Escalation Phase|Withdrawal by Subject|0
821876|NCT00963820|2611949|P4|Dose Escalation Phase|Withdrawal by Subject|0
821877|NCT00963820|2611950|P3|Dose Escalation Phase|Withdrawal by Subject|0
821878|NCT00963820|2611951|P2|Dose Escalation Phase|Withdrawal by Subject|0
821879|NCT00963820|2611952|P1|Dose Escalation Phase|Withdrawal by Subject|0
821880|NCT00963820|2611941|P12|Dose Escalation Phase|Adverse Event|0
821881|NCT00963820|2611942|P11|Dose Escalation Phase|Adverse Event|0
821882|NCT00963820|2611943|P10|Dose Escalation Phase|Adverse Event|0
821883|NCT00963820|2611944|P9|Dose Escalation Phase|Adverse Event|0
821884|NCT00963820|2611945|P8|Dose Escalation Phase|Adverse Event|1
821885|NCT00963820|2611946|P7|Dose Escalation Phase|Adverse Event|3
821886|NCT00963820|2611947|P6|Dose Escalation Phase|Adverse Event|0
821887|NCT00963820|2611948|P5|Dose Escalation Phase|Adverse Event|0
821888|NCT00963820|2611949|P4|Dose Escalation Phase|Adverse Event|0
821889|NCT00963820|2611950|P3|Dose Escalation Phase|Adverse Event|0
821890|NCT00963820|2611951|P2|Dose Escalation Phase|Adverse Event|0
821891|NCT00963820|2611952|P1|Dose Escalation Phase|Adverse Event|0
821892|NCT00963820|2611941|P12|Dose Escalation Phase|Progressive Disease|0
821893|NCT00963820|2611942|P11|Dose Escalation Phase|Progressive Disease|0
821894|NCT00963820|2611943|P10|Dose Escalation Phase|Progressive Disease|0
821895|NCT00963820|2611944|P9|Dose Escalation Phase|Progressive Disease|0
821896|NCT00963820|2611945|P8|Dose Escalation Phase|Progressive Disease|2
821897|NCT00963820|2611946|P7|Dose Escalation Phase|Progressive Disease|3
821898|NCT00963820|2611947|P6|Dose Escalation Phase|Progressive Disease|3
821899|NCT00963820|2611948|P5|Dose Escalation Phase|Progressive Disease|4
821900|NCT00963820|2611949|P4|Dose Escalation Phase|Progressive Disease|3
821901|NCT00963820|2611950|P3|Dose Escalation Phase|Progressive Disease|3
821902|NCT00963820|2611951|P2|Dose Escalation Phase|Progressive Disease|3
821903|NCT00963820|2611952|P1|Dose Escalation Phase|Progressive Disease|3
821904|NCT00963924|2612142|P2|Overall Study|Lost to Follow-up|1
821905|NCT00963924|2612143|P1|Overall Study|Lost to Follow-up|0
821906|NCT00963924|2612142|P2|Overall Study|Changed antipsychotic|1
821907|NCT00963924|2612143|P1|Overall Study|Changed antipsychotic|0
821908|NCT00963924|2612142|P2|Overall Study|Withdrawal by Subject|1
821909|NCT00963924|2612143|P1|Overall Study|Withdrawal by Subject|0
821910|NCT00963924|2612142|P2|Overall Study|Adverse Event|0
821911|NCT00963924|2612143|P1|Overall Study|Adverse Event|1
821912|NCT00963937|2612162|P3|Overall Study|Physician Decision|4
821913|NCT00963937|2612163|P2|Overall Study|Physician Decision|10
821914|NCT00963937|2612164|P1|Overall Study|Physician Decision|18
821915|NCT00963937|2612162|P3|Overall Study|Protocol Violation|0
821916|NCT00963937|2612163|P2|Overall Study|Protocol Violation|1
821917|NCT00963937|2612164|P1|Overall Study|Protocol Violation|1
821918|NCT00964678|2612238|P1|Overall Study|Physician Decision|4
821919|NCT00964743|2612245|P1|Overall Study|Neither patient completed 8 weeks of tre|2
821920|NCT00964795|2612253|P1|Overall Study|Other|23
821921|NCT00964795|2612253|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
821922|NCT00964795|2612253|P1|Overall Study|Termination of Study by Sponsor|169
821923|NCT00964795|2612253|P1|Overall Study|Lost to Follow-up|7
821924|NCT00964795|2612253|P1|Overall Study|Death|14
821925|NCT00964795|2612253|P1|Overall Study|Adverse Event|12
821926|NCT00964795|2612253|P1|Overall Study|Withdrawal by Subject|79
821927|NCT00964860|2612262|P2|Overall Study|Withdrawal by Subject|1
821928|NCT00964860|2612263|P1|Overall Study|Withdrawal by Subject|0
821929|NCT00964886|2612275|P4|Overall Study|Protocol Violation|0
821930|NCT00964886|2612276|P3|Overall Study|Protocol Violation|0
821931|NCT00964886|2612277|P2|Overall Study|Protocol Violation|2
821932|NCT00964886|2612278|P1|Overall Study|Protocol Violation|0
821933|NCT00964886|2612275|P4|Overall Study|Adverse Event|2
821934|NCT00964886|2612276|P3|Overall Study|Adverse Event|5
821935|NCT00964886|2612277|P2|Overall Study|Adverse Event|1
821936|NCT00964886|2612278|P1|Overall Study|Adverse Event|3
821937|NCT00964886|2612275|P4|Overall Study|Withdrawal by Subject|3
821938|NCT00964886|2612276|P3|Overall Study|Withdrawal by Subject|5
821939|NCT00964886|2612277|P2|Overall Study|Withdrawal by Subject|2
821940|NCT00964886|2612278|P1|Overall Study|Withdrawal by Subject|6
821941|NCT00964886|2612275|P4|Overall Study|Lost to Follow-up|4
821942|NCT00964886|2612276|P3|Overall Study|Lost to Follow-up|6
821943|NCT00964886|2612277|P2|Overall Study|Lost to Follow-up|2
821944|NCT00964886|2612278|P1|Overall Study|Lost to Follow-up|2
821945|NCT00965081|2612294|P2|Overall Study|Switched to Rescue Arm|12
821946|NCT00965081|2612295|P1|Overall Study|Switched to Rescue Arm|5
821947|NCT00965081|2612294|P2|Overall Study|Withdrawal by Subject|7
821948|NCT00965081|2612295|P1|Overall Study|Withdrawal by Subject|4
821949|NCT00965081|2612294|P2|Overall Study|Sponsor Decision|0
821950|NCT00965081|2612295|P1|Overall Study|Sponsor Decision|1
821951|NCT00965081|2612294|P2|Overall Study|Protocol Violation|5
821952|NCT00965081|2612295|P1|Overall Study|Protocol Violation|2
821953|NCT00965081|2612294|P2|Overall Study|Physician Decision|0
821954|NCT00965081|2612295|P1|Overall Study|Physician Decision|2
821955|NCT00965081|2612294|P2|Overall Study|Lost to Follow-up|5
821956|NCT00965081|2612295|P1|Overall Study|Lost to Follow-up|4
821957|NCT00965081|2612294|P2|Overall Study|Lack of Efficacy|5
821958|NCT00965081|2612295|P1|Overall Study|Lack of Efficacy|2
821959|NCT00965081|2612294|P2|Overall Study|Adverse Event|9
821960|NCT00965081|2612295|P1|Overall Study|Adverse Event|14
821961|NCT00965094|2612320|P2|Overall Study|Lost to Follow-up|1
821962|NCT00965094|2612321|P1|Overall Study|Lost to Follow-up|0
821963|NCT00965094|2612320|P2|Overall Study|Adverse Event|0
821964|NCT00965094|2612321|P1|Overall Study|Adverse Event|5
821977|NCT00965341|2612388|P2|Overall Study|Transportation issues|3
821978|NCT00965341|2612389|P1|Overall Study|Transportation issues|4
821979|NCT00965341|2612388|P2|Overall Study|Lost to Follow-up|0
821980|NCT00965341|2612389|P1|Overall Study|Lost to Follow-up|1
821981|NCT00965341|2612388|P2|Overall Study|Withdrew consent|5
821982|NCT00965341|2612389|P1|Overall Study|Withdrew consent|1
893316|NCT01282424|2833997|P1|Overall Study|Withdrew Consent|4
893317|NCT01282424|2833997|P1|Overall Study|Adverse Event|25
893318|NCT01282424|2833997|P1|Overall Study|Treatment Ongoing|40
893319|NCT01170663|2834016|P2|Overall Study|Withdrawal of consent without follow-up|11
893320|NCT01170663|2834017|P1|Overall Study|Withdrawal of consent without follow-up|8
893321|NCT01170663|2834016|P2|Overall Study|Lost to Follow-up|9
821989|NCT00965484|2612416|P1|Overall Study|Withdrawal by Subject|1
821990|NCT00965484|2612416|P1|Overall Study|Protocol Violation|1
821991|NCT00965497|2612423|P1|Overall Study|Physician Decision|1
821992|NCT00965523|2612428|P1|Study 224|Physician Decision|1
821993|NCT00965523|2612428|P1|Study 224|Progressive Disease|5
821994|NCT00965523|2612428|P1|Study 221|Physician Decision|3
821995|NCT00965523|2612428|P1|Study 221|Progressive Disease|4
821996|NCT00965562|2612436|P3|Overall Study|Withdrawal by Subject|0
821997|NCT00965562|2612437|P2|Overall Study|Withdrawal by Subject|2
821998|NCT00965562|2612438|P1|Overall Study|Withdrawal by Subject|2
821999|NCT00965562|2612436|P3|Overall Study|Lost to Follow-up|3
822000|NCT00965562|2612437|P2|Overall Study|Lost to Follow-up|2
822001|NCT00965562|2612438|P1|Overall Study|Lost to Follow-up|1
822003|NCT00965731|2612488|P2|Overall Study|Not specified|15
822004|NCT00965731|2612489|P1|Overall Study|Not specified|7
822005|NCT00965731|2612488|P2|Overall Study|Withdrawal by Subject|1
822006|NCT00965731|2612489|P1|Overall Study|Withdrawal by Subject|0
822007|NCT00965731|2612488|P2|Overall Study|Death|4
822008|NCT00965731|2612489|P1|Overall Study|Death|0
822009|NCT00965757|2612555|P4|Extension Phase|Not Specified|1
822010|NCT00965757|2612556|P3|Extension Phase|Not Specified|2
822011|NCT00965757|2612557|P2|Extension Phase|Not Specified|0
822012|NCT00965757|2612558|P1|Extension Phase|Not Specified|0
822013|NCT00965757|2612555|P4|Extension Phase|Protocol Violation|1
822014|NCT00965757|2612556|P3|Extension Phase|Protocol Violation|0
822015|NCT00965757|2612557|P2|Extension Phase|Protocol Violation|0
822016|NCT00965757|2612558|P1|Extension Phase|Protocol Violation|0
822017|NCT00965757|2612555|P4|Extension Phase|Ineligible after Taking Study Drug|3
822018|NCT00965757|2612556|P3|Extension Phase|Ineligible after Taking Study Drug|3
822019|NCT00965757|2612557|P2|Extension Phase|Ineligible after Taking Study Drug|0
822020|NCT00965757|2612558|P1|Extension Phase|Ineligible after Taking Study Drug|0
822021|NCT00965757|2612555|P4|Extension Phase|Lost to Follow-up|1
822022|NCT00965757|2612556|P3|Extension Phase|Lost to Follow-up|0
822023|NCT00965757|2612557|P2|Extension Phase|Lost to Follow-up|0
822024|NCT00965757|2612558|P1|Extension Phase|Lost to Follow-up|0
822025|NCT00965757|2612555|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
822026|NCT00965757|2612556|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
822027|NCT00965757|2612557|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
822028|NCT00965757|2612558|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
822029|NCT00965757|2612555|P4|Extension Phase|Lack of Efficacy|12
822030|NCT00965757|2612556|P3|Extension Phase|Lack of Efficacy|8
822031|NCT00965757|2612557|P2|Extension Phase|Lack of Efficacy|0
822032|NCT00965757|2612558|P1|Extension Phase|Lack of Efficacy|0
822033|NCT00965757|2612555|P4|Extension Phase|Abnormal Laboratory Value|1
822034|NCT00965757|2612556|P3|Extension Phase|Abnormal Laboratory Value|6
822035|NCT00965757|2612557|P2|Extension Phase|Abnormal Laboratory Value|0
893322|NCT01170663|2834017|P1|Overall Study|Lost to Follow-up|3
893323|NCT01170663|2834016|P2|Overall Study|Alive on treatment at data cut-off date|7
822036|NCT00965757|2612558|P1|Extension Phase|Abnormal Laboratory Value|0
822037|NCT00965757|2612555|P4|Extension Phase|Adverse drug reaction|3
822038|NCT00965757|2612556|P3|Extension Phase|Adverse drug reaction|6
822039|NCT00965757|2612557|P2|Extension Phase|Adverse drug reaction|0
822040|NCT00965757|2612558|P1|Extension Phase|Adverse drug reaction|0
822041|NCT00965757|2612555|P4|Extension Phase|Progression of concomitant disease|2
822042|NCT00965757|2612556|P3|Extension Phase|Progression of concomitant disease|4
822043|NCT00965757|2612557|P2|Extension Phase|Progression of concomitant disease|0
822044|NCT00965757|2612558|P1|Extension Phase|Progression of concomitant disease|0
822045|NCT00965757|2612555|P4|Double-blind Phase|Not specified|0
822046|NCT00965757|2612556|P3|Double-blind Phase|Not specified|0
822047|NCT00965757|2612557|P2|Double-blind Phase|Not specified|0
822048|NCT00965757|2612558|P1|Double-blind Phase|Not specified|1
822049|NCT00965757|2612555|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
822050|NCT00965757|2612556|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
822051|NCT00965757|2612557|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
822052|NCT00965757|2612558|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
822053|NCT00965757|2612555|P4|Double-blind Phase|Lost to Follow-up|0
822054|NCT00965757|2612556|P3|Double-blind Phase|Lost to Follow-up|0
822055|NCT00965757|2612557|P2|Double-blind Phase|Lost to Follow-up|1
822056|NCT00965757|2612558|P1|Double-blind Phase|Lost to Follow-up|0
822057|NCT00965757|2612555|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
822058|NCT00965757|2612556|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
822059|NCT00965757|2612557|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
822060|NCT00965757|2612558|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
822061|NCT00965757|2612555|P4|Double-blind Phase|Lack of Efficacy|0
822062|NCT00965757|2612556|P3|Double-blind Phase|Lack of Efficacy|0
822063|NCT00965757|2612557|P2|Double-blind Phase|Lack of Efficacy|11
822064|NCT00965757|2612558|P1|Double-blind Phase|Lack of Efficacy|7
822065|NCT00965757|2612555|P4|Double-blind Phase|Abnormal Laboratory Value|0
822066|NCT00965757|2612556|P3|Double-blind Phase|Abnormal Laboratory Value|0
822067|NCT00965757|2612557|P2|Double-blind Phase|Abnormal Laboratory Value|0
822068|NCT00965757|2612558|P1|Double-blind Phase|Abnormal Laboratory Value|2
822069|NCT00965757|2612555|P4|Double-blind Phase|Adverse drug reaction|0
822070|NCT00965757|2612556|P3|Double-blind Phase|Adverse drug reaction|0
822071|NCT00965757|2612557|P2|Double-blind Phase|Adverse drug reaction|1
822072|NCT00965757|2612558|P1|Double-blind Phase|Adverse drug reaction|2
822073|NCT00965757|2612555|P4|Double-blind Phase|Progression of concomitant disease|0
822074|NCT00965757|2612556|P3|Double-blind Phase|Progression of concomitant disease|0
822075|NCT00965757|2612557|P2|Double-blind Phase|Progression of concomitant disease|2
822076|NCT00965757|2612558|P1|Double-blind Phase|Progression of concomitant disease|1
822077|NCT00965848|2612590|P3|Overall Study|Unspecified|1
822078|NCT00965848|2612591|P2|Overall Study|Unspecified|0
822079|NCT00965848|2612592|P1|Overall Study|Unspecified|5
822080|NCT00965848|2612590|P3|Overall Study|Not Clinically Evaluable|1
822081|NCT00965848|2612591|P2|Overall Study|Not Clinically Evaluable|1
822082|NCT00965848|2612592|P1|Overall Study|Not Clinically Evaluable|7
822083|NCT00965848|2612590|P3|Overall Study|Indeterminate Clinical Outcome|1
822084|NCT00965848|2612591|P2|Overall Study|Indeterminate Clinical Outcome|0
822085|NCT00965848|2612592|P1|Overall Study|Indeterminate Clinical Outcome|2
822086|NCT00965848|2612590|P3|Overall Study|Withdrawal by Subject|0
822087|NCT00965848|2612591|P2|Overall Study|Withdrawal by Subject|0
822088|NCT00965848|2612592|P1|Overall Study|Withdrawal by Subject|1
822089|NCT00965848|2612590|P3|Overall Study|Lost to Follow-up|1
822090|NCT00965848|2612591|P2|Overall Study|Lost to Follow-up|0
822091|NCT00965848|2612592|P1|Overall Study|Lost to Follow-up|0
822092|NCT00965848|2612590|P3|Overall Study|Death|5
822093|NCT00965848|2612591|P2|Overall Study|Death|1
822094|NCT00965848|2612592|P1|Overall Study|Death|11
822095|NCT00965848|2612590|P3|Overall Study|Protocol Violation|1
822096|NCT00965848|2612591|P2|Overall Study|Protocol Violation|0
822097|NCT00965848|2612592|P1|Overall Study|Protocol Violation|3
822098|NCT00966264|2612651|P2|Overall Study|Lost to Follow-up|3
822099|NCT00966264|2612652|P1|Overall Study|Lost to Follow-up|4
822100|NCT00966277|2612660|P2|Overall Study|Treatment Plan Changed|1
822101|NCT00966277|2612661|P1|Overall Study|Treatment Plan Changed|0
822102|NCT00966277|2612660|P2|Overall Study|Ineligible|3
822103|NCT00966277|2612661|P1|Overall Study|Ineligible|1
822104|NCT00966277|2612660|P2|Overall Study|Withdrawal by Subject|0
822105|NCT00966277|2612661|P1|Overall Study|Withdrawal by Subject|3
822106|NCT00966654|2612702|P1|Overall Study|Study was terminated,PI left institution|12
822107|NCT00966875|2612727|P9|Part B|Entry Criteria|1
822108|NCT00966875|2612728|P8|Part B|Entry Criteria|0
822109|NCT00966875|2612729|P7|Part B|Entry Criteria|1
822110|NCT00966875|2612730|P6|Part B|Entry Criteria|0
822111|NCT00966875|2612731|P5|Part B|Entry Criteria|0
822112|NCT00966875|2612732|P4|Part B|Entry Criteria|0
822113|NCT00966875|2612733|P3|Part B|Entry Criteria|0
822114|NCT00966875|2612734|P2|Part B|Entry Criteria|0
822115|NCT00966875|2612735|P1|Part B|Entry Criteria|0
822116|NCT00966875|2612727|P9|Part B|Withdrawal by Subject|5
822117|NCT00966875|2612728|P8|Part B|Withdrawal by Subject|5
822118|NCT00966875|2612729|P7|Part B|Withdrawal by Subject|4
822119|NCT00966875|2612730|P6|Part B|Withdrawal by Subject|1
822120|NCT00966875|2612731|P5|Part B|Withdrawal by Subject|2
822121|NCT00966875|2612732|P4|Part B|Withdrawal by Subject|1
822122|NCT00966875|2612733|P3|Part B|Withdrawal by Subject|2
822123|NCT00966875|2612734|P2|Part B|Withdrawal by Subject|1
822124|NCT00966875|2612735|P1|Part B|Withdrawal by Subject|2
822125|NCT00966875|2612727|P9|Part B|Sponsor Decision|1
822126|NCT00966875|2612728|P8|Part B|Sponsor Decision|2
822127|NCT00966875|2612729|P7|Part B|Sponsor Decision|0
822128|NCT00966875|2612730|P6|Part B|Sponsor Decision|1
822129|NCT00966875|2612731|P5|Part B|Sponsor Decision|0
822130|NCT00966875|2612732|P4|Part B|Sponsor Decision|0
822131|NCT00966875|2612733|P3|Part B|Sponsor Decision|0
822132|NCT00966875|2612734|P2|Part B|Sponsor Decision|0
822133|NCT00966875|2612735|P1|Part B|Sponsor Decision|1
822134|NCT00966875|2612727|P9|Part B|Physician Decision|2
822135|NCT00966875|2612728|P8|Part B|Physician Decision|0
822136|NCT00966875|2612729|P7|Part B|Physician Decision|0
822137|NCT00966875|2612730|P6|Part B|Physician Decision|1
822138|NCT00966875|2612731|P5|Part B|Physician Decision|2
822139|NCT00966875|2612732|P4|Part B|Physician Decision|0
822140|NCT00966875|2612733|P3|Part B|Physician Decision|1
822141|NCT00966875|2612734|P2|Part B|Physician Decision|0
822142|NCT00966875|2612735|P1|Part B|Physician Decision|0
822143|NCT00966875|2612727|P9|Part B|Lost to Follow-up|1
822144|NCT00966875|2612728|P8|Part B|Lost to Follow-up|0
822145|NCT00966875|2612729|P7|Part B|Lost to Follow-up|0
822146|NCT00966875|2612730|P6|Part B|Lost to Follow-up|0
822147|NCT00966875|2612731|P5|Part B|Lost to Follow-up|0
822148|NCT00966875|2612732|P4|Part B|Lost to Follow-up|1
822149|NCT00966875|2612733|P3|Part B|Lost to Follow-up|0
822150|NCT00966875|2612734|P2|Part B|Lost to Follow-up|0
822151|NCT00966875|2612735|P1|Part B|Lost to Follow-up|0
822152|NCT00966875|2612727|P9|Part B|Lack of Efficacy|6
822153|NCT00966875|2612728|P8|Part B|Lack of Efficacy|9
822154|NCT00966875|2612729|P7|Part B|Lack of Efficacy|12
822155|NCT00966875|2612730|P6|Part B|Lack of Efficacy|3
822156|NCT00966875|2612731|P5|Part B|Lack of Efficacy|2
822157|NCT00966875|2612732|P4|Part B|Lack of Efficacy|1
822158|NCT00966875|2612733|P3|Part B|Lack of Efficacy|1
822159|NCT00966875|2612734|P2|Part B|Lack of Efficacy|1
822160|NCT00966875|2612735|P1|Part B|Lack of Efficacy|2
822161|NCT00966875|2612727|P9|Part B|Death|0
822162|NCT00966875|2612728|P8|Part B|Death|1
822163|NCT00966875|2612729|P7|Part B|Death|0
822164|NCT00966875|2612730|P6|Part B|Death|0
822165|NCT00966875|2612731|P5|Part B|Death|0
822166|NCT00966875|2612732|P4|Part B|Death|0
822167|NCT00966875|2612733|P3|Part B|Death|1
822168|NCT00966875|2612734|P2|Part B|Death|0
822169|NCT00966875|2612735|P1|Part B|Death|0
822170|NCT00966875|2612727|P9|Part B|Adverse Event|2
822171|NCT00966875|2612728|P8|Part B|Adverse Event|2
822172|NCT00966875|2612729|P7|Part B|Adverse Event|5
822173|NCT00966875|2612730|P6|Part B|Adverse Event|0
822174|NCT00966875|2612731|P5|Part B|Adverse Event|1
822175|NCT00966875|2612732|P4|Part B|Adverse Event|0
822176|NCT00966875|2612733|P3|Part B|Adverse Event|1
822177|NCT00966875|2612734|P2|Part B|Adverse Event|1
822178|NCT00966875|2612735|P1|Part B|Adverse Event|0
822179|NCT00966875|2612727|P9|Part A|Protocol Violation|1
822180|NCT00966875|2612728|P8|Part A|Protocol Violation|1
822181|NCT00966875|2612729|P7|Part A|Protocol Violation|2
822182|NCT00966875|2612730|P6|Part A|Protocol Violation|0
822183|NCT00966875|2612731|P5|Part A|Protocol Violation|0
822184|NCT00966875|2612732|P4|Part A|Protocol Violation|0
822185|NCT00966875|2612733|P3|Part A|Protocol Violation|0
822186|NCT00966875|2612734|P2|Part A|Protocol Violation|0
822187|NCT00966875|2612735|P1|Part A|Protocol Violation|0
822188|NCT00966875|2612727|P9|Part A|Withdrawal by Subject|1
822189|NCT00966875|2612728|P8|Part A|Withdrawal by Subject|1
822190|NCT00966875|2612729|P7|Part A|Withdrawal by Subject|5
822191|NCT00966875|2612730|P6|Part A|Withdrawal by Subject|0
822192|NCT00966875|2612731|P5|Part A|Withdrawal by Subject|3
822193|NCT00966875|2612732|P4|Part A|Withdrawal by Subject|1
822194|NCT00966875|2612733|P3|Part A|Withdrawal by Subject|1
822195|NCT00966875|2612734|P2|Part A|Withdrawal by Subject|2
822196|NCT00966875|2612735|P1|Part A|Withdrawal by Subject|2
822197|NCT00966875|2612727|P9|Part A|Sponsor Decision|1
822198|NCT00966875|2612728|P8|Part A|Sponsor Decision|2
822199|NCT00966875|2612729|P7|Part A|Sponsor Decision|0
822200|NCT00966875|2612730|P6|Part A|Sponsor Decision|0
822201|NCT00966875|2612731|P5|Part A|Sponsor Decision|1
822202|NCT00966875|2612732|P4|Part A|Sponsor Decision|0
822203|NCT00966875|2612733|P3|Part A|Sponsor Decision|1
822204|NCT00966875|2612734|P2|Part A|Sponsor Decision|0
822205|NCT00966875|2612735|P1|Part A|Sponsor Decision|0
822206|NCT00966875|2612727|P9|Part A|Physician Decision|2
822207|NCT00966875|2612728|P8|Part A|Physician Decision|0
822208|NCT00966875|2612729|P7|Part A|Physician Decision|1
822209|NCT00966875|2612730|P6|Part A|Physician Decision|0
822210|NCT00966875|2612731|P5|Part A|Physician Decision|1
822211|NCT00966875|2612732|P4|Part A|Physician Decision|0
822212|NCT00966875|2612733|P3|Part A|Physician Decision|0
822213|NCT00966875|2612734|P2|Part A|Physician Decision|0
822214|NCT00966875|2612735|P1|Part A|Physician Decision|0
822215|NCT00966875|2612727|P9|Part A|Parent/Caregiver Decision|0
822216|NCT00966875|2612728|P8|Part A|Parent/Caregiver Decision|0
822217|NCT00966875|2612729|P7|Part A|Parent/Caregiver Decision|0
822218|NCT00966875|2612730|P6|Part A|Parent/Caregiver Decision|0
822219|NCT00966875|2612731|P5|Part A|Parent/Caregiver Decision|0
822220|NCT00966875|2612732|P4|Part A|Parent/Caregiver Decision|1
822221|NCT00966875|2612733|P3|Part A|Parent/Caregiver Decision|0
822222|NCT00966875|2612734|P2|Part A|Parent/Caregiver Decision|0
822223|NCT00966875|2612735|P1|Part A|Parent/Caregiver Decision|0
822224|NCT00966875|2612727|P9|Part A|Lost to Follow-up|0
822225|NCT00966875|2612728|P8|Part A|Lost to Follow-up|0
822226|NCT00966875|2612729|P7|Part A|Lost to Follow-up|0
822227|NCT00966875|2612730|P6|Part A|Lost to Follow-up|1
822228|NCT00966875|2612731|P5|Part A|Lost to Follow-up|0
822229|NCT00966875|2612732|P4|Part A|Lost to Follow-up|0
822230|NCT00966875|2612733|P3|Part A|Lost to Follow-up|0
822231|NCT00966875|2612734|P2|Part A|Lost to Follow-up|0
822232|NCT00966875|2612735|P1|Part A|Lost to Follow-up|2
822233|NCT00966875|2612727|P9|Part A|Lack of Efficacy|0
822234|NCT00966875|2612728|P8|Part A|Lack of Efficacy|0
822235|NCT00966875|2612729|P7|Part A|Lack of Efficacy|4
822236|NCT00966875|2612730|P6|Part A|Lack of Efficacy|0
822237|NCT00966875|2612731|P5|Part A|Lack of Efficacy|0
822238|NCT00966875|2612732|P4|Part A|Lack of Efficacy|0
822239|NCT00966875|2612733|P3|Part A|Lack of Efficacy|0
822240|NCT00966875|2612734|P2|Part A|Lack of Efficacy|1
822241|NCT00966875|2612735|P1|Part A|Lack of Efficacy|0
822242|NCT00966875|2612727|P9|Part A|Entry Criteria|0
822243|NCT00966875|2612728|P8|Part A|Entry Criteria|0
822244|NCT00966875|2612729|P7|Part A|Entry Criteria|0
822245|NCT00966875|2612730|P6|Part A|Entry Criteria|2
822246|NCT00966875|2612731|P5|Part A|Entry Criteria|0
822247|NCT00966875|2612732|P4|Part A|Entry Criteria|0
822248|NCT00966875|2612733|P3|Part A|Entry Criteria|0
822249|NCT00966875|2612734|P2|Part A|Entry Criteria|0
822250|NCT00966875|2612735|P1|Part A|Entry Criteria|0
822251|NCT00966875|2612727|P9|Part A|Adverse Event|3
822252|NCT00966875|2612728|P8|Part A|Adverse Event|3
822253|NCT00966875|2612729|P7|Part A|Adverse Event|0
822254|NCT00966875|2612730|P6|Part A|Adverse Event|1
822255|NCT00966875|2612731|P5|Part A|Adverse Event|0
822256|NCT00966875|2612732|P4|Part A|Adverse Event|1
822257|NCT00966875|2612733|P3|Part A|Adverse Event|0
822258|NCT00966875|2612734|P2|Part A|Adverse Event|1
822259|NCT00966875|2612735|P1|Part A|Adverse Event|2
822260|NCT00966940|2613056|P2|Period 1, First 6 Weeks|Protocol Violation|0
822261|NCT00966940|2613057|P1|Period 1, First 6 Weeks|Protocol Violation|1
822262|NCT00966940|2613056|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
822263|NCT00966940|2613057|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
822264|NCT00954421|2613128|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
822265|NCT00954421|2613128|P1|6 Months of DBS|Withdrawal by Subject|1
822266|NCT00954421|2613128|P1|Screening|screen failures|3
822267|NCT00959894|2613134|P1|Overall Study|Subject moved out of town|1
822268|NCT00959894|2613134|P1|Overall Study|Need for contraindicated medication|1
822269|NCT00959894|2613134|P1|Overall Study|Withdrawal by Subject|1
822270|NCT00959894|2613134|P1|Overall Study|Adverse Event|3
822271|NCT00959894|2613134|P1|Overall Study|Lost to Follow-up|10
822272|NCT00959907|2613164|P2|Overall Study|Withdrawal by Subject|0
822273|NCT00959907|2613165|P1|Overall Study|Withdrawal by Subject|2
822274|NCT00959907|2613164|P2|Overall Study|Adverse Event|0
822275|NCT00959907|2613165|P1|Overall Study|Adverse Event|1
822276|NCT00959907|2613164|P2|Overall Study|Protocol Violation|1
822277|NCT00959907|2613165|P1|Overall Study|Protocol Violation|0
822278|NCT00959946|2613194|P8|Overall Study|Withdrawal by Subject|0
822279|NCT00959946|2613195|P7|Overall Study|Withdrawal by Subject|0
822280|NCT00959946|2613196|P6|Overall Study|Withdrawal by Subject|1
822281|NCT00959946|2613197|P5|Overall Study|Withdrawal by Subject|0
822282|NCT00959946|2613198|P4|Overall Study|Withdrawal by Subject|0
822283|NCT00959946|2613199|P3|Overall Study|Withdrawal by Subject|0
822284|NCT00959946|2613200|P2|Overall Study|Withdrawal by Subject|0
822285|NCT00959946|2613201|P1|Overall Study|Withdrawal by Subject|0
822286|NCT00959946|2613194|P8|Overall Study|Disease Progression|2
822287|NCT00959946|2613195|P7|Overall Study|Disease Progression|2
822288|NCT00959946|2613196|P6|Overall Study|Disease Progression|6
822289|NCT00959946|2613197|P5|Overall Study|Disease Progression|4
822290|NCT00959946|2613198|P4|Overall Study|Disease Progression|4
822291|NCT00959946|2613199|P3|Overall Study|Disease Progression|2
822292|NCT00959946|2613200|P2|Overall Study|Disease Progression|4
822293|NCT00959946|2613201|P1|Overall Study|Disease Progression|2
822294|NCT00959946|2613194|P8|Overall Study|Death|0
822295|NCT00959946|2613195|P7|Overall Study|Death|0
822296|NCT00959946|2613196|P6|Overall Study|Death|1
822297|NCT00959946|2613197|P5|Overall Study|Death|0
822298|NCT00959946|2613198|P4|Overall Study|Death|0
822299|NCT00959946|2613199|P3|Overall Study|Death|0
822300|NCT00959946|2613200|P2|Overall Study|Death|0
822301|NCT00959946|2613201|P1|Overall Study|Death|0
822302|NCT00959946|2613194|P8|Overall Study|Adverse Event|0
822303|NCT00959946|2613195|P7|Overall Study|Adverse Event|0
822304|NCT00959946|2613196|P6|Overall Study|Adverse Event|1
822305|NCT00959946|2613197|P5|Overall Study|Adverse Event|0
822306|NCT00959946|2613198|P4|Overall Study|Adverse Event|1
822307|NCT00959946|2613199|P3|Overall Study|Adverse Event|2
822308|NCT00959946|2613200|P2|Overall Study|Adverse Event|0
822309|NCT00959946|2613201|P1|Overall Study|Adverse Event|0
822310|NCT00960063|2613300|P3|Overall Study|Progression of Disease|3
822311|NCT00960063|2613301|P2|Overall Study|Progression of Disease|0
822312|NCT00960063|2613302|P1|Overall Study|Progression of Disease|0
822313|NCT00960063|2613300|P3|Overall Study|Adverse Event|0
822314|NCT00960063|2613301|P2|Overall Study|Adverse Event|0
822315|NCT00960063|2613302|P1|Overall Study|Adverse Event|1
822316|NCT00960076|2613342|P2|Overall Study|Did not attend the termination visit|1
822317|NCT00960076|2613343|P1|Overall Study|Did not attend the termination visit|0
822318|NCT00960076|2613342|P2|Overall Study|Hyperglycemia|5
822319|NCT00960076|2613343|P1|Overall Study|Hyperglycemia|1
822320|NCT00960076|2613342|P2|Overall Study|Severe non-compliance to protocol|2
822321|NCT00960076|2613343|P1|Overall Study|Severe non-compliance to protocol|1
822322|NCT00960076|2613342|P2|Overall Study|Lost to Follow-up|3
822323|NCT00960076|2613343|P1|Overall Study|Lost to Follow-up|3
822324|NCT00960076|2613342|P2|Overall Study|Withdrawal by Subject|2
822325|NCT00960076|2613343|P1|Overall Study|Withdrawal by Subject|1
822326|NCT00960076|2613342|P2|Overall Study|No longer met study criteria|5
822327|NCT00960076|2613343|P1|Overall Study|No longer met study criteria|1
822328|NCT00960076|2613342|P2|Overall Study|Adverse Event|7
822329|NCT00960076|2613343|P1|Overall Study|Adverse Event|1
822330|NCT00960115|2613357|P2|Overall Study|Ongoing treatment at data cut-off date|15
822331|NCT00960115|2613358|P1|Overall Study|Ongoing treatment at data cut-off date|19
822332|NCT00960141|2613373|P3|Overall Study|Withdrawal by Subject|1
822333|NCT00960141|2613374|P2|Overall Study|Withdrawal by Subject|2
822334|NCT00960141|2613375|P1|Overall Study|Withdrawal by Subject|1
822335|NCT00960141|2613373|P3|Overall Study|Protocol Violation|2
822336|NCT00960141|2613374|P2|Overall Study|Protocol Violation|3
822337|NCT00960141|2613375|P1|Overall Study|Protocol Violation|1
822338|NCT00960141|2613373|P3|Overall Study|Lost to Follow-up|0
822339|NCT00960141|2613374|P2|Overall Study|Lost to Follow-up|0
822340|NCT00960141|2613375|P1|Overall Study|Lost to Follow-up|1
822341|NCT00960141|2613373|P3|Overall Study|Lack of Efficacy|2
822342|NCT00960141|2613374|P2|Overall Study|Lack of Efficacy|4
822343|NCT00960141|2613375|P1|Overall Study|Lack of Efficacy|3
822344|NCT00960141|2613373|P3|Overall Study|Adverse Event|2
822345|NCT00960141|2613374|P2|Overall Study|Adverse Event|8
822346|NCT00960141|2613375|P1|Overall Study|Adverse Event|4
822347|NCT00960154|2613400|P2|Overall Study|Study termination|25
822348|NCT00960154|2613401|P1|Overall Study|Study termination|25
822349|NCT00960193|2613409|P1|14 Day Washout Period|Withdrawal by Subject|1
822350|NCT00960206|2613423|P3|Overall Study|Missing 10 year data|1
822351|NCT00960206|2613424|P2|Overall Study|Missing 10 year data|1
822352|NCT00960206|2613425|P1|Overall Study|Missing 10 year data|20
822353|NCT00960206|2613423|P3|Overall Study|Revision of study component|2
822354|NCT00960206|2613424|P2|Overall Study|Revision of study component|2
822355|NCT00960206|2613425|P1|Overall Study|Revision of study component|2
822356|NCT00960206|2613423|P3|Overall Study|Withdrawal by Subject|0
822357|NCT00960206|2613424|P2|Overall Study|Withdrawal by Subject|4
822358|NCT00960206|2613425|P1|Overall Study|Withdrawal by Subject|2
822359|NCT00960206|2613423|P3|Overall Study|Lost to Follow-up|8
822360|NCT00960206|2613424|P2|Overall Study|Lost to Follow-up|14
822361|NCT00960206|2613425|P1|Overall Study|Lost to Follow-up|8
822362|NCT00960206|2613423|P3|Overall Study|Unwilling/Unable to return|0
822363|NCT00960206|2613424|P2|Overall Study|Unwilling/Unable to return|2
822364|NCT00960206|2613425|P1|Overall Study|Unwilling/Unable to return|1
822365|NCT00960206|2613423|P3|Overall Study|Death|1
822366|NCT00960206|2613424|P2|Overall Study|Death|4
822367|NCT00960206|2613425|P1|Overall Study|Death|7
822368|NCT00960297|2613443|P1|Overall Study|Disease progression|1
822369|NCT00960297|2613443|P1|Overall Study|Venous port infection|1
822370|NCT00960297|2613443|P1|Overall Study|Physician Decision|1
822371|NCT00960323|2613447|P1|Atorvastatin Alone|Withdrawal by Subject|1
822372|NCT00960375|2613460|P2|Overall Study|Lost to Follow-up|22
822373|NCT00960375|2613461|P1|Overall Study|Lost to Follow-up|20
822374|NCT00960440|2613473|P4|Overall Study|Unspecified|0
822375|NCT00960440|2613474|P3|Overall Study|Unspecified|1
822376|NCT00960440|2613475|P2|Overall Study|Unspecified|1
822377|NCT00960440|2613476|P1|Overall Study|Unspecified|1
822378|NCT00960440|2613473|P4|Overall Study|Withdrawal by Subject|1
822379|NCT00960440|2613474|P3|Overall Study|Withdrawal by Subject|2
822380|NCT00960440|2613475|P2|Overall Study|Withdrawal by Subject|5
822381|NCT00960440|2613476|P1|Overall Study|Withdrawal by Subject|9
822382|NCT00960440|2613473|P4|Overall Study|Protocol Violation|4
822383|NCT00960440|2613474|P3|Overall Study|Protocol Violation|3
822384|NCT00960440|2613475|P2|Overall Study|Protocol Violation|8
822385|NCT00960440|2613476|P1|Overall Study|Protocol Violation|2
822386|NCT00960440|2613473|P4|Overall Study|Lack of Efficacy|8
822387|NCT00960440|2613474|P3|Overall Study|Lack of Efficacy|3
822388|NCT00960440|2613475|P2|Overall Study|Lack of Efficacy|5
822389|NCT00960440|2613476|P1|Overall Study|Lack of Efficacy|2
822390|NCT00960440|2613473|P4|Overall Study|Adverse Event|4
822391|NCT00960440|2613474|P3|Overall Study|Adverse Event|4
822392|NCT00960440|2613475|P2|Overall Study|Adverse Event|12
822393|NCT00960440|2613476|P1|Overall Study|Adverse Event|12
822394|NCT00960440|2613473|P4|Overall Study|Death|1
822395|NCT00960440|2613474|P3|Overall Study|Death|0
822396|NCT00960440|2613475|P2|Overall Study|Death|0
822397|NCT00960440|2613476|P1|Overall Study|Death|0
822398|NCT00960531|2613656|P10|Overall Study|Reason not Specified|1
822399|NCT00960531|2613657|P9|Overall Study|Reason not Specified|8
822400|NCT00960531|2613658|P8|Overall Study|Reason not Specified|0
822401|NCT00960531|2613659|P7|Overall Study|Reason not Specified|16
822402|NCT00960531|2613660|P6|Overall Study|Reason not Specified|0
822403|NCT00960531|2613661|P5|Overall Study|Reason not Specified|2
822404|NCT00960531|2613662|P4|Overall Study|Reason not Specified|1
822405|NCT00960531|2613663|P3|Overall Study|Reason not Specified|13
822406|NCT00960531|2613664|P2|Overall Study|Reason not Specified|1
822407|NCT00960531|2613665|P1|Overall Study|Reason not Specified|2
822408|NCT00960531|2613656|P10|Overall Study|Adverse Event (AE)|0
822409|NCT00960531|2613657|P9|Overall Study|Adverse Event (AE)|2
822410|NCT00960531|2613658|P8|Overall Study|Adverse Event (AE)|0
822411|NCT00960531|2613659|P7|Overall Study|Adverse Event (AE)|2
822412|NCT00960531|2613660|P6|Overall Study|Adverse Event (AE)|1
822413|NCT00960531|2613661|P5|Overall Study|Adverse Event (AE)|0
822414|NCT00960531|2613662|P4|Overall Study|Adverse Event (AE)|0
822415|NCT00960531|2613663|P3|Overall Study|Adverse Event (AE)|0
822416|NCT00960531|2613664|P2|Overall Study|Adverse Event (AE)|0
822417|NCT00960531|2613665|P1|Overall Study|Adverse Event (AE)|2
822418|NCT00960531|2613656|P10|Overall Study|Failed to Return|0
822419|NCT00960531|2613657|P9|Overall Study|Failed to Return|0
822420|NCT00960531|2613658|P8|Overall Study|Failed to Return|2
822421|NCT00960531|2613659|P7|Overall Study|Failed to Return|0
822422|NCT00960531|2613660|P6|Overall Study|Failed to Return|0
822423|NCT00960531|2613661|P5|Overall Study|Failed to Return|0
822424|NCT00960531|2613662|P4|Overall Study|Failed to Return|0
822425|NCT00960531|2613663|P3|Overall Study|Failed to Return|0
822426|NCT00960531|2613664|P2|Overall Study|Failed to Return|0
822427|NCT00960531|2613665|P1|Overall Study|Failed to Return|2
822428|NCT00960531|2613656|P10|Overall Study|Lost to Follow-up|0
822429|NCT00960531|2613657|P9|Overall Study|Lost to Follow-up|0
822430|NCT00960531|2613658|P8|Overall Study|Lost to Follow-up|0
822431|NCT00960531|2613659|P7|Overall Study|Lost to Follow-up|1
822432|NCT00960531|2613660|P6|Overall Study|Lost to Follow-up|0
822433|NCT00960531|2613661|P5|Overall Study|Lost to Follow-up|0
822434|NCT00960531|2613662|P4|Overall Study|Lost to Follow-up|0
822435|NCT00960531|2613663|P3|Overall Study|Lost to Follow-up|1
822436|NCT00960531|2613664|P2|Overall Study|Lost to Follow-up|0
822437|NCT00960531|2613665|P1|Overall Study|Lost to Follow-up|0
822438|NCT00960531|2613656|P10|Overall Study|Discontinuation of Study by Sponsor|0
822439|NCT00960531|2613657|P9|Overall Study|Discontinuation of Study by Sponsor|0
822440|NCT00960531|2613658|P8|Overall Study|Discontinuation of Study by Sponsor|1
822441|NCT00960531|2613659|P7|Overall Study|Discontinuation of Study by Sponsor|0
822442|NCT00960531|2613660|P6|Overall Study|Discontinuation of Study by Sponsor|0
822443|NCT00960531|2613661|P5|Overall Study|Discontinuation of Study by Sponsor|0
822444|NCT00960531|2613662|P4|Overall Study|Discontinuation of Study by Sponsor|0
822445|NCT00960531|2613663|P3|Overall Study|Discontinuation of Study by Sponsor|0
822446|NCT00960531|2613664|P2|Overall Study|Discontinuation of Study by Sponsor|0
822447|NCT00960531|2613665|P1|Overall Study|Discontinuation of Study by Sponsor|0
822448|NCT00960531|2613656|P10|Overall Study|Investigator Request|0
822449|NCT00960531|2613657|P9|Overall Study|Investigator Request|0
822450|NCT00960531|2613658|P8|Overall Study|Investigator Request|0
822451|NCT00960531|2613659|P7|Overall Study|Investigator Request|0
822452|NCT00960531|2613660|P6|Overall Study|Investigator Request|0
822453|NCT00960531|2613661|P5|Overall Study|Investigator Request|0
822454|NCT00960531|2613662|P4|Overall Study|Investigator Request|0
822455|NCT00960531|2613663|P3|Overall Study|Investigator Request|1
822456|NCT00960531|2613664|P2|Overall Study|Investigator Request|0
822457|NCT00960531|2613665|P1|Overall Study|Investigator Request|0
822458|NCT00960531|2613656|P10|Overall Study|Caregiver Request|0
822459|NCT00960531|2613657|P9|Overall Study|Caregiver Request|3
822460|NCT00960531|2613658|P8|Overall Study|Caregiver Request|1
822461|NCT00960531|2613659|P7|Overall Study|Caregiver Request|3
822462|NCT00960531|2613660|P6|Overall Study|Caregiver Request|2
822463|NCT00960531|2613661|P5|Overall Study|Caregiver Request|0
822464|NCT00960531|2613662|P4|Overall Study|Caregiver Request|5
822465|NCT00960531|2613663|P3|Overall Study|Caregiver Request|6
822466|NCT00960531|2613664|P2|Overall Study|Caregiver Request|0
822467|NCT00960531|2613665|P1|Overall Study|Caregiver Request|2
822468|NCT00960531|2613656|P10|Overall Study|Withdrawal by Subject|0
822469|NCT00960531|2613657|P9|Overall Study|Withdrawal by Subject|1
822470|NCT00960531|2613658|P8|Overall Study|Withdrawal by Subject|0
822471|NCT00960531|2613659|P7|Overall Study|Withdrawal by Subject|2
822472|NCT00960531|2613660|P6|Overall Study|Withdrawal by Subject|0
822473|NCT00960531|2613661|P5|Overall Study|Withdrawal by Subject|0
822474|NCT00960531|2613662|P4|Overall Study|Withdrawal by Subject|2
822475|NCT00960531|2613663|P3|Overall Study|Withdrawal by Subject|5
822476|NCT00960531|2613664|P2|Overall Study|Withdrawal by Subject|0
822477|NCT00960531|2613665|P1|Overall Study|Withdrawal by Subject|1
822478|NCT00960531|2613656|P10|Overall Study|Lack of Efficacy|0
822479|NCT00960531|2613657|P9|Overall Study|Lack of Efficacy|0
822480|NCT00960531|2613658|P8|Overall Study|Lack of Efficacy|0
822481|NCT00960531|2613659|P7|Overall Study|Lack of Efficacy|0
822482|NCT00960531|2613660|P6|Overall Study|Lack of Efficacy|0
822483|NCT00960531|2613661|P5|Overall Study|Lack of Efficacy|0
822484|NCT00960531|2613662|P4|Overall Study|Lack of Efficacy|0
822485|NCT00960531|2613663|P3|Overall Study|Lack of Efficacy|0
822486|NCT00960531|2613664|P2|Overall Study|Lack of Efficacy|0
822487|NCT00960531|2613665|P1|Overall Study|Lack of Efficacy|1
822488|NCT00960570|2613709|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
822489|NCT00960570|2613709|P1|1 Day Period Between Dosing|Adverse Event|2
822490|NCT00960570|2613709|P1|21 Day Washout Period|Withdrawal by Subject|1
822491|NCT00960570|2613709|P1|21 Day Washout Period|Adverse Event|1
822492|NCT00960661|2613731|P3|Interventional Phase|Lack of Efficacy|0
822493|NCT00960661|2613732|P2|Interventional Phase|Lack of Efficacy|2
822494|NCT00960661|2613733|P1|Interventional Phase|Lack of Efficacy|0
822495|NCT00960661|2613731|P3|Interventional Phase|sponsor decision|0
822496|NCT00960661|2613732|P2|Interventional Phase|sponsor decision|1
822497|NCT00960661|2613733|P1|Interventional Phase|sponsor decision|0
822498|NCT00960661|2613731|P3|Interventional Phase|Physician Decision|5
822499|NCT00960661|2613732|P2|Interventional Phase|Physician Decision|3
822500|NCT00960661|2613733|P1|Interventional Phase|Physician Decision|0
822501|NCT00960661|2613731|P3|Interventional Phase|Withdrawal by Subject|29
822502|NCT00960661|2613732|P2|Interventional Phase|Withdrawal by Subject|18
822503|NCT00960661|2613733|P1|Interventional Phase|Withdrawal by Subject|0
822504|NCT00960661|2613731|P3|Interventional Phase|Protocol Violation|2
822505|NCT00960661|2613732|P2|Interventional Phase|Protocol Violation|7
822506|NCT00960661|2613733|P1|Interventional Phase|Protocol Violation|0
822507|NCT00960661|2613731|P3|Interventional Phase|entry criteria not met|0
822508|NCT00960661|2613732|P2|Interventional Phase|entry criteria not met|3
822509|NCT00960661|2613733|P1|Interventional Phase|entry criteria not met|0
822510|NCT00960661|2613731|P3|Interventional Phase|Lost to Follow-up|2
822511|NCT00960661|2613732|P2|Interventional Phase|Lost to Follow-up|0
822512|NCT00960661|2613733|P1|Interventional Phase|Lost to Follow-up|0
822513|NCT00960661|2613731|P3|Interventional Phase|Death|0
822514|NCT00960661|2613732|P2|Interventional Phase|Death|1
822515|NCT00960661|2613733|P1|Interventional Phase|Death|0
822516|NCT00960661|2613731|P3|Interventional Phase|Adverse Event|8
822517|NCT00960661|2613732|P2|Interventional Phase|Adverse Event|17
822518|NCT00960661|2613733|P1|Interventional Phase|Adverse Event|0
822519|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
822520|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
822521|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
822522|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
822523|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
822524|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
822525|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
822526|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
822527|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
822528|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
822529|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
822530|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
822531|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
822532|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
822533|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
822534|NCT00960661|2613731|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
822535|NCT00960661|2613732|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
822536|NCT00960661|2613733|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
822537|NCT00960687|2613763|P2|Washout Period of 7 Days|Withdrawal by Subject|1
822538|NCT00960687|2613764|P1|Washout Period of 7 Days|Withdrawal by Subject|1
822539|NCT00960687|2613763|P2|Washout Period of 7 Days|Adverse Event|2
822540|NCT00960687|2613764|P1|Washout Period of 7 Days|Adverse Event|3
822541|NCT00960843|2613776|P2|Overall Study|Repeated needle dislodgment|1
822542|NCT00960843|2613777|P1|Overall Study|Repeated needle dislodgment|0
822543|NCT00960843|2613776|P2|Overall Study|Protocol Violation|4
822544|NCT00960843|2613777|P1|Overall Study|Protocol Violation|0
822545|NCT00960843|2613776|P2|Overall Study|Lost to Follow-up|0
822546|NCT00960843|2613777|P1|Overall Study|Lost to Follow-up|2
822547|NCT00960856|2613787|P4|Washout Period of 7 Days|Adverse Event|0
822548|NCT00960856|2613788|P3|Washout Period of 7 Days|Adverse Event|1
822549|NCT00960856|2613789|P2|Washout Period of 7 Days|Adverse Event|0
822550|NCT00960856|2613790|P1|Washout Period of 7 Days|Adverse Event|0
822551|NCT00960856|2613787|P4|Washout Period of 7 Days|Withdrawal by Subject|0
822552|NCT00960856|2613788|P3|Washout Period of 7 Days|Withdrawal by Subject|0
822553|NCT00960856|2613789|P2|Washout Period of 7 Days|Withdrawal by Subject|2
822554|NCT00960856|2613790|P1|Washout Period of 7 Days|Withdrawal by Subject|0
822555|NCT00960869|2613810|P2|Overall Study|Misc|18
822556|NCT00960869|2613811|P1|Overall Study|Misc|19
822557|NCT00960869|2613810|P2|Overall Study|Lost to Follow-up|4
822558|NCT00960869|2613811|P1|Overall Study|Lost to Follow-up|1
822559|NCT00960869|2613810|P2|Overall Study|Withdrawal by Subject|14
822560|NCT00960869|2613811|P1|Overall Study|Withdrawal by Subject|16
822561|NCT00960869|2613810|P2|Overall Study|Adverse Event|26
822562|NCT00960869|2613811|P1|Overall Study|Adverse Event|17
822563|NCT00960934|2613831|P6|Overall Study|Study Terminated by Sponsor|49
822564|NCT00960934|2613832|P5|Overall Study|Study Terminated by Sponsor|49
822565|NCT00960934|2613833|P4|Overall Study|Study Terminated by Sponsor|50
822566|NCT00960934|2613834|P3|Overall Study|Study Terminated by Sponsor|52
822567|NCT00960934|2613835|P2|Overall Study|Study Terminated by Sponsor|46
822568|NCT00960934|2613836|P1|Overall Study|Study Terminated by Sponsor|50
822569|NCT00960934|2613831|P6|Overall Study|Withdrawal by Subject|7
822570|NCT00960934|2613832|P5|Overall Study|Withdrawal by Subject|5
822571|NCT00960934|2613833|P4|Overall Study|Withdrawal by Subject|5
822572|NCT00960934|2613834|P3|Overall Study|Withdrawal by Subject|4
822573|NCT00960934|2613835|P2|Overall Study|Withdrawal by Subject|6
822574|NCT00960934|2613836|P1|Overall Study|Withdrawal by Subject|5
822575|NCT00960934|2613831|P6|Overall Study|Protocol Violation|2
822576|NCT00960934|2613832|P5|Overall Study|Protocol Violation|3
822577|NCT00960934|2613833|P4|Overall Study|Protocol Violation|3
822578|NCT00960934|2613834|P3|Overall Study|Protocol Violation|0
822579|NCT00960934|2613835|P2|Overall Study|Protocol Violation|4
822580|NCT00960934|2613836|P1|Overall Study|Protocol Violation|3
822581|NCT00960934|2613831|P6|Overall Study|Progressive Disease|1
822582|NCT00960934|2613832|P5|Overall Study|Progressive Disease|1
822583|NCT00960934|2613833|P4|Overall Study|Progressive Disease|0
822584|NCT00960934|2613834|P3|Overall Study|Progressive Disease|0
822585|NCT00960934|2613835|P2|Overall Study|Progressive Disease|1
822586|NCT00960934|2613836|P1|Overall Study|Progressive Disease|1
822587|NCT00960934|2613831|P6|Overall Study|Physician Decision|0
822588|NCT00960934|2613832|P5|Overall Study|Physician Decision|0
822589|NCT00960934|2613833|P4|Overall Study|Physician Decision|0
822590|NCT00960934|2613834|P3|Overall Study|Physician Decision|0
822591|NCT00960934|2613835|P2|Overall Study|Physician Decision|1
822592|NCT00960934|2613836|P1|Overall Study|Physician Decision|0
822593|NCT00960934|2613831|P6|Overall Study|Not Specified|2
822594|NCT00960934|2613832|P5|Overall Study|Not Specified|2
822595|NCT00960934|2613833|P4|Overall Study|Not Specified|4
822596|NCT00960934|2613834|P3|Overall Study|Not Specified|5
822597|NCT00960934|2613835|P2|Overall Study|Not Specified|1
822598|NCT00960934|2613836|P1|Overall Study|Not Specified|2
822599|NCT00960934|2613831|P6|Overall Study|Lost to Follow-up|0
822600|NCT00960934|2613832|P5|Overall Study|Lost to Follow-up|0
822601|NCT00960934|2613833|P4|Overall Study|Lost to Follow-up|0
822602|NCT00960934|2613834|P3|Overall Study|Lost to Follow-up|0
822603|NCT00960934|2613835|P2|Overall Study|Lost to Follow-up|1
822604|NCT00960934|2613836|P1|Overall Study|Lost to Follow-up|0
822605|NCT00960934|2613831|P6|Overall Study|Lack of Efficacy|0
822606|NCT00960934|2613832|P5|Overall Study|Lack of Efficacy|0
822607|NCT00960934|2613833|P4|Overall Study|Lack of Efficacy|0
822608|NCT00960934|2613834|P3|Overall Study|Lack of Efficacy|0
822609|NCT00960934|2613835|P2|Overall Study|Lack of Efficacy|0
822610|NCT00960934|2613836|P1|Overall Study|Lack of Efficacy|1
822611|NCT00960934|2613831|P6|Overall Study|Adverse Event|3
822612|NCT00960934|2613832|P5|Overall Study|Adverse Event|4
822613|NCT00960934|2613833|P4|Overall Study|Adverse Event|2
822614|NCT00960934|2613834|P3|Overall Study|Adverse Event|3
822615|NCT00960934|2613835|P2|Overall Study|Adverse Event|3
822616|NCT00960934|2613836|P1|Overall Study|Adverse Event|2
822617|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
822618|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
822619|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
822620|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
822621|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
822622|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
822623|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
822624|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
822625|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
822626|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
822627|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
822628|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
822629|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
822630|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
822631|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
822632|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
822633|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Death|0
822634|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Death|1
822635|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Death|0
822636|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Death|0
822637|NCT00960986|2613950|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
822638|NCT00960986|2613951|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
822639|NCT00960986|2613952|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
822640|NCT00960986|2613953|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
822641|NCT00960986|2613950|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
822642|NCT00960986|2613951|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
822643|NCT00960986|2613952|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
822644|NCT00960986|2613953|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
822645|NCT00960986|2613950|P4|Period 1 (Screening and Washout)|Protocol Violation|0
822646|NCT00960986|2613951|P3|Period 1 (Screening and Washout)|Protocol Violation|0
822647|NCT00960986|2613952|P2|Period 1 (Screening and Washout)|Protocol Violation|0
822648|NCT00960986|2613953|P1|Period 1 (Screening and Washout)|Protocol Violation|1
822649|NCT00960986|2613950|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
822650|NCT00960986|2613951|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
822651|NCT00960986|2613952|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
822652|NCT00960986|2613953|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
822653|NCT00960986|2613950|P4|Period 1 (Screening and Washout)|Adverse Event|1
822654|NCT00960986|2613951|P3|Period 1 (Screening and Washout)|Adverse Event|1
822655|NCT00960986|2613952|P2|Period 1 (Screening and Washout)|Adverse Event|2
822656|NCT00960986|2613953|P1|Period 1 (Screening and Washout)|Adverse Event|1
822657|NCT00960999|2614025|P2|Overall Study|RT dose constraints not met|0
822658|NCT00960999|2614026|P1|Overall Study|RT dose constraints not met|2
822659|NCT00960999|2614025|P2|Overall Study|Protocol Violation|2
822660|NCT00960999|2614026|P1|Overall Study|Protocol Violation|5
822661|NCT00960999|2614025|P2|Overall Study|Withdrawal by Subject|0
822662|NCT00960999|2614026|P1|Overall Study|Withdrawal by Subject|1
822663|NCT00967005|2614064|P2|Overall Study|Lost to Follow-up|10
822664|NCT00967005|2614065|P1|Overall Study|Lost to Follow-up|7
822665|NCT00967018|2614117|P1|Overall Study|Miscellaneous Reasons|9
822666|NCT00967018|2614117|P1|Overall Study|Withdrawal by Subject|1
822667|NCT00967018|2614117|P1|Overall Study|Lost to Follow-up|2
822668|NCT00967018|2614117|P1|Overall Study|Physician Decision|7
822669|NCT00967018|2614117|P1|Overall Study|Adverse Event|2
822670|NCT00967226|2614130|P2|Overall Study|Physician Decision|1
822671|NCT00967226|2614131|P1|Overall Study|Physician Decision|0
822672|NCT00967226|2614130|P2|Overall Study|Protocol Violation|0
822673|NCT00967226|2614131|P1|Overall Study|Protocol Violation|2
822674|NCT00967226|2614130|P2|Overall Study|Adverse Event|5
822675|NCT00967226|2614131|P1|Overall Study|Adverse Event|0
822676|NCT00968149|2614196|P2|Overall Study|Withdrawal by Subject|0
822677|NCT00968149|2614197|P1|Overall Study|Withdrawal by Subject|2
822678|NCT00968149|2614196|P2|Overall Study|Protocol Violation|0
822679|NCT00968149|2614197|P1|Overall Study|Protocol Violation|4
822680|NCT00968149|2614196|P2|Overall Study|Lost to Follow-up|1
822681|NCT00968149|2614197|P1|Overall Study|Lost to Follow-up|0
822682|NCT00968149|2614196|P2|Overall Study|Lack of Efficacy|4
822683|NCT00968149|2614197|P1|Overall Study|Lack of Efficacy|0
822684|NCT00968149|2614196|P2|Overall Study|Adverse Event|1
822685|NCT00968149|2614197|P1|Overall Study|Adverse Event|5
822686|NCT00968201|2614219|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
822687|NCT00968201|2614220|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
822688|NCT00968201|2614221|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
822689|NCT00968201|2614219|P3|Extension Study - (Period III)|Not Specified|2
822690|NCT00968201|2614220|P2|Extension Study - (Period III)|Not Specified|0
822691|NCT00968201|2614221|P1|Extension Study - (Period III)|Not Specified|0
822692|NCT00968201|2614219|P3|Extension Study - (Period III)|Noncompliance|3
822693|NCT00968201|2614220|P2|Extension Study - (Period III)|Noncompliance|0
822694|NCT00968201|2614221|P1|Extension Study - (Period III)|Noncompliance|0
822695|NCT00968201|2614219|P3|Extension Study - (Period III)|Patient Relocated|1
822696|NCT00968201|2614220|P2|Extension Study - (Period III)|Patient Relocated|1
822697|NCT00968201|2614221|P1|Extension Study - (Period III)|Patient Relocated|0
822698|NCT00968201|2614219|P3|Extension Study - (Period III)|Withdrawal by Subject|40
822699|NCT00968201|2614220|P2|Extension Study - (Period III)|Withdrawal by Subject|20
822700|NCT00968201|2614221|P1|Extension Study - (Period III)|Withdrawal by Subject|0
822701|NCT00968201|2614219|P3|Extension Study - (Period III)|Protocol Violation|14
822702|NCT00968201|2614220|P2|Extension Study - (Period III)|Protocol Violation|17
822703|NCT00968201|2614221|P1|Extension Study - (Period III)|Protocol Violation|0
822704|NCT00968201|2614219|P3|Extension Study - (Period III)|Lost to Follow-up|13
822705|NCT00968201|2614220|P2|Extension Study - (Period III)|Lost to Follow-up|7
822706|NCT00968201|2614221|P1|Extension Study - (Period III)|Lost to Follow-up|0
822707|NCT00968201|2614219|P3|Extension Study - (Period III)|Adverse Event|22
822708|NCT00968201|2614220|P2|Extension Study - (Period III)|Adverse Event|5
822709|NCT00968201|2614221|P1|Extension Study - (Period III)|Adverse Event|0
822710|NCT00968201|2614219|P3|Base Study - (Period II)|Site Error|1
822711|NCT00968201|2614220|P2|Base Study - (Period II)|Site Error|0
822712|NCT00968201|2614221|P1|Base Study - (Period II)|Site Error|0
822713|NCT00968201|2614219|P3|Base Study - (Period II)|Withdrawal by Subject|8
822714|NCT00968201|2614220|P2|Base Study - (Period II)|Withdrawal by Subject|0
822715|NCT00968201|2614221|P1|Base Study - (Period II)|Withdrawal by Subject|4
822716|NCT00968201|2614219|P3|Base Study - (Period II)|Protocol Violation|12
822717|NCT00968201|2614220|P2|Base Study - (Period II)|Protocol Violation|0
822718|NCT00968201|2614221|P1|Base Study - (Period II)|Protocol Violation|12
822719|NCT00968201|2614219|P3|Base Study - (Period II)|Lost to Follow-up|7
822720|NCT00968201|2614220|P2|Base Study - (Period II)|Lost to Follow-up|0
822721|NCT00968201|2614221|P1|Base Study - (Period II)|Lost to Follow-up|2
822722|NCT00968201|2614219|P3|Base Study - (Period II)|Lack of Efficacy|1
822723|NCT00968201|2614220|P2|Base Study - (Period II)|Lack of Efficacy|0
822724|NCT00968201|2614221|P1|Base Study - (Period II)|Lack of Efficacy|0
822725|NCT00968201|2614219|P3|Base Study - (Period II)|Adverse Event|16
822726|NCT00968201|2614220|P2|Base Study - (Period II)|Adverse Event|0
822727|NCT00968201|2614221|P1|Base Study - (Period II)|Adverse Event|8
822728|NCT00968617|2614285|P1|Overall Study|Study terminated by sponsor|6
822729|NCT00968669|2614301|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
822730|NCT00968669|2614302|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
822731|NCT00968669|2614303|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
822732|NCT00968669|2614304|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
822733|NCT00968669|2614301|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
822734|NCT00968669|2614302|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
822735|NCT00968669|2614303|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
822736|NCT00968669|2614304|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
822737|NCT00968669|2614301|P4|Overall Study|SUBJECT INCARCERATED|0
822738|NCT00968669|2614302|P3|Overall Study|SUBJECT INCARCERATED|0
822739|NCT00968669|2614303|P2|Overall Study|SUBJECT INCARCERATED|1
822740|NCT00968669|2614304|P1|Overall Study|SUBJECT INCARCERATED|0
822741|NCT00968669|2614301|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
822742|NCT00968669|2614302|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
822743|NCT00968669|2614303|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
822744|NCT00968669|2614304|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
822745|NCT00968669|2614301|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
822746|NCT00968669|2614302|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
822747|NCT00968669|2614303|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
822748|NCT00968669|2614304|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
822749|NCT00968669|2614301|P4|Overall Study|SPONSOR DECISION|0
822750|NCT00968669|2614302|P3|Overall Study|SPONSOR DECISION|0
822751|NCT00968669|2614303|P2|Overall Study|SPONSOR DECISION|1
822752|NCT00968669|2614304|P1|Overall Study|SPONSOR DECISION|0
822753|NCT00968669|2614301|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
822754|NCT00968669|2614302|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
822755|NCT00968669|2614303|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
822756|NCT00968669|2614304|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
822757|NCT00968669|2614301|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
822758|NCT00968669|2614302|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
822759|NCT00968669|2614303|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
822760|NCT00968669|2614304|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
822761|NCT00968669|2614301|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
822762|NCT00968669|2614302|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
822763|NCT00968669|2614303|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
822764|NCT00968669|2614304|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
822765|NCT00968669|2614301|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
822766|NCT00968669|2614302|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
822767|NCT00968669|2614303|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
822768|NCT00968669|2614304|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
822769|NCT00968669|2614301|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
822770|NCT00968669|2614302|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
822771|NCT00968669|2614303|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
822772|NCT00968669|2614304|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
822773|NCT00968669|2614301|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
822774|NCT00968669|2614302|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
822775|NCT00968669|2614303|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
822776|NCT00968669|2614304|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
822777|NCT00968669|2614301|P4|Overall Study|EARLY WITHDRAWAL|0
822778|NCT00968669|2614302|P3|Overall Study|EARLY WITHDRAWAL|0
822779|NCT00968669|2614303|P2|Overall Study|EARLY WITHDRAWAL|1
822780|NCT00968669|2614304|P1|Overall Study|EARLY WITHDRAWAL|0
822781|NCT00968669|2614301|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
822782|NCT00968669|2614302|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
822783|NCT00968669|2614303|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
822784|NCT00968669|2614304|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
822785|NCT00968669|2614301|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
822786|NCT00968669|2614302|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
822787|NCT00968669|2614303|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
822788|NCT00968669|2614304|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
822789|NCT00968669|2614301|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
822790|NCT00968669|2614302|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
822791|NCT00968669|2614303|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
822792|NCT00968669|2614304|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
822793|NCT00968669|2614301|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
822794|NCT00968669|2614302|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
822795|NCT00968669|2614303|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
822796|NCT00968669|2614304|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
822797|NCT00968669|2614301|P4|Overall Study|AE|0
822798|NCT00968669|2614302|P3|Overall Study|AE|0
822799|NCT00968669|2614303|P2|Overall Study|AE|0
822800|NCT00968669|2614304|P1|Overall Study|AE|1
822801|NCT00968669|2614301|P4|Overall Study|Pregnancy|0
822802|NCT00968669|2614302|P3|Overall Study|Pregnancy|2
822803|NCT00968669|2614303|P2|Overall Study|Pregnancy|0
822804|NCT00968669|2614304|P1|Overall Study|Pregnancy|0
822805|NCT00968669|2614301|P4|Overall Study|Withdrawal by Subject|3
822806|NCT00968669|2614302|P3|Overall Study|Withdrawal by Subject|5
822807|NCT00968669|2614303|P2|Overall Study|Withdrawal by Subject|7
822808|NCT00968669|2614304|P1|Overall Study|Withdrawal by Subject|9
822809|NCT00968669|2614301|P4|Overall Study|Lost to Follow-up|4
822810|NCT00968669|2614302|P3|Overall Study|Lost to Follow-up|1
822811|NCT00968669|2614303|P2|Overall Study|Lost to Follow-up|2
822812|NCT00968669|2614304|P1|Overall Study|Lost to Follow-up|5
822813|NCT00968708|2614396|P2|Overall Study|Other|34
822814|NCT00968708|2614397|P1|Overall Study|Other|26
822815|NCT00968708|2614396|P2|Overall Study|Investigator Discretion|1
822816|NCT00968708|2614397|P1|Overall Study|Investigator Discretion|0
822817|NCT00968708|2614396|P2|Overall Study|Voluntary Withdrawal|101
822818|NCT00968708|2614397|P1|Overall Study|Voluntary Withdrawal|104
822819|NCT00968708|2614396|P2|Overall Study|Lost to Follow-up|11
822820|NCT00968708|2614397|P1|Overall Study|Lost to Follow-up|19
822821|NCT00968708|2614396|P2|Overall Study|Major Protocol Deviation|1
822822|NCT00968708|2614397|P1|Overall Study|Major Protocol Deviation|0
822823|NCT00968708|2614396|P2|Overall Study|Adverse Event|150
822824|NCT00968708|2614397|P1|Overall Study|Adverse Event|169
822825|NCT00968799|2614405|P1|Overall Study|Advanced disease, HIPEC not applicable|2
822826|NCT00968812|2614416|P3|Overall Study|Not specified|40
822827|NCT00968812|2614417|P2|Overall Study|Not specified|37
822828|NCT00968812|2614418|P1|Overall Study|Not specified|25
822829|NCT00968812|2614416|P3|Overall Study|Unable to take rescue therapy|17
822830|NCT00968812|2614417|P2|Overall Study|Unable to take rescue therapy|12
822831|NCT00968812|2614418|P1|Overall Study|Unable to take rescue therapy|12
822832|NCT00968812|2614416|P3|Overall Study|Noncompliance with study drug|6
822833|NCT00968812|2614417|P2|Overall Study|Noncompliance with study drug|1
822834|NCT00968812|2614418|P1|Overall Study|Noncompliance with study drug|4
822835|NCT00968812|2614416|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
822836|NCT00968812|2614417|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
822837|NCT00968812|2614418|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
822838|NCT00968812|2614416|P3|Overall Study|Withdrawal by Subject|25
822839|NCT00968812|2614417|P2|Overall Study|Withdrawal by Subject|23
822840|NCT00968812|2614418|P1|Overall Study|Withdrawal by Subject|17
822841|NCT00968812|2614416|P3|Overall Study|Protocol Violation|3
822842|NCT00968812|2614417|P2|Overall Study|Protocol Violation|4
822843|NCT00968812|2614418|P1|Overall Study|Protocol Violation|7
822844|NCT00968812|2614416|P3|Overall Study|Physician Decision|9
822845|NCT00968812|2614417|P2|Overall Study|Physician Decision|5
822846|NCT00968812|2614418|P1|Overall Study|Physician Decision|8
822847|NCT00968812|2614416|P3|Overall Study|Lost to Follow-up|11
822848|NCT00968812|2614417|P2|Overall Study|Lost to Follow-up|12
822849|NCT00968812|2614418|P1|Overall Study|Lost to Follow-up|17
822850|NCT00968812|2614416|P3|Overall Study|Lack of Efficacy|16
822851|NCT00968812|2614417|P2|Overall Study|Lack of Efficacy|7
822852|NCT00968812|2614418|P1|Overall Study|Lack of Efficacy|9
822853|NCT00968812|2614416|P3|Overall Study|Death|1
822854|NCT00968812|2614417|P2|Overall Study|Death|2
822855|NCT00968812|2614418|P1|Overall Study|Death|2
822856|NCT00968812|2614416|P3|Overall Study|Adverse Event|33
822857|NCT00968812|2614417|P2|Overall Study|Adverse Event|46
822858|NCT00968812|2614418|P1|Overall Study|Adverse Event|30
822859|NCT00968981|2614481|P3|Overall Study|Withdrawal by Subject|3
822860|NCT00968981|2614482|P2|Overall Study|Withdrawal by Subject|3
822861|NCT00968981|2614483|P1|Overall Study|Withdrawal by Subject|1
822862|NCT00968981|2614481|P3|Overall Study|Physician Decision|5
822863|NCT00968981|2614482|P2|Overall Study|Physician Decision|3
822864|NCT00968981|2614483|P1|Overall Study|Physician Decision|5
822865|NCT00968981|2614481|P3|Overall Study|Lost to Follow-up|1
822866|NCT00968981|2614482|P2|Overall Study|Lost to Follow-up|0
822867|NCT00968981|2614483|P1|Overall Study|Lost to Follow-up|0
822868|NCT00968981|2614481|P3|Overall Study|Disease Progression|13
822869|NCT00968981|2614482|P2|Overall Study|Disease Progression|16
822870|NCT00968981|2614483|P1|Overall Study|Disease Progression|14
822871|NCT00968981|2614481|P3|Overall Study|Adverse Event|0
822872|NCT00968981|2614482|P2|Overall Study|Adverse Event|0
822873|NCT00968981|2614483|P1|Overall Study|Adverse Event|2
822874|NCT00969124|2614519|P1|Overall Study|Technical error|1
822875|NCT00969124|2614519|P1|Overall Study|Previously unrecognized disease|3
822876|NCT00969124|2614519|P1|Overall Study|Inability to reach cecum|9
822877|NCT00969124|2614519|P1|Overall Study|Inadequate bowel preparation|15
822878|NCT00969124|2614519|P1|Overall Study|Protocol Violation|2
822879|NCT00969150|2614527|P2|Overall Study|Other reasons|0
822880|NCT00969150|2614528|P1|Overall Study|Other reasons|1
822881|NCT00969150|2614527|P2|Overall Study|Lost to Follow-up|4
822882|NCT00969150|2614528|P1|Overall Study|Lost to Follow-up|5
822883|NCT00969150|2614527|P2|Overall Study|Withdrawal by Subject|9
822884|NCT00969150|2614528|P1|Overall Study|Withdrawal by Subject|13
822885|NCT00969150|2614527|P2|Overall Study|Protocol Violation|12
822886|NCT00969150|2614528|P1|Overall Study|Protocol Violation|9
822887|NCT00969150|2614527|P2|Overall Study|Lack of Efficacy|1
822888|NCT00969150|2614528|P1|Overall Study|Lack of Efficacy|1
822889|NCT00969150|2614527|P2|Overall Study|Adverse Event|14
822890|NCT00969150|2614528|P1|Overall Study|Adverse Event|4
822891|NCT00969228|2614538|P2|Overall Study|Porcine circovirus detection in vaccine|14
822892|NCT00969228|2614539|P1|Overall Study|Porcine circovirus detection in vaccine|38
822893|NCT00969228|2614538|P2|Overall Study|Withdrawal by Subject|0
822894|NCT00969228|2614539|P1|Overall Study|Withdrawal by Subject|4
822895|NCT00969228|2614538|P2|Overall Study|Adverse Event|0
822896|NCT00969228|2614539|P1|Overall Study|Adverse Event|1
822897|NCT00969280|2614557|P2|Overall Study|infection of influenza A(H1N1)|1
822898|NCT00969280|2614558|P1|Overall Study|infection of influenza A(H1N1)|0
822899|NCT00969280|2614557|P2|Overall Study|Withdrawal by Subject|1
822900|NCT00969280|2614558|P1|Overall Study|Withdrawal by Subject|0
822901|NCT00969280|2614557|P2|Overall Study|Protocol Violation|1
822902|NCT00969280|2614558|P1|Overall Study|Protocol Violation|2
822903|NCT00969436|2614567|P3|Overall Study|Lost to Follow-up|5
822904|NCT00969436|2614568|P2|Overall Study|Lost to Follow-up|8
822905|NCT00969436|2614569|P1|Overall Study|Lost to Follow-up|8
822906|NCT00969436|2614567|P3|Overall Study|Withdrawal by Subject|2
822907|NCT00969436|2614568|P2|Overall Study|Withdrawal by Subject|0
822908|NCT00969436|2614569|P1|Overall Study|Withdrawal by Subject|3
822909|NCT00969436|2614567|P3|Overall Study|Subject eliminated (other vaccine)|0
822910|NCT00969436|2614568|P2|Overall Study|Subject eliminated (other vaccine)|0
822911|NCT00969436|2614569|P1|Overall Study|Subject eliminated (other vaccine)|1
822912|NCT00969436|2614567|P3|Overall Study|Parents personal problem|1
822913|NCT00969436|2614568|P2|Overall Study|Parents personal problem|0
822914|NCT00969436|2614569|P1|Overall Study|Parents personal problem|0
822915|NCT00969436|2614567|P3|Overall Study|Father - serious health problem|1
822916|NCT00969436|2614568|P2|Overall Study|Father - serious health problem|0
822917|NCT00969436|2614569|P1|Overall Study|Father - serious health problem|0
822918|NCT00969436|2614567|P3|Overall Study|Migrated/moved from study area|2
822919|NCT00969436|2614568|P2|Overall Study|Migrated/moved from study area|10
822920|NCT00969436|2614569|P1|Overall Study|Migrated/moved from study area|12
822921|NCT00969436|2614567|P3|Overall Study|Protocol Violation|0
822922|NCT00969436|2614568|P2|Overall Study|Protocol Violation|3
822923|NCT00969436|2614569|P1|Overall Study|Protocol Violation|1
822924|NCT00969540|2614607|P2|Overall Study|Lost to Follow-up|1
822925|NCT00969540|2614608|P1|Overall Study|Lost to Follow-up|1
822926|NCT00969618|2614626|P1|Overall Study|Withdrawal by Subject|27
822927|NCT00969618|2614626|P1|Overall Study|Protocol Violation|9
822928|NCT00969618|2614626|P1|Overall Study|Physician Decision|1
822929|NCT00969618|2614626|P1|Overall Study|Lost to Follow-up|7
822930|NCT00969618|2614626|P1|Overall Study|Lack of Efficacy|2
822931|NCT00969618|2614626|P1|Overall Study|Entry Criteria Not Met|3
822932|NCT00969618|2614626|P1|Overall Study|Adverse Event|29
822933|NCT00969709|2614641|P4|Overall Study|Other reasons|0
822934|NCT00969709|2614642|P3|Overall Study|Other reasons|3
822935|NCT00969709|2614643|P2|Overall Study|Other reasons|0
822936|NCT00969709|2614644|P1|Overall Study|Other reasons|0
822937|NCT00969709|2614641|P4|Overall Study|Lost to Follow-up|15
822938|NCT00969709|2614642|P3|Overall Study|Lost to Follow-up|8
822939|NCT00969709|2614643|P2|Overall Study|Lost to Follow-up|14
822940|NCT00969709|2614644|P1|Overall Study|Lost to Follow-up|10
822941|NCT00969709|2614641|P4|Overall Study|Withdrawal by Subject|23
822942|NCT00969709|2614642|P3|Overall Study|Withdrawal by Subject|11
822943|NCT00969709|2614643|P2|Overall Study|Withdrawal by Subject|12
822944|NCT00969709|2614644|P1|Overall Study|Withdrawal by Subject|9
822945|NCT00969709|2614641|P4|Overall Study|Protocol Violation|10
822946|NCT00969709|2614642|P3|Overall Study|Protocol Violation|9
822947|NCT00969709|2614643|P2|Overall Study|Protocol Violation|5
822948|NCT00969709|2614644|P1|Overall Study|Protocol Violation|9
822949|NCT00969709|2614641|P4|Overall Study|Lack of Efficacy|3
822950|NCT00969709|2614642|P3|Overall Study|Lack of Efficacy|1
822951|NCT00969709|2614643|P2|Overall Study|Lack of Efficacy|4
822952|NCT00969709|2614644|P1|Overall Study|Lack of Efficacy|7
822953|NCT00969709|2614641|P4|Overall Study|Adverse Event|12
822954|NCT00969709|2614642|P3|Overall Study|Adverse Event|26
822955|NCT00969709|2614643|P2|Overall Study|Adverse Event|13
822956|NCT00969709|2614644|P1|Overall Study|Adverse Event|3
822957|NCT00964028|2614675|P2|Overall Study|Withdrawal by Subject|1
822958|NCT00964028|2614676|P1|Overall Study|Withdrawal by Subject|0
822959|NCT00964223|2614692|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
822960|NCT00964366|2614759|P2|Overall Study|Withdrawal by Subject|1
822961|NCT00964366|2614760|P1|Overall Study|Withdrawal by Subject|0
822962|NCT00964366|2614759|P2|Overall Study|Did not qualify at Day 1|0
822963|NCT00964366|2614760|P1|Overall Study|Did not qualify at Day 1|1
822964|NCT00964392|2614776|P2|Overall Study|Not completed|168
822965|NCT00964392|2614777|P1|Overall Study|Not completed|44
822966|NCT00964392|2614776|P2|Overall Study|Early Termination, non-study arrhythmia|6
822967|NCT00964392|2614777|P1|Overall Study|Early Termination, non-study arrhythmia|1
822968|NCT00964392|2614776|P2|Overall Study|Lost to Follow-up|10
822969|NCT00964392|2614777|P1|Overall Study|Lost to Follow-up|4
822970|NCT00964392|2614776|P2|Overall Study|Withdrawal by Subject|6
822971|NCT00964392|2614777|P1|Overall Study|Withdrawal by Subject|4
822972|NCT00970268|2614804|P2|Overall Study|Inclusion/Exclusion Criteria|0
822973|NCT00970268|2614805|P1|Overall Study|Inclusion/Exclusion Criteria|1
822974|NCT00970268|2614804|P2|Overall Study|Lost to Follow-up|2
822975|NCT00970268|2614805|P1|Overall Study|Lost to Follow-up|1
822976|NCT00970268|2614804|P2|Overall Study|COPD Exacerbation|2
822977|NCT00970268|2614805|P1|Overall Study|COPD Exacerbation|4
822978|NCT00970268|2614804|P2|Overall Study|Other Reason|1
822979|NCT00970268|2614805|P1|Overall Study|Other Reason|3
822980|NCT00970268|2614804|P2|Overall Study|Protocol Violation|7
822981|NCT00970268|2614805|P1|Overall Study|Protocol Violation|4
822982|NCT00970268|2614804|P2|Overall Study|Lack of Efficacy|6
822983|NCT00970268|2614805|P1|Overall Study|Lack of Efficacy|3
822984|NCT00970268|2614804|P2|Overall Study|Adverse Event|12
822985|NCT00970268|2614805|P1|Overall Study|Adverse Event|15
822986|NCT00970268|2614804|P2|Overall Study|Withdrawal by Subject|19
822987|NCT00970268|2614805|P1|Overall Study|Withdrawal by Subject|12
822988|NCT00970281|2614821|P2|Overall Study|Physician Decision|1
822989|NCT00970281|2614822|P1|Overall Study|Physician Decision|1
822990|NCT00970281|2614821|P2|Overall Study|Withdrawal by Subject|1
822991|NCT00970281|2614822|P1|Overall Study|Withdrawal by Subject|0
822992|NCT00970281|2614821|P2|Overall Study|Lack of Efficacy|14
822993|NCT00970281|2614822|P1|Overall Study|Lack of Efficacy|1
822994|NCT00970294|2614838|P1|Overall Study|Withdrawal by Subject|1
822995|NCT00970294|2614838|P1|Overall Study|Physician Decision|4
822996|NCT00970307|2614847|P3|Overall Study|Withdrawal by Subject|2
822997|NCT00970307|2614848|P2|Overall Study|Withdrawal by Subject|3
822998|NCT00970307|2614849|P1|Overall Study|Withdrawal by Subject|2
822999|NCT00970307|2614847|P3|Overall Study|Serious Adverse Event|0
823000|NCT00970307|2614848|P2|Overall Study|Serious Adverse Event|0
823001|NCT00970307|2614849|P1|Overall Study|Serious Adverse Event|1
823002|NCT00970359|2614944|P1|Overall Study|Not Treated|4
823003|NCT00970489|2614952|P2|Overall Study|Death/Withdrew/Criteria Violation|41
823004|NCT00970489|2614953|P1|Overall Study|Death/Withdrew/Criteria Violation|54
823005|NCT00970502|2614965|P1|Overall Study|Withdrawal by Subject|1
823006|NCT00970632|2614986|P3|Overall Study|Sponsor decision|1
823007|NCT00970632|2614987|P2|Overall Study|Sponsor decision|0
823008|NCT00970632|2614988|P1|Overall Study|Sponsor decision|1
823009|NCT00970632|2614986|P3|Overall Study|Entry criteria not met|2
823010|NCT00970632|2614987|P2|Overall Study|Entry criteria not met|2
823011|NCT00970632|2614988|P1|Overall Study|Entry criteria not met|0
823012|NCT00970632|2614986|P3|Overall Study|Withdrawal by Subject|4
823013|NCT00970632|2614987|P2|Overall Study|Withdrawal by Subject|6
823014|NCT00970632|2614988|P1|Overall Study|Withdrawal by Subject|7
823015|NCT00970632|2614986|P3|Overall Study|Protocol Violation|8
823016|NCT00970632|2614987|P2|Overall Study|Protocol Violation|5
823017|NCT00970632|2614988|P1|Overall Study|Protocol Violation|8
823018|NCT00970632|2614986|P3|Overall Study|Lost to Follow-up|2
823019|NCT00970632|2614987|P2|Overall Study|Lost to Follow-up|0
823020|NCT00970632|2614988|P1|Overall Study|Lost to Follow-up|3
823021|NCT00970632|2614986|P3|Overall Study|Lack of Efficacy|0
823022|NCT00970632|2614987|P2|Overall Study|Lack of Efficacy|0
823023|NCT00970632|2614988|P1|Overall Study|Lack of Efficacy|3
823024|NCT00970632|2614986|P3|Overall Study|Adverse Event|1
823025|NCT00970632|2614987|P2|Overall Study|Adverse Event|2
823026|NCT00970632|2614988|P1|Overall Study|Adverse Event|2
823027|NCT00970684|2615044|P1|Overall Study|Withdrawal by Subject|1
823028|NCT00970684|2615044|P1|Overall Study|Adverse Event|4
823029|NCT00970684|2615044|P1|Overall Study|Lack of Efficacy|5
823030|NCT00970944|2615096|P2|Overall Study|Physician Decision|2
823031|NCT00970944|2615097|P1|Overall Study|Physician Decision|0
823032|NCT00970944|2615096|P2|Overall Study|Death|0
823033|NCT00970944|2615097|P1|Overall Study|Death|1
823034|NCT00971048|2615109|P4|Overall Study|Physician Decision|1
823035|NCT00971048|2615110|P3|Overall Study|Physician Decision|0
823036|NCT00971048|2615111|P2|Overall Study|Physician Decision|0
823037|NCT00971048|2615112|P1|Overall Study|Physician Decision|0
823038|NCT00971048|2615109|P4|Overall Study|Adverse Event|0
823039|NCT00971048|2615110|P3|Overall Study|Adverse Event|1
823040|NCT00971048|2615111|P2|Overall Study|Adverse Event|0
823041|NCT00971048|2615112|P1|Overall Study|Adverse Event|0
823042|NCT00971048|2615109|P4|Overall Study|Protocol Violation|1
823043|NCT00971048|2615110|P3|Overall Study|Protocol Violation|0
823044|NCT00971048|2615111|P2|Overall Study|Protocol Violation|2
823045|NCT00971048|2615112|P1|Overall Study|Protocol Violation|1
823046|NCT00971204|2615134|P1|Overall Study|Lost to Follow-up|10
823047|NCT00971204|2615134|P1|Overall Study|Did not meet all criteria-not treated|14
823048|NCT00971243|2615143|P5|Open-label Period|Other reason|2
823049|NCT00971243|2615144|P4|Open-label Period|Other reason|0
823050|NCT00971243|2615145|P3|Open-label Period|Other reason|0
823051|NCT00971243|2615146|P2|Open-label Period|Other reason|0
823052|NCT00971243|2615147|P1|Open-label Period|Other reason|0
823053|NCT00971243|2615143|P5|Open-label Period|Withdrawal by Subject|1
823054|NCT00971243|2615144|P4|Open-label Period|Withdrawal by Subject|2
823055|NCT00971243|2615145|P3|Open-label Period|Withdrawal by Subject|0
823056|NCT00971243|2615146|P2|Open-label Period|Withdrawal by Subject|0
823057|NCT00971243|2615147|P1|Open-label Period|Withdrawal by Subject|1
823058|NCT00971243|2615143|P5|Open-label Period|Protocol Violation|1
823059|NCT00971243|2615144|P4|Open-label Period|Protocol Violation|0
823060|NCT00971243|2615145|P3|Open-label Period|Protocol Violation|1
823061|NCT00971243|2615146|P2|Open-label Period|Protocol Violation|1
823062|NCT00971243|2615147|P1|Open-label Period|Protocol Violation|1
823063|NCT00971243|2615143|P5|Open-label Period|Physician Decision|2
823064|NCT00971243|2615144|P4|Open-label Period|Physician Decision|7
823065|NCT00971243|2615145|P3|Open-label Period|Physician Decision|3
823066|NCT00971243|2615146|P2|Open-label Period|Physician Decision|9
823067|NCT00971243|2615147|P1|Open-label Period|Physician Decision|5
823068|NCT00971243|2615143|P5|Open-label Period|Adverse Event|0
823069|NCT00971243|2615144|P4|Open-label Period|Adverse Event|1
823070|NCT00971243|2615145|P3|Open-label Period|Adverse Event|1
823071|NCT00971243|2615146|P2|Open-label Period|Adverse Event|0
823072|NCT00971243|2615147|P1|Open-label Period|Adverse Event|1
823073|NCT00971243|2615143|P5|Double Blind Period|Other reasons|1
823074|NCT00971243|2615144|P4|Double Blind Period|Other reasons|0
823075|NCT00971243|2615145|P3|Double Blind Period|Other reasons|2
823076|NCT00971243|2615146|P2|Double Blind Period|Other reasons|0
823077|NCT00971243|2615147|P1|Double Blind Period|Other reasons|1
823078|NCT00971243|2615143|P5|Double Blind Period|Withdrawal by Subject|4
823079|NCT00971243|2615144|P4|Double Blind Period|Withdrawal by Subject|4
823080|NCT00971243|2615145|P3|Double Blind Period|Withdrawal by Subject|4
823081|NCT00971243|2615146|P2|Double Blind Period|Withdrawal by Subject|1
823082|NCT00971243|2615147|P1|Double Blind Period|Withdrawal by Subject|4
823083|NCT00971243|2615143|P5|Double Blind Period|Protocol Violation|2
823084|NCT00971243|2615144|P4|Double Blind Period|Protocol Violation|2
823085|NCT00971243|2615145|P3|Double Blind Period|Protocol Violation|3
823086|NCT00971243|2615146|P2|Double Blind Period|Protocol Violation|0
823087|NCT00971243|2615147|P1|Double Blind Period|Protocol Violation|2
823088|NCT00971243|2615143|P5|Double Blind Period|Physician Decision|7
823089|NCT00971243|2615144|P4|Double Blind Period|Physician Decision|6
823090|NCT00971243|2615145|P3|Double Blind Period|Physician Decision|7
823091|NCT00971243|2615146|P2|Double Blind Period|Physician Decision|6
823092|NCT00971243|2615147|P1|Double Blind Period|Physician Decision|10
823093|NCT00971243|2615143|P5|Double Blind Period|Lost to Follow-up|1
823094|NCT00971243|2615144|P4|Double Blind Period|Lost to Follow-up|0
823095|NCT00971243|2615145|P3|Double Blind Period|Lost to Follow-up|1
823096|NCT00971243|2615146|P2|Double Blind Period|Lost to Follow-up|1
823097|NCT00971243|2615147|P1|Double Blind Period|Lost to Follow-up|0
823098|NCT00971243|2615143|P5|Double Blind Period|Adverse Event|3
823099|NCT00971243|2615144|P4|Double Blind Period|Adverse Event|2
823100|NCT00971243|2615145|P3|Double Blind Period|Adverse Event|2
823101|NCT00971243|2615146|P2|Double Blind Period|Adverse Event|3
823102|NCT00971243|2615147|P1|Double Blind Period|Adverse Event|2
823103|NCT00971425|2615191|P2|Overall Study|Withdrawal by Subject|1
823104|NCT00971425|2615192|P1|Overall Study|Withdrawal by Subject|0
823105|NCT00971425|2615191|P2|Overall Study|Adverse Event|1
823106|NCT00971425|2615192|P1|Overall Study|Adverse Event|1
823107|NCT00971932|2615294|P1|Overall Study|Ongoing|4
823108|NCT00971932|2615294|P1|Overall Study|Investigator's decision|2
823109|NCT00971932|2615294|P1|Overall Study|Withdrawal by Subject|1
823110|NCT00971997|2615304|P1|Overall Study|Physician Decision|7
823111|NCT00971997|2615304|P1|Overall Study|Withdrawal by Subject|5
823112|NCT00971997|2615304|P1|Overall Study|Protocol Violation|4
823113|NCT00971997|2615304|P1|Overall Study|Death|1
823114|NCT00971997|2615304|P1|Overall Study|Adverse Event|2
823115|NCT00972023|2615322|P1|Overall Study|Withdrawal by Subject|1
823116|NCT00972153|2615336|P3|Overall Study|Equipment malfunction during case|0
823117|NCT00972153|2615337|P2|Overall Study|Equipment malfunction during case|1
823118|NCT00972153|2615338|P1|Overall Study|Equipment malfunction during case|0
823119|NCT00972244|2615361|P5|Overall Study|Various|2
823120|NCT00972244|2615362|P4|Overall Study|Various|0
823121|NCT00972244|2615363|P3|Overall Study|Various|0
823122|NCT00972244|2615364|P2|Overall Study|Various|0
823123|NCT00972244|2615365|P1|Overall Study|Various|0
823124|NCT00972244|2615361|P5|Overall Study|Death|0
823125|NCT00972244|2615362|P4|Overall Study|Death|0
823126|NCT00972244|2615363|P3|Overall Study|Death|0
823127|NCT00972244|2615364|P2|Overall Study|Death|0
823128|NCT00972244|2615365|P1|Overall Study|Death|1
823129|NCT00972244|2615361|P5|Overall Study|Safety|1
823130|NCT00972244|2615362|P4|Overall Study|Safety|0
823131|NCT00972244|2615363|P3|Overall Study|Safety|0
823132|NCT00972244|2615364|P2|Overall Study|Safety|0
823133|NCT00972244|2615365|P1|Overall Study|Safety|0
823134|NCT00972244|2615361|P5|Overall Study|Withdrawal by Subject|1
823135|NCT00972244|2615362|P4|Overall Study|Withdrawal by Subject|0
823136|NCT00972244|2615363|P3|Overall Study|Withdrawal by Subject|1
823137|NCT00972244|2615364|P2|Overall Study|Withdrawal by Subject|2
823138|NCT00972244|2615365|P1|Overall Study|Withdrawal by Subject|1
823139|NCT00972244|2615361|P5|Overall Study|Subject No Longer Meets Study Criteria|5
823140|NCT00972244|2615362|P4|Overall Study|Subject No Longer Meets Study Criteria|0
823141|NCT00972244|2615363|P3|Overall Study|Subject No Longer Meets Study Criteria|0
823142|NCT00972244|2615364|P2|Overall Study|Subject No Longer Meets Study Criteria|2
823143|NCT00972244|2615365|P1|Overall Study|Subject No Longer Meets Study Criteria|2
823144|NCT00972244|2615361|P5|Overall Study|Adverse Event|0
823145|NCT00972244|2615362|P4|Overall Study|Adverse Event|0
823146|NCT00972244|2615363|P3|Overall Study|Adverse Event|1
823147|NCT00972244|2615364|P2|Overall Study|Adverse Event|1
823148|NCT00972244|2615365|P1|Overall Study|Adverse Event|0
823149|NCT00972244|2615361|P5|Overall Study|Incorrect Enrolment|0
823150|NCT00972244|2615362|P4|Overall Study|Incorrect Enrolment|0
823151|NCT00972244|2615363|P3|Overall Study|Incorrect Enrolment|0
823152|NCT00972244|2615364|P2|Overall Study|Incorrect Enrolment|0
823153|NCT00972244|2615365|P1|Overall Study|Incorrect Enrolment|1
823154|NCT00972283|2615389|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
823155|NCT00972283|2615390|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
823156|NCT00972283|2615389|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
823157|NCT00972283|2615390|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
823158|NCT00972283|2615389|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
823159|NCT00972283|2615390|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
823160|NCT00972283|2615389|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
823161|NCT00972283|2615390|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
823162|NCT00972283|2615389|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
823163|NCT00972283|2615390|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
823164|NCT00972283|2615389|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
823165|NCT00972283|2615390|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
823166|NCT00972283|2615389|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
823167|NCT00972283|2615390|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
823168|NCT00972283|2615389|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
823169|NCT00972283|2615390|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
823170|NCT00972283|2615389|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
823171|NCT00972283|2615390|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
823172|NCT00972283|2615389|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
823173|NCT00972283|2615390|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
823174|NCT00972322|2615414|P2|Overall Study|Consistently high glucose values|0
823175|NCT00972322|2615415|P1|Overall Study|Consistently high glucose values|1
823176|NCT00972322|2615414|P2|Overall Study|Lost to Follow-up|1
823177|NCT00972322|2615415|P1|Overall Study|Lost to Follow-up|0
823178|NCT00972322|2615414|P2|Overall Study|Positive drug screen|1
823179|NCT00972322|2615415|P1|Overall Study|Positive drug screen|0
823180|NCT00972322|2615414|P2|Overall Study|Adverse Event|1
823181|NCT00972322|2615415|P1|Overall Study|Adverse Event|2
893324|NCT01170663|2834017|P1|Overall Study|Alive on treatment at data cut-off date|13
893325|NCT01106027|2834068|P1|Overall Study|Withdrawal by Subject|1
893326|NCT01066000|2834085|P1|Overall Study|Adverse Event|1
893327|NCT01066000|2834085|P1|Overall Study|Withdrawal by Subject|1
893328|NCT01066000|2834085|P1|Overall Study|Death|3
893329|NCT01066000|2834085|P1|Overall Study|Protocol Violation|4
893330|NCT00976560|2834098|P2|Overall Study|Withdrawal by Subject|3
893331|NCT00976560|2834099|P1|Overall Study|Withdrawal by Subject|2
893332|NCT00976560|2834098|P2|Overall Study|Physician Decision|0
893333|NCT00976560|2834099|P1|Overall Study|Physician Decision|2
893334|NCT00976560|2834098|P2|Overall Study|Lost to Follow-up|0
893335|NCT00976560|2834099|P1|Overall Study|Lost to Follow-up|1
893336|NCT00976560|2834098|P2|Overall Study|Protocol Violation|0
823196|NCT00972504|2615462|P1|Overall Study|Investigator discretion|1
823197|NCT00972504|2615462|P1|Overall Study|Adverse Event|2
823198|NCT00972543|2615503|P2|Overall Study|Early study termination by sponsor|1
823199|NCT00972543|2615504|P1|Overall Study|Early study termination by sponsor|4
823200|NCT00972543|2615503|P2|Overall Study|Adverse Event|0
823201|NCT00972543|2615504|P1|Overall Study|Adverse Event|1
823202|NCT00972595|2615578|P2|Period 1|Adverse Event|0
823203|NCT00972595|2615579|P1|Period 1|Adverse Event|1
823204|NCT00972738|2615684|P3|Overall Study|Unspecified|1
823205|NCT00972738|2615685|P2|Overall Study|Unspecified|2
823206|NCT00972738|2615686|P1|Overall Study|Unspecified|1
823207|NCT00972738|2615684|P3|Overall Study|Moved|1
823208|NCT00972738|2615685|P2|Overall Study|Moved|0
823209|NCT00972738|2615686|P1|Overall Study|Moved|0
823210|NCT00972738|2615684|P3|Overall Study|Withdrawal by Subject|4
823211|NCT00972738|2615685|P2|Overall Study|Withdrawal by Subject|1
823212|NCT00972738|2615686|P1|Overall Study|Withdrawal by Subject|5
823213|NCT00972738|2615684|P3|Overall Study|Lack of Efficacy|11
823214|NCT00972738|2615685|P2|Overall Study|Lack of Efficacy|1
823215|NCT00972738|2615686|P1|Overall Study|Lack of Efficacy|5
823216|NCT00972738|2615684|P3|Overall Study|Lost to Follow-up|1
823217|NCT00972738|2615685|P2|Overall Study|Lost to Follow-up|0
823218|NCT00972738|2615686|P1|Overall Study|Lost to Follow-up|1
823219|NCT00972738|2615684|P3|Overall Study|Protocol Violation|3
823220|NCT00972738|2615685|P2|Overall Study|Protocol Violation|1
823221|NCT00972738|2615686|P1|Overall Study|Protocol Violation|2
823222|NCT00972738|2615684|P3|Overall Study|Adverse Event|8
823223|NCT00972738|2615685|P2|Overall Study|Adverse Event|1
823224|NCT00972738|2615686|P1|Overall Study|Adverse Event|7
823225|NCT00972777|2615711|P2|Overall Study|Missed visit|0
823226|NCT00972777|2615712|P1|Overall Study|Missed visit|1
823227|NCT00972777|2615711|P2|Overall Study|Screening Failure|1
823228|NCT00972777|2615712|P1|Overall Study|Screening Failure|2
823229|NCT00972777|2615711|P2|Overall Study|Protocol Violation|2
823230|NCT00972777|2615712|P1|Overall Study|Protocol Violation|0
823231|NCT00972777|2615711|P2|Overall Study|Physician Decision|0
823232|NCT00972777|2615712|P1|Overall Study|Physician Decision|4
823233|NCT00972777|2615711|P2|Overall Study|Withdrawal by Subject|5
823234|NCT00972777|2615712|P1|Overall Study|Withdrawal by Subject|4
823235|NCT00972777|2615711|P2|Overall Study|Lost to Follow-up|4
823236|NCT00972777|2615712|P1|Overall Study|Lost to Follow-up|0
823237|NCT00972777|2615711|P2|Overall Study|Adverse Event|2
823238|NCT00972777|2615712|P1|Overall Study|Adverse Event|3
823239|NCT00972816|2615732|P8|Overall Study|Unable to classify|0
823240|NCT00972816|2615733|P7|Overall Study|Unable to classify|0
823241|NCT00972816|2615734|P6|Overall Study|Unable to classify|0
823242|NCT00972816|2615735|P5|Overall Study|Unable to classify|1
823243|NCT00972816|2615736|P4|Overall Study|Unable to classify|0
823244|NCT00972816|2615737|P3|Overall Study|Unable to classify|0
823245|NCT00972816|2615738|P2|Overall Study|Unable to classify|0
823246|NCT00972816|2615739|P1|Overall Study|Unable to classify|2
823247|NCT00972816|2615732|P8|Overall Study|Inappropriate enrolment|0
823248|NCT00972816|2615733|P7|Overall Study|Inappropriate enrolment|2
823249|NCT00972816|2615734|P6|Overall Study|Inappropriate enrolment|0
823250|NCT00972816|2615735|P5|Overall Study|Inappropriate enrolment|0
823251|NCT00972816|2615736|P4|Overall Study|Inappropriate enrolment|0
823252|NCT00972816|2615737|P3|Overall Study|Inappropriate enrolment|0
823253|NCT00972816|2615738|P2|Overall Study|Inappropriate enrolment|0
823254|NCT00972816|2615739|P1|Overall Study|Inappropriate enrolment|0
823255|NCT00972816|2615732|P8|Overall Study|Lost to Follow-up|7
823256|NCT00972816|2615733|P7|Overall Study|Lost to Follow-up|7
823257|NCT00972816|2615734|P6|Overall Study|Lost to Follow-up|10
823258|NCT00972816|2615735|P5|Overall Study|Lost to Follow-up|11
823259|NCT00972816|2615736|P4|Overall Study|Lost to Follow-up|5
823260|NCT00972816|2615737|P3|Overall Study|Lost to Follow-up|7
823261|NCT00972816|2615738|P2|Overall Study|Lost to Follow-up|9
823262|NCT00972816|2615739|P1|Overall Study|Lost to Follow-up|11
823263|NCT00972816|2615732|P8|Overall Study|Withdrawal by Subject|2
823264|NCT00972816|2615733|P7|Overall Study|Withdrawal by Subject|1
823265|NCT00972816|2615734|P6|Overall Study|Withdrawal by Subject|1
823266|NCT00972816|2615735|P5|Overall Study|Withdrawal by Subject|0
823267|NCT00972816|2615736|P4|Overall Study|Withdrawal by Subject|3
823268|NCT00972816|2615737|P3|Overall Study|Withdrawal by Subject|1
823269|NCT00972816|2615738|P2|Overall Study|Withdrawal by Subject|2
823270|NCT00972816|2615739|P1|Overall Study|Withdrawal by Subject|4
823271|NCT00972816|2615732|P8|Overall Study|Adverse Event|0
823272|NCT00972816|2615733|P7|Overall Study|Adverse Event|0
823273|NCT00972816|2615734|P6|Overall Study|Adverse Event|0
823274|NCT00972816|2615735|P5|Overall Study|Adverse Event|0
823275|NCT00972816|2615736|P4|Overall Study|Adverse Event|0
823276|NCT00972816|2615737|P3|Overall Study|Adverse Event|1
823277|NCT00972816|2615738|P2|Overall Study|Adverse Event|0
823278|NCT00972816|2615739|P1|Overall Study|Adverse Event|0
823279|NCT00967330|2615838|P2|Overall Study|Severe protocol deviation|1
823280|NCT00967330|2615839|P1|Overall Study|Severe protocol deviation|0
823281|NCT00967330|2615838|P2|Overall Study|Death|51
823282|NCT00967330|2615839|P1|Overall Study|Death|102
823283|NCT00967330|2615838|P2|Overall Study|Lost to Follow-up|1
823284|NCT00967330|2615839|P1|Overall Study|Lost to Follow-up|1
823285|NCT00967330|2615838|P2|Overall Study|Withdrawal by Subject|0
823286|NCT00967330|2615839|P1|Overall Study|Withdrawal by Subject|6
823287|NCT00967330|2615838|P2|Overall Study|Regular|3
823288|NCT00967330|2615839|P1|Overall Study|Regular|10
823289|NCT00967330|2615838|P2|Overall Study|Protocol Violation|4
823290|NCT00967330|2615839|P1|Overall Study|Protocol Violation|3
823291|NCT00967668|2615903|P3|Overall Study|Pregnancy|0
823292|NCT00967668|2615904|P2|Overall Study|Pregnancy|0
823293|NCT00967668|2615905|P1|Overall Study|Pregnancy|1
823294|NCT00967668|2615903|P3|Overall Study|Refused 12-mo assessment|9
823295|NCT00967668|2615904|P2|Overall Study|Refused 12-mo assessment|1
823296|NCT00967668|2615905|P1|Overall Study|Refused 12-mo assessment|3
823297|NCT00967668|2615903|P3|Overall Study|Lost to Follow-up|16
823298|NCT00967668|2615904|P2|Overall Study|Lost to Follow-up|9
823299|NCT00967668|2615905|P1|Overall Study|Lost to Follow-up|15
823300|NCT00967668|2615903|P3|Overall Study|Lost to follow-up at 12-mo|26
823301|NCT00967668|2615904|P2|Overall Study|Lost to follow-up at 12-mo|29
823302|NCT00967668|2615905|P1|Overall Study|Lost to follow-up at 12-mo|27
823303|NCT00967668|2615903|P3|Overall Study|Refused Year 2|4
823304|NCT00967668|2615904|P2|Overall Study|Refused Year 2|6
823305|NCT00967668|2615905|P1|Overall Study|Refused Year 2|11
823306|NCT00967668|2615903|P3|Overall Study|Removed due to behavior|2
823307|NCT00967668|2615904|P2|Overall Study|Removed due to behavior|1
823308|NCT00967668|2615905|P1|Overall Study|Removed due to behavior|1
823309|NCT00967668|2615903|P3|Overall Study|Death|4
823310|NCT00967668|2615904|P2|Overall Study|Death|2
823311|NCT00967668|2615905|P1|Overall Study|Death|0
823312|NCT00967668|2615903|P3|Overall Study|Withdrawal by Subject|8
823313|NCT00967668|2615904|P2|Overall Study|Withdrawal by Subject|8
823314|NCT00967668|2615905|P1|Overall Study|Withdrawal by Subject|13
823315|NCT00967694|2615916|P1|Overall Study|Withdrawal by Subject|6
823316|NCT00973349|2615936|P16|Overall Study|Unable to classify|0
823317|NCT00973349|2615937|P15|Overall Study|Unable to classify|0
823318|NCT00973349|2615938|P14|Overall Study|Unable to classify|0
823319|NCT00973349|2615939|P13|Overall Study|Unable to classify|0
823320|NCT00973349|2615940|P12|Overall Study|Unable to classify|0
823321|NCT00973349|2615941|P11|Overall Study|Unable to classify|0
823322|NCT00973349|2615942|P10|Overall Study|Unable to classify|1
823323|NCT00973349|2615943|P9|Overall Study|Unable to classify|0
823324|NCT00973349|2615944|P8|Overall Study|Unable to classify|0
823325|NCT00973349|2615945|P7|Overall Study|Unable to classify|0
823326|NCT00973349|2615946|P6|Overall Study|Unable to classify|1
823327|NCT00973349|2615947|P5|Overall Study|Unable to classify|1
823328|NCT00973349|2615948|P4|Overall Study|Unable to classify|0
823329|NCT00973349|2615949|P3|Overall Study|Unable to classify|0
823330|NCT00973349|2615950|P2|Overall Study|Unable to classify|0
823331|NCT00973349|2615951|P1|Overall Study|Unable to classify|0
823332|NCT00973349|2615936|P16|Overall Study|Protocol Violation|0
823333|NCT00973349|2615937|P15|Overall Study|Protocol Violation|0
823334|NCT00973349|2615938|P14|Overall Study|Protocol Violation|0
823335|NCT00973349|2615939|P13|Overall Study|Protocol Violation|0
823336|NCT00973349|2615940|P12|Overall Study|Protocol Violation|0
823337|NCT00973349|2615941|P11|Overall Study|Protocol Violation|0
823338|NCT00973349|2615942|P10|Overall Study|Protocol Violation|0
823339|NCT00973349|2615943|P9|Overall Study|Protocol Violation|1
823340|NCT00973349|2615944|P8|Overall Study|Protocol Violation|0
823341|NCT00973349|2615945|P7|Overall Study|Protocol Violation|0
823342|NCT00973349|2615946|P6|Overall Study|Protocol Violation|0
823343|NCT00973349|2615947|P5|Overall Study|Protocol Violation|0
823344|NCT00973349|2615948|P4|Overall Study|Protocol Violation|0
823345|NCT00973349|2615949|P3|Overall Study|Protocol Violation|0
823346|NCT00973349|2615950|P2|Overall Study|Protocol Violation|0
823347|NCT00973349|2615951|P1|Overall Study|Protocol Violation|0
823348|NCT00973349|2615936|P16|Overall Study|Inappropriate enrolment|1
823349|NCT00973349|2615937|P15|Overall Study|Inappropriate enrolment|1
823350|NCT00973349|2615938|P14|Overall Study|Inappropriate enrolment|0
823351|NCT00973349|2615939|P13|Overall Study|Inappropriate enrolment|1
823352|NCT00973349|2615940|P12|Overall Study|Inappropriate enrolment|0
823353|NCT00973349|2615941|P11|Overall Study|Inappropriate enrolment|0
823354|NCT00973349|2615942|P10|Overall Study|Inappropriate enrolment|2
823355|NCT00973349|2615943|P9|Overall Study|Inappropriate enrolment|0
823356|NCT00973349|2615944|P8|Overall Study|Inappropriate enrolment|0
823357|NCT00973349|2615945|P7|Overall Study|Inappropriate enrolment|0
823358|NCT00973349|2615946|P6|Overall Study|Inappropriate enrolment|0
823359|NCT00973349|2615947|P5|Overall Study|Inappropriate enrolment|0
823360|NCT00973349|2615948|P4|Overall Study|Inappropriate enrolment|0
823361|NCT00973349|2615949|P3|Overall Study|Inappropriate enrolment|1
823362|NCT00973349|2615950|P2|Overall Study|Inappropriate enrolment|0
823363|NCT00973349|2615951|P1|Overall Study|Inappropriate enrolment|0
823364|NCT00973349|2615936|P16|Overall Study|Lost to Follow-up|1
823365|NCT00973349|2615937|P15|Overall Study|Lost to Follow-up|0
823366|NCT00973349|2615938|P14|Overall Study|Lost to Follow-up|0
823367|NCT00973349|2615939|P13|Overall Study|Lost to Follow-up|0
823368|NCT00973349|2615940|P12|Overall Study|Lost to Follow-up|1
823369|NCT00973349|2615941|P11|Overall Study|Lost to Follow-up|0
823370|NCT00973349|2615942|P10|Overall Study|Lost to Follow-up|1
823371|NCT00973349|2615943|P9|Overall Study|Lost to Follow-up|2
823372|NCT00973349|2615944|P8|Overall Study|Lost to Follow-up|1
823373|NCT00973349|2615945|P7|Overall Study|Lost to Follow-up|0
823374|NCT00973349|2615946|P6|Overall Study|Lost to Follow-up|3
823375|NCT00973349|2615947|P5|Overall Study|Lost to Follow-up|1
823376|NCT00973349|2615948|P4|Overall Study|Lost to Follow-up|2
823377|NCT00973349|2615949|P3|Overall Study|Lost to Follow-up|2
823378|NCT00973349|2615950|P2|Overall Study|Lost to Follow-up|1
823379|NCT00973349|2615951|P1|Overall Study|Lost to Follow-up|3
823380|NCT00973349|2615936|P16|Overall Study|Withdrawal by Subject|0
823381|NCT00973349|2615937|P15|Overall Study|Withdrawal by Subject|0
823382|NCT00973349|2615938|P14|Overall Study|Withdrawal by Subject|0
823383|NCT00973349|2615939|P13|Overall Study|Withdrawal by Subject|0
823384|NCT00973349|2615940|P12|Overall Study|Withdrawal by Subject|1
823385|NCT00973349|2615941|P11|Overall Study|Withdrawal by Subject|0
823386|NCT00973349|2615942|P10|Overall Study|Withdrawal by Subject|2
823387|NCT00973349|2615943|P9|Overall Study|Withdrawal by Subject|0
823388|NCT00973349|2615944|P8|Overall Study|Withdrawal by Subject|2
823389|NCT00973349|2615945|P7|Overall Study|Withdrawal by Subject|2
823390|NCT00973349|2615946|P6|Overall Study|Withdrawal by Subject|0
823391|NCT00973349|2615947|P5|Overall Study|Withdrawal by Subject|2
823392|NCT00973349|2615948|P4|Overall Study|Withdrawal by Subject|3
823393|NCT00973349|2615949|P3|Overall Study|Withdrawal by Subject|2
823394|NCT00973349|2615950|P2|Overall Study|Withdrawal by Subject|2
823395|NCT00973349|2615951|P1|Overall Study|Withdrawal by Subject|1
823396|NCT00973349|2615936|P16|Overall Study|Adverse Event|0
823397|NCT00973349|2615937|P15|Overall Study|Adverse Event|1
823398|NCT00973349|2615938|P14|Overall Study|Adverse Event|0
823399|NCT00973349|2615939|P13|Overall Study|Adverse Event|0
823400|NCT00973349|2615940|P12|Overall Study|Adverse Event|0
823401|NCT00973349|2615941|P11|Overall Study|Adverse Event|0
823402|NCT00973349|2615942|P10|Overall Study|Adverse Event|0
823403|NCT00973349|2615943|P9|Overall Study|Adverse Event|1
823404|NCT00973349|2615944|P8|Overall Study|Adverse Event|0
823405|NCT00973349|2615945|P7|Overall Study|Adverse Event|0
823406|NCT00973349|2615946|P6|Overall Study|Adverse Event|0
823407|NCT00973349|2615947|P5|Overall Study|Adverse Event|1
823408|NCT00973349|2615948|P4|Overall Study|Adverse Event|0
823409|NCT00973349|2615949|P3|Overall Study|Adverse Event|0
823410|NCT00973349|2615950|P2|Overall Study|Adverse Event|0
823411|NCT00973349|2615951|P1|Overall Study|Adverse Event|0
823412|NCT00973362|2616051|P2|3-Year Follow-up|Lost to Follow-up|0
823413|NCT00973362|2616052|P1|3-Year Follow-up|Lost to Follow-up|17
823414|NCT00973362|2616051|P2|Baseline Evaluation|Inevaluable|223
823415|NCT00973362|2616052|P1|Baseline Evaluation|Inevaluable|686
823416|NCT00973362|2616051|P2|Baseline Evaluation|No colposcopy visit|0
823417|NCT00973362|2616052|P1|Baseline Evaluation|No colposcopy visit|62
823418|NCT00973362|2616051|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
823419|NCT00973362|2616052|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
823420|NCT00975975|2616061|P1|Overall Study|Death|6
823421|NCT00976027|2616069|P2|Overall Study|Withdrawal by Subject|66
823422|NCT00976027|2616070|P1|Overall Study|Withdrawal by Subject|107
823423|NCT00976027|2616069|P2|Overall Study|Lost to Follow-up|103
823424|NCT00976027|2616070|P1|Overall Study|Lost to Follow-up|208
823425|NCT00976027|2616069|P2|Overall Study|Protocol Violation|27
823426|NCT00976027|2616070|P1|Overall Study|Protocol Violation|60
823427|NCT00976027|2616069|P2|Overall Study|Adverse Event|2
823428|NCT00976027|2616070|P1|Overall Study|Adverse Event|0
823429|NCT00976027|2616069|P2|Overall Study|Serious Adverse Event|17
823430|NCT00976027|2616070|P1|Overall Study|Serious Adverse Event|36
823431|NCT00976209|2616089|P2|Treatment Period 2|Lost to Follow-up|1
823432|NCT00976209|2616090|P1|Treatment Period 2|Lost to Follow-up|0
823433|NCT00976209|2616089|P2|Treatment Period 2|Withdrawal by Subject|1
823434|NCT00976209|2616090|P1|Treatment Period 2|Withdrawal by Subject|0
823435|NCT00976209|2616089|P2|Wash-out Period|Unspecified|0
823436|NCT00976209|2616090|P1|Wash-out Period|Unspecified|1
823437|NCT00976209|2616089|P2|Wash-out Period|Protocol Violation|0
823438|NCT00976209|2616090|P1|Wash-out Period|Protocol Violation|1
823439|NCT00976209|2616089|P2|Wash-out Period|Lost to Follow-up|0
823440|NCT00976209|2616090|P1|Wash-out Period|Lost to Follow-up|1
823441|NCT00976209|2616089|P2|Wash-out Period|Adverse Event|2
823442|NCT00976209|2616090|P1|Wash-out Period|Adverse Event|1
823443|NCT00976209|2616089|P2|Treatment Period 1|Unspecified|1
823444|NCT00976209|2616090|P1|Treatment Period 1|Unspecified|0
823445|NCT00976209|2616089|P2|Treatment Period 1|Lost to Follow-up|0
823446|NCT00976209|2616090|P1|Treatment Period 1|Lost to Follow-up|2
823447|NCT00976209|2616089|P2|Treatment Period 1|Protocol Violation|0
823448|NCT00976209|2616090|P1|Treatment Period 1|Protocol Violation|1
823449|NCT00976274|2616104|P2|Overall Study|Physician Decision|2
823450|NCT00976274|2616105|P1|Overall Study|Physician Decision|1
823451|NCT00976274|2616104|P2|Overall Study|Withdrawal by Subject|1
823452|NCT00976274|2616105|P1|Overall Study|Withdrawal by Subject|1
823453|NCT00976274|2616104|P2|Overall Study|Lost to Follow-up|5
823454|NCT00976274|2616105|P1|Overall Study|Lost to Follow-up|5
823455|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
823456|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
823457|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
823458|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
823459|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
823460|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
823461|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
823462|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
823463|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Noncompliance|2
823464|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Noncompliance|2
823465|NCT00976391|2616126|P2|Follow-up Period (8 Weeks)|Adverse Event|1
823466|NCT00976391|2616127|P1|Follow-up Period (8 Weeks)|Adverse Event|3
823467|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Pregnancy|0
823468|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Pregnancy|1
823469|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
823470|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
823471|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Physician Decision|1
823472|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Physician Decision|1
823473|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
823474|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
823475|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
823476|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
823477|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Noncompliance|4
823478|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Noncompliance|4
823479|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Protocol Violation|1
823480|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Protocol Violation|1
823481|NCT00976391|2616126|P2|Treatment Period (52 Weeks)|Adverse Event|2
823482|NCT00976391|2616127|P1|Treatment Period (52 Weeks)|Adverse Event|16
823483|NCT00976456|2616166|P2|Overall Study|screening failure, unknown|4
823484|NCT00976456|2616167|P1|Overall Study|screening failure, unknown|11
823485|NCT00976456|2616166|P2|Overall Study|Withdrawal by Subject|1
823486|NCT00976456|2616167|P1|Overall Study|Withdrawal by Subject|3
823487|NCT00976456|2616166|P2|Overall Study|Lack of Efficacy|2
823488|NCT00976456|2616167|P1|Overall Study|Lack of Efficacy|5
823489|NCT00976456|2616166|P2|Overall Study|Death|9
823490|NCT00976456|2616167|P1|Overall Study|Death|7
823491|NCT00976456|2616166|P2|Overall Study|Adverse Event|22
823492|NCT00976456|2616167|P1|Overall Study|Adverse Event|17
823493|NCT00976482|2616175|P1|Overall Study|Protocol Violation|5
823494|NCT00976482|2616175|P1|Overall Study|Center terminated|1
823495|NCT00976482|2616175|P1|Overall Study|Withdrawal by Subject|45
823496|NCT00976482|2616175|P1|Overall Study|Death|208
823497|NCT00976495|2616182|P3|Overall Study|Withdrawal by Subject|0
823498|NCT00976495|2616183|P2|Overall Study|Withdrawal by Subject|1
823499|NCT00976495|2616184|P1|Overall Study|Withdrawal by Subject|0
823500|NCT00976508|2616203|P2|Overall Study|Terminated by the Sponsor|1
823501|NCT00976508|2616204|P1|Overall Study|Terminated by the Sponsor|0
823502|NCT00976508|2616203|P2|Overall Study|Subject Enrolled in Hospice|0
823503|NCT00976508|2616204|P1|Overall Study|Subject Enrolled in Hospice|1
823504|NCT00976508|2616203|P2|Overall Study|Disease Progression|4
823505|NCT00976508|2616204|P1|Overall Study|Disease Progression|4
823506|NCT00976508|2616203|P2|Overall Study|Withdrawal by Subject|0
823507|NCT00976508|2616204|P1|Overall Study|Withdrawal by Subject|1
823508|NCT00976508|2616203|P2|Overall Study|Lost to Follow-up|0
823509|NCT00976508|2616204|P1|Overall Study|Lost to Follow-up|1
823510|NCT00976508|2616203|P2|Overall Study|Death|1
823511|NCT00976508|2616204|P1|Overall Study|Death|7
823512|NCT00976573|2616255|P2|Overall Study|Cancel prior to receiving treatment|2
823513|NCT00976573|2616256|P1|Overall Study|Cancel prior to receiving treatment|4
823514|NCT00976573|2616255|P2|Overall Study|Ineligible|1
823515|NCT00976573|2616256|P1|Overall Study|Ineligible|0
823516|NCT00976677|2616470|P2|Overall Study|Unknown/Missing|0
823517|NCT00976677|2616471|P1|Overall Study|Unknown/Missing|1
823518|NCT00976677|2616470|P2|Overall Study|Trial unblinded|2
823519|NCT00976677|2616471|P1|Overall Study|Trial unblinded|2
823520|NCT00976677|2616470|P2|Overall Study|Disease progression|1
823521|NCT00976677|2616471|P1|Overall Study|Disease progression|1
823522|NCT00976677|2616470|P2|Overall Study|Withdrawal by Subject|2
823523|NCT00976677|2616471|P1|Overall Study|Withdrawal by Subject|0
823524|NCT00976677|2616470|P2|Overall Study|Adverse Event|0
823525|NCT00976677|2616471|P1|Overall Study|Adverse Event|1
823526|NCT00976703|2616479|P2|Overall Study|ineligible for study|2
823527|NCT00976703|2616480|P1|Overall Study|ineligible for study|2
823528|NCT00976703|2616479|P2|Overall Study|Physician Decision|1
823529|NCT00976703|2616480|P1|Overall Study|Physician Decision|1
823530|NCT00976716|2616492|P1|Overall Study|Adverse Event|1
823531|NCT00976911|2616510|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
823532|NCT00976911|2616511|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
823533|NCT00976911|2616510|P2|Overall Study|Not Specified|9
823534|NCT00976911|2616511|P1|Overall Study|Not Specified|8
823535|NCT00976911|2616510|P2|Overall Study|Protocol Violation|0
823536|NCT00976911|2616511|P1|Overall Study|Protocol Violation|2
823537|NCT00976911|2616510|P2|Overall Study|Adverse Event|1
823538|NCT00976911|2616511|P1|Overall Study|Adverse Event|0
823539|NCT00976911|2616510|P2|Overall Study|Death|126
823540|NCT00976911|2616511|P1|Overall Study|Death|138
823541|NCT00976911|2616510|P2|Overall Study|Withdrawal by Subject|6
823542|NCT00976911|2616511|P1|Overall Study|Withdrawal by Subject|4
823543|NCT00976937|2616531|P2|Overall Study|Personal and Familial Reason|2
823544|NCT00976937|2616532|P1|Overall Study|Personal and Familial Reason|2
823545|NCT00976937|2616531|P2|Overall Study|Poor compliance to protocol|0
823546|NCT00976937|2616532|P1|Overall Study|Poor compliance to protocol|3
823547|NCT00976937|2616531|P2|Overall Study|Withdrawal by Subject|3
823548|NCT00976937|2616532|P1|Overall Study|Withdrawal by Subject|5
823549|NCT00976937|2616531|P2|Overall Study|Lost to Follow-up|1
823550|NCT00976937|2616532|P1|Overall Study|Lost to Follow-up|2
823551|NCT00976937|2616531|P2|Overall Study|Adverse Event|5
823552|NCT00976937|2616532|P1|Overall Study|Adverse Event|4
823553|NCT00976950|2616572|P1|Overall Study|Events with no relationship to Aptivus|3
823554|NCT00976950|2616572|P1|Overall Study|Adverse Event|3
823555|NCT00976989|2616581|P3|Overall Study|Unspecified|1
823556|NCT00976989|2616582|P2|Overall Study|Unspecified|0
823557|NCT00976989|2616583|P1|Overall Study|Unspecified|1
823558|NCT00976989|2616581|P3|Overall Study|Recurrence of Disease|0
823559|NCT00976989|2616582|P2|Overall Study|Recurrence of Disease|1
823560|NCT00976989|2616583|P1|Overall Study|Recurrence of Disease|0
823561|NCT00976989|2616581|P3|Overall Study|Failure to Return|0
823562|NCT00976989|2616582|P2|Overall Study|Failure to Return|1
823563|NCT00976989|2616583|P1|Overall Study|Failure to Return|2
823564|NCT00976989|2616581|P3|Overall Study|Refused Treatment|5
823565|NCT00976989|2616582|P2|Overall Study|Refused Treatment|3
823566|NCT00976989|2616583|P1|Overall Study|Refused Treatment|4
823567|NCT00976989|2616581|P3|Overall Study|Death|10
823568|NCT00976989|2616582|P2|Overall Study|Death|7
823569|NCT00976989|2616583|P1|Overall Study|Death|5
823570|NCT00976989|2616581|P3|Overall Study|Violation of Selection Criteria at Entry|1
823571|NCT00976989|2616582|P2|Overall Study|Violation of Selection Criteria at Entry|0
823572|NCT00976989|2616583|P1|Overall Study|Violation of Selection Criteria at Entry|1
823573|NCT00977080|2616628|P4|Overall Study|Travel for family reasons|0
823574|NCT00977080|2616629|P3|Overall Study|Travel for family reasons|0
823575|NCT00977080|2616630|P2|Overall Study|Travel for family reasons|0
823576|NCT00977080|2616631|P1|Overall Study|Travel for family reasons|1
823577|NCT00977080|2616628|P4|Overall Study|Required kidney transplantation|1
823578|NCT00977080|2616629|P3|Overall Study|Required kidney transplantation|3
823579|NCT00977080|2616630|P2|Overall Study|Required kidney transplantation|3
823580|NCT00977080|2616631|P1|Overall Study|Required kidney transplantation|1
823581|NCT00977080|2616628|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
823582|NCT00977080|2616629|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
823583|NCT00977080|2616630|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
823584|NCT00977080|2616631|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
823585|NCT00977080|2616628|P4|Overall Study|Noncompliance|0
823586|NCT00977080|2616629|P3|Overall Study|Noncompliance|1
823587|NCT00977080|2616630|P2|Overall Study|Noncompliance|2
823588|NCT00977080|2616631|P1|Overall Study|Noncompliance|0
823589|NCT00977080|2616628|P4|Overall Study|Protocol Violation|3
823590|NCT00977080|2616629|P3|Overall Study|Protocol Violation|4
823591|NCT00977080|2616630|P2|Overall Study|Protocol Violation|3
823592|NCT00977080|2616631|P1|Overall Study|Protocol Violation|7
823593|NCT00977080|2616628|P4|Overall Study|Withdrawal by Subject|5
823594|NCT00977080|2616629|P3|Overall Study|Withdrawal by Subject|1
823595|NCT00977080|2616630|P2|Overall Study|Withdrawal by Subject|5
823596|NCT00977080|2616631|P1|Overall Study|Withdrawal by Subject|1
823597|NCT00977080|2616628|P4|Overall Study|Adverse Event|7
823598|NCT00977080|2616629|P3|Overall Study|Adverse Event|7
823599|NCT00977080|2616630|P2|Overall Study|Adverse Event|7
823600|NCT00977080|2616631|P1|Overall Study|Adverse Event|2
823601|NCT00977106|2616663|P2|Overall Study|Not specified|0
823602|NCT00977106|2616664|P1|Overall Study|Not specified|1
823603|NCT00977106|2616663|P2|Overall Study|Protocol Violation|1
823604|NCT00977106|2616664|P1|Overall Study|Protocol Violation|0
823605|NCT00977106|2616663|P2|Overall Study|Lack of Efficacy|2
823606|NCT00977106|2616664|P1|Overall Study|Lack of Efficacy|2
823607|NCT00977106|2616663|P2|Overall Study|Withdrawal by Subject|2
823608|NCT00977106|2616664|P1|Overall Study|Withdrawal by Subject|2
823609|NCT00977106|2616663|P2|Overall Study|Adverse Event|6
823610|NCT00977106|2616664|P1|Overall Study|Adverse Event|5
823611|NCT00977197|2616787|P2|Overall Study|Nonadherence|1
823612|NCT00977197|2616788|P1|Overall Study|Nonadherence|1
823613|NCT00977197|2616787|P2|Overall Study|Lost to Follow-up|3
823614|NCT00977197|2616788|P1|Overall Study|Lost to Follow-up|1
823615|NCT00977197|2616787|P2|Overall Study|Lack of Efficacy|0
823616|NCT00977197|2616788|P1|Overall Study|Lack of Efficacy|1
823617|NCT00977197|2616787|P2|Overall Study|Adverse Event|1
823618|NCT00977197|2616788|P1|Overall Study|Adverse Event|3
823619|NCT00977197|2616787|P2|Overall Study|Withdrawal by Subject|4
823620|NCT00977197|2616788|P1|Overall Study|Withdrawal by Subject|3
823621|NCT00977314|2616818|P2|Overall Study|Physician Decision|0
823622|NCT00977314|2616819|P1|Overall Study|Physician Decision|1
823623|NCT00977314|2616818|P2|Overall Study|Withdrawal by Subject|0
823624|NCT00977314|2616819|P1|Overall Study|Withdrawal by Subject|1
823625|NCT00977379|2616827|P2|Overall Study|Randomization Error|1
823626|NCT00977379|2616828|P1|Overall Study|Randomization Error|0
823627|NCT00977379|2616827|P2|Overall Study|Participant Moving House|1
823628|NCT00977379|2616828|P1|Overall Study|Participant Moving House|0
823629|NCT00977379|2616827|P2|Overall Study|Premature Study Termination|0
823630|NCT00977379|2616828|P1|Overall Study|Premature Study Termination|4
823631|NCT00977379|2616827|P2|Overall Study|Death|9
823632|NCT00977379|2616828|P1|Overall Study|Death|7
823633|NCT00977379|2616827|P2|Overall Study|Withdrawal by Subject|1
823634|NCT00977379|2616828|P1|Overall Study|Withdrawal by Subject|1
823635|NCT00977470|2616864|P2|Overall Study|Still on-study|0
823636|NCT00977470|2616865|P1|Overall Study|Still on-study|2
823637|NCT00977470|2616864|P2|Overall Study|prolonged recovery post-surgery|1
823638|NCT00977470|2616865|P1|Overall Study|prolonged recovery post-surgery|0
823639|NCT00977470|2616864|P2|Overall Study|clinical decline|1
823640|NCT00977470|2616865|P1|Overall Study|clinical decline|0
823641|NCT00977470|2616864|P2|Overall Study|Death|2
823642|NCT00977470|2616865|P1|Overall Study|Death|0
823643|NCT00977470|2616864|P2|Overall Study|Withdrawal by Subject|2
823644|NCT00977470|2616865|P1|Overall Study|Withdrawal by Subject|0
823645|NCT00977470|2616864|P2|Overall Study|Protocol Violation|0
823646|NCT00977470|2616865|P1|Overall Study|Protocol Violation|1
823647|NCT00977470|2616864|P2|Overall Study|Adverse Event|2
823648|NCT00977470|2616865|P1|Overall Study|Adverse Event|1
823649|NCT00977470|2616864|P2|Overall Study|Physician Decision|0
823650|NCT00977470|2616865|P1|Overall Study|Physician Decision|2
823651|NCT00977470|2616864|P2|Overall Study|Lack of Efficacy|30
823652|NCT00977470|2616865|P1|Overall Study|Lack of Efficacy|32
823653|NCT00977548|2616883|P1|Overall Study|Withdrawal by Subject|1
823654|NCT00977548|2616883|P1|Overall Study|Adverse Event|8
823655|NCT00977548|2616883|P1|Overall Study|Ineligible|4
823656|NCT00977561|2616892|P2|Overall Study|Unspecified|0
823657|NCT00977561|2616893|P1|Overall Study|Unspecified|2
823658|NCT00977561|2616892|P2|Overall Study|Study terminated|2
823659|NCT00977561|2616893|P1|Overall Study|Study terminated|0
823660|NCT00977561|2616892|P2|Overall Study|Death|2
823661|NCT00977561|2616893|P1|Overall Study|Death|3
823662|NCT00977613|2616920|P1|Overall Study|Lost to Follow-up|16
823663|NCT00977665|2616926|P2|Overall Study|Treatment failure|1
823664|NCT00977665|2616927|P1|Overall Study|Treatment failure|0
823665|NCT00977665|2616926|P2|Overall Study|Adverse Event|7
823666|NCT00977665|2616927|P1|Overall Study|Adverse Event|14
823667|NCT00977665|2616926|P2|Overall Study|Death|2
823668|NCT00977665|2616927|P1|Overall Study|Death|3
823669|NCT00977665|2616926|P2|Overall Study|Lost to Follow-up|0
823670|NCT00977665|2616927|P1|Overall Study|Lost to Follow-up|1
823671|NCT00977665|2616926|P2|Overall Study|Sponsor requested withdrawal|1
823672|NCT00977665|2616927|P1|Overall Study|Sponsor requested withdrawal|0
823673|NCT00977665|2616926|P2|Overall Study|Physician Decision|1
823674|NCT00977665|2616927|P1|Overall Study|Physician Decision|2
823675|NCT00977665|2616926|P2|Overall Study|Withdrawal by Subject|3
823676|NCT00977665|2616927|P1|Overall Study|Withdrawal by Subject|1
823677|NCT00977938|2616991|P4|Observation (30-33 mo. Post Procedure)|Other|0
823678|NCT00977938|2616992|P3|Observation (30-33 mo. Post Procedure)|Other|0
823679|NCT00977938|2616993|P2|Observation (30-33 mo. Post Procedure)|Other|4
823680|NCT00977938|2616994|P1|Observation (30-33 mo. Post Procedure)|Other|8
823681|NCT00977938|2616991|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
823682|NCT00977938|2616992|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
823683|NCT00977938|2616993|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
823684|NCT00977938|2616994|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
823685|NCT00977938|2616991|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
823686|NCT00977938|2616992|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
823687|NCT00977938|2616993|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
823688|NCT00977938|2616994|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
823689|NCT00977938|2616991|P4|Treatment (12-30 mo. Post Procedure)|Other|4
823690|NCT00977938|2616992|P3|Treatment (12-30 mo. Post Procedure)|Other|3
823691|NCT00977938|2616993|P2|Treatment (12-30 mo. Post Procedure)|Other|18
823692|NCT00977938|2616994|P1|Treatment (12-30 mo. Post Procedure)|Other|17
823693|NCT00977938|2616991|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
823694|NCT00977938|2616992|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
823695|NCT00977938|2616993|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
823696|NCT00977938|2616994|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
823697|NCT00977938|2616991|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
823698|NCT00977938|2616992|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
823699|NCT00977938|2616993|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
823700|NCT00977938|2616994|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
823701|NCT00978029|2617031|P3|Overall Study|Protocol Violation|0
823702|NCT00978029|2617032|P2|Overall Study|Protocol Violation|1
823703|NCT00978029|2617033|P1|Overall Study|Protocol Violation|0
823704|NCT00978029|2617031|P3|Overall Study|Withdrawal by Subject|1
823705|NCT00978029|2617032|P2|Overall Study|Withdrawal by Subject|0
823706|NCT00978029|2617033|P1|Overall Study|Withdrawal by Subject|0
823707|NCT00978029|2617031|P3|Overall Study|Adverse Event|5
823708|NCT00978029|2617032|P2|Overall Study|Adverse Event|2
823709|NCT00978029|2617033|P1|Overall Study|Adverse Event|1
823710|NCT00978042|2617058|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
823711|NCT00978042|2617059|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
823712|NCT00978042|2617058|P2|Initial Treatment Period|Consent withdrawn|9
823713|NCT00978042|2617059|P1|Initial Treatment Period|Consent withdrawn|22
823714|NCT00978042|2617058|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
823715|NCT00978042|2617059|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
823716|NCT00978042|2617058|P2|Initial Treatment Period|Adverse Event|0
823717|NCT00978042|2617059|P1|Initial Treatment Period|Adverse Event|2
823718|NCT00978042|2617058|P2|Initial Treatment Period|Lost to Follow-up|3
823719|NCT00978042|2617059|P1|Initial Treatment Period|Lost to Follow-up|21
823720|NCT00978042|2617058|P2|Initial Treatment Period|Ineligibility|0
823721|NCT00978042|2617059|P1|Initial Treatment Period|Ineligibility|1
823722|NCT00978042|2617058|P2|Initial Treatment Period|Treated in Error|3
823723|NCT00978042|2617059|P1|Initial Treatment Period|Treated in Error|0
823724|NCT00978120|2617073|P4|Overall Study|Moved out of state|1
823725|NCT00978120|2617074|P3|Overall Study|Moved out of state|0
823726|NCT00978120|2617075|P2|Overall Study|Moved out of state|0
823727|NCT00978120|2617076|P1|Overall Study|Moved out of state|0
823728|NCT00978120|2617073|P4|Overall Study|Withdrawal by Subject|0
823729|NCT00978120|2617074|P3|Overall Study|Withdrawal by Subject|0
823730|NCT00978120|2617075|P2|Overall Study|Withdrawal by Subject|0
823731|NCT00978120|2617076|P1|Overall Study|Withdrawal by Subject|2
823732|NCT00978120|2617073|P4|Overall Study|Lost to Follow-up|0
823733|NCT00978120|2617074|P3|Overall Study|Lost to Follow-up|3
823734|NCT00978120|2617075|P2|Overall Study|Lost to Follow-up|0
823735|NCT00978120|2617076|P1|Overall Study|Lost to Follow-up|0
823736|NCT00978120|2617073|P4|Overall Study|Death|1
823737|NCT00978120|2617074|P3|Overall Study|Death|0
823738|NCT00978120|2617075|P2|Overall Study|Death|0
823739|NCT00978120|2617076|P1|Overall Study|Death|0
823740|NCT00978341|2617126|P2|Washout Period of 2 Weeks|Adverse Event|0
823741|NCT00978341|2617127|P1|Washout Period of 2 Weeks|Adverse Event|1
823742|NCT00978380|2617145|P1|Overall Study|Unclassified|8
823743|NCT00978380|2617145|P1|Overall Study|Withdrawal criteria|9
823744|NCT00978380|2617145|P1|Overall Study|Protocol Violation|2
823745|NCT00978432|2617154|P3|Overall Study|Adverse Event|1
823746|NCT00978432|2617155|P2|Overall Study|Adverse Event|0
823747|NCT00978432|2617156|P1|Overall Study|Adverse Event|2
823748|NCT00978432|2617154|P3|Overall Study|Lack of Efficacy|3
823749|NCT00978432|2617155|P2|Overall Study|Lack of Efficacy|1
823750|NCT00978432|2617156|P1|Overall Study|Lack of Efficacy|1
823751|NCT00978432|2617154|P3|Overall Study|Withdrawal by Subject|1
823752|NCT00978432|2617155|P2|Overall Study|Withdrawal by Subject|0
823753|NCT00978432|2617156|P1|Overall Study|Withdrawal by Subject|0
823754|NCT00978627|2617191|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
823755|NCT00978627|2617192|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
823756|NCT00978627|2617191|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
823757|NCT00978627|2617192|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
823758|NCT00978627|2617191|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
823759|NCT00978627|2617192|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
823760|NCT00978627|2617191|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
823761|NCT00978627|2617192|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
823762|NCT00978627|2617191|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
823763|NCT00978627|2617192|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
823764|NCT00978627|2617191|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
823765|NCT00978627|2617192|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
823766|NCT00978627|2617191|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
823767|NCT00978627|2617192|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
823768|NCT00978627|2617191|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
823769|NCT00978627|2617192|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
823770|NCT00978627|2617191|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
823771|NCT00978627|2617192|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
823772|NCT00978731|2617218|P4|Overall Study|No response|0
823773|NCT00978731|2617219|P3|Overall Study|No response|0
823774|NCT00978731|2617220|P2|Overall Study|No response|0
823775|NCT00978731|2617221|P1|Overall Study|No response|1
823776|NCT00978731|2617218|P4|Overall Study|Study closure|1
823777|NCT00978731|2617219|P3|Overall Study|Study closure|1
823778|NCT00978731|2617220|P2|Overall Study|Study closure|4
823779|NCT00978731|2617221|P1|Overall Study|Study closure|3
823780|NCT00978731|2617218|P4|Overall Study|Disease progression/relapse|2
823781|NCT00978731|2617219|P3|Overall Study|Disease progression/relapse|2
823782|NCT00978731|2617220|P2|Overall Study|Disease progression/relapse|4
823783|NCT00978731|2617221|P1|Overall Study|Disease progression/relapse|5
823784|NCT00978731|2617218|P4|Overall Study|Deterioration without progression|0
823785|NCT00978731|2617219|P3|Overall Study|Deterioration without progression|0
823786|NCT00978731|2617220|P2|Overall Study|Deterioration without progression|1
823787|NCT00978731|2617221|P1|Overall Study|Deterioration without progression|0
823788|NCT00978731|2617218|P4|Overall Study|Administrative reason|0
823789|NCT00978731|2617219|P3|Overall Study|Administrative reason|1
823790|NCT00978731|2617220|P2|Overall Study|Administrative reason|3
823791|NCT00978731|2617221|P1|Overall Study|Administrative reason|3
823792|NCT00978731|2617218|P4|Overall Study|Participant's request|0
823793|NCT00978731|2617219|P3|Overall Study|Participant's request|0
823794|NCT00978731|2617220|P2|Overall Study|Participant's request|0
823795|NCT00978731|2617221|P1|Overall Study|Participant's request|1
823796|NCT00978731|2617218|P4|Overall Study|Adverse Event|0
823797|NCT00978731|2617219|P3|Overall Study|Adverse Event|0
823798|NCT00978731|2617220|P2|Overall Study|Adverse Event|2
823799|NCT00978731|2617221|P1|Overall Study|Adverse Event|5
823800|NCT00978731|2617218|P4|Overall Study|Lost to Follow-up|1
823801|NCT00978731|2617219|P3|Overall Study|Lost to Follow-up|0
823802|NCT00978731|2617220|P2|Overall Study|Lost to Follow-up|0
823803|NCT00978731|2617221|P1|Overall Study|Lost to Follow-up|0
823804|NCT00978731|2617218|P4|Overall Study|Death|0
823805|NCT00978731|2617219|P3|Overall Study|Death|1
823806|NCT00978731|2617220|P2|Overall Study|Death|1
823807|NCT00978731|2617221|P1|Overall Study|Death|4
823808|NCT00978757|2617261|P2|Overall Study|Physician Decision|3
823809|NCT00978757|2617262|P1|Overall Study|Physician Decision|1
823810|NCT00979212|2617310|P2|Overall Study|No protocol therapy received|0
823811|NCT00979212|2617311|P1|Overall Study|No protocol therapy received|1
823812|NCT00979212|2617310|P2|Overall Study|Protocol Violation|8
823813|NCT00979212|2617311|P1|Overall Study|Protocol Violation|1
823814|NCT00979420|2617333|P4|Overall Study|Other reasons not related to Viramune|1
823815|NCT00979420|2617334|P3|Overall Study|Other reasons not related to Viramune|0
823816|NCT00979420|2617335|P2|Overall Study|Other reasons not related to Viramune|0
823817|NCT00979420|2617336|P1|Overall Study|Other reasons not related to Viramune|3
823818|NCT00979420|2617333|P4|Overall Study|Lack of Efficacy|1
823819|NCT00979420|2617334|P3|Overall Study|Lack of Efficacy|1
823820|NCT00979420|2617335|P2|Overall Study|Lack of Efficacy|0
823821|NCT00979420|2617336|P1|Overall Study|Lack of Efficacy|3
823822|NCT00979420|2617333|P4|Overall Study|Adverse Event|0
823823|NCT00979420|2617334|P3|Overall Study|Adverse Event|0
823824|NCT00979420|2617335|P2|Overall Study|Adverse Event|0
823825|NCT00979420|2617336|P1|Overall Study|Adverse Event|1
823826|NCT00979576|2617420|P3|Combination Followed by Monotherapy|Progressive Disease|1
823827|NCT00979576|2617421|P2|Combination Followed by Monotherapy|Progressive Disease|2
823828|NCT00979576|2617422|P1|Combination Followed by Monotherapy|Progressive Disease|0
823829|NCT00979576|2617420|P3|Combination Treatment Phase|Adverse Event|2
823830|NCT00979576|2617421|P2|Combination Treatment Phase|Adverse Event|2
823831|NCT00979576|2617422|P1|Combination Treatment Phase|Adverse Event|0
823832|NCT00979576|2617420|P3|Combination Treatment Phase|Dose limiting toxicity|2
823833|NCT00979576|2617421|P2|Combination Treatment Phase|Dose limiting toxicity|3
823834|NCT00979576|2617422|P1|Combination Treatment Phase|Dose limiting toxicity|0
823835|NCT00979576|2617420|P3|Combination Treatment Phase|Progressive disease|5
823836|NCT00979576|2617421|P2|Combination Treatment Phase|Progressive disease|1
823837|NCT00979576|2617422|P1|Combination Treatment Phase|Progressive disease|3
823850|NCT00979628|2617644|P3|Overall Study|transferred to ICU|1
823851|NCT00979628|2617645|P2|Overall Study|transferred to ICU|2
823852|NCT00979628|2617646|P1|Overall Study|transferred to ICU|1
823853|NCT00979628|2617644|P3|Overall Study|received steroids|0
823854|NCT00979628|2617645|P2|Overall Study|received steroids|1
823855|NCT00979628|2617646|P1|Overall Study|received steroids|1
823856|NCT00979628|2617644|P3|Overall Study|received regimen < 24 hours|5
823857|NCT00979628|2617645|P2|Overall Study|received regimen < 24 hours|6
823858|NCT00979628|2617646|P1|Overall Study|received regimen < 24 hours|7
823859|NCT00979654|2617654|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
823860|NCT00979654|2617654|P1|Overall Study|Serious Adverse Event|1
823861|NCT00979654|2617654|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
823862|NCT00979654|2617654|P1|Overall Study|Per Principal Investigator’s Discretion|1
823863|NCT00979654|2617654|P1|Overall Study|Adverse Event of Diverticulitis|1
823864|NCT00979654|2617654|P1|Overall Study|Adverse Event|1
823865|NCT00979654|2617654|P1|Overall Study|Lack of Efficacy|6
823866|NCT00979654|2617654|P1|Overall Study|Death|1
823867|NCT00979654|2617654|P1|Overall Study|Withdrawal by Subject|22
823868|NCT00979654|2617654|P1|Overall Study|Lost to Follow-up|1
823869|NCT00979901|2617719|P4|Overall Study|Treatment Group Terminated by Sponsor|112
823870|NCT00979901|2617720|P3|Overall Study|Treatment Group Terminated by Sponsor|0
823871|NCT00979901|2617721|P2|Overall Study|Treatment Group Terminated by Sponsor|0
823872|NCT00979901|2617722|P1|Overall Study|Treatment Group Terminated by Sponsor|0
823873|NCT00979901|2617719|P4|Overall Study|Left Country|0
823874|NCT00979901|2617720|P3|Overall Study|Left Country|1
823875|NCT00979901|2617721|P2|Overall Study|Left Country|0
823876|NCT00979901|2617722|P1|Overall Study|Left Country|0
823877|NCT00979901|2617719|P4|Overall Study|Discontinued in Error|0
823878|NCT00979901|2617720|P3|Overall Study|Discontinued in Error|0
823879|NCT00979901|2617721|P2|Overall Study|Discontinued in Error|1
823880|NCT00979901|2617722|P1|Overall Study|Discontinued in Error|0
823881|NCT00979901|2617719|P4|Overall Study|elevated lab values pre-randomization|0
823882|NCT00979901|2617720|P3|Overall Study|elevated lab values pre-randomization|0
823883|NCT00979901|2617721|P2|Overall Study|elevated lab values pre-randomization|0
823884|NCT00979901|2617722|P1|Overall Study|elevated lab values pre-randomization|1
823885|NCT00979901|2617719|P4|Overall Study|vacation|0
823886|NCT00979901|2617720|P3|Overall Study|vacation|0
823887|NCT00979901|2617721|P2|Overall Study|vacation|0
823888|NCT00979901|2617722|P1|Overall Study|vacation|1
823889|NCT00979901|2617719|P4|Overall Study|out-of-state|0
823890|NCT00979901|2617720|P3|Overall Study|out-of-state|0
823891|NCT00979901|2617721|P2|Overall Study|out-of-state|0
823892|NCT00979901|2617722|P1|Overall Study|out-of-state|1
823893|NCT00979901|2617719|P4|Overall Study|Noncompliance|0
823894|NCT00979901|2617720|P3|Overall Study|Noncompliance|0
823895|NCT00979901|2617721|P2|Overall Study|Noncompliance|0
823896|NCT00979901|2617722|P1|Overall Study|Noncompliance|1
823897|NCT00979901|2617719|P4|Overall Study|Withdrawal by Subject|1
823898|NCT00979901|2617720|P3|Overall Study|Withdrawal by Subject|1
823899|NCT00979901|2617721|P2|Overall Study|Withdrawal by Subject|1
823900|NCT00979901|2617722|P1|Overall Study|Withdrawal by Subject|2
823901|NCT00979901|2617719|P4|Overall Study|Protocol Violation|1
823902|NCT00979901|2617720|P3|Overall Study|Protocol Violation|7
823903|NCT00979901|2617721|P2|Overall Study|Protocol Violation|2
823904|NCT00979901|2617722|P1|Overall Study|Protocol Violation|2
823905|NCT00979901|2617719|P4|Overall Study|Lost to Follow-up|0
823906|NCT00979901|2617720|P3|Overall Study|Lost to Follow-up|2
823907|NCT00979901|2617721|P2|Overall Study|Lost to Follow-up|1
823908|NCT00979901|2617722|P1|Overall Study|Lost to Follow-up|1
823909|NCT00979901|2617719|P4|Overall Study|Lack of Efficacy|0
823910|NCT00979901|2617720|P3|Overall Study|Lack of Efficacy|9
823911|NCT00979901|2617721|P2|Overall Study|Lack of Efficacy|4
823912|NCT00979901|2617722|P1|Overall Study|Lack of Efficacy|8
823913|NCT00979901|2617719|P4|Overall Study|Adverse Event|2
823914|NCT00979901|2617720|P3|Overall Study|Adverse Event|9
823915|NCT00979901|2617721|P2|Overall Study|Adverse Event|3
823916|NCT00979901|2617722|P1|Overall Study|Adverse Event|1
823917|NCT00979953|2617759|P4|Overall Study|Protocol Violation|2
823918|NCT00979953|2617760|P3|Overall Study|Protocol Violation|2
823919|NCT00979953|2617761|P2|Overall Study|Protocol Violation|0
823920|NCT00979953|2617762|P1|Overall Study|Protocol Violation|1
823921|NCT00979953|2617759|P4|Overall Study|Withdrawal by Subject|1
823922|NCT00979953|2617760|P3|Overall Study|Withdrawal by Subject|2
823923|NCT00979953|2617761|P2|Overall Study|Withdrawal by Subject|0
823924|NCT00979953|2617762|P1|Overall Study|Withdrawal by Subject|0
823925|NCT00979953|2617759|P4|Overall Study|Lost to Follow-up|0
823926|NCT00979953|2617760|P3|Overall Study|Lost to Follow-up|1
823927|NCT00979953|2617761|P2|Overall Study|Lost to Follow-up|1
823928|NCT00979953|2617762|P1|Overall Study|Lost to Follow-up|1
823929|NCT00979953|2617759|P4|Overall Study|Lack of Efficacy|0
823930|NCT00979953|2617760|P3|Overall Study|Lack of Efficacy|0
823931|NCT00979953|2617761|P2|Overall Study|Lack of Efficacy|2
823932|NCT00979953|2617762|P1|Overall Study|Lack of Efficacy|1
823933|NCT00979953|2617759|P4|Overall Study|Adverse Event|4
823934|NCT00979953|2617760|P3|Overall Study|Adverse Event|17
823935|NCT00979953|2617761|P2|Overall Study|Adverse Event|2
823936|NCT00979953|2617762|P1|Overall Study|Adverse Event|5
823937|NCT00979992|2617772|P1|Overall Study|Refused – Never Treated|2
823938|NCT00979992|2617772|P1|Overall Study|Ineligible - wrong cell type|2
823939|NCT00979992|2617772|P1|Overall Study|Ineligible - inadequate pathology|1
823940|NCT00980005|2617782|P2|Overall Study|Unspecified|3
823941|NCT00980005|2617783|P1|Overall Study|Unspecified|4
823942|NCT00980005|2617782|P2|Overall Study|Lost to Follow-up|43
823943|NCT00980005|2617783|P1|Overall Study|Lost to Follow-up|37
823944|NCT00980005|2617782|P2|Overall Study|Withdrawal by Subject|17
823945|NCT00980005|2617783|P1|Overall Study|Withdrawal by Subject|6
823946|NCT00980044|2617826|P3|Overall Study|Protocol Violation|2
823947|NCT00980044|2617827|P2|Overall Study|Protocol Violation|0
823948|NCT00980044|2617828|P1|Overall Study|Protocol Violation|0
823949|NCT00980044|2617826|P3|Overall Study|Withdrawal by Subject|3
823950|NCT00980044|2617827|P2|Overall Study|Withdrawal by Subject|7
823951|NCT00980044|2617828|P1|Overall Study|Withdrawal by Subject|5
823952|NCT00980148|2617847|P2|Overall Study|Various other reasons|9
823953|NCT00980148|2617848|P1|Overall Study|Various other reasons|8
823954|NCT00980148|2617847|P2|Overall Study|Negative for chlamydia at enrollment|9
823955|NCT00980148|2617848|P1|Overall Study|Negative for chlamydia at enrollment|12
823956|NCT00980148|2617847|P2|Overall Study|Received other antichlamydia treatment|14
823957|NCT00980148|2617848|P1|Overall Study|Received other antichlamydia treatment|20
823958|NCT00980148|2617847|P2|Overall Study|Discharged from facility|96
823959|NCT00980148|2617848|P1|Overall Study|Discharged from facility|89
823960|NCT00980174|2617856|P2|Overall Study|Other|1
823961|NCT00980174|2617857|P1|Overall Study|Other|0
823962|NCT00980174|2617856|P2|Overall Study|Death|1
823963|NCT00980174|2617857|P1|Overall Study|Death|1
823964|NCT00980174|2617856|P2|Overall Study|Ineligibility determined|1
823965|NCT00980174|2617857|P1|Overall Study|Ineligibility determined|2
823966|NCT00980174|2617856|P2|Overall Study|Adverse Event|3
823967|NCT00980174|2617857|P1|Overall Study|Adverse Event|0
823968|NCT00980174|2617856|P2|Overall Study|Withdrawal by Subject|4
823969|NCT00980174|2617857|P1|Overall Study|Withdrawal by Subject|1
823970|NCT00980200|2617873|P5|7-day Treatment Period 3|Lack of Efficacy|1
823971|NCT00980200|2617874|P4|7-day Treatment Period 3|Lack of Efficacy|0
823972|NCT00980200|2617875|P3|7-day Treatment Period 3|Lack of Efficacy|0
823973|NCT00980200|2617876|P2|7-day Treatment Period 3|Lack of Efficacy|1
823974|NCT00980200|2617877|P1|7-day Treatment Period 3|Lack of Efficacy|0
823975|NCT00980200|2617873|P5|7-day Treatment Period 1|Withdrawal by Subject|0
823976|NCT00980200|2617874|P4|7-day Treatment Period 1|Withdrawal by Subject|0
823977|NCT00980200|2617875|P3|7-day Treatment Period 1|Withdrawal by Subject|0
823978|NCT00980200|2617876|P2|7-day Treatment Period 1|Withdrawal by Subject|1
823979|NCT00980200|2617877|P1|7-day Treatment Period 1|Withdrawal by Subject|0
823980|NCT00980330|2617918|P7|Overall Study|(not specified)|0
823981|NCT00980330|2617919|P6|Overall Study|(not specified)|1
823982|NCT00980330|2617920|P5|Overall Study|(not specified)|1
823983|NCT00980330|2617921|P4|Overall Study|(not specified)|1
823984|NCT00980330|2617922|P3|Overall Study|(not specified)|0
823985|NCT00980330|2617923|P2|Overall Study|(not specified)|0
823986|NCT00980330|2617924|P1|Overall Study|(not specified)|2
823987|NCT00980330|2617918|P7|Overall Study|Withdrawal by Subject|5
823988|NCT00980330|2617919|P6|Overall Study|Withdrawal by Subject|2
823989|NCT00980330|2617920|P5|Overall Study|Withdrawal by Subject|3
823990|NCT00980330|2617921|P4|Overall Study|Withdrawal by Subject|1
823991|NCT00980330|2617922|P3|Overall Study|Withdrawal by Subject|4
823992|NCT00980330|2617923|P2|Overall Study|Withdrawal by Subject|4
823993|NCT00980330|2617924|P1|Overall Study|Withdrawal by Subject|2
823994|NCT00980330|2617918|P7|Overall Study|Lost to Follow-up|2
823995|NCT00980330|2617919|P6|Overall Study|Lost to Follow-up|1
823996|NCT00980330|2617920|P5|Overall Study|Lost to Follow-up|1
823997|NCT00980330|2617921|P4|Overall Study|Lost to Follow-up|2
823998|NCT00980330|2617922|P3|Overall Study|Lost to Follow-up|4
823999|NCT00980330|2617923|P2|Overall Study|Lost to Follow-up|1
824000|NCT00980330|2617924|P1|Overall Study|Lost to Follow-up|1
824001|NCT00980330|2617918|P7|Overall Study|Adverse Event|0
824002|NCT00980330|2617919|P6|Overall Study|Adverse Event|0
824003|NCT00980330|2617920|P5|Overall Study|Adverse Event|0
824004|NCT00980330|2617921|P4|Overall Study|Adverse Event|1
824005|NCT00980330|2617922|P3|Overall Study|Adverse Event|0
824006|NCT00980330|2617923|P2|Overall Study|Adverse Event|0
824007|NCT00980330|2617924|P1|Overall Study|Adverse Event|0
824008|NCT00980343|2618024|P2|Overall Study|no tumor at surgery - treatment effect|3
824009|NCT00980343|2618025|P1|Overall Study|no tumor at surgery - treatment effect|1
824010|NCT00980655|2618072|P2|Overall Study|Unspecified|1
824011|NCT00980655|2618073|P1|Overall Study|Unspecified|0
824012|NCT00980655|2618072|P2|Overall Study|Parent/legal guardian request|0
824013|NCT00980655|2618073|P1|Overall Study|Parent/legal guardian request|1
824014|NCT00980655|2618072|P2|Overall Study|Lost to Follow-up|1
824015|NCT00980655|2618073|P1|Overall Study|Lost to Follow-up|0
824016|NCT00980655|2618072|P2|Overall Study|Withdrawal by Subject|4
824017|NCT00980655|2618073|P1|Overall Study|Withdrawal by Subject|0
824018|NCT00980655|2618072|P2|Overall Study|Protocol Violation|7
824019|NCT00980655|2618073|P1|Overall Study|Protocol Violation|2
824020|NCT00980655|2618072|P2|Overall Study|Death|7
824021|NCT00980655|2618073|P1|Overall Study|Death|0
824022|NCT00980655|2618072|P2|Overall Study|Adverse Event|31
824023|NCT00980655|2618073|P1|Overall Study|Adverse Event|13
824024|NCT00980798|2618152|P2|Overall Study|Other|1
824025|NCT00980798|2618153|P1|Overall Study|Other|0
824026|NCT00980798|2618152|P2|Overall Study|Withdrawal by Subject|11
824027|NCT00980798|2618153|P1|Overall Study|Withdrawal by Subject|8
824028|NCT00980798|2618152|P2|Overall Study|Physician Decision|1
824029|NCT00980798|2618153|P1|Overall Study|Physician Decision|2
824030|NCT00980798|2618152|P2|Overall Study|Lost to Follow-up|1
824031|NCT00980798|2618153|P1|Overall Study|Lost to Follow-up|0
824032|NCT00980798|2618152|P2|Overall Study|Lack of Efficacy|5
824033|NCT00980798|2618153|P1|Overall Study|Lack of Efficacy|16
824034|NCT00980798|2618152|P2|Overall Study|Adverse Event|36
824035|NCT00980798|2618153|P1|Overall Study|Adverse Event|7
824036|NCT00980980|2618164|P3|Overall Study|Withdrawal by Hospital|0
824037|NCT00980980|2618165|P2|Overall Study|Withdrawal by Hospital|1
824038|NCT00980980|2618166|P1|Overall Study|Withdrawal by Hospital|0
824039|NCT00981019|2618195|P1|Overall Study|Hit the survey after closure|79
824040|NCT00981019|2618195|P1|Overall Study|Inadvertent exclusion|239
824041|NCT00981019|2618195|P1|Overall Study|Did not match target population|94
824042|NCT00981019|2618195|P1|Overall Study|Did not respond|65
824043|NCT00981058|2618212|P2|Overall Study|On study treatment at conclusion|0
824044|NCT00981058|2618213|P1|Overall Study|On study treatment at conclusion|9
824045|NCT00981058|2618212|P2|Overall Study|Withdrawal by Subject|23
824046|NCT00981058|2618213|P1|Overall Study|Withdrawal by Subject|25
824047|NCT00981058|2618212|P2|Overall Study|Randomization Error|2
824048|NCT00981058|2618213|P1|Overall Study|Randomization Error|1
824049|NCT00981058|2618212|P2|Overall Study|Radiologist Error|1
824050|NCT00981058|2618213|P1|Overall Study|Radiologist Error|0
824051|NCT00981058|2618212|P2|Overall Study|Noncompliance|0
824052|NCT00981058|2618213|P1|Overall Study|Noncompliance|1
824053|NCT00981058|2618212|P2|Overall Study|New Anticancer Therapy|6
824054|NCT00981058|2618213|P1|Overall Study|New Anticancer Therapy|6
824055|NCT00981058|2618212|P2|Overall Study|Lost to Follow-up|15
824056|NCT00981058|2618213|P1|Overall Study|Lost to Follow-up|16
824057|NCT00981058|2618212|P2|Overall Study|Progressive Disease|49
824058|NCT00981058|2618213|P1|Overall Study|Progressive Disease|61
824059|NCT00981058|2618212|P2|Overall Study|Adverse Event|1
824060|NCT00981058|2618213|P1|Overall Study|Adverse Event|1
824061|NCT00981084|2618235|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
824062|NCT00981084|2618236|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
824063|NCT00981084|2618235|P2|Post Intervention (Data Analysis)|poor effort|1
824064|NCT00981084|2618236|P1|Post Intervention (Data Analysis)|poor effort|1
824065|NCT00981175|2618253|P2|Booster Dose Vaccination|Lost to Follow-up|3
824066|NCT00981175|2618254|P1|Booster Dose Vaccination|Lost to Follow-up|2
824067|NCT00981175|2618253|P2|Primary Dose Vaccination|Lost to Follow-up|1
824068|NCT00981175|2618254|P1|Primary Dose Vaccination|Lost to Follow-up|2
824069|NCT00981175|2618253|P2|Primary Dose Vaccination|Protocol Violation|1
824070|NCT00981175|2618254|P1|Primary Dose Vaccination|Protocol Violation|0
824071|NCT00981175|2618253|P2|Primary Dose Vaccination|Adverse Event|0
824072|NCT00981175|2618254|P1|Primary Dose Vaccination|Adverse Event|1
824073|NCT00981292|2618326|P6|Day 3|Protocol Violation|1
824074|NCT00981292|2618327|P5|Day 3|Protocol Violation|0
824075|NCT00981292|2618328|P4|Day 3|Protocol Violation|0
824076|NCT00981292|2618329|P3|Day 3|Protocol Violation|0
824077|NCT00981292|2618330|P2|Day 3|Protocol Violation|0
824078|NCT00981292|2618331|P1|Day 3|Protocol Violation|0
824079|NCT00981292|2618326|P6|Day 2|Protocol Violation|0
824080|NCT00981292|2618327|P5|Day 2|Protocol Violation|0
824081|NCT00981292|2618328|P4|Day 2|Protocol Violation|0
824082|NCT00981292|2618329|P3|Day 2|Protocol Violation|0
824083|NCT00981292|2618330|P2|Day 2|Protocol Violation|0
824084|NCT00981292|2618331|P1|Day 2|Protocol Violation|2
824085|NCT00981292|2618326|P6|Day 1|Protocol Violation|2
824086|NCT00981292|2618327|P5|Day 1|Protocol Violation|0
824087|NCT00981292|2618328|P4|Day 1|Protocol Violation|0
824088|NCT00981292|2618329|P3|Day 1|Protocol Violation|0
824089|NCT00981292|2618330|P2|Day 1|Protocol Violation|0
824090|NCT00981292|2618331|P1|Day 1|Protocol Violation|1
824091|NCT00981409|2618369|P2|Overall Study|Prostate Cancer Treatment before Trial|0
824092|NCT00981409|2618370|P1|Overall Study|Prostate Cancer Treatment before Trial|2
824093|NCT00981409|2618369|P2|Overall Study|Protocol Violation|1
824094|NCT00981409|2618370|P1|Overall Study|Protocol Violation|0
824095|NCT00981409|2618369|P2|Overall Study|Adverse Event|0
824096|NCT00981409|2618370|P1|Overall Study|Adverse Event|4
824097|NCT00981461|2618402|P2|Overall Study|Lost to Follow-up|2
824098|NCT00981461|2618403|P1|Overall Study|Lost to Follow-up|5
893337|NCT00976560|2834099|P1|Overall Study|Protocol Violation|1
893338|NCT00976560|2834098|P2|Overall Study|Lack of Efficacy|5
893339|NCT00976560|2834099|P1|Overall Study|Lack of Efficacy|3
893340|NCT00976560|2834098|P2|Overall Study|Adverse Event|5
893341|NCT00976560|2834099|P1|Overall Study|Adverse Event|5
893342|NCT00903968|2834187|P8|Overall Study|Lack of Efficacy|3
893343|NCT00903968|2834188|P7|Overall Study|Lack of Efficacy|0
893344|NCT00903968|2834189|P6|Overall Study|Lack of Efficacy|0
893345|NCT00903968|2834190|P5|Overall Study|Lack of Efficacy|0
893346|NCT00903968|2834191|P4|Overall Study|Lack of Efficacy|0
893347|NCT00903968|2834192|P3|Overall Study|Lack of Efficacy|0
893348|NCT00903968|2834193|P2|Overall Study|Lack of Efficacy|0
893349|NCT00903968|2834194|P1|Overall Study|Lack of Efficacy|0
893350|NCT00903968|2834187|P8|Overall Study|Progressive Disease|18
824113|NCT00973622|2618430|P2|Overall Study|did not complete rTMS sessions|2
824114|NCT00973622|2618431|P1|Overall Study|did not complete rTMS sessions|11
824115|NCT00973622|2618430|P2|Overall Study|did not pass MRI screen|0
824116|NCT00973622|2618431|P1|Overall Study|did not pass MRI screen|6
824117|NCT00973622|2618430|P2|Overall Study|did not attend MRI|3
824118|NCT00973622|2618431|P1|Overall Study|did not attend MRI|14
824119|NCT00973700|2618442|P5|Overall Study|Unable to Classify|1
824120|NCT00973700|2618443|P4|Overall Study|Unable to Classify|2
824121|NCT00973700|2618444|P3|Overall Study|Unable to Classify|1
824122|NCT00973700|2618445|P2|Overall Study|Unable to Classify|0
824123|NCT00973700|2618446|P1|Overall Study|Unable to Classify|0
824124|NCT00973700|2618442|P5|Overall Study|Inappropriate enrolment|0
824125|NCT00973700|2618443|P4|Overall Study|Inappropriate enrolment|4
824126|NCT00973700|2618444|P3|Overall Study|Inappropriate enrolment|0
824127|NCT00973700|2618445|P2|Overall Study|Inappropriate enrolment|0
824128|NCT00973700|2618446|P1|Overall Study|Inappropriate enrolment|0
824129|NCT00973700|2618442|P5|Overall Study|Lost to Follow-up|5
824130|NCT00973700|2618443|P4|Overall Study|Lost to Follow-up|8
824131|NCT00973700|2618444|P3|Overall Study|Lost to Follow-up|1
824132|NCT00973700|2618445|P2|Overall Study|Lost to Follow-up|0
824133|NCT00973700|2618446|P1|Overall Study|Lost to Follow-up|5
824134|NCT00973700|2618442|P5|Overall Study|Withdrawal by Subject|4
824135|NCT00973700|2618443|P4|Overall Study|Withdrawal by Subject|4
824136|NCT00973700|2618444|P3|Overall Study|Withdrawal by Subject|8
824137|NCT00973700|2618445|P2|Overall Study|Withdrawal by Subject|2
824138|NCT00973700|2618446|P1|Overall Study|Withdrawal by Subject|2
824139|NCT00973765|2618506|P2|Overall Study|Lost to Follow-up|14
824140|NCT00973765|2618507|P1|Overall Study|Lost to Follow-up|8
824141|NCT00973921|2618513|P1|Overall Study|IVUS results were not available|9
824142|NCT00974090|2618542|P2|Period 2: Open-label Period|Withdrawal by Subject|0
824143|NCT00974090|2618543|P1|Period 2: Open-label Period|Withdrawal by Subject|1
824144|NCT00974090|2618542|P2|Period 2: Open-label Period|Physician Decision|3
824145|NCT00974090|2618543|P1|Period 2: Open-label Period|Physician Decision|0
824146|NCT00974090|2618542|P2|Period 2: Open-label Period|Lack of Efficacy|1
824147|NCT00974090|2618543|P1|Period 2: Open-label Period|Lack of Efficacy|3
824148|NCT00974090|2618542|P2|Period 2: Open-label Period|Adverse Event|6
824149|NCT00974090|2618543|P1|Period 2: Open-label Period|Adverse Event|4
824150|NCT00974090|2618542|P2|Period 1: Double Blind Period|Physician Decision|0
824151|NCT00974090|2618543|P1|Period 1: Double Blind Period|Physician Decision|1
824152|NCT00974090|2618542|P2|Period 1: Double Blind Period|Adverse Event|1
824153|NCT00974090|2618543|P1|Period 1: Double Blind Period|Adverse Event|2
824154|NCT00974220|2618559|P2|Treatment Period 1|noncompliant subjects|1
824155|NCT00974220|2618560|P1|Treatment Period 1|noncompliant subjects|0
824156|NCT00974220|2618559|P2|Treatment Period 1|Adverse Event|1
824157|NCT00974220|2618560|P1|Treatment Period 1|Adverse Event|2
824158|NCT00974233|2618568|P1|Maintenance Lenalidomide|Adverse Event|8
824159|NCT00974233|2618568|P1|Maintenance Lenalidomide|Lack of Efficacy|5
824160|NCT00974233|2618568|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
824161|NCT00974233|2618568|P1|Induction Chemoimmunotherapy|Adverse Event|7
824162|NCT00974233|2618568|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
824163|NCT00974233|2618568|P1|Induction Chemoimmunotherapy|Death|2
824164|NCT00974311|2618589|P2|Overall Study|Continuing Treatment|19
824165|NCT00974311|2618590|P1|Overall Study|Continuing Treatment|231
824166|NCT00974311|2618589|P2|Overall Study|Withdrawal of consent|5
824167|NCT00974311|2618590|P1|Overall Study|Withdrawal of consent|9
824168|NCT00974311|2618589|P2|Overall Study|Death|211
824169|NCT00974311|2618590|P1|Overall Study|Death|305
824170|NCT00974311|2618589|P2|Overall Study|Lost to Follow-up|1
824171|NCT00974311|2618590|P1|Overall Study|Lost to Follow-up|1
824172|NCT00974571|2618688|P3|Overall Study|Unspecified|10
824173|NCT00974571|2618689|P2|Overall Study|Unspecified|0
824174|NCT00974571|2618690|P1|Overall Study|Unspecified|4
824175|NCT00974571|2618688|P3|Overall Study|Patient Moved|1
824176|NCT00974571|2618689|P2|Overall Study|Patient Moved|0
824177|NCT00974571|2618690|P1|Overall Study|Patient Moved|1
824178|NCT00974571|2618688|P3|Overall Study|Withdrawal by Subject|16
824179|NCT00974571|2618689|P2|Overall Study|Withdrawal by Subject|5
824180|NCT00974571|2618690|P1|Overall Study|Withdrawal by Subject|14
824181|NCT00974571|2618688|P3|Overall Study|Protocol Violation|18
824182|NCT00974571|2618689|P2|Overall Study|Protocol Violation|4
824183|NCT00974571|2618690|P1|Overall Study|Protocol Violation|13
824184|NCT00974571|2618688|P3|Overall Study|Lost to Follow-up|2
824185|NCT00974571|2618689|P2|Overall Study|Lost to Follow-up|1
824186|NCT00974571|2618690|P1|Overall Study|Lost to Follow-up|2
824187|NCT00974571|2618688|P3|Overall Study|Lack of Efficacy|9
824188|NCT00974571|2618689|P2|Overall Study|Lack of Efficacy|2
824189|NCT00974571|2618690|P1|Overall Study|Lack of Efficacy|3
824190|NCT00974571|2618688|P3|Overall Study|Adverse Event|27
824191|NCT00974571|2618689|P2|Overall Study|Adverse Event|4
824192|NCT00974571|2618690|P1|Overall Study|Adverse Event|31
824193|NCT00974675|2618714|P4|Overall Study|Participant on holiday; unable to attend|1
824194|NCT00974675|2618715|P3|Overall Study|Participant on holiday; unable to attend|0
824195|NCT00974675|2618716|P2|Overall Study|Participant on holiday; unable to attend|0
824196|NCT00974675|2618717|P1|Overall Study|Participant on holiday; unable to attend|0
824197|NCT00974675|2618714|P4|Overall Study|Physician Decision|0
824198|NCT00974675|2618715|P3|Overall Study|Physician Decision|1
824199|NCT00974675|2618716|P2|Overall Study|Physician Decision|0
824200|NCT00974675|2618717|P1|Overall Study|Physician Decision|0
824201|NCT00974675|2618714|P4|Overall Study|Adverse Event|1
824202|NCT00974675|2618715|P3|Overall Study|Adverse Event|1
824203|NCT00974675|2618716|P2|Overall Study|Adverse Event|1
824204|NCT00974675|2618717|P1|Overall Study|Adverse Event|2
824205|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Various|0
824206|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Various|4
824207|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
824208|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
824209|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
824210|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
824211|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
824212|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
824213|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
824214|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
824215|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
824216|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
824217|NCT00974974|2618774|P2|Maintenance - Double Blind Treatment|Adverse Event|3
824218|NCT00974974|2618775|P1|Maintenance - Double Blind Treatment|Adverse Event|3
824219|NCT00974974|2618774|P2|IPX066 Dose Conversion|Protocol Violation|0
824220|NCT00974974|2618775|P1|IPX066 Dose Conversion|Protocol Violation|4
824221|NCT00974974|2618774|P2|IPX066 Dose Conversion|Various|0
824222|NCT00974974|2618775|P1|IPX066 Dose Conversion|Various|3
824223|NCT00974974|2618774|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
824224|NCT00974974|2618775|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
824225|NCT00974974|2618774|P2|IPX066 Dose Conversion|Lack of Efficacy|0
824226|NCT00974974|2618775|P1|IPX066 Dose Conversion|Lack of Efficacy|13
824227|NCT00974974|2618774|P2|IPX066 Dose Conversion|Death|0
824228|NCT00974974|2618775|P1|IPX066 Dose Conversion|Death|2
824229|NCT00974974|2618774|P2|IPX066 Dose Conversion|Adverse Event|0
824230|NCT00974974|2618775|P1|IPX066 Dose Conversion|Adverse Event|23
824231|NCT00974974|2618774|P2|IR CD-LD Dose Adjustment|Various|9
824232|NCT00974974|2618775|P1|IR CD-LD Dose Adjustment|Various|0
824233|NCT00974974|2618774|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
824234|NCT00974974|2618775|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
824235|NCT00974974|2618774|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
824236|NCT00974974|2618775|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
824237|NCT00974974|2618774|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
824238|NCT00974974|2618775|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
824239|NCT00974974|2618774|P2|IR CD-LD Dose Adjustment|Adverse Event|3
824240|NCT00974974|2618775|P1|IR CD-LD Dose Adjustment|Adverse Event|0
824241|NCT00975000|2618787|P2|Overall Study|Non-compliance|1
824242|NCT00975000|2618788|P1|Overall Study|Non-compliance|0
824243|NCT00975000|2618787|P2|Overall Study|Protocol-specified Criteria|0
824244|NCT00975000|2618788|P1|Overall Study|Protocol-specified Criteria|1
824245|NCT00975000|2618787|P2|Overall Study|Lost to Follow-up|1
824246|NCT00975000|2618788|P1|Overall Study|Lost to Follow-up|0
824247|NCT00975000|2618787|P2|Overall Study|Withdrawal by Subject|2
824248|NCT00975000|2618788|P1|Overall Study|Withdrawal by Subject|2
824249|NCT00975000|2618787|P2|Overall Study|Adverse Event|1
824250|NCT00975000|2618788|P1|Overall Study|Adverse Event|1
824251|NCT00975000|2618787|P2|Overall Study|Other|0
824252|NCT00975000|2618788|P1|Overall Study|Other|1
824253|NCT00975130|2618810|P3|Study Part 2|Protocol Violation|1
824254|NCT00975130|2618811|P2|Study Part 2|Protocol Violation|0
824255|NCT00975130|2618812|P1|Study Part 2|Protocol Violation|0
824256|NCT00975130|2618810|P3|Study Part 2|Administrative|0
824257|NCT00975130|2618811|P2|Study Part 2|Administrative|1
824258|NCT00975130|2618812|P1|Study Part 2|Administrative|0
824259|NCT00975130|2618810|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
824260|NCT00975130|2618811|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
824261|NCT00975130|2618812|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
824262|NCT00975130|2618810|P3|Study Part 2|Withdrew Consent|2
824263|NCT00975130|2618811|P2|Study Part 2|Withdrew Consent|6
824264|NCT00975130|2618812|P1|Study Part 2|Withdrew Consent|0
824265|NCT00975130|2618810|P3|Study Part 2|Withdrawal by Subject|5
824266|NCT00975130|2618811|P2|Study Part 2|Withdrawal by Subject|13
824267|NCT00975130|2618812|P1|Study Part 2|Withdrawal by Subject|0
824268|NCT00975130|2618810|P3|Study Part 2|Lost to Follow-up|1
824269|NCT00975130|2618811|P2|Study Part 2|Lost to Follow-up|0
824270|NCT00975130|2618812|P1|Study Part 2|Lost to Follow-up|0
824271|NCT00975130|2618810|P3|Study Part 2|Adverse Event|7
824272|NCT00975130|2618811|P2|Study Part 2|Adverse Event|14
824273|NCT00975130|2618812|P1|Study Part 2|Adverse Event|0
824274|NCT00975130|2618810|P3|Study Part 1|Withdrew Consent|0
824275|NCT00975130|2618811|P2|Study Part 1|Withdrew Consent|0
824276|NCT00975130|2618812|P1|Study Part 1|Withdrew Consent|24
824277|NCT00975130|2618810|P3|Study Part 1|Administrative|0
824278|NCT00975130|2618811|P2|Study Part 1|Administrative|0
824279|NCT00975130|2618812|P1|Study Part 1|Administrative|4
824280|NCT00975130|2618810|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
824281|NCT00975130|2618811|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
824282|NCT00975130|2618812|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
824283|NCT00975130|2618810|P3|Study Part 1|Protocol Violation|0
824284|NCT00975130|2618811|P2|Study Part 1|Protocol Violation|0
824285|NCT00975130|2618812|P1|Study Part 1|Protocol Violation|13
824286|NCT00975130|2618810|P3|Study Part 1|Withdrawal by Subject|0
824287|NCT00975130|2618811|P2|Study Part 1|Withdrawal by Subject|0
824288|NCT00975130|2618812|P1|Study Part 1|Withdrawal by Subject|61
824289|NCT00975130|2618810|P3|Study Part 1|Lost to Follow-up|0
824290|NCT00975130|2618811|P2|Study Part 1|Lost to Follow-up|0
824291|NCT00975130|2618812|P1|Study Part 1|Lost to Follow-up|19
824292|NCT00975130|2618810|P3|Study Part 1|Adverse Event|0
824293|NCT00975130|2618811|P2|Study Part 1|Adverse Event|0
824294|NCT00975130|2618812|P1|Study Part 1|Adverse Event|150
824295|NCT00975143|2618996|P2|Overall Study|Details not available|4
824296|NCT00975143|2618997|P1|Overall Study|Details not available|10
824297|NCT00975143|2618996|P2|Overall Study|Physician Decision|2
824298|NCT00975143|2618997|P1|Overall Study|Physician Decision|1
824299|NCT00975143|2618996|P2|Overall Study|Non-compliance|8
824300|NCT00975143|2618997|P1|Overall Study|Non-compliance|5
824301|NCT00975143|2618996|P2|Overall Study|Lost to Follow-up|16
824302|NCT00975143|2618997|P1|Overall Study|Lost to Follow-up|20
824303|NCT00975143|2618996|P2|Overall Study|Withdrawal by Subject|15
824304|NCT00975143|2618997|P1|Overall Study|Withdrawal by Subject|15
824305|NCT00975143|2618996|P2|Overall Study|Adverse Event|15
824306|NCT00975143|2618997|P1|Overall Study|Adverse Event|19
824307|NCT00975156|2619009|P2|Overall Study|Protocol Violation|1
824308|NCT00975156|2619010|P1|Overall Study|Protocol Violation|0
824309|NCT00975195|2619022|P2|Overall Study|Not treated|2
824310|NCT00975195|2619023|P1|Overall Study|Not treated|1
824311|NCT00975195|2619022|P2|Overall Study|Other reason not defined above|33
824312|NCT00975195|2619023|P1|Overall Study|Other reason not defined above|29
824313|NCT00975195|2619022|P2|Overall Study|Withdrawal by Subject|61
824314|NCT00975195|2619023|P1|Overall Study|Withdrawal by Subject|48
824315|NCT00975195|2619022|P2|Overall Study|Lost to Follow-up|7
824316|NCT00975195|2619023|P1|Overall Study|Lost to Follow-up|9
824317|NCT00975195|2619022|P2|Overall Study|Protocol Violation|23
824318|NCT00975195|2619023|P1|Overall Study|Protocol Violation|27
824319|NCT00975195|2619022|P2|Overall Study|Lack of Efficacy|6
824320|NCT00975195|2619023|P1|Overall Study|Lack of Efficacy|6
824321|NCT00975195|2619022|P2|Overall Study|Adverse Event|101
824322|NCT00975195|2619023|P1|Overall Study|Adverse Event|108
824323|NCT00975221|2619083|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
824324|NCT00975221|2619084|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
824325|NCT00975221|2619083|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
824326|NCT00975221|2619084|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
824327|NCT00975221|2619083|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
824328|NCT00975221|2619084|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
824329|NCT00975221|2619083|P2|Titration Phase (Weeks 1-12)|Other|1
824330|NCT00975221|2619084|P1|Titration Phase (Weeks 1-12)|Other|0
824331|NCT00975221|2619083|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
824332|NCT00975221|2619084|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
824333|NCT00975221|2619083|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
824334|NCT00975221|2619084|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
824335|NCT00975286|2619100|P2|Overall Study|Sponsor Decision|2
824336|NCT00975286|2619101|P1|Overall Study|Sponsor Decision|0
824337|NCT00975286|2619100|P2|Overall Study|Poor Compliance to Protocol|2
824338|NCT00975286|2619101|P1|Overall Study|Poor Compliance to Protocol|0
824339|NCT00975286|2619100|P2|Overall Study|Familial and Personal Reasons|2
824340|NCT00975286|2619101|P1|Overall Study|Familial and Personal Reasons|2
824341|NCT00975286|2619100|P2|Overall Study|Withdrawal by Subject|2
824342|NCT00975286|2619101|P1|Overall Study|Withdrawal by Subject|0
824343|NCT00975286|2619100|P2|Overall Study|Protocol Violation|2
824344|NCT00975286|2619101|P1|Overall Study|Protocol Violation|1
824345|NCT00975286|2619100|P2|Overall Study|Adverse Event|19
824346|NCT00975286|2619101|P1|Overall Study|Adverse Event|9
824347|NCT00975416|2619133|P2|Overall Study|early discharge from tx|5
824348|NCT00975416|2619134|P1|Overall Study|early discharge from tx|3
824349|NCT00975481|2619141|P6|Fifth Intervention Period|Withdrawal by Subject|0
824350|NCT00975481|2619142|P5|Fifth Intervention Period|Withdrawal by Subject|1
824351|NCT00975481|2619143|P4|Fifth Intervention Period|Withdrawal by Subject|0
824352|NCT00975481|2619144|P3|Fifth Intervention Period|Withdrawal by Subject|0
824353|NCT00975481|2619145|P2|Fifth Intervention Period|Withdrawal by Subject|0
824354|NCT00975481|2619146|P1|Fifth Intervention Period|Withdrawal by Subject|0
824355|NCT00975481|2619141|P6|Fourth Intervention Period|Withdrawal by Subject|0
824356|NCT00975481|2619142|P5|Fourth Intervention Period|Withdrawal by Subject|0
824357|NCT00975481|2619143|P4|Fourth Intervention Period|Withdrawal by Subject|1
824358|NCT00975481|2619144|P3|Fourth Intervention Period|Withdrawal by Subject|1
824359|NCT00975481|2619145|P2|Fourth Intervention Period|Withdrawal by Subject|0
824360|NCT00975481|2619146|P1|Fourth Intervention Period|Withdrawal by Subject|0
824361|NCT00975481|2619141|P6|Second Intervention Period|Withdrawal by Subject|0
824362|NCT00975481|2619142|P5|Second Intervention Period|Withdrawal by Subject|0
824363|NCT00975481|2619143|P4|Second Intervention Period|Withdrawal by Subject|0
824364|NCT00975481|2619144|P3|Second Intervention Period|Withdrawal by Subject|1
824365|NCT00975481|2619145|P2|Second Intervention Period|Withdrawal by Subject|0
824366|NCT00975481|2619146|P1|Second Intervention Period|Withdrawal by Subject|0
824367|NCT00975481|2619141|P6|Second Intervention Period|Adverse Event|0
824368|NCT00975481|2619142|P5|Second Intervention Period|Adverse Event|0
824369|NCT00975481|2619143|P4|Second Intervention Period|Adverse Event|0
824370|NCT00975481|2619144|P3|Second Intervention Period|Adverse Event|0
824371|NCT00975481|2619145|P2|Second Intervention Period|Adverse Event|1
824372|NCT00975481|2619146|P1|Second Intervention Period|Adverse Event|2
824373|NCT00975507|2619246|P2|Overall Study|Withdrawal by Subject|3
824374|NCT00975507|2619247|P1|Overall Study|Withdrawal by Subject|10
824375|NCT00975507|2619246|P2|Overall Study|Protocol Violation|0
824376|NCT00975507|2619247|P1|Overall Study|Protocol Violation|2
824377|NCT00975507|2619246|P2|Overall Study|Lost to Follow-up|1
824378|NCT00975507|2619247|P1|Overall Study|Lost to Follow-up|7
824379|NCT00975507|2619246|P2|Overall Study|Adverse Event|0
824380|NCT00975507|2619247|P1|Overall Study|Adverse Event|1
824381|NCT00975585|2619269|P2|Overall Study|Lens issue|2
824382|NCT00975585|2619270|P1|Overall Study|Lens issue|2
824383|NCT00975585|2619269|P2|Overall Study|Withdrawal by Subject|1
824384|NCT00975585|2619270|P1|Overall Study|Withdrawal by Subject|2
824385|NCT00975585|2619269|P2|Overall Study|Lost to Follow-up|5
824386|NCT00975585|2619270|P1|Overall Study|Lost to Follow-up|3
824387|NCT00975585|2619269|P2|Overall Study|Adverse Event|4
824388|NCT00975585|2619270|P1|Overall Study|Adverse Event|0
824389|NCT00975611|2619288|P1|Overall Study|Physician Decision|1
824390|NCT00975611|2619288|P1|Overall Study|Screen Fail|16
824391|NCT00975689|2619320|P2|Overall Study|Physician Decision|0
824392|NCT00975689|2619321|P1|Overall Study|Physician Decision|1
824393|NCT00975689|2619320|P2|Overall Study|Withdrawal by Subject|0
824394|NCT00975689|2619321|P1|Overall Study|Withdrawal by Subject|1
824395|NCT00975689|2619320|P2|Overall Study|Adverse Event|3
824396|NCT00975689|2619321|P1|Overall Study|Adverse Event|0
824397|NCT00975715|2619329|P2|Maintenance Period|Adverse Event|1
824398|NCT00975715|2619330|P1|Maintenance Period|Adverse Event|2
824399|NCT00975715|2619329|P2|Titration Period|Protocol Violation|0
824400|NCT00975715|2619330|P1|Titration Period|Protocol Violation|1
824401|NCT00975715|2619329|P2|Titration Period|Adverse Event|0
824402|NCT00975715|2619330|P1|Titration Period|Adverse Event|6
824403|NCT00975780|2619346|P2|Follow Up|Discharged from Facility|12
824404|NCT00975780|2619347|P1|Follow Up|Discharged from Facility|7
824405|NCT00975780|2619346|P2|Follow Up|Facility Withdrawal|23
824406|NCT00975780|2619347|P1|Follow Up|Facility Withdrawal|7
824407|NCT00975780|2619346|P2|Follow Up|Death|122
824408|NCT00975780|2619347|P1|Follow Up|Death|88
824409|NCT00975806|2619358|P3|Overall Study|Physician decision and disease related|1
824410|NCT00975806|2619359|P2|Overall Study|Physician decision and disease related|0
824411|NCT00975806|2619360|P1|Overall Study|Physician decision and disease related|1
824412|NCT00975806|2619358|P3|Overall Study|Death|0
824413|NCT00975806|2619359|P2|Overall Study|Death|1
824414|NCT00975806|2619360|P1|Overall Study|Death|0
824415|NCT00975806|2619358|P3|Overall Study|Withdrawal by Subject|0
824416|NCT00975806|2619359|P2|Overall Study|Withdrawal by Subject|0
824417|NCT00975806|2619360|P1|Overall Study|Withdrawal by Subject|1
824418|NCT00975806|2619358|P3|Overall Study|Disease Progression|1
824419|NCT00975806|2619359|P2|Overall Study|Disease Progression|5
824420|NCT00975806|2619360|P1|Overall Study|Disease Progression|1
824421|NCT00975806|2619358|P3|Overall Study|Adverse Event|2
824422|NCT00975806|2619359|P2|Overall Study|Adverse Event|1
824423|NCT00975806|2619360|P1|Overall Study|Adverse Event|2
824424|NCT00975923|2619384|P2|Overall Study|Withdrawal by Subject|1
824425|NCT00975923|2619385|P1|Overall Study|Withdrawal by Subject|0
824426|NCT00982735|2619454|P1|Overall Study|Patient ineligible for trial|224
824427|NCT00982735|2619454|P1|Overall Study|Lost to Follow-up|6
824428|NCT00983073|2619465|P1|Maintenance Period|Other Reason|7
824429|NCT00983073|2619465|P1|Maintenance Period|Lack of Efficacy|2
824430|NCT00983073|2619465|P1|Maintenance Period|Withdrawal by Subject|2
824431|NCT00983073|2619465|P1|Maintenance Period|Adverse Event|5
824432|NCT00983073|2619465|P1|Titration and Optimal Dose Period|Other reason|4
824433|NCT00983073|2619465|P1|Titration and Optimal Dose Period|Non-Compliance|1
824434|NCT00983073|2619465|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
824435|NCT00983073|2619465|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
824436|NCT00983073|2619465|P1|Titration and Optimal Dose Period|Adverse Event|19
824437|NCT00983294|2619517|P1|Colchicine With Azithromycin|Adverse Event|1
824438|NCT00983294|2619517|P1|14 Day Washout Period|Withdrawal by Subject|2
824439|NCT00983372|2619540|P1|Diltiazem ER Alone|Adverse Event|1
824440|NCT00983372|2619540|P1|Diltiazem ER Alone|missed diltiazem dose|2
824441|NCT00983372|2619540|P1|14 Day Washout Period|Withdrawal by Subject|1
824442|NCT00983385|2619551|P1|Observation Period|Not Evaluable due to Non Compliance|12
824443|NCT00983385|2619551|P1|Observation Period|Not eligible to be dosed|20
824444|NCT00983437|2619596|P1|Overall Study|Other Reason|26
824445|NCT00983437|2619596|P1|Overall Study|Lost to Follow-up|2
824446|NCT00983437|2619596|P1|Overall Study|Noncompliance to Study Procedures|1
824447|NCT00983437|2619596|P1|Overall Study|Withdrawal by Subject|8
824448|NCT00983437|2619596|P1|Overall Study|Lack of Efficacy|1
824449|NCT00983437|2619596|P1|Overall Study|Adverse Event|9
824450|NCT00983476|2619618|P3|Overall Study|Did not receive intervention|0
824451|NCT00983476|2619619|P2|Overall Study|Did not receive intervention|22
824452|NCT00983476|2619620|P1|Overall Study|Did not receive intervention|17
824453|NCT00983515|2619665|P1|Colchicine With Ritonavir|Lost to Follow-up|1
824454|NCT00983515|2619665|P1|Ritonavir Alone|liver panel out of range|6
824455|NCT00983749|2619703|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
824456|NCT00983749|2619704|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
824457|NCT00983827|2619724|P1|Overall Study|Withdrawal by Subject|1
824458|NCT00983853|2619734|P6|Overall Study|Unable to come to study follow-up visits|0
824459|NCT00983853|2619735|P5|Overall Study|Unable to come to study follow-up visits|0
824460|NCT00983853|2619736|P4|Overall Study|Unable to come to study follow-up visits|0
824461|NCT00983853|2619737|P3|Overall Study|Unable to come to study follow-up visits|0
824462|NCT00983853|2619738|P2|Overall Study|Unable to come to study follow-up visits|1
824463|NCT00983853|2619739|P1|Overall Study|Unable to come to study follow-up visits|0
824464|NCT00983853|2619734|P6|Overall Study|Withdrawal by Subject|0
824465|NCT00983853|2619735|P5|Overall Study|Withdrawal by Subject|1
824466|NCT00983853|2619736|P4|Overall Study|Withdrawal by Subject|0
824467|NCT00983853|2619737|P3|Overall Study|Withdrawal by Subject|1
824468|NCT00983853|2619738|P2|Overall Study|Withdrawal by Subject|0
824469|NCT00983853|2619739|P1|Overall Study|Withdrawal by Subject|0
824470|NCT00983853|2619734|P6|Overall Study|Lost to Follow-up|1
824471|NCT00983853|2619735|P5|Overall Study|Lost to Follow-up|2
824472|NCT00983853|2619736|P4|Overall Study|Lost to Follow-up|2
824473|NCT00983853|2619737|P3|Overall Study|Lost to Follow-up|2
824474|NCT00983853|2619738|P2|Overall Study|Lost to Follow-up|1
824475|NCT00983853|2619739|P1|Overall Study|Lost to Follow-up|1
824476|NCT00983892|2619769|P2|Overall Study|Withdrawal by Subject|12
824477|NCT00983892|2619770|P1|Overall Study|Withdrawal by Subject|10
824478|NCT00983905|2619776|P1|Colchicine Alone|Adverse Event|2
824479|NCT00983905|2619776|P1|Theophylline Alone|Adverse Event|1
824480|NCT00983918|2619791|P4|Overall Study|conversion to open cholecystectomy|2
824481|NCT00983918|2619792|P3|Overall Study|conversion to open cholecystectomy|2
824482|NCT00983918|2619793|P2|Overall Study|conversion to open cholecystectomy|2
824483|NCT00983918|2619794|P1|Overall Study|conversion to open cholecystectomy|0
824484|NCT00983931|2619804|P1|14 Day Washout Period|Physician Decision|1
824485|NCT00983957|2619814|P1|Overall Study|Personal Reasons|1
824486|NCT00983957|2619814|P1|Overall Study|Adverse Event|1
824487|NCT00984009|2619870|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
824488|NCT00984022|2619883|P2|Overall Study|Lost to Follow-up|14
824489|NCT00984022|2619884|P1|Overall Study|Lost to Follow-up|10
824490|NCT00984061|2619894|P1|Clarithromycin Alone|Protocol Violation|1
824491|NCT00984126|2619909|P4|Overall Study|Withdrawal criteria|9
824492|NCT00984126|2619910|P3|Overall Study|Withdrawal criteria|3
824493|NCT00984126|2619911|P2|Overall Study|Withdrawal criteria|1
824494|NCT00984126|2619912|P1|Overall Study|Withdrawal criteria|0
824495|NCT00984126|2619909|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
824496|NCT00984126|2619910|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
824497|NCT00984126|2619911|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
824498|NCT00984126|2619912|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
824499|NCT00984126|2619909|P4|Overall Study|Adverse Event|2
824500|NCT00984126|2619910|P3|Overall Study|Adverse Event|0
824501|NCT00984126|2619911|P2|Overall Study|Adverse Event|0
824502|NCT00984126|2619912|P1|Overall Study|Adverse Event|0
824503|NCT00984126|2619909|P4|Overall Study|Protocol Violation|2
824504|NCT00984126|2619910|P3|Overall Study|Protocol Violation|1
824505|NCT00984126|2619911|P2|Overall Study|Protocol Violation|0
824506|NCT00984126|2619912|P1|Overall Study|Protocol Violation|0
893351|NCT00903968|2834188|P7|Overall Study|Progressive Disease|0
893352|NCT00903968|2834189|P6|Overall Study|Progressive Disease|3
893353|NCT00903968|2834190|P5|Overall Study|Progressive Disease|3
893354|NCT00903968|2834191|P4|Overall Study|Progressive Disease|3
893355|NCT00903968|2834192|P3|Overall Study|Progressive Disease|2
893356|NCT00903968|2834193|P2|Overall Study|Progressive Disease|3
893357|NCT00903968|2834194|P1|Overall Study|Progressive Disease|2
893358|NCT00903968|2834187|P8|Overall Study|Physician Decision|0
893359|NCT00903968|2834188|P7|Overall Study|Physician Decision|0
893360|NCT00903968|2834189|P6|Overall Study|Physician Decision|1
893361|NCT00903968|2834190|P5|Overall Study|Physician Decision|0
893362|NCT00903968|2834191|P4|Overall Study|Physician Decision|0
893363|NCT00903968|2834192|P3|Overall Study|Physician Decision|0
893364|NCT00903968|2834193|P2|Overall Study|Physician Decision|0
893365|NCT00903968|2834194|P1|Overall Study|Physician Decision|0
893366|NCT00903968|2834187|P8|Overall Study|Non-Compliance|0
893367|NCT00903968|2834188|P7|Overall Study|Non-Compliance|0
893368|NCT00903968|2834189|P6|Overall Study|Non-Compliance|1
893369|NCT00903968|2834190|P5|Overall Study|Non-Compliance|0
893370|NCT00903968|2834191|P4|Overall Study|Non-Compliance|0
893371|NCT00903968|2834192|P3|Overall Study|Non-Compliance|0
893372|NCT00903968|2834193|P2|Overall Study|Non-Compliance|0
893373|NCT00903968|2834194|P1|Overall Study|Non-Compliance|0
893374|NCT00903968|2834187|P8|Overall Study|Withdrawal by Subject|4
824531|NCT00984204|2619969|P1|Overall Study|Lack of Efficacy|10
824532|NCT00984204|2619969|P1|Overall Study|Lost to Follow-up|4
824533|NCT00984204|2619969|P1|Overall Study|Death|1
824534|NCT00984256|2619977|P2|Overall Study|Withdrawal by Subject|1
824535|NCT00984256|2619978|P1|Overall Study|Withdrawal by Subject|0
893375|NCT00903968|2834188|P7|Overall Study|Withdrawal by Subject|0
893376|NCT00903968|2834189|P6|Overall Study|Withdrawal by Subject|1
824580|NCT00984295|2620025|P3|Overall Study|Incomplete safety follow-up|3
824581|NCT00984295|2620026|P2|Overall Study|Incomplete safety follow-up|2
824582|NCT00984295|2620027|P1|Overall Study|Incomplete safety follow-up|11
824583|NCT00984295|2620025|P3|Overall Study|Missed one or more blood samplings|2
824584|NCT00984295|2620026|P2|Overall Study|Missed one or more blood samplings|7
824585|NCT00984295|2620027|P1|Overall Study|Missed one or more blood samplings|3
824586|NCT00984295|2620025|P3|Overall Study|CAE – discontinued test vaccine|3
824587|NCT00984295|2620026|P2|Overall Study|CAE – discontinued test vaccine|1
824588|NCT00984295|2620027|P1|Overall Study|CAE – discontinued test vaccine|0
824589|NCT00984295|2620025|P3|Overall Study|Withdrawal by Subject|12
824590|NCT00984295|2620026|P2|Overall Study|Withdrawal by Subject|9
824591|NCT00984295|2620027|P1|Overall Study|Withdrawal by Subject|18
824592|NCT00984295|2620025|P3|Overall Study|Protocol Violation|4
824593|NCT00984295|2620026|P2|Overall Study|Protocol Violation|1
824594|NCT00984295|2620027|P1|Overall Study|Protocol Violation|2
824595|NCT00984295|2620025|P3|Overall Study|Lost to Follow-up|13
824596|NCT00984295|2620026|P2|Overall Study|Lost to Follow-up|12
824597|NCT00984295|2620027|P1|Overall Study|Lost to Follow-up|31
824598|NCT00984542|2620131|P1|Overall Study|clinical deterioration|2
824599|NCT00984542|2620131|P1|Overall Study|Withdrawal by Subject|3
824600|NCT00984542|2620131|P1|Overall Study|complicating disease|3
824601|NCT00984542|2620131|P1|Overall Study|Death|7
824602|NCT00984542|2620131|P1|Overall Study|toxicity|7
824603|NCT00984542|2620131|P1|Overall Study|disease progression|19
824604|NCT00984568|2620141|P2|Overall Study|Unknown Reason|3
824605|NCT00984568|2620142|P1|Overall Study|Unknown Reason|1
824606|NCT00984568|2620141|P2|Overall Study|Opportunistic Infection|0
824607|NCT00984568|2620142|P1|Overall Study|Opportunistic Infection|1
824608|NCT00984568|2620141|P2|Overall Study|Lost to Follow-up|1
824609|NCT00984568|2620142|P1|Overall Study|Lost to Follow-up|0
824610|NCT00984568|2620141|P2|Overall Study|Did Not Meet Randomization Criteria|0
824611|NCT00984568|2620142|P1|Overall Study|Did Not Meet Randomization Criteria|1
824612|NCT00984568|2620141|P2|Overall Study|Adverse Event|0
824613|NCT00984568|2620142|P1|Overall Study|Adverse Event|2
824614|NCT00984568|2620141|P2|Overall Study|Lack of Efficacy|0
824615|NCT00984568|2620142|P1|Overall Study|Lack of Efficacy|2
824616|NCT00984568|2620141|P2|Overall Study|Withdrawal by Subject|2
824617|NCT00984568|2620142|P1|Overall Study|Withdrawal by Subject|1
824618|NCT00984594|2620152|P2|Overall Study|Withdrawal by Subject|1
824619|NCT00984594|2620153|P1|Overall Study|Withdrawal by Subject|0
824620|NCT00984594|2620152|P2|Overall Study|Lost to Follow-up|0
824621|NCT00984594|2620153|P1|Overall Study|Lost to Follow-up|1
824622|NCT00984620|2620169|P2|Overall Study|reason other than listed above|4
824623|NCT00984620|2620170|P1|Overall Study|reason other than listed above|0
824624|NCT00984620|2620169|P2|Overall Study|Withdrawal by Subject|2
824625|NCT00984620|2620170|P1|Overall Study|Withdrawal by Subject|0
824626|NCT00984620|2620169|P2|Overall Study|Lost to Follow-up|1
824627|NCT00984620|2620170|P1|Overall Study|Lost to Follow-up|1
824628|NCT00984620|2620169|P2|Overall Study|Adverse Event|5
824629|NCT00984620|2620170|P1|Overall Study|Adverse Event|5
893377|NCT00903968|2834190|P5|Overall Study|Withdrawal by Subject|1
893378|NCT00903968|2834191|P4|Overall Study|Withdrawal by Subject|0
893379|NCT00903968|2834192|P3|Overall Study|Withdrawal by Subject|1
893380|NCT00903968|2834193|P2|Overall Study|Withdrawal by Subject|0
893381|NCT00903968|2834194|P1|Overall Study|Withdrawal by Subject|1
893382|NCT00903968|2834187|P8|Overall Study|DLT|0
893383|NCT00903968|2834188|P7|Overall Study|DLT|2
893384|NCT00903968|2834189|P6|Overall Study|DLT|0
893385|NCT00903968|2834190|P5|Overall Study|DLT|0
893386|NCT00903968|2834191|P4|Overall Study|DLT|0
893387|NCT00903968|2834192|P3|Overall Study|DLT|0
893388|NCT00903968|2834193|P2|Overall Study|DLT|0
893389|NCT00903968|2834194|P1|Overall Study|DLT|0
893390|NCT00903968|2834187|P8|Overall Study|Adverse Event|8
893391|NCT00903968|2834188|P7|Overall Study|Adverse Event|1
893392|NCT00903968|2834189|P6|Overall Study|Adverse Event|0
893393|NCT00903968|2834190|P5|Overall Study|Adverse Event|0
893394|NCT00903968|2834191|P4|Overall Study|Adverse Event|0
893395|NCT00903968|2834192|P3|Overall Study|Adverse Event|0
893396|NCT00903968|2834193|P2|Overall Study|Adverse Event|0
893397|NCT00903968|2834194|P1|Overall Study|Adverse Event|0
893398|NCT00622401|2834250|P3|Overall Study|Disease progression prior to treatment|0
893399|NCT00622401|2834251|P2|Overall Study|Disease progression prior to treatment|2
893400|NCT00622401|2834252|P1|Overall Study|Disease progression prior to treatment|3
893401|NCT00617409|2834262|P3|Overall Study|Alternative Therapy|0
893402|NCT00617409|2834263|P2|Overall Study|Alternative Therapy|2
893403|NCT00617409|2834264|P1|Overall Study|Alternative Therapy|1
893404|NCT00617409|2834262|P3|Overall Study|Death|4
893405|NCT00617409|2834263|P2|Overall Study|Death|5
893406|NCT00617409|2834264|P1|Overall Study|Death|3
893407|NCT00617409|2834262|P3|Overall Study|Disease Progression|18
893408|NCT00617409|2834263|P2|Overall Study|Disease Progression|8
893409|NCT00617409|2834264|P1|Overall Study|Disease Progression|8
893410|NCT00617409|2834262|P3|Overall Study|Adverse Event|3
893411|NCT00617409|2834263|P2|Overall Study|Adverse Event|2
893412|NCT00617409|2834264|P1|Overall Study|Adverse Event|0
893413|NCT00617409|2834262|P3|Overall Study|Withdrawal by Subject|2
893414|NCT00617409|2834263|P2|Overall Study|Withdrawal by Subject|1
893415|NCT00617409|2834264|P1|Overall Study|Withdrawal by Subject|4
893416|NCT00512148|2834283|P1|Primay Study Period|Withdrawal by Subject|1
824678|NCT00984867|2620258|P2|Overall Study|lack of efficacy and subject compliance|0
824679|NCT00984867|2620259|P1|Overall Study|lack of efficacy and subject compliance|1
824680|NCT00984867|2620258|P2|Overall Study|site closing|0
824681|NCT00984867|2620259|P1|Overall Study|site closing|1
824682|NCT00984867|2620258|P2|Overall Study|Subject no longer meets study criteria|1
824683|NCT00984867|2620259|P1|Overall Study|Subject no longer meets study criteria|1
824684|NCT00984867|2620258|P2|Overall Study|Poor/non-compliance|1
824685|NCT00984867|2620259|P1|Overall Study|Poor/non-compliance|0
824686|NCT00984867|2620258|P2|Overall Study|Lost to Follow-up|4
824687|NCT00984867|2620259|P1|Overall Study|Lost to Follow-up|3
824688|NCT00984867|2620258|P2|Overall Study|Withdrawal by Subject|4
824689|NCT00984867|2620259|P1|Overall Study|Withdrawal by Subject|13
824690|NCT00984867|2620258|P2|Overall Study|Death|0
824691|NCT00984867|2620259|P1|Overall Study|Death|1
824692|NCT00984867|2620258|P2|Overall Study|Adverse Event|7
824693|NCT00984867|2620259|P1|Overall Study|Adverse Event|3
824694|NCT00985114|2620290|P2|Overall Study|Withdrawal by Subject|2
824695|NCT00985114|2620291|P1|Overall Study|Withdrawal by Subject|0
824696|NCT00985114|2620290|P2|Overall Study|Adverse Event|0
824697|NCT00985114|2620291|P1|Overall Study|Adverse Event|1
824698|NCT00985153|2620305|P4|Overall Study|Incomplete Safety Follow-up|4
824699|NCT00985153|2620306|P3|Overall Study|Incomplete Safety Follow-up|4
824700|NCT00985153|2620307|P2|Overall Study|Incomplete Safety Follow-up|5
824701|NCT00985153|2620308|P1|Overall Study|Incomplete Safety Follow-up|3
824702|NCT00985153|2620305|P4|Overall Study|Missed One or More Bleeds|10
824703|NCT00985153|2620306|P3|Overall Study|Missed One or More Bleeds|8
824704|NCT00985153|2620307|P2|Overall Study|Missed One or More Bleeds|7
824705|NCT00985153|2620308|P1|Overall Study|Missed One or More Bleeds|7
824706|NCT00985153|2620305|P4|Overall Study|Withdrawal by Subject|10
893427|NCT00344461|2834297|P1|Overall Study|Withdrawal by Subject|2
893428|NCT00344461|2834297|P1|Overall Study|Protocol Violation|6
893429|NCT00344461|2834297|P1|Overall Study|Physician Decision|2
893430|NCT00344461|2834297|P1|Overall Study|Lost to Follow-up|2
893431|NCT00344461|2834297|P1|Overall Study|Lack of Efficacy|2
893432|NCT00344461|2834297|P1|Overall Study|Death|1
893433|NCT00344461|2834297|P1|Overall Study|Adverse Event|6
893434|NCT00278395|2834306|P1|Overall Study|Nonevaluable|1
824707|NCT00985153|2620306|P3|Overall Study|Withdrawal by Subject|11
824708|NCT00985153|2620307|P2|Overall Study|Withdrawal by Subject|11
824709|NCT00985153|2620308|P1|Overall Study|Withdrawal by Subject|6
824710|NCT00985153|2620305|P4|Overall Study|Protocol Violation|3
824711|NCT00985153|2620306|P3|Overall Study|Protocol Violation|4
824712|NCT00985153|2620307|P2|Overall Study|Protocol Violation|2
824713|NCT00985153|2620308|P1|Overall Study|Protocol Violation|3
824714|NCT00985153|2620305|P4|Overall Study|Lost to Follow-up|20
824715|NCT00985153|2620306|P3|Overall Study|Lost to Follow-up|17
824716|NCT00985153|2620307|P2|Overall Study|Lost to Follow-up|19
824717|NCT00985153|2620308|P1|Overall Study|Lost to Follow-up|16
824718|NCT00985166|2620353|P3|Overall Study|Unspecified|1
824719|NCT00985166|2620354|P2|Overall Study|Unspecified|0
824720|NCT00985166|2620355|P1|Overall Study|Unspecified|1
824721|NCT00985166|2620353|P3|Overall Study|Test not done|4
824722|NCT00985166|2620354|P2|Overall Study|Test not done|0
824723|NCT00985166|2620355|P1|Overall Study|Test not done|2
824724|NCT00985166|2620353|P3|Overall Study|Withdrawal by Subject|0
824725|NCT00985166|2620354|P2|Overall Study|Withdrawal by Subject|2
824726|NCT00985166|2620355|P1|Overall Study|Withdrawal by Subject|3
824727|NCT00985166|2620353|P3|Overall Study|Lost to Follow-up|2
824728|NCT00985166|2620354|P2|Overall Study|Lost to Follow-up|2
824729|NCT00985166|2620355|P1|Overall Study|Lost to Follow-up|3
824730|NCT00985192|2620371|P1|Overall Study|Determined to be Ineligible During Trial|2
824731|NCT00985192|2620371|P1|Overall Study|Disease Progression|1
824732|NCT00985192|2620371|P1|Overall Study|Withdrawal by Subject|1
824733|NCT00985231|2620382|P2|Overall Study|Study related symptoms & complaints|2
824734|NCT00985231|2620383|P1|Overall Study|Study related symptoms & complaints|0
824735|NCT00985231|2620382|P2|Overall Study|Lost to Follow-up|1
824736|NCT00985231|2620383|P1|Overall Study|Lost to Follow-up|0
824737|NCT00985231|2620382|P2|Overall Study|Withdrawal by Subject|0
824738|NCT00985231|2620383|P1|Overall Study|Withdrawal by Subject|1
824739|NCT00985231|2620382|P2|Overall Study|Protocol Violation|0
824740|NCT00985231|2620383|P1|Overall Study|Protocol Violation|1
824741|NCT00985231|2620382|P2|Overall Study|ineligible|0
824742|NCT00985231|2620383|P1|Overall Study|ineligible|1
824743|NCT00985439|2620399|P4|Overall Study|Adverse Event|0
824744|NCT00985439|2620400|P3|Overall Study|Adverse Event|1
824745|NCT00985439|2620401|P2|Overall Study|Adverse Event|0
824746|NCT00985439|2620402|P1|Overall Study|Adverse Event|0
824747|NCT00985491|2620412|P1|Overall Study|implant failure|3
824748|NCT00985491|2620412|P1|Overall Study|Withdrawal by Subject|1
824749|NCT00985491|2620412|P1|Overall Study|device migration|7
824750|NCT00985491|2620412|P1|Overall Study|Adverse Event|8
824751|NCT00985504|2620419|P2|Optimization Period|Withdrawal by Subject|8
824752|NCT00985504|2620420|P1|Optimization Period|Withdrawal by Subject|10
824753|NCT00985504|2620419|P2|Optimization Period|Protocol Violation|1
824754|NCT00985504|2620420|P1|Optimization Period|Protocol Violation|3
824755|NCT00985504|2620419|P2|Optimization Period|Physician Decision|0
824756|NCT00985504|2620420|P1|Optimization Period|Physician Decision|1
824757|NCT00985504|2620419|P2|Optimization Period|Lost to Follow-up|1
824758|NCT00985504|2620420|P1|Optimization Period|Lost to Follow-up|0
824759|NCT00985504|2620419|P2|Optimization Period|Lack of Efficacy|3
824760|NCT00985504|2620420|P1|Optimization Period|Lack of Efficacy|5
824761|NCT00985504|2620419|P2|Optimization Period|Death|1
824762|NCT00985504|2620420|P1|Optimization Period|Death|0
824763|NCT00985504|2620419|P2|Optimization Period|Adverse Event|9
824764|NCT00985504|2620420|P1|Optimization Period|Adverse Event|7
824765|NCT00985504|2620419|P2|Acute Treatment Period|Withdrawal by Subject|5
824766|NCT00985504|2620420|P1|Acute Treatment Period|Withdrawal by Subject|9
824767|NCT00985504|2620419|P2|Acute Treatment Period|Sponsor Decision|1
824768|NCT00985504|2620420|P1|Acute Treatment Period|Sponsor Decision|0
824769|NCT00985504|2620419|P2|Acute Treatment Period|Protocol Violation|0
824770|NCT00985504|2620420|P1|Acute Treatment Period|Protocol Violation|2
824771|NCT00985504|2620419|P2|Acute Treatment Period|Entry Criteria Not Met|2
824772|NCT00985504|2620420|P1|Acute Treatment Period|Entry Criteria Not Met|1
824773|NCT00985504|2620419|P2|Acute Treatment Period|Adverse Event|4
824774|NCT00985504|2620420|P1|Acute Treatment Period|Adverse Event|3
824775|NCT00988429|2620449|P3|Overall Study|other reasons|1
824776|NCT00988429|2620450|P2|Overall Study|other reasons|8
824777|NCT00988429|2620451|P1|Overall Study|other reasons|8
824778|NCT00988429|2620449|P3|Overall Study|Administrative Reasons|1
824779|NCT00988429|2620450|P2|Overall Study|Administrative Reasons|2
824780|NCT00988429|2620451|P1|Overall Study|Administrative Reasons|1
824781|NCT00988429|2620449|P3|Overall Study|Withdrawal by Subject|12
824782|NCT00988429|2620450|P2|Overall Study|Withdrawal by Subject|7
824783|NCT00988429|2620451|P1|Overall Study|Withdrawal by Subject|7
824784|NCT00988429|2620449|P3|Overall Study|Protocol Violation|3
824785|NCT00988429|2620450|P2|Overall Study|Protocol Violation|3
824786|NCT00988429|2620451|P1|Overall Study|Protocol Violation|4
824787|NCT00988429|2620449|P3|Overall Study|Pregnancy|0
824788|NCT00988429|2620450|P2|Overall Study|Pregnancy|1
824789|NCT00988429|2620451|P1|Overall Study|Pregnancy|2
824790|NCT00988429|2620449|P3|Overall Study|Physician Decision|3
824791|NCT00988429|2620450|P2|Overall Study|Physician Decision|0
824792|NCT00988429|2620451|P1|Overall Study|Physician Decision|1
824793|NCT00988429|2620449|P3|Overall Study|Non-Compliance with Study Drug|3
824794|NCT00988429|2620450|P2|Overall Study|Non-Compliance with Study Drug|1
824795|NCT00988429|2620451|P1|Overall Study|Non-Compliance with Study Drug|5
824796|NCT00988429|2620449|P3|Overall Study|Lack of Efficacy|1
824797|NCT00988429|2620450|P2|Overall Study|Lack of Efficacy|0
824798|NCT00988429|2620451|P1|Overall Study|Lack of Efficacy|0
824799|NCT00988429|2620449|P3|Overall Study|Adverse Event|45
824800|NCT00988429|2620450|P2|Overall Study|Adverse Event|21
824801|NCT00988429|2620451|P1|Overall Study|Adverse Event|9
824802|NCT00988442|2620464|P2|Overall Study|Early Study Closure|25
824803|NCT00988442|2620465|P1|Overall Study|Early Study Closure|29
824804|NCT00988442|2620464|P2|Overall Study|Lost to Follow-up|1
824805|NCT00988442|2620465|P1|Overall Study|Lost to Follow-up|0
824806|NCT00988442|2620464|P2|Overall Study|Death|2
824807|NCT00988442|2620465|P1|Overall Study|Death|1
824808|NCT00988533|2620525|P1|Overall Study|Lost to Follow-up|3
824809|NCT00988637|2620539|P2|Overall Study|non-compliance with study drug|1
824810|NCT00988637|2620540|P1|Overall Study|non-compliance with study drug|0
824811|NCT00988637|2620539|P2|Overall Study|Withdrawal by Subject|1
824812|NCT00988637|2620540|P1|Overall Study|Withdrawal by Subject|1
824813|NCT00988637|2620539|P2|Overall Study|Lost to Follow-up|1
824814|NCT00988637|2620540|P1|Overall Study|Lost to Follow-up|2
824815|NCT00988858|2620605|P1|Overall Study|Sponsor Decision|1
824816|NCT00988858|2620605|P1|Overall Study|Physician Decision|1
824817|NCT00988858|2620605|P1|Overall Study|Death|1
824818|NCT00988858|2620605|P1|Overall Study|Adverse Event|7
824819|NCT00988884|2620619|P2|Overall Study|Withdrawal by Subject|18
824820|NCT00988884|2620620|P1|Overall Study|Withdrawal by Subject|15
824821|NCT00988884|2620619|P2|Overall Study|Protocol Violation|1
824822|NCT00988884|2620620|P1|Overall Study|Protocol Violation|0
824823|NCT00988884|2620619|P2|Overall Study|Lost to Follow-up|16
824824|NCT00988884|2620620|P1|Overall Study|Lost to Follow-up|20
824825|NCT00988884|2620619|P2|Overall Study|Adverse Event|1
824826|NCT00988884|2620620|P1|Overall Study|Adverse Event|0
824827|NCT00989092|2620661|P2|Overall Study|Did not receive study drug|0
824828|NCT00989092|2620662|P1|Overall Study|Did not receive study drug|2
824829|NCT00989092|2620661|P2|Overall Study|Erythropoietin therapy initiated|0
824830|NCT00989092|2620662|P1|Overall Study|Erythropoietin therapy initiated|2
824831|NCT00989092|2620661|P2|Overall Study|Protocol deviation|0
824832|NCT00989092|2620662|P1|Overall Study|Protocol deviation|2
824833|NCT00989092|2620661|P2|Overall Study|Other|1
824834|NCT00989092|2620662|P1|Overall Study|Other|3
824835|NCT00989092|2620661|P2|Overall Study|Lost to Follow-up|2
824836|NCT00989092|2620662|P1|Overall Study|Lost to Follow-up|6
824837|NCT00989092|2620661|P2|Overall Study|Ineligibility determined|3
824838|NCT00989092|2620662|P1|Overall Study|Ineligibility determined|3
824839|NCT00989092|2620661|P2|Overall Study|Death|2
824840|NCT00989092|2620662|P1|Overall Study|Death|14
824841|NCT00989092|2620661|P2|Overall Study|Withdrawal by Subject|9
824842|NCT00989092|2620662|P1|Overall Study|Withdrawal by Subject|17
824843|NCT00989092|2620661|P2|Overall Study|Chemotherapy initiated|4
824844|NCT00989092|2620662|P1|Overall Study|Chemotherapy initiated|12
824845|NCT00989092|2620661|P2|Overall Study|Adverse Event|1
824846|NCT00989092|2620662|P1|Overall Study|Adverse Event|20
824847|NCT00989092|2620661|P2|Overall Study|Physician Decision|6
824848|NCT00989092|2620662|P1|Overall Study|Physician Decision|9
824849|NCT00989196|2620712|P2|Treatment Period|Lost to Follow-up|0
824850|NCT00989196|2620713|P1|Treatment Period|Lost to Follow-up|1
824851|NCT00989235|2620734|P2|Overall Study|Lost to Follow-up|1
824852|NCT00989235|2620735|P1|Overall Study|Lost to Follow-up|0
824853|NCT00989235|2620734|P2|Overall Study|Randomized by Mistake|2
824854|NCT00989235|2620735|P1|Overall Study|Randomized by Mistake|0
824855|NCT00989235|2620734|P2|Overall Study|Desire to Become Pregnant|0
824856|NCT00989235|2620735|P1|Overall Study|Desire to Become Pregnant|1
824857|NCT00989235|2620734|P2|Overall Study|Withdrawal of Consent|1
824858|NCT00989235|2620735|P1|Overall Study|Withdrawal of Consent|1
824859|NCT00989235|2620734|P2|Overall Study|Lack of Efficacy|0
824860|NCT00989235|2620735|P1|Overall Study|Lack of Efficacy|1
824861|NCT00989235|2620734|P2|Overall Study|Adverse Event|1
824862|NCT00989235|2620735|P1|Overall Study|Adverse Event|0
824863|NCT00989235|2620734|P2|Overall Study|Death|1
824864|NCT00989235|2620735|P1|Overall Study|Death|0
824865|NCT00989664|2620796|P1|Long-Term Follow-Up|Death|3
824866|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
824867|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
824868|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Death|1
824869|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
824870|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
824871|NCT00989664|2620796|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
824872|NCT00989833|2620838|P3|Overall Study|Incorrectly randomized|0
824873|NCT00989833|2620839|P2|Overall Study|Incorrectly randomized|0
824874|NCT00989833|2620840|P1|Overall Study|Incorrectly randomized|1
824875|NCT00989833|2620838|P3|Overall Study|Withdrawal by Subject|1
824876|NCT00989833|2620839|P2|Overall Study|Withdrawal by Subject|0
824877|NCT00989833|2620840|P1|Overall Study|Withdrawal by Subject|0
824878|NCT00989833|2620838|P3|Overall Study|Protocol Violation|1
824879|NCT00989833|2620839|P2|Overall Study|Protocol Violation|2
824880|NCT00989833|2620840|P1|Overall Study|Protocol Violation|1
824881|NCT00989833|2620838|P3|Overall Study|Lost to Follow-up|0
824882|NCT00989833|2620839|P2|Overall Study|Lost to Follow-up|1
824883|NCT00989833|2620840|P1|Overall Study|Lost to Follow-up|0
824884|NCT00989950|2620877|P4|Randomized Phase|Adverse Event|0
824885|NCT00989950|2620878|P3|Randomized Phase|Adverse Event|0
824886|NCT00989950|2620879|P2|Randomized Phase|Adverse Event|1
824887|NCT00989950|2620880|P1|Randomized Phase|Adverse Event|0
824888|NCT00989950|2620877|P4|Randomized Phase|Protocol Violation|0
824889|NCT00989950|2620878|P3|Randomized Phase|Protocol Violation|0
824890|NCT00989950|2620879|P2|Randomized Phase|Protocol Violation|0
824891|NCT00989950|2620880|P1|Randomized Phase|Protocol Violation|1
824892|NCT00990093|2620933|P2|Test Period 2 (15-28 Days)|Not specified|1
824893|NCT00990093|2620934|P1|Test Period 2 (15-28 Days)|Not specified|0
824894|NCT00990093|2620933|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
824895|NCT00990093|2620934|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
824896|NCT00990093|2620933|P2|Test Period 2 (15-28 Days)|Adverse Event|0
824897|NCT00990093|2620934|P1|Test Period 2 (15-28 Days)|Adverse Event|1
824898|NCT00990093|2620933|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
824899|NCT00990093|2620934|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
824900|NCT00990093|2620933|P2|Test Period 1 (1-14 Days)|Not Specified|0
824901|NCT00990093|2620934|P1|Test Period 1 (1-14 Days)|Not Specified|1
824902|NCT00990093|2620933|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
824903|NCT00990093|2620934|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
824904|NCT00990093|2620933|P2|Test Period 1 (1-14 Days)|Adverse Event|0
824905|NCT00990093|2620934|P1|Test Period 1 (1-14 Days)|Adverse Event|1
824906|NCT00990106|2620942|P2|Overall Study|scheduling conflicts|2
824907|NCT00990106|2620943|P1|Overall Study|scheduling conflicts|0
824908|NCT00990106|2620942|P2|Overall Study|planned major surgery|1
824909|NCT00990106|2620943|P1|Overall Study|planned major surgery|0
824910|NCT00990106|2620942|P2|Overall Study|started exclusionary medication|1
824911|NCT00990106|2620943|P1|Overall Study|started exclusionary medication|0
824912|NCT00990106|2620942|P2|Overall Study|relocation/deployment|1
824913|NCT00990106|2620943|P1|Overall Study|relocation/deployment|4
824914|NCT00990106|2620942|P2|Overall Study|opted for open label prazosin|1
824915|NCT00990106|2620943|P1|Overall Study|opted for open label prazosin|1
824916|NCT00990106|2620942|P2|Overall Study|Withdrawal by Subject|1
824917|NCT00990106|2620943|P1|Overall Study|Withdrawal by Subject|2
824918|NCT00990106|2620942|P2|Overall Study|Lost to Follow-up|3
824919|NCT00990106|2620943|P1|Overall Study|Lost to Follow-up|1
824920|NCT00990106|2620942|P2|Overall Study|"too busy to continue"|2
824921|NCT00990106|2620943|P1|Overall Study|"too busy to continue"|1
824922|NCT00990184|2620953|P1|Overall Study|Physician Decision|1
824923|NCT00990340|2620961|P2|First 14-day Treatment|Protocol Violation|2
824924|NCT00990340|2620962|P1|First 14-day Treatment|Protocol Violation|2
824925|NCT00990340|2620961|P2|First 14-day Treatment|Lost to Follow-up|1
824926|NCT00990340|2620962|P1|First 14-day Treatment|Lost to Follow-up|2
824927|NCT00990340|2620961|P2|First 14-day Treatment|Not Compliant|1
824928|NCT00990340|2620962|P1|First 14-day Treatment|Not Compliant|2
824929|NCT00990652|2621000|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
824930|NCT00990652|2621000|P1|Pre-surgical Bortezomib|Adverse Event|1
824931|NCT00990704|2621010|P2|Overall Study|Physician Decision|1
824932|NCT00990704|2621011|P1|Overall Study|Physician Decision|0
824933|NCT00990704|2621010|P2|Overall Study|Adverse Event|1
824934|NCT00990704|2621011|P1|Overall Study|Adverse Event|1
824935|NCT00990821|2621063|P14|Overall Study|Withdrawal by Subject|1
824936|NCT00990821|2621064|P13|Overall Study|Withdrawal by Subject|2
824937|NCT00990821|2621065|P12|Overall Study|Withdrawal by Subject|5
824938|NCT00990821|2621066|P11|Overall Study|Withdrawal by Subject|3
824939|NCT00990821|2621067|P10|Overall Study|Withdrawal by Subject|1
824940|NCT00990821|2621068|P9|Overall Study|Withdrawal by Subject|0
824941|NCT00990821|2621069|P8|Overall Study|Withdrawal by Subject|0
824942|NCT00990821|2621070|P7|Overall Study|Withdrawal by Subject|1
824943|NCT00990821|2621071|P6|Overall Study|Withdrawal by Subject|3
824944|NCT00990821|2621072|P5|Overall Study|Withdrawal by Subject|3
824945|NCT00990821|2621073|P4|Overall Study|Withdrawal by Subject|0
824946|NCT00990821|2621074|P3|Overall Study|Withdrawal by Subject|0
824947|NCT00990821|2621075|P2|Overall Study|Withdrawal by Subject|2
824948|NCT00990821|2621076|P1|Overall Study|Withdrawal by Subject|0
824949|NCT00982020|2621112|P2|Overall Study|Clinical Relapse|1
824950|NCT00982020|2621113|P1|Overall Study|Clinical Relapse|0
824951|NCT00982020|2621112|P2|Overall Study|Protocol Violation|2
824952|NCT00982020|2621113|P1|Overall Study|Protocol Violation|0
824953|NCT00982020|2621112|P2|Overall Study|Entry Criteria Not Met|1
824954|NCT00982020|2621113|P1|Overall Study|Entry Criteria Not Met|2
824955|NCT00982020|2621112|P2|Overall Study|Physician Decision|5
824956|NCT00982020|2621113|P1|Overall Study|Physician Decision|2
824957|NCT00982020|2621112|P2|Overall Study|Treatment Non-compliance|6
824958|NCT00982020|2621113|P1|Overall Study|Treatment Non-compliance|3
824959|NCT00982020|2621112|P2|Overall Study|Parent/Caregiver Decision|5
824960|NCT00982020|2621113|P1|Overall Study|Parent/Caregiver Decision|5
824961|NCT00982020|2621112|P2|Overall Study|Lack of Efficacy|4
824962|NCT00982020|2621113|P1|Overall Study|Lack of Efficacy|10
824963|NCT00982020|2621112|P2|Overall Study|Lost to Follow-up|11
824964|NCT00982020|2621113|P1|Overall Study|Lost to Follow-up|5
824965|NCT00982020|2621112|P2|Overall Study|Withdrawal by Subject|14
824966|NCT00982020|2621113|P1|Overall Study|Withdrawal by Subject|11
824967|NCT00982020|2621112|P2|Overall Study|Adverse Event|15
824968|NCT00982020|2621113|P1|Overall Study|Adverse Event|19
824969|NCT00982111|2621144|P2|Overall Study|Withdrawal by Subject|17
824970|NCT00982111|2621145|P1|Overall Study|Withdrawal by Subject|16
824971|NCT00982111|2621144|P2|Overall Study|On Study Treatment at Conclusion|0
824972|NCT00982111|2621145|P1|Overall Study|On Study Treatment at Conclusion|7
824973|NCT00982111|2621144|P2|Overall Study|New Anti-Cancer Therapy|5
824974|NCT00982111|2621145|P1|Overall Study|New Anti-Cancer Therapy|5
824975|NCT00982111|2621144|P2|Overall Study|Lost to Follow-up|6
824976|NCT00982111|2621145|P1|Overall Study|Lost to Follow-up|9
824977|NCT00982111|2621144|P2|Overall Study|Progressive Disease|37
824978|NCT00982111|2621145|P1|Overall Study|Progressive Disease|37
824979|NCT00982111|2621144|P2|Overall Study|Adverse Event|1
824980|NCT00982111|2621145|P1|Overall Study|Adverse Event|1
824981|NCT00982137|2621171|P4|Overall Study|Withdrawal by Subject|0
824982|NCT00982137|2621172|P3|Overall Study|Withdrawal by Subject|0
824983|NCT00982137|2621173|P2|Overall Study|Withdrawal by Subject|1
824984|NCT00982137|2621174|P1|Overall Study|Withdrawal by Subject|0
824985|NCT00982137|2621171|P4|Overall Study|Lost to Follow-up|1
824986|NCT00982137|2621172|P3|Overall Study|Lost to Follow-up|0
824987|NCT00982137|2621173|P2|Overall Study|Lost to Follow-up|0
824988|NCT00982137|2621174|P1|Overall Study|Lost to Follow-up|0
824989|NCT00982228|2621231|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
824990|NCT00982228|2621232|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
824991|NCT00982228|2621231|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
824992|NCT00982228|2621232|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
824993|NCT00982228|2621231|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
824994|NCT00982228|2621232|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
824995|NCT00982228|2621231|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
824996|NCT00982228|2621232|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
824997|NCT00982228|2621231|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
824998|NCT00982228|2621232|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
824999|NCT00982228|2621231|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
825000|NCT00982228|2621232|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
825001|NCT00982228|2621231|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
825002|NCT00982228|2621232|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
825003|NCT00982228|2621231|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
825004|NCT00982228|2621232|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
825005|NCT00982228|2621231|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
825006|NCT00982228|2621232|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
825007|NCT00982228|2621231|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
825008|NCT00982228|2621232|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
825009|NCT00982280|2621256|P1|Maintenance Period|Adverse Event|1
825010|NCT00982280|2621256|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
825011|NCT00982280|2621256|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
825012|NCT00982280|2621256|P1|Titration and Optimal Dose Period|Adverse Event|5
825013|NCT00982280|2621256|P1|Observation Period|Not eligible to be dosed|19
825014|NCT00982410|2621285|P2|12-month Follow-up Assessment|scheduled, no-show|0
825015|NCT00982410|2621286|P1|12-month Follow-up Assessment|scheduled, no-show|1
825016|NCT00982410|2621285|P2|12-month Follow-up Assessment|incarceration|1
825017|NCT00982410|2621286|P1|12-month Follow-up Assessment|incarceration|2
825018|NCT00982410|2621285|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
825019|NCT00982410|2621286|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
825020|NCT00982410|2621285|P2|12-month Follow-up Assessment|could not reach to schedule|5
825021|NCT00982410|2621286|P1|12-month Follow-up Assessment|could not reach to schedule|6
825022|NCT00982410|2621285|P2|12-month Follow-up Assessment|Death|2
825023|NCT00982410|2621286|P1|12-month Follow-up Assessment|Death|0
825024|NCT00982410|2621285|P2|6-month Follow-up Assessment|scheduled, no-show|1
825025|NCT00982410|2621286|P1|6-month Follow-up Assessment|scheduled, no-show|0
825026|NCT00982410|2621285|P2|6-month Follow-up Assessment|patent surgery|1
825027|NCT00982410|2621286|P1|6-month Follow-up Assessment|patent surgery|0
825028|NCT00982410|2621285|P2|6-month Follow-up Assessment|incarceration|2
825029|NCT00982410|2621286|P1|6-month Follow-up Assessment|incarceration|0
825030|NCT00982410|2621285|P2|6-month Follow-up Assessment|participant no transportation|0
825031|NCT00982410|2621286|P1|6-month Follow-up Assessment|participant no transportation|1
825032|NCT00982410|2621285|P2|6-month Follow-up Assessment|Could not reach to schedule|7
825033|NCT00982410|2621286|P1|6-month Follow-up Assessment|Could not reach to schedule|5
825034|NCT00982410|2621285|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
825035|NCT00982410|2621286|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
825036|NCT00982410|2621285|P2|3-month Follow-up Assessment|Scheduled, no-show|2
825037|NCT00982410|2621286|P1|3-month Follow-up Assessment|Scheduled, no-show|1
825038|NCT00982410|2621285|P2|3-month Follow-up Assessment|Could not reach to schedule|9
825039|NCT00982410|2621286|P1|3-month Follow-up Assessment|Could not reach to schedule|8
825040|NCT00982488|2621332|P5|Overall Study|Withdrawal by Subject|0
825041|NCT00982488|2621333|P4|Overall Study|Withdrawal by Subject|0
825042|NCT00982488|2621334|P3|Overall Study|Withdrawal by Subject|1
825043|NCT00982488|2621335|P2|Overall Study|Withdrawal by Subject|1
825044|NCT00982488|2621336|P1|Overall Study|Withdrawal by Subject|5
825045|NCT00982488|2621332|P5|Overall Study|Study drug toxicity|0
825046|NCT00982488|2621333|P4|Overall Study|Study drug toxicity|0
825047|NCT00982488|2621334|P3|Overall Study|Study drug toxicity|6
825048|NCT00982488|2621335|P2|Overall Study|Study drug toxicity|1
825049|NCT00982488|2621336|P1|Overall Study|Study drug toxicity|34
825050|NCT00982488|2621332|P5|Overall Study|Stem cell transplant|0
825051|NCT00982488|2621333|P4|Overall Study|Stem cell transplant|1
825052|NCT00982488|2621334|P3|Overall Study|Stem cell transplant|0
825053|NCT00982488|2621335|P2|Overall Study|Stem cell transplant|0
825054|NCT00982488|2621336|P1|Overall Study|Stem cell transplant|2
825055|NCT00982488|2621332|P5|Overall Study|Poor compliance/noncompliance|0
825056|NCT00982488|2621333|P4|Overall Study|Poor compliance/noncompliance|0
825057|NCT00982488|2621334|P3|Overall Study|Poor compliance/noncompliance|0
825058|NCT00982488|2621335|P2|Overall Study|Poor compliance/noncompliance|1
825059|NCT00982488|2621336|P1|Overall Study|Poor compliance/noncompliance|0
825060|NCT00982488|2621332|P5|Overall Study|Not specified|0
825061|NCT00982488|2621333|P4|Overall Study|Not specified|1
825062|NCT00982488|2621334|P3|Overall Study|Not specified|3
825063|NCT00982488|2621335|P2|Overall Study|Not specified|1
825064|NCT00982488|2621336|P1|Overall Study|Not specified|15
825065|NCT00982488|2621332|P5|Overall Study|Maximum clinical benefit|0
825066|NCT00982488|2621333|P4|Overall Study|Maximum clinical benefit|0
825067|NCT00982488|2621334|P3|Overall Study|Maximum clinical benefit|1
825068|NCT00982488|2621335|P2|Overall Study|Maximum clinical benefit|1
825069|NCT00982488|2621336|P1|Overall Study|Maximum clinical benefit|1
825070|NCT00982488|2621332|P5|Overall Study|Lost to Follow-up|0
825071|NCT00982488|2621333|P4|Overall Study|Lost to Follow-up|0
825072|NCT00982488|2621334|P3|Overall Study|Lost to Follow-up|0
825073|NCT00982488|2621335|P2|Overall Study|Lost to Follow-up|0
825074|NCT00982488|2621336|P1|Overall Study|Lost to Follow-up|1
825075|NCT00982488|2621332|P5|Overall Study|Disease progression|1
825076|NCT00982488|2621333|P4|Overall Study|Disease progression|1
825077|NCT00982488|2621334|P3|Overall Study|Disease progression|10
825078|NCT00982488|2621335|P2|Overall Study|Disease progression|5
825079|NCT00982488|2621336|P1|Overall Study|Disease progression|30
825080|NCT00982488|2621332|P5|Overall Study|Death|0
825081|NCT00982488|2621333|P4|Overall Study|Death|0
825082|NCT00982488|2621334|P3|Overall Study|Death|2
825083|NCT00982488|2621335|P2|Overall Study|Death|0
825084|NCT00982488|2621336|P1|Overall Study|Death|11
825085|NCT00982488|2621332|P5|Overall Study|Adverse event unrelated to study drug|0
825086|NCT00982488|2621333|P4|Overall Study|Adverse event unrelated to study drug|0
825087|NCT00982488|2621334|P3|Overall Study|Adverse event unrelated to study drug|0
825088|NCT00982488|2621335|P2|Overall Study|Adverse event unrelated to study drug|1
825089|NCT00982488|2621336|P1|Overall Study|Adverse event unrelated to study drug|5
825090|NCT00982488|2621332|P5|Overall Study|Administrative reason by sponsor|0
825091|NCT00982488|2621333|P4|Overall Study|Administrative reason by sponsor|0
825092|NCT00982488|2621334|P3|Overall Study|Administrative reason by sponsor|11
825093|NCT00982488|2621335|P2|Overall Study|Administrative reason by sponsor|3
825094|NCT00982488|2621336|P1|Overall Study|Administrative reason by sponsor|81
825095|NCT00982644|2621374|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
825096|NCT00982644|2621375|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
825097|NCT00982644|2621374|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
825098|NCT00982644|2621375|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
825099|NCT00982644|2621374|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
825100|NCT00982644|2621375|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
825101|NCT00982644|2621374|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
825102|NCT00982644|2621375|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
825103|NCT00982644|2621374|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
825104|NCT00982644|2621375|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
825105|NCT00982644|2621374|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
825106|NCT00982644|2621375|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
825107|NCT00982644|2621374|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
825108|NCT00982644|2621375|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
825109|NCT00982644|2621374|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
825110|NCT00982644|2621375|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
825111|NCT00982644|2621374|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
825112|NCT00982644|2621375|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
825113|NCT00982644|2621374|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
825114|NCT00982644|2621375|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
825115|NCT00982657|2621401|P4|Overall Study|On going at date of cut-off|1
825116|NCT00982657|2621402|P3|Overall Study|On going at date of cut-off|0
825117|NCT00982657|2621403|P2|Overall Study|On going at date of cut-off|0
825118|NCT00982657|2621404|P1|Overall Study|On going at date of cut-off|0
825119|NCT00982657|2621401|P4|Overall Study|Unspecified|4
825120|NCT00982657|2621402|P3|Overall Study|Unspecified|0
825121|NCT00982657|2621403|P2|Overall Study|Unspecified|0
825122|NCT00982657|2621404|P1|Overall Study|Unspecified|0
825123|NCT00982657|2621401|P4|Overall Study|Withdrawal by Subject|3
825124|NCT00982657|2621402|P3|Overall Study|Withdrawal by Subject|1
825125|NCT00982657|2621403|P2|Overall Study|Withdrawal by Subject|0
825126|NCT00982657|2621404|P1|Overall Study|Withdrawal by Subject|0
825127|NCT00982657|2621401|P4|Overall Study|Death|1
825128|NCT00982657|2621402|P3|Overall Study|Death|1
825129|NCT00982657|2621403|P2|Overall Study|Death|0
825130|NCT00982657|2621404|P1|Overall Study|Death|1
825131|NCT00991887|2621501|P2|Overall Study|Lost to Follow-up|1
825132|NCT00991887|2621502|P1|Overall Study|Lost to Follow-up|2
825133|NCT00991939|2621510|P2|Overall Study|Entire study terminated|1
825134|NCT00991939|2621511|P1|Overall Study|Entire study terminated|4
825135|NCT00991939|2621510|P2|Overall Study|Withdrawal by Subject|0
825136|NCT00991939|2621511|P1|Overall Study|Withdrawal by Subject|1
825137|NCT00991939|2621510|P2|Overall Study|Lost to Follow-up|1
825138|NCT00991939|2621511|P1|Overall Study|Lost to Follow-up|0
825139|NCT00991952|2621545|P2|Overall Study|Adverse Event|1
825140|NCT00991952|2621546|P1|Overall Study|Adverse Event|0
825141|NCT00992017|2621552|P1|Overall Study|Not adhere to study requirements|1
825142|NCT00992017|2621552|P1|Overall Study|Unable to get to clinic|5
825143|NCT00992017|2621552|P1|Overall Study|Withdrawal by Subject|2
825144|NCT00992017|2621552|P1|Overall Study|Lost to Follow-up|2
825145|NCT00992056|2621567|P2|Washout Period (2 Weeks)|Physician Decision|0
825146|NCT00992056|2621568|P1|Washout Period (2 Weeks)|Physician Decision|1
825147|NCT00992056|2621567|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
825148|NCT00992056|2621568|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
825149|NCT00992108|2621576|P2|Overall Study|Lost to Follow-up|1
825150|NCT00992108|2621577|P1|Overall Study|Lost to Follow-up|0
825151|NCT00992186|2621589|P1|Overall Study|Refusal To Receive Study Agent|3
825152|NCT00992186|2621589|P1|Overall Study|Progressive Disease|30
825153|NCT00992186|2621589|P1|Overall Study|Adverse Event|9
825154|NCT00992186|2621589|P1|Overall Study|Physician Decision|1
825155|NCT00992186|2621589|P1|Overall Study|Protocol Violation|1
825156|NCT00992186|2621589|P1|Overall Study|Withdrawal by Subject|2
825157|NCT00992394|2621653|P2|Overall Study|Other event|0
825158|NCT00992394|2621654|P1|Overall Study|Other event|1
825159|NCT00992394|2621653|P2|Overall Study|Lost to Follow-up|0
825160|NCT00992394|2621654|P1|Overall Study|Lost to Follow-up|2
825161|NCT00992394|2621653|P2|Overall Study|Protocol Violation|4
825162|NCT00992394|2621654|P1|Overall Study|Protocol Violation|2
825163|NCT00992394|2621653|P2|Overall Study|Physician Decision|0
825164|NCT00992394|2621654|P1|Overall Study|Physician Decision|1
825165|NCT00992394|2621653|P2|Overall Study|Withdrawal by Subject|2
825166|NCT00992394|2621654|P1|Overall Study|Withdrawal by Subject|8
825167|NCT00992394|2621653|P2|Overall Study|Adverse Event|5
825168|NCT00992394|2621654|P1|Overall Study|Adverse Event|4
825169|NCT00992394|2621653|P2|Overall Study|Lack of Efficacy|3
825170|NCT00992394|2621654|P1|Overall Study|Lack of Efficacy|6
825171|NCT00992407|2621698|P2|Overall Study|Study medication not administered|13
825172|NCT00992407|2621699|P1|Overall Study|Study medication not administered|17
825173|NCT00992407|2621698|P2|Overall Study|Loss of follow-up & Adverse events|1
825174|NCT00992407|2621699|P1|Overall Study|Loss of follow-up & Adverse events|2
825175|NCT00992407|2621698|P2|Overall Study|Unspecified|0
825176|NCT00992407|2621699|P1|Overall Study|Unspecified|2
825177|NCT00992407|2621698|P2|Overall Study|protocol Violation & Adverse events|4
825178|NCT00992407|2621699|P1|Overall Study|protocol Violation & Adverse events|2
825179|NCT00992407|2621698|P2|Overall Study|Adverse Event|2
825180|NCT00992407|2621699|P1|Overall Study|Adverse Event|3
825181|NCT00992407|2621698|P2|Overall Study|Lost to Follow-up|3
825182|NCT00992407|2621699|P1|Overall Study|Lost to Follow-up|3
825183|NCT00992407|2621698|P2|Overall Study|Protocol Violation|1
825184|NCT00992407|2621699|P1|Overall Study|Protocol Violation|2
825185|NCT00992446|2621812|P1|Overall Study|Maintenance Therapy Screen Fail|5
825186|NCT00992446|2621812|P1|Overall Study|Withdrawal by Subject|2
825187|NCT00992446|2621812|P1|Overall Study|Disease Progression|1
825188|NCT00992459|2621819|P2|Overall Study|Adverse Event|0
825189|NCT00992459|2621820|P1|Overall Study|Adverse Event|1
825190|NCT00992459|2621819|P2|Overall Study|Withdrawal by Subject|1
825191|NCT00992459|2621820|P1|Overall Study|Withdrawal by Subject|0
825192|NCT00992589|2621844|P4|Double-Blind Phase|Not specified|3
825193|NCT00992589|2621845|P3|Double-Blind Phase|Not specified|6
825194|NCT00992589|2621846|P2|Double-Blind Phase|Not specified|1
825195|NCT00992589|2621847|P1|Double-Blind Phase|Not specified|0
825196|NCT00992589|2621844|P4|Double-Blind Phase|Lost to Follow-up|2
825197|NCT00992589|2621845|P3|Double-Blind Phase|Lost to Follow-up|0
825198|NCT00992589|2621846|P2|Double-Blind Phase|Lost to Follow-up|0
825199|NCT00992589|2621847|P1|Double-Blind Phase|Lost to Follow-up|0
825200|NCT00992589|2621844|P4|Double-Blind Phase|Withdrawal by Subject|2
825201|NCT00992589|2621845|P3|Double-Blind Phase|Withdrawal by Subject|5
825202|NCT00992589|2621846|P2|Double-Blind Phase|Withdrawal by Subject|6
825203|NCT00992589|2621847|P1|Double-Blind Phase|Withdrawal by Subject|0
825204|NCT00992589|2621844|P4|Double-Blind Phase|Adverse Event|3
825205|NCT00992589|2621845|P3|Double-Blind Phase|Adverse Event|2
825206|NCT00992589|2621846|P2|Double-Blind Phase|Adverse Event|6
825207|NCT00992589|2621847|P1|Double-Blind Phase|Adverse Event|0
825208|NCT00992589|2621844|P4|Open-Label Phase|Not specified|0
825209|NCT00992589|2621845|P3|Open-Label Phase|Not specified|0
825210|NCT00992589|2621846|P2|Open-Label Phase|Not specified|0
825211|NCT00992589|2621847|P1|Open-Label Phase|Not specified|45
825212|NCT00992589|2621844|P4|Open-Label Phase|Physician Decision|0
825213|NCT00992589|2621845|P3|Open-Label Phase|Physician Decision|0
825214|NCT00992589|2621846|P2|Open-Label Phase|Physician Decision|0
825215|NCT00992589|2621847|P1|Open-Label Phase|Physician Decision|4
825216|NCT00992589|2621844|P4|Open-Label Phase|Protocol Violation|0
825217|NCT00992589|2621845|P3|Open-Label Phase|Protocol Violation|0
825218|NCT00992589|2621846|P2|Open-Label Phase|Protocol Violation|0
825219|NCT00992589|2621847|P1|Open-Label Phase|Protocol Violation|3
825220|NCT00992589|2621844|P4|Open-Label Phase|Lost to Follow-up|0
825221|NCT00992589|2621845|P3|Open-Label Phase|Lost to Follow-up|0
825222|NCT00992589|2621846|P2|Open-Label Phase|Lost to Follow-up|0
825223|NCT00992589|2621847|P1|Open-Label Phase|Lost to Follow-up|1
825224|NCT00992589|2621844|P4|Open-Label Phase|Withdrawal by Subject|0
825225|NCT00992589|2621845|P3|Open-Label Phase|Withdrawal by Subject|0
825226|NCT00992589|2621846|P2|Open-Label Phase|Withdrawal by Subject|0
825227|NCT00992589|2621847|P1|Open-Label Phase|Withdrawal by Subject|20
825228|NCT00992589|2621844|P4|Open-Label Phase|Adverse Event|0
825229|NCT00992589|2621845|P3|Open-Label Phase|Adverse Event|0
825230|NCT00992589|2621846|P2|Open-Label Phase|Adverse Event|0
825231|NCT00992589|2621847|P1|Open-Label Phase|Adverse Event|4
825232|NCT00992784|2621936|P3|Overall Study|Withdrawal by Subject|1
825233|NCT00992784|2621937|P2|Overall Study|Withdrawal by Subject|1
825234|NCT00992784|2621938|P1|Overall Study|Withdrawal by Subject|1
825235|NCT00992784|2621936|P3|Overall Study|Adverse Event|0
825236|NCT00992784|2621937|P2|Overall Study|Adverse Event|1
825237|NCT00992784|2621938|P1|Overall Study|Adverse Event|2
825238|NCT00992836|2622006|P1|Overall Study|Protocol Violation|2
825239|NCT00992836|2622006|P1|Overall Study|Withdrawal by Subject|2
825240|NCT00992836|2622006|P1|Overall Study|Lost to Follow-up|1
825241|NCT00992992|2622029|P1|Overall Study|Sponsor Closed the Study|4
825242|NCT00992992|2622029|P1|Overall Study|GlaxoSmithKline Closed the Study|2
825243|NCT00992992|2622029|P1|Overall Study|Death|16
825244|NCT00992992|2622029|P1|Overall Study|Lost to Follow-up|3
825245|NCT00993044|2622049|P1|Irinotecan 50 mg|Physician Decision|1
825246|NCT00993148|2622054|P1|Overall Study|never initiated treatment|1
825247|NCT00993148|2622054|P1|Overall Study|Lost to Follow-up|2
825248|NCT00993265|2622102|P2|Overall Study|Non-compliant with study medication|0
825249|NCT00993265|2622103|P1|Overall Study|Non-compliant with study medication|1
825250|NCT00993265|2622102|P2|Overall Study|Changed dose of concomitant drug|0
825251|NCT00993265|2622103|P1|Overall Study|Changed dose of concomitant drug|2
825252|NCT00993265|2622102|P2|Overall Study|Adverse Event|0
825253|NCT00993265|2622103|P1|Overall Study|Adverse Event|1
825254|NCT00993291|2622121|P1|Overall Study|Withdrawal by Subject|1
825255|NCT00993317|2622127|P2|Overall Study|Early study termination at the site|0
825256|NCT00993317|2622128|P1|Overall Study|Early study termination at the site|1
825257|NCT00993317|2622127|P2|Overall Study|Investigator's opinion|1
825258|NCT00993317|2622128|P1|Overall Study|Investigator's opinion|0
825259|NCT00993317|2622127|P2|Overall Study|Withdrawal by Subject|2
825260|NCT00993317|2622128|P1|Overall Study|Withdrawal by Subject|0
825261|NCT00993317|2622127|P2|Overall Study|Lack of Efficacy|18
825262|NCT00993317|2622128|P1|Overall Study|Lack of Efficacy|18
825263|NCT00993317|2622127|P2|Overall Study|Adverse Event|4
825264|NCT00993317|2622128|P1|Overall Study|Adverse Event|2
825265|NCT00993421|2622153|P7|Overall Study|Protocol Violation|1
825266|NCT00993421|2622154|P6|Overall Study|Protocol Violation|2
825267|NCT00993421|2622155|P5|Overall Study|Protocol Violation|0
825268|NCT00993421|2622156|P4|Overall Study|Protocol Violation|0
825269|NCT00993421|2622157|P3|Overall Study|Protocol Violation|0
825270|NCT00993421|2622158|P2|Overall Study|Protocol Violation|0
825271|NCT00993421|2622159|P1|Overall Study|Protocol Violation|0
825272|NCT00993421|2622153|P7|Overall Study|Physician Decision|1
825273|NCT00993421|2622154|P6|Overall Study|Physician Decision|1
825274|NCT00993421|2622155|P5|Overall Study|Physician Decision|0
825275|NCT00993421|2622156|P4|Overall Study|Physician Decision|0
825276|NCT00993421|2622157|P3|Overall Study|Physician Decision|0
825277|NCT00993421|2622158|P2|Overall Study|Physician Decision|0
825278|NCT00993421|2622159|P1|Overall Study|Physician Decision|0
825279|NCT00993421|2622153|P7|Overall Study|Entry Criteria Exclusion|0
825280|NCT00993421|2622154|P6|Overall Study|Entry Criteria Exclusion|1
825281|NCT00993421|2622155|P5|Overall Study|Entry Criteria Exclusion|0
825282|NCT00993421|2622156|P4|Overall Study|Entry Criteria Exclusion|3
825283|NCT00993421|2622157|P3|Overall Study|Entry Criteria Exclusion|1
825284|NCT00993421|2622158|P2|Overall Study|Entry Criteria Exclusion|0
825285|NCT00993421|2622159|P1|Overall Study|Entry Criteria Exclusion|0
825286|NCT00993421|2622153|P7|Overall Study|Death|1
825287|NCT00993421|2622154|P6|Overall Study|Death|0
825288|NCT00993421|2622155|P5|Overall Study|Death|0
825289|NCT00993421|2622156|P4|Overall Study|Death|0
825290|NCT00993421|2622157|P3|Overall Study|Death|0
825291|NCT00993421|2622158|P2|Overall Study|Death|0
825292|NCT00993421|2622159|P1|Overall Study|Death|0
825293|NCT00993421|2622153|P7|Overall Study|Withdrawal by Subject|3
825294|NCT00993421|2622154|P6|Overall Study|Withdrawal by Subject|5
825295|NCT00993421|2622155|P5|Overall Study|Withdrawal by Subject|3
825296|NCT00993421|2622156|P4|Overall Study|Withdrawal by Subject|3
825297|NCT00993421|2622157|P3|Overall Study|Withdrawal by Subject|3
825298|NCT00993421|2622158|P2|Overall Study|Withdrawal by Subject|2
825299|NCT00993421|2622159|P1|Overall Study|Withdrawal by Subject|3
825300|NCT00993421|2622153|P7|Overall Study|Lost to Follow-up|6
825301|NCT00993421|2622154|P6|Overall Study|Lost to Follow-up|0
825302|NCT00993421|2622155|P5|Overall Study|Lost to Follow-up|0
825303|NCT00993421|2622156|P4|Overall Study|Lost to Follow-up|0
825304|NCT00993421|2622157|P3|Overall Study|Lost to Follow-up|5
825305|NCT00993421|2622158|P2|Overall Study|Lost to Follow-up|5
825306|NCT00993421|2622159|P1|Overall Study|Lost to Follow-up|3
825307|NCT00993421|2622153|P7|Overall Study|Sponsor Decision|29
825308|NCT00993421|2622154|P6|Overall Study|Sponsor Decision|30
825309|NCT00993421|2622155|P5|Overall Study|Sponsor Decision|38
825310|NCT00993421|2622156|P4|Overall Study|Sponsor Decision|30
825311|NCT00993421|2622157|P3|Overall Study|Sponsor Decision|28
825312|NCT00993421|2622158|P2|Overall Study|Sponsor Decision|31
825313|NCT00993421|2622159|P1|Overall Study|Sponsor Decision|36
825314|NCT00993421|2622153|P7|Overall Study|Adverse Event|1
825315|NCT00993421|2622154|P6|Overall Study|Adverse Event|7
825316|NCT00993421|2622155|P5|Overall Study|Adverse Event|5
825317|NCT00993421|2622156|P4|Overall Study|Adverse Event|9
825318|NCT00993421|2622157|P3|Overall Study|Adverse Event|6
825319|NCT00993421|2622158|P2|Overall Study|Adverse Event|7
825320|NCT00993421|2622159|P1|Overall Study|Adverse Event|2
825321|NCT00993447|2622310|P2|Overall Study|Adverse Event|0
825322|NCT00993447|2622311|P1|Overall Study|Adverse Event|1
825323|NCT00993447|2622310|P2|Overall Study|Lost to Follow-up|3
825324|NCT00993447|2622311|P1|Overall Study|Lost to Follow-up|1
825325|NCT00993447|2622310|P2|Overall Study|Protocol Violation|8
825326|NCT00993447|2622311|P1|Overall Study|Protocol Violation|12
825327|NCT00993447|2622310|P2|Overall Study|Withdrawal by Subject|8
825328|NCT00993447|2622311|P1|Overall Study|Withdrawal by Subject|23
825329|NCT00993473|2622343|P2|Overall Study|Family event|0
825330|NCT00993473|2622344|P1|Overall Study|Family event|1
825331|NCT00993473|2622343|P2|Overall Study|Technical problem with CGM device|1
825332|NCT00993473|2622344|P1|Overall Study|Technical problem with CGM device|0
825333|NCT00993473|2622343|P2|Overall Study|Withdrawal by Subject|5
825334|NCT00993473|2622344|P1|Overall Study|Withdrawal by Subject|1
825335|NCT00993473|2622343|P2|Overall Study|Lost to Follow-up|0
825336|NCT00993473|2622344|P1|Overall Study|Lost to Follow-up|1
825337|NCT00993473|2622343|P2|Overall Study|Protocol Violation|2
825338|NCT00993473|2622344|P1|Overall Study|Protocol Violation|1
825339|NCT00993473|2622343|P2|Overall Study|Adverse Event|2
825340|NCT00993473|2622344|P1|Overall Study|Adverse Event|0
825341|NCT00993499|2622386|P6|Discontinued After Starting Course 3|Other adverse event|0
825342|NCT00993499|2622387|P5|Discontinued After Starting Course 3|Other adverse event|0
825343|NCT00993499|2622388|P4|Discontinued After Starting Course 3|Other adverse event|0
825344|NCT00993499|2622389|P3|Discontinued After Starting Course 3|Other adverse event|1
825345|NCT00993499|2622390|P2|Discontinued After Starting Course 3|Other adverse event|0
825346|NCT00993499|2622391|P1|Discontinued After Starting Course 3|Other adverse event|1
825347|NCT00993499|2622386|P6|Discontinued After Starting Course 3|DLT|0
825348|NCT00993499|2622387|P5|Discontinued After Starting Course 3|DLT|0
825349|NCT00993499|2622388|P4|Discontinued After Starting Course 3|DLT|1
825350|NCT00993499|2622389|P3|Discontinued After Starting Course 3|DLT|2
825351|NCT00993499|2622390|P2|Discontinued After Starting Course 3|DLT|0
825352|NCT00993499|2622391|P1|Discontinued After Starting Course 3|DLT|1
825353|NCT00993499|2622386|P6|Discontinued After Starting Course 3|Progressive Disease|3
825354|NCT00993499|2622387|P5|Discontinued After Starting Course 3|Progressive Disease|3
825355|NCT00993499|2622388|P4|Discontinued After Starting Course 3|Progressive Disease|1
825356|NCT00993499|2622389|P3|Discontinued After Starting Course 3|Progressive Disease|3
825357|NCT00993499|2622390|P2|Discontinued After Starting Course 3|Progressive Disease|4
825358|NCT00993499|2622391|P1|Discontinued After Starting Course 3|Progressive Disease|6
825359|NCT00993499|2622386|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
825360|NCT00993499|2622387|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
825361|NCT00993499|2622388|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
825362|NCT00993499|2622389|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
825363|NCT00993499|2622390|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
825364|NCT00993499|2622391|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
825365|NCT00993499|2622386|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
825366|NCT00993499|2622387|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
825367|NCT00993499|2622388|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
825368|NCT00993499|2622389|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
825369|NCT00993499|2622390|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
825370|NCT00993499|2622391|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
825371|NCT00993499|2622386|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
825372|NCT00993499|2622387|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
825373|NCT00993499|2622388|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
825374|NCT00993499|2622389|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
825375|NCT00993499|2622390|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
825376|NCT00993499|2622391|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
825377|NCT00993499|2622386|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
825378|NCT00993499|2622387|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
825379|NCT00993499|2622388|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
825380|NCT00993499|2622389|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
825381|NCT00993499|2622390|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
825382|NCT00993499|2622391|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
825383|NCT00993499|2622386|P6|Discontinued Before Starting Course 3|Progressive Disease|0
825384|NCT00993499|2622387|P5|Discontinued Before Starting Course 3|Progressive Disease|0
825385|NCT00993499|2622388|P4|Discontinued Before Starting Course 3|Progressive Disease|0
825386|NCT00993499|2622389|P3|Discontinued Before Starting Course 3|Progressive Disease|0
825387|NCT00993499|2622390|P2|Discontinued Before Starting Course 3|Progressive Disease|2
825388|NCT00993499|2622391|P1|Discontinued Before Starting Course 3|Progressive Disease|2
825389|NCT00993499|2622386|P6|Run-in Period (8 Days)|Progressive disease|0
825390|NCT00993499|2622387|P5|Run-in Period (8 Days)|Progressive disease|0
825391|NCT00993499|2622388|P4|Run-in Period (8 Days)|Progressive disease|0
825392|NCT00993499|2622389|P3|Run-in Period (8 Days)|Progressive disease|1
825393|NCT00993499|2622390|P2|Run-in Period (8 Days)|Progressive disease|1
825394|NCT00993499|2622391|P1|Run-in Period (8 Days)|Progressive disease|0
825395|NCT00993499|2622386|P6|Run-in Period (8 Days)|Consent withdrawn|0
825396|NCT00993499|2622387|P5|Run-in Period (8 Days)|Consent withdrawn|0
825397|NCT00993499|2622388|P4|Run-in Period (8 Days)|Consent withdrawn|0
825398|NCT00993499|2622389|P3|Run-in Period (8 Days)|Consent withdrawn|0
825399|NCT00993499|2622390|P2|Run-in Period (8 Days)|Consent withdrawn|1
825400|NCT00993499|2622391|P1|Run-in Period (8 Days)|Consent withdrawn|0
825401|NCT00993499|2622386|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
825402|NCT00993499|2622387|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
825403|NCT00993499|2622388|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
825404|NCT00993499|2622389|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
825405|NCT00993499|2622390|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
825406|NCT00993499|2622391|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
825407|NCT00993499|2622386|P6|Run-in Period (8 Days)|Adverse Event|0
825408|NCT00993499|2622387|P5|Run-in Period (8 Days)|Adverse Event|0
825409|NCT00993499|2622388|P4|Run-in Period (8 Days)|Adverse Event|0
825410|NCT00993499|2622389|P3|Run-in Period (8 Days)|Adverse Event|0
825411|NCT00993499|2622390|P2|Run-in Period (8 Days)|Adverse Event|1
825412|NCT00993499|2622391|P1|Run-in Period (8 Days)|Adverse Event|0
825415|NCT00993668|2622496|P2|Open-Label Period|Lost to Follow-up|1
825416|NCT00993668|2622497|P1|Open-Label Period|Lost to Follow-up|6
825417|NCT00993668|2622496|P2|Open-Label Period|Withdrawal by Subject|3
825418|NCT00993668|2622497|P1|Open-Label Period|Withdrawal by Subject|4
825419|NCT00993668|2622496|P2|Open-Label Period|Lack of Efficacy|3
825420|NCT00993668|2622497|P1|Open-Label Period|Lack of Efficacy|4
825421|NCT00993668|2622496|P2|Open-Label Period|Adverse Event|8
825422|NCT00993668|2622497|P1|Open-Label Period|Adverse Event|9
825423|NCT00993668|2622496|P2|Single-Blind Period|Lost to Follow-up|1
825424|NCT00993668|2622497|P1|Single-Blind Period|Lost to Follow-up|3
825425|NCT00993668|2622496|P2|Single-Blind Period|Lack of Efficacy|1
825426|NCT00993668|2622497|P1|Single-Blind Period|Lack of Efficacy|0
825427|NCT00993668|2622496|P2|Single-Blind Period|Adverse Event|1
825428|NCT00993668|2622497|P1|Single-Blind Period|Adverse Event|1
825429|NCT00993915|2622537|P1|Overall Study|Ongoing|3
825430|NCT00993915|2622537|P1|Overall Study|Not specified|1
825431|NCT00993915|2622537|P1|Overall Study|Withdrawal by Subject|2
825432|NCT00993915|2622537|P1|Overall Study|Insufficient clinical response|3
825433|NCT00993928|2622548|P2|Overall Study|ineligible|0
825434|NCT00993928|2622549|P1|Overall Study|ineligible|1
825435|NCT00993928|2622548|P2|Overall Study|Withdrawal by Subject|7
825436|NCT00993928|2622549|P1|Overall Study|Withdrawal by Subject|4
825437|NCT00993954|2622565|P2|Overall Study|Protocol Violation|2
825438|NCT00993954|2622566|P1|Overall Study|Protocol Violation|21
825439|NCT00994110|2622579|P2|Overall Study|Pt not eligible|5
825440|NCT00994110|2622580|P1|Overall Study|Pt not eligible|10
825441|NCT00994110|2622579|P2|Overall Study|Patient not resected|52
825442|NCT00994110|2622580|P1|Overall Study|Patient not resected|41
825443|NCT00994110|2622579|P2|Overall Study|Adverse Event|0
825444|NCT00994110|2622580|P1|Overall Study|Adverse Event|1
825445|NCT00994110|2622579|P2|Overall Study|Not Treated|8
825446|NCT00994110|2622580|P1|Overall Study|Not Treated|4
825447|NCT00994110|2622579|P2|Overall Study|Withdrawal by Subject|9
825448|NCT00994110|2622580|P1|Overall Study|Withdrawal by Subject|9
825449|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
825450|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
825451|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
825452|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
825453|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
825454|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
825455|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
825456|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
825457|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
825458|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
825459|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
825460|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
825461|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
825462|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
825463|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
825464|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
825465|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
825466|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
825467|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
825468|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
825469|NCT00994214|2622623|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
825470|NCT00994214|2622624|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
825471|NCT00994214|2622625|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
825472|NCT00994214|2622626|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
825473|NCT00985673|2622685|P6|Overall Study|Unspecified|0
825474|NCT00985673|2622686|P5|Overall Study|Unspecified|1
825475|NCT00985673|2622687|P4|Overall Study|Unspecified|0
825476|NCT00985673|2622688|P3|Overall Study|Unspecified|1
825477|NCT00985673|2622689|P2|Overall Study|Unspecified|0
825478|NCT00985673|2622690|P1|Overall Study|Unspecified|1
825479|NCT00985673|2622685|P6|Overall Study|Withdrawal by Subject|3
825480|NCT00985673|2622686|P5|Overall Study|Withdrawal by Subject|2
825481|NCT00985673|2622687|P4|Overall Study|Withdrawal by Subject|2
825482|NCT00985673|2622688|P3|Overall Study|Withdrawal by Subject|5
825483|NCT00985673|2622689|P2|Overall Study|Withdrawal by Subject|4
825484|NCT00985673|2622690|P1|Overall Study|Withdrawal by Subject|0
825485|NCT00985673|2622685|P6|Overall Study|Lost to Follow-up|3
825486|NCT00985673|2622686|P5|Overall Study|Lost to Follow-up|5
825487|NCT00985673|2622687|P4|Overall Study|Lost to Follow-up|10
825488|NCT00985673|2622688|P3|Overall Study|Lost to Follow-up|6
825489|NCT00985673|2622689|P2|Overall Study|Lost to Follow-up|7
825490|NCT00985673|2622690|P1|Overall Study|Lost to Follow-up|6
825491|NCT00985686|2622945|P4|Overall Study|Lost to Follow-up|2
825492|NCT00985686|2622946|P3|Overall Study|Lost to Follow-up|0
825493|NCT00985686|2622947|P2|Overall Study|Lost to Follow-up|1
825494|NCT00985686|2622948|P1|Overall Study|Lost to Follow-up|1
825495|NCT00985712|2622958|P2|Overall Study|Sponsor decision|2
825496|NCT00985712|2622959|P1|Overall Study|Sponsor decision|0
825497|NCT00985712|2622958|P2|Overall Study|Withdrawal by Subject|1
825498|NCT00985712|2622959|P1|Overall Study|Withdrawal by Subject|4
825499|NCT00985712|2622958|P2|Overall Study|Protocol Violation|1
825500|NCT00985712|2622959|P1|Overall Study|Protocol Violation|0
825501|NCT00985712|2622958|P2|Overall Study|Lost to Follow-up|2
825502|NCT00985712|2622959|P1|Overall Study|Lost to Follow-up|2
825503|NCT00985712|2622958|P2|Overall Study|Adverse Event|1
825504|NCT00985712|2622959|P1|Overall Study|Adverse Event|0
825505|NCT00985725|2622975|P2|Overall Study|Out-of-window visits|1
825506|NCT00985725|2622976|P1|Overall Study|Out-of-window visits|0
825507|NCT00985725|2622975|P2|Overall Study|Non-compliance|2
825508|NCT00985725|2622976|P1|Overall Study|Non-compliance|1
825509|NCT00985725|2622975|P2|Overall Study|Lack of Efficacy|1
825510|NCT00985725|2622976|P1|Overall Study|Lack of Efficacy|0
825511|NCT00985725|2622975|P2|Overall Study|Lost to Follow-up|1
825512|NCT00985725|2622976|P1|Overall Study|Lost to Follow-up|1
825513|NCT00985725|2622975|P2|Overall Study|Withdrawal by Subject|4
825514|NCT00985725|2622976|P1|Overall Study|Withdrawal by Subject|4
825515|NCT00985725|2622975|P2|Overall Study|Protocol Violation|3
825516|NCT00985725|2622976|P1|Overall Study|Protocol Violation|1
825517|NCT00985725|2622975|P2|Overall Study|Adverse Event|1
825518|NCT00985725|2622976|P1|Overall Study|Adverse Event|4
825519|NCT00985738|2623012|P2|Overall Study|Study closed prematurely|8
825520|NCT00985738|2623013|P1|Overall Study|Study closed prematurely|8
825521|NCT00985751|2623024|P5|Overall Study|Adverse Event|1
825522|NCT00985751|2623025|P4|Overall Study|Adverse Event|0
825523|NCT00985751|2623026|P3|Overall Study|Adverse Event|0
825524|NCT00985751|2623027|P2|Overall Study|Adverse Event|0
825525|NCT00985751|2623028|P1|Overall Study|Adverse Event|0
825526|NCT00985790|2623091|P2|Overall Study|Lost to Follow-up|7
825527|NCT00985790|2623092|P1|Overall Study|Lost to Follow-up|6
825528|NCT00985790|2623091|P2|Overall Study|Withdrawal by Subject|1
825529|NCT00985790|2623092|P1|Overall Study|Withdrawal by Subject|1
825530|NCT00985946|2623128|P1|Overall Study|Withdrawal by Subject|1
825531|NCT00985946|2623128|P1|Overall Study|Lost to Follow-up|6
825532|NCT00985959|2623139|P3|Overall Study|Unspecified|11
825533|NCT00985959|2623140|P2|Overall Study|Unspecified|0
825534|NCT00985959|2623141|P1|Overall Study|Unspecified|0
825535|NCT00985959|2623139|P3|Overall Study|Complete response observed over 2 cycles|4
825536|NCT00985959|2623140|P2|Overall Study|Complete response observed over 2 cycles|1
825537|NCT00985959|2623141|P1|Overall Study|Complete response observed over 2 cycles|0
825538|NCT00985959|2623139|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
825539|NCT00985959|2623140|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
825540|NCT00985959|2623141|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
825541|NCT00985959|2623139|P3|Overall Study|Unrecovered toxicity|7
825542|NCT00985959|2623140|P2|Overall Study|Unrecovered toxicity|0
825543|NCT00985959|2623141|P1|Overall Study|Unrecovered toxicity|0
825544|NCT00985959|2623139|P3|Overall Study|Progressive disease|8
825545|NCT00985959|2623140|P2|Overall Study|Progressive disease|2
825546|NCT00985959|2623141|P1|Overall Study|Progressive disease|1
825547|NCT00985959|2623139|P3|Overall Study|Withdrawal by Subject|8
825548|NCT00985959|2623140|P2|Overall Study|Withdrawal by Subject|0
825549|NCT00985959|2623141|P1|Overall Study|Withdrawal by Subject|0
825550|NCT00985959|2623139|P3|Overall Study|Adverse Event|19
825551|NCT00985959|2623140|P2|Overall Study|Adverse Event|0
825552|NCT00985959|2623141|P1|Overall Study|Adverse Event|0
825553|NCT00985985|2623168|P4|Overall Study|Other Reason|2
825554|NCT00985985|2623169|P3|Overall Study|Other Reason|4
825555|NCT00985985|2623170|P2|Overall Study|Other Reason|1
825556|NCT00985985|2623171|P1|Overall Study|Other Reason|6
825557|NCT00985985|2623168|P4|Overall Study|Withdrawal by Subject|2
825558|NCT00985985|2623169|P3|Overall Study|Withdrawal by Subject|2
825559|NCT00985985|2623170|P2|Overall Study|Withdrawal by Subject|2
825560|NCT00985985|2623171|P1|Overall Study|Withdrawal by Subject|4
825561|NCT00985985|2623168|P4|Overall Study|Lack of Efficacy|3
825562|NCT00985985|2623169|P3|Overall Study|Lack of Efficacy|1
825563|NCT00985985|2623170|P2|Overall Study|Lack of Efficacy|6
825564|NCT00985985|2623171|P1|Overall Study|Lack of Efficacy|5
825565|NCT00985985|2623168|P4|Overall Study|Protocol Violation|1
825566|NCT00985985|2623169|P3|Overall Study|Protocol Violation|0
825567|NCT00985985|2623170|P2|Overall Study|Protocol Violation|2
825568|NCT00985985|2623171|P1|Overall Study|Protocol Violation|1
825569|NCT00985985|2623168|P4|Overall Study|Lost to Follow-up|3
825570|NCT00985985|2623169|P3|Overall Study|Lost to Follow-up|2
825571|NCT00985985|2623170|P2|Overall Study|Lost to Follow-up|11
825572|NCT00985985|2623171|P1|Overall Study|Lost to Follow-up|4
825573|NCT00985985|2623168|P4|Overall Study|Adverse Event|2
825574|NCT00985985|2623169|P3|Overall Study|Adverse Event|2
825575|NCT00985985|2623170|P2|Overall Study|Adverse Event|2
825576|NCT00985985|2623171|P1|Overall Study|Adverse Event|4
825577|NCT00986102|2623213|P4|Overall Study|Withdrawal by Subject|0
825578|NCT00986102|2623214|P3|Overall Study|Withdrawal by Subject|0
825579|NCT00986102|2623215|P2|Overall Study|Withdrawal by Subject|1
825580|NCT00986102|2623216|P1|Overall Study|Withdrawal by Subject|1
825581|NCT00986102|2623213|P4|Overall Study|Lost to Follow-up|1
825582|NCT00986102|2623214|P3|Overall Study|Lost to Follow-up|0
825583|NCT00986102|2623215|P2|Overall Study|Lost to Follow-up|1
825584|NCT00986102|2623216|P1|Overall Study|Lost to Follow-up|0
825585|NCT00986154|2623264|P2|Overall Study|never received study drug|27
825586|NCT00986154|2623265|P1|Overall Study|never received study drug|25
825587|NCT00986154|2623264|P2|Overall Study|investigator/subject decide not continue|3
825588|NCT00986154|2623265|P1|Overall Study|investigator/subject decide not continue|6
825589|NCT00986154|2623264|P2|Overall Study|Withdrawal by Subject|33
825590|NCT00986154|2623265|P1|Overall Study|Withdrawal by Subject|32
825591|NCT00986154|2623264|P2|Overall Study|Lost to Follow-up|4
825592|NCT00986154|2623265|P1|Overall Study|Lost to Follow-up|7
825593|NCT00986154|2623264|P2|Overall Study|Death|127
825594|NCT00986154|2623265|P1|Overall Study|Death|136
825595|NCT00986180|2623277|P2|Overall Study|Miscellanies|11
825596|NCT00986180|2623278|P1|Overall Study|Miscellanies|10
825597|NCT00986180|2623277|P2|Overall Study|Withdrawal by Subject|9
825598|NCT00986180|2623278|P1|Overall Study|Withdrawal by Subject|1
825599|NCT00986180|2623277|P2|Overall Study|Protocol Violation|0
825600|NCT00986180|2623278|P1|Overall Study|Protocol Violation|2
825601|NCT00986180|2623277|P2|Overall Study|Physician Decision|3
825602|NCT00986180|2623278|P1|Overall Study|Physician Decision|1
825603|NCT00986180|2623277|P2|Overall Study|Lost to Follow-up|7
825604|NCT00986180|2623278|P1|Overall Study|Lost to Follow-up|5
825605|NCT00986180|2623277|P2|Overall Study|Lack of Efficacy|3
825606|NCT00986180|2623278|P1|Overall Study|Lack of Efficacy|4
825607|NCT00986180|2623277|P2|Overall Study|Adverse Event|23
825608|NCT00986180|2623278|P1|Overall Study|Adverse Event|21
825609|NCT00986232|2623358|P4|Overall Study|Incomplete safety follow-up|2
825610|NCT00986232|2623359|P3|Overall Study|Incomplete safety follow-up|2
825611|NCT00986232|2623360|P2|Overall Study|Incomplete safety follow-up|7
825612|NCT00986232|2623361|P1|Overall Study|Incomplete safety follow-up|3
825613|NCT00986232|2623358|P4|Overall Study|Missed one or more bleeds|7
825614|NCT00986232|2623359|P3|Overall Study|Missed one or more bleeds|6
825615|NCT00986232|2623360|P2|Overall Study|Missed one or more bleeds|10
825616|NCT00986232|2623361|P1|Overall Study|Missed one or more bleeds|13
825617|NCT00986232|2623358|P4|Overall Study|Withdrawal by Subject|3
825618|NCT00986232|2623359|P3|Overall Study|Withdrawal by Subject|12
825619|NCT00986232|2623360|P2|Overall Study|Withdrawal by Subject|16
825620|NCT00986232|2623361|P1|Overall Study|Withdrawal by Subject|13
825621|NCT00986232|2623358|P4|Overall Study|Protocol Violation|1
825622|NCT00986232|2623359|P3|Overall Study|Protocol Violation|0
825623|NCT00986232|2623360|P2|Overall Study|Protocol Violation|3
825624|NCT00986232|2623361|P1|Overall Study|Protocol Violation|2
825625|NCT00986232|2623358|P4|Overall Study|Lost to Follow-up|7
825626|NCT00986232|2623359|P3|Overall Study|Lost to Follow-up|12
825627|NCT00986232|2623360|P2|Overall Study|Lost to Follow-up|12
825628|NCT00986232|2623361|P1|Overall Study|Lost to Follow-up|19
825629|NCT00986232|2623358|P4|Overall Study|Adverse Event|0
825630|NCT00986232|2623359|P3|Overall Study|Adverse Event|3
825631|NCT00986232|2623360|P2|Overall Study|Adverse Event|2
825632|NCT00986232|2623361|P1|Overall Study|Adverse Event|1
825633|NCT00986245|2623433|P2|Second Intervention|Protocol Violation|1
825634|NCT00986245|2623434|P1|Second Intervention|Protocol Violation|0
825635|NCT00986245|2623433|P2|Second Intervention|Lost to Follow-up|0
825636|NCT00986245|2623434|P1|Second Intervention|Lost to Follow-up|1
825637|NCT00986245|2623433|P2|Second Intervention|Poor compliance|0
825638|NCT00986245|2623434|P1|Second Intervention|Poor compliance|1
825639|NCT00986245|2623433|P2|First Intervention|Out of indication|0
825640|NCT00986245|2623434|P1|First Intervention|Out of indication|1
825641|NCT00986245|2623433|P2|First Intervention|Protocol Violation|1
825642|NCT00986245|2623434|P1|First Intervention|Protocol Violation|0
825643|NCT00986245|2623433|P2|First Intervention|Withdrawal by Subject|1
825644|NCT00986245|2623434|P1|First Intervention|Withdrawal by Subject|0
825645|NCT00986245|2623433|P2|First Intervention|Lack of Efficacy|2
825646|NCT00986245|2623434|P1|First Intervention|Lack of Efficacy|1
825647|NCT00986245|2623433|P2|First Intervention|Poor compliance|4
825648|NCT00986245|2623434|P1|First Intervention|Poor compliance|8
825649|NCT00986258|2623467|P1|Maintenance Period|Withdrawal by Subject|2
825650|NCT00986258|2623467|P1|Maintenance Period|Lack of Efficacy|2
825651|NCT00986258|2623467|P1|Maintenance Period|Adverse Event|5
825652|NCT00986258|2623467|P1|Titration and Optimal Dose Period|Other|1
825653|NCT00986258|2623467|P1|Titration and Optimal Dose Period|Non-Compliance|1
825654|NCT00986258|2623467|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
825655|NCT00986258|2623467|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
825656|NCT00986258|2623467|P1|Titration and Optimal Dose Period|Adverse Event|15
825657|NCT00986258|2623467|P1|Observation Period|Not eligible to be dosed|11
825658|NCT00986349|2623495|P1|Overall Study|device migration|1
825659|NCT00986349|2623495|P1|Overall Study|Physician Decision|1
825660|NCT00986349|2623495|P1|Overall Study|Adverse Event|2
825661|NCT00986349|2623495|P1|Overall Study|Unsuccessful implant procedure|3
825662|NCT00986362|2623510|P2|Overall Study|Lost to Follow-up|1
825663|NCT00986362|2623511|P1|Overall Study|Lost to Follow-up|0
825664|NCT00986362|2623510|P2|Overall Study|Death|0
825665|NCT00986362|2623511|P1|Overall Study|Death|2
825666|NCT00986427|2623531|P2|Overall Study|Withdrawal by Subject|0
825667|NCT00986427|2623532|P1|Overall Study|Withdrawal by Subject|1
825668|NCT00986427|2623531|P2|Overall Study|Lack of Efficacy|0
825669|NCT00986427|2623532|P1|Overall Study|Lack of Efficacy|1
825670|NCT00986427|2623531|P2|Overall Study|Lost to Follow-up|0
825671|NCT00986427|2623532|P1|Overall Study|Lost to Follow-up|2
825672|NCT00986479|2623562|P2|Period 1|Administrative reasons|0
825673|NCT00986479|2623563|P1|Period 1|Administrative reasons|1
825674|NCT00986479|2623562|P2|Period 1|Improved mood|0
825675|NCT00986479|2623563|P1|Period 1|Improved mood|1
825676|NCT00986570|2623604|P1|Overall Study|Potential bias for objective assessment|1
825677|NCT00986570|2623604|P1|Overall Study|Lost to Follow-up|6
825678|NCT00986674|2623630|P3|Overall Study|unknown/not specify|9
825679|NCT00986674|2623631|P2|Overall Study|unknown/not specify|7
825680|NCT00986674|2623632|P1|Overall Study|unknown/not specify|0
825681|NCT00986674|2623630|P3|Overall Study|not start protocol therapy|1
825682|NCT00986674|2623631|P2|Overall Study|not start protocol therapy|3
825683|NCT00986674|2623632|P1|Overall Study|not start protocol therapy|4
825684|NCT00986674|2623630|P3|Overall Study|alternative therapy|1
825685|NCT00986674|2623631|P2|Overall Study|alternative therapy|0
825686|NCT00986674|2623632|P1|Overall Study|alternative therapy|0
825687|NCT00986674|2623630|P3|Overall Study|Withdrawal by Subject|1
825688|NCT00986674|2623631|P2|Overall Study|Withdrawal by Subject|2
825689|NCT00986674|2623632|P1|Overall Study|Withdrawal by Subject|6
825690|NCT00986674|2623630|P3|Overall Study|Death|4
825691|NCT00986674|2623631|P2|Overall Study|Death|0
825692|NCT00986674|2623632|P1|Overall Study|Death|5
825693|NCT00986674|2623630|P3|Overall Study|Adverse Event|9
825694|NCT00986674|2623631|P2|Overall Study|Adverse Event|8
825695|NCT00986674|2623632|P1|Overall Study|Adverse Event|4
825696|NCT00986674|2623630|P3|Overall Study|Lack of Efficacy|23
825697|NCT00986674|2623631|P2|Overall Study|Lack of Efficacy|25
825698|NCT00986674|2623632|P1|Overall Study|Lack of Efficacy|28
825699|NCT00986921|2623671|P2|Overall Study|Physician Decision|0
825700|NCT00986921|2623672|P1|Overall Study|Physician Decision|1
825701|NCT00986973|2623696|P1|Overall Study|Withdrawn by study team|1
825702|NCT00986986|2623708|P2|Overall Study|Lost to Follow-up|1
825703|NCT00986986|2623709|P1|Overall Study|Lost to Follow-up|0
825704|NCT00987337|2623731|P3|Overall Study|Participant Relapsed|5
825705|NCT00987337|2623732|P2|Overall Study|Participant Relapsed|20
825706|NCT00987337|2623733|P1|Overall Study|Participant Relapsed|18
825707|NCT00987337|2623731|P3|Overall Study|Protocol Violation|2
825708|NCT00987337|2623732|P2|Overall Study|Protocol Violation|0
825709|NCT00987337|2623733|P1|Overall Study|Protocol Violation|1
825710|NCT00987337|2623731|P3|Overall Study|Unspecified|5
825711|NCT00987337|2623732|P2|Overall Study|Unspecified|2
825712|NCT00987337|2623733|P1|Overall Study|Unspecified|0
825713|NCT00987337|2623731|P3|Overall Study|Withdrawal by Subject|9
825714|NCT00987337|2623732|P2|Overall Study|Withdrawal by Subject|9
825715|NCT00987337|2623733|P1|Overall Study|Withdrawal by Subject|6
825716|NCT00987337|2623731|P3|Overall Study|Lost to Follow-up|2
825717|NCT00987337|2623732|P2|Overall Study|Lost to Follow-up|6
825718|NCT00987337|2623733|P1|Overall Study|Lost to Follow-up|10
825719|NCT00987337|2623731|P3|Overall Study|Virologic Breakthrough|8
825720|NCT00987337|2623732|P2|Overall Study|Virologic Breakthrough|2
825721|NCT00987337|2623733|P1|Overall Study|Virologic Breakthrough|2
825722|NCT00987337|2623731|P3|Overall Study|Insufficient Virologic Response|12
825723|NCT00987337|2623732|P2|Overall Study|Insufficient Virologic Response|7
825724|NCT00987337|2623733|P1|Overall Study|Insufficient Virologic Response|10
825725|NCT00987337|2623731|P3|Overall Study|Adverse Event|8
825726|NCT00987337|2623732|P2|Overall Study|Adverse Event|9
825727|NCT00987337|2623733|P1|Overall Study|Adverse Event|10
825728|NCT00987402|2623779|P2|Overall Study|Insufficient data entry|98
825729|NCT00987402|2623780|P1|Overall Study|Insufficient data entry|86
825730|NCT00987467|2623803|P1|Overall Study|Lost to Follow-up|2
825731|NCT00987623|2623824|P2|Overall Study|Influenza|1
825732|NCT00987623|2623825|P1|Overall Study|Influenza|0
825733|NCT00987623|2623824|P2|Overall Study|Biomicroscopy|1
825734|NCT00987623|2623825|P1|Overall Study|Biomicroscopy|0
825735|NCT00987623|2623824|P2|Overall Study|Discomfort|0
825736|NCT00987623|2623825|P1|Overall Study|Discomfort|1
825737|NCT00987623|2623824|P2|Overall Study|Time/job conflict|0
825738|NCT00987623|2623825|P1|Overall Study|Time/job conflict|2
825739|NCT00987623|2623824|P2|Overall Study|Lost to Follow-up|1
825740|NCT00987623|2623825|P1|Overall Study|Lost to Follow-up|2
825741|NCT00987831|2623845|P3|Overall Study|Lost to Follow-up|0
825742|NCT00987831|2623846|P2|Overall Study|Lost to Follow-up|3
825743|NCT00987831|2623847|P1|Overall Study|Lost to Follow-up|0
825744|NCT00987831|2623845|P3|Overall Study|Never flared in 12 months|0
825745|NCT00987831|2623846|P2|Overall Study|Never flared in 12 months|0
825746|NCT00987831|2623847|P1|Overall Study|Never flared in 12 months|1
825747|NCT00987935|2623865|P9|Overall Study|Reason other than those specified above|1
825748|NCT00987935|2623866|P8|Overall Study|Reason other than those specified above|0
825749|NCT00987935|2623867|P7|Overall Study|Reason other than those specified above|0
825750|NCT00987935|2623868|P6|Overall Study|Reason other than those specified above|0
825751|NCT00987935|2623869|P5|Overall Study|Reason other than those specified above|0
825752|NCT00987935|2623870|P4|Overall Study|Reason other than those specified above|0
825753|NCT00987935|2623871|P3|Overall Study|Reason other than those specified above|0
825754|NCT00987935|2623872|P2|Overall Study|Reason other than those specified above|0
825755|NCT00987935|2623873|P1|Overall Study|Reason other than those specified above|0
825756|NCT00987935|2623865|P9|Overall Study|Refused to continue taking trial med.|2
825757|NCT00987935|2623866|P8|Overall Study|Refused to continue taking trial med.|4
825758|NCT00987935|2623867|P7|Overall Study|Refused to continue taking trial med.|4
825759|NCT00987935|2623868|P6|Overall Study|Refused to continue taking trial med.|0
825760|NCT00987935|2623869|P5|Overall Study|Refused to continue taking trial med.|1
825761|NCT00987935|2623870|P4|Overall Study|Refused to continue taking trial med.|0
825762|NCT00987935|2623871|P3|Overall Study|Refused to continue taking trial med.|0
825763|NCT00987935|2623872|P2|Overall Study|Refused to continue taking trial med.|0
825764|NCT00987935|2623873|P1|Overall Study|Refused to continue taking trial med.|1
825765|NCT00987935|2623865|P9|Overall Study|Adverse Event|6
825766|NCT00987935|2623866|P8|Overall Study|Adverse Event|10
825767|NCT00987935|2623867|P7|Overall Study|Adverse Event|2
825768|NCT00987935|2623868|P6|Overall Study|Adverse Event|0
825769|NCT00987935|2623869|P5|Overall Study|Adverse Event|1
825770|NCT00987935|2623870|P4|Overall Study|Adverse Event|1
825771|NCT00987935|2623871|P3|Overall Study|Adverse Event|0
825772|NCT00987935|2623872|P2|Overall Study|Adverse Event|1
825773|NCT00987935|2623873|P1|Overall Study|Adverse Event|0
825774|NCT00987935|2623865|P9|Overall Study|Progressive disease|23
825775|NCT00987935|2623866|P8|Overall Study|Progressive disease|48
825776|NCT00987935|2623867|P7|Overall Study|Progressive disease|9
825777|NCT00987935|2623868|P6|Overall Study|Progressive disease|3
825778|NCT00987935|2623869|P5|Overall Study|Progressive disease|5
825779|NCT00987935|2623870|P4|Overall Study|Progressive disease|2
825780|NCT00987935|2623871|P3|Overall Study|Progressive disease|3
825781|NCT00987935|2623872|P2|Overall Study|Progressive disease|2
825782|NCT00987935|2623873|P1|Overall Study|Progressive disease|3
825783|NCT00988065|2623934|P3|Overall Study|Noncompliance with protocol|9
825784|NCT00988065|2623935|P2|Overall Study|Noncompliance with protocol|6
825785|NCT00988065|2623936|P1|Overall Study|Noncompliance with protocol|5
825786|NCT00988065|2623934|P3|Overall Study|Subject withdrew consent|2
825787|NCT00988065|2623935|P2|Overall Study|Subject withdrew consent|5
825788|NCT00988065|2623936|P1|Overall Study|Subject withdrew consent|3
825789|NCT00988065|2623934|P3|Overall Study|Lost to Follow-up|2
825790|NCT00988065|2623935|P2|Overall Study|Lost to Follow-up|2
825791|NCT00988065|2623936|P1|Overall Study|Lost to Follow-up|1
825792|NCT00988065|2623934|P3|Overall Study|Adverse Event|2
825793|NCT00988065|2623935|P2|Overall Study|Adverse Event|10
825794|NCT00988065|2623936|P1|Overall Study|Adverse Event|4
825795|NCT00988091|2623958|P2|Open-label Period|Not specified|3
825796|NCT00988091|2623959|P1|Open-label Period|Not specified|2
825797|NCT00988091|2623958|P2|Open-label Period|Lost to Follow-up|5
825798|NCT00988091|2623959|P1|Open-label Period|Lost to Follow-up|3
825799|NCT00988091|2623958|P2|Open-label Period|Withdrawal by Subject|16
825800|NCT00988091|2623959|P1|Open-label Period|Withdrawal by Subject|10
825801|NCT00988091|2623958|P2|Open-label Period|Protocol Violation|1
825802|NCT00988091|2623959|P1|Open-label Period|Protocol Violation|1
825803|NCT00988091|2623958|P2|Open-label Period|Use of exclusionary medication|1
825804|NCT00988091|2623959|P1|Open-label Period|Use of exclusionary medication|1
825805|NCT00988091|2623958|P2|Open-label Period|Adverse Event|7
825806|NCT00988091|2623959|P1|Open-label Period|Adverse Event|4
825807|NCT00988091|2623958|P2|Double-blind Period|Use of exclusionary medication|3
825808|NCT00988091|2623959|P1|Double-blind Period|Use of exclusionary medication|2
825809|NCT00988091|2623958|P2|Double-blind Period|Adverse Event|9
825810|NCT00988091|2623959|P1|Double-blind Period|Adverse Event|6
825811|NCT00988091|2623958|P2|Double-blind Period|Not specified|8
825812|NCT00988091|2623959|P1|Double-blind Period|Not specified|8
825813|NCT00988091|2623958|P2|Double-blind Period|Lost to Follow-up|14
825814|NCT00988091|2623959|P1|Double-blind Period|Lost to Follow-up|12
825815|NCT00988091|2623958|P2|Double-blind Period|Withdrawal by Subject|13
825816|NCT00988091|2623959|P1|Double-blind Period|Withdrawal by Subject|15
825817|NCT00988117|2623978|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
825818|NCT00988117|2623978|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
825819|NCT00988169|2624033|P1|Overall Study|Withdrawal by Subject|1
825820|NCT00988208|2624039|P2|Overall Study|Unspecified|3
825821|NCT00988208|2624040|P1|Overall Study|Unspecified|8
825822|NCT00988208|2624039|P2|Overall Study|Subject decision/investigator discretion|32
825823|NCT00988208|2624040|P1|Overall Study|Subject decision/investigator discretion|32
825824|NCT00988208|2624039|P2|Overall Study|Clinical Deterioration|14
825825|NCT00988208|2624040|P1|Overall Study|Clinical Deterioration|7
825826|NCT00988208|2624039|P2|Overall Study|Biochemical Progression|7
825827|NCT00988208|2624040|P1|Overall Study|Biochemical Progression|21
825828|NCT00988208|2624039|P2|Overall Study|Clinical Progression|16
825829|NCT00988208|2624040|P1|Overall Study|Clinical Progression|17
825830|NCT00988208|2624039|P2|Overall Study|Sponsor Decision|78
825831|NCT00988208|2624040|P1|Overall Study|Sponsor Decision|102
825832|NCT00988208|2624039|P2|Overall Study|Protocol Violation|2
825833|NCT00988208|2624040|P1|Overall Study|Protocol Violation|9
825834|NCT00988208|2624039|P2|Overall Study|Lost to Follow-up|3
825835|NCT00988208|2624040|P1|Overall Study|Lost to Follow-up|2
825836|NCT00988208|2624039|P2|Overall Study|Death|15
825837|NCT00988208|2624040|P1|Overall Study|Death|9
825838|NCT00988208|2624039|P2|Overall Study|Withdrawal by Subject|57
825839|NCT00988208|2624040|P1|Overall Study|Withdrawal by Subject|50
825840|NCT00988208|2624039|P2|Overall Study|Disease Progression|89
825841|NCT00988208|2624040|P1|Overall Study|Disease Progression|103
825842|NCT00988208|2624039|P2|Overall Study|Adverse Event|122
825843|NCT00988208|2624040|P1|Overall Study|Adverse Event|71
825844|NCT00988221|2624055|P4|Part III|Refused Treatment|0
825845|NCT00988221|2624056|P3|Part III|Refused Treatment|1
825846|NCT00988221|2624057|P2|Part III|Refused Treatment|0
825847|NCT00988221|2624058|P1|Part III|Refused Treatment|0
825848|NCT00988221|2624055|P4|Part III|Insufficient Therapeutic Response|0
825849|NCT00988221|2624056|P3|Part III|Insufficient Therapeutic Response|1
825850|NCT00988221|2624057|P2|Part III|Insufficient Therapeutic Response|1
825851|NCT00988221|2624058|P1|Part III|Insufficient Therapeutic Response|0
825852|NCT00988221|2624055|P4|Part III|Adverse Event|0
825853|NCT00988221|2624056|P3|Part III|Adverse Event|1
825854|NCT00988221|2624057|P2|Part III|Adverse Event|0
825855|NCT00988221|2624058|P1|Part III|Adverse Event|1
825856|NCT00988221|2624055|P4|Part II|Reason not Specified|0
825857|NCT00988221|2624056|P3|Part II|Reason not Specified|1
825858|NCT00988221|2624057|P2|Part II|Reason not Specified|0
825859|NCT00988221|2624058|P1|Part II|Reason not Specified|0
825860|NCT00988221|2624055|P4|Part II|Withdrawal by Subject|2
825861|NCT00988221|2624056|P3|Part II|Withdrawal by Subject|2
825862|NCT00988221|2624057|P2|Part II|Withdrawal by Subject|0
825863|NCT00988221|2624058|P1|Part II|Withdrawal by Subject|0
825864|NCT00988221|2624055|P4|Part II|Adverse Event|1
825865|NCT00988221|2624056|P3|Part II|Adverse Event|0
825866|NCT00988221|2624057|P2|Part II|Adverse Event|0
825867|NCT00988221|2624058|P1|Part II|Adverse Event|1
825868|NCT00988221|2624055|P4|Part I|Lost to Follow-up|0
825869|NCT00988221|2624056|P3|Part I|Lost to Follow-up|0
825870|NCT00988221|2624057|P2|Part I|Lost to Follow-up|1
825871|NCT00988221|2624058|P1|Part I|Lost to Follow-up|0
825872|NCT00988221|2624055|P4|Part I|Refused Treatment|0
825873|NCT00988221|2624056|P3|Part I|Refused Treatment|1
825874|NCT00988221|2624057|P2|Part I|Refused Treatment|2
825875|NCT00988221|2624058|P1|Part I|Refused Treatment|0
825876|NCT00988221|2624055|P4|Part I|Insufficient Therapeutic Response|0
825877|NCT00988221|2624056|P3|Part I|Insufficient Therapeutic Response|5
825878|NCT00988221|2624057|P2|Part I|Insufficient Therapeutic Response|6
825879|NCT00988221|2624058|P1|Part I|Insufficient Therapeutic Response|4
825880|NCT00988221|2624055|P4|Part I|Adverse Event|0
825881|NCT00988221|2624056|P3|Part I|Adverse Event|2
825882|NCT00988221|2624057|P2|Part I|Adverse Event|1
825883|NCT00988221|2624058|P1|Part I|Adverse Event|0
825884|NCT00988247|2624231|P2|Overall Study|Not specified|0
825885|NCT00988247|2624232|P1|Overall Study|Not specified|3
825886|NCT00988247|2624231|P2|Overall Study|Sponsor requested withdrawal|1
825887|NCT00988247|2624232|P1|Overall Study|Sponsor requested withdrawal|3
825888|NCT00988247|2624231|P2|Overall Study|Protocol Violation|5
825889|NCT00988247|2624232|P1|Overall Study|Protocol Violation|4
825890|NCT00988247|2624231|P2|Overall Study|Lost to Follow-up|2
825891|NCT00988247|2624232|P1|Overall Study|Lost to Follow-up|11
825892|NCT00988247|2624231|P2|Overall Study|Pregnancy|2
825893|NCT00988247|2624232|P1|Overall Study|Pregnancy|1
825894|NCT00988247|2624231|P2|Overall Study|Withdrawal by Subject|13
825895|NCT00988247|2624232|P1|Overall Study|Withdrawal by Subject|44
825896|NCT00988247|2624231|P2|Overall Study|Adverse Event|3
825897|NCT00988247|2624232|P1|Overall Study|Adverse Event|17
825898|NCT00988351|2624311|P2|Overall Study|not using CPAP|3
825899|NCT00988351|2624312|P1|Overall Study|not using CPAP|5
825900|NCT00988351|2624311|P2|Overall Study|Lost to Follow-up|9
825901|NCT00988351|2624312|P1|Overall Study|Lost to Follow-up|6
825902|NCT00988351|2624311|P2|Overall Study|Withdrawal by Subject|0
825903|NCT00988351|2624312|P1|Overall Study|Withdrawal by Subject|8
825904|NCT00994240|2624328|P2|Overall Study|study termination|3
825905|NCT00994240|2624329|P1|Overall Study|study termination|2
825906|NCT00994240|2624328|P2|Overall Study|Withdrawal by Subject|0
825907|NCT00994240|2624329|P1|Overall Study|Withdrawal by Subject|1
825908|NCT00994240|2624328|P2|Overall Study|Lost to Follow-up|2
825909|NCT00994240|2624329|P1|Overall Study|Lost to Follow-up|3
825910|NCT00994279|2624337|P2|Overall Study|Multiple reasons|3
825911|NCT00994279|2624338|P1|Overall Study|Multiple reasons|1
825912|NCT00994279|2624337|P2|Overall Study|Toxicity|0
825913|NCT00994279|2624338|P1|Overall Study|Toxicity|1
825914|NCT00994279|2624337|P2|Overall Study|Withdrawal by Subject|2
825915|NCT00994279|2624338|P1|Overall Study|Withdrawal by Subject|2
825916|NCT00994422|2624361|P2|Overall Study|Lost to Follow-up|1
825917|NCT00994422|2624362|P1|Overall Study|Lost to Follow-up|7
825918|NCT00994448|2624374|P2|Overall Study|Physician Decision|0
825919|NCT00994448|2624375|P1|Overall Study|Physician Decision|1
825920|NCT00994448|2624374|P2|Overall Study|Withdrawal by Subject|1
825921|NCT00994448|2624375|P1|Overall Study|Withdrawal by Subject|1
825922|NCT00994448|2624374|P2|Overall Study|Lost to Follow-up|1
825923|NCT00994448|2624375|P1|Overall Study|Lost to Follow-up|5
825924|NCT00994448|2624374|P2|Overall Study|Adverse Event|0
825925|NCT00994448|2624375|P1|Overall Study|Adverse Event|1
825926|NCT00994461|2624384|P3|Overall Study|Adverse Event|0
825927|NCT00994461|2624385|P2|Overall Study|Adverse Event|1
825928|NCT00994461|2624386|P1|Overall Study|Adverse Event|2
825929|NCT00996892|2624412|P20|Expansion Stage 2A|Disease Progression|31
825930|NCT00996892|2624413|P19|Expansion Stage 2A|Disease Progression|0
825931|NCT00996892|2624414|P18|Expansion Stage 2A|Disease Progression|0
825932|NCT00996892|2624415|P17|Expansion Stage 2A|Disease Progression|0
825933|NCT00996892|2624416|P16|Expansion Stage 2A|Disease Progression|0
825934|NCT00996892|2624417|P15|Expansion Stage 2A|Disease Progression|0
825935|NCT00996892|2624418|P14|Expansion Stage 2A|Disease Progression|0
825936|NCT00996892|2624419|P13|Expansion Stage 2A|Disease Progression|0
825937|NCT00996892|2624420|P12|Expansion Stage 2A|Disease Progression|0
825938|NCT00996892|2624421|P11|Expansion Stage 2A|Disease Progression|0
825939|NCT00996892|2624422|P10|Expansion Stage 2A|Disease Progression|0
825940|NCT00996892|2624423|P9|Expansion Stage 2A|Disease Progression|0
825941|NCT00996892|2624424|P8|Expansion Stage 2A|Disease Progression|0
825942|NCT00996892|2624425|P7|Expansion Stage 2A|Disease Progression|0
825943|NCT00996892|2624426|P6|Expansion Stage 2A|Disease Progression|0
825944|NCT00996892|2624427|P5|Expansion Stage 2A|Disease Progression|0
825945|NCT00996892|2624428|P4|Expansion Stage 2A|Disease Progression|0
825946|NCT00996892|2624429|P3|Expansion Stage 2A|Disease Progression|0
825947|NCT00996892|2624430|P2|Expansion Stage 2A|Disease Progression|0
825948|NCT00996892|2624431|P1|Expansion Stage 2A|Disease Progression|0
825949|NCT00996892|2624412|P20|Expansion Stage 2A|Withdrawal by Subject|4
825950|NCT00996892|2624413|P19|Expansion Stage 2A|Withdrawal by Subject|0
825951|NCT00996892|2624414|P18|Expansion Stage 2A|Withdrawal by Subject|0
825952|NCT00996892|2624415|P17|Expansion Stage 2A|Withdrawal by Subject|0
825953|NCT00996892|2624416|P16|Expansion Stage 2A|Withdrawal by Subject|0
825954|NCT00996892|2624417|P15|Expansion Stage 2A|Withdrawal by Subject|0
825955|NCT00996892|2624418|P14|Expansion Stage 2A|Withdrawal by Subject|0
825956|NCT00996892|2624419|P13|Expansion Stage 2A|Withdrawal by Subject|0
825957|NCT00996892|2624420|P12|Expansion Stage 2A|Withdrawal by Subject|0
825958|NCT00996892|2624421|P11|Expansion Stage 2A|Withdrawal by Subject|0
825959|NCT00996892|2624422|P10|Expansion Stage 2A|Withdrawal by Subject|0
825960|NCT00996892|2624423|P9|Expansion Stage 2A|Withdrawal by Subject|0
825961|NCT00996892|2624424|P8|Expansion Stage 2A|Withdrawal by Subject|0
825962|NCT00996892|2624425|P7|Expansion Stage 2A|Withdrawal by Subject|0
825963|NCT00996892|2624426|P6|Expansion Stage 2A|Withdrawal by Subject|0
825964|NCT00996892|2624427|P5|Expansion Stage 2A|Withdrawal by Subject|0
825965|NCT00996892|2624428|P4|Expansion Stage 2A|Withdrawal by Subject|0
825966|NCT00996892|2624429|P3|Expansion Stage 2A|Withdrawal by Subject|0
825967|NCT00996892|2624430|P2|Expansion Stage 2A|Withdrawal by Subject|0
825968|NCT00996892|2624431|P1|Expansion Stage 2A|Withdrawal by Subject|0
825969|NCT00996892|2624412|P20|Expansion Stage 2A|Physician Decision|2
825970|NCT00996892|2624413|P19|Expansion Stage 2A|Physician Decision|0
825971|NCT00996892|2624414|P18|Expansion Stage 2A|Physician Decision|0
825972|NCT00996892|2624415|P17|Expansion Stage 2A|Physician Decision|0
825973|NCT00996892|2624416|P16|Expansion Stage 2A|Physician Decision|0
825974|NCT00996892|2624417|P15|Expansion Stage 2A|Physician Decision|0
825975|NCT00996892|2624418|P14|Expansion Stage 2A|Physician Decision|0
825976|NCT00996892|2624419|P13|Expansion Stage 2A|Physician Decision|0
825977|NCT00996892|2624420|P12|Expansion Stage 2A|Physician Decision|0
825978|NCT00996892|2624421|P11|Expansion Stage 2A|Physician Decision|0
825979|NCT00996892|2624422|P10|Expansion Stage 2A|Physician Decision|0
825980|NCT00996892|2624423|P9|Expansion Stage 2A|Physician Decision|0
825981|NCT00996892|2624424|P8|Expansion Stage 2A|Physician Decision|0
825982|NCT00996892|2624425|P7|Expansion Stage 2A|Physician Decision|0
825983|NCT00996892|2624426|P6|Expansion Stage 2A|Physician Decision|0
825984|NCT00996892|2624427|P5|Expansion Stage 2A|Physician Decision|0
825985|NCT00996892|2624428|P4|Expansion Stage 2A|Physician Decision|0
825986|NCT00996892|2624429|P3|Expansion Stage 2A|Physician Decision|0
825987|NCT00996892|2624430|P2|Expansion Stage 2A|Physician Decision|0
825988|NCT00996892|2624431|P1|Expansion Stage 2A|Physician Decision|0
825989|NCT00996892|2624412|P20|Expansion Stage 2A|Adverse Event|8
825990|NCT00996892|2624413|P19|Expansion Stage 2A|Adverse Event|0
825991|NCT00996892|2624414|P18|Expansion Stage 2A|Adverse Event|0
825992|NCT00996892|2624415|P17|Expansion Stage 2A|Adverse Event|0
825993|NCT00996892|2624416|P16|Expansion Stage 2A|Adverse Event|0
825994|NCT00996892|2624417|P15|Expansion Stage 2A|Adverse Event|0
825995|NCT00996892|2624418|P14|Expansion Stage 2A|Adverse Event|0
825996|NCT00996892|2624419|P13|Expansion Stage 2A|Adverse Event|0
825997|NCT00996892|2624420|P12|Expansion Stage 2A|Adverse Event|0
825998|NCT00996892|2624421|P11|Expansion Stage 2A|Adverse Event|0
825999|NCT00996892|2624422|P10|Expansion Stage 2A|Adverse Event|0
826000|NCT00996892|2624423|P9|Expansion Stage 2A|Adverse Event|0
826001|NCT00996892|2624424|P8|Expansion Stage 2A|Adverse Event|0
826002|NCT00996892|2624425|P7|Expansion Stage 2A|Adverse Event|0
826003|NCT00996892|2624426|P6|Expansion Stage 2A|Adverse Event|0
826004|NCT00996892|2624427|P5|Expansion Stage 2A|Adverse Event|0
826005|NCT00996892|2624428|P4|Expansion Stage 2A|Adverse Event|0
826006|NCT00996892|2624429|P3|Expansion Stage 2A|Adverse Event|0
826007|NCT00996892|2624430|P2|Expansion Stage 2A|Adverse Event|0
826008|NCT00996892|2624431|P1|Expansion Stage 2A|Adverse Event|0
826009|NCT00996892|2624412|P20|Expansion Stage 2|Disease Progression|0
826010|NCT00996892|2624413|P19|Expansion Stage 2|Disease Progression|28
826011|NCT00996892|2624414|P18|Expansion Stage 2|Disease Progression|0
826012|NCT00996892|2624415|P17|Expansion Stage 2|Disease Progression|0
826013|NCT00996892|2624416|P16|Expansion Stage 2|Disease Progression|0
826014|NCT00996892|2624417|P15|Expansion Stage 2|Disease Progression|0
826015|NCT00996892|2624418|P14|Expansion Stage 2|Disease Progression|0
826016|NCT00996892|2624419|P13|Expansion Stage 2|Disease Progression|0
826017|NCT00996892|2624420|P12|Expansion Stage 2|Disease Progression|0
826018|NCT00996892|2624421|P11|Expansion Stage 2|Disease Progression|0
826019|NCT00996892|2624422|P10|Expansion Stage 2|Disease Progression|0
826020|NCT00996892|2624423|P9|Expansion Stage 2|Disease Progression|0
826021|NCT00996892|2624424|P8|Expansion Stage 2|Disease Progression|0
826022|NCT00996892|2624425|P7|Expansion Stage 2|Disease Progression|0
826023|NCT00996892|2624426|P6|Expansion Stage 2|Disease Progression|0
826024|NCT00996892|2624427|P5|Expansion Stage 2|Disease Progression|0
826025|NCT00996892|2624428|P4|Expansion Stage 2|Disease Progression|0
826026|NCT00996892|2624429|P3|Expansion Stage 2|Disease Progression|0
826027|NCT00996892|2624430|P2|Expansion Stage 2|Disease Progression|0
826028|NCT00996892|2624431|P1|Expansion Stage 2|Disease Progression|0
826029|NCT00996892|2624412|P20|Expansion Stage 2|Withdrawal by Subject|0
826030|NCT00996892|2624413|P19|Expansion Stage 2|Withdrawal by Subject|1
826031|NCT00996892|2624414|P18|Expansion Stage 2|Withdrawal by Subject|0
826032|NCT00996892|2624415|P17|Expansion Stage 2|Withdrawal by Subject|0
826033|NCT00996892|2624416|P16|Expansion Stage 2|Withdrawal by Subject|0
826034|NCT00996892|2624417|P15|Expansion Stage 2|Withdrawal by Subject|0
826035|NCT00996892|2624418|P14|Expansion Stage 2|Withdrawal by Subject|0
826036|NCT00996892|2624419|P13|Expansion Stage 2|Withdrawal by Subject|0
826037|NCT00996892|2624420|P12|Expansion Stage 2|Withdrawal by Subject|0
826038|NCT00996892|2624421|P11|Expansion Stage 2|Withdrawal by Subject|0
826039|NCT00996892|2624422|P10|Expansion Stage 2|Withdrawal by Subject|0
826040|NCT00996892|2624423|P9|Expansion Stage 2|Withdrawal by Subject|0
826041|NCT00996892|2624424|P8|Expansion Stage 2|Withdrawal by Subject|0
826042|NCT00996892|2624425|P7|Expansion Stage 2|Withdrawal by Subject|0
826043|NCT00996892|2624426|P6|Expansion Stage 2|Withdrawal by Subject|0
826044|NCT00996892|2624427|P5|Expansion Stage 2|Withdrawal by Subject|0
826045|NCT00996892|2624428|P4|Expansion Stage 2|Withdrawal by Subject|0
826046|NCT00996892|2624429|P3|Expansion Stage 2|Withdrawal by Subject|0
826047|NCT00996892|2624430|P2|Expansion Stage 2|Withdrawal by Subject|0
826048|NCT00996892|2624431|P1|Expansion Stage 2|Withdrawal by Subject|0
826049|NCT00996892|2624412|P20|Expansion Stage 2|Physician Decision|0
826050|NCT00996892|2624413|P19|Expansion Stage 2|Physician Decision|1
826051|NCT00996892|2624414|P18|Expansion Stage 2|Physician Decision|0
826052|NCT00996892|2624415|P17|Expansion Stage 2|Physician Decision|0
826053|NCT00996892|2624416|P16|Expansion Stage 2|Physician Decision|0
826054|NCT00996892|2624417|P15|Expansion Stage 2|Physician Decision|0
826055|NCT00996892|2624418|P14|Expansion Stage 2|Physician Decision|0
826056|NCT00996892|2624419|P13|Expansion Stage 2|Physician Decision|0
826057|NCT00996892|2624420|P12|Expansion Stage 2|Physician Decision|0
826058|NCT00996892|2624421|P11|Expansion Stage 2|Physician Decision|0
826059|NCT00996892|2624422|P10|Expansion Stage 2|Physician Decision|0
826060|NCT00996892|2624423|P9|Expansion Stage 2|Physician Decision|0
826061|NCT00996892|2624424|P8|Expansion Stage 2|Physician Decision|0
826062|NCT00996892|2624425|P7|Expansion Stage 2|Physician Decision|0
826063|NCT00996892|2624426|P6|Expansion Stage 2|Physician Decision|0
826064|NCT00996892|2624427|P5|Expansion Stage 2|Physician Decision|0
826065|NCT00996892|2624428|P4|Expansion Stage 2|Physician Decision|0
826066|NCT00996892|2624429|P3|Expansion Stage 2|Physician Decision|0
826067|NCT00996892|2624430|P2|Expansion Stage 2|Physician Decision|0
826068|NCT00996892|2624431|P1|Expansion Stage 2|Physician Decision|0
826069|NCT00996892|2624412|P20|Expansion Stage 2|Death|0
826070|NCT00996892|2624413|P19|Expansion Stage 2|Death|2
826071|NCT00996892|2624414|P18|Expansion Stage 2|Death|0
826072|NCT00996892|2624415|P17|Expansion Stage 2|Death|0
826073|NCT00996892|2624416|P16|Expansion Stage 2|Death|0
826074|NCT00996892|2624417|P15|Expansion Stage 2|Death|0
826075|NCT00996892|2624418|P14|Expansion Stage 2|Death|0
826076|NCT00996892|2624419|P13|Expansion Stage 2|Death|0
826077|NCT00996892|2624420|P12|Expansion Stage 2|Death|0
826078|NCT00996892|2624421|P11|Expansion Stage 2|Death|0
826079|NCT00996892|2624422|P10|Expansion Stage 2|Death|0
826080|NCT00996892|2624423|P9|Expansion Stage 2|Death|0
826081|NCT00996892|2624424|P8|Expansion Stage 2|Death|0
826082|NCT00996892|2624425|P7|Expansion Stage 2|Death|0
826083|NCT00996892|2624426|P6|Expansion Stage 2|Death|0
826084|NCT00996892|2624427|P5|Expansion Stage 2|Death|0
826085|NCT00996892|2624428|P4|Expansion Stage 2|Death|0
826086|NCT00996892|2624429|P3|Expansion Stage 2|Death|0
826087|NCT00996892|2624430|P2|Expansion Stage 2|Death|0
826088|NCT00996892|2624431|P1|Expansion Stage 2|Death|0
826089|NCT00996892|2624412|P20|Expansion Stage 2|Adverse Event|0
826090|NCT00996892|2624413|P19|Expansion Stage 2|Adverse Event|3
826091|NCT00996892|2624414|P18|Expansion Stage 2|Adverse Event|0
826092|NCT00996892|2624415|P17|Expansion Stage 2|Adverse Event|0
826093|NCT00996892|2624416|P16|Expansion Stage 2|Adverse Event|0
826094|NCT00996892|2624417|P15|Expansion Stage 2|Adverse Event|0
826095|NCT00996892|2624418|P14|Expansion Stage 2|Adverse Event|0
826096|NCT00996892|2624419|P13|Expansion Stage 2|Adverse Event|0
826097|NCT00996892|2624420|P12|Expansion Stage 2|Adverse Event|0
826098|NCT00996892|2624421|P11|Expansion Stage 2|Adverse Event|0
826099|NCT00996892|2624422|P10|Expansion Stage 2|Adverse Event|0
826100|NCT00996892|2624423|P9|Expansion Stage 2|Adverse Event|0
826101|NCT00996892|2624424|P8|Expansion Stage 2|Adverse Event|0
826102|NCT00996892|2624425|P7|Expansion Stage 2|Adverse Event|0
826103|NCT00996892|2624426|P6|Expansion Stage 2|Adverse Event|0
826104|NCT00996892|2624427|P5|Expansion Stage 2|Adverse Event|0
826105|NCT00996892|2624428|P4|Expansion Stage 2|Adverse Event|0
826106|NCT00996892|2624429|P3|Expansion Stage 2|Adverse Event|0
826107|NCT00996892|2624430|P2|Expansion Stage 2|Adverse Event|0
826108|NCT00996892|2624431|P1|Expansion Stage 2|Adverse Event|0
826109|NCT00996892|2624412|P20|Dose-Escalation Stage 1B|Disease Progression|0
826110|NCT00996892|2624413|P19|Dose-Escalation Stage 1B|Disease Progression|0
826111|NCT00996892|2624414|P18|Dose-Escalation Stage 1B|Disease Progression|3
826112|NCT00996892|2624415|P17|Dose-Escalation Stage 1B|Disease Progression|3
826113|NCT00996892|2624416|P16|Dose-Escalation Stage 1B|Disease Progression|3
826114|NCT00996892|2624417|P15|Dose-Escalation Stage 1B|Disease Progression|4
826115|NCT00996892|2624418|P14|Dose-Escalation Stage 1B|Disease Progression|0
826116|NCT00996892|2624419|P13|Dose-Escalation Stage 1B|Disease Progression|0
826117|NCT00996892|2624420|P12|Dose-Escalation Stage 1B|Disease Progression|0
826118|NCT00996892|2624421|P11|Dose-Escalation Stage 1B|Disease Progression|0
826119|NCT00996892|2624422|P10|Dose-Escalation Stage 1B|Disease Progression|0
826120|NCT00996892|2624423|P9|Dose-Escalation Stage 1B|Disease Progression|0
826121|NCT00996892|2624424|P8|Dose-Escalation Stage 1B|Disease Progression|0
826122|NCT00996892|2624425|P7|Dose-Escalation Stage 1B|Disease Progression|0
826123|NCT00996892|2624426|P6|Dose-Escalation Stage 1B|Disease Progression|0
826124|NCT00996892|2624427|P5|Dose-Escalation Stage 1B|Disease Progression|0
826125|NCT00996892|2624428|P4|Dose-Escalation Stage 1B|Disease Progression|0
826126|NCT00996892|2624429|P3|Dose-Escalation Stage 1B|Disease Progression|0
826127|NCT00996892|2624430|P2|Dose-Escalation Stage 1B|Disease Progression|0
826128|NCT00996892|2624431|P1|Dose-Escalation Stage 1B|Disease Progression|0
826129|NCT00996892|2624412|P20|Dose-Escalation Stage 1B|Physician Decision|0
826130|NCT00996892|2624413|P19|Dose-Escalation Stage 1B|Physician Decision|0
826131|NCT00996892|2624414|P18|Dose-Escalation Stage 1B|Physician Decision|2
826132|NCT00996892|2624415|P17|Dose-Escalation Stage 1B|Physician Decision|0
826133|NCT00996892|2624416|P16|Dose-Escalation Stage 1B|Physician Decision|0
826134|NCT00996892|2624417|P15|Dose-Escalation Stage 1B|Physician Decision|0
826135|NCT00996892|2624418|P14|Dose-Escalation Stage 1B|Physician Decision|0
826136|NCT00996892|2624419|P13|Dose-Escalation Stage 1B|Physician Decision|0
826137|NCT00996892|2624420|P12|Dose-Escalation Stage 1B|Physician Decision|0
826138|NCT00996892|2624421|P11|Dose-Escalation Stage 1B|Physician Decision|0
826139|NCT00996892|2624422|P10|Dose-Escalation Stage 1B|Physician Decision|0
826140|NCT00996892|2624423|P9|Dose-Escalation Stage 1B|Physician Decision|0
826141|NCT00996892|2624424|P8|Dose-Escalation Stage 1B|Physician Decision|0
826142|NCT00996892|2624425|P7|Dose-Escalation Stage 1B|Physician Decision|0
826143|NCT00996892|2624426|P6|Dose-Escalation Stage 1B|Physician Decision|0
826144|NCT00996892|2624427|P5|Dose-Escalation Stage 1B|Physician Decision|0
826145|NCT00996892|2624428|P4|Dose-Escalation Stage 1B|Physician Decision|0
826146|NCT00996892|2624429|P3|Dose-Escalation Stage 1B|Physician Decision|0
826147|NCT00996892|2624430|P2|Dose-Escalation Stage 1B|Physician Decision|0
826148|NCT00996892|2624431|P1|Dose-Escalation Stage 1B|Physician Decision|0
826149|NCT00996892|2624412|P20|Dose-Escalation Stage 1A|Disease Progression|0
826150|NCT00996892|2624413|P19|Dose-Escalation Stage 1A|Disease Progression|0
826151|NCT00996892|2624414|P18|Dose-Escalation Stage 1A|Disease Progression|0
826152|NCT00996892|2624415|P17|Dose-Escalation Stage 1A|Disease Progression|0
826153|NCT00996892|2624416|P16|Dose-Escalation Stage 1A|Disease Progression|0
826154|NCT00996892|2624417|P15|Dose-Escalation Stage 1A|Disease Progression|0
826155|NCT00996892|2624418|P14|Dose-Escalation Stage 1A|Disease Progression|4
826156|NCT00996892|2624419|P13|Dose-Escalation Stage 1A|Disease Progression|6
826157|NCT00996892|2624420|P12|Dose-Escalation Stage 1A|Disease Progression|7
826158|NCT00996892|2624421|P11|Dose-Escalation Stage 1A|Disease Progression|5
826159|NCT00996892|2624422|P10|Dose-Escalation Stage 1A|Disease Progression|1
826160|NCT00996892|2624423|P9|Dose-Escalation Stage 1A|Disease Progression|3
826161|NCT00996892|2624424|P8|Dose-Escalation Stage 1A|Disease Progression|2
826162|NCT00996892|2624425|P7|Dose-Escalation Stage 1A|Disease Progression|0
826163|NCT00996892|2624426|P6|Dose-Escalation Stage 1A|Disease Progression|0
826164|NCT00996892|2624427|P5|Dose-Escalation Stage 1A|Disease Progression|0
826165|NCT00996892|2624428|P4|Dose-Escalation Stage 1A|Disease Progression|0
826166|NCT00996892|2624429|P3|Dose-Escalation Stage 1A|Disease Progression|0
826167|NCT00996892|2624430|P2|Dose-Escalation Stage 1A|Disease Progression|0
826168|NCT00996892|2624431|P1|Dose-Escalation Stage 1A|Disease Progression|0
826169|NCT00996892|2624412|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826170|NCT00996892|2624413|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826171|NCT00996892|2624414|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826172|NCT00996892|2624415|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826173|NCT00996892|2624416|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826174|NCT00996892|2624417|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826175|NCT00996892|2624418|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826176|NCT00996892|2624419|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
826177|NCT00996892|2624420|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
826178|NCT00996892|2624421|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
826179|NCT00996892|2624422|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
826180|NCT00996892|2624423|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826181|NCT00996892|2624424|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826182|NCT00996892|2624425|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826183|NCT00996892|2624426|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826184|NCT00996892|2624427|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826185|NCT00996892|2624428|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826186|NCT00996892|2624429|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826187|NCT00996892|2624430|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826188|NCT00996892|2624431|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
826189|NCT00996892|2624412|P20|Dose-Escalation Stage 1A|Physician Decision|0
826190|NCT00996892|2624413|P19|Dose-Escalation Stage 1A|Physician Decision|0
826191|NCT00996892|2624414|P18|Dose-Escalation Stage 1A|Physician Decision|0
826192|NCT00996892|2624415|P17|Dose-Escalation Stage 1A|Physician Decision|0
826193|NCT00996892|2624416|P16|Dose-Escalation Stage 1A|Physician Decision|0
826194|NCT00996892|2624417|P15|Dose-Escalation Stage 1A|Physician Decision|0
826195|NCT00996892|2624418|P14|Dose-Escalation Stage 1A|Physician Decision|0
826196|NCT00996892|2624419|P13|Dose-Escalation Stage 1A|Physician Decision|0
826197|NCT00996892|2624420|P12|Dose-Escalation Stage 1A|Physician Decision|0
826198|NCT00996892|2624421|P11|Dose-Escalation Stage 1A|Physician Decision|0
826199|NCT00996892|2624422|P10|Dose-Escalation Stage 1A|Physician Decision|0
826200|NCT00996892|2624423|P9|Dose-Escalation Stage 1A|Physician Decision|0
826201|NCT00996892|2624424|P8|Dose-Escalation Stage 1A|Physician Decision|1
826202|NCT00996892|2624425|P7|Dose-Escalation Stage 1A|Physician Decision|0
826203|NCT00996892|2624426|P6|Dose-Escalation Stage 1A|Physician Decision|0
826204|NCT00996892|2624427|P5|Dose-Escalation Stage 1A|Physician Decision|0
826205|NCT00996892|2624428|P4|Dose-Escalation Stage 1A|Physician Decision|0
826206|NCT00996892|2624429|P3|Dose-Escalation Stage 1A|Physician Decision|0
826207|NCT00996892|2624430|P2|Dose-Escalation Stage 1A|Physician Decision|0
826208|NCT00996892|2624431|P1|Dose-Escalation Stage 1A|Physician Decision|0
826209|NCT00996892|2624412|P20|Dose-Escalation Stage 1A|Death|0
826210|NCT00996892|2624413|P19|Dose-Escalation Stage 1A|Death|0
826211|NCT00996892|2624414|P18|Dose-Escalation Stage 1A|Death|0
826212|NCT00996892|2624415|P17|Dose-Escalation Stage 1A|Death|0
826213|NCT00996892|2624416|P16|Dose-Escalation Stage 1A|Death|0
826214|NCT00996892|2624417|P15|Dose-Escalation Stage 1A|Death|0
826215|NCT00996892|2624418|P14|Dose-Escalation Stage 1A|Death|0
826216|NCT00996892|2624419|P13|Dose-Escalation Stage 1A|Death|1
826217|NCT00996892|2624420|P12|Dose-Escalation Stage 1A|Death|1
826218|NCT00996892|2624421|P11|Dose-Escalation Stage 1A|Death|0
826219|NCT00996892|2624422|P10|Dose-Escalation Stage 1A|Death|2
826220|NCT00996892|2624423|P9|Dose-Escalation Stage 1A|Death|0
826221|NCT00996892|2624424|P8|Dose-Escalation Stage 1A|Death|0
826222|NCT00996892|2624425|P7|Dose-Escalation Stage 1A|Death|0
826223|NCT00996892|2624426|P6|Dose-Escalation Stage 1A|Death|0
826224|NCT00996892|2624427|P5|Dose-Escalation Stage 1A|Death|0
826225|NCT00996892|2624428|P4|Dose-Escalation Stage 1A|Death|0
826226|NCT00996892|2624429|P3|Dose-Escalation Stage 1A|Death|0
826227|NCT00996892|2624430|P2|Dose-Escalation Stage 1A|Death|0
826228|NCT00996892|2624431|P1|Dose-Escalation Stage 1A|Death|0
826229|NCT00996892|2624412|P20|Dose-Escalation Stage 1A|Adverse Event|0
826230|NCT00996892|2624413|P19|Dose-Escalation Stage 1A|Adverse Event|0
826231|NCT00996892|2624414|P18|Dose-Escalation Stage 1A|Adverse Event|0
826232|NCT00996892|2624415|P17|Dose-Escalation Stage 1A|Adverse Event|0
826233|NCT00996892|2624416|P16|Dose-Escalation Stage 1A|Adverse Event|0
826234|NCT00996892|2624417|P15|Dose-Escalation Stage 1A|Adverse Event|0
826235|NCT00996892|2624418|P14|Dose-Escalation Stage 1A|Adverse Event|1
826236|NCT00996892|2624419|P13|Dose-Escalation Stage 1A|Adverse Event|0
826237|NCT00996892|2624420|P12|Dose-Escalation Stage 1A|Adverse Event|0
826238|NCT00996892|2624421|P11|Dose-Escalation Stage 1A|Adverse Event|1
826239|NCT00996892|2624422|P10|Dose-Escalation Stage 1A|Adverse Event|0
826240|NCT00996892|2624423|P9|Dose-Escalation Stage 1A|Adverse Event|0
826241|NCT00996892|2624424|P8|Dose-Escalation Stage 1A|Adverse Event|0
826242|NCT00996892|2624425|P7|Dose-Escalation Stage 1A|Adverse Event|0
826243|NCT00996892|2624426|P6|Dose-Escalation Stage 1A|Adverse Event|0
826244|NCT00996892|2624427|P5|Dose-Escalation Stage 1A|Adverse Event|0
826245|NCT00996892|2624428|P4|Dose-Escalation Stage 1A|Adverse Event|0
826246|NCT00996892|2624429|P3|Dose-Escalation Stage 1A|Adverse Event|0
826247|NCT00996892|2624430|P2|Dose-Escalation Stage 1A|Adverse Event|0
826248|NCT00996892|2624431|P1|Dose-Escalation Stage 1A|Adverse Event|0
826249|NCT00996892|2624412|P20|Dose-Escalation Stage 1|Disease Progression|0
826250|NCT00996892|2624413|P19|Dose-Escalation Stage 1|Disease Progression|0
826251|NCT00996892|2624414|P18|Dose-Escalation Stage 1|Disease Progression|0
826252|NCT00996892|2624415|P17|Dose-Escalation Stage 1|Disease Progression|0
826253|NCT00996892|2624416|P16|Dose-Escalation Stage 1|Disease Progression|0
826254|NCT00996892|2624417|P15|Dose-Escalation Stage 1|Disease Progression|0
826255|NCT00996892|2624418|P14|Dose-Escalation Stage 1|Disease Progression|0
826256|NCT00996892|2624419|P13|Dose-Escalation Stage 1|Disease Progression|0
826257|NCT00996892|2624420|P12|Dose-Escalation Stage 1|Disease Progression|0
826258|NCT00996892|2624421|P11|Dose-Escalation Stage 1|Disease Progression|0
826259|NCT00996892|2624422|P10|Dose-Escalation Stage 1|Disease Progression|0
826260|NCT00996892|2624423|P9|Dose-Escalation Stage 1|Disease Progression|0
826261|NCT00996892|2624424|P8|Dose-Escalation Stage 1|Disease Progression|0
826262|NCT00996892|2624425|P7|Dose-Escalation Stage 1|Disease Progression|0
826263|NCT00996892|2624426|P6|Dose-Escalation Stage 1|Disease Progression|7
826264|NCT00996892|2624427|P5|Dose-Escalation Stage 1|Disease Progression|10
826265|NCT00996892|2624428|P4|Dose-Escalation Stage 1|Disease Progression|4
826266|NCT00996892|2624429|P3|Dose-Escalation Stage 1|Disease Progression|3
826267|NCT00996892|2624430|P2|Dose-Escalation Stage 1|Disease Progression|2
826268|NCT00996892|2624431|P1|Dose-Escalation Stage 1|Disease Progression|2
826269|NCT00996892|2624412|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
826270|NCT00996892|2624413|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
826271|NCT00996892|2624414|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
826272|NCT00996892|2624415|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
826273|NCT00996892|2624416|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
826274|NCT00996892|2624417|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
826275|NCT00996892|2624418|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
826276|NCT00996892|2624419|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
826277|NCT00996892|2624420|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
826278|NCT00996892|2624421|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
826279|NCT00996892|2624422|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
826280|NCT00996892|2624423|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
826281|NCT00996892|2624424|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
826282|NCT00996892|2624425|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
826283|NCT00996892|2624426|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
826284|NCT00996892|2624427|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
826285|NCT00996892|2624428|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
826286|NCT00996892|2624429|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
826287|NCT00996892|2624430|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
826288|NCT00996892|2624431|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
826289|NCT00996892|2624412|P20|Dose-Escalation Stage 1|Physician Decision|0
826290|NCT00996892|2624413|P19|Dose-Escalation Stage 1|Physician Decision|0
826291|NCT00996892|2624414|P18|Dose-Escalation Stage 1|Physician Decision|0
826292|NCT00996892|2624415|P17|Dose-Escalation Stage 1|Physician Decision|0
826293|NCT00996892|2624416|P16|Dose-Escalation Stage 1|Physician Decision|0
826294|NCT00996892|2624417|P15|Dose-Escalation Stage 1|Physician Decision|0
826295|NCT00996892|2624418|P14|Dose-Escalation Stage 1|Physician Decision|0
826296|NCT00996892|2624419|P13|Dose-Escalation Stage 1|Physician Decision|0
826297|NCT00996892|2624420|P12|Dose-Escalation Stage 1|Physician Decision|0
826298|NCT00996892|2624421|P11|Dose-Escalation Stage 1|Physician Decision|0
826299|NCT00996892|2624422|P10|Dose-Escalation Stage 1|Physician Decision|0
826300|NCT00996892|2624423|P9|Dose-Escalation Stage 1|Physician Decision|0
826301|NCT00996892|2624424|P8|Dose-Escalation Stage 1|Physician Decision|0
826302|NCT00996892|2624425|P7|Dose-Escalation Stage 1|Physician Decision|2
826303|NCT00996892|2624426|P6|Dose-Escalation Stage 1|Physician Decision|1
826304|NCT00996892|2624427|P5|Dose-Escalation Stage 1|Physician Decision|0
826305|NCT00996892|2624428|P4|Dose-Escalation Stage 1|Physician Decision|1
826306|NCT00996892|2624429|P3|Dose-Escalation Stage 1|Physician Decision|0
826307|NCT00996892|2624430|P2|Dose-Escalation Stage 1|Physician Decision|0
826308|NCT00996892|2624431|P1|Dose-Escalation Stage 1|Physician Decision|1
826309|NCT00996892|2624412|P20|Dose-Escalation Stage 1|Death|0
826310|NCT00996892|2624413|P19|Dose-Escalation Stage 1|Death|0
826311|NCT00996892|2624414|P18|Dose-Escalation Stage 1|Death|0
826312|NCT00996892|2624415|P17|Dose-Escalation Stage 1|Death|0
826313|NCT00996892|2624416|P16|Dose-Escalation Stage 1|Death|0
826314|NCT00996892|2624417|P15|Dose-Escalation Stage 1|Death|0
826315|NCT00996892|2624418|P14|Dose-Escalation Stage 1|Death|0
826316|NCT00996892|2624419|P13|Dose-Escalation Stage 1|Death|0
826317|NCT00996892|2624420|P12|Dose-Escalation Stage 1|Death|0
826318|NCT00996892|2624421|P11|Dose-Escalation Stage 1|Death|0
826319|NCT00996892|2624422|P10|Dose-Escalation Stage 1|Death|0
826320|NCT00996892|2624423|P9|Dose-Escalation Stage 1|Death|0
826321|NCT00996892|2624424|P8|Dose-Escalation Stage 1|Death|0
826322|NCT00996892|2624425|P7|Dose-Escalation Stage 1|Death|0
826323|NCT00996892|2624426|P6|Dose-Escalation Stage 1|Death|1
826324|NCT00996892|2624427|P5|Dose-Escalation Stage 1|Death|0
826325|NCT00996892|2624428|P4|Dose-Escalation Stage 1|Death|0
826326|NCT00996892|2624429|P3|Dose-Escalation Stage 1|Death|0
826327|NCT00996892|2624430|P2|Dose-Escalation Stage 1|Death|0
826328|NCT00996892|2624431|P1|Dose-Escalation Stage 1|Death|1
826329|NCT00996892|2624412|P20|Dose-Escalation Stage 1|Adverse Event|0
826330|NCT00996892|2624413|P19|Dose-Escalation Stage 1|Adverse Event|0
826331|NCT00996892|2624414|P18|Dose-Escalation Stage 1|Adverse Event|0
826332|NCT00996892|2624415|P17|Dose-Escalation Stage 1|Adverse Event|0
826333|NCT00996892|2624416|P16|Dose-Escalation Stage 1|Adverse Event|0
826334|NCT00996892|2624417|P15|Dose-Escalation Stage 1|Adverse Event|0
826335|NCT00996892|2624418|P14|Dose-Escalation Stage 1|Adverse Event|0
826336|NCT00996892|2624419|P13|Dose-Escalation Stage 1|Adverse Event|0
826337|NCT00996892|2624420|P12|Dose-Escalation Stage 1|Adverse Event|0
826338|NCT00996892|2624421|P11|Dose-Escalation Stage 1|Adverse Event|0
826339|NCT00996892|2624422|P10|Dose-Escalation Stage 1|Adverse Event|0
826340|NCT00996892|2624423|P9|Dose-Escalation Stage 1|Adverse Event|0
826341|NCT00996892|2624424|P8|Dose-Escalation Stage 1|Adverse Event|0
826342|NCT00996892|2624425|P7|Dose-Escalation Stage 1|Adverse Event|1
826343|NCT00996892|2624426|P6|Dose-Escalation Stage 1|Adverse Event|0
826344|NCT00996892|2624427|P5|Dose-Escalation Stage 1|Adverse Event|0
826345|NCT00996892|2624428|P4|Dose-Escalation Stage 1|Adverse Event|2
826346|NCT00996892|2624429|P3|Dose-Escalation Stage 1|Adverse Event|0
826347|NCT00996892|2624430|P2|Dose-Escalation Stage 1|Adverse Event|0
826348|NCT00996892|2624431|P1|Dose-Escalation Stage 1|Adverse Event|0
826349|NCT00996918|2625025|P5|Overall Study|Not Specified|0
826350|NCT00996918|2625026|P4|Overall Study|Not Specified|0
826351|NCT00996918|2625027|P3|Overall Study|Not Specified|0
826352|NCT00996918|2625028|P2|Overall Study|Not Specified|1
826353|NCT00996918|2625029|P1|Overall Study|Not Specified|3
826354|NCT00996918|2625025|P5|Overall Study|Loss of Caregiver|0
826355|NCT00996918|2625026|P4|Overall Study|Loss of Caregiver|0
826356|NCT00996918|2625027|P3|Overall Study|Loss of Caregiver|0
826357|NCT00996918|2625028|P2|Overall Study|Loss of Caregiver|1
826358|NCT00996918|2625029|P1|Overall Study|Loss of Caregiver|0
826359|NCT00996918|2625025|P5|Overall Study|Discontinuation of Study by Sponsor|2
826360|NCT00996918|2625026|P4|Overall Study|Discontinuation of Study by Sponsor|45
826361|NCT00996918|2625027|P3|Overall Study|Discontinuation of Study by Sponsor|30
826362|NCT00996918|2625028|P2|Overall Study|Discontinuation of Study by Sponsor|54
826363|NCT00996918|2625029|P1|Overall Study|Discontinuation of Study by Sponsor|31
826364|NCT00996918|2625025|P5|Overall Study|Physician Decision|0
826365|NCT00996918|2625026|P4|Overall Study|Physician Decision|0
826366|NCT00996918|2625027|P3|Overall Study|Physician Decision|0
826367|NCT00996918|2625028|P2|Overall Study|Physician Decision|0
826368|NCT00996918|2625029|P1|Overall Study|Physician Decision|1
826369|NCT00996918|2625025|P5|Overall Study|Withdrawal by Subject|2
826370|NCT00996918|2625026|P4|Overall Study|Withdrawal by Subject|3
826371|NCT00996918|2625027|P3|Overall Study|Withdrawal by Subject|3
826372|NCT00996918|2625028|P2|Overall Study|Withdrawal by Subject|4
826373|NCT00996918|2625029|P1|Overall Study|Withdrawal by Subject|1
826374|NCT00996918|2625025|P5|Overall Study|Adverse Event|0
826375|NCT00996918|2625026|P4|Overall Study|Adverse Event|6
826376|NCT00996918|2625027|P3|Overall Study|Adverse Event|2
826377|NCT00996918|2625028|P2|Overall Study|Adverse Event|5
826378|NCT00996918|2625029|P1|Overall Study|Adverse Event|2
826379|NCT00996918|2625025|P5|Overall Study|Lack of Efficacy|0
826380|NCT00996918|2625026|P4|Overall Study|Lack of Efficacy|2
826381|NCT00996918|2625027|P3|Overall Study|Lack of Efficacy|2
826382|NCT00996918|2625028|P2|Overall Study|Lack of Efficacy|1
826383|NCT00996918|2625029|P1|Overall Study|Lack of Efficacy|1
826384|NCT00996944|2625080|P2|Long-term Treatment Period|Study Closed/Terminated|5
826385|NCT00996944|2625081|P1|Long-term Treatment Period|Study Closed/Terminated|12
826386|NCT00996944|2625080|P2|Double-blind Treatment Period|Withdrawal by Subject|1
826387|NCT00996944|2625081|P1|Double-blind Treatment Period|Withdrawal by Subject|1
826388|NCT00996944|2625080|P2|Double-blind Treatment Period|Study Closed/Terminated|5
826389|NCT00996944|2625081|P1|Double-blind Treatment Period|Study Closed/Terminated|6
826390|NCT00996944|2625080|P2|Double-blind Treatment Period|Protocol Violation|0
826391|NCT00996944|2625081|P1|Double-blind Treatment Period|Protocol Violation|1
826392|NCT00996944|2625080|P2|Double-blind Treatment Period|Adverse Event|1
826393|NCT00996944|2625081|P1|Double-blind Treatment Period|Adverse Event|2
826394|NCT00996996|2625123|P1|Overall Study|Did Not Receive Study Medications|1
826395|NCT00996996|2625123|P1|Overall Study|Death|5
826396|NCT00996996|2625123|P1|Overall Study|Lost to Follow-up|9
826397|NCT00996996|2625123|P1|Overall Study|Non-compliance|8
826398|NCT00996996|2625123|P1|Overall Study|Progressive Disease|10
826399|NCT00997035|2625157|P2|3-month Follow-up Visit|Lost to Follow-up|6
826400|NCT00997035|2625158|P1|3-month Follow-up Visit|Lost to Follow-up|12
826401|NCT00997035|2625157|P2|3-week Followup Visit|Lost to Follow-up|6
826402|NCT00997035|2625158|P1|3-week Followup Visit|Lost to Follow-up|9
826403|NCT00997126|2625193|P2|Overall Study|Physician Decision|11
826404|NCT00997126|2625194|P1|Overall Study|Physician Decision|7
826405|NCT00997243|2625228|P1|Overall Study|Early termination of study by sponsor|7
826406|NCT00997321|2625240|P2|Overall Study|did not undergo sedation after enrollmen|3
826407|NCT00997321|2625241|P1|Overall Study|did not undergo sedation after enrollmen|0
826408|NCT00997334|2625253|P1|Overall Study|Ineligible|1
826409|NCT00997334|2625253|P1|Overall Study|No lesion amenable|1
826410|NCT00997334|2625253|P1|Overall Study|Urgent Palliative Care|2
826411|NCT00997334|2625253|P1|Overall Study|Death|2
826412|NCT00997334|2625253|P1|Overall Study|Withdrawal by Subject|3
826413|NCT00997334|2625253|P1|Overall Study|Patient non-compliance|1
826414|NCT00997334|2625253|P1|Overall Study|Adverse Event|3
826415|NCT00997334|2625253|P1|Overall Study|still on therapy|12
826416|NCT00997373|2625262|P2|Overall Study|could not have hysterectomy|0
826417|NCT00997373|2625263|P1|Overall Study|could not have hysterectomy|6
826418|NCT00997373|2625262|P2|Overall Study|wrong tumor type|0
826419|NCT00997373|2625263|P1|Overall Study|wrong tumor type|4
826420|NCT00997373|2625262|P2|Overall Study|Withdrawal by Subject|0
826421|NCT00997373|2625263|P1|Overall Study|Withdrawal by Subject|5
826422|NCT00997438|2625277|P3|Overall Study|Exclusion criteria at visit 1|3
826423|NCT00997438|2625278|P2|Overall Study|Exclusion criteria at visit 1|2
826424|NCT00997438|2625279|P1|Overall Study|Exclusion criteria at visit 1|2
826425|NCT00997438|2625277|P3|Overall Study|Withdrawal by Subject|0
826426|NCT00997438|2625278|P2|Overall Study|Withdrawal by Subject|1
826427|NCT00997438|2625279|P1|Overall Study|Withdrawal by Subject|1
826428|NCT00997438|2625277|P3|Overall Study|Blood draw difficulty|1
826429|NCT00997438|2625278|P2|Overall Study|Blood draw difficulty|0
826430|NCT00997438|2625279|P1|Overall Study|Blood draw difficulty|2
826431|NCT00997503|2625314|P1|Overall Study|Other reason|13
826432|NCT00997503|2625314|P1|Overall Study|Missed 12-month follow-up|85
826433|NCT00997503|2625314|P1|Overall Study|Physician Decision|10
826434|NCT00997503|2625314|P1|Overall Study|Adverse Event|3
826435|NCT00997503|2625314|P1|Overall Study|Lost to Follow-up|33
826436|NCT00997503|2625314|P1|Overall Study|Withdrawal by Subject|76
826437|NCT00997503|2625314|P1|Overall Study|Death|53
826438|NCT00997984|2625430|P3|Overall Study|Work schedule|2
826439|NCT00997984|2625431|P2|Overall Study|Work schedule|0
826440|NCT00997984|2625432|P1|Overall Study|Work schedule|0
826441|NCT00997984|2625430|P3|Overall Study|Suicidal ideation|1
826442|NCT00997984|2625431|P2|Overall Study|Suicidal ideation|0
826443|NCT00997984|2625432|P1|Overall Study|Suicidal ideation|0
826444|NCT00997984|2625430|P3|Overall Study|Wrong medication dispensed|0
826445|NCT00997984|2625431|P2|Overall Study|Wrong medication dispensed|1
826446|NCT00997984|2625432|P1|Overall Study|Wrong medication dispensed|0
826447|NCT00997984|2625430|P3|Overall Study|non-compliance|3
826448|NCT00997984|2625431|P2|Overall Study|non-compliance|2
826449|NCT00997984|2625432|P1|Overall Study|non-compliance|0
826450|NCT00997984|2625430|P3|Overall Study|Met exclusion criteria|0
826451|NCT00997984|2625431|P2|Overall Study|Met exclusion criteria|0
826452|NCT00997984|2625432|P1|Overall Study|Met exclusion criteria|1
826453|NCT00997984|2625430|P3|Overall Study|Lack of Efficacy|3
826454|NCT00997984|2625431|P2|Overall Study|Lack of Efficacy|6
826455|NCT00997984|2625432|P1|Overall Study|Lack of Efficacy|20
826456|NCT00997984|2625430|P3|Overall Study|Lost to Follow-up|4
826457|NCT00997984|2625431|P2|Overall Study|Lost to Follow-up|5
826458|NCT00997984|2625432|P1|Overall Study|Lost to Follow-up|8
826459|NCT00997984|2625430|P3|Overall Study|Withdrawal by Subject|5
826460|NCT00997984|2625431|P2|Overall Study|Withdrawal by Subject|9
826461|NCT00997984|2625432|P1|Overall Study|Withdrawal by Subject|6
826462|NCT00997984|2625430|P3|Overall Study|Protocol Violation|0
826463|NCT00997984|2625431|P2|Overall Study|Protocol Violation|3
826464|NCT00997984|2625432|P1|Overall Study|Protocol Violation|1
826465|NCT00997984|2625430|P3|Overall Study|Adverse Event|8
826466|NCT00997984|2625431|P2|Overall Study|Adverse Event|8
826467|NCT00997984|2625432|P1|Overall Study|Adverse Event|1
826468|NCT00998296|2625534|P11|Overall Study|Reason other than those specified above|0
826469|NCT00998296|2625535|P10|Overall Study|Reason other than those specified above|1
826470|NCT00998296|2625536|P9|Overall Study|Reason other than those specified above|0
826471|NCT00998296|2625537|P8|Overall Study|Reason other than those specified above|0
826472|NCT00998296|2625538|P7|Overall Study|Reason other than those specified above|0
826473|NCT00998296|2625539|P6|Overall Study|Reason other than those specified above|0
826474|NCT00998296|2625540|P5|Overall Study|Reason other than those specified above|0
826475|NCT00998296|2625541|P4|Overall Study|Reason other than those specified above|0
826476|NCT00998296|2625542|P3|Overall Study|Reason other than those specified above|0
826477|NCT00998296|2625543|P2|Overall Study|Reason other than those specified above|0
826478|NCT00998296|2625544|P1|Overall Study|Reason other than those specified above|0
826479|NCT00998296|2625534|P11|Overall Study|Refused to continue taking trial med.|0
826480|NCT00998296|2625535|P10|Overall Study|Refused to continue taking trial med.|2
826481|NCT00998296|2625536|P9|Overall Study|Refused to continue taking trial med.|0
826482|NCT00998296|2625537|P8|Overall Study|Refused to continue taking trial med.|0
826483|NCT00998296|2625538|P7|Overall Study|Refused to continue taking trial med.|0
826484|NCT00998296|2625539|P6|Overall Study|Refused to continue taking trial med.|0
826485|NCT00998296|2625540|P5|Overall Study|Refused to continue taking trial med.|0
826486|NCT00998296|2625541|P4|Overall Study|Refused to continue taking trial med.|0
826487|NCT00998296|2625542|P3|Overall Study|Refused to continue taking trial med.|0
826488|NCT00998296|2625543|P2|Overall Study|Refused to continue taking trial med.|0
826489|NCT00998296|2625544|P1|Overall Study|Refused to continue taking trial med.|0
826490|NCT00998296|2625534|P11|Overall Study|Other adverse event|2
826491|NCT00998296|2625535|P10|Overall Study|Other adverse event|1
826492|NCT00998296|2625536|P9|Overall Study|Other adverse event|0
826493|NCT00998296|2625537|P8|Overall Study|Other adverse event|0
826494|NCT00998296|2625538|P7|Overall Study|Other adverse event|0
826495|NCT00998296|2625539|P6|Overall Study|Other adverse event|0
826496|NCT00998296|2625540|P5|Overall Study|Other adverse event|1
826497|NCT00998296|2625541|P4|Overall Study|Other adverse event|0
826498|NCT00998296|2625542|P3|Overall Study|Other adverse event|0
826499|NCT00998296|2625543|P2|Overall Study|Other adverse event|0
826500|NCT00998296|2625544|P1|Overall Study|Other adverse event|0
826501|NCT00998296|2625534|P11|Overall Study|Dose limiting or dose reducing toxicity|0
826502|NCT00998296|2625535|P10|Overall Study|Dose limiting or dose reducing toxicity|0
826503|NCT00998296|2625536|P9|Overall Study|Dose limiting or dose reducing toxicity|2
826504|NCT00998296|2625537|P8|Overall Study|Dose limiting or dose reducing toxicity|2
826505|NCT00998296|2625538|P7|Overall Study|Dose limiting or dose reducing toxicity|0
826506|NCT00998296|2625539|P6|Overall Study|Dose limiting or dose reducing toxicity|0
826507|NCT00998296|2625540|P5|Overall Study|Dose limiting or dose reducing toxicity|1
826508|NCT00998296|2625541|P4|Overall Study|Dose limiting or dose reducing toxicity|0
826509|NCT00998296|2625542|P3|Overall Study|Dose limiting or dose reducing toxicity|0
826510|NCT00998296|2625543|P2|Overall Study|Dose limiting or dose reducing toxicity|0
826511|NCT00998296|2625544|P1|Overall Study|Dose limiting or dose reducing toxicity|0
826512|NCT00998296|2625534|P11|Overall Study|Progressive disease|5
826513|NCT00998296|2625535|P10|Overall Study|Progressive disease|14
826514|NCT00998296|2625536|P9|Overall Study|Progressive disease|0
826515|NCT00998296|2625537|P8|Overall Study|Progressive disease|0
826516|NCT00998296|2625538|P7|Overall Study|Progressive disease|1
826517|NCT00998296|2625539|P6|Overall Study|Progressive disease|0
826518|NCT00998296|2625540|P5|Overall Study|Progressive disease|0
826519|NCT00998296|2625541|P4|Overall Study|Progressive disease|0
826520|NCT00998296|2625542|P3|Overall Study|Progressive disease|0
826521|NCT00998296|2625543|P2|Overall Study|Progressive disease|1
826522|NCT00998296|2625544|P1|Overall Study|Progressive disease|0
826523|NCT00998309|2625611|P1|Overall Study|Protocol Violation|4
826524|NCT00998335|2625669|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
826525|NCT00998335|2625670|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
826526|NCT00998738|2625767|P1|Overall Study|Uknown|1
826527|NCT00998764|2625781|P2|Overall Study|Recurrent Episode of vasogenic edema|0
826528|NCT00998764|2625782|P1|Overall Study|Recurrent Episode of vasogenic edema|1
826529|NCT00998764|2625781|P2|Overall Study|Not specified|4
826530|NCT00998764|2625782|P1|Overall Study|Not specified|4
826531|NCT00998764|2625781|P2|Overall Study|Loss of Caregiver|3
826532|NCT00998764|2625782|P1|Overall Study|Loss of Caregiver|0
826533|NCT00998764|2625781|P2|Overall Study|Lost to Follow-up|1
826534|NCT00998764|2625782|P1|Overall Study|Lost to Follow-up|1
826535|NCT00998764|2625781|P2|Overall Study|Failed to Return|1
826536|NCT00998764|2625782|P1|Overall Study|Failed to Return|1
826537|NCT00998764|2625781|P2|Overall Study|Protocol Violation|1
826538|NCT00998764|2625782|P1|Overall Study|Protocol Violation|0
826539|NCT00998764|2625781|P2|Overall Study|Discontinuation of Study by Sponsor|217
826540|NCT00998764|2625782|P1|Overall Study|Discontinuation of Study by Sponsor|164
826541|NCT00998764|2625781|P2|Overall Study|Death|1
826542|NCT00998764|2625782|P1|Overall Study|Death|3
826543|NCT00998764|2625781|P2|Overall Study|Physician Decision|3
826544|NCT00998764|2625782|P1|Overall Study|Physician Decision|3
826545|NCT00998764|2625781|P2|Overall Study|Withdrawal by Subject|25
826546|NCT00998764|2625782|P1|Overall Study|Withdrawal by Subject|19
826547|NCT00998764|2625781|P2|Overall Study|Adverse Event|12
826548|NCT00998764|2625782|P1|Overall Study|Adverse Event|17
826549|NCT00998764|2625781|P2|Overall Study|Lack of Efficacy|6
826550|NCT00998764|2625782|P1|Overall Study|Lack of Efficacy|3
826551|NCT00998881|2625813|P2|Overall Study|Personal matter|0
826552|NCT00998881|2625814|P1|Overall Study|Personal matter|1
826553|NCT00998881|2625813|P2|Overall Study|Withdrawal by Subject|0
826554|NCT00998881|2625814|P1|Overall Study|Withdrawal by Subject|1
826555|NCT00998881|2625813|P2|Overall Study|Physician Decision|0
826556|NCT00998881|2625814|P1|Overall Study|Physician Decision|3
826557|NCT00998881|2625813|P2|Overall Study|Lack of Efficacy|0
826558|NCT00998881|2625814|P1|Overall Study|Lack of Efficacy|1
826559|NCT00998881|2625813|P2|Overall Study|Adverse Event|2
826560|NCT00998881|2625814|P1|Overall Study|Adverse Event|2
826561|NCT00998985|2625840|P14|Overall Study|Protocol Violation|0
826562|NCT00998985|2625841|P13|Overall Study|Protocol Violation|0
826563|NCT00998985|2625842|P12|Overall Study|Protocol Violation|0
826564|NCT00998985|2625843|P11|Overall Study|Protocol Violation|0
826565|NCT00998985|2625844|P10|Overall Study|Protocol Violation|0
826566|NCT00998985|2625845|P9|Overall Study|Protocol Violation|0
826567|NCT00998985|2625846|P8|Overall Study|Protocol Violation|0
826568|NCT00998985|2625847|P7|Overall Study|Protocol Violation|0
826569|NCT00998985|2625848|P6|Overall Study|Protocol Violation|1
826570|NCT00998985|2625849|P5|Overall Study|Protocol Violation|0
826571|NCT00998985|2625850|P4|Overall Study|Protocol Violation|0
826572|NCT00998985|2625851|P3|Overall Study|Protocol Violation|0
826573|NCT00998985|2625852|P2|Overall Study|Protocol Violation|0
826574|NCT00998985|2625853|P1|Overall Study|Protocol Violation|0
826575|NCT00998985|2625840|P14|Overall Study|Withdrawal by Subject|0
826576|NCT00998985|2625841|P13|Overall Study|Withdrawal by Subject|0
826577|NCT00998985|2625842|P12|Overall Study|Withdrawal by Subject|0
826578|NCT00998985|2625843|P11|Overall Study|Withdrawal by Subject|0
826579|NCT00998985|2625844|P10|Overall Study|Withdrawal by Subject|0
826580|NCT00998985|2625845|P9|Overall Study|Withdrawal by Subject|1
826581|NCT00998985|2625846|P8|Overall Study|Withdrawal by Subject|0
826582|NCT00998985|2625847|P7|Overall Study|Withdrawal by Subject|0
826583|NCT00998985|2625848|P6|Overall Study|Withdrawal by Subject|0
826584|NCT00998985|2625849|P5|Overall Study|Withdrawal by Subject|0
826585|NCT00998985|2625850|P4|Overall Study|Withdrawal by Subject|0
826586|NCT00998985|2625851|P3|Overall Study|Withdrawal by Subject|0
826587|NCT00998985|2625852|P2|Overall Study|Withdrawal by Subject|0
826588|NCT00998985|2625853|P1|Overall Study|Withdrawal by Subject|0
826589|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
826590|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
826591|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
826592|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
826593|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
826594|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
826595|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
826596|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
826597|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
826598|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
826599|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
826600|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
826601|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
826602|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
826603|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
826604|NCT00999167|2626016|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
826605|NCT00999167|2626017|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
826606|NCT00999167|2626018|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
826607|NCT00999167|2626016|P3|Part A: Open Label Safety run-in|Adverse Event|0
826608|NCT00999167|2626017|P2|Part A: Open Label Safety run-in|Adverse Event|0
826609|NCT00999167|2626018|P1|Part A: Open Label Safety run-in|Adverse Event|3
826610|NCT00999167|2626016|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
826611|NCT00999167|2626017|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
826612|NCT00999167|2626018|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
826613|NCT00991276|2626047|P6|Third Intervention Period|Withdrawal by Subject|0
826614|NCT00991276|2626048|P5|Third Intervention Period|Withdrawal by Subject|0
826615|NCT00991276|2626049|P4|Third Intervention Period|Withdrawal by Subject|1
826616|NCT00991276|2626050|P3|Third Intervention Period|Withdrawal by Subject|0
826617|NCT00991276|2626051|P2|Third Intervention Period|Withdrawal by Subject|0
826618|NCT00991276|2626052|P1|Third Intervention Period|Withdrawal by Subject|0
826619|NCT00991276|2626047|P6|Third Intervention Period|Adverse Event|0
826620|NCT00991276|2626048|P5|Third Intervention Period|Adverse Event|0
826621|NCT00991276|2626049|P4|Third Intervention Period|Adverse Event|0
826622|NCT00991276|2626050|P3|Third Intervention Period|Adverse Event|1
826623|NCT00991276|2626051|P2|Third Intervention Period|Adverse Event|0
826624|NCT00991276|2626052|P1|Third Intervention Period|Adverse Event|0
826625|NCT00991276|2626047|P6|Third Intervention Period|Unspecified|1
826626|NCT00991276|2626048|P5|Third Intervention Period|Unspecified|0
826627|NCT00991276|2626049|P4|Third Intervention Period|Unspecified|0
826628|NCT00991276|2626050|P3|Third Intervention Period|Unspecified|0
826629|NCT00991276|2626051|P2|Third Intervention Period|Unspecified|0
826630|NCT00991276|2626052|P1|Third Intervention Period|Unspecified|0
826631|NCT00991276|2626047|P6|Third Intervention Period|Protocol Violation|0
826632|NCT00991276|2626048|P5|Third Intervention Period|Protocol Violation|0
826633|NCT00991276|2626049|P4|Third Intervention Period|Protocol Violation|0
826634|NCT00991276|2626050|P3|Third Intervention Period|Protocol Violation|0
826635|NCT00991276|2626051|P2|Third Intervention Period|Protocol Violation|0
826636|NCT00991276|2626052|P1|Third Intervention Period|Protocol Violation|1
826637|NCT00991276|2626047|P6|Second Intervention Period|Unspecified|1
826638|NCT00991276|2626048|P5|Second Intervention Period|Unspecified|0
826639|NCT00991276|2626049|P4|Second Intervention Period|Unspecified|1
826640|NCT00991276|2626050|P3|Second Intervention Period|Unspecified|0
826641|NCT00991276|2626051|P2|Second Intervention Period|Unspecified|0
826642|NCT00991276|2626052|P1|Second Intervention Period|Unspecified|0
826643|NCT00991276|2626047|P6|Second Intervention Period|Protocol Violation|0
826644|NCT00991276|2626048|P5|Second Intervention Period|Protocol Violation|0
826645|NCT00991276|2626049|P4|Second Intervention Period|Protocol Violation|0
826646|NCT00991276|2626050|P3|Second Intervention Period|Protocol Violation|0
826647|NCT00991276|2626051|P2|Second Intervention Period|Protocol Violation|0
826648|NCT00991276|2626052|P1|Second Intervention Period|Protocol Violation|1
826649|NCT00991276|2626047|P6|Second Intervention Period|Adverse Event|0
826650|NCT00991276|2626048|P5|Second Intervention Period|Adverse Event|1
826651|NCT00991276|2626049|P4|Second Intervention Period|Adverse Event|1
826652|NCT00991276|2626050|P3|Second Intervention Period|Adverse Event|0
826653|NCT00991276|2626051|P2|Second Intervention Period|Adverse Event|2
826654|NCT00991276|2626052|P1|Second Intervention Period|Adverse Event|0
826655|NCT00991276|2626047|P6|First Intervention Period|Lost to Follow-up|0
826656|NCT00991276|2626048|P5|First Intervention Period|Lost to Follow-up|0
826657|NCT00991276|2626049|P4|First Intervention Period|Lost to Follow-up|1
826658|NCT00991276|2626050|P3|First Intervention Period|Lost to Follow-up|0
826659|NCT00991276|2626051|P2|First Intervention Period|Lost to Follow-up|1
826660|NCT00991276|2626052|P1|First Intervention Period|Lost to Follow-up|0
826661|NCT00991276|2626047|P6|First Intervention Period|Withdrawal by Subject|1
826662|NCT00991276|2626048|P5|First Intervention Period|Withdrawal by Subject|0
826663|NCT00991276|2626049|P4|First Intervention Period|Withdrawal by Subject|1
826664|NCT00991276|2626050|P3|First Intervention Period|Withdrawal by Subject|0
826665|NCT00991276|2626051|P2|First Intervention Period|Withdrawal by Subject|1
826666|NCT00991276|2626052|P1|First Intervention Period|Withdrawal by Subject|0
826667|NCT00991276|2626047|P6|First Intervention Period|Unspecified|0
826668|NCT00991276|2626048|P5|First Intervention Period|Unspecified|1
826669|NCT00991276|2626049|P4|First Intervention Period|Unspecified|1
826670|NCT00991276|2626050|P3|First Intervention Period|Unspecified|0
826671|NCT00991276|2626051|P2|First Intervention Period|Unspecified|0
826672|NCT00991276|2626052|P1|First Intervention Period|Unspecified|0
826673|NCT00991276|2626047|P6|First Intervention Period|Insufficient clinical response|0
826674|NCT00991276|2626048|P5|First Intervention Period|Insufficient clinical response|1
826675|NCT00991276|2626049|P4|First Intervention Period|Insufficient clinical response|0
826676|NCT00991276|2626050|P3|First Intervention Period|Insufficient clinical response|0
826677|NCT00991276|2626051|P2|First Intervention Period|Insufficient clinical response|0
826678|NCT00991276|2626052|P1|First Intervention Period|Insufficient clinical response|0
826679|NCT00991276|2626047|P6|First Intervention Period|Protocol Violation|0
826680|NCT00991276|2626048|P5|First Intervention Period|Protocol Violation|2
826681|NCT00991276|2626049|P4|First Intervention Period|Protocol Violation|0
826682|NCT00991276|2626050|P3|First Intervention Period|Protocol Violation|0
826683|NCT00991276|2626051|P2|First Intervention Period|Protocol Violation|0
826684|NCT00991276|2626052|P1|First Intervention Period|Protocol Violation|0
826685|NCT00991276|2626047|P6|First Intervention Period|Adverse Event|0
826686|NCT00991276|2626048|P5|First Intervention Period|Adverse Event|0
826687|NCT00991276|2626049|P4|First Intervention Period|Adverse Event|1
826688|NCT00991276|2626050|P3|First Intervention Period|Adverse Event|0
826689|NCT00991276|2626051|P2|First Intervention Period|Adverse Event|1
826690|NCT00991276|2626052|P1|First Intervention Period|Adverse Event|0
826691|NCT00991289|2626150|P1|Overall Study|Protocol Violation|2
826692|NCT00991289|2626150|P1|Overall Study|Lost to Follow-up|4
826693|NCT00991289|2626150|P1|Overall Study|Withdrawal by Subject|3
826694|NCT00991289|2626150|P1|Overall Study|Physician Decision|2
826695|NCT00991289|2626150|P1|Overall Study|Adverse Event|1
826696|NCT00991302|2626166|P2|Overall Study|Lost to Follow-up|12
826697|NCT00991302|2626167|P1|Overall Study|Lost to Follow-up|14
826698|NCT00991302|2626166|P2|Overall Study|Death|1
826699|NCT00991302|2626167|P1|Overall Study|Death|0
826700|NCT00991341|2626185|P2|Overall Study|Withdrawal by Subject|4
826701|NCT00991341|2626186|P1|Overall Study|Withdrawal by Subject|3
826702|NCT00991341|2626185|P2|Overall Study|Physician Decision|2
826703|NCT00991341|2626186|P1|Overall Study|Physician Decision|1
826704|NCT00991341|2626185|P2|Overall Study|no RBCs received 96hrs after randomized|155
826705|NCT00991341|2626186|P1|Overall Study|no RBCs received 96hrs after randomized|186
826706|NCT00991341|2626185|P2|Overall Study|Death|0
826707|NCT00991341|2626186|P1|Overall Study|Death|3
826708|NCT00991341|2626185|P2|Overall Study|no surgery w/in 30 days of randomization|18
826709|NCT00991341|2626186|P1|Overall Study|no surgery w/in 30 days of randomization|11
826710|NCT00991510|2626246|P2|Period III (Days 29-112)|Adverse Event|1
826711|NCT00991510|2626247|P1|Period III (Days 29-112)|Adverse Event|1
826712|NCT00991510|2626246|P2|Period I (Days 1-14)|Adverse Event|0
826713|NCT00991510|2626247|P1|Period I (Days 1-14)|Adverse Event|1
826714|NCT00999466|2626272|P3|Main Part|Adverse Event|2
826715|NCT00999466|2626273|P2|Main Part|Adverse Event|4
826716|NCT00999466|2626274|P1|Main Part|Adverse Event|0
826717|NCT00999466|2626272|P3|Main Part|Withdrawal by Subject|2
826718|NCT00999466|2626273|P2|Main Part|Withdrawal by Subject|0
826719|NCT00999466|2626274|P1|Main Part|Withdrawal by Subject|0
826720|NCT00999544|2626549|P1|Overall Study|Withdrawal by Subject|1
826721|NCT00999596|2626582|P1|Overall Study|Statistical population not required|101
826722|NCT01000610|2626587|P1|Overall Study|Treatment failure|1
826723|NCT01000610|2626587|P1|Overall Study|Lost to Follow-up|4
826724|NCT01000610|2626587|P1|Overall Study|Adverse Event|1
826725|NCT01000649|2626598|P4|Overall Study|Lost to Follow-up|2
826726|NCT01000649|2626599|P3|Overall Study|Lost to Follow-up|0
826727|NCT01000649|2626600|P2|Overall Study|Lost to Follow-up|2
826728|NCT01000649|2626601|P1|Overall Study|Lost to Follow-up|0
826729|NCT01000649|2626598|P4|Overall Study|Adverse Event|4
826730|NCT01000649|2626599|P3|Overall Study|Adverse Event|2
826731|NCT01000649|2626600|P2|Overall Study|Adverse Event|1
826732|NCT01000649|2626601|P1|Overall Study|Adverse Event|5
826733|NCT01000727|2626693|P2|Overall Study|Study closed/terminated|24
826734|NCT01000727|2626694|P1|Overall Study|Study closed/terminated|23
826735|NCT01000727|2626693|P2|Overall Study|Withdrawal by Subject|109
826736|NCT01000727|2626694|P1|Overall Study|Withdrawal by Subject|111
826737|NCT01000727|2626693|P2|Overall Study|Lost to Follow-up|43
826738|NCT01000727|2626694|P1|Overall Study|Lost to Follow-up|41
826739|NCT01000805|2626724|P2|Overall Study|Sponsor Decision|1
826740|NCT01000805|2626725|P1|Overall Study|Sponsor Decision|0
826741|NCT01000805|2626724|P2|Overall Study|Withdrawal by Subject|6
826742|NCT01000805|2626725|P1|Overall Study|Withdrawal by Subject|16
826743|NCT01000805|2626724|P2|Overall Study|Protocol Violation|8
826744|NCT01000805|2626725|P1|Overall Study|Protocol Violation|12
826745|NCT01000805|2626724|P2|Overall Study|Physician Decision|1
826746|NCT01000805|2626725|P1|Overall Study|Physician Decision|0
826747|NCT01000805|2626724|P2|Overall Study|Lost to Follow-up|21
826748|NCT01000805|2626725|P1|Overall Study|Lost to Follow-up|16
826749|NCT01000805|2626724|P2|Overall Study|Lack of Efficacy|16
826750|NCT01000805|2626725|P1|Overall Study|Lack of Efficacy|5
826751|NCT01000805|2626724|P2|Overall Study|Adverse Event|9
826752|NCT01000805|2626725|P1|Overall Study|Adverse Event|21
826753|NCT01000961|2626766|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
826754|NCT01000961|2626767|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
826755|NCT01000961|2626766|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
826756|NCT01000961|2626767|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
826757|NCT01000974|2626782|P3|Booster Vaccination Phase|Unspecified|4
826758|NCT01000974|2626783|P2|Booster Vaccination Phase|Unspecified|6
826759|NCT01000974|2626784|P1|Booster Vaccination Phase|Unspecified|24
826760|NCT01000974|2626782|P3|Booster Vaccination Phase|Lost to Follow-up|7
826761|NCT01000974|2626783|P2|Booster Vaccination Phase|Lost to Follow-up|5
826762|NCT01000974|2626784|P1|Booster Vaccination Phase|Lost to Follow-up|40
826763|NCT01000974|2626782|P3|Booster Vaccination Phase|Withdrawal by Subject|1
826764|NCT01000974|2626783|P2|Booster Vaccination Phase|Withdrawal by Subject|1
826765|NCT01000974|2626784|P1|Booster Vaccination Phase|Withdrawal by Subject|3
826766|NCT01000974|2626782|P3|Booster Vaccination Phase|Protocol Violation|2
826767|NCT01000974|2626783|P2|Booster Vaccination Phase|Protocol Violation|0
826768|NCT01000974|2626784|P1|Booster Vaccination Phase|Protocol Violation|0
826769|NCT01000974|2626782|P3|Primary Vaccination Phase|Unspecified|12
826770|NCT01000974|2626783|P2|Primary Vaccination Phase|Unspecified|9
826771|NCT01000974|2626784|P1|Primary Vaccination Phase|Unspecified|4
826772|NCT01000974|2626782|P3|Primary Vaccination Phase|Adverse Event|2
826773|NCT01000974|2626783|P2|Primary Vaccination Phase|Adverse Event|2
826774|NCT01000974|2626784|P1|Primary Vaccination Phase|Adverse Event|14
826775|NCT01000974|2626782|P3|Primary Vaccination Phase|Protocol Violation|2
826776|NCT01000974|2626783|P2|Primary Vaccination Phase|Protocol Violation|3
826777|NCT01000974|2626784|P1|Primary Vaccination Phase|Protocol Violation|40
826778|NCT01000974|2626782|P3|Primary Vaccination Phase|Lost to Follow-up|26
826779|NCT01000974|2626783|P2|Primary Vaccination Phase|Lost to Follow-up|19
826780|NCT01000974|2626784|P1|Primary Vaccination Phase|Lost to Follow-up|171
826781|NCT01000974|2626782|P3|Primary Vaccination Phase|Withdrawal by Subject|21
826782|NCT01000974|2626783|P2|Primary Vaccination Phase|Withdrawal by Subject|17
826783|NCT01000974|2626784|P1|Primary Vaccination Phase|Withdrawal by Subject|109
826784|NCT01001104|2626925|P4|Overall Study|Withdrawal by Subject|2
826785|NCT01001104|2626926|P3|Overall Study|Withdrawal by Subject|0
826786|NCT01001104|2626927|P2|Overall Study|Withdrawal by Subject|0
826787|NCT01001104|2626928|P1|Overall Study|Withdrawal by Subject|0
826788|NCT01001104|2626925|P4|Overall Study|Entry Criteria Not Met|1
826789|NCT01001104|2626926|P3|Overall Study|Entry Criteria Not Met|0
826790|NCT01001104|2626927|P2|Overall Study|Entry Criteria Not Met|0
826791|NCT01001104|2626928|P1|Overall Study|Entry Criteria Not Met|0
826792|NCT01001104|2626925|P4|Overall Study|Lost to Follow-up|0
826793|NCT01001104|2626926|P3|Overall Study|Lost to Follow-up|1
826794|NCT01001104|2626927|P2|Overall Study|Lost to Follow-up|0
826795|NCT01001104|2626928|P1|Overall Study|Lost to Follow-up|0
826796|NCT01001104|2626925|P4|Overall Study|Adverse Event|0
826797|NCT01001104|2626926|P3|Overall Study|Adverse Event|0
826798|NCT01001104|2626927|P2|Overall Study|Adverse Event|1
826799|NCT01001104|2626928|P1|Overall Study|Adverse Event|2
826800|NCT01001169|2626975|P2|Overall Study|Withdrawal by Subject|1
826801|NCT01001169|2626976|P1|Overall Study|Withdrawal by Subject|2
826802|NCT01001208|2627099|P2|Overall Study|Other|2
826803|NCT01001208|2627100|P1|Overall Study|Other|0
826804|NCT01001208|2627099|P2|Overall Study|Disease Progression|3
826805|NCT01001208|2627100|P1|Overall Study|Disease Progression|0
826806|NCT01001208|2627099|P2|Overall Study|Noncompliance|7
826807|NCT01001208|2627100|P1|Overall Study|Noncompliance|4
826808|NCT01001208|2627099|P2|Overall Study|Ineligibility Determined|2
826809|NCT01001208|2627100|P1|Overall Study|Ineligibility Determined|4
826810|NCT01001208|2627099|P2|Overall Study|Withdrawal by Subject|5
826811|NCT01001208|2627100|P1|Overall Study|Withdrawal by Subject|4
826812|NCT01001208|2627099|P2|Overall Study|Physician Decision|0
826813|NCT01001208|2627100|P1|Overall Study|Physician Decision|1
826814|NCT01001208|2627099|P2|Overall Study|Lost to Follow-up|9
826815|NCT01001208|2627100|P1|Overall Study|Lost to Follow-up|5
826816|NCT01001208|2627099|P2|Overall Study|Adverse Event|5
826817|NCT01001208|2627100|P1|Overall Study|Adverse Event|10
826818|NCT01001221|2627128|P5|Overall Study|Not treated; protocol exclusion|0
826819|NCT01001221|2627129|P4|Overall Study|Not treated; protocol exclusion|0
826820|NCT01001221|2627130|P3|Overall Study|Not treated; protocol exclusion|1
826821|NCT01001221|2627131|P2|Overall Study|Not treated; protocol exclusion|0
826822|NCT01001221|2627132|P1|Overall Study|Not treated; protocol exclusion|0
826823|NCT01001221|2627128|P5|Overall Study|Not specified|0
826824|NCT01001221|2627129|P4|Overall Study|Not specified|0
826825|NCT01001221|2627130|P3|Overall Study|Not specified|0
826826|NCT01001221|2627131|P2|Overall Study|Not specified|1
826827|NCT01001221|2627132|P1|Overall Study|Not specified|1
826828|NCT01001221|2627128|P5|Overall Study|Disease progression|0
826829|NCT01001221|2627129|P4|Overall Study|Disease progression|4
826830|NCT01001221|2627130|P3|Overall Study|Disease progression|2
826831|NCT01001221|2627131|P2|Overall Study|Disease progression|2
826832|NCT01001221|2627132|P1|Overall Study|Disease progression|3
826833|NCT01001221|2627128|P5|Overall Study|Adverse Event|0
826834|NCT01001221|2627129|P4|Overall Study|Adverse Event|2
826835|NCT01001221|2627130|P3|Overall Study|Adverse Event|0
826836|NCT01001221|2627131|P2|Overall Study|Adverse Event|2
826837|NCT01001221|2627132|P1|Overall Study|Adverse Event|1
826838|NCT01001234|2627310|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
826839|NCT01001234|2627311|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
826840|NCT01001234|2627312|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
826841|NCT01001234|2627313|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
826842|NCT01001234|2627314|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
826843|NCT01001234|2627310|P5|Overall Study|Not Treated: Physician Decision|0
826844|NCT01001234|2627311|P4|Overall Study|Not Treated: Physician Decision|0
826845|NCT01001234|2627312|P3|Overall Study|Not Treated: Physician Decision|0
826846|NCT01001234|2627313|P2|Overall Study|Not Treated: Physician Decision|4
826847|NCT01001234|2627314|P1|Overall Study|Not Treated: Physician Decision|37
826848|NCT01001234|2627310|P5|Overall Study|Not Treated: Pregnancy|0
826849|NCT01001234|2627311|P4|Overall Study|Not Treated: Pregnancy|0
826850|NCT01001234|2627312|P3|Overall Study|Not Treated: Pregnancy|0
826851|NCT01001234|2627313|P2|Overall Study|Not Treated: Pregnancy|0
826852|NCT01001234|2627314|P1|Overall Study|Not Treated: Pregnancy|3
826853|NCT01001234|2627310|P5|Overall Study|Not Treated: Lost to Follow-up|0
826854|NCT01001234|2627311|P4|Overall Study|Not Treated: Lost to Follow-up|5
826855|NCT01001234|2627312|P3|Overall Study|Not Treated: Lost to Follow-up|7
826856|NCT01001234|2627313|P2|Overall Study|Not Treated: Lost to Follow-up|4
826857|NCT01001234|2627314|P1|Overall Study|Not Treated: Lost to Follow-up|53
826858|NCT01001234|2627310|P5|Overall Study|Not Treated: Protocol Violation|0
826859|NCT01001234|2627311|P4|Overall Study|Not Treated: Protocol Violation|0
826860|NCT01001234|2627312|P3|Overall Study|Not Treated: Protocol Violation|0
826861|NCT01001234|2627313|P2|Overall Study|Not Treated: Protocol Violation|0
826862|NCT01001234|2627314|P1|Overall Study|Not Treated: Protocol Violation|3
826863|NCT01001234|2627310|P5|Overall Study|Not Treated: Withdrawal by Subject|0
826864|NCT01001234|2627311|P4|Overall Study|Not Treated: Withdrawal by Subject|0
826865|NCT01001234|2627312|P3|Overall Study|Not Treated: Withdrawal by Subject|2
826866|NCT01001234|2627313|P2|Overall Study|Not Treated: Withdrawal by Subject|2
826867|NCT01001234|2627314|P1|Overall Study|Not Treated: Withdrawal by Subject|23
826868|NCT01001234|2627310|P5|Overall Study|Not Treated: Adverse Event|0
826869|NCT01001234|2627311|P4|Overall Study|Not Treated: Adverse Event|0
826870|NCT01001234|2627312|P3|Overall Study|Not Treated: Adverse Event|0
826871|NCT01001234|2627313|P2|Overall Study|Not Treated: Adverse Event|0
826872|NCT01001234|2627314|P1|Overall Study|Not Treated: Adverse Event|1
826873|NCT01001234|2627310|P5|Overall Study|Physician Decision|0
826874|NCT01001234|2627311|P4|Overall Study|Physician Decision|0
826875|NCT01001234|2627312|P3|Overall Study|Physician Decision|0
826876|NCT01001234|2627313|P2|Overall Study|Physician Decision|0
826877|NCT01001234|2627314|P1|Overall Study|Physician Decision|1
826878|NCT01001234|2627310|P5|Overall Study|Lost to Follow-up|0
826879|NCT01001234|2627311|P4|Overall Study|Lost to Follow-up|2
826880|NCT01001234|2627312|P3|Overall Study|Lost to Follow-up|1
826881|NCT01001234|2627313|P2|Overall Study|Lost to Follow-up|0
826882|NCT01001234|2627314|P1|Overall Study|Lost to Follow-up|0
826883|NCT01001234|2627310|P5|Overall Study|Protocol Violation|0
826884|NCT01001234|2627311|P4|Overall Study|Protocol Violation|18
826885|NCT01001234|2627312|P3|Overall Study|Protocol Violation|19
826886|NCT01001234|2627313|P2|Overall Study|Protocol Violation|3
826887|NCT01001234|2627314|P1|Overall Study|Protocol Violation|34
826888|NCT01001234|2627310|P5|Overall Study|Withdrawal by Subject|0
826889|NCT01001234|2627311|P4|Overall Study|Withdrawal by Subject|0
826890|NCT01001234|2627312|P3|Overall Study|Withdrawal by Subject|3
826891|NCT01001234|2627313|P2|Overall Study|Withdrawal by Subject|0
826892|NCT01001234|2627314|P1|Overall Study|Withdrawal by Subject|2
826893|NCT01001299|2627326|P1|Overall Study|Withdrew Consent|1
826894|NCT01001299|2627326|P1|Overall Study|Began Taking Commercially Available Drug|2
826895|NCT01001299|2627326|P1|Overall Study|Death|1
826896|NCT01001299|2627326|P1|Overall Study|Adverse event or Intercurrent Illness|1
826897|NCT01001299|2627326|P1|Overall Study|Insufficient Therapeutic Response|20
826898|NCT01001325|2627352|P2|Overall Study|Protocol Violation|0
826899|NCT01001325|2627353|P1|Overall Study|Protocol Violation|2
826900|NCT01001325|2627352|P2|Overall Study|Lost to Follow-up|10
826901|NCT01001325|2627353|P1|Overall Study|Lost to Follow-up|16
826902|NCT01001377|2627361|P2|Overall Study|Death|384
826903|NCT01001377|2627362|P1|Overall Study|Death|391
826904|NCT01001377|2627361|P2|Overall Study|Lost to Follow-up|17
826905|NCT01001377|2627362|P1|Overall Study|Lost to Follow-up|14
826906|NCT01001377|2627361|P2|Overall Study|Withdrawal by Subject|20
826907|NCT01001377|2627362|P1|Overall Study|Withdrawal by Subject|19
826908|NCT01001377|2627361|P2|Overall Study|Ineligibility determined|0
826909|NCT01001377|2627362|P1|Overall Study|Ineligibility determined|2
826910|NCT01001390|2627390|P2|Overall Study|Failure to wear AFO device|0
826911|NCT01001390|2627391|P1|Overall Study|Failure to wear AFO device|2
826912|NCT01001429|2627408|P2|Overall Study|surgery cancelled|1
826913|NCT01001429|2627409|P1|Overall Study|surgery cancelled|0
826914|NCT01001494|2627442|P3|Overall Study|Other|3
826915|NCT01001494|2627443|P2|Overall Study|Other|1
826916|NCT01001494|2627444|P1|Overall Study|Other|0
826917|NCT01001494|2627442|P3|Overall Study|Lack of Efficacy|8
826918|NCT01001494|2627443|P2|Overall Study|Lack of Efficacy|0
826919|NCT01001494|2627444|P1|Overall Study|Lack of Efficacy|2
826920|NCT01001494|2627442|P3|Overall Study|COPD exacerbation|5
826921|NCT01001494|2627443|P2|Overall Study|COPD exacerbation|4
826922|NCT01001494|2627444|P1|Overall Study|COPD exacerbation|3
826923|NCT01001494|2627442|P3|Overall Study|Withdrawal by Subject|17
826924|NCT01001494|2627443|P2|Overall Study|Withdrawal by Subject|7
826925|NCT01001494|2627444|P1|Overall Study|Withdrawal by Subject|9
826926|NCT01001494|2627442|P3|Overall Study|Lost to Follow-up|1
826927|NCT01001494|2627443|P2|Overall Study|Lost to Follow-up|0
826928|NCT01001494|2627444|P1|Overall Study|Lost to Follow-up|2
826929|NCT01001494|2627442|P3|Overall Study|Protocol Violation|1
826930|NCT01001494|2627443|P2|Overall Study|Protocol Violation|1
826931|NCT01001494|2627444|P1|Overall Study|Protocol Violation|0
826932|NCT01001494|2627442|P3|Overall Study|Adverse Event|6
826933|NCT01001494|2627443|P2|Overall Study|Adverse Event|4
826934|NCT01001494|2627444|P1|Overall Study|Adverse Event|8
826935|NCT01001520|2627464|P2|Medication Period 2|Withdrawal by Subject|3
826936|NCT01001520|2627465|P1|Medication Period 2|Withdrawal by Subject|0
826937|NCT01001520|2627464|P2|Washout Period|Withdrawal by Subject|1
826938|NCT01001520|2627465|P1|Washout Period|Withdrawal by Subject|2
826939|NCT01001520|2627464|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
826940|NCT01001520|2627465|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
826941|NCT01001520|2627464|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
826942|NCT01001520|2627465|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
826943|NCT01001520|2627464|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
826944|NCT01001520|2627465|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
826945|NCT01001520|2627464|P2|Medication Period 1|Withdrawal by Subject|2
826946|NCT01001520|2627465|P1|Medication Period 1|Withdrawal by Subject|2
826947|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
826948|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
826949|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
826950|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Protocol deviation|1
826951|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Protocol deviation|0
826952|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Protocol deviation|0
826953|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
826954|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
826955|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
826956|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
826957|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
826958|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
826959|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
826960|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
826961|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
826962|NCT01001572|2627515|P3|Double-Blind Treatment Phase|Adverse Event|2
826963|NCT01001572|2627516|P2|Double-Blind Treatment Phase|Adverse Event|2
826964|NCT01001572|2627517|P1|Double-Blind Treatment Phase|Adverse Event|0
826965|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
826966|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
826967|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
826968|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
826969|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
826970|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
826971|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
826972|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
826973|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
826974|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
826975|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
826976|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
826977|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
826978|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
826979|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
826980|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
826981|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
826982|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
826983|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
826984|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
826985|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
826986|NCT01001572|2627515|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
826987|NCT01001572|2627516|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
826988|NCT01001572|2627517|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
826989|NCT01001702|2627531|P1|Overall Study|Lack of Efficacy per Investigator|3
826990|NCT01001702|2627531|P1|Overall Study|Withdrawal by Subject|19
826991|NCT01001702|2627531|P1|Overall Study|Investigator withdrew Subject|10
826992|NCT01001702|2627531|P1|Overall Study|Subject met Withdrawal Criteria|22
826993|NCT01001702|2627531|P1|Overall Study|Sponsor Discontinued Study|4
826994|NCT01001702|2627531|P1|Overall Study|Adverse Event|7
826995|NCT01001702|2627531|P1|Overall Study|Lost to Follow-up|7
826996|NCT01001767|2627544|P2|Overall Study|Physician Decision|0
826997|NCT01001767|2627545|P1|Overall Study|Physician Decision|1
826998|NCT01001767|2627544|P2|Overall Study|Lost to Follow-up|0
826999|NCT01001767|2627545|P1|Overall Study|Lost to Follow-up|1
827000|NCT01001767|2627544|P2|Overall Study|Protocol Violation|0
827001|NCT01001767|2627545|P1|Overall Study|Protocol Violation|1
827002|NCT01001767|2627544|P2|Overall Study|no baseline study performed|0
827003|NCT01001767|2627545|P1|Overall Study|no baseline study performed|1
827004|NCT01001832|2627566|P2|Follow-up Period|Not specified|1
827005|NCT01001832|2627567|P1|Follow-up Period|Not specified|2
827006|NCT01001832|2627566|P2|Follow-up Period|Follow-up no longer required /protocol|20
827007|NCT01001832|2627567|P1|Follow-up Period|Follow-up no longer required /protocol|15
827008|NCT01001832|2627566|P2|Follow-up Period|Withdrawal by Subject|0
827009|NCT01001832|2627567|P1|Follow-up Period|Withdrawal by Subject|1
827010|NCT01001832|2627566|P2|Long-term Period|Not specified|2
827011|NCT01001832|2627567|P1|Long-term Period|Not specified|1
827012|NCT01001832|2627566|P2|Long-term Period|Lack of Efficacy|2
827013|NCT01001832|2627567|P1|Long-term Period|Lack of Efficacy|0
827014|NCT01001832|2627566|P2|Long-term Period|Withdrawal by Subject|0
827015|NCT01001832|2627567|P1|Long-term Period|Withdrawal by Subject|1
827016|NCT01001832|2627566|P2|Long-term Period|Adverse Event|1
827017|NCT01001832|2627567|P1|Long-term Period|Adverse Event|2
827018|NCT01001832|2627566|P2|Short-term Period|Adverse Event|3
827019|NCT01001832|2627567|P1|Short-term Period|Adverse Event|2
827020|NCT01002105|2627623|P2|Overall Study|condition worsened|2
827021|NCT01002105|2627624|P1|Overall Study|condition worsened|4
827022|NCT01002105|2627623|P2|Overall Study|non compliance|3
827023|NCT01002105|2627624|P1|Overall Study|non compliance|5
827024|NCT01002105|2627623|P2|Overall Study|Lost to Follow-up|16
827025|NCT01002105|2627624|P1|Overall Study|Lost to Follow-up|10
827026|NCT01002339|2627664|P3|Overall Study|Randomized. Not transplanted|1
827027|NCT01002339|2627665|P2|Overall Study|Randomized. Not transplanted|0
827028|NCT01002339|2627666|P1|Overall Study|Randomized. Not transplanted|0
827029|NCT01002339|2627664|P3|Overall Study|Lung cancer detected before transplant|1
827030|NCT01002339|2627665|P2|Overall Study|Lung cancer detected before transplant|0
827031|NCT01002339|2627666|P1|Overall Study|Lung cancer detected before transplant|0
827032|NCT01002339|2627664|P3|Overall Study|Protocol Violation|2
827033|NCT01002339|2627665|P2|Overall Study|Protocol Violation|0
827034|NCT01002339|2627666|P1|Overall Study|Protocol Violation|0
827035|NCT01002339|2627664|P3|Overall Study|Incorrect treatment assignment|1
827036|NCT01002339|2627665|P2|Overall Study|Incorrect treatment assignment|0
827037|NCT01002339|2627666|P1|Overall Study|Incorrect treatment assignment|0
827038|NCT01002339|2627664|P3|Overall Study|Withdrawal by Subject|0
827039|NCT01002339|2627665|P2|Overall Study|Withdrawal by Subject|1
827040|NCT01002339|2627666|P1|Overall Study|Withdrawal by Subject|0
827041|NCT01002482|2627732|P2|Overall Study|Included twice|0
827042|NCT01002482|2627733|P1|Overall Study|Included twice|1
827043|NCT01002482|2627732|P2|Overall Study|Withdrawal by Subject|21
827044|NCT01002482|2627733|P1|Overall Study|Withdrawal by Subject|14
827045|NCT01002573|2627755|P2|Overall Study|Subject did not receive at least 1 dose|7
827046|NCT01002573|2627756|P1|Overall Study|Subject did not receive at least 1 dose|11
893435|NCT00278395|2834306|P1|Overall Study|Adverse Event|2
893436|NCT00252174|2834316|P3|Overall Study|Withdrawal by Subject|0
827049|NCT01002989|2627811|P1|Overall Study|exclusion criteria, no consent|5
827051|NCT00994682|2627840|P2|Pioglitazone Open Label|Physician Decision|1
827052|NCT00994682|2627841|P1|Pioglitazone Open Label|Physician Decision|6
827053|NCT00994682|2627840|P2|Pioglitazone Open Label|Lost to Follow-up|2
827054|NCT00994682|2627841|P1|Pioglitazone Open Label|Lost to Follow-up|3
827055|NCT00994682|2627840|P2|Pioglitazone Open Label|Withdrawal by Subject|4
827056|NCT00994682|2627841|P1|Pioglitazone Open Label|Withdrawal by Subject|4
827057|NCT00994682|2627840|P2|Double Bilnd|Adverse Event|0
827058|NCT00994682|2627841|P1|Double Bilnd|Adverse Event|1
827059|NCT00994682|2627840|P2|Double Bilnd|Lost to Follow-up|3
827060|NCT00994682|2627841|P1|Double Bilnd|Lost to Follow-up|3
827061|NCT00994682|2627840|P2|Double Bilnd|Withdrawal by Subject|6
827062|NCT00994682|2627841|P1|Double Bilnd|Withdrawal by Subject|5
827063|NCT00995007|2627932|P2|Overall Study|Toxicity|0
827064|NCT00995007|2627933|P1|Overall Study|Toxicity|8
827065|NCT00995007|2627932|P2|Overall Study|Refused further treatment|2
827066|NCT00995007|2627933|P1|Overall Study|Refused further treatment|8
827067|NCT00995007|2627932|P2|Overall Study|Withdrew consent|0
827068|NCT00995007|2627933|P1|Overall Study|Withdrew consent|1
827069|NCT00995020|2627951|P2|Overall Study|specimen fragmentation, thermal damage|2
827070|NCT00995020|2627952|P1|Overall Study|specimen fragmentation, thermal damage|1
827071|NCT00995020|2627951|P2|Overall Study|margin analysis not performed|5
827072|NCT00995020|2627952|P1|Overall Study|margin analysis not performed|2
827073|NCT00995085|2627960|P1|Overall Study|Withdrawal by Subject|5
827074|NCT00995345|2627969|P5|Overall Study|all other reasons combined|3
827075|NCT00995345|2627970|P4|Overall Study|all other reasons combined|1
827076|NCT00995345|2627971|P3|Overall Study|all other reasons combined|2
827077|NCT00995345|2627972|P2|Overall Study|all other reasons combined|2
827078|NCT00995345|2627973|P1|Overall Study|all other reasons combined|2
827079|NCT00995345|2627969|P5|Overall Study|Lost to Follow-up|0
827080|NCT00995345|2627970|P4|Overall Study|Lost to Follow-up|1
827081|NCT00995345|2627971|P3|Overall Study|Lost to Follow-up|2
827082|NCT00995345|2627972|P2|Overall Study|Lost to Follow-up|2
827083|NCT00995345|2627973|P1|Overall Study|Lost to Follow-up|2
827084|NCT00995345|2627969|P5|Overall Study|Adverse Event|1
827085|NCT00995345|2627970|P4|Overall Study|Adverse Event|0
827086|NCT00995345|2627971|P3|Overall Study|Adverse Event|2
827087|NCT00995345|2627972|P2|Overall Study|Adverse Event|1
827088|NCT00995345|2627973|P1|Overall Study|Adverse Event|3
827089|NCT00995345|2627969|P5|Overall Study|Withdrawal by Subject|1
827090|NCT00995345|2627970|P4|Overall Study|Withdrawal by Subject|3
827091|NCT00995345|2627971|P3|Overall Study|Withdrawal by Subject|1
827092|NCT00995345|2627972|P2|Overall Study|Withdrawal by Subject|2
827093|NCT00995345|2627973|P1|Overall Study|Withdrawal by Subject|4
827094|NCT00995371|2628002|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
827095|NCT00995371|2628003|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
827096|NCT00995410|2628016|P1|Overall Study|Misc|28
827097|NCT00995410|2628016|P1|Overall Study|Lost to Follow-up|2
827098|NCT00995410|2628016|P1|Overall Study|Withdrawal by Subject|7
827099|NCT00995410|2628016|P1|Overall Study|Adverse Event|51
827100|NCT00995436|2628024|P3|Overall Study|Withdrawal by Subject|0
827101|NCT00995436|2628025|P2|Overall Study|Withdrawal by Subject|5
827102|NCT00995436|2628026|P1|Overall Study|Withdrawal by Subject|2
827103|NCT00995488|2628049|P1|Overall Study|Withdrawal by Subject|1
827104|NCT00995553|2628097|P2|Overall Study|Withdrawal by Subject|6
827105|NCT00995553|2628098|P1|Overall Study|Withdrawal by Subject|2
827106|NCT00995566|2628106|P1|Overall Study|Early study termination|52
827107|NCT00995566|2628106|P1|Overall Study|Adverse Event|2
827108|NCT00995670|2628121|P3|Overall Study|Failed arterial cannulation|3
827109|NCT00995670|2628122|P2|Overall Study|Failed arterial cannulation|0
827110|NCT00995670|2628123|P1|Overall Study|Failed arterial cannulation|1
827111|NCT00995709|2628134|P3|Overall Study|Protocol Violation|0
827112|NCT00995709|2628135|P2|Overall Study|Protocol Violation|1
827113|NCT00995709|2628136|P1|Overall Study|Protocol Violation|2
827114|NCT00995709|2628134|P3|Overall Study|Death|0
827115|NCT00995709|2628135|P2|Overall Study|Death|1
827116|NCT00995709|2628136|P1|Overall Study|Death|0
827117|NCT00995709|2628134|P3|Overall Study|Lost to Follow-up|0
827118|NCT00995709|2628135|P2|Overall Study|Lost to Follow-up|0
827119|NCT00995709|2628136|P1|Overall Study|Lost to Follow-up|1
827120|NCT00995709|2628134|P3|Overall Study|Withdrawal by Subject|1
827121|NCT00995709|2628135|P2|Overall Study|Withdrawal by Subject|4
827122|NCT00995709|2628136|P1|Overall Study|Withdrawal by Subject|0
827123|NCT00995709|2628134|P3|Overall Study|Lack of Efficacy|4
827124|NCT00995709|2628135|P2|Overall Study|Lack of Efficacy|1
827125|NCT00995709|2628136|P1|Overall Study|Lack of Efficacy|0
827126|NCT00995709|2628134|P3|Overall Study|Adverse Event|0
827127|NCT00995709|2628135|P2|Overall Study|Adverse Event|2
827128|NCT00995709|2628136|P1|Overall Study|Adverse Event|4
827129|NCT00995774|2628182|P2|Training Period 2|Withdrawal by Subject|0
827130|NCT00995774|2628183|P1|Training Period 2|Withdrawal by Subject|2
827131|NCT00995865|2628194|P3|Overall Study|Lost to Follow-up|1
827132|NCT00995865|2628195|P2|Overall Study|Lost to Follow-up|0
827133|NCT00995865|2628196|P1|Overall Study|Lost to Follow-up|0
827134|NCT00995865|2628194|P3|Overall Study|Protocol Violation|0
827135|NCT00995865|2628195|P2|Overall Study|Protocol Violation|0
827136|NCT00995865|2628196|P1|Overall Study|Protocol Violation|2
827137|NCT00995930|2628237|P2|Overall Study|Adverse Event|14
827138|NCT00995930|2628238|P1|Overall Study|Adverse Event|11
827139|NCT00995930|2628237|P2|Overall Study|Withdrawal by Subject|4
827140|NCT00995930|2628238|P1|Overall Study|Withdrawal by Subject|3
827141|NCT00995930|2628237|P2|Overall Study|Lost to Follow-up|2
827142|NCT00995930|2628238|P1|Overall Study|Lost to Follow-up|1
827143|NCT00995930|2628237|P2|Overall Study|Administrative problems|2
827144|NCT00995930|2628238|P1|Overall Study|Administrative problems|4
827145|NCT00995930|2628237|P2|Overall Study|Death|1
827146|NCT00995930|2628238|P1|Overall Study|Death|0
827147|NCT00995930|2628237|P2|Overall Study|Protocol deviation|5
827148|NCT00995930|2628238|P1|Overall Study|Protocol deviation|2
827149|NCT00996034|2628267|P1|Overall Study|withdrawn by PI|1
827150|NCT00996034|2628267|P1|Overall Study|Lost to Follow-up|2
827151|NCT00996125|2628273|P2|Overall Study|Withdrawal by Subject|3
827152|NCT00996125|2628274|P1|Overall Study|Withdrawal by Subject|4
827153|NCT00996125|2628273|P2|Overall Study|Lost to Follow-up|6
827154|NCT00996125|2628274|P1|Overall Study|Lost to Follow-up|1
827155|NCT00996125|2628273|P2|Overall Study|Adverse Event|2
827156|NCT00996125|2628274|P1|Overall Study|Adverse Event|0
827157|NCT00996203|2628305|P1|Overall Study|Protocol Violation|2
827158|NCT00996203|2628305|P1|Overall Study|Lack of Efficacy|1
827159|NCT00996203|2628305|P1|Overall Study|Lost to Follow-up|1
827160|NCT00996203|2628305|P1|Overall Study|Adverse Event|3
827161|NCT00996216|2628324|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
827162|NCT00996216|2628324|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
827163|NCT00996216|2628324|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
893437|NCT00252174|2834317|P2|Overall Study|Withdrawal by Subject|1
893438|NCT00252174|2834318|P1|Overall Study|Withdrawal by Subject|0
827196|NCT00996333|2628416|P1|Overall Study|Other|5
827197|NCT00996333|2628416|P1|Overall Study|Physician Decision|1
827198|NCT00996333|2628416|P1|Overall Study|Adverse Event|1
827199|NCT00996333|2628416|P1|Overall Study|Death|4
827200|NCT00996333|2628416|P1|Overall Study|Withdrawal by Subject|1
827201|NCT00996333|2628416|P1|Overall Study|Screen failure|1
827202|NCT00996437|2628449|P2|Overall Study|Missed|5
827203|NCT00996437|2628450|P1|Overall Study|Missed|2
827204|NCT00996437|2628449|P2|Overall Study|Dropped|2
827205|NCT00996437|2628450|P1|Overall Study|Dropped|2
827206|NCT00996437|2628449|P2|Overall Study|Death|0
827207|NCT00996437|2628450|P1|Overall Study|Death|1
827208|NCT00996476|2628475|P5|Overall Study|Adverse Event|1
827209|NCT00996476|2628476|P4|Overall Study|Adverse Event|0
827210|NCT00996476|2628477|P3|Overall Study|Adverse Event|0
827211|NCT00996476|2628478|P2|Overall Study|Adverse Event|1
827212|NCT00996476|2628479|P1|Overall Study|Adverse Event|0
827213|NCT00996476|2628475|P5|Overall Study|Withdrawal by Subject|1
827214|NCT00996476|2628476|P4|Overall Study|Withdrawal by Subject|0
827215|NCT00996476|2628477|P3|Overall Study|Withdrawal by Subject|1
827216|NCT00996476|2628478|P2|Overall Study|Withdrawal by Subject|2
827217|NCT00996476|2628479|P1|Overall Study|Withdrawal by Subject|1
827218|NCT00996580|2628549|P1|Overall Study|Not specified|29
827219|NCT00996580|2628549|P1|Overall Study|Withdrawal by Subject|217
827220|NCT00996580|2628549|P1|Overall Study|Sponsor requested participant withdrawal|35
827221|NCT00996580|2628549|P1|Overall Study|Protocol Violation|16
827222|NCT00996580|2628549|P1|Overall Study|Pregnancy|68
827223|NCT00996580|2628549|P1|Overall Study|Physician Decision|5
827224|NCT00996580|2628549|P1|Overall Study|Noncompliance with the protocol|137
827225|NCT00996580|2628549|P1|Overall Study|Lost to Follow-up|480
827226|NCT00996580|2628549|P1|Overall Study|Adverse Event|466
827227|NCT00996593|2628577|P1|Long-Term Follow-Up|Site Closed|1
827228|NCT00996593|2628577|P1|Long-Term Follow-Up|Withdrawal by Subject|2
827229|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
827230|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
827231|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
827232|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Death|1
827233|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
827234|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
827323|NCT01003886|2628994|P1|Overall Study|Lost to Follow-up|169
827235|NCT00996593|2628577|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
827236|NCT00996606|2628605|P1|Overall Study|Withdrawal by Subject|3
827237|NCT00996606|2628605|P1|Overall Study|Protocol Violation|1
827238|NCT00996606|2628605|P1|Overall Study|Insufficient Therapeutic Response|2
827239|NCT00996606|2628605|P1|Overall Study|Adverse Event or Intercurrent Illness|2
827240|NCT00996632|2628701|P2|Overall Study|Physician Decision|0
827241|NCT00996632|2628702|P1|Overall Study|Physician Decision|0
827242|NCT00996658|2628712|P2|Overall Study|Other|7
827243|NCT00996658|2628713|P1|Overall Study|Other|9
827244|NCT00996658|2628712|P2|Overall Study|Non-compliance issues|3
827245|NCT00996658|2628713|P1|Overall Study|Non-compliance issues|3
827246|NCT00996658|2628712|P2|Overall Study|Lost to Follow-up|5
827247|NCT00996658|2628713|P1|Overall Study|Lost to Follow-up|2
827248|NCT00996658|2628712|P2|Overall Study|Protocol Violation|1
827249|NCT00996658|2628713|P1|Overall Study|Protocol Violation|0
827250|NCT00996658|2628712|P2|Overall Study|Adverse Event|5
827251|NCT00996658|2628713|P1|Overall Study|Adverse Event|2
827252|NCT00996736|2628741|P2|Overall Study|Visit not within 3-month window|3
827253|NCT00996736|2628742|P1|Overall Study|Visit not within 3-month window|5
827254|NCT00996736|2628741|P2|Overall Study|Lost to Follow-up|14
827255|NCT00996736|2628742|P1|Overall Study|Lost to Follow-up|15
827256|NCT00996736|2628741|P2|Overall Study|Death|1
827257|NCT00996736|2628742|P1|Overall Study|Death|1
827258|NCT00996801|2628775|P6|Overall Study|Withdrawal by Subject|9
827259|NCT00996801|2628776|P5|Overall Study|Withdrawal by Subject|5
827260|NCT00996801|2628777|P4|Overall Study|Withdrawal by Subject|5
827261|NCT00996801|2628778|P3|Overall Study|Withdrawal by Subject|9
827262|NCT00996801|2628779|P2|Overall Study|Withdrawal by Subject|6
827263|NCT00996801|2628780|P1|Overall Study|Withdrawal by Subject|8
827264|NCT00996801|2628775|P6|Overall Study|Study Terminated by Sponsor|0
827265|NCT00996801|2628776|P5|Overall Study|Study Terminated by Sponsor|46
827266|NCT00996801|2628777|P4|Overall Study|Study Terminated by Sponsor|0
827267|NCT00996801|2628778|P3|Overall Study|Study Terminated by Sponsor|0
827268|NCT00996801|2628779|P2|Overall Study|Study Terminated by Sponsor|1
827269|NCT00996801|2628780|P1|Overall Study|Study Terminated by Sponsor|0
827270|NCT00996801|2628775|P6|Overall Study|Protocol Violation|4
827271|NCT00996801|2628776|P5|Overall Study|Protocol Violation|3
827272|NCT00996801|2628777|P4|Overall Study|Protocol Violation|2
827273|NCT00996801|2628778|P3|Overall Study|Protocol Violation|1
827274|NCT00996801|2628779|P2|Overall Study|Protocol Violation|4
827275|NCT00996801|2628780|P1|Overall Study|Protocol Violation|3
827276|NCT00996801|2628775|P6|Overall Study|Progressive Disease|0
827277|NCT00996801|2628776|P5|Overall Study|Progressive Disease|0
827278|NCT00996801|2628777|P4|Overall Study|Progressive Disease|0
827279|NCT00996801|2628778|P3|Overall Study|Progressive Disease|0
827280|NCT00996801|2628779|P2|Overall Study|Progressive Disease|1
827281|NCT00996801|2628780|P1|Overall Study|Progressive Disease|0
827282|NCT00996801|2628775|P6|Overall Study|Physician Decision|0
827283|NCT00996801|2628776|P5|Overall Study|Physician Decision|0
827284|NCT00996801|2628777|P4|Overall Study|Physician Decision|1
827285|NCT00996801|2628778|P3|Overall Study|Physician Decision|0
827286|NCT00996801|2628779|P2|Overall Study|Physician Decision|0
827287|NCT00996801|2628780|P1|Overall Study|Physician Decision|0
827288|NCT00996801|2628775|P6|Overall Study|Lost to Follow-up|2
827289|NCT00996801|2628776|P5|Overall Study|Lost to Follow-up|3
827290|NCT00996801|2628777|P4|Overall Study|Lost to Follow-up|3
827291|NCT00996801|2628778|P3|Overall Study|Lost to Follow-up|0
827292|NCT00996801|2628779|P2|Overall Study|Lost to Follow-up|0
827293|NCT00996801|2628780|P1|Overall Study|Lost to Follow-up|0
827294|NCT00996801|2628775|P6|Overall Study|Lack of Efficacy|1
827295|NCT00996801|2628776|P5|Overall Study|Lack of Efficacy|0
827296|NCT00996801|2628777|P4|Overall Study|Lack of Efficacy|3
827297|NCT00996801|2628778|P3|Overall Study|Lack of Efficacy|1
827298|NCT00996801|2628779|P2|Overall Study|Lack of Efficacy|0
827299|NCT00996801|2628780|P1|Overall Study|Lack of Efficacy|3
827300|NCT00996801|2628775|P6|Overall Study|Adverse Event|3
827301|NCT00996801|2628776|P5|Overall Study|Adverse Event|31
827302|NCT00996801|2628777|P4|Overall Study|Adverse Event|17
827303|NCT00996801|2628778|P3|Overall Study|Adverse Event|12
827304|NCT00996801|2628779|P2|Overall Study|Adverse Event|4
827305|NCT00996801|2628780|P1|Overall Study|Adverse Event|6
827306|NCT01003184|2628925|P2|Overall Study|Physician Decision|0
827307|NCT01003184|2628926|P1|Overall Study|Physician Decision|1
827308|NCT01003184|2628925|P2|Overall Study|Withdrawal by Subject|6
827309|NCT01003184|2628926|P1|Overall Study|Withdrawal by Subject|1
827310|NCT01003184|2628925|P2|Overall Study|Protocol Violation|0
827311|NCT01003184|2628926|P1|Overall Study|Protocol Violation|3
827312|NCT01003184|2628925|P2|Overall Study|Loss of glucose control|1
827313|NCT01003184|2628926|P1|Overall Study|Loss of glucose control|1
827314|NCT01003184|2628925|P2|Overall Study|Lost to Follow-up|0
827315|NCT01003184|2628926|P1|Overall Study|Lost to Follow-up|1
827316|NCT01003184|2628925|P2|Overall Study|Adverse Event|5
827317|NCT01003184|2628926|P1|Overall Study|Adverse Event|12
827318|NCT01003210|2628960|P2|Overall Study|Lost to Follow-up|3
827319|NCT01003210|2628961|P1|Overall Study|Lost to Follow-up|1
827320|NCT01003886|2628994|P1|Overall Study|Adverse Event|3
827321|NCT01003886|2628994|P1|Overall Study|Unspecified|14
827322|NCT01003886|2628994|P1|Overall Study|Withdrawal by Subject|39
827324|NCT01003886|2628994|P1|Overall Study|Lack of Efficacy|5
827325|NCT01003899|2629003|P1|Overall Study|Progressive disease|34
827326|NCT01003899|2629003|P1|Overall Study|Not treated|1
827327|NCT01003899|2629003|P1|Overall Study|Not entered|4
827328|NCT01003899|2629003|P1|Overall Study|Other Adverse Event|8
827329|NCT01003990|2629024|P3|Overall Study|Subject Withdrew Consent|7
827330|NCT01003990|2629025|P2|Overall Study|Subject Withdrew Consent|5
827331|NCT01003990|2629026|P1|Overall Study|Subject Withdrew Consent|12
827332|NCT01003990|2629024|P3|Overall Study|No Longer Met Study Criteria|0
827333|NCT01003990|2629025|P2|Overall Study|No Longer Met Study Criteria|1
827334|NCT01003990|2629026|P1|Overall Study|No Longer Met Study Criteria|4
827335|NCT01003990|2629024|P3|Overall Study|Pregnancy|4
827336|NCT01003990|2629025|P2|Overall Study|Pregnancy|2
827337|NCT01003990|2629026|P1|Overall Study|Pregnancy|10
827338|NCT01003990|2629024|P3|Overall Study|Poor/Non-compliance|2
827339|NCT01003990|2629025|P2|Overall Study|Poor/Non-compliance|3
827340|NCT01003990|2629026|P1|Overall Study|Poor/Non-compliance|4
827341|NCT01003990|2629024|P3|Overall Study|Reasons Not Identified|8
827342|NCT01003990|2629025|P2|Overall Study|Reasons Not Identified|13
827343|NCT01003990|2629026|P1|Overall Study|Reasons Not Identified|14
827344|NCT01003990|2629024|P3|Overall Study|Lost to Follow-up|7
827345|NCT01003990|2629025|P2|Overall Study|Lost to Follow-up|12
827346|NCT01003990|2629026|P1|Overall Study|Lost to Follow-up|30
827347|NCT01003990|2629024|P3|Overall Study|Lack of Efficacy|3
827348|NCT01003990|2629025|P2|Overall Study|Lack of Efficacy|2
827349|NCT01003990|2629026|P1|Overall Study|Lack of Efficacy|10
827350|NCT01003990|2629024|P3|Overall Study|Death|1
827351|NCT01003990|2629025|P2|Overall Study|Death|8
827352|NCT01003990|2629026|P1|Overall Study|Death|0
827353|NCT01003990|2629024|P3|Overall Study|Adverse Event|11
827354|NCT01003990|2629025|P2|Overall Study|Adverse Event|5
827355|NCT01003990|2629026|P1|Overall Study|Adverse Event|8
893450|NCT02675907|2834480|P2|Study Overall|Lost to Follow-up|2
893451|NCT02675907|2834481|P1|Study Overall|Lost to Follow-up|0
893452|NCT02675907|2834480|P2|Study Overall|Withdrawal by Subject|2
893453|NCT02675907|2834481|P1|Study Overall|Withdrawal by Subject|2
893454|NCT02675907|2834480|P2|Study Overall|Lack of Efficacy|0
893455|NCT02675907|2834481|P1|Study Overall|Lack of Efficacy|1
893456|NCT02675907|2834480|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
893457|NCT02675907|2834481|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
893458|NCT02675907|2834480|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
893459|NCT02675907|2834481|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
893460|NCT02667288|2834511|P1|Overall Study|Withdrawal by Subject|5
893461|NCT02667288|2834511|P1|Overall Study|Lost to Follow-up|3
893462|NCT02667288|2834511|P1|Overall Study|Protocol Violation|5
827392|NCT01004146|2629081|P2|Overall Study|Withdrawal by Subject|5
827393|NCT01004146|2629082|P1|Overall Study|Withdrawal by Subject|4
827394|NCT01004159|2629088|P1|Overall Study|Disease Progression|18
827395|NCT01004159|2629088|P1|Overall Study|Adverse Event|2
827396|NCT01004172|2629093|P1|Overall Study|Symptomatic Deterioration|2
827397|NCT01004172|2629093|P1|Overall Study|Physician Decision|1
827398|NCT01004172|2629093|P1|Overall Study|Adverse Event|1
827399|NCT01004172|2629093|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
827400|NCT01004172|2629093|P1|Overall Study|Progressive Disease in Non-CNS Only|16
827401|NCT01004172|2629093|P1|Overall Study|Progressive Disease in CNS Only|16
827402|NCT01004185|2629101|P2|Overall Study|Withdrawal by Subject|1
827403|NCT01004185|2629102|P1|Overall Study|Withdrawal by Subject|2
827404|NCT01004185|2629101|P2|Overall Study|Sponsor Terminated Study|5
827405|NCT01004185|2629102|P1|Overall Study|Sponsor Terminated Study|4
827406|NCT01004185|2629101|P2|Overall Study|Lack of Efficacy|1
827407|NCT01004185|2629102|P1|Overall Study|Lack of Efficacy|2
827408|NCT01004185|2629101|P2|Overall Study|Lost to Follow-up|1
827409|NCT01004185|2629102|P1|Overall Study|Lost to Follow-up|0
827410|NCT01004185|2629101|P2|Overall Study|Adverse Event|1
827411|NCT01004185|2629102|P1|Overall Study|Adverse Event|1
827412|NCT01004250|2629110|P1|Follow-Up (FU) Period|Lost to Follow-up|1
827413|NCT01004250|2629110|P1|Maintenance Therapy Period|Physician Decision|4
827414|NCT01004250|2629110|P1|Maintenance Therapy Period|Withdrawal by Subject|5
827415|NCT01004250|2629110|P1|Maintenance Therapy Period|Protocol Violation|1
827416|NCT01004250|2629110|P1|Maintenance Therapy Period|Lost to Follow-up|1
827417|NCT01004250|2629110|P1|Maintenance Therapy Period|Adverse Event|15
827418|NCT01004250|2629110|P1|Induction Therapy Period|Physician Decision|2
827419|NCT01004250|2629110|P1|Induction Therapy Period|Withdrawal by Subject|2
827420|NCT01004250|2629110|P1|Induction Therapy Period|Entry Criteria Not Met|1
827421|NCT01004250|2629110|P1|Induction Therapy Period|Adverse Event|10
827422|NCT01004263|2629120|P1|Overall Study|Lack of Qualifying Event|2
827423|NCT01004263|2629120|P1|Overall Study|Physician Decision|15
827424|NCT01004263|2629120|P1|Overall Study|Pregnancy|2
827425|NCT01004263|2629120|P1|Overall Study|Lack of Efficacy|13
827426|NCT01004263|2629120|P1|Overall Study|Lost to Follow-up|64
827427|NCT01004263|2629120|P1|Overall Study|Protocol Violation|10
827428|NCT01004263|2629120|P1|Overall Study|Withdrawal by Subject|58
827429|NCT01004263|2629120|P1|Overall Study|Adverse Event|15
827430|NCT01004432|2629143|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
827431|NCT01004432|2629144|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
827432|NCT01004432|2629145|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
827433|NCT01004432|2629146|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
827434|NCT01004432|2629147|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
827435|NCT01004432|2629143|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
827436|NCT01004432|2629144|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
827437|NCT01004432|2629145|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
827438|NCT01004432|2629146|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
827439|NCT01004432|2629147|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
827440|NCT01004432|2629143|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
827441|NCT01004432|2629144|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
827442|NCT01004432|2629145|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
827443|NCT01004432|2629146|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
827444|NCT01004432|2629147|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
827445|NCT01004432|2629143|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
827446|NCT01004432|2629144|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
827447|NCT01004432|2629145|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
827448|NCT01004432|2629146|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
827449|NCT01004432|2629147|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
827450|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
827451|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
827452|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
827453|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
827454|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
827455|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
827456|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
827457|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
827458|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
827459|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
827460|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
827461|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
827462|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
827463|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
827464|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
827465|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
827466|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
827467|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
827468|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
827469|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
827470|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
827471|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
827472|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
827473|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
827474|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
827475|NCT01004432|2629143|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
827476|NCT01004432|2629144|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
827477|NCT01004432|2629145|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
827478|NCT01004432|2629146|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
827479|NCT01004432|2629147|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
827480|NCT01004432|2629143|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
827481|NCT01004432|2629144|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
827482|NCT01004432|2629145|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
827483|NCT01004432|2629146|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
827484|NCT01004432|2629147|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
827485|NCT01004432|2629143|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
827486|NCT01004432|2629144|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
827487|NCT01004432|2629145|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
827488|NCT01004432|2629146|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
827489|NCT01004432|2629147|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
827490|NCT01004432|2629143|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
827491|NCT01004432|2629144|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
827492|NCT01004432|2629145|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
827493|NCT01004432|2629146|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
827494|NCT01004432|2629147|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
827495|NCT01004432|2629143|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
827496|NCT01004432|2629144|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
827497|NCT01004432|2629145|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
827498|NCT01004432|2629146|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
827499|NCT01004432|2629147|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
827500|NCT01004432|2629143|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
827501|NCT01004432|2629144|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
827502|NCT01004432|2629145|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
827503|NCT01004432|2629146|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
827504|NCT01004432|2629147|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
827505|NCT01004510|2629167|P1|Overall Study|Adverse Event|1
827506|NCT01004614|2629175|P4|Washout|Withdrawal by Subject|0
827507|NCT01004614|2629176|P3|Washout|Withdrawal by Subject|0
827508|NCT01004614|2629177|P2|Washout|Withdrawal by Subject|1
827509|NCT01004614|2629178|P1|Washout|Withdrawal by Subject|0
827510|NCT01004822|2629272|P8|Overall Study|Unspecified|0
827511|NCT01004822|2629273|P7|Overall Study|Unspecified|0
827512|NCT01004822|2629274|P6|Overall Study|Unspecified|1
827513|NCT01004822|2629275|P5|Overall Study|Unspecified|0
827514|NCT01004822|2629276|P4|Overall Study|Unspecified|1
827515|NCT01004822|2629277|P3|Overall Study|Unspecified|4
827516|NCT01004822|2629278|P2|Overall Study|Unspecified|0
827517|NCT01004822|2629279|P1|Overall Study|Unspecified|0
827518|NCT01004822|2629272|P8|Overall Study|Adverse Event|1
827519|NCT01004822|2629273|P7|Overall Study|Adverse Event|1
827520|NCT01004822|2629274|P6|Overall Study|Adverse Event|0
827521|NCT01004822|2629275|P5|Overall Study|Adverse Event|0
827522|NCT01004822|2629276|P4|Overall Study|Adverse Event|0
827523|NCT01004822|2629277|P3|Overall Study|Adverse Event|0
827524|NCT01004822|2629278|P2|Overall Study|Adverse Event|0
827525|NCT01004822|2629279|P1|Overall Study|Adverse Event|0
827526|NCT01004822|2629272|P8|Overall Study|No longer willing to continue|0
827527|NCT01004822|2629273|P7|Overall Study|No longer willing to continue|1
827528|NCT01004822|2629274|P6|Overall Study|No longer willing to continue|1
827529|NCT01004822|2629275|P5|Overall Study|No longer willing to continue|2
827530|NCT01004822|2629276|P4|Overall Study|No longer willing to continue|1
827531|NCT01004822|2629277|P3|Overall Study|No longer willing to continue|0
827532|NCT01004822|2629278|P2|Overall Study|No longer willing to continue|0
827533|NCT01004822|2629279|P1|Overall Study|No longer willing to continue|0
827534|NCT01004822|2629272|P8|Overall Study|Global deterioration of health status|0
827535|NCT01004822|2629273|P7|Overall Study|Global deterioration of health status|1
827536|NCT01004822|2629274|P6|Overall Study|Global deterioration of health status|0
827537|NCT01004822|2629275|P5|Overall Study|Global deterioration of health status|0
827538|NCT01004822|2629276|P4|Overall Study|Global deterioration of health status|1
827539|NCT01004822|2629277|P3|Overall Study|Global deterioration of health status|0
827540|NCT01004822|2629278|P2|Overall Study|Global deterioration of health status|0
827541|NCT01004822|2629279|P1|Overall Study|Global deterioration of health status|0
827542|NCT01004822|2629272|P8|Overall Study|Objective progression or relapse|4
827543|NCT01004822|2629273|P7|Overall Study|Objective progression or relapse|1
827544|NCT01004822|2629274|P6|Overall Study|Objective progression or relapse|2
827545|NCT01004822|2629275|P5|Overall Study|Objective progression or relapse|2
827546|NCT01004822|2629276|P4|Overall Study|Objective progression or relapse|1
827547|NCT01004822|2629277|P3|Overall Study|Objective progression or relapse|0
827548|NCT01004822|2629278|P2|Overall Study|Objective progression or relapse|3
827549|NCT01004822|2629279|P1|Overall Study|Objective progression or relapse|3
827550|NCT01004848|2629390|P2|Overall Study|Lost to Follow-up|45
827551|NCT01004848|2629391|P1|Overall Study|Lost to Follow-up|55
827552|NCT01005251|2629480|P5|Overall Study|Lack of Efficacy|0
827553|NCT01005251|2629481|P4|Overall Study|Lack of Efficacy|1
827554|NCT01005251|2629482|P3|Overall Study|Lack of Efficacy|1
827555|NCT01005251|2629483|P2|Overall Study|Lack of Efficacy|0
827556|NCT01005251|2629484|P1|Overall Study|Lack of Efficacy|0
827557|NCT01005251|2629480|P5|Overall Study|Randomized in error|0
827558|NCT01005251|2629481|P4|Overall Study|Randomized in error|1
827559|NCT01005251|2629482|P3|Overall Study|Randomized in error|1
827560|NCT01005251|2629483|P2|Overall Study|Randomized in error|0
827561|NCT01005251|2629484|P1|Overall Study|Randomized in error|0
827562|NCT01005251|2629480|P5|Overall Study|Wrong drug dispensed|0
827563|NCT01005251|2629481|P4|Overall Study|Wrong drug dispensed|0
827564|NCT01005251|2629482|P3|Overall Study|Wrong drug dispensed|0
827565|NCT01005251|2629483|P2|Overall Study|Wrong drug dispensed|1
827566|NCT01005251|2629484|P1|Overall Study|Wrong drug dispensed|0
827567|NCT01005251|2629480|P5|Overall Study|Patient moved|0
827568|NCT01005251|2629481|P4|Overall Study|Patient moved|0
827569|NCT01005251|2629482|P3|Overall Study|Patient moved|0
827570|NCT01005251|2629483|P2|Overall Study|Patient moved|0
827571|NCT01005251|2629484|P1|Overall Study|Patient moved|1
827572|NCT01005251|2629480|P5|Overall Study|Physician Decision|2
827573|NCT01005251|2629481|P4|Overall Study|Physician Decision|0
827574|NCT01005251|2629482|P3|Overall Study|Physician Decision|0
827575|NCT01005251|2629483|P2|Overall Study|Physician Decision|0
827576|NCT01005251|2629484|P1|Overall Study|Physician Decision|0
827577|NCT01005251|2629480|P5|Overall Study|Lost to Follow-up|0
827578|NCT01005251|2629481|P4|Overall Study|Lost to Follow-up|0
827579|NCT01005251|2629482|P3|Overall Study|Lost to Follow-up|2
827580|NCT01005251|2629483|P2|Overall Study|Lost to Follow-up|4
827581|NCT01005251|2629484|P1|Overall Study|Lost to Follow-up|1
827582|NCT01005251|2629480|P5|Overall Study|Developed study-specific withdrawal crit|1
827583|NCT01005251|2629481|P4|Overall Study|Developed study-specific withdrawal crit|0
827584|NCT01005251|2629482|P3|Overall Study|Developed study-specific withdrawal crit|3
827585|NCT01005251|2629483|P2|Overall Study|Developed study-specific withdrawal crit|0
827586|NCT01005251|2629484|P1|Overall Study|Developed study-specific withdrawal crit|2
827587|NCT01005251|2629480|P5|Overall Study|Protocol Violation|2
827588|NCT01005251|2629481|P4|Overall Study|Protocol Violation|0
827589|NCT01005251|2629482|P3|Overall Study|Protocol Violation|0
827590|NCT01005251|2629483|P2|Overall Study|Protocol Violation|0
827591|NCT01005251|2629484|P1|Overall Study|Protocol Violation|1
827592|NCT01005251|2629480|P5|Overall Study|Adverse Event|4
827593|NCT01005251|2629481|P4|Overall Study|Adverse Event|5
827594|NCT01005251|2629482|P3|Overall Study|Adverse Event|8
827595|NCT01005251|2629483|P2|Overall Study|Adverse Event|6
827596|NCT01005251|2629484|P1|Overall Study|Adverse Event|2
827597|NCT01005251|2629480|P5|Overall Study|Eligibility criteria not fulfilled|0
827598|NCT01005251|2629481|P4|Overall Study|Eligibility criteria not fulfilled|1
827599|NCT01005251|2629482|P3|Overall Study|Eligibility criteria not fulfilled|4
827600|NCT01005251|2629483|P2|Overall Study|Eligibility criteria not fulfilled|0
827601|NCT01005251|2629484|P1|Overall Study|Eligibility criteria not fulfilled|4
827602|NCT01005251|2629480|P5|Overall Study|Withdrawal by Subject|9
827603|NCT01005251|2629481|P4|Overall Study|Withdrawal by Subject|4
827604|NCT01005251|2629482|P3|Overall Study|Withdrawal by Subject|3
827605|NCT01005251|2629483|P2|Overall Study|Withdrawal by Subject|5
827606|NCT01005251|2629484|P1|Overall Study|Withdrawal by Subject|2
827607|NCT01005316|2629514|P4|Overall Study|Retransplanted|0
827608|NCT01005316|2629515|P3|Overall Study|Retransplanted|0
827609|NCT01005316|2629516|P2|Overall Study|Retransplanted|1
827610|NCT01005316|2629517|P1|Overall Study|Retransplanted|0
827611|NCT01005316|2629514|P4|Overall Study|Transferred Care|3
827612|NCT01005316|2629515|P3|Overall Study|Transferred Care|1
827613|NCT01005316|2629516|P2|Overall Study|Transferred Care|0
827614|NCT01005316|2629517|P1|Overall Study|Transferred Care|1
827615|NCT01005316|2629514|P4|Overall Study|Delisted|0
827616|NCT01005316|2629515|P3|Overall Study|Delisted|0
827617|NCT01005316|2629516|P2|Overall Study|Delisted|0
827618|NCT01005316|2629517|P1|Overall Study|Delisted|8
827619|NCT01005316|2629514|P4|Overall Study|Consented to Another Study|0
827620|NCT01005316|2629515|P3|Overall Study|Consented to Another Study|0
827621|NCT01005316|2629516|P2|Overall Study|Consented to Another Study|0
827622|NCT01005316|2629517|P1|Overall Study|Consented to Another Study|2
827623|NCT01005316|2629514|P4|Overall Study|Withdrawal by Subject|2
827624|NCT01005316|2629515|P3|Overall Study|Withdrawal by Subject|0
827625|NCT01005316|2629516|P2|Overall Study|Withdrawal by Subject|1
827626|NCT01005316|2629517|P1|Overall Study|Withdrawal by Subject|1
827627|NCT01005316|2629514|P4|Overall Study|Sponsor Decision|0
827628|NCT01005316|2629515|P3|Overall Study|Sponsor Decision|0
827629|NCT01005316|2629516|P2|Overall Study|Sponsor Decision|3
827630|NCT01005316|2629517|P1|Overall Study|Sponsor Decision|6
827631|NCT01005316|2629514|P4|Overall Study|Physician Decision|0
827632|NCT01005316|2629515|P3|Overall Study|Physician Decision|0
827633|NCT01005316|2629516|P2|Overall Study|Physician Decision|0
827634|NCT01005316|2629517|P1|Overall Study|Physician Decision|6
827635|NCT01005316|2629514|P4|Overall Study|Lost to Follow-up|2
827636|NCT01005316|2629515|P3|Overall Study|Lost to Follow-up|0
827637|NCT01005316|2629516|P2|Overall Study|Lost to Follow-up|3
827638|NCT01005316|2629517|P1|Overall Study|Lost to Follow-up|1
827639|NCT01005316|2629514|P4|Overall Study|Study Termination|85
827640|NCT01005316|2629515|P3|Overall Study|Study Termination|9
827641|NCT01005316|2629516|P2|Overall Study|Study Termination|63
827642|NCT01005316|2629517|P1|Overall Study|Study Termination|5
827643|NCT01005316|2629514|P4|Overall Study|Death|15
827644|NCT01005316|2629515|P3|Overall Study|Death|1
827645|NCT01005316|2629516|P2|Overall Study|Death|5
827646|NCT01005316|2629517|P1|Overall Study|Death|20
827647|NCT01005316|2629514|P4|Overall Study|Adverse Event|1
827648|NCT01005316|2629515|P3|Overall Study|Adverse Event|0
827649|NCT01005316|2629516|P2|Overall Study|Adverse Event|0
827650|NCT01005316|2629517|P1|Overall Study|Adverse Event|0
827651|NCT01005329|2629569|P1|Overall Study|Ineligible or received no protocol trt.|4
827652|NCT01005602|2629624|P2|Overall Study|Excluded due to unreliable clinical data|0
827653|NCT01005602|2629625|P1|Overall Study|Excluded due to unreliable clinical data|1
827654|NCT01005680|2629647|P2|Overall Study|Physician Decision|1
827655|NCT01005680|2629648|P1|Overall Study|Physician Decision|1
827656|NCT01005680|2629647|P2|Overall Study|Withdrawal by Subject|4
827657|NCT01005680|2629648|P1|Overall Study|Withdrawal by Subject|1
827658|NCT01005680|2629647|P2|Overall Study|Lost to Follow-up|6
827659|NCT01005680|2629648|P1|Overall Study|Lost to Follow-up|4
827660|NCT01005719|2629679|P6|Period 2|Adverse Event|1
827661|NCT01005719|2629680|P5|Period 2|Adverse Event|1
827662|NCT01005719|2629681|P4|Period 2|Adverse Event|0
827663|NCT01005719|2629682|P3|Period 2|Adverse Event|0
827664|NCT01005719|2629683|P2|Period 2|Adverse Event|0
827665|NCT01005719|2629684|P1|Period 2|Adverse Event|0
827666|NCT01005719|2629679|P6|Period 1|Delay in completing study procedures|1
827667|NCT01005719|2629680|P5|Period 1|Delay in completing study procedures|0
827668|NCT01005719|2629681|P4|Period 1|Delay in completing study procedures|0
827669|NCT01005719|2629682|P3|Period 1|Delay in completing study procedures|0
827670|NCT01005719|2629683|P2|Period 1|Delay in completing study procedures|0
827671|NCT01005719|2629684|P1|Period 1|Delay in completing study procedures|0
827672|NCT01005719|2629679|P6|Period 1|Adverse Event|0
827673|NCT01005719|2629680|P5|Period 1|Adverse Event|0
827674|NCT01005719|2629681|P4|Period 1|Adverse Event|1
827675|NCT01005719|2629682|P3|Period 1|Adverse Event|0
827676|NCT01005719|2629683|P2|Period 1|Adverse Event|0
827677|NCT01005719|2629684|P1|Period 1|Adverse Event|0
827678|NCT01005732|2629740|P1|Overall Study|Death|1
827679|NCT01005732|2629740|P1|Overall Study|Lost to Follow-up|10
827680|NCT01005745|2629756|P1|Overall Study|Inappropriate antidiuretic hormone|1
827681|NCT01005745|2629756|P1|Overall Study|Death prior to treatment|1
827682|NCT01005745|2629756|P1|Overall Study|Disease progressed during TIL growth|3
827683|NCT01005745|2629756|P1|Overall Study|No TIL growth|1
827684|NCT01005875|2629761|P1|Overall Study|Death|3
827685|NCT01005901|2629796|P2|Overall Study|No longer requires study drug|1
827686|NCT01005901|2629797|P1|Overall Study|No longer requires study drug|0
827687|NCT01005901|2629796|P2|Overall Study|Patient's inability to use the device|1
827688|NCT01005901|2629797|P1|Overall Study|Patient's inability to use the device|1
827689|NCT01005901|2629796|P2|Overall Study|Lost to Follow-up|2
827690|NCT01005901|2629797|P1|Overall Study|Lost to Follow-up|1
827691|NCT01005901|2629796|P2|Overall Study|Death|3
827692|NCT01005901|2629797|P1|Overall Study|Death|2
827693|NCT01005901|2629796|P2|Overall Study|Protocol Violation|3
827694|NCT01005901|2629797|P1|Overall Study|Protocol Violation|4
827695|NCT01005901|2629796|P2|Overall Study|Unsatisfactory therapeutic effect|5
827696|NCT01005901|2629797|P1|Overall Study|Unsatisfactory therapeutic effect|5
827697|NCT01005901|2629796|P2|Overall Study|Administrative problems|13
827698|NCT01005901|2629797|P1|Overall Study|Administrative problems|21
827699|NCT01005901|2629796|P2|Overall Study|Adverse Event|16
827700|NCT01005901|2629797|P1|Overall Study|Adverse Event|30
827701|NCT01005901|2629796|P2|Overall Study|Withdrawal by Subject|14
827702|NCT01005901|2629797|P1|Overall Study|Withdrawal by Subject|38
827703|NCT01005914|2629835|P1|Overall Study|Withdrawal by Subject|1
827704|NCT01005914|2629835|P1|Overall Study|Lack of Efficacy|1
827705|NCT01005914|2629835|P1|Overall Study|Death|4
827706|NCT01005914|2629835|P1|Overall Study|Adverse Event|4
893485|NCT02419937|2834633|P2|Overall Study|Lost to Follow-up|0
893486|NCT02419937|2834634|P1|Overall Study|Lost to Follow-up|1
827752|NCT01006122|2629876|P2|Second Double-blind Intervention Period|Death|1
827753|NCT01006122|2629877|P1|Second Double-blind Intervention Period|Death|0
827754|NCT01006122|2629876|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
827755|NCT01006122|2629877|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
827756|NCT01006122|2629876|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
827757|NCT01006122|2629877|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
827758|NCT01006122|2629876|P2|Second Double-blind Intervention Period|Protocol Violation|0
827759|NCT01006122|2629877|P1|Second Double-blind Intervention Period|Protocol Violation|1
827760|NCT01006122|2629876|P2|Second Double-blind Intervention Period|Adverse Event|1
827761|NCT01006122|2629877|P1|Second Double-blind Intervention Period|Adverse Event|1
827762|NCT01006122|2629876|P2|First Double-blind Intervention Period|Adverse Event|4
827763|NCT01006122|2629877|P1|First Double-blind Intervention Period|Adverse Event|0
827764|NCT01006122|2629876|P2|First Double-blind Intervention Period|Unspecified|0
827765|NCT01006122|2629877|P1|First Double-blind Intervention Period|Unspecified|3
827766|NCT01006122|2629876|P2|First Double-blind Intervention Period|Lack of Efficacy|1
827767|NCT01006122|2629877|P1|First Double-blind Intervention Period|Lack of Efficacy|2
827768|NCT01006122|2629876|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
827769|NCT01006122|2629877|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
827770|NCT01006122|2629876|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
827771|NCT01006122|2629877|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
827772|NCT01006122|2629876|P2|First Double-blind Intervention Period|Pregnancy|1
827773|NCT01006122|2629877|P1|First Double-blind Intervention Period|Pregnancy|0
827774|NCT01006122|2629876|P2|First Double-blind Intervention Period|Protocol Violation|1
827775|NCT01006122|2629877|P1|First Double-blind Intervention Period|Protocol Violation|1
827776|NCT01006122|2629876|P2|First Double-blind Intervention Period|Lost to Follow-up|2
827777|NCT01006122|2629877|P1|First Double-blind Intervention Period|Lost to Follow-up|0
827778|NCT01006135|2629915|P1|Overall Study|Other|72
827779|NCT01006135|2629915|P1|Overall Study|Lost to Follow-up|32
827780|NCT01006135|2629915|P1|Overall Study|Protocol Violation|14
827781|NCT01006135|2629915|P1|Overall Study|Adverse Event|22
827782|NCT00999661|2629922|P1|Overall Study|Not meeting eligibility criteria|9
827783|NCT00999661|2629922|P1|Overall Study|Withdrawal by Subject|1
827784|NCT00999661|2629922|P1|Overall Study|Adverse Event|1
827785|NCT00999661|2629922|P1|Overall Study|Lost to Follow-up|59
827786|NCT00999687|2629928|P1|Second Intervention|Lack of Efficacy|1
827787|NCT00999687|2629928|P1|Second Intervention|Withdrawal by Subject|2
827788|NCT00999687|2629928|P1|First Intervention|Withdrawal by Subject|1
827789|NCT00999804|2629937|P2|Overall Study|Ineligible|0
827790|NCT00999804|2629938|P1|Overall Study|Ineligible|3
827791|NCT00999804|2629937|P2|Overall Study|Death|0
827792|NCT00999804|2629938|P1|Overall Study|Death|1
827793|NCT00999804|2629937|P2|Overall Study|Withdrawal by Subject|0
827794|NCT00999804|2629938|P1|Overall Study|Withdrawal by Subject|4
827795|NCT00999804|2629937|P2|Overall Study|Adverse Event|3
827796|NCT00999804|2629938|P1|Overall Study|Adverse Event|4
827797|NCT00999804|2629937|P2|Overall Study|Lack of Efficacy|2
827798|NCT00999804|2629938|P1|Overall Study|Lack of Efficacy|9
827799|NCT00999908|2629963|P3|Treatment Period 2|Protocol Violation|0
827800|NCT00999908|2629964|P2|Treatment Period 2|Protocol Violation|0
827801|NCT00999908|2629965|P1|Treatment Period 2|Protocol Violation|1
827802|NCT00999908|2629963|P3|Treatment Period 1|Subject withdrew consent|0
827803|NCT00999908|2629964|P2|Treatment Period 1|Subject withdrew consent|0
827804|NCT00999908|2629965|P1|Treatment Period 1|Subject withdrew consent|2
827805|NCT00999921|2629981|P2|Overall Study|Lost to Follow-up|19
827806|NCT00999921|2629982|P1|Overall Study|Lost to Follow-up|10
827807|NCT01000025|2629994|P2|Overall Study|Intercurrent Illness|7
827808|NCT01000025|2629995|P1|Overall Study|Intercurrent Illness|26
827809|NCT01000025|2629994|P2|Overall Study|Lack of Efficacy|208
827810|NCT01000025|2629995|P1|Overall Study|Lack of Efficacy|363
827811|NCT01000025|2629994|P2|Overall Study|Death|13
827812|NCT01000025|2629995|P1|Overall Study|Death|23
827813|NCT01000025|2629994|P2|Overall Study|Withdrawal by Subject|8
827814|NCT01000025|2629995|P1|Overall Study|Withdrawal by Subject|13
827815|NCT01000025|2629994|P2|Overall Study|Adverse Event|2
827816|NCT01000025|2629995|P1|Overall Study|Adverse Event|43
827817|NCT01000064|2630011|P2|Overall Study|Withdrawal by Subject|1
827818|NCT01000064|2630012|P1|Overall Study|Withdrawal by Subject|1
827819|NCT01000155|2630033|P1|Overall Study|Adverse Event|1
827820|NCT01000155|2630033|P1|Overall Study|Withdrawal by Subject|1
827821|NCT01000311|2630063|P2|Overall Study|Administrative reason|15
827822|NCT01000311|2630064|P1|Overall Study|Administrative reason|9
827823|NCT01000311|2630063|P2|Overall Study|Inappropriate enrollment|0
827824|NCT01000311|2630064|P1|Overall Study|Inappropriate enrollment|2
827825|NCT01000311|2630063|P2|Overall Study|Protocol Violation|2
827826|NCT01000311|2630064|P1|Overall Study|Protocol Violation|1
827827|NCT01000311|2630063|P2|Overall Study|Lost to Follow-up|24
827828|NCT01000311|2630064|P1|Overall Study|Lost to Follow-up|15
827829|NCT01000311|2630063|P2|Overall Study|Withdrawal by Subject|24
827830|NCT01000311|2630064|P1|Overall Study|Withdrawal by Subject|16
827831|NCT01000311|2630063|P2|Overall Study|Adverse Event|5
827832|NCT01000311|2630064|P1|Overall Study|Adverse Event|2
827833|NCT01000337|2630104|P2|Overall Study|Lost to Follow-up|3
827834|NCT01000337|2630105|P1|Overall Study|Lost to Follow-up|4
827835|NCT01000376|2630113|P2|Cycle 1 Day 1|Progressive Disease|0
827836|NCT01000376|2630114|P1|Cycle 1 Day 1|Progressive Disease|1
827837|NCT01000376|2630113|P2|Cycle 1 Day 1|Adverse Event|0
827838|NCT01000376|2630114|P1|Cycle 1 Day 1|Adverse Event|1
827839|NCT01000480|2630122|P1|Concurrent Therapy Phase|Physician Decision|1
827840|NCT01000480|2630122|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
827841|NCT01000480|2630122|P1|Concurrent Therapy Phase|Protocol Violation|2
827842|NCT01000480|2630122|P1|Concurrent Therapy Phase|Adverse Event|4
827843|NCT01000480|2630122|P1|Induction Phase|Entry Criteria Not Met|3
827844|NCT01000480|2630122|P1|Induction Phase|Physician Decision|1
827845|NCT01000480|2630122|P1|Induction Phase|Lost to Follow-up|1
827846|NCT01000480|2630122|P1|Induction Phase|Adverse Event|2
827847|NCT01000493|2630130|P2|Overall Study|Withdrawal by Subject|7
827848|NCT01000493|2630131|P1|Overall Study|Withdrawal by Subject|3
827849|NCT01000493|2630130|P2|Overall Study|Physician Decision|1
827850|NCT01000493|2630131|P1|Overall Study|Physician Decision|1
827851|NCT01000493|2630130|P2|Overall Study|Lost to Follow-up|9
827852|NCT01000493|2630131|P1|Overall Study|Lost to Follow-up|5
827853|NCT01000493|2630130|P2|Overall Study|Study closed/terminated|23
827854|NCT01000493|2630131|P1|Overall Study|Study closed/terminated|25
827855|NCT01000493|2630130|P2|Overall Study|Protocol Violation|8
827856|NCT01000493|2630131|P1|Overall Study|Protocol Violation|1
827857|NCT01000493|2630130|P2|Overall Study|Lack of Efficacy|1
827858|NCT01000493|2630131|P1|Overall Study|Lack of Efficacy|1
827859|NCT01000493|2630130|P2|Overall Study|Adverse Event|6
827860|NCT01000493|2630131|P1|Overall Study|Adverse Event|3
827885|NCT01006291|2630233|P3|Overall Study|Other|17
827886|NCT01006291|2630234|P2|Overall Study|Other|14
827887|NCT01006291|2630235|P1|Overall Study|Other|14
827888|NCT01006291|2630233|P3|Overall Study|Withdrawal criteria|4
827889|NCT01006291|2630234|P2|Overall Study|Withdrawal criteria|4
827890|NCT01006291|2630235|P1|Overall Study|Withdrawal criteria|5
827891|NCT01006291|2630233|P3|Overall Study|Protocol Violation|3
827892|NCT01006291|2630234|P2|Overall Study|Protocol Violation|3
827893|NCT01006291|2630235|P1|Overall Study|Protocol Violation|3
827894|NCT01006291|2630233|P3|Overall Study|Lack of Efficacy|1
827895|NCT01006291|2630234|P2|Overall Study|Lack of Efficacy|2
827896|NCT01006291|2630235|P1|Overall Study|Lack of Efficacy|2
827897|NCT01006291|2630233|P3|Overall Study|Adverse Event|2
827898|NCT01006291|2630234|P2|Overall Study|Adverse Event|1
827899|NCT01006291|2630235|P1|Overall Study|Adverse Event|2
827900|NCT01006356|2630252|P1|Overall Study|unspecified|23
827901|NCT01006356|2630252|P1|Overall Study|Protocol Violation|3
827902|NCT01006356|2630252|P1|Overall Study|Choice by participants|2
827903|NCT01006356|2630252|P1|Overall Study|Withdrawal by Subject|1
827904|NCT01006356|2630252|P1|Overall Study|Paticipants did not cooperate|6
827905|NCT01006356|2630252|P1|Overall Study|Physician Decision|1
827906|NCT01006356|2630252|P1|Overall Study|Adverse Event|6
827907|NCT01006889|2630264|P1|Overall Study|Withdrawal by Subject|3
827908|NCT01006980|2630277|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
827909|NCT01006980|2630278|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
827910|NCT01006980|2630277|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
827911|NCT01006980|2630278|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
827912|NCT01006980|2630277|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
827913|NCT01006980|2630278|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
827914|NCT01006980|2630277|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
827915|NCT01006980|2630278|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
827916|NCT01006980|2630277|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
827917|NCT01006980|2630278|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
827918|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
827919|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
827920|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
827921|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
827922|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
827923|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
827924|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
827925|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
827926|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Progression|218
827927|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Progression|257
827928|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Death|12
827929|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Death|13
827930|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Adverse Event|5
827931|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Adverse Event|25
827932|NCT01006980|2630277|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
827933|NCT01006980|2630278|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
827934|NCT01007123|2630319|P4|Overall Study|Lost to Follow-up|0
827935|NCT01007123|2630320|P3|Overall Study|Lost to Follow-up|0
827936|NCT01007123|2630321|P2|Overall Study|Lost to Follow-up|1
827937|NCT01007123|2630322|P1|Overall Study|Lost to Follow-up|0
827938|NCT01007123|2630319|P4|Overall Study|Withdrawal by Subject|0
827939|NCT01007123|2630320|P3|Overall Study|Withdrawal by Subject|1
827940|NCT01007123|2630321|P2|Overall Study|Withdrawal by Subject|0
827941|NCT01007123|2630322|P1|Overall Study|Withdrawal by Subject|1
827942|NCT01007123|2630319|P4|Overall Study|Protocol Violation|1
827943|NCT01007123|2630320|P3|Overall Study|Protocol Violation|2
827944|NCT01007123|2630321|P2|Overall Study|Protocol Violation|1
827945|NCT01007123|2630322|P1|Overall Study|Protocol Violation|1
827946|NCT01007123|2630319|P4|Overall Study|Lack of Efficacy|4
827947|NCT01007123|2630320|P3|Overall Study|Lack of Efficacy|1
827948|NCT01007123|2630321|P2|Overall Study|Lack of Efficacy|0
827949|NCT01007123|2630322|P1|Overall Study|Lack of Efficacy|1
827950|NCT01007123|2630319|P4|Overall Study|Adverse Event|1
827951|NCT01007123|2630320|P3|Overall Study|Adverse Event|7
827952|NCT01007123|2630321|P2|Overall Study|Adverse Event|4
827953|NCT01007123|2630322|P1|Overall Study|Adverse Event|3
827954|NCT01007149|2630353|P2|Overall Study|Administrative problems|1
827955|NCT01007149|2630354|P1|Overall Study|Administrative problems|0
827956|NCT01007253|2630376|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
827957|NCT01007253|2630377|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
827958|NCT01007253|2630378|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
827959|NCT01007253|2630379|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
827960|NCT01007396|2630409|P1|Overall Study|Lost to Follow-up|47
827961|NCT01007435|2630418|P4|Overall Study|Reason not Specified|1
827962|NCT01007435|2630419|P3|Overall Study|Reason not Specified|2
827963|NCT01007435|2630420|P2|Overall Study|Reason not Specified|1
827964|NCT01007435|2630421|P1|Overall Study|Reason not Specified|1
827965|NCT01007435|2630418|P4|Overall Study|Failure to Return|6
827966|NCT01007435|2630419|P3|Overall Study|Failure to Return|3
827967|NCT01007435|2630420|P2|Overall Study|Failure to Return|4
827968|NCT01007435|2630421|P1|Overall Study|Failure to Return|5
827969|NCT01007435|2630418|P4|Overall Study|Refused Treatment|8
827970|NCT01007435|2630419|P3|Overall Study|Refused Treatment|5
827971|NCT01007435|2630420|P2|Overall Study|Refused Treatment|13
827972|NCT01007435|2630421|P1|Overall Study|Refused Treatment|13
827973|NCT01007435|2630418|P4|Overall Study|Other Protocol Violation|0
827974|NCT01007435|2630419|P3|Overall Study|Other Protocol Violation|1
827975|NCT01007435|2630420|P2|Overall Study|Other Protocol Violation|0
827976|NCT01007435|2630421|P1|Overall Study|Other Protocol Violation|2
827977|NCT01007435|2630418|P4|Overall Study|Violation of Selection Criteria at Entry|0
827978|NCT01007435|2630419|P3|Overall Study|Violation of Selection Criteria at Entry|2
827979|NCT01007435|2630420|P2|Overall Study|Violation of Selection Criteria at Entry|5
827980|NCT01007435|2630421|P1|Overall Study|Violation of Selection Criteria at Entry|3
827981|NCT01007435|2630418|P4|Overall Study|Insufficient Therapeutic Response|9
827982|NCT01007435|2630419|P3|Overall Study|Insufficient Therapeutic Response|2
827983|NCT01007435|2630420|P2|Overall Study|Insufficient Therapeutic Response|7
827984|NCT01007435|2630421|P1|Overall Study|Insufficient Therapeutic Response|21
827985|NCT01007435|2630418|P4|Overall Study|Death|1
827986|NCT01007435|2630419|P3|Overall Study|Death|2
827987|NCT01007435|2630420|P2|Overall Study|Death|4
827988|NCT01007435|2630421|P1|Overall Study|Death|2
827989|NCT01007435|2630418|P4|Overall Study|Adverse Event|31
827990|NCT01007435|2630419|P3|Overall Study|Adverse Event|47
827991|NCT01007435|2630420|P2|Overall Study|Adverse Event|25
827992|NCT01007435|2630421|P1|Overall Study|Adverse Event|16
827993|NCT01007552|2630463|P1|Overall Study|Withdrawal by Subject|1
827994|NCT01007812|2630500|P2|Period 1, One Week|Discomfort|0
827995|NCT01007812|2630501|P1|Period 1, One Week|Discomfort|1
827996|NCT01007812|2630500|P2|Period 1, One Week|Lost to Follow-up|1
827997|NCT01007812|2630501|P1|Period 1, One Week|Lost to Follow-up|0
827998|NCT01007838|2630511|P4|Overall Study|Started home haemodialysis|0
827999|NCT01007838|2630512|P3|Overall Study|Started home haemodialysis|0
828000|NCT01007838|2630513|P2|Overall Study|Started home haemodialysis|0
828001|NCT01007838|2630514|P1|Overall Study|Started home haemodialysis|1
828002|NCT01007838|2630511|P4|Overall Study|Physician Decision|0
828003|NCT01007838|2630512|P3|Overall Study|Physician Decision|0
828004|NCT01007838|2630513|P2|Overall Study|Physician Decision|0
828005|NCT01007838|2630514|P1|Overall Study|Physician Decision|1
828006|NCT01007838|2630511|P4|Overall Study|Withdrawal by Subject|0
828007|NCT01007838|2630512|P3|Overall Study|Withdrawal by Subject|0
828008|NCT01007838|2630513|P2|Overall Study|Withdrawal by Subject|0
828009|NCT01007838|2630514|P1|Overall Study|Withdrawal by Subject|1
828010|NCT01007916|2630524|P2|Period 2, 4 Weeks of Wear|Relocation|0
828011|NCT01007916|2630525|P1|Period 2, 4 Weeks of Wear|Relocation|1
828012|NCT01007916|2630524|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
828013|NCT01007916|2630525|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
828014|NCT01007942|2630533|P2|Overall Study|Patients untreated|3
828015|NCT01007942|2630534|P1|Overall Study|Patients untreated|4
828016|NCT01007942|2630533|P2|Overall Study|Death|2
828017|NCT01007942|2630534|P1|Overall Study|Death|3
828018|NCT01007942|2630533|P2|Overall Study|Administrative problems|0
828019|NCT01007942|2630534|P1|Overall Study|Administrative problems|2
828020|NCT01007942|2630533|P2|Overall Study|Lost to Follow-up|0
828021|NCT01007942|2630534|P1|Overall Study|Lost to Follow-up|1
828022|NCT01007942|2630533|P2|Overall Study|Withdrawal by Subject|14
828023|NCT01007942|2630534|P1|Overall Study|Withdrawal by Subject|19
828024|NCT01007942|2630533|P2|Overall Study|Protocol Violation|1
828025|NCT01007942|2630534|P1|Overall Study|Protocol Violation|1
828026|NCT01007942|2630533|P2|Overall Study|New cancer therapy|1
828027|NCT01007942|2630534|P1|Overall Study|New cancer therapy|5
828028|NCT01007942|2630533|P2|Overall Study|Disease progression|242
828029|NCT01007942|2630534|P1|Overall Study|Disease progression|217
828030|NCT01007942|2630533|P2|Overall Study|Abnormal test procedure|1
828031|NCT01007942|2630534|P1|Overall Study|Abnormal test procedure|0
828032|NCT01007942|2630533|P2|Overall Study|Adverse Event|14
828033|NCT01007942|2630534|P1|Overall Study|Adverse Event|29
828034|NCT01008449|2630571|P2|Overall Study|Lost to Follow-up|19
828035|NCT01008449|2630572|P1|Overall Study|Lost to Follow-up|29
828036|NCT01008475|2630599|P7|Overall Study|Ongoing treatment at data cut-off date|4
828037|NCT01008475|2630600|P6|Overall Study|Ongoing treatment at data cut-off date|6
828038|NCT01008475|2630601|P5|Overall Study|Ongoing treatment at data cut-off date|5
828039|NCT01008475|2630602|P4|Overall Study|Ongoing treatment at data cut-off date|0
828040|NCT01008475|2630603|P3|Overall Study|Ongoing treatment at data cut-off date|0
828041|NCT01008475|2630604|P2|Overall Study|Ongoing treatment at data cut-off date|0
828042|NCT01008475|2630605|P1|Overall Study|Ongoing treatment at data cut-off date|0
828043|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
828044|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
828045|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
828046|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
828047|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
828048|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
828049|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
828050|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
828051|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
828052|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
828053|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
828054|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
828055|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
828056|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
828057|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
828058|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
828059|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
828060|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
828061|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Adverse Event|4
828062|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Adverse Event|14
828063|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Adverse Event|0
828064|NCT01008553|2630633|P3|Period 2 (Double-Blind Period)|Physician Decision|2
828065|NCT01008553|2630634|P2|Period 2 (Double-Blind Period)|Physician Decision|1
828066|NCT01008553|2630635|P1|Period 2 (Double-Blind Period)|Physician Decision|0
828067|NCT01008553|2630633|P3|Period 1 (Titration Period)|Not appropriate for this study|0
828068|NCT01008553|2630634|P2|Period 1 (Titration Period)|Not appropriate for this study|0
828069|NCT01008553|2630635|P1|Period 1 (Titration Period)|Not appropriate for this study|1
828146|NCT01008995|2630757|P1|After Controlled Period|Adverse Event|0
828070|NCT01008553|2630633|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
828071|NCT01008553|2630634|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
828072|NCT01008553|2630635|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
828073|NCT01008553|2630633|P3|Period 1 (Titration Period)|Determined to increase dosage|0
828074|NCT01008553|2630634|P2|Period 1 (Titration Period)|Determined to increase dosage|0
828075|NCT01008553|2630635|P1|Period 1 (Titration Period)|Determined to increase dosage|3
828076|NCT01008553|2630633|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
828077|NCT01008553|2630634|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
828078|NCT01008553|2630635|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
828079|NCT01008553|2630633|P3|Period 1 (Titration Period)|Adverse Event|0
828080|NCT01008553|2630634|P2|Period 1 (Titration Period)|Adverse Event|0
828081|NCT01008553|2630635|P1|Period 1 (Titration Period)|Adverse Event|33
828082|NCT01008553|2630633|P3|Period 1 (Titration Period)|Physician Decision|0
828083|NCT01008553|2630634|P2|Period 1 (Titration Period)|Physician Decision|0
828084|NCT01008553|2630635|P1|Period 1 (Titration Period)|Physician Decision|2
828085|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
828086|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
828087|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
828088|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
828089|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
828090|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
828091|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
828092|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
828093|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
828094|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
828095|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
828096|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
828097|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|Physician Decision|0
828098|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|Physician Decision|1
828099|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|Physician Decision|0
828100|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
828101|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
828102|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
828103|NCT01008618|2630684|P3|Period 2 (Double-Blind Period)|Adverse Event|2
828104|NCT01008618|2630685|P2|Period 2 (Double-Blind Period)|Adverse Event|11
828105|NCT01008618|2630686|P1|Period 2 (Double-Blind Period)|Adverse Event|0
828106|NCT01008618|2630684|P3|Period 1 (Titration Period)|Aggravated symptom|0
828107|NCT01008618|2630685|P2|Period 1 (Titration Period)|Aggravated symptom|0
828108|NCT01008618|2630686|P1|Period 1 (Titration Period)|Aggravated symptom|2
828109|NCT01008618|2630684|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
828110|NCT01008618|2630685|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
828111|NCT01008618|2630686|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
828112|NCT01008618|2630684|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
828113|NCT01008618|2630685|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
828114|NCT01008618|2630686|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
828115|NCT01008618|2630684|P3|Period 1 (Titration Period)|Adverse Event|0
828116|NCT01008618|2630685|P2|Period 1 (Titration Period)|Adverse Event|0
828117|NCT01008618|2630686|P1|Period 1 (Titration Period)|Adverse Event|33
828118|NCT01008618|2630684|P3|Period 1 (Titration Period)|Physician Decision|0
828119|NCT01008618|2630685|P2|Period 1 (Titration Period)|Physician Decision|0
828120|NCT01008618|2630686|P1|Period 1 (Titration Period)|Physician Decision|2
828121|NCT01008696|2630713|P2|Overall Study|Other|2
828122|NCT01008696|2630714|P1|Overall Study|Other|0
828123|NCT01008696|2630713|P2|Overall Study|Unspecified|3
828124|NCT01008696|2630714|P1|Overall Study|Unspecified|2
828125|NCT01008696|2630713|P2|Overall Study|Participants' non-cooperation|3
828126|NCT01008696|2630714|P1|Overall Study|Participants' non-cooperation|2
828127|NCT01008696|2630713|P2|Overall Study|Adverse Event|0
828128|NCT01008696|2630714|P1|Overall Study|Adverse Event|1
828129|NCT01008696|2630713|P2|Overall Study|Physician Decision|1
828130|NCT01008696|2630714|P1|Overall Study|Physician Decision|5
828131|NCT01008696|2630713|P2|Overall Study|Withdrawal by Subject|4
828132|NCT01008696|2630714|P1|Overall Study|Withdrawal by Subject|2
828133|NCT01008696|2630713|P2|Overall Study|Participant's evasion of hospital visit|4
828134|NCT01008696|2630714|P1|Overall Study|Participant's evasion of hospital visit|5
828135|NCT01008904|2630735|P1|Overall Study|unexpected unrelated surgery|1
828136|NCT01008904|2630735|P1|Overall Study|Adverse Event|2
828137|NCT01008904|2630735|P1|Overall Study|Lost to Follow-up|1
828138|NCT01008943|2630740|P1|Overall Study|Withdrawal by Subject|1
828139|NCT01008995|2630754|P4|After Controlled Period|Not specified|0
828140|NCT01008995|2630755|P3|After Controlled Period|Not specified|1
828141|NCT01008995|2630756|P2|After Controlled Period|Not specified|0
828142|NCT01008995|2630757|P1|After Controlled Period|Not specified|0
828143|NCT01008995|2630754|P4|After Controlled Period|Adverse Event|1
828144|NCT01008995|2630755|P3|After Controlled Period|Adverse Event|1
828145|NCT01008995|2630756|P2|After Controlled Period|Adverse Event|0
828147|NCT01008995|2630754|P4|Controlled Period|Not specified|0
828148|NCT01008995|2630755|P3|Controlled Period|Not specified|0
828149|NCT01008995|2630756|P2|Controlled Period|Not specified|1
828150|NCT01008995|2630757|P1|Controlled Period|Not specified|2
828151|NCT01008995|2630754|P4|Controlled Period|Adverse Event|0
828152|NCT01008995|2630755|P3|Controlled Period|Adverse Event|0
828153|NCT01008995|2630756|P2|Controlled Period|Adverse Event|2
828154|NCT01008995|2630757|P1|Controlled Period|Adverse Event|1
828155|NCT01009034|2630769|P1|Overall Study|Withdrawal by Subject|2
828156|NCT01009034|2630769|P1|Overall Study|Lost to Follow-up|2
828157|NCT01009047|2630777|P2|Overall Study|Unspecified|2
828158|NCT01009047|2630778|P1|Overall Study|Unspecified|3
828159|NCT01009047|2630777|P2|Overall Study|Withdrawal by consent|11
828160|NCT01009047|2630778|P1|Overall Study|Withdrawal by consent|16
828161|NCT01009047|2630777|P2|Overall Study|Lack of Efficacy|11
828162|NCT01009047|2630778|P1|Overall Study|Lack of Efficacy|4
828163|NCT01009047|2630777|P2|Overall Study|Lost to Follow-up|2
828164|NCT01009047|2630778|P1|Overall Study|Lost to Follow-up|0
828165|NCT01009047|2630777|P2|Overall Study|Adverse Event|0
828166|NCT01009047|2630778|P1|Overall Study|Adverse Event|5
828177|NCT01009086|2630842|P3|Overall Study|Unspecified|1
828178|NCT01009086|2630843|P2|Overall Study|Unspecified|5
828179|NCT01009086|2630844|P1|Overall Study|Unspecified|3
828180|NCT01009086|2630842|P3|Overall Study|Withdrawal by Subject|13
828181|NCT01009086|2630843|P2|Overall Study|Withdrawal by Subject|11
828182|NCT01009086|2630844|P1|Overall Study|Withdrawal by Subject|9
828183|NCT01009086|2630842|P3|Overall Study|Adverse Event|8
828184|NCT01009086|2630843|P2|Overall Study|Adverse Event|11
828185|NCT01009086|2630844|P1|Overall Study|Adverse Event|12
828186|NCT01009086|2630842|P3|Overall Study|Lost to Follow-up|3
828187|NCT01009086|2630843|P2|Overall Study|Lost to Follow-up|5
828188|NCT01009086|2630844|P1|Overall Study|Lost to Follow-up|4
828189|NCT01009086|2630842|P3|Overall Study|Lack of Efficacy|9
828190|NCT01009086|2630843|P2|Overall Study|Lack of Efficacy|15
828191|NCT01009086|2630844|P1|Overall Study|Lack of Efficacy|16
828192|NCT01009099|2630879|P2|Overall Study|Death|1
828193|NCT01009099|2630880|P1|Overall Study|Death|0
828194|NCT01009099|2630879|P2|Overall Study|Withdrawal by Subject|1
828195|NCT01009099|2630880|P1|Overall Study|Withdrawal by Subject|1
828196|NCT01009099|2630879|P2|Overall Study|Physician Decision|2
828197|NCT01009099|2630880|P1|Overall Study|Physician Decision|3
828198|NCT01009099|2630879|P2|Overall Study|Lost to Follow-up|0
828199|NCT01009099|2630880|P1|Overall Study|Lost to Follow-up|1
828200|NCT01009203|2630917|P1|Overall Study|Treatment-unrelated death|1
828201|NCT01009203|2630917|P1|Overall Study|Adverse Event|5
828202|NCT01009203|2630917|P1|Overall Study|Withdrawal by Subject|1
828269|NCT01009554|2630986|P2|Overall Study|Noncompliant with Study Product|3
828270|NCT01009554|2630987|P1|Overall Study|Noncompliant with Study Product|0
828271|NCT01009554|2630986|P2|Overall Study|Withdrawal by Subject|3
828272|NCT01009554|2630987|P1|Overall Study|Withdrawal by Subject|1
828273|NCT01009554|2630986|P2|Overall Study|Adverse Event|1
828274|NCT01009554|2630987|P1|Overall Study|Adverse Event|1
828275|NCT01009580|2631121|P2|Overall Study|Unclassified|21
828276|NCT01009580|2631122|P1|Overall Study|Unclassified|17
828277|NCT01009580|2631121|P2|Overall Study|Withdrawal Criteria|6
828278|NCT01009580|2631122|P1|Overall Study|Withdrawal Criteria|4
828279|NCT01009580|2631121|P2|Overall Study|Protocol Violation|3
828280|NCT01009580|2631122|P1|Overall Study|Protocol Violation|2
828281|NCT01009580|2631121|P2|Overall Study|Lack of Efficacy|1
828282|NCT01009580|2631122|P1|Overall Study|Lack of Efficacy|0
828283|NCT01009580|2631121|P2|Overall Study|Adverse Event|4
828284|NCT01009580|2631122|P1|Overall Study|Adverse Event|4
828285|NCT01012219|2631393|P1|Period 2|Withdrawal by Subject|1
828286|NCT01012219|2631393|P1|Period 1|Withdrawal by Subject|1
828287|NCT01012258|2631441|P1|Overall Study|Ongoing|29
828288|NCT01012258|2631441|P1|Overall Study|Another Tumor Discovered|1
828289|NCT01012258|2631441|P1|Overall Study|Another Anti-cancer Drug Received|1
828290|NCT01012258|2631441|P1|Overall Study|Symptomatic Deterioration|1
828291|NCT01012258|2631441|P1|Overall Study|Progressive Disease (PD)|18
828292|NCT01012258|2631441|P1|Overall Study|Adverse Event|1
828293|NCT01012258|2631441|P1|Overall Study|Lost to Follow-up|1
828294|NCT01012258|2631441|P1|Overall Study|Death|14
828295|NCT01012323|2631462|P1|Overall Study|Investigator Judgment|1
828296|NCT01012414|2631518|P1|Overall Study|Trial was stopped before completed|7
828297|NCT01012414|2631518|P1|Overall Study|Lost to Follow-up|1
828298|NCT01012414|2631518|P1|Overall Study|Withdrawal by Subject|2
828299|NCT01012440|2631525|P1|Overall Study|Withdrawal by Subject|2
828300|NCT01012622|2631533|P1|Overall Study|withdrawal of consent by a parent|2
828301|NCT01012622|2631533|P1|Overall Study|screening failure|1
828302|NCT01012622|2631533|P1|Overall Study|unspecified|1
828303|NCT01012622|2631533|P1|Overall Study|non-compliance with the drug|9
828304|NCT01012622|2631533|P1|Overall Study|Adverse Event|7
828305|NCT01012622|2631533|P1|Overall Study|Lost to Follow-up|5
828306|NCT01012622|2631533|P1|Overall Study|Withdrawal by Subject|6
893571|NCT02197130|2834861|P3|Overall Study|Other|3
893572|NCT02197130|2834862|P2|Overall Study|Other|0
893573|NCT02197130|2834863|P1|Overall Study|Other|1
893574|NCT02197130|2834861|P3|Overall Study|Withdrawal by Subject|4
893575|NCT02197130|2834862|P2|Overall Study|Withdrawal by Subject|3
893576|NCT02197130|2834863|P1|Overall Study|Withdrawal by Subject|0
893577|NCT02197130|2834861|P3|Overall Study|Does not meet entrance criteria|1
893578|NCT02197130|2834862|P2|Overall Study|Does not meet entrance criteria|0
893579|NCT02197130|2834863|P1|Overall Study|Does not meet entrance criteria|0
893580|NCT02197130|2834861|P3|Overall Study|Lost to Follow-up|1
893581|NCT02197130|2834862|P2|Overall Study|Lost to Follow-up|0
893582|NCT02197130|2834863|P1|Overall Study|Lost to Follow-up|2
893583|NCT02197130|2834861|P3|Overall Study|Death|0
893584|NCT02197130|2834862|P2|Overall Study|Death|1
893585|NCT02197130|2834863|P1|Overall Study|Death|0
893586|NCT02197130|2834861|P3|Overall Study|Adverse Event|23
893587|NCT02197130|2834862|P2|Overall Study|Adverse Event|4
893588|NCT02197130|2834863|P1|Overall Study|Adverse Event|13
828307|NCT01012713|2631572|P1|Overall Study|Lack of Efficacy|3
828308|NCT01012739|2631578|P4|Treatment Period 2|Abnormal test procedure results|1
828309|NCT01012739|2631579|P3|Treatment Period 2|Abnormal test procedure results|0
828310|NCT01012739|2631580|P2|Treatment Period 2|Abnormal test procedure results|0
828311|NCT01012739|2631581|P1|Treatment Period 2|Abnormal test procedure results|0
828312|NCT01012739|2631578|P4|Treatment Period 1|Adverse Event|1
828313|NCT01012739|2631579|P3|Treatment Period 1|Adverse Event|0
828314|NCT01012739|2631580|P2|Treatment Period 1|Adverse Event|0
828315|NCT01012739|2631581|P1|Treatment Period 1|Adverse Event|0
828316|NCT01012765|2631609|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
828317|NCT01012765|2631610|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
828318|NCT01012765|2631611|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
828319|NCT01012765|2631612|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
828320|NCT01012765|2631613|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
828321|NCT01012765|2631614|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
828322|NCT01012765|2631609|P6|Treatment Period 2|Adverse Event|0
828323|NCT01012765|2631610|P5|Treatment Period 2|Adverse Event|0
828324|NCT01012765|2631611|P4|Treatment Period 2|Adverse Event|0
828325|NCT01012765|2631612|P3|Treatment Period 2|Adverse Event|1
828326|NCT01012765|2631613|P2|Treatment Period 2|Adverse Event|1
828327|NCT01012765|2631614|P1|Treatment Period 2|Adverse Event|0
828328|NCT01012765|2631609|P6|Treatment Period 2|Abnormal laboratory value(s)|1
828329|NCT01012765|2631610|P5|Treatment Period 2|Abnormal laboratory value(s)|0
828330|NCT01012765|2631611|P4|Treatment Period 2|Abnormal laboratory value(s)|0
828331|NCT01012765|2631612|P3|Treatment Period 2|Abnormal laboratory value(s)|0
828332|NCT01012765|2631613|P2|Treatment Period 2|Abnormal laboratory value(s)|0
828333|NCT01012765|2631614|P1|Treatment Period 2|Abnormal laboratory value(s)|0
828334|NCT01012765|2631609|P6|Treatment Period 2|Withdrawal by Subject|0
828335|NCT01012765|2631610|P5|Treatment Period 2|Withdrawal by Subject|1
828336|NCT01012765|2631611|P4|Treatment Period 2|Withdrawal by Subject|0
828337|NCT01012765|2631612|P3|Treatment Period 2|Withdrawal by Subject|1
828338|NCT01012765|2631613|P2|Treatment Period 2|Withdrawal by Subject|0
828339|NCT01012765|2631614|P1|Treatment Period 2|Withdrawal by Subject|1
828340|NCT01012765|2631609|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
828341|NCT01012765|2631610|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
828342|NCT01012765|2631611|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
828343|NCT01012765|2631612|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
828344|NCT01012765|2631613|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
828345|NCT01012765|2631614|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
828346|NCT01012765|2631609|P6|Treatment Period 1|Protocol Violation|0
828347|NCT01012765|2631610|P5|Treatment Period 1|Protocol Violation|1
828348|NCT01012765|2631611|P4|Treatment Period 1|Protocol Violation|2
828349|NCT01012765|2631612|P3|Treatment Period 1|Protocol Violation|0
828350|NCT01012765|2631613|P2|Treatment Period 1|Protocol Violation|0
828351|NCT01012765|2631614|P1|Treatment Period 1|Protocol Violation|0
828352|NCT01012765|2631609|P6|Treatment Period 1|Administrative problems|0
828353|NCT01012765|2631610|P5|Treatment Period 1|Administrative problems|1
828354|NCT01012765|2631611|P4|Treatment Period 1|Administrative problems|1
828355|NCT01012765|2631612|P3|Treatment Period 1|Administrative problems|1
828356|NCT01012765|2631613|P2|Treatment Period 1|Administrative problems|0
828357|NCT01012765|2631614|P1|Treatment Period 1|Administrative problems|0
828358|NCT01012765|2631609|P6|Treatment Period 1|Withdrawal by Subject|0
828359|NCT01012765|2631610|P5|Treatment Period 1|Withdrawal by Subject|0
828360|NCT01012765|2631611|P4|Treatment Period 1|Withdrawal by Subject|0
828361|NCT01012765|2631612|P3|Treatment Period 1|Withdrawal by Subject|0
828362|NCT01012765|2631613|P2|Treatment Period 1|Withdrawal by Subject|0
828363|NCT01012765|2631614|P1|Treatment Period 1|Withdrawal by Subject|2
828364|NCT01012765|2631609|P6|Treatment Period 1|Adverse Event|0
828365|NCT01012765|2631610|P5|Treatment Period 1|Adverse Event|0
828366|NCT01012765|2631611|P4|Treatment Period 1|Adverse Event|0
828367|NCT01012765|2631612|P3|Treatment Period 1|Adverse Event|1
828368|NCT01012765|2631613|P2|Treatment Period 1|Adverse Event|0
828369|NCT01012765|2631614|P1|Treatment Period 1|Adverse Event|1
828370|NCT01012947|2631648|P5|Overall Study|Lost to Follow-up|142
828371|NCT01012947|2631649|P4|Overall Study|Lost to Follow-up|118
828372|NCT01012947|2631650|P3|Overall Study|Lost to Follow-up|130
828373|NCT01012947|2631651|P2|Overall Study|Lost to Follow-up|135
828374|NCT01012947|2631652|P1|Overall Study|Lost to Follow-up|131
828375|NCT01012973|2631666|P2|Overall Study|Withdrawal by Subject|6
828376|NCT01012973|2631667|P1|Overall Study|Withdrawal by Subject|4
828377|NCT01012973|2631666|P2|Overall Study|Protocol Violation|2
828378|NCT01012973|2631667|P1|Overall Study|Protocol Violation|5
828379|NCT01012973|2631666|P2|Overall Study|Increase in vis. acuity, never injected|1
828380|NCT01012973|2631667|P1|Overall Study|Increase in vis. acuity, never injected|0
828381|NCT01012973|2631666|P2|Overall Study|(Overseas travel - indefinite period)|0
828382|NCT01012973|2631667|P1|Overall Study|(Overseas travel - indefinite period)|1
828383|NCT01012973|2631666|P2|Overall Study|Lost to Follow-up|0
828384|NCT01012973|2631667|P1|Overall Study|Lost to Follow-up|1
828385|NCT01012973|2631666|P2|Overall Study|Lack of Efficacy|5
828386|NCT01012973|2631667|P1|Overall Study|Lack of Efficacy|0
828387|NCT01012973|2631666|P2|Overall Study|Adverse Event|5
828388|NCT01012973|2631667|P1|Overall Study|Adverse Event|5
828389|NCT01012999|2631687|P1|Overall Study|Protocol Violation|1
828390|NCT01013207|2631704|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
828391|NCT01013597|2631709|P1|Overall Study|Withdrawal by Subject|1
828392|NCT01013701|2631719|P1|Overall Study|study prematurely terminated|7
828393|NCT01013740|2631728|P2|Overall Study|Ongoing: Study records not completed|2
828394|NCT01013740|2631729|P1|Overall Study|Ongoing: Study records not completed|0
828395|NCT01013740|2631728|P2|Overall Study|Missing|1
828396|NCT01013740|2631729|P1|Overall Study|Missing|2
828397|NCT01013740|2631728|P2|Overall Study|study close / terminated : done in error|1
828398|NCT01013740|2631729|P1|Overall Study|study close / terminated : done in error|2
828399|NCT01013740|2631728|P2|Overall Study|Withdrawal by Subject|10
828400|NCT01013740|2631729|P1|Overall Study|Withdrawal by Subject|2
828401|NCT01013740|2631728|P2|Overall Study|Physician Decision|0
828402|NCT01013740|2631729|P1|Overall Study|Physician Decision|2
828403|NCT01013740|2631728|P2|Overall Study|Lost to Follow-up|5
828404|NCT01013740|2631729|P1|Overall Study|Lost to Follow-up|3
828405|NCT01013753|2631753|P1|Overall Study|Other|2
828406|NCT01013753|2631753|P1|Overall Study|Withdrawal by Subject|2
828407|NCT01013753|2631753|P1|Overall Study|Lost to Follow-up|1
828408|NCT01013753|2631753|P1|Overall Study|Protocol Violation|3
828409|NCT01013753|2631753|P1|Overall Study|Adverse Event|8
828410|NCT01013792|2631949|P2|Overall Study|Lost to Follow-up|1
828411|NCT01013792|2631950|P1|Overall Study|Lost to Follow-up|0
828412|NCT01013792|2631949|P2|Overall Study|Adverse Event|3
828413|NCT01013792|2631950|P1|Overall Study|Adverse Event|0
828414|NCT01013792|2631949|P2|Overall Study|Study suspended|1
828415|NCT01013792|2631950|P1|Overall Study|Study suspended|2
828416|NCT01013870|2631983|P2|Overall Study|Lost to Follow-up|3
828417|NCT01013870|2631984|P1|Overall Study|Lost to Follow-up|1
828418|NCT01013883|2632008|P2|Overall Study|Lost to Follow-up|2
828419|NCT01013883|2632009|P1|Overall Study|Lost to Follow-up|2
828420|NCT01013961|2632021|P2|Overall Study|Physician Decision|1
828421|NCT01013961|2632022|P1|Overall Study|Physician Decision|0
828422|NCT01013961|2632021|P2|Overall Study|Withdrawal by Subject|0
828423|NCT01013961|2632022|P1|Overall Study|Withdrawal by Subject|1
828424|NCT01013961|2632021|P2|Overall Study|Adverse Event|2
828425|NCT01013961|2632022|P1|Overall Study|Adverse Event|2
828426|NCT01014013|2632040|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
828427|NCT01014013|2632041|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
828428|NCT01014013|2632040|P2|Overall Study|Appendectomy|0
828429|NCT01014013|2632041|P1|Overall Study|Appendectomy|1
828430|NCT01014013|2632040|P2|Overall Study|Another antibiotic therapy required|1
828431|NCT01014013|2632041|P1|Overall Study|Another antibiotic therapy required|0
828432|NCT01014013|2632040|P2|Overall Study|Physician Decision|1
828433|NCT01014013|2632041|P1|Overall Study|Physician Decision|0
828434|NCT01014013|2632040|P2|Overall Study|Pathogen resistant|4
828435|NCT01014013|2632041|P1|Overall Study|Pathogen resistant|7
828436|NCT01014013|2632040|P2|Overall Study|Negative urine culture|0
828437|NCT01014013|2632041|P1|Overall Study|Negative urine culture|2
828438|NCT01014013|2632040|P2|Overall Study|Pathogen culture = no growth|34
828439|NCT01014013|2632041|P1|Overall Study|Pathogen culture = no growth|26
828440|NCT01014013|2632040|P2|Overall Study|Clinical/microbiologic failure|2
828441|NCT01014013|2632041|P1|Overall Study|Clinical/microbiologic failure|1
828442|NCT01014013|2632040|P2|Overall Study|Withdrawal by Subject|4
828443|NCT01014013|2632041|P1|Overall Study|Withdrawal by Subject|7
828444|NCT01014013|2632040|P2|Overall Study|Protocol Violation|3
828445|NCT01014013|2632041|P1|Overall Study|Protocol Violation|1
828446|NCT01014013|2632040|P2|Overall Study|Laboratory adverse experience|1
828447|NCT01014013|2632041|P1|Overall Study|Laboratory adverse experience|1
828448|NCT01014013|2632040|P2|Overall Study|Clinical adverse experience|2
828449|NCT01014013|2632041|P1|Overall Study|Clinical adverse experience|4
828450|NCT01014013|2632040|P2|Overall Study|Inclusion/Exclusion criteria not met|3
828451|NCT01014013|2632041|P1|Overall Study|Inclusion/Exclusion criteria not met|1
828452|NCT01014143|2632139|P3|Second Intervention|Lost to Follow-up|0
828453|NCT01014143|2632140|P2|Second Intervention|Lost to Follow-up|0
828454|NCT01014143|2632141|P1|Second Intervention|Lost to Follow-up|2
828455|NCT01014208|2632164|P2|Overall Study|Study Closed/terminated|83
828456|NCT01014208|2632165|P1|Overall Study|Study Closed/terminated|78
828457|NCT01014208|2632164|P2|Overall Study|Did Not Receive Study Drug|0
828458|NCT01014208|2632165|P1|Overall Study|Did Not Receive Study Drug|2
828459|NCT01014208|2632164|P2|Overall Study|Participant Withdrew Consent|12
828460|NCT01014208|2632165|P1|Overall Study|Participant Withdrew Consent|12
828461|NCT01014208|2632164|P2|Overall Study|Lost to Follow-up|5
828462|NCT01014208|2632165|P1|Overall Study|Lost to Follow-up|2
828463|NCT01014442|2632199|P2|Overall Study|Unspecified Reason|1
828464|NCT01014442|2632200|P1|Overall Study|Unspecified Reason|1
828465|NCT01014442|2632199|P2|Overall Study|Lack of Compliance|1
828466|NCT01014442|2632200|P1|Overall Study|Lack of Compliance|0
828467|NCT01014442|2632199|P2|Overall Study|Protocol Violation|5
828468|NCT01014442|2632200|P1|Overall Study|Protocol Violation|2
828469|NCT01014442|2632199|P2|Overall Study|Withdrawal by Subject|4
828470|NCT01014442|2632200|P1|Overall Study|Withdrawal by Subject|4
828471|NCT01014442|2632199|P2|Overall Study|Adverse Event|8
828472|NCT01014442|2632200|P1|Overall Study|Adverse Event|0
828473|NCT01014585|2632325|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
828474|NCT01014585|2632326|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
828475|NCT01014585|2632327|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
828476|NCT01014585|2632328|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
828477|NCT01014585|2632325|P4|Overall Study|Lost to Follow-up|2
828478|NCT01014585|2632326|P3|Overall Study|Lost to Follow-up|0
828479|NCT01014585|2632327|P2|Overall Study|Lost to Follow-up|0
828480|NCT01014585|2632328|P1|Overall Study|Lost to Follow-up|0
828481|NCT01014585|2632325|P4|Overall Study|Withdrawal by Subject|3
828482|NCT01014585|2632326|P3|Overall Study|Withdrawal by Subject|1
828483|NCT01014585|2632327|P2|Overall Study|Withdrawal by Subject|0
828484|NCT01014585|2632328|P1|Overall Study|Withdrawal by Subject|2
828485|NCT01014585|2632325|P4|Overall Study|Adverse Event|3
828486|NCT01014585|2632326|P3|Overall Study|Adverse Event|0
828487|NCT01014585|2632327|P2|Overall Study|Adverse Event|2
828488|NCT01014585|2632328|P1|Overall Study|Adverse Event|0
828489|NCT01006590|2632371|P2|Overall Study|Not specified|2
828490|NCT01006590|2632372|P1|Overall Study|Not specified|3
828491|NCT01006590|2632371|P2|Overall Study|Study specific discontinuation criteria|23
828492|NCT01006590|2632372|P1|Overall Study|Study specific discontinuation criteria|16
828493|NCT01006590|2632371|P2|Overall Study|Withdrawal by Subject|2
828494|NCT01006590|2632372|P1|Overall Study|Withdrawal by Subject|4
828495|NCT01006590|2632371|P2|Overall Study|Protocol Violation|0
828496|NCT01006590|2632372|P1|Overall Study|Protocol Violation|1
828497|NCT01006590|2632371|P2|Overall Study|Lost to Follow-up|1
828498|NCT01006590|2632372|P1|Overall Study|Lost to Follow-up|1
828499|NCT01006590|2632371|P2|Overall Study|Death|1
828500|NCT01006590|2632372|P1|Overall Study|Death|1
828501|NCT01006590|2632371|P2|Overall Study|Adverse Event|3
828502|NCT01006590|2632372|P1|Overall Study|Adverse Event|2
828503|NCT01006603|2632390|P2|Overall Study|Other|7
828504|NCT01006603|2632391|P1|Overall Study|Other|3
828505|NCT01006603|2632390|P2|Overall Study|Study specific discontinuation criteria|34
828506|NCT01006603|2632391|P1|Overall Study|Study specific discontinuation criteria|33
828507|NCT01006603|2632390|P2|Overall Study|Death|1
828508|NCT01006603|2632391|P1|Overall Study|Death|1
828509|NCT01006603|2632390|P2|Overall Study|Adverse Event|7
828510|NCT01006603|2632391|P1|Overall Study|Adverse Event|15
828511|NCT01006603|2632390|P2|Overall Study|Incorrect enrolment|2
828512|NCT01006603|2632391|P1|Overall Study|Incorrect enrolment|0
828513|NCT01006603|2632390|P2|Overall Study|Protocol Violation|3
828514|NCT01006603|2632391|P1|Overall Study|Protocol Violation|1
828515|NCT01006603|2632390|P2|Overall Study|Safety reason|1
828516|NCT01006603|2632391|P1|Overall Study|Safety reason|1
828517|NCT01006603|2632390|P2|Overall Study|Lost to Follow-up|1
828518|NCT01006603|2632391|P1|Overall Study|Lost to Follow-up|0
828519|NCT01006603|2632390|P2|Overall Study|Withdrawal by Subject|19
828520|NCT01006603|2632391|P1|Overall Study|Withdrawal by Subject|17
828521|NCT01006616|2632413|P4|Period 2 (18 Months)|Study Terminated|70
828522|NCT01006616|2632414|P3|Period 2 (18 Months)|Study Terminated|44
828523|NCT01006616|2632415|P2|Period 2 (18 Months)|Study Terminated|46
828524|NCT01006616|2632416|P1|Period 2 (18 Months)|Study Terminated|63
828525|NCT01006616|2632413|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
828526|NCT01006616|2632414|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
828527|NCT01006616|2632415|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
828528|NCT01006616|2632416|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
828529|NCT01006616|2632413|P4|Period 2 (18 Months)|Withdrawal by Subject|1
828530|NCT01006616|2632414|P3|Period 2 (18 Months)|Withdrawal by Subject|0
828531|NCT01006616|2632415|P2|Period 2 (18 Months)|Withdrawal by Subject|4
828532|NCT01006616|2632416|P1|Period 2 (18 Months)|Withdrawal by Subject|1
828533|NCT01006616|2632413|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
828534|NCT01006616|2632414|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
828535|NCT01006616|2632415|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
828536|NCT01006616|2632416|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
828537|NCT01006616|2632413|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
828538|NCT01006616|2632414|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
828539|NCT01006616|2632415|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
828540|NCT01006616|2632416|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
828541|NCT01006616|2632413|P4|Period 2 (18 Months)|Lost to Follow-up|0
828542|NCT01006616|2632414|P3|Period 2 (18 Months)|Lost to Follow-up|0
828543|NCT01006616|2632415|P2|Period 2 (18 Months)|Lost to Follow-up|0
828544|NCT01006616|2632416|P1|Period 2 (18 Months)|Lost to Follow-up|2
828545|NCT01006616|2632413|P4|Period 2 (18 Months)|Lack of Efficacy|2
828546|NCT01006616|2632414|P3|Period 2 (18 Months)|Lack of Efficacy|1
828547|NCT01006616|2632415|P2|Period 2 (18 Months)|Lack of Efficacy|0
828548|NCT01006616|2632416|P1|Period 2 (18 Months)|Lack of Efficacy|0
828549|NCT01006616|2632413|P4|Period 2 (18 Months)|Adverse Event|4
828550|NCT01006616|2632414|P3|Period 2 (18 Months)|Adverse Event|6
828551|NCT01006616|2632415|P2|Period 2 (18 Months)|Adverse Event|6
828552|NCT01006616|2632416|P1|Period 2 (18 Months)|Adverse Event|6
828553|NCT01006616|2632413|P4|Period 1 (6 Months)|Not Treated|1
828554|NCT01006616|2632414|P3|Period 1 (6 Months)|Not Treated|1
828555|NCT01006616|2632415|P2|Period 1 (6 Months)|Not Treated|0
828556|NCT01006616|2632416|P1|Period 1 (6 Months)|Not Treated|0
828557|NCT01006616|2632413|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
828558|NCT01006616|2632414|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
828559|NCT01006616|2632415|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
828560|NCT01006616|2632416|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
828561|NCT01006616|2632413|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
828562|NCT01006616|2632414|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
828563|NCT01006616|2632415|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
828564|NCT01006616|2632416|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
828565|NCT01006616|2632413|P4|Period 1 (6 Months)|Withdrawal by Subject|0
828566|NCT01006616|2632414|P3|Period 1 (6 Months)|Withdrawal by Subject|2
828567|NCT01006616|2632415|P2|Period 1 (6 Months)|Withdrawal by Subject|2
828568|NCT01006616|2632416|P1|Period 1 (6 Months)|Withdrawal by Subject|2
828569|NCT01006616|2632413|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
828570|NCT01006616|2632414|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
828571|NCT01006616|2632415|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
828572|NCT01006616|2632416|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
828573|NCT01006616|2632413|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
828574|NCT01006616|2632414|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
828575|NCT01006616|2632415|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
828576|NCT01006616|2632416|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
828577|NCT01006616|2632413|P4|Period 1 (6 Months)|Lost to Follow-up|0
828578|NCT01006616|2632414|P3|Period 1 (6 Months)|Lost to Follow-up|1
828579|NCT01006616|2632415|P2|Period 1 (6 Months)|Lost to Follow-up|0
828580|NCT01006616|2632416|P1|Period 1 (6 Months)|Lost to Follow-up|0
828581|NCT01006616|2632413|P4|Period 1 (6 Months)|Lack of Efficacy|4
828582|NCT01006616|2632414|P3|Period 1 (6 Months)|Lack of Efficacy|0
828583|NCT01006616|2632415|P2|Period 1 (6 Months)|Lack of Efficacy|4
828584|NCT01006616|2632416|P1|Period 1 (6 Months)|Lack of Efficacy|3
828585|NCT01006616|2632413|P4|Period 1 (6 Months)|Adverse Event|9
828586|NCT01006616|2632414|P3|Period 1 (6 Months)|Adverse Event|37
828587|NCT01006616|2632415|P2|Period 1 (6 Months)|Adverse Event|31
828588|NCT01006616|2632416|P1|Period 1 (6 Months)|Adverse Event|10
828589|NCT01006629|2632550|P1|Overall Study|Parent unable to perform site visit|4
828590|NCT01006629|2632550|P1|Overall Study|Parent refused to continue participation|1
828591|NCT01006629|2632550|P1|Overall Study|Adverse Event|1
828592|NCT01014689|2632572|P2|Overall Study|Pregnancy|0
828593|NCT01014689|2632573|P1|Overall Study|Pregnancy|1
828594|NCT01014689|2632572|P2|Overall Study|Lost to Follow-up|7
828595|NCT01014689|2632573|P1|Overall Study|Lost to Follow-up|3
828596|NCT01014689|2632572|P2|Overall Study|Protocol Violation|1
828597|NCT01014689|2632573|P1|Overall Study|Protocol Violation|1
828598|NCT01014689|2632572|P2|Overall Study|Withdrawal by Subject|4
828599|NCT01014689|2632573|P1|Overall Study|Withdrawal by Subject|5
828600|NCT01014689|2632572|P2|Overall Study|Adverse Event|0
828601|NCT01014689|2632573|P1|Overall Study|Adverse Event|3
828602|NCT01014689|2632572|P2|Overall Study|Lack of Efficacy|1
828603|NCT01014689|2632573|P1|Overall Study|Lack of Efficacy|0
828604|NCT01014910|2632617|P2|Overall Study|Withdrawal by Subject|2
828605|NCT01014910|2632618|P1|Overall Study|Withdrawal by Subject|0
828606|NCT01016600|2633238|P4|Overall Study|Did not start treatment|0
828607|NCT01016600|2633239|P3|Overall Study|Did not start treatment|0
828608|NCT01016600|2633240|P2|Overall Study|Did not start treatment|0
828609|NCT01016600|2633241|P1|Overall Study|Did not start treatment|1
828610|NCT01016912|2633424|P5|Follow-up Period|Other reason|0
828611|NCT01016912|2633425|P4|Follow-up Period|Other reason|1
828612|NCT01016912|2633426|P3|Follow-up Period|Other reason|1
828613|NCT01016912|2633427|P2|Follow-up Period|Other reason|0
828614|NCT01016912|2633428|P1|Follow-up Period|Other reason|0
828615|NCT01016912|2633424|P5|End of Treatment Period|Completed double-blind period only|0
828616|NCT01016912|2633425|P4|End of Treatment Period|Completed double-blind period only|0
828617|NCT01016912|2633426|P3|End of Treatment Period|Completed double-blind period only|0
828618|NCT01016912|2633427|P2|End of Treatment Period|Completed double-blind period only|1
828619|NCT01016912|2633428|P1|End of Treatment Period|Completed double-blind period only|0
828620|NCT01016912|2633424|P5|End of Treatment Period|Adverse Event|0
828621|NCT01016912|2633425|P4|End of Treatment Period|Adverse Event|0
828622|NCT01016912|2633426|P3|End of Treatment Period|Adverse Event|1
828623|NCT01016912|2633427|P2|End of Treatment Period|Adverse Event|1
828624|NCT01016912|2633428|P1|End of Treatment Period|Adverse Event|0
828625|NCT01016912|2633424|P5|End of Treatment Period|Lack of Efficacy|4
828626|NCT01016912|2633425|P4|End of Treatment Period|Lack of Efficacy|4
828627|NCT01016912|2633426|P3|End of Treatment Period|Lack of Efficacy|0
828628|NCT01016912|2633427|P2|End of Treatment Period|Lack of Efficacy|1
828629|NCT01016912|2633428|P1|End of Treatment Period|Lack of Efficacy|0
828630|NCT01016964|2633477|P2|Overall Study|Lost to Follow-up|3
828631|NCT01016964|2633478|P1|Overall Study|Lost to Follow-up|3
828632|NCT01016977|2633486|P2|Overall Study|Withdrawal by Subject|2
828633|NCT01016977|2633487|P1|Overall Study|Withdrawal by Subject|2
828634|NCT01016977|2633486|P2|Overall Study|Lost to Follow-up|0
828635|NCT01016977|2633487|P1|Overall Study|Lost to Follow-up|1
828636|NCT01017029|2633533|P2|Overall Study|Death|1
828637|NCT01017029|2633534|P1|Overall Study|Death|3
828638|NCT01017029|2633533|P2|Overall Study|Administrative problem|1
828639|NCT01017029|2633534|P1|Overall Study|Administrative problem|0
828640|NCT01017029|2633533|P2|Overall Study|Lost to Follow-up|0
828641|NCT01017029|2633534|P1|Overall Study|Lost to Follow-up|1
828642|NCT01017120|2633563|P2|Overall Study|Parent Unable to Provide Transportation|0
828643|NCT01017120|2633564|P1|Overall Study|Parent Unable to Provide Transportation|1
828644|NCT01017120|2633563|P2|Overall Study|Protocol Violation|0
828645|NCT01017120|2633564|P1|Overall Study|Protocol Violation|1
828646|NCT01017120|2633563|P2|Overall Study|Relocated Out of Town|2
828647|NCT01017120|2633564|P1|Overall Study|Relocated Out of Town|0
828648|NCT01017120|2633563|P2|Overall Study|Did Not Meet Eligibility Criteria|0
828649|NCT01017120|2633564|P1|Overall Study|Did Not Meet Eligibility Criteria|1
828650|NCT01017120|2633563|P2|Overall Study|Pregnancy|1
828651|NCT01017120|2633564|P1|Overall Study|Pregnancy|1
828652|NCT01017120|2633563|P2|Overall Study|Withdrawal by Subject|21
828653|NCT01017120|2633564|P1|Overall Study|Withdrawal by Subject|39
828654|NCT01017120|2633563|P2|Overall Study|Lack of Efficacy|0
828655|NCT01017120|2633564|P1|Overall Study|Lack of Efficacy|1
828656|NCT01017120|2633563|P2|Overall Study|Lost to Follow-up|11
828657|NCT01017120|2633564|P1|Overall Study|Lost to Follow-up|13
828658|NCT01017120|2633563|P2|Overall Study|Adverse Event|0
828659|NCT01017120|2633564|P1|Overall Study|Adverse Event|9
828660|NCT01017146|2633614|P2|Overall Study|Change in Work Situation|0
828661|NCT01017146|2633615|P1|Overall Study|Change in Work Situation|1
828662|NCT01017146|2633614|P2|Overall Study|Did Not Meet Eligibility Criteria|2
828663|NCT01017146|2633615|P1|Overall Study|Did Not Meet Eligibility Criteria|1
828664|NCT01017146|2633614|P2|Overall Study|Took Excluded Medication|0
828665|NCT01017146|2633615|P1|Overall Study|Took Excluded Medication|2
828666|NCT01017146|2633614|P2|Overall Study|Protocol Violation|0
828667|NCT01017146|2633615|P1|Overall Study|Protocol Violation|2
828668|NCT01017146|2633614|P2|Overall Study|Pregnancy|1
828669|NCT01017146|2633615|P1|Overall Study|Pregnancy|2
828670|NCT01017146|2633614|P2|Overall Study|Relocation|4
828671|NCT01017146|2633615|P1|Overall Study|Relocation|0
828672|NCT01017146|2633614|P2|Overall Study|Withdrawal by Subject|16
828673|NCT01017146|2633615|P1|Overall Study|Withdrawal by Subject|32
828674|NCT01017146|2633614|P2|Overall Study|Noncompliance with Study Product|1
828675|NCT01017146|2633615|P1|Overall Study|Noncompliance with Study Product|1
828676|NCT01017146|2633614|P2|Overall Study|Lost to Follow-up|14
828677|NCT01017146|2633615|P1|Overall Study|Lost to Follow-up|14
828678|NCT01017146|2633614|P2|Overall Study|Adverse Event|1
828679|NCT01017146|2633615|P1|Overall Study|Adverse Event|11
828680|NCT01017263|2633726|P1|Overall Study|not eligible|12
828681|NCT01017549|2633756|P1|One-year Follow-up|Withdrawal by Subject|5
828682|NCT01017549|2633756|P1|One-year Follow-up|Lost to Follow-up|2
828683|NCT01017549|2633756|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
828684|NCT01017575|2633766|P5|Overall Study|Withdrawal by Subject|0
828685|NCT01017575|2633767|P4|Overall Study|Withdrawal by Subject|0
828686|NCT01017575|2633768|P3|Overall Study|Withdrawal by Subject|0
828687|NCT01017575|2633769|P2|Overall Study|Withdrawal by Subject|0
828688|NCT01017575|2633770|P1|Overall Study|Withdrawal by Subject|1
828689|NCT01017575|2633766|P5|Overall Study|Adverse Event|2
828690|NCT01017575|2633767|P4|Overall Study|Adverse Event|0
828691|NCT01017575|2633768|P3|Overall Study|Adverse Event|0
828692|NCT01017575|2633769|P2|Overall Study|Adverse Event|1
828693|NCT01017575|2633770|P1|Overall Study|Adverse Event|0
828694|NCT01017575|2633766|P5|Overall Study|Lack of Efficacy|1
828695|NCT01017575|2633767|P4|Overall Study|Lack of Efficacy|1
828696|NCT01017575|2633768|P3|Overall Study|Lack of Efficacy|0
828697|NCT01017575|2633769|P2|Overall Study|Lack of Efficacy|1
828698|NCT01017575|2633770|P1|Overall Study|Lack of Efficacy|0
828699|NCT01017601|2633809|P2|Overall Study|Withdrawal by Subject|1
828700|NCT01017601|2633810|P1|Overall Study|Withdrawal by Subject|0
828701|NCT01017601|2633809|P2|Overall Study|Disease Progression|12
828702|NCT01017601|2633810|P1|Overall Study|Disease Progression|12
828703|NCT01017731|2633842|P1|Overall Study|Adverse Event|1
828704|NCT01017731|2633842|P1|Overall Study|Physician Decision|2
828705|NCT01017731|2633842|P1|Overall Study|Withdrawal by Subject|3
828706|NCT01017731|2633842|P1|Overall Study|Lost to Follow-up|2
828707|NCT01017874|2633861|P2|Overall Study|Physician Decision|3
828708|NCT01017874|2633862|P1|Overall Study|Physician Decision|1
828709|NCT01017874|2633861|P2|Overall Study|Lost to Follow-up|2
828710|NCT01017874|2633862|P1|Overall Study|Lost to Follow-up|3
828711|NCT01017874|2633861|P2|Overall Study|Sponsor decision|1
828712|NCT01017874|2633862|P1|Overall Study|Sponsor decision|3
828713|NCT01017874|2633861|P2|Overall Study|Withdrawal by Subject|20
828714|NCT01017874|2633862|P1|Overall Study|Withdrawal by Subject|23
828715|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Physician Decision|7
828716|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Physician Decision|9
828717|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Physician Decision|8
828718|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Physician Decision|10
828719|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Physician Decision|0
828720|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
828721|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
828722|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
828723|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
828724|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
828725|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
828726|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
828727|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
828728|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
828729|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
828730|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
828731|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
828732|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
828733|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
828734|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
828735|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
828736|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
828737|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
828738|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
828739|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
828740|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
828741|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
828742|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
828743|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
828744|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
828745|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
828746|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
828747|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
828748|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
828749|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
828750|NCT01017952|2633884|P5|52-week, Double-blind Treatment Period|Adverse Event|30
828751|NCT01017952|2633885|P4|52-week, Double-blind Treatment Period|Adverse Event|35
828752|NCT01017952|2633886|P3|52-week, Double-blind Treatment Period|Adverse Event|32
828753|NCT01017952|2633887|P2|52-week, Double-blind Treatment Period|Adverse Event|25
828754|NCT01017952|2633888|P1|52-week, Double-blind Treatment Period|Adverse Event|0
828755|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
828756|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
828757|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
828758|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
828759|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
828760|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Physician Decision|0
828761|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Physician Decision|0
828762|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Physician Decision|0
828763|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Physician Decision|0
828764|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Physician Decision|10
828765|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
828766|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
828767|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
828768|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
828769|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
828770|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
828771|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
828772|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
828773|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
828774|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
828775|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Adverse Event|0
828776|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Adverse Event|0
828777|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Adverse Event|0
828778|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Adverse Event|0
828779|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Adverse Event|23
828780|NCT01017952|2633884|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
828781|NCT01017952|2633885|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
828782|NCT01017952|2633886|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
828783|NCT01017952|2633887|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
828784|NCT01017952|2633888|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
828785|NCT01018030|2633913|P3|Overall Study|Did Not Receive Study Drug|0
828786|NCT01018030|2633914|P2|Overall Study|Did Not Receive Study Drug|3
828787|NCT01018030|2633915|P1|Overall Study|Did Not Receive Study Drug|1
828788|NCT01018030|2633913|P3|Overall Study|Lack of Efficacy|0
828789|NCT01018030|2633914|P2|Overall Study|Lack of Efficacy|0
828790|NCT01018030|2633915|P1|Overall Study|Lack of Efficacy|1
828791|NCT01018030|2633913|P3|Overall Study|Physician Decision|1
828792|NCT01018030|2633914|P2|Overall Study|Physician Decision|0
828793|NCT01018030|2633915|P1|Overall Study|Physician Decision|1
828794|NCT01018030|2633913|P3|Overall Study|Protocol Violation|0
828795|NCT01018030|2633914|P2|Overall Study|Protocol Violation|1
828796|NCT01018030|2633915|P1|Overall Study|Protocol Violation|2
828797|NCT01018030|2633913|P3|Overall Study|Lost to Follow-up|3
828798|NCT01018030|2633914|P2|Overall Study|Lost to Follow-up|0
828799|NCT01018030|2633915|P1|Overall Study|Lost to Follow-up|2
828800|NCT01018030|2633913|P3|Overall Study|Withdrawal by Subject|4
828801|NCT01018030|2633914|P2|Overall Study|Withdrawal by Subject|2
828802|NCT01018030|2633915|P1|Overall Study|Withdrawal by Subject|2
828803|NCT01018030|2633913|P3|Overall Study|Adverse Event|5
828804|NCT01018030|2633914|P2|Overall Study|Adverse Event|5
828805|NCT01018030|2633915|P1|Overall Study|Adverse Event|10
828806|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
828807|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
828808|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
828809|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
828810|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Physician Decision|3
828811|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Physician Decision|0
828812|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Physician Decision|1
828813|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Physician Decision|0
828814|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
828815|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
828816|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
828817|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
828818|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
828819|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
828820|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
828821|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
828822|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Protocol Violation|2
828823|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Protocol Violation|8
828824|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Protocol Violation|8
828825|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Protocol Violation|0
828826|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
828827|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
828828|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
828829|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
828830|NCT01018186|2634062|P4|52-week Double-blind Treatment Period|Adverse Event|6
828831|NCT01018186|2634063|P3|52-week Double-blind Treatment Period|Adverse Event|3
828832|NCT01018186|2634064|P2|52-week Double-blind Treatment Period|Adverse Event|5
828833|NCT01018186|2634065|P1|52-week Double-blind Treatment Period|Adverse Event|0
828834|NCT01018186|2634062|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
828835|NCT01018186|2634063|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
828836|NCT01018186|2634064|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
828837|NCT01018186|2634065|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
828838|NCT01018186|2634062|P4|2-week Run-in Period|Withdrawal by Subject|0
828839|NCT01018186|2634063|P3|2-week Run-in Period|Withdrawal by Subject|0
828840|NCT01018186|2634064|P2|2-week Run-in Period|Withdrawal by Subject|0
828841|NCT01018186|2634065|P1|2-week Run-in Period|Withdrawal by Subject|11
828842|NCT01018186|2634062|P4|2-week Run-in Period|Physician Decision|0
828843|NCT01018186|2634063|P3|2-week Run-in Period|Physician Decision|0
828844|NCT01018186|2634064|P2|2-week Run-in Period|Physician Decision|0
828845|NCT01018186|2634065|P1|2-week Run-in Period|Physician Decision|3
828846|NCT01018186|2634062|P4|2-week Run-in Period|Lost to Follow-up|0
828847|NCT01018186|2634063|P3|2-week Run-in Period|Lost to Follow-up|0
828848|NCT01018186|2634064|P2|2-week Run-in Period|Lost to Follow-up|0
828849|NCT01018186|2634065|P1|2-week Run-in Period|Lost to Follow-up|2
828850|NCT01018186|2634062|P4|2-week Run-in Period|Protocol Violation|0
828851|NCT01018186|2634063|P3|2-week Run-in Period|Protocol Violation|0
828852|NCT01018186|2634064|P2|2-week Run-in Period|Protocol Violation|0
828853|NCT01018186|2634065|P1|2-week Run-in Period|Protocol Violation|1
828854|NCT01018264|2634153|P2|Overall Study|Lost to Follow-up|1
828855|NCT01018264|2634154|P1|Overall Study|Lost to Follow-up|0
828856|NCT01018264|2634153|P2|Overall Study|Withdrawal by Subject|0
828857|NCT01018264|2634154|P1|Overall Study|Withdrawal by Subject|1
828858|NCT01018394|2634170|P2|Overall Study|Lost to Follow-up|3
828859|NCT01018394|2634171|P1|Overall Study|Lost to Follow-up|4
828860|NCT01018394|2634170|P2|Overall Study|Withdrawal by Subject|5
828861|NCT01018394|2634171|P1|Overall Study|Withdrawal by Subject|5
828862|NCT01018511|2634211|P4|Overall Study|Miscellaneous|0
828863|NCT01018511|2634212|P3|Overall Study|Miscellaneous|0
828864|NCT01018511|2634213|P2|Overall Study|Miscellaneous|2
828865|NCT01018511|2634214|P1|Overall Study|Miscellaneous|0
828866|NCT01018511|2634211|P4|Overall Study|Protocol Violation|9
828867|NCT01018511|2634212|P3|Overall Study|Protocol Violation|7
828868|NCT01018511|2634213|P2|Overall Study|Protocol Violation|8
828869|NCT01018511|2634214|P1|Overall Study|Protocol Violation|5
828870|NCT01018511|2634211|P4|Overall Study|Lost to Follow-up|0
828871|NCT01018511|2634212|P3|Overall Study|Lost to Follow-up|1
828872|NCT01018511|2634213|P2|Overall Study|Lost to Follow-up|0
828873|NCT01018511|2634214|P1|Overall Study|Lost to Follow-up|0
828874|NCT01018511|2634211|P4|Overall Study|Withdrawal by Subject|9
828875|NCT01018511|2634212|P3|Overall Study|Withdrawal by Subject|11
828876|NCT01018511|2634213|P2|Overall Study|Withdrawal by Subject|5
828877|NCT01018511|2634214|P1|Overall Study|Withdrawal by Subject|6
828878|NCT01018511|2634211|P4|Overall Study|Lack of Efficacy|2
828879|NCT01018511|2634212|P3|Overall Study|Lack of Efficacy|1
828880|NCT01018511|2634213|P2|Overall Study|Lack of Efficacy|1
828881|NCT01018511|2634214|P1|Overall Study|Lack of Efficacy|4
828882|NCT01018511|2634211|P4|Overall Study|Adverse Event|10
828883|NCT01018511|2634212|P3|Overall Study|Adverse Event|13
828884|NCT01018511|2634213|P2|Overall Study|Adverse Event|9
828885|NCT01018511|2634214|P1|Overall Study|Adverse Event|5
828886|NCT01018511|2634211|P4|Overall Study|Not fulfilling eligibility criteria|3
828887|NCT01018511|2634212|P3|Overall Study|Not fulfilling eligibility criteria|7
828888|NCT01018511|2634213|P2|Overall Study|Not fulfilling eligibility criteria|7
828889|NCT01018511|2634214|P1|Overall Study|Not fulfilling eligibility criteria|6
828890|NCT01018680|2634383|P2|Overall Study|Physician Decision|1
828891|NCT01018680|2634384|P1|Overall Study|Physician Decision|3
828892|NCT01018680|2634383|P2|Overall Study|Entry Criteria Not Met|4
828893|NCT01018680|2634384|P1|Overall Study|Entry Criteria Not Met|1
828894|NCT01018680|2634383|P2|Overall Study|Lost to Follow-up|3
828895|NCT01018680|2634384|P1|Overall Study|Lost to Follow-up|5
828896|NCT01018680|2634383|P2|Overall Study|Lack of Efficacy|2
828897|NCT01018680|2634384|P1|Overall Study|Lack of Efficacy|8
828898|NCT01018680|2634383|P2|Overall Study|Sponsor Decision|7
828899|NCT01018680|2634384|P1|Overall Study|Sponsor Decision|6
828900|NCT01018680|2634383|P2|Overall Study|Protocol Violation|8
828901|NCT01018680|2634384|P1|Overall Study|Protocol Violation|5
828902|NCT01018680|2634383|P2|Overall Study|Withdrawal by Subject|10
828903|NCT01018680|2634384|P1|Overall Study|Withdrawal by Subject|10
828904|NCT01018680|2634383|P2|Overall Study|Adverse Event|40
828905|NCT01018680|2634384|P1|Overall Study|Adverse Event|23
828906|NCT01018732|2634427|P3|Overall Study|Unable to Classify|1
828907|NCT01018732|2634428|P2|Overall Study|Unable to Classify|0
828908|NCT01018732|2634429|P1|Overall Study|Unable to Classify|0
828909|NCT01018732|2634427|P3|Overall Study|Inappropriate Enrollment|0
828910|NCT01018732|2634428|P2|Overall Study|Inappropriate Enrollment|1
828911|NCT01018732|2634429|P1|Overall Study|Inappropriate Enrollment|0
828912|NCT01018732|2634427|P3|Overall Study|Protocol Violation|0
828913|NCT01018732|2634428|P2|Overall Study|Protocol Violation|1
828914|NCT01018732|2634429|P1|Overall Study|Protocol Violation|1
828915|NCT01018732|2634427|P3|Overall Study|Lost to Follow-up|3
828916|NCT01018732|2634428|P2|Overall Study|Lost to Follow-up|0
828917|NCT01018732|2634429|P1|Overall Study|Lost to Follow-up|0
828918|NCT01009840|2634474|P1|Overall Study|Subject Withdrew Consent to Participate|1
828919|NCT01009840|2634474|P1|Overall Study|Subject was Withdrawn by Investigator|1
828920|NCT01009840|2634474|P1|Overall Study|Subject Met Withdrawal Criteria|7
828921|NCT01009840|2634474|P1|Overall Study|Adverse Event|4
828922|NCT01009840|2634474|P1|Overall Study|Lost to Follow-up|1
828923|NCT01009983|2634493|P1|Overall Study|necessary scans not completed|1
828946|NCT01010230|2634563|P2|Overall Study|Lost to Follow-up|2
828947|NCT01010230|2634564|P1|Overall Study|Lost to Follow-up|4
828948|NCT01010230|2634563|P2|Overall Study|Withdrawal by Subject|5
828949|NCT01010230|2634564|P1|Overall Study|Withdrawal by Subject|6
828950|NCT01010503|2634633|P1|Overall Study|Death|1
828951|NCT01010503|2634633|P1|Overall Study|Adverse Event|1
828952|NCT01010633|2634670|P2|Overall Study|Investigator decision|1
828953|NCT01010633|2634671|P1|Overall Study|Investigator decision|0
828954|NCT01010633|2634670|P2|Overall Study|Withdrawal by Subject|1
828955|NCT01010633|2634671|P1|Overall Study|Withdrawal by Subject|2
828956|NCT01010633|2634670|P2|Overall Study|Protocol Violation|2
828957|NCT01010633|2634671|P1|Overall Study|Protocol Violation|1
828958|NCT01010633|2634670|P2|Overall Study|Adverse Event|1
828959|NCT01010633|2634671|P1|Overall Study|Adverse Event|1
828960|NCT01010750|2634687|P6|Second Intervention|Adverse Event|0
828961|NCT01010750|2634688|P5|Second Intervention|Adverse Event|0
828962|NCT01010750|2634689|P4|Second Intervention|Adverse Event|0
828963|NCT01010750|2634690|P3|Second Intervention|Adverse Event|0
828964|NCT01010750|2634691|P2|Second Intervention|Adverse Event|1
828965|NCT01010750|2634692|P1|Second Intervention|Adverse Event|0
828966|NCT01010776|2634715|P1|Extension Phase|Not specified|3
828967|NCT01010776|2634715|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
828968|NCT01010776|2634715|P1|Main Phase|Did not received study medication|5
828969|NCT01010776|2634715|P1|Main Phase|Not specified|1
828970|NCT01010776|2634715|P1|Main Phase|Inform consent withdrawal|1
828971|NCT01010776|2634715|P1|Main Phase|Selection failure|2
828972|NCT01010776|2634715|P1|Main Phase|Non-compliance to study medication|5
828973|NCT01010776|2634715|P1|Main Phase|Lost to Follow-up|6
828974|NCT01010776|2634715|P1|Main Phase|Adverse Event|7
828975|NCT01010776|2634715|P1|Main Phase|Lack of Efficacy|8
828976|NCT01010776|2634715|P1|Main Phase|Withdrawal by Subject|14
828977|NCT01010867|2634737|P1|Overall Study|< 50% adherence to probiotic|1
828978|NCT01010971|2634790|P3|Overall Study|Other|2
828979|NCT01010971|2634791|P2|Overall Study|Other|0
828980|NCT01010971|2634792|P1|Overall Study|Other|1
828981|NCT01010971|2634790|P3|Overall Study|Lost to Follow-up|3
828982|NCT01010971|2634791|P2|Overall Study|Lost to Follow-up|2
828983|NCT01010971|2634792|P1|Overall Study|Lost to Follow-up|0
828984|NCT01010971|2634790|P3|Overall Study|Withdrawal by Subject|5
828985|NCT01010971|2634791|P2|Overall Study|Withdrawal by Subject|2
828986|NCT01010971|2634792|P1|Overall Study|Withdrawal by Subject|0
828987|NCT01010971|2634790|P3|Overall Study|Adverse Event|3
828988|NCT01010971|2634791|P2|Overall Study|Adverse Event|4
828989|NCT01010971|2634792|P1|Overall Study|Adverse Event|2
828990|NCT01011049|2634881|P4|Overall Study|Withdrawal by Subject|0
828991|NCT01011049|2634882|P3|Overall Study|Withdrawal by Subject|1
828992|NCT01011049|2634883|P2|Overall Study|Withdrawal by Subject|0
828993|NCT01011049|2634884|P1|Overall Study|Withdrawal by Subject|0
828994|NCT01011049|2634881|P4|Overall Study|Lost to Follow-up|0
828995|NCT01011049|2634882|P3|Overall Study|Lost to Follow-up|1
828996|NCT01011049|2634883|P2|Overall Study|Lost to Follow-up|2
828997|NCT01011049|2634884|P1|Overall Study|Lost to Follow-up|1
828998|NCT01011049|2634881|P4|Overall Study|Protocol Violation|0
828999|NCT01011049|2634882|P3|Overall Study|Protocol Violation|2
829000|NCT01011049|2634883|P2|Overall Study|Protocol Violation|0
829001|NCT01011049|2634884|P1|Overall Study|Protocol Violation|0
829002|NCT01011153|2634916|P3|Overall Study|Less than 78 cases completed|9
829003|NCT01011153|2634917|P2|Overall Study|Less than 78 cases completed|11
829004|NCT01011153|2634918|P1|Overall Study|Less than 78 cases completed|8
829005|NCT01011283|2634947|P2|Overall Study|Not Specified|2
829006|NCT01011283|2634948|P1|Overall Study|Not Specified|2
829007|NCT01011283|2634947|P2|Overall Study|Terminated by Sponsor|5
829008|NCT01011283|2634948|P1|Overall Study|Terminated by Sponsor|5
829009|NCT01011283|2634947|P2|Overall Study|Progressive Disease|2
829010|NCT01011283|2634948|P1|Overall Study|Progressive Disease|0
829011|NCT01011283|2634947|P2|Overall Study|Adverse Event|2
829012|NCT01011283|2634948|P1|Overall Study|Adverse Event|4
829013|NCT01011309|2634959|P3|Overall Study|Protocol Violation|3
829014|NCT01011309|2634960|P2|Overall Study|Protocol Violation|1
829015|NCT01011309|2634961|P1|Overall Study|Protocol Violation|0
829016|NCT01011309|2634959|P3|Overall Study|Lack of Efficacy|0
829017|NCT01011309|2634960|P2|Overall Study|Lack of Efficacy|1
829018|NCT01011309|2634961|P1|Overall Study|Lack of Efficacy|0
829019|NCT01011309|2634959|P3|Overall Study|Adverse Event|2
829020|NCT01011309|2634960|P2|Overall Study|Adverse Event|1
829021|NCT01011309|2634961|P1|Overall Study|Adverse Event|2
829022|NCT01011387|2634975|P1|Overall Study|Protocol Violation|1
829023|NCT01011387|2634975|P1|Overall Study|Adverse Event|2
829024|NCT01011387|2634975|P1|Overall Study|Withdrawal by Subject|3
829025|NCT01011465|2634987|P8|Overall Study|Withdrawal by Subject|0
829026|NCT01011465|2634988|P7|Overall Study|Withdrawal by Subject|1
829027|NCT01011465|2634989|P6|Overall Study|Withdrawal by Subject|0
829028|NCT01011465|2634990|P5|Overall Study|Withdrawal by Subject|1
829029|NCT01011465|2634991|P4|Overall Study|Withdrawal by Subject|0
829030|NCT01011465|2634992|P3|Overall Study|Withdrawal by Subject|0
829031|NCT01011465|2634993|P2|Overall Study|Withdrawal by Subject|1
829032|NCT01011465|2634994|P1|Overall Study|Withdrawal by Subject|2
829033|NCT01011556|2635026|P4|Overall Study|Inclusion/exclusion criteria not met|5
829034|NCT01011556|2635027|P3|Overall Study|Inclusion/exclusion criteria not met|3
829035|NCT01011556|2635028|P2|Overall Study|Inclusion/exclusion criteria not met|1
829036|NCT01011556|2635029|P1|Overall Study|Inclusion/exclusion criteria not met|2
829037|NCT01011556|2635026|P4|Overall Study|Sponsor decision|2
829038|NCT01011556|2635027|P3|Overall Study|Sponsor decision|1
829039|NCT01011556|2635028|P2|Overall Study|Sponsor decision|1
829040|NCT01011556|2635029|P1|Overall Study|Sponsor decision|0
829041|NCT01011556|2635026|P4|Overall Study|Withdrawal by Subject|4
829042|NCT01011556|2635027|P3|Overall Study|Withdrawal by Subject|4
829043|NCT01011556|2635028|P2|Overall Study|Withdrawal by Subject|2
829044|NCT01011556|2635029|P1|Overall Study|Withdrawal by Subject|1
829045|NCT01011556|2635026|P4|Overall Study|Protocol Violation|0
829046|NCT01011556|2635027|P3|Overall Study|Protocol Violation|0
829047|NCT01011556|2635028|P2|Overall Study|Protocol Violation|1
829048|NCT01011556|2635029|P1|Overall Study|Protocol Violation|0
829049|NCT01011556|2635026|P4|Overall Study|Physician Decision|1
829050|NCT01011556|2635027|P3|Overall Study|Physician Decision|0
829051|NCT01011556|2635028|P2|Overall Study|Physician Decision|0
829052|NCT01011556|2635029|P1|Overall Study|Physician Decision|1
829053|NCT01011556|2635026|P4|Overall Study|Lost to Follow-up|0
829054|NCT01011556|2635027|P3|Overall Study|Lost to Follow-up|0
829055|NCT01011556|2635028|P2|Overall Study|Lost to Follow-up|0
829056|NCT01011556|2635029|P1|Overall Study|Lost to Follow-up|1
829057|NCT01011556|2635026|P4|Overall Study|Adverse Event|1
829058|NCT01011556|2635027|P3|Overall Study|Adverse Event|2
829059|NCT01011556|2635028|P2|Overall Study|Adverse Event|3
829060|NCT01011556|2635029|P1|Overall Study|Adverse Event|1
829061|NCT01011673|2635112|P2|24 Hour Follow-up|Lost to Follow-up|3
829062|NCT01011673|2635113|P1|24 Hour Follow-up|Lost to Follow-up|3
829063|NCT01011673|2635112|P2|Randomized|Secondary headache|1
829064|NCT01011673|2635113|P1|Randomized|Secondary headache|2
829065|NCT01011738|2635124|P3|Overall Study|Unknown reasons|17
829066|NCT01011738|2635125|P2|Overall Study|Unknown reasons|291
829067|NCT01011738|2635126|P1|Overall Study|Unknown reasons|312
829068|NCT01011738|2635124|P3|Overall Study|Death|0
829069|NCT01011738|2635125|P2|Overall Study|Death|3
829070|NCT01011738|2635126|P1|Overall Study|Death|12
829071|NCT01011868|2635191|P3|After Week 78 Follow-up|Other reason not defined above|16
829072|NCT01011868|2635192|P2|After Week 78 Follow-up|Other reason not defined above|5
829073|NCT01011868|2635193|P1|After Week 78 Follow-up|Other reason not defined above|5
829074|NCT01011868|2635191|P3|After Week 78 Follow-up|Withdrawal by Subject|1
829075|NCT01011868|2635192|P2|After Week 78 Follow-up|Withdrawal by Subject|8
829076|NCT01011868|2635193|P1|After Week 78 Follow-up|Withdrawal by Subject|9
829077|NCT01011868|2635191|P3|After Week 78 Follow-up|Lost to Follow-up|4
829078|NCT01011868|2635192|P2|After Week 78 Follow-up|Lost to Follow-up|6
829079|NCT01011868|2635193|P1|After Week 78 Follow-up|Lost to Follow-up|11
829080|NCT01011868|2635191|P3|After Week 78 Follow-up|Protocol Violation|2
829081|NCT01011868|2635192|P2|After Week 78 Follow-up|Protocol Violation|1
829082|NCT01011868|2635193|P1|After Week 78 Follow-up|Protocol Violation|9
829083|NCT01011868|2635191|P3|After Week 78 Follow-up|Lack of Efficacy|0
829084|NCT01011868|2635192|P2|After Week 78 Follow-up|Lack of Efficacy|0
829085|NCT01011868|2635193|P1|After Week 78 Follow-up|Lack of Efficacy|4
829086|NCT01011868|2635191|P3|After Week 78 Follow-up|Adverse Event|21
829087|NCT01011868|2635192|P2|After Week 78 Follow-up|Adverse Event|18
829088|NCT01011868|2635193|P1|After Week 78 Follow-up|Adverse Event|14
829089|NCT01011868|2635191|P3|After Week 18 Follow-up|Other reason not defined above|12
829090|NCT01011868|2635192|P2|After Week 18 Follow-up|Other reason not defined above|3
829091|NCT01011868|2635193|P1|After Week 18 Follow-up|Other reason not defined above|2
829092|NCT01011868|2635191|P3|After Week 18 Follow-up|Withdrawal by Subject|0
829093|NCT01011868|2635192|P2|After Week 18 Follow-up|Withdrawal by Subject|3
829094|NCT01011868|2635193|P1|After Week 18 Follow-up|Withdrawal by Subject|6
829095|NCT01011868|2635191|P3|After Week 18 Follow-up|Lost to Follow-up|0
829096|NCT01011868|2635192|P2|After Week 18 Follow-up|Lost to Follow-up|3
829097|NCT01011868|2635193|P1|After Week 18 Follow-up|Lost to Follow-up|5
829098|NCT01011868|2635191|P3|After Week 18 Follow-up|Protocol Violation|1
829099|NCT01011868|2635192|P2|After Week 18 Follow-up|Protocol Violation|1
829100|NCT01011868|2635193|P1|After Week 18 Follow-up|Protocol Violation|1
829101|NCT01011868|2635191|P3|After Week 18 Follow-up|Lack of Efficacy|0
829102|NCT01011868|2635192|P2|After Week 18 Follow-up|Lack of Efficacy|0
829103|NCT01011868|2635193|P1|After Week 18 Follow-up|Lack of Efficacy|1
829104|NCT01011868|2635191|P3|After Week 18 Follow-up|Adverse Event|13
829105|NCT01011868|2635192|P2|After Week 18 Follow-up|Adverse Event|6
829106|NCT01011868|2635193|P1|After Week 18 Follow-up|Adverse Event|8
829107|NCT01011907|2635234|P2|Overall Study|Adverse Event|4
829108|NCT01011907|2635235|P1|Overall Study|Adverse Event|1
829109|NCT01011907|2635234|P2|Overall Study|Withdrawal by Subject|11
829110|NCT01011907|2635235|P1|Overall Study|Withdrawal by Subject|13
829115|NCT01011946|2635252|P1|Overall Study|No pathological lab value|1
829116|NCT01011946|2635252|P1|Overall Study|Transferred to another hospital|2
829117|NCT01012037|2635259|P3|Overall Study|Other reason (not specified)|1
829118|NCT01012037|2635260|P2|Overall Study|Other reason (not specified)|1
829119|NCT01012037|2635261|P1|Overall Study|Other reason (not specified)|1
829120|NCT01012037|2635259|P3|Overall Study|Withdrawal by Subject|1
829121|NCT01012037|2635260|P2|Overall Study|Withdrawal by Subject|4
829122|NCT01012037|2635261|P1|Overall Study|Withdrawal by Subject|0
829123|NCT01012037|2635259|P3|Overall Study|Protocol Violation|5
829124|NCT01012037|2635260|P2|Overall Study|Protocol Violation|3
829125|NCT01012037|2635261|P1|Overall Study|Protocol Violation|0
829126|NCT01012037|2635259|P3|Overall Study|Adverse Event|3
829127|NCT01012037|2635260|P2|Overall Study|Adverse Event|8
829128|NCT01012037|2635261|P1|Overall Study|Adverse Event|0
829129|NCT01018810|2635301|P5|Overall Study|Sponsor Decision|1
829130|NCT01018810|2635302|P4|Overall Study|Sponsor Decision|1
829131|NCT01018810|2635303|P3|Overall Study|Sponsor Decision|1
829132|NCT01018810|2635304|P2|Overall Study|Sponsor Decision|0
829133|NCT01018810|2635305|P1|Overall Study|Sponsor Decision|2
829134|NCT01018810|2635301|P5|Overall Study|Withdrawal by Subject|0
829135|NCT01018810|2635302|P4|Overall Study|Withdrawal by Subject|0
829136|NCT01018810|2635303|P3|Overall Study|Withdrawal by Subject|0
829137|NCT01018810|2635304|P2|Overall Study|Withdrawal by Subject|1
829138|NCT01018810|2635305|P1|Overall Study|Withdrawal by Subject|0
829139|NCT01018862|2635365|P3|Overall Study|administrative problems|4
829140|NCT01018862|2635366|P2|Overall Study|administrative problems|4
829141|NCT01018862|2635367|P1|Overall Study|administrative problems|5
829142|NCT01018862|2635365|P3|Overall Study|Withdrawal by Subject|1
829143|NCT01018862|2635366|P2|Overall Study|Withdrawal by Subject|2
829144|NCT01018862|2635367|P1|Overall Study|Withdrawal by Subject|1
829145|NCT01018862|2635365|P3|Overall Study|Protocol Violation|3
829146|NCT01018862|2635366|P2|Overall Study|Protocol Violation|3
829147|NCT01018862|2635367|P1|Overall Study|Protocol Violation|1
829148|NCT01018862|2635365|P3|Overall Study|Lost to Follow-up|0
829149|NCT01018862|2635366|P2|Overall Study|Lost to Follow-up|1
829150|NCT01018862|2635367|P1|Overall Study|Lost to Follow-up|3
829151|NCT01018862|2635365|P3|Overall Study|Lack of Efficacy|2
829152|NCT01018862|2635366|P2|Overall Study|Lack of Efficacy|0
829153|NCT01018862|2635367|P1|Overall Study|Lack of Efficacy|1
829154|NCT01018862|2635365|P3|Overall Study|Adverse Event|6
829155|NCT01018862|2635366|P2|Overall Study|Adverse Event|0
829156|NCT01018862|2635367|P1|Overall Study|Adverse Event|2
829157|NCT01018953|2635384|P1|Overall Study|Study termination by sponsor|5
829158|NCT01018953|2635384|P1|Overall Study|Withdrawal by Subject|1
829159|NCT01018953|2635384|P1|Overall Study|Adverse Event|2
829160|NCT01018979|2635396|P2|Overall Study|Not received at least one dose|1
829161|NCT01018979|2635397|P1|Overall Study|Not received at least one dose|0
829162|NCT01018979|2635396|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
829163|NCT01018979|2635397|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
829164|NCT01018992|2635429|P2|Overall Study|Lost to Follow-up|1
829165|NCT01018992|2635430|P1|Overall Study|Lost to Follow-up|5
829166|NCT01018992|2635429|P2|Overall Study|Protocol Violation|4
829167|NCT01018992|2635430|P1|Overall Study|Protocol Violation|0
829168|NCT01018992|2635429|P2|Overall Study|Withdrawal by Subject|8
829169|NCT01018992|2635430|P1|Overall Study|Withdrawal by Subject|3
829170|NCT01018992|2635429|P2|Overall Study|Adverse Event|3
829171|NCT01018992|2635430|P1|Overall Study|Adverse Event|8
829172|NCT01022762|2635453|P2|Overall Study|Unclassified|20
829173|NCT01022762|2635454|P1|Overall Study|Unclassified|12
829174|NCT01022762|2635453|P2|Overall Study|Protocol Violation|6
829175|NCT01022762|2635454|P1|Overall Study|Protocol Violation|7
829176|NCT01022762|2635453|P2|Overall Study|Lack of Efficacy|1
829177|NCT01022762|2635454|P1|Overall Study|Lack of Efficacy|0
829178|NCT01022762|2635453|P2|Overall Study|Adverse Event|1
829179|NCT01022762|2635454|P1|Overall Study|Adverse Event|3
829180|NCT01022996|2635480|P1|Overall Study|Protocol Violation|1
829181|NCT01022996|2635480|P1|Overall Study|Disease Progression|32
829182|NCT01022996|2635480|P1|Overall Study|Administrative problems|6
829183|NCT01022996|2635480|P1|Overall Study|Lost to Follow-up|1
829184|NCT01022996|2635480|P1|Overall Study|Withdrawal by Subject|3
829185|NCT01022996|2635480|P1|Overall Study|Adverse Event|14
829186|NCT01023022|2635489|P1|Overall Study|due to technical issues|2
829187|NCT01023022|2635489|P1|Overall Study|Lost to Follow-up|7
829188|NCT01023022|2635489|P1|Overall Study|Death|5
829189|NCT01023035|2635498|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
829190|NCT01023035|2635499|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
829191|NCT01023035|2635500|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
829192|NCT01023035|2635498|P3|Follow-up Period (up to Week 72)|Adverse Event|1
829193|NCT01023035|2635499|P2|Follow-up Period (up to Week 72)|Adverse Event|0
829194|NCT01023035|2635500|P1|Follow-up Period (up to Week 72)|Adverse Event|2
829195|NCT01023035|2635498|P3|Treatment Period|Treatment Failure|24
829196|NCT01023035|2635499|P2|Treatment Period|Treatment Failure|31
829197|NCT01023035|2635500|P1|Treatment Period|Treatment Failure|26
829198|NCT01023035|2635498|P3|Treatment Period|Non-Medical Reasons|44
829199|NCT01023035|2635499|P2|Treatment Period|Non-Medical Reasons|22
829200|NCT01023035|2635500|P1|Treatment Period|Non-Medical Reasons|19
829201|NCT01023035|2635498|P3|Treatment Period|Adverse Event|50
829202|NCT01023035|2635499|P2|Treatment Period|Adverse Event|32
829203|NCT01023035|2635500|P1|Treatment Period|Adverse Event|27
829204|NCT01023061|2635510|P1|Overall Study|Withdrawal prior to treatment|2
829205|NCT01023217|2635550|P2|Overall Study|Withdrawal by Subject|0
829206|NCT01023217|2635551|P1|Overall Study|Withdrawal by Subject|1
829207|NCT01023256|2635561|P4|Overall Study|Withdrawal by Subject|2
829208|NCT01023256|2635562|P3|Overall Study|Withdrawal by Subject|0
829209|NCT01023256|2635563|P2|Overall Study|Withdrawal by Subject|0
829210|NCT01023256|2635564|P1|Overall Study|Withdrawal by Subject|0
829211|NCT01023256|2635561|P4|Overall Study|Adverse Event|1
829212|NCT01023256|2635562|P3|Overall Study|Adverse Event|0
829213|NCT01023256|2635563|P2|Overall Study|Adverse Event|0
829214|NCT01023256|2635564|P1|Overall Study|Adverse Event|0
829215|NCT01023256|2635561|P4|Overall Study|Not specified|2
829216|NCT01023256|2635562|P3|Overall Study|Not specified|0
829217|NCT01023256|2635563|P2|Overall Study|Not specified|0
829218|NCT01023256|2635564|P1|Overall Study|Not specified|1
829219|NCT01023256|2635561|P4|Overall Study|Randomized but not treated|0
829220|NCT01023256|2635562|P3|Overall Study|Randomized but not treated|1
829221|NCT01023256|2635563|P2|Overall Study|Randomized but not treated|0
829222|NCT01023256|2635564|P1|Overall Study|Randomized but not treated|1
829223|NCT01023256|2635561|P4|Overall Study|Protocol Violation|0
829224|NCT01023256|2635562|P3|Overall Study|Protocol Violation|0
829225|NCT01023256|2635563|P2|Overall Study|Protocol Violation|3
829226|NCT01023256|2635564|P1|Overall Study|Protocol Violation|2
829227|NCT01023308|2635606|P2|Overall Study|Withdrawal by Subject|18
829228|NCT01023308|2635607|P1|Overall Study|Withdrawal by Subject|34
829229|NCT01023308|2635606|P2|Overall Study|Lost to Follow-up|0
829230|NCT01023308|2635607|P1|Overall Study|Lost to Follow-up|1
829231|NCT01023308|2635606|P2|Overall Study|Untreated|5
829232|NCT01023308|2635607|P1|Overall Study|Untreated|5
829233|NCT01023308|2635606|P2|Overall Study|Protocol Violation|4
829234|NCT01023308|2635607|P1|Overall Study|Protocol Violation|3
829235|NCT01023308|2635606|P2|Overall Study|New Cancer therapy|7
829236|NCT01023308|2635607|P1|Overall Study|New Cancer therapy|4
829237|NCT01023308|2635606|P2|Overall Study|Disease progression|153
829238|NCT01023308|2635607|P1|Overall Study|Disease progression|82
829239|NCT01023308|2635606|P2|Overall Study|Death|17
829240|NCT01023308|2635607|P1|Overall Study|Death|21
829241|NCT01023308|2635606|P2|Overall Study|Adverse Event|66
829242|NCT01023308|2635607|P1|Overall Study|Adverse Event|130
829243|NCT01023308|2635606|P2|Overall Study|Administrative problems|1
829244|NCT01023308|2635607|P1|Overall Study|Administrative problems|2
829245|NCT01023308|2635606|P2|Overall Study|Abnormal test proceedure results|8
829246|NCT01023308|2635607|P1|Overall Study|Abnormal test proceedure results|3
829247|NCT01023516|2635635|P2|Overall Study|Incorrect enrolment|2
829248|NCT01023516|2635636|P1|Overall Study|Incorrect enrolment|4
829249|NCT01023516|2635635|P2|Overall Study|Study-specific criteria|2
829250|NCT01023516|2635636|P1|Overall Study|Study-specific criteria|4
829251|NCT01023516|2635635|P2|Overall Study|Safety reason|3
829252|NCT01023516|2635636|P1|Overall Study|Safety reason|0
829253|NCT01023516|2635635|P2|Overall Study|Adverse Event|6
829254|NCT01023516|2635636|P1|Overall Study|Adverse Event|9
829255|NCT01023516|2635635|P2|Overall Study|Voluntary discontinuation|5
829256|NCT01023516|2635636|P1|Overall Study|Voluntary discontinuation|7
829257|NCT01023581|2635748|P7|Overall Study|Other|0
829258|NCT01023581|2635749|P6|Overall Study|Other|0
829259|NCT01023581|2635750|P5|Overall Study|Other|1
829260|NCT01023581|2635751|P4|Overall Study|Other|0
829261|NCT01023581|2635752|P3|Overall Study|Other|1
829262|NCT01023581|2635753|P2|Overall Study|Other|0
829263|NCT01023581|2635754|P1|Overall Study|Other|1
829264|NCT01023581|2635748|P7|Overall Study|Physician Decision|1
829265|NCT01023581|2635749|P6|Overall Study|Physician Decision|1
829266|NCT01023581|2635750|P5|Overall Study|Physician Decision|1
829267|NCT01023581|2635751|P4|Overall Study|Physician Decision|1
829268|NCT01023581|2635752|P3|Overall Study|Physician Decision|2
829269|NCT01023581|2635753|P2|Overall Study|Physician Decision|0
829270|NCT01023581|2635754|P1|Overall Study|Physician Decision|2
829271|NCT01023581|2635748|P7|Overall Study|Lack of Efficacy|1
829272|NCT01023581|2635749|P6|Overall Study|Lack of Efficacy|2
829273|NCT01023581|2635750|P5|Overall Study|Lack of Efficacy|1
829274|NCT01023581|2635751|P4|Overall Study|Lack of Efficacy|2
829275|NCT01023581|2635752|P3|Overall Study|Lack of Efficacy|6
829276|NCT01023581|2635753|P2|Overall Study|Lack of Efficacy|3
829277|NCT01023581|2635754|P1|Overall Study|Lack of Efficacy|9
829278|NCT01023581|2635748|P7|Overall Study|Pregnancy|0
829279|NCT01023581|2635749|P6|Overall Study|Pregnancy|1
829280|NCT01023581|2635750|P5|Overall Study|Pregnancy|0
829281|NCT01023581|2635751|P4|Overall Study|Pregnancy|2
829282|NCT01023581|2635752|P3|Overall Study|Pregnancy|0
829283|NCT01023581|2635753|P2|Overall Study|Pregnancy|0
829284|NCT01023581|2635754|P1|Overall Study|Pregnancy|0
829285|NCT01023581|2635748|P7|Overall Study|Withdrawal by Subject|5
829286|NCT01023581|2635749|P6|Overall Study|Withdrawal by Subject|8
829287|NCT01023581|2635750|P5|Overall Study|Withdrawal by Subject|6
829288|NCT01023581|2635751|P4|Overall Study|Withdrawal by Subject|10
829289|NCT01023581|2635752|P3|Overall Study|Withdrawal by Subject|16
829290|NCT01023581|2635753|P2|Overall Study|Withdrawal by Subject|8
829291|NCT01023581|2635754|P1|Overall Study|Withdrawal by Subject|13
829292|NCT01023581|2635748|P7|Overall Study|Lost to Follow-up|2
829293|NCT01023581|2635749|P6|Overall Study|Lost to Follow-up|2
829294|NCT01023581|2635750|P5|Overall Study|Lost to Follow-up|5
829295|NCT01023581|2635751|P4|Overall Study|Lost to Follow-up|2
829296|NCT01023581|2635752|P3|Overall Study|Lost to Follow-up|7
829297|NCT01023581|2635753|P2|Overall Study|Lost to Follow-up|8
829298|NCT01023581|2635754|P1|Overall Study|Lost to Follow-up|4
829299|NCT01023581|2635748|P7|Overall Study|Major protocol deviation|0
829300|NCT01023581|2635749|P6|Overall Study|Major protocol deviation|0
829301|NCT01023581|2635750|P5|Overall Study|Major protocol deviation|0
829302|NCT01023581|2635751|P4|Overall Study|Major protocol deviation|0
829303|NCT01023581|2635752|P3|Overall Study|Major protocol deviation|3
829304|NCT01023581|2635753|P2|Overall Study|Major protocol deviation|0
829305|NCT01023581|2635754|P1|Overall Study|Major protocol deviation|2
829306|NCT01023581|2635748|P7|Overall Study|Adverse Event|11
829307|NCT01023581|2635749|P6|Overall Study|Adverse Event|5
829308|NCT01023581|2635750|P5|Overall Study|Adverse Event|2
829309|NCT01023581|2635751|P4|Overall Study|Adverse Event|3
829310|NCT01023581|2635752|P3|Overall Study|Adverse Event|7
829311|NCT01023581|2635753|P2|Overall Study|Adverse Event|4
829312|NCT01023581|2635754|P1|Overall Study|Adverse Event|4
829313|NCT01023659|2635787|P3|Overall Study|Lost to Follow-up|99
829314|NCT01023659|2635788|P2|Overall Study|Lost to Follow-up|228
829315|NCT01023659|2635789|P1|Overall Study|Lost to Follow-up|73
829316|NCT01023672|2635798|P1|Overall Study|Death|1
829317|NCT01023672|2635798|P1|Overall Study|Worsening disease|2
829318|NCT01023815|2635825|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
829319|NCT01023815|2635826|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
829320|NCT01023815|2635827|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
829321|NCT01023815|2635828|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
829322|NCT01023815|2635825|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
829323|NCT01023815|2635826|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
829324|NCT01023815|2635827|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
829325|NCT01023815|2635828|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
829326|NCT01023815|2635825|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
829327|NCT01023815|2635826|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
829328|NCT01023815|2635827|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
829329|NCT01023815|2635828|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
829330|NCT01023815|2635825|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
829331|NCT01023815|2635826|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
829332|NCT01023815|2635827|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
829333|NCT01023815|2635828|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
829334|NCT01023815|2635825|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
829335|NCT01023815|2635826|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
829336|NCT01023815|2635827|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
829337|NCT01023815|2635828|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
829338|NCT01024036|2635866|P2|Unblinded Treatment|Lack of Efficacy|0
829339|NCT01024036|2635867|P1|Unblinded Treatment|Lack of Efficacy|2
829340|NCT01024036|2635866|P2|Unblinded Treatment|Adverse Event|0
829341|NCT01024036|2635867|P1|Unblinded Treatment|Adverse Event|1
829342|NCT01024036|2635866|P2|Blinded Treatment|Withdrawal by Subject|3
829343|NCT01024036|2635867|P1|Blinded Treatment|Withdrawal by Subject|4
829344|NCT01024036|2635866|P2|Blinded Treatment|Death|2
829345|NCT01024036|2635867|P1|Blinded Treatment|Death|0
829346|NCT01024036|2635866|P2|Blinded Treatment|Physician Decision|0
829347|NCT01024036|2635867|P1|Blinded Treatment|Physician Decision|1
829348|NCT01024036|2635866|P2|Blinded Treatment|Lack of Efficacy|14
829349|NCT01024036|2635867|P1|Blinded Treatment|Lack of Efficacy|16
829350|NCT01024036|2635866|P2|Blinded Treatment|Adverse Event|1
829351|NCT01024036|2635867|P1|Blinded Treatment|Adverse Event|1
829352|NCT01024244|2635900|P5|Overall Study|Withdrawal by Subject|0
829353|NCT01024244|2635901|P4|Overall Study|Withdrawal by Subject|0
829354|NCT01024244|2635902|P3|Overall Study|Withdrawal by Subject|0
829355|NCT01024244|2635903|P2|Overall Study|Withdrawal by Subject|1
829356|NCT01024244|2635904|P1|Overall Study|Withdrawal by Subject|0
829357|NCT01024244|2635900|P5|Overall Study|Sponsor Decision|10
829358|NCT01024244|2635901|P4|Overall Study|Sponsor Decision|12
829359|NCT01024244|2635902|P3|Overall Study|Sponsor Decision|14
829360|NCT01024244|2635903|P2|Overall Study|Sponsor Decision|7
829361|NCT01024244|2635904|P1|Overall Study|Sponsor Decision|14
829362|NCT01024244|2635900|P5|Overall Study|Protocol Violation|2
829363|NCT01024244|2635901|P4|Overall Study|Protocol Violation|0
829364|NCT01024244|2635902|P3|Overall Study|Protocol Violation|0
829365|NCT01024244|2635903|P2|Overall Study|Protocol Violation|0
829366|NCT01024244|2635904|P1|Overall Study|Protocol Violation|1
829367|NCT01024244|2635900|P5|Overall Study|Lack of Efficacy|0
829368|NCT01024244|2635901|P4|Overall Study|Lack of Efficacy|0
829369|NCT01024244|2635902|P3|Overall Study|Lack of Efficacy|0
829370|NCT01024244|2635903|P2|Overall Study|Lack of Efficacy|0
829371|NCT01024244|2635904|P1|Overall Study|Lack of Efficacy|1
829372|NCT01024244|2635900|P5|Overall Study|Entry Criteria Not Met|0
829373|NCT01024244|2635901|P4|Overall Study|Entry Criteria Not Met|0
829374|NCT01024244|2635902|P3|Overall Study|Entry Criteria Not Met|0
829375|NCT01024244|2635903|P2|Overall Study|Entry Criteria Not Met|1
829376|NCT01024244|2635904|P1|Overall Study|Entry Criteria Not Met|0
829377|NCT01024244|2635900|P5|Overall Study|Adverse Event|2
829378|NCT01024244|2635901|P4|Overall Study|Adverse Event|1
829379|NCT01024244|2635902|P3|Overall Study|Adverse Event|0
829380|NCT01024244|2635903|P2|Overall Study|Adverse Event|2
829381|NCT01024244|2635904|P1|Overall Study|Adverse Event|1
829382|NCT01024309|2636018|P2|Overall Study|Withdrawal by Subject|4
829383|NCT01024309|2636019|P1|Overall Study|Withdrawal by Subject|4
829384|NCT01024309|2636018|P2|Overall Study|Physician Decision|0
829385|NCT01024309|2636019|P1|Overall Study|Physician Decision|4
829386|NCT01024465|2636052|P1|Overall Study|Physician Decision|1
829387|NCT01024465|2636052|P1|Overall Study|Adverse Event|2
829388|NCT01024608|2636058|P2|Overall Study|Never received study treatment|0
829389|NCT01024608|2636059|P1|Overall Study|Never received study treatment|2
829390|NCT01024608|2636058|P2|Overall Study|Protocol Violation|3
829391|NCT01024608|2636059|P1|Overall Study|Protocol Violation|0
829392|NCT01024608|2636058|P2|Overall Study|Lost to Follow-up|1
829393|NCT01024608|2636059|P1|Overall Study|Lost to Follow-up|0
829394|NCT01024608|2636058|P2|Overall Study|Withdrawal by Subject|0
829395|NCT01024608|2636059|P1|Overall Study|Withdrawal by Subject|1
829396|NCT01024608|2636058|P2|Overall Study|Adverse Event|0
829397|NCT01024608|2636059|P1|Overall Study|Adverse Event|1
829398|NCT01024751|2636086|P2|Eligible Participants|Ineligible|1
829399|NCT01024751|2636087|P1|Eligible Participants|Ineligible|0
829400|NCT01024751|2636086|P2|Eligible Participants|Lost to Follow-up|1
829401|NCT01024751|2636087|P1|Eligible Participants|Lost to Follow-up|0
829402|NCT01024751|2636086|P2|Eligible Participants|Withdrawal by Subject|1
829403|NCT01024751|2636087|P1|Eligible Participants|Withdrawal by Subject|0
829404|NCT01024751|2636086|P2|Enrolled Participants|Ineligible at baseline|4
829405|NCT01024751|2636087|P1|Enrolled Participants|Ineligible at baseline|3
829406|NCT01024855|2636095|P1|Overall Study|Inclusion/exclusion criteria|1
829407|NCT01024946|2636100|P1|Overall Study|Adverse Event|1
829408|NCT01024946|2636100|P1|Overall Study|Withdrawal by Subject|1
829409|NCT01024946|2636100|P1|Overall Study|Screen Failure|3
829410|NCT01024959|2636104|P1|Overall Study|missing results required for analysis|17
829411|NCT01024959|2636104|P1|Overall Study|results not evaluable|12
829412|NCT01024959|2636104|P1|Overall Study|ineligible|12
829413|NCT01009645|2636151|P4|Overall Study|Lost to Follow-up|5
829414|NCT01009645|2636152|P3|Overall Study|Lost to Follow-up|4
829415|NCT01009645|2636153|P2|Overall Study|Lost to Follow-up|8
829416|NCT01009645|2636154|P1|Overall Study|Lost to Follow-up|2
829417|NCT01014975|2636168|P3|Overall Study|Lost to Follow-up|1
829418|NCT01014975|2636169|P2|Overall Study|Lost to Follow-up|0
829419|NCT01014975|2636170|P1|Overall Study|Lost to Follow-up|0
829420|NCT01014975|2636168|P3|Overall Study|Death|4
829421|NCT01014975|2636169|P2|Overall Study|Death|3
829422|NCT01014975|2636170|P1|Overall Study|Death|3
829423|NCT01014975|2636168|P3|Overall Study|Withdrawal by Subject|1
829424|NCT01014975|2636169|P2|Overall Study|Withdrawal by Subject|0
829425|NCT01014975|2636170|P1|Overall Study|Withdrawal by Subject|1
829426|NCT01014988|2636184|P6|Overall Study|Withdrawal by Subject|0
829427|NCT01014988|2636185|P5|Overall Study|Withdrawal by Subject|0
829428|NCT01014988|2636186|P4|Overall Study|Withdrawal by Subject|0
829429|NCT01014988|2636187|P3|Overall Study|Withdrawal by Subject|0
829430|NCT01014988|2636188|P2|Overall Study|Withdrawal by Subject|0
829431|NCT01014988|2636189|P1|Overall Study|Withdrawal by Subject|1
829432|NCT01014988|2636184|P6|Overall Study|Physician Decision|0
829433|NCT01014988|2636185|P5|Overall Study|Physician Decision|0
829434|NCT01014988|2636186|P4|Overall Study|Physician Decision|0
829435|NCT01014988|2636187|P3|Overall Study|Physician Decision|0
829436|NCT01014988|2636188|P2|Overall Study|Physician Decision|0
829437|NCT01014988|2636189|P1|Overall Study|Physician Decision|1
829438|NCT01014988|2636184|P6|Overall Study|Lost to Follow-up|0
829439|NCT01014988|2636185|P5|Overall Study|Lost to Follow-up|0
829440|NCT01014988|2636186|P4|Overall Study|Lost to Follow-up|0
829441|NCT01014988|2636187|P3|Overall Study|Lost to Follow-up|1
829442|NCT01014988|2636188|P2|Overall Study|Lost to Follow-up|0
829443|NCT01014988|2636189|P1|Overall Study|Lost to Follow-up|1
829444|NCT01014988|2636184|P6|Overall Study|Adverse Event|3
829445|NCT01014988|2636185|P5|Overall Study|Adverse Event|1
829446|NCT01014988|2636186|P4|Overall Study|Adverse Event|0
829447|NCT01014988|2636187|P3|Overall Study|Adverse Event|1
829448|NCT01014988|2636188|P2|Overall Study|Adverse Event|0
829449|NCT01014988|2636189|P1|Overall Study|Adverse Event|20
829466|NCT01015131|2636382|P1|Overall Study|Other Protocol Specified Criteria|4
829467|NCT01015131|2636382|P1|Overall Study|Withdrawal by Subject|2
829468|NCT01015131|2636382|P1|Overall Study|Protocol Violation|1
829469|NCT01015131|2636382|P1|Overall Study|Physician Decision|1
829470|NCT01015287|2636404|P2|Overall Study|Protocol Violation|1
829471|NCT01015287|2636405|P1|Overall Study|Protocol Violation|1
829472|NCT01015287|2636404|P2|Overall Study|Lost to Follow-up|1
829473|NCT01015287|2636405|P1|Overall Study|Lost to Follow-up|2
829474|NCT01015287|2636404|P2|Overall Study|Entry Criteria not Met|14
829475|NCT01015287|2636405|P1|Overall Study|Entry Criteria not Met|11
829476|NCT01015287|2636404|P2|Overall Study|Withdrawal by Subject|19
829477|NCT01015287|2636405|P1|Overall Study|Withdrawal by Subject|14
829478|NCT01015287|2636404|P2|Overall Study|Physician Decision|21
829479|NCT01015287|2636405|P1|Overall Study|Physician Decision|19
829480|NCT01015287|2636404|P2|Overall Study|Sponsor Decision|7
829481|NCT01015287|2636405|P1|Overall Study|Sponsor Decision|3
829482|NCT01015287|2636404|P2|Overall Study|Adverse Event|0
829483|NCT01015287|2636405|P1|Overall Study|Adverse Event|1
829484|NCT01015287|2636404|P2|Overall Study|Death|16
829485|NCT01015287|2636405|P1|Overall Study|Death|21
829486|NCT01015560|2636474|P1|Overall Study|Withdrawal by Subject|1
829487|NCT01015560|2636474|P1|Overall Study|Not protocol specified|1
829488|NCT01015560|2636474|P1|Overall Study|Adverse Event|1
829489|NCT01015638|2636480|P2|Overall Study|Withdrawal by Subject|0
829490|NCT01015638|2636481|P1|Overall Study|Withdrawal by Subject|1
829491|NCT01015677|2636512|P3|Overall Study|Withdrawal by Subject|0
829492|NCT01015677|2636513|P2|Overall Study|Withdrawal by Subject|1
829493|NCT01015677|2636514|P1|Overall Study|Withdrawal by Subject|1
829494|NCT01015677|2636512|P3|Overall Study|Protocol Violation|0
829495|NCT01015677|2636513|P2|Overall Study|Protocol Violation|1
829496|NCT01015677|2636514|P1|Overall Study|Protocol Violation|0
829497|NCT01015677|2636512|P3|Overall Study|Lack of Efficacy|0
829498|NCT01015677|2636513|P2|Overall Study|Lack of Efficacy|1
829499|NCT01015677|2636514|P1|Overall Study|Lack of Efficacy|0
829500|NCT01015677|2636512|P3|Overall Study|Adverse Event|0
829501|NCT01015677|2636513|P2|Overall Study|Adverse Event|1
829502|NCT01015677|2636514|P1|Overall Study|Adverse Event|0
829503|NCT01015703|2636539|P5|Overall Study|Protocol Violation|0
829504|NCT01015703|2636540|P4|Overall Study|Protocol Violation|0
829505|NCT01015703|2636541|P3|Overall Study|Protocol Violation|0
829506|NCT01015703|2636542|P2|Overall Study|Protocol Violation|0
829507|NCT01015703|2636543|P1|Overall Study|Protocol Violation|1
829508|NCT01015703|2636539|P5|Overall Study|Adverse Event|0
829509|NCT01015703|2636540|P4|Overall Study|Adverse Event|0
829510|NCT01015703|2636541|P3|Overall Study|Adverse Event|0
829511|NCT01015703|2636542|P2|Overall Study|Adverse Event|0
829512|NCT01015703|2636543|P1|Overall Study|Adverse Event|1
829513|NCT01015703|2636539|P5|Overall Study|Withdrawal by Subject|0
829514|NCT01015703|2636540|P4|Overall Study|Withdrawal by Subject|0
829515|NCT01015703|2636541|P3|Overall Study|Withdrawal by Subject|0
829516|NCT01015703|2636542|P2|Overall Study|Withdrawal by Subject|1
829517|NCT01015703|2636543|P1|Overall Study|Withdrawal by Subject|0
829518|NCT01015820|2636579|P2|Overall Study|Suboptimal measurements|0
829519|NCT01015820|2636580|P1|Overall Study|Suboptimal measurements|1
829520|NCT01016015|2636593|P1|Overall Study|Adverse Event|15
829521|NCT01016015|2636593|P1|Overall Study|Withdrawal by Subject|1
829522|NCT01016015|2636593|P1|Overall Study|Not Treated|3
829523|NCT01016067|2636599|P2|Overall Study|Withdrew due to Relocation|1
829524|NCT01016067|2636600|P1|Overall Study|Withdrew due to Relocation|0
829525|NCT01016067|2636599|P2|Overall Study|Physician Decision|1
829526|NCT01016067|2636600|P1|Overall Study|Physician Decision|1
829527|NCT01016067|2636599|P2|Overall Study|Lost to Follow-up|2
829528|NCT01016067|2636600|P1|Overall Study|Lost to Follow-up|1
829529|NCT01016132|2636627|P1|Overall Study|Discomfort|1
829530|NCT01025037|2636631|P1|Overall Study|Withdrawal by Subject|1
829531|NCT01025037|2636631|P1|Overall Study|Lost to Follow-up|7
829532|NCT01025037|2636631|P1|Overall Study|Adverse Event|3
829533|NCT01025154|2636644|P1|Overall Study|Withdrawal by Subject|1
829534|NCT01025154|2636644|P1|Overall Study|Lost to Follow-up|1
829535|NCT01025193|2636649|P1|Overall Study|Adverse Event|3
829536|NCT01025193|2636649|P1|Overall Study|Protocol Violation|1
829537|NCT01025232|2636661|P2|Overall Study|Study drug no longer available|6
829538|NCT01025232|2636662|P1|Overall Study|Study drug no longer available|3
829544|NCT01026038|2636753|P3|Overall Study|Lost to Follow-up|0
829545|NCT01026038|2636754|P2|Overall Study|Lost to Follow-up|1
829546|NCT01026038|2636755|P1|Overall Study|Lost to Follow-up|1
829547|NCT01026103|2636790|P1|Overall Study|did not receive study device bc of error|1
829548|NCT01026103|2636790|P1|Overall Study|Physician Decision|1
829549|NCT01026142|2636799|P2|Overall Study|Reasons not specified|23
829550|NCT01026142|2636800|P1|Overall Study|Reasons not specified|25
829551|NCT01026142|2636799|P2|Overall Study|Death|98
829552|NCT01026142|2636800|P1|Overall Study|Death|114
829553|NCT01026194|2636840|P2|Period 2：Open-label Period|Withdrawal by Subject|4
829554|NCT01026194|2636841|P1|Period 2：Open-label Period|Withdrawal by Subject|0
829555|NCT01026194|2636840|P2|Period 2：Open-label Period|Physician Decision|1
829556|NCT01026194|2636841|P1|Period 2：Open-label Period|Physician Decision|3
829557|NCT01026194|2636840|P2|Period 2：Open-label Period|Adverse Event|5
829558|NCT01026194|2636841|P1|Period 2：Open-label Period|Adverse Event|4
829559|NCT01026194|2636840|P2|Period 1：Double Blind Period|Physician Decision|4
829560|NCT01026194|2636841|P1|Period 1：Double Blind Period|Physician Decision|0
829561|NCT01026194|2636840|P2|Period 1：Double Blind Period|Lack of Efficacy|0
829562|NCT01026194|2636841|P1|Period 1：Double Blind Period|Lack of Efficacy|1
829563|NCT01026194|2636840|P2|Period 1：Double Blind Period|Adverse Event|1
829564|NCT01026194|2636841|P1|Period 1：Double Blind Period|Adverse Event|2
829565|NCT01026220|2636855|P3|Consolidation Maintenance|Withdrawal by Subject|6
829566|NCT01026220|2636856|P2|Consolidation Maintenance|Withdrawal by Subject|2
829567|NCT01026220|2636857|P1|Consolidation Maintenance|Withdrawal by Subject|0
829568|NCT01026220|2636855|P3|Consolidation Maintenance|Physician Decision|7
829569|NCT01026220|2636856|P2|Consolidation Maintenance|Physician Decision|2
829570|NCT01026220|2636857|P1|Consolidation Maintenance|Physician Decision|0
829571|NCT01026220|2636855|P3|Consolidation Maintenance|Lack of Efficacy|1
829572|NCT01026220|2636856|P2|Consolidation Maintenance|Lack of Efficacy|1
829573|NCT01026220|2636857|P1|Consolidation Maintenance|Lack of Efficacy|0
829574|NCT01026220|2636855|P3|Consolidation Maintenance|Death|0
829575|NCT01026220|2636856|P2|Consolidation Maintenance|Death|1
829576|NCT01026220|2636857|P1|Consolidation Maintenance|Death|0
829577|NCT01026220|2636855|P3|Induction|Ineligible|0
829578|NCT01026220|2636856|P2|Induction|Ineligible|0
829579|NCT01026220|2636857|P1|Induction|Ineligible|1
829580|NCT01026220|2636855|P3|Induction|Withdrawal by Subject|0
829581|NCT01026220|2636856|P2|Induction|Withdrawal by Subject|0
829582|NCT01026220|2636857|P1|Induction|Withdrawal by Subject|9
829583|NCT01026220|2636855|P3|Induction|Physician Decision|0
829584|NCT01026220|2636856|P2|Induction|Physician Decision|0
829585|NCT01026220|2636857|P1|Induction|Physician Decision|12
829586|NCT01026220|2636855|P3|Induction|Lack of Efficacy|0
829587|NCT01026220|2636856|P2|Induction|Lack of Efficacy|0
829588|NCT01026220|2636857|P1|Induction|Lack of Efficacy|2
829589|NCT01026220|2636855|P3|Induction|Death|0
829590|NCT01026220|2636856|P2|Induction|Death|0
829591|NCT01026220|2636857|P1|Induction|Death|1
829592|NCT01026324|2636882|P3|Follow up/Survival|Withdrawal by Subject|0
829593|NCT01026324|2636883|P2|Follow up/Survival|Withdrawal by Subject|0
829594|NCT01026324|2636884|P1|Follow up/Survival|Withdrawal by Subject|1
829595|NCT01026389|2636896|P2|Overall Study|change of treatment, patient moved|2
829596|NCT01026389|2636897|P1|Overall Study|change of treatment, patient moved|4
829597|NCT01026389|2636896|P2|Overall Study|Withdrawal by Subject|3
829598|NCT01026389|2636897|P1|Overall Study|Withdrawal by Subject|1
829599|NCT01026454|2637252|P2|Second Intervention|Pregnancy|1
829600|NCT01026454|2637253|P1|Second Intervention|Pregnancy|1
829601|NCT01026493|2637267|P8|Overall Study|Protocol Violation|1
829602|NCT01026493|2637268|P7|Overall Study|Protocol Violation|4
829603|NCT01026493|2637269|P6|Overall Study|Protocol Violation|3
829604|NCT01026493|2637270|P5|Overall Study|Protocol Violation|2
829605|NCT01026493|2637271|P4|Overall Study|Protocol Violation|0
829606|NCT01026493|2637272|P3|Overall Study|Protocol Violation|0
829607|NCT01026493|2637273|P2|Overall Study|Protocol Violation|1
829608|NCT01026493|2637274|P1|Overall Study|Protocol Violation|0
829609|NCT01026792|2637300|P1|Overall Study|Protocol Violation|1
829610|NCT01026818|2637317|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
829611|NCT01026818|2637318|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
829612|NCT01026818|2637319|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
829613|NCT01026818|2637320|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
829614|NCT01026818|2637317|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
829615|NCT01026818|2637318|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
829616|NCT01026818|2637319|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
829617|NCT01026818|2637320|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
829618|NCT01026818|2637317|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
829619|NCT01026818|2637318|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
829620|NCT01026818|2637319|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
829621|NCT01026818|2637320|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
829622|NCT01026818|2637317|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
829623|NCT01026818|2637318|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
829624|NCT01026818|2637319|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
829625|NCT01026818|2637320|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
829626|NCT01026818|2637317|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
829627|NCT01026818|2637318|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
829628|NCT01026818|2637319|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
829629|NCT01026818|2637320|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
829630|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
829631|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
829632|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
829633|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
829634|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
829635|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
829636|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
829637|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
829638|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
829639|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
829640|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
829641|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
829642|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
829643|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
829644|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
829645|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
829646|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
829647|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
829648|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
829649|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
829650|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
829651|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
829652|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
829653|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
829654|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
829655|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
829656|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
829657|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
829658|NCT01026818|2637317|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
829659|NCT01026818|2637318|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
829660|NCT01026818|2637319|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
829661|NCT01026818|2637320|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
829662|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
829663|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
829664|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
829665|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
829666|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
829667|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
829668|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
829669|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
829670|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
829671|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
829672|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
829673|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
829674|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
829675|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
829676|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
829677|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
829678|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
829679|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
829680|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
829681|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
829682|NCT01026818|2637317|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
829683|NCT01026818|2637318|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
829684|NCT01026818|2637319|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
829685|NCT01026818|2637320|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
829686|NCT01026818|2637317|P4|Screening Period|Physician Decision|0
829687|NCT01026818|2637318|P3|Screening Period|Physician Decision|0
829688|NCT01026818|2637319|P2|Screening Period|Physician Decision|0
829689|NCT01026818|2637320|P1|Screening Period|Physician Decision|1
829690|NCT01026818|2637317|P4|Screening Period|Adverse Event|0
829691|NCT01026818|2637318|P3|Screening Period|Adverse Event|0
829692|NCT01026818|2637319|P2|Screening Period|Adverse Event|0
829693|NCT01026818|2637320|P1|Screening Period|Adverse Event|2
829694|NCT01026818|2637317|P4|Screening Period|Protocol Deviation|0
829695|NCT01026818|2637318|P3|Screening Period|Protocol Deviation|0
829696|NCT01026818|2637319|P2|Screening Period|Protocol Deviation|0
829697|NCT01026818|2637320|P1|Screening Period|Protocol Deviation|3
829698|NCT01026818|2637317|P4|Screening Period|Withdrawal by Subject|0
829699|NCT01026818|2637318|P3|Screening Period|Withdrawal by Subject|0
829700|NCT01026818|2637319|P2|Screening Period|Withdrawal by Subject|0
829701|NCT01026818|2637320|P1|Screening Period|Withdrawal by Subject|49
829702|NCT01026818|2637317|P4|Screening Period|Entry Criteria Not Met|0
829703|NCT01026818|2637318|P3|Screening Period|Entry Criteria Not Met|0
829704|NCT01026818|2637319|P2|Screening Period|Entry Criteria Not Met|0
829705|NCT01026818|2637320|P1|Screening Period|Entry Criteria Not Met|105
829706|NCT01026831|2637400|P2|Overall Study|Withdrawal by Subject|5
829707|NCT01026831|2637401|P1|Overall Study|Withdrawal by Subject|7
829708|NCT01026831|2637400|P2|Overall Study|Protocol Violation|2
829709|NCT01026831|2637401|P1|Overall Study|Protocol Violation|0
829710|NCT01026831|2637400|P2|Overall Study|Physician Decision|1
829711|NCT01026831|2637401|P1|Overall Study|Physician Decision|1
829712|NCT01026831|2637400|P2|Overall Study|Lost to Follow-up|0
829713|NCT01026831|2637401|P1|Overall Study|Lost to Follow-up|2
829714|NCT01026831|2637400|P2|Overall Study|Adverse Event|3
829715|NCT01026831|2637401|P1|Overall Study|Adverse Event|4
829716|NCT01026948|2637435|P1|Overall Study|Physician Decision|8
829717|NCT01026974|2637444|P4|Overall Study|Inappropriate enrollment|0
829718|NCT01026974|2637445|P3|Overall Study|Inappropriate enrollment|1
829719|NCT01026974|2637446|P2|Overall Study|Inappropriate enrollment|0
829720|NCT01026974|2637447|P1|Overall Study|Inappropriate enrollment|0
829721|NCT01026974|2637444|P4|Overall Study|Adverse Event|1
829722|NCT01026974|2637445|P3|Overall Study|Adverse Event|0
829723|NCT01026974|2637446|P2|Overall Study|Adverse Event|0
829724|NCT01026974|2637447|P1|Overall Study|Adverse Event|0
829725|NCT01026974|2637444|P4|Overall Study|Lost to Follow-up|0
829726|NCT01026974|2637445|P3|Overall Study|Lost to Follow-up|4
829727|NCT01026974|2637446|P2|Overall Study|Lost to Follow-up|1
829728|NCT01026974|2637447|P1|Overall Study|Lost to Follow-up|1
829729|NCT01026974|2637444|P4|Overall Study|Withdrawal by Subject|2
829730|NCT01026974|2637445|P3|Overall Study|Withdrawal by Subject|7
829731|NCT01026974|2637446|P2|Overall Study|Withdrawal by Subject|1
829732|NCT01026974|2637447|P1|Overall Study|Withdrawal by Subject|0
829733|NCT01027273|2637533|P2|Overall Study|Death|2
829734|NCT01027273|2637534|P1|Overall Study|Death|2
829735|NCT01027273|2637533|P2|Overall Study|Lost to Follow-up|31
829736|NCT01027273|2637534|P1|Overall Study|Lost to Follow-up|57
829737|NCT01027286|2637552|P2|Overall Study|Lost to Follow-up|1
829738|NCT01027286|2637553|P1|Overall Study|Lost to Follow-up|0
829739|NCT01027286|2637552|P2|Overall Study|Unable to Obtain Required Blood Volume|0
829740|NCT01027286|2637553|P1|Overall Study|Unable to Obtain Required Blood Volume|1
829741|NCT01027351|2637577|P6|Overall Study|Protocol Violation|0
829742|NCT01027351|2637578|P5|Overall Study|Protocol Violation|1
829743|NCT01027351|2637579|P4|Overall Study|Protocol Violation|1
829744|NCT01027351|2637580|P3|Overall Study|Protocol Violation|0
829745|NCT01027351|2637581|P2|Overall Study|Protocol Violation|0
829746|NCT01027351|2637582|P1|Overall Study|Protocol Violation|1
829747|NCT01027351|2637577|P6|Overall Study|Inappropriate enrollment|0
829748|NCT01027351|2637578|P5|Overall Study|Inappropriate enrollment|1
829749|NCT01027351|2637579|P4|Overall Study|Inappropriate enrollment|0
829750|NCT01027351|2637580|P3|Overall Study|Inappropriate enrollment|0
829751|NCT01027351|2637581|P2|Overall Study|Inappropriate enrollment|0
829752|NCT01027351|2637582|P1|Overall Study|Inappropriate enrollment|0
829753|NCT01027351|2637577|P6|Overall Study|Lost to Follow-up|0
829754|NCT01027351|2637578|P5|Overall Study|Lost to Follow-up|6
829755|NCT01027351|2637579|P4|Overall Study|Lost to Follow-up|1
829756|NCT01027351|2637580|P3|Overall Study|Lost to Follow-up|0
829757|NCT01027351|2637581|P2|Overall Study|Lost to Follow-up|1
829758|NCT01027351|2637582|P1|Overall Study|Lost to Follow-up|1
829759|NCT01027351|2637577|P6|Overall Study|Withdrawal by Subject|5
829760|NCT01027351|2637578|P5|Overall Study|Withdrawal by Subject|3
829761|NCT01027351|2637579|P4|Overall Study|Withdrawal by Subject|0
829762|NCT01027351|2637580|P3|Overall Study|Withdrawal by Subject|1
829763|NCT01027351|2637581|P2|Overall Study|Withdrawal by Subject|0
829764|NCT01027351|2637582|P1|Overall Study|Withdrawal by Subject|1
829765|NCT01027364|2637668|P4|Overall Study|Withdrawal by Subject|0
829766|NCT01027364|2637669|P3|Overall Study|Withdrawal by Subject|0
829767|NCT01027364|2637670|P2|Overall Study|Withdrawal by Subject|2
829768|NCT01027364|2637671|P1|Overall Study|Withdrawal by Subject|1
829769|NCT01027364|2637668|P4|Overall Study|Protocol Violation|1
829770|NCT01027364|2637669|P3|Overall Study|Protocol Violation|0
829771|NCT01027364|2637670|P2|Overall Study|Protocol Violation|0
829772|NCT01027364|2637671|P1|Overall Study|Protocol Violation|1
829773|NCT01027364|2637668|P4|Overall Study|Lost to Follow-up|0
829774|NCT01027364|2637669|P3|Overall Study|Lost to Follow-up|0
829775|NCT01027364|2637670|P2|Overall Study|Lost to Follow-up|0
829776|NCT01027364|2637671|P1|Overall Study|Lost to Follow-up|1
829777|NCT01027364|2637668|P4|Overall Study|Adverse Event|0
829778|NCT01027364|2637669|P3|Overall Study|Adverse Event|1
829779|NCT01027364|2637670|P2|Overall Study|Adverse Event|0
829780|NCT01027364|2637671|P1|Overall Study|Adverse Event|1
829781|NCT01027650|2637785|P8|Overall Study|Lack of Efficacy|0
829782|NCT01027650|2637786|P7|Overall Study|Lack of Efficacy|0
829783|NCT01027650|2637787|P6|Overall Study|Lack of Efficacy|1
829784|NCT01027650|2637788|P5|Overall Study|Lack of Efficacy|0
829785|NCT01027650|2637789|P4|Overall Study|Lack of Efficacy|0
829786|NCT01027650|2637790|P3|Overall Study|Lack of Efficacy|0
829787|NCT01027650|2637791|P2|Overall Study|Lack of Efficacy|0
829788|NCT01027650|2637792|P1|Overall Study|Lack of Efficacy|0
829789|NCT01027650|2637785|P8|Overall Study|Lost to Follow-up|0
829790|NCT01027650|2637786|P7|Overall Study|Lost to Follow-up|1
829791|NCT01027650|2637787|P6|Overall Study|Lost to Follow-up|0
829792|NCT01027650|2637788|P5|Overall Study|Lost to Follow-up|0
829793|NCT01027650|2637789|P4|Overall Study|Lost to Follow-up|0
829794|NCT01027650|2637790|P3|Overall Study|Lost to Follow-up|0
829795|NCT01027650|2637791|P2|Overall Study|Lost to Follow-up|0
829796|NCT01027650|2637792|P1|Overall Study|Lost to Follow-up|0
829797|NCT01027650|2637785|P8|Overall Study|Personal Reasons|0
829798|NCT01027650|2637786|P7|Overall Study|Personal Reasons|0
829799|NCT01027650|2637787|P6|Overall Study|Personal Reasons|1
829800|NCT01027650|2637788|P5|Overall Study|Personal Reasons|2
829801|NCT01027650|2637789|P4|Overall Study|Personal Reasons|0
829802|NCT01027650|2637790|P3|Overall Study|Personal Reasons|0
829803|NCT01027650|2637791|P2|Overall Study|Personal Reasons|0
829804|NCT01027650|2637792|P1|Overall Study|Personal Reasons|0
829805|NCT01027884|2637858|P2|Overall Study|Spinal fixation surgery|3
829806|NCT01027884|2637859|P1|Overall Study|Spinal fixation surgery|0
829807|NCT01027884|2637858|P2|Overall Study|Lost to Follow-up|1
829808|NCT01027884|2637859|P1|Overall Study|Lost to Follow-up|0
829809|NCT01027884|2637858|P2|Overall Study|Withdrawal by Subject|1
829810|NCT01027884|2637859|P1|Overall Study|Withdrawal by Subject|0
829811|NCT01027884|2637858|P2|Overall Study|Non-compliance|1
829812|NCT01027884|2637859|P1|Overall Study|Non-compliance|1
829813|NCT01027884|2637858|P2|Overall Study|Protocol Violation|0
829814|NCT01027884|2637859|P1|Overall Study|Protocol Violation|1
829815|NCT01027884|2637858|P2|Overall Study|Adverse Event|1
829816|NCT01027884|2637859|P1|Overall Study|Adverse Event|2
829817|NCT01027897|2637873|P1|Overall Study|Withdrawal by Subject|1
829818|NCT01027897|2637873|P1|Overall Study|Protocol Violation|1
829819|NCT01028014|2637900|P6|Overall Study|Lost to Follow-up|2
829820|NCT01028014|2637901|P5|Overall Study|Lost to Follow-up|1
829821|NCT01028014|2637902|P4|Overall Study|Lost to Follow-up|1
829822|NCT01028014|2637903|P3|Overall Study|Lost to Follow-up|0
829823|NCT01028014|2637904|P2|Overall Study|Lost to Follow-up|2
829824|NCT01028014|2637905|P1|Overall Study|Lost to Follow-up|1
829825|NCT01028027|2637933|P2|Overall Study|Lack of Efficacy|1
829826|NCT01028027|2637934|P1|Overall Study|Lack of Efficacy|0
829827|NCT01028027|2637933|P2|Overall Study|Protocol Violation|1
829828|NCT01028027|2637934|P1|Overall Study|Protocol Violation|3
829829|NCT01028027|2637933|P2|Overall Study|Adverse Event|7
829830|NCT01028027|2637934|P1|Overall Study|Adverse Event|4
829831|NCT01028027|2637933|P2|Overall Study|Withdrawal by Subject|3
829832|NCT01028027|2637934|P1|Overall Study|Withdrawal by Subject|5
829833|NCT01028027|2637933|P2|Overall Study|Lost to Follow-up|1
829834|NCT01028027|2637934|P1|Overall Study|Lost to Follow-up|4
829835|NCT01028053|2637950|P1|Overall Study|Various reasons|4
829836|NCT01028053|2637950|P1|Overall Study|Terminated by Sponsor|1
829837|NCT01028053|2637950|P1|Overall Study|Technical Problem|1
829838|NCT01028053|2637950|P1|Overall Study|Physician Decision|2
829839|NCT01028053|2637950|P1|Overall Study|Protocol Violation|1
829840|NCT01028053|2637950|P1|Overall Study|Patient Request|11
829841|NCT01028053|2637950|P1|Overall Study|Screen Failure|113
829842|NCT01028222|2637979|P2|Overall Study|Adverse Event|0
829843|NCT01028222|2637980|P1|Overall Study|Adverse Event|2
829844|NCT01028222|2637979|P2|Overall Study|Crossover to nilotinib w/out progression|2
829845|NCT01028222|2637980|P1|Overall Study|Crossover to nilotinib w/out progression|0
829846|NCT01028222|2637979|P2|Overall Study|Withdrawal by Subject|0
829847|NCT01028222|2637980|P1|Overall Study|Withdrawal by Subject|1
829848|NCT01028222|2637979|P2|Overall Study|Lost to Follow-up|1
829849|NCT01028222|2637980|P1|Overall Study|Lost to Follow-up|0
829850|NCT01028222|2637979|P2|Overall Study|Administrative problems|1
829851|NCT01028222|2637980|P1|Overall Study|Administrative problems|1
829852|NCT01028222|2637979|P2|Overall Study|Disease progression|9
829853|NCT01028222|2637980|P1|Overall Study|Disease progression|33
829854|NCT01028222|2637979|P2|Overall Study|Protocol deviation|0
829855|NCT01028222|2637980|P1|Overall Study|Protocol deviation|1
829856|NCT01028300|2638001|P1|Overall Study|Study Terminated|4
829857|NCT01028352|2638008|P1|Overall Study|Withdrawal by Subject|1
829858|NCT01028352|2638008|P1|Overall Study|Ineligible due to baseline average pain|5
829859|NCT01028378|2638013|P1|Overall Study|Adminstrative Reasons|4
829860|NCT01028378|2638013|P1|Overall Study|Withdrawal by Subject|1
829861|NCT01028378|2638013|P1|Overall Study|Lost to Follow-up|12
829862|NCT01028391|2638027|P2|Overall Study|Needed excluded medication|1
829863|NCT01028391|2638028|P1|Overall Study|Needed excluded medication|1
829864|NCT01028391|2638027|P2|Overall Study|Withdrawal by Subject|3
829865|NCT01028391|2638028|P1|Overall Study|Withdrawal by Subject|6
829866|NCT01028391|2638027|P2|Overall Study|Physician Decision|1
829867|NCT01028391|2638028|P1|Overall Study|Physician Decision|0
829868|NCT01028391|2638027|P2|Overall Study|Lost to Follow-up|4
829869|NCT01028391|2638028|P1|Overall Study|Lost to Follow-up|3
829870|NCT01028391|2638027|P2|Overall Study|Lack of Efficacy|2
829871|NCT01028391|2638028|P1|Overall Study|Lack of Efficacy|0
829872|NCT01028391|2638027|P2|Overall Study|Adverse Event|0
829873|NCT01028391|2638028|P1|Overall Study|Adverse Event|4
829874|NCT01019135|2638039|P3|Overall Study|Did not attend CR|6
829875|NCT01019135|2638040|P2|Overall Study|Did not attend CR|13
829876|NCT01019135|2638041|P1|Overall Study|Did not attend CR|8
829877|NCT01019135|2638039|P3|Overall Study|Did not receive allocated intervention|25
829878|NCT01019135|2638040|P2|Overall Study|Did not receive allocated intervention|6
829879|NCT01019135|2638041|P1|Overall Study|Did not receive allocated intervention|12
829880|NCT01019317|2638067|P1|Overall Study|Not Eligible|4
829881|NCT01019369|2638073|P2|Overall Study|Withdrawal by Subject|1
829882|NCT01019369|2638074|P1|Overall Study|Withdrawal by Subject|0
829883|NCT01019369|2638073|P2|Overall Study|Lost to Follow-up|6
829884|NCT01019369|2638074|P1|Overall Study|Lost to Follow-up|10
829885|NCT01019486|2638083|P3|Overall Study|Withdrawal by Subject|1
829886|NCT01019486|2638084|P2|Overall Study|Withdrawal by Subject|1
829887|NCT01019486|2638085|P1|Overall Study|Withdrawal by Subject|1
829888|NCT01019694|2638100|P3|Overall Study|Other reason (not specified)|6
829889|NCT01019694|2638101|P2|Overall Study|Other reason (not specified)|5
829890|NCT01019694|2638102|P1|Overall Study|Other reason (not specified)|1
829891|NCT01019694|2638100|P3|Overall Study|Not treated|3
829892|NCT01019694|2638101|P2|Overall Study|Not treated|2
829893|NCT01019694|2638102|P1|Overall Study|Not treated|0
829894|NCT01019694|2638100|P3|Overall Study|Withdrawal by Subject|12
829895|NCT01019694|2638101|P2|Overall Study|Withdrawal by Subject|6
829896|NCT01019694|2638102|P1|Overall Study|Withdrawal by Subject|4
829897|NCT01019694|2638100|P3|Overall Study|Lost to Follow-up|3
829898|NCT01019694|2638101|P2|Overall Study|Lost to Follow-up|3
829899|NCT01019694|2638102|P1|Overall Study|Lost to Follow-up|5
829900|NCT01019694|2638100|P3|Overall Study|Protocol Violation|4
829901|NCT01019694|2638101|P2|Overall Study|Protocol Violation|6
829902|NCT01019694|2638102|P1|Overall Study|Protocol Violation|2
829903|NCT01019694|2638100|P3|Overall Study|Adverse Event|19
829904|NCT01019694|2638101|P2|Overall Study|Adverse Event|16
829905|NCT01019694|2638102|P1|Overall Study|Adverse Event|12
829906|NCT01019980|2638280|P2|Overall Study|Drug not available.|0
829907|NCT01019980|2638281|P1|Overall Study|Drug not available.|2
829908|NCT01020123|2638307|P7|Extention Period|Lost to Follow-up|0
829909|NCT01020123|2638308|P6|Extention Period|Lost to Follow-up|2
829910|NCT01020123|2638309|P5|Extention Period|Lost to Follow-up|0
829911|NCT01020123|2638310|P4|Extention Period|Lost to Follow-up|0
829912|NCT01020123|2638311|P3|Extention Period|Lost to Follow-up|0
829913|NCT01020123|2638312|P2|Extention Period|Lost to Follow-up|0
829914|NCT01020123|2638313|P1|Extention Period|Lost to Follow-up|0
829915|NCT01020123|2638307|P7|Extention Period|Protocol Violation|1
829916|NCT01020123|2638308|P6|Extention Period|Protocol Violation|0
829917|NCT01020123|2638309|P5|Extention Period|Protocol Violation|0
829918|NCT01020123|2638310|P4|Extention Period|Protocol Violation|0
829919|NCT01020123|2638311|P3|Extention Period|Protocol Violation|1
829920|NCT01020123|2638312|P2|Extention Period|Protocol Violation|1
829921|NCT01020123|2638313|P1|Extention Period|Protocol Violation|1
829922|NCT01020123|2638307|P7|Extention Period|Adverse Event|0
829923|NCT01020123|2638308|P6|Extention Period|Adverse Event|0
829924|NCT01020123|2638309|P5|Extention Period|Adverse Event|0
829925|NCT01020123|2638310|P4|Extention Period|Adverse Event|1
829926|NCT01020123|2638311|P3|Extention Period|Adverse Event|0
829927|NCT01020123|2638312|P2|Extention Period|Adverse Event|0
829928|NCT01020123|2638313|P1|Extention Period|Adverse Event|0
829929|NCT01020123|2638307|P7|Extention Period|Withdrawal by Subject|0
829930|NCT01020123|2638308|P6|Extention Period|Withdrawal by Subject|0
829931|NCT01020123|2638309|P5|Extention Period|Withdrawal by Subject|0
829932|NCT01020123|2638310|P4|Extention Period|Withdrawal by Subject|0
829933|NCT01020123|2638311|P3|Extention Period|Withdrawal by Subject|1
829934|NCT01020123|2638312|P2|Extention Period|Withdrawal by Subject|1
829935|NCT01020123|2638313|P1|Extention Period|Withdrawal by Subject|2
829936|NCT01020123|2638307|P7|Main Period|Unclasified|6
829937|NCT01020123|2638308|P6|Main Period|Unclasified|3
829938|NCT01020123|2638309|P5|Main Period|Unclasified|1
829939|NCT01020123|2638310|P4|Main Period|Unclasified|0
829940|NCT01020123|2638311|P3|Main Period|Unclasified|1
829941|NCT01020123|2638312|P2|Main Period|Unclasified|0
829942|NCT01020123|2638313|P1|Main Period|Unclasified|2
829943|NCT01020123|2638307|P7|Main Period|Lost to Follow-up|0
829944|NCT01020123|2638308|P6|Main Period|Lost to Follow-up|0
829945|NCT01020123|2638309|P5|Main Period|Lost to Follow-up|0
829946|NCT01020123|2638310|P4|Main Period|Lost to Follow-up|0
829947|NCT01020123|2638311|P3|Main Period|Lost to Follow-up|0
829948|NCT01020123|2638312|P2|Main Period|Lost to Follow-up|2
829949|NCT01020123|2638313|P1|Main Period|Lost to Follow-up|0
829950|NCT01020123|2638307|P7|Main Period|Protocol Violation|2
829951|NCT01020123|2638308|P6|Main Period|Protocol Violation|3
829952|NCT01020123|2638309|P5|Main Period|Protocol Violation|2
829953|NCT01020123|2638310|P4|Main Period|Protocol Violation|5
829954|NCT01020123|2638311|P3|Main Period|Protocol Violation|2
829955|NCT01020123|2638312|P2|Main Period|Protocol Violation|4
829956|NCT01020123|2638313|P1|Main Period|Protocol Violation|4
829957|NCT01020123|2638307|P7|Main Period|Adverse Event|1
829958|NCT01020123|2638308|P6|Main Period|Adverse Event|2
829959|NCT01020123|2638309|P5|Main Period|Adverse Event|1
829960|NCT01020123|2638310|P4|Main Period|Adverse Event|1
829961|NCT01020123|2638311|P3|Main Period|Adverse Event|2
829962|NCT01020123|2638312|P2|Main Period|Adverse Event|2
829963|NCT01020123|2638313|P1|Main Period|Adverse Event|5
829964|NCT01020123|2638307|P7|Main Period|Eligibility Criteria not fullfilled|0
829965|NCT01020123|2638308|P6|Main Period|Eligibility Criteria not fullfilled|0
829966|NCT01020123|2638309|P5|Main Period|Eligibility Criteria not fullfilled|1
829967|NCT01020123|2638310|P4|Main Period|Eligibility Criteria not fullfilled|0
829968|NCT01020123|2638311|P3|Main Period|Eligibility Criteria not fullfilled|0
829969|NCT01020123|2638312|P2|Main Period|Eligibility Criteria not fullfilled|1
829970|NCT01020123|2638313|P1|Main Period|Eligibility Criteria not fullfilled|0
829971|NCT01020123|2638307|P7|Main Period|Withdrawal by Subject|2
829972|NCT01020123|2638308|P6|Main Period|Withdrawal by Subject|3
829973|NCT01020123|2638309|P5|Main Period|Withdrawal by Subject|6
829974|NCT01020123|2638310|P4|Main Period|Withdrawal by Subject|1
829975|NCT01020123|2638311|P3|Main Period|Withdrawal by Subject|3
829976|NCT01020123|2638312|P2|Main Period|Withdrawal by Subject|5
829977|NCT01020123|2638313|P1|Main Period|Withdrawal by Subject|6
829978|NCT01020305|2638506|P1|Overall Study|Adverse Event|2
829979|NCT01020448|2638510|P1|Treatment|Lost to Follow-up|2
829980|NCT01020448|2638510|P1|Treatment|Lack of Efficacy|8
829981|NCT01020448|2638510|P1|Treatment|Disease Progression|2
829982|NCT01020448|2638510|P1|Treatment|Consent Withdrawn|3
829983|NCT01020448|2638510|P1|Treatment|Adverse Event|11
829984|NCT01020448|2638510|P1|Pre-assignment|Does Not Meet Entry Criteria|2
829985|NCT01020448|2638510|P1|Pre-assignment|Withdrawal by Subject|5
829986|NCT01020448|2638510|P1|Pre-assignment|Adverse Event|6
829987|NCT01020474|2638521|P2|Overall Study|Insufficient Clinical Response|3
829988|NCT01020474|2638522|P1|Overall Study|Insufficient Clinical Response|0
829989|NCT01020474|2638521|P2|Overall Study|Other Reasons|1
829990|NCT01020474|2638522|P1|Overall Study|Other Reasons|1
829991|NCT01020474|2638521|P2|Overall Study|Withdrawal by Subject|7
829992|NCT01020474|2638522|P1|Overall Study|Withdrawal by Subject|5
829993|NCT01020474|2638521|P2|Overall Study|Protocol Violation|2
829994|NCT01020474|2638522|P1|Overall Study|Protocol Violation|0
829995|NCT01020474|2638521|P2|Overall Study|Adverse Event|4
829996|NCT01020474|2638522|P1|Overall Study|Adverse Event|4
829997|NCT01020487|2638545|P3|Part 2 Open-label Period|Adverse Event|1
829998|NCT01020487|2638546|P2|Part 2 Open-label Period|Adverse Event|4
829999|NCT01020487|2638547|P1|Part 2 Open-label Period|Adverse Event|0
830000|NCT01020487|2638545|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
830001|NCT01020487|2638546|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
830002|NCT01020487|2638547|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
830003|NCT01020487|2638545|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
830004|NCT01020487|2638546|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
830005|NCT01020487|2638547|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
830006|NCT01020487|2638545|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
830007|NCT01020487|2638546|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
830008|NCT01020487|2638547|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
830009|NCT01020487|2638545|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
830010|NCT01020487|2638546|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
830011|NCT01020487|2638547|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
830012|NCT01020526|2638568|P1|Overall Study|Adverse Event|2
830013|NCT01020526|2638568|P1|Overall Study|Lost to Follow-up|1
830014|NCT01020526|2638568|P1|Overall Study|Insufficient clinical response|3
830015|NCT01020526|2638568|P1|Overall Study|Other reasons|3
830016|NCT01020526|2638568|P1|Overall Study|Withdrawal by Subject|5
830017|NCT01020747|2638583|P1|Overall Study|Withdrawal by Subject|1
830018|NCT01020773|2638590|P2|Overall Study|Withdrawal by Subject|3
830019|NCT01020773|2638591|P1|Overall Study|Withdrawal by Subject|4
830020|NCT01020786|2638597|P1|Maintenance Period|Sponsor Decision|1
830021|NCT01020786|2638597|P1|Maintenance Period|Withdrawal by Subject|8
830022|NCT01020786|2638597|P1|Maintenance Period|Progressive Disease|43
830023|NCT01020786|2638597|P1|Maintenance Period|Adverse Event|8
830024|NCT01020786|2638597|P1|Induction Period|Withdrawal by Subject|3
830025|NCT01020786|2638597|P1|Induction Period|Investigator Decision|3
830026|NCT01020786|2638597|P1|Induction Period|Progressive Disease|31
830027|NCT01020786|2638597|P1|Induction Period|Adverse Event|10
830028|NCT01020786|2638597|P1|Induction Period|Entry Criteria Not Met|2
830029|NCT01020799|2638612|P3|Overall Study|Lost to Follow-up|2
830030|NCT01020799|2638613|P2|Overall Study|Lost to Follow-up|4
830031|NCT01020799|2638614|P1|Overall Study|Lost to Follow-up|6
830032|NCT01020799|2638612|P3|Overall Study|Withdrawal by Subject|3
830033|NCT01020799|2638613|P2|Overall Study|Withdrawal by Subject|2
830034|NCT01020799|2638614|P1|Overall Study|Withdrawal by Subject|2
830035|NCT01020799|2638612|P3|Overall Study|Protocol Violation|0
830036|NCT01020799|2638613|P2|Overall Study|Protocol Violation|2
830037|NCT01020799|2638614|P1|Overall Study|Protocol Violation|3
830038|NCT01020799|2638612|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
830039|NCT01020799|2638613|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
830040|NCT01020799|2638614|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
830041|NCT01020799|2638612|P3|Overall Study|Adverse Event|2
830042|NCT01020799|2638613|P2|Overall Study|Adverse Event|3
830043|NCT01020799|2638614|P1|Overall Study|Adverse Event|4
830044|NCT01020812|2638637|P1|Overall Study|Protocol Violation|1
830045|NCT01020812|2638637|P1|Overall Study|Withdrawal by Subject|1
830046|NCT01020812|2638637|P1|Overall Study|Physician Decision|1
830047|NCT01020838|2638644|P1|Overall Study|Most common: Study ended by sponsor|77
830048|NCT01020838|2638644|P1|Overall Study|Lost to Follow-up|6
830049|NCT01020838|2638644|P1|Overall Study|Withdrawal by Subject|9
830050|NCT01020838|2638644|P1|Overall Study|Adverse Event|1
830051|NCT01020838|2638644|P1|Overall Study|Death|90
830052|NCT01020877|2638661|P2|Second Intervention|Withdrawal by Subject|0
830053|NCT01020877|2638662|P1|Second Intervention|Withdrawal by Subject|1
830054|NCT01020981|2638683|P2|Overall Study|Participant declined to complete survey|0
830055|NCT01020981|2638684|P1|Overall Study|Participant declined to complete survey|2
830056|NCT01020981|2638683|P2|Overall Study|Survey returned undeliverable|32
830057|NCT01020981|2638684|P1|Overall Study|Survey returned undeliverable|8
830058|NCT01020981|2638683|P2|Overall Study|Did not return mailed survey|58
830059|NCT01020981|2638684|P1|Overall Study|Did not return mailed survey|74
830060|NCT01021007|2638696|P2|Overall Study|Adverse Event|3
830061|NCT01021007|2638697|P1|Overall Study|Adverse Event|1
830062|NCT01021007|2638696|P2|Overall Study|Lost to Follow-up|1
830063|NCT01021007|2638697|P1|Overall Study|Lost to Follow-up|1
830064|NCT01021020|2638707|P1|14 Day Washout Period A|Physician Decision|1
830065|NCT01021020|2638707|P1|Period I|Withdrawal by Subject|1
830066|NCT01021020|2638707|P1|Period I|Protocol Violation|1
830067|NCT01021215|2638728|P2|Overall Study|Lost to Follow-up|0
830068|NCT01021215|2638729|P1|Overall Study|Lost to Follow-up|3
830069|NCT01021293|2638741|P2|Overall Study|Lost to Follow-up|1
830070|NCT01021293|2638742|P1|Overall Study|Lost to Follow-up|1
830071|NCT01021293|2638741|P2|Overall Study|Migrated/moved from study area|18
830072|NCT01021293|2638742|P1|Overall Study|Migrated/moved from study area|6
830073|NCT01021293|2638741|P2|Overall Study|Withdrawal by Subject|3
830074|NCT01021293|2638742|P1|Overall Study|Withdrawal by Subject|1
830075|NCT01021293|2638741|P2|Overall Study|Adverse Event|1
830076|NCT01021293|2638742|P1|Overall Study|Adverse Event|2
830077|NCT01021293|2638741|P2|Overall Study|Serious Adverse Event|1
830078|NCT01021293|2638742|P1|Overall Study|Serious Adverse Event|2
830079|NCT01021332|2638784|P1|Overall Study|Miscellaneous|3
830080|NCT01021332|2638784|P1|Overall Study|Protocol Violation|9
830081|NCT01021332|2638784|P1|Overall Study|Lost to Follow-up|4
830082|NCT01021332|2638784|P1|Overall Study|Withdrawal of Consent|23
830083|NCT01021332|2638784|P1|Overall Study|Lack of Efficacy|19
830084|NCT01021332|2638784|P1|Overall Study|Adverse Event|43
830085|NCT01021332|2638784|P1|Overall Study|Not fulfilling incl./excl.criteria|5
830086|NCT01021423|2638820|P2|Overall Study|Study terminated|5
830087|NCT01021423|2638821|P1|Overall Study|Study terminated|4
830088|NCT01021553|2638840|P3|Overall Study|Withdrawal by Subject|0
830089|NCT01021553|2638841|P2|Overall Study|Withdrawal by Subject|1
830090|NCT01021553|2638842|P1|Overall Study|Withdrawal by Subject|1
830091|NCT01021553|2638840|P3|Overall Study|Lost to Follow-up|1
830092|NCT01021553|2638841|P2|Overall Study|Lost to Follow-up|0
830093|NCT01021553|2638842|P1|Overall Study|Lost to Follow-up|0
830094|NCT01021553|2638840|P3|Overall Study|Protocol Violation|2
830095|NCT01021553|2638841|P2|Overall Study|Protocol Violation|2
830096|NCT01021553|2638842|P1|Overall Study|Protocol Violation|0
830097|NCT01021553|2638840|P3|Overall Study|Lack of Efficacy|0
830098|NCT01021553|2638841|P2|Overall Study|Lack of Efficacy|2
830099|NCT01021553|2638842|P1|Overall Study|Lack of Efficacy|2
830100|NCT01021553|2638840|P3|Overall Study|Adverse Event|0
830101|NCT01021553|2638841|P2|Overall Study|Adverse Event|0
830102|NCT01021553|2638842|P1|Overall Study|Adverse Event|1
830103|NCT01021683|2638905|P1|Overall Study|unspecified|8
830104|NCT01021683|2638905|P1|Overall Study|Recovery of neutrophil count|51
830105|NCT01021683|2638905|P1|Overall Study|Lack of Efficacy|12
830106|NCT01021813|2638932|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
830107|NCT01021813|2638933|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
830108|NCT01021813|2638934|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
830109|NCT01021813|2638935|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
830110|NCT01021813|2638936|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
830111|NCT01021813|2638932|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
830112|NCT01021813|2638933|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
830113|NCT01021813|2638934|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
830114|NCT01021813|2638935|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
830115|NCT01021813|2638936|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
830116|NCT01021813|2638932|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
830117|NCT01021813|2638933|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
830118|NCT01021813|2638934|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
830119|NCT01021813|2638935|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
830120|NCT01021813|2638936|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
830121|NCT01021813|2638932|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
830122|NCT01021813|2638933|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
830123|NCT01021813|2638934|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
830124|NCT01021813|2638935|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
830125|NCT01021813|2638936|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
830126|NCT01021813|2638932|P5|DB Randomized Discontinuation Phase|Adverse Event|1
830127|NCT01021813|2638933|P4|DB Randomized Discontinuation Phase|Adverse Event|3
830128|NCT01021813|2638934|P3|DB Randomized Discontinuation Phase|Adverse Event|0
830129|NCT01021813|2638935|P2|DB Randomized Discontinuation Phase|Adverse Event|0
830130|NCT01021813|2638936|P1|DB Randomized Discontinuation Phase|Adverse Event|0
830131|NCT01021813|2638932|P5|DB Treatment Phase|Withdrawal by Subject|0
830132|NCT01021813|2638933|P4|DB Treatment Phase|Withdrawal by Subject|0
830133|NCT01021813|2638934|P3|DB Treatment Phase|Withdrawal by Subject|0
830134|NCT01021813|2638935|P2|DB Treatment Phase|Withdrawal by Subject|24
830135|NCT01021813|2638936|P1|DB Treatment Phase|Withdrawal by Subject|60
830136|NCT01021813|2638932|P5|DB Treatment Phase|Protocol Violation|0
830137|NCT01021813|2638933|P4|DB Treatment Phase|Protocol Violation|0
830138|NCT01021813|2638934|P3|DB Treatment Phase|Protocol Violation|0
830139|NCT01021813|2638935|P2|DB Treatment Phase|Protocol Violation|3
830140|NCT01021813|2638936|P1|DB Treatment Phase|Protocol Violation|4
830141|NCT01021813|2638932|P5|DB Treatment Phase|Pregnancy|0
830142|NCT01021813|2638933|P4|DB Treatment Phase|Pregnancy|0
830143|NCT01021813|2638934|P3|DB Treatment Phase|Pregnancy|0
830144|NCT01021813|2638935|P2|DB Treatment Phase|Pregnancy|0
830145|NCT01021813|2638936|P1|DB Treatment Phase|Pregnancy|1
830146|NCT01021813|2638932|P5|DB Treatment Phase|Physician Decision|0
830147|NCT01021813|2638933|P4|DB Treatment Phase|Physician Decision|0
830148|NCT01021813|2638934|P3|DB Treatment Phase|Physician Decision|0
830149|NCT01021813|2638935|P2|DB Treatment Phase|Physician Decision|8
830150|NCT01021813|2638936|P1|DB Treatment Phase|Physician Decision|17
830151|NCT01021813|2638932|P5|DB Treatment Phase|Lost to Follow-up|0
830152|NCT01021813|2638933|P4|DB Treatment Phase|Lost to Follow-up|0
830153|NCT01021813|2638934|P3|DB Treatment Phase|Lost to Follow-up|0
830154|NCT01021813|2638935|P2|DB Treatment Phase|Lost to Follow-up|12
830155|NCT01021813|2638936|P1|DB Treatment Phase|Lost to Follow-up|14
830156|NCT01021813|2638932|P5|DB Treatment Phase|Lack of Efficacy|0
830157|NCT01021813|2638933|P4|DB Treatment Phase|Lack of Efficacy|0
830158|NCT01021813|2638934|P3|DB Treatment Phase|Lack of Efficacy|0
830159|NCT01021813|2638935|P2|DB Treatment Phase|Lack of Efficacy|28
830160|NCT01021813|2638936|P1|DB Treatment Phase|Lack of Efficacy|44
830161|NCT01021813|2638932|P5|DB Treatment Phase|Adverse Event|0
830162|NCT01021813|2638933|P4|DB Treatment Phase|Adverse Event|0
830163|NCT01021813|2638934|P3|DB Treatment Phase|Adverse Event|0
830164|NCT01021813|2638935|P2|DB Treatment Phase|Adverse Event|22
830165|NCT01021813|2638936|P1|DB Treatment Phase|Adverse Event|60
830166|NCT01021852|2638983|P8|Treatment Period 2|Withdrawal by Subject|2
830167|NCT01021852|2638984|P7|Treatment Period 2|Withdrawal by Subject|1
830168|NCT01021852|2638985|P6|Treatment Period 2|Withdrawal by Subject|0
830169|NCT01021852|2638986|P5|Treatment Period 2|Withdrawal by Subject|0
830170|NCT01021852|2638987|P4|Treatment Period 2|Withdrawal by Subject|0
830171|NCT01021852|2638988|P3|Treatment Period 2|Withdrawal by Subject|0
830172|NCT01021852|2638989|P2|Treatment Period 2|Withdrawal by Subject|0
830173|NCT01021852|2638990|P1|Treatment Period 2|Withdrawal by Subject|0
830174|NCT01021852|2638983|P8|Treatment Period 2|Protocol Violation|0
830175|NCT01021852|2638984|P7|Treatment Period 2|Protocol Violation|1
830176|NCT01021852|2638985|P6|Treatment Period 2|Protocol Violation|0
830177|NCT01021852|2638986|P5|Treatment Period 2|Protocol Violation|1
830178|NCT01021852|2638987|P4|Treatment Period 2|Protocol Violation|0
830179|NCT01021852|2638988|P3|Treatment Period 2|Protocol Violation|0
830180|NCT01021852|2638989|P2|Treatment Period 2|Protocol Violation|0
830181|NCT01021852|2638990|P1|Treatment Period 2|Protocol Violation|0
830182|NCT01021852|2638983|P8|Treatment Period 2|Physician Decision|0
830183|NCT01021852|2638984|P7|Treatment Period 2|Physician Decision|0
830184|NCT01021852|2638985|P6|Treatment Period 2|Physician Decision|0
830185|NCT01021852|2638986|P5|Treatment Period 2|Physician Decision|0
830186|NCT01021852|2638987|P4|Treatment Period 2|Physician Decision|0
830187|NCT01021852|2638988|P3|Treatment Period 2|Physician Decision|1
830188|NCT01021852|2638989|P2|Treatment Period 2|Physician Decision|0
830189|NCT01021852|2638990|P1|Treatment Period 2|Physician Decision|0
830190|NCT01021852|2638983|P8|Treatment Period 2|Lack of Efficacy|0
830191|NCT01021852|2638984|P7|Treatment Period 2|Lack of Efficacy|0
830192|NCT01021852|2638985|P6|Treatment Period 2|Lack of Efficacy|1
830193|NCT01021852|2638986|P5|Treatment Period 2|Lack of Efficacy|0
830194|NCT01021852|2638987|P4|Treatment Period 2|Lack of Efficacy|0
830195|NCT01021852|2638988|P3|Treatment Period 2|Lack of Efficacy|0
830196|NCT01021852|2638989|P2|Treatment Period 2|Lack of Efficacy|0
830197|NCT01021852|2638990|P1|Treatment Period 2|Lack of Efficacy|0
830198|NCT01021852|2638983|P8|Treatment Period 2|Adverse Event|0
830199|NCT01021852|2638984|P7|Treatment Period 2|Adverse Event|1
830200|NCT01021852|2638985|P6|Treatment Period 2|Adverse Event|0
830201|NCT01021852|2638986|P5|Treatment Period 2|Adverse Event|1
830202|NCT01021852|2638987|P4|Treatment Period 2|Adverse Event|0
830203|NCT01021852|2638988|P3|Treatment Period 2|Adverse Event|0
830204|NCT01021852|2638989|P2|Treatment Period 2|Adverse Event|1
830205|NCT01021852|2638990|P1|Treatment Period 2|Adverse Event|0
830206|NCT01021852|2638983|P8|Washout Period-No Drug|Adverse Event|0
830207|NCT01021852|2638984|P7|Washout Period-No Drug|Adverse Event|0
830208|NCT01021852|2638985|P6|Washout Period-No Drug|Adverse Event|1
830209|NCT01021852|2638986|P5|Washout Period-No Drug|Adverse Event|0
830210|NCT01021852|2638987|P4|Washout Period-No Drug|Adverse Event|0
830211|NCT01021852|2638988|P3|Washout Period-No Drug|Adverse Event|0
830212|NCT01021852|2638989|P2|Washout Period-No Drug|Adverse Event|0
830213|NCT01021852|2638990|P1|Washout Period-No Drug|Adverse Event|1
830214|NCT01021852|2638983|P8|Washout Period-Placebo|Protocol Violation|0
830215|NCT01021852|2638984|P7|Washout Period-Placebo|Protocol Violation|1
830216|NCT01021852|2638985|P6|Washout Period-Placebo|Protocol Violation|0
830217|NCT01021852|2638986|P5|Washout Period-Placebo|Protocol Violation|0
830218|NCT01021852|2638987|P4|Washout Period-Placebo|Protocol Violation|0
830219|NCT01021852|2638988|P3|Washout Period-Placebo|Protocol Violation|0
830220|NCT01021852|2638989|P2|Washout Period-Placebo|Protocol Violation|0
830221|NCT01021852|2638990|P1|Washout Period-Placebo|Protocol Violation|0
830222|NCT01021852|2638983|P8|Washout Period-Placebo|Lost to Follow-up|0
830223|NCT01021852|2638984|P7|Washout Period-Placebo|Lost to Follow-up|0
830224|NCT01021852|2638985|P6|Washout Period-Placebo|Lost to Follow-up|0
830225|NCT01021852|2638986|P5|Washout Period-Placebo|Lost to Follow-up|1
830226|NCT01021852|2638987|P4|Washout Period-Placebo|Lost to Follow-up|0
830227|NCT01021852|2638988|P3|Washout Period-Placebo|Lost to Follow-up|0
830228|NCT01021852|2638989|P2|Washout Period-Placebo|Lost to Follow-up|0
830229|NCT01021852|2638990|P1|Washout Period-Placebo|Lost to Follow-up|0
830230|NCT01021852|2638983|P8|Washout Period-Placebo|Adverse Event|0
830231|NCT01021852|2638984|P7|Washout Period-Placebo|Adverse Event|0
830232|NCT01021852|2638985|P6|Washout Period-Placebo|Adverse Event|1
830233|NCT01021852|2638986|P5|Washout Period-Placebo|Adverse Event|0
830234|NCT01021852|2638987|P4|Washout Period-Placebo|Adverse Event|1
830235|NCT01021852|2638988|P3|Washout Period-Placebo|Adverse Event|0
830236|NCT01021852|2638989|P2|Washout Period-Placebo|Adverse Event|0
830237|NCT01021852|2638990|P1|Washout Period-Placebo|Adverse Event|0
830238|NCT01021852|2638983|P8|Treatment Period 1|Not Treated|0
830239|NCT01021852|2638984|P7|Treatment Period 1|Not Treated|0
830240|NCT01021852|2638985|P6|Treatment Period 1|Not Treated|0
830241|NCT01021852|2638986|P5|Treatment Period 1|Not Treated|0
830242|NCT01021852|2638987|P4|Treatment Period 1|Not Treated|2
830243|NCT01021852|2638988|P3|Treatment Period 1|Not Treated|0
830244|NCT01021852|2638989|P2|Treatment Period 1|Not Treated|0
830245|NCT01021852|2638990|P1|Treatment Period 1|Not Treated|0
830246|NCT01021852|2638983|P8|Treatment Period 1|Withdrawal by Subject|1
830247|NCT01021852|2638984|P7|Treatment Period 1|Withdrawal by Subject|0
830248|NCT01021852|2638985|P6|Treatment Period 1|Withdrawal by Subject|0
830249|NCT01021852|2638986|P5|Treatment Period 1|Withdrawal by Subject|1
830250|NCT01021852|2638987|P4|Treatment Period 1|Withdrawal by Subject|0
830251|NCT01021852|2638988|P3|Treatment Period 1|Withdrawal by Subject|0
830252|NCT01021852|2638989|P2|Treatment Period 1|Withdrawal by Subject|0
830253|NCT01021852|2638990|P1|Treatment Period 1|Withdrawal by Subject|0
830254|NCT01021852|2638983|P8|Treatment Period 1|Pregnancy|0
830255|NCT01021852|2638984|P7|Treatment Period 1|Pregnancy|0
830256|NCT01021852|2638985|P6|Treatment Period 1|Pregnancy|0
830257|NCT01021852|2638986|P5|Treatment Period 1|Pregnancy|0
830258|NCT01021852|2638987|P4|Treatment Period 1|Pregnancy|0
830259|NCT01021852|2638988|P3|Treatment Period 1|Pregnancy|1
830260|NCT01021852|2638989|P2|Treatment Period 1|Pregnancy|0
830261|NCT01021852|2638990|P1|Treatment Period 1|Pregnancy|0
830262|NCT01021852|2638983|P8|Treatment Period 1|Adverse Event|0
830263|NCT01021852|2638984|P7|Treatment Period 1|Adverse Event|0
830264|NCT01021852|2638985|P6|Treatment Period 1|Adverse Event|2
830265|NCT01021852|2638986|P5|Treatment Period 1|Adverse Event|2
830266|NCT01021852|2638987|P4|Treatment Period 1|Adverse Event|0
830267|NCT01021852|2638988|P3|Treatment Period 1|Adverse Event|1
830268|NCT01021852|2638989|P2|Treatment Period 1|Adverse Event|1
830269|NCT01021852|2638990|P1|Treatment Period 1|Adverse Event|3
830270|NCT01021878|2639026|P2|Overall Study|Transplantation|1
830271|NCT01021878|2639027|P1|Overall Study|Transplantation|6
830272|NCT01021878|2639026|P2|Overall Study|Adverse Event|5
830273|NCT01021878|2639027|P1|Overall Study|Adverse Event|6
830274|NCT01021878|2639026|P2|Overall Study|Death|1
830275|NCT01021878|2639027|P1|Overall Study|Death|0
830276|NCT01021878|2639026|P2|Overall Study|Lost to Follow-up|3
830277|NCT01021878|2639027|P1|Overall Study|Lost to Follow-up|4
830278|NCT01022112|2639055|P5|Overall Study|Fasting plasma glucose level increased|7
830279|NCT01022112|2639056|P4|Overall Study|Fasting plasma glucose level increased|0
830280|NCT01022112|2639057|P3|Overall Study|Fasting plasma glucose level increased|0
830281|NCT01022112|2639058|P2|Overall Study|Fasting plasma glucose level increased|0
830282|NCT01022112|2639059|P1|Overall Study|Fasting plasma glucose level increased|1
830283|NCT01022112|2639055|P5|Overall Study|Withdrawal by Subject|1
830284|NCT01022112|2639056|P4|Overall Study|Withdrawal by Subject|2
830285|NCT01022112|2639057|P3|Overall Study|Withdrawal by Subject|2
830286|NCT01022112|2639058|P2|Overall Study|Withdrawal by Subject|1
830287|NCT01022112|2639059|P1|Overall Study|Withdrawal by Subject|0
830288|NCT01022112|2639055|P5|Overall Study|Physician Decision|1
830289|NCT01022112|2639056|P4|Overall Study|Physician Decision|0
830290|NCT01022112|2639057|P3|Overall Study|Physician Decision|1
830291|NCT01022112|2639058|P2|Overall Study|Physician Decision|0
830292|NCT01022112|2639059|P1|Overall Study|Physician Decision|0
830293|NCT01022112|2639055|P5|Overall Study|Lack of Efficacy|1
830294|NCT01022112|2639056|P4|Overall Study|Lack of Efficacy|0
830295|NCT01022112|2639057|P3|Overall Study|Lack of Efficacy|0
830296|NCT01022112|2639058|P2|Overall Study|Lack of Efficacy|0
830297|NCT01022112|2639059|P1|Overall Study|Lack of Efficacy|1
830298|NCT01022112|2639055|P5|Overall Study|Adverse Event|0
830299|NCT01022112|2639056|P4|Overall Study|Adverse Event|1
830300|NCT01022112|2639057|P3|Overall Study|Adverse Event|0
830301|NCT01022112|2639058|P2|Overall Study|Adverse Event|2
830302|NCT01022112|2639059|P1|Overall Study|Adverse Event|1
830303|NCT01022203|2639077|P2|Follow-Up Assessment|Lost to Follow-up|2
830304|NCT01022203|2639078|P1|Follow-Up Assessment|Lost to Follow-up|2
830305|NCT01022203|2639077|P2|Post Treatment Assessment|Adverse Event|2
830306|NCT01022203|2639078|P1|Post Treatment Assessment|Adverse Event|0
830307|NCT01022203|2639077|P2|Post Treatment Assessment|Physician Decision|0
830308|NCT01022203|2639078|P1|Post Treatment Assessment|Physician Decision|2
830309|NCT01022203|2639077|P2|Post Treatment Assessment|Withdrawal by Subject|12
830310|NCT01022203|2639078|P1|Post Treatment Assessment|Withdrawal by Subject|12
830311|NCT01022398|2639108|P2|Overall Study|Study terminated|2
830312|NCT01022398|2639109|P1|Overall Study|Study terminated|2
830313|NCT01022502|2639114|P1|Overall Study|Withdrawal by Subject|1
830314|NCT01022502|2639114|P1|Overall Study|employment related reasons|1
830315|NCT01022502|2639114|P1|Overall Study|Adverse Event|1
830316|NCT01028651|2639128|P1|Overall Study|Adverse Event|1
830317|NCT01028651|2639128|P1|Overall Study|Death|2
830318|NCT01033448|2639193|P1|Overall Study|Unknown disposition|1
830319|NCT01033448|2639193|P1|Overall Study|Withdrew due to other reasons|3
830320|NCT01033448|2639193|P1|Overall Study|Lost to Follow-up|3
830321|NCT01033448|2639193|P1|Overall Study|Positive HCV-RNA at week 48|1
830322|NCT01033448|2639193|P1|Overall Study|Withdrawal by Subject|4
830323|NCT01033487|2639201|P10|Fourth Intervention Period|Adverse Event|0
830324|NCT01033487|2639202|P9|Fourth Intervention Period|Adverse Event|1
830325|NCT01033487|2639203|P8|Fourth Intervention Period|Adverse Event|0
830326|NCT01033487|2639204|P7|Fourth Intervention Period|Adverse Event|0
830327|NCT01033487|2639205|P6|Fourth Intervention Period|Adverse Event|0
830328|NCT01033487|2639206|P5|Fourth Intervention Period|Adverse Event|0
830329|NCT01033487|2639207|P4|Fourth Intervention Period|Adverse Event|0
830330|NCT01033487|2639208|P3|Fourth Intervention Period|Adverse Event|0
830331|NCT01033487|2639209|P2|Fourth Intervention Period|Adverse Event|0
830332|NCT01033487|2639210|P1|Fourth Intervention Period|Adverse Event|0
830333|NCT01033734|2639268|P1|Overall Study|Withdrawal by Subject|1
830334|NCT01033747|2639322|P2|Overall Study|Stopped at end of Extension 1|0
830335|NCT01033747|2639323|P1|Overall Study|Stopped at end of Extension 1|2
830336|NCT01033747|2639322|P2|Overall Study|Stopped at end of prolongation visit 1|0
830337|NCT01033747|2639323|P1|Overall Study|Stopped at end of prolongation visit 1|1
830338|NCT01033747|2639322|P2|Overall Study|Withdrawal by Subject|6
830339|NCT01033747|2639323|P1|Overall Study|Withdrawal by Subject|9
830340|NCT01033747|2639322|P2|Overall Study|Protocol Violation|0
830341|NCT01033747|2639323|P1|Overall Study|Protocol Violation|1
830342|NCT01033747|2639322|P2|Overall Study|Unsatisfactory therapeutic effect|4
830343|NCT01033747|2639323|P1|Overall Study|Unsatisfactory therapeutic effect|14
830344|NCT01033747|2639322|P2|Overall Study|Abnormal test procedure|1
830345|NCT01033747|2639323|P1|Overall Study|Abnormal test procedure|0
830346|NCT01033747|2639322|P2|Overall Study|Abnormal Laboratory Value|0
830347|NCT01033747|2639323|P1|Overall Study|Abnormal Laboratory Value|1
830348|NCT01033747|2639322|P2|Overall Study|Adverse Event|4
830349|NCT01033747|2639323|P1|Overall Study|Adverse Event|9
830350|NCT01033825|2639338|P7|Overall Study|Other|0
830351|NCT01033825|2639339|P6|Overall Study|Other|0
830352|NCT01033825|2639340|P5|Overall Study|Other|1
830353|NCT01033825|2639341|P4|Overall Study|Other|0
830354|NCT01033825|2639342|P3|Overall Study|Other|0
830355|NCT01033825|2639343|P2|Overall Study|Other|0
830356|NCT01033825|2639344|P1|Overall Study|Other|0
830357|NCT01033825|2639338|P7|Overall Study|Protocol Violation|0
830358|NCT01033825|2639339|P6|Overall Study|Protocol Violation|0
830359|NCT01033825|2639340|P5|Overall Study|Protocol Violation|0
830360|NCT01033825|2639341|P4|Overall Study|Protocol Violation|0
830361|NCT01033825|2639342|P3|Overall Study|Protocol Violation|0
830362|NCT01033825|2639343|P2|Overall Study|Protocol Violation|0
830363|NCT01033825|2639344|P1|Overall Study|Protocol Violation|1
830364|NCT01033825|2639338|P7|Overall Study|Adverse Event|0
830365|NCT01033825|2639339|P6|Overall Study|Adverse Event|0
830366|NCT01033825|2639340|P5|Overall Study|Adverse Event|0
830367|NCT01033825|2639341|P4|Overall Study|Adverse Event|1
830368|NCT01033825|2639342|P3|Overall Study|Adverse Event|0
830369|NCT01033825|2639343|P2|Overall Study|Adverse Event|0
830370|NCT01033825|2639344|P1|Overall Study|Adverse Event|0
830371|NCT01033825|2639338|P7|Overall Study|Withdrawal by Subject|0
830372|NCT01033825|2639339|P6|Overall Study|Withdrawal by Subject|0
830373|NCT01033825|2639340|P5|Overall Study|Withdrawal by Subject|1
830374|NCT01033825|2639341|P4|Overall Study|Withdrawal by Subject|1
830375|NCT01033825|2639342|P3|Overall Study|Withdrawal by Subject|2
830376|NCT01033825|2639343|P2|Overall Study|Withdrawal by Subject|3
830377|NCT01033825|2639344|P1|Overall Study|Withdrawal by Subject|2
830378|NCT01033851|2639565|P2|Overall Study|Withdrawal by Subject|7
830379|NCT01033851|2639566|P1|Overall Study|Withdrawal by Subject|3
830380|NCT01033942|2639603|P3|Overall Study|Enrolled in Extension Study|0
830381|NCT01033942|2639604|P2|Overall Study|Enrolled in Extension Study|3
830382|NCT01033942|2639605|P1|Overall Study|Enrolled in Extension Study|0
830383|NCT01033942|2639603|P3|Overall Study|Lost to Follow-up|0
830384|NCT01033942|2639604|P2|Overall Study|Lost to Follow-up|0
830385|NCT01033942|2639605|P1|Overall Study|Lost to Follow-up|1
830386|NCT01033942|2639603|P3|Overall Study|Withdrawal by Subject|1
830387|NCT01033942|2639604|P2|Overall Study|Withdrawal by Subject|1
830388|NCT01033942|2639605|P1|Overall Study|Withdrawal by Subject|1
830389|NCT01034137|2639883|P3|Overall Study|Administrative or other|4
830390|NCT01034137|2639884|P2|Overall Study|Administrative or other|3
830391|NCT01034137|2639885|P1|Overall Study|Administrative or other|2
830392|NCT01034137|2639883|P3|Overall Study|Refused treatment or did not cooperate|1
830393|NCT01034137|2639884|P2|Overall Study|Refused treatment or did not cooperate|0
830394|NCT01034137|2639885|P1|Overall Study|Refused treatment or did not cooperate|2
830395|NCT01034137|2639883|P3|Overall Study|Protocol Violation|1
830396|NCT01034137|2639884|P2|Overall Study|Protocol Violation|2
830397|NCT01034137|2639885|P1|Overall Study|Protocol Violation|2
830398|NCT01034137|2639883|P3|Overall Study|Lack of Efficacy|13
830399|NCT01034137|2639884|P2|Overall Study|Lack of Efficacy|4
830400|NCT01034137|2639885|P1|Overall Study|Lack of Efficacy|9
830401|NCT01034137|2639883|P3|Overall Study|Withdrawal by Subject|3
830402|NCT01034137|2639884|P2|Overall Study|Withdrawal by Subject|3
830403|NCT01034137|2639885|P1|Overall Study|Withdrawal by Subject|4
830404|NCT01034137|2639883|P3|Overall Study|Adverse Event|8
830405|NCT01034137|2639884|P2|Overall Study|Adverse Event|10
830406|NCT01034137|2639885|P1|Overall Study|Adverse Event|9
830407|NCT01034163|2640018|P2|Overall Study|Abnormal laboratory value|0
830408|NCT01034163|2640019|P1|Overall Study|Abnormal laboratory value|1
830409|NCT01034163|2640018|P2|Overall Study|Administrative problems|1
830410|NCT01034163|2640019|P1|Overall Study|Administrative problems|0
830411|NCT01034163|2640018|P2|Overall Study|Adverse Event|0
830412|NCT01034163|2640019|P1|Overall Study|Adverse Event|6
830413|NCT01034163|2640018|P2|Overall Study|Disease progression|4
830414|NCT01034163|2640019|P1|Overall Study|Disease progression|3
830415|NCT01034163|2640018|P2|Overall Study|Protocol deviation|0
830416|NCT01034163|2640019|P1|Overall Study|Protocol deviation|1
830417|NCT01034163|2640018|P2|Overall Study|Withdrawal by Subject|2
830418|NCT01034163|2640019|P1|Overall Study|Withdrawal by Subject|8
830419|NCT01034163|2640018|P2|Overall Study|Treatment completed as per protocol|7
830420|NCT01034163|2640019|P1|Overall Study|Treatment completed as per protocol|8
830421|NCT01034176|2640027|P2|Overall Study|Lost to Follow-up|1
830422|NCT01034176|2640028|P1|Overall Study|Lost to Follow-up|0
830423|NCT01034176|2640027|P2|Overall Study|Withdrawal by Subject|1
830424|NCT01034176|2640028|P1|Overall Study|Withdrawal by Subject|0
830425|NCT01034176|2640027|P2|Overall Study|Physician Decision|0
830426|NCT01034176|2640028|P1|Overall Study|Physician Decision|2
830427|NCT01034306|2640038|P2|Overall Study|Noncomplience|0
830428|NCT01034306|2640039|P1|Overall Study|Noncomplience|1
830429|NCT01034306|2640038|P2|Overall Study|hospitalized and decided to stop|0
830430|NCT01034306|2640039|P1|Overall Study|hospitalized and decided to stop|1
830431|NCT01034306|2640038|P2|Overall Study|Withdrawal by Subject|2
830432|NCT01034306|2640039|P1|Overall Study|Withdrawal by Subject|2
830433|NCT01034306|2640038|P2|Overall Study|Lost to Follow-up|1
830434|NCT01034306|2640039|P1|Overall Study|Lost to Follow-up|0
830435|NCT01034306|2640038|P2|Overall Study|Adverse Event|0
830436|NCT01034306|2640039|P1|Overall Study|Adverse Event|1
830437|NCT01034358|2640045|P1|Overall Study|Protocol Violation|1
830438|NCT01034358|2640045|P1|Overall Study|Withdrawal by Subject|1
830439|NCT01034397|2640051|P2|Overall Study|Not specified|1
830440|NCT01034397|2640052|P1|Overall Study|Not specified|0
830441|NCT01034397|2640051|P2|Overall Study|Adverse Event|0
830442|NCT01034397|2640052|P1|Overall Study|Adverse Event|4
830443|NCT01034397|2640051|P2|Overall Study|Lack of Efficacy|0
830444|NCT01034397|2640052|P1|Overall Study|Lack of Efficacy|3
830445|NCT01034397|2640051|P2|Overall Study|Lack of compliance|1
830446|NCT01034397|2640052|P1|Overall Study|Lack of compliance|0
830447|NCT01034462|2640203|P2|Overall Study|Other reasons|2
830448|NCT01034462|2640204|P1|Overall Study|Other reasons|1
830449|NCT01034462|2640203|P2|Overall Study|Lost to Follow-up|16
830450|NCT01034462|2640204|P1|Overall Study|Lost to Follow-up|14
830451|NCT01034462|2640203|P2|Overall Study|Withdrawal by Subject|8
830452|NCT01034462|2640204|P1|Overall Study|Withdrawal by Subject|9
830453|NCT01034462|2640203|P2|Overall Study|Protocol Violation|7
830454|NCT01034462|2640204|P1|Overall Study|Protocol Violation|10
830455|NCT01034462|2640203|P2|Overall Study|Lack of Efficacy|4
830456|NCT01034462|2640204|P1|Overall Study|Lack of Efficacy|4
830457|NCT01034462|2640203|P2|Overall Study|Adverse Event|17
830458|NCT01034462|2640204|P1|Overall Study|Adverse Event|7
830459|NCT01034540|2640214|P2|Overall Study|Adverse Event|1
830460|NCT01034540|2640215|P1|Overall Study|Adverse Event|0
830461|NCT01034631|2640272|P3|Phase II|Determined Ineligible per protocol|0
830462|NCT01034631|2640273|P2|Phase II|Determined Ineligible per protocol|1
830463|NCT01034631|2640274|P1|Phase II|Determined Ineligible per protocol|0
830464|NCT01034631|2640272|P3|Phase II|Not Evaluable per protocol|2
830465|NCT01034631|2640273|P2|Phase II|Not Evaluable per protocol|0
830466|NCT01034631|2640274|P1|Phase II|Not Evaluable per protocol|0
830467|NCT01034631|2640272|P3|Phase I|Symptomatic Deterioration before Treatme|0
830468|NCT01034631|2640273|P2|Phase I|Symptomatic Deterioration before Treatme|0
830469|NCT01034631|2640274|P1|Phase I|Symptomatic Deterioration before Treatme|3
830470|NCT01034657|2640293|P3|Randomized Phase|Adverse Event|1
830471|NCT01034657|2640294|P2|Randomized Phase|Adverse Event|2
830472|NCT01034657|2640295|P1|Randomized Phase|Adverse Event|0
830473|NCT01034657|2640293|P3|Randomized Phase|Abnormal laboratory value|0
830474|NCT01034657|2640294|P2|Randomized Phase|Abnormal laboratory value|1
830475|NCT01034657|2640295|P1|Randomized Phase|Abnormal laboratory value|0
830476|NCT01034657|2640293|P3|Randomized Phase|Lack of Efficacy|0
830477|NCT01034657|2640294|P2|Randomized Phase|Lack of Efficacy|1
830478|NCT01034657|2640295|P1|Randomized Phase|Lack of Efficacy|5
830479|NCT01034657|2640293|P3|Randomized Phase|Withdrawal by Subject|0
830480|NCT01034657|2640294|P2|Randomized Phase|Withdrawal by Subject|2
830481|NCT01034657|2640295|P1|Randomized Phase|Withdrawal by Subject|0
830482|NCT01034657|2640293|P3|Core Phase|Protocol Violation|0
830483|NCT01034657|2640294|P2|Core Phase|Protocol Violation|0
830484|NCT01034657|2640295|P1|Core Phase|Protocol Violation|2
830485|NCT01034657|2640293|P3|Core Phase|Adverse Event|0
830486|NCT01034657|2640294|P2|Core Phase|Adverse Event|0
830487|NCT01034657|2640295|P1|Core Phase|Adverse Event|8
830488|NCT01034657|2640293|P3|Core Phase|Abnormal laboratory value|0
830489|NCT01034657|2640294|P2|Core Phase|Abnormal laboratory value|0
830490|NCT01034657|2640295|P1|Core Phase|Abnormal laboratory value|1
830491|NCT01034657|2640293|P3|Core Phase|Lack of Efficacy|0
830492|NCT01034657|2640294|P2|Core Phase|Lack of Efficacy|0
830493|NCT01034657|2640295|P1|Core Phase|Lack of Efficacy|2
830494|NCT01034657|2640293|P3|Core Phase|Withdrawal by Subject|0
830495|NCT01034657|2640294|P2|Core Phase|Withdrawal by Subject|0
830496|NCT01034657|2640295|P1|Core Phase|Withdrawal by Subject|1
830497|NCT01034709|2640335|P2|Overall Study|Protocol Violation|16
830498|NCT01034709|2640336|P1|Overall Study|Protocol Violation|9
830499|NCT01035060|2640361|P2|Overall Study|Physician Decision|0
830500|NCT01035060|2640362|P1|Overall Study|Physician Decision|2
830501|NCT01035060|2640361|P2|Overall Study|Withdrawal by Subject|6
830502|NCT01035060|2640362|P1|Overall Study|Withdrawal by Subject|8
830503|NCT01035060|2640361|P2|Overall Study|Did not quality after 2nd screening|1
830504|NCT01035060|2640362|P1|Overall Study|Did not quality after 2nd screening|14
830505|NCT01035060|2640361|P2|Overall Study|Lost to Follow-up|7
830506|NCT01035060|2640362|P1|Overall Study|Lost to Follow-up|0
830507|NCT01035138|2640371|P3|Overall Study|Lost to Follow-up|1
830508|NCT01035138|2640372|P2|Overall Study|Lost to Follow-up|0
830509|NCT01035138|2640373|P1|Overall Study|Lost to Follow-up|0
830510|NCT01035138|2640371|P3|Overall Study|Sponsor Decision|42
830511|NCT01035138|2640372|P2|Overall Study|Sponsor Decision|60
830512|NCT01035138|2640373|P1|Overall Study|Sponsor Decision|66
830513|NCT01035138|2640371|P3|Overall Study|Physician Decision|1
830514|NCT01035138|2640372|P2|Overall Study|Physician Decision|0
830515|NCT01035138|2640373|P1|Overall Study|Physician Decision|0
830516|NCT01035138|2640371|P3|Overall Study|Withdrawal by Subject|0
830517|NCT01035138|2640372|P2|Overall Study|Withdrawal by Subject|0
830518|NCT01035138|2640373|P1|Overall Study|Withdrawal by Subject|1
830519|NCT01035138|2640371|P3|Overall Study|Caregiver Decision|1
830520|NCT01035138|2640372|P2|Overall Study|Caregiver Decision|0
830521|NCT01035138|2640373|P1|Overall Study|Caregiver Decision|2
830522|NCT01035138|2640371|P3|Overall Study|Adverse Event|2
830523|NCT01035138|2640372|P2|Overall Study|Adverse Event|0
830524|NCT01035138|2640373|P1|Overall Study|Adverse Event|4
830525|NCT01035229|2640429|P2|Overall Study|Disease Progression|152
830526|NCT01035229|2640430|P1|Overall Study|Disease Progression|261
830527|NCT01035229|2640429|P2|Overall Study|Sponsor's decision to end study|3
830528|NCT01035229|2640430|P1|Overall Study|Sponsor's decision to end study|3
830529|NCT01035229|2640429|P2|Overall Study|Protocol Violation|2
830530|NCT01035229|2640430|P1|Overall Study|Protocol Violation|0
830531|NCT01035229|2640429|P2|Overall Study|New cancer therapy|0
830532|NCT01035229|2640430|P1|Overall Study|New cancer therapy|2
830533|NCT01035229|2640429|P2|Overall Study|Death|5
830534|NCT01035229|2640430|P1|Overall Study|Death|13
830535|NCT01035229|2640429|P2|Overall Study|Administrative problems|1
830536|NCT01035229|2640430|P1|Overall Study|Administrative problems|1
830537|NCT01035229|2640429|P2|Overall Study|Lost to Follow-up|0
830538|NCT01035229|2640430|P1|Overall Study|Lost to Follow-up|1
830539|NCT01035229|2640429|P2|Overall Study|Withdrawal by Subject|7
830540|NCT01035229|2640430|P1|Overall Study|Withdrawal by Subject|20
830541|NCT01035229|2640429|P2|Overall Study|Adverse Event|14
830542|NCT01035229|2640430|P1|Overall Study|Adverse Event|61
830543|NCT01035255|2640450|P2|Overall Study|patient's request|13
830544|NCT01035255|2640451|P1|Overall Study|patient's request|15
830545|NCT01035255|2640450|P2|Overall Study|Lost to Follow-up|5
830546|NCT01035255|2640451|P1|Overall Study|Lost to Follow-up|2
830547|NCT01035255|2640450|P2|Overall Study|Death|844
830548|NCT01035255|2640451|P1|Overall Study|Death|724
830549|NCT01035905|2640659|P2|Overall Study|Lack of Efficacy|1
830550|NCT01035905|2640660|P1|Overall Study|Lack of Efficacy|1
830551|NCT01020019|2640685|P2|Overall Study|moving|2
830552|NCT01020019|2640686|P1|Overall Study|moving|0
830553|NCT01020019|2640685|P2|Overall Study|not interested in treatment|4
830554|NCT01020019|2640686|P1|Overall Study|not interested in treatment|4
830555|NCT01020019|2640685|P2|Overall Study|Adverse Event|5
830556|NCT01020019|2640686|P1|Overall Study|Adverse Event|1
830557|NCT01020019|2640685|P2|Overall Study|Lost to Follow-up|18
830558|NCT01020019|2640686|P1|Overall Study|Lost to Follow-up|21
830559|NCT01025635|2640698|P2|Overall Study|Reason not known|2
830560|NCT01025635|2640699|P1|Overall Study|Reason not known|4
830561|NCT01025635|2640698|P2|Overall Study|Lost to Follow-up|13
830562|NCT01025635|2640699|P1|Overall Study|Lost to Follow-up|9
830563|NCT01025635|2640698|P2|Overall Study|Lack of Efficacy|1
830564|NCT01025635|2640699|P1|Overall Study|Lack of Efficacy|0
830565|NCT01025635|2640698|P2|Overall Study|Protocol Violation|2
830566|NCT01025635|2640699|P1|Overall Study|Protocol Violation|4
830567|NCT01025635|2640698|P2|Overall Study|Withdrawal by Subject|7
830568|NCT01025635|2640699|P1|Overall Study|Withdrawal by Subject|6
830569|NCT01025817|2640713|P2|Completed Study|Lost to Follow-up|1
830570|NCT01025817|2640714|P1|Completed Study|Lost to Follow-up|0
830571|NCT01025817|2640713|P2|Completed Study|Missing|0
830572|NCT01025817|2640714|P1|Completed Study|Missing|2
830573|NCT01025817|2640713|P2|Completed Study|Death|5
830574|NCT01025817|2640714|P1|Completed Study|Death|6
830575|NCT01025817|2640713|P2|Completed Study|Withdrawal by Subject|16
830576|NCT01025817|2640714|P1|Completed Study|Withdrawal by Subject|8
830577|NCT01025817|2640713|P2|Completed Study Medication|Lost to Follow-up|1
830578|NCT01025817|2640714|P1|Completed Study Medication|Lost to Follow-up|0
830579|NCT01025817|2640713|P2|Completed Study Medication|Subject no longer required study drug|1
830580|NCT01025817|2640714|P1|Completed Study Medication|Subject no longer required study drug|0
830581|NCT01025817|2640713|P2|Completed Study Medication|Abnormal lab values|2
830582|NCT01025817|2640714|P1|Completed Study Medication|Abnormal lab values|0
830583|NCT01025817|2640713|P2|Completed Study Medication|Death|2
830584|NCT01025817|2640714|P1|Completed Study Medication|Death|2
830585|NCT01025817|2640713|P2|Completed Study Medication|Graft loss|5
830586|NCT01025817|2640714|P1|Completed Study Medication|Graft loss|2
830587|NCT01025817|2640713|P2|Completed Study Medication|Abnormal test procedure|0
830588|NCT01025817|2640714|P1|Completed Study Medication|Abnormal test procedure|4
830589|NCT01025817|2640713|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
830590|NCT01025817|2640714|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
830591|NCT01025817|2640713|P2|Completed Study Medication|Administrative problems|5
830592|NCT01025817|2640714|P1|Completed Study Medication|Administrative problems|7
830593|NCT01025817|2640713|P2|Completed Study Medication|Withdrawal by Subject|9
830594|NCT01025817|2640714|P1|Completed Study Medication|Withdrawal by Subject|8
830595|NCT01025817|2640713|P2|Completed Study Medication|Protocol Deviation|8
830596|NCT01025817|2640714|P1|Completed Study Medication|Protocol Deviation|9
830597|NCT01025817|2640713|P2|Completed Study Medication|Adverse Event|39
830598|NCT01025817|2640714|P1|Completed Study Medication|Adverse Event|66
830599|NCT01025843|2640760|P10|Washout 4|Withdrawal by Subject|0
830600|NCT01025843|2640761|P9|Washout 4|Withdrawal by Subject|0
830601|NCT01025843|2640762|P8|Washout 4|Withdrawal by Subject|0
830602|NCT01025843|2640763|P7|Washout 4|Withdrawal by Subject|0
830603|NCT01025843|2640764|P6|Washout 4|Withdrawal by Subject|0
830604|NCT01025843|2640765|P5|Washout 4|Withdrawal by Subject|0
830605|NCT01025843|2640766|P4|Washout 4|Withdrawal by Subject|1
830606|NCT01025843|2640767|P3|Washout 4|Withdrawal by Subject|1
830607|NCT01025843|2640768|P2|Washout 4|Withdrawal by Subject|0
830608|NCT01025843|2640769|P1|Washout 4|Withdrawal by Subject|0
830609|NCT01036022|2640866|P6|Overall Study|Withdrawal by Subject|0
830610|NCT01036022|2640867|P5|Overall Study|Withdrawal by Subject|2
830611|NCT01036022|2640868|P4|Overall Study|Withdrawal by Subject|1
830612|NCT01036022|2640869|P3|Overall Study|Withdrawal by Subject|0
830613|NCT01036022|2640870|P2|Overall Study|Withdrawal by Subject|0
830614|NCT01036022|2640871|P1|Overall Study|Withdrawal by Subject|0
830615|NCT01036022|2640866|P6|Overall Study|Physician Decision|0
830616|NCT01036022|2640867|P5|Overall Study|Physician Decision|0
830617|NCT01036022|2640868|P4|Overall Study|Physician Decision|0
830618|NCT01036022|2640869|P3|Overall Study|Physician Decision|1
830619|NCT01036022|2640870|P2|Overall Study|Physician Decision|0
830620|NCT01036022|2640871|P1|Overall Study|Physician Decision|0
830621|NCT01036022|2640866|P6|Overall Study|Lack of Efficacy|1
830622|NCT01036022|2640867|P5|Overall Study|Lack of Efficacy|1
830623|NCT01036022|2640868|P4|Overall Study|Lack of Efficacy|0
830624|NCT01036022|2640869|P3|Overall Study|Lack of Efficacy|1
830625|NCT01036022|2640870|P2|Overall Study|Lack of Efficacy|1
830626|NCT01036022|2640871|P1|Overall Study|Lack of Efficacy|1
830627|NCT01036022|2640866|P6|Overall Study|Adverse Event|2
830628|NCT01036022|2640867|P5|Overall Study|Adverse Event|0
830629|NCT01036022|2640868|P4|Overall Study|Adverse Event|1
830630|NCT01036022|2640869|P3|Overall Study|Adverse Event|2
830631|NCT01036022|2640870|P2|Overall Study|Adverse Event|3
830632|NCT01036022|2640871|P1|Overall Study|Adverse Event|1
830633|NCT01036165|2640971|P1|Overall Study|Problems finding proper area to inject|1
830634|NCT01036165|2640971|P1|Overall Study|Device Related Issues|3
830635|NCT01036165|2640971|P1|Overall Study|Withdrawal by Subject|3
830636|NCT01036165|2640971|P1|Overall Study|Lost to Follow-up|2
830637|NCT01036165|2640971|P1|Overall Study|Adverse Event|6
830644|NCT01036438|2641005|P2|Overall Study|No effect of study treatment|1
830645|NCT01036438|2641006|P1|Overall Study|No effect of study treatment|3
830646|NCT01036438|2641005|P2|Overall Study|Death|1
830647|NCT01036438|2641006|P1|Overall Study|Death|0
830648|NCT01036438|2641005|P2|Overall Study|Adverse Event|8
830649|NCT01036438|2641006|P1|Overall Study|Adverse Event|7
830650|NCT01036529|2641033|P2|Overall Study|Sponsor study termination|12
830651|NCT01036529|2641034|P1|Overall Study|Sponsor study termination|11
830652|NCT01036529|2641033|P2|Overall Study|Withdrawal by Subject|1
830653|NCT01036529|2641034|P1|Overall Study|Withdrawal by Subject|1
830654|NCT01036529|2641033|P2|Overall Study|Physician Decision|0
830655|NCT01036529|2641034|P1|Overall Study|Physician Decision|1
830656|NCT01036529|2641033|P2|Overall Study|Lost to Follow-up|1
830657|NCT01036529|2641034|P1|Overall Study|Lost to Follow-up|0
830658|NCT01036529|2641033|P2|Overall Study|Adverse Event|1
830659|NCT01036529|2641034|P1|Overall Study|Adverse Event|0
830660|NCT01038128|2641040|P1|Overall Study|Withdrawal by Subject|2
830661|NCT01038128|2641040|P1|Overall Study|Lost to Follow-up|1
830662|NCT01038128|2641040|P1|Overall Study|Lack of Efficacy|1
830663|NCT01038323|2641051|P3|Overall Study|Withdrawal by Subject|4
830664|NCT01038323|2641052|P2|Overall Study|Withdrawal by Subject|2
830665|NCT01038323|2641053|P1|Overall Study|Withdrawal by Subject|3
830666|NCT01038609|2641106|P5|Overall Study|Refusal of Blood Draws|0
830667|NCT01038609|2641107|P4|Overall Study|Refusal of Blood Draws|0
830668|NCT01038609|2641108|P3|Overall Study|Refusal of Blood Draws|0
830669|NCT01038609|2641109|P2|Overall Study|Refusal of Blood Draws|1
830670|NCT01038609|2641110|P1|Overall Study|Refusal of Blood Draws|0
830671|NCT01038609|2641106|P5|Overall Study|Death in the Family|0
830672|NCT01038609|2641107|P4|Overall Study|Death in the Family|0
830673|NCT01038609|2641108|P3|Overall Study|Death in the Family|0
830674|NCT01038609|2641109|P2|Overall Study|Death in the Family|0
830675|NCT01038609|2641110|P1|Overall Study|Death in the Family|1
830676|NCT01038609|2641106|P5|Overall Study|Dosing Error|1
830677|NCT01038609|2641107|P4|Overall Study|Dosing Error|1
830678|NCT01038609|2641108|P3|Overall Study|Dosing Error|0
830679|NCT01038609|2641109|P2|Overall Study|Dosing Error|0
830680|NCT01038609|2641110|P1|Overall Study|Dosing Error|0
830681|NCT01038609|2641106|P5|Overall Study|Adverse Event|0
830682|NCT01038609|2641107|P4|Overall Study|Adverse Event|0
830683|NCT01038609|2641108|P3|Overall Study|Adverse Event|1
830684|NCT01038609|2641109|P2|Overall Study|Adverse Event|0
830685|NCT01038609|2641110|P1|Overall Study|Adverse Event|0
830686|NCT01038635|2641161|P9|Overall Study|Death|2
830687|NCT01038635|2641162|P8|Overall Study|Death|1
830688|NCT01038635|2641163|P7|Overall Study|Death|1
830689|NCT01038635|2641164|P6|Overall Study|Death|0
830690|NCT01038635|2641165|P5|Overall Study|Death|1
830691|NCT01038635|2641166|P4|Overall Study|Death|0
830692|NCT01038635|2641167|P3|Overall Study|Death|0
830693|NCT01038635|2641168|P2|Overall Study|Death|0
830694|NCT01038635|2641169|P1|Overall Study|Death|0
830695|NCT01038635|2641161|P9|Overall Study|Disease Progression|0
830696|NCT01038635|2641162|P8|Overall Study|Disease Progression|4
830697|NCT01038635|2641163|P7|Overall Study|Disease Progression|1
830698|NCT01038635|2641164|P6|Overall Study|Disease Progression|0
830699|NCT01038635|2641165|P5|Overall Study|Disease Progression|0
830700|NCT01038635|2641166|P4|Overall Study|Disease Progression|0
830701|NCT01038635|2641167|P3|Overall Study|Disease Progression|0
830702|NCT01038635|2641168|P2|Overall Study|Disease Progression|0
830703|NCT01038635|2641169|P1|Overall Study|Disease Progression|2
830704|NCT01038713|2641193|P3|Overall Study|Autoimmune Pancreatitis|0
830705|NCT01038713|2641194|P2|Overall Study|Autoimmune Pancreatitis|0
830706|NCT01038713|2641195|P1|Overall Study|Autoimmune Pancreatitis|1
830707|NCT01038713|2641193|P3|Overall Study|died from PEP|0
830708|NCT01038713|2641194|P2|Overall Study|died from PEP|1
830709|NCT01038713|2641195|P1|Overall Study|died from PEP|0
830710|NCT01038713|2641193|P3|Overall Study|Neuroendocrine Tumor|0
830711|NCT01038713|2641194|P2|Overall Study|Neuroendocrine Tumor|1
830712|NCT01038713|2641195|P1|Overall Study|Neuroendocrine Tumor|0
830713|NCT01038713|2641193|P3|Overall Study|Lost to Follow-up|0
830714|NCT01038713|2641194|P2|Overall Study|Lost to Follow-up|0
830715|NCT01038713|2641195|P1|Overall Study|Lost to Follow-up|3
830716|NCT01038713|2641193|P3|Overall Study|Patient to hospice|1
830717|NCT01038713|2641194|P2|Overall Study|Patient to hospice|1
830718|NCT01038713|2641195|P1|Overall Study|Patient to hospice|1
830719|NCT01038752|2641217|P2|Overall Study|Lost to Follow-up|3
830720|NCT01038752|2641218|P1|Overall Study|Lost to Follow-up|3
830721|NCT01038752|2641217|P2|Overall Study|Tumor Progression|2
830722|NCT01038752|2641218|P1|Overall Study|Tumor Progression|2
830723|NCT01038869|2641238|P1|Overall Study|Lost to Follow-up|6
830724|NCT01038869|2641238|P1|Overall Study|Withdrawal by Subject|1
830725|NCT01038921|2641248|P2|Overall Study|Physician Decision|0
830726|NCT01038921|2641249|P1|Overall Study|Physician Decision|1
830727|NCT01038921|2641248|P2|Overall Study|Withdrawal by Subject|0
830728|NCT01038921|2641249|P1|Overall Study|Withdrawal by Subject|1
830729|NCT01039376|2641265|P2|Overall Study|Ongoing|182
830730|NCT01039376|2641266|P1|Overall Study|Ongoing|189
830731|NCT01039376|2641265|P2|Overall Study|Withdrawal by Subject|17
830732|NCT01039376|2641266|P1|Overall Study|Withdrawal by Subject|11
830733|NCT01039376|2641265|P2|Overall Study|Physician Decision|2
830734|NCT01039376|2641266|P1|Overall Study|Physician Decision|4
830735|NCT01039376|2641265|P2|Overall Study|Lost to Follow-up|1
830736|NCT01039376|2641266|P1|Overall Study|Lost to Follow-up|2
830737|NCT01039428|2641326|P2|Overall Study|Withdrawal by Subject|0
830738|NCT01039428|2641327|P1|Overall Study|Withdrawal by Subject|1
830739|NCT01039428|2641326|P2|Overall Study|Protocol Violation|0
830740|NCT01039428|2641327|P1|Overall Study|Protocol Violation|1
830741|NCT01039519|2641349|P1|Survival Follow-up|Sponsor decision|4
830742|NCT01039519|2641349|P1|Survival Follow-up|Death|23
830743|NCT01039519|2641349|P1|Treatment|Physician Decision|2
830744|NCT01039519|2641349|P1|Treatment|Adverse Event|3
830745|NCT01039519|2641349|P1|Treatment|Treatment failure|2
830746|NCT01039519|2641349|P1|Treatment|Progressive disease|20
830747|NCT01039584|2641361|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
830748|NCT01039584|2641362|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
830749|NCT01039584|2641363|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
830750|NCT01039584|2641361|P3|Overall Study|Pap smear with significant pathology|3
830751|NCT01039584|2641362|P2|Overall Study|Pap smear with significant pathology|10
830752|NCT01039584|2641363|P1|Overall Study|Pap smear with significant pathology|10
830753|NCT01039584|2641361|P3|Overall Study|other|1
830754|NCT01039584|2641362|P2|Overall Study|other|3
830755|NCT01039584|2641363|P1|Overall Study|other|1
830756|NCT01039584|2641361|P3|Overall Study|Lack of Efficacy|10
830757|NCT01039584|2641362|P2|Overall Study|Lack of Efficacy|6
830758|NCT01039584|2641363|P1|Overall Study|Lack of Efficacy|7
830759|NCT01039584|2641361|P3|Overall Study|Negative Baseline culture for Candida|24
830760|NCT01039584|2641362|P2|Overall Study|Negative Baseline culture for Candida|59
830761|NCT01039584|2641363|P1|Overall Study|Negative Baseline culture for Candida|59
830762|NCT01039584|2641361|P3|Overall Study|Lost to Follow-up|4
830763|NCT01039584|2641362|P2|Overall Study|Lost to Follow-up|3
830764|NCT01039584|2641363|P1|Overall Study|Lost to Follow-up|5
830765|NCT01039584|2641361|P3|Overall Study|Protocol Violation|6
830766|NCT01039584|2641362|P2|Overall Study|Protocol Violation|4
830767|NCT01039584|2641363|P1|Overall Study|Protocol Violation|10
830768|NCT01039584|2641361|P3|Overall Study|Withdrawal by Subject|1
830769|NCT01039584|2641362|P2|Overall Study|Withdrawal by Subject|2
830770|NCT01039584|2641363|P1|Overall Study|Withdrawal by Subject|4
893635|NCT02102204|2834993|P1|Overall Study|Ongoing|5
893636|NCT02102204|2834993|P1|Overall Study|Sponsor Decision|5
893637|NCT02102204|2834993|P1|Overall Study|Lost to Follow-up|65
893638|NCT02102204|2834993|P1|Overall Study|Death|92
893639|NCT02102204|2834993|P1|Overall Study|Withdrawal by Subject|137
830781|NCT01040130|2641403|P6|Overall Study|Other reasons not listed above|0
830782|NCT01040130|2641404|P5|Overall Study|Other reasons not listed above|0
830783|NCT01040130|2641405|P4|Overall Study|Other reasons not listed above|0
830784|NCT01040130|2641406|P3|Overall Study|Other reasons not listed above|0
830785|NCT01040130|2641407|P2|Overall Study|Other reasons not listed above|0
830786|NCT01040130|2641408|P1|Overall Study|Other reasons not listed above|2
830787|NCT01040130|2641403|P6|Overall Study|Withdrawal by Subject|1
830788|NCT01040130|2641404|P5|Overall Study|Withdrawal by Subject|0
830789|NCT01040130|2641405|P4|Overall Study|Withdrawal by Subject|0
830790|NCT01040130|2641406|P3|Overall Study|Withdrawal by Subject|0
830791|NCT01040130|2641407|P2|Overall Study|Withdrawal by Subject|2
830792|NCT01040130|2641408|P1|Overall Study|Withdrawal by Subject|0
830793|NCT01040130|2641403|P6|Overall Study|Protocol Violation|0
830794|NCT01040130|2641404|P5|Overall Study|Protocol Violation|0
830795|NCT01040130|2641405|P4|Overall Study|Protocol Violation|0
830796|NCT01040130|2641406|P3|Overall Study|Protocol Violation|2
830797|NCT01040130|2641407|P2|Overall Study|Protocol Violation|0
830798|NCT01040130|2641408|P1|Overall Study|Protocol Violation|0
830799|NCT01040130|2641403|P6|Overall Study|Adverse Event|3
830800|NCT01040130|2641404|P5|Overall Study|Adverse Event|0
830801|NCT01040130|2641405|P4|Overall Study|Adverse Event|5
830802|NCT01040130|2641406|P3|Overall Study|Adverse Event|0
830803|NCT01040130|2641407|P2|Overall Study|Adverse Event|1
830804|NCT01040130|2641408|P1|Overall Study|Adverse Event|1
830805|NCT01040169|2641487|P2|Overall Study|Lost to Follow-up|8
830806|NCT01040169|2641488|P1|Overall Study|Lost to Follow-up|3
830807|NCT01029262|2641609|P2|Overall Study|Unspecified|5
830808|NCT01029262|2641610|P1|Overall Study|Unspecified|1
830809|NCT01029262|2641609|P2|Overall Study|Protocol Violation|3
830810|NCT01029262|2641610|P1|Overall Study|Protocol Violation|2
830811|NCT01029262|2641609|P2|Overall Study|Withdrawal by Subject|16
830812|NCT01029262|2641610|P1|Overall Study|Withdrawal by Subject|10
830813|NCT01029262|2641609|P2|Overall Study|Lack of therapeutic effect|69
830814|NCT01029262|2641610|P1|Overall Study|Lack of therapeutic effect|56
830815|NCT01029262|2641609|P2|Overall Study|Adverse Event|52
830816|NCT01029262|2641610|P1|Overall Study|Adverse Event|9
830817|NCT01029340|2641671|P6|Extension Period|Physician Decision|1
830818|NCT01029340|2641672|P5|Extension Period|Physician Decision|0
830819|NCT01029340|2641673|P4|Extension Period|Physician Decision|0
830820|NCT01029340|2641674|P3|Extension Period|Physician Decision|0
830821|NCT01029340|2641675|P2|Extension Period|Physician Decision|0
830822|NCT01029340|2641676|P1|Extension Period|Physician Decision|0
830823|NCT01029340|2641671|P6|Extension Period|Withdrawal by Subject|1
830824|NCT01029340|2641672|P5|Extension Period|Withdrawal by Subject|0
830825|NCT01029340|2641673|P4|Extension Period|Withdrawal by Subject|0
830826|NCT01029340|2641674|P3|Extension Period|Withdrawal by Subject|0
830827|NCT01029340|2641675|P2|Extension Period|Withdrawal by Subject|0
830828|NCT01029340|2641676|P1|Extension Period|Withdrawal by Subject|0
830829|NCT01029340|2641671|P6|Extension Period|non-compliance|1
830830|NCT01029340|2641672|P5|Extension Period|non-compliance|0
830831|NCT01029340|2641673|P4|Extension Period|non-compliance|0
830832|NCT01029340|2641674|P3|Extension Period|non-compliance|0
830833|NCT01029340|2641675|P2|Extension Period|non-compliance|0
830834|NCT01029340|2641676|P1|Extension Period|non-compliance|0
830835|NCT01029340|2641671|P6|Extension Period|starting another study|8
830836|NCT01029340|2641672|P5|Extension Period|starting another study|0
830837|NCT01029340|2641673|P4|Extension Period|starting another study|0
830838|NCT01029340|2641674|P3|Extension Period|starting another study|0
830839|NCT01029340|2641675|P2|Extension Period|starting another study|0
830840|NCT01029340|2641676|P1|Extension Period|starting another study|0
830841|NCT01029340|2641671|P6|Extension Period|Adverse Event|1
830842|NCT01029340|2641672|P5|Extension Period|Adverse Event|0
830843|NCT01029340|2641673|P4|Extension Period|Adverse Event|0
830844|NCT01029340|2641674|P3|Extension Period|Adverse Event|0
830845|NCT01029340|2641675|P2|Extension Period|Adverse Event|0
830846|NCT01029340|2641676|P1|Extension Period|Adverse Event|0
830847|NCT01029340|2641671|P6|Part B Treatment Period|Protocol Violation|0
830848|NCT01029340|2641672|P5|Part B Treatment Period|Protocol Violation|0
830849|NCT01029340|2641673|P4|Part B Treatment Period|Protocol Violation|0
830850|NCT01029340|2641674|P3|Part B Treatment Period|Protocol Violation|1
830851|NCT01029340|2641675|P2|Part B Treatment Period|Protocol Violation|0
830852|NCT01029340|2641676|P1|Part B Treatment Period|Protocol Violation|0
830853|NCT01029340|2641671|P6|Part B Treatment Period|Withdrawal by Subject|0
830854|NCT01029340|2641672|P5|Part B Treatment Period|Withdrawal by Subject|0
830855|NCT01029340|2641673|P4|Part B Treatment Period|Withdrawal by Subject|0
830856|NCT01029340|2641674|P3|Part B Treatment Period|Withdrawal by Subject|1
830857|NCT01029340|2641675|P2|Part B Treatment Period|Withdrawal by Subject|0
830858|NCT01029340|2641676|P1|Part B Treatment Period|Withdrawal by Subject|0
830867|NCT01029392|2641717|P2|Overall Study|Physician Decision|0
830868|NCT01029392|2641718|P1|Overall Study|Physician Decision|2
830869|NCT01029392|2641717|P2|Overall Study|Withdrawal by Subject|11
830870|NCT01029392|2641718|P1|Overall Study|Withdrawal by Subject|18
830871|NCT01029405|2641730|P4|Overall Study|Unspecified|1
830872|NCT01029405|2641731|P3|Overall Study|Unspecified|0
830873|NCT01029405|2641732|P2|Overall Study|Unspecified|1
830874|NCT01029405|2641733|P1|Overall Study|Unspecified|0
830875|NCT01029405|2641730|P4|Overall Study|Lost to Follow-up|2
830876|NCT01029405|2641731|P3|Overall Study|Lost to Follow-up|1
830877|NCT01029405|2641732|P2|Overall Study|Lost to Follow-up|1
830878|NCT01029405|2641733|P1|Overall Study|Lost to Follow-up|2
830879|NCT01029405|2641730|P4|Overall Study|Adverse Event|1
830880|NCT01029405|2641731|P3|Overall Study|Adverse Event|1
830881|NCT01029405|2641732|P2|Overall Study|Adverse Event|0
830882|NCT01029405|2641733|P1|Overall Study|Adverse Event|0
830883|NCT01029405|2641730|P4|Overall Study|Protocol Violation|1
830884|NCT01029405|2641731|P3|Overall Study|Protocol Violation|0
830885|NCT01029405|2641732|P2|Overall Study|Protocol Violation|0
830886|NCT01029405|2641733|P1|Overall Study|Protocol Violation|0
830887|NCT01029405|2641730|P4|Overall Study|Withdrawal by Subject|0
830888|NCT01029405|2641731|P3|Overall Study|Withdrawal by Subject|2
830889|NCT01029405|2641732|P2|Overall Study|Withdrawal by Subject|1
830890|NCT01029405|2641733|P1|Overall Study|Withdrawal by Subject|0
830891|NCT01029535|2641743|P1|Overall Study|Death|1
830892|NCT01029535|2641743|P1|Overall Study|Use of Another Treatment|1
830893|NCT01029535|2641743|P1|Overall Study|Adverse Event|1
830894|NCT01029535|2641743|P1|Overall Study|Participant Withdrew Consent|2
830895|NCT01029535|2641743|P1|Overall Study|Protocol Violation|2
830896|NCT01029535|2641743|P1|Overall Study|Lost to Follow-up|24
830897|NCT01029652|2641770|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
830898|NCT01029652|2641771|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
830899|NCT01029652|2641770|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
830900|NCT01029652|2641771|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
830901|NCT01029652|2641770|P2|Extension Study 2 (25-72 Weeks)|Death|1
830902|NCT01029652|2641771|P1|Extension Study 2 (25-72 Weeks)|Death|1
830903|NCT01029652|2641770|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
830904|NCT01029652|2641771|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
830905|NCT01029652|2641770|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
830906|NCT01029652|2641771|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
830907|NCT01029652|2641770|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
830908|NCT01029652|2641771|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
830909|NCT01029652|2641770|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
830910|NCT01029652|2641771|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
830911|NCT01029652|2641770|P2|Core Study (0-12 Weeks)|Death|1
830912|NCT01029652|2641771|P1|Core Study (0-12 Weeks)|Death|0
830913|NCT01029652|2641770|P2|Core Study (0-12 Weeks)|Administrative problems|1
830914|NCT01029652|2641771|P1|Core Study (0-12 Weeks)|Administrative problems|2
830915|NCT01029652|2641770|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
830916|NCT01029652|2641771|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
830917|NCT01029652|2641770|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
830918|NCT01029652|2641771|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
830919|NCT01029652|2641770|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
830920|NCT01029652|2641771|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
830921|NCT01029795|2641894|P2|Overall Study|Withdrawal by Subject|3
830922|NCT01029795|2641895|P1|Overall Study|Withdrawal by Subject|1
830923|NCT01029795|2641894|P2|Overall Study|Sponsor Decision|17
830924|NCT01029795|2641895|P1|Overall Study|Sponsor Decision|11
830925|NCT01029795|2641894|P2|Overall Study|Physician Decision|1
830926|NCT01029795|2641895|P1|Overall Study|Physician Decision|2
830927|NCT01029795|2641894|P2|Overall Study|Entry Criteria Not Met|1
830928|NCT01029795|2641895|P1|Overall Study|Entry Criteria Not Met|2
830929|NCT01029886|2641949|P2|Overall Study|Loss Glucose Control|1
830930|NCT01029886|2641950|P1|Overall Study|Loss Glucose Control|7
830931|NCT01029886|2641949|P2|Overall Study|Sponsor Decision|0
830932|NCT01029886|2641950|P1|Overall Study|Sponsor Decision|1
830933|NCT01029886|2641949|P2|Overall Study|Entry Criteria Not Met|5
830934|NCT01029886|2641950|P1|Overall Study|Entry Criteria Not Met|13
830935|NCT01029886|2641949|P2|Overall Study|Withdrawal by Subject|18
830936|NCT01029886|2641950|P1|Overall Study|Withdrawal by Subject|8
830937|NCT01029886|2641949|P2|Overall Study|Protocol Violation|5
830938|NCT01029886|2641950|P1|Overall Study|Protocol Violation|17
830939|NCT01029886|2641949|P2|Overall Study|Physician Decision|6
830940|NCT01029886|2641950|P1|Overall Study|Physician Decision|2
830941|NCT01029886|2641949|P2|Overall Study|Lost to Follow-up|0
830942|NCT01029886|2641950|P1|Overall Study|Lost to Follow-up|1
830943|NCT01029886|2641949|P2|Overall Study|Adverse Event|25
830944|NCT01029886|2641950|P1|Overall Study|Adverse Event|12
830945|NCT01029925|2641976|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
830946|NCT01029925|2641976|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
830947|NCT01029925|2641976|P1|Completion of Cycle 1 (28 Days)|Death|2
830948|NCT01030458|2641982|P2|Overall Study|Side effect of medication|1
830949|NCT01030458|2641983|P1|Overall Study|Side effect of medication|1
830950|NCT01030458|2641982|P2|Overall Study|Moved or changed job|13
830951|NCT01030458|2641983|P1|Overall Study|Moved or changed job|6
830952|NCT01030458|2641982|P2|Overall Study|Logistical reasons|5
830953|NCT01030458|2641983|P1|Overall Study|Logistical reasons|9
830954|NCT01030458|2641982|P2|Overall Study|Withdrawal by Subject|3
830955|NCT01030458|2641983|P1|Overall Study|Withdrawal by Subject|2
830956|NCT01030458|2641982|P2|Overall Study|Lost to Follow-up|10
830957|NCT01030458|2641983|P1|Overall Study|Lost to Follow-up|9
830958|NCT01030666|2642009|P2|Overall Study|Lost to Follow-up|2
830959|NCT01030666|2642010|P1|Overall Study|Lost to Follow-up|3
830960|NCT01030718|2642021|P3|Study CA180-036 Only|Other Reasons|0
830961|NCT01030718|2642022|P2|Study CA180-036 Only|Other Reasons|2
830962|NCT01030718|2642023|P1|Study CA180-036 Only|Other Reasons|0
830963|NCT01030718|2642021|P3|Study CA180-036 Only|Death|0
830964|NCT01030718|2642022|P2|Study CA180-036 Only|Death|1
830965|NCT01030718|2642023|P1|Study CA180-036 Only|Death|0
830966|NCT01030718|2642021|P3|Study CA180-036 Only|Adverse Event|0
830967|NCT01030718|2642022|P2|Study CA180-036 Only|Adverse Event|3
830968|NCT01030718|2642023|P1|Study CA180-036 Only|Adverse Event|2
830969|NCT01030718|2642021|P3|Study CA180-036 Only|insufficient effect|5
830970|NCT01030718|2642022|P2|Study CA180-036 Only|insufficient effect|1
830971|NCT01030718|2642023|P1|Study CA180-036 Only|insufficient effect|1
830972|NCT01030718|2642021|P3|Studies CA180-031 and -036 Combined|other reasons|0
830973|NCT01030718|2642022|P2|Studies CA180-031 and -036 Combined|other reasons|2
830974|NCT01030718|2642023|P1|Studies CA180-031 and -036 Combined|other reasons|0
830975|NCT01030718|2642021|P3|Studies CA180-031 and -036 Combined|Death|0
830976|NCT01030718|2642022|P2|Studies CA180-031 and -036 Combined|Death|1
830977|NCT01030718|2642023|P1|Studies CA180-031 and -036 Combined|Death|0
830978|NCT01030718|2642021|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
830979|NCT01030718|2642022|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
830980|NCT01030718|2642023|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
830981|NCT01030718|2642021|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
830982|NCT01030718|2642022|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
830983|NCT01030718|2642023|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
830984|NCT01030822|2642090|P3|Overall Study|Lost to Follow-up|7
830985|NCT01030822|2642091|P2|Overall Study|Lost to Follow-up|4
830986|NCT01030822|2642092|P1|Overall Study|Lost to Follow-up|9
830987|NCT01030822|2642090|P3|Overall Study|Withdrawal by Subject|16
830988|NCT01030822|2642091|P2|Overall Study|Withdrawal by Subject|13
830989|NCT01030822|2642092|P1|Overall Study|Withdrawal by Subject|16
830990|NCT01030822|2642090|P3|Overall Study|Moved/migrated from study area|3
830991|NCT01030822|2642091|P2|Overall Study|Moved/migrated from study area|7
830992|NCT01030822|2642092|P1|Overall Study|Moved/migrated from study area|6
830993|NCT01030952|2642141|P2|Overall Study|Unexplained|1
830994|NCT01030952|2642142|P1|Overall Study|Unexplained|1
830995|NCT01030952|2642141|P2|Overall Study|Lost to Follow-up|1
830996|NCT01030952|2642142|P1|Overall Study|Lost to Follow-up|0
830997|NCT01030952|2642141|P2|Overall Study|Informed consent withdrawal|0
830998|NCT01030952|2642142|P1|Overall Study|Informed consent withdrawal|1
830999|NCT01030952|2642141|P2|Overall Study|Protocol Violation|1
831000|NCT01030952|2642142|P1|Overall Study|Protocol Violation|0
893649|NCT02048241|2835016|P2|Overall Study|Withdrawal by Subject|1
893650|NCT02048241|2835017|P1|Overall Study|Withdrawal by Subject|0
831021|NCT01031004|2642203|P2|Overall Study|Lost to Follow-up|0
831022|NCT01031004|2642204|P1|Overall Study|Lost to Follow-up|1
831023|NCT01031004|2642203|P2|Overall Study|Protocol Violation|1
831024|NCT01031004|2642204|P1|Overall Study|Protocol Violation|0
831025|NCT01031381|2642268|P1|Overall Study|Withdrawal by Subject|6
831026|NCT01031381|2642268|P1|Overall Study|Physician Decision|3
831027|NCT01031446|2642273|P1|Overall Study|Still on treatment|1
831028|NCT01031446|2642273|P1|Overall Study|Withdrawal by Subject|3
831029|NCT01031446|2642273|P1|Overall Study|Physician Decision|4
831030|NCT01031446|2642273|P1|Overall Study|Adverse Event|9
831031|NCT01031446|2642273|P1|Overall Study|Disease Progression|38
831032|NCT01031628|2642314|P4|Overall Study|Study terminated early|0
831033|NCT01031628|2642315|P3|Overall Study|Study terminated early|3
831034|NCT01031628|2642316|P2|Overall Study|Study terminated early|1
831035|NCT01031628|2642317|P1|Overall Study|Study terminated early|0
831036|NCT01031680|2642329|P2|Overall Study|Various|2
831037|NCT01031680|2642330|P1|Overall Study|Various|0
831038|NCT01031680|2642329|P2|Overall Study|Administrative Reason by Sponsor|1
831039|NCT01031680|2642330|P1|Overall Study|Administrative Reason by Sponsor|0
831040|NCT01031680|2642329|P2|Overall Study|Incorrect Enrolment|2
831041|NCT01031680|2642330|P1|Overall Study|Incorrect Enrolment|1
831042|NCT01031680|2642329|P2|Overall Study|Safety|0
831043|NCT01031680|2642330|P1|Overall Study|Safety|1
831044|NCT01031680|2642329|P2|Overall Study|Poor/Non-compliance|6
831045|NCT01031680|2642330|P1|Overall Study|Poor/Non-compliance|5
831046|NCT01031680|2642329|P2|Overall Study|Subject No Longer Meets Study Criteria|17
831047|NCT01031680|2642330|P1|Overall Study|Subject No Longer Meets Study Criteria|26
831048|NCT01031680|2642329|P2|Overall Study|Death|1
831049|NCT01031680|2642330|P1|Overall Study|Death|2
831050|NCT01031680|2642329|P2|Overall Study|Withdrawal by Subject|16
831051|NCT01031680|2642330|P1|Overall Study|Withdrawal by Subject|12
831052|NCT01031680|2642329|P2|Overall Study|Lost to Follow-up|10
831053|NCT01031680|2642330|P1|Overall Study|Lost to Follow-up|2
831054|NCT01031680|2642329|P2|Overall Study|Adverse Event|3
831055|NCT01031680|2642330|P1|Overall Study|Adverse Event|8
831056|NCT01031706|2642348|P2|Overall Study|Withdrawal by Subject|1
831057|NCT01031706|2642349|P1|Overall Study|Withdrawal by Subject|1
831058|NCT01031706|2642348|P2|Overall Study|Adverse Event|0
831059|NCT01031706|2642349|P1|Overall Study|Adverse Event|1
831060|NCT01031979|2642383|P2|Overall Study|Lost to Follow-up|4
831061|NCT01031979|2642384|P1|Overall Study|Lost to Follow-up|5
831062|NCT01032018|2642398|P2|Overall Study|Death|1
831063|NCT01032018|2642399|P1|Overall Study|Death|0
831064|NCT01032018|2642398|P2|Overall Study|Lost to Follow-up|5
831065|NCT01032018|2642399|P1|Overall Study|Lost to Follow-up|6
831066|NCT01032044|2642409|P2|Overall Study|Lost to Follow-up|11
831067|NCT01032044|2642410|P1|Overall Study|Lost to Follow-up|11
831068|NCT01032044|2642409|P2|Overall Study|Adverse Event|1
831069|NCT01032044|2642410|P1|Overall Study|Adverse Event|0
831070|NCT01032044|2642409|P2|Overall Study|Protocol Violation|8
831071|NCT01032044|2642410|P1|Overall Study|Protocol Violation|14
831072|NCT01032070|2642418|P2|Overall Study|Withdrawal by Subject|2
831073|NCT01032070|2642419|P1|Overall Study|Withdrawal by Subject|0
831074|NCT01032070|2642418|P2|Overall Study|Medical or ethical reasons|2
831075|NCT01032070|2642419|P1|Overall Study|Medical or ethical reasons|0
831076|NCT01032070|2642418|P2|Overall Study|Disease progression|8
831077|NCT01032070|2642419|P1|Overall Study|Disease progression|13
831078|NCT01032174|2642676|P2|Overall Study|Adverse Event|1
831079|NCT01032174|2642677|P1|Overall Study|Adverse Event|0
831090|NCT01032291|2642728|P3|Proof of Concept|Never Received Study Drug|0
831091|NCT01032291|2642729|P2|Proof of Concept|Never Received Study Drug|1
831092|NCT01032291|2642730|P1|Proof of Concept|Never Received Study Drug|0
831093|NCT01032291|2642728|P3|Proof of Concept|Lack of Efficacy|0
831094|NCT01032291|2642729|P2|Proof of Concept|Lack of Efficacy|1
831095|NCT01032291|2642730|P1|Proof of Concept|Lack of Efficacy|0
831096|NCT01032291|2642728|P3|Proof of Concept|Death|2
831097|NCT01032291|2642729|P2|Proof of Concept|Death|1
831098|NCT01032291|2642730|P1|Proof of Concept|Death|0
831099|NCT01032291|2642728|P3|Proof of Concept|Adverse Event|1
831100|NCT01032291|2642729|P2|Proof of Concept|Adverse Event|5
831101|NCT01032291|2642730|P1|Proof of Concept|Adverse Event|0
831102|NCT01032291|2642728|P3|Safety Lead-in|Death|0
831103|NCT01032291|2642729|P2|Safety Lead-in|Death|0
831104|NCT01032291|2642730|P1|Safety Lead-in|Death|1
831105|NCT01032291|2642728|P3|Safety Lead-in|Adverse Event|0
831106|NCT01032291|2642729|P2|Safety Lead-in|Adverse Event|0
831107|NCT01032291|2642730|P1|Safety Lead-in|Adverse Event|1
831108|NCT01032382|2642756|P2|Overall Study|Index lesion relapse|3
831109|NCT01032382|2642757|P1|Overall Study|Index lesion relapse|1
831110|NCT01032382|2642756|P2|Overall Study|Treatment failure|1
831111|NCT01032382|2642757|P1|Overall Study|Treatment failure|3
831112|NCT01032382|2642756|P2|Overall Study|Disease dissemination|1
831113|NCT01032382|2642757|P1|Overall Study|Disease dissemination|1
831114|NCT01032837|2642844|P4|Overall Study|Refused treatment|1
831115|NCT01032837|2642845|P3|Overall Study|Refused treatment|0
831116|NCT01032837|2642846|P2|Overall Study|Refused treatment|0
831117|NCT01032837|2642847|P1|Overall Study|Refused treatment|0
831118|NCT01032837|2642844|P4|Overall Study|Failed to return|0
831119|NCT01032837|2642845|P3|Overall Study|Failed to return|1
831120|NCT01032837|2642846|P2|Overall Study|Failed to return|0
831121|NCT01032837|2642847|P1|Overall Study|Failed to return|0
831122|NCT01032837|2642844|P4|Overall Study|Withdrew consent|1
831123|NCT01032837|2642845|P3|Overall Study|Withdrew consent|0
831124|NCT01032837|2642846|P2|Overall Study|Withdrew consent|2
831125|NCT01032837|2642847|P1|Overall Study|Withdrew consent|0
831126|NCT01032837|2642844|P4|Overall Study|Adverse event/internal illness|1
831127|NCT01032837|2642845|P3|Overall Study|Adverse event/internal illness|0
831128|NCT01032837|2642846|P2|Overall Study|Adverse event/internal illness|1
831129|NCT01032837|2642847|P1|Overall Study|Adverse event/internal illness|0
831130|NCT01032889|2642903|P3|Overall Study|Miscellaneous Reasons|1
831131|NCT01032889|2642904|P2|Overall Study|Miscellaneous Reasons|1
831132|NCT01032889|2642905|P1|Overall Study|Miscellaneous Reasons|2
831133|NCT01032889|2642903|P3|Overall Study|Lack of Submental Fat|1
831134|NCT01032889|2642904|P2|Overall Study|Lack of Submental Fat|8
831135|NCT01032889|2642905|P1|Overall Study|Lack of Submental Fat|2
831136|NCT01032889|2642903|P3|Overall Study|Lost to Follow-up|0
831137|NCT01032889|2642904|P2|Overall Study|Lost to Follow-up|1
831138|NCT01032889|2642905|P1|Overall Study|Lost to Follow-up|1
831139|NCT01032889|2642903|P3|Overall Study|Patient Request|0
831140|NCT01032889|2642904|P2|Overall Study|Patient Request|1
831141|NCT01032889|2642905|P1|Overall Study|Patient Request|0
831142|NCT01032889|2642903|P3|Overall Study|Withdrawal of Consent|1
831143|NCT01032889|2642904|P2|Overall Study|Withdrawal of Consent|2
831144|NCT01032889|2642905|P1|Overall Study|Withdrawal of Consent|1
831145|NCT01032889|2642903|P3|Overall Study|Adverse Event|0
831146|NCT01032889|2642904|P2|Overall Study|Adverse Event|2
831147|NCT01032889|2642905|P1|Overall Study|Adverse Event|2
831148|NCT01032915|2642929|P4|Overall Study|Protocol Violation|1
831149|NCT01032915|2642930|P3|Overall Study|Protocol Violation|0
831150|NCT01032915|2642931|P2|Overall Study|Protocol Violation|0
831151|NCT01032915|2642932|P1|Overall Study|Protocol Violation|1
831152|NCT01032915|2642929|P4|Overall Study|Administrative reasons|4
831153|NCT01032915|2642930|P3|Overall Study|Administrative reasons|4
831154|NCT01032915|2642931|P2|Overall Study|Administrative reasons|6
831155|NCT01032915|2642932|P1|Overall Study|Administrative reasons|5
831156|NCT01032915|2642929|P4|Overall Study|Withdrawal by Subject|1
831157|NCT01032915|2642930|P3|Overall Study|Withdrawal by Subject|1
831158|NCT01032915|2642931|P2|Overall Study|Withdrawal by Subject|3
831159|NCT01032915|2642932|P1|Overall Study|Withdrawal by Subject|0
831160|NCT01032915|2642929|P4|Overall Study|Abnormal test procedure result|0
831161|NCT01032915|2642930|P3|Overall Study|Abnormal test procedure result|1
831162|NCT01032915|2642931|P2|Overall Study|Abnormal test procedure result|0
831163|NCT01032915|2642932|P1|Overall Study|Abnormal test procedure result|0
831164|NCT01032915|2642929|P4|Overall Study|Adverse Event|1
831165|NCT01032915|2642930|P3|Overall Study|Adverse Event|1
831166|NCT01032915|2642931|P2|Overall Study|Adverse Event|2
831167|NCT01032915|2642932|P1|Overall Study|Adverse Event|2
831168|NCT01033019|2642983|P2|Overall Study|Withdrawal by Subject|0
831169|NCT01033019|2642984|P1|Overall Study|Withdrawal by Subject|1
831170|NCT01033071|2643004|P3|Overall Study|Other|3
831171|NCT01033071|2643005|P2|Overall Study|Other|4
831172|NCT01033071|2643006|P1|Overall Study|Other|6
831173|NCT01033071|2643004|P3|Overall Study|Lack of Efficacy|1
831174|NCT01033071|2643005|P2|Overall Study|Lack of Efficacy|1
831175|NCT01033071|2643006|P1|Overall Study|Lack of Efficacy|0
831176|NCT01033071|2643004|P3|Overall Study|Withdrawal by Subject|11
831177|NCT01033071|2643005|P2|Overall Study|Withdrawal by Subject|14
831178|NCT01033071|2643006|P1|Overall Study|Withdrawal by Subject|17
831179|NCT01033071|2643004|P3|Overall Study|Lost to Follow-up|5
831180|NCT01033071|2643005|P2|Overall Study|Lost to Follow-up|5
831181|NCT01033071|2643006|P1|Overall Study|Lost to Follow-up|4
831182|NCT01033071|2643004|P3|Overall Study|Protocol Violation|1
831183|NCT01033071|2643005|P2|Overall Study|Protocol Violation|2
831184|NCT01033071|2643006|P1|Overall Study|Protocol Violation|0
831185|NCT01033071|2643004|P3|Overall Study|Adverse Event|26
831186|NCT01033071|2643005|P2|Overall Study|Adverse Event|51
831187|NCT01033071|2643006|P1|Overall Study|Adverse Event|28
831188|NCT01040351|2643076|P2|Overall Study|poor ovarian response|2
831189|NCT01040351|2643077|P1|Overall Study|poor ovarian response|1
831190|NCT01040403|2643085|P1|Overall Study|Other reason not defined above|6
831191|NCT01040403|2643085|P1|Overall Study|Not treated|1
831192|NCT01040403|2643085|P1|Overall Study|Lost to Follow-up|1
831193|NCT01040403|2643085|P1|Overall Study|Protocol Violation|2
831194|NCT01040403|2643085|P1|Overall Study|Adverse Event|10
831195|NCT01041859|2643282|P3|Double-Blind Maintenance|Withdrawal by Subject|9
831196|NCT01041859|2643283|P2|Double-Blind Maintenance|Withdrawal by Subject|8
831197|NCT01041859|2643284|P1|Double-Blind Maintenance|Withdrawal by Subject|0
831198|NCT01041859|2643282|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
831199|NCT01041859|2643283|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
831200|NCT01041859|2643284|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
831201|NCT01041859|2643282|P3|Double-Blind Maintenance|Other|2
831202|NCT01041859|2643283|P2|Double-Blind Maintenance|Other|6
831203|NCT01041859|2643284|P1|Double-Blind Maintenance|Other|0
831204|NCT01041859|2643282|P3|Double-Blind Maintenance|Protocol Violation|3
831205|NCT01041859|2643283|P2|Double-Blind Maintenance|Protocol Violation|1
831206|NCT01041859|2643284|P1|Double-Blind Maintenance|Protocol Violation|0
831207|NCT01041859|2643282|P3|Double-Blind Maintenance|Physician Decision|1
831208|NCT01041859|2643283|P2|Double-Blind Maintenance|Physician Decision|2
831209|NCT01041859|2643284|P1|Double-Blind Maintenance|Physician Decision|0
831210|NCT01041859|2643282|P3|Double-Blind Maintenance|Lost to Follow-up|0
831211|NCT01041859|2643283|P2|Double-Blind Maintenance|Lost to Follow-up|1
831212|NCT01041859|2643284|P1|Double-Blind Maintenance|Lost to Follow-up|0
831213|NCT01041859|2643282|P3|Double-Blind Maintenance|Lack of Efficacy|11
831214|NCT01041859|2643283|P2|Double-Blind Maintenance|Lack of Efficacy|3
831215|NCT01041859|2643284|P1|Double-Blind Maintenance|Lack of Efficacy|0
831216|NCT01041859|2643282|P3|Double-Blind Maintenance|Adverse Event|13
831217|NCT01041859|2643283|P2|Double-Blind Maintenance|Adverse Event|23
831218|NCT01041859|2643284|P1|Double-Blind Maintenance|Adverse Event|0
831219|NCT01041859|2643282|P3|Open-Label Titration|Withdrawal by Subject|0
831220|NCT01041859|2643283|P2|Open-Label Titration|Withdrawal by Subject|0
831221|NCT01041859|2643284|P1|Open-Label Titration|Withdrawal by Subject|11
831222|NCT01041859|2643282|P3|Open-Label Titration|Noncompliance With Study Drug|0
831223|NCT01041859|2643283|P2|Open-Label Titration|Noncompliance With Study Drug|0
831224|NCT01041859|2643284|P1|Open-Label Titration|Noncompliance With Study Drug|8
831225|NCT01041859|2643282|P3|Open-Label Titration|Other|0
831226|NCT01041859|2643283|P2|Open-Label Titration|Other|0
831227|NCT01041859|2643284|P1|Open-Label Titration|Other|7
831228|NCT01041859|2643282|P3|Open-Label Titration|Protocol Violation|0
831229|NCT01041859|2643283|P2|Open-Label Titration|Protocol Violation|0
831230|NCT01041859|2643284|P1|Open-Label Titration|Protocol Violation|1
831231|NCT01041859|2643282|P3|Open-Label Titration|Physician Decision|0
831232|NCT01041859|2643283|P2|Open-Label Titration|Physician Decision|0
831233|NCT01041859|2643284|P1|Open-Label Titration|Physician Decision|1
831234|NCT01041859|2643282|P3|Open-Label Titration|Lost to Follow-up|0
831235|NCT01041859|2643283|P2|Open-Label Titration|Lost to Follow-up|0
831236|NCT01041859|2643284|P1|Open-Label Titration|Lost to Follow-up|1
831237|NCT01041859|2643282|P3|Open-Label Titration|Lack of Efficacy|0
831238|NCT01041859|2643283|P2|Open-Label Titration|Lack of Efficacy|0
831239|NCT01041859|2643284|P1|Open-Label Titration|Lack of Efficacy|3
831240|NCT01041859|2643282|P3|Open-Label Titration|Adverse Event|0
831241|NCT01041859|2643283|P2|Open-Label Titration|Adverse Event|0
831242|NCT01041859|2643284|P1|Open-Label Titration|Adverse Event|69
831243|NCT01041976|2643301|P2|Overall Study|Death|4
831244|NCT01041976|2643302|P1|Overall Study|Death|0
831245|NCT01041976|2643301|P2|Overall Study|Incarceration|0
831246|NCT01041976|2643302|P1|Overall Study|Incarceration|2
831247|NCT01041976|2643301|P2|Overall Study|Withdrawal by Subject|0
831248|NCT01041976|2643302|P1|Overall Study|Withdrawal by Subject|3
831249|NCT01042093|2643314|P4|Overall Study|Withdrawal by Subject|1
831250|NCT01042093|2643315|P3|Overall Study|Withdrawal by Subject|0
831251|NCT01042093|2643316|P2|Overall Study|Withdrawal by Subject|0
831252|NCT01042093|2643317|P1|Overall Study|Withdrawal by Subject|0
831253|NCT01042093|2643314|P4|Overall Study|Protocol Violation|3
831254|NCT01042093|2643315|P3|Overall Study|Protocol Violation|2
831255|NCT01042093|2643316|P2|Overall Study|Protocol Violation|2
831256|NCT01042093|2643317|P1|Overall Study|Protocol Violation|2
831257|NCT01042158|2643354|P1|Overall Study|Physician Decision|1
831258|NCT01042236|2643361|P6|Treatment Period 3|Protocol Violation|0
831259|NCT01042236|2643362|P5|Treatment Period 3|Protocol Violation|0
831260|NCT01042236|2643363|P4|Treatment Period 3|Protocol Violation|1
831261|NCT01042236|2643364|P3|Treatment Period 3|Protocol Violation|0
831262|NCT01042236|2643365|P2|Treatment Period 3|Protocol Violation|0
831263|NCT01042236|2643366|P1|Treatment Period 3|Protocol Violation|0
831264|NCT01042236|2643361|P6|Treatment Period 3|Adverse Event|0
831265|NCT01042236|2643362|P5|Treatment Period 3|Adverse Event|0
831266|NCT01042236|2643363|P4|Treatment Period 3|Adverse Event|1
831267|NCT01042236|2643364|P3|Treatment Period 3|Adverse Event|0
831268|NCT01042236|2643365|P2|Treatment Period 3|Adverse Event|0
831269|NCT01042236|2643366|P1|Treatment Period 3|Adverse Event|0
831270|NCT01042236|2643361|P6|Treatment Period 1|Adverse Event|0
831271|NCT01042236|2643362|P5|Treatment Period 1|Adverse Event|1
831272|NCT01042236|2643363|P4|Treatment Period 1|Adverse Event|0
831273|NCT01042236|2643364|P3|Treatment Period 1|Adverse Event|0
831274|NCT01042236|2643365|P2|Treatment Period 1|Adverse Event|1
831275|NCT01042236|2643366|P1|Treatment Period 1|Adverse Event|0
831276|NCT01042392|2643427|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
831277|NCT01042392|2643428|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
831278|NCT01042392|2643429|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
831279|NCT01042392|2643430|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
831280|NCT01042392|2643427|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
831281|NCT01042392|2643428|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
831282|NCT01042392|2643429|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
831283|NCT01042392|2643430|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
831284|NCT01042392|2643427|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
831285|NCT01042392|2643428|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
831286|NCT01042392|2643429|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
831287|NCT01042392|2643430|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
831288|NCT01042392|2643427|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
831289|NCT01042392|2643428|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
831290|NCT01042392|2643429|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
831291|NCT01042392|2643430|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
831292|NCT01042392|2643427|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
831293|NCT01042392|2643428|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
831294|NCT01042392|2643429|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
831295|NCT01042392|2643430|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
831296|NCT01042392|2643427|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
831297|NCT01042392|2643428|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
831298|NCT01042392|2643429|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
831299|NCT01042392|2643430|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
831300|NCT01042392|2643427|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
831301|NCT01042392|2643428|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
831302|NCT01042392|2643429|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
831303|NCT01042392|2643430|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
831304|NCT01042392|2643427|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
831305|NCT01042392|2643428|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
831306|NCT01042392|2643429|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
831307|NCT01042392|2643430|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
831308|NCT01042392|2643427|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
831309|NCT01042392|2643428|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
831310|NCT01042392|2643429|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
831311|NCT01042392|2643430|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
831315|NCT01042600|2643490|P2|Overall Study|Ineligible|0
831316|NCT01042600|2643491|P1|Overall Study|Ineligible|1
831317|NCT01042678|2643515|P6|Overall Study|Physician Decision|0
831318|NCT01042678|2643516|P5|Overall Study|Physician Decision|0
831319|NCT01042678|2643517|P4|Overall Study|Physician Decision|0
831320|NCT01042678|2643518|P3|Overall Study|Physician Decision|0
831321|NCT01042678|2643519|P2|Overall Study|Physician Decision|0
831322|NCT01042678|2643520|P1|Overall Study|Physician Decision|1
831323|NCT01042938|2643549|P2|Overall Study|Ineligible: RTOG study conflict|0
831324|NCT01042938|2643550|P1|Overall Study|Ineligible: RTOG study conflict|1
831325|NCT01042938|2643549|P2|Overall Study|Protocol Violation|1
831326|NCT01042938|2643550|P1|Overall Study|Protocol Violation|1
831327|NCT01042938|2643549|P2|Overall Study|Withdrawal by Subject|1
831328|NCT01042938|2643550|P1|Overall Study|Withdrawal by Subject|1
831329|NCT01042977|2643564|P2|Overall Study|Various|0
831330|NCT01042977|2643565|P1|Overall Study|Various|3
831331|NCT01042977|2643564|P2|Overall Study|Administrative reason by sponsor|1
831332|NCT01042977|2643565|P1|Overall Study|Administrative reason by sponsor|0
831333|NCT01042977|2643564|P2|Overall Study|Safety|2
831334|NCT01042977|2643565|P1|Overall Study|Safety|0
831335|NCT01042977|2643564|P2|Overall Study|Incorrect enrollment|4
831336|NCT01042977|2643565|P1|Overall Study|Incorrect enrollment|6
831337|NCT01042977|2643564|P2|Overall Study|Subject no longer meets study criteria|13
831338|NCT01042977|2643565|P1|Overall Study|Subject no longer meets study criteria|15
831339|NCT01042977|2643564|P2|Overall Study|Poor/non-compliance|4
831340|NCT01042977|2643565|P1|Overall Study|Poor/non-compliance|3
831341|NCT01042977|2643564|P2|Overall Study|Lost to Follow-up|2
831342|NCT01042977|2643565|P1|Overall Study|Lost to Follow-up|0
831343|NCT01042977|2643564|P2|Overall Study|Withdrawal by Subject|16
831344|NCT01042977|2643565|P1|Overall Study|Withdrawal by Subject|8
831345|NCT01042977|2643564|P2|Overall Study|Death|1
831346|NCT01042977|2643565|P1|Overall Study|Death|2
831347|NCT01042977|2643564|P2|Overall Study|Adverse Event|12
831348|NCT01042977|2643565|P1|Overall Study|Adverse Event|4
831349|NCT01043185|2643630|P10|Period 6 - Third Washout Period|Protocol Violation|0
831350|NCT01043185|2643631|P9|Period 6 - Third Washout Period|Protocol Violation|1
831351|NCT01043185|2643632|P8|Period 6 - Third Washout Period|Protocol Violation|0
831352|NCT01043185|2643633|P7|Period 6 - Third Washout Period|Protocol Violation|0
831353|NCT01043185|2643634|P6|Period 6 - Third Washout Period|Protocol Violation|0
831354|NCT01043185|2643635|P5|Period 6 - Third Washout Period|Protocol Violation|0
831355|NCT01043185|2643636|P4|Period 6 - Third Washout Period|Protocol Violation|0
831356|NCT01043185|2643637|P3|Period 6 - Third Washout Period|Protocol Violation|0
831357|NCT01043185|2643638|P2|Period 6 - Third Washout Period|Protocol Violation|0
831358|NCT01043185|2643639|P1|Period 6 - Third Washout Period|Protocol Violation|0
831359|NCT01043705|2643741|P3|Overall Study|Unspecified|25
831360|NCT01043705|2643742|P2|Overall Study|Unspecified|19
831361|NCT01043705|2643743|P1|Overall Study|Unspecified|0
831362|NCT01043705|2643741|P3|Overall Study|Screen Fail|0
831363|NCT01043705|2643742|P2|Overall Study|Screen Fail|0
831364|NCT01043705|2643743|P1|Overall Study|Screen Fail|21
831365|NCT01043705|2643741|P3|Overall Study|Adverse Event|0
831366|NCT01043705|2643742|P2|Overall Study|Adverse Event|2
831367|NCT01043705|2643743|P1|Overall Study|Adverse Event|0
831368|NCT01043705|2643741|P3|Overall Study|Subsequent Procedure|29
831369|NCT01043705|2643742|P2|Overall Study|Subsequent Procedure|24
831370|NCT01043705|2643743|P1|Overall Study|Subsequent Procedure|9
831371|NCT01043705|2643741|P3|Overall Study|Site Closure|0
831372|NCT01043705|2643742|P2|Overall Study|Site Closure|0
831373|NCT01043705|2643743|P1|Overall Study|Site Closure|8
831374|NCT01043705|2643741|P3|Overall Study|Withdrawal by Subject|0
831375|NCT01043705|2643742|P2|Overall Study|Withdrawal by Subject|6
831376|NCT01043705|2643743|P1|Overall Study|Withdrawal by Subject|8
831377|NCT01043705|2643741|P3|Overall Study|Protocol Violation|0
831378|NCT01043705|2643742|P2|Overall Study|Protocol Violation|1
831379|NCT01043705|2643743|P1|Overall Study|Protocol Violation|2
831380|NCT01043705|2643741|P3|Overall Study|Multiple Reasons|0
831381|NCT01043705|2643742|P2|Overall Study|Multiple Reasons|7
831382|NCT01043705|2643743|P1|Overall Study|Multiple Reasons|4
831383|NCT01043705|2643741|P3|Overall Study|Lost to Follow-up|0
831384|NCT01043705|2643742|P2|Overall Study|Lost to Follow-up|12
831385|NCT01043705|2643743|P1|Overall Study|Lost to Follow-up|27
831386|NCT01043705|2643741|P3|Overall Study|Death|26
831387|NCT01043705|2643742|P2|Overall Study|Death|60
831388|NCT01043705|2643743|P1|Overall Study|Death|28
831389|NCT01043874|2643753|P1|Overall Study|Administrative Problems|1
831390|NCT01043874|2643753|P1|Overall Study|Lack of Efficacy|1
831391|NCT01043874|2643753|P1|Overall Study|Withdrawal by Subject|1
831392|NCT01043874|2643753|P1|Overall Study|Adverse Event|3
831393|NCT01036724|2643855|P2|Overall Study|Protocol Violation|5
831394|NCT01036724|2643856|P1|Overall Study|Protocol Violation|4
831395|NCT01036724|2643855|P2|Overall Study|Lack of Efficacy|1
831396|NCT01036724|2643856|P1|Overall Study|Lack of Efficacy|1
831397|NCT01036724|2643855|P2|Overall Study|Adverse Event|2
831398|NCT01036724|2643856|P1|Overall Study|Adverse Event|1
831399|NCT01036763|2643864|P1|Overall Study|Other reason (not specified)|40
831400|NCT01036763|2643864|P1|Overall Study|Lost to Follow-up|28
831401|NCT01036763|2643864|P1|Overall Study|Adverse Event|25
831402|NCT01037088|2643895|P1|Overall Study|Withdrawal by Subject|3
831403|NCT01037114|2643903|P1|Year 20|Others|1
831404|NCT01037127|2643918|P2|Overall Study|Study Closed Terminated|17
831405|NCT01037127|2643919|P1|Overall Study|Study Closed Terminated|2
831406|NCT01037127|2643918|P2|Overall Study|Physician Decision|0
831407|NCT01037127|2643919|P1|Overall Study|Physician Decision|1
831408|NCT01037127|2643918|P2|Overall Study|Lost to Follow-up|4
831409|NCT01037127|2643919|P1|Overall Study|Lost to Follow-up|2
831410|NCT01037218|2643966|P4|Overall Study|Various|1
831411|NCT01037218|2643967|P3|Overall Study|Various|3
831412|NCT01037218|2643968|P2|Overall Study|Various|2
831413|NCT01037218|2643969|P1|Overall Study|Various|3
831414|NCT01037218|2643966|P4|Overall Study|Protocol Violation|2
831415|NCT01037218|2643967|P3|Overall Study|Protocol Violation|2
831416|NCT01037218|2643968|P2|Overall Study|Protocol Violation|0
831417|NCT01037218|2643969|P1|Overall Study|Protocol Violation|0
831418|NCT01037218|2643966|P4|Overall Study|Partner Withdrew Consent|1
831419|NCT01037218|2643967|P3|Overall Study|Partner Withdrew Consent|2
831420|NCT01037218|2643968|P2|Overall Study|Partner Withdrew Consent|3
831421|NCT01037218|2643969|P1|Overall Study|Partner Withdrew Consent|0
831422|NCT01037218|2643966|P4|Overall Study|Withdrawal by Subject|4
831423|NCT01037218|2643967|P3|Overall Study|Withdrawal by Subject|7
831424|NCT01037218|2643968|P2|Overall Study|Withdrawal by Subject|7
831425|NCT01037218|2643969|P1|Overall Study|Withdrawal by Subject|6
831426|NCT01037218|2643966|P4|Overall Study|Lost to Follow-up|2
831427|NCT01037218|2643967|P3|Overall Study|Lost to Follow-up|4
831428|NCT01037218|2643968|P2|Overall Study|Lost to Follow-up|5
831429|NCT01037218|2643969|P1|Overall Study|Lost to Follow-up|3
831430|NCT01037218|2643966|P4|Overall Study|Lack of Efficacy|5
831431|NCT01037218|2643967|P3|Overall Study|Lack of Efficacy|1
831432|NCT01037218|2643968|P2|Overall Study|Lack of Efficacy|2
831433|NCT01037218|2643969|P1|Overall Study|Lack of Efficacy|0
831434|NCT01037218|2643966|P4|Overall Study|Adverse Event|1
831435|NCT01037218|2643967|P3|Overall Study|Adverse Event|2
831436|NCT01037218|2643968|P2|Overall Study|Adverse Event|2
831437|NCT01037218|2643969|P1|Overall Study|Adverse Event|4
831438|NCT01037244|2644031|P4|Overall Study|Various|1
831439|NCT01037244|2644032|P3|Overall Study|Various|1
831440|NCT01037244|2644033|P2|Overall Study|Various|2
831441|NCT01037244|2644034|P1|Overall Study|Various|3
831442|NCT01037244|2644031|P4|Overall Study|Partner Withdrew Consent|0
831443|NCT01037244|2644032|P3|Overall Study|Partner Withdrew Consent|0
831444|NCT01037244|2644033|P2|Overall Study|Partner Withdrew Consent|1
831445|NCT01037244|2644034|P1|Overall Study|Partner Withdrew Consent|2
831446|NCT01037244|2644031|P4|Overall Study|Withdrawal by Subject|5
831447|NCT01037244|2644032|P3|Overall Study|Withdrawal by Subject|3
831448|NCT01037244|2644033|P2|Overall Study|Withdrawal by Subject|5
831449|NCT01037244|2644034|P1|Overall Study|Withdrawal by Subject|1
831450|NCT01037244|2644031|P4|Overall Study|Lost to Follow-up|4
831451|NCT01037244|2644032|P3|Overall Study|Lost to Follow-up|4
831452|NCT01037244|2644033|P2|Overall Study|Lost to Follow-up|3
831453|NCT01037244|2644034|P1|Overall Study|Lost to Follow-up|3
831454|NCT01037244|2644031|P4|Overall Study|Lack of Efficacy|1
831455|NCT01037244|2644032|P3|Overall Study|Lack of Efficacy|0
831456|NCT01037244|2644033|P2|Overall Study|Lack of Efficacy|1
831457|NCT01037244|2644034|P1|Overall Study|Lack of Efficacy|1
831458|NCT01037244|2644031|P4|Overall Study|Adverse Event|3
831459|NCT01037244|2644032|P3|Overall Study|Adverse Event|6
831460|NCT01037244|2644033|P2|Overall Study|Adverse Event|2
831461|NCT01037244|2644034|P1|Overall Study|Adverse Event|3
831462|NCT01044290|2644167|P3|Follow-Up 2|Withdrawal by Subject|1
831463|NCT01044290|2644168|P2|Follow-Up 2|Withdrawal by Subject|1
831464|NCT01044290|2644169|P1|Follow-Up 2|Withdrawal by Subject|0
831465|NCT01044290|2644167|P3|Follow-Up 2|Death|1
831466|NCT01044290|2644168|P2|Follow-Up 2|Death|1
831467|NCT01044290|2644169|P1|Follow-Up 2|Death|0
831468|NCT01044290|2644167|P3|Follow-up 1|Withdrawal by Subject|0
831469|NCT01044290|2644168|P2|Follow-up 1|Withdrawal by Subject|2
831470|NCT01044290|2644169|P1|Follow-up 1|Withdrawal by Subject|2
831471|NCT01044290|2644167|P3|Follow-up 1|Death|1
831472|NCT01044290|2644168|P2|Follow-up 1|Death|3
831473|NCT01044290|2644169|P1|Follow-up 1|Death|3
831474|NCT01044303|2644192|P1|Overall Study|Lost to Follow-up|2
831475|NCT01044459|2644201|P2|Overall Study|Lost to Follow-up|12
831476|NCT01044459|2644202|P1|Overall Study|Lost to Follow-up|18
831477|NCT01044459|2644201|P2|Overall Study|COPD exacerbation|8
831478|NCT01044459|2644202|P1|Overall Study|COPD exacerbation|9
831479|NCT01044459|2644201|P2|Overall Study|Other Reason|14
831480|NCT01044459|2644202|P1|Overall Study|Other Reason|7
831481|NCT01044459|2644201|P2|Overall Study|Protocol Violation|16
831482|NCT01044459|2644202|P1|Overall Study|Protocol Violation|11
831483|NCT01044459|2644201|P2|Overall Study|Lack of Efficacy|12
831484|NCT01044459|2644202|P1|Overall Study|Lack of Efficacy|23
831485|NCT01044459|2644201|P2|Overall Study|Adverse Event|20
831486|NCT01044459|2644202|P1|Overall Study|Adverse Event|22
831487|NCT01044459|2644201|P2|Overall Study|Terminated by Sponsor|21
831488|NCT01044459|2644202|P1|Overall Study|Terminated by Sponsor|22
831489|NCT01044459|2644201|P2|Overall Study|Withdrawal by Subject|28
831490|NCT01044459|2644202|P1|Overall Study|Withdrawal by Subject|21
831491|NCT01044498|2644212|P2|Overall Study|Not specified|0
831492|NCT01044498|2644213|P1|Overall Study|Not specified|1
831493|NCT01044498|2644212|P2|Overall Study|Adverse Event|1
831494|NCT01044498|2644213|P1|Overall Study|Adverse Event|1
831495|NCT01044498|2644212|P2|Overall Study|Withdrew consent|1
831496|NCT01044498|2644213|P1|Overall Study|Withdrew consent|1
831497|NCT01045694|2644368|P1|Overall Study|Withdrawal by Subject|2
831498|NCT01045707|2644376|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
831499|NCT01045707|2644377|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
831500|NCT01045707|2644376|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
831501|NCT01045707|2644377|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
831502|NCT01045707|2644376|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
831503|NCT01045707|2644377|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
831504|NCT01045707|2644376|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
831505|NCT01045707|2644377|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
831506|NCT01045707|2644376|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
831507|NCT01045707|2644377|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
831508|NCT01045707|2644376|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
831509|NCT01045707|2644377|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
831510|NCT01045707|2644376|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
831511|NCT01045707|2644377|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
831512|NCT01045707|2644376|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
831513|NCT01045707|2644377|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
831514|NCT01045707|2644376|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
831515|NCT01045707|2644377|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
831516|NCT01045798|2644395|P2|Overall Study|Received Systemic Antifungal Prestudy|1
831517|NCT01045798|2644396|P1|Overall Study|Received Systemic Antifungal Prestudy|0
831518|NCT01045798|2644395|P2|Overall Study|Changed to Other Antifungal Therapy|2
831519|NCT01045798|2644396|P1|Overall Study|Changed to Other Antifungal Therapy|1
831520|NCT01045798|2644395|P2|Overall Study|Invasive Fungal Infection at Baseline|1
831521|NCT01045798|2644396|P1|Overall Study|Invasive Fungal Infection at Baseline|0
831522|NCT01045798|2644395|P2|Overall Study|Changed to Open-Label Caspofungin|0
831523|NCT01045798|2644396|P1|Overall Study|Changed to Open-Label Caspofungin|1
831524|NCT01045967|2644404|P2|Second Intervention|Protocol Violation|1
831525|NCT01045967|2644405|P1|Second Intervention|Protocol Violation|0
831526|NCT01045993|2644419|P4|Overall Study|Treated-later found eligibility not met|0
831527|NCT01045993|2644420|P3|Overall Study|Treated-later found eligibility not met|0
831528|NCT01045993|2644421|P2|Overall Study|Treated-later found eligibility not met|1
831529|NCT01045993|2644422|P1|Overall Study|Treated-later found eligibility not met|0
831530|NCT01046084|2644498|P2|Third Washout of 7 Days|Withdrawal by Subject|0
831531|NCT01046084|2644499|P1|Third Washout of 7 Days|Withdrawal by Subject|2
831532|NCT01046110|2644511|P2|Overall Study|Unclassified|35
831533|NCT01046110|2644512|P1|Overall Study|Unclassified|36
831534|NCT01046110|2644511|P2|Overall Study|Withdrawal Criteria|5
831535|NCT01046110|2644512|P1|Overall Study|Withdrawal Criteria|3
831536|NCT01046110|2644511|P2|Overall Study|Protocol Violation|12
831537|NCT01046110|2644512|P1|Overall Study|Protocol Violation|7
831538|NCT01046110|2644511|P2|Overall Study|Lack of Efficacy|1
831539|NCT01046110|2644512|P1|Overall Study|Lack of Efficacy|0
831540|NCT01046110|2644511|P2|Overall Study|Adverse Event|2
831541|NCT01046110|2644512|P1|Overall Study|Adverse Event|9
831542|NCT01046136|2644522|P2|Overall Study|Lost to Follow-up|3
831543|NCT01046136|2644523|P1|Overall Study|Lost to Follow-up|3
831544|NCT01046136|2644522|P2|Overall Study|Physician Decision|1
831545|NCT01046136|2644523|P1|Overall Study|Physician Decision|1
831546|NCT01046136|2644522|P2|Overall Study|Withdrawal by Subject|4
831547|NCT01046136|2644523|P1|Overall Study|Withdrawal by Subject|0
831548|NCT01046253|2644535|P2|Second Intervention|Protocol Violation|1
831549|NCT01046253|2644536|P1|Second Intervention|Protocol Violation|0
831550|NCT01046253|2644535|P2|Second Intervention|Adverse Event|1
831551|NCT01046253|2644536|P1|Second Intervention|Adverse Event|0
831552|NCT01046396|2644546|P1|Overall Study|Withdrawal by Subject|5
831553|NCT01046565|2644555|P1|Overall Study|Withdrawal by Subject|7
831554|NCT01046565|2644555|P1|Overall Study|Adverse Event|2
831555|NCT01046643|2644566|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
831556|NCT01046643|2644567|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
831557|NCT01046643|2644568|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
831558|NCT01046643|2644569|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
831559|NCT01046682|2644593|P2|Overall Study|Adverse Event|0
831560|NCT01046682|2644594|P1|Overall Study|Adverse Event|2
831561|NCT01046695|2644602|P2|Overall Study|TENS interfered with the cardiac monitor|1
831562|NCT01046695|2644603|P1|Overall Study|TENS interfered with the cardiac monitor|0
831563|NCT01046695|2644602|P2|Overall Study|Subject had a pacemaker|1
831564|NCT01046695|2644603|P1|Overall Study|Subject had a pacemaker|0
831565|NCT01046877|2644613|P1|Overall Study|Exited voluntarily after tube extrusion|11
831566|NCT01046877|2644613|P1|Overall Study|Exited voluntarily before tube extrusion|7
831567|NCT01046903|2644627|P1|Overall Study|Unspecified|5
831568|NCT01046903|2644627|P1|Overall Study|Withdrawal by Subject|3
831569|NCT01046903|2644627|P1|Overall Study|Adverse Event|4
831570|NCT01046903|2644627|P1|Overall Study|Lost to Follow-up|16
831571|NCT01047293|2644660|P4|Overall Study|DLT criteria not fulfilled|0
831572|NCT01047293|2644661|P3|Overall Study|DLT criteria not fulfilled|0
831573|NCT01047293|2644662|P2|Overall Study|DLT criteria not fulfilled|1
831574|NCT01047293|2644663|P1|Overall Study|DLT criteria not fulfilled|1
831575|NCT01047306|2644672|P2|Overall Study|Lost to Follow-up|0
831576|NCT01047306|2644673|P1|Overall Study|Lost to Follow-up|1
831577|NCT01047306|2644672|P2|Overall Study|Withdrawal by Subject|0
831578|NCT01047306|2644673|P1|Overall Study|Withdrawal by Subject|2
831579|NCT01047332|2644749|P2|Overall Study|Lost to Follow-up|3
831580|NCT01047332|2644750|P1|Overall Study|Lost to Follow-up|8
831581|NCT01047332|2644749|P2|Overall Study|Died Unobstructed|41
831582|NCT01047332|2644750|P1|Overall Study|Died Unobstructed|38
831583|NCT01047332|2644749|P2|Overall Study|SEMS Obstruction|20
831584|NCT01047332|2644750|P1|Overall Study|SEMS Obstruction|11
831585|NCT01047345|2644764|P3|Extension|Lost to Follow-up|5
831586|NCT01047345|2644765|P2|Extension|Lost to Follow-up|0
831587|NCT01047345|2644766|P1|Extension|Lost to Follow-up|0
831588|NCT01047345|2644764|P3|Extension|Withdrawal by Subject|1
831589|NCT01047345|2644765|P2|Extension|Withdrawal by Subject|0
831590|NCT01047345|2644766|P1|Extension|Withdrawal by Subject|0
831591|NCT01047345|2644764|P3|Base Study|Withdrawal by Subject|0
831592|NCT01047345|2644765|P2|Base Study|Withdrawal by Subject|4
831593|NCT01047345|2644766|P1|Base Study|Withdrawal by Subject|12
831594|NCT01047345|2644764|P3|Base Study|Protocol Violation|0
831595|NCT01047345|2644765|P2|Base Study|Protocol Violation|1
831596|NCT01047345|2644766|P1|Base Study|Protocol Violation|3
831597|NCT01047345|2644764|P3|Base Study|Lost to Follow-up|0
831598|NCT01047345|2644765|P2|Base Study|Lost to Follow-up|1
831599|NCT01047345|2644766|P1|Base Study|Lost to Follow-up|4
831600|NCT01047345|2644764|P3|Base Study|Adverse Event|0
831601|NCT01047345|2644765|P2|Base Study|Adverse Event|0
831602|NCT01047345|2644766|P1|Base Study|Adverse Event|3
831603|NCT01047436|2644795|P2|Overall Study|Protocol Violation|0
831604|NCT01047436|2644796|P1|Overall Study|Protocol Violation|1
831605|NCT01047553|2644837|P2|Overall Study|PI's decision|1
831606|NCT01047553|2644838|P1|Overall Study|PI's decision|0
831607|NCT01047553|2644837|P2|Overall Study|Sever Non-Compliance to Protocol|0
831608|NCT01047553|2644838|P1|Overall Study|Sever Non-Compliance to Protocol|1
831609|NCT01047553|2644837|P2|Overall Study|Lost to Follow-up|0
831610|NCT01047553|2644838|P1|Overall Study|Lost to Follow-up|1
831611|NCT01047553|2644837|P2|Overall Study|Development of Study-Specific Withdrawal|1
831612|NCT01047553|2644838|P1|Overall Study|Development of Study-Specific Withdrawal|1
831613|NCT01047553|2644837|P2|Overall Study|Withdrawal by Subject|2
831614|NCT01047553|2644838|P1|Overall Study|Withdrawal by Subject|4
831615|NCT01047553|2644837|P2|Overall Study|Adverse Event|5
831616|NCT01047553|2644838|P1|Overall Study|Adverse Event|10
831617|NCT01040689|2644940|P4|Overall Study|Other reasons not listed above|0
831618|NCT01040689|2644941|P3|Overall Study|Other reasons not listed above|0
831619|NCT01040689|2644942|P2|Overall Study|Other reasons not listed above|1
831620|NCT01040689|2644943|P1|Overall Study|Other reasons not listed above|0
831621|NCT01040689|2644940|P4|Overall Study|Withdrawal by Subject|0
831622|NCT01040689|2644941|P3|Overall Study|Withdrawal by Subject|1
831623|NCT01040689|2644942|P2|Overall Study|Withdrawal by Subject|1
831624|NCT01040689|2644943|P1|Overall Study|Withdrawal by Subject|2
831625|NCT01040689|2644940|P4|Overall Study|Lost to Follow-up|0
831626|NCT01040689|2644941|P3|Overall Study|Lost to Follow-up|0
831627|NCT01040689|2644942|P2|Overall Study|Lost to Follow-up|0
831628|NCT01040689|2644943|P1|Overall Study|Lost to Follow-up|1
831629|NCT01040689|2644940|P4|Overall Study|Lack of Efficacy|0
831630|NCT01040689|2644941|P3|Overall Study|Lack of Efficacy|1
831631|NCT01040689|2644942|P2|Overall Study|Lack of Efficacy|0
831632|NCT01040689|2644943|P1|Overall Study|Lack of Efficacy|0
831633|NCT01040689|2644940|P4|Overall Study|Adverse Event|4
831634|NCT01040689|2644941|P3|Overall Study|Adverse Event|2
831635|NCT01040689|2644942|P2|Overall Study|Adverse Event|0
831636|NCT01040689|2644943|P1|Overall Study|Adverse Event|0
831637|NCT01040728|2645013|P4|Overall Study|Other reasons not listed above|0
831638|NCT01040728|2645014|P3|Overall Study|Other reasons not listed above|0
831639|NCT01040728|2645015|P2|Overall Study|Other reasons not listed above|1
831640|NCT01040728|2645016|P1|Overall Study|Other reasons not listed above|0
831641|NCT01040728|2645013|P4|Overall Study|Lack of Efficacy|1
831642|NCT01040728|2645014|P3|Overall Study|Lack of Efficacy|0
831643|NCT01040728|2645015|P2|Overall Study|Lack of Efficacy|1
831644|NCT01040728|2645016|P1|Overall Study|Lack of Efficacy|0
831645|NCT01040728|2645013|P4|Overall Study|Protocol Violation|1
831646|NCT01040728|2645014|P3|Overall Study|Protocol Violation|0
831647|NCT01040728|2645015|P2|Overall Study|Protocol Violation|0
831648|NCT01040728|2645016|P1|Overall Study|Protocol Violation|0
831649|NCT01040728|2645013|P4|Overall Study|Withdrawal by Subject|0
831650|NCT01040728|2645014|P3|Overall Study|Withdrawal by Subject|1
831651|NCT01040728|2645015|P2|Overall Study|Withdrawal by Subject|1
831652|NCT01040728|2645016|P1|Overall Study|Withdrawal by Subject|0
831653|NCT01040728|2645013|P4|Overall Study|Adverse Event|4
831654|NCT01040728|2645014|P3|Overall Study|Adverse Event|0
831655|NCT01040728|2645015|P2|Overall Study|Adverse Event|8
831656|NCT01040728|2645016|P1|Overall Study|Adverse Event|4
831657|NCT01040780|2645088|P2|Overall Study|Protocol Violation|3
831658|NCT01040780|2645089|P1|Overall Study|Protocol Violation|1
831659|NCT01040793|2645103|P6|Overall Study|Other reasons not listed above|0
831660|NCT01040793|2645104|P5|Overall Study|Other reasons not listed above|1
831661|NCT01040793|2645105|P4|Overall Study|Other reasons not listed above|0
831662|NCT01040793|2645106|P3|Overall Study|Other reasons not listed above|1
831663|NCT01040793|2645107|P2|Overall Study|Other reasons not listed above|0
831664|NCT01040793|2645108|P1|Overall Study|Other reasons not listed above|0
831665|NCT01040793|2645103|P6|Overall Study|Withdrawal by Subject|0
831666|NCT01040793|2645104|P5|Overall Study|Withdrawal by Subject|0
831667|NCT01040793|2645105|P4|Overall Study|Withdrawal by Subject|2
831668|NCT01040793|2645106|P3|Overall Study|Withdrawal by Subject|0
831669|NCT01040793|2645107|P2|Overall Study|Withdrawal by Subject|0
831670|NCT01040793|2645108|P1|Overall Study|Withdrawal by Subject|0
831671|NCT01040793|2645103|P6|Overall Study|Lost to Follow-up|0
831672|NCT01040793|2645104|P5|Overall Study|Lost to Follow-up|0
831673|NCT01040793|2645105|P4|Overall Study|Lost to Follow-up|0
831674|NCT01040793|2645106|P3|Overall Study|Lost to Follow-up|1
831675|NCT01040793|2645107|P2|Overall Study|Lost to Follow-up|1
831676|NCT01040793|2645108|P1|Overall Study|Lost to Follow-up|0
831677|NCT01040793|2645103|P6|Overall Study|Protocol Violation|0
831678|NCT01040793|2645104|P5|Overall Study|Protocol Violation|1
831679|NCT01040793|2645105|P4|Overall Study|Protocol Violation|0
831680|NCT01040793|2645106|P3|Overall Study|Protocol Violation|1
831681|NCT01040793|2645107|P2|Overall Study|Protocol Violation|1
831682|NCT01040793|2645108|P1|Overall Study|Protocol Violation|1
831683|NCT01040793|2645103|P6|Overall Study|Adverse Event|1
831684|NCT01040793|2645104|P5|Overall Study|Adverse Event|2
831685|NCT01040793|2645105|P4|Overall Study|Adverse Event|2
831686|NCT01040793|2645106|P3|Overall Study|Adverse Event|0
831687|NCT01040793|2645107|P2|Overall Study|Adverse Event|3
831688|NCT01040793|2645108|P1|Overall Study|Adverse Event|5
831689|NCT01040832|2645196|P2|Overall Study|Unspecified|1
831690|NCT01040832|2645197|P1|Overall Study|Unspecified|2
831691|NCT01040832|2645196|P2|Overall Study|Symptomatic deterioration|5
831692|NCT01040832|2645197|P1|Overall Study|Symptomatic deterioration|2
831693|NCT01040832|2645196|P2|Overall Study|Progressive disease|17
831694|NCT01040832|2645197|P1|Overall Study|Progressive disease|32
831695|NCT01040832|2645196|P2|Overall Study|Withdrawal by Subject|3
831696|NCT01040832|2645197|P1|Overall Study|Withdrawal by Subject|2
831697|NCT01040832|2645196|P2|Overall Study|Death|6
831698|NCT01040832|2645197|P1|Overall Study|Death|4
831699|NCT01040832|2645196|P2|Overall Study|Adverse Event|5
831700|NCT01040832|2645197|P1|Overall Study|Adverse Event|4
831701|NCT01040845|2645213|P2|Overall Study|Physician Decision|0
831702|NCT01040845|2645214|P1|Overall Study|Physician Decision|1
831703|NCT01040845|2645213|P2|Overall Study|Withdrawal by Subject|1
831704|NCT01040845|2645214|P1|Overall Study|Withdrawal by Subject|1
831705|NCT01040871|2645260|P2|Overall Study|Randomized and Not Treated|1
831706|NCT01040871|2645261|P1|Overall Study|Randomized and Not Treated|2
831707|NCT01040871|2645260|P2|Overall Study|drug supply issue|0
831708|NCT01040871|2645261|P1|Overall Study|drug supply issue|1
831709|NCT01040871|2645260|P2|Overall Study|Lack of Efficacy|1
831710|NCT01040871|2645261|P1|Overall Study|Lack of Efficacy|1
831711|NCT01040871|2645260|P2|Overall Study|Death|3
831712|NCT01040871|2645261|P1|Overall Study|Death|1
831713|NCT01040871|2645260|P2|Overall Study|Withdrawal by Subject|0
831714|NCT01040871|2645261|P1|Overall Study|Withdrawal by Subject|2
831715|NCT01040871|2645260|P2|Overall Study|Adverse Event|2
831716|NCT01040871|2645261|P1|Overall Study|Adverse Event|6
831717|NCT01041287|2645292|P2|Treatment Period 2 (3 Months)|Adverse Event|2
831718|NCT01041287|2645293|P1|Treatment Period 2 (3 Months)|Adverse Event|0
831719|NCT01041287|2645292|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
831720|NCT01041287|2645293|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
831721|NCT01041404|2645305|P2|Overall Study|Not Specified|23
831722|NCT01041404|2645306|P1|Overall Study|Not Specified|11
831723|NCT01041404|2645305|P2|Overall Study|Failure to Return|2
831724|NCT01041404|2645306|P1|Overall Study|Failure to Return|1
831725|NCT01041404|2645305|P2|Overall Study|Withdrawal by Subject|23
831726|NCT01041404|2645306|P1|Overall Study|Withdrawal by Subject|29
831727|NCT01041404|2645305|P2|Overall Study|Protocol Violation|0
831728|NCT01041404|2645306|P1|Overall Study|Protocol Violation|4
831729|NCT01041404|2645305|P2|Overall Study|Violation of Selection Criteria|1
831730|NCT01041404|2645306|P1|Overall Study|Violation of Selection Criteria|0
831731|NCT01041404|2645305|P2|Overall Study|Lack of Efficacy|210
831732|NCT01041404|2645306|P1|Overall Study|Lack of Efficacy|200
831733|NCT01041404|2645305|P2|Overall Study|Adverse Event|35
831734|NCT01041404|2645306|P1|Overall Study|Adverse Event|45
831735|NCT01041417|2645347|P2|Overall Study|Death|0
831736|NCT01041417|2645348|P1|Overall Study|Death|1
831737|NCT01041417|2645347|P2|Overall Study|Lost to Follow-up|1
831738|NCT01041417|2645348|P1|Overall Study|Lost to Follow-up|1
831739|NCT01041417|2645347|P2|Overall Study|Adverse Event|2
831740|NCT01041417|2645348|P1|Overall Study|Adverse Event|5
831741|NCT01041573|2645388|P4|Overall Study|positive to anti-HCV|0
831742|NCT01041573|2645389|P3|Overall Study|positive to anti-HCV|0
831743|NCT01041573|2645390|P2|Overall Study|positive to anti-HCV|0
831744|NCT01041573|2645391|P1|Overall Study|positive to anti-HCV|1
831745|NCT01041573|2645388|P4|Overall Study|further blood extraction|0
831746|NCT01041573|2645389|P3|Overall Study|further blood extraction|0
831747|NCT01041573|2645390|P2|Overall Study|further blood extraction|1
831748|NCT01041573|2645391|P1|Overall Study|further blood extraction|0
831749|NCT01041573|2645388|P4|Overall Study|relocation|1
831750|NCT01041573|2645389|P3|Overall Study|relocation|3
831751|NCT01041573|2645390|P2|Overall Study|relocation|4
831752|NCT01041573|2645391|P1|Overall Study|relocation|1
831753|NCT01041573|2645388|P4|Overall Study|Adverse Event|0
831754|NCT01041573|2645389|P3|Overall Study|Adverse Event|0
831755|NCT01041573|2645390|P2|Overall Study|Adverse Event|2
831756|NCT01041573|2645391|P1|Overall Study|Adverse Event|0
831757|NCT01041573|2645388|P4|Overall Study|Lost to Follow-up|1
831758|NCT01041573|2645389|P3|Overall Study|Lost to Follow-up|2
831759|NCT01041573|2645390|P2|Overall Study|Lost to Follow-up|1
831760|NCT01041573|2645391|P1|Overall Study|Lost to Follow-up|0
831761|NCT01041573|2645388|P4|Overall Study|Death|0
831762|NCT01041573|2645389|P3|Overall Study|Death|0
831763|NCT01041573|2645390|P2|Overall Study|Death|0
831764|NCT01041573|2645391|P1|Overall Study|Death|1
831765|NCT01041573|2645388|P4|Overall Study|Withdrawal by Subject|0
831766|NCT01041573|2645389|P3|Overall Study|Withdrawal by Subject|2
831767|NCT01041573|2645390|P2|Overall Study|Withdrawal by Subject|5
831768|NCT01041573|2645391|P1|Overall Study|Withdrawal by Subject|2
831769|NCT01041638|2645401|P1|Overall Study|Withdrawal by Subject|11
831770|NCT01041638|2645401|P1|Overall Study|Physician Decision|4
831771|NCT01041638|2645401|P1|Overall Study|Lack of Efficacy|7
831772|NCT01041638|2645401|P1|Overall Study|Death|1
831773|NCT01041638|2645401|P1|Overall Study|Adverse Event|4
831774|NCT01048099|2645405|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
831775|NCT01048099|2645405|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
831776|NCT01048242|2645424|P2|Overall Study|See study flow chart|2
831777|NCT01048242|2645425|P1|Overall Study|See study flow chart|4
831778|NCT01048333|2645431|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
831779|NCT01048333|2645432|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
831780|NCT01048333|2645433|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
831781|NCT01048333|2645434|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
831782|NCT01048333|2645435|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
831783|NCT01048333|2645436|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
831784|NCT01048788|2645470|P3|Overall Study|Withdrawal by Subject|0
831785|NCT01048788|2645471|P2|Overall Study|Withdrawal by Subject|1
831786|NCT01048788|2645472|P1|Overall Study|Withdrawal by Subject|0
831787|NCT01048788|2645470|P3|Overall Study|Lack of Efficacy|1
831788|NCT01048788|2645471|P2|Overall Study|Lack of Efficacy|0
831789|NCT01048788|2645472|P1|Overall Study|Lack of Efficacy|0
831790|NCT01048788|2645470|P3|Overall Study|Adverse Event|1
831791|NCT01048788|2645471|P2|Overall Study|Adverse Event|1
831792|NCT01048788|2645472|P1|Overall Study|Adverse Event|5
831793|NCT01048866|2645482|P2|Overall Study|not specified|1
831794|NCT01048866|2645483|P1|Overall Study|not specified|1
831795|NCT01048866|2645482|P2|Overall Study|Lost to Follow-up|2
831796|NCT01048866|2645483|P1|Overall Study|Lost to Follow-up|0
831797|NCT01048866|2645482|P2|Overall Study|Withdrawal by Subject|2
831798|NCT01048866|2645483|P1|Overall Study|Withdrawal by Subject|0
831799|NCT01048866|2645482|P2|Overall Study|Physician Decision|0
831800|NCT01048866|2645483|P1|Overall Study|Physician Decision|1
831801|NCT01048866|2645482|P2|Overall Study|Protocol Violation|0
831802|NCT01048866|2645483|P1|Overall Study|Protocol Violation|1
831803|NCT01048866|2645482|P2|Overall Study|Adverse Event|0
831804|NCT01048866|2645483|P1|Overall Study|Adverse Event|1
831805|NCT01048944|2645545|P4|Overall Study|Protocol Violation|2
831806|NCT01048944|2645546|P3|Overall Study|Protocol Violation|10
831807|NCT01048944|2645547|P2|Overall Study|Protocol Violation|10
831808|NCT01048944|2645548|P1|Overall Study|Protocol Violation|8
831809|NCT01049009|2645564|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
831810|NCT01049009|2645565|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
831811|NCT01049009|2645564|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
831812|NCT01049009|2645565|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
831813|NCT01049009|2645564|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
831814|NCT01049009|2645565|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
831815|NCT01049009|2645564|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
831816|NCT01049009|2645565|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
831817|NCT01049217|2645575|P2|Overall Study|Randomized but not Treated|2
831818|NCT01049217|2645576|P1|Overall Study|Randomized but not Treated|0
831819|NCT01049217|2645575|P2|Overall Study|Unspecified|2
831820|NCT01049217|2645576|P1|Overall Study|Unspecified|1
831821|NCT01049217|2645575|P2|Overall Study|Study Terminated by Sponsor|43
831822|NCT01049217|2645576|P1|Overall Study|Study Terminated by Sponsor|43
831823|NCT01049217|2645575|P2|Overall Study|Pregnancy|0
831824|NCT01049217|2645576|P1|Overall Study|Pregnancy|1
831825|NCT01049217|2645575|P2|Overall Study|Protocol Violation|3
831826|NCT01049217|2645576|P1|Overall Study|Protocol Violation|1
831827|NCT01049217|2645575|P2|Overall Study|Withdrawal by Subject|3
831828|NCT01049217|2645576|P1|Overall Study|Withdrawal by Subject|4
831829|NCT01049217|2645575|P2|Overall Study|Lost to Follow-up|8
831830|NCT01049217|2645576|P1|Overall Study|Lost to Follow-up|3
831831|NCT01049217|2645575|P2|Overall Study|Lack of Efficacy|1
831832|NCT01049217|2645576|P1|Overall Study|Lack of Efficacy|1
831833|NCT01049217|2645575|P2|Overall Study|Adverse Event|1
831834|NCT01049217|2645576|P1|Overall Study|Adverse Event|2
831835|NCT01049308|2645650|P1|Pill Counts|Withdrawal by Subject|83
831836|NCT01049334|2645659|P2|Overall Study|Protocol Violation|1
831837|NCT01049334|2645660|P1|Overall Study|Protocol Violation|0
831838|NCT01049334|2645659|P2|Overall Study|Physician Decision|0
831839|NCT01049334|2645660|P1|Overall Study|Physician Decision|2
831840|NCT01049334|2645659|P2|Overall Study|Adverse Event|3
831841|NCT01049334|2645660|P1|Overall Study|Adverse Event|2
831842|NCT01049334|2645659|P2|Overall Study|Withdrawal by Subject|3
831843|NCT01049334|2645660|P1|Overall Study|Withdrawal by Subject|5
831844|NCT01049360|2645696|P20|Period 4|Withdrawal by Subject|0
831845|NCT01049360|2645697|P19|Period 4|Withdrawal by Subject|0
831846|NCT01049360|2645698|P18|Period 4|Withdrawal by Subject|0
831847|NCT01049360|2645699|P17|Period 4|Withdrawal by Subject|0
831848|NCT01049360|2645700|P16|Period 4|Withdrawal by Subject|0
831849|NCT01049360|2645701|P15|Period 4|Withdrawal by Subject|0
831850|NCT01049360|2645702|P14|Period 4|Withdrawal by Subject|0
831851|NCT01049360|2645703|P13|Period 4|Withdrawal by Subject|0
831852|NCT01049360|2645704|P12|Period 4|Withdrawal by Subject|0
831853|NCT01049360|2645705|P11|Period 4|Withdrawal by Subject|0
831854|NCT01049360|2645706|P10|Period 4|Withdrawal by Subject|0
831855|NCT01049360|2645707|P9|Period 4|Withdrawal by Subject|0
831856|NCT01049360|2645708|P8|Period 4|Withdrawal by Subject|0
831857|NCT01049360|2645709|P7|Period 4|Withdrawal by Subject|0
831858|NCT01049360|2645710|P6|Period 4|Withdrawal by Subject|0
831859|NCT01049360|2645711|P5|Period 4|Withdrawal by Subject|0
831860|NCT01049360|2645712|P4|Period 4|Withdrawal by Subject|1
831861|NCT01049360|2645713|P3|Period 4|Withdrawal by Subject|0
831862|NCT01049360|2645714|P2|Period 4|Withdrawal by Subject|0
831863|NCT01049360|2645715|P1|Period 4|Withdrawal by Subject|0
831864|NCT01049360|2645696|P20|Period 4|Protocol Violation|0
831865|NCT01049360|2645697|P19|Period 4|Protocol Violation|0
831866|NCT01049360|2645698|P18|Period 4|Protocol Violation|1
831867|NCT01049360|2645699|P17|Period 4|Protocol Violation|0
831868|NCT01049360|2645700|P16|Period 4|Protocol Violation|0
831869|NCT01049360|2645701|P15|Period 4|Protocol Violation|0
831870|NCT01049360|2645702|P14|Period 4|Protocol Violation|0
831871|NCT01049360|2645703|P13|Period 4|Protocol Violation|0
831872|NCT01049360|2645704|P12|Period 4|Protocol Violation|0
831873|NCT01049360|2645705|P11|Period 4|Protocol Violation|0
831874|NCT01049360|2645706|P10|Period 4|Protocol Violation|0
831875|NCT01049360|2645707|P9|Period 4|Protocol Violation|0
831876|NCT01049360|2645708|P8|Period 4|Protocol Violation|0
831877|NCT01049360|2645709|P7|Period 4|Protocol Violation|0
831878|NCT01049360|2645710|P6|Period 4|Protocol Violation|0
831879|NCT01049360|2645711|P5|Period 4|Protocol Violation|0
831880|NCT01049360|2645712|P4|Period 4|Protocol Violation|0
831881|NCT01049360|2645713|P3|Period 4|Protocol Violation|0
831882|NCT01049360|2645714|P2|Period 4|Protocol Violation|0
831883|NCT01049360|2645715|P1|Period 4|Protocol Violation|0
831884|NCT01049360|2645696|P20|Period 2|Lack of Efficacy|0
831885|NCT01049360|2645697|P19|Period 2|Lack of Efficacy|0
831886|NCT01049360|2645698|P18|Period 2|Lack of Efficacy|0
831887|NCT01049360|2645699|P17|Period 2|Lack of Efficacy|0
831888|NCT01049360|2645700|P16|Period 2|Lack of Efficacy|0
831889|NCT01049360|2645701|P15|Period 2|Lack of Efficacy|0
831890|NCT01049360|2645702|P14|Period 2|Lack of Efficacy|0
831891|NCT01049360|2645703|P13|Period 2|Lack of Efficacy|0
831892|NCT01049360|2645704|P12|Period 2|Lack of Efficacy|0
831893|NCT01049360|2645705|P11|Period 2|Lack of Efficacy|0
831894|NCT01049360|2645706|P10|Period 2|Lack of Efficacy|0
831895|NCT01049360|2645707|P9|Period 2|Lack of Efficacy|0
831896|NCT01049360|2645708|P8|Period 2|Lack of Efficacy|0
831897|NCT01049360|2645709|P7|Period 2|Lack of Efficacy|0
831898|NCT01049360|2645710|P6|Period 2|Lack of Efficacy|1
831899|NCT01049360|2645711|P5|Period 2|Lack of Efficacy|0
831900|NCT01049360|2645712|P4|Period 2|Lack of Efficacy|0
831901|NCT01049360|2645713|P3|Period 2|Lack of Efficacy|0
831902|NCT01049360|2645714|P2|Period 2|Lack of Efficacy|0
831903|NCT01049360|2645715|P1|Period 2|Lack of Efficacy|0
831904|NCT01049360|2645696|P20|Period 2|Withdrawal by Subject|1
831905|NCT01049360|2645697|P19|Period 2|Withdrawal by Subject|0
831906|NCT01049360|2645698|P18|Period 2|Withdrawal by Subject|0
831907|NCT01049360|2645699|P17|Period 2|Withdrawal by Subject|0
831908|NCT01049360|2645700|P16|Period 2|Withdrawal by Subject|0
831909|NCT01049360|2645701|P15|Period 2|Withdrawal by Subject|1
831910|NCT01049360|2645702|P14|Period 2|Withdrawal by Subject|0
831911|NCT01049360|2645703|P13|Period 2|Withdrawal by Subject|0
831912|NCT01049360|2645704|P12|Period 2|Withdrawal by Subject|0
831913|NCT01049360|2645705|P11|Period 2|Withdrawal by Subject|0
831914|NCT01049360|2645706|P10|Period 2|Withdrawal by Subject|0
831915|NCT01049360|2645707|P9|Period 2|Withdrawal by Subject|0
831916|NCT01049360|2645708|P8|Period 2|Withdrawal by Subject|0
831917|NCT01049360|2645709|P7|Period 2|Withdrawal by Subject|0
831918|NCT01049360|2645710|P6|Period 2|Withdrawal by Subject|0
831919|NCT01049360|2645711|P5|Period 2|Withdrawal by Subject|0
831920|NCT01049360|2645712|P4|Period 2|Withdrawal by Subject|1
831921|NCT01049360|2645713|P3|Period 2|Withdrawal by Subject|0
831922|NCT01049360|2645714|P2|Period 2|Withdrawal by Subject|0
831923|NCT01049360|2645715|P1|Period 2|Withdrawal by Subject|0
831924|NCT01049360|2645696|P20|Period 2|Adverse Event|1
831925|NCT01049360|2645697|P19|Period 2|Adverse Event|0
831926|NCT01049360|2645698|P18|Period 2|Adverse Event|0
831927|NCT01049360|2645699|P17|Period 2|Adverse Event|0
831928|NCT01049360|2645700|P16|Period 2|Adverse Event|0
831929|NCT01049360|2645701|P15|Period 2|Adverse Event|0
831930|NCT01049360|2645702|P14|Period 2|Adverse Event|0
831931|NCT01049360|2645703|P13|Period 2|Adverse Event|0
831932|NCT01049360|2645704|P12|Period 2|Adverse Event|0
831933|NCT01049360|2645705|P11|Period 2|Adverse Event|0
831934|NCT01049360|2645706|P10|Period 2|Adverse Event|0
831935|NCT01049360|2645707|P9|Period 2|Adverse Event|1
831936|NCT01049360|2645708|P8|Period 2|Adverse Event|0
831937|NCT01049360|2645709|P7|Period 2|Adverse Event|0
831938|NCT01049360|2645710|P6|Period 2|Adverse Event|0
831939|NCT01049360|2645711|P5|Period 2|Adverse Event|0
831940|NCT01049360|2645712|P4|Period 2|Adverse Event|0
831941|NCT01049360|2645713|P3|Period 2|Adverse Event|0
831942|NCT01049360|2645714|P2|Period 2|Adverse Event|1
831943|NCT01049360|2645715|P1|Period 2|Adverse Event|0
831944|NCT01049360|2645696|P20|Period 2|Protocol Violation|0
831945|NCT01049360|2645697|P19|Period 2|Protocol Violation|0
831946|NCT01049360|2645698|P18|Period 2|Protocol Violation|0
831947|NCT01049360|2645699|P17|Period 2|Protocol Violation|0
831948|NCT01049360|2645700|P16|Period 2|Protocol Violation|1
831949|NCT01049360|2645701|P15|Period 2|Protocol Violation|1
831950|NCT01049360|2645702|P14|Period 2|Protocol Violation|0
831951|NCT01049360|2645703|P13|Period 2|Protocol Violation|0
831952|NCT01049360|2645704|P12|Period 2|Protocol Violation|0
831953|NCT01049360|2645705|P11|Period 2|Protocol Violation|0
831954|NCT01049360|2645706|P10|Period 2|Protocol Violation|0
831955|NCT01049360|2645707|P9|Period 2|Protocol Violation|0
831956|NCT01049360|2645708|P8|Period 2|Protocol Violation|0
831957|NCT01049360|2645709|P7|Period 2|Protocol Violation|0
831958|NCT01049360|2645710|P6|Period 2|Protocol Violation|0
831959|NCT01049360|2645711|P5|Period 2|Protocol Violation|0
831960|NCT01049360|2645712|P4|Period 2|Protocol Violation|1
831961|NCT01049360|2645713|P3|Period 2|Protocol Violation|0
831962|NCT01049360|2645714|P2|Period 2|Protocol Violation|0
831963|NCT01049360|2645715|P1|Period 2|Protocol Violation|0
831964|NCT01049360|2645696|P20|Period 1|Withdrawal by Subject|0
831965|NCT01049360|2645697|P19|Period 1|Withdrawal by Subject|0
831966|NCT01049360|2645698|P18|Period 1|Withdrawal by Subject|0
831967|NCT01049360|2645699|P17|Period 1|Withdrawal by Subject|0
831968|NCT01049360|2645700|P16|Period 1|Withdrawal by Subject|0
831969|NCT01049360|2645701|P15|Period 1|Withdrawal by Subject|0
831970|NCT01049360|2645702|P14|Period 1|Withdrawal by Subject|0
831971|NCT01049360|2645703|P13|Period 1|Withdrawal by Subject|1
831972|NCT01049360|2645704|P12|Period 1|Withdrawal by Subject|0
831973|NCT01049360|2645705|P11|Period 1|Withdrawal by Subject|1
831974|NCT01049360|2645706|P10|Period 1|Withdrawal by Subject|0
831975|NCT01049360|2645707|P9|Period 1|Withdrawal by Subject|1
831976|NCT01049360|2645708|P8|Period 1|Withdrawal by Subject|0
831977|NCT01049360|2645709|P7|Period 1|Withdrawal by Subject|0
831978|NCT01049360|2645710|P6|Period 1|Withdrawal by Subject|0
831979|NCT01049360|2645711|P5|Period 1|Withdrawal by Subject|0
831980|NCT01049360|2645712|P4|Period 1|Withdrawal by Subject|0
831981|NCT01049360|2645713|P3|Period 1|Withdrawal by Subject|0
831982|NCT01049360|2645714|P2|Period 1|Withdrawal by Subject|0
831983|NCT01049360|2645715|P1|Period 1|Withdrawal by Subject|0
831984|NCT01049360|2645696|P20|Period 1|Did not meet inc/exc criteria|0
831985|NCT01049360|2645697|P19|Period 1|Did not meet inc/exc criteria|0
831986|NCT01049360|2645698|P18|Period 1|Did not meet inc/exc criteria|0
831987|NCT01049360|2645699|P17|Period 1|Did not meet inc/exc criteria|0
831988|NCT01049360|2645700|P16|Period 1|Did not meet inc/exc criteria|0
831989|NCT01049360|2645701|P15|Period 1|Did not meet inc/exc criteria|0
831990|NCT01049360|2645702|P14|Period 1|Did not meet inc/exc criteria|0
831991|NCT01049360|2645703|P13|Period 1|Did not meet inc/exc criteria|0
831992|NCT01049360|2645704|P12|Period 1|Did not meet inc/exc criteria|0
831993|NCT01049360|2645705|P11|Period 1|Did not meet inc/exc criteria|0
831994|NCT01049360|2645706|P10|Period 1|Did not meet inc/exc criteria|0
831995|NCT01049360|2645707|P9|Period 1|Did not meet inc/exc criteria|1
831996|NCT01049360|2645708|P8|Period 1|Did not meet inc/exc criteria|1
831997|NCT01049360|2645709|P7|Period 1|Did not meet inc/exc criteria|0
831998|NCT01049360|2645710|P6|Period 1|Did not meet inc/exc criteria|0
831999|NCT01049360|2645711|P5|Period 1|Did not meet inc/exc criteria|0
832000|NCT01049360|2645712|P4|Period 1|Did not meet inc/exc criteria|0
832001|NCT01049360|2645713|P3|Period 1|Did not meet inc/exc criteria|0
832002|NCT01049360|2645714|P2|Period 1|Did not meet inc/exc criteria|0
832003|NCT01049360|2645715|P1|Period 1|Did not meet inc/exc criteria|0
832004|NCT01049360|2645696|P20|Period 1|Adverse Event|0
832005|NCT01049360|2645697|P19|Period 1|Adverse Event|1
832006|NCT01049360|2645698|P18|Period 1|Adverse Event|0
832007|NCT01049360|2645699|P17|Period 1|Adverse Event|1
832008|NCT01049360|2645700|P16|Period 1|Adverse Event|0
832009|NCT01049360|2645701|P15|Period 1|Adverse Event|0
832010|NCT01049360|2645702|P14|Period 1|Adverse Event|1
832011|NCT01049360|2645703|P13|Period 1|Adverse Event|1
832012|NCT01049360|2645704|P12|Period 1|Adverse Event|0
832013|NCT01049360|2645705|P11|Period 1|Adverse Event|0
832014|NCT01049360|2645706|P10|Period 1|Adverse Event|0
832015|NCT01049360|2645707|P9|Period 1|Adverse Event|0
832016|NCT01049360|2645708|P8|Period 1|Adverse Event|1
832017|NCT01049360|2645709|P7|Period 1|Adverse Event|0
832018|NCT01049360|2645710|P6|Period 1|Adverse Event|0
832019|NCT01049360|2645711|P5|Period 1|Adverse Event|0
832020|NCT01049360|2645712|P4|Period 1|Adverse Event|1
832021|NCT01049360|2645713|P3|Period 1|Adverse Event|0
832022|NCT01049360|2645714|P2|Period 1|Adverse Event|1
832023|NCT01049360|2645715|P1|Period 1|Adverse Event|0
832024|NCT01049373|2645739|P2|Overall Study|Non-cooperation|1
832025|NCT01049373|2645740|P1|Overall Study|Non-cooperation|0
832026|NCT01049373|2645739|P2|Overall Study|Not specified|1
832027|NCT01049373|2645740|P1|Overall Study|Not specified|1
832028|NCT01049373|2645739|P2|Overall Study|no evaluable study values|21
832029|NCT01049373|2645740|P1|Overall Study|no evaluable study values|9
832030|NCT01049373|2645739|P2|Overall Study|Lost to Follow-up|4
832031|NCT01049373|2645740|P1|Overall Study|Lost to Follow-up|9
832032|NCT01049373|2645739|P2|Overall Study|Adverse Event|3
832033|NCT01049373|2645740|P1|Overall Study|Adverse Event|3
832034|NCT01049373|2645739|P2|Overall Study|Withdrawal by Subject|5
832035|NCT01049373|2645740|P1|Overall Study|Withdrawal by Subject|8
832036|NCT01049373|2645739|P2|Overall Study|Protocol Violation|9
832037|NCT01049373|2645740|P1|Overall Study|Protocol Violation|9
832038|NCT01049503|2645760|P6|Overall Study|Lost to Follow-up|8
832039|NCT01049503|2645761|P5|Overall Study|Lost to Follow-up|27
832040|NCT01049503|2645762|P4|Overall Study|Lost to Follow-up|26
832041|NCT01049503|2645763|P3|Overall Study|Lost to Follow-up|24
832042|NCT01049503|2645764|P2|Overall Study|Lost to Follow-up|12
832043|NCT01049503|2645765|P1|Overall Study|Lost to Follow-up|11
832044|NCT01049581|2645796|P2|Overall Study|Lost to Follow-up|1
832045|NCT01049581|2645797|P1|Overall Study|Lost to Follow-up|2
832046|NCT01049984|2645850|P2|Overall Study|Treatment failure|2
832047|NCT01049984|2645851|P1|Overall Study|Treatment failure|0
832048|NCT01049984|2645850|P2|Overall Study|Adverse Event|7
832049|NCT01049984|2645851|P1|Overall Study|Adverse Event|13
832050|NCT01049984|2645850|P2|Overall Study|Lost to Follow-up|1
832051|NCT01049984|2645851|P1|Overall Study|Lost to Follow-up|2
832052|NCT01049984|2645850|P2|Overall Study|Protocol Violation|4
832053|NCT01049984|2645851|P1|Overall Study|Protocol Violation|3
832054|NCT01049984|2645850|P2|Overall Study|Withdrawal by Subject|5
832055|NCT01049984|2645851|P1|Overall Study|Withdrawal by Subject|1
832056|NCT01050062|2645869|P2|Overall Study|Others|11
832057|NCT01050062|2645870|P1|Overall Study|Others|17
832058|NCT01050062|2645869|P2|Overall Study|Physician Decision|9
832059|NCT01050062|2645870|P1|Overall Study|Physician Decision|74
832060|NCT01050062|2645869|P2|Overall Study|Lack of Efficacy|35
832061|NCT01050062|2645870|P1|Overall Study|Lack of Efficacy|22
832062|NCT01050062|2645869|P2|Overall Study|Lost to Follow-up|35
832063|NCT01050062|2645870|P1|Overall Study|Lost to Follow-up|83
832064|NCT01050062|2645869|P2|Overall Study|Adverse Event|22
832065|NCT01050062|2645870|P1|Overall Study|Adverse Event|75
832066|NCT01050205|2645919|P2|Overall Study|Discontinued Intervention|0
832067|NCT01050205|2645920|P1|Overall Study|Discontinued Intervention|2
832068|NCT01050205|2645919|P2|Overall Study|Relocated from area|2
832069|NCT01050205|2645920|P1|Overall Study|Relocated from area|1
832070|NCT01050205|2645919|P2|Overall Study|Withdrawal by Subject|1
832071|NCT01050205|2645920|P1|Overall Study|Withdrawal by Subject|1
832072|NCT01050205|2645919|P2|Overall Study|Lost to Follow-up|1
832073|NCT01050205|2645920|P1|Overall Study|Lost to Follow-up|7
832074|NCT01050218|2645948|P1|Overall Study|Family emergency|1
832075|NCT01050218|2645948|P1|Overall Study|Serious Adverse Event|1
832076|NCT01050218|2645948|P1|Overall Study|Failed to return|7
832077|NCT01050218|2645948|P1|Overall Study|Compliance|2
832078|NCT01050218|2645948|P1|Overall Study|Discontinued by sponsor|18
832079|NCT01050218|2645948|P1|Overall Study|Withdrawal by Subject|18
832080|NCT01050218|2645948|P1|Overall Study|Protocol Violation|3
832081|NCT01050218|2645948|P1|Overall Study|Lack of Efficacy|8
832082|NCT01050218|2645948|P1|Overall Study|Adverse Event|37
832083|NCT01050257|2645955|P3|Overall Study|Death|1
832084|NCT01050257|2645956|P2|Overall Study|Death|0
832085|NCT01050257|2645957|P1|Overall Study|Death|0
832086|NCT01050257|2645955|P3|Overall Study|Failure to return|0
832087|NCT01050257|2645956|P2|Overall Study|Failure to return|2
832088|NCT01050257|2645957|P1|Overall Study|Failure to return|0
832089|NCT01050257|2645955|P3|Overall Study|Violation criteria|0
832090|NCT01050257|2645956|P2|Overall Study|Violation criteria|1
832091|NCT01050257|2645957|P1|Overall Study|Violation criteria|0
832092|NCT01050257|2645955|P3|Overall Study|Refused treatment/ Did not Cooperate|0
832093|NCT01050257|2645956|P2|Overall Study|Refused treatment/ Did not Cooperate|1
832094|NCT01050257|2645957|P1|Overall Study|Refused treatment/ Did not Cooperate|1
832095|NCT01050257|2645955|P3|Overall Study|No reason specified|2
832096|NCT01050257|2645956|P2|Overall Study|No reason specified|0
832097|NCT01050257|2645957|P1|Overall Study|No reason specified|0
832098|NCT01050257|2645955|P3|Overall Study|Withdrawal by Subject|0
832099|NCT01050257|2645956|P2|Overall Study|Withdrawal by Subject|3
832100|NCT01050257|2645957|P1|Overall Study|Withdrawal by Subject|0
832101|NCT01050257|2645955|P3|Overall Study|Admin/Other (did not switch to oral)|2
832102|NCT01050257|2645956|P2|Overall Study|Admin/Other (did not switch to oral)|2
832103|NCT01050257|2645957|P1|Overall Study|Admin/Other (did not switch to oral)|6
832104|NCT01050257|2645955|P3|Overall Study|Adverse Event|2
832105|NCT01050257|2645956|P2|Overall Study|Adverse Event|4
832106|NCT01050257|2645957|P1|Overall Study|Adverse Event|4
832107|NCT01050530|2645994|P2|Overall Study|Protocol Violation|0
832108|NCT01050530|2645995|P1|Overall Study|Protocol Violation|1
832109|NCT01050530|2645994|P2|Overall Study|Withdrawal by Subject|3
832110|NCT01050530|2645995|P1|Overall Study|Withdrawal by Subject|0
832111|NCT01050530|2645994|P2|Overall Study|Lack of Efficacy|4
832112|NCT01050530|2645995|P1|Overall Study|Lack of Efficacy|1
832113|NCT01050530|2645994|P2|Overall Study|Adverse Event|3
832114|NCT01050530|2645995|P1|Overall Study|Adverse Event|6
832115|NCT01050543|2646005|P2|Overall Study|Administrative|1
832116|NCT01050543|2646006|P1|Overall Study|Administrative|4
832117|NCT01050543|2646005|P2|Overall Study|Protocol Violation|1
832118|NCT01050543|2646006|P1|Overall Study|Protocol Violation|0
832119|NCT01050543|2646005|P2|Overall Study|Withdrawal by Subject|2
832120|NCT01050543|2646006|P1|Overall Study|Withdrawal by Subject|0
832121|NCT01050569|2646015|P3|Overall Study|Physician Decision|3
832122|NCT01050569|2646016|P2|Overall Study|Physician Decision|3
832123|NCT01050569|2646017|P1|Overall Study|Physician Decision|3
832124|NCT01050569|2646015|P3|Overall Study|Adverse Event|0
832125|NCT01050569|2646016|P2|Overall Study|Adverse Event|0
832126|NCT01050569|2646017|P1|Overall Study|Adverse Event|1
832127|NCT01050569|2646015|P3|Overall Study|Lack of Efficacy|3
832128|NCT01050569|2646016|P2|Overall Study|Lack of Efficacy|4
832129|NCT01050569|2646017|P1|Overall Study|Lack of Efficacy|5
832130|NCT01050569|2646015|P3|Overall Study|Withdrawal by Subject|11
832131|NCT01050569|2646016|P2|Overall Study|Withdrawal by Subject|3
832132|NCT01050569|2646017|P1|Overall Study|Withdrawal by Subject|9
832133|NCT01050569|2646015|P3|Overall Study|Lost to Follow-up|16
832134|NCT01050569|2646016|P2|Overall Study|Lost to Follow-up|14
832135|NCT01050569|2646017|P1|Overall Study|Lost to Follow-up|20
832136|NCT01050634|2646047|P1|Overall Study|Ongoing at Date of Cut-Off|5
832137|NCT01050634|2646047|P1|Overall Study|Other|21
832138|NCT01050634|2646047|P1|Overall Study|Lost to Follow-up|2
832139|NCT01050634|2646047|P1|Overall Study|Adverse Event|42
832140|NCT01050634|2646047|P1|Overall Study|Death|2
832141|NCT01050634|2646047|P1|Overall Study|Enrolled, but Not Treated|56
832142|NCT01050673|2646084|P2|Overall Study|Physician Decision|5
832143|NCT01050673|2646085|P1|Overall Study|Physician Decision|4
832144|NCT01050764|2646107|P1|Overall Study|Death, after HSCT|1
832145|NCT01050764|2646107|P1|Overall Study|Donor mobilization failure, death|1
832146|NCT01050764|2646107|P1|Overall Study|Death, before HSCT|1
832147|NCT01050790|2646116|P1|Overall Study|Adverse Event|1
832148|NCT01050816|2646126|P1|Overall Study|patient's refusal|2
832149|NCT01050816|2646126|P1|Overall Study|Lost to Follow-up|2
832150|NCT01050998|2646147|P5|Overall Study|Data integrity issues|4
832151|NCT01050998|2646148|P4|Overall Study|Data integrity issues|1
832152|NCT01050998|2646149|P3|Overall Study|Data integrity issues|1
832153|NCT01050998|2646150|P2|Overall Study|Data integrity issues|0
832154|NCT01050998|2646151|P1|Overall Study|Data integrity issues|0
832155|NCT01050998|2646147|P5|Overall Study|Unspecified|5
832156|NCT01050998|2646148|P4|Overall Study|Unspecified|1
832157|NCT01050998|2646149|P3|Overall Study|Unspecified|1
832158|NCT01050998|2646150|P2|Overall Study|Unspecified|2
832159|NCT01050998|2646151|P1|Overall Study|Unspecified|3
832160|NCT01050998|2646147|P5|Overall Study|Withdrawal by Subject|3
832161|NCT01050998|2646148|P4|Overall Study|Withdrawal by Subject|1
832162|NCT01050998|2646149|P3|Overall Study|Withdrawal by Subject|0
832163|NCT01050998|2646150|P2|Overall Study|Withdrawal by Subject|0
832164|NCT01050998|2646151|P1|Overall Study|Withdrawal by Subject|0
832165|NCT01050998|2646147|P5|Overall Study|Adverse Event|2
832166|NCT01050998|2646148|P4|Overall Study|Adverse Event|0
832167|NCT01050998|2646149|P3|Overall Study|Adverse Event|1
832168|NCT01050998|2646150|P2|Overall Study|Adverse Event|0
832169|NCT01050998|2646151|P1|Overall Study|Adverse Event|1
832170|NCT01044732|2646525|P2|Overall Study|Technical error or malfunction|14
832171|NCT01044732|2646526|P1|Overall Study|Technical error or malfunction|15
832172|NCT01044732|2646525|P2|Overall Study|Inability to reach cecum|2
832173|NCT01044732|2646526|P1|Overall Study|Inability to reach cecum|5
832174|NCT01044732|2646525|P2|Overall Study|Inadequate bowel preparation|17
832175|NCT01044732|2646526|P1|Overall Study|Inadequate bowel preparation|11
832176|NCT01044732|2646525|P2|Overall Study|Withdrawal by Subject|1
832177|NCT01044732|2646526|P1|Overall Study|Withdrawal by Subject|0
832178|NCT01044732|2646525|P2|Overall Study|Protocol Violation|12
832179|NCT01044732|2646526|P1|Overall Study|Protocol Violation|11
832180|NCT01044732|2646525|P2|Overall Study|Physician Decision|3
832181|NCT01044732|2646526|P1|Overall Study|Physician Decision|5
832182|NCT01044732|2646525|P2|Overall Study|Lost to Follow-up|1
832183|NCT01044732|2646526|P1|Overall Study|Lost to Follow-up|2
832184|NCT01045096|2646620|P3|Overall Study|Other|0
832185|NCT01045096|2646621|P2|Overall Study|Other|0
832186|NCT01045096|2646622|P1|Overall Study|Other|1
832187|NCT01045096|2646620|P3|Overall Study|Withdrawal by Subject|0
832188|NCT01045096|2646621|P2|Overall Study|Withdrawal by Subject|0
832189|NCT01045096|2646622|P1|Overall Study|Withdrawal by Subject|2
832190|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
832191|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
832192|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
832193|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
832194|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
832195|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
832196|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
832197|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
832198|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
832199|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
832200|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
832201|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
832202|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
832203|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
832204|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
832205|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
832206|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
832207|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
832208|NCT01045161|2646658|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
832209|NCT01045161|2646659|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
832210|NCT01045161|2646660|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
832211|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
832212|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
832213|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
832214|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
832215|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
832216|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
832217|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
832218|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
832219|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
832220|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
832221|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
832222|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
832223|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
832224|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
832225|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
832226|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
832227|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
832228|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
832229|NCT01045161|2646658|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
832230|NCT01045161|2646659|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
832231|NCT01045161|2646660|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
832232|NCT01045421|2646697|P11|Phase 2|Other|1
832233|NCT01045421|2646698|P10|Phase 2|Other|0
832234|NCT01045421|2646699|P9|Phase 2|Other|0
832235|NCT01045421|2646700|P8|Phase 2|Other|3
832236|NCT01045421|2646701|P7|Phase 2|Other|0
832237|NCT01045421|2646702|P6|Phase 2|Other|0
832238|NCT01045421|2646703|P5|Phase 2|Other|0
832239|NCT01045421|2646704|P4|Phase 2|Other|0
832240|NCT01045421|2646705|P3|Phase 2|Other|0
832241|NCT01045421|2646706|P2|Phase 2|Other|0
832242|NCT01045421|2646707|P1|Phase 2|Other|0
832243|NCT01045421|2646697|P11|Phase 2|Death|0
832244|NCT01045421|2646698|P10|Phase 2|Death|2
832245|NCT01045421|2646699|P9|Phase 2|Death|1
832246|NCT01045421|2646700|P8|Phase 2|Death|1
832247|NCT01045421|2646701|P7|Phase 2|Death|0
832248|NCT01045421|2646702|P6|Phase 2|Death|0
832249|NCT01045421|2646703|P5|Phase 2|Death|0
832250|NCT01045421|2646704|P4|Phase 2|Death|0
832251|NCT01045421|2646705|P3|Phase 2|Death|0
832252|NCT01045421|2646706|P2|Phase 2|Death|0
832253|NCT01045421|2646707|P1|Phase 2|Death|0
832254|NCT01045421|2646697|P11|Phase 2|Progressive Disease|1
832255|NCT01045421|2646698|P10|Phase 2|Progressive Disease|1
832256|NCT01045421|2646699|P9|Phase 2|Progressive Disease|1
832257|NCT01045421|2646700|P8|Phase 2|Progressive Disease|1
832258|NCT01045421|2646701|P7|Phase 2|Progressive Disease|0
832259|NCT01045421|2646702|P6|Phase 2|Progressive Disease|0
832260|NCT01045421|2646703|P5|Phase 2|Progressive Disease|0
832261|NCT01045421|2646704|P4|Phase 2|Progressive Disease|0
832262|NCT01045421|2646705|P3|Phase 2|Progressive Disease|0
832263|NCT01045421|2646706|P2|Phase 2|Progressive Disease|0
832264|NCT01045421|2646707|P1|Phase 2|Progressive Disease|0
832265|NCT01045421|2646697|P11|Phase 1|Withdrawal by Subject|0
832266|NCT01045421|2646698|P10|Phase 1|Withdrawal by Subject|0
832267|NCT01045421|2646699|P9|Phase 1|Withdrawal by Subject|0
832268|NCT01045421|2646700|P8|Phase 1|Withdrawal by Subject|0
832269|NCT01045421|2646701|P7|Phase 1|Withdrawal by Subject|0
832270|NCT01045421|2646702|P6|Phase 1|Withdrawal by Subject|0
832271|NCT01045421|2646703|P5|Phase 1|Withdrawal by Subject|0
832272|NCT01045421|2646704|P4|Phase 1|Withdrawal by Subject|1
832273|NCT01045421|2646705|P3|Phase 1|Withdrawal by Subject|0
832274|NCT01045421|2646706|P2|Phase 1|Withdrawal by Subject|0
832275|NCT01045421|2646707|P1|Phase 1|Withdrawal by Subject|0
832276|NCT01045421|2646697|P11|Phase 1|Progressive Disease|0
832277|NCT01045421|2646698|P10|Phase 1|Progressive Disease|0
832278|NCT01045421|2646699|P9|Phase 1|Progressive Disease|0
832279|NCT01045421|2646700|P8|Phase 1|Progressive Disease|0
832280|NCT01045421|2646701|P7|Phase 1|Progressive Disease|0
832281|NCT01045421|2646702|P6|Phase 1|Progressive Disease|0
832282|NCT01045421|2646703|P5|Phase 1|Progressive Disease|1
832283|NCT01045421|2646704|P4|Phase 1|Progressive Disease|0
832284|NCT01045421|2646705|P3|Phase 1|Progressive Disease|0
832285|NCT01045421|2646706|P2|Phase 1|Progressive Disease|0
832286|NCT01045421|2646707|P1|Phase 1|Progressive Disease|0
832287|NCT01045447|2646789|P2|Overall Study|Unclassified|13
832288|NCT01045447|2646790|P1|Overall Study|Unclassified|17
832289|NCT01045447|2646789|P2|Overall Study|Withdrawal Criteria|10
832290|NCT01045447|2646790|P1|Overall Study|Withdrawal Criteria|10
832291|NCT01045447|2646789|P2|Overall Study|Protocol Violation|3
832292|NCT01045447|2646790|P1|Overall Study|Protocol Violation|6
832293|NCT01045447|2646789|P2|Overall Study|Lack of Efficacy|1
832294|NCT01045447|2646790|P1|Overall Study|Lack of Efficacy|3
832295|NCT01045447|2646789|P2|Overall Study|Adverse Event|1
832296|NCT01045447|2646790|P1|Overall Study|Adverse Event|0
832297|NCT01051323|2646808|P1|Overall Study|Missing|37
832298|NCT01051323|2646808|P1|Overall Study|Unspecified|148
832299|NCT01051323|2646808|P1|Overall Study|Hospitalization|28
832300|NCT01051323|2646808|P1|Overall Study|Death|129
832301|NCT01051323|2646808|P1|Overall Study|Lost to Follow-up|31
832302|NCT01051323|2646808|P1|Overall Study|Withdrawal by Subject|13
832303|NCT01051323|2646808|P1|Overall Study|Dialysis dependency|22
832304|NCT01051323|2646808|P1|Overall Study|Transplantation|28
832305|NCT01051323|2646808|P1|Overall Study|Discontinuation of treatment|103
832306|NCT01051466|2646845|P2|Overall Study|Physician Decision|0
832307|NCT01051466|2646846|P1|Overall Study|Physician Decision|1
832308|NCT01051466|2646845|P2|Overall Study|Entry Criteria Not Met|3
832309|NCT01051466|2646846|P1|Overall Study|Entry Criteria Not Met|0
832310|NCT01051466|2646845|P2|Overall Study|Withdrawal by Subject|1
832311|NCT01051466|2646846|P1|Overall Study|Withdrawal by Subject|5
832312|NCT01051466|2646845|P2|Overall Study|Lost to Follow-up|1
832313|NCT01051466|2646846|P1|Overall Study|Lost to Follow-up|1
832314|NCT01051466|2646845|P2|Overall Study|Adverse Event|0
832315|NCT01051466|2646846|P1|Overall Study|Adverse Event|1
832316|NCT01052116|2646880|P2|Overall Study|Spirometry not performed|4
832317|NCT01052116|2646881|P1|Overall Study|Spirometry not performed|0
832318|NCT01052116|2646880|P2|Overall Study|Withdrawal by Subject|6
832319|NCT01052116|2646881|P1|Overall Study|Withdrawal by Subject|3
832320|NCT01052116|2646880|P2|Overall Study|Lost to Follow-up|17
832321|NCT01052116|2646881|P1|Overall Study|Lost to Follow-up|11
832322|NCT01052272|2646900|P4|Overall Study|decline in health|0
832323|NCT01052272|2646901|P3|Overall Study|decline in health|1
832324|NCT01052272|2646902|P2|Overall Study|decline in health|0
832325|NCT01052272|2646903|P1|Overall Study|decline in health|0
832326|NCT01052272|2646900|P4|Overall Study|placed in long-term care|0
832327|NCT01052272|2646901|P3|Overall Study|placed in long-term care|1
832328|NCT01052272|2646902|P2|Overall Study|placed in long-term care|0
832329|NCT01052272|2646903|P1|Overall Study|placed in long-term care|0
832330|NCT01052272|2646900|P4|Overall Study|Withdrawal by Subject|2
832331|NCT01052272|2646901|P3|Overall Study|Withdrawal by Subject|3
832332|NCT01052272|2646902|P2|Overall Study|Withdrawal by Subject|2
832333|NCT01052272|2646903|P1|Overall Study|Withdrawal by Subject|0
832334|NCT01052272|2646900|P4|Overall Study|patient refuses follow-up|4
832335|NCT01052272|2646901|P3|Overall Study|patient refuses follow-up|2
832336|NCT01052272|2646902|P2|Overall Study|patient refuses follow-up|4
832337|NCT01052272|2646903|P1|Overall Study|patient refuses follow-up|5
832338|NCT01052272|2646900|P4|Overall Study|Physician Decision|0
832339|NCT01052272|2646901|P3|Overall Study|Physician Decision|0
832340|NCT01052272|2646902|P2|Overall Study|Physician Decision|1
832341|NCT01052272|2646903|P1|Overall Study|Physician Decision|0
832342|NCT01052272|2646900|P4|Overall Study|Death|1
832343|NCT01052272|2646901|P3|Overall Study|Death|1
832344|NCT01052272|2646902|P2|Overall Study|Death|0
832345|NCT01052272|2646903|P1|Overall Study|Death|0
832346|NCT01052428|2646939|P2|Overall Study|Withdrawal by Subject|1
832347|NCT01052428|2646940|P1|Overall Study|Withdrawal by Subject|0
832348|NCT01052428|2646939|P2|Overall Study|Death|0
832349|NCT01052428|2646940|P1|Overall Study|Death|1
832350|NCT01052480|2646960|P2|Overall Study|Death|5
832351|NCT01052480|2646961|P1|Overall Study|Death|1
832352|NCT01052480|2646960|P2|Overall Study|Physician Decision|2
832353|NCT01052480|2646961|P1|Overall Study|Physician Decision|0
832354|NCT01052480|2646960|P2|Overall Study|Withdrawal by Subject|7
832355|NCT01052480|2646961|P1|Overall Study|Withdrawal by Subject|3
832356|NCT01052480|2646960|P2|Overall Study|Protocol Violation|0
832357|NCT01052480|2646961|P1|Overall Study|Protocol Violation|1
832358|NCT01052480|2646960|P2|Overall Study|Lost to Follow-up|3
832359|NCT01052480|2646961|P1|Overall Study|Lost to Follow-up|3
832360|NCT01052662|2647027|P3|Overall Study|Administrative|0
832361|NCT01052662|2647028|P2|Overall Study|Administrative|3
832362|NCT01052662|2647029|P1|Overall Study|Administrative|0
832363|NCT01052662|2647027|P3|Overall Study|Legal Problem|0
832364|NCT01052662|2647028|P2|Overall Study|Legal Problem|0
832365|NCT01052662|2647029|P1|Overall Study|Legal Problem|2
832366|NCT01052662|2647027|P3|Overall Study|Adverse Event|0
832367|NCT01052662|2647028|P2|Overall Study|Adverse Event|1
832368|NCT01052662|2647029|P1|Overall Study|Adverse Event|1
832369|NCT01052662|2647027|P3|Overall Study|Pharmacy issue|3
832370|NCT01052662|2647028|P2|Overall Study|Pharmacy issue|3
832371|NCT01052662|2647029|P1|Overall Study|Pharmacy issue|1
832372|NCT01052662|2647027|P3|Overall Study|Withdrawal by Subject|1
832373|NCT01052662|2647028|P2|Overall Study|Withdrawal by Subject|2
832374|NCT01052662|2647029|P1|Overall Study|Withdrawal by Subject|3
832375|NCT01052662|2647027|P3|Overall Study|Lost to Follow-up|18
832376|NCT01052662|2647028|P2|Overall Study|Lost to Follow-up|13
832377|NCT01052662|2647029|P1|Overall Study|Lost to Follow-up|15
832378|NCT01052714|2647056|P3|Overall Study|Withdrawal by Subject|1
832379|NCT01052714|2647057|P2|Overall Study|Withdrawal by Subject|12
832380|NCT01052714|2647058|P1|Overall Study|Withdrawal by Subject|7
832381|NCT01052714|2647056|P3|Overall Study|Physician Decision|1
832382|NCT01052714|2647057|P2|Overall Study|Physician Decision|9
832383|NCT01052714|2647058|P1|Overall Study|Physician Decision|9
832384|NCT01052714|2647056|P3|Overall Study|Lost to Follow-up|0
832385|NCT01052714|2647057|P2|Overall Study|Lost to Follow-up|3
832386|NCT01052714|2647058|P1|Overall Study|Lost to Follow-up|2
832387|NCT01052714|2647056|P3|Overall Study|Death|0
832388|NCT01052714|2647057|P2|Overall Study|Death|2
832389|NCT01052714|2647058|P1|Overall Study|Death|1
832390|NCT01052714|2647056|P3|Overall Study|Adverse Event|0
832391|NCT01052714|2647057|P2|Overall Study|Adverse Event|3
832392|NCT01052714|2647058|P1|Overall Study|Adverse Event|6
832393|NCT01052844|2647111|P2|Overall Study|Adverse Event|1
832394|NCT01052844|2647112|P1|Overall Study|Adverse Event|0
832395|NCT01053247|2647207|P3|Overall Study|Adverse Event|3
832396|NCT01053247|2647208|P2|Overall Study|Adverse Event|9
832397|NCT01053247|2647209|P1|Overall Study|Adverse Event|0
832398|NCT01053247|2647207|P3|Overall Study|Lost to Follow-up|7
832399|NCT01053247|2647208|P2|Overall Study|Lost to Follow-up|5
832400|NCT01053247|2647209|P1|Overall Study|Lost to Follow-up|8
832401|NCT01053247|2647207|P3|Overall Study|Protocol Violation|2
832402|NCT01053247|2647208|P2|Overall Study|Protocol Violation|1
832403|NCT01053247|2647209|P1|Overall Study|Protocol Violation|2
832404|NCT01053247|2647207|P3|Overall Study|Lack of Efficacy|1
832405|NCT01053247|2647208|P2|Overall Study|Lack of Efficacy|0
832406|NCT01053247|2647209|P1|Overall Study|Lack of Efficacy|1
832407|NCT01053247|2647207|P3|Overall Study|Withdrawal by Subject|15
832408|NCT01053247|2647208|P2|Overall Study|Withdrawal by Subject|4
832409|NCT01053247|2647209|P1|Overall Study|Withdrawal by Subject|9
832410|NCT01053429|2647235|P1|Overall Study|Unspecified|309
832411|NCT01053429|2647235|P1|Overall Study|Adverse Event|64
832412|NCT01053663|2647264|P1|Overall Study|Negative Influenza Diagnosis|1
832413|NCT01053663|2647264|P1|Overall Study|Transferred to Another Hospital|1
832414|NCT01053663|2647264|P1|Overall Study|Poor IV Access|1
832415|NCT01053663|2647264|P1|Overall Study|Lost to Follow-up|1
832416|NCT01053663|2647264|P1|Overall Study|Death|2
832417|NCT01053741|2647307|P2|2nd Study Intervention|Physician Decision|1
832418|NCT01053741|2647308|P1|2nd Study Intervention|Physician Decision|0
832419|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
832420|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
832421|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
832422|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
832423|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
832424|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
832425|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Physician Decision|4
832426|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Physician Decision|5
832427|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Physician Decision|5
832582|NCT01054729|2647834|P3|Overall Study|PEG/RBV Non-responder|1
832428|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Physician Decision|2
832429|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Physician Decision|5
832430|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Physician Decision|0
832431|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
832432|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
832433|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
832434|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
832435|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
832436|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
832437|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
832438|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
832439|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
832440|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
832441|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
832442|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
832443|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
832444|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
832445|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
832446|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
832447|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
832448|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
832449|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
832450|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
832451|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
832452|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
832453|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
832454|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
832455|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
832456|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
832457|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
832458|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
832459|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
832460|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
832461|NCT01053988|2647335|P6|24-week, Double-blind Treatment Period|Adverse Event|14
832462|NCT01053988|2647336|P5|24-week, Double-blind Treatment Period|Adverse Event|17
832463|NCT01053988|2647337|P4|24-week, Double-blind Treatment Period|Adverse Event|24
832464|NCT01053988|2647338|P3|24-week, Double-blind Treatment Period|Adverse Event|23
832465|NCT01053988|2647339|P2|24-week, Double-blind Treatment Period|Adverse Event|15
832466|NCT01053988|2647340|P1|24-week, Double-blind Treatment Period|Adverse Event|0
832467|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
832468|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
832469|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
832470|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
832471|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
832472|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
832473|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Physician Decision|0
832474|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Physician Decision|0
832475|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Physician Decision|0
832476|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Physician Decision|0
832477|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Physician Decision|0
832478|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Physician Decision|5
832479|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Adverse Event|0
832480|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Adverse Event|0
832481|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Adverse Event|0
832482|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Adverse Event|0
832483|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Adverse Event|0
832484|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Adverse Event|6
832485|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
832486|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
832487|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
832488|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
832489|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
832490|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
832491|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
832492|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
832493|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
832494|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
832495|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
832496|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
832497|NCT01053988|2647335|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
832498|NCT01053988|2647336|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
832499|NCT01053988|2647337|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
832500|NCT01053988|2647338|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
832501|NCT01053988|2647339|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
832502|NCT01053988|2647340|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
832503|NCT01054170|2647378|P2|Overall Study|Adverse Event|4
832504|NCT01054170|2647379|P1|Overall Study|Adverse Event|0
832505|NCT01054170|2647378|P2|Overall Study|Withdrawal by Subject|2
832506|NCT01054170|2647379|P1|Overall Study|Withdrawal by Subject|3
832507|NCT01054170|2647378|P2|Overall Study|Protocol Violation|0
832508|NCT01054170|2647379|P1|Overall Study|Protocol Violation|1
832509|NCT01054222|2647442|P1|Overall Study|Withdrawal by Subject|6
832510|NCT01054222|2647442|P1|Overall Study|Lost to Follow-up|4
832511|NCT01054222|2647442|P1|Overall Study|Lack of Efficacy|1
832512|NCT01054560|2647491|P2|Overall Study|Physician Decision|0
832513|NCT01054560|2647492|P1|Overall Study|Physician Decision|1
832514|NCT01054560|2647491|P2|Overall Study|Withdrawal by Subject|2
832515|NCT01054560|2647492|P1|Overall Study|Withdrawal by Subject|0
832516|NCT01054560|2647491|P2|Overall Study|Lost to Follow-up|5
832517|NCT01054560|2647492|P1|Overall Study|Lost to Follow-up|2
832518|NCT01054560|2647491|P2|Overall Study|Death|21
832519|NCT01054560|2647492|P1|Overall Study|Death|10
832520|NCT01054573|2647518|P4|Overall Study|Withdrawal by Subject|1
832521|NCT01054573|2647519|P3|Overall Study|Withdrawal by Subject|2
832522|NCT01054573|2647520|P2|Overall Study|Withdrawal by Subject|2
832523|NCT01054573|2647521|P1|Overall Study|Withdrawal by Subject|0
832524|NCT01054573|2647518|P4|Overall Study|Lost to Follow-up|0
832525|NCT01054573|2647519|P3|Overall Study|Lost to Follow-up|0
832526|NCT01054573|2647520|P2|Overall Study|Lost to Follow-up|2
832527|NCT01054573|2647521|P1|Overall Study|Lost to Follow-up|0
832528|NCT01054573|2647518|P4|Overall Study|Adverse Event|1
832529|NCT01054573|2647519|P3|Overall Study|Adverse Event|1
832530|NCT01054573|2647520|P2|Overall Study|Adverse Event|0
832531|NCT01054573|2647521|P1|Overall Study|Adverse Event|1
832532|NCT01048502|2647594|P4|Overall Study|Physician Decision|1
832533|NCT01048502|2647595|P3|Overall Study|Physician Decision|0
832534|NCT01048502|2647596|P2|Overall Study|Physician Decision|3
832535|NCT01048502|2647597|P1|Overall Study|Physician Decision|0
832536|NCT01048502|2647594|P4|Overall Study|Withdrawal by Subject|3
832537|NCT01048502|2647595|P3|Overall Study|Withdrawal by Subject|5
832538|NCT01048502|2647596|P2|Overall Study|Withdrawal by Subject|4
832539|NCT01048502|2647597|P1|Overall Study|Withdrawal by Subject|1
832540|NCT01048502|2647594|P4|Overall Study|Adverse Event|0
832541|NCT01048502|2647595|P3|Overall Study|Adverse Event|0
832542|NCT01048502|2647596|P2|Overall Study|Adverse Event|0
832543|NCT01048502|2647597|P1|Overall Study|Adverse Event|1
832544|NCT01048502|2647594|P4|Overall Study|Lost to Follow-up|0
832545|NCT01048502|2647595|P3|Overall Study|Lost to Follow-up|0
832546|NCT01048502|2647596|P2|Overall Study|Lost to Follow-up|0
832547|NCT01048502|2647597|P1|Overall Study|Lost to Follow-up|2
832548|NCT01048541|2647608|P2|Overall Study|Withdrawal by Subject|0
832549|NCT01048541|2647609|P1|Overall Study|Withdrawal by Subject|1
832550|NCT01048671|2647665|P3|Overall Study|Protocol Violation|1
832551|NCT01048671|2647666|P2|Overall Study|Protocol Violation|1
832552|NCT01048671|2647667|P1|Overall Study|Protocol Violation|0
832553|NCT01054599|2647785|P2|Overall Study|Withdrawal by Subject|1
832554|NCT01054599|2647786|P1|Overall Study|Withdrawal by Subject|0
832555|NCT01054599|2647785|P2|Overall Study|Adverse Event|1
832556|NCT01054599|2647786|P1|Overall Study|Adverse Event|0
832557|NCT01054599|2647785|P2|Overall Study|Lost to Follow-up|2
832558|NCT01054599|2647786|P1|Overall Study|Lost to Follow-up|0
832559|NCT01054599|2647785|P2|Overall Study|Visual impairment, WTAR <80|1
832560|NCT01054599|2647786|P1|Overall Study|Visual impairment, WTAR <80|0
832561|NCT01054599|2647785|P2|Overall Study|Timing/scheduling difficulties|1
832562|NCT01054599|2647786|P1|Overall Study|Timing/scheduling difficulties|1
832563|NCT01054599|2647785|P2|Overall Study|Spells/seizure-like episodes|1
832564|NCT01054599|2647786|P1|Overall Study|Spells/seizure-like episodes|1
832565|NCT01054599|2647785|P2|Overall Study|Protocol Violation|0
832566|NCT01054599|2647786|P1|Overall Study|Protocol Violation|1
832567|NCT01054599|2647785|P2|Overall Study|Dizziness due to phenytoin toxicity|0
832568|NCT01054599|2647786|P1|Overall Study|Dizziness due to phenytoin toxicity|1
832569|NCT01054729|2647833|P4|Overall Study|Lack of Efficacy|1
832570|NCT01054729|2647834|P3|Overall Study|Lack of Efficacy|0
832571|NCT01054729|2647835|P2|Overall Study|Lack of Efficacy|0
832572|NCT01054729|2647836|P1|Overall Study|Lack of Efficacy|0
832573|NCT01054729|2647833|P4|Overall Study|Subject moved|0
832574|NCT01054729|2647834|P3|Overall Study|Subject moved|1
832575|NCT01054729|2647835|P2|Overall Study|Subject moved|0
832576|NCT01054729|2647836|P1|Overall Study|Subject moved|0
832577|NCT01054729|2647833|P4|Overall Study|Personal/Obligations|0
832578|NCT01054729|2647834|P3|Overall Study|Personal/Obligations|0
832579|NCT01054729|2647835|P2|Overall Study|Personal/Obligations|1
832580|NCT01054729|2647836|P1|Overall Study|Personal/Obligations|0
832581|NCT01054729|2647833|P4|Overall Study|PEG/RBV Non-responder|0
832583|NCT01054729|2647835|P2|Overall Study|PEG/RBV Non-responder|0
832584|NCT01054729|2647836|P1|Overall Study|PEG/RBV Non-responder|1
832585|NCT01054729|2647833|P4|Overall Study|Non-responder|1
832586|NCT01054729|2647834|P3|Overall Study|Non-responder|1
832587|NCT01054729|2647835|P2|Overall Study|Non-responder|0
832588|NCT01054729|2647836|P1|Overall Study|Non-responder|1
832589|NCT01054729|2647833|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
832590|NCT01054729|2647834|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
832591|NCT01054729|2647835|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
832592|NCT01054729|2647836|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
832593|NCT01054729|2647833|P4|Overall Study|Lost to Follow-up|0
832594|NCT01054729|2647834|P3|Overall Study|Lost to Follow-up|0
832595|NCT01054729|2647835|P2|Overall Study|Lost to Follow-up|1
832596|NCT01054729|2647836|P1|Overall Study|Lost to Follow-up|0
832597|NCT01054729|2647833|P4|Overall Study|Withdrawal by Subject|0
832598|NCT01054729|2647834|P3|Overall Study|Withdrawal by Subject|1
832599|NCT01054729|2647835|P2|Overall Study|Withdrawal by Subject|0
832600|NCT01054729|2647836|P1|Overall Study|Withdrawal by Subject|1
832601|NCT01054729|2647833|P4|Overall Study|Adverse Event|1
832602|NCT01054729|2647834|P3|Overall Study|Adverse Event|2
832603|NCT01054729|2647835|P2|Overall Study|Adverse Event|1
832604|NCT01054729|2647836|P1|Overall Study|Adverse Event|1
832605|NCT01054729|2647833|P4|Overall Study|Randomized but Not Treated|0
832606|NCT01054729|2647834|P3|Overall Study|Randomized but Not Treated|0
832607|NCT01054729|2647835|P2|Overall Study|Randomized but Not Treated|1
832608|NCT01054729|2647836|P1|Overall Study|Randomized but Not Treated|0
832609|NCT01054820|2647901|P1|Overall Study|Withdrawal by Subject|2
832610|NCT01054846|2647917|P2|Overall Study|Lost to Follow-up|17
832611|NCT01054846|2647918|P1|Overall Study|Lost to Follow-up|76
893708|NCT01984684|2835234|P2|Overall Study|Subject had inadequate IV access|1
893709|NCT01984684|2835235|P1|Overall Study|Subject had inadequate IV access|0
832726|NCT01056107|2648050|P3|Overall Study|Withdrawal by Subject|3
893710|NCT01984684|2835234|P2|Overall Study|Study drug not available at site|1
893711|NCT01984684|2835235|P1|Overall Study|Study drug not available at site|1
893712|NCT01984684|2835234|P2|Overall Study|Subject incarcerated|0
893713|NCT01984684|2835235|P1|Overall Study|Subject incarcerated|1
893714|NCT01984684|2835234|P2|Overall Study|Noncompliance with study drug|1
893715|NCT01984684|2835235|P1|Overall Study|Noncompliance with study drug|2
893716|NCT01984684|2835234|P2|Overall Study|Death|1
893717|NCT01984684|2835235|P1|Overall Study|Death|0
893718|NCT01984684|2835234|P2|Overall Study|Protocol Violation|2
893719|NCT01984684|2835235|P1|Overall Study|Protocol Violation|4
893720|NCT01984684|2835234|P2|Overall Study|Physician Decision|2
893721|NCT01984684|2835235|P1|Overall Study|Physician Decision|4
893722|NCT01984684|2835234|P2|Overall Study|Lack of Efficacy|6
893723|NCT01984684|2835235|P1|Overall Study|Lack of Efficacy|3
893724|NCT01984684|2835234|P2|Overall Study|Withdrawal by Subject|9
893725|NCT01984684|2835235|P1|Overall Study|Withdrawal by Subject|9
893726|NCT01984684|2835234|P2|Overall Study|Adverse Event|12
893727|NCT01984684|2835235|P1|Overall Study|Adverse Event|8
893728|NCT01984684|2835234|P2|Overall Study|Lost to Follow-up|24
893729|NCT01984684|2835235|P1|Overall Study|Lost to Follow-up|25
893730|NCT01972464|2835256|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
893731|NCT01972464|2835257|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
893732|NCT01972464|2835256|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
893733|NCT01972464|2835257|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
893734|NCT01972464|2835256|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
893735|NCT01972464|2835257|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
893736|NCT01972464|2835256|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
893737|NCT01972464|2835257|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
893738|NCT01959529|2835273|P2|Overall Study|Lack of glycaemic control|1
893739|NCT01959529|2835274|P1|Overall Study|Lack of glycaemic control|1
893740|NCT01959529|2835273|P2|Overall Study|Hypoglycaemia|1
893741|NCT01959529|2835274|P1|Overall Study|Hypoglycaemia|1
893742|NCT01959529|2835273|P2|Overall Study|Other|68
893743|NCT01959529|2835274|P1|Overall Study|Other|70
893744|NCT01959529|2835273|P2|Overall Study|Lost to Follow-up|1
893745|NCT01959529|2835274|P1|Overall Study|Lost to Follow-up|4
893746|NCT01959529|2835273|P2|Overall Study|Adverse event (not hypoglycaemia)|1
893747|NCT01959529|2835274|P1|Overall Study|Adverse event (not hypoglycaemia)|0
893768|NCT01939197|2835479|P7|Overall Study|Lost to Follow-up|2
893769|NCT01939197|2835480|P6|Overall Study|Lost to Follow-up|1
893770|NCT01939197|2835481|P5|Overall Study|Lost to Follow-up|3
893771|NCT01939197|2835482|P4|Overall Study|Lost to Follow-up|1
893772|NCT01939197|2835483|P3|Overall Study|Lost to Follow-up|0
893773|NCT01939197|2835484|P2|Overall Study|Lost to Follow-up|1
893774|NCT01939197|2835485|P1|Overall Study|Lost to Follow-up|0
893775|NCT01939197|2835479|P7|Overall Study|Withdrawal by Subject|0
893776|NCT01939197|2835480|P6|Overall Study|Withdrawal by Subject|0
893777|NCT01939197|2835481|P5|Overall Study|Withdrawal by Subject|1
832717|NCT01055834|2648010|P2|Treatment Period I|Adverse Event|0
832718|NCT01055834|2648011|P1|Treatment Period I|Adverse Event|1
832719|NCT01055886|2648025|P2|Overall Study|Withdrawal by PI|1
832720|NCT01055886|2648026|P1|Overall Study|Withdrawal by PI|0
832721|NCT01055886|2648025|P2|Overall Study|Lost to Follow-up|1
832722|NCT01055886|2648026|P1|Overall Study|Lost to Follow-up|1
832723|NCT01055886|2648025|P2|Overall Study|Withdrawal by Subject|9
832724|NCT01055886|2648026|P1|Overall Study|Withdrawal by Subject|4
832725|NCT01056107|2648049|P4|Overall Study|Withdrawal by Subject|0
893778|NCT01939197|2835482|P4|Overall Study|Withdrawal by Subject|0
893779|NCT01939197|2835483|P3|Overall Study|Withdrawal by Subject|0
893780|NCT01939197|2835484|P2|Overall Study|Withdrawal by Subject|0
893781|NCT01939197|2835485|P1|Overall Study|Withdrawal by Subject|1
832727|NCT01056107|2648051|P2|Overall Study|Withdrawal by Subject|1
832728|NCT01056107|2648052|P1|Overall Study|Withdrawal by Subject|0
832729|NCT01056263|2648113|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
832730|NCT01056263|2648113|P1|Overall Study|Objective progression or relapse|1
832731|NCT01056263|2648113|P1|Overall Study|Neoplasm progression|1
832732|NCT01056263|2648113|P1|Overall Study|Progressive disease|2
832733|NCT01056263|2648113|P1|Overall Study|Lack of Efficacy|29
832734|NCT01056263|2648113|P1|Overall Study|Withdrawal by Subject|1
832735|NCT01056263|2648113|P1|Overall Study|Death|1
832736|NCT01056263|2648113|P1|Overall Study|Adverse Event|12
832737|NCT01056276|2648119|P2|Maintenance Therapy|Continuing maintenance therapy|14
832738|NCT01056276|2648120|P1|Maintenance Therapy|Continuing maintenance therapy|0
832739|NCT01056276|2648119|P2|Maintenance Therapy|Intercurrent Illness|1
832740|NCT01056276|2648120|P1|Maintenance Therapy|Intercurrent Illness|0
832741|NCT01056276|2648119|P2|Maintenance Therapy|Withdrawal by Subject|1
832742|NCT01056276|2648120|P1|Maintenance Therapy|Withdrawal by Subject|0
832743|NCT01056276|2648119|P2|Maintenance Therapy|Physician Decision|1
832744|NCT01056276|2648120|P1|Maintenance Therapy|Physician Decision|0
832745|NCT01056276|2648119|P2|Maintenance Therapy|Progressive Disease|9
832746|NCT01056276|2648120|P1|Maintenance Therapy|Progressive Disease|0
832747|NCT01056276|2648119|P2|Maintenance Therapy|Toxicity|2
832748|NCT01056276|2648120|P1|Maintenance Therapy|Toxicity|0
832749|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
832750|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
832751|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Death|1
832752|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Death|3
832753|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Physician Decision|0
832754|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Physician Decision|3
832755|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
832756|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
832757|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Disease Progression|2
832758|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Disease Progression|2
832759|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
832760|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
832761|NCT01056276|2648119|P2|Treatment Period-Cycles 1-8|Toxicity|1
832762|NCT01056276|2648120|P1|Treatment Period-Cycles 1-8|Toxicity|2
832763|NCT01056289|2648134|P4|Double-blind Phase|Physician Decision|0
832764|NCT01056289|2648135|P3|Double-blind Phase|Physician Decision|1
832765|NCT01056289|2648136|P2|Double-blind Phase|Physician Decision|0
832766|NCT01056289|2648137|P1|Double-blind Phase|Physician Decision|0
832767|NCT01056289|2648134|P4|Double-blind Phase|Discontinuation symptom|2
832768|NCT01056289|2648135|P3|Double-blind Phase|Discontinuation symptom|2
832769|NCT01056289|2648136|P2|Double-blind Phase|Discontinuation symptom|1
832770|NCT01056289|2648137|P1|Double-blind Phase|Discontinuation symptom|0
832771|NCT01056289|2648134|P4|Double-blind Phase|Withdrawal by Subject|2
832772|NCT01056289|2648135|P3|Double-blind Phase|Withdrawal by Subject|4
832773|NCT01056289|2648136|P2|Double-blind Phase|Withdrawal by Subject|0
832774|NCT01056289|2648137|P1|Double-blind Phase|Withdrawal by Subject|0
832775|NCT01056289|2648134|P4|Double-blind Phase|Protocol Violation|1
832776|NCT01056289|2648135|P3|Double-blind Phase|Protocol Violation|1
832777|NCT01056289|2648136|P2|Double-blind Phase|Protocol Violation|0
832778|NCT01056289|2648137|P1|Double-blind Phase|Protocol Violation|0
832779|NCT01056289|2648134|P4|Double-blind Phase|Unspecified|2
832780|NCT01056289|2648135|P3|Double-blind Phase|Unspecified|1
832781|NCT01056289|2648136|P2|Double-blind Phase|Unspecified|0
832782|NCT01056289|2648137|P1|Double-blind Phase|Unspecified|0
832783|NCT01056289|2648134|P4|Double-blind Phase|Lost to Follow-up|2
832784|NCT01056289|2648135|P3|Double-blind Phase|Lost to Follow-up|2
832785|NCT01056289|2648136|P2|Double-blind Phase|Lost to Follow-up|2
832786|NCT01056289|2648137|P1|Double-blind Phase|Lost to Follow-up|0
832787|NCT01056289|2648134|P4|Double-blind Phase|Adverse Event|1
832788|NCT01056289|2648135|P3|Double-blind Phase|Adverse Event|2
832789|NCT01056289|2648136|P2|Double-blind Phase|Adverse Event|1
832790|NCT01056289|2648137|P1|Double-blind Phase|Adverse Event|0
832791|NCT01056289|2648134|P4|Open-label Phase|Not randomized to Double-blind phase|0
832792|NCT01056289|2648135|P3|Open-label Phase|Not randomized to Double-blind phase|0
832793|NCT01056289|2648136|P2|Open-label Phase|Not randomized to Double-blind phase|0
832794|NCT01056289|2648137|P1|Open-label Phase|Not randomized to Double-blind phase|1
832795|NCT01056289|2648134|P4|Open-label Phase|Lack of Efficacy|0
832796|NCT01056289|2648135|P3|Open-label Phase|Lack of Efficacy|0
832797|NCT01056289|2648136|P2|Open-label Phase|Lack of Efficacy|0
832798|NCT01056289|2648137|P1|Open-label Phase|Lack of Efficacy|18
832799|NCT01056289|2648134|P4|Open-label Phase|Withdrawal by Subject|0
832800|NCT01056289|2648135|P3|Open-label Phase|Withdrawal by Subject|0
832801|NCT01056289|2648136|P2|Open-label Phase|Withdrawal by Subject|0
832802|NCT01056289|2648137|P1|Open-label Phase|Withdrawal by Subject|26
832803|NCT01056289|2648134|P4|Open-label Phase|Protocol Violation|0
832804|NCT01056289|2648135|P3|Open-label Phase|Protocol Violation|0
832805|NCT01056289|2648136|P2|Open-label Phase|Protocol Violation|0
832806|NCT01056289|2648137|P1|Open-label Phase|Protocol Violation|6
832807|NCT01056289|2648134|P4|Open-label Phase|Unspecified|0
832808|NCT01056289|2648135|P3|Open-label Phase|Unspecified|0
832809|NCT01056289|2648136|P2|Open-label Phase|Unspecified|0
832810|NCT01056289|2648137|P1|Open-label Phase|Unspecified|9
832811|NCT01056289|2648134|P4|Open-label Phase|Lost to Follow-up|0
832812|NCT01056289|2648135|P3|Open-label Phase|Lost to Follow-up|0
832813|NCT01056289|2648136|P2|Open-label Phase|Lost to Follow-up|0
832814|NCT01056289|2648137|P1|Open-label Phase|Lost to Follow-up|30
832815|NCT01056289|2648134|P4|Open-label Phase|Adverse Event|0
832816|NCT01056289|2648135|P3|Open-label Phase|Adverse Event|0
832817|NCT01056289|2648136|P2|Open-label Phase|Adverse Event|0
832818|NCT01056289|2648137|P1|Open-label Phase|Adverse Event|29
832819|NCT01056341|2648211|P5|Overall Study|Other reasons|5
832820|NCT01056341|2648212|P4|Overall Study|Other reasons|9
832821|NCT01056341|2648213|P3|Overall Study|Other reasons|8
832822|NCT01056341|2648214|P2|Overall Study|Other reasons|4
832823|NCT01056341|2648215|P1|Overall Study|Other reasons|4
832824|NCT01056341|2648211|P5|Overall Study|Lack of Efficacy|9
832825|NCT01056341|2648212|P4|Overall Study|Lack of Efficacy|25
832826|NCT01056341|2648213|P3|Overall Study|Lack of Efficacy|7
832827|NCT01056341|2648214|P2|Overall Study|Lack of Efficacy|30
832828|NCT01056341|2648215|P1|Overall Study|Lack of Efficacy|32
832829|NCT01056341|2648211|P5|Overall Study|Treatment Intolerance|0
832830|NCT01056341|2648212|P4|Overall Study|Treatment Intolerance|2
832831|NCT01056341|2648213|P3|Overall Study|Treatment Intolerance|0
832832|NCT01056341|2648214|P2|Overall Study|Treatment Intolerance|2
832833|NCT01056341|2648215|P1|Overall Study|Treatment Intolerance|0
832834|NCT01056380|2648236|P2|Overall Study|Lost to Follow-up|3
832835|NCT01056380|2648237|P1|Overall Study|Lost to Follow-up|2
832836|NCT01056484|2648261|P2|Follow up - Non-randomized|Withdrawal by Subject|2
832837|NCT01056484|2648262|P1|Follow up - Non-randomized|Withdrawal by Subject|0
832838|NCT01056484|2648261|P2|Randomized Controlled Trial|Physician Decision|0
832839|NCT01056484|2648262|P1|Randomized Controlled Trial|Physician Decision|1
832840|NCT01056484|2648261|P2|Randomized Controlled Trial|Withdrawal by Subject|1
832841|NCT01056484|2648262|P1|Randomized Controlled Trial|Withdrawal by Subject|6
832842|NCT01056510|2648278|P2|Overall Study|Missing|1
832843|NCT01056510|2648279|P1|Overall Study|Missing|0
832844|NCT01056510|2648278|P2|Overall Study|Not Specified|12
832845|NCT01056510|2648279|P1|Overall Study|Not Specified|10
832846|NCT01056510|2648278|P2|Overall Study|Lost to Follow-up|6
832847|NCT01056510|2648279|P1|Overall Study|Lost to Follow-up|5
832848|NCT01056510|2648278|P2|Overall Study|Physician Decision|5
832849|NCT01056510|2648279|P1|Overall Study|Physician Decision|4
832850|NCT01056510|2648278|P2|Overall Study|Noncompliance|3
832851|NCT01056510|2648279|P1|Overall Study|Noncompliance|1
832852|NCT01056510|2648278|P2|Overall Study|Death|34
832853|NCT01056510|2648279|P1|Overall Study|Death|29
832854|NCT01056510|2648278|P2|Overall Study|Withdrawal by Subject|2
832855|NCT01056510|2648279|P1|Overall Study|Withdrawal by Subject|4
832856|NCT01056510|2648278|P2|Overall Study|Dropout Before Start of Treatment|1
832857|NCT01056510|2648279|P1|Overall Study|Dropout Before Start of Treatment|1
832858|NCT01056523|2648323|P7|Overall Study|Death|1
832859|NCT01056523|2648324|P6|Overall Study|Death|0
832860|NCT01056523|2648325|P5|Overall Study|Death|0
832861|NCT01056523|2648326|P4|Overall Study|Death|3
832862|NCT01056523|2648327|P3|Overall Study|Death|2
832863|NCT01056523|2648328|P2|Overall Study|Death|0
832864|NCT01056523|2648329|P1|Overall Study|Death|1
832865|NCT01056640|2648345|P2|Overall Study|Death|4
832866|NCT01056640|2648346|P1|Overall Study|Death|15
832867|NCT01056640|2648345|P2|Overall Study|Withdrawal by Subject|8
832868|NCT01056640|2648346|P1|Overall Study|Withdrawal by Subject|11
832869|NCT01056653|2648355|P3|Overall Study|Lost to Follow-up|2
832870|NCT01056653|2648356|P2|Overall Study|Lost to Follow-up|0
832871|NCT01056653|2648357|P1|Overall Study|Lost to Follow-up|0
832872|NCT01056718|2648371|P1|Overall Study|Ischemia on baseline stress test|1
832873|NCT01056718|2648371|P1|Overall Study|Withdrawal by Subject|2
832874|NCT01056822|2648403|P2|Overall Study|Lost to Follow-up|0
832875|NCT01056822|2648404|P1|Overall Study|Lost to Follow-up|1
832876|NCT01056822|2648403|P2|Overall Study|Withdrawal by Subject|1
832877|NCT01056822|2648404|P1|Overall Study|Withdrawal by Subject|1
832878|NCT01056822|2648403|P2|Overall Study|Protocol Violation|5
832879|NCT01056822|2648404|P1|Overall Study|Protocol Violation|6
832880|NCT01056822|2648403|P2|Overall Study|Adverse Event|1
832881|NCT01056822|2648404|P1|Overall Study|Adverse Event|0
832882|NCT01057251|2648523|P2|Overall Study|Other Reason|1
832883|NCT01057251|2648524|P1|Overall Study|Other Reason|1
832884|NCT01057251|2648523|P2|Overall Study|Lost to Follow-up|6
832885|NCT01057251|2648524|P1|Overall Study|Lost to Follow-up|7
832886|NCT01057251|2648523|P2|Overall Study|Withdrawal by Subject|5
832887|NCT01057251|2648524|P1|Overall Study|Withdrawal by Subject|4
832888|NCT01057251|2648523|P2|Overall Study|Protocol Violation|2
832889|NCT01057251|2648524|P1|Overall Study|Protocol Violation|6
832890|NCT01057251|2648523|P2|Overall Study|Lack of Efficacy|11
832891|NCT01057251|2648524|P1|Overall Study|Lack of Efficacy|2
832892|NCT01057251|2648523|P2|Overall Study|Adverse Event|2
832893|NCT01057251|2648524|P1|Overall Study|Adverse Event|4
832894|NCT01057251|2648523|P2|Overall Study|Did not meet InclusionExclusion criteria|2
832895|NCT01057251|2648524|P1|Overall Study|Did not meet InclusionExclusion criteria|4
832896|NCT01057394|2648536|P2|Overall Study|Not eligible|2
832897|NCT01057394|2648537|P1|Overall Study|Not eligible|0
832898|NCT01057433|2648541|P1|Overall Study|Adverse Event|1
832899|NCT01057589|2648545|P1|Overall Study|Lost to Follow-up|1
832900|NCT01057589|2648545|P1|Overall Study|Death|8
832901|NCT01057589|2648545|P1|Overall Study|Sponsor Decision|1
832902|NCT01057589|2648545|P1|Overall Study|Withdrawal by Subject|3
832903|NCT01057589|2648545|P1|Overall Study|Physician Decision|8
832904|NCT01057589|2648545|P1|Overall Study|Adverse Event|10
832905|NCT01057589|2648545|P1|Overall Study|Disease Progression|35
832906|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
832907|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
832908|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
832909|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
832910|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Unspecified|1
832911|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
832912|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
832913|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
832914|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
832915|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
832916|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
832917|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
832918|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
832919|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
832920|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
832921|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
832922|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
832923|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
832924|NCT01057693|2648554|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
832925|NCT01057693|2648555|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
832926|NCT01057693|2648556|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
832927|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Unspecified|0
832928|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Unspecified|0
832929|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Unspecified|6
832930|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
832931|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
832932|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
832933|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
832934|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
832935|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
832936|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
832937|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
832938|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
832939|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
832940|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
832941|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
832942|NCT01057693|2648554|P3|Between Single-Blind and Double-Blind|Adverse Event|0
832943|NCT01057693|2648555|P2|Between Single-Blind and Double-Blind|Adverse Event|0
832944|NCT01057693|2648556|P1|Between Single-Blind and Double-Blind|Adverse Event|5
832945|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Unspecified|0
832946|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Unspecified|0
832947|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Unspecified|2
832948|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
832949|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
832950|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
832951|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
832952|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
832953|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
832954|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
832955|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
832956|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
832957|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
832958|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
832959|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
832960|NCT01057693|2648554|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
832961|NCT01057693|2648555|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
832962|NCT01057693|2648556|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
832963|NCT01057810|2648604|P2|Overall Study|Unspecified|14
832964|NCT01057810|2648605|P1|Overall Study|Unspecified|7
832965|NCT01057810|2648604|P2|Overall Study|No longer met study criteria|1
832966|NCT01057810|2648605|P1|Overall Study|No longer met study criteria|0
832967|NCT01057810|2648604|P2|Overall Study|Poor/non-compliance|1
832968|NCT01057810|2648605|P1|Overall Study|Poor/non-compliance|0
832969|NCT01057810|2648604|P2|Overall Study|Maximum clinical benefit|5
832970|NCT01057810|2648605|P1|Overall Study|Maximum clinical benefit|5
832971|NCT01057810|2648604|P2|Overall Study|Death|12
832972|NCT01057810|2648605|P1|Overall Study|Death|2
832973|NCT01057810|2648604|P2|Overall Study|Withdrawal by Subject|25
832974|NCT01057810|2648605|P1|Overall Study|Withdrawal by Subject|10
832975|NCT01057810|2648604|P2|Overall Study|Adverse event unrelated to study drug|29
832976|NCT01057810|2648605|P1|Overall Study|Adverse event unrelated to study drug|13
832977|NCT01057810|2648604|P2|Overall Study|Study drug toxicity|114
832978|NCT01057810|2648605|P1|Overall Study|Study drug toxicity|5
832979|NCT01057810|2648604|P2|Overall Study|Disease progression|197
832980|NCT01057810|2648605|P1|Overall Study|Disease progression|156
832983|NCT01058005|2648660|P3|Overall Study|Reason Missing|1
832984|NCT01058005|2648661|P2|Overall Study|Reason Missing|3
832985|NCT01058005|2648662|P1|Overall Study|Reason Missing|5
832986|NCT01058005|2648660|P3|Overall Study|Withdrawn Due to Study Termination|7
832987|NCT01058005|2648661|P2|Overall Study|Withdrawn Due to Study Termination|13
832988|NCT01058005|2648662|P1|Overall Study|Withdrawn Due to Study Termination|27
832989|NCT01058005|2648660|P3|Overall Study|Withdrawal by Subject|11
832990|NCT01058005|2648661|P2|Overall Study|Withdrawal by Subject|5
832991|NCT01058005|2648662|P1|Overall Study|Withdrawal by Subject|4
832992|NCT01058005|2648660|P3|Overall Study|Physician Decision|0
832993|NCT01058005|2648661|P2|Overall Study|Physician Decision|2
832994|NCT01058005|2648662|P1|Overall Study|Physician Decision|2
832995|NCT01058005|2648660|P3|Overall Study|Adverse Event|1
832996|NCT01058005|2648661|P2|Overall Study|Adverse Event|2
832997|NCT01058005|2648662|P1|Overall Study|Adverse Event|0
832998|NCT01058096|2648677|P2|Double-blind Treatment Phase|Other Unspecified|0
832999|NCT01058096|2648678|P1|Double-blind Treatment Phase|Other Unspecified|2
833000|NCT01058096|2648677|P2|Double-blind Treatment Phase|Lost to Follow-up|1
833001|NCT01058096|2648678|P1|Double-blind Treatment Phase|Lost to Follow-up|0
833002|NCT01058096|2648677|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
833003|NCT01058096|2648678|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
833004|NCT01058096|2648677|P2|Double-blind Treatment Phase|Protocol Violation|1
833005|NCT01058096|2648678|P1|Double-blind Treatment Phase|Protocol Violation|2
833006|NCT01058096|2648677|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
833007|NCT01058096|2648678|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
833008|NCT01058096|2648677|P2|Double-blind Treatment Phase|Adverse Event|15
833009|NCT01058096|2648678|P1|Double-blind Treatment Phase|Adverse Event|11
833038|NCT01051739|2648715|P2|Overall Study|Withdrawal by Subject|10
833039|NCT01051739|2648716|P1|Overall Study|Withdrawal by Subject|25
833040|NCT01051739|2648715|P2|Overall Study|Death|3
833041|NCT01051739|2648716|P1|Overall Study|Death|3
833042|NCT01051817|2648733|P2|Overall Study|Protocol Violation|1
833043|NCT01051817|2648734|P1|Overall Study|Protocol Violation|0
833044|NCT01051817|2648733|P2|Overall Study|Withdrawal by Subject|5
833045|NCT01051817|2648734|P1|Overall Study|Withdrawal by Subject|3
833046|NCT01051817|2648733|P2|Overall Study|Abnormal Test Proceedure reults|1
833047|NCT01051817|2648734|P1|Overall Study|Abnormal Test Proceedure reults|0
833048|NCT01051817|2648733|P2|Overall Study|Adverse Event|2
833049|NCT01051817|2648734|P1|Overall Study|Adverse Event|0
833050|NCT01051856|2648746|P2|Overall Study|Withdrawal by Subject|0
833051|NCT01051856|2648747|P1|Overall Study|Withdrawal by Subject|1
833052|NCT01051921|2648755|P1|Overall Study|patient moved|1
833053|NCT01051921|2648755|P1|Overall Study|virological failure|1
833054|NCT01051921|2648755|P1|Overall Study|Lost to Follow-up|4
833055|NCT01051921|2648755|P1|Overall Study|Withdrawal by Subject|7
833056|NCT01051921|2648755|P1|Overall Study|Adverse Event|8
833057|NCT01051921|2648755|P1|Overall Study|Physician Decision|9
833058|NCT01051986|2648762|P2|Overall Study|Protocol Violation|3
833059|NCT01051986|2648763|P1|Overall Study|Protocol Violation|2
833060|NCT01051986|2648762|P2|Overall Study|Withdrawal by Subject|1
833061|NCT01051986|2648763|P1|Overall Study|Withdrawal by Subject|2
833062|NCT01051986|2648762|P2|Overall Study|Death|0
833063|NCT01051986|2648763|P1|Overall Study|Death|1
833064|NCT01052038|2648780|P3|Overall Study|Protocol Violation|3
833065|NCT01052038|2648781|P2|Overall Study|Protocol Violation|3
833066|NCT01052038|2648782|P1|Overall Study|Protocol Violation|2
833067|NCT01052038|2648780|P3|Overall Study|Lost to Follow-up|1
833068|NCT01052038|2648781|P2|Overall Study|Lost to Follow-up|3
833069|NCT01052038|2648782|P1|Overall Study|Lost to Follow-up|2
833070|NCT01052077|2648804|P4|Phase A+|Withdrawal by Subject|7
833071|NCT01052077|2648805|P3|Phase A+|Withdrawal by Subject|0
833072|NCT01052077|2648806|P2|Phase A+|Withdrawal by Subject|0
833073|NCT01052077|2648807|P1|Phase A+|Withdrawal by Subject|0
833074|NCT01052077|2648804|P4|Phase A+|Met Withdrawal Criteria|2
833075|NCT01052077|2648805|P3|Phase A+|Met Withdrawal Criteria|0
833076|NCT01052077|2648806|P2|Phase A+|Met Withdrawal Criteria|0
833077|NCT01052077|2648807|P1|Phase A+|Met Withdrawal Criteria|0
833078|NCT01052077|2648804|P4|Phase A+|Adverse Event|4
833079|NCT01052077|2648805|P3|Phase A+|Adverse Event|0
833080|NCT01052077|2648806|P2|Phase A+|Adverse Event|0
833081|NCT01052077|2648807|P1|Phase A+|Adverse Event|0
833082|NCT01052077|2648804|P4|Phase A+|Lost to Follow-up|8
833083|NCT01052077|2648805|P3|Phase A+|Lost to Follow-up|0
833084|NCT01052077|2648806|P2|Phase A+|Lost to Follow-up|0
833085|NCT01052077|2648807|P1|Phase A+|Lost to Follow-up|0
833086|NCT01052077|2648804|P4|Phase B|Lack of Efficacy|0
833087|NCT01052077|2648805|P3|Phase B|Lack of Efficacy|0
833088|NCT01052077|2648806|P2|Phase B|Lack of Efficacy|1
833089|NCT01052077|2648807|P1|Phase B|Lack of Efficacy|0
833090|NCT01052077|2648804|P4|Phase B|Protocol Deviation|0
833091|NCT01052077|2648805|P3|Phase B|Protocol Deviation|4
833092|NCT01052077|2648806|P2|Phase B|Protocol Deviation|3
833093|NCT01052077|2648807|P1|Phase B|Protocol Deviation|0
833094|NCT01052077|2648804|P4|Phase B|Withdrawal by Subject|0
833095|NCT01052077|2648805|P3|Phase B|Withdrawal by Subject|5
833096|NCT01052077|2648806|P2|Phase B|Withdrawal by Subject|0
833097|NCT01052077|2648807|P1|Phase B|Withdrawal by Subject|0
833098|NCT01052077|2648804|P4|Phase B|Physician Decision|0
833099|NCT01052077|2648805|P3|Phase B|Physician Decision|1
833100|NCT01052077|2648806|P2|Phase B|Physician Decision|1
833101|NCT01052077|2648807|P1|Phase B|Physician Decision|0
833102|NCT01052077|2648804|P4|Phase B|Met Withdrawal Criteria|0
833103|NCT01052077|2648805|P3|Phase B|Met Withdrawal Criteria|1
833104|NCT01052077|2648806|P2|Phase B|Met Withdrawal Criteria|2
833105|NCT01052077|2648807|P1|Phase B|Met Withdrawal Criteria|0
833106|NCT01052077|2648804|P4|Phase B|Adverse Event|0
833107|NCT01052077|2648805|P3|Phase B|Adverse Event|2
833108|NCT01052077|2648806|P2|Phase B|Adverse Event|9
833109|NCT01052077|2648807|P1|Phase B|Adverse Event|0
833110|NCT01052077|2648804|P4|Phase B|Lost to Follow-up|0
833111|NCT01052077|2648805|P3|Phase B|Lost to Follow-up|3
833112|NCT01052077|2648806|P2|Phase B|Lost to Follow-up|2
833113|NCT01052077|2648807|P1|Phase B|Lost to Follow-up|0
833114|NCT01052077|2648804|P4|Phase A|Protocol Deviation|0
833115|NCT01052077|2648805|P3|Phase A|Protocol Deviation|0
833116|NCT01052077|2648806|P2|Phase A|Protocol Deviation|0
833117|NCT01052077|2648807|P1|Phase A|Protocol Deviation|27
833118|NCT01052077|2648804|P4|Phase A|Withdrawal by Subject|0
833119|NCT01052077|2648805|P3|Phase A|Withdrawal by Subject|0
833120|NCT01052077|2648806|P2|Phase A|Withdrawal by Subject|0
833121|NCT01052077|2648807|P1|Phase A|Withdrawal by Subject|29
833122|NCT01052077|2648804|P4|Phase A|Physician Decision|0
833123|NCT01052077|2648805|P3|Phase A|Physician Decision|0
833124|NCT01052077|2648806|P2|Phase A|Physician Decision|0
833125|NCT01052077|2648807|P1|Phase A|Physician Decision|10
833126|NCT01052077|2648804|P4|Phase A|Met Withdrawal Criteria|0
833127|NCT01052077|2648805|P3|Phase A|Met Withdrawal Criteria|0
833128|NCT01052077|2648806|P2|Phase A|Met Withdrawal Criteria|0
833129|NCT01052077|2648807|P1|Phase A|Met Withdrawal Criteria|26
833130|NCT01052077|2648804|P4|Phase A|Adverse Event|0
833131|NCT01052077|2648805|P3|Phase A|Adverse Event|0
833132|NCT01052077|2648806|P2|Phase A|Adverse Event|0
833133|NCT01052077|2648807|P1|Phase A|Adverse Event|32
833134|NCT01052077|2648804|P4|Phase A|Lost to Follow-up|0
833135|NCT01052077|2648805|P3|Phase A|Lost to Follow-up|0
833136|NCT01052077|2648806|P2|Phase A|Lost to Follow-up|0
833137|NCT01052077|2648807|P1|Phase A|Lost to Follow-up|22
833138|NCT01058265|2648833|P2|Overall Study|Lost to Follow-up|12
833139|NCT01058265|2648834|P1|Overall Study|Lost to Follow-up|11
833140|NCT01058304|2648844|P2|Overall Study|Developed exclusion criterion|12
833141|NCT01058304|2648845|P1|Overall Study|Developed exclusion criterion|6
833142|NCT01058304|2648844|P2|Overall Study|Lost to Follow-up|16
833143|NCT01058304|2648845|P1|Overall Study|Lost to Follow-up|13
833144|NCT01058304|2648844|P2|Overall Study|Withdrawal by Subject|5
833145|NCT01058304|2648845|P1|Overall Study|Withdrawal by Subject|8
833146|NCT01058356|2648853|P1|Overall Study|Lost to Follow-up|4
833147|NCT01058356|2648853|P1|Overall Study|Withdrawal by Subject|21
833148|NCT01058356|2648853|P1|Overall Study|Administration of contraindicated drugs|12
833149|NCT01058356|2648853|P1|Overall Study|Adverse Event|5
833150|NCT01058421|2648860|P2|6 Month Outcomes|Remained in Other Facility|3
833151|NCT01058421|2648861|P1|6 Month Outcomes|Remained in Other Facility|1
833152|NCT01058421|2648860|P2|6 Month Outcomes|Lost to Follow-up|21
833153|NCT01058421|2648861|P1|6 Month Outcomes|Lost to Follow-up|16
833154|NCT01058421|2648860|P2|6 Month Outcomes|Death|2
833155|NCT01058421|2648861|P1|6 Month Outcomes|Death|2
833156|NCT01058421|2648860|P2|3 Month Outcomes|Remained in Other Facility|8
833157|NCT01058421|2648861|P1|3 Month Outcomes|Remained in Other Facility|5
833158|NCT01058421|2648860|P2|3 Month Outcomes|Remained in Hospital|2
833159|NCT01058421|2648861|P1|3 Month Outcomes|Remained in Hospital|0
833160|NCT01058421|2648860|P2|3 Month Outcomes|Lost to Follow-up|11
833161|NCT01058421|2648861|P1|3 Month Outcomes|Lost to Follow-up|12
833162|NCT01058421|2648860|P2|3 Month Outcomes|Death|5
833163|NCT01058421|2648861|P1|3 Month Outcomes|Death|3
833164|NCT01058421|2648860|P2|1 Month Outcomes|Remained in Other Facility|17
833165|NCT01058421|2648861|P1|1 Month Outcomes|Remained in Other Facility|16
833166|NCT01058421|2648860|P2|1 Month Outcomes|Remained in Hospital|12
833167|NCT01058421|2648861|P1|1 Month Outcomes|Remained in Hospital|5
833168|NCT01058421|2648860|P2|1 Month Outcomes|Lost to Follow-up|7
833169|NCT01058421|2648861|P1|1 Month Outcomes|Lost to Follow-up|8
833170|NCT01058421|2648860|P2|1 Month Outcomes|Death|6
833171|NCT01058421|2648861|P1|1 Month Outcomes|Death|10
833172|NCT01060072|2648885|P2|Overall Study|Excluded Medications|1
833173|NCT01060072|2648886|P1|Overall Study|Excluded Medications|0
833174|NCT01060072|2648885|P2|Overall Study|Acute cholecystitis|0
833175|NCT01060072|2648886|P1|Overall Study|Acute cholecystitis|1
833176|NCT01060072|2648885|P2|Overall Study|Protocol Violation|1
833177|NCT01060072|2648886|P1|Overall Study|Protocol Violation|0
833178|NCT01060072|2648885|P2|Overall Study|Physician Decision|2
833179|NCT01060072|2648886|P1|Overall Study|Physician Decision|0
833180|NCT01060072|2648885|P2|Overall Study|Adverse Event|1
833181|NCT01060072|2648886|P1|Overall Study|Adverse Event|1
833182|NCT01060111|2648903|P3|Overall Study|Unspecified|4
833183|NCT01060111|2648904|P2|Overall Study|Unspecified|3
833184|NCT01060111|2648905|P1|Overall Study|Unspecified|2
833185|NCT01060111|2648903|P3|Overall Study|Participants' non-cooperation|0
833186|NCT01060111|2648904|P2|Overall Study|Participants' non-cooperation|0
833187|NCT01060111|2648905|P1|Overall Study|Participants' non-cooperation|1
833188|NCT01060111|2648903|P3|Overall Study|Adverse event and insufficient effect|0
833189|NCT01060111|2648904|P2|Overall Study|Adverse event and insufficient effect|1
833190|NCT01060111|2648905|P1|Overall Study|Adverse event and insufficient effect|0
833191|NCT01060111|2648903|P3|Overall Study|Participants' non-cooperation|6
833192|NCT01060111|2648904|P2|Overall Study|Participants' non-cooperation|6
833193|NCT01060111|2648905|P1|Overall Study|Participants' non-cooperation|8
833194|NCT01060111|2648903|P3|Overall Study|Participants' evasion for hospital visit|2
833195|NCT01060111|2648904|P2|Overall Study|Participants' evasion for hospital visit|3
833196|NCT01060111|2648905|P1|Overall Study|Participants' evasion for hospital visit|0
833197|NCT01060111|2648903|P3|Overall Study|Inappropriate participant|5
833198|NCT01060111|2648904|P2|Overall Study|Inappropriate participant|4
833199|NCT01060111|2648905|P1|Overall Study|Inappropriate participant|5
833200|NCT01060111|2648903|P3|Overall Study|Lack of Efficacy|0
833201|NCT01060111|2648904|P2|Overall Study|Lack of Efficacy|1
833202|NCT01060111|2648905|P1|Overall Study|Lack of Efficacy|2
833203|NCT01060111|2648903|P3|Overall Study|Adverse Event|18
833204|NCT01060111|2648904|P2|Overall Study|Adverse Event|5
833205|NCT01060111|2648905|P1|Overall Study|Adverse Event|9
833206|NCT01060124|2648922|P1|Overall Study|Withdrawal by Subject|7
833207|NCT01060124|2648922|P1|Overall Study|Adverse Event|14
833208|NCT01060124|2648922|P1|Overall Study|Unspecified|16
833209|NCT01060150|2648930|P1|Overall Study|Enrolled, but not treated|2
833210|NCT01060150|2648930|P1|Overall Study|Withdrawal by Subject|8
833211|NCT01060150|2648930|P1|Overall Study|Protocol Violation|6
833212|NCT01060150|2648930|P1|Overall Study|Lost to Follow-up|1
833213|NCT01060150|2648930|P1|Overall Study|Adverse Event|6
833214|NCT01060540|2648947|P2|Overall Study|Physician Decision|1
833215|NCT01060540|2648948|P1|Overall Study|Physician Decision|0
833216|NCT01060540|2648947|P2|Overall Study|Death|1
833217|NCT01060540|2648948|P1|Overall Study|Death|2
833218|NCT01060540|2648947|P2|Overall Study|Lost to Follow-up|43
833219|NCT01060540|2648948|P1|Overall Study|Lost to Follow-up|52
833220|NCT01060540|2648947|P2|Overall Study|Withdrawal by Subject|20
833221|NCT01060540|2648948|P1|Overall Study|Withdrawal by Subject|10
833222|NCT01060553|2648962|P2|Overall Study|Lack of Efficacy|0
833223|NCT01060553|2648963|P1|Overall Study|Lack of Efficacy|1
833224|NCT01060553|2648962|P2|Overall Study|Withdrawal by Subject|5
833225|NCT01060553|2648963|P1|Overall Study|Withdrawal by Subject|5
833226|NCT01060553|2648962|P2|Overall Study|Lost to Follow-up|5
833227|NCT01060553|2648963|P1|Overall Study|Lost to Follow-up|3
833228|NCT01060670|2648987|P2|Run In|screen failure|238
833229|NCT01060670|2648988|P1|Run In|screen failure|0
833230|NCT01061008|2649008|P2|Overall Study|Adverse Event|1
833231|NCT01061008|2649009|P1|Overall Study|Adverse Event|0
833232|NCT01061008|2649008|P2|Overall Study|Unable to exercise following surgery|0
833233|NCT01061008|2649009|P1|Overall Study|Unable to exercise following surgery|1
833234|NCT01061008|2649008|P2|Overall Study|Withdrawal by Subject|3
833235|NCT01061008|2649009|P1|Overall Study|Withdrawal by Subject|1
833236|NCT01061008|2649008|P2|Overall Study|Death|0
833237|NCT01061008|2649009|P1|Overall Study|Death|1
833238|NCT01061008|2649008|P2|Overall Study|Badiocephalic fistula failed|2
833239|NCT01061008|2649009|P1|Overall Study|Badiocephalic fistula failed|3
833240|NCT01061177|2649020|P1|Overall Study|Death|4
833241|NCT01061177|2649020|P1|Overall Study|Administratie problems|4
833242|NCT01061177|2649020|P1|Overall Study|Abnormal test procedure results|4
833243|NCT01061177|2649020|P1|Overall Study|Abnormal laboratory values|6
833244|NCT01061177|2649020|P1|Overall Study|New cancer therapy|9
833245|NCT01061177|2649020|P1|Overall Study|Lost to Follow-up|9
833246|NCT01061177|2649020|P1|Overall Study|Protocol Violation|11
833247|NCT01061177|2649020|P1|Overall Study|Disease progression|17
833248|NCT01061177|2649020|P1|Overall Study|Withdrawal by Subject|27
833249|NCT01061177|2649020|P1|Overall Study|Adverse Event|117
833250|NCT01061333|2649039|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
833251|NCT01061333|2649040|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
833252|NCT01061359|2649078|P1|Overall Study|Secondary neoplasm|11
833253|NCT01061359|2649078|P1|Overall Study|Relapse|187
833254|NCT01061359|2649078|P1|Overall Study|Lost to Follow-up|1072
833255|NCT01061359|2649078|P1|Overall Study|Death|32
833256|NCT01061385|2649086|P2|Overall Study|subject decision not related to AE|1
833257|NCT01061385|2649087|P1|Overall Study|subject decision not related to AE|0
833258|NCT01061385|2649086|P2|Overall Study|Lost to Follow-up|0
833259|NCT01061385|2649087|P1|Overall Study|Lost to Follow-up|1
833260|NCT01061567|2649099|P1|Overall Study|Other reason than stated above|3
833261|NCT01061567|2649099|P1|Overall Study|Withdrawal by Subject|11
833262|NCT01061567|2649099|P1|Overall Study|Protocol Violation|1
833263|NCT01061567|2649099|P1|Overall Study|Lost to Follow-up|24
833264|NCT01061567|2649099|P1|Overall Study|Lack of Efficacy|3
833265|NCT01061567|2649099|P1|Overall Study|Death|2
833266|NCT01061567|2649099|P1|Overall Study|Adverse Event|32
833267|NCT01061606|2649108|P1|Overall Study|alternative therapy|2
833268|NCT01061606|2649108|P1|Overall Study|Disease Progression|4
833269|NCT01061606|2649108|P1|Overall Study|Death|1
833270|NCT01061606|2649108|P1|Overall Study|Adverse Event|1
833277|NCT01061710|2649132|P1|Overall Study|Protocol Violation|14
833278|NCT01061723|2649146|P6|Overall Study|Other than specified above|1
833279|NCT01061723|2649147|P5|Overall Study|Other than specified above|0
833280|NCT01061723|2649148|P4|Overall Study|Other than specified above|1
833281|NCT01061723|2649149|P3|Overall Study|Other than specified above|1
833282|NCT01061723|2649150|P2|Overall Study|Other than specified above|1
833283|NCT01061723|2649151|P1|Overall Study|Other than specified above|2
833284|NCT01061723|2649146|P6|Overall Study|Randomized but not treated|1
833285|NCT01061723|2649147|P5|Overall Study|Randomized but not treated|0
833286|NCT01061723|2649148|P4|Overall Study|Randomized but not treated|0
833287|NCT01061723|2649149|P3|Overall Study|Randomized but not treated|0
833288|NCT01061723|2649150|P2|Overall Study|Randomized but not treated|0
833289|NCT01061723|2649151|P1|Overall Study|Randomized but not treated|0
833290|NCT01061723|2649146|P6|Overall Study|Lack of Efficacy|1
833291|NCT01061723|2649147|P5|Overall Study|Lack of Efficacy|1
833292|NCT01061723|2649148|P4|Overall Study|Lack of Efficacy|2
833293|NCT01061723|2649149|P3|Overall Study|Lack of Efficacy|4
833294|NCT01061723|2649150|P2|Overall Study|Lack of Efficacy|3
833295|NCT01061723|2649151|P1|Overall Study|Lack of Efficacy|2
833296|NCT01061723|2649146|P6|Overall Study|Adverse Event|6
833297|NCT01061723|2649147|P5|Overall Study|Adverse Event|2
833298|NCT01061723|2649148|P4|Overall Study|Adverse Event|5
833299|NCT01061723|2649149|P3|Overall Study|Adverse Event|5
833300|NCT01061723|2649150|P2|Overall Study|Adverse Event|2
833301|NCT01061723|2649151|P1|Overall Study|Adverse Event|0
833302|NCT01061736|2649241|P10|Overall Study|Other than specified above|21
833303|NCT01061736|2649242|P9|Overall Study|Other than specified above|15
833304|NCT01061736|2649243|P8|Overall Study|Other than specified above|18
833305|NCT01061736|2649244|P7|Overall Study|Other than specified above|0
833306|NCT01061736|2649245|P6|Overall Study|Other than specified above|0
833307|NCT01061736|2649246|P5|Overall Study|Other than specified above|1
833308|NCT01061736|2649247|P4|Overall Study|Other than specified above|0
833309|NCT01061736|2649248|P3|Overall Study|Other than specified above|2
833310|NCT01061736|2649249|P2|Overall Study|Other than specified above|1
833311|NCT01061736|2649250|P1|Overall Study|Other than specified above|0
833312|NCT01061736|2649241|P10|Overall Study|Not treated|0
833313|NCT01061736|2649242|P9|Overall Study|Not treated|1
833314|NCT01061736|2649243|P8|Overall Study|Not treated|2
833315|NCT01061736|2649244|P7|Overall Study|Not treated|0
833316|NCT01061736|2649245|P6|Overall Study|Not treated|0
833317|NCT01061736|2649246|P5|Overall Study|Not treated|1
833318|NCT01061736|2649247|P4|Overall Study|Not treated|0
833319|NCT01061736|2649248|P3|Overall Study|Not treated|0
833320|NCT01061736|2649249|P2|Overall Study|Not treated|0
833321|NCT01061736|2649250|P1|Overall Study|Not treated|0
833322|NCT01061736|2649241|P10|Overall Study|Poor compliance to protocol|9
833323|NCT01061736|2649242|P9|Overall Study|Poor compliance to protocol|5
833324|NCT01061736|2649243|P8|Overall Study|Poor compliance to protocol|2
833325|NCT01061736|2649244|P7|Overall Study|Poor compliance to protocol|0
833326|NCT01061736|2649245|P6|Overall Study|Poor compliance to protocol|0
833327|NCT01061736|2649246|P5|Overall Study|Poor compliance to protocol|0
833328|NCT01061736|2649247|P4|Overall Study|Poor compliance to protocol|0
833329|NCT01061736|2649248|P3|Overall Study|Poor compliance to protocol|0
833330|NCT01061736|2649249|P2|Overall Study|Poor compliance to protocol|0
833331|NCT01061736|2649250|P1|Overall Study|Poor compliance to protocol|0
833332|NCT01061736|2649241|P10|Overall Study|Lack of Efficacy|10
833333|NCT01061736|2649242|P9|Overall Study|Lack of Efficacy|9
833334|NCT01061736|2649243|P8|Overall Study|Lack of Efficacy|9
833335|NCT01061736|2649244|P7|Overall Study|Lack of Efficacy|1
833336|NCT01061736|2649245|P6|Overall Study|Lack of Efficacy|2
833337|NCT01061736|2649246|P5|Overall Study|Lack of Efficacy|1
833338|NCT01061736|2649247|P4|Overall Study|Lack of Efficacy|1
833339|NCT01061736|2649248|P3|Overall Study|Lack of Efficacy|1
833340|NCT01061736|2649249|P2|Overall Study|Lack of Efficacy|2
833341|NCT01061736|2649250|P1|Overall Study|Lack of Efficacy|0
833342|NCT01061736|2649241|P10|Overall Study|Adverse Event|34
833343|NCT01061736|2649242|P9|Overall Study|Adverse Event|67
833344|NCT01061736|2649243|P8|Overall Study|Adverse Event|63
833345|NCT01061736|2649244|P7|Overall Study|Adverse Event|4
833346|NCT01061736|2649245|P6|Overall Study|Adverse Event|1
833347|NCT01061736|2649246|P5|Overall Study|Adverse Event|4
833348|NCT01061736|2649247|P4|Overall Study|Adverse Event|2
833349|NCT01061736|2649248|P3|Overall Study|Adverse Event|3
833350|NCT01061736|2649249|P2|Overall Study|Adverse Event|1
833351|NCT01061736|2649250|P1|Overall Study|Adverse Event|13
833352|NCT01061736|2649241|P10|Overall Study|Dose regimen not selected|0
833353|NCT01061736|2649242|P9|Overall Study|Dose regimen not selected|0
833354|NCT01061736|2649243|P8|Overall Study|Dose regimen not selected|0
833355|NCT01061736|2649244|P7|Overall Study|Dose regimen not selected|79
833356|NCT01061736|2649245|P6|Overall Study|Dose regimen not selected|0
833357|NCT01061736|2649246|P5|Overall Study|Dose regimen not selected|0
833358|NCT01061736|2649247|P4|Overall Study|Dose regimen not selected|0
833359|NCT01061736|2649248|P3|Overall Study|Dose regimen not selected|0
833360|NCT01061736|2649249|P2|Overall Study|Dose regimen not selected|0
833361|NCT01061736|2649250|P1|Overall Study|Dose regimen not selected|0
833362|NCT01061775|2649283|P1|Overall Study|Lost to Follow-up|1
833363|NCT01061775|2649283|P1|Overall Study|Physician Decision|2
833364|NCT01061866|2649290|P1|Overall Study|Adverse Event|2
833365|NCT01062061|2649294|P1|Overall Study|Failed to meet inclusion criteria|2
833366|NCT01062061|2649294|P1|Overall Study|Outside chief indications|10
833367|NCT01062061|2649294|P1|Overall Study|Investigated before study start|13
833368|NCT01062061|2649294|P1|Overall Study|Enrolled more than once|2
833369|NCT01062113|2649316|P3|Overall Study|Withdrawal by Subject|0
833370|NCT01062113|2649317|P2|Overall Study|Withdrawal by Subject|0
833371|NCT01062113|2649318|P1|Overall Study|Withdrawal by Subject|1
833372|NCT01062113|2649316|P3|Overall Study|Lack of Efficacy|31
833373|NCT01062113|2649317|P2|Overall Study|Lack of Efficacy|22
833374|NCT01062113|2649318|P1|Overall Study|Lack of Efficacy|38
833375|NCT01062113|2649316|P3|Overall Study|Adverse Event|0
833376|NCT01062113|2649317|P2|Overall Study|Adverse Event|0
833377|NCT01062113|2649318|P1|Overall Study|Adverse Event|1
833378|NCT01062256|2649342|P3|Overall Study|Administrative|0
833379|NCT01062256|2649343|P2|Overall Study|Administrative|2
833380|NCT01062256|2649344|P1|Overall Study|Administrative|0
833381|NCT01062256|2649342|P3|Overall Study|Ineligible|3
833382|NCT01062256|2649343|P2|Overall Study|Ineligible|4
833383|NCT01062256|2649344|P1|Overall Study|Ineligible|1
833384|NCT01062256|2649342|P3|Overall Study|Withdrawal by Subject|1
833385|NCT01062256|2649343|P2|Overall Study|Withdrawal by Subject|1
833386|NCT01062256|2649344|P1|Overall Study|Withdrawal by Subject|1
833387|NCT01062256|2649342|P3|Overall Study|Adverse Event|0
833388|NCT01062256|2649343|P2|Overall Study|Adverse Event|0
833389|NCT01062256|2649344|P1|Overall Study|Adverse Event|1
893801|NCT01831791|2835732|P1|Overall Study|Withdrawal by Subject|10
833392|NCT01054976|2649404|P1|Overall Study|Not specified|8
833393|NCT01054976|2649404|P1|Overall Study|Withdrawal by Subject|4
833394|NCT01054976|2649404|P1|Overall Study|Uncooperative participations to study|7
833395|NCT01054976|2649404|P1|Overall Study|Adverse Event|16
833396|NCT01055132|2649412|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
833397|NCT01055132|2649413|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
833398|NCT01055132|2649412|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
833399|NCT01055132|2649413|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
833400|NCT01055197|2649447|P2|Overall Study|Withdrawal by Subject|0
833401|NCT01055197|2649448|P1|Overall Study|Withdrawal by Subject|2
833402|NCT01055197|2649447|P2|Overall Study|Protocol Violation|2
833403|NCT01055197|2649448|P1|Overall Study|Protocol Violation|7
833404|NCT01055262|2649482|P1|Overall Study|Uncooperativeness|1
833405|NCT01055262|2649482|P1|Overall Study|Protocol Violation|3
833406|NCT01055262|2649482|P1|Overall Study|Adverse Event|5
833407|NCT01055314|2649495|P2|Overall Study|No treatment|0
833408|NCT01055314|2649496|P1|Overall Study|No treatment|1
833409|NCT01055314|2649495|P2|Overall Study|Refusal of further protocol therapy|4
833410|NCT01055314|2649496|P1|Overall Study|Refusal of further protocol therapy|10
833411|NCT01055314|2649495|P2|Overall Study|Ineligible|5
833412|NCT01055314|2649496|P1|Overall Study|Ineligible|3
833413|NCT01055314|2649495|P2|Overall Study|Withdrawal by Subject|0
833414|NCT01055314|2649496|P1|Overall Study|Withdrawal by Subject|1
833415|NCT01055314|2649495|P2|Overall Study|Physician Decision|5
833416|NCT01055314|2649496|P1|Overall Study|Physician Decision|10
833417|NCT01055314|2649495|P2|Overall Study|Lack of Efficacy|19
833418|NCT01055314|2649496|P1|Overall Study|Lack of Efficacy|11
833419|NCT01055314|2649495|P2|Overall Study|Death|1
833420|NCT01055314|2649496|P1|Overall Study|Death|2
833421|NCT01055314|2649495|P2|Overall Study|Adverse Event|4
833422|NCT01055314|2649496|P1|Overall Study|Adverse Event|7
833423|NCT01055457|2649518|P10|Overall Study|Adverse Event|0
833424|NCT01055457|2649519|P9|Overall Study|Adverse Event|0
833425|NCT01055457|2649520|P8|Overall Study|Adverse Event|0
833426|NCT01055457|2649521|P7|Overall Study|Adverse Event|0
833427|NCT01055457|2649522|P6|Overall Study|Adverse Event|0
833428|NCT01055457|2649523|P5|Overall Study|Adverse Event|0
833429|NCT01055457|2649524|P4|Overall Study|Adverse Event|1
833430|NCT01055457|2649525|P3|Overall Study|Adverse Event|0
833431|NCT01055457|2649526|P2|Overall Study|Adverse Event|0
833432|NCT01055457|2649527|P1|Overall Study|Adverse Event|0
833433|NCT01055457|2649518|P10|Overall Study|Pregnancy|0
833434|NCT01055457|2649519|P9|Overall Study|Pregnancy|0
833435|NCT01055457|2649520|P8|Overall Study|Pregnancy|0
833436|NCT01055457|2649521|P7|Overall Study|Pregnancy|0
833437|NCT01055457|2649522|P6|Overall Study|Pregnancy|0
833438|NCT01055457|2649523|P5|Overall Study|Pregnancy|0
833439|NCT01055457|2649524|P4|Overall Study|Pregnancy|1
833440|NCT01055457|2649525|P3|Overall Study|Pregnancy|0
833441|NCT01055457|2649526|P2|Overall Study|Pregnancy|0
833442|NCT01055457|2649527|P1|Overall Study|Pregnancy|0
833443|NCT01055457|2649518|P10|Overall Study|Discomfort|0
833444|NCT01055457|2649519|P9|Overall Study|Discomfort|0
833445|NCT01055457|2649520|P8|Overall Study|Discomfort|0
833446|NCT01055457|2649521|P7|Overall Study|Discomfort|0
833447|NCT01055457|2649522|P6|Overall Study|Discomfort|0
833448|NCT01055457|2649523|P5|Overall Study|Discomfort|1
833449|NCT01055457|2649524|P4|Overall Study|Discomfort|0
833450|NCT01055457|2649525|P3|Overall Study|Discomfort|0
833451|NCT01055457|2649526|P2|Overall Study|Discomfort|0
833452|NCT01055457|2649527|P1|Overall Study|Discomfort|0
833453|NCT01055457|2649518|P10|Overall Study|Subject Ineligible|0
833454|NCT01055457|2649519|P9|Overall Study|Subject Ineligible|0
833455|NCT01055457|2649520|P8|Overall Study|Subject Ineligible|0
833456|NCT01055457|2649521|P7|Overall Study|Subject Ineligible|0
833457|NCT01055457|2649522|P6|Overall Study|Subject Ineligible|0
833458|NCT01055457|2649523|P5|Overall Study|Subject Ineligible|1
833459|NCT01055457|2649524|P4|Overall Study|Subject Ineligible|0
833460|NCT01055457|2649525|P3|Overall Study|Subject Ineligible|1
833461|NCT01055457|2649526|P2|Overall Study|Subject Ineligible|0
833462|NCT01055457|2649527|P1|Overall Study|Subject Ineligible|1
833463|NCT01055457|2649518|P10|Overall Study|Subject Disinterest|0
833464|NCT01055457|2649519|P9|Overall Study|Subject Disinterest|0
833465|NCT01055457|2649520|P8|Overall Study|Subject Disinterest|1
833466|NCT01055457|2649521|P7|Overall Study|Subject Disinterest|0
833467|NCT01055457|2649522|P6|Overall Study|Subject Disinterest|0
833468|NCT01055457|2649523|P5|Overall Study|Subject Disinterest|0
833469|NCT01055457|2649524|P4|Overall Study|Subject Disinterest|0
833470|NCT01055457|2649525|P3|Overall Study|Subject Disinterest|0
833471|NCT01055457|2649526|P2|Overall Study|Subject Disinterest|0
833472|NCT01055457|2649527|P1|Overall Study|Subject Disinterest|0
833473|NCT01055457|2649518|P10|Overall Study|Protocol Violation|1
833474|NCT01055457|2649519|P9|Overall Study|Protocol Violation|0
833475|NCT01055457|2649520|P8|Overall Study|Protocol Violation|0
833476|NCT01055457|2649521|P7|Overall Study|Protocol Violation|1
833477|NCT01055457|2649522|P6|Overall Study|Protocol Violation|2
833478|NCT01055457|2649523|P5|Overall Study|Protocol Violation|1
833479|NCT01055457|2649524|P4|Overall Study|Protocol Violation|1
833480|NCT01055457|2649525|P3|Overall Study|Protocol Violation|1
833481|NCT01055457|2649526|P2|Overall Study|Protocol Violation|0
833482|NCT01055457|2649527|P1|Overall Study|Protocol Violation|0
833483|NCT01055457|2649518|P10|Overall Study|Lost to Follow-up|0
833484|NCT01055457|2649519|P9|Overall Study|Lost to Follow-up|0
833485|NCT01055457|2649520|P8|Overall Study|Lost to Follow-up|0
833486|NCT01055457|2649521|P7|Overall Study|Lost to Follow-up|0
833487|NCT01055457|2649522|P6|Overall Study|Lost to Follow-up|1
833488|NCT01055457|2649523|P5|Overall Study|Lost to Follow-up|0
833489|NCT01055457|2649524|P4|Overall Study|Lost to Follow-up|0
833490|NCT01055457|2649525|P3|Overall Study|Lost to Follow-up|0
833491|NCT01055457|2649526|P2|Overall Study|Lost to Follow-up|1
833492|NCT01055457|2649527|P1|Overall Study|Lost to Follow-up|0
833493|NCT01055613|2649561|P2|Overall Study|Subject Disinterest|1
833494|NCT01055613|2649562|P1|Overall Study|Subject Disinterest|1
833495|NCT01055613|2649561|P2|Overall Study|Protocol Violation|1
833496|NCT01055613|2649562|P1|Overall Study|Protocol Violation|1
833497|NCT01055613|2649561|P2|Overall Study|Lost to Follow-up|1
833498|NCT01055613|2649562|P1|Overall Study|Lost to Follow-up|1
833499|NCT01055613|2649561|P2|Overall Study|Discomfort|1
833500|NCT01055613|2649562|P1|Overall Study|Discomfort|2
833501|NCT01055613|2649561|P2|Overall Study|Unacceptable lens fit|0
833502|NCT01055613|2649562|P1|Overall Study|Unacceptable lens fit|1
833503|NCT01055613|2649561|P2|Overall Study|No Longer Meets Eligibility Criteria|0
833504|NCT01055613|2649562|P1|Overall Study|No Longer Meets Eligibility Criteria|3
833505|NCT01055639|2649572|P2|Overall Study|Withdrawal by Subject|11
833506|NCT01055639|2649573|P1|Overall Study|Withdrawal by Subject|8
833507|NCT01055639|2649572|P2|Overall Study|Protocol Violation|5
833508|NCT01055639|2649573|P1|Overall Study|Protocol Violation|5
833509|NCT01055639|2649572|P2|Overall Study|Lost to Follow-up|11
833510|NCT01055639|2649573|P1|Overall Study|Lost to Follow-up|8
833511|NCT01055639|2649572|P2|Overall Study|Lack of Efficacy|1
833512|NCT01055639|2649573|P1|Overall Study|Lack of Efficacy|0
833513|NCT01055639|2649572|P2|Overall Study|Adverse Event|1
833514|NCT01055639|2649573|P1|Overall Study|Adverse Event|0
833515|NCT01062763|2649642|P2|Overall Study|Adverse Event|4
833516|NCT01062763|2649643|P1|Overall Study|Adverse Event|3
833517|NCT01062841|2649655|P2|Overall Study|Withdrawal by Study|0
833518|NCT01062841|2649656|P1|Overall Study|Withdrawal by Study|3
833519|NCT01062841|2649655|P2|Overall Study|Withdrawal by Subject|0
833520|NCT01062841|2649656|P1|Overall Study|Withdrawal by Subject|2
833521|NCT01062841|2649655|P2|Overall Study|Death|5
833522|NCT01062841|2649656|P1|Overall Study|Death|3
833523|NCT01062841|2649655|P2|Overall Study|Indwelling Device Removed|48
833524|NCT01062841|2649656|P1|Overall Study|Indwelling Device Removed|41
833525|NCT01065350|2649686|P2|Overall Study|Received incorrect drug allocation|1
833526|NCT01065350|2649687|P1|Overall Study|Received incorrect drug allocation|0
833575|NCT01065597|2649861|P1|Overall Study|Adverse Event|1
833576|NCT01065766|2649875|P1|Overall Study|Violated dosage/administration|25
833577|NCT01065766|2649875|P1|Overall Study|Contraindication to administration|6
833578|NCT01065766|2649875|P1|Overall Study|Assessed before the contracted date|1
833579|NCT01065779|2649887|P1|Overall Study|Inclusion Criteria Violation|7
833580|NCT01065779|2649887|P1|Overall Study|Failed to Follow-up|10
833581|NCT01065779|2649887|P1|Overall Study|Not Administered With Study Drug|17
833582|NCT01065779|2649887|P1|Overall Study|Non-enrollment Period Administration|10
833583|NCT01065779|2649887|P1|Overall Study|Investigation Before Contract Date|37
833584|NCT01065779|2649887|P1|Overall Study|Duplicate Investigation|1
833585|NCT01065818|2649898|P1|Overall Study|Not a candidate for surgery|1
833586|NCT01065818|2649898|P1|Overall Study|Withdrawal by Subject|1
833592|NCT01066039|2649917|P1|Overall Study|Drug/Dose Adjustment Required|1
833593|NCT01066039|2649917|P1|Overall Study|Failure to Control Blood Pressure|1
833594|NCT01066039|2649917|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
833595|NCT01066039|2649917|P1|Overall Study|Additional Antihypertensive Required|4
833596|NCT01066039|2649917|P1|Overall Study|Dropout due to Insulin Administration|1
833597|NCT01066039|2649917|P1|Overall Study|Investigator’s Request|1
833598|NCT01066039|2649917|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
833599|NCT01066039|2649917|P1|Overall Study|Protocol Violation|2
833600|NCT01066039|2649917|P1|Overall Study|Withdrawal by Subject|17
833601|NCT01066039|2649917|P1|Overall Study|Adverse Event|6
833602|NCT01066104|2649932|P2|Overall Study|Protocol Violation|0
833603|NCT01066104|2649933|P1|Overall Study|Protocol Violation|1
833604|NCT01066104|2649932|P2|Overall Study|Adverse Event|1
833605|NCT01066104|2649933|P1|Overall Study|Adverse Event|1
833606|NCT01066143|2649941|P1|Overall Study|ineligible for the study|8
833607|NCT01066156|2649945|P1|Overall Study|Withdrawal by Subject|1
833608|NCT01066156|2649945|P1|Overall Study|Lost to Follow-up|7
833609|NCT01066156|2649945|P1|Overall Study|ineligible|2
833610|NCT01066546|2649968|P1|Overall Study|Study terminated by sponsor|5
833611|NCT01066585|2649981|P2|Overall Study|Withdrawal by Subject|3
833612|NCT01066585|2649982|P1|Overall Study|Withdrawal by Subject|0
833613|NCT01066585|2649981|P2|Overall Study|Protocol Violation|0
833614|NCT01066585|2649982|P1|Overall Study|Protocol Violation|1
833615|NCT01066780|2650007|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
833616|NCT01066780|2650008|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
833617|NCT01066793|2650018|P6|Overall Study|Treatment Stopped|0
833618|NCT01066793|2650019|P5|Overall Study|Treatment Stopped|0
833619|NCT01066793|2650020|P4|Overall Study|Treatment Stopped|1
833620|NCT01066793|2650021|P3|Overall Study|Treatment Stopped|0
833621|NCT01066793|2650022|P2|Overall Study|Treatment Stopped|1
833622|NCT01066793|2650023|P1|Overall Study|Treatment Stopped|2
833623|NCT01066793|2650018|P6|Overall Study|Treatment Never Started|0
833624|NCT01066793|2650019|P5|Overall Study|Treatment Never Started|0
833625|NCT01066793|2650020|P4|Overall Study|Treatment Never Started|1
833626|NCT01066793|2650021|P3|Overall Study|Treatment Never Started|4
833627|NCT01066793|2650022|P2|Overall Study|Treatment Never Started|5
833628|NCT01066793|2650023|P1|Overall Study|Treatment Never Started|18
833629|NCT01066793|2650018|P6|Overall Study|Treatment Interrupted|0
833630|NCT01066793|2650019|P5|Overall Study|Treatment Interrupted|0
833631|NCT01066793|2650020|P4|Overall Study|Treatment Interrupted|0
833632|NCT01066793|2650021|P3|Overall Study|Treatment Interrupted|0
833633|NCT01066793|2650022|P2|Overall Study|Treatment Interrupted|1
833634|NCT01066793|2650023|P1|Overall Study|Treatment Interrupted|1
833635|NCT01066793|2650018|P6|Overall Study|Result Not Available|0
833636|NCT01066793|2650019|P5|Overall Study|Result Not Available|0
833637|NCT01066793|2650020|P4|Overall Study|Result Not Available|0
833638|NCT01066793|2650021|P3|Overall Study|Result Not Available|0
833639|NCT01066793|2650022|P2|Overall Study|Result Not Available|0
833640|NCT01066793|2650023|P1|Overall Study|Result Not Available|1
833641|NCT01066793|2650018|P6|Overall Study|Relapse|0
833642|NCT01066793|2650019|P5|Overall Study|Relapse|0
833643|NCT01066793|2650020|P4|Overall Study|Relapse|3
833644|NCT01066793|2650021|P3|Overall Study|Relapse|2
833645|NCT01066793|2650022|P2|Overall Study|Relapse|8
833646|NCT01066793|2650023|P1|Overall Study|Relapse|20
833647|NCT01066793|2650018|P6|Overall Study|Other|0
833648|NCT01066793|2650019|P5|Overall Study|Other|0
833649|NCT01066793|2650020|P4|Overall Study|Other|2
833650|NCT01066793|2650021|P3|Overall Study|Other|6
833651|NCT01066793|2650022|P2|Overall Study|Other|5
833652|NCT01066793|2650023|P1|Overall Study|Other|15
833653|NCT01066793|2650018|P6|Overall Study|Non-responders|0
833654|NCT01066793|2650019|P5|Overall Study|Non-responders|0
833655|NCT01066793|2650020|P4|Overall Study|Non-responders|25
833656|NCT01066793|2650021|P3|Overall Study|Non-responders|11
833657|NCT01066793|2650022|P2|Overall Study|Non-responders|5
833658|NCT01066793|2650023|P1|Overall Study|Non-responders|104
833659|NCT01066793|2650018|P6|Overall Study|Miscellaneous|0
833660|NCT01066793|2650019|P5|Overall Study|Miscellaneous|0
833661|NCT01066793|2650020|P4|Overall Study|Miscellaneous|0
833662|NCT01066793|2650021|P3|Overall Study|Miscellaneous|6
833663|NCT01066793|2650022|P2|Overall Study|Miscellaneous|5
833664|NCT01066793|2650023|P1|Overall Study|Miscellaneous|4
833665|NCT01066793|2650018|P6|Overall Study|Lab test not done|0
833666|NCT01066793|2650019|P5|Overall Study|Lab test not done|0
833667|NCT01066793|2650020|P4|Overall Study|Lab test not done|1
833668|NCT01066793|2650021|P3|Overall Study|Lab test not done|0
833669|NCT01066793|2650022|P2|Overall Study|Lab test not done|0
833670|NCT01066793|2650023|P1|Overall Study|Lab test not done|7
833671|NCT01066793|2650018|P6|Overall Study|Early Termination|0
833672|NCT01066793|2650019|P5|Overall Study|Early Termination|0
833673|NCT01066793|2650020|P4|Overall Study|Early Termination|0
833674|NCT01066793|2650021|P3|Overall Study|Early Termination|0
833675|NCT01066793|2650022|P2|Overall Study|Early Termination|0
833676|NCT01066793|2650023|P1|Overall Study|Early Termination|3
833677|NCT01066793|2650018|P6|Overall Study|Withdrawal by Subject|0
833678|NCT01066793|2650019|P5|Overall Study|Withdrawal by Subject|0
833679|NCT01066793|2650020|P4|Overall Study|Withdrawal by Subject|0
833680|NCT01066793|2650021|P3|Overall Study|Withdrawal by Subject|1
833681|NCT01066793|2650022|P2|Overall Study|Withdrawal by Subject|4
833682|NCT01066793|2650023|P1|Overall Study|Withdrawal by Subject|7
833683|NCT01066793|2650018|P6|Overall Study|Protocol Violation|0
833684|NCT01066793|2650019|P5|Overall Study|Protocol Violation|0
833685|NCT01066793|2650020|P4|Overall Study|Protocol Violation|0
833686|NCT01066793|2650021|P3|Overall Study|Protocol Violation|2
833687|NCT01066793|2650022|P2|Overall Study|Protocol Violation|2
833688|NCT01066793|2650023|P1|Overall Study|Protocol Violation|3
833689|NCT01066793|2650018|P6|Overall Study|Physician Decision|0
833690|NCT01066793|2650019|P5|Overall Study|Physician Decision|0
833691|NCT01066793|2650020|P4|Overall Study|Physician Decision|0
833692|NCT01066793|2650021|P3|Overall Study|Physician Decision|0
833693|NCT01066793|2650022|P2|Overall Study|Physician Decision|0
833694|NCT01066793|2650023|P1|Overall Study|Physician Decision|3
833695|NCT01066793|2650018|P6|Overall Study|Lost to Follow-up|1
833696|NCT01066793|2650019|P5|Overall Study|Lost to Follow-up|0
833697|NCT01066793|2650020|P4|Overall Study|Lost to Follow-up|16
833698|NCT01066793|2650021|P3|Overall Study|Lost to Follow-up|82
833699|NCT01066793|2650022|P2|Overall Study|Lost to Follow-up|39
833700|NCT01066793|2650023|P1|Overall Study|Lost to Follow-up|180
833701|NCT01066793|2650018|P6|Overall Study|Lack of Efficacy|0
833702|NCT01066793|2650019|P5|Overall Study|Lack of Efficacy|0
833703|NCT01066793|2650020|P4|Overall Study|Lack of Efficacy|0
833704|NCT01066793|2650021|P3|Overall Study|Lack of Efficacy|0
833705|NCT01066793|2650022|P2|Overall Study|Lack of Efficacy|1
833706|NCT01066793|2650023|P1|Overall Study|Lack of Efficacy|2
833707|NCT01066793|2650018|P6|Overall Study|Death|0
833708|NCT01066793|2650019|P5|Overall Study|Death|0
833709|NCT01066793|2650020|P4|Overall Study|Death|0
833710|NCT01066793|2650021|P3|Overall Study|Death|1
833711|NCT01066793|2650022|P2|Overall Study|Death|1
833712|NCT01066793|2650023|P1|Overall Study|Death|4
833713|NCT01066819|2650169|P6|Overall Study|Other|0
833714|NCT01066819|2650170|P5|Overall Study|Other|0
833715|NCT01066819|2650171|P4|Overall Study|Other|0
833716|NCT01066819|2650172|P3|Overall Study|Other|1
833717|NCT01066819|2650173|P2|Overall Study|Other|1
833718|NCT01066819|2650174|P1|Overall Study|Other|5
833719|NCT01066819|2650169|P6|Overall Study|Treatment stopped|0
833720|NCT01066819|2650170|P5|Overall Study|Treatment stopped|0
833721|NCT01066819|2650171|P4|Overall Study|Treatment stopped|1
833722|NCT01066819|2650172|P3|Overall Study|Treatment stopped|2
833723|NCT01066819|2650173|P2|Overall Study|Treatment stopped|1
833724|NCT01066819|2650174|P1|Overall Study|Treatment stopped|12
833725|NCT01066819|2650169|P6|Overall Study|Treatment never started|2
833726|NCT01066819|2650170|P5|Overall Study|Treatment never started|2
833727|NCT01066819|2650171|P4|Overall Study|Treatment never started|3
833728|NCT01066819|2650172|P3|Overall Study|Treatment never started|19
833729|NCT01066819|2650173|P2|Overall Study|Treatment never started|19
833730|NCT01066819|2650174|P1|Overall Study|Treatment never started|85
833731|NCT01066819|2650169|P6|Overall Study|Spontaneous cure|0
833732|NCT01066819|2650170|P5|Overall Study|Spontaneous cure|0
833733|NCT01066819|2650171|P4|Overall Study|Spontaneous cure|0
833734|NCT01066819|2650172|P3|Overall Study|Spontaneous cure|0
833735|NCT01066819|2650173|P2|Overall Study|Spontaneous cure|0
833736|NCT01066819|2650174|P1|Overall Study|Spontaneous cure|1
833737|NCT01066819|2650169|P6|Overall Study|Screen failure|0
833738|NCT01066819|2650170|P5|Overall Study|Screen failure|0
833739|NCT01066819|2650171|P4|Overall Study|Screen failure|0
833740|NCT01066819|2650172|P3|Overall Study|Screen failure|0
833741|NCT01066819|2650173|P2|Overall Study|Screen failure|0
833742|NCT01066819|2650174|P1|Overall Study|Screen failure|1
833743|NCT01066819|2650169|P6|Overall Study|Results not available|0
833744|NCT01066819|2650170|P5|Overall Study|Results not available|0
833745|NCT01066819|2650171|P4|Overall Study|Results not available|0
833746|NCT01066819|2650172|P3|Overall Study|Results not available|0
833747|NCT01066819|2650173|P2|Overall Study|Results not available|0
833748|NCT01066819|2650174|P1|Overall Study|Results not available|1
833749|NCT01066819|2650169|P6|Overall Study|Relapse|0
833750|NCT01066819|2650170|P5|Overall Study|Relapse|0
833751|NCT01066819|2650171|P4|Overall Study|Relapse|0
833752|NCT01066819|2650172|P3|Overall Study|Relapse|3
833753|NCT01066819|2650173|P2|Overall Study|Relapse|4
833754|NCT01066819|2650174|P1|Overall Study|Relapse|16
833755|NCT01066819|2650169|P6|Overall Study|Not categorised|0
833756|NCT01066819|2650170|P5|Overall Study|Not categorised|0
833757|NCT01066819|2650171|P4|Overall Study|Not categorised|1
833758|NCT01066819|2650172|P3|Overall Study|Not categorised|6
833759|NCT01066819|2650173|P2|Overall Study|Not categorised|2
833760|NCT01066819|2650174|P1|Overall Study|Not categorised|9
833761|NCT01066819|2650169|P6|Overall Study|Non responders|1
833762|NCT01066819|2650170|P5|Overall Study|Non responders|0
833763|NCT01066819|2650171|P4|Overall Study|Non responders|2
833764|NCT01066819|2650172|P3|Overall Study|Non responders|7
833765|NCT01066819|2650173|P2|Overall Study|Non responders|2
833766|NCT01066819|2650174|P1|Overall Study|Non responders|123
833767|NCT01066819|2650169|P6|Overall Study|Miscellaneous|0
833768|NCT01066819|2650170|P5|Overall Study|Miscellaneous|0
833769|NCT01066819|2650171|P4|Overall Study|Miscellaneous|1
833770|NCT01066819|2650172|P3|Overall Study|Miscellaneous|18
833771|NCT01066819|2650173|P2|Overall Study|Miscellaneous|10
833772|NCT01066819|2650174|P1|Overall Study|Miscellaneous|28
833773|NCT01066819|2650169|P6|Overall Study|Lab test not done|0
833774|NCT01066819|2650170|P5|Overall Study|Lab test not done|0
833775|NCT01066819|2650171|P4|Overall Study|Lab test not done|1
833776|NCT01066819|2650172|P3|Overall Study|Lab test not done|2
833777|NCT01066819|2650173|P2|Overall Study|Lab test not done|0
833778|NCT01066819|2650174|P1|Overall Study|Lab test not done|9
833779|NCT01066819|2650169|P6|Overall Study|Failed to return|3
833780|NCT01066819|2650170|P5|Overall Study|Failed to return|2
833781|NCT01066819|2650171|P4|Overall Study|Failed to return|7
833782|NCT01066819|2650172|P3|Overall Study|Failed to return|68
833783|NCT01066819|2650173|P2|Overall Study|Failed to return|107
833784|NCT01066819|2650174|P1|Overall Study|Failed to return|298
833785|NCT01066819|2650169|P6|Overall Study|Early termination|0
833786|NCT01066819|2650170|P5|Overall Study|Early termination|0
833787|NCT01066819|2650171|P4|Overall Study|Early termination|0
833788|NCT01066819|2650172|P3|Overall Study|Early termination|0
833789|NCT01066819|2650173|P2|Overall Study|Early termination|0
833790|NCT01066819|2650174|P1|Overall Study|Early termination|2
833791|NCT01066819|2650169|P6|Overall Study|Not met inclusion/exclusion criteria|0
833792|NCT01066819|2650170|P5|Overall Study|Not met inclusion/exclusion criteria|0
833793|NCT01066819|2650171|P4|Overall Study|Not met inclusion/exclusion criteria|0
833794|NCT01066819|2650172|P3|Overall Study|Not met inclusion/exclusion criteria|0
833795|NCT01066819|2650173|P2|Overall Study|Not met inclusion/exclusion criteria|0
833796|NCT01066819|2650174|P1|Overall Study|Not met inclusion/exclusion criteria|1
833797|NCT01066819|2650169|P6|Overall Study|Administrative|0
833798|NCT01066819|2650170|P5|Overall Study|Administrative|0
833799|NCT01066819|2650171|P4|Overall Study|Administrative|0
833800|NCT01066819|2650172|P3|Overall Study|Administrative|2
833801|NCT01066819|2650173|P2|Overall Study|Administrative|4
833802|NCT01066819|2650174|P1|Overall Study|Administrative|6
833803|NCT01066819|2650169|P6|Overall Study|Withdrawal by Subject|0
833804|NCT01066819|2650170|P5|Overall Study|Withdrawal by Subject|0
833805|NCT01066819|2650171|P4|Overall Study|Withdrawal by Subject|0
833806|NCT01066819|2650172|P3|Overall Study|Withdrawal by Subject|6
833807|NCT01066819|2650173|P2|Overall Study|Withdrawal by Subject|11
833808|NCT01066819|2650174|P1|Overall Study|Withdrawal by Subject|29
833809|NCT01066819|2650169|P6|Overall Study|Protocol Violation|0
833810|NCT01066819|2650170|P5|Overall Study|Protocol Violation|0
833811|NCT01066819|2650171|P4|Overall Study|Protocol Violation|0
833812|NCT01066819|2650172|P3|Overall Study|Protocol Violation|0
833813|NCT01066819|2650173|P2|Overall Study|Protocol Violation|6
833814|NCT01066819|2650174|P1|Overall Study|Protocol Violation|12
833815|NCT01066819|2650169|P6|Overall Study|Physician Decision|0
833816|NCT01066819|2650170|P5|Overall Study|Physician Decision|0
833817|NCT01066819|2650171|P4|Overall Study|Physician Decision|0
833818|NCT01066819|2650172|P3|Overall Study|Physician Decision|3
833819|NCT01066819|2650173|P2|Overall Study|Physician Decision|2
833820|NCT01066819|2650174|P1|Overall Study|Physician Decision|6
833821|NCT01066819|2650169|P6|Overall Study|Lack of Efficacy|0
833822|NCT01066819|2650170|P5|Overall Study|Lack of Efficacy|0
833823|NCT01066819|2650171|P4|Overall Study|Lack of Efficacy|1
833824|NCT01066819|2650172|P3|Overall Study|Lack of Efficacy|2
833825|NCT01066819|2650173|P2|Overall Study|Lack of Efficacy|1
833826|NCT01066819|2650174|P1|Overall Study|Lack of Efficacy|22
833827|NCT01066819|2650169|P6|Overall Study|Death|0
833828|NCT01066819|2650170|P5|Overall Study|Death|0
833829|NCT01066819|2650171|P4|Overall Study|Death|0
833830|NCT01066819|2650172|P3|Overall Study|Death|1
833831|NCT01066819|2650173|P2|Overall Study|Death|0
833832|NCT01066819|2650174|P1|Overall Study|Death|5
833833|NCT01066819|2650169|P6|Overall Study|Adverse Event|0
833834|NCT01066819|2650170|P5|Overall Study|Adverse Event|0
833835|NCT01066819|2650171|P4|Overall Study|Adverse Event|0
833836|NCT01066819|2650172|P3|Overall Study|Adverse Event|6
833837|NCT01066819|2650173|P2|Overall Study|Adverse Event|1
833838|NCT01066819|2650174|P1|Overall Study|Adverse Event|18
833839|NCT01066871|2650313|P4|Overall Study|Unspecified|2
833840|NCT01066871|2650314|P3|Overall Study|Unspecified|1
833841|NCT01066871|2650315|P2|Overall Study|Unspecified|2
833842|NCT01066871|2650316|P1|Overall Study|Unspecified|0
833843|NCT01066871|2650313|P4|Overall Study|Withdrawal by Subject|0
833844|NCT01066871|2650314|P3|Overall Study|Withdrawal by Subject|0
833845|NCT01066871|2650315|P2|Overall Study|Withdrawal by Subject|1
833846|NCT01066871|2650316|P1|Overall Study|Withdrawal by Subject|3
833847|NCT01066871|2650313|P4|Overall Study|Lack of Efficacy|1
833848|NCT01066871|2650314|P3|Overall Study|Lack of Efficacy|0
833849|NCT01066871|2650315|P2|Overall Study|Lack of Efficacy|0
833850|NCT01066871|2650316|P1|Overall Study|Lack of Efficacy|0
833851|NCT01066871|2650313|P4|Overall Study|Protocol Violation|2
833852|NCT01066871|2650314|P3|Overall Study|Protocol Violation|3
833853|NCT01066871|2650315|P2|Overall Study|Protocol Violation|0
833854|NCT01066871|2650316|P1|Overall Study|Protocol Violation|1
833855|NCT01066871|2650313|P4|Overall Study|Lost to Follow-up|0
833856|NCT01066871|2650314|P3|Overall Study|Lost to Follow-up|2
833857|NCT01066871|2650315|P2|Overall Study|Lost to Follow-up|2
833858|NCT01066871|2650316|P1|Overall Study|Lost to Follow-up|0
833859|NCT01066897|2650376|P2|Overall Study|stopped study after developing the flu.|0
833860|NCT01066897|2650377|P1|Overall Study|stopped study after developing the flu.|1
833861|NCT01066897|2650376|P2|Overall Study|Withdrawal by Subject|0
833862|NCT01066897|2650377|P1|Overall Study|Withdrawal by Subject|1
833867|NCT01067105|2650408|P1|Overall Study|Other|31
833868|NCT01067105|2650408|P1|Overall Study|Physician Decision|6
833869|NCT01067105|2650408|P1|Overall Study|Lost to Follow-up|6
833870|NCT01067105|2650408|P1|Overall Study|Withdrawal by Subject|36
833871|NCT01067105|2650408|P1|Overall Study|Protocol Violation|48
833872|NCT01067105|2650408|P1|Overall Study|Adverse Event|14
833873|NCT01067326|2650427|P2|Overall Study|Early Study Termination|1
833874|NCT01067326|2650428|P1|Overall Study|Early Study Termination|1
833875|NCT01067326|2650427|P2|Overall Study|Withdrawal by Subject|0
833876|NCT01067326|2650428|P1|Overall Study|Withdrawal by Subject|1
833877|NCT01067326|2650427|P2|Overall Study|Adverse Event|2
833878|NCT01067326|2650428|P1|Overall Study|Adverse Event|0
833879|NCT01067339|2650442|P2|Overall Study|Withdrawal by Subject|5
833880|NCT01067339|2650443|P1|Overall Study|Withdrawal by Subject|6
833881|NCT01067352|2650454|P3|Overall Study|Physician Decision|0
833882|NCT01067352|2650455|P2|Overall Study|Physician Decision|1
833883|NCT01067352|2650456|P1|Overall Study|Physician Decision|0
833884|NCT01067352|2650454|P3|Overall Study|Withdrawal by Subject|1
833885|NCT01067352|2650455|P2|Overall Study|Withdrawal by Subject|2
833886|NCT01067352|2650456|P1|Overall Study|Withdrawal by Subject|1
833887|NCT01058642|2650483|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
833888|NCT01058642|2650484|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
833889|NCT01058642|2650485|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
833890|NCT01058642|2650486|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
833891|NCT01058642|2650483|P4|Treatment Period 1|Protocol Violation|1
833892|NCT01058642|2650484|P3|Treatment Period 1|Protocol Violation|0
833893|NCT01058642|2650485|P2|Treatment Period 1|Protocol Violation|0
833894|NCT01058642|2650486|P1|Treatment Period 1|Protocol Violation|0
833895|NCT01058642|2650483|P4|Treatment Period 1|Lack of Efficacy|1
833896|NCT01058642|2650484|P3|Treatment Period 1|Lack of Efficacy|0
833897|NCT01058642|2650485|P2|Treatment Period 1|Lack of Efficacy|0
833898|NCT01058642|2650486|P1|Treatment Period 1|Lack of Efficacy|0
833899|NCT01058642|2650483|P4|Treatment Period 1|Withdrawal by Subject|0
833900|NCT01058642|2650484|P3|Treatment Period 1|Withdrawal by Subject|0
833901|NCT01058642|2650485|P2|Treatment Period 1|Withdrawal by Subject|0
833902|NCT01058642|2650486|P1|Treatment Period 1|Withdrawal by Subject|1
833903|NCT01058642|2650483|P4|Treatment Period 1|Physician Decision|0
833904|NCT01058642|2650484|P3|Treatment Period 1|Physician Decision|1
833905|NCT01058642|2650485|P2|Treatment Period 1|Physician Decision|0
833906|NCT01058642|2650486|P1|Treatment Period 1|Physician Decision|0
833907|NCT01058642|2650483|P4|Treatment Period 1|Adverse Event|0
833908|NCT01058642|2650484|P3|Treatment Period 1|Adverse Event|1
833909|NCT01058642|2650485|P2|Treatment Period 1|Adverse Event|1
833910|NCT01058642|2650486|P1|Treatment Period 1|Adverse Event|0
833911|NCT01058655|2650498|P4|Overall Study|Other|4
833912|NCT01058655|2650499|P3|Overall Study|Other|0
833913|NCT01058655|2650500|P2|Overall Study|Other|0
833914|NCT01058655|2650501|P1|Overall Study|Other|0
833915|NCT01058655|2650498|P4|Overall Study|Disease Progression|24
833916|NCT01058655|2650499|P3|Overall Study|Disease Progression|4
833917|NCT01058655|2650500|P2|Overall Study|Disease Progression|2
833918|NCT01058655|2650501|P1|Overall Study|Disease Progression|1
833919|NCT01058655|2650498|P4|Overall Study|Death|0
833920|NCT01058655|2650499|P3|Overall Study|Death|1
833921|NCT01058655|2650500|P2|Overall Study|Death|1
833922|NCT01058655|2650501|P1|Overall Study|Death|0
833923|NCT01058655|2650498|P4|Overall Study|Clinical Progression (non-RECIST)|7
833924|NCT01058655|2650499|P3|Overall Study|Clinical Progression (non-RECIST)|0
833925|NCT01058655|2650500|P2|Overall Study|Clinical Progression (non-RECIST)|0
833926|NCT01058655|2650501|P1|Overall Study|Clinical Progression (non-RECIST)|1
833927|NCT01058655|2650498|P4|Overall Study|Symptomatic Deterioration|1
833928|NCT01058655|2650499|P3|Overall Study|Symptomatic Deterioration|0
833929|NCT01058655|2650500|P2|Overall Study|Symptomatic Deterioration|0
833930|NCT01058655|2650501|P1|Overall Study|Symptomatic Deterioration|0
833931|NCT01058655|2650498|P4|Overall Study|Prolonged Treatment Delay|2
833932|NCT01058655|2650499|P3|Overall Study|Prolonged Treatment Delay|0
833933|NCT01058655|2650500|P2|Overall Study|Prolonged Treatment Delay|0
833934|NCT01058655|2650501|P1|Overall Study|Prolonged Treatment Delay|0
833935|NCT01058655|2650498|P4|Overall Study|Withdrawal by Subject|4
833936|NCT01058655|2650499|P3|Overall Study|Withdrawal by Subject|3
833937|NCT01058655|2650500|P2|Overall Study|Withdrawal by Subject|0
833938|NCT01058655|2650501|P1|Overall Study|Withdrawal by Subject|1
833939|NCT01058668|2650518|P3|Double-blind Treatment Phase|Other Unspecified|0
833940|NCT01058668|2650519|P2|Double-blind Treatment Phase|Other Unspecified|1
833941|NCT01058668|2650520|P1|Double-blind Treatment Phase|Other Unspecified|1
833942|NCT01058668|2650518|P3|Double-blind Treatment Phase|Lost to Follow-up|1
833943|NCT01058668|2650519|P2|Double-blind Treatment Phase|Lost to Follow-up|1
833944|NCT01058668|2650520|P1|Double-blind Treatment Phase|Lost to Follow-up|0
833945|NCT01058668|2650518|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
833946|NCT01058668|2650519|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
833947|NCT01058668|2650520|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
833948|NCT01058668|2650518|P3|Double-blind Treatment Phase|Protocol Violation|2
833949|NCT01058668|2650519|P2|Double-blind Treatment Phase|Protocol Violation|1
833950|NCT01058668|2650520|P1|Double-blind Treatment Phase|Protocol Violation|1
833951|NCT01058668|2650518|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
833952|NCT01058668|2650519|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
833953|NCT01058668|2650520|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
833954|NCT01058668|2650518|P3|Double-blind Treatment Phase|Adverse Event|25
833955|NCT01058668|2650519|P2|Double-blind Treatment Phase|Adverse Event|15
833956|NCT01058668|2650520|P1|Double-blind Treatment Phase|Adverse Event|8
833957|NCT01058863|2650531|P1|Overall Study|Randomized in error|1
833958|NCT01058863|2650531|P1|Overall Study|Sponsor requested withdrawal|1
833959|NCT01058863|2650531|P1|Overall Study|Withdrawal by Subject|1
833960|NCT01058863|2650531|P1|Overall Study|Lost to Follow-up|1
833961|NCT01059071|2650564|P4|Overall Study|Physician Decision|1
833962|NCT01059071|2650565|P3|Overall Study|Physician Decision|0
833963|NCT01059071|2650566|P2|Overall Study|Physician Decision|0
833964|NCT01059071|2650567|P1|Overall Study|Physician Decision|0
833965|NCT01059071|2650564|P4|Overall Study|Withdrawal by Subject|2
833966|NCT01059071|2650565|P3|Overall Study|Withdrawal by Subject|0
833967|NCT01059071|2650566|P2|Overall Study|Withdrawal by Subject|0
833968|NCT01059071|2650567|P1|Overall Study|Withdrawal by Subject|1
833969|NCT01059071|2650564|P4|Overall Study|Lack of Efficacy|3
833970|NCT01059071|2650565|P3|Overall Study|Lack of Efficacy|2
833971|NCT01059071|2650566|P2|Overall Study|Lack of Efficacy|4
833972|NCT01059071|2650567|P1|Overall Study|Lack of Efficacy|1
833973|NCT01059175|2650581|P2|Overall Study|Lost to Follow-up|1
833974|NCT01059175|2650582|P1|Overall Study|Lost to Follow-up|0
833975|NCT01059175|2650581|P2|Overall Study|Adverse Event|2
833976|NCT01059175|2650582|P1|Overall Study|Adverse Event|4
833977|NCT01059175|2650581|P2|Overall Study|Death|17
833978|NCT01059175|2650582|P1|Overall Study|Death|17
833979|NCT01059344|2650610|P2|Overall Study|Other|6
833980|NCT01059344|2650611|P1|Overall Study|Other|3
833981|NCT01059344|2650610|P2|Overall Study|Lost to Follow-up|1
833982|NCT01059344|2650611|P1|Overall Study|Lost to Follow-up|1
833983|NCT01059344|2650610|P2|Overall Study|Withdrawal by Subject|9
833984|NCT01059344|2650611|P1|Overall Study|Withdrawal by Subject|6
833985|NCT01059344|2650610|P2|Overall Study|Adverse Event|30
833986|NCT01059344|2650611|P1|Overall Study|Adverse Event|12
833987|NCT01059526|2650631|P2|Overall Study|Patient found to be dermatographic|0
833988|NCT01059526|2650632|P1|Overall Study|Patient found to be dermatographic|1
833989|NCT01059526|2650631|P2|Overall Study|Lost to Follow-up|1
833990|NCT01059526|2650632|P1|Overall Study|Lost to Follow-up|4
833991|NCT01059526|2650631|P2|Overall Study|Withdrawal by Subject|1
833992|NCT01059526|2650632|P1|Overall Study|Withdrawal by Subject|3
833993|NCT01059526|2650631|P2|Overall Study|Protocol Violation|1
833994|NCT01059526|2650632|P1|Overall Study|Protocol Violation|0
833995|NCT01059526|2650631|P2|Overall Study|Adverse Event|2
833996|NCT01059526|2650632|P1|Overall Study|Adverse Event|2
833997|NCT01059526|2650631|P2|Overall Study|Patient enrolled but not treated|17
833998|NCT01059526|2650632|P1|Overall Study|Patient enrolled but not treated|20
833999|NCT01059565|2650642|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
834000|NCT01059565|2650643|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
834001|NCT01059565|2650642|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
834002|NCT01059565|2650643|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
834003|NCT01059565|2650642|P2|24-Week Open-Label Phase|Subject noncompliance|0
834004|NCT01059565|2650643|P1|24-Week Open-Label Phase|Subject noncompliance|1
834005|NCT01059565|2650642|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
834006|NCT01059565|2650643|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
834007|NCT01059565|2650642|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
834008|NCT01059565|2650643|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
834009|NCT01059565|2650642|P2|24-Week Open-Label Phase|Adverse Event|0
834010|NCT01059565|2650643|P1|24-Week Open-Label Phase|Adverse Event|2
834011|NCT01059565|2650642|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
834012|NCT01059565|2650643|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
834013|NCT01059565|2650642|P2|24-Week Randomized Phase|Lost to Follow-up|1
834014|NCT01059565|2650643|P1|24-Week Randomized Phase|Lost to Follow-up|0
834015|NCT01059565|2650642|P2|24-Week Randomized Phase|Withdrawal by Subject|1
834016|NCT01059565|2650643|P1|24-Week Randomized Phase|Withdrawal by Subject|3
834017|NCT01059565|2650642|P2|24-Week Randomized Phase|Adverse Event|0
834018|NCT01059565|2650643|P1|24-Week Randomized Phase|Adverse Event|5
834019|NCT01059565|2650642|P2|24-Week Randomized Phase|Randomized but not treated|0
834020|NCT01059565|2650643|P1|24-Week Randomized Phase|Randomized but not treated|1
834021|NCT01059617|2650681|P4|Overall Study|Unspecified|6
834022|NCT01059617|2650682|P3|Overall Study|Unspecified|8
834023|NCT01059617|2650683|P2|Overall Study|Unspecified|1
834024|NCT01059617|2650684|P1|Overall Study|Unspecified|7
834055|NCT01059773|2651022|P2|Overall Study|Other|3
834056|NCT01059773|2651023|P1|Overall Study|Other|1
834057|NCT01059773|2651022|P2|Overall Study|Ineligible follow TB screening criteria|1
834058|NCT01059773|2651023|P1|Overall Study|Ineligible follow TB screening criteria|0
834059|NCT01059773|2651022|P2|Overall Study|Malignancy including squamous cell skin|1
834060|NCT01059773|2651023|P1|Overall Study|Malignancy including squamous cell skin|0
834061|NCT01059773|2651022|P2|Overall Study|Death|1
834062|NCT01059773|2651023|P1|Overall Study|Death|0
834063|NCT01059773|2651022|P2|Overall Study|Lack of Efficacy|3
834064|NCT01059773|2651023|P1|Overall Study|Lack of Efficacy|3
834065|NCT01059773|2651022|P2|Overall Study|Physician Decision|4
834066|NCT01059773|2651023|P1|Overall Study|Physician Decision|5
834067|NCT01059773|2651022|P2|Overall Study|Protocol Violation|2
834068|NCT01059773|2651023|P1|Overall Study|Protocol Violation|6
834069|NCT01059773|2651022|P2|Overall Study|Pregnancy|1
834070|NCT01059773|2651023|P1|Overall Study|Pregnancy|1
834071|NCT01059773|2651022|P2|Overall Study|Lost to Follow-up|1
834072|NCT01059773|2651023|P1|Overall Study|Lost to Follow-up|1
834073|NCT01059773|2651022|P2|Overall Study|Withdrawal by Subject|5
834074|NCT01059773|2651023|P1|Overall Study|Withdrawal by Subject|1
834075|NCT01059773|2651022|P2|Overall Study|Adverse Event|2
834076|NCT01059773|2651023|P1|Overall Study|Adverse Event|2
834077|NCT01059799|2651055|P2|Overall Study|Other|3
834078|NCT01059799|2651056|P1|Overall Study|Other|12
834079|NCT01059799|2651055|P2|Overall Study|Withdrawal criteria|2
834080|NCT01059799|2651056|P1|Overall Study|Withdrawal criteria|13
834081|NCT01059799|2651055|P2|Overall Study|Protocol Violation|2
834082|NCT01059799|2651056|P1|Overall Study|Protocol Violation|3
834083|NCT01059799|2651055|P2|Overall Study|Lack of Efficacy|0
834084|NCT01059799|2651056|P1|Overall Study|Lack of Efficacy|1
834085|NCT01059799|2651055|P2|Overall Study|Adverse Event|3
834086|NCT01059799|2651056|P1|Overall Study|Adverse Event|2
834087|NCT01059812|2651070|P2|Overall Study|Unclassified|4
834088|NCT01059812|2651071|P1|Overall Study|Unclassified|14
834089|NCT01059812|2651070|P2|Overall Study|Withdrawal Criteria|4
834090|NCT01059812|2651071|P1|Overall Study|Withdrawal Criteria|9
834091|NCT01059812|2651070|P2|Overall Study|Protocol Violation|1
834092|NCT01059812|2651071|P1|Overall Study|Protocol Violation|3
834093|NCT01059812|2651070|P2|Overall Study|Lack of Efficacy|2
834094|NCT01059812|2651071|P1|Overall Study|Lack of Efficacy|2
834095|NCT01059812|2651070|P2|Overall Study|Adverse Event|5
834096|NCT01059812|2651071|P1|Overall Study|Adverse Event|9
834097|NCT01059825|2651091|P7|Treatment Period|Adverse event not related to study drug|0
834098|NCT01059825|2651092|P6|Treatment Period|Adverse event not related to study drug|1
834099|NCT01059825|2651093|P5|Treatment Period|Adverse event not related to study drug|1
834100|NCT01059825|2651094|P4|Treatment Period|Adverse event not related to study drug|1
834101|NCT01059825|2651095|P3|Treatment Period|Adverse event not related to study drug|2
834102|NCT01059825|2651096|P2|Treatment Period|Adverse event not related to study drug|1
834103|NCT01059825|2651097|P1|Treatment Period|Adverse event not related to study drug|0
834104|NCT01059825|2651091|P7|Treatment Period|Insufficient clinical response|0
834105|NCT01059825|2651092|P6|Treatment Period|Insufficient clinical response|0
834106|NCT01059825|2651093|P5|Treatment Period|Insufficient clinical response|0
834107|NCT01059825|2651094|P4|Treatment Period|Insufficient clinical response|0
834108|NCT01059825|2651095|P3|Treatment Period|Insufficient clinical response|0
834109|NCT01059825|2651096|P2|Treatment Period|Insufficient clinical response|0
834110|NCT01059825|2651097|P1|Treatment Period|Insufficient clinical response|3
834111|NCT01059825|2651091|P7|Treatment Period|Adverse event related to study drug|0
834112|NCT01059825|2651092|P6|Treatment Period|Adverse event related to study drug|0
834113|NCT01059825|2651093|P5|Treatment Period|Adverse event related to study drug|0
834114|NCT01059825|2651094|P4|Treatment Period|Adverse event related to study drug|1
834115|NCT01059825|2651095|P3|Treatment Period|Adverse event related to study drug|1
834116|NCT01059825|2651096|P2|Treatment Period|Adverse event related to study drug|0
834117|NCT01059825|2651097|P1|Treatment Period|Adverse event related to study drug|1
834118|NCT01059825|2651091|P7|Treatment Period|Protocol Violation|0
834119|NCT01059825|2651092|P6|Treatment Period|Protocol Violation|1
834120|NCT01059825|2651093|P5|Treatment Period|Protocol Violation|1
834121|NCT01059825|2651094|P4|Treatment Period|Protocol Violation|1
834122|NCT01059825|2651095|P3|Treatment Period|Protocol Violation|1
834123|NCT01059825|2651096|P2|Treatment Period|Protocol Violation|0
834124|NCT01059825|2651097|P1|Treatment Period|Protocol Violation|0
834125|NCT01059825|2651091|P7|Treatment Period|Other reason not specified|0
834126|NCT01059825|2651092|P6|Treatment Period|Other reason not specified|0
834127|NCT01059825|2651093|P5|Treatment Period|Other reason not specified|0
834128|NCT01059825|2651094|P4|Treatment Period|Other reason not specified|2
834129|NCT01059825|2651095|P3|Treatment Period|Other reason not specified|1
834130|NCT01059825|2651096|P2|Treatment Period|Other reason not specified|2
834131|NCT01059825|2651097|P1|Treatment Period|Other reason not specified|1
834132|NCT01059825|2651091|P7|Treatment Period|Withdrawal by Subject|0
834133|NCT01059825|2651092|P6|Treatment Period|Withdrawal by Subject|1
834134|NCT01059825|2651093|P5|Treatment Period|Withdrawal by Subject|4
834135|NCT01059825|2651094|P4|Treatment Period|Withdrawal by Subject|5
834136|NCT01059825|2651095|P3|Treatment Period|Withdrawal by Subject|1
834137|NCT01059825|2651096|P2|Treatment Period|Withdrawal by Subject|0
834138|NCT01059825|2651097|P1|Treatment Period|Withdrawal by Subject|3
834139|NCT01059825|2651091|P7|Treatment Period|Lost to Follow-up|0
834140|NCT01059825|2651092|P6|Treatment Period|Lost to Follow-up|0
834141|NCT01059825|2651093|P5|Treatment Period|Lost to Follow-up|2
834142|NCT01059825|2651094|P4|Treatment Period|Lost to Follow-up|1
834143|NCT01059825|2651095|P3|Treatment Period|Lost to Follow-up|0
834144|NCT01059825|2651096|P2|Treatment Period|Lost to Follow-up|1
834145|NCT01059825|2651097|P1|Treatment Period|Lost to Follow-up|2
834146|NCT01059825|2651091|P7|Enrolled, Run-in Period|Protocol Violation|5
834147|NCT01059825|2651092|P6|Enrolled, Run-in Period|Protocol Violation|0
834148|NCT01059825|2651093|P5|Enrolled, Run-in Period|Protocol Violation|0
834149|NCT01059825|2651094|P4|Enrolled, Run-in Period|Protocol Violation|0
834150|NCT01059825|2651095|P3|Enrolled, Run-in Period|Protocol Violation|0
834151|NCT01059825|2651096|P2|Enrolled, Run-in Period|Protocol Violation|0
834152|NCT01059825|2651097|P1|Enrolled, Run-in Period|Protocol Violation|0
834153|NCT01059825|2651091|P7|Enrolled, Run-in Period|Other reason not specified|7
834154|NCT01059825|2651092|P6|Enrolled, Run-in Period|Other reason not specified|0
834155|NCT01059825|2651093|P5|Enrolled, Run-in Period|Other reason not specified|0
834156|NCT01059825|2651094|P4|Enrolled, Run-in Period|Other reason not specified|0
834157|NCT01059825|2651095|P3|Enrolled, Run-in Period|Other reason not specified|0
834158|NCT01059825|2651096|P2|Enrolled, Run-in Period|Other reason not specified|0
834159|NCT01059825|2651097|P1|Enrolled, Run-in Period|Other reason not specified|0
834160|NCT01059825|2651091|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
834161|NCT01059825|2651092|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
834162|NCT01059825|2651093|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
834163|NCT01059825|2651094|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
834164|NCT01059825|2651095|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
834165|NCT01059825|2651096|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
834166|NCT01059825|2651097|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
834167|NCT01059825|2651091|P7|Enrolled, Run-in Period|Lost to Follow-up|5
834168|NCT01059825|2651092|P6|Enrolled, Run-in Period|Lost to Follow-up|0
834169|NCT01059825|2651093|P5|Enrolled, Run-in Period|Lost to Follow-up|0
834170|NCT01059825|2651094|P4|Enrolled, Run-in Period|Lost to Follow-up|0
834171|NCT01059825|2651095|P3|Enrolled, Run-in Period|Lost to Follow-up|0
834172|NCT01059825|2651096|P2|Enrolled, Run-in Period|Lost to Follow-up|0
834173|NCT01059825|2651097|P1|Enrolled, Run-in Period|Lost to Follow-up|0
834174|NCT01059825|2651091|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
834175|NCT01059825|2651092|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
834176|NCT01059825|2651093|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
834177|NCT01059825|2651094|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
834178|NCT01059825|2651095|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
834179|NCT01059825|2651096|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
834180|NCT01059825|2651097|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
834181|NCT01059825|2651091|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
834182|NCT01059825|2651092|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
834183|NCT01059825|2651093|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
834184|NCT01059825|2651094|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
834185|NCT01059825|2651095|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
834186|NCT01059825|2651096|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
834187|NCT01059825|2651097|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
834188|NCT01059864|2651303|P3|Double-Blind Treatment Phase|Adverse Event|3
834189|NCT01059864|2651304|P2|Double-Blind Treatment Phase|Adverse Event|3
834190|NCT01059864|2651305|P1|Double-Blind Treatment Phase|Adverse Event|0
834191|NCT01059864|2651303|P3|Open-Label Run-In Phase|Protocol Violation|0
834192|NCT01059864|2651304|P2|Open-Label Run-In Phase|Protocol Violation|0
834193|NCT01059864|2651305|P1|Open-Label Run-In Phase|Protocol Violation|2
834194|NCT01059864|2651303|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
834195|NCT01059864|2651304|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
834196|NCT01059864|2651305|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
834197|NCT01059864|2651303|P3|Open-Label Run-In Phase|Lost to Follow-up|0
834198|NCT01059864|2651304|P2|Open-Label Run-In Phase|Lost to Follow-up|0
834199|NCT01059864|2651305|P1|Open-Label Run-In Phase|Lost to Follow-up|2
834200|NCT01059864|2651303|P3|Open-Label Run-In Phase|Lack of Efficacy|0
834201|NCT01059864|2651304|P2|Open-Label Run-In Phase|Lack of Efficacy|0
834202|NCT01059864|2651305|P1|Open-Label Run-In Phase|Lack of Efficacy|1
834203|NCT01059864|2651303|P3|Open-Label Run-In Phase|Adverse Event|0
834204|NCT01059864|2651304|P2|Open-Label Run-In Phase|Adverse Event|0
834205|NCT01059864|2651305|P1|Open-Label Run-In Phase|Adverse Event|7
834206|NCT01059903|2651354|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
834207|NCT01059903|2651355|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
834208|NCT01060007|2651410|P1|Overall Study|Inevaluable for response at surgery|3
834209|NCT01060007|2651410|P1|Overall Study|Withdrawal by Subject|1
834210|NCT01060059|2651426|P2|Overall Study|lack of compliance|2
834211|NCT01060059|2651427|P1|Overall Study|lack of compliance|5
834212|NCT01060059|2651426|P2|Overall Study|lack of glycemic control|1
834213|NCT01060059|2651427|P1|Overall Study|lack of glycemic control|2
834214|NCT01060059|2651426|P2|Overall Study|Withdrawal by Subject|23
834215|NCT01060059|2651427|P1|Overall Study|Withdrawal by Subject|35
834216|NCT01060059|2651426|P2|Overall Study|entry criteria not met|3
834217|NCT01060059|2651427|P1|Overall Study|entry criteria not met|4
834218|NCT01060059|2651426|P2|Overall Study|Lost to Follow-up|34
834219|NCT01060059|2651427|P1|Overall Study|Lost to Follow-up|18
834220|NCT01060059|2651426|P2|Overall Study|Death|3
834221|NCT01060059|2651427|P1|Overall Study|Death|2
834222|NCT01060059|2651426|P2|Overall Study|Adverse Event|1
834223|NCT01060059|2651427|P1|Overall Study|Adverse Event|1
834224|NCT01067846|2651527|P2|Overall Study|participation in other tx study|0
834225|NCT01067846|2651528|P1|Overall Study|participation in other tx study|1
834226|NCT01067846|2651527|P2|Overall Study|Withdrawal by Subject|0
834227|NCT01067846|2651528|P1|Overall Study|Withdrawal by Subject|1
834228|NCT01067846|2651527|P2|Overall Study|Lost to Follow-up|19
834229|NCT01067846|2651528|P1|Overall Study|Lost to Follow-up|17
834230|NCT01068158|2651538|P2|Overall Study|Protocol Violation|2
834231|NCT01068158|2651539|P1|Overall Study|Protocol Violation|0
834232|NCT01068158|2651538|P2|Overall Study|Lost to Follow-up|0
834233|NCT01068158|2651539|P1|Overall Study|Lost to Follow-up|7
834234|NCT01068158|2651538|P2|Overall Study|Withdrawal by Subject|2
834235|NCT01068158|2651539|P1|Overall Study|Withdrawal by Subject|1
834236|NCT01068262|2651555|P4|Overall Study|Withdrawal by Subject|0
834237|NCT01068262|2651556|P3|Overall Study|Withdrawal by Subject|0
834238|NCT01068262|2651557|P2|Overall Study|Withdrawal by Subject|1
834239|NCT01068262|2651558|P1|Overall Study|Withdrawal by Subject|0
834240|NCT01068262|2651555|P4|Overall Study|Protocol Violation|0
834241|NCT01068262|2651556|P3|Overall Study|Protocol Violation|0
834242|NCT01068262|2651557|P2|Overall Study|Protocol Violation|0
834243|NCT01068262|2651558|P1|Overall Study|Protocol Violation|1
834244|NCT01068262|2651555|P4|Overall Study|Adverse Event|0
834245|NCT01068262|2651556|P3|Overall Study|Adverse Event|1
834246|NCT01068262|2651557|P2|Overall Study|Adverse Event|0
834247|NCT01068262|2651558|P1|Overall Study|Adverse Event|2
834248|NCT01068418|2651586|P1|Overall Study|Physician Decision|12
834249|NCT01068509|2651594|P3|Overall Study|Reason Not Specified|0
834250|NCT01068509|2651595|P2|Overall Study|Reason Not Specified|1
834251|NCT01068509|2651596|P1|Overall Study|Reason Not Specified|0
834252|NCT01068509|2651594|P3|Overall Study|Withdrew Consent|2
834253|NCT01068509|2651595|P2|Overall Study|Withdrew Consent|1
834254|NCT01068509|2651596|P1|Overall Study|Withdrew Consent|0
834255|NCT01068509|2651594|P3|Overall Study|Lost to Follow-up|0
834256|NCT01068509|2651595|P2|Overall Study|Lost to Follow-up|0
834257|NCT01068509|2651596|P1|Overall Study|Lost to Follow-up|1
834258|NCT01068509|2651594|P3|Overall Study|Disease Progression|18
834259|NCT01068509|2651595|P2|Overall Study|Disease Progression|20
834260|NCT01068509|2651596|P1|Overall Study|Disease Progression|5
834261|NCT01068509|2651594|P3|Overall Study|Death|1
834262|NCT01068509|2651595|P2|Overall Study|Death|0
834263|NCT01068509|2651596|P1|Overall Study|Death|0
834264|NCT01068600|2651620|P2|Overall Study|Administrative problems|1
834265|NCT01068600|2651621|P1|Overall Study|Administrative problems|0
834266|NCT01068600|2651620|P2|Overall Study|Unsatisfactory therapeutic effect|4
834267|NCT01068600|2651621|P1|Overall Study|Unsatisfactory therapeutic effect|0
834268|NCT01068600|2651620|P2|Overall Study|Protocol deviation|1
834269|NCT01068600|2651621|P1|Overall Study|Protocol deviation|1
834270|NCT01068600|2651620|P2|Overall Study|Lost to Follow-up|2
834271|NCT01068600|2651621|P1|Overall Study|Lost to Follow-up|1
834272|NCT01068600|2651620|P2|Overall Study|Abnormal laboratory value(s)|0
834273|NCT01068600|2651621|P1|Overall Study|Abnormal laboratory value(s)|1
834274|NCT01068600|2651620|P2|Overall Study|Adverse Event|3
834275|NCT01068600|2651621|P1|Overall Study|Adverse Event|3
834276|NCT01068600|2651620|P2|Overall Study|Withdrawal by Subject|6
834277|NCT01068600|2651621|P1|Overall Study|Withdrawal by Subject|5
834278|NCT01068626|2651631|P2|Overall Study|Withdrawal by Subject|2
834279|NCT01068626|2651632|P1|Overall Study|Withdrawal by Subject|0
834280|NCT01068626|2651631|P2|Overall Study|Adverse Event|0
834281|NCT01068626|2651632|P1|Overall Study|Adverse Event|3
834282|NCT01068652|2651650|P2|Overall Study|Unclassified|4
834283|NCT01068652|2651651|P1|Overall Study|Unclassified|7
834284|NCT01068652|2651650|P2|Overall Study|Patient was not eligible|0
834285|NCT01068652|2651651|P1|Overall Study|Patient was not eligible|1
834286|NCT01068652|2651650|P2|Overall Study|Withdrawal criteria|2
834287|NCT01068652|2651651|P1|Overall Study|Withdrawal criteria|1
834288|NCT01068652|2651650|P2|Overall Study|Protocol Violation|6
834289|NCT01068652|2651651|P1|Overall Study|Protocol Violation|3
834290|NCT01068652|2651650|P2|Overall Study|Lost to Follow-up|1
834291|NCT01068652|2651651|P1|Overall Study|Lost to Follow-up|2
834292|NCT01068652|2651650|P2|Overall Study|Lack of Efficacy|2
834293|NCT01068652|2651651|P1|Overall Study|Lack of Efficacy|0
834294|NCT01068652|2651650|P2|Overall Study|Adverse Event|0
834295|NCT01068652|2651651|P1|Overall Study|Adverse Event|4
834296|NCT01068665|2651691|P2|Overall Study|Other|12
834297|NCT01068665|2651692|P1|Overall Study|Other|17
834298|NCT01068665|2651691|P2|Overall Study|Withdrawal Criteria|9
834299|NCT01068665|2651692|P1|Overall Study|Withdrawal Criteria|3
834300|NCT01068665|2651691|P2|Overall Study|Protocol Violation|2
834301|NCT01068665|2651692|P1|Overall Study|Protocol Violation|5
834302|NCT01068665|2651691|P2|Overall Study|Lack of Efficacy|2
834303|NCT01068665|2651692|P1|Overall Study|Lack of Efficacy|0
834304|NCT01068665|2651691|P2|Overall Study|Adverse Event|4
834305|NCT01068665|2651692|P1|Overall Study|Adverse Event|5
834306|NCT01068678|2651702|P2|Overall Study|Unclassified|15
834307|NCT01068678|2651703|P1|Overall Study|Unclassified|18
834308|NCT01068678|2651702|P2|Overall Study|Withdrawal criteria|6
834309|NCT01068678|2651703|P1|Overall Study|Withdrawal criteria|12
834310|NCT01068678|2651702|P2|Overall Study|Protocol Violation|1
834311|NCT01068678|2651703|P1|Overall Study|Protocol Violation|5
834312|NCT01068678|2651702|P2|Overall Study|Lack of Efficacy|2
834313|NCT01068678|2651703|P1|Overall Study|Lack of Efficacy|3
834314|NCT01068717|2651711|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
834315|NCT01068717|2651712|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
834316|NCT01068717|2651713|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
834317|NCT01068717|2651714|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
834318|NCT01068730|2651768|P4|Period 4|Family emergency|0
834319|NCT01068730|2651769|P3|Period 4|Family emergency|0
834320|NCT01068730|2651770|P2|Period 4|Family emergency|1
834321|NCT01068730|2651771|P1|Period 4|Family emergency|0
834322|NCT01068730|2651768|P4|Period 3|Personal reason|0
834323|NCT01068730|2651769|P3|Period 3|Personal reason|0
834324|NCT01068730|2651770|P2|Period 3|Personal reason|0
834325|NCT01068730|2651771|P1|Period 3|Personal reason|1
834326|NCT01068743|2651825|P4|Period 3|Adverse Event|0
834327|NCT01068743|2651826|P3|Period 3|Adverse Event|0
834328|NCT01068743|2651827|P2|Period 3|Adverse Event|1
834329|NCT01068743|2651828|P1|Period 3|Adverse Event|0
834330|NCT01068769|2651902|P1|Overall Study|Ineligible|1
834331|NCT01068860|2651928|P10|Overall Study|Lost to Follow-up|0
834332|NCT01068860|2651929|P9|Overall Study|Lost to Follow-up|0
834333|NCT01068860|2651930|P8|Overall Study|Lost to Follow-up|0
834334|NCT01068860|2651931|P7|Overall Study|Lost to Follow-up|0
834335|NCT01068860|2651932|P6|Overall Study|Lost to Follow-up|0
834336|NCT01068860|2651933|P5|Overall Study|Lost to Follow-up|0
834337|NCT01068860|2651934|P4|Overall Study|Lost to Follow-up|0
834338|NCT01068860|2651935|P3|Overall Study|Lost to Follow-up|0
834339|NCT01068860|2651936|P2|Overall Study|Lost to Follow-up|1
834340|NCT01068860|2651937|P1|Overall Study|Lost to Follow-up|0
834341|NCT01068860|2651928|P10|Overall Study|Administrative problems; misrandomized|1
834342|NCT01068860|2651929|P9|Overall Study|Administrative problems; misrandomized|0
834343|NCT01068860|2651930|P8|Overall Study|Administrative problems; misrandomized|0
834344|NCT01068860|2651931|P7|Overall Study|Administrative problems; misrandomized|0
834345|NCT01068860|2651932|P6|Overall Study|Administrative problems; misrandomized|0
834346|NCT01068860|2651933|P5|Overall Study|Administrative problems; misrandomized|0
834347|NCT01068860|2651934|P4|Overall Study|Administrative problems; misrandomized|1
834348|NCT01068860|2651935|P3|Overall Study|Administrative problems; misrandomized|0
834349|NCT01068860|2651936|P2|Overall Study|Administrative problems; misrandomized|0
834350|NCT01068860|2651937|P1|Overall Study|Administrative problems; misrandomized|0
834351|NCT01068860|2651928|P10|Overall Study|Withdrawal by Subject|3
834352|NCT01068860|2651929|P9|Overall Study|Withdrawal by Subject|0
834353|NCT01068860|2651930|P8|Overall Study|Withdrawal by Subject|0
834354|NCT01068860|2651931|P7|Overall Study|Withdrawal by Subject|0
834355|NCT01068860|2651932|P6|Overall Study|Withdrawal by Subject|2
834356|NCT01068860|2651933|P5|Overall Study|Withdrawal by Subject|0
834357|NCT01068860|2651934|P4|Overall Study|Withdrawal by Subject|0
834358|NCT01068860|2651935|P3|Overall Study|Withdrawal by Subject|0
834359|NCT01068860|2651936|P2|Overall Study|Withdrawal by Subject|0
834360|NCT01068860|2651937|P1|Overall Study|Withdrawal by Subject|0
834361|NCT01068912|2652112|P3|Overall Study|other underlying illness|3
834362|NCT01068912|2652113|P2|Overall Study|other underlying illness|3
834363|NCT01068912|2652114|P1|Overall Study|other underlying illness|0
834364|NCT01068912|2652112|P3|Overall Study|aggravation influenza|1
834365|NCT01068912|2652113|P2|Overall Study|aggravation influenza|1
834366|NCT01068912|2652114|P1|Overall Study|aggravation influenza|1
834367|NCT01068912|2652112|P3|Overall Study|Protocol Violation|0
834368|NCT01068912|2652113|P2|Overall Study|Protocol Violation|2
834369|NCT01068912|2652114|P1|Overall Study|Protocol Violation|0
834370|NCT01068912|2652112|P3|Overall Study|Lost to Follow-up|3
834371|NCT01068912|2652113|P2|Overall Study|Lost to Follow-up|7
834372|NCT01068912|2652114|P1|Overall Study|Lost to Follow-up|3
834373|NCT01068912|2652112|P3|Overall Study|Withdrawal by Subject|6
834374|NCT01068912|2652113|P2|Overall Study|Withdrawal by Subject|6
834375|NCT01068912|2652114|P1|Overall Study|Withdrawal by Subject|5
834376|NCT01068912|2652112|P3|Overall Study|Adverse Event|2
834377|NCT01068912|2652113|P2|Overall Study|Adverse Event|3
834378|NCT01068912|2652114|P1|Overall Study|Adverse Event|2
834379|NCT01069120|2652152|P1|Overall Study|Study prematurely terminated|27
834380|NCT01069172|2652158|P2|Overall Study|Withdrawal by Subject|0
834381|NCT01069172|2652159|P1|Overall Study|Withdrawal by Subject|1
834382|NCT01069289|2652180|P2|Overall Study|Due to deteriorating health condition|0
834383|NCT01069289|2652181|P1|Overall Study|Due to deteriorating health condition|1
834384|NCT01069289|2652180|P2|Overall Study|Severe non-compliance to protocol|2
834385|NCT01069289|2652181|P1|Overall Study|Severe non-compliance to protocol|3
834386|NCT01069289|2652180|P2|Overall Study|Eligibility criteria not fulfilled|0
834387|NCT01069289|2652181|P1|Overall Study|Eligibility criteria not fulfilled|2
834388|NCT01069289|2652180|P2|Overall Study|Adverse Event|28
834389|NCT01069289|2652181|P1|Overall Study|Adverse Event|21
834390|NCT01069289|2652180|P2|Overall Study|Withdrawal by Subject|26
834391|NCT01069289|2652181|P1|Overall Study|Withdrawal by Subject|15
834392|NCT01069341|2652219|P1|Overall Study|Lost to Follow-up|1
834393|NCT01069419|2652230|P1|Overall Study|Missing termination information|13
834394|NCT01069419|2652230|P1|Overall Study|Other Reason|43
834395|NCT01069419|2652230|P1|Overall Study|Withdrawal by Subject|34
834396|NCT01069419|2652230|P1|Overall Study|Remission of disease|11
834397|NCT01069419|2652230|P1|Overall Study|Lost to Follow-up|49
834398|NCT01069419|2652230|P1|Overall Study|Lack of Efficacy|332
834399|NCT01069419|2652230|P1|Overall Study|Adverse Event|233
834400|NCT01069484|2652239|P2|Overall Study|Illness mother or child|1
834401|NCT01069484|2652240|P1|Overall Study|Illness mother or child|3
834402|NCT01069484|2652239|P2|Overall Study|No specific reason|2
834403|NCT01069484|2652240|P1|Overall Study|No specific reason|8
834404|NCT01069484|2652239|P2|Overall Study|Death-in-near-family|0
834405|NCT01069484|2652240|P1|Overall Study|Death-in-near-family|1
834406|NCT01069523|2652250|P2|Overall Study|Withdrawal by Subject|7
834407|NCT01069523|2652251|P1|Overall Study|Withdrawal by Subject|4
834408|NCT01069627|2652286|P1|Overall Study|Protocol Violation|1
834409|NCT01069627|2652286|P1|Overall Study|Adverse Event|12
834410|NCT01069627|2652286|P1|Overall Study|Disease progression|7
834411|NCT01069861|2652307|P1|Overall Study|Did not meet entrance criteria|1
834412|NCT01069861|2652307|P1|Overall Study|Adverse Event|1
834413|NCT01069861|2652307|P1|Overall Study|Death|1
834414|NCT01069900|2652322|P2|Overall Study|Insufficient Therapeutic effect|0
834415|NCT01069900|2652323|P1|Overall Study|Insufficient Therapeutic effect|1
834416|NCT01069900|2652322|P2|Overall Study|Protocol Violation|1
834417|NCT01069900|2652323|P1|Overall Study|Protocol Violation|4
834418|NCT01069900|2652322|P2|Overall Study|Withdrawal by Subject|1
834419|NCT01069900|2652323|P1|Overall Study|Withdrawal by Subject|6
834420|NCT01069900|2652322|P2|Overall Study|Lost to Follow-up|1
834421|NCT01069900|2652323|P1|Overall Study|Lost to Follow-up|7
834422|NCT01069900|2652322|P2|Overall Study|Technical problems|1
834423|NCT01069900|2652323|P1|Overall Study|Technical problems|0
834424|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Removal|0
834425|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Removal|1
834426|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Physician Decision|2
834427|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Physician Decision|0
834428|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
834429|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
834430|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
834431|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
834432|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
834433|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
834434|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
834435|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
834436|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Protocol Violation|1
834437|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Protocol Violation|0
834438|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
834439|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
834440|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
834441|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
834442|NCT01069939|2652369|P2|Randomised and Included in the Analyses|Adverse Event|22
834443|NCT01069939|2652370|P1|Randomised and Included in the Analyses|Adverse Event|17
834444|NCT01070043|2652396|P3|Double-Blind Treatment|Adverse Event|2
834445|NCT01070043|2652397|P2|Double-Blind Treatment|Adverse Event|0
834446|NCT01070043|2652398|P1|Double-Blind Treatment|Adverse Event|0
834447|NCT01070043|2652396|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
834448|NCT01070043|2652397|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
834449|NCT01070043|2652398|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
834450|NCT01070303|2652430|P1|Overall Study|Other|18
834451|NCT01070303|2652430|P1|Overall Study|Administrative Reason|1
834452|NCT01070303|2652430|P1|Overall Study|Lack of Efficacy|2
834453|NCT01070303|2652430|P1|Overall Study|Protocol Violation|0
834454|NCT01070303|2652430|P1|Overall Study|Lost to Follow-up|9
834455|NCT01070303|2652430|P1|Overall Study|Withdrawal by Subject|20
834456|NCT01070303|2652430|P1|Overall Study|Adverse Event|39
834457|NCT01070316|2652486|P1|Extension Phase|Withdrawal by Subject|1
834458|NCT01070316|2652486|P1|Extension Phase|Lack of Efficacy|3
834459|NCT01070329|2652493|P2|Overall Study|Sponsor Decision|1
834460|NCT01070329|2652494|P1|Overall Study|Sponsor Decision|0
834461|NCT01070329|2652493|P2|Overall Study|Entry Criteria Not Met|0
834462|NCT01070329|2652494|P1|Overall Study|Entry Criteria Not Met|1
834463|NCT01070329|2652493|P2|Overall Study|Physician Decision|1
834464|NCT01070329|2652494|P1|Overall Study|Physician Decision|2
834465|NCT01070329|2652493|P2|Overall Study|Lack of Efficacy|6
834466|NCT01070329|2652494|P1|Overall Study|Lack of Efficacy|2
834467|NCT01070329|2652493|P2|Overall Study|Protocol Violation|8
834468|NCT01070329|2652494|P1|Overall Study|Protocol Violation|3
834469|NCT01070329|2652493|P2|Overall Study|Withdrawal by Subject|11
834470|NCT01070329|2652494|P1|Overall Study|Withdrawal by Subject|9
834471|NCT01070329|2652493|P2|Overall Study|Lost to Follow-up|12
834472|NCT01070329|2652494|P1|Overall Study|Lost to Follow-up|22
834473|NCT01070329|2652493|P2|Overall Study|Adverse Event|10
834474|NCT01070329|2652494|P1|Overall Study|Adverse Event|13
834475|NCT01070381|2652526|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
834476|NCT01070381|2652527|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
834477|NCT01070381|2652526|P2|Period 2, 1 Week of Wear|Handling|1
834478|NCT01070381|2652527|P1|Period 2, 1 Week of Wear|Handling|0
834479|NCT01070394|2652533|P1|Overall Study|Withdrawal by Subject|1
834480|NCT01070394|2652533|P1|Overall Study|Adverse Event|6
834481|NCT01063036|2652544|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
834482|NCT01063036|2652544|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
834483|NCT01063036|2652544|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
834484|NCT01063036|2652544|P1|Participants Treated With Study Drug|Pregnancy|1
834485|NCT01063036|2652544|P1|Participants Treated With Study Drug|Lost to Follow-up|1
834486|NCT01063036|2652544|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
834487|NCT01063036|2652544|P1|Participants Treated With Study Drug|Protocol Violation|1
834488|NCT01063036|2652544|P1|Participants Treated With Study Drug|Adverse Event|1
834489|NCT01063062|2652576|P2|Overall Study|Miscellaneous reason|1
834490|NCT01063062|2652577|P1|Overall Study|Miscellaneous reason|0
834491|NCT01063062|2652576|P2|Overall Study|Lost to Follow-up|2
834492|NCT01063062|2652577|P1|Overall Study|Lost to Follow-up|0
834493|NCT01063062|2652576|P2|Overall Study|Investigator's request|0
834494|NCT01063062|2652577|P1|Overall Study|Investigator's request|1
834495|NCT01063062|2652576|P2|Overall Study|Protocol Violation|4
834496|NCT01063062|2652577|P1|Overall Study|Protocol Violation|5
834497|NCT01063062|2652576|P2|Overall Study|Adverse Event|4
834498|NCT01063062|2652577|P1|Overall Study|Adverse Event|2
834499|NCT01063062|2652576|P2|Overall Study|Patient withdrew consent|1
834500|NCT01063062|2652577|P1|Overall Study|Patient withdrew consent|0
834501|NCT01063153|2652636|P2|Overall Study|Physician Decision|4
834502|NCT01063153|2652637|P1|Overall Study|Physician Decision|0
834503|NCT01063153|2652636|P2|Overall Study|Withdrawal by Subject|1
834504|NCT01063153|2652637|P1|Overall Study|Withdrawal by Subject|0
834505|NCT01063153|2652636|P2|Overall Study|Lost to Follow-up|7
834506|NCT01063153|2652637|P1|Overall Study|Lost to Follow-up|0
834507|NCT01063153|2652636|P2|Overall Study|Found Ineligible During Screening|0
834508|NCT01063153|2652637|P1|Overall Study|Found Ineligible During Screening|2
834509|NCT01063348|2652649|P2|Overall Study|Lost to Follow-up|10
834510|NCT01063348|2652650|P1|Overall Study|Lost to Follow-up|3
834511|NCT01063517|2652660|P2|Overall Study|Death|48
834512|NCT01063517|2652661|P1|Overall Study|Death|33
834513|NCT01063517|2652660|P2|Overall Study|Withdrawal by Subject|2
834514|NCT01063517|2652661|P1|Overall Study|Withdrawal by Subject|1
834515|NCT01063517|2652660|P2|Overall Study|Lost to Follow-up|3
834516|NCT01063517|2652661|P1|Overall Study|Lost to Follow-up|4
834517|NCT01063517|2652660|P2|Overall Study|Study reached data cut-off|7
834518|NCT01063517|2652661|P1|Overall Study|Study reached data cut-off|19
834519|NCT01063517|2652660|P2|Overall Study|Consent withdrawal|0
834520|NCT01063517|2652661|P1|Overall Study|Consent withdrawal|1
834521|NCT01063595|2652699|P2|First Intervention|Reason not Specified|1
834522|NCT01063595|2652700|P1|First Intervention|Reason not Specified|0
834523|NCT01063595|2652699|P2|First Intervention|Withdrawal by Subject|0
834524|NCT01063595|2652700|P1|First Intervention|Withdrawal by Subject|1
834525|NCT01063595|2652699|P2|First Intervention|Adverse Event|4
834526|NCT01063595|2652700|P1|First Intervention|Adverse Event|1
834527|NCT01063595|2652699|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
834528|NCT01063595|2652700|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
834529|NCT01063595|2652699|P2|Enrolled in Study and Randomized|Adverse Event|1
834530|NCT01063595|2652700|P1|Enrolled in Study and Randomized|Adverse Event|0
834531|NCT01063595|2652699|P2|Enrolled in Study and Randomized|Reason not Specified|0
834532|NCT01063595|2652700|P1|Enrolled in Study and Randomized|Reason not Specified|1
834533|NCT01063764|2652715|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
834534|NCT01063764|2652715|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
834535|NCT01063764|2652715|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
834536|NCT01063764|2652715|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
834537|NCT01063764|2652715|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
834538|NCT01063764|2652715|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
834539|NCT01063764|2652715|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
834540|NCT01063855|2652731|P2|Overall Study|Reason not specified|11
834541|NCT01063855|2652732|P1|Overall Study|Reason not specified|13
834542|NCT01063855|2652731|P2|Overall Study|Withdrawal by Subject|8
834543|NCT01063855|2652732|P1|Overall Study|Withdrawal by Subject|11
834544|NCT01063855|2652731|P2|Overall Study|Lack of Efficacy|1
834545|NCT01063855|2652732|P1|Overall Study|Lack of Efficacy|0
834546|NCT01063855|2652731|P2|Overall Study|Pregnancy|0
834547|NCT01063855|2652732|P1|Overall Study|Pregnancy|1
834548|NCT01063855|2652731|P2|Overall Study|Lost to Follow-up|4
834549|NCT01063855|2652732|P1|Overall Study|Lost to Follow-up|8
834550|NCT01063855|2652731|P2|Overall Study|Death|1
834551|NCT01063855|2652732|P1|Overall Study|Death|0
834552|NCT01063855|2652731|P2|Overall Study|Adverse Event|4
834553|NCT01063855|2652732|P1|Overall Study|Adverse Event|4
834554|NCT01063868|2652756|P2|Overall Study|Study Terminated By Sponsor|4
834555|NCT01063868|2652757|P1|Overall Study|Study Terminated By Sponsor|23
834556|NCT01063868|2652756|P2|Overall Study|Withdrawal by Subject|1
834557|NCT01063868|2652757|P1|Overall Study|Withdrawal by Subject|3
834558|NCT01063868|2652756|P2|Overall Study|Adverse Event|7
834559|NCT01063868|2652757|P1|Overall Study|Adverse Event|9
834560|NCT01063881|2652766|P3|Overall Study|Reason for not completed not specified|0
834561|NCT01063881|2652767|P2|Overall Study|Reason for not completed not specified|1
834562|NCT01063881|2652768|P1|Overall Study|Reason for not completed not specified|5
834563|NCT01063881|2652766|P3|Overall Study|Withdrawal by Subject|0
834564|NCT01063881|2652767|P2|Overall Study|Withdrawal by Subject|1
834565|NCT01063881|2652768|P1|Overall Study|Withdrawal by Subject|25
834566|NCT01063881|2652766|P3|Overall Study|Lost to Follow-up|1
834567|NCT01063881|2652767|P2|Overall Study|Lost to Follow-up|7
834568|NCT01063881|2652768|P1|Overall Study|Lost to Follow-up|13
834569|NCT01063881|2652766|P3|Overall Study|Adverse Event|0
834570|NCT01063881|2652767|P2|Overall Study|Adverse Event|2
834571|NCT01063881|2652768|P1|Overall Study|Adverse Event|12
834572|NCT01064167|2652828|P2|Overall Study|Protocol Violation|15
834573|NCT01064167|2652829|P1|Overall Study|Protocol Violation|14
834574|NCT01064297|2652863|P3|Overall Study|Lost to Follow-up|133
834575|NCT01064297|2652864|P2|Overall Study|Lost to Follow-up|48
834576|NCT01064297|2652865|P1|Overall Study|Lost to Follow-up|791
834577|NCT01064310|2652911|P3|Open Label Pazopinib|Physician Decision|20
834578|NCT01064310|2652912|P2|Open Label Pazopinib|Physician Decision|0
834579|NCT01064310|2652913|P1|Open Label Pazopinib|Physician Decision|0
834580|NCT01064310|2652911|P3|Open Label Pazopinib|Lack of Efficacy|51
834581|NCT01064310|2652912|P2|Open Label Pazopinib|Lack of Efficacy|0
834582|NCT01064310|2652913|P1|Open Label Pazopinib|Lack of Efficacy|0
834583|NCT01064310|2652911|P3|Open Label Pazopinib|Adverse Event|12
834584|NCT01064310|2652912|P2|Open Label Pazopinib|Adverse Event|0
834585|NCT01064310|2652913|P1|Open Label Pazopinib|Adverse Event|0
834586|NCT01064310|2652911|P3|Open Label Pazopinib|Withdrawal by Subject|1
834587|NCT01064310|2652912|P2|Open Label Pazopinib|Withdrawal by Subject|0
834588|NCT01064310|2652913|P1|Open Label Pazopinib|Withdrawal by Subject|0
834589|NCT01064310|2652911|P3|Period 2|Lack of Efficacy|0
834590|NCT01064310|2652912|P2|Period 2|Lack of Efficacy|4
834591|NCT01064310|2652913|P1|Period 2|Lack of Efficacy|1
834592|NCT01064310|2652911|P3|Period 2|Entered Open-label Period|0
834593|NCT01064310|2652912|P2|Period 2|Entered Open-label Period|0
834594|NCT01064310|2652913|P1|Period 2|Entered Open-label Period|1
834595|NCT01064310|2652911|P3|Period 2|Physician Decision|0
834596|NCT01064310|2652912|P2|Period 2|Physician Decision|1
834597|NCT01064310|2652913|P1|Period 2|Physician Decision|0
834598|NCT01064310|2652911|P3|Period 2|Adverse Event|0
834599|NCT01064310|2652912|P2|Period 2|Adverse Event|1
834600|NCT01064310|2652913|P1|Period 2|Adverse Event|2
834601|NCT01064310|2652911|P3|Period 1|Entered Open-label Period|0
834602|NCT01064310|2652912|P2|Period 1|Entered Open-label Period|1
834603|NCT01064310|2652913|P1|Period 1|Entered Open-label Period|1
834604|NCT01064310|2652911|P3|Period 1|Lack of Efficacy|0
834605|NCT01064310|2652912|P2|Period 1|Lack of Efficacy|5
834606|NCT01064310|2652913|P1|Period 1|Lack of Efficacy|3
834607|NCT01064310|2652911|P3|Period 1|Withdrawal by Subject|0
834608|NCT01064310|2652912|P2|Period 1|Withdrawal by Subject|2
834609|NCT01064310|2652913|P1|Period 1|Withdrawal by Subject|2
834610|NCT01064310|2652911|P3|Period 1|Physician Decision|0
834611|NCT01064310|2652912|P2|Period 1|Physician Decision|0
834612|NCT01064310|2652913|P1|Period 1|Physician Decision|1
834613|NCT01064310|2652911|P3|Period 1|Adverse Event|0
834614|NCT01064310|2652912|P2|Period 1|Adverse Event|10
834615|NCT01064310|2652913|P1|Period 1|Adverse Event|7
834616|NCT01064401|2652975|P2|Overall Study|Not Specified|1
834617|NCT01064401|2652976|P1|Overall Study|Not Specified|2
834618|NCT01064401|2652975|P2|Overall Study|Site Closure|5
834619|NCT01064401|2652976|P1|Overall Study|Site Closure|4
834620|NCT01064401|2652975|P2|Overall Study|Noncompliance|8
834621|NCT01064401|2652976|P1|Overall Study|Noncompliance|7
834622|NCT01064401|2652975|P2|Overall Study|Pregnancy|7
834623|NCT01064401|2652976|P1|Overall Study|Pregnancy|4
834624|NCT01064401|2652975|P2|Overall Study|Death|0
834625|NCT01064401|2652976|P1|Overall Study|Death|4
834626|NCT01064401|2652975|P2|Overall Study|Investigator Decision|6
834627|NCT01064401|2652976|P1|Overall Study|Investigator Decision|4
834628|NCT01064401|2652975|P2|Overall Study|Consent Withdrawn|80
834629|NCT01064401|2652976|P1|Overall Study|Consent Withdrawn|98
834630|NCT01064401|2652975|P2|Overall Study|Lost to Follow-up|9
834631|NCT01064401|2652976|P1|Overall Study|Lost to Follow-up|12
834632|NCT01064401|2652975|P2|Overall Study|Lack of Efficacy|23
834633|NCT01064401|2652976|P1|Overall Study|Lack of Efficacy|46
834634|NCT01064401|2652975|P2|Overall Study|Adverse Event|56
834635|NCT01064401|2652976|P1|Overall Study|Adverse Event|47
834636|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Not specified|1
834637|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Not specified|2
834638|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Not specified|5
834639|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
834640|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
834641|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
834642|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
834643|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
834644|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
834645|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
834646|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
834647|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
834648|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
834649|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
834650|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
834651|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
834652|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
834653|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
834654|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Death|0
834655|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Death|1
834656|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Death|0
834657|NCT01064414|2652993|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
834658|NCT01064414|2652994|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
834659|NCT01064414|2652995|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
834660|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Not specified|2
834661|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Not specified|7
834662|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Not specified|4
834663|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
834664|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
834665|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
834666|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
834667|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
834668|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
834669|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Protocol Violation|1
834670|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Protocol Violation|0
834671|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Protocol Violation|1
834672|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Death|0
834673|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Death|1
834674|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Death|0
834675|NCT01064414|2652993|P3|Core Period: Baseline to Week 26|Adverse Event|2
834676|NCT01064414|2652994|P2|Core Period: Baseline to Week 26|Adverse Event|4
834677|NCT01064414|2652995|P1|Core Period: Baseline to Week 26|Adverse Event|4
834678|NCT01064622|2653015|P2|Randomized Phase II|Protocol Violation|1
834679|NCT01064622|2653016|P1|Randomized Phase II|Protocol Violation|0
834680|NCT01064622|2653015|P2|Randomized Phase II|Withdrawal by Subject|2
834681|NCT01064622|2653016|P1|Randomized Phase II|Withdrawal by Subject|2
834682|NCT01064687|2653041|P4|Overall Study|Treatment Noncompliance|0
834683|NCT01064687|2653042|P3|Overall Study|Treatment Noncompliance|1
834684|NCT01064687|2653043|P2|Overall Study|Treatment Noncompliance|1
834685|NCT01064687|2653044|P1|Overall Study|Treatment Noncompliance|1
834686|NCT01064687|2653041|P4|Overall Study|Withdrawal by Subject|5
834687|NCT01064687|2653042|P3|Overall Study|Withdrawal by Subject|12
834688|NCT01064687|2653043|P2|Overall Study|Withdrawal by Subject|7
834689|NCT01064687|2653044|P1|Overall Study|Withdrawal by Subject|9
834690|NCT01064687|2653041|P4|Overall Study|Sponsor Decision|0
834691|NCT01064687|2653042|P3|Overall Study|Sponsor Decision|3
834692|NCT01064687|2653043|P2|Overall Study|Sponsor Decision|0
834693|NCT01064687|2653044|P1|Overall Study|Sponsor Decision|0
834694|NCT01064687|2653041|P4|Overall Study|Protocol Violation|1
834695|NCT01064687|2653042|P3|Overall Study|Protocol Violation|0
834696|NCT01064687|2653043|P2|Overall Study|Protocol Violation|1
834697|NCT01064687|2653044|P1|Overall Study|Protocol Violation|1
834698|NCT01064687|2653041|P4|Overall Study|Physician Decision|0
834699|NCT01064687|2653042|P3|Overall Study|Physician Decision|0
834700|NCT01064687|2653043|P2|Overall Study|Physician Decision|2
834701|NCT01064687|2653044|P1|Overall Study|Physician Decision|2
834702|NCT01064687|2653041|P4|Overall Study|Lost to Follow-up|5
834703|NCT01064687|2653042|P3|Overall Study|Lost to Follow-up|13
834704|NCT01064687|2653043|P2|Overall Study|Lost to Follow-up|10
834705|NCT01064687|2653044|P1|Overall Study|Lost to Follow-up|7
834706|NCT01064687|2653041|P4|Overall Study|Lack of Efficacy|3
834707|NCT01064687|2653042|P3|Overall Study|Lack of Efficacy|2
834708|NCT01064687|2653043|P2|Overall Study|Lack of Efficacy|0
834709|NCT01064687|2653044|P1|Overall Study|Lack of Efficacy|1
834710|NCT01064687|2653041|P4|Overall Study|Entry Criteria Not Met|0
834711|NCT01064687|2653042|P3|Overall Study|Entry Criteria Not Met|0
834712|NCT01064687|2653043|P2|Overall Study|Entry Criteria Not Met|0
834713|NCT01064687|2653044|P1|Overall Study|Entry Criteria Not Met|3
834714|NCT01064687|2653041|P4|Overall Study|Death|0
834715|NCT01064687|2653042|P3|Overall Study|Death|0
834716|NCT01064687|2653043|P2|Overall Study|Death|1
834717|NCT01064687|2653044|P1|Overall Study|Death|1
834718|NCT01064687|2653041|P4|Overall Study|Adverse Event|3
834719|NCT01064687|2653042|P3|Overall Study|Adverse Event|10
834720|NCT01064687|2653043|P2|Overall Study|Adverse Event|4
834721|NCT01064687|2653044|P1|Overall Study|Adverse Event|9
834722|NCT01064739|2653221|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
834723|NCT01064817|2653279|P2|Study Completion|Withdrawal by Subject|0
834724|NCT01064817|2653280|P1|Study Completion|Withdrawal by Subject|1
834725|NCT01064817|2653279|P2|Study Completion|Physician Decision|0
834726|NCT01064817|2653280|P1|Study Completion|Physician Decision|1
834727|NCT01064856|2653305|P4|Open-label (OL) Period|Not specified|7
834728|NCT01064856|2653306|P3|Open-label (OL) Period|Not specified|7
834729|NCT01064856|2653307|P2|Open-label (OL) Period|Not specified|0
834730|NCT01064856|2653308|P1|Open-label (OL) Period|Not specified|0
834731|NCT01064856|2653305|P4|Open-label (OL) Period|Lost to Follow-up|1
834732|NCT01064856|2653306|P3|Open-label (OL) Period|Lost to Follow-up|2
834733|NCT01064856|2653307|P2|Open-label (OL) Period|Lost to Follow-up|0
834734|NCT01064856|2653308|P1|Open-label (OL) Period|Lost to Follow-up|0
834735|NCT01064856|2653305|P4|Open-label (OL) Period|Consent withdrawn by participant|6
834736|NCT01064856|2653306|P3|Open-label (OL) Period|Consent withdrawn by participant|5
834737|NCT01064856|2653307|P2|Open-label (OL) Period|Consent withdrawn by participant|0
834738|NCT01064856|2653308|P1|Open-label (OL) Period|Consent withdrawn by participant|0
834739|NCT01064856|2653305|P4|Open-label (OL) Period|Adverse Event|6
834740|NCT01064856|2653306|P3|Open-label (OL) Period|Adverse Event|12
834741|NCT01064856|2653307|P2|Open-label (OL) Period|Adverse Event|0
834742|NCT01064856|2653308|P1|Open-label (OL) Period|Adverse Event|0
834743|NCT01064856|2653305|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
834744|NCT01064856|2653306|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
834745|NCT01064856|2653307|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
834746|NCT01064856|2653308|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
834747|NCT01064856|2653305|P4|Double-blind (DB) Period|Adverse Event|0
834748|NCT01064856|2653306|P3|Double-blind (DB) Period|Adverse Event|0
834749|NCT01064856|2653307|P2|Double-blind (DB) Period|Adverse Event|0
834750|NCT01064856|2653308|P1|Double-blind (DB) Period|Adverse Event|1
834751|NCT01064947|2653370|P1|Overall Study|negative culture|41
834752|NCT01070550|2653413|P6|Overall Study|Withdrawal by Subject|0
834753|NCT01070550|2653414|P5|Overall Study|Withdrawal by Subject|0
834754|NCT01070550|2653415|P4|Overall Study|Withdrawal by Subject|0
834755|NCT01070550|2653416|P3|Overall Study|Withdrawal by Subject|3
834756|NCT01070550|2653417|P2|Overall Study|Withdrawal by Subject|0
834757|NCT01070550|2653418|P1|Overall Study|Withdrawal by Subject|35
834758|NCT01070550|2653413|P6|Overall Study|Other|0
834759|NCT01070550|2653414|P5|Overall Study|Other|0
834760|NCT01070550|2653415|P4|Overall Study|Other|1
834761|NCT01070550|2653416|P3|Overall Study|Other|0
834762|NCT01070550|2653417|P2|Overall Study|Other|0
834763|NCT01070550|2653418|P1|Overall Study|Other|5
834764|NCT01070550|2653413|P6|Overall Study|Treatment was stopped early|0
834765|NCT01070550|2653414|P5|Overall Study|Treatment was stopped early|0
834766|NCT01070550|2653415|P4|Overall Study|Treatment was stopped early|0
834767|NCT01070550|2653416|P3|Overall Study|Treatment was stopped early|0
834768|NCT01070550|2653417|P2|Overall Study|Treatment was stopped early|0
834769|NCT01070550|2653418|P1|Overall Study|Treatment was stopped early|7
834770|NCT01070550|2653413|P6|Overall Study|Treatment unavailable|0
834771|NCT01070550|2653414|P5|Overall Study|Treatment unavailable|0
834772|NCT01070550|2653415|P4|Overall Study|Treatment unavailable|0
834773|NCT01070550|2653416|P3|Overall Study|Treatment unavailable|0
834774|NCT01070550|2653417|P2|Overall Study|Treatment unavailable|0
834775|NCT01070550|2653418|P1|Overall Study|Treatment unavailable|1
834776|NCT01070550|2653413|P6|Overall Study|Treatment stopped|0
834777|NCT01070550|2653414|P5|Overall Study|Treatment stopped|0
834778|NCT01070550|2653415|P4|Overall Study|Treatment stopped|0
834779|NCT01070550|2653416|P3|Overall Study|Treatment stopped|0
834780|NCT01070550|2653417|P2|Overall Study|Treatment stopped|0
834781|NCT01070550|2653418|P1|Overall Study|Treatment stopped|3
834782|NCT01070550|2653413|P6|Overall Study|Treatment restarted|0
834783|NCT01070550|2653414|P5|Overall Study|Treatment restarted|0
834784|NCT01070550|2653415|P4|Overall Study|Treatment restarted|0
834785|NCT01070550|2653416|P3|Overall Study|Treatment restarted|0
834786|NCT01070550|2653417|P2|Overall Study|Treatment restarted|1
834787|NCT01070550|2653418|P1|Overall Study|Treatment restarted|0
834788|NCT01070550|2653413|P6|Overall Study|Treatment not started|0
834789|NCT01070550|2653414|P5|Overall Study|Treatment not started|0
834790|NCT01070550|2653415|P4|Overall Study|Treatment not started|0
834791|NCT01070550|2653416|P3|Overall Study|Treatment not started|4
834792|NCT01070550|2653417|P2|Overall Study|Treatment not started|2
834793|NCT01070550|2653418|P1|Overall Study|Treatment not started|14
834794|NCT01070550|2653413|P6|Overall Study|Treatment interrupted|0
834795|NCT01070550|2653414|P5|Overall Study|Treatment interrupted|0
834796|NCT01070550|2653415|P4|Overall Study|Treatment interrupted|1
834797|NCT01070550|2653416|P3|Overall Study|Treatment interrupted|1
834798|NCT01070550|2653417|P2|Overall Study|Treatment interrupted|0
834799|NCT01070550|2653418|P1|Overall Study|Treatment interrupted|7
834800|NCT01070550|2653413|P6|Overall Study|Treatment duration shortened|0
834801|NCT01070550|2653414|P5|Overall Study|Treatment duration shortened|0
834802|NCT01070550|2653415|P4|Overall Study|Treatment duration shortened|0
834803|NCT01070550|2653416|P3|Overall Study|Treatment duration shortened|0
834804|NCT01070550|2653417|P2|Overall Study|Treatment duration shortened|0
834805|NCT01070550|2653418|P1|Overall Study|Treatment duration shortened|1
834806|NCT01070550|2653413|P6|Overall Study|Sponsor decision|0
834807|NCT01070550|2653414|P5|Overall Study|Sponsor decision|0
834808|NCT01070550|2653415|P4|Overall Study|Sponsor decision|0
834809|NCT01070550|2653416|P3|Overall Study|Sponsor decision|0
834810|NCT01070550|2653417|P2|Overall Study|Sponsor decision|0
834811|NCT01070550|2653418|P1|Overall Study|Sponsor decision|1
834812|NCT01070550|2653413|P6|Overall Study|Screen failure|0
834813|NCT01070550|2653414|P5|Overall Study|Screen failure|0
834814|NCT01070550|2653415|P4|Overall Study|Screen failure|0
834815|NCT01070550|2653416|P3|Overall Study|Screen failure|0
834816|NCT01070550|2653417|P2|Overall Study|Screen failure|0
834817|NCT01070550|2653418|P1|Overall Study|Screen failure|1
834818|NCT01070550|2653413|P6|Overall Study|Result not available|0
834819|NCT01070550|2653414|P5|Overall Study|Result not available|0
834820|NCT01070550|2653415|P4|Overall Study|Result not available|0
834821|NCT01070550|2653416|P3|Overall Study|Result not available|3
834822|NCT01070550|2653417|P2|Overall Study|Result not available|1
834823|NCT01070550|2653418|P1|Overall Study|Result not available|3
834824|NCT01070550|2653413|P6|Overall Study|Relapse|0
834825|NCT01070550|2653414|P5|Overall Study|Relapse|0
834826|NCT01070550|2653415|P4|Overall Study|Relapse|4
834827|NCT01070550|2653416|P3|Overall Study|Relapse|14
834828|NCT01070550|2653417|P2|Overall Study|Relapse|5
834829|NCT01070550|2653418|P1|Overall Study|Relapse|44
834830|NCT01070550|2653413|P6|Overall Study|Protocol Violation|0
834831|NCT01070550|2653414|P5|Overall Study|Protocol Violation|0
834832|NCT01070550|2653415|P4|Overall Study|Protocol Violation|1
834833|NCT01070550|2653416|P3|Overall Study|Protocol Violation|1
834834|NCT01070550|2653417|P2|Overall Study|Protocol Violation|1
834835|NCT01070550|2653418|P1|Overall Study|Protocol Violation|15
834836|NCT01070550|2653413|P6|Overall Study|Not categorized|1
834837|NCT01070550|2653414|P5|Overall Study|Not categorized|0
834838|NCT01070550|2653415|P4|Overall Study|Not categorized|1
834839|NCT01070550|2653416|P3|Overall Study|Not categorized|6
834840|NCT01070550|2653417|P2|Overall Study|Not categorized|2
834841|NCT01070550|2653418|P1|Overall Study|Not categorized|33
834842|NCT01070550|2653413|P6|Overall Study|Non-responders|2
834843|NCT01070550|2653414|P5|Overall Study|Non-responders|0
834844|NCT01070550|2653415|P4|Overall Study|Non-responders|20
834845|NCT01070550|2653416|P3|Overall Study|Non-responders|21
834846|NCT01070550|2653417|P2|Overall Study|Non-responders|4
834847|NCT01070550|2653418|P1|Overall Study|Non-responders|493
834848|NCT01070550|2653413|P6|Overall Study|New treatment started|0
834849|NCT01070550|2653414|P5|Overall Study|New treatment started|0
834850|NCT01070550|2653415|P4|Overall Study|New treatment started|2
834851|NCT01070550|2653416|P3|Overall Study|New treatment started|0
834852|NCT01070550|2653417|P2|Overall Study|New treatment started|1
834853|NCT01070550|2653418|P1|Overall Study|New treatment started|3
834854|NCT01070550|2653413|P6|Overall Study|Miscellaneous|0
834855|NCT01070550|2653414|P5|Overall Study|Miscellaneous|0
834856|NCT01070550|2653415|P4|Overall Study|Miscellaneous|1
834857|NCT01070550|2653416|P3|Overall Study|Miscellaneous|3
834858|NCT01070550|2653417|P2|Overall Study|Miscellaneous|2
834859|NCT01070550|2653418|P1|Overall Study|Miscellaneous|12
834860|NCT01070550|2653413|P6|Overall Study|Lack of Efficacy|1
834861|NCT01070550|2653414|P5|Overall Study|Lack of Efficacy|0
834862|NCT01070550|2653415|P4|Overall Study|Lack of Efficacy|5
834863|NCT01070550|2653416|P3|Overall Study|Lack of Efficacy|5
834864|NCT01070550|2653417|P2|Overall Study|Lack of Efficacy|1
834865|NCT01070550|2653418|P1|Overall Study|Lack of Efficacy|65
834866|NCT01070550|2653413|P6|Overall Study|Lab test not done|1
834867|NCT01070550|2653414|P5|Overall Study|Lab test not done|0
834868|NCT01070550|2653415|P4|Overall Study|Lab test not done|1
834869|NCT01070550|2653416|P3|Overall Study|Lab test not done|4
834870|NCT01070550|2653417|P2|Overall Study|Lab test not done|3
834871|NCT01070550|2653418|P1|Overall Study|Lab test not done|22
834872|NCT01070550|2653413|P6|Overall Study|Incomplete treatment|0
834873|NCT01070550|2653414|P5|Overall Study|Incomplete treatment|0
834874|NCT01070550|2653415|P4|Overall Study|Incomplete treatment|0
834875|NCT01070550|2653416|P3|Overall Study|Incomplete treatment|0
834876|NCT01070550|2653417|P2|Overall Study|Incomplete treatment|0
834877|NCT01070550|2653418|P1|Overall Study|Incomplete treatment|2
834878|NCT01070550|2653413|P6|Overall Study|Failed to return|2
834879|NCT01070550|2653414|P5|Overall Study|Failed to return|1
834880|NCT01070550|2653415|P4|Overall Study|Failed to return|40
834881|NCT01070550|2653416|P3|Overall Study|Failed to return|144
834882|NCT01070550|2653417|P2|Overall Study|Failed to return|33
834883|NCT01070550|2653418|P1|Overall Study|Failed to return|450
834884|NCT01070550|2653413|P6|Overall Study|Early termination|0
834885|NCT01070550|2653414|P5|Overall Study|Early termination|0
834886|NCT01070550|2653415|P4|Overall Study|Early termination|0
834887|NCT01070550|2653416|P3|Overall Study|Early termination|0
834888|NCT01070550|2653417|P2|Overall Study|Early termination|0
834889|NCT01070550|2653418|P1|Overall Study|Early termination|3
834890|NCT01070550|2653413|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
834891|NCT01070550|2653414|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
834892|NCT01070550|2653415|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
834893|NCT01070550|2653416|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
834894|NCT01070550|2653417|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
834895|NCT01070550|2653418|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
834896|NCT01070550|2653413|P6|Overall Study|Death|0
834897|NCT01070550|2653414|P5|Overall Study|Death|0
834898|NCT01070550|2653415|P4|Overall Study|Death|0
834899|NCT01070550|2653416|P3|Overall Study|Death|3
834900|NCT01070550|2653417|P2|Overall Study|Death|4
834901|NCT01070550|2653418|P1|Overall Study|Death|20
834902|NCT01070550|2653413|P6|Overall Study|Adverse Event|0
834903|NCT01070550|2653414|P5|Overall Study|Adverse Event|0
834904|NCT01070550|2653415|P4|Overall Study|Adverse Event|0
834905|NCT01070550|2653416|P3|Overall Study|Adverse Event|3
834906|NCT01070550|2653417|P2|Overall Study|Adverse Event|1
834907|NCT01070550|2653418|P1|Overall Study|Adverse Event|43
834908|NCT01070771|2653567|P1|Overall Study|Protocol Violation|1
834909|NCT01070771|2653567|P1|Overall Study|Adverse Event|2
834910|NCT01070784|2653574|P2|Overall Study|Adverse Event|9
834911|NCT01070784|2653575|P1|Overall Study|Adverse Event|14
834912|NCT01070784|2653574|P2|Overall Study|Withdrawal by Subject|9
834913|NCT01070784|2653575|P1|Overall Study|Withdrawal by Subject|6
834914|NCT01071915|2653680|P1|Overall Study|Miscellaneous Reasons|2
834915|NCT01071915|2653680|P1|Overall Study|Withdrawal by Subject|2
834916|NCT01071915|2653680|P1|Overall Study|Physician Decision|2
834917|NCT01071915|2653680|P1|Overall Study|Adverse Event|3
835324|NCT01072201|2654016|P2|Overall Study|Lost to Follow-up|1
835325|NCT01072201|2654017|P1|Overall Study|Lost to Follow-up|0
835326|NCT01072344|2654051|P2|Overall Study|Lost to Follow-up|4
835327|NCT01072344|2654052|P1|Overall Study|Lost to Follow-up|3
835328|NCT01072344|2654051|P2|Overall Study|Protocol Violation|2
835329|NCT01072344|2654052|P1|Overall Study|Protocol Violation|1
835330|NCT01072344|2654051|P2|Overall Study|Relasped-reached end point|12
835331|NCT01072344|2654052|P1|Overall Study|Relasped-reached end point|7
835332|NCT01072357|2654068|P2|Overall Study|Lost to Follow-up|1
835333|NCT01072357|2654069|P1|Overall Study|Lost to Follow-up|0
835334|NCT01072396|2654079|P2|Period Two|Lost to Follow-up|0
835335|NCT01072396|2654080|P1|Period Two|Lost to Follow-up|1
835336|NCT01072396|2654079|P2|Period Two|Adverse Event|3
835337|NCT01072396|2654080|P1|Period Two|Adverse Event|0
835338|NCT01072396|2654079|P2|Washout Period|Missing termination information|1
835339|NCT01072396|2654080|P1|Washout Period|Missing termination information|0
835340|NCT01072396|2654079|P2|Period One|Withdrawal by Subject|0
835341|NCT01072396|2654080|P1|Period One|Withdrawal by Subject|2
835342|NCT01072396|2654079|P2|Period One|Protocol Violation|1
835343|NCT01072396|2654080|P1|Period One|Protocol Violation|2
835344|NCT01072396|2654079|P2|Period One|Adverse Event|1
835345|NCT01072396|2654080|P1|Period One|Adverse Event|1
835346|NCT01072448|2654096|P2|Overall Study|Death|2
835347|NCT01072448|2654097|P1|Overall Study|Death|0
835348|NCT01072448|2654096|P2|Overall Study|Abnormal laboratory value(s)|1
835349|NCT01072448|2654097|P1|Overall Study|Abnormal laboratory value(s)|0
835350|NCT01072448|2654096|P2|Overall Study|Lost to Follow-up|1
835351|NCT01072448|2654097|P1|Overall Study|Lost to Follow-up|1
835352|NCT01072448|2654096|P2|Overall Study|Unsatisfactory therapeutic effect|3
835353|NCT01072448|2654097|P1|Overall Study|Unsatisfactory therapeutic effect|1
835354|NCT01072448|2654096|P2|Overall Study|Abnormal test procedure result(s)|0
835355|NCT01072448|2654097|P1|Overall Study|Abnormal test procedure result(s)|1
835356|NCT01072448|2654096|P2|Overall Study|Protocol deviation|4
835357|NCT01072448|2654097|P1|Overall Study|Protocol deviation|3
835358|NCT01072448|2654096|P2|Overall Study|Subject withdrew consent|9
835359|NCT01072448|2654097|P1|Overall Study|Subject withdrew consent|4
835360|NCT01072448|2654096|P2|Overall Study|Adverse Event|10
835361|NCT01072448|2654097|P1|Overall Study|Adverse Event|9
835362|NCT01072500|2654107|P2|Overall Study|Withdrawal by Subject|10
835363|NCT01072500|2654108|P1|Overall Study|Withdrawal by Subject|17
835364|NCT01072500|2654107|P2|Overall Study|Lost to Follow-up|2
835365|NCT01072500|2654108|P1|Overall Study|Lost to Follow-up|5
835366|NCT01072500|2654107|P2|Overall Study|Death|2
835367|NCT01072500|2654108|P1|Overall Study|Death|2
835368|NCT01072539|2654130|P1|Overall Study|Protocol Violation|2
835369|NCT01072539|2654130|P1|Overall Study|Treated prior to the Site Initiation|1
835370|NCT01072630|2654148|P3|Overall Study|Not specified|1
835371|NCT01072630|2654149|P2|Overall Study|Not specified|2
835372|NCT01072630|2654150|P1|Overall Study|Not specified|3
835373|NCT01072630|2654148|P3|Overall Study|Noncompliance with study procedures|1
835374|NCT01072630|2654149|P2|Overall Study|Noncompliance with study procedures|2
835375|NCT01072630|2654150|P1|Overall Study|Noncompliance with study procedures|1
835376|NCT01072630|2654148|P3|Overall Study|Noncompliance with study medication|1
835377|NCT01072630|2654149|P2|Overall Study|Noncompliance with study medication|1
835378|NCT01072630|2654150|P1|Overall Study|Noncompliance with study medication|1
835379|NCT01072630|2654148|P3|Overall Study|Lost to Follow-up|1
835380|NCT01072630|2654149|P2|Overall Study|Lost to Follow-up|11
835381|NCT01072630|2654150|P1|Overall Study|Lost to Follow-up|11
835382|NCT01072630|2654148|P3|Overall Study|Protocol Violation|4
835383|NCT01072630|2654149|P2|Overall Study|Protocol Violation|8
835384|NCT01072630|2654150|P1|Overall Study|Protocol Violation|10
835385|NCT01072630|2654148|P3|Overall Study|Withdrawal by Subject|2
835386|NCT01072630|2654149|P2|Overall Study|Withdrawal by Subject|7
835387|NCT01072630|2654150|P1|Overall Study|Withdrawal by Subject|8
835388|NCT01072630|2654148|P3|Overall Study|Lack of Efficacy|1
835389|NCT01072630|2654149|P2|Overall Study|Lack of Efficacy|10
835390|NCT01072630|2654150|P1|Overall Study|Lack of Efficacy|10
835391|NCT01072630|2654148|P3|Overall Study|Adverse Event|2
835392|NCT01072630|2654149|P2|Overall Study|Adverse Event|19
835393|NCT01072630|2654150|P1|Overall Study|Adverse Event|11
835394|NCT01072877|2654267|P5|Overall Study|Lost to Follow-up|0
835395|NCT01072877|2654268|P4|Overall Study|Lost to Follow-up|2
835396|NCT01072877|2654269|P3|Overall Study|Lost to Follow-up|0
835397|NCT01072877|2654270|P2|Overall Study|Lost to Follow-up|1
835398|NCT01072877|2654271|P1|Overall Study|Lost to Follow-up|1
835399|NCT01072929|2654296|P3|Overall Study|Not specified|0
835400|NCT01072929|2654297|P2|Overall Study|Not specified|3
835401|NCT01072929|2654298|P1|Overall Study|Not specified|0
835402|NCT01072929|2654296|P3|Overall Study|Noncompliance with study procedures|1
835403|NCT01072929|2654297|P2|Overall Study|Noncompliance with study procedures|0
835404|NCT01072929|2654298|P1|Overall Study|Noncompliance with study procedures|1
835405|NCT01072929|2654296|P3|Overall Study|Noncompliance with study medication|0
835406|NCT01072929|2654297|P2|Overall Study|Noncompliance with study medication|3
835407|NCT01072929|2654298|P1|Overall Study|Noncompliance with study medication|0
835408|NCT01072929|2654296|P3|Overall Study|Lost to Follow-up|1
835409|NCT01072929|2654297|P2|Overall Study|Lost to Follow-up|4
835410|NCT01072929|2654298|P1|Overall Study|Lost to Follow-up|8
835411|NCT01072929|2654296|P3|Overall Study|Protocol Violation|2
835412|NCT01072929|2654297|P2|Overall Study|Protocol Violation|11
835413|NCT01072929|2654298|P1|Overall Study|Protocol Violation|13
835414|NCT01072929|2654296|P3|Overall Study|Withdrawal by Subject|3
835415|NCT01072929|2654297|P2|Overall Study|Withdrawal by Subject|15
835416|NCT01072929|2654298|P1|Overall Study|Withdrawal by Subject|7
835417|NCT01072929|2654296|P3|Overall Study|Lack of Efficacy|0
835418|NCT01072929|2654297|P2|Overall Study|Lack of Efficacy|4
835419|NCT01072929|2654298|P1|Overall Study|Lack of Efficacy|7
835420|NCT01072929|2654296|P3|Overall Study|Adverse Event|2
835421|NCT01072929|2654297|P2|Overall Study|Adverse Event|11
835422|NCT01072929|2654298|P1|Overall Study|Adverse Event|8
835423|NCT01073163|2654372|P1|Overall Study|Early termination|1
835424|NCT01073163|2654372|P1|Overall Study|Disease Progression|1
835425|NCT01073163|2654372|P1|Overall Study|Adverse Event|1
835426|NCT01073267|2654392|P1|Overall Study|Disease Progression|3
835427|NCT01073293|2654398|P2|Overall Study|Withdrawal by Subject|10
835428|NCT01073293|2654399|P1|Overall Study|Withdrawal by Subject|5
835429|NCT01073293|2654398|P2|Overall Study|Lost to Follow-up|1
835430|NCT01073293|2654399|P1|Overall Study|Lost to Follow-up|0
835431|NCT01073462|2654427|P1|Overall Study|Lost to Follow-up|7
835432|NCT01073462|2654427|P1|Overall Study|Serious adverse event|2
835433|NCT01073462|2654427|P1|Overall Study|Low parathyroid hormone levels|8
835434|NCT01073462|2654427|P1|Overall Study|Kidney transplant|10
835435|NCT01073462|2654427|P1|Overall Study|Death|14
835436|NCT01073566|2654440|P2|Period 2 (6 Weeks)|Adverse Event|0
835437|NCT01073566|2654441|P1|Period 2 (6 Weeks)|Adverse Event|1
835438|NCT01073605|2654456|P3|Overall Study|Randomized But Not Treated|1
835439|NCT01073605|2654457|P2|Overall Study|Randomized But Not Treated|1
835440|NCT01073605|2654458|P1|Overall Study|Randomized But Not Treated|0
835441|NCT01073605|2654456|P3|Overall Study|Withdrawal by Subject|22
835442|NCT01073605|2654457|P2|Overall Study|Withdrawal by Subject|39
835443|NCT01073605|2654458|P1|Overall Study|Withdrawal by Subject|31
835444|NCT01073605|2654456|P3|Overall Study|Other|29
835445|NCT01073605|2654457|P2|Overall Study|Other|21
835446|NCT01073605|2654458|P1|Overall Study|Other|25
835447|NCT01073605|2654456|P3|Overall Study|Lost to Follow-up|9
835448|NCT01073605|2654457|P2|Overall Study|Lost to Follow-up|4
835449|NCT01073605|2654458|P1|Overall Study|Lost to Follow-up|3
835450|NCT01073605|2654456|P3|Overall Study|Adverse Event|0
835451|NCT01073605|2654457|P2|Overall Study|Adverse Event|1
835452|NCT01073605|2654458|P1|Overall Study|Adverse Event|2
835453|NCT01073605|2654456|P3|Overall Study|Ongoing at Cutoff Date|0
835454|NCT01073605|2654457|P2|Overall Study|Ongoing at Cutoff Date|1
835455|NCT01073605|2654458|P1|Overall Study|Ongoing at Cutoff Date|1
835456|NCT01073618|2654502|P1|Overall Study|Unspecified|80
835457|NCT01073618|2654502|P1|Overall Study|Adverse Event|19
835458|NCT01073618|2654502|P1|Overall Study|Death|208
835459|NCT01073631|2654507|P1|Overall Study|Unspecified|63
835460|NCT01073631|2654507|P1|Overall Study|Adverse Event|24
835461|NCT01073631|2654507|P1|Overall Study|Death|82
835462|NCT01073865|2654523|P2|Overall Study|Withdrawal by Subject|5
835463|NCT01073865|2654524|P1|Overall Study|Withdrawal by Subject|5
835464|NCT01073865|2654523|P2|Overall Study|Death|2
835465|NCT01073865|2654524|P1|Overall Study|Death|3
835466|NCT01073865|2654523|P2|Overall Study|Lost to Follow-up|1
835467|NCT01073865|2654524|P1|Overall Study|Lost to Follow-up|1
835468|NCT01073865|2654523|P2|Overall Study|Reasons other than below|31
835469|NCT01073865|2654524|P1|Overall Study|Reasons other than below|19
835470|NCT01073930|2654536|P2|Overall Study|Inadequate prep; unable to do procedure|1
835471|NCT01073930|2654537|P1|Overall Study|Inadequate prep; unable to do procedure|0
835472|NCT01073930|2654536|P2|Overall Study|Noncompliance with study drug|1
835473|NCT01073930|2654537|P1|Overall Study|Noncompliance with study drug|0
835474|NCT01073930|2654536|P2|Overall Study|Adverse Event|1
835475|NCT01073930|2654537|P1|Overall Study|Adverse Event|0
835476|NCT01073930|2654536|P2|Overall Study|Lost to Follow-up|1
835477|NCT01073930|2654537|P1|Overall Study|Lost to Follow-up|0
835478|NCT01073930|2654536|P2|Overall Study|Withdrawal by Subject|2
835479|NCT01073930|2654537|P1|Overall Study|Withdrawal by Subject|3
835480|NCT01073943|2654561|P2|Overall Study|Could not tolerate prep|0
835481|NCT01073943|2654562|P1|Overall Study|Could not tolerate prep|1
835482|NCT01073943|2654561|P2|Overall Study|Unable to return for follow-up|1
835483|NCT01073943|2654562|P1|Overall Study|Unable to return for follow-up|0
835484|NCT01073943|2654561|P2|Overall Study|Subject forgot|1
835485|NCT01073943|2654562|P1|Overall Study|Subject forgot|0
835486|NCT01073943|2654561|P2|Overall Study|Power outage; colonoscopy not done|0
835487|NCT01073943|2654562|P1|Overall Study|Power outage; colonoscopy not done|1
835488|NCT01073943|2654561|P2|Overall Study|Lost to Follow-up|2
835489|NCT01073943|2654562|P1|Overall Study|Lost to Follow-up|0
835490|NCT01073943|2654561|P2|Overall Study|Adverse Event|1
835491|NCT01073943|2654562|P1|Overall Study|Adverse Event|1
835492|NCT01073943|2654561|P2|Overall Study|Protocol Violation|1
835493|NCT01073943|2654562|P1|Overall Study|Protocol Violation|2
835494|NCT01073943|2654561|P2|Overall Study|Withdrawal by Subject|2
835495|NCT01073943|2654562|P1|Overall Study|Withdrawal by Subject|8
835496|NCT01074008|2654595|P9|Overall Study|Lost to Follow-up|4
835497|NCT01074008|2654596|P8|Overall Study|Lost to Follow-up|0
835498|NCT01074008|2654597|P7|Overall Study|Lost to Follow-up|1
835499|NCT01074008|2654598|P6|Overall Study|Lost to Follow-up|0
835500|NCT01074008|2654599|P5|Overall Study|Lost to Follow-up|1
835501|NCT01074008|2654600|P4|Overall Study|Lost to Follow-up|1
835502|NCT01074008|2654601|P3|Overall Study|Lost to Follow-up|1
835503|NCT01074008|2654602|P2|Overall Study|Lost to Follow-up|1
835504|NCT01074008|2654603|P1|Overall Study|Lost to Follow-up|0
835505|NCT01074008|2654595|P9|Overall Study|Withdrawal by Subject|0
835506|NCT01074008|2654596|P8|Overall Study|Withdrawal by Subject|0
835507|NCT01074008|2654597|P7|Overall Study|Withdrawal by Subject|0
835508|NCT01074008|2654598|P6|Overall Study|Withdrawal by Subject|0
835509|NCT01074008|2654599|P5|Overall Study|Withdrawal by Subject|1
835510|NCT01074008|2654600|P4|Overall Study|Withdrawal by Subject|0
835511|NCT01074008|2654601|P3|Overall Study|Withdrawal by Subject|1
835512|NCT01074008|2654602|P2|Overall Study|Withdrawal by Subject|1
835513|NCT01074008|2654603|P1|Overall Study|Withdrawal by Subject|1
835514|NCT01074008|2654595|P9|Overall Study|Adverse Event|0
835515|NCT01074008|2654596|P8|Overall Study|Adverse Event|0
835516|NCT01074008|2654597|P7|Overall Study|Adverse Event|0
835517|NCT01074008|2654598|P6|Overall Study|Adverse Event|0
835518|NCT01074008|2654599|P5|Overall Study|Adverse Event|0
835519|NCT01074008|2654600|P4|Overall Study|Adverse Event|0
835520|NCT01074008|2654601|P3|Overall Study|Adverse Event|0
835521|NCT01074008|2654602|P2|Overall Study|Adverse Event|1
835522|NCT01074008|2654603|P1|Overall Study|Adverse Event|0
835523|NCT01074047|2654718|P2|Extension Phase|Death|0
835524|NCT01074047|2654719|P1|Extension Phase|Death|5
835525|NCT01074047|2654718|P2|Extension Phase|Withdrawal by Subject|0
835526|NCT01074047|2654719|P1|Extension Phase|Withdrawal by Subject|2
835527|NCT01074047|2654718|P2|Extension Phase|Disease Progression|0
835528|NCT01074047|2654719|P1|Extension Phase|Disease Progression|9
835529|NCT01074047|2654718|P2|Extension Phase|Adverse Event|0
835530|NCT01074047|2654719|P1|Extension Phase|Adverse Event|5
835531|NCT01074047|2654718|P2|Extension Phase|Physician Decision|0
835532|NCT01074047|2654719|P1|Extension Phase|Physician Decision|1
835533|NCT01074047|2654718|P2|Survival Follow-Up Phase|Alive at study closure|3
835534|NCT01074047|2654719|P1|Survival Follow-Up Phase|Alive at study closure|1
835535|NCT01074047|2654718|P2|Survival Follow-Up Phase|Death|124
835536|NCT01074047|2654719|P1|Survival Follow-Up Phase|Death|116
835537|NCT01074047|2654718|P2|Survival Follow-Up Phase|Lost to Follow-up|1
835538|NCT01074047|2654719|P1|Survival Follow-Up Phase|Lost to Follow-up|2
835539|NCT01074047|2654718|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
835540|NCT01074047|2654719|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
835541|NCT01074047|2654718|P2|Treatment Phase|Miscellaneous|39
835542|NCT01074047|2654719|P1|Treatment Phase|Miscellaneous|32
835543|NCT01074047|2654718|P2|Treatment Phase|Protocol Violation|1
835544|NCT01074047|2654719|P1|Treatment Phase|Protocol Violation|0
835545|NCT01074047|2654718|P2|Treatment Phase|Lost to Follow-up|1
835546|NCT01074047|2654719|P1|Treatment Phase|Lost to Follow-up|0
835547|NCT01074047|2654718|P2|Treatment Phase|Death|58
835548|NCT01074047|2654719|P1|Treatment Phase|Death|53
835549|NCT01074047|2654718|P2|Treatment Phase|Withdrawal by Subject|48
835550|NCT01074047|2654719|P1|Treatment Phase|Withdrawal by Subject|27
835551|NCT01074047|2654718|P2|Treatment Phase|Disease Progression|21
835552|NCT01074047|2654719|P1|Treatment Phase|Disease Progression|16
835553|NCT01074047|2654718|P2|Treatment Phase|Adverse Event|66
835554|NCT01074047|2654719|P1|Treatment Phase|Adverse Event|89
835555|NCT01074216|2654844|P1|Overall Study|Not Treated|12
835556|NCT01074216|2654844|P1|Overall Study|Physician Decision|1
835557|NCT01074229|2654851|P3|Overall Study|Change to open surgical procedure|4
835558|NCT01074229|2654852|P2|Overall Study|Change to open surgical procedure|3
835559|NCT01074229|2654853|P1|Overall Study|Change to open surgical procedure|1
835560|NCT01074229|2654851|P3|Overall Study|Lost to Follow-up|0
835561|NCT01074229|2654852|P2|Overall Study|Lost to Follow-up|0
835562|NCT01074229|2654853|P1|Overall Study|Lost to Follow-up|1
835563|NCT01074242|2654864|P1|Overall Study|Duplicate Case Report Form|5
835564|NCT01074242|2654864|P1|Overall Study|Violation of vaccine dose or dosage|351
835565|NCT01074242|2654864|P1|Overall Study|Case report unclear|6
835566|NCT01074242|2654864|P1|Overall Study|Lost to Follow-up|1
835567|NCT01074242|2654864|P1|Overall Study|Case report before date of contract|40
835568|NCT01074255|2654869|P1|Overall Study|Did not receive EMEND|2
835569|NCT01074268|2654875|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
835570|NCT01074268|2654876|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
835571|NCT01074268|2654875|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
835572|NCT01074268|2654876|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
835573|NCT01074268|2654875|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
835574|NCT01074268|2654876|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
835575|NCT01074268|2654875|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
835576|NCT01074268|2654876|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
835577|NCT01074268|2654875|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
835578|NCT01074268|2654876|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
835579|NCT01074268|2654875|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
835580|NCT01074268|2654876|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
835581|NCT01074268|2654875|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
835582|NCT01074268|2654876|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
835583|NCT01074268|2654875|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
835584|NCT01074268|2654876|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
835585|NCT01074268|2654875|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
835586|NCT01074268|2654876|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
835587|NCT01074307|2654904|P2|Overall Study|Protocol Violation|5
835588|NCT01074307|2654905|P1|Overall Study|Protocol Violation|8
835589|NCT01074307|2654904|P2|Overall Study|Exclusion criterion|1
835590|NCT01074307|2654905|P1|Overall Study|Exclusion criterion|0
835591|NCT01074307|2654904|P2|Overall Study|No primary endpoint evaluation|6
835592|NCT01074307|2654905|P1|Overall Study|No primary endpoint evaluation|14
835593|NCT01067976|2654925|P1|Overall Study|Study prematurely discontinued|2
835594|NCT01067976|2654925|P1|Overall Study|Study drug never administered|20
835595|NCT01074450|2654995|P2|Second Intervention|Physician Decision|1
835596|NCT01074450|2654996|P1|Second Intervention|Physician Decision|0
835597|NCT01074450|2654995|P2|Second Intervention|Protocol Violation|0
835598|NCT01074450|2654996|P1|Second Intervention|Protocol Violation|1
835599|NCT01074450|2654995|P2|First Intervention|Emesis in Dosing Interval|2
835600|NCT01074450|2654996|P1|First Intervention|Emesis in Dosing Interval|0
835601|NCT01074502|2655019|P1|Overall Study|Withdrawal by Subject|1
835602|NCT01074554|2655030|P2|Overall Study|Lost to Follow-up|1
835603|NCT01074554|2655031|P1|Overall Study|Lost to Follow-up|0
835604|NCT01074554|2655030|P2|Overall Study|Adverse Event|3
835605|NCT01074554|2655031|P1|Overall Study|Adverse Event|3
835607|NCT01075074|2655050|P3|Overall Study|Surgeon changed to open incisional case|2
835608|NCT01075074|2655051|P2|Overall Study|Surgeon changed to open incisional case|2
835609|NCT01075074|2655052|P1|Overall Study|Surgeon changed to open incisional case|1
835610|NCT01075100|2655082|P2|Overall Study|Other|1
835611|NCT01075100|2655083|P1|Overall Study|Other|3
835612|NCT01075100|2655082|P2|Overall Study|Disease Progression|29
835613|NCT01075100|2655083|P1|Overall Study|Disease Progression|25
835614|NCT01075100|2655082|P2|Overall Study|Investigator Request|1
835615|NCT01075100|2655083|P1|Overall Study|Investigator Request|2
835616|NCT01075100|2655082|P2|Overall Study|Patient Request|4
835617|NCT01075100|2655083|P1|Overall Study|Patient Request|4
835618|NCT01075100|2655082|P2|Overall Study|Adverse Event|18
835619|NCT01075100|2655083|P1|Overall Study|Adverse Event|15
835620|NCT01075152|2655101|P2|Overall Study|Withdrawal by Subject|0
835621|NCT01075152|2655102|P1|Overall Study|Withdrawal by Subject|1
835622|NCT01075178|2655128|P2|Subject Chart Review|matched partner excluded (reasons above)|3
835623|NCT01075178|2655129|P1|Subject Chart Review|matched partner excluded (reasons above)|6
835624|NCT01075178|2655128|P2|Subject Chart Review|no data collected due to site closure|4
835625|NCT01075178|2655129|P1|Subject Chart Review|no data collected due to site closure|3
835626|NCT01075178|2655128|P2|Subject Chart Review|died before chart review period|2
835627|NCT01075178|2655129|P1|Subject Chart Review|died before chart review period|0
835628|NCT01075178|2655128|P2|Subject Matching|eligible but not matched|403
835629|NCT01075178|2655129|P1|Subject Matching|eligible but not matched|130
835630|NCT01075191|2655141|P1|Overall Study|Unknown Reasons|1
835631|NCT01075191|2655141|P1|Overall Study|Patient's Wish|2
835632|NCT01075191|2655141|P1|Overall Study|Therapy Break|3
835633|NCT01075191|2655141|P1|Overall Study|Noncompliance|3
835634|NCT01075191|2655141|P1|Overall Study|Adverse Event|4
835635|NCT01075191|2655141|P1|Overall Study|Co-morbidities|1
835636|NCT01075191|2655141|P1|Overall Study|Intensification|3
835637|NCT01075191|2655141|P1|Overall Study|Death|1
835638|NCT01075217|2655169|P2|Overall Study|Physician Decision|0
835639|NCT01075217|2655170|P1|Overall Study|Physician Decision|1
835640|NCT01075217|2655169|P2|Overall Study|Adverse Event|1
835641|NCT01075217|2655170|P1|Overall Study|Adverse Event|1
835642|NCT01075243|2655189|P3|Overall Study|Withdrawal by Subject|0
835643|NCT01075243|2655190|P2|Overall Study|Withdrawal by Subject|1
835644|NCT01075243|2655191|P1|Overall Study|Withdrawal by Subject|1
835645|NCT01075243|2655189|P3|Overall Study|Lost to Follow-up|0
835646|NCT01075243|2655190|P2|Overall Study|Lost to Follow-up|2
835647|NCT01075243|2655191|P1|Overall Study|Lost to Follow-up|5
835648|NCT01075256|2655244|P3|Overall Study|Withdrawal by Subject|0
835649|NCT01075256|2655245|P2|Overall Study|Withdrawal by Subject|0
835650|NCT01075256|2655246|P1|Overall Study|Withdrawal by Subject|1
835651|NCT01075282|2655278|P3|Overall Study|Death|2
835652|NCT01075282|2655279|P2|Overall Study|Death|1
835653|NCT01075282|2655280|P1|Overall Study|Death|0
835654|NCT01075282|2655278|P3|Overall Study|Protocol Violation|1
835655|NCT01075282|2655279|P2|Overall Study|Protocol Violation|2
835656|NCT01075282|2655280|P1|Overall Study|Protocol Violation|0
835657|NCT01075282|2655278|P3|Overall Study|Treatment Non-compliance|2
835658|NCT01075282|2655279|P2|Overall Study|Treatment Non-compliance|2
835659|NCT01075282|2655280|P1|Overall Study|Treatment Non-compliance|1
835660|NCT01075282|2655278|P3|Overall Study|Lack of Efficacy|0
835661|NCT01075282|2655279|P2|Overall Study|Lack of Efficacy|1
835662|NCT01075282|2655280|P1|Overall Study|Lack of Efficacy|1
835663|NCT01075282|2655278|P3|Overall Study|Physician Decision|3
835664|NCT01075282|2655279|P2|Overall Study|Physician Decision|3
835665|NCT01075282|2655280|P1|Overall Study|Physician Decision|3
835666|NCT01075282|2655278|P3|Overall Study|Lost to Follow-up|3
835667|NCT01075282|2655279|P2|Overall Study|Lost to Follow-up|3
835668|NCT01075282|2655280|P1|Overall Study|Lost to Follow-up|3
835669|NCT01075282|2655278|P3|Overall Study|Entry Criteria Not Met|0
835670|NCT01075282|2655279|P2|Overall Study|Entry Criteria Not Met|2
835671|NCT01075282|2655280|P1|Overall Study|Entry Criteria Not Met|3
835672|NCT01075282|2655278|P3|Overall Study|Adverse Event|5
835673|NCT01075282|2655279|P2|Overall Study|Adverse Event|8
835674|NCT01075282|2655280|P1|Overall Study|Adverse Event|9
835675|NCT01075282|2655278|P3|Overall Study|Withdrawal by Subject|11
835676|NCT01075282|2655279|P2|Overall Study|Withdrawal by Subject|7
835677|NCT01075282|2655280|P1|Overall Study|Withdrawal by Subject|11
835678|NCT01075646|2655379|P4|Overall Study|Lost to Follow-up|2
835679|NCT01075646|2655380|P3|Overall Study|Lost to Follow-up|1
835680|NCT01075646|2655381|P2|Overall Study|Lost to Follow-up|3
835681|NCT01075646|2655382|P1|Overall Study|Lost to Follow-up|4
835682|NCT01075685|2655414|P2|Overall Study|Lost to Follow-up|220
835683|NCT01075685|2655415|P1|Overall Study|Lost to Follow-up|563
835684|NCT01075685|2655414|P2|Overall Study|Withdrawal by Subject|5
835685|NCT01075685|2655415|P1|Overall Study|Withdrawal by Subject|20
835686|NCT01075685|2655414|P2|Overall Study|Protocol Violation|1
835687|NCT01075685|2655415|P1|Overall Study|Protocol Violation|9
835688|NCT01075763|2655429|P2|Overall Study|Withdrawal by Subject|2
835689|NCT01075763|2655430|P1|Overall Study|Withdrawal by Subject|2
835690|NCT01075763|2655429|P2|Overall Study|Lack of Efficacy|1
835691|NCT01075763|2655430|P1|Overall Study|Lack of Efficacy|0
835692|NCT01075763|2655429|P2|Overall Study|Lost to Follow-up|1
835693|NCT01075763|2655430|P1|Overall Study|Lost to Follow-up|2
835694|NCT01075815|2655454|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
835695|NCT01075815|2655455|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
835696|NCT01075815|2655454|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
835697|NCT01075815|2655455|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
835698|NCT01075815|2655454|P2|Overall Study|Withdrawal before r-hCG administration|1
835699|NCT01075815|2655455|P1|Overall Study|Withdrawal before r-hCG administration|6
835700|NCT01075958|2655491|P1|Overall Study|Blood sample could not be obtained|44
835756|NCT01076036|2655572|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
835757|NCT01076075|2655579|P2|Overall Study|Withdrawal by Subject|19
835758|NCT01076075|2655580|P1|Overall Study|Withdrawal by Subject|8
835759|NCT01076075|2655579|P2|Overall Study|Protocol Violation|1
835760|NCT01076075|2655580|P1|Overall Study|Protocol Violation|0
835761|NCT01076075|2655579|P2|Overall Study|other|9
835762|NCT01076075|2655580|P1|Overall Study|other|19
835763|NCT01076075|2655579|P2|Overall Study|Lost to Follow-up|5
835764|NCT01076075|2655580|P1|Overall Study|Lost to Follow-up|6
835765|NCT01076075|2655579|P2|Overall Study|Lack of Efficacy|4
835766|NCT01076075|2655580|P1|Overall Study|Lack of Efficacy|5
835767|NCT01076075|2655579|P2|Overall Study|Adverse Event|9
835768|NCT01076075|2655580|P1|Overall Study|Adverse Event|3
835769|NCT01076088|2655600|P6|Overall Study|Other protocol specified criteria|1
835770|NCT01076088|2655601|P5|Overall Study|Other protocol specified criteria|0
835771|NCT01076088|2655602|P4|Overall Study|Other protocol specified criteria|0
835772|NCT01076088|2655603|P3|Overall Study|Other protocol specified criteria|0
835773|NCT01076088|2655604|P2|Overall Study|Other protocol specified criteria|0
835774|NCT01076088|2655605|P1|Overall Study|Other protocol specified criteria|0
835775|NCT01076088|2655600|P6|Overall Study|Withdrawal by Subject|17
835776|NCT01076088|2655601|P5|Overall Study|Withdrawal by Subject|11
835777|NCT01076088|2655602|P4|Overall Study|Withdrawal by Subject|10
835778|NCT01076088|2655603|P3|Overall Study|Withdrawal by Subject|14
835779|NCT01076088|2655604|P2|Overall Study|Withdrawal by Subject|8
835780|NCT01076088|2655605|P1|Overall Study|Withdrawal by Subject|8
835781|NCT01076088|2655600|P6|Overall Study|Physician Decision|0
835782|NCT01076088|2655601|P5|Overall Study|Physician Decision|1
835783|NCT01076088|2655602|P4|Overall Study|Physician Decision|1
835784|NCT01076088|2655603|P3|Overall Study|Physician Decision|0
835785|NCT01076088|2655604|P2|Overall Study|Physician Decision|3
835786|NCT01076088|2655605|P1|Overall Study|Physician Decision|1
835787|NCT01076088|2655600|P6|Overall Study|Non-compliance with study drug|0
835788|NCT01076088|2655601|P5|Overall Study|Non-compliance with study drug|0
835789|NCT01076088|2655602|P4|Overall Study|Non-compliance with study drug|1
835790|NCT01076088|2655603|P3|Overall Study|Non-compliance with study drug|0
835791|NCT01076088|2655604|P2|Overall Study|Non-compliance with study drug|0
835792|NCT01076088|2655605|P1|Overall Study|Non-compliance with study drug|0
835793|NCT01076088|2655600|P6|Overall Study|Lost to Follow-up|2
835794|NCT01076088|2655601|P5|Overall Study|Lost to Follow-up|1
835795|NCT01076088|2655602|P4|Overall Study|Lost to Follow-up|1
835796|NCT01076088|2655603|P3|Overall Study|Lost to Follow-up|0
835797|NCT01076088|2655604|P2|Overall Study|Lost to Follow-up|1
835798|NCT01076088|2655605|P1|Overall Study|Lost to Follow-up|1
835799|NCT01076088|2655600|P6|Overall Study|Adverse Event|3
835800|NCT01076088|2655601|P5|Overall Study|Adverse Event|3
835801|NCT01076088|2655602|P4|Overall Study|Adverse Event|2
835802|NCT01076088|2655603|P3|Overall Study|Adverse Event|3
835803|NCT01076088|2655604|P2|Overall Study|Adverse Event|6
835804|NCT01076088|2655605|P1|Overall Study|Adverse Event|1
835805|NCT01076153|2655631|P1|Overall Study|Adverse Event|1
835806|NCT01076153|2655631|P1|Overall Study|Symptoms improved/resolved|10
835807|NCT01076166|2655639|P1|Overall Study|Symptoms improved/resolved|6
835808|NCT01076166|2655639|P1|Overall Study|Adverse Event|3
835809|NCT01076179|2655646|P1|Overall Study|Withdrawal by Subject|1
835810|NCT01076192|2655669|P1|Overall Study|Not specified|197
835811|NCT01076335|2655732|P1|Overall Study|Withdrawal without treatment|1
835812|NCT01076335|2655732|P1|Overall Study|Withdrawal by Subject|3
835813|NCT01076361|2655740|P1|Overall Study|22 leads were excluded from analysis|21
835814|NCT01076647|2655769|P2|Overall Study|Unclassified|12
835815|NCT01076647|2655770|P1|Overall Study|Unclassified|12
835816|NCT01076647|2655769|P2|Overall Study|Withdrawal criteria|2
835817|NCT01076647|2655770|P1|Overall Study|Withdrawal criteria|2
835818|NCT01076647|2655769|P2|Overall Study|Protocol Violation|9
835819|NCT01076647|2655770|P1|Overall Study|Protocol Violation|7
835820|NCT01076647|2655769|P2|Overall Study|Lack of Efficacy|1
835821|NCT01076647|2655770|P1|Overall Study|Lack of Efficacy|0
835822|NCT01076647|2655769|P2|Overall Study|Adverse Event|1
835823|NCT01076647|2655770|P1|Overall Study|Adverse Event|4
835824|NCT01076959|2655795|P1|Overall Study|Other|119
835825|NCT01076959|2655795|P1|Overall Study|Lost to Follow-up|241
835826|NCT01076959|2655795|P1|Overall Study|Non-compliance|274
835827|NCT01076959|2655795|P1|Overall Study|Lack of Efficacy|849
835828|NCT01076959|2655795|P1|Overall Study|Adverse Event|767
835829|NCT01077024|2655835|P2|Overall Study|unspecified|4
835830|NCT01077024|2655836|P1|Overall Study|unspecified|4
835831|NCT01077024|2655835|P2|Overall Study|Incarcerated|8
835832|NCT01077024|2655836|P1|Overall Study|Incarcerated|7
835833|NCT01077024|2655835|P2|Overall Study|Withdrawal by Subject|2
835834|NCT01077024|2655836|P1|Overall Study|Withdrawal by Subject|0
835835|NCT01077024|2655835|P2|Overall Study|Lost to Follow-up|14
835836|NCT01077024|2655836|P1|Overall Study|Lost to Follow-up|20
835837|NCT01077050|2655854|P1|Overall Study|Screen failure|8
835838|NCT01077050|2655854|P1|Overall Study|Subjects signed ICF could not be located|1
835839|NCT01077063|2655860|P2|Overall Study|Withdrawal by Subject|2
835840|NCT01077063|2655861|P1|Overall Study|Withdrawal by Subject|0
835841|NCT01077063|2655860|P2|Overall Study|Death|1
835842|NCT01077063|2655861|P1|Overall Study|Death|1
835843|NCT01077063|2655860|P2|Overall Study|Adverse Event|0
835844|NCT01077063|2655861|P1|Overall Study|Adverse Event|3
835845|NCT01077076|2655867|P6|Third Intervention|Death in the participant's family|1
835846|NCT01077076|2655868|P5|Third Intervention|Death in the participant's family|0
835847|NCT01077076|2655869|P4|Third Intervention|Death in the participant's family|0
835848|NCT01077076|2655870|P3|Third Intervention|Death in the participant's family|0
835849|NCT01077076|2655871|P2|Third Intervention|Death in the participant's family|0
835850|NCT01077076|2655872|P1|Third Intervention|Death in the participant's family|0
835851|NCT01077076|2655867|P6|First Intervention|Withdrawal by Subject|0
835852|NCT01077076|2655868|P5|First Intervention|Withdrawal by Subject|0
835853|NCT01077076|2655869|P4|First Intervention|Withdrawal by Subject|0
835854|NCT01077076|2655870|P3|First Intervention|Withdrawal by Subject|0
835855|NCT01077076|2655871|P2|First Intervention|Withdrawal by Subject|0
835856|NCT01077076|2655872|P1|First Intervention|Withdrawal by Subject|1
835857|NCT01077128|2655880|P1|Overall Study|Not available|54
835858|NCT01077128|2655880|P1|Overall Study|Lack of efficacy/disease exacerbation|1
835859|NCT01077128|2655880|P1|Overall Study|Adverse event and disease exacerbation|1
835860|NCT01077128|2655880|P1|Overall Study|Adverse event and consent withdrawal|1
835861|NCT01077128|2655880|P1|Overall Study|Disease exacerbation|1
835862|NCT01077128|2655880|P1|Overall Study|Lack of Efficacy|1
835863|NCT01077128|2655880|P1|Overall Study|Adverse Event|8
835864|NCT01077193|2655938|P1|Overall Study|Study Terminated by Sponsor|40
835865|NCT01077193|2655938|P1|Overall Study|Lack of Efficacy|1
835866|NCT01077193|2655938|P1|Overall Study|Withdrawal by Subject|2
835867|NCT01077193|2655938|P1|Overall Study|Lost to Follow-up|1
835868|NCT01077258|2655942|P1|Overall Study|Other reasons|260
835869|NCT01077258|2655942|P1|Overall Study|Clinical remission|37
835870|NCT01077258|2655942|P1|Overall Study|Lack of Efficacy|663
835871|NCT01077258|2655942|P1|Overall Study|Adverse drug reaction|218
835872|NCT01077258|2655942|P1|Overall Study|Lost to Follow-up|1390
835873|NCT01077271|2655982|P1|Overall Study|Mother unconvinced of the necessity|1
835874|NCT01077271|2655982|P1|Overall Study|End of RSV season nearly reached|1
835875|NCT01077271|2655982|P1|Overall Study|Parents thought too many injections|2
835876|NCT01077271|2655982|P1|Overall Study|Changed doctors|2
835877|NCT01077271|2655982|P1|Overall Study|Quota used up (insurance reimb issue)|2
835878|NCT01077271|2655982|P1|Overall Study|Noncompliance|2
835879|NCT01077271|2655982|P1|Overall Study|Screen failure, did not take palivizumab|4
835880|NCT01077271|2655982|P1|Overall Study|Parental desire|8
835881|NCT01077284|2656023|P3|Overall Study|Other|1
835882|NCT01077284|2656024|P2|Overall Study|Other|0
835883|NCT01077284|2656025|P1|Overall Study|Other|0
835884|NCT01077284|2656023|P3|Overall Study|Withdrawal by Subject|1
835885|NCT01077284|2656024|P2|Overall Study|Withdrawal by Subject|3
835886|NCT01077284|2656025|P1|Overall Study|Withdrawal by Subject|2
835887|NCT01077284|2656023|P3|Overall Study|Lost to Follow-up|0
835888|NCT01077284|2656024|P2|Overall Study|Lost to Follow-up|2
835889|NCT01077284|2656025|P1|Overall Study|Lost to Follow-up|1
835890|NCT01077284|2656023|P3|Overall Study|Adverse Event|1
835891|NCT01077284|2656024|P2|Overall Study|Adverse Event|0
835892|NCT01077284|2656025|P1|Overall Study|Adverse Event|2
835893|NCT01077323|2656068|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
835894|NCT01077323|2656069|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
835895|NCT01077323|2656070|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
835896|NCT01077323|2656068|P3|Overall Study|Dispensing of drug in baseline period|256446
835897|NCT01077323|2656069|P2|Overall Study|Dispensing of drug in baseline period|120229
835898|NCT01077323|2656070|P1|Overall Study|Dispensing of drug in baseline period|0
835899|NCT01077323|2656068|P3|Overall Study|<9 months enroll before drug dispensed|11655523
835900|NCT01077323|2656069|P2|Overall Study|<9 months enroll before drug dispensed|263954
835901|NCT01077323|2656070|P1|Overall Study|<9 months enroll before drug dispensed|11226
835902|NCT01077362|2656090|P3|Overall Study|Not Specified|2
835903|NCT01077362|2656091|P2|Overall Study|Not Specified|1
835904|NCT01077362|2656092|P1|Overall Study|Not Specified|0
835905|NCT01077362|2656090|P3|Overall Study|Withdrawal by Subject|5
835906|NCT01077362|2656091|P2|Overall Study|Withdrawal by Subject|3
835907|NCT01077362|2656092|P1|Overall Study|Withdrawal by Subject|5
835908|NCT01077362|2656090|P3|Overall Study|Adverse Event|4
835909|NCT01077362|2656091|P2|Overall Study|Adverse Event|7
835910|NCT01077362|2656092|P1|Overall Study|Adverse Event|12
835911|NCT01077362|2656090|P3|Overall Study|Lost to Follow-up|3
835912|NCT01077362|2656091|P2|Overall Study|Lost to Follow-up|0
835913|NCT01077362|2656092|P1|Overall Study|Lost to Follow-up|1
835914|NCT01077362|2656090|P3|Overall Study|Lack of Efficacy|10
835915|NCT01077362|2656091|P2|Overall Study|Lack of Efficacy|8
835916|NCT01077362|2656092|P1|Overall Study|Lack of Efficacy|13
835917|NCT01077375|2656127|P2|Overall Study|Other Reason|1
835918|NCT01077375|2656128|P1|Overall Study|Other Reason|0
835919|NCT01077375|2656127|P2|Overall Study|Lost to Follow-up|5
835920|NCT01077375|2656128|P1|Overall Study|Lost to Follow-up|2
835921|NCT01077375|2656127|P2|Overall Study|Withdrawal by Subject|6
835922|NCT01077375|2656128|P1|Overall Study|Withdrawal by Subject|0
835923|NCT01077375|2656127|P2|Overall Study|Lack of Efficacy|8
835924|NCT01077375|2656128|P1|Overall Study|Lack of Efficacy|6
835925|NCT01077375|2656127|P2|Overall Study|Adverse Event|15
835926|NCT01077375|2656128|P1|Overall Study|Adverse Event|2
835927|NCT01070888|2656151|P2|Washout (14 Days)|Physician Decision|0
835928|NCT01070888|2656152|P1|Washout (14 Days)|Physician Decision|1
835929|NCT01070888|2656151|P2|First Intervention (14 Days)|Lost to Follow-up|1
835930|NCT01070888|2656152|P1|First Intervention (14 Days)|Lost to Follow-up|0
835931|NCT01070888|2656151|P2|First Intervention (14 Days)|Adverse Event|1
835932|NCT01070888|2656152|P1|First Intervention (14 Days)|Adverse Event|0
835933|NCT01070953|2656158|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
835934|NCT01070953|2656158|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
835935|NCT01070953|2656158|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
835936|NCT01070953|2656158|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
835937|NCT01070953|2656158|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
835938|NCT01070953|2656158|P1|Participants for Safety Evaluation|Uncontracted participants|4
835939|NCT01070953|2656158|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
835940|NCT01070953|2656158|P1|Participants for Safety Evaluation|Duplicated participants|22
835941|NCT01070953|2656158|P1|Participants for Safety Evaluation|Off-label use|283
835942|NCT01070953|2656158|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
835943|NCT01070966|2656169|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
835944|NCT01070966|2656169|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
835945|NCT01070966|2656169|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
835946|NCT01070966|2656169|P1|Participants for Safety Evaluation|TMT given before date of contract|3
835947|NCT01070966|2656169|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
835948|NCT01070966|2656169|P1|Participants for Safety Evaluation|Duplicate Participants|4
835949|NCT01070966|2656169|P1|Participants for Safety Evaluation|Off-label use|9
835950|NCT01070966|2656169|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
835951|NCT01070979|2656183|P3|Overall Study|No study drug taken|0
835952|NCT01070979|2656184|P2|Overall Study|No study drug taken|1
835953|NCT01070979|2656185|P1|Overall Study|No study drug taken|0
835954|NCT01070979|2656183|P3|Overall Study|Withdrawal by Subject|1
835955|NCT01070979|2656184|P2|Overall Study|Withdrawal by Subject|1
835956|NCT01070979|2656185|P1|Overall Study|Withdrawal by Subject|3
835957|NCT01070979|2656183|P3|Overall Study|Surgery, moving, personal, abn. labs|2
835958|NCT01070979|2656184|P2|Overall Study|Surgery, moving, personal, abn. labs|4
835959|NCT01070979|2656185|P1|Overall Study|Surgery, moving, personal, abn. labs|4
835960|NCT01070979|2656183|P3|Overall Study|Protocol Violation|6
835961|NCT01070979|2656184|P2|Overall Study|Protocol Violation|2
835962|NCT01070979|2656185|P1|Overall Study|Protocol Violation|0
835963|NCT01070979|2656183|P3|Overall Study|Lost to Follow-up|1
835964|NCT01070979|2656184|P2|Overall Study|Lost to Follow-up|1
835965|NCT01070979|2656185|P1|Overall Study|Lost to Follow-up|2
835966|NCT01070979|2656183|P3|Overall Study|Adverse Event|3
835967|NCT01070979|2656184|P2|Overall Study|Adverse Event|3
835968|NCT01070979|2656185|P1|Overall Study|Adverse Event|2
835969|NCT01071070|2656234|P2|Overall Study|Hypercalcemia|0
835970|NCT01071070|2656235|P1|Overall Study|Hypercalcemia|1
835971|NCT01071070|2656234|P2|Overall Study|Missed 3 consecutive doses of study drug|0
835972|NCT01071070|2656235|P1|Overall Study|Missed 3 consecutive doses of study drug|2
835973|NCT01071070|2656234|P2|Overall Study|Withdrawal by Subject|0
835974|NCT01071070|2656235|P1|Overall Study|Withdrawal by Subject|1
835975|NCT01071070|2656234|P2|Overall Study|Adverse Event|3
835976|NCT01071070|2656235|P1|Overall Study|Adverse Event|0
835977|NCT01071083|2656262|P5|Overall Study|Subject Refused to Continue|0
835978|NCT01071083|2656263|P4|Overall Study|Subject Refused to Continue|0
835979|NCT01071083|2656264|P3|Overall Study|Subject Refused to Continue|0
835980|NCT01071083|2656265|P2|Overall Study|Subject Refused to Continue|0
835981|NCT01071083|2656266|P1|Overall Study|Subject Refused to Continue|1
835982|NCT01071083|2656262|P5|Overall Study|Did Not Want Per Protocol Treatment|1
835983|NCT01071083|2656263|P4|Overall Study|Did Not Want Per Protocol Treatment|0
835984|NCT01071083|2656264|P3|Overall Study|Did Not Want Per Protocol Treatment|1
835985|NCT01071083|2656265|P2|Overall Study|Did Not Want Per Protocol Treatment|0
835986|NCT01071083|2656266|P1|Overall Study|Did Not Want Per Protocol Treatment|0
835987|NCT01071083|2656262|P5|Overall Study|Did Not Meet Eligibility Criteria|1
835988|NCT01071083|2656263|P4|Overall Study|Did Not Meet Eligibility Criteria|1
835989|NCT01071083|2656264|P3|Overall Study|Did Not Meet Eligibility Criteria|1
835990|NCT01071083|2656265|P2|Overall Study|Did Not Meet Eligibility Criteria|0
835991|NCT01071083|2656266|P1|Overall Study|Did Not Meet Eligibility Criteria|0
835992|NCT01071083|2656262|P5|Overall Study|Images Not Usable (Motion)|0
835993|NCT01071083|2656263|P4|Overall Study|Images Not Usable (Motion)|0
835994|NCT01071083|2656264|P3|Overall Study|Images Not Usable (Motion)|0
835995|NCT01071083|2656265|P2|Overall Study|Images Not Usable (Motion)|1
835996|NCT01071083|2656266|P1|Overall Study|Images Not Usable (Motion)|0
835997|NCT01071083|2656262|P5|Overall Study|Subject Moved|0
835998|NCT01071083|2656263|P4|Overall Study|Subject Moved|0
835999|NCT01071083|2656264|P3|Overall Study|Subject Moved|0
836000|NCT01071083|2656265|P2|Overall Study|Subject Moved|1
836001|NCT01071083|2656266|P1|Overall Study|Subject Moved|0
836002|NCT01071083|2656262|P5|Overall Study|Early Rescue|1
836003|NCT01071083|2656263|P4|Overall Study|Early Rescue|0
836004|NCT01071083|2656264|P3|Overall Study|Early Rescue|0
836005|NCT01071083|2656265|P2|Overall Study|Early Rescue|0
836006|NCT01071083|2656266|P1|Overall Study|Early Rescue|1
836007|NCT01071083|2656262|P5|Overall Study|Physician Decision|1
836008|NCT01071083|2656263|P4|Overall Study|Physician Decision|1
836009|NCT01071083|2656264|P3|Overall Study|Physician Decision|0
836010|NCT01071083|2656265|P2|Overall Study|Physician Decision|0
836011|NCT01071083|2656266|P1|Overall Study|Physician Decision|1
836012|NCT01071083|2656262|P5|Overall Study|Withdrawal by Subject|3
836013|NCT01071083|2656263|P4|Overall Study|Withdrawal by Subject|0
836014|NCT01071083|2656264|P3|Overall Study|Withdrawal by Subject|2
836015|NCT01071083|2656265|P2|Overall Study|Withdrawal by Subject|0
836016|NCT01071083|2656266|P1|Overall Study|Withdrawal by Subject|3
836017|NCT01071083|2656262|P5|Overall Study|Adverse Event|1
836018|NCT01071083|2656263|P4|Overall Study|Adverse Event|0
836019|NCT01071083|2656264|P3|Overall Study|Adverse Event|1
836020|NCT01071083|2656265|P2|Overall Study|Adverse Event|0
836021|NCT01071083|2656266|P1|Overall Study|Adverse Event|1
836022|NCT01071096|2656283|P2|First Intervention (90 Days)|Lost to Follow-up|0
836023|NCT01071096|2656284|P1|First Intervention (90 Days)|Lost to Follow-up|1
836024|NCT01071200|2656305|P2|Overall Study|No viable embryos|1
836025|NCT01071200|2656306|P1|Overall Study|No viable embryos|0
836026|NCT01071200|2656305|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
836027|NCT01071200|2656306|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
836028|NCT01071200|2656305|P2|Overall Study|No oocytes retrieved|1
836029|NCT01071200|2656306|P1|Overall Study|No oocytes retrieved|1
836030|NCT01071200|2656305|P2|Overall Study|No fertilization|0
836031|NCT01071200|2656306|P1|Overall Study|No fertilization|4
836032|NCT01071200|2656305|P2|Overall Study|Lack of ovarian response|1
836033|NCT01071200|2656306|P1|Overall Study|Lack of ovarian response|1
836034|NCT01071252|2656343|P5|Overall Study|Death|1
836035|NCT01071252|2656344|P4|Overall Study|Death|0
836036|NCT01071252|2656345|P3|Overall Study|Death|0
836037|NCT01071252|2656346|P2|Overall Study|Death|0
836038|NCT01071252|2656347|P1|Overall Study|Death|0
836039|NCT01071252|2656343|P5|Overall Study|Adverse Event|0
836040|NCT01071252|2656344|P4|Overall Study|Adverse Event|1
836041|NCT01071252|2656345|P3|Overall Study|Adverse Event|0
836042|NCT01071252|2656346|P2|Overall Study|Adverse Event|1
836043|NCT01071252|2656347|P1|Overall Study|Adverse Event|1
836044|NCT01071252|2656343|P5|Overall Study|Lost to Follow-up|0
836045|NCT01071252|2656344|P4|Overall Study|Lost to Follow-up|2
836046|NCT01071252|2656345|P3|Overall Study|Lost to Follow-up|1
836047|NCT01071252|2656346|P2|Overall Study|Lost to Follow-up|0
836048|NCT01071252|2656347|P1|Overall Study|Lost to Follow-up|1
836049|NCT01071252|2656343|P5|Overall Study|administrative problems|1
836050|NCT01071252|2656344|P4|Overall Study|administrative problems|2
836051|NCT01071252|2656345|P3|Overall Study|administrative problems|0
836052|NCT01071252|2656346|P2|Overall Study|administrative problems|1
836053|NCT01071252|2656347|P1|Overall Study|administrative problems|1
836054|NCT01071252|2656343|P5|Overall Study|Withdrawal by Subject|3
836055|NCT01071252|2656344|P4|Overall Study|Withdrawal by Subject|2
836056|NCT01071252|2656345|P3|Overall Study|Withdrawal by Subject|1
836057|NCT01071252|2656346|P2|Overall Study|Withdrawal by Subject|2
836058|NCT01071252|2656347|P1|Overall Study|Withdrawal by Subject|8
836059|NCT01071252|2656343|P5|Overall Study|unsatisfactory therapeutic effect|6
836060|NCT01071252|2656344|P4|Overall Study|unsatisfactory therapeutic effect|0
836061|NCT01071252|2656345|P3|Overall Study|unsatisfactory therapeutic effect|2
836062|NCT01071252|2656346|P2|Overall Study|unsatisfactory therapeutic effect|6
836063|NCT01071252|2656347|P1|Overall Study|unsatisfactory therapeutic effect|4
836064|NCT01071278|2656373|P1|Overall Study|Completion Status Unknown|459
836065|NCT01071278|2656373|P1|Overall Study|Premature Discontinuation|254
836066|NCT01071395|2656381|P2|Overall Study|Adverse Event|1
836067|NCT01071395|2656382|P1|Overall Study|Adverse Event|3
836068|NCT01071395|2656381|P2|Overall Study|Withdrawal by Subject|1
836069|NCT01071395|2656382|P1|Overall Study|Withdrawal by Subject|2
893802|NCT01808261|2835769|P2|Overall Study|Lost to Follow-up|1
893803|NCT01808261|2835770|P1|Overall Study|Lost to Follow-up|3
893804|NCT01808261|2835769|P2|Overall Study|Consent withdrawn by subject|7
836073|NCT01071798|2656406|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
836074|NCT01071798|2656406|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
836075|NCT01071798|2656406|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
836076|NCT01071798|2656406|P1|Subpopulation Who Received Two Cycles|Remission|1
836077|NCT01071798|2656406|P1|Participants Who Received One Cycle|Severe concomitant disease|2
836078|NCT01071798|2656406|P1|Participants Who Received One Cycle|Change of therapy|6
836079|NCT01071798|2656406|P1|Participants Who Received One Cycle|Death|5
836080|NCT01071798|2656406|P1|Participants Who Received One Cycle|Patient requirement|20
836081|NCT01071798|2656406|P1|Participants Who Received One Cycle|Lack of tolerability|14
836082|NCT01071798|2656406|P1|Participants Who Received One Cycle|Lack of Efficacy|18
836083|NCT01077544|2656428|P2|Overall Study|Disease Progression|1
836084|NCT01077544|2656429|P1|Overall Study|Disease Progression|0
836085|NCT01077544|2656428|P2|Overall Study|Adverse Event|1
836086|NCT01077544|2656429|P1|Overall Study|Adverse Event|0
836087|NCT01077544|2656428|P2|Overall Study|New Cancer Therapy|3
836088|NCT01077544|2656429|P1|Overall Study|New Cancer Therapy|3
836089|NCT01077622|2656527|P1|Overall Study|Withdrawal by Subject|1
836090|NCT01077622|2656527|P1|Overall Study|Physician Decision|2
836091|NCT01077713|2656575|P2|Overall Study|Unspecified|2
836092|NCT01077713|2656576|P1|Overall Study|Unspecified|4
836093|NCT01077713|2656575|P2|Overall Study|Adverse Event|1
836094|NCT01077713|2656576|P1|Overall Study|Adverse Event|2
836095|NCT01077713|2656575|P2|Overall Study|Lost to Follow-up|1
836096|NCT01077713|2656576|P1|Overall Study|Lost to Follow-up|1
836097|NCT01077713|2656575|P2|Overall Study|Death|29
836098|NCT01077713|2656576|P1|Overall Study|Death|28
836099|NCT01077713|2656575|P2|Overall Study|Progressive Disease (PD)|1
836100|NCT01077713|2656576|P1|Overall Study|Progressive Disease (PD)|0
836101|NCT01077713|2656575|P2|Overall Study|Withdrawal by Subject|2
836102|NCT01077713|2656576|P1|Overall Study|Withdrawal by Subject|1
836103|NCT01077739|2656602|P2|Overall Study|Not specified|2
836104|NCT01077739|2656603|P1|Overall Study|Not specified|2
836105|NCT01077739|2656602|P2|Overall Study|Unacceptable toxicity|2
836106|NCT01077739|2656603|P1|Overall Study|Unacceptable toxicity|1
836107|NCT01077739|2656602|P2|Overall Study|Death|3
836108|NCT01077739|2656603|P1|Overall Study|Death|0
836109|NCT01077739|2656602|P2|Overall Study|Withdrawal by Subject|0
836110|NCT01077739|2656603|P1|Overall Study|Withdrawal by Subject|1
836111|NCT01077739|2656602|P2|Overall Study|Premature withdrawal|3
836112|NCT01077739|2656603|P1|Overall Study|Premature withdrawal|1
836113|NCT01077804|2656615|P1|Overall Study|Other|18
836114|NCT01077804|2656615|P1|Overall Study|Refused to continue|79
836115|NCT01077804|2656615|P1|Overall Study|Unreachable|102
836116|NCT01078441|2656830|P1|Overall Study|Withdrawal by Subject|1
836117|NCT01078454|2656836|P2|Overall Study|Death|1
836118|NCT01078454|2656837|P1|Overall Study|Death|0
836119|NCT01078454|2656836|P2|Overall Study|Adverse Event|1
836120|NCT01078454|2656837|P1|Overall Study|Adverse Event|1
836121|NCT01078545|2656843|P1|Overall Study|Participant moved to another physician|1
836122|NCT01078545|2656843|P1|Overall Study|Death|3
836123|NCT01078545|2656843|P1|Overall Study|Withdrawal by Subject|3
836124|NCT01078545|2656843|P1|Overall Study|Physician Decision|6
836125|NCT01078545|2656843|P1|Overall Study|Lost to Follow-up|13
836126|NCT01078571|2656851|P1|Overall Study|Protocol Violation|2
836127|NCT01078571|2656851|P1|Overall Study|Lost to Follow-up|8
836128|NCT01078571|2656851|P1|Overall Study|Withdrawal by Subject|12
836129|NCT01078571|2656851|P1|Overall Study|Reason not reported|21
836130|NCT01078571|2656851|P1|Overall Study|Lack of effectiveness|36
836131|NCT01078571|2656851|P1|Overall Study|Adverse Event|36
836132|NCT01078584|2656867|P1|Overall Study|Multiple Reasons|2
836133|NCT01078584|2656867|P1|Overall Study|Serious Adverse Event|27
836134|NCT01078584|2656867|P1|Overall Study|Protocol Violation|75
836135|NCT01078584|2656867|P1|Overall Study|Lack of Efficacy|98
836136|NCT01078584|2656867|P1|Overall Study|Physician Discontinued Patient|12
836137|NCT01078584|2656867|P1|Overall Study|Physician Switched Medication|26
836138|NCT01078584|2656867|P1|Overall Study|Blood Pressure Controlled|49
836139|NCT01078584|2656867|P1|Overall Study|Non-compliance|67
836140|NCT01078584|2656867|P1|Overall Study|Physician Withdrew from Study|90
836141|NCT01078584|2656867|P1|Overall Study|Withdrawal of Consent|244
836142|NCT01078584|2656867|P1|Overall Study|Non-serious Adverse Event|577
836143|NCT01078584|2656867|P1|Overall Study|Lost to Follow-up|670
836144|NCT01078584|2656867|P1|Overall Study|Final Status Unknown|1073
836145|NCT01078623|2656948|P20|Treatment Period 4|Withdrawal by Subject|0
836146|NCT01078623|2656949|P19|Treatment Period 4|Withdrawal by Subject|0
836147|NCT01078623|2656950|P18|Treatment Period 4|Withdrawal by Subject|0
836148|NCT01078623|2656951|P17|Treatment Period 4|Withdrawal by Subject|0
836149|NCT01078623|2656952|P16|Treatment Period 4|Withdrawal by Subject|1
836150|NCT01078623|2656953|P15|Treatment Period 4|Withdrawal by Subject|0
836151|NCT01078623|2656954|P14|Treatment Period 4|Withdrawal by Subject|0
836152|NCT01078623|2656955|P13|Treatment Period 4|Withdrawal by Subject|0
836153|NCT01078623|2656956|P12|Treatment Period 4|Withdrawal by Subject|0
836154|NCT01078623|2656957|P11|Treatment Period 4|Withdrawal by Subject|0
836155|NCT01078623|2656958|P10|Treatment Period 4|Withdrawal by Subject|0
836156|NCT01078623|2656959|P9|Treatment Period 4|Withdrawal by Subject|0
836157|NCT01078623|2656960|P8|Treatment Period 4|Withdrawal by Subject|0
836158|NCT01078623|2656961|P7|Treatment Period 4|Withdrawal by Subject|0
836159|NCT01078623|2656962|P6|Treatment Period 4|Withdrawal by Subject|0
836160|NCT01078623|2656963|P5|Treatment Period 4|Withdrawal by Subject|0
836161|NCT01078623|2656964|P4|Treatment Period 4|Withdrawal by Subject|0
836162|NCT01078623|2656965|P3|Treatment Period 4|Withdrawal by Subject|0
836163|NCT01078623|2656966|P2|Treatment Period 4|Withdrawal by Subject|0
836164|NCT01078623|2656967|P1|Treatment Period 4|Withdrawal by Subject|0
836165|NCT01078623|2656948|P20|Treatment Period 4|Adverse Event|0
836166|NCT01078623|2656949|P19|Treatment Period 4|Adverse Event|0
836167|NCT01078623|2656950|P18|Treatment Period 4|Adverse Event|0
836168|NCT01078623|2656951|P17|Treatment Period 4|Adverse Event|0
836169|NCT01078623|2656952|P16|Treatment Period 4|Adverse Event|0
836170|NCT01078623|2656953|P15|Treatment Period 4|Adverse Event|0
836171|NCT01078623|2656954|P14|Treatment Period 4|Adverse Event|0
836172|NCT01078623|2656955|P13|Treatment Period 4|Adverse Event|0
836173|NCT01078623|2656956|P12|Treatment Period 4|Adverse Event|0
836174|NCT01078623|2656957|P11|Treatment Period 4|Adverse Event|0
836175|NCT01078623|2656958|P10|Treatment Period 4|Adverse Event|0
836176|NCT01078623|2656959|P9|Treatment Period 4|Adverse Event|0
836177|NCT01078623|2656960|P8|Treatment Period 4|Adverse Event|0
836178|NCT01078623|2656961|P7|Treatment Period 4|Adverse Event|0
836179|NCT01078623|2656962|P6|Treatment Period 4|Adverse Event|0
836180|NCT01078623|2656963|P5|Treatment Period 4|Adverse Event|0
836181|NCT01078623|2656964|P4|Treatment Period 4|Adverse Event|0
836182|NCT01078623|2656965|P3|Treatment Period 4|Adverse Event|1
836183|NCT01078623|2656966|P2|Treatment Period 4|Adverse Event|0
836184|NCT01078623|2656967|P1|Treatment Period 4|Adverse Event|0
836185|NCT01078623|2656948|P20|Treatment Period 3|Adverse Event|0
836186|NCT01078623|2656949|P19|Treatment Period 3|Adverse Event|0
836187|NCT01078623|2656950|P18|Treatment Period 3|Adverse Event|0
836188|NCT01078623|2656951|P17|Treatment Period 3|Adverse Event|0
836189|NCT01078623|2656952|P16|Treatment Period 3|Adverse Event|0
836190|NCT01078623|2656953|P15|Treatment Period 3|Adverse Event|0
836191|NCT01078623|2656954|P14|Treatment Period 3|Adverse Event|1
836192|NCT01078623|2656955|P13|Treatment Period 3|Adverse Event|0
836193|NCT01078623|2656956|P12|Treatment Period 3|Adverse Event|0
836194|NCT01078623|2656957|P11|Treatment Period 3|Adverse Event|0
836195|NCT01078623|2656958|P10|Treatment Period 3|Adverse Event|0
836196|NCT01078623|2656959|P9|Treatment Period 3|Adverse Event|0
836197|NCT01078623|2656960|P8|Treatment Period 3|Adverse Event|0
836198|NCT01078623|2656961|P7|Treatment Period 3|Adverse Event|0
836199|NCT01078623|2656962|P6|Treatment Period 3|Adverse Event|0
836200|NCT01078623|2656963|P5|Treatment Period 3|Adverse Event|1
836201|NCT01078623|2656964|P4|Treatment Period 3|Adverse Event|0
836202|NCT01078623|2656965|P3|Treatment Period 3|Adverse Event|0
836203|NCT01078623|2656966|P2|Treatment Period 3|Adverse Event|0
836204|NCT01078623|2656967|P1|Treatment Period 3|Adverse Event|0
836205|NCT01078623|2656948|P20|Treatment Period 2|Withdrawal by Subject|0
836206|NCT01078623|2656949|P19|Treatment Period 2|Withdrawal by Subject|0
836207|NCT01078623|2656950|P18|Treatment Period 2|Withdrawal by Subject|0
836208|NCT01078623|2656951|P17|Treatment Period 2|Withdrawal by Subject|0
836209|NCT01078623|2656952|P16|Treatment Period 2|Withdrawal by Subject|0
836210|NCT01078623|2656953|P15|Treatment Period 2|Withdrawal by Subject|0
836211|NCT01078623|2656954|P14|Treatment Period 2|Withdrawal by Subject|0
836212|NCT01078623|2656955|P13|Treatment Period 2|Withdrawal by Subject|0
836213|NCT01078623|2656956|P12|Treatment Period 2|Withdrawal by Subject|0
836214|NCT01078623|2656957|P11|Treatment Period 2|Withdrawal by Subject|0
836215|NCT01078623|2656958|P10|Treatment Period 2|Withdrawal by Subject|0
836216|NCT01078623|2656959|P9|Treatment Period 2|Withdrawal by Subject|0
836217|NCT01078623|2656960|P8|Treatment Period 2|Withdrawal by Subject|0
836218|NCT01078623|2656961|P7|Treatment Period 2|Withdrawal by Subject|0
836219|NCT01078623|2656962|P6|Treatment Period 2|Withdrawal by Subject|1
836220|NCT01078623|2656963|P5|Treatment Period 2|Withdrawal by Subject|0
836221|NCT01078623|2656964|P4|Treatment Period 2|Withdrawal by Subject|0
836222|NCT01078623|2656965|P3|Treatment Period 2|Withdrawal by Subject|0
836223|NCT01078623|2656966|P2|Treatment Period 2|Withdrawal by Subject|0
836224|NCT01078623|2656967|P1|Treatment Period 2|Withdrawal by Subject|0
836225|NCT01078623|2656948|P20|Treatment Period 2|Adverse Event|0
836226|NCT01078623|2656949|P19|Treatment Period 2|Adverse Event|1
836227|NCT01078623|2656950|P18|Treatment Period 2|Adverse Event|0
836228|NCT01078623|2656951|P17|Treatment Period 2|Adverse Event|0
836229|NCT01078623|2656952|P16|Treatment Period 2|Adverse Event|0
836230|NCT01078623|2656953|P15|Treatment Period 2|Adverse Event|0
836231|NCT01078623|2656954|P14|Treatment Period 2|Adverse Event|0
836232|NCT01078623|2656955|P13|Treatment Period 2|Adverse Event|0
836233|NCT01078623|2656956|P12|Treatment Period 2|Adverse Event|0
836234|NCT01078623|2656957|P11|Treatment Period 2|Adverse Event|0
836235|NCT01078623|2656958|P10|Treatment Period 2|Adverse Event|0
836236|NCT01078623|2656959|P9|Treatment Period 2|Adverse Event|0
836237|NCT01078623|2656960|P8|Treatment Period 2|Adverse Event|0
836238|NCT01078623|2656961|P7|Treatment Period 2|Adverse Event|1
836239|NCT01078623|2656962|P6|Treatment Period 2|Adverse Event|0
836240|NCT01078623|2656963|P5|Treatment Period 2|Adverse Event|0
836241|NCT01078623|2656964|P4|Treatment Period 2|Adverse Event|0
836242|NCT01078623|2656965|P3|Treatment Period 2|Adverse Event|0
836243|NCT01078623|2656966|P2|Treatment Period 2|Adverse Event|0
836244|NCT01078623|2656967|P1|Treatment Period 2|Adverse Event|0
836245|NCT01078623|2656948|P20|Treatment Period 1|Protocol Violation|0
836246|NCT01078623|2656949|P19|Treatment Period 1|Protocol Violation|0
836247|NCT01078623|2656950|P18|Treatment Period 1|Protocol Violation|0
836248|NCT01078623|2656951|P17|Treatment Period 1|Protocol Violation|0
836249|NCT01078623|2656952|P16|Treatment Period 1|Protocol Violation|0
836250|NCT01078623|2656953|P15|Treatment Period 1|Protocol Violation|0
836251|NCT01078623|2656954|P14|Treatment Period 1|Protocol Violation|0
836252|NCT01078623|2656955|P13|Treatment Period 1|Protocol Violation|0
836253|NCT01078623|2656956|P12|Treatment Period 1|Protocol Violation|0
836254|NCT01078623|2656957|P11|Treatment Period 1|Protocol Violation|0
836255|NCT01078623|2656958|P10|Treatment Period 1|Protocol Violation|0
836256|NCT01078623|2656959|P9|Treatment Period 1|Protocol Violation|0
836257|NCT01078623|2656960|P8|Treatment Period 1|Protocol Violation|0
836258|NCT01078623|2656961|P7|Treatment Period 1|Protocol Violation|0
836259|NCT01078623|2656962|P6|Treatment Period 1|Protocol Violation|1
836260|NCT01078623|2656963|P5|Treatment Period 1|Protocol Violation|0
836261|NCT01078623|2656964|P4|Treatment Period 1|Protocol Violation|0
836262|NCT01078623|2656965|P3|Treatment Period 1|Protocol Violation|0
836263|NCT01078623|2656966|P2|Treatment Period 1|Protocol Violation|0
836264|NCT01078623|2656967|P1|Treatment Period 1|Protocol Violation|0
836265|NCT01078623|2656948|P20|Treatment Period 1|Withdrawal by Subject|0
836266|NCT01078623|2656949|P19|Treatment Period 1|Withdrawal by Subject|0
836267|NCT01078623|2656950|P18|Treatment Period 1|Withdrawal by Subject|0
836268|NCT01078623|2656951|P17|Treatment Period 1|Withdrawal by Subject|0
836269|NCT01078623|2656952|P16|Treatment Period 1|Withdrawal by Subject|0
836270|NCT01078623|2656953|P15|Treatment Period 1|Withdrawal by Subject|0
836271|NCT01078623|2656954|P14|Treatment Period 1|Withdrawal by Subject|0
836272|NCT01078623|2656955|P13|Treatment Period 1|Withdrawal by Subject|0
836273|NCT01078623|2656956|P12|Treatment Period 1|Withdrawal by Subject|0
836274|NCT01078623|2656957|P11|Treatment Period 1|Withdrawal by Subject|1
836275|NCT01078623|2656958|P10|Treatment Period 1|Withdrawal by Subject|0
836276|NCT01078623|2656959|P9|Treatment Period 1|Withdrawal by Subject|0
836277|NCT01078623|2656960|P8|Treatment Period 1|Withdrawal by Subject|1
836278|NCT01078623|2656961|P7|Treatment Period 1|Withdrawal by Subject|0
836279|NCT01078623|2656962|P6|Treatment Period 1|Withdrawal by Subject|0
836280|NCT01078623|2656963|P5|Treatment Period 1|Withdrawal by Subject|0
836281|NCT01078623|2656964|P4|Treatment Period 1|Withdrawal by Subject|0
836282|NCT01078623|2656965|P3|Treatment Period 1|Withdrawal by Subject|0
836283|NCT01078623|2656966|P2|Treatment Period 1|Withdrawal by Subject|0
836284|NCT01078623|2656967|P1|Treatment Period 1|Withdrawal by Subject|0
836285|NCT01078623|2656948|P20|Treatment Period 1|Adverse Event|0
836286|NCT01078623|2656949|P19|Treatment Period 1|Adverse Event|0
836287|NCT01078623|2656950|P18|Treatment Period 1|Adverse Event|0
836288|NCT01078623|2656951|P17|Treatment Period 1|Adverse Event|0
836289|NCT01078623|2656952|P16|Treatment Period 1|Adverse Event|0
836290|NCT01078623|2656953|P15|Treatment Period 1|Adverse Event|0
836291|NCT01078623|2656954|P14|Treatment Period 1|Adverse Event|0
836292|NCT01078623|2656955|P13|Treatment Period 1|Adverse Event|0
836293|NCT01078623|2656956|P12|Treatment Period 1|Adverse Event|0
836294|NCT01078623|2656957|P11|Treatment Period 1|Adverse Event|0
836295|NCT01078623|2656958|P10|Treatment Period 1|Adverse Event|1
836296|NCT01078623|2656959|P9|Treatment Period 1|Adverse Event|1
836297|NCT01078623|2656960|P8|Treatment Period 1|Adverse Event|0
836298|NCT01078623|2656961|P7|Treatment Period 1|Adverse Event|1
836299|NCT01078623|2656962|P6|Treatment Period 1|Adverse Event|0
836300|NCT01078623|2656963|P5|Treatment Period 1|Adverse Event|0
836301|NCT01078623|2656964|P4|Treatment Period 1|Adverse Event|0
836302|NCT01078623|2656965|P3|Treatment Period 1|Adverse Event|1
836303|NCT01078623|2656966|P2|Treatment Period 1|Adverse Event|1
836304|NCT01078623|2656967|P1|Treatment Period 1|Adverse Event|1
836305|NCT01078662|2656994|P5|Overall Study|Lost to Follow-up|0
836306|NCT01078662|2656995|P4|Overall Study|Lost to Follow-up|0
836307|NCT01078662|2656996|P3|Overall Study|Lost to Follow-up|0
836308|NCT01078662|2656997|P2|Overall Study|Lost to Follow-up|0
836309|NCT01078662|2656998|P1|Overall Study|Lost to Follow-up|1
836310|NCT01078662|2656994|P5|Overall Study|Protocol Violation|0
836311|NCT01078662|2656995|P4|Overall Study|Protocol Violation|0
836312|NCT01078662|2656996|P3|Overall Study|Protocol Violation|0
836313|NCT01078662|2656997|P2|Overall Study|Protocol Violation|1
836314|NCT01078662|2656998|P1|Overall Study|Protocol Violation|0
836315|NCT01078662|2656994|P5|Overall Study|Withdrawal by Subject|0
836316|NCT01078662|2656995|P4|Overall Study|Withdrawal by Subject|0
836317|NCT01078662|2656996|P3|Overall Study|Withdrawal by Subject|1
836318|NCT01078662|2656997|P2|Overall Study|Withdrawal by Subject|11
836319|NCT01078662|2656998|P1|Overall Study|Withdrawal by Subject|4
836320|NCT01078662|2656994|P5|Overall Study|Patients reached data cut-off|3
836321|NCT01078662|2656995|P4|Overall Study|Patients reached data cut-off|2
836322|NCT01078662|2656996|P3|Overall Study|Patients reached data cut-off|2
836323|NCT01078662|2656997|P2|Overall Study|Patients reached data cut-off|53
836324|NCT01078662|2656998|P1|Overall Study|Patients reached data cut-off|12
836325|NCT01078662|2656994|P5|Overall Study|Death|8
836326|NCT01078662|2656995|P4|Overall Study|Death|5
836327|NCT01078662|2656996|P3|Overall Study|Death|18
836328|NCT01078662|2656997|P2|Overall Study|Death|103
836329|NCT01078662|2656998|P1|Overall Study|Death|41
836330|NCT01078675|2657039|P2|Overall Study|Adverse Event|0
836331|NCT01078675|2657040|P1|Overall Study|Adverse Event|3
836332|NCT01078675|2657039|P2|Overall Study|Provided in CRF for specific reasons|3
836333|NCT01078675|2657040|P1|Overall Study|Provided in CRF for specific reasons|2
836334|NCT01078675|2657039|P2|Overall Study|Protocol Violation|0
836335|NCT01078675|2657040|P1|Overall Study|Protocol Violation|56
836336|NCT01078675|2657039|P2|Overall Study|Withdrawal by Subject|3
836337|NCT01078675|2657040|P1|Overall Study|Withdrawal by Subject|7
836338|NCT01078805|2657070|P1|Overall Study|Didn't take study drug|82
836339|NCT01078805|2657070|P1|Overall Study|Other|173
836340|NCT01078805|2657070|P1|Overall Study|Withdrawal by Subject|739
836341|NCT01078805|2657070|P1|Overall Study|Sponsor decision|46
836342|NCT01078805|2657070|P1|Overall Study|Serious adverse event|26
836343|NCT01078805|2657070|P1|Overall Study|Physician Decision|169
836344|NCT01078805|2657070|P1|Overall Study|Lost to Follow-up|676
836345|NCT01078805|2657070|P1|Overall Study|Death|134
836346|NCT01078805|2657070|P1|Overall Study|Clinically significant abnormal lab|5
836347|NCT01078922|2657113|P1|Overall Study|Adverse Event|1
836348|NCT01078974|2657118|P1|Overall Study|Adverse Event|3
836349|NCT01079130|2657129|P6|Overall Study|Lost to Follow-up|0
836350|NCT01079130|2657130|P5|Overall Study|Lost to Follow-up|1
836351|NCT01079130|2657131|P4|Overall Study|Lost to Follow-up|0
836352|NCT01079130|2657132|P3|Overall Study|Lost to Follow-up|0
836353|NCT01079130|2657133|P2|Overall Study|Lost to Follow-up|0
836354|NCT01079130|2657134|P1|Overall Study|Lost to Follow-up|0
836355|NCT01079130|2657129|P6|Overall Study|Unsatisfactory therapeutic effect|0
836356|NCT01079130|2657130|P5|Overall Study|Unsatisfactory therapeutic effect|0
836357|NCT01079130|2657131|P4|Overall Study|Unsatisfactory therapeutic effect|2
836358|NCT01079130|2657132|P3|Overall Study|Unsatisfactory therapeutic effect|0
836359|NCT01079130|2657133|P2|Overall Study|Unsatisfactory therapeutic effect|0
836360|NCT01079130|2657134|P1|Overall Study|Unsatisfactory therapeutic effect|0
836361|NCT01079130|2657129|P6|Overall Study|Abnormal test procedure result(s)|0
836362|NCT01079130|2657130|P5|Overall Study|Abnormal test procedure result(s)|1
836363|NCT01079130|2657131|P4|Overall Study|Abnormal test procedure result(s)|0
836364|NCT01079130|2657132|P3|Overall Study|Abnormal test procedure result(s)|0
836365|NCT01079130|2657133|P2|Overall Study|Abnormal test procedure result(s)|0
836366|NCT01079130|2657134|P1|Overall Study|Abnormal test procedure result(s)|0
836367|NCT01079130|2657129|P6|Overall Study|Protocol deviation|0
836368|NCT01079130|2657130|P5|Overall Study|Protocol deviation|0
836369|NCT01079130|2657131|P4|Overall Study|Protocol deviation|2
836370|NCT01079130|2657132|P3|Overall Study|Protocol deviation|1
836371|NCT01079130|2657133|P2|Overall Study|Protocol deviation|2
836372|NCT01079130|2657134|P1|Overall Study|Protocol deviation|0
836373|NCT01079130|2657129|P6|Overall Study|Withdrawal by Subject|3
836374|NCT01079130|2657130|P5|Overall Study|Withdrawal by Subject|1
836375|NCT01079130|2657131|P4|Overall Study|Withdrawal by Subject|0
836376|NCT01079130|2657132|P3|Overall Study|Withdrawal by Subject|0
836377|NCT01079130|2657133|P2|Overall Study|Withdrawal by Subject|1
836378|NCT01079130|2657134|P1|Overall Study|Withdrawal by Subject|0
836379|NCT01079130|2657129|P6|Overall Study|Administrative problems|1
836380|NCT01079130|2657130|P5|Overall Study|Administrative problems|0
836381|NCT01079130|2657131|P4|Overall Study|Administrative problems|0
836382|NCT01079130|2657132|P3|Overall Study|Administrative problems|0
836383|NCT01079130|2657133|P2|Overall Study|Administrative problems|3
836384|NCT01079130|2657134|P1|Overall Study|Administrative problems|1
836385|NCT01079130|2657129|P6|Overall Study|Adverse Event|1
836386|NCT01079130|2657130|P5|Overall Study|Adverse Event|5
836387|NCT01079130|2657131|P4|Overall Study|Adverse Event|1
836388|NCT01079130|2657132|P3|Overall Study|Adverse Event|0
836389|NCT01079130|2657133|P2|Overall Study|Adverse Event|1
836390|NCT01079130|2657134|P1|Overall Study|Adverse Event|1
836391|NCT01079182|2657229|P1|Overall Study|Reasons not Evaluated|271
836392|NCT01079182|2657229|P1|Overall Study|ADR and Lack of Effectiveness|39
836393|NCT01079182|2657229|P1|Overall Study|Lack of Efficacy|514
836394|NCT01079182|2657229|P1|Overall Study|Adverse Drug Reaction (ADR)|261
836395|NCT01079182|2657229|P1|Overall Study|Lost to Follow-up|1634
836396|NCT01079195|2657256|P1|Overall Study|Non-compliance|2
836397|NCT01079195|2657256|P1|Overall Study|No Follow-up Documentation Available|4
836398|NCT01079195|2657256|P1|Overall Study|Improved Status of Participant|4
836399|NCT01079195|2657256|P1|Overall Study|Physician Decision|4
836400|NCT01079195|2657256|P1|Overall Study|Lack of Effectiveness|12
836401|NCT01079195|2657256|P1|Overall Study|Financial Reasons|15
836402|NCT01079195|2657256|P1|Overall Study|Withdrawal by Subject|18
836403|NCT01079195|2657256|P1|Overall Study|Reason Unknown|39
836404|NCT01079195|2657256|P1|Overall Study|Adverse Event|157
836405|NCT01079195|2657256|P1|Overall Study|No Documentation Available|437
836406|NCT01079195|2657256|P1|Overall Study|No Documentation of Tarka Therapy|739
836407|NCT01079234|2657265|P4|Extension: Week 27 to 52|Unclassified|7
836408|NCT01079234|2657266|P3|Extension: Week 27 to 52|Unclassified|4
836409|NCT01079234|2657267|P2|Extension: Week 27 to 52|Unclassified|0
836410|NCT01079234|2657268|P1|Extension: Week 27 to 52|Unclassified|0
836411|NCT01079234|2657265|P4|Extension: Week 27 to 52|Withdrawal criteria|2
836412|NCT01079234|2657266|P3|Extension: Week 27 to 52|Withdrawal criteria|4
836413|NCT01079234|2657267|P2|Extension: Week 27 to 52|Withdrawal criteria|0
836414|NCT01079234|2657268|P1|Extension: Week 27 to 52|Withdrawal criteria|0
836415|NCT01079234|2657265|P4|Extension: Week 27 to 52|Protocol Violation|5
836416|NCT01079234|2657266|P3|Extension: Week 27 to 52|Protocol Violation|2
836417|NCT01079234|2657267|P2|Extension: Week 27 to 52|Protocol Violation|0
836418|NCT01079234|2657268|P1|Extension: Week 27 to 52|Protocol Violation|0
836419|NCT01079234|2657265|P4|Extension: Week 27 to 52|Lack of Efficacy|2
836420|NCT01079234|2657266|P3|Extension: Week 27 to 52|Lack of Efficacy|0
836421|NCT01079234|2657267|P2|Extension: Week 27 to 52|Lack of Efficacy|0
836422|NCT01079234|2657268|P1|Extension: Week 27 to 52|Lack of Efficacy|0
836423|NCT01079234|2657265|P4|Extension: Week 27 to 52|Adverse Event|0
836424|NCT01079234|2657266|P3|Extension: Week 27 to 52|Adverse Event|1
836425|NCT01079234|2657267|P2|Extension: Week 27 to 52|Adverse Event|0
836426|NCT01079234|2657268|P1|Extension: Week 27 to 52|Adverse Event|0
836427|NCT01079234|2657265|P4|Main: Week 0 to 26|Unclassified|0
836428|NCT01079234|2657266|P3|Main: Week 0 to 26|Unclassified|4
836429|NCT01079234|2657267|P2|Main: Week 0 to 26|Unclassified|13
836430|NCT01079234|2657268|P1|Main: Week 0 to 26|Unclassified|7
836431|NCT01079234|2657265|P4|Main: Week 0 to 26|Withdrawal criteria|0
836432|NCT01079234|2657266|P3|Main: Week 0 to 26|Withdrawal criteria|2
836433|NCT01079234|2657267|P2|Main: Week 0 to 26|Withdrawal criteria|6
836434|NCT01079234|2657268|P1|Main: Week 0 to 26|Withdrawal criteria|6
836435|NCT01079234|2657265|P4|Main: Week 0 to 26|Protocol Violation|0
836436|NCT01079234|2657266|P3|Main: Week 0 to 26|Protocol Violation|4
836437|NCT01079234|2657267|P2|Main: Week 0 to 26|Protocol Violation|2
836438|NCT01079234|2657268|P1|Main: Week 0 to 26|Protocol Violation|6
836439|NCT01079234|2657265|P4|Main: Week 0 to 26|Lack of Efficacy|0
836440|NCT01079234|2657266|P3|Main: Week 0 to 26|Lack of Efficacy|1
836441|NCT01079234|2657267|P2|Main: Week 0 to 26|Lack of Efficacy|1
836442|NCT01079234|2657268|P1|Main: Week 0 to 26|Lack of Efficacy|2
836443|NCT01079234|2657265|P4|Main: Week 0 to 26|Adverse Event|0
836444|NCT01079234|2657266|P3|Main: Week 0 to 26|Adverse Event|1
836445|NCT01079234|2657267|P2|Main: Week 0 to 26|Adverse Event|4
836446|NCT01079234|2657268|P1|Main: Week 0 to 26|Adverse Event|5
893805|NCT01808261|2835770|P1|Overall Study|Consent withdrawn by subject|6
893806|NCT01808261|2835769|P2|Overall Study|Adverse event, non-fatal|0
893807|NCT01808261|2835770|P1|Overall Study|Adverse event, non-fatal|2
893808|NCT01808261|2835769|P2|Overall Study|Study Closed/Terminated|23
893809|NCT01808261|2835770|P1|Overall Study|Study Closed/Terminated|25
893810|NCT01808261|2835769|P2|Overall Study|Physician Decision|2
893811|NCT01808261|2835770|P1|Overall Study|Physician Decision|0
836457|NCT01079832|2657340|P1|Overall Study|Withdrawal by Subject|1
836458|NCT01079936|2657352|P5|Phase II|Insurance Issue|1
836459|NCT01079936|2657353|P4|Phase II|Insurance Issue|0
836460|NCT01079936|2657354|P3|Phase II|Insurance Issue|0
836461|NCT01079936|2657355|P2|Phase II|Insurance Issue|0
836462|NCT01079936|2657356|P1|Phase II|Insurance Issue|0
836463|NCT01079936|2657352|P5|Phase II|Adverse Event|0
836464|NCT01079936|2657353|P4|Phase II|Adverse Event|0
836465|NCT01079936|2657354|P3|Phase II|Adverse Event|1
836466|NCT01079936|2657355|P2|Phase II|Adverse Event|0
836467|NCT01079936|2657356|P1|Phase II|Adverse Event|0
836468|NCT01079936|2657352|P5|Phase I: MTD|No Stem Cell Transplantation|0
836469|NCT01079936|2657353|P4|Phase I: MTD|No Stem Cell Transplantation|0
836470|NCT01079936|2657354|P3|Phase I: MTD|No Stem Cell Transplantation|0
836471|NCT01079936|2657355|P2|Phase I: MTD|No Stem Cell Transplantation|0
836472|NCT01079936|2657356|P1|Phase I: MTD|No Stem Cell Transplantation|2
836473|NCT01079936|2657352|P5|Phase I: MTD|First Remission Status|0
836474|NCT01079936|2657353|P4|Phase I: MTD|First Remission Status|0
836475|NCT01079936|2657354|P3|Phase I: MTD|First Remission Status|0
836476|NCT01079936|2657355|P2|Phase I: MTD|First Remission Status|0
836477|NCT01079936|2657356|P1|Phase I: MTD|First Remission Status|2
836478|NCT01079949|2657377|P2|Overall Study|Randomized but not treated|0
836479|NCT01079949|2657378|P1|Overall Study|Randomized but not treated|1
836480|NCT01079949|2657377|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
836481|NCT01079949|2657378|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
836482|NCT01079949|2657377|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
836483|NCT01079949|2657378|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
836484|NCT01079949|2657377|P2|Overall Study|Withdrawal before r-hCG administration|3
836485|NCT01079949|2657378|P1|Overall Study|Withdrawal before r-hCG administration|2
836486|NCT01079962|2657422|P2|Overall Study|Due to arrhythmia/bradycardia|1
836487|NCT01079962|2657423|P1|Overall Study|Due to arrhythmia/bradycardia|1
836488|NCT01079962|2657422|P2|Overall Study|Participant not returning for next visit|0
836489|NCT01079962|2657423|P1|Overall Study|Participant not returning for next visit|1
836490|NCT01079962|2657422|P2|Overall Study|Inclusion/exclusion criteria|3
836491|NCT01079962|2657423|P1|Overall Study|Inclusion/exclusion criteria|1
836492|NCT01079962|2657422|P2|Overall Study|No blood pressure (BP) control|0
836493|NCT01079962|2657423|P1|Overall Study|No blood pressure (BP) control|3
836494|NCT01079962|2657422|P2|Overall Study|Protocol Violation|2
836495|NCT01079962|2657423|P1|Overall Study|Protocol Violation|2
836496|NCT01079962|2657422|P2|Overall Study|Withdrawal by Subject|7
836497|NCT01079962|2657423|P1|Overall Study|Withdrawal by Subject|5
836498|NCT01079962|2657422|P2|Overall Study|Adverse Event|2
836499|NCT01079962|2657423|P1|Overall Study|Adverse Event|2
836500|NCT01079988|2657454|P5|Overall Study|Other|1
836501|NCT01079988|2657455|P4|Overall Study|Other|2
836502|NCT01079988|2657456|P3|Overall Study|Other|0
836503|NCT01079988|2657457|P2|Overall Study|Other|0
836504|NCT01079988|2657458|P1|Overall Study|Other|0
836505|NCT01079988|2657454|P5|Overall Study|Lack of Efficacy|0
836506|NCT01079988|2657455|P4|Overall Study|Lack of Efficacy|0
836507|NCT01079988|2657456|P3|Overall Study|Lack of Efficacy|0
836508|NCT01079988|2657457|P2|Overall Study|Lack of Efficacy|0
836509|NCT01079988|2657458|P1|Overall Study|Lack of Efficacy|1
836510|NCT01079988|2657454|P5|Overall Study|Lost to Follow-up|0
836511|NCT01079988|2657455|P4|Overall Study|Lost to Follow-up|1
836512|NCT01079988|2657456|P3|Overall Study|Lost to Follow-up|0
836513|NCT01079988|2657457|P2|Overall Study|Lost to Follow-up|0
836514|NCT01079988|2657458|P1|Overall Study|Lost to Follow-up|0
836515|NCT01080131|2657490|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
836516|NCT01080131|2657491|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
836517|NCT01080131|2657490|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
836518|NCT01080131|2657491|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
836519|NCT01080131|2657490|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
836520|NCT01080131|2657491|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
836521|NCT01080131|2657490|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
836522|NCT01080131|2657491|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
836523|NCT01080131|2657490|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
836524|NCT01080131|2657491|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
836525|NCT01080131|2657490|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
836526|NCT01080131|2657491|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
836527|NCT01080131|2657490|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
836528|NCT01080131|2657491|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
836529|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
836530|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
836531|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Death|0
836532|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Death|1
836533|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Administrative problems|1
836534|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Administrative problems|0
836535|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
836536|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
836537|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
836538|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
836539|NCT01080131|2657490|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
836540|NCT01080131|2657491|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
836541|NCT01080300|2657628|P2|Overall Study|Reasons not specified|6
836542|NCT01080300|2657629|P1|Overall Study|Reasons not specified|4
836543|NCT01080300|2657628|P2|Overall Study|Withdrawal by Subject|28
836544|NCT01080300|2657629|P1|Overall Study|Withdrawal by Subject|12
836545|NCT01080300|2657628|P2|Overall Study|Death|1
836546|NCT01080300|2657629|P1|Overall Study|Death|0
836547|NCT01080300|2657628|P2|Overall Study|Lost to Follow-up|6
836548|NCT01080300|2657629|P1|Overall Study|Lost to Follow-up|10
836549|NCT01080300|2657628|P2|Overall Study|Protocol Violation|13
836550|NCT01080300|2657629|P1|Overall Study|Protocol Violation|7
836551|NCT01080300|2657628|P2|Overall Study|Lack of Efficacy|15
836552|NCT01080300|2657629|P1|Overall Study|Lack of Efficacy|12
836553|NCT01080300|2657628|P2|Overall Study|Adverse Event|35
836554|NCT01080300|2657629|P1|Overall Study|Adverse Event|49
836555|NCT01080326|2657637|P1|Overall Study|Surgeon decision|1
836556|NCT01080326|2657637|P1|Overall Study|Patient deterioration prior to procedure|3
836561|NCT01080625|2657665|P3|Overall Study|Physician Decision|1
836562|NCT01080625|2657666|P2|Overall Study|Physician Decision|2
836563|NCT01080625|2657667|P1|Overall Study|Physician Decision|0
836564|NCT01080768|2657699|P2|Overall Study|Protocol Deviation|1
836565|NCT01080768|2657700|P1|Overall Study|Protocol Deviation|2
836566|NCT01080807|2657761|P2|Overall Study|Moved away without notifying center|0
836567|NCT01080807|2657762|P1|Overall Study|Moved away without notifying center|1
836568|NCT01080807|2657761|P2|Overall Study|Switched to first shift|0
836569|NCT01080807|2657762|P1|Overall Study|Switched to first shift|1
836570|NCT01080807|2657761|P2|Overall Study|Work schedule and travel|1
836571|NCT01080807|2657762|P1|Overall Study|Work schedule and travel|0
836572|NCT01080807|2657761|P2|Overall Study|Work schedule changing|1
836573|NCT01080807|2657762|P1|Overall Study|Work schedule changing|1
836574|NCT01080807|2657761|P2|Overall Study|Stopped working consistent night shifts|1
836575|NCT01080807|2657762|P1|Overall Study|Stopped working consistent night shifts|0
836576|NCT01080807|2657761|P2|Overall Study|Laid off or terminated from job|2
836577|NCT01080807|2657762|P1|Overall Study|Laid off or terminated from job|1
836578|NCT01080807|2657761|P2|Overall Study|Began working day shift|2
836579|NCT01080807|2657762|P1|Overall Study|Began working day shift|0
836580|NCT01080807|2657761|P2|Overall Study|Noncompliance to study procedures|1
836581|NCT01080807|2657762|P1|Overall Study|Noncompliance to study procedures|1
836582|NCT01080807|2657761|P2|Overall Study|Noncompliance with drug administration|1
836583|NCT01080807|2657762|P1|Overall Study|Noncompliance with drug administration|1
836584|NCT01080807|2657761|P2|Overall Study|Lost to Follow-up|4
836585|NCT01080807|2657762|P1|Overall Study|Lost to Follow-up|6
836586|NCT01080807|2657761|P2|Overall Study|Protocol Violation|6
836587|NCT01080807|2657762|P1|Overall Study|Protocol Violation|7
836588|NCT01080807|2657761|P2|Overall Study|Withdrawal by Subject|2
836589|NCT01080807|2657762|P1|Overall Study|Withdrawal by Subject|7
836590|NCT01080807|2657761|P2|Overall Study|Lack of Efficacy|1
836591|NCT01080807|2657762|P1|Overall Study|Lack of Efficacy|0
836592|NCT01080807|2657761|P2|Overall Study|Adverse Event|1
836593|NCT01080807|2657762|P1|Overall Study|Adverse Event|9
836594|NCT01074931|2657816|P1|Overall Study|Death|5
836595|NCT01074931|2657816|P1|Overall Study|Economic reasons|1
836596|NCT01074944|2657828|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
836597|NCT01074944|2657829|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
836598|NCT01074944|2657830|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
836599|NCT01074944|2657831|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
836600|NCT01074944|2657832|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
836601|NCT01074944|2657828|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
836602|NCT01074944|2657829|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
836603|NCT01074944|2657830|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
836604|NCT01074944|2657831|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
836605|NCT01074944|2657832|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
836606|NCT01074944|2657828|P5|Long Term Treatment|Withdrawal by Subject|0
836607|NCT01074944|2657829|P4|Long Term Treatment|Withdrawal by Subject|2
836608|NCT01074944|2657830|P3|Long Term Treatment|Withdrawal by Subject|0
836609|NCT01074944|2657831|P2|Long Term Treatment|Withdrawal by Subject|0
836610|NCT01074944|2657832|P1|Long Term Treatment|Withdrawal by Subject|0
836611|NCT01074944|2657828|P5|Long Term Treatment|Entered in Period, But Not Treated|0
836612|NCT01074944|2657829|P4|Long Term Treatment|Entered in Period, But Not Treated|1
836613|NCT01074944|2657830|P3|Long Term Treatment|Entered in Period, But Not Treated|0
836614|NCT01074944|2657831|P2|Long Term Treatment|Entered in Period, But Not Treated|0
836615|NCT01074944|2657832|P1|Long Term Treatment|Entered in Period, But Not Treated|0
836616|NCT01074944|2657828|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
836617|NCT01074944|2657829|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
836618|NCT01074944|2657830|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
836619|NCT01074944|2657831|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
836620|NCT01074944|2657832|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
836621|NCT01074944|2657828|P5|Long Term Treatment|Lost to Follow-up|0
836622|NCT01074944|2657829|P4|Long Term Treatment|Lost to Follow-up|2
836623|NCT01074944|2657830|P3|Long Term Treatment|Lost to Follow-up|0
836624|NCT01074944|2657831|P2|Long Term Treatment|Lost to Follow-up|0
836625|NCT01074944|2657832|P1|Long Term Treatment|Lost to Follow-up|0
836626|NCT01074944|2657828|P5|Long Term Treatment|Adverse Event|0
836627|NCT01074944|2657829|P4|Long Term Treatment|Adverse Event|3
836628|NCT01074944|2657830|P3|Long Term Treatment|Adverse Event|0
836629|NCT01074944|2657831|P2|Long Term Treatment|Adverse Event|0
836630|NCT01074944|2657832|P1|Long Term Treatment|Adverse Event|0
836631|NCT01074944|2657828|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
836632|NCT01074944|2657829|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
836633|NCT01074944|2657830|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
836634|NCT01074944|2657831|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
836635|NCT01074944|2657832|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
836636|NCT01074944|2657828|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
836637|NCT01074944|2657829|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
836638|NCT01074944|2657830|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
836639|NCT01074944|2657831|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
836640|NCT01074944|2657832|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
836641|NCT01074944|2657828|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
836642|NCT01074944|2657829|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
836643|NCT01074944|2657830|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
836644|NCT01074944|2657831|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
836645|NCT01074944|2657832|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
836646|NCT01074944|2657828|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
836647|NCT01074944|2657829|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
836648|NCT01074944|2657830|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
836649|NCT01074944|2657831|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
836650|NCT01074944|2657832|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
836651|NCT01074944|2657828|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
836652|NCT01074944|2657829|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
836653|NCT01074944|2657830|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
836654|NCT01074944|2657831|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
836655|NCT01074944|2657832|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
836656|NCT01074944|2657828|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
836657|NCT01074944|2657829|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
836658|NCT01074944|2657830|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
836659|NCT01074944|2657831|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
836660|NCT01074944|2657832|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
836661|NCT01074944|2657828|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
836662|NCT01074944|2657829|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
836663|NCT01074944|2657830|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
836664|NCT01074944|2657831|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
836665|NCT01074944|2657832|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
836666|NCT01074944|2657828|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
836667|NCT01074944|2657829|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
836668|NCT01074944|2657830|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
836669|NCT01074944|2657831|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
836670|NCT01074944|2657832|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
836671|NCT01074944|2657828|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
836672|NCT01074944|2657829|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
836673|NCT01074944|2657830|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
836674|NCT01074944|2657831|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
836675|NCT01074944|2657832|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
836676|NCT01081132|2657921|P2|Overall Study|Protocol Violation|1
836677|NCT01081132|2657922|P1|Overall Study|Protocol Violation|3
836678|NCT01081132|2657921|P2|Overall Study|Declined Taper Phase|1
836679|NCT01081132|2657922|P1|Overall Study|Declined Taper Phase|0
836680|NCT01081132|2657921|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
836681|NCT01081132|2657922|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
836682|NCT01081132|2657921|P2|Overall Study|Stopped Taking Meds|0
836683|NCT01081132|2657922|P1|Overall Study|Stopped Taking Meds|2
836684|NCT01081132|2657921|P2|Overall Study|Missed Visits|1
836685|NCT01081132|2657922|P1|Overall Study|Missed Visits|1
836686|NCT01081132|2657921|P2|Overall Study|Lack Of Compliance|1
836687|NCT01081132|2657922|P1|Overall Study|Lack Of Compliance|0
836688|NCT01081132|2657921|P2|Overall Study|Non Compliance|2
836689|NCT01081132|2657922|P1|Overall Study|Non Compliance|4
836690|NCT01081132|2657921|P2|Overall Study|Adverse Event|9
836691|NCT01081132|2657922|P1|Overall Study|Adverse Event|3
836692|NCT01081132|2657921|P2|Overall Study|Lost to Follow-up|11
836693|NCT01081132|2657922|P1|Overall Study|Lost to Follow-up|4
836694|NCT01081132|2657921|P2|Overall Study|Withdrawal by Subject|16
836695|NCT01081132|2657922|P1|Overall Study|Withdrawal by Subject|13
836696|NCT01081132|2657921|P2|Overall Study|Lack of Efficacy|9
836697|NCT01081132|2657922|P1|Overall Study|Lack of Efficacy|25
836698|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
836699|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
836781|NCT01081912|2658110|P3|Conversion/Titration|Adverse Event|0
836700|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
836701|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
836702|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
836703|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
836704|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
836705|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
836706|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
836707|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
836708|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
836709|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
836710|NCT01081145|2657960|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
836711|NCT01081145|2657961|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
836712|NCT01081145|2657960|P2|Open-Label Phase|Protocol Violation|0
836713|NCT01081145|2657961|P1|Open-Label Phase|Protocol Violation|4
836714|NCT01081145|2657960|P2|Open-Label Phase|Lost to Follow-up|0
836715|NCT01081145|2657961|P1|Open-Label Phase|Lost to Follow-up|11
836716|NCT01081145|2657960|P2|Open-Label Phase|Not specified|0
836717|NCT01081145|2657961|P1|Open-Label Phase|Not specified|12
836718|NCT01081145|2657960|P2|Open-Label Phase|Withdrawal by Subject|0
836719|NCT01081145|2657961|P1|Open-Label Phase|Withdrawal by Subject|41
836720|NCT01081145|2657960|P2|Open-Label Phase|Adverse Event|0
836721|NCT01081145|2657961|P1|Open-Label Phase|Adverse Event|42
836722|NCT01081145|2657960|P2|Open-Label Phase|Response criteria not met|0
836723|NCT01081145|2657961|P1|Open-Label Phase|Response criteria not met|46
836724|NCT01081145|2657960|P2|Open-Label Phase|Lack of Efficacy|0
836725|NCT01081145|2657961|P1|Open-Label Phase|Lack of Efficacy|56
836726|NCT01081249|2657987|P2|Overall Study|Diagnosed with Bipolar Disorder|1
836727|NCT01081249|2657988|P1|Overall Study|Diagnosed with Bipolar Disorder|0
836728|NCT01081301|2657994|P1|Overall Study|Lost to Follow-up|4
836729|NCT01081301|2657994|P1|Overall Study|Patient too ill|2
836730|NCT01081301|2657994|P1|Overall Study|Too busy|5
836731|NCT01081301|2657994|P1|Overall Study|Bereaved|3
836732|NCT01081873|2658032|P1|Overall Study|Other|47
836733|NCT01081873|2658032|P1|Overall Study|Progression of prostate cancer|13
836734|NCT01081873|2658032|P1|Overall Study|Lost to Follow-up|142
836735|NCT01081873|2658032|P1|Overall Study|Withdrawal by Subject|10
836736|NCT01081873|2658032|P1|Overall Study|Death|86
836737|NCT01081886|2658101|P2|Overall Study|Study termination|13
836738|NCT01081886|2658102|P1|Overall Study|Study termination|11
836739|NCT01081912|2658110|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
836740|NCT01081912|2658111|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
836741|NCT01081912|2658112|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
836742|NCT01081912|2658110|P3|Maintenance Treatment|Non-Compliance|7
836743|NCT01081912|2658111|P2|Maintenance Treatment|Non-Compliance|4
836744|NCT01081912|2658112|P1|Maintenance Treatment|Non-Compliance|0
836745|NCT01081912|2658110|P3|Maintenance Treatment|Withdrawal by Subject|5
836746|NCT01081912|2658111|P2|Maintenance Treatment|Withdrawal by Subject|5
836747|NCT01081912|2658112|P1|Maintenance Treatment|Withdrawal by Subject|0
836748|NCT01081912|2658110|P3|Maintenance Treatment|Protocol Violation|2
836749|NCT01081912|2658111|P2|Maintenance Treatment|Protocol Violation|1
836750|NCT01081912|2658112|P1|Maintenance Treatment|Protocol Violation|0
836751|NCT01081912|2658110|P3|Maintenance Treatment|Physician Decision|1
836752|NCT01081912|2658111|P2|Maintenance Treatment|Physician Decision|0
836753|NCT01081912|2658112|P1|Maintenance Treatment|Physician Decision|0
836754|NCT01081912|2658110|P3|Maintenance Treatment|Lost to Follow-up|0
836755|NCT01081912|2658111|P2|Maintenance Treatment|Lost to Follow-up|1
836756|NCT01081912|2658112|P1|Maintenance Treatment|Lost to Follow-up|0
836757|NCT01081912|2658110|P3|Maintenance Treatment|Lack of Efficacy|64
836758|NCT01081912|2658111|P2|Maintenance Treatment|Lack of Efficacy|14
836759|NCT01081912|2658112|P1|Maintenance Treatment|Lack of Efficacy|0
836760|NCT01081912|2658110|P3|Maintenance Treatment|Adverse Event|12
836761|NCT01081912|2658111|P2|Maintenance Treatment|Adverse Event|2
836762|NCT01081912|2658112|P1|Maintenance Treatment|Adverse Event|0
836763|NCT01081912|2658110|P3|Conversion/Titration|Non-Compliance|0
836764|NCT01081912|2658111|P2|Conversion/Titration|Non-Compliance|0
836765|NCT01081912|2658112|P1|Conversion/Titration|Non-Compliance|47
836766|NCT01081912|2658110|P3|Conversion/Titration|Withdrawal by Subject|0
836767|NCT01081912|2658111|P2|Conversion/Titration|Withdrawal by Subject|0
836768|NCT01081912|2658112|P1|Conversion/Titration|Withdrawal by Subject|23
836769|NCT01081912|2658110|P3|Conversion/Titration|Protocol Violation|0
836770|NCT01081912|2658111|P2|Conversion/Titration|Protocol Violation|0
836771|NCT01081912|2658112|P1|Conversion/Titration|Protocol Violation|67
836772|NCT01081912|2658110|P3|Conversion/Titration|Physician Decision|0
836773|NCT01081912|2658111|P2|Conversion/Titration|Physician Decision|0
836774|NCT01081912|2658112|P1|Conversion/Titration|Physician Decision|2
836775|NCT01081912|2658110|P3|Conversion/Titration|Lost to Follow-up|0
836776|NCT01081912|2658111|P2|Conversion/Titration|Lost to Follow-up|0
836777|NCT01081912|2658112|P1|Conversion/Titration|Lost to Follow-up|5
836778|NCT01081912|2658110|P3|Conversion/Titration|Lack of Efficacy|0
836779|NCT01081912|2658111|P2|Conversion/Titration|Lack of Efficacy|0
836780|NCT01081912|2658112|P1|Conversion/Titration|Lack of Efficacy|17
836782|NCT01081912|2658111|P2|Conversion/Titration|Adverse Event|0
836783|NCT01081912|2658112|P1|Conversion/Titration|Adverse Event|47
836784|NCT01081951|2658121|P2|Overall Study|Lost to Follow-up|1
836785|NCT01081951|2658122|P1|Overall Study|Lost to Follow-up|0
836786|NCT01081951|2658121|P2|Overall Study|Allocated treatment but did not take it|1
836787|NCT01081951|2658122|P1|Overall Study|Allocated treatment but did not take it|0
836788|NCT01081951|2658121|P2|Overall Study|Withdrawal by Subject|6
836789|NCT01081951|2658122|P1|Overall Study|Withdrawal by Subject|2
836790|NCT01081951|2658121|P2|Overall Study|Death|47
836791|NCT01081951|2658122|P1|Overall Study|Death|54
836792|NCT01082081|2658135|P3|Overall Study|Other Reason|0
836793|NCT01082081|2658136|P2|Overall Study|Other Reason|1
836794|NCT01082081|2658137|P1|Overall Study|Other Reason|0
836795|NCT01082081|2658135|P3|Overall Study|Withdrawal by Subject|1
836796|NCT01082081|2658136|P2|Overall Study|Withdrawal by Subject|0
836797|NCT01082081|2658137|P1|Overall Study|Withdrawal by Subject|0
836798|NCT01082081|2658135|P3|Overall Study|Lost to Follow-up|1
836799|NCT01082081|2658136|P2|Overall Study|Lost to Follow-up|0
836800|NCT01082081|2658137|P1|Overall Study|Lost to Follow-up|0
836801|NCT01082211|2658193|P1|Overall Study|No protocol treatment received|3
836802|NCT01082211|2658193|P1|Overall Study|Protocol Violation|4
836803|NCT01082328|2658204|P1|Overall Study|Adverse Event|1
836804|NCT01082367|2658215|P2|Follow-up (F-U) Period|Adverse Event|1
836805|NCT01082367|2658216|P1|Follow-up (F-U) Period|Adverse Event|0
836806|NCT01082367|2658215|P2|Follow-up (F-U) Period|Abnormal lab values|0
836807|NCT01082367|2658216|P1|Follow-up (F-U) Period|Abnormal lab values|1
836808|NCT01082367|2658215|P2|Follow-up (F-U) Period|Administrative problems|0
836809|NCT01082367|2658216|P1|Follow-up (F-U) Period|Administrative problems|1
836810|NCT01082367|2658215|P2|Double-blind Period|Adverse Event|1
836811|NCT01082367|2658216|P1|Double-blind Period|Adverse Event|0
836812|NCT01082367|2658215|P2|Double-blind Period|Lack of Efficacy|11
836813|NCT01082367|2658216|P1|Double-blind Period|Lack of Efficacy|5
836814|NCT01082367|2658215|P2|Double-blind Period|Administrative problems|1
836815|NCT01082367|2658216|P1|Double-blind Period|Administrative problems|0
836822|NCT01082640|2658301|P3|Overall Study|Other|3
836823|NCT01082640|2658302|P2|Overall Study|Other|1
836824|NCT01082640|2658303|P1|Overall Study|Other|2
836825|NCT01082640|2658301|P3|Overall Study|Lost to Follow-up|0
836826|NCT01082640|2658302|P2|Overall Study|Lost to Follow-up|3
836827|NCT01082640|2658303|P1|Overall Study|Lost to Follow-up|0
836828|NCT01082640|2658301|P3|Overall Study|Major protocol deviation|0
836829|NCT01082640|2658302|P2|Overall Study|Major protocol deviation|3
836830|NCT01082640|2658303|P1|Overall Study|Major protocol deviation|3
836831|NCT01082640|2658301|P3|Overall Study|Withdrawal by Subject|2
836832|NCT01082640|2658302|P2|Overall Study|Withdrawal by Subject|3
836833|NCT01082640|2658303|P1|Overall Study|Withdrawal by Subject|3
836834|NCT01082640|2658301|P3|Overall Study|Adverse Event|3
836835|NCT01082640|2658302|P2|Overall Study|Adverse Event|5
836836|NCT01082640|2658303|P1|Overall Study|Adverse Event|9
836837|NCT01082874|2658327|P4|Overall Study|Withdrawal by Subject|3
836838|NCT01082874|2658328|P3|Overall Study|Withdrawal by Subject|5
836839|NCT01082874|2658329|P2|Overall Study|Withdrawal by Subject|2
836840|NCT01082874|2658330|P1|Overall Study|Withdrawal by Subject|1
836841|NCT01082874|2658327|P4|Overall Study|Lost to Follow-up|10
836842|NCT01082874|2658328|P3|Overall Study|Lost to Follow-up|6
836843|NCT01082874|2658329|P2|Overall Study|Lost to Follow-up|10
836844|NCT01082874|2658330|P1|Overall Study|Lost to Follow-up|10
836845|NCT01082965|2658357|P2|Overall Study|Unspecified|1
836846|NCT01082965|2658358|P1|Overall Study|Unspecified|1
836847|NCT01082965|2658357|P2|Overall Study|Protocol Violation|1
836848|NCT01082965|2658358|P1|Overall Study|Protocol Violation|0
836849|NCT01083121|2658376|P1|Overall Study|Use of Humira outside the approved label|81
836850|NCT01083160|2658384|P1|Overall Study|Adverse Event|1
836851|NCT01083173|2658391|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
836852|NCT01083173|2658392|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
836853|NCT01083173|2658391|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
836854|NCT01083173|2658392|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
836855|NCT01083173|2658391|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
836856|NCT01083173|2658392|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
836857|NCT01083173|2658391|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
836858|NCT01083173|2658392|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
836859|NCT01083173|2658391|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
836860|NCT01083173|2658392|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
836861|NCT01083173|2658391|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
836862|NCT01083173|2658392|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
836863|NCT01083173|2658391|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
836864|NCT01083173|2658392|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
836865|NCT01083173|2658391|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
836866|NCT01083173|2658392|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
836867|NCT01083173|2658391|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
836868|NCT01083173|2658392|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
836869|NCT01083173|2658391|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
836870|NCT01083173|2658392|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
836871|NCT01083173|2658391|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
836872|NCT01083173|2658392|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
836873|NCT01083186|2658410|P1|Overall Study|Non-compliance to Study Treatment|1
836874|NCT01083186|2658410|P1|Overall Study|Administrative Reasons|2
836875|NCT01083186|2658410|P1|Overall Study|Hemodialysis Initiation|28
836876|NCT01083186|2658410|P1|Overall Study|Lack of Efficacy|2
836877|NCT01083186|2658410|P1|Overall Study|Adverse Event|3
836878|NCT01083186|2658410|P1|Overall Study|Death|3
836879|NCT01083186|2658410|P1|Overall Study|Consent Withdrawal|7
836880|NCT01083186|2658410|P1|Overall Study|Lost to Follow-up|48
836881|NCT01083316|2658456|P1|Overall Study|Withdrawal by Subject|1
836882|NCT01083316|2658456|P1|Overall Study|Adverse Event|2
836883|NCT01083485|2658473|P2|Overall Study|Other|0
836884|NCT01083485|2658474|P1|Overall Study|Other|1
836885|NCT01083485|2658473|P2|Overall Study|Withdrawal by Subject|2
836886|NCT01083485|2658474|P1|Overall Study|Withdrawal by Subject|5
836887|NCT01083485|2658473|P2|Overall Study|Protocol Violation|0
836888|NCT01083485|2658474|P1|Overall Study|Protocol Violation|1
836889|NCT01083485|2658473|P2|Overall Study|Adverse Event|1
836890|NCT01083485|2658474|P1|Overall Study|Adverse Event|0
836891|NCT01083576|2658484|P2|Overall Study|Treatment Failure|1
836892|NCT01083576|2658485|P1|Overall Study|Treatment Failure|6
836893|NCT01083602|2658513|P1|Overall Study|Lack of Efficacy|36
836894|NCT01083602|2658513|P1|Overall Study|Withdrawal by Subject|5
836895|NCT01083602|2658513|P1|Overall Study|Death|1
836896|NCT01083602|2658513|P1|Overall Study|New Cancer Therapy|2
836897|NCT01083602|2658513|P1|Overall Study|Adverse Event|11
836898|NCT01083641|2658522|P1|Overall Study|Withdrawal by Subject|2
836899|NCT01083680|2658543|P1|Overall Study|Withdrawal by Subject|1086
836900|NCT01083680|2658543|P1|Overall Study|Lost to Follow-up|2758
836901|NCT01083693|2658555|P3|Overall Study|Reason unknown|1
836902|NCT01083693|2658556|P2|Overall Study|Reason unknown|0
836903|NCT01083693|2658557|P1|Overall Study|Reason unknown|0
836904|NCT01083693|2658555|P3|Overall Study|Withdrawal by Subject|2
836905|NCT01083693|2658556|P2|Overall Study|Withdrawal by Subject|0
836906|NCT01083693|2658557|P1|Overall Study|Withdrawal by Subject|3
836907|NCT01083693|2658555|P3|Overall Study|Other medical condition/surgery|0
836908|NCT01083693|2658556|P2|Overall Study|Other medical condition/surgery|1
836909|NCT01083693|2658557|P1|Overall Study|Other medical condition/surgery|1
836910|NCT01083693|2658555|P3|Overall Study|Complete remission|0
836911|NCT01083693|2658556|P2|Overall Study|Complete remission|1
836912|NCT01083693|2658557|P1|Overall Study|Complete remission|0
836913|NCT01083693|2658555|P3|Overall Study|Patient Moved|0
836914|NCT01083693|2658556|P2|Overall Study|Patient Moved|1
836915|NCT01083693|2658557|P1|Overall Study|Patient Moved|0
836916|NCT01083693|2658555|P3|Overall Study|Lack of effectiveness|2
836917|NCT01083693|2658556|P2|Overall Study|Lack of effectiveness|2
836918|NCT01083693|2658557|P1|Overall Study|Lack of effectiveness|13
836919|NCT01083693|2658555|P3|Overall Study|Lost to Follow-up|2
836920|NCT01083693|2658556|P2|Overall Study|Lost to Follow-up|0
836921|NCT01083693|2658557|P1|Overall Study|Lost to Follow-up|2
836922|NCT01083693|2658555|P3|Overall Study|Adverse Event|0
836923|NCT01083693|2658556|P2|Overall Study|Adverse Event|1
836924|NCT01083693|2658557|P1|Overall Study|Adverse Event|1
836925|NCT01083771|2658685|P1|Overall Study|Withdrawal by Subject|3
836926|NCT01083771|2658685|P1|Overall Study|non-compliant|2
836927|NCT01083810|2658693|P3|Overall Study|Virologic failure|0
836928|NCT01083810|2658694|P2|Overall Study|Virologic failure|8
836929|NCT01083810|2658695|P1|Overall Study|Virologic failure|1
836930|NCT01083810|2658693|P3|Overall Study|Therapy break|2
836931|NCT01083810|2658694|P2|Overall Study|Therapy break|2
836932|NCT01083810|2658695|P1|Overall Study|Therapy break|1
836933|NCT01083810|2658693|P3|Overall Study|Participation in study|0
836934|NCT01083810|2658694|P2|Overall Study|Participation in study|0
836935|NCT01083810|2658695|P1|Overall Study|Participation in study|1
836936|NCT01083810|2658693|P3|Overall Study|Co-morbidities|0
836937|NCT01083810|2658694|P2|Overall Study|Co-morbidities|0
836938|NCT01083810|2658695|P1|Overall Study|Co-morbidities|1
836939|NCT01083810|2658693|P3|Overall Study|Death|3
836940|NCT01083810|2658694|P2|Overall Study|Death|2
836941|NCT01083810|2658695|P1|Overall Study|Death|2
836942|NCT01083810|2658693|P3|Overall Study|Simplification|0
836943|NCT01083810|2658694|P2|Overall Study|Simplification|1
836944|NCT01083810|2658695|P1|Overall Study|Simplification|4
836945|NCT01083810|2658693|P3|Overall Study|Non-compliance|2
836946|NCT01083810|2658694|P2|Overall Study|Non-compliance|7
836947|NCT01083810|2658695|P1|Overall Study|Non-compliance|4
836948|NCT01083810|2658693|P3|Overall Study|Reason not reported|1
836949|NCT01083810|2658694|P2|Overall Study|Reason not reported|1
836950|NCT01083810|2658695|P1|Overall Study|Reason not reported|6
836951|NCT01083810|2658693|P3|Overall Study|Withdrawal by Subject|4
836952|NCT01083810|2658694|P2|Overall Study|Withdrawal by Subject|2
836953|NCT01083810|2658695|P1|Overall Study|Withdrawal by Subject|7
836954|NCT01083810|2658693|P3|Overall Study|Adverse Event|4
836955|NCT01083810|2658694|P2|Overall Study|Adverse Event|11
836956|NCT01083810|2658695|P1|Overall Study|Adverse Event|15
836957|NCT01083810|2658693|P3|Overall Study|Lost to Follow-up|4
836958|NCT01083810|2658694|P2|Overall Study|Lost to Follow-up|11
836959|NCT01083810|2658695|P1|Overall Study|Lost to Follow-up|23
836960|NCT01084005|2658768|P2|Overall Study|Withdrawal by Subject|1
836961|NCT01084005|2658769|P1|Overall Study|Withdrawal by Subject|1
836962|NCT01084005|2658768|P2|Overall Study|Protocol Violation|7
836963|NCT01084005|2658769|P1|Overall Study|Protocol Violation|3
836964|NCT01084005|2658768|P2|Overall Study|Adverse Event|8
836965|NCT01084005|2658769|P1|Overall Study|Adverse Event|1
836966|NCT01084083|2658797|P1|Overall Study|Never started assigned therapy|1
836967|NCT01084083|2658797|P1|Overall Study|Other|2
836968|NCT01084083|2658797|P1|Overall Study|Complicating disease|1
836969|NCT01084083|2658797|P1|Overall Study|Withdrawal by Subject|2
836970|NCT01084083|2658797|P1|Overall Study|Death|1
836971|NCT01084083|2658797|P1|Overall Study|Adverse Event|5
836972|NCT01084135|2658807|P2|20 Week|Physician Decision|1
836973|NCT01084135|2658808|P1|20 Week|Physician Decision|0
836974|NCT01084174|2658829|P2|Overall Study|Participant noncompliance|1
836975|NCT01084174|2658830|P1|Overall Study|Participant noncompliance|0
836976|NCT01084174|2658829|P2|Overall Study|Anaphylaxis|1
836977|NCT01084174|2658830|P1|Overall Study|Anaphylaxis|0
836978|NCT01084174|2658829|P2|Overall Study|Eosinophilic esophagitis|1
836979|NCT01084174|2658830|P1|Overall Study|Eosinophilic esophagitis|0
836980|NCT01084174|2658829|P2|Overall Study|gastrointestinal symptoms|1
836981|NCT01084174|2658830|P1|Overall Study|gastrointestinal symptoms|1
836982|NCT01084239|2658850|P2|28-Day Follow-up|Lost to Follow-up|9
836983|NCT01084239|2658851|P1|28-Day Follow-up|Lost to Follow-up|4
836984|NCT01077960|2659002|P1|Overall Study|Reason unspecified|1
836985|NCT01077960|2659002|P1|Overall Study|Subject decision|1
836986|NCT01077960|2659002|P1|Overall Study|Lost to Follow-up|5
836987|NCT01077960|2659002|P1|Overall Study|Protocol Violation|3
836988|NCT01077960|2659002|P1|Overall Study|Adverse Event|6
836989|NCT01078090|2659064|P1|Overall Study|Other|523
836990|NCT01078090|2659064|P1|Overall Study|ADR and lack of efficacy|61
836991|NCT01078090|2659064|P1|Overall Study|Lack of Efficacy|1193
836992|NCT01078090|2659064|P1|Overall Study|Adverse drug reaction (ADR)|453
836993|NCT01078090|2659064|P1|Overall Study|Lost to Follow-up|2363
836994|NCT01078116|2659105|P1|Overall Study|Case report form not completed|3
836995|NCT01078116|2659105|P1|Overall Study|Lack of effectiveness|15
836996|NCT01078116|2659105|P1|Overall Study|Withdrawal by Subject|8
836997|NCT01078116|2659105|P1|Overall Study|Adverse Event|5
836998|NCT01078116|2659105|P1|Overall Study|Lost to Follow-up|17
836999|NCT01078155|2659113|P1|Overall Study|Lost to Follow-up|15
837000|NCT01078155|2659113|P1|Overall Study|Participant's Decision|6
837001|NCT01078155|2659113|P1|Overall Study|Lack of Efficacy|16
837002|NCT01078155|2659113|P1|Overall Study|Adverse Event|7
837003|NCT01078298|2659213|P2|Overall Study|Unspecified|32
837004|NCT01078298|2659214|P1|Overall Study|Unspecified|24
837005|NCT01078298|2659213|P2|Overall Study|Did not meet entrance criteria|1
837006|NCT01078298|2659214|P1|Overall Study|Did not meet entrance criteria|0
837007|NCT01078298|2659213|P2|Overall Study|Death|0
837008|NCT01078298|2659214|P1|Overall Study|Death|2
837009|NCT01078298|2659213|P2|Overall Study|Adverse Event|5
837010|NCT01078298|2659214|P1|Overall Study|Adverse Event|6
837011|NCT01078298|2659213|P2|Overall Study|Protocol Violation|6
837012|NCT01078298|2659214|P1|Overall Study|Protocol Violation|6
837013|NCT01078298|2659213|P2|Overall Study|Withdrawal by Subject|33
837014|NCT01078298|2659214|P1|Overall Study|Withdrawal by Subject|31
837015|NCT01078298|2659213|P2|Overall Study|Lost to Follow-up|13
837016|NCT01078298|2659214|P1|Overall Study|Lost to Follow-up|12
837017|NCT01078389|2659387|P2|Overall Study|Other|2
837018|NCT01078389|2659388|P1|Overall Study|Other|9
837019|NCT01078389|2659387|P2|Overall Study|Voluntary Withdrawal|36
837020|NCT01078389|2659388|P1|Overall Study|Voluntary Withdrawal|20
837021|NCT01078389|2659387|P2|Overall Study|Lost to Follow-up|23
837022|NCT01078389|2659388|P1|Overall Study|Lost to Follow-up|23
837023|NCT01078389|2659387|P2|Overall Study|Major Protocol Deviation|0
837024|NCT01078389|2659388|P1|Overall Study|Major Protocol Deviation|2
837025|NCT01078389|2659387|P2|Overall Study|Adverse Event|6
837026|NCT01078389|2659388|P1|Overall Study|Adverse Event|10
837027|NCT01084538|2659436|P1|Overall Study|Reason unknown|8
837028|NCT01084538|2659436|P1|Overall Study|Over-suppression of parathyroid gland|2
837029|NCT01084538|2659436|P1|Overall Study|Change of residence|2
837030|NCT01084538|2659436|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
837031|NCT01084538|2659436|P1|Overall Study|Hyperphosphatemia|2
837032|NCT01084538|2659436|P1|Overall Study|Patient noncompliance|2
837033|NCT01084538|2659436|P1|Overall Study|Lack of effectiveness|2
837034|NCT01084538|2659436|P1|Overall Study|Serious Adverse Event|3
837035|NCT01084538|2659436|P1|Overall Study|Kidney transplant|6
837036|NCT01084538|2659436|P1|Overall Study|Adverse Event|9
837037|NCT01084538|2659436|P1|Overall Study|Drug not available|30
837038|NCT01084551|2659446|P3|Overall Study|Physician Decision|0
837039|NCT01084551|2659447|P2|Overall Study|Physician Decision|0
837040|NCT01084551|2659448|P1|Overall Study|Physician Decision|1
837041|NCT01084551|2659446|P3|Overall Study|Lost to Follow-up|3
837042|NCT01084551|2659447|P2|Overall Study|Lost to Follow-up|0
837043|NCT01084551|2659448|P1|Overall Study|Lost to Follow-up|0
837044|NCT01084551|2659446|P3|Overall Study|Protocol Violation|0
837045|NCT01084551|2659447|P2|Overall Study|Protocol Violation|4
837046|NCT01084551|2659448|P1|Overall Study|Protocol Violation|2
837047|NCT01084551|2659446|P3|Overall Study|Withdrawal by Subject|0
837048|NCT01084551|2659447|P2|Overall Study|Withdrawal by Subject|1
837049|NCT01084551|2659448|P1|Overall Study|Withdrawal by Subject|2
837050|NCT01084551|2659446|P3|Overall Study|Lack of Efficacy|1
837051|NCT01084551|2659447|P2|Overall Study|Lack of Efficacy|0
837052|NCT01084551|2659448|P1|Overall Study|Lack of Efficacy|2
837053|NCT01084551|2659446|P3|Overall Study|Adverse Event|4
837054|NCT01084551|2659447|P2|Overall Study|Adverse Event|9
837055|NCT01084551|2659448|P1|Overall Study|Adverse Event|2
837056|NCT01084603|2659486|P1|Washout Period 4|Adverse Event|1
837057|NCT01084603|2659486|P1|Oral Nicotine 1|Withdrawal by Subject|1
837058|NCT01084603|2659486|P1|Nicorette® Gum|Withdrawal by Subject|1
837059|NCT01084603|2659486|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
837060|NCT01084603|2659486|P1|Baseline|Withdrawal by Subject|2
837061|NCT01084668|2659519|P1|Overall Study|Non-compliance|1
837062|NCT01084668|2659519|P1|Overall Study|Pregnancy|1
837063|NCT01084668|2659519|P1|Overall Study|Withdrawal by Subject|2
837064|NCT01084668|2659519|P1|Overall Study|Lack of Efficacy|5
893815|NCT01466660|2835874|P2|Overall Study|Other reason not defined above|6
893816|NCT01466660|2835875|P1|Overall Study|Other reason not defined above|3
893817|NCT01466660|2835874|P2|Overall Study|Refused continuation of trial medication|3
893818|NCT01466660|2835875|P1|Overall Study|Refused continuation of trial medication|4
893819|NCT01466660|2835874|P2|Overall Study|Protocol Violation|1
893820|NCT01466660|2835875|P1|Overall Study|Protocol Violation|1
893821|NCT01466660|2835874|P2|Overall Study|Other adverse event|17
893822|NCT01466660|2835875|P1|Overall Study|Other adverse event|18
893823|NCT01466660|2835874|P2|Overall Study|Worsening of underlying cancer disease|2
893824|NCT01466660|2835875|P1|Overall Study|Worsening of underlying cancer disease|5
893825|NCT01466660|2835874|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
893826|NCT01466660|2835875|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
837116|NCT01086410|2659546|P4|Overall Study|Lost to Follow-up|0
837117|NCT01086410|2659547|P3|Overall Study|Lost to Follow-up|1
837118|NCT01086410|2659548|P2|Overall Study|Lost to Follow-up|0
837119|NCT01086410|2659549|P1|Overall Study|Lost to Follow-up|0
837120|NCT01086410|2659546|P4|Overall Study|Protocol Violation|0
837121|NCT01086410|2659547|P3|Overall Study|Protocol Violation|0
837122|NCT01086410|2659548|P2|Overall Study|Protocol Violation|1
837123|NCT01086410|2659549|P1|Overall Study|Protocol Violation|1
837124|NCT01086410|2659546|P4|Overall Study|Lack of Efficacy|0
837125|NCT01086410|2659547|P3|Overall Study|Lack of Efficacy|0
837126|NCT01086410|2659548|P2|Overall Study|Lack of Efficacy|1
837127|NCT01086410|2659549|P1|Overall Study|Lack of Efficacy|1
837128|NCT01086410|2659546|P4|Overall Study|Adverse Event|2
837129|NCT01086410|2659547|P3|Overall Study|Adverse Event|0
837130|NCT01086410|2659548|P2|Overall Study|Adverse Event|0
837131|NCT01086410|2659549|P1|Overall Study|Adverse Event|1
837132|NCT01086423|2659646|P3|Overall Study|Lost to Follow-up|1
837133|NCT01086423|2659647|P2|Overall Study|Lost to Follow-up|0
837134|NCT01086423|2659648|P1|Overall Study|Lost to Follow-up|0
837135|NCT01086423|2659646|P3|Overall Study|Withdrawal by Subject|3
837136|NCT01086423|2659647|P2|Overall Study|Withdrawal by Subject|1
837137|NCT01086423|2659648|P1|Overall Study|Withdrawal by Subject|5
837138|NCT01086423|2659646|P3|Overall Study|Adverse event, non-fatal|0
837139|NCT01086423|2659647|P2|Overall Study|Adverse event, non-fatal|1
837140|NCT01086423|2659648|P1|Overall Study|Adverse event, non-fatal|2
837141|NCT01086423|2659646|P3|Overall Study|Adverse event, fatal|0
837142|NCT01086423|2659647|P2|Overall Study|Adverse event, fatal|1
837143|NCT01086423|2659648|P1|Overall Study|Adverse event, fatal|1
837144|NCT01086423|2659646|P3|Overall Study|Migrated/moved from study area|4
837145|NCT01086423|2659647|P2|Overall Study|Migrated/moved from study area|0
837146|NCT01086423|2659648|P1|Overall Study|Migrated/moved from study area|2
837147|NCT01086423|2659646|P3|Overall Study|Protocol Violation|1
837148|NCT01086423|2659647|P2|Overall Study|Protocol Violation|0
837149|NCT01086423|2659648|P1|Overall Study|Protocol Violation|0
837150|NCT01086969|2659782|P3|Overall Study|Withdrawal by Subject|0
837151|NCT01086969|2659783|P2|Overall Study|Withdrawal by Subject|2
837152|NCT01086969|2659784|P1|Overall Study|Withdrawal by Subject|1
837153|NCT01087489|2659801|P2|Overall Study|unable to survey by telephone|1
837154|NCT01087489|2659802|P1|Overall Study|unable to survey by telephone|0
837155|NCT01087489|2659801|P2|Overall Study|Death|1
837156|NCT01087489|2659802|P1|Overall Study|Death|0
837157|NCT01087489|2659801|P2|Overall Study|enrolled in another VA study|1
837158|NCT01087489|2659802|P1|Overall Study|enrolled in another VA study|0
837159|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
837160|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
837161|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
837162|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
837163|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
837164|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
837165|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
837166|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
837167|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
837168|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
837169|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
837170|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
837171|NCT01087502|2659814|P2|Up to Final Analysis (Week 52)|Adverse Event|10
837172|NCT01087502|2659815|P1|Up to Final Analysis (Week 52)|Adverse Event|17
837173|NCT01087502|2659814|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
837174|NCT01087502|2659815|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
837175|NCT01087502|2659814|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
837176|NCT01087502|2659815|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
837177|NCT01087502|2659814|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
837178|NCT01087502|2659815|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
837179|NCT01087502|2659814|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
837180|NCT01087502|2659815|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
837181|NCT01087502|2659814|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
837182|NCT01087502|2659815|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
837183|NCT01087528|2659834|P1|Overall Study|Incomplete CE procedure|6
837184|NCT01087528|2659834|P1|Overall Study|Withdrawal by Subject|1
837185|NCT01087723|2659859|P2|Overall Study|Reason Not Specified|2
837186|NCT01087723|2659860|P1|Overall Study|Reason Not Specified|1
837187|NCT01087723|2659859|P2|Overall Study|Lost to Follow-up|4
837188|NCT01087723|2659860|P1|Overall Study|Lost to Follow-up|1
837189|NCT01087723|2659859|P2|Overall Study|Physician Decision|0
837190|NCT01087723|2659860|P1|Overall Study|Physician Decision|2
837191|NCT01087723|2659859|P2|Overall Study|Withdrawal by Subject|13
837192|NCT01087723|2659860|P1|Overall Study|Withdrawal by Subject|10
837193|NCT01087723|2659859|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
837194|NCT01087723|2659860|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
837195|NCT01087736|2659884|P2|Overall Study|Withdrawal by Subject|1
837196|NCT01087736|2659885|P1|Overall Study|Withdrawal by Subject|0
837197|NCT01087736|2659884|P2|Overall Study|Death|1
837198|NCT01087736|2659885|P1|Overall Study|Death|0
837199|NCT01087736|2659884|P2|Overall Study|Lost to Follow-up|0
837200|NCT01087736|2659885|P1|Overall Study|Lost to Follow-up|1
837201|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
837202|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
837203|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
837204|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
837205|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
837206|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
837207|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
837208|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
837209|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
837210|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
837211|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
837212|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
837213|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
837214|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
837215|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
837216|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|Unspecified|4
837217|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|Unspecified|2
837218|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|Unspecified|0
837219|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|Unspecified|0
837220|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|Unspecified|0
837221|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
837222|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
837223|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
837224|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
837225|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
837226|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
837227|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
837228|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
837229|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
837230|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
837231|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
837232|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
837233|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
837234|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
837235|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
837236|NCT01087762|2659896|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
837237|NCT01087762|2659897|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
837238|NCT01087762|2659898|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
837239|NCT01087762|2659899|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
837240|NCT01087762|2659900|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
837241|NCT01087762|2659896|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
837242|NCT01087762|2659897|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
837243|NCT01087762|2659898|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
837244|NCT01087762|2659899|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
837245|NCT01087762|2659900|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
837246|NCT01087762|2659896|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
837247|NCT01087762|2659897|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
837248|NCT01087762|2659898|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
837249|NCT01087762|2659899|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
837250|NCT01087762|2659900|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
837251|NCT01087762|2659896|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
837252|NCT01087762|2659897|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
837253|NCT01087762|2659898|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
837254|NCT01087762|2659899|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
837255|NCT01087762|2659900|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
837256|NCT01087762|2659896|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
837257|NCT01087762|2659897|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
837258|NCT01087762|2659898|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
837259|NCT01087762|2659899|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
837260|NCT01087762|2659900|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
837261|NCT01087762|2659896|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
837262|NCT01087762|2659897|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
837263|NCT01087762|2659898|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
837264|NCT01087762|2659899|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
837265|NCT01087762|2659900|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
837266|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Personal reasons|1
837267|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Personal reasons|0
837268|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Personal reasons|0
837269|NCT01087788|2659949|P3|Open-Label Period (OL-P)|No participation in study extension|1
837270|NCT01087788|2659950|P2|Open-Label Period (OL-P)|No participation in study extension|0
837271|NCT01087788|2659951|P1|Open-Label Period (OL-P)|No participation in study extension|0
837272|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Principal investigator decision|2
837273|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Principal investigator decision|1
837274|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Principal investigator decision|0
837275|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Sponsor request|0
837276|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Sponsor request|0
837277|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Sponsor request|1
837278|NCT01087788|2659949|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
837279|NCT01087788|2659950|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
837280|NCT01087788|2659951|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
837281|NCT01087788|2659949|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
837282|NCT01087788|2659950|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
837283|NCT01087788|2659951|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
837284|NCT01087788|2659949|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
837285|NCT01087788|2659950|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
837286|NCT01087788|2659951|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
837287|NCT01087788|2659949|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
837288|NCT01087788|2659950|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
837289|NCT01087788|2659951|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
837290|NCT01087788|2659949|P3|Open-Label Period (OL-P)|AE, serious fatal|1
837291|NCT01087788|2659950|P2|Open-Label Period (OL-P)|AE, serious fatal|0
837292|NCT01087788|2659951|P1|Open-Label Period (OL-P)|AE, serious fatal|2
837293|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
837294|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
837295|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
837296|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
837297|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
837298|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
837299|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Protocol Violation|0
837300|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Protocol Violation|1
837301|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Protocol Violation|2
837302|NCT01087788|2659949|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
837303|NCT01087788|2659950|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
837304|NCT01087788|2659951|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
837305|NCT01087788|2659949|P3|24-weeks Dose-blind Period|Patient moved|1
837306|NCT01087788|2659950|P2|24-weeks Dose-blind Period|Patient moved|0
837307|NCT01087788|2659951|P1|24-weeks Dose-blind Period|Patient moved|0
837308|NCT01087788|2659949|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
837309|NCT01087788|2659950|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
837310|NCT01087788|2659951|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
837311|NCT01087788|2659949|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
837312|NCT01087788|2659950|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
837313|NCT01087788|2659951|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
837314|NCT01087788|2659949|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
837315|NCT01087788|2659950|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
837316|NCT01087788|2659951|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
837317|NCT01087788|2659949|P3|24-weeks Dose-blind Period|AE, serious fatal|0
837318|NCT01087788|2659950|P2|24-weeks Dose-blind Period|AE, serious fatal|1
837319|NCT01087788|2659951|P1|24-weeks Dose-blind Period|AE, serious fatal|0
837320|NCT01087788|2659949|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
837321|NCT01087788|2659950|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
837322|NCT01087788|2659951|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
837323|NCT01087788|2659949|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
837324|NCT01087788|2659950|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
837325|NCT01087788|2659951|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
837326|NCT01087788|2659949|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
837327|NCT01087788|2659950|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
837328|NCT01087788|2659951|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
837329|NCT01087788|2659949|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
837330|NCT01087788|2659950|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
837331|NCT01087788|2659951|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
837332|NCT01087788|2659949|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
837333|NCT01087788|2659950|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
837334|NCT01087788|2659951|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
837335|NCT01087788|2659949|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
837336|NCT01087788|2659950|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
837337|NCT01087788|2659951|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
837338|NCT01087788|2659949|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
837339|NCT01087788|2659950|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
837340|NCT01087788|2659951|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
837341|NCT01087788|2659949|P3|24-weeks Double-blind Period|AE, unknown type|1
837342|NCT01087788|2659950|P2|24-weeks Double-blind Period|AE, unknown type|0
837343|NCT01087788|2659951|P1|24-weeks Double-blind Period|AE, unknown type|0
837344|NCT01087788|2659949|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
837345|NCT01087788|2659950|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
837346|NCT01087788|2659951|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
837347|NCT01087788|2659949|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
837348|NCT01087788|2659950|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
837349|NCT01087788|2659951|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
837350|NCT01087788|2659949|P3|24-weeks Double-blind Period|AE, serious fatal|1
837351|NCT01087788|2659950|P2|24-weeks Double-blind Period|AE, serious fatal|1
837352|NCT01087788|2659951|P1|24-weeks Double-blind Period|AE, serious fatal|0
837353|NCT01087788|2659949|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
837354|NCT01087788|2659950|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
837355|NCT01087788|2659951|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
837356|NCT01087788|2659949|P3|24-weeks Double-blind Period|Lost to Follow-up|1
837357|NCT01087788|2659950|P2|24-weeks Double-blind Period|Lost to Follow-up|1
837358|NCT01087788|2659951|P1|24-weeks Double-blind Period|Lost to Follow-up|4
837359|NCT01087788|2659949|P3|24-weeks Double-blind Period|Protocol Violation|0
837360|NCT01087788|2659950|P2|24-weeks Double-blind Period|Protocol Violation|1
837361|NCT01087788|2659951|P1|24-weeks Double-blind Period|Protocol Violation|0
837362|NCT01087788|2659949|P3|24-weeks Double-blind Period|Lack of Efficacy|1
837363|NCT01087788|2659950|P2|24-weeks Double-blind Period|Lack of Efficacy|0
837364|NCT01087788|2659951|P1|24-weeks Double-blind Period|Lack of Efficacy|2
837365|NCT01087814|2659989|P2|Second Intervention (5 Days)|Physician Decision|0
837366|NCT01087814|2659990|P1|Second Intervention (5 Days)|Physician Decision|1
837367|NCT01087814|2659989|P2|First Intervention (5 Days)|Withdrawal by Subject|1
837368|NCT01087814|2659990|P1|First Intervention (5 Days)|Withdrawal by Subject|3
837369|NCT01087905|2660004|P8|Overall Study|Withdrawal by Subject|5
837370|NCT01087905|2660005|P7|Overall Study|Withdrawal by Subject|3
837371|NCT01087905|2660006|P6|Overall Study|Withdrawal by Subject|3
837372|NCT01087905|2660007|P5|Overall Study|Withdrawal by Subject|4
837373|NCT01087905|2660008|P4|Overall Study|Withdrawal by Subject|5
837374|NCT01087905|2660009|P3|Overall Study|Withdrawal by Subject|4
837375|NCT01087905|2660010|P2|Overall Study|Withdrawal by Subject|4
837376|NCT01087905|2660011|P1|Overall Study|Withdrawal by Subject|5
837377|NCT01087905|2660004|P8|Overall Study|Lost to Follow-up|24
837378|NCT01087905|2660005|P7|Overall Study|Lost to Follow-up|20
837379|NCT01087905|2660006|P6|Overall Study|Lost to Follow-up|25
837380|NCT01087905|2660007|P5|Overall Study|Lost to Follow-up|27
837381|NCT01087905|2660008|P4|Overall Study|Lost to Follow-up|31
837382|NCT01087905|2660009|P3|Overall Study|Lost to Follow-up|18
837383|NCT01087905|2660010|P2|Overall Study|Lost to Follow-up|28
837384|NCT01087905|2660011|P1|Overall Study|Lost to Follow-up|24
837385|NCT01087944|2660060|P2|Period 2 (Week 4-6)|Adverse Event|2
837386|NCT01087944|2660061|P1|Period 2 (Week 4-6)|Adverse Event|0
837387|NCT01087944|2660060|P2|Period 1 (Week 1-3)|Adverse Event|0
837388|NCT01087944|2660061|P1|Period 1 (Week 1-3)|Adverse Event|1
837389|NCT01087957|2660091|P2|Overall Study|Physician Decision|9
837390|NCT01087957|2660092|P1|Overall Study|Physician Decision|5
837391|NCT01087957|2660091|P2|Overall Study|Withdrawal by Subject|15
837392|NCT01087957|2660092|P1|Overall Study|Withdrawal by Subject|18
837393|NCT01087957|2660091|P2|Overall Study|Protocol Violation|25
837394|NCT01087957|2660092|P1|Overall Study|Protocol Violation|13
837395|NCT01087957|2660091|P2|Overall Study|Lost to Follow-up|4
837396|NCT01087957|2660092|P1|Overall Study|Lost to Follow-up|3
837397|NCT01087957|2660091|P2|Overall Study|Death|2
837398|NCT01087957|2660092|P1|Overall Study|Death|2
837399|NCT01087970|2660118|P1|Overall Study|Protocol Violation|2
837400|NCT01088399|2660160|P3|Overall Study|Study summary visit not completed|80
837401|NCT01088399|2660161|P2|Overall Study|Study summary visit not completed|283
837402|NCT01088399|2660162|P1|Overall Study|Study summary visit not completed|2398
837403|NCT01088399|2660160|P3|Overall Study|Enrollment criteria not met|70
837404|NCT01088399|2660161|P2|Overall Study|Enrollment criteria not met|119
837405|NCT01088399|2660162|P1|Overall Study|Enrollment criteria not met|48
837406|NCT01088399|2660160|P3|Overall Study|Protocol Violation|0
837407|NCT01088399|2660161|P2|Overall Study|Protocol Violation|1
837408|NCT01088399|2660162|P1|Overall Study|Protocol Violation|10
837409|NCT01088399|2660160|P3|Overall Study|Sponsor decision|7
837410|NCT01088399|2660161|P2|Overall Study|Sponsor decision|298
837411|NCT01088399|2660162|P1|Overall Study|Sponsor decision|1573
837412|NCT01088399|2660160|P3|Overall Study|Change to or start of somatropin therapy|12
837413|NCT01088399|2660161|P2|Overall Study|Change to or start of somatropin therapy|17
837414|NCT01088399|2660162|P1|Overall Study|Change to or start of somatropin therapy|234
837415|NCT01088399|2660160|P3|Overall Study|Withdrawal by Subject|33
837416|NCT01088399|2660161|P2|Overall Study|Withdrawal by Subject|195
837417|NCT01088399|2660162|P1|Overall Study|Withdrawal by Subject|544
837418|NCT01088399|2660160|P3|Overall Study|Physician Decision|16
837419|NCT01088399|2660161|P2|Overall Study|Physician Decision|88
837420|NCT01088399|2660162|P1|Overall Study|Physician Decision|531
837421|NCT01088399|2660160|P3|Overall Study|Lost to Follow-up|58
837422|NCT01088399|2660161|P2|Overall Study|Lost to Follow-up|278
837423|NCT01088399|2660162|P1|Overall Study|Lost to Follow-up|1070
837424|NCT01088399|2660160|P3|Overall Study|Lack of Efficacy|5
837425|NCT01088399|2660161|P2|Overall Study|Lack of Efficacy|7
837426|NCT01088399|2660162|P1|Overall Study|Lack of Efficacy|298
837427|NCT01088399|2660160|P3|Overall Study|Death|0
837428|NCT01088399|2660161|P2|Overall Study|Death|45
837429|NCT01088399|2660162|P1|Overall Study|Death|204
837430|NCT01088399|2660160|P3|Overall Study|Adverse Event|0
837431|NCT01088399|2660161|P2|Overall Study|Adverse Event|16
837432|NCT01088399|2660162|P1|Overall Study|Adverse Event|211
837433|NCT01088438|2660187|P2|Overall Study|Lost to Follow-up|30
837434|NCT01088438|2660188|P1|Overall Study|Lost to Follow-up|18
837435|NCT01088438|2660187|P2|Overall Study|Withdrawal by Subject|6
837436|NCT01088438|2660188|P1|Overall Study|Withdrawal by Subject|11
837437|NCT01088503|2660256|P3|Overall Study|Death|7
837438|NCT01088503|2660257|P2|Overall Study|Death|358
837439|NCT01088503|2660258|P1|Overall Study|Death|64
837440|NCT01088503|2660256|P3|Overall Study|Withdrawal by Subject|10
837441|NCT01088503|2660257|P2|Overall Study|Withdrawal by Subject|327
837442|NCT01088503|2660258|P1|Overall Study|Withdrawal by Subject|118
837443|NCT01088529|2660281|P2|Overall Study|Did not receive study treatment|1
837444|NCT01088529|2660282|P1|Overall Study|Did not receive study treatment|0
837445|NCT01081626|2660335|P2|Overall Study|Unspecified|30
837446|NCT01081626|2660336|P1|Overall Study|Unspecified|33
837447|NCT01081626|2660335|P2|Overall Study|Lost to Follow-up|1
837448|NCT01081626|2660336|P1|Overall Study|Lost to Follow-up|0
837449|NCT01081626|2660335|P2|Overall Study|Overstimulation|1
837450|NCT01081626|2660336|P1|Overall Study|Overstimulation|0
837451|NCT01081626|2660335|P2|Overall Study|Low antral follicle count|0
837452|NCT01081626|2660336|P1|Overall Study|Low antral follicle count|1
837453|NCT01081626|2660335|P2|Overall Study|Missing Estradiol|28
837454|NCT01081626|2660336|P1|Overall Study|Missing Estradiol|25
837455|NCT01081626|2660335|P2|Overall Study|Dosing error|1
837456|NCT01081626|2660336|P1|Overall Study|Dosing error|1
837457|NCT01081665|2660362|P1|Overall Study|Lack of Efficacy|1
837458|NCT01081665|2660362|P1|Overall Study|Adverse Event|1
837459|NCT01081665|2660362|P1|Overall Study|Change in renal replacement therapy|2
837460|NCT01081665|2660362|P1|Overall Study|Regulation of iPTH|5
837461|NCT01081665|2660362|P1|Overall Study|Change of dialysis unit|10
837462|NCT01081665|2660362|P1|Overall Study|Withdrawal by Subject|17
837463|NCT01081665|2660362|P1|Overall Study|Lost to Follow-up|18
837464|NCT01081665|2660362|P1|Overall Study|Death|41
837465|NCT01081769|2660374|P2|CORE Intent-To-Treat|Patient Moved|2
837466|NCT01081769|2660375|P1|CORE Intent-To-Treat|Patient Moved|2
837467|NCT01081769|2660374|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
837468|NCT01081769|2660375|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
837469|NCT01081769|2660374|P2|CORE Intent-To-Treat|Ineligibility|4
837470|NCT01081769|2660375|P1|CORE Intent-To-Treat|Ineligibility|3
837471|NCT01081769|2660374|P2|CORE Intent-To-Treat|Other|1
837472|NCT01081769|2660375|P1|CORE Intent-To-Treat|Other|0
837473|NCT01081769|2660374|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
837474|NCT01081769|2660375|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
837475|NCT01081769|2660374|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
837476|NCT01081769|2660375|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
837477|NCT01081769|2660374|P2|CORE Intent-To-Treat|Pregnancy|0
837478|NCT01081769|2660375|P1|CORE Intent-To-Treat|Pregnancy|1
837479|NCT01081769|2660374|P2|CORE Intent-To-Treat|Lost to Follow-up|5
837480|NCT01081769|2660375|P1|CORE Intent-To-Treat|Lost to Follow-up|4
837481|NCT01081769|2660374|P2|CORE Intent-To-Treat|Lack of Efficacy|6
837482|NCT01081769|2660375|P1|CORE Intent-To-Treat|Lack of Efficacy|2
837483|NCT01081769|2660374|P2|CORE Intent-To-Treat|Death|1
837484|NCT01081769|2660375|P1|CORE Intent-To-Treat|Death|1
837485|NCT01081769|2660374|P2|CORE Intent-To-Treat|Adverse Event|11
837486|NCT01081769|2660375|P1|CORE Intent-To-Treat|Adverse Event|14
837487|NCT01081769|2660374|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
837488|NCT01081769|2660375|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
837489|NCT01081769|2660374|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
837490|NCT01081769|2660375|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
837491|NCT01081769|2660374|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
837492|NCT01081769|2660375|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
837493|NCT01081769|2660374|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
837494|NCT01081769|2660375|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
837495|NCT01081795|2660412|P3|Overall Study|Unspecified|0
837496|NCT01081795|2660413|P2|Overall Study|Unspecified|2
837497|NCT01081795|2660414|P1|Overall Study|Unspecified|1
837498|NCT01081795|2660412|P3|Overall Study|Using drug with restricted days of use|2
837499|NCT01081795|2660413|P2|Overall Study|Using drug with restricted days of use|3
837500|NCT01081795|2660414|P1|Overall Study|Using drug with restricted days of use|2
837501|NCT01081795|2660412|P3|Overall Study|Use of a prohibited concomitant drug|1
837502|NCT01081795|2660413|P2|Overall Study|Use of a prohibited concomitant drug|1
837503|NCT01081795|2660414|P1|Overall Study|Use of a prohibited concomitant drug|1
837504|NCT01081795|2660412|P3|Overall Study|Ineligible for participation|0
837505|NCT01081795|2660413|P2|Overall Study|Ineligible for participation|0
837506|NCT01081795|2660414|P1|Overall Study|Ineligible for participation|1
837507|NCT01081795|2660412|P3|Overall Study|Revocation of informed consent|0
837508|NCT01081795|2660413|P2|Overall Study|Revocation of informed consent|0
837509|NCT01081795|2660414|P1|Overall Study|Revocation of informed consent|2
837510|NCT01081795|2660412|P3|Overall Study|Subject’s schedule|2
837511|NCT01081795|2660413|P2|Overall Study|Subject’s schedule|1
837512|NCT01081795|2660414|P1|Overall Study|Subject’s schedule|1
837513|NCT01081795|2660412|P3|Overall Study|Lack of Efficacy|19
837514|NCT01081795|2660413|P2|Overall Study|Lack of Efficacy|5
837515|NCT01081795|2660414|P1|Overall Study|Lack of Efficacy|7
837516|NCT01081795|2660412|P3|Overall Study|Adverse Event|6
837517|NCT01081795|2660413|P2|Overall Study|Adverse Event|23
837518|NCT01081795|2660414|P1|Overall Study|Adverse Event|18
837519|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
837520|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
837521|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
837522|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
837523|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
837524|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
837525|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
837526|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
837527|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
837528|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
837529|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Not specified|0
837530|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Not specified|0
837531|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Not specified|4
837532|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Not specified|5
837533|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Not specified|4
837534|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
837535|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
837536|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
837537|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
837538|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
837539|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
837540|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
837541|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
837542|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
837543|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
837544|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
837545|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
837546|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
837547|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
837548|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
837549|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
837550|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
837551|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
837552|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
837553|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
837554|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
837555|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
837556|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
837557|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
837558|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
837559|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Death|0
837560|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Death|0
837561|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Death|0
837562|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Death|0
837563|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Death|1
837564|NCT01081834|2660454|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
837565|NCT01081834|2660455|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
837566|NCT01081834|2660456|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
837567|NCT01081834|2660457|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
837568|NCT01081834|2660458|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
837569|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
837570|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
837571|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
837572|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
837573|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
837574|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Not specified|0
837575|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Not specified|1
837576|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Not specified|3
837577|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Not specified|4
837578|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Not specified|4
837579|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
837580|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
837581|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
837582|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
837583|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
837584|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
837585|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
837586|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
837587|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
837588|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
837589|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
837590|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
837591|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
837592|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
837593|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
837594|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Protocol Violation|2
837595|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Protocol Violation|0
837596|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Protocol Violation|0
837597|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Protocol Violation|4
837598|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Protocol Violation|0
837599|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
837600|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
837601|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
837602|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
837603|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
837604|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Death|0
837605|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Death|0
837606|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Death|0
837607|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Death|0
837608|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Death|1
837609|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Adverse Event|1
837610|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Adverse Event|1
837611|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Adverse Event|3
837612|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Adverse Event|5
837613|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Adverse Event|2
837614|NCT01081834|2660454|P5|Core Period: Baseline to Week 26|Pregnancy|0
837615|NCT01081834|2660455|P4|Core Period: Baseline to Week 26|Pregnancy|0
837616|NCT01081834|2660456|P3|Core Period: Baseline to Week 26|Pregnancy|0
837617|NCT01081834|2660457|P2|Core Period: Baseline to Week 26|Pregnancy|0
837618|NCT01081834|2660458|P1|Core Period: Baseline to Week 26|Pregnancy|1
837619|NCT01088984|2660518|P2|Phase 2|Not Specified|1
837620|NCT01088984|2660519|P1|Phase 2|Not Specified|0
837621|NCT01088984|2660518|P2|Phase 2|DIsease Progression|25
837622|NCT01088984|2660519|P1|Phase 2|DIsease Progression|0
837623|NCT01088984|2660518|P2|Phase 2|Withdrawal by Subject|1
837624|NCT01088984|2660519|P1|Phase 2|Withdrawal by Subject|0
837625|NCT01088984|2660518|P2|Phase 2|Death|5
837626|NCT01088984|2660519|P1|Phase 2|Death|0
837627|NCT01088984|2660518|P2|Phase 1|Not Specified|1
837628|NCT01088984|2660519|P1|Phase 1|Not Specified|1
837629|NCT01088984|2660518|P2|Phase 1|Disease Progression|4
837630|NCT01088984|2660519|P1|Phase 1|Disease Progression|2
837631|NCT01088984|2660518|P2|Phase 1|Death|1
837632|NCT01088984|2660519|P1|Phase 1|Death|2
837633|NCT01088997|2660539|P2|Overall Study|Excluded prior to receiving drug|1
837634|NCT01088997|2660540|P1|Overall Study|Excluded prior to receiving drug|1
837635|NCT01088997|2660539|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
837636|NCT01088997|2660540|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
837637|NCT01088997|2660539|P2|Overall Study|Physician Decision|1
837638|NCT01088997|2660540|P1|Overall Study|Physician Decision|1
837639|NCT01089023|2660549|P1|Overall Study|Lack of Efficacy|1
837640|NCT01089023|2660549|P1|Overall Study|Protocol Violation|1
837641|NCT01089023|2660549|P1|Overall Study|Withdrawal by Subject|1
837642|NCT01089023|2660549|P1|Overall Study|Adverse Event|1
837643|NCT01089023|2660549|P1|Overall Study|Lost to Follow-up|3
837644|NCT01089127|2660601|P6|Overall Study|Protocol deviation|0
837645|NCT01089127|2660602|P5|Overall Study|Protocol deviation|1
837646|NCT01089127|2660603|P4|Overall Study|Protocol deviation|0
837647|NCT01089127|2660604|P3|Overall Study|Protocol deviation|0
837648|NCT01089127|2660605|P2|Overall Study|Protocol deviation|1
837649|NCT01089127|2660606|P1|Overall Study|Protocol deviation|0
837650|NCT01089127|2660601|P6|Overall Study|Lost to Follow-up|0
837651|NCT01089127|2660602|P5|Overall Study|Lost to Follow-up|1
837652|NCT01089127|2660603|P4|Overall Study|Lost to Follow-up|0
837653|NCT01089127|2660604|P3|Overall Study|Lost to Follow-up|0
837654|NCT01089127|2660605|P2|Overall Study|Lost to Follow-up|1
837655|NCT01089127|2660606|P1|Overall Study|Lost to Follow-up|1
837656|NCT01089127|2660601|P6|Overall Study|Abnormal test procedure result(s)|0
837657|NCT01089127|2660602|P5|Overall Study|Abnormal test procedure result(s)|0
837658|NCT01089127|2660603|P4|Overall Study|Abnormal test procedure result(s)|0
837659|NCT01089127|2660604|P3|Overall Study|Abnormal test procedure result(s)|0
837660|NCT01089127|2660605|P2|Overall Study|Abnormal test procedure result(s)|1
837661|NCT01089127|2660606|P1|Overall Study|Abnormal test procedure result(s)|2
837662|NCT01089127|2660601|P6|Overall Study|Subject withdrew consent|2
837663|NCT01089127|2660602|P5|Overall Study|Subject withdrew consent|0
837664|NCT01089127|2660603|P4|Overall Study|Subject withdrew consent|1
837665|NCT01089127|2660604|P3|Overall Study|Subject withdrew consent|1
837666|NCT01089127|2660605|P2|Overall Study|Subject withdrew consent|1
837667|NCT01089127|2660606|P1|Overall Study|Subject withdrew consent|0
837668|NCT01089127|2660601|P6|Overall Study|Adverse Event|1
837669|NCT01089127|2660602|P5|Overall Study|Adverse Event|0
837670|NCT01089127|2660603|P4|Overall Study|Adverse Event|0
837671|NCT01089127|2660604|P3|Overall Study|Adverse Event|1
837672|NCT01089127|2660605|P2|Overall Study|Adverse Event|1
837673|NCT01089127|2660606|P1|Overall Study|Adverse Event|5
837674|NCT01090011|2660626|P1|Overall Study|Other reason not defined above|5
837675|NCT01090011|2660626|P1|Overall Study|Refusal to start/continue medication|5
837676|NCT01090011|2660626|P1|Overall Study|Protocol Violation|1
837677|NCT01090011|2660626|P1|Overall Study|Adverse Event|32
837678|NCT01090011|2660626|P1|Overall Study|Progressive disease|128
837679|NCT01090050|2660696|P2|Overall Study|Physician Decision|1
837680|NCT01090050|2660697|P1|Overall Study|Physician Decision|0
837681|NCT01090050|2660696|P2|Overall Study|Lack of Efficacy|5
837682|NCT01090050|2660697|P1|Overall Study|Lack of Efficacy|1
837683|NCT01090050|2660696|P2|Overall Study|Lost to Follow-up|1
837684|NCT01090050|2660697|P1|Overall Study|Lost to Follow-up|0
837685|NCT01090063|2660717|P1|Treatment|Withdrawal by Subject|4
837686|NCT01090063|2660717|P1|Screen|Screen Failed|4
837687|NCT01090076|2660733|P2|Overall Study|Withdrawal by Subject|1
837688|NCT01090076|2660734|P1|Overall Study|Withdrawal by Subject|0
837689|NCT01090076|2660733|P2|Overall Study|Death|1
837690|NCT01090076|2660734|P1|Overall Study|Death|1
837691|NCT01090102|2660746|P2|Second 12 Weeks|Withdrawal by Subject|1
837692|NCT01090102|2660747|P1|Second 12 Weeks|Withdrawal by Subject|0
837693|NCT01090102|2660746|P2|First 12 Weeks|Death|1
837694|NCT01090102|2660747|P1|First 12 Weeks|Death|1
837695|NCT01090102|2660746|P2|First 12 Weeks|Adverse Event|0
837696|NCT01090102|2660747|P1|First 12 Weeks|Adverse Event|2
837697|NCT01090102|2660746|P2|First 12 Weeks|Withdrawal by Subject|1
837698|NCT01090102|2660747|P1|First 12 Weeks|Withdrawal by Subject|1
837699|NCT01090310|2660770|P4|Extension Study|Subject withdrew consent|0
837700|NCT01090310|2660771|P3|Extension Study|Subject withdrew consent|0
837701|NCT01090310|2660772|P2|Extension Study|Subject withdrew consent|1
837702|NCT01090310|2660773|P1|Extension Study|Subject withdrew consent|0
837703|NCT01090310|2660770|P4|Extension Study|Unsatisfactory therapeutic effect|1
837704|NCT01090310|2660771|P3|Extension Study|Unsatisfactory therapeutic effect|1
837705|NCT01090310|2660772|P2|Extension Study|Unsatisfactory therapeutic effect|0
837706|NCT01090310|2660773|P1|Extension Study|Unsatisfactory therapeutic effect|1
837707|NCT01090310|2660770|P4|Extension Study|Adverse Event|1
837708|NCT01090310|2660771|P3|Extension Study|Adverse Event|0
837709|NCT01090310|2660772|P2|Extension Study|Adverse Event|0
837710|NCT01090310|2660773|P1|Extension Study|Adverse Event|0
837711|NCT01090310|2660770|P4|Extension Study|Aministrative problems|18
837712|NCT01090310|2660771|P3|Extension Study|Aministrative problems|14
837713|NCT01090310|2660772|P2|Extension Study|Aministrative problems|15
837714|NCT01090310|2660773|P1|Extension Study|Aministrative problems|13
837715|NCT01090310|2660770|P4|Core Study|Protocol deviation|1
837716|NCT01090310|2660771|P3|Core Study|Protocol deviation|0
837717|NCT01090310|2660772|P2|Core Study|Protocol deviation|0
837718|NCT01090310|2660773|P1|Core Study|Protocol deviation|1
837719|NCT01090310|2660770|P4|Core Study|Administrative reasons|4
837720|NCT01090310|2660771|P3|Core Study|Administrative reasons|4
837721|NCT01090310|2660772|P2|Core Study|Administrative reasons|6
837722|NCT01090310|2660773|P1|Core Study|Administrative reasons|5
837723|NCT01090310|2660770|P4|Core Study|Abnormal test procedure result|0
837724|NCT01090310|2660771|P3|Core Study|Abnormal test procedure result|1
837725|NCT01090310|2660772|P2|Core Study|Abnormal test procedure result|0
837726|NCT01090310|2660773|P1|Core Study|Abnormal test procedure result|0
837727|NCT01090310|2660770|P4|Core Study|Subject withdrew consent|1
837728|NCT01090310|2660771|P3|Core Study|Subject withdrew consent|1
837729|NCT01090310|2660772|P2|Core Study|Subject withdrew consent|3
837730|NCT01090310|2660773|P1|Core Study|Subject withdrew consent|0
837731|NCT01090310|2660770|P4|Core Study|Adverse Event|1
837732|NCT01090310|2660771|P3|Core Study|Adverse Event|1
837733|NCT01090310|2660772|P2|Core Study|Adverse Event|2
837734|NCT01090310|2660773|P1|Core Study|Adverse Event|2
837735|NCT01090323|2660801|P2|Overall Study|Stopped end of extension 1#|1
837736|NCT01090323|2660802|P1|Overall Study|Stopped end of extension 1#|3
837737|NCT01090323|2660801|P2|Overall Study|Stopped end of core|0
837738|NCT01090323|2660802|P1|Overall Study|Stopped end of core|7
837739|NCT01090323|2660801|P2|Overall Study|Death|2
837740|NCT01090323|2660802|P1|Overall Study|Death|1
837741|NCT01090323|2660801|P2|Overall Study|Administrative problems|4
837742|NCT01090323|2660802|P1|Overall Study|Administrative problems|6
837743|NCT01090323|2660801|P2|Overall Study|Lost to Follow-up|6
837744|NCT01090323|2660802|P1|Overall Study|Lost to Follow-up|11
837745|NCT01090323|2660801|P2|Overall Study|Withdrew consent|11
837746|NCT01090323|2660802|P1|Overall Study|Withdrew consent|33
837747|NCT01090323|2660801|P2|Overall Study|Protocol Violation|1
837748|NCT01090323|2660802|P1|Overall Study|Protocol Violation|2
837749|NCT01090323|2660801|P2|Overall Study|Condition no longer requires drug|4
837750|NCT01090323|2660802|P1|Overall Study|Condition no longer requires drug|5
837751|NCT01090323|2660801|P2|Overall Study|Unsatisfactory therapeutic effect|2
837752|NCT01090323|2660802|P1|Overall Study|Unsatisfactory therapeutic effect|4
837753|NCT01090323|2660801|P2|Overall Study|Abnormal Test Procedure Results|0
837754|NCT01090323|2660802|P1|Overall Study|Abnormal Test Procedure Results|2
837755|NCT01090323|2660801|P2|Overall Study|Abnormal Lab Values|1
837756|NCT01090323|2660802|P1|Overall Study|Abnormal Lab Values|3
837757|NCT01090323|2660801|P2|Overall Study|Adverse Event|2
837758|NCT01090323|2660802|P1|Overall Study|Adverse Event|12
893887|NCT01205152|2836332|P1|Overall Study|Death|1
837780|NCT01090453|2660854|P2|Overall Study|Eligibility Criteria|1
837781|NCT01090453|2660855|P1|Overall Study|Eligibility Criteria|0
837782|NCT01090453|2660854|P2|Overall Study|Unspecified|4
837783|NCT01090453|2660855|P1|Overall Study|Unspecified|2
837784|NCT01090453|2660854|P2|Overall Study|Protocol Violation|0
837785|NCT01090453|2660855|P1|Overall Study|Protocol Violation|2
837786|NCT01090453|2660854|P2|Overall Study|Non serious AEs|0
837787|NCT01090453|2660855|P1|Overall Study|Non serious AEs|1
837788|NCT01090453|2660854|P2|Overall Study|Lost to Follow-up|7
837789|NCT01090453|2660855|P1|Overall Study|Lost to Follow-up|7
837790|NCT01090453|2660854|P2|Overall Study|Withdrawal by Subject|2
837791|NCT01090453|2660855|P1|Overall Study|Withdrawal by Subject|1
837792|NCT01090739|2660908|P1|36 Month Follow-up|Visit still pending|17
837793|NCT01090739|2660908|P1|36 Month Follow-up|Withdrawal by Subject|6
837794|NCT01090739|2660908|P1|24 Month Follow-up|Death|1
837795|NCT01090739|2660908|P1|24 Month Follow-up|Lost to Follow-up|1
837796|NCT01090739|2660908|P1|24 Month Follow-up|Withdrawal by Subject|7
837797|NCT01090739|2660908|P1|12 Month Follow-up|Death|1
837798|NCT01090739|2660908|P1|12 Month Follow-up|Physician Decision|1
837799|NCT01090739|2660908|P1|12 Month Follow-up|Lost to Follow-up|1
837800|NCT01090739|2660908|P1|12 Month Follow-up|Withdrawal by Subject|2
837801|NCT01090739|2660908|P1|Enrollment|Adverse Event|1
837802|NCT01090739|2660908|P1|Enrollment|Study implant limit reached|2
837803|NCT01090739|2660908|P1|Enrollment|Sponsor termination of site|4
837804|NCT01090739|2660908|P1|Enrollment|Physician Decision|5
837805|NCT01090739|2660908|P1|Enrollment|Lost to Follow-up|5
837806|NCT01090739|2660908|P1|Enrollment|Protocol Violation|14
837807|NCT01090739|2660908|P1|Enrollment|Withdrawal by Subject|24
837808|NCT01090765|2660944|P6|Overall Study|Vasovagal reaction with first infusion|0
837809|NCT01090765|2660945|P5|Overall Study|Vasovagal reaction with first infusion|1
837810|NCT01090765|2660946|P4|Overall Study|Vasovagal reaction with first infusion|0
837811|NCT01090765|2660947|P3|Overall Study|Vasovagal reaction with first infusion|0
837812|NCT01090765|2660948|P2|Overall Study|Vasovagal reaction with first infusion|0
837813|NCT01090765|2660949|P1|Overall Study|Vasovagal reaction with first infusion|0
837814|NCT01090765|2660944|P6|Overall Study|Developed a DVT, needed anticoagulation|0
837815|NCT01090765|2660945|P5|Overall Study|Developed a DVT, needed anticoagulation|0
837816|NCT01090765|2660946|P4|Overall Study|Developed a DVT, needed anticoagulation|1
837817|NCT01090765|2660947|P3|Overall Study|Developed a DVT, needed anticoagulation|0
837818|NCT01090765|2660948|P2|Overall Study|Developed a DVT, needed anticoagulation|0
837819|NCT01090765|2660949|P1|Overall Study|Developed a DVT, needed anticoagulation|0
837820|NCT01090765|2660944|P6|Overall Study|Patient withdrew consent|1
837821|NCT01090765|2660945|P5|Overall Study|Patient withdrew consent|1
837822|NCT01090765|2660946|P4|Overall Study|Patient withdrew consent|0
837823|NCT01090765|2660947|P3|Overall Study|Patient withdrew consent|0
837824|NCT01090765|2660948|P2|Overall Study|Patient withdrew consent|0
837825|NCT01090765|2660949|P1|Overall Study|Patient withdrew consent|0
837826|NCT01090973|2660964|P1|Overall Study|Disease progression|1
837827|NCT01091103|2660974|P1|Overall Study|Progressive Disease|3
837828|NCT01091103|2660974|P1|Overall Study|Adverse Event|1
837829|NCT01091246|2661062|P3|Overall Study|Subject not dosed|1
837830|NCT01091246|2661063|P2|Overall Study|Subject not dosed|0
837831|NCT01091246|2661064|P1|Overall Study|Subject not dosed|2
837832|NCT01091246|2661062|P3|Overall Study|Withdrawal by Subject|4
837833|NCT01091246|2661063|P2|Overall Study|Withdrawal by Subject|5
837834|NCT01091246|2661064|P1|Overall Study|Withdrawal by Subject|9
837835|NCT01091246|2661062|P3|Overall Study|Adverse Event|1
837836|NCT01091246|2661063|P2|Overall Study|Adverse Event|0
837837|NCT01091246|2661064|P1|Overall Study|Adverse Event|1
837838|NCT01091246|2661062|P3|Overall Study|Lost to Follow-up|7
837839|NCT01091246|2661063|P2|Overall Study|Lost to Follow-up|11
837840|NCT01091246|2661064|P1|Overall Study|Lost to Follow-up|23
837841|NCT01091259|2661138|P1|Overall Study|Lack of Efficacy|2
837842|NCT01091259|2661138|P1|Overall Study|Adverse Event|3
837843|NCT01091454|2661146|P1|Overall Study|Ineligible|1
837844|NCT01091519|2661157|P2|Overall Study|Randomized not treated|4
837845|NCT01091519|2661158|P1|Overall Study|Randomized not treated|4
837846|NCT01091519|2661157|P2|Overall Study|Unspecified|8
837847|NCT01091519|2661158|P1|Overall Study|Unspecified|6
837848|NCT01091519|2661157|P2|Overall Study|Withdrawal by Subject|2
837849|NCT01091519|2661158|P1|Overall Study|Withdrawal by Subject|2
837850|NCT01091519|2661157|P2|Overall Study|Lost to Follow-up|24
837851|NCT01091519|2661158|P1|Overall Study|Lost to Follow-up|14
837852|NCT01091519|2661157|P2|Overall Study|Lack of Efficacy|19
837853|NCT01091519|2661158|P1|Overall Study|Lack of Efficacy|16
837854|NCT01091519|2661157|P2|Overall Study|Death|0
837855|NCT01091519|2661158|P1|Overall Study|Death|1
837856|NCT01091519|2661157|P2|Overall Study|Adverse Event|16
837857|NCT01091519|2661158|P1|Overall Study|Adverse Event|12
837858|NCT01091662|2661172|P2|Overall Study|unable to swallow capsule|1
837859|NCT01091662|2661173|P1|Overall Study|unable to swallow capsule|0
837860|NCT01091662|2661172|P2|Overall Study|Protocol Violation|2
837861|NCT01091662|2661173|P1|Overall Study|Protocol Violation|0
837862|NCT01091662|2661172|P2|Overall Study|Pregnancy|1
837863|NCT01091662|2661173|P1|Overall Study|Pregnancy|0
837864|NCT01091662|2661172|P2|Overall Study|Lost to Follow-up|1
837865|NCT01091662|2661173|P1|Overall Study|Lost to Follow-up|0
837866|NCT01091662|2661172|P2|Overall Study|met exclusion criteria|0
837867|NCT01091662|2661173|P1|Overall Study|met exclusion criteria|1
837868|NCT01091662|2661172|P2|Overall Study|met exit criteria|13
837869|NCT01091662|2661173|P1|Overall Study|met exit criteria|7
837870|NCT01091662|2661172|P2|Overall Study|Withdrawal by Subject|6
837871|NCT01091662|2661173|P1|Overall Study|Withdrawal by Subject|7
837872|NCT01091662|2661172|P2|Overall Study|Physician Decision|1
837873|NCT01091662|2661173|P1|Overall Study|Physician Decision|1
837874|NCT01091662|2661172|P2|Overall Study|Adverse Event|9
837875|NCT01091662|2661173|P1|Overall Study|Adverse Event|1
837876|NCT01091675|2661209|P1|Overall Study|Lack of Efficacy|27
837877|NCT01091675|2661209|P1|Overall Study|Adverse Event|7
837878|NCT01091974|2661238|P4|Overall Study|side-effects|2
837879|NCT01091974|2661239|P3|Overall Study|side-effects|0
837880|NCT01091974|2661240|P2|Overall Study|side-effects|1
837881|NCT01091974|2661241|P1|Overall Study|side-effects|1
837882|NCT01091974|2661238|P4|Overall Study|Withdrawal by Subject|2
837883|NCT01091974|2661239|P3|Overall Study|Withdrawal by Subject|2
837884|NCT01091974|2661240|P2|Overall Study|Withdrawal by Subject|3
837885|NCT01091974|2661241|P1|Overall Study|Withdrawal by Subject|1
837886|NCT01091974|2661238|P4|Overall Study|resumed sleep medication|2
837887|NCT01091974|2661239|P3|Overall Study|resumed sleep medication|1
837888|NCT01091974|2661240|P2|Overall Study|resumed sleep medication|0
837889|NCT01091974|2661241|P1|Overall Study|resumed sleep medication|0
837890|NCT01091974|2661238|P4|Overall Study|Did not start intervention|1
837891|NCT01091974|2661239|P3|Overall Study|Did not start intervention|3
837892|NCT01091974|2661240|P2|Overall Study|Did not start intervention|1
837893|NCT01091974|2661241|P1|Overall Study|Did not start intervention|3
837894|NCT01084707|2661266|P1|Overall Study|Withdrawal by Subject|6
837895|NCT01085045|2661315|P1|Part B|Adverse Event|6
837896|NCT01085045|2661315|P1|Part B|Lost to Follow-up|1
837897|NCT01085045|2661315|P1|Part B|Protocol Specified Criteria|6
837898|NCT01085045|2661315|P1|Part B|Withdrawal by Subject|2
837899|NCT01085045|2661315|P1|Part A|Protocol Specified Criteria|7
837900|NCT01085045|2661315|P1|Part A|Protocol Violation|1
837901|NCT01085045|2661315|P1|Part A|Adverse Event|6
837902|NCT01085045|2661315|P1|Part A|Withdrawal by Subject|4
837903|NCT01085136|2661415|P3|Part B|Other reason not defined above|3
837904|NCT01085136|2661416|P2|Part B|Other reason not defined above|6
837905|NCT01085136|2661417|P1|Part B|Other reason not defined above|0
837906|NCT01085136|2661415|P3|Part B|Not treated|8
837907|NCT01085136|2661416|P2|Part B|Not treated|4
837908|NCT01085136|2661417|P1|Part B|Not treated|0
837909|NCT01085136|2661415|P3|Part B|Refusal to continue trial medication|7
837910|NCT01085136|2661416|P2|Part B|Refusal to continue trial medication|12
837911|NCT01085136|2661417|P1|Part B|Refusal to continue trial medication|0
837912|NCT01085136|2661415|P3|Part B|Other AE|8
837913|NCT01085136|2661416|P2|Part B|Other AE|29
837914|NCT01085136|2661417|P1|Part B|Other AE|0
837915|NCT01085136|2661415|P3|Part A|Other reason not defined above|0
837916|NCT01085136|2661416|P2|Part A|Other reason not defined above|0
837917|NCT01085136|2661417|P1|Part A|Other reason not defined above|30
837918|NCT01085136|2661415|P3|Part A|Refusal to continue trial medication|0
837919|NCT01085136|2661416|P2|Part A|Refusal to continue trial medication|0
837920|NCT01085136|2661417|P1|Part A|Refusal to continue trial medication|64
837921|NCT01085136|2661415|P3|Part A|Lost to Follow-up|0
837922|NCT01085136|2661416|P2|Part A|Lost to Follow-up|0
837923|NCT01085136|2661417|P1|Part A|Lost to Follow-up|3
837924|NCT01085136|2661415|P3|Part A|Protocol Violation|0
837925|NCT01085136|2661416|P2|Part A|Protocol Violation|0
837926|NCT01085136|2661417|P1|Part A|Protocol Violation|3
837927|NCT01085136|2661415|P3|Part A|Other Adverse event|0
837928|NCT01085136|2661416|P2|Part A|Other Adverse event|0
837929|NCT01085136|2661417|P1|Part A|Other Adverse event|223
837930|NCT01085201|2661438|P5|Overall Study|Fond ineligible after consent|0
837931|NCT01085201|2661439|P4|Overall Study|Fond ineligible after consent|0
837932|NCT01085201|2661440|P3|Overall Study|Fond ineligible after consent|1
837933|NCT01085201|2661441|P2|Overall Study|Fond ineligible after consent|1
837934|NCT01085201|2661442|P1|Overall Study|Fond ineligible after consent|0
837935|NCT01085201|2661438|P5|Overall Study|Unknown- no study drug|0
837936|NCT01085201|2661439|P4|Overall Study|Unknown- no study drug|0
837937|NCT01085201|2661440|P3|Overall Study|Unknown- no study drug|0
837938|NCT01085201|2661441|P2|Overall Study|Unknown- no study drug|0
837939|NCT01085201|2661442|P1|Overall Study|Unknown- no study drug|2
837940|NCT01085201|2661438|P5|Overall Study|Scheduling conflict|0
837941|NCT01085201|2661439|P4|Overall Study|Scheduling conflict|0
837942|NCT01085201|2661440|P3|Overall Study|Scheduling conflict|1
837943|NCT01085201|2661441|P2|Overall Study|Scheduling conflict|0
837944|NCT01085201|2661442|P1|Overall Study|Scheduling conflict|1
837945|NCT01085214|2661464|P1|Overall Study|Alternate treatment required|1
837946|NCT01085357|2661526|P2|Overall Study|Lost to Follow-up|0
837947|NCT01085357|2661527|P1|Overall Study|Lost to Follow-up|2
837948|NCT01085357|2661526|P2|Overall Study|Death|1
837949|NCT01085357|2661527|P1|Overall Study|Death|11
837950|NCT01085357|2661526|P2|Overall Study|Investigator Decision|1
837951|NCT01085357|2661527|P1|Overall Study|Investigator Decision|1
837952|NCT01085357|2661526|P2|Overall Study|Subject Decision|3
837953|NCT01085357|2661527|P1|Overall Study|Subject Decision|4
837954|NCT01085357|2661526|P2|Overall Study|Adverse Event|1
837955|NCT01085357|2661527|P1|Overall Study|Adverse Event|1
837956|NCT01085591|2661566|P3|Overall Study|Not Properly Consented|0
837957|NCT01085591|2661567|P2|Overall Study|Not Properly Consented|0
837958|NCT01085591|2661568|P1|Overall Study|Not Properly Consented|1
837959|NCT01085591|2661566|P3|Overall Study|Other|0
837960|NCT01085591|2661567|P2|Overall Study|Other|1
837961|NCT01085591|2661568|P1|Overall Study|Other|0
837962|NCT01085591|2661566|P3|Overall Study|Protocol Violation|1
837963|NCT01085591|2661567|P2|Overall Study|Protocol Violation|1
837964|NCT01085591|2661568|P1|Overall Study|Protocol Violation|1
837965|NCT01085591|2661566|P3|Overall Study|Lost to Follow-up|1
837966|NCT01085591|2661567|P2|Overall Study|Lost to Follow-up|1
837967|NCT01085591|2661568|P1|Overall Study|Lost to Follow-up|0
837968|NCT01085591|2661566|P3|Overall Study|Withdrawal by Subject|1
837969|NCT01085591|2661567|P2|Overall Study|Withdrawal by Subject|2
837970|NCT01085591|2661568|P1|Overall Study|Withdrawal by Subject|0
837971|NCT01085591|2661566|P3|Overall Study|Physician Decision|1
837972|NCT01085591|2661567|P2|Overall Study|Physician Decision|0
837973|NCT01085591|2661568|P1|Overall Study|Physician Decision|1
837974|NCT01085591|2661566|P3|Overall Study|Adverse Event|3
837975|NCT01085591|2661567|P2|Overall Study|Adverse Event|1
837976|NCT01085591|2661568|P1|Overall Study|Adverse Event|0
837977|NCT01085682|2661602|P2|Overall Study|Withdrawal by Subject|25
837978|NCT01085682|2661603|P1|Overall Study|Withdrawal by Subject|25
837979|NCT01085734|2661611|P2|Overall Study|Withdrawal by Subject|1
837980|NCT01085734|2661612|P1|Overall Study|Withdrawal by Subject|0
837981|NCT01085734|2661611|P2|Overall Study|Lost to Follow-up|1
837982|NCT01085734|2661612|P1|Overall Study|Lost to Follow-up|0
837983|NCT01085734|2661611|P2|Overall Study|Death|0
837984|NCT01085734|2661612|P1|Overall Study|Death|1
837985|NCT01085734|2661611|P2|Overall Study|Adverse Event|2
837986|NCT01085734|2661612|P1|Overall Study|Adverse Event|0
837987|NCT01086033|2661714|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
837988|NCT01086033|2661714|P1|Overall Study|AE and Other Reason|1
837989|NCT01086033|2661714|P1|Overall Study|AE and Lost to Follow-up|1
837990|NCT01086033|2661714|P1|Overall Study|Death|1
837991|NCT01086033|2661714|P1|Overall Study|AE and Lack of Efficacy|4
837992|NCT01086033|2661714|P1|Overall Study|Withdrew consent and Other Reason|4
837993|NCT01086033|2661714|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
837994|NCT01086033|2661714|P1|Overall Study|AE and Withdrew Consent|5
837995|NCT01086033|2661714|P1|Overall Study|Other|13
837996|NCT01086033|2661714|P1|Overall Study|Other|14
837997|NCT01086033|2661714|P1|Overall Study|Withdrawal by Subject|41
837998|NCT01086033|2661714|P1|Overall Study|Adverse Event|42
837999|NCT01086033|2661714|P1|Overall Study|Lost to Follow-up|86
838000|NCT01086033|2661714|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
838001|NCT01086215|2661730|P4|Overall Study|Lost to Follow-up|2
838002|NCT01086215|2661731|P3|Overall Study|Lost to Follow-up|18
838003|NCT01086215|2661732|P2|Overall Study|Lost to Follow-up|39
838004|NCT01086215|2661733|P1|Overall Study|Lost to Follow-up|22
838005|NCT01086215|2661730|P4|Overall Study|Death|1
838006|NCT01086215|2661731|P3|Overall Study|Death|8
838007|NCT01086215|2661732|P2|Overall Study|Death|8
838008|NCT01086215|2661733|P1|Overall Study|Death|14
838009|NCT01092416|2661751|P1|12-Month Follow-up|Data collected after close of 1Y window|2
838010|NCT01092416|2661751|P1|12-Month Follow-up|Missed 1-year follow-up|1
838011|NCT01092416|2661751|P1|12-Month Follow-up|Withdrawal by Subject|2
838012|NCT01092416|2661751|P1|12-Month Follow-up|Lost to Follow-up|4
838013|NCT01092416|2661751|P1|12-Month Follow-up|Death|16
838014|NCT01092416|2661751|P1|30-Day Follow-up|Data collected after close of 30D window|5
838015|NCT01092416|2661751|P1|30-Day Follow-up|Missed 30-day follow-up|3
838016|NCT01092416|2661751|P1|30-Day Follow-up|Death|2
838017|NCT01092416|2661751|P1|Enrollment|Atherectomy device not inserted|3
838018|NCT01092507|2661779|P2|Overall Study|Withdrawal by Subject|0
838019|NCT01092507|2661780|P1|Overall Study|Withdrawal by Subject|2
838020|NCT01092546|2661798|P1|Overall Study|Subjects withdrawn prior to dosing|4
838021|NCT01092637|2661810|P2|Overall Study|Death|49
838022|NCT01092637|2661811|P1|Overall Study|Death|47
838023|NCT01092663|2661823|P2|Overall Study|Protocol Violation|1
838024|NCT01092663|2661824|P1|Overall Study|Protocol Violation|0
838025|NCT01092663|2661823|P2|Overall Study|Adverse Event|1
838026|NCT01092663|2661824|P1|Overall Study|Adverse Event|1
838027|NCT01092663|2661823|P2|Overall Study|High fasting triglyceride|0
838028|NCT01092663|2661824|P1|Overall Study|High fasting triglyceride|2
838029|NCT01092663|2661823|P2|Overall Study|Glucose >300mg/dL|0
838030|NCT01092663|2661824|P1|Overall Study|Glucose >300mg/dL|1
838031|NCT01092663|2661823|P2|Overall Study|Withdrawal by Subject|2
838032|NCT01092663|2661824|P1|Overall Study|Withdrawal by Subject|3
838033|NCT01092702|2661870|P1|Overall Study|Lost to Follow-up|2
838034|NCT01092702|2661870|P1|Overall Study|Withdrawal by Subject|7
838035|NCT01095094|2661874|P1|Overall Study|Physician Decision|1
838036|NCT01095094|2661874|P1|Overall Study|Death|1
838037|NCT01095094|2661874|P1|Overall Study|Withdrawal by Subject|1
838038|NCT01095250|2661883|P4|Overall Study|Withdrawal by Subject|0
838039|NCT01095250|2661884|P3|Overall Study|Withdrawal by Subject|1
838040|NCT01095250|2661885|P2|Overall Study|Withdrawal by Subject|0
838041|NCT01095250|2661886|P1|Overall Study|Withdrawal by Subject|0
838042|NCT01095250|2661883|P4|Overall Study|administrative reasons|5
838043|NCT01095250|2661884|P3|Overall Study|administrative reasons|7
838044|NCT01095250|2661885|P2|Overall Study|administrative reasons|10
838045|NCT01095250|2661886|P1|Overall Study|administrative reasons|8
838046|NCT01095653|2661953|P3|Overall Study|non-compliance, not met criteria, etc.|5
838047|NCT01095653|2661954|P2|Overall Study|non-compliance, not met criteria, etc.|6
838048|NCT01095653|2661955|P1|Overall Study|non-compliance, not met criteria, etc.|10
838049|NCT01095653|2661953|P3|Overall Study|Withdrawal by Subject|3
838050|NCT01095653|2661954|P2|Overall Study|Withdrawal by Subject|5
838051|NCT01095653|2661955|P1|Overall Study|Withdrawal by Subject|4
838052|NCT01095653|2661953|P3|Overall Study|Lost to Follow-up|4
838053|NCT01095653|2661954|P2|Overall Study|Lost to Follow-up|0
838054|NCT01095653|2661955|P1|Overall Study|Lost to Follow-up|1
838055|NCT01095653|2661953|P3|Overall Study|Adverse Event|4
838056|NCT01095653|2661954|P2|Overall Study|Adverse Event|4
838057|NCT01095653|2661955|P1|Overall Study|Adverse Event|1
838058|NCT01095653|2661953|P3|Overall Study|Lack of Efficacy|0
838059|NCT01095653|2661954|P2|Overall Study|Lack of Efficacy|0
838060|NCT01095653|2661955|P1|Overall Study|Lack of Efficacy|3
838061|NCT01095666|2661978|P3|Overall Study|Non-compliance, not met criteria etc.|2
838062|NCT01095666|2661979|P2|Overall Study|Non-compliance, not met criteria etc.|2
838063|NCT01095666|2661980|P1|Overall Study|Non-compliance, not met criteria etc.|7
838064|NCT01095666|2661978|P3|Overall Study|Withdrawal by Subject|1
838065|NCT01095666|2661979|P2|Overall Study|Withdrawal by Subject|6
838066|NCT01095666|2661980|P1|Overall Study|Withdrawal by Subject|6
838067|NCT01095666|2661978|P3|Overall Study|Lost to Follow-up|0
838068|NCT01095666|2661979|P2|Overall Study|Lost to Follow-up|2
838069|NCT01095666|2661980|P1|Overall Study|Lost to Follow-up|2
838070|NCT01095666|2661978|P3|Overall Study|Adverse Event|3
838071|NCT01095666|2661979|P2|Overall Study|Adverse Event|1
838072|NCT01095666|2661980|P1|Overall Study|Adverse Event|2
838073|NCT01095666|2661978|P3|Overall Study|Lack of Efficacy|1
838074|NCT01095666|2661979|P2|Overall Study|Lack of Efficacy|0
838075|NCT01095666|2661980|P1|Overall Study|Lack of Efficacy|0
838076|NCT01095796|2662011|P2|Overall Study|Participant Transferred to Another Study|200
838077|NCT01095796|2662012|P1|Overall Study|Participant Transferred to Another Study|215
838078|NCT01095796|2662011|P2|Overall Study|Protocol Violation|0
838079|NCT01095796|2662012|P1|Overall Study|Protocol Violation|1
838080|NCT01095796|2662011|P2|Overall Study|Participant Noncompliance|10
838081|NCT01095796|2662012|P1|Overall Study|Participant Noncompliance|5
838082|NCT01095796|2662011|P2|Overall Study|Lost to Follow-up|29
838083|NCT01095796|2662012|P1|Overall Study|Lost to Follow-up|27
838084|NCT01095796|2662011|P2|Overall Study|Withdrew Consent|22
838085|NCT01095796|2662012|P1|Overall Study|Withdrew Consent|16
838086|NCT01095796|2662011|P2|Overall Study|Investigator's Discretion|2
838087|NCT01095796|2662012|P1|Overall Study|Investigator's Discretion|7
838088|NCT01095796|2662011|P2|Overall Study|Lack of Efficacy|3
838089|NCT01095796|2662012|P1|Overall Study|Lack of Efficacy|5
838090|NCT01095796|2662011|P2|Overall Study|Pregnancy|0
838091|NCT01095796|2662012|P1|Overall Study|Pregnancy|2
838092|NCT01095796|2662011|P2|Overall Study|Death|2
838093|NCT01095796|2662012|P1|Overall Study|Death|3
838094|NCT01095796|2662011|P2|Overall Study|Adverse Event|19
838095|NCT01095796|2662012|P1|Overall Study|Adverse Event|9
838096|NCT01095796|2662011|P2|Overall Study|Randomized but Not Treated|2
838097|NCT01095796|2662012|P1|Overall Study|Randomized but Not Treated|5
838098|NCT01095835|2662033|P3|Overall Study|Protocol Violation|0
838099|NCT01095835|2662034|P2|Overall Study|Protocol Violation|2
838100|NCT01095835|2662035|P1|Overall Study|Protocol Violation|1
838101|NCT01095835|2662033|P3|Overall Study|Non study compliance|1
838102|NCT01095835|2662034|P2|Overall Study|Non study compliance|0
838103|NCT01095835|2662035|P1|Overall Study|Non study compliance|0
838104|NCT01095835|2662033|P3|Overall Study|Withdrawal by Subject|0
838105|NCT01095835|2662034|P2|Overall Study|Withdrawal by Subject|3
838106|NCT01095835|2662035|P1|Overall Study|Withdrawal by Subject|1
838107|NCT01095835|2662033|P3|Overall Study|Physician Decision|1
838108|NCT01095835|2662034|P2|Overall Study|Physician Decision|0
838109|NCT01095835|2662035|P1|Overall Study|Physician Decision|0
838110|NCT01095835|2662033|P3|Overall Study|Lack of Efficacy|0
838111|NCT01095835|2662034|P2|Overall Study|Lack of Efficacy|1
838112|NCT01095835|2662035|P1|Overall Study|Lack of Efficacy|0
838113|NCT01095835|2662033|P3|Overall Study|Adverse Event|6
838114|NCT01095835|2662034|P2|Overall Study|Adverse Event|6
838115|NCT01095835|2662035|P1|Overall Study|Adverse Event|8
838116|NCT01095978|2662075|P1|Overall Study|Adverse Event|1
838117|NCT01095978|2662075|P1|Overall Study|Did not take Klacid SR|2
838118|NCT01096017|2662102|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
838119|NCT01096017|2662103|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
838120|NCT01096056|2662133|P2|Overall Study|Lost to Follow-up|1
838121|NCT01096056|2662134|P1|Overall Study|Lost to Follow-up|0
838122|NCT01096186|2662166|P1|Overall Study|Noncompliance with study drug|1
838123|NCT01096186|2662166|P1|Overall Study|Physician Decision|1
838124|NCT01096186|2662166|P1|Overall Study|Withdrawal by Subject|22
838125|NCT01096186|2662166|P1|Overall Study|Lost to Follow-up|2
838126|NCT01096186|2662166|P1|Overall Study|Lack of Efficacy|4
838127|NCT01096186|2662166|P1|Overall Study|Death|4
838128|NCT01096186|2662166|P1|Overall Study|Adverse Event|16
838129|NCT01096316|2662174|P2|Overall Study|Lost to Follow-up|9
838130|NCT01096316|2662175|P1|Overall Study|Lost to Follow-up|15
838131|NCT01096342|2662185|P1|Overall Study|Protocol Violation|1
838132|NCT01096446|2662193|P2|Overall Study|Protocol Violation|0
838133|NCT01096446|2662194|P1|Overall Study|Protocol Violation|2
838134|NCT01096446|2662193|P2|Overall Study|Death|0
838135|NCT01096446|2662194|P1|Overall Study|Death|1
838136|NCT01096550|2662201|P2|Overall Study|Lost to Follow-up|9
838137|NCT01096550|2662202|P1|Overall Study|Lost to Follow-up|12
838138|NCT01096550|2662201|P2|Overall Study|non-African American participant|6
838139|NCT01096550|2662202|P1|Overall Study|non-African American participant|13
838140|NCT01096550|2662201|P2|Overall Study|Withdrawal by Subject|1
838141|NCT01096550|2662202|P1|Overall Study|Withdrawal by Subject|0
838142|NCT01096550|2662201|P2|Overall Study|clinic readmission|1
838143|NCT01096550|2662202|P1|Overall Study|clinic readmission|1
838144|NCT01096550|2662201|P2|Overall Study|non-regular treatment track at clinic|1
838145|NCT01096550|2662202|P1|Overall Study|non-regular treatment track at clinic|1
838146|NCT01096550|2662201|P2|Overall Study|discontinued site|11
838147|NCT01096550|2662202|P1|Overall Study|discontinued site|10
838148|NCT01096589|2662212|P4|Overall Study|found treatment exhausting|1
838149|NCT01096589|2662213|P3|Overall Study|found treatment exhausting|0
838150|NCT01096589|2662214|P2|Overall Study|found treatment exhausting|0
838151|NCT01096589|2662215|P1|Overall Study|found treatment exhausting|0
838152|NCT01096589|2662212|P4|Overall Study|Compliance with protocol|0
838153|NCT01096589|2662213|P3|Overall Study|Compliance with protocol|1
838154|NCT01096589|2662214|P2|Overall Study|Compliance with protocol|0
838155|NCT01096589|2662215|P1|Overall Study|Compliance with protocol|0
838156|NCT01096589|2662212|P4|Overall Study|Withdrawal by Subject|1
838157|NCT01096589|2662213|P3|Overall Study|Withdrawal by Subject|1
838158|NCT01096589|2662214|P2|Overall Study|Withdrawal by Subject|1
838159|NCT01096589|2662215|P1|Overall Study|Withdrawal by Subject|2
838160|NCT01096589|2662212|P4|Overall Study|Adverse Event|1
838161|NCT01096589|2662213|P3|Overall Study|Adverse Event|2
838162|NCT01096589|2662214|P2|Overall Study|Adverse Event|1
838163|NCT01096589|2662215|P1|Overall Study|Adverse Event|2
838164|NCT01096784|2662295|P2|Overall Study|Other Unspecified|1
838165|NCT01096784|2662296|P1|Overall Study|Other Unspecified|0
838166|NCT01096784|2662295|P2|Overall Study|Administrative Decision|1
838167|NCT01096784|2662296|P1|Overall Study|Administrative Decision|0
838168|NCT01096784|2662295|P2|Overall Study|Protocol Deviation|2
838169|NCT01096784|2662296|P1|Overall Study|Protocol Deviation|2
838170|NCT01096784|2662295|P2|Overall Study|Adverse Event|9
838171|NCT01096784|2662296|P1|Overall Study|Adverse Event|11
838172|NCT01096784|2662295|P2|Overall Study|Withdrawal by Subject|1
838173|NCT01096784|2662296|P1|Overall Study|Withdrawal by Subject|2
838174|NCT01097005|2662364|P1|Overall Study|Discontinuance by complication|50
838175|NCT01097005|2662364|P1|Overall Study|Adverse Event|14
838176|NCT01097005|2662364|P1|Overall Study|Deviation from exclusion criteria|37
838177|NCT01097005|2662364|P1|Overall Study|No examination data available|244
838178|NCT01097005|2662364|P1|Overall Study|Poor medication compliance|1
838179|NCT01097005|2662364|P1|Overall Study|Subjects cannot visit the hospital|1
838180|NCT01097005|2662364|P1|Overall Study|Case Report Form not collected|18
838181|NCT01097057|2662370|P1|Overall Study|Physician Decision|3
838182|NCT01097421|2662388|P1|Overall Study|Withdrawal by Subject|3
838183|NCT01097421|2662388|P1|Overall Study|Lost to Follow-up|1
838184|NCT01097421|2662388|P1|Overall Study|Protocol Violation|2
838185|NCT01097421|2662388|P1|Overall Study|Adverse Event|8
838186|NCT01089361|2662429|P2|Overall Study|Death|0
838187|NCT01089361|2662430|P1|Overall Study|Death|1
838188|NCT01089413|2662451|P1|Overall Study|Unspecified|71
838189|NCT01089413|2662451|P1|Overall Study|Metastasectomy|13
838190|NCT01089413|2662451|P1|Overall Study|Death|10
838191|NCT01089413|2662451|P1|Overall Study|Unacceptable Toxicity|12
838192|NCT01089413|2662451|P1|Overall Study|Participant Withdrew Consent|1
838193|NCT01089413|2662451|P1|Overall Study|Progressive Disease|93
838194|NCT01089413|2662451|P1|Overall Study|Lost to Follow-up|1
838195|NCT01089504|2662470|P2|Overall Study|Withdrawal by Subject|0
838196|NCT01089504|2662471|P1|Overall Study|Withdrawal by Subject|2
838197|NCT01089504|2662470|P2|Overall Study|Lost to Follow-up|1
838198|NCT01089504|2662471|P1|Overall Study|Lost to Follow-up|1
838199|NCT01089543|2662504|P4|Overall Study|Adverse Event|0
838200|NCT01089543|2662505|P3|Overall Study|Adverse Event|0
838201|NCT01089543|2662506|P2|Overall Study|Adverse Event|1
838202|NCT01089543|2662507|P1|Overall Study|Adverse Event|0
838203|NCT01089543|2662504|P4|Overall Study|Physician Decision|1
838204|NCT01089543|2662505|P3|Overall Study|Physician Decision|0
838205|NCT01089543|2662506|P2|Overall Study|Physician Decision|0
838206|NCT01089543|2662507|P1|Overall Study|Physician Decision|1
838207|NCT01089543|2662504|P4|Overall Study|Withdrawal by Subject|1
838208|NCT01089543|2662505|P3|Overall Study|Withdrawal by Subject|3
838209|NCT01089543|2662506|P2|Overall Study|Withdrawal by Subject|3
838210|NCT01089543|2662507|P1|Overall Study|Withdrawal by Subject|2
838211|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
838212|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
838213|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
838214|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
838215|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
838216|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
838217|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
838218|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
838219|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
838220|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
838221|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
838222|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
838223|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
838224|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
838225|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
838226|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
838227|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
838228|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
838229|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
838230|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
838231|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
838232|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
838233|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
838234|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
838235|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
838236|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
838237|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
838238|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
838239|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
838240|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
838241|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
838242|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
838243|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
838244|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
838245|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
838246|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
838247|NCT01089556|2662523|P6|Study Period III (Weeks 9-16)|Adverse Event|3
838248|NCT01089556|2662524|P5|Study Period III (Weeks 9-16)|Adverse Event|4
838249|NCT01089556|2662525|P4|Study Period III (Weeks 9-16)|Adverse Event|2
838250|NCT01089556|2662526|P3|Study Period III (Weeks 9-16)|Adverse Event|4
838251|NCT01089556|2662527|P2|Study Period III (Weeks 9-16)|Adverse Event|0
838252|NCT01089556|2662528|P1|Study Period III (Weeks 9-16)|Adverse Event|0
838253|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
838254|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
838255|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
838256|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
838257|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
838258|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
838259|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
838260|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
838261|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
838262|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
838263|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
838264|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
838265|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
838266|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
838267|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
838268|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
838269|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
838270|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
838271|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Physician Decision|0
838272|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Physician Decision|0
838273|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Physician Decision|0
838274|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Physician Decision|0
838275|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Physician Decision|0
838276|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Physician Decision|4
838277|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
838278|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
838279|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
838280|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
838281|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
838282|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
838283|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
838284|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
838285|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
838286|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
838287|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
838288|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
838289|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
838290|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
838291|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
838292|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
838293|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
838294|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
838295|NCT01089556|2662523|P6|Study Period II (Weeks 1-8)|Adverse Event|0
838296|NCT01089556|2662524|P5|Study Period II (Weeks 1-8)|Adverse Event|0
838297|NCT01089556|2662525|P4|Study Period II (Weeks 1-8)|Adverse Event|0
838298|NCT01089556|2662526|P3|Study Period II (Weeks 1-8)|Adverse Event|0
838299|NCT01089556|2662527|P2|Study Period II (Weeks 1-8)|Adverse Event|39
838300|NCT01089556|2662528|P1|Study Period II (Weeks 1-8)|Adverse Event|35
838301|NCT01089582|2662629|P1|Overall Study|Withdrawal by Subject|1
838302|NCT01089582|2662629|P1|Overall Study|Unspecified|4
838303|NCT01089582|2662629|P1|Overall Study|Lost to Follow-up|8
838304|NCT01089582|2662629|P1|Overall Study|Adverse Event|15
838305|NCT01089582|2662629|P1|Overall Study|Death|2
838306|NCT01089608|2662652|P2|Overall Study|Lost to Follow-up|2
838307|NCT01089608|2662653|P1|Overall Study|Lost to Follow-up|0
838308|NCT01089608|2662652|P2|Overall Study|Adverse Event|4
838309|NCT01089608|2662653|P1|Overall Study|Adverse Event|0
838310|NCT01097616|2662685|P8|DB RO Phase|Not Treated in RO|0
838311|NCT01097616|2662686|P7|DB RO Phase|Not Treated in RO|0
838312|NCT01097616|2662687|P6|DB RO Phase|Not Treated in RO|1
838313|NCT01097616|2662688|P5|DB RO Phase|Not Treated in RO|0
838314|NCT01097616|2662689|P4|DB RO Phase|Not Treated in RO|0
838315|NCT01097616|2662690|P3|DB RO Phase|Not Treated in RO|0
838316|NCT01097616|2662691|P2|DB RO Phase|Not Treated in RO|0
838317|NCT01097616|2662692|P1|DB RO Phase|Not Treated in RO|0
838318|NCT01097616|2662685|P8|DB RO Phase|Lost to Follow-up|1
838319|NCT01097616|2662686|P7|DB RO Phase|Lost to Follow-up|0
838320|NCT01097616|2662687|P6|DB RO Phase|Lost to Follow-up|0
838321|NCT01097616|2662688|P5|DB RO Phase|Lost to Follow-up|1
838322|NCT01097616|2662689|P4|DB RO Phase|Lost to Follow-up|1
838323|NCT01097616|2662690|P3|DB RO Phase|Lost to Follow-up|0
838324|NCT01097616|2662691|P2|DB RO Phase|Lost to Follow-up|0
838325|NCT01097616|2662692|P1|DB RO Phase|Lost to Follow-up|0
838326|NCT01097616|2662685|P8|DB RO Phase|Withdrawal by Subject|0
838327|NCT01097616|2662686|P7|DB RO Phase|Withdrawal by Subject|0
838328|NCT01097616|2662687|P6|DB RO Phase|Withdrawal by Subject|1
838329|NCT01097616|2662688|P5|DB RO Phase|Withdrawal by Subject|0
838330|NCT01097616|2662689|P4|DB RO Phase|Withdrawal by Subject|0
838331|NCT01097616|2662690|P3|DB RO Phase|Withdrawal by Subject|0
838332|NCT01097616|2662691|P2|DB RO Phase|Withdrawal by Subject|0
838333|NCT01097616|2662692|P1|DB RO Phase|Withdrawal by Subject|0
838334|NCT01097616|2662685|P8|DB RO Phase|Adverse Event|0
838335|NCT01097616|2662686|P7|DB RO Phase|Adverse Event|1
838336|NCT01097616|2662687|P6|DB RO Phase|Adverse Event|0
838337|NCT01097616|2662688|P5|DB RO Phase|Adverse Event|0
838338|NCT01097616|2662689|P4|DB RO Phase|Adverse Event|0
838339|NCT01097616|2662690|P3|DB RO Phase|Adverse Event|0
838340|NCT01097616|2662691|P2|DB RO Phase|Adverse Event|0
838341|NCT01097616|2662692|P1|DB RO Phase|Adverse Event|0
838342|NCT01097616|2662685|P8|Optional DB EXT Phase|Physician Decision|0
838343|NCT01097616|2662686|P7|Optional DB EXT Phase|Physician Decision|0
838344|NCT01097616|2662687|P6|Optional DB EXT Phase|Physician Decision|0
838345|NCT01097616|2662688|P5|Optional DB EXT Phase|Physician Decision|0
838346|NCT01097616|2662689|P4|Optional DB EXT Phase|Physician Decision|0
838347|NCT01097616|2662690|P3|Optional DB EXT Phase|Physician Decision|0
838348|NCT01097616|2662691|P2|Optional DB EXT Phase|Physician Decision|0
838349|NCT01097616|2662692|P1|Optional DB EXT Phase|Physician Decision|1
838350|NCT01097616|2662685|P8|Optional DB EXT Phase|Lack of Efficacy|0
838351|NCT01097616|2662686|P7|Optional DB EXT Phase|Lack of Efficacy|0
838352|NCT01097616|2662687|P6|Optional DB EXT Phase|Lack of Efficacy|0
838353|NCT01097616|2662688|P5|Optional DB EXT Phase|Lack of Efficacy|0
838354|NCT01097616|2662689|P4|Optional DB EXT Phase|Lack of Efficacy|0
838355|NCT01097616|2662690|P3|Optional DB EXT Phase|Lack of Efficacy|1
838356|NCT01097616|2662691|P2|Optional DB EXT Phase|Lack of Efficacy|1
838357|NCT01097616|2662692|P1|Optional DB EXT Phase|Lack of Efficacy|1
838358|NCT01097616|2662685|P8|Optional DB EXT Phase|Lost to Follow-up|0
838359|NCT01097616|2662686|P7|Optional DB EXT Phase|Lost to Follow-up|0
838360|NCT01097616|2662687|P6|Optional DB EXT Phase|Lost to Follow-up|0
838361|NCT01097616|2662688|P5|Optional DB EXT Phase|Lost to Follow-up|0
838362|NCT01097616|2662689|P4|Optional DB EXT Phase|Lost to Follow-up|0
838363|NCT01097616|2662690|P3|Optional DB EXT Phase|Lost to Follow-up|1
838364|NCT01097616|2662691|P2|Optional DB EXT Phase|Lost to Follow-up|5
838365|NCT01097616|2662692|P1|Optional DB EXT Phase|Lost to Follow-up|1
838366|NCT01097616|2662685|P8|Optional DB EXT Phase|Protocol Violation|0
838367|NCT01097616|2662686|P7|Optional DB EXT Phase|Protocol Violation|0
838368|NCT01097616|2662687|P6|Optional DB EXT Phase|Protocol Violation|0
838369|NCT01097616|2662688|P5|Optional DB EXT Phase|Protocol Violation|0
838370|NCT01097616|2662689|P4|Optional DB EXT Phase|Protocol Violation|0
838371|NCT01097616|2662690|P3|Optional DB EXT Phase|Protocol Violation|3
838372|NCT01097616|2662691|P2|Optional DB EXT Phase|Protocol Violation|2
838373|NCT01097616|2662692|P1|Optional DB EXT Phase|Protocol Violation|0
838374|NCT01097616|2662685|P8|Optional DB EXT Phase|Withdrawal by Subject|0
838375|NCT01097616|2662686|P7|Optional DB EXT Phase|Withdrawal by Subject|0
838376|NCT01097616|2662687|P6|Optional DB EXT Phase|Withdrawal by Subject|0
838377|NCT01097616|2662688|P5|Optional DB EXT Phase|Withdrawal by Subject|0
838378|NCT01097616|2662689|P4|Optional DB EXT Phase|Withdrawal by Subject|0
838379|NCT01097616|2662690|P3|Optional DB EXT Phase|Withdrawal by Subject|3
838380|NCT01097616|2662691|P2|Optional DB EXT Phase|Withdrawal by Subject|6
838381|NCT01097616|2662692|P1|Optional DB EXT Phase|Withdrawal by Subject|12
838382|NCT01097616|2662685|P8|Optional DB EXT Phase|Adverse Event|0
838383|NCT01097616|2662686|P7|Optional DB EXT Phase|Adverse Event|0
838384|NCT01097616|2662687|P6|Optional DB EXT Phase|Adverse Event|0
838385|NCT01097616|2662688|P5|Optional DB EXT Phase|Adverse Event|0
838386|NCT01097616|2662689|P4|Optional DB EXT Phase|Adverse Event|0
838387|NCT01097616|2662690|P3|Optional DB EXT Phase|Adverse Event|2
838388|NCT01097616|2662691|P2|Optional DB EXT Phase|Adverse Event|7
838389|NCT01097616|2662692|P1|Optional DB EXT Phase|Adverse Event|0
838390|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838391|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838392|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838393|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838394|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838395|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
838396|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838397|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838398|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838399|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838400|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838401|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838402|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838403|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838404|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
838405|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
838406|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838407|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838408|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838409|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838410|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838411|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
838412|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
838413|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
838414|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838415|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838416|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838417|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838418|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838419|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
838420|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
838421|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
838422|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838423|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838424|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838425|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838426|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838427|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838428|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
838429|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
838430|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838431|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838432|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838433|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838434|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838435|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
838436|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
838437|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
838438|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838439|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838440|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838441|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838442|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838443|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
838444|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
838445|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
838446|NCT01097616|2662685|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838447|NCT01097616|2662686|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838448|NCT01097616|2662687|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838449|NCT01097616|2662688|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838450|NCT01097616|2662689|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838451|NCT01097616|2662690|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
838452|NCT01097616|2662691|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
838453|NCT01097616|2662692|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
838454|NCT01097629|2662766|P8|DB RO Phase|Lost to Follow-up|0
838455|NCT01097629|2662767|P7|DB RO Phase|Lost to Follow-up|2
838456|NCT01097629|2662768|P6|DB RO Phase|Lost to Follow-up|0
838457|NCT01097629|2662769|P5|DB RO Phase|Lost to Follow-up|0
838458|NCT01097629|2662770|P4|DB RO Phase|Lost to Follow-up|0
838459|NCT01097629|2662771|P3|DB RO Phase|Lost to Follow-up|0
838460|NCT01097629|2662772|P2|DB RO Phase|Lost to Follow-up|0
838461|NCT01097629|2662773|P1|DB RO Phase|Lost to Follow-up|0
838462|NCT01097629|2662766|P8|DB RO Phase|Protocol Violation|0
838463|NCT01097629|2662767|P7|DB RO Phase|Protocol Violation|1
838464|NCT01097629|2662768|P6|DB RO Phase|Protocol Violation|1
838465|NCT01097629|2662769|P5|DB RO Phase|Protocol Violation|0
838466|NCT01097629|2662770|P4|DB RO Phase|Protocol Violation|1
838467|NCT01097629|2662771|P3|DB RO Phase|Protocol Violation|0
838468|NCT01097629|2662772|P2|DB RO Phase|Protocol Violation|0
838469|NCT01097629|2662773|P1|DB RO Phase|Protocol Violation|0
838470|NCT01097629|2662766|P8|DB RO Phase|Withdrawal by Subject|1
838471|NCT01097629|2662767|P7|DB RO Phase|Withdrawal by Subject|0
838472|NCT01097629|2662768|P6|DB RO Phase|Withdrawal by Subject|0
838473|NCT01097629|2662769|P5|DB RO Phase|Withdrawal by Subject|0
838474|NCT01097629|2662770|P4|DB RO Phase|Withdrawal by Subject|0
838475|NCT01097629|2662771|P3|DB RO Phase|Withdrawal by Subject|0
838476|NCT01097629|2662772|P2|DB RO Phase|Withdrawal by Subject|0
838477|NCT01097629|2662773|P1|DB RO Phase|Withdrawal by Subject|0
838478|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838479|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838480|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838481|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838482|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
838483|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
838484|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
838485|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
838486|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838487|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838488|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838489|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838490|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838491|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
838492|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
838493|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
838494|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838495|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838496|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838497|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838498|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
838499|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
838500|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
838501|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
838502|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838503|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838504|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838505|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838506|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
838507|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
838508|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
838509|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
838510|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838511|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838512|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838513|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838514|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
838515|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
838516|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
838517|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
838518|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838519|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838520|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838521|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838522|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
838523|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
838524|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
838525|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
838526|NCT01097629|2662766|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838527|NCT01097629|2662767|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838528|NCT01097629|2662768|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838529|NCT01097629|2662769|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838530|NCT01097629|2662770|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
838531|NCT01097629|2662771|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
838532|NCT01097629|2662772|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
838533|NCT01097629|2662773|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
838534|NCT01097655|2662821|P1|Overall Study|Did Not Meet Inclusion Criteria|8
838535|NCT01097655|2662821|P1|Overall Study|Subject Documented Twice|1
838536|NCT01097655|2662821|P1|Overall Study|Withdrawal by Subject|1
838537|NCT01097668|2662830|P2|Overall Study|Lost to Follow-up|0
838538|NCT01097668|2662831|P1|Overall Study|Lost to Follow-up|1
838539|NCT01097668|2662830|P2|Overall Study|Withdrawal by Subject|2
838540|NCT01097668|2662831|P1|Overall Study|Withdrawal by Subject|1
838541|NCT01097694|2662843|P2|Overall Study|Withdrawal by Subject|1
838542|NCT01097694|2662844|P1|Overall Study|Withdrawal by Subject|3
838543|NCT01097694|2662843|P2|Overall Study|Lost to Follow-up|3
838544|NCT01097694|2662844|P1|Overall Study|Lost to Follow-up|0
838545|NCT01097694|2662843|P2|Overall Study|Adverse Event|0
838546|NCT01097694|2662844|P1|Overall Study|Adverse Event|5
838547|NCT01097863|2662918|P3|Overall Study|Did not return for final visit|1
838548|NCT01097863|2662919|P2|Overall Study|Did not return for final visit|0
838549|NCT01097863|2662920|P1|Overall Study|Did not return for final visit|0
838550|NCT01097863|2662918|P3|Overall Study|Discomfort|1
838551|NCT01097863|2662919|P2|Overall Study|Discomfort|0
838552|NCT01097863|2662920|P1|Overall Study|Discomfort|1
838553|NCT01098032|2662930|P2|Overall Study|Withdrawal by Subject|1
838554|NCT01098032|2662931|P1|Overall Study|Withdrawal by Subject|1
838557|NCT01098097|2662948|P1|Overall Study|No reason reported|31
838558|NCT01098097|2662948|P1|Overall Study|Status unknown|16
838559|NCT01098097|2662948|P1|Overall Study|Lost to Follow-up|18
838560|NCT01098097|2662948|P1|Overall Study|Adverse Event|17
838561|NCT01098110|2662960|P3|Overall Study|Untreated|0
838562|NCT01098110|2662961|P2|Overall Study|Untreated|1
838563|NCT01098110|2662962|P1|Overall Study|Untreated|1
838564|NCT01098110|2662960|P3|Overall Study|Not Specified|5
838565|NCT01098110|2662961|P2|Overall Study|Not Specified|7
838566|NCT01098110|2662962|P1|Overall Study|Not Specified|4
838567|NCT01098110|2662960|P3|Overall Study|Lack of Efficacy|27
838568|NCT01098110|2662961|P2|Overall Study|Lack of Efficacy|9
838569|NCT01098110|2662962|P1|Overall Study|Lack of Efficacy|13
838570|NCT01098110|2662960|P3|Overall Study|Adverse Event|43
838571|NCT01098110|2662961|P2|Overall Study|Adverse Event|32
838572|NCT01098110|2662962|P1|Overall Study|Adverse Event|30
838573|NCT01098110|2662960|P3|Overall Study|Withdrawal by Subject|19
838574|NCT01098110|2662961|P2|Overall Study|Withdrawal by Subject|24
838575|NCT01098110|2662962|P1|Overall Study|Withdrawal by Subject|14
838576|NCT01098162|2663003|P1|Overall Study|Reason Unknown|26
838577|NCT01098162|2663003|P1|Overall Study|Other Reason|1
838578|NCT01098162|2663003|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
838579|NCT01098162|2663003|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
838580|NCT01098162|2663003|P1|Overall Study|Adverse Event & Lost to Follow-up|2
838581|NCT01098162|2663003|P1|Overall Study|Adverse Event & Wish of Patient|13
838582|NCT01098162|2663003|P1|Overall Study|Adverse Event & Lack of Efficacy|6
838583|NCT01098162|2663003|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
838584|NCT01098162|2663003|P1|Overall Study|Lost to Follow-up|9
838585|NCT01098162|2663003|P1|Overall Study|Wish of Patient|7
838586|NCT01098162|2663003|P1|Overall Study|Lack of Efficacy|4
838587|NCT01098162|2663003|P1|Overall Study|Adverse Event|37
838588|NCT01098240|2663012|P3|Double-Blind Phase|Adverse Event|3
838589|NCT01098240|2663013|P2|Double-Blind Phase|Adverse Event|3
838590|NCT01098240|2663014|P1|Double-Blind Phase|Adverse Event|0
838591|NCT01098240|2663012|P3|Double-Blind Phase|Withdrawal by Subject|3
838592|NCT01098240|2663013|P2|Double-Blind Phase|Withdrawal by Subject|1
838593|NCT01098240|2663014|P1|Double-Blind Phase|Withdrawal by Subject|0
838594|NCT01098240|2663012|P3|Double-Blind Phase|Insufficient Clinical Response|2
838595|NCT01098240|2663013|P2|Double-Blind Phase|Insufficient Clinical Response|1
838596|NCT01098240|2663014|P1|Double-Blind Phase|Insufficient Clinical Response|0
838597|NCT01098240|2663012|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
838598|NCT01098240|2663013|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
838599|NCT01098240|2663014|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
838600|NCT01098240|2663012|P3|Double-Blind Phase|Unspecified|2
838601|NCT01098240|2663013|P2|Double-Blind Phase|Unspecified|2
838602|NCT01098240|2663014|P1|Double-Blind Phase|Unspecified|0
838603|NCT01098240|2663012|P3|Double-Blind Phase|Lost to Follow-up|0
838604|NCT01098240|2663013|P2|Double-Blind Phase|Lost to Follow-up|2
838605|NCT01098240|2663014|P1|Double-Blind Phase|Lost to Follow-up|0
838606|NCT01098240|2663012|P3|Double-Blind Phase|Protocol Violation|4
838607|NCT01098240|2663013|P2|Double-Blind Phase|Protocol Violation|2
838608|NCT01098240|2663014|P1|Double-Blind Phase|Protocol Violation|0
838609|NCT01098240|2663012|P3|Double-Blind Phase|Study Terminated by Sponsor|8
838610|NCT01098240|2663013|P2|Double-Blind Phase|Study Terminated by Sponsor|5
838611|NCT01098240|2663014|P1|Double-Blind Phase|Study Terminated by Sponsor|0
838612|NCT01098240|2663012|P3|Open-Label Phase|Adverse Event|0
838613|NCT01098240|2663013|P2|Open-Label Phase|Adverse Event|0
838614|NCT01098240|2663014|P1|Open-Label Phase|Adverse Event|12
838615|NCT01098240|2663012|P3|Open-Label Phase|Withdrawal by Subject|0
838616|NCT01098240|2663013|P2|Open-Label Phase|Withdrawal by Subject|0
838617|NCT01098240|2663014|P1|Open-Label Phase|Withdrawal by Subject|9
838618|NCT01098240|2663012|P3|Open-Label Phase|Pregnancy|0
838619|NCT01098240|2663013|P2|Open-Label Phase|Pregnancy|0
838620|NCT01098240|2663014|P1|Open-Label Phase|Pregnancy|1
838621|NCT01098240|2663012|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
838622|NCT01098240|2663013|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
838623|NCT01098240|2663014|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
838624|NCT01098240|2663012|P3|Open-Label Phase|Unspecified|0
838625|NCT01098240|2663013|P2|Open-Label Phase|Unspecified|0
838626|NCT01098240|2663014|P1|Open-Label Phase|Unspecified|19
838627|NCT01098240|2663012|P3|Open-Label Phase|Lost to Follow-up|0
838628|NCT01098240|2663013|P2|Open-Label Phase|Lost to Follow-up|0
838629|NCT01098240|2663014|P1|Open-Label Phase|Lost to Follow-up|13
838630|NCT01098240|2663012|P3|Open-Label Phase|Protocol Violation|0
838631|NCT01098240|2663013|P2|Open-Label Phase|Protocol Violation|0
838632|NCT01098240|2663014|P1|Open-Label Phase|Protocol Violation|4
838633|NCT01098240|2663012|P3|Open-Label Phase|Study Terminated by Sponsor|0
838634|NCT01098240|2663013|P2|Open-Label Phase|Study Terminated by Sponsor|0
838635|NCT01098240|2663014|P1|Open-Label Phase|Study Terminated by Sponsor|27
838636|NCT01098305|2663057|P2|Overall Study|Lost to Follow-up|33
838637|NCT01098305|2663058|P1|Overall Study|Lost to Follow-up|31
838638|NCT01098461|2663083|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
838639|NCT01098461|2663084|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
838640|NCT01098461|2663085|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
838641|NCT01098461|2663086|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
838642|NCT01098461|2663083|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
838643|NCT01098461|2663084|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
838644|NCT01098461|2663085|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
838645|NCT01098461|2663086|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
838646|NCT01098461|2663083|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
838647|NCT01098461|2663084|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
838648|NCT01098461|2663085|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
838649|NCT01098461|2663086|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
838650|NCT01098461|2663083|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
838651|NCT01098461|2663084|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
838652|NCT01098461|2663085|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
838653|NCT01098461|2663086|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
838654|NCT01098461|2663083|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
838655|NCT01098461|2663084|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
838656|NCT01098461|2663085|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
838657|NCT01098461|2663086|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
838658|NCT01098461|2663083|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
838659|NCT01098461|2663084|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
838660|NCT01098461|2663085|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
838661|NCT01098461|2663086|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
838662|NCT01098461|2663083|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
838663|NCT01098461|2663084|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
838664|NCT01098461|2663085|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
838665|NCT01098461|2663086|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
838666|NCT01098487|2663116|P1|Overall Study|Physician Decision|1
838667|NCT01098487|2663116|P1|Overall Study|Lost to Follow-up|3
838668|NCT01098487|2663116|P1|Overall Study|Withdrawal by Subject|7
838669|NCT01098487|2663116|P1|Overall Study|Lack of Efficacy|11
838670|NCT01098487|2663116|P1|Overall Study|Adverse Event|22
838671|NCT01098539|2663145|P2|Overall Study|Physician Decision|3
838672|NCT01098539|2663146|P1|Overall Study|Physician Decision|5
838673|NCT01098539|2663145|P2|Overall Study|Withdrawal by Subject|26
838674|NCT01098539|2663146|P1|Overall Study|Withdrawal by Subject|12
838675|NCT01098539|2663145|P2|Overall Study|Lost to Follow-up|4
838676|NCT01098539|2663146|P1|Overall Study|Lost to Follow-up|4
838677|NCT01098539|2663145|P2|Overall Study|Noncompliance|5
838678|NCT01098539|2663146|P1|Overall Study|Noncompliance|3
838679|NCT01098539|2663145|P2|Overall Study|Protocol Violation|4
838680|NCT01098539|2663146|P1|Overall Study|Protocol Violation|1
838681|NCT01098539|2663145|P2|Overall Study|Adverse Event|26
838682|NCT01098539|2663146|P1|Overall Study|Adverse Event|26
838683|NCT01098812|2663249|P3|Overall Study|Lost to Follow-up|0
838684|NCT01098812|2663250|P2|Overall Study|Lost to Follow-up|1
838685|NCT01098812|2663251|P1|Overall Study|Lost to Follow-up|0
838686|NCT01098812|2663249|P3|Overall Study|Death|1
838687|NCT01098812|2663250|P2|Overall Study|Death|0
838688|NCT01098812|2663251|P1|Overall Study|Death|2
838689|NCT01098851|2663263|P2|Overall Study|Equipment failure|0
838690|NCT01098851|2663264|P1|Overall Study|Equipment failure|1
838691|NCT01099215|2663306|P2|Overall Study|Adverse Event|1
838692|NCT01099215|2663307|P1|Overall Study|Adverse Event|0
838693|NCT01099215|2663306|P2|Overall Study|Withdrawal by Subject|0
838694|NCT01099215|2663307|P1|Overall Study|Withdrawal by Subject|1
838695|NCT01099267|2663343|P1|MDS-003 Study|Secondary Malign Disease|1
838696|NCT01099267|2663343|P1|MDS-003 Study|Loss of Response|1
838697|NCT01099267|2663343|P1|MDS-003 Study|Non-Compliance|2
838698|NCT01099267|2663343|P1|MDS-003 Study|Investigator Decision|2
838699|NCT01099267|2663343|P1|MDS-003 Study|Disease Progression|7
838700|NCT01099267|2663343|P1|MDS-003 Study|Study Closed by Sponsor|2
838701|NCT01099267|2663343|P1|MDS-003 Study|Death|11
838702|NCT01099267|2663343|P1|MDS-003 Study|Lost to Follow-up|1
838703|NCT01099267|2663343|P1|MDS-003 Study|Withdrawal by Subject|8
838704|NCT01099267|2663343|P1|MDS-003 Study|Lack of Efficacy|52
838705|NCT01099267|2663343|P1|MDS-003 Study|Adverse Event|37
838706|NCT01099397|2663373|P1|Overall Study|Withdrawal by Subject|5
838707|NCT01099397|2663373|P1|Overall Study|Protocol Violation|4
838708|NCT01099397|2663373|P1|Overall Study|Lost to Follow-up|4
838709|NCT01099579|2663396|P3|Stage 2 (ATV Capsules )|Ongoing treatment|15
838710|NCT01099579|2663397|P2|Stage 2 (ATV Capsules )|Ongoing treatment|13
838711|NCT01099579|2663398|P1|Stage 2 (ATV Capsules )|Ongoing treatment|14
838712|NCT01099579|2663396|P3|Stage 2 (ATV Capsules )|Lost to Follow-up|0
838713|NCT01099579|2663397|P2|Stage 2 (ATV Capsules )|Lost to Follow-up|1
838714|NCT01099579|2663398|P1|Stage 2 (ATV Capsules )|Lost to Follow-up|0
838715|NCT01099579|2663396|P3|Stage 2 (ATV Capsules )|No longer met study criteria|0
838716|NCT01099579|2663397|P2|Stage 2 (ATV Capsules )|No longer met study criteria|0
838717|NCT01099579|2663398|P1|Stage 2 (ATV Capsules )|No longer met study criteria|2
838718|NCT01099579|2663396|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
838719|NCT01099579|2663397|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
838720|NCT01099579|2663398|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
838721|NCT01099579|2663396|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
838722|NCT01099579|2663397|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
838723|NCT01099579|2663398|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
838724|NCT01099579|2663396|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
838725|NCT01099579|2663397|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
838726|NCT01099579|2663398|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
838727|NCT01099579|2663396|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
838728|NCT01099579|2663397|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
838729|NCT01099579|2663398|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
838730|NCT01099709|2663465|P2|Period 1|Adverse Event|0
838731|NCT01099709|2663466|P1|Period 1|Adverse Event|1
838732|NCT01099709|2663465|P2|Period 1|Positive cotinine test|1
838733|NCT01099709|2663466|P1|Period 1|Positive cotinine test|0
838734|NCT01099709|2663465|P2|Period 1|Withdrawal by Subject|1
838735|NCT01099709|2663466|P1|Period 1|Withdrawal by Subject|0
838736|NCT01099917|2663534|P1|Overall Study|Not Treated|24
838737|NCT01099917|2663534|P1|Overall Study|Adverse Event|3
838738|NCT01100073|2663538|P1|Overall Study|Missing|5
838739|NCT01100073|2663538|P1|Overall Study|not known|8
838740|NCT01100073|2663538|P1|Overall Study|Insufficient tolerability +patients wish|8
838741|NCT01100073|2663538|P1|Overall Study|Lack of effect + patient's wish|2
838742|NCT01100073|2663538|P1|Overall Study|Lost to Follow-up|39
838743|NCT01100073|2663538|P1|Overall Study|Withdrawal by Subject|13
838744|NCT01100073|2663538|P1|Overall Study|Insufficient Tolerability|21
838745|NCT01100073|2663538|P1|Overall Study|Lack of Efficacy|4
838746|NCT01100086|2663553|P2|Period 1|Withdrawal by Subject|0
838747|NCT01100086|2663554|P1|Period 1|Withdrawal by Subject|1
838748|NCT01100307|2663593|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
838749|NCT01100307|2663594|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
838750|NCT01100307|2663593|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
838751|NCT01100307|2663594|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
838752|NCT01100307|2663593|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
838753|NCT01100307|2663594|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
838754|NCT01100307|2663593|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
838755|NCT01100307|2663594|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
838756|NCT01100307|2663593|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
838757|NCT01100307|2663594|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
838758|NCT01100307|2663593|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
838759|NCT01100307|2663594|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
838760|NCT01100320|2663636|P2|Period 2|Withdrawal by Subject|1
838761|NCT01100320|2663637|P1|Period 2|Withdrawal by Subject|1
838762|NCT01100320|2663636|P2|Period 1|Adverse Event|2
838763|NCT01100320|2663637|P1|Period 1|Adverse Event|2
838764|NCT01100320|2663636|P2|Period 1|Positive Drug Screen|1
838765|NCT01100320|2663637|P1|Period 1|Positive Drug Screen|1
838766|NCT01100320|2663636|P2|Period 1|Withdrawal by Subject|4
838767|NCT01100320|2663637|P1|Period 1|Withdrawal by Subject|2
838768|NCT01100437|2663647|P3|Maintenance|Sponsor termination of study|1
838769|NCT01100437|2663648|P2|Maintenance|Sponsor termination of study|0
838770|NCT01100437|2663649|P1|Maintenance|Sponsor termination of study|0
838771|NCT01100437|2663647|P3|Maintenance|Withdrawal by Subject|1
838772|NCT01100437|2663648|P2|Maintenance|Withdrawal by Subject|0
838773|NCT01100437|2663649|P1|Maintenance|Withdrawal by Subject|0
838774|NCT01100437|2663647|P3|Titration/Stabilization|Sponsor canceled study|1
838775|NCT01100437|2663648|P2|Titration/Stabilization|Sponsor canceled study|0
838776|NCT01100437|2663649|P1|Titration/Stabilization|Sponsor canceled study|0
838777|NCT01100437|2663647|P3|Titration/Stabilization|Non-compliance|1
838778|NCT01100437|2663648|P2|Titration/Stabilization|Non-compliance|0
838779|NCT01100437|2663649|P1|Titration/Stabilization|Non-compliance|0
838780|NCT01100437|2663647|P3|Titration/Stabilization|Adverse Event|4
838781|NCT01100437|2663648|P2|Titration/Stabilization|Adverse Event|0
838782|NCT01100437|2663649|P1|Titration/Stabilization|Adverse Event|0
838783|NCT01092728|2663688|P2|Overall Study|Prohibited Concomitant Medications|0
838784|NCT01092728|2663689|P1|Overall Study|Prohibited Concomitant Medications|1
838785|NCT01092728|2663688|P2|Overall Study|Disease Progression|13
838786|NCT01092728|2663689|P1|Overall Study|Disease Progression|1
838787|NCT01092728|2663688|P2|Overall Study|Adverse Event|1
838788|NCT01092728|2663689|P1|Overall Study|Adverse Event|0
838789|NCT01092728|2663688|P2|Overall Study|Withdrawal by Subject|0
838790|NCT01092728|2663689|P1|Overall Study|Withdrawal by Subject|2
838791|NCT01092780|2663701|P4|Washout Period 2|Adverse Event|0
838792|NCT01092780|2663702|P3|Washout Period 2|Adverse Event|1
838793|NCT01092780|2663703|P2|Washout Period 2|Adverse Event|1
838794|NCT01092780|2663704|P1|Washout Period 2|Adverse Event|0
838795|NCT01092780|2663701|P4|Washout Period 1|Noncompliance with nCPAP|0
838796|NCT01092780|2663702|P3|Washout Period 1|Noncompliance with nCPAP|0
838797|NCT01092780|2663703|P2|Washout Period 1|Noncompliance with nCPAP|0
838798|NCT01092780|2663704|P1|Washout Period 1|Noncompliance with nCPAP|1
838799|NCT01092780|2663701|P4|Washout Period 1|Adverse Event|0
838800|NCT01092780|2663702|P3|Washout Period 1|Adverse Event|0
838801|NCT01092780|2663703|P2|Washout Period 1|Adverse Event|1
838802|NCT01092780|2663704|P1|Washout Period 1|Adverse Event|0
838803|NCT01092832|2663736|P2|Overall Study|Not specified|0
838804|NCT01092832|2663737|P1|Overall Study|Not specified|1
838805|NCT01093222|2663804|P1|Overall Study|Not protocol specified|1
838806|NCT01093222|2663804|P1|Overall Study|Death|2
838807|NCT01093222|2663804|P1|Overall Study|Progression/relapse|24
838808|NCT01093222|2663804|P1|Overall Study|Adverse Event|7
838809|NCT01093222|2663804|P1|Overall Study|Ineligible|6
838822|NCT01093599|2663962|P2|Overall Study|Lost to Follow-up|46
838823|NCT01093599|2663963|P1|Overall Study|Lost to Follow-up|32
838824|NCT01093625|2663971|P2|1-Year Visit|Lost to Follow-up|3
838825|NCT01093625|2663972|P1|1-Year Visit|Lost to Follow-up|5
838826|NCT01093625|2663971|P2|6-Month Visit|Lost to Follow-up|2
838827|NCT01093625|2663972|P1|6-Month Visit|Lost to Follow-up|2
838828|NCT01093625|2663971|P2|6-Month Visit|Withdrawal by Subject|7
838829|NCT01093625|2663972|P1|6-Month Visit|Withdrawal by Subject|6
838830|NCT01093625|2663971|P2|3-Month Visit|Lost to Follow-up|0
838831|NCT01093625|2663972|P1|3-Month Visit|Lost to Follow-up|2
838832|NCT01093625|2663971|P2|1-Month Visit|Lost to Follow-up|0
838833|NCT01093625|2663972|P1|1-Month Visit|Lost to Follow-up|2
838834|NCT01093625|2663971|P2|2-Week Visit|Withdrawal by Subject|0
838835|NCT01093625|2663972|P1|2-Week Visit|Withdrawal by Subject|1
838836|NCT01093625|2663971|P2|Baseline and Dispensed|Withdrawal by Subject|0
838837|NCT01093625|2663972|P1|Baseline and Dispensed|Withdrawal by Subject|2
838838|NCT01093755|2664022|P2|Overall Study|Withdrawal by Subject|4
838839|NCT01093755|2664023|P1|Overall Study|Withdrawal by Subject|3
838840|NCT01093846|2664051|P3|Overall Study|Administrative Problems|15
838841|NCT01093846|2664052|P2|Overall Study|Administrative Problems|17
838842|NCT01093846|2664053|P1|Overall Study|Administrative Problems|18
838843|NCT01093846|2664051|P3|Overall Study|Condition no longer required study drug|1
838844|NCT01093846|2664052|P2|Overall Study|Condition no longer required study drug|1
838845|NCT01093846|2664053|P1|Overall Study|Condition no longer required study drug|1
838846|NCT01093846|2664051|P3|Overall Study|Lack of Efficacy|4
838847|NCT01093846|2664052|P2|Overall Study|Lack of Efficacy|0
838848|NCT01093846|2664053|P1|Overall Study|Lack of Efficacy|0
838849|NCT01093846|2664051|P3|Overall Study|Adverse Event|1
838850|NCT01093846|2664052|P2|Overall Study|Adverse Event|0
838851|NCT01093846|2664053|P1|Overall Study|Adverse Event|0
838852|NCT01094119|2664065|P2|Overall Study|Lack of Efficacy|4
838853|NCT01094119|2664066|P1|Overall Study|Lack of Efficacy|2
838854|NCT01094171|2664074|P1|Overall Study|Unspecified|1
838855|NCT01094171|2664074|P1|Overall Study|Migration from the study area|3
838856|NCT01094171|2664074|P1|Overall Study|Informed consent withdrawal|4
838857|NCT01094171|2664074|P1|Overall Study|Lost to Follow-up|2
838858|NCT01094730|2664187|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
838859|NCT01094730|2664188|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
838860|NCT01094730|2664187|P2|Period 2 (14 Days)|Adverse Event|1
838861|NCT01094730|2664188|P1|Period 2 (14 Days)|Adverse Event|0
838862|NCT01094730|2664187|P2|Period 2 (14 Days)|No time for the follow-up visit|0
838863|NCT01094730|2664188|P1|Period 2 (14 Days)|No time for the follow-up visit|1
838864|NCT01094730|2664187|P2|Period 2 (14 Days)|Protocol Violation|0
838865|NCT01094730|2664188|P1|Period 2 (14 Days)|Protocol Violation|2
838866|NCT01094730|2664187|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
838867|NCT01094730|2664188|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
838868|NCT01094730|2664187|P2|Period 1 (14 Days)|No time for the follow-up visit|0
838869|NCT01094730|2664188|P1|Period 1 (14 Days)|No time for the follow-up visit|1
838870|NCT01094730|2664187|P2|Period 1 (14 Days)|Withdrawal by Subject|1
838871|NCT01094730|2664188|P1|Period 1 (14 Days)|Withdrawal by Subject|0
838872|NCT01094730|2664187|P2|Period 1 (14 Days)|Lost to Follow-up|1
838873|NCT01094730|2664188|P1|Period 1 (14 Days)|Lost to Follow-up|0
838875|NCT01094808|2664219|P3|Overall Study|Withdrawal by Subject|0
838876|NCT01094808|2664220|P2|Overall Study|Withdrawal by Subject|1
838877|NCT01094808|2664221|P1|Overall Study|Withdrawal by Subject|1
838878|NCT01094886|2664256|P1|Overall Study|Withdrawal by Subject|5
838879|NCT01094886|2664256|P1|Overall Study|Adverse Event|2
838880|NCT01100502|2664265|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
838881|NCT01100502|2664266|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
838882|NCT01100502|2664265|P2|Long-Term Follow-up|Lost to Follow-up|2
838883|NCT01100502|2664266|P1|Long-Term Follow-up|Lost to Follow-up|5
838884|NCT01100502|2664265|P2|Long-Term Follow-up|Withdrawal by Subject|8
838885|NCT01100502|2664266|P1|Long-Term Follow-up|Withdrawal by Subject|10
838886|NCT01100502|2664265|P2|Treatment Period|Progressive Disease|69
838887|NCT01100502|2664266|P1|Treatment Period|Progressive Disease|24
838888|NCT01100502|2664265|P2|Treatment Period|Withdrawal by Subject|4
838889|NCT01100502|2664266|P1|Treatment Period|Withdrawal by Subject|9
838890|NCT01100502|2664265|P2|Treatment Period|Adverse Event|10
838891|NCT01100502|2664266|P1|Treatment Period|Adverse Event|54
838892|NCT01100567|2664278|P2|Overall Study|Deemed ineligible after consent|1
838893|NCT01100567|2664279|P1|Overall Study|Deemed ineligible after consent|0
838894|NCT01100567|2664278|P2|Overall Study|Physician Decision|1
838895|NCT01100567|2664279|P1|Overall Study|Physician Decision|0
838896|NCT01100567|2664278|P2|Overall Study|Lost to Follow-up|2
838897|NCT01100567|2664279|P1|Overall Study|Lost to Follow-up|1
838898|NCT01100567|2664278|P2|Overall Study|Early Hospital Discharge|4
838899|NCT01100567|2664279|P1|Overall Study|Early Hospital Discharge|6
838900|NCT01100567|2664278|P2|Overall Study|Withdrawal by Subject|8
838901|NCT01100567|2664279|P1|Overall Study|Withdrawal by Subject|5
838902|NCT01100658|2664312|P1|Overall Study|Withdrawal by Subject|1
838903|NCT01101165|2664347|P2|Period 2|Adverse Event|0
838904|NCT01101165|2664348|P1|Period 2|Adverse Event|1
838905|NCT01101165|2664347|P2|Period 2|Withdrawal by Subject|1
838906|NCT01101165|2664348|P1|Period 2|Withdrawal by Subject|3
838907|NCT01101165|2664347|P2|Period 1|Lost to Follow-up|0
838908|NCT01101165|2664348|P1|Period 1|Lost to Follow-up|1
838909|NCT01101165|2664347|P2|Period 1|Positive Drug Screen|1
838910|NCT01101165|2664348|P1|Period 1|Positive Drug Screen|0
838911|NCT01101165|2664347|P2|Period 1|Withdrawal by Subject|2
838912|NCT01101165|2664348|P1|Period 1|Withdrawal by Subject|0
838913|NCT01101165|2664347|P2|Period 1|Adverse Event|2
838914|NCT01101165|2664348|P1|Period 1|Adverse Event|1
838915|NCT01101178|2664358|P2|Period 2|Withdrawal by Subject|1
838916|NCT01101178|2664359|P1|Period 2|Withdrawal by Subject|0
838917|NCT01101178|2664358|P2|Period 1|Adverse Event|1
838918|NCT01101178|2664359|P1|Period 1|Adverse Event|2
838919|NCT01101178|2664358|P2|Period 1|Positive drug screen|1
838920|NCT01101178|2664359|P1|Period 1|Positive drug screen|1
838921|NCT01101178|2664358|P2|Period 1|Withdrawal by Subject|2
838922|NCT01101178|2664359|P1|Period 1|Withdrawal by Subject|1
838923|NCT01101191|2664370|P2|Period 1|Adverse Event|2
838924|NCT01101191|2664371|P1|Period 1|Adverse Event|1
838925|NCT01101191|2664370|P2|Period 1|Withdrawal by Subject|0
838926|NCT01101191|2664371|P1|Period 1|Withdrawal by Subject|1
838927|NCT01101308|2664382|P2|Period 1|Positive for cotinine|0
838928|NCT01101308|2664383|P1|Period 1|Positive for cotinine|1
838929|NCT01101308|2664382|P2|Period 1|Adverse Event|1
838930|NCT01101308|2664383|P1|Period 1|Adverse Event|2
838931|NCT01101321|2664394|P2|Period 1|Adverse Event|3
838932|NCT01101321|2664395|P1|Period 1|Adverse Event|3
838933|NCT01101321|2664394|P2|Period 1|Withdrawal by Subject|1
838934|NCT01101321|2664395|P1|Period 1|Withdrawal by Subject|1
838935|NCT01101477|2664421|P3|Overall Study|Protocol Violation|1
838936|NCT01101477|2664422|P2|Overall Study|Protocol Violation|3
838937|NCT01101477|2664423|P1|Overall Study|Protocol Violation|5
838938|NCT01101542|2664431|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
838939|NCT01101542|2664431|P1|Year 6 Surveillance Period|Pregnancy|1
838940|NCT01101542|2664431|P1|Year 6 Surveillance Period|Lost to Follow-up|986
838941|NCT01101542|2664431|P1|Year 5 Surveillance Period|Pregnancy|1
838942|NCT01101542|2664431|P1|Year 5 Surveillance Period|Lost to Follow-up|140
838943|NCT01101542|2664431|P1|Year 4 Surveillance Period|Unspecified|287
838944|NCT01101542|2664431|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
838945|NCT01101542|2664431|P1|Year 3 Surveillance Period|Lost to Follow-up|7
838946|NCT01101841|2664449|P2|Overall Study|Eligibility Criteria|2
838947|NCT01101841|2664450|P1|Overall Study|Eligibility Criteria|1
838948|NCT01101841|2664449|P2|Overall Study|Suicidality Tracking Scale|1
838949|NCT01101841|2664450|P1|Overall Study|Suicidality Tracking Scale|3
838950|NCT01101841|2664449|P2|Overall Study|Not Specified|1
838951|NCT01101841|2664450|P1|Overall Study|Not Specified|0
838952|NCT01101841|2664449|P2|Overall Study|Lack of Efficacy|2
838953|NCT01101841|2664450|P1|Overall Study|Lack of Efficacy|0
838954|NCT01101841|2664449|P2|Overall Study|Physician Decision|2
838955|NCT01101841|2664450|P1|Overall Study|Physician Decision|0
838956|NCT01101841|2664449|P2|Overall Study|Protocol Violation|1
838957|NCT01101841|2664450|P1|Overall Study|Protocol Violation|1
838958|NCT01101841|2664449|P2|Overall Study|Withdrawal by Subject|40
838959|NCT01101841|2664450|P1|Overall Study|Withdrawal by Subject|21
838960|NCT01101841|2664449|P2|Overall Study|Lost to Follow-up|3
838961|NCT01101841|2664450|P1|Overall Study|Lost to Follow-up|9
838962|NCT01101841|2664449|P2|Overall Study|Adverse Event|15
838963|NCT01101841|2664450|P1|Overall Study|Adverse Event|15
838964|NCT01102140|2664516|P2|Overall Study|Investigator terminated study|2
838965|NCT01102140|2664517|P1|Overall Study|Investigator terminated study|2
838966|NCT01102140|2664516|P2|Overall Study|Lost to Follow-up|0
838967|NCT01102140|2664517|P1|Overall Study|Lost to Follow-up|1
838968|NCT01102257|2664540|P2|Overall Study|Adverse Event|0
838969|NCT01102257|2664541|P1|Overall Study|Adverse Event|1
838970|NCT01102257|2664540|P2|Overall Study|Adverse Event|0
838971|NCT01102257|2664541|P1|Overall Study|Adverse Event|1
838972|NCT01102374|2664562|P2|Overall Study|Lost to Follow-up|6
838973|NCT01102374|2664563|P1|Overall Study|Lost to Follow-up|7
838974|NCT01102374|2664562|P2|Overall Study|Death|13
838975|NCT01102374|2664563|P1|Overall Study|Death|9
838976|NCT01102491|2664610|P2|Overall Study|Protocol Violation|12
838977|NCT01102491|2664611|P1|Overall Study|Protocol Violation|11
838978|NCT01102777|2664632|P2|Overall Study|Lost to Follow-up|10
838979|NCT01102777|2664633|P1|Overall Study|Lost to Follow-up|7
838980|NCT01102777|2664632|P2|Overall Study|Death|6
838981|NCT01102777|2664633|P1|Overall Study|Death|2
838982|NCT01102803|2664659|P2|Post to Follow-Up|Lost to Follow-up|3
838983|NCT01102803|2664660|P1|Post to Follow-Up|Lost to Follow-up|1
838984|NCT01102803|2664659|P2|Baseline to Post-Treatment|Lost to Follow-up|0
838985|NCT01102803|2664660|P1|Baseline to Post-Treatment|Lost to Follow-up|3
838986|NCT01102972|2664684|P2|Overall Study|Withdrawal by Subject|6
838987|NCT01102972|2664685|P1|Overall Study|Withdrawal by Subject|6
838988|NCT01102972|2664684|P2|Overall Study|Investigator Discretion|0
838989|NCT01102972|2664685|P1|Overall Study|Investigator Discretion|2
838990|NCT01102972|2664684|P2|Overall Study|Lost to Follow-up|5
838991|NCT01102972|2664685|P1|Overall Study|Lost to Follow-up|10
838992|NCT01102972|2664684|P2|Overall Study|Protocol Violation|0
838993|NCT01102972|2664685|P1|Overall Study|Protocol Violation|1
838994|NCT01102972|2664684|P2|Overall Study|Lack of Efficacy|1
838995|NCT01102972|2664685|P1|Overall Study|Lack of Efficacy|2
838996|NCT01102972|2664684|P2|Overall Study|Adverse Event|2
838997|NCT01102972|2664685|P1|Overall Study|Adverse Event|8
838998|NCT01103063|2664739|P2|Overall Study|Death|1
838999|NCT01103063|2664740|P1|Overall Study|Death|3
839000|NCT01103063|2664739|P2|Overall Study|Study terminated by Sponsor|342
839001|NCT01103063|2664740|P1|Overall Study|Study terminated by Sponsor|326
839002|NCT01103063|2664739|P2|Overall Study|Protocol Violation|0
839003|NCT01103063|2664740|P1|Overall Study|Protocol Violation|1
839004|NCT01103063|2664739|P2|Overall Study|Not specified|11
839005|NCT01103063|2664740|P1|Overall Study|Not specified|16
839006|NCT01103063|2664739|P2|Overall Study|Withdrawal by Subject|15
839007|NCT01103063|2664740|P1|Overall Study|Withdrawal by Subject|60
839008|NCT01103063|2664739|P2|Overall Study|Lost to Follow-up|51
839009|NCT01103063|2664740|P1|Overall Study|Lost to Follow-up|68
839010|NCT01103063|2664739|P2|Overall Study|Adverse Event|1
839011|NCT01103063|2664740|P1|Overall Study|Adverse Event|3
839012|NCT01103141|2664808|P2|Overall Study|Lost to Follow-up|1
839013|NCT01103141|2664809|P1|Overall Study|Lost to Follow-up|2
839014|NCT01103141|2664808|P2|Overall Study|Death|1
839015|NCT01103141|2664809|P1|Overall Study|Death|0
839016|NCT01103232|2664817|P2|Overall Study|Protocol Violation|1
839017|NCT01103232|2664818|P1|Overall Study|Protocol Violation|0
839018|NCT01103232|2664817|P2|Overall Study|Withdrawal by Subject|1
839019|NCT01103232|2664818|P1|Overall Study|Withdrawal by Subject|1
839020|NCT01103284|2664836|P2|Overall Study|Missing CRF entries for study completion|2
839021|NCT01103284|2664837|P1|Overall Study|Missing CRF entries for study completion|0
839022|NCT01103284|2664836|P2|Overall Study|Not described|1
839023|NCT01103284|2664837|P1|Overall Study|Not described|2
839024|NCT01103284|2664836|P2|Overall Study|Termination by the Sponsor|1
839025|NCT01103284|2664837|P1|Overall Study|Termination by the Sponsor|0
839026|NCT01103284|2664836|P2|Overall Study|Dermal Hypersensitivity|1
839027|NCT01103284|2664837|P1|Overall Study|Dermal Hypersensitivity|0
839028|NCT01103284|2664836|P2|Overall Study|Withdrawal by Subject|18
839029|NCT01103284|2664837|P1|Overall Study|Withdrawal by Subject|14
839030|NCT01103284|2664836|P2|Overall Study|Adverse Event|5
839031|NCT01103284|2664837|P1|Overall Study|Adverse Event|0
839032|NCT01103284|2664836|P2|Overall Study|Protocol Violation|5
839033|NCT01103284|2664837|P1|Overall Study|Protocol Violation|12
839034|NCT01103284|2664836|P2|Overall Study|Pregnancy|1
839035|NCT01103284|2664837|P1|Overall Study|Pregnancy|3
839036|NCT01103284|2664836|P2|Overall Study|Lost to Follow-up|10
839037|NCT01103284|2664837|P1|Overall Study|Lost to Follow-up|9
839038|NCT01103284|2664836|P2|Overall Study|Death|0
839039|NCT01103284|2664837|P1|Overall Study|Death|2
839040|NCT01103323|2664853|P2|Switched From Placebo to Regorafenib|Adverse Event|1
839041|NCT01103323|2664854|P1|Switched From Placebo to Regorafenib|Adverse Event|0
839042|NCT01103323|2664853|P2|Without/Before Drug Switch|Switch to Regorafenib|4
839043|NCT01103323|2664854|P1|Without/Before Drug Switch|Switch to Regorafenib|0
839044|NCT01103323|2664853|P2|Without/Before Drug Switch|did not receive study treatment|2
839045|NCT01103323|2664854|P1|Without/Before Drug Switch|did not receive study treatment|5
839046|NCT01103323|2664853|P2|Without/Before Drug Switch|Physician Decision|0
839047|NCT01103323|2664854|P1|Without/Before Drug Switch|Physician Decision|2
839048|NCT01103323|2664853|P2|Without/Before Drug Switch|Protocol Violation|0
839049|NCT01103323|2664854|P1|Without/Before Drug Switch|Protocol Violation|2
839050|NCT01103323|2664853|P2|Without/Before Drug Switch|Withdrawal by Subject|5
839051|NCT01103323|2664854|P1|Without/Before Drug Switch|Withdrawal by Subject|17
839052|NCT01103323|2664853|P2|Without/Before Drug Switch|Adverse Event|7
839053|NCT01103323|2664854|P1|Without/Before Drug Switch|Adverse Event|50
839054|NCT01103362|2664869|P1|Overall Study|study terminated|596
839055|NCT01103466|2664944|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
839056|NCT01103466|2664945|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
839057|NCT01103466|2664946|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
839058|NCT01103466|2664944|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
839059|NCT01103466|2664945|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
839060|NCT01103466|2664946|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
839061|NCT01103466|2664944|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
839062|NCT01103466|2664945|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
839063|NCT01103466|2664946|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
839064|NCT01103466|2664944|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
839065|NCT01103466|2664945|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
839066|NCT01103466|2664946|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
839067|NCT01103466|2664944|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
839068|NCT01103466|2664945|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
839069|NCT01103466|2664946|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
839070|NCT01103466|2664944|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
839071|NCT01103466|2664945|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
839072|NCT01103466|2664946|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
839073|NCT01103479|2664957|P3|Overall Study|Saw non-study physician|0
839074|NCT01103479|2664958|P2|Overall Study|Saw non-study physician|0
839075|NCT01103479|2664959|P1|Overall Study|Saw non-study physician|2
839076|NCT01103479|2664957|P3|Overall Study|Active cancer|0
839077|NCT01103479|2664958|P2|Overall Study|Active cancer|0
839078|NCT01103479|2664959|P1|Overall Study|Active cancer|1
839079|NCT01103479|2664957|P3|Overall Study|Family history of CRC|2
839080|NCT01103479|2664958|P2|Overall Study|Family history of CRC|0
839081|NCT01103479|2664959|P1|Overall Study|Family history of CRC|1
839082|NCT01103479|2664957|P3|Overall Study|Up to date with CRC screening|12
839083|NCT01103479|2664958|P2|Overall Study|Up to date with CRC screening|9
839084|NCT01103479|2664959|P1|Overall Study|Up to date with CRC screening|1
839085|NCT01103713|2664995|P1|Overall Study|Not specified|1
839086|NCT01103713|2664995|P1|Overall Study|Study terminated by sponsor|2
839087|NCT01103713|2664995|P1|Overall Study|Withdrawal by Subject|8
839088|NCT01103713|2664995|P1|Overall Study|Lost to Follow-up|2
839089|NCT01104701|2665025|P4|Overall Study|Physician Decision|0
839090|NCT01104701|2665026|P3|Overall Study|Physician Decision|0
839091|NCT01104701|2665027|P2|Overall Study|Physician Decision|2
839092|NCT01104701|2665028|P1|Overall Study|Physician Decision|0
839093|NCT01104701|2665025|P4|Overall Study|Adverse Event|1
839094|NCT01104701|2665026|P3|Overall Study|Adverse Event|0
839095|NCT01104701|2665027|P2|Overall Study|Adverse Event|0
839096|NCT01104701|2665028|P1|Overall Study|Adverse Event|0
839097|NCT01104701|2665025|P4|Overall Study|Withdrawal by Subject|1
839098|NCT01104701|2665026|P3|Overall Study|Withdrawal by Subject|2
839099|NCT01104701|2665027|P2|Overall Study|Withdrawal by Subject|1
839100|NCT01104701|2665028|P1|Overall Study|Withdrawal by Subject|0
839101|NCT01104870|2665085|P3|Overall Study|Withdrawal by Subject|1
839102|NCT01104870|2665086|P2|Overall Study|Withdrawal by Subject|0
839103|NCT01104870|2665087|P1|Overall Study|Withdrawal by Subject|0
839104|NCT01104870|2665085|P3|Overall Study|Death|1
839105|NCT01104870|2665086|P2|Overall Study|Death|0
839106|NCT01104870|2665087|P1|Overall Study|Death|0
839107|NCT01104870|2665085|P3|Overall Study|Adverse Event|0
839108|NCT01104870|2665086|P2|Overall Study|Adverse Event|1
839109|NCT01104870|2665087|P1|Overall Study|Adverse Event|1
839110|NCT01105065|2665116|P1|Overall Study|Technical Problems|1
839111|NCT01105065|2665116|P1|Overall Study|Adverse Event|5
839112|NCT01105091|2665124|P2|Overall Study|Death|0
839113|NCT01105091|2665125|P1|Overall Study|Death|2
839114|NCT01105130|2665163|P3|Overall Study|Multiple Reasons|2
839115|NCT01105130|2665164|P2|Overall Study|Multiple Reasons|0
839116|NCT01105130|2665165|P1|Overall Study|Multiple Reasons|3
839117|NCT01105130|2665163|P3|Overall Study|Toxicity|2
839118|NCT01105130|2665164|P2|Overall Study|Toxicity|3
839119|NCT01105130|2665165|P1|Overall Study|Toxicity|1
839120|NCT01105130|2665163|P3|Overall Study|Never Started|4
839121|NCT01105130|2665164|P2|Overall Study|Never Started|2
839122|NCT01105130|2665165|P1|Overall Study|Never Started|2
839123|NCT01105130|2665163|P3|Overall Study|Withdrawal by Subject|2
839124|NCT01105130|2665164|P2|Overall Study|Withdrawal by Subject|6
839125|NCT01105130|2665165|P1|Overall Study|Withdrawal by Subject|4
839126|NCT01105377|2665221|P2|Overall Study|Withdrawal by Subject|1
839127|NCT01105377|2665222|P1|Overall Study|Withdrawal by Subject|0
839128|NCT01105533|2665230|P9|Overall Study|Physician Decision|0
839129|NCT01105533|2665231|P8|Overall Study|Physician Decision|1
839130|NCT01105533|2665232|P7|Overall Study|Physician Decision|0
839131|NCT01105533|2665233|P6|Overall Study|Physician Decision|0
839132|NCT01105533|2665234|P5|Overall Study|Physician Decision|0
839133|NCT01105533|2665235|P4|Overall Study|Physician Decision|0
839134|NCT01105533|2665236|P3|Overall Study|Physician Decision|0
839135|NCT01105533|2665237|P2|Overall Study|Physician Decision|0
839136|NCT01105533|2665238|P1|Overall Study|Physician Decision|0
839137|NCT01105533|2665230|P9|Overall Study|Unspecified|2
839138|NCT01105533|2665231|P8|Overall Study|Unspecified|1
839139|NCT01105533|2665232|P7|Overall Study|Unspecified|3
839140|NCT01105533|2665233|P6|Overall Study|Unspecified|0
839141|NCT01105533|2665234|P5|Overall Study|Unspecified|1
839142|NCT01105533|2665235|P4|Overall Study|Unspecified|0
839143|NCT01105533|2665236|P3|Overall Study|Unspecified|0
839144|NCT01105533|2665237|P2|Overall Study|Unspecified|0
839145|NCT01105533|2665238|P1|Overall Study|Unspecified|0
839146|NCT01105533|2665230|P9|Overall Study|Adverse Event|1
839147|NCT01105533|2665231|P8|Overall Study|Adverse Event|0
839148|NCT01105533|2665232|P7|Overall Study|Adverse Event|2
839149|NCT01105533|2665233|P6|Overall Study|Adverse Event|2
839150|NCT01105533|2665234|P5|Overall Study|Adverse Event|1
839151|NCT01105533|2665235|P4|Overall Study|Adverse Event|0
839152|NCT01105533|2665236|P3|Overall Study|Adverse Event|0
839153|NCT01105533|2665237|P2|Overall Study|Adverse Event|0
839154|NCT01105533|2665238|P1|Overall Study|Adverse Event|0
839155|NCT01105533|2665230|P9|Overall Study|Lack of Efficacy|9
839156|NCT01105533|2665231|P8|Overall Study|Lack of Efficacy|2
839157|NCT01105533|2665232|P7|Overall Study|Lack of Efficacy|3
839158|NCT01105533|2665233|P6|Overall Study|Lack of Efficacy|5
839159|NCT01105533|2665234|P5|Overall Study|Lack of Efficacy|4
839160|NCT01105533|2665235|P4|Overall Study|Lack of Efficacy|3
839161|NCT01105533|2665236|P3|Overall Study|Lack of Efficacy|3
839162|NCT01105533|2665237|P2|Overall Study|Lack of Efficacy|1
839163|NCT01105533|2665238|P1|Overall Study|Lack of Efficacy|1
839164|NCT01105533|2665230|P9|Overall Study|Death|0
839165|NCT01105533|2665231|P8|Overall Study|Death|0
839166|NCT01105533|2665232|P7|Overall Study|Death|0
839167|NCT01105533|2665233|P6|Overall Study|Death|0
839168|NCT01105533|2665234|P5|Overall Study|Death|1
839169|NCT01105533|2665235|P4|Overall Study|Death|0
839170|NCT01105533|2665236|P3|Overall Study|Death|0
839171|NCT01105533|2665237|P2|Overall Study|Death|0
839172|NCT01105533|2665238|P1|Overall Study|Death|0
839173|NCT01105767|2665370|P3|Overall Study|Lost to Follow-up|1184
839174|NCT01105767|2665371|P2|Overall Study|Lost to Follow-up|1614
839175|NCT01105767|2665372|P1|Overall Study|Lost to Follow-up|1160
839176|NCT01105936|2665383|P4|Period 3|Protocol Violation|0
839177|NCT01105936|2665384|P3|Period 3|Protocol Violation|0
839178|NCT01105936|2665385|P2|Period 3|Protocol Violation|2
839179|NCT01105936|2665386|P1|Period 3|Protocol Violation|0
839180|NCT01105936|2665383|P4|Period 2|Adverse Event|0
839181|NCT01105936|2665384|P3|Period 2|Adverse Event|0
839182|NCT01105936|2665385|P2|Period 2|Adverse Event|0
839183|NCT01105936|2665386|P1|Period 2|Adverse Event|1
839184|NCT01105936|2665383|P4|Period 1|Adverse Event|1
839185|NCT01105936|2665384|P3|Period 1|Adverse Event|0
839186|NCT01105936|2665385|P2|Period 1|Adverse Event|0
839187|NCT01105936|2665386|P1|Period 1|Adverse Event|0
839188|NCT01106014|2665414|P2|Overall Study|Lost to Follow-up|3
839189|NCT01106014|2665415|P1|Overall Study|Lost to Follow-up|2
839190|NCT01106014|2665414|P2|Overall Study|Administrative reason|6
839191|NCT01106014|2665415|P1|Overall Study|Administrative reason|7
839192|NCT01106014|2665414|P2|Overall Study|Withdrawal by Subject|37
839193|NCT01106014|2665415|P1|Overall Study|Withdrawal by Subject|43
839194|NCT01106014|2665414|P2|Overall Study|Adverse Event|42
839195|NCT01106014|2665415|P1|Overall Study|Adverse Event|78
839196|NCT01106014|2665414|P2|Overall Study|Morbidity or Mortality primary endpoint|242
839197|NCT01106014|2665415|P1|Overall Study|Morbidity or Mortality primary endpoint|155
839198|NCT01106092|2665434|P4|Overall Study|Withdrawal by Subject|1
839199|NCT01106092|2665435|P3|Overall Study|Withdrawal by Subject|0
839200|NCT01106092|2665436|P2|Overall Study|Withdrawal by Subject|0
839201|NCT01106092|2665437|P1|Overall Study|Withdrawal by Subject|0
839202|NCT01106157|2665517|P2|Overall Study|Withdrawal by Subject|0
839203|NCT01106157|2665518|P1|Overall Study|Withdrawal by Subject|1
839204|NCT01106248|2665542|P1|Overall Study|Administrative|2
839205|NCT01106248|2665542|P1|Overall Study|Adverse Event|1
839206|NCT01106287|2665552|P4|Overall Study|Adverse Event|0
839207|NCT01106287|2665553|P3|Overall Study|Adverse Event|0
839208|NCT01106287|2665554|P2|Overall Study|Adverse Event|0
839209|NCT01106287|2665555|P1|Overall Study|Adverse Event|1
839210|NCT01106352|2665586|P5|Overall Study|Home hospice since July 2013|0
839211|NCT01106352|2665587|P4|Overall Study|Home hospice since July 2013|1
839212|NCT01106352|2665588|P3|Overall Study|Home hospice since July 2013|0
839213|NCT01106352|2665589|P2|Overall Study|Home hospice since July 2013|0
839214|NCT01106352|2665590|P1|Overall Study|Home hospice since July 2013|0
839215|NCT01106352|2665586|P5|Overall Study|Subject entered hospice|0
839216|NCT01106352|2665587|P4|Overall Study|Subject entered hospice|1
839217|NCT01106352|2665588|P3|Overall Study|Subject entered hospice|0
839218|NCT01106352|2665589|P2|Overall Study|Subject entered hospice|0
839219|NCT01106352|2665590|P1|Overall Study|Subject entered hospice|0
839220|NCT01106352|2665586|P5|Overall Study|Went on hospice|0
839221|NCT01106352|2665587|P4|Overall Study|Went on hospice|1
839222|NCT01106352|2665588|P3|Overall Study|Went on hospice|0
839223|NCT01106352|2665589|P2|Overall Study|Went on hospice|0
839224|NCT01106352|2665590|P1|Overall Study|Went on hospice|0
839225|NCT01106352|2665586|P5|Overall Study|Withdrawal by Subject|2
839226|NCT01106352|2665587|P4|Overall Study|Withdrawal by Subject|3
839227|NCT01106352|2665588|P3|Overall Study|Withdrawal by Subject|0
839228|NCT01106352|2665589|P2|Overall Study|Withdrawal by Subject|0
839229|NCT01106352|2665590|P1|Overall Study|Withdrawal by Subject|0
839230|NCT01106352|2665586|P5|Overall Study|Disease progression|0
839231|NCT01106352|2665587|P4|Overall Study|Disease progression|1
839232|NCT01106352|2665588|P3|Overall Study|Disease progression|0
839233|NCT01106352|2665589|P2|Overall Study|Disease progression|0
839234|NCT01106352|2665590|P1|Overall Study|Disease progression|0
839235|NCT01106352|2665586|P5|Overall Study|Death|1
839236|NCT01106352|2665587|P4|Overall Study|Death|3
839237|NCT01106352|2665588|P3|Overall Study|Death|1
839238|NCT01106352|2665589|P2|Overall Study|Death|0
839239|NCT01106352|2665590|P1|Overall Study|Death|0
839240|NCT01106352|2665586|P5|Overall Study|Lost to Follow-up|1
839241|NCT01106352|2665587|P4|Overall Study|Lost to Follow-up|0
839242|NCT01106352|2665588|P3|Overall Study|Lost to Follow-up|0
839243|NCT01106352|2665589|P2|Overall Study|Lost to Follow-up|0
839244|NCT01106352|2665590|P1|Overall Study|Lost to Follow-up|0
839245|NCT01106352|2665586|P5|Overall Study|Too ill to come in for the visit|0
839246|NCT01106352|2665587|P4|Overall Study|Too ill to come in for the visit|0
839247|NCT01106352|2665588|P3|Overall Study|Too ill to come in for the visit|1
839248|NCT01106352|2665589|P2|Overall Study|Too ill to come in for the visit|0
839249|NCT01106352|2665590|P1|Overall Study|Too ill to come in for the visit|0
839250|NCT01106352|2665586|P5|Overall Study|Sponsor Decision|0
839251|NCT01106352|2665587|P4|Overall Study|Sponsor Decision|0
839252|NCT01106352|2665588|P3|Overall Study|Sponsor Decision|0
839253|NCT01106352|2665589|P2|Overall Study|Sponsor Decision|0
839254|NCT01106352|2665590|P1|Overall Study|Sponsor Decision|1
839255|NCT01106352|2665586|P5|Overall Study|Subjects untreated|4
839256|NCT01106352|2665587|P4|Overall Study|Subjects untreated|3
839257|NCT01106352|2665588|P3|Overall Study|Subjects untreated|0
839258|NCT01106352|2665589|P2|Overall Study|Subjects untreated|0
839259|NCT01106352|2665590|P1|Overall Study|Subjects untreated|0
839260|NCT01106404|2665683|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
839261|NCT01106404|2665684|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
839262|NCT01106404|2665683|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
839263|NCT01106404|2665684|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
839264|NCT01106404|2665683|P2|Period I (First 6 Weeks)|Physician Decision|0
839265|NCT01106404|2665684|P1|Period I (First 6 Weeks)|Physician Decision|1
839266|NCT01106404|2665683|P2|Period I (First 6 Weeks)|Adverse Event|0
839267|NCT01106404|2665684|P1|Period I (First 6 Weeks)|Adverse Event|2
839268|NCT01106430|2665699|P2|Overall Study|Withdrawal by Subject|4
839269|NCT01106430|2665700|P1|Overall Study|Withdrawal by Subject|8
839270|NCT01106430|2665699|P2|Overall Study|Protocol Violation|2
839271|NCT01106430|2665700|P1|Overall Study|Protocol Violation|7
839272|NCT01106430|2665699|P2|Overall Study|Previous Use Of Marijuana|0
839273|NCT01106430|2665700|P1|Overall Study|Previous Use Of Marijuana|1
839274|NCT01106430|2665699|P2|Overall Study|Hard Time Swallowing The Pills|0
839275|NCT01106430|2665700|P1|Overall Study|Hard Time Swallowing The Pills|1
839276|NCT01106430|2665699|P2|Overall Study|Noncompliance|1
839277|NCT01106430|2665700|P1|Overall Study|Noncompliance|0
839278|NCT01106430|2665699|P2|Overall Study|Refused To Take Medication|1
839279|NCT01106430|2665700|P1|Overall Study|Refused To Take Medication|0
839280|NCT01106430|2665699|P2|Overall Study|Moved Out Of State|1
839281|NCT01106430|2665700|P1|Overall Study|Moved Out Of State|0
839282|NCT01106430|2665699|P2|Overall Study|Early Termination Requested By Sponsor|0
839283|NCT01106430|2665700|P1|Overall Study|Early Termination Requested By Sponsor|1
839284|NCT01106430|2665699|P2|Overall Study|Lost to Follow-up|1
839285|NCT01106430|2665700|P1|Overall Study|Lost to Follow-up|5
839286|NCT01106430|2665699|P2|Overall Study|Lack of Efficacy|13
839287|NCT01106430|2665700|P1|Overall Study|Lack of Efficacy|2
839288|NCT01106430|2665699|P2|Overall Study|Adverse Event|10
839289|NCT01106430|2665700|P1|Overall Study|Adverse Event|8
839294|NCT01106586|2665752|P2|Overall Study|Participant Transferred to Another Study|197
839295|NCT01106586|2665753|P1|Overall Study|Participant Transferred to Another Study|212
839296|NCT01106586|2665752|P2|Overall Study|Protocol Violation|0
839297|NCT01106586|2665753|P1|Overall Study|Protocol Violation|1
839298|NCT01106586|2665752|P2|Overall Study|Participant Noncompliance|10
839299|NCT01106586|2665753|P1|Overall Study|Participant Noncompliance|12
839300|NCT01106586|2665752|P2|Overall Study|Lost to Follow-up|20
839301|NCT01106586|2665753|P1|Overall Study|Lost to Follow-up|24
839302|NCT01106586|2665752|P2|Overall Study|Withdrew Consent|30
839303|NCT01106586|2665753|P1|Overall Study|Withdrew Consent|18
839304|NCT01106586|2665752|P2|Overall Study|Investigator's Discretion|8
839305|NCT01106586|2665753|P1|Overall Study|Investigator's Discretion|5
839306|NCT01106586|2665752|P2|Overall Study|Lack of Efficacy|0
839307|NCT01106586|2665753|P1|Overall Study|Lack of Efficacy|1
839308|NCT01106586|2665752|P2|Overall Study|Pregnancy|2
839309|NCT01106586|2665753|P1|Overall Study|Pregnancy|2
839310|NCT01106586|2665752|P2|Overall Study|Death|3
839311|NCT01106586|2665753|P1|Overall Study|Death|1
839312|NCT01106586|2665752|P2|Overall Study|Adverse Event|15
839313|NCT01106586|2665753|P1|Overall Study|Adverse Event|9
839314|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Not specified|4
839315|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Not specified|5
839316|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Not specified|5
839317|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
839318|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
839319|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
839320|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
839321|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
839322|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
839323|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
839324|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
839325|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
839326|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
839327|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
839328|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
839329|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
839330|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
839331|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
839332|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
839333|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
839334|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
839335|NCT01106625|2665774|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
839336|NCT01106625|2665775|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
839337|NCT01106625|2665776|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
839338|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Not specified|4
839339|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Not specified|7
839340|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Not specified|8
839341|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
839342|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
839343|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
839344|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
839345|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
839346|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
839347|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
839348|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
839349|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
839350|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
839351|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
839352|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
839353|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Protocol Violation|3
839354|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Protocol Violation|1
839355|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Protocol Violation|2
839356|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Physician Decision|0
839357|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Physician Decision|0
839358|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Physician Decision|1
839359|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
839360|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
839361|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
839362|NCT01106625|2665774|P3|Core Period: Baseline to Week 26|Adverse Event|8
839363|NCT01106625|2665775|P2|Core Period: Baseline to Week 26|Adverse Event|8
839364|NCT01106625|2665776|P1|Core Period: Baseline to Week 26|Adverse Event|6
839365|NCT01106651|2665808|P3|Overall Study|Death|0
839366|NCT01106651|2665809|P2|Overall Study|Death|3
839367|NCT01106651|2665810|P1|Overall Study|Death|0
839368|NCT01106651|2665808|P3|Overall Study|Not specified|21
839369|NCT01106651|2665809|P2|Overall Study|Not specified|31
839370|NCT01106651|2665810|P1|Overall Study|Not specified|34
839371|NCT01106651|2665808|P3|Overall Study|Noncompliance with study drug|2
839372|NCT01106651|2665809|P2|Overall Study|Noncompliance with study drug|0
839373|NCT01106651|2665810|P1|Overall Study|Noncompliance with study drug|1
839374|NCT01106651|2665808|P3|Overall Study|Withdrawal by Subject|4
839375|NCT01106651|2665809|P2|Overall Study|Withdrawal by Subject|7
839376|NCT01106651|2665810|P1|Overall Study|Withdrawal by Subject|14
839377|NCT01106651|2665808|P3|Overall Study|Protocol Violation|1
839378|NCT01106651|2665809|P2|Overall Study|Protocol Violation|2
839379|NCT01106651|2665810|P1|Overall Study|Protocol Violation|1
839380|NCT01106651|2665808|P3|Overall Study|Physician Decision|1
839381|NCT01106651|2665809|P2|Overall Study|Physician Decision|3
839382|NCT01106651|2665810|P1|Overall Study|Physician Decision|4
839383|NCT01106651|2665808|P3|Overall Study|Lost to Follow-up|6
839384|NCT01106651|2665809|P2|Overall Study|Lost to Follow-up|2
839385|NCT01106651|2665810|P1|Overall Study|Lost to Follow-up|8
839386|NCT01106651|2665808|P3|Overall Study|Adverse Event|23
839387|NCT01106651|2665809|P2|Overall Study|Adverse Event|9
839388|NCT01106651|2665810|P1|Overall Study|Adverse Event|17
839389|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Not specified|5
839390|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Not specified|8
839391|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Not specified|5
839392|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Not specified|6
839393|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
839394|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
839395|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
839396|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
839397|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
839398|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
839399|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
839400|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
839401|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
839402|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
839403|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
839404|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
839405|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
839406|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
839407|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
839408|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
839409|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
839410|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
839411|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
839412|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
839413|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
839414|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
839415|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
839416|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
839417|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
839418|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
839419|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
839420|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
839421|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Death|1
839422|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Death|0
839423|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Death|0
839424|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Death|0
839425|NCT01106677|2665864|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
839426|NCT01106677|2665865|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
839427|NCT01106677|2665866|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
839428|NCT01106677|2665867|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
839429|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Pregnancy|0
839430|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Pregnancy|0
839431|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Pregnancy|1
839432|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Pregnancy|0
839433|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Not specified|23
839434|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Not specified|8
839435|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Not specified|14
839436|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Not specified|8
839437|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Product quality complaint|0
839438|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Product quality complaint|1
839439|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Product quality complaint|1
839440|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Product quality complaint|0
839441|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
839442|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
839443|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
839444|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
839445|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
839446|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
839447|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
839448|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
839449|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
839450|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
839451|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
839452|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
839453|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
839454|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
839455|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
839456|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
839457|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Protocol Violation|3
839458|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Protocol Violation|0
839459|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Protocol Violation|1
839460|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Protocol Violation|0
839461|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Physician Decision|1
839462|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Physician Decision|3
839463|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Physician Decision|1
839464|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Physician Decision|2
839465|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
839466|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
839467|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
839468|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
839469|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
839470|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
839471|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
839472|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
839473|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Death|0
839474|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Death|1
839475|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Death|0
839476|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Death|0
839477|NCT01106677|2665864|P4|Core Period: Baseline to Week 26|Adverse Event|8
839478|NCT01106677|2665865|P3|Core Period: Baseline to Week 26|Adverse Event|6
839479|NCT01106677|2665866|P2|Core Period: Baseline to Week 26|Adverse Event|18
839480|NCT01106677|2665867|P1|Core Period: Baseline to Week 26|Adverse Event|7
839481|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
839482|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
839483|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
839484|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Not specified|4
839485|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Not specified|3
839486|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Not specified|8
839487|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
839488|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
839489|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
839490|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
839491|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
839492|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
839493|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
839494|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
839495|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
839496|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
839497|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
839498|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
839499|NCT01106690|2665930|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
839500|NCT01106690|2665931|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
839501|NCT01106690|2665932|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
839502|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Not specified|6
839503|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Not specified|2
839504|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Not specified|10
839505|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
839506|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
839507|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
839508|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
839509|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
839510|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
839511|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
839512|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
839513|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
839514|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
839515|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
839516|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
839517|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
839518|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
839519|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
839520|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Protocol Violation|0
839521|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Protocol Violation|0
839522|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Protocol Violation|1
839523|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
839524|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
839525|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
839526|NCT01106690|2665930|P3|Core Period: Baseline to Week 26|Adverse Event|4
839527|NCT01106690|2665931|P2|Core Period: Baseline to Week 26|Adverse Event|1
839528|NCT01106690|2665932|P1|Core Period: Baseline to Week 26|Adverse Event|6
839529|NCT01106846|2665966|P2|Overall Study|Change in surgical procedure|1
839530|NCT01106846|2665967|P1|Overall Study|Change in surgical procedure|0
839531|NCT01106911|2666012|P1|Overall Study|deemed ineligible after screening|3
839532|NCT01106911|2666012|P1|Overall Study|Physician Decision|2
839533|NCT01106976|2666026|P1|Overall Study|Lost to Follow-up|8
839534|NCT01100853|2666032|P2|Overall Study|Withdrawal by Subject|4
839535|NCT01100853|2666033|P1|Overall Study|Withdrawal by Subject|6
839536|NCT01100853|2666032|P2|Overall Study|Received <4 study injections|13
839537|NCT01100853|2666033|P1|Overall Study|Received <4 study injections|10
839538|NCT01100853|2666032|P2|Overall Study|Lost to Follow-up|6
839539|NCT01100853|2666033|P1|Overall Study|Lost to Follow-up|11
839540|NCT01100944|2666060|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
839541|NCT01100944|2666061|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
839542|NCT01100944|2666062|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
839543|NCT01100944|2666060|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
839544|NCT01100944|2666061|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
839545|NCT01100944|2666062|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
839546|NCT01100944|2666060|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
839547|NCT01100944|2666061|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
839548|NCT01100944|2666062|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
839549|NCT01100944|2666060|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
839550|NCT01100944|2666061|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
839551|NCT01100944|2666062|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
839552|NCT01101022|2666109|P2|Overall Study|Vacation|1
839553|NCT01101022|2666110|P1|Overall Study|Vacation|0
839554|NCT01101022|2666109|P2|Overall Study|Work schedule|1
839555|NCT01101022|2666110|P1|Overall Study|Work schedule|1
839556|NCT01101022|2666109|P2|Overall Study|Non-compliance|0
839557|NCT01101022|2666110|P1|Overall Study|Non-compliance|1
839558|NCT01101022|2666109|P2|Overall Study|Sponsor decision|1
839559|NCT01101022|2666110|P1|Overall Study|Sponsor decision|1
839560|NCT01101022|2666109|P2|Overall Study|Lack of Efficacy|7
839561|NCT01101022|2666110|P1|Overall Study|Lack of Efficacy|0
839562|NCT01101022|2666109|P2|Overall Study|Lost to Follow-up|4
839563|NCT01101022|2666110|P1|Overall Study|Lost to Follow-up|1
839564|NCT01101022|2666109|P2|Overall Study|Withdrawal by Subject|8
839565|NCT01101022|2666110|P1|Overall Study|Withdrawal by Subject|3
839566|NCT01101022|2666109|P2|Overall Study|Protocol Violation|3
839567|NCT01101022|2666110|P1|Overall Study|Protocol Violation|4
839568|NCT01101022|2666109|P2|Overall Study|Adverse Event|2
839569|NCT01101022|2666110|P1|Overall Study|Adverse Event|6
839570|NCT01107197|2666146|P2|Overall Study|Withdrawal by Subject|5
839571|NCT01107197|2666147|P1|Overall Study|Withdrawal by Subject|3
839572|NCT01107197|2666146|P2|Overall Study|Lost to Follow-up|8
839573|NCT01107197|2666147|P1|Overall Study|Lost to Follow-up|5
839574|NCT01107197|2666146|P2|Overall Study|Death|10
839575|NCT01107197|2666147|P1|Overall Study|Death|12
839576|NCT01107353|2666167|P2|Overall Study|Positive Drug Screen|0
839577|NCT01107353|2666168|P1|Overall Study|Positive Drug Screen|1
839578|NCT01107379|2666174|P1|Overall Study|Lost to Follow-up|3
839579|NCT01107379|2666174|P1|Overall Study|Withdrawal by Subject|18
839580|NCT01107392|2666185|P2|Overall Study|Administrative decision|0
839581|NCT01107392|2666186|P1|Overall Study|Administrative decision|1
839582|NCT01107392|2666185|P2|Overall Study|Personal Reasons|3
839583|NCT01107392|2666186|P1|Overall Study|Personal Reasons|2
839584|NCT01107392|2666185|P2|Overall Study|Adverse Event|0
839585|NCT01107392|2666186|P1|Overall Study|Adverse Event|2
839586|NCT01107405|2666203|P5|Overall Study|Protocol Violation|0
839587|NCT01107405|2666204|P4|Overall Study|Protocol Violation|1
839588|NCT01107405|2666205|P3|Overall Study|Protocol Violation|1
839589|NCT01107405|2666206|P2|Overall Study|Protocol Violation|0
839590|NCT01107405|2666207|P1|Overall Study|Protocol Violation|0
839591|NCT01107405|2666203|P5|Overall Study|Withdrawal by Subject|1
839592|NCT01107405|2666204|P4|Overall Study|Withdrawal by Subject|2
839593|NCT01107405|2666205|P3|Overall Study|Withdrawal by Subject|1
839594|NCT01107405|2666206|P2|Overall Study|Withdrawal by Subject|0
839595|NCT01107405|2666207|P1|Overall Study|Withdrawal by Subject|1
839596|NCT01107405|2666203|P5|Overall Study|Adverse Event|2
839597|NCT01107405|2666204|P4|Overall Study|Adverse Event|0
839598|NCT01107405|2666205|P3|Overall Study|Adverse Event|0
839599|NCT01107405|2666206|P2|Overall Study|Adverse Event|1
839600|NCT01107405|2666207|P1|Overall Study|Adverse Event|1
839601|NCT01107418|2666248|P1|Overall Study|Entered Extension Study|1
839602|NCT01107418|2666248|P1|Overall Study|Started Other Therapy|1
839603|NCT01107418|2666248|P1|Overall Study|Study Closing|1
839604|NCT01107418|2666248|P1|Overall Study|Withdrawal by Subject|1
839605|NCT01107418|2666248|P1|Overall Study|Adverse Event|3
839606|NCT01107418|2666248|P1|Overall Study|Disease Progression|45
839607|NCT01107457|2666321|P6|Part B and C|Clinical Relapse|4
839608|NCT01107457|2666322|P5|Part B and C|Clinical Relapse|0
839609|NCT01107457|2666323|P4|Part B and C|Clinical Relapse|0
839610|NCT01107457|2666324|P3|Part B and C|Clinical Relapse|0
839611|NCT01107457|2666325|P2|Part B and C|Clinical Relapse|0
839612|NCT01107457|2666326|P1|Part B and C|Clinical Relapse|0
839613|NCT01107457|2666321|P6|Part B and C|Withdrawal by Subject|16
839614|NCT01107457|2666322|P5|Part B and C|Withdrawal by Subject|0
839615|NCT01107457|2666323|P4|Part B and C|Withdrawal by Subject|0
839616|NCT01107457|2666324|P3|Part B and C|Withdrawal by Subject|0
839617|NCT01107457|2666325|P2|Part B and C|Withdrawal by Subject|0
839618|NCT01107457|2666326|P1|Part B and C|Withdrawal by Subject|0
839619|NCT01107457|2666321|P6|Part B and C|Sponsor Decision|66
839620|NCT01107457|2666322|P5|Part B and C|Sponsor Decision|0
839621|NCT01107457|2666323|P4|Part B and C|Sponsor Decision|0
839622|NCT01107457|2666324|P3|Part B and C|Sponsor Decision|0
839623|NCT01107457|2666325|P2|Part B and C|Sponsor Decision|0
839624|NCT01107457|2666326|P1|Part B and C|Sponsor Decision|0
839625|NCT01107457|2666321|P6|Part B and C|Protocol Violation|1
839626|NCT01107457|2666322|P5|Part B and C|Protocol Violation|0
839627|NCT01107457|2666323|P4|Part B and C|Protocol Violation|0
839628|NCT01107457|2666324|P3|Part B and C|Protocol Violation|0
839629|NCT01107457|2666325|P2|Part B and C|Protocol Violation|0
839630|NCT01107457|2666326|P1|Part B and C|Protocol Violation|0
839631|NCT01107457|2666321|P6|Part B and C|Lost to Follow-up|10
839632|NCT01107457|2666322|P5|Part B and C|Lost to Follow-up|0
839633|NCT01107457|2666323|P4|Part B and C|Lost to Follow-up|0
839634|NCT01107457|2666324|P3|Part B and C|Lost to Follow-up|0
839635|NCT01107457|2666325|P2|Part B and C|Lost to Follow-up|0
839636|NCT01107457|2666326|P1|Part B and C|Lost to Follow-up|0
839637|NCT01107457|2666321|P6|Part B and C|Lack of Efficacy|7
839638|NCT01107457|2666322|P5|Part B and C|Lack of Efficacy|0
839639|NCT01107457|2666323|P4|Part B and C|Lack of Efficacy|0
839640|NCT01107457|2666324|P3|Part B and C|Lack of Efficacy|0
839641|NCT01107457|2666325|P2|Part B and C|Lack of Efficacy|0
839642|NCT01107457|2666326|P1|Part B and C|Lack of Efficacy|0
839643|NCT01107457|2666321|P6|Part B and C|Physician Decision|3
839644|NCT01107457|2666322|P5|Part B and C|Physician Decision|0
839645|NCT01107457|2666323|P4|Part B and C|Physician Decision|0
839646|NCT01107457|2666324|P3|Part B and C|Physician Decision|0
839647|NCT01107457|2666325|P2|Part B and C|Physician Decision|0
839648|NCT01107457|2666326|P1|Part B and C|Physician Decision|0
839649|NCT01107457|2666321|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
839650|NCT01107457|2666322|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
839651|NCT01107457|2666323|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
839652|NCT01107457|2666324|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
839653|NCT01107457|2666325|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
839654|NCT01107457|2666326|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
839655|NCT01107457|2666321|P6|Part B and C|Adverse Event|12
839656|NCT01107457|2666322|P5|Part B and C|Adverse Event|0
839657|NCT01107457|2666323|P4|Part B and C|Adverse Event|0
839658|NCT01107457|2666324|P3|Part B and C|Adverse Event|0
839659|NCT01107457|2666325|P2|Part B and C|Adverse Event|0
839660|NCT01107457|2666326|P1|Part B and C|Adverse Event|0
839661|NCT01107457|2666321|P6|Part A|Protocol Violation|0
839662|NCT01107457|2666322|P5|Part A|Protocol Violation|0
839663|NCT01107457|2666323|P4|Part A|Protocol Violation|0
839664|NCT01107457|2666324|P3|Part A|Protocol Violation|0
839665|NCT01107457|2666325|P2|Part A|Protocol Violation|1
839666|NCT01107457|2666326|P1|Part A|Protocol Violation|0
839667|NCT01107457|2666321|P6|Part A|Lack of Efficacy|0
839668|NCT01107457|2666322|P5|Part A|Lack of Efficacy|0
839669|NCT01107457|2666323|P4|Part A|Lack of Efficacy|0
839670|NCT01107457|2666324|P3|Part A|Lack of Efficacy|0
839671|NCT01107457|2666325|P2|Part A|Lack of Efficacy|0
839672|NCT01107457|2666326|P1|Part A|Lack of Efficacy|1
839673|NCT01107457|2666321|P6|Part A|Lost to Follow-up|0
839674|NCT01107457|2666322|P5|Part A|Lost to Follow-up|0
839675|NCT01107457|2666323|P4|Part A|Lost to Follow-up|0
839676|NCT01107457|2666324|P3|Part A|Lost to Follow-up|0
839677|NCT01107457|2666325|P2|Part A|Lost to Follow-up|1
839678|NCT01107457|2666326|P1|Part A|Lost to Follow-up|0
839679|NCT01107457|2666321|P6|Part A|Withdrawal by Subject|0
839680|NCT01107457|2666322|P5|Part A|Withdrawal by Subject|1
839681|NCT01107457|2666323|P4|Part A|Withdrawal by Subject|3
839682|NCT01107457|2666324|P3|Part A|Withdrawal by Subject|0
839683|NCT01107457|2666325|P2|Part A|Withdrawal by Subject|3
839684|NCT01107457|2666326|P1|Part A|Withdrawal by Subject|3
839685|NCT01107457|2666321|P6|Part A|Adverse Event|0
839686|NCT01107457|2666322|P5|Part A|Adverse Event|0
839687|NCT01107457|2666323|P4|Part A|Adverse Event|0
839688|NCT01107457|2666324|P3|Part A|Adverse Event|1
839689|NCT01107457|2666325|P2|Part A|Adverse Event|2
839690|NCT01107457|2666326|P1|Part A|Adverse Event|1
839691|NCT01107743|2666465|P1|Overall Study|Protocol Violation|46
839692|NCT01107886|2666572|P2|Overall Study|Administrative withdrawal of consent|5
839693|NCT01107886|2666573|P1|Overall Study|Administrative withdrawal of consent|7
839694|NCT01107886|2666572|P2|Overall Study|Withdrawal by Subject|196
839695|NCT01107886|2666573|P1|Overall Study|Withdrawal by Subject|180
839696|NCT01107886|2666572|P2|Overall Study|Lost to Follow-up|13
839697|NCT01107886|2666573|P1|Overall Study|Lost to Follow-up|15
839698|NCT01107899|2666586|P3|Overall Study|Withdrawal by Subject|1
839699|NCT01107899|2666587|P2|Overall Study|Withdrawal by Subject|0
839700|NCT01107899|2666588|P1|Overall Study|Withdrawal by Subject|0
839701|NCT01107899|2666586|P3|Overall Study|Physician Decision|3
839702|NCT01107899|2666587|P2|Overall Study|Physician Decision|0
839703|NCT01107899|2666588|P1|Overall Study|Physician Decision|5
839704|NCT01107912|2666636|P6|Period 3|Withdrawal by Subject|0
839705|NCT01107912|2666637|P5|Period 3|Withdrawal by Subject|0
839706|NCT01107912|2666638|P4|Period 3|Withdrawal by Subject|1
839707|NCT01107912|2666639|P3|Period 3|Withdrawal by Subject|0
839708|NCT01107912|2666640|P2|Period 3|Withdrawal by Subject|0
839709|NCT01107912|2666641|P1|Period 3|Withdrawal by Subject|0
839710|NCT01107912|2666636|P6|Period 3|Adverse Event|0
839711|NCT01107912|2666637|P5|Period 3|Adverse Event|0
839712|NCT01107912|2666638|P4|Period 3|Adverse Event|0
839713|NCT01107912|2666639|P3|Period 3|Adverse Event|1
839714|NCT01107912|2666640|P2|Period 3|Adverse Event|1
839715|NCT01107912|2666641|P1|Period 3|Adverse Event|0
839716|NCT01107912|2666636|P6|Period 2|Physician Decision|0
839717|NCT01107912|2666637|P5|Period 2|Physician Decision|0
839718|NCT01107912|2666638|P4|Period 2|Physician Decision|0
839719|NCT01107912|2666639|P3|Period 2|Physician Decision|1
839720|NCT01107912|2666640|P2|Period 2|Physician Decision|0
839721|NCT01107912|2666641|P1|Period 2|Physician Decision|0
839722|NCT01107912|2666636|P6|Period 1|Withdrawal by Subject|0
839723|NCT01107912|2666637|P5|Period 1|Withdrawal by Subject|0
839724|NCT01107912|2666638|P4|Period 1|Withdrawal by Subject|0
839725|NCT01107912|2666639|P3|Period 1|Withdrawal by Subject|0
839726|NCT01107912|2666640|P2|Period 1|Withdrawal by Subject|0
839727|NCT01107912|2666641|P1|Period 1|Withdrawal by Subject|1
839728|NCT01107912|2666636|P6|Period 1|Physician Decision|0
839729|NCT01107912|2666637|P5|Period 1|Physician Decision|1
839730|NCT01107912|2666638|P4|Period 1|Physician Decision|0
839731|NCT01107912|2666639|P3|Period 1|Physician Decision|0
839732|NCT01107912|2666640|P2|Period 1|Physician Decision|0
839733|NCT01107912|2666641|P1|Period 1|Physician Decision|0
839734|NCT01107912|2666636|P6|Period 1|Adverse Event|0
839735|NCT01107912|2666637|P5|Period 1|Adverse Event|2
839736|NCT01107912|2666638|P4|Period 1|Adverse Event|0
839737|NCT01107912|2666639|P3|Period 1|Adverse Event|0
839738|NCT01107912|2666640|P2|Period 1|Adverse Event|0
839739|NCT01107912|2666641|P1|Period 1|Adverse Event|0
839740|NCT01107925|2666679|P6|Period 2|Withdrawal by Subject|1
839741|NCT01107925|2666680|P5|Period 2|Withdrawal by Subject|0
839742|NCT01107925|2666681|P4|Period 2|Withdrawal by Subject|0
839743|NCT01107925|2666682|P3|Period 2|Withdrawal by Subject|0
839744|NCT01107925|2666683|P2|Period 2|Withdrawal by Subject|1
839745|NCT01107925|2666684|P1|Period 2|Withdrawal by Subject|0
839746|NCT01107925|2666679|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
839747|NCT01107925|2666680|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
839748|NCT01107925|2666681|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
839749|NCT01107925|2666682|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
839750|NCT01107925|2666683|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
839751|NCT01107925|2666684|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
839752|NCT01108055|2666729|P1|Overall Study|Not evaluable- didn't complete treatment|4
839753|NCT01108055|2666729|P1|Overall Study|Ineligible|11
839754|NCT01108185|2666758|P1|Overall Study|Lost to Follow-up|12
839755|NCT01108185|2666758|P1|Overall Study|Non-compliance|15
839756|NCT01108237|2666773|P2|Overall Study|Did not meet criteria for analysis|0
839757|NCT01108237|2666774|P1|Overall Study|Did not meet criteria for analysis|7
839758|NCT01108237|2666773|P2|Overall Study|No alignment data|17
839759|NCT01108237|2666774|P1|Overall Study|No alignment data|2
839760|NCT01108263|2666782|P2|Overall Study|Adverse Event|1
839761|NCT01108263|2666783|P1|Overall Study|Adverse Event|0
839762|NCT01108341|2666791|P1|Overall Study|not specified|1
839763|NCT01108341|2666791|P1|Overall Study|Lost to Follow-up|1
839764|NCT01108341|2666791|P1|Overall Study|Withdrawal by Subject|1
839765|NCT01108341|2666791|P1|Overall Study|Death|2
839766|NCT01108458|2666839|P1|Overall Study|Withdrawal by Subject|1
839767|NCT01108510|2666850|P2|Overall Study|Death|1
839768|NCT01108510|2666851|P1|Overall Study|Death|1
839769|NCT01108510|2666850|P2|Overall Study|Pregnancy|3
839770|NCT01108510|2666851|P1|Overall Study|Pregnancy|0
839771|NCT01108510|2666850|P2|Overall Study|Lack of Efficacy|0
839772|NCT01108510|2666851|P1|Overall Study|Lack of Efficacy|3
839773|NCT01108510|2666850|P2|Overall Study|Participant Noncompliance|7
839774|NCT01108510|2666851|P1|Overall Study|Participant Noncompliance|5
839775|NCT01108510|2666850|P2|Overall Study|Investigator’s Discretion|10
839776|NCT01108510|2666851|P1|Overall Study|Investigator’s Discretion|12
839777|NCT01108510|2666850|P2|Overall Study|Withdrew Consent|15
839778|NCT01108510|2666851|P1|Overall Study|Withdrew Consent|21
839779|NCT01108510|2666850|P2|Overall Study|Lost to Follow-up|17
839780|NCT01108510|2666851|P1|Overall Study|Lost to Follow-up|20
839781|NCT01108510|2666850|P2|Overall Study|Adverse Event|19
839782|NCT01108510|2666851|P1|Overall Study|Adverse Event|26
839783|NCT01108510|2666850|P2|Overall Study|Joined Another Gilead-sponsored Study|195
839784|NCT01108510|2666851|P1|Overall Study|Joined Another Gilead-sponsored Study|186
839785|NCT01108510|2666850|P2|Overall Study|Randomized but Not Treated|1
839786|NCT01108510|2666851|P1|Overall Study|Randomized but Not Treated|5
839787|NCT01108523|2666871|P1|Overall Study|Protocol Violation|4
839788|NCT01108718|2666878|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
839789|NCT01108718|2666879|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
839790|NCT01108731|2666886|P2|Overall Study|Adverse Event|3
839791|NCT01108731|2666887|P1|Overall Study|Adverse Event|3
839792|NCT01108731|2666886|P2|Overall Study|Withdrawal by Subject|1
839793|NCT01108731|2666887|P1|Overall Study|Withdrawal by Subject|1
839794|NCT01108796|2666901|P2|Overall Study|Lost to Follow-up|6
839795|NCT01108796|2666902|P1|Overall Study|Lost to Follow-up|7
839796|NCT01108796|2666901|P2|Overall Study|Adverse Event|1
839797|NCT01108796|2666902|P1|Overall Study|Adverse Event|0
839798|NCT01108809|2666934|P1|Overall Study|Lost to Follow-up|1
839799|NCT01108809|2666934|P1|Overall Study|Adverse Event|3
839800|NCT01109173|2667003|P4|Overall Study|Not Specifiied|14
839801|NCT01109173|2667004|P3|Overall Study|Not Specifiied|9
839802|NCT01109173|2667005|P2|Overall Study|Not Specifiied|4
839803|NCT01109173|2667006|P1|Overall Study|Not Specifiied|5
839804|NCT01109173|2667003|P4|Overall Study|Patient Did Not Use Study Medication|7
839805|NCT01109173|2667004|P3|Overall Study|Patient Did Not Use Study Medication|11
839806|NCT01109173|2667005|P2|Overall Study|Patient Did Not Use Study Medication|26
839807|NCT01109173|2667006|P1|Overall Study|Patient Did Not Use Study Medication|34
839808|NCT01109173|2667003|P4|Overall Study|Protocol Violation|2
839809|NCT01109173|2667004|P3|Overall Study|Protocol Violation|1
839810|NCT01109173|2667005|P2|Overall Study|Protocol Violation|5
839811|NCT01109173|2667006|P1|Overall Study|Protocol Violation|4
839812|NCT01109173|2667003|P4|Overall Study|Treatment Failure|64
839813|NCT01109173|2667004|P3|Overall Study|Treatment Failure|69
839814|NCT01109173|2667005|P2|Overall Study|Treatment Failure|32
839815|NCT01109173|2667006|P1|Overall Study|Treatment Failure|25
839816|NCT01109173|2667003|P4|Overall Study|Noncompliance|0
839817|NCT01109173|2667004|P3|Overall Study|Noncompliance|0
839818|NCT01109173|2667005|P2|Overall Study|Noncompliance|1
839819|NCT01109173|2667006|P1|Overall Study|Noncompliance|0
839820|NCT01109173|2667003|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
839821|NCT01109173|2667004|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
839822|NCT01109173|2667005|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
839823|NCT01109173|2667006|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
839824|NCT01109173|2667003|P4|Overall Study|Lost to Follow-up|0
839825|NCT01109173|2667004|P3|Overall Study|Lost to Follow-up|0
839826|NCT01109173|2667005|P2|Overall Study|Lost to Follow-up|1
839827|NCT01109173|2667006|P1|Overall Study|Lost to Follow-up|0
839828|NCT01109173|2667003|P4|Overall Study|Adverse Event|6
839829|NCT01109173|2667004|P3|Overall Study|Adverse Event|9
839830|NCT01109173|2667005|P2|Overall Study|Adverse Event|17
839831|NCT01109173|2667006|P1|Overall Study|Adverse Event|15
839832|NCT01109316|2667026|P3|Study Period 3|Withdrawal by Subject|1
839833|NCT01109316|2667027|P2|Study Period 3|Withdrawal by Subject|1
839834|NCT01109316|2667028|P1|Study Period 3|Withdrawal by Subject|0
839835|NCT01109316|2667026|P3|Study Period 3|Lost to Follow-up|0
839836|NCT01109316|2667027|P2|Study Period 3|Lost to Follow-up|1
839837|NCT01109316|2667028|P1|Study Period 3|Lost to Follow-up|0
839838|NCT01109316|2667026|P3|Study Period 2|Withdrawal by Subject|0
839839|NCT01109316|2667027|P2|Study Period 2|Withdrawal by Subject|1
839840|NCT01109316|2667028|P1|Study Period 2|Withdrawal by Subject|1
839841|NCT01109316|2667026|P3|Study Period 2|Protocol Violation|0
839842|NCT01109316|2667027|P2|Study Period 2|Protocol Violation|1
839843|NCT01109316|2667028|P1|Study Period 2|Protocol Violation|0
839844|NCT01109316|2667026|P3|Study Period 2|Physician Decision|1
839845|NCT01109316|2667027|P2|Study Period 2|Physician Decision|0
839846|NCT01109316|2667028|P1|Study Period 2|Physician Decision|0
839847|NCT01109316|2667026|P3|Study Period 2|Entry Criteria Not Met|1
839848|NCT01109316|2667027|P2|Study Period 2|Entry Criteria Not Met|0
839849|NCT01109316|2667028|P1|Study Period 2|Entry Criteria Not Met|0
839850|NCT01109316|2667026|P3|Study Period 1|Sponsor Decision|2
839851|NCT01109316|2667027|P2|Study Period 1|Sponsor Decision|0
839852|NCT01109316|2667028|P1|Study Period 1|Sponsor Decision|0
839853|NCT01109316|2667026|P3|Study Period 1|Withdrawal by Subject|2
839854|NCT01109316|2667027|P2|Study Period 1|Withdrawal by Subject|1
839855|NCT01109316|2667028|P1|Study Period 1|Withdrawal by Subject|0
839856|NCT01109316|2667026|P3|Study Period 1|Lost to Follow-up|0
839857|NCT01109316|2667027|P2|Study Period 1|Lost to Follow-up|2
839858|NCT01109316|2667028|P1|Study Period 1|Lost to Follow-up|0
839859|NCT01109316|2667026|P3|Study Period 1|Adverse Event|0
839860|NCT01109316|2667027|P2|Study Period 1|Adverse Event|1
839861|NCT01109316|2667028|P1|Study Period 1|Adverse Event|0
839862|NCT01109524|2667078|P1|Overall Study|Not specified|5
839863|NCT01109524|2667078|P1|Overall Study|Participant requested to end treatment|4
839864|NCT01109524|2667078|P1|Overall Study|No longer meets criteria|2
839865|NCT01109524|2667078|P1|Overall Study|Death|2
839866|NCT01109524|2667078|P1|Overall Study|Maximum clinical benefit|3
839867|NCT01109524|2667078|P1|Overall Study|Withdrawal by Subject|2
839868|NCT01109524|2667078|P1|Overall Study|Adverse Event|4
839869|NCT01109524|2667078|P1|Overall Study|Study Drug toxicity|6
839870|NCT01109524|2667078|P1|Overall Study|Disease Progression|29
839871|NCT01109849|2667110|P5|Adaptive Randomization: Weight Recovery|moved away|0
839872|NCT01109849|2667111|P4|Adaptive Randomization: Weight Recovery|moved away|2
839873|NCT01109849|2667112|P3|Adaptive Randomization: Weight Recovery|moved away|0
839874|NCT01109849|2667113|P2|Adaptive Randomization: Weight Recovery|moved away|0
839875|NCT01109849|2667114|P1|Adaptive Randomization: Weight Recovery|moved away|0
839876|NCT01109849|2667110|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
839877|NCT01109849|2667111|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
839878|NCT01109849|2667112|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
839879|NCT01109849|2667113|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
839880|NCT01109849|2667114|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
839881|NCT01109849|2667110|P5|Initial Randomization: ADHD Treatment|move away|0
839882|NCT01109849|2667111|P4|Initial Randomization: ADHD Treatment|move away|0
839883|NCT01109849|2667112|P3|Initial Randomization: ADHD Treatment|move away|0
839884|NCT01109849|2667113|P2|Initial Randomization: ADHD Treatment|move away|7
839885|NCT01109849|2667114|P1|Initial Randomization: ADHD Treatment|move away|2
839886|NCT01109849|2667110|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
839887|NCT01109849|2667111|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
839888|NCT01109849|2667112|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
839889|NCT01109849|2667113|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
839890|NCT01109849|2667114|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
839891|NCT01109849|2667110|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
839892|NCT01109849|2667111|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
839893|NCT01109849|2667112|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
839894|NCT01109849|2667113|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
839895|NCT01109849|2667114|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
839896|NCT01109849|2667110|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
839897|NCT01109849|2667111|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
839898|NCT01109849|2667112|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
839899|NCT01109849|2667113|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
839900|NCT01109849|2667114|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
839901|NCT01109979|2667165|P2|Overall Study|Withdrawal by Subject|1
839902|NCT01109979|2667166|P1|Overall Study|Withdrawal by Subject|0
839903|NCT01109979|2667165|P2|Overall Study|Physician Decision|0
839904|NCT01109979|2667166|P1|Overall Study|Physician Decision|2
839905|NCT01110005|2667174|P2|Overall Study|Withdrawal by Subject|1
839906|NCT01110005|2667175|P1|Overall Study|Withdrawal by Subject|0
839907|NCT01110005|2667174|P2|Overall Study|missing consent|2
839908|NCT01110005|2667175|P1|Overall Study|missing consent|3
839909|NCT01110005|2667174|P2|Overall Study|ineligible|2
839910|NCT01110005|2667175|P1|Overall Study|ineligible|1
839911|NCT01103960|2667198|P2|Overall Study|Other|0
839912|NCT01103960|2667199|P1|Overall Study|Other|1
839913|NCT01103960|2667198|P2|Overall Study|Withdrawal by Subject|1
839914|NCT01103960|2667199|P1|Overall Study|Withdrawal by Subject|2
839915|NCT01103960|2667198|P2|Overall Study|Adverse Event|1
839916|NCT01103960|2667199|P1|Overall Study|Adverse Event|2
839917|NCT01104155|2667250|P2|Overall Study|Not specified|4
839918|NCT01104155|2667251|P1|Overall Study|Not specified|3
839919|NCT01104155|2667250|P2|Overall Study|Withdrawal of consent|1
839920|NCT01104155|2667251|P1|Overall Study|Withdrawal of consent|1
839921|NCT01104155|2667250|P2|Overall Study|Participant choice|5
839922|NCT01104155|2667251|P1|Overall Study|Participant choice|6
839923|NCT01104155|2667250|P2|Overall Study|Adverse Event|8
839924|NCT01104155|2667251|P1|Overall Study|Adverse Event|15
839925|NCT01104246|2667274|P1|Overall Study|did not meet inclusion criteria|4
839926|NCT01104246|2667274|P1|Overall Study|Withdrawal by Subject|1
839927|NCT01104311|2667289|P2|Overall Study|Adverse Event|2
839928|NCT01104311|2667290|P1|Overall Study|Adverse Event|1
839929|NCT01104311|2667289|P2|Overall Study|low compliance|1
839930|NCT01104311|2667290|P1|Overall Study|low compliance|1
839931|NCT01104311|2667289|P2|Overall Study|Physician Decision|2
839932|NCT01104311|2667290|P1|Overall Study|Physician Decision|2
839933|NCT01104311|2667289|P2|Overall Study|Protocol Violation|1
839934|NCT01104311|2667290|P1|Overall Study|Protocol Violation|0
839935|NCT01104311|2667289|P2|Overall Study|Withdrawal by Subject|6
839936|NCT01104311|2667290|P1|Overall Study|Withdrawal by Subject|6
839937|NCT01104376|2667308|P1|Overall Study|Consented but excluded after labs|13
839938|NCT01104376|2667308|P1|Overall Study|Withdrawal by Subject|15
839939|NCT01104493|2667314|P2|Overall Study|Lost to Follow-up|2
839940|NCT01104493|2667315|P1|Overall Study|Lost to Follow-up|0
839941|NCT01104558|2667333|P1|Overall Study|Missing of genetic analysis results|1
839942|NCT01104558|2667333|P1|Overall Study|Missing of primary efficacy assessment|10
839943|NCT01104558|2667333|P1|Overall Study|Protocol Violation|6
839944|NCT01104584|2667374|P1|Overall Study|Study prematurely discontinued|2
839945|NCT01104584|2667374|P1|Overall Study|Study drug never administered|21
839946|NCT01104636|2667444|P1|Overall Study|Ongoing|21
839947|NCT01104636|2667444|P1|Overall Study|Adverse Event|40
839948|NCT01104636|2667444|P1|Overall Study|Pregnancy|2
839949|NCT01104636|2667444|P1|Overall Study|Study terminated by sponsor|1
839950|NCT01104636|2667444|P1|Overall Study|Unspecified|43
839951|NCT01104636|2667444|P1|Overall Study|Withdrawal by Subject|4
839952|NCT01104636|2667444|P1|Overall Study|Lost to Follow-up|24
839953|NCT01104636|2667444|P1|Overall Study|Lack of Efficacy|43
839954|NCT01104662|2667457|P8|Overall Study|Randomized but not treated|0
839955|NCT01104662|2667458|P7|Overall Study|Randomized but not treated|0
839956|NCT01104662|2667459|P6|Overall Study|Randomized but not treated|1
839957|NCT01104662|2667460|P5|Overall Study|Randomized but not treated|0
839958|NCT01104662|2667461|P4|Overall Study|Randomized but not treated|0
839959|NCT01104662|2667462|P3|Overall Study|Randomized but not treated|1
839960|NCT01104662|2667463|P2|Overall Study|Randomized but not treated|4
839961|NCT01104662|2667464|P1|Overall Study|Randomized but not treated|3
839962|NCT01104662|2667457|P8|Overall Study|Reason not specified|0
839963|NCT01104662|2667458|P7|Overall Study|Reason not specified|0
839964|NCT01104662|2667459|P6|Overall Study|Reason not specified|1
839965|NCT01104662|2667460|P5|Overall Study|Reason not specified|0
839966|NCT01104662|2667461|P4|Overall Study|Reason not specified|0
839967|NCT01104662|2667462|P3|Overall Study|Reason not specified|0
839968|NCT01104662|2667463|P2|Overall Study|Reason not specified|3
839969|NCT01104662|2667464|P1|Overall Study|Reason not specified|3
839970|NCT01104662|2667457|P8|Overall Study|Participant left investigator’s care|0
839971|NCT01104662|2667458|P7|Overall Study|Participant left investigator’s care|0
839972|NCT01104662|2667459|P6|Overall Study|Participant left investigator’s care|0
839973|NCT01104662|2667460|P5|Overall Study|Participant left investigator’s care|0
839974|NCT01104662|2667461|P4|Overall Study|Participant left investigator’s care|0
839975|NCT01104662|2667462|P3|Overall Study|Participant left investigator’s care|0
839976|NCT01104662|2667463|P2|Overall Study|Participant left investigator’s care|1
839977|NCT01104662|2667464|P1|Overall Study|Participant left investigator’s care|1
839978|NCT01104662|2667457|P8|Overall Study|Clinical Failure|0
839979|NCT01104662|2667458|P7|Overall Study|Clinical Failure|0
839980|NCT01104662|2667459|P6|Overall Study|Clinical Failure|1
839981|NCT01104662|2667460|P5|Overall Study|Clinical Failure|0
839982|NCT01104662|2667461|P4|Overall Study|Clinical Failure|0
839983|NCT01104662|2667462|P3|Overall Study|Clinical Failure|0
839984|NCT01104662|2667463|P2|Overall Study|Clinical Failure|0
839985|NCT01104662|2667464|P1|Overall Study|Clinical Failure|1
839986|NCT01104662|2667457|P8|Overall Study|Adverse Event|0
839987|NCT01104662|2667458|P7|Overall Study|Adverse Event|0
839988|NCT01104662|2667459|P6|Overall Study|Adverse Event|1
839989|NCT01104662|2667460|P5|Overall Study|Adverse Event|1
839990|NCT01104662|2667461|P4|Overall Study|Adverse Event|1
839991|NCT01104662|2667462|P3|Overall Study|Adverse Event|0
839992|NCT01104662|2667463|P2|Overall Study|Adverse Event|2
839993|NCT01104662|2667464|P1|Overall Study|Adverse Event|2
840006|NCT01110239|2667526|P4|7.5 Min Ischemia|Withdrawal by Subject|0
840007|NCT01110239|2667527|P3|7.5 Min Ischemia|Withdrawal by Subject|1
840008|NCT01110239|2667528|P2|7.5 Min Ischemia|Withdrawal by Subject|0
840009|NCT01110239|2667529|P1|7.5 Min Ischemia|Withdrawal by Subject|0
840010|NCT01110239|2667526|P4|Sham Preconditioning|Withdrawal by Subject|0
840011|NCT01110239|2667527|P3|Sham Preconditioning|Withdrawal by Subject|1
840012|NCT01110239|2667528|P2|Sham Preconditioning|Withdrawal by Subject|0
840013|NCT01110239|2667529|P1|Sham Preconditioning|Withdrawal by Subject|0
840014|NCT01110330|2667559|P3|Overall Study|Not specified|1
840015|NCT01110330|2667560|P2|Overall Study|Not specified|1
840016|NCT01110330|2667561|P1|Overall Study|Not specified|1
840017|NCT01110330|2667559|P3|Overall Study|Withdrawal by Subject|2
840018|NCT01110330|2667560|P2|Overall Study|Withdrawal by Subject|6
840019|NCT01110330|2667561|P1|Overall Study|Withdrawal by Subject|0
840020|NCT01110330|2667559|P3|Overall Study|Protocol Violation|4
840021|NCT01110330|2667560|P2|Overall Study|Protocol Violation|0
840022|NCT01110330|2667561|P1|Overall Study|Protocol Violation|2
840023|NCT01110330|2667559|P3|Overall Study|Physician Decision|0
840024|NCT01110330|2667560|P2|Overall Study|Physician Decision|1
840025|NCT01110330|2667561|P1|Overall Study|Physician Decision|0
840026|NCT01110330|2667559|P3|Overall Study|Lost to Follow-up|15
840027|NCT01110330|2667560|P2|Overall Study|Lost to Follow-up|10
840028|NCT01110330|2667561|P1|Overall Study|Lost to Follow-up|9
840029|NCT01110330|2667559|P3|Overall Study|Lack of Efficacy|1
840030|NCT01110330|2667560|P2|Overall Study|Lack of Efficacy|1
840031|NCT01110330|2667561|P1|Overall Study|Lack of Efficacy|3
840032|NCT01110330|2667559|P3|Overall Study|Adverse Event|3
840033|NCT01110330|2667560|P2|Overall Study|Adverse Event|4
840034|NCT01110330|2667561|P1|Overall Study|Adverse Event|0
840035|NCT01110382|2667574|P2|Overall Study|Protocol Violation|1
840036|NCT01110382|2667575|P1|Overall Study|Protocol Violation|0
840037|NCT01110382|2667574|P2|Overall Study|Withdrawal by Subject|1
840038|NCT01110382|2667575|P1|Overall Study|Withdrawal by Subject|0
840039|NCT01110408|2667595|P2|Overall Study|Protocol Violation|0
840040|NCT01110408|2667596|P1|Overall Study|Protocol Violation|1
840041|NCT01115491|2667739|P1|Overall Study|Physician Decision|1
840042|NCT01115491|2667739|P1|Overall Study|Withdrawal by Subject|1
840043|NCT01115491|2667739|P1|Overall Study|Lost to Follow-up|3
840044|NCT01115491|2667739|P1|Overall Study|Adverse Event|3
840045|NCT01115491|2667739|P1|Overall Study|Death|22
840046|NCT01115569|2667772|P2|Maintenance Phase|Administrative|1
840047|NCT01115569|2667773|P1|Maintenance Phase|Administrative|0
840048|NCT01115569|2667772|P2|Maintenance Phase|Non-Compliance with Study Drug|48
840049|NCT01115569|2667773|P1|Maintenance Phase|Non-Compliance with Study Drug|0
840050|NCT01115569|2667772|P2|Maintenance Phase|Withdrawal by Subject|27
840051|NCT01115569|2667773|P1|Maintenance Phase|Withdrawal by Subject|0
840052|NCT01115569|2667772|P2|Maintenance Phase|Protocol Violation|9
840053|NCT01115569|2667773|P1|Maintenance Phase|Protocol Violation|0
840054|NCT01115569|2667772|P2|Maintenance Phase|Physician Decision|3
840055|NCT01115569|2667773|P1|Maintenance Phase|Physician Decision|0
840056|NCT01115569|2667772|P2|Maintenance Phase|Lost to Follow-up|8
840057|NCT01115569|2667773|P1|Maintenance Phase|Lost to Follow-up|0
840058|NCT01115569|2667772|P2|Maintenance Phase|Adverse Event|43
840059|NCT01115569|2667773|P1|Maintenance Phase|Adverse Event|0
840060|NCT01115569|2667772|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
840061|NCT01115569|2667773|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
840062|NCT01115569|2667772|P2|Conversion/Titration Phase|Withdrawal by Subject|0
840063|NCT01115569|2667773|P1|Conversion/Titration Phase|Withdrawal by Subject|26
840064|NCT01115569|2667772|P2|Conversion/Titration Phase|Protocol Violation|0
840065|NCT01115569|2667773|P1|Conversion/Titration Phase|Protocol Violation|68
840066|NCT01115569|2667772|P2|Conversion/Titration Phase|Physician Decision|0
840067|NCT01115569|2667773|P1|Conversion/Titration Phase|Physician Decision|5
840068|NCT01115569|2667772|P2|Conversion/Titration Phase|Lost to Follow-up|0
840069|NCT01115569|2667773|P1|Conversion/Titration Phase|Lost to Follow-up|3
840070|NCT01115569|2667772|P2|Conversion/Titration Phase|Adverse Event|0
840071|NCT01115569|2667773|P1|Conversion/Titration Phase|Adverse Event|59
840072|NCT01115738|2667945|P3|Overall Study|Withdrawal by Subject|9
840073|NCT01115738|2667946|P2|Overall Study|Withdrawal by Subject|6
840074|NCT01115738|2667947|P1|Overall Study|Withdrawal by Subject|6
840075|NCT01115738|2667945|P3|Overall Study|Physician Decision|17
840076|NCT01115738|2667946|P2|Overall Study|Physician Decision|15
840077|NCT01115738|2667947|P1|Overall Study|Physician Decision|18
840078|NCT01115738|2667945|P3|Overall Study|Lost to Follow-up|1
840079|NCT01115738|2667946|P2|Overall Study|Lost to Follow-up|0
840080|NCT01115738|2667947|P1|Overall Study|Lost to Follow-up|0
840081|NCT01115738|2667945|P3|Overall Study|Death|0
840082|NCT01115738|2667946|P2|Overall Study|Death|0
840083|NCT01115738|2667947|P1|Overall Study|Death|1
840084|NCT01115855|2667983|P2|Overall Study|Unspecified|6
840085|NCT01115855|2667984|P1|Overall Study|Unspecified|8
840086|NCT01115855|2667983|P2|Overall Study|Withdrawal by Subject|5
840087|NCT01115855|2667984|P1|Overall Study|Withdrawal by Subject|5
840088|NCT01115855|2667983|P2|Overall Study|Protocol Violation|1
840089|NCT01115855|2667984|P1|Overall Study|Protocol Violation|0
840090|NCT01115855|2667983|P2|Overall Study|Lab Abnormality|1
840091|NCT01115855|2667984|P1|Overall Study|Lab Abnormality|1
840092|NCT01115855|2667983|P2|Overall Study|Death|5
840093|NCT01115855|2667984|P1|Overall Study|Death|6
840094|NCT01115855|2667983|P2|Overall Study|Adverse Event|18
840095|NCT01115855|2667984|P1|Overall Study|Adverse Event|16
840096|NCT01115933|2668032|P1|Overall Study|Did not receive XIENCE PRIME SV|1
840097|NCT01115998|2668129|P2|Overall Study|Lost to Follow-up|6
840098|NCT01115998|2668130|P1|Overall Study|Lost to Follow-up|6
840099|NCT01116232|2668241|P1|Overall Study|Progressive diease|4
840116|NCT01116687|2668293|P1|Overall Study|Withdrawal by Subject|4
840117|NCT01116882|2668302|P2|12-month|Withdrawal by Subject|8
840118|NCT01116882|2668303|P1|12-month|Withdrawal by Subject|5
840119|NCT01116882|2668302|P2|12-month|Other Reasons|49
840120|NCT01116882|2668303|P1|12-month|Other Reasons|151
840121|NCT01116882|2668302|P2|12-month|Lost to Follow-up|42
840122|NCT01116882|2668303|P1|12-month|Lost to Follow-up|111
840123|NCT01116882|2668302|P2|30-day|Other Reasons|6
840124|NCT01116882|2668303|P1|30-day|Other Reasons|16
840125|NCT01116882|2668302|P2|30-day|Withdrawal by Subject|4
840126|NCT01116882|2668303|P1|30-day|Withdrawal by Subject|2
840127|NCT01116882|2668302|P2|30-day|Lost to Follow-up|21
840128|NCT01116882|2668303|P1|30-day|Lost to Follow-up|50
840129|NCT01117012|2668466|P2|Overall Study|Undefined|3
840130|NCT01117012|2668467|P1|Overall Study|Undefined|4
840131|NCT01117012|2668466|P2|Overall Study|Withdrawal by Subject|0
840132|NCT01117012|2668467|P1|Overall Study|Withdrawal by Subject|3
840133|NCT01117012|2668466|P2|Overall Study|Death|1
840134|NCT01117012|2668467|P1|Overall Study|Death|1
840135|NCT01117012|2668466|P2|Overall Study|Adverse Event|1
840136|NCT01117012|2668467|P1|Overall Study|Adverse Event|0
840137|NCT01117051|2668485|P2|Overall Study|Convenience issue|0
840138|NCT01117051|2668486|P1|Overall Study|Convenience issue|1
840139|NCT01117051|2668485|P2|Overall Study|Randomized by mistake|1
840140|NCT01117051|2668486|P1|Overall Study|Randomized by mistake|0
840141|NCT01117051|2668485|P2|Overall Study|Surgical procedure|1
840142|NCT01117051|2668486|P1|Overall Study|Surgical procedure|0
840143|NCT01117051|2668485|P2|Overall Study|Sponsor's decision|1
840144|NCT01117051|2668486|P1|Overall Study|Sponsor's decision|3
840145|NCT01117051|2668485|P2|Overall Study|Did not meet in-/exclusion criteria|1
840146|NCT01117051|2668486|P1|Overall Study|Did not meet in-/exclusion criteria|0
840147|NCT01117051|2668485|P2|Overall Study|Lost to Follow-up|1
840148|NCT01117051|2668486|P1|Overall Study|Lost to Follow-up|0
840149|NCT01117051|2668485|P2|Overall Study|Adverse Event|3
840150|NCT01117051|2668486|P1|Overall Study|Adverse Event|4
840151|NCT01117051|2668485|P2|Overall Study|Withdrawal by Subject|3
840152|NCT01117051|2668486|P1|Overall Study|Withdrawal by Subject|5
840153|NCT01117181|2668507|P2|Overall Study|Withdrawal by Subject|2
840154|NCT01117181|2668508|P1|Overall Study|Withdrawal by Subject|0
840155|NCT01117181|2668507|P2|Overall Study|Lost to Follow-up|0
840156|NCT01117181|2668508|P1|Overall Study|Lost to Follow-up|1
840157|NCT01117337|2668537|P2|Overall Study|Lost to Follow-up|0
840158|NCT01117337|2668538|P1|Overall Study|Lost to Follow-up|4
840159|NCT01117350|2668550|P2|Extension Period|Prohibited medication|1
840160|NCT01117350|2668551|P1|Extension Period|Prohibited medication|0
840161|NCT01117350|2668550|P2|Extension Period|Inclusion criteria not respected|1
840162|NCT01117350|2668551|P1|Extension Period|Inclusion criteria not respected|0
840163|NCT01117350|2668550|P2|Extension Period|Lack of Efficacy|2
840164|NCT01117350|2668551|P1|Extension Period|Lack of Efficacy|0
840165|NCT01117350|2668550|P2|Extension Period|Withdrawal by Subject|3
840166|NCT01117350|2668551|P1|Extension Period|Withdrawal by Subject|0
840167|NCT01117350|2668550|P2|Extension Period|Lost to Follow-up|2
840168|NCT01117350|2668551|P1|Extension Period|Lost to Follow-up|0
840169|NCT01117350|2668550|P2|Extension Period|Protocol Violation|2
840170|NCT01117350|2668551|P1|Extension Period|Protocol Violation|0
840171|NCT01117350|2668550|P2|Extension Period|Adverse Event|2
840172|NCT01117350|2668551|P1|Extension Period|Adverse Event|0
840173|NCT01117350|2668550|P2|Extension Period|Not included in extension, not treated|50
840174|NCT01117350|2668551|P1|Extension Period|Not included in extension, not treated|0
840175|NCT01117350|2668550|P2|Comparative Period|Move to another city/country|1
840176|NCT01117350|2668551|P1|Comparative Period|Move to another city/country|2
840177|NCT01117350|2668550|P2|Comparative Period|Physician Decision|1
840178|NCT01117350|2668551|P1|Comparative Period|Physician Decision|0
840179|NCT01117350|2668550|P2|Comparative Period|Lack of Efficacy|0
840180|NCT01117350|2668551|P1|Comparative Period|Lack of Efficacy|1
840181|NCT01117350|2668550|P2|Comparative Period|Protocol Violation|12
840182|NCT01117350|2668551|P1|Comparative Period|Protocol Violation|8
840183|NCT01117350|2668550|P2|Comparative Period|Withdrawal by Subject|13
840184|NCT01117350|2668551|P1|Comparative Period|Withdrawal by Subject|9
840185|NCT01117350|2668550|P2|Comparative Period|Lost to Follow-up|7
840186|NCT01117350|2668551|P1|Comparative Period|Lost to Follow-up|11
840187|NCT01117350|2668550|P2|Comparative Period|Adverse Event|33
840188|NCT01117350|2668551|P1|Comparative Period|Adverse Event|6
840189|NCT01117350|2668550|P2|Comparative Period|Not Treated|8
840190|NCT01117350|2668551|P1|Comparative Period|Not Treated|5
840191|NCT01117428|2668587|P6|Overall Study|Progressive disease|17
840192|NCT01117428|2668588|P5|Overall Study|Progressive disease|16
840193|NCT01117428|2668589|P4|Overall Study|Progressive disease|12
840194|NCT01117428|2668590|P3|Overall Study|Progressive disease|10
840195|NCT01117428|2668591|P2|Overall Study|Progressive disease|27
840196|NCT01117428|2668592|P1|Overall Study|Progressive disease|15
840197|NCT01117428|2668587|P6|Overall Study|Withdrawal by Subject|0
840198|NCT01117428|2668588|P5|Overall Study|Withdrawal by Subject|0
840199|NCT01117428|2668589|P4|Overall Study|Withdrawal by Subject|0
840200|NCT01117428|2668590|P3|Overall Study|Withdrawal by Subject|1
840201|NCT01117428|2668591|P2|Overall Study|Withdrawal by Subject|0
840202|NCT01117428|2668592|P1|Overall Study|Withdrawal by Subject|0
840203|NCT01117428|2668587|P6|Overall Study|Physician Decision|0
840204|NCT01117428|2668588|P5|Overall Study|Physician Decision|0
840205|NCT01117428|2668589|P4|Overall Study|Physician Decision|0
840206|NCT01117428|2668590|P3|Overall Study|Physician Decision|0
840207|NCT01117428|2668591|P2|Overall Study|Physician Decision|1
840208|NCT01117428|2668592|P1|Overall Study|Physician Decision|0
840209|NCT01117428|2668587|P6|Overall Study|Death|1
840210|NCT01117428|2668588|P5|Overall Study|Death|0
840211|NCT01117428|2668589|P4|Overall Study|Death|0
840212|NCT01117428|2668590|P3|Overall Study|Death|2
840213|NCT01117428|2668591|P2|Overall Study|Death|1
840214|NCT01117428|2668592|P1|Overall Study|Death|0
840215|NCT01117428|2668587|P6|Overall Study|Adverse Event|2
840216|NCT01117428|2668588|P5|Overall Study|Adverse Event|1
840217|NCT01117428|2668589|P4|Overall Study|Adverse Event|0
840218|NCT01117428|2668590|P3|Overall Study|Adverse Event|0
840219|NCT01117428|2668591|P2|Overall Study|Adverse Event|0
840220|NCT01117428|2668592|P1|Overall Study|Adverse Event|4
840221|NCT01117428|2668587|P6|Overall Study|Lack of Efficacy|0
840222|NCT01117428|2668588|P5|Overall Study|Lack of Efficacy|0
840223|NCT01117428|2668589|P4|Overall Study|Lack of Efficacy|0
840224|NCT01117428|2668590|P3|Overall Study|Lack of Efficacy|0
840225|NCT01117428|2668591|P2|Overall Study|Lack of Efficacy|0
840226|NCT01117428|2668592|P1|Overall Study|Lack of Efficacy|1
840227|NCT01107535|2668624|P1|Overall Study|Death|5
840228|NCT01117454|2668634|P2|Overall Study|Pregnancy|1
840229|NCT01117454|2668635|P1|Overall Study|Pregnancy|0
840230|NCT01117480|2668641|P1|Overall Study|Did Not Start Adalimumab Therapy|20
840231|NCT01117480|2668641|P1|Overall Study|Protocol Violation|8
840232|NCT01117623|2668655|P8|Overall Study|Invest. text: completed all planned txs|0
840233|NCT01117623|2668656|P7|Overall Study|Invest. text: completed all planned txs|0
840234|NCT01117623|2668657|P6|Overall Study|Invest. text: completed all planned txs|1
840235|NCT01117623|2668658|P5|Overall Study|Invest. text: completed all planned txs|0
840236|NCT01117623|2668659|P4|Overall Study|Invest. text: completed all planned txs|0
840237|NCT01117623|2668660|P3|Overall Study|Invest. text: completed all planned txs|0
840238|NCT01117623|2668661|P2|Overall Study|Invest. text: completed all planned txs|0
840239|NCT01117623|2668662|P1|Overall Study|Invest. text: completed all planned txs|0
840240|NCT01117623|2668655|P8|Overall Study|Non-compliance with study medication|1
840241|NCT01117623|2668656|P7|Overall Study|Non-compliance with study medication|0
840242|NCT01117623|2668657|P6|Overall Study|Non-compliance with study medication|0
840243|NCT01117623|2668658|P5|Overall Study|Non-compliance with study medication|0
840244|NCT01117623|2668659|P4|Overall Study|Non-compliance with study medication|0
840245|NCT01117623|2668660|P3|Overall Study|Non-compliance with study medication|0
840246|NCT01117623|2668661|P2|Overall Study|Non-compliance with study medication|0
840247|NCT01117623|2668662|P1|Overall Study|Non-compliance with study medication|0
840248|NCT01117623|2668655|P8|Overall Study|Withdrawal by Subject|1
840249|NCT01117623|2668656|P7|Overall Study|Withdrawal by Subject|1
840250|NCT01117623|2668657|P6|Overall Study|Withdrawal by Subject|1
840251|NCT01117623|2668658|P5|Overall Study|Withdrawal by Subject|0
840252|NCT01117623|2668659|P4|Overall Study|Withdrawal by Subject|0
840253|NCT01117623|2668660|P3|Overall Study|Withdrawal by Subject|2
840254|NCT01117623|2668661|P2|Overall Study|Withdrawal by Subject|0
840255|NCT01117623|2668662|P1|Overall Study|Withdrawal by Subject|0
840256|NCT01117623|2668655|P8|Overall Study|Disease progression, recurrence, relapse|22
840257|NCT01117623|2668656|P7|Overall Study|Disease progression, recurrence, relapse|5
840258|NCT01117623|2668657|P6|Overall Study|Disease progression, recurrence, relapse|14
840259|NCT01117623|2668658|P5|Overall Study|Disease progression, recurrence, relapse|8
840260|NCT01117623|2668659|P4|Overall Study|Disease progression, recurrence, relapse|6
840261|NCT01117623|2668660|P3|Overall Study|Disease progression, recurrence, relapse|5
840262|NCT01117623|2668661|P2|Overall Study|Disease progression, recurrence, relapse|6
840263|NCT01117623|2668662|P1|Overall Study|Disease progression, recurrence, relapse|3
840264|NCT01117623|2668655|P8|Overall Study|Adverse Event|2
840265|NCT01117623|2668656|P7|Overall Study|Adverse Event|0
840266|NCT01117623|2668657|P6|Overall Study|Adverse Event|0
840267|NCT01117623|2668658|P5|Overall Study|Adverse Event|2
840268|NCT01117623|2668659|P4|Overall Study|Adverse Event|0
840269|NCT01117623|2668660|P3|Overall Study|Adverse Event|4
840270|NCT01117623|2668661|P2|Overall Study|Adverse Event|2
840271|NCT01117623|2668662|P1|Overall Study|Adverse Event|0
840272|NCT01117766|2668819|P2|Second Intervention|Withdrawal by Subject|1
840273|NCT01117766|2668820|P1|Second Intervention|Withdrawal by Subject|0
840274|NCT01117766|2668819|P2|Second Intervention|Adverse Event|2
840275|NCT01117766|2668820|P1|Second Intervention|Adverse Event|0
840276|NCT01117766|2668819|P2|Second Intervention|Unspecified|2
840277|NCT01117766|2668820|P1|Second Intervention|Unspecified|1
840278|NCT01117766|2668819|P2|Second Intervention|Lost to Follow-up|0
840279|NCT01117766|2668820|P1|Second Intervention|Lost to Follow-up|1
840280|NCT01117766|2668819|P2|Washout Period|Protocol Violation|2
840281|NCT01117766|2668820|P1|Washout Period|Protocol Violation|0
840282|NCT01117766|2668819|P2|First Intervention|Protocol Violation|0
840283|NCT01117766|2668820|P1|First Intervention|Protocol Violation|1
840284|NCT01117766|2668819|P2|First Intervention|Unspecified|0
840285|NCT01117766|2668820|P1|First Intervention|Unspecified|0
840286|NCT01117766|2668819|P2|First Intervention|Adverse Event|1
840287|NCT01117766|2668820|P1|First Intervention|Adverse Event|0
840288|NCT01119001|2668844|P1|Overall Study|Withdrawal by Subject|2
840289|NCT01119118|2668854|P1|Overall Study|Adverse Event|1
840290|NCT01119131|2668865|P3|Overall Study|Physician Decision|1
840291|NCT01119131|2668866|P2|Overall Study|Physician Decision|0
840292|NCT01119131|2668867|P1|Overall Study|Physician Decision|0
840293|NCT01119131|2668865|P3|Overall Study|Non-Compliance|4
840294|NCT01119131|2668866|P2|Overall Study|Non-Compliance|0
840295|NCT01119131|2668867|P1|Overall Study|Non-Compliance|1
840296|NCT01119131|2668865|P3|Overall Study|Adverse Event|1
840297|NCT01119131|2668866|P2|Overall Study|Adverse Event|1
840298|NCT01119131|2668867|P1|Overall Study|Adverse Event|1
840299|NCT01119287|2668943|P6|Overall Study|Patient Decision, not related to AE|0
840300|NCT01119287|2668944|P5|Overall Study|Patient Decision, not related to AE|1
840301|NCT01119287|2668945|P4|Overall Study|Patient Decision, not related to AE|2
840302|NCT01119287|2668946|P3|Overall Study|Patient Decision, not related to AE|2
840303|NCT01119287|2668947|P2|Overall Study|Patient Decision, not related to AE|0
840304|NCT01119287|2668948|P1|Overall Study|Patient Decision, not related to AE|0
840305|NCT01119443|2668963|P2|Crossover Period 1 (5 Days)|Adverse Event|1
840306|NCT01119443|2668964|P1|Crossover Period 1 (5 Days)|Adverse Event|0
840307|NCT01119625|2669003|P2|Overall Study|Unspecified|1
840308|NCT01119625|2669004|P1|Overall Study|Unspecified|0
840309|NCT01119625|2669003|P2|Overall Study|Withdrawal by Subject|1
840310|NCT01119625|2669004|P1|Overall Study|Withdrawal by Subject|2
840311|NCT01119625|2669003|P2|Overall Study|Lost to Follow-up|2
840312|NCT01119625|2669004|P1|Overall Study|Lost to Follow-up|1
840313|NCT01119703|2669046|P2|Overall Study|Adverse Event|1
840314|NCT01119703|2669047|P1|Overall Study|Adverse Event|0
840315|NCT01119768|2669093|P2|Treatment Period|Lack of Efficacy|25
840316|NCT01119768|2669094|P1|Treatment Period|Lack of Efficacy|18
840317|NCT01119859|2669122|P2|Overall Study|Failure to return|0
840318|NCT01119859|2669123|P1|Overall Study|Failure to return|3
840319|NCT01119859|2669122|P2|Overall Study|Refused treatment|6
840320|NCT01119859|2669123|P1|Overall Study|Refused treatment|3
840321|NCT01119859|2669122|P2|Overall Study|Insufficient therapeutic response|14
840322|NCT01119859|2669123|P1|Overall Study|Insufficient therapeutic response|7
840323|NCT01119859|2669122|P2|Overall Study|Death|0
840324|NCT01119859|2669123|P1|Overall Study|Death|2
840325|NCT01119859|2669122|P2|Overall Study|Adverse Event|10
840326|NCT01119859|2669123|P1|Overall Study|Adverse Event|9
840327|NCT01119937|2669141|P2|Overall Study|Withdrawal by Subject|1
840328|NCT01119937|2669142|P1|Overall Study|Withdrawal by Subject|2
840329|NCT01119937|2669141|P2|Overall Study|Unsatisfactory therapeutic effect|0
840330|NCT01119937|2669142|P1|Overall Study|Unsatisfactory therapeutic effect|3
840331|NCT01119937|2669141|P2|Overall Study|Protocol deviation|1
840332|NCT01119937|2669142|P1|Overall Study|Protocol deviation|3
840333|NCT01119937|2669141|P2|Overall Study|Adverse Event|5
840334|NCT01119937|2669142|P1|Overall Study|Adverse Event|11
840335|NCT01119950|2669168|P1|Overall Study|Death|1
840336|NCT01119950|2669168|P1|Overall Study|Abnormal lab value|1
840337|NCT01119950|2669168|P1|Overall Study|Administrative|2
840338|NCT01119950|2669168|P1|Overall Study|Lost to Follow-up|4
840339|NCT01119950|2669168|P1|Overall Study|Protocol Violation|5
840340|NCT01119950|2669168|P1|Overall Study|Withdrawal by Subject|9
840341|NCT01119950|2669168|P1|Overall Study|Adverse Event|25
840342|NCT01120067|2669415|P2|Overall Study|fail to engage >3 sessions|0
840343|NCT01120067|2669416|P1|Overall Study|fail to engage >3 sessions|2
840344|NCT01120067|2669415|P2|Overall Study|Lost to Follow-up|1
840345|NCT01120067|2669416|P1|Overall Study|Lost to Follow-up|3
840346|NCT01120093|2669422|P5|Treatment Period 5|Adverse Event|0
840347|NCT01120093|2669423|P4|Treatment Period 5|Adverse Event|1
840348|NCT01120093|2669424|P3|Treatment Period 5|Adverse Event|0
840349|NCT01120093|2669425|P2|Treatment Period 5|Adverse Event|1
840350|NCT01120093|2669426|P1|Treatment Period 5|Adverse Event|0
840351|NCT01120093|2669422|P5|Treatment Period 4|Adverse Event|0
840352|NCT01120093|2669423|P4|Treatment Period 4|Adverse Event|0
840353|NCT01120093|2669424|P3|Treatment Period 4|Adverse Event|0
840354|NCT01120093|2669425|P2|Treatment Period 4|Adverse Event|0
840355|NCT01120093|2669426|P1|Treatment Period 4|Adverse Event|1
840356|NCT01120093|2669422|P5|Treatment Period 3|Withdrawal by Subject|0
840357|NCT01120093|2669423|P4|Treatment Period 3|Withdrawal by Subject|0
840358|NCT01120093|2669424|P3|Treatment Period 3|Withdrawal by Subject|1
840359|NCT01120093|2669425|P2|Treatment Period 3|Withdrawal by Subject|0
840360|NCT01120093|2669426|P1|Treatment Period 3|Withdrawal by Subject|0
840361|NCT01120093|2669422|P5|Treatment Period 3|Adverse Event|1
840362|NCT01120093|2669423|P4|Treatment Period 3|Adverse Event|0
840363|NCT01120093|2669424|P3|Treatment Period 3|Adverse Event|0
840364|NCT01120093|2669425|P2|Treatment Period 3|Adverse Event|0
840365|NCT01120093|2669426|P1|Treatment Period 3|Adverse Event|0
840366|NCT01120093|2669422|P5|Treatment Period 3|Lack of Efficacy|0
840367|NCT01120093|2669423|P4|Treatment Period 3|Lack of Efficacy|1
840368|NCT01120093|2669424|P3|Treatment Period 3|Lack of Efficacy|0
840369|NCT01120093|2669425|P2|Treatment Period 3|Lack of Efficacy|0
840370|NCT01120093|2669426|P1|Treatment Period 3|Lack of Efficacy|0
840371|NCT01120093|2669422|P5|Treatment Period 2|Withdrawal by Subject|1
840372|NCT01120093|2669423|P4|Treatment Period 2|Withdrawal by Subject|0
840373|NCT01120093|2669424|P3|Treatment Period 2|Withdrawal by Subject|0
840374|NCT01120093|2669425|P2|Treatment Period 2|Withdrawal by Subject|0
840375|NCT01120093|2669426|P1|Treatment Period 2|Withdrawal by Subject|0
840376|NCT01120093|2669422|P5|Treatment Period 2|Adverse Event|0
840377|NCT01120093|2669423|P4|Treatment Period 2|Adverse Event|1
840378|NCT01120093|2669424|P3|Treatment Period 2|Adverse Event|0
840379|NCT01120093|2669425|P2|Treatment Period 2|Adverse Event|0
840380|NCT01120093|2669426|P1|Treatment Period 2|Adverse Event|0
840381|NCT01120093|2669422|P5|Treatment Period 1|Withdrawal by Subject|0
840382|NCT01120093|2669423|P4|Treatment Period 1|Withdrawal by Subject|0
840383|NCT01120093|2669424|P3|Treatment Period 1|Withdrawal by Subject|0
840384|NCT01120093|2669425|P2|Treatment Period 1|Withdrawal by Subject|1
840385|NCT01120093|2669426|P1|Treatment Period 1|Withdrawal by Subject|0
840386|NCT01120093|2669422|P5|Treatment Period 1|Adverse Event|1
840387|NCT01120093|2669423|P4|Treatment Period 1|Adverse Event|0
840388|NCT01120093|2669424|P3|Treatment Period 1|Adverse Event|1
840389|NCT01120093|2669425|P2|Treatment Period 1|Adverse Event|0
840390|NCT01120093|2669426|P1|Treatment Period 1|Adverse Event|0
893951|NCT00892099|2836595|P3|Overall Study|Lost to Follow-up|1
893952|NCT00892099|2836596|P2|Overall Study|Lost to Follow-up|0
893953|NCT00892099|2836597|P1|Overall Study|Lost to Follow-up|0
893954|NCT00892099|2836595|P3|Overall Study|investigator decision|1
893955|NCT00892099|2836596|P2|Overall Study|investigator decision|0
840412|NCT01120210|2669599|P2|MAIN INFUSION|Withdrawal by Subject|1
840413|NCT01120210|2669600|P1|MAIN INFUSION|Withdrawal by Subject|0
840414|NCT01120210|2669599|P2|MAIN INFUSION|Adverse Event|0
840415|NCT01120210|2669600|P1|MAIN INFUSION|Adverse Event|1
840416|NCT01120275|2669671|P1|Overall Study|Not specific|1
840417|NCT01120275|2669671|P1|Overall Study|Refusal|1
840418|NCT01120275|2669671|P1|Overall Study|Withdrawal by Subject|1
840419|NCT01120275|2669671|P1|Overall Study|Ineligible|3
840420|NCT01120275|2669671|P1|Overall Study|Progression|27
840421|NCT01120275|2669671|P1|Overall Study|Adverse Event|3
840422|NCT01120379|2669678|P1|Four Year Timepoint|Any other reason for early termination|217
840423|NCT01120379|2669678|P1|Four Year Timepoint|Physician Decision|5
840424|NCT01120379|2669678|P1|Four Year Timepoint|Death|131
840425|NCT01120379|2669678|P1|Four Year Timepoint|Lost to Follow-up|10
840426|NCT01120379|2669678|P1|Four Year Timepoint|Withdrawal by Subject|5
840427|NCT01120379|2669678|P1|Three Year Timepoint|Any other reason for early termination|17
840428|NCT01120379|2669678|P1|Three Year Timepoint|Physician Decision|9
840429|NCT01120379|2669678|P1|Three Year Timepoint|Death|120
840430|NCT01120379|2669678|P1|Three Year Timepoint|Lost to Follow-up|43
840431|NCT01120379|2669678|P1|Three Year Timepoint|Withdrawal by Subject|25
840432|NCT01120379|2669678|P1|Two Year Timepoint|Any other reason for early termination|4
840433|NCT01120379|2669678|P1|Two Year Timepoint|Physician Decision|12
840434|NCT01120379|2669678|P1|Two Year Timepoint|Death|123
840435|NCT01120379|2669678|P1|Two Year Timepoint|Lost to Follow-up|87
840436|NCT01120379|2669678|P1|Two Year Timepoint|Withdrawal by Subject|11
840437|NCT01120379|2669678|P1|One Year Timepoint|Any other reason for early termination|5
840438|NCT01120379|2669678|P1|One Year Timepoint|Physician Decision|9
840439|NCT01120379|2669678|P1|One Year Timepoint|Death|108
840440|NCT01120379|2669678|P1|One Year Timepoint|Lost to Follow-up|115
840441|NCT01120379|2669678|P1|One Year Timepoint|Withdrawal by Subject|41
840442|NCT01120626|2669747|P2|Overall Study|Withdrawal by Subject|0
840443|NCT01120626|2669748|P1|Overall Study|Withdrawal by Subject|1
840444|NCT01120691|2669759|P3|Overall Study|Abnormal laboratory value(s)|4
840445|NCT01120691|2669760|P2|Overall Study|Abnormal laboratory value(s)|3
840446|NCT01120691|2669761|P1|Overall Study|Abnormal laboratory value(s)|1
840447|NCT01120691|2669759|P3|Overall Study|Patient's inability to use the device|0
840448|NCT01120691|2669760|P2|Overall Study|Patient's inability to use the device|1
840449|NCT01120691|2669761|P1|Overall Study|Patient's inability to use the device|3
840450|NCT01120691|2669759|P3|Overall Study|Abnormal test procedure result(s)|1
840451|NCT01120691|2669760|P2|Overall Study|Abnormal test procedure result(s)|2
840452|NCT01120691|2669761|P1|Overall Study|Abnormal test procedure result(s)|3
840453|NCT01120691|2669759|P3|Overall Study|Lost to Follow-up|4
840454|NCT01120691|2669760|P2|Overall Study|Lost to Follow-up|6
840455|NCT01120691|2669761|P1|Overall Study|Lost to Follow-up|5
840456|NCT01120691|2669759|P3|Overall Study|Protocol deviation|12
840457|NCT01120691|2669760|P2|Overall Study|Protocol deviation|12
840458|NCT01120691|2669761|P1|Overall Study|Protocol deviation|13
893956|NCT00892099|2836597|P1|Overall Study|investigator decision|0
840459|NCT01120691|2669759|P3|Overall Study|Administrative problems|9
840460|NCT01120691|2669760|P2|Overall Study|Administrative problems|8
840461|NCT01120691|2669761|P1|Overall Study|Administrative problems|15
840462|NCT01120691|2669759|P3|Overall Study|Unsatisfactory therapeutic effect|38
840463|NCT01120691|2669760|P2|Overall Study|Unsatisfactory therapeutic effect|32
840464|NCT01120691|2669761|P1|Overall Study|Unsatisfactory therapeutic effect|18
840465|NCT01120691|2669759|P3|Overall Study|Death|24
840466|NCT01120691|2669760|P2|Overall Study|Death|22
840467|NCT01120691|2669761|P1|Overall Study|Death|21
840468|NCT01120691|2669759|P3|Overall Study|Subject withdrew consent|44
840469|NCT01120691|2669760|P2|Overall Study|Subject withdrew consent|50
840470|NCT01120691|2669761|P1|Overall Study|Subject withdrew consent|33
840471|NCT01120691|2669759|P3|Overall Study|Adverse Event|47
840472|NCT01120691|2669760|P2|Overall Study|Adverse Event|67
840473|NCT01120691|2669761|P1|Overall Study|Adverse Event|59
840474|NCT01120717|2669892|P2|Overall Study|Abnormal Test Procedure Result(s)|0
840475|NCT01120717|2669893|P1|Overall Study|Abnormal Test Procedure Result(s)|1
840476|NCT01120717|2669892|P2|Overall Study|Death|1
840477|NCT01120717|2669893|P1|Overall Study|Death|3
840478|NCT01120717|2669892|P2|Overall Study|Lost to Follow-up|3
840479|NCT01120717|2669893|P1|Overall Study|Lost to Follow-up|2
840480|NCT01120717|2669892|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
840481|NCT01120717|2669893|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
840482|NCT01120717|2669892|P2|Overall Study|Protocol Deviation|5
840483|NCT01120717|2669893|P1|Overall Study|Protocol Deviation|2
840484|NCT01120717|2669892|P2|Overall Study|Adverse Event|6
840485|NCT01120717|2669893|P1|Overall Study|Adverse Event|10
840486|NCT01120717|2669892|P2|Overall Study|Withdrawal by Subject|6
840487|NCT01120717|2669893|P1|Overall Study|Withdrawal by Subject|11
893957|NCT00892099|2836595|P3|Overall Study|kidney function recovered|0
840489|NCT01120899|2669921|P1|Overall Study|Withdrawal by Subject|3
840490|NCT01121146|2669950|P2|Overall Study|Lost to Follow-up|16
840491|NCT01121146|2669951|P1|Overall Study|Lost to Follow-up|7
840492|NCT01121146|2669950|P2|Overall Study|Adverse Event|11
840493|NCT01121146|2669951|P1|Overall Study|Adverse Event|2
840494|NCT01121146|2669950|P2|Overall Study|Death|15
840495|NCT01121146|2669951|P1|Overall Study|Death|17
840496|NCT01121185|2669977|P2|Overall Study|Not transplanted|0
840497|NCT01121185|2669978|P1|Overall Study|Not transplanted|1
840498|NCT01121185|2669977|P2|Overall Study|Not infused|1
840499|NCT01121185|2669978|P1|Overall Study|Not infused|0
840500|NCT01121263|2670013|P2|Overall Study|Withdrawal by Subject|1
840501|NCT01121263|2670014|P1|Overall Study|Withdrawal by Subject|0
840502|NCT01121263|2670013|P2|Overall Study|Lost to Follow-up|12
840503|NCT01121263|2670014|P1|Overall Study|Lost to Follow-up|22
840504|NCT01121263|2670013|P2|Overall Study|Death|2
840505|NCT01121263|2670014|P1|Overall Study|Death|3
840506|NCT01121393|2670024|P2|Overall Study|Not treated|9
840507|NCT01121393|2670025|P1|Overall Study|Not treated|3
840508|NCT01121393|2670024|P2|Overall Study|Refused cont. medication|7
840509|NCT01121393|2670025|P1|Overall Study|Refused cont. medication|7
840510|NCT01121393|2670024|P2|Overall Study|Lost to Follow-up|0
840511|NCT01121393|2670025|P1|Overall Study|Lost to Follow-up|1
840512|NCT01121393|2670024|P2|Overall Study|Non-compliant with protocol|3
840513|NCT01121393|2670025|P1|Overall Study|Non-compliant with protocol|0
840514|NCT01121393|2670024|P2|Overall Study|Other Adverse events|45
840515|NCT01121393|2670025|P1|Overall Study|Other Adverse events|22
840516|NCT01121393|2670024|P2|Overall Study|Progressive disease|20
840517|NCT01121393|2670025|P1|Overall Study|Progressive disease|186
840518|NCT01121406|2670070|P2|Overall Study|Not treated|0
840519|NCT01121406|2670071|P1|Overall Study|Not treated|1
840520|NCT01121406|2670070|P2|Overall Study|Reason other than specified above|6
840521|NCT01121406|2670071|P1|Overall Study|Reason other than specified above|2
840522|NCT01121406|2670070|P2|Overall Study|Refused continuation of study med.|2
840523|NCT01121406|2670071|P1|Overall Study|Refused continuation of study med.|1
840524|NCT01121406|2670070|P2|Overall Study|Lost to Follow-up|1
840525|NCT01121406|2670071|P1|Overall Study|Lost to Follow-up|0
840526|NCT01121406|2670070|P2|Overall Study|Non−compliant with protocol|2
840527|NCT01121406|2670071|P1|Overall Study|Non−compliant with protocol|0
840528|NCT01121406|2670070|P2|Overall Study|Other AE|10
840529|NCT01121406|2670071|P1|Overall Study|Other AE|3
840530|NCT01121406|2670070|P2|Overall Study|Wors. or AE of underlying cancer disease|6
840531|NCT01121406|2670071|P1|Overall Study|Wors. or AE of underlying cancer disease|4
840532|NCT01121406|2670070|P2|Overall Study|Progressive disease RECIST|28
840533|NCT01121406|2670071|P1|Overall Study|Progressive disease RECIST|44
840534|NCT01110915|2670177|P2|Overall Study|Withdrawal by Subject|1
840535|NCT01110915|2670178|P1|Overall Study|Withdrawal by Subject|7
840536|NCT01110915|2670177|P2|Overall Study|Lost to Follow-up|0
840537|NCT01110915|2670178|P1|Overall Study|Lost to Follow-up|1
840538|NCT01110915|2670177|P2|Overall Study|Death|1
840539|NCT01110915|2670178|P1|Overall Study|Death|2
840540|NCT01111123|2670219|P2|Maintenance Phase|Lost to Follow-up|2
840541|NCT01111123|2670220|P1|Maintenance Phase|Lost to Follow-up|0
840542|NCT01111123|2670219|P2|Open- Label Phase|Failed to be clear or almost cleared|0
840543|NCT01111123|2670220|P1|Open- Label Phase|Failed to be clear or almost cleared|14
840544|NCT01111149|2670231|P3|Overall Study|Withdrawal by Subject|2
840545|NCT01111149|2670232|P2|Overall Study|Withdrawal by Subject|0
840546|NCT01111149|2670233|P1|Overall Study|Withdrawal by Subject|1
840547|NCT01111149|2670231|P3|Overall Study|Protocol Violation|2
840548|NCT01111149|2670232|P2|Overall Study|Protocol Violation|1
840549|NCT01111149|2670233|P1|Overall Study|Protocol Violation|1
840550|NCT01111240|2670312|P1|Overall Study|Not Specified|312
840551|NCT01111240|2670312|P1|Overall Study|Lack of Efficacy and Adverse Event|19
840552|NCT01111240|2670312|P1|Overall Study|Lack of Efficacy|545
840553|NCT01111240|2670312|P1|Overall Study|Adverse Event|190
840554|NCT01111292|2670336|P2|Treatment|Physician Decision|1
840555|NCT01111292|2670337|P1|Treatment|Physician Decision|1
840556|NCT01111461|2670508|P1|Overall Study|Not specified|6
840557|NCT01111461|2670508|P1|Overall Study|Withdrawal by Subject|1
840558|NCT01111461|2670508|P1|Overall Study|Lost to Follow-up|1
840559|NCT01111461|2670508|P1|Overall Study|Participant choice|11
840560|NCT01111461|2670508|P1|Overall Study|Adverse Event|32
840561|NCT01111526|2670521|P3|Overall Study|GVHD Disease Progression|2
840562|NCT01111526|2670522|P2|Overall Study|GVHD Disease Progression|1
840563|NCT01111526|2670523|P1|Overall Study|GVHD Disease Progression|0
840564|NCT01111838|2670535|P1|Overall Study|Other Complicating Disease|1
840565|NCT01111838|2670535|P1|Overall Study|Clinical deterioration|1
840566|NCT01111838|2670535|P1|Overall Study|Not Treated|3
840567|NCT01111838|2670535|P1|Overall Study|Patient Ineligible|2
840568|NCT01111851|2670541|P2|Overall Study|All planned PET scans were not obtained.|0
840569|NCT01111851|2670542|P1|Overall Study|All planned PET scans were not obtained.|2
840570|NCT01112514|2670554|P1|Overall Study|Lost to Follow-up|1
840571|NCT01112579|2670560|P2|Overall Study|Death|2
840572|NCT01112579|2670561|P1|Overall Study|Death|0
840573|NCT01112579|2670560|P2|Overall Study|Missed Visit|1
840574|NCT01112579|2670561|P1|Overall Study|Missed Visit|1
840575|NCT01112917|2670640|P2|Overall Study|Unable to Convert Filter|0
840576|NCT01112917|2670641|P1|Overall Study|Unable to Convert Filter|3
840577|NCT01112917|2670640|P2|Overall Study|Withdrawal by Subject|3
840578|NCT01112917|2670641|P1|Overall Study|Withdrawal by Subject|1
840579|NCT01112917|2670640|P2|Overall Study|Lost to Follow-up|1
840580|NCT01112917|2670641|P1|Overall Study|Lost to Follow-up|1
840581|NCT01112917|2670640|P2|Overall Study|Death|11
840582|NCT01112917|2670641|P1|Overall Study|Death|2
840583|NCT01113463|2670671|P1|Overall Study|Physician Decision|5
840584|NCT01113541|2670676|P1|Overall Study|Adverse Event|4
840585|NCT01113541|2670676|P1|Overall Study|Study Terminated by Sponsor|7
840586|NCT01113541|2670676|P1|Overall Study|Protocol Violation|1
840587|NCT01113541|2670676|P1|Overall Study|Withdrawal by Subject|1
840590|NCT01113710|2670743|P1|Overall Study|Subject Did Not Receive Neupro|3
840591|NCT01113710|2670743|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
840592|NCT01113710|2670743|P1|Overall Study|Lack of Patient's Compliance/Other|1
840593|NCT01113710|2670743|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
840594|NCT01113710|2670743|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
840595|NCT01113710|2670743|P1|Overall Study|Compliance/Efficacy/AE/Other|1
840596|NCT01113710|2670743|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
840597|NCT01113710|2670743|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
840598|NCT01113710|2670743|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
840599|NCT01113710|2670743|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
840600|NCT01113710|2670743|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
840601|NCT01113710|2670743|P1|Overall Study|Lack of Efficacy/Adverse Event|3
840602|NCT01113710|2670743|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
840603|NCT01113710|2670743|P1|Overall Study|Lack of Efficacy/Other|4
840604|NCT01113710|2670743|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
840605|NCT01113710|2670743|P1|Overall Study|Adverse Event/Other|5
840606|NCT01113710|2670743|P1|Overall Study|Other|7
840607|NCT01113710|2670743|P1|Overall Study|Lack of Patient's Compliance|8
840608|NCT01113710|2670743|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
840609|NCT01113710|2670743|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
840610|NCT01113710|2670743|P1|Overall Study|Lost to Follow-up|20
840611|NCT01113710|2670743|P1|Overall Study|Withdrawal by Subject|28
840612|NCT01113710|2670743|P1|Overall Study|No Information Available|40
840613|NCT01113710|2670743|P1|Overall Study|Lack of Efficacy|41
840614|NCT01113710|2670743|P1|Overall Study|Adverse Event|64
840615|NCT01113749|2670767|P2|Overall Study|Lost to Follow-up|2
840616|NCT01113749|2670768|P1|Overall Study|Lost to Follow-up|1
840617|NCT01113931|2670780|P2|Overall Study|Withdrawal by Subject|0
840618|NCT01113931|2670781|P1|Overall Study|Withdrawal by Subject|3
840619|NCT01113931|2670780|P2|Overall Study|Various|4
840620|NCT01113931|2670781|P1|Overall Study|Various|2
840621|NCT01113931|2670780|P2|Overall Study|Lost to Follow-up|9
840622|NCT01113931|2670781|P1|Overall Study|Lost to Follow-up|12
840623|NCT01113931|2670780|P2|Overall Study|Physician Decision|2
840624|NCT01113931|2670781|P1|Overall Study|Physician Decision|0
840625|NCT01113931|2670780|P2|Overall Study|Adverse Event|2
840626|NCT01113931|2670781|P1|Overall Study|Adverse Event|2
840627|NCT01114360|2670806|P2|Intervention 1 (4 Weeks)|Physician Decision|1
840628|NCT01114360|2670807|P1|Intervention 1 (4 Weeks)|Physician Decision|0
840629|NCT01114373|2670843|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
840630|NCT01114373|2670844|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
840631|NCT01114373|2670843|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
840632|NCT01114373|2670844|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
840633|NCT01114373|2670843|P2|Intervention 1 (4 Weeks)|Incarceration|0
840634|NCT01114373|2670844|P1|Intervention 1 (4 Weeks)|Incarceration|1
840635|NCT01114373|2670843|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
840636|NCT01114373|2670844|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
840637|NCT01114438|2670876|P1|Overall Study|Withdrawal by Subject|2
840638|NCT01114438|2670876|P1|Overall Study|Physician Decision|1
840639|NCT01114438|2670876|P1|Overall Study|concomitant medication|1
840640|NCT01114438|2670876|P1|Overall Study|Adverse Event|10
840641|NCT01114516|2670909|P2|Overall Study|Lost to Follow-up|1
840642|NCT01114516|2670910|P1|Overall Study|Lost to Follow-up|2
840643|NCT01114529|2670927|P3|Completed Study Phase at Month 24|Missing|0
840644|NCT01114529|2670928|P2|Completed Study Phase at Month 24|Missing|0
840645|NCT01114529|2670929|P1|Completed Study Phase at Month 24|Missing|2
840646|NCT01114529|2670927|P3|Completed Study Phase at Month 24|Other|0
840647|NCT01114529|2670928|P2|Completed Study Phase at Month 24|Other|0
840648|NCT01114529|2670929|P1|Completed Study Phase at Month 24|Other|2
840649|NCT01114529|2670927|P3|Completed Study Phase at Month 24|Death|4
840650|NCT01114529|2670928|P2|Completed Study Phase at Month 24|Death|5
840651|NCT01114529|2670929|P1|Completed Study Phase at Month 24|Death|8
840652|NCT01114529|2670927|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
840653|NCT01114529|2670928|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
840654|NCT01114529|2670929|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
840655|NCT01114529|2670927|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
840656|NCT01114529|2670928|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
840657|NCT01114529|2670929|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
840658|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Missing|0
840659|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Missing|0
840660|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Missing|2
840661|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Protocol Violation|2
840662|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Protocol Violation|5
840663|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Protocol Violation|0
840664|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Graft loss|0
840665|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Graft loss|2
840666|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Graft loss|0
840667|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Death|2
840668|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Death|1
840669|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Death|2
840670|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Administrative problems|2
840671|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Administrative problems|1
840672|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Administrative problems|2
840673|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
840674|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
840675|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
840676|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
840677|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
840678|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
840679|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
840680|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
840681|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
840682|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
840683|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
840684|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
840685|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
840686|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
840687|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
840688|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
840689|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
840690|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
840691|NCT01114529|2670927|P3|Completed Study Medication at Month 24|Adverse Event|17
840692|NCT01114529|2670928|P2|Completed Study Medication at Month 24|Adverse Event|18
840693|NCT01114529|2670929|P1|Completed Study Medication at Month 24|Adverse Event|87
840694|NCT01114672|2670959|P2|Overall Study|transplanted|0
840695|NCT01114672|2670960|P1|Overall Study|transplanted|1
840696|NCT01114672|2670959|P2|Overall Study|Lost to Follow-up|0
840697|NCT01114672|2670960|P1|Overall Study|Lost to Follow-up|1
840698|NCT01114672|2670959|P2|Overall Study|Withdrawal by Subject|1
840699|NCT01114672|2670960|P1|Overall Study|Withdrawal by Subject|2
840700|NCT01114672|2670959|P2|Overall Study|Death|1
840701|NCT01114672|2670960|P1|Overall Study|Death|0
893958|NCT00892099|2836596|P2|Overall Study|kidney function recovered|1
893959|NCT00892099|2836597|P1|Overall Study|kidney function recovered|0
893960|NCT00892099|2836595|P3|Overall Study|no further details|1
840705|NCT01114737|2670986|P2|Open-Label Treatment Period|Difficult Personal Events|0
840706|NCT01114737|2670987|P1|Open-Label Treatment Period|Difficult Personal Events|1
840707|NCT01114737|2670986|P2|Open-Label Treatment Period|Lost to Follow-up|1
840708|NCT01114737|2670987|P1|Open-Label Treatment Period|Lost to Follow-up|3
840709|NCT01114737|2670986|P2|Open-Label Treatment Period|Withdrawal by Subject|1
840710|NCT01114737|2670987|P1|Open-Label Treatment Period|Withdrawal by Subject|1
840711|NCT01114737|2670986|P2|Randomized Treatment Period|Pregnancy|0
840712|NCT01114737|2670987|P1|Randomized Treatment Period|Pregnancy|1
840713|NCT01114737|2670986|P2|Randomized Treatment Period|Lost to Follow-up|1
840714|NCT01114737|2670987|P1|Randomized Treatment Period|Lost to Follow-up|1
840715|NCT01114737|2670986|P2|Randomized Treatment Period|Withdrawal by Subject|0
840716|NCT01114737|2670987|P1|Randomized Treatment Period|Withdrawal by Subject|1
840717|NCT01114828|2671037|P2|Overall Study|Withdrawal by Subject|1
840718|NCT01114828|2671038|P1|Overall Study|Withdrawal by Subject|0
840719|NCT01114828|2671037|P2|Overall Study|Protocol Violation|0
840720|NCT01114828|2671038|P1|Overall Study|Protocol Violation|2
840721|NCT01114828|2671037|P2|Overall Study|Lack of Efficacy|2
840722|NCT01114828|2671038|P1|Overall Study|Lack of Efficacy|0
840723|NCT01114828|2671037|P2|Overall Study|Adverse Event|1
840724|NCT01114828|2671038|P1|Overall Study|Adverse Event|1
840725|NCT01114880|2671048|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
840726|NCT01114880|2671049|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
840727|NCT01114880|2671048|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
840728|NCT01114880|2671049|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
840729|NCT01114880|2671048|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
840730|NCT01114880|2671049|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
840731|NCT01114880|2671048|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
840732|NCT01114880|2671049|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
840733|NCT01114880|2671048|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
840734|NCT01114880|2671049|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
840735|NCT01114880|2671048|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
840736|NCT01114880|2671049|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
840737|NCT01121484|2671127|P2|Overall Study|Randomized, not treated|4
840738|NCT01121484|2671128|P1|Overall Study|Randomized, not treated|1
840739|NCT01121484|2671127|P2|Overall Study|unspecified|3
840740|NCT01121484|2671128|P1|Overall Study|unspecified|3
840741|NCT01121484|2671127|P2|Overall Study|Discontinuation of study by sponsor|1
840742|NCT01121484|2671128|P1|Overall Study|Discontinuation of study by sponsor|0
840743|NCT01121484|2671127|P2|Overall Study|Withdrawal by Subject|7
840744|NCT01121484|2671128|P1|Overall Study|Withdrawal by Subject|8
840745|NCT01121484|2671127|P2|Overall Study|Protocol Violation|0
840746|NCT01121484|2671128|P1|Overall Study|Protocol Violation|1
840747|NCT01121484|2671127|P2|Overall Study|Physician Decision|3
840748|NCT01121484|2671128|P1|Overall Study|Physician Decision|0
840749|NCT01121484|2671127|P2|Overall Study|Lost to Follow-up|9
840750|NCT01121484|2671128|P1|Overall Study|Lost to Follow-up|5
840751|NCT01121484|2671127|P2|Overall Study|Lack of Efficacy|11
840752|NCT01121484|2671128|P1|Overall Study|Lack of Efficacy|3
840753|NCT01121484|2671127|P2|Overall Study|Adverse Event|5
840754|NCT01121484|2671128|P1|Overall Study|Adverse Event|12
840755|NCT01121536|2671144|P1|Overall Study|Not specified|118
840756|NCT01121536|2671144|P1|Overall Study|Lost to Follow-up|39
840757|NCT01121536|2671144|P1|Overall Study|Noncompliance with study procedures|9
840758|NCT01121536|2671144|P1|Overall Study|Noncompliance with study medication|12
840759|NCT01121536|2671144|P1|Overall Study|Protocol Violation|20
840760|NCT01121536|2671144|P1|Overall Study|Withdrawal by Subject|65
840761|NCT01121536|2671144|P1|Overall Study|Lack of Efficacy|35
840762|NCT01121536|2671144|P1|Overall Study|Adverse Event|63
840763|NCT01121549|2671163|P1|Overall Study|Unspecified|58
840764|NCT01121549|2671163|P1|Overall Study|Withdrawal by Subject|16
840765|NCT01121549|2671163|P1|Overall Study|Protocol Violation|33
840766|NCT01121549|2671163|P1|Overall Study|Pregnancy|1
840767|NCT01121549|2671163|P1|Overall Study|Study terminated by sponsor|197
840768|NCT01121549|2671163|P1|Overall Study|Did not meet entrance criteria|9
840769|NCT01121549|2671163|P1|Overall Study|Lost to Follow-up|12
840770|NCT01121549|2671163|P1|Overall Study|Lack of Efficacy|11
840771|NCT01121549|2671163|P1|Overall Study|Adverse Event|10
840772|NCT01121562|2671174|P1|Overall Study|Met study discontinuation criteria|1
840773|NCT01121562|2671174|P1|Overall Study|Sponsor Decision|1
840774|NCT01121562|2671174|P1|Overall Study|Adverse Event|1
840775|NCT01121562|2671174|P1|Overall Study|Withdrawal by Subject|1
840776|NCT01121562|2671174|P1|Overall Study|Objective progression or relapse|8
840777|NCT01121575|2671189|P6|Overall Study|Death|1
840778|NCT01121575|2671190|P5|Overall Study|Death|7
840779|NCT01121575|2671191|P4|Overall Study|Death|1
840780|NCT01121575|2671192|P3|Overall Study|Death|0
840781|NCT01121575|2671193|P2|Overall Study|Death|0
840782|NCT01121575|2671194|P1|Overall Study|Death|6
840783|NCT01121575|2671189|P6|Overall Study|Unspecified Reasons|10
840784|NCT01121575|2671190|P5|Overall Study|Unspecified Reasons|13
840785|NCT01121575|2671191|P4|Overall Study|Unspecified Reasons|5
840786|NCT01121575|2671192|P3|Overall Study|Unspecified Reasons|7
840787|NCT01121575|2671193|P2|Overall Study|Unspecified Reasons|6
840788|NCT01121575|2671194|P1|Overall Study|Unspecified Reasons|8
840789|NCT01121575|2671189|P6|Overall Study|Participant Refused Further Follow-Up|1
840790|NCT01121575|2671190|P5|Overall Study|Participant Refused Further Follow-Up|5
840791|NCT01121575|2671191|P4|Overall Study|Participant Refused Further Follow-Up|0
840792|NCT01121575|2671192|P3|Overall Study|Participant Refused Further Follow-Up|0
840793|NCT01121575|2671193|P2|Overall Study|Participant Refused Further Follow-Up|0
840794|NCT01121575|2671194|P1|Overall Study|Participant Refused Further Follow-Up|0
840795|NCT01121666|2671320|P2|Overall Study|Protocol Violation|10
840796|NCT01121666|2671321|P1|Overall Study|Protocol Violation|29
840797|NCT01121757|2671373|P2|Combination|Disease Progression|0
840798|NCT01121757|2671374|P1|Combination|Disease Progression|2
840799|NCT01121757|2671373|P2|Combination|Physician Decision|1
840800|NCT01121757|2671374|P1|Combination|Physician Decision|0
840801|NCT01121757|2671373|P2|First Drug|Disease Progression|2
840802|NCT01121757|2671374|P1|First Drug|Disease Progression|0
840803|NCT01121757|2671373|P2|First Drug|Death|0
840804|NCT01121757|2671374|P1|First Drug|Death|1
840805|NCT01123356|2671388|P1|Overall Study|Withdrawal by Subject|1
840806|NCT01123356|2671388|P1|Overall Study|Lack of Efficacy|4
840807|NCT01123356|2671388|P1|Overall Study|Adverse Event|2
840808|NCT01123395|2671396|P2|Washout Period of 14 Days|Withdrawal by Subject|1
840809|NCT01123395|2671397|P1|Washout Period of 14 Days|Withdrawal by Subject|0
840810|NCT01123642|2671416|P1|Overall Study|ineligible at baseline assessment|36
840811|NCT01123642|2671416|P1|Overall Study|Withdrawal by Subject|9
840812|NCT01123642|2671416|P1|Overall Study|Lost to Follow-up|23
840813|NCT01123850|2671420|P1|Overall Study|Slow enrollment|45
840814|NCT01123889|2671427|P2|Overall Study|Lost to Follow-up|1
840815|NCT01123889|2671428|P1|Overall Study|Lost to Follow-up|3
840816|NCT01123941|2671461|P2|Overall Study|Lost to Follow-up|1
840817|NCT01123941|2671462|P1|Overall Study|Lost to Follow-up|2
840818|NCT01123980|2671476|P2|Overall Study|Unclassified|7
840819|NCT01123980|2671477|P1|Overall Study|Unclassified|6
840820|NCT01123980|2671476|P2|Overall Study|Withdrawal by Subject|3
840821|NCT01123980|2671477|P1|Overall Study|Withdrawal by Subject|5
840822|NCT01123980|2671476|P2|Overall Study|Protocol Violation|6
840823|NCT01123980|2671477|P1|Overall Study|Protocol Violation|6
840824|NCT01123980|2671476|P2|Overall Study|Lost to Follow-up|6
840825|NCT01123980|2671477|P1|Overall Study|Lost to Follow-up|0
840826|NCT01123980|2671476|P2|Overall Study|Physician Decision|1
840827|NCT01123980|2671477|P1|Overall Study|Physician Decision|0
840828|NCT01123980|2671476|P2|Overall Study|Lack of Efficacy|0
840829|NCT01123980|2671477|P1|Overall Study|Lack of Efficacy|1
840830|NCT01123980|2671476|P2|Overall Study|Adverse Event|1
840831|NCT01123980|2671477|P1|Overall Study|Adverse Event|1
840832|NCT01124006|2671498|P3|Overall Study|Other|1
840833|NCT01124006|2671499|P2|Overall Study|Other|0
840834|NCT01124006|2671500|P1|Overall Study|Other|0
840835|NCT01124006|2671498|P3|Overall Study|Lost to Follow-up|1
840836|NCT01124006|2671499|P2|Overall Study|Lost to Follow-up|0
840837|NCT01124006|2671500|P1|Overall Study|Lost to Follow-up|1
840838|NCT01124006|2671498|P3|Overall Study|Withdrawal by Subject|0
840839|NCT01124006|2671499|P2|Overall Study|Withdrawal by Subject|2
840840|NCT01124006|2671500|P1|Overall Study|Withdrawal by Subject|2
840841|NCT01124045|2671528|P2|Overall Study|Physician Decision|2
840842|NCT01124045|2671529|P1|Overall Study|Physician Decision|0
840843|NCT01124045|2671528|P2|Overall Study|Lost to Follow-up|1
840844|NCT01124045|2671529|P1|Overall Study|Lost to Follow-up|0
840845|NCT01124097|2671563|P4|Overall Study|Physician Decision|0
840846|NCT01124097|2671564|P3|Overall Study|Physician Decision|0
840847|NCT01124097|2671565|P2|Overall Study|Physician Decision|1
840848|NCT01124097|2671566|P1|Overall Study|Physician Decision|2
840849|NCT01124097|2671563|P4|Overall Study|Protocol Violation|1
840850|NCT01124097|2671564|P3|Overall Study|Protocol Violation|2
840851|NCT01124097|2671565|P2|Overall Study|Protocol Violation|0
840852|NCT01124097|2671566|P1|Overall Study|Protocol Violation|2
840853|NCT01124097|2671563|P4|Overall Study|Adverse Event|7
840854|NCT01124097|2671564|P3|Overall Study|Adverse Event|15
840855|NCT01124097|2671565|P2|Overall Study|Adverse Event|15
840856|NCT01124097|2671566|P1|Overall Study|Adverse Event|24
840857|NCT01124097|2671563|P4|Overall Study|Lack of Efficacy|3
840858|NCT01124097|2671564|P3|Overall Study|Lack of Efficacy|1
840859|NCT01124097|2671565|P2|Overall Study|Lack of Efficacy|3
840860|NCT01124097|2671566|P1|Overall Study|Lack of Efficacy|2
840861|NCT01124097|2671563|P4|Overall Study|Withdrawal by Subject|3
840862|NCT01124097|2671564|P3|Overall Study|Withdrawal by Subject|2
840863|NCT01124097|2671565|P2|Overall Study|Withdrawal by Subject|3
840864|NCT01124097|2671566|P1|Overall Study|Withdrawal by Subject|4
840865|NCT01124149|2671576|P1|Maintenance Phase|Non-compliance|1
840866|NCT01124149|2671576|P1|Maintenance Phase|Coordinator error|1
840867|NCT01124149|2671576|P1|Maintenance Phase|Protocol Violation|5
840868|NCT01124149|2671576|P1|Maintenance Phase|Withdrawal by Subject|10
840869|NCT01124149|2671576|P1|Maintenance Phase|Lost to Follow-up|15
840870|NCT01124149|2671576|P1|Maintenance Phase|Adverse Event|24
840871|NCT01124149|2671576|P1|Maintenance Phase|Lack of Efficacy|40
840872|NCT01124149|2671576|P1|Acute Phase|Sponsor decision|1
840873|NCT01124149|2671576|P1|Acute Phase|Travelling to another country|1
840874|NCT01124149|2671576|P1|Acute Phase|Low hemoglobin|1
840875|NCT01124149|2671576|P1|Acute Phase|Non-compliance|1
840876|NCT01124149|2671576|P1|Acute Phase|UC symptoms not ameliorated|1
840877|NCT01124149|2671576|P1|Acute Phase|Sponsor request|1
840878|NCT01124149|2671576|P1|Acute Phase|Prolonged antibiotic therapy|1
840879|NCT01124149|2671576|P1|Acute Phase|Lost to Follow-up|2
840880|NCT01124149|2671576|P1|Acute Phase|Protocol Violation|14
840881|NCT01124149|2671576|P1|Acute Phase|Lack of Efficacy|17
840882|NCT01124149|2671576|P1|Acute Phase|Adverse Event|21
840883|NCT01124149|2671576|P1|Acute Phase|Withdrawal by Subject|22
840884|NCT01124162|2671594|P2|Washout of 7 Days|Withdrawal by Subject|0
840885|NCT01124162|2671595|P1|Washout of 7 Days|Withdrawal by Subject|1
840886|NCT01124162|2671594|P2|First Intervention|Adverse Event|0
840887|NCT01124162|2671595|P1|First Intervention|Adverse Event|2
840888|NCT01124175|2671613|P2|Washout of 7 Days|Withdrawal by Subject|2
840889|NCT01124175|2671614|P1|Washout of 7 Days|Withdrawal by Subject|0
840890|NCT01124292|2671646|P3|Overall Study|piercing track closed|1
840891|NCT01124292|2671647|P2|Overall Study|piercing track closed|2
840892|NCT01124292|2671648|P1|Overall Study|piercing track closed|0
840893|NCT01124292|2671646|P3|Overall Study|medical issue unrelated to the study|2
840894|NCT01124292|2671647|P2|Overall Study|medical issue unrelated to the study|0
840895|NCT01124292|2671648|P1|Overall Study|medical issue unrelated to the study|0
840896|NCT01124292|2671646|P3|Overall Study|Withdrawal by Subject|2
840897|NCT01124292|2671647|P2|Overall Study|Withdrawal by Subject|6
840898|NCT01124292|2671648|P1|Overall Study|Withdrawal by Subject|0
840899|NCT01124292|2671646|P3|Overall Study|Physician Decision|2
840900|NCT01124292|2671647|P2|Overall Study|Physician Decision|3
840901|NCT01124292|2671648|P1|Overall Study|Physician Decision|0
840902|NCT01124292|2671646|P3|Overall Study|Lost to Follow-up|3
840903|NCT01124292|2671647|P2|Overall Study|Lost to Follow-up|4
840904|NCT01124292|2671648|P1|Overall Study|Lost to Follow-up|2
893961|NCT00892099|2836596|P2|Overall Study|no further details|0
893962|NCT00892099|2836597|P1|Overall Study|no further details|1
893963|NCT00892099|2836595|P3|Overall Study|Prolonged hospitalization|1
893964|NCT00892099|2836596|P2|Overall Study|Prolonged hospitalization|0
893965|NCT00892099|2836597|P1|Overall Study|Prolonged hospitalization|1
893966|NCT00892099|2836595|P3|Overall Study|replocated|2
893967|NCT00892099|2836596|P2|Overall Study|replocated|0
893968|NCT00892099|2836597|P1|Overall Study|replocated|1
893969|NCT00892099|2836595|P3|Overall Study|Adverse Event|0
893970|NCT00892099|2836596|P2|Overall Study|Adverse Event|0
893971|NCT00892099|2836597|P1|Overall Study|Adverse Event|1
893972|NCT00892099|2836595|P3|Overall Study|Death|1
893973|NCT00892099|2836596|P2|Overall Study|Death|0
893974|NCT00892099|2836597|P1|Overall Study|Death|1
840935|NCT01124448|2671777|P2|Overall Study|Protocol Violation|0
840936|NCT01124448|2671778|P1|Overall Study|Protocol Violation|2
840937|NCT01124448|2671777|P2|Overall Study|Lost to Follow-up|3
840938|NCT01124448|2671778|P1|Overall Study|Lost to Follow-up|0
840939|NCT01124604|2671786|P2|Overall Study|Disease Progression|1
840940|NCT01124604|2671787|P1|Overall Study|Disease Progression|0
840941|NCT01124604|2671786|P2|Overall Study|Withdrawal by Subject|0
840942|NCT01124604|2671787|P1|Overall Study|Withdrawal by Subject|4
840943|NCT01124604|2671786|P2|Overall Study|Lack of Efficacy|0
840944|NCT01124604|2671787|P1|Overall Study|Lack of Efficacy|1
840945|NCT01124604|2671786|P2|Overall Study|Adverse Event|1
840946|NCT01124604|2671787|P1|Overall Study|Adverse Event|10
840947|NCT01124617|2671826|P2|Overall Study|Unspecified|1
840948|NCT01124617|2671827|P1|Overall Study|Unspecified|2
840949|NCT01124617|2671826|P2|Overall Study|Withdrawal by Subject|1
840950|NCT01124617|2671827|P1|Overall Study|Withdrawal by Subject|9
840951|NCT01124617|2671826|P2|Overall Study|Protocol Violation|1
840952|NCT01124617|2671827|P1|Overall Study|Protocol Violation|1
840953|NCT01124617|2671826|P2|Overall Study|Lack of Efficacy|1
840954|NCT01124617|2671827|P1|Overall Study|Lack of Efficacy|2
840955|NCT01124617|2671826|P2|Overall Study|Adverse Event|2
840956|NCT01124617|2671827|P1|Overall Study|Adverse Event|5
840957|NCT01124643|2671857|P1|Overall Study|Death|1
840958|NCT01124838|2671894|P2|Overall Study|Lost to Follow-up|0
840959|NCT01124838|2671895|P1|Overall Study|Lost to Follow-up|2
840960|NCT01124838|2671894|P2|Overall Study|Withdrawal by Subject|2
840961|NCT01124838|2671895|P1|Overall Study|Withdrawal by Subject|3
840962|NCT01124838|2671894|P2|Overall Study|Lack of Efficacy|0
840963|NCT01124838|2671895|P1|Overall Study|Lack of Efficacy|2
840964|NCT01124838|2671894|P2|Overall Study|Adverse Event|11
840965|NCT01124838|2671895|P1|Overall Study|Adverse Event|7
840966|NCT01124838|2671894|P2|Overall Study|Miscellaneous|2
840967|NCT01124838|2671895|P1|Overall Study|Miscellaneous|4
840968|NCT01124864|2671945|P6|Overall Study|Protocol Violation|0
840969|NCT01124864|2671946|P5|Overall Study|Protocol Violation|1
840970|NCT01124864|2671947|P4|Overall Study|Protocol Violation|0
840971|NCT01124864|2671948|P3|Overall Study|Protocol Violation|0
840972|NCT01124864|2671949|P2|Overall Study|Protocol Violation|0
840973|NCT01124864|2671950|P1|Overall Study|Protocol Violation|1
840974|NCT01124864|2671945|P6|Overall Study|Lost to Follow-up|0
840975|NCT01124864|2671946|P5|Overall Study|Lost to Follow-up|0
840976|NCT01124864|2671947|P4|Overall Study|Lost to Follow-up|1
840977|NCT01124864|2671948|P3|Overall Study|Lost to Follow-up|0
840978|NCT01124864|2671949|P2|Overall Study|Lost to Follow-up|1
840979|NCT01124864|2671950|P1|Overall Study|Lost to Follow-up|1
840980|NCT01124864|2671945|P6|Overall Study|Withdrawal by Subject|1
840981|NCT01124864|2671946|P5|Overall Study|Withdrawal by Subject|2
840982|NCT01124864|2671947|P4|Overall Study|Withdrawal by Subject|0
840983|NCT01124864|2671948|P3|Overall Study|Withdrawal by Subject|4
840984|NCT01124864|2671949|P2|Overall Study|Withdrawal by Subject|3
840985|NCT01124864|2671950|P1|Overall Study|Withdrawal by Subject|2
840986|NCT01124864|2671945|P6|Overall Study|Death|0
840987|NCT01124864|2671946|P5|Overall Study|Death|1
840988|NCT01124864|2671947|P4|Overall Study|Death|2
840989|NCT01124864|2671948|P3|Overall Study|Death|6
840990|NCT01124864|2671949|P2|Overall Study|Death|9
840991|NCT01124864|2671950|P1|Overall Study|Death|6
840992|NCT01124864|2671945|P6|Overall Study|Follow up phase competed as per protocol|2
840993|NCT01124864|2671946|P5|Overall Study|Follow up phase competed as per protocol|26
840994|NCT01124864|2671947|P4|Overall Study|Follow up phase competed as per protocol|18
840995|NCT01124864|2671948|P3|Overall Study|Follow up phase competed as per protocol|24
840996|NCT01124864|2671949|P2|Overall Study|Follow up phase competed as per protocol|22
840997|NCT01124864|2671950|P1|Overall Study|Follow up phase competed as per protocol|18
840998|NCT01124916|2671984|P2|Overall Study|Lost to Follow-up|2
840999|NCT01124916|2671985|P1|Overall Study|Lost to Follow-up|3
841000|NCT01125189|2672022|P3|Follow up Period|Other reasons|5
841001|NCT01125189|2672023|P2|Follow up Period|Other reasons|4
841002|NCT01125189|2672024|P1|Follow up Period|Other reasons|4
841003|NCT01125189|2672022|P3|Follow up Period|Lost to Follow-up|6
841004|NCT01125189|2672023|P2|Follow up Period|Lost to Follow-up|9
841005|NCT01125189|2672024|P1|Follow up Period|Lost to Follow-up|12
841006|NCT01125189|2672022|P3|Follow up Period|Death|0
841007|NCT01125189|2672023|P2|Follow up Period|Death|0
841008|NCT01125189|2672024|P1|Follow up Period|Death|1
841009|NCT01125189|2672022|P3|Follow up Period|Withdrawal by Subject|5
841010|NCT01125189|2672023|P2|Follow up Period|Withdrawal by Subject|2
841011|NCT01125189|2672024|P1|Follow up Period|Withdrawal by Subject|3
841012|NCT01125189|2672022|P3|Treatment Period|Completed 24 week treatment period only|2
841013|NCT01125189|2672023|P2|Treatment Period|Completed 24 week treatment period only|1
841014|NCT01125189|2672024|P1|Treatment Period|Completed 24 week treatment period only|2
841015|NCT01125189|2672022|P3|Treatment Period|Other reasons|0
841016|NCT01125189|2672023|P2|Treatment Period|Other reasons|1
841017|NCT01125189|2672024|P1|Treatment Period|Other reasons|1
841018|NCT01125189|2672022|P3|Treatment Period|Participants requested to discontinue|4
841019|NCT01125189|2672023|P2|Treatment Period|Participants requested to discontinue|3
841020|NCT01125189|2672024|P1|Treatment Period|Participants requested to discontinue|1
841021|NCT01125189|2672022|P3|Treatment Period|Poor compliance/noncompliance|0
841022|NCT01125189|2672023|P2|Treatment Period|Poor compliance/noncompliance|1
841023|NCT01125189|2672024|P1|Treatment Period|Poor compliance/noncompliance|0
841024|NCT01125189|2672022|P3|Treatment Period|Lost to Follow-up|1
841025|NCT01125189|2672023|P2|Treatment Period|Lost to Follow-up|2
841026|NCT01125189|2672024|P1|Treatment Period|Lost to Follow-up|1
841027|NCT01125189|2672022|P3|Treatment Period|Death|0
841028|NCT01125189|2672023|P2|Treatment Period|Death|0
841029|NCT01125189|2672024|P1|Treatment Period|Death|1
841030|NCT01125189|2672022|P3|Treatment Period|Withdrawal by Subject|1
841031|NCT01125189|2672023|P2|Treatment Period|Withdrawal by Subject|1
841032|NCT01125189|2672024|P1|Treatment Period|Withdrawal by Subject|3
841033|NCT01125189|2672022|P3|Treatment Period|Adverse Event|8
841034|NCT01125189|2672023|P2|Treatment Period|Adverse Event|8
841035|NCT01125189|2672024|P1|Treatment Period|Adverse Event|7
841036|NCT01125189|2672022|P3|Treatment Period|Lack of Efficacy|25
841037|NCT01125189|2672023|P2|Treatment Period|Lack of Efficacy|18
841038|NCT01125189|2672024|P1|Treatment Period|Lack of Efficacy|15
841039|NCT01125514|2672075|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
841040|NCT01125514|2672075|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
841041|NCT01125514|2672075|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
841042|NCT01125514|2672075|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
841043|NCT01125514|2672075|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
841044|NCT01125514|2672075|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
841045|NCT01125566|2672149|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
841046|NCT01125566|2672150|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
841126|NCT01118143|2672392|P1|Overall Study|Withdrawal by Subject|2
841047|NCT01125566|2672151|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
841048|NCT01125566|2672149|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
841049|NCT01125566|2672150|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
841050|NCT01125566|2672151|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
841051|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
841052|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
841053|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
841054|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Not treated|0
841055|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Not treated|0
841056|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Not treated|2
841057|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
841058|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
841059|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
841060|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
841061|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
841062|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
841063|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
841064|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
841065|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
841066|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
841067|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
841068|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
841069|NCT01125566|2672149|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
841070|NCT01125566|2672150|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
841071|NCT01125566|2672151|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
841072|NCT01125722|2672197|P2|Overall Study|Lost to Follow-up|0
841073|NCT01125722|2672198|P1|Overall Study|Lost to Follow-up|1
841074|NCT01125722|2672197|P2|Overall Study|Withdrawal by Subject|1
841075|NCT01125722|2672198|P1|Overall Study|Withdrawal by Subject|2
841076|NCT01125748|2672214|P2|Overall Study|Patient Decision to Withdraw|4
841077|NCT01125748|2672215|P1|Overall Study|Patient Decision to Withdraw|2
841078|NCT01125748|2672214|P2|Overall Study|Physician Decision|7
841079|NCT01125748|2672215|P1|Overall Study|Physician Decision|8
841080|NCT01125748|2672214|P2|Overall Study|Lost to Follow-up|1
841081|NCT01125748|2672215|P1|Overall Study|Lost to Follow-up|0
841082|NCT01125748|2672214|P2|Overall Study|Adverse Event|2
841083|NCT01125748|2672215|P1|Overall Study|Adverse Event|0
841086|NCT01112267|2672280|P2|Overall Study|Participants not receive any study drug|2
841087|NCT01112267|2672281|P1|Overall Study|Participants not receive any study drug|1
841088|NCT01112267|2672280|P2|Overall Study|Participants not compliant|2
841089|NCT01112267|2672281|P1|Overall Study|Participants not compliant|1
841090|NCT01112267|2672280|P2|Overall Study|Protocol Violation|3
841091|NCT01112267|2672281|P1|Overall Study|Protocol Violation|5
841092|NCT01112267|2672280|P2|Overall Study|Withdrawal by Subject|5
841093|NCT01112267|2672281|P1|Overall Study|Withdrawal by Subject|3
841094|NCT01112267|2672280|P2|Overall Study|Adverse Event|6
841095|NCT01112267|2672281|P1|Overall Study|Adverse Event|24
841096|NCT01117857|2672299|P1|Overall Study|Physician Decision|1
841097|NCT01117857|2672299|P1|Overall Study|Withdrawal by Subject|4
841098|NCT01117857|2672299|P1|Overall Study|Lost to Follow-up|4
841099|NCT01117870|2672309|P2|Overall Study|Inability to place needle|0
841100|NCT01117870|2672310|P1|Overall Study|Inability to place needle|1
841101|NCT01117987|2672335|P2|Overall Study|Administrative problems|22
841102|NCT01117987|2672336|P1|Overall Study|Administrative problems|25
841103|NCT01117987|2672335|P2|Overall Study|Adverse Event|26
841104|NCT01117987|2672336|P1|Overall Study|Adverse Event|19
841105|NCT01117987|2672335|P2|Overall Study|Withdrawal by Subject|10
841106|NCT01117987|2672336|P1|Overall Study|Withdrawal by Subject|5
841107|NCT01117987|2672335|P2|Overall Study|Death|10
841108|NCT01117987|2672336|P1|Overall Study|Death|5
841109|NCT01117987|2672335|P2|Overall Study|Lack of Efficacy|4
841110|NCT01117987|2672336|P1|Overall Study|Lack of Efficacy|3
841111|NCT01117987|2672335|P2|Overall Study|Abnormal test procedure result|0
841112|NCT01117987|2672336|P1|Overall Study|Abnormal test procedure result|2
841113|NCT01117987|2672335|P2|Overall Study|Lost to Follow-up|1
841114|NCT01117987|2672336|P1|Overall Study|Lost to Follow-up|1
841115|NCT01117987|2672335|P2|Overall Study|Subject no longer requires study drug|0
841116|NCT01117987|2672336|P1|Overall Study|Subject no longer requires study drug|1
841117|NCT01117987|2672335|P2|Overall Study|Protocol deviation|1
841118|NCT01117987|2672336|P1|Overall Study|Protocol deviation|0
841125|NCT01118143|2672391|P2|Overall Study|Withdrawal by Subject|5
841127|NCT01118312|2672590|P2|Overall Study|Withdrawal by Subject|3
841128|NCT01118312|2672591|P1|Overall Study|Withdrawal by Subject|1
841129|NCT01118312|2672590|P2|Overall Study|Lost to Follow-up|32
841130|NCT01118312|2672591|P1|Overall Study|Lost to Follow-up|33
841131|NCT01118325|2672602|P3|Overall Study|Adverse Event|1
841132|NCT01118325|2672603|P2|Overall Study|Adverse Event|0
841133|NCT01118325|2672604|P1|Overall Study|Adverse Event|1
841134|NCT01118377|2672648|P1|Overall Study|Failure to Return|3
841135|NCT01118377|2672648|P1|Overall Study|Death|38
841136|NCT01118377|2672648|P1|Overall Study|Did Not Receive Study Medication|1
841137|NCT01118455|2672656|P2|Baseline [Visits 1 & 2]|Adverse Event|0
841138|NCT01118455|2672657|P1|Baseline [Visits 1 & 2]|Adverse Event|1
841139|NCT01118663|2672694|P2|Overall Study|Withdrawal by Subject|1
841140|NCT01118663|2672695|P1|Overall Study|Withdrawal by Subject|0
841141|NCT01118663|2672694|P2|Overall Study|Adverse Event|1
841142|NCT01118663|2672695|P1|Overall Study|Adverse Event|2
841143|NCT01118728|2672709|P1|Overall Study|Lost to Follow-up|4
841144|NCT01118728|2672709|P1|Overall Study|Withdrawal by Subject|3
841145|NCT01118728|2672709|P1|Overall Study|Sponsor's decision to discontinue study|172
841146|NCT01118728|2672709|P1|Overall Study|Lack of Efficacy|27
841147|NCT01118728|2672709|P1|Overall Study|Adverse Event|17
841148|NCT01118780|2672725|P2|Overall Study|Withdrawal by Subject|8
841149|NCT01118780|2672726|P1|Overall Study|Withdrawal by Subject|13
841150|NCT01118780|2672725|P2|Overall Study|Protocol Violation|6
841151|NCT01118780|2672726|P1|Overall Study|Protocol Violation|3
841152|NCT01118780|2672725|P2|Overall Study|Physician Decision|0
841153|NCT01118780|2672726|P1|Overall Study|Physician Decision|2
841154|NCT01118780|2672725|P2|Overall Study|Lack of Efficacy|6
841155|NCT01118780|2672726|P1|Overall Study|Lack of Efficacy|2
841156|NCT01118780|2672725|P2|Overall Study|Death|0
841157|NCT01118780|2672726|P1|Overall Study|Death|1
841158|NCT01118780|2672725|P2|Overall Study|Adverse Event|15
841159|NCT01118780|2672726|P1|Overall Study|Adverse Event|15
841160|NCT01118949|2672792|P1|Overall Study|Withdrawal by Subject|4
841161|NCT01118949|2672792|P1|Overall Study|Adverse Event|5
841162|NCT01118962|2672801|P1|Overall Study|Non-compliance with Medicinal Product|1
841163|NCT01118962|2672801|P1|Overall Study|Pregnancy|1
841164|NCT01118962|2672801|P1|Overall Study|Withdrawal by Subject|4
841165|NCT01118962|2672801|P1|Overall Study|Protocol Violation|1
841166|NCT01118962|2672801|P1|Overall Study|Lack of Efficacy|1
841167|NCT01118962|2672801|P1|Overall Study|Adverse Event|2
841168|NCT01118975|2672808|P2|Overall Study|Adverse Event|1
841169|NCT01118975|2672809|P1|Overall Study|Adverse Event|0
841170|NCT01125800|2672856|P5|Phase II|Disease progression|8
841171|NCT01125800|2672857|P4|Phase II|Disease progression|1
841172|NCT01125800|2672858|P3|Phase II|Disease progression|0
841173|NCT01125800|2672859|P2|Phase II|Disease progression|0
841174|NCT01125800|2672860|P1|Phase II|Disease progression|0
841175|NCT01125800|2672856|P5|Phase II|Adverse Event|2
841176|NCT01125800|2672857|P4|Phase II|Adverse Event|0
841177|NCT01125800|2672858|P3|Phase II|Adverse Event|0
841178|NCT01125800|2672859|P2|Phase II|Adverse Event|0
841179|NCT01125800|2672860|P1|Phase II|Adverse Event|0
841180|NCT01125800|2672856|P5|Phase II|Protocol Violation|1
841181|NCT01125800|2672857|P4|Phase II|Protocol Violation|0
841182|NCT01125800|2672858|P3|Phase II|Protocol Violation|0
841183|NCT01125800|2672859|P2|Phase II|Protocol Violation|0
841184|NCT01125800|2672860|P1|Phase II|Protocol Violation|0
841185|NCT01125800|2672856|P5|Phase I|Disease progression|0
841186|NCT01125800|2672857|P4|Phase I|Disease progression|3
841187|NCT01125800|2672858|P3|Phase I|Disease progression|1
841188|NCT01125800|2672859|P2|Phase I|Disease progression|4
841189|NCT01125800|2672860|P1|Phase I|Disease progression|5
841190|NCT01125800|2672856|P5|Phase I|Withdrawal by Subject|0
841191|NCT01125800|2672857|P4|Phase I|Withdrawal by Subject|0
841192|NCT01125800|2672858|P3|Phase I|Withdrawal by Subject|1
841193|NCT01125800|2672859|P2|Phase I|Withdrawal by Subject|0
841194|NCT01125800|2672860|P1|Phase I|Withdrawal by Subject|0
841195|NCT01125800|2672856|P5|Phase I|Administrative problems|0
841196|NCT01125800|2672857|P4|Phase I|Administrative problems|0
841197|NCT01125800|2672858|P3|Phase I|Administrative problems|0
841198|NCT01125800|2672859|P2|Phase I|Administrative problems|0
841199|NCT01125800|2672860|P1|Phase I|Administrative problems|1
841200|NCT01125800|2672856|P5|Phase I|Adverse Event|0
841201|NCT01125800|2672857|P4|Phase I|Adverse Event|7
841202|NCT01125800|2672858|P3|Phase I|Adverse Event|1
841203|NCT01125800|2672859|P2|Phase I|Adverse Event|2
841204|NCT01125800|2672860|P1|Phase I|Adverse Event|2
841205|NCT01125800|2672856|P5|Phase I|Protocol Violation|0
841206|NCT01125800|2672857|P4|Phase I|Protocol Violation|1
841207|NCT01125800|2672858|P3|Phase I|Protocol Violation|1
841208|NCT01125800|2672859|P2|Phase I|Protocol Violation|3
841209|NCT01125800|2672860|P1|Phase I|Protocol Violation|0
841210|NCT01125813|2672897|P1|Overall Study|Screen Failures|4
841211|NCT01125813|2672897|P1|Overall Study|Withdrawal by Subject|1
841212|NCT01125813|2672897|P1|Overall Study|Death|1
841213|NCT01125917|2672902|P1|Overall Study|Lack of Efficacy|19
841214|NCT01125917|2672902|P1|Overall Study|Administrative|223
841215|NCT01125917|2672902|P1|Overall Study|Withdrawal by Subject|31
841216|NCT01125917|2672902|P1|Overall Study|Lost to Follow-up|23
841217|NCT01125917|2672902|P1|Overall Study|Adverse Event|43
841218|NCT01125930|2672908|P2|Overall Study|Lost to Follow-up|2
841219|NCT01125930|2672909|P1|Overall Study|Lost to Follow-up|0
841220|NCT01125930|2672908|P2|Overall Study|Protocol Violation|1
841221|NCT01125930|2672909|P1|Overall Study|Protocol Violation|0
841222|NCT01125930|2672908|P2|Overall Study|Withdrawal by Subject|6
841223|NCT01125930|2672909|P1|Overall Study|Withdrawal by Subject|1
841224|NCT01125930|2672908|P2|Overall Study|Adverse Event|1
841225|NCT01125930|2672909|P1|Overall Study|Adverse Event|0
841226|NCT01126060|2673065|P2|Overall Study|Protocol Violation|2
841227|NCT01126060|2673066|P1|Overall Study|Protocol Violation|0
841228|NCT01126359|2673087|P2|First Intervention (20-minutes)|Physician Decision|1
841229|NCT01126359|2673088|P1|First Intervention (20-minutes)|Physician Decision|0
841242|NCT01126437|2673137|P3|Overall Study|Other reason not specified|178
841243|NCT01126437|2673138|P2|Overall Study|Other reason not specified|176
841244|NCT01126437|2673139|P1|Overall Study|Other reason not specified|210
841245|NCT01126437|2673137|P3|Overall Study|Withdrawal by Subject|319
841246|NCT01126437|2673138|P2|Overall Study|Withdrawal by Subject|335
841247|NCT01126437|2673139|P1|Overall Study|Withdrawal by Subject|331
841248|NCT01126437|2673137|P3|Overall Study|Lost to Follow-up|55
841249|NCT01126437|2673138|P2|Overall Study|Lost to Follow-up|63
841250|NCT01126437|2673139|P1|Overall Study|Lost to Follow-up|52
841251|NCT01126437|2673137|P3|Overall Study|Protocol Violation|41
841252|NCT01126437|2673138|P2|Overall Study|Protocol Violation|66
841253|NCT01126437|2673139|P1|Overall Study|Protocol Violation|64
841254|NCT01126437|2673137|P3|Overall Study|Lack of Efficacy|59
841255|NCT01126437|2673138|P2|Overall Study|Lack of Efficacy|60
841256|NCT01126437|2673139|P1|Overall Study|Lack of Efficacy|65
841257|NCT01126437|2673137|P3|Overall Study|Adverse Event|635
841258|NCT01126437|2673138|P2|Overall Study|Adverse Event|606
841259|NCT01126437|2673139|P1|Overall Study|Adverse Event|602
841260|NCT01126437|2673137|P3|Overall Study|Sites with data irregularities/fraud|7
841261|NCT01126437|2673138|P2|Overall Study|Sites with data irregularities/fraud|6
841262|NCT01126437|2673139|P1|Overall Study|Sites with data irregularities/fraud|6
841263|NCT01126437|2673137|P3|Overall Study|Not treated|19
841264|NCT01126437|2673138|P2|Overall Study|Not treated|18
841265|NCT01126437|2673139|P1|Overall Study|Not treated|11
841266|NCT01126541|2673174|P3|Overall Study|Administrative reason or other|2
841267|NCT01126541|2673175|P2|Overall Study|Administrative reason or other|1
841268|NCT01126541|2673176|P1|Overall Study|Administrative reason or other|1
841269|NCT01126541|2673174|P3|Overall Study|Protocol Violation|1
841270|NCT01126541|2673175|P2|Overall Study|Protocol Violation|0
841271|NCT01126541|2673176|P1|Overall Study|Protocol Violation|0
841272|NCT01126541|2673174|P3|Overall Study|Withdrawal by Subject|6
841273|NCT01126541|2673175|P2|Overall Study|Withdrawal by Subject|5
841274|NCT01126541|2673176|P1|Overall Study|Withdrawal by Subject|2
841275|NCT01126541|2673174|P3|Overall Study|Lost to Follow-up|2
841276|NCT01126541|2673175|P2|Overall Study|Lost to Follow-up|2
841277|NCT01126541|2673176|P1|Overall Study|Lost to Follow-up|1
841278|NCT01126541|2673174|P3|Overall Study|Lack of Efficacy|11
841279|NCT01126541|2673175|P2|Overall Study|Lack of Efficacy|1
841280|NCT01126541|2673176|P1|Overall Study|Lack of Efficacy|6
841281|NCT01126541|2673174|P3|Overall Study|Death|0
841282|NCT01126541|2673175|P2|Overall Study|Death|1
841283|NCT01126541|2673176|P1|Overall Study|Death|0
841284|NCT01126541|2673174|P3|Overall Study|Adverse Event|4
841285|NCT01126541|2673175|P2|Overall Study|Adverse Event|2
841286|NCT01126541|2673176|P1|Overall Study|Adverse Event|0
841287|NCT01126580|2673260|P3|Overall Study|Treatment Non-compliance|3
841288|NCT01126580|2673261|P2|Overall Study|Treatment Non-compliance|2
841289|NCT01126580|2673262|P1|Overall Study|Treatment Non-compliance|0
841290|NCT01126580|2673260|P3|Overall Study|Lost to Follow-up|9
841291|NCT01126580|2673261|P2|Overall Study|Lost to Follow-up|13
841292|NCT01126580|2673262|P1|Overall Study|Lost to Follow-up|15
841293|NCT01126580|2673260|P3|Overall Study|Protocol Violation|2
841294|NCT01126580|2673261|P2|Overall Study|Protocol Violation|1
841295|NCT01126580|2673262|P1|Overall Study|Protocol Violation|0
841296|NCT01126580|2673260|P3|Overall Study|Lack of Efficacy|4
841297|NCT01126580|2673261|P2|Overall Study|Lack of Efficacy|3
841298|NCT01126580|2673262|P1|Overall Study|Lack of Efficacy|2
841299|NCT01126580|2673260|P3|Overall Study|Entry Criteria Not Met|2
841300|NCT01126580|2673261|P2|Overall Study|Entry Criteria Not Met|1
841301|NCT01126580|2673262|P1|Overall Study|Entry Criteria Not Met|1
841302|NCT01126580|2673260|P3|Overall Study|Physician Decision|2
841303|NCT01126580|2673261|P2|Overall Study|Physician Decision|1
841304|NCT01126580|2673262|P1|Overall Study|Physician Decision|1
841305|NCT01126580|2673260|P3|Overall Study|Sponsor Decision|7
841306|NCT01126580|2673261|P2|Overall Study|Sponsor Decision|4
841307|NCT01126580|2673262|P1|Overall Study|Sponsor Decision|5
841308|NCT01126580|2673260|P3|Overall Study|Withdrawal by Subject|14
841309|NCT01126580|2673261|P2|Overall Study|Withdrawal by Subject|19
841310|NCT01126580|2673262|P1|Overall Study|Withdrawal by Subject|11
841311|NCT01126580|2673260|P3|Overall Study|Adverse Event|12
841312|NCT01126580|2673261|P2|Overall Study|Adverse Event|8
841313|NCT01126580|2673262|P1|Overall Study|Adverse Event|14
841314|NCT01126619|2673367|P1|Overall Study|Non-compliance|1
841315|NCT01126619|2673367|P1|Overall Study|Withdrawal by Subject|9
841316|NCT01126619|2673367|P1|Overall Study|Serious adverse event|1
841317|NCT01126619|2673367|P1|Overall Study|Investigator decision|4
841318|NCT01126619|2673367|P1|Overall Study|Not eligible for the study|2
841319|NCT01127139|2673424|P1|Overall Study|Reason not specified|1
841320|NCT01127139|2673424|P1|Overall Study|Lack of Efficacy|4
841321|NCT01127139|2673424|P1|Overall Study|Incompliance|12
841322|NCT01127139|2673424|P1|Overall Study|Adverse Event|40
841323|NCT01127165|2673441|P2|Overall Study|Protocol Violation|1
841324|NCT01127165|2673442|P1|Overall Study|Protocol Violation|0
841325|NCT01127165|2673441|P2|Overall Study|Withdrawal by Subject|3
841326|NCT01127165|2673442|P1|Overall Study|Withdrawal by Subject|1
841327|NCT01127165|2673441|P2|Overall Study|Lost to Follow-up|5
841328|NCT01127165|2673442|P1|Overall Study|Lost to Follow-up|3
841329|NCT01127165|2673441|P2|Overall Study|Lack of Efficacy|8
841330|NCT01127165|2673442|P1|Overall Study|Lack of Efficacy|10
841331|NCT01127165|2673441|P2|Overall Study|Adverse Event|2
841332|NCT01127165|2673442|P1|Overall Study|Adverse Event|2
841333|NCT01127256|2673456|P2|Overall Study|Protocol Violation|0
841334|NCT01127256|2673457|P1|Overall Study|Protocol Violation|1
841335|NCT01127256|2673456|P2|Overall Study|Withdrawal by Subject|9
841336|NCT01127256|2673457|P1|Overall Study|Withdrawal by Subject|5
841337|NCT01127256|2673456|P2|Overall Study|Lost to Follow-up|17
841338|NCT01127256|2673457|P1|Overall Study|Lost to Follow-up|16
841339|NCT01127256|2673456|P2|Overall Study|Lack of Efficacy|0
841340|NCT01127256|2673457|P1|Overall Study|Lack of Efficacy|4
841341|NCT01127256|2673456|P2|Overall Study|Adverse Event|13
841342|NCT01127256|2673457|P1|Overall Study|Adverse Event|13
841343|NCT01127607|2673562|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
841344|NCT01127607|2673563|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
841345|NCT01127607|2673562|P2|Phase II (Between Subjects)|Lost to Follow-up|2
841346|NCT01127607|2673563|P1|Phase II (Between Subjects)|Lost to Follow-up|0
841347|NCT01127646|2673636|P2|Overall Study|Protocol Violation|1
841348|NCT01127646|2673637|P1|Overall Study|Protocol Violation|0
841349|NCT01127646|2673636|P2|Overall Study|Entry Criteria Not Met|0
841350|NCT01127646|2673637|P1|Overall Study|Entry Criteria Not Met|1
841351|NCT01127763|2673703|P1|Overall Study|Physician Decision|2
841352|NCT01127763|2673703|P1|Overall Study|Withdrawal by Subject|1
841353|NCT01127763|2673703|P1|Overall Study|Adverse Event|2
841354|NCT01128114|2673725|P1|Overall Study|Screening Failed|2
841355|NCT01128114|2673725|P1|Overall Study|Treatment Withdrawn|6
841356|NCT01128153|2673731|P2|Overall Study|Developed discontinuation criteria|1
841357|NCT01128153|2673732|P1|Overall Study|Developed discontinuation criteria|1
841358|NCT01128153|2673731|P2|Overall Study|Protocol Violation|0
841359|NCT01128153|2673732|P1|Overall Study|Protocol Violation|2
841360|NCT01128153|2673731|P2|Overall Study|Incorrect enrolment to study|1
841361|NCT01128153|2673732|P1|Overall Study|Incorrect enrolment to study|2
841362|NCT01128153|2673731|P2|Overall Study|Withdrawal by Subject|3
841363|NCT01128153|2673732|P1|Overall Study|Withdrawal by Subject|2
841364|NCT01128153|2673731|P2|Overall Study|Condition under investigation worsened|7
841365|NCT01128153|2673732|P1|Overall Study|Condition under investigation worsened|8
841366|NCT01128153|2673731|P2|Overall Study|Adverse Event|3
841367|NCT01128153|2673732|P1|Overall Study|Adverse Event|1
841368|NCT01128179|2673750|P2|Overall Study|Protocol Violation|0
841369|NCT01128179|2673751|P1|Overall Study|Protocol Violation|1
841370|NCT01128179|2673750|P2|Overall Study|Death|0
841371|NCT01128179|2673751|P1|Overall Study|Death|1
841372|NCT01128244|2673800|P1|Overall Study|Scheduling conflict|2
841373|NCT01128244|2673800|P1|Overall Study|Adverse Event|1
841374|NCT01128296|2673821|P6|Overall Study|Withdrawal by Subject|2
841375|NCT01128296|2673822|P5|Overall Study|Withdrawal by Subject|0
841376|NCT01128296|2673823|P4|Overall Study|Withdrawal by Subject|0
841377|NCT01128296|2673824|P3|Overall Study|Withdrawal by Subject|0
841378|NCT01128296|2673825|P2|Overall Study|Withdrawal by Subject|0
841379|NCT01128296|2673826|P1|Overall Study|Withdrawal by Subject|0
841380|NCT01128296|2673821|P6|Overall Study|Physician Decision|3
841381|NCT01128296|2673822|P5|Overall Study|Physician Decision|0
841382|NCT01128296|2673823|P4|Overall Study|Physician Decision|0
841383|NCT01128296|2673824|P3|Overall Study|Physician Decision|0
841384|NCT01128296|2673825|P2|Overall Study|Physician Decision|0
841385|NCT01128296|2673826|P1|Overall Study|Physician Decision|0
841386|NCT01128361|2673846|P2|Overall Study|Withdrawal by Subject|2
841387|NCT01128361|2673847|P1|Overall Study|Withdrawal by Subject|5
841388|NCT01128361|2673846|P2|Overall Study|Lost to Follow-up|1
841389|NCT01128361|2673847|P1|Overall Study|Lost to Follow-up|0
841390|NCT01128400|2673862|P3|Overall Study|were not invited to participate on taste|15
841391|NCT01128400|2673863|P2|Overall Study|were not invited to participate on taste|0
841392|NCT01128400|2673864|P1|Overall Study|were not invited to participate on taste|0
841393|NCT01128400|2673862|P3|Overall Study|Screening failure|0
841394|NCT01128400|2673863|P2|Overall Study|Screening failure|0
841395|NCT01128400|2673864|P1|Overall Study|Screening failure|1
841396|NCT01128400|2673862|P3|Overall Study|Lost to Follow-up|1
841397|NCT01128400|2673863|P2|Overall Study|Lost to Follow-up|0
841398|NCT01128400|2673864|P1|Overall Study|Lost to Follow-up|1
841399|NCT01128413|2673877|P2|Overall Study|Pt made DNR|0
841400|NCT01128413|2673878|P1|Overall Study|Pt made DNR|1
841401|NCT01128413|2673877|P2|Overall Study|NICOM Monitor Problems|1
841402|NCT01128413|2673878|P1|Overall Study|NICOM Monitor Problems|2
841403|NCT01128413|2673877|P2|Overall Study|Withdrawal by Subject|0
841404|NCT01128413|2673878|P1|Overall Study|Withdrawal by Subject|1
841405|NCT01128543|2673902|P1|Overall Study|Protocol Violation|1
841406|NCT01128543|2673902|P1|Overall Study|Withdrawal by Subject|3
841407|NCT01128569|2673908|P6|Treatment Period 2|Withdrawal by Subject|0
841408|NCT01128569|2673909|P5|Treatment Period 2|Withdrawal by Subject|0
841409|NCT01128569|2673910|P4|Treatment Period 2|Withdrawal by Subject|0
841410|NCT01128569|2673911|P3|Treatment Period 2|Withdrawal by Subject|0
841411|NCT01128569|2673912|P2|Treatment Period 2|Withdrawal by Subject|1
841412|NCT01128569|2673913|P1|Treatment Period 2|Withdrawal by Subject|0
841413|NCT01128569|2673908|P6|Washout Period 1|Adverse Event|0
841414|NCT01128569|2673909|P5|Washout Period 1|Adverse Event|0
841415|NCT01128569|2673910|P4|Washout Period 1|Adverse Event|0
841416|NCT01128569|2673911|P3|Washout Period 1|Adverse Event|1
841417|NCT01128569|2673912|P2|Washout Period 1|Adverse Event|0
841418|NCT01128569|2673913|P1|Washout Period 1|Adverse Event|0
841419|NCT01128595|2673930|P4|Treatment Period 3|Withdrawal by Subject|0
841420|NCT01128595|2673931|P3|Treatment Period 3|Withdrawal by Subject|0
841421|NCT01128595|2673932|P2|Treatment Period 3|Withdrawal by Subject|1
841422|NCT01128595|2673933|P1|Treatment Period 3|Withdrawal by Subject|0
841423|NCT01128738|2673965|P2|Second TP|Withdrawal by Subject|2
841424|NCT01128738|2673966|P1|Second TP|Withdrawal by Subject|0
841425|NCT01128738|2673965|P2|Second TP|Lost to Follow-up|1
841426|NCT01128738|2673966|P1|Second TP|Lost to Follow-up|0
841427|NCT01128738|2673965|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
841428|NCT01128738|2673966|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
841429|NCT01128738|2673965|P2|First Treatment Phase (TP)|Lost to Follow-up|0
841430|NCT01128738|2673966|P1|First Treatment Phase (TP)|Lost to Follow-up|1
841431|NCT01121900|2674089|P2|Washout Period of 7 Days|Withdrawal by Subject|1
841432|NCT01121900|2674090|P1|Washout Period of 7 Days|Withdrawal by Subject|0
841433|NCT01121900|2674089|P2|First Intervention Period|Adverse Event|1
841434|NCT01121900|2674090|P1|First Intervention Period|Adverse Event|1
841435|NCT01121913|2674108|P4|Third Washout Period|Adverse Event|0
841436|NCT01121913|2674109|P3|Third Washout Period|Adverse Event|0
841437|NCT01121913|2674110|P2|Third Washout Period|Adverse Event|0
841438|NCT01121913|2674111|P1|Third Washout Period|Adverse Event|1
841439|NCT01121913|2674108|P4|Second Washout Period|Withdrawal by Subject|0
841440|NCT01121913|2674109|P3|Second Washout Period|Withdrawal by Subject|1
841441|NCT01121913|2674110|P2|Second Washout Period|Withdrawal by Subject|0
841442|NCT01121913|2674111|P1|Second Washout Period|Withdrawal by Subject|0
841443|NCT01121913|2674108|P4|Second Intervention Period|Adverse Event|0
841444|NCT01121913|2674109|P3|Second Intervention Period|Adverse Event|1
841445|NCT01121913|2674110|P2|Second Intervention Period|Adverse Event|0
841446|NCT01121913|2674111|P1|Second Intervention Period|Adverse Event|0
841447|NCT01121913|2674108|P4|First Washout Period|Withdrawal by Subject|0
841448|NCT01121913|2674109|P3|First Washout Period|Withdrawal by Subject|0
841449|NCT01121913|2674110|P2|First Washout Period|Withdrawal by Subject|0
841450|NCT01121913|2674111|P1|First Washout Period|Withdrawal by Subject|1
841451|NCT01121913|2674108|P4|First Intervention Period|Adverse Event|0
841452|NCT01121913|2674109|P3|First Intervention Period|Adverse Event|1
841453|NCT01121913|2674110|P2|First Intervention Period|Adverse Event|0
841454|NCT01121913|2674111|P1|First Intervention Period|Adverse Event|0
841455|NCT01121926|2674141|P2|Washout Period|Positive pregnancy test|1
841456|NCT01121926|2674142|P1|Washout Period|Positive pregnancy test|0
841457|NCT01121926|2674141|P2|Washout Period|Adverse Event|1
841458|NCT01121926|2674142|P1|Washout Period|Adverse Event|0
841459|NCT01121926|2674141|P2|First Intervention Period|Adverse Event|0
841460|NCT01121926|2674142|P1|First Intervention Period|Adverse Event|1
841461|NCT01121991|2674174|P1|Overall Study|No Fertilization|1
841462|NCT01121991|2674174|P1|Overall Study|No Oocytes Retrieved|3
841463|NCT01121991|2674174|P1|Overall Study|Lack of Ovarian Response|2
841464|NCT01122264|2674457|P3|Overall Study|Lack of Efficacy|1
841465|NCT01122264|2674458|P2|Overall Study|Lack of Efficacy|1
841466|NCT01122264|2674459|P1|Overall Study|Lack of Efficacy|3
841467|NCT01122264|2674457|P3|Overall Study|Physician Decision|1
841468|NCT01122264|2674458|P2|Overall Study|Physician Decision|1
841469|NCT01122264|2674459|P1|Overall Study|Physician Decision|3
841470|NCT01122264|2674457|P3|Overall Study|Withdrawal by Subject|16
841471|NCT01122264|2674458|P2|Overall Study|Withdrawal by Subject|6
841472|NCT01122264|2674459|P1|Overall Study|Withdrawal by Subject|6
841473|NCT01122264|2674457|P3|Overall Study|Protocol Violation|9
841474|NCT01122264|2674458|P2|Overall Study|Protocol Violation|7
841475|NCT01122264|2674459|P1|Overall Study|Protocol Violation|7
841476|NCT01122264|2674457|P3|Overall Study|Entry Criteria Not Met|0
841477|NCT01122264|2674458|P2|Overall Study|Entry Criteria Not Met|0
841478|NCT01122264|2674459|P1|Overall Study|Entry Criteria Not Met|1
841479|NCT01122264|2674457|P3|Overall Study|Lost to Follow-up|13
841480|NCT01122264|2674458|P2|Overall Study|Lost to Follow-up|9
841481|NCT01122264|2674459|P1|Overall Study|Lost to Follow-up|5
841482|NCT01122264|2674457|P3|Overall Study|Death|0
841483|NCT01122264|2674458|P2|Overall Study|Death|0
841484|NCT01122264|2674459|P1|Overall Study|Death|1
841485|NCT01122264|2674457|P3|Overall Study|Adverse Event|7
841486|NCT01122264|2674458|P2|Overall Study|Adverse Event|5
841487|NCT01122264|2674459|P1|Overall Study|Adverse Event|6
841488|NCT01122381|2674518|P2|Overall Study|study terminated early|1
841489|NCT01122381|2674519|P1|Overall Study|study terminated early|0
841490|NCT01122394|2674527|P2|Overall Study|Adverse Event|1
841491|NCT01122394|2674528|P1|Overall Study|Adverse Event|0
841492|NCT01122394|2674527|P2|Overall Study|Lost to Follow-up|2
841493|NCT01122394|2674528|P1|Overall Study|Lost to Follow-up|2
841494|NCT01122394|2674527|P2|Overall Study|Withdrawal by Subject|1
841495|NCT01122394|2674528|P1|Overall Study|Withdrawal by Subject|1
841496|NCT01122576|2674560|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
841497|NCT01122576|2674561|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
841498|NCT01122576|2674562|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
841499|NCT01122576|2674560|P3|Post-Cataract Surgery|Central Macular Edema|1
841500|NCT01122576|2674561|P2|Post-Cataract Surgery|Central Macular Edema|0
841501|NCT01122576|2674562|P1|Post-Cataract Surgery|Central Macular Edema|0
841502|NCT01122576|2674560|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
841503|NCT01122576|2674561|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
841504|NCT01122576|2674562|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
841505|NCT01122680|2674699|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
841506|NCT01122680|2674700|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
841507|NCT01122680|2674701|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
841508|NCT01122680|2674702|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
841509|NCT01122680|2674699|P4|Period 3 (4 Weeks)|Adverse Event|0
841510|NCT01122680|2674700|P3|Period 3 (4 Weeks)|Adverse Event|0
841511|NCT01122680|2674701|P2|Period 3 (4 Weeks)|Adverse Event|0
841512|NCT01122680|2674702|P1|Period 3 (4 Weeks)|Adverse Event|1
841513|NCT01122680|2674699|P4|Period 2 (4 Weeks)|Other|0
841514|NCT01122680|2674700|P3|Period 2 (4 Weeks)|Other|0
841515|NCT01122680|2674701|P2|Period 2 (4 Weeks)|Other|0
841516|NCT01122680|2674702|P1|Period 2 (4 Weeks)|Other|1
841517|NCT01122680|2674699|P4|Period 2 (4 Weeks)|Protocol Violation|1
841518|NCT01122680|2674700|P3|Period 2 (4 Weeks)|Protocol Violation|0
841519|NCT01122680|2674701|P2|Period 2 (4 Weeks)|Protocol Violation|0
841520|NCT01122680|2674702|P1|Period 2 (4 Weeks)|Protocol Violation|0
841521|NCT01122680|2674699|P4|Period 1 (4 Weeks)|Other|0
841522|NCT01122680|2674700|P3|Period 1 (4 Weeks)|Other|0
841523|NCT01122680|2674701|P2|Period 1 (4 Weeks)|Other|1
841524|NCT01122680|2674702|P1|Period 1 (4 Weeks)|Other|1
841525|NCT01122680|2674699|P4|Period 1 (4 Weeks)|Protocol Violation|0
841526|NCT01122680|2674700|P3|Period 1 (4 Weeks)|Protocol Violation|0
841527|NCT01122680|2674701|P2|Period 1 (4 Weeks)|Protocol Violation|0
841528|NCT01122680|2674702|P1|Period 1 (4 Weeks)|Protocol Violation|1
841529|NCT01122680|2674699|P4|Period 1 (4 Weeks)|Adverse Event|0
841530|NCT01122680|2674700|P3|Period 1 (4 Weeks)|Adverse Event|0
841531|NCT01122680|2674701|P2|Period 1 (4 Weeks)|Adverse Event|0
841532|NCT01122680|2674702|P1|Period 1 (4 Weeks)|Adverse Event|1
841533|NCT01122862|2674764|P3|Period 2|Adverse Event|1
841534|NCT01122862|2674765|P2|Period 2|Adverse Event|0
841535|NCT01122862|2674766|P1|Period 2|Adverse Event|0
841536|NCT01122862|2674764|P3|Period 1|Protocol Violation|0
841537|NCT01122862|2674765|P2|Period 1|Protocol Violation|1
841538|NCT01122862|2674766|P1|Period 1|Protocol Violation|0
841539|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
841540|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
841541|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
841542|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
841543|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
841544|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
841545|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
841546|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
841547|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
841548|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
841549|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
841550|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
841551|NCT01122927|2674805|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
841552|NCT01122927|2674806|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
841553|NCT01122927|2674805|P2|Period 1 - Conversion Phase|Protocol Deviation|0
841554|NCT01122927|2674806|P1|Period 1 - Conversion Phase|Protocol Deviation|1
841555|NCT01122927|2674805|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
841556|NCT01122927|2674806|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
841557|NCT01122927|2674805|P2|Period 1 - Conversion Phase|Physician Decision|0
841558|NCT01122927|2674806|P1|Period 1 - Conversion Phase|Physician Decision|2
841559|NCT01122927|2674805|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
841560|NCT01122927|2674806|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
841561|NCT01122927|2674805|P2|Period 1 - Conversion Phase|Adverse Event|0
841562|NCT01122927|2674806|P1|Period 1 - Conversion Phase|Adverse Event|3
841563|NCT01123083|2674839|P2|Overall Study|Participant/legal representative request|3
841564|NCT01123083|2674840|P1|Overall Study|Participant/legal representative request|7
841565|NCT01123083|2674839|P2|Overall Study|Withdrew for another reason not covered|1
841566|NCT01123083|2674840|P1|Overall Study|Withdrew for another reason not covered|0
841567|NCT01123083|2674839|P2|Overall Study|Adverse Event|0
841568|NCT01123083|2674840|P1|Overall Study|Adverse Event|1
841569|NCT01123083|2674839|P2|Overall Study|Lost to Follow-up|6
841570|NCT01123083|2674840|P1|Overall Study|Lost to Follow-up|2
841571|NCT01123083|2674839|P2|Overall Study|Administrative reasons|4
841572|NCT01123083|2674840|P1|Overall Study|Administrative reasons|0
841573|NCT01123083|2674839|P2|Overall Study|Investigator recommendation|1
841574|NCT01123083|2674840|P1|Overall Study|Investigator recommendation|1
841575|NCT01123148|2674864|P1|Overall Study|Didn't meet milestone criteria|1
841576|NCT01123148|2674864|P1|Overall Study|Coughing caused unacceptable EEG quality|1
841577|NCT01123161|2674870|P2|Overall Study|Withdrawal by Subject|0
841578|NCT01123161|2674871|P1|Overall Study|Withdrawal by Subject|1
841579|NCT01123161|2674870|P2|Overall Study|Lost to Follow-up|0
841580|NCT01123161|2674871|P1|Overall Study|Lost to Follow-up|1
841581|NCT01123200|2674889|P1|Overall Study|Withdrawal by Subject|1
841582|NCT01128894|2674901|P2|Overall Study|Conflicting HbA1c Results at Screening|0
841583|NCT01128894|2674902|P1|Overall Study|Conflicting HbA1c Results at Screening|1
841584|NCT01128894|2674901|P2|Overall Study|Physician Decision|1
841585|NCT01128894|2674902|P1|Overall Study|Physician Decision|2
841586|NCT01128894|2674901|P2|Overall Study|Withdrawal by Subject|12
841587|NCT01128894|2674902|P1|Overall Study|Withdrawal by Subject|10
841588|NCT01128894|2674901|P2|Overall Study|Lost to Follow-up|8
841589|NCT01128894|2674902|P1|Overall Study|Lost to Follow-up|8
841590|NCT01128894|2674901|P2|Overall Study|Noncompliance|5
841591|NCT01128894|2674902|P1|Overall Study|Noncompliance|4
841592|NCT01128894|2674901|P2|Overall Study|Protocol Violation|1
841593|NCT01128894|2674902|P1|Overall Study|Protocol Violation|2
841594|NCT01128894|2674901|P2|Overall Study|Adverse Event|41
841595|NCT01128894|2674902|P1|Overall Study|Adverse Event|31
841596|NCT01128946|2674920|P4|Period III|Protocol Violation|0
841597|NCT01128946|2674921|P3|Period III|Protocol Violation|0
841598|NCT01128946|2674922|P2|Period III|Protocol Violation|0
841599|NCT01128946|2674923|P1|Period III|Protocol Violation|1
841600|NCT01128946|2674920|P4|Period II|Withdrawal by Subject|1
841601|NCT01128946|2674921|P3|Period II|Withdrawal by Subject|0
841602|NCT01128946|2674922|P2|Period II|Withdrawal by Subject|0
841603|NCT01128946|2674923|P1|Period II|Withdrawal by Subject|0
841604|NCT01128946|2674920|P4|Period II|Protocol Violation|0
841605|NCT01128946|2674921|P3|Period II|Protocol Violation|0
841606|NCT01128946|2674922|P2|Period II|Protocol Violation|1
841607|NCT01128946|2674923|P1|Period II|Protocol Violation|0
841608|NCT01128946|2674920|P4|Period I|Withdrawal by Subject|1
841609|NCT01128946|2674921|P3|Period I|Withdrawal by Subject|1
841610|NCT01128946|2674922|P2|Period I|Withdrawal by Subject|0
841611|NCT01128946|2674923|P1|Period I|Withdrawal by Subject|0
841612|NCT01128946|2674920|P4|Period I|Protocol Violation|0
841613|NCT01128946|2674921|P3|Period I|Protocol Violation|0
841614|NCT01128946|2674922|P2|Period I|Protocol Violation|1
841615|NCT01128946|2674923|P1|Period I|Protocol Violation|0
841616|NCT01128959|2674939|P1|Treatment Period|Withdrawal by Subject|1
841617|NCT01128959|2674939|P1|Treatment Period|Adverse Event|3
841618|NCT01128959|2674939|P1|Lead in Period|Adverse Event|3
841619|NCT01129011|2674980|P2|Overall Study|misc|4
841620|NCT01129011|2674981|P1|Overall Study|misc|7
841621|NCT01129011|2674980|P2|Overall Study|Duodenal Ulcer|8
841622|NCT01129011|2674981|P1|Overall Study|Duodenal Ulcer|2
841623|NCT01129011|2674980|P2|Overall Study|Lost to Follow-up|7
841624|NCT01129011|2674981|P1|Overall Study|Lost to Follow-up|6
841625|NCT01129011|2674980|P2|Overall Study|Withdrawal by Subject|8
841626|NCT01129011|2674981|P1|Overall Study|Withdrawal by Subject|24
841627|NCT01129011|2674980|P2|Overall Study|Adverse Event|30
841628|NCT01129011|2674981|P1|Overall Study|Adverse Event|20
841629|NCT01129102|2675006|P3|Overall Study|Lost to Follow-up|0
841630|NCT01129102|2675007|P2|Overall Study|Lost to Follow-up|0
841631|NCT01129102|2675008|P1|Overall Study|Lost to Follow-up|2
841632|NCT01129102|2675006|P3|Overall Study|Adverse Event|1
841633|NCT01129102|2675007|P2|Overall Study|Adverse Event|2
841634|NCT01129102|2675008|P1|Overall Study|Adverse Event|2
841635|NCT01129102|2675006|P3|Overall Study|Pregnancy|1
841636|NCT01129102|2675007|P2|Overall Study|Pregnancy|0
841637|NCT01129102|2675008|P1|Overall Study|Pregnancy|0
841638|NCT01129102|2675006|P3|Overall Study|Protocol Violation|1
841639|NCT01129102|2675007|P2|Overall Study|Protocol Violation|1
841640|NCT01129102|2675008|P1|Overall Study|Protocol Violation|0
841641|NCT01129102|2675006|P3|Overall Study|Withdrawal by Subject|3
841642|NCT01129102|2675007|P2|Overall Study|Withdrawal by Subject|0
841643|NCT01129102|2675008|P1|Overall Study|Withdrawal by Subject|2
841644|NCT01129102|2675006|P3|Overall Study|No study drug treatment|1
841645|NCT01129102|2675007|P2|Overall Study|No study drug treatment|3
841646|NCT01129102|2675008|P1|Overall Study|No study drug treatment|2
841647|NCT01129115|2675021|P4|Overall Study|Protocol Violation|2
841648|NCT01129115|2675022|P3|Overall Study|Protocol Violation|2
841649|NCT01129115|2675023|P2|Overall Study|Protocol Violation|2
841650|NCT01129115|2675024|P1|Overall Study|Protocol Violation|0
841651|NCT01129115|2675021|P4|Overall Study|Withdrawal by Subject|4
841652|NCT01129115|2675022|P3|Overall Study|Withdrawal by Subject|1
841653|NCT01129115|2675023|P2|Overall Study|Withdrawal by Subject|3
841654|NCT01129115|2675024|P1|Overall Study|Withdrawal by Subject|1
841655|NCT01129115|2675021|P4|Overall Study|Adverse Event|3
841656|NCT01129115|2675022|P3|Overall Study|Adverse Event|3
841657|NCT01129115|2675023|P2|Overall Study|Adverse Event|2
841658|NCT01129115|2675024|P1|Overall Study|Adverse Event|1
841659|NCT01129128|2675061|P3|Overall Study|Physician Decision|0
841660|NCT01129128|2675062|P2|Overall Study|Physician Decision|0
841661|NCT01129128|2675063|P1|Overall Study|Physician Decision|1
841662|NCT01129128|2675061|P3|Overall Study|Withdrawal by Subject|3
841663|NCT01129128|2675062|P2|Overall Study|Withdrawal by Subject|1
841664|NCT01129128|2675063|P1|Overall Study|Withdrawal by Subject|0
841665|NCT01129128|2675061|P3|Overall Study|Protocol Violation|0
841666|NCT01129128|2675062|P2|Overall Study|Protocol Violation|1
841667|NCT01129128|2675063|P1|Overall Study|Protocol Violation|0
841668|NCT01129128|2675061|P3|Overall Study|Lost to Follow-up|1
841669|NCT01129128|2675062|P2|Overall Study|Lost to Follow-up|2
841670|NCT01129128|2675063|P1|Overall Study|Lost to Follow-up|2
841671|NCT01132118|2675103|P2|Second Intervention (8 Weeks)|Adverse Event|1
841672|NCT01132118|2675104|P1|Second Intervention (8 Weeks)|Adverse Event|0
841673|NCT01132118|2675103|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
841674|NCT01132118|2675104|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
841675|NCT01132118|2675103|P2|First Intervention (8 Weeks)|Adverse Event|0
841676|NCT01132118|2675104|P1|First Intervention (8 Weeks)|Adverse Event|1
841677|NCT01132313|2675157|P12|Overall Study|Other reason not defined above|0
841678|NCT01132313|2675158|P11|Overall Study|Other reason not defined above|0
841679|NCT01132313|2675159|P10|Overall Study|Other reason not defined above|0
841680|NCT01132313|2675160|P9|Overall Study|Other reason not defined above|0
841681|NCT01132313|2675161|P8|Overall Study|Other reason not defined above|1
841682|NCT01132313|2675162|P7|Overall Study|Other reason not defined above|0
841683|NCT01132313|2675163|P6|Overall Study|Other reason not defined above|0
841684|NCT01132313|2675164|P5|Overall Study|Other reason not defined above|0
841685|NCT01132313|2675165|P4|Overall Study|Other reason not defined above|0
841686|NCT01132313|2675166|P3|Overall Study|Other reason not defined above|0
841687|NCT01132313|2675167|P2|Overall Study|Other reason not defined above|0
841688|NCT01132313|2675168|P1|Overall Study|Other reason not defined above|0
841689|NCT01132313|2675157|P12|Overall Study|Lack of antiviral response|0
841690|NCT01132313|2675158|P11|Overall Study|Lack of antiviral response|1
841691|NCT01132313|2675159|P10|Overall Study|Lack of antiviral response|0
841692|NCT01132313|2675160|P9|Overall Study|Lack of antiviral response|0
841693|NCT01132313|2675161|P8|Overall Study|Lack of antiviral response|0
841694|NCT01132313|2675162|P7|Overall Study|Lack of antiviral response|21
841695|NCT01132313|2675163|P6|Overall Study|Lack of antiviral response|18
841696|NCT01132313|2675164|P5|Overall Study|Lack of antiviral response|18
841697|NCT01132313|2675165|P4|Overall Study|Lack of antiviral response|18
841698|NCT01132313|2675166|P3|Overall Study|Lack of antiviral response|12
841699|NCT01132313|2675167|P2|Overall Study|Lack of antiviral response|0
841700|NCT01132313|2675168|P1|Overall Study|Lack of antiviral response|0
841701|NCT01132313|2675157|P12|Overall Study|Withdrawal by Subject|0
841702|NCT01132313|2675158|P11|Overall Study|Withdrawal by Subject|0
841703|NCT01132313|2675159|P10|Overall Study|Withdrawal by Subject|2
841704|NCT01132313|2675160|P9|Overall Study|Withdrawal by Subject|0
841705|NCT01132313|2675161|P8|Overall Study|Withdrawal by Subject|0
841706|NCT01132313|2675162|P7|Overall Study|Withdrawal by Subject|1
841707|NCT01132313|2675163|P6|Overall Study|Withdrawal by Subject|0
841708|NCT01132313|2675164|P5|Overall Study|Withdrawal by Subject|6
841709|NCT01132313|2675165|P4|Overall Study|Withdrawal by Subject|3
841710|NCT01132313|2675166|P3|Overall Study|Withdrawal by Subject|3
841711|NCT01132313|2675167|P2|Overall Study|Withdrawal by Subject|0
841712|NCT01132313|2675168|P1|Overall Study|Withdrawal by Subject|0
841713|NCT01132313|2675157|P12|Overall Study|Lost to Follow-up|0
841714|NCT01132313|2675158|P11|Overall Study|Lost to Follow-up|0
841715|NCT01132313|2675159|P10|Overall Study|Lost to Follow-up|0
841716|NCT01132313|2675160|P9|Overall Study|Lost to Follow-up|0
841717|NCT01132313|2675161|P8|Overall Study|Lost to Follow-up|1
841718|NCT01132313|2675162|P7|Overall Study|Lost to Follow-up|0
841719|NCT01132313|2675163|P6|Overall Study|Lost to Follow-up|0
841720|NCT01132313|2675164|P5|Overall Study|Lost to Follow-up|0
841721|NCT01132313|2675165|P4|Overall Study|Lost to Follow-up|0
841722|NCT01132313|2675166|P3|Overall Study|Lost to Follow-up|1
841723|NCT01132313|2675167|P2|Overall Study|Lost to Follow-up|0
841724|NCT01132313|2675168|P1|Overall Study|Lost to Follow-up|0
841725|NCT01132313|2675157|P12|Overall Study|Protocol Violation|0
841726|NCT01132313|2675158|P11|Overall Study|Protocol Violation|0
841727|NCT01132313|2675159|P10|Overall Study|Protocol Violation|0
841728|NCT01132313|2675160|P9|Overall Study|Protocol Violation|0
841729|NCT01132313|2675161|P8|Overall Study|Protocol Violation|0
841730|NCT01132313|2675162|P7|Overall Study|Protocol Violation|0
841731|NCT01132313|2675163|P6|Overall Study|Protocol Violation|0
841732|NCT01132313|2675164|P5|Overall Study|Protocol Violation|0
841733|NCT01132313|2675165|P4|Overall Study|Protocol Violation|1
841734|NCT01132313|2675166|P3|Overall Study|Protocol Violation|0
841735|NCT01132313|2675167|P2|Overall Study|Protocol Violation|0
841736|NCT01132313|2675168|P1|Overall Study|Protocol Violation|0
841737|NCT01132313|2675157|P12|Overall Study|Adverse Event|0
841738|NCT01132313|2675158|P11|Overall Study|Adverse Event|0
841739|NCT01132313|2675159|P10|Overall Study|Adverse Event|2
841740|NCT01132313|2675160|P9|Overall Study|Adverse Event|7
841741|NCT01132313|2675161|P8|Overall Study|Adverse Event|3
841742|NCT01132313|2675162|P7|Overall Study|Adverse Event|5
841743|NCT01132313|2675163|P6|Overall Study|Adverse Event|6
841744|NCT01132313|2675164|P5|Overall Study|Adverse Event|19
841745|NCT01132313|2675165|P4|Overall Study|Adverse Event|10
841746|NCT01132313|2675166|P3|Overall Study|Adverse Event|4
841747|NCT01132313|2675167|P2|Overall Study|Adverse Event|0
841748|NCT01132313|2675168|P1|Overall Study|Adverse Event|0
841749|NCT01132313|2675157|P12|Overall Study|Not treated|0
841750|NCT01132313|2675158|P11|Overall Study|Not treated|0
841751|NCT01132313|2675159|P10|Overall Study|Not treated|0
841752|NCT01132313|2675160|P9|Overall Study|Not treated|0
841753|NCT01132313|2675161|P8|Overall Study|Not treated|0
841754|NCT01132313|2675162|P7|Overall Study|Not treated|3
841755|NCT01132313|2675163|P6|Overall Study|Not treated|1
841756|NCT01132313|2675164|P5|Overall Study|Not treated|2
841757|NCT01132313|2675165|P4|Overall Study|Not treated|0
841758|NCT01132313|2675166|P3|Overall Study|Not treated|0
841759|NCT01132313|2675167|P2|Overall Study|Not treated|0
841760|NCT01132313|2675168|P1|Overall Study|Not treated|2
841761|NCT01132313|2675157|P12|Overall Study|Lack of Efficacy|0
841762|NCT01132313|2675158|P11|Overall Study|Lack of Efficacy|0
841763|NCT01132313|2675159|P10|Overall Study|Lack of Efficacy|16
841764|NCT01132313|2675160|P9|Overall Study|Lack of Efficacy|14
841765|NCT01132313|2675161|P8|Overall Study|Lack of Efficacy|3
841766|NCT01132313|2675162|P7|Overall Study|Lack of Efficacy|0
841767|NCT01132313|2675163|P6|Overall Study|Lack of Efficacy|0
841768|NCT01132313|2675164|P5|Overall Study|Lack of Efficacy|0
841769|NCT01132313|2675165|P4|Overall Study|Lack of Efficacy|0
841770|NCT01132313|2675166|P3|Overall Study|Lack of Efficacy|0
841771|NCT01132313|2675167|P2|Overall Study|Lack of Efficacy|0
841772|NCT01132313|2675168|P1|Overall Study|Lack of Efficacy|1
841773|NCT01132326|2675223|P1|Overall Study|Subject Unable to Come To Visits|1
841774|NCT01132326|2675223|P1|Overall Study|Death|5
841775|NCT01132326|2675223|P1|Overall Study|Caregiver Withdrew Consent|1
841776|NCT01132326|2675223|P1|Overall Study|Pregnancy|1
841777|NCT01132326|2675223|P1|Overall Study|Declining Health|1
841778|NCT01132326|2675223|P1|Overall Study|Study Termination|80
841779|NCT01132326|2675223|P1|Overall Study|Physician Decision|10
841780|NCT01132326|2675223|P1|Overall Study|Withdrawal by Subject|40
841781|NCT01132326|2675223|P1|Overall Study|Lost to Follow-up|16
841782|NCT01132326|2675223|P1|Overall Study|Protocol Violation|1
841783|NCT01132326|2675223|P1|Overall Study|Adverse Event|37
841784|NCT01132326|2675223|P1|Overall Study|Lack of Efficacy|25
841785|NCT01132495|2675236|P4|Overall Study|Various reasons|12
841786|NCT01132495|2675237|P3|Overall Study|Various reasons|20
841787|NCT01132495|2675238|P2|Overall Study|Various reasons|38
841788|NCT01132495|2675239|P1|Overall Study|Various reasons|40
841789|NCT01132547|2675305|P2|Overall Study|Death|0
841790|NCT01132547|2675306|P1|Overall Study|Death|1
841791|NCT01132547|2675305|P2|Overall Study|Withdrawal by Subject|1
841792|NCT01132547|2675306|P1|Overall Study|Withdrawal by Subject|3
841793|NCT01132651|2675318|P2|Overall Study|Lost to Follow-up|1
841794|NCT01132651|2675319|P1|Overall Study|Lost to Follow-up|1
841795|NCT01132664|2675332|P5|BM Cohort|Withdrawal by Subject|1
841796|NCT01132664|2675333|P4|BM Cohort|Withdrawal by Subject|0
841797|NCT01132664|2675334|P3|BM Cohort|Withdrawal by Subject|0
841798|NCT01132664|2675335|P2|BM Cohort|Withdrawal by Subject|0
841799|NCT01132664|2675336|P1|BM Cohort|Withdrawal by Subject|0
841800|NCT01132664|2675332|P5|BM Cohort|Adverse Event|1
841801|NCT01132664|2675333|P4|BM Cohort|Adverse Event|0
841802|NCT01132664|2675334|P3|BM Cohort|Adverse Event|0
841803|NCT01132664|2675335|P2|BM Cohort|Adverse Event|0
841804|NCT01132664|2675336|P1|BM Cohort|Adverse Event|0
841805|NCT01132664|2675332|P5|BM Cohort|Disease progression|4
841806|NCT01132664|2675333|P4|BM Cohort|Disease progression|3
841807|NCT01132664|2675334|P3|BM Cohort|Disease progression|0
841808|NCT01132664|2675335|P2|BM Cohort|Disease progression|0
841809|NCT01132664|2675336|P1|BM Cohort|Disease progression|0
841810|NCT01132664|2675332|P5|Phase ll|Disease progression|0
841811|NCT01132664|2675333|P4|Phase ll|Disease progression|0
841812|NCT01132664|2675334|P3|Phase ll|Disease progression|35
841813|NCT01132664|2675335|P2|Phase ll|Disease progression|0
841814|NCT01132664|2675336|P1|Phase ll|Disease progression|0
841815|NCT01132664|2675332|P5|Phase ll|Withdrawal by Subject|0
841816|NCT01132664|2675333|P4|Phase ll|Withdrawal by Subject|0
841817|NCT01132664|2675334|P3|Phase ll|Withdrawal by Subject|3
841818|NCT01132664|2675335|P2|Phase ll|Withdrawal by Subject|0
841819|NCT01132664|2675336|P1|Phase ll|Withdrawal by Subject|0
841820|NCT01132664|2675332|P5|Phase ll|Adverse Event|0
841821|NCT01132664|2675333|P4|Phase ll|Adverse Event|0
841822|NCT01132664|2675334|P3|Phase ll|Adverse Event|10
841823|NCT01132664|2675335|P2|Phase ll|Adverse Event|0
841824|NCT01132664|2675336|P1|Phase ll|Adverse Event|0
841825|NCT01132664|2675332|P5|Phase ll|Death|0
841826|NCT01132664|2675333|P4|Phase ll|Death|0
841827|NCT01132664|2675334|P3|Phase ll|Death|2
841828|NCT01132664|2675335|P2|Phase ll|Death|0
841829|NCT01132664|2675336|P1|Phase ll|Death|0
841830|NCT01132664|2675332|P5|Phase lb|Disease Progression|0
841831|NCT01132664|2675333|P4|Phase lb|Disease Progression|0
841832|NCT01132664|2675334|P3|Phase lb|Disease Progression|0
841833|NCT01132664|2675335|P2|Phase lb|Disease Progression|9
841834|NCT01132664|2675336|P1|Phase lb|Disease Progression|4
841835|NCT01132664|2675332|P5|Phase lb|Withdrawal by Subject|0
841836|NCT01132664|2675333|P4|Phase lb|Withdrawal by Subject|0
841837|NCT01132664|2675334|P3|Phase lb|Withdrawal by Subject|0
841838|NCT01132664|2675335|P2|Phase lb|Withdrawal by Subject|2
841839|NCT01132664|2675336|P1|Phase lb|Withdrawal by Subject|1
841840|NCT01132664|2675332|P5|Phase lb|Adverse Event|0
841841|NCT01132664|2675333|P4|Phase lb|Adverse Event|0
841842|NCT01132664|2675334|P3|Phase lb|Adverse Event|0
841843|NCT01132664|2675335|P2|Phase lb|Adverse Event|1
841844|NCT01132664|2675336|P1|Phase lb|Adverse Event|0
841845|NCT01132820|2675387|P1|Overall Study|Inadequate data|1
841846|NCT01132820|2675387|P1|Overall Study|Never treated|1
841847|NCT01132820|2675387|P1|Overall Study|Ineligible:Inadequate pathology|1
841848|NCT01132820|2675387|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
841849|NCT01132820|2675387|P1|Overall Study|Ineligible: wrong cell type|1
841850|NCT01133171|2675454|P3|Overall Study|Withdrawal by Subject|0
841851|NCT01133171|2675455|P2|Overall Study|Withdrawal by Subject|2
841852|NCT01133171|2675456|P1|Overall Study|Withdrawal by Subject|1
841853|NCT01133275|2675466|P1|Overall Study|Cerebrovascular accident (CVA)|1
841854|NCT01133275|2675466|P1|Overall Study|Withdrawal by Subject|1
841855|NCT01133288|2675471|P1|Intervention Allocation|study terminated|2
841856|NCT01133288|2675471|P1|Eligibility Assessment|met exclusion criteria|5
841857|NCT01133379|2675479|P3|Overall Study|Lost to Follow-up|1
841858|NCT01133379|2675480|P2|Overall Study|Lost to Follow-up|1
841859|NCT01133379|2675481|P1|Overall Study|Lost to Follow-up|1
841860|NCT01133379|2675479|P3|Overall Study|Withdrawal by Subject|1
841861|NCT01133379|2675480|P2|Overall Study|Withdrawal by Subject|1
841862|NCT01133379|2675481|P1|Overall Study|Withdrawal by Subject|0
841863|NCT01133392|2675536|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
841864|NCT01133392|2675537|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
841865|NCT01133392|2675536|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
841866|NCT01133392|2675537|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
841867|NCT01133418|2675553|P2|Overall Study|Lost to Follow-up|6
841868|NCT01133418|2675554|P1|Overall Study|Lost to Follow-up|5
841869|NCT01133522|2675576|P10|Overall Study|Physician Decision|0
841870|NCT01133522|2675577|P9|Overall Study|Physician Decision|0
841871|NCT01133522|2675578|P8|Overall Study|Physician Decision|0
841872|NCT01133522|2675579|P7|Overall Study|Physician Decision|0
841873|NCT01133522|2675580|P6|Overall Study|Physician Decision|0
841874|NCT01133522|2675581|P5|Overall Study|Physician Decision|1
841875|NCT01133522|2675582|P4|Overall Study|Physician Decision|0
841876|NCT01133522|2675583|P3|Overall Study|Physician Decision|0
841877|NCT01133522|2675584|P2|Overall Study|Physician Decision|0
841878|NCT01133522|2675585|P1|Overall Study|Physician Decision|0
841879|NCT01133522|2675576|P10|Overall Study|Withdrawal by Subject|0
841880|NCT01133522|2675577|P9|Overall Study|Withdrawal by Subject|0
841881|NCT01133522|2675578|P8|Overall Study|Withdrawal by Subject|0
841882|NCT01133522|2675579|P7|Overall Study|Withdrawal by Subject|0
841883|NCT01133522|2675580|P6|Overall Study|Withdrawal by Subject|0
841884|NCT01133522|2675581|P5|Overall Study|Withdrawal by Subject|0
841885|NCT01133522|2675582|P4|Overall Study|Withdrawal by Subject|1
841886|NCT01133522|2675583|P3|Overall Study|Withdrawal by Subject|0
841887|NCT01133522|2675584|P2|Overall Study|Withdrawal by Subject|1
841888|NCT01133522|2675585|P1|Overall Study|Withdrawal by Subject|0
841889|NCT01133626|2675654|P3|Overall Study|Not specified|0
841890|NCT01133626|2675655|P2|Overall Study|Not specified|2
841891|NCT01133626|2675656|P1|Overall Study|Not specified|0
841892|NCT01133626|2675654|P3|Overall Study|Withdrawal by Subject|2
841893|NCT01133626|2675655|P2|Overall Study|Withdrawal by Subject|2
841894|NCT01133626|2675656|P1|Overall Study|Withdrawal by Subject|1
841895|NCT01133626|2675654|P3|Overall Study|Adverse Event|0
841896|NCT01133626|2675655|P2|Overall Study|Adverse Event|1
841897|NCT01133626|2675656|P1|Overall Study|Adverse Event|0
841898|NCT01133665|2675664|P1|Overall Study|Physician Decision|2
841899|NCT01133704|2675707|P2|Overall Study|Study Closure|0
841900|NCT01133704|2675708|P1|Overall Study|Study Closure|1
841901|NCT01133704|2675707|P2|Overall Study|Patient refused to continue|0
841902|NCT01133704|2675708|P1|Overall Study|Patient refused to continue|4
841903|NCT01133704|2675707|P2|Overall Study|Death|26
841904|NCT01133704|2675708|P1|Overall Study|Death|44
841905|NCT01133756|2675719|P3|Overall Study|Progression of Disease|1
841906|NCT01133756|2675720|P2|Overall Study|Progression of Disease|0
841907|NCT01133756|2675721|P1|Overall Study|Progression of Disease|0
841908|NCT01133756|2675719|P3|Overall Study|Withdrawal by Subject|0
841909|NCT01133756|2675720|P2|Overall Study|Withdrawal by Subject|1
841910|NCT01133756|2675721|P1|Overall Study|Withdrawal by Subject|0
841911|NCT01133756|2675719|P3|Overall Study|Investigator Decision|0
841912|NCT01133756|2675720|P2|Overall Study|Investigator Decision|0
841913|NCT01133756|2675721|P1|Overall Study|Investigator Decision|1
841914|NCT01133756|2675719|P3|Overall Study|Adverse Event|1
841915|NCT01133756|2675720|P2|Overall Study|Adverse Event|2
841916|NCT01133756|2675721|P1|Overall Study|Adverse Event|1
841917|NCT01133821|2675737|P2|Overall Study|Refused participation|3
841918|NCT01133821|2675738|P1|Overall Study|Refused participation|1
841919|NCT01133821|2675737|P2|Overall Study|Protocol Violation|1
841920|NCT01133821|2675738|P1|Overall Study|Protocol Violation|0
841921|NCT01133821|2675737|P2|Overall Study|preferred other treatment|1
841922|NCT01133821|2675738|P1|Overall Study|preferred other treatment|1
841923|NCT01133821|2675737|P2|Overall Study|Withdrawal by Subject|3
841924|NCT01133821|2675738|P1|Overall Study|Withdrawal by Subject|8
841925|NCT01133821|2675737|P2|Overall Study|Lost to Follow-up|11
841926|NCT01133821|2675738|P1|Overall Study|Lost to Follow-up|8
841927|NCT01133847|2675747|P3|Follow-Up Phase|Lost to Follow-up|7
841928|NCT01133847|2675748|P2|Follow-Up Phase|Lost to Follow-up|3
841929|NCT01133847|2675749|P1|Follow-Up Phase|Lost to Follow-up|1
841930|NCT01133847|2675747|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
841931|NCT01133847|2675748|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
841932|NCT01133847|2675749|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
841933|NCT01133977|2675799|P5|Overall Study|Withdrawal by Subject|1
841934|NCT01133977|2675800|P4|Overall Study|Withdrawal by Subject|5
841935|NCT01133977|2675801|P3|Overall Study|Withdrawal by Subject|0
841936|NCT01133977|2675802|P2|Overall Study|Withdrawal by Subject|0
841937|NCT01133977|2675803|P1|Overall Study|Withdrawal by Subject|0
841938|NCT01133977|2675799|P5|Overall Study|Lost to Follow-up|1
841939|NCT01133977|2675800|P4|Overall Study|Lost to Follow-up|2
841940|NCT01133977|2675801|P3|Overall Study|Lost to Follow-up|0
841941|NCT01133977|2675802|P2|Overall Study|Lost to Follow-up|0
841942|NCT01133977|2675803|P1|Overall Study|Lost to Follow-up|0
841943|NCT01133977|2675799|P5|Overall Study|Started a New Line of Therapy|33
841944|NCT01133977|2675800|P4|Overall Study|Started a New Line of Therapy|25
841945|NCT01133977|2675801|P3|Overall Study|Started a New Line of Therapy|4
841946|NCT01133977|2675802|P2|Overall Study|Started a New Line of Therapy|6
841947|NCT01133977|2675803|P1|Overall Study|Started a New Line of Therapy|2
841948|NCT01133977|2675799|P5|Overall Study|Death|3
841949|NCT01133977|2675800|P4|Overall Study|Death|7
841950|NCT01133977|2675801|P3|Overall Study|Death|1
841951|NCT01133977|2675802|P2|Overall Study|Death|1
841952|NCT01133977|2675803|P1|Overall Study|Death|1
841953|NCT01133977|2675799|P5|Overall Study|Adverse Event|0
841954|NCT01133977|2675800|P4|Overall Study|Adverse Event|0
841955|NCT01133977|2675801|P3|Overall Study|Adverse Event|1
841956|NCT01133977|2675802|P2|Overall Study|Adverse Event|0
841957|NCT01133977|2675803|P1|Overall Study|Adverse Event|0
841958|NCT01134042|2675856|P3|Overall Study|Withdrawal by Subject|7
841959|NCT01134042|2675857|P2|Overall Study|Withdrawal by Subject|4
841960|NCT01134042|2675858|P1|Overall Study|Withdrawal by Subject|13
841961|NCT01134042|2675856|P3|Overall Study|Physician Decision|1
841962|NCT01134042|2675857|P2|Overall Study|Physician Decision|8
841963|NCT01134042|2675858|P1|Overall Study|Physician Decision|4
841964|NCT01134042|2675856|P3|Overall Study|Lost to Follow-up|1
841965|NCT01134042|2675857|P2|Overall Study|Lost to Follow-up|0
841966|NCT01134042|2675858|P1|Overall Study|Lost to Follow-up|2
841967|NCT01134042|2675856|P3|Overall Study|Protocol Violation|5
841968|NCT01134042|2675857|P2|Overall Study|Protocol Violation|3
841969|NCT01134042|2675858|P1|Overall Study|Protocol Violation|5
841970|NCT01134042|2675856|P3|Overall Study|Lack of Efficacy|18
841971|NCT01134042|2675857|P2|Overall Study|Lack of Efficacy|6
841972|NCT01134042|2675858|P1|Overall Study|Lack of Efficacy|21
841973|NCT01134042|2675856|P3|Overall Study|Adverse Event|2
841974|NCT01134042|2675857|P2|Overall Study|Adverse Event|7
841975|NCT01134042|2675858|P1|Overall Study|Adverse Event|3
841976|NCT01134107|2675906|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
841977|NCT01134107|2675907|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
841978|NCT01134107|2675906|P2|Period 2-Second Treatment Intervention|Physician Decision|0
841979|NCT01134107|2675907|P1|Period 2-Second Treatment Intervention|Physician Decision|1
841980|NCT01134107|2675906|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
841981|NCT01134107|2675907|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
841982|NCT01134107|2675906|P2|Period 1-First Treatment Intervention|Physician Decision|0
841983|NCT01134107|2675907|P1|Period 1-First Treatment Intervention|Physician Decision|1
841984|NCT01134107|2675906|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
841985|NCT01134107|2675907|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
841986|NCT01134107|2675906|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
841987|NCT01134107|2675907|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
841988|NCT01134107|2675906|P2|Period 1-First Treatment Intervention|Adverse Event|0
841989|NCT01134107|2675907|P1|Period 1-First Treatment Intervention|Adverse Event|1
841990|NCT01126268|2675939|P1|Overall Study|Adverse Event|1
841991|NCT01134315|2675976|P2|Overall Study|Other Reason|17
841992|NCT01134315|2675977|P1|Overall Study|Other Reason|8
841993|NCT01134315|2675976|P2|Overall Study|Adverse Event|2
841994|NCT01134315|2675977|P1|Overall Study|Adverse Event|1
841995|NCT01134393|2676102|P1|Overall Study|Other|6
841996|NCT01134393|2676102|P1|Overall Study|Withdrawal by Subject|11
841997|NCT01134393|2676102|P1|Overall Study|Lost to Follow-up|3
841998|NCT01134393|2676102|P1|Overall Study|Protocol Violation|12
841999|NCT01134393|2676102|P1|Overall Study|Lack of Efficacy|2
842000|NCT01134393|2676102|P1|Overall Study|Adverse Event|18
842001|NCT01135992|2676131|P1|Overall Study|Unclassified|7
842002|NCT01135992|2676131|P1|Overall Study|Withdrawal criteria|10
842003|NCT01135992|2676131|P1|Overall Study|Protocol Violation|2
842004|NCT01135992|2676131|P1|Overall Study|Lack of Efficacy|1
842005|NCT01135992|2676131|P1|Overall Study|Adverse Event|1
842006|NCT01136174|2676144|P4|Overall Study|Adverse Event|4
842007|NCT01136174|2676145|P3|Overall Study|Adverse Event|0
842008|NCT01136174|2676146|P2|Overall Study|Adverse Event|0
842009|NCT01136174|2676147|P1|Overall Study|Adverse Event|0
842010|NCT01136291|2676233|P2|Overall Study|Lost to Follow-up|1
842011|NCT01136291|2676234|P1|Overall Study|Lost to Follow-up|1
842012|NCT01136356|2676244|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
842013|NCT01136356|2676245|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
842014|NCT01136356|2676244|P2|First 18-day Withdrawal|Physician Decision|0
842015|NCT01136356|2676245|P1|First 18-day Withdrawal|Physician Decision|1
842016|NCT01136356|2676244|P2|First 18-day Withdrawal|Withdrawal by Subject|0
842017|NCT01136356|2676245|P1|First 18-day Withdrawal|Withdrawal by Subject|3
842018|NCT01136382|2676256|P2|Overall Study|Withdrawal by Subject|1
842019|NCT01136382|2676257|P1|Overall Study|Withdrawal by Subject|4
842020|NCT01136382|2676256|P2|Overall Study|Severe Non-Compliance to Protocol|2
842021|NCT01136382|2676257|P1|Overall Study|Severe Non-Compliance to Protocol|0
842022|NCT01136382|2676256|P2|Overall Study|Study-Specific Withdrawal Criteria|25
842023|NCT01136382|2676257|P1|Overall Study|Study-Specific Withdrawal Criteria|48
842024|NCT01136382|2676256|P2|Overall Study|Not Specified|3
842025|NCT01136382|2676257|P1|Overall Study|Not Specified|8
842026|NCT01136408|2676286|P3|Overall Study|Protocol Violation|1
842027|NCT01136408|2676287|P2|Overall Study|Protocol Violation|1
842028|NCT01136408|2676288|P1|Overall Study|Protocol Violation|1
842029|NCT01136408|2676286|P3|Overall Study|Adverse Event|4
842030|NCT01136408|2676287|P2|Overall Study|Adverse Event|8
842031|NCT01136408|2676288|P1|Overall Study|Adverse Event|4
842032|NCT01136655|2676347|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
842033|NCT01136655|2676347|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
842034|NCT01136655|2676347|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
842035|NCT01136655|2676347|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
842036|NCT01136746|2676375|P2|Overall Study|Death|0
842037|NCT01136746|2676376|P1|Overall Study|Death|1
842038|NCT01136746|2676375|P2|Overall Study|Protocol Violation|1
842039|NCT01136746|2676376|P1|Overall Study|Protocol Violation|2
842040|NCT01136746|2676375|P2|Overall Study|Lost to Follow-up|2
842041|NCT01136746|2676376|P1|Overall Study|Lost to Follow-up|0
842042|NCT01136772|2676438|P2|Overall Study|Did not follow up after first injection|2
842043|NCT01136772|2676439|P1|Overall Study|Did not follow up after first injection|2
842044|NCT01136772|2676438|P2|Overall Study|Did not receive injection|7
842045|NCT01136772|2676439|P1|Overall Study|Did not receive injection|10
842046|NCT01136772|2676438|P2|Overall Study|Withdrawal by Subject|36
842047|NCT01136772|2676439|P1|Overall Study|Withdrawal by Subject|33
842048|NCT01136772|2676438|P2|Overall Study|Administrative|12
842049|NCT01136772|2676439|P1|Overall Study|Administrative|14
842050|NCT01136772|2676438|P2|Overall Study|Lack of Efficacy|39
842051|NCT01136772|2676439|P1|Overall Study|Lack of Efficacy|42
842052|NCT01136772|2676438|P2|Overall Study|Adverse Event|14
842053|NCT01136772|2676439|P1|Overall Study|Adverse Event|15
842054|NCT01136785|2676449|P2|Overall Study|Protocol Violation|1
842055|NCT01136785|2676450|P1|Overall Study|Protocol Violation|2
842056|NCT01136876|2676465|P2|Overall Study|Physician Decision|5
842057|NCT01136876|2676466|P1|Overall Study|Physician Decision|3
842058|NCT01136876|2676465|P2|Overall Study|Lost to Follow-up|1
842059|NCT01136876|2676466|P1|Overall Study|Lost to Follow-up|0
842060|NCT01136915|2676476|P2|Overall Study|Exclusion criterion met|1
842061|NCT01136915|2676477|P1|Overall Study|Exclusion criterion met|0
842062|NCT01136915|2676476|P2|Overall Study|Lost to Follow-up|0
842063|NCT01136915|2676477|P1|Overall Study|Lost to Follow-up|2
842064|NCT01136954|2676487|P2|Overall Study|Not Specified|3
842065|NCT01136954|2676488|P1|Overall Study|Not Specified|1
842066|NCT01136954|2676487|P2|Overall Study|Physician Decision|1
842067|NCT01136954|2676488|P1|Overall Study|Physician Decision|0
842068|NCT01136954|2676487|P2|Overall Study|Lack of Efficacy|13
842069|NCT01136954|2676488|P1|Overall Study|Lack of Efficacy|14
842070|NCT01136954|2676487|P2|Overall Study|Withdrawal by Subject|2
842071|NCT01136954|2676488|P1|Overall Study|Withdrawal by Subject|6
842072|NCT01136954|2676487|P2|Overall Study|Adverse Event|2
842073|NCT01136954|2676488|P1|Overall Study|Adverse Event|3
842074|NCT01136967|2676502|P2|Overall Study|Diagnosis of Second Primary Cancer|1
842075|NCT01136967|2676503|P1|Overall Study|Diagnosis of Second Primary Cancer|0
842076|NCT01136967|2676502|P2|Overall Study|Increase in Lesion Size|2
842077|NCT01136967|2676503|P1|Overall Study|Increase in Lesion Size|0
842078|NCT01136967|2676502|P2|Overall Study|Investigator's Choice|1
842079|NCT01136967|2676503|P1|Overall Study|Investigator's Choice|1
842080|NCT01136967|2676502|P2|Overall Study|Non Compliance|0
842081|NCT01136967|2676503|P1|Overall Study|Non Compliance|1
842082|NCT01136967|2676502|P2|Overall Study|Radiation|0
842083|NCT01136967|2676503|P1|Overall Study|Radiation|1
842084|NCT01136967|2676502|P2|Overall Study|Clinical Progression|5
842085|NCT01136967|2676503|P1|Overall Study|Clinical Progression|3
842086|NCT01136967|2676502|P2|Overall Study|Withdrawal by Subject|2
842087|NCT01136967|2676503|P1|Overall Study|Withdrawal by Subject|1
842088|NCT01136967|2676502|P2|Overall Study|Lost to Follow-up|1
842089|NCT01136967|2676503|P1|Overall Study|Lost to Follow-up|0
842090|NCT01136967|2676502|P2|Overall Study|Participant Choice|3
842091|NCT01136967|2676503|P1|Overall Study|Participant Choice|8
842092|NCT01136967|2676502|P2|Overall Study|Adverse Event|12
842093|NCT01136967|2676503|P1|Overall Study|Adverse Event|9
842094|NCT01137071|2676525|P1|Overall Study|Wrongly Included|1
842095|NCT01137071|2676525|P1|Overall Study|Withdrawal by Subject|2
842096|NCT01137071|2676525|P1|Overall Study|Disease Progression|11
842097|NCT01137292|2676586|P1|Overall Study|Unspecified|7
842098|NCT01137292|2676586|P1|Overall Study|Lost to Follow-up|1
842099|NCT01137292|2676586|P1|Overall Study|Lack of Efficacy|13
842100|NCT01137292|2676586|P1|Overall Study|Adverse Event|3
842101|NCT01137292|2676586|P1|Overall Study|Death|30
842102|NCT01137435|2676613|P1|Overall Study|Off label usage|4
842103|NCT01137435|2676613|P1|Overall Study|Lost to Follow-up|24
842104|NCT01137474|2676624|P4|Overall Study|Administrative reason by sponsor|0
842105|NCT01137474|2676625|P3|Overall Study|Administrative reason by sponsor|0
842106|NCT01137474|2676626|P2|Overall Study|Administrative reason by sponsor|1
842107|NCT01137474|2676627|P1|Overall Study|Administrative reason by sponsor|0
842108|NCT01137474|2676624|P4|Overall Study|Pregnancy|0
842109|NCT01137474|2676625|P3|Overall Study|Pregnancy|0
842110|NCT01137474|2676626|P2|Overall Study|Pregnancy|1
842111|NCT01137474|2676627|P1|Overall Study|Pregnancy|0
842112|NCT01137474|2676624|P4|Overall Study|Not specified|0
842113|NCT01137474|2676625|P3|Overall Study|Not specified|0
842114|NCT01137474|2676626|P2|Overall Study|Not specified|1
842115|NCT01137474|2676627|P1|Overall Study|Not specified|3
842116|NCT01137474|2676624|P4|Overall Study|Lack of Efficacy|2
842117|NCT01137474|2676625|P3|Overall Study|Lack of Efficacy|0
842118|NCT01137474|2676626|P2|Overall Study|Lack of Efficacy|0
842119|NCT01137474|2676627|P1|Overall Study|Lack of Efficacy|0
842120|NCT01137474|2676624|P4|Overall Study|Lost to Follow-up|2
842121|NCT01137474|2676625|P3|Overall Study|Lost to Follow-up|0
842122|NCT01137474|2676626|P2|Overall Study|Lost to Follow-up|1
842123|NCT01137474|2676627|P1|Overall Study|Lost to Follow-up|5
842124|NCT01137474|2676624|P4|Overall Study|No longer met study criteria|5
842125|NCT01137474|2676625|P3|Overall Study|No longer met study criteria|0
842126|NCT01137474|2676626|P2|Overall Study|No longer met study criteria|1
842127|NCT01137474|2676627|P1|Overall Study|No longer met study criteria|6
842128|NCT01137474|2676624|P4|Overall Study|Withdrawal by Subject|9
842129|NCT01137474|2676625|P3|Overall Study|Withdrawal by Subject|6
842130|NCT01137474|2676626|P2|Overall Study|Withdrawal by Subject|2
842131|NCT01137474|2676627|P1|Overall Study|Withdrawal by Subject|7
842132|NCT01137474|2676624|P4|Overall Study|Adverse Event|3
842133|NCT01137474|2676625|P3|Overall Study|Adverse Event|1
842134|NCT01137474|2676626|P2|Overall Study|Adverse Event|5
842135|NCT01137474|2676627|P1|Overall Study|Adverse Event|3
842136|NCT01137578|2676650|P3|Overall Study|Not Specified|6
842137|NCT01137578|2676651|P2|Overall Study|Not Specified|2
842138|NCT01137578|2676652|P1|Overall Study|Not Specified|12
842139|NCT01137578|2676650|P3|Overall Study|Withdrawal by Subject|0
842140|NCT01137578|2676651|P2|Overall Study|Withdrawal by Subject|0
842141|NCT01137578|2676652|P1|Overall Study|Withdrawal by Subject|1
842142|NCT01137578|2676650|P3|Overall Study|Participant requested to Discontinue|0
842143|NCT01137578|2676651|P2|Overall Study|Participant requested to Discontinue|0
842144|NCT01137578|2676652|P1|Overall Study|Participant requested to Discontinue|3
842145|NCT01137604|2676696|P4|Overall Study|Clinical Decline|1
842146|NCT01137604|2676697|P3|Overall Study|Clinical Decline|1
842147|NCT01137604|2676698|P2|Overall Study|Clinical Decline|0
842148|NCT01137604|2676699|P1|Overall Study|Clinical Decline|0
842149|NCT01137604|2676696|P4|Overall Study|Participant's Decision|0
842150|NCT01137604|2676697|P3|Overall Study|Participant's Decision|0
842151|NCT01137604|2676698|P2|Overall Study|Participant's Decision|0
842152|NCT01137604|2676699|P1|Overall Study|Participant's Decision|1
842153|NCT01137604|2676696|P4|Overall Study|Clinical Progression|0
842154|NCT01137604|2676697|P3|Overall Study|Clinical Progression|1
842155|NCT01137604|2676698|P2|Overall Study|Clinical Progression|2
842156|NCT01137604|2676699|P1|Overall Study|Clinical Progression|0
842157|NCT01137604|2676696|P4|Overall Study|Withdrawal by Subject|1
842158|NCT01137604|2676697|P3|Overall Study|Withdrawal by Subject|2
842159|NCT01137604|2676698|P2|Overall Study|Withdrawal by Subject|2
842160|NCT01137604|2676699|P1|Overall Study|Withdrawal by Subject|0
842161|NCT01137604|2676696|P4|Overall Study|Adverse Event|9
842162|NCT01137604|2676697|P3|Overall Study|Adverse Event|9
842163|NCT01137604|2676698|P2|Overall Study|Adverse Event|6
842164|NCT01137604|2676699|P1|Overall Study|Adverse Event|1
842165|NCT01137682|2676736|P3|Overall Study|Protocol Violation|1
842166|NCT01137682|2676737|P2|Overall Study|Protocol Violation|1
842167|NCT01137682|2676738|P1|Overall Study|Protocol Violation|0
842168|NCT01137682|2676736|P3|Overall Study|Administrative Problems|0
842169|NCT01137682|2676737|P2|Overall Study|Administrative Problems|1
842170|NCT01137682|2676738|P1|Overall Study|Administrative Problems|2
842171|NCT01137682|2676736|P3|Overall Study|Withdrawal by Subject|2
842172|NCT01137682|2676737|P2|Overall Study|Withdrawal by Subject|2
842173|NCT01137682|2676738|P1|Overall Study|Withdrawal by Subject|2
842174|NCT01137682|2676736|P3|Overall Study|Adverse Event|0
842175|NCT01137682|2676737|P2|Overall Study|Adverse Event|4
842176|NCT01137682|2676738|P1|Overall Study|Adverse Event|2
842177|NCT01137773|2676751|P2|Overall Study|Lost to Follow-up|0
842178|NCT01137773|2676752|P1|Overall Study|Lost to Follow-up|6
842179|NCT01137773|2676751|P2|Overall Study|Death|3
842180|NCT01137773|2676752|P1|Overall Study|Death|3
842181|NCT01137786|2676762|P2|Overall Study|Withdrawal by Subject|1
842182|NCT01137786|2676763|P1|Overall Study|Withdrawal by Subject|1
842183|NCT01137786|2676762|P2|Overall Study|Lost to Follow-up|2
842184|NCT01137786|2676763|P1|Overall Study|Lost to Follow-up|0
842185|NCT01137812|2676773|P2|Overall Study|Not specified|27
842186|NCT01137812|2676774|P1|Overall Study|Not specified|19
842187|NCT01137812|2676773|P2|Overall Study|Patient met glycemic withdrawal criteria|85
842188|NCT01137812|2676774|P1|Overall Study|Patient met glycemic withdrawal criteria|40
842189|NCT01137812|2676773|P2|Overall Study|Death|0
842190|NCT01137812|2676774|P1|Overall Study|Death|2
842191|NCT01137812|2676773|P2|Overall Study|Withdrawal by Subject|13
842192|NCT01137812|2676774|P1|Overall Study|Withdrawal by Subject|5
842193|NCT01137812|2676773|P2|Overall Study|Protocol Violation|4
842194|NCT01137812|2676774|P1|Overall Study|Protocol Violation|5
842195|NCT01137812|2676773|P2|Overall Study|Physician Decision|17
842196|NCT01137812|2676774|P1|Overall Study|Physician Decision|25
842197|NCT01137812|2676773|P2|Overall Study|Lost to Follow-up|8
842198|NCT01137812|2676774|P1|Overall Study|Lost to Follow-up|6
842199|NCT01137812|2676773|P2|Overall Study|Adverse Event|14
842200|NCT01137812|2676774|P1|Overall Study|Adverse Event|21
842201|NCT01138007|2676868|P3|Overall Study|Withdrawal by Subject|15
842202|NCT01138007|2676869|P2|Overall Study|Withdrawal by Subject|6
842203|NCT01138007|2676870|P1|Overall Study|Withdrawal by Subject|5
842204|NCT01138007|2676868|P3|Overall Study|Physician Decision|3
842205|NCT01138007|2676869|P2|Overall Study|Physician Decision|5
842206|NCT01138007|2676870|P1|Overall Study|Physician Decision|0
842207|NCT01138007|2676868|P3|Overall Study|Lost to Follow-up|5
842208|NCT01138007|2676869|P2|Overall Study|Lost to Follow-up|3
842209|NCT01138007|2676870|P1|Overall Study|Lost to Follow-up|3
842210|NCT01138007|2676868|P3|Overall Study|Protocol-Defined Stopping Criteria|8
842211|NCT01138007|2676869|P2|Overall Study|Protocol-Defined Stopping Criteria|1
842212|NCT01138007|2676870|P1|Overall Study|Protocol-Defined Stopping Criteria|6
842213|NCT01138007|2676868|P3|Overall Study|Protocol Violation|2
842214|NCT01138007|2676869|P2|Overall Study|Protocol Violation|3
842215|NCT01138007|2676870|P1|Overall Study|Protocol Violation|2
842216|NCT01138007|2676868|P3|Overall Study|Lack of Efficacy|6
842217|NCT01138007|2676869|P2|Overall Study|Lack of Efficacy|0
842218|NCT01138007|2676870|P1|Overall Study|Lack of Efficacy|2
842219|NCT01138007|2676868|P3|Overall Study|Adverse Event|9
842220|NCT01138007|2676869|P2|Overall Study|Adverse Event|12
842221|NCT01138007|2676870|P1|Overall Study|Adverse Event|4
842222|NCT01138046|2676902|P1|Overall Study|Withdrawal due to death|6
842223|NCT01138111|2676944|P1|Overall Study|Lost to Follow-up|2
842224|NCT01138111|2676944|P1|Overall Study|Death|1
842225|NCT01138111|2676944|P1|Overall Study|Adverse Event|1
842226|NCT01138111|2676944|P1|Overall Study|Withdrawal by Subject|5
842227|NCT01138150|2677004|P2|Overall Study|Physician Decision|0
842228|NCT01138150|2677005|P1|Overall Study|Physician Decision|1
842229|NCT01138150|2677004|P2|Overall Study|blood unable to be processed|1
842230|NCT01138150|2677005|P1|Overall Study|blood unable to be processed|0
842231|NCT01129284|2677077|P3|Overall Study|Adverse Event|1
842232|NCT01129284|2677078|P2|Overall Study|Adverse Event|0
842233|NCT01129284|2677079|P1|Overall Study|Adverse Event|2
842234|NCT01129336|2677092|P2|Overall Study|Death|4
842235|NCT01129336|2677093|P1|Overall Study|Death|0
842236|NCT01129336|2677092|P2|Overall Study|Missing Study Completion Status|3
842237|NCT01129336|2677093|P1|Overall Study|Missing Study Completion Status|2
842238|NCT01129336|2677092|P2|Overall Study|Adverse Event|1
842239|NCT01129336|2677093|P1|Overall Study|Adverse Event|0
842240|NCT01129336|2677092|P2|Overall Study|Withdrawal by Subject|4
842241|NCT01129336|2677093|P1|Overall Study|Withdrawal by Subject|7
842242|NCT01129336|2677092|P2|Overall Study|Lost to Follow-up|0
842243|NCT01129336|2677093|P1|Overall Study|Lost to Follow-up|1
842244|NCT01129336|2677092|P2|Overall Study|Disease Progression|4
842245|NCT01129336|2677093|P1|Overall Study|Disease Progression|1
842246|NCT01129336|2677092|P2|Overall Study|Protocol Violation|0
842247|NCT01129336|2677093|P1|Overall Study|Protocol Violation|1
842248|NCT01129557|2677133|P3|Overall Study|Novartis terminated study early|2
842249|NCT01129557|2677134|P2|Overall Study|Novartis terminated study early|3
842250|NCT01129557|2677135|P1|Overall Study|Novartis terminated study early|3
842251|NCT01129557|2677133|P3|Overall Study|Adverse Event|2
842252|NCT01129557|2677134|P2|Overall Study|Adverse Event|2
842253|NCT01129557|2677135|P1|Overall Study|Adverse Event|1
842254|NCT01129583|2677205|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
842255|NCT01129583|2677206|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
842256|NCT01129583|2677205|P2|Overall Study|Lost to Follow-up|1
842257|NCT01129583|2677206|P1|Overall Study|Lost to Follow-up|1
842258|NCT01129583|2677205|P2|Overall Study|Death|0
842259|NCT01129583|2677206|P1|Overall Study|Death|1
842260|NCT01129622|2677216|P1|Overall Study|Withdrawal by Subject|2
842261|NCT01129921|2677237|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
842262|NCT01129921|2677238|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
842263|NCT01129921|2677237|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
842264|NCT01129921|2677238|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
842265|NCT01129921|2677237|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
842266|NCT01129921|2677238|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
842267|NCT01129921|2677237|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
842268|NCT01129921|2677238|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
842269|NCT01129960|2677252|P4|Overall Study|Pregnancy|0
842270|NCT01129960|2677253|P3|Overall Study|Pregnancy|0
842271|NCT01129960|2677254|P2|Overall Study|Pregnancy|0
842272|NCT01129960|2677255|P1|Overall Study|Pregnancy|1
842273|NCT01129960|2677252|P4|Overall Study|Physician Decision|0
842274|NCT01129960|2677253|P3|Overall Study|Physician Decision|0
842275|NCT01129960|2677254|P2|Overall Study|Physician Decision|0
842276|NCT01129960|2677255|P1|Overall Study|Physician Decision|1
842277|NCT01129960|2677252|P4|Overall Study|Discontinuation of the study by Sponsor|0
842278|NCT01129960|2677253|P3|Overall Study|Discontinuation of the study by Sponsor|0
842279|NCT01129960|2677254|P2|Overall Study|Discontinuation of the study by Sponsor|1
842280|NCT01129960|2677255|P1|Overall Study|Discontinuation of the study by Sponsor|0
842281|NCT01129960|2677252|P4|Overall Study|Lost to Follow-up|3
842282|NCT01129960|2677253|P3|Overall Study|Lost to Follow-up|3
842283|NCT01129960|2677254|P2|Overall Study|Lost to Follow-up|2
842284|NCT01129960|2677255|P1|Overall Study|Lost to Follow-up|0
842285|NCT01129960|2677252|P4|Overall Study|Protocol Violation|0
842286|NCT01129960|2677253|P3|Overall Study|Protocol Violation|3
842287|NCT01129960|2677254|P2|Overall Study|Protocol Violation|2
842288|NCT01129960|2677255|P1|Overall Study|Protocol Violation|1
842289|NCT01129960|2677252|P4|Overall Study|Adverse Event|7
842290|NCT01129960|2677253|P3|Overall Study|Adverse Event|16
842291|NCT01129960|2677254|P2|Overall Study|Adverse Event|16
842292|NCT01129960|2677255|P1|Overall Study|Adverse Event|23
842293|NCT01129960|2677252|P4|Overall Study|Lack of Efficacy|1
842294|NCT01129960|2677253|P3|Overall Study|Lack of Efficacy|1
842295|NCT01129960|2677254|P2|Overall Study|Lack of Efficacy|1
842296|NCT01129960|2677255|P1|Overall Study|Lack of Efficacy|1
842297|NCT01129960|2677252|P4|Overall Study|Withdrawal by Subject|2
842298|NCT01129960|2677253|P3|Overall Study|Withdrawal by Subject|3
842299|NCT01129960|2677254|P2|Overall Study|Withdrawal by Subject|0
842300|NCT01129960|2677255|P1|Overall Study|Withdrawal by Subject|3
842301|NCT01130051|2677265|P2|Washout Period of 14 Days|Protocol Violation|1
842302|NCT01130051|2677266|P1|Washout Period of 14 Days|Protocol Violation|1
842303|NCT01130051|2677265|P2|Washout Period of 14 Days|Withdrawal by Subject|1
842304|NCT01130051|2677266|P1|Washout Period of 14 Days|Withdrawal by Subject|0
842305|NCT01130103|2677278|P2|Maintenance Treatment|Withdrawal by Subject|0
842306|NCT01130103|2677279|P1|Maintenance Treatment|Withdrawal by Subject|1
842307|NCT01130103|2677278|P2|Maintenance Treatment|Lost to Follow-up|1
842308|NCT01130103|2677279|P1|Maintenance Treatment|Lost to Follow-up|1
842309|NCT01130103|2677278|P2|Maintenance Treatment|Lack of Efficacy|1
842310|NCT01130103|2677279|P1|Maintenance Treatment|Lack of Efficacy|0
842311|NCT01130103|2677278|P2|Randomized Treatment|Withdrawal by Subject|2
842312|NCT01130103|2677279|P1|Randomized Treatment|Withdrawal by Subject|1
842313|NCT01130103|2677278|P2|Randomized Treatment|Protocol Violation|2
842314|NCT01130103|2677279|P1|Randomized Treatment|Protocol Violation|3
842315|NCT01130103|2677278|P2|Randomized Treatment|Lost to Follow-up|0
842316|NCT01130103|2677279|P1|Randomized Treatment|Lost to Follow-up|1
842317|NCT01130103|2677278|P2|Randomized Treatment|Adverse Event|1
842318|NCT01130103|2677279|P1|Randomized Treatment|Adverse Event|1
842319|NCT01130168|2677293|P6|Period 1|Adverse Event|0
842320|NCT01130168|2677294|P5|Period 1|Adverse Event|0
842321|NCT01130168|2677295|P4|Period 1|Adverse Event|1
842322|NCT01130168|2677296|P3|Period 1|Adverse Event|0
842323|NCT01130168|2677297|P2|Period 1|Adverse Event|0
842324|NCT01130168|2677298|P1|Period 1|Adverse Event|0
842325|NCT01130168|2677293|P6|Period 1|Discontinued For Other Reason|0
842326|NCT01130168|2677294|P5|Period 1|Discontinued For Other Reason|0
842327|NCT01130168|2677295|P4|Period 1|Discontinued For Other Reason|1
842328|NCT01130168|2677296|P3|Period 1|Discontinued For Other Reason|1
842329|NCT01130168|2677297|P2|Period 1|Discontinued For Other Reason|0
842330|NCT01130168|2677298|P1|Period 1|Discontinued For Other Reason|0
842331|NCT01130168|2677293|P6|Period 1|Withdrawal by Subject|0
842332|NCT01130168|2677294|P5|Period 1|Withdrawal by Subject|0
842333|NCT01130168|2677295|P4|Period 1|Withdrawal by Subject|1
842334|NCT01130168|2677296|P3|Period 1|Withdrawal by Subject|0
842335|NCT01130168|2677297|P2|Period 1|Withdrawal by Subject|1
842336|NCT01130168|2677298|P1|Period 1|Withdrawal by Subject|0
842337|NCT01130337|2677333|P1|Overall Study|Surgical resection (R2)|1
842338|NCT01130337|2677333|P1|Overall Study|Toxicity, AE/intercurrent disease|7
842339|NCT01130337|2677333|P1|Overall Study|Disease progression|1
842340|NCT01130337|2677333|P1|Overall Study|Death|1
842341|NCT01130337|2677333|P1|Overall Study|Principal investigator decision|1
842342|NCT01130337|2677333|P1|Overall Study|Withdrawal by Subject|3
894016|NCT00733980|2836876|P2|Overall Study|Withdrawal by Subject|2
894017|NCT00733980|2836877|P1|Overall Study|Withdrawal by Subject|6
894018|NCT00733980|2836876|P2|Overall Study|Physician Decision|3
894019|NCT00733980|2836877|P1|Overall Study|Physician Decision|2
894020|NCT00733980|2836876|P2|Overall Study|Lost to Follow-up|11
894021|NCT00733980|2836877|P1|Overall Study|Lost to Follow-up|6
894022|NCT00733980|2836876|P2|Overall Study|Protocol defined stopping criteria reach|1
894023|NCT00733980|2836877|P1|Overall Study|Protocol defined stopping criteria reach|1
894024|NCT00733980|2836876|P2|Overall Study|Protocol Violation|1
894025|NCT00733980|2836877|P1|Overall Study|Protocol Violation|2
894026|NCT00733980|2836876|P2|Overall Study|Lack of Efficacy|1
894027|NCT00733980|2836877|P1|Overall Study|Lack of Efficacy|0
894028|NCT00733980|2836876|P2|Overall Study|Adverse Event|2
894029|NCT00733980|2836877|P1|Overall Study|Adverse Event|5
842371|NCT01130532|2677361|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
842372|NCT01130532|2677362|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
842373|NCT01130532|2677363|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
842374|NCT01130532|2677364|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
842375|NCT01130532|2677361|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
842376|NCT01130532|2677362|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
842377|NCT01130532|2677363|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
842378|NCT01130532|2677364|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
842379|NCT01130532|2677361|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
842380|NCT01130532|2677362|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
842381|NCT01130532|2677363|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
842382|NCT01130532|2677364|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
842383|NCT01130532|2677361|P4|Period IV (Weeks 13-16)|Adverse Event|1
842384|NCT01130532|2677362|P3|Period IV (Weeks 13-16)|Adverse Event|0
842385|NCT01130532|2677363|P2|Period IV (Weeks 13-16)|Adverse Event|0
842386|NCT01130532|2677364|P1|Period IV (Weeks 13-16)|Adverse Event|0
842387|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
842388|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
842389|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
842390|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
842391|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Sponsor Decision|0
842392|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Sponsor Decision|2
842393|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Sponsor Decision|4
842394|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Sponsor Decision|3
842395|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Protocol Violation|0
842396|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Protocol Violation|1
842397|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Protocol Violation|0
842398|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Protocol Violation|0
842399|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
842400|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
842401|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
842402|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
842403|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
842404|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
842405|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
842406|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
842407|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
842408|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
842409|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
842410|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
842411|NCT01130532|2677361|P4|Period III (Weeks 0-12)|Adverse Event|0
842412|NCT01130532|2677362|P3|Period III (Weeks 0-12)|Adverse Event|2
842413|NCT01130532|2677363|P2|Period III (Weeks 0-12)|Adverse Event|3
842414|NCT01130532|2677364|P1|Period III (Weeks 0-12)|Adverse Event|3
842415|NCT01130597|2677409|P1|Overall Study|Protocol Violation|1
842416|NCT01130597|2677409|P1|Overall Study|Death|1
842417|NCT01130597|2677409|P1|Overall Study|Adverse Event|4
842418|NCT01130597|2677409|P1|Overall Study|Protocol-specified (High K+)|1
842419|NCT01130831|2677444|P1|Overall Study|Information was missing|3
842420|NCT01130831|2677444|P1|Overall Study|Death|4
842421|NCT01130831|2677444|P1|Overall Study|Withdrawal by Subject|7
842422|NCT01130883|2677513|P1|Overall Study|Adverse Event|3
842423|NCT01130883|2677513|P1|Overall Study|Reason Unknown|1
842424|NCT01130883|2677513|P1|Overall Study|Patient Noncompliance|6
842425|NCT01130974|2677529|P2|Overall Study|Ineligibility criteria|2
842426|NCT01130974|2677530|P1|Overall Study|Ineligibility criteria|5
842427|NCT01130974|2677529|P2|Overall Study|Withdrawal by Subject|1
842428|NCT01130974|2677530|P1|Overall Study|Withdrawal by Subject|0
842429|NCT01130974|2677529|P2|Overall Study|Protocol Violation|10
842430|NCT01130974|2677530|P1|Overall Study|Protocol Violation|10
842431|NCT01131078|2677582|P3|Overall Study|Other|0
842432|NCT01131078|2677583|P2|Overall Study|Other|1
842433|NCT01131078|2677584|P1|Overall Study|Other|0
842434|NCT01131078|2677582|P3|Overall Study|Death|2
842435|NCT01131078|2677583|P2|Overall Study|Death|0
842436|NCT01131078|2677584|P1|Overall Study|Death|4
842437|NCT01131078|2677582|P3|Overall Study|Physician Decision|8
842438|NCT01131078|2677583|P2|Overall Study|Physician Decision|6
842439|NCT01131078|2677584|P1|Overall Study|Physician Decision|10
842440|NCT01131078|2677582|P3|Overall Study|Non-compliance|0
842441|NCT01131078|2677583|P2|Overall Study|Non-compliance|0
842442|NCT01131078|2677584|P1|Overall Study|Non-compliance|3
842443|NCT01131078|2677582|P3|Overall Study|Withdrawal by Subject|3
842444|NCT01131078|2677583|P2|Overall Study|Withdrawal by Subject|4
842445|NCT01131078|2677584|P1|Overall Study|Withdrawal by Subject|2
842446|NCT01131078|2677582|P3|Overall Study|Lost to Follow-up|1
842447|NCT01131078|2677583|P2|Overall Study|Lost to Follow-up|1
842448|NCT01131078|2677584|P1|Overall Study|Lost to Follow-up|1
842449|NCT01131078|2677582|P3|Overall Study|Protocol Violation|0
842450|NCT01131078|2677583|P2|Overall Study|Protocol Violation|0
842451|NCT01131078|2677584|P1|Overall Study|Protocol Violation|1
842452|NCT01131078|2677582|P3|Overall Study|Progressive Disease|71
842453|NCT01131078|2677583|P2|Overall Study|Progressive Disease|77
842454|NCT01131078|2677584|P1|Overall Study|Progressive Disease|58
842455|NCT01131078|2677582|P3|Overall Study|Adverse Event|17
842456|NCT01131078|2677583|P2|Overall Study|Adverse Event|12
842457|NCT01131078|2677584|P1|Overall Study|Adverse Event|22
842458|NCT01131130|2677640|P1|Period 3- Crossover|+ Slit lamp finding|1
842459|NCT01131130|2677640|P1|Period 1 - Baseline|Pregnancy|1
842466|NCT01131299|2677664|P2|Overall Study|Withdrawal by Subject|7
842467|NCT01131299|2677665|P1|Overall Study|Withdrawal by Subject|4
842468|NCT01131455|2677679|P3|Overall Study|Death of PI|0
842469|NCT01131455|2677680|P2|Overall Study|Death of PI|4
842470|NCT01131455|2677681|P1|Overall Study|Death of PI|6
842471|NCT01131494|2677689|P1|Overall Study|Withdrawal by Subject|2
842472|NCT01131507|2677696|P1|Overall Study|Withdrawal by Subject|1
842473|NCT01131507|2677696|P1|Overall Study|Lost to Follow-up|1
842474|NCT01131507|2677696|P1|Overall Study|Adverse Event|1
842481|NCT01131585|2677728|P2|Overall Study|Study termination|32
842482|NCT01131585|2677729|P1|Overall Study|Study termination|78
842483|NCT01131585|2677728|P2|Overall Study|Administrative problems|1
842484|NCT01131585|2677729|P1|Overall Study|Administrative problems|1
842485|NCT01131585|2677728|P2|Overall Study|Lost to Follow-up|1
842486|NCT01131585|2677729|P1|Overall Study|Lost to Follow-up|0
842487|NCT01131585|2677728|P2|Overall Study|Withdrawal by Subject|3
842488|NCT01131585|2677729|P1|Overall Study|Withdrawal by Subject|3
842489|NCT01131585|2677728|P2|Overall Study|Protocol Violation|1
842490|NCT01131585|2677729|P1|Overall Study|Protocol Violation|2
842491|NCT01131585|2677728|P2|Overall Study|Unsatisfactory therapeutic effect|3
842492|NCT01131585|2677729|P1|Overall Study|Unsatisfactory therapeutic effect|0
842493|NCT01131585|2677728|P2|Overall Study|Abnormal laboratory value|0
842494|NCT01131585|2677729|P1|Overall Study|Abnormal laboratory value|1
842495|NCT01131585|2677728|P2|Overall Study|Adverse Event|2
842496|NCT01131585|2677729|P1|Overall Study|Adverse Event|0
842497|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
842498|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
842499|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
842500|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
842501|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
842502|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
842503|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
842504|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
842505|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
842506|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
842507|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
842508|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
842509|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
842510|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
842511|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
894048|NCT00625183|2837103|P1|Overall Study|Disease Progression|1
842512|NCT01131676|2677738|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
842513|NCT01131676|2677739|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
842514|NCT01131676|2677740|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
842515|NCT01131676|2677738|P3|Discontinuation From Treatment|Adverse Event|273
842516|NCT01131676|2677739|P2|Discontinuation From Treatment|Adverse Event|267
842517|NCT01131676|2677740|P1|Discontinuation From Treatment|Adverse Event|303
842518|NCT01131676|2677738|P3|Discontinuation From Treatment|Other than those specified|125
842519|NCT01131676|2677739|P2|Discontinuation From Treatment|Other than those specified|142
842520|NCT01131676|2677740|P1|Discontinuation From Treatment|Other than those specified|162
842521|NCT01131676|2677738|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
842522|NCT01131676|2677739|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
842523|NCT01131676|2677740|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
842524|NCT01131676|2677738|P3|Discontinuation From Treatment|Lost to Follow-up|6
842525|NCT01131676|2677739|P2|Discontinuation From Treatment|Lost to Follow-up|9
842526|NCT01131676|2677740|P1|Discontinuation From Treatment|Lost to Follow-up|15
842527|NCT01131676|2677738|P3|Discontinuation From Treatment|Non compliant with protocol|12
842528|NCT01131676|2677739|P2|Discontinuation From Treatment|Non compliant with protocol|15
842529|NCT01131676|2677740|P1|Discontinuation From Treatment|Non compliant with protocol|15
842530|NCT01131676|2677738|P3|Discontinuation From Treatment|Lack of Efficacy|0
842531|NCT01131676|2677739|P2|Discontinuation From Treatment|Lack of Efficacy|1
842532|NCT01131676|2677740|P1|Discontinuation From Treatment|Lack of Efficacy|11
842533|NCT01131676|2677738|P3|Discontinuation From Treatment|Not treated|2
842534|NCT01131676|2677739|P2|Discontinuation From Treatment|Not treated|2
842535|NCT01131676|2677740|P1|Discontinuation From Treatment|Not treated|4
842536|NCT01131676|2677738|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
842537|NCT01131676|2677739|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
842538|NCT01131676|2677740|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
842539|NCT01138501|2677810|P1|Overall Study|Withdrawal by Subject|3
842540|NCT01138501|2677810|P1|Overall Study|Protocol Violation|2
842541|NCT01138657|2677836|P2|Overall Study|Miscellaneous Reasons|4
842542|NCT01138657|2677837|P1|Overall Study|Miscellaneous Reasons|3
842543|NCT01138657|2677836|P2|Overall Study|Lost to Follow-up|3
842544|NCT01138657|2677837|P1|Overall Study|Lost to Follow-up|0
842545|NCT01138657|2677836|P2|Overall Study|Lack of Efficacy|1
842546|NCT01138657|2677837|P1|Overall Study|Lack of Efficacy|2
842547|NCT01138657|2677836|P2|Overall Study|Adverse Event|10
842548|NCT01138657|2677837|P1|Overall Study|Adverse Event|3
842549|NCT01138826|2677896|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
842550|NCT01138826|2677897|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
842551|NCT01138826|2677898|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
842552|NCT01138826|2677899|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
842553|NCT01138826|2677900|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
842554|NCT01138826|2677901|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
842555|NCT01139008|2677945|P1|Overall Study|Non-compliant, lost product|1
842556|NCT01139008|2677945|P1|Overall Study|Withdrawal by Subject|5
842557|NCT01139021|2677960|P6|Overall Study|Withdrawal by Subject|0
842558|NCT01139021|2677961|P5|Overall Study|Withdrawal by Subject|4
842559|NCT01139021|2677962|P4|Overall Study|Withdrawal by Subject|1
842560|NCT01139021|2677963|P3|Overall Study|Withdrawal by Subject|0
842561|NCT01139021|2677964|P2|Overall Study|Withdrawal by Subject|0
842562|NCT01139021|2677965|P1|Overall Study|Withdrawal by Subject|0
842563|NCT01139021|2677960|P6|Overall Study|Protocol Violation|0
842564|NCT01139021|2677961|P5|Overall Study|Protocol Violation|2
842565|NCT01139021|2677962|P4|Overall Study|Protocol Violation|0
842566|NCT01139021|2677963|P3|Overall Study|Protocol Violation|0
842567|NCT01139021|2677964|P2|Overall Study|Protocol Violation|0
842568|NCT01139021|2677965|P1|Overall Study|Protocol Violation|1
842569|NCT01139021|2677960|P6|Overall Study|Lost to Follow-up|0
842570|NCT01139021|2677961|P5|Overall Study|Lost to Follow-up|2
842571|NCT01139021|2677962|P4|Overall Study|Lost to Follow-up|0
842572|NCT01139021|2677963|P3|Overall Study|Lost to Follow-up|0
842573|NCT01139021|2677964|P2|Overall Study|Lost to Follow-up|0
842574|NCT01139021|2677965|P1|Overall Study|Lost to Follow-up|0
842575|NCT01139021|2677960|P6|Overall Study|Adverse Event|0
842576|NCT01139021|2677961|P5|Overall Study|Adverse Event|1
842577|NCT01139021|2677962|P4|Overall Study|Adverse Event|0
842578|NCT01139021|2677963|P3|Overall Study|Adverse Event|0
842579|NCT01139021|2677964|P2|Overall Study|Adverse Event|0
842580|NCT01139021|2677965|P1|Overall Study|Adverse Event|0
842581|NCT01139047|2678001|P1|Overall Study|Withdrawal by Subject|1
842582|NCT01139125|2678010|P1|Overall Study|Withdrawal by Subject|1
842583|NCT01139164|2678017|P3|Overall Study|Withdrawn prior to study start|0
842584|NCT01139164|2678018|P2|Overall Study|Withdrawn prior to study start|2
842585|NCT01139164|2678019|P1|Overall Study|Withdrawn prior to study start|0
842586|NCT01139450|2678077|P3|Overall Study|Adverse Event|3
842587|NCT01139450|2678078|P2|Overall Study|Adverse Event|2
842588|NCT01139450|2678079|P1|Overall Study|Adverse Event|2
842589|NCT01139450|2678077|P3|Overall Study|Administrative|1
842590|NCT01139450|2678078|P2|Overall Study|Administrative|0
842591|NCT01139450|2678079|P1|Overall Study|Administrative|0
842592|NCT01139450|2678077|P3|Overall Study|Lost to Follow-up|11
842593|NCT01139450|2678078|P2|Overall Study|Lost to Follow-up|7
842594|NCT01139450|2678079|P1|Overall Study|Lost to Follow-up|9
842595|NCT01139450|2678077|P3|Overall Study|Protocol Violation|2
842596|NCT01139450|2678078|P2|Overall Study|Protocol Violation|5
842597|NCT01139450|2678079|P1|Overall Study|Protocol Violation|6
842598|NCT01139450|2678077|P3|Overall Study|Lack of Efficacy|8
842599|NCT01139450|2678078|P2|Overall Study|Lack of Efficacy|1
842600|NCT01139450|2678079|P1|Overall Study|Lack of Efficacy|3
842601|NCT01139450|2678077|P3|Overall Study|Withdrawal by Subject|13
842602|NCT01139450|2678078|P2|Overall Study|Withdrawal by Subject|10
842603|NCT01139450|2678079|P1|Overall Study|Withdrawal by Subject|7
842604|NCT01139580|2678118|P2|Overall Study|Participant Randomization in Error|1
842605|NCT01139580|2678119|P1|Overall Study|Participant Randomization in Error|0
842606|NCT01139580|2678118|P2|Overall Study|Beginning Study Exclusion Treatment|1
842607|NCT01139580|2678119|P1|Overall Study|Beginning Study Exclusion Treatment|0
842608|NCT01139580|2678118|P2|Overall Study|Misrandomized|0
842609|NCT01139580|2678119|P1|Overall Study|Misrandomized|1
842610|NCT01139580|2678118|P2|Overall Study|Did Not Meet Exclusion Criteria|0
842611|NCT01139580|2678119|P1|Overall Study|Did Not Meet Exclusion Criteria|1
842612|NCT01139580|2678118|P2|Overall Study|Used Excluded Medicine After Enrollment|0
842613|NCT01139580|2678119|P1|Overall Study|Used Excluded Medicine After Enrollment|1
842614|NCT01139580|2678118|P2|Overall Study|Withdrawal by Subject|9
842615|NCT01139580|2678119|P1|Overall Study|Withdrawal by Subject|6
842616|NCT01139580|2678118|P2|Overall Study|Lack of Efficacy|2
842617|NCT01139580|2678119|P1|Overall Study|Lack of Efficacy|0
842618|NCT01139580|2678118|P2|Overall Study|Lost to Follow-up|1
842619|NCT01139580|2678119|P1|Overall Study|Lost to Follow-up|9
842620|NCT01139580|2678118|P2|Overall Study|Adverse Event|4
842621|NCT01139580|2678119|P1|Overall Study|Adverse Event|5
842622|NCT01139658|2678137|P2|Overall Study|Not specified|75
842623|NCT01139658|2678138|P1|Overall Study|Not specified|28
842624|NCT01139658|2678137|P2|Overall Study|No documentation of treatment|0
842625|NCT01139658|2678138|P1|Overall Study|No documentation of treatment|1
842626|NCT01139658|2678137|P2|Overall Study|Withdrawal by Subject|4
842627|NCT01139658|2678138|P1|Overall Study|Withdrawal by Subject|2
842628|NCT01139658|2678137|P2|Overall Study|Lack of Efficacy|7
842629|NCT01139658|2678138|P1|Overall Study|Lack of Efficacy|15
842630|NCT01139658|2678137|P2|Overall Study|Adverse Event|27
842631|NCT01139658|2678138|P1|Overall Study|Adverse Event|10
842632|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
842633|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
842634|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
842635|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
842636|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
842637|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
842638|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
842639|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
842640|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
842641|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
842642|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
842643|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
842644|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
842645|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
842646|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
842647|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
842648|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
842649|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
842650|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
842651|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
842652|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
842653|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Death|1
842654|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Death|1
842655|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Death|0
842656|NCT01139762|2678176|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
842657|NCT01139762|2678177|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
842658|NCT01139762|2678178|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
842659|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
842660|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
842661|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
842662|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
842663|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
842664|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
842665|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Physician Decision|0
842666|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Physician Decision|0
842667|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Physician Decision|12
842668|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
842669|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
842759|NCT01140906|2678417|P1|Overall Study|Adverse Event|7
842670|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
842671|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Adverse Event|0
842672|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Adverse Event|0
842673|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Adverse Event|1
842674|NCT01139762|2678176|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
842675|NCT01139762|2678177|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
842676|NCT01139762|2678178|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
842677|NCT01140048|2678231|P1|Overall Study|Lost to Follow-up|31
842678|NCT01140048|2678231|P1|Overall Study|Withdrawal by Subject|13
842679|NCT01140048|2678231|P1|Overall Study|Physician Decision|1
842680|NCT01140061|2678247|P10|Extension|Laboratory Adverse Event|1
842681|NCT01140061|2678248|P9|Extension|Laboratory Adverse Event|0
842682|NCT01140061|2678249|P8|Extension|Laboratory Adverse Event|0
842683|NCT01140061|2678250|P7|Extension|Laboratory Adverse Event|0
842684|NCT01140061|2678251|P6|Extension|Laboratory Adverse Event|0
842685|NCT01140061|2678252|P5|Extension|Laboratory Adverse Event|0
842686|NCT01140061|2678253|P4|Extension|Laboratory Adverse Event|0
842687|NCT01140061|2678254|P3|Extension|Laboratory Adverse Event|0
842688|NCT01140061|2678255|P2|Extension|Laboratory Adverse Event|0
842689|NCT01140061|2678256|P1|Extension|Laboratory Adverse Event|0
842690|NCT01140061|2678247|P10|Part I|Adverse Event|0
842691|NCT01140061|2678248|P9|Part I|Adverse Event|0
842692|NCT01140061|2678249|P8|Part I|Adverse Event|0
842693|NCT01140061|2678250|P7|Part I|Adverse Event|0
842694|NCT01140061|2678251|P6|Part I|Adverse Event|0
842695|NCT01140061|2678252|P5|Part I|Adverse Event|0
842696|NCT01140061|2678253|P4|Part I|Adverse Event|0
842697|NCT01140061|2678254|P3|Part I|Adverse Event|0
842698|NCT01140061|2678255|P2|Part I|Adverse Event|0
842699|NCT01140061|2678256|P1|Part I|Adverse Event|1
842700|NCT01140347|2678305|P2|Overall Study|Withdrawal by Subject|8
842701|NCT01140347|2678306|P1|Overall Study|Withdrawal by Subject|13
842702|NCT01140347|2678305|P2|Overall Study|Lost to Follow-up|6
842703|NCT01140347|2678306|P1|Overall Study|Lost to Follow-up|5
842704|NCT01140477|2678335|P2|Overall Study|Subject explanted|1
842705|NCT01140477|2678336|P1|Overall Study|Subject explanted|0
842706|NCT01140477|2678335|P2|Overall Study|Death|1
842707|NCT01140477|2678336|P1|Overall Study|Death|1
842708|NCT01140477|2678335|P2|Overall Study|Surgical complication preventing implant|0
842709|NCT01140477|2678336|P1|Overall Study|Surgical complication preventing implant|2
842710|NCT01140477|2678335|P2|Overall Study|Withdrawal by Subject|4
842711|NCT01140477|2678336|P1|Overall Study|Withdrawal by Subject|1
842712|NCT01140477|2678335|P2|Overall Study|Lost to Follow-up|0
842713|NCT01140477|2678336|P1|Overall Study|Lost to Follow-up|4
842714|NCT01140503|2678345|P1|Overall Study|Withdrawal by Subject|1
842715|NCT01140646|2678351|P1|Overall Study|Refused Further Treatment|5
842716|NCT01140646|2678351|P1|Overall Study|Adverse Event|4
842717|NCT01140867|2678388|P1|Overall Study|Medication Noncompliance|2
842718|NCT01140867|2678388|P1|Overall Study|Uncooperative patient|2
842719|NCT01140867|2678388|P1|Overall Study|Protocol Violation|1
842720|NCT01140867|2678388|P1|Overall Study|Withdrawal by Subject|1
842721|NCT01140867|2678388|P1|Overall Study|Lost to Follow-up|2
842722|NCT01140867|2678388|P1|Overall Study|Lack of Efficacy|3
842723|NCT01140867|2678388|P1|Overall Study|Adverse Event|22
842724|NCT01140880|2678397|P2|Overall Study|Protocol Violation|30
842725|NCT01140880|2678398|P1|Overall Study|Protocol Violation|0
842726|NCT01140880|2678397|P2|Overall Study|Lost to Follow-up|10
842727|NCT01140880|2678398|P1|Overall Study|Lost to Follow-up|8
842728|NCT01140880|2678397|P2|Overall Study|Withdrawal by Subject|3
842729|NCT01140880|2678398|P1|Overall Study|Withdrawal by Subject|6
842730|NCT01140880|2678397|P2|Overall Study|Death|1
842731|NCT01140880|2678398|P1|Overall Study|Death|0
842732|NCT01140906|2678414|P4|Overall Study|Administrative or other reason|2
842733|NCT01140906|2678415|P3|Overall Study|Administrative or other reason|3
842734|NCT01140906|2678416|P2|Overall Study|Administrative or other reason|5
842735|NCT01140906|2678417|P1|Overall Study|Administrative or other reason|0
842736|NCT01140906|2678414|P4|Overall Study|Lost to Follow-up|2
842737|NCT01140906|2678415|P3|Overall Study|Lost to Follow-up|0
842738|NCT01140906|2678416|P2|Overall Study|Lost to Follow-up|1
842739|NCT01140906|2678417|P1|Overall Study|Lost to Follow-up|1
842740|NCT01140906|2678414|P4|Overall Study|Withdrawal of consent|2
842741|NCT01140906|2678415|P3|Overall Study|Withdrawal of consent|2
842742|NCT01140906|2678416|P2|Overall Study|Withdrawal of consent|6
842743|NCT01140906|2678417|P1|Overall Study|Withdrawal of consent|6
842744|NCT01140906|2678414|P4|Overall Study|Protocol Violation|1
842745|NCT01140906|2678415|P3|Overall Study|Protocol Violation|2
842746|NCT01140906|2678416|P2|Overall Study|Protocol Violation|3
842747|NCT01140906|2678417|P1|Overall Study|Protocol Violation|5
842748|NCT01140906|2678414|P4|Overall Study|Non-compliance|1
842749|NCT01140906|2678415|P3|Overall Study|Non-compliance|0
842750|NCT01140906|2678416|P2|Overall Study|Non-compliance|1
842751|NCT01140906|2678417|P1|Overall Study|Non-compliance|0
842752|NCT01140906|2678414|P4|Overall Study|Lack of Efficacy|1
842753|NCT01140906|2678415|P3|Overall Study|Lack of Efficacy|2
842754|NCT01140906|2678416|P2|Overall Study|Lack of Efficacy|8
842755|NCT01140906|2678417|P1|Overall Study|Lack of Efficacy|6
842756|NCT01140906|2678414|P4|Overall Study|Adverse Event|7
842757|NCT01140906|2678415|P3|Overall Study|Adverse Event|17
842758|NCT01140906|2678416|P2|Overall Study|Adverse Event|10
842760|NCT01141205|2678457|P2|Overall Study|Withdrawal by Subject|1
842761|NCT01141205|2678458|P1|Overall Study|Withdrawal by Subject|1
842762|NCT01141205|2678457|P2|Overall Study|Lost to Follow-up|0
842763|NCT01141205|2678458|P1|Overall Study|Lost to Follow-up|1
842764|NCT01141205|2678457|P2|Overall Study|Physician Decision|1
842765|NCT01141205|2678458|P1|Overall Study|Physician Decision|1
842766|NCT01141283|2678470|P1|Overall Study|Lack of Efficacy|10
842767|NCT01141283|2678470|P1|Overall Study|Administrative|4
842768|NCT01141283|2678470|P1|Overall Study|Withdrawal by Subject|14
842769|NCT01141283|2678470|P1|Overall Study|Lost to Follow-up|4
842770|NCT01141283|2678470|P1|Overall Study|Adverse Event|56
842771|NCT01134614|2678569|P2|Overall Study|Patient in hospice care|1
842772|NCT01134614|2678570|P1|Overall Study|Patient in hospice care|0
842773|NCT01134614|2678569|P2|Overall Study|Symptomatic deterioration|1
842774|NCT01134614|2678570|P1|Overall Study|Symptomatic deterioration|0
842775|NCT01134614|2678569|P2|Overall Study|Pt received tx not allowed on study|1
842776|NCT01134614|2678570|P1|Overall Study|Pt received tx not allowed on study|0
842777|NCT01134614|2678569|P2|Overall Study|Never started treatment|1
842778|NCT01134614|2678570|P1|Overall Study|Never started treatment|4
842779|NCT01134614|2678569|P2|Overall Study|Physician's decision|1
842780|NCT01134614|2678570|P1|Overall Study|Physician's decision|0
842781|NCT01134614|2678569|P2|Overall Study|Complicating disease|1
842782|NCT01134614|2678570|P1|Overall Study|Complicating disease|2
842783|NCT01134614|2678569|P2|Overall Study|Alternative therapy|0
842784|NCT01134614|2678570|P1|Overall Study|Alternative therapy|2
842785|NCT01134614|2678569|P2|Overall Study|Withdrawal by Subject|2
842786|NCT01134614|2678570|P1|Overall Study|Withdrawal by Subject|3
842787|NCT01134614|2678569|P2|Overall Study|Death|8
842788|NCT01134614|2678570|P1|Overall Study|Death|5
842789|NCT01134614|2678569|P2|Overall Study|Adverse Event|39
842790|NCT01134614|2678570|P1|Overall Study|Adverse Event|26
842791|NCT01134614|2678569|P2|Overall Study|Progressive disease|54
842792|NCT01134614|2678570|P1|Overall Study|Progressive disease|60
842793|NCT01134614|2678569|P2|Overall Study|Still on treatment as of March 2013|13
842794|NCT01134614|2678570|P1|Overall Study|Still on treatment as of March 2013|21
842795|NCT01134627|2678582|P2|Overall Study|Unspecified|14
842796|NCT01134627|2678583|P1|Overall Study|Unspecified|11
842797|NCT01134627|2678582|P2|Overall Study|Planning to become pregnant/pregnancy|0
842798|NCT01134627|2678583|P1|Overall Study|Planning to become pregnant/pregnancy|1
842799|NCT01134627|2678582|P2|Overall Study|Withdrawal by Subject|3
842800|NCT01134627|2678583|P1|Overall Study|Withdrawal by Subject|4
842801|NCT01134627|2678582|P2|Overall Study|Lack of Efficacy|12
842802|NCT01134627|2678583|P1|Overall Study|Lack of Efficacy|2
842803|NCT01134627|2678582|P2|Overall Study|Protocol Violation|5
842804|NCT01134627|2678583|P1|Overall Study|Protocol Violation|3
842805|NCT01134627|2678582|P2|Overall Study|Lost to Follow-up|2
842806|NCT01134627|2678583|P1|Overall Study|Lost to Follow-up|1
842807|NCT01134627|2678582|P2|Overall Study|Adverse Event|31
842808|NCT01134627|2678583|P1|Overall Study|Adverse Event|47
842809|NCT01134705|2678613|P2|Overall Study|Other|6
842810|NCT01134705|2678614|P1|Overall Study|Other|1
842811|NCT01134705|2678613|P2|Overall Study|Protocol Violation|1
842812|NCT01134705|2678614|P1|Overall Study|Protocol Violation|1
842813|NCT01134705|2678613|P2|Overall Study|Lost to Follow-up|2
842814|NCT01134705|2678614|P1|Overall Study|Lost to Follow-up|5
842815|NCT01134705|2678613|P2|Overall Study|Pregnancy|0
842816|NCT01134705|2678614|P1|Overall Study|Pregnancy|1
842817|NCT01134705|2678613|P2|Overall Study|Withdrawal by Subject|6
842818|NCT01134705|2678614|P1|Overall Study|Withdrawal by Subject|6
842819|NCT01134705|2678613|P2|Overall Study|Adverse Event|7
842820|NCT01134705|2678614|P1|Overall Study|Adverse Event|1
842821|NCT01134731|2678627|P3|Overall Study|Lost to Follow-up|3
842822|NCT01134731|2678628|P2|Overall Study|Lost to Follow-up|4
842823|NCT01134731|2678629|P1|Overall Study|Lost to Follow-up|5
842824|NCT01134731|2678627|P3|Overall Study|Withdrawal by Subject|1
842825|NCT01134731|2678628|P2|Overall Study|Withdrawal by Subject|3
842826|NCT01134731|2678629|P1|Overall Study|Withdrawal by Subject|3
842827|NCT01134731|2678627|P3|Overall Study|Lack of Efficacy|1
842828|NCT01134731|2678628|P2|Overall Study|Lack of Efficacy|0
842829|NCT01134731|2678629|P1|Overall Study|Lack of Efficacy|0
842830|NCT01134731|2678627|P3|Overall Study|Physician Decision|2
842831|NCT01134731|2678628|P2|Overall Study|Physician Decision|2
842832|NCT01134731|2678629|P1|Overall Study|Physician Decision|2
842833|NCT01134731|2678627|P3|Overall Study|Adverse Event|1
842834|NCT01134731|2678628|P2|Overall Study|Adverse Event|2
842835|NCT01134731|2678629|P1|Overall Study|Adverse Event|3
842836|NCT01134783|2678642|P2|Overall Study|Lost to Follow-up|20
842837|NCT01134783|2678643|P1|Overall Study|Lost to Follow-up|5
842838|NCT01134783|2678642|P2|Overall Study|Withdrawal by Subject|9
842839|NCT01134783|2678643|P1|Overall Study|Withdrawal by Subject|15
842840|NCT01134783|2678642|P2|Overall Study|Pregnancy|8
842841|NCT01134783|2678643|P1|Overall Study|Pregnancy|16
842842|NCT01134939|2678693|P8|Overall Study|Termination page not available|0
842843|NCT01134939|2678694|P7|Overall Study|Termination page not available|7
842844|NCT01134939|2678695|P6|Overall Study|Termination page not available|3
842845|NCT01134939|2678696|P5|Overall Study|Termination page not available|0
842846|NCT01134939|2678697|P4|Overall Study|Termination page not available|8
842847|NCT01134939|2678698|P3|Overall Study|Termination page not available|5
842848|NCT01134939|2678699|P2|Overall Study|Termination page not available|6
842849|NCT01134939|2678700|P1|Overall Study|Termination page not available|4
842850|NCT01134939|2678693|P8|Overall Study|Death|0
842851|NCT01134939|2678694|P7|Overall Study|Death|0
842852|NCT01134939|2678695|P6|Overall Study|Death|0
842853|NCT01134939|2678696|P5|Overall Study|Death|0
842854|NCT01134939|2678697|P4|Overall Study|Death|0
842855|NCT01134939|2678698|P3|Overall Study|Death|0
842856|NCT01134939|2678699|P2|Overall Study|Death|1
842857|NCT01134939|2678700|P1|Overall Study|Death|0
842858|NCT01134939|2678693|P8|Overall Study|Lost to Follow-up|0
842859|NCT01134939|2678694|P7|Overall Study|Lost to Follow-up|0
842860|NCT01134939|2678695|P6|Overall Study|Lost to Follow-up|1
842861|NCT01134939|2678696|P5|Overall Study|Lost to Follow-up|2
842862|NCT01134939|2678697|P4|Overall Study|Lost to Follow-up|1
842863|NCT01134939|2678698|P3|Overall Study|Lost to Follow-up|0
842864|NCT01134939|2678699|P2|Overall Study|Lost to Follow-up|3
842865|NCT01134939|2678700|P1|Overall Study|Lost to Follow-up|2
842866|NCT01134939|2678693|P8|Overall Study|Lack of Efficacy|0
842867|NCT01134939|2678694|P7|Overall Study|Lack of Efficacy|1
842868|NCT01134939|2678695|P6|Overall Study|Lack of Efficacy|0
842869|NCT01134939|2678696|P5|Overall Study|Lack of Efficacy|3
842870|NCT01134939|2678697|P4|Overall Study|Lack of Efficacy|0
842871|NCT01134939|2678698|P3|Overall Study|Lack of Efficacy|1
842872|NCT01134939|2678699|P2|Overall Study|Lack of Efficacy|5
842873|NCT01134939|2678700|P1|Overall Study|Lack of Efficacy|2
842874|NCT01134939|2678693|P8|Overall Study|Adverse Event|0
842875|NCT01134939|2678694|P7|Overall Study|Adverse Event|1
842876|NCT01134939|2678695|P6|Overall Study|Adverse Event|5
842877|NCT01134939|2678696|P5|Overall Study|Adverse Event|5
842878|NCT01134939|2678697|P4|Overall Study|Adverse Event|5
842879|NCT01134939|2678698|P3|Overall Study|Adverse Event|4
842880|NCT01134939|2678699|P2|Overall Study|Adverse Event|3
842881|NCT01134939|2678700|P1|Overall Study|Adverse Event|9
842882|NCT01135017|2678826|P2|Overall Study|Other than above|4
842883|NCT01135017|2678827|P1|Overall Study|Other than above|3
842884|NCT01135017|2678826|P2|Overall Study|Adverse Event|8
842885|NCT01135017|2678827|P1|Overall Study|Adverse Event|3
842886|NCT01135134|2678858|P2|Overall Study|Did not meet protocol eligibility|0
842887|NCT01135134|2678859|P1|Overall Study|Did not meet protocol eligibility|1
842888|NCT01135134|2678858|P2|Overall Study|Adverse Event|1
842889|NCT01135134|2678859|P1|Overall Study|Adverse Event|1
842890|NCT01135498|2679024|P1|Overall Study|Ongoing at time of analysis|2
842891|NCT01135498|2679024|P1|Overall Study|Death|1
842892|NCT01135498|2679024|P1|Overall Study|Withdrawal by Subject|4
842893|NCT01135498|2679024|P1|Overall Study|Investigator judgement|25
842894|NCT01135498|2679024|P1|Overall Study|Progressive disease|38
842895|NCT01135498|2679024|P1|Overall Study|Adverse Event|20
842896|NCT01135511|2679042|P9|Overall Study|Withdrawal by Subject|1
842897|NCT01135511|2679043|P8|Overall Study|Withdrawal by Subject|0
842898|NCT01135511|2679044|P7|Overall Study|Withdrawal by Subject|1
842899|NCT01135511|2679045|P6|Overall Study|Withdrawal by Subject|0
842900|NCT01135511|2679046|P5|Overall Study|Withdrawal by Subject|0
842901|NCT01135511|2679047|P4|Overall Study|Withdrawal by Subject|0
842902|NCT01135511|2679048|P3|Overall Study|Withdrawal by Subject|0
842903|NCT01135511|2679049|P2|Overall Study|Withdrawal by Subject|0
842904|NCT01135511|2679050|P1|Overall Study|Withdrawal by Subject|0
842905|NCT01135511|2679042|P9|Overall Study|noncompliance with study drug taken|0
842906|NCT01135511|2679043|P8|Overall Study|noncompliance with study drug taken|0
842907|NCT01135511|2679044|P7|Overall Study|noncompliance with study drug taken|0
842908|NCT01135511|2679045|P6|Overall Study|noncompliance with study drug taken|0
842909|NCT01135511|2679046|P5|Overall Study|noncompliance with study drug taken|1
842910|NCT01135511|2679047|P4|Overall Study|noncompliance with study drug taken|0
842911|NCT01135511|2679048|P3|Overall Study|noncompliance with study drug taken|0
842912|NCT01135511|2679049|P2|Overall Study|noncompliance with study drug taken|0
842913|NCT01135511|2679050|P1|Overall Study|noncompliance with study drug taken|0
842914|NCT01135511|2679042|P9|Overall Study|could not visit the clinic|0
842915|NCT01135511|2679043|P8|Overall Study|could not visit the clinic|0
842916|NCT01135511|2679044|P7|Overall Study|could not visit the clinic|0
842917|NCT01135511|2679045|P6|Overall Study|could not visit the clinic|0
842918|NCT01135511|2679046|P5|Overall Study|could not visit the clinic|0
842919|NCT01135511|2679047|P4|Overall Study|could not visit the clinic|0
842920|NCT01135511|2679048|P3|Overall Study|could not visit the clinic|2
842921|NCT01135511|2679049|P2|Overall Study|could not visit the clinic|1
842922|NCT01135511|2679050|P1|Overall Study|could not visit the clinic|0
842923|NCT01135511|2679042|P9|Overall Study|Pregnancy|0
842924|NCT01135511|2679043|P8|Overall Study|Pregnancy|0
842925|NCT01135511|2679044|P7|Overall Study|Pregnancy|0
842926|NCT01135511|2679045|P6|Overall Study|Pregnancy|0
842927|NCT01135511|2679046|P5|Overall Study|Pregnancy|0
842928|NCT01135511|2679047|P4|Overall Study|Pregnancy|1
842929|NCT01135511|2679048|P3|Overall Study|Pregnancy|0
842930|NCT01135511|2679049|P2|Overall Study|Pregnancy|0
842931|NCT01135511|2679050|P1|Overall Study|Pregnancy|0
842932|NCT01135511|2679042|P9|Overall Study|Protocol Violation|0
842933|NCT01135511|2679043|P8|Overall Study|Protocol Violation|0
842934|NCT01135511|2679044|P7|Overall Study|Protocol Violation|0
842935|NCT01135511|2679045|P6|Overall Study|Protocol Violation|0
842936|NCT01135511|2679046|P5|Overall Study|Protocol Violation|0
842937|NCT01135511|2679047|P4|Overall Study|Protocol Violation|0
842938|NCT01135511|2679048|P3|Overall Study|Protocol Violation|3
842939|NCT01135511|2679049|P2|Overall Study|Protocol Violation|0
842940|NCT01135511|2679050|P1|Overall Study|Protocol Violation|0
842941|NCT01135511|2679042|P9|Overall Study|Lack of Efficacy|0
842942|NCT01135511|2679043|P8|Overall Study|Lack of Efficacy|0
842943|NCT01135511|2679044|P7|Overall Study|Lack of Efficacy|0
842944|NCT01135511|2679045|P6|Overall Study|Lack of Efficacy|0
842945|NCT01135511|2679046|P5|Overall Study|Lack of Efficacy|0
842946|NCT01135511|2679047|P4|Overall Study|Lack of Efficacy|2
842947|NCT01135511|2679048|P3|Overall Study|Lack of Efficacy|1
842948|NCT01135511|2679049|P2|Overall Study|Lack of Efficacy|1
842949|NCT01135511|2679050|P1|Overall Study|Lack of Efficacy|0
842950|NCT01135511|2679042|P9|Overall Study|Adverse Event|0
842951|NCT01135511|2679043|P8|Overall Study|Adverse Event|1
842952|NCT01135511|2679044|P7|Overall Study|Adverse Event|0
842953|NCT01135511|2679045|P6|Overall Study|Adverse Event|1
842954|NCT01135511|2679046|P5|Overall Study|Adverse Event|0
842955|NCT01135511|2679047|P4|Overall Study|Adverse Event|0
842956|NCT01135511|2679048|P3|Overall Study|Adverse Event|2
842957|NCT01135511|2679049|P2|Overall Study|Adverse Event|1
842958|NCT01135511|2679050|P1|Overall Study|Adverse Event|0
842959|NCT01135524|2679332|P1|Overall Study|Lack of Efficacy|8
842960|NCT01135524|2679332|P1|Overall Study|Administrative|151
842961|NCT01135524|2679332|P1|Overall Study|Lost to Follow-up|3
842962|NCT01135524|2679332|P1|Overall Study|Adverse Event|20
842963|NCT01135524|2679332|P1|Overall Study|Withdrawal by Subject|14
842964|NCT01135914|2679339|P3|Overall Study|Adverse Event|2
842965|NCT01135914|2679340|P2|Overall Study|Adverse Event|1
842966|NCT01135914|2679341|P1|Overall Study|Adverse Event|0
842967|NCT01135914|2679339|P3|Overall Study|Lack of Efficacy|10
842968|NCT01135914|2679340|P2|Overall Study|Lack of Efficacy|1
842969|NCT01135914|2679341|P1|Overall Study|Lack of Efficacy|2
842970|NCT01135914|2679339|P3|Overall Study|Protocol Violation|3
842971|NCT01135914|2679340|P2|Overall Study|Protocol Violation|0
842972|NCT01135914|2679341|P1|Overall Study|Protocol Violation|0
842973|NCT01135914|2679339|P3|Overall Study|Lost to Follow-up|1
842974|NCT01135914|2679340|P2|Overall Study|Lost to Follow-up|0
842975|NCT01135914|2679341|P1|Overall Study|Lost to Follow-up|1
842976|NCT01135914|2679339|P3|Overall Study|Withdrawal by Subject|6
842977|NCT01135914|2679340|P2|Overall Study|Withdrawal by Subject|3
842978|NCT01135914|2679341|P1|Overall Study|Withdrawal by Subject|1
842979|NCT01142193|2679423|P2|Overall Study|Other|2
842980|NCT01142193|2679424|P1|Overall Study|Other|1
842981|NCT01142193|2679423|P2|Overall Study|Protocol Discontinuation Criterion Met|0
842982|NCT01142193|2679424|P1|Overall Study|Protocol Discontinuation Criterion Met|1
842983|NCT01142193|2679423|P2|Overall Study|Withdrawal by Subject|3
842984|NCT01142193|2679424|P1|Overall Study|Withdrawal by Subject|4
842985|NCT01142193|2679423|P2|Overall Study|Physician Decision|1
842986|NCT01142193|2679424|P1|Overall Study|Physician Decision|1
842987|NCT01142193|2679423|P2|Overall Study|Lack of Efficacy|1
842988|NCT01142193|2679424|P1|Overall Study|Lack of Efficacy|2
842989|NCT01142193|2679423|P2|Overall Study|Adverse Event|4
842990|NCT01142193|2679424|P1|Overall Study|Adverse Event|12
842991|NCT01142336|2679461|P2|Overall Study|Lost to Follow-up|1
842992|NCT01142336|2679462|P1|Overall Study|Lost to Follow-up|0
842993|NCT01142336|2679461|P2|Overall Study|Adverse Event|1
842994|NCT01142336|2679462|P1|Overall Study|Adverse Event|1
842995|NCT01142388|2679474|P2|Overall Study|Never started therapy|3
842996|NCT01142388|2679475|P1|Overall Study|Never started therapy|7
842997|NCT01142388|2679474|P2|Overall Study|Other|1
842998|NCT01142388|2679475|P1|Overall Study|Other|1
842999|NCT01142388|2679474|P2|Overall Study|Other complications|2
843000|NCT01142388|2679475|P1|Overall Study|Other complications|0
843001|NCT01142388|2679474|P2|Overall Study|Alternative therapy|0
843002|NCT01142388|2679475|P1|Overall Study|Alternative therapy|1
843003|NCT01142388|2679474|P2|Overall Study|Withdrawal by Subject|3
843004|NCT01142388|2679475|P1|Overall Study|Withdrawal by Subject|5
843005|NCT01142388|2679474|P2|Overall Study|Death|2
843006|NCT01142388|2679475|P1|Overall Study|Death|3
843007|NCT01142388|2679474|P2|Overall Study|Adverse Event|5
843008|NCT01142388|2679475|P1|Overall Study|Adverse Event|9
843009|NCT01142388|2679474|P2|Overall Study|Lack of Efficacy|31
843010|NCT01142388|2679475|P1|Overall Study|Lack of Efficacy|21
843011|NCT01142466|2679487|P2|Overall Study|Withdrawal by Subject|1
843012|NCT01142466|2679488|P1|Overall Study|Withdrawal by Subject|1
843013|NCT01142466|2679487|P2|Overall Study|Adverse Event|1
843014|NCT01142466|2679488|P1|Overall Study|Adverse Event|2
843015|NCT01142596|2679508|P2|Overall Study|Other reason (not specified)|4
843016|NCT01142596|2679509|P1|Overall Study|Other reason (not specified)|5
843017|NCT01142596|2679508|P2|Overall Study|Lost to Follow-up|3
843018|NCT01142596|2679509|P1|Overall Study|Lost to Follow-up|2
843019|NCT01142596|2679508|P2|Overall Study|Lack of Efficacy|9
843020|NCT01142596|2679509|P1|Overall Study|Lack of Efficacy|5
843021|NCT01142596|2679508|P2|Overall Study|Adverse Event|35
843022|NCT01142596|2679509|P1|Overall Study|Adverse Event|8
843023|NCT01142596|2679508|P2|Overall Study|Withdrawal by Subject|35
843024|NCT01142596|2679509|P1|Overall Study|Withdrawal by Subject|9
843025|NCT01142661|2679559|P1|Overall Study|Physician Decision|1
843026|NCT01142661|2679559|P1|Overall Study|Withdrawal by Subject|1
843027|NCT01142661|2679559|P1|Overall Study|Adverse Event|2
843028|NCT01142726|2679567|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
843029|NCT01142726|2679568|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
843030|NCT01142726|2679569|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
843031|NCT01142726|2679567|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
843032|NCT01142726|2679568|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
843033|NCT01142726|2679569|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
843034|NCT01142726|2679567|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
843035|NCT01142726|2679568|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
843036|NCT01142726|2679569|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
843037|NCT01142726|2679567|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
843038|NCT01142726|2679568|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
843039|NCT01142726|2679569|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
843040|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
843041|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
843042|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
843043|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
843044|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
843045|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
843046|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
843047|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
843048|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
843049|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
843050|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
843051|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
843052|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
843053|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
843054|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
843055|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
843056|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
843057|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
843058|NCT01142726|2679567|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
843059|NCT01142726|2679568|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
843060|NCT01142726|2679569|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
843061|NCT01142726|2679567|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
843062|NCT01142726|2679568|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
843063|NCT01142726|2679569|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
843064|NCT01142726|2679567|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
843065|NCT01142726|2679568|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
843066|NCT01142726|2679569|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
843067|NCT01142726|2679567|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
843068|NCT01142726|2679568|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
843069|NCT01142726|2679569|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
843070|NCT01142726|2679567|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
843071|NCT01142726|2679568|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
843072|NCT01142726|2679569|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
843073|NCT01142726|2679567|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
843074|NCT01142726|2679568|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
843075|NCT01142726|2679569|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
843076|NCT01142908|2679634|P2|Overall Study|Withdrawal by Subject|0
843077|NCT01142908|2679635|P1|Overall Study|Withdrawal by Subject|3
843078|NCT01142908|2679634|P2|Overall Study|Excluded - did not meet criteria|5
843079|NCT01142908|2679635|P1|Overall Study|Excluded - did not meet criteria|9
843080|NCT01142908|2679634|P2|Overall Study|Death|4
843081|NCT01142908|2679635|P1|Overall Study|Death|1
843082|NCT01142908|2679634|P2|Overall Study|Lost to Follow-up|13
843083|NCT01142908|2679635|P1|Overall Study|Lost to Follow-up|19
843084|NCT01143038|2679681|P1|Overall Study|Death|1
843085|NCT01143038|2679681|P1|Overall Study|Protocol Deviation|1
843086|NCT01143038|2679681|P1|Overall Study|Lost to Follow-up|2
843087|NCT01143038|2679681|P1|Overall Study|Adverse Event|3
843088|NCT01143038|2679681|P1|Overall Study|Requirement for alternative therapy|5
843089|NCT01143038|2679681|P1|Overall Study|Withdrawal by Subject|4
843090|NCT01143051|2679695|P6|3-14 Day Washout|Withdrawal by Subject|1
843091|NCT01143051|2679696|P5|3-14 Day Washout|Withdrawal by Subject|0
843092|NCT01143051|2679697|P4|3-14 Day Washout|Withdrawal by Subject|0
843093|NCT01143051|2679698|P3|3-14 Day Washout|Withdrawal by Subject|0
843094|NCT01143051|2679699|P2|3-14 Day Washout|Withdrawal by Subject|0
843095|NCT01143051|2679700|P1|3-14 Day Washout|Withdrawal by Subject|0
843096|NCT01143051|2679695|P6|3-14 Day Washout|Withdrawal by Subject|0
843097|NCT01143051|2679696|P5|3-14 Day Washout|Withdrawal by Subject|0
843098|NCT01143051|2679697|P4|3-14 Day Washout|Withdrawal by Subject|0
843099|NCT01143051|2679698|P3|3-14 Day Washout|Withdrawal by Subject|1
843100|NCT01143051|2679699|P2|3-14 Day Washout|Withdrawal by Subject|0
843101|NCT01143051|2679700|P1|3-14 Day Washout|Withdrawal by Subject|0
843102|NCT01143077|2679726|P3|Overall Study|Principal Investigator Decision|1
843103|NCT01143077|2679727|P2|Overall Study|Principal Investigator Decision|0
843104|NCT01143077|2679728|P1|Overall Study|Principal Investigator Decision|2
843105|NCT01143077|2679726|P3|Overall Study|Administrative|0
843106|NCT01143077|2679727|P2|Overall Study|Administrative|0
843107|NCT01143077|2679728|P1|Overall Study|Administrative|1
843108|NCT01143077|2679726|P3|Overall Study|Non-compliance with study drug|1
843109|NCT01143077|2679727|P2|Overall Study|Non-compliance with study drug|1
843110|NCT01143077|2679728|P1|Overall Study|Non-compliance with study drug|0
843111|NCT01143077|2679726|P3|Overall Study|Withdrawal by Subject|3
843112|NCT01143077|2679727|P2|Overall Study|Withdrawal by Subject|3
843113|NCT01143077|2679728|P1|Overall Study|Withdrawal by Subject|4
843114|NCT01143077|2679726|P3|Overall Study|Protocol Violation|0
843115|NCT01143077|2679727|P2|Overall Study|Protocol Violation|0
843116|NCT01143077|2679728|P1|Overall Study|Protocol Violation|2
843117|NCT01143077|2679726|P3|Overall Study|Lost to Follow-up|4
843118|NCT01143077|2679727|P2|Overall Study|Lost to Follow-up|3
843119|NCT01143077|2679728|P1|Overall Study|Lost to Follow-up|2
843120|NCT01143077|2679726|P3|Overall Study|Adverse Event|5
843121|NCT01143077|2679727|P2|Overall Study|Adverse Event|6
843122|NCT01143077|2679728|P1|Overall Study|Adverse Event|5
843123|NCT01143077|2679726|P3|Overall Study|Lack of Efficacy|1
843124|NCT01143077|2679727|P2|Overall Study|Lack of Efficacy|2
843125|NCT01143077|2679728|P1|Overall Study|Lack of Efficacy|0
843126|NCT01143090|2679739|P1|Overall Study|Administrative|1
843127|NCT01143090|2679739|P1|Overall Study|Failure to meet eligibility criteria|1
843128|NCT01143090|2679739|P1|Overall Study|Non-compliance with study drug|1
843129|NCT01143090|2679739|P1|Overall Study|Withdrawal by Subject|18
843130|NCT01143090|2679739|P1|Overall Study|Protocol Violation|2
843131|NCT01143090|2679739|P1|Overall Study|Lost to Follow-up|9
843132|NCT01143090|2679739|P1|Overall Study|Adverse Event|17
843133|NCT01143090|2679739|P1|Overall Study|Lack of Efficacy|2
843134|NCT01143207|2679754|P1|Overall Study|Lost to Follow-up|2
843135|NCT01143259|2679765|P2|Overall Study|Screen Failure|9
843136|NCT01143259|2679766|P1|Overall Study|Screen Failure|7
843137|NCT01143259|2679765|P2|Overall Study|Protocol Violation|9
843138|NCT01143259|2679766|P1|Overall Study|Protocol Violation|13
843139|NCT01143259|2679765|P2|Overall Study|Withdrawal by Subject|2
843140|NCT01143259|2679766|P1|Overall Study|Withdrawal by Subject|3
843141|NCT01143324|2679795|P1|Overall Study|Explant of the device|4
843142|NCT01143324|2679795|P1|Overall Study|Withdrawal by Subject|4
843143|NCT01143324|2679795|P1|Overall Study|Lost to Follow-up|11
843144|NCT01143337|2679813|P3|Overall Study|Other reason|5
843145|NCT01143337|2679814|P2|Overall Study|Other reason|0
843146|NCT01143337|2679815|P1|Overall Study|Other reason|0
843147|NCT01143337|2679813|P3|Overall Study|Withdrawal by Subject|1
843148|NCT01143337|2679814|P2|Overall Study|Withdrawal by Subject|0
843149|NCT01143337|2679815|P1|Overall Study|Withdrawal by Subject|0
843150|NCT01143337|2679813|P3|Overall Study|Protocol Violation|0
843151|NCT01143337|2679814|P2|Overall Study|Protocol Violation|0
843152|NCT01143337|2679815|P1|Overall Study|Protocol Violation|1
843153|NCT01143337|2679813|P3|Overall Study|Lack of Efficacy|1
843154|NCT01143337|2679814|P2|Overall Study|Lack of Efficacy|2
843155|NCT01143337|2679815|P1|Overall Study|Lack of Efficacy|6
843156|NCT01143337|2679813|P3|Overall Study|Adverse Event|5
843157|NCT01143337|2679814|P2|Overall Study|Adverse Event|9
843158|NCT01143337|2679815|P1|Overall Study|Adverse Event|3
843159|NCT01143402|2679832|P3|Overall Study|Not Treated|1
843160|NCT01143402|2679833|P2|Overall Study|Not Treated|0
843161|NCT01143402|2679834|P1|Overall Study|Not Treated|0
843162|NCT01143402|2679832|P3|Overall Study|Rapid clinical decline|0
843163|NCT01143402|2679833|P2|Overall Study|Rapid clinical decline|1
843164|NCT01143402|2679834|P1|Overall Study|Rapid clinical decline|1
843165|NCT01143714|2679939|P2|Overall Study|wound size increased|0
843166|NCT01143714|2679940|P1|Overall Study|wound size increased|1
843167|NCT01143714|2679939|P2|Overall Study|wound closed = deemed healed|0
843168|NCT01143714|2679940|P1|Overall Study|wound closed = deemed healed|1
843169|NCT01143714|2679939|P2|Overall Study|Subject non-compliance|1
843170|NCT01143714|2679940|P1|Overall Study|Subject non-compliance|0
843171|NCT01143714|2679939|P2|Overall Study|Withdrawal by Subject|0
843172|NCT01143714|2679940|P1|Overall Study|Withdrawal by Subject|1
843173|NCT01143714|2679939|P2|Overall Study|Adverse Event|2
843174|NCT01143714|2679940|P1|Overall Study|Adverse Event|4
843175|NCT01143896|2680023|P2|Overall Study|Death|3
843176|NCT01143896|2680024|P1|Overall Study|Death|6
843177|NCT01143896|2680023|P2|Overall Study|Withdrawal by Subject|5
843178|NCT01143896|2680024|P1|Overall Study|Withdrawal by Subject|13
843179|NCT01143896|2680023|P2|Overall Study|Lost to Follow-up|13
843180|NCT01143896|2680024|P1|Overall Study|Lost to Follow-up|18
843181|NCT01143896|2680023|P2|Overall Study|Did not complete Baseline Interview|4
843182|NCT01143896|2680024|P1|Overall Study|Did not complete Baseline Interview|5
843183|NCT01144052|2680051|P2|Overall Study|Withdrawal by Subject|1
843184|NCT01144052|2680052|P1|Overall Study|Withdrawal by Subject|1
843185|NCT01144182|2680074|P2|Overall Study|Lost to Follow-up|9
843186|NCT01144182|2680075|P1|Overall Study|Lost to Follow-up|9
843187|NCT01144182|2680074|P2|Overall Study|Withdrawal by Subject|6
843188|NCT01144182|2680075|P1|Overall Study|Withdrawal by Subject|3
843189|NCT01144182|2680074|P2|Overall Study|Death|6
843190|NCT01144182|2680075|P1|Overall Study|Death|5
843191|NCT01144299|2680128|P2|Overall Study|Withdrawal by Subject|0
843192|NCT01144299|2680129|P1|Overall Study|Withdrawal by Subject|1
843193|NCT01144299|2680128|P2|Overall Study|Lost to Follow-up|0
843194|NCT01144299|2680129|P1|Overall Study|Lost to Follow-up|1
843195|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Physician Decision|1
843196|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Physician Decision|0
843197|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Physician Decision|0
843198|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Relapse|5
843199|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Relapse|5
843200|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Relapse|0
843201|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
843202|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
843203|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
843204|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
843205|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
843206|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
843207|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Death|0
843208|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Death|2
843209|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Death|0
843210|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Adverse Event|1
843211|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Adverse Event|3
843212|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Adverse Event|0
843213|NCT01144364|2680153|P3|Follow-Up/Maintenance Phase|Disease progression|29
843214|NCT01144364|2680154|P2|Follow-Up/Maintenance Phase|Disease progression|23
843215|NCT01144364|2680155|P1|Follow-Up/Maintenance Phase|Disease progression|0
843216|NCT01144364|2680153|P3|Induction Phase|Protocol Violation|0
843217|NCT01144364|2680154|P2|Induction Phase|Protocol Violation|0
843218|NCT01144364|2680155|P1|Induction Phase|Protocol Violation|1
843219|NCT01144364|2680153|P3|Induction Phase|Secondary neoplasia|0
843220|NCT01144364|2680154|P2|Induction Phase|Secondary neoplasia|0
843221|NCT01144364|2680155|P1|Induction Phase|Secondary neoplasia|1
843222|NCT01144364|2680153|P3|Induction Phase|Stable disease|0
843223|NCT01144364|2680154|P2|Induction Phase|Stable disease|0
843224|NCT01144364|2680155|P1|Induction Phase|Stable disease|2
843225|NCT01144364|2680153|P3|Induction Phase|Physician Decision|0
843226|NCT01144364|2680154|P2|Induction Phase|Physician Decision|0
843227|NCT01144364|2680155|P1|Induction Phase|Physician Decision|1
843228|NCT01144364|2680153|P3|Induction Phase|Lost to Follow-up|0
843229|NCT01144364|2680154|P2|Induction Phase|Lost to Follow-up|0
843230|NCT01144364|2680155|P1|Induction Phase|Lost to Follow-up|2
843231|NCT01144364|2680153|P3|Induction Phase|Withdrawal by Subject|0
843232|NCT01144364|2680154|P2|Induction Phase|Withdrawal by Subject|0
843233|NCT01144364|2680155|P1|Induction Phase|Withdrawal by Subject|1
843234|NCT01144364|2680153|P3|Induction Phase|Death|0
843235|NCT01144364|2680154|P2|Induction Phase|Death|0
843236|NCT01144364|2680155|P1|Induction Phase|Death|1
843237|NCT01144364|2680153|P3|Induction Phase|Adverse Event|0
843238|NCT01144364|2680154|P2|Induction Phase|Adverse Event|0
843239|NCT01144364|2680155|P1|Induction Phase|Adverse Event|9
843240|NCT01144364|2680153|P3|Induction Phase|Disease progression|0
843241|NCT01144364|2680154|P2|Induction Phase|Disease progression|0
843242|NCT01144364|2680155|P1|Induction Phase|Disease progression|14
843243|NCT01144403|2680179|P1|Overall Study|Adverse Event|1
843244|NCT01144403|2680179|P1|Overall Study|Death|1
843245|NCT01144403|2680179|P1|Overall Study|Lost to Follow-up|3
843262|NCT01144715|2680249|P2|Overall Study|Adverse Event|1
843263|NCT01144715|2680250|P1|Overall Study|Adverse Event|0
843264|NCT01144715|2680249|P2|Overall Study|Withdrawal by Subject|1
843265|NCT01144715|2680250|P1|Overall Study|Withdrawal by Subject|2
843266|NCT01144715|2680249|P2|Overall Study|Lost to Follow-up|1
843267|NCT01144715|2680250|P1|Overall Study|Lost to Follow-up|2
843268|NCT01145352|2680281|P1|Overall Study|Syringe formulation was used|1
843269|NCT01145352|2680281|P1|Overall Study|Treated before marketing approval|4
843270|NCT01145352|2680281|P1|Overall Study|Found to have been registered twice|6
843271|NCT01145417|2680302|P2|Overall Study|Unspecified|0
843272|NCT01145417|2680303|P1|Overall Study|Unspecified|1
843273|NCT01145417|2680302|P2|Overall Study|Study terminated by sponsor|43
843274|NCT01145417|2680303|P1|Overall Study|Study terminated by sponsor|35
843275|NCT01145417|2680302|P2|Overall Study|Adverse Event|1
843276|NCT01145417|2680303|P1|Overall Study|Adverse Event|0
894070|NCT00463580|2837132|P2|Overall Study|Medical/psychiatric complications|2
843277|NCT01145417|2680302|P2|Overall Study|Pregnancy|0
843278|NCT01145417|2680303|P1|Overall Study|Pregnancy|1
843279|NCT01145417|2680302|P2|Overall Study|Withdrawal by Subject|2
843280|NCT01145417|2680303|P1|Overall Study|Withdrawal by Subject|1
843281|NCT01145417|2680302|P2|Overall Study|Lost to Follow-up|1
843282|NCT01145417|2680303|P1|Overall Study|Lost to Follow-up|2
843283|NCT01145417|2680302|P2|Overall Study|Death|0
843284|NCT01145417|2680303|P1|Overall Study|Death|1
843285|NCT01145482|2680327|P2|First Intervention (1 Day)|Withdrawal by Subject|1
843286|NCT01145482|2680328|P1|First Intervention (1 Day)|Withdrawal by Subject|0
843290|NCT01145508|2680342|P2|Overall Study|Never started treatment|1
843291|NCT01145508|2680343|P1|Overall Study|Never started treatment|1
843292|NCT01145508|2680342|P2|Overall Study|Physician Decision|1
843293|NCT01145508|2680343|P1|Overall Study|Physician Decision|2
843294|NCT01145508|2680342|P2|Overall Study|Death|0
843295|NCT01145508|2680343|P1|Overall Study|Death|1
843296|NCT01145508|2680342|P2|Overall Study|Adverse Event|0
843297|NCT01145508|2680343|P1|Overall Study|Adverse Event|1
843298|NCT01145560|2680359|P3|Overall Study|Withdrawal of therapy|1
843299|NCT01145560|2680360|P2|Overall Study|Withdrawal of therapy|0
843300|NCT01145560|2680361|P1|Overall Study|Withdrawal of therapy|0
843301|NCT01145560|2680359|P3|Overall Study|False insurance information|0
843302|NCT01145560|2680360|P2|Overall Study|False insurance information|1
843303|NCT01145560|2680361|P1|Overall Study|False insurance information|0
843304|NCT01145560|2680359|P3|Overall Study|Accidental unblinding of study treatment|0
843305|NCT01145560|2680360|P2|Overall Study|Accidental unblinding of study treatment|1
843306|NCT01145560|2680361|P1|Overall Study|Accidental unblinding of study treatment|0
843307|NCT01145560|2680359|P3|Overall Study|No study drug by 24h after organ failure|0
843308|NCT01145560|2680360|P2|Overall Study|No study drug by 24h after organ failure|0
843309|NCT01145560|2680361|P1|Overall Study|No study drug by 24h after organ failure|1
843310|NCT01145560|2680359|P3|Overall Study|Lost to Follow-up|1
843311|NCT01145560|2680360|P2|Overall Study|Lost to Follow-up|1
843312|NCT01145560|2680361|P1|Overall Study|Lost to Follow-up|1
843313|NCT01145560|2680359|P3|Overall Study|Withdrawal by Subject|0
843314|NCT01145560|2680360|P2|Overall Study|Withdrawal by Subject|1
843315|NCT01145560|2680361|P1|Overall Study|Withdrawal by Subject|2
843316|NCT01145625|2680380|P2|Overall Study|Pregnancy|1
843317|NCT01145625|2680381|P1|Overall Study|Pregnancy|0
843318|NCT01145625|2680380|P2|Overall Study|Withdrawal by Subject|16
843319|NCT01145625|2680381|P1|Overall Study|Withdrawal by Subject|7
843320|NCT01145625|2680380|P2|Overall Study|Protocol Violation|1
843321|NCT01145625|2680381|P1|Overall Study|Protocol Violation|3
843322|NCT01145625|2680380|P2|Overall Study|Adverse Event|4
843323|NCT01145625|2680381|P1|Overall Study|Adverse Event|6
843324|NCT01145625|2680380|P2|Overall Study|Lost to Follow-up|9
843325|NCT01145625|2680381|P1|Overall Study|Lost to Follow-up|8
843326|NCT01145755|2680405|P3|Overall Study|Positive urine ethanol|0
843327|NCT01145755|2680406|P2|Overall Study|Positive urine ethanol|1
843328|NCT01145755|2680407|P1|Overall Study|Positive urine ethanol|0
843329|NCT01145755|2680405|P3|Overall Study|Withdrawal by Subject|1
843330|NCT01145755|2680406|P2|Overall Study|Withdrawal by Subject|0
843331|NCT01145755|2680407|P1|Overall Study|Withdrawal by Subject|0
843332|NCT01145755|2680405|P3|Overall Study|Patient could not swollow medication|1
843333|NCT01145755|2680406|P2|Overall Study|Patient could not swollow medication|0
843334|NCT01145755|2680407|P1|Overall Study|Patient could not swollow medication|0
843335|NCT01145755|2680405|P3|Overall Study|Lack of Efficacy|0
843336|NCT01145755|2680406|P2|Overall Study|Lack of Efficacy|1
843337|NCT01145755|2680407|P1|Overall Study|Lack of Efficacy|0
843338|NCT01145755|2680405|P3|Overall Study|Study Closure|17
843339|NCT01145755|2680406|P2|Overall Study|Study Closure|14
843340|NCT01145755|2680407|P1|Overall Study|Study Closure|14
843341|NCT01145755|2680405|P3|Overall Study|Protocol Violation|1
843342|NCT01145755|2680406|P2|Overall Study|Protocol Violation|3
843343|NCT01145755|2680407|P1|Overall Study|Protocol Violation|0
843344|NCT01145755|2680405|P3|Overall Study|Lost to Follow-up|1
843345|NCT01145755|2680406|P2|Overall Study|Lost to Follow-up|3
843346|NCT01145755|2680407|P1|Overall Study|Lost to Follow-up|2
843347|NCT01145755|2680405|P3|Overall Study|Withdrawal by Subject|2
843348|NCT01145755|2680406|P2|Overall Study|Withdrawal by Subject|2
843349|NCT01145755|2680407|P1|Overall Study|Withdrawal by Subject|2
843350|NCT01145755|2680405|P3|Overall Study|Adverse Event|2
843351|NCT01145755|2680406|P2|Overall Study|Adverse Event|4
843352|NCT01145755|2680407|P1|Overall Study|Adverse Event|2
843353|NCT01145898|2680423|P2|3-year Treatment|medication change by treating physician|16
843354|NCT01145898|2680424|P1|3-year Treatment|medication change by treating physician|3
843355|NCT01146054|2680455|P1|Overall Study|Lost to Follow-up|1
843356|NCT01146054|2680455|P1|Overall Study|Other illness precluded treatment|2
843357|NCT01146054|2680455|P1|Overall Study|Rapid tumor progression|2
843358|NCT01146054|2680455|P1|Overall Study|Did not meet dose constraints for SBRT|5
843359|NCT01146288|2680470|P2|First Intervention(1 Day)|Adverse Event|1
843360|NCT01146288|2680471|P1|First Intervention(1 Day)|Adverse Event|0
843361|NCT01146613|2680565|P2|Overall Study|Outpatient detox|0
843362|NCT01146613|2680566|P1|Overall Study|Outpatient detox|1
843363|NCT01146613|2680565|P2|Overall Study|schedule conflict|0
843364|NCT01146613|2680566|P1|Overall Study|schedule conflict|1
843365|NCT01146613|2680565|P2|Overall Study|Withdrawal by Subject|3
843366|NCT01146613|2680566|P1|Overall Study|Withdrawal by Subject|0
843367|NCT01146613|2680565|P2|Overall Study|Physician Decision|0
843368|NCT01146613|2680566|P1|Overall Study|Physician Decision|1
843369|NCT01146613|2680565|P2|Overall Study|Death|0
843370|NCT01146613|2680566|P1|Overall Study|Death|1
843371|NCT01146613|2680565|P2|Overall Study|Lack of Efficacy|1
843372|NCT01146613|2680566|P1|Overall Study|Lack of Efficacy|0
843373|NCT01146613|2680565|P2|Overall Study|Lost to Follow-up|8
843374|NCT01146613|2680566|P1|Overall Study|Lost to Follow-up|3
843375|NCT01146782|2680572|P1|Primary Endpoint Cohort|Physician Decision|1
843376|NCT01146782|2680572|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
843377|NCT01146782|2680572|P1|Safety Cohort|TST <4 hrs|14
843378|NCT01146782|2680572|P1|Safety Cohort|Control AHI <5|4
843379|NCT01146782|2680572|P1|Safety Cohort|Withdrawal by Subject|4
843380|NCT01146782|2680572|P1|Safety Cohort|Screen Failure|61
843381|NCT01146782|2680572|P1|Screening Cohort|Withdrawal by Subject|29
843382|NCT01146782|2680572|P1|Screening Cohort|Physician Decision|1
843383|NCT01146782|2680572|P1|Screening Cohort|Lost to Follow-up|4
843384|NCT01146782|2680572|P1|Screening Cohort|Screen Failure|187
843385|NCT01146860|2680587|P2|Overall Study|Withdrawal by Subject|1
843386|NCT01146860|2680588|P1|Overall Study|Withdrawal by Subject|0
843387|NCT01146873|2680604|P2|Overall Study|Transfer out|6
843388|NCT01146873|2680605|P1|Overall Study|Transfer out|0
843389|NCT01146912|2680626|P8|Overall Study|Duplicate patient|0
843390|NCT01146912|2680627|P7|Overall Study|Duplicate patient|0
843391|NCT01146912|2680628|P6|Overall Study|Duplicate patient|0
843392|NCT01146912|2680629|P5|Overall Study|Duplicate patient|0
843393|NCT01146912|2680630|P4|Overall Study|Duplicate patient|0
843394|NCT01146912|2680631|P3|Overall Study|Duplicate patient|1
843395|NCT01146912|2680632|P2|Overall Study|Duplicate patient|0
843396|NCT01146912|2680633|P1|Overall Study|Duplicate patient|0
843397|NCT01146912|2680626|P8|Overall Study|< 14 weeks gestational age|0
843398|NCT01146912|2680627|P7|Overall Study|< 14 weeks gestational age|0
843399|NCT01146912|2680628|P6|Overall Study|< 14 weeks gestational age|0
843400|NCT01146912|2680629|P5|Overall Study|< 14 weeks gestational age|0
843401|NCT01146912|2680630|P4|Overall Study|< 14 weeks gestational age|2
843402|NCT01146912|2680631|P3|Overall Study|< 14 weeks gestational age|3
843403|NCT01146912|2680632|P2|Overall Study|< 14 weeks gestational age|0
843404|NCT01146912|2680633|P1|Overall Study|< 14 weeks gestational age|0
843405|NCT01146912|2680626|P8|Overall Study|Already received influenza vaccination|0
843406|NCT01146912|2680627|P7|Overall Study|Already received influenza vaccination|56
843407|NCT01146912|2680628|P6|Overall Study|Already received influenza vaccination|61
843408|NCT01146912|2680629|P5|Overall Study|Already received influenza vaccination|41
843409|NCT01146912|2680630|P4|Overall Study|Already received influenza vaccination|15
843410|NCT01146912|2680631|P3|Overall Study|Already received influenza vaccination|13
843411|NCT01146912|2680632|P2|Overall Study|Already received influenza vaccination|822
843412|NCT01146912|2680633|P1|Overall Study|Already received influenza vaccination|817
843413|NCT01146951|2680655|P2|Overall Study|Adverse Event|1
843414|NCT01146951|2680656|P1|Overall Study|Adverse Event|4
843415|NCT01147055|2680678|P2|First Intervention Period|Lost to Follow-up|0
843416|NCT01147055|2680679|P1|First Intervention Period|Lost to Follow-up|1
843417|NCT01147068|2680718|P7|Subjects That Completed Safety Follow-up|Ineligible|0
843418|NCT01147068|2680719|P6|Subjects That Completed Safety Follow-up|Ineligible|0
843419|NCT01147068|2680720|P5|Subjects That Completed Safety Follow-up|Ineligible|0
843420|NCT01147068|2680721|P4|Subjects That Completed Safety Follow-up|Ineligible|0
843421|NCT01147068|2680722|P3|Subjects That Completed Safety Follow-up|Ineligible|0
843422|NCT01147068|2680723|P2|Subjects That Completed Safety Follow-up|Ineligible|1
843423|NCT01147068|2680724|P1|Subjects That Completed Safety Follow-up|Ineligible|0
843424|NCT01147068|2680718|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843425|NCT01147068|2680719|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843426|NCT01147068|2680720|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843427|NCT01147068|2680721|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
843428|NCT01147068|2680722|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843429|NCT01147068|2680723|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843430|NCT01147068|2680724|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
843431|NCT01147068|2680718|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
843432|NCT01147068|2680719|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
843433|NCT01147068|2680720|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
843434|NCT01147068|2680721|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
843435|NCT01147068|2680722|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
843436|NCT01147068|2680723|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
843437|NCT01147068|2680724|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
843438|NCT01147068|2680718|P7|Subjects That Received 2nd Dose|Other|0
843439|NCT01147068|2680719|P6|Subjects That Received 2nd Dose|Other|0
843440|NCT01147068|2680720|P5|Subjects That Received 2nd Dose|Other|1
843441|NCT01147068|2680721|P4|Subjects That Received 2nd Dose|Other|0
843442|NCT01147068|2680722|P3|Subjects That Received 2nd Dose|Other|3
843443|NCT01147068|2680723|P2|Subjects That Received 2nd Dose|Other|3
843444|NCT01147068|2680724|P1|Subjects That Received 2nd Dose|Other|0
843445|NCT01147068|2680718|P7|Subjects That Received 2nd Dose|Did not complete the study|0
843446|NCT01147068|2680719|P6|Subjects That Received 2nd Dose|Did not complete the study|1
843447|NCT01147068|2680720|P5|Subjects That Received 2nd Dose|Did not complete the study|0
843448|NCT01147068|2680721|P4|Subjects That Received 2nd Dose|Did not complete the study|0
843449|NCT01147068|2680722|P3|Subjects That Received 2nd Dose|Did not complete the study|0
843450|NCT01147068|2680723|P2|Subjects That Received 2nd Dose|Did not complete the study|1
843451|NCT01147068|2680724|P1|Subjects That Received 2nd Dose|Did not complete the study|0
843452|NCT01147068|2680718|P7|Subjects That Received 2nd Dose|Ineligible|0
843453|NCT01147068|2680719|P6|Subjects That Received 2nd Dose|Ineligible|0
843454|NCT01147068|2680720|P5|Subjects That Received 2nd Dose|Ineligible|0
843455|NCT01147068|2680721|P4|Subjects That Received 2nd Dose|Ineligible|0
843456|NCT01147068|2680722|P3|Subjects That Received 2nd Dose|Ineligible|0
843457|NCT01147068|2680723|P2|Subjects That Received 2nd Dose|Ineligible|1
843458|NCT01147068|2680724|P1|Subjects That Received 2nd Dose|Ineligible|0
843459|NCT01147068|2680718|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
843460|NCT01147068|2680719|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
843461|NCT01147068|2680720|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
843462|NCT01147068|2680721|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
843463|NCT01147068|2680722|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
843464|NCT01147068|2680723|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
843465|NCT01147068|2680724|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
894071|NCT00463580|2837133|P1|Overall Study|Medical/psychiatric complications|0
843468|NCT01147250|2680767|P2|Overall Study|Other than specified|1
843469|NCT01147250|2680768|P1|Overall Study|Other than specified|0
843470|NCT01147250|2680767|P2|Overall Study|Site termination by sponsor|5
843471|NCT01147250|2680768|P1|Overall Study|Site termination by sponsor|13
843472|NCT01147250|2680767|P2|Overall Study|Withdrawal by Subject|88
843473|NCT01147250|2680768|P1|Overall Study|Withdrawal by Subject|83
843474|NCT01147250|2680767|P2|Overall Study|Lost to Follow-up|11
843475|NCT01147250|2680768|P1|Overall Study|Lost to Follow-up|14
843476|NCT01147341|2680815|P2|Open Label Period|Subject moved|0
843477|NCT01147341|2680816|P1|Open Label Period|Subject moved|1
843478|NCT01147341|2680815|P2|Open Label Period|Lack of Efficacy|0
843479|NCT01147341|2680816|P1|Open Label Period|Lack of Efficacy|3
843480|NCT01147341|2680815|P2|Double Blind Period|Withdrawal by Subject|1
843481|NCT01147341|2680816|P1|Double Blind Period|Withdrawal by Subject|0
843482|NCT01147341|2680815|P2|Double Blind Period|Lack of Efficacy|1
843483|NCT01147341|2680816|P1|Double Blind Period|Lack of Efficacy|1
843484|NCT01147393|2680855|P1|Dose Level -1|Dose Limited Toxicity|1
843485|NCT01147393|2680855|P1|Dose Level 1|Dose limiting Toxicity|2
843486|NCT01147458|2680894|P4|Second Intervention|Unspecified|0
843487|NCT01147458|2680895|P3|Second Intervention|Unspecified|1
843488|NCT01147458|2680896|P2|Second Intervention|Unspecified|0
843489|NCT01147458|2680897|P1|Second Intervention|Unspecified|0
843490|NCT01147458|2680894|P4|Second Intervention|Adverse Event|1
843491|NCT01147458|2680895|P3|Second Intervention|Adverse Event|1
843492|NCT01147458|2680896|P2|Second Intervention|Adverse Event|0
843493|NCT01147458|2680897|P1|Second Intervention|Adverse Event|2
843494|NCT01147458|2680894|P4|Second Intervention|Withdrawal by Subject|0
843495|NCT01147458|2680895|P3|Second Intervention|Withdrawal by Subject|0
843496|NCT01147458|2680896|P2|Second Intervention|Withdrawal by Subject|1
843497|NCT01147458|2680897|P1|Second Intervention|Withdrawal by Subject|0
843498|NCT01147458|2680894|P4|Second Intervention|Protocol Violation|0
843499|NCT01147458|2680895|P3|Second Intervention|Protocol Violation|1
843500|NCT01147458|2680896|P2|Second Intervention|Protocol Violation|1
843501|NCT01147458|2680897|P1|Second Intervention|Protocol Violation|0
843502|NCT01147458|2680894|P4|Second Intervention|Study terminated by sponsor|3
843503|NCT01147458|2680895|P3|Second Intervention|Study terminated by sponsor|5
843504|NCT01147458|2680896|P2|Second Intervention|Study terminated by sponsor|5
843505|NCT01147458|2680897|P1|Second Intervention|Study terminated by sponsor|7
843506|NCT01147458|2680894|P4|First Intervention|Unspecified|0
843507|NCT01147458|2680895|P3|First Intervention|Unspecified|0
843508|NCT01147458|2680896|P2|First Intervention|Unspecified|2
843509|NCT01147458|2680897|P1|First Intervention|Unspecified|1
843510|NCT01147458|2680894|P4|First Intervention|Adverse Event|3
843511|NCT01147458|2680895|P3|First Intervention|Adverse Event|2
843512|NCT01147458|2680896|P2|First Intervention|Adverse Event|3
843513|NCT01147458|2680897|P1|First Intervention|Adverse Event|0
843514|NCT01147458|2680894|P4|First Intervention|Withdrawal by Subject|0
843515|NCT01147458|2680895|P3|First Intervention|Withdrawal by Subject|1
843516|NCT01147458|2680896|P2|First Intervention|Withdrawal by Subject|0
843517|NCT01147458|2680897|P1|First Intervention|Withdrawal by Subject|3
843518|NCT01147458|2680894|P4|First Intervention|Protocol Violation|3
843519|NCT01147458|2680895|P3|First Intervention|Protocol Violation|2
843520|NCT01147458|2680896|P2|First Intervention|Protocol Violation|3
843521|NCT01147458|2680897|P1|First Intervention|Protocol Violation|2
843522|NCT01147458|2680894|P4|First Intervention|Study terminated by sponsor|8
843523|NCT01147458|2680895|P3|First Intervention|Study terminated by sponsor|7
843524|NCT01147458|2680896|P2|First Intervention|Study terminated by sponsor|8
843610|NCT01147744|2681155|P1|Overall Study|Physician Decision|0
843525|NCT01147458|2680897|P1|First Intervention|Study terminated by sponsor|8
843526|NCT01147471|2680947|P2|6 Month Follow Up|Lost to Follow-up|2
843527|NCT01147471|2680948|P1|6 Month Follow Up|Lost to Follow-up|4
843528|NCT01147471|2680947|P2|3 Month Follow Up|Physician Decision|1
843529|NCT01147471|2680948|P1|3 Month Follow Up|Physician Decision|0
843530|NCT01147471|2680947|P2|3 Month Follow Up|Lost to Follow-up|1
843531|NCT01147471|2680948|P1|3 Month Follow Up|Lost to Follow-up|1
843532|NCT01147471|2680947|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
843533|NCT01147471|2680948|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
843534|NCT01147471|2680947|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
843535|NCT01147471|2680948|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
843536|NCT01147471|2680947|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
843537|NCT01147471|2680948|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
843538|NCT01147497|2680964|P2|Overall Study|failed insertion|0
843539|NCT01147497|2680965|P1|Overall Study|failed insertion|2
894072|NCT00463580|2837132|P2|Overall Study|schedule conflict|0
843543|NCT01142115|2681017|P2|First Intervention|Adverse Event|0
843544|NCT01142115|2681018|P1|First Intervention|Adverse Event|1
843545|NCT01142115|2681017|P2|First Intervention|Lack of Efficacy|1
843546|NCT01142115|2681018|P1|First Intervention|Lack of Efficacy|1
843547|NCT01142128|2681037|P1|Overall Study|Withdrawal by Subject|2
843548|NCT01142128|2681037|P1|Overall Study|Lost to Follow-up|1
843549|NCT01142128|2681037|P1|Overall Study|Physician Decision|1
843550|NCT01147640|2681071|P2|Overall Study|Didn't meet eligibility criteria|0
843551|NCT01147640|2681072|P1|Overall Study|Didn't meet eligibility criteria|1
843552|NCT01147640|2681071|P2|Overall Study|Lost to Follow-up|1
843553|NCT01147640|2681072|P1|Overall Study|Lost to Follow-up|0
843554|NCT01147640|2681071|P2|Overall Study|Withdrawal by Subject|0
843555|NCT01147640|2681072|P1|Overall Study|Withdrawal by Subject|1
843556|NCT01147640|2681071|P2|Overall Study|Physician Decision|0
843557|NCT01147640|2681072|P1|Overall Study|Physician Decision|1
843558|NCT01147640|2681071|P2|Overall Study|Adverse Event|0
843559|NCT01147640|2681072|P1|Overall Study|Adverse Event|2
894073|NCT00463580|2837133|P1|Overall Study|schedule conflict|2
894074|NCT00463580|2837132|P2|Overall Study|Lost to Follow-up|0
843562|NCT01147744|2681149|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
843563|NCT01147744|2681150|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
843564|NCT01147744|2681151|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
843565|NCT01147744|2681152|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
843566|NCT01147744|2681153|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
843567|NCT01147744|2681154|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
843568|NCT01147744|2681155|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
843569|NCT01147744|2681149|P7|Overall Study|Sponsor decision to amend protocol|6
843570|NCT01147744|2681150|P6|Overall Study|Sponsor decision to amend protocol|2
843571|NCT01147744|2681151|P5|Overall Study|Sponsor decision to amend protocol|7
843572|NCT01147744|2681152|P4|Overall Study|Sponsor decision to amend protocol|5
843573|NCT01147744|2681153|P3|Overall Study|Sponsor decision to amend protocol|2
843574|NCT01147744|2681154|P2|Overall Study|Sponsor decision to amend protocol|4
843575|NCT01147744|2681155|P1|Overall Study|Sponsor decision to amend protocol|7
843576|NCT01147744|2681149|P7|Overall Study|Lost to Follow-up|0
843577|NCT01147744|2681150|P6|Overall Study|Lost to Follow-up|0
843578|NCT01147744|2681151|P5|Overall Study|Lost to Follow-up|0
843579|NCT01147744|2681152|P4|Overall Study|Lost to Follow-up|0
843580|NCT01147744|2681153|P3|Overall Study|Lost to Follow-up|0
843581|NCT01147744|2681154|P2|Overall Study|Lost to Follow-up|1
843582|NCT01147744|2681155|P1|Overall Study|Lost to Follow-up|0
843583|NCT01147744|2681149|P7|Overall Study|Withdrawal by Subject|2
843584|NCT01147744|2681150|P6|Overall Study|Withdrawal by Subject|5
843585|NCT01147744|2681151|P5|Overall Study|Withdrawal by Subject|2
843586|NCT01147744|2681152|P4|Overall Study|Withdrawal by Subject|2
843587|NCT01147744|2681153|P3|Overall Study|Withdrawal by Subject|2
843588|NCT01147744|2681154|P2|Overall Study|Withdrawal by Subject|4
843589|NCT01147744|2681155|P1|Overall Study|Withdrawal by Subject|8
843590|NCT01147744|2681149|P7|Overall Study|Adverse Event|2
843591|NCT01147744|2681150|P6|Overall Study|Adverse Event|1
843592|NCT01147744|2681151|P5|Overall Study|Adverse Event|2
843593|NCT01147744|2681152|P4|Overall Study|Adverse Event|0
843594|NCT01147744|2681153|P3|Overall Study|Adverse Event|3
843595|NCT01147744|2681154|P2|Overall Study|Adverse Event|2
843596|NCT01147744|2681155|P1|Overall Study|Adverse Event|1
843597|NCT01147744|2681149|P7|Overall Study|Lack of Efficacy|7
843598|NCT01147744|2681150|P6|Overall Study|Lack of Efficacy|8
843599|NCT01147744|2681151|P5|Overall Study|Lack of Efficacy|13
843600|NCT01147744|2681152|P4|Overall Study|Lack of Efficacy|11
843601|NCT01147744|2681153|P3|Overall Study|Lack of Efficacy|9
843602|NCT01147744|2681154|P2|Overall Study|Lack of Efficacy|11
843603|NCT01147744|2681155|P1|Overall Study|Lack of Efficacy|11
843604|NCT01147744|2681149|P7|Overall Study|Physician Decision|1
843605|NCT01147744|2681150|P6|Overall Study|Physician Decision|0
843606|NCT01147744|2681151|P5|Overall Study|Physician Decision|0
843607|NCT01147744|2681152|P4|Overall Study|Physician Decision|0
843608|NCT01147744|2681153|P3|Overall Study|Physician Decision|1
843609|NCT01147744|2681154|P2|Overall Study|Physician Decision|1
894075|NCT00463580|2837133|P1|Overall Study|Lost to Follow-up|1
843611|NCT01147744|2681149|P7|Overall Study|Protocol Violation|1
843612|NCT01147744|2681150|P6|Overall Study|Protocol Violation|3
843613|NCT01147744|2681151|P5|Overall Study|Protocol Violation|1
843614|NCT01147744|2681152|P4|Overall Study|Protocol Violation|0
843615|NCT01147744|2681153|P3|Overall Study|Protocol Violation|1
843616|NCT01147744|2681154|P2|Overall Study|Protocol Violation|0
843617|NCT01147744|2681155|P1|Overall Study|Protocol Violation|1
843618|NCT01147809|2681254|P6|Phase II (168 Days)|Ongoing|0
843619|NCT01147809|2681255|P5|Phase II (168 Days)|Ongoing|1
843620|NCT01147809|2681256|P4|Phase II (168 Days)|Ongoing|0
843621|NCT01147809|2681257|P3|Phase II (168 Days)|Ongoing|0
843622|NCT01147809|2681258|P2|Phase II (168 Days)|Ongoing|0
843623|NCT01147809|2681259|P1|Phase II (168 Days)|Ongoing|0
843624|NCT01147809|2681254|P6|Phase II (168 Days)|Withdrawal by Subject|15
843625|NCT01147809|2681255|P5|Phase II (168 Days)|Withdrawal by Subject|7
843626|NCT01147809|2681256|P4|Phase II (168 Days)|Withdrawal by Subject|0
843627|NCT01147809|2681257|P3|Phase II (168 Days)|Withdrawal by Subject|0
843628|NCT01147809|2681258|P2|Phase II (168 Days)|Withdrawal by Subject|0
843629|NCT01147809|2681259|P1|Phase II (168 Days)|Withdrawal by Subject|0
843630|NCT01147809|2681254|P6|Phase II (168 Days)|Physician Decision|11
843631|NCT01147809|2681255|P5|Phase II (168 Days)|Physician Decision|5
843632|NCT01147809|2681256|P4|Phase II (168 Days)|Physician Decision|0
843633|NCT01147809|2681257|P3|Phase II (168 Days)|Physician Decision|0
843634|NCT01147809|2681258|P2|Phase II (168 Days)|Physician Decision|0
843635|NCT01147809|2681259|P1|Phase II (168 Days)|Physician Decision|0
843636|NCT01147809|2681254|P6|Phase II (168 Days)|Protocol Violation|1
843637|NCT01147809|2681255|P5|Phase II (168 Days)|Protocol Violation|0
843638|NCT01147809|2681256|P4|Phase II (168 Days)|Protocol Violation|0
843639|NCT01147809|2681257|P3|Phase II (168 Days)|Protocol Violation|0
843640|NCT01147809|2681258|P2|Phase II (168 Days)|Protocol Violation|0
843641|NCT01147809|2681259|P1|Phase II (168 Days)|Protocol Violation|0
843642|NCT01147809|2681254|P6|Phase II (168 Days)|Adverse Event|6
843643|NCT01147809|2681255|P5|Phase II (168 Days)|Adverse Event|3
843644|NCT01147809|2681256|P4|Phase II (168 Days)|Adverse Event|0
843645|NCT01147809|2681257|P3|Phase II (168 Days)|Adverse Event|0
843646|NCT01147809|2681258|P2|Phase II (168 Days)|Adverse Event|0
843647|NCT01147809|2681259|P1|Phase II (168 Days)|Adverse Event|0
843648|NCT01147809|2681254|P6|Phase I (168 Days)|Withdrawal by Subject|0
843649|NCT01147809|2681255|P5|Phase I (168 Days)|Withdrawal by Subject|0
843650|NCT01147809|2681256|P4|Phase I (168 Days)|Withdrawal by Subject|3
843651|NCT01147809|2681257|P3|Phase I (168 Days)|Withdrawal by Subject|0
843652|NCT01147809|2681258|P2|Phase I (168 Days)|Withdrawal by Subject|0
843653|NCT01147809|2681259|P1|Phase I (168 Days)|Withdrawal by Subject|0
843654|NCT01147809|2681254|P6|Phase I (168 Days)|Physician Decision|0
843655|NCT01147809|2681255|P5|Phase I (168 Days)|Physician Decision|0
843656|NCT01147809|2681256|P4|Phase I (168 Days)|Physician Decision|0
843657|NCT01147809|2681257|P3|Phase I (168 Days)|Physician Decision|2
843658|NCT01147809|2681258|P2|Phase I (168 Days)|Physician Decision|1
843659|NCT01147809|2681259|P1|Phase I (168 Days)|Physician Decision|0
843660|NCT01147809|2681254|P6|Phase I (168 Days)|Lost to Follow-up|0
843661|NCT01147809|2681255|P5|Phase I (168 Days)|Lost to Follow-up|0
843662|NCT01147809|2681256|P4|Phase I (168 Days)|Lost to Follow-up|1
843663|NCT01147809|2681257|P3|Phase I (168 Days)|Lost to Follow-up|0
843664|NCT01147809|2681258|P2|Phase I (168 Days)|Lost to Follow-up|0
843665|NCT01147809|2681259|P1|Phase I (168 Days)|Lost to Follow-up|1
843666|NCT01147809|2681254|P6|Phase I (168 Days)|Adverse Event|0
843667|NCT01147809|2681255|P5|Phase I (168 Days)|Adverse Event|0
843668|NCT01147809|2681256|P4|Phase I (168 Days)|Adverse Event|1
843669|NCT01147809|2681257|P3|Phase I (168 Days)|Adverse Event|0
843670|NCT01147809|2681258|P2|Phase I (168 Days)|Adverse Event|0
843671|NCT01147809|2681259|P1|Phase I (168 Days)|Adverse Event|0
843672|NCT01147822|2681375|P2|Overall Study|Not Completed/Ongoing|102
843673|NCT01147822|2681376|P1|Overall Study|Not Completed/Ongoing|111
843674|NCT01147822|2681375|P2|Overall Study|Withdrawal by Subject|13
843675|NCT01147822|2681376|P1|Overall Study|Withdrawal by Subject|8
843676|NCT01147822|2681375|P2|Overall Study|Physician Decision|2
843677|NCT01147822|2681376|P1|Overall Study|Physician Decision|0
843678|NCT01147822|2681375|P2|Overall Study|Lost to Follow-up|2
843679|NCT01147822|2681376|P1|Overall Study|Lost to Follow-up|3
843680|NCT01147822|2681375|P2|Overall Study|Protocol Violation|1
843681|NCT01147822|2681376|P1|Overall Study|Protocol Violation|0
843682|NCT01147822|2681375|P2|Overall Study|Death|59
843683|NCT01147822|2681376|P1|Overall Study|Death|66
843684|NCT01147848|2681392|P3|Randomized Phase|Withdrawal by Subject|9
843685|NCT01147848|2681393|P2|Randomized Phase|Withdrawal by Subject|7
843686|NCT01147848|2681394|P1|Randomized Phase|Withdrawal by Subject|0
843687|NCT01147848|2681392|P3|Randomized Phase|Physician Decision|1
843688|NCT01147848|2681393|P2|Randomized Phase|Physician Decision|0
843689|NCT01147848|2681394|P1|Randomized Phase|Physician Decision|0
843690|NCT01147848|2681392|P3|Randomized Phase|Lost to Follow-up|7
843691|NCT01147848|2681393|P2|Randomized Phase|Lost to Follow-up|5
843692|NCT01147848|2681394|P1|Randomized Phase|Lost to Follow-up|0
843693|NCT01147848|2681392|P3|Randomized Phase|Protocol Violation|10
843694|NCT01147848|2681393|P2|Randomized Phase|Protocol Violation|7
843695|NCT01147848|2681394|P1|Randomized Phase|Protocol Violation|0
843696|NCT01147848|2681392|P3|Randomized Phase|Lack of Efficacy|11
843697|NCT01147848|2681393|P2|Randomized Phase|Lack of Efficacy|20
843698|NCT01147848|2681394|P1|Randomized Phase|Lack of Efficacy|0
843699|NCT01147848|2681392|P3|Randomized Phase|Adverse Event|8
843700|NCT01147848|2681393|P2|Randomized Phase|Adverse Event|6
843701|NCT01147848|2681394|P1|Randomized Phase|Adverse Event|0
843702|NCT01147848|2681392|P3|Run-in Period|Run-in Failure|0
843703|NCT01147848|2681393|P2|Run-in Period|Run-in Failure|0
843704|NCT01147848|2681394|P1|Run-in Period|Run-in Failure|135
843705|NCT01147848|2681392|P3|Run-in Period|Screen Failure|0
843706|NCT01147848|2681393|P2|Run-in Period|Screen Failure|0
843707|NCT01147848|2681394|P1|Run-in Period|Screen Failure|623
843708|NCT01147874|2681424|P1|Overall Study|Withdrawal by Subject|24
843709|NCT01147874|2681424|P1|Overall Study|Sponsor's Decision|2
843710|NCT01147874|2681424|P1|Overall Study|Protocol Violation|5
843711|NCT01147874|2681424|P1|Overall Study|Unspecified|5
843712|NCT01147874|2681424|P1|Overall Study|Lost to Follow-up|25
843713|NCT01147874|2681424|P1|Overall Study|Investigator’s Request|1
843714|NCT01147874|2681424|P1|Overall Study|Adverse Event|5
843715|NCT01147900|2681433|P3|At Year 10|Lost to Follow-up|0
843716|NCT01147900|2681434|P2|At Year 10|Lost to Follow-up|1
843717|NCT01147900|2681435|P1|At Year 10|Lost to Follow-up|0
843718|NCT01147926|2681496|P2|Overall Study|Colonoscopy result|1
843719|NCT01147926|2681497|P1|Overall Study|Colonoscopy result|0
843720|NCT01147926|2681496|P2|Overall Study|Went on holiday|1
843721|NCT01147926|2681497|P1|Overall Study|Went on holiday|0
843722|NCT01147926|2681496|P2|Overall Study|Too busy, no time for study|0
843723|NCT01147926|2681497|P1|Overall Study|Too busy, no time for study|1
843724|NCT01147926|2681496|P2|Overall Study|Lack of Efficacy|0
843725|NCT01147926|2681497|P1|Overall Study|Lack of Efficacy|1
843726|NCT01147926|2681496|P2|Overall Study|Sponsor's Decision|1
843727|NCT01147926|2681497|P1|Overall Study|Sponsor's Decision|0
843728|NCT01147926|2681496|P2|Overall Study|Lost to Follow-up|2
843729|NCT01147926|2681497|P1|Overall Study|Lost to Follow-up|0
843730|NCT01147926|2681496|P2|Overall Study|Selection criteria not met|1
843731|NCT01147926|2681497|P1|Overall Study|Selection criteria not met|3
843732|NCT01147926|2681496|P2|Overall Study|Principal investigator left hospital|3
843733|NCT01147926|2681497|P1|Overall Study|Principal investigator left hospital|1
843734|NCT01147926|2681496|P2|Overall Study|Subject Non-Compliant|4
843735|NCT01147926|2681497|P1|Overall Study|Subject Non-Compliant|5
843736|NCT01147926|2681496|P2|Overall Study|Adverse Event|6
843737|NCT01147926|2681497|P1|Overall Study|Adverse Event|7
843738|NCT01147926|2681496|P2|Overall Study|Subject Withdrew Consent|10
843739|NCT01147926|2681497|P1|Overall Study|Subject Withdrew Consent|9
843740|NCT01149057|2681529|P1|Overall Study|Unspecified|6
843741|NCT01149057|2681529|P1|Overall Study|High Parathyroid Hormone Value|1
843742|NCT01149057|2681529|P1|Overall Study|Lost to Follow-up|1
843743|NCT01149057|2681529|P1|Overall Study|Participant Non-Compliance|2
843744|NCT01149057|2681529|P1|Overall Study|B Cell Depletion|4
843745|NCT01149057|2681529|P1|Overall Study|Positive Hepatitis B Core Antibody|5
843746|NCT01149057|2681529|P1|Overall Study|Withdrawal by Subject|9
843747|NCT01149057|2681529|P1|Overall Study|Adverse Event|13
843748|NCT01149057|2681529|P1|Overall Study|Lack of Efficacy|16
843749|NCT01149148|2681556|P2|Overall Study|Death|0
843750|NCT01149148|2681557|P1|Overall Study|Death|1
843751|NCT01149148|2681556|P2|Overall Study|Lost to Follow-up|2
843752|NCT01149148|2681557|P1|Overall Study|Lost to Follow-up|1
843753|NCT01149421|2681568|P3|Overall Study|Protocol Violation|6
843754|NCT01149421|2681569|P2|Overall Study|Protocol Violation|2
843755|NCT01149421|2681570|P1|Overall Study|Protocol Violation|2
843756|NCT01149421|2681568|P3|Overall Study|Entry Criteria Not Met|2
843757|NCT01149421|2681569|P2|Overall Study|Entry Criteria Not Met|1
843758|NCT01149421|2681570|P1|Overall Study|Entry Criteria Not Met|1
843759|NCT01149421|2681568|P3|Overall Study|Physician Decision|6
843760|NCT01149421|2681569|P2|Overall Study|Physician Decision|3
843761|NCT01149421|2681570|P1|Overall Study|Physician Decision|5
843762|NCT01149421|2681568|P3|Overall Study|Lost to Follow-up|5
843763|NCT01149421|2681569|P2|Overall Study|Lost to Follow-up|4
843764|NCT01149421|2681570|P1|Overall Study|Lost to Follow-up|2
843765|NCT01149421|2681568|P3|Overall Study|Sponsor Decision|1
843766|NCT01149421|2681569|P2|Overall Study|Sponsor Decision|1
843767|NCT01149421|2681570|P1|Overall Study|Sponsor Decision|0
843768|NCT01149421|2681568|P3|Overall Study|Withdrawal by Subject|13
843769|NCT01149421|2681569|P2|Overall Study|Withdrawal by Subject|12
843770|NCT01149421|2681570|P1|Overall Study|Withdrawal by Subject|20
843771|NCT01149421|2681568|P3|Overall Study|Adverse Event|11
843772|NCT01149421|2681569|P2|Overall Study|Adverse Event|6
843773|NCT01149421|2681570|P1|Overall Study|Adverse Event|22
843774|NCT01149460|2681665|P2|Overall Study|Withdrawal by Subject|2
843775|NCT01149460|2681666|P1|Overall Study|Withdrawal by Subject|0
843776|NCT01149473|2681684|P2|Washout of 7 Days|Withdrawal by Subject|1
843777|NCT01149473|2681685|P1|Washout of 7 Days|Withdrawal by Subject|1
843778|NCT01149473|2681684|P2|First Intervention|Adverse Event|1
843779|NCT01149473|2681685|P1|First Intervention|Adverse Event|1
843780|NCT01149486|2681703|P2|First Intervention|Adverse Event|1
843781|NCT01149486|2681704|P1|First Intervention|Adverse Event|0
843782|NCT01149538|2681733|P2|Overall Study|Withdrawal by Subject|3
843783|NCT01149538|2681734|P1|Overall Study|Withdrawal by Subject|5
843784|NCT01149538|2681733|P2|Overall Study|Lost to Follow-up|1
843785|NCT01149538|2681734|P1|Overall Study|Lost to Follow-up|0
843786|NCT01149655|2681763|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
843787|NCT01149655|2681764|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
843788|NCT01149655|2681765|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
843789|NCT01149655|2681766|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
843790|NCT01149655|2681763|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
843791|NCT01149655|2681764|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
843792|NCT01149655|2681765|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
843793|NCT01149655|2681766|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
843794|NCT01149655|2681763|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
843795|NCT01149655|2681764|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
843796|NCT01149655|2681765|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
843797|NCT01149655|2681766|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
843798|NCT01149655|2681763|P4|Period 3-DB Maintenance Phase|Physician Decision|0
843799|NCT01149655|2681764|P3|Period 3-DB Maintenance Phase|Physician Decision|1
843800|NCT01149655|2681765|P2|Period 3-DB Maintenance Phase|Physician Decision|0
843801|NCT01149655|2681766|P1|Period 3-DB Maintenance Phase|Physician Decision|0
843802|NCT01149655|2681763|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
843803|NCT01149655|2681764|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
843804|NCT01149655|2681765|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
843805|NCT01149655|2681766|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
843806|NCT01149655|2681763|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
843807|NCT01149655|2681764|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
843808|NCT01149655|2681765|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
843809|NCT01149655|2681766|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
843810|NCT01149655|2681763|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
843811|NCT01149655|2681764|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
843812|NCT01149655|2681765|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
843813|NCT01149655|2681766|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
843814|NCT01149655|2681763|P4|Period 2-Stabilization Phase|Physician Decision|0
843815|NCT01149655|2681764|P3|Period 2-Stabilization Phase|Physician Decision|0
843816|NCT01149655|2681765|P2|Period 2-Stabilization Phase|Physician Decision|3
843817|NCT01149655|2681766|P1|Period 2-Stabilization Phase|Physician Decision|0
843818|NCT01149655|2681763|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
843819|NCT01149655|2681764|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
843820|NCT01149655|2681765|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
843821|NCT01149655|2681766|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
843822|NCT01149655|2681763|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
843823|NCT01149655|2681764|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
843824|NCT01149655|2681765|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
843825|NCT01149655|2681766|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
843826|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
843827|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
843828|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
843829|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
843830|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
843831|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
843832|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
843833|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
843834|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Physician Decision|0
843835|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Physician Decision|0
843836|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Physician Decision|0
843837|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Physician Decision|2
843838|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
843839|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
843840|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
843841|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
843842|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
843843|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
843844|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
843845|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
843846|NCT01149655|2681763|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
843847|NCT01149655|2681764|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
843848|NCT01149655|2681765|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
843849|NCT01149655|2681766|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
843850|NCT01149863|2681864|P1|Overall Study|Missing data or Not receiveing studydrug|3
843851|NCT01150097|2681893|P3|Months 24 to 48 Post-transplantation|Death|0
843852|NCT01150097|2681894|P2|Months 24 to 48 Post-transplantation|Death|0
843853|NCT01150097|2681895|P1|Months 24 to 48 Post-transplantation|Death|2
843854|NCT01150097|2681893|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
843855|NCT01150097|2681894|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
843856|NCT01150097|2681895|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
843857|NCT01150097|2681893|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
843858|NCT01150097|2681894|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
843859|NCT01150097|2681895|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
843860|NCT01150097|2681893|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
843861|NCT01150097|2681894|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
843862|NCT01150097|2681895|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
843863|NCT01150097|2681893|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
843864|NCT01150097|2681894|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
843865|NCT01150097|2681895|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
843866|NCT01150097|2681893|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
843867|NCT01150097|2681894|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
843868|NCT01150097|2681895|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
843869|NCT01150097|2681893|P3|Months 24 to 36 Post-transplantation|Death|0
843870|NCT01150097|2681894|P2|Months 24 to 36 Post-transplantation|Death|0
843871|NCT01150097|2681895|P1|Months 24 to 36 Post-transplantation|Death|2
843872|NCT01150123|2681936|P18|Overall Study|Lost to Follow-up|0
843873|NCT01150123|2681937|P17|Overall Study|Lost to Follow-up|0
843874|NCT01150123|2681938|P16|Overall Study|Lost to Follow-up|0
843875|NCT01150123|2681939|P15|Overall Study|Lost to Follow-up|0
843876|NCT01150123|2681940|P14|Overall Study|Lost to Follow-up|0
843877|NCT01150123|2681941|P13|Overall Study|Lost to Follow-up|2
843878|NCT01150123|2681942|P12|Overall Study|Lost to Follow-up|1
843879|NCT01150123|2681943|P11|Overall Study|Lost to Follow-up|1
843880|NCT01150123|2681944|P10|Overall Study|Lost to Follow-up|1
843881|NCT01150123|2681945|P9|Overall Study|Lost to Follow-up|3
843882|NCT01150123|2681946|P8|Overall Study|Lost to Follow-up|0
843883|NCT01150123|2681947|P7|Overall Study|Lost to Follow-up|0
843884|NCT01150123|2681948|P6|Overall Study|Lost to Follow-up|5
843885|NCT01150123|2681949|P5|Overall Study|Lost to Follow-up|2
843886|NCT01150123|2681950|P4|Overall Study|Lost to Follow-up|2
843887|NCT01150123|2681951|P3|Overall Study|Lost to Follow-up|2
843888|NCT01150123|2681952|P2|Overall Study|Lost to Follow-up|1
843889|NCT01150123|2681953|P1|Overall Study|Lost to Follow-up|2
843890|NCT01150123|2681936|P18|Overall Study|Withdrawal by Subject|1
843891|NCT01150123|2681937|P17|Overall Study|Withdrawal by Subject|0
843892|NCT01150123|2681938|P16|Overall Study|Withdrawal by Subject|1
843893|NCT01150123|2681939|P15|Overall Study|Withdrawal by Subject|0
843894|NCT01150123|2681940|P14|Overall Study|Withdrawal by Subject|0
843895|NCT01150123|2681941|P13|Overall Study|Withdrawal by Subject|1
843896|NCT01150123|2681942|P12|Overall Study|Withdrawal by Subject|0
843897|NCT01150123|2681943|P11|Overall Study|Withdrawal by Subject|1
843898|NCT01150123|2681944|P10|Overall Study|Withdrawal by Subject|0
843899|NCT01150123|2681945|P9|Overall Study|Withdrawal by Subject|2
843900|NCT01150123|2681946|P8|Overall Study|Withdrawal by Subject|3
843901|NCT01150123|2681947|P7|Overall Study|Withdrawal by Subject|0
843902|NCT01150123|2681948|P6|Overall Study|Withdrawal by Subject|1
843903|NCT01150123|2681949|P5|Overall Study|Withdrawal by Subject|1
843904|NCT01150123|2681950|P4|Overall Study|Withdrawal by Subject|1
843905|NCT01150123|2681951|P3|Overall Study|Withdrawal by Subject|2
843906|NCT01150123|2681952|P2|Overall Study|Withdrawal by Subject|1
843907|NCT01150123|2681953|P1|Overall Study|Withdrawal by Subject|1
843908|NCT01150357|2682129|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
843909|NCT01150357|2682130|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
843910|NCT01150357|2682131|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
843911|NCT01150357|2682129|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
843912|NCT01150357|2682130|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
843913|NCT01150357|2682131|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
843914|NCT01150357|2682129|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
843915|NCT01150357|2682130|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
843916|NCT01150357|2682131|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
843917|NCT01150357|2682129|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
843918|NCT01150357|2682130|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
843919|NCT01150357|2682131|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
843920|NCT01150357|2682129|P3|Dose Response Phase (Phase 1)|Adverse Event|1
843921|NCT01150357|2682130|P2|Dose Response Phase (Phase 1)|Adverse Event|0
843922|NCT01150357|2682131|P1|Dose Response Phase (Phase 1)|Adverse Event|0
843923|NCT01150357|2682129|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
843924|NCT01150357|2682130|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
843925|NCT01150357|2682131|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
843926|NCT01150357|2682129|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
843927|NCT01150357|2682130|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
843928|NCT01150357|2682131|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
843929|NCT01150474|2682215|P2|Overall Study|Surgery Changed|0
843930|NCT01150474|2682216|P1|Overall Study|Surgery Changed|1
843931|NCT01150474|2682215|P2|Overall Study|Drug not administered|0
843932|NCT01150474|2682216|P1|Overall Study|Drug not administered|1
843933|NCT01150474|2682215|P2|Overall Study|Drug did not arrive in time|0
843934|NCT01150474|2682216|P1|Overall Study|Drug did not arrive in time|1
843935|NCT01150474|2682215|P2|Overall Study|Rectotomy|0
843936|NCT01150474|2682216|P1|Overall Study|Rectotomy|1
843937|NCT01150474|2682215|P2|Overall Study|Multiple Studies|1
843938|NCT01150474|2682216|P1|Overall Study|Multiple Studies|0
843939|NCT01150474|2682215|P2|Overall Study|Cancer found|0
843940|NCT01150474|2682216|P1|Overall Study|Cancer found|1
843941|NCT01150474|2682215|P2|Overall Study|Withdrawal by Subject|2
843942|NCT01150474|2682216|P1|Overall Study|Withdrawal by Subject|5
843943|NCT01151020|2682310|P1|Overall Study|Still be eligible for follow-up|79
843944|NCT01151020|2682310|P1|Overall Study|Patients did not receive the device|2
843945|NCT01151020|2682310|P1|Overall Study|Withdrawal by Subject|12
843946|NCT01151020|2682310|P1|Overall Study|Lost to Follow-up|1
843947|NCT01151020|2682310|P1|Overall Study|Conversion to open repair|1
843948|NCT01151020|2682310|P1|Overall Study|Death|15
843949|NCT01151085|2682330|P1|Overall Study|Protocol Violation|25
843950|NCT01151085|2682330|P1|Overall Study|Lost to Follow-up|31
843951|NCT01151098|2682346|P1|Overall Study|Miscellaneous|13
843952|NCT01151098|2682346|P1|Overall Study|Protocol Violation|1
843953|NCT01151098|2682346|P1|Overall Study|Lack of Efficacy|15
843954|NCT01151098|2682346|P1|Overall Study|Lost to Follow-up|6
843955|NCT01151098|2682346|P1|Overall Study|Adverse Event|82
843956|NCT01151137|2682352|P2|Overall Study|Lost to Follow-up|1
843957|NCT01151137|2682353|P1|Overall Study|Lost to Follow-up|1
843958|NCT01151137|2682352|P2|Overall Study|Death|27
843959|NCT01151137|2682353|P1|Overall Study|Death|15
843960|NCT01151215|2682399|P3|Overall Study|Safety as judged by the investigator|1
843961|NCT01151215|2682400|P2|Overall Study|Safety as judged by the investigator|0
843962|NCT01151215|2682401|P1|Overall Study|Safety as judged by the investigator|0
843963|NCT01151215|2682399|P3|Overall Study|Disease progression|1
843964|NCT01151215|2682400|P2|Overall Study|Disease progression|1
843965|NCT01151215|2682401|P1|Overall Study|Disease progression|0
843966|NCT01151215|2682399|P3|Overall Study|Withdrawal by Subject|2
843967|NCT01151215|2682400|P2|Overall Study|Withdrawal by Subject|1
843968|NCT01151215|2682401|P1|Overall Study|Withdrawal by Subject|3
843969|NCT01151215|2682399|P3|Overall Study|Lost to Follow-up|3
843970|NCT01151215|2682400|P2|Overall Study|Lost to Follow-up|0
843971|NCT01151215|2682401|P1|Overall Study|Lost to Follow-up|0
843972|NCT01151215|2682399|P3|Overall Study|Death|11
843973|NCT01151215|2682400|P2|Overall Study|Death|20
843974|NCT01151215|2682401|P1|Overall Study|Death|16
843975|NCT01151215|2682399|P3|Overall Study|Worsening of condition under study|1
843976|NCT01151215|2682400|P2|Overall Study|Worsening of condition under study|1
843977|NCT01151215|2682401|P1|Overall Study|Worsening of condition under study|1
843978|NCT01151280|2682412|P1|Overall Study|Lack of Efficacy|3
843979|NCT01151280|2682412|P1|Overall Study|Adverse Event|1
843980|NCT01151345|2682422|P2|First Intervention Period|Protocol Violation|1
843981|NCT01151345|2682423|P1|First Intervention Period|Protocol Violation|0
843982|NCT01151410|2682473|P2|Overall Study|Abnormal laboratory value(s)|1
843983|NCT01151410|2682474|P1|Overall Study|Abnormal laboratory value(s)|0
843984|NCT01151410|2682473|P2|Overall Study|Unsatisfactory therapeutic effect|1
843985|NCT01151410|2682474|P1|Overall Study|Unsatisfactory therapeutic effect|1
843986|NCT01151410|2682473|P2|Overall Study|Administrative problems|1
843987|NCT01151410|2682474|P1|Overall Study|Administrative problems|1
843988|NCT01151410|2682473|P2|Overall Study|Protocol deviation|1
843989|NCT01151410|2682474|P1|Overall Study|Protocol deviation|2
843990|NCT01151410|2682473|P2|Overall Study|Adverse Event|2
843991|NCT01151410|2682474|P1|Overall Study|Adverse Event|1
843992|NCT01151410|2682473|P2|Overall Study|Lost to Follow-up|4
843993|NCT01151410|2682474|P1|Overall Study|Lost to Follow-up|3
843994|NCT01151410|2682473|P2|Overall Study|Withdrawal by Subject|5
843995|NCT01151410|2682474|P1|Overall Study|Withdrawal by Subject|3
843996|NCT01145053|2682547|P1|Overall Study|Other|18
843997|NCT01145053|2682547|P1|Overall Study|Withdrawal by Subject|25
843998|NCT01145053|2682547|P1|Overall Study|Lost to Follow-up|28
843999|NCT01145053|2682547|P1|Overall Study|Adverse Event|22
844000|NCT01151579|2682559|P2|Overall Study|Not meet inclusion criteria|4
844001|NCT01151579|2682560|P1|Overall Study|Not meet inclusion criteria|6
844002|NCT01151579|2682559|P2|Overall Study|Withdrawal by Subject|2
844003|NCT01151579|2682560|P1|Overall Study|Withdrawal by Subject|3
844004|NCT01151579|2682559|P2|Overall Study|Physician Decision|1
844005|NCT01151579|2682560|P1|Overall Study|Physician Decision|3
844006|NCT01152788|2682625|P2|Overall Study|No treatment|1
844007|NCT01152788|2682626|P1|Overall Study|No treatment|0
844008|NCT01152788|2682625|P2|Overall Study|Withdrawal by Subject|3
844009|NCT01152788|2682626|P1|Overall Study|Withdrawal by Subject|0
844010|NCT01152814|2682638|P1|Overall Study|Lost to Follow-up|2
894076|NCT00398632|2837141|P1|Overall Study|Lack of Efficacy|1
894077|NCT00398632|2837141|P1|Overall Study|Withdrawal by Subject|1
844019|NCT01153009|2682662|P4|Overall Study|Other|2
844020|NCT01153009|2682663|P3|Overall Study|Other|3
844021|NCT01153009|2682664|P2|Overall Study|Other|1
844022|NCT01153009|2682665|P1|Overall Study|Other|1
844023|NCT01153009|2682662|P4|Overall Study|Lost to Follow-up|15
844024|NCT01153009|2682663|P3|Overall Study|Lost to Follow-up|11
844025|NCT01153009|2682664|P2|Overall Study|Lost to Follow-up|8
844026|NCT01153009|2682665|P1|Overall Study|Lost to Follow-up|8
844027|NCT01153009|2682662|P4|Overall Study|Withdrawal of Consent|6
844028|NCT01153009|2682663|P3|Overall Study|Withdrawal of Consent|4
844029|NCT01153009|2682664|P2|Overall Study|Withdrawal of Consent|5
844030|NCT01153009|2682665|P1|Overall Study|Withdrawal of Consent|5
844031|NCT01153009|2682662|P4|Overall Study|Protocol Deviations|2
844032|NCT01153009|2682663|P3|Overall Study|Protocol Deviations|3
844033|NCT01153009|2682664|P2|Overall Study|Protocol Deviations|3
844034|NCT01153009|2682665|P1|Overall Study|Protocol Deviations|4
844035|NCT01153009|2682662|P4|Overall Study|Noncompliance with Study Medication|1
844036|NCT01153009|2682663|P3|Overall Study|Noncompliance with Study Medication|4
844037|NCT01153009|2682664|P2|Overall Study|Noncompliance with Study Medication|3
844038|NCT01153009|2682665|P1|Overall Study|Noncompliance with Study Medication|1
844039|NCT01153009|2682662|P4|Overall Study|Lack of Efficacy|1
844040|NCT01153009|2682663|P3|Overall Study|Lack of Efficacy|2
844041|NCT01153009|2682664|P2|Overall Study|Lack of Efficacy|0
844042|NCT01153009|2682665|P1|Overall Study|Lack of Efficacy|9
844043|NCT01153009|2682662|P4|Overall Study|Adverse Event|10
844044|NCT01153009|2682663|P3|Overall Study|Adverse Event|14
844045|NCT01153009|2682664|P2|Overall Study|Adverse Event|14
844046|NCT01153009|2682665|P1|Overall Study|Adverse Event|4
844047|NCT01153269|2682695|P1|Overall Study|Antiretroviral therapy break|1
844048|NCT01153269|2682695|P1|Overall Study|Withdrawal by Subject|1
844049|NCT01153321|2682756|P2|Overall Study|Adverse Event|1
844050|NCT01153321|2682757|P1|Overall Study|Adverse Event|1
844051|NCT01153321|2682756|P2|Overall Study|Withdrawal by Subject|1
844052|NCT01153321|2682757|P1|Overall Study|Withdrawal by Subject|0
844053|NCT01153321|2682756|P2|Overall Study|Development of study withdrawal criteria|1
844054|NCT01153321|2682757|P1|Overall Study|Development of study withdrawal criteria|0
844055|NCT01153347|2682873|P4|Overall Study|Death|0
844056|NCT01153347|2682874|P3|Overall Study|Death|0
844057|NCT01153347|2682875|P2|Overall Study|Death|0
844058|NCT01153347|2682876|P1|Overall Study|Death|1
844059|NCT01153347|2682873|P4|Overall Study|Not specified|0
844060|NCT01153347|2682874|P3|Overall Study|Not specified|4
844061|NCT01153347|2682875|P2|Overall Study|Not specified|5
844062|NCT01153347|2682876|P1|Overall Study|Not specified|5
844063|NCT01153347|2682873|P4|Overall Study|Lost to Follow-up|8
844064|NCT01153347|2682874|P3|Overall Study|Lost to Follow-up|11
844065|NCT01153347|2682875|P2|Overall Study|Lost to Follow-up|9
844066|NCT01153347|2682876|P1|Overall Study|Lost to Follow-up|4
844067|NCT01153347|2682873|P4|Overall Study|Study-specific withdrawal criteria|2
844068|NCT01153347|2682874|P3|Overall Study|Study-specific withdrawal criteria|1
844069|NCT01153347|2682875|P2|Overall Study|Study-specific withdrawal criteria|3
844070|NCT01153347|2682876|P1|Overall Study|Study-specific withdrawal criteria|4
844071|NCT01153347|2682873|P4|Overall Study|Lack of Efficacy|4
844072|NCT01153347|2682874|P3|Overall Study|Lack of Efficacy|0
844073|NCT01153347|2682875|P2|Overall Study|Lack of Efficacy|2
844074|NCT01153347|2682876|P1|Overall Study|Lack of Efficacy|2
844075|NCT01153347|2682873|P4|Overall Study|Condition under investigation worsened|0
844076|NCT01153347|2682874|P3|Overall Study|Condition under investigation worsened|0
844077|NCT01153347|2682875|P2|Overall Study|Condition under investigation worsened|1
844078|NCT01153347|2682876|P1|Overall Study|Condition under investigation worsened|1
844079|NCT01153347|2682873|P4|Overall Study|Severe non-compliance to protocol|3
844080|NCT01153347|2682874|P3|Overall Study|Severe non-compliance to protocol|4
844081|NCT01153347|2682875|P2|Overall Study|Severe non-compliance to protocol|7
844082|NCT01153347|2682876|P1|Overall Study|Severe non-compliance to protocol|6
844083|NCT01153347|2682873|P4|Overall Study|Adverse Event|7
844084|NCT01153347|2682874|P3|Overall Study|Adverse Event|21
844085|NCT01153347|2682875|P2|Overall Study|Adverse Event|9
844086|NCT01153347|2682876|P1|Overall Study|Adverse Event|3
844087|NCT01153347|2682873|P4|Overall Study|Eligibility criteria not fulfilled|1
844088|NCT01153347|2682874|P3|Overall Study|Eligibility criteria not fulfilled|2
844089|NCT01153347|2682875|P2|Overall Study|Eligibility criteria not fulfilled|1
844090|NCT01153347|2682876|P1|Overall Study|Eligibility criteria not fulfilled|0
844091|NCT01153347|2682873|P4|Overall Study|Withdrawal by Subject|7
844092|NCT01153347|2682874|P3|Overall Study|Withdrawal by Subject|7
844093|NCT01153347|2682875|P2|Overall Study|Withdrawal by Subject|7
844094|NCT01153347|2682876|P1|Overall Study|Withdrawal by Subject|7
844095|NCT01153425|2682976|P2|Overall Study|Withdrawal by Subject|3
844096|NCT01153425|2682977|P1|Overall Study|Withdrawal by Subject|3
844097|NCT01153633|2683019|P2|Overall Study|Therapeutic failure|3
844098|NCT01153633|2683020|P1|Overall Study|Therapeutic failure|3
844099|NCT01153633|2683019|P2|Overall Study|Protocol Violation|1
844100|NCT01153633|2683020|P1|Overall Study|Protocol Violation|1
844101|NCT01153698|2683069|P1|Overall Study|Not treated with Pradaxa|5
844102|NCT01153698|2683069|P1|Overall Study|Other|2
844103|NCT01153698|2683069|P1|Overall Study|Switch to other anticoagulants|4
844104|NCT01153698|2683069|P1|Overall Study|Withdrawal by Subject|2
844105|NCT01153698|2683069|P1|Overall Study|Lost to Follow-up|4
844106|NCT01153698|2683069|P1|Overall Study|Adverse Event|12
844107|NCT01153724|2683103|P1|Treatment Period 2|Other reason not defined above|1
844108|NCT01153724|2683103|P1|Treatment Period 2|Adverse Event|1
844109|NCT01153724|2683103|P1|Treatment Period 1|Withdrawal by Subject|1
844110|NCT01153763|2683123|P1|Overall Study|Withdrawal by Subject|2
844111|NCT01153763|2683123|P1|Overall Study|Physician Decision|2
844112|NCT01153763|2683123|P1|Overall Study|Lost to Follow-up|1
844113|NCT01153763|2683123|P1|Overall Study|Study Closed|16
844114|NCT01153815|2683141|P2|Overall Study|Withdrawal by Subject|4
844115|NCT01153815|2683142|P1|Overall Study|Withdrawal by Subject|6
844116|NCT01153815|2683141|P2|Overall Study|Adverse Event|1
844117|NCT01153815|2683142|P1|Overall Study|Adverse Event|3
844118|NCT01153841|2683166|P2|Overall Study|Lost to Follow-up|0
844119|NCT01153841|2683167|P1|Overall Study|Lost to Follow-up|2
844120|NCT01153841|2683166|P2|Overall Study|Protocol Violation|0
844121|NCT01153841|2683167|P1|Overall Study|Protocol Violation|2
844122|NCT01153841|2683166|P2|Overall Study|Withdrawal by Subject|0
844123|NCT01153841|2683167|P1|Overall Study|Withdrawal by Subject|1
844124|NCT01153841|2683166|P2|Overall Study|Adverse Event|0
844125|NCT01153841|2683167|P1|Overall Study|Adverse Event|1
844126|NCT01153893|2683183|P2|Overall Study|Adverse Event|0
844127|NCT01153893|2683184|P1|Overall Study|Adverse Event|1
844128|NCT01153958|2683210|P2|Overall Study|Study Terminated|32
844129|NCT01153958|2683211|P1|Overall Study|Study Terminated|36
844130|NCT01153971|2683227|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
844131|NCT01153971|2683227|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
844132|NCT01153971|2683227|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
844133|NCT01153971|2683227|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
844134|NCT01153971|2683227|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
844135|NCT01153971|2683227|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
844136|NCT01153971|2683227|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
844137|NCT01153984|2683248|P1|Overall Study|Adverse Event|1
844138|NCT01153984|2683248|P1|Overall Study|Withdrawal by Subject|1
844139|NCT01154010|2683261|P2|Overall Study|Lost to Follow-up|1
844140|NCT01154010|2683262|P1|Overall Study|Lost to Follow-up|0
844141|NCT01154036|2683271|P8|Phase II|Withdrawal by Subject|4
844142|NCT01154036|2683272|P7|Phase II|Withdrawal by Subject|5
844143|NCT01154036|2683273|P6|Phase II|Withdrawal by Subject|2
844144|NCT01154036|2683274|P5|Phase II|Withdrawal by Subject|4
844145|NCT01154036|2683275|P4|Phase II|Withdrawal by Subject|0
844146|NCT01154036|2683276|P3|Phase II|Withdrawal by Subject|0
844147|NCT01154036|2683277|P2|Phase II|Withdrawal by Subject|0
844148|NCT01154036|2683278|P1|Phase II|Withdrawal by Subject|0
844149|NCT01154036|2683271|P8|Phase II|Protocol Violation|0
844150|NCT01154036|2683272|P7|Phase II|Protocol Violation|0
844151|NCT01154036|2683273|P6|Phase II|Protocol Violation|2
844152|NCT01154036|2683274|P5|Phase II|Protocol Violation|1
844153|NCT01154036|2683275|P4|Phase II|Protocol Violation|0
844154|NCT01154036|2683276|P3|Phase II|Protocol Violation|0
844155|NCT01154036|2683277|P2|Phase II|Protocol Violation|0
844156|NCT01154036|2683278|P1|Phase II|Protocol Violation|0
844157|NCT01154036|2683271|P8|Phase II|Lost to Follow-up|1
844158|NCT01154036|2683272|P7|Phase II|Lost to Follow-up|2
844159|NCT01154036|2683273|P6|Phase II|Lost to Follow-up|0
844160|NCT01154036|2683274|P5|Phase II|Lost to Follow-up|2
844161|NCT01154036|2683275|P4|Phase II|Lost to Follow-up|1
844162|NCT01154036|2683276|P3|Phase II|Lost to Follow-up|0
844163|NCT01154036|2683277|P2|Phase II|Lost to Follow-up|0
844164|NCT01154036|2683278|P1|Phase II|Lost to Follow-up|0
844165|NCT01154036|2683271|P8|Phase II|Physician Decision|0
844166|NCT01154036|2683272|P7|Phase II|Physician Decision|1
844167|NCT01154036|2683273|P6|Phase II|Physician Decision|0
844168|NCT01154036|2683274|P5|Phase II|Physician Decision|0
844169|NCT01154036|2683275|P4|Phase II|Physician Decision|0
844170|NCT01154036|2683276|P3|Phase II|Physician Decision|0
844171|NCT01154036|2683277|P2|Phase II|Physician Decision|0
844172|NCT01154036|2683278|P1|Phase II|Physician Decision|0
844173|NCT01154036|2683271|P8|Phase II|Adverse Event|1
844174|NCT01154036|2683272|P7|Phase II|Adverse Event|1
844175|NCT01154036|2683273|P6|Phase II|Adverse Event|1
844176|NCT01154036|2683274|P5|Phase II|Adverse Event|1
844177|NCT01154036|2683275|P4|Phase II|Adverse Event|0
844178|NCT01154036|2683276|P3|Phase II|Adverse Event|0
844179|NCT01154036|2683277|P2|Phase II|Adverse Event|0
844180|NCT01154036|2683278|P1|Phase II|Adverse Event|0
844181|NCT01154036|2683271|P8|Phase I|Adverse Event|0
844182|NCT01154036|2683272|P7|Phase I|Adverse Event|0
844183|NCT01154036|2683273|P6|Phase I|Adverse Event|0
844184|NCT01154036|2683274|P5|Phase I|Adverse Event|0
844185|NCT01154036|2683275|P4|Phase I|Adverse Event|0
844186|NCT01154036|2683276|P3|Phase I|Adverse Event|12
844187|NCT01154036|2683277|P2|Phase I|Adverse Event|11
844188|NCT01154036|2683278|P1|Phase I|Adverse Event|1
844189|NCT01154036|2683271|P8|Phase I|Withdrawal by Subject|0
844190|NCT01154036|2683272|P7|Phase I|Withdrawal by Subject|0
844191|NCT01154036|2683273|P6|Phase I|Withdrawal by Subject|0
844192|NCT01154036|2683274|P5|Phase I|Withdrawal by Subject|0
844193|NCT01154036|2683275|P4|Phase I|Withdrawal by Subject|0
844194|NCT01154036|2683276|P3|Phase I|Withdrawal by Subject|29
844195|NCT01154036|2683277|P2|Phase I|Withdrawal by Subject|10
844196|NCT01154036|2683278|P1|Phase I|Withdrawal by Subject|2
844197|NCT01154036|2683271|P8|Phase I|Protocol Violation|0
844198|NCT01154036|2683272|P7|Phase I|Protocol Violation|0
844199|NCT01154036|2683273|P6|Phase I|Protocol Violation|0
844200|NCT01154036|2683274|P5|Phase I|Protocol Violation|0
844201|NCT01154036|2683275|P4|Phase I|Protocol Violation|0
844202|NCT01154036|2683276|P3|Phase I|Protocol Violation|9
844203|NCT01154036|2683277|P2|Phase I|Protocol Violation|3
844204|NCT01154036|2683278|P1|Phase I|Protocol Violation|0
844205|NCT01154036|2683271|P8|Phase I|Lost to Follow-up|0
844206|NCT01154036|2683272|P7|Phase I|Lost to Follow-up|0
844207|NCT01154036|2683273|P6|Phase I|Lost to Follow-up|0
844208|NCT01154036|2683274|P5|Phase I|Lost to Follow-up|0
844209|NCT01154036|2683275|P4|Phase I|Lost to Follow-up|0
844210|NCT01154036|2683276|P3|Phase I|Lost to Follow-up|6
844211|NCT01154036|2683277|P2|Phase I|Lost to Follow-up|3
844212|NCT01154036|2683278|P1|Phase I|Lost to Follow-up|0
844213|NCT01154036|2683271|P8|Phase I|Physician Decision|0
844214|NCT01154036|2683272|P7|Phase I|Physician Decision|0
844215|NCT01154036|2683273|P6|Phase I|Physician Decision|0
844216|NCT01154036|2683274|P5|Phase I|Physician Decision|0
844217|NCT01154036|2683275|P4|Phase I|Physician Decision|0
844218|NCT01154036|2683276|P3|Phase I|Physician Decision|0
844219|NCT01154036|2683277|P2|Phase I|Physician Decision|1
844220|NCT01154036|2683278|P1|Phase I|Physician Decision|0
844221|NCT01154127|2683402|P2|Period 2 (21 Days)|Protocol Deviation|1
844222|NCT01154127|2683403|P1|Period 2 (21 Days)|Protocol Deviation|0
844223|NCT01154127|2683402|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
844224|NCT01154127|2683403|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
844225|NCT01154127|2683402|P2|Washout (14 - 28 Days)|Adverse Event|0
844226|NCT01154127|2683403|P1|Washout (14 - 28 Days)|Adverse Event|2
844227|NCT01154127|2683402|P2|Period 1 (21 Days)|Withdrawal by Subject|2
844228|NCT01154127|2683403|P1|Period 1 (21 Days)|Withdrawal by Subject|0
844229|NCT01154127|2683402|P2|Period 1 (21 Days)|Adverse Event|4
844230|NCT01154127|2683403|P1|Period 1 (21 Days)|Adverse Event|3
844231|NCT01154140|2683427|P2|Overall Study|Randomized but not treated|2
844232|NCT01154140|2683428|P1|Overall Study|Randomized but not treated|1
844233|NCT01154140|2683427|P2|Overall Study|Ongoing at date of cut-off|115
844234|NCT01154140|2683428|P1|Overall Study|Ongoing at date of cut-off|119
844235|NCT01154140|2683427|P2|Overall Study|Not specified|1
844236|NCT01154140|2683428|P1|Overall Study|Not specified|1
844237|NCT01154140|2683427|P2|Overall Study|Withdrawal by Subject|5
844238|NCT01154140|2683428|P1|Overall Study|Withdrawal by Subject|7
844239|NCT01154140|2683427|P2|Overall Study|Lost to Follow-up|2
844240|NCT01154140|2683428|P1|Overall Study|Lost to Follow-up|0
844241|NCT01154140|2683427|P2|Overall Study|Death|46
844242|NCT01154140|2683428|P1|Overall Study|Death|44
844243|NCT01154153|2683477|P2|Overall Study|Withdrew consent|0
844244|NCT01154153|2683478|P1|Overall Study|Withdrew consent|1
844245|NCT01154153|2683477|P2|Overall Study|Unable to use labs|3
844246|NCT01154153|2683478|P1|Overall Study|Unable to use labs|2
844247|NCT01154153|2683477|P2|Overall Study|Poor compliance to protocol|0
844248|NCT01154153|2683478|P1|Overall Study|Poor compliance to protocol|2
844249|NCT01154166|2683496|P2|Overall Study|Poor Compliance|0
844250|NCT01154166|2683497|P1|Overall Study|Poor Compliance|1
844251|NCT01154166|2683496|P2|Overall Study|Disease Progression|0
844252|NCT01154166|2683497|P1|Overall Study|Disease Progression|1
844253|NCT01154166|2683496|P2|Overall Study|Lack of Efficacy|0
844254|NCT01154166|2683497|P1|Overall Study|Lack of Efficacy|3
844255|NCT01154166|2683496|P2|Overall Study|Withdrawal by Subject|1
844256|NCT01154166|2683497|P1|Overall Study|Withdrawal by Subject|10
844257|NCT01154166|2683496|P2|Overall Study|Protocol Violation|1
844258|NCT01154166|2683497|P1|Overall Study|Protocol Violation|4
844259|NCT01154166|2683496|P2|Overall Study|Lost to Follow-up|1
844260|NCT01154166|2683497|P1|Overall Study|Lost to Follow-up|1
844261|NCT01154166|2683496|P2|Overall Study|Adverse Event|9
844262|NCT01154166|2683497|P1|Overall Study|Adverse Event|14
844263|NCT01154218|2683527|P4|Fourth Intervention Period|Withdrawal by Subject|0
844264|NCT01154218|2683528|P3|Fourth Intervention Period|Withdrawal by Subject|0
844265|NCT01154218|2683529|P2|Fourth Intervention Period|Withdrawal by Subject|0
844266|NCT01154218|2683530|P1|Fourth Intervention Period|Withdrawal by Subject|1
844267|NCT01154218|2683527|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
844268|NCT01154218|2683528|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
844269|NCT01154218|2683529|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
844270|NCT01154218|2683530|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
844271|NCT01154218|2683527|P4|Third Intervention Period|Adverse Event|0
844272|NCT01154218|2683528|P3|Third Intervention Period|Adverse Event|0
844273|NCT01154218|2683529|P2|Third Intervention Period|Adverse Event|1
844274|NCT01154218|2683530|P1|Third Intervention Period|Adverse Event|0
844275|NCT01154231|2683580|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
844276|NCT01154231|2683580|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
844277|NCT01154283|2683588|P2|7-12 Weeks|Withdrawal by Subject|1
844278|NCT01154283|2683589|P1|7-12 Weeks|Withdrawal by Subject|0
844279|NCT01154283|2683588|P2|7-12 Weeks|Death|0
844280|NCT01154283|2683589|P1|7-12 Weeks|Death|1
844281|NCT01154283|2683588|P2|0-6 Weeks|Death|1
844282|NCT01154283|2683589|P1|0-6 Weeks|Death|0
844283|NCT01154283|2683588|P2|0-6 Weeks|Withdrawal by Subject|2
844284|NCT01154283|2683589|P1|0-6 Weeks|Withdrawal by Subject|7
844285|NCT01154296|2683603|P2|6-month Follow-up|Declined by Study Coordinator|4
844286|NCT01154296|2683604|P1|6-month Follow-up|Declined by Study Coordinator|5
844287|NCT01154296|2683603|P2|6-month Follow-up|Death|2
844288|NCT01154296|2683604|P1|6-month Follow-up|Death|3
844289|NCT01154296|2683603|P2|6-month Follow-up|Withdrew consent|15
844290|NCT01154296|2683604|P1|6-month Follow-up|Withdrew consent|14
844291|NCT01154296|2683603|P2|6-month Follow-up|Incarcerated|32
844292|NCT01154296|2683604|P1|6-month Follow-up|Incarcerated|37
844293|NCT01154296|2683603|P2|6-month Follow-up|Lost contact|275
844294|NCT01154296|2683604|P1|6-month Follow-up|Lost contact|269
844295|NCT01154296|2683603|P2|Randomization and Intervention|Left clinic early|0
844296|NCT01154296|2683604|P1|Randomization and Intervention|Left clinic early|2
844297|NCT01154296|2683603|P2|Randomization and Intervention|Left before test|1
844298|NCT01154296|2683604|P1|Randomization and Intervention|Left before test|0
844299|NCT01154296|2683603|P2|Randomization and Intervention|Did not return|0
844300|NCT01154296|2683604|P1|Randomization and Intervention|Did not return|1
844301|NCT01154296|2683603|P2|Randomization and Intervention|Declined by staff|0
844302|NCT01154296|2683604|P1|Randomization and Intervention|Declined by staff|1
844303|NCT01154296|2683603|P2|Randomization and Intervention|Decided to decline|1
844304|NCT01154296|2683604|P1|Randomization and Intervention|Decided to decline|1
844305|NCT01154452|2683641|P4|Phase II|Adverse Event|4
844306|NCT01154452|2683642|P3|Phase II|Adverse Event|4
844307|NCT01154452|2683643|P2|Phase II|Adverse Event|0
844308|NCT01154452|2683644|P1|Phase II|Adverse Event|0
844309|NCT01154452|2683641|P4|Phase II|Withdrawal by Subject|2
844310|NCT01154452|2683642|P3|Phase II|Withdrawal by Subject|1
844311|NCT01154452|2683643|P2|Phase II|Withdrawal by Subject|0
844312|NCT01154452|2683644|P1|Phase II|Withdrawal by Subject|0
844313|NCT01154452|2683641|P4|Phase Ib|Adverse Event|0
844314|NCT01154452|2683642|P3|Phase Ib|Adverse Event|0
844315|NCT01154452|2683643|P2|Phase Ib|Adverse Event|1
844316|NCT01154452|2683644|P1|Phase Ib|Adverse Event|2
844317|NCT01154452|2683641|P4|Phase Ib|Not Treated|0
844318|NCT01154452|2683642|P3|Phase Ib|Not Treated|0
844319|NCT01154452|2683643|P2|Phase Ib|Not Treated|0
844320|NCT01154452|2683644|P1|Phase Ib|Not Treated|1
844321|NCT01154673|2683702|P2|Overall Study|moved out of province|0
844322|NCT01154673|2683703|P1|Overall Study|moved out of province|1
844323|NCT01154673|2683702|P2|Overall Study|Lost to Follow-up|0
844324|NCT01154673|2683703|P1|Overall Study|Lost to Follow-up|1
844373|NCT01155011|2683828|P2|6 to 12 Months|Death|5
844374|NCT01155011|2683829|P1|6 to 12 Months|Death|1
844375|NCT01155011|2683828|P2|6 to 12 Months|Withdrawal by Subject|5
844376|NCT01155011|2683829|P1|6 to 12 Months|Withdrawal by Subject|8
844377|NCT01155011|2683828|P2|Baseline to 6 Months|Death|1
844378|NCT01155011|2683829|P1|Baseline to 6 Months|Death|0
844379|NCT01155011|2683828|P2|Baseline to 6 Months|investigator decision, moved|5
844380|NCT01155011|2683829|P1|Baseline to 6 Months|investigator decision, moved|4
844381|NCT01155011|2683828|P2|Baseline to 6 Months|Withdrawal by Subject|19
844382|NCT01155011|2683829|P1|Baseline to 6 Months|Withdrawal by Subject|18
844383|NCT01155024|2683839|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
844384|NCT01155024|2683840|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
844385|NCT01155024|2683839|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
844386|NCT01155024|2683840|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
844387|NCT01155024|2683839|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
844388|NCT01155024|2683840|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
844389|NCT01155063|2683848|P1|Overall Study|Study terminated by sponsor|87
844390|NCT01155063|2683848|P1|Overall Study|Withdrawal by Subject|1
844391|NCT01155063|2683848|P1|Overall Study|Adverse Event|1
844392|NCT01148017|2683862|P4|Overall Study|Unable to classify|0
844393|NCT01148017|2683863|P3|Overall Study|Unable to classify|0
844394|NCT01148017|2683864|P2|Overall Study|Unable to classify|1
844395|NCT01148017|2683865|P1|Overall Study|Unable to classify|3
844396|NCT01148017|2683862|P4|Overall Study|Administrative reason|0
844397|NCT01148017|2683863|P3|Overall Study|Administrative reason|0
844398|NCT01148017|2683864|P2|Overall Study|Administrative reason|9
844399|NCT01148017|2683865|P1|Overall Study|Administrative reason|22
844400|NCT01148017|2683862|P4|Overall Study|Inappropriate enrollment|0
844401|NCT01148017|2683863|P3|Overall Study|Inappropriate enrollment|0
844402|NCT01148017|2683864|P2|Overall Study|Inappropriate enrollment|0
844403|NCT01148017|2683865|P1|Overall Study|Inappropriate enrollment|1
844404|NCT01148017|2683862|P4|Overall Study|Lost to Follow-up|0
844405|NCT01148017|2683863|P3|Overall Study|Lost to Follow-up|0
844406|NCT01148017|2683864|P2|Overall Study|Lost to Follow-up|10
844407|NCT01148017|2683865|P1|Overall Study|Lost to Follow-up|23
844408|NCT01148017|2683862|P4|Overall Study|Withdrawal by Subject|0
844409|NCT01148017|2683863|P3|Overall Study|Withdrawal by Subject|0
844410|NCT01148017|2683864|P2|Overall Study|Withdrawal by Subject|14
844411|NCT01148017|2683865|P1|Overall Study|Withdrawal by Subject|31
844412|NCT01148511|2683919|P3|Randomized|Not Specified|1
844413|NCT01148511|2683920|P2|Randomized|Not Specified|1
844414|NCT01148511|2683921|P1|Randomized|Not Specified|0
844415|NCT01148511|2683919|P3|Randomized|Consent withdrawal|3
844416|NCT01148511|2683920|P2|Randomized|Consent withdrawal|5
844417|NCT01148511|2683921|P1|Randomized|Consent withdrawal|0
844418|NCT01148511|2683919|P3|Randomized|Lost to Follow-up|1
844419|NCT01148511|2683920|P2|Randomized|Lost to Follow-up|1
844420|NCT01148511|2683921|P1|Randomized|Lost to Follow-up|0
844421|NCT01148511|2683919|P3|Randomized|Protocol Violation|1
844422|NCT01148511|2683920|P2|Randomized|Protocol Violation|2
844423|NCT01148511|2683921|P1|Randomized|Protocol Violation|0
844424|NCT01148511|2683919|P3|Randomized|Adverse Event|0
844425|NCT01148511|2683920|P2|Randomized|Adverse Event|1
844426|NCT01148511|2683921|P1|Randomized|Adverse Event|0
844427|NCT01148511|2683919|P3|Exposed to Study Drug|Lost to Follow-up|0
844428|NCT01148511|2683920|P2|Exposed to Study Drug|Lost to Follow-up|0
844429|NCT01148511|2683921|P1|Exposed to Study Drug|Lost to Follow-up|4
844430|NCT01148511|2683919|P3|Exposed to Study Drug|Protocol Violation|0
844431|NCT01148511|2683920|P2|Exposed to Study Drug|Protocol Violation|0
844432|NCT01148511|2683921|P1|Exposed to Study Drug|Protocol Violation|2
844433|NCT01148537|2684006|P3|Overall Study|Adverse Event|1
844434|NCT01148537|2684007|P2|Overall Study|Adverse Event|0
844435|NCT01148537|2684008|P1|Overall Study|Adverse Event|2
844436|NCT01148537|2684006|P3|Overall Study|Withdrawal by Subject|2
844437|NCT01148537|2684007|P2|Overall Study|Withdrawal by Subject|0
844438|NCT01148537|2684008|P1|Overall Study|Withdrawal by Subject|1
844439|NCT01148693|2684031|P2|Overall Study|Attempts for cannulation were failed|10
844440|NCT01148693|2684032|P1|Overall Study|Attempts for cannulation were failed|13
844441|NCT01148771|2684046|P2|Washout Period|Withdrawal by Subject|1
844442|NCT01148771|2684047|P1|Washout Period|Withdrawal by Subject|0
844443|NCT01148862|2684081|P2|Second Intervention|Withdrawal by Subject|2
844444|NCT01148862|2684082|P1|Second Intervention|Withdrawal by Subject|0
844445|NCT01148979|2684092|P2|Overall Study|Lost to Follow-up|1
844446|NCT01148979|2684093|P1|Overall Study|Lost to Follow-up|0
844447|NCT01155141|2684099|P1|Overall Study|Screen Failure|1
844448|NCT01155141|2684099|P1|Overall Study|Withdrawal by Subject|1
844449|NCT01155167|2684126|P2|Overall Study|Access site changed to femoral artery|0
844450|NCT01155167|2684127|P1|Overall Study|Access site changed to femoral artery|1
844451|NCT01155167|2684126|P2|Overall Study|Insufficient ultrasound data|0
844452|NCT01155167|2684127|P1|Overall Study|Insufficient ultrasound data|2
844453|NCT01155219|2684148|P2|Overall Study|non-medical reason|2
844454|NCT01155219|2684149|P1|Overall Study|non-medical reason|1
844455|NCT01155219|2684148|P2|Overall Study|Adverse Event|1
844456|NCT01155219|2684149|P1|Overall Study|Adverse Event|3
844457|NCT01155284|2684157|P2|Overall Study|Adverse Event|0
844458|NCT01155284|2684158|P1|Overall Study|Adverse Event|1
844459|NCT01155284|2684157|P2|Overall Study|Physician Decision|0
844460|NCT01155284|2684158|P1|Overall Study|Physician Decision|1
844461|NCT01155284|2684157|P2|Overall Study|Lost to Follow-up|2
844462|NCT01155284|2684158|P1|Overall Study|Lost to Follow-up|1
844463|NCT01155284|2684157|P2|Overall Study|Withdrawal by Subject|3
844464|NCT01155284|2684158|P1|Overall Study|Withdrawal by Subject|4
844465|NCT01155323|2684166|P2|Second Intervention|Lost to Follow-up|1
844466|NCT01155323|2684167|P1|Second Intervention|Lost to Follow-up|1
844467|NCT01155323|2684166|P2|First Intervention|exclusion criteria|1
844468|NCT01155323|2684167|P1|First Intervention|exclusion criteria|1
844469|NCT01155726|2684192|P4|Period 1, 3 Days (Masked)|Inconvenience|0
844470|NCT01155726|2684193|P3|Period 1, 3 Days (Masked)|Inconvenience|2
844471|NCT01155726|2684194|P2|Period 1, 3 Days (Masked)|Inconvenience|0
844472|NCT01155726|2684195|P1|Period 1, 3 Days (Masked)|Inconvenience|1
844473|NCT01155869|2684235|P2|Overall Study|Lost to Follow-up|1
844474|NCT01155869|2684236|P1|Overall Study|Lost to Follow-up|3
844475|NCT01156012|2684255|P2|Overall Study|Non respect of one of inclusion criteria|1
844476|NCT01156012|2684256|P1|Overall Study|Non respect of one of inclusion criteria|2
844477|NCT01156012|2684255|P2|Overall Study|use of commercial drug instead of study|1
844478|NCT01156012|2684256|P1|Overall Study|use of commercial drug instead of study|0
844479|NCT01156012|2684255|P2|Overall Study|Withdrawal by Subject|0
844480|NCT01156012|2684256|P1|Overall Study|Withdrawal by Subject|1
844481|NCT01156012|2684255|P2|Overall Study|Lost to Follow-up|0
844482|NCT01156012|2684256|P1|Overall Study|Lost to Follow-up|1
844483|NCT01156012|2684255|P2|Overall Study|Adverse Event|1
844484|NCT01156012|2684256|P1|Overall Study|Adverse Event|3
844485|NCT01156051|2684264|P2|Overall Study|patient not compliant with protocol|1
844486|NCT01156051|2684265|P1|Overall Study|patient not compliant with protocol|0
844487|NCT01156051|2684264|P2|Overall Study|Lost to Follow-up|0
844488|NCT01156051|2684265|P1|Overall Study|Lost to Follow-up|1
844489|NCT01156116|2684279|P2|Overall Study|CPAP intolerance|0
844490|NCT01156116|2684280|P1|Overall Study|CPAP intolerance|2
844491|NCT01156116|2684279|P2|Overall Study|Withdrawal by Subject|1
844492|NCT01156116|2684280|P1|Overall Study|Withdrawal by Subject|3
844493|NCT01156142|2684294|P2|Overall Study|Ineligible|1
844494|NCT01156142|2684295|P1|Overall Study|Ineligible|0
844495|NCT01156142|2684294|P2|Overall Study|Withdrawal by Subject|6
844496|NCT01156142|2684295|P1|Overall Study|Withdrawal by Subject|8
844497|NCT01156311|2684313|P4|6-month Add-on Therapy Period|Not Specified|2
844498|NCT01156311|2684314|P3|6-month Add-on Therapy Period|Not Specified|1
844499|NCT01156311|2684315|P2|6-month Add-on Therapy Period|Not Specified|0
844500|NCT01156311|2684316|P1|6-month Add-on Therapy Period|Not Specified|0
844501|NCT01156311|2684313|P4|6-month Add-on Therapy Period|Physician Decision|0
844502|NCT01156311|2684314|P3|6-month Add-on Therapy Period|Physician Decision|1
844503|NCT01156311|2684315|P2|6-month Add-on Therapy Period|Physician Decision|0
844504|NCT01156311|2684316|P1|6-month Add-on Therapy Period|Physician Decision|0
844505|NCT01156311|2684313|P4|6-month Add-on Therapy Period|Disease Activity|2
844506|NCT01156311|2684314|P3|6-month Add-on Therapy Period|Disease Activity|1
844507|NCT01156311|2684315|P2|6-month Add-on Therapy Period|Disease Activity|0
844508|NCT01156311|2684316|P1|6-month Add-on Therapy Period|Disease Activity|0
844509|NCT01156311|2684313|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
844510|NCT01156311|2684314|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
844511|NCT01156311|2684315|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
844512|NCT01156311|2684316|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
844513|NCT01156311|2684313|P4|6-month Add-on Therapy Period|Adverse Event|6
844514|NCT01156311|2684314|P3|6-month Add-on Therapy Period|Adverse Event|7
844515|NCT01156311|2684315|P2|6-month Add-on Therapy Period|Adverse Event|0
844516|NCT01156311|2684316|P1|6-month Add-on Therapy Period|Adverse Event|0
844517|NCT01156311|2684313|P4|2-Month Monotherapy Period|Not specified|0
844518|NCT01156311|2684314|P3|2-Month Monotherapy Period|Not specified|0
844519|NCT01156311|2684315|P2|2-Month Monotherapy Period|Not specified|0
844520|NCT01156311|2684316|P1|2-Month Monotherapy Period|Not specified|1
844521|NCT01156311|2684313|P4|2-Month Monotherapy Period|Physician Decision|0
844522|NCT01156311|2684314|P3|2-Month Monotherapy Period|Physician Decision|0
844523|NCT01156311|2684315|P2|2-Month Monotherapy Period|Physician Decision|1
844524|NCT01156311|2684316|P1|2-Month Monotherapy Period|Physician Decision|0
844525|NCT01156311|2684313|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
844526|NCT01156311|2684314|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
844527|NCT01156311|2684315|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
844528|NCT01156311|2684316|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
844529|NCT01156363|2684338|P1|Overall Study|Unspecified|6
844530|NCT01156363|2684338|P1|Overall Study|Refused Treatment|4
844531|NCT01156363|2684338|P1|Overall Study|Failure to Return|1
844532|NCT01156363|2684338|P1|Overall Study|Insufficient Therapeutic Response|5
844533|NCT01156363|2684338|P1|Overall Study|Adverse Event|6
844534|NCT01156376|2684361|P3|Overall Study|Withdrawal by Subject|3
844535|NCT01156376|2684362|P2|Overall Study|Withdrawal by Subject|0
844536|NCT01156376|2684363|P1|Overall Study|Withdrawal by Subject|0
844537|NCT01156376|2684361|P3|Overall Study|Adverse Event|1
844538|NCT01156376|2684362|P2|Overall Study|Adverse Event|0
844539|NCT01156376|2684363|P1|Overall Study|Adverse Event|1
844540|NCT01156480|2684586|P2|Overall Study|change in diagnosis|1
844541|NCT01156480|2684587|P1|Overall Study|change in diagnosis|0
844542|NCT01156532|2684595|P1|Overall Study|Lost to Follow-up|1
844543|NCT01156532|2684595|P1|Overall Study|Family Reasons|1
844544|NCT01156792|2684668|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
844545|NCT01156792|2684668|P1|Overall Study|Withdrawal by Subject|9
844546|NCT01156792|2684668|P1|Overall Study|Physician Decision|3
844547|NCT01156792|2684668|P1|Overall Study|Lost to Follow-up|3
844548|NCT01156792|2684668|P1|Overall Study|Protocol Violation|6
844549|NCT01156792|2684668|P1|Overall Study|Lack of Efficacy|36
844550|NCT01156792|2684668|P1|Overall Study|Adverse Event|1
844551|NCT01156844|2684737|P4|Overall Study|Protocol deviation|0
844552|NCT01156844|2684738|P3|Overall Study|Protocol deviation|0
844553|NCT01156844|2684739|P2|Overall Study|Protocol deviation|0
844554|NCT01156844|2684740|P1|Overall Study|Protocol deviation|2
844555|NCT01156844|2684737|P4|Overall Study|Administrative problems|1
844556|NCT01156844|2684738|P3|Overall Study|Administrative problems|0
844557|NCT01156844|2684739|P2|Overall Study|Administrative problems|1
844558|NCT01156844|2684740|P1|Overall Study|Administrative problems|0
844559|NCT01156844|2684737|P4|Overall Study|Lost to Follow-up|0
844560|NCT01156844|2684738|P3|Overall Study|Lost to Follow-up|1
844561|NCT01156844|2684739|P2|Overall Study|Lost to Follow-up|0
844562|NCT01156844|2684740|P1|Overall Study|Lost to Follow-up|0
844563|NCT01156844|2684737|P4|Overall Study|Withdrawal by Subject|2
844564|NCT01156844|2684738|P3|Overall Study|Withdrawal by Subject|2
844565|NCT01156844|2684739|P2|Overall Study|Withdrawal by Subject|0
844566|NCT01156844|2684740|P1|Overall Study|Withdrawal by Subject|0
844567|NCT01156844|2684737|P4|Overall Study|Abnormal test procedure result(s)|2
844568|NCT01156844|2684738|P3|Overall Study|Abnormal test procedure result(s)|2
844569|NCT01156844|2684739|P2|Overall Study|Abnormal test procedure result(s)|1
844570|NCT01156844|2684740|P1|Overall Study|Abnormal test procedure result(s)|0
844571|NCT01156844|2684737|P4|Overall Study|Adverse Event|1
844572|NCT01156844|2684738|P3|Overall Study|Adverse Event|1
844573|NCT01156844|2684739|P2|Overall Study|Adverse Event|0
844574|NCT01156844|2684740|P1|Overall Study|Adverse Event|0
844575|NCT01157065|2684770|P2|Overall Study|Death|1
844576|NCT01157065|2684771|P1|Overall Study|Death|0
844577|NCT01157078|2684781|P2|Overall Study|Not specified|4
844578|NCT01157078|2684782|P1|Overall Study|Not specified|2
844579|NCT01157078|2684781|P2|Overall Study|Lost to Follow-up|5
844580|NCT01157078|2684782|P1|Overall Study|Lost to Follow-up|7
844581|NCT01157078|2684781|P2|Overall Study|Study-specific withdrawal criteria|2
844582|NCT01157078|2684782|P1|Overall Study|Study-specific withdrawal criteria|2
844583|NCT01157078|2684781|P2|Overall Study|Lack of Efficacy|0
844584|NCT01157078|2684782|P1|Overall Study|Lack of Efficacy|2
844585|NCT01157078|2684781|P2|Overall Study|Condition under investigation worsened|1
844586|NCT01157078|2684782|P1|Overall Study|Condition under investigation worsened|0
844587|NCT01157078|2684781|P2|Overall Study|Severe non-compliance to protocol|4
844588|NCT01157078|2684782|P1|Overall Study|Severe non-compliance to protocol|2
844589|NCT01157078|2684781|P2|Overall Study|Adverse Event|6
844590|NCT01157078|2684782|P1|Overall Study|Adverse Event|6
844591|NCT01157078|2684781|P2|Overall Study|Eligibility criteria not fulfilled|0
844592|NCT01157078|2684782|P1|Overall Study|Eligibility criteria not fulfilled|2
844593|NCT01157078|2684781|P2|Overall Study|Withdrawal by Subject|14
844594|NCT01157078|2684782|P1|Overall Study|Withdrawal by Subject|12
844595|NCT01157117|2684833|P3|Overall Study|Unknown (Pending Final Form Submission)|13
844596|NCT01157117|2684834|P2|Overall Study|Unknown (Pending Final Form Submission)|5
844597|NCT01157117|2684835|P1|Overall Study|Unknown (Pending Final Form Submission)|4
844598|NCT01157117|2684833|P3|Overall Study|Lost to Follow-up|1
844599|NCT01157117|2684834|P2|Overall Study|Lost to Follow-up|0
844600|NCT01157117|2684835|P1|Overall Study|Lost to Follow-up|0
844601|NCT01157117|2684833|P3|Overall Study|Lack of Efficacy|0
844602|NCT01157117|2684834|P2|Overall Study|Lack of Efficacy|1
844603|NCT01157117|2684835|P1|Overall Study|Lack of Efficacy|1
844604|NCT01157117|2684833|P3|Overall Study|Withdrawal by Subject|1
844605|NCT01157117|2684834|P2|Overall Study|Withdrawal by Subject|1
844606|NCT01157117|2684835|P1|Overall Study|Withdrawal by Subject|4
844607|NCT01157117|2684833|P3|Overall Study|Dosing Symptoms|0
844608|NCT01157117|2684834|P2|Overall Study|Dosing Symptoms|4
844609|NCT01157117|2684835|P1|Overall Study|Dosing Symptoms|0
844610|NCT01157169|2684876|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
844611|NCT01157169|2684877|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
844612|NCT01157169|2684876|P2|First Intervention|Emesis Within 4 hrs of Administration|2
844613|NCT01157169|2684877|P1|First Intervention|Emesis Within 4 hrs of Administration|4
844614|NCT01157169|2684876|P2|First Intervention|Protocol Violation|0
844615|NCT01157169|2684877|P1|First Intervention|Protocol Violation|0
844616|NCT01157182|2684895|P2|Washout of 28 Days|Adverse Event|0
844617|NCT01157182|2684896|P1|Washout of 28 Days|Adverse Event|2
844618|NCT01157234|2684944|P2|Overall Study|Withdrawal by Subject|0
844619|NCT01157234|2684945|P1|Overall Study|Withdrawal by Subject|1
844620|NCT01157351|2684977|P2|Overall Study|Randomized but not Treated|2
844621|NCT01157351|2684978|P1|Overall Study|Randomized but not Treated|4
844622|NCT01157351|2684977|P2|Overall Study|Noncompliance with Study Drug|3
844623|NCT01157351|2684978|P1|Overall Study|Noncompliance with Study Drug|0
844624|NCT01157351|2684977|P2|Overall Study|Unspecified|36
844625|NCT01157351|2684978|P1|Overall Study|Unspecified|32
844626|NCT01157351|2684977|P2|Overall Study|Protocol Violation|1
844627|NCT01157351|2684978|P1|Overall Study|Protocol Violation|0
844628|NCT01157351|2684977|P2|Overall Study|Physician Decision|4
844629|NCT01157351|2684978|P1|Overall Study|Physician Decision|5
844630|NCT01157351|2684977|P2|Overall Study|Withdrawal by Subject|27
844631|NCT01157351|2684978|P1|Overall Study|Withdrawal by Subject|37
844632|NCT01157351|2684977|P2|Overall Study|Lost to Follow-up|55
844633|NCT01157351|2684978|P1|Overall Study|Lost to Follow-up|53
844634|NCT01157351|2684977|P2|Overall Study|Death|0
844635|NCT01157351|2684978|P1|Overall Study|Death|1
844636|NCT01157351|2684977|P2|Overall Study|Adverse Event|4
844637|NCT01157351|2684978|P1|Overall Study|Adverse Event|5
844638|NCT01157377|2685001|P7|Overall Study|Other Miscellaneous Reasons|1
844639|NCT01157377|2685002|P6|Overall Study|Other Miscellaneous Reasons|1
844640|NCT01157377|2685003|P5|Overall Study|Other Miscellaneous Reasons|1
844641|NCT01157377|2685004|P4|Overall Study|Other Miscellaneous Reasons|0
844642|NCT01157377|2685005|P3|Overall Study|Other Miscellaneous Reasons|0
844643|NCT01157377|2685006|P2|Overall Study|Other Miscellaneous Reasons|2
844644|NCT01157377|2685007|P1|Overall Study|Other Miscellaneous Reasons|0
844645|NCT01157377|2685001|P7|Overall Study|Lack of Efficacy|1
844646|NCT01157377|2685002|P6|Overall Study|Lack of Efficacy|0
844647|NCT01157377|2685003|P5|Overall Study|Lack of Efficacy|0
844648|NCT01157377|2685004|P4|Overall Study|Lack of Efficacy|0
844649|NCT01157377|2685005|P3|Overall Study|Lack of Efficacy|0
844650|NCT01157377|2685006|P2|Overall Study|Lack of Efficacy|0
844651|NCT01157377|2685007|P1|Overall Study|Lack of Efficacy|0
844652|NCT01157377|2685001|P7|Overall Study|Protocol Violation|0
844653|NCT01157377|2685002|P6|Overall Study|Protocol Violation|1
844654|NCT01157377|2685003|P5|Overall Study|Protocol Violation|0
844655|NCT01157377|2685004|P4|Overall Study|Protocol Violation|0
844656|NCT01157377|2685005|P3|Overall Study|Protocol Violation|0
844657|NCT01157377|2685006|P2|Overall Study|Protocol Violation|0
844658|NCT01157377|2685007|P1|Overall Study|Protocol Violation|0
844659|NCT01157377|2685001|P7|Overall Study|Personal Reasons|0
844660|NCT01157377|2685002|P6|Overall Study|Personal Reasons|0
844661|NCT01157377|2685003|P5|Overall Study|Personal Reasons|0
844662|NCT01157377|2685004|P4|Overall Study|Personal Reasons|1
844663|NCT01157377|2685005|P3|Overall Study|Personal Reasons|0
844664|NCT01157377|2685006|P2|Overall Study|Personal Reasons|1
844665|NCT01157377|2685007|P1|Overall Study|Personal Reasons|2
844666|NCT01157377|2685001|P7|Overall Study|Lost to Follow-up|0
844667|NCT01157377|2685002|P6|Overall Study|Lost to Follow-up|1
844668|NCT01157377|2685003|P5|Overall Study|Lost to Follow-up|1
844669|NCT01157377|2685004|P4|Overall Study|Lost to Follow-up|0
844670|NCT01157377|2685005|P3|Overall Study|Lost to Follow-up|1
844671|NCT01157377|2685006|P2|Overall Study|Lost to Follow-up|0
844672|NCT01157377|2685007|P1|Overall Study|Lost to Follow-up|0
844673|NCT01157845|2685045|P1|Overall Study|Device malfunction|1
844674|NCT01157845|2685045|P1|Overall Study|Study was ended|1
844675|NCT01157845|2685045|P1|Overall Study|Protocol Violation|13
844676|NCT01157845|2685045|P1|Overall Study|Physician Decision|3
844677|NCT01157845|2685045|P1|Overall Study|Withdrawal by Subject|12
844678|NCT01157845|2685045|P1|Overall Study|Lost to Follow-up|5
844679|NCT01152190|2685067|P2|Overall Study|Withdrawal by Subject|3
844680|NCT01152190|2685068|P1|Overall Study|Withdrawal by Subject|1
844681|NCT01152190|2685067|P2|Overall Study|Protocol Violation|1
844682|NCT01152190|2685068|P1|Overall Study|Protocol Violation|1
844683|NCT01152190|2685067|P2|Overall Study|Death|0
844684|NCT01152190|2685068|P1|Overall Study|Death|1
844685|NCT01152190|2685067|P2|Overall Study|Adverse Event|4
844686|NCT01152190|2685068|P1|Overall Study|Adverse Event|2
844687|NCT01152385|2685111|P4|Overall Study|Unspecified|3
844688|NCT01152385|2685112|P3|Overall Study|Unspecified|2
844689|NCT01152385|2685113|P2|Overall Study|Unspecified|3
844690|NCT01152385|2685114|P1|Overall Study|Unspecified|4
844691|NCT01152385|2685111|P4|Overall Study|Study-specific withdrawal criteria|0
844692|NCT01152385|2685112|P3|Overall Study|Study-specific withdrawal criteria|2
844693|NCT01152385|2685113|P2|Overall Study|Study-specific withdrawal criteria|1
844694|NCT01152385|2685114|P1|Overall Study|Study-specific withdrawal criteria|1
844695|NCT01152385|2685111|P4|Overall Study|Adverse Event|0
844696|NCT01152385|2685112|P3|Overall Study|Adverse Event|0
844697|NCT01152385|2685113|P2|Overall Study|Adverse Event|1
844698|NCT01152385|2685114|P1|Overall Study|Adverse Event|1
844699|NCT01152385|2685111|P4|Overall Study|Protocol Violation|1
844700|NCT01152385|2685112|P3|Overall Study|Protocol Violation|0
844701|NCT01152385|2685113|P2|Overall Study|Protocol Violation|0
844702|NCT01152385|2685114|P1|Overall Study|Protocol Violation|0
844703|NCT01152385|2685111|P4|Overall Study|Withdrawal by Subject|1
844704|NCT01152385|2685112|P3|Overall Study|Withdrawal by Subject|1
844705|NCT01152385|2685113|P2|Overall Study|Withdrawal by Subject|1
844706|NCT01152385|2685114|P1|Overall Study|Withdrawal by Subject|3
844707|NCT01152437|2685155|P3|Overall Study|Refusal to continue taking trial medicat|2
844708|NCT01152437|2685156|P2|Overall Study|Refusal to continue taking trial medicat|0
844709|NCT01152437|2685157|P1|Overall Study|Refusal to continue taking trial medicat|1
844710|NCT01152437|2685155|P3|Overall Study|Progressive disease|32
844711|NCT01152437|2685156|P2|Overall Study|Progressive disease|13
844712|NCT01152437|2685157|P1|Overall Study|Progressive disease|27
844713|NCT01152437|2685155|P3|Overall Study|Not treated|2
844714|NCT01152437|2685156|P2|Overall Study|Not treated|1
844715|NCT01152437|2685157|P1|Overall Study|Not treated|0
844716|NCT01152437|2685155|P3|Overall Study|Other Adverse Event|7
844717|NCT01152437|2685156|P2|Overall Study|Other Adverse Event|1
844718|NCT01152437|2685157|P1|Overall Study|Other Adverse Event|8
844719|NCT01152450|2685173|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
844720|NCT01152450|2685174|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
844721|NCT01152450|2685175|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
844722|NCT01152450|2685176|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
844723|NCT01152450|2685177|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
844724|NCT01152450|2685178|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
844725|NCT01152450|2685173|P6|Period 1 (4 Weeks)|Protocol Violation|0
844726|NCT01152450|2685174|P5|Period 1 (4 Weeks)|Protocol Violation|1
844727|NCT01152450|2685175|P4|Period 1 (4 Weeks)|Protocol Violation|0
844728|NCT01152450|2685176|P3|Period 1 (4 Weeks)|Protocol Violation|0
844729|NCT01152450|2685177|P2|Period 1 (4 Weeks)|Protocol Violation|0
844730|NCT01152450|2685178|P1|Period 1 (4 Weeks)|Protocol Violation|0
844731|NCT01152450|2685173|P6|Period 1 (4 Weeks)|Adverse Event|1
844732|NCT01152450|2685174|P5|Period 1 (4 Weeks)|Adverse Event|1
844733|NCT01152450|2685175|P4|Period 1 (4 Weeks)|Adverse Event|0
844734|NCT01152450|2685176|P3|Period 1 (4 Weeks)|Adverse Event|0
844735|NCT01152450|2685177|P2|Period 1 (4 Weeks)|Adverse Event|0
844736|NCT01152450|2685178|P1|Period 1 (4 Weeks)|Adverse Event|0
844737|NCT01152554|2685248|P2|Overall Study|Death|1
844738|NCT01152554|2685249|P1|Overall Study|Death|1
844739|NCT01152554|2685248|P2|Overall Study|Not specified|8
844740|NCT01152554|2685249|P1|Overall Study|Not specified|28
844741|NCT01152554|2685248|P2|Overall Study|Lost to Follow-up|32
844742|NCT01152554|2685249|P1|Overall Study|Lost to Follow-up|87
844743|NCT01152554|2685248|P2|Overall Study|Study-specific withdrawal criteria|8
844744|NCT01152554|2685249|P1|Overall Study|Study-specific withdrawal criteria|17
844745|NCT01152554|2685248|P2|Overall Study|Lack of Efficacy|3
844746|NCT01152554|2685249|P1|Overall Study|Lack of Efficacy|20
844747|NCT01152554|2685248|P2|Overall Study|Condition under investigation worsened|2
844748|NCT01152554|2685249|P1|Overall Study|Condition under investigation worsened|5
844749|NCT01152554|2685248|P2|Overall Study|Severe non-compliance to protocol|14
844750|NCT01152554|2685249|P1|Overall Study|Severe non-compliance to protocol|36
844751|NCT01152554|2685248|P2|Overall Study|Adverse Event|14
844752|NCT01152554|2685249|P1|Overall Study|Adverse Event|67
844753|NCT01152554|2685248|P2|Overall Study|Eligiblity criteria not fulfilled|1
844754|NCT01152554|2685249|P1|Overall Study|Eligiblity criteria not fulfilled|0
844755|NCT01152554|2685248|P2|Overall Study|Withdrawal by Subject|28
844756|NCT01152554|2685249|P1|Overall Study|Withdrawal by Subject|73
844757|NCT01152580|2685273|P2|Overall Study|Withdrawal by Subject|1
844758|NCT01152580|2685274|P1|Overall Study|Withdrawal by Subject|0
844759|NCT01158118|2685296|P2|Overall Study|Death|1
844760|NCT01158118|2685297|P1|Overall Study|Death|0
844761|NCT01158118|2685296|P2|Overall Study|Suffered stroke prior to transplant|1
844762|NCT01158118|2685297|P1|Overall Study|Suffered stroke prior to transplant|0
844763|NCT01158118|2685296|P2|Overall Study|Donor match was a screen failure|1
844764|NCT01158118|2685297|P1|Overall Study|Donor match was a screen failure|0
844765|NCT01158118|2685296|P2|Overall Study|Screen failure|0
844766|NCT01158118|2685297|P1|Overall Study|Screen failure|1
844767|NCT01158261|2685313|P1|Overall Study|Withdrawal by Subject|1
844768|NCT01158261|2685313|P1|Overall Study|Death|7
844769|NCT01158261|2685313|P1|Overall Study|Lost to Follow-up|9
844770|NCT01158378|2685319|P2|Overall Study|Withdrawal by Subject|0
844771|NCT01158378|2685320|P1|Overall Study|Withdrawal by Subject|4
844772|NCT01158378|2685319|P2|Overall Study|Lost to Follow-up|4
844773|NCT01158378|2685320|P1|Overall Study|Lost to Follow-up|2
844774|NCT01158378|2685319|P2|Overall Study|Death|5
844775|NCT01158378|2685320|P1|Overall Study|Death|4
844776|NCT01160484|2685372|P1|Overall Study|inclusion/exclusion criteria failure|1
844777|NCT01160484|2685372|P1|Overall Study|Withdrawal by Subject|2
844778|NCT01160484|2685372|P1|Overall Study|Adverse Event|6
844779|NCT01160484|2685372|P1|Overall Study|Lack of Efficacy|9
844780|NCT01160614|2685384|P2|Overall Study|Withdrawal by Subject|2
844781|NCT01160614|2685385|P1|Overall Study|Withdrawal by Subject|0
844782|NCT01160640|2685435|P2|Overall Study|Withdrawal by Subject|3
844783|NCT01160640|2685436|P1|Overall Study|Withdrawal by Subject|0
844784|NCT01160640|2685435|P2|Overall Study|Incarceration|0
844785|NCT01160640|2685436|P1|Overall Study|Incarceration|1
844786|NCT01160640|2685435|P2|Overall Study|Physician Decision|3
844787|NCT01160640|2685436|P1|Overall Study|Physician Decision|3
844788|NCT01160744|2685454|P4|Overall Study|Alive and Still on Treatment|14
844789|NCT01160744|2685455|P3|Overall Study|Alive and Still on Treatment|8
844790|NCT01160744|2685456|P2|Overall Study|Alive and Still on Treatment|11
844791|NCT01160744|2685457|P1|Overall Study|Alive and Still on Treatment|9
844792|NCT01160744|2685454|P4|Overall Study|Not Specified|4
844793|NCT01160744|2685455|P3|Overall Study|Not Specified|5
844794|NCT01160744|2685456|P2|Overall Study|Not Specified|9
844795|NCT01160744|2685457|P1|Overall Study|Not Specified|5
844796|NCT01160744|2685454|P4|Overall Study|Not meet inclusion/exclusion criteria|0
844797|NCT01160744|2685455|P3|Overall Study|Not meet inclusion/exclusion criteria|1
844798|NCT01160744|2685456|P2|Overall Study|Not meet inclusion/exclusion criteria|0
844799|NCT01160744|2685457|P1|Overall Study|Not meet inclusion/exclusion criteria|0
844800|NCT01160744|2685454|P4|Overall Study|Withdrawal by Subject|4
844801|NCT01160744|2685455|P3|Overall Study|Withdrawal by Subject|6
844802|NCT01160744|2685456|P2|Overall Study|Withdrawal by Subject|5
844803|NCT01160744|2685457|P1|Overall Study|Withdrawal by Subject|6
844804|NCT01160770|2685491|P1|Overall Study|Other Reasons|1
844805|NCT01160770|2685491|P1|Overall Study|Lack of Efficacy|15
844806|NCT01160770|2685491|P1|Overall Study|Death|9
844807|NCT01160770|2685491|P1|Overall Study|Study termination or sponsor request|1
844808|NCT01160770|2685491|P1|Overall Study|Lost to Follow-up|7
844809|NCT01160770|2685491|P1|Overall Study|Physician Decision|1
844810|NCT01160770|2685491|P1|Overall Study|Subject/parent/caregiver request|33
844811|NCT01160770|2685491|P1|Overall Study|Protocol Violation|2
844812|NCT01160770|2685491|P1|Overall Study|Adverse Event|10
844813|NCT01160822|2685507|P7|Overall Study|Protocol deviation|0
844814|NCT01160822|2685508|P6|Overall Study|Protocol deviation|0
844815|NCT01160822|2685509|P5|Overall Study|Protocol deviation|2
844816|NCT01160822|2685510|P4|Overall Study|Protocol deviation|0
844817|NCT01160822|2685511|P3|Overall Study|Protocol deviation|0
844818|NCT01160822|2685512|P2|Overall Study|Protocol deviation|0
844819|NCT01160822|2685513|P1|Overall Study|Protocol deviation|0
844820|NCT01160822|2685507|P7|Overall Study|Administrative problems|0
844821|NCT01160822|2685508|P6|Overall Study|Administrative problems|0
844822|NCT01160822|2685509|P5|Overall Study|Administrative problems|1
844823|NCT01160822|2685510|P4|Overall Study|Administrative problems|0
844824|NCT01160822|2685511|P3|Overall Study|Administrative problems|0
844825|NCT01160822|2685512|P2|Overall Study|Administrative problems|0
844826|NCT01160822|2685513|P1|Overall Study|Administrative problems|0
844827|NCT01160822|2685507|P7|Overall Study|Lost to Follow-up|0
844828|NCT01160822|2685508|P6|Overall Study|Lost to Follow-up|0
844829|NCT01160822|2685509|P5|Overall Study|Lost to Follow-up|1
844830|NCT01160822|2685510|P4|Overall Study|Lost to Follow-up|0
844831|NCT01160822|2685511|P3|Overall Study|Lost to Follow-up|0
844832|NCT01160822|2685512|P2|Overall Study|Lost to Follow-up|0
844833|NCT01160822|2685513|P1|Overall Study|Lost to Follow-up|0
844834|NCT01160822|2685507|P7|Overall Study|Withdrawal by Subject|1
844835|NCT01160822|2685508|P6|Overall Study|Withdrawal by Subject|0
844836|NCT01160822|2685509|P5|Overall Study|Withdrawal by Subject|0
844837|NCT01160822|2685510|P4|Overall Study|Withdrawal by Subject|0
844838|NCT01160822|2685511|P3|Overall Study|Withdrawal by Subject|0
844839|NCT01160822|2685512|P2|Overall Study|Withdrawal by Subject|0
844840|NCT01160822|2685513|P1|Overall Study|Withdrawal by Subject|0
844841|NCT01160822|2685507|P7|Overall Study|Unsatisfactory therapeutic effect|3
844842|NCT01160822|2685508|P6|Overall Study|Unsatisfactory therapeutic effect|5
844843|NCT01160822|2685509|P5|Overall Study|Unsatisfactory therapeutic effect|4
844844|NCT01160822|2685510|P4|Overall Study|Unsatisfactory therapeutic effect|0
844845|NCT01160822|2685511|P3|Overall Study|Unsatisfactory therapeutic effect|0
844846|NCT01160822|2685512|P2|Overall Study|Unsatisfactory therapeutic effect|0
844847|NCT01160822|2685513|P1|Overall Study|Unsatisfactory therapeutic effect|0
844848|NCT01160822|2685507|P7|Overall Study|Adverse Event|5
844849|NCT01160822|2685508|P6|Overall Study|Adverse Event|2
844850|NCT01160822|2685509|P5|Overall Study|Adverse Event|1
844851|NCT01160822|2685510|P4|Overall Study|Adverse Event|0
844852|NCT01160822|2685511|P3|Overall Study|Adverse Event|0
844853|NCT01160822|2685512|P2|Overall Study|Adverse Event|0
844854|NCT01160822|2685513|P1|Overall Study|Adverse Event|0
844855|NCT01161173|2685713|P1|Overall Study|Reasons Not Specified|23
844856|NCT01161173|2685713|P1|Overall Study|End of Study|2
844857|NCT01161173|2685713|P1|Overall Study|Death|194
844858|NCT01161173|2685713|P1|Overall Study|Unacceptable Toxicity|21
844859|NCT01161173|2685713|P1|Overall Study|Withdrawal of Consent|5
844860|NCT01161173|2685713|P1|Overall Study|Progressive Disease|82
844861|NCT01161173|2685713|P1|Overall Study|Lost to Follow-up|7
844862|NCT01161173|2685713|P1|Overall Study|Protocol Violation|13
844863|NCT01161407|2685769|P2|Overall Study|Protocol Violation|1
844864|NCT01161407|2685770|P1|Overall Study|Protocol Violation|3
844865|NCT01161446|2685794|P2|Overall Study|Withdrawal by Subject|1
844866|NCT01161446|2685795|P1|Overall Study|Withdrawal by Subject|0
844867|NCT01161446|2685794|P2|Overall Study|Lost to Follow-up|14
844868|NCT01161446|2685795|P1|Overall Study|Lost to Follow-up|18
844869|NCT01161472|2685807|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
844870|NCT01161472|2685808|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
844871|NCT01161472|2685809|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
844872|NCT01161472|2685810|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
844873|NCT01161498|2685866|P2|Overall Study|Disease Progression|1
844874|NCT01161498|2685867|P1|Overall Study|Disease Progression|0
844875|NCT01161537|2685891|P1|Part B|Withdrawal by Subject|2
844876|NCT01161628|2685918|P1|Overall Study|Lack of Efficacy|2
844877|NCT01161628|2685918|P1|Overall Study|Death|6
844878|NCT01162122|2685945|P2|Overall Study|Missing primary reason|0
844879|NCT01162122|2685946|P1|Overall Study|Missing primary reason|1
844880|NCT01162122|2685945|P2|Overall Study|Unable to classify|7
844881|NCT01162122|2685946|P1|Overall Study|Unable to classify|3
844882|NCT01162122|2685945|P2|Overall Study|Administrative reason|1
844883|NCT01162122|2685946|P1|Overall Study|Administrative reason|1
844884|NCT01162122|2685945|P2|Overall Study|Inappropriate enrollment|4
844885|NCT01162122|2685946|P1|Overall Study|Inappropriate enrollment|5
844886|NCT01162122|2685945|P2|Overall Study|Protocol Violation|2
844887|NCT01162122|2685946|P1|Overall Study|Protocol Violation|2
844888|NCT01162122|2685945|P2|Overall Study|Death|46
844889|NCT01162122|2685946|P1|Overall Study|Death|51
844890|NCT01162122|2685945|P2|Overall Study|Adverse Event|2
844891|NCT01162122|2685946|P1|Overall Study|Adverse Event|3
844892|NCT01162122|2685945|P2|Overall Study|Lost to Follow-up|91
844893|NCT01162122|2685946|P1|Overall Study|Lost to Follow-up|73
844894|NCT01162122|2685945|P2|Overall Study|Withdrawal by Subject|43
844895|NCT01162122|2685946|P1|Overall Study|Withdrawal by Subject|52
844896|NCT01162135|2686003|P1|Overall Study|Ineligible|1
844897|NCT01162135|2686003|P1|Overall Study|Severe back pain|1
844898|NCT01162135|2686003|P1|Overall Study|Withdrawal by Subject|1
844899|NCT01162304|2686007|P1|Overall Study|Beck scale to high|11
844900|NCT01162421|2686034|P2|Overall Study|Not specified|3
844901|NCT01162421|2686035|P1|Overall Study|Not specified|2
844902|NCT01162421|2686034|P2|Overall Study|Lack of Efficacy|2
844903|NCT01162421|2686035|P1|Overall Study|Lack of Efficacy|2
844904|NCT01162421|2686034|P2|Overall Study|Lost to Follow-up|2
844905|NCT01162421|2686035|P1|Overall Study|Lost to Follow-up|0
844906|NCT01162421|2686034|P2|Overall Study|Adverse Event|5
844907|NCT01162421|2686035|P1|Overall Study|Adverse Event|2
844908|NCT01162421|2686034|P2|Overall Study|Did not receive study drug|1
844909|NCT01162421|2686035|P1|Overall Study|Did not receive study drug|2
844910|NCT01162473|2686115|P2|Overall Study|Withdrawal by Subject|4
844911|NCT01162473|2686116|P1|Overall Study|Withdrawal by Subject|0
844912|NCT01162473|2686115|P2|Overall Study|Adverse Event|1
844913|NCT01162473|2686116|P1|Overall Study|Adverse Event|2
894084|NCT03255733|2837236|P1|Overall Study|Lost to Follow-up|4
844916|NCT01155466|2686159|P5|Overall Study|Randomized not treated|2
844917|NCT01155466|2686160|P4|Overall Study|Randomized not treated|0
844918|NCT01155466|2686161|P3|Overall Study|Randomized not treated|3
844919|NCT01155466|2686162|P2|Overall Study|Randomized not treated|2
844920|NCT01155466|2686163|P1|Overall Study|Randomized not treated|2
844921|NCT01155466|2686159|P5|Overall Study|Administrative|0
844922|NCT01155466|2686160|P4|Overall Study|Administrative|0
844923|NCT01155466|2686161|P3|Overall Study|Administrative|0
844924|NCT01155466|2686162|P2|Overall Study|Administrative|3
844925|NCT01155466|2686163|P1|Overall Study|Administrative|0
844926|NCT01155466|2686159|P5|Overall Study|Protocol Violation|1
844927|NCT01155466|2686160|P4|Overall Study|Protocol Violation|0
844928|NCT01155466|2686161|P3|Overall Study|Protocol Violation|2
844929|NCT01155466|2686162|P2|Overall Study|Protocol Violation|0
844930|NCT01155466|2686163|P1|Overall Study|Protocol Violation|0
844931|NCT01155466|2686159|P5|Overall Study|Withdrawal by Subject|4
844932|NCT01155466|2686160|P4|Overall Study|Withdrawal by Subject|4
844933|NCT01155466|2686161|P3|Overall Study|Withdrawal by Subject|9
844934|NCT01155466|2686162|P2|Overall Study|Withdrawal by Subject|5
844935|NCT01155466|2686163|P1|Overall Study|Withdrawal by Subject|7
844936|NCT01155466|2686159|P5|Overall Study|Lost to Follow-up|2
844937|NCT01155466|2686160|P4|Overall Study|Lost to Follow-up|0
844938|NCT01155466|2686161|P3|Overall Study|Lost to Follow-up|0
844939|NCT01155466|2686162|P2|Overall Study|Lost to Follow-up|0
844940|NCT01155466|2686163|P1|Overall Study|Lost to Follow-up|0
844941|NCT01155466|2686159|P5|Overall Study|Adverse Event|18
844942|NCT01155466|2686160|P4|Overall Study|Adverse Event|17
844943|NCT01155466|2686161|P3|Overall Study|Adverse Event|6
844944|NCT01155466|2686162|P2|Overall Study|Adverse Event|15
844945|NCT01155466|2686163|P1|Overall Study|Adverse Event|13
844946|NCT01155479|2686220|P5|Part II|Non-Compliance with Protocol|0
844947|NCT01155479|2686221|P4|Part II|Non-Compliance with Protocol|2
844948|NCT01155479|2686222|P3|Part II|Non-Compliance with Protocol|0
844949|NCT01155479|2686223|P2|Part II|Non-Compliance with Protocol|1
844950|NCT01155479|2686224|P1|Part II|Non-Compliance with Protocol|0
844951|NCT01155479|2686220|P5|Part II|Treatment Failure|1
844952|NCT01155479|2686221|P4|Part II|Treatment Failure|0
844953|NCT01155479|2686222|P3|Part II|Treatment Failure|2
844954|NCT01155479|2686223|P2|Part II|Treatment Failure|1
844955|NCT01155479|2686224|P1|Part II|Treatment Failure|0
844956|NCT01155479|2686220|P5|Part II|Lost to Follow-up|1
844957|NCT01155479|2686221|P4|Part II|Lost to Follow-up|0
844958|NCT01155479|2686222|P3|Part II|Lost to Follow-up|0
844959|NCT01155479|2686223|P2|Part II|Lost to Follow-up|0
844960|NCT01155479|2686224|P1|Part II|Lost to Follow-up|1
844961|NCT01155479|2686220|P5|Part II|Withdrawal by Subject|3
844962|NCT01155479|2686221|P4|Part II|Withdrawal by Subject|7
844963|NCT01155479|2686222|P3|Part II|Withdrawal by Subject|12
844964|NCT01155479|2686223|P2|Part II|Withdrawal by Subject|4
844965|NCT01155479|2686224|P1|Part II|Withdrawal by Subject|8
844966|NCT01155479|2686220|P5|Part II|Administrative|46
844967|NCT01155479|2686221|P4|Part II|Administrative|38
844968|NCT01155479|2686222|P3|Part II|Administrative|36
844969|NCT01155479|2686223|P2|Part II|Administrative|49
844970|NCT01155479|2686224|P1|Part II|Administrative|43
844971|NCT01155479|2686220|P5|Part II|Adverse Event|4
844972|NCT01155479|2686221|P4|Part II|Adverse Event|3
844973|NCT01155479|2686222|P3|Part II|Adverse Event|8
844974|NCT01155479|2686223|P2|Part II|Adverse Event|6
844975|NCT01155479|2686224|P1|Part II|Adverse Event|7
844976|NCT01155479|2686220|P5|Part I|Non-Compliance with Protocol|2
844977|NCT01155479|2686221|P4|Part I|Non-Compliance with Protocol|3
844978|NCT01155479|2686222|P3|Part I|Non-Compliance with Protocol|3
844979|NCT01155479|2686223|P2|Part I|Non-Compliance with Protocol|1
844980|NCT01155479|2686224|P1|Part I|Non-Compliance with Protocol|2
844981|NCT01155479|2686220|P5|Part I|Did Not Receive Treatment|1
844982|NCT01155479|2686221|P4|Part I|Did Not Receive Treatment|6
844983|NCT01155479|2686222|P3|Part I|Did Not Receive Treatment|2
844984|NCT01155479|2686223|P2|Part I|Did Not Receive Treatment|2
844985|NCT01155479|2686224|P1|Part I|Did Not Receive Treatment|4
844986|NCT01155479|2686220|P5|Part I|Treatment Failure|2
844987|NCT01155479|2686221|P4|Part I|Treatment Failure|1
844988|NCT01155479|2686222|P3|Part I|Treatment Failure|3
844989|NCT01155479|2686223|P2|Part I|Treatment Failure|0
844990|NCT01155479|2686224|P1|Part I|Treatment Failure|3
844991|NCT01155479|2686220|P5|Part I|Lost to Follow-up|0
844992|NCT01155479|2686221|P4|Part I|Lost to Follow-up|1
844993|NCT01155479|2686222|P3|Part I|Lost to Follow-up|1
844994|NCT01155479|2686223|P2|Part I|Lost to Follow-up|0
844995|NCT01155479|2686224|P1|Part I|Lost to Follow-up|0
844996|NCT01155479|2686220|P5|Part I|Withdrawal by Subject|9
844997|NCT01155479|2686221|P4|Part I|Withdrawal by Subject|8
844998|NCT01155479|2686222|P3|Part I|Withdrawal by Subject|8
844999|NCT01155479|2686223|P2|Part I|Withdrawal by Subject|13
845000|NCT01155479|2686224|P1|Part I|Withdrawal by Subject|11
845001|NCT01155479|2686220|P5|Part I|Did Not Meet Protocol Eligibility|3
845002|NCT01155479|2686221|P4|Part I|Did Not Meet Protocol Eligibility|1
845003|NCT01155479|2686222|P3|Part I|Did Not Meet Protocol Eligibility|2
845004|NCT01155479|2686223|P2|Part I|Did Not Meet Protocol Eligibility|1
845005|NCT01155479|2686224|P1|Part I|Did Not Meet Protocol Eligibility|3
845006|NCT01155479|2686220|P5|Part I|Administrative|0
845007|NCT01155479|2686221|P4|Part I|Administrative|0
845008|NCT01155479|2686222|P3|Part I|Administrative|2
845009|NCT01155479|2686223|P2|Part I|Administrative|2
845010|NCT01155479|2686224|P1|Part I|Administrative|2
845011|NCT01155479|2686220|P5|Part I|Adverse Event|6
845012|NCT01155479|2686221|P4|Part I|Adverse Event|7
845013|NCT01155479|2686222|P3|Part I|Adverse Event|18
845014|NCT01155479|2686223|P2|Part I|Adverse Event|8
845015|NCT01155479|2686224|P1|Part I|Adverse Event|13
845016|NCT01155531|2686275|P4|Overall Study|Withdrawal by Subject|0
845017|NCT01155531|2686276|P3|Overall Study|Withdrawal by Subject|1
845018|NCT01155531|2686277|P2|Overall Study|Withdrawal by Subject|0
845019|NCT01155531|2686278|P1|Overall Study|Withdrawal by Subject|1
845020|NCT01155531|2686275|P4|Overall Study|Lost to Follow-up|1
845021|NCT01155531|2686276|P3|Overall Study|Lost to Follow-up|0
845022|NCT01155531|2686277|P2|Overall Study|Lost to Follow-up|0
845023|NCT01155531|2686278|P1|Overall Study|Lost to Follow-up|0
845024|NCT01155531|2686275|P4|Overall Study|Adverse Event|0
845025|NCT01155531|2686276|P3|Overall Study|Adverse Event|1
845026|NCT01155531|2686277|P2|Overall Study|Adverse Event|0
845027|NCT01155531|2686278|P1|Overall Study|Adverse Event|0
845028|NCT01155570|2686296|P1|Overall Study|Other Reasons|23
845029|NCT01155570|2686296|P1|Overall Study|Participant's Economic Reasons + Other|1
845030|NCT01155570|2686296|P1|Overall Study|Adverse Event + Other Reasons|7
845031|NCT01155570|2686296|P1|Overall Study|Adverse Event + Lack of Efficacy|2
845032|NCT01155570|2686296|P1|Overall Study|No Hospital Visits|7
845033|NCT01155570|2686296|P1|Overall Study|Participant's Economic Reasons|17
845034|NCT01155570|2686296|P1|Overall Study|Lack of Efficacy|46
845035|NCT01155570|2686296|P1|Overall Study|Adverse Event|39
845036|NCT01162863|2686329|P3|Overall Study|Adverse Event|0
845037|NCT01162863|2686330|P2|Overall Study|Adverse Event|1
845038|NCT01162863|2686331|P1|Overall Study|Adverse Event|0
845039|NCT01162863|2686329|P3|Overall Study|Lack of Efficacy|0
845040|NCT01162863|2686330|P2|Overall Study|Lack of Efficacy|0
845041|NCT01162863|2686331|P1|Overall Study|Lack of Efficacy|1
845042|NCT01163032|2686348|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
845043|NCT01163032|2686349|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
845044|NCT01163032|2686350|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
845045|NCT01163032|2686348|P3|Open Label Extension Phase|Study Termination|7
845046|NCT01163032|2686349|P2|Open Label Extension Phase|Study Termination|0
845047|NCT01163032|2686350|P1|Open Label Extension Phase|Study Termination|0
845048|NCT01163032|2686348|P3|Open Label Extension Phase|Protocol Violation|1
845049|NCT01163032|2686349|P2|Open Label Extension Phase|Protocol Violation|0
845050|NCT01163032|2686350|P1|Open Label Extension Phase|Protocol Violation|0
845051|NCT01163032|2686348|P3|Open Label Extension Phase|Withdrawal by Subject|3
845052|NCT01163032|2686349|P2|Open Label Extension Phase|Withdrawal by Subject|0
845053|NCT01163032|2686350|P1|Open Label Extension Phase|Withdrawal by Subject|0
845054|NCT01163032|2686348|P3|Open Label Extension Phase|Adverse Event|3
845055|NCT01163032|2686349|P2|Open Label Extension Phase|Adverse Event|0
845056|NCT01163032|2686350|P1|Open Label Extension Phase|Adverse Event|0
845057|NCT01163032|2686348|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
845058|NCT01163032|2686349|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
845059|NCT01163032|2686350|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
845060|NCT01163032|2686348|P3|Randomization Phase|Various*|0
845061|NCT01163032|2686349|P2|Randomization Phase|Various*|4
845062|NCT01163032|2686350|P1|Randomization Phase|Various*|5
845063|NCT01163032|2686348|P3|Randomization Phase|Protocol Violation|0
845064|NCT01163032|2686349|P2|Randomization Phase|Protocol Violation|1
845065|NCT01163032|2686350|P1|Randomization Phase|Protocol Violation|0
845066|NCT01163032|2686348|P3|Randomization Phase|Adverse Event|0
845067|NCT01163032|2686349|P2|Randomization Phase|Adverse Event|3
845068|NCT01163032|2686350|P1|Randomization Phase|Adverse Event|3
845069|NCT01163032|2686348|P3|Randomization Phase|Withdrawal by Subject|0
845070|NCT01163032|2686349|P2|Randomization Phase|Withdrawal by Subject|3
845071|NCT01163032|2686350|P1|Randomization Phase|Withdrawal by Subject|2
845072|NCT01163253|2686437|P2|Overall Study|Other Unspecified|34
845073|NCT01163253|2686438|P1|Overall Study|Other Unspecified|170
845074|NCT01163253|2686437|P2|Overall Study|Ongoing|4
845075|NCT01163253|2686438|P1|Overall Study|Ongoing|13
845076|NCT01163253|2686437|P2|Overall Study|Death|5
845077|NCT01163253|2686438|P1|Overall Study|Death|17
845078|NCT01163253|2686437|P2|Overall Study|Adverse Event|78
845079|NCT01163253|2686438|P1|Overall Study|Adverse Event|300
845080|NCT01163253|2686437|P2|Overall Study|Insufficient Clinical Response|29
845081|NCT01163253|2686438|P1|Overall Study|Insufficient Clinical Response|423
845082|NCT01163253|2686437|P2|Overall Study|Lost to Follow-up|23
845083|NCT01163253|2686438|P1|Overall Study|Lost to Follow-up|125
845084|NCT01163253|2686437|P2|Overall Study|Medication Error|0
845085|NCT01163253|2686438|P1|Overall Study|Medication Error|1
845086|NCT01163253|2686437|P2|Overall Study|Withdrawal by Subject|50
845087|NCT01163253|2686438|P1|Overall Study|Withdrawal by Subject|199
845088|NCT01163253|2686437|P2|Overall Study|Protocol Violation|12
845089|NCT01163253|2686438|P1|Overall Study|Protocol Violation|43
845090|NCT01163253|2686437|P2|Overall Study|Study Terminated by Sponsor|349
845091|NCT01163253|2686438|P1|Overall Study|Study Terminated by Sponsor|978
845092|NCT01163253|2686437|P2|Overall Study|Withdrawn Due to Pregnancy|2
845093|NCT01163253|2686438|P1|Overall Study|Withdrawn Due to Pregnancy|12
845094|NCT01163266|2686601|P3|Overall Study|Other|2
845095|NCT01163266|2686602|P2|Overall Study|Other|1
845096|NCT01163266|2686603|P1|Overall Study|Other|1
845097|NCT01163266|2686601|P3|Overall Study|Lost to Follow-up|10
845098|NCT01163266|2686602|P2|Overall Study|Lost to Follow-up|7
845099|NCT01163266|2686603|P1|Overall Study|Lost to Follow-up|7
845100|NCT01163266|2686601|P3|Overall Study|Withdrawal of Consent|3
845101|NCT01163266|2686602|P2|Overall Study|Withdrawal of Consent|7
845102|NCT01163266|2686603|P1|Overall Study|Withdrawal of Consent|5
845103|NCT01163266|2686601|P3|Overall Study|Protocol Deviations|5
845104|NCT01163266|2686602|P2|Overall Study|Protocol Deviations|2
845105|NCT01163266|2686603|P1|Overall Study|Protocol Deviations|2
845106|NCT01163266|2686601|P3|Overall Study|Noncompliance with Study Drug|0
845107|NCT01163266|2686602|P2|Overall Study|Noncompliance with Study Drug|2
845108|NCT01163266|2686603|P1|Overall Study|Noncompliance with Study Drug|0
845109|NCT01163266|2686601|P3|Overall Study|Lack of Efficacy|1
845110|NCT01163266|2686602|P2|Overall Study|Lack of Efficacy|3
845111|NCT01163266|2686603|P1|Overall Study|Lack of Efficacy|1
845112|NCT01163266|2686601|P3|Overall Study|Pretreatment Event or Adverse Event|7
845113|NCT01163266|2686602|P2|Overall Study|Pretreatment Event or Adverse Event|9
845114|NCT01163266|2686603|P1|Overall Study|Pretreatment Event or Adverse Event|2
845115|NCT01163279|2686628|P2|Overall Study|Withdrawal by Subject|0
845116|NCT01163279|2686629|P1|Overall Study|Withdrawal by Subject|2
845117|NCT01163292|2686657|P2|Overall Study|No further visits|7
845118|NCT01163292|2686658|P1|Overall Study|No further visits|5
845119|NCT01163292|2686657|P2|Overall Study|Economic reasons|0
845120|NCT01163292|2686658|P1|Overall Study|Economic reasons|6
845121|NCT01163292|2686657|P2|Overall Study|Refusal to receive adalimumab|0
845122|NCT01163292|2686658|P1|Overall Study|Refusal to receive adalimumab|7
845123|NCT01163292|2686657|P2|Overall Study|Sufficient response to adalimumab|0
845124|NCT01163292|2686658|P1|Overall Study|Sufficient response to adalimumab|8
845125|NCT01163292|2686657|P2|Overall Study|Initiation of biological therapy|15
845126|NCT01163292|2686658|P1|Overall Study|Initiation of biological therapy|0
845127|NCT01163292|2686657|P2|Overall Study|Adverse Event|0
845128|NCT01163292|2686658|P1|Overall Study|Adverse Event|6
845129|NCT01163292|2686657|P2|Overall Study|Lack of Efficacy|0
845130|NCT01163292|2686658|P1|Overall Study|Lack of Efficacy|9
845131|NCT01163318|2686672|P1|Overall Study|Multiple Reasons Per Participant|224
845132|NCT01163318|2686672|P1|Overall Study|Participants Without Case Report Form|7
845133|NCT01163318|2686672|P1|Overall Study|History/comorbidity of malignant tumor|3
845134|NCT01163318|2686672|P1|Overall Study|Did Not Continue Use of Adalimumab|26
845135|NCT01163318|2686672|P1|Overall Study|Off-Label Use of Adalimumab|8
845136|NCT01163474|2686684|P1|Overall Study|Lost to Follow-up|3
845137|NCT01163474|2686684|P1|Overall Study|Tech barriers to videoteleconference vis|12
845138|NCT01163474|2686684|P1|Overall Study|Withdrawal by Subject|1
845139|NCT01163617|2686699|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845140|NCT01163617|2686700|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845141|NCT01163617|2686701|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845142|NCT01163617|2686702|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845143|NCT01163617|2686703|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845144|NCT01163617|2686704|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
845145|NCT01163617|2686705|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845146|NCT01163617|2686706|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
845147|NCT01163617|2686699|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845148|NCT01163617|2686700|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845149|NCT01163617|2686701|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845150|NCT01163617|2686702|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845151|NCT01163617|2686703|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845152|NCT01163617|2686704|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845153|NCT01163617|2686705|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
845154|NCT01163617|2686706|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
845155|NCT01163617|2686699|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845156|NCT01163617|2686700|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845157|NCT01163617|2686701|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845158|NCT01163617|2686702|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845159|NCT01163617|2686703|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845160|NCT01163617|2686704|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845161|NCT01163617|2686705|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
845162|NCT01163617|2686706|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
845163|NCT01163721|2686737|P2|Overall Study|Physician Decision|1
845164|NCT01163721|2686738|P1|Overall Study|Physician Decision|0
845165|NCT01163721|2686737|P2|Overall Study|Lost to Follow-up|1
845166|NCT01163721|2686738|P1|Overall Study|Lost to Follow-up|0
845167|NCT01163721|2686737|P2|Overall Study|Withdrawal by Subject|4
845168|NCT01163721|2686738|P1|Overall Study|Withdrawal by Subject|3
845169|NCT01163721|2686737|P2|Overall Study|Adverse Event|6
845170|NCT01163721|2686738|P1|Overall Study|Adverse Event|5
845171|NCT01163747|2686750|P2|Overall Study|Refused Treatment|4
845172|NCT01163747|2686751|P1|Overall Study|Refused Treatment|6
845173|NCT01163747|2686750|P2|Overall Study|Protocol Violation|1
845174|NCT01163747|2686751|P1|Overall Study|Protocol Violation|0
845175|NCT01163747|2686750|P2|Overall Study|Insufficient Therapeutic Response|1
845176|NCT01163747|2686751|P1|Overall Study|Insufficient Therapeutic Response|0
845177|NCT01163747|2686750|P2|Overall Study|Adverse Event|5
845178|NCT01163747|2686751|P1|Overall Study|Adverse Event|0
845183|NCT01163916|2686864|P3|Overall Study|Other|16
845184|NCT01163916|2686865|P2|Overall Study|Other|4
845185|NCT01163916|2686866|P1|Overall Study|Other|24
845186|NCT01163916|2686864|P3|Overall Study|Lack of Efficacy|1
845187|NCT01163916|2686865|P2|Overall Study|Lack of Efficacy|0
845188|NCT01163916|2686866|P1|Overall Study|Lack of Efficacy|2
845189|NCT01163916|2686864|P3|Overall Study|Adverse Event|1
845190|NCT01163916|2686865|P2|Overall Study|Adverse Event|0
845191|NCT01163916|2686866|P1|Overall Study|Adverse Event|2
845192|NCT01163916|2686864|P3|Overall Study|Withdrawal by Subject|2
845193|NCT01163916|2686865|P2|Overall Study|Withdrawal by Subject|0
845194|NCT01163916|2686866|P1|Overall Study|Withdrawal by Subject|2
845195|NCT01164007|2686911|P1|Overall Study|Medical Decision|3
845196|NCT01164007|2686911|P1|Overall Study|Withdrawal by Subject|1
845197|NCT01164007|2686911|P1|Overall Study|Protocol Violation|1
845198|NCT01164007|2686911|P1|Overall Study|Progression of Disease|30
845199|NCT01164007|2686911|P1|Overall Study|Adverse Event|5
845200|NCT01164475|2686944|P2|Overall Study|Protocol Violation|0
845201|NCT01164475|2686945|P1|Overall Study|Protocol Violation|1
845202|NCT01164475|2686944|P2|Overall Study|Progressive disease|1
845203|NCT01164475|2686945|P1|Overall Study|Progressive disease|0
845204|NCT01164475|2686944|P2|Overall Study|Other|1
845205|NCT01164475|2686945|P1|Overall Study|Other|0
845206|NCT01164475|2686944|P2|Overall Study|Lack of Efficacy|0
845207|NCT01164475|2686945|P1|Overall Study|Lack of Efficacy|1
845208|NCT01164501|2686972|P3|Overall Study|Other reason not defined above|4
845209|NCT01164501|2686973|P2|Overall Study|Other reason not defined above|1
845210|NCT01164501|2686974|P1|Overall Study|Other reason not defined above|9
845211|NCT01164501|2686972|P3|Overall Study|Patient refusal to continue,not due toAE|8
845212|NCT01164501|2686973|P2|Overall Study|Patient refusal to continue,not due toAE|4
845213|NCT01164501|2686974|P1|Overall Study|Patient refusal to continue,not due toAE|10
845214|NCT01164501|2686972|P3|Overall Study|Lost to Follow-up|3
845215|NCT01164501|2686973|P2|Overall Study|Lost to Follow-up|0
845216|NCT01164501|2686974|P1|Overall Study|Lost to Follow-up|3
845217|NCT01164501|2686972|P3|Overall Study|Non compliant with protocol|4
845218|NCT01164501|2686973|P2|Overall Study|Non compliant with protocol|1
845219|NCT01164501|2686974|P1|Overall Study|Non compliant with protocol|1
845220|NCT01164501|2686972|P3|Overall Study|Lack of Efficacy|1
845221|NCT01164501|2686973|P2|Overall Study|Lack of Efficacy|0
845222|NCT01164501|2686974|P1|Overall Study|Lack of Efficacy|0
845223|NCT01164501|2686972|P3|Overall Study|Adverse Event|21
845224|NCT01164501|2686973|P2|Overall Study|Adverse Event|4
845225|NCT01164501|2686974|P1|Overall Study|Adverse Event|18
845226|NCT01164501|2686972|P3|Overall Study|Not treated|1
845227|NCT01164501|2686973|P2|Overall Study|Not treated|0
845228|NCT01164501|2686974|P1|Overall Study|Not treated|2
845229|NCT01164579|2686992|P3|Overall Study|Reason not specified|0
845230|NCT01164579|2686993|P2|Overall Study|Reason not specified|0
845231|NCT01164579|2686994|P1|Overall Study|Reason not specified|1
845232|NCT01164579|2686992|P3|Overall Study|Adverse Event|5
845233|NCT01164579|2686993|P2|Overall Study|Adverse Event|2
845234|NCT01164579|2686994|P1|Overall Study|Adverse Event|4
845235|NCT01164579|2686992|P3|Overall Study|Protocol Violation|2
845236|NCT01164579|2686993|P2|Overall Study|Protocol Violation|1
845237|NCT01164579|2686994|P1|Overall Study|Protocol Violation|0
845238|NCT01164579|2686992|P3|Overall Study|Withdrawal by Subject|3
845239|NCT01164579|2686993|P2|Overall Study|Withdrawal by Subject|5
845240|NCT01164579|2686994|P1|Overall Study|Withdrawal by Subject|2
845241|NCT01164579|2686992|P3|Overall Study|Lost to Follow-up|0
845242|NCT01164579|2686993|P2|Overall Study|Lost to Follow-up|1
845243|NCT01164579|2686994|P1|Overall Study|Lost to Follow-up|1
845244|NCT01164579|2686992|P3|Overall Study|Lack of Efficacy|6
845245|NCT01164579|2686993|P2|Overall Study|Lack of Efficacy|0
845246|NCT01164579|2686994|P1|Overall Study|Lack of Efficacy|0
845247|NCT01164722|2687086|P2|Overall Study|enrolled on other study, concomitant med|3
845248|NCT01164722|2687087|P1|Overall Study|enrolled on other study, concomitant med|1
845249|NCT01164722|2687086|P2|Overall Study|met protocol criteria for non-treatment|1
845250|NCT01164722|2687087|P1|Overall Study|met protocol criteria for non-treatment|11
845251|NCT01164722|2687086|P2|Overall Study|Lost to Follow-up|6
845252|NCT01164722|2687087|P1|Overall Study|Lost to Follow-up|3
845253|NCT01164722|2687086|P2|Overall Study|Withdrawal by Subject|4
845254|NCT01164722|2687087|P1|Overall Study|Withdrawal by Subject|3
845255|NCT01164722|2687086|P2|Overall Study|Adverse Event|1
845256|NCT01164722|2687087|P1|Overall Study|Adverse Event|0
845257|NCT01164865|2687103|P2|Overall Study|Lost to Follow-up|1
845258|NCT01164865|2687104|P1|Overall Study|Lost to Follow-up|2
845259|NCT01164891|2687112|P1|Overall Study|Adverse Event|1
845260|NCT01164891|2687112|P1|Overall Study|Disease Progression|5
845261|NCT01165021|2687130|P1|Overall Study|Death|1
845262|NCT01165138|2687152|P4|Overall Study|Withdrawal by Subject|3
845263|NCT01165138|2687153|P3|Overall Study|Withdrawal by Subject|6
845264|NCT01165138|2687154|P2|Overall Study|Withdrawal by Subject|6
845265|NCT01165138|2687155|P1|Overall Study|Withdrawal by Subject|0
845266|NCT01165138|2687152|P4|Overall Study|Physician Decision|6
845267|NCT01165138|2687153|P3|Overall Study|Physician Decision|7
845268|NCT01165138|2687154|P2|Overall Study|Physician Decision|6
845269|NCT01165138|2687155|P1|Overall Study|Physician Decision|0
845270|NCT01165138|2687152|P4|Overall Study|Lost to Follow-up|2
845271|NCT01165138|2687153|P3|Overall Study|Lost to Follow-up|1
845272|NCT01165138|2687154|P2|Overall Study|Lost to Follow-up|0
845273|NCT01165138|2687155|P1|Overall Study|Lost to Follow-up|0
845274|NCT01165138|2687152|P4|Overall Study|Protocol Violation|2
845275|NCT01165138|2687153|P3|Overall Study|Protocol Violation|0
845276|NCT01165138|2687154|P2|Overall Study|Protocol Violation|7
845277|NCT01165138|2687155|P1|Overall Study|Protocol Violation|0
845278|NCT01165138|2687152|P4|Overall Study|Lack of Efficacy|7
845279|NCT01165138|2687153|P3|Overall Study|Lack of Efficacy|6
845280|NCT01165138|2687154|P2|Overall Study|Lack of Efficacy|32
845281|NCT01165138|2687155|P1|Overall Study|Lack of Efficacy|0
845282|NCT01165138|2687152|P4|Overall Study|Adverse Event|2
845283|NCT01165138|2687153|P3|Overall Study|Adverse Event|0
845284|NCT01165138|2687154|P2|Overall Study|Adverse Event|1
845285|NCT01165138|2687155|P1|Overall Study|Adverse Event|0
845330|NCT01165216|2687432|P2|Overall Study|Disease progression|3
845331|NCT01165216|2687433|P1|Overall Study|Disease progression|1
845332|NCT01165216|2687432|P2|Overall Study|Withdrawal by Subject|1
845333|NCT01165216|2687433|P1|Overall Study|Withdrawal by Subject|1
845334|NCT01165216|2687432|P2|Overall Study|Adverse Event|3
845335|NCT01165216|2687433|P1|Overall Study|Adverse Event|6
845336|NCT01165242|2687456|P3|Overall Study|Lost to Follow-up|10
845337|NCT01165242|2687457|P2|Overall Study|Lost to Follow-up|7
845338|NCT01165242|2687458|P1|Overall Study|Lost to Follow-up|9
845339|NCT01165242|2687456|P3|Overall Study|Extended Holiday|1
845340|NCT01165242|2687457|P2|Overall Study|Extended Holiday|0
845341|NCT01165242|2687458|P1|Overall Study|Extended Holiday|0
845342|NCT01165242|2687456|P3|Overall Study|Withdrawal by Subject|2
845343|NCT01165242|2687457|P2|Overall Study|Withdrawal by Subject|2
845344|NCT01165242|2687458|P1|Overall Study|Withdrawal by Subject|0
845345|NCT01165242|2687456|P3|Overall Study|Visit 2 Declined by Subject|1
845346|NCT01165242|2687457|P2|Overall Study|Visit 2 Declined by Subject|0
845347|NCT01165242|2687458|P1|Overall Study|Visit 2 Declined by Subject|0
845348|NCT01165242|2687456|P3|Overall Study|Incarcerated Subjects|0
845349|NCT01165242|2687457|P2|Overall Study|Incarcerated Subjects|1
845350|NCT01165242|2687458|P1|Overall Study|Incarcerated Subjects|0
845351|NCT01165242|2687456|P3|Overall Study|Unreachable Subjects|0
845352|NCT01165242|2687457|P2|Overall Study|Unreachable Subjects|0
845353|NCT01165242|2687458|P1|Overall Study|Unreachable Subjects|1
845354|NCT01165281|2687492|P2|Overall Study|Other|0
845355|NCT01165281|2687493|P1|Overall Study|Other|6
845356|NCT01165281|2687492|P2|Overall Study|Progressive Disease|14
845357|NCT01165281|2687493|P1|Overall Study|Progressive Disease|10
845358|NCT01165281|2687492|P2|Overall Study|Noncompliance with Study Drug|4
845359|NCT01165281|2687493|P1|Overall Study|Noncompliance with Study Drug|1
845360|NCT01165281|2687492|P2|Overall Study|Withdrawal by Subject|7
845361|NCT01165281|2687493|P1|Overall Study|Withdrawal by Subject|8
845362|NCT01165281|2687492|P2|Overall Study|Protocol Violation|5
845363|NCT01165281|2687493|P1|Overall Study|Protocol Violation|6
845364|NCT01165281|2687492|P2|Overall Study|Physician Decision|1
845365|NCT01165281|2687493|P1|Overall Study|Physician Decision|8
845366|NCT01165281|2687492|P2|Overall Study|Lost to Follow-up|1
845367|NCT01165281|2687493|P1|Overall Study|Lost to Follow-up|0
845368|NCT01165281|2687492|P2|Overall Study|Lack of Efficacy|1
845369|NCT01165281|2687493|P1|Overall Study|Lack of Efficacy|4
845370|NCT01165281|2687492|P2|Overall Study|Death|4
845371|NCT01165281|2687493|P1|Overall Study|Death|3
845372|NCT01165281|2687492|P2|Overall Study|Adverse Event|14
845373|NCT01165281|2687493|P1|Overall Study|Adverse Event|12
845374|NCT01165307|2687513|P2|Overall Study|Subject not available for contact|0
845375|NCT01165307|2687514|P1|Overall Study|Subject not available for contact|1
845376|NCT01165307|2687513|P2|Overall Study|Withdrawal by Subject|0
845377|NCT01165307|2687514|P1|Overall Study|Withdrawal by Subject|2
845378|NCT01165307|2687513|P2|Overall Study|Lost to Follow-up|3
845379|NCT01165307|2687514|P1|Overall Study|Lost to Follow-up|11
845380|NCT01165320|2687544|P3|Overall Study|Reason unknown|0
845381|NCT01165320|2687545|P2|Overall Study|Reason unknown|1
845382|NCT01165320|2687546|P1|Overall Study|Reason unknown|0
845383|NCT01165320|2687544|P3|Overall Study|Lack of Efficacy|0
845384|NCT01165320|2687545|P2|Overall Study|Lack of Efficacy|2
845385|NCT01165320|2687546|P1|Overall Study|Lack of Efficacy|0
845386|NCT01165320|2687544|P3|Overall Study|Laboratory adverse experience|0
845387|NCT01165320|2687545|P2|Overall Study|Laboratory adverse experience|0
845388|NCT01165320|2687546|P1|Overall Study|Laboratory adverse experience|1
845389|NCT01165320|2687544|P3|Overall Study|Clinical adverse experience|0
845390|NCT01165320|2687545|P2|Overall Study|Clinical adverse experience|1
845391|NCT01165320|2687546|P1|Overall Study|Clinical adverse experience|2
845392|NCT01165424|2687554|P1|Overall Study|Participant moved (relocated)|1
845393|NCT01165424|2687554|P1|Overall Study|Did not meet entry criteria|1
845394|NCT01165424|2687554|P1|Overall Study|Laboratory adverse experiences|1
845395|NCT01165424|2687554|P1|Overall Study|Clinical adverse experiences|1
845396|NCT01165554|2687575|P1|Overall Study|Withdrawal by Subject|23
845397|NCT01165684|2687584|P2|Overall Study|Unclassified|22
845398|NCT01165684|2687585|P1|Overall Study|Unclassified|16
845399|NCT01165684|2687584|P2|Overall Study|Withdrawal Criteria|13
845400|NCT01165684|2687585|P1|Overall Study|Withdrawal Criteria|2
845401|NCT01165684|2687584|P2|Overall Study|Protocol Violation|15
845402|NCT01165684|2687585|P1|Overall Study|Protocol Violation|7
845403|NCT01165684|2687584|P2|Overall Study|Lack of Efficacy|1
845404|NCT01165684|2687585|P1|Overall Study|Lack of Efficacy|2
845405|NCT01165684|2687584|P2|Overall Study|Adverse Event|1
845406|NCT01165684|2687585|P1|Overall Study|Adverse Event|1
845407|NCT01158534|2687619|P1|Overall Study|Other|1
845408|NCT01158534|2687619|P1|Overall Study|Death|1
845409|NCT01158534|2687619|P1|Overall Study|Withdrawal by Subject|1
845410|NCT01158924|2687657|P2|Overall Study|Lost to Follow-up|1
845411|NCT01158924|2687658|P1|Overall Study|Lost to Follow-up|0
845412|NCT01158924|2687657|P2|Overall Study|Withdrawal by Subject|2
845413|NCT01158924|2687658|P1|Overall Study|Withdrawal by Subject|1
845414|NCT01159171|2687684|P1|Overall Study|Death|1
845415|NCT01159171|2687684|P1|Overall Study|Medical Decision|4
845416|NCT01159171|2687684|P1|Overall Study|Need for Surgery|5
845417|NCT01159171|2687684|P1|Overall Study|Protocol Violation|1
845418|NCT01159171|2687684|P1|Overall Study|Progression of Disease|28
845419|NCT01159171|2687684|P1|Overall Study|Adverse Event|11
845420|NCT01159431|2687738|P2|Overall Study|Lack of Efficacy|3
845421|NCT01159431|2687739|P1|Overall Study|Lack of Efficacy|0
845422|NCT01159431|2687738|P2|Overall Study|non-compliance|1
845423|NCT01159431|2687739|P1|Overall Study|non-compliance|1
845424|NCT01159431|2687738|P2|Overall Study|Adverse Event|2
845425|NCT01159431|2687739|P1|Overall Study|Adverse Event|1
845426|NCT01159574|2687768|P1|Follow Up Phase|still being followed for overall surviva|18
845427|NCT01159574|2687768|P1|Follow Up Phase|Lost to Follow-up|2
845428|NCT01159574|2687768|P1|Treatment Phase|still on treatment|2
845429|NCT01159574|2687768|P1|Treatment Phase|Withdrawal by Subject|7
845430|NCT01159574|2687768|P1|Treatment Phase|Physician Decision|2
845431|NCT01159574|2687768|P1|Treatment Phase|Death|6
845432|NCT01159574|2687768|P1|Treatment Phase|Adverse Event|3
845433|NCT01159574|2687768|P1|Treatment Phase|non-evaluable/not included in analysis|1
845434|NCT01159600|2687782|P8|Overall Study|Other reason not defined above|3
845435|NCT01159600|2687783|P7|Overall Study|Other reason not defined above|3
845436|NCT01159600|2687784|P6|Overall Study|Other reason not defined above|7
845437|NCT01159600|2687785|P5|Overall Study|Other reason not defined above|5
845438|NCT01159600|2687786|P4|Overall Study|Other reason not defined above|2
845439|NCT01159600|2687787|P3|Overall Study|Other reason not defined above|4
845440|NCT01159600|2687788|P2|Overall Study|Other reason not defined above|0
845441|NCT01159600|2687789|P1|Overall Study|Other reason not defined above|3
845442|NCT01159600|2687782|P8|Overall Study|Patient refusal to continue,not due toAE|5
845443|NCT01159600|2687783|P7|Overall Study|Patient refusal to continue,not due toAE|2
845444|NCT01159600|2687784|P6|Overall Study|Patient refusal to continue,not due toAE|4
845445|NCT01159600|2687785|P5|Overall Study|Patient refusal to continue,not due toAE|4
845446|NCT01159600|2687786|P4|Overall Study|Patient refusal to continue,not due toAE|5
845447|NCT01159600|2687787|P3|Overall Study|Patient refusal to continue,not due toAE|4
845448|NCT01159600|2687788|P2|Overall Study|Patient refusal to continue,not due toAE|2
845449|NCT01159600|2687789|P1|Overall Study|Patient refusal to continue,not due toAE|7
845450|NCT01159600|2687782|P8|Overall Study|Lost to Follow-up|2
845451|NCT01159600|2687783|P7|Overall Study|Lost to Follow-up|3
845452|NCT01159600|2687784|P6|Overall Study|Lost to Follow-up|0
845453|NCT01159600|2687785|P5|Overall Study|Lost to Follow-up|3
845454|NCT01159600|2687786|P4|Overall Study|Lost to Follow-up|3
845455|NCT01159600|2687787|P3|Overall Study|Lost to Follow-up|4
845456|NCT01159600|2687788|P2|Overall Study|Lost to Follow-up|3
845457|NCT01159600|2687789|P1|Overall Study|Lost to Follow-up|2
845458|NCT01159600|2687782|P8|Overall Study|Non compliant with protocol|0
845459|NCT01159600|2687783|P7|Overall Study|Non compliant with protocol|2
845460|NCT01159600|2687784|P6|Overall Study|Non compliant with protocol|0
845461|NCT01159600|2687785|P5|Overall Study|Non compliant with protocol|2
845462|NCT01159600|2687786|P4|Overall Study|Non compliant with protocol|0
845463|NCT01159600|2687787|P3|Overall Study|Non compliant with protocol|0
845464|NCT01159600|2687788|P2|Overall Study|Non compliant with protocol|1
845465|NCT01159600|2687789|P1|Overall Study|Non compliant with protocol|2
845466|NCT01159600|2687782|P8|Overall Study|Lack of Efficacy|1
845467|NCT01159600|2687783|P7|Overall Study|Lack of Efficacy|0
845468|NCT01159600|2687784|P6|Overall Study|Lack of Efficacy|0
845469|NCT01159600|2687785|P5|Overall Study|Lack of Efficacy|2
845470|NCT01159600|2687786|P4|Overall Study|Lack of Efficacy|0
845471|NCT01159600|2687787|P3|Overall Study|Lack of Efficacy|0
845472|NCT01159600|2687788|P2|Overall Study|Lack of Efficacy|0
845473|NCT01159600|2687789|P1|Overall Study|Lack of Efficacy|0
845474|NCT01159600|2687782|P8|Overall Study|Adverse Event|5
845475|NCT01159600|2687783|P7|Overall Study|Adverse Event|7
845476|NCT01159600|2687784|P6|Overall Study|Adverse Event|6
845477|NCT01159600|2687785|P5|Overall Study|Adverse Event|8
845478|NCT01159600|2687786|P4|Overall Study|Adverse Event|1
845479|NCT01159600|2687787|P3|Overall Study|Adverse Event|5
845480|NCT01159600|2687788|P2|Overall Study|Adverse Event|2
845481|NCT01159600|2687789|P1|Overall Study|Adverse Event|7
845482|NCT01159600|2687782|P8|Overall Study|Not treated|2
845483|NCT01159600|2687783|P7|Overall Study|Not treated|2
845484|NCT01159600|2687784|P6|Overall Study|Not treated|1
845485|NCT01159600|2687785|P5|Overall Study|Not treated|0
845486|NCT01159600|2687786|P4|Overall Study|Not treated|0
845487|NCT01159600|2687787|P3|Overall Study|Not treated|1
845488|NCT01159600|2687788|P2|Overall Study|Not treated|0
845489|NCT01159600|2687789|P1|Overall Study|Not treated|0
845490|NCT01159665|2687837|P6|Overall Study|Withdrawal by Subject|0
845491|NCT01159665|2687838|P5|Overall Study|Withdrawal by Subject|0
845492|NCT01159665|2687839|P4|Overall Study|Withdrawal by Subject|0
845493|NCT01159665|2687840|P3|Overall Study|Withdrawal by Subject|0
845494|NCT01159665|2687841|P2|Overall Study|Withdrawal by Subject|1
845495|NCT01159665|2687842|P1|Overall Study|Withdrawal by Subject|0
845496|NCT01159691|2687862|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
845497|NCT01159691|2687862|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
845498|NCT01159691|2687862|P1|Overall Study|Disc. Neupro other & unknown reasons|7
845499|NCT01159691|2687862|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
845500|NCT01159691|2687862|P1|Overall Study|Discontinued Neupro due to other reasons|1
845501|NCT01159691|2687862|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
845502|NCT01159691|2687862|P1|Overall Study|Unknown reasons|1
845503|NCT01159691|2687862|P1|Overall Study|Lost to Follow-up|2
845504|NCT01159769|2687884|P1|Overall Study|Adverse Event|1
845523|NCT01159938|2687920|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
845524|NCT01159938|2687921|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
845525|NCT01159938|2687922|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
845526|NCT01159938|2687923|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
845527|NCT01159938|2687924|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
845528|NCT01165996|2688071|P1|Overall Study|Physician Decision|1
845529|NCT01165996|2688071|P1|Overall Study|Death|1
845530|NCT01166178|2688085|P2|Overall Study|Study was terminated|8
845531|NCT01166178|2688086|P1|Overall Study|Study was terminated|20
845532|NCT01166178|2688085|P2|Overall Study|Withdrawal by Subject|0
845533|NCT01166178|2688086|P1|Overall Study|Withdrawal by Subject|1
845534|NCT01166282|2688129|P3|Open-label Period|Irregular Compliance|1
845535|NCT01166282|2688130|P2|Open-label Period|Irregular Compliance|0
845536|NCT01166282|2688131|P1|Open-label Period|Irregular Compliance|0
845537|NCT01166282|2688129|P3|Open-label Period|Remission|4
845538|NCT01166282|2688130|P2|Open-label Period|Remission|0
845539|NCT01166282|2688131|P1|Open-label Period|Remission|0
845540|NCT01166282|2688129|P3|Open-label Period|Lack of Efficacy|2
845541|NCT01166282|2688130|P2|Open-label Period|Lack of Efficacy|0
845542|NCT01166282|2688131|P1|Open-label Period|Lack of Efficacy|0
845543|NCT01166282|2688129|P3|Open-label Period|Withdrawal by Subject|4
845544|NCT01166282|2688130|P2|Open-label Period|Withdrawal by Subject|0
845545|NCT01166282|2688131|P1|Open-label Period|Withdrawal by Subject|0
845546|NCT01166282|2688129|P3|Open-label Period|Adverse Event|6
845547|NCT01166282|2688130|P2|Open-label Period|Adverse Event|0
845548|NCT01166282|2688131|P1|Open-label Period|Adverse Event|0
845549|NCT01166646|2688155|P2|Overall Study|Adverse Event|0
845550|NCT01166646|2688156|P1|Overall Study|Adverse Event|1
845551|NCT01166646|2688155|P2|Overall Study|Protocol Violation|1
845552|NCT01166646|2688156|P1|Overall Study|Protocol Violation|0
845553|NCT01166659|2688172|P1|Overall Study|Study Closed at Site|1
845554|NCT01166659|2688172|P1|Overall Study|Lost to Follow-up|1
845555|NCT01166659|2688172|P1|Overall Study|Death|1
845556|NCT01166659|2688172|P1|Overall Study|Investigator Decision|2
845557|NCT01166659|2688172|P1|Overall Study|Subject Decision|8
845558|NCT01166750|2688192|P2|Overall Study|Lost to Follow-up|0
845559|NCT01166750|2688193|P1|Overall Study|Lost to Follow-up|1
845560|NCT01166763|2688199|P1|Overall Study|Withdrawal by Subject|3
845561|NCT01166958|2688207|P2|Overall Study|Withdrawal by Subject|0
845562|NCT01166958|2688208|P1|Overall Study|Withdrawal by Subject|1
845563|NCT01167023|2688244|P3|Overall Study|Withdrawal by Subject|1
845564|NCT01167023|2688245|P2|Overall Study|Withdrawal by Subject|0
845565|NCT01167023|2688246|P1|Overall Study|Withdrawal by Subject|0
845566|NCT01167023|2688244|P3|Overall Study|Sponsor Decision|0
845567|NCT01167023|2688245|P2|Overall Study|Sponsor Decision|1
845568|NCT01167023|2688246|P1|Overall Study|Sponsor Decision|0
845569|NCT01167023|2688244|P3|Overall Study|Screen Failure|0
845570|NCT01167023|2688245|P2|Overall Study|Screen Failure|1
845571|NCT01167023|2688246|P1|Overall Study|Screen Failure|0
845572|NCT01167023|2688244|P3|Overall Study|Lost to Follow-up|1
845573|NCT01167023|2688245|P2|Overall Study|Lost to Follow-up|1
845574|NCT01167023|2688246|P1|Overall Study|Lost to Follow-up|0
845575|NCT01167140|2688264|P1|Overall Study|Withdrawal by Subject|1
845576|NCT01167153|2688272|P2|Overall Study|Subject initiation withdrawal, Other|8
845577|NCT01167153|2688273|P1|Overall Study|Subject initiation withdrawal, Other|5
845578|NCT01167153|2688272|P2|Overall Study|Withdrawal consent|1
845579|NCT01167153|2688273|P1|Overall Study|Withdrawal consent|1
845580|NCT01167153|2688272|P2|Overall Study|Investigator initiation withdrawal,Other|1
845581|NCT01167153|2688273|P1|Overall Study|Investigator initiation withdrawal,Other|1
845582|NCT01167153|2688272|P2|Overall Study|Non-compliance to concomitant medication|2
845583|NCT01167153|2688273|P1|Overall Study|Non-compliance to concomitant medication|0
845584|NCT01167153|2688272|P2|Overall Study|Lost to Follow-up|9
845585|NCT01167153|2688273|P1|Overall Study|Lost to Follow-up|7
845586|NCT01167153|2688272|P2|Overall Study|Hypotension|0
845587|NCT01167153|2688273|P1|Overall Study|Hypotension|1
845588|NCT01167153|2688272|P2|Overall Study|AE including clinical laboratory AE|8
845589|NCT01167153|2688273|P1|Overall Study|AE including clinical laboratory AE|2
845590|NCT01167153|2688272|P2|Overall Study|Non-effective therapy|4
845591|NCT01167153|2688273|P1|Overall Study|Non-effective therapy|1
845592|NCT01167192|2688291|P1|Overall Study|Insurance denial|1
845593|NCT01167192|2688291|P1|Overall Study|Withdrawal by Subject|1
845594|NCT01167192|2688291|P1|Overall Study|Death|1
845595|NCT01167192|2688291|P1|Overall Study|Adverse Event|1
845596|NCT01167257|2688308|P2|Overall Study|Withdrew consent|1
845597|NCT01167257|2688309|P1|Overall Study|Withdrew consent|1
845598|NCT01167257|2688308|P2|Overall Study|Lost to Follow-up|2
845599|NCT01167257|2688309|P1|Overall Study|Lost to Follow-up|2
845600|NCT01167426|2688331|P1|Overall Study|Sponsor Decision|1
845601|NCT01167426|2688331|P1|Overall Study|Withdrawal by Subject|2
845602|NCT01167426|2688331|P1|Overall Study|Protocol Violation|1
845603|NCT01167426|2688331|P1|Overall Study|Lost to Follow-up|6
845604|NCT01167582|2688349|P2|Overall Study|Lost to Follow-up|1
845605|NCT01167582|2688350|P1|Overall Study|Lost to Follow-up|0
845606|NCT01167634|2688375|P4|Overall Study|Withdrawal by Subject|0
845607|NCT01167634|2688376|P3|Overall Study|Withdrawal by Subject|0
845608|NCT01167634|2688377|P2|Overall Study|Withdrawal by Subject|1
845609|NCT01167634|2688378|P1|Overall Study|Withdrawal by Subject|1
845610|NCT01167634|2688375|P4|Overall Study|Lost to Follow-up|4
845611|NCT01167634|2688376|P3|Overall Study|Lost to Follow-up|3
845612|NCT01167634|2688377|P2|Overall Study|Lost to Follow-up|3
845613|NCT01167634|2688378|P1|Overall Study|Lost to Follow-up|1
845614|NCT01167881|2688403|P2|Overall Study|Other not defined above|55
845615|NCT01167881|2688404|P1|Overall Study|Other not defined above|31
845616|NCT01167881|2688403|P2|Overall Study|Not treated|0
845617|NCT01167881|2688404|P1|Overall Study|Not treated|4
845618|NCT01167881|2688403|P2|Overall Study|Patient refusal to cont., not due to AE|40
845619|NCT01167881|2688404|P1|Overall Study|Patient refusal to cont., not due to AE|45
845620|NCT01167881|2688403|P2|Overall Study|Lost to Follow-up|20
845621|NCT01167881|2688404|P1|Overall Study|Lost to Follow-up|19
845622|NCT01167881|2688403|P2|Overall Study|Non compliant with protocol|18
845623|NCT01167881|2688404|P1|Overall Study|Non compliant with protocol|9
845624|NCT01167881|2688403|P2|Overall Study|Lack of Efficacy|7
845625|NCT01167881|2688404|P1|Overall Study|Lack of Efficacy|4
845626|NCT01167881|2688403|P2|Overall Study|Adverse Event|51
845627|NCT01167881|2688404|P1|Overall Study|Adverse Event|47
845628|NCT01168232|2688443|P1|Overall Study|Ineligible-Inadequate pathology|1
845629|NCT01168232|2688443|P1|Overall Study|Ineligible- Wrong cell type|6
845630|NCT01168232|2688443|P1|Overall Study|Ineligible-Second primary cancer site|1
845631|NCT01168349|2688450|P1|Overall Study|Protocol Violation|76
845632|NCT01168349|2688450|P1|Overall Study|Unspecified|22
845633|NCT01168349|2688450|P1|Overall Study|Kidney transplantation|3
845634|NCT01168349|2688450|P1|Overall Study|Withdrawal by Subject|9
845635|NCT01168349|2688450|P1|Overall Study|Lost to Follow-up|34
845636|NCT01168349|2688450|P1|Overall Study|Death|157
845637|NCT01168427|2688556|P1|Overall Study|Patient exited prior to implant|1
845638|NCT01168596|2688563|P2|Overall Study|Withdrawal by Subject|1
845639|NCT01168596|2688564|P1|Overall Study|Withdrawal by Subject|3
845640|NCT01163149|2688611|P3|Extension Treatment Period|Noncompliance|1
845641|NCT01163149|2688612|P2|Extension Treatment Period|Noncompliance|0
845642|NCT01163149|2688613|P1|Extension Treatment Period|Noncompliance|0
845643|NCT01163149|2688611|P3|Extension Treatment Period|Adverse Event|0
845644|NCT01163149|2688612|P2|Extension Treatment Period|Adverse Event|1
845645|NCT01163149|2688613|P1|Extension Treatment Period|Adverse Event|0
845646|NCT01163149|2688611|P3|Extension Treatment Period|Withdrawal by Subject|1
845647|NCT01163149|2688612|P2|Extension Treatment Period|Withdrawal by Subject|0
845648|NCT01163149|2688613|P1|Extension Treatment Period|Withdrawal by Subject|2
845649|NCT01168856|2688721|P2|Overall Study|Protocol Violation|6
845650|NCT01168856|2688722|P1|Overall Study|Protocol Violation|4
845651|NCT01168856|2688721|P2|Overall Study|Unspecified|291
845652|NCT01168856|2688722|P1|Overall Study|Unspecified|1
845653|NCT01168856|2688721|P2|Overall Study|Death|2
845654|NCT01168856|2688722|P1|Overall Study|Death|0
845655|NCT01168856|2688721|P2|Overall Study|Participant received anti-HCV treatment|0
845656|NCT01168856|2688722|P1|Overall Study|Participant received anti-HCV treatment|1
845657|NCT01168856|2688721|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
845658|NCT01168856|2688722|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
845659|NCT01168856|2688721|P2|Overall Study|Physician Decision|1
845660|NCT01168856|2688722|P1|Overall Study|Physician Decision|2
845661|NCT01168856|2688721|P2|Overall Study|Withdrawal by Subject|8
845662|NCT01168856|2688722|P1|Overall Study|Withdrawal by Subject|6
845663|NCT01168856|2688721|P2|Overall Study|Lost to Follow-up|34
845664|NCT01168856|2688722|P1|Overall Study|Lost to Follow-up|4
845665|NCT01170364|2688814|P2|Overall Study|Protocol Violation|1
845666|NCT01170364|2688815|P1|Overall Study|Protocol Violation|4
845667|NCT01170598|2688867|P1|Overall Study|Refused|1
845668|NCT01170598|2688867|P1|Overall Study|Lost to Follow-up|1
845669|NCT01170598|2688867|P1|Overall Study|Death|3
845670|NCT01170598|2688867|P1|Overall Study|Withdrawal by Subject|1
845677|NCT01170962|2688965|P3|Follow up Period|Others|3
845678|NCT01170962|2688966|P2|Follow up Period|Others|7
845679|NCT01170962|2688967|P1|Follow up Period|Others|10
845680|NCT01170962|2688965|P3|Follow up Period|Death|0
845681|NCT01170962|2688966|P2|Follow up Period|Death|2
845682|NCT01170962|2688967|P1|Follow up Period|Death|2
845683|NCT01170962|2688965|P3|Follow up Period|Lost to Follow-up|1
845684|NCT01170962|2688966|P2|Follow up Period|Lost to Follow-up|8
845685|NCT01170962|2688967|P1|Follow up Period|Lost to Follow-up|13
845686|NCT01170962|2688965|P3|Follow up Period|Withdrawal by Subject|2
845687|NCT01170962|2688966|P2|Follow up Period|Withdrawal by Subject|10
845688|NCT01170962|2688967|P1|Follow up Period|Withdrawal by Subject|14
845689|NCT01170962|2688965|P3|Treatment Period|Completed 24 Week treatment period only|0
845690|NCT01170962|2688966|P2|Treatment Period|Completed 24 Week treatment period only|2
845691|NCT01170962|2688967|P1|Treatment Period|Completed 24 Week treatment period only|10
845692|NCT01170962|2688965|P3|Treatment Period|Request to discontinue treatment|1
845693|NCT01170962|2688966|P2|Treatment Period|Request to discontinue treatment|3
845694|NCT01170962|2688967|P1|Treatment Period|Request to discontinue treatment|7
845695|NCT01170962|2688965|P3|Treatment Period|Participant no longer meets criteria|0
845696|NCT01170962|2688966|P2|Treatment Period|Participant no longer meets criteria|1
845697|NCT01170962|2688967|P1|Treatment Period|Participant no longer meets criteria|0
845698|NCT01170962|2688965|P3|Treatment Period|Lost to Follow-up|1
845699|NCT01170962|2688966|P2|Treatment Period|Lost to Follow-up|1
845700|NCT01170962|2688967|P1|Treatment Period|Lost to Follow-up|1
845701|NCT01170962|2688965|P3|Treatment Period|Withdrawal by Subject|0
845702|NCT01170962|2688966|P2|Treatment Period|Withdrawal by Subject|1
845703|NCT01170962|2688967|P1|Treatment Period|Withdrawal by Subject|2
845704|NCT01170962|2688965|P3|Treatment Period|Adverse Event|3
845705|NCT01170962|2688966|P2|Treatment Period|Adverse Event|12
845706|NCT01170962|2688967|P1|Treatment Period|Adverse Event|11
845707|NCT01170962|2688965|P3|Treatment Period|Lack of Efficacy|7
845708|NCT01170962|2688966|P2|Treatment Period|Lack of Efficacy|91
845709|NCT01170962|2688967|P1|Treatment Period|Lack of Efficacy|96
845710|NCT01171183|2689023|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
845711|NCT01171183|2689024|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
845712|NCT01171183|2689023|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
845713|NCT01171183|2689024|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
845714|NCT01171183|2689023|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
845715|NCT01171183|2689024|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
845716|NCT01171183|2689023|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
845717|NCT01171183|2689024|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
845718|NCT01171183|2689023|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
845719|NCT01171183|2689024|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
845720|NCT01171183|2689023|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
845721|NCT01171183|2689024|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
845722|NCT01171521|2689032|P1|Overall Study|screen failure|1
845723|NCT01171521|2689032|P1|Overall Study|Lost to Follow-up|5
845724|NCT01171534|2689039|P2|Overall Study|screen failure|1
845725|NCT01171534|2689040|P1|Overall Study|screen failure|0
845726|NCT01171534|2689039|P2|Overall Study|Lost to Follow-up|2
845727|NCT01171534|2689040|P1|Overall Study|Lost to Follow-up|0
845728|NCT01171612|2689048|P1|Overall Study|Lost to Follow-up|51
845729|NCT01171677|2689058|P2|Overall Study|completed <70% IntenSati classes|0
845730|NCT01171677|2689059|P1|Overall Study|completed <70% IntenSati classes|5
845731|NCT01171677|2689058|P2|Overall Study|Adverse Event|0
845732|NCT01171677|2689059|P1|Overall Study|Adverse Event|1
845733|NCT01171677|2689058|P2|Overall Study|Withdrawal by Subject|3
845734|NCT01171677|2689059|P1|Overall Study|Withdrawal by Subject|0
845735|NCT01171820|2689115|P2|Overall Study|1-Year Missed Visit|1
845736|NCT01171820|2689116|P1|Overall Study|1-Year Missed Visit|1
845737|NCT01171820|2689115|P2|Overall Study|Physician Decision|1
845738|NCT01171820|2689116|P1|Overall Study|Physician Decision|0
845739|NCT01171820|2689115|P2|Overall Study|Withdrawal by Subject|0
845740|NCT01171820|2689116|P1|Overall Study|Withdrawal by Subject|2
845741|NCT01171820|2689115|P2|Overall Study|Lost to Follow-up|1
845742|NCT01171820|2689116|P1|Overall Study|Lost to Follow-up|0
845743|NCT01171820|2689115|P2|Overall Study|Death|3
845744|NCT01171820|2689116|P1|Overall Study|Death|3
845745|NCT01171963|2689181|P2|Overall Study|Withdrawal by Subject|129
845746|NCT01171963|2689182|P1|Overall Study|Withdrawal by Subject|114
845747|NCT01171963|2689181|P2|Overall Study|Other - diarrhoea|0
845748|NCT01171963|2689182|P1|Overall Study|Other - diarrhoea|1
845749|NCT01171963|2689181|P2|Overall Study|Lost to Follow-up|24
845750|NCT01171963|2689182|P1|Overall Study|Lost to Follow-up|23
845751|NCT01171963|2689181|P2|Overall Study|Adverse Event|15
845752|NCT01171963|2689182|P1|Overall Study|Adverse Event|10
845753|NCT01171976|2689241|P3|Overall Study|Adverse Event|5
845754|NCT01171976|2689242|P2|Overall Study|Adverse Event|2
845755|NCT01171976|2689243|P1|Overall Study|Adverse Event|6
845756|NCT01171976|2689241|P3|Overall Study|Abnormal test result|0
845757|NCT01171976|2689242|P2|Overall Study|Abnormal test result|0
845758|NCT01171976|2689243|P1|Overall Study|Abnormal test result|1
845759|NCT01171976|2689241|P3|Overall Study|Withdrawal by Subject|6
845760|NCT01171976|2689242|P2|Overall Study|Withdrawal by Subject|5
845761|NCT01171976|2689243|P1|Overall Study|Withdrawal by Subject|1
845762|NCT01171976|2689241|P3|Overall Study|Lost to Follow-up|2
845763|NCT01171976|2689242|P2|Overall Study|Lost to Follow-up|0
845764|NCT01171976|2689243|P1|Overall Study|Lost to Follow-up|4
845765|NCT01171976|2689241|P3|Overall Study|Death|1
845766|NCT01171976|2689242|P2|Overall Study|Death|4
845767|NCT01171976|2689243|P1|Overall Study|Death|2
845768|NCT01171976|2689241|P3|Overall Study|Protocol Violation|1
845769|NCT01171976|2689242|P2|Overall Study|Protocol Violation|0
845770|NCT01171976|2689243|P1|Overall Study|Protocol Violation|0
845771|NCT01171989|2689281|P3|Overall Study|Lost to Follow-up|1
845772|NCT01171989|2689282|P2|Overall Study|Lost to Follow-up|0
845773|NCT01171989|2689283|P1|Overall Study|Lost to Follow-up|0
845774|NCT01172288|2689385|P2|Overall Study|Protocol Violation|1
845775|NCT01172288|2689386|P1|Overall Study|Protocol Violation|0
845776|NCT01172288|2689385|P2|Overall Study|Adverse Event|0
845777|NCT01172288|2689386|P1|Overall Study|Adverse Event|1
845778|NCT01172535|2689428|P1|Overall Study|Unwilling to adhere to study requirement|1
845779|NCT01172535|2689428|P1|Overall Study|Ineligible at study entry|1
845780|NCT01172535|2689428|P1|Overall Study|Lost to Follow-up|1
845781|NCT01172535|2689428|P1|Overall Study|Withdrawal by Subject|2
845782|NCT01172535|2689428|P1|Overall Study|Death|3
845783|NCT01172808|2689480|P4|Overall Study|Other|7
845784|NCT01172808|2689481|P3|Overall Study|Other|9
845785|NCT01172808|2689482|P2|Overall Study|Other|5
845786|NCT01172808|2689483|P1|Overall Study|Other|6
845787|NCT01172808|2689480|P4|Overall Study|Withdrawal by Subject|2
845788|NCT01172808|2689481|P3|Overall Study|Withdrawal by Subject|3
845789|NCT01172808|2689482|P2|Overall Study|Withdrawal by Subject|1
845790|NCT01172808|2689483|P1|Overall Study|Withdrawal by Subject|4
845791|NCT01172808|2689480|P4|Overall Study|Lost to Follow-up|3
845792|NCT01172808|2689481|P3|Overall Study|Lost to Follow-up|1
845793|NCT01172808|2689482|P2|Overall Study|Lost to Follow-up|1
845794|NCT01172808|2689483|P1|Overall Study|Lost to Follow-up|0
845795|NCT01172808|2689480|P4|Overall Study|Protocol Violation|0
845796|NCT01172808|2689481|P3|Overall Study|Protocol Violation|2
845797|NCT01172808|2689482|P2|Overall Study|Protocol Violation|2
845798|NCT01172808|2689483|P1|Overall Study|Protocol Violation|2
845799|NCT01172808|2689480|P4|Overall Study|Lack of Efficacy|0
845800|NCT01172808|2689481|P3|Overall Study|Lack of Efficacy|0
845801|NCT01172808|2689482|P2|Overall Study|Lack of Efficacy|0
845802|NCT01172808|2689483|P1|Overall Study|Lack of Efficacy|1
845803|NCT01172808|2689480|P4|Overall Study|Adverse Event|3
845804|NCT01172808|2689481|P3|Overall Study|Adverse Event|8
845805|NCT01172808|2689482|P2|Overall Study|Adverse Event|4
845806|NCT01172808|2689483|P1|Overall Study|Adverse Event|8
845807|NCT01172821|2689573|P4|Overall Study|Other|3
845808|NCT01172821|2689574|P3|Overall Study|Other|5
845809|NCT01172821|2689575|P2|Overall Study|Other|4
845810|NCT01172821|2689576|P1|Overall Study|Other|3
845811|NCT01172821|2689573|P4|Overall Study|Withdrawal by Subject|3
845812|NCT01172821|2689574|P3|Overall Study|Withdrawal by Subject|3
845813|NCT01172821|2689575|P2|Overall Study|Withdrawal by Subject|3
845814|NCT01172821|2689576|P1|Overall Study|Withdrawal by Subject|2
845815|NCT01172821|2689573|P4|Overall Study|Lost to Follow-up|2
845816|NCT01172821|2689574|P3|Overall Study|Lost to Follow-up|2
845817|NCT01172821|2689575|P2|Overall Study|Lost to Follow-up|1
845818|NCT01172821|2689576|P1|Overall Study|Lost to Follow-up|4
845819|NCT01172821|2689573|P4|Overall Study|Protocol Violation|2
845820|NCT01172821|2689574|P3|Overall Study|Protocol Violation|1
845821|NCT01172821|2689575|P2|Overall Study|Protocol Violation|2
845822|NCT01172821|2689576|P1|Overall Study|Protocol Violation|0
845823|NCT01172821|2689573|P4|Overall Study|Adverse Event|7
845824|NCT01172821|2689574|P3|Overall Study|Adverse Event|2
845825|NCT01172821|2689575|P2|Overall Study|Adverse Event|2
845826|NCT01172821|2689576|P1|Overall Study|Adverse Event|5
845827|NCT01172847|2689662|P1|Overall Study|Withdrawal by Subject|3
845828|NCT01172873|2689696|P2|Overall Study|Withdrawal by Subject|2
845829|NCT01172873|2689697|P1|Overall Study|Withdrawal by Subject|3
845830|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
845831|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
845832|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
845833|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
845834|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
845835|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
845836|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
845837|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
845838|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
845839|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
845840|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
845841|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
845842|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
845843|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
845844|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
845845|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|9
845846|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
845847|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
845848|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
845849|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|5
845850|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
845851|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845852|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845853|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845854|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845855|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|1
845856|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845857|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
845858|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
845859|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
845860|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
845861|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
845862|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
845863|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
845864|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
845865|NCT01172938|2689710|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
845866|NCT01172938|2689711|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
845867|NCT01172938|2689712|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
845868|NCT01172938|2689713|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
845869|NCT01172938|2689714|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|5
845870|NCT01172938|2689715|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
845871|NCT01172938|2689716|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
845872|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
845873|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
845874|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
845875|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
845876|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Not specified|1
845877|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Not specified|2
845878|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
845879|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845880|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845881|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845882|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845883|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845884|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
845885|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
845886|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Death|0
845887|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Death|0
845888|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Death|0
845889|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Death|0
845890|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Death|0
845891|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Death|1
845892|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Death|0
845893|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
845894|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
845895|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
845896|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
845897|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
845898|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|5
845899|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|2
845900|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
845901|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
845902|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
845903|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
845904|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|2
845905|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
845906|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
845907|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
845908|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
845909|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
845910|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
845911|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
845912|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
845913|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
845914|NCT01172938|2689710|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
845915|NCT01172938|2689711|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
845916|NCT01172938|2689712|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
845917|NCT01172938|2689713|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
845918|NCT01172938|2689714|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
845919|NCT01172938|2689715|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
845920|NCT01172938|2689716|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|11
845925|NCT01173120|2689932|P1|Overall Study|Switch-Difficulty With Device|12
845926|NCT01173120|2689932|P1|Overall Study|Switch-Participant Decision|12
845927|NCT01173120|2689932|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
845928|NCT01173120|2689932|P1|Overall Study|Participant Decision|2
845929|NCT01173120|2689932|P1|Overall Study|Lost to Follow-up|1
845930|NCT01173120|2689932|P1|Overall Study|Lack of Efficacy|2
894093|NCT02563899|2837351|P4|Overall Study|Withdrawal by Subject|0
894094|NCT02563899|2837352|P3|Overall Study|Withdrawal by Subject|1
894095|NCT02563899|2837353|P2|Overall Study|Withdrawal by Subject|0
894096|NCT02563899|2837354|P1|Overall Study|Withdrawal by Subject|0
894097|NCT02563899|2837351|P4|Overall Study|Protocol Violation|0
894098|NCT02563899|2837352|P3|Overall Study|Protocol Violation|0
894099|NCT02563899|2837353|P2|Overall Study|Protocol Violation|0
894100|NCT02563899|2837354|P1|Overall Study|Protocol Violation|1
845954|NCT01175382|2690054|P3|Overall Study|Unable to tolerate study meds|1
845955|NCT01175382|2690055|P2|Overall Study|Unable to tolerate study meds|1
845956|NCT01175382|2690056|P1|Overall Study|Unable to tolerate study meds|0
845957|NCT01175382|2690054|P3|Overall Study|Unwilling to follow protocol|0
845958|NCT01175382|2690055|P2|Overall Study|Unwilling to follow protocol|1
845959|NCT01175382|2690056|P1|Overall Study|Unwilling to follow protocol|0
845960|NCT01175382|2690054|P3|Overall Study|Unable/unwilling to attend visits|2
845961|NCT01175382|2690055|P2|Overall Study|Unable/unwilling to attend visits|1
845962|NCT01175382|2690056|P1|Overall Study|Unable/unwilling to attend visits|3
845963|NCT01175382|2690054|P3|Overall Study|No longer having problem|1
845964|NCT01175382|2690055|P2|Overall Study|No longer having problem|0
845965|NCT01175382|2690056|P1|Overall Study|No longer having problem|1
845966|NCT01175382|2690054|P3|Overall Study|Withdrawal by Subject|1
845967|NCT01175382|2690055|P2|Overall Study|Withdrawal by Subject|0
845968|NCT01175382|2690056|P1|Overall Study|Withdrawal by Subject|0
845969|NCT01175382|2690054|P3|Overall Study|Physician Decision|0
845970|NCT01175382|2690055|P2|Overall Study|Physician Decision|1
845971|NCT01175382|2690056|P1|Overall Study|Physician Decision|0
845972|NCT01175382|2690054|P3|Overall Study|Lost to Follow-up|1
845973|NCT01175382|2690055|P2|Overall Study|Lost to Follow-up|3
845974|NCT01175382|2690056|P1|Overall Study|Lost to Follow-up|4
845975|NCT01175473|2690149|P2|Overall Study|Adverse Event|2
845976|NCT01175473|2690150|P1|Overall Study|Adverse Event|2
845977|NCT01175590|2690176|P2|Overall Study|Protocol Violation|1
845978|NCT01175590|2690177|P1|Overall Study|Protocol Violation|0
845979|NCT01175590|2690176|P2|Overall Study|Herpes Simplex Dermatitis|0
845980|NCT01175590|2690177|P1|Overall Study|Herpes Simplex Dermatitis|1
845981|NCT01175590|2690176|P2|Overall Study|Treated not as randomized|2
845982|NCT01175590|2690177|P1|Overall Study|Treated not as randomized|3
845983|NCT01175590|2690176|P2|Overall Study|Residual Bacterial Conjunctivitis|0
845984|NCT01175590|2690177|P1|Overall Study|Residual Bacterial Conjunctivitis|1
845985|NCT01175590|2690176|P2|Overall Study|Lack of Efficacy|1
845986|NCT01175590|2690177|P1|Overall Study|Lack of Efficacy|1
845987|NCT01175590|2690176|P2|Overall Study|Physician Decision|4
845988|NCT01175590|2690177|P1|Overall Study|Physician Decision|1
845989|NCT01175590|2690176|P2|Overall Study|Adverse Event|0
845990|NCT01175590|2690177|P1|Overall Study|Adverse Event|4
845991|NCT01175590|2690176|P2|Overall Study|Withdrawal by Subject|2
845992|NCT01175590|2690177|P1|Overall Study|Withdrawal by Subject|0
845993|NCT01175590|2690176|P2|Overall Study|Lost to Follow-up|0
845994|NCT01175590|2690177|P1|Overall Study|Lost to Follow-up|1
845995|NCT01175668|2690211|P2|Overall Study|Withdrawal by Subject|0
845996|NCT01175668|2690212|P1|Overall Study|Withdrawal by Subject|2
845997|NCT01175707|2690222|P2|Overall Study|Adverse Event|6
845998|NCT01175707|2690223|P1|Overall Study|Adverse Event|4
845999|NCT01175811|2690268|P2|Overall Study|Withdrawal by Subject|7
846000|NCT01175811|2690269|P1|Overall Study|Withdrawal by Subject|6
846001|NCT01175811|2690268|P2|Overall Study|Protocol Violation|2
846002|NCT01175811|2690269|P1|Overall Study|Protocol Violation|1
846003|NCT01175811|2690268|P2|Overall Study|Physician Decision|1
846004|NCT01175811|2690269|P1|Overall Study|Physician Decision|1
846005|NCT01175811|2690268|P2|Overall Study|Lost to Follow-up|2
846006|NCT01175811|2690269|P1|Overall Study|Lost to Follow-up|3
846007|NCT01175811|2690268|P2|Overall Study|Lack of Efficacy|0
846008|NCT01175811|2690269|P1|Overall Study|Lack of Efficacy|1
846009|NCT01175811|2690268|P2|Overall Study|Entry criteria not met|1
846010|NCT01175811|2690269|P1|Overall Study|Entry criteria not met|3
846011|NCT01175811|2690268|P2|Overall Study|Adverse Event|1
846012|NCT01175811|2690269|P1|Overall Study|Adverse Event|1
846013|NCT01175824|2690295|P2|Overall Study|Entry Criteria Not Met|4
846014|NCT01175824|2690296|P1|Overall Study|Entry Criteria Not Met|6
846015|NCT01175824|2690295|P2|Overall Study|Sponsor Decision|0
846016|NCT01175824|2690296|P1|Overall Study|Sponsor Decision|1
846017|NCT01175824|2690295|P2|Overall Study|Withdrawal by Subject|7
846018|NCT01175824|2690296|P1|Overall Study|Withdrawal by Subject|3
846019|NCT01175824|2690295|P2|Overall Study|Protocol Violation|5
846020|NCT01175824|2690296|P1|Overall Study|Protocol Violation|2
846021|NCT01175824|2690295|P2|Overall Study|Physician Decision|4
846022|NCT01175824|2690296|P1|Overall Study|Physician Decision|0
846023|NCT01175824|2690295|P2|Overall Study|Lost to Follow-up|1
846024|NCT01175824|2690296|P1|Overall Study|Lost to Follow-up|0
846025|NCT01175824|2690295|P2|Overall Study|Lack of Efficacy|0
846026|NCT01175824|2690296|P1|Overall Study|Lack of Efficacy|2
846027|NCT01175824|2690295|P2|Overall Study|Adverse Event|1
846028|NCT01175824|2690296|P1|Overall Study|Adverse Event|2
846029|NCT01176032|2690394|P2|Overall Study|Not available|0
846030|NCT01176032|2690395|P1|Overall Study|Not available|1
846031|NCT01176032|2690394|P2|Overall Study|Informed consent withdrawn|0
846032|NCT01176032|2690395|P1|Overall Study|Informed consent withdrawn|3
846033|NCT01176032|2690394|P2|Overall Study|Protocol Violation|0
846034|NCT01176032|2690395|P1|Overall Study|Protocol Violation|1
846035|NCT01176032|2690394|P2|Overall Study|Unsatisfactory therapeutic effect|1
846036|NCT01176032|2690395|P1|Overall Study|Unsatisfactory therapeutic effect|0
846037|NCT01176032|2690394|P2|Overall Study|Adverse Event|0
846038|NCT01176032|2690395|P1|Overall Study|Adverse Event|1
846039|NCT01176058|2690455|P2|Overall Study|Withdrawal by Subject|0
846040|NCT01176058|2690456|P1|Overall Study|Withdrawal by Subject|1
846041|NCT01176058|2690455|P2|Overall Study|Insufficient mycological response|1
846042|NCT01176058|2690456|P1|Overall Study|Insufficient mycological response|0
846043|NCT01176058|2690455|P2|Overall Study|Insufficient clinical response|2
846044|NCT01176058|2690456|P1|Overall Study|Insufficient clinical response|2
846045|NCT01176058|2690455|P2|Overall Study|Adverse Event|0
846046|NCT01176058|2690456|P1|Overall Study|Adverse Event|1
846047|NCT01176240|2690482|P2|Study 306B|withdrew prior to dosing|1
846048|NCT01176240|2690483|P1|Study 306B|withdrew prior to dosing|2
846049|NCT01176240|2690482|P2|Study 306B|Lost to Follow-up|1
846050|NCT01176240|2690483|P1|Study 306B|Lost to Follow-up|0
846051|NCT01176240|2690482|P2|Study 306B|Supine Hypertension|2
846052|NCT01176240|2690483|P1|Study 306B|Supine Hypertension|1
846053|NCT01176240|2690482|P2|Study 306B|Physician Decision|1
846054|NCT01176240|2690483|P1|Study 306B|Physician Decision|2
846055|NCT01176240|2690482|P2|Study 306B|Withdrawal by Subject|1
846056|NCT01176240|2690483|P1|Study 306B|Withdrawal by Subject|4
846057|NCT01176240|2690482|P2|Study 306B|Protocol Violation|3
846058|NCT01176240|2690483|P1|Study 306B|Protocol Violation|2
846059|NCT01176240|2690482|P2|Study 306B|Adverse Event|5
846060|NCT01176240|2690483|P1|Study 306B|Adverse Event|10
846061|NCT01176240|2690482|P2|Study 306B|Lack of Efficacy|3
846062|NCT01176240|2690483|P1|Study 306B|Lack of Efficacy|5
846063|NCT01176240|2690482|P2|Study 306A|Stop due to diverse problems|0
846064|NCT01176240|2690483|P1|Study 306A|Stop due to diverse problems|1
846065|NCT01176240|2690482|P2|Study 306A|Withdrawal by Subject|1
846066|NCT01176240|2690483|P1|Study 306A|Withdrawal by Subject|0
846067|NCT01176240|2690482|P2|Study 306A|Protocol Violation|1
846068|NCT01176240|2690483|P1|Study 306A|Protocol Violation|0
846069|NCT01176240|2690482|P2|Study 306A|Lack of Efficacy|1
846070|NCT01176240|2690483|P1|Study 306A|Lack of Efficacy|2
846071|NCT01176292|2690509|P2|Overall Study|Has not scheduled one-year visit yet|2
846072|NCT01176292|2690510|P1|Overall Study|Has not scheduled one-year visit yet|2
846073|NCT01176292|2690509|P2|Overall Study|Physician Decision|2
846074|NCT01176292|2690510|P1|Overall Study|Physician Decision|0
846075|NCT01176292|2690509|P2|Overall Study|Adverse Event|1
846076|NCT01176292|2690510|P1|Overall Study|Adverse Event|1
846077|NCT01176292|2690509|P2|Overall Study|Lost to Follow-up|4
846078|NCT01176292|2690510|P1|Overall Study|Lost to Follow-up|2
846079|NCT01176513|2690536|P1|Overall Study|Withdrew subjects prior to dosing|3
846080|NCT01176565|2690543|P2|Overall Study|Not Analyzed (any other reason)|2
846081|NCT01176565|2690544|P1|Overall Study|Not Analyzed (any other reason)|1
846082|NCT01176565|2690543|P2|Overall Study|Withdrawal by Subject|1
846083|NCT01176565|2690544|P1|Overall Study|Withdrawal by Subject|7
846084|NCT01176565|2690543|P2|Overall Study|Lost to Follow-up|16
846085|NCT01176565|2690544|P1|Overall Study|Lost to Follow-up|12
846086|NCT01176773|2690562|P1|Overall Study|Withdrew consent|1
846087|NCT01176773|2690562|P1|Overall Study|Screen Failure|2
846088|NCT01176968|2690591|P2|Overall Study|Reason not defined|3
846089|NCT01176968|2690592|P1|Overall Study|Reason not defined|5
846090|NCT01176968|2690591|P2|Overall Study|Study terminated by sponsor|1
846091|NCT01176968|2690592|P1|Overall Study|Study terminated by sponsor|0
846092|NCT01176968|2690591|P2|Overall Study|Did Not Meet Entrance Criteria|0
846093|NCT01176968|2690592|P1|Overall Study|Did Not Meet Entrance Criteria|1
846094|NCT01176968|2690591|P2|Overall Study|Protocol Violation|1
846095|NCT01176968|2690592|P1|Overall Study|Protocol Violation|2
846096|NCT01176968|2690591|P2|Overall Study|Withdrawal by Subject|48
846097|NCT01176968|2690592|P1|Overall Study|Withdrawal by Subject|48
846098|NCT01176968|2690591|P2|Overall Study|Lost to Follow-up|14
846099|NCT01176968|2690592|P1|Overall Study|Lost to Follow-up|16
846100|NCT01176968|2690591|P2|Overall Study|Lack of Efficacy|1
846101|NCT01176968|2690592|P1|Overall Study|Lack of Efficacy|0
846102|NCT01176968|2690591|P2|Overall Study|Death|3
846103|NCT01176968|2690592|P1|Overall Study|Death|2
846104|NCT01176968|2690591|P2|Overall Study|Adverse Event|11
846105|NCT01176968|2690592|P1|Overall Study|Adverse Event|10
846106|NCT01177007|2690624|P1|Overall Study|Change in treatment modality|21
846107|NCT01177007|2690624|P1|Overall Study|Required additional Y90 treatment|6
846108|NCT01177007|2690624|P1|Overall Study|Entered hospice care|5
846109|NCT01177007|2690624|P1|Overall Study|Death|4
846110|NCT01177007|2690624|P1|Overall Study|Lost to Follow-up|2
846111|NCT01177228|2690659|P4|Overall Study|Withdrawal by Subject|0
846112|NCT01177228|2690660|P3|Overall Study|Withdrawal by Subject|0
846113|NCT01177228|2690661|P2|Overall Study|Withdrawal by Subject|1
846114|NCT01177228|2690662|P1|Overall Study|Withdrawal by Subject|0
846115|NCT01177228|2690659|P4|Overall Study|Worsening disease activity|0
846116|NCT01177228|2690660|P3|Overall Study|Worsening disease activity|0
846117|NCT01177228|2690661|P2|Overall Study|Worsening disease activity|0
846118|NCT01177228|2690662|P1|Overall Study|Worsening disease activity|1
846119|NCT01177228|2690659|P4|Overall Study|Positive tuberculosis test|0
846120|NCT01177228|2690660|P3|Overall Study|Positive tuberculosis test|0
846121|NCT01177228|2690661|P2|Overall Study|Positive tuberculosis test|1
846122|NCT01177228|2690662|P1|Overall Study|Positive tuberculosis test|0
846123|NCT01177293|2690700|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
846124|NCT01177293|2690701|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
846125|NCT01177384|2690717|P2|Overall Study|Withdrawal by Subject|12
846126|NCT01177384|2690718|P1|Overall Study|Withdrawal by Subject|5
846127|NCT01177384|2690717|P2|Overall Study|Protocol Violation|2
846128|NCT01177384|2690718|P1|Overall Study|Protocol Violation|0
846129|NCT01177384|2690717|P2|Overall Study|Physician Decision|3
846130|NCT01177384|2690718|P1|Overall Study|Physician Decision|0
846131|NCT01177384|2690717|P2|Overall Study|Lost to Follow-up|4
846132|NCT01177384|2690718|P1|Overall Study|Lost to Follow-up|3
846133|NCT01177384|2690717|P2|Overall Study|Lack of Efficacy|1
846134|NCT01177384|2690718|P1|Overall Study|Lack of Efficacy|0
846135|NCT01177384|2690717|P2|Overall Study|Adverse Event|4
846136|NCT01177384|2690718|P1|Overall Study|Adverse Event|6
846137|NCT01177410|2690733|P3|Overall Study|Lost to Follow-up|0
846138|NCT01177410|2690734|P2|Overall Study|Lost to Follow-up|1
846139|NCT01177410|2690735|P1|Overall Study|Lost to Follow-up|0
846140|NCT01177410|2690733|P3|Overall Study|Withdrawal by Subject|3
846141|NCT01177410|2690734|P2|Overall Study|Withdrawal by Subject|4
846142|NCT01177410|2690735|P1|Overall Study|Withdrawal by Subject|1
846143|NCT01177410|2690733|P3|Overall Study|Adverse Event|2
846144|NCT01177410|2690734|P2|Overall Study|Adverse Event|2
846145|NCT01177410|2690735|P1|Overall Study|Adverse Event|0
846146|NCT01168973|2690748|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
846147|NCT01168973|2690749|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
846148|NCT01168973|2690748|P2|Overall Study|Sponsor Decision|1
846149|NCT01168973|2690749|P1|Overall Study|Sponsor Decision|2
846150|NCT01168973|2690748|P2|Overall Study|Physician Decision|19
846151|NCT01168973|2690749|P1|Overall Study|Physician Decision|37
846152|NCT01168973|2690748|P2|Overall Study|Death|45
846153|NCT01168973|2690749|P1|Overall Study|Death|42
846154|NCT01168973|2690748|P2|Overall Study|Withdrawal by Subject|53
846155|NCT01168973|2690749|P1|Overall Study|Withdrawal by Subject|90
846156|NCT01168973|2690748|P2|Overall Study|Adverse Event|55
846157|NCT01168973|2690749|P1|Overall Study|Adverse Event|94
846158|NCT01168973|2690748|P2|Overall Study|Progressive Disease|429
846159|NCT01168973|2690749|P1|Overall Study|Progressive Disease|341
846160|NCT01168999|2690796|P4|Overall Study|Lost to Follow-up|0
846161|NCT01168999|2690797|P3|Overall Study|Lost to Follow-up|0
846162|NCT01168999|2690798|P2|Overall Study|Lost to Follow-up|1
846163|NCT01168999|2690799|P1|Overall Study|Lost to Follow-up|2
846164|NCT01169038|2690841|P1|Overall Study|Required antibiotic administration|1
846165|NCT01169038|2690841|P1|Overall Study|Adverse Event|5
846166|NCT01169038|2690841|P1|Overall Study|Death|1
846167|NCT01169103|2690860|P2|Overall Study|Withdrawal by Subject|1
846168|NCT01169103|2690861|P1|Overall Study|Withdrawal by Subject|3
846169|NCT01169103|2690860|P2|Overall Study|Lost to Follow-up|3
846170|NCT01169103|2690861|P1|Overall Study|Lost to Follow-up|3
846171|NCT01169493|2690910|P6|Period 3 (6 Months)|Physician Decision|0
846172|NCT01169493|2690911|P5|Period 3 (6 Months)|Physician Decision|0
846173|NCT01169493|2690912|P4|Period 3 (6 Months)|Physician Decision|0
846174|NCT01169493|2690913|P3|Period 3 (6 Months)|Physician Decision|1
846175|NCT01169493|2690914|P2|Period 3 (6 Months)|Physician Decision|1
846176|NCT01169493|2690915|P1|Period 3 (6 Months)|Physician Decision|0
846177|NCT01169493|2690910|P6|Period 3 (6 Months)|Adverse Event|0
846178|NCT01169493|2690911|P5|Period 3 (6 Months)|Adverse Event|0
846179|NCT01169493|2690912|P4|Period 3 (6 Months)|Adverse Event|0
846180|NCT01169493|2690913|P3|Period 3 (6 Months)|Adverse Event|0
846181|NCT01169493|2690914|P2|Period 3 (6 Months)|Adverse Event|1
846182|NCT01169493|2690915|P1|Period 3 (6 Months)|Adverse Event|0
846183|NCT01169493|2690910|P6|Period 1 (6 Months)|Withdrawal by Subject|3
846184|NCT01169493|2690911|P5|Period 1 (6 Months)|Withdrawal by Subject|0
846185|NCT01169493|2690912|P4|Period 1 (6 Months)|Withdrawal by Subject|0
846186|NCT01169493|2690913|P3|Period 1 (6 Months)|Withdrawal by Subject|2
846187|NCT01169493|2690914|P2|Period 1 (6 Months)|Withdrawal by Subject|1
846188|NCT01169493|2690915|P1|Period 1 (6 Months)|Withdrawal by Subject|0
846189|NCT01169558|2690956|P1|Overall Study|Partial response|2
846190|NCT01169558|2690956|P1|Overall Study|Protocol Violation|2
846191|NCT01169558|2690956|P1|Overall Study|Non-compliance|2
846192|NCT01169558|2690956|P1|Overall Study|Need for Surgery|4
846193|NCT01169558|2690956|P1|Overall Study|Lost to Follow-up|4
846194|NCT01169558|2690956|P1|Overall Study|Stable Disease|4
846195|NCT01169558|2690956|P1|Overall Study|Medical Decision|7
846196|NCT01169558|2690956|P1|Overall Study|Withdrawal of Consent|8
846197|NCT01169558|2690956|P1|Overall Study|Adverse Event|25
846198|NCT01169558|2690956|P1|Overall Study|Disease progression|98
846199|NCT01169649|2690971|P1|Overall Study|Patient Not Treated|3
846200|NCT01169675|2690980|P5|Overall Study|Other Reason Not Defined Above|1
846201|NCT01169675|2690981|P4|Overall Study|Other Reason Not Defined Above|1
846202|NCT01169675|2690982|P3|Overall Study|Other Reason Not Defined Above|0
846203|NCT01169675|2690983|P2|Overall Study|Other Reason Not Defined Above|0
846204|NCT01169675|2690984|P1|Overall Study|Other Reason Not Defined Above|0
846205|NCT01169675|2690980|P5|Overall Study|Withdrawal by Subject|2
846206|NCT01169675|2690981|P4|Overall Study|Withdrawal by Subject|1
846207|NCT01169675|2690982|P3|Overall Study|Withdrawal by Subject|0
846208|NCT01169675|2690983|P2|Overall Study|Withdrawal by Subject|0
846209|NCT01169675|2690984|P1|Overall Study|Withdrawal by Subject|1
846210|NCT01169675|2690980|P5|Overall Study|Adverse Event|0
846211|NCT01169675|2690981|P4|Overall Study|Adverse Event|0
846212|NCT01169675|2690982|P3|Overall Study|Adverse Event|2
846213|NCT01169675|2690983|P2|Overall Study|Adverse Event|1
846214|NCT01169675|2690984|P1|Overall Study|Adverse Event|5
846215|NCT01169675|2690980|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
846216|NCT01169675|2690981|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
846217|NCT01169675|2690982|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
846218|NCT01169675|2690983|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
846219|NCT01169675|2690984|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
846220|NCT01169675|2690980|P5|Overall Study|Progressive disease|1
846221|NCT01169675|2690981|P4|Overall Study|Progressive disease|15
846222|NCT01169675|2690982|P3|Overall Study|Progressive disease|5
846223|NCT01169675|2690983|P2|Overall Study|Progressive disease|2
846224|NCT01169675|2690984|P1|Overall Study|Progressive disease|13
846225|NCT01169701|2691023|P2|Overall Study|Sponsor decision|1
846226|NCT01169701|2691024|P1|Overall Study|Sponsor decision|0
846227|NCT01169701|2691023|P2|Overall Study|Serious adverse event|1
846228|NCT01169701|2691024|P1|Overall Study|Serious adverse event|0
846229|NCT01169701|2691023|P2|Overall Study|Administrative problems|1
846230|NCT01169701|2691024|P1|Overall Study|Administrative problems|0
846231|NCT01169701|2691023|P2|Overall Study|Death|1
846232|NCT01169701|2691024|P1|Overall Study|Death|0
846233|NCT01169701|2691023|P2|Overall Study|Exclusion criteria|0
846234|NCT01169701|2691024|P1|Overall Study|Exclusion criteria|2
846235|NCT01169701|2691023|P2|Overall Study|Adverse Event|2
846236|NCT01169701|2691024|P1|Overall Study|Adverse Event|1
846237|NCT01169701|2691023|P2|Overall Study|Withdrawal by Subject|3
846238|NCT01169701|2691024|P1|Overall Study|Withdrawal by Subject|1
846239|NCT01169701|2691023|P2|Overall Study|Lost to Follow-up|1
846240|NCT01169701|2691024|P1|Overall Study|Lost to Follow-up|1
846241|NCT01169779|2691067|P2|Overall Study|Familial and personal reasons|3
846242|NCT01169779|2691068|P1|Overall Study|Familial and personal reasons|3
846243|NCT01169779|2691067|P2|Overall Study|Withdrawal by Subject|2
846244|NCT01169779|2691068|P1|Overall Study|Withdrawal by Subject|3
846245|NCT01169779|2691067|P2|Overall Study|Protocol Violation|1
846246|NCT01169779|2691068|P1|Overall Study|Protocol Violation|1
846247|NCT01169779|2691067|P2|Overall Study|Lack of Efficacy|0
846248|NCT01169779|2691068|P1|Overall Study|Lack of Efficacy|1
846249|NCT01169779|2691067|P2|Overall Study|Adverse Event|11
846250|NCT01169779|2691068|P1|Overall Study|Adverse Event|3
846251|NCT01169987|2691092|P1|Overall Study|Not Specified|4
846252|NCT01169987|2691092|P1|Overall Study|Lost to Follow-up|24
846253|NCT01169987|2691092|P1|Overall Study|Withdrawal by Subject|3
846254|NCT01170039|2691158|P2|Overall Study|Lack of funding, drug not available|3
846255|NCT01170039|2691159|P1|Overall Study|Lack of funding, drug not available|3
846256|NCT01170039|2691158|P2|Overall Study|Withdrawal by Subject|3
846257|NCT01170039|2691159|P1|Overall Study|Withdrawal by Subject|5
846258|NCT01170091|2691171|P1|Overall Study|Treatment duration is less than 4 weeks|21
846259|NCT01170091|2691171|P1|Overall Study|Missing efficacy evaluation|3
846260|NCT01170208|2691192|P3|Overall Study|Protocol Violation|1
846261|NCT01170208|2691193|P2|Overall Study|Protocol Violation|0
846262|NCT01170208|2691194|P1|Overall Study|Protocol Violation|1
846263|NCT01170208|2691192|P3|Overall Study|Withdrawal by Subject|1
846264|NCT01170208|2691193|P2|Overall Study|Withdrawal by Subject|0
846265|NCT01170208|2691194|P1|Overall Study|Withdrawal by Subject|5
846266|NCT01170221|2691204|P2|Overall Study|Randomized but not treated|0
846267|NCT01170221|2691205|P1|Overall Study|Randomized but not treated|1
846268|NCT01170221|2691204|P2|Overall Study|Subject completed only screening and LFU|0
846269|NCT01170221|2691205|P1|Overall Study|Subject completed only screening and LFU|1
846270|NCT01170221|2691204|P2|Overall Study|Withdrawal by Subject|7
846271|NCT01170221|2691205|P1|Overall Study|Withdrawal by Subject|9
846272|NCT01170221|2691204|P2|Overall Study|Lost to Follow-up|21
846273|NCT01170221|2691205|P1|Overall Study|Lost to Follow-up|22
846274|NCT01170273|2691236|P2|Overall Study|Adverse Event|1
846275|NCT01170273|2691237|P1|Overall Study|Adverse Event|0
846276|NCT01170273|2691236|P2|Overall Study|Death|0
846277|NCT01170273|2691237|P1|Overall Study|Death|1
846278|NCT01170273|2691236|P2|Overall Study|Protocol Violation|0
846279|NCT01170273|2691237|P1|Overall Study|Protocol Violation|1
846280|NCT01170273|2691236|P2|Overall Study|Lost to Follow-up|8
846281|NCT01170273|2691237|P1|Overall Study|Lost to Follow-up|6
846282|NCT01177553|2691245|P2|Overall Study|babies not yet 6 months of age|0
846283|NCT01177553|2691246|P1|Overall Study|babies not yet 6 months of age|1
846284|NCT01177670|2691252|P1|Overall Study|Withdrawal by Subject|4
846285|NCT01177670|2691252|P1|Overall Study|Physician Decision|50
846286|NCT01177670|2691252|P1|Overall Study|Study Terminated|115
846287|NCT01177722|2691267|P4|Overall Study|Withdrawal by Subject|6
846288|NCT01177722|2691268|P3|Overall Study|Withdrawal by Subject|4
846289|NCT01177722|2691269|P2|Overall Study|Withdrawal by Subject|6
846290|NCT01177722|2691270|P1|Overall Study|Withdrawal by Subject|10
846291|NCT01177722|2691267|P4|Overall Study|Lost to Follow-up|1
846292|NCT01177722|2691268|P3|Overall Study|Lost to Follow-up|3
846293|NCT01177722|2691269|P2|Overall Study|Lost to Follow-up|4
846294|NCT01177722|2691270|P1|Overall Study|Lost to Follow-up|3
846295|NCT01177722|2691267|P4|Overall Study|Protocol Violation|0
846296|NCT01177722|2691268|P3|Overall Study|Protocol Violation|1
846297|NCT01177722|2691269|P2|Overall Study|Protocol Violation|0
846298|NCT01177722|2691270|P1|Overall Study|Protocol Violation|0
846299|NCT01177722|2691267|P4|Overall Study|Serious Adverse Event|0
846300|NCT01177722|2691268|P3|Overall Study|Serious Adverse Event|1
846301|NCT01177722|2691269|P2|Overall Study|Serious Adverse Event|0
846302|NCT01177722|2691270|P1|Overall Study|Serious Adverse Event|0
846303|NCT01177800|2691302|P2|Overall Study|Withdrawal of informed consent|1
846304|NCT01177800|2691303|P1|Overall Study|Withdrawal of informed consent|0
846305|NCT01177800|2691302|P2|Overall Study|Physician Decision|0
846306|NCT01177800|2691303|P1|Overall Study|Physician Decision|1
846307|NCT01177800|2691302|P2|Overall Study|Protocol Violation|1
846308|NCT01177800|2691303|P1|Overall Study|Protocol Violation|0
846309|NCT01177800|2691302|P2|Overall Study|Adverse Event|3
846310|NCT01177800|2691303|P1|Overall Study|Adverse Event|9
846311|NCT01177813|2691322|P5|Overall Study|Other reason not defined above|2
846312|NCT01177813|2691323|P4|Overall Study|Other reason not defined above|3
846313|NCT01177813|2691324|P3|Overall Study|Other reason not defined above|2
846314|NCT01177813|2691325|P2|Overall Study|Other reason not defined above|2
846315|NCT01177813|2691326|P1|Overall Study|Other reason not defined above|5
846316|NCT01177813|2691322|P5|Overall Study|Withdrawal by Subject|3
846317|NCT01177813|2691323|P4|Overall Study|Withdrawal by Subject|5
846318|NCT01177813|2691324|P3|Overall Study|Withdrawal by Subject|6
846319|NCT01177813|2691325|P2|Overall Study|Withdrawal by Subject|7
846320|NCT01177813|2691326|P1|Overall Study|Withdrawal by Subject|12
846321|NCT01177813|2691322|P5|Overall Study|Lost to Follow-up|0
846322|NCT01177813|2691323|P4|Overall Study|Lost to Follow-up|3
846323|NCT01177813|2691324|P3|Overall Study|Lost to Follow-up|6
846324|NCT01177813|2691325|P2|Overall Study|Lost to Follow-up|5
846325|NCT01177813|2691326|P1|Overall Study|Lost to Follow-up|12
846326|NCT01177813|2691322|P5|Overall Study|Protocol Violation|1
846327|NCT01177813|2691323|P4|Overall Study|Protocol Violation|0
846328|NCT01177813|2691324|P3|Overall Study|Protocol Violation|2
846329|NCT01177813|2691325|P2|Overall Study|Protocol Violation|2
846330|NCT01177813|2691326|P1|Overall Study|Protocol Violation|3
846331|NCT01177813|2691322|P5|Overall Study|Lack of Efficacy|0
846332|NCT01177813|2691323|P4|Overall Study|Lack of Efficacy|0
846333|NCT01177813|2691324|P3|Overall Study|Lack of Efficacy|0
846334|NCT01177813|2691325|P2|Overall Study|Lack of Efficacy|0
846335|NCT01177813|2691326|P1|Overall Study|Lack of Efficacy|1
846336|NCT01177813|2691322|P5|Overall Study|Adverse Event|3
846337|NCT01177813|2691323|P4|Overall Study|Adverse Event|6
846338|NCT01177813|2691324|P3|Overall Study|Adverse Event|4
846339|NCT01177813|2691325|P2|Overall Study|Adverse Event|2
846340|NCT01177813|2691326|P1|Overall Study|Adverse Event|8
846341|NCT01179048|2691355|P2|Overall Study|Alive|142
846342|NCT01179048|2691356|P1|Overall Study|Alive|127
846343|NCT01179048|2691355|P2|Overall Study|Lost to Follow-up|9
846344|NCT01179048|2691356|P1|Overall Study|Lost to Follow-up|8
846345|NCT01179048|2691355|P2|Overall Study|Withdrawn - does not allow contact|8
846346|NCT01179048|2691356|P1|Overall Study|Withdrawn - does not allow contact|4
894119|NCT02281318|2837446|P2|Overall Study|Withdrawal by Subject|2
894120|NCT02281318|2837447|P1|Overall Study|Withdrawal by Subject|6
894121|NCT02281318|2837446|P2|Overall Study|Physician Decision|0
894122|NCT02281318|2837447|P1|Overall Study|Physician Decision|2
894123|NCT02281318|2837446|P2|Overall Study|Lost to Follow-up|1
894124|NCT02281318|2837447|P1|Overall Study|Lost to Follow-up|2
894125|NCT02281318|2837446|P2|Overall Study|Lack of Efficacy|0
894126|NCT02281318|2837447|P1|Overall Study|Lack of Efficacy|2
846358|NCT01179334|2691431|P2|Long-term Extension (LTE) Period|Adverse Event|4
846359|NCT01179334|2691432|P1|Long-term Extension (LTE) Period|Adverse Event|2
846360|NCT01179334|2691431|P2|Long-term Extension (LTE) Period|Death|0
846361|NCT01179334|2691432|P1|Long-term Extension (LTE) Period|Death|3
846362|NCT01179334|2691431|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
846363|NCT01179334|2691432|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
846364|NCT01179334|2691431|P2|Treatment Period|Adverse Event|0
846365|NCT01179334|2691432|P1|Treatment Period|Adverse Event|1
846366|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Other|4
846367|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Other|7
846368|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Protocol Violation|0
846369|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Protocol Violation|1
846370|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
846371|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
846372|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
846373|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
846374|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
846375|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
846376|NCT01179347|2691462|P2|Open-label Period (12 Weeks)|Adverse Event|9
846377|NCT01179347|2691463|P1|Open-label Period (12 Weeks)|Adverse Event|5
846378|NCT01179347|2691462|P2|Double-blind Period (12 Weeks)|Other|4
846379|NCT01179347|2691463|P1|Double-blind Period (12 Weeks)|Other|2
846380|NCT01179347|2691462|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
846381|NCT01179347|2691463|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
846382|NCT01179347|2691462|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
846383|NCT01179347|2691463|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
846384|NCT01179347|2691462|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
846385|NCT01179347|2691463|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
846386|NCT01179347|2691462|P2|Double-blind Period (12 Weeks)|Adverse Event|6
846387|NCT01179347|2691463|P1|Double-blind Period (12 Weeks)|Adverse Event|2
846388|NCT01179399|2691483|P1|Overall Study|Withdrawal by Subject|1
846389|NCT01179399|2691483|P1|Overall Study|Lack of Efficacy|30
846390|NCT01179399|2691483|P1|Overall Study|Adverse Event|1
846391|NCT01179516|2691511|P3|Overall Study|Other|2
846392|NCT01179516|2691512|P2|Overall Study|Other|0
846393|NCT01179516|2691513|P1|Overall Study|Other|2
846394|NCT01179516|2691511|P3|Overall Study|Lost to Follow-up|3
846395|NCT01179516|2691512|P2|Overall Study|Lost to Follow-up|7
846396|NCT01179516|2691513|P1|Overall Study|Lost to Follow-up|7
846397|NCT01179516|2691511|P3|Overall Study|Withdrawal of Consent|10
846398|NCT01179516|2691512|P2|Overall Study|Withdrawal of Consent|6
846399|NCT01179516|2691513|P1|Overall Study|Withdrawal of Consent|2
846400|NCT01179516|2691511|P3|Overall Study|Protocol Deviations|3
846401|NCT01179516|2691512|P2|Overall Study|Protocol Deviations|3
846402|NCT01179516|2691513|P1|Overall Study|Protocol Deviations|4
846403|NCT01179516|2691511|P3|Overall Study|Noncompliance with Study Drug|1
846404|NCT01179516|2691512|P2|Overall Study|Noncompliance with Study Drug|0
846405|NCT01179516|2691513|P1|Overall Study|Noncompliance with Study Drug|2
846406|NCT01179516|2691511|P3|Overall Study|Lack of Efficacy|0
846407|NCT01179516|2691512|P2|Overall Study|Lack of Efficacy|2
846408|NCT01179516|2691513|P1|Overall Study|Lack of Efficacy|4
846409|NCT01179516|2691511|P3|Overall Study|Pretreatment Event or Adverse Event|12
846410|NCT01179516|2691512|P2|Overall Study|Pretreatment Event or Adverse Event|8
846411|NCT01179516|2691513|P1|Overall Study|Pretreatment Event or Adverse Event|6
846412|NCT01179672|2691565|P2|Overall Study|Physician Decision|1
846413|NCT01179672|2691566|P1|Overall Study|Physician Decision|1
846414|NCT01179672|2691565|P2|Overall Study|Protocol Violation|2
846415|NCT01179672|2691566|P1|Overall Study|Protocol Violation|2
846416|NCT01179672|2691565|P2|Overall Study|Lost to Follow-up|1
846417|NCT01179672|2691566|P1|Overall Study|Lost to Follow-up|0
846418|NCT01179672|2691565|P2|Overall Study|Entry Criteria Not Met|2
846419|NCT01179672|2691566|P1|Overall Study|Entry Criteria Not Met|0
846420|NCT01179672|2691565|P2|Overall Study|Withdrawal by Subject|12
846421|NCT01179672|2691566|P1|Overall Study|Withdrawal by Subject|10
846422|NCT01179672|2691565|P2|Overall Study|Adverse Event|8
846423|NCT01179672|2691566|P1|Overall Study|Adverse Event|17
846424|NCT01179737|2691596|P4|Extension|The study was terminated|0
846425|NCT01179737|2691597|P3|Extension|The study was terminated|0
846426|NCT01179737|2691598|P2|Extension|The study was terminated|0
846427|NCT01179737|2691599|P1|Extension|The study was terminated|3
894127|NCT02281318|2837446|P2|Overall Study|Adverse Event|2
894128|NCT02281318|2837447|P1|Overall Study|Adverse Event|2
846428|NCT01179737|2691596|P4|Cohort 1 & Cohort 2 Expansion|Death|0
846429|NCT01179737|2691597|P3|Cohort 1 & Cohort 2 Expansion|Death|0
846430|NCT01179737|2691598|P2|Cohort 1 & Cohort 2 Expansion|Death|0
846431|NCT01179737|2691599|P1|Cohort 1 & Cohort 2 Expansion|Death|1
846432|NCT01179737|2691596|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
846433|NCT01179737|2691597|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
846434|NCT01179737|2691598|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
846435|NCT01179737|2691599|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
846436|NCT01179737|2691596|P4|Cohort 1 & Cohort 2|Death|0
846437|NCT01179737|2691597|P3|Cohort 1 & Cohort 2|Death|1
846438|NCT01179737|2691598|P2|Cohort 1 & Cohort 2|Death|0
846439|NCT01179737|2691599|P1|Cohort 1 & Cohort 2|Death|0
846440|NCT01179737|2691596|P4|Cohort 1 & Cohort 2|Administrative problems|4
846441|NCT01179737|2691597|P3|Cohort 1 & Cohort 2|Administrative problems|2
846442|NCT01179737|2691598|P2|Cohort 1 & Cohort 2|Administrative problems|0
846443|NCT01179737|2691599|P1|Cohort 1 & Cohort 2|Administrative problems|0
846444|NCT01179737|2691596|P4|Cohort 1 & Cohort 2|Withdrew consent|0
846445|NCT01179737|2691597|P3|Cohort 1 & Cohort 2|Withdrew consent|0
846446|NCT01179737|2691598|P2|Cohort 1 & Cohort 2|Withdrew consent|0
846447|NCT01179737|2691599|P1|Cohort 1 & Cohort 2|Withdrew consent|2
846448|NCT01179737|2691596|P4|Cohort 1 & Cohort 2|Adverse Event|0
846449|NCT01179737|2691597|P3|Cohort 1 & Cohort 2|Adverse Event|1
846450|NCT01179737|2691598|P2|Cohort 1 & Cohort 2|Adverse Event|1
846451|NCT01179737|2691599|P1|Cohort 1 & Cohort 2|Adverse Event|3
846452|NCT01179919|2691608|P1|Overall Study|Adverse Event|1
846453|NCT01179919|2691608|P1|Overall Study|Protocol Violation|1
846464|NCT01180244|2691673|P2|Overall Study|Lost to Follow-up|0
846465|NCT01180244|2691674|P1|Overall Study|Lost to Follow-up|1
846466|NCT01180244|2691673|P2|Overall Study|Protocol Violation|0
846467|NCT01180244|2691674|P1|Overall Study|Protocol Violation|1
846468|NCT01180244|2691673|P2|Overall Study|Withdrawal by Subject|1
846469|NCT01180244|2691674|P1|Overall Study|Withdrawal by Subject|0
846470|NCT01180244|2691673|P2|Overall Study|Adverse Event|0
846471|NCT01180244|2691674|P1|Overall Study|Adverse Event|1
846472|NCT01180244|2691673|P2|Overall Study|Physician Decision|0
846473|NCT01180244|2691674|P1|Overall Study|Physician Decision|3
846474|NCT01180244|2691673|P2|Overall Study|Lack of Efficacy|7
846475|NCT01180244|2691674|P1|Overall Study|Lack of Efficacy|0
846476|NCT01180296|2691690|P2|Overall Study|Protocol Violation|2
846477|NCT01180296|2691691|P1|Overall Study|Protocol Violation|1
846478|NCT01180400|2691699|P2|Overall Study|Not specified|1
846479|NCT01180400|2691700|P1|Overall Study|Not specified|0
846480|NCT01180400|2691699|P2|Overall Study|Lost to Follow-up|3
846481|NCT01180400|2691700|P1|Overall Study|Lost to Follow-up|2
846482|NCT01180400|2691699|P2|Overall Study|Study-specific withdrawal criteria|2
846483|NCT01180400|2691700|P1|Overall Study|Study-specific withdrawal criteria|1
846484|NCT01180400|2691699|P2|Overall Study|Lack of Efficacy|0
846485|NCT01180400|2691700|P1|Overall Study|Lack of Efficacy|2
846486|NCT01180400|2691699|P2|Overall Study|Condition under investigation worsened|1
846487|NCT01180400|2691700|P1|Overall Study|Condition under investigation worsened|2
846488|NCT01180400|2691699|P2|Overall Study|Severe non-compliance to protocol|2
846489|NCT01180400|2691700|P1|Overall Study|Severe non-compliance to protocol|1
846490|NCT01180400|2691699|P2|Overall Study|Adverse Event|10
846491|NCT01180400|2691700|P1|Overall Study|Adverse Event|12
846492|NCT01180400|2691699|P2|Overall Study|Eligibility criteria not fulfilled|2
846493|NCT01180400|2691700|P1|Overall Study|Eligibility criteria not fulfilled|0
846494|NCT01180400|2691699|P2|Overall Study|Withdrawal by Subject|6
846495|NCT01180400|2691700|P1|Overall Study|Withdrawal by Subject|5
846496|NCT01180647|2691748|P2|Overall Study|Lost to Follow-up|6
846497|NCT01180647|2691749|P1|Overall Study|Lost to Follow-up|5
846498|NCT01180660|2691767|P2|Overall Study|Changed to open surgery|0
846499|NCT01180660|2691768|P1|Overall Study|Changed to open surgery|1
846500|NCT01180777|2691776|P1|Overall Study|Adverse Event|1
846501|NCT01180777|2691776|P1|Overall Study|Lost to Follow-up|1
846502|NCT01180777|2691776|P1|Overall Study|Poor lens fit|4
846503|NCT01180777|2691776|P1|Overall Study|Protocol Violation|6
846504|NCT01180790|2691795|P7|Overall Study|Severe coronary atherosclerosis (death)|0
846505|NCT01180790|2691796|P6|Overall Study|Severe coronary atherosclerosis (death)|0
846506|NCT01180790|2691797|P5|Overall Study|Severe coronary atherosclerosis (death)|0
846507|NCT01180790|2691798|P4|Overall Study|Severe coronary atherosclerosis (death)|0
846508|NCT01180790|2691799|P3|Overall Study|Severe coronary atherosclerosis (death)|1
846509|NCT01180790|2691800|P2|Overall Study|Severe coronary atherosclerosis (death)|0
846510|NCT01180790|2691801|P1|Overall Study|Severe coronary atherosclerosis (death)|0
846511|NCT01180790|2691795|P7|Overall Study|compliance|0
846512|NCT01180790|2691796|P6|Overall Study|compliance|0
846513|NCT01180790|2691797|P5|Overall Study|compliance|0
846514|NCT01180790|2691798|P4|Overall Study|compliance|0
846515|NCT01180790|2691799|P3|Overall Study|compliance|0
846516|NCT01180790|2691800|P2|Overall Study|compliance|1
846517|NCT01180790|2691801|P1|Overall Study|compliance|0
846518|NCT01180790|2691795|P7|Overall Study|Lack of Efficacy|0
846519|NCT01180790|2691796|P6|Overall Study|Lack of Efficacy|3
846520|NCT01180790|2691797|P5|Overall Study|Lack of Efficacy|1
846521|NCT01180790|2691798|P4|Overall Study|Lack of Efficacy|6
846522|NCT01180790|2691799|P3|Overall Study|Lack of Efficacy|5
846523|NCT01180790|2691800|P2|Overall Study|Lack of Efficacy|2
846524|NCT01180790|2691801|P1|Overall Study|Lack of Efficacy|1
846525|NCT01180790|2691795|P7|Overall Study|Physician Decision|0
846526|NCT01180790|2691796|P6|Overall Study|Physician Decision|0
846527|NCT01180790|2691797|P5|Overall Study|Physician Decision|0
846528|NCT01180790|2691798|P4|Overall Study|Physician Decision|1
846529|NCT01180790|2691799|P3|Overall Study|Physician Decision|0
846530|NCT01180790|2691800|P2|Overall Study|Physician Decision|0
846531|NCT01180790|2691801|P1|Overall Study|Physician Decision|1
846532|NCT01180790|2691795|P7|Overall Study|Lost to Follow-up|1
846533|NCT01180790|2691796|P6|Overall Study|Lost to Follow-up|0
846534|NCT01180790|2691797|P5|Overall Study|Lost to Follow-up|1
846535|NCT01180790|2691798|P4|Overall Study|Lost to Follow-up|2
846536|NCT01180790|2691799|P3|Overall Study|Lost to Follow-up|0
846537|NCT01180790|2691800|P2|Overall Study|Lost to Follow-up|1
846538|NCT01180790|2691801|P1|Overall Study|Lost to Follow-up|3
846539|NCT01180790|2691795|P7|Overall Study|Withdrawal by Subject|0
846540|NCT01180790|2691796|P6|Overall Study|Withdrawal by Subject|1
846541|NCT01180790|2691797|P5|Overall Study|Withdrawal by Subject|2
846542|NCT01180790|2691798|P4|Overall Study|Withdrawal by Subject|0
846543|NCT01180790|2691799|P3|Overall Study|Withdrawal by Subject|5
846544|NCT01180790|2691800|P2|Overall Study|Withdrawal by Subject|0
846545|NCT01180790|2691801|P1|Overall Study|Withdrawal by Subject|3
846546|NCT01180790|2691795|P7|Overall Study|Adverse Event|0
846547|NCT01180790|2691796|P6|Overall Study|Adverse Event|3
846548|NCT01180790|2691797|P5|Overall Study|Adverse Event|1
846549|NCT01180790|2691798|P4|Overall Study|Adverse Event|0
846550|NCT01180790|2691799|P3|Overall Study|Adverse Event|2
846551|NCT01180790|2691800|P2|Overall Study|Adverse Event|1
846552|NCT01180790|2691801|P1|Overall Study|Adverse Event|1
846553|NCT01180985|2691881|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
846554|NCT01180985|2691882|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
846555|NCT01180998|2691902|P3|Overall Study|Poor lens handling|2
846556|NCT01180998|2691903|P2|Overall Study|Poor lens handling|0
846557|NCT01180998|2691904|P1|Overall Study|Poor lens handling|0
846558|NCT01180998|2691902|P3|Overall Study|Poor comfort|4
846559|NCT01180998|2691903|P2|Overall Study|Poor comfort|0
846560|NCT01180998|2691904|P1|Overall Study|Poor comfort|3
846561|NCT01180998|2691902|P3|Overall Study|Withdrawal by Subject|1
846562|NCT01180998|2691903|P2|Overall Study|Withdrawal by Subject|0
846563|NCT01180998|2691904|P1|Overall Study|Withdrawal by Subject|0
846564|NCT01180998|2691902|P3|Overall Study|Protocol Violation|0
846565|NCT01180998|2691903|P2|Overall Study|Protocol Violation|2
846566|NCT01180998|2691904|P1|Overall Study|Protocol Violation|1
846567|NCT01180998|2691902|P3|Overall Study|Lost to Follow-up|1
846568|NCT01180998|2691903|P2|Overall Study|Lost to Follow-up|0
846569|NCT01180998|2691904|P1|Overall Study|Lost to Follow-up|0
846570|NCT01180998|2691902|P3|Overall Study|Poor Vision|2
846571|NCT01180998|2691903|P2|Overall Study|Poor Vision|2
846572|NCT01180998|2691904|P1|Overall Study|Poor Vision|0
846573|NCT01181011|2691918|P1|Overall Study|Lost to Follow-up|1
846574|NCT01181011|2691918|P1|Overall Study|Adverse Event|2
846575|NCT01181102|2691980|P2|Overall Study|Withdrawal by Subject|12
846576|NCT01181102|2691981|P1|Overall Study|Withdrawal by Subject|10
846577|NCT01181102|2691980|P2|Overall Study|Protocol Violation|6
846578|NCT01181102|2691981|P1|Overall Study|Protocol Violation|5
846579|NCT01181102|2691980|P2|Overall Study|Physician Decision|1
846580|NCT01181102|2691981|P1|Overall Study|Physician Decision|3
846581|NCT01181102|2691980|P2|Overall Study|Lost to Follow-up|0
846582|NCT01181102|2691981|P1|Overall Study|Lost to Follow-up|2
846583|NCT01181102|2691980|P2|Overall Study|Lack of Efficacy|1
846584|NCT01181102|2691981|P1|Overall Study|Lack of Efficacy|3
846585|NCT01181102|2691980|P2|Overall Study|Adverse Event|26
846586|NCT01181102|2691981|P1|Overall Study|Adverse Event|28
846587|NCT01181128|2691992|P3|Overall Study|Not Specified|1
846588|NCT01181128|2691993|P2|Overall Study|Not Specified|1
846589|NCT01181128|2691994|P1|Overall Study|Not Specified|1
846590|NCT01181128|2691992|P3|Overall Study|Adverse Event|0
846591|NCT01181128|2691993|P2|Overall Study|Adverse Event|2
846592|NCT01181128|2691994|P1|Overall Study|Adverse Event|0
846593|NCT01181128|2691992|P3|Overall Study|Physician Decision|0
846594|NCT01181128|2691993|P2|Overall Study|Physician Decision|0
846595|NCT01181128|2691994|P1|Overall Study|Physician Decision|2
846596|NCT01181128|2691992|P3|Overall Study|Death|0
846597|NCT01181128|2691993|P2|Overall Study|Death|0
846598|NCT01181128|2691994|P1|Overall Study|Death|1
846599|NCT01181128|2691992|P3|Overall Study|Withdrawal by Subject|0
846600|NCT01181128|2691993|P2|Overall Study|Withdrawal by Subject|2
846601|NCT01181128|2691994|P1|Overall Study|Withdrawal by Subject|2
846602|NCT01181141|2692082|P2|Overall Study|Withdrawal by Subject|1
846603|NCT01181141|2692083|P1|Overall Study|Withdrawal by Subject|3
846604|NCT01181141|2692082|P2|Overall Study|Protocol Violation|1
846605|NCT01181141|2692083|P1|Overall Study|Protocol Violation|3
846606|NCT01181141|2692082|P2|Overall Study|Physician Decision|0
846607|NCT01181141|2692083|P1|Overall Study|Physician Decision|2
846608|NCT01181141|2692082|P2|Overall Study|Lost to Follow-up|1
846609|NCT01181141|2692083|P1|Overall Study|Lost to Follow-up|1
846610|NCT01181141|2692082|P2|Overall Study|Lack of Efficacy|0
846611|NCT01181141|2692083|P1|Overall Study|Lack of Efficacy|1
846612|NCT01181141|2692082|P2|Overall Study|Adverse Event|1
846613|NCT01181141|2692083|P1|Overall Study|Adverse Event|2
846614|NCT01181167|2692091|P2|Overall Study|Withdrawal by Subject|8
846615|NCT01181167|2692092|P1|Overall Study|Withdrawal by Subject|6
846616|NCT01181167|2692091|P2|Overall Study|Protocol Violation|0
846617|NCT01181167|2692092|P1|Overall Study|Protocol Violation|3
846618|NCT01181167|2692091|P2|Overall Study|Physician Decision|3
846619|NCT01181167|2692092|P1|Overall Study|Physician Decision|2
846620|NCT01181167|2692091|P2|Overall Study|Lost to Follow-up|0
846621|NCT01181167|2692092|P1|Overall Study|Lost to Follow-up|1
846622|NCT01181167|2692091|P2|Overall Study|Adverse Event|21
846623|NCT01181167|2692092|P1|Overall Study|Adverse Event|11
846624|NCT01181271|2692107|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
846625|NCT01181271|2692107|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
846626|NCT01181271|2692107|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
846627|NCT01181271|2692107|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
846628|NCT01173471|2692332|P4|Overall Study|Reason given as Other|0
846629|NCT01173471|2692333|P3|Overall Study|Reason given as Other|1
846630|NCT01173471|2692334|P2|Overall Study|Reason given as Other|0
846631|NCT01173471|2692335|P1|Overall Study|Reason given as Other|0
846632|NCT01173471|2692332|P4|Overall Study|Lost to Follow-up|0
846633|NCT01173471|2692333|P3|Overall Study|Lost to Follow-up|1
846634|NCT01173471|2692334|P2|Overall Study|Lost to Follow-up|0
846635|NCT01173471|2692335|P1|Overall Study|Lost to Follow-up|0
846636|NCT01173471|2692332|P4|Overall Study|Condition under investigation worsened|0
846637|NCT01173471|2692333|P3|Overall Study|Condition under investigation worsened|0
846638|NCT01173471|2692334|P2|Overall Study|Condition under investigation worsened|0
846639|NCT01173471|2692335|P1|Overall Study|Condition under investigation worsened|2
846640|NCT01173471|2692332|P4|Overall Study|Eligibility criteria not fulfilled|1
846641|NCT01173471|2692333|P3|Overall Study|Eligibility criteria not fulfilled|1
846642|NCT01173471|2692334|P2|Overall Study|Eligibility criteria not fulfilled|0
846643|NCT01173471|2692335|P1|Overall Study|Eligibility criteria not fulfilled|0
846644|NCT01173523|2692355|P2|Overall Study|Other|3
846645|NCT01173523|2692356|P1|Overall Study|Other|2
846646|NCT01173523|2692355|P2|Overall Study|Progressive Disease|8
846647|NCT01173523|2692356|P1|Overall Study|Progressive Disease|10
846648|NCT01173523|2692355|P2|Overall Study|Clinical Progression|1
846649|NCT01173523|2692356|P1|Overall Study|Clinical Progression|1
846650|NCT01173653|2692370|P2|Overall Study|Pts unwilling to provide follow-up|41
846651|NCT01173653|2692371|P1|Overall Study|Pts unwilling to provide follow-up|53
846652|NCT01173679|2692377|P1|Overall Study|Death|1
846653|NCT01173718|2692383|P1|Overall Study|Abandonment of study graft|27
846654|NCT01173718|2692383|P1|Overall Study|Death|17
846655|NCT01174004|2692417|P2|Overall Study|Physician Decision|0
846656|NCT01174004|2692418|P1|Overall Study|Physician Decision|1
846657|NCT01174004|2692417|P2|Overall Study|Protocol Violation|1
846658|NCT01174004|2692418|P1|Overall Study|Protocol Violation|0
846659|NCT01174004|2692417|P2|Overall Study|At Discretion of Sponsor|2
846660|NCT01174004|2692418|P1|Overall Study|At Discretion of Sponsor|2
846661|NCT01174004|2692417|P2|Overall Study|Withdrawal by Subject|3
846662|NCT01174004|2692418|P1|Overall Study|Withdrawal by Subject|2
846663|NCT01174004|2692417|P2|Overall Study|Adverse Event|10
846664|NCT01174004|2692418|P1|Overall Study|Adverse Event|2
846665|NCT01174043|2692457|P1|Overall Study|Withdrawal by Subject|2
846666|NCT01174043|2692457|P1|Overall Study|Death|1
846667|NCT01174043|2692457|P1|Overall Study|Adverse Event|3
846668|NCT01174043|2692457|P1|Overall Study|Disease progression|5
846669|NCT01174160|2692465|P2|Overall Study|Withdrawal by Subject|0
846670|NCT01174160|2692466|P1|Overall Study|Withdrawal by Subject|1
846671|NCT01174160|2692465|P2|Overall Study|Protocol Violation|6
846672|NCT01174160|2692466|P1|Overall Study|Protocol Violation|4
846673|NCT01174160|2692465|P2|Overall Study|Physician Decision|0
846674|NCT01174160|2692466|P1|Overall Study|Physician Decision|1
846675|NCT01174160|2692465|P2|Overall Study|Lost to Follow-up|0
846676|NCT01174160|2692466|P1|Overall Study|Lost to Follow-up|1
846677|NCT01174160|2692465|P2|Overall Study|Adverse Event|0
846678|NCT01174160|2692466|P1|Overall Study|Adverse Event|1
846679|NCT01174173|2692472|P1|Overall Study|drug-drug interaction|1
846680|NCT01174186|2692482|P2|Overall Study|Withdrawal by Subject|2
846681|NCT01174186|2692483|P1|Overall Study|Withdrawal by Subject|0
846682|NCT01174186|2692482|P2|Overall Study|Lost to Follow-up|1
846683|NCT01174186|2692483|P1|Overall Study|Lost to Follow-up|0
846684|NCT01174264|2692493|P3|Steady-state Pharmacokinetics|Not evaluable|2
846685|NCT01174264|2692494|P2|Steady-state Pharmacokinetics|Not evaluable|0
846686|NCT01174264|2692495|P1|Steady-state Pharmacokinetics|Not evaluable|6
846687|NCT01174264|2692493|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
846688|NCT01174264|2692494|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
846689|NCT01174264|2692495|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
846690|NCT01174264|2692493|P3|Single Dose Pharmacokinetics|Early progressive disease|1
846691|NCT01174264|2692494|P2|Single Dose Pharmacokinetics|Early progressive disease|0
846692|NCT01174264|2692495|P1|Single Dose Pharmacokinetics|Early progressive disease|1
846693|NCT01174342|2692527|P1|Overall Study|Conversion to cesarean section|4
846710|NCT01174459|2692721|P1|Overall Study|case report form (CRF) not collected|5
846711|NCT01174550|2692728|P2|Overall Study|Withdrawal by Subject|289
846712|NCT01174550|2692729|P1|Overall Study|Withdrawal by Subject|543
846713|NCT01174550|2692728|P2|Overall Study|Lost to Follow-up|510
846714|NCT01174550|2692729|P1|Overall Study|Lost to Follow-up|652
846715|NCT01174550|2692728|P2|Overall Study|Death|74
846716|NCT01174550|2692729|P1|Overall Study|Death|75
846717|NCT01175018|2692810|P2|Overall Study|Adverse Event|1
846718|NCT01175018|2692811|P1|Overall Study|Adverse Event|3
846719|NCT01181531|2692876|P2|Overall Study|Adverse Event|1
846720|NCT01181531|2692877|P1|Overall Study|Adverse Event|0
846721|NCT01181531|2692876|P2|Overall Study|Death|12
846722|NCT01181531|2692877|P1|Overall Study|Death|9
846723|NCT01181531|2692876|P2|Overall Study|Protocol Violation|6
846724|NCT01181531|2692877|P1|Overall Study|Protocol Violation|6
846725|NCT01181531|2692876|P2|Overall Study|Withdrawal by Subject|7
846726|NCT01181531|2692877|P1|Overall Study|Withdrawal by Subject|8
846727|NCT01181531|2692876|P2|Overall Study|Pregnancy|1
846728|NCT01181531|2692877|P1|Overall Study|Pregnancy|0
846729|NCT01181531|2692876|P2|Overall Study|Protocol Specified Criteria|8
846730|NCT01181531|2692877|P1|Overall Study|Protocol Specified Criteria|15
846731|NCT01181531|2692876|P2|Overall Study|Ineligibility determined|2
846732|NCT01181531|2692877|P1|Overall Study|Ineligibility determined|1
846733|NCT01181531|2692876|P2|Overall Study|Noncompliance|2
846734|NCT01181531|2692877|P1|Overall Study|Noncompliance|2
846735|NCT01181531|2692876|P2|Overall Study|Physician Decision|1
846736|NCT01181531|2692877|P1|Overall Study|Physician Decision|3
846737|NCT01181531|2692876|P2|Overall Study|Partial consent by subject withdrawn|1
846738|NCT01181531|2692877|P1|Overall Study|Partial consent by subject withdrawn|0
846739|NCT01181531|2692876|P2|Overall Study|Not known|12
846740|NCT01181531|2692877|P1|Overall Study|Not known|17
846741|NCT01181609|2692887|P1|Overall Study|Death|50
846742|NCT01181609|2692887|P1|Overall Study|Lost to Follow-up|1
846743|NCT01181609|2692887|P1|Overall Study|Withdrawal by Subject|1
846744|NCT01181609|2692887|P1|Overall Study|Adverse Event|1
846745|NCT01182194|2692900|P2|Washout of 28 Days|Withdrawal by Subject|0
846746|NCT01182194|2692901|P1|Washout of 28 Days|Withdrawal by Subject|1
846747|NCT01182207|2692919|P2|Second Intervention|Emeses within 1 hour of dosing|0
846748|NCT01182207|2692920|P1|Second Intervention|Emeses within 1 hour of dosing|1
846749|NCT01182207|2692919|P2|First Intervention|Positive Hepatitis Results|1
846750|NCT01182207|2692920|P1|First Intervention|Positive Hepatitis Results|0
846751|NCT01182285|2692936|P3|Third Intervention Week 11-52|Other|2
846752|NCT01182285|2692937|P2|Third Intervention Week 11-52|Other|0
846753|NCT01182285|2692938|P1|Third Intervention Week 11-52|Other|0
846754|NCT01182285|2692936|P3|Third Intervention Week 11-52|Disease Progression|6
846755|NCT01182285|2692937|P2|Third Intervention Week 11-52|Disease Progression|0
846756|NCT01182285|2692938|P1|Third Intervention Week 11-52|Disease Progression|0
846757|NCT01182285|2692936|P3|First Intervention Week 1-10|Non-compliance|0
846758|NCT01182285|2692937|P2|First Intervention Week 1-10|Non-compliance|0
846759|NCT01182285|2692938|P1|First Intervention Week 1-10|Non-compliance|1
846760|NCT01182285|2692936|P3|First Intervention Week 1-10|Adverse Event|0
846761|NCT01182285|2692937|P2|First Intervention Week 1-10|Adverse Event|0
846762|NCT01182285|2692938|P1|First Intervention Week 1-10|Adverse Event|1
846763|NCT01182285|2692936|P3|First Intervention Week 1-10|Disease progression|0
846764|NCT01182285|2692937|P2|First Intervention Week 1-10|Disease progression|0
846765|NCT01182285|2692938|P1|First Intervention Week 1-10|Disease progression|1
846766|NCT01182298|2692946|P1|Overall Study|Withdrawal by Subject|2
846767|NCT01182298|2692946|P1|Overall Study|Lack of Efficacy|4
846768|NCT01182337|2692952|P2|Overall Study|Lost to Follow-up|1
846769|NCT01182337|2692953|P1|Overall Study|Lost to Follow-up|0
846770|NCT01182337|2692952|P2|Overall Study|Withdrawal by Subject|1
846771|NCT01182337|2692953|P1|Overall Study|Withdrawal by Subject|3
846772|NCT01182428|2692982|P2|Overall Study|Withdrawal by Subject|0
846773|NCT01182428|2692983|P1|Overall Study|Withdrawal by Subject|1
846774|NCT01182428|2692982|P2|Overall Study|Lost to Follow-up|1
846775|NCT01182428|2692983|P1|Overall Study|Lost to Follow-up|9
846776|NCT01182428|2692982|P2|Overall Study|Physician Decision|0
846777|NCT01182428|2692983|P1|Overall Study|Physician Decision|1
846778|NCT01183013|2693097|P7|Overall Study|Reasons other than stated above|13
846779|NCT01183013|2693098|P6|Overall Study|Reasons other than stated above|15
846780|NCT01183013|2693099|P5|Overall Study|Reasons other than stated above|12
846781|NCT01183013|2693100|P4|Overall Study|Reasons other than stated above|12
846782|NCT01183013|2693101|P3|Overall Study|Reasons other than stated above|17
846783|NCT01183013|2693102|P2|Overall Study|Reasons other than stated above|11
846784|NCT01183013|2693103|P1|Overall Study|Reasons other than stated above|15
846785|NCT01183013|2693097|P7|Overall Study|Withdrawal by Subject|10
846786|NCT01183013|2693098|P6|Overall Study|Withdrawal by Subject|9
846787|NCT01183013|2693099|P5|Overall Study|Withdrawal by Subject|7
846788|NCT01183013|2693100|P4|Overall Study|Withdrawal by Subject|8
846789|NCT01183013|2693101|P3|Overall Study|Withdrawal by Subject|10
846790|NCT01183013|2693102|P2|Overall Study|Withdrawal by Subject|13
846791|NCT01183013|2693103|P1|Overall Study|Withdrawal by Subject|9
846792|NCT01183013|2693097|P7|Overall Study|Lost to Follow-up|5
846793|NCT01183013|2693098|P6|Overall Study|Lost to Follow-up|6
846794|NCT01183013|2693099|P5|Overall Study|Lost to Follow-up|2
846795|NCT01183013|2693100|P4|Overall Study|Lost to Follow-up|3
846796|NCT01183013|2693101|P3|Overall Study|Lost to Follow-up|4
846797|NCT01183013|2693102|P2|Overall Study|Lost to Follow-up|3
846798|NCT01183013|2693103|P1|Overall Study|Lost to Follow-up|7
846799|NCT01183013|2693097|P7|Overall Study|Protocol Violation|3
846800|NCT01183013|2693098|P6|Overall Study|Protocol Violation|3
846801|NCT01183013|2693099|P5|Overall Study|Protocol Violation|4
846802|NCT01183013|2693100|P4|Overall Study|Protocol Violation|0
846803|NCT01183013|2693101|P3|Overall Study|Protocol Violation|4
846804|NCT01183013|2693102|P2|Overall Study|Protocol Violation|2
846805|NCT01183013|2693103|P1|Overall Study|Protocol Violation|5
846806|NCT01183013|2693097|P7|Overall Study|Lack of Efficacy|0
846807|NCT01183013|2693098|P6|Overall Study|Lack of Efficacy|2
846808|NCT01183013|2693099|P5|Overall Study|Lack of Efficacy|1
846809|NCT01183013|2693100|P4|Overall Study|Lack of Efficacy|2
846810|NCT01183013|2693101|P3|Overall Study|Lack of Efficacy|1
846811|NCT01183013|2693102|P2|Overall Study|Lack of Efficacy|2
846812|NCT01183013|2693103|P1|Overall Study|Lack of Efficacy|3
846813|NCT01183013|2693097|P7|Overall Study|Adverse Event|6
846814|NCT01183013|2693098|P6|Overall Study|Adverse Event|10
846815|NCT01183013|2693099|P5|Overall Study|Adverse Event|10
846816|NCT01183013|2693100|P4|Overall Study|Adverse Event|5
846817|NCT01183013|2693101|P3|Overall Study|Adverse Event|5
846818|NCT01183013|2693102|P2|Overall Study|Adverse Event|8
846819|NCT01183013|2693103|P1|Overall Study|Adverse Event|6
846820|NCT01183065|2693182|P1|Overall Study|Patient no longer fits eligibility crite|1
846821|NCT01183104|2693188|P2|Overall Study|Did not receive study drug|9
846822|NCT01183104|2693189|P1|Overall Study|Did not receive study drug|5
846823|NCT01183104|2693188|P2|Overall Study|Nonparticipation in Extension Study|50
846824|NCT01183104|2693189|P1|Overall Study|Nonparticipation in Extension Study|39
846825|NCT01183104|2693188|P2|Overall Study|Withdrawal by Subject|11
846826|NCT01183104|2693189|P1|Overall Study|Withdrawal by Subject|6
846827|NCT01183104|2693188|P2|Overall Study|Physician Decision|8
846828|NCT01183104|2693189|P1|Overall Study|Physician Decision|5
846829|NCT01183104|2693188|P2|Overall Study|Lost to Follow-up|7
846830|NCT01183104|2693189|P1|Overall Study|Lost to Follow-up|14
846831|NCT01183104|2693188|P2|Overall Study|Death|1
846832|NCT01183104|2693189|P1|Overall Study|Death|0
846833|NCT01183104|2693188|P2|Overall Study|Adverse Event|6
846834|NCT01183104|2693189|P1|Overall Study|Adverse Event|8
846835|NCT01183234|2693289|P2|First Intervention|Adverse Event|0
846836|NCT01183234|2693290|P1|First Intervention|Adverse Event|1
846837|NCT01183390|2693323|P2|First Intervention|Adverse Event|1
846838|NCT01183390|2693324|P1|First Intervention|Adverse Event|0
846839|NCT01183468|2693336|P4|Overall Study|Withdrawal by Subject|0
846840|NCT01183468|2693337|P3|Overall Study|Withdrawal by Subject|0
846841|NCT01183468|2693338|P2|Overall Study|Withdrawal by Subject|1
846842|NCT01183468|2693339|P1|Overall Study|Withdrawal by Subject|0
846843|NCT01183468|2693336|P4|Overall Study|Physician Decision|0
846844|NCT01183468|2693337|P3|Overall Study|Physician Decision|0
846845|NCT01183468|2693338|P2|Overall Study|Physician Decision|0
846846|NCT01183468|2693339|P1|Overall Study|Physician Decision|1
846847|NCT01183468|2693336|P4|Overall Study|Lost to Follow-up|0
846848|NCT01183468|2693337|P3|Overall Study|Lost to Follow-up|0
846849|NCT01183468|2693338|P2|Overall Study|Lost to Follow-up|1
846850|NCT01183468|2693339|P1|Overall Study|Lost to Follow-up|2
846851|NCT01183780|2693388|P2|Overall Study|Lost to Follow-up|11
846852|NCT01183780|2693389|P1|Overall Study|Lost to Follow-up|6
846853|NCT01183780|2693388|P2|Overall Study|Withdrawal by Subject|14
846854|NCT01183780|2693389|P1|Overall Study|Withdrawal by Subject|25
846855|NCT01183858|2693408|P2|Overall Study|Lost to Follow-up|1
846856|NCT01183858|2693409|P1|Overall Study|Lost to Follow-up|1
846857|NCT01183858|2693408|P2|Overall Study|Death related to Progressive Disease|5
846858|NCT01183858|2693409|P1|Overall Study|Death related to Progressive Disease|4
846859|NCT01183858|2693408|P2|Overall Study|Progressive Disease|115
846860|NCT01183858|2693409|P1|Overall Study|Progressive Disease|112
846861|NCT01183858|2693408|P2|Overall Study|Administrative/Other|6
846862|NCT01183858|2693409|P1|Overall Study|Administrative/Other|6
846863|NCT01183858|2693408|P2|Overall Study|Protocol Violation|0
846864|NCT01183858|2693409|P1|Overall Study|Protocol Violation|1
846865|NCT01183858|2693408|P2|Overall Study|Discontinued Smoking|1
846866|NCT01183858|2693409|P1|Overall Study|Discontinued Smoking|3
846867|NCT01183858|2693408|P2|Overall Study|Withdrew Consent|4
846868|NCT01183858|2693409|P1|Overall Study|Withdrew Consent|4
846869|NCT01183858|2693408|P2|Overall Study|Refused Treatment|4
846870|NCT01183858|2693409|P1|Overall Study|Refused Treatment|1
846871|NCT01183858|2693408|P2|Overall Study|Insufficient Therapeutic Response|0
846872|NCT01183858|2693409|P1|Overall Study|Insufficient Therapeutic Response|2
846873|NCT01183858|2693408|P2|Overall Study|Investigator's Decision|3
846874|NCT01183858|2693409|P1|Overall Study|Investigator's Decision|0
846875|NCT01183858|2693408|P2|Overall Study|Adverse Event|11
846876|NCT01183858|2693409|P1|Overall Study|Adverse Event|14
846877|NCT01183858|2693408|P2|Overall Study|Death not related to Progressive Disease|6
846878|NCT01183858|2693409|P1|Overall Study|Death not related to Progressive Disease|5
846879|NCT01183975|2693429|P1|Overall Study|Lost to Follow-up|73
846880|NCT01184053|2693443|P1|Overall Study|progression while on treatment|3
846881|NCT01184079|2693452|P2|Overall Study|Lost to Follow-up|2
846882|NCT01184079|2693453|P1|Overall Study|Lost to Follow-up|14
846883|NCT01184118|2693463|P1|Overall Study|Withdrawal by Subject|5
846884|NCT01184118|2693463|P1|Overall Study|Exclusionary medical condition|2
846885|NCT01184118|2693463|P1|Overall Study|FEV1 <60% predicted|2
846886|NCT01184118|2693463|P1|Overall Study|No physiologic confirmation of asthma|8
846887|NCT01184118|2693463|P1|Overall Study|Only asthma step 1 - screen fail|1
846888|NCT01177943|2693494|P2|First Intervention|Withdrawal by Subject|0
846889|NCT01177943|2693495|P1|First Intervention|Withdrawal by Subject|2
846890|NCT01177969|2693518|P2|Overall Study|Withdrawal by Subject|2
846891|NCT01177969|2693519|P1|Overall Study|Withdrawal by Subject|1
846892|NCT01177969|2693518|P2|Overall Study|Protocol Violation|1
846893|NCT01177969|2693519|P1|Overall Study|Protocol Violation|2
846894|NCT01178073|2693530|P3|Overall Study|Missing Completion Status|0
846895|NCT01178073|2693531|P2|Overall Study|Missing Completion Status|0
846896|NCT01178073|2693532|P1|Overall Study|Missing Completion Status|1
846897|NCT01178073|2693530|P3|Overall Study|Withdrawal by Subject|8
846898|NCT01178073|2693531|P2|Overall Study|Withdrawal by Subject|6
846899|NCT01178073|2693532|P1|Overall Study|Withdrawal by Subject|10
846900|NCT01178073|2693530|P3|Overall Study|Physician Decision|10
846901|NCT01178073|2693531|P2|Overall Study|Physician Decision|10
846902|NCT01178073|2693532|P1|Overall Study|Physician Decision|14
846903|NCT01178073|2693530|P3|Overall Study|Lost to Follow-up|3
846904|NCT01178073|2693531|P2|Overall Study|Lost to Follow-up|0
846905|NCT01178073|2693532|P1|Overall Study|Lost to Follow-up|2
846906|NCT01178073|2693530|P3|Overall Study|Protocol Violation|1
846907|NCT01178073|2693531|P2|Overall Study|Protocol Violation|1
846908|NCT01178073|2693532|P1|Overall Study|Protocol Violation|1
846909|NCT01178073|2693530|P3|Overall Study|Adverse Event|24
846910|NCT01178073|2693531|P2|Overall Study|Adverse Event|27
846911|NCT01178073|2693532|P1|Overall Study|Adverse Event|34
846912|NCT01178099|2693565|P2|Overall Study|Physician Decision|1
846913|NCT01178099|2693566|P1|Overall Study|Physician Decision|0
846914|NCT01178125|2693604|P1|Overall Study|Investigator Decision|5
846915|NCT01178125|2693604|P1|Overall Study|Protocol Violation|17
846916|NCT01178125|2693604|P1|Overall Study|Sponsor Decision|28
846917|NCT01178125|2693604|P1|Overall Study|Other Reason|39
846918|NCT01178125|2693604|P1|Overall Study|Pregnancy|55
846919|NCT01178125|2693604|P1|Overall Study|Noncompliance|184
846920|NCT01178125|2693604|P1|Overall Study|Withdrawal by Subject|209
846921|NCT01178125|2693604|P1|Overall Study|Adverse Event|244
846922|NCT01178125|2693604|P1|Overall Study|Lost to Follow-up|397
846923|NCT01178138|2693631|P1|Overall Study|Physician Decision|8
846924|NCT01178138|2693631|P1|Overall Study|Withdrawal by Subject|7
846925|NCT01178138|2693631|P1|Overall Study|Lost to Follow-up|8
846926|NCT01178281|2693874|P2|Overall Study|Prohibited Medications|2
846927|NCT01178281|2693875|P1|Overall Study|Prohibited Medications|0
846928|NCT01178281|2693874|P2|Overall Study|Adverse Event|9
846929|NCT01178281|2693875|P1|Overall Study|Adverse Event|39
846930|NCT01178281|2693874|P2|Overall Study|Withdrawal by Subject|7
846931|NCT01178281|2693875|P1|Overall Study|Withdrawal by Subject|18
846932|NCT01178281|2693874|P2|Overall Study|Death|5
846933|NCT01178281|2693875|P1|Overall Study|Death|4
846934|NCT01178281|2693874|P2|Overall Study|Disease Progression|6
846935|NCT01178281|2693875|P1|Overall Study|Disease Progression|18
846936|NCT01178281|2693874|P2|Overall Study|Non-compliance to study drug|0
846937|NCT01178281|2693875|P1|Overall Study|Non-compliance to study drug|1
846938|NCT01178281|2693874|P2|Overall Study|Lack of Efficacy|38
846939|NCT01178281|2693875|P1|Overall Study|Lack of Efficacy|60
846940|NCT01178281|2693874|P2|Overall Study|Loss of Clinical Benefit|7
846941|NCT01178281|2693875|P1|Overall Study|Loss of Clinical Benefit|5
846942|NCT01178281|2693874|P2|Overall Study|Physician Decision|3
846943|NCT01178281|2693875|P1|Overall Study|Physician Decision|4
846951|NCT01178385|2693963|P2|Overall Study|Withdrawal by Subject|0
846952|NCT01178385|2693964|P1|Overall Study|Withdrawal by Subject|2
846953|NCT01178671|2693998|P2|Overall Study|Physician Decision|6
846954|NCT01178671|2693999|P1|Overall Study|Physician Decision|4
846955|NCT01178671|2693998|P2|Overall Study|Lost to Follow-up|1
846956|NCT01178671|2693999|P1|Overall Study|Lost to Follow-up|3
846957|NCT01178671|2693998|P2|Overall Study|Lack of Efficacy|1
846958|NCT01178671|2693999|P1|Overall Study|Lack of Efficacy|0
846959|NCT01178671|2693998|P2|Overall Study|Protocol Violation|1
846960|NCT01178671|2693999|P1|Overall Study|Protocol Violation|1
846961|NCT01178671|2693998|P2|Overall Study|Adverse Event|6
846962|NCT01178671|2693999|P1|Overall Study|Adverse Event|4
846963|NCT01178762|2694023|P1|Overall Study|Lost to Follow-up|15
846964|NCT01178853|2694063|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
846965|NCT01178853|2694064|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
846966|NCT01178853|2694063|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
846967|NCT01178853|2694064|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
846968|NCT01178853|2694063|P2|Period 3 (Warfarin Titration)|Adverse Event|0
846969|NCT01178853|2694064|P1|Period 3 (Warfarin Titration)|Adverse Event|1
846970|NCT01178853|2694063|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
846971|NCT01178853|2694064|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
846972|NCT01178853|2694063|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
846973|NCT01178853|2694064|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
846974|NCT01184846|2694083|P1|Overall Study|Insufficient response|1
846975|NCT01184846|2694083|P1|Overall Study|Adverse Event|2
846976|NCT01184859|2694106|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
846977|NCT01184859|2694107|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
846978|NCT01184859|2694108|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
846979|NCT01184859|2694109|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
846980|NCT01184859|2694110|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
846981|NCT01184859|2694106|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
846982|NCT01184859|2694107|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
846983|NCT01184859|2694108|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
846984|NCT01184859|2694109|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
846985|NCT01184859|2694110|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
846986|NCT01184859|2694106|P5|Period 1: Single Dose|Adverse Event|1
846987|NCT01184859|2694107|P4|Period 1: Single Dose|Adverse Event|0
846988|NCT01184859|2694108|P3|Period 1: Single Dose|Adverse Event|0
846989|NCT01184859|2694109|P2|Period 1: Single Dose|Adverse Event|0
846990|NCT01184859|2694110|P1|Period 1: Single Dose|Adverse Event|0
846991|NCT01184859|2694106|P5|Period 1: Single Dose|Protocol Violation|0
846992|NCT01184859|2694107|P4|Period 1: Single Dose|Protocol Violation|0
846993|NCT01184859|2694108|P3|Period 1: Single Dose|Protocol Violation|0
846994|NCT01184859|2694109|P2|Period 1: Single Dose|Protocol Violation|1
846995|NCT01184859|2694110|P1|Period 1: Single Dose|Protocol Violation|0
846996|NCT01184859|2694106|P5|Period 1: Single Dose|Insufficient urine production|0
846997|NCT01184859|2694107|P4|Period 1: Single Dose|Insufficient urine production|0
846998|NCT01184859|2694108|P3|Period 1: Single Dose|Insufficient urine production|0
846999|NCT01184859|2694109|P2|Period 1: Single Dose|Insufficient urine production|1
847000|NCT01184859|2694110|P1|Period 1: Single Dose|Insufficient urine production|0
847001|NCT01184872|2694204|P2|Overall Study|Protocol deviation|0
847002|NCT01184872|2694205|P1|Overall Study|Protocol deviation|1
847003|NCT01184872|2694204|P2|Overall Study|Administrative problems|1
847004|NCT01184872|2694205|P1|Overall Study|Administrative problems|1
847005|NCT01184872|2694204|P2|Overall Study|Lost to Follow-up|1
847006|NCT01184872|2694205|P1|Overall Study|Lost to Follow-up|0
847007|NCT01184872|2694204|P2|Overall Study|Withdrawal by Subject|0
847008|NCT01184872|2694205|P1|Overall Study|Withdrawal by Subject|2
847009|NCT01184872|2694204|P2|Overall Study|Unsatisfactory therapeutic effect|2
847010|NCT01184872|2694205|P1|Overall Study|Unsatisfactory therapeutic effect|3
847011|NCT01184872|2694204|P2|Overall Study|Adverse Event|4
847012|NCT01184872|2694205|P1|Overall Study|Adverse Event|3
847013|NCT01184989|2694231|P1|Overall Study|Withdrawal by Subject|1
847014|NCT01184989|2694231|P1|Overall Study|Adverse Event|11
847015|NCT01185834|2694237|P1|Overall Study|Early exit - Site error|2
847016|NCT01185834|2694237|P1|Overall Study|Time/Job Conflict|2
847017|NCT01185834|2694237|P1|Overall Study|Biomicroscopy|4
847018|NCT01185834|2694237|P1|Overall Study|Discomfort|4
847019|NCT01185834|2694237|P1|Overall Study|Lost to Follow-up|2
847020|NCT01185964|2694245|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
847021|NCT01185964|2694246|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
847022|NCT01185964|2694247|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
847023|NCT01185964|2694248|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
847024|NCT01185964|2694245|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
847025|NCT01185964|2694246|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
847113|NCT01186744|2694357|P5|Overall Study|Lack of Efficacy|2
847026|NCT01185964|2694247|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
847027|NCT01185964|2694248|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
847028|NCT01185964|2694245|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
847029|NCT01185964|2694246|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
847030|NCT01185964|2694247|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
847031|NCT01185964|2694248|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
847032|NCT01185964|2694245|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
847033|NCT01185964|2694246|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
847034|NCT01185964|2694247|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
847035|NCT01185964|2694248|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
847036|NCT01185964|2694245|P4|Phase 1b and Phase 2|Adverse Event|0
847037|NCT01185964|2694246|P3|Phase 1b and Phase 2|Adverse Event|2
847038|NCT01185964|2694247|P2|Phase 1b and Phase 2|Adverse Event|0
847039|NCT01185964|2694248|P1|Phase 1b and Phase 2|Adverse Event|1
847040|NCT01185964|2694245|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
847041|NCT01185964|2694246|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
847042|NCT01185964|2694247|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
847043|NCT01185964|2694248|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
847044|NCT01185964|2694245|P4|Phase 1b and Phase 2|Other Therapy Started|0
847045|NCT01185964|2694246|P3|Phase 1b and Phase 2|Other Therapy Started|3
847046|NCT01185964|2694247|P2|Phase 1b and Phase 2|Other Therapy Started|3
847047|NCT01185964|2694248|P1|Phase 1b and Phase 2|Other Therapy Started|0
847048|NCT01185964|2694245|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
847049|NCT01185964|2694246|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
847050|NCT01185964|2694247|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
847051|NCT01185964|2694248|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
847052|NCT01186419|2694304|P2|Overall Study|Not specified|1
847053|NCT01186419|2694305|P1|Overall Study|Not specified|1
847054|NCT01186419|2694304|P2|Overall Study|Physician Decision|3
847055|NCT01186419|2694305|P1|Overall Study|Physician Decision|0
847056|NCT01186419|2694304|P2|Overall Study|Adverse Event|2
847057|NCT01186419|2694305|P1|Overall Study|Adverse Event|1
847058|NCT01186419|2694304|P2|Overall Study|Withdrawal by Subject|3
847059|NCT01186419|2694305|P1|Overall Study|Withdrawal by Subject|5
847060|NCT01186458|2694312|P1|Overall Study|Adverse Event|1
847064|NCT01186744|2694356|P6|Overall Study|Death|0
847065|NCT01186744|2694357|P5|Overall Study|Death|0
847066|NCT01186744|2694358|P4|Overall Study|Death|0
847067|NCT01186744|2694359|P3|Overall Study|Death|0
847068|NCT01186744|2694360|P2|Overall Study|Death|0
847069|NCT01186744|2694361|P1|Overall Study|Death|1
847070|NCT01186744|2694356|P6|Overall Study|Adverse Event|4
847071|NCT01186744|2694357|P5|Overall Study|Adverse Event|1
847072|NCT01186744|2694358|P4|Overall Study|Adverse Event|0
847073|NCT01186744|2694359|P3|Overall Study|Adverse Event|1
847074|NCT01186744|2694360|P2|Overall Study|Adverse Event|14
847075|NCT01186744|2694361|P1|Overall Study|Adverse Event|10
847076|NCT01186744|2694356|P6|Overall Study|Not specified|5
847077|NCT01186744|2694357|P5|Overall Study|Not specified|1
847078|NCT01186744|2694358|P4|Overall Study|Not specified|2
847079|NCT01186744|2694359|P3|Overall Study|Not specified|1
847080|NCT01186744|2694360|P2|Overall Study|Not specified|10
847081|NCT01186744|2694361|P1|Overall Study|Not specified|9
847082|NCT01186744|2694356|P6|Overall Study|Study terminated by Sponsor|0
847083|NCT01186744|2694357|P5|Overall Study|Study terminated by Sponsor|0
847084|NCT01186744|2694358|P4|Overall Study|Study terminated by Sponsor|0
847085|NCT01186744|2694359|P3|Overall Study|Study terminated by Sponsor|0
847086|NCT01186744|2694360|P2|Overall Study|Study terminated by Sponsor|0
847087|NCT01186744|2694361|P1|Overall Study|Study terminated by Sponsor|1
847088|NCT01186744|2694356|P6|Overall Study|Withdrawal by Subject|6
847089|NCT01186744|2694357|P5|Overall Study|Withdrawal by Subject|0
847090|NCT01186744|2694358|P4|Overall Study|Withdrawal by Subject|5
847091|NCT01186744|2694359|P3|Overall Study|Withdrawal by Subject|2
847092|NCT01186744|2694360|P2|Overall Study|Withdrawal by Subject|10
847093|NCT01186744|2694361|P1|Overall Study|Withdrawal by Subject|14
847094|NCT01186744|2694356|P6|Overall Study|Screen failure|0
847095|NCT01186744|2694357|P5|Overall Study|Screen failure|0
847096|NCT01186744|2694358|P4|Overall Study|Screen failure|1
847097|NCT01186744|2694359|P3|Overall Study|Screen failure|0
847098|NCT01186744|2694360|P2|Overall Study|Screen failure|1
847099|NCT01186744|2694361|P1|Overall Study|Screen failure|1
847100|NCT01186744|2694356|P6|Overall Study|Lost to Follow-up|4
847101|NCT01186744|2694357|P5|Overall Study|Lost to Follow-up|1
847102|NCT01186744|2694358|P4|Overall Study|Lost to Follow-up|1
847103|NCT01186744|2694359|P3|Overall Study|Lost to Follow-up|2
847104|NCT01186744|2694360|P2|Overall Study|Lost to Follow-up|16
847105|NCT01186744|2694361|P1|Overall Study|Lost to Follow-up|15
847106|NCT01186744|2694356|P6|Overall Study|Protocol Violation|2
847107|NCT01186744|2694357|P5|Overall Study|Protocol Violation|1
847108|NCT01186744|2694358|P4|Overall Study|Protocol Violation|1
847109|NCT01186744|2694359|P3|Overall Study|Protocol Violation|0
847110|NCT01186744|2694360|P2|Overall Study|Protocol Violation|2
847111|NCT01186744|2694361|P1|Overall Study|Protocol Violation|1
847112|NCT01186744|2694356|P6|Overall Study|Lack of Efficacy|5
847114|NCT01186744|2694358|P4|Overall Study|Lack of Efficacy|2
847115|NCT01186744|2694359|P3|Overall Study|Lack of Efficacy|0
847116|NCT01186744|2694360|P2|Overall Study|Lack of Efficacy|99
847117|NCT01186744|2694361|P1|Overall Study|Lack of Efficacy|156
847118|NCT01186796|2694779|P2|Overall Study|Protocol Violation|1
847119|NCT01186796|2694780|P1|Overall Study|Protocol Violation|0
847120|NCT01186796|2694779|P2|Overall Study|Withdrawal by Subject|1
847121|NCT01186796|2694780|P1|Overall Study|Withdrawal by Subject|1
847122|NCT01186796|2694779|P2|Overall Study|Adverse Event|0
847123|NCT01186796|2694780|P1|Overall Study|Adverse Event|3
847124|NCT01186848|2694794|P1|Overall Study|Adverse Event|2
847125|NCT01186848|2694794|P1|Overall Study|Withdrawal by Subject|2
847126|NCT01186848|2694794|P1|Overall Study|Lost to Follow-up|4
847127|NCT01186939|2694800|P1|Overall Study|Transformation to AML|1
847128|NCT01186939|2694800|P1|Overall Study|Bone marrow transplant|1
847129|NCT01186939|2694800|P1|Overall Study|Myocardial infarction|1
847130|NCT01186939|2694800|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
847131|NCT01186939|2694800|P1|Overall Study|Started additional treatment|1
847132|NCT01186939|2694800|P1|Overall Study|Sponsor decision|4
847133|NCT01186939|2694800|P1|Overall Study|Program closed|5
847134|NCT01186939|2694800|P1|Overall Study|No longer receiving clinical benefit|17
847135|NCT01186939|2694800|P1|Overall Study|Withdrawal by Subject|2
847136|NCT01186939|2694800|P1|Overall Study|Death|7
847137|NCT01187043|2694823|P5|Overall Study|Unable to make scheduled visits|1
847138|NCT01187043|2694824|P4|Overall Study|Unable to make scheduled visits|0
847139|NCT01187043|2694825|P3|Overall Study|Unable to make scheduled visits|4
847140|NCT01187043|2694826|P2|Overall Study|Unable to make scheduled visits|0
847141|NCT01187043|2694827|P1|Overall Study|Unable to make scheduled visits|1
847142|NCT01187043|2694823|P5|Overall Study|Adverse Event|1
847143|NCT01187043|2694824|P4|Overall Study|Adverse Event|0
847144|NCT01187043|2694825|P3|Overall Study|Adverse Event|0
847145|NCT01187043|2694826|P2|Overall Study|Adverse Event|0
847146|NCT01187043|2694827|P1|Overall Study|Adverse Event|0
847147|NCT01187433|2694854|P2|Overall Study|Withdrawal by Subject|2
847148|NCT01187433|2694855|P1|Overall Study|Withdrawal by Subject|5
847149|NCT01187433|2694854|P2|Overall Study|Protocol Violation|2
847150|NCT01187433|2694855|P1|Overall Study|Protocol Violation|6
847151|NCT01187550|2695021|P2|Overall Study|Randomized but not treated|0
847152|NCT01187550|2695022|P1|Overall Study|Randomized but not treated|8
847153|NCT01187550|2695021|P2|Overall Study|Unspecified|0
847154|NCT01187550|2695022|P1|Overall Study|Unspecified|3
847155|NCT01187550|2695021|P2|Overall Study|Protocol Violation|1
847156|NCT01187550|2695022|P1|Overall Study|Protocol Violation|3
847157|NCT01187901|2695063|P2|Overall Study|Pregnancy|2
847158|NCT01187901|2695064|P1|Overall Study|Pregnancy|0
847159|NCT01187901|2695063|P2|Overall Study|No Endpoint due to Early Study Halt|3
847160|NCT01187901|2695064|P1|Overall Study|No Endpoint due to Early Study Halt|2
847161|NCT01187901|2695063|P2|Overall Study|Adverse Event|0
847162|NCT01187901|2695064|P1|Overall Study|Adverse Event|3
847163|NCT01187901|2695063|P2|Overall Study|Suspected Allergic Reaction|1
847164|NCT01187901|2695064|P1|Overall Study|Suspected Allergic Reaction|1
847165|NCT01187901|2695063|P2|Overall Study|Unrelated Health Reasons|2
847166|NCT01187901|2695064|P1|Overall Study|Unrelated Health Reasons|1
847167|NCT01187901|2695063|P2|Overall Study|Lost to Follow-up|2
847168|NCT01187901|2695064|P1|Overall Study|Lost to Follow-up|1
847169|NCT01187901|2695063|P2|Overall Study|Protocol Violation|0
847170|NCT01187901|2695064|P1|Overall Study|Protocol Violation|1
847171|NCT01187953|2695086|P2|Overall Study|Withdrawal by Subject|3
847172|NCT01187953|2695087|P1|Overall Study|Withdrawal by Subject|3
847173|NCT01187953|2695086|P2|Overall Study|Lost to Follow-up|3
847174|NCT01187953|2695087|P1|Overall Study|Lost to Follow-up|0
847175|NCT01187953|2695086|P2|Overall Study|Adverse Event|2
847176|NCT01187953|2695087|P1|Overall Study|Adverse Event|1
847177|NCT01187953|2695086|P2|Overall Study|Death|13
847178|NCT01187953|2695087|P1|Overall Study|Death|11
847179|NCT01188226|2695100|P1|Overall Study|Withdrawal by Subject|4
847180|NCT01181726|2695141|P2|First Intervention|Adverse Event|0
847181|NCT01181726|2695142|P1|First Intervention|Adverse Event|1
847182|NCT01181778|2695188|P1|Overall Study|Physician Decision|48
847201|NCT01181921|2695257|P1|Overall Study|Lost to Follow-up|1
847202|NCT01181986|2695268|P3|Phase 2|Medical condition|0
847203|NCT01181986|2695269|P2|Phase 2|Medical condition|1
847204|NCT01181986|2695270|P1|Phase 2|Medical condition|0
847205|NCT01181986|2695268|P3|Phase 2|Adverse Event|0
847206|NCT01181986|2695269|P2|Phase 2|Adverse Event|3
847207|NCT01181986|2695270|P1|Phase 2|Adverse Event|0
847208|NCT01181986|2695268|P3|Phase 1|Protocol Violation|0
847209|NCT01181986|2695269|P2|Phase 1|Protocol Violation|0
847210|NCT01181986|2695270|P1|Phase 1|Protocol Violation|1
847211|NCT01181986|2695268|P3|Phase 1|Adverse Event|1
847212|NCT01181986|2695269|P2|Phase 1|Adverse Event|0
847213|NCT01181986|2695270|P1|Phase 1|Adverse Event|0
847214|NCT01181986|2695268|P3|Phase 1|Lost to Follow-up|1
847215|NCT01181986|2695269|P2|Phase 1|Lost to Follow-up|1
847216|NCT01181986|2695270|P1|Phase 1|Lost to Follow-up|0
847217|NCT01182181|2695303|P2|Washout of 21 Days|Withdrawal by Subject|1
847218|NCT01182181|2695304|P1|Washout of 21 Days|Withdrawal by Subject|0
847219|NCT01182181|2695303|P2|First Intervention|Adverse Event|0
847220|NCT01182181|2695304|P1|First Intervention|Adverse Event|1
847221|NCT01188343|2695315|P3|Overall Study|Withdrawal by Subject|0
847222|NCT01188343|2695316|P2|Overall Study|Withdrawal by Subject|24
847223|NCT01188343|2695317|P1|Overall Study|Withdrawal by Subject|1
847224|NCT01188343|2695315|P3|Overall Study|Not vaccinated|1
847225|NCT01188343|2695316|P2|Overall Study|Not vaccinated|2
847226|NCT01188343|2695317|P1|Overall Study|Not vaccinated|0
847227|NCT01188538|2695392|P2|Overall Study|Lost to Follow-up|1
847228|NCT01188538|2695393|P1|Overall Study|Lost to Follow-up|0
847229|NCT01188551|2695405|P4|Overall Study|Pharmacy issues|0
847230|NCT01188551|2695406|P3|Overall Study|Pharmacy issues|0
847231|NCT01188551|2695407|P2|Overall Study|Pharmacy issues|0
847232|NCT01188551|2695408|P1|Overall Study|Pharmacy issues|1
847233|NCT01188564|2695424|P2|Double-blind Phase|randomized not treated|0
847234|NCT01188564|2695425|P1|Double-blind Phase|randomized not treated|1
847235|NCT01190254|2695455|P3|Overall Study|Did not meet protocol eligibility|0
847236|NCT01190254|2695456|P2|Overall Study|Did not meet protocol eligibility|0
847237|NCT01190254|2695457|P1|Overall Study|Did not meet protocol eligibility|1
847238|NCT01190254|2695455|P3|Overall Study|Protocol Violation|2
847239|NCT01190254|2695456|P2|Overall Study|Protocol Violation|0
847240|NCT01190254|2695457|P1|Overall Study|Protocol Violation|2
847241|NCT01190254|2695455|P3|Overall Study|Withdrawal by Subject|7
847242|NCT01190254|2695456|P2|Overall Study|Withdrawal by Subject|5
847243|NCT01190254|2695457|P1|Overall Study|Withdrawal by Subject|4
847244|NCT01190254|2695455|P3|Overall Study|Lost to Follow-up|0
847245|NCT01190254|2695456|P2|Overall Study|Lost to Follow-up|2
847246|NCT01190254|2695457|P1|Overall Study|Lost to Follow-up|4
847247|NCT01190254|2695455|P3|Overall Study|Lack of Efficacy|5
847248|NCT01190254|2695456|P2|Overall Study|Lack of Efficacy|4
847249|NCT01190254|2695457|P1|Overall Study|Lack of Efficacy|7
847250|NCT01190254|2695455|P3|Overall Study|Adverse Event|8
847251|NCT01190254|2695456|P2|Overall Study|Adverse Event|6
847252|NCT01190254|2695457|P1|Overall Study|Adverse Event|3
847253|NCT01190267|2695521|P2|Overall Study|Protocol Violation|1
847254|NCT01190267|2695522|P1|Overall Study|Protocol Violation|8
847255|NCT01190267|2695521|P2|Overall Study|Withdrawal by Subject|1
847256|NCT01190267|2695522|P1|Overall Study|Withdrawal by Subject|13
847257|NCT01190267|2695521|P2|Overall Study|Lost to Follow-up|0
847258|NCT01190267|2695522|P1|Overall Study|Lost to Follow-up|2
847259|NCT01190267|2695521|P2|Overall Study|Treatment Failure|2
847260|NCT01190267|2695522|P1|Overall Study|Treatment Failure|8
847261|NCT01190267|2695521|P2|Overall Study|Adverse Event|0
847262|NCT01190267|2695522|P1|Overall Study|Adverse Event|10
847263|NCT01190436|2695539|P1|Overall Study|Unspecified|4
847264|NCT01190436|2695539|P1|Overall Study|Lost to Follow-up|35
847265|NCT01190514|2695553|P4|Third Intervention (Period 3)|Adverse Event|0
847266|NCT01190514|2695554|P3|Third Intervention (Period 3)|Adverse Event|0
847267|NCT01190514|2695555|P2|Third Intervention (Period 3)|Adverse Event|0
847268|NCT01190514|2695556|P1|Third Intervention (Period 3)|Adverse Event|1
847269|NCT01190514|2695553|P4|First Intervention (Period 1)|Adverse Event|0
847270|NCT01190514|2695554|P3|First Intervention (Period 1)|Adverse Event|0
847271|NCT01190514|2695555|P2|First Intervention (Period 1)|Adverse Event|0
847272|NCT01190514|2695556|P1|First Intervention (Period 1)|Adverse Event|1
847273|NCT01190813|2695619|P2|Overall Study|Adverse Event|1
847274|NCT01190813|2695620|P1|Overall Study|Adverse Event|0
847275|NCT01190813|2695619|P2|Overall Study|Refused study treatment after randomized|0
847276|NCT01190813|2695620|P1|Overall Study|Refused study treatment after randomized|1
847277|NCT01190813|2695619|P2|Overall Study|Withdrawal by Subject|1
847278|NCT01190813|2695620|P1|Overall Study|Withdrawal by Subject|2
847279|NCT01190813|2695619|P2|Overall Study|Lost to Follow-up|2
847280|NCT01190813|2695620|P1|Overall Study|Lost to Follow-up|1
847281|NCT01190839|2695712|P2|Overall Study|Randomized but not treated|4
847282|NCT01190839|2695713|P1|Overall Study|Randomized but not treated|2
847283|NCT01190839|2695712|P2|Overall Study|Undefined|31
847284|NCT01190839|2695713|P1|Overall Study|Undefined|35
847285|NCT01190839|2695712|P2|Overall Study|Trial stopped by Sponsor|68
847286|NCT01190839|2695713|P1|Overall Study|Trial stopped by Sponsor|71
847287|NCT01190839|2695712|P2|Overall Study|Death|0
847288|NCT01190839|2695713|P1|Overall Study|Death|1
847289|NCT01190839|2695712|P2|Overall Study|Lost to Follow-up|1
847290|NCT01190839|2695713|P1|Overall Study|Lost to Follow-up|7
847291|NCT01190839|2695712|P2|Overall Study|Protocol Violation|2
847292|NCT01190839|2695713|P1|Overall Study|Protocol Violation|2
847293|NCT01190839|2695712|P2|Overall Study|Adverse Event|41
847294|NCT01190839|2695713|P1|Overall Study|Adverse Event|32
847295|NCT01190865|2695725|P1|Overall Study|Non-compliance|2
847296|NCT01190865|2695725|P1|Overall Study|Withdrawal by Subject|1
847297|NCT01190891|2695749|P2|Overall Study|Withdrawal by Subject|0
847298|NCT01190891|2695750|P1|Overall Study|Withdrawal by Subject|5
847299|NCT01190891|2695749|P2|Overall Study|Protocol Violation|0
847300|NCT01190891|2695750|P1|Overall Study|Protocol Violation|1
847301|NCT01191008|2695758|P1|Overall Study|Lost to Follow-up|8
847302|NCT01191008|2695758|P1|Overall Study|Protocol Violation|7
847303|NCT01191086|2695764|P1|Overall Study|Other|1
847304|NCT01191086|2695764|P1|Overall Study|Discontinuation criterion met|1
847305|NCT01191086|2695764|P1|Overall Study|Withdrawal by Subject|24
847306|NCT01191086|2695764|P1|Overall Study|Physician Decision|2
847307|NCT01191086|2695764|P1|Overall Study|Lost to Follow-up|4
847308|NCT01191086|2695764|P1|Overall Study|Lack of Efficacy|10
847309|NCT01191086|2695764|P1|Overall Study|Adverse Event|20
847310|NCT01191190|2695768|P1|Overall Study|Withdrawal by Subject|1
847311|NCT01191268|2695832|P3|Overall Study|Sponsor Decision|0
847312|NCT01191268|2695833|P2|Overall Study|Sponsor Decision|2
847313|NCT01191268|2695834|P1|Overall Study|Sponsor Decision|0
847314|NCT01191268|2695832|P3|Overall Study|Protocol Violation|1
847315|NCT01191268|2695833|P2|Overall Study|Protocol Violation|0
847316|NCT01191268|2695834|P1|Overall Study|Protocol Violation|1
847317|NCT01191268|2695832|P3|Overall Study|Death|3
847318|NCT01191268|2695833|P2|Overall Study|Death|1
847319|NCT01191268|2695834|P1|Overall Study|Death|0
847320|NCT01191268|2695832|P3|Overall Study|Entry Criteria Not Met|1
847321|NCT01191268|2695833|P2|Overall Study|Entry Criteria Not Met|1
847322|NCT01191268|2695834|P1|Overall Study|Entry Criteria Not Met|3
847323|NCT01191268|2695832|P3|Overall Study|Lost to Follow-up|9
847324|NCT01191268|2695833|P2|Overall Study|Lost to Follow-up|5
847325|NCT01191268|2695834|P1|Overall Study|Lost to Follow-up|8
847326|NCT01191268|2695832|P3|Overall Study|Physician Decision|9
847327|NCT01191268|2695833|P2|Overall Study|Physician Decision|8
847328|NCT01191268|2695834|P1|Overall Study|Physician Decision|6
847329|NCT01191268|2695832|P3|Overall Study|Adverse Event|8
847330|NCT01191268|2695833|P2|Overall Study|Adverse Event|13
847331|NCT01191268|2695834|P1|Overall Study|Adverse Event|21
847332|NCT01191268|2695832|P3|Overall Study|Withdrawal by Subject|21
847333|NCT01191268|2695833|P2|Overall Study|Withdrawal by Subject|25
847334|NCT01191268|2695834|P1|Overall Study|Withdrawal by Subject|19
847335|NCT01191762|2696059|P2|Overall Study|Adverse Event|0
847336|NCT01191762|2696060|P1|Overall Study|Adverse Event|1
847337|NCT01191788|2696068|P2|Overall Study|Lost to Follow-up|22
847338|NCT01191788|2696069|P1|Overall Study|Lost to Follow-up|21
847339|NCT01191801|2696079|P2|Overall Study|Not Provided|27
847340|NCT01191801|2696080|P1|Overall Study|Not Provided|45
847341|NCT01191801|2696079|P2|Overall Study|Withdrawal by Subject|4
847342|NCT01191801|2696080|P1|Overall Study|Withdrawal by Subject|1
847343|NCT01191801|2696079|P2|Overall Study|Physician Decision|24
847344|NCT01191801|2696080|P1|Overall Study|Physician Decision|47
847345|NCT01191801|2696079|P2|Overall Study|Protocol Violation|4
847346|NCT01191801|2696080|P1|Overall Study|Protocol Violation|2
847347|NCT01191801|2696079|P2|Overall Study|Adverse Event|8
847348|NCT01191801|2696080|P1|Overall Study|Adverse Event|9
847349|NCT01191801|2696079|P2|Overall Study|Lack of Efficacy|258
847350|NCT01191801|2696080|P1|Overall Study|Lack of Efficacy|176
847351|NCT01191801|2696079|P2|Overall Study|Death|12
847352|NCT01191801|2696080|P1|Overall Study|Death|36
847353|NCT01191944|2696109|P2|Overall Study|Other|3
847354|NCT01191944|2696110|P1|Overall Study|Other|1
847355|NCT01191944|2696109|P2|Overall Study|Withdrawal by Subject|2
847356|NCT01191944|2696110|P1|Overall Study|Withdrawal by Subject|4
847357|NCT01191944|2696109|P2|Overall Study|Protocol Violation|2
847358|NCT01191944|2696110|P1|Overall Study|Protocol Violation|1
847359|NCT01191944|2696109|P2|Overall Study|Adverse Event|12
847360|NCT01191944|2696110|P1|Overall Study|Adverse Event|11
847361|NCT01192022|2696158|P5|Overall Study|Parents did not allow all follow up|0
847362|NCT01192022|2696159|P4|Overall Study|Parents did not allow all follow up|1
847363|NCT01192022|2696160|P3|Overall Study|Parents did not allow all follow up|0
847364|NCT01192022|2696161|P2|Overall Study|Parents did not allow all follow up|0
847365|NCT01192022|2696162|P1|Overall Study|Parents did not allow all follow up|0
847366|NCT01192022|2696158|P5|Overall Study|Patient needed surgery|0
847367|NCT01192022|2696159|P4|Overall Study|Patient needed surgery|0
847368|NCT01192022|2696160|P3|Overall Study|Patient needed surgery|0
847369|NCT01192022|2696161|P2|Overall Study|Patient needed surgery|1
847370|NCT01192022|2696162|P1|Overall Study|Patient needed surgery|0
847371|NCT01192022|2696158|P5|Overall Study|Patient too sick from chemotherapy|0
847372|NCT01192022|2696159|P4|Overall Study|Patient too sick from chemotherapy|0
847373|NCT01192022|2696160|P3|Overall Study|Patient too sick from chemotherapy|0
847374|NCT01192022|2696161|P2|Overall Study|Patient too sick from chemotherapy|1
847375|NCT01192022|2696162|P1|Overall Study|Patient too sick from chemotherapy|0
847376|NCT01192022|2696158|P5|Overall Study|Physician withdrew-patient hardship|0
847377|NCT01192022|2696159|P4|Overall Study|Physician withdrew-patient hardship|0
847378|NCT01192022|2696160|P3|Overall Study|Physician withdrew-patient hardship|0
847465|NCT01185080|2696560|P3|Overall Study|Personal reasons|1
847379|NCT01192022|2696161|P2|Overall Study|Physician withdrew-patient hardship|0
847380|NCT01192022|2696162|P1|Overall Study|Physician withdrew-patient hardship|1
847381|NCT01192022|2696158|P5|Overall Study|Fatal Adverse Event|1
847382|NCT01192022|2696159|P4|Overall Study|Fatal Adverse Event|0
847383|NCT01192022|2696160|P3|Overall Study|Fatal Adverse Event|0
847384|NCT01192022|2696161|P2|Overall Study|Fatal Adverse Event|6
847385|NCT01192022|2696162|P1|Overall Study|Fatal Adverse Event|4
847386|NCT01192022|2696158|P5|Overall Study|Adverse Event|0
847387|NCT01192022|2696159|P4|Overall Study|Adverse Event|0
847388|NCT01192022|2696160|P3|Overall Study|Adverse Event|0
847389|NCT01192022|2696161|P2|Overall Study|Adverse Event|0
847390|NCT01192022|2696162|P1|Overall Study|Adverse Event|1
847391|NCT01192022|2696158|P5|Overall Study|Lost to Follow-up|0
847392|NCT01192022|2696159|P4|Overall Study|Lost to Follow-up|1
847393|NCT01192022|2696160|P3|Overall Study|Lost to Follow-up|1
847394|NCT01192022|2696161|P2|Overall Study|Lost to Follow-up|2
847395|NCT01192022|2696162|P1|Overall Study|Lost to Follow-up|4
847396|NCT01192022|2696158|P5|Overall Study|Withdrawal of Consent|0
847397|NCT01192022|2696159|P4|Overall Study|Withdrawal of Consent|0
847398|NCT01192022|2696160|P3|Overall Study|Withdrawal of Consent|0
847399|NCT01192022|2696161|P2|Overall Study|Withdrawal of Consent|1
847400|NCT01192022|2696162|P1|Overall Study|Withdrawal of Consent|3
847401|NCT01192126|2696183|P2|First Intervention (1 Week)|Lost to Follow-up|1
847402|NCT01192126|2696184|P1|First Intervention (1 Week)|Lost to Follow-up|1
847403|NCT01192126|2696183|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
847404|NCT01192126|2696184|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
847405|NCT01192152|2696262|P2|Period 3|family emergency|0
847406|NCT01192152|2696263|P1|Period 3|family emergency|1
847407|NCT01192152|2696262|P2|Period 1|left prematurely (while on treatment B)|1
847408|NCT01192152|2696263|P1|Period 1|left prematurely (while on treatment B)|0
847409|NCT01192178|2696366|P2|Overall Study|Lack of Efficacy|2
847410|NCT01192178|2696367|P1|Overall Study|Lack of Efficacy|1
847411|NCT01192178|2696366|P2|Overall Study|Adverse Event|1
847412|NCT01192178|2696367|P1|Overall Study|Adverse Event|2
847413|NCT01192178|2696366|P2|Overall Study|Lost to Follow-up|3
847414|NCT01192178|2696367|P1|Overall Study|Lost to Follow-up|3
847415|NCT01192178|2696366|P2|Overall Study|Physician Decision|4
847416|NCT01192178|2696367|P1|Overall Study|Physician Decision|2
847417|NCT01192178|2696366|P2|Overall Study|Protocol Violation|3
847418|NCT01192178|2696367|P1|Overall Study|Protocol Violation|10
847419|NCT01192178|2696366|P2|Overall Study|Withdrawal by Subject|10
847420|NCT01192178|2696367|P1|Overall Study|Withdrawal by Subject|6
847421|NCT01192191|2696389|P2|Overall Study|Withdrawal by Subject|6
847422|NCT01192191|2696390|P1|Overall Study|Withdrawal by Subject|1
847423|NCT01192191|2696389|P2|Overall Study|Lost to Follow-up|1
847424|NCT01192191|2696390|P1|Overall Study|Lost to Follow-up|0
847425|NCT01192191|2696389|P2|Overall Study|Participants Reached Stopping Criteria|2
847426|NCT01192191|2696390|P1|Overall Study|Participants Reached Stopping Criteria|3
847427|NCT01192191|2696389|P2|Overall Study|Adverse Event|12
847428|NCT01192191|2696390|P1|Overall Study|Adverse Event|7
847429|NCT01192204|2696416|P2|Overall Study|could not keep recall appointments|0
847430|NCT01192204|2696417|P1|Overall Study|could not keep recall appointments|1
847441|NCT01192347|2696462|P1|Overall Study|Patient did not show up for visits|1
847442|NCT01192347|2696462|P1|Overall Study|Patient not visiting hospital regularly|1
847443|NCT01192347|2696462|P1|Overall Study|Patient seen in different hospital|1
847444|NCT01192347|2696462|P1|Overall Study|Suspected serious adverse drug reaction|1
847445|NCT01192347|2696462|P1|Overall Study|Adverse Event|1
847446|NCT01192347|2696462|P1|Overall Study|Withdrawal by Subject|1
847447|NCT01192347|2696462|P1|Overall Study|Lost to Follow-up|3
847448|NCT01192347|2696462|P1|Overall Study|Death|3
847449|NCT01192412|2696485|P2|Overall Study|Withdrawal by Subject|1
847450|NCT01192412|2696486|P1|Overall Study|Withdrawal by Subject|2
847451|NCT01192412|2696485|P2|Overall Study|Lost to Follow-up|1
847452|NCT01192412|2696486|P1|Overall Study|Lost to Follow-up|2
847453|NCT01192516|2696497|P3|Overall Study|Unable to follow Actiwatch instructions|0
847454|NCT01192516|2696498|P2|Overall Study|Unable to follow Actiwatch instructions|2
847455|NCT01192516|2696499|P1|Overall Study|Unable to follow Actiwatch instructions|4
847456|NCT01192516|2696497|P3|Overall Study|started new treatment|0
847457|NCT01192516|2696498|P2|Overall Study|started new treatment|1
847458|NCT01192516|2696499|P1|Overall Study|started new treatment|5
847459|NCT01192516|2696497|P3|Overall Study|Withdrawal by Subject|1
847460|NCT01192516|2696498|P2|Overall Study|Withdrawal by Subject|4
847461|NCT01192516|2696499|P1|Overall Study|Withdrawal by Subject|4
847462|NCT01192516|2696497|P3|Overall Study|Lost to Follow-up|7
847463|NCT01192516|2696498|P2|Overall Study|Lost to Follow-up|10
847464|NCT01192516|2696499|P1|Overall Study|Lost to Follow-up|7
847466|NCT01185080|2696561|P2|Overall Study|Personal reasons|0
847467|NCT01185080|2696562|P1|Overall Study|Personal reasons|0
847468|NCT01185080|2696560|P3|Overall Study|Adverse Event|0
847469|NCT01185080|2696561|P2|Overall Study|Adverse Event|1
847470|NCT01185080|2696562|P1|Overall Study|Adverse Event|1
847471|NCT01185249|2696609|P1|Overall Study|Patients discharged or change in status|42
847472|NCT01185288|2696616|P2|Overall Study|Noncompliance|1
847473|NCT01185288|2696617|P1|Overall Study|Noncompliance|0
847474|NCT01185288|2696616|P2|Overall Study|Did not meet inclusion criteria|0
847475|NCT01185288|2696617|P1|Overall Study|Did not meet inclusion criteria|1
847476|NCT01185288|2696616|P2|Overall Study|Investigator discretion|0
847477|NCT01185288|2696617|P1|Overall Study|Investigator discretion|1
847478|NCT01185288|2696616|P2|Overall Study|Lack of Efficacy|0
847479|NCT01185288|2696617|P1|Overall Study|Lack of Efficacy|2
847480|NCT01185288|2696616|P2|Overall Study|Lost to Follow-up|5
847481|NCT01185288|2696617|P1|Overall Study|Lost to Follow-up|2
847482|NCT01185288|2696616|P2|Overall Study|Withdrawal by Subject|4
847483|NCT01185288|2696617|P1|Overall Study|Withdrawal by Subject|6
847484|NCT01185288|2696616|P2|Overall Study|Adverse Event|6
847485|NCT01185288|2696617|P1|Overall Study|Adverse Event|7
847486|NCT01185301|2696639|P4|Overall Study|Other Reason|2
847487|NCT01185301|2696640|P3|Overall Study|Other Reason|2
847488|NCT01185301|2696641|P2|Overall Study|Other Reason|2
847489|NCT01185301|2696642|P1|Overall Study|Other Reason|3
847490|NCT01185301|2696639|P4|Overall Study|Lost to Follow-up|1
847491|NCT01185301|2696640|P3|Overall Study|Lost to Follow-up|0
847492|NCT01185301|2696641|P2|Overall Study|Lost to Follow-up|0
847493|NCT01185301|2696642|P1|Overall Study|Lost to Follow-up|2
847494|NCT01185301|2696639|P4|Overall Study|Withdrawal by Subject|3
847495|NCT01185301|2696640|P3|Overall Study|Withdrawal by Subject|2
847496|NCT01185301|2696641|P2|Overall Study|Withdrawal by Subject|5
847497|NCT01185301|2696642|P1|Overall Study|Withdrawal by Subject|7
847498|NCT01185301|2696639|P4|Overall Study|Adverse Event|3
847499|NCT01185301|2696640|P3|Overall Study|Adverse Event|2
847500|NCT01185301|2696641|P2|Overall Study|Adverse Event|0
847501|NCT01185301|2696642|P1|Overall Study|Adverse Event|3
847502|NCT01185353|2696705|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
847503|NCT01185353|2696706|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
847504|NCT01185353|2696707|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
847505|NCT01185353|2696708|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
847506|NCT01185353|2696709|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
847507|NCT01185353|2696710|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
847508|NCT01185353|2696711|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
847509|NCT01185353|2696712|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
847510|NCT01185353|2696713|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
847511|NCT01185353|2696714|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
847512|NCT01185353|2696705|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
847513|NCT01185353|2696706|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
847514|NCT01185353|2696707|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
847515|NCT01185353|2696708|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847516|NCT01185353|2696709|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847517|NCT01185353|2696710|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847518|NCT01185353|2696711|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847519|NCT01185353|2696712|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847520|NCT01185353|2696713|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847521|NCT01185353|2696714|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
847522|NCT01185353|2696705|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847523|NCT01185353|2696706|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
847524|NCT01185353|2696707|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
847525|NCT01185353|2696708|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847526|NCT01185353|2696709|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847527|NCT01185353|2696710|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847528|NCT01185353|2696711|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847529|NCT01185353|2696712|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847530|NCT01185353|2696713|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847531|NCT01185353|2696714|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
847532|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Reason missing|0
847533|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Reason missing|1
847534|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Reason missing|0
847535|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Reason missing|0
847536|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Reason missing|0
847537|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Reason missing|0
847538|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Reason missing|0
847539|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Reason missing|0
847540|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Reason missing|0
847541|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Reason missing|0
847542|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
847543|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
847544|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
847545|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
847546|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
847547|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
847548|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
847549|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
847550|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
847551|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
847552|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
847553|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847554|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847555|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847556|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847557|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847558|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847559|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847560|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847561|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
847562|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Death|1
847563|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Death|0
847564|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Death|0
847565|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Death|0
847566|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Death|0
847567|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Death|0
847568|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Death|0
847569|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Death|0
847570|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Death|0
847571|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Death|0
847572|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847573|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
847574|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847575|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847576|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847577|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847578|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847579|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847580|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847581|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
847582|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
847583|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
847584|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
847585|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847586|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847587|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847588|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847589|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847590|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847591|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
847592|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
847593|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
847594|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
847595|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847596|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847597|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847598|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847599|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847600|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847601|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
847602|NCT01185353|2696705|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
847603|NCT01185353|2696706|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
847604|NCT01185353|2696707|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
847605|NCT01185353|2696708|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
847606|NCT01185353|2696709|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
847607|NCT01185353|2696710|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
847608|NCT01185353|2696711|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
847609|NCT01185353|2696712|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
847610|NCT01185353|2696713|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
847611|NCT01185353|2696714|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
847612|NCT01185353|2696705|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847613|NCT01185353|2696706|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847614|NCT01185353|2696707|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847615|NCT01185353|2696708|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
847616|NCT01185353|2696709|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847617|NCT01185353|2696710|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847618|NCT01185353|2696711|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847619|NCT01185353|2696712|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847620|NCT01185353|2696713|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847621|NCT01185353|2696714|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
847622|NCT01185353|2696705|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847623|NCT01185353|2696706|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847624|NCT01185353|2696707|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847625|NCT01185353|2696708|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
847626|NCT01185353|2696709|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
847627|NCT01185353|2696710|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847628|NCT01185353|2696711|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
847629|NCT01185353|2696712|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
847630|NCT01185353|2696713|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847631|NCT01185353|2696714|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
847632|NCT01185353|2696705|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847633|NCT01185353|2696706|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847634|NCT01185353|2696707|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847635|NCT01185353|2696708|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
847636|NCT01185353|2696709|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847637|NCT01185353|2696710|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847638|NCT01185353|2696711|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
847639|NCT01185353|2696712|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847640|NCT01185353|2696713|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847641|NCT01185353|2696714|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
847642|NCT01185353|2696705|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847643|NCT01185353|2696706|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847644|NCT01185353|2696707|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847645|NCT01185353|2696708|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847646|NCT01185353|2696709|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847647|NCT01185353|2696710|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847648|NCT01185353|2696711|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
847649|NCT01185353|2696712|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847650|NCT01185353|2696713|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
847651|NCT01185353|2696714|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
847652|NCT01185353|2696705|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
847653|NCT01185353|2696706|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
847654|NCT01185353|2696707|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
847655|NCT01185353|2696708|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
847656|NCT01185353|2696709|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
847657|NCT01185353|2696710|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
847658|NCT01185353|2696711|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
847659|NCT01185353|2696712|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
847660|NCT01185353|2696713|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
847661|NCT01185353|2696714|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
847662|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847663|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847664|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847665|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847666|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847667|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
847668|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847669|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847670|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
847671|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
847672|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
847673|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
847674|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
847675|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
847676|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
847677|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
847678|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
847679|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
847680|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
847681|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
847682|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
847683|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
847684|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
847685|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
847686|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
847687|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
847688|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
847689|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
847690|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
847691|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
847692|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847693|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847694|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847695|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847696|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847697|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
847698|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847699|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847700|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
847701|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
847702|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847703|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847704|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847705|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847706|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847707|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
847708|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847709|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847710|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847711|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
847712|NCT01185353|2696705|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
847713|NCT01185353|2696706|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
847714|NCT01185353|2696707|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
847715|NCT01185353|2696708|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
847716|NCT01185353|2696709|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
847717|NCT01185353|2696710|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
847718|NCT01185353|2696711|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
847719|NCT01185353|2696712|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
847720|NCT01185353|2696713|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
847721|NCT01185353|2696714|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
847722|NCT01185509|2696874|P2|Overall Study|Intercurrent Illness|1
847723|NCT01185509|2696875|P1|Overall Study|Intercurrent Illness|0
847724|NCT01185509|2696874|P2|Overall Study|Death|1
847725|NCT01185509|2696875|P1|Overall Study|Death|0
847726|NCT01185509|2696874|P2|Overall Study|Withdrawal by Subject|1
847727|NCT01185509|2696875|P1|Overall Study|Withdrawal by Subject|0
847728|NCT01185509|2696874|P2|Overall Study|Physician Decision|2
847729|NCT01185509|2696875|P1|Overall Study|Physician Decision|2
847730|NCT01185509|2696874|P2|Overall Study|Progression/Relapse|15
847731|NCT01185509|2696875|P1|Overall Study|Progression/Relapse|9
847732|NCT01185522|2696885|P1|Overall Study|Other reasons|12
847733|NCT01185522|2696885|P1|Overall Study|Poor tolerance|39
847734|NCT01185522|2696885|P1|Overall Study|Withdrawal by Subject|10
847735|NCT01185522|2696885|P1|Overall Study|Lost to Follow-up|19
847736|NCT01185522|2696885|P1|Overall Study|Lack of Efficacy|28
847737|NCT01185561|2696911|P2|Overall Study|Withdrawal by Subject|8
847738|NCT01185561|2696912|P1|Overall Study|Withdrawal by Subject|2
847739|NCT01185561|2696911|P2|Overall Study|Lost to Follow-up|4
847740|NCT01185561|2696912|P1|Overall Study|Lost to Follow-up|0
847741|NCT01185600|2696926|P2|Overall Study|Hold by DSMB|2
847742|NCT01185600|2696927|P1|Overall Study|Hold by DSMB|1
847743|NCT01185600|2696926|P2|Overall Study|Withdrawal by Subject|1
847744|NCT01185600|2696927|P1|Overall Study|Withdrawal by Subject|1
847745|NCT01185600|2696926|P2|Overall Study|Physician Decision|35
847746|NCT01185600|2696927|P1|Overall Study|Physician Decision|29
847747|NCT01185600|2696926|P2|Overall Study|Lost to Follow-up|5
847748|NCT01185600|2696927|P1|Overall Study|Lost to Follow-up|0
847749|NCT01185600|2696926|P2|Overall Study|Death|1
847750|NCT01185600|2696927|P1|Overall Study|Death|0
847751|NCT01185600|2696926|P2|Overall Study|Adverse Event|1
847752|NCT01185600|2696927|P1|Overall Study|Adverse Event|1
847753|NCT01185704|2696949|P2|Overall Study|Ectopic pregnancy|1
847754|NCT01185704|2696950|P1|Overall Study|Ectopic pregnancy|0
847755|NCT01185704|2696949|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
847756|NCT01185704|2696950|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
847757|NCT01185704|2696949|P2|Overall Study|Lack of ovarian response|1
847758|NCT01185704|2696950|P1|Overall Study|Lack of ovarian response|5
847759|NCT01185704|2696949|P2|Overall Study|Randomized but not treated|3
847760|NCT01185704|2696950|P1|Overall Study|Randomized but not treated|3
847761|NCT01185782|2696986|P2|Overall Study|Randomized but not treated|4
847762|NCT01185782|2696987|P1|Overall Study|Randomized but not treated|0
847763|NCT01185782|2696986|P2|Overall Study|Unspecified|5
847764|NCT01185782|2696987|P1|Overall Study|Unspecified|2
847765|NCT01185782|2696986|P2|Overall Study|Poor Response to Treatment|1
847766|NCT01185782|2696987|P1|Overall Study|Poor Response to Treatment|3
847767|NCT01185782|2696986|P2|Overall Study|Protocol Violation|0
847768|NCT01185782|2696987|P1|Overall Study|Protocol Violation|1
847769|NCT01185782|2696986|P2|Overall Study|Adverse Event|1
847770|NCT01185782|2696987|P1|Overall Study|Adverse Event|0
847771|NCT01192776|2697017|P4|Overall Study|Lost to Follow-up|5
847772|NCT01192776|2697018|P3|Overall Study|Lost to Follow-up|3
847773|NCT01192776|2697019|P2|Overall Study|Lost to Follow-up|6
847774|NCT01192776|2697020|P1|Overall Study|Lost to Follow-up|3
847775|NCT01192776|2697017|P4|Overall Study|Death|15
847776|NCT01192776|2697018|P3|Overall Study|Death|18
847777|NCT01192776|2697019|P2|Overall Study|Death|15
847778|NCT01192776|2697020|P1|Overall Study|Death|8
847779|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847780|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|1
847781|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847782|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847783|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847784|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847785|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847786|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
847787|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
847788|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847789|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847790|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847791|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847792|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847793|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847794|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
847795|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
847796|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|5
847797|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
847798|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
847799|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
847800|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
847801|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
847802|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
847803|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|6
847804|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|12
847805|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
847806|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|1
847807|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
847808|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
847809|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
847810|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
847811|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847812|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|2
847813|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847814|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|1
847815|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847816|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847817|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847818|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
847819|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|33
847820|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|35
847821|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
847822|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
847823|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
847824|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
847825|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
847826|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
847827|NCT01194219|2697103|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|5
847828|NCT01194219|2697104|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|6
847829|NCT01194219|2697105|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
847830|NCT01194219|2697106|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
847831|NCT01194219|2697107|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
847832|NCT01194219|2697108|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
847833|NCT01194219|2697109|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
847834|NCT01194219|2697110|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
847835|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
847836|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
847837|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
847838|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
847839|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Unspecified|1
847840|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
847841|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
847842|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
847843|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847844|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847845|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847846|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847847|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Protocol Violation|1
847848|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847849|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847850|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Protocol Violation|0
847851|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847852|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847853|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847854|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847855|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847856|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|9
847857|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847858|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
847859|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847860|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847861|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847862|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847863|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|3
847864|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|12
847865|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847866|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
847867|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847868|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847869|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847870|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847871|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|1
847872|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|2
847873|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847874|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
847875|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847876|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847877|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847878|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847879|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|15
847880|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|37
847881|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847882|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
847883|NCT01194219|2697103|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
847884|NCT01194219|2697104|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
847885|NCT01194219|2697105|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
847886|NCT01194219|2697106|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
847887|NCT01194219|2697107|P4|Maintenance Phase (Weeks16-32)|Adverse Event|9
847888|NCT01194219|2697108|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
847889|NCT01194219|2697109|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
847890|NCT01194219|2697110|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
847891|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847892|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847893|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847894|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847895|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847896|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
847897|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
847898|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
847899|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847900|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847901|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847902|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847903|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847904|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
847905|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|1
847906|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|7
847907|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847908|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847909|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847910|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847911|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847912|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
847913|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|9
847914|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|7
847915|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Death|0
847916|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Death|0
847917|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Death|0
847918|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Death|0
847919|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Death|0
847920|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Death|0
847921|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Death|1
847922|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Death|0
847923|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847924|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847925|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847926|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847927|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847928|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
847929|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
848004|NCT01194258|2697172|P1|Period 1 (12 Weeks)|Death|0
847930|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|12
847931|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847932|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847933|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847934|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847935|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847936|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847937|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
847938|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|7
847939|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847940|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847941|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847942|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847943|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847944|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
847945|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|7
847946|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
847947|NCT01194219|2697103|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847948|NCT01194219|2697104|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847949|NCT01194219|2697105|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847950|NCT01194219|2697106|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847951|NCT01194219|2697107|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847952|NCT01194219|2697108|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
847953|NCT01194219|2697109|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|5
847954|NCT01194219|2697110|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|23
847955|NCT01194245|2697145|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
847956|NCT01194245|2697146|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
847957|NCT01194245|2697147|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
847958|NCT01194245|2697148|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
847959|NCT01194245|2697149|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
847960|NCT01194245|2697145|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
847961|NCT01194245|2697146|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
847962|NCT01194245|2697147|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
847963|NCT01194245|2697148|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
847964|NCT01194245|2697149|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
847965|NCT01194245|2697145|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
847966|NCT01194245|2697146|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
847967|NCT01194245|2697147|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
847968|NCT01194245|2697148|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
847969|NCT01194245|2697149|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
847970|NCT01194245|2697145|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
847971|NCT01194245|2697146|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
847972|NCT01194245|2697147|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
847973|NCT01194245|2697148|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
847974|NCT01194245|2697149|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
847975|NCT01194245|2697145|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
847976|NCT01194245|2697146|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
847977|NCT01194245|2697147|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
847978|NCT01194245|2697148|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
847979|NCT01194245|2697149|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
847980|NCT01194245|2697145|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
847981|NCT01194245|2697146|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
847982|NCT01194245|2697147|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
847983|NCT01194245|2697148|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
847984|NCT01194245|2697149|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
847985|NCT01194258|2697168|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
847986|NCT01194258|2697169|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
847987|NCT01194258|2697170|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
847988|NCT01194258|2697171|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
847989|NCT01194258|2697172|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
847990|NCT01194258|2697168|P5|Period 2 (12 Weeks)|Adverse Event|0
847991|NCT01194258|2697169|P4|Period 2 (12 Weeks)|Adverse Event|0
847992|NCT01194258|2697170|P3|Period 2 (12 Weeks)|Adverse Event|0
847993|NCT01194258|2697171|P2|Period 2 (12 Weeks)|Adverse Event|1
847994|NCT01194258|2697172|P1|Period 2 (12 Weeks)|Adverse Event|0
847995|NCT01194258|2697168|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
847996|NCT01194258|2697169|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
847997|NCT01194258|2697170|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
847998|NCT01194258|2697171|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
847999|NCT01194258|2697172|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
848000|NCT01194258|2697168|P5|Period 1 (12 Weeks)|Death|1
848001|NCT01194258|2697169|P4|Period 1 (12 Weeks)|Death|0
848002|NCT01194258|2697170|P3|Period 1 (12 Weeks)|Death|0
848003|NCT01194258|2697171|P2|Period 1 (12 Weeks)|Death|0
848005|NCT01194258|2697168|P5|Titration Period|Titration failure|0
848006|NCT01194258|2697169|P4|Titration Period|Titration failure|0
848007|NCT01194258|2697170|P3|Titration Period|Titration failure|0
848008|NCT01194258|2697171|P2|Titration Period|Titration failure|0
848009|NCT01194258|2697172|P1|Titration Period|Titration failure|3
848010|NCT01194258|2697168|P5|Titration Period|Lost to Follow-up|0
848011|NCT01194258|2697169|P4|Titration Period|Lost to Follow-up|0
848012|NCT01194258|2697170|P3|Titration Period|Lost to Follow-up|0
848013|NCT01194258|2697171|P2|Titration Period|Lost to Follow-up|0
848014|NCT01194258|2697172|P1|Titration Period|Lost to Follow-up|2
848015|NCT01194258|2697168|P5|Titration Period|Withdrawal by Subject|0
848016|NCT01194258|2697169|P4|Titration Period|Withdrawal by Subject|0
848017|NCT01194258|2697170|P3|Titration Period|Withdrawal by Subject|0
848018|NCT01194258|2697171|P2|Titration Period|Withdrawal by Subject|0
848019|NCT01194258|2697172|P1|Titration Period|Withdrawal by Subject|6
848020|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Death|2
848021|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Death|0
848022|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Death|2
848023|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Death|1
848024|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
848025|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
848026|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
848027|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
848028|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Adverse Event|12
848029|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Adverse Event|2
848030|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Adverse Event|21
848031|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Adverse Event|35
848032|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Protocol Violation|1
848033|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Protocol Violation|0
848034|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Protocol Violation|0
848035|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Protocol Violation|0
848036|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Other|0
848037|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Other|0
848038|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Other|1
848039|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Other|2
848040|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Pregnancy|1
848041|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Pregnancy|1
848042|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Pregnancy|3
848043|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Pregnancy|1
848044|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
848045|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
848046|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
848047|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
848048|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
848049|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
848050|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
848051|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
848052|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
848053|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
848054|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
848055|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
848056|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
848057|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
848058|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
848059|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
848060|NCT01194414|2697204|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
848061|NCT01194414|2697205|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
848062|NCT01194414|2697206|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
848063|NCT01194414|2697207|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
848064|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Death|0
848065|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Death|0
848066|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Death|1
848067|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Death|0
848068|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
848069|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
848070|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
848071|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
848072|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Adverse Event|0
848073|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Adverse Event|0
848074|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Adverse Event|40
848075|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Adverse Event|28
848076|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Other|0
848077|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Other|0
848078|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Other|1
848079|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Other|0
848080|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
848081|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
848082|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
848083|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
848084|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Pregnancy|0
848085|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Pregnancy|0
848086|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Pregnancy|2
848087|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Pregnancy|2
848088|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
848089|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
848090|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
848091|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
848092|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Protocol Violation|0
848093|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Protocol Violation|0
848094|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Protocol Violation|3
848095|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Protocol Violation|5
848096|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
848097|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
848098|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
848099|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
848100|NCT01194414|2697204|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
848101|NCT01194414|2697205|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
848102|NCT01194414|2697206|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
848103|NCT01194414|2697207|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
848107|NCT01194531|2697315|P2|Overall Study|Physician Decision|2
848108|NCT01194531|2697316|P1|Overall Study|Physician Decision|0
848109|NCT01194531|2697315|P2|Overall Study|Protocol Violation|1
848110|NCT01194531|2697316|P1|Overall Study|Protocol Violation|4
848111|NCT01194531|2697315|P2|Overall Study|Withdrawal by Subject|0
848112|NCT01194531|2697316|P1|Overall Study|Withdrawal by Subject|1
848113|NCT01194830|2697331|P2|Overall Study|Other Reason|8
848114|NCT01194830|2697332|P1|Overall Study|Other Reason|12
848115|NCT01194830|2697331|P2|Overall Study|Non-compliance issues|4
848116|NCT01194830|2697332|P1|Overall Study|Non-compliance issues|4
848117|NCT01194830|2697331|P2|Overall Study|Lack of Efficacy|1
848118|NCT01194830|2697332|P1|Overall Study|Lack of Efficacy|1
848119|NCT01194830|2697331|P2|Overall Study|Withdrawal by Subject|1
848120|NCT01194830|2697332|P1|Overall Study|Withdrawal by Subject|2
848121|NCT01194830|2697331|P2|Overall Study|Lost to Follow-up|7
848122|NCT01194830|2697332|P1|Overall Study|Lost to Follow-up|9
848123|NCT01194830|2697331|P2|Overall Study|Protocol Violation|4
848124|NCT01194830|2697332|P1|Overall Study|Protocol Violation|5
848125|NCT01194830|2697331|P2|Overall Study|Adverse Event|2
848126|NCT01194830|2697332|P1|Overall Study|Adverse Event|3
848127|NCT01194869|2697377|P1|Overall Study|Toxicity|2
848128|NCT01194869|2697377|P1|Overall Study|Disease Progression|2
848129|NCT01194973|2697388|P1|26 Week Treatment Period|Pregnancy|1
848130|NCT01194973|2697388|P1|26 Week Treatment Period|Lack of Efficacy|1
848131|NCT01194973|2697388|P1|26 Week Treatment Period|Adverse Event|1
848132|NCT01194973|2697388|P1|Screening Period|Screen Failure|3
848133|NCT01194999|2697403|P1|Overall Study|Lost to Follow-up|17
848134|NCT01195090|2697420|P2|Overall Study|Protocol Violation|4
848135|NCT01195090|2697421|P1|Overall Study|Protocol Violation|3
848136|NCT01195090|2697420|P2|Overall Study|Lost to Follow-up|2
848137|NCT01195090|2697421|P1|Overall Study|Lost to Follow-up|2
848138|NCT01195090|2697420|P2|Overall Study|Adverse Event|2
848139|NCT01195090|2697421|P1|Overall Study|Adverse Event|1
848140|NCT01195103|2697482|P3|Overall Study|Withdrawal by Subject|0
848141|NCT01195103|2697483|P2|Overall Study|Withdrawal by Subject|0
848142|NCT01195103|2697484|P1|Overall Study|Withdrawal by Subject|1
848143|NCT01195272|2697501|P1|Overall Study|Lack of Efficacy|3
848144|NCT01195272|2697501|P1|Overall Study|Adverse Event|1
848145|NCT01195363|2697520|P2|Overall Study|incarceration|0
848146|NCT01195363|2697521|P1|Overall Study|incarceration|1
848147|NCT01195363|2697520|P2|Overall Study|Lack of Efficacy|4
848148|NCT01195363|2697521|P1|Overall Study|Lack of Efficacy|0
848149|NCT01195363|2697520|P2|Overall Study|Adverse Event|1
848150|NCT01195363|2697521|P1|Overall Study|Adverse Event|3
848151|NCT01195363|2697520|P2|Overall Study|Lost to Follow-up|4
848152|NCT01195363|2697521|P1|Overall Study|Lost to Follow-up|7
848153|NCT01195415|2697527|P1|Overall Study|No repeat biopsy due to progression|2
848154|NCT01195623|2697562|P2|Overall Study|Lost to Follow-up|37
848155|NCT01195623|2697563|P1|Overall Study|Lost to Follow-up|35
848156|NCT01195636|2697573|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
848157|NCT01195636|2697574|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
848158|NCT01195636|2697573|P2|Second Intervention (3 Weeks)|Adverse Event|1
848159|NCT01195636|2697574|P1|Second Intervention (3 Weeks)|Adverse Event|1
848160|NCT01195636|2697573|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
848161|NCT01195636|2697574|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
848162|NCT01195636|2697573|P2|Washout Period (2 Weeks)|Adverse Event|1
848163|NCT01195636|2697574|P1|Washout Period (2 Weeks)|Adverse Event|1
848164|NCT01195636|2697573|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
848165|NCT01195636|2697574|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
848166|NCT01195636|2697573|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
848167|NCT01195636|2697574|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
848168|NCT01195636|2697573|P2|First Intervention (3 Weeks)|Protocol Violation|0
848169|NCT01195636|2697574|P1|First Intervention (3 Weeks)|Protocol Violation|1
848170|NCT01195636|2697573|P2|First Intervention (3 Weeks)|Adverse Event|3
848171|NCT01195636|2697574|P1|First Intervention (3 Weeks)|Adverse Event|2
848172|NCT01195662|2697601|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
848173|NCT01195662|2697602|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
848174|NCT01195662|2697603|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
848175|NCT01195662|2697601|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
848176|NCT01195662|2697602|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
848177|NCT01195662|2697603|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
848178|NCT01195662|2697601|P3|Double Blind Treatment Period|Missing disposition information|1
848179|NCT01195662|2697602|P2|Double Blind Treatment Period|Missing disposition information|1
848180|NCT01195662|2697603|P1|Double Blind Treatment Period|Missing disposition information|0
848181|NCT01195662|2697601|P3|Double Blind Treatment Period|Non-specified|0
848182|NCT01195662|2697602|P2|Double Blind Treatment Period|Non-specified|0
848183|NCT01195662|2697603|P1|Double Blind Treatment Period|Non-specified|3
848184|NCT01195662|2697601|P3|Double Blind Treatment Period|Lack of Efficacy|0
848185|NCT01195662|2697602|P2|Double Blind Treatment Period|Lack of Efficacy|0
848186|NCT01195662|2697603|P1|Double Blind Treatment Period|Lack of Efficacy|2
848187|NCT01195662|2697601|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
848188|NCT01195662|2697602|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
848189|NCT01195662|2697603|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
848190|NCT01195662|2697601|P3|Double Blind Treatment Period|Requested discontinue treatment|1
848191|NCT01195662|2697602|P2|Double Blind Treatment Period|Requested discontinue treatment|0
848192|NCT01195662|2697603|P1|Double Blind Treatment Period|Requested discontinue treatment|1
848193|NCT01195662|2697601|P3|Double Blind Treatment Period|Administrative reason|1
848194|NCT01195662|2697602|P2|Double Blind Treatment Period|Administrative reason|1
848195|NCT01195662|2697603|P1|Double Blind Treatment Period|Administrative reason|2
848196|NCT01195662|2697601|P3|Double Blind Treatment Period|Lost to Follow-up|3
848197|NCT01195662|2697602|P2|Double Blind Treatment Period|Lost to Follow-up|2
848198|NCT01195662|2697603|P1|Double Blind Treatment Period|Lost to Follow-up|3
848199|NCT01195662|2697601|P3|Double Blind Treatment Period|Withdrawal by Subject|4
848200|NCT01195662|2697602|P2|Double Blind Treatment Period|Withdrawal by Subject|4
848201|NCT01195662|2697603|P1|Double Blind Treatment Period|Withdrawal by Subject|6
848202|NCT01195662|2697601|P3|Double Blind Treatment Period|Adverse Event|2
848203|NCT01195662|2697602|P2|Double Blind Treatment Period|Adverse Event|1
848204|NCT01195662|2697603|P1|Double Blind Treatment Period|Adverse Event|4
848205|NCT01195675|2697631|P1|Overall Study|Withdrawal by Subject|2
848206|NCT01195675|2697631|P1|Overall Study|Adverse Event|1
848207|NCT01195831|2697889|P2|Overall Study|Protocol Violation|2
848208|NCT01195831|2697890|P1|Overall Study|Protocol Violation|0
848209|NCT01195831|2697889|P2|Overall Study|Adverse Event|2
848210|NCT01195831|2697890|P1|Overall Study|Adverse Event|4
848211|NCT01195831|2697889|P2|Overall Study|Withdrawal by Subject|2
848212|NCT01195831|2697890|P1|Overall Study|Withdrawal by Subject|2
848213|NCT01195831|2697889|P2|Overall Study|Lost to Follow-up|4
848214|NCT01195831|2697890|P1|Overall Study|Lost to Follow-up|2
848215|NCT01195844|2697904|P1|Overall Study|Fecal sample not collected|40
848216|NCT01195948|2697928|P3|Overall Study|Lost to Follow-up|2
848217|NCT01195948|2697929|P2|Overall Study|Lost to Follow-up|1
848218|NCT01195948|2697930|P1|Overall Study|Lost to Follow-up|0
848219|NCT01196026|2697962|P6|Overall Study|Unspecified|0
848220|NCT01196026|2697963|P5|Overall Study|Unspecified|0
848221|NCT01196026|2697964|P4|Overall Study|Unspecified|0
848222|NCT01196026|2697965|P3|Overall Study|Unspecified|0
848223|NCT01196026|2697966|P2|Overall Study|Unspecified|1
848224|NCT01196026|2697967|P1|Overall Study|Unspecified|0
848225|NCT01196026|2697962|P6|Overall Study|Lost to Follow-up|0
848226|NCT01196026|2697963|P5|Overall Study|Lost to Follow-up|1
848227|NCT01196026|2697964|P4|Overall Study|Lost to Follow-up|0
848228|NCT01196026|2697965|P3|Overall Study|Lost to Follow-up|0
848229|NCT01196026|2697966|P2|Overall Study|Lost to Follow-up|3
848230|NCT01196026|2697967|P1|Overall Study|Lost to Follow-up|0
848231|NCT01196026|2697962|P6|Overall Study|Withdrawal by Subject|0
848232|NCT01196026|2697963|P5|Overall Study|Withdrawal by Subject|0
848233|NCT01196026|2697964|P4|Overall Study|Withdrawal by Subject|0
848234|NCT01196026|2697965|P3|Overall Study|Withdrawal by Subject|0
848235|NCT01196026|2697966|P2|Overall Study|Withdrawal by Subject|4
848236|NCT01196026|2697967|P1|Overall Study|Withdrawal by Subject|1
848237|NCT01196052|2698200|P1|Overall Study|Withdrawal by Subject|6
848238|NCT01196052|2698200|P1|Overall Study|Reason not Specified|5
848239|NCT01196052|2698200|P1|Overall Study|Noncompliance to Protocol Requirements|2
848240|NCT01196052|2698200|P1|Overall Study|Lost to Follow-up|1
848241|NCT01196052|2698200|P1|Overall Study|Adverse Event|9
848242|NCT01196078|2698213|P2|Overall Study|Death|4
848243|NCT01196078|2698214|P1|Overall Study|Death|6
848244|NCT01196078|2698213|P2|Overall Study|Lost to Follow-up|0
848245|NCT01196078|2698214|P1|Overall Study|Lost to Follow-up|1
848246|NCT01196078|2698213|P2|Overall Study|Lack of Efficacy|23
848247|NCT01196078|2698214|P1|Overall Study|Lack of Efficacy|17
848248|NCT01196078|2698213|P2|Overall Study|Protocol Violation|1
848249|NCT01196078|2698214|P1|Overall Study|Protocol Violation|2
848250|NCT01196078|2698213|P2|Overall Study|Adverse Event|4
848251|NCT01196078|2698214|P1|Overall Study|Adverse Event|4
848252|NCT01196078|2698213|P2|Overall Study|Withdrawal by Subject|5
848253|NCT01196078|2698214|P1|Overall Study|Withdrawal by Subject|3
848254|NCT01196104|2698244|P2|Overall Study|Various|1
848255|NCT01196104|2698245|P1|Overall Study|Various|0
848256|NCT01196104|2698244|P2|Overall Study|Withdrawal by Subject|3
848257|NCT01196104|2698245|P1|Overall Study|Withdrawal by Subject|3
848258|NCT01196104|2698244|P2|Overall Study|Physician Decision|1
848259|NCT01196104|2698245|P1|Overall Study|Physician Decision|0
848260|NCT01196104|2698244|P2|Overall Study|Lost to Follow-up|0
848261|NCT01196104|2698245|P1|Overall Study|Lost to Follow-up|1
848262|NCT01196429|2698304|P2|Overall Study|Refused – Never Treated|0
848263|NCT01196429|2698305|P1|Overall Study|Refused – Never Treated|1
848264|NCT01196429|2698304|P2|Overall Study|Ineligible - wrong cell type|0
848265|NCT01196429|2698305|P1|Overall Study|Ineligible - wrong cell type|1
848266|NCT01196429|2698304|P2|Overall Study|Ineligible - inadequate pathology|0
848267|NCT01196429|2698305|P1|Overall Study|Ineligible - inadequate pathology|1
848268|NCT01188655|2698339|P1|Overall Study|Unspecified|11
848269|NCT01188655|2698339|P1|Overall Study|Lost to Follow-up|1
848270|NCT01188655|2698339|P1|Overall Study|Lack of Efficacy|1
848271|NCT01188668|2698354|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
848272|NCT01188668|2698354|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
848273|NCT01188668|2698354|P1|Period 1: ARIP Alone|Protocol Violation|2
848274|NCT01188681|2698391|P4|Overall Study|Withdrawal by Subject|1
848275|NCT01188681|2698392|P3|Overall Study|Withdrawal by Subject|0
848276|NCT01188681|2698393|P2|Overall Study|Withdrawal by Subject|0
848277|NCT01188681|2698394|P1|Overall Study|Withdrawal by Subject|0
848278|NCT01188681|2698391|P4|Overall Study|bladder cancer|0
848279|NCT01188681|2698392|P3|Overall Study|bladder cancer|1
848280|NCT01188681|2698393|P2|Overall Study|bladder cancer|0
848281|NCT01188681|2698394|P1|Overall Study|bladder cancer|0
848282|NCT01188772|2698425|P4|Overall Study|Withdrawal by Subject|0
848283|NCT01188772|2698426|P3|Overall Study|Withdrawal by Subject|2
848284|NCT01188772|2698427|P2|Overall Study|Withdrawal by Subject|0
848285|NCT01188772|2698428|P1|Overall Study|Withdrawal by Subject|0
848286|NCT01188772|2698425|P4|Overall Study|Virologic Failure|0
848287|NCT01188772|2698426|P3|Overall Study|Virologic Failure|0
848288|NCT01188772|2698427|P2|Overall Study|Virologic Failure|0
848289|NCT01188772|2698428|P1|Overall Study|Virologic Failure|1
848290|NCT01188772|2698425|P4|Overall Study|Treatment Failure|0
848291|NCT01188772|2698426|P3|Overall Study|Treatment Failure|1
848292|NCT01188772|2698427|P2|Overall Study|Treatment Failure|0
848293|NCT01188772|2698428|P1|Overall Study|Treatment Failure|0
848294|NCT01188772|2698425|P4|Overall Study|Terminated by Sponsor|0
848295|NCT01188772|2698426|P3|Overall Study|Terminated by Sponsor|1
848296|NCT01188772|2698427|P2|Overall Study|Terminated by Sponsor|0
848297|NCT01188772|2698428|P1|Overall Study|Terminated by Sponsor|0
848298|NCT01188772|2698425|P4|Overall Study|Physician Decision|0
848299|NCT01188772|2698426|P3|Overall Study|Physician Decision|1
848300|NCT01188772|2698427|P2|Overall Study|Physician Decision|0
848301|NCT01188772|2698428|P1|Overall Study|Physician Decision|0
848302|NCT01188772|2698425|P4|Overall Study|Non-responder|0
848303|NCT01188772|2698426|P3|Overall Study|Non-responder|3
848304|NCT01188772|2698427|P2|Overall Study|Non-responder|0
848305|NCT01188772|2698428|P1|Overall Study|Non-responder|0
848306|NCT01188772|2698425|P4|Overall Study|Lost to Follow-up|1
848307|NCT01188772|2698426|P3|Overall Study|Lost to Follow-up|1
848308|NCT01188772|2698427|P2|Overall Study|Lost to Follow-up|1
848309|NCT01188772|2698428|P1|Overall Study|Lost to Follow-up|4
848310|NCT01188772|2698425|P4|Overall Study|Adverse Event|0
848311|NCT01188772|2698426|P3|Overall Study|Adverse Event|2
848312|NCT01188772|2698427|P2|Overall Study|Adverse Event|1
848313|NCT01188772|2698428|P1|Overall Study|Adverse Event|0
848314|NCT01188772|2698425|P4|Overall Study|Randomized but Not Treated|0
848315|NCT01188772|2698426|P3|Overall Study|Randomized but Not Treated|0
848316|NCT01188772|2698427|P2|Overall Study|Randomized but Not Treated|1
848317|NCT01188772|2698428|P1|Overall Study|Randomized but Not Treated|0
848318|NCT01188798|2698485|P2|Overall Study|Protocol closure|1
848319|NCT01188798|2698486|P1|Overall Study|Protocol closure|1
848320|NCT01188798|2698485|P2|Overall Study|Required additional transplant|1
848321|NCT01188798|2698486|P1|Overall Study|Required additional transplant|1
848322|NCT01188798|2698485|P2|Overall Study|Death|1
848323|NCT01188798|2698486|P1|Overall Study|Death|0
848324|NCT01188811|2698496|P2|Overall Study|Adverse Event|0
848325|NCT01188811|2698497|P1|Overall Study|Adverse Event|6
848326|NCT01188811|2698496|P2|Overall Study|Withdrawal by Subject|2
848327|NCT01188811|2698497|P1|Overall Study|Withdrawal by Subject|0
848328|NCT01188967|2698538|P2|Overall Study|Lost to Follow-up|2
848329|NCT01188967|2698539|P1|Overall Study|Lost to Follow-up|3
848330|NCT01188967|2698538|P2|Overall Study|Physician Decision|1
848331|NCT01188967|2698539|P1|Overall Study|Physician Decision|1
848332|NCT01188967|2698538|P2|Overall Study|Withdrawal by Subject|1
848333|NCT01188967|2698539|P1|Overall Study|Withdrawal by Subject|1
848334|NCT01189032|2698554|P3|Overall Study|Protocol Violation|1
848335|NCT01189032|2698555|P2|Overall Study|Protocol Violation|1
848336|NCT01189032|2698556|P1|Overall Study|Protocol Violation|1
848337|NCT01189032|2698554|P3|Overall Study|Withdrawal by Subject|1
848338|NCT01189032|2698555|P2|Overall Study|Withdrawal by Subject|0
848339|NCT01189032|2698556|P1|Overall Study|Withdrawal by Subject|1
848340|NCT01189032|2698554|P3|Overall Study|Lack of Efficacy|0
848341|NCT01189032|2698555|P2|Overall Study|Lack of Efficacy|3
848342|NCT01189032|2698556|P1|Overall Study|Lack of Efficacy|2
848343|NCT01189032|2698554|P3|Overall Study|Adverse Event|4
848344|NCT01189032|2698555|P2|Overall Study|Adverse Event|3
848345|NCT01189032|2698556|P1|Overall Study|Adverse Event|1
848346|NCT01189201|2698610|P1|Overall Study|Adverse Event|1
848347|NCT01189227|2698666|P2|Overall Study|Study terminated due to low accrual|3
848348|NCT01189227|2698667|P1|Overall Study|Study terminated due to low accrual|6
848349|NCT01189435|2698749|P1|Overall Study|Physician Decision|1
848350|NCT01189435|2698749|P1|Overall Study|Withdrawal by Subject|1
848351|NCT01189461|2698753|P1|Overall Study|Unspecified|8
848352|NCT01189461|2698753|P1|Overall Study|Did not meet entrance criteria|3
848353|NCT01189461|2698753|P1|Overall Study|Adverse Event|2
848354|NCT01189461|2698753|P1|Overall Study|Protocol Violation|1
848355|NCT01189461|2698753|P1|Overall Study|Withdrawal by Subject|6
848356|NCT01189461|2698753|P1|Overall Study|Lost to Follow-up|1
848357|NCT01189461|2698753|P1|Overall Study|Lack of Efficacy|13
848358|NCT01189487|2698760|P1|Overall Study|Adverse Event|1
848359|NCT01189487|2698760|P1|Overall Study|Lack of Efficacy|2
848360|NCT01189500|2698768|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
848361|NCT01189500|2698768|P1|Period 1: TAMOX Alone|Adverse Event|1
848362|NCT01189604|2698836|P7|Overall Study|Withdrawal by Subject|0
848363|NCT01189604|2698837|P6|Overall Study|Withdrawal by Subject|0
848364|NCT01189604|2698838|P5|Overall Study|Withdrawal by Subject|0
848365|NCT01189604|2698839|P4|Overall Study|Withdrawal by Subject|0
848366|NCT01189604|2698840|P3|Overall Study|Withdrawal by Subject|0
848367|NCT01189604|2698841|P2|Overall Study|Withdrawal by Subject|0
848368|NCT01189604|2698842|P1|Overall Study|Withdrawal by Subject|1
848369|NCT01189604|2698836|P7|Overall Study|Adverse Event|1
848370|NCT01189604|2698837|P6|Overall Study|Adverse Event|0
848371|NCT01189604|2698838|P5|Overall Study|Adverse Event|2
848372|NCT01189604|2698839|P4|Overall Study|Adverse Event|0
848373|NCT01189604|2698840|P3|Overall Study|Adverse Event|0
848374|NCT01189604|2698841|P2|Overall Study|Adverse Event|1
848375|NCT01189604|2698842|P1|Overall Study|Adverse Event|0
848376|NCT01189604|2698836|P7|Overall Study|Impossible to visit|0
848377|NCT01189604|2698837|P6|Overall Study|Impossible to visit|1
848378|NCT01189604|2698838|P5|Overall Study|Impossible to visit|0
848379|NCT01189604|2698839|P4|Overall Study|Impossible to visit|0
848380|NCT01189604|2698840|P3|Overall Study|Impossible to visit|0
848381|NCT01189604|2698841|P2|Overall Study|Impossible to visit|0
848382|NCT01189604|2698842|P1|Overall Study|Impossible to visit|0
848383|NCT01189812|2698959|P2|Overall Study|Moved out of State|2
848384|NCT01189812|2698960|P1|Overall Study|Moved out of State|1
848385|NCT01189812|2698959|P2|Overall Study|Out of Window|3
848386|NCT01189812|2698960|P1|Overall Study|Out of Window|4
848387|NCT01189812|2698959|P2|Overall Study|Adverse Event|0
848388|NCT01189812|2698960|P1|Overall Study|Adverse Event|1
848389|NCT01189812|2698959|P2|Overall Study|Withdrawal by Subject|3
848390|NCT01189812|2698960|P1|Overall Study|Withdrawal by Subject|2
848391|NCT01189890|2698968|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
848392|NCT01189890|2698969|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
848393|NCT01189890|2698968|P2|Overall Study|Physician Decision|4
848394|NCT01189890|2698969|P1|Overall Study|Physician Decision|5
848395|NCT01189890|2698968|P2|Overall Study|Non Compliance|1
848396|NCT01189890|2698969|P1|Overall Study|Non Compliance|0
848397|NCT01189890|2698968|P2|Overall Study|Withdrawal by Subject|11
848398|NCT01189890|2698969|P1|Overall Study|Withdrawal by Subject|15
848399|NCT01189890|2698968|P2|Overall Study|Protocol Violation|5
848400|NCT01189890|2698969|P1|Overall Study|Protocol Violation|1
848401|NCT01189890|2698968|P2|Overall Study|Lost to Follow-up|7
848402|NCT01189890|2698969|P1|Overall Study|Lost to Follow-up|1
848403|NCT01189890|2698968|P2|Overall Study|Lack of Efficacy|2
848404|NCT01189890|2698969|P1|Overall Study|Lack of Efficacy|7
848405|NCT01189890|2698968|P2|Overall Study|Adverse Event|4
848406|NCT01189890|2698969|P1|Overall Study|Adverse Event|3
848407|NCT01190007|2698989|P1|Overall Study|Participant was arrested|1
848408|NCT01190007|2698989|P1|Overall Study|Difficulty of visit for complications|1
848409|NCT01190007|2698989|P1|Overall Study|Adverse Event|8
848410|NCT01190007|2698989|P1|Overall Study|Withdrawal by Subject|4
848411|NCT01190098|2699025|P2|Overall Study|Other|1
848412|NCT01190098|2699026|P1|Overall Study|Other|0
848413|NCT01190098|2699025|P2|Overall Study|Lack of transportation|0
848414|NCT01190098|2699026|P1|Overall Study|Lack of transportation|1
848415|NCT01190098|2699025|P2|Overall Study|Patient coomorbidity|1
848416|NCT01190098|2699026|P1|Overall Study|Patient coomorbidity|0
848417|NCT01190098|2699025|P2|Overall Study|Adverse Event|0
848418|NCT01190098|2699026|P1|Overall Study|Adverse Event|2
848419|NCT01190124|2699049|P3|Overall Study|Lost to Follow-up|0
848420|NCT01190124|2699050|P2|Overall Study|Lost to Follow-up|0
848421|NCT01190124|2699051|P1|Overall Study|Lost to Follow-up|2
848422|NCT01190124|2699049|P3|Overall Study|Therapeutic Failure|1
848423|NCT01190124|2699050|P2|Overall Study|Therapeutic Failure|0
848424|NCT01190124|2699051|P1|Overall Study|Therapeutic Failure|12
848425|NCT01190124|2699049|P3|Overall Study|Death|0
848426|NCT01190124|2699050|P2|Overall Study|Death|0
848427|NCT01190124|2699051|P1|Overall Study|Death|3
848428|NCT01190150|2699089|P2|Washout|Difficulty in adherence|1
848429|NCT01190150|2699090|P1|Washout|Difficulty in adherence|0
848430|NCT01190150|2699089|P2|Washout|Withdrawal by Subject|1
848431|NCT01190150|2699090|P1|Washout|Withdrawal by Subject|0
848432|NCT01190150|2699089|P2|First Treatment|Withdrawal by Subject|0
848433|NCT01190150|2699090|P1|First Treatment|Withdrawal by Subject|1
848434|NCT01190215|2699116|P2|Up to Month 6|Lost to Follow-up|0
848435|NCT01190215|2699117|P1|Up to Month 6|Lost to Follow-up|2
848436|NCT01196741|2699187|P2|Overall Study|Protocol Violation|1
848437|NCT01196741|2699188|P1|Overall Study|Protocol Violation|2
848438|NCT01196741|2699187|P2|Overall Study|Other|2
848439|NCT01196741|2699188|P1|Overall Study|Other|3
848440|NCT01196741|2699187|P2|Overall Study|Other reason|3
848441|NCT01196741|2699188|P1|Overall Study|Other reason|3
848442|NCT01196741|2699187|P2|Overall Study|Withdrawal by Subject|0
848443|NCT01196741|2699188|P1|Overall Study|Withdrawal by Subject|3
848444|NCT01196741|2699187|P2|Overall Study|Dose limiting Adverse Event|1
848445|NCT01196741|2699188|P1|Overall Study|Dose limiting Adverse Event|2
848446|NCT01196741|2699187|P2|Overall Study|Serious Adverse Event|1
848447|NCT01196741|2699188|P1|Overall Study|Serious Adverse Event|3
848448|NCT01196741|2699187|P2|Overall Study|Adverse Event|6
848449|NCT01196741|2699188|P1|Overall Study|Adverse Event|10
848450|NCT01196741|2699187|P2|Overall Study|Disease progression|14
848451|NCT01196741|2699188|P1|Overall Study|Disease progression|34
848452|NCT01196975|2699211|P5|Overall Study|Lost to Follow-up|11
848453|NCT01196975|2699212|P4|Overall Study|Lost to Follow-up|5
848454|NCT01196975|2699213|P3|Overall Study|Lost to Follow-up|5
848455|NCT01196975|2699214|P2|Overall Study|Lost to Follow-up|6
848456|NCT01196975|2699215|P1|Overall Study|Lost to Follow-up|11
848457|NCT01196975|2699211|P5|Overall Study|Withdrawal by Subject|0
848458|NCT01196975|2699212|P4|Overall Study|Withdrawal by Subject|1
848459|NCT01196975|2699213|P3|Overall Study|Withdrawal by Subject|0
848460|NCT01196975|2699214|P2|Overall Study|Withdrawal by Subject|1
848461|NCT01196975|2699215|P1|Overall Study|Withdrawal by Subject|2
848462|NCT01196975|2699211|P5|Overall Study|Adverse Event|2
848463|NCT01196975|2699212|P4|Overall Study|Adverse Event|0
848464|NCT01196975|2699213|P3|Overall Study|Adverse Event|0
848465|NCT01196975|2699214|P2|Overall Study|Adverse Event|2
848466|NCT01196975|2699215|P1|Overall Study|Adverse Event|2
848467|NCT01196988|2699351|P4|Overall Study|Unspecified|0
848468|NCT01196988|2699352|P3|Overall Study|Unspecified|0
848469|NCT01196988|2699353|P2|Overall Study|Unspecified|0
848470|NCT01196988|2699354|P1|Overall Study|Unspecified|2
848471|NCT01196988|2699351|P4|Overall Study|Lost to Follow-up|1
848472|NCT01196988|2699352|P3|Overall Study|Lost to Follow-up|21
848473|NCT01196988|2699353|P2|Overall Study|Lost to Follow-up|29
848474|NCT01196988|2699354|P1|Overall Study|Lost to Follow-up|16
848475|NCT01196988|2699351|P4|Overall Study|Withdrawal by Subject|0
848476|NCT01196988|2699352|P3|Overall Study|Withdrawal by Subject|4
848477|NCT01196988|2699353|P2|Overall Study|Withdrawal by Subject|1
848478|NCT01196988|2699354|P1|Overall Study|Withdrawal by Subject|5
848479|NCT01196988|2699351|P4|Overall Study|Adverse Event|0
848480|NCT01196988|2699352|P3|Overall Study|Adverse Event|0
848481|NCT01196988|2699353|P2|Overall Study|Adverse Event|2
848482|NCT01196988|2699354|P1|Overall Study|Adverse Event|1
848483|NCT01197911|2699455|P3|Overall Study|Adverse Event|1
848484|NCT01197911|2699456|P2|Overall Study|Adverse Event|0
848485|NCT01197911|2699457|P1|Overall Study|Adverse Event|0
848486|NCT01198145|2699542|P2|Overall Study|Withdrawal by Subject|1
848487|NCT01198145|2699543|P1|Overall Study|Withdrawal by Subject|1
848488|NCT01198275|2699565|P2|Overall Study|spontaneous return to sinus rhythm|2
848489|NCT01198275|2699566|P1|Overall Study|spontaneous return to sinus rhythm|4
848490|NCT01198275|2699565|P2|Overall Study|Adverse Event|3
848491|NCT01198275|2699566|P1|Overall Study|Adverse Event|2
848492|NCT01198509|2699635|P6|Overall Study|Withdrawal by Subject|0
848493|NCT01198509|2699636|P5|Overall Study|Withdrawal by Subject|0
848494|NCT01198509|2699637|P4|Overall Study|Withdrawal by Subject|0
848495|NCT01198509|2699638|P3|Overall Study|Withdrawal by Subject|0
848496|NCT01198509|2699639|P2|Overall Study|Withdrawal by Subject|0
848497|NCT01198509|2699640|P1|Overall Study|Withdrawal by Subject|1
848498|NCT01198548|2699657|P1|Overall Study|Administrative Decision|1
848499|NCT01198548|2699657|P1|Overall Study|Disease Progression|9
848500|NCT01198574|2699670|P4|Overall Study|Resigned from schools|4
848501|NCT01198574|2699671|P3|Overall Study|Resigned from schools|1
848502|NCT01198574|2699672|P2|Overall Study|Resigned from schools|1
848503|NCT01198574|2699673|P1|Overall Study|Resigned from schools|4
848504|NCT01198600|2699691|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
848505|NCT01198600|2699692|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
848506|NCT01198600|2699693|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
848507|NCT01198600|2699694|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
848508|NCT01198600|2699691|P4|Phase 2: 56 Days of Wear|Relocation|0
848509|NCT01198600|2699692|P3|Phase 2: 56 Days of Wear|Relocation|2
848510|NCT01198600|2699693|P2|Phase 2: 56 Days of Wear|Relocation|0
848511|NCT01198600|2699694|P1|Phase 2: 56 Days of Wear|Relocation|0
848512|NCT01198600|2699691|P4|Phase 2: 56 Days of Wear|Inconvenience|0
848513|NCT01198600|2699692|P3|Phase 2: 56 Days of Wear|Inconvenience|2
848514|NCT01198600|2699693|P2|Phase 2: 56 Days of Wear|Inconvenience|0
848515|NCT01198600|2699694|P1|Phase 2: 56 Days of Wear|Inconvenience|0
848516|NCT01198600|2699691|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
848517|NCT01198600|2699692|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
848518|NCT01198600|2699693|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
848519|NCT01198600|2699694|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
848520|NCT01198600|2699691|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
848521|NCT01198600|2699692|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
848522|NCT01198600|2699693|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
848523|NCT01198600|2699694|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
848524|NCT01198600|2699691|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
848525|NCT01198600|2699692|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
848526|NCT01198600|2699693|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
848527|NCT01198600|2699694|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
848528|NCT01198600|2699691|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
848529|NCT01198600|2699692|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
848530|NCT01198600|2699693|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
848531|NCT01198600|2699694|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
848532|NCT01198756|2699735|P4|Overall Study|Lost to Follow-up|18
848533|NCT01198756|2699736|P3|Overall Study|Lost to Follow-up|23
848534|NCT01198756|2699737|P2|Overall Study|Lost to Follow-up|36
848535|NCT01198756|2699738|P1|Overall Study|Lost to Follow-up|29
848536|NCT01198756|2699735|P4|Overall Study|Withdrawal by Subject|5
848537|NCT01198756|2699736|P3|Overall Study|Withdrawal by Subject|7
848538|NCT01198756|2699737|P2|Overall Study|Withdrawal by Subject|4
848539|NCT01198756|2699738|P1|Overall Study|Withdrawal by Subject|9
848540|NCT01198756|2699735|P4|Overall Study|Protocol Violation|2
848541|NCT01198756|2699736|P3|Overall Study|Protocol Violation|0
848542|NCT01198756|2699737|P2|Overall Study|Protocol Violation|0
848543|NCT01198756|2699738|P1|Overall Study|Protocol Violation|0
848544|NCT01198756|2699735|P4|Overall Study|Adverse Event|1
848545|NCT01198756|2699736|P3|Overall Study|Adverse Event|0
848546|NCT01198756|2699737|P2|Overall Study|Adverse Event|0
848547|NCT01198756|2699738|P1|Overall Study|Adverse Event|0
848548|NCT01198795|2699843|P1|Overall Study|Other Reason|4
848549|NCT01198795|2699843|P1|Overall Study|Protocol Violation|2
848550|NCT01198795|2699843|P1|Overall Study|Lack of Efficacy|5
848551|NCT01198795|2699843|P1|Overall Study|Adverse Event|9
848552|NCT01198795|2699843|P1|Overall Study|Lost to Follow-up|15
848553|NCT01198795|2699843|P1|Overall Study|Withdrawal by Subject|17
848554|NCT01198795|2699843|P1|Overall Study|Did not meet InclusionExclusion criteria|30
848555|NCT01198873|2699849|P2|Overall Study|Other than above|2
848556|NCT01198873|2699850|P1|Overall Study|Other than above|4
848557|NCT01198873|2699849|P2|Overall Study|Study closure|23
848558|NCT01198873|2699850|P1|Overall Study|Study closure|29
848559|NCT01198873|2699849|P2|Overall Study|Adverse Event|7
848560|NCT01198873|2699850|P1|Overall Study|Adverse Event|4
848561|NCT01198977|2699866|P2|Overall Study|Lost to Follow-up|0
848562|NCT01198977|2699867|P1|Overall Study|Lost to Follow-up|1
848563|NCT01199016|2699877|P1|Overall Study|Lost to Follow-up|25
848564|NCT01199016|2699877|P1|Overall Study|Withdrawal by Subject|21
848565|NCT01199016|2699877|P1|Overall Study|Other|13
848566|NCT01199016|2699877|P1|Overall Study|Protocol Violation|9
848567|NCT01199016|2699877|P1|Overall Study|Entrance criteria|5
848568|NCT01199016|2699877|P1|Overall Study|No longer meets eligibility criteria|4
848569|NCT01199042|2699884|P1|At Home (3 Months)|Lost to Follow-up|1
848570|NCT01199042|2699884|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
848571|NCT01199471|2699910|P1|Overall Study|Physician Decision|1
848572|NCT01199471|2699910|P1|Overall Study|Withdrawal by Subject|1
848573|NCT01199471|2699910|P1|Overall Study|Protocol Violation|4
848574|NCT01199601|2699921|P2|Overall Study|Insecurity prevented staff interviewing.|9
848575|NCT01199601|2699922|P1|Overall Study|Insecurity prevented staff interviewing.|7
848576|NCT01199601|2699921|P2|Overall Study|Withdrawal by Subject|3
848577|NCT01199601|2699922|P1|Overall Study|Withdrawal by Subject|15
848578|NCT01199601|2699921|P2|Overall Study|Lost to Follow-up|66
848579|NCT01199601|2699922|P1|Overall Study|Lost to Follow-up|47
848580|NCT01199705|2699932|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
848581|NCT01199822|2699978|P3|Overall Study|Investigator discontinued therapy|0
848582|NCT01199822|2699979|P2|Overall Study|Investigator discontinued therapy|1
848583|NCT01199822|2699980|P1|Overall Study|Investigator discontinued therapy|0
848584|NCT01199861|2700015|P2|Overall Study|Adverse Event|0
848585|NCT01199861|2700016|P1|Overall Study|Adverse Event|1
848586|NCT01199861|2700015|P2|Overall Study|Administrative problems|0
848587|NCT01199861|2700016|P1|Overall Study|Administrative problems|1
848588|NCT01199939|2700047|P1|Overall Study|Reached a virologic endpoint|4
848589|NCT01199939|2700047|P1|Overall Study|Lost to Follow-up|2
848590|NCT01199939|2700047|P1|Overall Study|Protocol Violation|3
848591|NCT01199939|2700047|P1|Overall Study|Adverse Event|4
848592|NCT01200069|2700083|P2|Overall Study|Withdrawal by Subject|1
848593|NCT01200069|2700084|P1|Overall Study|Withdrawal by Subject|0
848594|NCT01200342|2700140|P1|Overall Study|Disease Progression|1
848597|NCT01200368|2700165|P3|Toddler Dose|Adverse Event|1
848598|NCT01200368|2700166|P2|Toddler Dose|Adverse Event|3
848599|NCT01200368|2700167|P1|Toddler Dose|Adverse Event|0
848600|NCT01200368|2700165|P3|After Infant Series|Unspecified|2
848601|NCT01200368|2700166|P2|After Infant Series|Unspecified|2
848602|NCT01200368|2700167|P1|After Infant Series|Unspecified|1
848603|NCT01200368|2700165|P3|After Infant Series|Lost to Follow-up|0
848604|NCT01200368|2700166|P2|After Infant Series|Lost to Follow-up|0
848605|NCT01200368|2700167|P1|After Infant Series|Lost to Follow-up|1
848606|NCT01200368|2700165|P3|After Infant Series|Withdrawal by Subject|4
848607|NCT01200368|2700166|P2|After Infant Series|Withdrawal by Subject|8
848608|NCT01200368|2700167|P1|After Infant Series|Withdrawal by Subject|10
848609|NCT01200368|2700165|P3|After Infant Series|Adverse Event|3
848610|NCT01200368|2700166|P2|After Infant Series|Adverse Event|6
848611|NCT01200368|2700167|P1|After Infant Series|Adverse Event|6
848612|NCT01200368|2700165|P3|Infant Series|Unspecified|0
848613|NCT01200368|2700166|P2|Infant Series|Unspecified|0
848614|NCT01200368|2700167|P1|Infant Series|Unspecified|1
848615|NCT01200368|2700165|P3|Infant Series|Randomized, not vaccinated|1
848616|NCT01200368|2700166|P2|Infant Series|Randomized, not vaccinated|1
848617|NCT01200368|2700167|P1|Infant Series|Randomized, not vaccinated|0
848618|NCT01200368|2700165|P3|Infant Series|Did not meet entrance criteria|0
848619|NCT01200368|2700166|P2|Infant Series|Did not meet entrance criteria|1
848620|NCT01200368|2700167|P1|Infant Series|Did not meet entrance criteria|0
848621|NCT01200368|2700165|P3|Infant Series|Withdrawal by Subject|2
848622|NCT01200368|2700166|P2|Infant Series|Withdrawal by Subject|2
848623|NCT01200368|2700167|P1|Infant Series|Withdrawal by Subject|0
848624|NCT01200368|2700165|P3|Infant Series|Adverse Event|3
848625|NCT01200368|2700166|P2|Infant Series|Adverse Event|2
848626|NCT01200368|2700167|P1|Infant Series|Adverse Event|2
848627|NCT01193101|2700235|P4|Overall Study|Abnormal test procedure results|0
848628|NCT01193101|2700236|P3|Overall Study|Abnormal test procedure results|0
848629|NCT01193101|2700237|P2|Overall Study|Abnormal test procedure results|1
848630|NCT01193101|2700238|P1|Overall Study|Abnormal test procedure results|0
848631|NCT01193101|2700235|P4|Overall Study|Administrative problems|0
848632|NCT01193101|2700236|P3|Overall Study|Administrative problems|1
848633|NCT01193101|2700237|P2|Overall Study|Administrative problems|0
848634|NCT01193101|2700238|P1|Overall Study|Administrative problems|0
848635|NCT01193101|2700235|P4|Overall Study|Withdrawal by Subject|1
848636|NCT01193101|2700236|P3|Overall Study|Withdrawal by Subject|1
848637|NCT01193101|2700237|P2|Overall Study|Withdrawal by Subject|4
848638|NCT01193101|2700238|P1|Overall Study|Withdrawal by Subject|2
848639|NCT01193101|2700235|P4|Overall Study|Lack of Efficacy|8
848640|NCT01193101|2700236|P3|Overall Study|Lack of Efficacy|0
848641|NCT01193101|2700237|P2|Overall Study|Lack of Efficacy|1
848642|NCT01193101|2700238|P1|Overall Study|Lack of Efficacy|3
848643|NCT01193101|2700235|P4|Overall Study|Adverse Event|3
848644|NCT01193101|2700236|P3|Overall Study|Adverse Event|1
848645|NCT01193101|2700237|P2|Overall Study|Adverse Event|1
848646|NCT01193101|2700238|P1|Overall Study|Adverse Event|0
848647|NCT01193127|2700317|P4|Treated|Withdrawal by Subject|1
848648|NCT01193127|2700318|P3|Treated|Withdrawal by Subject|0
848649|NCT01193127|2700319|P2|Treated|Withdrawal by Subject|0
848650|NCT01193127|2700320|P1|Treated|Withdrawal by Subject|0
848651|NCT01193127|2700317|P4|Randomized|Surgery Cancelled|1
848652|NCT01193127|2700318|P3|Randomized|Surgery Cancelled|0
848653|NCT01193127|2700319|P2|Randomized|Surgery Cancelled|0
848654|NCT01193127|2700320|P1|Randomized|Surgery Cancelled|0
848655|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
848656|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
848657|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
848658|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
848659|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
848660|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
848661|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Pregnancy|0
848662|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Pregnancy|1
848663|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
848664|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
848665|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Death|0
848666|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Death|2
848667|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Adverse Event|3
848668|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Adverse Event|12
848669|NCT01193153|2700622|P2|Double Blind Relapse Prevention Period|Unspecified|3
848670|NCT01193153|2700623|P1|Double Blind Relapse Prevention Period|Unspecified|2
848671|NCT01193153|2700622|P2|Open-label Stabilization Period|Unspecified|0
848672|NCT01193153|2700623|P1|Open-label Stabilization Period|Unspecified|8
848673|NCT01193153|2700622|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
848674|NCT01193153|2700623|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
848675|NCT01193153|2700622|P2|Open-label Stabilization Period|Withdrawal by Subject|0
848676|NCT01193153|2700623|P1|Open-label Stabilization Period|Withdrawal by Subject|29
848677|NCT01193153|2700622|P2|Open-label Stabilization Period|Lack of Efficacy|0
848678|NCT01193153|2700623|P1|Open-label Stabilization Period|Lack of Efficacy|5
848679|NCT01193153|2700622|P2|Open-label Stabilization Period|Lost to Follow-up|0
848680|NCT01193153|2700623|P1|Open-label Stabilization Period|Lost to Follow-up|10
848681|NCT01193153|2700622|P2|Open-label Stabilization Period|Death|0
848682|NCT01193153|2700623|P1|Open-label Stabilization Period|Death|2
848683|NCT01193153|2700622|P2|Open-label Stabilization Period|Adverse Event|0
848684|NCT01193153|2700623|P1|Open-label Stabilization Period|Adverse Event|9
848685|NCT01193153|2700622|P2|Open-label Lead in Period|Lack of Efficacy|0
848686|NCT01193153|2700623|P1|Open-label Lead in Period|Lack of Efficacy|26
848687|NCT01193153|2700622|P2|Open-label Lead in Period|Death|0
848688|NCT01193153|2700623|P1|Open-label Lead in Period|Death|1
848689|NCT01193153|2700622|P2|Open-label Lead in Period|Adverse Event|0
848690|NCT01193153|2700623|P1|Open-label Lead in Period|Adverse Event|41
848691|NCT01193153|2700622|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
848692|NCT01193153|2700623|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
848693|NCT01193153|2700622|P2|Open-label Lead in Period|Unspecified|0
848694|NCT01193153|2700623|P1|Open-label Lead in Period|Unspecified|14
848695|NCT01193153|2700622|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
848696|NCT01193153|2700623|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
848697|NCT01193153|2700622|P2|Open-label Lead in Period|Withdrawal by Subject|0
848698|NCT01193153|2700623|P1|Open-label Lead in Period|Withdrawal by Subject|69
848699|NCT01193153|2700622|P2|Open-label Lead in Period|Pregnancy|0
848700|NCT01193153|2700623|P1|Open-label Lead in Period|Pregnancy|1
848701|NCT01193153|2700622|P2|Open-label Lead in Period|Lost to Follow-up|0
848702|NCT01193153|2700623|P1|Open-label Lead in Period|Lost to Follow-up|32
848703|NCT01193218|2700659|P8|12-52 Weeks|Other reason than above|0
848704|NCT01193218|2700660|P7|12-52 Weeks|Other reason than above|0
848705|NCT01193218|2700661|P6|12-52 Weeks|Other reason than above|0
848706|NCT01193218|2700662|P5|12-52 Weeks|Other reason than above|1
848707|NCT01193218|2700663|P4|12-52 Weeks|Other reason than above|1
848708|NCT01193218|2700664|P3|12-52 Weeks|Other reason than above|0
848709|NCT01193218|2700665|P2|12-52 Weeks|Other reason than above|0
848710|NCT01193218|2700666|P1|12-52 Weeks|Other reason than above|1
848711|NCT01193218|2700659|P8|12-52 Weeks|Withdrawal by Subject|2
848712|NCT01193218|2700660|P7|12-52 Weeks|Withdrawal by Subject|1
848713|NCT01193218|2700661|P6|12-52 Weeks|Withdrawal by Subject|2
848714|NCT01193218|2700662|P5|12-52 Weeks|Withdrawal by Subject|0
848715|NCT01193218|2700663|P4|12-52 Weeks|Withdrawal by Subject|0
848716|NCT01193218|2700664|P3|12-52 Weeks|Withdrawal by Subject|3
848717|NCT01193218|2700665|P2|12-52 Weeks|Withdrawal by Subject|0
848718|NCT01193218|2700666|P1|12-52 Weeks|Withdrawal by Subject|3
848719|NCT01193218|2700659|P8|12-52 Weeks|Lack of Efficacy|0
848720|NCT01193218|2700660|P7|12-52 Weeks|Lack of Efficacy|1
848721|NCT01193218|2700661|P6|12-52 Weeks|Lack of Efficacy|0
848722|NCT01193218|2700662|P5|12-52 Weeks|Lack of Efficacy|0
848723|NCT01193218|2700663|P4|12-52 Weeks|Lack of Efficacy|0
848724|NCT01193218|2700664|P3|12-52 Weeks|Lack of Efficacy|0
848725|NCT01193218|2700665|P2|12-52 Weeks|Lack of Efficacy|0
848726|NCT01193218|2700666|P1|12-52 Weeks|Lack of Efficacy|0
848727|NCT01193218|2700659|P8|12-52 Weeks|Adverse Event|2
848728|NCT01193218|2700660|P7|12-52 Weeks|Adverse Event|1
848729|NCT01193218|2700661|P6|12-52 Weeks|Adverse Event|3
848730|NCT01193218|2700662|P5|12-52 Weeks|Adverse Event|3
848731|NCT01193218|2700663|P4|12-52 Weeks|Adverse Event|2
848732|NCT01193218|2700664|P3|12-52 Weeks|Adverse Event|1
848733|NCT01193218|2700665|P2|12-52 Weeks|Adverse Event|0
848734|NCT01193218|2700666|P1|12-52 Weeks|Adverse Event|1
848735|NCT01193218|2700659|P8|0-12 Weeks|Withdrawal by Subject|0
848736|NCT01193218|2700660|P7|0-12 Weeks|Withdrawal by Subject|1
848737|NCT01193218|2700661|P6|0-12 Weeks|Withdrawal by Subject|0
848738|NCT01193218|2700662|P5|0-12 Weeks|Withdrawal by Subject|0
848739|NCT01193218|2700663|P4|0-12 Weeks|Withdrawal by Subject|0
848740|NCT01193218|2700664|P3|0-12 Weeks|Withdrawal by Subject|2
848741|NCT01193218|2700665|P2|0-12 Weeks|Withdrawal by Subject|0
848742|NCT01193218|2700666|P1|0-12 Weeks|Withdrawal by Subject|3
848743|NCT01193218|2700659|P8|0-12 Weeks|Protocol Violation|0
848744|NCT01193218|2700660|P7|0-12 Weeks|Protocol Violation|0
848745|NCT01193218|2700661|P6|0-12 Weeks|Protocol Violation|1
848746|NCT01193218|2700662|P5|0-12 Weeks|Protocol Violation|1
848747|NCT01193218|2700663|P4|0-12 Weeks|Protocol Violation|0
848748|NCT01193218|2700664|P3|0-12 Weeks|Protocol Violation|0
848749|NCT01193218|2700665|P2|0-12 Weeks|Protocol Violation|0
848750|NCT01193218|2700666|P1|0-12 Weeks|Protocol Violation|0
848751|NCT01193218|2700659|P8|0-12 Weeks|Adverse Event|0
848752|NCT01193218|2700660|P7|0-12 Weeks|Adverse Event|2
848753|NCT01193218|2700661|P6|0-12 Weeks|Adverse Event|2
848754|NCT01193218|2700662|P5|0-12 Weeks|Adverse Event|0
848755|NCT01193218|2700663|P4|0-12 Weeks|Adverse Event|0
848756|NCT01193218|2700664|P3|0-12 Weeks|Adverse Event|1
848757|NCT01193218|2700665|P2|0-12 Weeks|Adverse Event|0
848758|NCT01193218|2700666|P1|0-12 Weeks|Adverse Event|6
848759|NCT01193244|2700699|P2|Overall Study|Lost to Follow-up|15
848760|NCT01193244|2700700|P1|Overall Study|Lost to Follow-up|6
848761|NCT01193244|2700699|P2|Overall Study|Other|278
848762|NCT01193244|2700700|P1|Overall Study|Other|303
848763|NCT01193244|2700699|P2|Overall Study|Withdrawal by Subject|97
848764|NCT01193244|2700700|P1|Overall Study|Withdrawal by Subject|79
848765|NCT01193283|2700750|P1|Overall Study|Death|1
848766|NCT01193335|2700756|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
848767|NCT01193335|2700757|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
848768|NCT01193335|2700756|P2|2-Year Follow-up|No Longer Willing to Participate|6
848769|NCT01193335|2700757|P1|2-Year Follow-up|No Longer Willing to Participate|5
848770|NCT01193335|2700756|P2|1-Year Follow-up|Lost to Follow-up|0
848771|NCT01193335|2700757|P1|1-Year Follow-up|Lost to Follow-up|4
848772|NCT01193335|2700756|P2|1-Year Follow-up|No Longer Willing to Participate|9
848773|NCT01193335|2700757|P1|1-Year Follow-up|No Longer Willing to Participate|7
848774|NCT01193335|2700756|P2|After Infant Series|No Longer Met Eligibility Criteria|1
848775|NCT01193335|2700757|P1|After Infant Series|No Longer Met Eligibility Criteria|0
848776|NCT01193335|2700756|P2|After Infant Series|Lost to Follow-up|2
848777|NCT01193335|2700757|P1|After Infant Series|Lost to Follow-up|1
848778|NCT01193348|2700852|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
848779|NCT01193348|2700852|P1|Extension Treatment Period|Physician Decision|1
848780|NCT01193348|2700852|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
848781|NCT01193348|2700852|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
848782|NCT01193348|2700852|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
848783|NCT01193348|2700852|P1|Screening Period|Screen Failure|5
848784|NCT01193556|2700872|P2|Overall Study|Study termination|25
848785|NCT01193556|2700873|P1|Overall Study|Study termination|26
848786|NCT01193582|2700885|P4|12 Month Follow-up|Withdrawal by Subject|11
848787|NCT01193582|2700886|P3|12 Month Follow-up|Withdrawal by Subject|3
848788|NCT01193582|2700887|P2|12 Month Follow-up|Withdrawal by Subject|0
848789|NCT01193582|2700888|P1|12 Month Follow-up|Withdrawal by Subject|6
848790|NCT01193582|2700885|P4|12 Month Follow-up|Death|0
848791|NCT01193582|2700886|P3|12 Month Follow-up|Death|1
848792|NCT01193582|2700887|P2|12 Month Follow-up|Death|0
848793|NCT01193582|2700888|P1|12 Month Follow-up|Death|0
848794|NCT01193582|2700885|P4|Vaccination Series|Withdrawal by Subject|3
848795|NCT01193582|2700886|P3|Vaccination Series|Withdrawal by Subject|8
848796|NCT01193582|2700887|P2|Vaccination Series|Withdrawal by Subject|13
848797|NCT01193582|2700888|P1|Vaccination Series|Withdrawal by Subject|11
848798|NCT01193608|2700922|P6|Overall Study|Adverse Event|0
848799|NCT01193608|2700923|P5|Overall Study|Adverse Event|1
848800|NCT01193608|2700924|P4|Overall Study|Adverse Event|0
848801|NCT01193608|2700925|P3|Overall Study|Adverse Event|0
848802|NCT01193608|2700926|P2|Overall Study|Adverse Event|0
848803|NCT01193608|2700927|P1|Overall Study|Adverse Event|0
848804|NCT01193608|2700922|P6|Overall Study|Lost to Follow-up|2
848805|NCT01193608|2700923|P5|Overall Study|Lost to Follow-up|1
848806|NCT01193608|2700924|P4|Overall Study|Lost to Follow-up|0
848807|NCT01193608|2700925|P3|Overall Study|Lost to Follow-up|0
848808|NCT01193608|2700926|P2|Overall Study|Lost to Follow-up|0
848809|NCT01193608|2700927|P1|Overall Study|Lost to Follow-up|0
848810|NCT01193608|2700922|P6|Overall Study|Withdrawal by Subject|0
848811|NCT01193608|2700923|P5|Overall Study|Withdrawal by Subject|3
848812|NCT01193608|2700924|P4|Overall Study|Withdrawal by Subject|3
848813|NCT01193608|2700925|P3|Overall Study|Withdrawal by Subject|2
848814|NCT01193608|2700926|P2|Overall Study|Withdrawal by Subject|1
848815|NCT01193608|2700927|P1|Overall Study|Withdrawal by Subject|0
848816|NCT01193608|2700922|P6|Overall Study|Unspecified|0
848817|NCT01193608|2700923|P5|Overall Study|Unspecified|0
848818|NCT01193608|2700924|P4|Overall Study|Unspecified|0
848819|NCT01193608|2700925|P3|Overall Study|Unspecified|0
848820|NCT01193608|2700926|P2|Overall Study|Unspecified|1
848821|NCT01193608|2700927|P1|Overall Study|Unspecified|0
848822|NCT01193660|2701163|P3|Overall Study|Physician Decision|1
848823|NCT01193660|2701164|P2|Overall Study|Physician Decision|0
848824|NCT01193660|2701165|P1|Overall Study|Physician Decision|1
848825|NCT01193660|2701163|P3|Overall Study|Death|0
848826|NCT01193660|2701164|P2|Overall Study|Death|0
848827|NCT01193660|2701165|P1|Overall Study|Death|1
848828|NCT01193660|2701163|P3|Overall Study|Withdrawal by Subject|1
848829|NCT01193660|2701164|P2|Overall Study|Withdrawal by Subject|3
848830|NCT01193660|2701165|P1|Overall Study|Withdrawal by Subject|2
848831|NCT01193686|2701205|P2|Overall Study|Removed by Investigators; unable to matc|0
848832|NCT01193686|2701206|P1|Overall Study|Removed by Investigators; unable to matc|3
848833|NCT01193686|2701205|P2|Overall Study|Withdrawal by Subject|1
848834|NCT01193686|2701206|P1|Overall Study|Withdrawal by Subject|4
848835|NCT01193920|2701271|P10|Overall Study|Unable to classify|0
848836|NCT01193920|2701272|P9|Overall Study|Unable to classify|0
848837|NCT01193920|2701273|P8|Overall Study|Unable to classify|1
848838|NCT01193920|2701274|P7|Overall Study|Unable to classify|0
848839|NCT01193920|2701275|P6|Overall Study|Unable to classify|0
848840|NCT01193920|2701276|P5|Overall Study|Unable to classify|0
848841|NCT01193920|2701277|P4|Overall Study|Unable to classify|1
848842|NCT01193920|2701278|P3|Overall Study|Unable to classify|0
848843|NCT01193920|2701279|P2|Overall Study|Unable to classify|0
848844|NCT01193920|2701280|P1|Overall Study|Unable to classify|0
848845|NCT01193920|2701271|P10|Overall Study|Death|4
848846|NCT01193920|2701272|P9|Overall Study|Death|2
848847|NCT01193920|2701273|P8|Overall Study|Death|3
848848|NCT01193920|2701274|P7|Overall Study|Death|2
848849|NCT01193920|2701275|P6|Overall Study|Death|0
848850|NCT01193920|2701276|P5|Overall Study|Death|0
848851|NCT01193920|2701277|P4|Overall Study|Death|1
848852|NCT01193920|2701278|P3|Overall Study|Death|0
848853|NCT01193920|2701279|P2|Overall Study|Death|0
848854|NCT01193920|2701280|P1|Overall Study|Death|0
848855|NCT01193920|2701271|P10|Overall Study|Protocol Violation|0
848856|NCT01193920|2701272|P9|Overall Study|Protocol Violation|0
848857|NCT01193920|2701273|P8|Overall Study|Protocol Violation|0
848858|NCT01193920|2701274|P7|Overall Study|Protocol Violation|0
848859|NCT01193920|2701275|P6|Overall Study|Protocol Violation|0
848860|NCT01193920|2701276|P5|Overall Study|Protocol Violation|0
848861|NCT01193920|2701277|P4|Overall Study|Protocol Violation|0
848862|NCT01193920|2701278|P3|Overall Study|Protocol Violation|0
848863|NCT01193920|2701279|P2|Overall Study|Protocol Violation|0
848864|NCT01193920|2701280|P1|Overall Study|Protocol Violation|1
848865|NCT01193920|2701271|P10|Overall Study|Lost to Follow-up|3
848866|NCT01193920|2701272|P9|Overall Study|Lost to Follow-up|2
848867|NCT01193920|2701273|P8|Overall Study|Lost to Follow-up|0
848868|NCT01193920|2701274|P7|Overall Study|Lost to Follow-up|1
848869|NCT01193920|2701275|P6|Overall Study|Lost to Follow-up|3
848870|NCT01193920|2701276|P5|Overall Study|Lost to Follow-up|3
848871|NCT01193920|2701277|P4|Overall Study|Lost to Follow-up|1
848872|NCT01193920|2701278|P3|Overall Study|Lost to Follow-up|1
848873|NCT01193920|2701279|P2|Overall Study|Lost to Follow-up|0
848874|NCT01193920|2701280|P1|Overall Study|Lost to Follow-up|1
848875|NCT01193920|2701271|P10|Overall Study|Withdrawal by Subject|0
848876|NCT01193920|2701272|P9|Overall Study|Withdrawal by Subject|1
848877|NCT01193920|2701273|P8|Overall Study|Withdrawal by Subject|0
848878|NCT01193920|2701274|P7|Overall Study|Withdrawal by Subject|3
848879|NCT01193920|2701275|P6|Overall Study|Withdrawal by Subject|1
848880|NCT01193920|2701276|P5|Overall Study|Withdrawal by Subject|3
848881|NCT01193920|2701277|P4|Overall Study|Withdrawal by Subject|1
848882|NCT01193920|2701278|P3|Overall Study|Withdrawal by Subject|5
848883|NCT01193920|2701279|P2|Overall Study|Withdrawal by Subject|0
848884|NCT01193920|2701280|P1|Overall Study|Withdrawal by Subject|1
848885|NCT01194154|2701345|P2|Overall Study|Did not receive study medication|4
848886|NCT01194154|2701346|P1|Overall Study|Did not receive study medication|2
848887|NCT01194154|2701345|P2|Overall Study|Unspecified|0
848888|NCT01194154|2701346|P1|Overall Study|Unspecified|4
848889|NCT01194154|2701345|P2|Overall Study|Treatment with prohibited medication|5
848890|NCT01194154|2701346|P1|Overall Study|Treatment with prohibited medication|4
848891|NCT01194154|2701345|P2|Overall Study|Skipping of CERA treatment at two visits|0
848892|NCT01194154|2701346|P1|Overall Study|Skipping of CERA treatment at two visits|3
848893|NCT01194154|2701345|P2|Overall Study|Hemoglobin increase|3
848894|NCT01194154|2701346|P1|Overall Study|Hemoglobin increase|12
848895|NCT01194154|2701345|P2|Overall Study|Hemoglobin decrease|1
848896|NCT01194154|2701346|P1|Overall Study|Hemoglobin decrease|0
848897|NCT01194154|2701345|P2|Overall Study|Blood pressure increase|3
848898|NCT01194154|2701346|P1|Overall Study|Blood pressure increase|5
848899|NCT01194154|2701345|P2|Overall Study|Withdrawal by Subject|6
848900|NCT01194154|2701346|P1|Overall Study|Withdrawal by Subject|5
848901|NCT01194154|2701345|P2|Overall Study|Protocol Violation|1
848902|NCT01194154|2701346|P1|Overall Study|Protocol Violation|0
848903|NCT01194154|2701345|P2|Overall Study|Lost to Follow-up|3
848904|NCT01194154|2701346|P1|Overall Study|Lost to Follow-up|2
848905|NCT01194154|2701345|P2|Overall Study|Adverse Event|7
848906|NCT01194154|2701346|P1|Overall Study|Adverse Event|12
848907|NCT01200511|2701391|P1|Overall Study|Adverse Event|1
848908|NCT01200511|2701391|P1|Overall Study|Withdrawal by Subject|1
848909|NCT01200511|2701391|P1|Overall Study|Lost to Follow-up|3
848910|NCT01200524|2701402|P3|Overall Study|Non availability of study nurse|1
848911|NCT01200524|2701403|P2|Overall Study|Non availability of study nurse|0
848912|NCT01200524|2701404|P1|Overall Study|Non availability of study nurse|0
848913|NCT01200524|2701402|P3|Overall Study|Adverse Event|0
848914|NCT01200524|2701403|P2|Overall Study|Adverse Event|0
848915|NCT01200524|2701404|P1|Overall Study|Adverse Event|1
848916|NCT01200524|2701402|P3|Overall Study|Withdrawal by Subject|3
848917|NCT01200524|2701403|P2|Overall Study|Withdrawal by Subject|1
848918|NCT01200524|2701404|P1|Overall Study|Withdrawal by Subject|1
848919|NCT01201759|2701460|P2|Visit 4 Crossover|Lost to Follow-up|1
848920|NCT01201759|2701461|P1|Visit 4 Crossover|Lost to Follow-up|0
848921|NCT01201759|2701460|P2|Visit 3 - Washout|Lost to Follow-up|0
848922|NCT01201759|2701461|P1|Visit 3 - Washout|Lost to Follow-up|1
848923|NCT01201759|2701460|P2|Visit 3 - Washout|Adverse Event|3
848924|NCT01201759|2701461|P1|Visit 3 - Washout|Adverse Event|0
848925|NCT01201759|2701460|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
848926|NCT01201759|2701461|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
848927|NCT01201785|2701484|P1|Overall Study|Lost to Follow-up|16
848928|NCT01201798|2701490|P2|Overall Study|Treatment Failure|8
848929|NCT01201798|2701491|P1|Overall Study|Treatment Failure|1
848930|NCT01201798|2701490|P2|Overall Study|Protocol Violation|1
848931|NCT01201798|2701491|P1|Overall Study|Protocol Violation|1
848932|NCT01201798|2701490|P2|Overall Study|Noncompliance|0
848933|NCT01201798|2701491|P1|Overall Study|Noncompliance|1
848934|NCT01201798|2701490|P2|Overall Study|Decision Unrelated to an Adverse Event|1
848935|NCT01201798|2701491|P1|Overall Study|Decision Unrelated to an Adverse Event|1
848936|NCT01201798|2701490|P2|Overall Study|Lost to Follow-up|5
848937|NCT01201798|2701491|P1|Overall Study|Lost to Follow-up|3
848938|NCT01201798|2701490|P2|Overall Study|Adverse Event|0
848939|NCT01201798|2701491|P1|Overall Study|Adverse Event|2
848940|NCT01201811|2701515|P1|Overall Study|Physician Decision|1
848941|NCT01201811|2701515|P1|Overall Study|Treatment Failure|2
848942|NCT01201811|2701515|P1|Overall Study|Death|4
848943|NCT01201811|2701515|P1|Overall Study|Withdrawal by Subject|3
848944|NCT01201811|2701515|P1|Overall Study|Disease progression|3
848945|NCT01201811|2701515|P1|Overall Study|Adverse Event|6
848946|NCT01201915|2701538|P3|Overall Study|Target Lesion Progression|0
848947|NCT01201915|2701539|P2|Overall Study|Target Lesion Progression|3
848948|NCT01201915|2701540|P1|Overall Study|Target Lesion Progression|0
848949|NCT01201915|2701538|P3|Overall Study|Subject Decision|5
848950|NCT01201915|2701539|P2|Overall Study|Subject Decision|3
848951|NCT01201915|2701540|P1|Overall Study|Subject Decision|3
848952|NCT01201915|2701538|P3|Overall Study|Physician Decision|0
848953|NCT01201915|2701539|P2|Overall Study|Physician Decision|0
848954|NCT01201915|2701540|P1|Overall Study|Physician Decision|3
848955|NCT01201915|2701538|P3|Overall Study|Lost to Follow-up|0
848956|NCT01201915|2701539|P2|Overall Study|Lost to Follow-up|4
848957|NCT01201915|2701540|P1|Overall Study|Lost to Follow-up|0
848958|NCT01201915|2701538|P3|Overall Study|Adverse Event|1
848959|NCT01201915|2701539|P2|Overall Study|Adverse Event|1
848960|NCT01201915|2701540|P1|Overall Study|Adverse Event|2
848961|NCT01201967|2701553|P2|Overall Study|Lost to Follow-up|5
848962|NCT01201967|2701554|P1|Overall Study|Lost to Follow-up|6
848963|NCT01202188|2701620|P5|Overall Study|Abnormal test procedure result (s)|0
848964|NCT01202188|2701621|P4|Overall Study|Abnormal test procedure result (s)|0
848965|NCT01202188|2701622|P3|Overall Study|Abnormal test procedure result (s)|2
848966|NCT01202188|2701623|P2|Overall Study|Abnormal test procedure result (s)|0
848967|NCT01202188|2701624|P1|Overall Study|Abnormal test procedure result (s)|0
848968|NCT01202188|2701620|P5|Overall Study|Death|0
848969|NCT01202188|2701621|P4|Overall Study|Death|1
848970|NCT01202188|2701622|P3|Overall Study|Death|1
848971|NCT01202188|2701623|P2|Overall Study|Death|1
848972|NCT01202188|2701624|P1|Overall Study|Death|1
848973|NCT01202188|2701620|P5|Overall Study|Lost to Follow-up|1
848974|NCT01202188|2701621|P4|Overall Study|Lost to Follow-up|4
848975|NCT01202188|2701622|P3|Overall Study|Lost to Follow-up|0
848976|NCT01202188|2701623|P2|Overall Study|Lost to Follow-up|1
848977|NCT01202188|2701624|P1|Overall Study|Lost to Follow-up|1
848978|NCT01202188|2701620|P5|Overall Study|Unsatisfactory therapeutic effect|8
848979|NCT01202188|2701621|P4|Overall Study|Unsatisfactory therapeutic effect|5
848980|NCT01202188|2701622|P3|Overall Study|Unsatisfactory therapeutic effect|2
848981|NCT01202188|2701623|P2|Overall Study|Unsatisfactory therapeutic effect|8
848982|NCT01202188|2701624|P1|Overall Study|Unsatisfactory therapeutic effect|2
848983|NCT01202188|2701620|P5|Overall Study|Administrative problems|2
848984|NCT01202188|2701621|P4|Overall Study|Administrative problems|1
848985|NCT01202188|2701622|P3|Overall Study|Administrative problems|1
848986|NCT01202188|2701623|P2|Overall Study|Administrative problems|2
848987|NCT01202188|2701624|P1|Overall Study|Administrative problems|3
848988|NCT01202188|2701620|P5|Overall Study|Adverse Event|10
848989|NCT01202188|2701621|P4|Overall Study|Adverse Event|10
848990|NCT01202188|2701622|P3|Overall Study|Adverse Event|13
848991|NCT01202188|2701623|P2|Overall Study|Adverse Event|23
848992|NCT01202188|2701624|P1|Overall Study|Adverse Event|5
848993|NCT01202188|2701620|P5|Overall Study|Subject withdrew consent|13
848994|NCT01202188|2701621|P4|Overall Study|Subject withdrew consent|11
848995|NCT01202188|2701622|P3|Overall Study|Subject withdrew consent|22
848996|NCT01202188|2701623|P2|Overall Study|Subject withdrew consent|13
848997|NCT01202188|2701624|P1|Overall Study|Subject withdrew consent|12
848998|NCT01202188|2701620|P5|Overall Study|Protocol deviation|11
848999|NCT01202188|2701621|P4|Overall Study|Protocol deviation|10
849000|NCT01202188|2701622|P3|Overall Study|Protocol deviation|12
849001|NCT01202188|2701623|P2|Overall Study|Protocol deviation|8
849002|NCT01202188|2701624|P1|Overall Study|Protocol deviation|14
849003|NCT01202227|2701730|P1|Overall Study|Lack of Efficacy|1
849004|NCT01202227|2701730|P1|Overall Study|Withdrawal by Subject|2
849005|NCT01202227|2701730|P1|Overall Study|Adverse Event|16
849006|NCT01202279|2701795|P2|Overall Study|study compliance|2
849007|NCT01202279|2701796|P1|Overall Study|study compliance|5
849008|NCT01202279|2701795|P2|Overall Study|Protocol Violation|1
849009|NCT01202279|2701796|P1|Overall Study|Protocol Violation|1
849010|NCT01202279|2701795|P2|Overall Study|Lost to Follow-up|7
849011|NCT01202279|2701796|P1|Overall Study|Lost to Follow-up|10
849012|NCT01202279|2701795|P2|Overall Study|Physician Decision|1
849013|NCT01202279|2701796|P1|Overall Study|Physician Decision|0
849014|NCT01202279|2701795|P2|Overall Study|Withdrawal by Subject|10
849015|NCT01202279|2701796|P1|Overall Study|Withdrawal by Subject|13
849016|NCT01202279|2701795|P2|Overall Study|Adverse Event|6
849017|NCT01202279|2701796|P1|Overall Study|Adverse Event|8
849018|NCT01202591|2701840|P6|Overall Study|Objective Disease Progression|0
849019|NCT01202591|2701841|P5|Overall Study|Objective Disease Progression|2
849020|NCT01202591|2701842|P4|Overall Study|Objective Disease Progression|0
849021|NCT01202591|2701843|P3|Overall Study|Objective Disease Progression|0
849022|NCT01202591|2701844|P2|Overall Study|Objective Disease Progression|0
849023|NCT01202591|2701845|P1|Overall Study|Objective Disease Progression|0
849024|NCT01202591|2701840|P6|Overall Study|Withdrawal by Subject|1
849025|NCT01202591|2701841|P5|Overall Study|Withdrawal by Subject|2
849026|NCT01202591|2701842|P4|Overall Study|Withdrawal by Subject|0
849027|NCT01202591|2701843|P3|Overall Study|Withdrawal by Subject|0
849028|NCT01202591|2701844|P2|Overall Study|Withdrawal by Subject|0
849029|NCT01202591|2701845|P1|Overall Study|Withdrawal by Subject|0
849030|NCT01202591|2701840|P6|Overall Study|Other reason as per investigator|3
849031|NCT01202591|2701841|P5|Overall Study|Other reason as per investigator|1
849032|NCT01202591|2701842|P4|Overall Study|Other reason as per investigator|3
849033|NCT01202591|2701843|P3|Overall Study|Other reason as per investigator|7
849034|NCT01202591|2701844|P2|Overall Study|Other reason as per investigator|4
849035|NCT01202591|2701845|P1|Overall Study|Other reason as per investigator|3
849036|NCT01202591|2701840|P6|Overall Study|Adverse Event|0
849037|NCT01202591|2701841|P5|Overall Study|Adverse Event|0
849038|NCT01202591|2701842|P4|Overall Study|Adverse Event|4
849039|NCT01202591|2701843|P3|Overall Study|Adverse Event|4
849040|NCT01202591|2701844|P2|Overall Study|Adverse Event|1
849041|NCT01202591|2701845|P1|Overall Study|Adverse Event|2
849042|NCT01202747|2701881|P1|Overall Study|Withdrawal by Subject|1
849043|NCT01202877|2701888|P3|Overall Study|Death|1
849044|NCT01202877|2701889|P2|Overall Study|Death|0
849045|NCT01202877|2701890|P1|Overall Study|Death|0
849046|NCT01202877|2701888|P3|Overall Study|Withdrawal by Subject|1
849047|NCT01202877|2701889|P2|Overall Study|Withdrawal by Subject|0
849048|NCT01202877|2701890|P1|Overall Study|Withdrawal by Subject|0
849049|NCT01202877|2701888|P3|Overall Study|Adverse Event|2
849050|NCT01202877|2701889|P2|Overall Study|Adverse Event|0
849051|NCT01202877|2701890|P1|Overall Study|Adverse Event|0
849052|NCT01202877|2701888|P3|Overall Study|Disease Progression|2
849053|NCT01202877|2701889|P2|Overall Study|Disease Progression|1
849054|NCT01202877|2701890|P1|Overall Study|Disease Progression|0
849055|NCT01202903|2701901|P2|Overall Study|Withdrawal by Subject|4
849056|NCT01202903|2701902|P1|Overall Study|Withdrawal by Subject|4
849057|NCT01202903|2701901|P2|Overall Study|Adverse Event|3
849058|NCT01202903|2701902|P1|Overall Study|Adverse Event|3
849059|NCT01202903|2701901|P2|Overall Study|Lack of Efficacy|3
849060|NCT01202903|2701902|P1|Overall Study|Lack of Efficacy|1
849061|NCT01202903|2701901|P2|Overall Study|Lost to Follow-up|1
849062|NCT01202903|2701902|P1|Overall Study|Lost to Follow-up|1
849063|NCT01202903|2701901|P2|Overall Study|Death|0
849064|NCT01202903|2701902|P1|Overall Study|Death|1
849065|NCT01202903|2701901|P2|Overall Study|Protocol Violation|1
849066|NCT01202903|2701902|P1|Overall Study|Protocol Violation|0
849067|NCT01202903|2701901|P2|Overall Study|Administrative Probelms|4
849068|NCT01202903|2701902|P1|Overall Study|Administrative Probelms|1
849069|NCT01202955|2701928|P2|Period 1: 10 Days|Withdrawal by Subject|2
849070|NCT01202955|2701929|P1|Period 1: 10 Days|Withdrawal by Subject|0
849071|NCT01203072|2701955|P5|Overall Study|Withdrawal by Subject|3
849072|NCT01203072|2701956|P4|Overall Study|Withdrawal by Subject|2
849073|NCT01203072|2701957|P3|Overall Study|Withdrawal by Subject|1
849074|NCT01203072|2701958|P2|Overall Study|Withdrawal by Subject|2
849075|NCT01203072|2701959|P1|Overall Study|Withdrawal by Subject|2
849076|NCT01203072|2701955|P5|Overall Study|Protocol Violation|1
849077|NCT01203072|2701956|P4|Overall Study|Protocol Violation|0
849078|NCT01203072|2701957|P3|Overall Study|Protocol Violation|0
849079|NCT01203072|2701958|P2|Overall Study|Protocol Violation|0
849080|NCT01203072|2701959|P1|Overall Study|Protocol Violation|2
849081|NCT01203072|2701955|P5|Overall Study|Lost to Follow-up|0
849082|NCT01203072|2701956|P4|Overall Study|Lost to Follow-up|0
849083|NCT01203072|2701957|P3|Overall Study|Lost to Follow-up|0
849084|NCT01203072|2701958|P2|Overall Study|Lost to Follow-up|1
849085|NCT01203072|2701959|P1|Overall Study|Lost to Follow-up|0
849086|NCT01203072|2701955|P5|Overall Study|Lack of Efficacy|0
849087|NCT01203072|2701956|P4|Overall Study|Lack of Efficacy|0
849088|NCT01203072|2701957|P3|Overall Study|Lack of Efficacy|0
849089|NCT01203072|2701958|P2|Overall Study|Lack of Efficacy|0
849090|NCT01203072|2701959|P1|Overall Study|Lack of Efficacy|1
849091|NCT01203072|2701955|P5|Overall Study|Adverse Event|2
849092|NCT01203072|2701956|P4|Overall Study|Adverse Event|4
849093|NCT01203072|2701957|P3|Overall Study|Adverse Event|2
849094|NCT01203072|2701958|P2|Overall Study|Adverse Event|3
849095|NCT01203072|2701959|P1|Overall Study|Adverse Event|5
849096|NCT01203098|2701979|P3|Overall Study|Withdrawal by Subject|3
849097|NCT01203098|2701980|P2|Overall Study|Withdrawal by Subject|1
849098|NCT01203098|2701981|P1|Overall Study|Withdrawal by Subject|1
849099|NCT01203098|2701979|P3|Overall Study|Physician Decision|0
849100|NCT01203098|2701980|P2|Overall Study|Physician Decision|2
849101|NCT01203098|2701981|P1|Overall Study|Physician Decision|2
849102|NCT01203098|2701979|P3|Overall Study|Lost to Follow-up|1
849103|NCT01203098|2701980|P2|Overall Study|Lost to Follow-up|0
849104|NCT01203098|2701981|P1|Overall Study|Lost to Follow-up|0
849105|NCT01203098|2701979|P3|Overall Study|Adverse Event|7
849106|NCT01203098|2701980|P2|Overall Study|Adverse Event|1
849107|NCT01203098|2701981|P1|Overall Study|Adverse Event|3
849108|NCT01203787|2702025|P2|Overall Study|Adverse Event|15
849109|NCT01203787|2702026|P1|Overall Study|Adverse Event|11
849110|NCT01203787|2702025|P2|Overall Study|Lost to Follow-up|0
849111|NCT01203787|2702026|P1|Overall Study|Lost to Follow-up|2
849112|NCT01203787|2702025|P2|Overall Study|Withdrawal by Subject|2
849113|NCT01203787|2702026|P1|Overall Study|Withdrawal by Subject|6
849114|NCT01203787|2702025|P2|Overall Study|Death|10
849115|NCT01203787|2702026|P1|Overall Study|Death|12
849116|NCT01203852|2702053|P1|Washout 2 Weeks|Physician Decision|46
849117|NCT01203852|2702053|P1|Metoprolol 8 Weeks|Physician Decision|470
849118|NCT01203878|2702063|P3|Overall Study|Adverse Event|2
849119|NCT01203878|2702064|P2|Overall Study|Adverse Event|0
849120|NCT01203878|2702065|P1|Overall Study|Adverse Event|0
849121|NCT01203878|2702063|P3|Overall Study|Withdrawal by Subject|1
849122|NCT01203878|2702064|P2|Overall Study|Withdrawal by Subject|0
849123|NCT01203878|2702065|P1|Overall Study|Withdrawal by Subject|0
849124|NCT01203917|2702076|P1|Overall Study|Due to EGFR M+I patient|1
849125|NCT01203917|2702076|P1|Overall Study|Due to objective disease progression|1
849126|NCT01203917|2702076|P1|Overall Study|Withdrawal by Subject|3
849127|NCT01203917|2702076|P1|Overall Study|Lost to Follow-up|2
849128|NCT01203917|2702076|P1|Overall Study|Death|29
849129|NCT01203930|2702088|P2|Overall Study|Adverse Event|5
849130|NCT01203930|2702089|P1|Overall Study|Adverse Event|17
849131|NCT01203930|2702088|P2|Overall Study|Poor tolerance of study drug|1
849132|NCT01203930|2702089|P1|Overall Study|Poor tolerance of study drug|0
849133|NCT01203930|2702088|P2|Overall Study|Study Terminated by Sponsor|12
849134|NCT01203930|2702089|P1|Overall Study|Study Terminated by Sponsor|0
849135|NCT01203930|2702088|P2|Overall Study|Investigator Request|8
849136|NCT01203930|2702089|P1|Overall Study|Investigator Request|0
849137|NCT01203930|2702088|P2|Overall Study|Withdrew Consent|10
849138|NCT01203930|2702089|P1|Overall Study|Withdrew Consent|1
849139|NCT01203930|2702088|P2|Overall Study|Death|1
849140|NCT01203930|2702089|P1|Overall Study|Death|3
849141|NCT01203930|2702088|P2|Overall Study|Disease Progression|4
849142|NCT01203930|2702089|P1|Overall Study|Disease Progression|0
849143|NCT01197417|2702124|P2|Overall Study|No 25-hour magnesium level|2
849144|NCT01197417|2702125|P1|Overall Study|No 25-hour magnesium level|0
849145|NCT01197417|2702124|P2|Overall Study|Found to be ineligible|5
849146|NCT01197417|2702125|P1|Overall Study|Found to be ineligible|2
849147|NCT01197417|2702124|P2|Overall Study|Hypotension|2
849148|NCT01197417|2702125|P1|Overall Study|Hypotension|1
849149|NCT01197417|2702124|P2|Overall Study|Not consented in time to receive drug|1
849150|NCT01197417|2702125|P1|Overall Study|Not consented in time to receive drug|0
849151|NCT01197417|2702124|P2|Overall Study|Subject transferred to intensive care|1
849152|NCT01197417|2702125|P1|Overall Study|Subject transferred to intensive care|0
849153|NCT01197417|2702124|P2|Overall Study|Site miscommunication|1
849154|NCT01197417|2702125|P1|Overall Study|Site miscommunication|0
849155|NCT01197417|2702124|P2|Overall Study|Withdrawal by Subject|4
849156|NCT01197417|2702125|P1|Overall Study|Withdrawal by Subject|2
849157|NCT01197417|2702124|P2|Overall Study|Physician Decision|2
849158|NCT01197417|2702125|P1|Overall Study|Physician Decision|3
849159|NCT01197508|2702161|P4|Overall Study|Not specified|2
849160|NCT01197508|2702162|P3|Overall Study|Not specified|2
849161|NCT01197508|2702163|P2|Overall Study|Not specified|3
849162|NCT01197508|2702164|P1|Overall Study|Not specified|2
849163|NCT01197508|2702161|P4|Overall Study|Lost to Follow-up|0
849164|NCT01197508|2702162|P3|Overall Study|Lost to Follow-up|2
849165|NCT01197508|2702163|P2|Overall Study|Lost to Follow-up|1
849166|NCT01197508|2702164|P1|Overall Study|Lost to Follow-up|1
849167|NCT01197508|2702161|P4|Overall Study|Study-specific withdrawal criteria|2
849168|NCT01197508|2702162|P3|Overall Study|Study-specific withdrawal criteria|1
849169|NCT01197508|2702163|P2|Overall Study|Study-specific withdrawal criteria|0
849170|NCT01197508|2702164|P1|Overall Study|Study-specific withdrawal criteria|0
849171|NCT01197508|2702161|P4|Overall Study|Lack of Efficacy|1
849172|NCT01197508|2702162|P3|Overall Study|Lack of Efficacy|2
849173|NCT01197508|2702163|P2|Overall Study|Lack of Efficacy|2
849174|NCT01197508|2702164|P1|Overall Study|Lack of Efficacy|1
849175|NCT01197508|2702161|P4|Overall Study|Condition under investigation worsened|1
849176|NCT01197508|2702162|P3|Overall Study|Condition under investigation worsened|1
849177|NCT01197508|2702163|P2|Overall Study|Condition under investigation worsened|1
849178|NCT01197508|2702164|P1|Overall Study|Condition under investigation worsened|1
849179|NCT01197508|2702161|P4|Overall Study|Severe non-compliance to protocol|3
849180|NCT01197508|2702162|P3|Overall Study|Severe non-compliance to protocol|1
849181|NCT01197508|2702163|P2|Overall Study|Severe non-compliance to protocol|3
849182|NCT01197508|2702164|P1|Overall Study|Severe non-compliance to protocol|0
849183|NCT01197508|2702161|P4|Overall Study|Adverse Event|3
849184|NCT01197508|2702162|P3|Overall Study|Adverse Event|23
849185|NCT01197508|2702163|P2|Overall Study|Adverse Event|13
849186|NCT01197508|2702164|P1|Overall Study|Adverse Event|10
849187|NCT01197508|2702161|P4|Overall Study|Eligiblity criteria not fulfilled|0
849188|NCT01197508|2702162|P3|Overall Study|Eligiblity criteria not fulfilled|2
849189|NCT01197508|2702163|P2|Overall Study|Eligiblity criteria not fulfilled|0
849190|NCT01197508|2702164|P1|Overall Study|Eligiblity criteria not fulfilled|0
849191|NCT01197508|2702161|P4|Overall Study|Withdrawal by Subject|4
849192|NCT01197508|2702162|P3|Overall Study|Withdrawal by Subject|15
849193|NCT01197508|2702163|P2|Overall Study|Withdrawal by Subject|7
849194|NCT01197508|2702164|P1|Overall Study|Withdrawal by Subject|8
849195|NCT01197521|2702261|P3|Overall Study|Adverse Event|24
849196|NCT01197521|2702262|P2|Overall Study|Adverse Event|28
849197|NCT01197521|2702263|P1|Overall Study|Adverse Event|25
849198|NCT01197521|2702261|P3|Overall Study|Lost to Follow-up|2
849199|NCT01197521|2702262|P2|Overall Study|Lost to Follow-up|2
849200|NCT01197521|2702263|P1|Overall Study|Lost to Follow-up|3
849201|NCT01197521|2702261|P3|Overall Study|Dev. of study specific discont. criteria|2
849202|NCT01197521|2702262|P2|Overall Study|Dev. of study specific discont. criteria|16
849203|NCT01197521|2702263|P1|Overall Study|Dev. of study specific discont. criteria|6
849204|NCT01197521|2702261|P3|Overall Study|Lack of therapeutic response|4
849205|NCT01197521|2702262|P2|Overall Study|Lack of therapeutic response|3
849206|NCT01197521|2702263|P1|Overall Study|Lack of therapeutic response|2
849207|NCT01197521|2702261|P3|Overall Study|Severe non-compliance to protocol|3
849208|NCT01197521|2702262|P2|Overall Study|Severe non-compliance to protocol|3
849209|NCT01197521|2702263|P1|Overall Study|Severe non-compliance to protocol|1
849210|NCT01197521|2702261|P3|Overall Study|Enrolment in long term extension|87
849211|NCT01197521|2702262|P2|Overall Study|Enrolment in long term extension|36
849212|NCT01197521|2702263|P1|Overall Study|Enrolment in long term extension|42
849213|NCT01197521|2702261|P3|Overall Study|Not reported|21
849214|NCT01197521|2702262|P2|Overall Study|Not reported|25
849215|NCT01197521|2702263|P1|Overall Study|Not reported|24
849216|NCT01197534|2702307|P3|Overall Study|Adverse Event|24
849217|NCT01197534|2702308|P2|Overall Study|Adverse Event|36
849218|NCT01197534|2702309|P1|Overall Study|Adverse Event|35
849219|NCT01197534|2702307|P3|Overall Study|Lost to Follow-up|2
849220|NCT01197534|2702308|P2|Overall Study|Lost to Follow-up|4
849221|NCT01197534|2702309|P1|Overall Study|Lost to Follow-up|1
849222|NCT01197534|2702307|P3|Overall Study|Dev. of study specific discont. criteria|2
849223|NCT01197534|2702308|P2|Overall Study|Dev. of study specific discont. criteria|6
849224|NCT01197534|2702309|P1|Overall Study|Dev. of study specific discont. criteria|13
849225|NCT01197534|2702307|P3|Overall Study|Lack of therapeutic response|9
849226|NCT01197534|2702308|P2|Overall Study|Lack of therapeutic response|4
849227|NCT01197534|2702309|P1|Overall Study|Lack of therapeutic response|9
849228|NCT01197534|2702307|P3|Overall Study|Severe non-compliance to protocol|1
849229|NCT01197534|2702308|P2|Overall Study|Severe non-compliance to protocol|4
849230|NCT01197534|2702309|P1|Overall Study|Severe non-compliance to protocol|3
849231|NCT01197534|2702307|P3|Overall Study|Enrolment in long term extension|119
849232|NCT01197534|2702308|P2|Overall Study|Enrolment in long term extension|66
849233|NCT01197534|2702309|P1|Overall Study|Enrolment in long term extension|57
849234|NCT01197534|2702307|P3|Overall Study|Not reported|16
849235|NCT01197534|2702308|P2|Overall Study|Not reported|10
849236|NCT01197534|2702309|P1|Overall Study|Not reported|16
849237|NCT01197560|2702358|P2|Overall Study|Missing|1
849238|NCT01197560|2702359|P1|Overall Study|Missing|0
849239|NCT01197560|2702358|P2|Overall Study|Elected to discontinue before cycle end|2
849240|NCT01197560|2702359|P1|Overall Study|Elected to discontinue before cycle end|0
849241|NCT01197560|2702358|P2|Overall Study|Proceeded to transplant|1
849242|NCT01197560|2702359|P1|Overall Study|Proceeded to transplant|1
849243|NCT01197560|2702358|P2|Overall Study|Disease progression|35
849244|NCT01197560|2702359|P1|Overall Study|Disease progression|39
849245|NCT01197560|2702358|P2|Overall Study|Withdrawal by Subject|1
849246|NCT01197560|2702359|P1|Overall Study|Withdrawal by Subject|1
849247|NCT01197560|2702358|P2|Overall Study|Death|5
849248|NCT01197560|2702359|P1|Overall Study|Death|1
849249|NCT01197560|2702358|P2|Overall Study|Adverse Event|8
849250|NCT01197560|2702359|P1|Overall Study|Adverse Event|4
849251|NCT01197755|2702386|P3|Overall Study|eg, change in circumstances|2
849252|NCT01197755|2702387|P2|Overall Study|eg, change in circumstances|3
849253|NCT01197755|2702388|P1|Overall Study|eg, change in circumstances|7
849254|NCT01197755|2702386|P3|Overall Study|Lost to Follow-up|1
849255|NCT01197755|2702387|P2|Overall Study|Lost to Follow-up|0
849256|NCT01197755|2702388|P1|Overall Study|Lost to Follow-up|0
849257|NCT01197755|2702386|P3|Overall Study|Withdrawal by Subject|0
849258|NCT01197755|2702387|P2|Overall Study|Withdrawal by Subject|0
849259|NCT01197755|2702388|P1|Overall Study|Withdrawal by Subject|1
849260|NCT01197755|2702386|P3|Overall Study|Severe non-compliance to the protocol|2
849261|NCT01197755|2702387|P2|Overall Study|Severe non-compliance to the protocol|1
849262|NCT01197755|2702388|P1|Overall Study|Severe non-compliance to the protocol|2
849263|NCT01197755|2702386|P3|Overall Study|Lack of therapeutic response|4
849264|NCT01197755|2702387|P2|Overall Study|Lack of therapeutic response|7
849265|NCT01197755|2702388|P1|Overall Study|Lack of therapeutic response|0
849266|NCT01197755|2702386|P3|Overall Study|Entered the long-term extension study|35
849267|NCT01197755|2702387|P2|Overall Study|Entered the long-term extension study|21
849268|NCT01197755|2702388|P1|Overall Study|Entered the long-term extension study|18
849269|NCT01197755|2702386|P3|Overall Study|Study-specific discontinuation criteria|0
849270|NCT01197755|2702387|P2|Overall Study|Study-specific discontinuation criteria|1
849271|NCT01197755|2702388|P1|Overall Study|Study-specific discontinuation criteria|2
849272|NCT01197755|2702386|P3|Overall Study|Adverse Event|10
849273|NCT01197755|2702387|P2|Overall Study|Adverse Event|10
849274|NCT01197755|2702388|P1|Overall Study|Adverse Event|8
849275|NCT01197794|2702435|P7|Overall Study|Other|4
849276|NCT01197794|2702436|P6|Overall Study|Other|2
849277|NCT01197794|2702437|P5|Overall Study|Other|2
849278|NCT01197794|2702438|P4|Overall Study|Other|0
849279|NCT01197794|2702439|P3|Overall Study|Other|3
849280|NCT01197794|2702440|P2|Overall Study|Other|1
849281|NCT01197794|2702441|P1|Overall Study|Other|1
849282|NCT01197794|2702435|P7|Overall Study|Lost to Follow-up|0
849283|NCT01197794|2702436|P6|Overall Study|Lost to Follow-up|1
849284|NCT01197794|2702437|P5|Overall Study|Lost to Follow-up|0
849285|NCT01197794|2702438|P4|Overall Study|Lost to Follow-up|1
849286|NCT01197794|2702439|P3|Overall Study|Lost to Follow-up|0
849287|NCT01197794|2702440|P2|Overall Study|Lost to Follow-up|1
849288|NCT01197794|2702441|P1|Overall Study|Lost to Follow-up|1
849289|NCT01197794|2702435|P7|Overall Study|Withdrawal by Subject|6
849290|NCT01197794|2702436|P6|Overall Study|Withdrawal by Subject|5
849291|NCT01197794|2702437|P5|Overall Study|Withdrawal by Subject|1
849292|NCT01197794|2702438|P4|Overall Study|Withdrawal by Subject|1
849293|NCT01197794|2702439|P3|Overall Study|Withdrawal by Subject|4
849294|NCT01197794|2702440|P2|Overall Study|Withdrawal by Subject|3
849295|NCT01197794|2702441|P1|Overall Study|Withdrawal by Subject|3
849296|NCT01197794|2702435|P7|Overall Study|Eligibility criteria not fulfilled|6
849297|NCT01197794|2702436|P6|Overall Study|Eligibility criteria not fulfilled|9
849298|NCT01197794|2702437|P5|Overall Study|Eligibility criteria not fulfilled|5
849299|NCT01197794|2702438|P4|Overall Study|Eligibility criteria not fulfilled|5
849300|NCT01197794|2702439|P3|Overall Study|Eligibility criteria not fulfilled|2
849301|NCT01197794|2702440|P2|Overall Study|Eligibility criteria not fulfilled|8
849302|NCT01197794|2702441|P1|Overall Study|Eligibility criteria not fulfilled|5
849303|NCT01197794|2702435|P7|Overall Study|Development of study withdrawal criteria|1
849304|NCT01197794|2702436|P6|Overall Study|Development of study withdrawal criteria|0
849305|NCT01197794|2702437|P5|Overall Study|Development of study withdrawal criteria|0
849306|NCT01197794|2702438|P4|Overall Study|Development of study withdrawal criteria|1
849307|NCT01197794|2702439|P3|Overall Study|Development of study withdrawal criteria|0
849308|NCT01197794|2702440|P2|Overall Study|Development of study withdrawal criteria|0
849309|NCT01197794|2702441|P1|Overall Study|Development of study withdrawal criteria|3
849310|NCT01197794|2702435|P7|Overall Study|Protocol Violation|1
849311|NCT01197794|2702436|P6|Overall Study|Protocol Violation|0
849312|NCT01197794|2702437|P5|Overall Study|Protocol Violation|2
849313|NCT01197794|2702438|P4|Overall Study|Protocol Violation|0
849314|NCT01197794|2702439|P3|Overall Study|Protocol Violation|0
849315|NCT01197794|2702440|P2|Overall Study|Protocol Violation|0
849316|NCT01197794|2702441|P1|Overall Study|Protocol Violation|0
849317|NCT01197794|2702435|P7|Overall Study|Adverse Event|3
849318|NCT01197794|2702436|P6|Overall Study|Adverse Event|2
849319|NCT01197794|2702437|P5|Overall Study|Adverse Event|4
849320|NCT01197794|2702438|P4|Overall Study|Adverse Event|4
849321|NCT01197794|2702439|P3|Overall Study|Adverse Event|4
849322|NCT01197794|2702440|P2|Overall Study|Adverse Event|2
849323|NCT01197794|2702441|P1|Overall Study|Adverse Event|3
849324|NCT01203956|2702536|P2|Second Two-week Period|Non-compliant: no evaluable results|6
849325|NCT01203956|2702537|P1|Second Two-week Period|Non-compliant: no evaluable results|5
849326|NCT01206101|2702564|P2|Overall Study|Unclassified|0
849327|NCT01206101|2702565|P1|Overall Study|Unclassified|1
849328|NCT01206101|2702564|P2|Overall Study|Physician Decision|1
849329|NCT01206101|2702565|P1|Overall Study|Physician Decision|0
849330|NCT01206101|2702564|P2|Overall Study|Adverse Event|0
849331|NCT01206101|2702565|P1|Overall Study|Adverse Event|1
849332|NCT01206140|2702583|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
849333|NCT01206140|2702584|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
849334|NCT01206322|2702596|P4|Overall Study|Adverse Event|1
849335|NCT01206322|2702597|P3|Overall Study|Adverse Event|0
849336|NCT01206322|2702598|P2|Overall Study|Adverse Event|0
849337|NCT01206322|2702599|P1|Overall Study|Adverse Event|0
849339|NCT01206517|2702668|P6|Overall Study|Withdrawal by Subject|0
849340|NCT01206517|2702669|P5|Overall Study|Withdrawal by Subject|1
849341|NCT01206517|2702670|P4|Overall Study|Withdrawal by Subject|0
849342|NCT01206517|2702671|P3|Overall Study|Withdrawal by Subject|2
849343|NCT01206517|2702672|P2|Overall Study|Withdrawal by Subject|0
849344|NCT01206517|2702673|P1|Overall Study|Withdrawal by Subject|0
849345|NCT01206582|2702704|P2|Overall Study|Discontinued intervention before week 8|2
849346|NCT01206582|2702705|P1|Overall Study|Discontinued intervention before week 8|1
849347|NCT01206582|2702704|P2|Overall Study|Withdrew prior to study|0
849348|NCT01206582|2702705|P1|Overall Study|Withdrew prior to study|1
849349|NCT01206777|2702779|P1|Overall Study|Adverse Event|1
849350|NCT01206777|2702779|P1|Overall Study|Death|1
849351|NCT01207102|2702785|P1|Overall Study|Withdrawal by Treating Physician|1
849352|NCT01207102|2702785|P1|Overall Study|progression|2
849353|NCT01207102|2702785|P1|Overall Study|Adverse Event|2
849354|NCT01207102|2702785|P1|Overall Study|Withdrawal by Subject|5
849355|NCT01207219|2702793|P3|Overall Study|Lost to Follow-up|6
849356|NCT01207219|2702794|P2|Overall Study|Lost to Follow-up|8
849357|NCT01207219|2702795|P1|Overall Study|Lost to Follow-up|6
849358|NCT01207219|2702793|P3|Overall Study|changed diagnosis during study period|1
849359|NCT01207219|2702794|P2|Overall Study|changed diagnosis during study period|3
849360|NCT01207219|2702795|P1|Overall Study|changed diagnosis during study period|5
849361|NCT01207388|2702815|P1|Overall Study|Other|1
849362|NCT01207388|2702815|P1|Overall Study|Physician Decision|2
849363|NCT01207388|2702815|P1|Overall Study|Disease Relapse|10
849364|NCT01207388|2702815|P1|Overall Study|Adverse Event|20
849365|NCT01207414|2702846|P2|Overall Study|Randomized in error|0
849366|NCT01207414|2702847|P1|Overall Study|Randomized in error|1
849367|NCT01207414|2702846|P2|Overall Study|Protocol deviation|9
849368|NCT01207414|2702847|P1|Overall Study|Protocol deviation|12
849369|NCT01207414|2702846|P2|Overall Study|Administrative problems|1
849370|NCT01207414|2702847|P1|Overall Study|Administrative problems|1
849371|NCT01207414|2702846|P2|Overall Study|Lost to Follow-up|17
849372|NCT01207414|2702847|P1|Overall Study|Lost to Follow-up|15
849373|NCT01207414|2702846|P2|Overall Study|Patient withdrew consent|11
849374|NCT01207414|2702847|P1|Overall Study|Patient withdrew consent|14
849375|NCT01207414|2702846|P2|Overall Study|Unsatisfactory therapeutic effect|4
849376|NCT01207414|2702847|P1|Overall Study|Unsatisfactory therapeutic effect|5
849377|NCT01207414|2702846|P2|Overall Study|Abnormal test procedure results|1
849378|NCT01207414|2702847|P1|Overall Study|Abnormal test procedure results|0
849379|NCT01207414|2702846|P2|Overall Study|Adverse Event|39
849380|NCT01207414|2702847|P1|Overall Study|Adverse Event|25
849381|NCT01207427|2702866|P3|Double-blind Treatment Period|Withdrawal by Subject|0
849382|NCT01207427|2702867|P2|Double-blind Treatment Period|Withdrawal by Subject|0
849383|NCT01207427|2702868|P1|Double-blind Treatment Period|Withdrawal by Subject|1
849384|NCT01207427|2702866|P3|Double-blind Treatment Period|Protocol Violation|1
849385|NCT01207427|2702867|P2|Double-blind Treatment Period|Protocol Violation|1
849386|NCT01207427|2702868|P1|Double-blind Treatment Period|Protocol Violation|2
849387|NCT01207427|2702866|P3|Double-blind Treatment Period|Lost to Follow-up|1
849388|NCT01207427|2702867|P2|Double-blind Treatment Period|Lost to Follow-up|0
849389|NCT01207427|2702868|P1|Double-blind Treatment Period|Lost to Follow-up|0
849390|NCT01207427|2702866|P3|Double-blind Treatment Period|Adverse Event|0
849391|NCT01207427|2702867|P2|Double-blind Treatment Period|Adverse Event|1
849392|NCT01207427|2702868|P1|Double-blind Treatment Period|Adverse Event|0
849393|NCT01207453|2702878|P2|2nd Intervention|Lost to Follow-up|0
849394|NCT01207453|2702879|P1|2nd Intervention|Lost to Follow-up|1
849395|NCT01207453|2702878|P2|2nd Intervention|Adverse Event|2
849396|NCT01207453|2702879|P1|2nd Intervention|Adverse Event|1
849397|NCT01207453|2702878|P2|Washout|Lost to Follow-up|0
849398|NCT01207453|2702879|P1|Washout|Lost to Follow-up|1
849399|NCT01207453|2702878|P2|Washout|Adverse Event|0
849400|NCT01207453|2702879|P1|Washout|Adverse Event|1
849401|NCT01207453|2702878|P2|First Intervention|Adverse Event|1
849402|NCT01207453|2702879|P1|First Intervention|Adverse Event|2
849403|NCT01207492|2702905|P1|Overall Study|Toxicity|1
849404|NCT01207492|2702905|P1|Overall Study|Progressive disease|3
849405|NCT01207492|2702905|P1|Overall Study|Physician Decision|1
849406|NCT01207492|2702905|P1|Overall Study|Withdrawal by Subject|9
849407|NCT01207492|2702905|P1|Overall Study|Still on study|1
849408|NCT01207583|2702929|P3|Overall Study|Lost to Follow-up|0
849409|NCT01207583|2702930|P2|Overall Study|Lost to Follow-up|2
849410|NCT01207583|2702931|P1|Overall Study|Lost to Follow-up|0
849411|NCT01207583|2702929|P3|Overall Study|Participant failed to return|0
849412|NCT01207583|2702930|P2|Overall Study|Participant failed to return|0
849413|NCT01207583|2702931|P1|Overall Study|Participant failed to return|1
849414|NCT01207583|2702929|P3|Overall Study|Withdrawal by Subject|1
849415|NCT01207583|2702930|P2|Overall Study|Withdrawal by Subject|3
849416|NCT01207583|2702931|P1|Overall Study|Withdrawal by Subject|0
849417|NCT01207596|2702969|P1|Overall Study|Withdrawal by Subject|1
849418|NCT01207596|2702969|P1|Overall Study|Adverse Event|3
849419|NCT01207596|2702969|P1|Overall Study|Lack of Efficacy|1
849420|NCT01207596|2702969|P1|Overall Study|Physician Decision|4
849421|NCT01207687|2702987|P1|Overall Study|Withdrawal by Subject|1
849422|NCT01207687|2702987|P1|Overall Study|Adverse Event|1
849423|NCT01208181|2703030|P5|Part 2|Lack of Efficacy|0
849424|NCT01208181|2703031|P4|Part 2|Lack of Efficacy|7
849425|NCT01208181|2703032|P3|Part 2|Lack of Efficacy|5
849426|NCT01208181|2703033|P2|Part 2|Lack of Efficacy|0
849427|NCT01208181|2703034|P1|Part 2|Lack of Efficacy|0
849428|NCT01208181|2703030|P5|Part 2|Lost to Follow-up|0
849429|NCT01208181|2703031|P4|Part 2|Lost to Follow-up|2
849430|NCT01208181|2703032|P3|Part 2|Lost to Follow-up|1
849431|NCT01208181|2703033|P2|Part 2|Lost to Follow-up|0
849432|NCT01208181|2703034|P1|Part 2|Lost to Follow-up|0
849433|NCT01208181|2703030|P5|Part 2|Non-compliance with study drug|0
849434|NCT01208181|2703031|P4|Part 2|Non-compliance with study drug|1
849435|NCT01208181|2703032|P3|Part 2|Non-compliance with study drug|1
849436|NCT01208181|2703033|P2|Part 2|Non-compliance with study drug|0
849437|NCT01208181|2703034|P1|Part 2|Non-compliance with study drug|0
849438|NCT01208181|2703030|P5|Part 2|Physician Decision|0
849439|NCT01208181|2703031|P4|Part 2|Physician Decision|2
849440|NCT01208181|2703032|P3|Part 2|Physician Decision|1
849441|NCT01208181|2703033|P2|Part 2|Physician Decision|0
849442|NCT01208181|2703034|P1|Part 2|Physician Decision|0
849443|NCT01208181|2703030|P5|Part 2|Protocol Violation|0
849444|NCT01208181|2703031|P4|Part 2|Protocol Violation|0
849445|NCT01208181|2703032|P3|Part 2|Protocol Violation|1
849446|NCT01208181|2703033|P2|Part 2|Protocol Violation|0
849447|NCT01208181|2703034|P1|Part 2|Protocol Violation|0
849448|NCT01208181|2703030|P5|Part 2|Withdrawal by Subject|0
849449|NCT01208181|2703031|P4|Part 2|Withdrawal by Subject|1
849450|NCT01208181|2703032|P3|Part 2|Withdrawal by Subject|1
849451|NCT01208181|2703033|P2|Part 2|Withdrawal by Subject|0
849452|NCT01208181|2703034|P1|Part 2|Withdrawal by Subject|0
849453|NCT01208181|2703030|P5|Part 2|Adverse Event|0
849454|NCT01208181|2703031|P4|Part 2|Adverse Event|7
849455|NCT01208181|2703032|P3|Part 2|Adverse Event|6
849456|NCT01208181|2703033|P2|Part 2|Adverse Event|0
849457|NCT01208181|2703034|P1|Part 2|Adverse Event|0
849458|NCT01208181|2703030|P5|Part 1|Adverse Event|4
849459|NCT01208181|2703031|P4|Part 1|Adverse Event|0
849460|NCT01208181|2703032|P3|Part 1|Adverse Event|0
849461|NCT01208181|2703033|P2|Part 1|Adverse Event|24
849462|NCT01208181|2703034|P1|Part 1|Adverse Event|26
849463|NCT01208181|2703030|P5|Part 1|Lack of Efficacy|17
849464|NCT01208181|2703031|P4|Part 1|Lack of Efficacy|0
849465|NCT01208181|2703032|P3|Part 1|Lack of Efficacy|0
849466|NCT01208181|2703033|P2|Part 1|Lack of Efficacy|12
849467|NCT01208181|2703034|P1|Part 1|Lack of Efficacy|37
849468|NCT01208181|2703030|P5|Part 1|Lost to Follow-up|1
849469|NCT01208181|2703031|P4|Part 1|Lost to Follow-up|0
849470|NCT01208181|2703032|P3|Part 1|Lost to Follow-up|0
849471|NCT01208181|2703033|P2|Part 1|Lost to Follow-up|3
849472|NCT01208181|2703034|P1|Part 1|Lost to Follow-up|5
849473|NCT01208181|2703030|P5|Part 1|Non-compliance with study drug|0
849474|NCT01208181|2703031|P4|Part 1|Non-compliance with study drug|0
849475|NCT01208181|2703032|P3|Part 1|Non-compliance with study drug|0
849476|NCT01208181|2703033|P2|Part 1|Non-compliance with study drug|1
849477|NCT01208181|2703034|P1|Part 1|Non-compliance with study drug|1
849478|NCT01208181|2703030|P5|Part 1|Physician Decision|0
849479|NCT01208181|2703031|P4|Part 1|Physician Decision|0
849480|NCT01208181|2703032|P3|Part 1|Physician Decision|0
849481|NCT01208181|2703033|P2|Part 1|Physician Decision|0
849482|NCT01208181|2703034|P1|Part 1|Physician Decision|4
849483|NCT01208181|2703030|P5|Part 1|Protocol Violation|0
849484|NCT01208181|2703031|P4|Part 1|Protocol Violation|0
849485|NCT01208181|2703032|P3|Part 1|Protocol Violation|0
849486|NCT01208181|2703033|P2|Part 1|Protocol Violation|5
849487|NCT01208181|2703034|P1|Part 1|Protocol Violation|10
849488|NCT01208181|2703030|P5|Part 1|Technical problem|0
849489|NCT01208181|2703031|P4|Part 1|Technical problem|0
849490|NCT01208181|2703032|P3|Part 1|Technical problem|0
849491|NCT01208181|2703033|P2|Part 1|Technical problem|0
849492|NCT01208181|2703034|P1|Part 1|Technical problem|5
849493|NCT01208181|2703030|P5|Part 1|Withdrawal by Subject|0
849494|NCT01208181|2703031|P4|Part 1|Withdrawal by Subject|0
849495|NCT01208181|2703032|P3|Part 1|Withdrawal by Subject|0
849496|NCT01208181|2703033|P2|Part 1|Withdrawal by Subject|10
849497|NCT01208181|2703034|P1|Part 1|Withdrawal by Subject|11
849498|NCT01208207|2703066|P7|Part II|Technical Problems|0
849499|NCT01208207|2703067|P6|Part II|Technical Problems|1
849500|NCT01208207|2703068|P5|Part II|Technical Problems|0
849501|NCT01208207|2703069|P4|Part II|Technical Problems|1
849502|NCT01208207|2703070|P3|Part II|Technical Problems|0
849503|NCT01208207|2703071|P2|Part II|Technical Problems|0
849504|NCT01208207|2703072|P1|Part II|Technical Problems|0
849505|NCT01208207|2703066|P7|Part II|Protocol Violation|0
849506|NCT01208207|2703067|P6|Part II|Protocol Violation|0
849507|NCT01208207|2703068|P5|Part II|Protocol Violation|0
849508|NCT01208207|2703069|P4|Part II|Protocol Violation|1
849509|NCT01208207|2703070|P3|Part II|Protocol Violation|0
849510|NCT01208207|2703071|P2|Part II|Protocol Violation|0
849511|NCT01208207|2703072|P1|Part II|Protocol Violation|0
849512|NCT01208207|2703066|P7|Part II|Physician Decision|0
849513|NCT01208207|2703067|P6|Part II|Physician Decision|2
849514|NCT01208207|2703068|P5|Part II|Physician Decision|0
849515|NCT01208207|2703069|P4|Part II|Physician Decision|1
849516|NCT01208207|2703070|P3|Part II|Physician Decision|0
849517|NCT01208207|2703071|P2|Part II|Physician Decision|0
849518|NCT01208207|2703072|P1|Part II|Physician Decision|0
849519|NCT01208207|2703066|P7|Part II|Non-Compliance With Study Drug|0
849520|NCT01208207|2703067|P6|Part II|Non-Compliance With Study Drug|1
849521|NCT01208207|2703068|P5|Part II|Non-Compliance With Study Drug|1
849522|NCT01208207|2703069|P4|Part II|Non-Compliance With Study Drug|4
849523|NCT01208207|2703070|P3|Part II|Non-Compliance With Study Drug|0
849524|NCT01208207|2703071|P2|Part II|Non-Compliance With Study Drug|0
849525|NCT01208207|2703072|P1|Part II|Non-Compliance With Study Drug|0
849526|NCT01208207|2703066|P7|Part II|Lost to Follow-up|1
849527|NCT01208207|2703067|P6|Part II|Lost to Follow-up|2
849528|NCT01208207|2703068|P5|Part II|Lost to Follow-up|0
849529|NCT01208207|2703069|P4|Part II|Lost to Follow-up|4
849530|NCT01208207|2703070|P3|Part II|Lost to Follow-up|0
849531|NCT01208207|2703071|P2|Part II|Lost to Follow-up|0
849532|NCT01208207|2703072|P1|Part II|Lost to Follow-up|0
849533|NCT01208207|2703066|P7|Part II|Lack of Efficacy|3
849534|NCT01208207|2703067|P6|Part II|Lack of Efficacy|3
849535|NCT01208207|2703068|P5|Part II|Lack of Efficacy|4
849536|NCT01208207|2703069|P4|Part II|Lack of Efficacy|6
849537|NCT01208207|2703070|P3|Part II|Lack of Efficacy|0
849538|NCT01208207|2703071|P2|Part II|Lack of Efficacy|0
849539|NCT01208207|2703072|P1|Part II|Lack of Efficacy|0
849540|NCT01208207|2703066|P7|Part II|Adverse Event|2
849541|NCT01208207|2703067|P6|Part II|Adverse Event|4
849542|NCT01208207|2703068|P5|Part II|Adverse Event|9
849543|NCT01208207|2703069|P4|Part II|Adverse Event|5
849544|NCT01208207|2703070|P3|Part II|Adverse Event|0
849545|NCT01208207|2703071|P2|Part II|Adverse Event|0
849546|NCT01208207|2703072|P1|Part II|Adverse Event|0
849547|NCT01208207|2703066|P7|Part II|Withdrawal by Subject|5
849548|NCT01208207|2703067|P6|Part II|Withdrawal by Subject|3
849549|NCT01208207|2703068|P5|Part II|Withdrawal by Subject|9
849550|NCT01208207|2703069|P4|Part II|Withdrawal by Subject|10
849551|NCT01208207|2703070|P3|Part II|Withdrawal by Subject|0
849552|NCT01208207|2703071|P2|Part II|Withdrawal by Subject|0
849553|NCT01208207|2703072|P1|Part II|Withdrawal by Subject|0
849554|NCT01208207|2703066|P7|Part I|Withdrawal by Subject|0
849555|NCT01208207|2703067|P6|Part I|Withdrawal by Subject|0
849556|NCT01208207|2703068|P5|Part I|Withdrawal by Subject|0
849557|NCT01208207|2703069|P4|Part I|Withdrawal by Subject|0
849558|NCT01208207|2703070|P3|Part I|Withdrawal by Subject|4
849559|NCT01208207|2703071|P2|Part I|Withdrawal by Subject|4
849560|NCT01208207|2703072|P1|Part I|Withdrawal by Subject|14
849561|NCT01208207|2703066|P7|Part I|Protocol Violation|0
849562|NCT01208207|2703067|P6|Part I|Protocol Violation|0
849563|NCT01208207|2703068|P5|Part I|Protocol Violation|0
849564|NCT01208207|2703069|P4|Part I|Protocol Violation|0
849565|NCT01208207|2703070|P3|Part I|Protocol Violation|2
849566|NCT01208207|2703071|P2|Part I|Protocol Violation|0
849567|NCT01208207|2703072|P1|Part I|Protocol Violation|8
849568|NCT01208207|2703066|P7|Part I|Progressive Disease|0
849569|NCT01208207|2703067|P6|Part I|Progressive Disease|0
849570|NCT01208207|2703068|P5|Part I|Progressive Disease|0
849571|NCT01208207|2703069|P4|Part I|Progressive Disease|0
849572|NCT01208207|2703070|P3|Part I|Progressive Disease|0
849573|NCT01208207|2703071|P2|Part I|Progressive Disease|0
849574|NCT01208207|2703072|P1|Part I|Progressive Disease|1
849575|NCT01208207|2703066|P7|Part I|Physician Decision|0
849576|NCT01208207|2703067|P6|Part I|Physician Decision|0
849577|NCT01208207|2703068|P5|Part I|Physician Decision|0
849578|NCT01208207|2703069|P4|Part I|Physician Decision|0
849579|NCT01208207|2703070|P3|Part I|Physician Decision|0
849580|NCT01208207|2703071|P2|Part I|Physician Decision|1
849581|NCT01208207|2703072|P1|Part I|Physician Decision|0
849582|NCT01208207|2703066|P7|Part I|Non-Compliance With Study Drug|0
849583|NCT01208207|2703067|P6|Part I|Non-Compliance With Study Drug|0
849584|NCT01208207|2703068|P5|Part I|Non-Compliance With Study Drug|0
849585|NCT01208207|2703069|P4|Part I|Non-Compliance With Study Drug|0
849586|NCT01208207|2703070|P3|Part I|Non-Compliance With Study Drug|1
849587|NCT01208207|2703071|P2|Part I|Non-Compliance With Study Drug|0
849588|NCT01208207|2703072|P1|Part I|Non-Compliance With Study Drug|1
849589|NCT01208207|2703066|P7|Part I|Lost to Follow-up|0
849590|NCT01208207|2703067|P6|Part I|Lost to Follow-up|0
849591|NCT01208207|2703068|P5|Part I|Lost to Follow-up|0
849592|NCT01208207|2703069|P4|Part I|Lost to Follow-up|0
849593|NCT01208207|2703070|P3|Part I|Lost to Follow-up|0
849594|NCT01208207|2703071|P2|Part I|Lost to Follow-up|1
849595|NCT01208207|2703072|P1|Part I|Lost to Follow-up|6
849596|NCT01208207|2703066|P7|Part I|Lack of Efficacy|0
849597|NCT01208207|2703067|P6|Part I|Lack of Efficacy|0
849598|NCT01208207|2703068|P5|Part I|Lack of Efficacy|0
849599|NCT01208207|2703069|P4|Part I|Lack of Efficacy|0
849600|NCT01208207|2703070|P3|Part I|Lack of Efficacy|2
849601|NCT01208207|2703071|P2|Part I|Lack of Efficacy|3
849602|NCT01208207|2703072|P1|Part I|Lack of Efficacy|21
849603|NCT01208207|2703066|P7|Part I|Adverse Event|0
849604|NCT01208207|2703067|P6|Part I|Adverse Event|0
849605|NCT01208207|2703068|P5|Part I|Adverse Event|0
849606|NCT01208207|2703069|P4|Part I|Adverse Event|0
849607|NCT01208207|2703070|P3|Part I|Adverse Event|6
849608|NCT01208207|2703071|P2|Part I|Adverse Event|2
849609|NCT01208207|2703072|P1|Part I|Adverse Event|19
849610|NCT01208233|2703113|P6|Overall Study|Withdrawal by Subject|2
849611|NCT01208233|2703114|P5|Overall Study|Withdrawal by Subject|4
849612|NCT01208233|2703115|P4|Overall Study|Withdrawal by Subject|1
849613|NCT01208233|2703116|P3|Overall Study|Withdrawal by Subject|1
849614|NCT01208233|2703117|P2|Overall Study|Withdrawal by Subject|0
849615|NCT01208233|2703118|P1|Overall Study|Withdrawal by Subject|1
849616|NCT01208233|2703113|P6|Overall Study|Unspecified|1
849617|NCT01208233|2703114|P5|Overall Study|Unspecified|0
849618|NCT01208233|2703115|P4|Overall Study|Unspecified|0
849619|NCT01208233|2703116|P3|Overall Study|Unspecified|0
849620|NCT01208233|2703117|P2|Overall Study|Unspecified|1
849621|NCT01208233|2703118|P1|Overall Study|Unspecified|2
849622|NCT01208233|2703113|P6|Overall Study|Protocol Violation|0
849623|NCT01208233|2703114|P5|Overall Study|Protocol Violation|3
849624|NCT01208233|2703115|P4|Overall Study|Protocol Violation|0
849625|NCT01208233|2703116|P3|Overall Study|Protocol Violation|0
849626|NCT01208233|2703117|P2|Overall Study|Protocol Violation|0
849627|NCT01208233|2703118|P1|Overall Study|Protocol Violation|0
849628|NCT01208233|2703113|P6|Overall Study|Study terminated by sponsor|7
849629|NCT01208233|2703114|P5|Overall Study|Study terminated by sponsor|10
849630|NCT01208233|2703115|P4|Overall Study|Study terminated by sponsor|0
849631|NCT01208233|2703116|P3|Overall Study|Study terminated by sponsor|0
849632|NCT01208233|2703117|P2|Overall Study|Study terminated by sponsor|0
849633|NCT01208233|2703118|P1|Overall Study|Study terminated by sponsor|0
849634|NCT01208233|2703113|P6|Overall Study|Medication error without adverse event|1
849635|NCT01208233|2703114|P5|Overall Study|Medication error without adverse event|0
849636|NCT01208233|2703115|P4|Overall Study|Medication error without adverse event|0
849637|NCT01208233|2703116|P3|Overall Study|Medication error without adverse event|0
849638|NCT01208233|2703117|P2|Overall Study|Medication error without adverse event|0
849639|NCT01208233|2703118|P1|Overall Study|Medication error without adverse event|0
849640|NCT01208233|2703113|P6|Overall Study|Did not meet entrance criteria|0
849641|NCT01208233|2703114|P5|Overall Study|Did not meet entrance criteria|1
849642|NCT01208233|2703115|P4|Overall Study|Did not meet entrance criteria|0
849643|NCT01208233|2703116|P3|Overall Study|Did not meet entrance criteria|1
849644|NCT01208233|2703117|P2|Overall Study|Did not meet entrance criteria|1
849645|NCT01208233|2703118|P1|Overall Study|Did not meet entrance criteria|2
849646|NCT01208233|2703113|P6|Overall Study|Death|5
849647|NCT01208233|2703114|P5|Overall Study|Death|3
849648|NCT01208233|2703115|P4|Overall Study|Death|0
849649|NCT01208233|2703116|P3|Overall Study|Death|0
849650|NCT01208233|2703117|P2|Overall Study|Death|0
849651|NCT01208233|2703118|P1|Overall Study|Death|0
849652|NCT01208233|2703113|P6|Overall Study|Adverse Event|5
849653|NCT01208233|2703114|P5|Overall Study|Adverse Event|3
849654|NCT01208233|2703115|P4|Overall Study|Adverse Event|0
849655|NCT01208233|2703116|P3|Overall Study|Adverse Event|2
849656|NCT01208233|2703117|P2|Overall Study|Adverse Event|1
849657|NCT01208233|2703118|P1|Overall Study|Adverse Event|0
849658|NCT01200758|2703231|P4|Stage 2|Death|5
849659|NCT01200758|2703232|P3|Stage 2|Death|3
849660|NCT01200758|2703233|P2|Stage 2|Death|0
849661|NCT01200758|2703234|P1|Stage 2|Death|0
849662|NCT01200758|2703231|P4|Stage 2|Protocol Violation|4
849663|NCT01200758|2703232|P3|Stage 2|Protocol Violation|1
849664|NCT01200758|2703233|P2|Stage 2|Protocol Violation|0
849665|NCT01200758|2703234|P1|Stage 2|Protocol Violation|0
849666|NCT01200758|2703231|P4|Stage 2|Lost to Follow-up|1
849667|NCT01200758|2703232|P3|Stage 2|Lost to Follow-up|3
849668|NCT01200758|2703233|P2|Stage 2|Lost to Follow-up|0
849669|NCT01200758|2703234|P1|Stage 2|Lost to Follow-up|0
849670|NCT01200758|2703231|P4|Stage 2|Withdrawal by Subject|1
849671|NCT01200758|2703232|P3|Stage 2|Withdrawal by Subject|4
849672|NCT01200758|2703233|P2|Stage 2|Withdrawal by Subject|0
849673|NCT01200758|2703234|P1|Stage 2|Withdrawal by Subject|0
849674|NCT01200758|2703231|P4|Stage 2|Adverse Event|9
849675|NCT01200758|2703232|P3|Stage 2|Adverse Event|5
849676|NCT01200758|2703233|P2|Stage 2|Adverse Event|0
849677|NCT01200758|2703234|P1|Stage 2|Adverse Event|0
849678|NCT01200758|2703231|P4|Stage 2|Physician Decision|7
849679|NCT01200758|2703232|P3|Stage 2|Physician Decision|5
849680|NCT01200758|2703233|P2|Stage 2|Physician Decision|0
849681|NCT01200758|2703234|P1|Stage 2|Physician Decision|0
849682|NCT01200758|2703231|P4|Stage 2|Lack of Efficacy|2
849683|NCT01200758|2703232|P3|Stage 2|Lack of Efficacy|4
849684|NCT01200758|2703233|P2|Stage 2|Lack of Efficacy|0
849685|NCT01200758|2703234|P1|Stage 2|Lack of Efficacy|0
849686|NCT01200758|2703231|P4|Stage 2|Disease Progression|21
849687|NCT01200758|2703232|P3|Stage 2|Disease Progression|16
849688|NCT01200758|2703233|P2|Stage 2|Disease Progression|0
849689|NCT01200758|2703234|P1|Stage 2|Disease Progression|0
849690|NCT01200758|2703231|P4|Stage I|Disease Progression|0
849691|NCT01200758|2703232|P3|Stage I|Disease Progression|0
849692|NCT01200758|2703233|P2|Stage I|Disease Progression|7
849693|NCT01200758|2703234|P1|Stage I|Disease Progression|9
849694|NCT01200758|2703231|P4|Stage I|Withdrawal by Subject|0
849695|NCT01200758|2703232|P3|Stage I|Withdrawal by Subject|0
849696|NCT01200758|2703233|P2|Stage I|Withdrawal by Subject|2
849697|NCT01200758|2703234|P1|Stage I|Withdrawal by Subject|1
849698|NCT01200758|2703231|P4|Stage I|Adverse Event|0
849699|NCT01200758|2703232|P3|Stage I|Adverse Event|0
849700|NCT01200758|2703233|P2|Stage I|Adverse Event|5
849701|NCT01200758|2703234|P1|Stage I|Adverse Event|5
849702|NCT01200758|2703231|P4|Stage I|Lack of Efficacy|0
849703|NCT01200758|2703232|P3|Stage I|Lack of Efficacy|0
849704|NCT01200758|2703233|P2|Stage I|Lack of Efficacy|1
849705|NCT01200758|2703234|P1|Stage I|Lack of Efficacy|2
849706|NCT01200758|2703231|P4|Stage I|Physician Decision|0
849707|NCT01200758|2703232|P3|Stage I|Physician Decision|0
849708|NCT01200758|2703233|P2|Stage I|Physician Decision|1
849709|NCT01200758|2703234|P1|Stage I|Physician Decision|1
849710|NCT01200758|2703231|P4|Stage I|Death|0
849711|NCT01200758|2703232|P3|Stage I|Death|0
849712|NCT01200758|2703233|P2|Stage I|Death|1
849713|NCT01200758|2703234|P1|Stage I|Death|0
849714|NCT01200797|2703288|P1|Overall Study|Disease Progression|13
849715|NCT01200797|2703288|P1|Overall Study|Adverse Event|4
849716|NCT01200797|2703288|P1|Overall Study|symptomatic deterioration|2
849723|NCT01200992|2703323|P2|Overall Study|Randomized but not treated|0
849724|NCT01200992|2703324|P1|Overall Study|Randomized but not treated|2
849725|NCT01200992|2703323|P2|Overall Study|Study terminated early|41
849726|NCT01200992|2703324|P1|Overall Study|Study terminated early|35
849727|NCT01201265|2703332|P1|Overall Study|Disease Progression|4
849728|NCT01201265|2703332|P1|Overall Study|Withdrawal by Subject|7
849729|NCT01201265|2703332|P1|Overall Study|Lost to Follow-up|10
849730|NCT01201265|2703332|P1|Overall Study|Insufficient Therapeutic Response|3
849731|NCT01201265|2703332|P1|Overall Study|Death|14
849732|NCT01201317|2703347|P3|Overall Study|Safety, possible history of tuberculosis|1
849733|NCT01201317|2703348|P2|Overall Study|Safety, possible history of tuberculosis|0
849734|NCT01201317|2703349|P1|Overall Study|Safety, possible history of tuberculosis|0
849735|NCT01201317|2703347|P3|Overall Study|Lack of Efficacy|0
849736|NCT01201317|2703348|P2|Overall Study|Lack of Efficacy|0
849737|NCT01201317|2703349|P1|Overall Study|Lack of Efficacy|1
849738|NCT01201317|2703347|P3|Overall Study|Decrease in renal function|0
849739|NCT01201317|2703348|P2|Overall Study|Decrease in renal function|1
849740|NCT01201317|2703349|P1|Overall Study|Decrease in renal function|0
849741|NCT01201317|2703347|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
849742|NCT01201317|2703348|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
849743|NCT01201317|2703349|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
849744|NCT01201317|2703347|P3|Overall Study|Study-specific withdrawal criteria|1
849745|NCT01201317|2703348|P2|Overall Study|Study-specific withdrawal criteria|0
849746|NCT01201317|2703349|P1|Overall Study|Study-specific withdrawal criteria|0
849747|NCT01201317|2703347|P3|Overall Study|Death|0
849748|NCT01201317|2703348|P2|Overall Study|Death|1
849749|NCT01201317|2703349|P1|Overall Study|Death|0
849750|NCT01201317|2703347|P3|Overall Study|Protocol Violation|1
849751|NCT01201317|2703348|P2|Overall Study|Protocol Violation|1
849752|NCT01201317|2703349|P1|Overall Study|Protocol Violation|0
849753|NCT01201317|2703347|P3|Overall Study|Screen failure|0
849754|NCT01201317|2703348|P2|Overall Study|Screen failure|1
849755|NCT01201317|2703349|P1|Overall Study|Screen failure|1
849756|NCT01201317|2703347|P3|Overall Study|Adverse Event|2
849757|NCT01201317|2703348|P2|Overall Study|Adverse Event|2
849758|NCT01201317|2703349|P1|Overall Study|Adverse Event|2
849759|NCT01201317|2703347|P3|Overall Study|Withdrawal by Subject|3
849760|NCT01201317|2703348|P2|Overall Study|Withdrawal by Subject|0
849761|NCT01201317|2703349|P1|Overall Study|Withdrawal by Subject|5
849762|NCT01201343|2703369|P1|Overall Study|Randomized, not treated|3
849763|NCT01201343|2703369|P1|Overall Study|Participant wrongly included in trial|1
849764|NCT01201343|2703369|P1|Overall Study|Lack of Efficacy|2
849765|NCT01201343|2703369|P1|Overall Study|Lost to Follow-up|2
849766|NCT01201343|2703369|P1|Overall Study|Withdrawal by Subject|5
849767|NCT01201343|2703369|P1|Overall Study|Adverse Event|6
849768|NCT01208337|2703380|P1|Overall Study|Death|3
849769|NCT01208402|2703390|P2|Overall Study|Withdrawal by Subject|0
849770|NCT01208402|2703391|P1|Overall Study|Withdrawal by Subject|1
849771|NCT01208415|2703407|P1|Overall Study|Still be eligible for follow-up|33
849772|NCT01208415|2703407|P1|Overall Study|Device not placed|1
849773|NCT01208415|2703407|P1|Overall Study|Withdrawal by Subject|3
849774|NCT01208415|2703407|P1|Overall Study|Lost to Follow-up|2
849775|NCT01208415|2703407|P1|Overall Study|Death|1
849776|NCT01208870|2703413|P2|Overall Study|Lost to Follow-up|8
849777|NCT01208870|2703414|P1|Overall Study|Lost to Follow-up|2
849778|NCT01208961|2703430|P2|High-Fat Period III|Protocol Violation|0
849779|NCT01208961|2703431|P1|High-Fat Period III|Protocol Violation|1
849780|NCT01209143|2703442|P2|Overall Study|Disease progression|16
849781|NCT01209143|2703443|P1|Overall Study|Disease progression|11
849782|NCT01209143|2703442|P2|Overall Study|Withdrawal by Subject|1
849783|NCT01209143|2703443|P1|Overall Study|Withdrawal by Subject|2
849784|NCT01209143|2703442|P2|Overall Study|Lost to Follow-up|0
849785|NCT01209143|2703443|P1|Overall Study|Lost to Follow-up|1
849786|NCT01209143|2703442|P2|Overall Study|Physician Decision|1
849787|NCT01209143|2703443|P1|Overall Study|Physician Decision|3
849788|NCT01209143|2703442|P2|Overall Study|Death|1
849789|NCT01209143|2703443|P1|Overall Study|Death|0
849790|NCT01209143|2703442|P2|Overall Study|Adverse Event|1
849791|NCT01209143|2703443|P1|Overall Study|Adverse Event|2
849792|NCT01209286|2703510|P3|Overall Study|Other|0
849793|NCT01209286|2703511|P2|Overall Study|Other|1
849794|NCT01209286|2703512|P1|Overall Study|Other|0
849795|NCT01209286|2703510|P3|Overall Study|Physician Decision|0
849796|NCT01209286|2703511|P2|Overall Study|Physician Decision|2
849797|NCT01209286|2703512|P1|Overall Study|Physician Decision|0
849798|NCT01209286|2703510|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
849799|NCT01209286|2703511|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
849800|NCT01209286|2703512|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
849801|NCT01209286|2703510|P3|Overall Study|Hematological Relapse After Remission|1
849802|NCT01209286|2703511|P2|Overall Study|Hematological Relapse After Remission|1
849803|NCT01209286|2703512|P1|Overall Study|Hematological Relapse After Remission|0
849804|NCT01209286|2703510|P3|Overall Study|Adverse Event|1
849805|NCT01209286|2703511|P2|Overall Study|Adverse Event|3
849806|NCT01209286|2703512|P1|Overall Study|Adverse Event|4
849807|NCT01209520|2703563|P1|Overall Study|Withdrawal by Subject|3
849808|NCT01209624|2703568|P1|Overall Study|Unspecified|4
849809|NCT01209624|2703568|P1|Overall Study|Lost to Follow-up|290
849810|NCT01209624|2703568|P1|Overall Study|Lack of Efficacy|17
849811|NCT01209624|2703568|P1|Overall Study|Adverse Event|13
849812|NCT01209624|2703568|P1|Overall Study|Death|2
849813|NCT01209689|2703601|P2|Overall Study|Sponsor's Decision to Stop the Study|17
849814|NCT01209689|2703602|P1|Overall Study|Sponsor's Decision to Stop the Study|68
849815|NCT01209689|2703601|P2|Overall Study|Failure to Return|0
849816|NCT01209689|2703602|P1|Overall Study|Failure to Return|3
849817|NCT01209689|2703601|P2|Overall Study|Violation of Selection Criteria at Entry|0
849818|NCT01209689|2703602|P1|Overall Study|Violation of Selection Criteria at Entry|1
849819|NCT01209689|2703601|P2|Overall Study|Adverse Event|0
849820|NCT01209689|2703602|P1|Overall Study|Adverse Event|4
849821|NCT01209689|2703601|P2|Overall Study|Refused Treatment|3
849822|NCT01209689|2703602|P1|Overall Study|Refused Treatment|8
849823|NCT01209689|2703601|P2|Overall Study|Insufficient Therapeutic Response|2
849824|NCT01209689|2703602|P1|Overall Study|Insufficient Therapeutic Response|7
849825|NCT01209767|2703667|P1|Overall Study|Lost to Follow-up|3
849826|NCT01209767|2703667|P1|Overall Study|Withdrawal by Subject|1
849827|NCT01209780|2703679|P5|Overall Study|Inappropriate enrollment|1
849828|NCT01209780|2703680|P4|Overall Study|Inappropriate enrollment|0
849829|NCT01209780|2703681|P3|Overall Study|Inappropriate enrollment|0
849830|NCT01209780|2703682|P2|Overall Study|Inappropriate enrollment|2
849831|NCT01209780|2703683|P1|Overall Study|Inappropriate enrollment|0
849832|NCT01209780|2703679|P5|Overall Study|Protocol Violation|0
849833|NCT01209780|2703680|P4|Overall Study|Protocol Violation|0
849834|NCT01209780|2703681|P3|Overall Study|Protocol Violation|0
849835|NCT01209780|2703682|P2|Overall Study|Protocol Violation|1
849836|NCT01209780|2703683|P1|Overall Study|Protocol Violation|0
849837|NCT01209780|2703679|P5|Overall Study|Lost to Follow-up|4
849838|NCT01209780|2703680|P4|Overall Study|Lost to Follow-up|9
849839|NCT01209780|2703681|P3|Overall Study|Lost to Follow-up|3
849840|NCT01209780|2703682|P2|Overall Study|Lost to Follow-up|12
849841|NCT01209780|2703683|P1|Overall Study|Lost to Follow-up|17
849842|NCT01209780|2703679|P5|Overall Study|Withdrawal by Subject|0
849843|NCT01209780|2703680|P4|Overall Study|Withdrawal by Subject|1
849844|NCT01209780|2703681|P3|Overall Study|Withdrawal by Subject|1
849845|NCT01209780|2703682|P2|Overall Study|Withdrawal by Subject|2
849846|NCT01209780|2703683|P1|Overall Study|Withdrawal by Subject|9
849847|NCT01209780|2703679|P5|Overall Study|Adverse Event|0
849848|NCT01209780|2703680|P4|Overall Study|Adverse Event|0
849849|NCT01209780|2703681|P3|Overall Study|Adverse Event|0
849850|NCT01209780|2703682|P2|Overall Study|Adverse Event|1
849851|NCT01209780|2703683|P1|Overall Study|Adverse Event|0
849852|NCT01209949|2703709|P1|Overall Study|Lost to Follow-up|3
849853|NCT01210001|2703718|P3|Overall Study|Other reason not defined above|1
849854|NCT01210001|2703719|P2|Overall Study|Other reason not defined above|2
849855|NCT01210001|2703720|P1|Overall Study|Other reason not defined above|2
849856|NCT01210001|2703718|P3|Overall Study|Patient refusal to continue,not due toAE|1
849857|NCT01210001|2703719|P2|Overall Study|Patient refusal to continue,not due toAE|2
849858|NCT01210001|2703720|P1|Overall Study|Patient refusal to continue,not due toAE|6
849859|NCT01210001|2703718|P3|Overall Study|Lost to Follow-up|2
849860|NCT01210001|2703719|P2|Overall Study|Lost to Follow-up|3
849861|NCT01210001|2703720|P1|Overall Study|Lost to Follow-up|4
849862|NCT01210001|2703718|P3|Overall Study|Non compliant with protocol|3
849863|NCT01210001|2703719|P2|Overall Study|Non compliant with protocol|2
849864|NCT01210001|2703720|P1|Overall Study|Non compliant with protocol|2
849865|NCT01210001|2703718|P3|Overall Study|Adverse Event|5
849866|NCT01210001|2703719|P2|Overall Study|Adverse Event|2
849867|NCT01210001|2703720|P1|Overall Study|Adverse Event|4
849868|NCT01210001|2703718|P3|Overall Study|Not treated|0
849869|NCT01210001|2703719|P2|Overall Study|Not treated|0
849870|NCT01210001|2703720|P1|Overall Study|Not treated|1
849871|NCT01210118|2703751|P2|Overall Study|Spontaneous abortion|3
849872|NCT01210118|2703752|P1|Overall Study|Spontaneous abortion|1
849873|NCT01210118|2703751|P2|Overall Study|Protocol Violation|1
849874|NCT01210118|2703752|P1|Overall Study|Protocol Violation|1
849875|NCT01210118|2703751|P2|Overall Study|Lost to Follow-up|1
849876|NCT01210118|2703752|P1|Overall Study|Lost to Follow-up|1
849877|NCT01210144|2703766|P2|Overall Study|No transfer|0
849878|NCT01210144|2703767|P1|Overall Study|No transfer|1
849879|NCT01210144|2703766|P2|Overall Study|No fertilization|0
849880|NCT01210144|2703767|P1|Overall Study|No fertilization|1
849881|NCT01210144|2703766|P2|Overall Study|Lack of ovarian response|0
849882|NCT01210144|2703767|P1|Overall Study|Lack of ovarian response|1
849883|NCT01210443|2703801|P1|Overall Study|Study terminated by sponsor|2
849884|NCT01210495|2703813|P4|Overall Study|Lost to Follow-up|0
849885|NCT01210495|2703814|P3|Overall Study|Lost to Follow-up|1
849886|NCT01210495|2703815|P2|Overall Study|Lost to Follow-up|0
849887|NCT01210495|2703816|P1|Overall Study|Lost to Follow-up|0
849888|NCT01210495|2703813|P4|Overall Study|Ongoing on Treatment|1
849889|NCT01210495|2703814|P3|Overall Study|Ongoing on Treatment|7
849890|NCT01210495|2703815|P2|Overall Study|Ongoing on Treatment|0
849891|NCT01210495|2703816|P1|Overall Study|Ongoing on Treatment|0
849892|NCT01210495|2703813|P4|Overall Study|Ongoing in Follow-up|13
849893|NCT01210495|2703814|P3|Overall Study|Ongoing in Follow-up|14
849894|NCT01210495|2703815|P2|Overall Study|Ongoing in Follow-up|1
849895|NCT01210495|2703816|P1|Overall Study|Ongoing in Follow-up|0
849896|NCT01210495|2703813|P4|Overall Study|Death|52
849897|NCT01210495|2703814|P3|Overall Study|Death|101
849898|NCT01210495|2703815|P2|Overall Study|Death|6
849899|NCT01210495|2703816|P1|Overall Study|Death|14
849900|NCT01210495|2703813|P4|Overall Study|Participant Refused Further Follow-Up|2
849901|NCT01210495|2703814|P3|Overall Study|Participant Refused Further Follow-Up|11
849902|NCT01210495|2703815|P2|Overall Study|Participant Refused Further Follow-Up|0
849903|NCT01210495|2703816|P1|Overall Study|Participant Refused Further Follow-Up|1
849904|NCT01210651|2703880|P2|Overall Study|Injury outside study|0
849905|NCT01210651|2703881|P1|Overall Study|Injury outside study|2
849906|NCT01210651|2703880|P2|Overall Study|Withdrawal by Subject|1
849907|NCT01210651|2703881|P1|Overall Study|Withdrawal by Subject|1
849908|NCT01210651|2703880|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
849909|NCT01210651|2703881|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
849910|NCT01210651|2703880|P2|Overall Study|schedule conflicts|5
849911|NCT01210651|2703881|P1|Overall Study|schedule conflicts|1
849912|NCT01210651|2703880|P2|Overall Study|Lost to Follow-up|1
849913|NCT01210651|2703881|P1|Overall Study|Lost to Follow-up|1
849914|NCT01210690|2703895|P1|Overall Study|Patient could not take glucose|1
849915|NCT01210690|2703895|P1|Overall Study|Patient refused to swallow|1
849916|NCT01210690|2703895|P1|Overall Study|Withdrawal by Subject|1
849917|NCT01210690|2703895|P1|Overall Study|Disease Remission|1
849918|NCT01210690|2703895|P1|Overall Study|Lost to Follow-up|3
849919|NCT01210690|2703895|P1|Overall Study|Lack of Efficacy|12
849920|NCT01210690|2703895|P1|Overall Study|Adverse Event|7
849921|NCT01210807|2703917|P2|Overall Study|Not implanted bilaterally|1
849922|NCT01210807|2703918|P1|Overall Study|Not implanted bilaterally|2
849923|NCT01210807|2703917|P2|Overall Study|Lost to Follow-up|2
849924|NCT01210807|2703918|P1|Overall Study|Lost to Follow-up|1
849925|NCT01204294|2703955|P7|Overall Study|Other (house moving)|0
849926|NCT01204294|2703956|P6|Overall Study|Other (house moving)|0
849927|NCT01204294|2703957|P5|Overall Study|Other (house moving)|0
849928|NCT01204294|2703958|P4|Overall Study|Other (house moving)|0
849929|NCT01204294|2703959|P3|Overall Study|Other (house moving)|1
849930|NCT01204294|2703960|P2|Overall Study|Other (house moving)|0
849931|NCT01204294|2703961|P1|Overall Study|Other (house moving)|0
849932|NCT01204294|2703955|P7|Overall Study|Lack of Efficacy|0
849933|NCT01204294|2703956|P6|Overall Study|Lack of Efficacy|0
849934|NCT01204294|2703957|P5|Overall Study|Lack of Efficacy|0
849935|NCT01204294|2703958|P4|Overall Study|Lack of Efficacy|2
849936|NCT01204294|2703959|P3|Overall Study|Lack of Efficacy|0
849937|NCT01204294|2703960|P2|Overall Study|Lack of Efficacy|0
849938|NCT01204294|2703961|P1|Overall Study|Lack of Efficacy|0
849939|NCT01204294|2703955|P7|Overall Study|Withdrawal by Subject|2
849940|NCT01204294|2703956|P6|Overall Study|Withdrawal by Subject|1
849941|NCT01204294|2703957|P5|Overall Study|Withdrawal by Subject|1
849942|NCT01204294|2703958|P4|Overall Study|Withdrawal by Subject|1
849943|NCT01204294|2703959|P3|Overall Study|Withdrawal by Subject|2
849944|NCT01204294|2703960|P2|Overall Study|Withdrawal by Subject|2
849945|NCT01204294|2703961|P1|Overall Study|Withdrawal by Subject|0
849946|NCT01204294|2703955|P7|Overall Study|Protocol Violation|0
849947|NCT01204294|2703956|P6|Overall Study|Protocol Violation|0
849948|NCT01204294|2703957|P5|Overall Study|Protocol Violation|0
849949|NCT01204294|2703958|P4|Overall Study|Protocol Violation|1
849950|NCT01204294|2703959|P3|Overall Study|Protocol Violation|2
849951|NCT01204294|2703960|P2|Overall Study|Protocol Violation|0
849952|NCT01204294|2703961|P1|Overall Study|Protocol Violation|1
849953|NCT01204294|2703955|P7|Overall Study|Adverse Event|0
849954|NCT01204294|2703956|P6|Overall Study|Adverse Event|4
849955|NCT01204294|2703957|P5|Overall Study|Adverse Event|1
849956|NCT01204294|2703958|P4|Overall Study|Adverse Event|7
849957|NCT01204294|2703959|P3|Overall Study|Adverse Event|0
849958|NCT01204294|2703960|P2|Overall Study|Adverse Event|6
849959|NCT01204294|2703961|P1|Overall Study|Adverse Event|2
849960|NCT01204398|2703984|P1|Overall Study|Adverse Event|1
849961|NCT01204658|2703998|P4|Primary Phase|Adverse Event|0
849962|NCT01204658|2703999|P3|Primary Phase|Adverse Event|1
849963|NCT01204658|2704000|P2|Primary Phase|Adverse Event|0
849964|NCT01204658|2704001|P1|Primary Phase|Adverse Event|0
849965|NCT01204671|2704116|P5|Overall Study|Physician Decision|0
849966|NCT01204671|2704117|P4|Overall Study|Physician Decision|1
849967|NCT01204671|2704118|P3|Overall Study|Physician Decision|0
849968|NCT01204671|2704119|P2|Overall Study|Physician Decision|0
849969|NCT01204671|2704120|P1|Overall Study|Physician Decision|0
849970|NCT01204671|2704116|P5|Overall Study|Unknown Completion Status|0
849971|NCT01204671|2704117|P4|Overall Study|Unknown Completion Status|0
849972|NCT01204671|2704118|P3|Overall Study|Unknown Completion Status|0
849973|NCT01204671|2704119|P2|Overall Study|Unknown Completion Status|1
849974|NCT01204671|2704120|P1|Overall Study|Unknown Completion Status|1
849975|NCT01204671|2704116|P5|Overall Study|Lost to Follow-up|0
849976|NCT01204671|2704117|P4|Overall Study|Lost to Follow-up|4
849977|NCT01204671|2704118|P3|Overall Study|Lost to Follow-up|6
849978|NCT01204671|2704119|P2|Overall Study|Lost to Follow-up|8
849979|NCT01204671|2704120|P1|Overall Study|Lost to Follow-up|7
849980|NCT01204671|2704116|P5|Overall Study|Withdrawal by Subject|3
849981|NCT01204671|2704117|P4|Overall Study|Withdrawal by Subject|5
849982|NCT01204671|2704118|P3|Overall Study|Withdrawal by Subject|4
849983|NCT01204671|2704119|P2|Overall Study|Withdrawal by Subject|3
849984|NCT01204671|2704120|P1|Overall Study|Withdrawal by Subject|2
849985|NCT01204671|2704116|P5|Overall Study|Adverse Event|1
849986|NCT01204671|2704117|P4|Overall Study|Adverse Event|3
849987|NCT01204671|2704118|P3|Overall Study|Adverse Event|3
849988|NCT01204671|2704119|P2|Overall Study|Adverse Event|3
849989|NCT01204671|2704120|P1|Overall Study|Adverse Event|4
849990|NCT01204697|2704180|P2|Overall Study|Randomized, but not treated|1
849991|NCT01204697|2704181|P1|Overall Study|Randomized, but not treated|0
849992|NCT01204697|2704180|P2|Overall Study|Withdrawal by Subject|4
849993|NCT01204697|2704181|P1|Overall Study|Withdrawal by Subject|2
849994|NCT01204697|2704180|P2|Overall Study|Lost to Follow-up|4
849995|NCT01204697|2704181|P1|Overall Study|Lost to Follow-up|3
849996|NCT01204697|2704180|P2|Overall Study|Death|27
849997|NCT01204697|2704181|P1|Overall Study|Death|26
849998|NCT01204775|2704216|P2|Overall Study|Withdrawal by Subject|0
849999|NCT01204775|2704217|P1|Overall Study|Withdrawal by Subject|1
850000|NCT01204775|2704216|P2|Overall Study|Poor/non-compliance|1
850001|NCT01204775|2704217|P1|Overall Study|Poor/non-compliance|0
850002|NCT01205035|2704244|P2|Overall Study|Physician Decision|0
850003|NCT01205035|2704245|P1|Overall Study|Physician Decision|1
850004|NCT01205035|2704244|P2|Overall Study|Withdrawal by Subject|0
850005|NCT01205035|2704245|P1|Overall Study|Withdrawal by Subject|1
850006|NCT01205126|2704261|P2|Maintenance Phase|Withdrawal by Subject|11
850007|NCT01205126|2704262|P1|Maintenance Phase|Withdrawal by Subject|8
850008|NCT01205126|2704261|P2|Maintenance Phase|Lost to Follow-up|5
850009|NCT01205126|2704262|P1|Maintenance Phase|Lost to Follow-up|5
850010|NCT01205126|2704261|P2|Maintenance Phase|Unspecified|8
850011|NCT01205126|2704262|P1|Maintenance Phase|Unspecified|11
850012|NCT01205126|2704261|P2|Maintenance Phase|Prohibited drugs used|0
850013|NCT01205126|2704262|P1|Maintenance Phase|Prohibited drugs used|1
850014|NCT01205126|2704261|P2|Maintenance Phase|More than the maximum dosage required|5
850015|NCT01205126|2704262|P1|Maintenance Phase|More than the maximum dosage required|5
850016|NCT01205126|2704261|P2|Maintenance Phase|Death|4
850017|NCT01205126|2704262|P1|Maintenance Phase|Death|4
850018|NCT01205126|2704261|P2|Maintenance Phase|Adverse Event|7
850019|NCT01205126|2704262|P1|Maintenance Phase|Adverse Event|3
850020|NCT01205126|2704261|P2|Between Titration & Maintenance Phase|Unspecified|4
850021|NCT01205126|2704262|P1|Between Titration & Maintenance Phase|Unspecified|0
850022|NCT01205126|2704261|P2|Titration Phase|Unspecified|6
850023|NCT01205126|2704262|P1|Titration Phase|Unspecified|8
850024|NCT01205126|2704261|P2|Titration Phase|More than maximum dosage required|3
850025|NCT01205126|2704262|P1|Titration Phase|More than maximum dosage required|2
850026|NCT01205126|2704261|P2|Titration Phase|No stable titration dose|0
850027|NCT01205126|2704262|P1|Titration Phase|No stable titration dose|1
850028|NCT01205126|2704261|P2|Titration Phase|Lost to Follow-up|2
850029|NCT01205126|2704262|P1|Titration Phase|Lost to Follow-up|2
850030|NCT01205126|2704261|P2|Titration Phase|Withdrawal by Subject|5
850031|NCT01205126|2704262|P1|Titration Phase|Withdrawal by Subject|5
850032|NCT01205126|2704261|P2|Titration Phase|Adverse Event|3
850033|NCT01205126|2704262|P1|Titration Phase|Adverse Event|5
850034|NCT01205230|2704280|P2|Overall Study|Physician Decision|0
850035|NCT01205230|2704281|P1|Overall Study|Physician Decision|1
850036|NCT01205230|2704280|P2|Overall Study|Adverse Event|0
850037|NCT01205230|2704281|P1|Overall Study|Adverse Event|4
850038|NCT01205269|2704324|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
850039|NCT01205269|2704325|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
850040|NCT01205269|2704326|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
850041|NCT01205269|2704327|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
850042|NCT01205269|2704328|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
850043|NCT01205269|2704329|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
850044|NCT01205451|2704375|P2|Overall Study|Withdrawal by Subject|9
850045|NCT01205451|2704376|P1|Overall Study|Withdrawal by Subject|5
850046|NCT01205451|2704375|P2|Overall Study|Lost to Follow-up|1
850047|NCT01205451|2704376|P1|Overall Study|Lost to Follow-up|1
850048|NCT01205581|2704441|P6|Overall Study|Withdrawal by Subject|0
850049|NCT01205581|2704442|P5|Overall Study|Withdrawal by Subject|0
850050|NCT01205581|2704443|P4|Overall Study|Withdrawal by Subject|0
850051|NCT01205581|2704444|P3|Overall Study|Withdrawal by Subject|0
850052|NCT01205581|2704445|P2|Overall Study|Withdrawal by Subject|0
850053|NCT01205581|2704446|P1|Overall Study|Withdrawal by Subject|1
850054|NCT01205685|2704514|P1|Overall Study|Withdrawal by Subject|1
850055|NCT01205685|2704514|P1|Overall Study|Disease Progression|10
850056|NCT01211145|2704525|P4|Overall Study|Patient decision|2
850057|NCT01211145|2704526|P3|Overall Study|Patient decision|0
850058|NCT01211145|2704527|P2|Overall Study|Patient decision|1
850059|NCT01211145|2704528|P1|Overall Study|Patient decision|2
850060|NCT01211145|2704525|P4|Overall Study|Eligibility criteria not fulfilled|15
850061|NCT01211145|2704526|P3|Overall Study|Eligibility criteria not fulfilled|10
850062|NCT01211145|2704527|P2|Overall Study|Eligibility criteria not fulfilled|12
850063|NCT01211145|2704528|P1|Overall Study|Eligibility criteria not fulfilled|16
850064|NCT01211145|2704525|P4|Overall Study|Severe noncompliance to protocol|0
850065|NCT01211145|2704526|P3|Overall Study|Severe noncompliance to protocol|0
850066|NCT01211145|2704527|P2|Overall Study|Severe noncompliance to protocol|0
850067|NCT01211145|2704528|P1|Overall Study|Severe noncompliance to protocol|1
850068|NCT01211145|2704525|P4|Overall Study|Study-specific withdrawal criteria|0
850069|NCT01211145|2704526|P3|Overall Study|Study-specific withdrawal criteria|0
850070|NCT01211145|2704527|P2|Overall Study|Study-specific withdrawal criteria|0
850071|NCT01211145|2704528|P1|Overall Study|Study-specific withdrawal criteria|1
850072|NCT01211145|2704525|P4|Overall Study|Lost to Follow-up|2
850073|NCT01211145|2704526|P3|Overall Study|Lost to Follow-up|1
850074|NCT01211145|2704527|P2|Overall Study|Lost to Follow-up|2
850075|NCT01211145|2704528|P1|Overall Study|Lost to Follow-up|3
850076|NCT01211145|2704525|P4|Overall Study|Reason not specified|1
850077|NCT01211145|2704526|P3|Overall Study|Reason not specified|2
850078|NCT01211145|2704527|P2|Overall Study|Reason not specified|2
850079|NCT01211145|2704528|P1|Overall Study|Reason not specified|3
850080|NCT01211184|2704561|P3|Overall Study|Withdrawal by Subject|1
850081|NCT01211184|2704562|P2|Overall Study|Withdrawal by Subject|2
850082|NCT01211184|2704563|P1|Overall Study|Withdrawal by Subject|0
850083|NCT01211197|2704574|P6|Washout Period 2 (7 Days)|Adverse Event|0
850084|NCT01211197|2704575|P5|Washout Period 2 (7 Days)|Adverse Event|0
850085|NCT01211197|2704576|P4|Washout Period 2 (7 Days)|Adverse Event|0
850086|NCT01211197|2704577|P3|Washout Period 2 (7 Days)|Adverse Event|0
850087|NCT01211197|2704578|P2|Washout Period 2 (7 Days)|Adverse Event|0
850088|NCT01211197|2704579|P1|Washout Period 2 (7 Days)|Adverse Event|1
850089|NCT01211197|2704574|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
850090|NCT01211197|2704575|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
850091|NCT01211197|2704576|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
850092|NCT01211197|2704577|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
850093|NCT01211197|2704578|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
850094|NCT01211197|2704579|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
850095|NCT01213836|2704705|P2|Period 1, First Intervention|Withdrawal by Subject|1
850096|NCT01213836|2704706|P1|Period 1, First Intervention|Withdrawal by Subject|1
850097|NCT01213836|2704705|P2|Period 1, First Intervention|Protocol Violation|1
850098|NCT01213836|2704706|P1|Period 1, First Intervention|Protocol Violation|0
850099|NCT01213836|2704705|P2|Period 1, First Intervention|Adverse Event|1
850100|NCT01213836|2704706|P1|Period 1, First Intervention|Adverse Event|2
850101|NCT01213966|2704728|P4|Overall Study|Protocol Violation|1
850102|NCT01213966|2704729|P3|Overall Study|Protocol Violation|3
850103|NCT01213966|2704730|P2|Overall Study|Protocol Violation|0
850104|NCT01213966|2704731|P1|Overall Study|Protocol Violation|1
850105|NCT01214174|2704886|P3|Overall Study|Withdrawal by Subject|1
850106|NCT01214174|2704887|P2|Overall Study|Withdrawal by Subject|0
850107|NCT01214174|2704888|P1|Overall Study|Withdrawal by Subject|0
850108|NCT01214187|2704898|P2|Overall Study|Withdrawal by Subject|3
850109|NCT01214187|2704899|P1|Overall Study|Withdrawal by Subject|0
850110|NCT01214187|2704898|P2|Overall Study|Death|1
850111|NCT01214187|2704899|P1|Overall Study|Death|1
850112|NCT01214187|2704898|P2|Overall Study|Adverse Event|2
850113|NCT01214187|2704899|P1|Overall Study|Adverse Event|6
850114|NCT01214239|2704915|P2|Overall Study|patient's private reason|1
850115|NCT01214239|2704916|P1|Overall Study|patient's private reason|1
850116|NCT01214239|2704915|P2|Overall Study|Lack of Efficacy|2
850117|NCT01214239|2704916|P1|Overall Study|Lack of Efficacy|1
850118|NCT01214239|2704915|P2|Overall Study|Withdrawal by Subject|9
850119|NCT01214239|2704916|P1|Overall Study|Withdrawal by Subject|4
850120|NCT01214239|2704915|P2|Overall Study|Lost to Follow-up|1
850121|NCT01214239|2704916|P1|Overall Study|Lost to Follow-up|1
850122|NCT01214239|2704915|P2|Overall Study|Protocol Violation|1
850123|NCT01214239|2704916|P1|Overall Study|Protocol Violation|2
850124|NCT01214239|2704915|P2|Overall Study|Adverse Event|4
850125|NCT01214239|2704916|P1|Overall Study|Adverse Event|3
850126|NCT01214252|2704948|P1|Overall Study|Not eligible per protocol|82
850127|NCT01214395|2704958|P1|Overall Study|All patients had infection|5
850128|NCT01214434|2704965|P2|Overall Study|Site error|0
850129|NCT01214434|2704966|P1|Overall Study|Site error|1
850130|NCT01214434|2704965|P2|Overall Study|Lost to Follow-up|2
850131|NCT01214434|2704966|P1|Overall Study|Lost to Follow-up|2
850132|NCT01214434|2704965|P2|Overall Study|Withdrawal by Subject|0
850133|NCT01214434|2704966|P1|Overall Study|Withdrawal by Subject|1
850134|NCT01214616|2704986|P4|Overall Study|Withdrawal by Subject|1
850135|NCT01214616|2704987|P3|Overall Study|Withdrawal by Subject|0
850136|NCT01214616|2704988|P2|Overall Study|Withdrawal by Subject|0
850137|NCT01214616|2704989|P1|Overall Study|Withdrawal by Subject|1
850138|NCT01214616|2704986|P4|Overall Study|Other adverse events|1
850139|NCT01214616|2704987|P3|Overall Study|Other adverse events|1
850140|NCT01214616|2704988|P2|Overall Study|Other adverse events|1
850141|NCT01214616|2704989|P1|Overall Study|Other adverse events|0
850142|NCT01214616|2704986|P4|Overall Study|Dose limiting toxicity|0
850143|NCT01214616|2704987|P3|Overall Study|Dose limiting toxicity|0
850144|NCT01214616|2704988|P2|Overall Study|Dose limiting toxicity|2
850145|NCT01214616|2704989|P1|Overall Study|Dose limiting toxicity|0
850146|NCT01214616|2704986|P4|Overall Study|Progressive disease|4
850147|NCT01214616|2704987|P3|Overall Study|Progressive disease|2
850148|NCT01214616|2704988|P2|Overall Study|Progressive disease|2
850149|NCT01214616|2704989|P1|Overall Study|Progressive disease|2
850150|NCT01214720|2705025|P2|Overall Study|Lost to Follow-up|2
850151|NCT01214720|2705026|P1|Overall Study|Lost to Follow-up|6
850152|NCT01214720|2705025|P2|Overall Study|Alive and in follow-up|48
850153|NCT01214720|2705026|P1|Overall Study|Alive and in follow-up|45
850154|NCT01214720|2705025|P2|Overall Study|Alive and still on treatment|18
850155|NCT01214720|2705026|P1|Overall Study|Alive and still on treatment|34
850201|NCT01214915|2705188|P1|Overall Study|Lack of Efficacy|3
850202|NCT01214915|2705188|P1|Overall Study|Adverse Event|8
850203|NCT01215032|2705213|P1|Overall Study|Lack of Efficacy|17
850204|NCT01215032|2705213|P1|Overall Study|Adverse Event|3
850205|NCT01215097|2705223|P2|Overall Study|patient's private reason|1
850206|NCT01215097|2705224|P1|Overall Study|patient's private reason|1
850207|NCT01215097|2705223|P2|Overall Study|patient's refusal to come|2
850208|NCT01215097|2705224|P1|Overall Study|patient's refusal to come|2
850209|NCT01215097|2705223|P2|Overall Study|Lack of Efficacy|3
850210|NCT01215097|2705224|P1|Overall Study|Lack of Efficacy|0
850211|NCT01215097|2705223|P2|Overall Study|Withdrawal by Subject|3
850212|NCT01215097|2705224|P1|Overall Study|Withdrawal by Subject|6
850213|NCT01215097|2705223|P2|Overall Study|Lost to Follow-up|0
850214|NCT01215097|2705224|P1|Overall Study|Lost to Follow-up|2
850215|NCT01215097|2705223|P2|Overall Study|Protocol Violation|2
850216|NCT01215097|2705224|P1|Overall Study|Protocol Violation|0
850217|NCT01215097|2705223|P2|Overall Study|Adverse Event|3
850218|NCT01215097|2705224|P1|Overall Study|Adverse Event|1
850219|NCT01215227|2705335|P6|Overall Study|Randomized but not treated|1
850220|NCT01215227|2705336|P5|Overall Study|Randomized but not treated|0
850221|NCT01215227|2705337|P4|Overall Study|Randomized but not treated|1
850222|NCT01215227|2705338|P3|Overall Study|Randomized but not treated|1
850223|NCT01215227|2705339|P2|Overall Study|Randomized but not treated|0
850224|NCT01215227|2705340|P1|Overall Study|Randomized but not treated|0
850225|NCT01215227|2705335|P6|Overall Study|Missing Status|0
850226|NCT01215227|2705336|P5|Overall Study|Missing Status|0
850227|NCT01215227|2705337|P4|Overall Study|Missing Status|0
850228|NCT01215227|2705338|P3|Overall Study|Missing Status|0
850229|NCT01215227|2705339|P2|Overall Study|Missing Status|1
850230|NCT01215227|2705340|P1|Overall Study|Missing Status|0
850231|NCT01215227|2705335|P6|Overall Study|Administrative|40
850232|NCT01215227|2705336|P5|Overall Study|Administrative|28
850233|NCT01215227|2705337|P4|Overall Study|Administrative|24
850234|NCT01215227|2705338|P3|Overall Study|Administrative|42
850235|NCT01215227|2705339|P2|Overall Study|Administrative|73
850236|NCT01215227|2705340|P1|Overall Study|Administrative|83
850237|NCT01215227|2705335|P6|Overall Study|Non-Compliance With Protocol|0
850238|NCT01215227|2705336|P5|Overall Study|Non-Compliance With Protocol|0
850239|NCT01215227|2705337|P4|Overall Study|Non-Compliance With Protocol|0
850240|NCT01215227|2705338|P3|Overall Study|Non-Compliance With Protocol|1
850241|NCT01215227|2705339|P2|Overall Study|Non-Compliance With Protocol|6
850242|NCT01215227|2705340|P1|Overall Study|Non-Compliance With Protocol|2
850243|NCT01215227|2705335|P6|Overall Study|Subject Withdrew Consent|8
850244|NCT01215227|2705336|P5|Overall Study|Subject Withdrew Consent|11
850245|NCT01215227|2705337|P4|Overall Study|Subject Withdrew Consent|10
850246|NCT01215227|2705338|P3|Overall Study|Subject Withdrew Consent|7
850247|NCT01215227|2705339|P2|Overall Study|Subject Withdrew Consent|20
850248|NCT01215227|2705340|P1|Overall Study|Subject Withdrew Consent|16
850249|NCT01215227|2705335|P6|Overall Study|Lost to Follow-up|2
850250|NCT01215227|2705336|P5|Overall Study|Lost to Follow-up|1
850251|NCT01215227|2705337|P4|Overall Study|Lost to Follow-up|1
850252|NCT01215227|2705338|P3|Overall Study|Lost to Follow-up|1
850253|NCT01215227|2705339|P2|Overall Study|Lost to Follow-up|4
850254|NCT01215227|2705340|P1|Overall Study|Lost to Follow-up|1
850255|NCT01215227|2705335|P6|Overall Study|Treatment Failure|1
850256|NCT01215227|2705336|P5|Overall Study|Treatment Failure|1
850257|NCT01215227|2705337|P4|Overall Study|Treatment Failure|5
850258|NCT01215227|2705338|P3|Overall Study|Treatment Failure|1
850259|NCT01215227|2705339|P2|Overall Study|Treatment Failure|4
850260|NCT01215227|2705340|P1|Overall Study|Treatment Failure|8
850261|NCT01215227|2705335|P6|Overall Study|Adverse Event|6
850262|NCT01215227|2705336|P5|Overall Study|Adverse Event|7
850263|NCT01215227|2705337|P4|Overall Study|Adverse Event|8
850264|NCT01215227|2705338|P3|Overall Study|Adverse Event|4
850265|NCT01215227|2705339|P2|Overall Study|Adverse Event|11
850266|NCT01215227|2705340|P1|Overall Study|Adverse Event|11
850267|NCT01215357|2705493|P1|Overall Study|Protocol Violation|9
850268|NCT01215357|2705493|P1|Overall Study|Withdrawal by Subject|3
850269|NCT01215422|2705501|P4|Overall Study|Did not complete all intubations|0
850270|NCT01215422|2705502|P3|Overall Study|Did not complete all intubations|0
850271|NCT01215422|2705503|P2|Overall Study|Did not complete all intubations|0
850272|NCT01215422|2705504|P1|Overall Study|Did not complete all intubations|7
850273|NCT01215422|2705501|P4|Overall Study|Failed intubations|8
850274|NCT01215422|2705502|P3|Overall Study|Failed intubations|3
850275|NCT01215422|2705503|P2|Overall Study|Failed intubations|0
850276|NCT01215422|2705504|P1|Overall Study|Failed intubations|0
850277|NCT01215422|2705501|P4|Overall Study|Relocation|0
850278|NCT01215422|2705502|P3|Overall Study|Relocation|0
850279|NCT01215422|2705503|P2|Overall Study|Relocation|0
850280|NCT01215422|2705504|P1|Overall Study|Relocation|1
850281|NCT01215435|2705528|P2|Overall Study|Unclassified|5
850282|NCT01215435|2705529|P1|Overall Study|Unclassified|5
850283|NCT01215435|2705528|P2|Overall Study|Lost to Follow-up|0
850284|NCT01215435|2705529|P1|Overall Study|Lost to Follow-up|3
850285|NCT01215435|2705528|P2|Overall Study|Withdrawal Criteria|11
850286|NCT01215435|2705529|P1|Overall Study|Withdrawal Criteria|8
850287|NCT01215435|2705528|P2|Overall Study|Protocol Violation|0
850288|NCT01215435|2705529|P1|Overall Study|Protocol Violation|2
850289|NCT01215435|2705528|P2|Overall Study|Adverse Event|0
850290|NCT01215435|2705529|P1|Overall Study|Adverse Event|1
850291|NCT01215513|2705539|P1|Overall Study|Miscellaneous reasons (CS42A)|2
850292|NCT01215513|2705539|P1|Overall Study|Withdrawal by subject (CS42A)|5
850293|NCT01215513|2705539|P1|Overall Study|Physician decision (CS42A)|6
850294|NCT01215513|2705539|P1|Overall Study|Adverse event (CS42A)|2
850295|NCT01215513|2705539|P1|Overall Study|Not enrolled from CS42 to CS42A|21
850296|NCT01215513|2705539|P1|Overall Study|Not completed CS42|9
850297|NCT01215721|2705674|P1|Overall Study|Adverse Event|2
850298|NCT01215734|2705680|P2|Overall Study|Death|1
850299|NCT01215734|2705681|P1|Overall Study|Death|0
850300|NCT01215851|2705714|P6|Follow up Period|Lost to Follow-up|1
850301|NCT01215851|2705715|P5|Follow up Period|Lost to Follow-up|0
850302|NCT01215851|2705716|P4|Follow up Period|Lost to Follow-up|0
850303|NCT01215851|2705717|P3|Follow up Period|Lost to Follow-up|0
850304|NCT01215851|2705718|P2|Follow up Period|Lost to Follow-up|0
850305|NCT01215851|2705719|P1|Follow up Period|Lost to Follow-up|0
850306|NCT01215851|2705714|P6|Treatment Period|Adverse Event|1
850307|NCT01215851|2705715|P5|Treatment Period|Adverse Event|0
850308|NCT01215851|2705716|P4|Treatment Period|Adverse Event|3
850309|NCT01215851|2705717|P3|Treatment Period|Adverse Event|1
850310|NCT01215851|2705718|P2|Treatment Period|Adverse Event|1
850311|NCT01215851|2705719|P1|Treatment Period|Adverse Event|1
850312|NCT01215955|2705770|P4|Overall Study|Quality Issues|2
850313|NCT01215955|2705771|P3|Overall Study|Quality Issues|3
850314|NCT01215955|2705772|P2|Overall Study|Quality Issues|0
850315|NCT01215955|2705773|P1|Overall Study|Quality Issues|0
850316|NCT01215955|2705770|P4|Overall Study|Withdrawal by Subject|9
850317|NCT01215955|2705771|P3|Overall Study|Withdrawal by Subject|13
850318|NCT01215955|2705772|P2|Overall Study|Withdrawal by Subject|15
850319|NCT01215955|2705773|P1|Overall Study|Withdrawal by Subject|14
850320|NCT01215955|2705770|P4|Overall Study|Sponsor Decision|1
850321|NCT01215955|2705771|P3|Overall Study|Sponsor Decision|0
850322|NCT01215955|2705772|P2|Overall Study|Sponsor Decision|2
850323|NCT01215955|2705773|P1|Overall Study|Sponsor Decision|1
850324|NCT01215955|2705770|P4|Overall Study|Protocol Violation|8
850325|NCT01215955|2705771|P3|Overall Study|Protocol Violation|8
850326|NCT01215955|2705772|P2|Overall Study|Protocol Violation|13
850327|NCT01215955|2705773|P1|Overall Study|Protocol Violation|17
850328|NCT01215955|2705770|P4|Overall Study|Physician Decision|11
850329|NCT01215955|2705771|P3|Overall Study|Physician Decision|8
850330|NCT01215955|2705772|P2|Overall Study|Physician Decision|10
850331|NCT01215955|2705773|P1|Overall Study|Physician Decision|4
850332|NCT01215955|2705770|P4|Overall Study|Lost to Follow-up|9
850333|NCT01215955|2705771|P3|Overall Study|Lost to Follow-up|8
850334|NCT01215955|2705772|P2|Overall Study|Lost to Follow-up|4
850335|NCT01215955|2705773|P1|Overall Study|Lost to Follow-up|4
850336|NCT01215955|2705770|P4|Overall Study|Lack of Efficacy|0
850337|NCT01215955|2705771|P3|Overall Study|Lack of Efficacy|1
850338|NCT01215955|2705772|P2|Overall Study|Lack of Efficacy|2
850339|NCT01215955|2705773|P1|Overall Study|Lack of Efficacy|1
850340|NCT01215955|2705770|P4|Overall Study|Entry Criteria Not Met|7
850341|NCT01215955|2705771|P3|Overall Study|Entry Criteria Not Met|4
850342|NCT01215955|2705772|P2|Overall Study|Entry Criteria Not Met|3
850343|NCT01215955|2705773|P1|Overall Study|Entry Criteria Not Met|1
850344|NCT01215955|2705770|P4|Overall Study|Death|3
850345|NCT01215955|2705771|P3|Overall Study|Death|1
850346|NCT01215955|2705772|P2|Overall Study|Death|0
850347|NCT01215955|2705773|P1|Overall Study|Death|2
850348|NCT01215955|2705770|P4|Overall Study|Adverse Event|3
850349|NCT01215955|2705771|P3|Overall Study|Adverse Event|2
850350|NCT01215955|2705772|P2|Overall Study|Adverse Event|4
850351|NCT01215955|2705773|P1|Overall Study|Adverse Event|1
850352|NCT01215968|2705841|P2|Overall Study|Not received study drug|1
850353|NCT01215968|2705842|P1|Overall Study|Not received study drug|0
850354|NCT01215968|2705841|P2|Overall Study|Protocol Violation|4
850355|NCT01215968|2705842|P1|Overall Study|Protocol Violation|2
850356|NCT01215968|2705841|P2|Overall Study|Adverse Event|2
850357|NCT01215968|2705842|P1|Overall Study|Adverse Event|0
850358|NCT01215981|2705860|P2|Overall Study|Withdrawal by Subject|0
850359|NCT01215981|2705861|P1|Overall Study|Withdrawal by Subject|1
850360|NCT01215981|2705860|P2|Overall Study|Protocol Violation|0
850361|NCT01215981|2705861|P1|Overall Study|Protocol Violation|1
850362|NCT01215981|2705860|P2|Overall Study|Physician Decision|1
850363|NCT01215981|2705861|P1|Overall Study|Physician Decision|0
850364|NCT01216072|2705871|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
850365|NCT01216072|2705872|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
850366|NCT01216072|2705871|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
850367|NCT01216072|2705872|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
850368|NCT01216072|2705871|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
850369|NCT01216072|2705872|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
850370|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
850371|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
850372|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
850373|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
850374|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
850375|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
850376|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
850377|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
850378|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
850379|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
850380|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
850381|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
850382|NCT01216072|2705871|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
850383|NCT01216072|2705872|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
850384|NCT01217073|2705908|P8|Extension Period|Withdrawal by Subject|8
850385|NCT01217073|2705909|P7|Extension Period|Withdrawal by Subject|30
850386|NCT01217073|2705910|P6|Extension Period|Withdrawal by Subject|0
850387|NCT01217073|2705911|P5|Extension Period|Withdrawal by Subject|0
850388|NCT01217073|2705912|P4|Extension Period|Withdrawal by Subject|0
850389|NCT01217073|2705913|P3|Extension Period|Withdrawal by Subject|0
850390|NCT01217073|2705914|P2|Extension Period|Withdrawal by Subject|0
850391|NCT01217073|2705915|P1|Extension Period|Withdrawal by Subject|0
850392|NCT01217073|2705908|P8|Extension Period|Site discontinued study participation|2
850393|NCT01217073|2705909|P7|Extension Period|Site discontinued study participation|7
850394|NCT01217073|2705910|P6|Extension Period|Site discontinued study participation|0
850395|NCT01217073|2705911|P5|Extension Period|Site discontinued study participation|0
850396|NCT01217073|2705912|P4|Extension Period|Site discontinued study participation|0
850397|NCT01217073|2705913|P3|Extension Period|Site discontinued study participation|0
850398|NCT01217073|2705914|P2|Extension Period|Site discontinued study participation|0
850399|NCT01217073|2705915|P1|Extension Period|Site discontinued study participation|0
850400|NCT01217073|2705908|P8|Extension Period|Protocol Violation|1
850401|NCT01217073|2705909|P7|Extension Period|Protocol Violation|2
850402|NCT01217073|2705910|P6|Extension Period|Protocol Violation|0
850403|NCT01217073|2705911|P5|Extension Period|Protocol Violation|0
850404|NCT01217073|2705912|P4|Extension Period|Protocol Violation|0
850405|NCT01217073|2705913|P3|Extension Period|Protocol Violation|0
850406|NCT01217073|2705914|P2|Extension Period|Protocol Violation|0
850407|NCT01217073|2705915|P1|Extension Period|Protocol Violation|0
850408|NCT01217073|2705908|P8|Extension Period|Physician Decision|1
850409|NCT01217073|2705909|P7|Extension Period|Physician Decision|4
850410|NCT01217073|2705910|P6|Extension Period|Physician Decision|0
850411|NCT01217073|2705911|P5|Extension Period|Physician Decision|0
850412|NCT01217073|2705912|P4|Extension Period|Physician Decision|0
850413|NCT01217073|2705913|P3|Extension Period|Physician Decision|0
850414|NCT01217073|2705914|P2|Extension Period|Physician Decision|0
850415|NCT01217073|2705915|P1|Extension Period|Physician Decision|0
850416|NCT01217073|2705908|P8|Extension Period|Non-compliance with study drug|1
850417|NCT01217073|2705909|P7|Extension Period|Non-compliance with study drug|0
850418|NCT01217073|2705910|P6|Extension Period|Non-compliance with study drug|0
850419|NCT01217073|2705911|P5|Extension Period|Non-compliance with study drug|0
850420|NCT01217073|2705912|P4|Extension Period|Non-compliance with study drug|0
850421|NCT01217073|2705913|P3|Extension Period|Non-compliance with study drug|0
850422|NCT01217073|2705914|P2|Extension Period|Non-compliance with study drug|0
850423|NCT01217073|2705915|P1|Extension Period|Non-compliance with study drug|0
850424|NCT01217073|2705908|P8|Extension Period|Lost to Follow-up|1
850425|NCT01217073|2705909|P7|Extension Period|Lost to Follow-up|9
850426|NCT01217073|2705910|P6|Extension Period|Lost to Follow-up|0
850427|NCT01217073|2705911|P5|Extension Period|Lost to Follow-up|0
850428|NCT01217073|2705912|P4|Extension Period|Lost to Follow-up|0
850429|NCT01217073|2705913|P3|Extension Period|Lost to Follow-up|0
850430|NCT01217073|2705914|P2|Extension Period|Lost to Follow-up|0
850431|NCT01217073|2705915|P1|Extension Period|Lost to Follow-up|0
850432|NCT01217073|2705908|P8|Extension Period|Lack of Efficacy|0
850433|NCT01217073|2705909|P7|Extension Period|Lack of Efficacy|3
850434|NCT01217073|2705910|P6|Extension Period|Lack of Efficacy|0
850435|NCT01217073|2705911|P5|Extension Period|Lack of Efficacy|0
850436|NCT01217073|2705912|P4|Extension Period|Lack of Efficacy|0
850437|NCT01217073|2705913|P3|Extension Period|Lack of Efficacy|0
850438|NCT01217073|2705914|P2|Extension Period|Lack of Efficacy|0
850439|NCT01217073|2705915|P1|Extension Period|Lack of Efficacy|0
850440|NCT01217073|2705908|P8|Extension Period|Excluded medication|0
850441|NCT01217073|2705909|P7|Extension Period|Excluded medication|2
850442|NCT01217073|2705910|P6|Extension Period|Excluded medication|0
850443|NCT01217073|2705911|P5|Extension Period|Excluded medication|0
850444|NCT01217073|2705912|P4|Extension Period|Excluded medication|0
850445|NCT01217073|2705913|P3|Extension Period|Excluded medication|0
850446|NCT01217073|2705914|P2|Extension Period|Excluded medication|0
850447|NCT01217073|2705915|P1|Extension Period|Excluded medication|0
850448|NCT01217073|2705908|P8|Extension Period|Death|0
850449|NCT01217073|2705909|P7|Extension Period|Death|1
850450|NCT01217073|2705910|P6|Extension Period|Death|0
850451|NCT01217073|2705911|P5|Extension Period|Death|0
850452|NCT01217073|2705912|P4|Extension Period|Death|0
850453|NCT01217073|2705913|P3|Extension Period|Death|0
850454|NCT01217073|2705914|P2|Extension Period|Death|0
850455|NCT01217073|2705915|P1|Extension Period|Death|0
850456|NCT01217073|2705908|P8|Extension Period|Creatinine/eGFR|1
850457|NCT01217073|2705909|P7|Extension Period|Creatinine/eGFR|11
850458|NCT01217073|2705910|P6|Extension Period|Creatinine/eGFR|0
850459|NCT01217073|2705911|P5|Extension Period|Creatinine/eGFR|0
850460|NCT01217073|2705912|P4|Extension Period|Creatinine/eGFR|0
850461|NCT01217073|2705913|P3|Extension Period|Creatinine/eGFR|0
850462|NCT01217073|2705914|P2|Extension Period|Creatinine/eGFR|0
850463|NCT01217073|2705915|P1|Extension Period|Creatinine/eGFR|0
850464|NCT01217073|2705908|P8|Extension Period|Contraindication to study medication|0
850465|NCT01217073|2705909|P7|Extension Period|Contraindication to study medication|1
850466|NCT01217073|2705910|P6|Extension Period|Contraindication to study medication|0
850467|NCT01217073|2705911|P5|Extension Period|Contraindication to study medication|0
850468|NCT01217073|2705912|P4|Extension Period|Contraindication to study medication|0
850469|NCT01217073|2705913|P3|Extension Period|Contraindication to study medication|0
850470|NCT01217073|2705914|P2|Extension Period|Contraindication to study medication|0
850471|NCT01217073|2705915|P1|Extension Period|Contraindication to study medication|0
850472|NCT01217073|2705908|P8|Extension Period|ALT/AST|0
850473|NCT01217073|2705909|P7|Extension Period|ALT/AST|2
850474|NCT01217073|2705910|P6|Extension Period|ALT/AST|0
850475|NCT01217073|2705911|P5|Extension Period|ALT/AST|0
850476|NCT01217073|2705912|P4|Extension Period|ALT/AST|0
850477|NCT01217073|2705913|P3|Extension Period|ALT/AST|0
850478|NCT01217073|2705914|P2|Extension Period|ALT/AST|0
850479|NCT01217073|2705915|P1|Extension Period|ALT/AST|0
850480|NCT01217073|2705908|P8|Extension Period|Adverse Event|5
850481|NCT01217073|2705909|P7|Extension Period|Adverse Event|19
850482|NCT01217073|2705910|P6|Extension Period|Adverse Event|0
850483|NCT01217073|2705911|P5|Extension Period|Adverse Event|0
850484|NCT01217073|2705912|P4|Extension Period|Adverse Event|0
850485|NCT01217073|2705913|P3|Extension Period|Adverse Event|0
850486|NCT01217073|2705914|P2|Extension Period|Adverse Event|0
850487|NCT01217073|2705915|P1|Extension Period|Adverse Event|0
850488|NCT01217073|2705908|P8|Base Period|Withdrawal by Subject|0
850489|NCT01217073|2705909|P7|Base Period|Withdrawal by Subject|0
850490|NCT01217073|2705910|P6|Base Period|Withdrawal by Subject|5
850491|NCT01217073|2705911|P5|Base Period|Withdrawal by Subject|5
850492|NCT01217073|2705912|P4|Base Period|Withdrawal by Subject|1
850493|NCT01217073|2705913|P3|Base Period|Withdrawal by Subject|5
850494|NCT01217073|2705914|P2|Base Period|Withdrawal by Subject|5
850495|NCT01217073|2705915|P1|Base Period|Withdrawal by Subject|4
850496|NCT01217073|2705908|P8|Base Period|Protocol Violation|0
850497|NCT01217073|2705909|P7|Base Period|Protocol Violation|0
850498|NCT01217073|2705910|P6|Base Period|Protocol Violation|2
850499|NCT01217073|2705911|P5|Base Period|Protocol Violation|1
850500|NCT01217073|2705912|P4|Base Period|Protocol Violation|0
850501|NCT01217073|2705913|P3|Base Period|Protocol Violation|0
850502|NCT01217073|2705914|P2|Base Period|Protocol Violation|0
850503|NCT01217073|2705915|P1|Base Period|Protocol Violation|1
850504|NCT01217073|2705908|P8|Base Period|Physician Decision|0
850505|NCT01217073|2705909|P7|Base Period|Physician Decision|0
850506|NCT01217073|2705910|P6|Base Period|Physician Decision|0
850507|NCT01217073|2705911|P5|Base Period|Physician Decision|1
850508|NCT01217073|2705912|P4|Base Period|Physician Decision|0
850509|NCT01217073|2705913|P3|Base Period|Physician Decision|0
850510|NCT01217073|2705914|P2|Base Period|Physician Decision|0
850511|NCT01217073|2705915|P1|Base Period|Physician Decision|0
850512|NCT01217073|2705908|P8|Base Period|Lost to Follow-up|0
850513|NCT01217073|2705909|P7|Base Period|Lost to Follow-up|0
850514|NCT01217073|2705910|P6|Base Period|Lost to Follow-up|0
850515|NCT01217073|2705911|P5|Base Period|Lost to Follow-up|3
850516|NCT01217073|2705912|P4|Base Period|Lost to Follow-up|1
850517|NCT01217073|2705913|P3|Base Period|Lost to Follow-up|1
850518|NCT01217073|2705914|P2|Base Period|Lost to Follow-up|0
850519|NCT01217073|2705915|P1|Base Period|Lost to Follow-up|0
850520|NCT01217073|2705908|P8|Base Period|Lack of Efficacy|0
850521|NCT01217073|2705909|P7|Base Period|Lack of Efficacy|0
850522|NCT01217073|2705910|P6|Base Period|Lack of Efficacy|1
850523|NCT01217073|2705911|P5|Base Period|Lack of Efficacy|0
850524|NCT01217073|2705912|P4|Base Period|Lack of Efficacy|0
850525|NCT01217073|2705913|P3|Base Period|Lack of Efficacy|0
850526|NCT01217073|2705914|P2|Base Period|Lack of Efficacy|0
850527|NCT01217073|2705915|P1|Base Period|Lack of Efficacy|0
850528|NCT01217073|2705908|P8|Base Period|Excluded medication|0
850529|NCT01217073|2705909|P7|Base Period|Excluded medication|0
850530|NCT01217073|2705910|P6|Base Period|Excluded medication|0
850531|NCT01217073|2705911|P5|Base Period|Excluded medication|1
850532|NCT01217073|2705912|P4|Base Period|Excluded medication|0
850533|NCT01217073|2705913|P3|Base Period|Excluded medication|0
850534|NCT01217073|2705914|P2|Base Period|Excluded medication|0
850535|NCT01217073|2705915|P1|Base Period|Excluded medication|0
850536|NCT01217073|2705908|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
850537|NCT01217073|2705909|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
850538|NCT01217073|2705910|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
850539|NCT01217073|2705911|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
850540|NCT01217073|2705912|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
850541|NCT01217073|2705913|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
850542|NCT01217073|2705914|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
850543|NCT01217073|2705915|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
850544|NCT01217073|2705908|P8|Base Period|Adverse Event|0
850545|NCT01217073|2705909|P7|Base Period|Adverse Event|0
850546|NCT01217073|2705910|P6|Base Period|Adverse Event|1
850547|NCT01217073|2705911|P5|Base Period|Adverse Event|4
850548|NCT01217073|2705912|P4|Base Period|Adverse Event|0
850549|NCT01217073|2705913|P3|Base Period|Adverse Event|1
850550|NCT01217073|2705914|P2|Base Period|Adverse Event|0
850551|NCT01217073|2705915|P1|Base Period|Adverse Event|1
850552|NCT01217112|2705988|P5|Overall Study|Physician Decision|1
850553|NCT01217112|2705989|P4|Overall Study|Physician Decision|0
850554|NCT01217112|2705990|P3|Overall Study|Physician Decision|0
850555|NCT01217112|2705991|P2|Overall Study|Physician Decision|0
850556|NCT01217112|2705992|P1|Overall Study|Physician Decision|0
850557|NCT01217112|2705988|P5|Overall Study|Withdrawal by Subject|0
850558|NCT01217112|2705989|P4|Overall Study|Withdrawal by Subject|0
850559|NCT01217112|2705990|P3|Overall Study|Withdrawal by Subject|1
850560|NCT01217112|2705991|P2|Overall Study|Withdrawal by Subject|0
850561|NCT01217112|2705992|P1|Overall Study|Withdrawal by Subject|0
850562|NCT01217112|2705988|P5|Overall Study|Adverse Event|0
850563|NCT01217112|2705989|P4|Overall Study|Adverse Event|2
850564|NCT01217112|2705990|P3|Overall Study|Adverse Event|0
850565|NCT01217112|2705991|P2|Overall Study|Adverse Event|2
850566|NCT01217112|2705992|P1|Overall Study|Adverse Event|0
850567|NCT01217463|2706235|P2|Overall Study|Other|1
850568|NCT01217463|2706236|P1|Overall Study|Other|1
850569|NCT01217463|2706235|P2|Overall Study|Patient Non-compliant|0
850570|NCT01217463|2706236|P1|Overall Study|Patient Non-compliant|1
850571|NCT01217463|2706235|P2|Overall Study|Surgery on the Target Limb|1
850572|NCT01217463|2706236|P1|Overall Study|Surgery on the Target Limb|0
850573|NCT01217463|2706235|P2|Overall Study|Withdrawal by Subject|0
850574|NCT01217463|2706236|P1|Overall Study|Withdrawal by Subject|3
850575|NCT01217463|2706235|P2|Overall Study|Physician Decision|1
850576|NCT01217463|2706236|P1|Overall Study|Physician Decision|0
850577|NCT01217463|2706235|P2|Overall Study|Adverse Event|5
850578|NCT01217463|2706236|P1|Overall Study|Adverse Event|8
850579|NCT01217476|2706246|P2|Overall Study|Other|0
850580|NCT01217476|2706247|P1|Overall Study|Other|2
850581|NCT01217476|2706246|P2|Overall Study|Protocol Deviation|0
850582|NCT01217476|2706247|P1|Overall Study|Protocol Deviation|1
850583|NCT01217476|2706246|P2|Overall Study|Surgery on the Target Limb|2
850584|NCT01217476|2706247|P1|Overall Study|Surgery on the Target Limb|0
850585|NCT01217476|2706246|P2|Overall Study|Withdrawal by Subject|3
850586|NCT01217476|2706247|P1|Overall Study|Withdrawal by Subject|3
850587|NCT01217476|2706246|P2|Overall Study|Physician Decision|1
850588|NCT01217476|2706247|P1|Overall Study|Physician Decision|0
850589|NCT01217476|2706246|P2|Overall Study|Adverse Event|1
850590|NCT01217476|2706247|P1|Overall Study|Adverse Event|6
850591|NCT01217606|2706276|P2|9-Month Masked Extension|Lack of Efficacy|0
850592|NCT01217606|2706277|P1|9-Month Masked Extension|Lack of Efficacy|2
850593|NCT01217606|2706276|P2|9-Month Masked Extension|Pregnancy|0
850594|NCT01217606|2706277|P1|9-Month Masked Extension|Pregnancy|1
850595|NCT01217606|2706276|P2|9-Month Masked Extension|Lost to Follow-up|0
850596|NCT01217606|2706277|P1|9-Month Masked Extension|Lost to Follow-up|1
850597|NCT01217606|2706276|P2|9-Month Masked Extension|Personal Reasons|1
850598|NCT01217606|2706277|P1|9-Month Masked Extension|Personal Reasons|2
850599|NCT01217606|2706276|P2|9-Month Masked Extension|Other Reasons|4
850600|NCT01217606|2706277|P1|9-Month Masked Extension|Other Reasons|4
850601|NCT01217606|2706276|P2|9-Month Masked Extension|Adverse Event|6
850602|NCT01217606|2706277|P1|9-Month Masked Extension|Adverse Event|3
850603|NCT01217606|2706276|P2|Initial Treatment Phase|Adverse Event|6
850604|NCT01217606|2706277|P1|Initial Treatment Phase|Adverse Event|10
850605|NCT01217606|2706276|P2|Initial Treatment Phase|Lack of Efficacy|0
850606|NCT01217606|2706277|P1|Initial Treatment Phase|Lack of Efficacy|1
850607|NCT01217606|2706276|P2|Initial Treatment Phase|Personal Reasons|2
850608|NCT01217606|2706277|P1|Initial Treatment Phase|Personal Reasons|0
850609|NCT01217606|2706276|P2|Initial Treatment Phase|Protocol Violation|2
850610|NCT01217606|2706277|P1|Initial Treatment Phase|Protocol Violation|3
850611|NCT01217606|2706276|P2|Initial Treatment Phase|Other Reasons|2
850612|NCT01217606|2706277|P1|Initial Treatment Phase|Other Reasons|0
850613|NCT01217801|2706310|P2|Period 1|Withdrawal by Subject|1
850614|NCT01217801|2706311|P1|Period 1|Withdrawal by Subject|0
850615|NCT01217801|2706310|P2|Period 1|Protocol Violation|1
850616|NCT01217801|2706311|P1|Period 1|Protocol Violation|1
850617|NCT01217814|2706320|P3|Overall Study|Lack of Efficacy|1
850618|NCT01217814|2706321|P2|Overall Study|Lack of Efficacy|0
850619|NCT01217814|2706322|P1|Overall Study|Lack of Efficacy|0
850620|NCT01217814|2706320|P3|Overall Study|Adverse Event|0
850621|NCT01217814|2706321|P2|Overall Study|Adverse Event|1
850622|NCT01217814|2706322|P1|Overall Study|Adverse Event|1
850623|NCT01217892|2706368|P4|Overall Study|Poor/Non-Compliance|0
850624|NCT01217892|2706369|P3|Overall Study|Poor/Non-Compliance|1
850625|NCT01217892|2706370|P2|Overall Study|Poor/Non-Compliance|0
850626|NCT01217892|2706371|P1|Overall Study|Poor/Non-Compliance|0
850627|NCT01217892|2706368|P4|Overall Study|Incorrect enrollment|0
850628|NCT01217892|2706369|P3|Overall Study|Incorrect enrollment|1
850629|NCT01217892|2706370|P2|Overall Study|Incorrect enrollment|1
850630|NCT01217892|2706371|P1|Overall Study|Incorrect enrollment|0
850631|NCT01217892|2706368|P4|Overall Study|Subject no longer meets study criteria|8
850632|NCT01217892|2706369|P3|Overall Study|Subject no longer meets study criteria|4
850633|NCT01217892|2706370|P2|Overall Study|Subject no longer meets study criteria|2
850634|NCT01217892|2706371|P1|Overall Study|Subject no longer meets study criteria|5
850635|NCT01217892|2706368|P4|Overall Study|Lab value|0
850636|NCT01217892|2706369|P3|Overall Study|Lab value|1
850637|NCT01217892|2706370|P2|Overall Study|Lab value|0
850638|NCT01217892|2706371|P1|Overall Study|Lab value|1
850639|NCT01217892|2706368|P4|Overall Study|Withdrawal by Subject|0
850640|NCT01217892|2706369|P3|Overall Study|Withdrawal by Subject|1
850641|NCT01217892|2706370|P2|Overall Study|Withdrawal by Subject|2
850642|NCT01217892|2706371|P1|Overall Study|Withdrawal by Subject|0
850643|NCT01217892|2706368|P4|Overall Study|Adverse Event|0
850644|NCT01217892|2706369|P3|Overall Study|Adverse Event|1
850645|NCT01217892|2706370|P2|Overall Study|Adverse Event|1
850646|NCT01217892|2706371|P1|Overall Study|Adverse Event|1
850647|NCT01217944|2706400|P3|Overall Study|Lack of Efficacy|0
850648|NCT01217944|2706401|P2|Overall Study|Lack of Efficacy|0
850649|NCT01217944|2706402|P1|Overall Study|Lack of Efficacy|1
850650|NCT01217944|2706400|P3|Overall Study|Withdrawal by Subject|0
850651|NCT01217944|2706401|P2|Overall Study|Withdrawal by Subject|2
850652|NCT01217944|2706402|P1|Overall Study|Withdrawal by Subject|1
850653|NCT01217944|2706400|P3|Overall Study|Lost to Follow-up|0
850654|NCT01217944|2706401|P2|Overall Study|Lost to Follow-up|1
850655|NCT01217944|2706402|P1|Overall Study|Lost to Follow-up|3
850656|NCT01217944|2706400|P3|Overall Study|Protocol Violation|0
850657|NCT01217944|2706401|P2|Overall Study|Protocol Violation|1
850658|NCT01217944|2706402|P1|Overall Study|Protocol Violation|1
850659|NCT01217957|2706446|P5|Phase 2|Withdrawal by Patient|1
850660|NCT01217957|2706447|P4|Phase 2|Withdrawal by Patient|0
850661|NCT01217957|2706448|P3|Phase 2|Withdrawal by Patient|0
850662|NCT01217957|2706449|P2|Phase 2|Withdrawal by Patient|0
850663|NCT01217957|2706450|P1|Phase 2|Withdrawal by Patient|0
850664|NCT01217957|2706446|P5|Phase 1|Withdrawal by Patient|0
850665|NCT01217957|2706447|P4|Phase 1|Withdrawal by Patient|1
850666|NCT01217957|2706448|P3|Phase 1|Withdrawal by Patient|1
850667|NCT01217957|2706449|P2|Phase 1|Withdrawal by Patient|0
850668|NCT01217957|2706450|P1|Phase 1|Withdrawal by Patient|1
850669|NCT01218009|2706508|P2|Overall Study|Sponsor terminated study|163
850670|NCT01218009|2706509|P1|Overall Study|Sponsor terminated study|161
850671|NCT01218009|2706508|P2|Overall Study|Withdrawal by Subject|1
850672|NCT01218009|2706509|P1|Overall Study|Withdrawal by Subject|3
850673|NCT01218009|2706508|P2|Overall Study|Protocol Violation|1
850674|NCT01218009|2706509|P1|Overall Study|Protocol Violation|2
850675|NCT01218087|2706529|P2|Overall Study|Transferred|5
850676|NCT01218087|2706530|P1|Overall Study|Transferred|8
850677|NCT01218087|2706529|P2|Overall Study|Withdrawal by Subject|0
850678|NCT01218087|2706530|P1|Overall Study|Withdrawal by Subject|5
850679|NCT01218087|2706529|P2|Overall Study|Death|1
850680|NCT01218087|2706530|P1|Overall Study|Death|2
850681|NCT01218100|2706542|P4|Overall Study|Other Reason|4
850682|NCT01218100|2706543|P3|Overall Study|Other Reason|6
850683|NCT01218100|2706544|P2|Overall Study|Other Reason|2
850684|NCT01218100|2706545|P1|Overall Study|Other Reason|2
850685|NCT01218100|2706542|P4|Overall Study|Lost to Follow-up|1
850686|NCT01218100|2706543|P3|Overall Study|Lost to Follow-up|2
850687|NCT01218100|2706544|P2|Overall Study|Lost to Follow-up|8
850688|NCT01218100|2706545|P1|Overall Study|Lost to Follow-up|3
850689|NCT01218100|2706542|P4|Overall Study|Withdrawal by Subject|7
850690|NCT01218100|2706543|P3|Overall Study|Withdrawal by Subject|6
850691|NCT01218100|2706544|P2|Overall Study|Withdrawal by Subject|2
850692|NCT01218100|2706545|P1|Overall Study|Withdrawal by Subject|5
850693|NCT01218100|2706542|P4|Overall Study|Protocol Violation|1
850694|NCT01218100|2706543|P3|Overall Study|Protocol Violation|1
850695|NCT01218100|2706544|P2|Overall Study|Protocol Violation|0
850696|NCT01218100|2706545|P1|Overall Study|Protocol Violation|0
850697|NCT01218100|2706542|P4|Overall Study|Lack of Efficacy|12
850698|NCT01218100|2706543|P3|Overall Study|Lack of Efficacy|5
850699|NCT01218100|2706544|P2|Overall Study|Lack of Efficacy|6
850700|NCT01218100|2706545|P1|Overall Study|Lack of Efficacy|9
850701|NCT01218100|2706542|P4|Overall Study|Adverse Event|7
850702|NCT01218100|2706543|P3|Overall Study|Adverse Event|6
850703|NCT01218100|2706544|P2|Overall Study|Adverse Event|6
850704|NCT01218100|2706545|P1|Overall Study|Adverse Event|4
850705|NCT01218100|2706542|P4|Overall Study|Did not meet InclusionExclusion criteria|2
850706|NCT01218100|2706543|P3|Overall Study|Did not meet InclusionExclusion criteria|1
850707|NCT01218100|2706544|P2|Overall Study|Did not meet InclusionExclusion criteria|1
850708|NCT01218100|2706545|P1|Overall Study|Did not meet InclusionExclusion criteria|1
850709|NCT01218243|2706561|P2|Overall Study|Protocol Violation|10
850710|NCT01218243|2706562|P1|Overall Study|Protocol Violation|5
850711|NCT01218243|2706561|P2|Overall Study|Lost to Follow-up|3
850712|NCT01218243|2706562|P1|Overall Study|Lost to Follow-up|3
850713|NCT01218243|2706561|P2|Overall Study|Lack of Efficacy|1
850714|NCT01218243|2706562|P1|Overall Study|Lack of Efficacy|1
850715|NCT01218308|2706578|P2|Overall Study|Unspecified|21
850716|NCT01218308|2706579|P1|Overall Study|Unspecified|14
850717|NCT01218308|2706578|P2|Overall Study|Lost to Follow-up|31
850718|NCT01218308|2706579|P1|Overall Study|Lost to Follow-up|27
850719|NCT01218308|2706578|P2|Overall Study|Withdrawal by Subject|64
850720|NCT01218308|2706579|P1|Overall Study|Withdrawal by Subject|61
850721|NCT01218308|2706578|P2|Overall Study|Protocol Violation|2
850722|NCT01218308|2706579|P1|Overall Study|Protocol Violation|0
850723|NCT01218308|2706578|P2|Overall Study|Adverse Event|2
850724|NCT01218308|2706579|P1|Overall Study|Adverse Event|1
850731|NCT01218477|2706789|P4|Overall Study|Maximum clinical benefit|0
850732|NCT01218477|2706790|P3|Overall Study|Maximum clinical benefit|0
850733|NCT01218477|2706791|P2|Overall Study|Maximum clinical benefit|2
850734|NCT01218477|2706792|P1|Overall Study|Maximum clinical benefit|0
850735|NCT01218477|2706789|P4|Overall Study|Administrative reason by sponsor|0
850736|NCT01218477|2706790|P3|Overall Study|Administrative reason by sponsor|1
850737|NCT01218477|2706791|P2|Overall Study|Administrative reason by sponsor|0
850738|NCT01218477|2706792|P1|Overall Study|Administrative reason by sponsor|0
850739|NCT01218477|2706789|P4|Overall Study|Prepared for cell transplantation|0
850740|NCT01218477|2706790|P3|Overall Study|Prepared for cell transplantation|1
850741|NCT01218477|2706791|P2|Overall Study|Prepared for cell transplantation|1
850742|NCT01218477|2706792|P1|Overall Study|Prepared for cell transplantation|0
850743|NCT01218477|2706789|P4|Overall Study|Withdrawal by Subject|0
850744|NCT01218477|2706790|P3|Overall Study|Withdrawal by Subject|1
850745|NCT01218477|2706791|P2|Overall Study|Withdrawal by Subject|0
850746|NCT01218477|2706792|P1|Overall Study|Withdrawal by Subject|0
850747|NCT01218477|2706789|P4|Overall Study|No longer meets study criteria|0
850748|NCT01218477|2706790|P3|Overall Study|No longer meets study criteria|0
850749|NCT01218477|2706791|P2|Overall Study|No longer meets study criteria|0
850750|NCT01218477|2706792|P1|Overall Study|No longer meets study criteria|1
850751|NCT01218477|2706789|P4|Overall Study|Study drug toxicity|0
850752|NCT01218477|2706790|P3|Overall Study|Study drug toxicity|5
850753|NCT01218477|2706791|P2|Overall Study|Study drug toxicity|2
850754|NCT01218477|2706792|P1|Overall Study|Study drug toxicity|0
850755|NCT01218477|2706789|P4|Overall Study|Disease progression|2
850756|NCT01218477|2706790|P3|Overall Study|Disease progression|6
850757|NCT01218477|2706791|P2|Overall Study|Disease progression|3
850758|NCT01218477|2706792|P1|Overall Study|Disease progression|2
850759|NCT01218594|2706809|P1|Overall Study|Physician Decision|6
850760|NCT01218594|2706809|P1|Overall Study|Adverse Event|2
850761|NCT01218594|2706809|P1|Overall Study|Withdrawal by Subject|3
850762|NCT01218594|2706809|P1|Overall Study|Death|1
850763|NCT01218646|2706817|P4|Overall Study|Protocol Violation|1
850764|NCT01218646|2706818|P3|Overall Study|Protocol Violation|1
850765|NCT01218646|2706819|P2|Overall Study|Protocol Violation|0
850766|NCT01218646|2706820|P1|Overall Study|Protocol Violation|0
850767|NCT01218646|2706817|P4|Overall Study|Lost to Follow-up|0
850768|NCT01218646|2706818|P3|Overall Study|Lost to Follow-up|0
850769|NCT01218646|2706819|P2|Overall Study|Lost to Follow-up|0
850770|NCT01218646|2706820|P1|Overall Study|Lost to Follow-up|1
850771|NCT01218646|2706817|P4|Overall Study|Adverse Event|0
850772|NCT01218646|2706818|P3|Overall Study|Adverse Event|1
850773|NCT01218646|2706819|P2|Overall Study|Adverse Event|0
850774|NCT01218646|2706820|P1|Overall Study|Adverse Event|0
850775|NCT01218802|2706860|P2|Overall Study|Incarcerated|0
850776|NCT01218802|2706861|P1|Overall Study|Incarcerated|2
850777|NCT01218802|2706860|P2|Overall Study|Adverse Event|2
850778|NCT01218802|2706861|P1|Overall Study|Adverse Event|0
850779|NCT01218802|2706860|P2|Overall Study|Withdrawal by Subject|10
850780|NCT01218802|2706861|P1|Overall Study|Withdrawal by Subject|3
850781|NCT01218802|2706860|P2|Overall Study|Lost to Follow-up|6
850782|NCT01218802|2706861|P1|Overall Study|Lost to Follow-up|5
850783|NCT01218867|2706880|P11|Overall Study|Death during treatment|0
850784|NCT01218867|2706881|P10|Overall Study|Death during treatment|0
850785|NCT01218867|2706882|P9|Overall Study|Death during treatment|0
850786|NCT01218867|2706883|P8|Overall Study|Death during treatment|0
850787|NCT01218867|2706884|P7|Overall Study|Death during treatment|1
850788|NCT01218867|2706885|P6|Overall Study|Death during treatment|0
850789|NCT01218867|2706886|P5|Overall Study|Death during treatment|0
850790|NCT01218867|2706887|P4|Overall Study|Death during treatment|0
850791|NCT01218867|2706888|P3|Overall Study|Death during treatment|0
850792|NCT01218867|2706889|P2|Overall Study|Death during treatment|0
850793|NCT01218867|2706890|P1|Overall Study|Death during treatment|0
850794|NCT01211535|2706989|P2|Overall Study|Adverse Event|1
850795|NCT01211535|2706990|P1|Overall Study|Adverse Event|0
850796|NCT01211613|2706999|P3|Overall Study|Withdrawal by Subject|0
850797|NCT01211613|2707000|P2|Overall Study|Withdrawal by Subject|0
850798|NCT01211613|2707001|P1|Overall Study|Withdrawal by Subject|1
850799|NCT01211613|2706999|P3|Overall Study|Lost to Follow-up|2
850800|NCT01211613|2707000|P2|Overall Study|Lost to Follow-up|2
850801|NCT01211613|2707001|P1|Overall Study|Lost to Follow-up|2
850802|NCT01211665|2707014|P2|Overall Study|Death|0
850803|NCT01211665|2707015|P1|Overall Study|Death|1
850804|NCT01211665|2707014|P2|Overall Study|Withdrawal by Subject|0
850805|NCT01211665|2707015|P1|Overall Study|Withdrawal by Subject|1
850806|NCT01211769|2707062|P4|Overall Study|Adverse Event|1
850807|NCT01211769|2707063|P3|Overall Study|Adverse Event|1
850808|NCT01211769|2707064|P2|Overall Study|Adverse Event|1
850809|NCT01211769|2707065|P1|Overall Study|Adverse Event|0
850810|NCT01211769|2707062|P4|Overall Study|Physician Decision|1
850811|NCT01211769|2707063|P3|Overall Study|Physician Decision|2
850812|NCT01211769|2707064|P2|Overall Study|Physician Decision|0
850813|NCT01211769|2707065|P1|Overall Study|Physician Decision|2
850814|NCT01211769|2707062|P4|Overall Study|Lost to Follow-up|9
850815|NCT01211769|2707063|P3|Overall Study|Lost to Follow-up|5
850816|NCT01211769|2707064|P2|Overall Study|Lost to Follow-up|9
850817|NCT01211769|2707065|P1|Overall Study|Lost to Follow-up|7
850818|NCT01212094|2707098|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
850819|NCT01212094|2707099|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
850820|NCT01212094|2707100|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
850821|NCT01212094|2707098|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
850822|NCT01212094|2707099|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
850823|NCT01212094|2707100|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
850824|NCT01212094|2707098|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
850825|NCT01212094|2707099|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
850826|NCT01212094|2707100|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
850827|NCT01212094|2707098|P3|Year 1: Baseline Monitoring|Started on DMT|0
850828|NCT01212094|2707099|P2|Year 1: Baseline Monitoring|Started on DMT|0
850829|NCT01212094|2707100|P1|Year 1: Baseline Monitoring|Started on DMT|2
850830|NCT01212094|2707098|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
850831|NCT01212094|2707099|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
850832|NCT01212094|2707100|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
850833|NCT01212094|2707098|P3|Year 1: Baseline Monitoring|Study terminated|0
850834|NCT01212094|2707099|P2|Year 1: Baseline Monitoring|Study terminated|0
850835|NCT01212094|2707100|P1|Year 1: Baseline Monitoring|Study terminated|7
850836|NCT01212159|2707133|P2|Overall Study|Withdrawal by Subject|12
850837|NCT01212159|2707134|P1|Overall Study|Withdrawal by Subject|12
850838|NCT01212185|2707155|P2|Overall Study|Protocol Violation|1
850839|NCT01212185|2707156|P1|Overall Study|Protocol Violation|2
850840|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
850841|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
850842|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
850843|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
850844|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
850845|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
850846|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
850847|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
850848|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
850849|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
850850|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
850851|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
850852|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
850853|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
850854|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
850855|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
850856|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
850857|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
850858|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|7
850859|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
850860|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
850861|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850862|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850863|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850864|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850865|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|2
850866|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850867|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
850868|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
850869|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
850870|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
850871|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
850872|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
850873|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
850874|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
850875|NCT01212757|2707220|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
850876|NCT01212757|2707221|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
850877|NCT01212757|2707222|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
850878|NCT01212757|2707223|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
850879|NCT01212757|2707224|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|3
850880|NCT01212757|2707225|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
850881|NCT01212757|2707226|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
850882|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
850883|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
850884|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
850885|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
850886|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
850887|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
850888|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
850889|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
850890|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
850891|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
850892|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
850893|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
850894|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
850895|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
850896|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
850897|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
850898|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
850899|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
850900|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
850901|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
850902|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
850903|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
850904|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
850905|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
850906|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
850907|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
850908|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
850909|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
850910|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
850911|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
850912|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
850913|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
850914|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
850915|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
850916|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
850917|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
850918|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
850919|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
850920|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
850921|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
850922|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
850923|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
850924|NCT01212757|2707220|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
850925|NCT01212757|2707221|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
850926|NCT01212757|2707222|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
850927|NCT01212757|2707223|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
850928|NCT01212757|2707224|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
850929|NCT01212757|2707225|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
850930|NCT01212757|2707226|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
894230|NCT02045797|2837642|P3|Overall Study|Withdrawal by Subject|0
894231|NCT02045797|2837643|P2|Overall Study|Withdrawal by Subject|2
894232|NCT02045797|2837644|P1|Overall Study|Withdrawal by Subject|1
894233|NCT02045797|2837642|P3|Overall Study|Physician Decision|0
894234|NCT02045797|2837643|P2|Overall Study|Physician Decision|1
894235|NCT02045797|2837644|P1|Overall Study|Physician Decision|0
894236|NCT02045797|2837642|P3|Overall Study|Lost to Follow-up|1
894237|NCT02045797|2837643|P2|Overall Study|Lost to Follow-up|3
894238|NCT02045797|2837644|P1|Overall Study|Lost to Follow-up|2
894239|NCT02045797|2837642|P3|Overall Study|Lack of Efficacy|0
894240|NCT02045797|2837643|P2|Overall Study|Lack of Efficacy|0
894241|NCT02045797|2837644|P1|Overall Study|Lack of Efficacy|1
894242|NCT02045797|2837642|P3|Overall Study|Adverse Event|0
894243|NCT02045797|2837643|P2|Overall Study|Adverse Event|1
894244|NCT02045797|2837644|P1|Overall Study|Adverse Event|3
894287|NCT01949090|2837837|P5|Overall Study|Lost to Follow-up|1
894288|NCT01949090|2837838|P4|Overall Study|Lost to Follow-up|1
894289|NCT01949090|2837839|P3|Overall Study|Lost to Follow-up|0
894290|NCT01949090|2837840|P2|Overall Study|Lost to Follow-up|1
894291|NCT01949090|2837841|P1|Overall Study|Lost to Follow-up|2
894292|NCT01949090|2837837|P5|Overall Study|Protocol non-compliance|1
894293|NCT01949090|2837838|P4|Overall Study|Protocol non-compliance|0
894294|NCT01949090|2837839|P3|Overall Study|Protocol non-compliance|0
894295|NCT01949090|2837840|P2|Overall Study|Protocol non-compliance|0
894296|NCT01949090|2837841|P1|Overall Study|Protocol non-compliance|0
851089|NCT01221623|2707929|P1|Overall Study|Withdrawal by Subject|19
894297|NCT01949090|2837837|P5|Overall Study|Withdrawal by Subject|1
894298|NCT01949090|2837838|P4|Overall Study|Withdrawal by Subject|0
894299|NCT01949090|2837839|P3|Overall Study|Withdrawal by Subject|0
894300|NCT01949090|2837840|P2|Overall Study|Withdrawal by Subject|0
894301|NCT01949090|2837841|P1|Overall Study|Withdrawal by Subject|2
894302|NCT01949090|2837837|P5|Overall Study|Serious Adverse Event|1
894303|NCT01949090|2837838|P4|Overall Study|Serious Adverse Event|0
894304|NCT01949090|2837839|P3|Overall Study|Serious Adverse Event|2
894305|NCT01949090|2837840|P2|Overall Study|Serious Adverse Event|1
894306|NCT01949090|2837841|P1|Overall Study|Serious Adverse Event|0
851015|NCT01212991|2707612|P2|Overall Study|Continuing Treatment|61
851016|NCT01212991|2707613|P1|Overall Study|Continuing Treatment|367
851017|NCT01212991|2707612|P2|Overall Study|Withdrawal by Subject|14
851018|NCT01212991|2707613|P1|Overall Study|Withdrawal by Subject|4
851019|NCT01212991|2707612|P2|Overall Study|Death|299
851020|NCT01212991|2707613|P1|Overall Study|Death|241
851021|NCT01212991|2707612|P2|Overall Study|Lost to Follow-up|0
851022|NCT01212991|2707613|P1|Overall Study|Lost to Follow-up|1
851023|NCT01213173|2707662|P2|Overall Study|Incorrect Enrollment|3
851024|NCT01213173|2707663|P1|Overall Study|Incorrect Enrollment|1
851025|NCT01213173|2707662|P2|Overall Study|Withdrawal by Subject|5
851026|NCT01213173|2707663|P1|Overall Study|Withdrawal by Subject|5
851027|NCT01213173|2707662|P2|Overall Study|Adverse Event|8
851028|NCT01213173|2707663|P1|Overall Study|Adverse Event|4
851029|NCT01213173|2707662|P2|Overall Study|Protocol Violation|0
851030|NCT01213173|2707663|P1|Overall Study|Protocol Violation|2
851031|NCT01213251|2707700|P3|Overall Study|Missed 18-Month Follow-up|1
851032|NCT01213251|2707701|P2|Overall Study|Missed 18-Month Follow-up|0
851033|NCT01213251|2707702|P1|Overall Study|Missed 18-Month Follow-up|0
851034|NCT01213251|2707700|P3|Overall Study|Protocol Violation|0
851035|NCT01213251|2707701|P2|Overall Study|Protocol Violation|1
851036|NCT01213251|2707702|P1|Overall Study|Protocol Violation|1
851037|NCT01213251|2707700|P3|Overall Study|Exit|8
851038|NCT01213251|2707701|P2|Overall Study|Exit|2
851039|NCT01213251|2707702|P1|Overall Study|Exit|3
851040|NCT01213251|2707700|P3|Overall Study|Death|2
851041|NCT01213251|2707701|P2|Overall Study|Death|1
851042|NCT01213251|2707702|P1|Overall Study|Death|2
851043|NCT01213264|2707726|P3|Overall Study|Lost to Follow-up|6
851044|NCT01213264|2707727|P2|Overall Study|Lost to Follow-up|2
851045|NCT01213264|2707728|P1|Overall Study|Lost to Follow-up|1
851046|NCT01213264|2707726|P3|Overall Study|Adverse Event|0
851047|NCT01213264|2707727|P2|Overall Study|Adverse Event|0
851048|NCT01213264|2707728|P1|Overall Study|Adverse Event|1
851049|NCT01221272|2707770|P2|Period 2|Adverse Event|2
851050|NCT01221272|2707771|P1|Period 2|Adverse Event|0
851051|NCT01221272|2707770|P2|Period 1|Significant Dosing Noncompliance|1
851052|NCT01221272|2707771|P1|Period 1|Significant Dosing Noncompliance|0
851053|NCT01221272|2707770|P2|Period 1|Consent Withdrawal|1
851054|NCT01221272|2707771|P1|Period 1|Consent Withdrawal|0
851055|NCT01221272|2707770|P2|Period 1|Adverse Event|0
851056|NCT01221272|2707771|P1|Period 1|Adverse Event|2
851057|NCT01221285|2707786|P1|Overall Study|Withdrawal by Subject|1
851058|NCT01221350|2707816|P2|Overall Study|Withdrawal by Subject|2
851059|NCT01221350|2707817|P1|Overall Study|Withdrawal by Subject|4
851060|NCT01221350|2707816|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
851061|NCT01221350|2707817|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
851062|NCT01221350|2707816|P2|Overall Study|Discontinued intervention (GERD)|0
851063|NCT01221350|2707817|P1|Overall Study|Discontinued intervention (GERD)|1
851064|NCT01221363|2707859|P2|Overall Study|Withdrawal by Subject|5
851065|NCT01221363|2707860|P1|Overall Study|Withdrawal by Subject|11
851066|NCT01221363|2707859|P2|Overall Study|Pregnancy|0
851067|NCT01221363|2707860|P1|Overall Study|Pregnancy|1
851068|NCT01221597|2707903|P2|Overall Study|Death|0
851069|NCT01221597|2707904|P1|Overall Study|Death|2
851070|NCT01221597|2707903|P2|Overall Study|Other|4
851071|NCT01221597|2707904|P1|Overall Study|Other|3
851072|NCT01221597|2707903|P2|Overall Study|Protocol Violation|0
851073|NCT01221597|2707904|P1|Overall Study|Protocol Violation|1
851074|NCT01221597|2707903|P2|Overall Study|Lost to Follow-up|5
851075|NCT01221597|2707904|P1|Overall Study|Lost to Follow-up|6
851076|NCT01221597|2707903|P2|Overall Study|Withdrawal by Subject|6
851077|NCT01221597|2707904|P1|Overall Study|Withdrawal by Subject|20
851078|NCT01221597|2707903|P2|Overall Study|Adverse Event|1
851079|NCT01221597|2707904|P1|Overall Study|Adverse Event|4
851080|NCT01221623|2707928|P2|Overall Study|Other|2
851081|NCT01221623|2707929|P1|Overall Study|Other|5
851082|NCT01221623|2707928|P2|Overall Study|Death|0
851083|NCT01221623|2707929|P1|Overall Study|Death|1
851084|NCT01221623|2707928|P2|Overall Study|Adverse Event|3
851085|NCT01221623|2707929|P1|Overall Study|Adverse Event|6
851086|NCT01221623|2707928|P2|Overall Study|Lost to Follow-up|1
851087|NCT01221623|2707929|P1|Overall Study|Lost to Follow-up|7
851088|NCT01221623|2707928|P2|Overall Study|Withdrawal by Subject|8
851090|NCT01221727|2707953|P2|Overall Study|Withdrawal by Subject|1
851091|NCT01221727|2707954|P1|Overall Study|Withdrawal by Subject|1
851092|NCT01221727|2707953|P2|Overall Study|Physician Decision|0
851093|NCT01221727|2707954|P1|Overall Study|Physician Decision|2
851095|NCT01221948|2707978|P1|Overall Study|Protocol Violation|4
851096|NCT01221948|2707978|P1|Overall Study|Death|1
851097|NCT01221948|2707978|P1|Overall Study|not disclosed|2
851098|NCT01221948|2707978|P1|Overall Study|Withdrawal by Subject|2
851099|NCT01221948|2707978|P1|Overall Study|Physician Decision|5
851100|NCT01222078|2707989|P1|Overall Study|Early termination of the study|1
851101|NCT01222104|2708023|P1|Overall Study|Death|10
851102|NCT01222104|2708023|P1|Overall Study|Lost to Follow-up|37
851103|NCT01222403|2708132|P2|Overall Study|Inappropriate enrollment|2
851104|NCT01222403|2708133|P1|Overall Study|Inappropriate enrollment|0
851105|NCT01222416|2708145|P2|Overall Study|Death|0
851106|NCT01222416|2708146|P1|Overall Study|Death|1
851107|NCT01222416|2708145|P2|Overall Study|missed view/scan|0
851108|NCT01222416|2708146|P1|Overall Study|missed view/scan|1
851109|NCT01222416|2708145|P2|Overall Study|scheduling|0
851110|NCT01222416|2708146|P1|Overall Study|scheduling|6
851111|NCT01222416|2708145|P2|Overall Study|Withdrawal by Subject|0
851112|NCT01222416|2708146|P1|Overall Study|Withdrawal by Subject|5
851113|NCT01222416|2708145|P2|Overall Study|Adverse Event|0
851114|NCT01222416|2708146|P1|Overall Study|Adverse Event|4
851115|NCT01222416|2708145|P2|Overall Study|ineligible;metastasis|0
851116|NCT01222416|2708146|P1|Overall Study|ineligible;metastasis|3
851117|NCT01222507|2708154|P1|Overall Study|Withdrawal by Subject|1
851118|NCT01222507|2708154|P1|Overall Study|Physician Decision|1
851119|NCT01222520|2708160|P2|Double-blind Period|Study medication stolen|0
851120|NCT01222520|2708161|P1|Double-blind Period|Study medication stolen|1
851121|NCT01222520|2708160|P2|Double-blind Period|Lack of Efficacy|1
851122|NCT01222520|2708161|P1|Double-blind Period|Lack of Efficacy|0
851123|NCT01222520|2708160|P2|Double-blind Period|Adverse Event|1
851124|NCT01222520|2708161|P1|Double-blind Period|Adverse Event|0
851125|NCT01222520|2708160|P2|Open-label run-in Period|Number of patients fulfilled|3
851126|NCT01222520|2708161|P1|Open-label run-in Period|Number of patients fulfilled|0
851127|NCT01222520|2708160|P2|Open-label run-in Period|Blood pressure criteria not met|18
851128|NCT01222520|2708161|P1|Open-label run-in Period|Blood pressure criteria not met|0
851129|NCT01222520|2708160|P2|Open-label run-in Period|Withdrawal by Subject|2
851130|NCT01222520|2708161|P1|Open-label run-in Period|Withdrawal by Subject|0
851131|NCT01222533|2708179|P1|Overall Study|Other|4
851132|NCT01222533|2708179|P1|Overall Study|Withdrawal by Subject|5
851133|NCT01222533|2708179|P1|Overall Study|Adverse Event|5
851134|NCT01222715|2708347|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
851135|NCT01222715|2708348|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
851136|NCT01222715|2708347|P2|Overall Study|Ineligible|1
851137|NCT01222715|2708348|P1|Overall Study|Ineligible|0
851138|NCT01222715|2708347|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
851139|NCT01222715|2708348|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
851140|NCT01222715|2708347|P2|Overall Study|Refusal of further protocol therapy|4
851141|NCT01222715|2708348|P1|Overall Study|Refusal of further protocol therapy|0
851142|NCT01222715|2708347|P2|Overall Study|Physician Decision|2
851143|NCT01222715|2708348|P1|Overall Study|Physician Decision|12
851144|NCT01222715|2708347|P2|Overall Study|Lack of Efficacy|14
851145|NCT01222715|2708348|P1|Overall Study|Lack of Efficacy|22
851146|NCT01222715|2708347|P2|Overall Study|Death|1
851147|NCT01222715|2708348|P1|Overall Study|Death|0
851148|NCT01222715|2708347|P2|Overall Study|Adverse Event|4
851149|NCT01222715|2708348|P1|Overall Study|Adverse Event|0
851150|NCT01223027|2708389|P2|Overall Study|Study terminated by sponsor|8
851151|NCT01223027|2708390|P1|Overall Study|Study terminated by sponsor|2
851152|NCT01223027|2708389|P2|Overall Study|New therapy for study indication|8
851153|NCT01223027|2708390|P1|Overall Study|New therapy for study indication|17
851154|NCT01223027|2708389|P2|Overall Study|Subject/guardian decicion|16
851155|NCT01223027|2708390|P1|Overall Study|Subject/guardian decicion|18
851156|NCT01223027|2708389|P2|Overall Study|Protocol Violation|1
851157|NCT01223027|2708390|P1|Overall Study|Protocol Violation|2
851158|NCT01223027|2708389|P2|Overall Study|Progressive Disease|183
851159|NCT01223027|2708390|P1|Overall Study|Progressive Disease|167
851160|NCT01223027|2708389|P2|Overall Study|Physician Decision|8
851161|NCT01223027|2708390|P1|Overall Study|Physician Decision|4
851162|NCT01223027|2708389|P2|Overall Study|Lost to Follow-up|1
851163|NCT01223027|2708390|P1|Overall Study|Lost to Follow-up|2
851164|NCT01223027|2708389|P2|Overall Study|Death|42
851165|NCT01223027|2708390|P1|Overall Study|Death|42
851166|NCT01223027|2708389|P2|Overall Study|Adverse Event|10
851167|NCT01223027|2708390|P1|Overall Study|Adverse Event|20
851168|NCT01223196|2708413|P2|Overall Study|Withdrawal by Subject|0
851169|NCT01223196|2708414|P1|Overall Study|Withdrawal by Subject|1
851170|NCT01223196|2708413|P2|Overall Study|Physician Decision|0
851171|NCT01223196|2708414|P1|Overall Study|Physician Decision|1
851172|NCT01223196|2708413|P2|Overall Study|Lost to Follow-up|0
851173|NCT01223196|2708414|P1|Overall Study|Lost to Follow-up|2
851174|NCT01223365|2708447|P1|Open-label Treatment Period|Physician Decision|2
851175|NCT01223365|2708447|P1|Open-label Treatment Period|Starting physical therapy|1
851176|NCT01223365|2708447|P1|Open-label Treatment Period|"Out of window"|1
851177|NCT01223365|2708447|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
851178|NCT01223365|2708447|P1|Open-label Treatment Period|Moved out of area|2
851179|NCT01223365|2708447|P1|Open-label Treatment Period|Noncompliance with study procedures|6
851180|NCT01223365|2708447|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
851181|NCT01223365|2708447|P1|Open-label Treatment Period|Lost to Follow-up|7
851182|NCT01223365|2708447|P1|Open-label Treatment Period|Protocol Violation|15
851183|NCT01223365|2708447|P1|Open-label Treatment Period|Withdrawal by Subject|19
851184|NCT01223365|2708447|P1|Open-label Treatment Period|Lack of Efficacy|2
851185|NCT01223365|2708447|P1|Open-label Treatment Period|Adverse Event|39
851186|NCT01223365|2708447|P1|Open-label Titration Period|Starting physical therapy|1
851187|NCT01223365|2708447|P1|Open-label Titration Period|Noncompliance with study procedures|2
851188|NCT01223365|2708447|P1|Open-label Titration Period|Noncompliance with study drug admin|1
851189|NCT01223365|2708447|P1|Open-label Titration Period|Lost to Follow-up|2
851190|NCT01223365|2708447|P1|Open-label Titration Period|Protocol Violation|1
851191|NCT01223365|2708447|P1|Open-label Titration Period|Withdrawal by Subject|5
851192|NCT01223365|2708447|P1|Open-label Titration Period|Lack of Efficacy|3
851193|NCT01223365|2708447|P1|Open-label Titration Period|Adverse Event|23
851194|NCT01223365|2708447|P1|Open-label Titration Period|Enrolled but not treated|1
851195|NCT01216163|2708515|P3|Overall Study|Withdrawal by Subject|0
851196|NCT01216163|2708516|P2|Overall Study|Withdrawal by Subject|1
851197|NCT01216163|2708517|P1|Overall Study|Withdrawal by Subject|1
851198|NCT01216319|2708576|P1|Overall Study|Unanticipated chemo for breast cancer|2
851199|NCT01216319|2708576|P1|Overall Study|Lost to Follow-up|2
851200|NCT01223937|2708700|P2|Overall Study|Not specified|1
851201|NCT01223937|2708701|P1|Overall Study|Not specified|4
851202|NCT01223937|2708700|P2|Overall Study|Protocol Violation|7
851203|NCT01223937|2708701|P1|Overall Study|Protocol Violation|8
851204|NCT01223937|2708700|P2|Overall Study|Adverse Event|4
851205|NCT01223937|2708701|P1|Overall Study|Adverse Event|1
851206|NCT01223937|2708700|P2|Overall Study|Lost to Follow-up|4
851207|NCT01223937|2708701|P1|Overall Study|Lost to Follow-up|1
851208|NCT01223937|2708700|P2|Overall Study|Withdrawal by Subject|2
851209|NCT01223937|2708701|P1|Overall Study|Withdrawal by Subject|3
851210|NCT01224639|2708750|P8|Overall Study|Adverse Event|1
851211|NCT01224639|2708751|P7|Overall Study|Adverse Event|0
851212|NCT01224639|2708752|P6|Overall Study|Adverse Event|0
851213|NCT01224639|2708753|P5|Overall Study|Adverse Event|0
851214|NCT01224639|2708754|P4|Overall Study|Adverse Event|0
851215|NCT01224639|2708755|P3|Overall Study|Adverse Event|0
851216|NCT01224639|2708756|P2|Overall Study|Adverse Event|0
851217|NCT01224639|2708757|P1|Overall Study|Adverse Event|0
851218|NCT01224639|2708750|P8|Overall Study|Withdrawal by Subject|1
851219|NCT01224639|2708751|P7|Overall Study|Withdrawal by Subject|1
851220|NCT01224639|2708752|P6|Overall Study|Withdrawal by Subject|0
851221|NCT01224639|2708753|P5|Overall Study|Withdrawal by Subject|2
851222|NCT01224639|2708754|P4|Overall Study|Withdrawal by Subject|0
851223|NCT01224639|2708755|P3|Overall Study|Withdrawal by Subject|0
851224|NCT01224639|2708756|P2|Overall Study|Withdrawal by Subject|0
851225|NCT01224639|2708757|P1|Overall Study|Withdrawal by Subject|0
851226|NCT01224782|2708863|P1|Overall Study|Transplantation|1
851227|NCT01224782|2708863|P1|Overall Study|Deterioration|1
851228|NCT01224782|2708863|P1|Overall Study|Financial Reasons|1
851229|NCT01224782|2708863|P1|Overall Study|Change of Treatment|1
851230|NCT01224782|2708863|P1|Overall Study|Start of Dialysis|3
851231|NCT01224782|2708863|P1|Overall Study|Not Specified|4
851232|NCT01224782|2708863|P1|Overall Study|Noncompliance|10
851233|NCT01224782|2708863|P1|Overall Study|Adverse Reaction|11
851234|NCT01224782|2708863|P1|Overall Study|Adverse Event|12
851235|NCT01224782|2708863|P1|Overall Study|Improvement|13
851236|NCT01224782|2708863|P1|Overall Study|Death|14
851237|NCT01224782|2708863|P1|Overall Study|Withdrawal by Subject|16
851238|NCT01224782|2708863|P1|Overall Study|Lost to Follow-up|177
851239|NCT01224821|2708872|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
851240|NCT01224821|2708872|P1|Long-Term Follow-Up|Death|2
851241|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
851242|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
851243|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
851244|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
851245|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
851246|NCT01224821|2708872|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
851247|NCT01225146|2708943|P2|Overall Study|Sponsor discontinued making 2mg drug|2
851248|NCT01225146|2708944|P1|Overall Study|Sponsor discontinued making 2mg drug|0
851249|NCT01225159|2708962|P2|Overall Study|Change operation|0
851250|NCT01225159|2708963|P1|Overall Study|Change operation|1
851251|NCT01225211|2708981|P10|Overall Study|Unspecified|1
851252|NCT01225211|2708982|P9|Overall Study|Unspecified|0
851253|NCT01225211|2708983|P8|Overall Study|Unspecified|0
851254|NCT01225211|2708984|P7|Overall Study|Unspecified|0
851255|NCT01225211|2708985|P6|Overall Study|Unspecified|0
851256|NCT01225211|2708986|P5|Overall Study|Unspecified|0
851257|NCT01225211|2708987|P4|Overall Study|Unspecified|0
851258|NCT01225211|2708988|P3|Overall Study|Unspecified|0
851259|NCT01225211|2708989|P2|Overall Study|Unspecified|0
851260|NCT01225211|2708990|P1|Overall Study|Unspecified|0
851261|NCT01225211|2708981|P10|Overall Study|Withdrawal by Subject|3
851262|NCT01225211|2708982|P9|Overall Study|Withdrawal by Subject|1
851263|NCT01225211|2708983|P8|Overall Study|Withdrawal by Subject|0
851264|NCT01225211|2708984|P7|Overall Study|Withdrawal by Subject|1
851265|NCT01225211|2708985|P6|Overall Study|Withdrawal by Subject|0
851266|NCT01225211|2708986|P5|Overall Study|Withdrawal by Subject|0
851267|NCT01225211|2708987|P4|Overall Study|Withdrawal by Subject|0
851268|NCT01225211|2708988|P3|Overall Study|Withdrawal by Subject|0
851269|NCT01225211|2708989|P2|Overall Study|Withdrawal by Subject|0
851270|NCT01225211|2708990|P1|Overall Study|Withdrawal by Subject|0
851271|NCT01225211|2708981|P10|Overall Study|Adverse Event|1
851272|NCT01225211|2708982|P9|Overall Study|Adverse Event|0
851273|NCT01225211|2708983|P8|Overall Study|Adverse Event|0
851274|NCT01225211|2708984|P7|Overall Study|Adverse Event|0
851275|NCT01225211|2708985|P6|Overall Study|Adverse Event|0
851276|NCT01225211|2708986|P5|Overall Study|Adverse Event|0
851277|NCT01225211|2708987|P4|Overall Study|Adverse Event|0
851278|NCT01225211|2708988|P3|Overall Study|Adverse Event|1
851279|NCT01225211|2708989|P2|Overall Study|Adverse Event|0
851280|NCT01225211|2708990|P1|Overall Study|Adverse Event|0
851281|NCT01225549|2709122|P10|Period 6 - Washout|Disallowed medication|0
851282|NCT01225549|2709123|P9|Period 6 - Washout|Disallowed medication|0
851283|NCT01225549|2709124|P8|Period 6 - Washout|Disallowed medication|0
851284|NCT01225549|2709125|P7|Period 6 - Washout|Disallowed medication|0
851285|NCT01225549|2709126|P6|Period 6 - Washout|Disallowed medication|0
851286|NCT01225549|2709127|P5|Period 6 - Washout|Disallowed medication|0
851287|NCT01225549|2709128|P4|Period 6 - Washout|Disallowed medication|1
851288|NCT01225549|2709129|P3|Period 6 - Washout|Disallowed medication|0
851289|NCT01225549|2709130|P2|Period 6 - Washout|Disallowed medication|0
851290|NCT01225549|2709131|P1|Period 6 - Washout|Disallowed medication|0
851291|NCT01225549|2709122|P10|Period 4 - Washout|Disallowed medication|0
851292|NCT01225549|2709123|P9|Period 4 - Washout|Disallowed medication|0
851293|NCT01225549|2709124|P8|Period 4 - Washout|Disallowed medication|0
851294|NCT01225549|2709125|P7|Period 4 - Washout|Disallowed medication|0
851295|NCT01225549|2709126|P6|Period 4 - Washout|Disallowed medication|0
851296|NCT01225549|2709127|P5|Period 4 - Washout|Disallowed medication|0
851297|NCT01225549|2709128|P4|Period 4 - Washout|Disallowed medication|0
851298|NCT01225549|2709129|P3|Period 4 - Washout|Disallowed medication|0
851299|NCT01225549|2709130|P2|Period 4 - Washout|Disallowed medication|1
851300|NCT01225549|2709131|P1|Period 4 - Washout|Disallowed medication|0
851301|NCT01225562|2709176|P3|Overall Study|Lost to Follow-up|1
851302|NCT01225562|2709177|P2|Overall Study|Lost to Follow-up|6
851303|NCT01225562|2709178|P1|Overall Study|Lost to Follow-up|3
851304|NCT01225562|2709176|P3|Overall Study|Withdrawal by Subject|52
851305|NCT01225562|2709177|P2|Overall Study|Withdrawal by Subject|50
851306|NCT01225562|2709178|P1|Overall Study|Withdrawal by Subject|52
851307|NCT01225731|2709200|P13|Part 3|Withdrawal by Subject|4
851308|NCT01225731|2709201|P12|Part 3|Withdrawal by Subject|6
851309|NCT01225731|2709202|P11|Part 3|Withdrawal by Subject|4
851310|NCT01225731|2709203|P10|Part 3|Withdrawal by Subject|0
851311|NCT01225731|2709204|P9|Part 3|Withdrawal by Subject|0
851312|NCT01225731|2709205|P8|Part 3|Withdrawal by Subject|0
851313|NCT01225731|2709206|P7|Part 3|Withdrawal by Subject|0
851314|NCT01225731|2709207|P6|Part 3|Withdrawal by Subject|0
851315|NCT01225731|2709208|P5|Part 3|Withdrawal by Subject|0
851316|NCT01225731|2709209|P4|Part 3|Withdrawal by Subject|0
851317|NCT01225731|2709210|P3|Part 3|Withdrawal by Subject|0
851318|NCT01225731|2709211|P2|Part 3|Withdrawal by Subject|0
851319|NCT01225731|2709212|P1|Part 3|Withdrawal by Subject|0
851320|NCT01225731|2709200|P13|Part 3|Physician Decision|2
851321|NCT01225731|2709201|P12|Part 3|Physician Decision|1
851322|NCT01225731|2709202|P11|Part 3|Physician Decision|0
851323|NCT01225731|2709203|P10|Part 3|Physician Decision|0
851324|NCT01225731|2709204|P9|Part 3|Physician Decision|0
851325|NCT01225731|2709205|P8|Part 3|Physician Decision|0
851326|NCT01225731|2709206|P7|Part 3|Physician Decision|0
851327|NCT01225731|2709207|P6|Part 3|Physician Decision|0
851328|NCT01225731|2709208|P5|Part 3|Physician Decision|0
851329|NCT01225731|2709209|P4|Part 3|Physician Decision|0
851330|NCT01225731|2709210|P3|Part 3|Physician Decision|0
851331|NCT01225731|2709211|P2|Part 3|Physician Decision|0
851332|NCT01225731|2709212|P1|Part 3|Physician Decision|0
851333|NCT01225731|2709200|P13|Part 3|Lost to Follow-up|1
851334|NCT01225731|2709201|P12|Part 3|Lost to Follow-up|2
851335|NCT01225731|2709202|P11|Part 3|Lost to Follow-up|1
851336|NCT01225731|2709203|P10|Part 3|Lost to Follow-up|0
851337|NCT01225731|2709204|P9|Part 3|Lost to Follow-up|0
851338|NCT01225731|2709205|P8|Part 3|Lost to Follow-up|0
851339|NCT01225731|2709206|P7|Part 3|Lost to Follow-up|0
851340|NCT01225731|2709207|P6|Part 3|Lost to Follow-up|0
851341|NCT01225731|2709208|P5|Part 3|Lost to Follow-up|0
851342|NCT01225731|2709209|P4|Part 3|Lost to Follow-up|0
851343|NCT01225731|2709210|P3|Part 3|Lost to Follow-up|0
851344|NCT01225731|2709211|P2|Part 3|Lost to Follow-up|0
851345|NCT01225731|2709212|P1|Part 3|Lost to Follow-up|0
851346|NCT01225731|2709200|P13|Part 3|Adverse Event|0
851347|NCT01225731|2709201|P12|Part 3|Adverse Event|1
851348|NCT01225731|2709202|P11|Part 3|Adverse Event|1
851349|NCT01225731|2709203|P10|Part 3|Adverse Event|0
851350|NCT01225731|2709204|P9|Part 3|Adverse Event|0
851351|NCT01225731|2709205|P8|Part 3|Adverse Event|0
851352|NCT01225731|2709206|P7|Part 3|Adverse Event|0
851353|NCT01225731|2709207|P6|Part 3|Adverse Event|0
851354|NCT01225731|2709208|P5|Part 3|Adverse Event|0
851355|NCT01225731|2709209|P4|Part 3|Adverse Event|0
851356|NCT01225731|2709210|P3|Part 3|Adverse Event|0
851357|NCT01225731|2709211|P2|Part 3|Adverse Event|0
851358|NCT01225731|2709212|P1|Part 3|Adverse Event|0
851359|NCT01225731|2709200|P13|Part 2|Withdrawal by Subject|0
851360|NCT01225731|2709201|P12|Part 2|Withdrawal by Subject|0
851361|NCT01225731|2709202|P11|Part 2|Withdrawal by Subject|0
851362|NCT01225731|2709203|P10|Part 2|Withdrawal by Subject|0
851363|NCT01225731|2709204|P9|Part 2|Withdrawal by Subject|1
851364|NCT01225731|2709205|P8|Part 2|Withdrawal by Subject|4
851365|NCT01225731|2709206|P7|Part 2|Withdrawal by Subject|3
851366|NCT01225731|2709207|P6|Part 2|Withdrawal by Subject|1
851367|NCT01225731|2709208|P5|Part 2|Withdrawal by Subject|0
851368|NCT01225731|2709209|P4|Part 2|Withdrawal by Subject|0
851369|NCT01225731|2709210|P3|Part 2|Withdrawal by Subject|0
851370|NCT01225731|2709211|P2|Part 2|Withdrawal by Subject|0
851371|NCT01225731|2709212|P1|Part 2|Withdrawal by Subject|0
851372|NCT01225731|2709200|P13|Part 2|Physician Decision|0
851373|NCT01225731|2709201|P12|Part 2|Physician Decision|0
851374|NCT01225731|2709202|P11|Part 2|Physician Decision|0
851375|NCT01225731|2709203|P10|Part 2|Physician Decision|0
851376|NCT01225731|2709204|P9|Part 2|Physician Decision|2
851377|NCT01225731|2709205|P8|Part 2|Physician Decision|2
851378|NCT01225731|2709206|P7|Part 2|Physician Decision|0
851379|NCT01225731|2709207|P6|Part 2|Physician Decision|0
851380|NCT01225731|2709208|P5|Part 2|Physician Decision|0
851381|NCT01225731|2709209|P4|Part 2|Physician Decision|0
851382|NCT01225731|2709210|P3|Part 2|Physician Decision|0
851383|NCT01225731|2709211|P2|Part 2|Physician Decision|0
851384|NCT01225731|2709212|P1|Part 2|Physician Decision|0
851385|NCT01225731|2709200|P13|Part 2|Lost to Follow-up|0
851386|NCT01225731|2709201|P12|Part 2|Lost to Follow-up|0
851387|NCT01225731|2709202|P11|Part 2|Lost to Follow-up|0
851388|NCT01225731|2709203|P10|Part 2|Lost to Follow-up|0
851389|NCT01225731|2709204|P9|Part 2|Lost to Follow-up|1
851390|NCT01225731|2709205|P8|Part 2|Lost to Follow-up|3
851391|NCT01225731|2709206|P7|Part 2|Lost to Follow-up|0
851392|NCT01225731|2709207|P6|Part 2|Lost to Follow-up|0
851393|NCT01225731|2709208|P5|Part 2|Lost to Follow-up|0
851394|NCT01225731|2709209|P4|Part 2|Lost to Follow-up|0
851395|NCT01225731|2709210|P3|Part 2|Lost to Follow-up|0
851396|NCT01225731|2709211|P2|Part 2|Lost to Follow-up|0
851397|NCT01225731|2709212|P1|Part 2|Lost to Follow-up|0
851398|NCT01225731|2709200|P13|Part 2|Pregnancy|0
851399|NCT01225731|2709201|P12|Part 2|Pregnancy|0
851400|NCT01225731|2709202|P11|Part 2|Pregnancy|0
851401|NCT01225731|2709203|P10|Part 2|Pregnancy|0
851402|NCT01225731|2709204|P9|Part 2|Pregnancy|1
851403|NCT01225731|2709205|P8|Part 2|Pregnancy|0
851404|NCT01225731|2709206|P7|Part 2|Pregnancy|1
851405|NCT01225731|2709207|P6|Part 2|Pregnancy|0
851406|NCT01225731|2709208|P5|Part 2|Pregnancy|0
851407|NCT01225731|2709209|P4|Part 2|Pregnancy|0
851408|NCT01225731|2709210|P3|Part 2|Pregnancy|0
851409|NCT01225731|2709211|P2|Part 2|Pregnancy|0
851410|NCT01225731|2709212|P1|Part 2|Pregnancy|0
851411|NCT01225731|2709200|P13|Part 2|Lack of Efficacy|0
851412|NCT01225731|2709201|P12|Part 2|Lack of Efficacy|0
851413|NCT01225731|2709202|P11|Part 2|Lack of Efficacy|0
851414|NCT01225731|2709203|P10|Part 2|Lack of Efficacy|0
851415|NCT01225731|2709204|P9|Part 2|Lack of Efficacy|3
851416|NCT01225731|2709205|P8|Part 2|Lack of Efficacy|12
851417|NCT01225731|2709206|P7|Part 2|Lack of Efficacy|0
851418|NCT01225731|2709207|P6|Part 2|Lack of Efficacy|1
851419|NCT01225731|2709208|P5|Part 2|Lack of Efficacy|0
851420|NCT01225731|2709209|P4|Part 2|Lack of Efficacy|0
851421|NCT01225731|2709210|P3|Part 2|Lack of Efficacy|0
851422|NCT01225731|2709211|P2|Part 2|Lack of Efficacy|0
851423|NCT01225731|2709212|P1|Part 2|Lack of Efficacy|0
851424|NCT01225731|2709200|P13|Part 2|Adverse Event|0
851425|NCT01225731|2709201|P12|Part 2|Adverse Event|0
851426|NCT01225731|2709202|P11|Part 2|Adverse Event|0
851427|NCT01225731|2709203|P10|Part 2|Adverse Event|0
851428|NCT01225731|2709204|P9|Part 2|Adverse Event|2
851429|NCT01225731|2709205|P8|Part 2|Adverse Event|4
851430|NCT01225731|2709206|P7|Part 2|Adverse Event|4
851431|NCT01225731|2709207|P6|Part 2|Adverse Event|0
851432|NCT01225731|2709208|P5|Part 2|Adverse Event|0
851433|NCT01225731|2709209|P4|Part 2|Adverse Event|0
851434|NCT01225731|2709210|P3|Part 2|Adverse Event|0
851435|NCT01225731|2709211|P2|Part 2|Adverse Event|0
851436|NCT01225731|2709212|P1|Part 2|Adverse Event|0
851437|NCT01225731|2709200|P13|Part 2|Protocol Violation|0
851438|NCT01225731|2709201|P12|Part 2|Protocol Violation|0
851439|NCT01225731|2709202|P11|Part 2|Protocol Violation|0
851440|NCT01225731|2709203|P10|Part 2|Protocol Violation|0
851441|NCT01225731|2709204|P9|Part 2|Protocol Violation|1
851442|NCT01225731|2709205|P8|Part 2|Protocol Violation|0
851443|NCT01225731|2709206|P7|Part 2|Protocol Violation|0
851444|NCT01225731|2709207|P6|Part 2|Protocol Violation|1
851445|NCT01225731|2709208|P5|Part 2|Protocol Violation|0
851446|NCT01225731|2709209|P4|Part 2|Protocol Violation|0
851447|NCT01225731|2709210|P3|Part 2|Protocol Violation|0
851448|NCT01225731|2709211|P2|Part 2|Protocol Violation|0
851449|NCT01225731|2709212|P1|Part 2|Protocol Violation|0
851450|NCT01225731|2709200|P13|Part 1|Protocol Violation|0
851451|NCT01225731|2709201|P12|Part 1|Protocol Violation|0
851452|NCT01225731|2709202|P11|Part 1|Protocol Violation|0
851453|NCT01225731|2709203|P10|Part 1|Protocol Violation|0
851454|NCT01225731|2709204|P9|Part 1|Protocol Violation|0
851455|NCT01225731|2709205|P8|Part 1|Protocol Violation|0
851456|NCT01225731|2709206|P7|Part 1|Protocol Violation|0
851457|NCT01225731|2709207|P6|Part 1|Protocol Violation|0
851458|NCT01225731|2709208|P5|Part 1|Protocol Violation|0
851459|NCT01225731|2709209|P4|Part 1|Protocol Violation|1
851460|NCT01225731|2709210|P3|Part 1|Protocol Violation|0
851461|NCT01225731|2709211|P2|Part 1|Protocol Violation|0
851462|NCT01225731|2709212|P1|Part 1|Protocol Violation|0
851463|NCT01225731|2709200|P13|Part 1|Withdrawal by Subject|0
851464|NCT01225731|2709201|P12|Part 1|Withdrawal by Subject|0
851465|NCT01225731|2709202|P11|Part 1|Withdrawal by Subject|0
851466|NCT01225731|2709203|P10|Part 1|Withdrawal by Subject|0
851467|NCT01225731|2709204|P9|Part 1|Withdrawal by Subject|0
851468|NCT01225731|2709205|P8|Part 1|Withdrawal by Subject|0
851469|NCT01225731|2709206|P7|Part 1|Withdrawal by Subject|0
851470|NCT01225731|2709207|P6|Part 1|Withdrawal by Subject|0
851471|NCT01225731|2709208|P5|Part 1|Withdrawal by Subject|4
851472|NCT01225731|2709209|P4|Part 1|Withdrawal by Subject|0
851473|NCT01225731|2709210|P3|Part 1|Withdrawal by Subject|0
851474|NCT01225731|2709211|P2|Part 1|Withdrawal by Subject|3
851475|NCT01225731|2709212|P1|Part 1|Withdrawal by Subject|0
851476|NCT01225731|2709200|P13|Part 1|Adverse Event|0
851477|NCT01225731|2709201|P12|Part 1|Adverse Event|0
851478|NCT01225731|2709202|P11|Part 1|Adverse Event|0
851479|NCT01225731|2709203|P10|Part 1|Adverse Event|0
851480|NCT01225731|2709204|P9|Part 1|Adverse Event|0
851481|NCT01225731|2709205|P8|Part 1|Adverse Event|0
851482|NCT01225731|2709206|P7|Part 1|Adverse Event|0
851483|NCT01225731|2709207|P6|Part 1|Adverse Event|0
851484|NCT01225731|2709208|P5|Part 1|Adverse Event|1
851485|NCT01225731|2709209|P4|Part 1|Adverse Event|1
851486|NCT01225731|2709210|P3|Part 1|Adverse Event|1
851487|NCT01225731|2709211|P2|Part 1|Adverse Event|2
851488|NCT01225731|2709212|P1|Part 1|Adverse Event|1
851489|NCT01225731|2709200|P13|Part 1|Did not meet eligibility criteria|0
851490|NCT01225731|2709201|P12|Part 1|Did not meet eligibility criteria|0
851491|NCT01225731|2709202|P11|Part 1|Did not meet eligibility criteria|0
851492|NCT01225731|2709203|P10|Part 1|Did not meet eligibility criteria|0
851493|NCT01225731|2709204|P9|Part 1|Did not meet eligibility criteria|0
851494|NCT01225731|2709205|P8|Part 1|Did not meet eligibility criteria|0
851495|NCT01225731|2709206|P7|Part 1|Did not meet eligibility criteria|0
851496|NCT01225731|2709207|P6|Part 1|Did not meet eligibility criteria|0
851497|NCT01225731|2709208|P5|Part 1|Did not meet eligibility criteria|1
851498|NCT01225731|2709209|P4|Part 1|Did not meet eligibility criteria|0
851499|NCT01225731|2709210|P3|Part 1|Did not meet eligibility criteria|0
851500|NCT01225731|2709211|P2|Part 1|Did not meet eligibility criteria|0
851501|NCT01225731|2709212|P1|Part 1|Did not meet eligibility criteria|1
851502|NCT01225822|2709309|P5|Overall Study|Not Specified|7
851503|NCT01225822|2709310|P4|Overall Study|Not Specified|10
851504|NCT01225822|2709311|P3|Overall Study|Not Specified|7
851505|NCT01225822|2709312|P2|Overall Study|Not Specified|10
851506|NCT01225822|2709313|P1|Overall Study|Not Specified|13
851507|NCT01225822|2709309|P5|Overall Study|Withdrawal by Subject|6
851508|NCT01225822|2709310|P4|Overall Study|Withdrawal by Subject|11
851509|NCT01225822|2709311|P3|Overall Study|Withdrawal by Subject|7
851510|NCT01225822|2709312|P2|Overall Study|Withdrawal by Subject|7
851511|NCT01225822|2709313|P1|Overall Study|Withdrawal by Subject|6
851512|NCT01225822|2709309|P5|Overall Study|Lost to Follow-up|0
851513|NCT01225822|2709310|P4|Overall Study|Lost to Follow-up|1
851514|NCT01225822|2709311|P3|Overall Study|Lost to Follow-up|0
851515|NCT01225822|2709312|P2|Overall Study|Lost to Follow-up|0
851516|NCT01225822|2709313|P1|Overall Study|Lost to Follow-up|0
851517|NCT01225822|2709309|P5|Overall Study|Protocol Violation|4
851518|NCT01225822|2709310|P4|Overall Study|Protocol Violation|7
851519|NCT01225822|2709311|P3|Overall Study|Protocol Violation|6
851520|NCT01225822|2709312|P2|Overall Study|Protocol Violation|8
851521|NCT01225822|2709313|P1|Overall Study|Protocol Violation|6
851522|NCT01225822|2709309|P5|Overall Study|Adverse Event|14
851523|NCT01225822|2709310|P4|Overall Study|Adverse Event|23
851524|NCT01225822|2709311|P3|Overall Study|Adverse Event|18
851525|NCT01225822|2709312|P2|Overall Study|Adverse Event|31
851526|NCT01225822|2709313|P1|Overall Study|Adverse Event|13
851527|NCT01225835|2709377|P2|Overall Study|not specified|1
851528|NCT01225835|2709378|P1|Overall Study|not specified|1
851529|NCT01225835|2709377|P2|Overall Study|Adverse Event|1
851530|NCT01225835|2709378|P1|Overall Study|Adverse Event|2
851531|NCT01225835|2709377|P2|Overall Study|Did not meet hCG criterion|0
851532|NCT01225835|2709378|P1|Overall Study|Did not meet hCG criterion|2
851533|NCT01225835|2709377|P2|Overall Study|Completed protocol|1
851534|NCT01225835|2709378|P1|Overall Study|Completed protocol|2
851538|NCT01225952|2709441|P3|Overall Study|Surgical complications|0
851539|NCT01225952|2709442|P2|Overall Study|Surgical complications|0
851540|NCT01225952|2709443|P1|Overall Study|Surgical complications|1
851541|NCT01225952|2709441|P3|Overall Study|Withdrawal by Subject|5
851542|NCT01225952|2709442|P2|Overall Study|Withdrawal by Subject|4
851543|NCT01225952|2709443|P1|Overall Study|Withdrawal by Subject|4
851544|NCT01225952|2709441|P3|Overall Study|Study Eye Explanted|1
851545|NCT01225952|2709442|P2|Overall Study|Study Eye Explanted|0
851546|NCT01225952|2709443|P1|Overall Study|Study Eye Explanted|0
851547|NCT01225952|2709441|P3|Overall Study|Lost to Follow-up|0
851548|NCT01225952|2709442|P2|Overall Study|Lost to Follow-up|0
851549|NCT01225952|2709443|P1|Overall Study|Lost to Follow-up|1
851550|NCT01225991|2709526|P1|Overall Study|Withdrawal by Subject|6
851551|NCT01226043|2709532|P4|30-week Observational Phase|Physician Decision|2
851552|NCT01226043|2709533|P3|30-week Observational Phase|Physician Decision|2
851553|NCT01226043|2709534|P2|30-week Observational Phase|Physician Decision|0
851554|NCT01226043|2709535|P1|30-week Observational Phase|Physician Decision|0
851555|NCT01226043|2709532|P4|30-week Observational Phase|Withdrawal by Subject|7
851556|NCT01226043|2709533|P3|30-week Observational Phase|Withdrawal by Subject|1
851557|NCT01226043|2709534|P2|30-week Observational Phase|Withdrawal by Subject|0
851558|NCT01226043|2709535|P1|30-week Observational Phase|Withdrawal by Subject|0
851559|NCT01226043|2709532|P4|30-week Observational Phase|Lost to Follow-up|2
851560|NCT01226043|2709533|P3|30-week Observational Phase|Lost to Follow-up|2
851561|NCT01226043|2709534|P2|30-week Observational Phase|Lost to Follow-up|0
851562|NCT01226043|2709535|P1|30-week Observational Phase|Lost to Follow-up|0
851563|NCT01226043|2709532|P4|30-week Observational Phase|Protocol Violation|1
851564|NCT01226043|2709533|P3|30-week Observational Phase|Protocol Violation|0
851565|NCT01226043|2709534|P2|30-week Observational Phase|Protocol Violation|0
851566|NCT01226043|2709535|P1|30-week Observational Phase|Protocol Violation|0
851567|NCT01226043|2709532|P4|30-week Observational Phase|Adverse Event|1
851568|NCT01226043|2709533|P3|30-week Observational Phase|Adverse Event|1
851569|NCT01226043|2709534|P2|30-week Observational Phase|Adverse Event|0
851570|NCT01226043|2709535|P1|30-week Observational Phase|Adverse Event|0
851571|NCT01226043|2709532|P4|6-week Re-randomization Phase|completed in error|1
851572|NCT01226043|2709533|P3|6-week Re-randomization Phase|completed in error|0
851573|NCT01226043|2709534|P2|6-week Re-randomization Phase|completed in error|0
851574|NCT01226043|2709535|P1|6-week Re-randomization Phase|completed in error|0
851575|NCT01226043|2709532|P4|6-week Re-randomization Phase|Physician Decision|2
851576|NCT01226043|2709533|P3|6-week Re-randomization Phase|Physician Decision|3
851577|NCT01226043|2709534|P2|6-week Re-randomization Phase|Physician Decision|0
851578|NCT01226043|2709535|P1|6-week Re-randomization Phase|Physician Decision|0
851579|NCT01226043|2709532|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
851580|NCT01226043|2709533|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
851581|NCT01226043|2709534|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
851582|NCT01226043|2709535|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
851583|NCT01226043|2709532|P4|6-week Re-randomization Phase|Lost to Follow-up|3
851584|NCT01226043|2709533|P3|6-week Re-randomization Phase|Lost to Follow-up|1
851585|NCT01226043|2709534|P2|6-week Re-randomization Phase|Lost to Follow-up|0
851586|NCT01226043|2709535|P1|6-week Re-randomization Phase|Lost to Follow-up|0
851587|NCT01226043|2709532|P4|6-week Re-randomization Phase|Protocol Violation|1
851588|NCT01226043|2709533|P3|6-week Re-randomization Phase|Protocol Violation|1
851589|NCT01226043|2709534|P2|6-week Re-randomization Phase|Protocol Violation|0
851590|NCT01226043|2709535|P1|6-week Re-randomization Phase|Protocol Violation|0
851591|NCT01226043|2709532|P4|6-week Re-randomization Phase|Adverse Event|1
851592|NCT01226043|2709533|P3|6-week Re-randomization Phase|Adverse Event|1
851593|NCT01226043|2709534|P2|6-week Re-randomization Phase|Adverse Event|0
851594|NCT01226043|2709535|P1|6-week Re-randomization Phase|Adverse Event|0
851595|NCT01226043|2709532|P4|4-week Crossover Phase - Period 2|Physician Decision|0
851596|NCT01226043|2709533|P3|4-week Crossover Phase - Period 2|Physician Decision|0
851597|NCT01226043|2709534|P2|4-week Crossover Phase - Period 2|Physician Decision|5
851598|NCT01226043|2709535|P1|4-week Crossover Phase - Period 2|Physician Decision|4
851599|NCT01226043|2709532|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
851600|NCT01226043|2709533|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
851601|NCT01226043|2709534|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
851602|NCT01226043|2709535|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
851603|NCT01226043|2709532|P4|4-week Crossover Phase - Period 1|Physician Decision|0
851604|NCT01226043|2709533|P3|4-week Crossover Phase - Period 1|Physician Decision|0
851605|NCT01226043|2709534|P2|4-week Crossover Phase - Period 1|Physician Decision|6
851606|NCT01226043|2709535|P1|4-week Crossover Phase - Period 1|Physician Decision|0
851607|NCT01226043|2709532|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
851608|NCT01226043|2709533|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
851609|NCT01226043|2709534|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
851610|NCT01226043|2709535|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
851611|NCT01226043|2709532|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
851612|NCT01226043|2709533|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
851613|NCT01226043|2709534|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
851614|NCT01226043|2709535|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
851615|NCT01226043|2709532|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
851616|NCT01226043|2709533|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
851617|NCT01226043|2709534|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
851618|NCT01226043|2709535|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
851619|NCT01226095|2709573|P1|Overall Study|Poor compliance|1
851620|NCT01226121|2709599|P3|Overall Study|Lost to Follow-up|1
851621|NCT01226121|2709600|P2|Overall Study|Lost to Follow-up|0
851622|NCT01226121|2709601|P1|Overall Study|Lost to Follow-up|2
851623|NCT01226459|2709619|P2|Overall Study|Pregnancy|0
851624|NCT01226459|2709620|P1|Overall Study|Pregnancy|1
851625|NCT01226459|2709619|P2|Overall Study|Lost to Follow-up|8
851626|NCT01226459|2709620|P1|Overall Study|Lost to Follow-up|4
851627|NCT01226459|2709619|P2|Overall Study|Withdrawal by Subject|13
851628|NCT01226459|2709620|P1|Overall Study|Withdrawal by Subject|10
851629|NCT01226459|2709619|P2|Overall Study|Protocol Violation|3
851630|NCT01226459|2709620|P1|Overall Study|Protocol Violation|4
851631|NCT01226459|2709619|P2|Overall Study|Adverse Event|8
851632|NCT01226459|2709620|P1|Overall Study|Adverse Event|2
851633|NCT01226511|2709632|P2|Taper Period|Parent/Caregiver Decision|1
851634|NCT01226511|2709633|P1|Taper Period|Parent/Caregiver Decision|1
851635|NCT01226511|2709632|P2|Taper Period|Protocol Violation|0
851636|NCT01226511|2709633|P1|Taper Period|Protocol Violation|1
851637|NCT01226511|2709632|P2|Taper Period|Lost to Follow-up|2
851638|NCT01226511|2709633|P1|Taper Period|Lost to Follow-up|2
851639|NCT01226511|2709632|P2|Taper Period|Adverse Event|0
851640|NCT01226511|2709633|P1|Taper Period|Adverse Event|1
851641|NCT01226511|2709632|P2|Extension Treatment Period|Sponsor Decision|1
851642|NCT01226511|2709633|P1|Extension Treatment Period|Sponsor Decision|1
851643|NCT01226511|2709632|P2|Extension Treatment Period|Parent/Caregiver Decision|8
851644|NCT01226511|2709633|P1|Extension Treatment Period|Parent/Caregiver Decision|8
851645|NCT01226511|2709632|P2|Extension Treatment Period|Withdrawal by Subject|3
851646|NCT01226511|2709633|P1|Extension Treatment Period|Withdrawal by Subject|1
851647|NCT01226511|2709632|P2|Extension Treatment Period|Protocol Violation|2
851648|NCT01226511|2709633|P1|Extension Treatment Period|Protocol Violation|2
851649|NCT01226511|2709632|P2|Extension Treatment Period|Lost to Follow-up|3
851650|NCT01226511|2709633|P1|Extension Treatment Period|Lost to Follow-up|4
851651|NCT01226511|2709632|P2|Extension Treatment Period|Lack of Efficacy|2
851652|NCT01226511|2709633|P1|Extension Treatment Period|Lack of Efficacy|3
851653|NCT01226511|2709632|P2|Extension Treatment Period|Adverse Event|8
851654|NCT01226511|2709633|P1|Extension Treatment Period|Adverse Event|8
851655|NCT01226511|2709632|P2|Acute Treatment Period|Withdrawal by Subject|6
851656|NCT01226511|2709633|P1|Acute Treatment Period|Withdrawal by Subject|10
851657|NCT01226511|2709632|P2|Acute Treatment Period|Protocol Violation|5
851658|NCT01226511|2709633|P1|Acute Treatment Period|Protocol Violation|5
851659|NCT01226511|2709632|P2|Acute Treatment Period|Parent/caregiver decision|7
851660|NCT01226511|2709633|P1|Acute Treatment Period|Parent/caregiver decision|5
851661|NCT01226511|2709632|P2|Acute Treatment Period|Lost to Follow-up|6
851662|NCT01226511|2709633|P1|Acute Treatment Period|Lost to Follow-up|3
851663|NCT01226511|2709632|P2|Acute Treatment Period|Lack of Efficacy|1
851664|NCT01226511|2709633|P1|Acute Treatment Period|Lack of Efficacy|2
851665|NCT01226511|2709632|P2|Acute Treatment Period|Adverse Event|6
851666|NCT01226511|2709633|P1|Acute Treatment Period|Adverse Event|7
851667|NCT01226745|2709795|P6|Overall Study|Unspecified|1
851668|NCT01226745|2709796|P5|Overall Study|Unspecified|3
851669|NCT01226745|2709797|P4|Overall Study|Unspecified|4
851670|NCT01226745|2709798|P3|Overall Study|Unspecified|8
851671|NCT01226745|2709799|P2|Overall Study|Unspecified|7
851672|NCT01226745|2709800|P1|Overall Study|Unspecified|6
851673|NCT01226745|2709795|P6|Overall Study|Death|1
851674|NCT01226745|2709796|P5|Overall Study|Death|0
851675|NCT01226745|2709797|P4|Overall Study|Death|0
851676|NCT01226745|2709798|P3|Overall Study|Death|0
851677|NCT01226745|2709799|P2|Overall Study|Death|0
851678|NCT01226745|2709800|P1|Overall Study|Death|1
851679|NCT01226745|2709795|P6|Overall Study|Lost to Follow-up|2
851680|NCT01226745|2709796|P5|Overall Study|Lost to Follow-up|1
851681|NCT01226745|2709797|P4|Overall Study|Lost to Follow-up|1
851682|NCT01226745|2709798|P3|Overall Study|Lost to Follow-up|6
851683|NCT01226745|2709799|P2|Overall Study|Lost to Follow-up|6
851684|NCT01226745|2709800|P1|Overall Study|Lost to Follow-up|2
851685|NCT01226745|2709795|P6|Overall Study|Did not complete schedule of assessments|1
851686|NCT01226745|2709796|P5|Overall Study|Did not complete schedule of assessments|0
851687|NCT01226745|2709797|P4|Overall Study|Did not complete schedule of assessments|0
851688|NCT01226745|2709798|P3|Overall Study|Did not complete schedule of assessments|6
851689|NCT01226745|2709799|P2|Overall Study|Did not complete schedule of assessments|3
851690|NCT01226745|2709800|P1|Overall Study|Did not complete schedule of assessments|8
851691|NCT01227018|2709887|P1|Overall Study|Withdrew after beginning treatment|4
851692|NCT01227018|2709887|P1|Overall Study|Toxicity|2
851693|NCT01227018|2709887|P1|Overall Study|Disease progression|9
851694|NCT01219933|2710017|P1|Overall Study|Lack of Efficacy|1
851695|NCT01219933|2710017|P1|Overall Study|Protocol Violation|8
851696|NCT01219933|2710017|P1|Overall Study|Withdrawal by Subject|5
851697|NCT01219933|2710017|P1|Overall Study|GC free|1
851698|NCT01219933|2710017|P1|Overall Study|Lost to Follow-up|3
851699|NCT01219933|2710017|P1|Overall Study|No LDA maintained|7
851700|NCT01219933|2710017|P1|Overall Study|No LDA reached|5
851701|NCT01219933|2710017|P1|Overall Study|Adverse Event|8
851702|NCT01219985|2710054|P1|Overall Study|Physician Decision|20
851703|NCT01220128|2710067|P7|Overall Study|Consent withdrawn by subject|0
851704|NCT01220128|2710068|P6|Overall Study|Consent withdrawn by subject|0
851705|NCT01220128|2710069|P5|Overall Study|Consent withdrawn by subject|0
851706|NCT01220128|2710070|P4|Overall Study|Consent withdrawn by subject|0
851707|NCT01220128|2710071|P3|Overall Study|Consent withdrawn by subject|0
851708|NCT01220128|2710072|P2|Overall Study|Consent withdrawn by subject|0
851709|NCT01220128|2710073|P1|Overall Study|Consent withdrawn by subject|1
851710|NCT01220128|2710067|P7|Overall Study|Unspecified|0
851711|NCT01220128|2710068|P6|Overall Study|Unspecified|0
851712|NCT01220128|2710069|P5|Overall Study|Unspecified|0
851713|NCT01220128|2710070|P4|Overall Study|Unspecified|0
851714|NCT01220128|2710071|P3|Overall Study|Unspecified|1
851715|NCT01220128|2710072|P2|Overall Study|Unspecified|0
851716|NCT01220128|2710073|P1|Overall Study|Unspecified|0
851717|NCT01220128|2710067|P7|Overall Study|Adverse event, non-fatal|3
851718|NCT01220128|2710068|P6|Overall Study|Adverse event, non-fatal|0
851719|NCT01220128|2710069|P5|Overall Study|Adverse event, non-fatal|0
851720|NCT01220128|2710070|P4|Overall Study|Adverse event, non-fatal|0
851721|NCT01220128|2710071|P3|Overall Study|Adverse event, non-fatal|0
851722|NCT01220128|2710072|P2|Overall Study|Adverse event, non-fatal|0
851723|NCT01220128|2710073|P1|Overall Study|Adverse event, non-fatal|1
851724|NCT01220128|2710067|P7|Overall Study|Adverse event, serious fatal|1
851725|NCT01220128|2710068|P6|Overall Study|Adverse event, serious fatal|0
851726|NCT01220128|2710069|P5|Overall Study|Adverse event, serious fatal|0
851727|NCT01220128|2710070|P4|Overall Study|Adverse event, serious fatal|0
851728|NCT01220128|2710071|P3|Overall Study|Adverse event, serious fatal|0
851729|NCT01220128|2710072|P2|Overall Study|Adverse event, serious fatal|0
851730|NCT01220128|2710073|P1|Overall Study|Adverse event, serious fatal|2
851731|NCT01220128|2710067|P7|Overall Study|Sponsor study termination|1
851732|NCT01220128|2710068|P6|Overall Study|Sponsor study termination|0
851733|NCT01220128|2710069|P5|Overall Study|Sponsor study termination|0
851734|NCT01220128|2710070|P4|Overall Study|Sponsor study termination|0
851735|NCT01220128|2710071|P3|Overall Study|Sponsor study termination|0
851736|NCT01220128|2710072|P2|Overall Study|Sponsor study termination|1
851737|NCT01220128|2710073|P1|Overall Study|Sponsor study termination|0
851738|NCT01220128|2710067|P7|Overall Study|Progressive disease|0
851739|NCT01220128|2710068|P6|Overall Study|Progressive disease|0
851740|NCT01220128|2710069|P5|Overall Study|Progressive disease|0
851741|NCT01220128|2710070|P4|Overall Study|Progressive disease|0
851742|NCT01220128|2710071|P3|Overall Study|Progressive disease|2
851743|NCT01220128|2710072|P2|Overall Study|Progressive disease|0
851744|NCT01220128|2710073|P1|Overall Study|Progressive disease|0
851745|NCT01220180|2710281|P1|Overall Study|Randomized but not treated|1
851746|NCT01220180|2710281|P1|Overall Study|Death|1
851747|NCT01220180|2710281|P1|Overall Study|Lack of Efficacy|22
851748|NCT01220180|2710281|P1|Overall Study|Adverse Event|35
851749|NCT01220180|2710281|P1|Overall Study|Unspecified|72
851750|NCT01220180|2710281|P1|Overall Study|Lost to Follow-up|76
851751|NCT01220297|2710306|P1|Overall Study|Lost to Follow-up|1
851752|NCT01220297|2710306|P1|Overall Study|Death|2
851753|NCT01220401|2710320|P1|Overall Study|Protocol Violation|1
851754|NCT01220401|2710320|P1|Overall Study|Withdrawal by Subject|2
851755|NCT01220557|2710354|P2|Overall Study|attended less than 6 lessons|2
851756|NCT01220557|2710355|P1|Overall Study|attended less than 6 lessons|1
851757|NCT01220557|2710354|P2|Overall Study|Lost to Follow-up|3
851758|NCT01220557|2710355|P1|Overall Study|Lost to Follow-up|5
851762|NCT01221090|2710390|P4|Overall Study|Withdrawal by Subject|2
851763|NCT01221090|2710391|P3|Overall Study|Withdrawal by Subject|27
851764|NCT01221090|2710392|P2|Overall Study|Withdrawal by Subject|22
851765|NCT01221090|2710393|P1|Overall Study|Withdrawal by Subject|0
851766|NCT01221090|2710390|P4|Overall Study|Non-Compliant or Unable to Contact|20
851767|NCT01221090|2710391|P3|Overall Study|Non-Compliant or Unable to Contact|15
851768|NCT01221090|2710392|P2|Overall Study|Non-Compliant or Unable to Contact|12
851769|NCT01221090|2710393|P1|Overall Study|Non-Compliant or Unable to Contact|15
851770|NCT01227265|2710422|P3|Overall Study|Adverse Event|5
851771|NCT01227265|2710423|P2|Overall Study|Adverse Event|10
851772|NCT01227265|2710424|P1|Overall Study|Adverse Event|6
851773|NCT01227265|2710422|P3|Overall Study|Lost to Follow-up|3
851774|NCT01227265|2710423|P2|Overall Study|Lost to Follow-up|0
851775|NCT01227265|2710424|P1|Overall Study|Lost to Follow-up|2
851776|NCT01227265|2710422|P3|Overall Study|Withdrawal by Subject|3
851777|NCT01227265|2710423|P2|Overall Study|Withdrawal by Subject|7
851778|NCT01227265|2710424|P1|Overall Study|Withdrawal by Subject|7
851779|NCT01227265|2710422|P3|Overall Study|Protocol Violation|0
851780|NCT01227265|2710423|P2|Overall Study|Protocol Violation|1
851781|NCT01227265|2710424|P1|Overall Study|Protocol Violation|2
851782|NCT01227265|2710422|P3|Overall Study|Did Not Meet Protocol Eligibility|1
851783|NCT01227265|2710423|P2|Overall Study|Did Not Meet Protocol Eligibility|0
851784|NCT01227265|2710424|P1|Overall Study|Did Not Meet Protocol Eligibility|0
851785|NCT01227265|2710422|P3|Overall Study|Administrative|2
851786|NCT01227265|2710423|P2|Overall Study|Administrative|0
851787|NCT01227265|2710424|P1|Overall Study|Administrative|1
851788|NCT01227265|2710422|P3|Overall Study|Did Not Receive Treatment|0
851789|NCT01227265|2710423|P2|Overall Study|Did Not Receive Treatment|2
851790|NCT01227265|2710424|P1|Overall Study|Did Not Receive Treatment|1
851791|NCT01227278|2710452|P2|Overall Study|Unspecified|2
851792|NCT01227278|2710453|P1|Overall Study|Unspecified|1
851793|NCT01227278|2710452|P2|Overall Study|Death|2
851794|NCT01227278|2710453|P1|Overall Study|Death|0
851795|NCT01227278|2710452|P2|Overall Study|Withdrawal by Subject|4
851796|NCT01227278|2710453|P1|Overall Study|Withdrawal by Subject|4
851797|NCT01227395|2710489|P2|Overall Study|Protocol Violation|1
851798|NCT01227395|2710490|P1|Overall Study|Protocol Violation|0
851799|NCT01227421|2710521|P3|Overall Study|Randomized in error|0
851800|NCT01227421|2710522|P2|Overall Study|Randomized in error|1
851801|NCT01227421|2710523|P1|Overall Study|Randomized in error|1
851802|NCT01227421|2710521|P3|Overall Study|Protocol Violation|2
851803|NCT01227421|2710522|P2|Overall Study|Protocol Violation|1
851804|NCT01227421|2710523|P1|Overall Study|Protocol Violation|1
851805|NCT01227421|2710521|P3|Overall Study|Withdrawal by Subject|1
851806|NCT01227421|2710522|P2|Overall Study|Withdrawal by Subject|2
851807|NCT01227421|2710523|P1|Overall Study|Withdrawal by Subject|1
851808|NCT01227421|2710521|P3|Overall Study|Adverse Event|2
851809|NCT01227421|2710522|P2|Overall Study|Adverse Event|7
851810|NCT01227421|2710523|P1|Overall Study|Adverse Event|2
851811|NCT01227421|2710521|P3|Overall Study|Lost to Follow-up|5
851812|NCT01227421|2710522|P2|Overall Study|Lost to Follow-up|7
851813|NCT01227421|2710523|P1|Overall Study|Lost to Follow-up|6
851814|NCT01228591|2710584|P2|Baseline|Lack of Efficacy|2
851815|NCT01228591|2710585|P1|Baseline|Lack of Efficacy|1
894325|NCT01921270|2838102|P1|Overall Study|Withdrawal by Subject|1
894326|NCT01637961|2838217|P1|Overall Study|Ineligible: inadequate pathology|1
894327|NCT01637961|2838217|P1|Overall Study|Ineligible: wrong primary|1
851820|NCT01228747|2710620|P2|Overall Study|Other Reason|5
851821|NCT01228747|2710621|P1|Overall Study|Other Reason|2
851822|NCT01228747|2710620|P2|Overall Study|Withdrawal by Subject|1
851823|NCT01228747|2710621|P1|Overall Study|Withdrawal by Subject|5
851824|NCT01228747|2710620|P2|Overall Study|Lost to Follow-up|3
851825|NCT01228747|2710621|P1|Overall Study|Lost to Follow-up|4
851826|NCT01228747|2710620|P2|Overall Study|Protocol Violation|5
851827|NCT01228747|2710621|P1|Overall Study|Protocol Violation|6
851828|NCT01228747|2710620|P2|Overall Study|Lack of Efficacy|27
851829|NCT01228747|2710621|P1|Overall Study|Lack of Efficacy|40
851830|NCT01228747|2710620|P2|Overall Study|Adverse Event|4
851831|NCT01228747|2710621|P1|Overall Study|Adverse Event|8
851832|NCT01229111|2710674|P1|Overall Study|Death|1
851833|NCT01229150|2710686|P4|Overall Study|Toxicity|0
851834|NCT01229150|2710687|P3|Overall Study|Toxicity|0
851835|NCT01229150|2710688|P2|Overall Study|Toxicity|2
851836|NCT01229150|2710689|P1|Overall Study|Toxicity|2
851837|NCT01229176|2710754|P8|Overall Study|Lost to Follow-up|2
851838|NCT01229176|2710755|P7|Overall Study|Lost to Follow-up|0
851839|NCT01229176|2710756|P6|Overall Study|Lost to Follow-up|1
851840|NCT01229176|2710757|P5|Overall Study|Lost to Follow-up|1
851841|NCT01229176|2710758|P4|Overall Study|Lost to Follow-up|0
851842|NCT01229176|2710759|P3|Overall Study|Lost to Follow-up|0
851843|NCT01229176|2710760|P2|Overall Study|Lost to Follow-up|3
851844|NCT01229176|2710761|P1|Overall Study|Lost to Follow-up|0
851845|NCT01229176|2710754|P8|Overall Study|Withdrawal by Subject|1
851846|NCT01229176|2710755|P7|Overall Study|Withdrawal by Subject|0
851847|NCT01229176|2710756|P6|Overall Study|Withdrawal by Subject|1
851848|NCT01229176|2710757|P5|Overall Study|Withdrawal by Subject|1
851849|NCT01229176|2710758|P4|Overall Study|Withdrawal by Subject|1
851850|NCT01229176|2710759|P3|Overall Study|Withdrawal by Subject|0
851851|NCT01229176|2710760|P2|Overall Study|Withdrawal by Subject|0
851852|NCT01229176|2710761|P1|Overall Study|Withdrawal by Subject|0
851853|NCT01229254|2710835|P3|Overall Study|Non-compliance with Study Drug|1
851854|NCT01229254|2710836|P2|Overall Study|Non-compliance with Study Drug|1
851855|NCT01229254|2710837|P1|Overall Study|Non-compliance with Study Drug|0
851856|NCT01229254|2710835|P3|Overall Study|Withdrawal by Subject|1
851857|NCT01229254|2710836|P2|Overall Study|Withdrawal by Subject|0
851858|NCT01229254|2710837|P1|Overall Study|Withdrawal by Subject|1
851859|NCT01229254|2710835|P3|Overall Study|Protocol Violation|5
851860|NCT01229254|2710836|P2|Overall Study|Protocol Violation|6
851861|NCT01229254|2710837|P1|Overall Study|Protocol Violation|4
851862|NCT01229254|2710835|P3|Overall Study|Physician Decision|0
851863|NCT01229254|2710836|P2|Overall Study|Physician Decision|3
851864|NCT01229254|2710837|P1|Overall Study|Physician Decision|0
851865|NCT01229254|2710835|P3|Overall Study|Lost to Follow-up|1
851866|NCT01229254|2710836|P2|Overall Study|Lost to Follow-up|0
851867|NCT01229254|2710837|P1|Overall Study|Lost to Follow-up|3
851868|NCT01229254|2710835|P3|Overall Study|Adverse Event|3
851869|NCT01229254|2710836|P2|Overall Study|Adverse Event|5
851870|NCT01229254|2710837|P1|Overall Study|Adverse Event|4
851871|NCT01229254|2710835|P3|Overall Study|Not Continuing Into Safety Extension|1
851872|NCT01229254|2710836|P2|Overall Study|Not Continuing Into Safety Extension|1
851873|NCT01229254|2710837|P1|Overall Study|Not Continuing Into Safety Extension|3
851874|NCT01229371|2710850|P4|Overall Study|Withdrawal by Subject|0
851875|NCT01229371|2710851|P3|Overall Study|Withdrawal by Subject|0
851876|NCT01229371|2710852|P2|Overall Study|Withdrawal by Subject|1
851877|NCT01229371|2710853|P1|Overall Study|Withdrawal by Subject|0
851878|NCT01229397|2710877|P2|Overall Study|Migrated/moved from study area|0
851879|NCT01229397|2710878|P1|Overall Study|Migrated/moved from study area|1
851880|NCT01229397|2710877|P2|Overall Study|Lost to Follow-up|6
851881|NCT01229397|2710878|P1|Overall Study|Lost to Follow-up|7
851882|NCT01229397|2710877|P2|Overall Study|Withdrawal by Subject|3
851883|NCT01229397|2710878|P1|Overall Study|Withdrawal by Subject|3
851884|NCT01229436|2710914|P1|Overall Study|Lost to Follow-up|3
851885|NCT01229436|2710914|P1|Overall Study|Withdrawal by Subject|2
851886|NCT01229735|2710988|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
851887|NCT01229735|2710989|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
851888|NCT01229735|2710988|P2|Overall Study|AE, non-serious non-fatal|17
851889|NCT01229735|2710989|P1|Overall Study|AE, non-serious non-fatal|13
851890|NCT01229735|2710988|P2|Overall Study|SAE, non-fatal|4
851891|NCT01229735|2710989|P1|Overall Study|SAE, non-fatal|0
851892|NCT01229735|2710988|P2|Overall Study|Other Reason|10
851893|NCT01229735|2710989|P1|Overall Study|Other Reason|13
851894|NCT01229735|2710988|P2|Overall Study|Withdrawal by Subject|17
851895|NCT01229735|2710989|P1|Overall Study|Withdrawal by Subject|18
851896|NCT01229735|2710988|P2|Overall Study|Lost to Follow-up|2
851897|NCT01229735|2710989|P1|Overall Study|Lost to Follow-up|0
851898|NCT01229735|2710988|P2|Overall Study|Protocol Violation|8
851899|NCT01229735|2710989|P1|Overall Study|Protocol Violation|13
851900|NCT01229735|2710988|P2|Overall Study|Lack of Efficacy|8
851901|NCT01229735|2710989|P1|Overall Study|Lack of Efficacy|8
851902|NCT01230060|2711070|P1|Overall Study|Withdrawal by Subject|1
851903|NCT01230307|2711084|P2|Overall Study|LVAD Placement|2
851904|NCT01230307|2711085|P1|Overall Study|LVAD Placement|0
851905|NCT01230710|2711142|P1|Overall Study|Withdrawal of Consent|1
851906|NCT01230710|2711142|P1|Overall Study|Death|4
851907|NCT01230710|2711142|P1|Overall Study|Lost to Follow-up|3
851908|NCT01230710|2711142|P1|Overall Study|Disease Progression|41
851909|NCT01230749|2711154|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
851910|NCT01230749|2711155|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
851911|NCT01230749|2711156|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
851912|NCT01230749|2711157|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
851913|NCT01230749|2711154|P4|Overall Study|Withdrawal by Subject|0
851914|NCT01230749|2711155|P3|Overall Study|Withdrawal by Subject|0
851915|NCT01230749|2711156|P2|Overall Study|Withdrawal by Subject|1
851916|NCT01230749|2711157|P1|Overall Study|Withdrawal by Subject|0
851917|NCT01230749|2711154|P4|Overall Study|Physician Decision|0
851918|NCT01230749|2711155|P3|Overall Study|Physician Decision|1
851919|NCT01230749|2711156|P2|Overall Study|Physician Decision|0
851920|NCT01230749|2711157|P1|Overall Study|Physician Decision|0
851921|NCT01230749|2711154|P4|Overall Study|Adverse Event|1
851922|NCT01230749|2711155|P3|Overall Study|Adverse Event|0
851923|NCT01230749|2711156|P2|Overall Study|Adverse Event|0
851924|NCT01230749|2711157|P1|Overall Study|Adverse Event|0
851925|NCT01230788|2711192|P1|Overall Study|Prescribed exclusion drug|1
851926|NCT01230814|2711202|P2|Overall Study|Discontinued (not due to adverse event)|1
851927|NCT01230814|2711203|P1|Overall Study|Discontinued (not due to adverse event)|2
851928|NCT01230814|2711202|P2|Overall Study|Lost to Follow-up|3
851929|NCT01230814|2711203|P1|Overall Study|Lost to Follow-up|11
851930|NCT01230827|2711219|P4|Overall Study|Study terminated by Sponsor|63
851931|NCT01230827|2711220|P3|Overall Study|Study terminated by Sponsor|56
851932|NCT01230827|2711221|P2|Overall Study|Study terminated by Sponsor|2
851933|NCT01230827|2711222|P1|Overall Study|Study terminated by Sponsor|0
851934|NCT01230827|2711219|P4|Overall Study|Recovery|0
851935|NCT01230827|2711220|P3|Overall Study|Recovery|0
851936|NCT01230827|2711221|P2|Overall Study|Recovery|6
851937|NCT01230827|2711222|P1|Overall Study|Recovery|0
851938|NCT01230827|2711219|P4|Overall Study|Adverse Event|7
851939|NCT01230827|2711220|P3|Overall Study|Adverse Event|3
851940|NCT01230827|2711221|P2|Overall Study|Adverse Event|2
851941|NCT01230827|2711222|P1|Overall Study|Adverse Event|4
851942|NCT01230827|2711219|P4|Overall Study|Lack of Efficacy|3
851943|NCT01230827|2711220|P3|Overall Study|Lack of Efficacy|2
851944|NCT01230827|2711221|P2|Overall Study|Lack of Efficacy|1
851945|NCT01230827|2711222|P1|Overall Study|Lack of Efficacy|14
851946|NCT01230827|2711219|P4|Overall Study|Withdrawal by Subject|2
851947|NCT01230827|2711220|P3|Overall Study|Withdrawal by Subject|3
851948|NCT01230827|2711221|P2|Overall Study|Withdrawal by Subject|0
851949|NCT01230827|2711222|P1|Overall Study|Withdrawal by Subject|1
851950|NCT01230827|2711219|P4|Overall Study|Lost to Follow-up|3
851951|NCT01230827|2711220|P3|Overall Study|Lost to Follow-up|1
851952|NCT01230827|2711221|P2|Overall Study|Lost to Follow-up|0
851953|NCT01230827|2711222|P1|Overall Study|Lost to Follow-up|0
851954|NCT01230892|2711238|P2|Overall Study|Lost to Follow-up|0
851955|NCT01230892|2711239|P1|Overall Study|Lost to Follow-up|2
851956|NCT01230892|2711238|P2|Overall Study|Withdrawal by Subject|1
851957|NCT01230892|2711239|P1|Overall Study|Withdrawal by Subject|1
851958|NCT01224171|2711247|P2|Overall Study|Lost to Follow-up|3
851959|NCT01224171|2711248|P1|Overall Study|Lost to Follow-up|0
851960|NCT01224171|2711247|P2|Overall Study|Withdrawal of Consent|4
851961|NCT01224171|2711248|P1|Overall Study|Withdrawal of Consent|2
851962|NCT01224171|2711247|P2|Overall Study|Lack of Efficacy|1
851963|NCT01224171|2711248|P1|Overall Study|Lack of Efficacy|5
851964|NCT01224171|2711247|P2|Overall Study|Protocol Violation|1
851965|NCT01224171|2711248|P1|Overall Study|Protocol Violation|0
851966|NCT01224171|2711247|P2|Overall Study|Adverse Event|4
851967|NCT01224171|2711248|P1|Overall Study|Adverse Event|8
851968|NCT01224431|2711281|P2|Overall Study|no video record|1
851969|NCT01224431|2711282|P1|Overall Study|no video record|0
851970|NCT01224431|2711281|P2|Overall Study|not randomized|4
851971|NCT01224431|2711282|P1|Overall Study|not randomized|0
851972|NCT01231321|2711302|P1|Overall Study|Lack of Efficacy|2
851973|NCT01231321|2711302|P1|Overall Study|Adverse Event|3
851974|NCT01233232|2711337|P3|Overall Study|Voluntary Discontinuation by Subject|0
851975|NCT01233232|2711338|P2|Overall Study|Voluntary Discontinuation by Subject|0
851976|NCT01233232|2711339|P1|Overall Study|Voluntary Discontinuation by Subject|1
851977|NCT01233258|2711395|P6|First Intervention (6 Months)|Non-compliance with study medication|0
851978|NCT01233258|2711396|P5|First Intervention (6 Months)|Non-compliance with study medication|0
851979|NCT01233258|2711397|P4|First Intervention (6 Months)|Non-compliance with study medication|0
851980|NCT01233258|2711398|P3|First Intervention (6 Months)|Non-compliance with study medication|0
851981|NCT01233258|2711399|P2|First Intervention (6 Months)|Non-compliance with study medication|0
851982|NCT01233258|2711400|P1|First Intervention (6 Months)|Non-compliance with study medication|1
851983|NCT01233258|2711395|P6|First Intervention (6 Months)|Protocol Violation|0
851984|NCT01233258|2711396|P5|First Intervention (6 Months)|Protocol Violation|0
851985|NCT01233258|2711397|P4|First Intervention (6 Months)|Protocol Violation|0
851986|NCT01233258|2711398|P3|First Intervention (6 Months)|Protocol Violation|1
851987|NCT01233258|2711399|P2|First Intervention (6 Months)|Protocol Violation|0
851988|NCT01233258|2711400|P1|First Intervention (6 Months)|Protocol Violation|0
851989|NCT01233258|2711395|P6|First Intervention (6 Months)|Withdrawal by Subject|1
851990|NCT01233258|2711396|P5|First Intervention (6 Months)|Withdrawal by Subject|0
851991|NCT01233258|2711397|P4|First Intervention (6 Months)|Withdrawal by Subject|1
851992|NCT01233258|2711398|P3|First Intervention (6 Months)|Withdrawal by Subject|0
851993|NCT01233258|2711399|P2|First Intervention (6 Months)|Withdrawal by Subject|0
851994|NCT01233258|2711400|P1|First Intervention (6 Months)|Withdrawal by Subject|0
851995|NCT01233284|2711417|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
851996|NCT01233284|2711418|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
851997|NCT01233284|2711419|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
851998|NCT01233284|2711420|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
851999|NCT01233284|2711421|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
852000|NCT01233284|2711417|P5|Period 4 (4 Weeks)|Adverse Event|0
852001|NCT01233284|2711418|P4|Period 4 (4 Weeks)|Adverse Event|0
852002|NCT01233284|2711419|P3|Period 4 (4 Weeks)|Adverse Event|0
852003|NCT01233284|2711420|P2|Period 4 (4 Weeks)|Adverse Event|1
852004|NCT01233284|2711421|P1|Period 4 (4 Weeks)|Adverse Event|0
852005|NCT01233284|2711417|P5|Period 3 (4 Weeks)|Other|0
852006|NCT01233284|2711418|P4|Period 3 (4 Weeks)|Other|1
852007|NCT01233284|2711419|P3|Period 3 (4 Weeks)|Other|0
852008|NCT01233284|2711420|P2|Period 3 (4 Weeks)|Other|0
852009|NCT01233284|2711421|P1|Period 3 (4 Weeks)|Other|0
852010|NCT01233284|2711417|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
852011|NCT01233284|2711418|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
852012|NCT01233284|2711419|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
852013|NCT01233284|2711420|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
852014|NCT01233284|2711421|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
852015|NCT01233284|2711417|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
852016|NCT01233284|2711418|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
852017|NCT01233284|2711419|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
852018|NCT01233284|2711420|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
852019|NCT01233284|2711421|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
852020|NCT01233284|2711417|P5|Period 1 (4 Weeks)|Other|0
852021|NCT01233284|2711418|P4|Period 1 (4 Weeks)|Other|0
852022|NCT01233284|2711419|P3|Period 1 (4 Weeks)|Other|1
852023|NCT01233284|2711420|P2|Period 1 (4 Weeks)|Other|0
852024|NCT01233284|2711421|P1|Period 1 (4 Weeks)|Other|0
852025|NCT01233284|2711417|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
852026|NCT01233284|2711418|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
852027|NCT01233284|2711419|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
852028|NCT01233284|2711420|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
852029|NCT01233284|2711421|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
852030|NCT01233284|2711417|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
852031|NCT01233284|2711418|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
852032|NCT01233284|2711419|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
852033|NCT01233284|2711420|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
852034|NCT01233284|2711421|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
852035|NCT01233687|2711499|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
852036|NCT01233687|2711499|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
852037|NCT01233687|2711499|P1|Phase II AMG 102 + Erlotinib|Death|1
852038|NCT01233817|2711550|P1|Overall Study|Withdrawal by Subject|2
852039|NCT01233817|2711550|P1|Overall Study|Lost to Follow-up|1
852040|NCT01233869|2711558|P4|Extended Treatment Period (46 Months)|Adverse Event|1
852041|NCT01233869|2711559|P3|Extended Treatment Period (46 Months)|Adverse Event|0
852042|NCT01233869|2711560|P2|Extended Treatment Period (46 Months)|Adverse Event|0
852043|NCT01233869|2711561|P1|Extended Treatment Period (46 Months)|Adverse Event|1
852044|NCT01233869|2711558|P4|Extended Treatment Period (46 Months)|Unspecified|3
852045|NCT01233869|2711559|P3|Extended Treatment Period (46 Months)|Unspecified|0
852046|NCT01233869|2711560|P2|Extended Treatment Period (46 Months)|Unspecified|0
852047|NCT01233869|2711561|P1|Extended Treatment Period (46 Months)|Unspecified|3
852048|NCT01233869|2711558|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
852049|NCT01233869|2711559|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
852050|NCT01233869|2711560|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
852051|NCT01233869|2711561|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
852052|NCT01233869|2711558|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
852053|NCT01233869|2711559|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
852054|NCT01233869|2711560|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
852055|NCT01233869|2711561|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
852056|NCT01233869|2711558|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
852057|NCT01233869|2711559|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
852058|NCT01233869|2711560|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
852059|NCT01233869|2711561|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
852060|NCT01233869|2711558|P4|Initial Treatment Period (24 Months)|Adverse Event|3
852061|NCT01233869|2711559|P3|Initial Treatment Period (24 Months)|Adverse Event|0
852062|NCT01233869|2711560|P2|Initial Treatment Period (24 Months)|Adverse Event|17
852063|NCT01233869|2711561|P1|Initial Treatment Period (24 Months)|Adverse Event|9
852064|NCT01233869|2711558|P4|Initial Treatment Period (24 Months)|Death|0
852065|NCT01233869|2711559|P3|Initial Treatment Period (24 Months)|Death|0
852066|NCT01233869|2711560|P2|Initial Treatment Period (24 Months)|Death|0
852067|NCT01233869|2711561|P1|Initial Treatment Period (24 Months)|Death|1
852068|NCT01233999|2711658|P1|Overall Study|Lost to Follow-up|1
852069|NCT01233999|2711658|P1|Overall Study|Withdrawal by Subject|1
852086|NCT01234467|2711725|P1|Overall Study|Other complicating disease (stroke)|1
852087|NCT01234467|2711725|P1|Overall Study|Physician Decision|1
852088|NCT01234467|2711725|P1|Overall Study|Clinical deterioration|1
852089|NCT01234467|2711725|P1|Overall Study|Disease Progression|2
852090|NCT01234467|2711725|P1|Overall Study|Withdrawal by Subject|2
852091|NCT01234467|2711725|P1|Overall Study|Death|2
852092|NCT01234467|2711725|P1|Overall Study|Adverse Event|3
852093|NCT01234675|2711734|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
852094|NCT01234675|2711735|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
852095|NCT01234675|2711734|P2|First Intervention (6 Weeks)|Adverse Event|1
852096|NCT01234675|2711735|P1|First Intervention (6 Weeks)|Adverse Event|0
852097|NCT01234883|2711787|P2|Overall Study|Inclusion/exclusion failure|0
852098|NCT01234883|2711788|P1|Overall Study|Inclusion/exclusion failure|1
852099|NCT01234883|2711787|P2|Overall Study|Technical difficulties with IV infusion|1
852100|NCT01234883|2711788|P1|Overall Study|Technical difficulties with IV infusion|0
852101|NCT01234883|2711787|P2|Overall Study|Parent/guardian withdrew consent|2
852102|NCT01234883|2711788|P1|Overall Study|Parent/guardian withdrew consent|1
852103|NCT01234883|2711787|P2|Overall Study|Early treatment release|10
852104|NCT01234883|2711788|P1|Overall Study|Early treatment release|8
852105|NCT01235234|2711831|P3|Overall Study|Adverse Event|1
852106|NCT01235234|2711832|P2|Overall Study|Adverse Event|2
852107|NCT01235234|2711833|P1|Overall Study|Adverse Event|2
852108|NCT01235338|2711843|P2|Overall Study|Prohibited meds|0
852109|NCT01235338|2711844|P1|Overall Study|Prohibited meds|1
852110|NCT01235338|2711843|P2|Overall Study|Positive drug screen|1
852111|NCT01235338|2711844|P1|Overall Study|Positive drug screen|0
852112|NCT01235338|2711843|P2|Overall Study|Exclusion criteria violations|1
852113|NCT01235338|2711844|P1|Overall Study|Exclusion criteria violations|1
852114|NCT01235338|2711843|P2|Overall Study|Withdrawal by Subject|0
852115|NCT01235338|2711844|P1|Overall Study|Withdrawal by Subject|5
852116|NCT01235338|2711843|P2|Overall Study|Protocol Violation|1
852117|NCT01235338|2711844|P1|Overall Study|Protocol Violation|1
852118|NCT01235338|2711843|P2|Overall Study|Adverse Event|2
852119|NCT01235338|2711844|P1|Overall Study|Adverse Event|3
852120|NCT01235403|2711895|P1|Overall Study|Other reasons for premature termination|4
852121|NCT01235403|2711895|P1|Overall Study|Lack of Efficacy|2
852122|NCT01235403|2711895|P1|Overall Study|Withdrawal by Subject|4
852123|NCT01235403|2711895|P1|Overall Study|Lost to Follow-up|2
852124|NCT01235403|2711895|P1|Overall Study|Adverse Event|14
852125|NCT01235442|2711903|P2|Overall Study|Other unspecified|2
852126|NCT01235442|2711904|P1|Overall Study|Other unspecified|1
852127|NCT01235442|2711903|P2|Overall Study|Administrative decision|2
852128|NCT01235442|2711904|P1|Overall Study|Administrative decision|1
852129|NCT01235442|2711903|P2|Overall Study|Noncompliance|2
852130|NCT01235442|2711904|P1|Overall Study|Noncompliance|1
852131|NCT01235442|2711903|P2|Overall Study|Lack of Efficacy|3
852132|NCT01235442|2711904|P1|Overall Study|Lack of Efficacy|1
852133|NCT01235442|2711903|P2|Overall Study|Withdrawal by Subject|9
852134|NCT01235442|2711904|P1|Overall Study|Withdrawal by Subject|15
852135|NCT01235442|2711903|P2|Overall Study|Adverse Event|6
852136|NCT01235442|2711904|P1|Overall Study|Adverse Event|4
852137|NCT01235442|2711903|P2|Overall Study|Protocol Violation|3
852138|NCT01235442|2711904|P1|Overall Study|Protocol Violation|3
852139|NCT01235442|2711903|P2|Overall Study|Ineligibility determined|4
852140|NCT01235442|2711904|P1|Overall Study|Ineligibility determined|5
852141|NCT01235442|2711903|P2|Overall Study|Pregnancy|1
852142|NCT01235442|2711904|P1|Overall Study|Pregnancy|1
852143|NCT01235442|2711903|P2|Overall Study|Death|2
852144|NCT01235442|2711904|P1|Overall Study|Death|0
852145|NCT01235442|2711903|P2|Overall Study|Lost to Follow-up|10
852146|NCT01235442|2711904|P1|Overall Study|Lost to Follow-up|12
852147|NCT01235507|2711922|P1|Overall Study|Withdrawal by Subject|1
852148|NCT01235507|2711922|P1|Overall Study|Adverse Event|1
852149|NCT01235546|2711936|P2|Overall Study|Protocol Violation|1
852150|NCT01235546|2711937|P1|Overall Study|Protocol Violation|1
852151|NCT01235546|2711936|P2|Overall Study|Staff error, medication not administered|0
852152|NCT01235546|2711937|P1|Overall Study|Staff error, medication not administered|1
852153|NCT01235598|2711963|P2|Overall Study|Withdrawal by Subject|0
852154|NCT01235598|2711964|P1|Overall Study|Withdrawal by Subject|1
852155|NCT01235598|2711963|P2|Overall Study|Lack of Efficacy|1
852156|NCT01235598|2711964|P1|Overall Study|Lack of Efficacy|0
852157|NCT01235598|2711963|P2|Overall Study|Adverse Event|3
852158|NCT01235598|2711964|P1|Overall Study|Adverse Event|0
852159|NCT01227512|2712009|P2|Overall Study|Participant met withdrawal criteria|1
852160|NCT01227512|2712010|P1|Overall Study|Participant met withdrawal criteria|0
852161|NCT01227512|2712009|P2|Overall Study|Withdrawal by Subject|0
852162|NCT01227512|2712010|P1|Overall Study|Withdrawal by Subject|3
852163|NCT01227512|2712009|P2|Overall Study|Adverse Event|3
852164|NCT01227512|2712010|P1|Overall Study|Adverse Event|4
852165|NCT01227512|2712009|P2|Overall Study|Physician Decision|6
852166|NCT01227512|2712010|P1|Overall Study|Physician Decision|6
852167|NCT01227564|2712038|P3|Overall Study|Participant moved to another town|1
852168|NCT01227564|2712039|P2|Overall Study|Participant moved to another town|0
852169|NCT01227564|2712040|P1|Overall Study|Participant moved to another town|0
852170|NCT01227564|2712038|P3|Overall Study|No Longer Willing to Participate|5
852171|NCT01227564|2712039|P2|Overall Study|No Longer Willing to Participate|2
852172|NCT01227564|2712040|P1|Overall Study|No Longer Willing to Participate|4
852173|NCT01227577|2712171|P1|Overall Study|Adverse Event|17
852174|NCT01227577|2712171|P1|Overall Study|Lack of Efficacy|5
852175|NCT01227577|2712171|P1|Overall Study|Withdrawal by Subject|4
852176|NCT01227577|2712171|P1|Overall Study|Lost to Follow-up|1
852177|NCT01227577|2712171|P1|Overall Study|Administrative problems|2
852178|NCT01227577|2712171|P1|Overall Study|Death|3
852179|NCT01227577|2712171|P1|Overall Study|Protocol deviation|3
852180|NCT01227629|2712193|P10|Overall Study|Not Specified|1
852181|NCT01227629|2712194|P9|Overall Study|Not Specified|2
852182|NCT01227629|2712195|P8|Overall Study|Not Specified|0
852183|NCT01227629|2712196|P7|Overall Study|Not Specified|0
852184|NCT01227629|2712197|P6|Overall Study|Not Specified|0
852185|NCT01227629|2712198|P5|Overall Study|Not Specified|0
852186|NCT01227629|2712199|P4|Overall Study|Not Specified|1
852187|NCT01227629|2712200|P3|Overall Study|Not Specified|0
852188|NCT01227629|2712201|P2|Overall Study|Not Specified|0
852189|NCT01227629|2712202|P1|Overall Study|Not Specified|0
852190|NCT01227629|2712193|P10|Overall Study|Withdrawal by Subject|1
852191|NCT01227629|2712194|P9|Overall Study|Withdrawal by Subject|0
852192|NCT01227629|2712195|P8|Overall Study|Withdrawal by Subject|0
852193|NCT01227629|2712196|P7|Overall Study|Withdrawal by Subject|2
852194|NCT01227629|2712197|P6|Overall Study|Withdrawal by Subject|0
852195|NCT01227629|2712198|P5|Overall Study|Withdrawal by Subject|0
852196|NCT01227629|2712199|P4|Overall Study|Withdrawal by Subject|0
852197|NCT01227629|2712200|P3|Overall Study|Withdrawal by Subject|0
852198|NCT01227629|2712201|P2|Overall Study|Withdrawal by Subject|0
852199|NCT01227629|2712202|P1|Overall Study|Withdrawal by Subject|0
852200|NCT01227629|2712193|P10|Overall Study|Lost to Follow-up|0
852201|NCT01227629|2712194|P9|Overall Study|Lost to Follow-up|0
852202|NCT01227629|2712195|P8|Overall Study|Lost to Follow-up|0
852203|NCT01227629|2712196|P7|Overall Study|Lost to Follow-up|0
852204|NCT01227629|2712197|P6|Overall Study|Lost to Follow-up|0
852205|NCT01227629|2712198|P5|Overall Study|Lost to Follow-up|1
852206|NCT01227629|2712199|P4|Overall Study|Lost to Follow-up|0
852207|NCT01227629|2712200|P3|Overall Study|Lost to Follow-up|0
852208|NCT01227629|2712201|P2|Overall Study|Lost to Follow-up|0
852209|NCT01227629|2712202|P1|Overall Study|Lost to Follow-up|0
852210|NCT01227629|2712193|P10|Overall Study|Protocol Violation|0
852211|NCT01227629|2712194|P9|Overall Study|Protocol Violation|0
852212|NCT01227629|2712195|P8|Overall Study|Protocol Violation|0
852213|NCT01227629|2712196|P7|Overall Study|Protocol Violation|0
852214|NCT01227629|2712197|P6|Overall Study|Protocol Violation|0
852215|NCT01227629|2712198|P5|Overall Study|Protocol Violation|0
852216|NCT01227629|2712199|P4|Overall Study|Protocol Violation|1
852217|NCT01227629|2712200|P3|Overall Study|Protocol Violation|0
852218|NCT01227629|2712201|P2|Overall Study|Protocol Violation|0
852219|NCT01227629|2712202|P1|Overall Study|Protocol Violation|0
852220|NCT01227629|2712193|P10|Overall Study|Adverse Event|0
852221|NCT01227629|2712194|P9|Overall Study|Adverse Event|4
852222|NCT01227629|2712195|P8|Overall Study|Adverse Event|6
852223|NCT01227629|2712196|P7|Overall Study|Adverse Event|6
852224|NCT01227629|2712197|P6|Overall Study|Adverse Event|1
852225|NCT01227629|2712198|P5|Overall Study|Adverse Event|1
852226|NCT01227629|2712199|P4|Overall Study|Adverse Event|6
852227|NCT01227629|2712200|P3|Overall Study|Adverse Event|1
852228|NCT01227629|2712201|P2|Overall Study|Adverse Event|2
852229|NCT01227629|2712202|P1|Overall Study|Adverse Event|2
852230|NCT01227668|2712462|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
852231|NCT01227668|2712463|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
852232|NCT01227668|2712462|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
852233|NCT01227668|2712463|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
852234|NCT01227668|2712462|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
852235|NCT01227668|2712463|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
852236|NCT01227668|2712462|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
852237|NCT01227668|2712463|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
852238|NCT01227668|2712462|P2|Phase 2 (Randomization Phase)|Adverse Event|1
852239|NCT01227668|2712463|P1|Phase 2 (Randomization Phase)|Adverse Event|0
852240|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
852241|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
852242|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
852243|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
852244|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
852245|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
852246|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
852247|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
852248|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
852249|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
852250|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
852251|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
852252|NCT01227668|2712462|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
852253|NCT01227668|2712463|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
852254|NCT01227707|2712486|P1|Overall Study|Death|1
852255|NCT01227707|2712486|P1|Overall Study|Medical decision|6
852256|NCT01227707|2712486|P1|Overall Study|Patient non-compliance|3
852257|NCT01227707|2712486|P1|Overall Study|Withdrawal by Subject|1
852258|NCT01227707|2712486|P1|Overall Study|Progression of disease|3
852259|NCT01227707|2712486|P1|Overall Study|Adverse Event|10
852260|NCT01227824|2712570|P2|Open-label Phase|Ongoing|0
852261|NCT01227824|2712571|P1|Open-label Phase|Ongoing|337
852262|NCT01227824|2712570|P2|Open-label Phase|Protocol Violation|0
852263|NCT01227824|2712571|P1|Open-label Phase|Protocol Violation|1
852264|NCT01227824|2712570|P2|Double-blind Phase|Withdrawal by Subject|14
852265|NCT01227824|2712571|P1|Double-blind Phase|Withdrawal by Subject|10
852266|NCT01227824|2712570|P2|Double-blind Phase|Lost to Follow-up|10
852267|NCT01227824|2712571|P1|Double-blind Phase|Lost to Follow-up|6
852268|NCT01227824|2712570|P2|Double-blind Phase|Study Closed/Terminated|4
852269|NCT01227824|2712571|P1|Double-blind Phase|Study Closed/Terminated|6
852270|NCT01227824|2712570|P2|Double-blind Phase|Met Protocol-defined Stopping Criteria|3
852271|NCT01227824|2712571|P1|Double-blind Phase|Met Protocol-defined Stopping Criteria|2
852272|NCT01227824|2712570|P2|Double-blind Phase|Protocol Violation|16
852273|NCT01227824|2712571|P1|Double-blind Phase|Protocol Violation|13
852274|NCT01227824|2712570|P2|Double-blind Phase|Lack of Efficacy|25
852275|NCT01227824|2712571|P1|Double-blind Phase|Lack of Efficacy|17
852276|NCT01227824|2712570|P2|Double-blind Phase|Adverse Event|7
852277|NCT01227824|2712571|P1|Double-blind Phase|Adverse Event|8
852278|NCT01227889|2712601|P2|Crossover Phase|Withdrawal by Subject|1
852279|NCT01227889|2712602|P1|Crossover Phase|Withdrawal by Subject|0
852280|NCT01227889|2712601|P2|Crossover Phase|Study Terminated By Sponsor|1
852281|NCT01227889|2712602|P1|Crossover Phase|Study Terminated By Sponsor|0
852282|NCT01227889|2712601|P2|Crossover Phase|Progressive Disease|31
852283|NCT01227889|2712602|P1|Crossover Phase|Progressive Disease|0
852284|NCT01227889|2712601|P2|Crossover Phase|Physician Decision|3
852285|NCT01227889|2712602|P1|Crossover Phase|Physician Decision|0
852286|NCT01227889|2712601|P2|Crossover Phase|Adverse Event|1
852287|NCT01227889|2712602|P1|Crossover Phase|Adverse Event|0
852288|NCT01227889|2712601|P2|Randomized Phase (RP)|Withdrawal by Subject|3
852289|NCT01227889|2712602|P1|Randomized Phase (RP)|Withdrawal by Subject|15
852290|NCT01227889|2712601|P2|Randomized Phase (RP)|Missing|3
852291|NCT01227889|2712602|P1|Randomized Phase (RP)|Missing|1
852292|NCT01227889|2712601|P2|Randomized Phase (RP)|Study terminated by sponsor|0
852293|NCT01227889|2712602|P1|Randomized Phase (RP)|Study terminated by sponsor|10
852294|NCT01227889|2712601|P2|Randomized Phase (RP)|Progressive Disease|52
852295|NCT01227889|2712602|P1|Randomized Phase (RP)|Progressive Disease|135
852296|NCT01227889|2712601|P2|Randomized Phase (RP)|Physician Decision|5
852297|NCT01227889|2712602|P1|Randomized Phase (RP)|Physician Decision|13
852298|NCT01227889|2712601|P2|Randomized Phase (RP)|Adverse Event|0
852299|NCT01227889|2712602|P1|Randomized Phase (RP)|Adverse Event|13
852300|NCT01227902|2712631|P4|Overall Study|Withdrawal by Subject|3
852301|NCT01227902|2712632|P3|Overall Study|Withdrawal by Subject|4
852302|NCT01227902|2712633|P2|Overall Study|Withdrawal by Subject|2
852303|NCT01227902|2712634|P1|Overall Study|Withdrawal by Subject|4
852304|NCT01227902|2712631|P4|Overall Study|Physician Decision|0
852305|NCT01227902|2712632|P3|Overall Study|Physician Decision|1
852306|NCT01227902|2712633|P2|Overall Study|Physician Decision|1
852307|NCT01227902|2712634|P1|Overall Study|Physician Decision|0
852308|NCT01227902|2712631|P4|Overall Study|Lost to Follow-up|2
852309|NCT01227902|2712632|P3|Overall Study|Lost to Follow-up|1
852310|NCT01227902|2712633|P2|Overall Study|Lost to Follow-up|0
852311|NCT01227902|2712634|P1|Overall Study|Lost to Follow-up|0
852312|NCT01227902|2712631|P4|Overall Study|Protocol Violation|0
852313|NCT01227902|2712632|P3|Overall Study|Protocol Violation|0
852314|NCT01227902|2712633|P2|Overall Study|Protocol Violation|0
852315|NCT01227902|2712634|P1|Overall Study|Protocol Violation|1
852316|NCT01227902|2712631|P4|Overall Study|Lack of Efficacy|1
852317|NCT01227902|2712632|P3|Overall Study|Lack of Efficacy|2
852318|NCT01227902|2712633|P2|Overall Study|Lack of Efficacy|2
852319|NCT01227902|2712634|P1|Overall Study|Lack of Efficacy|1
852320|NCT01227902|2712631|P4|Overall Study|Adverse Event|4
852321|NCT01227902|2712632|P3|Overall Study|Adverse Event|11
852322|NCT01227902|2712633|P2|Overall Study|Adverse Event|8
852323|NCT01227902|2712634|P1|Overall Study|Adverse Event|12
852324|NCT01227928|2712727|P2|Overall Study|Death|12
852325|NCT01227928|2712728|P1|Overall Study|Death|14
852326|NCT01227928|2712727|P2|Overall Study|Withdrawal by Subject|3
852327|NCT01227928|2712728|P1|Overall Study|Withdrawal by Subject|4
852328|NCT01227928|2712727|P2|Overall Study|Lost to Follow-up|2
852329|NCT01227928|2712728|P1|Overall Study|Lost to Follow-up|4
852330|NCT01227954|2712762|P1|Overall Study|No protocol treatment|7
852331|NCT01227954|2712762|P1|Overall Study|Protocol Violation|6
852332|NCT01227967|2712776|P2|Overall Study|Taking Additional Antiviral Drug|0
852333|NCT01227967|2712777|P1|Overall Study|Taking Additional Antiviral Drug|1
852334|NCT01227967|2712776|P2|Overall Study|Never Started Treatment|4
852335|NCT01227967|2712777|P1|Overall Study|Never Started Treatment|0
852336|NCT01227967|2712776|P2|Overall Study|Physician Decision|1
852337|NCT01227967|2712777|P1|Overall Study|Physician Decision|0
852338|NCT01227967|2712776|P2|Overall Study|Withdrawal by Subject|3
852339|NCT01227967|2712777|P1|Overall Study|Withdrawal by Subject|4
852340|NCT01227967|2712776|P2|Overall Study|Lost to Follow-up|3
852341|NCT01227967|2712777|P1|Overall Study|Lost to Follow-up|8
852342|NCT01227967|2712776|P2|Overall Study|Death|1
852343|NCT01227967|2712777|P1|Overall Study|Death|0
852344|NCT01227967|2712776|P2|Overall Study|Protocol Violation|1
852345|NCT01227967|2712777|P1|Overall Study|Protocol Violation|3
852346|NCT01228019|2712860|P1|Overall Study|Violation of Entry Criterion|9
852347|NCT01228019|2712860|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
852348|NCT01228019|2712860|P1|Overall Study|Missing pre-treatment data|72
852349|NCT01228019|2712860|P1|Overall Study|Duplicate enrollment|1
852350|NCT01228019|2712860|P1|Overall Study|Dose Violation|70
852351|NCT01228071|2712875|P1|Overall Study|Withdrawal by Subject|1
852352|NCT01228071|2712875|P1|Overall Study|Protocol Violation|1
852353|NCT01228175|2712919|P2|Overall Study|Physician Decision|1
852354|NCT01228175|2712920|P1|Overall Study|Physician Decision|1
852355|NCT01228175|2712919|P2|Overall Study|Withdrawal by Subject|2
852356|NCT01228175|2712920|P1|Overall Study|Withdrawal by Subject|1
852357|NCT01228175|2712919|P2|Overall Study|Lost to Follow-up|50
852358|NCT01228175|2712920|P1|Overall Study|Lost to Follow-up|61
852359|NCT01235715|2712937|P2|Overall Study|Physician Decision|2
852360|NCT01235715|2712938|P1|Overall Study|Physician Decision|0
852361|NCT01235728|2712976|P8|Overall Study|Protocol Violation|0
852362|NCT01235728|2712977|P7|Overall Study|Protocol Violation|0
852363|NCT01235728|2712978|P6|Overall Study|Protocol Violation|0
852364|NCT01235728|2712979|P5|Overall Study|Protocol Violation|0
852365|NCT01235728|2712980|P4|Overall Study|Protocol Violation|1
852366|NCT01235728|2712981|P3|Overall Study|Protocol Violation|0
852367|NCT01235728|2712982|P2|Overall Study|Protocol Violation|0
852368|NCT01235728|2712983|P1|Overall Study|Protocol Violation|0
852369|NCT01235741|2712994|P3|Follow-Up Post Treatment up to Month 6|not specified|0
852370|NCT01235741|2712995|P2|Follow-Up Post Treatment up to Month 6|not specified|1
852371|NCT01235741|2712996|P1|Follow-Up Post Treatment up to Month 6|not specified|0
852372|NCT01235741|2712994|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
852373|NCT01235741|2712995|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
852374|NCT01235741|2712996|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
852375|NCT01235741|2712994|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
852376|NCT01235741|2712995|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
852377|NCT01235741|2712996|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
852378|NCT01235741|2712994|P3|Randomized to Treatment|Sponsor terminated study|34
852379|NCT01235741|2712995|P2|Randomized to Treatment|Sponsor terminated study|35
852380|NCT01235741|2712996|P1|Randomized to Treatment|Sponsor terminated study|0
852381|NCT01235741|2712994|P3|Randomized to Treatment|Adverse Event|1
852382|NCT01235741|2712995|P2|Randomized to Treatment|Adverse Event|1
852383|NCT01235741|2712996|P1|Randomized to Treatment|Adverse Event|0
852384|NCT01235741|2712994|P3|Randomized to Treatment|Withdrawal by Subject|1
852385|NCT01235741|2712995|P2|Randomized to Treatment|Withdrawal by Subject|0
852386|NCT01235741|2712996|P1|Randomized to Treatment|Withdrawal by Subject|0
852387|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
852388|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
852389|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
852390|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
852391|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
852392|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
852393|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
852394|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
852395|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
852396|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
852397|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
852398|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
852399|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
852400|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
852401|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
852402|NCT01235741|2712994|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
852403|NCT01235741|2712995|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
852404|NCT01235741|2712996|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
852405|NCT01235975|2713045|P2|Overall Study|Lost to Follow-up|3
852406|NCT01235975|2713046|P1|Overall Study|Lost to Follow-up|7
852407|NCT01235975|2713045|P2|Overall Study|Migrated/moved from study area|1
852408|NCT01235975|2713046|P1|Overall Study|Migrated/moved from study area|2
852409|NCT01235975|2713045|P2|Overall Study|Withdrawal by Subject|2
852410|NCT01235975|2713046|P1|Overall Study|Withdrawal by Subject|8
852411|NCT01235975|2713045|P2|Overall Study|Serious Adverse Event|1
852412|NCT01235975|2713046|P1|Overall Study|Serious Adverse Event|0
852413|NCT01236001|2713080|P2|Overall Study|Planned Visit After End of Study|1
852414|NCT01236001|2713081|P1|Overall Study|Planned Visit After End of Study|0
852415|NCT01236001|2713080|P2|Overall Study|Incompliance|0
852416|NCT01236001|2713081|P1|Overall Study|Incompliance|1
852417|NCT01236001|2713080|P2|Overall Study|Lost to Follow-up|1
852418|NCT01236001|2713081|P1|Overall Study|Lost to Follow-up|6
852419|NCT01236001|2713080|P2|Overall Study|Lack of Efficacy|6
852420|NCT01236001|2713081|P1|Overall Study|Lack of Efficacy|6
852421|NCT01236001|2713080|P2|Overall Study|Adverse Event|14
852422|NCT01236001|2713081|P1|Overall Study|Adverse Event|5
852423|NCT01236339|2713138|P2|Overall Study|Termination of study by sponsor|13
852424|NCT01236339|2713139|P1|Overall Study|Termination of study by sponsor|11
852425|NCT01236365|2713159|P2|Overall Study|Dropped at Randomization due to high LFT|0
852426|NCT01236365|2713160|P1|Overall Study|Dropped at Randomization due to high LFT|1
852427|NCT01236365|2713159|P2|Overall Study|Moved Out of State|0
852428|NCT01236365|2713160|P1|Overall Study|Moved Out of State|1
852429|NCT01236365|2713159|P2|Overall Study|Lost to Follow-up|2
852430|NCT01236365|2713160|P1|Overall Study|Lost to Follow-up|0
852431|NCT01236534|2713194|P2|Overall Study|Adverse Event|0
852432|NCT01236534|2713195|P1|Overall Study|Adverse Event|3
852433|NCT01236573|2713214|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
852434|NCT01236573|2713215|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852435|NCT01236573|2713216|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852436|NCT01236573|2713217|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852437|NCT01236573|2713218|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852438|NCT01236573|2713219|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852439|NCT01236573|2713220|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852440|NCT01236573|2713221|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852441|NCT01236573|2713222|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852442|NCT01236573|2713223|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852443|NCT01236573|2713224|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
852444|NCT01236573|2713214|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852445|NCT01236573|2713215|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852446|NCT01236573|2713216|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
852447|NCT01236573|2713217|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852448|NCT01236573|2713218|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852449|NCT01236573|2713219|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852450|NCT01236573|2713220|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852451|NCT01236573|2713221|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852452|NCT01236573|2713222|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852453|NCT01236573|2713223|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852454|NCT01236573|2713224|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
852455|NCT01236573|2713214|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852456|NCT01236573|2713215|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
852457|NCT01236573|2713216|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
852458|NCT01236573|2713217|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852459|NCT01236573|2713218|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
852460|NCT01236573|2713219|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852461|NCT01236573|2713220|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852462|NCT01236573|2713221|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852463|NCT01236573|2713222|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852464|NCT01236573|2713223|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852465|NCT01236573|2713224|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
852466|NCT01237054|2713277|P1|Overall Study|imaging 10C0096|1
852467|NCT01237223|2713324|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
852468|NCT01237223|2713325|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
852469|NCT01237223|2713326|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
852470|NCT01237223|2713327|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
852471|NCT01237223|2713328|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
852472|NCT01237223|2713329|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
852473|NCT01237223|2713324|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
852474|NCT01237223|2713325|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
852475|NCT01237223|2713326|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
852476|NCT01237223|2713327|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
852477|NCT01237223|2713328|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
852478|NCT01237223|2713329|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
852479|NCT01237223|2713324|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
852480|NCT01237223|2713325|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
852481|NCT01237223|2713326|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
852482|NCT01237223|2713327|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
852483|NCT01237223|2713328|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
852484|NCT01237223|2713329|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
852485|NCT01237223|2713324|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
852486|NCT01237223|2713325|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
852487|NCT01237223|2713326|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
852488|NCT01237223|2713327|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
852489|NCT01237223|2713328|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
852490|NCT01237223|2713329|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
852491|NCT01237223|2713324|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
852492|NCT01237223|2713325|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
852493|NCT01237223|2713326|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
852494|NCT01237223|2713327|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
852495|NCT01237223|2713328|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
852496|NCT01237223|2713329|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
852497|NCT01237223|2713324|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
852498|NCT01237223|2713325|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
852499|NCT01237223|2713326|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
852500|NCT01237223|2713327|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
852501|NCT01237223|2713328|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
852502|NCT01237223|2713329|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
852503|NCT01237223|2713324|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
852504|NCT01237223|2713325|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
852505|NCT01237223|2713326|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
852506|NCT01237223|2713327|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
852507|NCT01237223|2713328|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
852508|NCT01237223|2713329|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
852509|NCT01237223|2713324|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
852510|NCT01237223|2713325|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
852511|NCT01237223|2713326|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
852512|NCT01237223|2713327|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
852513|NCT01237223|2713328|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
852514|NCT01237223|2713329|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
852515|NCT01237223|2713324|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
852516|NCT01237223|2713325|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
852517|NCT01237223|2713326|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
852518|NCT01237223|2713327|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
852519|NCT01237223|2713328|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
852520|NCT01237223|2713329|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
852521|NCT01237223|2713324|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
852522|NCT01237223|2713325|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
852523|NCT01237223|2713326|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
852524|NCT01237223|2713327|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
852525|NCT01237223|2713328|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
852526|NCT01237223|2713329|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
852527|NCT01237327|2713379|P2|Overall Study|Lost to Follow-up|0
852528|NCT01237327|2713380|P1|Overall Study|Lost to Follow-up|3
852529|NCT01237327|2713379|P2|Overall Study|Withdrawal by Subject|3
852530|NCT01237327|2713380|P1|Overall Study|Withdrawal by Subject|1
852531|NCT01237327|2713379|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
852532|NCT01237327|2713380|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
852533|NCT01237327|2713379|P2|Overall Study|Progression of Disease: Extension Study|13
852534|NCT01237327|2713380|P1|Overall Study|Progression of Disease: Extension Study|15
852535|NCT01237327|2713379|P2|Overall Study|Progression of Disease: Core Study|22
852536|NCT01237327|2713380|P1|Overall Study|Progression of Disease: Core Study|18
852537|NCT01237327|2713379|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
852538|NCT01237327|2713380|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
852539|NCT01237327|2713379|P2|Overall Study|Protocol Violation: Core Study|0
852540|NCT01237327|2713380|P1|Overall Study|Protocol Violation: Core Study|1
852541|NCT01237340|2713394|P1|Overall Study|Early termination of the trial|36
852542|NCT01237340|2713394|P1|Overall Study|Withdrawal by Subject|1
852543|NCT01237340|2713394|P1|Overall Study|Adverse Event|3
852544|NCT01238211|2713435|P1|Overall Study|Investigator/Patient Decision|3
852545|NCT01238211|2713435|P1|Overall Study|Non-protocol treatment|4
852546|NCT01238211|2713435|P1|Overall Study|Withdrawal by Subject|7
852547|NCT01238211|2713435|P1|Overall Study|Relapse/Progression|2
852548|NCT01238211|2713435|P1|Overall Study|Death|4
852549|NCT01238211|2713435|P1|Overall Study|Adverse Event|7
852550|NCT01238211|2713435|P1|Overall Study|Continues active treatment|31
852551|NCT01238575|2713457|P2|Overall Study|Adverse Event|0
852552|NCT01238575|2713458|P1|Overall Study|Adverse Event|2
852553|NCT01238575|2713457|P2|Overall Study|Lack of Efficacy|4
852554|NCT01238575|2713458|P1|Overall Study|Lack of Efficacy|2
852555|NCT01238588|2713494|P1|Overall Study|Physician Decision|2
852556|NCT01238588|2713494|P1|Overall Study|Withdrawal by Subject|1
852557|NCT01231373|2713526|P4|Overall Study|Withdrew Consent|0
852558|NCT01231373|2713527|P3|Overall Study|Withdrew Consent|0
852559|NCT01231373|2713528|P2|Overall Study|Withdrew Consent|0
852560|NCT01231373|2713529|P1|Overall Study|Withdrew Consent|1
852561|NCT01231373|2713526|P4|Overall Study|Lost to Follow-up|1
852562|NCT01231373|2713527|P3|Overall Study|Lost to Follow-up|0
852563|NCT01231373|2713528|P2|Overall Study|Lost to Follow-up|0
852564|NCT01231373|2713529|P1|Overall Study|Lost to Follow-up|0
852565|NCT01231373|2713526|P4|Overall Study|Withdrew consent prior to randomization|0
852566|NCT01231373|2713527|P3|Overall Study|Withdrew consent prior to randomization|0
852567|NCT01231373|2713528|P2|Overall Study|Withdrew consent prior to randomization|1
852568|NCT01231373|2713529|P1|Overall Study|Withdrew consent prior to randomization|2
852569|NCT01231464|2713556|P2|Overall Study|Withdrawal by Subject|2
852570|NCT01231464|2713557|P1|Overall Study|Withdrawal by Subject|3
852571|NCT01231464|2713556|P2|Overall Study|Lost to Follow-up|2
852572|NCT01231464|2713557|P1|Overall Study|Lost to Follow-up|1
852573|NCT01231464|2713556|P2|Overall Study|Protocol Violation|2
852574|NCT01231464|2713557|P1|Overall Study|Protocol Violation|1
852575|NCT01231464|2713556|P2|Overall Study|Adverse Event|1
852576|NCT01231464|2713557|P1|Overall Study|Adverse Event|0
852577|NCT01231503|2713575|P8|Overall Study|Protocol Violation|0
852578|NCT01231503|2713576|P7|Overall Study|Protocol Violation|0
852579|NCT01231503|2713577|P6|Overall Study|Protocol Violation|0
852580|NCT01231503|2713578|P5|Overall Study|Protocol Violation|0
852581|NCT01231503|2713579|P4|Overall Study|Protocol Violation|1
852582|NCT01231503|2713580|P3|Overall Study|Protocol Violation|0
852583|NCT01231503|2713581|P2|Overall Study|Protocol Violation|0
852584|NCT01231503|2713582|P1|Overall Study|Protocol Violation|0
852585|NCT01231503|2713575|P8|Overall Study|Lost to Follow-up|6
852586|NCT01231503|2713576|P7|Overall Study|Lost to Follow-up|6
852587|NCT01231503|2713577|P6|Overall Study|Lost to Follow-up|9
852588|NCT01231503|2713578|P5|Overall Study|Lost to Follow-up|7
852589|NCT01231503|2713579|P4|Overall Study|Lost to Follow-up|5
852590|NCT01231503|2713580|P3|Overall Study|Lost to Follow-up|8
852591|NCT01231503|2713581|P2|Overall Study|Lost to Follow-up|10
852592|NCT01231503|2713582|P1|Overall Study|Lost to Follow-up|8
852593|NCT01231503|2713575|P8|Overall Study|Withdrawal by Subject|2
852594|NCT01231503|2713576|P7|Overall Study|Withdrawal by Subject|1
852595|NCT01231503|2713577|P6|Overall Study|Withdrawal by Subject|5
852596|NCT01231503|2713578|P5|Overall Study|Withdrawal by Subject|3
852597|NCT01231503|2713579|P4|Overall Study|Withdrawal by Subject|1
852598|NCT01231503|2713580|P3|Overall Study|Withdrawal by Subject|3
852599|NCT01231503|2713581|P2|Overall Study|Withdrawal by Subject|3
852600|NCT01231503|2713582|P1|Overall Study|Withdrawal by Subject|6
852601|NCT01231503|2713575|P8|Overall Study|Adverse event, serious fatal|0
852602|NCT01231503|2713576|P7|Overall Study|Adverse event, serious fatal|0
852603|NCT01231503|2713577|P6|Overall Study|Adverse event, serious fatal|1
852604|NCT01231503|2713578|P5|Overall Study|Adverse event, serious fatal|0
852605|NCT01231503|2713579|P4|Overall Study|Adverse event, serious fatal|1
852606|NCT01231503|2713580|P3|Overall Study|Adverse event, serious fatal|1
852607|NCT01231503|2713581|P2|Overall Study|Adverse event, serious fatal|0
852608|NCT01231503|2713582|P1|Overall Study|Adverse event, serious fatal|0
852609|NCT01231503|2713575|P8|Overall Study|Adverse Event|0
852610|NCT01231503|2713576|P7|Overall Study|Adverse Event|0
852611|NCT01231503|2713577|P6|Overall Study|Adverse Event|1
852612|NCT01231503|2713578|P5|Overall Study|Adverse Event|0
852613|NCT01231503|2713579|P4|Overall Study|Adverse Event|0
852614|NCT01231503|2713580|P3|Overall Study|Adverse Event|0
852615|NCT01231503|2713581|P2|Overall Study|Adverse Event|0
852616|NCT01231503|2713582|P1|Overall Study|Adverse Event|0
852643|NCT01231581|2713823|P2|Overall Study|Ongoing|0
852644|NCT01231581|2713824|P1|Overall Study|Ongoing|1
852645|NCT01231581|2713823|P2|Overall Study|Death|64
852646|NCT01231581|2713824|P1|Overall Study|Death|65
852647|NCT01231581|2713823|P2|Overall Study|Study Closed/Terminated|5
852648|NCT01231581|2713824|P1|Overall Study|Study Closed/Terminated|6
852649|NCT01231581|2713823|P2|Overall Study|Withdrawal by Subject|9
852650|NCT01231581|2713824|P1|Overall Study|Withdrawal by Subject|6
852651|NCT01231581|2713823|P2|Overall Study|Lost to Follow-up|2
852652|NCT01231581|2713824|P1|Overall Study|Lost to Follow-up|2
852653|NCT01231607|2713847|P5|Overall Study|Withdrawal by Subject|9
852654|NCT01231607|2713848|P4|Overall Study|Withdrawal by Subject|17
852655|NCT01231607|2713849|P3|Overall Study|Withdrawal by Subject|14
852656|NCT01231607|2713850|P2|Overall Study|Withdrawal by Subject|9
852657|NCT01231607|2713851|P1|Overall Study|Withdrawal by Subject|9
852658|NCT01231607|2713847|P5|Overall Study|Protocol Violation|2
852659|NCT01231607|2713848|P4|Overall Study|Protocol Violation|2
852660|NCT01231607|2713849|P3|Overall Study|Protocol Violation|0
852661|NCT01231607|2713850|P2|Overall Study|Protocol Violation|2
852662|NCT01231607|2713851|P1|Overall Study|Protocol Violation|3
852663|NCT01231607|2713847|P5|Overall Study|Physician Decision|4
852664|NCT01231607|2713848|P4|Overall Study|Physician Decision|5
852665|NCT01231607|2713849|P3|Overall Study|Physician Decision|3
852666|NCT01231607|2713850|P2|Overall Study|Physician Decision|4
852667|NCT01231607|2713851|P1|Overall Study|Physician Decision|4
852668|NCT01231607|2713847|P5|Overall Study|Lost to Follow-up|4
852669|NCT01231607|2713848|P4|Overall Study|Lost to Follow-up|10
852670|NCT01231607|2713849|P3|Overall Study|Lost to Follow-up|10
852671|NCT01231607|2713850|P2|Overall Study|Lost to Follow-up|11
852672|NCT01231607|2713851|P1|Overall Study|Lost to Follow-up|13
852673|NCT01231607|2713847|P5|Overall Study|Adverse Event|5
852674|NCT01231607|2713848|P4|Overall Study|Adverse Event|4
852675|NCT01231607|2713849|P3|Overall Study|Adverse Event|4
852676|NCT01231607|2713850|P2|Overall Study|Adverse Event|8
852677|NCT01231607|2713851|P1|Overall Study|Adverse Event|0
852678|NCT01231984|2713975|P4|Study Period 2|Did not continue to meet I/E Criteria|1
852679|NCT01231984|2713976|P3|Study Period 2|Did not continue to meet I/E Criteria|0
852680|NCT01231984|2713977|P2|Study Period 2|Did not continue to meet I/E Criteria|1
852681|NCT01231984|2713978|P1|Study Period 2|Did not continue to meet I/E Criteria|1
852682|NCT01231984|2713975|P4|Study Period 2|Lost to Follow-up|3
852683|NCT01231984|2713976|P3|Study Period 2|Lost to Follow-up|0
852684|NCT01231984|2713977|P2|Study Period 2|Lost to Follow-up|0
852685|NCT01231984|2713978|P1|Study Period 2|Lost to Follow-up|1
852686|NCT01231984|2713975|P4|Study Period 2|Withdrawal by Subject|0
852687|NCT01231984|2713976|P3|Study Period 2|Withdrawal by Subject|0
852688|NCT01231984|2713977|P2|Study Period 2|Withdrawal by Subject|1
852689|NCT01231984|2713978|P1|Study Period 2|Withdrawal by Subject|1
852690|NCT01231984|2713975|P4|Study Period 1|Not Specified|1
852691|NCT01231984|2713976|P3|Study Period 1|Not Specified|0
852692|NCT01231984|2713977|P2|Study Period 1|Not Specified|0
852693|NCT01231984|2713978|P1|Study Period 1|Not Specified|0
852694|NCT01231984|2713975|P4|Study Period 1|Adverse Event|0
852695|NCT01231984|2713976|P3|Study Period 1|Adverse Event|0
852696|NCT01231984|2713977|P2|Study Period 1|Adverse Event|0
852697|NCT01231984|2713978|P1|Study Period 1|Adverse Event|1
852698|NCT01231984|2713975|P4|Study Period 1|Protocol Violation|3
852699|NCT01231984|2713976|P3|Study Period 1|Protocol Violation|2
852700|NCT01231984|2713977|P2|Study Period 1|Protocol Violation|4
852701|NCT01231984|2713978|P1|Study Period 1|Protocol Violation|3
852702|NCT01231984|2713975|P4|Study Period 1|Non-compliance with study requirements|1
852703|NCT01231984|2713976|P3|Study Period 1|Non-compliance with study requirements|2
852704|NCT01231984|2713977|P2|Study Period 1|Non-compliance with study requirements|0
852705|NCT01231984|2713978|P1|Study Period 1|Non-compliance with study requirements|5
852706|NCT01231984|2713975|P4|Study Period 1|Screen Failure|1
852707|NCT01231984|2713976|P3|Study Period 1|Screen Failure|0
852708|NCT01231984|2713977|P2|Study Period 1|Screen Failure|0
852709|NCT01231984|2713978|P1|Study Period 1|Screen Failure|0
852710|NCT01231984|2713975|P4|Study Period 1|Did not continue to meet I/E Criteria|2
852711|NCT01231984|2713976|P3|Study Period 1|Did not continue to meet I/E Criteria|2
852712|NCT01231984|2713977|P2|Study Period 1|Did not continue to meet I/E Criteria|2
852713|NCT01231984|2713978|P1|Study Period 1|Did not continue to meet I/E Criteria|2
852714|NCT01231984|2713975|P4|Study Period 1|Lost to Follow-up|0
852715|NCT01231984|2713976|P3|Study Period 1|Lost to Follow-up|1
852716|NCT01231984|2713977|P2|Study Period 1|Lost to Follow-up|1
852717|NCT01231984|2713978|P1|Study Period 1|Lost to Follow-up|1
852718|NCT01231984|2713975|P4|Study Period 1|Withdrawal by Subject|1
852719|NCT01231984|2713976|P3|Study Period 1|Withdrawal by Subject|0
852720|NCT01231984|2713977|P2|Study Period 1|Withdrawal by Subject|0
852721|NCT01231984|2713978|P1|Study Period 1|Withdrawal by Subject|0
852722|NCT01232127|2713999|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
852723|NCT01232127|2714000|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
852724|NCT01232127|2714001|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
894335|NCT01463527|2838260|P2|Overall Study|Crying >20% of sedation|6
894336|NCT01463527|2838261|P1|Overall Study|Crying >20% of sedation|5
894337|NCT01463527|2838260|P2|Overall Study|Protocol Violation|1
894338|NCT01463527|2838261|P1|Overall Study|Protocol Violation|1
894339|NCT01434290|2838271|P2|Overall Study|No protocol treatment|4
894340|NCT01434290|2838272|P1|Overall Study|No protocol treatment|2
894341|NCT01434290|2838271|P2|Overall Study|Protocol Violation|3
894342|NCT01434290|2838272|P1|Overall Study|Protocol Violation|6
894343|NCT01428258|2838300|P2|Intervention 1|Withdrawal by Subject|0
894344|NCT01428258|2838301|P1|Intervention 1|Withdrawal by Subject|2
894345|NCT01394627|2838344|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
894346|NCT01394627|2838345|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
894347|NCT01394627|2838344|P2|First Intervention (1 Day)|poor intravenous access|1
894348|NCT01394627|2838345|P1|First Intervention (1 Day)|poor intravenous access|0
894365|NCT01262898|2838482|P4|Overall Study|Withdrawal by Subject|0
894366|NCT01262898|2838483|P3|Overall Study|Withdrawal by Subject|0
894367|NCT01262898|2838484|P2|Overall Study|Withdrawal by Subject|1
894368|NCT01262898|2838485|P1|Overall Study|Withdrawal by Subject|1
894369|NCT01262898|2838482|P4|Overall Study|Lost to Follow-up|0
894370|NCT01262898|2838483|P3|Overall Study|Lost to Follow-up|0
894371|NCT01262898|2838484|P2|Overall Study|Lost to Follow-up|0
894372|NCT01262898|2838485|P1|Overall Study|Lost to Follow-up|1
894373|NCT01262898|2838482|P4|Overall Study|Protocol Violation|0
894374|NCT01262898|2838483|P3|Overall Study|Protocol Violation|0
894375|NCT01262898|2838484|P2|Overall Study|Protocol Violation|1
894376|NCT01262898|2838485|P1|Overall Study|Protocol Violation|1
894377|NCT01246011|2838608|P3|Overall Study|Withdrawal by Subject|1
894378|NCT01246011|2838609|P2|Overall Study|Withdrawal by Subject|0
894379|NCT01246011|2838610|P1|Overall Study|Withdrawal by Subject|0
894380|NCT01246011|2838608|P3|Overall Study|If needed warfarin clinically, withdrawn|3
894381|NCT01246011|2838609|P2|Overall Study|If needed warfarin clinically, withdrawn|0
894382|NCT01246011|2838610|P1|Overall Study|If needed warfarin clinically, withdrawn|0
894383|NCT01231555|2838624|P3|Overall Study|Withdrawal by Subject|0
894384|NCT01231555|2838625|P2|Overall Study|Withdrawal by Subject|2
894385|NCT01231555|2838626|P1|Overall Study|Withdrawal by Subject|0
894386|NCT01231555|2838624|P3|Overall Study|Study terminated|8
894387|NCT01231555|2838625|P2|Overall Study|Study terminated|5
894388|NCT01231555|2838626|P1|Overall Study|Study terminated|8
894389|NCT01199731|2838663|P3|Overall Study|Withdrawal by Subject|0
894390|NCT01199731|2838664|P2|Overall Study|Withdrawal by Subject|0
894391|NCT01199731|2838665|P1|Overall Study|Withdrawal by Subject|2
894392|NCT01199731|2838663|P3|Overall Study|Physician Decision|1
894393|NCT01199731|2838664|P2|Overall Study|Physician Decision|1
894394|NCT01199731|2838665|P1|Overall Study|Physician Decision|0
894395|NCT01199731|2838663|P3|Overall Study|Lost to Follow-up|2
894396|NCT01199731|2838664|P2|Overall Study|Lost to Follow-up|0
894397|NCT01199731|2838665|P1|Overall Study|Lost to Follow-up|0
894398|NCT01199731|2838663|P3|Overall Study|Study closed/terminated|7
894399|NCT01199731|2838664|P2|Overall Study|Study closed/terminated|9
894400|NCT01199731|2838665|P1|Overall Study|Study closed/terminated|7
894401|NCT01199731|2838663|P3|Overall Study|Adverse Event|0
894402|NCT01199731|2838664|P2|Overall Study|Adverse Event|1
894403|NCT01199731|2838665|P1|Overall Study|Adverse Event|0
894416|NCT01011933|2838734|P1|Overall Study|Never treated|1
894417|NCT01011933|2838734|P1|Overall Study|Inadequate pathology|1
894418|NCT01011933|2838734|P1|Overall Study|Improper pre-protocol Rx|1
894419|NCT01011933|2838734|P1|Overall Study|Wrong cell type|1
894434|NCT00941070|2838812|P1|Overall Study|Patient non-compliant|1
894435|NCT00934947|2838830|P2|Overall Study|Adverse Event|2
894436|NCT00934947|2838831|P1|Overall Study|Adverse Event|0
894437|NCT00903201|2838846|P3|Overall Study|Withdrawal by Subject|1
894438|NCT00903201|2838847|P2|Overall Study|Withdrawal by Subject|0
894439|NCT00903201|2838848|P1|Overall Study|Withdrawal by Subject|1
894440|NCT00903201|2838846|P3|Overall Study|Physician Decision|1
894441|NCT00903201|2838847|P2|Overall Study|Physician Decision|0
894442|NCT00903201|2838848|P1|Overall Study|Physician Decision|1
894443|NCT00903201|2838846|P3|Overall Study|Lost to Follow-up|0
894444|NCT00903201|2838847|P2|Overall Study|Lost to Follow-up|1
894445|NCT00903201|2838848|P1|Overall Study|Lost to Follow-up|0
894446|NCT00903201|2838846|P3|Overall Study|Protocol Violation|0
894447|NCT00903201|2838847|P2|Overall Study|Protocol Violation|1
894448|NCT00903201|2838848|P1|Overall Study|Protocol Violation|2
894449|NCT00903201|2838846|P3|Overall Study|Adverse Event|0
894450|NCT00903201|2838847|P2|Overall Study|Adverse Event|4
894451|NCT00903201|2838848|P1|Overall Study|Adverse Event|1
894499|NCT00640224|2839212|P4|Overall Study|Headaches|0
894500|NCT00640224|2839213|P3|Overall Study|Headaches|0
894501|NCT00640224|2839214|P2|Overall Study|Headaches|1
894502|NCT00640224|2839215|P1|Overall Study|Headaches|0
894503|NCT00640224|2839212|P4|Overall Study|Withdrawal by Subject|0
894504|NCT00640224|2839213|P3|Overall Study|Withdrawal by Subject|0
894505|NCT00640224|2839214|P2|Overall Study|Withdrawal by Subject|0
894506|NCT00640224|2839215|P1|Overall Study|Withdrawal by Subject|1
894507|NCT00640224|2839212|P4|Overall Study|Lost to Follow-up|0
894508|NCT00640224|2839213|P3|Overall Study|Lost to Follow-up|0
894509|NCT00640224|2839214|P2|Overall Study|Lost to Follow-up|2
852885|NCT01232296|2714073|P2|Overall Study|Death|6
852886|NCT01232296|2714074|P1|Overall Study|Death|1
852887|NCT01232296|2714073|P2|Overall Study|Subject/guardian decision|2
852888|NCT01232296|2714074|P1|Overall Study|Subject/guardian decision|10
852889|NCT01232296|2714073|P2|Overall Study|Technical problems|0
852890|NCT01232296|2714074|P1|Overall Study|Technical problems|3
852891|NCT01232296|2714073|P2|Overall Study|Study terminated by sponsor|1
852892|NCT01232296|2714074|P1|Overall Study|Study terminated by sponsor|0
852893|NCT01232296|2714073|P2|Overall Study|Progressive disease|61
852894|NCT01232296|2714074|P1|Overall Study|Progressive disease|43
852895|NCT01232296|2714073|P2|Overall Study|Physician Decision|1
852896|NCT01232296|2714074|P1|Overall Study|Physician Decision|1
852897|NCT01232296|2714073|P2|Overall Study|Adverse Event|12
852898|NCT01232296|2714074|P1|Overall Study|Adverse Event|24
852899|NCT01232491|2714100|P2|Overall Study|Other|18
852900|NCT01232491|2714101|P1|Overall Study|Other|21
852901|NCT01232491|2714100|P2|Overall Study|Withdrawal Criteria|21
852902|NCT01232491|2714101|P1|Overall Study|Withdrawal Criteria|12
852903|NCT01232491|2714100|P2|Overall Study|Protocol Violation|11
852904|NCT01232491|2714101|P1|Overall Study|Protocol Violation|13
852905|NCT01232491|2714100|P2|Overall Study|Lack of Efficacy|5
852906|NCT01232491|2714101|P1|Overall Study|Lack of Efficacy|1
852907|NCT01232491|2714100|P2|Overall Study|Adverse Event|8
852908|NCT01232491|2714101|P1|Overall Study|Adverse Event|13
852909|NCT01232569|2714158|P4|Double-blind Treatment Period|Death|0
852910|NCT01232569|2714159|P3|Double-blind Treatment Period|Death|0
852911|NCT01232569|2714160|P2|Double-blind Treatment Period|Death|0
852912|NCT01232569|2714161|P1|Double-blind Treatment Period|Death|2
852913|NCT01232569|2714158|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
852914|NCT01232569|2714159|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
852915|NCT01232569|2714160|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
852916|NCT01232569|2714161|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
852917|NCT01232569|2714158|P4|Double-blind Treatment Period|Physician Decision|0
852918|NCT01232569|2714159|P3|Double-blind Treatment Period|Physician Decision|0
852919|NCT01232569|2714160|P2|Double-blind Treatment Period|Physician Decision|0
852920|NCT01232569|2714161|P1|Double-blind Treatment Period|Physician Decision|1
852921|NCT01232569|2714158|P4|Double-blind Treatment Period|Lack of Efficacy|0
852922|NCT01232569|2714159|P3|Double-blind Treatment Period|Lack of Efficacy|0
852923|NCT01232569|2714160|P2|Double-blind Treatment Period|Lack of Efficacy|2
852924|NCT01232569|2714161|P1|Double-blind Treatment Period|Lack of Efficacy|1
852925|NCT01232569|2714158|P4|Double-blind Treatment Period|Lost to Follow-up|0
894510|NCT00640224|2839215|P1|Overall Study|Lost to Follow-up|5
894511|NCT00621777|2839315|P2|Randomized Phase|Death|1
894512|NCT00621777|2839316|P1|Randomized Phase|Death|0
894513|NCT00621777|2839315|P2|Randomized Phase|administrative|3
894514|NCT00621777|2839316|P1|Randomized Phase|administrative|0
894515|NCT00621777|2839315|P2|Randomized Phase|Withdrawal by Subject|9
894516|NCT00621777|2839316|P1|Randomized Phase|Withdrawal by Subject|1
894517|NCT00621777|2839315|P2|Randomized Phase|Lost to Follow-up|3
894518|NCT00621777|2839316|P1|Randomized Phase|Lost to Follow-up|3
852926|NCT01232569|2714159|P3|Double-blind Treatment Period|Lost to Follow-up|0
852927|NCT01232569|2714160|P2|Double-blind Treatment Period|Lost to Follow-up|0
852928|NCT01232569|2714161|P1|Double-blind Treatment Period|Lost to Follow-up|4
852929|NCT01232569|2714158|P4|Double-blind Treatment Period|Escape|0
852930|NCT01232569|2714159|P3|Double-blind Treatment Period|Escape|0
852931|NCT01232569|2714160|P2|Double-blind Treatment Period|Escape|2
852932|NCT01232569|2714161|P1|Double-blind Treatment Period|Escape|2
852933|NCT01232569|2714158|P4|Double-blind Treatment Period|Withdrawal by Subject|0
852934|NCT01232569|2714159|P3|Double-blind Treatment Period|Withdrawal by Subject|0
852935|NCT01232569|2714160|P2|Double-blind Treatment Period|Withdrawal by Subject|2
852936|NCT01232569|2714161|P1|Double-blind Treatment Period|Withdrawal by Subject|9
852937|NCT01232790|2714202|P2|Second Crossover|Withdrawal by Subject|2
852938|NCT01232790|2714203|P1|Second Crossover|Withdrawal by Subject|1
852939|NCT01232790|2714202|P2|First Crossover|Withdrawal by Subject|0
852940|NCT01232790|2714203|P1|First Crossover|Withdrawal by Subject|1
852941|NCT01232790|2714202|P2|Initial Assessment|Withdrawal by Subject|1
852942|NCT01232790|2714203|P1|Initial Assessment|Withdrawal by Subject|0
852943|NCT01232790|2714202|P2|Randomization|Physician Decision|1
852944|NCT01232790|2714203|P1|Randomization|Physician Decision|0
852945|NCT01232790|2714202|P2|Randomization|Protocol Violation|1
852946|NCT01232790|2714203|P1|Randomization|Protocol Violation|0
852947|NCT01232790|2714202|P2|Randomization|Withdrawal by Subject|0
852948|NCT01232790|2714203|P1|Randomization|Withdrawal by Subject|2
894519|NCT00621777|2839315|P2|Randomized Phase|Adverse Event|3
894520|NCT00621777|2839316|P1|Randomized Phase|Adverse Event|3
852951|NCT01232894|2714276|P2|Overall Study|Physician Decision|1
852952|NCT01232894|2714277|P1|Overall Study|Physician Decision|2
852953|NCT01232894|2714276|P2|Overall Study|Withdrawal by Subject|5
852954|NCT01232894|2714277|P1|Overall Study|Withdrawal by Subject|8
852955|NCT01232894|2714276|P2|Overall Study|Protocol Violation|1
852956|NCT01232894|2714277|P1|Overall Study|Protocol Violation|1
852957|NCT01232894|2714276|P2|Overall Study|Death|0
852958|NCT01232894|2714277|P1|Overall Study|Death|1
852959|NCT01232894|2714276|P2|Overall Study|Lost to Follow-up|1
852960|NCT01232894|2714277|P1|Overall Study|Lost to Follow-up|0
852961|NCT01233050|2714300|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
852962|NCT01233050|2714301|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
852963|NCT01233076|2714317|P2|Period 2, One Week|Lost to Follow-up|0
852964|NCT01233076|2714318|P1|Period 2, One Week|Lost to Follow-up|1
852965|NCT01238822|2714324|P1|Overall Study|COULD NOT SWALLOW PILLS|3
852966|NCT01238848|2714336|P2|Overall Study|Physician Decision|5
852967|NCT01238848|2714337|P1|Overall Study|Physician Decision|13
852968|NCT01238861|2714351|P6|Overall Study|Withdrawal by Subject|9
852969|NCT01238861|2714352|P5|Overall Study|Withdrawal by Subject|10
852970|NCT01238861|2714353|P4|Overall Study|Withdrawal by Subject|8
852971|NCT01238861|2714354|P3|Overall Study|Withdrawal by Subject|4
852972|NCT01238861|2714355|P2|Overall Study|Withdrawal by Subject|5
852973|NCT01238861|2714356|P1|Overall Study|Withdrawal by Subject|6
852974|NCT01238861|2714351|P6|Overall Study|Adverse Event|0
852975|NCT01238861|2714352|P5|Overall Study|Adverse Event|0
852976|NCT01238861|2714353|P4|Overall Study|Adverse Event|0
852977|NCT01238861|2714354|P3|Overall Study|Adverse Event|0
852978|NCT01238861|2714355|P2|Overall Study|Adverse Event|1
852979|NCT01238861|2714356|P1|Overall Study|Adverse Event|0
852980|NCT01238861|2714351|P6|Overall Study|Lack of compliance|1
852981|NCT01238861|2714352|P5|Overall Study|Lack of compliance|0
852982|NCT01238861|2714353|P4|Overall Study|Lack of compliance|0
852983|NCT01238861|2714354|P3|Overall Study|Lack of compliance|0
852984|NCT01238861|2714355|P2|Overall Study|Lack of compliance|0
852985|NCT01238861|2714356|P1|Overall Study|Lack of compliance|0
852986|NCT01238861|2714351|P6|Overall Study|Serious adverse event|1
852987|NCT01238861|2714352|P5|Overall Study|Serious adverse event|0
852988|NCT01238861|2714353|P4|Overall Study|Serious adverse event|0
852989|NCT01238861|2714354|P3|Overall Study|Serious adverse event|0
852990|NCT01238861|2714355|P2|Overall Study|Serious adverse event|0
852991|NCT01238861|2714356|P1|Overall Study|Serious adverse event|0
852992|NCT01238861|2714351|P6|Overall Study|Unable to continue visits|1
852993|NCT01238861|2714352|P5|Overall Study|Unable to continue visits|0
852994|NCT01238861|2714353|P4|Overall Study|Unable to continue visits|1
852995|NCT01238861|2714354|P3|Overall Study|Unable to continue visits|0
852996|NCT01238861|2714355|P2|Overall Study|Unable to continue visits|0
852997|NCT01238861|2714356|P1|Overall Study|Unable to continue visits|0
852998|NCT01238861|2714351|P6|Overall Study|Personal problems|0
852999|NCT01238861|2714352|P5|Overall Study|Personal problems|0
853000|NCT01238861|2714353|P4|Overall Study|Personal problems|1
853001|NCT01238861|2714354|P3|Overall Study|Personal problems|0
853002|NCT01238861|2714355|P2|Overall Study|Personal problems|0
853003|NCT01238861|2714356|P1|Overall Study|Personal problems|0
853004|NCT01238861|2714351|P6|Overall Study|Strongyloides stercoralis antibodies +|0
853005|NCT01238861|2714352|P5|Overall Study|Strongyloides stercoralis antibodies +|0
853006|NCT01238861|2714353|P4|Overall Study|Strongyloides stercoralis antibodies +|1
853007|NCT01238861|2714354|P3|Overall Study|Strongyloides stercoralis antibodies +|0
853008|NCT01238861|2714355|P2|Overall Study|Strongyloides stercoralis antibodies +|0
853009|NCT01238861|2714356|P1|Overall Study|Strongyloides stercoralis antibodies +|0
853010|NCT01238861|2714351|P6|Overall Study|Subject moved out of state/area|0
853011|NCT01238861|2714352|P5|Overall Study|Subject moved out of state/area|0
853012|NCT01238861|2714353|P4|Overall Study|Subject moved out of state/area|1
853013|NCT01238861|2714354|P3|Overall Study|Subject moved out of state/area|1
853014|NCT01238861|2714355|P2|Overall Study|Subject moved out of state/area|0
853015|NCT01238861|2714356|P1|Overall Study|Subject moved out of state/area|0
853016|NCT01238861|2714351|P6|Overall Study|Subject traveled to Argentina by 1 year|0
853017|NCT01238861|2714352|P5|Overall Study|Subject traveled to Argentina by 1 year|0
853018|NCT01238861|2714353|P4|Overall Study|Subject traveled to Argentina by 1 year|0
853019|NCT01238861|2714354|P3|Overall Study|Subject traveled to Argentina by 1 year|1
853020|NCT01238861|2714355|P2|Overall Study|Subject traveled to Argentina by 1 year|0
853021|NCT01238861|2714356|P1|Overall Study|Subject traveled to Argentina by 1 year|0
853022|NCT01238861|2714351|P6|Overall Study|Incorrect enrollment/randomization|0
853023|NCT01238861|2714352|P5|Overall Study|Incorrect enrollment/randomization|1
853024|NCT01238861|2714353|P4|Overall Study|Incorrect enrollment/randomization|0
853025|NCT01238861|2714354|P3|Overall Study|Incorrect enrollment/randomization|1
853026|NCT01238861|2714355|P2|Overall Study|Incorrect enrollment/randomization|0
853027|NCT01238861|2714356|P1|Overall Study|Incorrect enrollment/randomization|0
853028|NCT01238861|2714351|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
853029|NCT01238861|2714352|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
853030|NCT01238861|2714353|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
853031|NCT01238861|2714354|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
853032|NCT01238861|2714355|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
853033|NCT01238861|2714356|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
853034|NCT01238861|2714351|P6|Overall Study|Unplanned surgery|0
853035|NCT01238861|2714352|P5|Overall Study|Unplanned surgery|0
853036|NCT01238861|2714353|P4|Overall Study|Unplanned surgery|0
853037|NCT01238861|2714354|P3|Overall Study|Unplanned surgery|0
853038|NCT01238861|2714355|P2|Overall Study|Unplanned surgery|0
853039|NCT01238861|2714356|P1|Overall Study|Unplanned surgery|1
853040|NCT01238861|2714351|P6|Overall Study|Lost to Follow-up|2
853041|NCT01238861|2714352|P5|Overall Study|Lost to Follow-up|1
853042|NCT01238861|2714353|P4|Overall Study|Lost to Follow-up|1
853043|NCT01238861|2714354|P3|Overall Study|Lost to Follow-up|3
853044|NCT01238861|2714355|P2|Overall Study|Lost to Follow-up|2
853045|NCT01238861|2714356|P1|Overall Study|Lost to Follow-up|4
853046|NCT01238900|2714434|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
853047|NCT01238900|2714434|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
853048|NCT01238991|2714452|P10|Overall Study|Admission to a nursing home|0
853049|NCT01238991|2714453|P9|Overall Study|Admission to a nursing home|0
853050|NCT01238991|2714454|P8|Overall Study|Admission to a nursing home|0
853051|NCT01238991|2714455|P7|Overall Study|Admission to a nursing home|0
853052|NCT01238991|2714456|P6|Overall Study|Admission to a nursing home|0
853053|NCT01238991|2714457|P5|Overall Study|Admission to a nursing home|0
853054|NCT01238991|2714458|P4|Overall Study|Admission to a nursing home|0
853055|NCT01238991|2714459|P3|Overall Study|Admission to a nursing home|1
853056|NCT01238991|2714460|P2|Overall Study|Admission to a nursing home|0
853057|NCT01238991|2714461|P1|Overall Study|Admission to a nursing home|1
853058|NCT01238991|2714452|P10|Overall Study|Caregiver's request|0
853059|NCT01238991|2714453|P9|Overall Study|Caregiver's request|1
853060|NCT01238991|2714454|P8|Overall Study|Caregiver's request|0
853061|NCT01238991|2714455|P7|Overall Study|Caregiver's request|0
853062|NCT01238991|2714456|P6|Overall Study|Caregiver's request|0
853063|NCT01238991|2714457|P5|Overall Study|Caregiver's request|0
853064|NCT01238991|2714458|P4|Overall Study|Caregiver's request|0
853065|NCT01238991|2714459|P3|Overall Study|Caregiver's request|0
853066|NCT01238991|2714460|P2|Overall Study|Caregiver's request|0
853067|NCT01238991|2714461|P1|Overall Study|Caregiver's request|0
853068|NCT01238991|2714452|P10|Overall Study|Study Terminated by Sponsor|2
853069|NCT01238991|2714453|P9|Overall Study|Study Terminated by Sponsor|2
853070|NCT01238991|2714454|P8|Overall Study|Study Terminated by Sponsor|4
853071|NCT01238991|2714455|P7|Overall Study|Study Terminated by Sponsor|7
853072|NCT01238991|2714456|P6|Overall Study|Study Terminated by Sponsor|0
853073|NCT01238991|2714457|P5|Overall Study|Study Terminated by Sponsor|1
853074|NCT01238991|2714458|P4|Overall Study|Study Terminated by Sponsor|0
853075|NCT01238991|2714459|P3|Overall Study|Study Terminated by Sponsor|0
853076|NCT01238991|2714460|P2|Overall Study|Study Terminated by Sponsor|0
853077|NCT01238991|2714461|P1|Overall Study|Study Terminated by Sponsor|0
853078|NCT01238991|2714452|P10|Overall Study|Withdrawal by Subject|0
853079|NCT01238991|2714453|P9|Overall Study|Withdrawal by Subject|0
853080|NCT01238991|2714454|P8|Overall Study|Withdrawal by Subject|0
853081|NCT01238991|2714455|P7|Overall Study|Withdrawal by Subject|0
853082|NCT01238991|2714456|P6|Overall Study|Withdrawal by Subject|0
853083|NCT01238991|2714457|P5|Overall Study|Withdrawal by Subject|0
853084|NCT01238991|2714458|P4|Overall Study|Withdrawal by Subject|0
853085|NCT01238991|2714459|P3|Overall Study|Withdrawal by Subject|1
853086|NCT01238991|2714460|P2|Overall Study|Withdrawal by Subject|0
853087|NCT01238991|2714461|P1|Overall Study|Withdrawal by Subject|0
853088|NCT01238991|2714452|P10|Overall Study|Lack of Efficacy|0
853089|NCT01238991|2714453|P9|Overall Study|Lack of Efficacy|1
853090|NCT01238991|2714454|P8|Overall Study|Lack of Efficacy|0
853091|NCT01238991|2714455|P7|Overall Study|Lack of Efficacy|0
853092|NCT01238991|2714456|P6|Overall Study|Lack of Efficacy|0
853093|NCT01238991|2714457|P5|Overall Study|Lack of Efficacy|0
853094|NCT01238991|2714458|P4|Overall Study|Lack of Efficacy|0
853095|NCT01238991|2714459|P3|Overall Study|Lack of Efficacy|1
853096|NCT01238991|2714460|P2|Overall Study|Lack of Efficacy|0
853097|NCT01238991|2714461|P1|Overall Study|Lack of Efficacy|0
853098|NCT01238991|2714452|P10|Overall Study|Death|0
853099|NCT01238991|2714453|P9|Overall Study|Death|0
853100|NCT01238991|2714454|P8|Overall Study|Death|0
853101|NCT01238991|2714455|P7|Overall Study|Death|0
853102|NCT01238991|2714456|P6|Overall Study|Death|0
853103|NCT01238991|2714457|P5|Overall Study|Death|0
853104|NCT01238991|2714458|P4|Overall Study|Death|1
853105|NCT01238991|2714459|P3|Overall Study|Death|0
853106|NCT01238991|2714460|P2|Overall Study|Death|0
853107|NCT01238991|2714461|P1|Overall Study|Death|0
853108|NCT01238991|2714452|P10|Overall Study|Adverse Event|0
853109|NCT01238991|2714453|P9|Overall Study|Adverse Event|0
853110|NCT01238991|2714454|P8|Overall Study|Adverse Event|1
853111|NCT01238991|2714455|P7|Overall Study|Adverse Event|1
853112|NCT01238991|2714456|P6|Overall Study|Adverse Event|0
853113|NCT01238991|2714457|P5|Overall Study|Adverse Event|1
853114|NCT01238991|2714458|P4|Overall Study|Adverse Event|1
853115|NCT01238991|2714459|P3|Overall Study|Adverse Event|3
853116|NCT01238991|2714460|P2|Overall Study|Adverse Event|0
853117|NCT01238991|2714461|P1|Overall Study|Adverse Event|1
853118|NCT01239680|2714550|P2|Overall Study|Withdrawal by Subject|0
853119|NCT01239680|2714551|P1|Overall Study|Withdrawal by Subject|2
853120|NCT01239732|2714557|P1|Overall Study|Unspecified|19
853121|NCT01239732|2714557|P1|Overall Study|Treatment failure|2
853122|NCT01239732|2714557|P1|Overall Study|Investigator's decision|4
853123|NCT01239732|2714557|P1|Overall Study|Study termination by sponsor|2
853124|NCT01239732|2714557|P1|Overall Study|Participant non compliance|5
853125|NCT01239732|2714557|P1|Overall Study|Protocol Violation|3
853126|NCT01239732|2714557|P1|Overall Study|Adverse Event|6
853127|NCT01239732|2714557|P1|Overall Study|Withdrawal by Subject|87
853128|NCT01239732|2714557|P1|Overall Study|Death|226
853129|NCT01239732|2714557|P1|Overall Study|Termination of study per protocol|667
853130|NCT01239745|2714568|P1|Overall Study|Adverse Event|1
853131|NCT01239745|2714568|P1|Overall Study|Study terminated by sponsor|45
853132|NCT01239797|2714581|P2|Treated Participants|Poor/Non-compliance|1
853133|NCT01239797|2714582|P1|Treated Participants|Poor/Non-compliance|0
853134|NCT01239797|2714581|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
853135|NCT01239797|2714582|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
853136|NCT01239797|2714581|P2|Treated Participants|Death|1
853137|NCT01239797|2714582|P1|Treated Participants|Death|1
853138|NCT01239797|2714581|P2|Treated Participants|Non-specified|11
853139|NCT01239797|2714582|P1|Treated Participants|Non-specified|1
853140|NCT01239797|2714581|P2|Treated Participants|Withdrawal by Subject|23
853141|NCT01239797|2714582|P1|Treated Participants|Withdrawal by Subject|27
853142|NCT01239797|2714581|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
853143|NCT01239797|2714582|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
853144|NCT01239797|2714581|P2|Treated Participants|Study Drug Toxicity|44
853145|NCT01239797|2714582|P1|Treated Participants|Study Drug Toxicity|30
853146|NCT01239797|2714581|P2|Treated Participants|Disease Progression|161
853147|NCT01239797|2714582|P1|Treated Participants|Disease Progression|153
853148|NCT01239992|2714590|P1|Overall Study|Withdrawal by Subject|2
853149|NCT01240135|2714606|P2|Period Two, 14 Days of Wear|Adverse Event|1
853150|NCT01240135|2714607|P1|Period Two, 14 Days of Wear|Adverse Event|0
853151|NCT01240135|2714606|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
853152|NCT01240135|2714607|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
853153|NCT01240200|2714617|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
853154|NCT01240200|2714618|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
853155|NCT01240356|2714632|P2|Overall Study|MRI contraindication|0
853156|NCT01240356|2714633|P1|Overall Study|MRI contraindication|1
853157|NCT01240356|2714632|P2|Overall Study|Withdrawal by Subject|0
853158|NCT01240356|2714633|P1|Overall Study|Withdrawal by Subject|2
853159|NCT01240382|2714646|P2|Overall Study|Fear of adverse events|1
853160|NCT01240382|2714647|P1|Overall Study|Fear of adverse events|0
853161|NCT01240382|2714646|P2|Overall Study|Lack of Efficacy|2
853162|NCT01240382|2714647|P1|Overall Study|Lack of Efficacy|0
853163|NCT01240382|2714646|P2|Overall Study|Adverse Event|1
853164|NCT01240382|2714647|P1|Overall Study|Adverse Event|2
853165|NCT01240551|2714657|P2|Overall Study|Lost to Follow-up|1
853166|NCT01240551|2714658|P1|Overall Study|Lost to Follow-up|1
853167|NCT01240551|2714657|P2|Overall Study|Refused further treatment|2
853168|NCT01240551|2714658|P1|Overall Study|Refused further treatment|3
853169|NCT01240590|2714671|P5|Phase II|Refused further treatment|1
853170|NCT01240590|2714672|P4|Phase II|Refused further treatment|2
853171|NCT01240590|2714673|P3|Phase II|Refused further treatment|0
853172|NCT01240590|2714674|P2|Phase II|Refused further treatment|0
853173|NCT01240590|2714675|P1|Phase II|Refused further treatment|0
853174|NCT01240590|2714671|P5|Phase I|Refused further treatment|0
853175|NCT01240590|2714672|P4|Phase I|Refused further treatment|0
853176|NCT01240590|2714673|P3|Phase I|Refused further treatment|3
853177|NCT01240590|2714674|P2|Phase I|Refused further treatment|0
853178|NCT01240590|2714675|P1|Phase I|Refused further treatment|0
853179|NCT01240746|2714704|P3|Overall Study|Withdrawal by Subject|59
853180|NCT01240746|2714705|P2|Overall Study|Withdrawal by Subject|13
853181|NCT01240746|2714706|P1|Overall Study|Withdrawal by Subject|10
853182|NCT01240746|2714704|P3|Overall Study|Protocol Violation|72
853183|NCT01240746|2714705|P2|Overall Study|Protocol Violation|15
853184|NCT01240746|2714706|P1|Overall Study|Protocol Violation|24
853185|NCT01240746|2714704|P3|Overall Study|Lost to Follow-up|102
853186|NCT01240746|2714705|P2|Overall Study|Lost to Follow-up|20
853187|NCT01240746|2714706|P1|Overall Study|Lost to Follow-up|23
853188|NCT01240746|2714704|P3|Overall Study|Adverse Event|10
853189|NCT01240746|2714705|P2|Overall Study|Adverse Event|0
853190|NCT01240746|2714706|P1|Overall Study|Adverse Event|2
853191|NCT01240785|2714758|P2|Overall Study|Protocol Violation|3
853192|NCT01240785|2714759|P1|Overall Study|Protocol Violation|0
853193|NCT01240785|2714758|P2|Overall Study|Lost to Follow-up|0
853194|NCT01240785|2714759|P1|Overall Study|Lost to Follow-up|1
853195|NCT01240811|2714790|P3|Overall Study|Withdrawal by Subject|1
853196|NCT01240811|2714791|P2|Overall Study|Withdrawal by Subject|0
853197|NCT01240811|2714792|P1|Overall Study|Withdrawal by Subject|0
853198|NCT01240811|2714790|P3|Overall Study|Physician Decision|0
853199|NCT01240811|2714791|P2|Overall Study|Physician Decision|1
853200|NCT01240811|2714792|P1|Overall Study|Physician Decision|0
853201|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
853202|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
853203|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
853204|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
853205|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
853206|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
853207|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
853208|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
853209|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
853210|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
853211|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
853212|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
853213|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
853214|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
853215|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
853216|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
853217|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
853218|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
853219|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
853220|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
853221|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
853222|NCT01240863|2714802|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
853223|NCT01240863|2714803|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
853224|NCT01240863|2714804|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
853225|NCT01240863|2714802|P3|Open-label Titration Period|Not specified|0
853226|NCT01240863|2714803|P2|Open-label Titration Period|Not specified|0
853227|NCT01240863|2714804|P1|Open-label Titration Period|Not specified|7
853228|NCT01240863|2714802|P3|Open-label Titration Period|Dropped out prior to dosing|0
853229|NCT01240863|2714803|P2|Open-label Titration Period|Dropped out prior to dosing|0
853230|NCT01240863|2714804|P1|Open-label Titration Period|Dropped out prior to dosing|2
853231|NCT01240863|2714802|P3|Open-label Titration Period|Noncompliance to study procedures|0
853232|NCT01240863|2714803|P2|Open-label Titration Period|Noncompliance to study procedures|0
853233|NCT01240863|2714804|P1|Open-label Titration Period|Noncompliance to study procedures|3
853234|NCT01240863|2714802|P3|Open-label Titration Period|Noncompliance to study drug admin|0
853235|NCT01240863|2714803|P2|Open-label Titration Period|Noncompliance to study drug admin|0
853236|NCT01240863|2714804|P1|Open-label Titration Period|Noncompliance to study drug admin|3
853237|NCT01240863|2714802|P3|Open-label Titration Period|Protocol Violation|0
853238|NCT01240863|2714803|P2|Open-label Titration Period|Protocol Violation|0
853239|NCT01240863|2714804|P1|Open-label Titration Period|Protocol Violation|7
853240|NCT01240863|2714802|P3|Open-label Titration Period|Withdrawal by Subject|0
853241|NCT01240863|2714803|P2|Open-label Titration Period|Withdrawal by Subject|0
853242|NCT01240863|2714804|P1|Open-label Titration Period|Withdrawal by Subject|9
853243|NCT01240863|2714802|P3|Open-label Titration Period|Lack of Efficacy|0
853244|NCT01240863|2714803|P2|Open-label Titration Period|Lack of Efficacy|0
853245|NCT01240863|2714804|P1|Open-label Titration Period|Lack of Efficacy|19
853246|NCT01240863|2714802|P3|Open-label Titration Period|Adverse Event|0
853247|NCT01240863|2714803|P2|Open-label Titration Period|Adverse Event|0
853248|NCT01240863|2714804|P1|Open-label Titration Period|Adverse Event|47
853249|NCT01240915|2714964|P9|Overall Study|Insufficient Clinical Response|3
853250|NCT01240915|2714965|P8|Overall Study|Insufficient Clinical Response|0
853251|NCT01240915|2714966|P7|Overall Study|Insufficient Clinical Response|6
853252|NCT01240915|2714967|P6|Overall Study|Insufficient Clinical Response|3
853253|NCT01240915|2714968|P5|Overall Study|Insufficient Clinical Response|1
853254|NCT01240915|2714969|P4|Overall Study|Insufficient Clinical Response|0
853255|NCT01240915|2714970|P3|Overall Study|Insufficient Clinical Response|0
853256|NCT01240915|2714971|P2|Overall Study|Insufficient Clinical Response|0
853257|NCT01240915|2714972|P1|Overall Study|Insufficient Clinical Response|0
853258|NCT01240915|2714964|P9|Overall Study|Unspecified|0
853259|NCT01240915|2714965|P8|Overall Study|Unspecified|0
853260|NCT01240915|2714966|P7|Overall Study|Unspecified|0
853261|NCT01240915|2714967|P6|Overall Study|Unspecified|0
853262|NCT01240915|2714968|P5|Overall Study|Unspecified|2
853263|NCT01240915|2714969|P4|Overall Study|Unspecified|0
853264|NCT01240915|2714970|P3|Overall Study|Unspecified|0
853265|NCT01240915|2714971|P2|Overall Study|Unspecified|0
853266|NCT01240915|2714972|P1|Overall Study|Unspecified|0
853267|NCT01240915|2714964|P9|Overall Study|Withdrawal by Subject|3
853268|NCT01240915|2714965|P8|Overall Study|Withdrawal by Subject|3
853269|NCT01240915|2714966|P7|Overall Study|Withdrawal by Subject|2
853270|NCT01240915|2714967|P6|Overall Study|Withdrawal by Subject|4
853271|NCT01240915|2714968|P5|Overall Study|Withdrawal by Subject|0
853272|NCT01240915|2714969|P4|Overall Study|Withdrawal by Subject|2
853273|NCT01240915|2714970|P3|Overall Study|Withdrawal by Subject|0
853274|NCT01240915|2714971|P2|Overall Study|Withdrawal by Subject|1
853275|NCT01240915|2714972|P1|Overall Study|Withdrawal by Subject|2
853276|NCT01240915|2714964|P9|Overall Study|Lost to Follow-up|1
853277|NCT01240915|2714965|P8|Overall Study|Lost to Follow-up|1
853278|NCT01240915|2714966|P7|Overall Study|Lost to Follow-up|0
853279|NCT01240915|2714967|P6|Overall Study|Lost to Follow-up|1
853280|NCT01240915|2714968|P5|Overall Study|Lost to Follow-up|1
853281|NCT01240915|2714969|P4|Overall Study|Lost to Follow-up|0
853282|NCT01240915|2714970|P3|Overall Study|Lost to Follow-up|0
853283|NCT01240915|2714971|P2|Overall Study|Lost to Follow-up|0
853284|NCT01240915|2714972|P1|Overall Study|Lost to Follow-up|0
853285|NCT01240915|2714964|P9|Overall Study|Adverse Event|1
853286|NCT01240915|2714965|P8|Overall Study|Adverse Event|0
853287|NCT01240915|2714966|P7|Overall Study|Adverse Event|0
853288|NCT01240915|2714967|P6|Overall Study|Adverse Event|2
853289|NCT01240915|2714968|P5|Overall Study|Adverse Event|0
853290|NCT01240915|2714969|P4|Overall Study|Adverse Event|1
853291|NCT01240915|2714970|P3|Overall Study|Adverse Event|0
853292|NCT01240915|2714971|P2|Overall Study|Adverse Event|0
853293|NCT01240915|2714972|P1|Overall Study|Adverse Event|0
853294|NCT01241240|2715153|P2|Overall Study|Personal Reasons|1
853295|NCT01241240|2715154|P1|Overall Study|Personal Reasons|1
853296|NCT01241240|2715153|P2|Overall Study|Lost to Follow-up|4
853297|NCT01241240|2715154|P1|Overall Study|Lost to Follow-up|2
853298|NCT01241240|2715153|P2|Overall Study|Adverse Event|4
853299|NCT01241240|2715154|P1|Overall Study|Adverse Event|5
853300|NCT01241279|2715166|P2|Overall Study|Lost to Follow-up|1
853301|NCT01241279|2715167|P1|Overall Study|Lost to Follow-up|0
853302|NCT01241292|2715177|P2|Overall Study|Withdrawal by Subject|2
853303|NCT01241292|2715178|P1|Overall Study|Withdrawal by Subject|0
853304|NCT01241292|2715177|P2|Overall Study|Disease Progression|0
853305|NCT01241292|2715178|P1|Overall Study|Disease Progression|1
853306|NCT01241552|2715231|P4|Overall Study|Lost to Follow-up|16
853307|NCT01241552|2715232|P3|Overall Study|Lost to Follow-up|15
853308|NCT01241552|2715233|P2|Overall Study|Lost to Follow-up|11
853309|NCT01241552|2715234|P1|Overall Study|Lost to Follow-up|2
853310|NCT01241552|2715231|P4|Overall Study|Physician Decision|3
853311|NCT01241552|2715232|P3|Overall Study|Physician Decision|2
853312|NCT01241552|2715233|P2|Overall Study|Physician Decision|4
853313|NCT01241552|2715234|P1|Overall Study|Physician Decision|2
853314|NCT01241552|2715231|P4|Overall Study|Withdrawal by Subject|15
853315|NCT01241552|2715232|P3|Overall Study|Withdrawal by Subject|14
853316|NCT01241552|2715233|P2|Overall Study|Withdrawal by Subject|15
853317|NCT01241552|2715234|P1|Overall Study|Withdrawal by Subject|7
853318|NCT01241552|2715231|P4|Overall Study|Protocol Violation|1
853319|NCT01241552|2715232|P3|Overall Study|Protocol Violation|6
853320|NCT01241552|2715233|P2|Overall Study|Protocol Violation|2
853321|NCT01241552|2715234|P1|Overall Study|Protocol Violation|0
853322|NCT01241552|2715231|P4|Overall Study|Progressive Disease|2
853323|NCT01241552|2715232|P3|Overall Study|Progressive Disease|1
853324|NCT01241552|2715233|P2|Overall Study|Progressive Disease|0
853325|NCT01241552|2715234|P1|Overall Study|Progressive Disease|0
853326|NCT01241552|2715231|P4|Overall Study|Technical Problems|2
853327|NCT01241552|2715232|P3|Overall Study|Technical Problems|2
853328|NCT01241552|2715233|P2|Overall Study|Technical Problems|0
853329|NCT01241552|2715234|P1|Overall Study|Technical Problems|2
853330|NCT01241552|2715231|P4|Overall Study|Adverse Event|0
853331|NCT01241552|2715232|P3|Overall Study|Adverse Event|0
853332|NCT01241552|2715233|P2|Overall Study|Adverse Event|1
853333|NCT01241552|2715234|P1|Overall Study|Adverse Event|1
853334|NCT01241552|2715231|P4|Overall Study|Death|25
853335|NCT01241552|2715232|P3|Overall Study|Death|20
853336|NCT01241552|2715233|P2|Overall Study|Death|30
853337|NCT01241552|2715234|P1|Overall Study|Death|26
853338|NCT01241552|2715231|P4|Overall Study|Lack of Efficacy|0
853339|NCT01241552|2715232|P3|Overall Study|Lack of Efficacy|0
853340|NCT01241552|2715233|P2|Overall Study|Lack of Efficacy|0
853341|NCT01241552|2715234|P1|Overall Study|Lack of Efficacy|1
853342|NCT01241591|2715313|P4|Overall Study|Adverse Event|4
853343|NCT01241591|2715314|P3|Overall Study|Adverse Event|12
853344|NCT01241591|2715315|P2|Overall Study|Adverse Event|11
853345|NCT01241591|2715316|P1|Overall Study|Adverse Event|3
853346|NCT01241591|2715313|P4|Overall Study|Not specified|1
853347|NCT01241591|2715314|P3|Overall Study|Not specified|0
853348|NCT01241591|2715315|P2|Overall Study|Not specified|1
853349|NCT01241591|2715316|P1|Overall Study|Not specified|0
853350|NCT01241591|2715313|P4|Overall Study|Withdrawal by Subject|2
853351|NCT01241591|2715314|P3|Overall Study|Withdrawal by Subject|2
853352|NCT01241591|2715315|P2|Overall Study|Withdrawal by Subject|4
853353|NCT01241591|2715316|P1|Overall Study|Withdrawal by Subject|6
853354|NCT01241591|2715313|P4|Overall Study|Screen Failure|0
853355|NCT01241591|2715314|P3|Overall Study|Screen Failure|1
853356|NCT01241591|2715315|P2|Overall Study|Screen Failure|2
853357|NCT01241591|2715316|P1|Overall Study|Screen Failure|3
853358|NCT01241591|2715313|P4|Overall Study|Lost to Follow-up|2
853359|NCT01241591|2715314|P3|Overall Study|Lost to Follow-up|2
853360|NCT01241591|2715315|P2|Overall Study|Lost to Follow-up|2
853361|NCT01241591|2715316|P1|Overall Study|Lost to Follow-up|1
853362|NCT01241591|2715313|P4|Overall Study|Protocol Violation|0
853363|NCT01241591|2715314|P3|Overall Study|Protocol Violation|3
853364|NCT01241591|2715315|P2|Overall Study|Protocol Violation|2
853365|NCT01241591|2715316|P1|Overall Study|Protocol Violation|5
853366|NCT01241591|2715313|P4|Overall Study|Lack of Efficacy|3
853367|NCT01241591|2715314|P3|Overall Study|Lack of Efficacy|2
853368|NCT01241591|2715315|P2|Overall Study|Lack of Efficacy|2
853369|NCT01241591|2715316|P1|Overall Study|Lack of Efficacy|5
853370|NCT01241760|2715508|P2|Overall Study|Not specified|1
853371|NCT01241760|2715509|P1|Overall Study|Not specified|1
853372|NCT01241760|2715508|P2|Overall Study|Switch To Commercially Available Medicat|4
853373|NCT01241760|2715509|P1|Overall Study|Switch To Commercially Available Medicat|1
853374|NCT01241760|2715508|P2|Overall Study|Withdrawal by Subject|13
853375|NCT01241760|2715509|P1|Overall Study|Withdrawal by Subject|13
853376|NCT01241760|2715508|P2|Overall Study|Lost to Follow-up|22
853377|NCT01241760|2715509|P1|Overall Study|Lost to Follow-up|18
853378|NCT01241760|2715508|P2|Overall Study|Adverse Event|0
853379|NCT01241760|2715509|P1|Overall Study|Adverse Event|1
853380|NCT01242020|2715550|P2|Overall Study|Failed screening|0
853381|NCT01242020|2715551|P1|Overall Study|Failed screening|1
853382|NCT01242020|2715550|P2|Overall Study|Withdrawal by Subject|0
853383|NCT01242020|2715551|P1|Overall Study|Withdrawal by Subject|2
853384|NCT01236118|2715753|P3|Overall Study|Withdrawal by Subject|1
853385|NCT01236118|2715754|P2|Overall Study|Withdrawal by Subject|0
853386|NCT01236118|2715755|P1|Overall Study|Withdrawal by Subject|0
853387|NCT01236118|2715753|P3|Overall Study|Physician Decision|0
853388|NCT01236118|2715754|P2|Overall Study|Physician Decision|1
853389|NCT01236118|2715755|P1|Overall Study|Physician Decision|0
853390|NCT01236118|2715753|P3|Overall Study|Adverse Event|2
853391|NCT01236118|2715754|P2|Overall Study|Adverse Event|0
853392|NCT01236118|2715755|P1|Overall Study|Adverse Event|2
853393|NCT01242085|2715788|P3|Overall Study|medically unable to have surgery|0
853394|NCT01242085|2715789|P2|Overall Study|medically unable to have surgery|5
853395|NCT01242085|2715790|P1|Overall Study|medically unable to have surgery|4
853396|NCT01242085|2715788|P3|Overall Study|Withdrawal by Subject|0
853397|NCT01242085|2715789|P2|Overall Study|Withdrawal by Subject|2
853398|NCT01242085|2715790|P1|Overall Study|Withdrawal by Subject|4
853399|NCT01242111|2715798|P1|Overall Study|Did not consent to MOR-100 follow-up|1
853400|NCT01242111|2715798|P1|Overall Study|Withdrawal by Subject|1
853401|NCT01242111|2715798|P1|Overall Study|Adverse Event|1
853402|NCT01242176|2715807|P2|Washout Period of 7 Days|Non-compliant with protocol|0
853403|NCT01242176|2715808|P1|Washout Period of 7 Days|Non-compliant with protocol|1
853404|NCT01242176|2715807|P2|Washout Period of 7 Days|Adverse Event|2
853405|NCT01242176|2715808|P1|Washout Period of 7 Days|Adverse Event|0
853406|NCT01242371|2715820|P2|Overall Study|Protocol Violation|3
853407|NCT01242371|2715821|P1|Overall Study|Protocol Violation|0
853408|NCT01242371|2715820|P2|Overall Study|Withdrawal by Subject|2
853409|NCT01242371|2715821|P1|Overall Study|Withdrawal by Subject|2
853410|NCT01243892|2715829|P2|Overall Study|Did not meet eligibility criteria|0
853411|NCT01243892|2715830|P1|Overall Study|Did not meet eligibility criteria|2
853412|NCT01243944|2715842|P2|Overall Study|Physician Decision|2
853413|NCT01243944|2715843|P1|Overall Study|Physician Decision|2
853414|NCT01243944|2715842|P2|Overall Study|Patient decision|5
853415|NCT01243944|2715843|P1|Overall Study|Patient decision|6
853416|NCT01243944|2715842|P2|Overall Study|Disease progression|1
853417|NCT01243944|2715843|P1|Overall Study|Disease progression|5
853418|NCT01243944|2715842|P2|Overall Study|Lack of Efficacy|98
853419|NCT01243944|2715843|P1|Overall Study|Lack of Efficacy|0
853420|NCT01243944|2715842|P2|Overall Study|Adverse Event|2
853421|NCT01243944|2715843|P1|Overall Study|Adverse Event|4
853422|NCT01244061|2715867|P2|Overall Study|Randomized but not treated|2
853423|NCT01244061|2715868|P1|Overall Study|Randomized but not treated|2
853424|NCT01244061|2715867|P2|Overall Study|Adverse Event|2
853425|NCT01244061|2715868|P1|Overall Study|Adverse Event|5
853426|NCT01244061|2715867|P2|Overall Study|Protocol Violation|1
853427|NCT01244061|2715868|P1|Overall Study|Protocol Violation|1
853428|NCT01244061|2715867|P2|Overall Study|Not specified|19
853429|NCT01244061|2715868|P1|Overall Study|Not specified|8
853430|NCT01244061|2715867|P2|Overall Study|Withdrawal by Subject|46
853431|NCT01244061|2715868|P1|Overall Study|Withdrawal by Subject|29
853432|NCT01244061|2715867|P2|Overall Study|Lost to Follow-up|30
853433|NCT01244061|2715868|P1|Overall Study|Lost to Follow-up|34
853434|NCT01244061|2715867|P2|Overall Study|Lack of Efficacy|3
853435|NCT01244061|2715868|P1|Overall Study|Lack of Efficacy|1
853436|NCT01244061|2715867|P2|Overall Study|Did not meet entrance criteria|0
853437|NCT01244061|2715868|P1|Overall Study|Did not meet entrance criteria|1
853438|NCT01244061|2715867|P2|Overall Study|Death|0
853439|NCT01244061|2715868|P1|Overall Study|Death|1
853440|NCT01244126|2715883|P3|Overall Study|Protocol Violation|9
853441|NCT01244126|2715884|P2|Overall Study|Protocol Violation|3
853442|NCT01244126|2715885|P1|Overall Study|Protocol Violation|3
853443|NCT01244425|2715907|P2|Overall Study|Adverse Event|1
853444|NCT01244425|2715908|P1|Overall Study|Adverse Event|1
853445|NCT01244425|2715907|P2|Overall Study|Withdrawal by Subject|2
853446|NCT01244425|2715908|P1|Overall Study|Withdrawal by Subject|2
853447|NCT01244490|2715944|P3|Overall Study|Not specified|1
853448|NCT01244490|2715945|P2|Overall Study|Not specified|0
853449|NCT01244490|2715946|P1|Overall Study|Not specified|0
853450|NCT01244490|2715944|P3|Overall Study|Lost to Follow-up|3
853451|NCT01244490|2715945|P2|Overall Study|Lost to Follow-up|6
853452|NCT01244490|2715946|P1|Overall Study|Lost to Follow-up|0
853453|NCT01244490|2715944|P3|Overall Study|Adverse Event|5
853454|NCT01244490|2715945|P2|Overall Study|Adverse Event|9
853455|NCT01244490|2715946|P1|Overall Study|Adverse Event|1
853456|NCT01244490|2715944|P3|Overall Study|Withdrawal by Subject|9
853457|NCT01244490|2715945|P2|Overall Study|Withdrawal by Subject|4
853458|NCT01244490|2715946|P1|Overall Study|Withdrawal by Subject|4
853459|NCT01244490|2715944|P3|Overall Study|Lack of Efficacy|5
853460|NCT01244490|2715945|P2|Overall Study|Lack of Efficacy|5
853461|NCT01244490|2715946|P1|Overall Study|Lack of Efficacy|14
853462|NCT01244516|2716007|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
853463|NCT01244516|2716008|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
853464|NCT01244516|2716009|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
853465|NCT01244516|2716007|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
853466|NCT01244516|2716008|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
853467|NCT01244516|2716009|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
853468|NCT01244516|2716007|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
853469|NCT01244516|2716008|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
853470|NCT01244516|2716009|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
853471|NCT01244516|2716007|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
853472|NCT01244516|2716008|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
853473|NCT01244516|2716009|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
853474|NCT01244516|2716007|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
853475|NCT01244516|2716008|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
853476|NCT01244516|2716009|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
853477|NCT01244516|2716007|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
853478|NCT01244516|2716008|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
853479|NCT01244516|2716009|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
853480|NCT01244516|2716007|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
853481|NCT01244516|2716008|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
853482|NCT01244516|2716009|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
853483|NCT01244620|2716044|P4|Overall Study|Study terminated|4
853484|NCT01244620|2716045|P3|Overall Study|Study terminated|4
853485|NCT01244620|2716046|P2|Overall Study|Study terminated|4
853486|NCT01244620|2716047|P1|Overall Study|Study terminated|4
853487|NCT01244815|2716097|P4|Overall Study|Did Not Meet Protocol Eligibility|0
853488|NCT01244815|2716098|P3|Overall Study|Did Not Meet Protocol Eligibility|0
853489|NCT01244815|2716099|P2|Overall Study|Did Not Meet Protocol Eligibility|1
853490|NCT01244815|2716100|P1|Overall Study|Did Not Meet Protocol Eligibility|0
853491|NCT01244815|2716097|P4|Overall Study|Protocol Violation|1
853492|NCT01244815|2716098|P3|Overall Study|Protocol Violation|3
853493|NCT01244815|2716099|P2|Overall Study|Protocol Violation|4
853494|NCT01244815|2716100|P1|Overall Study|Protocol Violation|7
853495|NCT01244815|2716097|P4|Overall Study|Withdrawal by Subject|3
853496|NCT01244815|2716098|P3|Overall Study|Withdrawal by Subject|0
853497|NCT01244815|2716099|P2|Overall Study|Withdrawal by Subject|2
853498|NCT01244815|2716100|P1|Overall Study|Withdrawal by Subject|0
853499|NCT01244815|2716097|P4|Overall Study|Lost to Follow-up|2
853500|NCT01244815|2716098|P3|Overall Study|Lost to Follow-up|3
853501|NCT01244815|2716099|P2|Overall Study|Lost to Follow-up|2
853502|NCT01244815|2716100|P1|Overall Study|Lost to Follow-up|3
853503|NCT01244815|2716097|P4|Overall Study|Treatment Failure|1
853504|NCT01244815|2716098|P3|Overall Study|Treatment Failure|0
853505|NCT01244815|2716099|P2|Overall Study|Treatment Failure|0
853506|NCT01244815|2716100|P1|Overall Study|Treatment Failure|0
853507|NCT01244815|2716097|P4|Overall Study|Adverse Event|5
853508|NCT01244815|2716098|P3|Overall Study|Adverse Event|5
853509|NCT01244815|2716099|P2|Overall Study|Adverse Event|7
853510|NCT01244815|2716100|P1|Overall Study|Adverse Event|4
853511|NCT01244815|2716097|P4|Overall Study|Not Treated|0
853512|NCT01244815|2716098|P3|Overall Study|Not Treated|0
853513|NCT01244815|2716099|P2|Overall Study|Not Treated|1
853514|NCT01244815|2716100|P1|Overall Study|Not Treated|0
853515|NCT01244828|2716174|P1|Overall Study|Other reason (not specified)|1
853516|NCT01244828|2716174|P1|Overall Study|Lost to Follow-up|2
853517|NCT01244828|2716174|P1|Overall Study|Lack of Efficacy|7
853518|NCT01244828|2716174|P1|Overall Study|Withdrawal by Subject|31
853519|NCT01244828|2716174|P1|Overall Study|Adverse Event|37
853520|NCT01244893|2716186|P2|1-Week Follow Up|Lost to Follow-up|0
853521|NCT01244893|2716187|P1|1-Week Follow Up|Lost to Follow-up|1
853522|NCT01244893|2716186|P2|Baseline|Protocol Violation|1
853523|NCT01244893|2716187|P1|Baseline|Protocol Violation|0
853524|NCT01244906|2716199|P1|Overall Study|Progression of disease post treatment|6
853525|NCT01244906|2716199|P1|Overall Study|Death|2
853526|NCT01244984|2716211|P3|Overall Study|Withdrawal by Subject|2
853527|NCT01244984|2716212|P2|Overall Study|Withdrawal by Subject|2
853528|NCT01244984|2716213|P1|Overall Study|Withdrawal by Subject|1
853529|NCT01244984|2716211|P3|Overall Study|Protocol Defined Stopping Criteria|0
853530|NCT01244984|2716212|P2|Overall Study|Protocol Defined Stopping Criteria|1
853531|NCT01244984|2716213|P1|Overall Study|Protocol Defined Stopping Criteria|1
853532|NCT01244984|2716211|P3|Overall Study|Protocol Violation|0
853533|NCT01244984|2716212|P2|Overall Study|Protocol Violation|0
853534|NCT01244984|2716213|P1|Overall Study|Protocol Violation|1
853535|NCT01244984|2716211|P3|Overall Study|Adverse Event|2
853536|NCT01244984|2716212|P2|Overall Study|Adverse Event|11
853537|NCT01244984|2716213|P1|Overall Study|Adverse Event|2
853538|NCT01245049|2716289|P2|Overall Study|Lost to Follow-up|2
853539|NCT01245049|2716290|P1|Overall Study|Lost to Follow-up|1
853540|NCT01245049|2716289|P2|Overall Study|Withdrawal by Subject|1
853541|NCT01245049|2716290|P1|Overall Study|Withdrawal by Subject|0
853542|NCT01245049|2716289|P2|Overall Study|Migrated/moved from study area|1
853543|NCT01245049|2716290|P1|Overall Study|Migrated/moved from study area|0
894521|NCT00621777|2839315|P2|Open Phase|Lost to Follow-up|0
894522|NCT00621777|2839316|P1|Open Phase|Lost to Follow-up|10
894523|NCT00621777|2839315|P2|Open Phase|administrative|0
894524|NCT00621777|2839316|P1|Open Phase|administrative|13
894525|NCT00621777|2839315|P2|Open Phase|Withdrawal by Subject|0
894526|NCT00621777|2839316|P1|Open Phase|Withdrawal by Subject|17
894527|NCT00621777|2839315|P2|Open Phase|Did not abstain during open phase|0
894528|NCT00621777|2839316|P1|Open Phase|Did not abstain during open phase|56
894529|NCT00621777|2839315|P2|Open Phase|Adverse Event|0
894530|NCT00621777|2839316|P1|Open Phase|Adverse Event|20
894531|NCT00590980|2839327|P1|Overall Study|Did not meet all inclusion criteria|10
894532|NCT00270855|2839333|P2|Overall Study|Withdrawal by Subject|8
894533|NCT00270855|2839334|P1|Overall Study|Withdrawal by Subject|8
894534|NCT00089609|2839392|P2|Overall Study|Withdrawal by Subject|1
894535|NCT00089609|2839393|P1|Overall Study|Withdrawal by Subject|3
894536|NCT00025155|2839410|P1|Overall Study|Ineligible: Second primary cancer site|1
894537|NCT00025155|2839410|P1|Overall Study|Ineligible: Wrong primary cancer site|1
853568|NCT01245101|2716378|P2|Period 3 (Treatment)|Withdrawal by Subject|0
853569|NCT01245101|2716379|P1|Period 3 (Treatment)|Withdrawal by Subject|1
853570|NCT01245101|2716378|P2|Period 2 (Washout)|Withdrawal by Subject|0
853571|NCT01245101|2716379|P1|Period 2 (Washout)|Withdrawal by Subject|1
853572|NCT01245101|2716378|P2|Period 1 (Treatment)|Withdrawal by Subject|0
853573|NCT01245101|2716379|P1|Period 1 (Treatment)|Withdrawal by Subject|2
853574|NCT01245140|2716389|P2|Overall Study|Refused Treatment/Did Not Coopera|1
853575|NCT01245140|2716390|P1|Overall Study|Refused Treatment/Did Not Coopera|0
853576|NCT01245140|2716389|P2|Overall Study|Withdrawal by Subject|1
853577|NCT01245140|2716390|P1|Overall Study|Withdrawal by Subject|0
853578|NCT01245140|2716389|P2|Overall Study|Protocol Violation|1
853579|NCT01245140|2716390|P1|Overall Study|Protocol Violation|0
853580|NCT01245140|2716389|P2|Overall Study|Lack of Efficacy|4
853581|NCT01245140|2716390|P1|Overall Study|Lack of Efficacy|2
853582|NCT01245140|2716389|P2|Overall Study|Adverse Event|3
853583|NCT01245140|2716390|P1|Overall Study|Adverse Event|1
853584|NCT01245283|2716458|P3|Overall Study|Lost to Follow-up|11
853585|NCT01245283|2716459|P2|Overall Study|Lost to Follow-up|11
853586|NCT01245283|2716460|P1|Overall Study|Lost to Follow-up|14
853587|NCT01245374|2716492|P1|Overall Study|Withdrawal by Subject|3
853588|NCT01245374|2716492|P1|Overall Study|Protocol Violation|1
853589|NCT01245387|2716512|P1|Overall Study|Missing discontinuation status|369
853590|NCT01245387|2716512|P1|Overall Study|Unspecified|131
853591|NCT01245387|2716512|P1|Overall Study|Death|3
853592|NCT01245387|2716512|P1|Overall Study|Adverse Event|9
853593|NCT01245387|2716512|P1|Overall Study|Lack of Efficacy|195
853594|NCT01245387|2716512|P1|Overall Study|Lost to Follow-up|106
853595|NCT01245751|2716646|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
853596|NCT01245751|2716647|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
853597|NCT01245751|2716648|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
853598|NCT01245751|2716649|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
853599|NCT01245751|2716646|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
853600|NCT01245751|2716647|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
853601|NCT01245751|2716648|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
853602|NCT01245751|2716649|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
853603|NCT01245751|2716646|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
853604|NCT01245751|2716647|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
853605|NCT01245751|2716648|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
853606|NCT01245751|2716649|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
853607|NCT01245764|2716666|P4|Study Phase A|Lost to Follow-up|0
853608|NCT01245764|2716667|P3|Study Phase A|Lost to Follow-up|5
853609|NCT01245764|2716668|P2|Study Phase A|Lost to Follow-up|0
853610|NCT01245764|2716669|P1|Study Phase A|Lost to Follow-up|0
853611|NCT01245764|2716666|P4|Study Phase A|Protocol Violation|2
853612|NCT01245764|2716667|P3|Study Phase A|Protocol Violation|2
853613|NCT01245764|2716668|P2|Study Phase A|Protocol Violation|3
853614|NCT01245764|2716669|P1|Study Phase A|Protocol Violation|6
853615|NCT01245764|2716666|P4|Study Phase A|Other|1
853616|NCT01245764|2716667|P3|Study Phase A|Other|3
853617|NCT01245764|2716668|P2|Study Phase A|Other|2
853618|NCT01245764|2716669|P1|Study Phase A|Other|3
853625|NCT01246206|2716725|P1|Overall Study|Patient did not receive study regiments.|1
853626|NCT01239043|2716758|P2|Overall Study|Protocol Violation|1
853627|NCT01239043|2716759|P1|Overall Study|Protocol Violation|2
853628|NCT01239121|2716786|P3|Overall Study|Withdrawal by Subject|0
853629|NCT01239121|2716787|P2|Overall Study|Withdrawal by Subject|4
853630|NCT01239121|2716788|P1|Overall Study|Withdrawal by Subject|2
853631|NCT01239316|2716806|P1|Overall Study|Adverse Event|1
853632|NCT01239316|2716806|P1|Overall Study|Progression/Relapse|11
853633|NCT01239342|2716816|P2|Overall Study|Reason Unknown|1
853634|NCT01239342|2716817|P1|Overall Study|Reason Unknown|1
853635|NCT01239342|2716816|P2|Overall Study|Withdrawal by Subject|5
853636|NCT01239342|2716817|P1|Overall Study|Withdrawal by Subject|1
853637|NCT01239342|2716816|P2|Overall Study|Adverse Event|0
853638|NCT01239342|2716817|P1|Overall Study|Adverse Event|1
894538|NCT02815397|2839426|P1|Overall Study|Physician Decision|2
894539|NCT02792062|2839439|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
894540|NCT02792062|2839440|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
894541|NCT02792062|2839441|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
894542|NCT02792062|2839442|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
894543|NCT02792062|2839443|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
894544|NCT02792062|2839444|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
853664|NCT01247922|2717062|P1|Overall Study|Disease progression|4
853665|NCT01248013|2717079|P1|Overall Study|Withdrawal by Subject|14
853666|NCT01248065|2717085|P2|Overall Study|Other|5
853667|NCT01248065|2717086|P1|Overall Study|Other|3
853668|NCT01248065|2717085|P2|Overall Study|Third treatment failure event|1
853669|NCT01248065|2717086|P1|Overall Study|Third treatment failure event|3
853670|NCT01248065|2717085|P2|Overall Study|Adverse Event|0
853671|NCT01248065|2717086|P1|Overall Study|Adverse Event|3
853672|NCT01248065|2717085|P2|Overall Study|Withdrawal by Subject|11
853673|NCT01248065|2717086|P1|Overall Study|Withdrawal by Subject|14
853674|NCT01248065|2717085|P2|Overall Study|Lost to Follow-up|5
853675|NCT01248065|2717086|P1|Overall Study|Lost to Follow-up|3
853680|NCT01248364|2717124|P4|Overall Study|Adverse Event|0
853681|NCT01248364|2717125|P3|Overall Study|Adverse Event|0
853682|NCT01248364|2717126|P2|Overall Study|Adverse Event|1
853683|NCT01248364|2717127|P1|Overall Study|Adverse Event|0
853684|NCT01248455|2717173|P1|Overall Study|switched to alternate treatment|1
853685|NCT01248468|2717181|P3|Overall Study|Withdrawal by Subject|0
853686|NCT01248468|2717182|P2|Overall Study|Withdrawal by Subject|2
853687|NCT01248468|2717183|P1|Overall Study|Withdrawal by Subject|4
853688|NCT01248468|2717181|P3|Overall Study|Pregnancy|0
853689|NCT01248468|2717182|P2|Overall Study|Pregnancy|0
853690|NCT01248468|2717183|P1|Overall Study|Pregnancy|1
853691|NCT01248468|2717181|P3|Overall Study|Lost to Follow-up|4
853692|NCT01248468|2717182|P2|Overall Study|Lost to Follow-up|12
853693|NCT01248468|2717183|P1|Overall Study|Lost to Follow-up|9
853694|NCT01248468|2717181|P3|Overall Study|Administrative problem|0
853695|NCT01248468|2717182|P2|Overall Study|Administrative problem|0
853696|NCT01248468|2717183|P1|Overall Study|Administrative problem|1
853699|NCT01248728|2717223|P2|Overall Study|Lack of Efficacy|0
853700|NCT01248728|2717224|P1|Overall Study|Lack of Efficacy|1
853701|NCT01248728|2717223|P2|Overall Study|Withdrawal by Subject|1
853702|NCT01248728|2717224|P1|Overall Study|Withdrawal by Subject|2
853703|NCT01248728|2717223|P2|Overall Study|Adverse Event|1
853704|NCT01248728|2717224|P1|Overall Study|Adverse Event|1
853705|NCT01248780|2717240|P2|Overall Study|Not treated|1
853706|NCT01248780|2717241|P1|Overall Study|Not treated|0
853707|NCT01248780|2717240|P2|Overall Study|Withdrawal by Subject|4
853708|NCT01248780|2717241|P1|Overall Study|Withdrawal by Subject|4
853709|NCT01248780|2717240|P2|Overall Study|Protocol Violation|1
853710|NCT01248780|2717241|P1|Overall Study|Protocol Violation|1
853711|NCT01248780|2717240|P2|Overall Study|Adverse Event|7
853712|NCT01248780|2717241|P1|Overall Study|Adverse Event|2
853713|NCT01248780|2717240|P2|Overall Study|Death|1
853714|NCT01248780|2717241|P1|Overall Study|Death|0
853715|NCT01248780|2717240|P2|Overall Study|Lost to Follow-up|1
853716|NCT01248780|2717241|P1|Overall Study|Lost to Follow-up|0
853717|NCT01248780|2717240|P2|Overall Study|Lack of Efficacy|0
853718|NCT01248780|2717241|P1|Overall Study|Lack of Efficacy|2
853719|NCT01248793|2717255|P2|Overall Study|Withdrawal by Subject|3
853720|NCT01248793|2717256|P1|Overall Study|Withdrawal by Subject|3
853721|NCT01248793|2717255|P2|Overall Study|Protocol Violation|1
853722|NCT01248793|2717256|P1|Overall Study|Protocol Violation|0
853723|NCT01248793|2717255|P2|Overall Study|Adverse Event|1
853724|NCT01248793|2717256|P1|Overall Study|Adverse Event|1
853725|NCT01248793|2717255|P2|Overall Study|Lost to Follow-up|1
853726|NCT01248793|2717256|P1|Overall Study|Lost to Follow-up|0
853727|NCT01248884|2717271|P3|Overall Study|Adverse Event|0
853728|NCT01248884|2717272|P2|Overall Study|Adverse Event|0
853729|NCT01248884|2717273|P1|Overall Study|Adverse Event|1
853730|NCT01248884|2717271|P3|Overall Study|Withdrawal by Subject|1
853731|NCT01248884|2717272|P2|Overall Study|Withdrawal by Subject|3
853732|NCT01248884|2717273|P1|Overall Study|Withdrawal by Subject|1
853733|NCT01248936|2717323|P1|Overall Study|Other reason|3
853734|NCT01248936|2717323|P1|Overall Study|Refused Treatment|1
853735|NCT01248936|2717323|P1|Overall Study|Lost to Follow-up|7
853736|NCT01248936|2717323|P1|Overall Study|Adverse Event|8
853737|NCT01248936|2717323|P1|Overall Study|Withdrawal of Consent|20
853738|NCT01248936|2717323|P1|Overall Study|Death|26
853739|NCT01248936|2717323|P1|Overall Study|Progression of Disease|50
853740|NCT01248936|2717323|P1|Overall Study|Sponsor Decision|259
853741|NCT01248949|2717338|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
853742|NCT01248949|2717339|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
853743|NCT01248949|2717340|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
853744|NCT01248949|2717341|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
853745|NCT01248949|2717342|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
853746|NCT01248949|2717338|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
853747|NCT01248949|2717339|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
853748|NCT01248949|2717340|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
853749|NCT01248949|2717341|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
853750|NCT01248949|2717342|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
853751|NCT01248949|2717338|P5|Overall Study|Pi Decision Due To Declining Status|0
853752|NCT01248949|2717339|P4|Overall Study|Pi Decision Due To Declining Status|0
853753|NCT01248949|2717340|P3|Overall Study|Pi Decision Due To Declining Status|1
853754|NCT01248949|2717341|P2|Overall Study|Pi Decision Due To Declining Status|0
853755|NCT01248949|2717342|P1|Overall Study|Pi Decision Due To Declining Status|0
853756|NCT01248949|2717338|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
853757|NCT01248949|2717339|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
853758|NCT01248949|2717340|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
853759|NCT01248949|2717341|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
853760|NCT01248949|2717342|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
853761|NCT01248949|2717338|P5|Overall Study|Participant Went To Hospice|0
853762|NCT01248949|2717339|P4|Overall Study|Participant Went To Hospice|0
853763|NCT01248949|2717340|P3|Overall Study|Participant Went To Hospice|1
853764|NCT01248949|2717341|P2|Overall Study|Participant Went To Hospice|0
853765|NCT01248949|2717342|P1|Overall Study|Participant Went To Hospice|0
853766|NCT01248949|2717338|P5|Overall Study|Entered Hospice And Refused Follow Up|1
853767|NCT01248949|2717339|P4|Overall Study|Entered Hospice And Refused Follow Up|0
853768|NCT01248949|2717340|P3|Overall Study|Entered Hospice And Refused Follow Up|0
853769|NCT01248949|2717341|P2|Overall Study|Entered Hospice And Refused Follow Up|0
853770|NCT01248949|2717342|P1|Overall Study|Entered Hospice And Refused Follow Up|0
853771|NCT01248949|2717338|P5|Overall Study|Palliative Radiation To Brain Metastases|0
853772|NCT01248949|2717339|P4|Overall Study|Palliative Radiation To Brain Metastases|0
853773|NCT01248949|2717340|P3|Overall Study|Palliative Radiation To Brain Metastases|0
853774|NCT01248949|2717341|P2|Overall Study|Palliative Radiation To Brain Metastases|0
853775|NCT01248949|2717342|P1|Overall Study|Palliative Radiation To Brain Metastases|1
853776|NCT01248949|2717338|P5|Overall Study|Alternative Therapy.|0
853777|NCT01248949|2717339|P4|Overall Study|Alternative Therapy.|0
853778|NCT01248949|2717340|P3|Overall Study|Alternative Therapy.|0
853779|NCT01248949|2717341|P2|Overall Study|Alternative Therapy.|0
853780|NCT01248949|2717342|P1|Overall Study|Alternative Therapy.|1
853781|NCT01248949|2717338|P5|Overall Study|Alternative Therapy|0
853782|NCT01248949|2717339|P4|Overall Study|Alternative Therapy|0
853783|NCT01248949|2717340|P3|Overall Study|Alternative Therapy|0
853784|NCT01248949|2717341|P2|Overall Study|Alternative Therapy|0
853785|NCT01248949|2717342|P1|Overall Study|Alternative Therapy|1
853786|NCT01248949|2717338|P5|Overall Study|Death|2
853787|NCT01248949|2717339|P4|Overall Study|Death|6
853788|NCT01248949|2717340|P3|Overall Study|Death|21
853789|NCT01248949|2717341|P2|Overall Study|Death|7
853790|NCT01248949|2717342|P1|Overall Study|Death|22
853791|NCT01248949|2717338|P5|Overall Study|Withdrawal by Subject|1
853792|NCT01248949|2717339|P4|Overall Study|Withdrawal by Subject|3
853793|NCT01248949|2717340|P3|Overall Study|Withdrawal by Subject|11
853794|NCT01248949|2717341|P2|Overall Study|Withdrawal by Subject|3
853795|NCT01248949|2717342|P1|Overall Study|Withdrawal by Subject|5
853796|NCT01248949|2717338|P5|Overall Study|Lost to Follow-up|0
853797|NCT01248949|2717339|P4|Overall Study|Lost to Follow-up|1
853798|NCT01248949|2717340|P3|Overall Study|Lost to Follow-up|2
853799|NCT01248949|2717341|P2|Overall Study|Lost to Follow-up|2
853800|NCT01248949|2717342|P1|Overall Study|Lost to Follow-up|2
853801|NCT01249092|2717454|P1|Overall Study|Unable to tolerate expected SE -nausea|1
853802|NCT01249092|2717454|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
853803|NCT01249118|2717460|P3|First Washout Period|Physician Decision|0
853804|NCT01249118|2717461|P2|First Washout Period|Physician Decision|1
853805|NCT01249118|2717462|P1|First Washout Period|Physician Decision|0
853806|NCT01249131|2717496|P6|Washout Period of 10 Days|Adverse Event|0
853807|NCT01249131|2717497|P5|Washout Period of 10 Days|Adverse Event|1
853808|NCT01249131|2717498|P4|Washout Period of 10 Days|Adverse Event|0
853809|NCT01249131|2717499|P3|Washout Period of 10 Days|Adverse Event|0
853810|NCT01249131|2717500|P2|Washout Period of 10 Days|Adverse Event|0
853811|NCT01249131|2717501|P1|Washout Period of 10 Days|Adverse Event|0
853812|NCT01249157|2717521|P1|Overall Study|Withdrawal by Subject|1
853813|NCT01249261|2717527|P2|Overall Study|Withdrawal by Subject|0
853814|NCT01249261|2717528|P1|Overall Study|Withdrawal by Subject|1
853815|NCT01249274|2717558|P2|Overall Study|Received inpatient substance treatment|2
853816|NCT01249274|2717559|P1|Overall Study|Received inpatient substance treatment|1
853817|NCT01249274|2717558|P2|Overall Study|Lost to Follow-up|4
853818|NCT01249274|2717559|P1|Overall Study|Lost to Follow-up|3
853819|NCT01249417|2717586|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
853820|NCT01249417|2717587|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
853821|NCT01249417|2717588|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
853822|NCT01249417|2717586|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
853823|NCT01249417|2717587|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
853824|NCT01249417|2717588|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
853825|NCT01249417|2717586|P3|Treatment Phase - ITT Population|Adverse Event|1
853826|NCT01249417|2717587|P2|Treatment Phase - ITT Population|Adverse Event|0
853827|NCT01249417|2717588|P1|Treatment Phase - ITT Population|Adverse Event|0
853828|NCT01249417|2717586|P3|Treatment Phase - ITT Population|Not specified|1
853829|NCT01249417|2717587|P2|Treatment Phase - ITT Population|Not specified|0
853830|NCT01249417|2717588|P1|Treatment Phase - ITT Population|Not specified|0
853831|NCT01249417|2717586|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
853832|NCT01249417|2717587|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
853833|NCT01249417|2717588|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
853834|NCT01249417|2717586|P3|Randomised Population|Study treatment not received|2
853835|NCT01249417|2717587|P2|Randomised Population|Study treatment not received|0
853836|NCT01249417|2717588|P1|Randomised Population|Study treatment not received|0
853837|NCT01249651|2717602|P1|Overall Study|Sponsor Decision|1
853838|NCT01249651|2717602|P1|Overall Study|Protocol Violation|1
853839|NCT01249651|2717602|P1|Overall Study|Adverse Event|1
853840|NCT01249651|2717602|P1|Overall Study|Withdrawal by Subject|4
853841|NCT01242514|2717612|P3|Overall Study|Adverse Event|19
853842|NCT01242514|2717613|P2|Overall Study|Adverse Event|18
853843|NCT01242514|2717614|P1|Overall Study|Adverse Event|129
853844|NCT01242514|2717612|P3|Overall Study|Lost to Follow-up|4
853845|NCT01242514|2717613|P2|Overall Study|Lost to Follow-up|5
853846|NCT01242514|2717614|P1|Overall Study|Lost to Follow-up|14
853847|NCT01242514|2717612|P3|Overall Study|Dev. of study specific discont. criteria|5
853848|NCT01242514|2717613|P2|Overall Study|Dev. of study specific discont. criteria|3
853849|NCT01242514|2717614|P1|Overall Study|Dev. of study specific discont. criteria|21
853850|NCT01242514|2717612|P3|Overall Study|Lack of therapeutic response|10
853851|NCT01242514|2717613|P2|Overall Study|Lack of therapeutic response|16
853852|NCT01242514|2717614|P1|Overall Study|Lack of therapeutic response|99
853853|NCT01242514|2717612|P3|Overall Study|Severe non-compliance to protocol|1
853854|NCT01242514|2717613|P2|Overall Study|Severe non-compliance to protocol|2
853855|NCT01242514|2717614|P1|Overall Study|Severe non-compliance to protocol|5
853856|NCT01242514|2717612|P3|Overall Study|Subject decision|2
853857|NCT01242514|2717613|P2|Overall Study|Subject decision|8
853858|NCT01242514|2717614|P1|Overall Study|Subject decision|33
853859|NCT01242514|2717612|P3|Overall Study|e.g., project closure|171
853860|NCT01242514|2717613|P2|Overall Study|e.g., project closure|305
853861|NCT01242514|2717614|P1|Overall Study|e.g., project closure|1042
853862|NCT01242748|2717650|P2|Overall Study|Miscellaneous reasons|3
853863|NCT01242748|2717651|P1|Overall Study|Miscellaneous reasons|8
853864|NCT01242748|2717650|P2|Overall Study|Withdrawal by Subject|2
853865|NCT01242748|2717651|P1|Overall Study|Withdrawal by Subject|10
853866|NCT01242748|2717650|P2|Overall Study|Protocol Violation|0
853867|NCT01242748|2717651|P1|Overall Study|Protocol Violation|1
853868|NCT01242748|2717650|P2|Overall Study|Physician Decision|2
853869|NCT01242748|2717651|P1|Overall Study|Physician Decision|3
853870|NCT01242748|2717650|P2|Overall Study|Lost to Follow-up|2
853871|NCT01242748|2717651|P1|Overall Study|Lost to Follow-up|6
853872|NCT01242748|2717650|P2|Overall Study|Adverse Event|5
853873|NCT01242748|2717651|P1|Overall Study|Adverse Event|10
853874|NCT01242813|2717671|P1|Overall Study|Lost to Follow-up|2
853895|NCT01243242|2717717|P2|Overall Study|non compliance|0
853896|NCT01243242|2717718|P1|Overall Study|non compliance|1
853897|NCT01243242|2717717|P2|Overall Study|sponsor decision|1
853898|NCT01243242|2717718|P1|Overall Study|sponsor decision|0
853899|NCT01243242|2717717|P2|Overall Study|Physician Decision|1
853900|NCT01243242|2717718|P1|Overall Study|Physician Decision|0
853901|NCT01243242|2717717|P2|Overall Study|Withdrawal by Subject|1
853902|NCT01243242|2717718|P1|Overall Study|Withdrawal by Subject|1
853903|NCT01243242|2717717|P2|Overall Study|Adverse Event|1
853904|NCT01243242|2717718|P1|Overall Study|Adverse Event|1
853905|NCT01243411|2717823|P1|Overall Study|Other|8
853906|NCT01243411|2717823|P1|Overall Study|Adverse Event|5
853907|NCT01243411|2717823|P1|Overall Study|Lost to Follow-up|10
853908|NCT01243411|2717823|P1|Overall Study|Withdrawal by Subject|18
853909|NCT01243671|2717869|P1|Overall Study|Not Specified|1
853910|NCT01243671|2717869|P1|Overall Study|Anti-adalimumab antibody positive|1
853911|NCT01243671|2717869|P1|Overall Study|Adverse Event|3
853912|NCT01243775|2717882|P1|Overall Study|Withdrawal by Subject|2
853913|NCT01249664|2717891|P2|Overall Study|Adverse Event|0
853914|NCT01249664|2717892|P1|Overall Study|Adverse Event|1
853915|NCT01249664|2717891|P2|Overall Study|Withdrawal by Subject|0
853916|NCT01249664|2717892|P1|Overall Study|Withdrawal by Subject|5
853917|NCT01249833|2717944|P2|Overall Study|Lost to Follow-up|1
853918|NCT01249833|2717945|P1|Overall Study|Lost to Follow-up|0
853919|NCT01251120|2718014|P2|Overall Study|Lack of Efficacy|1
853920|NCT01251120|2718015|P1|Overall Study|Lack of Efficacy|0
853921|NCT01251146|2718037|P2|Overall Study|Lost to Follow-up|10
853922|NCT01251146|2718038|P1|Overall Study|Lost to Follow-up|3
853927|NCT01251354|2718108|P1|Overall Study|Disease Progression|4
853928|NCT01251354|2718108|P1|Overall Study|Investigator's Decision|1
853929|NCT01251354|2718108|P1|Overall Study|Adverse Event|1
853930|NCT01251380|2718118|P1|Overall Study|Lost to Follow-up|2
853931|NCT01251380|2718118|P1|Overall Study|Adverse Event|1
853932|NCT01251380|2718118|P1|Overall Study|Lack of Efficacy|1
853933|NCT01251380|2718118|P1|Overall Study|Withdrawal by Subject|6
853934|NCT01251380|2718118|P1|Overall Study|Other (Not otherwise specified)|12
853935|NCT01251614|2718180|P3|Overall Study|Lost to Follow-up|0
853936|NCT01251614|2718181|P2|Overall Study|Lost to Follow-up|1
853937|NCT01251614|2718182|P1|Overall Study|Lost to Follow-up|0
853938|NCT01251614|2718180|P3|Overall Study|Withdrawal by Subject|1
853939|NCT01251614|2718181|P2|Overall Study|Withdrawal by Subject|2
853940|NCT01251614|2718182|P1|Overall Study|Withdrawal by Subject|0
853941|NCT01251614|2718180|P3|Overall Study|Loss of Disease Control|0
853942|NCT01251614|2718181|P2|Overall Study|Loss of Disease Control|1
853943|NCT01251614|2718182|P1|Overall Study|Loss of Disease Control|0
853944|NCT01251614|2718180|P3|Overall Study|Pregnancy|2
853945|NCT01251614|2718181|P2|Overall Study|Pregnancy|0
853946|NCT01251614|2718182|P1|Overall Study|Pregnancy|0
853947|NCT01251614|2718180|P3|Overall Study|Clearing of Psoriatic Lesions|0
853948|NCT01251614|2718181|P2|Overall Study|Clearing of Psoriatic Lesions|0
853949|NCT01251614|2718182|P1|Overall Study|Clearing of Psoriatic Lesions|1
853950|NCT01251614|2718180|P3|Overall Study|Lack of Efficacy|4
853951|NCT01251614|2718181|P2|Overall Study|Lack of Efficacy|9
853952|NCT01251614|2718182|P1|Overall Study|Lack of Efficacy|1
853953|NCT01251614|2718180|P3|Overall Study|Adverse Event|1
853954|NCT01251614|2718181|P2|Overall Study|Adverse Event|0
853955|NCT01251614|2718182|P1|Overall Study|Adverse Event|1
853956|NCT01251653|2718263|P9|Overall Study|Other reason not mentioned above|0
853957|NCT01251653|2718264|P8|Overall Study|Other reason not mentioned above|2
853958|NCT01251653|2718265|P7|Overall Study|Other reason not mentioned above|0
853959|NCT01251653|2718266|P6|Overall Study|Other reason not mentioned above|0
853960|NCT01251653|2718267|P5|Overall Study|Other reason not mentioned above|0
853961|NCT01251653|2718268|P4|Overall Study|Other reason not mentioned above|0
853962|NCT01251653|2718269|P3|Overall Study|Other reason not mentioned above|0
853963|NCT01251653|2718270|P2|Overall Study|Other reason not mentioned above|0
853964|NCT01251653|2718271|P1|Overall Study|Other reason not mentioned above|0
853965|NCT01251653|2718263|P9|Overall Study|Withdrawal by Subject|0
853966|NCT01251653|2718264|P8|Overall Study|Withdrawal by Subject|1
853967|NCT01251653|2718265|P7|Overall Study|Withdrawal by Subject|0
853968|NCT01251653|2718266|P6|Overall Study|Withdrawal by Subject|1
853969|NCT01251653|2718267|P5|Overall Study|Withdrawal by Subject|1
853970|NCT01251653|2718268|P4|Overall Study|Withdrawal by Subject|0
853971|NCT01251653|2718269|P3|Overall Study|Withdrawal by Subject|1
853972|NCT01251653|2718270|P2|Overall Study|Withdrawal by Subject|0
853973|NCT01251653|2718271|P1|Overall Study|Withdrawal by Subject|1
853974|NCT01251653|2718263|P9|Overall Study|Adverse Event|1
853975|NCT01251653|2718264|P8|Overall Study|Adverse Event|2
853976|NCT01251653|2718265|P7|Overall Study|Adverse Event|2
853977|NCT01251653|2718266|P6|Overall Study|Adverse Event|0
853978|NCT01251653|2718267|P5|Overall Study|Adverse Event|1
853979|NCT01251653|2718268|P4|Overall Study|Adverse Event|1
853980|NCT01251653|2718269|P3|Overall Study|Adverse Event|2
853981|NCT01251653|2718270|P2|Overall Study|Adverse Event|0
853982|NCT01251653|2718271|P1|Overall Study|Adverse Event|1
853983|NCT01251653|2718263|P9|Overall Study|Dose-limiting toxicity|0
853984|NCT01251653|2718264|P8|Overall Study|Dose-limiting toxicity|0
853985|NCT01251653|2718265|P7|Overall Study|Dose-limiting toxicity|2
853986|NCT01251653|2718266|P6|Overall Study|Dose-limiting toxicity|0
853987|NCT01251653|2718267|P5|Overall Study|Dose-limiting toxicity|0
853988|NCT01251653|2718268|P4|Overall Study|Dose-limiting toxicity|1
853989|NCT01251653|2718269|P3|Overall Study|Dose-limiting toxicity|1
853990|NCT01251653|2718270|P2|Overall Study|Dose-limiting toxicity|1
853991|NCT01251653|2718271|P1|Overall Study|Dose-limiting toxicity|0
853992|NCT01251653|2718263|P9|Overall Study|Progressive Disease|5
853993|NCT01251653|2718264|P8|Overall Study|Progressive Disease|7
853994|NCT01251653|2718265|P7|Overall Study|Progressive Disease|14
853995|NCT01251653|2718266|P6|Overall Study|Progressive Disease|17
853996|NCT01251653|2718267|P5|Overall Study|Progressive Disease|0
853997|NCT01251653|2718268|P4|Overall Study|Progressive Disease|4
853998|NCT01251653|2718269|P3|Overall Study|Progressive Disease|16
853999|NCT01251653|2718270|P2|Overall Study|Progressive Disease|7
854000|NCT01251653|2718271|P1|Overall Study|Progressive Disease|1
854001|NCT01251770|2718432|P2|Overall Study|Protocol Violation|7
854002|NCT01251770|2718433|P1|Overall Study|Protocol Violation|13
854003|NCT01251952|2718441|P1|Overall Study|Adverse Event|1
854006|NCT01252134|2718466|P6|Period 1, 8 Hours|Personal Reasons|0
854007|NCT01252134|2718467|P5|Period 1, 8 Hours|Personal Reasons|0
854008|NCT01252134|2718468|P4|Period 1, 8 Hours|Personal Reasons|0
854009|NCT01252134|2718469|P3|Period 1, 8 Hours|Personal Reasons|1
854010|NCT01252134|2718470|P2|Period 1, 8 Hours|Personal Reasons|1
854011|NCT01252134|2718471|P1|Period 1, 8 Hours|Personal Reasons|0
854012|NCT01252186|2718496|P3|Overall Study|Other - Miscellaneous Reasons|7
854013|NCT01252186|2718497|P2|Overall Study|Other - Miscellaneous Reasons|5
854014|NCT01252186|2718498|P1|Overall Study|Other - Miscellaneous Reasons|5
854015|NCT01252186|2718496|P3|Overall Study|Lost to Follow-up|11
854016|NCT01252186|2718497|P2|Overall Study|Lost to Follow-up|10
854017|NCT01252186|2718498|P1|Overall Study|Lost to Follow-up|10
854018|NCT01252186|2718496|P3|Overall Study|Sponsor Request|0
854019|NCT01252186|2718497|P2|Overall Study|Sponsor Request|1
854020|NCT01252186|2718498|P1|Overall Study|Sponsor Request|2
854021|NCT01252186|2718496|P3|Overall Study|Pregnancy|0
854022|NCT01252186|2718497|P2|Overall Study|Pregnancy|2
854023|NCT01252186|2718498|P1|Overall Study|Pregnancy|2
854024|NCT01252186|2718496|P3|Overall Study|Protocol Violation|1
854025|NCT01252186|2718497|P2|Overall Study|Protocol Violation|0
854026|NCT01252186|2718498|P1|Overall Study|Protocol Violation|0
854027|NCT01252186|2718496|P3|Overall Study|Non-compliance|4
854028|NCT01252186|2718497|P2|Overall Study|Non-compliance|3
854029|NCT01252186|2718498|P1|Overall Study|Non-compliance|0
854030|NCT01252186|2718496|P3|Overall Study|Physician Decision|1
854031|NCT01252186|2718497|P2|Overall Study|Physician Decision|0
854032|NCT01252186|2718498|P1|Overall Study|Physician Decision|0
854033|NCT01252186|2718496|P3|Overall Study|Withdrawal by Subject|2
854034|NCT01252186|2718497|P2|Overall Study|Withdrawal by Subject|5
854035|NCT01252186|2718498|P1|Overall Study|Withdrawal by Subject|2
854036|NCT01252186|2718496|P3|Overall Study|Adverse Event|8
854037|NCT01252186|2718497|P2|Overall Study|Adverse Event|6
854038|NCT01252186|2718498|P1|Overall Study|Adverse Event|9
854039|NCT01252238|2718569|P3|Overall Study|Sponsor terminated study|4
854040|NCT01252238|2718570|P2|Overall Study|Sponsor terminated study|4
854041|NCT01252238|2718571|P1|Overall Study|Sponsor terminated study|4
854042|NCT01252251|2718579|P1|Overall Study|Withdrawal by Subject|1
854043|NCT01252290|2718596|P1|Overall Study|Withdrawal by Subject|1
854044|NCT01252355|2718607|P3|Overall Study|Other Than Above|7
854045|NCT01252355|2718608|P2|Overall Study|Other Than Above|7
854046|NCT01252355|2718609|P1|Overall Study|Other Than Above|8
854047|NCT01252355|2718607|P3|Overall Study|Randomized but not Treated|0
854048|NCT01252355|2718608|P2|Overall Study|Randomized but not Treated|0
854049|NCT01252355|2718609|P1|Overall Study|Randomized but not Treated|2
854050|NCT01252355|2718607|P3|Overall Study|Sponsor Early Termination of Study|146
854051|NCT01252355|2718608|P2|Overall Study|Sponsor Early Termination of Study|149
854052|NCT01252355|2718609|P1|Overall Study|Sponsor Early Termination of Study|149
854053|NCT01252355|2718607|P3|Overall Study|Progressive Disease|0
854054|NCT01252355|2718608|P2|Overall Study|Progressive Disease|0
854055|NCT01252355|2718609|P1|Overall Study|Progressive Disease|2
854056|NCT01252355|2718607|P3|Overall Study|Poor Compliance to Protocol|1
854057|NCT01252355|2718608|P2|Overall Study|Poor Compliance to Protocol|1
854058|NCT01252355|2718609|P1|Overall Study|Poor Compliance to Protocol|1
854059|NCT01252355|2718607|P3|Overall Study|Lost to Follow-up|1
854060|NCT01252355|2718608|P2|Overall Study|Lost to Follow-up|0
854061|NCT01252355|2718609|P1|Overall Study|Lost to Follow-up|0
854062|NCT01252355|2718607|P3|Overall Study|Lack of Efficacy|2
854063|NCT01252355|2718608|P2|Overall Study|Lack of Efficacy|4
854064|NCT01252355|2718609|P1|Overall Study|Lack of Efficacy|6
854065|NCT01252355|2718607|P3|Overall Study|Adverse Event|22
854066|NCT01252355|2718608|P2|Overall Study|Adverse Event|17
854067|NCT01252355|2718609|P1|Overall Study|Adverse Event|9
854068|NCT01252810|2718649|P2|Overall Study|Various reasons|0
854069|NCT01252810|2718650|P1|Overall Study|Various reasons|8
854070|NCT01252810|2718649|P2|Overall Study|Physician Decision|1
854071|NCT01252810|2718650|P1|Overall Study|Physician Decision|2
854072|NCT01252810|2718649|P2|Overall Study|Lost to Follow-up|1
854073|NCT01252810|2718650|P1|Overall Study|Lost to Follow-up|0
854074|NCT01252810|2718649|P2|Overall Study|Withdrawal by Subject|1
854075|NCT01252810|2718650|P1|Overall Study|Withdrawal by Subject|4
854076|NCT01252940|2718662|P2|Extension Phase|Withdrawal by Subject|1
854077|NCT01252940|2718663|P1|Extension Phase|Withdrawal by Subject|1
854078|NCT01252940|2718662|P2|Extension Phase|Subject Non-compliance|0
854079|NCT01252940|2718663|P1|Extension Phase|Subject Non-compliance|1
854080|NCT01252940|2718662|P2|Extension Phase|Physician Decision|1
854081|NCT01252940|2718663|P1|Extension Phase|Physician Decision|0
854082|NCT01252940|2718662|P2|Extension Phase|Lost to Follow-up|0
854083|NCT01252940|2718663|P1|Extension Phase|Lost to Follow-up|5
854084|NCT01252940|2718662|P2|Extension Phase|Lack of Efficacy|0
854085|NCT01252940|2718663|P1|Extension Phase|Lack of Efficacy|1
854086|NCT01252940|2718662|P2|Extension Phase|Adverse Event|1
854087|NCT01252940|2718663|P1|Extension Phase|Adverse Event|2
854088|NCT01252940|2718662|P2|Main Study Phase|Subject Non-compliance|1
854089|NCT01252940|2718663|P1|Main Study Phase|Subject Non-compliance|1
854090|NCT01252940|2718662|P2|Main Study Phase|Withdrawal by Subject|5
854091|NCT01252940|2718663|P1|Main Study Phase|Withdrawal by Subject|6
854092|NCT01252940|2718662|P2|Main Study Phase|Protocol Violation|2
854093|NCT01252940|2718663|P1|Main Study Phase|Protocol Violation|4
854094|NCT01252940|2718662|P2|Main Study Phase|Physician Decision|0
854095|NCT01252940|2718663|P1|Main Study Phase|Physician Decision|1
854096|NCT01252940|2718662|P2|Main Study Phase|Lost to Follow-up|1
854097|NCT01252940|2718663|P1|Main Study Phase|Lost to Follow-up|6
854098|NCT01252940|2718662|P2|Main Study Phase|Lack of Efficacy|0
854099|NCT01252940|2718663|P1|Main Study Phase|Lack of Efficacy|1
854100|NCT01252940|2718662|P2|Main Study Phase|Adverse Event|1
854101|NCT01252940|2718663|P1|Main Study Phase|Adverse Event|3
854102|NCT01252940|2718662|P2|Main Study Phase|Randomized but not treated|2
854103|NCT01252940|2718663|P1|Main Study Phase|Randomized but not treated|4
854104|NCT01252966|2718694|P2|Overall Study|Withdrawal by Subject|3
854105|NCT01252966|2718695|P1|Overall Study|Withdrawal by Subject|7
854106|NCT01252966|2718694|P2|Overall Study|Lost to Follow-up|10
854107|NCT01252966|2718695|P1|Overall Study|Lost to Follow-up|16
854108|NCT01253018|2718711|P2|Overall Study|Withdrawal by Subject|1
854109|NCT01253018|2718712|P1|Overall Study|Withdrawal by Subject|1
854110|NCT01253018|2718711|P2|Overall Study|Robot Repair Issues|0
854111|NCT01253018|2718712|P1|Overall Study|Robot Repair Issues|2
854112|NCT01253018|2718711|P2|Overall Study|Lost to Follow-up|1
854113|NCT01253018|2718712|P1|Overall Study|Lost to Follow-up|1
854114|NCT01253044|2718726|P2|Overall Study|Lost to Follow-up|29
854115|NCT01253044|2718727|P1|Overall Study|Lost to Follow-up|38
854116|NCT01253135|2718744|P1|Amended Protocol|Non-compliance|1
854117|NCT01253135|2718744|P1|Original Protocol|Protocol Amendment|15
854118|NCT01253174|2718758|P6|Period 3|Pregnancy|0
854119|NCT01253174|2718759|P5|Period 3|Pregnancy|0
854120|NCT01253174|2718760|P4|Period 3|Pregnancy|0
854121|NCT01253174|2718761|P3|Period 3|Pregnancy|1
854122|NCT01253174|2718762|P2|Period 3|Pregnancy|0
854123|NCT01253174|2718763|P1|Period 3|Pregnancy|0
854124|NCT01253174|2718758|P6|Period 3|Withdrawal by Subject|0
854125|NCT01253174|2718759|P5|Period 3|Withdrawal by Subject|1
854126|NCT01253174|2718760|P4|Period 3|Withdrawal by Subject|0
854127|NCT01253174|2718761|P3|Period 3|Withdrawal by Subject|0
854128|NCT01253174|2718762|P2|Period 3|Withdrawal by Subject|1
854129|NCT01253174|2718763|P1|Period 3|Withdrawal by Subject|0
854130|NCT01253174|2718758|P6|Period 2|Adverse Event|0
854131|NCT01253174|2718759|P5|Period 2|Adverse Event|0
854132|NCT01253174|2718760|P4|Period 2|Adverse Event|0
854133|NCT01253174|2718761|P3|Period 2|Adverse Event|1
854134|NCT01253174|2718762|P2|Period 2|Adverse Event|0
854135|NCT01253174|2718763|P1|Period 2|Adverse Event|0
854136|NCT01253174|2718758|P6|Period 1|Randomized but not treated|0
854137|NCT01253174|2718759|P5|Period 1|Randomized but not treated|1
854138|NCT01253174|2718760|P4|Period 1|Randomized but not treated|0
854139|NCT01253174|2718761|P3|Period 1|Randomized but not treated|1
854140|NCT01253174|2718762|P2|Period 1|Randomized but not treated|1
854141|NCT01253174|2718763|P1|Period 1|Randomized but not treated|0
854142|NCT01253187|2718792|P6|Period 3|non-compliance|0
854143|NCT01253187|2718793|P5|Period 3|non-compliance|1
854144|NCT01253187|2718794|P4|Period 3|non-compliance|0
854145|NCT01253187|2718795|P3|Period 3|non-compliance|0
854146|NCT01253187|2718796|P2|Period 3|non-compliance|0
854147|NCT01253187|2718797|P1|Period 3|non-compliance|0
854148|NCT01253187|2718792|P6|Period 3|difficulty with blood sampling|0
854149|NCT01253187|2718793|P5|Period 3|difficulty with blood sampling|0
854150|NCT01253187|2718794|P4|Period 3|difficulty with blood sampling|0
854151|NCT01253187|2718795|P3|Period 3|difficulty with blood sampling|0
854152|NCT01253187|2718796|P2|Period 3|difficulty with blood sampling|1
854153|NCT01253187|2718797|P1|Period 3|difficulty with blood sampling|0
854154|NCT01253187|2718792|P6|Period 3|Pregnancy|0
854155|NCT01253187|2718793|P5|Period 3|Pregnancy|0
854156|NCT01253187|2718794|P4|Period 3|Pregnancy|0
854157|NCT01253187|2718795|P3|Period 3|Pregnancy|0
854158|NCT01253187|2718796|P2|Period 3|Pregnancy|0
854159|NCT01253187|2718797|P1|Period 3|Pregnancy|1
854160|NCT01253187|2718792|P6|Period 2|Withdrawal by Subject|0
854161|NCT01253187|2718793|P5|Period 2|Withdrawal by Subject|1
854162|NCT01253187|2718794|P4|Period 2|Withdrawal by Subject|0
854163|NCT01253187|2718795|P3|Period 2|Withdrawal by Subject|0
854164|NCT01253187|2718796|P2|Period 2|Withdrawal by Subject|0
854165|NCT01253187|2718797|P1|Period 2|Withdrawal by Subject|0
854166|NCT01253265|2718831|P5|Overall Study|Withdrawal by Subject|1
854167|NCT01253265|2718832|P4|Overall Study|Withdrawal by Subject|0
854168|NCT01253265|2718833|P3|Overall Study|Withdrawal by Subject|0
854169|NCT01253265|2718834|P2|Overall Study|Withdrawal by Subject|0
854170|NCT01253265|2718835|P1|Overall Study|Withdrawal by Subject|0
854171|NCT01253265|2718831|P5|Overall Study|Met Predefined Discontinuation Criteria|0
854172|NCT01253265|2718832|P4|Overall Study|Met Predefined Discontinuation Criteria|0
854173|NCT01253265|2718833|P3|Overall Study|Met Predefined Discontinuation Criteria|0
854174|NCT01253265|2718834|P2|Overall Study|Met Predefined Discontinuation Criteria|0
854175|NCT01253265|2718835|P1|Overall Study|Met Predefined Discontinuation Criteria|1
854176|NCT01253304|2718883|P4|Overall Study|Adverse Event|1
854177|NCT01253304|2718884|P3|Overall Study|Adverse Event|0
854178|NCT01253304|2718885|P2|Overall Study|Adverse Event|0
854179|NCT01253304|2718886|P1|Overall Study|Adverse Event|0
854180|NCT01253317|2718920|P1|Overall Study|Adverse Event|2
854181|NCT01253369|2718953|P1|Overall Study|Not Evaluable|3
854182|NCT01253369|2718953|P1|Overall Study|Progressive disease|23
854183|NCT01253369|2718953|P1|Overall Study|Death|1
854184|NCT01253369|2718953|P1|Overall Study|Withdrawal by Subject|2
854185|NCT01253369|2718953|P1|Overall Study|Adverse Event|4
854186|NCT01253408|2718961|P3|Overall Study|Adverse Event|0
854187|NCT01253408|2718962|P2|Overall Study|Adverse Event|1
854188|NCT01253408|2718963|P1|Overall Study|Adverse Event|0
854189|NCT01253447|2718986|P1|Overall Study|Adverse Event|2
854190|NCT01253564|2719017|P1|Overall Study|Serious Adverse Event|1
854191|NCT01253564|2719017|P1|Overall Study|Withdrawal by Subject|1
854192|NCT01253564|2719017|P1|Overall Study|Disease Progression|22
854193|NCT01253577|2719034|P1|Overall Study|Lost to Follow-up|3
854194|NCT01246960|2719059|P2|Overall Study|Withdrawal (by participant or physician)|3
854195|NCT01246960|2719060|P1|Overall Study|Withdrawal (by participant or physician)|3
854196|NCT01246960|2719059|P2|Overall Study|Lost to Follow-up|1
854197|NCT01246960|2719060|P1|Overall Study|Lost to Follow-up|3
854198|NCT01246973|2719080|P2|Overall Study|Withdrawal by Subject|13
854199|NCT01246973|2719081|P1|Overall Study|Withdrawal by Subject|7
854200|NCT01246973|2719080|P2|Overall Study|Adverse Event|9
854201|NCT01246973|2719081|P1|Overall Study|Adverse Event|16
854202|NCT01246973|2719080|P2|Overall Study|unspecified|25
854203|NCT01246973|2719081|P1|Overall Study|unspecified|38
854204|NCT01246999|2719093|P4|Overall Study|Withdrawal by Subject|2
854205|NCT01246999|2719094|P3|Overall Study|Withdrawal by Subject|0
854206|NCT01246999|2719095|P2|Overall Study|Withdrawal by Subject|0
854207|NCT01246999|2719096|P1|Overall Study|Withdrawal by Subject|0
854208|NCT01246999|2719093|P4|Overall Study|Lost to Follow-up|0
854209|NCT01246999|2719094|P3|Overall Study|Lost to Follow-up|0
854210|NCT01246999|2719095|P2|Overall Study|Lost to Follow-up|1
854211|NCT01246999|2719096|P1|Overall Study|Lost to Follow-up|0
854212|NCT01247090|2719149|P3|Overall Study|Withdrawal by Subject|0
854213|NCT01247090|2719150|P2|Overall Study|Withdrawal by Subject|1
854214|NCT01247090|2719151|P1|Overall Study|Withdrawal by Subject|0
854215|NCT01247090|2719149|P3|Overall Study|Physician Decision|0
854216|NCT01247090|2719150|P2|Overall Study|Physician Decision|0
854217|NCT01247090|2719151|P1|Overall Study|Physician Decision|1
854218|NCT01253811|2719159|P1|Overall Study|Withdrawal criteria|1
854219|NCT01254292|2719214|P2|LCS12 Extension Phase|Lost to Follow-up|0
854220|NCT01254292|2719215|P1|LCS12 Extension Phase|Lost to Follow-up|1
854221|NCT01254292|2719214|P2|LCS12 Extension Phase|Pregnancy|0
854222|NCT01254292|2719215|P1|LCS12 Extension Phase|Pregnancy|2
854223|NCT01254292|2719214|P2|LCS12 Extension Phase|Other unknown|0
854224|NCT01254292|2719215|P1|LCS12 Extension Phase|Other unknown|4
854225|NCT01254292|2719214|P2|LCS12 Extension Phase|Withdrawal by Subject|0
854226|NCT01254292|2719215|P1|LCS12 Extension Phase|Withdrawal by Subject|7
854227|NCT01254292|2719214|P2|LCS12 Extension Phase|Adverse Event|0
854228|NCT01254292|2719215|P1|LCS12 Extension Phase|Adverse Event|9
854229|NCT01254292|2719214|P2|LCS12 Extension Phase|Wish for pregnancy|0
854230|NCT01254292|2719215|P1|LCS12 Extension Phase|Wish for pregnancy|14
854231|NCT01254292|2719214|P2|Comparative Phase|Wish for pregnancy|6
854232|NCT01254292|2719215|P1|Comparative Phase|Wish for pregnancy|4
854233|NCT01254292|2719214|P2|Comparative Phase|Protocol Violation|2
854234|NCT01254292|2719215|P1|Comparative Phase|Protocol Violation|1
854235|NCT01254292|2719214|P2|Comparative Phase|Withdrawal by Subject|21
854236|NCT01254292|2719215|P1|Comparative Phase|Withdrawal by Subject|20
854237|NCT01254292|2719214|P2|Comparative Phase|Pregnancy|6
854238|NCT01254292|2719215|P1|Comparative Phase|Pregnancy|2
854239|NCT01254292|2719214|P2|Comparative Phase|Lost to Follow-up|21
854240|NCT01254292|2719215|P1|Comparative Phase|Lost to Follow-up|3
854241|NCT01254292|2719214|P2|Comparative Phase|Adverse Event|25
854242|NCT01254292|2719215|P1|Comparative Phase|Adverse Event|25
854243|NCT01254305|2719278|P3|Overall Study|Other Reasons|2
854244|NCT01254305|2719279|P2|Overall Study|Other Reasons|0
854245|NCT01254305|2719280|P1|Overall Study|Other Reasons|0
854246|NCT01254305|2719278|P3|Overall Study|Lost to Follow-up|5
854247|NCT01254305|2719279|P2|Overall Study|Lost to Follow-up|6
854248|NCT01254305|2719280|P1|Overall Study|Lost to Follow-up|10
854249|NCT01254305|2719278|P3|Overall Study|Withdrawal by Subject|4
854250|NCT01254305|2719279|P2|Overall Study|Withdrawal by Subject|2
854251|NCT01254305|2719280|P1|Overall Study|Withdrawal by Subject|4
854252|NCT01254305|2719278|P3|Overall Study|Protocol Violation|3
854253|NCT01254305|2719279|P2|Overall Study|Protocol Violation|7
854254|NCT01254305|2719280|P1|Overall Study|Protocol Violation|1
854255|NCT01254305|2719278|P3|Overall Study|Lack of Efficacy|1
854256|NCT01254305|2719279|P2|Overall Study|Lack of Efficacy|0
854257|NCT01254305|2719280|P1|Overall Study|Lack of Efficacy|1
854258|NCT01254305|2719278|P3|Overall Study|Adverse Event|2
854259|NCT01254305|2719279|P2|Overall Study|Adverse Event|3
854260|NCT01254305|2719280|P1|Overall Study|Adverse Event|6
854261|NCT01254318|2719294|P1|Overall Study|Death|47
854262|NCT01254318|2719294|P1|Overall Study|Lost to Follow-up|5
854263|NCT01254331|2719300|P1|Extension Phase|Lost to Follow-up|3
854264|NCT01254331|2719300|P1|Extension Phase|Lack of Efficacy|1
854265|NCT01254331|2719300|P1|Initial Phase|Pregnancy|1
854266|NCT01254331|2719300|P1|Initial Phase|Withdrawal by Subject|1
854267|NCT01254331|2719300|P1|Initial Phase|Adverse Event|3
854268|NCT01254344|2719320|P2|Overall Study|Withdrawal by Subject|6
854269|NCT01254344|2719321|P1|Overall Study|Withdrawal by Subject|3
854270|NCT01254344|2719320|P2|Overall Study|Protocol Violation|4
854271|NCT01254344|2719321|P1|Overall Study|Protocol Violation|1
854272|NCT01254344|2719320|P2|Overall Study|Physician Decision|4
854273|NCT01254344|2719321|P1|Overall Study|Physician Decision|7
854274|NCT01254344|2719320|P2|Overall Study|Adverse Event|5
854275|NCT01254344|2719321|P1|Overall Study|Adverse Event|2
854276|NCT01254409|2719348|P4|Overall Study|Adverse Event|0
854277|NCT01254409|2719349|P3|Overall Study|Adverse Event|0
854278|NCT01254409|2719350|P2|Overall Study|Adverse Event|1
854279|NCT01254409|2719351|P1|Overall Study|Adverse Event|0
854280|NCT01254565|2719409|P6|Overall Study|Other|0
854281|NCT01254565|2719410|P5|Overall Study|Other|0
854282|NCT01254565|2719411|P4|Overall Study|Other|1
854283|NCT01254565|2719412|P3|Overall Study|Other|0
854284|NCT01254565|2719413|P2|Overall Study|Other|0
854285|NCT01254565|2719414|P1|Overall Study|Other|0
854286|NCT01254565|2719409|P6|Overall Study|Did not Receive Treatment|4
854287|NCT01254565|2719410|P5|Overall Study|Did not Receive Treatment|3
854288|NCT01254565|2719411|P4|Overall Study|Did not Receive Treatment|0
854289|NCT01254565|2719412|P3|Overall Study|Did not Receive Treatment|0
854290|NCT01254565|2719413|P2|Overall Study|Did not Receive Treatment|1
854291|NCT01254565|2719414|P1|Overall Study|Did not Receive Treatment|1
854292|NCT01254565|2719409|P6|Overall Study|Non-compliance to Study Procedures|0
854293|NCT01254565|2719410|P5|Overall Study|Non-compliance to Study Procedures|1
854294|NCT01254565|2719411|P4|Overall Study|Non-compliance to Study Procedures|0
854295|NCT01254565|2719412|P3|Overall Study|Non-compliance to Study Procedures|0
854296|NCT01254565|2719413|P2|Overall Study|Non-compliance to Study Procedures|0
854297|NCT01254565|2719414|P1|Overall Study|Non-compliance to Study Procedures|0
854298|NCT01254604|2719466|P2|Overall Study|Adverse Event|2
854299|NCT01254604|2719467|P1|Overall Study|Adverse Event|3
854300|NCT01254604|2719466|P2|Overall Study|Withdrawal by Subject|4
854301|NCT01254604|2719467|P1|Overall Study|Withdrawal by Subject|2
854302|NCT01254604|2719466|P2|Overall Study|Protocol Violation|2
854303|NCT01254604|2719467|P1|Overall Study|Protocol Violation|2
854304|NCT01254604|2719466|P2|Overall Study|Lost to Follow-up|1
854305|NCT01254604|2719467|P1|Overall Study|Lost to Follow-up|1
854306|NCT01254643|2719479|P1|Overall Study|Withdrawal by Subject|1
854307|NCT01254656|2719490|P3|Overall Study|Death|0
854308|NCT01254656|2719491|P2|Overall Study|Death|1
854309|NCT01254656|2719492|P1|Overall Study|Death|0
854310|NCT01254656|2719490|P3|Overall Study|Adverse Event|0
854311|NCT01254656|2719491|P2|Overall Study|Adverse Event|1
854312|NCT01254656|2719492|P1|Overall Study|Adverse Event|1
854313|NCT01254656|2719490|P3|Overall Study|Pregnancy|2
854314|NCT01254656|2719491|P2|Overall Study|Pregnancy|0
854315|NCT01254656|2719492|P1|Overall Study|Pregnancy|0
854316|NCT01254656|2719490|P3|Overall Study|Withdrawal by Subject|1
854317|NCT01254656|2719491|P2|Overall Study|Withdrawal by Subject|2
854318|NCT01254656|2719492|P1|Overall Study|Withdrawal by Subject|2
854319|NCT01254656|2719490|P3|Overall Study|Lost to Follow-up|2
854320|NCT01254656|2719491|P2|Overall Study|Lost to Follow-up|0
854321|NCT01254656|2719492|P1|Overall Study|Lost to Follow-up|1
854322|NCT01254656|2719490|P3|Overall Study|Lack of Efficacy|0
854323|NCT01254656|2719491|P2|Overall Study|Lack of Efficacy|0
854324|NCT01254656|2719492|P1|Overall Study|Lack of Efficacy|3
854325|NCT01254656|2719490|P3|Overall Study|Discontinued due to termination of study|13
854326|NCT01254656|2719491|P2|Overall Study|Discontinued due to termination of study|39
854327|NCT01254656|2719492|P1|Overall Study|Discontinued due to termination of study|40
854328|NCT01254669|2719520|P2|Overall Study|called to clinic during intervention|1
854329|NCT01254669|2719521|P1|Overall Study|called to clinic during intervention|1
854330|NCT01254669|2719520|P2|Overall Study|time constraint|2
854331|NCT01254669|2719521|P1|Overall Study|time constraint|2
854332|NCT01254669|2719520|P2|Overall Study|Withdrawal by Subject|1
854333|NCT01254669|2719521|P1|Overall Study|Withdrawal by Subject|0
854334|NCT01254721|2719531|P2|Overall Study|Wrongly randomization|1
854335|NCT01254721|2719532|P1|Overall Study|Wrongly randomization|0
854336|NCT01254721|2719531|P2|Overall Study|Withdrawal by Subject|11
854337|NCT01254721|2719532|P1|Overall Study|Withdrawal by Subject|8
854338|NCT01254721|2719531|P2|Overall Study|Adverse Event|3
854339|NCT01254721|2719532|P1|Overall Study|Adverse Event|2
854340|NCT01254721|2719531|P2|Overall Study|technical problum|0
854341|NCT01254721|2719532|P1|Overall Study|technical problum|1
854342|NCT01254721|2719531|P2|Overall Study|Death|1
854343|NCT01254721|2719532|P1|Overall Study|Death|0
854344|NCT01254721|2719531|P2|Overall Study|Lack of Efficacy|2
854345|NCT01254721|2719532|P1|Overall Study|Lack of Efficacy|4
854346|NCT01254721|2719531|P2|Overall Study|Lost to Follow-up|4
854347|NCT01254721|2719532|P1|Overall Study|Lost to Follow-up|0
854348|NCT01254747|2719544|P4|Overall Study|Discomfort|0
854349|NCT01254747|2719545|P3|Overall Study|Discomfort|0
854350|NCT01254747|2719546|P2|Overall Study|Discomfort|4
854351|NCT01254747|2719547|P1|Overall Study|Discomfort|0
854352|NCT01254747|2719544|P4|Overall Study|Biomicroscopy|0
854353|NCT01254747|2719545|P3|Overall Study|Biomicroscopy|1
854354|NCT01254747|2719546|P2|Overall Study|Biomicroscopy|0
854355|NCT01254747|2719547|P1|Overall Study|Biomicroscopy|0
854356|NCT01254747|2719544|P4|Overall Study|Lost to Follow-up|0
854357|NCT01254747|2719545|P3|Overall Study|Lost to Follow-up|1
854358|NCT01254747|2719546|P2|Overall Study|Lost to Follow-up|0
854359|NCT01254747|2719547|P1|Overall Study|Lost to Follow-up|0
854360|NCT01254747|2719544|P4|Overall Study|Symptoms and problems|0
854361|NCT01254747|2719545|P3|Overall Study|Symptoms and problems|1
854362|NCT01254747|2719546|P2|Overall Study|Symptoms and problems|2
854363|NCT01254747|2719547|P1|Overall Study|Symptoms and problems|0
854364|NCT01254747|2719544|P4|Overall Study|Difficult removal handling|0
854365|NCT01254747|2719545|P3|Overall Study|Difficult removal handling|1
854366|NCT01254747|2719546|P2|Overall Study|Difficult removal handling|0
854367|NCT01254747|2719547|P1|Overall Study|Difficult removal handling|0
854368|NCT01254747|2719544|P4|Overall Study|Unacceptable subjective vision|2
854369|NCT01254747|2719545|P3|Overall Study|Unacceptable subjective vision|0
854370|NCT01254747|2719546|P2|Overall Study|Unacceptable subjective vision|0
854371|NCT01254747|2719547|P1|Overall Study|Unacceptable subjective vision|0
854372|NCT01254890|2719611|P2|Overall Study|Disease Progression|5
854373|NCT01254890|2719612|P1|Overall Study|Disease Progression|0
854374|NCT01254890|2719611|P2|Overall Study|Withdrawal by Subject|2
854375|NCT01254890|2719612|P1|Overall Study|Withdrawal by Subject|1
854376|NCT01254890|2719611|P2|Overall Study|Ineligible|3
854377|NCT01254890|2719612|P1|Overall Study|Ineligible|0
854378|NCT01255306|2719625|P2|Overall Study|Physician Decision|1
854379|NCT01255306|2719626|P1|Overall Study|Physician Decision|1
854380|NCT01255423|2719637|P2|Overall Study|Use of prohibited medications|1
854381|NCT01255423|2719638|P1|Overall Study|Use of prohibited medications|0
854382|NCT01255423|2719637|P2|Overall Study|Abnormal Laboratory value|2
854383|NCT01255423|2719638|P1|Overall Study|Abnormal Laboratory value|3
854384|NCT01255436|2719654|P2|Overall Study|Death, stroke, or MI|3
854385|NCT01255436|2719655|P1|Overall Study|Death, stroke, or MI|4
854386|NCT01255436|2719654|P2|Overall Study|Lost to Follow-up|191
854387|NCT01255436|2719655|P1|Overall Study|Lost to Follow-up|178
854388|NCT01255592|2719674|P2|Overall Study|Other|1
854389|NCT01255592|2719675|P1|Overall Study|Other|0
854390|NCT01255592|2719674|P2|Overall Study|Withdrawal by Subject|0
854391|NCT01255592|2719675|P1|Overall Study|Withdrawal by Subject|1
854392|NCT01255592|2719674|P2|Overall Study|Adverse Event|0
854393|NCT01255592|2719675|P1|Overall Study|Adverse Event|5
854394|NCT01255631|2719733|P2|Overall Study|poor enrollment, no data analyzed|6
854395|NCT01255631|2719734|P1|Overall Study|poor enrollment, no data analyzed|9
854396|NCT01255722|2719753|P3|Overall Study|beta-blocker contraindicated|0
854397|NCT01255722|2719754|P2|Overall Study|beta-blocker contraindicated|0
854398|NCT01255722|2719755|P1|Overall Study|beta-blocker contraindicated|2
854399|NCT01255722|2719753|P3|Overall Study|asymptomatic patient|0
854400|NCT01255722|2719754|P2|Overall Study|asymptomatic patient|0
854401|NCT01255722|2719755|P1|Overall Study|asymptomatic patient|1
854402|NCT01255722|2719753|P3|Overall Study|Adverse Event|1
854403|NCT01255722|2719754|P2|Overall Study|Adverse Event|1
854404|NCT01255722|2719755|P1|Overall Study|Adverse Event|0
854405|NCT01255761|2719780|P2|Overall Study|Other Reasons|18
854406|NCT01255761|2719781|P1|Overall Study|Other Reasons|37
854407|NCT01255761|2719780|P2|Overall Study|Withdrawal by Subject|27
854408|NCT01255761|2719781|P1|Overall Study|Withdrawal by Subject|11
854409|NCT01255761|2719780|P2|Overall Study|Lost to Follow-up|8
854410|NCT01255761|2719781|P1|Overall Study|Lost to Follow-up|10
854411|NCT01255761|2719780|P2|Overall Study|Protocol Violation|5
854412|NCT01255761|2719781|P1|Overall Study|Protocol Violation|9
854413|NCT01255761|2719780|P2|Overall Study|Lack of Efficacy|74
854414|NCT01255761|2719781|P1|Overall Study|Lack of Efficacy|86
854415|NCT01255761|2719780|P2|Overall Study|Adverse Event|43
854416|NCT01255761|2719781|P1|Overall Study|Adverse Event|29
854417|NCT01255787|2719867|P4|Overall Study|Noncompliance with Study Drug|0
854418|NCT01255787|2719868|P3|Overall Study|Noncompliance with Study Drug|0
854419|NCT01255787|2719869|P2|Overall Study|Noncompliance with Study Drug|1
854420|NCT01255787|2719870|P1|Overall Study|Noncompliance with Study Drug|3
854421|NCT01255787|2719867|P4|Overall Study|Lack of Efficacy|2
854422|NCT01255787|2719868|P3|Overall Study|Lack of Efficacy|2
854423|NCT01255787|2719869|P2|Overall Study|Lack of Efficacy|2
854424|NCT01255787|2719870|P1|Overall Study|Lack of Efficacy|2
854425|NCT01255787|2719867|P4|Overall Study|Pregnancy|1
854426|NCT01255787|2719868|P3|Overall Study|Pregnancy|0
854427|NCT01255787|2719869|P2|Overall Study|Pregnancy|0
854428|NCT01255787|2719870|P1|Overall Study|Pregnancy|0
854429|NCT01255787|2719867|P4|Overall Study|Withdrawal of Consent|4
854430|NCT01255787|2719868|P3|Overall Study|Withdrawal of Consent|3
854431|NCT01255787|2719869|P2|Overall Study|Withdrawal of Consent|9
854432|NCT01255787|2719870|P1|Overall Study|Withdrawal of Consent|3
854433|NCT01255787|2719867|P4|Overall Study|Lost to Follow-up|2
854434|NCT01255787|2719868|P3|Overall Study|Lost to Follow-up|4
854435|NCT01255787|2719869|P2|Overall Study|Lost to Follow-up|2
854436|NCT01255787|2719870|P1|Overall Study|Lost to Follow-up|1
854437|NCT01255787|2719867|P4|Overall Study|Major Protocol Deviation|4
854438|NCT01255787|2719868|P3|Overall Study|Major Protocol Deviation|0
854439|NCT01255787|2719869|P2|Overall Study|Major Protocol Deviation|1
854440|NCT01255787|2719870|P1|Overall Study|Major Protocol Deviation|1
854441|NCT01255787|2719867|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
854442|NCT01255787|2719868|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
854443|NCT01255787|2719869|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
854444|NCT01255787|2719870|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
854445|NCT01255904|2719898|P2|Overall Study|Physician Decision|4
854446|NCT01255904|2719899|P1|Overall Study|Physician Decision|1
854447|NCT01256008|2719908|P3|Overall Study|Withdrawal by Subject|10
854448|NCT01256008|2719909|P2|Overall Study|Withdrawal by Subject|3
854449|NCT01256008|2719910|P1|Overall Study|Withdrawal by Subject|2
854450|NCT01256008|2719908|P3|Overall Study|Lost to Follow-up|11
854451|NCT01256008|2719909|P2|Overall Study|Lost to Follow-up|4
854452|NCT01256008|2719910|P1|Overall Study|Lost to Follow-up|6
854453|NCT01256060|2719939|P4|Overall Study|Lost to Follow-up|0
854454|NCT01256060|2719940|P3|Overall Study|Lost to Follow-up|0
854455|NCT01256060|2719941|P2|Overall Study|Lost to Follow-up|1
854456|NCT01256060|2719942|P1|Overall Study|Lost to Follow-up|0
854457|NCT01256177|2719985|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
854458|NCT01256177|2719986|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
854459|NCT01256177|2719985|P2|Overall Study|Lack of Efficacy|2
854460|NCT01256177|2719986|P1|Overall Study|Lack of Efficacy|11
854461|NCT01256177|2719985|P2|Overall Study|Condition under Investigation Worsened|0
854462|NCT01256177|2719986|P1|Overall Study|Condition under Investigation Worsened|1
854463|NCT01256177|2719985|P2|Overall Study|Severe Non-Compliance to Protocol|2
854464|NCT01256177|2719986|P1|Overall Study|Severe Non-Compliance to Protocol|4
854465|NCT01256177|2719985|P2|Overall Study|Adverse Event|9
854466|NCT01256177|2719986|P1|Overall Study|Adverse Event|8
854467|NCT01256177|2719985|P2|Overall Study|Lost to Follow-up|2
854468|NCT01256177|2719986|P1|Overall Study|Lost to Follow-up|2
854469|NCT01256177|2719985|P2|Overall Study|Withdrawal by Subject|22
854470|NCT01256177|2719986|P1|Overall Study|Withdrawal by Subject|23
854471|NCT01256190|2720010|P2|Overall Study|Lost to Follow-up|0
854472|NCT01256190|2720011|P1|Overall Study|Lost to Follow-up|2
854473|NCT01256294|2720029|P2|Overall Study|Protocol deviation|1
854474|NCT01256294|2720030|P1|Overall Study|Protocol deviation|2
854475|NCT01256294|2720029|P2|Overall Study|Withdrawal by Subject|1
854476|NCT01256294|2720030|P1|Overall Study|Withdrawal by Subject|1
854477|NCT01256294|2720029|P2|Overall Study|Adverse Event|0
854478|NCT01256294|2720030|P1|Overall Study|Adverse Event|1
854479|NCT01256385|2720048|P2|Overall Study|Withdrawal by Subject|2
854480|NCT01256385|2720049|P1|Overall Study|Withdrawal by Subject|2
854481|NCT01256385|2720048|P2|Overall Study|Physician Decision|1
854482|NCT01256385|2720049|P1|Overall Study|Physician Decision|1
854483|NCT01256411|2720073|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
854484|NCT01256411|2720074|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
854485|NCT01256411|2720075|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
854486|NCT01256411|2720076|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
854487|NCT01256411|2720077|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
854488|NCT01256411|2720078|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
854489|NCT01256411|2720073|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
854490|NCT01256411|2720074|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
854491|NCT01256411|2720075|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
854492|NCT01256411|2720076|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
854493|NCT01256411|2720077|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
854494|NCT01256411|2720078|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
854495|NCT01256411|2720073|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
854496|NCT01256411|2720074|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
854497|NCT01256411|2720075|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
854498|NCT01256411|2720076|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
854499|NCT01256411|2720077|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
854500|NCT01256411|2720078|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
854501|NCT01256411|2720073|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
854502|NCT01256411|2720074|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
854503|NCT01256411|2720075|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
854504|NCT01256411|2720076|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
854505|NCT01256411|2720077|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
854506|NCT01256411|2720078|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
854507|NCT01256411|2720073|P6|Extension by Mono or Combination Therapy|Adverse Event|1
854508|NCT01256411|2720074|P5|Extension by Mono or Combination Therapy|Adverse Event|6
854509|NCT01256411|2720075|P4|Extension by Mono or Combination Therapy|Adverse Event|0
854510|NCT01256411|2720076|P3|Extension by Mono or Combination Therapy|Adverse Event|0
854511|NCT01256411|2720077|P2|Extension by Mono or Combination Therapy|Adverse Event|0
854512|NCT01256411|2720078|P1|Extension by Mono or Combination Therapy|Adverse Event|0
854513|NCT01256411|2720073|P6|Extension by Maximum Treatment|Adverse Event|0
854514|NCT01256411|2720074|P5|Extension by Maximum Treatment|Adverse Event|0
854515|NCT01256411|2720075|P4|Extension by Maximum Treatment|Adverse Event|0
854516|NCT01256411|2720076|P3|Extension by Maximum Treatment|Adverse Event|1
854517|NCT01256411|2720077|P2|Extension by Maximum Treatment|Adverse Event|2
854518|NCT01256411|2720078|P1|Extension by Maximum Treatment|Adverse Event|4
854519|NCT01256411|2720073|P6|Extension by Maximum Treatment|Lack of Efficacy|0
854520|NCT01256411|2720074|P5|Extension by Maximum Treatment|Lack of Efficacy|0
854521|NCT01256411|2720075|P4|Extension by Maximum Treatment|Lack of Efficacy|0
854522|NCT01256411|2720076|P3|Extension by Maximum Treatment|Lack of Efficacy|1
854523|NCT01256411|2720077|P2|Extension by Maximum Treatment|Lack of Efficacy|0
854524|NCT01256411|2720078|P1|Extension by Maximum Treatment|Lack of Efficacy|1
854525|NCT01256411|2720073|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
854526|NCT01256411|2720074|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
854527|NCT01256411|2720075|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
854528|NCT01256411|2720076|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
854529|NCT01256411|2720077|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
854530|NCT01256411|2720078|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
854531|NCT01256411|2720073|P6|Extension by Maximum Treatment|Lost to Follow-up|0
854532|NCT01256411|2720074|P5|Extension by Maximum Treatment|Lost to Follow-up|0
854533|NCT01256411|2720075|P4|Extension by Maximum Treatment|Lost to Follow-up|0
854534|NCT01256411|2720076|P3|Extension by Maximum Treatment|Lost to Follow-up|0
854535|NCT01256411|2720077|P2|Extension by Maximum Treatment|Lost to Follow-up|2
854536|NCT01256411|2720078|P1|Extension by Maximum Treatment|Lost to Follow-up|1
854537|NCT01256411|2720073|P6|Extension by Maximum Treatment|Protocol deviation|0
854538|NCT01256411|2720074|P5|Extension by Maximum Treatment|Protocol deviation|0
854539|NCT01256411|2720075|P4|Extension by Maximum Treatment|Protocol deviation|0
854540|NCT01256411|2720076|P3|Extension by Maximum Treatment|Protocol deviation|1
854541|NCT01256411|2720077|P2|Extension by Maximum Treatment|Protocol deviation|0
854542|NCT01256411|2720078|P1|Extension by Maximum Treatment|Protocol deviation|0
854543|NCT01256450|2720133|P3|Double-blind Treatment|Not specified|12
854544|NCT01256450|2720134|P2|Double-blind Treatment|Not specified|9
854545|NCT01256450|2720135|P1|Double-blind Treatment|Not specified|0
854546|NCT01256450|2720133|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
854547|NCT01256450|2720134|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
854548|NCT01256450|2720135|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
854549|NCT01256450|2720133|P3|Double-blind Treatment|Non-compliance|4
854550|NCT01256450|2720134|P2|Double-blind Treatment|Non-compliance|5
854551|NCT01256450|2720135|P1|Double-blind Treatment|Non-compliance|0
854552|NCT01256450|2720133|P3|Double-blind Treatment|Lack of analgesic effect|6
854553|NCT01256450|2720134|P2|Double-blind Treatment|Lack of analgesic effect|5
854554|NCT01256450|2720135|P1|Double-blind Treatment|Lack of analgesic effect|0
854555|NCT01256450|2720133|P3|Double-blind Treatment|Withdrawal by Subject|1
854556|NCT01256450|2720134|P2|Double-blind Treatment|Withdrawal by Subject|0
854557|NCT01256450|2720135|P1|Double-blind Treatment|Withdrawal by Subject|0
854558|NCT01256450|2720133|P3|Double-blind Treatment|Lost to Follow-up|7
854559|NCT01256450|2720134|P2|Double-blind Treatment|Lost to Follow-up|1
854560|NCT01256450|2720135|P1|Double-blind Treatment|Lost to Follow-up|0
854561|NCT01256450|2720133|P3|Double-blind Treatment|Adverse Event|6
854562|NCT01256450|2720134|P2|Double-blind Treatment|Adverse Event|8
854563|NCT01256450|2720135|P1|Double-blind Treatment|Adverse Event|0
854564|NCT01256450|2720133|P3|Open-label Titration|Not specified|0
854565|NCT01256450|2720134|P2|Open-label Titration|Not specified|0
854566|NCT01256450|2720135|P1|Open-label Titration|Not specified|13
854567|NCT01256450|2720133|P3|Open-label Titration|Screen failure|0
854568|NCT01256450|2720134|P2|Open-label Titration|Screen failure|0
854569|NCT01256450|2720135|P1|Open-label Titration|Screen failure|1
854570|NCT01256450|2720133|P3|Open-label Titration|Non-compliance|0
854571|NCT01256450|2720134|P2|Open-label Titration|Non-compliance|0
854572|NCT01256450|2720135|P1|Open-label Titration|Non-compliance|9
854573|NCT01256450|2720133|P3|Open-label Titration|Lack of analgesic effect|0
854574|NCT01256450|2720134|P2|Open-label Titration|Lack of analgesic effect|0
854575|NCT01256450|2720135|P1|Open-label Titration|Lack of analgesic effect|30
854576|NCT01256450|2720133|P3|Open-label Titration|Lost to Follow-up|0
854577|NCT01256450|2720134|P2|Open-label Titration|Lost to Follow-up|0
854578|NCT01256450|2720135|P1|Open-label Titration|Lost to Follow-up|7
854579|NCT01256450|2720133|P3|Open-label Titration|Adverse Event|0
854580|NCT01256450|2720134|P2|Open-label Titration|Adverse Event|0
854581|NCT01256450|2720135|P1|Open-label Titration|Adverse Event|39
854582|NCT01256476|2720162|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
854583|NCT01256476|2720163|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
854584|NCT01256476|2720162|P2|Overall Study|Subject non-compliance|1
854585|NCT01256476|2720163|P1|Overall Study|Subject non-compliance|0
854586|NCT01256476|2720162|P2|Overall Study|Physician Decision|1
854587|NCT01256476|2720163|P1|Overall Study|Physician Decision|0
854588|NCT01256476|2720162|P2|Overall Study|Persistent ALT or AST elevation|0
854589|NCT01256476|2720163|P1|Overall Study|Persistent ALT or AST elevation|1
854590|NCT01256476|2720162|P2|Overall Study|Lost to Follow-up|2
854591|NCT01256476|2720163|P1|Overall Study|Lost to Follow-up|1
854592|NCT01256476|2720162|P2|Overall Study|Withdrawal by Subject|1
854593|NCT01256476|2720163|P1|Overall Study|Withdrawal by Subject|2
854594|NCT01256476|2720162|P2|Overall Study|Adverse Event|1
854595|NCT01256476|2720163|P1|Overall Study|Adverse Event|2
854599|NCT01256567|2720179|P1|Overall Study|Withdrawal by Subject|1
854600|NCT01256658|2720191|P2|Period 1|Death|44
854601|NCT01256658|2720192|P1|Period 1|Death|48
854602|NCT01256658|2720191|P2|Period 1|Withdrawal by Subject|43
854603|NCT01256658|2720192|P1|Period 1|Withdrawal by Subject|35
854604|NCT01256658|2720191|P2|Period 1|Lost to Follow-up|661
854605|NCT01256658|2720192|P1|Period 1|Lost to Follow-up|837
854606|NCT01256684|2720245|P3|Overall Study|Entry criteria not met/non-compliance|6
854607|NCT01256684|2720246|P2|Overall Study|Entry criteria not met/non-compliance|7
854608|NCT01256684|2720247|P1|Overall Study|Entry criteria not met/non-compliance|4
854609|NCT01256684|2720245|P3|Overall Study|Lack of Efficacy|1
854610|NCT01256684|2720246|P2|Overall Study|Lack of Efficacy|1
854611|NCT01256684|2720247|P1|Overall Study|Lack of Efficacy|0
854612|NCT01256684|2720245|P3|Overall Study|Physician Decision|0
854613|NCT01256684|2720246|P2|Overall Study|Physician Decision|1
854614|NCT01256684|2720247|P1|Overall Study|Physician Decision|0
854615|NCT01256684|2720245|P3|Overall Study|Withdrawal by Subject|2
854616|NCT01256684|2720246|P2|Overall Study|Withdrawal by Subject|0
854617|NCT01256684|2720247|P1|Overall Study|Withdrawal by Subject|4
854618|NCT01256684|2720245|P3|Overall Study|Adverse Event|2
854619|NCT01256684|2720246|P2|Overall Study|Adverse Event|4
854620|NCT01256684|2720247|P1|Overall Study|Adverse Event|1
854621|NCT01250002|2720281|P2|Overall Study|Change to open surgical procedure|3
854622|NCT01250002|2720282|P1|Overall Study|Change to open surgical procedure|4
854623|NCT01250054|2720290|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
854624|NCT01250054|2720291|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
854625|NCT01250119|2720297|P2|Treatment Phase|Unknown reason|4
854626|NCT01250119|2720298|P1|Treatment Phase|Unknown reason|0
854627|NCT01250119|2720297|P2|Treatment Phase|Adverse Event|2
854628|NCT01250119|2720298|P1|Treatment Phase|Adverse Event|0
854629|NCT01250119|2720297|P2|Treatment Phase|Withdrawal by Subject|1
854630|NCT01250119|2720298|P1|Treatment Phase|Withdrawal by Subject|0
854631|NCT01250119|2720297|P2|Treatment Phase|Death|2
854632|NCT01250119|2720298|P1|Treatment Phase|Death|0
854633|NCT01250119|2720297|P2|Treatment Phase|Progressive Disease|32
854634|NCT01250119|2720298|P1|Treatment Phase|Progressive Disease|0
854635|NCT01250119|2720297|P2|Diagnostic Phase|Participants Not Tested|0
854636|NCT01250119|2720298|P1|Diagnostic Phase|Participants Not Tested|44
854637|NCT01250119|2720297|P2|Diagnostic Phase|Failed to Produce a Test Results|0
854638|NCT01250119|2720298|P1|Diagnostic Phase|Failed to Produce a Test Results|69
854639|NCT01250145|2720315|P2|Overall Study|Withdrawal by Subject|4
854640|NCT01250145|2720316|P1|Overall Study|Withdrawal by Subject|0
854641|NCT01250145|2720315|P2|Overall Study|Adverse Event|1
854642|NCT01250145|2720316|P1|Overall Study|Adverse Event|2
854643|NCT01250171|2720339|P3|Overall Study|Administrative reasons|0
854644|NCT01250171|2720340|P2|Overall Study|Administrative reasons|0
854645|NCT01250171|2720341|P1|Overall Study|Administrative reasons|1
854646|NCT01250379|2720400|P2|Overall Study|Participant noncompliance|0
854647|NCT01250379|2720401|P1|Overall Study|Participant noncompliance|2
854648|NCT01250379|2720400|P2|Overall Study|Not specified|4
854649|NCT01250379|2720401|P1|Overall Study|Not specified|0
854650|NCT01250379|2720400|P2|Overall Study|Adverse Event|4
854651|NCT01250379|2720401|P1|Overall Study|Adverse Event|5
854652|NCT01250379|2720400|P2|Overall Study|Lost to Follow-up|6
854653|NCT01250379|2720401|P1|Overall Study|Lost to Follow-up|9
854654|NCT01250379|2720400|P2|Overall Study|Protocol Violation|8
854655|NCT01250379|2720401|P1|Overall Study|Protocol Violation|2
854656|NCT01250379|2720400|P2|Overall Study|Physician Decision|3
854657|NCT01250379|2720401|P1|Overall Study|Physician Decision|11
854658|NCT01250379|2720400|P2|Overall Study|Withdrawal by Subject|20
854659|NCT01250379|2720401|P1|Overall Study|Withdrawal by Subject|32
854660|NCT01250379|2720400|P2|Overall Study|Death|148
854661|NCT01250379|2720401|P1|Overall Study|Death|141
854662|NCT01250418|2720461|P2|Overall Study|monitor data failure|1
854663|NCT01250418|2720462|P1|Overall Study|monitor data failure|1
854664|NCT01250509|2720470|P2|Overall Study|Lost to Follow-up|2
854665|NCT01250509|2720471|P1|Overall Study|Lost to Follow-up|5
854666|NCT01250756|2720550|P2|After Toddler Dose|Adverse Event|1
854667|NCT01250756|2720551|P1|After Toddler Dose|Adverse Event|0
854668|NCT01250756|2720550|P2|Toddler Dose|Adverse Event|1
854669|NCT01250756|2720551|P1|Toddler Dose|Adverse Event|0
854670|NCT01250756|2720550|P2|After Infant Series|Unspecified|1
854671|NCT01250756|2720551|P1|After Infant Series|Unspecified|2
854672|NCT01250756|2720550|P2|After Infant Series|Withdrawal by Subject|1
854673|NCT01250756|2720551|P1|After Infant Series|Withdrawal by Subject|4
854674|NCT01250756|2720550|P2|After Infant Series|Adverse Event|2
854675|NCT01250756|2720551|P1|After Infant Series|Adverse Event|5
854676|NCT01250756|2720550|P2|Infant Series|Unspecified|0
854677|NCT01250756|2720551|P1|Infant Series|Unspecified|22
854678|NCT01250756|2720550|P2|Infant Series|Randomized, Not Vaccinated|2
854679|NCT01250756|2720551|P1|Infant Series|Randomized, Not Vaccinated|2
854680|NCT01250756|2720550|P2|Infant Series|Withdrawal by Subject|5
854681|NCT01250756|2720551|P1|Infant Series|Withdrawal by Subject|4
854682|NCT01250769|2720605|P4|Overall Study|Adverse Event|0
854683|NCT01250769|2720606|P3|Overall Study|Adverse Event|1
854684|NCT01250769|2720607|P2|Overall Study|Adverse Event|0
854685|NCT01250769|2720608|P1|Overall Study|Adverse Event|0
854686|NCT01250769|2720605|P4|Overall Study|Withdrawal by Subject|0
854687|NCT01250769|2720606|P3|Overall Study|Withdrawal by Subject|1
854688|NCT01250769|2720607|P2|Overall Study|Withdrawal by Subject|1
854689|NCT01250769|2720608|P1|Overall Study|Withdrawal by Subject|0
854690|NCT01250925|2720665|P3|Overall Study|Adverse Event|1
854691|NCT01250925|2720666|P2|Overall Study|Adverse Event|0
854692|NCT01250925|2720667|P1|Overall Study|Adverse Event|0
854693|NCT01250925|2720665|P3|Overall Study|Physician Decision|1
854694|NCT01250925|2720666|P2|Overall Study|Physician Decision|2
854695|NCT01250925|2720667|P1|Overall Study|Physician Decision|0
854696|NCT01250925|2720665|P3|Overall Study|Protocol Violation|0
854697|NCT01250925|2720666|P2|Overall Study|Protocol Violation|0
854698|NCT01250925|2720667|P1|Overall Study|Protocol Violation|2
854699|NCT01250925|2720665|P3|Overall Study|Withdrawal by Subject|0
854700|NCT01250925|2720666|P2|Overall Study|Withdrawal by Subject|0
854701|NCT01250925|2720667|P1|Overall Study|Withdrawal by Subject|2
854702|NCT01250925|2720665|P3|Overall Study|Lost to Follow-up|0
854703|NCT01250925|2720666|P2|Overall Study|Lost to Follow-up|1
854704|NCT01250925|2720667|P1|Overall Study|Lost to Follow-up|1
854705|NCT01258803|2720807|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
854706|NCT01258803|2720808|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
854707|NCT01258803|2720809|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
854708|NCT01258803|2720810|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
854709|NCT01258803|2720811|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
854710|NCT01258803|2720812|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
854711|NCT01258803|2720807|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
854712|NCT01258803|2720808|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
854713|NCT01258803|2720809|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
854714|NCT01258803|2720810|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
854715|NCT01258803|2720811|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
854716|NCT01258803|2720812|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
854717|NCT01258803|2720807|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
854718|NCT01258803|2720808|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
854719|NCT01258803|2720809|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
854720|NCT01258803|2720810|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
854721|NCT01258803|2720811|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
854722|NCT01258803|2720812|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
854723|NCT01258998|2720867|P1|Overall Study|Ineligible|1
854724|NCT01259024|2720884|P1|Overall Study|Physician Decision|1
854725|NCT01259102|2720893|P5|Overall Study|Other|1
854726|NCT01259102|2720894|P4|Overall Study|Other|1
854727|NCT01259102|2720895|P3|Overall Study|Other|1
854728|NCT01259102|2720896|P2|Overall Study|Other|0
854729|NCT01259102|2720897|P1|Overall Study|Other|0
854730|NCT01259102|2720893|P5|Overall Study|Adverse Event|0
854731|NCT01259102|2720894|P4|Overall Study|Adverse Event|1
854732|NCT01259102|2720895|P3|Overall Study|Adverse Event|1
854733|NCT01259102|2720896|P2|Overall Study|Adverse Event|0
854734|NCT01259102|2720897|P1|Overall Study|Adverse Event|1
854735|NCT01259115|2720954|P2|Period 2|Adverse Event|0
854736|NCT01259115|2720955|P1|Period 2|Adverse Event|1
854737|NCT01259115|2720954|P2|Period 1|Lost to Follow-up|1
854738|NCT01259115|2720955|P1|Period 1|Lost to Follow-up|0
854739|NCT01259115|2720954|P2|Period 1|Protocol Violation|0
854740|NCT01259115|2720955|P1|Period 1|Protocol Violation|2
854741|NCT01259115|2720954|P2|Period 1|Adverse Event|0
854742|NCT01259115|2720955|P1|Period 1|Adverse Event|1
854743|NCT01259245|2720988|P2|Overall Study|Death|2
854744|NCT01259245|2720989|P1|Overall Study|Death|1
854745|NCT01259245|2720988|P2|Overall Study|Withdrawal by Subject|24
854746|NCT01259245|2720989|P1|Overall Study|Withdrawal by Subject|27
854747|NCT01259284|2721016|P3|Overall Study|Study Termination|0
854748|NCT01259284|2721017|P2|Overall Study|Study Termination|0
854749|NCT01259284|2721018|P1|Overall Study|Study Termination|2
854750|NCT01259297|2721034|P8|Double Blind Randomized Period|Other reasons|1
854751|NCT01259297|2721035|P7|Double Blind Randomized Period|Other reasons|3
854752|NCT01259297|2721036|P6|Double Blind Randomized Period|Other reasons|2
854753|NCT01259297|2721037|P5|Double Blind Randomized Period|Other reasons|1
854754|NCT01259297|2721038|P4|Double Blind Randomized Period|Other reasons|0
854755|NCT01259297|2721039|P3|Double Blind Randomized Period|Other reasons|0
854756|NCT01259297|2721040|P2|Double Blind Randomized Period|Other reasons|1
854757|NCT01259297|2721041|P1|Double Blind Randomized Period|Other reasons|0
854758|NCT01259297|2721034|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
854759|NCT01259297|2721035|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
854760|NCT01259297|2721036|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
854761|NCT01259297|2721037|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
854762|NCT01259297|2721038|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
854763|NCT01259297|2721039|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
854764|NCT01259297|2721040|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
854765|NCT01259297|2721041|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
854766|NCT01259297|2721034|P8|Double Blind Randomized Period|Death|1
854767|NCT01259297|2721035|P7|Double Blind Randomized Period|Death|2
854768|NCT01259297|2721036|P6|Double Blind Randomized Period|Death|5
854769|NCT01259297|2721037|P5|Double Blind Randomized Period|Death|1
854770|NCT01259297|2721038|P4|Double Blind Randomized Period|Death|2
854771|NCT01259297|2721039|P3|Double Blind Randomized Period|Death|1
854772|NCT01259297|2721040|P2|Double Blind Randomized Period|Death|1
854773|NCT01259297|2721041|P1|Double Blind Randomized Period|Death|1
854774|NCT01259375|2721069|P1|Overall Study|Adverse Event|1
854775|NCT01259401|2721080|P2|4-month Follow-up|Lost to Follow-up|1
854776|NCT01259401|2721081|P1|4-month Follow-up|Lost to Follow-up|0
854777|NCT01259401|2721080|P2|4-month Follow-up|Death|1
854778|NCT01259401|2721081|P1|4-month Follow-up|Death|0
854779|NCT01259466|2721119|P2|Overall Study|Withdrawal by Subject|9
854780|NCT01259466|2721120|P1|Overall Study|Withdrawal by Subject|1
854781|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
854782|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
854783|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
854784|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
854785|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
854786|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
854787|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
854788|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
854789|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
854790|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
854791|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
854792|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
854793|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
854794|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
854795|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
854796|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
854797|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
854798|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
854799|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
854800|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
854801|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
854802|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
854803|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
854804|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
854805|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
854806|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
854807|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
854808|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
854809|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
854810|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
854811|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
854812|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
854813|NCT01259492|2721132|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
854814|NCT01259492|2721133|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
854815|NCT01259492|2721134|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
854816|NCT01259492|2721135|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
854817|NCT01259492|2721132|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
854818|NCT01259492|2721133|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
854819|NCT01259492|2721134|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
854820|NCT01259492|2721135|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
854821|NCT01259492|2721132|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
854822|NCT01259492|2721133|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
854823|NCT01259492|2721134|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
854824|NCT01259492|2721135|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
854825|NCT01259492|2721132|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
854826|NCT01259492|2721133|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
854827|NCT01259492|2721134|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
854828|NCT01259492|2721135|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
854829|NCT01259492|2721132|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
854830|NCT01259492|2721133|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
854831|NCT01259492|2721134|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
854832|NCT01259492|2721135|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
854833|NCT01259492|2721132|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
854834|NCT01259492|2721133|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
854835|NCT01259492|2721134|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
854836|NCT01259492|2721135|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
854837|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Protocol Violation|1
854838|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Protocol Violation|3
854839|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Protocol Violation|6
854840|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Protocol Violation|5
854841|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Administrative Problems|2
854842|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Administrative Problems|1
854843|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Administrative Problems|1
854844|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Administrative Problems|0
854845|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
854846|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
854847|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
854848|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
854849|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
854850|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
854851|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
854852|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
854853|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
854854|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
854855|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
854856|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
854857|NCT01259492|2721132|P4|Period 1 (9 Weeks)|Adverse Event|3
854858|NCT01259492|2721133|P3|Period 1 (9 Weeks)|Adverse Event|26
854859|NCT01259492|2721134|P2|Period 1 (9 Weeks)|Adverse Event|18
854860|NCT01259492|2721135|P1|Period 1 (9 Weeks)|Adverse Event|13
854861|NCT01259713|2721199|P2|Overall Study|Subject Withdrew Consent|7
854862|NCT01259713|2721200|P1|Overall Study|Subject Withdrew Consent|12
854863|NCT01259713|2721199|P2|Overall Study|Protocol Violation|4
854864|NCT01259713|2721200|P1|Overall Study|Protocol Violation|5
854865|NCT01259713|2721199|P2|Overall Study|Lack of Efficacy|0
854866|NCT01259713|2721200|P1|Overall Study|Lack of Efficacy|2
854867|NCT01259713|2721199|P2|Overall Study|Investigators Discretion|6
854868|NCT01259713|2721200|P1|Overall Study|Investigators Discretion|14
854869|NCT01259713|2721199|P2|Overall Study|Death Not Related to IFI|1
854870|NCT01259713|2721200|P1|Overall Study|Death Not Related to IFI|8
854871|NCT01259713|2721199|P2|Overall Study|Adverse Event|23
854872|NCT01259713|2721200|P1|Overall Study|Adverse Event|54
854873|NCT01259726|2721226|P4|Overall Study|Lost to Follow-up|3
854874|NCT01259726|2721227|P3|Overall Study|Lost to Follow-up|1
854875|NCT01259726|2721228|P2|Overall Study|Lost to Follow-up|1
854876|NCT01259726|2721229|P1|Overall Study|Lost to Follow-up|1
854877|NCT01259726|2721226|P4|Overall Study|Withdrawal by Subject|1
854878|NCT01259726|2721227|P3|Overall Study|Withdrawal by Subject|2
854879|NCT01259726|2721228|P2|Overall Study|Withdrawal by Subject|3
854880|NCT01259726|2721229|P1|Overall Study|Withdrawal by Subject|1
854881|NCT01259726|2721226|P4|Overall Study|Physician Decision|1
854882|NCT01259726|2721227|P3|Overall Study|Physician Decision|1
854883|NCT01259726|2721228|P2|Overall Study|Physician Decision|0
854884|NCT01259726|2721229|P1|Overall Study|Physician Decision|2
854885|NCT01259726|2721226|P4|Overall Study|Death|0
854886|NCT01259726|2721227|P3|Overall Study|Death|0
854887|NCT01259726|2721228|P2|Overall Study|Death|0
854888|NCT01259726|2721229|P1|Overall Study|Death|1
854889|NCT01260142|2721265|P6|Treatment Period 1|Withdrawal by Subject|1
854890|NCT01260142|2721266|P5|Treatment Period 1|Withdrawal by Subject|0
854891|NCT01260142|2721267|P4|Treatment Period 1|Withdrawal by Subject|0
854892|NCT01260142|2721268|P3|Treatment Period 1|Withdrawal by Subject|0
854893|NCT01260142|2721269|P2|Treatment Period 1|Withdrawal by Subject|0
854894|NCT01260142|2721270|P1|Treatment Period 1|Withdrawal by Subject|0
854895|NCT01260142|2721265|P6|Treatment Period 1|Unexplained elevated sys. BP|0
854896|NCT01260142|2721266|P5|Treatment Period 1|Unexplained elevated sys. BP|1
854897|NCT01260142|2721267|P4|Treatment Period 1|Unexplained elevated sys. BP|0
854898|NCT01260142|2721268|P3|Treatment Period 1|Unexplained elevated sys. BP|0
854899|NCT01260142|2721269|P2|Treatment Period 1|Unexplained elevated sys. BP|0
854900|NCT01260142|2721270|P1|Treatment Period 1|Unexplained elevated sys. BP|0
854901|NCT01260142|2721265|P6|Treatment Period 1|Study on hold|2
854902|NCT01260142|2721266|P5|Treatment Period 1|Study on hold|1
854903|NCT01260142|2721267|P4|Treatment Period 1|Study on hold|0
854904|NCT01260142|2721268|P3|Treatment Period 1|Study on hold|0
854905|NCT01260142|2721269|P2|Treatment Period 1|Study on hold|1
854906|NCT01260142|2721270|P1|Treatment Period 1|Study on hold|1
854907|NCT01260194|2721320|P1|Overall Study|Withdrawal of Consent|1
854908|NCT01260311|2721355|P1|Overall Study|Fesoterodine Started Before Enrollment|1
854909|NCT01260311|2721355|P1|Overall Study|Medication Stopped|1
854910|NCT01260311|2721355|P1|Overall Study|Gone to Province|2
854911|NCT01260311|2721355|P1|Overall Study|Financial Constraints|77
854912|NCT01260311|2721355|P1|Overall Study|Withdrawal by Subject|6
854913|NCT01260311|2721355|P1|Overall Study|Lost to Follow-up|25
854914|NCT01260311|2721355|P1|Overall Study|Lack of Efficacy|4
854915|NCT01260311|2721355|P1|Overall Study|Adverse Event|11
854916|NCT01260350|2721400|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
854917|NCT01260350|2721401|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
854918|NCT01260350|2721402|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
854919|NCT01260350|2721403|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
854920|NCT01260350|2721404|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
854921|NCT01260350|2721405|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
854922|NCT01260350|2721406|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
854923|NCT01260350|2721407|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
854924|NCT01260350|2721408|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
854925|NCT01260350|2721409|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
854926|NCT01260350|2721410|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
854927|NCT01260350|2721411|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
854928|NCT01260350|2721412|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
854929|NCT01260350|2721413|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
854930|NCT01260350|2721414|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
854931|NCT01260350|2721415|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
854932|NCT01260350|2721416|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
854933|NCT01260350|2721417|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
854934|NCT01260350|2721418|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
854935|NCT01260350|2721419|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
854936|NCT01260350|2721420|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
854937|NCT01260350|2721421|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
854938|NCT01260350|2721400|P22|Overall Study|Lack of Efficacy|0
854939|NCT01260350|2721401|P21|Overall Study|Lack of Efficacy|3
854940|NCT01260350|2721402|P20|Overall Study|Lack of Efficacy|0
854941|NCT01260350|2721403|P19|Overall Study|Lack of Efficacy|0
854942|NCT01260350|2721404|P18|Overall Study|Lack of Efficacy|1
854943|NCT01260350|2721405|P17|Overall Study|Lack of Efficacy|0
854944|NCT01260350|2721406|P16|Overall Study|Lack of Efficacy|0
854945|NCT01260350|2721407|P15|Overall Study|Lack of Efficacy|0
854946|NCT01260350|2721408|P14|Overall Study|Lack of Efficacy|0
854947|NCT01260350|2721409|P13|Overall Study|Lack of Efficacy|0
854948|NCT01260350|2721410|P12|Overall Study|Lack of Efficacy|0
854949|NCT01260350|2721411|P11|Overall Study|Lack of Efficacy|0
854950|NCT01260350|2721412|P10|Overall Study|Lack of Efficacy|0
854951|NCT01260350|2721413|P9|Overall Study|Lack of Efficacy|0
854952|NCT01260350|2721414|P8|Overall Study|Lack of Efficacy|0
854953|NCT01260350|2721415|P7|Overall Study|Lack of Efficacy|0
854954|NCT01260350|2721416|P6|Overall Study|Lack of Efficacy|0
854955|NCT01260350|2721417|P5|Overall Study|Lack of Efficacy|0
854956|NCT01260350|2721418|P4|Overall Study|Lack of Efficacy|0
854957|NCT01260350|2721419|P3|Overall Study|Lack of Efficacy|0
854958|NCT01260350|2721420|P2|Overall Study|Lack of Efficacy|0
854959|NCT01260350|2721421|P1|Overall Study|Lack of Efficacy|0
854960|NCT01260467|2721617|P1|Overall Study|Withdrawal by Subject|2
854961|NCT01260584|2721636|P4|Period 2|Withdrawal by Subject|0
854962|NCT01260584|2721637|P3|Period 2|Withdrawal by Subject|0
854963|NCT01260584|2721638|P2|Period 2|Withdrawal by Subject|1
854964|NCT01260584|2721639|P1|Period 2|Withdrawal by Subject|0
854965|NCT01260584|2721636|P4|Period 2|Adverse Event|0
854966|NCT01260584|2721637|P3|Period 2|Adverse Event|2
854967|NCT01260584|2721638|P2|Period 2|Adverse Event|0
854968|NCT01260584|2721639|P1|Period 2|Adverse Event|1
854969|NCT01260584|2721636|P4|Period 2|Protocol Violation|1
854970|NCT01260584|2721637|P3|Period 2|Protocol Violation|3
854971|NCT01260584|2721638|P2|Period 2|Protocol Violation|2
854972|NCT01260584|2721639|P1|Period 2|Protocol Violation|0
854973|NCT01260584|2721636|P4|Period 1|Adverse Event|0
854974|NCT01260584|2721637|P3|Period 1|Adverse Event|1
854975|NCT01260584|2721638|P2|Period 1|Adverse Event|0
854976|NCT01260584|2721639|P1|Period 1|Adverse Event|0
854977|NCT01260584|2721636|P4|Period 1|Protocol Violation|1
854978|NCT01260584|2721637|P3|Period 1|Protocol Violation|1
854979|NCT01260584|2721638|P2|Period 1|Protocol Violation|0
854980|NCT01260584|2721639|P1|Period 1|Protocol Violation|0
854981|NCT01260701|2721715|P1|Overall Study|Did not begin protocol therapy|1
854982|NCT01260701|2721715|P1|Overall Study|Ineligible|4
854983|NCT01260701|2721715|P1|Overall Study|Under review|1
854984|NCT01260701|2721715|P1|Overall Study|Not protocol specified|3
854985|NCT01260701|2721715|P1|Overall Study|Death|2
854986|NCT01260701|2721715|P1|Overall Study|Progression|53
854987|NCT01260701|2721715|P1|Overall Study|Withdrawal by Subject|2
854988|NCT01260701|2721715|P1|Overall Study|Adverse Event|9
854989|NCT01260896|2721766|P2|First Intervention|Withdrawn Due to Emesis|0
854990|NCT01260896|2721767|P1|First Intervention|Withdrawn Due to Emesis|2
854991|NCT01260922|2721785|P2|Second Intervention|Emesis|2
854992|NCT01260922|2721786|P1|Second Intervention|Emesis|0
854993|NCT01260922|2721785|P2|Washout of 28 Days|Withdrawal by Subject|2
854994|NCT01260922|2721786|P1|Washout of 28 Days|Withdrawal by Subject|4
854995|NCT01260922|2721785|P2|First Intervention|Withdrawal by Subject|1
854996|NCT01260922|2721786|P1|First Intervention|Withdrawal by Subject|0
854997|NCT01260948|2721796|P2|Second Intervention|Emesis|1
854998|NCT01260948|2721797|P1|Second Intervention|Emesis|0
854999|NCT01260948|2721796|P2|Washout of 28 Days|Withdrawal by Subject|3
855000|NCT01260948|2721797|P1|Washout of 28 Days|Withdrawal by Subject|1
855001|NCT01261000|2721805|P1|Overall Study|Screen failure|1
855002|NCT01254045|2721824|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
855003|NCT01254045|2721825|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
855004|NCT01254045|2721826|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
855005|NCT01254045|2721827|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
855006|NCT01254045|2721828|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
855007|NCT01254045|2721829|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
855008|NCT01254188|2721840|P1|Overall Study|per investigator discretion|20
855009|NCT01254188|2721840|P1|Overall Study|Adverse Event|43
855010|NCT01254188|2721840|P1|Overall Study|Withdrawal by Subject|7
855011|NCT01254188|2721840|P1|Overall Study|Lost to Follow-up|5
855012|NCT01254188|2721840|P1|Overall Study|Death|4
855013|NCT01254188|2721840|P1|Overall Study|Pregnancy|2
855014|NCT01254188|2721840|P1|Overall Study|Protocol Violation|6
855015|NCT01254188|2721840|P1|Overall Study|Disease Progression|6
855016|NCT01261325|2721871|P3|Overall Study|AE, serious fatal|2
855017|NCT01261325|2721872|P2|Overall Study|AE, serious fatal|0
855018|NCT01261325|2721873|P1|Overall Study|AE, serious fatal|0
855019|NCT01261325|2721871|P3|Overall Study|Lost to Follow-up|3
855020|NCT01261325|2721872|P2|Overall Study|Lost to Follow-up|1
855021|NCT01261325|2721873|P1|Overall Study|Lost to Follow-up|0
855022|NCT01261325|2721871|P3|Overall Study|Protocol Violation|1
855023|NCT01261325|2721872|P2|Overall Study|Protocol Violation|3
855024|NCT01261325|2721873|P1|Overall Study|Protocol Violation|0
855025|NCT01261325|2721871|P3|Overall Study|Randomized in Error|1
855026|NCT01261325|2721872|P2|Overall Study|Randomized in Error|0
855027|NCT01261325|2721873|P1|Overall Study|Randomized in Error|0
855028|NCT01261325|2721871|P3|Overall Study|Screen Failure|0
855029|NCT01261325|2721872|P2|Overall Study|Screen Failure|0
855030|NCT01261325|2721873|P1|Overall Study|Screen Failure|1
855031|NCT01261325|2721871|P3|Overall Study|Erroneously Randomized|0
855032|NCT01261325|2721872|P2|Overall Study|Erroneously Randomized|0
855033|NCT01261325|2721873|P1|Overall Study|Erroneously Randomized|1
855034|NCT01261325|2721871|P3|Overall Study|Patient Randomized by Mistake|0
855035|NCT01261325|2721872|P2|Overall Study|Patient Randomized by Mistake|1
855036|NCT01261325|2721873|P1|Overall Study|Patient Randomized by Mistake|0
855037|NCT01261325|2721871|P3|Overall Study|Non Compliance|0
855038|NCT01261325|2721872|P2|Overall Study|Non Compliance|0
855039|NCT01261325|2721873|P1|Overall Study|Non Compliance|2
855040|NCT01261325|2721871|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
855041|NCT01261325|2721872|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
855042|NCT01261325|2721873|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
855043|NCT01261325|2721871|P3|Overall Study|AE, non-serious non-fatal|13
855044|NCT01261325|2721872|P2|Overall Study|AE, non-serious non-fatal|15
855045|NCT01261325|2721873|P1|Overall Study|AE, non-serious non-fatal|9
855046|NCT01261325|2721871|P3|Overall Study|SAE, non-fatal|1
855047|NCT01261325|2721872|P2|Overall Study|SAE, non-fatal|5
855048|NCT01261325|2721873|P1|Overall Study|SAE, non-fatal|1
855049|NCT01261325|2721871|P3|Overall Study|Withdrawal by Subject|4
855050|NCT01261325|2721872|P2|Overall Study|Withdrawal by Subject|2
855051|NCT01261325|2721873|P1|Overall Study|Withdrawal by Subject|2
855052|NCT01261325|2721871|P3|Overall Study|Lack of Efficacy|0
855053|NCT01261325|2721872|P2|Overall Study|Lack of Efficacy|1
855054|NCT01261325|2721873|P1|Overall Study|Lack of Efficacy|1
855055|NCT01261390|2721909|P4|Overall Study|Lost to Follow-up|6
855056|NCT01261390|2721910|P3|Overall Study|Lost to Follow-up|5
855057|NCT01261390|2721911|P2|Overall Study|Lost to Follow-up|6
855058|NCT01261390|2721912|P1|Overall Study|Lost to Follow-up|1
855059|NCT01261390|2721909|P4|Overall Study|Loss of Interest in the Study|0
855060|NCT01261390|2721910|P3|Overall Study|Loss of Interest in the Study|0
855061|NCT01261390|2721911|P2|Overall Study|Loss of Interest in the Study|1
855062|NCT01261390|2721912|P1|Overall Study|Loss of Interest in the Study|3
855063|NCT01261390|2721909|P4|Overall Study|Relocation|0
855064|NCT01261390|2721910|P3|Overall Study|Relocation|0
855065|NCT01261390|2721911|P2|Overall Study|Relocation|1
855066|NCT01261390|2721912|P1|Overall Study|Relocation|0
855067|NCT01261390|2721909|P4|Overall Study|Dissatisfaction with Treatment|2
855068|NCT01261390|2721910|P3|Overall Study|Dissatisfaction with Treatment|1
855069|NCT01261390|2721911|P2|Overall Study|Dissatisfaction with Treatment|1
855070|NCT01261390|2721912|P1|Overall Study|Dissatisfaction with Treatment|2
855071|NCT01261390|2721909|P4|Overall Study|Significant Concurrent Illness|0
855072|NCT01261390|2721910|P3|Overall Study|Significant Concurrent Illness|1
855073|NCT01261390|2721911|P2|Overall Study|Significant Concurrent Illness|0
855074|NCT01261390|2721912|P1|Overall Study|Significant Concurrent Illness|1
855075|NCT01264380|2722094|P3|Period C|Adverse Event|1
855076|NCT01264380|2722095|P2|Period C|Adverse Event|0
855077|NCT01264380|2722096|P1|Period C|Adverse Event|0
855078|NCT01264380|2722094|P3|Period C|Withdrawal by Subject|1
855079|NCT01264380|2722095|P2|Period C|Withdrawal by Subject|0
855080|NCT01264380|2722096|P1|Period C|Withdrawal by Subject|0
855081|NCT01264380|2722094|P3|Period C|Follow-up for survival status|6
855082|NCT01264380|2722095|P2|Period C|Follow-up for survival status|0
855083|NCT01264380|2722096|P1|Period C|Follow-up for survival status|0
855084|NCT01264380|2722094|P3|Period C|Death|2
855085|NCT01264380|2722095|P2|Period C|Death|0
855086|NCT01264380|2722096|P1|Period C|Death|0
855087|NCT01264380|2722094|P3|Period C|Disease Progression|4
855088|NCT01264380|2722095|P2|Period C|Disease Progression|0
855089|NCT01264380|2722096|P1|Period C|Disease Progression|0
855090|NCT01264770|2722140|P6|Overall Study|Adverse Event|1
855091|NCT01264770|2722141|P5|Overall Study|Adverse Event|2
855092|NCT01264770|2722142|P4|Overall Study|Adverse Event|0
855093|NCT01264770|2722143|P3|Overall Study|Adverse Event|8
855094|NCT01264770|2722144|P2|Overall Study|Adverse Event|7
855095|NCT01264770|2722145|P1|Overall Study|Adverse Event|7
855096|NCT01264770|2722140|P6|Overall Study|Lost to Follow-up|0
855097|NCT01264770|2722141|P5|Overall Study|Lost to Follow-up|0
855098|NCT01264770|2722142|P4|Overall Study|Lost to Follow-up|1
855099|NCT01264770|2722143|P3|Overall Study|Lost to Follow-up|1
855100|NCT01264770|2722144|P2|Overall Study|Lost to Follow-up|0
855101|NCT01264770|2722145|P1|Overall Study|Lost to Follow-up|0
855102|NCT01264770|2722140|P6|Overall Study|Dev. of study specific discont. criteria|1
855103|NCT01264770|2722141|P5|Overall Study|Dev. of study specific discont. criteria|1
855104|NCT01264770|2722142|P4|Overall Study|Dev. of study specific discont. criteria|0
855105|NCT01264770|2722143|P3|Overall Study|Dev. of study specific discont. criteria|0
855106|NCT01264770|2722144|P2|Overall Study|Dev. of study specific discont. criteria|0
855107|NCT01264770|2722145|P1|Overall Study|Dev. of study specific discont. criteria|2
855108|NCT01264770|2722140|P6|Overall Study|Lack of therapeutic response|0
855109|NCT01264770|2722141|P5|Overall Study|Lack of therapeutic response|1
855110|NCT01264770|2722142|P4|Overall Study|Lack of therapeutic response|1
855111|NCT01264770|2722143|P3|Overall Study|Lack of therapeutic response|2
855112|NCT01264770|2722144|P2|Overall Study|Lack of therapeutic response|0
855113|NCT01264770|2722145|P1|Overall Study|Lack of therapeutic response|1
855114|NCT01264770|2722140|P6|Overall Study|Severe non-compliance to protocol|0
855115|NCT01264770|2722141|P5|Overall Study|Severe non-compliance to protocol|0
855116|NCT01264770|2722142|P4|Overall Study|Severe non-compliance to protocol|1
855117|NCT01264770|2722143|P3|Overall Study|Severe non-compliance to protocol|1
855118|NCT01264770|2722144|P2|Overall Study|Severe non-compliance to protocol|0
855119|NCT01264770|2722145|P1|Overall Study|Severe non-compliance to protocol|0
855120|NCT01264770|2722140|P6|Overall Study|e.g., change in circumstances|4
855121|NCT01264770|2722141|P5|Overall Study|e.g., change in circumstances|4
855122|NCT01264770|2722142|P4|Overall Study|e.g., change in circumstances|3
855123|NCT01264770|2722143|P3|Overall Study|e.g., change in circumstances|3
855124|NCT01264770|2722144|P2|Overall Study|e.g., change in circumstances|3
855125|NCT01264770|2722145|P1|Overall Study|e.g., change in circumstances|8
855126|NCT01264770|2722140|P6|Overall Study|Not reported|0
855127|NCT01264770|2722141|P5|Overall Study|Not reported|0
855128|NCT01264770|2722142|P4|Overall Study|Not reported|0
855129|NCT01264770|2722143|P3|Overall Study|Not reported|1
855130|NCT01264770|2722144|P2|Overall Study|Not reported|0
855131|NCT01264770|2722145|P1|Overall Study|Not reported|0
855132|NCT01264835|2722229|P1|Overall Study|Lost to Follow-up|1
855133|NCT01264887|2722233|P1|Overall Study|Not Specified|2
855134|NCT01264887|2722233|P1|Overall Study|Sponsor Decision Administrative Reasons|2
855135|NCT01264887|2722233|P1|Overall Study|Withdrawal by Subject|6
855136|NCT01264887|2722233|P1|Overall Study|Physician Decision|4
855137|NCT01264887|2722233|P1|Overall Study|Lack of Efficacy|5
855138|NCT01264887|2722233|P1|Overall Study|Death|7
855139|NCT01264887|2722233|P1|Overall Study|Adverse Event|5
855140|NCT01264939|2722246|P2|Overall Study|Disease Progression|11
855141|NCT01264939|2722247|P1|Overall Study|Disease Progression|8
855142|NCT01264939|2722246|P2|Overall Study|Patient/Guardian Decision|10
855143|NCT01264939|2722247|P1|Overall Study|Patient/Guardian Decision|8
855144|NCT01264939|2722246|P2|Overall Study|Physician Decision|1
855145|NCT01264939|2722247|P1|Overall Study|Physician Decision|1
855146|NCT01264939|2722246|P2|Overall Study|Lost to Follow-up|3
855147|NCT01264939|2722247|P1|Overall Study|Lost to Follow-up|0
855148|NCT01264939|2722246|P2|Overall Study|Adverse Event|3
855149|NCT01264939|2722247|P1|Overall Study|Adverse Event|1
855150|NCT01265056|2722294|P2|Overall Study|Withdrawal by Subject|1
855151|NCT01265056|2722295|P1|Overall Study|Withdrawal by Subject|1
855152|NCT01265056|2722294|P2|Overall Study|Withdrawal by Subject|1
855153|NCT01265056|2722295|P1|Overall Study|Withdrawal by Subject|1
855154|NCT01265394|2722301|P1|Overall Study|Subjects withdrawn|37
855155|NCT01265420|2722306|P1|Overall Study|Lost to Follow-up|1
855156|NCT01265498|2722348|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
855157|NCT01265498|2722349|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
855158|NCT01265511|2722451|P2|Overall Study|Met stopping rules|2
855159|NCT01265511|2722452|P1|Overall Study|Met stopping rules|0
855160|NCT01265511|2722451|P2|Overall Study|Lack of Efficacy|1
855161|NCT01265511|2722452|P1|Overall Study|Lack of Efficacy|2
855162|NCT01265563|2722490|P5|Overall Study|Withdrawal by Subject|2
855163|NCT01265563|2722491|P4|Overall Study|Withdrawal by Subject|0
855164|NCT01265563|2722492|P3|Overall Study|Withdrawal by Subject|1
855165|NCT01265563|2722493|P2|Overall Study|Withdrawal by Subject|1
855166|NCT01265563|2722494|P1|Overall Study|Withdrawal by Subject|0
855167|NCT01265615|2722515|P4|Overall Study|Protocol Violation|3
855168|NCT01265615|2722516|P3|Overall Study|Protocol Violation|4
855169|NCT01265615|2722517|P2|Overall Study|Protocol Violation|2
855170|NCT01265615|2722518|P1|Overall Study|Protocol Violation|2
855171|NCT01265784|2722582|P3|Overall Study|Incorrectly Randomized|1
855172|NCT01265784|2722583|P2|Overall Study|Incorrectly Randomized|0
855173|NCT01265784|2722584|P1|Overall Study|Incorrectly Randomized|0
855174|NCT01265784|2722582|P3|Overall Study|Protocol Violation|0
855175|NCT01265784|2722583|P2|Overall Study|Protocol Violation|0
855176|NCT01265784|2722584|P1|Overall Study|Protocol Violation|2
855177|NCT01265784|2722582|P3|Overall Study|Death|0
855178|NCT01265784|2722583|P2|Overall Study|Death|0
855179|NCT01265784|2722584|P1|Overall Study|Death|3
855180|NCT01265784|2722582|P3|Overall Study|Adverse Event|0
855181|NCT01265784|2722583|P2|Overall Study|Adverse Event|0
855182|NCT01265784|2722584|P1|Overall Study|Adverse Event|1
855183|NCT01265784|2722582|P3|Overall Study|Physician Decision|1
855184|NCT01265784|2722583|P2|Overall Study|Physician Decision|0
855185|NCT01265784|2722584|P1|Overall Study|Physician Decision|1
855186|NCT01265784|2722582|P3|Overall Study|Withdrawal by Subject|0
855187|NCT01265784|2722583|P2|Overall Study|Withdrawal by Subject|5
855188|NCT01265784|2722584|P1|Overall Study|Withdrawal by Subject|0
855189|NCT01265784|2722582|P3|Overall Study|Lost to Follow-up|2
855190|NCT01265784|2722583|P2|Overall Study|Lost to Follow-up|3
855191|NCT01265784|2722584|P1|Overall Study|Lost to Follow-up|5
855192|NCT01265797|2722652|P2|Open Label Month|Lost to Follow-up|1
855193|NCT01265797|2722653|P1|Open Label Month|Lost to Follow-up|0
855194|NCT01265797|2722652|P2|Blinded Month|Diary data incomplete|1
855195|NCT01265797|2722653|P1|Blinded Month|Diary data incomplete|0
855196|NCT01265797|2722652|P2|Blinded Month|Adverse Event|0
855197|NCT01265797|2722653|P1|Blinded Month|Adverse Event|2
855198|NCT01265797|2722652|P2|Blinded Month|Protocol Violation|1
855199|NCT01265797|2722653|P1|Blinded Month|Protocol Violation|2
855200|NCT01265797|2722652|P2|Blinded Month|Lost to Follow-up|0
855201|NCT01265797|2722653|P1|Blinded Month|Lost to Follow-up|1
855202|NCT01265797|2722652|P2|Blinded Month|Lack of Efficacy|0
855203|NCT01265797|2722653|P1|Blinded Month|Lack of Efficacy|5
855204|NCT01265797|2722652|P2|Run-in Month|1st seizure during run-in month|1
855205|NCT01265797|2722653|P1|Run-in Month|1st seizure during run-in month|0
855206|NCT01265797|2722652|P2|Run-in Month|Withdrawal by Subject|4
855207|NCT01265797|2722653|P1|Run-in Month|Withdrawal by Subject|0
855208|NCT01265823|2722681|P1|Overall Study|Participant Request|1
855209|NCT01265823|2722681|P1|Overall Study|Protocol Violation|1
855210|NCT01265823|2722681|P1|Overall Study|Failure to Return|4
855211|NCT01265823|2722681|P1|Overall Study|Unsatisfactory Response Efficacy|1
855212|NCT01265875|2722708|P1|Overall Study|Uncooperative/unreliable|1
855213|NCT01265953|2722718|P2|Overall Study|Non compliance|3
855214|NCT01265953|2722719|P1|Overall Study|Non compliance|5
855215|NCT01265992|2722744|P1|Overall Study|Did not receive treatment|1
855216|NCT01265992|2722744|P1|Overall Study|Stopped treatment|3
855217|NCT01265992|2722744|P1|Overall Study|Administrative reasons|2
855218|NCT01265992|2722744|P1|Overall Study|Adverse Event|1
855219|NCT01265992|2722744|P1|Overall Study|Withdrawal by Subject|1
855220|NCT01265992|2722744|P1|Overall Study|Lost to Follow-up|1
855221|NCT01266018|2722757|P2|Overall Study|Progressive disease|1
855222|NCT01266018|2722758|P1|Overall Study|Progressive disease|0
855223|NCT01266018|2722757|P2|Overall Study|Physician Decision|0
855224|NCT01266018|2722758|P1|Overall Study|Physician Decision|1
855225|NCT01266031|2722772|P3|Overall Study|Adverse Event|3
855226|NCT01266031|2722773|P2|Overall Study|Adverse Event|0
855227|NCT01266031|2722774|P1|Overall Study|Adverse Event|0
855228|NCT01266031|2722772|P3|Overall Study|Not treated|0
855229|NCT01266031|2722773|P2|Overall Study|Not treated|3
855230|NCT01266031|2722774|P1|Overall Study|Not treated|0
855231|NCT01266070|2722782|P1|Overall Study|Protocol Violation|1
855232|NCT01266070|2722782|P1|Overall Study|Adverse Event|3
855233|NCT01266122|2722789|P2|Overall Study|Lost to Follow-up|6
855234|NCT01266122|2722790|P1|Overall Study|Lost to Follow-up|6
855235|NCT01266148|2722800|P2|Overall Study|missing mGFR value + AE|0
855236|NCT01266148|2722801|P1|Overall Study|missing mGFR value + AE|1
855237|NCT01266148|2722800|P2|Overall Study|Death|3
855238|NCT01266148|2722801|P1|Overall Study|Death|2
855239|NCT01266148|2722800|P2|Overall Study|2 2R rejections|0
855240|NCT01266148|2722801|P1|Overall Study|2 2R rejections|1
855241|NCT01266148|2722800|P2|Overall Study|Ongoing rejection|0
855242|NCT01266148|2722801|P1|Overall Study|Ongoing rejection|1
855243|NCT01266148|2722800|P2|Overall Study|Adverse Event|0
855244|NCT01266148|2722801|P1|Overall Study|Adverse Event|2
855245|NCT01266265|2722829|P2|Overall Study|Clinical worsening|1
855246|NCT01266265|2722830|P1|Overall Study|Clinical worsening|1
855247|NCT01266265|2722829|P2|Overall Study|Site closed early|3
855248|NCT01266265|2722830|P1|Overall Study|Site closed early|4
855249|NCT01266265|2722829|P2|Overall Study|Lung transplant|5
855250|NCT01266265|2722830|P1|Overall Study|Lung transplant|6
855251|NCT01266265|2722829|P2|Overall Study|Non-compliance|5
855252|NCT01266265|2722830|P1|Overall Study|Non-compliance|8
855253|NCT01266265|2722829|P2|Overall Study|Enrolled in another clinical study|26
855254|NCT01266265|2722830|P1|Overall Study|Enrolled in another clinical study|15
855255|NCT01266265|2722829|P2|Overall Study|Stopped/changed PAH medication(s)|9
855256|NCT01266265|2722830|P1|Overall Study|Stopped/changed PAH medication(s)|16
855257|NCT01266265|2722829|P2|Overall Study|Transferred care to another provider|28
855258|NCT01266265|2722830|P1|Overall Study|Transferred care to another provider|22
855259|NCT01266265|2722829|P2|Overall Study|Respiratory-related adverse event|1
855260|NCT01266265|2722830|P1|Overall Study|Respiratory-related adverse event|2
855261|NCT01266265|2722829|P2|Overall Study|Withdrawal by Subject|11
855262|NCT01266265|2722830|P1|Overall Study|Withdrawal by Subject|13
855263|NCT01266265|2722829|P2|Overall Study|Lost to Follow-up|28
855264|NCT01266265|2722830|P1|Overall Study|Lost to Follow-up|23
855265|NCT01266265|2722829|P2|Overall Study|Death|73
855266|NCT01266265|2722830|P1|Overall Study|Death|95
855267|NCT01266291|2722836|P1|Overall Study|Adverse Event|1
855268|NCT01257204|2722853|P3|Follow-up Period (up to Week 48)|Unspecified|5
855269|NCT01257204|2722854|P2|Follow-up Period (up to Week 48)|Unspecified|0
855270|NCT01257204|2722855|P1|Follow-up Period (up to Week 48)|Unspecified|0
855271|NCT01257204|2722853|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
855272|NCT01257204|2722854|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
855273|NCT01257204|2722855|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
855274|NCT01257204|2722853|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
855275|NCT01257204|2722854|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
855276|NCT01257204|2722855|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
855277|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
855278|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
855279|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
855280|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
855281|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
855282|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
855283|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
855284|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
855285|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
855286|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
855287|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
855288|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
855289|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Adverse Event|2
855290|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Adverse Event|1
855291|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Adverse Event|3
855292|NCT01257204|2722853|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
855293|NCT01257204|2722854|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
855294|NCT01257204|2722855|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
855295|NCT01257230|2722923|P3|Overall Study|Other reason not defined above|3
855296|NCT01257230|2722924|P2|Overall Study|Other reason not defined above|5
855297|NCT01257230|2722925|P1|Overall Study|Other reason not defined above|1
855298|NCT01257230|2722923|P3|Overall Study|Withdrawal by Subject|1
855299|NCT01257230|2722924|P2|Overall Study|Withdrawal by Subject|4
855300|NCT01257230|2722925|P1|Overall Study|Withdrawal by Subject|0
855301|NCT01257230|2722923|P3|Overall Study|Protocol Violation|1
855302|NCT01257230|2722924|P2|Overall Study|Protocol Violation|0
855303|NCT01257230|2722925|P1|Overall Study|Protocol Violation|3
855304|NCT01257230|2722923|P3|Overall Study|Lack of Efficacy|0
855305|NCT01257230|2722924|P2|Overall Study|Lack of Efficacy|1
855306|NCT01257230|2722925|P1|Overall Study|Lack of Efficacy|0
855307|NCT01257230|2722923|P3|Overall Study|Adverse Event|0
855308|NCT01257230|2722924|P2|Overall Study|Adverse Event|0
855309|NCT01257230|2722925|P1|Overall Study|Adverse Event|2
855310|NCT01257230|2722923|P3|Overall Study|Not Treated|1
855311|NCT01257230|2722924|P2|Overall Study|Not Treated|0
855312|NCT01257230|2722925|P1|Overall Study|Not Treated|0
855313|NCT01257425|2723001|P2|Overall Study|Death|0
855314|NCT01257425|2723002|P1|Overall Study|Death|1
855315|NCT01257425|2723001|P2|Overall Study|Withdrawal by Subject|1
855316|NCT01257425|2723002|P1|Overall Study|Withdrawal by Subject|0
855317|NCT01257425|2723001|P2|Overall Study|Protocol Violation|1
855318|NCT01257425|2723002|P1|Overall Study|Protocol Violation|1
855319|NCT01257425|2723001|P2|Overall Study|Adverse Event|1
855320|NCT01257425|2723002|P1|Overall Study|Adverse Event|1
855321|NCT01257425|2723001|P2|Overall Study|Lack of Efficacy|3
855322|NCT01257425|2723002|P1|Overall Study|Lack of Efficacy|3
855323|NCT01257503|2723035|P2|Overall Study|strep culture positive at enrollment|0
855324|NCT01257503|2723036|P1|Overall Study|strep culture positive at enrollment|1
855325|NCT01257503|2723035|P2|Overall Study|Over 5 years old at enrollment|1
855326|NCT01257503|2723036|P1|Overall Study|Over 5 years old at enrollment|0
855327|NCT01257503|2723035|P2|Overall Study|Lost to Follow-up|10
855328|NCT01257503|2723036|P1|Overall Study|Lost to Follow-up|7
894591|NCT02553772|2839788|P2|Overall Study|Other Miscellaneous Reasons|1
894592|NCT02553772|2839789|P1|Overall Study|Other Miscellaneous Reasons|0
894593|NCT02553772|2839788|P2|Overall Study|Lack of Efficacy|0
855333|NCT01257581|2723074|P3|Overall Study|Death|4
855334|NCT01257581|2723075|P2|Overall Study|Death|2
855335|NCT01257581|2723076|P1|Overall Study|Death|2
855336|NCT01257581|2723074|P3|Overall Study|Early Termination|2
855337|NCT01257581|2723075|P2|Overall Study|Early Termination|1
855338|NCT01257581|2723076|P1|Overall Study|Early Termination|3
855339|NCT01258101|2723190|P4|Overall Study|Other reason|8
855340|NCT01258101|2723191|P3|Overall Study|Other reason|1
855341|NCT01258101|2723192|P2|Overall Study|Other reason|8
855342|NCT01258101|2723193|P1|Overall Study|Other reason|7
855343|NCT01258101|2723190|P4|Overall Study|PCR positive at week 24|1
855344|NCT01258101|2723191|P3|Overall Study|PCR positive at week 24|0
855345|NCT01258101|2723192|P2|Overall Study|PCR positive at week 24|0
855346|NCT01258101|2723193|P1|Overall Study|PCR positive at week 24|0
855347|NCT01258101|2723190|P4|Overall Study|Lost to Follow-up|6
855348|NCT01258101|2723191|P3|Overall Study|Lost to Follow-up|0
855349|NCT01258101|2723192|P2|Overall Study|Lost to Follow-up|5
855350|NCT01258101|2723193|P1|Overall Study|Lost to Follow-up|5
855351|NCT01258101|2723190|P4|Overall Study|Patient´s compliance|2
855352|NCT01258101|2723191|P3|Overall Study|Patient´s compliance|1
855353|NCT01258101|2723192|P2|Overall Study|Patient´s compliance|3
855354|NCT01258101|2723193|P1|Overall Study|Patient´s compliance|4
855355|NCT01258101|2723190|P4|Overall Study|Patient is not able to attend visits|6
855356|NCT01258101|2723191|P3|Overall Study|Patient is not able to attend visits|7
855357|NCT01258101|2723192|P2|Overall Study|Patient is not able to attend visits|9
855358|NCT01258101|2723193|P1|Overall Study|Patient is not able to attend visits|8
855359|NCT01258101|2723190|P4|Overall Study|Informed consent has been withdrawn|1
855360|NCT01258101|2723191|P3|Overall Study|Informed consent has been withdrawn|1
855361|NCT01258101|2723192|P2|Overall Study|Informed consent has been withdrawn|2
855362|NCT01258101|2723193|P1|Overall Study|Informed consent has been withdrawn|2
855363|NCT01258101|2723190|P4|Overall Study|Extra exclusion criterion amended|1
855364|NCT01258101|2723191|P3|Overall Study|Extra exclusion criterion amended|1
855365|NCT01258101|2723192|P2|Overall Study|Extra exclusion criterion amended|1
855366|NCT01258101|2723193|P1|Overall Study|Extra exclusion criterion amended|2
855367|NCT01258101|2723190|P4|Overall Study|Adverse Event|0
855368|NCT01258101|2723191|P3|Overall Study|Adverse Event|0
855369|NCT01258101|2723192|P2|Overall Study|Adverse Event|6
855370|NCT01258101|2723193|P1|Overall Study|Adverse Event|5
855371|NCT01258595|2723349|P2|Overall Study|Withdrawal by Subject|1
855372|NCT01258595|2723350|P1|Overall Study|Withdrawal by Subject|0
855373|NCT01258595|2723349|P2|Overall Study|Lost to Follow-up|0
855374|NCT01258595|2723350|P1|Overall Study|Lost to Follow-up|1
855375|NCT01258660|2723366|P2|Overall Study|Invalid for primary analysis data set|6
855376|NCT01258660|2723367|P1|Overall Study|Invalid for primary analysis data set|4
855377|NCT01258660|2723366|P2|Overall Study|Protocol Violation|1
855378|NCT01258660|2723367|P1|Overall Study|Protocol Violation|0
855379|NCT01258660|2723366|P2|Overall Study|due to relocation|0
855380|NCT01258660|2723367|P1|Overall Study|due to relocation|2
855381|NCT01258660|2723366|P2|Overall Study|Withdrawal by Subject|0
855382|NCT01258660|2723367|P1|Overall Study|Withdrawal by Subject|3
855383|NCT01258660|2723366|P2|Overall Study|Adverse Event|4
855384|NCT01258660|2723367|P1|Overall Study|Adverse Event|2
855385|NCT01258738|2723386|P2|Open-label Period|Withdrawn due to pregnancy|1
855386|NCT01258738|2723387|P1|Open-label Period|Withdrawn due to pregnancy|1
855387|NCT01258738|2723386|P2|Open-label Period|Other Reasons|1
855388|NCT01258738|2723387|P1|Open-label Period|Other Reasons|0
855389|NCT01258738|2723386|P2|Open-label Period|Adverse Event|5
855390|NCT01258738|2723387|P1|Open-label Period|Adverse Event|4
855391|NCT01258738|2723386|P2|Open-label Period|Protocol Violation|2
855392|NCT01258738|2723387|P1|Open-label Period|Protocol Violation|2
855393|NCT01258738|2723386|P2|Open-label Period|Withdrawal by Subject|6
855394|NCT01258738|2723387|P1|Open-label Period|Withdrawal by Subject|5
855395|NCT01258738|2723386|P2|Open-label Period|Lost to Follow-up|2
855396|NCT01258738|2723387|P1|Open-label Period|Lost to Follow-up|0
855397|NCT01258738|2723386|P2|Open-label Period|Insufficient clinical response|3
855398|NCT01258738|2723387|P1|Open-label Period|Insufficient clinical response|5
855399|NCT01258738|2723386|P2|Open-label Period|Did not meet inclusion criteria|1
855400|NCT01258738|2723387|P1|Open-label Period|Did not meet inclusion criteria|0
855401|NCT01258738|2723386|P2|Double-blind Period|Adverse Event|1
855402|NCT01258738|2723387|P1|Double-blind Period|Adverse Event|3
855403|NCT01258738|2723386|P2|Double-blind Period|Protocol Violation|1
855404|NCT01258738|2723387|P1|Double-blind Period|Protocol Violation|1
855405|NCT01258738|2723386|P2|Double-blind Period|Withdrawal by Subject|2
855406|NCT01258738|2723387|P1|Double-blind Period|Withdrawal by Subject|2
855407|NCT01258738|2723386|P2|Double-blind Period|Did not meet inclusion criteria|3
855408|NCT01258738|2723387|P1|Double-blind Period|Did not meet inclusion criteria|3
855409|NCT01266824|2723525|P2|Overall Study|Study terminated prior to completion|3
855410|NCT01266824|2723526|P1|Overall Study|Study terminated prior to completion|2
855411|NCT01266850|2723543|P5|Overall Study|Site Closure|0
855412|NCT01266850|2723544|P4|Overall Study|Site Closure|1
855413|NCT01266850|2723545|P3|Overall Study|Site Closure|1
855414|NCT01266850|2723546|P2|Overall Study|Site Closure|1
855415|NCT01266850|2723547|P1|Overall Study|Site Closure|0
855416|NCT01266850|2723543|P5|Overall Study|Adverse Event|1
855417|NCT01266850|2723544|P4|Overall Study|Adverse Event|0
855418|NCT01266850|2723545|P3|Overall Study|Adverse Event|0
855419|NCT01266850|2723546|P2|Overall Study|Adverse Event|0
855420|NCT01266850|2723547|P1|Overall Study|Adverse Event|0
855421|NCT01266850|2723543|P5|Overall Study|Protocol Violation|2
855422|NCT01266850|2723544|P4|Overall Study|Protocol Violation|1
855423|NCT01266850|2723545|P3|Overall Study|Protocol Violation|0
855424|NCT01266850|2723546|P2|Overall Study|Protocol Violation|1
855425|NCT01266850|2723547|P1|Overall Study|Protocol Violation|0
855426|NCT01266850|2723543|P5|Overall Study|Physician Decision|3
855427|NCT01266850|2723544|P4|Overall Study|Physician Decision|4
855428|NCT01266850|2723545|P3|Overall Study|Physician Decision|4
855429|NCT01266850|2723546|P2|Overall Study|Physician Decision|6
855430|NCT01266850|2723547|P1|Overall Study|Physician Decision|3
855431|NCT01266850|2723543|P5|Overall Study|Withdrawal by Subject|12
855432|NCT01266850|2723544|P4|Overall Study|Withdrawal by Subject|9
855433|NCT01266850|2723545|P3|Overall Study|Withdrawal by Subject|6
855434|NCT01266850|2723546|P2|Overall Study|Withdrawal by Subject|9
855435|NCT01266850|2723547|P1|Overall Study|Withdrawal by Subject|8
855436|NCT01266850|2723543|P5|Overall Study|Lost to Follow-up|12
855437|NCT01266850|2723544|P4|Overall Study|Lost to Follow-up|13
855438|NCT01266850|2723545|P3|Overall Study|Lost to Follow-up|13
855439|NCT01266850|2723546|P2|Overall Study|Lost to Follow-up|19
855440|NCT01266850|2723547|P1|Overall Study|Lost to Follow-up|19
855441|NCT01266876|2723604|P5|Overall Study|Adverse Event|0
855442|NCT01266876|2723605|P4|Overall Study|Adverse Event|1
855443|NCT01266876|2723606|P3|Overall Study|Adverse Event|0
855444|NCT01266876|2723607|P2|Overall Study|Adverse Event|0
855445|NCT01266876|2723608|P1|Overall Study|Adverse Event|0
855446|NCT01266967|2723712|P2|Overall Study|Withdrawal by Subject|3
855447|NCT01266967|2723713|P1|Overall Study|Withdrawal by Subject|3
855448|NCT01266967|2723712|P2|Overall Study|Physician Decision|1
855449|NCT01266967|2723713|P1|Overall Study|Physician Decision|0
855450|NCT01266967|2723712|P2|Overall Study|Lost to Follow-up|1
855451|NCT01266967|2723713|P1|Overall Study|Lost to Follow-up|2
855452|NCT01266967|2723712|P2|Overall Study|Study Closed/Terminated|17
855453|NCT01266967|2723713|P1|Overall Study|Study Closed/Terminated|15
855454|NCT01266967|2723712|P2|Overall Study|Death|61
855455|NCT01266967|2723713|P1|Overall Study|Death|69
855456|NCT01267266|2723814|P2|Lead-in Phase|Withdrawal by Subject|0
855457|NCT01267266|2723815|P1|Lead-in Phase|Withdrawal by Subject|1
855458|NCT01267266|2723814|P2|Lead-in Phase|Adverse Event|0
855459|NCT01267266|2723815|P1|Lead-in Phase|Adverse Event|2
855460|NCT01267266|2723814|P2|Lead-in Phase|Lack of Efficacy|0
855461|NCT01267266|2723815|P1|Lead-in Phase|Lack of Efficacy|20
855462|NCT01267266|2723814|P2|Enrollment Phase|Withdrawal by Subject|0
855463|NCT01267266|2723815|P1|Enrollment Phase|Withdrawal by Subject|2
855464|NCT01267994|2723893|P1|Overall Study|Adverse Event|2
855465|NCT01268098|2723899|P2|Overall Study|Adverse Event|0
855466|NCT01268098|2723900|P1|Overall Study|Adverse Event|1
855467|NCT01268150|2723917|P1|Extension Phase|Not specified|6
855468|NCT01268150|2723917|P1|Extension Phase|Disease progression|18
855469|NCT01268150|2723917|P1|Extension Phase|Adverse Event|3
855470|NCT01268150|2723917|P1|Treatment Phase|Not specified|4
855471|NCT01268150|2723917|P1|Treatment Phase|Withdrawal by Subject|3
855472|NCT01268150|2723917|P1|Treatment Phase|Adverse Event|3
855473|NCT01268150|2723917|P1|Treatment Phase|Progression of disease|18
855474|NCT01268267|2723939|P1|Overall Study|Protocol Violation|1
855475|NCT01268293|2723946|P1|Overall Study|Subject choice|1
855476|NCT01268293|2723946|P1|Overall Study|Adverse Event|1
855477|NCT01268293|2723946|P1|Overall Study|Disease progression|7
855478|NCT01268306|2723951|P1|Overall Study|Lost to Follow-up|1
855479|NCT01268488|2723955|P1|Overall Study|Physician Decision|2
855480|NCT01268488|2723955|P1|Overall Study|Adverse Event|3
855481|NCT01268501|2723962|P1|Overall Study|Handling Difficulties|2
855482|NCT01268501|2723962|P1|Overall Study|Unacceptable Subjective Vision|3
855483|NCT01268501|2723962|P1|Overall Study|Withdrawal by Subject|3
855484|NCT01268501|2723962|P1|Overall Study|Lost to Follow-up|1
855485|NCT01268566|2723975|P1|Overall Study|Death|30
855486|NCT01268566|2723975|P1|Overall Study|Withdrawal by Subject|12
855487|NCT01268566|2723975|P1|Overall Study|Lost to Follow-up|1
855488|NCT01268891|2724002|P2|Overall Study|Administrative or other reason(s)|0
855489|NCT01268891|2724003|P1|Overall Study|Administrative or other reason(s)|1
855490|NCT01268891|2724002|P2|Overall Study|Withdrawal of Consent|1
855491|NCT01268891|2724003|P1|Overall Study|Withdrawal of Consent|3
855492|NCT01268891|2724002|P2|Overall Study|Lack of Efficacy|0
855493|NCT01268891|2724003|P1|Overall Study|Lack of Efficacy|1
855494|NCT01268891|2724002|P2|Overall Study|Adverse Event|7
855495|NCT01268891|2724003|P1|Overall Study|Adverse Event|3
855496|NCT01269125|2724035|P3|Overall Study|Lost to Follow-up|0
855497|NCT01269125|2724036|P2|Overall Study|Lost to Follow-up|0
855498|NCT01269125|2724037|P1|Overall Study|Lost to Follow-up|4
855499|NCT01269125|2724035|P3|Overall Study|Adverse Event|0
855500|NCT01269125|2724036|P2|Overall Study|Adverse Event|5
855501|NCT01269125|2724037|P1|Overall Study|Adverse Event|3
855502|NCT01269346|2724057|P1|Extension Phase|Started a prohibited con med|1
855503|NCT01269346|2724057|P1|Extension Phase|Clinical progression|1
855504|NCT01269346|2724057|P1|Extension Phase|Physician decision or participant choice|9
855505|NCT01269346|2724057|P1|Extension Phase|Disease progression|22
855506|NCT01269346|2724057|P1|Extension Phase|Withdrawal by Subject|4
855507|NCT01269346|2724057|P1|Extension Phase|Adverse Event|6
855508|NCT01269346|2724057|P1|Treatment Phase|Not specified|2
855509|NCT01269346|2724057|P1|Treatment Phase|Withdrawal by Subject|1
855510|NCT01269346|2724057|P1|Treatment Phase|Adverse Event|3
855511|NCT01269346|2724057|P1|Treatment Phase|Disease progression|3
855512|NCT01261975|2724073|P1|Overall Study|Surgical complication|1
855513|NCT01262027|2724092|P1|Overall Study|Protocol Violation|1
855514|NCT01262027|2724092|P1|Overall Study|Withdrawal by Subject|3
855515|NCT01262027|2724092|P1|Overall Study|Adverse Event|1
855516|NCT01262092|2724099|P2|Gabapentin Taper|noncompliance - missed medications|0
855517|NCT01262092|2724100|P1|Gabapentin Taper|noncompliance - missed medications|1
855518|NCT01262092|2724099|P2|Buprenorphine Taper|noncompliance - missed medication|1
855519|NCT01262092|2724100|P1|Buprenorphine Taper|noncompliance - missed medication|1
855520|NCT01262092|2724099|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
855521|NCT01262092|2724100|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
855522|NCT01262092|2724099|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
855523|NCT01262092|2724100|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
855524|NCT01262287|2724157|P2|Overall Study|Lost to Follow-up|1
855525|NCT01262287|2724158|P1|Overall Study|Lost to Follow-up|2
855526|NCT01262352|2724174|P2|Washout|Extended Washout|1
855527|NCT01262352|2724175|P1|Washout|Extended Washout|0
855528|NCT01262352|2724174|P2|Washout|Adverse Event|1
855529|NCT01262352|2724175|P1|Washout|Adverse Event|1
855530|NCT01262352|2724174|P2|Period 1|Illness after randomization|0
855531|NCT01262352|2724175|P1|Period 1|Illness after randomization|1
855532|NCT01262456|2724190|P3|1-Month Open-Label Extension Period|Other Reason|0
855533|NCT01262456|2724191|P2|1-Month Open-Label Extension Period|Other Reason|1
855534|NCT01262456|2724192|P1|1-Month Open-Label Extension Period|Other Reason|0
855535|NCT01262456|2724190|P3|1-Month Open-Label Extension Period|Protocol Violation|2
855536|NCT01262456|2724191|P2|1-Month Open-Label Extension Period|Protocol Violation|0
855537|NCT01262456|2724192|P1|1-Month Open-Label Extension Period|Protocol Violation|1
855538|NCT01262456|2724190|P3|1-Month Open-Label Extension Period|Adverse Event|2
855539|NCT01262456|2724191|P2|1-Month Open-Label Extension Period|Adverse Event|0
855540|NCT01262456|2724192|P1|1-Month Open-Label Extension Period|Adverse Event|2
855541|NCT01262456|2724190|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
855542|NCT01262456|2724191|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
855543|NCT01262456|2724192|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
855544|NCT01262456|2724190|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
855545|NCT01262456|2724191|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
855546|NCT01262456|2724192|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
855547|NCT01262456|2724190|P3|3-Month Double-Blind Period|Protocol Violation|6
855548|NCT01262456|2724191|P2|3-Month Double-Blind Period|Protocol Violation|6
855549|NCT01262456|2724192|P1|3-Month Double-Blind Period|Protocol Violation|3
855550|NCT01262456|2724190|P3|3-Month Double-Blind Period|Adverse Event|8
855551|NCT01262456|2724191|P2|3-Month Double-Blind Period|Adverse Event|4
855552|NCT01262456|2724192|P1|3-Month Double-Blind Period|Adverse Event|6
855553|NCT01262456|2724190|P3|3-Month Double-Blind Period|Lost to Follow-up|3
855554|NCT01262456|2724191|P2|3-Month Double-Blind Period|Lost to Follow-up|5
855555|NCT01262456|2724192|P1|3-Month Double-Blind Period|Lost to Follow-up|4
855556|NCT01262456|2724190|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
855557|NCT01262456|2724191|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
855558|NCT01262456|2724192|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
855559|NCT01262560|2724247|P3|Overall Study|Protocol Violation|2
855560|NCT01262560|2724248|P2|Overall Study|Protocol Violation|1
855561|NCT01262560|2724249|P1|Overall Study|Protocol Violation|0
855562|NCT01262573|2724286|P2|Overall Study|Withdrawal by Subject|1
855563|NCT01262573|2724287|P1|Overall Study|Withdrawal by Subject|0
855564|NCT01262820|2724308|P1|Overall Study|Drug held for 21+ days|1
855565|NCT01262820|2724308|P1|Overall Study|Lack of Efficacy|9
855566|NCT01262820|2724308|P1|Overall Study|Adverse Event|5
855567|NCT01262872|2724332|P8|Step 2|Migrated/moved from study area|3
855568|NCT01262872|2724333|P7|Step 2|Migrated/moved from study area|2
855569|NCT01262872|2724334|P6|Step 2|Migrated/moved from study area|6
855570|NCT01262872|2724335|P5|Step 2|Migrated/moved from study area|2
855571|NCT01262872|2724336|P4|Step 2|Migrated/moved from study area|3
855572|NCT01262872|2724337|P3|Step 2|Migrated/moved from study area|4
855573|NCT01262872|2724338|P2|Step 2|Migrated/moved from study area|0
855574|NCT01262872|2724339|P1|Step 2|Migrated/moved from study area|0
855575|NCT01262872|2724332|P8|Step 2|Withdrawal by Subject|1
855576|NCT01262872|2724333|P7|Step 2|Withdrawal by Subject|2
855577|NCT01262872|2724334|P6|Step 2|Withdrawal by Subject|1
855578|NCT01262872|2724335|P5|Step 2|Withdrawal by Subject|3
855579|NCT01262872|2724336|P4|Step 2|Withdrawal by Subject|6
855580|NCT01262872|2724337|P3|Step 2|Withdrawal by Subject|4
855581|NCT01262872|2724338|P2|Step 2|Withdrawal by Subject|0
855582|NCT01262872|2724339|P1|Step 2|Withdrawal by Subject|0
855583|NCT01262872|2724332|P8|Step 2|Protocol Violation|1
855584|NCT01262872|2724333|P7|Step 2|Protocol Violation|3
855585|NCT01262872|2724334|P6|Step 2|Protocol Violation|0
855586|NCT01262872|2724335|P5|Step 2|Protocol Violation|0
855587|NCT01262872|2724336|P4|Step 2|Protocol Violation|0
855588|NCT01262872|2724337|P3|Step 2|Protocol Violation|1
855589|NCT01262872|2724338|P2|Step 2|Protocol Violation|0
855590|NCT01262872|2724339|P1|Step 2|Protocol Violation|0
855591|NCT01262872|2724332|P8|Step 2|Death|1
855592|NCT01262872|2724333|P7|Step 2|Death|2
855593|NCT01262872|2724334|P6|Step 2|Death|2
855594|NCT01262872|2724335|P5|Step 2|Death|0
855595|NCT01262872|2724336|P4|Step 2|Death|1
855596|NCT01262872|2724337|P3|Step 2|Death|0
855597|NCT01262872|2724338|P2|Step 2|Death|0
855598|NCT01262872|2724339|P1|Step 2|Death|0
855599|NCT01262989|2724592|P2|Period 2|Intercurrent disease|1
855600|NCT01262989|2724593|P1|Period 2|Intercurrent disease|0
855601|NCT01262989|2724592|P2|Period 1|Positive answer for exclusion criteria|1
855602|NCT01262989|2724593|P1|Period 1|Positive answer for exclusion criteria|0
855603|NCT01262989|2724592|P2|Period 1|Intercurrent disease|1
855604|NCT01262989|2724593|P1|Period 1|Intercurrent disease|0
855605|NCT01262989|2724592|P2|Period 1|Lost to Follow-up|1
855606|NCT01262989|2724593|P1|Period 1|Lost to Follow-up|1
855607|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
855608|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
855609|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
855610|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
855611|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
855612|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
855613|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
855614|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
855615|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
855616|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
855617|NCT01263015|2724605|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
855618|NCT01263015|2724606|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
855619|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
855620|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
855621|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
855622|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
855623|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
855624|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
855625|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
855626|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
855627|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
855628|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
855629|NCT01263015|2724605|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
855630|NCT01263015|2724606|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
855631|NCT01263028|2724632|P1|Overall Study|Study terminated due to low enrollment.|4
855632|NCT01263028|2724632|P1|Overall Study|Adverse Event|1
855633|NCT01263028|2724632|P1|Overall Study|Withdrawal by Subject|1
855634|NCT01263054|2724642|P2|Overall Study|Other|1
855635|NCT01263054|2724643|P1|Overall Study|Other|0
855636|NCT01263054|2724642|P2|Overall Study|Qualification Violation|0
855637|NCT01263054|2724643|P1|Overall Study|Qualification Violation|1
855638|NCT01263054|2724642|P2|Overall Study|Withdrawal by Subject|3
855639|NCT01263054|2724643|P1|Overall Study|Withdrawal by Subject|1
855640|NCT01263054|2724642|P2|Overall Study|Lost to Follow-up|2
855641|NCT01263054|2724643|P1|Overall Study|Lost to Follow-up|2
855642|NCT01263054|2724642|P2|Overall Study|Death|0
855643|NCT01263054|2724643|P1|Overall Study|Death|1
855644|NCT01263444|2724693|P1|Overall Study|Protocol Violation|1
855645|NCT01263444|2724693|P1|Overall Study|Withdrawal by Subject|1
855646|NCT01263444|2724693|P1|Overall Study|Adverse Event|8
855647|NCT01263470|2724706|P6|Overall Study|Study Drug Non-compliance|0
855648|NCT01263470|2724707|P5|Overall Study|Study Drug Non-compliance|1
855649|NCT01263470|2724708|P4|Overall Study|Study Drug Non-compliance|0
855650|NCT01263470|2724709|P3|Overall Study|Study Drug Non-compliance|0
855651|NCT01263470|2724710|P2|Overall Study|Study Drug Non-compliance|0
855652|NCT01263470|2724711|P1|Overall Study|Study Drug Non-compliance|0
855653|NCT01263470|2724706|P6|Overall Study|Participant Unavailability|0
855654|NCT01263470|2724707|P5|Overall Study|Participant Unavailability|0
855655|NCT01263470|2724708|P4|Overall Study|Participant Unavailability|0
855656|NCT01263470|2724709|P3|Overall Study|Participant Unavailability|0
855657|NCT01263470|2724710|P2|Overall Study|Participant Unavailability|1
855658|NCT01263470|2724711|P1|Overall Study|Participant Unavailability|0
855659|NCT01263470|2724706|P6|Overall Study|Lack of Efficacy|0
855660|NCT01263470|2724707|P5|Overall Study|Lack of Efficacy|0
855661|NCT01263470|2724708|P4|Overall Study|Lack of Efficacy|0
855662|NCT01263470|2724709|P3|Overall Study|Lack of Efficacy|2
855663|NCT01263470|2724710|P2|Overall Study|Lack of Efficacy|0
855664|NCT01263470|2724711|P1|Overall Study|Lack of Efficacy|0
855665|NCT01263470|2724706|P6|Overall Study|Withdrawal by Subject|2
855666|NCT01263470|2724707|P5|Overall Study|Withdrawal by Subject|0
855667|NCT01263470|2724708|P4|Overall Study|Withdrawal by Subject|2
855668|NCT01263470|2724709|P3|Overall Study|Withdrawal by Subject|1
855669|NCT01263470|2724710|P2|Overall Study|Withdrawal by Subject|1
855670|NCT01263470|2724711|P1|Overall Study|Withdrawal by Subject|0
855671|NCT01263470|2724706|P6|Overall Study|Protocol Violation|1
855672|NCT01263470|2724707|P5|Overall Study|Protocol Violation|0
855673|NCT01263470|2724708|P4|Overall Study|Protocol Violation|0
855674|NCT01263470|2724709|P3|Overall Study|Protocol Violation|0
855675|NCT01263470|2724710|P2|Overall Study|Protocol Violation|1
855676|NCT01263470|2724711|P1|Overall Study|Protocol Violation|0
855677|NCT01263470|2724706|P6|Overall Study|Adverse Event|2
855678|NCT01263470|2724707|P5|Overall Study|Adverse Event|2
855679|NCT01263470|2724708|P4|Overall Study|Adverse Event|1
855680|NCT01263470|2724709|P3|Overall Study|Adverse Event|1
855681|NCT01263470|2724710|P2|Overall Study|Adverse Event|2
855682|NCT01263470|2724711|P1|Overall Study|Adverse Event|2
855683|NCT01263483|2724824|P3|Overall Study|Participant Unavailability|1
855684|NCT01263483|2724825|P2|Overall Study|Participant Unavailability|1
855685|NCT01263483|2724826|P1|Overall Study|Participant Unavailability|0
855686|NCT01263483|2724824|P3|Overall Study|Protocol Violation|1
855687|NCT01263483|2724825|P2|Overall Study|Protocol Violation|1
855688|NCT01263483|2724826|P1|Overall Study|Protocol Violation|0
855689|NCT01263483|2724824|P3|Overall Study|Lack of Efficacy|0
855690|NCT01263483|2724825|P2|Overall Study|Lack of Efficacy|0
855691|NCT01263483|2724826|P1|Overall Study|Lack of Efficacy|2
855692|NCT01263483|2724824|P3|Overall Study|Withdrawal by Subject|0
855693|NCT01263483|2724825|P2|Overall Study|Withdrawal by Subject|0
855694|NCT01263483|2724826|P1|Overall Study|Withdrawal by Subject|1
855695|NCT01263483|2724824|P3|Overall Study|Adverse Event|3
855696|NCT01263483|2724825|P2|Overall Study|Adverse Event|0
855697|NCT01263483|2724826|P1|Overall Study|Adverse Event|4
855698|NCT01263496|2724887|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
855699|NCT01263496|2724888|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
855700|NCT01263496|2724889|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
855701|NCT01263496|2724890|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
855702|NCT01263496|2724891|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
855703|NCT01263496|2724892|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
855704|NCT01263496|2724893|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
855705|NCT01263496|2724894|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
855706|NCT01263496|2724895|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
855707|NCT01263496|2724887|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
855708|NCT01263496|2724888|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
855709|NCT01263496|2724889|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
855710|NCT01263496|2724890|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
855711|NCT01263496|2724891|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
855712|NCT01263496|2724892|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
855713|NCT01263496|2724893|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
855714|NCT01263496|2724894|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
855715|NCT01263496|2724895|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
855716|NCT01263496|2724887|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
855717|NCT01263496|2724888|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
855718|NCT01263496|2724889|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
855719|NCT01263496|2724890|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
855720|NCT01263496|2724891|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
855721|NCT01263496|2724892|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
855722|NCT01263496|2724893|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
855723|NCT01263496|2724894|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
855724|NCT01263496|2724895|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
855725|NCT01263496|2724887|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
855726|NCT01263496|2724888|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
855727|NCT01263496|2724889|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
855728|NCT01263496|2724890|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
855729|NCT01263496|2724891|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
855730|NCT01263496|2724892|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
855731|NCT01263496|2724893|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
855732|NCT01263496|2724894|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
855733|NCT01263496|2724895|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
855734|NCT01263496|2724887|P9|Entered - Long-Term Extension Study|Adverse Event|1
855735|NCT01263496|2724888|P8|Entered - Long-Term Extension Study|Adverse Event|0
855736|NCT01263496|2724889|P7|Entered - Long-Term Extension Study|Adverse Event|0
855737|NCT01263496|2724890|P6|Entered - Long-Term Extension Study|Adverse Event|0
855738|NCT01263496|2724891|P5|Entered - Long-Term Extension Study|Adverse Event|1
855739|NCT01263496|2724892|P4|Entered - Long-Term Extension Study|Adverse Event|3
855740|NCT01263496|2724893|P3|Entered - Long-Term Extension Study|Adverse Event|6
855741|NCT01263496|2724894|P2|Entered - Long-Term Extension Study|Adverse Event|5
855742|NCT01263496|2724895|P1|Entered - Long-Term Extension Study|Adverse Event|0
855743|NCT01263496|2724887|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
855744|NCT01263496|2724888|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
855745|NCT01263496|2724889|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
855746|NCT01263496|2724890|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
855747|NCT01263496|2724891|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
855748|NCT01263496|2724892|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
855749|NCT01263496|2724893|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
855750|NCT01263496|2724894|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
855751|NCT01263496|2724895|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
855752|NCT01263496|2724887|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
855753|NCT01263496|2724888|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
855754|NCT01263496|2724889|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
855755|NCT01263496|2724890|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
855756|NCT01263496|2724891|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
855757|NCT01263496|2724892|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
855758|NCT01263496|2724893|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
855759|NCT01263496|2724894|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
855760|NCT01263496|2724895|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
855761|NCT01263509|2725189|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
855762|NCT01263509|2725190|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
855763|NCT01263509|2725191|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
855764|NCT01263509|2725192|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
855765|NCT01263509|2725189|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
855766|NCT01263509|2725190|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
855767|NCT01263509|2725191|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
855768|NCT01263509|2725192|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
855769|NCT01263509|2725189|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
855770|NCT01263509|2725190|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
855771|NCT01263509|2725191|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
855772|NCT01263509|2725192|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
855773|NCT01263509|2725189|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
855774|NCT01263509|2725190|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
855775|NCT01263509|2725191|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
855776|NCT01263509|2725192|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
855777|NCT01263509|2725189|P4|Entered - Long-Term Extension Study|Adverse Event|1
855778|NCT01263509|2725190|P3|Entered - Long-Term Extension Study|Adverse Event|4
855779|NCT01263509|2725191|P2|Entered - Long-Term Extension Study|Adverse Event|5
855780|NCT01263509|2725192|P1|Entered - Long-Term Extension Study|Adverse Event|5
855781|NCT01263561|2725318|P2|Overall Study|Death|2
855782|NCT01263561|2725319|P1|Overall Study|Death|1
855783|NCT01263639|2725331|P2|Overall Study|Exclusion =Admission greater than 7 days|9
855784|NCT01263639|2725332|P1|Overall Study|Exclusion =Admission greater than 7 days|7
855785|NCT01263639|2725331|P2|Overall Study|Lost to Follow-up|70
855786|NCT01263639|2725332|P1|Overall Study|Lost to Follow-up|66
855787|NCT01263665|2725338|P1|Overall Study|Surgical Bypass|2
855788|NCT01263665|2725338|P1|Overall Study|Amputation above the ankle|1
855789|NCT01263665|2725338|P1|Overall Study|Death|2
855790|NCT01263665|2725338|P1|Overall Study|Lost to Follow-up|3
855791|NCT01263665|2725338|P1|Overall Study|Withdrew Consent|1
855792|NCT01263691|2725349|P6|Overall Study|Adverse Event|0
855793|NCT01263691|2725350|P5|Overall Study|Adverse Event|0
855794|NCT01263691|2725351|P4|Overall Study|Adverse Event|0
855795|NCT01263691|2725352|P3|Overall Study|Adverse Event|0
855796|NCT01263691|2725353|P2|Overall Study|Adverse Event|0
855797|NCT01263691|2725354|P1|Overall Study|Adverse Event|1
855798|NCT01263691|2725349|P6|Overall Study|Withdrawal by Subject|0
855799|NCT01263691|2725350|P5|Overall Study|Withdrawal by Subject|0
855800|NCT01263691|2725351|P4|Overall Study|Withdrawal by Subject|0
855801|NCT01263691|2725352|P3|Overall Study|Withdrawal by Subject|0
855802|NCT01263691|2725353|P2|Overall Study|Withdrawal by Subject|0
855803|NCT01263691|2725354|P1|Overall Study|Withdrawal by Subject|1
855804|NCT01263691|2725349|P6|Overall Study|Lost to Follow-up|0
855805|NCT01263691|2725350|P5|Overall Study|Lost to Follow-up|0
855806|NCT01263691|2725351|P4|Overall Study|Lost to Follow-up|1
855807|NCT01263691|2725352|P3|Overall Study|Lost to Follow-up|1
855808|NCT01263691|2725353|P2|Overall Study|Lost to Follow-up|0
855809|NCT01263691|2725354|P1|Overall Study|Lost to Follow-up|1
855810|NCT01263873|2725495|P2|Overall Study|One provider unable to complete numbers|1
855811|NCT01263873|2725496|P1|Overall Study|One provider unable to complete numbers|1
855812|NCT01263925|2725508|P2|Overall Study|Withdrawal/ Not specified|1
855813|NCT01263925|2725509|P1|Overall Study|Withdrawal/ Not specified|0
855814|NCT01263925|2725508|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
855815|NCT01263925|2725509|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
855816|NCT01263925|2725508|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
855817|NCT01263925|2725509|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
855818|NCT01263925|2725508|P2|Overall Study|AE/ Withdrawal|4
855819|NCT01263925|2725509|P1|Overall Study|AE/ Withdrawal|1
855820|NCT01263925|2725508|P2|Overall Study|AE/ Unsatisfactory Compliance|2
855821|NCT01263925|2725509|P1|Overall Study|AE/ Unsatisfactory Compliance|2
855822|NCT01263925|2725508|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
855823|NCT01263925|2725509|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
855824|NCT01263925|2725508|P2|Overall Study|Lost to Follow-up|1
855825|NCT01263925|2725509|P1|Overall Study|Lost to Follow-up|3
855826|NCT01263925|2725508|P2|Overall Study|Not specified|4
855827|NCT01263925|2725509|P1|Overall Study|Not specified|4
855828|NCT01263925|2725508|P2|Overall Study|Withdrawal by Subject|8
855829|NCT01263925|2725509|P1|Overall Study|Withdrawal by Subject|6
855830|NCT01263925|2725508|P2|Overall Study|Unsatisfactory Compliance of Subject|5
855831|NCT01263925|2725509|P1|Overall Study|Unsatisfactory Compliance of Subject|8
855832|NCT01263925|2725508|P2|Overall Study|Adverse Event|22
855833|NCT01263925|2725509|P1|Overall Study|Adverse Event|23
855834|NCT01263925|2725508|P2|Overall Study|Lack of Efficacy|1
855835|NCT01263925|2725509|P1|Overall Study|Lack of Efficacy|0
855836|NCT01263925|2725508|P2|Overall Study|Protocol Violation|0
855837|NCT01263925|2725509|P1|Overall Study|Protocol Violation|1
855838|NCT01264016|2725541|P1|Overall Study|Felt faint at sight of blood|1
855839|NCT01264016|2725541|P1|Overall Study|Withdrawal by Subject|1
855840|NCT01264081|2725547|P1|Started Treatment|Not complete cycle 1 due to death|1
855841|NCT01264081|2725547|P1|Started Treatment|Withdrawal by Subject|1
855842|NCT01264081|2725547|P1|Participants Screened|Screening failures|30
855843|NCT01269918|2725578|P2|Overall Study|Did not receive study drug|3
855844|NCT01269918|2725579|P1|Overall Study|Did not receive study drug|0
855845|NCT01274429|2725611|P1|Overall Study|Study closed do to lack of funding|5
855846|NCT01274533|2725616|P1|Overall Study|Disease progression|2
855847|NCT01274533|2725616|P1|Overall Study|Non-compliance|1
855848|NCT01274533|2725616|P1|Overall Study|Withdrawal by Subject|1
855849|NCT01274559|2725623|P2|Overall Study|Withdrawal by Subject|13
855850|NCT01274559|2725624|P1|Overall Study|Withdrawal by Subject|25
855851|NCT01274559|2725623|P2|Overall Study|Study Terminated by Sponsor|87
855852|NCT01274559|2725624|P1|Overall Study|Study Terminated by Sponsor|79
855853|NCT01274559|2725623|P2|Overall Study|Protocol Violation|23
855854|NCT01274559|2725624|P1|Overall Study|Protocol Violation|28
855855|NCT01274559|2725623|P2|Overall Study|Physician Decision|1
855856|NCT01274559|2725624|P1|Overall Study|Physician Decision|2
855857|NCT01274559|2725623|P2|Overall Study|Non-compliance with Study Drug|4
855858|NCT01274559|2725624|P1|Overall Study|Non-compliance with Study Drug|2
855859|NCT01274559|2725623|P2|Overall Study|Lost to Follow-up|3
855860|NCT01274559|2725624|P1|Overall Study|Lost to Follow-up|3
855861|NCT01274559|2725623|P2|Overall Study|Death|1
855862|NCT01274559|2725624|P1|Overall Study|Death|1
855863|NCT01274559|2725623|P2|Overall Study|Adverse Event|13
855864|NCT01274559|2725624|P1|Overall Study|Adverse Event|57
855865|NCT01274637|2725693|P2|Overall Study|Lost to Follow-up|1
855866|NCT01274637|2725694|P1|Overall Study|Lost to Follow-up|0
855867|NCT01274637|2725693|P2|Overall Study|Withdrawal by Subject|1
855868|NCT01274637|2725694|P1|Overall Study|Withdrawal by Subject|0
855869|NCT01274715|2725710|P1|Overall Study|After consent, met exclusion criteria.|1
855870|NCT01274715|2725710|P1|Overall Study|After consent, met exclusion criteria.|1
855871|NCT01274715|2725710|P1|Overall Study|After consent, met exclusion criteria.|1
855872|NCT01274715|2725710|P1|Overall Study|Lost to Follow-up|1
855873|NCT01275066|2725737|P3|Overall Study|Not Diagnosed w/ Disease|0
855874|NCT01275066|2725738|P2|Overall Study|Not Diagnosed w/ Disease|0
855875|NCT01275066|2725739|P1|Overall Study|Not Diagnosed w/ Disease|1
855876|NCT01275066|2725737|P3|Overall Study|Withdrawal by Subject|1
855877|NCT01275066|2725738|P2|Overall Study|Withdrawal by Subject|0
855878|NCT01275066|2725739|P1|Overall Study|Withdrawal by Subject|0
855879|NCT01275131|2725763|P4|Period 2 (Crossover)|Withdrawal by Subject|2
855880|NCT01275131|2725764|P3|Period 2 (Crossover)|Withdrawal by Subject|1
855881|NCT01275131|2725765|P2|Period 2 (Crossover)|Withdrawal by Subject|0
855882|NCT01275131|2725766|P1|Period 2 (Crossover)|Withdrawal by Subject|1
855883|NCT01275131|2725763|P4|Period 2 (Crossover)|Adverse Event|0
855884|NCT01275131|2725764|P3|Period 2 (Crossover)|Adverse Event|0
855885|NCT01275131|2725765|P2|Period 2 (Crossover)|Adverse Event|1
855886|NCT01275131|2725766|P1|Period 2 (Crossover)|Adverse Event|0
855887|NCT01275131|2725763|P4|Period 1|Physician Decision|0
855888|NCT01275131|2725764|P3|Period 1|Physician Decision|0
855889|NCT01275131|2725765|P2|Period 1|Physician Decision|0
855890|NCT01275131|2725766|P1|Period 1|Physician Decision|1
855891|NCT01275131|2725763|P4|Period 1|Withdrawal by Subject|2
855892|NCT01275131|2725764|P3|Period 1|Withdrawal by Subject|3
855893|NCT01275131|2725765|P2|Period 1|Withdrawal by Subject|0
855894|NCT01275131|2725766|P1|Period 1|Withdrawal by Subject|1
855895|NCT01275196|2725802|P2|Overall Study|Suboptimal response/treatment failure|6
855896|NCT01275196|2725803|P1|Overall Study|Suboptimal response/treatment failure|5
855897|NCT01275196|2725802|P2|Overall Study|Protocol Violation|0
855898|NCT01275196|2725803|P1|Overall Study|Protocol Violation|1
855899|NCT01275196|2725802|P2|Overall Study|Disease Progression|5
855900|NCT01275196|2725803|P1|Overall Study|Disease Progression|6
855901|NCT01275196|2725802|P2|Overall Study|Lost to Follow-up|0
855902|NCT01275196|2725803|P1|Overall Study|Lost to Follow-up|1
855903|NCT01275196|2725802|P2|Overall Study|Withdrawal by Subject|5
855904|NCT01275196|2725803|P1|Overall Study|Withdrawal by Subject|4
855905|NCT01275196|2725802|P2|Overall Study|Adverse Event|5
855906|NCT01275196|2725803|P1|Overall Study|Adverse Event|3
855907|NCT01275430|2725851|P1|Overall Study|Inability to achieve maximum p-wave|1
855908|NCT01275430|2725851|P1|Overall Study|Device Malfunction|1
855909|NCT01275430|2725851|P1|Overall Study|No Contrast Injection|6
855910|NCT01275430|2725851|P1|Overall Study|Adverse Event|1
855911|NCT01275625|2725863|P1|Overall Study|Not specified|1
855912|NCT01275625|2725863|P1|Overall Study|Adverse Event|4
855913|NCT01275625|2725863|P1|Overall Study|Protocol Violation|1
855914|NCT01275625|2725863|P1|Overall Study|Withdrawal by Subject|3
855915|NCT01275625|2725863|P1|Overall Study|Lost to Follow-up|1
855916|NCT01275625|2725863|P1|Overall Study|Lack of Efficacy|2
855917|NCT01275625|2725863|P1|Overall Study|Death|1
855918|NCT01275755|2725879|P2|Run-out Placebo Period|Lost to Follow-up|0
855919|NCT01275755|2725880|P1|Run-out Placebo Period|Lost to Follow-up|1
855920|NCT01275755|2725879|P2|Double-blind Treatment Period|Withdrawal by Subject|0
855921|NCT01275755|2725880|P1|Double-blind Treatment Period|Withdrawal by Subject|1
855922|NCT01275755|2725879|P2|Double-blind Treatment Period|Lost to Follow-up|1
855923|NCT01275755|2725880|P1|Double-blind Treatment Period|Lost to Follow-up|1
855924|NCT01275755|2725879|P2|Double-blind Treatment Period|Adverse Event|2
855925|NCT01275755|2725880|P1|Double-blind Treatment Period|Adverse Event|0
855926|NCT01275833|2725888|P2|Overall Study|Study terminated|1
855927|NCT01275833|2725889|P1|Overall Study|Study terminated|1
855928|NCT01276054|2725897|P2|Overall Study|No one to oversee trial after P.I. left|2
855929|NCT01276054|2725898|P1|Overall Study|No one to oversee trial after P.I. left|2
855930|NCT01276106|2725908|P4|Overall Study|Insufficient therapeutic effects|0
855931|NCT01276106|2725909|P3|Overall Study|Insufficient therapeutic effects|2
855932|NCT01276106|2725910|P2|Overall Study|Insufficient therapeutic effects|0
855933|NCT01276106|2725911|P1|Overall Study|Insufficient therapeutic effects|0
855934|NCT01276106|2725908|P4|Overall Study|Protocol Violation|2
855935|NCT01276106|2725909|P3|Overall Study|Protocol Violation|0
855936|NCT01276106|2725910|P2|Overall Study|Protocol Violation|1
855937|NCT01276106|2725911|P1|Overall Study|Protocol Violation|1
855938|NCT01276106|2725908|P4|Overall Study|Physician Decision|1
855939|NCT01276106|2725909|P3|Overall Study|Physician Decision|1
855940|NCT01276106|2725910|P2|Overall Study|Physician Decision|0
855941|NCT01276106|2725911|P1|Overall Study|Physician Decision|0
855942|NCT01276106|2725908|P4|Overall Study|Lost to Follow-up|0
855943|NCT01276106|2725909|P3|Overall Study|Lost to Follow-up|1
855944|NCT01276106|2725910|P2|Overall Study|Lost to Follow-up|1
855945|NCT01276106|2725911|P1|Overall Study|Lost to Follow-up|2
855946|NCT01276106|2725908|P4|Overall Study|Lack of Efficacy|1
855947|NCT01276106|2725909|P3|Overall Study|Lack of Efficacy|0
855948|NCT01276106|2725910|P2|Overall Study|Lack of Efficacy|1
855949|NCT01276106|2725911|P1|Overall Study|Lack of Efficacy|0
855950|NCT01276106|2725908|P4|Overall Study|Withdrawal by Subject|6
855951|NCT01276106|2725909|P3|Overall Study|Withdrawal by Subject|1
855952|NCT01276106|2725910|P2|Overall Study|Withdrawal by Subject|3
855953|NCT01276106|2725911|P1|Overall Study|Withdrawal by Subject|6
855954|NCT01276106|2725908|P4|Overall Study|Adverse Event|3
855955|NCT01276106|2725909|P3|Overall Study|Adverse Event|11
855956|NCT01276106|2725910|P2|Overall Study|Adverse Event|3
855957|NCT01276106|2725911|P1|Overall Study|Adverse Event|3
855958|NCT01276223|2725954|P3|Overall Study|Protocol Violation|0
855959|NCT01276223|2725955|P2|Overall Study|Protocol Violation|0
855960|NCT01276223|2725956|P1|Overall Study|Protocol Violation|1
855961|NCT01276223|2725954|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
855962|NCT01276223|2725955|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
855963|NCT01276223|2725956|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
855964|NCT01276223|2725954|P3|Overall Study|Not specified|1
855965|NCT01276223|2725955|P2|Overall Study|Not specified|0
855966|NCT01276223|2725956|P1|Overall Study|Not specified|0
855967|NCT01276223|2725954|P3|Overall Study|Lost to Follow-up|1
855968|NCT01276223|2725955|P2|Overall Study|Lost to Follow-up|0
855969|NCT01276223|2725956|P1|Overall Study|Lost to Follow-up|0
855970|NCT01276223|2725954|P3|Overall Study|Adverse Event|1
855971|NCT01276223|2725955|P2|Overall Study|Adverse Event|4
855972|NCT01276223|2725956|P1|Overall Study|Adverse Event|7
855973|NCT01276288|2725963|P4|Overall Study|not treated|0
855974|NCT01276288|2725964|P3|Overall Study|not treated|0
855975|NCT01276288|2725965|P2|Overall Study|not treated|0
855976|NCT01276288|2725966|P1|Overall Study|not treated|1
855977|NCT01276288|2725963|P4|Overall Study|Adverse Event|0
855978|NCT01276288|2725964|P3|Overall Study|Adverse Event|0
855979|NCT01276288|2725965|P2|Overall Study|Adverse Event|1
855980|NCT01276288|2725966|P1|Overall Study|Adverse Event|1
855981|NCT01276327|2726120|P2|Overall Study|Withdrawal by Subject|0
855982|NCT01276327|2726121|P1|Overall Study|Withdrawal by Subject|1
855983|NCT01276327|2726120|P2|Overall Study|Adverse Event|3
855984|NCT01276327|2726121|P1|Overall Study|Adverse Event|1
855985|NCT01276353|2726145|P2|Extension|Prohibited concomitant medications|1
855986|NCT01276353|2726146|P1|Extension|Prohibited concomitant medications|0
855987|NCT01276353|2726145|P2|Extension|Physician Decision|0
855988|NCT01276353|2726146|P1|Extension|Physician Decision|1
855989|NCT01276353|2726145|P2|Extension|Withdrawal of study drug 4 days in a row|1
855990|NCT01276353|2726146|P1|Extension|Withdrawal of study drug 4 days in a row|3
855991|NCT01276353|2726145|P2|Extension|Withdrawal by Subject|2
855992|NCT01276353|2726146|P1|Extension|Withdrawal by Subject|1
855993|NCT01276353|2726145|P2|Extension|Adverse Event|5
855994|NCT01276353|2726146|P1|Extension|Adverse Event|2
855995|NCT01276353|2726145|P2|Double-blind|Withdrawal by Subject|0
855996|NCT01276353|2726146|P1|Double-blind|Withdrawal by Subject|1
855997|NCT01276353|2726145|P2|Double-blind|Adverse Event|0
855998|NCT01276353|2726146|P1|Double-blind|Adverse Event|2
855999|NCT01276457|2726158|P2|Extension Study|Lack of Efficacy|1
856000|NCT01276457|2726159|P1|Extension Study|Lack of Efficacy|3
856001|NCT01276457|2726158|P2|Extension Study|Death|1
856002|NCT01276457|2726159|P1|Extension Study|Death|0
856003|NCT01276457|2726158|P2|Extension Study|Lost to Follow-up|0
856004|NCT01276457|2726159|P1|Extension Study|Lost to Follow-up|3
856005|NCT01276457|2726158|P2|Core Study|Lack of Efficacy|12
856006|NCT01276457|2726159|P1|Core Study|Lack of Efficacy|3
856007|NCT01276457|2726158|P2|Core Study|Death|2
856008|NCT01276457|2726159|P1|Core Study|Death|2
856009|NCT01276457|2726158|P2|Core Study|Administrative problems|1
856010|NCT01276457|2726159|P1|Core Study|Administrative problems|1
856011|NCT01276457|2726158|P2|Core Study|Lost to Follow-up|2
856012|NCT01276457|2726159|P1|Core Study|Lost to Follow-up|1
856013|NCT01276457|2726158|P2|Core Study|Adverse Event|3
856014|NCT01276457|2726159|P1|Core Study|Adverse Event|6
894594|NCT02553772|2839789|P1|Overall Study|Lack of Efficacy|1
894595|NCT02553772|2839788|P2|Overall Study|Withdrawal of Consent|1
894596|NCT02553772|2839789|P1|Overall Study|Withdrawal of Consent|1
894597|NCT02553772|2839788|P2|Overall Study|Lost to Follow-up|1
894598|NCT02553772|2839789|P1|Overall Study|Lost to Follow-up|2
894599|NCT02553772|2839788|P2|Overall Study|Adverse Event|3
894600|NCT02553772|2839789|P1|Overall Study|Adverse Event|2
894601|NCT02502734|2839839|P2|Washout Period|Adverse Event|0
894602|NCT02502734|2839840|P1|Washout Period|Adverse Event|1
894603|NCT02502734|2839839|P2|Double-blind Treatment Period 1|Adverse Event|0
894604|NCT02502734|2839840|P1|Double-blind Treatment Period 1|Adverse Event|1
894605|NCT02322216|2839880|P2|Overall Study|Withdrawal by Subject|4
894606|NCT02322216|2839881|P1|Overall Study|Withdrawal by Subject|1
894607|NCT02322216|2839880|P2|Overall Study|Adverse Event|0
894608|NCT02322216|2839881|P1|Overall Study|Adverse Event|1
894609|NCT02251717|2839899|P2|Overall Study|Withdrew Consent|0
894610|NCT02251717|2839900|P1|Overall Study|Withdrew Consent|1
894611|NCT02251717|2839899|P2|Overall Study|Adverse Event|1
894612|NCT02251717|2839900|P1|Overall Study|Adverse Event|0
894613|NCT02202980|2839926|P14|Overall Study|Withdrew Consent|0
894614|NCT02202980|2839927|P13|Overall Study|Withdrew Consent|0
894615|NCT02202980|2839928|P12|Overall Study|Withdrew Consent|0
894616|NCT02202980|2839929|P11|Overall Study|Withdrew Consent|0
894617|NCT02202980|2839930|P10|Overall Study|Withdrew Consent|0
894618|NCT02202980|2839931|P9|Overall Study|Withdrew Consent|1
894619|NCT02202980|2839932|P8|Overall Study|Withdrew Consent|0
894620|NCT02202980|2839933|P7|Overall Study|Withdrew Consent|0
894621|NCT02202980|2839934|P6|Overall Study|Withdrew Consent|0
894622|NCT02202980|2839935|P5|Overall Study|Withdrew Consent|0
894623|NCT02202980|2839936|P4|Overall Study|Withdrew Consent|0
894624|NCT02202980|2839937|P3|Overall Study|Withdrew Consent|2
894625|NCT02202980|2839938|P2|Overall Study|Withdrew Consent|1
894626|NCT02202980|2839939|P1|Overall Study|Withdrew Consent|0
894627|NCT02202980|2839926|P14|Overall Study|Lost to Follow-up|0
894628|NCT02202980|2839927|P13|Overall Study|Lost to Follow-up|1
894629|NCT02202980|2839928|P12|Overall Study|Lost to Follow-up|0
894630|NCT02202980|2839929|P11|Overall Study|Lost to Follow-up|0
894631|NCT02202980|2839930|P10|Overall Study|Lost to Follow-up|0
894632|NCT02202980|2839931|P9|Overall Study|Lost to Follow-up|1
894633|NCT02202980|2839932|P8|Overall Study|Lost to Follow-up|1
894634|NCT02202980|2839933|P7|Overall Study|Lost to Follow-up|0
894635|NCT02202980|2839934|P6|Overall Study|Lost to Follow-up|0
894636|NCT02202980|2839935|P5|Overall Study|Lost to Follow-up|0
894637|NCT02202980|2839936|P4|Overall Study|Lost to Follow-up|1
894638|NCT02202980|2839937|P3|Overall Study|Lost to Follow-up|1
894639|NCT02202980|2839938|P2|Overall Study|Lost to Follow-up|1
894640|NCT02202980|2839939|P1|Overall Study|Lost to Follow-up|0
894641|NCT02202980|2839926|P14|Overall Study|Protocol Violation|0
894642|NCT02202980|2839927|P13|Overall Study|Protocol Violation|0
894643|NCT02202980|2839928|P12|Overall Study|Protocol Violation|0
894644|NCT02202980|2839929|P11|Overall Study|Protocol Violation|0
894645|NCT02202980|2839930|P10|Overall Study|Protocol Violation|0
894646|NCT02202980|2839931|P9|Overall Study|Protocol Violation|0
894647|NCT02202980|2839932|P8|Overall Study|Protocol Violation|0
894648|NCT02202980|2839933|P7|Overall Study|Protocol Violation|0
894649|NCT02202980|2839934|P6|Overall Study|Protocol Violation|0
894650|NCT02202980|2839935|P5|Overall Study|Protocol Violation|3
894651|NCT02202980|2839936|P4|Overall Study|Protocol Violation|3
894652|NCT02202980|2839937|P3|Overall Study|Protocol Violation|0
894653|NCT02202980|2839938|P2|Overall Study|Protocol Violation|0
894654|NCT02202980|2839939|P1|Overall Study|Protocol Violation|0
894655|NCT02202980|2839926|P14|Overall Study|Lack of Efficacy|0
894656|NCT02202980|2839927|P13|Overall Study|Lack of Efficacy|10
894657|NCT02202980|2839928|P12|Overall Study|Lack of Efficacy|3
894658|NCT02202980|2839929|P11|Overall Study|Lack of Efficacy|0
894659|NCT02202980|2839930|P10|Overall Study|Lack of Efficacy|0
894660|NCT02202980|2839931|P9|Overall Study|Lack of Efficacy|2
894661|NCT02202980|2839932|P8|Overall Study|Lack of Efficacy|2
894662|NCT02202980|2839933|P7|Overall Study|Lack of Efficacy|11
894663|NCT02202980|2839934|P6|Overall Study|Lack of Efficacy|1
894664|NCT02202980|2839935|P5|Overall Study|Lack of Efficacy|3
894665|NCT02202980|2839936|P4|Overall Study|Lack of Efficacy|0
894666|NCT02202980|2839937|P3|Overall Study|Lack of Efficacy|7
894667|NCT02202980|2839938|P2|Overall Study|Lack of Efficacy|0
894668|NCT02202980|2839939|P1|Overall Study|Lack of Efficacy|1
894669|NCT02132949|2840027|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
894670|NCT02132949|2840028|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
894671|NCT02132949|2840027|P2|Adjuvant Treatment Period|Protocol Deviation|0
894672|NCT02132949|2840028|P1|Adjuvant Treatment Period|Protocol Deviation|1
894673|NCT02132949|2840027|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
894674|NCT02132949|2840028|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
856100|NCT01261624|2726439|P2|Week 13 to Week 24|Insufficient Response|1
856101|NCT01261624|2726440|P1|Week 13 to Week 24|Insufficient Response|0
856102|NCT01261624|2726439|P2|Week 0 to Week 12|Insufficient Response|2
856103|NCT01261624|2726440|P1|Week 0 to Week 12|Insufficient Response|0
856104|NCT01261624|2726439|P2|Week 0 to Week 12|Disease Progression|1
856105|NCT01261624|2726440|P1|Week 0 to Week 12|Disease Progression|1
856106|NCT01267175|2726468|P1|Overall Study|Lost to Follow-up|1
856107|NCT01267175|2726468|P1|Overall Study|Withdrawal by Subject|1
856108|NCT01267201|2726473|P6|Second Intervention Period|Withdrawal by Subject|0
856109|NCT01267201|2726474|P5|Second Intervention Period|Withdrawal by Subject|0
856110|NCT01267201|2726475|P4|Second Intervention Period|Withdrawal by Subject|0
856111|NCT01267201|2726476|P3|Second Intervention Period|Withdrawal by Subject|0
856112|NCT01267201|2726477|P2|Second Intervention Period|Withdrawal by Subject|1
856113|NCT01267201|2726478|P1|Second Intervention Period|Withdrawal by Subject|0
856114|NCT01267201|2726473|P6|First Intervention Period|Withdrawal by Subject|0
856115|NCT01267201|2726474|P5|First Intervention Period|Withdrawal by Subject|0
856116|NCT01267201|2726475|P4|First Intervention Period|Withdrawal by Subject|0
856117|NCT01267201|2726476|P3|First Intervention Period|Withdrawal by Subject|0
856118|NCT01267201|2726477|P2|First Intervention Period|Withdrawal by Subject|0
856119|NCT01267201|2726478|P1|First Intervention Period|Withdrawal by Subject|1
856120|NCT01267253|2726522|P1|Overall Study|Inevaluable-never received study treatme|2
856121|NCT01267253|2726522|P1|Overall Study|Ineligible - required test not done|1
856122|NCT01276756|2726560|P2|Overall Study|Adverse Event|2
856123|NCT01276756|2726561|P1|Overall Study|Adverse Event|3
856124|NCT01276756|2726560|P2|Overall Study|Lost to Follow-up|0
856125|NCT01276756|2726561|P1|Overall Study|Lost to Follow-up|2
856126|NCT01276821|2726577|P2|Overall Study|Protocol Violation|1
856127|NCT01276821|2726578|P1|Overall Study|Protocol Violation|0
856128|NCT01276847|2726599|P3|Overall Study|Withdrawal by Subject|0
856129|NCT01276847|2726600|P2|Overall Study|Withdrawal by Subject|0
856130|NCT01276847|2726601|P1|Overall Study|Withdrawal by Subject|1
856131|NCT01277822|2726611|P2|Overall Study|Participant moved|0
856132|NCT01277822|2726612|P1|Overall Study|Participant moved|1
856133|NCT01277822|2726611|P2|Overall Study|Contraindicated medication used|1
856134|NCT01277822|2726612|P1|Overall Study|Contraindicated medication used|2
856135|NCT01277822|2726611|P2|Overall Study|Lost to Follow-up|1
856136|NCT01277822|2726612|P1|Overall Study|Lost to Follow-up|2
856137|NCT01277822|2726611|P2|Overall Study|Protocol Violation|0
856138|NCT01277822|2726612|P1|Overall Study|Protocol Violation|1
856139|NCT01277822|2726611|P2|Overall Study|Physician Decision|1
856140|NCT01277822|2726612|P1|Overall Study|Physician Decision|1
856141|NCT01277822|2726611|P2|Overall Study|Withdrawal by Subject|7
856142|NCT01277822|2726612|P1|Overall Study|Withdrawal by Subject|6
856143|NCT01277822|2726611|P2|Overall Study|Adverse Event|1
856144|NCT01277822|2726612|P1|Overall Study|Adverse Event|2
856145|NCT01277861|2726634|P2|Overall Study|Physician Decision|2
856146|NCT01277861|2726635|P1|Overall Study|Physician Decision|2
856147|NCT01278030|2726647|P2|Overall Study|Withdrawal by Subject|4
856148|NCT01278030|2726648|P1|Overall Study|Withdrawal by Subject|8
856149|NCT01278160|2726656|P2|Overall Study|Unclassified|2
856150|NCT01278160|2726657|P1|Overall Study|Unclassified|1
856151|NCT01278160|2726656|P2|Overall Study|Withdrawal by Subject|2
856152|NCT01278160|2726657|P1|Overall Study|Withdrawal by Subject|3
856153|NCT01278160|2726656|P2|Overall Study|Lost to Follow-up|1
856154|NCT01278160|2726657|P1|Overall Study|Lost to Follow-up|0
856155|NCT01278160|2726656|P2|Overall Study|Adverse Event|1
856156|NCT01278160|2726657|P1|Overall Study|Adverse Event|1
856157|NCT01278173|2726671|P1|Overall Study|Withdrawal by Subject|1
856158|NCT01278173|2726671|P1|Overall Study|Protocol Violation|1
856159|NCT01278173|2726671|P1|Overall Study|Administrative or other reason|4
856160|NCT01278173|2726671|P1|Overall Study|Adverse Event|8
856161|NCT01278173|2726671|P1|Overall Study|Lack of Efficacy|13
856162|NCT01278342|2726685|P3|Overall Study|Other|0
856163|NCT01278342|2726686|P2|Overall Study|Other|0
856164|NCT01278342|2726687|P1|Overall Study|Other|1
856165|NCT01278342|2726685|P3|Overall Study|Administrative problems|0
856166|NCT01278342|2726686|P2|Overall Study|Administrative problems|0
856167|NCT01278342|2726687|P1|Overall Study|Administrative problems|2
856168|NCT01278342|2726685|P3|Overall Study|Lost to Follow-up|0
856169|NCT01278342|2726686|P2|Overall Study|Lost to Follow-up|0
856170|NCT01278342|2726687|P1|Overall Study|Lost to Follow-up|1
856171|NCT01278342|2726685|P3|Overall Study|Physician Decision|0
856172|NCT01278342|2726686|P2|Overall Study|Physician Decision|1
856173|NCT01278342|2726687|P1|Overall Study|Physician Decision|0
894675|NCT02132949|2840027|P2|Adjuvant Treatment Period|Physician Decision|0
856175|NCT01278407|2726714|P5|Extension Phase|Not Specified|3
856176|NCT01278407|2726715|P4|Extension Phase|Not Specified|1
856177|NCT01278407|2726716|P3|Extension Phase|Not Specified|0
856178|NCT01278407|2726717|P2|Extension Phase|Not Specified|0
856179|NCT01278407|2726718|P1|Extension Phase|Not Specified|0
856180|NCT01278407|2726714|P5|Extension Phase|Participant's Choice|11
856181|NCT01278407|2726715|P4|Extension Phase|Participant's Choice|4
856182|NCT01278407|2726716|P3|Extension Phase|Participant's Choice|0
856183|NCT01278407|2726717|P2|Extension Phase|Participant's Choice|0
856184|NCT01278407|2726718|P1|Extension Phase|Participant's Choice|0
856185|NCT01278407|2726714|P5|Extension Phase|Adverse Event|16
856186|NCT01278407|2726715|P4|Extension Phase|Adverse Event|7
856187|NCT01278407|2726716|P3|Extension Phase|Adverse Event|0
856188|NCT01278407|2726717|P2|Extension Phase|Adverse Event|0
856189|NCT01278407|2726718|P1|Extension Phase|Adverse Event|0
856190|NCT01278407|2726714|P5|Confirmatory Phase|Not Specified|0
856191|NCT01278407|2726715|P4|Confirmatory Phase|Not Specified|0
856192|NCT01278407|2726716|P3|Confirmatory Phase|Not Specified|2
856193|NCT01278407|2726717|P2|Confirmatory Phase|Not Specified|1
856194|NCT01278407|2726718|P1|Confirmatory Phase|Not Specified|1
856195|NCT01278407|2726714|P5|Confirmatory Phase|Participant's Choice|0
856196|NCT01278407|2726715|P4|Confirmatory Phase|Participant's Choice|0
856197|NCT01278407|2726716|P3|Confirmatory Phase|Participant's Choice|3
856198|NCT01278407|2726717|P2|Confirmatory Phase|Participant's Choice|5
856199|NCT01278407|2726718|P1|Confirmatory Phase|Participant's Choice|3
856200|NCT01278407|2726714|P5|Confirmatory Phase|Adverse Event|0
856201|NCT01278407|2726715|P4|Confirmatory Phase|Adverse Event|0
856202|NCT01278407|2726716|P3|Confirmatory Phase|Adverse Event|1
856203|NCT01278407|2726717|P2|Confirmatory Phase|Adverse Event|10
856204|NCT01278407|2726718|P1|Confirmatory Phase|Adverse Event|5
856205|NCT01278615|2726744|P1|Overall Study|Withdrawal by Subject|2
856206|NCT01278745|2726756|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
856207|NCT01278745|2726757|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
856208|NCT01278745|2726758|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
856209|NCT01278745|2726759|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
856210|NCT01278745|2726756|P4|Overall Study|Ineligible|61
856211|NCT01278745|2726757|P3|Overall Study|Ineligible|42
856212|NCT01278745|2726758|P2|Overall Study|Ineligible|0
856213|NCT01278745|2726759|P1|Overall Study|Ineligible|0
856214|NCT01278745|2726756|P4|Overall Study|Sponsor Decision|6
856215|NCT01278745|2726757|P3|Overall Study|Sponsor Decision|62
856216|NCT01278745|2726758|P2|Overall Study|Sponsor Decision|0
856217|NCT01278745|2726759|P1|Overall Study|Sponsor Decision|1
856218|NCT01278745|2726756|P4|Overall Study|Withdrawal by Subject|1
856219|NCT01278745|2726757|P3|Overall Study|Withdrawal by Subject|5
856220|NCT01278745|2726758|P2|Overall Study|Withdrawal by Subject|1
856221|NCT01278745|2726759|P1|Overall Study|Withdrawal by Subject|1
856222|NCT01278745|2726756|P4|Overall Study|Physician Decision|9
856223|NCT01278745|2726757|P3|Overall Study|Physician Decision|0
856224|NCT01278745|2726758|P2|Overall Study|Physician Decision|0
856225|NCT01278745|2726759|P1|Overall Study|Physician Decision|1
856226|NCT01278745|2726756|P4|Overall Study|Death|0
856227|NCT01278745|2726757|P3|Overall Study|Death|7
856228|NCT01278745|2726758|P2|Overall Study|Death|5
856229|NCT01278745|2726759|P1|Overall Study|Death|2
856230|NCT01278797|2726791|P2|Period 1|Protocol Violation|0
856231|NCT01278797|2726792|P1|Period 1|Protocol Violation|1
856232|NCT01278797|2726791|P2|Period 1|Adverse Event|1
856233|NCT01278797|2726792|P1|Period 1|Adverse Event|0
856234|NCT01279044|2726861|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
856235|NCT01279044|2726862|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
856236|NCT01279044|2726863|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
856237|NCT01279044|2726861|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
856238|NCT01279044|2726862|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
856239|NCT01279044|2726863|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
856240|NCT01279044|2726861|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
856241|NCT01279044|2726862|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
856242|NCT01279044|2726863|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
856243|NCT01279070|2726883|P2|Overall Study|Acute exacerbation|1
856244|NCT01279070|2726884|P1|Overall Study|Acute exacerbation|3
856245|NCT01279070|2726883|P2|Overall Study|Withdrawal by Subject|3
856246|NCT01279070|2726884|P1|Overall Study|Withdrawal by Subject|2
856247|NCT01279200|2726913|P2|Overall Study|Adverse Event|0
856248|NCT01279200|2726914|P1|Overall Study|Adverse Event|1
856249|NCT01279200|2726913|P2|Overall Study|Lost to Follow-up|1
856250|NCT01279200|2726914|P1|Overall Study|Lost to Follow-up|0
856251|NCT01279200|2726913|P2|Overall Study|ultrasound screening failure|1
856252|NCT01279200|2726914|P1|Overall Study|ultrasound screening failure|0
856253|NCT01279200|2726913|P2|Overall Study|Inconvenience of ultrasound visit|1
856254|NCT01279200|2726914|P1|Overall Study|Inconvenience of ultrasound visit|0
856255|NCT01279200|2726913|P2|Overall Study|Patient withdrawal due to high cost|1
856256|NCT01279200|2726914|P1|Overall Study|Patient withdrawal due to high cost|0
856257|NCT01279200|2726913|P2|Overall Study|Withdrawal by Subject|3
856258|NCT01279200|2726914|P1|Overall Study|Withdrawal by Subject|1
856259|NCT01279447|2726943|P2|Overall Study|Lost to Follow-up|1
856260|NCT01279447|2726944|P1|Overall Study|Lost to Follow-up|3
856261|NCT01280266|2727000|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
856262|NCT01280266|2727001|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
856263|NCT01280266|2727000|P2|First Intervention (Week 1-4)|Adverse Event|0
856264|NCT01280266|2727001|P1|First Intervention (Week 1-4)|Adverse Event|1
856265|NCT01270139|2727035|P3|Overall Study|Lost to Follow-up|2
856266|NCT01270139|2727036|P2|Overall Study|Lost to Follow-up|9
856267|NCT01270139|2727037|P1|Overall Study|Lost to Follow-up|10
856268|NCT01270139|2727035|P3|Overall Study|Adverse Event|18
856269|NCT01270139|2727036|P2|Overall Study|Adverse Event|17
856270|NCT01270139|2727037|P1|Overall Study|Adverse Event|8
856271|NCT01270256|2727097|P2|Overall Study|Withdrawal by Subject|0
856272|NCT01270256|2727098|P1|Overall Study|Withdrawal by Subject|1
856273|NCT01270464|2727107|P3|Overall Study|Not Specified|3
856274|NCT01270464|2727108|P2|Overall Study|Not Specified|1
856275|NCT01270464|2727109|P1|Overall Study|Not Specified|1
856276|NCT01270464|2727107|P3|Overall Study|Lost to Follow-up|1
856277|NCT01270464|2727108|P2|Overall Study|Lost to Follow-up|3
856278|NCT01270464|2727109|P1|Overall Study|Lost to Follow-up|2
856279|NCT01270464|2727107|P3|Overall Study|Withdrawal by Subject|4
856280|NCT01270464|2727108|P2|Overall Study|Withdrawal by Subject|1
856281|NCT01270464|2727109|P1|Overall Study|Withdrawal by Subject|2
856282|NCT01270464|2727107|P3|Overall Study|Adverse Event|7
856283|NCT01270464|2727108|P2|Overall Study|Adverse Event|1
856284|NCT01270464|2727109|P1|Overall Study|Adverse Event|9
856285|NCT01270464|2727107|P3|Overall Study|Lack of Efficacy|1
856286|NCT01270464|2727108|P2|Overall Study|Lack of Efficacy|3
856287|NCT01270464|2727109|P1|Overall Study|Lack of Efficacy|2
856288|NCT01270464|2727107|P3|Overall Study|Protocol Violation|2
856289|NCT01270464|2727108|P2|Overall Study|Protocol Violation|3
856290|NCT01270464|2727109|P1|Overall Study|Protocol Violation|4
856291|NCT01270503|2727156|P1|Overall Study|Lost to Follow-up|1
856292|NCT01270620|2727208|P2|Overall Study|Withdrawal by Subject|3
856293|NCT01270620|2727209|P1|Overall Study|Withdrawal by Subject|1
856340|NCT01271803|2727295|P12|Stage 2|Ongoing in the Study|14
856341|NCT01271803|2727296|P11|Stage 2|Ongoing in the Study|6
856342|NCT01271803|2727297|P10|Stage 2|Ongoing in the Study|0
856343|NCT01271803|2727298|P9|Stage 2|Ongoing in the Study|0
856344|NCT01271803|2727299|P8|Stage 2|Ongoing in the Study|0
856345|NCT01271803|2727300|P7|Stage 2|Ongoing in the Study|0
856346|NCT01271803|2727301|P6|Stage 2|Ongoing in the Study|0
856347|NCT01271803|2727302|P5|Stage 2|Ongoing in the Study|0
856348|NCT01271803|2727303|P4|Stage 2|Ongoing in the Study|0
856349|NCT01271803|2727304|P3|Stage 2|Ongoing in the Study|0
856350|NCT01271803|2727305|P2|Stage 2|Ongoing in the Study|0
856351|NCT01271803|2727306|P1|Stage 2|Ongoing in the Study|0
856352|NCT01271803|2727295|P12|Stage 2|Unspecified|0
856353|NCT01271803|2727296|P11|Stage 2|Unspecified|1
856354|NCT01271803|2727297|P10|Stage 2|Unspecified|0
856355|NCT01271803|2727298|P9|Stage 2|Unspecified|0
856356|NCT01271803|2727299|P8|Stage 2|Unspecified|0
856357|NCT01271803|2727300|P7|Stage 2|Unspecified|0
856358|NCT01271803|2727301|P6|Stage 2|Unspecified|0
856359|NCT01271803|2727302|P5|Stage 2|Unspecified|0
856360|NCT01271803|2727303|P4|Stage 2|Unspecified|0
856361|NCT01271803|2727304|P3|Stage 2|Unspecified|0
856362|NCT01271803|2727305|P2|Stage 2|Unspecified|0
856363|NCT01271803|2727306|P1|Stage 2|Unspecified|0
856364|NCT01271803|2727295|P12|Stage 2|Physician Decision|1
856365|NCT01271803|2727296|P11|Stage 2|Physician Decision|0
856366|NCT01271803|2727297|P10|Stage 2|Physician Decision|0
856367|NCT01271803|2727298|P9|Stage 2|Physician Decision|0
856368|NCT01271803|2727299|P8|Stage 2|Physician Decision|0
856369|NCT01271803|2727300|P7|Stage 2|Physician Decision|0
856370|NCT01271803|2727301|P6|Stage 2|Physician Decision|0
856371|NCT01271803|2727302|P5|Stage 2|Physician Decision|0
856372|NCT01271803|2727303|P4|Stage 2|Physician Decision|0
856373|NCT01271803|2727304|P3|Stage 2|Physician Decision|0
856374|NCT01271803|2727305|P2|Stage 2|Physician Decision|0
856375|NCT01271803|2727306|P1|Stage 2|Physician Decision|0
856376|NCT01271803|2727295|P12|Stage 2|Withdrawal by Subject|2
856377|NCT01271803|2727296|P11|Stage 2|Withdrawal by Subject|0
856378|NCT01271803|2727297|P10|Stage 2|Withdrawal by Subject|0
856379|NCT01271803|2727298|P9|Stage 2|Withdrawal by Subject|0
856380|NCT01271803|2727299|P8|Stage 2|Withdrawal by Subject|0
856381|NCT01271803|2727300|P7|Stage 2|Withdrawal by Subject|0
856382|NCT01271803|2727301|P6|Stage 2|Withdrawal by Subject|0
856383|NCT01271803|2727302|P5|Stage 2|Withdrawal by Subject|0
856384|NCT01271803|2727303|P4|Stage 2|Withdrawal by Subject|0
856385|NCT01271803|2727304|P3|Stage 2|Withdrawal by Subject|0
856386|NCT01271803|2727305|P2|Stage 2|Withdrawal by Subject|0
856387|NCT01271803|2727306|P1|Stage 2|Withdrawal by Subject|0
856388|NCT01271803|2727295|P12|Stage 2|Death|2
856389|NCT01271803|2727296|P11|Stage 2|Death|2
856390|NCT01271803|2727297|P10|Stage 2|Death|0
856391|NCT01271803|2727298|P9|Stage 2|Death|0
856392|NCT01271803|2727299|P8|Stage 2|Death|0
856393|NCT01271803|2727300|P7|Stage 2|Death|0
856394|NCT01271803|2727301|P6|Stage 2|Death|0
856395|NCT01271803|2727302|P5|Stage 2|Death|0
856396|NCT01271803|2727303|P4|Stage 2|Death|0
856397|NCT01271803|2727304|P3|Stage 2|Death|0
856398|NCT01271803|2727305|P2|Stage 2|Death|0
856399|NCT01271803|2727306|P1|Stage 2|Death|0
856400|NCT01271803|2727295|P12|Stage 2|Adverse Event|3
856401|NCT01271803|2727296|P11|Stage 2|Adverse Event|1
856402|NCT01271803|2727297|P10|Stage 2|Adverse Event|0
856403|NCT01271803|2727298|P9|Stage 2|Adverse Event|0
856404|NCT01271803|2727299|P8|Stage 2|Adverse Event|0
856405|NCT01271803|2727300|P7|Stage 2|Adverse Event|0
856406|NCT01271803|2727301|P6|Stage 2|Adverse Event|0
856407|NCT01271803|2727302|P5|Stage 2|Adverse Event|0
856408|NCT01271803|2727303|P4|Stage 2|Adverse Event|0
856409|NCT01271803|2727304|P3|Stage 2|Adverse Event|0
856410|NCT01271803|2727305|P2|Stage 2|Adverse Event|0
856411|NCT01271803|2727306|P1|Stage 2|Adverse Event|0
856412|NCT01271803|2727295|P12|Stage 2|Progressive disease|17
856413|NCT01271803|2727296|P11|Stage 2|Progressive disease|17
856414|NCT01271803|2727297|P10|Stage 2|Progressive disease|0
856415|NCT01271803|2727298|P9|Stage 2|Progressive disease|0
856416|NCT01271803|2727299|P8|Stage 2|Progressive disease|0
856417|NCT01271803|2727300|P7|Stage 2|Progressive disease|0
856418|NCT01271803|2727301|P6|Stage 2|Progressive disease|0
856419|NCT01271803|2727302|P5|Stage 2|Progressive disease|0
856420|NCT01271803|2727303|P4|Stage 2|Progressive disease|0
856421|NCT01271803|2727304|P3|Stage 2|Progressive disease|0
856422|NCT01271803|2727305|P2|Stage 2|Progressive disease|0
856423|NCT01271803|2727306|P1|Stage 2|Progressive disease|0
856424|NCT01271803|2727295|P12|Stage 1|Ongoing in the Study|0
856425|NCT01271803|2727296|P11|Stage 1|Ongoing in the Study|0
856426|NCT01271803|2727297|P10|Stage 1|Ongoing in the Study|0
856427|NCT01271803|2727298|P9|Stage 1|Ongoing in the Study|1
856428|NCT01271803|2727299|P8|Stage 1|Ongoing in the Study|1
856429|NCT01271803|2727300|P7|Stage 1|Ongoing in the Study|1
856430|NCT01271803|2727301|P6|Stage 1|Ongoing in the Study|0
856431|NCT01271803|2727302|P5|Stage 1|Ongoing in the Study|3
856432|NCT01271803|2727303|P4|Stage 1|Ongoing in the Study|1
856433|NCT01271803|2727304|P3|Stage 1|Ongoing in the Study|11
856434|NCT01271803|2727305|P2|Stage 1|Ongoing in the Study|1
856435|NCT01271803|2727306|P1|Stage 1|Ongoing in the Study|0
856436|NCT01271803|2727295|P12|Stage 1|Unspecified|0
856437|NCT01271803|2727296|P11|Stage 1|Unspecified|0
856438|NCT01271803|2727297|P10|Stage 1|Unspecified|0
856439|NCT01271803|2727298|P9|Stage 1|Unspecified|0
856440|NCT01271803|2727299|P8|Stage 1|Unspecified|0
856441|NCT01271803|2727300|P7|Stage 1|Unspecified|0
856442|NCT01271803|2727301|P6|Stage 1|Unspecified|0
856443|NCT01271803|2727302|P5|Stage 1|Unspecified|0
856444|NCT01271803|2727303|P4|Stage 1|Unspecified|0
856445|NCT01271803|2727304|P3|Stage 1|Unspecified|2
856446|NCT01271803|2727305|P2|Stage 1|Unspecified|0
856447|NCT01271803|2727306|P1|Stage 1|Unspecified|0
856448|NCT01271803|2727295|P12|Stage 1|Withdrawal by Subject|0
856449|NCT01271803|2727296|P11|Stage 1|Withdrawal by Subject|0
856450|NCT01271803|2727297|P10|Stage 1|Withdrawal by Subject|0
856451|NCT01271803|2727298|P9|Stage 1|Withdrawal by Subject|0
856452|NCT01271803|2727299|P8|Stage 1|Withdrawal by Subject|0
856453|NCT01271803|2727300|P7|Stage 1|Withdrawal by Subject|0
856454|NCT01271803|2727301|P6|Stage 1|Withdrawal by Subject|0
856455|NCT01271803|2727302|P5|Stage 1|Withdrawal by Subject|0
856456|NCT01271803|2727303|P4|Stage 1|Withdrawal by Subject|0
856457|NCT01271803|2727304|P3|Stage 1|Withdrawal by Subject|1
856458|NCT01271803|2727305|P2|Stage 1|Withdrawal by Subject|0
856459|NCT01271803|2727306|P1|Stage 1|Withdrawal by Subject|0
856460|NCT01271803|2727295|P12|Stage 1|Physician Decision|0
856461|NCT01271803|2727296|P11|Stage 1|Physician Decision|0
856462|NCT01271803|2727297|P10|Stage 1|Physician Decision|0
856463|NCT01271803|2727298|P9|Stage 1|Physician Decision|0
856464|NCT01271803|2727299|P8|Stage 1|Physician Decision|0
856465|NCT01271803|2727300|P7|Stage 1|Physician Decision|1
856466|NCT01271803|2727301|P6|Stage 1|Physician Decision|0
856467|NCT01271803|2727302|P5|Stage 1|Physician Decision|0
856468|NCT01271803|2727303|P4|Stage 1|Physician Decision|0
856469|NCT01271803|2727304|P3|Stage 1|Physician Decision|0
856470|NCT01271803|2727305|P2|Stage 1|Physician Decision|0
856471|NCT01271803|2727306|P1|Stage 1|Physician Decision|1
856472|NCT01271803|2727295|P12|Stage 1|Death|0
856473|NCT01271803|2727296|P11|Stage 1|Death|0
856474|NCT01271803|2727297|P10|Stage 1|Death|0
856475|NCT01271803|2727298|P9|Stage 1|Death|0
856476|NCT01271803|2727299|P8|Stage 1|Death|0
856477|NCT01271803|2727300|P7|Stage 1|Death|0
856478|NCT01271803|2727301|P6|Stage 1|Death|1
856479|NCT01271803|2727302|P5|Stage 1|Death|0
856480|NCT01271803|2727303|P4|Stage 1|Death|0
856481|NCT01271803|2727304|P3|Stage 1|Death|0
856482|NCT01271803|2727305|P2|Stage 1|Death|0
856483|NCT01271803|2727306|P1|Stage 1|Death|1
856484|NCT01271803|2727295|P12|Stage 1|Adverse Event|0
856485|NCT01271803|2727296|P11|Stage 1|Adverse Event|0
856486|NCT01271803|2727297|P10|Stage 1|Adverse Event|0
856487|NCT01271803|2727298|P9|Stage 1|Adverse Event|0
856488|NCT01271803|2727299|P8|Stage 1|Adverse Event|0
856489|NCT01271803|2727300|P7|Stage 1|Adverse Event|0
856490|NCT01271803|2727301|P6|Stage 1|Adverse Event|0
856491|NCT01271803|2727302|P5|Stage 1|Adverse Event|0
856492|NCT01271803|2727303|P4|Stage 1|Adverse Event|0
856493|NCT01271803|2727304|P3|Stage 1|Adverse Event|1
856494|NCT01271803|2727305|P2|Stage 1|Adverse Event|0
856495|NCT01271803|2727306|P1|Stage 1|Adverse Event|0
856496|NCT01271803|2727295|P12|Stage 1|Progressive disease|0
856497|NCT01271803|2727296|P11|Stage 1|Progressive disease|0
856498|NCT01271803|2727297|P10|Stage 1|Progressive disease|2
856499|NCT01271803|2727298|P9|Stage 1|Progressive disease|4
856500|NCT01271803|2727299|P8|Stage 1|Progressive disease|2
856501|NCT01271803|2727300|P7|Stage 1|Progressive disease|2
856502|NCT01271803|2727301|P6|Stage 1|Progressive disease|3
856503|NCT01271803|2727302|P5|Stage 1|Progressive disease|1
856504|NCT01271803|2727303|P4|Stage 1|Progressive disease|2
856505|NCT01271803|2727304|P3|Stage 1|Progressive disease|12
856506|NCT01271803|2727305|P2|Stage 1|Progressive disease|7
856507|NCT01271803|2727306|P1|Stage 1|Progressive disease|3
856508|NCT01272011|2727524|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
856509|NCT01272011|2727525|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
856510|NCT01272011|2727526|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
856511|NCT01272180|2727550|P4|Overall Study|Protocol Violation|1
856512|NCT01272180|2727551|P3|Overall Study|Protocol Violation|0
856513|NCT01272180|2727552|P2|Overall Study|Protocol Violation|1
856514|NCT01272180|2727553|P1|Overall Study|Protocol Violation|0
856515|NCT01272180|2727550|P4|Overall Study|Inappropriate enrollment|1
856516|NCT01272180|2727551|P3|Overall Study|Inappropriate enrollment|1
856517|NCT01272180|2727552|P2|Overall Study|Inappropriate enrollment|0
856518|NCT01272180|2727553|P1|Overall Study|Inappropriate enrollment|0
856519|NCT01272180|2727550|P4|Overall Study|Lost to Follow-up|10
856520|NCT01272180|2727551|P3|Overall Study|Lost to Follow-up|8
856521|NCT01272180|2727552|P2|Overall Study|Lost to Follow-up|14
856522|NCT01272180|2727553|P1|Overall Study|Lost to Follow-up|15
856523|NCT01272180|2727550|P4|Overall Study|Withdrawal by Subject|2
856524|NCT01272180|2727551|P3|Overall Study|Withdrawal by Subject|3
856525|NCT01272180|2727552|P2|Overall Study|Withdrawal by Subject|6
856526|NCT01272180|2727553|P1|Overall Study|Withdrawal by Subject|2
856527|NCT01272180|2727550|P4|Overall Study|Adverse Event|0
856528|NCT01272180|2727551|P3|Overall Study|Adverse Event|1
856529|NCT01272180|2727552|P2|Overall Study|Adverse Event|0
856530|NCT01272180|2727553|P1|Overall Study|Adverse Event|0
856531|NCT01272193|2727592|P2|Overall Study|Unclassified|7
856532|NCT01272193|2727593|P1|Overall Study|Unclassified|8
856533|NCT01272193|2727592|P2|Overall Study|Withdrawal Criteria|1
856534|NCT01272193|2727593|P1|Overall Study|Withdrawal Criteria|1
856535|NCT01272193|2727592|P2|Overall Study|Lack of Efficacy|3
856536|NCT01272193|2727593|P1|Overall Study|Lack of Efficacy|0
856537|NCT01272193|2727592|P2|Overall Study|Adverse Event|1
856538|NCT01272193|2727593|P1|Overall Study|Adverse Event|1
894676|NCT02132949|2840028|P1|Adjuvant Treatment Period|Physician Decision|1
894677|NCT02132949|2840027|P2|Adjuvant Treatment Period|Disease Relapse|1
894678|NCT02132949|2840028|P1|Adjuvant Treatment Period|Disease Relapse|0
894679|NCT02132949|2840027|P2|Adjuvant Treatment Period|Disease Progression|1
894680|NCT02132949|2840028|P1|Adjuvant Treatment Period|Disease Progression|0
894681|NCT02132949|2840027|P2|Adjuvant Treatment Period|Reason unspecified|1
894682|NCT02132949|2840028|P1|Adjuvant Treatment Period|Reason unspecified|0
894683|NCT02132949|2840027|P2|Adjuvant Treatment Period|Adverse Event|6
894684|NCT02132949|2840028|P1|Adjuvant Treatment Period|Adverse Event|4
894685|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
894686|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
894687|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Adverse Event|3
894688|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Adverse Event|6
894689|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Disease Progression|1
894690|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Disease Progression|1
894691|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
894692|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
894693|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Physician Decision|0
894694|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Physician Decision|2
894695|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
894696|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
894697|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Reason unspecified|1
894698|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Reason unspecified|3
894699|NCT02132949|2840027|P2|Neoadjuvant Treatment Period|Early surgery|3
894700|NCT02132949|2840028|P1|Neoadjuvant Treatment Period|Early surgery|4
894701|NCT02100644|2840056|P3|LTG Escalation Phase|Withdrawal by Subject|0
894702|NCT02100644|2840057|P2|LTG Escalation Phase|Withdrawal by Subject|0
894703|NCT02100644|2840058|P1|LTG Escalation Phase|Withdrawal by Subject|3
894704|NCT02100644|2840056|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
894705|NCT02100644|2840057|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
894706|NCT02100644|2840058|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
894707|NCT02100644|2840056|P3|LTG Escalation Phase|Adverse Event|0
894708|NCT02100644|2840057|P2|LTG Escalation Phase|Adverse Event|0
894709|NCT02100644|2840058|P1|LTG Escalation Phase|Adverse Event|9
894718|NCT01995513|2840091|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
894719|NCT01995513|2840092|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
894720|NCT01995513|2840093|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
894721|NCT01995513|2840091|P3|Double Blind Treatment Period|Disease Progression|93
894722|NCT01995513|2840092|P2|Double Blind Treatment Period|Disease Progression|82
894723|NCT01995513|2840093|P1|Double Blind Treatment Period|Disease Progression|0
894724|NCT01995513|2840091|P3|Double Blind Treatment Period|Death|1
894725|NCT01995513|2840092|P2|Double Blind Treatment Period|Death|0
894726|NCT01995513|2840093|P1|Double Blind Treatment Period|Death|0
894727|NCT01995513|2840091|P3|Double Blind Treatment Period|Withdrawal by Subject|6
894728|NCT01995513|2840092|P2|Double Blind Treatment Period|Withdrawal by Subject|4
894729|NCT01995513|2840093|P1|Double Blind Treatment Period|Withdrawal by Subject|0
894730|NCT01995513|2840091|P3|Double Blind Treatment Period|Other|2
894731|NCT01995513|2840092|P2|Double Blind Treatment Period|Other|1
894732|NCT01995513|2840093|P1|Double Blind Treatment Period|Other|0
894733|NCT01995513|2840091|P3|Double Blind Treatment Period|Adverse Event|5
894734|NCT01995513|2840092|P2|Double Blind Treatment Period|Adverse Event|12
894735|NCT01995513|2840093|P1|Double Blind Treatment Period|Adverse Event|0
894736|NCT01995513|2840091|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
894737|NCT01995513|2840092|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
894738|NCT01995513|2840093|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
894739|NCT01995513|2840091|P3|Open Label Treatment Period|Death|0
894740|NCT01995513|2840092|P2|Open Label Treatment Period|Death|0
894741|NCT01995513|2840093|P1|Open Label Treatment Period|Death|8
894742|NCT01995513|2840091|P3|Open Label Treatment Period|Adverse Event|0
894743|NCT01995513|2840092|P2|Open Label Treatment Period|Adverse Event|0
894744|NCT01995513|2840093|P1|Open Label Treatment Period|Adverse Event|35
894745|NCT01995513|2840091|P3|Open Label Treatment Period|No PSA response at week 13|0
894746|NCT01995513|2840092|P2|Open Label Treatment Period|No PSA response at week 13|0
894747|NCT01995513|2840093|P1|Open Label Treatment Period|No PSA response at week 13|43
894748|NCT01995513|2840091|P3|Open Label Treatment Period|Disease Progression|0
894749|NCT01995513|2840092|P2|Open Label Treatment Period|Disease Progression|0
894750|NCT01995513|2840093|P1|Open Label Treatment Period|Disease Progression|64
894751|NCT01995513|2840091|P3|Open Label Treatment Period|Protocol Violation|0
894752|NCT01995513|2840092|P2|Open Label Treatment Period|Protocol Violation|0
894753|NCT01995513|2840093|P1|Open Label Treatment Period|Protocol Violation|1
894754|NCT01995513|2840091|P3|Open Label Treatment Period|Withdrawal by Subject|0
894755|NCT01995513|2840092|P2|Open Label Treatment Period|Withdrawal by Subject|0
894756|NCT01995513|2840093|P1|Open Label Treatment Period|Withdrawal by Subject|14
894757|NCT01995513|2840091|P3|Open Label Treatment Period|Other|0
894758|NCT01995513|2840092|P2|Open Label Treatment Period|Other|0
894759|NCT01995513|2840093|P1|Open Label Treatment Period|Other|9
894767|NCT01929317|2840180|P2|Long-term Phase|Study Closed/Terminated|3
894768|NCT01929317|2840181|P1|Long-term Phase|Study Closed/Terminated|5
894769|NCT01929317|2840180|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
894770|NCT01929317|2840181|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
894771|NCT01929317|2840180|P2|Long-term Phase|Protocol Violation|0
894772|NCT01929317|2840181|P1|Long-term Phase|Protocol Violation|1
894773|NCT01929317|2840180|P2|Long-term Phase|Withdrawal by Subject|0
894774|NCT01929317|2840181|P1|Long-term Phase|Withdrawal by Subject|4
894775|NCT01929317|2840180|P2|Long-term Phase|Physician Decision|0
894776|NCT01929317|2840181|P1|Long-term Phase|Physician Decision|3
894777|NCT01929317|2840180|P2|Long-term Phase|Adverse Event|1
894778|NCT01929317|2840181|P1|Long-term Phase|Adverse Event|5
894779|NCT01929317|2840180|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
894780|NCT01929317|2840181|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
894781|NCT01929317|2840180|P2|Dose Increase Effect Verification Phase|Physician Decision|0
894782|NCT01929317|2840181|P1|Dose Increase Effect Verification Phase|Physician Decision|1
894783|NCT01929317|2840180|P2|Dose Increase Effect Verification Phase|Adverse Event|1
894784|NCT01929317|2840181|P1|Dose Increase Effect Verification Phase|Adverse Event|5
856665|NCT01272635|2727744|P4|Overall Study|Lost to Follow-up|23
856666|NCT01272635|2727745|P3|Overall Study|Lost to Follow-up|31
856667|NCT01272635|2727746|P2|Overall Study|Lost to Follow-up|20
856668|NCT01272635|2727747|P1|Overall Study|Lost to Follow-up|31
856669|NCT01272661|2727766|P3|Overall Study|lost to followup/case closed/ no birth|72
856670|NCT01272661|2727767|P2|Overall Study|lost to followup/case closed/ no birth|209
856671|NCT01272661|2727768|P1|Overall Study|lost to followup/case closed/ no birth|126
856672|NCT01272804|2727797|P6|Overall Study|Adverse Event|1
856673|NCT01272804|2727798|P5|Overall Study|Adverse Event|2
856674|NCT01272804|2727799|P4|Overall Study|Adverse Event|0
856675|NCT01272804|2727800|P3|Overall Study|Adverse Event|0
856676|NCT01272804|2727801|P2|Overall Study|Adverse Event|0
856677|NCT01272804|2727802|P1|Overall Study|Adverse Event|1
856678|NCT01272869|2727959|P2|Period 2 (14 Days)|Adverse Event|0
856679|NCT01272869|2727960|P1|Period 2 (14 Days)|Adverse Event|1
856680|NCT01272908|2727970|P1|Re-Treatment Period|Withdrawal by Subject|1
856681|NCT01272908|2727970|P1|Re-Treatment Period|Lack of Efficacy|3
856682|NCT01272908|2727970|P1|Re-Treatment Period|Adverse Event|2
856683|NCT01272908|2727970|P1|Initial Treatment Period|Withdrawal by Subject|1
856684|NCT01272908|2727970|P1|Initial Treatment Period|Protocol Violation|1
856685|NCT01272908|2727970|P1|Initial Treatment Period|Lack of Efficacy|5
856686|NCT01272908|2727970|P1|Initial Treatment Period|Adverse Event|1
856687|NCT01272921|2728006|P2|Overall Study|Protocol Violation|1
856688|NCT01272921|2728007|P1|Overall Study|Protocol Violation|2
856689|NCT01272934|2728017|P2|Overall Study|Abnormal Laboratory Value|1
856690|NCT01272934|2728018|P1|Overall Study|Abnormal Laboratory Value|0
856691|NCT01272934|2728017|P2|Overall Study|Adverse Event|1
856692|NCT01272934|2728018|P1|Overall Study|Adverse Event|0
856693|NCT01272947|2728028|P2|Overall Study|Abnormal Laboratory Value|2
856694|NCT01272947|2728029|P1|Overall Study|Abnormal Laboratory Value|2
856695|NCT01273038|2728039|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
856696|NCT01273038|2728040|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
856697|NCT01273038|2728039|P2|Second Intervention (14 Days)|Adverse Event|1
856698|NCT01273038|2728040|P1|Second Intervention (14 Days)|Adverse Event|0
856699|NCT01273064|2728051|P5|Overall Study|Physician Decision|1
856700|NCT01273064|2728052|P4|Overall Study|Physician Decision|0
856701|NCT01273064|2728053|P3|Overall Study|Physician Decision|0
856702|NCT01273064|2728054|P2|Overall Study|Physician Decision|0
856703|NCT01273064|2728055|P1|Overall Study|Physician Decision|0
856704|NCT01273064|2728051|P5|Overall Study|Lost to Follow-up|0
856705|NCT01273064|2728052|P4|Overall Study|Lost to Follow-up|0
856706|NCT01273064|2728053|P3|Overall Study|Lost to Follow-up|0
856707|NCT01273064|2728054|P2|Overall Study|Lost to Follow-up|0
856708|NCT01273064|2728055|P1|Overall Study|Lost to Follow-up|1
856709|NCT01273064|2728051|P5|Overall Study|Study Termination|8
856710|NCT01273064|2728052|P4|Overall Study|Study Termination|16
856711|NCT01273064|2728053|P3|Overall Study|Study Termination|26
856712|NCT01273064|2728054|P2|Overall Study|Study Termination|27
856713|NCT01273064|2728055|P1|Overall Study|Study Termination|13
856714|NCT01273064|2728051|P5|Overall Study|Withdrawal by Subject|0
856715|NCT01273064|2728052|P4|Overall Study|Withdrawal by Subject|2
856716|NCT01273064|2728053|P3|Overall Study|Withdrawal by Subject|2
856717|NCT01273064|2728054|P2|Overall Study|Withdrawal by Subject|2
856718|NCT01273064|2728055|P1|Overall Study|Withdrawal by Subject|4
856719|NCT01273064|2728051|P5|Overall Study|Adverse Event|1
856720|NCT01273064|2728052|P4|Overall Study|Adverse Event|2
856721|NCT01273064|2728053|P3|Overall Study|Adverse Event|3
856722|NCT01273064|2728054|P2|Overall Study|Adverse Event|1
856723|NCT01273064|2728055|P1|Overall Study|Adverse Event|5
856724|NCT01273181|2728076|P4|Phase 2, Dose 2|Death during treatment|1
856725|NCT01273181|2728077|P3|Phase 2, Dose 2|Death during treatment|0
856726|NCT01273181|2728078|P2|Phase 2, Dose 2|Death during treatment|0
856727|NCT01273181|2728079|P1|Phase 2, Dose 2|Death during treatment|0
856728|NCT01273181|2728076|P4|Phase 2, Dose 1|Study termination|0
856729|NCT01273181|2728077|P3|Phase 2, Dose 1|Study termination|1
856730|NCT01273181|2728078|P2|Phase 2, Dose 1|Study termination|0
856731|NCT01273181|2728079|P1|Phase 2, Dose 1|Study termination|0
856732|NCT01273181|2728076|P4|Phase I, Dose 2|Death during treatment|0
856733|NCT01273181|2728077|P3|Phase I, Dose 2|Death during treatment|0
856734|NCT01273181|2728078|P2|Phase I, Dose 2|Death during treatment|1
856735|NCT01273181|2728079|P1|Phase I, Dose 2|Death during treatment|0
856736|NCT01273181|2728076|P4|Phase I, Dose 1|Study termination|0
856737|NCT01273181|2728077|P3|Phase I, Dose 1|Study termination|0
856738|NCT01273181|2728078|P2|Phase I, Dose 1|Study termination|0
856739|NCT01273181|2728079|P1|Phase I, Dose 1|Study termination|1
856740|NCT01273519|2728096|P3|Overall Study|Not Specified|1
856741|NCT01273519|2728097|P2|Overall Study|Not Specified|1
856742|NCT01273519|2728098|P1|Overall Study|Not Specified|6
856743|NCT01273519|2728096|P3|Overall Study|Lack of Efficacy|4
856744|NCT01273519|2728097|P2|Overall Study|Lack of Efficacy|3
856745|NCT01273519|2728098|P1|Overall Study|Lack of Efficacy|8
856746|NCT01273519|2728096|P3|Overall Study|Lost to Follow-up|3
856747|NCT01273519|2728097|P2|Overall Study|Lost to Follow-up|1
856748|NCT01273519|2728098|P1|Overall Study|Lost to Follow-up|2
856749|NCT01273519|2728096|P3|Overall Study|Adverse Event|0
856750|NCT01273519|2728097|P2|Overall Study|Adverse Event|0
856751|NCT01273519|2728098|P1|Overall Study|Adverse Event|3
856752|NCT01273597|2728131|P1|Overall Study|Reason Not Reported|1
856753|NCT01273597|2728131|P1|Overall Study|Underwent Kidney Transplantation|2
856754|NCT01273597|2728131|P1|Overall Study|Adverse Event|5
856755|NCT01273623|2728143|P1|Overall Study|did not meet IVUS criteria|29
856756|NCT01273805|2728163|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
856757|NCT01273805|2728164|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
856758|NCT01273818|2728183|P3|Overall Study|Physician Decision|9
856759|NCT01273818|2728184|P2|Overall Study|Physician Decision|2
856760|NCT01273818|2728185|P1|Overall Study|Physician Decision|13
856761|NCT01273883|2728204|P2|Second Intervention|Lack of Efficacy|0
856762|NCT01273883|2728205|P1|Second Intervention|Lack of Efficacy|1
856763|NCT01273883|2728204|P2|Second Intervention|Lost to Follow-up|1
856764|NCT01273883|2728205|P1|Second Intervention|Lost to Follow-up|1
856765|NCT01273883|2728204|P2|First Intervention|Adverse Event|1
856766|NCT01273883|2728205|P1|First Intervention|Adverse Event|2
856767|NCT01280357|2728221|P1|Overall Study|IInsufficient data/No data supplied|12
856768|NCT01280357|2728221|P1|Overall Study|Excluded no internal monitoring|14
856769|NCT01280591|2728247|P4|Overall Study|Does not meet exclusion #27 criteria|1
856770|NCT01280591|2728248|P3|Overall Study|Does not meet exclusion #27 criteria|0
856771|NCT01280591|2728249|P2|Overall Study|Does not meet exclusion #27 criteria|0
856772|NCT01280591|2728250|P1|Overall Study|Does not meet exclusion #27 criteria|0
856773|NCT01280591|2728247|P4|Overall Study|Withdrawal by Subject|2
856774|NCT01280591|2728248|P3|Overall Study|Withdrawal by Subject|0
856775|NCT01280591|2728249|P2|Overall Study|Withdrawal by Subject|0
856776|NCT01280591|2728250|P1|Overall Study|Withdrawal by Subject|0
856777|NCT01280955|2728359|P1|Overall Study|Withdrawal by Subject|1
856778|NCT01280955|2728359|P1|Overall Study|Death|2
856779|NCT01280968|2728392|P2|Overall Study|Unable to Smoke in Supine Position|0
856780|NCT01280968|2728393|P1|Overall Study|Unable to Smoke in Supine Position|1
856781|NCT01280968|2728392|P2|Overall Study|Pre-existing Neurological Condition|0
856782|NCT01280968|2728393|P1|Overall Study|Pre-existing Neurological Condition|1
856783|NCT01280968|2728392|P2|Overall Study|Scheduling Conflicts|1
856784|NCT01280968|2728393|P1|Overall Study|Scheduling Conflicts|1
856785|NCT01280968|2728392|P2|Overall Study|Adverse Event|0
856786|NCT01280968|2728393|P1|Overall Study|Adverse Event|1
856787|NCT01280968|2728392|P2|Overall Study|Anxiety|0
856788|NCT01280968|2728393|P1|Overall Study|Anxiety|2
856789|NCT01280968|2728392|P2|Overall Study|Commuting Problems|0
856790|NCT01280968|2728393|P1|Overall Study|Commuting Problems|2
856791|NCT01280968|2728392|P2|Overall Study|Unable to Follow Experimental Protocol|0
856792|NCT01280968|2728393|P1|Overall Study|Unable to Follow Experimental Protocol|2
856793|NCT01280968|2728392|P2|Overall Study|Lost to Follow-up|2
856794|NCT01280968|2728393|P1|Overall Study|Lost to Follow-up|8
856795|NCT01280981|2728409|P1|Overall Study|Study site closure|1
856796|NCT01280981|2728409|P1|Overall Study|Elective surgery|2
856797|NCT01280981|2728409|P1|Overall Study|Withdrawal of consent|3
856798|NCT01280981|2728409|P1|Overall Study|Non-compliance with protocol|3
856799|NCT01280981|2728409|P1|Overall Study|Failed to return|45
856800|NCT01280981|2728409|P1|Overall Study|Irregular or discontinued menses|3
856801|NCT01280981|2728409|P1|Overall Study|Adverse Event|6
856802|NCT01280981|2728409|P1|Overall Study|Lost to Follow-up|3
856803|NCT01280981|2728409|P1|Overall Study|Lack of Efficacy|13
856804|NCT01280981|2728409|P1|Overall Study|Protocol Violation|2
856805|NCT01280981|2728409|P1|Overall Study|Withdrawal by Subject|11
856807|NCT01281202|2728435|P2|Overall Study|Incarceration|3
856808|NCT01281202|2728436|P1|Overall Study|Incarceration|0
856809|NCT01281202|2728435|P2|Overall Study|Lost to Follow-up|13
856810|NCT01281202|2728436|P1|Overall Study|Lost to Follow-up|11
856811|NCT01281202|2728435|P2|Overall Study|Administrative|8
856812|NCT01281202|2728436|P1|Overall Study|Administrative|2
856813|NCT01281202|2728435|P2|Overall Study|Protocol Violation|10
856814|NCT01281202|2728436|P1|Overall Study|Protocol Violation|11
856815|NCT01281202|2728435|P2|Overall Study|Withdrawal by Subject|2
856816|NCT01281202|2728436|P1|Overall Study|Withdrawal by Subject|2
856817|NCT01281202|2728435|P2|Overall Study|Adverse Event|0
856818|NCT01281202|2728436|P1|Overall Study|Adverse Event|2
856819|NCT01281306|2728451|P7|Overall Study|Randomized in error|0
856820|NCT01281306|2728452|P6|Overall Study|Randomized in error|0
856821|NCT01281306|2728453|P5|Overall Study|Randomized in error|0
856822|NCT01281306|2728454|P4|Overall Study|Randomized in error|1
856823|NCT01281306|2728455|P3|Overall Study|Randomized in error|0
856824|NCT01281306|2728456|P2|Overall Study|Randomized in error|0
856825|NCT01281306|2728457|P1|Overall Study|Randomized in error|1
856826|NCT01281306|2728451|P7|Overall Study|Adverse Event|3
856827|NCT01281306|2728452|P6|Overall Study|Adverse Event|3
856828|NCT01281306|2728453|P5|Overall Study|Adverse Event|5
856829|NCT01281306|2728454|P4|Overall Study|Adverse Event|3
856830|NCT01281306|2728455|P3|Overall Study|Adverse Event|2
856831|NCT01281306|2728456|P2|Overall Study|Adverse Event|2
856832|NCT01281306|2728457|P1|Overall Study|Adverse Event|3
856833|NCT01281306|2728451|P7|Overall Study|Death|0
856834|NCT01281306|2728452|P6|Overall Study|Death|0
856835|NCT01281306|2728453|P5|Overall Study|Death|0
856836|NCT01281306|2728454|P4|Overall Study|Death|0
856837|NCT01281306|2728455|P3|Overall Study|Death|0
856838|NCT01281306|2728456|P2|Overall Study|Death|0
856839|NCT01281306|2728457|P1|Overall Study|Death|1
856840|NCT01281306|2728451|P7|Overall Study|Lost to Follow-up|1
856841|NCT01281306|2728452|P6|Overall Study|Lost to Follow-up|0
856842|NCT01281306|2728453|P5|Overall Study|Lost to Follow-up|0
856843|NCT01281306|2728454|P4|Overall Study|Lost to Follow-up|2
856844|NCT01281306|2728455|P3|Overall Study|Lost to Follow-up|0
856845|NCT01281306|2728456|P2|Overall Study|Lost to Follow-up|0
856846|NCT01281306|2728457|P1|Overall Study|Lost to Follow-up|1
856847|NCT01281306|2728451|P7|Overall Study|Condition no longer requires study drug|1
856848|NCT01281306|2728452|P6|Overall Study|Condition no longer requires study drug|1
856849|NCT01281306|2728453|P5|Overall Study|Condition no longer requires study drug|0
856850|NCT01281306|2728454|P4|Overall Study|Condition no longer requires study drug|0
856851|NCT01281306|2728455|P3|Overall Study|Condition no longer requires study drug|0
856852|NCT01281306|2728456|P2|Overall Study|Condition no longer requires study drug|0
856853|NCT01281306|2728457|P1|Overall Study|Condition no longer requires study drug|1
856854|NCT01281306|2728451|P7|Overall Study|Protocol deviation|0
856855|NCT01281306|2728452|P6|Overall Study|Protocol deviation|0
856856|NCT01281306|2728453|P5|Overall Study|Protocol deviation|1
856857|NCT01281306|2728454|P4|Overall Study|Protocol deviation|1
856858|NCT01281306|2728455|P3|Overall Study|Protocol deviation|1
856859|NCT01281306|2728456|P2|Overall Study|Protocol deviation|1
856860|NCT01281306|2728457|P1|Overall Study|Protocol deviation|0
856861|NCT01281306|2728451|P7|Overall Study|Withdrawal by Subject|1
856862|NCT01281306|2728452|P6|Overall Study|Withdrawal by Subject|3
856863|NCT01281306|2728453|P5|Overall Study|Withdrawal by Subject|1
856864|NCT01281306|2728454|P4|Overall Study|Withdrawal by Subject|4
856865|NCT01281306|2728455|P3|Overall Study|Withdrawal by Subject|2
856866|NCT01281306|2728456|P2|Overall Study|Withdrawal by Subject|0
856867|NCT01281306|2728457|P1|Overall Study|Withdrawal by Subject|1
856868|NCT01281306|2728451|P7|Overall Study|Lack of Efficacy|1
856869|NCT01281306|2728452|P6|Overall Study|Lack of Efficacy|0
856870|NCT01281306|2728453|P5|Overall Study|Lack of Efficacy|2
856871|NCT01281306|2728454|P4|Overall Study|Lack of Efficacy|0
856872|NCT01281306|2728455|P3|Overall Study|Lack of Efficacy|3
856873|NCT01281306|2728456|P2|Overall Study|Lack of Efficacy|1
856874|NCT01281306|2728457|P1|Overall Study|Lack of Efficacy|0
856875|NCT01281644|2728597|P1|Overall Study|Withdrawal by Subject|2
856876|NCT01281644|2728597|P1|Overall Study|Lost to Follow-up|3
856877|NCT01281839|2728607|P2|Overall Study|Reason not specified|1
856878|NCT01281839|2728608|P1|Overall Study|Reason not specified|0
856879|NCT01281839|2728607|P2|Overall Study|Withdrawal by Subject|10
856880|NCT01281839|2728608|P1|Overall Study|Withdrawal by Subject|4
856881|NCT01281839|2728607|P2|Overall Study|Lost to Follow-up|3
856882|NCT01281839|2728608|P1|Overall Study|Lost to Follow-up|6
856883|NCT01281865|2728671|P2|Overall Study|Lack of Efficacy|0
856884|NCT01281865|2728672|P1|Overall Study|Lack of Efficacy|1
856885|NCT01281865|2728671|P2|Overall Study|Withdrawal by Subject|0
856886|NCT01281865|2728672|P1|Overall Study|Withdrawal by Subject|1
856887|NCT01281865|2728671|P2|Overall Study|Adverse Event|1
856888|NCT01281865|2728672|P1|Overall Study|Adverse Event|1
856889|NCT01281917|2728678|P1|Overall Study|Withdrawal by Subject|1
856890|NCT01282164|2728718|P2|Overall Study|Lack of hypoglycemia during ITT|0
856891|NCT01282164|2728719|P1|Overall Study|Lack of hypoglycemia during ITT|1
856892|NCT01282203|2728742|P1|Overall Study|Adverse Event|1
856893|NCT01282229|2728762|P1|Overall Study|Protocol Violation|2
856894|NCT01282294|2728803|P1|Overall Study|Physician Decision|1
856895|NCT01282294|2728803|P1|Overall Study|Patient non-compliance|2
856896|NCT01282294|2728803|P1|Overall Study|Adverse Event|1
856897|NCT01282294|2728803|P1|Overall Study|Screening failure|1
856898|NCT01282294|2728803|P1|Overall Study|Lost to Follow-up|14
856899|NCT01282372|2728821|P1|Overall Study|Adverse Event|12
856900|NCT01282372|2728821|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
856901|NCT01282372|2728821|P1|Overall Study|Presence of AE, Regression of Symptoms|1
856902|NCT01282372|2728821|P1|Overall Study|Presence of AE, Lack of Efficacy|1
856903|NCT01282372|2728821|P1|Overall Study|Death|1
856904|NCT01282372|2728821|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
856905|NCT01282372|2728821|P1|Overall Study|Withdrawal by Subject|11
856906|NCT01282372|2728821|P1|Overall Study|Lost to Follow-up|23
856907|NCT01282372|2728821|P1|Overall Study|Lack of Efficacy / Exacerbation|25
856912|NCT01282476|2728866|P1|Overall Study|Death|11
856913|NCT01282801|2728882|P2|Second Intervention|Emesis During Critical Breakfast|1
856914|NCT01282801|2728883|P1|Second Intervention|Emesis During Critical Breakfast|0
856915|NCT01282814|2728901|P2|Washout of 7 Days|Withdrawal by Subject|0
856916|NCT01282814|2728902|P1|Washout of 7 Days|Withdrawal by Subject|2
856917|NCT01282814|2728901|P2|First Intervention|Emesis During Dosing Interval|3
856918|NCT01282814|2728902|P1|First Intervention|Emesis During Dosing Interval|0
856919|NCT01282866|2728912|P1|Overall Study|Adverse Event|1
856920|NCT01283035|2728924|P1|Overall Study|Subject later found ineligible|1
856921|NCT01283139|2728937|P4|Overall Study|Participant randomized in error|0
856922|NCT01283139|2728938|P3|Overall Study|Participant randomized in error|1
856923|NCT01283139|2728939|P2|Overall Study|Participant randomized in error|0
856924|NCT01283139|2728940|P1|Overall Study|Participant randomized in error|0
856925|NCT01283139|2728937|P4|Overall Study|Missed follow-up visit|2
856926|NCT01283139|2728938|P3|Overall Study|Missed follow-up visit|2
856927|NCT01283139|2728939|P2|Overall Study|Missed follow-up visit|1
856928|NCT01283139|2728940|P1|Overall Study|Missed follow-up visit|0
856929|NCT01283139|2728937|P4|Overall Study|Pregnancy|0
856930|NCT01283139|2728938|P3|Overall Study|Pregnancy|1
856931|NCT01283139|2728939|P2|Overall Study|Pregnancy|1
856932|NCT01283139|2728940|P1|Overall Study|Pregnancy|0
856933|NCT01283139|2728937|P4|Overall Study|Participant's refusal to continue|1
856934|NCT01283139|2728938|P3|Overall Study|Participant's refusal to continue|1
856935|NCT01283139|2728939|P2|Overall Study|Participant's refusal to continue|3
856936|NCT01283139|2728940|P1|Overall Study|Participant's refusal to continue|0
856937|NCT01283139|2728937|P4|Overall Study|Early termination due to AE/SAE|0
856938|NCT01283139|2728938|P3|Overall Study|Early termination due to AE/SAE|0
856939|NCT01283139|2728939|P2|Overall Study|Early termination due to AE/SAE|1
856940|NCT01283139|2728940|P1|Overall Study|Early termination due to AE/SAE|1
856941|NCT01283139|2728937|P4|Overall Study|Lack of Efficacy|1
856942|NCT01283139|2728938|P3|Overall Study|Lack of Efficacy|2
856943|NCT01283139|2728939|P2|Overall Study|Lack of Efficacy|2
856944|NCT01283139|2728940|P1|Overall Study|Lack of Efficacy|1
856945|NCT01283139|2728937|P4|Overall Study|Death|2
856946|NCT01283139|2728938|P3|Overall Study|Death|2
856947|NCT01283139|2728939|P2|Overall Study|Death|0
856948|NCT01283139|2728940|P1|Overall Study|Death|2
856949|NCT01283139|2728937|P4|Overall Study|Withdrawal by Subject|8
856950|NCT01283139|2728938|P3|Overall Study|Withdrawal by Subject|6
856951|NCT01283139|2728939|P2|Overall Study|Withdrawal by Subject|8
856952|NCT01283139|2728940|P1|Overall Study|Withdrawal by Subject|8
856953|NCT01283139|2728937|P4|Overall Study|Lost to Follow-up|1
856954|NCT01283139|2728938|P3|Overall Study|Lost to Follow-up|3
856955|NCT01283139|2728939|P2|Overall Study|Lost to Follow-up|2
856956|NCT01283139|2728940|P1|Overall Study|Lost to Follow-up|5
856957|NCT01283152|2728984|P2|Overall Study|Refused HESA|0
856958|NCT01283152|2728985|P1|Overall Study|Refused HESA|1
856959|NCT01283152|2728984|P2|Overall Study|Discharged prior to 24 hr assessment|0
856960|NCT01283152|2728985|P1|Overall Study|Discharged prior to 24 hr assessment|1
856961|NCT01283282|2728995|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
856962|NCT01283282|2728996|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
856963|NCT01283282|2728995|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
856964|NCT01283282|2728996|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
856965|NCT01283282|2728995|P2|First Intervention (6 Weeks)|Physician Decision|1
856966|NCT01283282|2728996|P1|First Intervention (6 Weeks)|Physician Decision|0
856967|NCT01283334|2729023|P1|Overall Study|Physician Decision|1
856968|NCT01283334|2729023|P1|Overall Study|Adverse Event|4
856969|NCT01283334|2729023|P1|Overall Study|Inability to Swallow Everolimus Pills|1
856970|NCT01283334|2729023|P1|Overall Study|Withdrawal by Subject|1
856971|NCT01270802|2729168|P2|Overall Study|Lost to Follow-up|1
856972|NCT01270802|2729169|P1|Overall Study|Lost to Follow-up|0
856973|NCT01270802|2729168|P2|Overall Study|Adverse Event|0
856974|NCT01270802|2729169|P1|Overall Study|Adverse Event|1
856975|NCT01270802|2729168|P2|Overall Study|Withdrawal by Subject|0
856976|NCT01270802|2729169|P1|Overall Study|Withdrawal by Subject|1
856977|NCT01270828|2729179|P3|Double Blind Phase|Adverse event related to study drug|0
856978|NCT01270828|2729180|P2|Double Blind Phase|Adverse event related to study drug|7
856979|NCT01270828|2729181|P1|Double Blind Phase|Adverse event related to study drug|5
856980|NCT01270828|2729179|P3|Double Blind Phase|Adverse event not related to study drug|0
856981|NCT01270828|2729180|P2|Double Blind Phase|Adverse event not related to study drug|1
856982|NCT01270828|2729181|P1|Double Blind Phase|Adverse event not related to study drug|1
856983|NCT01270828|2729179|P3|Double Blind Phase|Lack of Efficacy|0
856984|NCT01270828|2729180|P2|Double Blind Phase|Lack of Efficacy|11
856985|NCT01270828|2729181|P1|Double Blind Phase|Lack of Efficacy|2
856986|NCT01270828|2729179|P3|Double Blind Phase|Lost to Follow-up|0
856987|NCT01270828|2729180|P2|Double Blind Phase|Lost to Follow-up|2
856988|NCT01270828|2729181|P1|Double Blind Phase|Lost to Follow-up|1
856989|NCT01270828|2729179|P3|Double Blind Phase|Withdrawal by Subject|0
856990|NCT01270828|2729180|P2|Double Blind Phase|Withdrawal by Subject|15
856991|NCT01270828|2729181|P1|Double Blind Phase|Withdrawal by Subject|6
856992|NCT01270828|2729179|P3|Double Blind Phase|Reason Unspecified|0
856993|NCT01270828|2729180|P2|Double Blind Phase|Reason Unspecified|4
856994|NCT01270828|2729181|P1|Double Blind Phase|Reason Unspecified|7
856995|NCT01270828|2729179|P3|Double Blind Phase|Protocol and GCP non-compliance|0
856996|NCT01270828|2729180|P2|Double Blind Phase|Protocol and GCP non-compliance|3
856997|NCT01270828|2729181|P1|Double Blind Phase|Protocol and GCP non-compliance|4
856998|NCT01270828|2729179|P3|Double Blind Phase|Protocol Violation|0
856999|NCT01270828|2729180|P2|Double Blind Phase|Protocol Violation|1
857000|NCT01270828|2729181|P1|Double Blind Phase|Protocol Violation|0
857001|NCT01270828|2729179|P3|Double Blind Phase|Death|0
857002|NCT01270828|2729180|P2|Double Blind Phase|Death|1
857003|NCT01270828|2729181|P1|Double Blind Phase|Death|0
857004|NCT01270828|2729179|P3|Pregabalin CR SB|Protocol Violation|8
857005|NCT01270828|2729180|P2|Pregabalin CR SB|Protocol Violation|0
857006|NCT01270828|2729181|P1|Pregabalin CR SB|Protocol Violation|0
857007|NCT01270828|2729179|P3|Pregabalin CR SB|Unrelated AE|8
857008|NCT01270828|2729180|P2|Pregabalin CR SB|Unrelated AE|0
857009|NCT01270828|2729181|P1|Pregabalin CR SB|Unrelated AE|0
857010|NCT01270828|2729179|P3|Pregabalin CR SB|Lost to Follow-up|10
857011|NCT01270828|2729180|P2|Pregabalin CR SB|Lost to Follow-up|0
857012|NCT01270828|2729181|P1|Pregabalin CR SB|Lost to Follow-up|0
857013|NCT01270828|2729179|P3|Pregabalin CR SB|Withdrawal by Subject|29
857014|NCT01270828|2729180|P2|Pregabalin CR SB|Withdrawal by Subject|0
857015|NCT01270828|2729181|P1|Pregabalin CR SB|Withdrawal by Subject|0
857016|NCT01270828|2729179|P3|Pregabalin CR SB|Lack of Efficacy|32
857017|NCT01270828|2729180|P2|Pregabalin CR SB|Lack of Efficacy|0
857018|NCT01270828|2729181|P1|Pregabalin CR SB|Lack of Efficacy|0
857019|NCT01270828|2729179|P3|Pregabalin CR SB|Related adverse event|46
857020|NCT01270828|2729180|P2|Pregabalin CR SB|Related adverse event|0
857021|NCT01270828|2729181|P1|Pregabalin CR SB|Related adverse event|0
857022|NCT01270828|2729179|P3|Pregabalin CR SB|Enrolled but not treated|5
857023|NCT01270828|2729180|P2|Pregabalin CR SB|Enrolled but not treated|0
857024|NCT01270828|2729181|P1|Pregabalin CR SB|Enrolled but not treated|0
857025|NCT01270828|2729179|P3|Pregabalin CR SB|Reason Unspecified|8
857026|NCT01270828|2729180|P2|Pregabalin CR SB|Reason Unspecified|0
857027|NCT01270828|2729181|P1|Pregabalin CR SB|Reason Unspecified|0
857028|NCT01270841|2729225|P4|Overall Study|Enrolled in error|0
857029|NCT01270841|2729226|P3|Overall Study|Enrolled in error|0
857030|NCT01270841|2729227|P2|Overall Study|Enrolled in error|1
857031|NCT01270841|2729228|P1|Overall Study|Enrolled in error|0
857032|NCT01270841|2729225|P4|Overall Study|Protocol Violation|0
857033|NCT01270841|2729226|P3|Overall Study|Protocol Violation|0
857034|NCT01270841|2729227|P2|Overall Study|Protocol Violation|5
857035|NCT01270841|2729228|P1|Overall Study|Protocol Violation|1
857036|NCT01270841|2729225|P4|Overall Study|Did not qualify|5
857037|NCT01270841|2729226|P3|Overall Study|Did not qualify|4
857038|NCT01270841|2729227|P2|Overall Study|Did not qualify|3
857039|NCT01270841|2729228|P1|Overall Study|Did not qualify|6
857040|NCT01270841|2729225|P4|Overall Study|Physician Decision|0
857041|NCT01270841|2729226|P3|Overall Study|Physician Decision|0
857042|NCT01270841|2729227|P2|Overall Study|Physician Decision|1
857043|NCT01270841|2729228|P1|Overall Study|Physician Decision|0
857044|NCT01270841|2729225|P4|Overall Study|Lost to Follow-up|2
857045|NCT01270841|2729226|P3|Overall Study|Lost to Follow-up|4
857046|NCT01270841|2729227|P2|Overall Study|Lost to Follow-up|1
857047|NCT01270841|2729228|P1|Overall Study|Lost to Follow-up|3
857048|NCT01270841|2729225|P4|Overall Study|Withdrawal by Subject|3
857049|NCT01270841|2729226|P3|Overall Study|Withdrawal by Subject|3
857050|NCT01270841|2729227|P2|Overall Study|Withdrawal by Subject|2
857051|NCT01270841|2729228|P1|Overall Study|Withdrawal by Subject|3
857052|NCT01270841|2729225|P4|Overall Study|Adverse Event|3
857053|NCT01270841|2729226|P3|Overall Study|Adverse Event|0
857054|NCT01270841|2729227|P2|Overall Study|Adverse Event|1
857055|NCT01270841|2729228|P1|Overall Study|Adverse Event|0
857056|NCT01270880|2729267|P1|Overall Study|Never rec'd treatment, but registered.|1
857057|NCT01270958|2729276|P1|Overall Study|Did not meet inclusion criteria for age|2
857058|NCT01270958|2729276|P1|Overall Study|Lost to Follow-up|2
857059|NCT01270971|2729302|P2|Overall Study|Non-specific|3
857060|NCT01270971|2729303|P1|Overall Study|Non-specific|7
857061|NCT01270971|2729302|P2|Overall Study|Non compliance|2
857062|NCT01270971|2729303|P1|Overall Study|Non compliance|2
857063|NCT01270971|2729302|P2|Overall Study|Adverse Event|2
857064|NCT01270971|2729303|P1|Overall Study|Adverse Event|1
857065|NCT01270971|2729302|P2|Overall Study|Lost to Follow-up|5
857066|NCT01270971|2729303|P1|Overall Study|Lost to Follow-up|18
857067|NCT01270971|2729302|P2|Overall Study|Withdrawal by Subject|11
857068|NCT01270971|2729303|P1|Overall Study|Withdrawal by Subject|24
857069|NCT01277042|2729390|P2|Overall Study|Withdrawal by Subject|0
857070|NCT01277042|2729391|P1|Overall Study|Withdrawal by Subject|2
857071|NCT01277042|2729390|P2|Overall Study|Lost to Follow-up|2
857072|NCT01277042|2729391|P1|Overall Study|Lost to Follow-up|2
857073|NCT01277042|2729390|P2|Overall Study|Adverse Event|3
857074|NCT01277042|2729391|P1|Overall Study|Adverse Event|4
857075|NCT01277211|2729455|P2|Overall Study|Discontinued prior to treatment|13
857076|NCT01277211|2729456|P1|Overall Study|Discontinued prior to treatment|24
857077|NCT01277211|2729455|P2|Overall Study|Pregnancy wish|2
857078|NCT01277211|2729456|P1|Overall Study|Pregnancy wish|0
857079|NCT01277211|2729455|P2|Overall Study|Administrative|0
857080|NCT01277211|2729456|P1|Overall Study|Administrative|3
857081|NCT01277211|2729455|P2|Overall Study|Did not meet protocol eligibility|0
857082|NCT01277211|2729456|P1|Overall Study|Did not meet protocol eligibility|1
857083|NCT01277211|2729455|P2|Overall Study|Non-compliance with protocol|4
857084|NCT01277211|2729456|P1|Overall Study|Non-compliance with protocol|13
857085|NCT01277211|2729455|P2|Overall Study|Withdrew Consent|9
857086|NCT01277211|2729456|P1|Overall Study|Withdrew Consent|9
857087|NCT01277211|2729455|P2|Overall Study|Did not wish to continue|0
857088|NCT01277211|2729456|P1|Overall Study|Did not wish to continue|17
857089|NCT01277211|2729455|P2|Overall Study|Lost to Follow-up|9
857090|NCT01277211|2729456|P1|Overall Study|Lost to Follow-up|14
857091|NCT01277211|2729455|P2|Overall Study|Pregnancy|4
857092|NCT01277211|2729456|P1|Overall Study|Pregnancy|9
857093|NCT01277211|2729455|P2|Overall Study|Adverse Event|22
857094|NCT01277211|2729456|P1|Overall Study|Adverse Event|60
857095|NCT01277302|2729469|P3|8-Month Alternate Dose Regimen Period|Relocation|1
857096|NCT01277302|2729470|P2|8-Month Alternate Dose Regimen Period|Relocation|0
857097|NCT01277302|2729471|P1|8-Month Alternate Dose Regimen Period|Relocation|1
857098|NCT01277302|2729469|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
857099|NCT01277302|2729470|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
857100|NCT01277302|2729471|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
857101|NCT01277302|2729469|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
857102|NCT01277302|2729470|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
857103|NCT01277302|2729471|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
857104|NCT01277302|2729469|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
857105|NCT01277302|2729470|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
857106|NCT01277302|2729471|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
857107|NCT01277302|2729469|P3|8-Month Alternate Dose Regimen Period|Death|0
857108|NCT01277302|2729470|P2|8-Month Alternate Dose Regimen Period|Death|1
857109|NCT01277302|2729471|P1|8-Month Alternate Dose Regimen Period|Death|0
857110|NCT01277302|2729469|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
857111|NCT01277302|2729470|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
857112|NCT01277302|2729471|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
857113|NCT01277302|2729469|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
857114|NCT01277302|2729470|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
857115|NCT01277302|2729471|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
857116|NCT01277302|2729469|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
857117|NCT01277302|2729470|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
857118|NCT01277302|2729471|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
857119|NCT01277302|2729469|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
857120|NCT01277302|2729470|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
857121|NCT01277302|2729471|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
857122|NCT01277510|2729512|P2|Open-label Phase|Never received investigational product|0
857123|NCT01277510|2729513|P1|Open-label Phase|Never received investigational product|2
857124|NCT01277510|2729512|P2|Open-label Phase|Protocol-specified criteria|0
857125|NCT01277510|2729513|P1|Open-label Phase|Protocol-specified criteria|1
857126|NCT01277510|2729512|P2|Open-label Phase|Administrative decision|3
857127|NCT01277510|2729513|P1|Open-label Phase|Administrative decision|4
857128|NCT01277510|2729512|P2|Double-blind Phase|Other|1
857129|NCT01277510|2729513|P1|Double-blind Phase|Other|1
857130|NCT01277510|2729512|P2|Double-blind Phase|Protocol-specified criteria|6
857131|NCT01277510|2729513|P1|Double-blind Phase|Protocol-specified criteria|2
857132|NCT01277510|2729512|P2|Double-blind Phase|Death|1
857133|NCT01277510|2729513|P1|Double-blind Phase|Death|0
857134|NCT01277510|2729512|P2|Double-blind Phase|Administrative decision|9
857135|NCT01277510|2729513|P1|Double-blind Phase|Administrative decision|7
857136|NCT01277510|2729512|P2|Double-blind Phase|Withdrawal by Subject|0
857137|NCT01277510|2729513|P1|Double-blind Phase|Withdrawal by Subject|2
857138|NCT01277510|2729512|P2|Double-blind Phase|Adverse Event|0
857139|NCT01277510|2729513|P1|Double-blind Phase|Adverse Event|1
857140|NCT01277510|2729512|P2|Double-blind Phase|Non-compliance|1
857141|NCT01277510|2729513|P1|Double-blind Phase|Non-compliance|0
857142|NCT01277523|2729538|P3|Overall Study|Other Reason not Defined|0
857143|NCT01277523|2729539|P2|Overall Study|Other Reason not Defined|1
857144|NCT01277523|2729540|P1|Overall Study|Other Reason not Defined|0
857145|NCT01277523|2729538|P3|Overall Study|Protocol Violation|0
857146|NCT01277523|2729539|P2|Overall Study|Protocol Violation|0
857147|NCT01277523|2729540|P1|Overall Study|Protocol Violation|2
857148|NCT01277523|2729538|P3|Overall Study|Adverse Event|0
857149|NCT01277523|2729539|P2|Overall Study|Adverse Event|0
857150|NCT01277523|2729540|P1|Overall Study|Adverse Event|1
857151|NCT01277549|2729592|P2|Overall Study|Physician Decision|1
857152|NCT01277549|2729593|P1|Overall Study|Physician Decision|2
857153|NCT01277549|2729592|P2|Overall Study|Protocol Violation|1
857154|NCT01277549|2729593|P1|Overall Study|Protocol Violation|10
857155|NCT01277549|2729592|P2|Overall Study|Withdrawal by Subject|3
857156|NCT01277549|2729593|P1|Overall Study|Withdrawal by Subject|1
857157|NCT01277549|2729592|P2|Overall Study|Failed to meet eligibility criteria|9
857158|NCT01277549|2729593|P1|Overall Study|Failed to meet eligibility criteria|13
857159|NCT01277601|2729611|P4|Overall Study|Subject Terminated from Study by Sponsor|2
857160|NCT01277601|2729612|P3|Overall Study|Subject Terminated from Study by Sponsor|0
857161|NCT01277601|2729613|P2|Overall Study|Subject Terminated from Study by Sponsor|1
857162|NCT01277601|2729614|P1|Overall Study|Subject Terminated from Study by Sponsor|0
857163|NCT01277601|2729611|P4|Overall Study|Protocol Violation|0
857164|NCT01277601|2729612|P3|Overall Study|Protocol Violation|5
857165|NCT01277601|2729613|P2|Overall Study|Protocol Violation|2
857166|NCT01277601|2729614|P1|Overall Study|Protocol Violation|0
857167|NCT01277601|2729611|P4|Overall Study|Subject Never Dosed with Study Drug|1
857168|NCT01277601|2729612|P3|Overall Study|Subject Never Dosed with Study Drug|3
857169|NCT01277601|2729613|P2|Overall Study|Subject Never Dosed with Study Drug|2
857170|NCT01277601|2729614|P1|Overall Study|Subject Never Dosed with Study Drug|1
857171|NCT01277601|2729611|P4|Overall Study|Noncompliance with Study Drug|0
857172|NCT01277601|2729612|P3|Overall Study|Noncompliance with Study Drug|2
857173|NCT01277601|2729613|P2|Overall Study|Noncompliance with Study Drug|3
857174|NCT01277601|2729614|P1|Overall Study|Noncompliance with Study Drug|1
857175|NCT01277601|2729611|P4|Overall Study|Pregnancy|1
857176|NCT01277601|2729612|P3|Overall Study|Pregnancy|4
857177|NCT01277601|2729613|P2|Overall Study|Pregnancy|2
857178|NCT01277601|2729614|P1|Overall Study|Pregnancy|2
857179|NCT01277601|2729611|P4|Overall Study|Physician Decision|6
857180|NCT01277601|2729612|P3|Overall Study|Physician Decision|1
857181|NCT01277601|2729613|P2|Overall Study|Physician Decision|5
857182|NCT01277601|2729614|P1|Overall Study|Physician Decision|3
857183|NCT01277601|2729611|P4|Overall Study|Lost to Follow-up|2
857184|NCT01277601|2729612|P3|Overall Study|Lost to Follow-up|4
857185|NCT01277601|2729613|P2|Overall Study|Lost to Follow-up|9
857186|NCT01277601|2729614|P1|Overall Study|Lost to Follow-up|7
857187|NCT01277601|2729611|P4|Overall Study|Withdrawal by Subject|17
857188|NCT01277601|2729612|P3|Overall Study|Withdrawal by Subject|8
857189|NCT01277601|2729613|P2|Overall Study|Withdrawal by Subject|21
857190|NCT01277601|2729614|P1|Overall Study|Withdrawal by Subject|18
857191|NCT01277601|2729611|P4|Overall Study|Adverse Event|7
857192|NCT01277601|2729612|P3|Overall Study|Adverse Event|0
857193|NCT01277601|2729613|P2|Overall Study|Adverse Event|3
857194|NCT01277601|2729614|P1|Overall Study|Adverse Event|5
857195|NCT01277666|2729706|P3|Overall Study|Death|1
857196|NCT01277666|2729707|P2|Overall Study|Death|0
857197|NCT01277666|2729708|P1|Overall Study|Death|0
857198|NCT01277666|2729706|P3|Overall Study|Withdrawal by Subject|6
857199|NCT01277666|2729707|P2|Overall Study|Withdrawal by Subject|8
857200|NCT01277666|2729708|P1|Overall Study|Withdrawal by Subject|7
857201|NCT01277666|2729706|P3|Overall Study|Lost to Follow-up|2
857202|NCT01277666|2729707|P2|Overall Study|Lost to Follow-up|1
857203|NCT01277666|2729708|P1|Overall Study|Lost to Follow-up|1
857204|NCT01277666|2729706|P3|Overall Study|Protocol Defined Stopping criteria|6
857205|NCT01277666|2729707|P2|Overall Study|Protocol Defined Stopping criteria|2
857206|NCT01277666|2729708|P1|Overall Study|Protocol Defined Stopping criteria|1
857207|NCT01277666|2729706|P3|Overall Study|Protocol Violation|2
857208|NCT01277666|2729707|P2|Overall Study|Protocol Violation|3
857209|NCT01277666|2729708|P1|Overall Study|Protocol Violation|2
857210|NCT01277666|2729706|P3|Overall Study|Lack of Efficacy|12
857211|NCT01277666|2729707|P2|Overall Study|Lack of Efficacy|20
857212|NCT01277666|2729708|P1|Overall Study|Lack of Efficacy|8
857213|NCT01277666|2729706|P3|Overall Study|Adverse Event|20
857214|NCT01277666|2729707|P2|Overall Study|Adverse Event|25
857215|NCT01277666|2729708|P1|Overall Study|Adverse Event|26
857216|NCT01277718|2729737|P2|Period 2 - Second Intervention|Physician Decision|2
857217|NCT01277718|2729738|P1|Period 2 - Second Intervention|Physician Decision|0
857218|NCT01277718|2729737|P2|Period 2 - Second Intervention|Protocol Violation|1
857219|NCT01277718|2729738|P1|Period 2 - Second Intervention|Protocol Violation|0
857220|NCT01277757|2729749|P1|Overall Study|Withdrawal by Subject|1
857221|NCT01277757|2729749|P1|Overall Study|Disease Progression|1
857222|NCT01283464|2729758|P2|Overall Study|Physician Decision|0
857223|NCT01283464|2729759|P1|Overall Study|Physician Decision|1
857224|NCT01283464|2729758|P2|Overall Study|Withdrawal by Subject|0
857225|NCT01283464|2729759|P1|Overall Study|Withdrawal by Subject|1
857226|NCT01283464|2729758|P2|Overall Study|Lost to Follow-up|1
857227|NCT01283464|2729759|P1|Overall Study|Lost to Follow-up|0
857228|NCT01283516|2729774|P9|Overall Study|Withdrawal by Subject|11
857229|NCT01283516|2729775|P8|Overall Study|Withdrawal by Subject|0
857230|NCT01283516|2729776|P7|Overall Study|Withdrawal by Subject|0
857231|NCT01283516|2729777|P6|Overall Study|Withdrawal by Subject|0
857232|NCT01283516|2729778|P5|Overall Study|Withdrawal by Subject|1
857233|NCT01283516|2729779|P4|Overall Study|Withdrawal by Subject|0
857234|NCT01283516|2729780|P3|Overall Study|Withdrawal by Subject|0
857235|NCT01283516|2729781|P2|Overall Study|Withdrawal by Subject|0
857236|NCT01283516|2729782|P1|Overall Study|Withdrawal by Subject|0
857237|NCT01283516|2729774|P9|Overall Study|Disease Progression|81
857238|NCT01283516|2729775|P8|Overall Study|Disease Progression|2
857239|NCT01283516|2729776|P7|Overall Study|Disease Progression|6
857240|NCT01283516|2729777|P6|Overall Study|Disease Progression|7
857241|NCT01283516|2729778|P5|Overall Study|Disease Progression|12
857242|NCT01283516|2729779|P4|Overall Study|Disease Progression|3
857243|NCT01283516|2729780|P3|Overall Study|Disease Progression|2
857244|NCT01283516|2729781|P2|Overall Study|Disease Progression|2
857245|NCT01283516|2729782|P1|Overall Study|Disease Progression|2
857246|NCT01283516|2729774|P9|Overall Study|Death|6
857247|NCT01283516|2729775|P8|Overall Study|Death|1
857248|NCT01283516|2729776|P7|Overall Study|Death|0
857249|NCT01283516|2729777|P6|Overall Study|Death|1
857250|NCT01283516|2729778|P5|Overall Study|Death|0
857251|NCT01283516|2729779|P4|Overall Study|Death|0
857252|NCT01283516|2729780|P3|Overall Study|Death|0
857253|NCT01283516|2729781|P2|Overall Study|Death|0
857254|NCT01283516|2729782|P1|Overall Study|Death|0
857255|NCT01283516|2729774|P9|Overall Study|Adverse Event|24
857256|NCT01283516|2729775|P8|Overall Study|Adverse Event|0
857257|NCT01283516|2729776|P7|Overall Study|Adverse Event|2
857258|NCT01283516|2729777|P6|Overall Study|Adverse Event|0
857259|NCT01283516|2729778|P5|Overall Study|Adverse Event|0
857260|NCT01283516|2729779|P4|Overall Study|Adverse Event|0
857261|NCT01283516|2729780|P3|Overall Study|Adverse Event|0
857262|NCT01283516|2729781|P2|Overall Study|Adverse Event|0
857263|NCT01283516|2729782|P1|Overall Study|Adverse Event|0
857264|NCT01283581|2729851|P3|Overall Study|"Early termination"|1
857265|NCT01283581|2729852|P2|Overall Study|"Early termination"|0
857266|NCT01283581|2729853|P1|Overall Study|"Early termination"|0
857267|NCT01283581|2729851|P3|Overall Study|Investigator unblinded|1
857268|NCT01283581|2729852|P2|Overall Study|Investigator unblinded|0
857269|NCT01283581|2729853|P1|Overall Study|Investigator unblinded|0
857270|NCT01283581|2729851|P3|Overall Study|Noncompliance|0
857271|NCT01283581|2729852|P2|Overall Study|Noncompliance|0
857272|NCT01283581|2729853|P1|Overall Study|Noncompliance|1
857273|NCT01283581|2729851|P3|Overall Study|Protocol Violation|2
857274|NCT01283581|2729852|P2|Overall Study|Protocol Violation|1
857275|NCT01283581|2729853|P1|Overall Study|Protocol Violation|0
857276|NCT01283581|2729851|P3|Overall Study|Physician Decision|2
857277|NCT01283581|2729852|P2|Overall Study|Physician Decision|1
857278|NCT01283581|2729853|P1|Overall Study|Physician Decision|0
857279|NCT01283581|2729851|P3|Overall Study|Adverse Event|4
857280|NCT01283581|2729852|P2|Overall Study|Adverse Event|1
857281|NCT01283581|2729853|P1|Overall Study|Adverse Event|1
857282|NCT01283581|2729851|P3|Overall Study|Withdrawal by Subject|2
857283|NCT01283581|2729852|P2|Overall Study|Withdrawal by Subject|5
857284|NCT01283581|2729853|P1|Overall Study|Withdrawal by Subject|2
857285|NCT01283581|2729851|P3|Overall Study|Lost to Follow-up|8
857286|NCT01283581|2729852|P2|Overall Study|Lost to Follow-up|6
857287|NCT01283581|2729853|P1|Overall Study|Lost to Follow-up|8
857288|NCT01287039|2729901|P2|Overall Study|Lost to Follow-up|2
857289|NCT01287039|2729902|P1|Overall Study|Lost to Follow-up|3
857290|NCT01287039|2729901|P2|Overall Study|Withdrawal by Subject|11
857291|NCT01287039|2729902|P1|Overall Study|Withdrawal by Subject|14
857292|NCT01287039|2729901|P2|Overall Study|Adverse Event|4
857293|NCT01287039|2729902|P1|Overall Study|Adverse Event|7
857294|NCT01287039|2729901|P2|Overall Study|Change of residence|0
857295|NCT01287039|2729902|P1|Overall Study|Change of residence|1
857296|NCT01287039|2729901|P2|Overall Study|Death|0
857297|NCT01287039|2729902|P1|Overall Study|Death|1
857298|NCT01287039|2729901|P2|Overall Study|Problem with travel|1
857299|NCT01287039|2729902|P1|Overall Study|Problem with travel|0
857300|NCT01287039|2729901|P2|Overall Study|Noncompliance with study medication|1
857301|NCT01287039|2729902|P1|Overall Study|Noncompliance with study medication|0
857302|NCT01287039|2729901|P2|Overall Study|Excluded medication taken|0
857303|NCT01287039|2729902|P1|Overall Study|Excluded medication taken|1
857304|NCT01287039|2729901|P2|Overall Study|Protocol Violation|3
857305|NCT01287039|2729902|P1|Overall Study|Protocol Violation|2
857306|NCT01287039|2729901|P2|Overall Study|Elective surgery|1
857307|NCT01287039|2729902|P1|Overall Study|Elective surgery|0
857308|NCT01287039|2729901|P2|Overall Study|Change of location/residence|3
857309|NCT01287039|2729902|P1|Overall Study|Change of location/residence|0
857310|NCT01287039|2729901|P2|Overall Study|Noncompliance with study procedures|1
857311|NCT01287039|2729902|P1|Overall Study|Noncompliance with study procedures|0
857312|NCT01287065|2729932|P6|Treatment Period 1|Withdrawal by Subject|1
857313|NCT01287065|2729933|P5|Treatment Period 1|Withdrawal by Subject|0
857314|NCT01287065|2729934|P4|Treatment Period 1|Withdrawal by Subject|0
857315|NCT01287065|2729935|P3|Treatment Period 1|Withdrawal by Subject|0
857316|NCT01287065|2729936|P2|Treatment Period 1|Withdrawal by Subject|0
857317|NCT01287065|2729937|P1|Treatment Period 1|Withdrawal by Subject|0
857318|NCT01287065|2729932|P6|Treatment Period 1|Adverse Event|0
857319|NCT01287065|2729933|P5|Treatment Period 1|Adverse Event|1
857320|NCT01287065|2729934|P4|Treatment Period 1|Adverse Event|0
857321|NCT01287065|2729935|P3|Treatment Period 1|Adverse Event|0
857322|NCT01287065|2729936|P2|Treatment Period 1|Adverse Event|0
857323|NCT01287065|2729937|P1|Treatment Period 1|Adverse Event|0
857324|NCT01287117|2729958|P4|Overall Study|Disease Progression|5
857325|NCT01287117|2729959|P3|Overall Study|Disease Progression|6
857326|NCT01287117|2729960|P2|Overall Study|Disease Progression|5
857327|NCT01287117|2729961|P1|Overall Study|Disease Progression|10
857328|NCT01287117|2729958|P4|Overall Study|Patient/Legal Guardian's Decision|5
857329|NCT01287117|2729959|P3|Overall Study|Patient/Legal Guardian's Decision|8
857330|NCT01287117|2729960|P2|Overall Study|Patient/Legal Guardian's Decision|6
857331|NCT01287117|2729961|P1|Overall Study|Patient/Legal Guardian's Decision|2
857332|NCT01287117|2729958|P4|Overall Study|Physician Decision|1
857333|NCT01287117|2729959|P3|Overall Study|Physician Decision|1
857334|NCT01287117|2729960|P2|Overall Study|Physician Decision|1
857335|NCT01287117|2729961|P1|Overall Study|Physician Decision|0
857336|NCT01287117|2729958|P4|Overall Study|Lost to Follow-up|0
857337|NCT01287117|2729959|P3|Overall Study|Lost to Follow-up|0
857338|NCT01287117|2729960|P2|Overall Study|Lost to Follow-up|1
857339|NCT01287117|2729961|P1|Overall Study|Lost to Follow-up|1
857340|NCT01287117|2729958|P4|Overall Study|Adverse Event|1
857341|NCT01287117|2729959|P3|Overall Study|Adverse Event|1
857342|NCT01287117|2729960|P2|Overall Study|Adverse Event|1
857343|NCT01287117|2729961|P1|Overall Study|Adverse Event|2
857344|NCT01287195|2730007|P1|Overall Study|Withdrawal by Subject|2
857345|NCT01287221|2730029|P2|Overall Study|Withdrawal by Subject|1
857346|NCT01287221|2730030|P1|Overall Study|Withdrawal by Subject|0
857347|NCT01287221|2730029|P2|Overall Study|Adverse Event|3
857348|NCT01287221|2730030|P1|Overall Study|Adverse Event|3
857349|NCT01287221|2730029|P2|Overall Study|Lack of Perceived Benefit|1
857350|NCT01287221|2730030|P1|Overall Study|Lack of Perceived Benefit|1
857351|NCT01287364|2730050|P2|Overall Study|Other Reason|2
857352|NCT01287364|2730051|P1|Overall Study|Other Reason|4
857353|NCT01287364|2730050|P2|Overall Study|Protocol Violation|5
857354|NCT01287364|2730051|P1|Overall Study|Protocol Violation|5
857355|NCT01287364|2730050|P2|Overall Study|Adverse Event|3
857356|NCT01287364|2730051|P1|Overall Study|Adverse Event|0
857357|NCT01287403|2730071|P1|1st Intervention (1 Day)|Adverse Event|1
857358|NCT01287416|2730087|P2|6 Month Follow-up|Lost to Follow-up|2
857359|NCT01287416|2730088|P1|6 Month Follow-up|Lost to Follow-up|3
857360|NCT01287416|2730087|P2|Pre-post Training|Lost to Follow-up|1
857361|NCT01287416|2730088|P1|Pre-post Training|Lost to Follow-up|5
857362|NCT01287416|2730087|P2|Pre-post Training|Withdrawal by Subject|24
857363|NCT01287416|2730088|P1|Pre-post Training|Withdrawal by Subject|17
857364|NCT01287611|2730126|P2|Overall Study|Exclusion due to expanded Kerr incision|3
857365|NCT01287611|2730127|P1|Overall Study|Exclusion due to expanded Kerr incision|4
857366|NCT01287611|2730126|P2|Overall Study|Lost to Follow-up|16
857367|NCT01287611|2730127|P1|Overall Study|Lost to Follow-up|29
857388|NCT01287754|2730174|P2|Overall Study|Protocol Violation|3
857389|NCT01287754|2730175|P1|Overall Study|Protocol Violation|0
857390|NCT01287754|2730174|P2|Overall Study|Lost to Follow-up|6
857391|NCT01287754|2730175|P1|Overall Study|Lost to Follow-up|1
857392|NCT01287754|2730174|P2|Overall Study|Death|12
857393|NCT01287754|2730175|P1|Overall Study|Death|2
857394|NCT01287832|2730187|P2|Overall Study|Death|1
857395|NCT01287832|2730188|P1|Overall Study|Death|0
857396|NCT01287832|2730187|P2|Overall Study|Adverse Event|0
857397|NCT01287832|2730188|P1|Overall Study|Adverse Event|1
857398|NCT01287897|2730198|P4|Overall Study|Unspecified|0
857399|NCT01287897|2730199|P3|Overall Study|Unspecified|1
857400|NCT01287897|2730200|P2|Overall Study|Unspecified|0
857401|NCT01287897|2730201|P1|Overall Study|Unspecified|1
857402|NCT01287897|2730198|P4|Overall Study|Not meeting entrance criteria|0
857403|NCT01287897|2730199|P3|Overall Study|Not meeting entrance criteria|0
857404|NCT01287897|2730200|P2|Overall Study|Not meeting entrance criteria|1
857405|NCT01287897|2730201|P1|Overall Study|Not meeting entrance criteria|1
857406|NCT01287897|2730198|P4|Overall Study|Not consented properly|0
857407|NCT01287897|2730199|P3|Overall Study|Not consented properly|0
857408|NCT01287897|2730200|P2|Overall Study|Not consented properly|1
857409|NCT01287897|2730201|P1|Overall Study|Not consented properly|0
857410|NCT01287897|2730198|P4|Overall Study|Withdrawal by Subject|2
857411|NCT01287897|2730199|P3|Overall Study|Withdrawal by Subject|3
857412|NCT01287897|2730200|P2|Overall Study|Withdrawal by Subject|5
857413|NCT01287897|2730201|P1|Overall Study|Withdrawal by Subject|1
857414|NCT01287897|2730198|P4|Overall Study|Lost to Follow-up|0
857415|NCT01287897|2730199|P3|Overall Study|Lost to Follow-up|2
857416|NCT01287897|2730200|P2|Overall Study|Lost to Follow-up|0
857417|NCT01287897|2730201|P1|Overall Study|Lost to Follow-up|0
857418|NCT01287897|2730198|P4|Overall Study|Protocol Violation|1
857419|NCT01287897|2730199|P3|Overall Study|Protocol Violation|0
857420|NCT01287897|2730200|P2|Overall Study|Protocol Violation|1
857421|NCT01287897|2730201|P1|Overall Study|Protocol Violation|1
857422|NCT01287897|2730198|P4|Overall Study|Lack of Efficacy|0
857423|NCT01287897|2730199|P3|Overall Study|Lack of Efficacy|0
857424|NCT01287897|2730200|P2|Overall Study|Lack of Efficacy|0
857425|NCT01287897|2730201|P1|Overall Study|Lack of Efficacy|2
857426|NCT01287897|2730198|P4|Overall Study|Adverse Event|4
857427|NCT01287897|2730199|P3|Overall Study|Adverse Event|6
857428|NCT01287897|2730200|P2|Overall Study|Adverse Event|3
857429|NCT01287897|2730201|P1|Overall Study|Adverse Event|5
857430|NCT01288079|2730264|P4|Overall Study|Other or Study Termination|8
857431|NCT01288079|2730265|P3|Overall Study|Other or Study Termination|14
857432|NCT01288079|2730266|P2|Overall Study|Other or Study Termination|15
857433|NCT01288079|2730267|P1|Overall Study|Other or Study Termination|11
857434|NCT01288079|2730264|P4|Overall Study|Lost to Follow-up|0
857435|NCT01288079|2730265|P3|Overall Study|Lost to Follow-up|1
857436|NCT01288079|2730266|P2|Overall Study|Lost to Follow-up|1
857437|NCT01288079|2730267|P1|Overall Study|Lost to Follow-up|1
857438|NCT01288079|2730264|P4|Overall Study|Study-Specific Withdrawal Criteria|0
857439|NCT01288079|2730265|P3|Overall Study|Study-Specific Withdrawal Criteria|0
857440|NCT01288079|2730266|P2|Overall Study|Study-Specific Withdrawal Criteria|1
857441|NCT01288079|2730267|P1|Overall Study|Study-Specific Withdrawal Criteria|1
857442|NCT01288079|2730264|P4|Overall Study|Lack of Efficacy|2
857443|NCT01288079|2730265|P3|Overall Study|Lack of Efficacy|0
857444|NCT01288079|2730266|P2|Overall Study|Lack of Efficacy|2
857445|NCT01288079|2730267|P1|Overall Study|Lack of Efficacy|2
857446|NCT01288079|2730264|P4|Overall Study|Condition under Investigation Worsened|1
857447|NCT01288079|2730265|P3|Overall Study|Condition under Investigation Worsened|0
857448|NCT01288079|2730266|P2|Overall Study|Condition under Investigation Worsened|0
857449|NCT01288079|2730267|P1|Overall Study|Condition under Investigation Worsened|0
857450|NCT01288079|2730264|P4|Overall Study|Severe Non-Compliance to Protocol|3
857451|NCT01288079|2730265|P3|Overall Study|Severe Non-Compliance to Protocol|1
857452|NCT01288079|2730266|P2|Overall Study|Severe Non-Compliance to Protocol|3
857453|NCT01288079|2730267|P1|Overall Study|Severe Non-Compliance to Protocol|1
857454|NCT01288079|2730264|P4|Overall Study|Adverse Event|3
857455|NCT01288079|2730265|P3|Overall Study|Adverse Event|2
857456|NCT01288079|2730266|P2|Overall Study|Adverse Event|1
857457|NCT01288079|2730267|P1|Overall Study|Adverse Event|2
857458|NCT01288079|2730264|P4|Overall Study|Withdrawal by Subject|0
857459|NCT01288079|2730265|P3|Overall Study|Withdrawal by Subject|1
857460|NCT01288079|2730266|P2|Overall Study|Withdrawal by Subject|4
857461|NCT01288079|2730267|P1|Overall Study|Withdrawal by Subject|2
857462|NCT01288209|2730279|P2|Overall Study|Not specified|0
857463|NCT01288209|2730280|P1|Overall Study|Not specified|1
857464|NCT01288209|2730279|P2|Overall Study|Withdrawal by Subject|3
857465|NCT01288209|2730280|P1|Overall Study|Withdrawal by Subject|1
857466|NCT01288287|2730306|P1|Overall Study|Unknown Status|7
857467|NCT01288287|2730306|P1|Overall Study|Unknown Reason|1
857468|NCT01288287|2730306|P1|Overall Study|Other Reason|13
857469|NCT01288287|2730306|P1|Overall Study|Lack of Efficacy|13
857470|NCT01288287|2730306|P1|Overall Study|Withdrawal by Subject|4
857471|NCT01288287|2730306|P1|Overall Study|Lost to Follow-up|8
857472|NCT01288443|2730325|P6|Overall Study|Other than above|0
857473|NCT01288443|2730326|P5|Overall Study|Other than above|1
857474|NCT01288443|2730327|P4|Overall Study|Other than above|2
857475|NCT01288443|2730328|P3|Overall Study|Other than above|0
857476|NCT01288443|2730329|P2|Overall Study|Other than above|0
857477|NCT01288443|2730330|P1|Overall Study|Other than above|0
857478|NCT01288443|2730325|P6|Overall Study|Study drug auto-injector administration|1
857479|NCT01288443|2730326|P5|Overall Study|Study drug auto-injector administration|1
857480|NCT01288443|2730327|P4|Overall Study|Study drug auto-injector administration|0
857481|NCT01288443|2730328|P3|Overall Study|Study drug auto-injector administration|0
857482|NCT01288443|2730329|P2|Overall Study|Study drug auto-injector administration|0
857483|NCT01288443|2730330|P1|Overall Study|Study drug auto-injector administration|0
857484|NCT01288443|2730325|P6|Overall Study|Lost to Follow-up|0
857485|NCT01288443|2730326|P5|Overall Study|Lost to Follow-up|0
857486|NCT01288443|2730327|P4|Overall Study|Lost to Follow-up|0
857487|NCT01288443|2730328|P3|Overall Study|Lost to Follow-up|0
857488|NCT01288443|2730329|P2|Overall Study|Lost to Follow-up|1
857489|NCT01288443|2730330|P1|Overall Study|Lost to Follow-up|0
857490|NCT01288443|2730325|P6|Overall Study|Consent withdrawn by Participant|1
857491|NCT01288443|2730326|P5|Overall Study|Consent withdrawn by Participant|0
857492|NCT01288443|2730327|P4|Overall Study|Consent withdrawn by Participant|0
857493|NCT01288443|2730328|P3|Overall Study|Consent withdrawn by Participant|0
857494|NCT01288443|2730329|P2|Overall Study|Consent withdrawn by Participant|0
857495|NCT01288443|2730330|P1|Overall Study|Consent withdrawn by Participant|0
857496|NCT01288443|2730325|P6|Overall Study|Participant Moved|1
857497|NCT01288443|2730326|P5|Overall Study|Participant Moved|2
857498|NCT01288443|2730327|P4|Overall Study|Participant Moved|1
857499|NCT01288443|2730328|P3|Overall Study|Participant Moved|0
857500|NCT01288443|2730329|P2|Overall Study|Participant Moved|0
857501|NCT01288443|2730330|P1|Overall Study|Participant Moved|0
857502|NCT01288443|2730325|P6|Overall Study|Poor compliance to protocol|1
857503|NCT01288443|2730326|P5|Overall Study|Poor compliance to protocol|0
857504|NCT01288443|2730327|P4|Overall Study|Poor compliance to protocol|0
857505|NCT01288443|2730328|P3|Overall Study|Poor compliance to protocol|0
857506|NCT01288443|2730329|P2|Overall Study|Poor compliance to protocol|0
857507|NCT01288443|2730330|P1|Overall Study|Poor compliance to protocol|0
857508|NCT01288443|2730325|P6|Overall Study|Adverse Event|1
857509|NCT01288443|2730326|P5|Overall Study|Adverse Event|3
857510|NCT01288443|2730327|P4|Overall Study|Adverse Event|1
857511|NCT01288443|2730328|P3|Overall Study|Adverse Event|1
857512|NCT01288443|2730329|P2|Overall Study|Adverse Event|0
857513|NCT01288443|2730330|P1|Overall Study|Adverse Event|0
857514|NCT01288469|2730383|P3|Overall Study|Exclusion criteria finally met|0
857515|NCT01288469|2730384|P2|Overall Study|Exclusion criteria finally met|0
857516|NCT01288469|2730385|P1|Overall Study|Exclusion criteria finally met|1
857517|NCT01288469|2730383|P3|Overall Study|Consent withdrawn by subject|1
857518|NCT01288469|2730384|P2|Overall Study|Consent withdrawn by subject|1
857519|NCT01288469|2730385|P1|Overall Study|Consent withdrawn by subject|1
857520|NCT01288469|2730383|P3|Overall Study|Participant Moved|0
857521|NCT01288469|2730384|P2|Overall Study|Participant Moved|0
857522|NCT01288469|2730385|P1|Overall Study|Participant Moved|1
857523|NCT01288469|2730383|P3|Overall Study|Poor compliance to protocol|0
857524|NCT01288469|2730384|P2|Overall Study|Poor compliance to protocol|1
857525|NCT01288469|2730385|P1|Overall Study|Poor compliance to protocol|0
857526|NCT01288469|2730383|P3|Overall Study|Adverse Event|1
857527|NCT01288469|2730384|P2|Overall Study|Adverse Event|1
857528|NCT01288469|2730385|P1|Overall Study|Adverse Event|4
857529|NCT01288612|2730418|P3|Overall Study|Unable to intubate|0
857530|NCT01288612|2730419|P2|Overall Study|Unable to intubate|3
857531|NCT01288612|2730420|P1|Overall Study|Unable to intubate|0
857532|NCT01288612|2730418|P3|Overall Study|Declined|62
857533|NCT01288612|2730419|P2|Overall Study|Declined|63
857534|NCT01288612|2730420|P1|Overall Study|Declined|78
857535|NCT01288612|2730418|P3|Overall Study|Unable to contact|20
857536|NCT01288612|2730419|P2|Overall Study|Unable to contact|16
857537|NCT01288612|2730420|P1|Overall Study|Unable to contact|11
857538|NCT01288729|2730451|P2|Overall Study|Withdrawal by Subject|0
857539|NCT01288729|2730452|P1|Overall Study|Withdrawal by Subject|1
857540|NCT01288911|2730512|P2|Overall Study|Randomized but never received study drug|2
857541|NCT01288911|2730513|P1|Overall Study|Randomized but never received study drug|1
857542|NCT01288911|2730512|P2|Overall Study|Miscellaneous Reason|39
857543|NCT01288911|2730513|P1|Overall Study|Miscellaneous Reason|23
857544|NCT01288911|2730512|P2|Overall Study|Withdrawal by Subject|21
857545|NCT01288911|2730513|P1|Overall Study|Withdrawal by Subject|21
857546|NCT01288911|2730512|P2|Overall Study|Protocol Violation|0
857547|NCT01288911|2730513|P1|Overall Study|Protocol Violation|1
857548|NCT01288911|2730512|P2|Overall Study|Progressive Disease|99
857549|NCT01288911|2730513|P1|Overall Study|Progressive Disease|69
857550|NCT01288911|2730512|P2|Overall Study|Lost to Follow-up|2
857551|NCT01288911|2730513|P1|Overall Study|Lost to Follow-up|0
857552|NCT01288911|2730512|P2|Overall Study|Death|7
857553|NCT01288911|2730513|P1|Overall Study|Death|10
857554|NCT01289015|2730543|P2|Overall Study|Negative baseline culture and others|20
857555|NCT01289015|2730544|P1|Overall Study|Negative baseline culture and others|33
857556|NCT01289015|2730543|P2|Overall Study|Disease progression|0
857557|NCT01289015|2730544|P1|Overall Study|Disease progression|1
857558|NCT01289015|2730543|P2|Overall Study|Withdrawal by Subject|8
857559|NCT01289015|2730544|P1|Overall Study|Withdrawal by Subject|17
857560|NCT01289015|2730543|P2|Overall Study|Lost to Follow-up|17
857561|NCT01289015|2730544|P1|Overall Study|Lost to Follow-up|33
857562|NCT01289015|2730543|P2|Overall Study|Adverse Event|0
857563|NCT01289015|2730544|P1|Overall Study|Adverse Event|3
857564|NCT01289015|2730543|P2|Overall Study|Protocol Violation|9
857565|NCT01289015|2730544|P1|Overall Study|Protocol Violation|12
857566|NCT01289028|2730552|P1|Overall Study|Missing reason for discon|1
857567|NCT01289028|2730552|P1|Overall Study|Abnormal Lab Value|1
857568|NCT01289028|2730552|P1|Overall Study|New Cancer Therapy|2
857569|NCT01289028|2730552|P1|Overall Study|Lost to Follow-up|2
857570|NCT01289028|2730552|P1|Overall Study|No longer required|2
857571|NCT01289028|2730552|P1|Overall Study|Lack of Efficacy|2
857572|NCT01289028|2730552|P1|Overall Study|Death|4
857573|NCT01289028|2730552|P1|Overall Study|Withdrawal by Subject|6
857574|NCT01289028|2730552|P1|Overall Study|Adverse Event|14
857575|NCT01289028|2730552|P1|Overall Study|Progressive Disease|49
857576|NCT01289041|2730564|P1|Overall Study|Death|1
857577|NCT01289041|2730564|P1|Overall Study|Withdrawal by Subject|3
857578|NCT01289041|2730564|P1|Overall Study|Progressive Disease|41
857579|NCT01289041|2730564|P1|Overall Study|Physician Decision|1
857580|NCT01289041|2730564|P1|Overall Study|Adverse Event|24
857581|NCT01289119|2730616|P6|Overall Study|Other|0
857582|NCT01289119|2730617|P5|Overall Study|Other|0
857583|NCT01289119|2730618|P4|Overall Study|Other|0
857584|NCT01289119|2730619|P3|Overall Study|Other|1
857585|NCT01289119|2730620|P2|Overall Study|Other|0
857586|NCT01289119|2730621|P1|Overall Study|Other|1
857587|NCT01289119|2730616|P6|Overall Study|Lack of Efficacy|1
857588|NCT01289119|2730617|P5|Overall Study|Lack of Efficacy|1
857589|NCT01289119|2730618|P4|Overall Study|Lack of Efficacy|1
857590|NCT01289119|2730619|P3|Overall Study|Lack of Efficacy|1
857591|NCT01289119|2730620|P2|Overall Study|Lack of Efficacy|1
857592|NCT01289119|2730621|P1|Overall Study|Lack of Efficacy|0
857593|NCT01289119|2730616|P6|Overall Study|Pregnancy|0
857594|NCT01289119|2730617|P5|Overall Study|Pregnancy|0
857595|NCT01289119|2730618|P4|Overall Study|Pregnancy|0
857596|NCT01289119|2730619|P3|Overall Study|Pregnancy|0
857597|NCT01289119|2730620|P2|Overall Study|Pregnancy|1
857598|NCT01289119|2730621|P1|Overall Study|Pregnancy|0
857599|NCT01289119|2730616|P6|Overall Study|Withdrawal by Subject|1
857600|NCT01289119|2730617|P5|Overall Study|Withdrawal by Subject|1
857601|NCT01289119|2730618|P4|Overall Study|Withdrawal by Subject|3
857602|NCT01289119|2730619|P3|Overall Study|Withdrawal by Subject|4
857603|NCT01289119|2730620|P2|Overall Study|Withdrawal by Subject|2
857604|NCT01289119|2730621|P1|Overall Study|Withdrawal by Subject|4
857605|NCT01289119|2730616|P6|Overall Study|Lost to Follow-up|1
857606|NCT01289119|2730617|P5|Overall Study|Lost to Follow-up|0
857607|NCT01289119|2730618|P4|Overall Study|Lost to Follow-up|0
857608|NCT01289119|2730619|P3|Overall Study|Lost to Follow-up|0
857609|NCT01289119|2730620|P2|Overall Study|Lost to Follow-up|3
857610|NCT01289119|2730621|P1|Overall Study|Lost to Follow-up|0
857611|NCT01289119|2730616|P6|Overall Study|Major Protocol Deviation|1
857612|NCT01289119|2730617|P5|Overall Study|Major Protocol Deviation|2
857613|NCT01289119|2730618|P4|Overall Study|Major Protocol Deviation|0
857614|NCT01289119|2730619|P3|Overall Study|Major Protocol Deviation|3
857615|NCT01289119|2730620|P2|Overall Study|Major Protocol Deviation|1
857616|NCT01289119|2730621|P1|Overall Study|Major Protocol Deviation|2
857617|NCT01289119|2730616|P6|Overall Study|Adverse Event|0
857618|NCT01289119|2730617|P5|Overall Study|Adverse Event|1
857619|NCT01289119|2730618|P4|Overall Study|Adverse Event|2
857620|NCT01289119|2730619|P3|Overall Study|Adverse Event|0
857621|NCT01289119|2730620|P2|Overall Study|Adverse Event|1
857622|NCT01289119|2730621|P1|Overall Study|Adverse Event|2
857623|NCT01289210|2730701|P1|Overall Study|Adverse Event|1
857624|NCT01280656|2730708|P3|Overall Study|Other|7
857625|NCT01280656|2730709|P2|Overall Study|Other|7
857626|NCT01280656|2730710|P1|Overall Study|Other|1
857627|NCT01280656|2730708|P3|Overall Study|Treatment shortening (RGT)|5
857628|NCT01280656|2730709|P2|Overall Study|Treatment shortening (RGT)|4
857629|NCT01280656|2730710|P1|Overall Study|Treatment shortening (RGT)|0
857630|NCT01280656|2730708|P3|Overall Study|Lack of Efficacy|38
857631|NCT01280656|2730709|P2|Overall Study|Lack of Efficacy|22
857632|NCT01280656|2730710|P1|Overall Study|Lack of Efficacy|1
857633|NCT01280656|2730708|P3|Overall Study|Adverse Event|13
857634|NCT01280656|2730709|P2|Overall Study|Adverse Event|14
857635|NCT01280656|2730710|P1|Overall Study|Adverse Event|1
857636|NCT01289418|2730816|P1|Day 29 Survey|participants did not complete the survey|2185
857637|NCT01289418|2730816|P1|Day 29 Survey|email address invalid|283
857638|NCT01289418|2730816|P1|Day 8 Survey|participants did not complete the survey|1935
857639|NCT01289418|2730816|P1|Day 8 Survey|email address invalid|283
857640|NCT01289574|2730880|P3|Overall Study|Subject wanted alternate treatment|0
857641|NCT01289574|2730881|P2|Overall Study|Subject wanted alternate treatment|1
857642|NCT01289574|2730882|P1|Overall Study|Subject wanted alternate treatment|0
857643|NCT01289574|2730880|P3|Overall Study|Adverse Event|0
857644|NCT01289574|2730881|P2|Overall Study|Adverse Event|1
857645|NCT01289574|2730882|P1|Overall Study|Adverse Event|0
857646|NCT01289574|2730880|P3|Overall Study|Withdrawal by Subject|1
857647|NCT01289574|2730881|P2|Overall Study|Withdrawal by Subject|1
857648|NCT01289574|2730882|P1|Overall Study|Withdrawal by Subject|1
857649|NCT01289574|2730880|P3|Overall Study|Lost to Follow-up|1
857650|NCT01289574|2730881|P2|Overall Study|Lost to Follow-up|0
857651|NCT01289574|2730882|P1|Overall Study|Lost to Follow-up|2
857652|NCT01289574|2730880|P3|Overall Study|Lack of Efficacy|1
857653|NCT01289574|2730881|P2|Overall Study|Lack of Efficacy|0
857654|NCT01289574|2730882|P1|Overall Study|Lack of Efficacy|4
857655|NCT01290224|2730896|P1|Overall Study|Refused Further Treatment|4
857656|NCT01290224|2730896|P1|Overall Study|Adverse Event|1
857657|NCT01290263|2730909|P5|Overall Study|Participant Non-Compliance|1
857658|NCT01290263|2730910|P4|Overall Study|Participant Non-Compliance|1
857659|NCT01290263|2730911|P3|Overall Study|Participant Non-Compliance|0
857660|NCT01290263|2730912|P2|Overall Study|Participant Non-Compliance|0
857661|NCT01290263|2730913|P1|Overall Study|Participant Non-Compliance|0
857662|NCT01290263|2730909|P5|Overall Study|Withdrawal by Subject|2
857663|NCT01290263|2730910|P4|Overall Study|Withdrawal by Subject|1
857664|NCT01290263|2730911|P3|Overall Study|Withdrawal by Subject|0
857665|NCT01290263|2730912|P2|Overall Study|Withdrawal by Subject|1
857666|NCT01290263|2730913|P1|Overall Study|Withdrawal by Subject|3
857667|NCT01290263|2730909|P5|Overall Study|Lack of Efficacy|33
857668|NCT01290263|2730910|P4|Overall Study|Lack of Efficacy|24
857669|NCT01290263|2730911|P3|Overall Study|Lack of Efficacy|7
857670|NCT01290263|2730912|P2|Overall Study|Lack of Efficacy|2
857671|NCT01290263|2730913|P1|Overall Study|Lack of Efficacy|8
857672|NCT01290263|2730909|P5|Overall Study|Adverse Event|1
857673|NCT01290263|2730910|P4|Overall Study|Adverse Event|1
857674|NCT01290263|2730911|P3|Overall Study|Adverse Event|0
857675|NCT01290263|2730912|P2|Overall Study|Adverse Event|0
857676|NCT01290263|2730913|P1|Overall Study|Adverse Event|0
857677|NCT01290341|2730931|P2|Overall Study|Negative baseline culture and others|11
857678|NCT01290341|2730932|P1|Overall Study|Negative baseline culture and others|44
857679|NCT01290341|2730931|P2|Overall Study|Withdrawal by Subject|5
857680|NCT01290341|2730932|P1|Overall Study|Withdrawal by Subject|19
857681|NCT01290341|2730931|P2|Overall Study|Lost to Follow-up|10
857682|NCT01290341|2730932|P1|Overall Study|Lost to Follow-up|21
857683|NCT01290341|2730931|P2|Overall Study|Adverse Event|0
857684|NCT01290341|2730932|P1|Overall Study|Adverse Event|1
857685|NCT01290341|2730931|P2|Overall Study|Protocol Violation|3
857686|NCT01290341|2730932|P1|Overall Study|Protocol Violation|7
857687|NCT01290666|2731003|P1|Overall Study|Early Termination of Study|4
857688|NCT01290666|2731003|P1|Overall Study|Withdrawal by Subject|23
857689|NCT01290666|2731003|P1|Overall Study|Lost to Follow-up|11
857690|NCT01290679|2731009|P2|Overall Study|Subject Entered Another Trial|5
857691|NCT01290679|2731010|P1|Overall Study|Subject Entered Another Trial|0
857692|NCT01290679|2731009|P2|Overall Study|Withdrawal by Subject|5
857693|NCT01290679|2731010|P1|Overall Study|Withdrawal by Subject|6
857694|NCT01290679|2731009|P2|Overall Study|Protocol Violation|1
857695|NCT01290679|2731010|P1|Overall Study|Protocol Violation|0
857696|NCT01290679|2731009|P2|Overall Study|Lost to Follow-up|10
857697|NCT01290679|2731010|P1|Overall Study|Lost to Follow-up|8
857698|NCT01290679|2731009|P2|Overall Study|Adverse Event|0
857699|NCT01290679|2731010|P1|Overall Study|Adverse Event|2
857700|NCT01290718|2731079|P1|Overall Study|Early termination of the study|4
857701|NCT01290731|2731086|P1|Overall Study|Withdrawal by Subject|1
857702|NCT01290757|2731100|P2|Overall Study|Other|1
857703|NCT01290757|2731101|P1|Overall Study|Other|0
857704|NCT01290757|2731100|P2|Overall Study|Protocol Violation|1
857705|NCT01290757|2731101|P1|Overall Study|Protocol Violation|1
857706|NCT01290757|2731100|P2|Overall Study|Adverse Event|0
857707|NCT01290757|2731101|P1|Overall Study|Adverse Event|1
857708|NCT01290796|2731117|P1|Overall Study|Withdrawal by Sponsor|1
857709|NCT01290796|2731117|P1|Overall Study|Secondary Surgical Intervention|2
857710|NCT01290796|2731117|P1|Overall Study|Physician Decision|2
857711|NCT01290796|2731117|P1|Overall Study|Withdrawal by Subject|4
857712|NCT01290796|2731117|P1|Overall Study|Lost to Follow-up|21
857713|NCT01290822|2731131|P1|Overall Study|Physician Decision|10
857714|NCT01290822|2731131|P1|Overall Study|Withdrawal by Subject|1
857715|NCT01290887|2731142|P2|Overall Study|Not specified|6
857716|NCT01290887|2731143|P1|Overall Study|Not specified|3
857717|NCT01290887|2731142|P2|Overall Study|Sponsor closure of study|476
857718|NCT01290887|2731143|P1|Overall Study|Sponsor closure of study|420
857719|NCT01290887|2731142|P2|Overall Study|Non-compliance to study medications|0
857720|NCT01290887|2731143|P1|Overall Study|Non-compliance to study medications|1
857721|NCT01290887|2731142|P2|Overall Study|Non-compliance to study procedures|1
857722|NCT01290887|2731143|P1|Overall Study|Non-compliance to study procedures|0
857723|NCT01290887|2731142|P2|Overall Study|Lost to Follow-up|4
857724|NCT01290887|2731143|P1|Overall Study|Lost to Follow-up|4
857725|NCT01290887|2731142|P2|Overall Study|Protocol Violation|1
857726|NCT01290887|2731143|P1|Overall Study|Protocol Violation|2
857727|NCT01290887|2731142|P2|Overall Study|Withdrawal by Subject|32
857728|NCT01290887|2731143|P1|Overall Study|Withdrawal by Subject|26
857729|NCT01290887|2731142|P2|Overall Study|Lack of Efficacy|5
857730|NCT01290887|2731143|P1|Overall Study|Lack of Efficacy|4
857731|NCT01290887|2731142|P2|Overall Study|Adverse Event|11
857732|NCT01290887|2731143|P1|Overall Study|Adverse Event|6
857733|NCT01291017|2731204|P1|Overall Study|Withdrawal by Subject|3
857734|NCT01291017|2731204|P1|Overall Study|Lost to Follow-up|2
857735|NCT01291173|2731263|P4|Overall Study|Excluded therapy|0
857736|NCT01291173|2731264|P3|Overall Study|Excluded therapy|1
857737|NCT01291173|2731265|P2|Overall Study|Excluded therapy|0
857738|NCT01291173|2731266|P1|Overall Study|Excluded therapy|0
857739|NCT01291173|2731263|P4|Overall Study|Subject was unblinded|0
857740|NCT01291173|2731264|P3|Overall Study|Subject was unblinded|1
857741|NCT01291173|2731265|P2|Overall Study|Subject was unblinded|0
857742|NCT01291173|2731266|P1|Overall Study|Subject was unblinded|0
857743|NCT01291173|2731263|P4|Overall Study|Lack of compliance|1
857744|NCT01291173|2731264|P3|Overall Study|Lack of compliance|0
857745|NCT01291173|2731265|P2|Overall Study|Lack of compliance|0
857746|NCT01291173|2731266|P1|Overall Study|Lack of compliance|0
857747|NCT01291173|2731263|P4|Overall Study|Unable to meet visit schedule|0
857748|NCT01291173|2731264|P3|Overall Study|Unable to meet visit schedule|1
857749|NCT01291173|2731265|P2|Overall Study|Unable to meet visit schedule|0
857750|NCT01291173|2731266|P1|Overall Study|Unable to meet visit schedule|0
857751|NCT01291173|2731263|P4|Overall Study|Lost to Follow-up|2
857752|NCT01291173|2731264|P3|Overall Study|Lost to Follow-up|3
857753|NCT01291173|2731265|P2|Overall Study|Lost to Follow-up|6
857754|NCT01291173|2731266|P1|Overall Study|Lost to Follow-up|4
857755|NCT01291173|2731263|P4|Overall Study|Withdrawal by Subject|2
857756|NCT01291173|2731264|P3|Overall Study|Withdrawal by Subject|4
857757|NCT01291173|2731265|P2|Overall Study|Withdrawal by Subject|4
857758|NCT01291173|2731266|P1|Overall Study|Withdrawal by Subject|6
857759|NCT01291173|2731263|P4|Overall Study|Protocol Violation|5
857760|NCT01291173|2731264|P3|Overall Study|Protocol Violation|2
857761|NCT01291173|2731265|P2|Overall Study|Protocol Violation|2
857762|NCT01291173|2731266|P1|Overall Study|Protocol Violation|7
857763|NCT01291173|2731263|P4|Overall Study|Adverse Event|3
857764|NCT01291173|2731264|P3|Overall Study|Adverse Event|1
857765|NCT01291173|2731265|P2|Overall Study|Adverse Event|3
857766|NCT01291173|2731266|P1|Overall Study|Adverse Event|0
857767|NCT01291225|2731330|P2|Overall Study|Lost to Follow-up|39
857768|NCT01291225|2731331|P1|Overall Study|Lost to Follow-up|85
857769|NCT01291277|2731347|P2|Overall Study|Lost to Follow-up|1
857770|NCT01291277|2731348|P1|Overall Study|Lost to Follow-up|3
857771|NCT01291277|2731347|P2|Overall Study|Death|2
857772|NCT01291277|2731348|P1|Overall Study|Death|2
857773|NCT01292057|2731411|P2|Overall Study|Lost to Follow-up|1
857774|NCT01292057|2731412|P1|Overall Study|Lost to Follow-up|1
857775|NCT01292057|2731411|P2|Overall Study|Protocol Violation|1
857776|NCT01292057|2731412|P1|Overall Study|Protocol Violation|1
857777|NCT01292187|2731447|P2|Overall Study|All other reasons|3
857778|NCT01292187|2731448|P1|Overall Study|All other reasons|1
857779|NCT01292187|2731447|P2|Overall Study|Withdrawal by Subject|5
857780|NCT01292187|2731448|P1|Overall Study|Withdrawal by Subject|6
857781|NCT01292187|2731447|P2|Overall Study|Adverse Event|5
857782|NCT01292187|2731448|P1|Overall Study|Adverse Event|10
857783|NCT01292226|2731456|P1|Overall Study|Not specified|2
857784|NCT01292226|2731456|P1|Overall Study|Withdrawal by Subject|1
857785|NCT01292226|2731456|P1|Overall Study|Protocol Violation|3
857786|NCT01292226|2731456|P1|Overall Study|Graft loss|1
857787|NCT01292226|2731456|P1|Overall Study|Death|1
857788|NCT01292226|2731456|P1|Overall Study|Adverse Event|5
857789|NCT01292239|2731489|P2|Overall Study|Withdrawal by Subject|6
857790|NCT01292239|2731490|P1|Overall Study|Withdrawal by Subject|3
857791|NCT01292239|2731489|P2|Overall Study|Not specified|1
857792|NCT01292239|2731490|P1|Overall Study|Not specified|1
857793|NCT01292473|2731530|P4|Overall Study|Disease Progression|6
857794|NCT01292473|2731531|P3|Overall Study|Disease Progression|3
857795|NCT01292473|2731532|P2|Overall Study|Disease Progression|1
857796|NCT01292473|2731533|P1|Overall Study|Disease Progression|0
857797|NCT01292473|2731530|P4|Overall Study|Physician Decision|0
857798|NCT01292473|2731531|P3|Overall Study|Physician Decision|0
857799|NCT01292473|2731532|P2|Overall Study|Physician Decision|1
857800|NCT01292473|2731533|P1|Overall Study|Physician Decision|0
857801|NCT01292473|2731530|P4|Overall Study|Withdrawal by Subject|3
857802|NCT01292473|2731531|P3|Overall Study|Withdrawal by Subject|3
857803|NCT01292473|2731532|P2|Overall Study|Withdrawal by Subject|4
857804|NCT01292473|2731533|P1|Overall Study|Withdrawal by Subject|3
857805|NCT01292473|2731530|P4|Overall Study|Lost to Follow-up|2
857806|NCT01292473|2731531|P3|Overall Study|Lost to Follow-up|2
857807|NCT01292473|2731532|P2|Overall Study|Lost to Follow-up|1
857808|NCT01292473|2731533|P1|Overall Study|Lost to Follow-up|1
857809|NCT01292473|2731530|P4|Overall Study|Adverse Event|1
857810|NCT01292473|2731531|P3|Overall Study|Adverse Event|1
857811|NCT01292473|2731532|P2|Overall Study|Adverse Event|0
857812|NCT01292473|2731533|P1|Overall Study|Adverse Event|1
857813|NCT01292486|2731575|P1|Overall Study|Physician Decision|1
857814|NCT01292486|2731575|P1|Overall Study|Adverse Event|1
857815|NCT01292486|2731575|P1|Overall Study|Did not meet screening criteria|2
857816|NCT01292486|2731575|P1|Overall Study|Protocol Violation|2
857817|NCT01292603|2731599|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
857818|NCT01292603|2731600|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
857819|NCT01292603|2731601|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
857820|NCT01292603|2731602|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
857821|NCT01292603|2731603|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
857822|NCT01292603|2731604|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
857823|NCT01292603|2731599|P6|Part 2: Survival Follow-UP|Death|3
857824|NCT01292603|2731600|P5|Part 2: Survival Follow-UP|Death|1
857825|NCT01292603|2731601|P4|Part 2: Survival Follow-UP|Death|0
857826|NCT01292603|2731602|P3|Part 2: Survival Follow-UP|Death|0
857827|NCT01292603|2731603|P2|Part 2: Survival Follow-UP|Death|0
857828|NCT01292603|2731604|P1|Part 2: Survival Follow-UP|Death|0
857829|NCT01292603|2731599|P6|Part 2: Regular Follow-Up|Noncompliance|0
857830|NCT01292603|2731600|P5|Part 2: Regular Follow-Up|Noncompliance|1
857831|NCT01292603|2731601|P4|Part 2: Regular Follow-Up|Noncompliance|0
857832|NCT01292603|2731602|P3|Part 2: Regular Follow-Up|Noncompliance|0
857833|NCT01292603|2731603|P2|Part 2: Regular Follow-Up|Noncompliance|0
857834|NCT01292603|2731604|P1|Part 2: Regular Follow-Up|Noncompliance|0
857835|NCT01292603|2731599|P6|Part 2: Regular Follow-Up|Disease Progression|4
857836|NCT01292603|2731600|P5|Part 2: Regular Follow-Up|Disease Progression|2
857837|NCT01292603|2731601|P4|Part 2: Regular Follow-Up|Disease Progression|0
857838|NCT01292603|2731602|P3|Part 2: Regular Follow-Up|Disease Progression|0
857839|NCT01292603|2731603|P2|Part 2: Regular Follow-Up|Disease Progression|0
857840|NCT01292603|2731604|P1|Part 2: Regular Follow-Up|Disease Progression|0
857841|NCT01292603|2731599|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
857842|NCT01292603|2731600|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
857843|NCT01292603|2731601|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
857844|NCT01292603|2731602|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
857845|NCT01292603|2731603|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
857846|NCT01292603|2731604|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
857847|NCT01292603|2731599|P6|Part 2: Regular Follow-Up|Death|2
857848|NCT01292603|2731600|P5|Part 2: Regular Follow-Up|Death|2
857849|NCT01292603|2731601|P4|Part 2: Regular Follow-Up|Death|0
857850|NCT01292603|2731602|P3|Part 2: Regular Follow-Up|Death|0
857851|NCT01292603|2731603|P2|Part 2: Regular Follow-Up|Death|0
857852|NCT01292603|2731604|P1|Part 2: Regular Follow-Up|Death|0
857853|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
857854|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
857855|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
857856|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
857857|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
857858|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
857859|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
857860|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
857861|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
857862|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
857863|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
857864|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
857865|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Adverse Event|9
857866|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Adverse Event|7
857867|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Adverse Event|0
857868|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Adverse Event|0
857869|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Adverse Event|0
857870|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Adverse Event|0
857871|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
857872|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
857873|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
857874|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
857875|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
857876|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
857877|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Physician Decision|0
857878|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Physician Decision|2
857879|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Physician Decision|0
857880|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Physician Decision|0
857881|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Physician Decision|0
857882|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Physician Decision|0
857883|NCT01292603|2731599|P6|Part 2: Dose Confirmation Period|Death|0
857884|NCT01292603|2731600|P5|Part 2: Dose Confirmation Period|Death|1
857885|NCT01292603|2731601|P4|Part 2: Dose Confirmation Period|Death|0
857886|NCT01292603|2731602|P3|Part 2: Dose Confirmation Period|Death|0
857887|NCT01292603|2731603|P2|Part 2: Dose Confirmation Period|Death|0
857888|NCT01292603|2731604|P1|Part 2: Dose Confirmation Period|Death|0
857889|NCT01292603|2731599|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
857890|NCT01292603|2731600|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
857891|NCT01292603|2731601|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
857892|NCT01292603|2731602|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
857893|NCT01292603|2731603|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
857894|NCT01292603|2731604|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
857895|NCT01292603|2731599|P6|Part 1: Survival Follow-Up|Death|0
857896|NCT01292603|2731600|P5|Part 1: Survival Follow-Up|Death|0
857897|NCT01292603|2731601|P4|Part 1: Survival Follow-Up|Death|0
857898|NCT01292603|2731602|P3|Part 1: Survival Follow-Up|Death|1
857899|NCT01292603|2731603|P2|Part 1: Survival Follow-Up|Death|0
857900|NCT01292603|2731604|P1|Part 1: Survival Follow-Up|Death|1
857901|NCT01292603|2731599|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
857902|NCT01292603|2731600|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
857903|NCT01292603|2731601|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
857904|NCT01292603|2731602|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
857905|NCT01292603|2731603|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
857906|NCT01292603|2731604|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
857907|NCT01292603|2731599|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
857908|NCT01292603|2731600|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
857909|NCT01292603|2731601|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
857910|NCT01292603|2731602|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
857911|NCT01292603|2731603|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
857912|NCT01292603|2731604|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
857913|NCT01292603|2731599|P6|Part 1: Regular Follow-Up Period|Death|0
857914|NCT01292603|2731600|P5|Part 1: Regular Follow-Up Period|Death|0
857915|NCT01292603|2731601|P4|Part 1: Regular Follow-Up Period|Death|0
857916|NCT01292603|2731602|P3|Part 1: Regular Follow-Up Period|Death|2
857917|NCT01292603|2731603|P2|Part 1: Regular Follow-Up Period|Death|0
857918|NCT01292603|2731604|P1|Part 1: Regular Follow-Up Period|Death|1
857919|NCT01292603|2731599|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
857920|NCT01292603|2731600|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
857921|NCT01292603|2731601|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
857922|NCT01292603|2731602|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
857923|NCT01292603|2731603|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
857924|NCT01292603|2731604|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
857925|NCT01292603|2731599|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
857926|NCT01292603|2731600|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
857927|NCT01292603|2731601|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
857928|NCT01292603|2731602|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
857929|NCT01292603|2731603|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
857930|NCT01292603|2731604|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
857931|NCT01292603|2731599|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
857932|NCT01292603|2731600|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
857933|NCT01292603|2731601|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
857934|NCT01292603|2731602|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
857935|NCT01292603|2731603|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
857936|NCT01292603|2731604|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
857937|NCT01292603|2731599|P6|Part 1: Pilot Dose Selection Period|Death|0
857938|NCT01292603|2731600|P5|Part 1: Pilot Dose Selection Period|Death|0
857939|NCT01292603|2731601|P4|Part 1: Pilot Dose Selection Period|Death|1
857940|NCT01292603|2731602|P3|Part 1: Pilot Dose Selection Period|Death|0
857941|NCT01292603|2731603|P2|Part 1: Pilot Dose Selection Period|Death|0
857942|NCT01292603|2731604|P1|Part 1: Pilot Dose Selection Period|Death|0
857943|NCT01292603|2731599|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
857944|NCT01292603|2731600|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
857945|NCT01292603|2731601|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
857946|NCT01292603|2731602|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
857947|NCT01292603|2731603|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
857948|NCT01292603|2731604|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
857949|NCT01284361|2731666|P1|Overall Study|Lost to Follow-up|2
857950|NCT01284361|2731666|P1|Overall Study|Adverse Event|1
857951|NCT01284361|2731666|P1|Overall Study|Protocol Violation|5
857952|NCT01284361|2731666|P1|Overall Study|Withdrawal by Subject|1
857953|NCT01284491|2731677|P1|Overall Study|Study termination|13
857956|NCT01284621|2731705|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
857957|NCT01284621|2731706|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
857958|NCT01284621|2731707|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
857959|NCT01284621|2731708|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
857960|NCT01284621|2731709|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
857961|NCT01284621|2731710|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
857962|NCT01284634|2731756|P4|Overall Study|Adverse Event|1
857963|NCT01284634|2731757|P3|Overall Study|Adverse Event|2
857964|NCT01284634|2731758|P2|Overall Study|Adverse Event|0
857965|NCT01284634|2731759|P1|Overall Study|Adverse Event|1
857966|NCT01284959|2731904|P3|Overall Study|Adverse Event|1
857967|NCT01284959|2731905|P2|Overall Study|Adverse Event|0
857968|NCT01284959|2731906|P1|Overall Study|Adverse Event|0
857969|NCT01284959|2731904|P3|Overall Study|Withdrawal by Subject|0
857970|NCT01284959|2731905|P2|Overall Study|Withdrawal by Subject|0
857971|NCT01284959|2731906|P1|Overall Study|Withdrawal by Subject|1
894867|NCT01594411|2840620|P1|Overall Study|Lost to Follow-up|2
858032|NCT01285323|2732203|P2|Overall Study|Not specified|3
858033|NCT01285323|2732204|P1|Overall Study|Not specified|1
858034|NCT01285323|2732203|P2|Overall Study|Lost to Follow-up|1
858035|NCT01285323|2732204|P1|Overall Study|Lost to Follow-up|1
858036|NCT01285323|2732203|P2|Overall Study|Non-compliance with study procedures|3
858037|NCT01285323|2732204|P1|Overall Study|Non-compliance with study procedures|2
858038|NCT01285323|2732203|P2|Overall Study|Protocol Violation|2
858039|NCT01285323|2732204|P1|Overall Study|Protocol Violation|1
858040|NCT01285323|2732203|P2|Overall Study|Withdrawal by Subject|11
858041|NCT01285323|2732204|P1|Overall Study|Withdrawal by Subject|15
858042|NCT01285323|2732203|P2|Overall Study|Lack of Efficacy|2
858043|NCT01285323|2732204|P1|Overall Study|Lack of Efficacy|4
858044|NCT01285323|2732203|P2|Overall Study|Adverse Event|8
858045|NCT01285323|2732204|P1|Overall Study|Adverse Event|9
858046|NCT01285401|2732238|P2|Overall Study|Prematurely withdrawn from the study|29
858047|NCT01285401|2732239|P1|Overall Study|Prematurely withdrawn from the study|17
858048|NCT01285492|2732291|P2|Overall Study|Death|0
858049|NCT01285492|2732292|P1|Overall Study|Death|1
858050|NCT01285492|2732291|P2|Overall Study|Withdrawal by Subject|1
858051|NCT01285492|2732292|P1|Overall Study|Withdrawal by Subject|2
858052|NCT01285492|2732291|P2|Overall Study|Protocol Violation|0
858053|NCT01285492|2732292|P1|Overall Study|Protocol Violation|3
858054|NCT01285492|2732291|P2|Overall Study|Adverse Event|0
858055|NCT01285492|2732292|P1|Overall Study|Adverse Event|11
858056|NCT01285518|2732318|P8|Overall Study|Lost to Follow-up|0
858057|NCT01285518|2732319|P7|Overall Study|Lost to Follow-up|0
858058|NCT01285518|2732320|P6|Overall Study|Lost to Follow-up|1
858059|NCT01285518|2732321|P5|Overall Study|Lost to Follow-up|0
858060|NCT01285518|2732322|P4|Overall Study|Lost to Follow-up|0
858061|NCT01285518|2732323|P3|Overall Study|Lost to Follow-up|0
858062|NCT01285518|2732324|P2|Overall Study|Lost to Follow-up|0
858063|NCT01285518|2732325|P1|Overall Study|Lost to Follow-up|0
858098|NCT01285908|2732656|P3|Baseline Measurement|unable to tolerate procedure|0
858099|NCT01285908|2732657|P2|Baseline Measurement|unable to tolerate procedure|0
858100|NCT01285908|2732658|P1|Baseline Measurement|unable to tolerate procedure|1
858101|NCT01285908|2732656|P3|Baseline Measurement|History of stroke, exclusion criteria|0
858102|NCT01285908|2732657|P2|Baseline Measurement|History of stroke, exclusion criteria|0
858103|NCT01285908|2732658|P1|Baseline Measurement|History of stroke, exclusion criteria|1
858104|NCT01285908|2732656|P3|Baseline Measurement|unable to insert catheter|0
858105|NCT01285908|2732657|P2|Baseline Measurement|unable to insert catheter|0
858106|NCT01285908|2732658|P1|Baseline Measurement|unable to insert catheter|1
858119|NCT01286077|2732712|P2|Overall Study|refill medication not received in time|0
858120|NCT01286077|2732713|P1|Overall Study|refill medication not received in time|1
858121|NCT01286077|2732712|P2|Overall Study|Progression of disease|1
858122|NCT01286077|2732713|P1|Overall Study|Progression of disease|0
858123|NCT01286077|2732712|P2|Overall Study|Patient's decision to stop treatment|0
858124|NCT01286077|2732713|P1|Overall Study|Patient's decision to stop treatment|3
858125|NCT01286077|2732712|P2|Overall Study|The subject starts with alternative MMY|3
858126|NCT01286077|2732713|P1|Overall Study|The subject starts with alternative MMY|0
858127|NCT01286077|2732712|P2|Overall Study|Non-compliance|0
858128|NCT01286077|2732713|P1|Overall Study|Non-compliance|1
858129|NCT01286077|2732712|P2|Overall Study|Intercurrent illness|0
858130|NCT01286077|2732713|P1|Overall Study|Intercurrent illness|1
858131|NCT01286077|2732712|P2|Overall Study|Withdrawal by Subject|2
858132|NCT01286077|2732713|P1|Overall Study|Withdrawal by Subject|0
858133|NCT01286077|2732712|P2|Overall Study|Protocol Violation|1
858134|NCT01286077|2732713|P1|Overall Study|Protocol Violation|1
858135|NCT01286077|2732712|P2|Overall Study|Death|0
858136|NCT01286077|2732713|P1|Overall Study|Death|1
858137|NCT01286077|2732712|P2|Overall Study|Adverse Event|0
858138|NCT01286077|2732713|P1|Overall Study|Adverse Event|2
858139|NCT01286129|2732749|P2|Overall Study|Could not comply with study requirements|4
858140|NCT01286129|2732750|P1|Overall Study|Could not comply with study requirements|4
858141|NCT01286129|2732749|P2|Overall Study|Withdrawal by Subject|1
858142|NCT01286129|2732750|P1|Overall Study|Withdrawal by Subject|4
858143|NCT01286168|2732758|P1|Overall Study|Surgical Drains Fell Out at Home|2
858144|NCT01286168|2732758|P1|Overall Study|Withdrawal by Subject|1
858145|NCT01286207|2732773|P3|Overall Study|Unspecified|13
858146|NCT01286207|2732774|P2|Overall Study|Unspecified|47
858147|NCT01286207|2732775|P1|Overall Study|Unspecified|37
858148|NCT01286207|2732773|P3|Overall Study|Lack of Response|8
858149|NCT01286207|2732774|P2|Overall Study|Lack of Response|38
858150|NCT01286207|2732775|P1|Overall Study|Lack of Response|92
858151|NCT01286207|2732773|P3|Overall Study|Withdrawal by Subject|41
858152|NCT01286207|2732774|P2|Overall Study|Withdrawal by Subject|79
858153|NCT01286207|2732775|P1|Overall Study|Withdrawal by Subject|93
858154|NCT01286207|2732773|P3|Overall Study|Lost to Follow-up|20
858155|NCT01286207|2732774|P2|Overall Study|Lost to Follow-up|43
858156|NCT01286207|2732775|P1|Overall Study|Lost to Follow-up|49
858157|NCT01286207|2732773|P3|Overall Study|Adverse Event|8
858158|NCT01286207|2732774|P2|Overall Study|Adverse Event|41
858159|NCT01286207|2732775|P1|Overall Study|Adverse Event|27
858160|NCT01286311|2732797|P2|Overall Study|Physician did not want outreach sent|0
858161|NCT01286311|2732798|P1|Overall Study|Physician did not want outreach sent|14
858162|NCT01286480|2732880|P2|Overall Study|Withdrawal by Subject|3
858163|NCT01286480|2732881|P1|Overall Study|Withdrawal by Subject|5
858164|NCT01286558|2732895|P2|Overall Study|Withdrawal by Subject|1
858165|NCT01286558|2732896|P1|Overall Study|Withdrawal by Subject|0
858166|NCT01286558|2732895|P2|Overall Study|Adverse Event|1
858167|NCT01286558|2732896|P1|Overall Study|Adverse Event|1
858168|NCT01286740|2732926|P1|Overall Study|Protocol Violation|1
858169|NCT01286740|2732926|P1|Overall Study|Enrolled but not treated|1
858170|NCT01286753|2732944|P2|Overall Study|Participant to Receive Radiotherapy|0
858171|NCT01286753|2732945|P1|Overall Study|Participant to Receive Radiotherapy|1
858172|NCT01286753|2732944|P2|Overall Study|Discontinued to Join Extension Study|4
858173|NCT01286753|2732945|P1|Overall Study|Discontinued to Join Extension Study|6
858174|NCT01286753|2732944|P2|Overall Study|Withdrawal of Consent|2
858175|NCT01286753|2732945|P1|Overall Study|Withdrawal of Consent|0
858176|NCT01286753|2732944|P2|Overall Study|Refused Treatment|0
858177|NCT01286753|2732945|P1|Overall Study|Refused Treatment|1
858178|NCT01286753|2732944|P2|Overall Study|Progression|13
858179|NCT01286753|2732945|P1|Overall Study|Progression|11
858180|NCT01286753|2732944|P2|Overall Study|Adverse Event|6
858181|NCT01286753|2732945|P1|Overall Study|Adverse Event|7
858182|NCT01292837|2732973|P1|Overall Study|Further treatment determined|1
858183|NCT01292837|2732973|P1|Overall Study|Adverse Event|1
858184|NCT01292876|2732982|P1|Overall Study|Physician Decision|4
858185|NCT01292928|2732988|P1|Overall Study|Physician Decision|2
858186|NCT01292928|2732988|P1|Overall Study|Lost to Follow-up|6
858187|NCT01292928|2732988|P1|Overall Study|Withdrawal by Subject|8
858188|NCT01292928|2732988|P1|Overall Study|Death|8
858189|NCT01293968|2733019|P2|Overall Study|non-cooperation|3
858190|NCT01293968|2733020|P1|Overall Study|non-cooperation|3
858191|NCT01294046|2733026|P1|Overall Study|Stimulation response inadqequate|1
858192|NCT01294046|2733026|P1|Overall Study|Eligibility criteria expanded|1
858193|NCT01294046|2733026|P1|Overall Study|Infection and surgical explant|1
858196|NCT01294371|2733086|P1|Overall Study|Other|14
858197|NCT01294371|2733086|P1|Overall Study|Administrative Reason|1
858198|NCT01294371|2733086|P1|Overall Study|Lost to Follow-up|6
858199|NCT01294371|2733086|P1|Overall Study|Withdrawal by Subject|12
858200|NCT01294371|2733086|P1|Overall Study|Adverse Event|1
858201|NCT01294397|2733128|P1|Overall Study|Administrative Decision|1
858202|NCT01294397|2733128|P1|Overall Study|Withdrawal by Subject|1
858203|NCT01294423|2733141|P3|Overall Study|poor/non-compliance|1
858204|NCT01294423|2733142|P2|Overall Study|poor/non-compliance|0
858205|NCT01294423|2733143|P1|Overall Study|poor/non-compliance|1
858206|NCT01294423|2733141|P3|Overall Study|subject no longer meets study criteria|2
858207|NCT01294423|2733142|P2|Overall Study|subject no longer meets study criteria|5
858208|NCT01294423|2733143|P1|Overall Study|subject no longer meets study criteria|2
858209|NCT01294423|2733141|P3|Overall Study|Withdrawal by Subject|2
858210|NCT01294423|2733142|P2|Overall Study|Withdrawal by Subject|2
858211|NCT01294423|2733143|P1|Overall Study|Withdrawal by Subject|1
858212|NCT01294423|2733141|P3|Overall Study|Adverse Event|3
858213|NCT01294423|2733142|P2|Overall Study|Adverse Event|2
858214|NCT01294423|2733143|P1|Overall Study|Adverse Event|1
858215|NCT01294436|2733159|P2|Overall Study|poor/non-compliance|5
858216|NCT01294436|2733160|P1|Overall Study|poor/non-compliance|2
858217|NCT01294436|2733159|P2|Overall Study|subject no longer meets study criteria|20
858218|NCT01294436|2733160|P1|Overall Study|subject no longer meets study criteria|5
858219|NCT01294436|2733159|P2|Overall Study|Withdrawal by Subject|28
858220|NCT01294436|2733160|P1|Overall Study|Withdrawal by Subject|11
858221|NCT01294436|2733159|P2|Overall Study|Adverse Event|17
858222|NCT01294436|2733160|P1|Overall Study|Adverse Event|10
858223|NCT01294449|2733194|P2|Overall Study|Withdrawal by Subject|3
858224|NCT01294449|2733195|P1|Overall Study|Withdrawal by Subject|1
858225|NCT01294449|2733194|P2|Overall Study|Death|12
858226|NCT01294449|2733195|P1|Overall Study|Death|11
858227|NCT01294462|2733203|P2|Overall Study|Withdrawal by Subject|63
858228|NCT01294462|2733204|P1|Overall Study|Withdrawal by Subject|65
858229|NCT01294462|2733203|P2|Overall Study|Lost to Follow-up|0
858230|NCT01294462|2733204|P1|Overall Study|Lost to Follow-up|1
858231|NCT01294514|2733216|P1|Overall Study|Excluded due to Arrhythmia|1
858232|NCT01294553|2733224|P1|Overall Study|Protocol Violation|268
858233|NCT01294553|2733224|P1|Overall Study|Duplicated Participants|1
858234|NCT01294592|2733232|P2|Overall Study|Withdrawal by Subject|28
858235|NCT01294592|2733233|P1|Overall Study|Withdrawal by Subject|28
858236|NCT01294592|2733232|P2|Overall Study|Physician Decision|11
858237|NCT01294592|2733233|P1|Overall Study|Physician Decision|6
858238|NCT01294592|2733232|P2|Overall Study|Lost to Follow-up|9
858239|NCT01294592|2733233|P1|Overall Study|Lost to Follow-up|7
858240|NCT01294592|2733232|P2|Overall Study|Protocol Violation|7
858241|NCT01294592|2733233|P1|Overall Study|Protocol Violation|1
858242|NCT01294592|2733232|P2|Overall Study|Lack of Efficacy|5
858243|NCT01294592|2733233|P1|Overall Study|Lack of Efficacy|7
858244|NCT01294592|2733232|P2|Overall Study|Adverse Event|13
858245|NCT01294592|2733233|P1|Overall Study|Adverse Event|28
858246|NCT01294644|2733264|P3|Overall Study|Miscellaneous Reason|4
858247|NCT01294644|2733265|P2|Overall Study|Miscellaneous Reason|1
858248|NCT01294644|2733266|P1|Overall Study|Miscellaneous Reason|2
858249|NCT01294644|2733264|P3|Overall Study|Lost to Follow-up|5
858250|NCT01294644|2733265|P2|Overall Study|Lost to Follow-up|2
858251|NCT01294644|2733266|P1|Overall Study|Lost to Follow-up|3
858252|NCT01294644|2733264|P3|Overall Study|Withdrawal by Subject|4
858253|NCT01294644|2733265|P2|Overall Study|Withdrawal by Subject|7
858254|NCT01294644|2733266|P1|Overall Study|Withdrawal by Subject|3
858255|NCT01294644|2733264|P3|Overall Study|Adverse Event|1
858256|NCT01294644|2733265|P2|Overall Study|Adverse Event|0
858257|NCT01294644|2733266|P1|Overall Study|Adverse Event|2
858258|NCT01294683|2733297|P2|Post Crossover (Period III)|Withdrawal by Subject|2
858259|NCT01294683|2733298|P1|Post Crossover (Period III)|Withdrawal by Subject|3
858260|NCT01294683|2733297|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
858261|NCT01294683|2733298|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
858262|NCT01294683|2733297|P2|Post Crossover (Period III)|Lost to Follow-up|3
858263|NCT01294683|2733298|P1|Post Crossover (Period III)|Lost to Follow-up|1
858264|NCT01294683|2733297|P2|Post Crossover (Period III)|Adverse Event|6
858265|NCT01294683|2733298|P1|Post Crossover (Period III)|Adverse Event|6
858266|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
858267|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
858268|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Technical Problems|1
858269|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Technical Problems|0
858270|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
858271|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
858272|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Protocol Violation|5
858273|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Protocol Violation|5
858274|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Physician Decision|0
858275|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Physician Decision|1
858276|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
858277|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
858278|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
858279|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
858280|NCT01294683|2733297|P2|Precrossover (Periods I/II)|Adverse Event|52
858281|NCT01294683|2733298|P1|Precrossover (Periods I/II)|Adverse Event|49
858282|NCT01294696|2733350|P1|Overall Study|Site closure|52
858283|NCT01294696|2733350|P1|Overall Study|Missing BPI Response|7
858284|NCT01294696|2733350|P1|Overall Study|Protocol Violation|8
858285|NCT01294696|2733350|P1|Overall Study|Screening failures|7
858286|NCT01294787|2733409|P6|Period 3|Adverse Event|0
858287|NCT01294787|2733410|P5|Period 3|Adverse Event|1
858288|NCT01294787|2733411|P4|Period 3|Adverse Event|0
858289|NCT01294787|2733412|P3|Period 3|Adverse Event|0
858290|NCT01294787|2733413|P2|Period 3|Adverse Event|0
858291|NCT01294787|2733414|P1|Period 3|Adverse Event|0
858292|NCT01294787|2733409|P6|Period 2|No longer needs study drug|0
858293|NCT01294787|2733410|P5|Period 2|No longer needs study drug|0
858294|NCT01294787|2733411|P4|Period 2|No longer needs study drug|1
858295|NCT01294787|2733412|P3|Period 2|No longer needs study drug|0
858296|NCT01294787|2733413|P2|Period 2|No longer needs study drug|0
858297|NCT01294787|2733414|P1|Period 2|No longer needs study drug|0
858298|NCT01294787|2733409|P6|Period 2|Adverse Event|0
858299|NCT01294787|2733410|P5|Period 2|Adverse Event|0
858300|NCT01294787|2733411|P4|Period 2|Adverse Event|1
858301|NCT01294787|2733412|P3|Period 2|Adverse Event|0
858302|NCT01294787|2733413|P2|Period 2|Adverse Event|3
858303|NCT01294787|2733414|P1|Period 2|Adverse Event|0
858304|NCT01294787|2733409|P6|Period 1|Administrative problem|1
858305|NCT01294787|2733410|P5|Period 1|Administrative problem|0
858306|NCT01294787|2733411|P4|Period 1|Administrative problem|0
858307|NCT01294787|2733412|P3|Period 1|Administrative problem|1
858308|NCT01294787|2733413|P2|Period 1|Administrative problem|0
858309|NCT01294787|2733414|P1|Period 1|Administrative problem|0
858310|NCT01294787|2733409|P6|Period 1|Withdrawal by Subject|1
858311|NCT01294787|2733410|P5|Period 1|Withdrawal by Subject|1
858312|NCT01294787|2733411|P4|Period 1|Withdrawal by Subject|1
858313|NCT01294787|2733412|P3|Period 1|Withdrawal by Subject|0
858314|NCT01294787|2733413|P2|Period 1|Withdrawal by Subject|0
858315|NCT01294787|2733414|P1|Period 1|Withdrawal by Subject|0
858316|NCT01294787|2733409|P6|Period 1|Adverse Event|0
858317|NCT01294787|2733410|P5|Period 1|Adverse Event|1
858318|NCT01294787|2733411|P4|Period 1|Adverse Event|0
858319|NCT01294787|2733412|P3|Period 1|Adverse Event|0
858320|NCT01294787|2733413|P2|Period 1|Adverse Event|0
858321|NCT01294787|2733414|P1|Period 1|Adverse Event|0
858322|NCT01294800|2733460|P4|Overall Study|Did Not Meet Protocol Eligibility|0
858323|NCT01294800|2733461|P3|Overall Study|Did Not Meet Protocol Eligibility|1
858324|NCT01294800|2733462|P2|Overall Study|Did Not Meet Protocol Eligibility|1
858325|NCT01294800|2733463|P1|Overall Study|Did Not Meet Protocol Eligibility|2
858326|NCT01294800|2733460|P4|Overall Study|Non-compliance With Protocol|0
858327|NCT01294800|2733461|P3|Overall Study|Non-compliance With Protocol|1
858328|NCT01294800|2733462|P2|Overall Study|Non-compliance With Protocol|1
858329|NCT01294800|2733463|P1|Overall Study|Non-compliance With Protocol|0
858330|NCT01294800|2733460|P4|Overall Study|Lost to Follow-up|0
858331|NCT01294800|2733461|P3|Overall Study|Lost to Follow-up|1
858332|NCT01294800|2733462|P2|Overall Study|Lost to Follow-up|0
858333|NCT01294800|2733463|P1|Overall Study|Lost to Follow-up|0
858334|NCT01294800|2733460|P4|Overall Study|Subject Withdrew Consent|11
858335|NCT01294800|2733461|P3|Overall Study|Subject Withdrew Consent|2
858336|NCT01294800|2733462|P2|Overall Study|Subject Withdrew Consent|2
858337|NCT01294800|2733463|P1|Overall Study|Subject Withdrew Consent|2
858338|NCT01294800|2733460|P4|Overall Study|Adverse Event|5
858339|NCT01294800|2733461|P3|Overall Study|Adverse Event|12
858340|NCT01294800|2733462|P2|Overall Study|Adverse Event|6
858341|NCT01294800|2733463|P1|Overall Study|Adverse Event|7
858342|NCT01294917|2733489|P1|Overall Study|Inconvenience|1
858343|NCT01294917|2733489|P1|Overall Study|Relocation|5
858344|NCT01295034|2733497|P2|Overall Study|Lost to Follow-up|5
858345|NCT01295034|2733498|P1|Overall Study|Lost to Follow-up|5
858346|NCT01295281|2733527|P2|First Intervention (7 Days)|Death|1
858347|NCT01295281|2733528|P1|First Intervention (7 Days)|Death|0
858353|NCT01295814|2733551|P2|Overall Study|Withdrawal by Subject|0
858354|NCT01295814|2733552|P1|Overall Study|Withdrawal by Subject|2
858355|NCT01295814|2733551|P2|Overall Study|Lack of Efficacy|2
858356|NCT01295814|2733552|P1|Overall Study|Lack of Efficacy|0
858357|NCT01295905|2733588|P2|Overall Study|Met exclusion criteria|0
858358|NCT01295905|2733589|P1|Overall Study|Met exclusion criteria|1
858359|NCT01295905|2733588|P2|Overall Study|Did not meet inclusion criteria|0
858360|NCT01295905|2733589|P1|Overall Study|Did not meet inclusion criteria|1
858361|NCT01296035|2733601|P1|Overall Study|Withdrawal by Subject|1
858362|NCT01296152|2733606|P1|Overall Study|Unwilling to adhere to study requirement|1
858363|NCT01283971|2733635|P2|Overall Study|Administrative reasons|1
858364|NCT01283971|2733636|P1|Overall Study|Administrative reasons|1
858365|NCT01283971|2733635|P2|Overall Study|Failure to return|1
858366|NCT01283971|2733636|P1|Overall Study|Failure to return|0
858367|NCT01283971|2733635|P2|Overall Study|Refused treatment|1
858368|NCT01283971|2733636|P1|Overall Study|Refused treatment|3
858369|NCT01283971|2733635|P2|Overall Study|Protocol Violation|1
858370|NCT01283971|2733636|P1|Overall Study|Protocol Violation|5
858371|NCT01283971|2733635|P2|Overall Study|Insufficient therapeutic responses|3
858372|NCT01283971|2733636|P1|Overall Study|Insufficient therapeutic responses|3
858373|NCT01283971|2733635|P2|Overall Study|Adverse Event|5
858374|NCT01283971|2733636|P1|Overall Study|Adverse Event|3
858375|NCT01284062|2733684|P4|Overall Study|Site Closed|0
858376|NCT01284062|2733685|P3|Overall Study|Site Closed|1
858377|NCT01284062|2733686|P2|Overall Study|Site Closed|0
858378|NCT01284062|2733687|P1|Overall Study|Site Closed|0
858379|NCT01284062|2733684|P4|Overall Study|Unspecified|1
858380|NCT01284062|2733685|P3|Overall Study|Unspecified|0
858381|NCT01284062|2733686|P2|Overall Study|Unspecified|0
858382|NCT01284062|2733687|P1|Overall Study|Unspecified|0
858383|NCT01284062|2733684|P4|Overall Study|Withdrawal by Subject|5
858384|NCT01284062|2733685|P3|Overall Study|Withdrawal by Subject|2
858385|NCT01284062|2733686|P2|Overall Study|Withdrawal by Subject|1
858386|NCT01284062|2733687|P1|Overall Study|Withdrawal by Subject|3
858387|NCT01284062|2733684|P4|Overall Study|Protocol Violation|2
858388|NCT01284062|2733685|P3|Overall Study|Protocol Violation|0
858389|NCT01284062|2733686|P2|Overall Study|Protocol Violation|0
858390|NCT01284062|2733687|P1|Overall Study|Protocol Violation|1
858391|NCT01284062|2733684|P4|Overall Study|Medication error without adverse event|0
858392|NCT01284062|2733685|P3|Overall Study|Medication error without adverse event|1
858393|NCT01284062|2733686|P2|Overall Study|Medication error without adverse event|0
858394|NCT01284062|2733687|P1|Overall Study|Medication error without adverse event|0
858395|NCT01284062|2733684|P4|Overall Study|Lack of Efficacy|1
858396|NCT01284062|2733685|P3|Overall Study|Lack of Efficacy|2
858397|NCT01284062|2733686|P2|Overall Study|Lack of Efficacy|2
858398|NCT01284062|2733687|P1|Overall Study|Lack of Efficacy|3
858399|NCT01284062|2733684|P4|Overall Study|Adverse Event|5
858400|NCT01284062|2733685|P3|Overall Study|Adverse Event|0
858401|NCT01284062|2733686|P2|Overall Study|Adverse Event|5
858402|NCT01284062|2733687|P1|Overall Study|Adverse Event|4
858403|NCT01284114|2733759|P1|Overall Study|dizziness|1
858404|NCT01284114|2733759|P1|Overall Study|Symptomatic hypotension|1
858405|NCT01284114|2733759|P1|Overall Study|From the results of ALLTITUDE study|1
858406|NCT01284114|2733759|P1|Overall Study|viral infection|1
858407|NCT01289639|2733779|P3|Overall Study|Lost to Follow-up|0
858408|NCT01289639|2733780|P2|Overall Study|Lost to Follow-up|0
858409|NCT01289639|2733781|P1|Overall Study|Lost to Follow-up|1
858410|NCT01289782|2733806|P2|Overall Study|Reason not specified|2
858411|NCT01289782|2733807|P1|Overall Study|Reason not specified|1
858412|NCT01289782|2733806|P2|Overall Study|Sponsor's Decision|0
858413|NCT01289782|2733807|P1|Overall Study|Sponsor's Decision|1
858414|NCT01289782|2733806|P2|Overall Study|Withdrawal by Subject|2
858415|NCT01289782|2733807|P1|Overall Study|Withdrawal by Subject|8
858416|NCT01289782|2733806|P2|Overall Study|Protocol Violation|1
858417|NCT01289782|2733807|P1|Overall Study|Protocol Violation|1
858418|NCT01289782|2733806|P2|Overall Study|Lost to Follow-up|7
858419|NCT01289782|2733807|P1|Overall Study|Lost to Follow-up|14
858420|NCT01289821|2733876|P1|Survival Follow-up Period|Clinical endpoint reached|16
858421|NCT01289821|2733876|P1|Survival Follow-up Period|Lost to Follow-up|1
858422|NCT01289821|2733876|P1|Survival Follow-up Period|Protocol Violation|1
858423|NCT01289821|2733876|P1|Safety Follow-up Period|Unspecified reason|1
858424|NCT01289821|2733876|P1|Safety Follow-up Period|Protocol Violation|3
858425|NCT01289821|2733876|P1|Safety Follow-up Period|Withdrawal by Subject|1
858426|NCT01289821|2733876|P1|Treatment Period|Therapeutic procedure required|1
858427|NCT01289821|2733876|P1|Treatment Period|Clinical Progression|2
858428|NCT01289821|2733876|P1|Treatment Period|Radiological Progression|43
858429|NCT01289821|2733876|P1|Treatment Period|Adverse Event|4
858430|NCT01289821|2733876|P1|Treatment Period|Physician Decision|3
858431|NCT01289821|2733876|P1|Treatment Period|Withdrawal by Subject|1
858432|NCT01289847|2733885|P1|Overall Study|Patient could not comply with visits|1
858433|NCT01289990|2733907|P13|Overall Study|Not treated|0
858434|NCT01289990|2733908|P12|Overall Study|Not treated|2
858435|NCT01289990|2733909|P11|Overall Study|Not treated|1
858436|NCT01289990|2733910|P10|Overall Study|Not treated|0
858437|NCT01289990|2733911|P9|Overall Study|Not treated|1
858438|NCT01289990|2733912|P8|Overall Study|Not treated|0
858439|NCT01289990|2733913|P7|Overall Study|Not treated|1
858440|NCT01289990|2733914|P6|Overall Study|Not treated|0
858441|NCT01289990|2733915|P5|Overall Study|Not treated|0
858442|NCT01289990|2733916|P4|Overall Study|Not treated|0
858443|NCT01289990|2733917|P3|Overall Study|Not treated|0
858444|NCT01289990|2733918|P2|Overall Study|Not treated|0
858445|NCT01289990|2733919|P1|Overall Study|Not treated|0
858446|NCT01289990|2733907|P13|Overall Study|did not continue in extension|56
858447|NCT01289990|2733908|P12|Overall Study|did not continue in extension|34
858448|NCT01289990|2733909|P11|Overall Study|did not continue in extension|45
858449|NCT01289990|2733910|P10|Overall Study|did not continue in extension|48
858450|NCT01289990|2733911|P9|Overall Study|did not continue in extension|44
858451|NCT01289990|2733912|P8|Overall Study|did not continue in extension|36
858452|NCT01289990|2733913|P7|Overall Study|did not continue in extension|54
858453|NCT01289990|2733914|P6|Overall Study|did not continue in extension|50
858454|NCT01289990|2733915|P5|Overall Study|did not continue in extension|48
858455|NCT01289990|2733916|P4|Overall Study|did not continue in extension|51
858456|NCT01289990|2733917|P3|Overall Study|did not continue in extension|51
858457|NCT01289990|2733918|P2|Overall Study|did not continue in extension|45
858458|NCT01289990|2733919|P1|Overall Study|did not continue in extension|41
858459|NCT01289990|2733907|P13|Overall Study|discontinued in preceding trial|24
858460|NCT01289990|2733908|P12|Overall Study|discontinued in preceding trial|17
858461|NCT01289990|2733909|P11|Overall Study|discontinued in preceding trial|17
858462|NCT01289990|2733910|P10|Overall Study|discontinued in preceding trial|21
858463|NCT01289990|2733911|P9|Overall Study|discontinued in preceding trial|17
858464|NCT01289990|2733912|P8|Overall Study|discontinued in preceding trial|8
858465|NCT01289990|2733913|P7|Overall Study|discontinued in preceding trial|18
858466|NCT01289990|2733914|P6|Overall Study|discontinued in preceding trial|12
858467|NCT01289990|2733915|P5|Overall Study|discontinued in preceding trial|11
858468|NCT01289990|2733916|P4|Overall Study|discontinued in preceding trial|17
858469|NCT01289990|2733917|P3|Overall Study|discontinued in preceding trial|41
858470|NCT01289990|2733918|P2|Overall Study|discontinued in preceding trial|20
858471|NCT01289990|2733919|P1|Overall Study|discontinued in preceding trial|18
858472|NCT01289990|2733907|P13|Overall Study|Withdrawal by Subject|16
858473|NCT01289990|2733908|P12|Overall Study|Withdrawal by Subject|13
858474|NCT01289990|2733909|P11|Overall Study|Withdrawal by Subject|11
858475|NCT01289990|2733910|P10|Overall Study|Withdrawal by Subject|13
858476|NCT01289990|2733911|P9|Overall Study|Withdrawal by Subject|12
858477|NCT01289990|2733912|P8|Overall Study|Withdrawal by Subject|9
858478|NCT01289990|2733913|P7|Overall Study|Withdrawal by Subject|13
858479|NCT01289990|2733914|P6|Overall Study|Withdrawal by Subject|7
858480|NCT01289990|2733915|P5|Overall Study|Withdrawal by Subject|8
858481|NCT01289990|2733916|P4|Overall Study|Withdrawal by Subject|13
858482|NCT01289990|2733917|P3|Overall Study|Withdrawal by Subject|12
858483|NCT01289990|2733918|P2|Overall Study|Withdrawal by Subject|14
858484|NCT01289990|2733919|P1|Overall Study|Withdrawal by Subject|15
858485|NCT01289990|2733907|P13|Overall Study|Lost to Follow-up|2
858486|NCT01289990|2733908|P12|Overall Study|Lost to Follow-up|1
858487|NCT01289990|2733909|P11|Overall Study|Lost to Follow-up|2
858488|NCT01289990|2733910|P10|Overall Study|Lost to Follow-up|4
858489|NCT01289990|2733911|P9|Overall Study|Lost to Follow-up|1
858490|NCT01289990|2733912|P8|Overall Study|Lost to Follow-up|2
858491|NCT01289990|2733913|P7|Overall Study|Lost to Follow-up|2
858492|NCT01289990|2733914|P6|Overall Study|Lost to Follow-up|4
858493|NCT01289990|2733915|P5|Overall Study|Lost to Follow-up|3
858494|NCT01289990|2733916|P4|Overall Study|Lost to Follow-up|5
858495|NCT01289990|2733917|P3|Overall Study|Lost to Follow-up|5
858496|NCT01289990|2733918|P2|Overall Study|Lost to Follow-up|2
858497|NCT01289990|2733919|P1|Overall Study|Lost to Follow-up|3
858498|NCT01289990|2733907|P13|Overall Study|Death|0
858499|NCT01289990|2733908|P12|Overall Study|Death|1
858500|NCT01289990|2733909|P11|Overall Study|Death|0
858501|NCT01289990|2733910|P10|Overall Study|Death|0
858502|NCT01289990|2733911|P9|Overall Study|Death|0
858503|NCT01289990|2733912|P8|Overall Study|Death|0
858504|NCT01289990|2733913|P7|Overall Study|Death|0
858505|NCT01289990|2733914|P6|Overall Study|Death|1
858506|NCT01289990|2733915|P5|Overall Study|Death|2
858507|NCT01289990|2733916|P4|Overall Study|Death|1
858508|NCT01289990|2733917|P3|Overall Study|Death|0
858509|NCT01289990|2733918|P2|Overall Study|Death|0
858510|NCT01289990|2733919|P1|Overall Study|Death|0
858511|NCT01290029|2734103|P1|Overall Study|Other|2
858512|NCT01290068|2734118|P2|Overall Study|Other|1
858513|NCT01290068|2734119|P1|Overall Study|Other|3
858514|NCT01290068|2734118|P2|Overall Study|Withdrawal by subject prior to implant|2
858515|NCT01290068|2734119|P1|Overall Study|Withdrawal by subject prior to implant|0
858516|NCT01290068|2734118|P2|Overall Study|Lost to Follow-up|0
858517|NCT01290068|2734119|P1|Overall Study|Lost to Follow-up|3
858518|NCT01290068|2734118|P2|Overall Study|Adverse Event|3
858519|NCT01290068|2734119|P1|Overall Study|Adverse Event|1
858520|NCT01290094|2734131|P1|Overall Study|Lost to Follow-up|5
858521|NCT01290094|2734131|P1|Overall Study|Withdrawal by Subject|1
858522|NCT01296412|2734162|P2|Overall Study|Withdrawal by Subject|13
858523|NCT01296412|2734163|P1|Overall Study|Withdrawal by Subject|10
858524|NCT01296412|2734162|P2|Overall Study|Pregnancy|1
858525|NCT01296412|2734163|P1|Overall Study|Pregnancy|0
858526|NCT01296412|2734162|P2|Overall Study|Physician Decision|3
858527|NCT01296412|2734163|P1|Overall Study|Physician Decision|1
858528|NCT01296412|2734162|P2|Overall Study|Other reason not specified|15
858529|NCT01296412|2734163|P1|Overall Study|Other reason not specified|20
858530|NCT01296412|2734162|P2|Overall Study|Non-compliance with study drug|2
858531|NCT01296412|2734163|P1|Overall Study|Non-compliance with study drug|1
858532|NCT01296412|2734162|P2|Overall Study|Lost to Follow-up|7
858533|NCT01296412|2734163|P1|Overall Study|Lost to Follow-up|10
858534|NCT01296412|2734162|P2|Overall Study|Lack of Efficacy|0
858535|NCT01296412|2734163|P1|Overall Study|Lack of Efficacy|1
858536|NCT01296412|2734162|P2|Overall Study|Adverse Event|29
858537|NCT01296412|2734163|P1|Overall Study|Adverse Event|8
858538|NCT01299571|2734175|P1|Overall Study|Protocol Violation|107
858539|NCT01299584|2734181|P1|Overall Study|Protocol Violation|9
858540|NCT01299805|2734190|P2|Overall Study|Adverse Event|0
858541|NCT01299805|2734191|P1|Overall Study|Adverse Event|2
858542|NCT01299896|2734221|P2|Overall Study|Lost to Follow-up|11
858543|NCT01299896|2734222|P1|Overall Study|Lost to Follow-up|0
858544|NCT01299896|2734221|P2|Overall Study|Withdrawal by Subject|7
858545|NCT01299896|2734222|P1|Overall Study|Withdrawal by Subject|1
858549|NCT01299961|2734240|P1|Overall Study|Lost to Follow-up|1
858550|NCT01299961|2734240|P1|Overall Study|Lack of Efficacy|2
858551|NCT01299961|2734240|P1|Overall Study|Adverse Event|3
858552|NCT01300052|2734248|P2|Overall Study|Protocol Violation|1
858553|NCT01300052|2734249|P1|Overall Study|Protocol Violation|1
858554|NCT01300052|2734248|P2|Overall Study|Withdrawal by Subject|2
858555|NCT01300052|2734249|P1|Overall Study|Withdrawal by Subject|2
858556|NCT01300052|2734248|P2|Overall Study|Adverse Event|0
858557|NCT01300052|2734249|P1|Overall Study|Adverse Event|3
858558|NCT01300234|2734269|P2|Overall Study|Lost to Follow-up|2
858559|NCT01300234|2734270|P1|Overall Study|Lost to Follow-up|0
858560|NCT01300234|2734269|P2|Overall Study|Withdrawal by Subject|5
858561|NCT01300234|2734270|P1|Overall Study|Withdrawal by Subject|1
858562|NCT01300234|2734269|P2|Overall Study|Protocol Violation|3
858563|NCT01300234|2734270|P1|Overall Study|Protocol Violation|2
858564|NCT01300234|2734269|P2|Overall Study|Adverse Event|0
858565|NCT01300234|2734270|P1|Overall Study|Adverse Event|1
858566|NCT01300247|2734302|P2|Overall Study|Non-Compliance|1
858567|NCT01300247|2734303|P1|Overall Study|Non-Compliance|0
858568|NCT01300247|2734302|P2|Overall Study|Withdrawal by Subject|0
858569|NCT01300247|2734303|P1|Overall Study|Withdrawal by Subject|1
858570|NCT01300247|2734302|P2|Overall Study|Lost to Follow-up|0
858571|NCT01300247|2734303|P1|Overall Study|Lost to Follow-up|2
858572|NCT01300247|2734302|P2|Overall Study|Death|1
858573|NCT01300247|2734303|P1|Overall Study|Death|1
858574|NCT01300260|2734335|P2|Period 2 of Study: Second Intervention|Adverse Event|1
858575|NCT01300260|2734336|P1|Period 2 of Study: Second Intervention|Adverse Event|0
858576|NCT01300260|2734335|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
858577|NCT01300260|2734336|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
858578|NCT01300260|2734335|P2|Period 1 of Study: First Intervention|Adverse Event|1
858579|NCT01300260|2734336|P1|Period 1 of Study: First Intervention|Adverse Event|0
858580|NCT01300286|2734366|P1|Overall Study|did not get dosed|1
858581|NCT01300338|2734376|P2|Overall Study|Lost to Follow-up|0
858582|NCT01300338|2734377|P1|Overall Study|Lost to Follow-up|5
858583|NCT01300351|2734387|P2|Overall Study|Withdrawal by Subject|10
858584|NCT01300351|2734388|P1|Overall Study|Withdrawal by Subject|7
858585|NCT01300351|2734387|P2|Overall Study|Adverse Event|4
858586|NCT01300351|2734388|P1|Overall Study|Adverse Event|0
858587|NCT01300351|2734387|P2|Overall Study|Lost to Follow-up|1
858588|NCT01300351|2734388|P1|Overall Study|Lost to Follow-up|0
858589|NCT01300351|2734387|P2|Overall Study|Ongoing treatment at data cut-off|23
858590|NCT01300351|2734388|P1|Overall Study|Ongoing treatment at data cut-off|27
858591|NCT01300351|2734387|P2|Overall Study|Did not receive treatment|0
858592|NCT01300351|2734388|P1|Overall Study|Did not receive treatment|2
858593|NCT01300455|2734404|P2|Washout|Withdrawal by Subject|0
858594|NCT01300455|2734405|P1|Washout|Withdrawal by Subject|1
858595|NCT01300546|2734425|P2|Overall Study|Adverse Event|1
858596|NCT01300546|2734426|P1|Overall Study|Adverse Event|0
858597|NCT01300546|2734425|P2|Overall Study|Lack of Efficacy|3
858598|NCT01300546|2734426|P1|Overall Study|Lack of Efficacy|0
858599|NCT01300546|2734425|P2|Overall Study|Lost to Follow-up|2
858600|NCT01300546|2734426|P1|Overall Study|Lost to Follow-up|0
858601|NCT01300546|2734425|P2|Overall Study|Withdrawal by Subject|0
858602|NCT01300546|2734426|P1|Overall Study|Withdrawal by Subject|1
858604|NCT01300728|2734481|P2|Overall Study|Physician Decision|0
858605|NCT01300728|2734482|P1|Overall Study|Physician Decision|1
858606|NCT01300728|2734481|P2|Overall Study|Withdrawal by Subject|1
858607|NCT01300728|2734482|P1|Overall Study|Withdrawal by Subject|1
858608|NCT01300741|2734496|P1|Overall Study|Discomfort|1
858609|NCT01300741|2734496|P1|Overall Study|Lost to Follow-up|1
858610|NCT01300741|2734496|P1|Overall Study|Lens deposits|1
858611|NCT01300767|2734524|P1|Overall Study|Unacceptable fit|1
858612|NCT01300767|2734524|P1|Overall Study|Biomicroscopy|1
858613|NCT01300767|2734524|P1|Overall Study|Discomfort|2
858614|NCT01300819|2734554|P2|Overall Study|Follow up call was not done|0
858615|NCT01300819|2734555|P1|Overall Study|Follow up call was not done|1
858616|NCT01300819|2734554|P2|Overall Study|Safety follow up not done by mistake|1
858617|NCT01300819|2734555|P1|Overall Study|Safety follow up not done by mistake|0
858618|NCT01300819|2734554|P2|Overall Study|Administrative reason|1
858619|NCT01300819|2734555|P1|Overall Study|Administrative reason|0
858620|NCT01300819|2734554|P2|Overall Study|Refusal to down titrate study drug|1
858621|NCT01300819|2734555|P1|Overall Study|Refusal to down titrate study drug|0
858622|NCT01300819|2734554|P2|Overall Study|Patient was 1 month late for Visit 10|1
858623|NCT01300819|2734555|P1|Overall Study|Patient was 1 month late for Visit 10|0
858624|NCT01300819|2734554|P2|Overall Study|Withdrawal by Subject|12
858625|NCT01300819|2734555|P1|Overall Study|Withdrawal by Subject|10
858626|NCT01300819|2734554|P2|Overall Study|Lack of Efficacy|1
858627|NCT01300819|2734555|P1|Overall Study|Lack of Efficacy|2
858628|NCT01300819|2734554|P2|Overall Study|Adverse Event|27
858629|NCT01300819|2734555|P1|Overall Study|Adverse Event|9
858630|NCT01300923|2734583|P2|Overall Study|Physician Decision|2
858631|NCT01300923|2734584|P1|Overall Study|Physician Decision|0
858632|NCT01301027|2734597|P2|Overall Study|Volume Overload|0
858633|NCT01301027|2734598|P1|Overall Study|Volume Overload|3
858634|NCT01301027|2734597|P2|Overall Study|Transplant|2
858635|NCT01301027|2734598|P1|Overall Study|Transplant|0
858636|NCT01301027|2734597|P2|Overall Study|Fracture|3
858637|NCT01301027|2734598|P1|Overall Study|Fracture|1
858638|NCT01301027|2734597|P2|Overall Study|Adverse Event|2
858639|NCT01301027|2734598|P1|Overall Study|Adverse Event|0
858640|NCT01301027|2734597|P2|Overall Study|Withdrawal by Subject|3
858641|NCT01301027|2734598|P1|Overall Study|Withdrawal by Subject|2
858642|NCT01301027|2734597|P2|Overall Study|Physician Decision|0
858643|NCT01301027|2734598|P1|Overall Study|Physician Decision|2
858644|NCT01301066|2734612|P2|Overall Study|Other|0
858645|NCT01301066|2734613|P1|Overall Study|Other|2
858646|NCT01301066|2734612|P2|Overall Study|Physician Decision|1
858647|NCT01301066|2734613|P1|Overall Study|Physician Decision|0
858648|NCT01301066|2734612|P2|Overall Study|Sponsor Decision|1
858649|NCT01301066|2734613|P1|Overall Study|Sponsor Decision|2
858650|NCT01301066|2734612|P2|Overall Study|Adverse Event|6
858651|NCT01301066|2734613|P1|Overall Study|Adverse Event|6
858652|NCT01301066|2734612|P2|Overall Study|Withdrawal by Subject|9
858653|NCT01301066|2734613|P1|Overall Study|Withdrawal by Subject|4
858654|NCT01301066|2734612|P2|Overall Study|Protocol Violation|7
858655|NCT01301066|2734613|P1|Overall Study|Protocol Violation|8
858656|NCT01301066|2734612|P2|Overall Study|Lost to Follow-up|11
858657|NCT01301066|2734613|P1|Overall Study|Lost to Follow-up|5
858658|NCT01301079|2734621|P2|Overall Study|Lost to Follow-up|2
858659|NCT01301079|2734622|P1|Overall Study|Lost to Follow-up|2
858660|NCT01301092|2734701|P3|Overall Study|Lost to Follow-up|1
858661|NCT01301092|2734702|P2|Overall Study|Lost to Follow-up|0
858662|NCT01301092|2734703|P1|Overall Study|Lost to Follow-up|0
858663|NCT01301274|2734720|P2|Overall Study|Physician Decision|1
858664|NCT01301274|2734721|P1|Overall Study|Physician Decision|2
858665|NCT01301508|2734735|P2|Overall Study|Lost to Follow-up|1
858666|NCT01301508|2734736|P1|Overall Study|Lost to Follow-up|0
858667|NCT01301508|2734735|P2|Overall Study|Withdrawal by Subject|2
858668|NCT01301508|2734736|P1|Overall Study|Withdrawal by Subject|1
858669|NCT01301729|2734754|P1|Overall Study|Violated Selection Criteria|1
858670|NCT01301729|2734754|P1|Overall Study|Participant did not Return for Treatment|1
858671|NCT01301729|2734754|P1|Overall Study|Withdrawal by Subject|2
858672|NCT01301833|2734781|P4|Overall Study|Personal matter|0
858673|NCT01301833|2734782|P3|Overall Study|Personal matter|0
858674|NCT01301833|2734783|P2|Overall Study|Personal matter|0
858675|NCT01301833|2734784|P1|Overall Study|Personal matter|1
858676|NCT01301833|2734781|P4|Overall Study|Withdrawal by Subject|2
858677|NCT01301833|2734782|P3|Overall Study|Withdrawal by Subject|1
858678|NCT01301833|2734783|P2|Overall Study|Withdrawal by Subject|1
858679|NCT01301833|2734784|P1|Overall Study|Withdrawal by Subject|3
858680|NCT01301833|2734781|P4|Overall Study|Physician Decision|0
858681|NCT01301833|2734782|P3|Overall Study|Physician Decision|1
858682|NCT01301833|2734783|P2|Overall Study|Physician Decision|1
858683|NCT01301833|2734784|P1|Overall Study|Physician Decision|3
858684|NCT01301833|2734781|P4|Overall Study|Lack of Efficacy|0
858685|NCT01301833|2734782|P3|Overall Study|Lack of Efficacy|0
858686|NCT01301833|2734783|P2|Overall Study|Lack of Efficacy|1
858687|NCT01301833|2734784|P1|Overall Study|Lack of Efficacy|1
858688|NCT01301833|2734781|P4|Overall Study|Adverse Event|5
858689|NCT01301833|2734782|P3|Overall Study|Adverse Event|5
858690|NCT01301833|2734783|P2|Overall Study|Adverse Event|5
858691|NCT01301833|2734784|P1|Overall Study|Adverse Event|7
858692|NCT01301950|2734812|P2|Overall Study|Surgery was cancelled by patient|1
858693|NCT01301950|2734813|P1|Overall Study|Surgery was cancelled by patient|0
858694|NCT01302041|2734838|P1|Overall Study|Other - Miscellaneous Reason|1
858695|NCT01302041|2734838|P1|Overall Study|Withdrawal by Subject|1
858696|NCT01302041|2734838|P1|Overall Study|Death|3
858697|NCT01302041|2734838|P1|Overall Study|Continuing on Study|45
858698|NCT01293006|2734871|P4|Period 2|Lost to Follow-up|0
858699|NCT01293006|2734872|P3|Period 2|Lost to Follow-up|0
858700|NCT01293006|2734873|P2|Period 2|Lost to Follow-up|0
858701|NCT01293006|2734874|P1|Period 2|Lost to Follow-up|1
858702|NCT01293032|2734899|P4|Treatment|Disease Progression, relapse|0
858703|NCT01293032|2734900|P3|Treatment|Disease Progression, relapse|0
858704|NCT01293032|2734901|P2|Treatment|Disease Progression, relapse|1
858705|NCT01293032|2734902|P1|Treatment|Disease Progression, relapse|0
858706|NCT01293032|2734899|P4|Treatment|Withdrawal by Subject|0
858707|NCT01293032|2734900|P3|Treatment|Withdrawal by Subject|0
858708|NCT01293032|2734901|P2|Treatment|Withdrawal by Subject|4
858709|NCT01293032|2734902|P1|Treatment|Withdrawal by Subject|2
858710|NCT01293032|2734899|P4|Treatment|Adverse Event|1
858711|NCT01293032|2734900|P3|Treatment|Adverse Event|1
858712|NCT01293032|2734901|P2|Treatment|Adverse Event|0
858713|NCT01293032|2734902|P1|Treatment|Adverse Event|0
858714|NCT01293032|2734899|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
858715|NCT01293032|2734900|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
858716|NCT01293032|2734901|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
858717|NCT01293032|2734902|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
858718|NCT01293084|2734909|P1|Overall Study|Withdrawal by Subject|2
858719|NCT01293084|2734909|P1|Overall Study|Physician Decision|3
858720|NCT01293240|2734917|P1|Overall Study|Noncompliance|2
858721|NCT01293539|2734932|P1|Overall Study|Physician Decision|1
858722|NCT01293695|2734938|P2|Overall Study|Lost to Follow-up|6
858723|NCT01293695|2734939|P1|Overall Study|Lost to Follow-up|8
858724|NCT01293695|2734938|P2|Overall Study|Withdrawal by Subject|1
858725|NCT01293695|2734939|P1|Overall Study|Withdrawal by Subject|7
858726|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Unspecified|9
858727|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Unspecified|4
858728|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Unspecified|0
858729|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
858730|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
858731|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
858732|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Adverse Event|10
858733|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Adverse Event|10
858734|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Adverse Event|0
858735|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Protocol Violation|6
858736|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Protocol Violation|3
858737|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Protocol Violation|0
858738|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
858739|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
858740|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
858741|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
858742|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
858743|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
858744|NCT01302054|2734953|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
858745|NCT01302054|2734954|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
858746|NCT01302054|2734955|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
858747|NCT01302054|2734953|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
858748|NCT01302054|2734954|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
858749|NCT01302054|2734955|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
858750|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Unspecified|0
858751|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Unspecified|0
858752|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Unspecified|7
858753|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
858754|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
858755|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
858756|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
858757|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
858758|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
858759|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
858760|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
858761|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
858762|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
858763|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
858764|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
858765|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
858766|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
858767|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
858768|NCT01302054|2734953|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
858769|NCT01302054|2734954|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
858770|NCT01302054|2734955|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
858771|NCT01302067|2734985|P3|Overall Study|Adverse Event|45
858772|NCT01302067|2734986|P2|Overall Study|Adverse Event|14
858773|NCT01302067|2734987|P1|Overall Study|Adverse Event|27
858774|NCT01302067|2734985|P3|Overall Study|Protocol Violation|8
858775|NCT01302067|2734986|P2|Overall Study|Protocol Violation|0
858776|NCT01302067|2734987|P1|Overall Study|Protocol Violation|11
858777|NCT01302067|2734985|P3|Overall Study|Not specified|3
858778|NCT01302067|2734986|P2|Overall Study|Not specified|1
858779|NCT01302067|2734987|P1|Overall Study|Not specified|1
858780|NCT01302067|2734985|P3|Overall Study|Withdrawal by Subject|10
858781|NCT01302067|2734986|P2|Overall Study|Withdrawal by Subject|6
858782|NCT01302067|2734987|P1|Overall Study|Withdrawal by Subject|13
858783|NCT01302067|2734985|P3|Overall Study|Lost to Follow-up|15
858784|NCT01302067|2734986|P2|Overall Study|Lost to Follow-up|4
858785|NCT01302067|2734987|P1|Overall Study|Lost to Follow-up|9
858786|NCT01302067|2734985|P3|Overall Study|Lack of Efficacy|2
858787|NCT01302067|2734986|P2|Overall Study|Lack of Efficacy|4
858788|NCT01302067|2734987|P1|Overall Study|Lack of Efficacy|8
858789|NCT01302067|2734985|P3|Overall Study|Physician Decision|14
858790|NCT01302067|2734986|P2|Overall Study|Physician Decision|5
858791|NCT01302067|2734987|P1|Overall Study|Physician Decision|9
858792|NCT01302067|2734985|P3|Overall Study|Death|1
858793|NCT01302067|2734986|P2|Overall Study|Death|0
858794|NCT01302067|2734987|P1|Overall Study|Death|0
858795|NCT01302119|2735060|P2|Overall Study|Non-specific|1
858796|NCT01302119|2735061|P1|Overall Study|Non-specific|4
858797|NCT01302119|2735060|P2|Overall Study|Non-compliance|2
858798|NCT01302119|2735061|P1|Overall Study|Non-compliance|4
858799|NCT01302119|2735060|P2|Overall Study|Adverse Event|1
858800|NCT01302119|2735061|P1|Overall Study|Adverse Event|2
858801|NCT01302119|2735060|P2|Overall Study|Lost to Follow-up|4
858802|NCT01302119|2735061|P1|Overall Study|Lost to Follow-up|10
858803|NCT01302119|2735060|P2|Overall Study|Withdrawal by Subject|20
858804|NCT01302119|2735061|P1|Overall Study|Withdrawal by Subject|30
858805|NCT01302366|2735073|P1|Overall Study|patient choice or noncompliance|5
858806|NCT01302691|2735081|P2|Overall Study|Protocol Violation|0
858807|NCT01302691|2735082|P1|Overall Study|Protocol Violation|1
858808|NCT01302691|2735081|P2|Overall Study|Physician Decision|1
858809|NCT01302691|2735082|P1|Overall Study|Physician Decision|0
858810|NCT01302691|2735081|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
858811|NCT01302691|2735082|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
858812|NCT01302691|2735081|P2|Overall Study|Lost to Follow-up|0
858813|NCT01302691|2735082|P1|Overall Study|Lost to Follow-up|1
858814|NCT01302691|2735081|P2|Overall Study|Death|1
858815|NCT01302691|2735082|P1|Overall Study|Death|0
858816|NCT01302691|2735081|P2|Overall Study|Adverse Event|0
858817|NCT01302691|2735082|P1|Overall Study|Adverse Event|2
858818|NCT01302899|2735130|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
858819|NCT01302899|2735131|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
858820|NCT01302899|2735130|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
858821|NCT01302899|2735131|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
858822|NCT01302938|2735183|P2|Overall Study|Adverse Event|0
858823|NCT01302938|2735184|P1|Overall Study|Adverse Event|1
858824|NCT01302938|2735183|P2|Overall Study|Withdrawal by Subject|0
858825|NCT01302938|2735184|P1|Overall Study|Withdrawal by Subject|1
858826|NCT01303159|2735227|P1|Overall Study|Study Termination|7
858827|NCT01303159|2735227|P1|Overall Study|Death|16
858828|NCT01303380|2735265|P1|Overall Study|Lack of compliance to study procedures|1
858829|NCT01303445|2735302|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
858830|NCT01303445|2735303|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
858831|NCT01303445|2735302|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
858832|NCT01303445|2735303|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
858833|NCT01303445|2735302|P2|Washout (14 Days)|Lost to Follow-up|2
858834|NCT01303445|2735303|P1|Washout (14 Days)|Lost to Follow-up|0
858835|NCT01303445|2735302|P2|Washout (14 Days)|Protocol Violation|0
858836|NCT01303445|2735303|P1|Washout (14 Days)|Protocol Violation|1
858837|NCT01303445|2735302|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
858838|NCT01303445|2735303|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
858839|NCT01303445|2735302|P2|Second Intervention (7 Days)|Adverse Event|2
858840|NCT01303445|2735303|P1|Second Intervention (7 Days)|Adverse Event|0
858841|NCT01303445|2735302|P2|First Intervention (7 Days)|Withdrawal by Subject|0
858842|NCT01303445|2735303|P1|First Intervention (7 Days)|Withdrawal by Subject|1
858843|NCT01303510|2735335|P2|Overall Study|Lost to Follow-up|0
858844|NCT01303510|2735336|P1|Overall Study|Lost to Follow-up|1
858845|NCT01303627|2735352|P2|Overall Study|the failure while performing URS|1
858846|NCT01303627|2735353|P1|Overall Study|the failure while performing URS|0
858847|NCT01303861|2735402|P4|Overall Study|Pregnancy|0
858848|NCT01303861|2735403|P3|Overall Study|Pregnancy|0
858849|NCT01303861|2735404|P2|Overall Study|Pregnancy|0
858850|NCT01303861|2735405|P1|Overall Study|Pregnancy|1
858851|NCT01303861|2735402|P4|Overall Study|Adverse Event|5
858852|NCT01303861|2735403|P3|Overall Study|Adverse Event|0
858853|NCT01303861|2735404|P2|Overall Study|Adverse Event|1
858854|NCT01303861|2735405|P1|Overall Study|Adverse Event|4
858855|NCT01303861|2735402|P4|Overall Study|Withdrawal by Subject|23
858856|NCT01303861|2735403|P3|Overall Study|Withdrawal by Subject|8
858857|NCT01303861|2735404|P2|Overall Study|Withdrawal by Subject|8
858858|NCT01303861|2735405|P1|Overall Study|Withdrawal by Subject|16
858859|NCT01303861|2735402|P4|Overall Study|Lack of Efficacy|0
858860|NCT01303861|2735403|P3|Overall Study|Lack of Efficacy|1
858861|NCT01303861|2735404|P2|Overall Study|Lack of Efficacy|2
858862|NCT01303861|2735405|P1|Overall Study|Lack of Efficacy|3
858863|NCT01303861|2735402|P4|Overall Study|Lost to Follow-up|31
858864|NCT01303861|2735403|P3|Overall Study|Lost to Follow-up|27
858865|NCT01303861|2735404|P2|Overall Study|Lost to Follow-up|14
858866|NCT01303861|2735405|P1|Overall Study|Lost to Follow-up|34
858867|NCT01304147|2735445|P2|Second Intervention (7days)|Withdrawal by Subject|1
858868|NCT01304147|2735446|P1|Second Intervention (7days)|Withdrawal by Subject|1
858869|NCT01304329|2735571|P6|Third Intervention (3 Days)|Adverse Event|0
858870|NCT01304329|2735572|P5|Third Intervention (3 Days)|Adverse Event|0
858871|NCT01304329|2735573|P4|Third Intervention (3 Days)|Adverse Event|0
858872|NCT01304329|2735574|P3|Third Intervention (3 Days)|Adverse Event|0
858873|NCT01304329|2735575|P2|Third Intervention (3 Days)|Adverse Event|1
858874|NCT01304329|2735576|P1|Third Intervention (3 Days)|Adverse Event|0
858875|NCT01304498|2735595|P2|Overall Study|Lost to Follow-up|1
858876|NCT01304498|2735596|P1|Overall Study|Lost to Follow-up|2
858877|NCT01304498|2735595|P2|Overall Study|Protocol Violation|0
858878|NCT01304498|2735596|P1|Overall Study|Protocol Violation|1
858879|NCT01304498|2735595|P2|Overall Study|Withdrawal by Subject|3
858880|NCT01304498|2735596|P1|Overall Study|Withdrawal by Subject|2
858881|NCT01304498|2735595|P2|Overall Study|Adverse Event|1
858882|NCT01304498|2735596|P1|Overall Study|Adverse Event|1
858883|NCT01304693|2735649|P5|Overall Study|Decision Unrelated to an Adverse Event|0
858884|NCT01304693|2735650|P4|Overall Study|Decision Unrelated to an Adverse Event|1
858885|NCT01304693|2735651|P3|Overall Study|Decision Unrelated to an Adverse Event|1
858886|NCT01304693|2735652|P2|Overall Study|Decision Unrelated to an Adverse Event|0
858887|NCT01304693|2735653|P1|Overall Study|Decision Unrelated to an Adverse Event|0
858888|NCT01304693|2735649|P5|Overall Study|Adverse Event|1
858889|NCT01304693|2735650|P4|Overall Study|Adverse Event|0
858890|NCT01304693|2735651|P3|Overall Study|Adverse Event|0
858891|NCT01304693|2735652|P2|Overall Study|Adverse Event|0
858892|NCT01304693|2735653|P1|Overall Study|Adverse Event|0
858893|NCT01304706|2735670|P1|Overall Study|Discontinued due to failed drug admin.|1
858894|NCT01304706|2735670|P1|Overall Study|Lost to Follow-up|7
858895|NCT01304706|2735670|P1|Overall Study|Withdrawal by Subject|3
858896|NCT01304706|2735670|P1|Overall Study|Death|3
858897|NCT01304706|2735670|P1|Overall Study|Lack of Efficacy|1
858898|NCT01304706|2735670|P1|Overall Study|Adverse Event|2
858899|NCT01305044|2735682|P2|Overall Study|Withdrawal by Subject|6
858900|NCT01305044|2735683|P1|Overall Study|Withdrawal by Subject|3
858901|NCT01296672|2735720|P2|Overall Study|Lost to Follow-up|18
858902|NCT01296672|2735721|P1|Overall Study|Lost to Follow-up|73
858903|NCT01296698|2735733|P2|Overall Study|Study Terminated by Sponsor|12
858904|NCT01296698|2735734|P1|Overall Study|Study Terminated by Sponsor|209
858905|NCT01296698|2735733|P2|Overall Study|Difficulty Contacting Subject|0
858906|NCT01296698|2735734|P1|Overall Study|Difficulty Contacting Subject|2
858907|NCT01296698|2735733|P2|Overall Study|Withdrawal by Subject|0
858908|NCT01296698|2735734|P1|Overall Study|Withdrawal by Subject|12
858909|NCT01296698|2735733|P2|Overall Study|Lost to Follow-up|1
858910|NCT01296698|2735734|P1|Overall Study|Lost to Follow-up|19
858911|NCT01296698|2735733|P2|Overall Study|Death|0
858912|NCT01296698|2735734|P1|Overall Study|Death|1
858913|NCT01296698|2735733|P2|Overall Study|Adverse Event|0
858914|NCT01296698|2735734|P1|Overall Study|Adverse Event|1
858915|NCT01297062|2735792|P7|Overall Study|Subject Decision|2
858916|NCT01297062|2735793|P6|Overall Study|Subject Decision|1
858917|NCT01297062|2735794|P5|Overall Study|Subject Decision|1
858918|NCT01297062|2735795|P4|Overall Study|Subject Decision|1
858919|NCT01297062|2735796|P3|Overall Study|Subject Decision|0
858920|NCT01297062|2735797|P2|Overall Study|Subject Decision|1
858921|NCT01297062|2735798|P1|Overall Study|Subject Decision|1
858922|NCT01297062|2735792|P7|Overall Study|Protocol Violation|0
858923|NCT01297062|2735793|P6|Overall Study|Protocol Violation|0
858924|NCT01297062|2735794|P5|Overall Study|Protocol Violation|1
858925|NCT01297062|2735795|P4|Overall Study|Protocol Violation|0
858926|NCT01297062|2735796|P3|Overall Study|Protocol Violation|0
858927|NCT01297062|2735797|P2|Overall Study|Protocol Violation|0
858928|NCT01297062|2735798|P1|Overall Study|Protocol Violation|0
858929|NCT01297062|2735792|P7|Overall Study|Physician Decision|6
858930|NCT01297062|2735793|P6|Overall Study|Physician Decision|0
858931|NCT01297062|2735794|P5|Overall Study|Physician Decision|0
858932|NCT01297062|2735795|P4|Overall Study|Physician Decision|0
858933|NCT01297062|2735796|P3|Overall Study|Physician Decision|1
858934|NCT01297062|2735797|P2|Overall Study|Physician Decision|0
858935|NCT01297062|2735798|P1|Overall Study|Physician Decision|1
858936|NCT01297062|2735792|P7|Overall Study|Adverse Event|0
858937|NCT01297062|2735793|P6|Overall Study|Adverse Event|0
858938|NCT01297062|2735794|P5|Overall Study|Adverse Event|0
858939|NCT01297062|2735795|P4|Overall Study|Adverse Event|0
858940|NCT01297062|2735796|P3|Overall Study|Adverse Event|1
858941|NCT01297062|2735797|P2|Overall Study|Adverse Event|0
858942|NCT01297062|2735798|P1|Overall Study|Adverse Event|2
858943|NCT01297270|2735828|P3|Overall Study|Not treated|0
858944|NCT01297270|2735829|P2|Overall Study|Not treated|1
858945|NCT01297270|2735830|P1|Overall Study|Not treated|0
858946|NCT01297270|2735828|P3|Overall Study|Other reason not defined above|1
858947|NCT01297270|2735829|P2|Overall Study|Other reason not defined above|3
858948|NCT01297270|2735830|P1|Overall Study|Other reason not defined above|3
858949|NCT01297270|2735828|P3|Overall Study|Withdrawal by Subject|7
858950|NCT01297270|2735829|P2|Overall Study|Withdrawal by Subject|15
858951|NCT01297270|2735830|P1|Overall Study|Withdrawal by Subject|7
858952|NCT01297270|2735828|P3|Overall Study|Protocol Violation|0
858953|NCT01297270|2735829|P2|Overall Study|Protocol Violation|2
858954|NCT01297270|2735830|P1|Overall Study|Protocol Violation|0
858955|NCT01297270|2735828|P3|Overall Study|Lost to Follow-up|1
858956|NCT01297270|2735829|P2|Overall Study|Lost to Follow-up|2
858957|NCT01297270|2735830|P1|Overall Study|Lost to Follow-up|1
858958|NCT01297270|2735828|P3|Overall Study|Lack of Efficacy|15
858959|NCT01297270|2735829|P2|Overall Study|Lack of Efficacy|17
858960|NCT01297270|2735830|P1|Overall Study|Lack of Efficacy|15
858961|NCT01297270|2735828|P3|Overall Study|Adverse Event|5
858962|NCT01297270|2735829|P2|Overall Study|Adverse Event|32
858963|NCT01297270|2735830|P1|Overall Study|Adverse Event|19
858964|NCT01297322|2735875|P2|Overall Study|Withdrawal by Subject|1
858965|NCT01297322|2735876|P1|Overall Study|Withdrawal by Subject|0
858966|NCT01297322|2735875|P2|Overall Study|Lost to Follow-up|0
858967|NCT01297322|2735876|P1|Overall Study|Lost to Follow-up|1
858968|NCT01297465|2735917|P2|Overall Study|Intention to Freeze all Embryos|1
858969|NCT01297465|2735918|P1|Overall Study|Intention to Freeze all Embryos|0
858970|NCT01297465|2735917|P2|Overall Study|All Embryos Discarded|1
858971|NCT01297465|2735918|P1|Overall Study|All Embryos Discarded|0
858972|NCT01297465|2735917|P2|Overall Study|No Fertilization|4
858973|NCT01297465|2735918|P1|Overall Study|No Fertilization|6
858974|NCT01297465|2735917|P2|Overall Study|Poor oocyte quality|1
858975|NCT01297465|2735918|P1|Overall Study|Poor oocyte quality|0
858976|NCT01297465|2735917|P2|Overall Study|No Oocytes Retrieved|1
858977|NCT01297465|2735918|P1|Overall Study|No Oocytes Retrieved|1
858978|NCT01297465|2735917|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
858979|NCT01297465|2735918|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
858980|NCT01297465|2735917|P2|Overall Study|Lack of Ovarian Response|1
858981|NCT01297465|2735918|P1|Overall Study|Lack of Ovarian Response|1
858982|NCT01297491|2735952|P2|Overall Study|Death|1
858983|NCT01297491|2735953|P1|Overall Study|Death|2
858984|NCT01297491|2735952|P2|Overall Study|Patient/Guardian decision|4
858985|NCT01297491|2735953|P1|Overall Study|Patient/Guardian decision|3
858986|NCT01297491|2735952|P2|Overall Study|Progressive disease|20
858987|NCT01297491|2735953|P1|Overall Study|Progressive disease|11
858988|NCT01297491|2735952|P2|Overall Study|Physician Decision|2
858989|NCT01297491|2735953|P1|Overall Study|Physician Decision|3
858990|NCT01297491|2735952|P2|Overall Study|Adverse Event|6
858991|NCT01297491|2735953|P1|Overall Study|Adverse Event|11
858992|NCT01297504|2735969|P1|Overall Study|Protocol Violation|3
858993|NCT01297504|2735969|P1|Overall Study|Site Closure|3
858994|NCT01297504|2735969|P1|Overall Study|Withdrawal by Subject|9
858995|NCT01297504|2735969|P1|Overall Study|Lost to Follow-up|43
858996|NCT01297504|2735969|P1|Overall Study|Death|3
858997|NCT01297504|2735969|P1|Overall Study|No Study Visits|4
858998|NCT01297504|2735969|P1|Overall Study|Received Palivizumab in Previous Season|1
858999|NCT01297504|2735969|P1|Overall Study|Invalid Consent|1
859000|NCT01297517|2735984|P3|Overall Study|Inadequate Control of IOP|2
859001|NCT01297517|2735985|P2|Overall Study|Inadequate Control of IOP|1
859002|NCT01297517|2735986|P1|Overall Study|Inadequate Control of IOP|1
859003|NCT01297517|2735984|P3|Overall Study|Protocol Violation|1
859004|NCT01297517|2735985|P2|Overall Study|Protocol Violation|1
859005|NCT01297517|2735986|P1|Overall Study|Protocol Violation|1
859006|NCT01297517|2735984|P3|Overall Study|Noncompliance|0
859007|NCT01297517|2735985|P2|Overall Study|Noncompliance|0
859008|NCT01297517|2735986|P1|Overall Study|Noncompliance|1
859009|NCT01297517|2735984|P3|Overall Study|Patient Decision Unrelated to AE|7
859010|NCT01297517|2735985|P2|Overall Study|Patient Decision Unrelated to AE|3
859011|NCT01297517|2735986|P1|Overall Study|Patient Decision Unrelated to AE|2
859012|NCT01297517|2735984|P3|Overall Study|Lost to Follow-up|1
859013|NCT01297517|2735985|P2|Overall Study|Lost to Follow-up|0
859014|NCT01297517|2735986|P1|Overall Study|Lost to Follow-up|1
859015|NCT01297517|2735984|P3|Overall Study|Adverse Event|16
859016|NCT01297517|2735985|P2|Overall Study|Adverse Event|7
859017|NCT01297517|2735986|P1|Overall Study|Adverse Event|21
859018|NCT01297920|2736030|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
859019|NCT01297920|2736031|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
859020|NCT01297920|2736032|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
859021|NCT01297920|2736030|P3|Overall Study|Inadequate Control of IOP|17
859022|NCT01297920|2736031|P2|Overall Study|Inadequate Control of IOP|9
859023|NCT01297920|2736032|P1|Overall Study|Inadequate Control of IOP|7
859024|NCT01297920|2736030|P3|Overall Study|Protocol Violation|0
859025|NCT01297920|2736031|P2|Overall Study|Protocol Violation|3
859026|NCT01297920|2736032|P1|Overall Study|Protocol Violation|1
859027|NCT01297920|2736030|P3|Overall Study|Noncompliance|0
859028|NCT01297920|2736031|P2|Overall Study|Noncompliance|0
859029|NCT01297920|2736032|P1|Overall Study|Noncompliance|1
859030|NCT01297920|2736030|P3|Overall Study|Patient Decision Unrelated to AE|2
859031|NCT01297920|2736031|P2|Overall Study|Patient Decision Unrelated to AE|5
859032|NCT01297920|2736032|P1|Overall Study|Patient Decision Unrelated to AE|6
859033|NCT01297920|2736030|P3|Overall Study|Adverse Event|38
859034|NCT01297920|2736031|P2|Overall Study|Adverse Event|10
859035|NCT01297920|2736032|P1|Overall Study|Adverse Event|42
859052|NCT01298362|2736105|P2|Overall Study|Did not provide 12month BMD measurements|43
859053|NCT01298362|2736106|P1|Overall Study|Did not provide 12month BMD measurements|38
859054|NCT01298492|2736124|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
859055|NCT01298492|2736124|P1|Overall Study|Adverse Event(Related to Study Drug)|8
859056|NCT01298492|2736124|P1|Overall Study|Protocol Violation|2
859057|NCT01298492|2736124|P1|Overall Study|Withdrawn Due to Pregnancy|1
859058|NCT01298492|2736124|P1|Overall Study|Other (Unspecified)|7
859059|NCT01298492|2736124|P1|Overall Study|Withdrawal by Subject|47
859060|NCT01298492|2736124|P1|Overall Study|Lost to Follow-up|12
859061|NCT01298492|2736124|P1|Overall Study|Insufficient Clinical Response|22
859062|NCT01298492|2736124|P1|Overall Study|Death|2
859063|NCT01298518|2736133|P3|Overall Study|Withdrawal by Subject|1
859064|NCT01298518|2736134|P2|Overall Study|Withdrawal by Subject|0
859065|NCT01298518|2736135|P1|Overall Study|Withdrawal by Subject|0
859066|NCT01298531|2736189|P2|Overall Study|Not specified|1
859067|NCT01298531|2736190|P1|Overall Study|Not specified|2
859068|NCT01298531|2736189|P2|Overall Study|Does not meet entrance criteria|1
859069|NCT01298531|2736190|P1|Overall Study|Does not meet entrance criteria|0
859070|NCT01298531|2736189|P2|Overall Study|Adverse Event|3
859071|NCT01298531|2736190|P1|Overall Study|Adverse Event|4
859072|NCT01298531|2736189|P2|Overall Study|Protocol Violation|1
859073|NCT01298531|2736190|P1|Overall Study|Protocol Violation|1
859074|NCT01298531|2736189|P2|Overall Study|Lost to Follow-up|0
859075|NCT01298531|2736190|P1|Overall Study|Lost to Follow-up|2
859076|NCT01298531|2736189|P2|Overall Study|Lack of Efficacy|1
859077|NCT01298531|2736190|P1|Overall Study|Lack of Efficacy|0
859078|NCT01298648|2736325|P1|Overall Study|Lost to Follow-up|21
859079|NCT01298648|2736325|P1|Overall Study|Withdrawal by Subject|2
859080|NCT01298661|2736337|P3|Overall Study|Withdrawal by Subject|2
859081|NCT01298661|2736338|P2|Overall Study|Withdrawal by Subject|0
859082|NCT01298661|2736339|P1|Overall Study|Withdrawal by Subject|2
894912|NCT01467427|2840809|P2|Overall Study|Not continuing in extension phase|2
894913|NCT01467427|2840810|P1|Overall Study|Not continuing in extension phase|0
894914|NCT01467427|2840809|P2|Overall Study|Entered extension phase|11
859093|NCT01299025|2736442|P2|Overall Study|Lost to Follow-up|0
859094|NCT01299025|2736443|P1|Overall Study|Lost to Follow-up|1
859095|NCT01299025|2736442|P2|Overall Study|Withdrawal by Subject|1
859096|NCT01299025|2736443|P1|Overall Study|Withdrawal by Subject|2
859097|NCT01299376|2736499|P2|Extension (Weeks 9 to 52)|Physician Decision|0
859098|NCT01299376|2736500|P1|Extension (Weeks 9 to 52)|Physician Decision|1
859099|NCT01299376|2736499|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
859100|NCT01299376|2736500|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
859101|NCT01299376|2736499|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
859102|NCT01299376|2736500|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
859103|NCT01299376|2736499|P2|Extension (Weeks 9 to 52)|Adverse Event|3
859104|NCT01299376|2736500|P1|Extension (Weeks 9 to 52)|Adverse Event|2
859105|NCT01299376|2736499|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
859106|NCT01299376|2736500|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
859107|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
859108|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
859109|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
859110|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
859111|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
859112|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
859113|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
859114|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
859115|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
859116|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
859117|NCT01299376|2736499|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
859118|NCT01299376|2736500|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
859119|NCT01299389|2736532|P4|Post-observational|unspecified|6
859120|NCT01299389|2736533|P3|Post-observational|unspecified|12
859121|NCT01299389|2736534|P2|Post-observational|unspecified|0
859122|NCT01299389|2736535|P1|Post-observational|unspecified|0
859123|NCT01299389|2736532|P4|Double-blind|fail to meet “study population” criteria|0
859124|NCT01299389|2736533|P3|Double-blind|fail to meet “study population” criteria|0
859125|NCT01299389|2736534|P2|Double-blind|fail to meet “study population” criteria|1
859126|NCT01299389|2736535|P1|Double-blind|fail to meet “study population” criteria|0
859127|NCT01299389|2736532|P4|Double-blind|unspecified|0
859128|NCT01299389|2736533|P3|Double-blind|unspecified|0
859129|NCT01299389|2736534|P2|Double-blind|unspecified|1
859130|NCT01299389|2736535|P1|Double-blind|unspecified|1
859131|NCT01299389|2736532|P4|Double-blind|Withdrawal by Subject|0
859132|NCT01299389|2736533|P3|Double-blind|Withdrawal by Subject|0
859133|NCT01299389|2736534|P2|Double-blind|Withdrawal by Subject|13
859134|NCT01299389|2736535|P1|Double-blind|Withdrawal by Subject|16
859135|NCT01299389|2736532|P4|Double-blind|Lost to Follow-up|0
859136|NCT01299389|2736533|P3|Double-blind|Lost to Follow-up|0
859137|NCT01299389|2736534|P2|Double-blind|Lost to Follow-up|1
859138|NCT01299389|2736535|P1|Double-blind|Lost to Follow-up|2
859139|NCT01299389|2736532|P4|Double-blind|Lack of Efficacy|0
859140|NCT01299389|2736533|P3|Double-blind|Lack of Efficacy|0
859141|NCT01299389|2736534|P2|Double-blind|Lack of Efficacy|21
859142|NCT01299389|2736535|P1|Double-blind|Lack of Efficacy|45
859143|NCT01299389|2736532|P4|Double-blind|Adverse Event|0
859144|NCT01299389|2736533|P3|Double-blind|Adverse Event|0
859145|NCT01299389|2736534|P2|Double-blind|Adverse Event|27
859146|NCT01299389|2736535|P1|Double-blind|Adverse Event|45
859147|NCT01299480|2736725|P5|Overall Study|Started, but not vaccinated|0
859148|NCT01299480|2736726|P4|Overall Study|Started, but not vaccinated|1
859149|NCT01299480|2736727|P3|Overall Study|Started, but not vaccinated|1
859150|NCT01299480|2736728|P2|Overall Study|Started, but not vaccinated|0
859151|NCT01299480|2736729|P1|Overall Study|Started, but not vaccinated|0
859152|NCT01299480|2736725|P5|Overall Study|Unspecified|3
859153|NCT01299480|2736726|P4|Overall Study|Unspecified|0
859154|NCT01299480|2736727|P3|Overall Study|Unspecified|3
859155|NCT01299480|2736728|P2|Overall Study|Unspecified|2
859156|NCT01299480|2736729|P1|Overall Study|Unspecified|3
859157|NCT01299480|2736725|P5|Overall Study|Lost to Follow-up|2
859158|NCT01299480|2736726|P4|Overall Study|Lost to Follow-up|1
859159|NCT01299480|2736727|P3|Overall Study|Lost to Follow-up|2
859160|NCT01299480|2736728|P2|Overall Study|Lost to Follow-up|1
894915|NCT01467427|2840810|P1|Overall Study|Entered extension phase|11
859161|NCT01299480|2736729|P1|Overall Study|Lost to Follow-up|3
859162|NCT01299480|2736725|P5|Overall Study|Physician Decision|0
859163|NCT01299480|2736726|P4|Overall Study|Physician Decision|2
859164|NCT01299480|2736727|P3|Overall Study|Physician Decision|0
859165|NCT01299480|2736728|P2|Overall Study|Physician Decision|1
859166|NCT01299480|2736729|P1|Overall Study|Physician Decision|1
859167|NCT01299480|2736725|P5|Overall Study|Withdrawal due to pregnancy|0
859168|NCT01299480|2736726|P4|Overall Study|Withdrawal due to pregnancy|0
859169|NCT01299480|2736727|P3|Overall Study|Withdrawal due to pregnancy|1
859170|NCT01299480|2736728|P2|Overall Study|Withdrawal due to pregnancy|1
859171|NCT01299480|2736729|P1|Overall Study|Withdrawal due to pregnancy|0
859172|NCT01299480|2736725|P5|Overall Study|Adverse Event|0
859173|NCT01299480|2736726|P4|Overall Study|Adverse Event|4
859174|NCT01299480|2736727|P3|Overall Study|Adverse Event|5
859175|NCT01299480|2736728|P2|Overall Study|Adverse Event|4
859176|NCT01299480|2736729|P1|Overall Study|Adverse Event|6
859177|NCT01299480|2736725|P5|Overall Study|Withdrawal by Subject|4
859178|NCT01299480|2736726|P4|Overall Study|Withdrawal by Subject|3
859179|NCT01299480|2736727|P3|Overall Study|Withdrawal by Subject|7
859180|NCT01299480|2736728|P2|Overall Study|Withdrawal by Subject|4
859181|NCT01299480|2736729|P1|Overall Study|Withdrawal by Subject|3
859182|NCT01299480|2736725|P5|Overall Study|Protocol Violation|1
859183|NCT01299480|2736726|P4|Overall Study|Protocol Violation|1
859184|NCT01299480|2736727|P3|Overall Study|Protocol Violation|8
859185|NCT01299480|2736728|P2|Overall Study|Protocol Violation|5
859186|NCT01299480|2736729|P1|Overall Study|Protocol Violation|7
859187|NCT01299480|2736725|P5|Overall Study|No longer willing to participate|10
859188|NCT01299480|2736726|P4|Overall Study|No longer willing to participate|13
859189|NCT01299480|2736727|P3|Overall Study|No longer willing to participate|14
859190|NCT01299480|2736728|P2|Overall Study|No longer willing to participate|17
859191|NCT01299480|2736729|P1|Overall Study|No longer willing to participate|19
859192|NCT01305200|2736767|P3|Overall Study|Death|0
859193|NCT01305200|2736768|P2|Overall Study|Death|2
859194|NCT01305200|2736769|P1|Overall Study|Death|0
859195|NCT01305200|2736767|P3|Overall Study|Ineligible|1
859196|NCT01305200|2736768|P2|Overall Study|Ineligible|2
859197|NCT01305200|2736769|P1|Overall Study|Ineligible|1
859198|NCT01305200|2736767|P3|Overall Study|Withdrawal by Subject|1
859199|NCT01305200|2736768|P2|Overall Study|Withdrawal by Subject|21
859200|NCT01305200|2736769|P1|Overall Study|Withdrawal by Subject|24
859201|NCT01305200|2736767|P3|Overall Study|Physician Decision|1
859202|NCT01305200|2736768|P2|Overall Study|Physician Decision|6
859203|NCT01305200|2736769|P1|Overall Study|Physician Decision|4
859204|NCT01305239|2736808|P1|Overall Study|Exemestane taken prior to inclusion only|1
859205|NCT01305239|2736808|P1|Overall Study|Adverse Event|22
859206|NCT01305408|2736844|P2|Overall Study|Not specified|0
859207|NCT01305408|2736845|P1|Overall Study|Not specified|1
859208|NCT01305408|2736844|P2|Overall Study|Noncompliance with study procedures|1
859209|NCT01305408|2736845|P1|Overall Study|Noncompliance with study procedures|0
859210|NCT01305408|2736844|P2|Overall Study|Noncompliance with study medication|1
859211|NCT01305408|2736845|P1|Overall Study|Noncompliance with study medication|0
859212|NCT01305408|2736844|P2|Overall Study|Lost to Follow-up|3
859213|NCT01305408|2736845|P1|Overall Study|Lost to Follow-up|5
859214|NCT01305408|2736844|P2|Overall Study|Protocol Violation|6
859215|NCT01305408|2736845|P1|Overall Study|Protocol Violation|4
859216|NCT01305408|2736844|P2|Overall Study|Withdrawal by Subject|9
859217|NCT01305408|2736845|P1|Overall Study|Withdrawal by Subject|9
859218|NCT01305408|2736844|P2|Overall Study|Lack of Efficacy|4
859219|NCT01305408|2736845|P1|Overall Study|Lack of Efficacy|3
859220|NCT01305408|2736844|P2|Overall Study|Adverse Event|7
859221|NCT01305408|2736845|P1|Overall Study|Adverse Event|10
859222|NCT01306214|2736908|P3|Overall Study|Not treated|1
859223|NCT01306214|2736909|P2|Overall Study|Not treated|1
859224|NCT01306214|2736910|P1|Overall Study|Not treated|1
859225|NCT01306214|2736908|P3|Overall Study|Withdrawal by Subject|16
859226|NCT01306214|2736909|P2|Overall Study|Withdrawal by Subject|22
859227|NCT01306214|2736910|P1|Overall Study|Withdrawal by Subject|24
859228|NCT01306214|2736908|P3|Overall Study|Lost to Follow-up|4
859229|NCT01306214|2736909|P2|Overall Study|Lost to Follow-up|5
859230|NCT01306214|2736910|P1|Overall Study|Lost to Follow-up|3
859231|NCT01306214|2736908|P3|Overall Study|Death|1
859232|NCT01306214|2736909|P2|Overall Study|Death|0
859233|NCT01306214|2736910|P1|Overall Study|Death|0
859234|NCT01306253|2736929|P2|Overall Study|Lost to Follow-up|1
859235|NCT01306253|2736930|P1|Overall Study|Lost to Follow-up|1
859236|NCT01306305|2736967|P2|Overall Study|Withdrew consent|0
859237|NCT01306305|2736968|P1|Overall Study|Withdrew consent|1
859238|NCT01306305|2736967|P2|Overall Study|Lost to Follow-up|0
859239|NCT01306305|2736968|P1|Overall Study|Lost to Follow-up|1
859240|NCT01306617|2736985|P3|Overall Study|Non-compliance|0
859241|NCT01306617|2736986|P2|Overall Study|Non-compliance|1
859242|NCT01306617|2736987|P1|Overall Study|Non-compliance|0
859243|NCT01306617|2736985|P3|Overall Study|Virologic Failure|5
859244|NCT01306617|2736986|P2|Overall Study|Virologic Failure|0
859245|NCT01306617|2736987|P1|Overall Study|Virologic Failure|0
859246|NCT01306617|2736985|P3|Overall Study|Adverse Event|0
859247|NCT01306617|2736986|P2|Overall Study|Adverse Event|0
859248|NCT01306617|2736987|P1|Overall Study|Adverse Event|1
859249|NCT01306643|2737028|P1|Overall Study|Other: Change in Eligibility Status|1
859250|NCT01306643|2737028|P1|Overall Study|Disease Progression|7
859251|NCT01306643|2737028|P1|Overall Study|Adverse Event|5
859252|NCT01306877|2737039|P2|Overall Study|Physician Decision|1
859253|NCT01306877|2737040|P1|Overall Study|Physician Decision|0
859254|NCT01306877|2737039|P2|Overall Study|Lost to Follow-up|3
859255|NCT01306877|2737040|P1|Overall Study|Lost to Follow-up|3
859256|NCT01306968|2737062|P4|Overall Study|Withdrew over privacy concerns|1
859257|NCT01306968|2737063|P3|Overall Study|Withdrew over privacy concerns|0
859258|NCT01306968|2737064|P2|Overall Study|Withdrew over privacy concerns|0
859259|NCT01306968|2737065|P1|Overall Study|Withdrew over privacy concerns|0
859260|NCT01306968|2737062|P4|Overall Study|Withdrew - time commitment|2
859261|NCT01306968|2737063|P3|Overall Study|Withdrew - time commitment|0
859262|NCT01306968|2737064|P2|Overall Study|Withdrew - time commitment|0
859263|NCT01306968|2737065|P1|Overall Study|Withdrew - time commitment|0
859264|NCT01306968|2737062|P4|Overall Study|Relocated and left active duty|1
859265|NCT01306968|2737063|P3|Overall Study|Relocated and left active duty|1
859266|NCT01306968|2737064|P2|Overall Study|Relocated and left active duty|1
859267|NCT01306968|2737065|P1|Overall Study|Relocated and left active duty|0
859268|NCT01306968|2737062|P4|Overall Study|Physician Decision|0
859269|NCT01306968|2737063|P3|Overall Study|Physician Decision|0
859270|NCT01306968|2737064|P2|Overall Study|Physician Decision|1
859271|NCT01306968|2737065|P1|Overall Study|Physician Decision|0
859272|NCT01306968|2737062|P4|Overall Study|Lost to Follow-up|0
859273|NCT01306968|2737063|P3|Overall Study|Lost to Follow-up|0
859274|NCT01306968|2737064|P2|Overall Study|Lost to Follow-up|1
859275|NCT01306968|2737065|P1|Overall Study|Lost to Follow-up|1
859276|NCT01307020|2737106|P10|Overall Study|Electronic data capture failure|0
859277|NCT01307020|2737107|P9|Overall Study|Electronic data capture failure|0
859278|NCT01307020|2737108|P8|Overall Study|Electronic data capture failure|0
859279|NCT01307020|2737109|P7|Overall Study|Electronic data capture failure|0
859280|NCT01307020|2737110|P6|Overall Study|Electronic data capture failure|0
859281|NCT01307020|2737111|P5|Overall Study|Electronic data capture failure|0
859282|NCT01307020|2737112|P4|Overall Study|Electronic data capture failure|0
859283|NCT01307020|2737113|P3|Overall Study|Electronic data capture failure|0
859284|NCT01307020|2737114|P2|Overall Study|Electronic data capture failure|1
859285|NCT01307020|2737115|P1|Overall Study|Electronic data capture failure|0
859286|NCT01307020|2737106|P10|Overall Study|Lost to Follow-up|0
859287|NCT01307020|2737107|P9|Overall Study|Lost to Follow-up|0
859288|NCT01307020|2737108|P8|Overall Study|Lost to Follow-up|0
859289|NCT01307020|2737109|P7|Overall Study|Lost to Follow-up|1
859290|NCT01307020|2737110|P6|Overall Study|Lost to Follow-up|0
859291|NCT01307020|2737111|P5|Overall Study|Lost to Follow-up|0
859292|NCT01307020|2737112|P4|Overall Study|Lost to Follow-up|1
859293|NCT01307020|2737113|P3|Overall Study|Lost to Follow-up|1
859294|NCT01307020|2737114|P2|Overall Study|Lost to Follow-up|0
859295|NCT01307020|2737115|P1|Overall Study|Lost to Follow-up|0
859296|NCT01307033|2737159|P4|44-week Open-label Extension|Death|1
859297|NCT01307033|2737160|P3|44-week Open-label Extension|Death|0
859298|NCT01307033|2737161|P2|44-week Open-label Extension|Death|0
859299|NCT01307033|2737162|P1|44-week Open-label Extension|Death|0
859300|NCT01307033|2737159|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
859301|NCT01307033|2737160|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
859302|NCT01307033|2737161|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
859303|NCT01307033|2737162|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
859304|NCT01307033|2737159|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
859305|NCT01307033|2737160|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
859306|NCT01307033|2737161|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
859307|NCT01307033|2737162|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
859308|NCT01307033|2737159|P4|44-week Open-label Extension|Physician Decision|0
859309|NCT01307033|2737160|P3|44-week Open-label Extension|Physician Decision|1
859310|NCT01307033|2737161|P2|44-week Open-label Extension|Physician Decision|0
859311|NCT01307033|2737162|P1|44-week Open-label Extension|Physician Decision|0
859312|NCT01307033|2737159|P4|44-week Open-label Extension|Withdrawal by Subject|1
859313|NCT01307033|2737160|P3|44-week Open-label Extension|Withdrawal by Subject|2
859314|NCT01307033|2737161|P2|44-week Open-label Extension|Withdrawal by Subject|0
859315|NCT01307033|2737162|P1|44-week Open-label Extension|Withdrawal by Subject|0
859316|NCT01307033|2737159|P4|44-week Open-label Extension|Adverse Event|1
859317|NCT01307033|2737160|P3|44-week Open-label Extension|Adverse Event|2
859318|NCT01307033|2737161|P2|44-week Open-label Extension|Adverse Event|0
859319|NCT01307033|2737162|P1|44-week Open-label Extension|Adverse Event|0
859320|NCT01307033|2737159|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
859321|NCT01307033|2737160|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
859322|NCT01307033|2737161|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
859323|NCT01307033|2737162|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
859324|NCT01307033|2737159|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
859325|NCT01307033|2737160|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
859326|NCT01307033|2737161|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
859327|NCT01307033|2737162|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
859328|NCT01307033|2737159|P4|8-week Double-blind Period|Lack of Efficacy|0
859329|NCT01307033|2737160|P3|8-week Double-blind Period|Lack of Efficacy|0
859330|NCT01307033|2737161|P2|8-week Double-blind Period|Lack of Efficacy|0
859331|NCT01307033|2737162|P1|8-week Double-blind Period|Lack of Efficacy|1
859332|NCT01307033|2737159|P4|8-week Double-blind Period|Withdrawal by Subject|0
859333|NCT01307033|2737160|P3|8-week Double-blind Period|Withdrawal by Subject|0
859334|NCT01307033|2737161|P2|8-week Double-blind Period|Withdrawal by Subject|1
859335|NCT01307033|2737162|P1|8-week Double-blind Period|Withdrawal by Subject|4
859336|NCT01307033|2737159|P4|8-week Double-blind Period|Adverse Event|0
859337|NCT01307033|2737160|P3|8-week Double-blind Period|Adverse Event|0
859338|NCT01307033|2737161|P2|8-week Double-blind Period|Adverse Event|0
859339|NCT01307033|2737162|P1|8-week Double-blind Period|Adverse Event|2
859340|NCT01307046|2737176|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
859341|NCT01307046|2737177|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
859342|NCT01307046|2737176|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
859343|NCT01307046|2737177|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
859344|NCT01307046|2737176|P2|Overall Study|Withdrawal by Subject|1
859345|NCT01307046|2737177|P1|Overall Study|Withdrawal by Subject|1
859346|NCT01307046|2737176|P2|Overall Study|Physician Decision|0
859347|NCT01307046|2737177|P1|Overall Study|Physician Decision|2
859348|NCT01307046|2737176|P2|Overall Study|Lack of Efficacy|2
859349|NCT01307046|2737177|P1|Overall Study|Lack of Efficacy|0
859350|NCT01307046|2737176|P2|Overall Study|Adverse Event|3
859351|NCT01307046|2737177|P1|Overall Study|Adverse Event|3
859352|NCT01307111|2737190|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
859353|NCT01307111|2737191|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
859354|NCT01307111|2737190|P2|IUD Insertion|Lost to Follow-up|0
859355|NCT01307111|2737191|P1|IUD Insertion|Lost to Follow-up|2
859356|NCT01307319|2737202|P3|Overall Study|Not specified|3
859357|NCT01307319|2737203|P2|Overall Study|Not specified|4
859358|NCT01307319|2737204|P1|Overall Study|Not specified|0
859359|NCT01307319|2737202|P3|Overall Study|Withdrawal by Subject|2
859360|NCT01307319|2737203|P2|Overall Study|Withdrawal by Subject|1
859361|NCT01307319|2737204|P1|Overall Study|Withdrawal by Subject|0
859362|NCT01307319|2737202|P3|Overall Study|Protocol Violation|0
859363|NCT01307319|2737203|P2|Overall Study|Protocol Violation|1
859364|NCT01307319|2737204|P1|Overall Study|Protocol Violation|1
859365|NCT01307319|2737202|P3|Overall Study|Lost to Follow-up|1
859366|NCT01307319|2737203|P2|Overall Study|Lost to Follow-up|0
859367|NCT01307319|2737204|P1|Overall Study|Lost to Follow-up|1
859368|NCT01307319|2737202|P3|Overall Study|Adverse Event|1
859369|NCT01307319|2737203|P2|Overall Study|Adverse Event|2
859370|NCT01307319|2737204|P1|Overall Study|Adverse Event|2
859371|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859372|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
859373|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859374|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859375|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859376|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859377|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
859378|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Unspecified|0
859379|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Unspecified|0
859380|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Unspecified|0
859381|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Unspecified|1
859382|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Unspecified|0
859383|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Unspecified|0
859384|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Unspecified|0
859385|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859386|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859387|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859388|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
859389|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859390|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859391|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
859392|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
859393|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
859394|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
859395|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
859396|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
859397|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
859398|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
859399|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859400|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
859401|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859402|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859403|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859404|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859405|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
859406|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
859407|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
859408|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
859409|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
859410|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
859411|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
859412|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
859413|NCT01307423|2737218|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
859414|NCT01307423|2737219|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
859415|NCT01307423|2737220|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
859416|NCT01307423|2737221|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
859417|NCT01307423|2737222|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
859418|NCT01307423|2737223|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
859419|NCT01307423|2737224|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
859420|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
859421|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
859422|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
859423|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
859424|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
859425|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
859426|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
859427|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
859428|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
859429|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
859430|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
859431|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
859432|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
859433|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
859434|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859435|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859436|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859437|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859438|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859439|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
859440|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
859441|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
859442|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
859443|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
859444|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
859445|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
859446|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
859447|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
859448|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859449|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859450|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859451|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859452|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
859453|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859454|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
859455|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
859456|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
859457|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
859458|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
859459|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
859460|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
859461|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
859462|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
859463|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
859464|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
859465|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
859466|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
859467|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
859468|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
859469|NCT01307423|2737218|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
859470|NCT01307423|2737219|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
859471|NCT01307423|2737220|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
859472|NCT01307423|2737221|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
859473|NCT01307423|2737222|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
859474|NCT01307423|2737223|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
859475|NCT01307423|2737224|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
859476|NCT01307787|2737376|P2|Overall Study|Withdrawal by Subject|0
859477|NCT01307787|2737377|P1|Overall Study|Withdrawal by Subject|2
894916|NCT01467427|2840809|P2|Overall Study|Withdrawal by Subject|0
894917|NCT01467427|2840810|P1|Overall Study|Withdrawal by Subject|1
859480|NCT01308424|2737412|P3|Randomization|Physician Decision|1
859481|NCT01308424|2737413|P2|Randomization|Physician Decision|1
859482|NCT01308424|2737414|P1|Randomization|Physician Decision|0
859483|NCT01308424|2737412|P3|Randomization|Lost to Follow-up|0
859484|NCT01308424|2737413|P2|Randomization|Lost to Follow-up|1
859485|NCT01308424|2737414|P1|Randomization|Lost to Follow-up|0
859486|NCT01308424|2737412|P3|Randomization|Adverse Event|1
859487|NCT01308424|2737413|P2|Randomization|Adverse Event|1
859488|NCT01308424|2737414|P1|Randomization|Adverse Event|0
859489|NCT01308424|2737412|P3|Baseline Eligibility|Screen Failures|0
859490|NCT01308424|2737413|P2|Baseline Eligibility|Screen Failures|0
859491|NCT01308424|2737414|P1|Baseline Eligibility|Screen Failures|71
859492|NCT01308463|2737425|P1|Overall Study|Revision|2
859493|NCT01308463|2737425|P1|Overall Study|Death|4
859494|NCT01308463|2737425|P1|Overall Study|Study Discontinued|23
859495|NCT01308476|2737434|P2|Overall Study|Other|0
859496|NCT01308476|2737435|P1|Overall Study|Other|1
859497|NCT01308476|2737434|P2|Overall Study|Lost to Follow-up|2
859498|NCT01308476|2737435|P1|Overall Study|Lost to Follow-up|2
859502|NCT01308580|2737500|P2|Overall Study|Lost to Follow-up|7
859503|NCT01308580|2737501|P1|Overall Study|Lost to Follow-up|12
859504|NCT01302392|2737596|P2|Overall Study|Withdrawal by Subject|1
859505|NCT01302392|2737597|P1|Overall Study|Withdrawal by Subject|6
859506|NCT01302392|2737596|P2|Overall Study|Lost to Follow-up|0
859507|NCT01302392|2737597|P1|Overall Study|Lost to Follow-up|1
859508|NCT01302418|2737617|P1|Overall Study|Non-evaluable|9
859509|NCT01302418|2737617|P1|Overall Study|Protocol Violation|9
859510|NCT01302548|2737663|P2|Overall Study|Lost to Follow-up|1
859511|NCT01302548|2737664|P1|Overall Study|Lost to Follow-up|2
859512|NCT01308736|2737676|P2|Overall Study|Did not attend a single session|5
859513|NCT01308736|2737677|P1|Overall Study|Did not attend a single session|6
859514|NCT01308749|2737685|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
859515|NCT01308749|2737686|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
859516|NCT01308749|2737685|P2|Period 2: Open Label Treatment|Adverse Event|1
859517|NCT01308749|2737686|P1|Period 2: Open Label Treatment|Adverse Event|0
859518|NCT01308749|2737685|P2|Period 1: Double Blind Treatment|Adverse Event|0
859519|NCT01308749|2737686|P1|Period 1: Double Blind Treatment|Adverse Event|1
859520|NCT01308762|2737717|P3|Overall Study|Protocol Violation|0
859521|NCT01308762|2737718|P2|Overall Study|Protocol Violation|1
859522|NCT01308762|2737719|P1|Overall Study|Protocol Violation|0
859523|NCT01308788|2737732|P2|2-year Treatment|medication change by treating physician|11
859524|NCT01308788|2737733|P1|2-year Treatment|medication change by treating physician|4
859525|NCT01309659|2737854|P2|Overall Study|Protocol Violation|1
859526|NCT01309659|2737855|P1|Overall Study|Protocol Violation|0
859527|NCT01309672|2737895|P1|Overall Study|Withdrawal by Subject|3
859528|NCT01309672|2737895|P1|Overall Study|Adverse Event|5
859529|NCT01309672|2737895|P1|Overall Study|Unspecified|9
859530|NCT01309672|2737895|P1|Overall Study|Lack of Efficacy|20
894949|NCT01352117|2840942|P2|Overall Study|Ineligible (no KS diagnosis)|0
894950|NCT01352117|2840943|P1|Overall Study|Ineligible (no KS diagnosis)|1
894951|NCT01352117|2840942|P2|Overall Study|Did not initiate study treatment|0
894952|NCT01352117|2840943|P1|Overall Study|Did not initiate study treatment|1
894953|NCT01352117|2840942|P2|Overall Study|Non-adherent to study requirements|0
894954|NCT01352117|2840943|P1|Overall Study|Non-adherent to study requirements|1
894955|NCT01352117|2840942|P2|Overall Study|Lost to Follow-up|4
894956|NCT01352117|2840943|P1|Overall Study|Lost to Follow-up|2
894957|NCT01352117|2840942|P2|Overall Study|Withdrawal by Subject|0
894958|NCT01352117|2840943|P1|Overall Study|Withdrawal by Subject|1
894959|NCT01352117|2840942|P2|Overall Study|Death|12
894960|NCT01352117|2840943|P1|Overall Study|Death|13
894961|NCT01352117|2840942|P2|Overall Study|On study|80
894962|NCT01352117|2840943|P1|Overall Study|On study|49
894963|NCT01312428|2840997|P2|Overall Study|Study Termination|4
894964|NCT01312428|2840998|P1|Overall Study|Study Termination|3
859596|NCT01309828|2738126|P2|Overall Study|Other|0
859597|NCT01309828|2738127|P1|Overall Study|Other|1
859598|NCT01309828|2738126|P2|Overall Study|Major Protocol Deviation|1
859599|NCT01309828|2738127|P1|Overall Study|Major Protocol Deviation|0
859600|NCT01309828|2738126|P2|Overall Study|Voluntary Withdrawal|4
859601|NCT01309828|2738127|P1|Overall Study|Voluntary Withdrawal|5
859602|NCT01309828|2738126|P2|Overall Study|Adverse Event|11
859603|NCT01309828|2738127|P1|Overall Study|Adverse Event|10
859604|NCT01309841|2738142|P3|Overall Study|Severe non-compliance with protocol|2
859605|NCT01309841|2738143|P2|Overall Study|Severe non-compliance with protocol|5
859606|NCT01309841|2738144|P1|Overall Study|Severe non-compliance with protocol|0
859607|NCT01309841|2738142|P3|Overall Study|Did Not Receive Treatment|1
859608|NCT01309841|2738143|P2|Overall Study|Did Not Receive Treatment|0
859609|NCT01309841|2738144|P1|Overall Study|Did Not Receive Treatment|2
859610|NCT01309841|2738142|P3|Overall Study|Withdrawal by Subject|13
859611|NCT01309841|2738143|P2|Overall Study|Withdrawal by Subject|6
859612|NCT01309841|2738144|P1|Overall Study|Withdrawal by Subject|17
859613|NCT01309841|2738142|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
859614|NCT01309841|2738143|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
859615|NCT01309841|2738144|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
859616|NCT01309841|2738142|P3|Overall Study|Death|0
859617|NCT01309841|2738143|P2|Overall Study|Death|0
859618|NCT01309841|2738144|P1|Overall Study|Death|1
859619|NCT01309841|2738142|P3|Overall Study|Adverse Event|11
859620|NCT01309841|2738143|P2|Overall Study|Adverse Event|22
859621|NCT01309841|2738144|P1|Overall Study|Adverse Event|9
859622|NCT01309841|2738142|P3|Overall Study|Lack of Efficacy|2
859623|NCT01309841|2738143|P2|Overall Study|Lack of Efficacy|0
859624|NCT01309841|2738144|P1|Overall Study|Lack of Efficacy|0
859625|NCT01309841|2738142|P3|Overall Study|Study-Specific Withdrawal Criteria|2
859626|NCT01309841|2738143|P2|Overall Study|Study-Specific Withdrawal Criteria|1
859627|NCT01309841|2738144|P1|Overall Study|Study-Specific Withdrawal Criteria|3
859628|NCT01309841|2738142|P3|Overall Study|Lost to Follow-up|4
859629|NCT01309841|2738143|P2|Overall Study|Lost to Follow-up|6
859630|NCT01309841|2738144|P1|Overall Study|Lost to Follow-up|7
859631|NCT01309841|2738142|P3|Overall Study|Other|1
859632|NCT01309841|2738143|P2|Overall Study|Other|1
859633|NCT01309841|2738144|P1|Overall Study|Other|0
859634|NCT01309893|2738193|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
859635|NCT01309893|2738194|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
859636|NCT01309893|2738193|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
859637|NCT01309893|2738194|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
859638|NCT01309919|2738206|P2|Overall Study|Did not receive a postpartum IUD|48
859639|NCT01309919|2738207|P1|Overall Study|Did not receive a postpartum IUD|17
859640|NCT01309997|2738221|P2|Overall Study|Withdrawal by Subject|1
859641|NCT01309997|2738222|P1|Overall Study|Withdrawal by Subject|1
859642|NCT01309997|2738221|P2|Overall Study|Lack of Efficacy|2
859643|NCT01309997|2738222|P1|Overall Study|Lack of Efficacy|2
859644|NCT01309997|2738221|P2|Overall Study|Death|3
859645|NCT01309997|2738222|P1|Overall Study|Death|1
859646|NCT01309997|2738221|P2|Overall Study|Adverse Event|0
859647|NCT01309997|2738222|P1|Overall Study|Adverse Event|1
859648|NCT01310127|2738246|P2|Overall Study|advanced psc cataract outlier|0
859649|NCT01310127|2738247|P1|Overall Study|advanced psc cataract outlier|1
859650|NCT01310127|2738246|P2|Overall Study|Protocol Violation|1
859651|NCT01310127|2738247|P1|Overall Study|Protocol Violation|1
859652|NCT01310413|2738292|P7|From Day U0 to Day U385|Lost to Follow-up|2
859653|NCT01310413|2738293|P6|From Day U0 to Day U385|Lost to Follow-up|0
859654|NCT01310413|2738294|P5|From Day U0 to Day U385|Lost to Follow-up|0
859655|NCT01310413|2738295|P4|From Day U0 to Day U385|Lost to Follow-up|0
859656|NCT01310413|2738296|P3|From Day U0 to Day U385|Lost to Follow-up|0
859657|NCT01310413|2738297|P2|From Day U0 to Day U385|Lost to Follow-up|0
859658|NCT01310413|2738298|P1|From Day U0 to Day U385|Lost to Follow-up|0
859659|NCT01310413|2738292|P7|From Day U0 to Day U385|Withdrawal by Subject|1
859660|NCT01310413|2738293|P6|From Day U0 to Day U385|Withdrawal by Subject|0
859661|NCT01310413|2738294|P5|From Day U0 to Day U385|Withdrawal by Subject|0
859662|NCT01310413|2738295|P4|From Day U0 to Day U385|Withdrawal by Subject|0
859663|NCT01310413|2738296|P3|From Day U0 to Day U385|Withdrawal by Subject|0
859664|NCT01310413|2738297|P2|From Day U0 to Day U385|Withdrawal by Subject|0
859665|NCT01310413|2738298|P1|From Day U0 to Day U385|Withdrawal by Subject|0
859666|NCT01310413|2738292|P7|Day 0 to Day 385|Unspecified|0
859667|NCT01310413|2738293|P6|Day 0 to Day 385|Unspecified|0
859668|NCT01310413|2738294|P5|Day 0 to Day 385|Unspecified|0
859669|NCT01310413|2738295|P4|Day 0 to Day 385|Unspecified|0
859670|NCT01310413|2738296|P3|Day 0 to Day 385|Unspecified|3
859671|NCT01310413|2738297|P2|Day 0 to Day 385|Unspecified|0
859672|NCT01310413|2738298|P1|Day 0 to Day 385|Unspecified|1
859673|NCT01310413|2738292|P7|Day 0 to Day 385|Migrated/moved from study area|0
859674|NCT01310413|2738293|P6|Day 0 to Day 385|Migrated/moved from study area|0
859675|NCT01310413|2738294|P5|Day 0 to Day 385|Migrated/moved from study area|1
859676|NCT01310413|2738295|P4|Day 0 to Day 385|Migrated/moved from study area|1
859677|NCT01310413|2738296|P3|Day 0 to Day 385|Migrated/moved from study area|1
859678|NCT01310413|2738297|P2|Day 0 to Day 385|Migrated/moved from study area|3
859679|NCT01310413|2738298|P1|Day 0 to Day 385|Migrated/moved from study area|3
859680|NCT01310413|2738292|P7|Day 0 to Day 385|Lost to Follow-up|0
859681|NCT01310413|2738293|P6|Day 0 to Day 385|Lost to Follow-up|2
859682|NCT01310413|2738294|P5|Day 0 to Day 385|Lost to Follow-up|1
859683|NCT01310413|2738295|P4|Day 0 to Day 385|Lost to Follow-up|5
859684|NCT01310413|2738296|P3|Day 0 to Day 385|Lost to Follow-up|3
859685|NCT01310413|2738297|P2|Day 0 to Day 385|Lost to Follow-up|3
859686|NCT01310413|2738298|P1|Day 0 to Day 385|Lost to Follow-up|18
859687|NCT01310413|2738292|P7|Day 0 to Day 385|Withdrawal by Subject|0
859688|NCT01310413|2738293|P6|Day 0 to Day 385|Withdrawal by Subject|1
859689|NCT01310413|2738294|P5|Day 0 to Day 385|Withdrawal by Subject|1
859690|NCT01310413|2738295|P4|Day 0 to Day 385|Withdrawal by Subject|2
859691|NCT01310413|2738296|P3|Day 0 to Day 385|Withdrawal by Subject|0
859692|NCT01310413|2738297|P2|Day 0 to Day 385|Withdrawal by Subject|2
859693|NCT01310413|2738298|P1|Day 0 to Day 385|Withdrawal by Subject|5
859696|NCT01310777|2738478|P3|Overall Study|Other|2
859697|NCT01310777|2738479|P2|Overall Study|Other|1
859698|NCT01310777|2738480|P1|Overall Study|Other|4
859699|NCT01310777|2738478|P3|Overall Study|Inadequate Control of IOP|10
859700|NCT01310777|2738479|P2|Overall Study|Inadequate Control of IOP|7
859701|NCT01310777|2738480|P1|Overall Study|Inadequate Control of IOP|5
859702|NCT01310777|2738478|P3|Overall Study|Patient's Decision Unrelated to AE|2
859703|NCT01310777|2738479|P2|Overall Study|Patient's Decision Unrelated to AE|1
859704|NCT01310777|2738480|P1|Overall Study|Patient's Decision Unrelated to AE|1
859705|NCT01310777|2738478|P3|Overall Study|Lost to Follow-up|1
859706|NCT01310777|2738479|P2|Overall Study|Lost to Follow-up|4
859707|NCT01310777|2738480|P1|Overall Study|Lost to Follow-up|0
859708|NCT01310777|2738478|P3|Overall Study|Adverse Event|15
859709|NCT01310777|2738479|P2|Overall Study|Adverse Event|1
859710|NCT01310777|2738480|P1|Overall Study|Adverse Event|23
859711|NCT01310803|2738490|P2|Overall Study|Subject terminated by Sponsor|0
859712|NCT01310803|2738491|P1|Overall Study|Subject terminated by Sponsor|1
859713|NCT01310868|2738508|P1|Overall Study|Do not have histologically confirmed GBM|13
859716|NCT01311505|2738549|P2|First Intervention Period|Protocol Violation|1
859717|NCT01311505|2738550|P1|First Intervention Period|Protocol Violation|0
859718|NCT01311557|2738580|P2|Overall Study|Withdrawal by Subject|2
859719|NCT01311557|2738581|P1|Overall Study|Withdrawal by Subject|1
859720|NCT01311557|2738580|P2|Overall Study|Lost to Follow-up|1
859721|NCT01311557|2738581|P1|Overall Study|Lost to Follow-up|0
859722|NCT01311557|2738580|P2|Overall Study|Protocol Violation|2
859723|NCT01311557|2738581|P1|Overall Study|Protocol Violation|4
859724|NCT01311557|2738580|P2|Overall Study|Serious adverse event|1
859725|NCT01311557|2738581|P1|Overall Study|Serious adverse event|0
859726|NCT01311661|2738597|P1|Overall Study|Withdrawal by Subject|2
859727|NCT01311661|2738597|P1|Overall Study|Protocol Violation|3
859728|NCT01311661|2738597|P1|Overall Study|Adverse Event|2
894984|NCT01169350|2841200|P1|Overall Study|Lost to Follow-up|2
894985|NCT01169350|2841200|P1|Overall Study|Physician Decision|3
859733|NCT01305564|2738801|P1|Overall Study|Physician Decision|3
859734|NCT01305564|2738801|P1|Overall Study|Withdrawal by Subject|1
859735|NCT01305564|2738801|P1|Overall Study|Lost to Follow-up|12
859736|NCT01305564|2738801|P1|Overall Study|Death|21
859737|NCT01305577|2738819|P3|Overall Study|Protocol Deviation|1
859738|NCT01305577|2738820|P2|Overall Study|Protocol Deviation|1
859739|NCT01305577|2738821|P1|Overall Study|Protocol Deviation|0
859740|NCT01305577|2738819|P3|Overall Study|Lost to Follow-up|2
859741|NCT01305577|2738820|P2|Overall Study|Lost to Follow-up|3
859742|NCT01305577|2738821|P1|Overall Study|Lost to Follow-up|4
859743|NCT01305577|2738819|P3|Overall Study|Withdrawal by Subject|6
859744|NCT01305577|2738820|P2|Overall Study|Withdrawal by Subject|5
859745|NCT01305577|2738821|P1|Overall Study|Withdrawal by Subject|7
859746|NCT01305577|2738819|P3|Overall Study|Adverse Event|1
859747|NCT01305577|2738820|P2|Overall Study|Adverse Event|2
859748|NCT01305577|2738821|P1|Overall Study|Adverse Event|2
859749|NCT01306032|2738881|P6|Disease Progression/Crossover|other/symptomatic progression|0
859750|NCT01306032|2738882|P5|Disease Progression/Crossover|other/symptomatic progression|0
859751|NCT01306032|2738883|P4|Disease Progression/Crossover|other/symptomatic progression|2
859752|NCT01306032|2738884|P3|Disease Progression/Crossover|other/symptomatic progression|0
859753|NCT01306032|2738885|P2|Disease Progression/Crossover|other/symptomatic progression|2
859754|NCT01306032|2738886|P1|Disease Progression/Crossover|other/symptomatic progression|0
859755|NCT01306032|2738881|P6|Disease Progression/Crossover|Withdrawal by Subject|0
859756|NCT01306032|2738882|P5|Disease Progression/Crossover|Withdrawal by Subject|0
859757|NCT01306032|2738883|P4|Disease Progression/Crossover|Withdrawal by Subject|1
859758|NCT01306032|2738884|P3|Disease Progression/Crossover|Withdrawal by Subject|0
859759|NCT01306032|2738885|P2|Disease Progression/Crossover|Withdrawal by Subject|0
859760|NCT01306032|2738886|P1|Disease Progression/Crossover|Withdrawal by Subject|0
859761|NCT01306032|2738881|P6|First Intervention|Progressive disease|0
859762|NCT01306032|2738882|P5|First Intervention|Progressive disease|2
859763|NCT01306032|2738883|P4|First Intervention|Progressive disease|0
859764|NCT01306032|2738884|P3|First Intervention|Progressive disease|0
859765|NCT01306032|2738885|P2|First Intervention|Progressive disease|0
859766|NCT01306032|2738886|P1|First Intervention|Progressive disease|0
859767|NCT01306032|2738881|P6|First Intervention|Ineligible|1
859768|NCT01306032|2738882|P5|First Intervention|Ineligible|0
859769|NCT01306032|2738883|P4|First Intervention|Ineligible|0
859770|NCT01306032|2738884|P3|First Intervention|Ineligible|0
859771|NCT01306032|2738885|P2|First Intervention|Ineligible|0
859772|NCT01306032|2738886|P1|First Intervention|Ineligible|0
859773|NCT01306032|2738881|P6|First Intervention|Death|0
859774|NCT01306032|2738882|P5|First Intervention|Death|0
859775|NCT01306032|2738883|P4|First Intervention|Death|0
859776|NCT01306032|2738884|P3|First Intervention|Death|1
859777|NCT01306032|2738885|P2|First Intervention|Death|0
859778|NCT01306032|2738886|P1|First Intervention|Death|0
859779|NCT01306032|2738881|P6|First Intervention|Withdrawal by Subject|0
859780|NCT01306032|2738882|P5|First Intervention|Withdrawal by Subject|0
859781|NCT01306032|2738883|P4|First Intervention|Withdrawal by Subject|1
859782|NCT01306032|2738884|P3|First Intervention|Withdrawal by Subject|0
859783|NCT01306032|2738885|P2|First Intervention|Withdrawal by Subject|2
859784|NCT01306032|2738886|P1|First Intervention|Withdrawal by Subject|0
859785|NCT01306032|2738881|P6|First Intervention|Adverse Event|1
859786|NCT01306032|2738882|P5|First Intervention|Adverse Event|0
859787|NCT01306032|2738883|P4|First Intervention|Adverse Event|0
859788|NCT01306032|2738884|P3|First Intervention|Adverse Event|1
859789|NCT01306032|2738885|P2|First Intervention|Adverse Event|0
859790|NCT01306032|2738886|P1|First Intervention|Adverse Event|1
859791|NCT01306162|2738942|P4|Washout 1|Non-compliance to protocol|0
859792|NCT01306162|2738943|P3|Washout 1|Non-compliance to protocol|0
859793|NCT01306162|2738944|P2|Washout 1|Non-compliance to protocol|1
859794|NCT01306162|2738945|P1|Washout 1|Non-compliance to protocol|0
859795|NCT01306162|2738942|P4|Period 1|Adverse Event|1
859796|NCT01306162|2738943|P3|Period 1|Adverse Event|0
859797|NCT01306162|2738944|P2|Period 1|Adverse Event|0
859798|NCT01306162|2738945|P1|Period 1|Adverse Event|0
859799|NCT01306201|2738983|P1|Overall Study|Files unreadable|3
859800|NCT01306201|2738983|P1|Overall Study|Files could not be processed|3
859801|NCT01306201|2738983|P1|Overall Study|Arrhythmia|4
859802|NCT01312129|2738993|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
859803|NCT01312129|2738994|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
859804|NCT01313624|2739021|P2|Open-Label Phase|Lost to Follow-up|1
859805|NCT01313624|2739022|P1|Open-Label Phase|Lost to Follow-up|1
859806|NCT01313624|2739021|P2|Open-Label Phase|Withdrawal by Subject|2
859807|NCT01313624|2739022|P1|Open-Label Phase|Withdrawal by Subject|2
859808|NCT01313624|2739021|P2|Open-Label Phase|Adverse Event|10
859809|NCT01313624|2739022|P1|Open-Label Phase|Adverse Event|1
859810|NCT01313624|2739021|P2|Double-Blind Phase|Lack of Efficacy|0
859811|NCT01313624|2739022|P1|Double-Blind Phase|Lack of Efficacy|1
859812|NCT01313624|2739021|P2|Double-Blind Phase|Physician Decision|0
859813|NCT01313624|2739022|P1|Double-Blind Phase|Physician Decision|1
859814|NCT01313624|2739021|P2|Double-Blind Phase|Lost to Follow-up|2
859815|NCT01313624|2739022|P1|Double-Blind Phase|Lost to Follow-up|0
859816|NCT01313624|2739021|P2|Double-Blind Phase|Withdrawal by Subject|4
859817|NCT01313624|2739022|P1|Double-Blind Phase|Withdrawal by Subject|9
859818|NCT01313624|2739021|P2|Double-Blind Phase|Adverse Event|4
859819|NCT01313624|2739022|P1|Double-Blind Phase|Adverse Event|27
859844|NCT01313650|2739067|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
859845|NCT01313650|2739068|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
859846|NCT01313650|2739069|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
859847|NCT01313650|2739070|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
859848|NCT01313650|2739067|P4|Overall Study|Protocol Violation|6
859849|NCT01313650|2739068|P3|Overall Study|Protocol Violation|5
859850|NCT01313650|2739069|P2|Overall Study|Protocol Violation|7
859851|NCT01313650|2739070|P1|Overall Study|Protocol Violation|4
859852|NCT01313650|2739067|P4|Overall Study|Withdrawal by Subject|15
859853|NCT01313650|2739068|P3|Overall Study|Withdrawal by Subject|15
859854|NCT01313650|2739069|P2|Overall Study|Withdrawal by Subject|20
859855|NCT01313650|2739070|P1|Overall Study|Withdrawal by Subject|16
859856|NCT01313650|2739067|P4|Overall Study|Lost to Follow-up|2
859857|NCT01313650|2739068|P3|Overall Study|Lost to Follow-up|3
859858|NCT01313650|2739069|P2|Overall Study|Lost to Follow-up|0
859859|NCT01313650|2739070|P1|Overall Study|Lost to Follow-up|1
859860|NCT01313650|2739067|P4|Overall Study|Lack of Efficacy|20
859861|NCT01313650|2739068|P3|Overall Study|Lack of Efficacy|32
859862|NCT01313650|2739069|P2|Overall Study|Lack of Efficacy|20
859863|NCT01313650|2739070|P1|Overall Study|Lack of Efficacy|37
859864|NCT01313650|2739067|P4|Overall Study|Adverse Event|23
859865|NCT01313650|2739068|P3|Overall Study|Adverse Event|24
859866|NCT01313650|2739069|P2|Overall Study|Adverse Event|34
859867|NCT01313650|2739070|P1|Overall Study|Adverse Event|9
859868|NCT01313663|2739094|P2|Overall Study|Withdrawal by Subject|1
859869|NCT01313663|2739095|P1|Overall Study|Withdrawal by Subject|2
859870|NCT01313663|2739094|P2|Overall Study|Physician Decision|2
859871|NCT01313663|2739095|P1|Overall Study|Physician Decision|0
859872|NCT01313663|2739094|P2|Overall Study|Lost to Follow-up|1
859873|NCT01313663|2739095|P1|Overall Study|Lost to Follow-up|0
859874|NCT01313663|2739094|P2|Overall Study|Study Closed/Terminated|4
859875|NCT01313663|2739095|P1|Overall Study|Study Closed/Terminated|2
895030|NCT01032200|2841367|P2|Overall Study|Multiple|1
895031|NCT01032200|2841368|P1|Overall Study|Multiple|1
895032|NCT01032200|2841367|P2|Overall Study|Progression|0
895033|NCT01032200|2841368|P1|Overall Study|Progression|1
895034|NCT01032200|2841367|P2|Overall Study|Toxicity|2
895035|NCT01032200|2841368|P1|Overall Study|Toxicity|0
895036|NCT01032200|2841367|P2|Overall Study|Withdrawal by Subject|3
895037|NCT01032200|2841368|P1|Overall Study|Withdrawal by Subject|1
895038|NCT01032200|2841367|P2|Overall Study|Death|1
895039|NCT01032200|2841368|P1|Overall Study|Death|1
895040|NCT01006707|2841382|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
895041|NCT01006707|2841383|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
895042|NCT01006707|2841384|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
895043|NCT01006707|2841382|P3|Study Session 1|Lost to Follow-up|0
895044|NCT01006707|2841383|P2|Study Session 1|Lost to Follow-up|0
895045|NCT01006707|2841384|P1|Study Session 1|Lost to Follow-up|2
895046|NCT00965146|2841410|P1|Overall Study|Overall Study Termination|145
895047|NCT00965146|2841410|P1|Overall Study|Revision / Removal of Study Implant|6
895048|NCT00965146|2841410|P1|Overall Study|Intercurrent illness|1
895049|NCT00965146|2841410|P1|Overall Study|Unwilling to return|11
895050|NCT00965146|2841410|P1|Overall Study|Unable to return|1
895051|NCT00965146|2841410|P1|Overall Study|Withdrawal by Subject|17
895052|NCT00965146|2841410|P1|Overall Study|Lost to Follow-up|22
895053|NCT00965146|2841410|P1|Overall Study|Death|7
859920|NCT01313689|2739156|P4|24-Week Randomization 2|Withdrawal by Subject|1
859921|NCT01313689|2739157|P3|24-Week Randomization 2|Withdrawal by Subject|1
859922|NCT01313689|2739158|P2|24-Week Randomization 2|Withdrawal by Subject|0
859923|NCT01313689|2739159|P1|24-Week Randomization 2|Withdrawal by Subject|0
859924|NCT01313689|2739156|P4|24-Week Randomization 2|Adverse Event|0
859925|NCT01313689|2739157|P3|24-Week Randomization 2|Adverse Event|2
859926|NCT01313689|2739158|P2|24-Week Randomization 2|Adverse Event|0
859927|NCT01313689|2739159|P1|24-Week Randomization 2|Adverse Event|0
859928|NCT01313689|2739156|P4|24-Week Randomization 1|Withdrawal by Subject|0
859929|NCT01313689|2739157|P3|24-Week Randomization 1|Withdrawal by Subject|0
859930|NCT01313689|2739158|P2|24-Week Randomization 1|Withdrawal by Subject|0
859931|NCT01313689|2739159|P1|24-Week Randomization 1|Withdrawal by Subject|5
859932|NCT01313689|2739156|P4|24-Week Randomization 1|Physician Decision|0
859933|NCT01313689|2739157|P3|24-Week Randomization 1|Physician Decision|0
859934|NCT01313689|2739158|P2|24-Week Randomization 1|Physician Decision|5
859935|NCT01313689|2739159|P1|24-Week Randomization 1|Physician Decision|4
859936|NCT01313689|2739156|P4|24-Week Randomization 1|Adverse Event|0
859937|NCT01313689|2739157|P3|24-Week Randomization 1|Adverse Event|0
859938|NCT01313689|2739158|P2|24-Week Randomization 1|Adverse Event|5
859939|NCT01313689|2739159|P1|24-Week Randomization 1|Adverse Event|10
859940|NCT01313728|2739222|P1|Informed Consent to Baseline|Withdrawal by Subject|1
859941|NCT01313780|2739239|P2|Overall Study|missing data|3
859942|NCT01313780|2739240|P1|Overall Study|missing data|3
859943|NCT01313780|2739239|P2|Overall Study|Protocol Violation|4
859944|NCT01313780|2739240|P1|Overall Study|Protocol Violation|10
859945|NCT01313780|2739239|P2|Overall Study|Withdrawal by Subject|8
859946|NCT01313780|2739240|P1|Overall Study|Withdrawal by Subject|2
859947|NCT01313780|2739239|P2|Overall Study|Adverse Event|11
859948|NCT01313780|2739240|P1|Overall Study|Adverse Event|6
859949|NCT01313780|2739239|P2|Overall Study|Lack of Efficacy|2
859950|NCT01313780|2739240|P1|Overall Study|Lack of Efficacy|4
859951|NCT01313858|2739251|P3|Overall Study|Lost to Follow-up|47
859952|NCT01313858|2739252|P2|Overall Study|Lost to Follow-up|51
859953|NCT01313858|2739253|P1|Overall Study|Lost to Follow-up|35
859954|NCT01313858|2739251|P3|Overall Study|Premature Treatment Termination|191
859955|NCT01313858|2739252|P2|Overall Study|Premature Treatment Termination|219
859956|NCT01313858|2739253|P1|Overall Study|Premature Treatment Termination|251
859958|NCT01313923|2739290|P1|Overall Study|Physician Decision|3
859959|NCT01314105|2739367|P2|Overall Study|Progressive Disease|4
859960|NCT01314105|2739368|P1|Overall Study|Progressive Disease|6
895064|NCT00891527|2841441|P1|Overall Study|Withdrawal by Subject|2
859969|NCT01314261|2739401|P4|Overall Study|Virologic Failure|1
859970|NCT01314261|2739402|P3|Overall Study|Virologic Failure|0
859971|NCT01314261|2739403|P2|Overall Study|Virologic Failure|1
859972|NCT01314261|2739404|P1|Overall Study|Virologic Failure|0
859973|NCT01314261|2739401|P4|Overall Study|Lost to Follow-up|2
859974|NCT01314261|2739402|P3|Overall Study|Lost to Follow-up|2
859975|NCT01314261|2739403|P2|Overall Study|Lost to Follow-up|0
859976|NCT01314261|2739404|P1|Overall Study|Lost to Follow-up|1
859977|NCT01314261|2739401|P4|Overall Study|Withdrawal by Subject|0
859978|NCT01314261|2739402|P3|Overall Study|Withdrawal by Subject|1
859979|NCT01314261|2739403|P2|Overall Study|Withdrawal by Subject|3
859980|NCT01314261|2739404|P1|Overall Study|Withdrawal by Subject|0
859981|NCT01314261|2739401|P4|Overall Study|Adverse Event|0
859982|NCT01314261|2739402|P3|Overall Study|Adverse Event|0
859983|NCT01314261|2739403|P2|Overall Study|Adverse Event|0
859984|NCT01314261|2739404|P1|Overall Study|Adverse Event|1
859985|NCT01314443|2739486|P4|Overall Study|Protocol Violation|1
859986|NCT01314443|2739487|P3|Overall Study|Protocol Violation|1
859987|NCT01314443|2739488|P2|Overall Study|Protocol Violation|2
859988|NCT01314443|2739489|P1|Overall Study|Protocol Violation|2
859989|NCT01314443|2739486|P4|Overall Study|Withdrawal by Subject|1
859990|NCT01314443|2739487|P3|Overall Study|Withdrawal by Subject|1
859991|NCT01314443|2739488|P2|Overall Study|Withdrawal by Subject|1
859992|NCT01314443|2739489|P1|Overall Study|Withdrawal by Subject|2
859993|NCT01314703|2739507|P1|Overall Study|screen failure and closed enrollment|8
859994|NCT01314716|2739514|P2|Open-Label Phase|Physician Decision|4
859995|NCT01314716|2739515|P1|Open-Label Phase|Physician Decision|5
859996|NCT01314716|2739514|P2|Open-Label Phase|Withdrawal by Subject|2
859997|NCT01314716|2739515|P1|Open-Label Phase|Withdrawal by Subject|1
859998|NCT01314716|2739514|P2|Open-Label Phase|Adverse Event|6
859999|NCT01314716|2739515|P1|Open-Label Phase|Adverse Event|4
860000|NCT01314716|2739514|P2|Double-Blind Phase|Physician Decision|1
860001|NCT01314716|2739515|P1|Double-Blind Phase|Physician Decision|0
860002|NCT01314716|2739514|P2|Double-Blind Phase|Sponsor request|2
860003|NCT01314716|2739515|P1|Double-Blind Phase|Sponsor request|1
860004|NCT01314716|2739514|P2|Double-Blind Phase|Lost to Follow-up|1
860005|NCT01314716|2739515|P1|Double-Blind Phase|Lost to Follow-up|0
860006|NCT01314716|2739514|P2|Double-Blind Phase|Withdrawal by Subject|6
860007|NCT01314716|2739515|P1|Double-Blind Phase|Withdrawal by Subject|5
860008|NCT01314716|2739514|P2|Double-Blind Phase|Adverse Event|4
860009|NCT01314716|2739515|P1|Double-Blind Phase|Adverse Event|10
860010|NCT01314716|2739514|P2|Double-Blind Phase|Randomized but not treated|1
860011|NCT01314716|2739515|P1|Double-Blind Phase|Randomized but not treated|1
860012|NCT01314872|2739549|P15|Period 2|Lost to Follow-up|6
860013|NCT01314872|2739550|P14|Period 2|Lost to Follow-up|2
860014|NCT01314872|2739551|P13|Period 2|Lost to Follow-up|7
860015|NCT01314872|2739552|P12|Period 2|Lost to Follow-up|6
860016|NCT01314872|2739553|P11|Period 2|Lost to Follow-up|0
860017|NCT01314872|2739554|P10|Period 2|Lost to Follow-up|0
860018|NCT01314872|2739555|P9|Period 2|Lost to Follow-up|0
860019|NCT01314872|2739556|P8|Period 2|Lost to Follow-up|0
860020|NCT01314872|2739557|P7|Period 2|Lost to Follow-up|0
860021|NCT01314872|2739558|P6|Period 2|Lost to Follow-up|0
860022|NCT01314872|2739559|P5|Period 2|Lost to Follow-up|0
860023|NCT01314872|2739560|P4|Period 2|Lost to Follow-up|0
860024|NCT01314872|2739561|P3|Period 2|Lost to Follow-up|0
860025|NCT01314872|2739562|P2|Period 2|Lost to Follow-up|0
860026|NCT01314872|2739563|P1|Period 2|Lost to Follow-up|0
860027|NCT01314872|2739549|P15|Period 2|Withdrawal by Subject|4
860028|NCT01314872|2739550|P14|Period 2|Withdrawal by Subject|12
860029|NCT01314872|2739551|P13|Period 2|Withdrawal by Subject|17
860030|NCT01314872|2739552|P12|Period 2|Withdrawal by Subject|14
860031|NCT01314872|2739553|P11|Period 2|Withdrawal by Subject|0
860032|NCT01314872|2739554|P10|Period 2|Withdrawal by Subject|0
860033|NCT01314872|2739555|P9|Period 2|Withdrawal by Subject|0
860034|NCT01314872|2739556|P8|Period 2|Withdrawal by Subject|0
860035|NCT01314872|2739557|P7|Period 2|Withdrawal by Subject|0
860036|NCT01314872|2739558|P6|Period 2|Withdrawal by Subject|0
860037|NCT01314872|2739559|P5|Period 2|Withdrawal by Subject|0
860038|NCT01314872|2739560|P4|Period 2|Withdrawal by Subject|0
860039|NCT01314872|2739561|P3|Period 2|Withdrawal by Subject|0
860040|NCT01314872|2739562|P2|Period 2|Withdrawal by Subject|0
860041|NCT01314872|2739563|P1|Period 2|Withdrawal by Subject|0
860042|NCT01314872|2739549|P15|Period 2|Adverse event, non-fatal|9
860043|NCT01314872|2739550|P14|Period 2|Adverse event, non-fatal|24
860044|NCT01314872|2739551|P13|Period 2|Adverse event, non-fatal|16
860045|NCT01314872|2739552|P12|Period 2|Adverse event, non-fatal|13
860046|NCT01314872|2739553|P11|Period 2|Adverse event, non-fatal|0
860047|NCT01314872|2739554|P10|Period 2|Adverse event, non-fatal|0
860048|NCT01314872|2739555|P9|Period 2|Adverse event, non-fatal|0
860049|NCT01314872|2739556|P8|Period 2|Adverse event, non-fatal|0
860050|NCT01314872|2739557|P7|Period 2|Adverse event, non-fatal|0
860051|NCT01314872|2739558|P6|Period 2|Adverse event, non-fatal|0
860052|NCT01314872|2739559|P5|Period 2|Adverse event, non-fatal|0
860053|NCT01314872|2739560|P4|Period 2|Adverse event, non-fatal|0
860054|NCT01314872|2739561|P3|Period 2|Adverse event, non-fatal|0
860055|NCT01314872|2739562|P2|Period 2|Adverse event, non-fatal|0
860056|NCT01314872|2739563|P1|Period 2|Adverse event, non-fatal|0
860057|NCT01314872|2739549|P15|Period 2|Study terminated by Sponsor|0
860058|NCT01314872|2739550|P14|Period 2|Study terminated by Sponsor|3
860059|NCT01314872|2739551|P13|Period 2|Study terminated by Sponsor|2
860060|NCT01314872|2739552|P12|Period 2|Study terminated by Sponsor|2
860061|NCT01314872|2739553|P11|Period 2|Study terminated by Sponsor|0
860062|NCT01314872|2739554|P10|Period 2|Study terminated by Sponsor|0
860063|NCT01314872|2739555|P9|Period 2|Study terminated by Sponsor|0
860064|NCT01314872|2739556|P8|Period 2|Study terminated by Sponsor|0
860065|NCT01314872|2739557|P7|Period 2|Study terminated by Sponsor|0
860066|NCT01314872|2739558|P6|Period 2|Study terminated by Sponsor|0
860067|NCT01314872|2739559|P5|Period 2|Study terminated by Sponsor|0
860068|NCT01314872|2739560|P4|Period 2|Study terminated by Sponsor|0
860069|NCT01314872|2739561|P3|Period 2|Study terminated by Sponsor|0
860070|NCT01314872|2739562|P2|Period 2|Study terminated by Sponsor|0
860071|NCT01314872|2739563|P1|Period 2|Study terminated by Sponsor|0
860072|NCT01314872|2739549|P15|Period 2|Pregnancy|1
860073|NCT01314872|2739550|P14|Period 2|Pregnancy|0
860074|NCT01314872|2739551|P13|Period 2|Pregnancy|0
860075|NCT01314872|2739552|P12|Period 2|Pregnancy|0
860076|NCT01314872|2739553|P11|Period 2|Pregnancy|0
860077|NCT01314872|2739554|P10|Period 2|Pregnancy|0
860078|NCT01314872|2739555|P9|Period 2|Pregnancy|0
860079|NCT01314872|2739556|P8|Period 2|Pregnancy|0
860080|NCT01314872|2739557|P7|Period 2|Pregnancy|0
860081|NCT01314872|2739558|P6|Period 2|Pregnancy|0
860082|NCT01314872|2739559|P5|Period 2|Pregnancy|0
860083|NCT01314872|2739560|P4|Period 2|Pregnancy|0
860084|NCT01314872|2739561|P3|Period 2|Pregnancy|0
860085|NCT01314872|2739562|P2|Period 2|Pregnancy|0
860086|NCT01314872|2739563|P1|Period 2|Pregnancy|0
860087|NCT01314872|2739549|P15|Period 2|Lack of Efficacy|2
860088|NCT01314872|2739550|P14|Period 2|Lack of Efficacy|9
860089|NCT01314872|2739551|P13|Period 2|Lack of Efficacy|12
860090|NCT01314872|2739552|P12|Period 2|Lack of Efficacy|7
860091|NCT01314872|2739553|P11|Period 2|Lack of Efficacy|0
860092|NCT01314872|2739554|P10|Period 2|Lack of Efficacy|0
860093|NCT01314872|2739555|P9|Period 2|Lack of Efficacy|0
860094|NCT01314872|2739556|P8|Period 2|Lack of Efficacy|0
860095|NCT01314872|2739557|P7|Period 2|Lack of Efficacy|0
860096|NCT01314872|2739558|P6|Period 2|Lack of Efficacy|0
860097|NCT01314872|2739559|P5|Period 2|Lack of Efficacy|0
860098|NCT01314872|2739560|P4|Period 2|Lack of Efficacy|0
860099|NCT01314872|2739561|P3|Period 2|Lack of Efficacy|0
860100|NCT01314872|2739562|P2|Period 2|Lack of Efficacy|0
860101|NCT01314872|2739563|P1|Period 2|Lack of Efficacy|0
860102|NCT01314872|2739549|P15|Period 2|Non-compliance with study drug|2
860103|NCT01314872|2739550|P14|Period 2|Non-compliance with study drug|1
860104|NCT01314872|2739551|P13|Period 2|Non-compliance with study drug|3
860105|NCT01314872|2739552|P12|Period 2|Non-compliance with study drug|3
860106|NCT01314872|2739553|P11|Period 2|Non-compliance with study drug|0
860107|NCT01314872|2739554|P10|Period 2|Non-compliance with study drug|0
860108|NCT01314872|2739555|P9|Period 2|Non-compliance with study drug|0
860109|NCT01314872|2739556|P8|Period 2|Non-compliance with study drug|0
860110|NCT01314872|2739557|P7|Period 2|Non-compliance with study drug|0
860111|NCT01314872|2739558|P6|Period 2|Non-compliance with study drug|0
860112|NCT01314872|2739559|P5|Period 2|Non-compliance with study drug|0
860113|NCT01314872|2739560|P4|Period 2|Non-compliance with study drug|0
860114|NCT01314872|2739561|P3|Period 2|Non-compliance with study drug|0
860115|NCT01314872|2739562|P2|Period 2|Non-compliance with study drug|0
860116|NCT01314872|2739563|P1|Period 2|Non-compliance with study drug|0
860117|NCT01314872|2739549|P15|Period 2|Protocol Violation|0
860118|NCT01314872|2739550|P14|Period 2|Protocol Violation|2
860119|NCT01314872|2739551|P13|Period 2|Protocol Violation|3
860120|NCT01314872|2739552|P12|Period 2|Protocol Violation|3
860121|NCT01314872|2739553|P11|Period 2|Protocol Violation|0
860122|NCT01314872|2739554|P10|Period 2|Protocol Violation|0
860123|NCT01314872|2739555|P9|Period 2|Protocol Violation|0
860124|NCT01314872|2739556|P8|Period 2|Protocol Violation|0
860125|NCT01314872|2739557|P7|Period 2|Protocol Violation|0
860126|NCT01314872|2739558|P6|Period 2|Protocol Violation|0
860127|NCT01314872|2739559|P5|Period 2|Protocol Violation|0
860128|NCT01314872|2739560|P4|Period 2|Protocol Violation|0
860129|NCT01314872|2739561|P3|Period 2|Protocol Violation|0
860130|NCT01314872|2739562|P2|Period 2|Protocol Violation|0
860131|NCT01314872|2739563|P1|Period 2|Protocol Violation|0
860132|NCT01314872|2739549|P15|Treatment Period 1|Lost to Follow-up|0
860133|NCT01314872|2739550|P14|Treatment Period 1|Lost to Follow-up|0
860134|NCT01314872|2739551|P13|Treatment Period 1|Lost to Follow-up|0
860135|NCT01314872|2739552|P12|Treatment Period 1|Lost to Follow-up|0
860136|NCT01314872|2739553|P11|Treatment Period 1|Lost to Follow-up|0
860137|NCT01314872|2739554|P10|Treatment Period 1|Lost to Follow-up|0
860138|NCT01314872|2739555|P9|Treatment Period 1|Lost to Follow-up|1
860139|NCT01314872|2739556|P8|Treatment Period 1|Lost to Follow-up|1
860140|NCT01314872|2739557|P7|Treatment Period 1|Lost to Follow-up|1
860141|NCT01314872|2739558|P6|Treatment Period 1|Lost to Follow-up|1
860142|NCT01314872|2739559|P5|Treatment Period 1|Lost to Follow-up|1
860143|NCT01314872|2739560|P4|Treatment Period 1|Lost to Follow-up|2
860144|NCT01314872|2739561|P3|Treatment Period 1|Lost to Follow-up|2
860145|NCT01314872|2739562|P2|Treatment Period 1|Lost to Follow-up|1
860146|NCT01314872|2739563|P1|Treatment Period 1|Lost to Follow-up|0
860147|NCT01314872|2739549|P15|Treatment Period 1|Withdrawal by Subject|0
860148|NCT01314872|2739550|P14|Treatment Period 1|Withdrawal by Subject|0
860149|NCT01314872|2739551|P13|Treatment Period 1|Withdrawal by Subject|0
860150|NCT01314872|2739552|P12|Treatment Period 1|Withdrawal by Subject|0
860151|NCT01314872|2739553|P11|Treatment Period 1|Withdrawal by Subject|1
860152|NCT01314872|2739554|P10|Treatment Period 1|Withdrawal by Subject|2
860153|NCT01314872|2739555|P9|Treatment Period 1|Withdrawal by Subject|2
860154|NCT01314872|2739556|P8|Treatment Period 1|Withdrawal by Subject|2
860155|NCT01314872|2739557|P7|Treatment Period 1|Withdrawal by Subject|3
860156|NCT01314872|2739558|P6|Treatment Period 1|Withdrawal by Subject|1
860157|NCT01314872|2739559|P5|Treatment Period 1|Withdrawal by Subject|3
860158|NCT01314872|2739560|P4|Treatment Period 1|Withdrawal by Subject|2
860159|NCT01314872|2739561|P3|Treatment Period 1|Withdrawal by Subject|0
860160|NCT01314872|2739562|P2|Treatment Period 1|Withdrawal by Subject|1
860161|NCT01314872|2739563|P1|Treatment Period 1|Withdrawal by Subject|3
860162|NCT01314872|2739549|P15|Treatment Period 1|Adverse event, non-fatal|0
860163|NCT01314872|2739550|P14|Treatment Period 1|Adverse event, non-fatal|0
860164|NCT01314872|2739551|P13|Treatment Period 1|Adverse event, non-fatal|0
860165|NCT01314872|2739552|P12|Treatment Period 1|Adverse event, non-fatal|0
860166|NCT01314872|2739553|P11|Treatment Period 1|Adverse event, non-fatal|1
860167|NCT01314872|2739554|P10|Treatment Period 1|Adverse event, non-fatal|0
860168|NCT01314872|2739555|P9|Treatment Period 1|Adverse event, non-fatal|3
860169|NCT01314872|2739556|P8|Treatment Period 1|Adverse event, non-fatal|2
860170|NCT01314872|2739557|P7|Treatment Period 1|Adverse event, non-fatal|4
860171|NCT01314872|2739558|P6|Treatment Period 1|Adverse event, non-fatal|4
860172|NCT01314872|2739559|P5|Treatment Period 1|Adverse event, non-fatal|2
860173|NCT01314872|2739560|P4|Treatment Period 1|Adverse event, non-fatal|2
860174|NCT01314872|2739561|P3|Treatment Period 1|Adverse event, non-fatal|3
860175|NCT01314872|2739562|P2|Treatment Period 1|Adverse event, non-fatal|2
860176|NCT01314872|2739563|P1|Treatment Period 1|Adverse event, non-fatal|4
860177|NCT01314872|2739549|P15|Treatment Period 1|Lack of Efficacy|0
860178|NCT01314872|2739550|P14|Treatment Period 1|Lack of Efficacy|0
860179|NCT01314872|2739551|P13|Treatment Period 1|Lack of Efficacy|0
860180|NCT01314872|2739552|P12|Treatment Period 1|Lack of Efficacy|0
860181|NCT01314872|2739553|P11|Treatment Period 1|Lack of Efficacy|0
860182|NCT01314872|2739554|P10|Treatment Period 1|Lack of Efficacy|0
860183|NCT01314872|2739555|P9|Treatment Period 1|Lack of Efficacy|0
860184|NCT01314872|2739556|P8|Treatment Period 1|Lack of Efficacy|2
860185|NCT01314872|2739557|P7|Treatment Period 1|Lack of Efficacy|0
860186|NCT01314872|2739558|P6|Treatment Period 1|Lack of Efficacy|1
860187|NCT01314872|2739559|P5|Treatment Period 1|Lack of Efficacy|0
860188|NCT01314872|2739560|P4|Treatment Period 1|Lack of Efficacy|0
860189|NCT01314872|2739561|P3|Treatment Period 1|Lack of Efficacy|0
860190|NCT01314872|2739562|P2|Treatment Period 1|Lack of Efficacy|0
860191|NCT01314872|2739563|P1|Treatment Period 1|Lack of Efficacy|1
860192|NCT01314872|2739549|P15|Treatment Period 1|Physician Decision|0
860193|NCT01314872|2739550|P14|Treatment Period 1|Physician Decision|0
860194|NCT01314872|2739551|P13|Treatment Period 1|Physician Decision|0
860195|NCT01314872|2739552|P12|Treatment Period 1|Physician Decision|0
860196|NCT01314872|2739553|P11|Treatment Period 1|Physician Decision|0
860197|NCT01314872|2739554|P10|Treatment Period 1|Physician Decision|1
860198|NCT01314872|2739555|P9|Treatment Period 1|Physician Decision|0
860199|NCT01314872|2739556|P8|Treatment Period 1|Physician Decision|0
860200|NCT01314872|2739557|P7|Treatment Period 1|Physician Decision|0
860201|NCT01314872|2739558|P6|Treatment Period 1|Physician Decision|0
860202|NCT01314872|2739559|P5|Treatment Period 1|Physician Decision|0
860203|NCT01314872|2739560|P4|Treatment Period 1|Physician Decision|1
860204|NCT01314872|2739561|P3|Treatment Period 1|Physician Decision|0
860205|NCT01314872|2739562|P2|Treatment Period 1|Physician Decision|1
860206|NCT01314872|2739563|P1|Treatment Period 1|Physician Decision|0
860207|NCT01314872|2739549|P15|Treatment Period 1|Protocol Violation|0
860208|NCT01314872|2739550|P14|Treatment Period 1|Protocol Violation|0
860209|NCT01314872|2739551|P13|Treatment Period 1|Protocol Violation|0
860210|NCT01314872|2739552|P12|Treatment Period 1|Protocol Violation|0
860211|NCT01314872|2739553|P11|Treatment Period 1|Protocol Violation|1
860212|NCT01314872|2739554|P10|Treatment Period 1|Protocol Violation|1
860213|NCT01314872|2739555|P9|Treatment Period 1|Protocol Violation|0
860214|NCT01314872|2739556|P8|Treatment Period 1|Protocol Violation|0
860215|NCT01314872|2739557|P7|Treatment Period 1|Protocol Violation|0
860216|NCT01314872|2739558|P6|Treatment Period 1|Protocol Violation|0
860217|NCT01314872|2739559|P5|Treatment Period 1|Protocol Violation|1
860218|NCT01314872|2739560|P4|Treatment Period 1|Protocol Violation|0
860219|NCT01314872|2739561|P3|Treatment Period 1|Protocol Violation|1
860220|NCT01314872|2739562|P2|Treatment Period 1|Protocol Violation|1
860221|NCT01314872|2739563|P1|Treatment Period 1|Protocol Violation|2
860222|NCT01315028|2739663|P2|Overall Study|Death|1
860223|NCT01315028|2739664|P1|Overall Study|Death|0
860224|NCT01315028|2739663|P2|Overall Study|Lost to Follow-up|0
860225|NCT01315028|2739664|P1|Overall Study|Lost to Follow-up|1
860226|NCT01315249|2739712|P2|Overall Study|Death|1
860227|NCT01315249|2739713|P1|Overall Study|Death|0
860228|NCT01315249|2739712|P2|Overall Study|Lost to Follow-up|2
860229|NCT01315249|2739713|P1|Overall Study|Lost to Follow-up|0
860230|NCT01315249|2739712|P2|Overall Study|Lack of Efficacy|1
860231|NCT01315249|2739713|P1|Overall Study|Lack of Efficacy|0
860232|NCT01315249|2739712|P2|Overall Study|inability to use device|0
860233|NCT01315249|2739713|P1|Overall Study|inability to use device|1
860234|NCT01315249|2739712|P2|Overall Study|Administrative problems|0
860235|NCT01315249|2739713|P1|Overall Study|Administrative problems|1
860236|NCT01315249|2739712|P2|Overall Study|Abnormal test results|2
860237|NCT01315249|2739713|P1|Overall Study|Abnormal test results|1
860238|NCT01315249|2739712|P2|Overall Study|Protocol Violation|5
860239|NCT01315249|2739713|P1|Overall Study|Protocol Violation|8
860240|NCT01315249|2739712|P2|Overall Study|Withdrawal by Subject|10
860241|NCT01315249|2739713|P1|Overall Study|Withdrawal by Subject|11
860242|NCT01315249|2739712|P2|Overall Study|Adverse Event|26
860243|NCT01315249|2739713|P1|Overall Study|Adverse Event|22
860244|NCT01315847|2739771|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
860245|NCT01315847|2739772|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
860246|NCT01315847|2739771|P2|Part I, Period 1|Reached maximum number of arterial lines|0
860247|NCT01315847|2739772|P1|Part I, Period 1|Reached maximum number of arterial lines|3
860248|NCT01316055|2739796|P3|Overall Study|Lost to Follow-up|0
860249|NCT01316055|2739797|P2|Overall Study|Lost to Follow-up|0
860250|NCT01316055|2739798|P1|Overall Study|Lost to Follow-up|1
860251|NCT01309100|2739812|P1|Overall Study|Positive Slit lamp finding|1
860252|NCT01309100|2739812|P1|Overall Study|Protocol Violation|1
860253|NCT01309204|2739825|P2|Overall Study|Other|1
860254|NCT01309204|2739826|P1|Overall Study|Other|4
860255|NCT01309204|2739825|P2|Overall Study|Inadequate control of IOP|4
860256|NCT01309204|2739826|P1|Overall Study|Inadequate control of IOP|4
860257|NCT01309204|2739825|P2|Overall Study|Subject's decision unrelated to an AE|10
860258|NCT01309204|2739826|P1|Overall Study|Subject's decision unrelated to an AE|9
860259|NCT01309204|2739825|P2|Overall Study|Lost to Follow-up|2
860260|NCT01309204|2739826|P1|Overall Study|Lost to Follow-up|2
860261|NCT01309204|2739825|P2|Overall Study|Adverse Event|58
860262|NCT01309204|2739826|P1|Overall Study|Adverse Event|48
860263|NCT01309243|2739834|P2|Extension Phase|Lost to Follow-up|0
860264|NCT01309243|2739835|P1|Extension Phase|Lost to Follow-up|6
860265|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Protocol Violation|1
860266|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Protocol Violation|1
860267|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
860268|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
860269|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
860270|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
860271|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Withdrew Consent|18
860272|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Withdrew Consent|12
860273|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Investigators Discretion|6
860274|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Investigators Discretion|3
860275|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
860276|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
860277|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Pregnancy|0
860278|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Pregnancy|2
860279|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Death|1
860280|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Death|0
860281|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Adverse Event|43
860282|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Adverse Event|12
860283|NCT01309243|2739834|P2|Randomized Phase Through Week 96|Randomized but not treated|7
860284|NCT01309243|2739835|P1|Randomized Phase Through Week 96|Randomized but not treated|6
860285|NCT01309269|2739859|P1|Overall Study|Enrolled but not Treated|107
860286|NCT01309269|2739859|P1|Overall Study|Study Completion Data Not Recorded|95
860287|NCT01309269|2739859|P1|Overall Study|Other|1
860288|NCT01309269|2739859|P1|Overall Study|Unspecified|256
860289|NCT01309269|2739859|P1|Overall Study|Administrative Problems|141
860290|NCT01309269|2739859|P1|Overall Study|Kidney Transplant|25
860291|NCT01309269|2739859|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
860292|NCT01309269|2739859|P1|Overall Study|Lack of Acceptance|15
860293|NCT01309269|2739859|P1|Overall Study|Withdrawal by Subject|25
860294|NCT01309269|2739859|P1|Overall Study|Adverse Event|56
860295|NCT01309282|2739865|P1|Overall Study|Lost to Follow-up|1
860296|NCT01309308|2739884|P2|Overall Study|Lost to Follow-up|4
860297|NCT01309308|2739885|P1|Overall Study|Lost to Follow-up|6
860298|NCT01309386|2739923|P2|Overall Study|Adverse Event|8
860299|NCT01309386|2739924|P1|Overall Study|Adverse Event|5
860300|NCT01309386|2739923|P2|Overall Study|Lack of Efficacy|1
860301|NCT01309386|2739924|P1|Overall Study|Lack of Efficacy|3
860302|NCT01309386|2739923|P2|Overall Study|Physician Decision|1
860303|NCT01309386|2739924|P1|Overall Study|Physician Decision|1
860304|NCT01309386|2739923|P2|Overall Study|Progressive disease|11
860305|NCT01309386|2739924|P1|Overall Study|Progressive disease|9
860306|NCT01309386|2739923|P2|Overall Study|Withdrawal by Subject|0
860307|NCT01309386|2739924|P1|Overall Study|Withdrawal by Subject|2
860308|NCT01309386|2739923|P2|Overall Study|Unspecified|0
860309|NCT01309386|2739924|P1|Overall Study|Unspecified|2
860310|NCT01316224|2739953|P1|Overall Study|Not Specified|1
860311|NCT01316224|2739953|P1|Overall Study|Adverse Event With Treatment Failure|1
860312|NCT01316224|2739953|P1|Overall Study|Withdrawal by Subject|1
860313|NCT01316224|2739953|P1|Overall Study|Lack of Efficacy|1
860314|NCT01316224|2739953|P1|Overall Study|Adverse Event|3
860315|NCT01316224|2739953|P1|Overall Study|Protocol Violation|3
860316|NCT01316380|2740098|P3|Overall Study|Not treated|0
860317|NCT01316380|2740099|P2|Overall Study|Not treated|0
860318|NCT01316380|2740100|P1|Overall Study|Not treated|1
860319|NCT01316380|2740098|P3|Overall Study|Other|1
860320|NCT01316380|2740099|P2|Overall Study|Other|1
860321|NCT01316380|2740100|P1|Overall Study|Other|0
860322|NCT01316380|2740098|P3|Overall Study|Withdrawal by Subject|0
860323|NCT01316380|2740099|P2|Overall Study|Withdrawal by Subject|2
860324|NCT01316380|2740100|P1|Overall Study|Withdrawal by Subject|1
860325|NCT01316380|2740098|P3|Overall Study|Protocol Violation|1
860326|NCT01316380|2740099|P2|Overall Study|Protocol Violation|0
860327|NCT01316380|2740100|P1|Overall Study|Protocol Violation|0
860328|NCT01316380|2740098|P3|Overall Study|Adverse Event|1
860329|NCT01316380|2740099|P2|Overall Study|Adverse Event|2
860330|NCT01316380|2740100|P1|Overall Study|Adverse Event|0
860331|NCT01316419|2740138|P1|Overall Study|Lost to Follow-up|19
860332|NCT01316419|2740138|P1|Overall Study|Violated inclusion/exclusion criterion|143
860333|NCT01316419|2740138|P1|Overall Study|Not treated|103
860334|NCT01318499|2740164|P3|Overall Study|Not Specified|22
860335|NCT01318499|2740165|P2|Overall Study|Not Specified|10
860336|NCT01318499|2740166|P1|Overall Study|Not Specified|7
860337|NCT01318499|2740164|P3|Overall Study|Patient Did Not Use Study Medication|14
860338|NCT01318499|2740165|P2|Overall Study|Patient Did Not Use Study Medication|28
860339|NCT01318499|2740166|P1|Overall Study|Patient Did Not Use Study Medication|18
860340|NCT01318499|2740164|P3|Overall Study|Protocol Violation|2
860341|NCT01318499|2740165|P2|Overall Study|Protocol Violation|4
860342|NCT01318499|2740166|P1|Overall Study|Protocol Violation|2
860343|NCT01318499|2740164|P3|Overall Study|Treatment Failure|101
860344|NCT01318499|2740165|P2|Overall Study|Treatment Failure|19
860345|NCT01318499|2740166|P1|Overall Study|Treatment Failure|19
860346|NCT01318499|2740164|P3|Overall Study|Noncompliance|0
860347|NCT01318499|2740165|P2|Overall Study|Noncompliance|3
860348|NCT01318499|2740166|P1|Overall Study|Noncompliance|2
860349|NCT01318499|2740164|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
860350|NCT01318499|2740165|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
860351|NCT01318499|2740166|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
860352|NCT01318499|2740164|P3|Overall Study|Adverse Event|6
860353|NCT01318499|2740165|P2|Overall Study|Adverse Event|11
860354|NCT01318499|2740166|P1|Overall Study|Adverse Event|16
860355|NCT01318512|2740184|P1|Maintenance Period (6 Months)|Protocol Violation|9
860356|NCT01318512|2740184|P1|Maintenance Period (6 Months)|Death|2
860357|NCT01318876|2740293|P1|Day 29 Survey|survey not completed-don't know why|1825
860358|NCT01318876|2740293|P1|Day 8 Survey|survey not completed-don't know why|1724
860359|NCT01318876|2740293|P1|Day 8 Survey|email address invalid|96
860362|NCT01318993|2740307|P1|Overall Study|Withdrawal by Subject|24
860363|NCT01318993|2740307|P1|Overall Study|Physician Decision|13
860364|NCT01318993|2740307|P1|Overall Study|Lost to Follow-up|4
860365|NCT01318993|2740307|P1|Overall Study|Study closed or terminated|174
860366|NCT01318993|2740307|P1|Overall Study|Protocol based stopping criteria|6
860367|NCT01318993|2740307|P1|Overall Study|Protocol Violation|3
860368|NCT01318993|2740307|P1|Overall Study|Lack of Efficacy|121
860369|NCT01318993|2740307|P1|Overall Study|Adverse Event|53
860370|NCT01319383|2740345|P2|Overall Study|No in vivo response to interval doses|1
860371|NCT01319383|2740346|P1|Overall Study|No in vivo response to interval doses|0
860372|NCT01319383|2740345|P2|Overall Study|Lack of Efficacy|9
860373|NCT01319383|2740346|P1|Overall Study|Lack of Efficacy|5
860374|NCT01319383|2740345|P2|Overall Study|Physician Decision|0
860375|NCT01319383|2740346|P1|Overall Study|Physician Decision|3
860376|NCT01319383|2740345|P2|Overall Study|No ex vivo or in vivo response|0
860377|NCT01319383|2740346|P1|Overall Study|No ex vivo or in vivo response|4
860378|NCT01319422|2740369|P2|Overall Study|Withdrawal by Subject|0
860379|NCT01319422|2740370|P1|Overall Study|Withdrawal by Subject|1
860380|NCT01319721|2740423|P2|Overall Study|Lost to Follow-up|6
860381|NCT01319721|2740424|P1|Overall Study|Lost to Follow-up|1
860382|NCT01319877|2740553|P2|Overall Study|Reason Not Specified|5
860383|NCT01319877|2740554|P1|Overall Study|Reason Not Specified|4
860384|NCT01319877|2740553|P2|Overall Study|Withdrawal by Subject|1
860385|NCT01319877|2740554|P1|Overall Study|Withdrawal by Subject|0
860386|NCT01319877|2740553|P2|Overall Study|Disease Progression|2
860387|NCT01319877|2740554|P1|Overall Study|Disease Progression|2
860388|NCT01319877|2740553|P2|Overall Study|Physician Decision|0
860389|NCT01319877|2740554|P1|Overall Study|Physician Decision|2
860390|NCT01319877|2740553|P2|Overall Study|Lost to Follow-up|37
860391|NCT01319877|2740554|P1|Overall Study|Lost to Follow-up|100
860392|NCT01320202|2740618|P2|Overall Study|regained renal function|0
860393|NCT01320202|2740619|P1|Overall Study|regained renal function|1
860394|NCT01320202|2740618|P2|Overall Study|ineligible|0
860395|NCT01320202|2740619|P1|Overall Study|ineligible|3
860396|NCT01320202|2740618|P2|Overall Study|sponsor request|0
860397|NCT01320202|2740619|P1|Overall Study|sponsor request|2
860398|NCT01320202|2740618|P2|Overall Study|moved/changed dialysis|2
860399|NCT01320202|2740619|P1|Overall Study|moved/changed dialysis|5
860400|NCT01320202|2740618|P2|Overall Study|blood transfusion|7
860401|NCT01320202|2740619|P1|Overall Study|blood transfusion|1
860402|NCT01320202|2740618|P2|Overall Study|kidney transplant|2
860403|NCT01320202|2740619|P1|Overall Study|kidney transplant|1
860404|NCT01320202|2740618|P2|Overall Study|non-protocol change to ESA or IV iron|20
860405|NCT01320202|2740619|P1|Overall Study|non-protocol change to ESA or IV iron|17
860406|NCT01320202|2740618|P2|Overall Study|Withdrawal by Subject|3
860407|NCT01320202|2740619|P1|Overall Study|Withdrawal by Subject|10
860408|NCT01320202|2740618|P2|Overall Study|Protocol Violation|1
860409|NCT01320202|2740619|P1|Overall Study|Protocol Violation|2
860410|NCT01320202|2740618|P2|Overall Study|Physician Decision|1
860411|NCT01320202|2740619|P1|Overall Study|Physician Decision|3
860412|NCT01320202|2740618|P2|Overall Study|Lost to Follow-up|0
860413|NCT01320202|2740619|P1|Overall Study|Lost to Follow-up|1
860414|NCT01320202|2740618|P2|Overall Study|Death|3
860415|NCT01320202|2740619|P1|Overall Study|Death|5
860416|NCT01320202|2740618|P2|Overall Study|Adverse Event|5
860417|NCT01320202|2740619|P1|Overall Study|Adverse Event|5
860418|NCT01320293|2740654|P1|Overall Study|Adverse Event|1
860419|NCT01320293|2740654|P1|Overall Study|Lack of Efficacy|1
860420|NCT01320683|2740681|P1|Overall Study|Positive antibody response|1
860421|NCT01320722|2740691|P5|Overall Study|Withdrew due to Health Condition|1
860422|NCT01320722|2740692|P4|Overall Study|Withdrew due to Health Condition|0
860423|NCT01320722|2740693|P3|Overall Study|Withdrew due to Health Condition|0
860424|NCT01320722|2740694|P2|Overall Study|Withdrew due to Health Condition|0
860425|NCT01320722|2740695|P1|Overall Study|Withdrew due to Health Condition|0
860426|NCT01320722|2740691|P5|Overall Study|Started an Exclusionary Medication|1
860427|NCT01320722|2740692|P4|Overall Study|Started an Exclusionary Medication|0
860428|NCT01320722|2740693|P3|Overall Study|Started an Exclusionary Medication|0
860429|NCT01320722|2740694|P2|Overall Study|Started an Exclusionary Medication|0
860430|NCT01320722|2740695|P1|Overall Study|Started an Exclusionary Medication|0
860431|NCT01320722|2740691|P5|Overall Study|Pregnancy|0
860432|NCT01320722|2740692|P4|Overall Study|Pregnancy|1
860433|NCT01320722|2740693|P3|Overall Study|Pregnancy|0
860434|NCT01320722|2740694|P2|Overall Study|Pregnancy|0
860435|NCT01320722|2740695|P1|Overall Study|Pregnancy|0
860436|NCT01320722|2740691|P5|Overall Study|Not Compliant with Study Procedures|0
860437|NCT01320722|2740692|P4|Overall Study|Not Compliant with Study Procedures|4
860438|NCT01320722|2740693|P3|Overall Study|Not Compliant with Study Procedures|0
860439|NCT01320722|2740694|P2|Overall Study|Not Compliant with Study Procedures|0
860440|NCT01320722|2740695|P1|Overall Study|Not Compliant with Study Procedures|0
860441|NCT01320722|2740691|P5|Overall Study|Adverse Event|0
860442|NCT01320722|2740692|P4|Overall Study|Adverse Event|6
860443|NCT01320722|2740693|P3|Overall Study|Adverse Event|3
860444|NCT01320722|2740694|P2|Overall Study|Adverse Event|0
860445|NCT01320722|2740695|P1|Overall Study|Adverse Event|0
860446|NCT01320722|2740691|P5|Overall Study|Non-compliant with Medication|0
860447|NCT01320722|2740692|P4|Overall Study|Non-compliant with Medication|0
860448|NCT01320722|2740693|P3|Overall Study|Non-compliant with Medication|1
860449|NCT01320722|2740694|P2|Overall Study|Non-compliant with Medication|0
860450|NCT01320722|2740695|P1|Overall Study|Non-compliant with Medication|0
860451|NCT01320722|2740691|P5|Overall Study|Participant Developed a Rash|1
860452|NCT01320722|2740692|P4|Overall Study|Participant Developed a Rash|1
860453|NCT01320722|2740693|P3|Overall Study|Participant Developed a Rash|2
860454|NCT01320722|2740694|P2|Overall Study|Participant Developed a Rash|0
860455|NCT01320722|2740695|P1|Overall Study|Participant Developed a Rash|0
860456|NCT01320722|2740691|P5|Overall Study|Not Available for the 8 Week Visit|0
860457|NCT01320722|2740692|P4|Overall Study|Not Available for the 8 Week Visit|0
860458|NCT01320722|2740693|P3|Overall Study|Not Available for the 8 Week Visit|0
860459|NCT01320722|2740694|P2|Overall Study|Not Available for the 8 Week Visit|3
860460|NCT01320722|2740695|P1|Overall Study|Not Available for the 8 Week Visit|0
860461|NCT01320722|2740691|P5|Overall Study|Lost to Follow-up|3
860462|NCT01320722|2740692|P4|Overall Study|Lost to Follow-up|1
860463|NCT01320722|2740693|P3|Overall Study|Lost to Follow-up|0
860464|NCT01320722|2740694|P2|Overall Study|Lost to Follow-up|1
860465|NCT01320722|2740695|P1|Overall Study|Lost to Follow-up|0
860466|NCT01320722|2740691|P5|Overall Study|Did not Receive Intervention|2
860467|NCT01320722|2740692|P4|Overall Study|Did not Receive Intervention|1
860468|NCT01320722|2740693|P3|Overall Study|Did not Receive Intervention|1
860469|NCT01320722|2740694|P2|Overall Study|Did not Receive Intervention|2
860470|NCT01320722|2740695|P1|Overall Study|Did not Receive Intervention|3
860471|NCT01320735|2740732|P1|Overall Study|Investigator Unable to be Contacted|17
860472|NCT01320735|2740732|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
860473|NCT01320735|2740732|P1|Overall Study|Not Specified|1
860474|NCT01320735|2740732|P1|Overall Study|Protocol Violation|1
860475|NCT01320735|2740732|P1|Overall Study|Progression/Hormone-Refractory Pca|55
860476|NCT01320735|2740732|P1|Overall Study|Administrative Reason|6
860477|NCT01320735|2740732|P1|Overall Study|Lost to Follow-up|13
860478|NCT01320735|2740732|P1|Overall Study|Withdrawal by Subject|3
860479|NCT01320735|2740732|P1|Overall Study|Adverse Event|3
860482|NCT01312467|2740773|P1|Overall Study|Ineligible|4
860483|NCT01312467|2740773|P1|Overall Study|Another medical condition|1
860484|NCT01312467|2740773|P1|Overall Study|Deported to country of origin|1
860485|NCT01312467|2740773|P1|Overall Study|Withdrawal by Subject|2
860486|NCT01312467|2740773|P1|Overall Study|Lost to Follow-up|1
860487|NCT01312467|2740773|P1|Overall Study|Adverse Event|4
860488|NCT01312961|2740870|P2|Overall Study|Other than specified above|3
860489|NCT01312961|2740871|P1|Overall Study|Other than specified above|2
860490|NCT01312961|2740870|P2|Overall Study|Poor compliance to protocol|0
860491|NCT01312961|2740871|P1|Overall Study|Poor compliance to protocol|1
860492|NCT01312961|2740870|P2|Overall Study|Lack of Efficacy|1
860493|NCT01312961|2740871|P1|Overall Study|Lack of Efficacy|11
860494|NCT01312961|2740870|P2|Overall Study|Adverse Event|3
860495|NCT01312961|2740871|P1|Overall Study|Adverse Event|3
860496|NCT01313039|2740897|P1|Overall Study|Adverse Event|1
860497|NCT01313039|2740897|P1|Overall Study|Physician Decision|1
860498|NCT01313078|2740901|P1|Overall Study|Withdrawal by Subject|1
860499|NCT01313078|2740901|P1|Overall Study|Discontinued study drug|1
860500|NCT01313078|2740901|P1|Overall Study|Death|1
860501|NCT01313117|2740906|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
860502|NCT01313117|2740906|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
860503|NCT01313182|2740915|P2|Overall Study|Protocol Violation|92
860504|NCT01313182|2740916|P1|Overall Study|Protocol Violation|66
860505|NCT01313208|2740924|P2|Open-label Phase (Weeks 13 - 24)|Other|0
860506|NCT01313208|2740925|P1|Open-label Phase (Weeks 13 - 24)|Other|2
860507|NCT01313208|2740924|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
860508|NCT01313208|2740925|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
860509|NCT01313208|2740924|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
860510|NCT01313208|2740925|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
860511|NCT01313208|2740924|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
860596|NCT01323192|2741480|P1|Overall Study|Withdrawal by Subject|3
860512|NCT01313208|2740925|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
860513|NCT01313208|2740924|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
860514|NCT01313208|2740925|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
860515|NCT01313208|2740924|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
860516|NCT01313208|2740925|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
860517|NCT01313208|2740924|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
860518|NCT01313208|2740925|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
860519|NCT01313208|2740924|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
860520|NCT01313208|2740925|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
860521|NCT01313208|2740924|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
860522|NCT01313208|2740925|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
860523|NCT01313221|2741016|P3|Overall Study|Pregnancy|2
860524|NCT01313221|2741017|P2|Overall Study|Pregnancy|0
860525|NCT01313221|2741018|P1|Overall Study|Pregnancy|0
860526|NCT01313221|2741016|P3|Overall Study|Physician Decision|2
860527|NCT01313221|2741017|P2|Overall Study|Physician Decision|0
860528|NCT01313221|2741018|P1|Overall Study|Physician Decision|0
860529|NCT01313221|2741016|P3|Overall Study|Disease progression|2
860530|NCT01313221|2741017|P2|Overall Study|Disease progression|0
860531|NCT01313221|2741018|P1|Overall Study|Disease progression|0
860532|NCT01313221|2741016|P3|Overall Study|Adverse Event|7
860533|NCT01313221|2741017|P2|Overall Study|Adverse Event|0
860534|NCT01313221|2741018|P1|Overall Study|Adverse Event|0
860535|NCT01313221|2741016|P3|Overall Study|Other|0
860536|NCT01313221|2741017|P2|Overall Study|Other|0
860537|NCT01313221|2741018|P1|Overall Study|Other|1
860538|NCT01313221|2741016|P3|Overall Study|Lost to Follow-up|1
860539|NCT01313221|2741017|P2|Overall Study|Lost to Follow-up|3
860540|NCT01313221|2741018|P1|Overall Study|Lost to Follow-up|6
860541|NCT01313221|2741016|P3|Overall Study|Requirement for alternative therapy|1
860542|NCT01313221|2741017|P2|Overall Study|Requirement for alternative therapy|1
860543|NCT01313221|2741018|P1|Overall Study|Requirement for alternative therapy|0
860544|NCT01313221|2741016|P3|Overall Study|Withdrawal by Subject|5
860545|NCT01313221|2741017|P2|Overall Study|Withdrawal by Subject|3
860546|NCT01313221|2741018|P1|Overall Study|Withdrawal by Subject|2
860547|NCT01313221|2741016|P3|Overall Study|Non-compliance|2
860548|NCT01313221|2741017|P2|Overall Study|Non-compliance|0
860549|NCT01313221|2741018|P1|Overall Study|Non-compliance|3
860550|NCT01313221|2741016|P3|Overall Study|Protocol Violation|1
860551|NCT01313221|2741017|P2|Overall Study|Protocol Violation|1
860552|NCT01313221|2741018|P1|Overall Study|Protocol Violation|0
860553|NCT01313273|2741070|P2|Overall Study|Screening Chromogranin A-in normal range|1
860554|NCT01313273|2741071|P1|Overall Study|Screening Chromogranin A-in normal range|0
860555|NCT01313273|2741070|P2|Overall Study|Withdrawal by Subject|0
860556|NCT01313273|2741071|P1|Overall Study|Withdrawal by Subject|1
860557|NCT01313273|2741070|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
860558|NCT01313273|2741071|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
860559|NCT01313299|2741086|P3|Overall Study|Lack of subject compliance|1
860560|NCT01313299|2741087|P2|Overall Study|Lack of subject compliance|0
860561|NCT01313299|2741088|P1|Overall Study|Lack of subject compliance|0
860562|NCT01313299|2741086|P3|Overall Study|Family reason and moved out of state|0
860563|NCT01313299|2741087|P2|Overall Study|Family reason and moved out of state|2
860564|NCT01313299|2741088|P1|Overall Study|Family reason and moved out of state|0
860565|NCT01313299|2741086|P3|Overall Study|Withdrawal by Subject|2
860566|NCT01313299|2741087|P2|Overall Study|Withdrawal by Subject|0
860567|NCT01313299|2741088|P1|Overall Study|Withdrawal by Subject|1
860568|NCT01313299|2741086|P3|Overall Study|Protocol Violation|0
860569|NCT01313299|2741087|P2|Overall Study|Protocol Violation|0
860570|NCT01313299|2741088|P1|Overall Study|Protocol Violation|2
860571|NCT01313299|2741086|P3|Overall Study|Lost to Follow-up|0
860572|NCT01313299|2741087|P2|Overall Study|Lost to Follow-up|0
860573|NCT01313299|2741088|P1|Overall Study|Lost to Follow-up|1
860574|NCT01313299|2741086|P3|Overall Study|Adverse Event|1
860575|NCT01313299|2741087|P2|Overall Study|Adverse Event|1
860576|NCT01313299|2741088|P1|Overall Study|Adverse Event|3
860577|NCT01313312|2741102|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
860578|NCT01313312|2741102|P1|Overall Study|Subject Withdrawn Early in Error|4
860579|NCT01313312|2741102|P1|Overall Study|Observational Phase|1
860580|NCT01313312|2741102|P1|Overall Study|Investigator Decision|1
860581|NCT01313312|2741102|P1|Overall Study|Lack of Efficacy|3
860582|NCT01313312|2741102|P1|Overall Study|Withdrawal by Subject|18
860583|NCT01313312|2741102|P1|Overall Study|Adverse Event|5
860584|NCT01320943|2741232|P2|Overall Study|Randomized but not Treated|1
860585|NCT01320943|2741233|P1|Overall Study|Randomized but not Treated|0
860586|NCT01320943|2741232|P2|Overall Study|Physician Decision|1
860587|NCT01320943|2741233|P1|Overall Study|Physician Decision|0
860588|NCT01320943|2741232|P2|Overall Study|Lost to Follow-up|0
860589|NCT01320943|2741233|P1|Overall Study|Lost to Follow-up|1
860590|NCT01321008|2741252|P1|Overall Study|Early Study Termination|1
860591|NCT01323192|2741479|P2|Overall Study|Nonmedical reasons|1
860592|NCT01323192|2741480|P1|Overall Study|Nonmedical reasons|0
860593|NCT01323192|2741479|P2|Overall Study|Noncompliance with study medication|3
860594|NCT01323192|2741480|P1|Overall Study|Noncompliance with study medication|0
860595|NCT01323192|2741479|P2|Overall Study|Withdrawal by Subject|1
860597|NCT01323192|2741479|P2|Overall Study|Adverse Event|1
860598|NCT01323192|2741480|P1|Overall Study|Adverse Event|6
860599|NCT01323270|2741498|P2|Overall Study|Randomized, but not vaccinated|0
860600|NCT01323270|2741499|P1|Overall Study|Randomized, but not vaccinated|1
860601|NCT01323270|2741498|P2|Overall Study|Death|0
860602|NCT01323270|2741499|P1|Overall Study|Death|1
860603|NCT01323270|2741498|P2|Overall Study|Not eligible|1
860604|NCT01323270|2741499|P1|Overall Study|Not eligible|1
860605|NCT01323270|2741498|P2|Overall Study|Physician Decision|2
860606|NCT01323270|2741499|P1|Overall Study|Physician Decision|0
860607|NCT01323270|2741498|P2|Overall Study|Unspecified|3
860608|NCT01323270|2741499|P1|Overall Study|Unspecified|0
860609|NCT01323270|2741498|P2|Overall Study|Adverse Event|0
860610|NCT01323270|2741499|P1|Overall Study|Adverse Event|8
860611|NCT01323270|2741498|P2|Overall Study|Lost to Follow-up|6
860612|NCT01323270|2741499|P1|Overall Study|Lost to Follow-up|4
860613|NCT01323270|2741498|P2|Overall Study|Protocol Violation|7
860614|NCT01323270|2741499|P1|Overall Study|Protocol Violation|9
860615|NCT01323270|2741498|P2|Overall Study|Withdrawal by Subject|10
860616|NCT01323270|2741499|P1|Overall Study|Withdrawal by Subject|19
895065|NCT00866359|2841449|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
895066|NCT00866359|2841450|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
895067|NCT00866359|2841451|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
895068|NCT00866359|2841452|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
895069|NCT00866359|2841449|P4|Treatment Phase (Days 1 to 85)|Other|0
895070|NCT00866359|2841450|P3|Treatment Phase (Days 1 to 85)|Other|0
860623|NCT01323478|2741530|P1|Overall Study|Administrative or Other Reasons|8
860624|NCT01323478|2741530|P1|Overall Study|Withdrawal of Consent|1
860625|NCT01323478|2741530|P1|Overall Study|Protocol Violation|1
860626|NCT01323478|2741530|P1|Overall Study|Non-compliance With Study Product|3
860627|NCT01323478|2741530|P1|Overall Study|Lack of Efficacy|4
860628|NCT01323478|2741530|P1|Overall Study|Adverse Event|7
860629|NCT01323582|2741545|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
860630|NCT01323582|2741546|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
860631|NCT01323582|2741545|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
860632|NCT01323582|2741546|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
860633|NCT01323582|2741545|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
860634|NCT01323582|2741546|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
860635|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
860636|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
860637|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
860638|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Physician Decision|1
860639|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Physician Decision|2
860640|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Physician Decision|0
860641|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
860642|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
860643|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
860644|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
860645|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
860646|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
860647|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
860648|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
860649|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
860650|NCT01323621|2741573|P3|12-week, Double-blind Treatment Period|Adverse Event|5
860651|NCT01323621|2741574|P2|12-week, Double-blind Treatment Period|Adverse Event|1
860652|NCT01323621|2741575|P1|12-week, Double-blind Treatment Period|Adverse Event|0
860653|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
860654|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
860655|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
860656|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
860657|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
860658|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
860659|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Protocol Violation|0
860660|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Protocol Violation|0
860661|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Protocol Violation|1
860662|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
860663|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
860664|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
860665|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Physician Decision|0
860666|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Physician Decision|0
860667|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Physician Decision|7
860668|NCT01323621|2741573|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
860669|NCT01323621|2741574|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
860670|NCT01323621|2741575|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
895071|NCT00866359|2841451|P2|Treatment Phase (Days 1 to 85)|Other|0
895072|NCT00866359|2841452|P1|Treatment Phase (Days 1 to 85)|Other|1
895073|NCT00866359|2841449|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
895074|NCT00866359|2841450|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
895075|NCT00866359|2841451|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
895076|NCT00866359|2841452|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
895077|NCT00866359|2841449|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
895078|NCT00866359|2841450|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
895079|NCT00866359|2841451|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
895080|NCT00866359|2841452|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
895081|NCT00866359|2841449|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
895082|NCT00866359|2841450|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
895083|NCT00866359|2841451|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
895084|NCT00866359|2841452|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
895085|NCT00866359|2841449|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
895086|NCT00866359|2841450|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
895087|NCT00866359|2841451|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
895088|NCT00866359|2841452|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
895089|NCT00833989|2841513|P4|Overall Study|Withdrawal by Subject|1
895090|NCT00833989|2841514|P3|Overall Study|Withdrawal by Subject|1
895091|NCT00833989|2841515|P2|Overall Study|Withdrawal by Subject|0
895092|NCT00833989|2841516|P1|Overall Study|Withdrawal by Subject|3
895093|NCT00833989|2841513|P4|Overall Study|Physician Decision|1
895094|NCT00833989|2841514|P3|Overall Study|Physician Decision|0
895095|NCT00833989|2841515|P2|Overall Study|Physician Decision|0
895096|NCT00833989|2841516|P1|Overall Study|Physician Decision|0
895097|NCT00753545|2841622|P2|Overall Study|Voluntary Discontinuation of Patient|3
895098|NCT00753545|2841623|P1|Overall Study|Voluntary Discontinuation of Patient|7
895099|NCT00753545|2841622|P2|Overall Study|Protocol Violation|0
895100|NCT00753545|2841623|P1|Overall Study|Protocol Violation|1
895101|NCT00753545|2841622|P2|Overall Study|Lost to Follow-up|3
895102|NCT00753545|2841623|P1|Overall Study|Lost to Follow-up|2
895103|NCT00753545|2841622|P2|Overall Study|Death|112
895104|NCT00753545|2841623|P1|Overall Study|Death|98
860710|NCT01323647|2741597|P2|Overall Study|Lost to Follow-up|0
860711|NCT01323647|2741598|P1|Overall Study|Lost to Follow-up|2
860712|NCT01323647|2741597|P2|Overall Study|Withdrawal by Subject|0
860713|NCT01323647|2741598|P1|Overall Study|Withdrawal by Subject|5
860714|NCT01323647|2741597|P2|Overall Study|Migrated/moved from study area|0
860715|NCT01323647|2741598|P1|Overall Study|Migrated/moved from study area|2
860716|NCT01323660|2741613|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
860717|NCT01323660|2741614|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
860718|NCT01323660|2741615|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
860719|NCT01323660|2741616|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
860720|NCT01323660|2741617|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
860721|NCT01323660|2741618|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
860722|NCT01323660|2741613|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
860723|NCT01323660|2741614|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
860724|NCT01323660|2741615|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
860725|NCT01323660|2741616|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
860726|NCT01323660|2741617|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
860727|NCT01323660|2741618|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
860728|NCT01323660|2741613|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
860729|NCT01323660|2741614|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
860730|NCT01323660|2741615|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
860731|NCT01323660|2741616|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
860732|NCT01323660|2741617|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
860733|NCT01323660|2741618|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
860734|NCT01323660|2741613|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
860735|NCT01323660|2741614|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
860736|NCT01323660|2741615|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
860737|NCT01323660|2741616|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
860738|NCT01323660|2741617|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
860739|NCT01323660|2741618|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
860740|NCT01323660|2741613|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
860741|NCT01323660|2741614|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
860742|NCT01323660|2741615|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
860743|NCT01323660|2741616|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
860744|NCT01323660|2741617|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
860745|NCT01323660|2741618|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
860746|NCT01323660|2741613|P6|Washout Period (14 Days)|Lack of Efficacy|2
860747|NCT01323660|2741614|P5|Washout Period (14 Days)|Lack of Efficacy|2
860748|NCT01323660|2741615|P4|Washout Period (14 Days)|Lack of Efficacy|3
860749|NCT01323660|2741616|P3|Washout Period (14 Days)|Lack of Efficacy|1
895112|NCT00666562|2841705|P3|Overall Study|Concomitant Medication|0
895113|NCT00666562|2841706|P2|Overall Study|Concomitant Medication|1
860750|NCT01323660|2741617|P2|Washout Period (14 Days)|Lack of Efficacy|0
860751|NCT01323660|2741618|P1|Washout Period (14 Days)|Lack of Efficacy|0
860752|NCT01323660|2741613|P6|Washout Period (14 Days)|Adverse Event|0
860753|NCT01323660|2741614|P5|Washout Period (14 Days)|Adverse Event|1
860754|NCT01323660|2741615|P4|Washout Period (14 Days)|Adverse Event|0
860755|NCT01323660|2741616|P3|Washout Period (14 Days)|Adverse Event|0
860756|NCT01323660|2741617|P2|Washout Period (14 Days)|Adverse Event|0
860757|NCT01323660|2741618|P1|Washout Period (14 Days)|Adverse Event|0
860758|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
860759|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
860760|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
860761|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
860762|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
860763|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
860764|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
860765|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
860766|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
860767|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
860768|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
860769|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
860770|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
860771|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
860772|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
860773|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
860774|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
860775|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
860776|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
860777|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
860778|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
860779|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
860780|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
860781|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
860782|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
860783|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
860784|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
860785|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
860786|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
860787|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
860788|NCT01323660|2741613|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
860789|NCT01323660|2741614|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
860790|NCT01323660|2741615|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
860791|NCT01323660|2741616|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
860792|NCT01323660|2741617|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
860793|NCT01323660|2741618|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
860794|NCT01323673|2741664|P2|Overall Study|Withdrawal by Subject|3
860795|NCT01323673|2741665|P1|Overall Study|Withdrawal by Subject|2
860796|NCT01323673|2741664|P2|Overall Study|Protocol Violation|0
860797|NCT01323673|2741665|P1|Overall Study|Protocol Violation|1
860798|NCT01323673|2741664|P2|Overall Study|Lost to Follow-up|1
860799|NCT01323673|2741665|P1|Overall Study|Lost to Follow-up|0
860800|NCT01323673|2741664|P2|Overall Study|Adverse Event|1
860801|NCT01323673|2741665|P1|Overall Study|Adverse Event|0
860802|NCT01323790|2741699|P3|Overall Study|Severe non-compliance with protocol|2
860803|NCT01323790|2741700|P2|Overall Study|Severe non-compliance with protocol|2
860804|NCT01323790|2741701|P1|Overall Study|Severe non-compliance with protocol|2
860805|NCT01323790|2741699|P3|Overall Study|Did Not Receive Treatment|1
860806|NCT01323790|2741700|P2|Overall Study|Did Not Receive Treatment|0
860807|NCT01323790|2741701|P1|Overall Study|Did Not Receive Treatment|2
860808|NCT01323790|2741699|P3|Overall Study|Withdrawal by Subject|13
860809|NCT01323790|2741700|P2|Overall Study|Withdrawal by Subject|20
860810|NCT01323790|2741701|P1|Overall Study|Withdrawal by Subject|23
860811|NCT01323790|2741699|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
860812|NCT01323790|2741700|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
860813|NCT01323790|2741701|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
860814|NCT01323790|2741699|P3|Overall Study|Adverse Event|12
860815|NCT01323790|2741700|P2|Overall Study|Adverse Event|24
860816|NCT01323790|2741701|P1|Overall Study|Adverse Event|11
860817|NCT01323790|2741699|P3|Overall Study|Lack of Efficacy|3
860818|NCT01323790|2741700|P2|Overall Study|Lack of Efficacy|0
860819|NCT01323790|2741701|P1|Overall Study|Lack of Efficacy|3
860820|NCT01323790|2741699|P3|Overall Study|Study-Specific Withdrawal Criteria|3
860821|NCT01323790|2741700|P2|Overall Study|Study-Specific Withdrawal Criteria|3
860822|NCT01323790|2741701|P1|Overall Study|Study-Specific Withdrawal Criteria|0
860823|NCT01323790|2741699|P3|Overall Study|Lost to Follow-up|9
860824|NCT01323790|2741700|P2|Overall Study|Lost to Follow-up|9
860825|NCT01323790|2741701|P1|Overall Study|Lost to Follow-up|11
860826|NCT01323790|2741699|P3|Overall Study|Other|1
860827|NCT01323790|2741700|P2|Overall Study|Other|2
860828|NCT01323790|2741701|P1|Overall Study|Other|3
860829|NCT01323920|2741770|P1|Overall Study|Withdrawal by Subject|1
860830|NCT01323920|2741770|P1|Overall Study|Death|5
860843|NCT01324024|2741898|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
860844|NCT01324024|2741899|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
860845|NCT01324102|2741914|P2|Overall Study|illness|6
860846|NCT01324102|2741915|P1|Overall Study|illness|1
860847|NCT01324271|2741937|P2|Overall Study|Physician Decision|0
860848|NCT01324271|2741938|P1|Overall Study|Physician Decision|1
860849|NCT01324271|2741937|P2|Overall Study|Lost to Follow-up|0
860850|NCT01324271|2741938|P1|Overall Study|Lost to Follow-up|3
860851|NCT01324310|2741944|P1|Overall Study|Disease Progression|1
860852|NCT01324310|2741944|P1|Overall Study|Adverse Event|1
860853|NCT01324323|2741964|P1|Overall Study|Withdrawal by Subject|1
860854|NCT01324349|2741986|P2|Overall Study|Withdrawal by Subject|1
860855|NCT01324349|2741987|P1|Overall Study|Withdrawal by Subject|0
860856|NCT01324349|2741986|P2|Overall Study|Death|1
860857|NCT01324349|2741987|P1|Overall Study|Death|1
860858|NCT01324388|2742000|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
860859|NCT01324388|2742001|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
860860|NCT01324388|2742002|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
860861|NCT01324388|2742003|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
860862|NCT01324388|2742000|P4|Part 2 of Study: First Intervention|Protocol Violation|1
860863|NCT01324388|2742001|P3|Part 2 of Study: First Intervention|Protocol Violation|0
860864|NCT01324388|2742002|P2|Part 2 of Study: First Intervention|Protocol Violation|0
860865|NCT01324388|2742003|P1|Part 2 of Study: First Intervention|Protocol Violation|0
860866|NCT01324388|2742000|P4|Part 1 of Study|Physician Decision|0
860867|NCT01324388|2742001|P3|Part 1 of Study|Physician Decision|0
860868|NCT01324388|2742002|P2|Part 1 of Study|Physician Decision|0
860869|NCT01324388|2742003|P1|Part 1 of Study|Physician Decision|1
860870|NCT01324388|2742000|P4|Part 1 of Study|Protocol Violation|0
860871|NCT01324388|2742001|P3|Part 1 of Study|Protocol Violation|0
860872|NCT01324388|2742002|P2|Part 1 of Study|Protocol Violation|2
860873|NCT01324388|2742003|P1|Part 1 of Study|Protocol Violation|1
860874|NCT01324388|2742000|P4|Part 1 of Study|Adverse Event|0
860875|NCT01324388|2742001|P3|Part 1 of Study|Adverse Event|0
860876|NCT01324388|2742002|P2|Part 1 of Study|Adverse Event|0
860877|NCT01324388|2742003|P1|Part 1 of Study|Adverse Event|2
860878|NCT01324401|2742024|P2|Overall Study|Adverse Event|3
860879|NCT01324401|2742025|P1|Overall Study|Adverse Event|1
860880|NCT01324401|2742024|P2|Overall Study|Withdrawn before any treatment|3
860881|NCT01324401|2742025|P1|Overall Study|Withdrawn before any treatment|0
860882|NCT01324440|2742035|P2|Overall Study|Subject moved|1
860883|NCT01324440|2742036|P1|Overall Study|Subject moved|0
860884|NCT01324570|2742050|P2|Overall Study|Administrative|2
860885|NCT01324570|2742051|P1|Overall Study|Administrative|0
860886|NCT01324570|2742050|P2|Overall Study|Confirmed or suspected diversion|1
860887|NCT01324570|2742051|P1|Overall Study|Confirmed or suspected diversion|0
860888|NCT01324570|2742050|P2|Overall Study|Lack of Efficacy|1
860889|NCT01324570|2742051|P1|Overall Study|Lack of Efficacy|0
860890|NCT01324570|2742050|P2|Overall Study|Withdrawal by Subject|3
860891|NCT01324570|2742051|P1|Overall Study|Withdrawal by Subject|0
860892|NCT01324570|2742050|P2|Overall Study|Adverse Event|7
860893|NCT01324570|2742051|P1|Overall Study|Adverse Event|4
860900|NCT01324947|2742114|P1|Overall Study|1 discontinued before starting drug|1
860901|NCT01324947|2742114|P1|Overall Study|Withdrawal by Subject|3
860902|NCT01324947|2742114|P1|Overall Study|Progressive Disease|50
860903|NCT01324947|2742114|P1|Overall Study|Unspecified|3
860904|NCT01324947|2742114|P1|Overall Study|Death|10
860905|NCT01324947|2742114|P1|Overall Study|Adverse Event|7
860906|NCT01324999|2742125|P1|Overall Study|Withdrawal by Subject|2
860907|NCT01324999|2742125|P1|Overall Study|Adverse Event|3
860908|NCT01316575|2742138|P2|Overall Study|Required alternate treatment|1
860909|NCT01316575|2742139|P1|Overall Study|Required alternate treatment|0
860910|NCT01316575|2742138|P2|Overall Study|Withdrawal by Subject|0
860911|NCT01316575|2742139|P1|Overall Study|Withdrawal by Subject|2
860912|NCT01316614|2742151|P1|Overall Study|Medically unstable|1
860913|NCT01316614|2742151|P1|Overall Study|Inadequate number of passes|2
860914|NCT01316614|2742151|P1|Overall Study|Cystic lesion|5
860915|NCT01316614|2742151|P1|Overall Study|Cytology slides not available for review|4
861002|NCT01316939|2742308|P1|Overall Study|Withdrawal by Subject|1
860916|NCT01316614|2742151|P1|Overall Study|No solid lesion and FNA not indicated|25
860917|NCT01316692|2742166|P1|Overall Study|Disease Progression|7
860918|NCT01316692|2742166|P1|Overall Study|Adverse Event|5
895114|NCT00666562|2841707|P1|Overall Study|Concomitant Medication|0
895115|NCT00666562|2841705|P3|Overall Study|Withdrawal by Subject|0
895116|NCT00666562|2841706|P2|Overall Study|Withdrawal by Subject|1
895117|NCT00666562|2841707|P1|Overall Study|Withdrawal by Subject|0
860964|NCT01316913|2742271|P4|Overall Study|Withdrawal by Subject|6
860965|NCT01316913|2742272|P3|Overall Study|Withdrawal by Subject|10
860966|NCT01316913|2742273|P2|Overall Study|Withdrawal by Subject|9
860967|NCT01316913|2742274|P1|Overall Study|Withdrawal by Subject|10
860968|NCT01316913|2742271|P4|Overall Study|Lost to Follow-up|2
860969|NCT01316913|2742272|P3|Overall Study|Lost to Follow-up|0
860970|NCT01316913|2742273|P2|Overall Study|Lost to Follow-up|1
860971|NCT01316913|2742274|P1|Overall Study|Lost to Follow-up|0
860972|NCT01316913|2742271|P4|Overall Study|Protocol-defined Stopping Criteria|6
860973|NCT01316913|2742272|P3|Overall Study|Protocol-defined Stopping Criteria|11
860974|NCT01316913|2742273|P2|Overall Study|Protocol-defined Stopping Criteria|8
860975|NCT01316913|2742274|P1|Overall Study|Protocol-defined Stopping Criteria|7
860976|NCT01316913|2742271|P4|Overall Study|Protocol Violation|1
860977|NCT01316913|2742272|P3|Overall Study|Protocol Violation|4
860978|NCT01316913|2742273|P2|Overall Study|Protocol Violation|4
860979|NCT01316913|2742274|P1|Overall Study|Protocol Violation|1
860980|NCT01316913|2742271|P4|Overall Study|Lack of Efficacy|13
860981|NCT01316913|2742272|P3|Overall Study|Lack of Efficacy|9
860982|NCT01316913|2742273|P2|Overall Study|Lack of Efficacy|12
860983|NCT01316913|2742274|P1|Overall Study|Lack of Efficacy|22
860984|NCT01316913|2742271|P4|Overall Study|Adverse Event|11
860985|NCT01316913|2742272|P3|Overall Study|Adverse Event|15
860986|NCT01316913|2742273|P2|Overall Study|Adverse Event|20
860987|NCT01316913|2742274|P1|Overall Study|Adverse Event|17
860988|NCT01316939|2742306|P3|Overall Study|Protocol Violation|0
860989|NCT01316939|2742307|P2|Overall Study|Protocol Violation|1
860990|NCT01316939|2742308|P1|Overall Study|Protocol Violation|0
860991|NCT01316939|2742306|P3|Overall Study|Met Liver chemistry stopping criteria|1
860992|NCT01316939|2742307|P2|Overall Study|Met Liver chemistry stopping criteria|0
860993|NCT01316939|2742308|P1|Overall Study|Met Liver chemistry stopping criteria|1
860994|NCT01316939|2742306|P3|Overall Study|Lost to Follow-up|2
860995|NCT01316939|2742307|P2|Overall Study|Lost to Follow-up|0
860996|NCT01316939|2742308|P1|Overall Study|Lost to Follow-up|0
860997|NCT01316939|2742306|P3|Overall Study|Physician Decision|1
860998|NCT01316939|2742307|P2|Overall Study|Physician Decision|2
860999|NCT01316939|2742308|P1|Overall Study|Physician Decision|2
861000|NCT01316939|2742306|P3|Overall Study|Withdrawal by Subject|6
861001|NCT01316939|2742307|P2|Overall Study|Withdrawal by Subject|3
861003|NCT01316939|2742306|P3|Overall Study|Adverse Event|11
861004|NCT01316939|2742307|P2|Overall Study|Adverse Event|12
861005|NCT01316939|2742308|P1|Overall Study|Adverse Event|9
861006|NCT01316939|2742306|P3|Overall Study|Lack of Efficacy|25
861007|NCT01316939|2742307|P2|Overall Study|Lack of Efficacy|25
861008|NCT01316939|2742308|P1|Overall Study|Lack of Efficacy|24
861009|NCT01316939|2742306|P3|Overall Study|Study closed/terminated|23
861010|NCT01316939|2742307|P2|Overall Study|Study closed/terminated|25
861011|NCT01316939|2742308|P1|Overall Study|Study closed/terminated|26
861012|NCT01317004|2742390|P2|Overall Study|Adverse Event|3
861013|NCT01317004|2742391|P1|Overall Study|Adverse Event|3
861014|NCT01317004|2742390|P2|Overall Study|Protocol Violation|2
861015|NCT01317004|2742391|P1|Overall Study|Protocol Violation|0
861016|NCT01317004|2742390|P2|Overall Study|Withdrawal by Subject|4
861017|NCT01317004|2742391|P1|Overall Study|Withdrawal by Subject|1
861018|NCT01317160|2742411|P2|Overall Study|Withdrawal by Subject|2
861019|NCT01317160|2742412|P1|Overall Study|Withdrawal by Subject|0
861020|NCT01317160|2742411|P2|Overall Study|Lost to Follow-up|3
861021|NCT01317160|2742412|P1|Overall Study|Lost to Follow-up|3
861022|NCT01317160|2742411|P2|Overall Study|Incorrect inclusion|1
861023|NCT01317160|2742412|P1|Overall Study|Incorrect inclusion|1
861024|NCT01317615|2742420|P1|Overall Study|Adverse Event|7
861025|NCT01317615|2742420|P1|Overall Study|Abnormal laboratory value(s)|1
861026|NCT01317615|2742420|P1|Overall Study|Withdrawal by Subject|5
861027|NCT01317615|2742420|P1|Overall Study|Death|6
861028|NCT01317615|2742420|P1|Overall Study|New cancer therapy|5
861029|NCT01317615|2742420|P1|Overall Study|Disease progression|25
861030|NCT01317641|2742438|P9|Overall Study|Withdrawal by Subject|0
861031|NCT01317641|2742439|P8|Overall Study|Withdrawal by Subject|0
861032|NCT01317641|2742440|P7|Overall Study|Withdrawal by Subject|1
861033|NCT01317641|2742441|P6|Overall Study|Withdrawal by Subject|0
861034|NCT01317641|2742442|P5|Overall Study|Withdrawal by Subject|0
861035|NCT01317641|2742443|P4|Overall Study|Withdrawal by Subject|0
861036|NCT01317641|2742444|P3|Overall Study|Withdrawal by Subject|0
861037|NCT01317641|2742445|P2|Overall Study|Withdrawal by Subject|0
861038|NCT01317641|2742446|P1|Overall Study|Withdrawal by Subject|0
861039|NCT01317641|2742438|P9|Overall Study|Disease progression|4
861040|NCT01317641|2742439|P8|Overall Study|Disease progression|3
861041|NCT01317641|2742440|P7|Overall Study|Disease progression|0
861042|NCT01317641|2742441|P6|Overall Study|Disease progression|0
861043|NCT01317641|2742442|P5|Overall Study|Disease progression|0
861044|NCT01317641|2742443|P4|Overall Study|Disease progression|0
861045|NCT01317641|2742444|P3|Overall Study|Disease progression|0
861046|NCT01317641|2742445|P2|Overall Study|Disease progression|0
861047|NCT01317641|2742446|P1|Overall Study|Disease progression|0
861048|NCT01317641|2742438|P9|Overall Study|Protocol Violation|0
861049|NCT01317641|2742439|P8|Overall Study|Protocol Violation|0
861050|NCT01317641|2742440|P7|Overall Study|Protocol Violation|0
861051|NCT01317641|2742441|P6|Overall Study|Protocol Violation|0
861052|NCT01317641|2742442|P5|Overall Study|Protocol Violation|0
861053|NCT01317641|2742443|P4|Overall Study|Protocol Violation|0
861054|NCT01317641|2742444|P3|Overall Study|Protocol Violation|0
861055|NCT01317641|2742445|P2|Overall Study|Protocol Violation|0
861056|NCT01317641|2742446|P1|Overall Study|Protocol Violation|1
861057|NCT01317641|2742438|P9|Overall Study|Adverse Event|0
861058|NCT01317641|2742439|P8|Overall Study|Adverse Event|1
861059|NCT01317641|2742440|P7|Overall Study|Adverse Event|2
861060|NCT01317641|2742441|P6|Overall Study|Adverse Event|0
861061|NCT01317641|2742442|P5|Overall Study|Adverse Event|0
861062|NCT01317641|2742443|P4|Overall Study|Adverse Event|1
861063|NCT01317641|2742444|P3|Overall Study|Adverse Event|0
861064|NCT01317641|2742445|P2|Overall Study|Adverse Event|1
861065|NCT01317641|2742446|P1|Overall Study|Adverse Event|0
861066|NCT01317641|2742438|P9|Overall Study|Not treated|1
861067|NCT01317641|2742439|P8|Overall Study|Not treated|1
861068|NCT01317641|2742440|P7|Overall Study|Not treated|0
861069|NCT01317641|2742441|P6|Overall Study|Not treated|0
861070|NCT01317641|2742442|P5|Overall Study|Not treated|0
861071|NCT01317641|2742443|P4|Overall Study|Not treated|0
861072|NCT01317641|2742444|P3|Overall Study|Not treated|0
861073|NCT01317641|2742445|P2|Overall Study|Not treated|0
861074|NCT01317641|2742446|P1|Overall Study|Not treated|0
861075|NCT01317797|2742567|P3|Overall Study|Withdrawal of Patient|1
861076|NCT01317797|2742568|P2|Overall Study|Withdrawal of Patient|0
861077|NCT01317797|2742569|P1|Overall Study|Withdrawal of Patient|0
861078|NCT01317797|2742567|P3|Overall Study|Other|0
861079|NCT01317797|2742568|P2|Overall Study|Other|1
861080|NCT01317797|2742569|P1|Overall Study|Other|0
861081|NCT01318070|2742633|P3|Overall Study|Principal Investigator Discretion|0
861082|NCT01318070|2742634|P2|Overall Study|Principal Investigator Discretion|0
861083|NCT01318070|2742635|P1|Overall Study|Principal Investigator Discretion|1
861084|NCT01318070|2742633|P3|Overall Study|Lack of Efficacy|1
861085|NCT01318070|2742634|P2|Overall Study|Lack of Efficacy|0
861086|NCT01318070|2742635|P1|Overall Study|Lack of Efficacy|0
861087|NCT01318070|2742633|P3|Overall Study|Withdrawal by Subject|1
861088|NCT01318070|2742634|P2|Overall Study|Withdrawal by Subject|1
861089|NCT01318070|2742635|P1|Overall Study|Withdrawal by Subject|0
861090|NCT01318070|2742633|P3|Overall Study|Adverse Event|5
861091|NCT01318070|2742634|P2|Overall Study|Adverse Event|1
861092|NCT01318070|2742635|P1|Overall Study|Adverse Event|1
861093|NCT01318083|2742670|P3|Overall Study|Lack of Study Medication Compliance|0
861094|NCT01318083|2742671|P2|Overall Study|Lack of Study Medication Compliance|1
861095|NCT01318083|2742672|P1|Overall Study|Lack of Study Medication Compliance|0
861096|NCT01318083|2742670|P3|Overall Study|Treatment Complications|0
861097|NCT01318083|2742671|P2|Overall Study|Treatment Complications|0
861098|NCT01318083|2742672|P1|Overall Study|Treatment Complications|1
861099|NCT01318083|2742670|P3|Overall Study|Lack of Efficacy|1
861100|NCT01318083|2742671|P2|Overall Study|Lack of Efficacy|0
861101|NCT01318083|2742672|P1|Overall Study|Lack of Efficacy|0
861102|NCT01318083|2742670|P3|Overall Study|Withdrawal by Subject|2
861103|NCT01318083|2742671|P2|Overall Study|Withdrawal by Subject|0
861104|NCT01318083|2742672|P1|Overall Study|Withdrawal by Subject|1
861105|NCT01318083|2742670|P3|Overall Study|Adverse Event|2
861106|NCT01318083|2742671|P2|Overall Study|Adverse Event|1
861107|NCT01318083|2742672|P1|Overall Study|Adverse Event|4
861108|NCT01318109|2742707|P3|Overall Study|Schedule Conflict|0
861109|NCT01318109|2742708|P2|Overall Study|Schedule Conflict|1
861110|NCT01318109|2742709|P1|Overall Study|Schedule Conflict|0
861111|NCT01318109|2742707|P3|Overall Study|Withdrawal by Subject|0
861112|NCT01318109|2742708|P2|Overall Study|Withdrawal by Subject|0
861113|NCT01318109|2742709|P1|Overall Study|Withdrawal by Subject|1
861114|NCT01318109|2742707|P3|Overall Study|Adverse Event|0
861115|NCT01318109|2742708|P2|Overall Study|Adverse Event|2
861116|NCT01318109|2742709|P1|Overall Study|Adverse Event|0
861117|NCT01318122|2742743|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
861118|NCT01318122|2742744|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
861119|NCT01318122|2742745|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
861120|NCT01318122|2742746|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
861121|NCT01318122|2742743|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
861122|NCT01318122|2742744|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
861123|NCT01318122|2742745|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
861124|NCT01318122|2742746|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
861125|NCT01318122|2742743|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
861126|NCT01318122|2742744|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
861127|NCT01318122|2742745|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
861128|NCT01318122|2742746|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
861129|NCT01318122|2742743|P4|Entered - Long-Term Extension Study|Adverse Event|4
861130|NCT01318122|2742744|P3|Entered - Long-Term Extension Study|Adverse Event|2
861131|NCT01318122|2742745|P2|Entered - Long-Term Extension Study|Adverse Event|6
861132|NCT01318122|2742746|P1|Entered - Long-Term Extension Study|Adverse Event|6
861133|NCT01318122|2742743|P4|Enrolled - Long-Term Extension Study|Other|0
861134|NCT01318122|2742744|P3|Enrolled - Long-Term Extension Study|Other|0
861135|NCT01318122|2742745|P2|Enrolled - Long-Term Extension Study|Other|0
861136|NCT01318122|2742746|P1|Enrolled - Long-Term Extension Study|Other|1
861137|NCT01318122|2742743|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
861138|NCT01318122|2742744|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
861139|NCT01318122|2742745|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
861140|NCT01318122|2742746|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
861141|NCT01318135|2742816|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
861142|NCT01318135|2742817|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861143|NCT01318135|2742818|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861144|NCT01318135|2742819|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861145|NCT01318135|2742820|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861146|NCT01318135|2742821|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861147|NCT01318135|2742822|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861148|NCT01318135|2742823|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
861149|NCT01318135|2742816|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
861150|NCT01318135|2742817|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
861151|NCT01318135|2742818|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
861152|NCT01318135|2742819|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
861153|NCT01318135|2742820|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
861154|NCT01318135|2742821|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
861155|NCT01318135|2742822|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
861156|NCT01318135|2742823|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
861157|NCT01318135|2742816|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
861158|NCT01318135|2742817|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
861159|NCT01318135|2742818|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
861160|NCT01318135|2742819|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
861161|NCT01318135|2742820|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
861162|NCT01318135|2742821|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
861163|NCT01318135|2742822|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
861164|NCT01318135|2742823|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
861165|NCT01318135|2742816|P8|Entered - Long-Term Extension Study|Protocol Violation|0
861166|NCT01318135|2742817|P7|Entered - Long-Term Extension Study|Protocol Violation|0
861167|NCT01318135|2742818|P6|Entered - Long-Term Extension Study|Protocol Violation|0
861168|NCT01318135|2742819|P5|Entered - Long-Term Extension Study|Protocol Violation|1
861169|NCT01318135|2742820|P4|Entered - Long-Term Extension Study|Protocol Violation|0
861170|NCT01318135|2742821|P3|Entered - Long-Term Extension Study|Protocol Violation|0
861171|NCT01318135|2742822|P2|Entered - Long-Term Extension Study|Protocol Violation|1
861172|NCT01318135|2742823|P1|Entered - Long-Term Extension Study|Protocol Violation|1
861173|NCT01318135|2742816|P8|Entered - Long-Term Extension Study|Adverse Event|0
861174|NCT01318135|2742817|P7|Entered - Long-Term Extension Study|Adverse Event|0
861175|NCT01318135|2742818|P6|Entered - Long-Term Extension Study|Adverse Event|2
861176|NCT01318135|2742819|P5|Entered - Long-Term Extension Study|Adverse Event|4
861177|NCT01318135|2742820|P4|Entered - Long-Term Extension Study|Adverse Event|3
861178|NCT01318135|2742821|P3|Entered - Long-Term Extension Study|Adverse Event|4
861179|NCT01318135|2742822|P2|Entered - Long-Term Extension Study|Adverse Event|3
861180|NCT01318135|2742823|P1|Entered - Long-Term Extension Study|Adverse Event|9
861181|NCT01318135|2742816|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
861182|NCT01318135|2742817|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
861183|NCT01318135|2742818|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
861184|NCT01318135|2742819|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
861185|NCT01318135|2742820|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
861186|NCT01318135|2742821|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
861187|NCT01318135|2742822|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
861188|NCT01318135|2742823|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
861189|NCT01318135|2742816|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
861190|NCT01318135|2742817|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
861191|NCT01318135|2742818|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
861192|NCT01318135|2742819|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
861193|NCT01318135|2742820|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
861194|NCT01318135|2742821|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
861195|NCT01318135|2742822|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
861196|NCT01318135|2742823|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
861197|NCT01318382|2743000|P1|Overall Study|Protocol Violation|1
861198|NCT01318382|2743000|P1|Overall Study|Device Malfunction|10
861199|NCT01318382|2743000|P1|Overall Study|Physician Decision|2
861200|NCT01325337|2743063|P5|Overall Study|Withdrawal by Subject|1
861201|NCT01325337|2743064|P4|Overall Study|Withdrawal by Subject|0
861202|NCT01325337|2743065|P3|Overall Study|Withdrawal by Subject|1
861203|NCT01325337|2743066|P2|Overall Study|Withdrawal by Subject|0
861204|NCT01325337|2743067|P1|Overall Study|Withdrawal by Subject|1
861205|NCT01325337|2743063|P5|Overall Study|Personal Reasons|3
861206|NCT01325337|2743064|P4|Overall Study|Personal Reasons|8
861207|NCT01325337|2743065|P3|Overall Study|Personal Reasons|4
861208|NCT01325337|2743066|P2|Overall Study|Personal Reasons|5
861209|NCT01325337|2743067|P1|Overall Study|Personal Reasons|2
861210|NCT01325337|2743063|P5|Overall Study|Lost to Follow-up|2
861211|NCT01325337|2743064|P4|Overall Study|Lost to Follow-up|1
861212|NCT01325337|2743065|P3|Overall Study|Lost to Follow-up|2
861213|NCT01325337|2743066|P2|Overall Study|Lost to Follow-up|2
861214|NCT01325337|2743067|P1|Overall Study|Lost to Follow-up|2
861215|NCT01325337|2743063|P5|Overall Study|Adverse Event|2
861216|NCT01325337|2743064|P4|Overall Study|Adverse Event|1
861217|NCT01325337|2743065|P3|Overall Study|Adverse Event|2
861218|NCT01325337|2743066|P2|Overall Study|Adverse Event|2
861219|NCT01325337|2743067|P1|Overall Study|Adverse Event|0
861220|NCT01325350|2743109|P5|Overall Study|Did Not Receive Treatment|1
861221|NCT01325350|2743110|P4|Overall Study|Did Not Receive Treatment|0
861222|NCT01325350|2743111|P3|Overall Study|Did Not Receive Treatment|1
861223|NCT01325350|2743112|P2|Overall Study|Did Not Receive Treatment|1
861224|NCT01325350|2743113|P1|Overall Study|Did Not Receive Treatment|0
861225|NCT01325350|2743109|P5|Overall Study|Withdrawal by Subject|0
861226|NCT01325350|2743110|P4|Overall Study|Withdrawal by Subject|1
861227|NCT01325350|2743111|P3|Overall Study|Withdrawal by Subject|1
861228|NCT01325350|2743112|P2|Overall Study|Withdrawal by Subject|0
861229|NCT01325350|2743113|P1|Overall Study|Withdrawal by Subject|0
861230|NCT01325350|2743109|P5|Overall Study|Protocol Violation|0
861231|NCT01325350|2743110|P4|Overall Study|Protocol Violation|1
861232|NCT01325350|2743111|P3|Overall Study|Protocol Violation|0
861233|NCT01325350|2743112|P2|Overall Study|Protocol Violation|0
861234|NCT01325350|2743113|P1|Overall Study|Protocol Violation|0
861235|NCT01325350|2743109|P5|Overall Study|Personal Reasons|3
861236|NCT01325350|2743110|P4|Overall Study|Personal Reasons|5
861237|NCT01325350|2743111|P3|Overall Study|Personal Reasons|6
861238|NCT01325350|2743112|P2|Overall Study|Personal Reasons|1
861239|NCT01325350|2743113|P1|Overall Study|Personal Reasons|2
861240|NCT01325350|2743109|P5|Overall Study|Lost to Follow-up|5
861241|NCT01325350|2743110|P4|Overall Study|Lost to Follow-up|1
861242|NCT01325350|2743111|P3|Overall Study|Lost to Follow-up|5
861243|NCT01325350|2743112|P2|Overall Study|Lost to Follow-up|0
861244|NCT01325350|2743113|P1|Overall Study|Lost to Follow-up|1
861245|NCT01325350|2743109|P5|Overall Study|Pregnancy|1
861246|NCT01325350|2743110|P4|Overall Study|Pregnancy|0
861247|NCT01325350|2743111|P3|Overall Study|Pregnancy|1
861248|NCT01325350|2743112|P2|Overall Study|Pregnancy|0
861249|NCT01325350|2743113|P1|Overall Study|Pregnancy|0
861250|NCT01325350|2743109|P5|Overall Study|Adverse Event|2
861251|NCT01325350|2743110|P4|Overall Study|Adverse Event|1
861252|NCT01325350|2743111|P3|Overall Study|Adverse Event|3
861253|NCT01325350|2743112|P2|Overall Study|Adverse Event|3
861254|NCT01325350|2743113|P1|Overall Study|Adverse Event|3
861255|NCT01326026|2743201|P2|Overall Study|Other|3
861256|NCT01326026|2743202|P1|Overall Study|Other|3
861257|NCT01326026|2743201|P2|Overall Study|Withdrawal Criteria|7
861258|NCT01326026|2743202|P1|Overall Study|Withdrawal Criteria|5
861259|NCT01326026|2743201|P2|Overall Study|Adverse Event|3
861260|NCT01326026|2743202|P1|Overall Study|Adverse Event|4
861261|NCT01326533|2743218|P2|Overall Study|Adverse Event|0
861262|NCT01326533|2743219|P1|Overall Study|Adverse Event|1
861263|NCT01326533|2743218|P2|Overall Study|Withdrawal by Subject|0
861264|NCT01326533|2743219|P1|Overall Study|Withdrawal by Subject|1
861265|NCT01326533|2743218|P2|Overall Study|Lost to Follow-up|0
861266|NCT01326533|2743219|P1|Overall Study|Lost to Follow-up|2
861267|NCT01326845|2743229|P2|Overall Study|Misisng|3
861268|NCT01326845|2743230|P1|Overall Study|Misisng|1
861269|NCT01326845|2743229|P2|Overall Study|Adverse Event|0
861270|NCT01326845|2743230|P1|Overall Study|Adverse Event|1
861271|NCT01326845|2743229|P2|Overall Study|Administrative Problems|2
861272|NCT01326845|2743230|P1|Overall Study|Administrative Problems|5
861273|NCT01326910|2743254|P2|Overall Study|Protocol Violation|1
861274|NCT01326910|2743255|P1|Overall Study|Protocol Violation|1
861275|NCT01326910|2743254|P2|Overall Study|Withdrawal by Subject|2
861276|NCT01326910|2743255|P1|Overall Study|Withdrawal by Subject|3
861277|NCT01326962|2743267|P1|Overall Study|Not Specified|2
861278|NCT01326962|2743267|P1|Overall Study|Lost to Follow-up|3
861279|NCT01326962|2743267|P1|Overall Study|Withdrawal by Subject|1
861280|NCT01326962|2743267|P1|Overall Study|Adverse Event|1
861281|NCT01327053|2743285|P2|Overall Study|Untreated|1
861282|NCT01327053|2743286|P1|Overall Study|Untreated|0
861283|NCT01327053|2743285|P2|Overall Study|Withdrawal by Subject|28
861284|NCT01327053|2743286|P1|Overall Study|Withdrawal by Subject|5
861285|NCT01327053|2743285|P2|Overall Study|Protocol Violation|1
861286|NCT01327053|2743286|P1|Overall Study|Protocol Violation|0
861287|NCT01327053|2743285|P2|Overall Study|Progressive Disease|6
861288|NCT01327053|2743286|P1|Overall Study|Progressive Disease|15
861289|NCT01327053|2743285|P2|Overall Study|Physician Decision|10
861290|NCT01327053|2743286|P1|Overall Study|Physician Decision|3
861291|NCT01327053|2743285|P2|Overall Study|Non-compliance with study treatment|3
861292|NCT01327053|2743286|P1|Overall Study|Non-compliance with study treatment|0
861293|NCT01327053|2743285|P2|Overall Study|Lost to Follow-up|4
861294|NCT01327053|2743286|P1|Overall Study|Lost to Follow-up|1
861295|NCT01327053|2743285|P2|Overall Study|Death|4
861296|NCT01327053|2743286|P1|Overall Study|Death|0
861297|NCT01327053|2743285|P2|Overall Study|Adverse Event|48
861298|NCT01327053|2743286|P1|Overall Study|Adverse Event|16
861299|NCT01327300|2743314|P2|Washout (3 Weeks)|Withdrawal by Subject|0
861300|NCT01327300|2743315|P1|Washout (3 Weeks)|Withdrawal by Subject|1
861301|NCT01327339|2743460|P1|Overall Study|Protocol Violation|8
861302|NCT01327482|2743466|P1|Overall Study|Adverse Event|1
861303|NCT01327495|2743477|P6|Overall Study|Physician Decision|0
861304|NCT01327495|2743478|P5|Overall Study|Physician Decision|2
861305|NCT01327495|2743479|P4|Overall Study|Physician Decision|0
861306|NCT01327495|2743480|P3|Overall Study|Physician Decision|0
861307|NCT01327495|2743481|P2|Overall Study|Physician Decision|0
861308|NCT01327495|2743482|P1|Overall Study|Physician Decision|0
861309|NCT01327495|2743477|P6|Overall Study|Withdrawal by Subject|0
861310|NCT01327495|2743478|P5|Overall Study|Withdrawal by Subject|1
861311|NCT01327495|2743479|P4|Overall Study|Withdrawal by Subject|0
861312|NCT01327495|2743480|P3|Overall Study|Withdrawal by Subject|1
861313|NCT01327495|2743481|P2|Overall Study|Withdrawal by Subject|1
861314|NCT01327495|2743482|P1|Overall Study|Withdrawal by Subject|0
861315|NCT01327495|2743477|P6|Overall Study|Adverse Event|2
861316|NCT01327495|2743478|P5|Overall Study|Adverse Event|0
861317|NCT01327495|2743479|P4|Overall Study|Adverse Event|0
861318|NCT01327495|2743480|P3|Overall Study|Adverse Event|1
861319|NCT01327495|2743481|P2|Overall Study|Adverse Event|1
861320|NCT01327495|2743482|P1|Overall Study|Adverse Event|2
861341|NCT01327599|2743622|P1|Overall Study|Withdrawal of Consent|1
861342|NCT01327599|2743622|P1|Overall Study|Could Not Attend Visit|1
861343|NCT01327599|2743622|P1|Overall Study|Adverse Event|1
861344|NCT01327651|2743639|P9|Post Study Follow-up|Lost to Follow-up|2
861345|NCT01327651|2743640|P8|Post Study Follow-up|Lost to Follow-up|1
861346|NCT01327651|2743641|P7|Post Study Follow-up|Lost to Follow-up|4
861347|NCT01327651|2743642|P6|Post Study Follow-up|Lost to Follow-up|0
861348|NCT01327651|2743643|P5|Post Study Follow-up|Lost to Follow-up|0
861349|NCT01327651|2743644|P4|Post Study Follow-up|Lost to Follow-up|0
861350|NCT01327651|2743645|P3|Post Study Follow-up|Lost to Follow-up|1
861351|NCT01327651|2743646|P2|Post Study Follow-up|Lost to Follow-up|1
861352|NCT01327651|2743647|P1|Post Study Follow-up|Lost to Follow-up|0
861353|NCT01327651|2743639|P9|Self-administered Dosing Period|Withdrawal by Subject|1
861354|NCT01327651|2743640|P8|Self-administered Dosing Period|Withdrawal by Subject|1
861355|NCT01327651|2743641|P7|Self-administered Dosing Period|Withdrawal by Subject|2
861356|NCT01327651|2743642|P6|Self-administered Dosing Period|Withdrawal by Subject|0
861357|NCT01327651|2743643|P5|Self-administered Dosing Period|Withdrawal by Subject|0
861358|NCT01327651|2743644|P4|Self-administered Dosing Period|Withdrawal by Subject|1
861359|NCT01327651|2743645|P3|Self-administered Dosing Period|Withdrawal by Subject|0
861360|NCT01327651|2743646|P2|Self-administered Dosing Period|Withdrawal by Subject|1
861361|NCT01327651|2743647|P1|Self-administered Dosing Period|Withdrawal by Subject|0
861362|NCT01327651|2743639|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
861363|NCT01327651|2743640|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
861364|NCT01327651|2743641|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
861365|NCT01327651|2743642|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
861366|NCT01327651|2743643|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
861367|NCT01327651|2743644|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
861368|NCT01327651|2743645|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
861369|NCT01327651|2743646|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
861370|NCT01327651|2743647|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
861371|NCT01327651|2743639|P9|Self-administered Dosing Period|Lost to Follow-up|10
861372|NCT01327651|2743640|P8|Self-administered Dosing Period|Lost to Follow-up|9
861373|NCT01327651|2743641|P7|Self-administered Dosing Period|Lost to Follow-up|8
861374|NCT01327651|2743642|P6|Self-administered Dosing Period|Lost to Follow-up|0
861375|NCT01327651|2743643|P5|Self-administered Dosing Period|Lost to Follow-up|3
861376|NCT01327651|2743644|P4|Self-administered Dosing Period|Lost to Follow-up|2
861377|NCT01327651|2743645|P3|Self-administered Dosing Period|Lost to Follow-up|4
861378|NCT01327651|2743646|P2|Self-administered Dosing Period|Lost to Follow-up|2
861379|NCT01327651|2743647|P1|Self-administered Dosing Period|Lost to Follow-up|3
861380|NCT01327703|2743781|P2|Second Treatment Period|Protocol Violation|1
861381|NCT01327703|2743782|P1|Second Treatment Period|Protocol Violation|0
861382|NCT01327703|2743781|P2|Second Treatment Period|Adverse Event|1
861383|NCT01327703|2743782|P1|Second Treatment Period|Adverse Event|1
861384|NCT01327885|2743816|P2|Overall Study|Ongoing|1
861385|NCT01327885|2743817|P1|Overall Study|Ongoing|1
861386|NCT01327885|2743816|P2|Overall Study|Not treated|1
861387|NCT01327885|2743817|P1|Overall Study|Not treated|1
861388|NCT01327885|2743816|P2|Overall Study|Withdrawal of consent from study|4
861389|NCT01327885|2743817|P1|Overall Study|Withdrawal of consent from study|2
861390|NCT01327885|2743816|P2|Overall Study|Not specified|6
861391|NCT01327885|2743817|P1|Overall Study|Not specified|8
861392|NCT01327885|2743816|P2|Overall Study|Subject choice|10
861393|NCT01327885|2743817|P1|Overall Study|Subject choice|5
861394|NCT01327885|2743816|P2|Overall Study|Adverse Event|10
861395|NCT01327885|2743817|P1|Overall Study|Adverse Event|14
861396|NCT01327885|2743816|P2|Overall Study|Clinical progression|27
861397|NCT01327885|2743817|P1|Overall Study|Clinical progression|24
861398|NCT01327885|2743816|P2|Overall Study|Disease progression-according to RECIST|165
861399|NCT01327885|2743817|P1|Overall Study|Disease progression-according to RECIST|173
861400|NCT01328041|2743854|P1|Overall Study|Withdrawal by Subject|7
861401|NCT01328041|2743854|P1|Overall Study|Physician Decision|2
861402|NCT01328041|2743854|P1|Overall Study|Lost to Follow-up|7
861403|NCT01328041|2743854|P1|Overall Study|Protocol Violation|7
861404|NCT01328041|2743854|P1|Overall Study|Lack of Efficacy|27
861405|NCT01328041|2743854|P1|Overall Study|Adverse Event|7
861406|NCT01328054|2743876|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
861407|NCT01328054|2743877|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
861408|NCT01328054|2743876|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
861409|NCT01328054|2743877|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
861410|NCT01328054|2743876|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
861411|NCT01328054|2743877|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
861412|NCT01328080|2743902|P1|Overall Study|Lost to Follow-up|5
861413|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Death|1
861414|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Death|1
861415|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Death|0
861416|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Death|0
861417|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
861418|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
861419|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
861420|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
861421|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
861422|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
861423|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
861424|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
861425|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Not specified|0
861426|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Not specified|5
861427|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Not specified|0
861428|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Not specified|0
861429|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
861430|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
861431|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
861432|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
861433|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Participant choice|0
861434|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Participant choice|3
861435|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Participant choice|0
861436|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Participant choice|0
861437|NCT01321554|2743986|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
861438|NCT01321554|2743987|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
861439|NCT01321554|2743988|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
861440|NCT01321554|2743989|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
861441|NCT01321554|2743986|P4|Randomization Phase|Death|0
861442|NCT01321554|2743987|P3|Randomization Phase|Death|0
861443|NCT01321554|2743988|P2|Randomization Phase|Death|1
861444|NCT01321554|2743989|P1|Randomization Phase|Death|0
861445|NCT01321554|2743986|P4|Randomization Phase|Withdrawal by Subject|0
861446|NCT01321554|2743987|P3|Randomization Phase|Withdrawal by Subject|0
861447|NCT01321554|2743988|P2|Randomization Phase|Withdrawal by Subject|0
861448|NCT01321554|2743989|P1|Randomization Phase|Withdrawal by Subject|4
861449|NCT01321554|2743986|P4|Randomization Phase|Participant choice|0
861450|NCT01321554|2743987|P3|Randomization Phase|Participant choice|0
861451|NCT01321554|2743988|P2|Randomization Phase|Participant choice|0
861452|NCT01321554|2743989|P1|Randomization Phase|Participant choice|4
861453|NCT01321554|2743986|P4|Randomization Phase|Adverse Event|0
861454|NCT01321554|2743987|P3|Randomization Phase|Adverse Event|0
861455|NCT01321554|2743988|P2|Randomization Phase|Adverse Event|3
861456|NCT01321554|2743989|P1|Randomization Phase|Adverse Event|37
861457|NCT01321697|2744002|P1|Overall Study|Study Terminated|7
861458|NCT01321710|2744009|P3|Overall Study|Lost to Follow-up|0
861459|NCT01321710|2744010|P2|Overall Study|Lost to Follow-up|5
861460|NCT01321710|2744011|P1|Overall Study|Lost to Follow-up|4
861461|NCT01321723|2744029|P3|Overall Study|Withdrawal by Subject|2
861462|NCT01321723|2744030|P2|Overall Study|Withdrawal by Subject|0
861463|NCT01321723|2744031|P1|Overall Study|Withdrawal by Subject|2
861464|NCT01321723|2744029|P3|Overall Study|Adverse Event|2
861465|NCT01321723|2744030|P2|Overall Study|Adverse Event|5
861466|NCT01321723|2744031|P1|Overall Study|Adverse Event|3
861467|NCT01321749|2744052|P2|Overall Study|Withdrawal by Subject|4
861468|NCT01321749|2744053|P1|Overall Study|Withdrawal by Subject|5
861469|NCT01321749|2744052|P2|Overall Study|Protocol Violation|7
861470|NCT01321749|2744053|P1|Overall Study|Protocol Violation|4
861471|NCT01321749|2744052|P2|Overall Study|Lost to Follow-up|11
861472|NCT01321749|2744053|P1|Overall Study|Lost to Follow-up|4
861473|NCT01322009|2744061|P2|Overall Study|ng tube discontinued|1
861474|NCT01322009|2744062|P1|Overall Study|ng tube discontinued|0
861475|NCT01322009|2744061|P2|Overall Study|Adverse Event|1
861476|NCT01322009|2744062|P1|Overall Study|Adverse Event|0
861477|NCT01322009|2744061|P2|Overall Study|Death|1
861478|NCT01322009|2744062|P1|Overall Study|Death|0
861479|NCT01322347|2744098|P2|Overall Study|moved/changed dialysis|4
861480|NCT01322347|2744099|P1|Overall Study|moved/changed dialysis|2
861481|NCT01322347|2744098|P2|Overall Study|study drug withheld > 12 wks|1
861482|NCT01322347|2744099|P1|Overall Study|study drug withheld > 12 wks|0
861483|NCT01322347|2744098|P2|Overall Study|kidney transplant|1
861484|NCT01322347|2744099|P1|Overall Study|kidney transplant|3
861485|NCT01322347|2744098|P2|Overall Study|ineligible|3
861486|NCT01322347|2744099|P1|Overall Study|ineligible|6
861487|NCT01322347|2744098|P2|Overall Study|sponsor decision|3
861488|NCT01322347|2744099|P1|Overall Study|sponsor decision|1
861489|NCT01322347|2744098|P2|Overall Study|blood transfusion|5
861490|NCT01322347|2744099|P1|Overall Study|blood transfusion|5
861491|NCT01322347|2744098|P2|Overall Study|non-protocol change to ESA or IV iron|6
861492|NCT01322347|2744099|P1|Overall Study|non-protocol change to ESA or IV iron|14
861493|NCT01322347|2744098|P2|Overall Study|Withdrawal by Subject|4
861494|NCT01322347|2744099|P1|Overall Study|Withdrawal by Subject|1
861495|NCT01322347|2744098|P2|Overall Study|Protocol Violation|2
861496|NCT01322347|2744099|P1|Overall Study|Protocol Violation|5
861497|NCT01322347|2744098|P2|Overall Study|Physician Decision|1
861498|NCT01322347|2744099|P1|Overall Study|Physician Decision|2
861499|NCT01322347|2744098|P2|Overall Study|Death|3
861500|NCT01322347|2744099|P1|Overall Study|Death|5
861501|NCT01322347|2744098|P2|Overall Study|Adverse Event|2
861502|NCT01322347|2744099|P1|Overall Study|Adverse Event|7
861503|NCT01322386|2744141|P2|Overall Study|Physician Decision|1
861504|NCT01322386|2744142|P1|Overall Study|Physician Decision|0
861505|NCT01322386|2744141|P2|Overall Study|Protocol Violation|1
861506|NCT01322386|2744142|P1|Overall Study|Protocol Violation|0
861507|NCT01328366|2744150|P1|Overall Study|Lost to Follow-up|7
861508|NCT01328366|2744150|P1|Overall Study|Withdrawal by Subject|2
861509|NCT01328366|2744150|P1|Overall Study|Death|1
861510|NCT01328431|2744218|P2|12 Month (12M)|Lost to Follow-up|91
861511|NCT01328431|2744219|P1|12 Month (12M)|Lost to Follow-up|82
861512|NCT01328431|2744218|P2|12 Month (12M)|Death|6
861513|NCT01328431|2744219|P1|12 Month (12M)|Death|2
861514|NCT01328431|2744218|P2|3 Month (3M)|Lost to Follow-up|70
861515|NCT01328431|2744219|P1|3 Month (3M)|Lost to Follow-up|75
861516|NCT01328431|2744218|P2|3 Month (3M)|Death|2
861517|NCT01328431|2744219|P1|3 Month (3M)|Death|2
861518|NCT01328431|2744218|P2|1 Month (1M)|Lost to Follow-up|58
861519|NCT01328431|2744219|P1|1 Month (1M)|Lost to Follow-up|55
861520|NCT01328431|2744218|P2|Baseline|Protocol Violation|2
861521|NCT01328431|2744219|P1|Baseline|Protocol Violation|0
861612|NCT01328496|2744278|P2|Overall Study|Significant Change in Health Status|0
861613|NCT01328496|2744279|P1|Overall Study|Significant Change in Health Status|1
861614|NCT01328548|2744299|P2|Overall Study|Protocol Violation|0
861615|NCT01328548|2744300|P1|Overall Study|Protocol Violation|1
861616|NCT01328548|2744299|P2|Overall Study|Death|0
861617|NCT01328548|2744300|P1|Overall Study|Death|3
861618|NCT01328574|2744318|P1|Overall Study|Refused further treatment|1
861619|NCT01329263|2744355|P2|Overall Study|Withdrawal by Subject|2
861620|NCT01329263|2744356|P1|Overall Study|Withdrawal by Subject|1
861621|NCT01329263|2744355|P2|Overall Study|Lost to Follow-up|21
861622|NCT01329263|2744356|P1|Overall Study|Lost to Follow-up|4
861623|NCT01329419|2744368|P1|Overall Study|Protocol Violation|235
861624|NCT01329549|2744374|P1|Overall Study|Adverse Event|1
861625|NCT01329549|2744374|P1|Overall Study|Withdrawal by Subject|1
861626|NCT01329562|2744387|P2|Overall Study|Physician Decision|1
861627|NCT01329562|2744388|P1|Overall Study|Physician Decision|0
861628|NCT01329562|2744387|P2|Overall Study|Subject withdrew due to personal issues.|2
861629|NCT01329562|2744388|P1|Overall Study|Subject withdrew due to personal issues.|3
861630|NCT01329562|2744387|P2|Overall Study|Lost to Follow-up|1
861631|NCT01329562|2744388|P1|Overall Study|Lost to Follow-up|1
861632|NCT01329562|2744387|P2|Overall Study|Protocol Violation|3
861633|NCT01329562|2744388|P1|Overall Study|Protocol Violation|5
861634|NCT01329939|2744465|P4|Overall Study|Adverse Event|3
861635|NCT01329939|2744466|P3|Overall Study|Adverse Event|0
861636|NCT01329939|2744467|P2|Overall Study|Adverse Event|0
861637|NCT01329939|2744468|P1|Overall Study|Adverse Event|0
861638|NCT01329939|2744465|P4|Overall Study|Withdrawal by Subject|0
861639|NCT01329939|2744466|P3|Overall Study|Withdrawal by Subject|0
861640|NCT01329939|2744467|P2|Overall Study|Withdrawal by Subject|1
861641|NCT01329939|2744468|P1|Overall Study|Withdrawal by Subject|0
861642|NCT01329939|2744465|P4|Overall Study|Lost to Follow-up|2
861643|NCT01329939|2744466|P3|Overall Study|Lost to Follow-up|1
861644|NCT01329939|2744467|P2|Overall Study|Lost to Follow-up|0
861645|NCT01329939|2744468|P1|Overall Study|Lost to Follow-up|3
861646|NCT01329978|2744509|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
861647|NCT01329978|2744510|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
861648|NCT01329978|2744511|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
861649|NCT01329978|2744512|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
861650|NCT01329978|2744513|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
861651|NCT01329978|2744509|P5|Rerandomization Treatment Period|Lost to Follow-up|3
861652|NCT01329978|2744510|P4|Rerandomization Treatment Period|Lost to Follow-up|5
861653|NCT01329978|2744511|P3|Rerandomization Treatment Period|Lost to Follow-up|0
861654|NCT01329978|2744512|P2|Rerandomization Treatment Period|Lost to Follow-up|0
861655|NCT01329978|2744513|P1|Rerandomization Treatment Period|Lost to Follow-up|0
861656|NCT01329978|2744509|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
861657|NCT01329978|2744510|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
861658|NCT01329978|2744511|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
861659|NCT01329978|2744512|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
861660|NCT01329978|2744513|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
861661|NCT01329978|2744509|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
861662|NCT01329978|2744510|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
861663|NCT01329978|2744511|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
861664|NCT01329978|2744512|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
861665|NCT01329978|2744513|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
861666|NCT01329978|2744509|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
861667|NCT01329978|2744510|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
861668|NCT01329978|2744511|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
861669|NCT01329978|2744512|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
861670|NCT01329978|2744513|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
861671|NCT01329978|2744509|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
861672|NCT01329978|2744510|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
861673|NCT01329978|2744511|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
861674|NCT01329978|2744512|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
861675|NCT01329978|2744513|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
861676|NCT01329978|2744509|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
861677|NCT01329978|2744510|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
861678|NCT01329978|2744511|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
861679|NCT01329978|2744512|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
861680|NCT01329978|2744513|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
861681|NCT01330017|2744588|P5|Overall Study|Unknown Reason|2
861682|NCT01330017|2744589|P4|Overall Study|Unknown Reason|7
861683|NCT01330017|2744590|P3|Overall Study|Unknown Reason|5
861684|NCT01330017|2744591|P2|Overall Study|Unknown Reason|3
861685|NCT01330017|2744592|P1|Overall Study|Unknown Reason|5
861686|NCT01330017|2744588|P5|Overall Study|Protocol Violation|0
861687|NCT01330017|2744589|P4|Overall Study|Protocol Violation|1
861688|NCT01330017|2744590|P3|Overall Study|Protocol Violation|0
861689|NCT01330017|2744591|P2|Overall Study|Protocol Violation|0
861690|NCT01330017|2744592|P1|Overall Study|Protocol Violation|0
861691|NCT01330017|2744588|P5|Overall Study|Lost to Follow-up|0
861692|NCT01330017|2744589|P4|Overall Study|Lost to Follow-up|0
861693|NCT01330017|2744590|P3|Overall Study|Lost to Follow-up|1
861694|NCT01330017|2744591|P2|Overall Study|Lost to Follow-up|0
861695|NCT01330017|2744592|P1|Overall Study|Lost to Follow-up|0
861696|NCT01330017|2744588|P5|Overall Study|Withdrawal by Subject|1
861697|NCT01330017|2744589|P4|Overall Study|Withdrawal by Subject|0
861698|NCT01330017|2744590|P3|Overall Study|Withdrawal by Subject|1
861699|NCT01330017|2744591|P2|Overall Study|Withdrawal by Subject|0
861700|NCT01330017|2744592|P1|Overall Study|Withdrawal by Subject|0
861701|NCT01330017|2744588|P5|Overall Study|Adverse Event|0
861702|NCT01330017|2744589|P4|Overall Study|Adverse Event|4
861703|NCT01330017|2744590|P3|Overall Study|Adverse Event|1
861704|NCT01330017|2744591|P2|Overall Study|Adverse Event|1
861705|NCT01330017|2744592|P1|Overall Study|Adverse Event|0
861706|NCT01330030|2744640|P2|Overall Study|Lost to Follow-up|17
861707|NCT01330030|2744641|P1|Overall Study|Lost to Follow-up|16
861708|NCT01330108|2744658|P1|Overall Study|Withdrawal by Subject|4
861709|NCT01330303|2744687|P2|Period 1|Withdrawal by Subject|1
861710|NCT01330303|2744688|P1|Period 1|Withdrawal by Subject|0
861711|NCT01330303|2744687|P2|Period 1|Protocol Violation|1
861712|NCT01330303|2744688|P1|Period 1|Protocol Violation|0
861713|NCT01330303|2744687|P2|Period 1|Adverse Event|0
861714|NCT01330303|2744688|P1|Period 1|Adverse Event|1
861715|NCT01330316|2744700|P2|Overall Study|other than above|1
861716|NCT01330316|2744701|P1|Overall Study|other than above|0
861717|NCT01330316|2744700|P2|Overall Study|Withdrawal by Subject|1
861718|NCT01330316|2744701|P1|Overall Study|Withdrawal by Subject|0
861719|NCT01330316|2744700|P2|Overall Study|Lost to Follow-up|1
861720|NCT01330316|2744701|P1|Overall Study|Lost to Follow-up|0
861721|NCT01330316|2744700|P2|Overall Study|Lack of Efficacy|10
861722|NCT01330316|2744701|P1|Overall Study|Lack of Efficacy|0
861723|NCT01330316|2744700|P2|Overall Study|Adverse Event|2
861724|NCT01330316|2744701|P1|Overall Study|Adverse Event|2
861725|NCT01330381|2744754|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
861726|NCT01330381|2744755|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
861727|NCT01330381|2744756|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
861728|NCT01330381|2744754|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
861729|NCT01330381|2744755|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
861730|NCT01330381|2744756|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
861731|NCT01330381|2744754|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
861732|NCT01330381|2744755|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
861733|NCT01330381|2744756|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
861734|NCT01330381|2744754|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
861735|NCT01330381|2744755|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
861736|NCT01330381|2744756|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
861737|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
861738|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
861739|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
861740|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
861826|NCT01325428|2744987|P1|Part A|Other reason not defined above|2
861741|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
861742|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
861743|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
861744|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
861745|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
861746|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
861747|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
861748|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
861749|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
861750|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
861751|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
861752|NCT01330381|2744754|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
861753|NCT01330381|2744755|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
861754|NCT01330381|2744756|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
861755|NCT01330433|2744819|P2|Overall Study|Lost to Follow-up|0
861756|NCT01330433|2744820|P1|Overall Study|Lost to Follow-up|1
861757|NCT01330433|2744819|P2|Overall Study|Death|3
861758|NCT01330433|2744820|P1|Overall Study|Death|1
861759|NCT01330628|2744842|P2|Overall Study|Didn't receive study treatment|0
861760|NCT01330628|2744843|P1|Overall Study|Didn't receive study treatment|1
861761|NCT01330628|2744842|P2|Overall Study|Withdrawn|6
861762|NCT01330628|2744843|P1|Overall Study|Withdrawn|18
861763|NCT01330628|2744842|P2|Overall Study|Adverse Event|25
861764|NCT01330628|2744843|P1|Overall Study|Adverse Event|44
861765|NCT01330628|2744842|P2|Overall Study|Lost to Follow-up|6
861766|NCT01330628|2744843|P1|Overall Study|Lost to Follow-up|5
861767|NCT01330628|2744842|P2|Overall Study|Death|3
861768|NCT01330628|2744843|P1|Overall Study|Death|2
861769|NCT01330914|2744851|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
861770|NCT01330914|2744851|P1|Overall Study|Withdrawal by Subject|4
861771|NCT01331005|2744857|P2|Overall Study|Withdrawal by Subject|3
861772|NCT01331005|2744858|P1|Overall Study|Withdrawal by Subject|2
861773|NCT01331005|2744857|P2|Overall Study|Lost to Follow-up|1
861774|NCT01331005|2744858|P1|Overall Study|Lost to Follow-up|2
861775|NCT01331109|2744864|P1|Overall Study|Study Terminated by Sponsor|38
861776|NCT01331109|2744864|P1|Overall Study|Lost to Follow-up|1
861777|NCT01331109|2744864|P1|Overall Study|Withdrawal by Subject|7
861778|NCT01331109|2744864|P1|Overall Study|Protocol Violation|3
861779|NCT01331109|2744864|P1|Overall Study|Lack of Efficacy|2
861780|NCT01331109|2744864|P1|Overall Study|Adverse Event|6
861787|NCT01331291|2744908|P2|Overall Study|Death|1
861788|NCT01331291|2744909|P1|Overall Study|Death|0
861789|NCT01331291|2744908|P2|Overall Study|Lack of Efficacy|8
861790|NCT01331291|2744909|P1|Overall Study|Lack of Efficacy|2
861791|NCT01331681|2744934|P3|Overall Study|Not Received Study Treatment|2
861792|NCT01331681|2744935|P2|Overall Study|Not Received Study Treatment|0
861793|NCT01331681|2744936|P1|Overall Study|Not Received Study Treatment|0
861794|NCT01331681|2744934|P3|Overall Study|Switching to other therapy|1
861795|NCT01331681|2744935|P2|Overall Study|Switching to other therapy|0
861796|NCT01331681|2744936|P1|Overall Study|Switching to other therapy|0
861797|NCT01331681|2744934|P3|Overall Study|Sponsor decision|0
861798|NCT01331681|2744935|P2|Overall Study|Sponsor decision|1
861799|NCT01331681|2744936|P1|Overall Study|Sponsor decision|1
861800|NCT01331681|2744934|P3|Overall Study|Therapeutic procedure required|0
861801|NCT01331681|2744935|P2|Overall Study|Therapeutic procedure required|0
861802|NCT01331681|2744936|P1|Overall Study|Therapeutic procedure required|1
861803|NCT01331681|2744934|P3|Overall Study|Physician Decision|4
861804|NCT01331681|2744935|P2|Overall Study|Physician Decision|0
861805|NCT01331681|2744936|P1|Overall Study|Physician Decision|2
861806|NCT01331681|2744934|P3|Overall Study|Lost to Follow-up|1
861807|NCT01331681|2744935|P2|Overall Study|Lost to Follow-up|4
861808|NCT01331681|2744936|P1|Overall Study|Lost to Follow-up|2
861809|NCT01331681|2744934|P3|Overall Study|Protocol Violation|0
861810|NCT01331681|2744935|P2|Overall Study|Protocol Violation|1
861811|NCT01331681|2744936|P1|Overall Study|Protocol Violation|1
861812|NCT01331681|2744934|P3|Overall Study|Withdrawal by Subject|15
861813|NCT01331681|2744935|P2|Overall Study|Withdrawal by Subject|8
861814|NCT01331681|2744936|P1|Overall Study|Withdrawal by Subject|12
861815|NCT01331681|2744934|P3|Overall Study|Lack of Efficacy|0
861816|NCT01331681|2744935|P2|Overall Study|Lack of Efficacy|1
861817|NCT01331681|2744936|P1|Overall Study|Lack of Efficacy|0
861818|NCT01331681|2744934|P3|Overall Study|Death|2
861819|NCT01331681|2744935|P2|Overall Study|Death|6
861820|NCT01331681|2744936|P1|Overall Study|Death|6
861821|NCT01331681|2744934|P3|Overall Study|Adverse Event|10
861822|NCT01331681|2744935|P2|Overall Study|Adverse Event|13
861823|NCT01331681|2744936|P1|Overall Study|Adverse Event|10
861824|NCT01325428|2744987|P1|Part B|Other reason not defined above|1
861825|NCT01325428|2744987|P1|Part B|Refused continue taking trial medication|2
861827|NCT01325428|2744987|P1|Part A|Refused continue taking trial medication|2
861828|NCT01325428|2744987|P1|Part A|Other adverse event|1
861829|NCT01325428|2744987|P1|Part A|Clinical signs, symptoms of progression|2
861830|NCT01325428|2744987|P1|Part A|Progressive disease according to RECIST|9
861831|NCT01325493|2745004|P2|Overall Study|Allergy|0
861832|NCT01325493|2745005|P1|Overall Study|Allergy|1
861833|NCT01325493|2745004|P2|Overall Study|loss of neuromonitoring signals|2
861834|NCT01325493|2745005|P1|Overall Study|loss of neuromonitoring signals|0
861835|NCT01325493|2745004|P2|Overall Study|Protocol Violation|1
861836|NCT01325493|2745005|P1|Overall Study|Protocol Violation|0
861837|NCT01325532|2745019|P2|Overall Study|Withdrawal by Subject|0
861838|NCT01325532|2745020|P1|Overall Study|Withdrawal by Subject|2
861839|NCT01325623|2745030|P1|Overall Study|Withdrawal by Subject|3
861840|NCT01325701|2745074|P2|Overall Study|Rollerover Extension Study|0
861841|NCT01325701|2745075|P1|Overall Study|Rollerover Extension Study|4
861842|NCT01325701|2745074|P2|Overall Study|Withdrawal by Subject|1
861843|NCT01325701|2745075|P1|Overall Study|Withdrawal by Subject|2
861844|NCT01325701|2745074|P2|Overall Study|Physician Decision|2
861845|NCT01325701|2745075|P1|Overall Study|Physician Decision|2
861846|NCT01325701|2745074|P2|Overall Study|Protocol Violation|0
861847|NCT01325701|2745075|P1|Overall Study|Protocol Violation|1
861848|NCT01325701|2745074|P2|Overall Study|Adverse Event|0
861849|NCT01325701|2745075|P1|Overall Study|Adverse Event|12
861850|NCT01331824|2745085|P1|Overall Study|Withdrawal by Subject|1
861851|NCT01331824|2745085|P1|Overall Study|Disease Progression|9
861852|NCT01331824|2745085|P1|Overall Study|Death|1
861853|NCT01331824|2745085|P1|Overall Study|Adverse Event|2
861854|NCT01331837|2745093|P2|Overall Study|Withdrawal by Subject|16
861855|NCT01331837|2745094|P1|Overall Study|Withdrawal by Subject|13
861856|NCT01331837|2745093|P2|Overall Study|Info not recorded|16
861857|NCT01331837|2745094|P1|Overall Study|Info not recorded|10
861858|NCT01331837|2745093|P2|Overall Study|Lost to Follow-up|1
861859|NCT01331837|2745094|P1|Overall Study|Lost to Follow-up|3
861860|NCT01331837|2745093|P2|Overall Study|Death|34
861861|NCT01331837|2745094|P1|Overall Study|Death|30
861862|NCT01332019|2745136|P2|Overall Study|Adverse Event|22
861863|NCT01332019|2745137|P1|Overall Study|Adverse Event|13
861864|NCT01332019|2745136|P2|Overall Study|Lost to Follow-up|7
861865|NCT01332019|2745137|P1|Overall Study|Lost to Follow-up|4
861866|NCT01332019|2745136|P2|Overall Study|Withdrawal by Subject|71
861867|NCT01332019|2745137|P1|Overall Study|Withdrawal by Subject|73
861868|NCT01332019|2745136|P2|Overall Study|Physician Decision|3
861869|NCT01332019|2745137|P1|Overall Study|Physician Decision|4
861870|NCT01332019|2745136|P2|Overall Study|Death|1
861871|NCT01332019|2745137|P1|Overall Study|Death|2
861872|NCT01332019|2745136|P2|Overall Study|Not Specified|18
861873|NCT01332019|2745137|P1|Overall Study|Not Specified|16
861874|NCT01332019|2745136|P2|Overall Study|Was Not Dosed|0
861875|NCT01332019|2745137|P1|Overall Study|Was Not Dosed|1
861876|NCT01333111|2745222|P3|Overall Study|Ineffective therapy|1
861877|NCT01333111|2745223|P2|Overall Study|Ineffective therapy|0
861878|NCT01333111|2745224|P1|Overall Study|Ineffective therapy|0
861879|NCT01333111|2745222|P3|Overall Study|Non-compliance|0
861880|NCT01333111|2745223|P2|Overall Study|Non-compliance|0
861881|NCT01333111|2745224|P1|Overall Study|Non-compliance|1
861882|NCT01333111|2745222|P3|Overall Study|withdrawal criteria|0
861883|NCT01333111|2745223|P2|Overall Study|withdrawal criteria|1
861884|NCT01333111|2745224|P1|Overall Study|withdrawal criteria|0
861885|NCT01333111|2745222|P3|Overall Study|unclassified|0
861886|NCT01333111|2745223|P2|Overall Study|unclassified|0
861887|NCT01333111|2745224|P1|Overall Study|unclassified|1
861888|NCT01333111|2745222|P3|Overall Study|personal reasons|1
861889|NCT01333111|2745223|P2|Overall Study|personal reasons|0
861890|NCT01333111|2745224|P1|Overall Study|personal reasons|0
861891|NCT01333111|2745222|P3|Overall Study|patient undergoing major surgery|0
861892|NCT01333111|2745223|P2|Overall Study|patient undergoing major surgery|2
861893|NCT01333111|2745224|P1|Overall Study|patient undergoing major surgery|0
861894|NCT01333189|2745250|P2|Overall Study|Moved from region|1
861895|NCT01333189|2745251|P1|Overall Study|Moved from region|0
861896|NCT01333189|2745250|P2|Overall Study|Transportation difficulties|1
861897|NCT01333189|2745251|P1|Overall Study|Transportation difficulties|0
861898|NCT01333189|2745250|P2|Overall Study|Adverse Event|0
861899|NCT01333189|2745251|P1|Overall Study|Adverse Event|1
861900|NCT01333189|2745250|P2|Overall Study|Time constraints|0
861901|NCT01333189|2745251|P1|Overall Study|Time constraints|1
861902|NCT01333397|2745284|P5|Overall Study|Lost to Follow-up|0
861903|NCT01333397|2745285|P4|Overall Study|Lost to Follow-up|1
861904|NCT01333397|2745286|P3|Overall Study|Lost to Follow-up|0
861905|NCT01333397|2745287|P2|Overall Study|Lost to Follow-up|0
861906|NCT01333397|2745288|P1|Overall Study|Lost to Follow-up|1
861907|NCT01333475|2745375|P2|Overall Study|Toxicity|3
861908|NCT01333475|2745376|P1|Overall Study|Toxicity|1
861909|NCT01333475|2745375|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
861910|NCT01333475|2745376|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
861911|NCT01333501|2745405|P2|Overall Study|Withdrawn consent|12
861912|NCT01333501|2745406|P1|Overall Study|Withdrawn consent|3
861913|NCT01333501|2745405|P2|Overall Study|Unsatisfactory therapeutic effect|7
861914|NCT01333501|2745406|P1|Overall Study|Unsatisfactory therapeutic effect|1
861915|NCT01333501|2745405|P2|Overall Study|Abnormal laboratory value|1
861916|NCT01333501|2745406|P1|Overall Study|Abnormal laboratory value|2
861917|NCT01333501|2745405|P2|Overall Study|Adverse Event|1
861918|NCT01333501|2745406|P1|Overall Study|Adverse Event|3
861919|NCT01333722|2745465|P2|Overall Study|Withdrawal by Subject|1
861920|NCT01333722|2745466|P1|Overall Study|Withdrawal by Subject|0
861921|NCT01333722|2745465|P2|Overall Study|Lack of Efficacy|2
861922|NCT01333722|2745466|P1|Overall Study|Lack of Efficacy|0
861923|NCT01333865|2745491|P1|Overall Study|Adverse Event|2
861924|NCT01333956|2745500|P4|Overall Study|Withdrawal by Subject|0
861925|NCT01333956|2745501|P3|Overall Study|Withdrawal by Subject|1
861926|NCT01333956|2745502|P2|Overall Study|Withdrawal by Subject|2
861927|NCT01333956|2745503|P1|Overall Study|Withdrawal by Subject|0
861928|NCT01333956|2745500|P4|Overall Study|Unable to complete study procedure|1
861929|NCT01333956|2745501|P3|Overall Study|Unable to complete study procedure|0
861930|NCT01333956|2745502|P2|Overall Study|Unable to complete study procedure|0
861931|NCT01333956|2745503|P1|Overall Study|Unable to complete study procedure|1
861932|NCT01333956|2745500|P4|Overall Study|Lost to Follow-up|1
861933|NCT01333956|2745501|P3|Overall Study|Lost to Follow-up|0
861934|NCT01333956|2745502|P2|Overall Study|Lost to Follow-up|2
861935|NCT01333956|2745503|P1|Overall Study|Lost to Follow-up|1
861936|NCT01334125|2745539|P2|Overall Study|Lost to Follow-up|3
861937|NCT01334125|2745540|P1|Overall Study|Lost to Follow-up|3
861938|NCT01334515|2745582|P2|Overall Study|Withdrawal by Subject|1
861939|NCT01334515|2745583|P1|Overall Study|Withdrawal by Subject|1
861940|NCT01334515|2745582|P2|Overall Study|Physician Decision|1
861941|NCT01334515|2745583|P1|Overall Study|Physician Decision|1
861942|NCT01334515|2745582|P2|Overall Study|Lack of Efficacy|21
861943|NCT01334515|2745583|P1|Overall Study|Lack of Efficacy|8
861944|NCT01334515|2745582|P2|Overall Study|Death|0
861945|NCT01334515|2745583|P1|Overall Study|Death|1
861946|NCT01334515|2745582|P2|Overall Study|Adverse Event|6
861947|NCT01334515|2745583|P1|Overall Study|Adverse Event|1
861948|NCT01334554|2745593|P2|Overall Study|Adverse Event|2
861949|NCT01334554|2745594|P1|Overall Study|Adverse Event|4
861950|NCT01334606|2745602|P1|Overall Study|Study Terminated due to slow enrolment|18
861952|NCT01334866|2745641|P1|Overall Study|medically necessary post-procedure|1
861953|NCT01334866|2745641|P1|Overall Study|medically necessary prior to procedure|2
861954|NCT01334866|2745641|P1|Overall Study|Physician Decision|3
861955|NCT01334866|2745641|P1|Overall Study|Lost to Follow-up|3
861956|NCT01334866|2745641|P1|Overall Study|Withdrawal by Subject|10
861957|NCT01334918|2745651|P2|Overall Study|Withdrawal by Subject|1
861958|NCT01334918|2745652|P1|Overall Study|Withdrawal by Subject|0
861959|NCT01334918|2745651|P2|Overall Study|Adverse Event|0
861960|NCT01334918|2745652|P1|Overall Study|Adverse Event|2
861961|NCT01334918|2745651|P2|Overall Study|Did not receive study drug|0
861962|NCT01334918|2745652|P1|Overall Study|Did not receive study drug|6
861963|NCT01335464|2745776|P2|Overall Study|Reason other than those stated above|1
861964|NCT01335464|2745777|P1|Overall Study|Reason other than those stated above|1
861965|NCT01335464|2745776|P2|Overall Study|Not treated|0
861966|NCT01335464|2745777|P1|Overall Study|Not treated|2
861967|NCT01335464|2745776|P2|Overall Study|Consent withdrawn, not due to AE|23
861968|NCT01335464|2745777|P1|Overall Study|Consent withdrawn, not due to AE|12
861969|NCT01335464|2745776|P2|Overall Study|Non compliant with protocol|0
861970|NCT01335464|2745777|P1|Overall Study|Non compliant with protocol|2
861971|NCT01335464|2745776|P2|Overall Study|Adverse Event|25
861972|NCT01335464|2745777|P1|Overall Study|Adverse Event|15
861973|NCT01335477|2745841|P2|Overall Study|Reason other than those stated above|2
861974|NCT01335477|2745842|P1|Overall Study|Reason other than those stated above|2
861975|NCT01335477|2745841|P2|Overall Study|Not treated|2
861976|NCT01335477|2745842|P1|Overall Study|Not treated|1
861977|NCT01335477|2745841|P2|Overall Study|Consent withdrawn, not due to AE|9
861978|NCT01335477|2745842|P1|Overall Study|Consent withdrawn, not due to AE|7
861979|NCT01335477|2745841|P2|Overall Study|Lost to Follow-up|2
861980|NCT01335477|2745842|P1|Overall Study|Lost to Follow-up|1
861981|NCT01335477|2745841|P2|Overall Study|Non compliant with protocol|2
861982|NCT01335477|2745842|P1|Overall Study|Non compliant with protocol|0
861983|NCT01335477|2745841|P2|Overall Study|Adverse Event|42
861984|NCT01335477|2745842|P1|Overall Study|Adverse Event|30
861985|NCT01328717|2745904|P1|Overall Study|Adverse Event|1
861986|NCT01328756|2745909|P1|Overall Study|Unspecified|29
861987|NCT01328756|2745909|P1|Overall Study|Lost to Follow-up|5
861988|NCT01328756|2745909|P1|Overall Study|Withdrawal by Subject|41
861989|NCT01328756|2745909|P1|Overall Study|Lack of Efficacy|5
861990|NCT01328756|2745909|P1|Overall Study|Adverse Event|39
861991|NCT01328756|2745909|P1|Overall Study|Protocol Violation|4
861992|NCT01328951|2745973|P2|Overall Study|Not Specified|6
861993|NCT01328951|2745974|P1|Overall Study|Not Specified|11
861994|NCT01328951|2745973|P2|Overall Study|Study Closed by the Sponsor|31
861995|NCT01328951|2745974|P1|Overall Study|Study Closed by the Sponsor|36
861996|NCT01328951|2745973|P2|Overall Study|Withdrawal by Subject|6
861997|NCT01328951|2745974|P1|Overall Study|Withdrawal by Subject|6
861998|NCT01328951|2745973|P2|Overall Study|Lost to Follow-up|7
861999|NCT01328951|2745974|P1|Overall Study|Lost to Follow-up|6
862000|NCT01328951|2745973|P2|Overall Study|Death|258
862001|NCT01328951|2745974|P1|Overall Study|Death|243
862002|NCT01328951|2745973|P2|Overall Study|Adverse Event|0
862003|NCT01328951|2745974|P1|Overall Study|Adverse Event|2
862004|NCT01328951|2745973|P2|Overall Study|Disease Progression|14
862005|NCT01328951|2745974|P1|Overall Study|Disease Progression|17
862006|NCT01329029|2746018|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
862007|NCT01329029|2746019|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
862008|NCT01329029|2746018|P2|Overall Study|Lost to Follow-up|5
862009|NCT01329029|2746019|P1|Overall Study|Lost to Follow-up|8
862010|NCT01329029|2746018|P2|Overall Study|Physician Decision|13
862011|NCT01329029|2746019|P1|Overall Study|Physician Decision|16
862012|NCT01329029|2746018|P2|Overall Study|COPD Exacerbation|18
862013|NCT01329029|2746019|P1|Overall Study|COPD Exacerbation|11
862014|NCT01329029|2746018|P2|Overall Study|Other|20
862015|NCT01329029|2746019|P1|Overall Study|Other|14
862016|NCT01329029|2746018|P2|Overall Study|Death|19
862017|NCT01329029|2746019|P1|Overall Study|Death|16
862018|NCT01329029|2746018|P2|Overall Study|Adverse Event|29
862019|NCT01329029|2746019|P1|Overall Study|Adverse Event|82
862020|NCT01329029|2746018|P2|Overall Study|Withdrawal by Subject|87
862021|NCT01329029|2746019|P1|Overall Study|Withdrawal by Subject|117
862082|NCT01335971|2746211|P3|Overall Study|Did not complete bronchoscopy|1
862083|NCT01335971|2746212|P2|Overall Study|Did not complete bronchoscopy|1
862084|NCT01335971|2746213|P1|Overall Study|Did not complete bronchoscopy|1
862085|NCT01335971|2746211|P3|Overall Study|Withdrawal by Subject|0
862086|NCT01335971|2746212|P2|Overall Study|Withdrawal by Subject|0
862087|NCT01335971|2746213|P1|Overall Study|Withdrawal by Subject|1
862088|NCT01335997|2746250|P2|Period III|Lost to Follow-up|0
862089|NCT01335997|2746251|P1|Period III|Lost to Follow-up|1
862090|NCT01335997|2746250|P2|Period III|Protocol Violation|1
862091|NCT01335997|2746251|P1|Period III|Protocol Violation|0
862092|NCT01335997|2746250|P2|Period III|Study Terminated by Sponsor|76
862093|NCT01335997|2746251|P1|Period III|Study Terminated by Sponsor|77
862094|NCT01335997|2746250|P2|Period III|Adverse Event|2
862095|NCT01335997|2746251|P1|Period III|Adverse Event|0
862096|NCT01335997|2746250|P2|Period I and II|Physician Decision|1
862097|NCT01335997|2746251|P1|Period I and II|Physician Decision|2
862098|NCT01335997|2746250|P2|Period I and II|Protocol Violation|10
862099|NCT01335997|2746251|P1|Period I and II|Protocol Violation|9
862100|NCT01335997|2746250|P2|Period I and II|Study Terminated by Sponsor|415
862101|NCT01335997|2746251|P1|Period I and II|Study Terminated by Sponsor|406
862102|NCT01335997|2746250|P2|Period I and II|Withdrawal by Subject|4
862103|NCT01335997|2746251|P1|Period I and II|Withdrawal by Subject|9
862104|NCT01335997|2746250|P2|Period I and II|Lost to Follow-up|5
862105|NCT01335997|2746251|P1|Period I and II|Lost to Follow-up|3
862106|NCT01335997|2746250|P2|Period I and II|Noncompliance with Study Drug|1
862107|NCT01335997|2746251|P1|Period I and II|Noncompliance with Study Drug|1
862108|NCT01335997|2746250|P2|Period I and II|Adverse Event|43
862109|NCT01335997|2746251|P1|Period I and II|Adverse Event|63
862110|NCT01336023|2746264|P3|Week 27 to 52|Unclassified|9
862111|NCT01336023|2746265|P2|Week 27 to 52|Unclassified|18
862112|NCT01336023|2746266|P1|Week 27 to 52|Unclassified|13
862113|NCT01336023|2746264|P3|Week 27 to 52|Withdrawal Criteria|16
862114|NCT01336023|2746265|P2|Week 27 to 52|Withdrawal Criteria|19
862115|NCT01336023|2746266|P1|Week 27 to 52|Withdrawal Criteria|14
862116|NCT01336023|2746264|P3|Week 27 to 52|Protocol Violation|1
862117|NCT01336023|2746265|P2|Week 27 to 52|Protocol Violation|2
862118|NCT01336023|2746266|P1|Week 27 to 52|Protocol Violation|0
862119|NCT01336023|2746264|P3|Week 27 to 52|Adverse Event|2
862120|NCT01336023|2746265|P2|Week 27 to 52|Adverse Event|5
862121|NCT01336023|2746266|P1|Week 27 to 52|Adverse Event|1
862122|NCT01336023|2746264|P3|Week 0 to Week 26|Unclassified|9
862123|NCT01336023|2746265|P2|Week 0 to Week 26|Unclassified|16
862124|NCT01336023|2746266|P1|Week 0 to Week 26|Unclassified|5
862125|NCT01336023|2746264|P3|Week 0 to Week 26|Withdrawal Criteria|40
862126|NCT01336023|2746265|P2|Week 0 to Week 26|Withdrawal Criteria|69
862127|NCT01336023|2746266|P1|Week 0 to Week 26|Withdrawal Criteria|34
862128|NCT01336023|2746264|P3|Week 0 to Week 26|Protocol Violation|0
862129|NCT01336023|2746265|P2|Week 0 to Week 26|Protocol Violation|2
862130|NCT01336023|2746266|P1|Week 0 to Week 26|Protocol Violation|1
862131|NCT01336023|2746264|P3|Week 0 to Week 26|Lack of Efficacy|0
862132|NCT01336023|2746265|P2|Week 0 to Week 26|Lack of Efficacy|1
862133|NCT01336023|2746266|P1|Week 0 to Week 26|Lack of Efficacy|0
862134|NCT01336023|2746264|P3|Week 0 to Week 26|Adverse Event|24
862135|NCT01336023|2746265|P2|Week 0 to Week 26|Adverse Event|10
862136|NCT01336023|2746266|P1|Week 0 to Week 26|Adverse Event|8
862137|NCT01336205|2746302|P2|Overall Study|Did not receive treatment|0
862138|NCT01336205|2746303|P1|Overall Study|Did not receive treatment|4
862139|NCT01336205|2746302|P2|Overall Study|Withdrawal by Subject|38
862140|NCT01336205|2746303|P1|Overall Study|Withdrawal by Subject|72
862141|NCT01336205|2746302|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
862142|NCT01336205|2746303|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
862143|NCT01336205|2746302|P2|Overall Study|Death|1
862144|NCT01336205|2746303|P1|Overall Study|Death|1
862145|NCT01336205|2746302|P2|Overall Study|Adverse Event|6
862146|NCT01336205|2746303|P1|Overall Study|Adverse Event|56
862147|NCT01336205|2746302|P2|Overall Study|Severe noncompliance with protocol|2
862148|NCT01336205|2746303|P1|Overall Study|Severe noncompliance with protocol|9
862149|NCT01336205|2746302|P2|Overall Study|Lack of Efficacy|0
862150|NCT01336205|2746303|P1|Overall Study|Lack of Efficacy|4
862151|NCT01336205|2746302|P2|Overall Study|Study-Specific Withdrawal Criteria|7
862152|NCT01336205|2746303|P1|Overall Study|Study-Specific Withdrawal Criteria|16
862153|NCT01336205|2746302|P2|Overall Study|Lost to Follow-up|20
862154|NCT01336205|2746303|P1|Overall Study|Lost to Follow-up|40
862155|NCT01336205|2746302|P2|Overall Study|Other|9
862156|NCT01336205|2746303|P1|Overall Study|Other|22
862157|NCT01336569|2746330|P1|Overall Study|Lost to Follow-up|4
862210|NCT01336647|2746357|P3|Overall Study|Lost to Follow-up|3
862211|NCT01336647|2746358|P2|Overall Study|Lost to Follow-up|1
862212|NCT01336647|2746359|P1|Overall Study|Lost to Follow-up|4
862213|NCT01336712|2746370|P1|Overall Study|Lack of Efficacy|1
862214|NCT01336712|2746370|P1|Overall Study|Death|2
862215|NCT01336738|2746385|P5|Overall Study|Unspecified|4
862216|NCT01336738|2746386|P4|Overall Study|Unspecified|3
862217|NCT01336738|2746387|P3|Overall Study|Unspecified|2
862218|NCT01336738|2746388|P2|Overall Study|Unspecified|3
862219|NCT01336738|2746389|P1|Overall Study|Unspecified|3
862220|NCT01336738|2746385|P5|Overall Study|Withdrawal by Subject|1
862221|NCT01336738|2746386|P4|Overall Study|Withdrawal by Subject|1
862222|NCT01336738|2746387|P3|Overall Study|Withdrawal by Subject|2
862223|NCT01336738|2746388|P2|Overall Study|Withdrawal by Subject|0
862224|NCT01336738|2746389|P1|Overall Study|Withdrawal by Subject|2
862225|NCT01336738|2746385|P5|Overall Study|Protocol Violation|0
862226|NCT01336738|2746386|P4|Overall Study|Protocol Violation|0
862227|NCT01336738|2746387|P3|Overall Study|Protocol Violation|0
862228|NCT01336738|2746388|P2|Overall Study|Protocol Violation|1
862229|NCT01336738|2746389|P1|Overall Study|Protocol Violation|0
862230|NCT01336738|2746385|P5|Overall Study|Did not meet entrance criteria|0
862231|NCT01336738|2746386|P4|Overall Study|Did not meet entrance criteria|0
862232|NCT01336738|2746387|P3|Overall Study|Did not meet entrance criteria|0
862233|NCT01336738|2746388|P2|Overall Study|Did not meet entrance criteria|1
862234|NCT01336738|2746389|P1|Overall Study|Did not meet entrance criteria|0
862235|NCT01336738|2746385|P5|Overall Study|Lost to Follow-up|2
862236|NCT01336738|2746386|P4|Overall Study|Lost to Follow-up|2
862237|NCT01336738|2746387|P3|Overall Study|Lost to Follow-up|2
862238|NCT01336738|2746388|P2|Overall Study|Lost to Follow-up|1
862239|NCT01336738|2746389|P1|Overall Study|Lost to Follow-up|2
862240|NCT01336738|2746385|P5|Overall Study|Adverse Event|3
862241|NCT01336738|2746386|P4|Overall Study|Adverse Event|1
862242|NCT01336738|2746387|P3|Overall Study|Adverse Event|2
862243|NCT01336738|2746388|P2|Overall Study|Adverse Event|3
862244|NCT01336738|2746389|P1|Overall Study|Adverse Event|0
862245|NCT01336764|2746433|P2|Overall Study|Withdrawal by Subject|5
862246|NCT01336764|2746434|P1|Overall Study|Withdrawal by Subject|5
862247|NCT01336894|2746442|P2|Follow-up|Study terminated prematurely|7
862248|NCT01336894|2746443|P1|Follow-up|Study terminated prematurely|2
862249|NCT01336972|2746464|P3|Overall Study|Adverse Event|0
862250|NCT01336972|2746465|P2|Overall Study|Adverse Event|1
862251|NCT01336972|2746466|P1|Overall Study|Adverse Event|1
862252|NCT01337050|2746504|P3|Overall Study|Participants refused further follow-up|7
862253|NCT01337050|2746505|P2|Overall Study|Participants refused further follow-up|7
862254|NCT01337050|2746506|P1|Overall Study|Participants refused further follow-up|0
862255|NCT01337050|2746504|P3|Overall Study|Unspecified|8
862256|NCT01337050|2746505|P2|Overall Study|Unspecified|6
862257|NCT01337050|2746506|P1|Overall Study|Unspecified|4
862258|NCT01337050|2746504|P3|Overall Study|Death|4
862259|NCT01337050|2746505|P2|Overall Study|Death|0
862260|NCT01337050|2746506|P1|Overall Study|Death|0
862261|NCT01337115|2746570|P2|Overall Study|Protocol Violation|0
862262|NCT01337115|2746571|P1|Overall Study|Protocol Violation|2
862263|NCT01337167|2746585|P2|Toddler Vaccinations|Withdrawal by Subject|0
862264|NCT01337167|2746586|P1|Toddler Vaccinations|Withdrawal by Subject|3
862265|NCT01337167|2746585|P2|Toddler Vaccinations|Protocol Violation|1
862266|NCT01337167|2746586|P1|Toddler Vaccinations|Protocol Violation|0
862267|NCT01337167|2746585|P2|Toddler Vaccinations|Lost to Follow-up|12
862268|NCT01337167|2746586|P1|Toddler Vaccinations|Lost to Follow-up|11
862269|NCT01337167|2746585|P2|Interim Period|Other protocol criterion not met|1
862270|NCT01337167|2746586|P1|Interim Period|Other protocol criterion not met|0
862271|NCT01337167|2746585|P2|Interim Period|Withdrawal by Subject|10
862272|NCT01337167|2746586|P1|Interim Period|Withdrawal by Subject|18
862273|NCT01337167|2746585|P2|Interim Period|Protocol Violation|3
862274|NCT01337167|2746586|P1|Interim Period|Protocol Violation|5
862275|NCT01337167|2746585|P2|Interim Period|Physician Decision|3
862276|NCT01337167|2746586|P1|Interim Period|Physician Decision|6
862277|NCT01337167|2746585|P2|Interim Period|Non-compliance with study drug|0
862278|NCT01337167|2746586|P1|Interim Period|Non-compliance with study drug|1
862279|NCT01337167|2746585|P2|Interim Period|Lost to Follow-up|23
862280|NCT01337167|2746586|P1|Interim Period|Lost to Follow-up|51
862281|NCT01337167|2746585|P2|Infant Series|Randomized but not vaccinated|3
862282|NCT01337167|2746586|P1|Infant Series|Randomized but not vaccinated|5
862283|NCT01337167|2746585|P2|Infant Series|Withdrawal by Subject|4
862284|NCT01337167|2746586|P1|Infant Series|Withdrawal by Subject|15
862285|NCT01337167|2746585|P2|Infant Series|Protocol Violation|9
862286|NCT01337167|2746586|P1|Infant Series|Protocol Violation|22
862287|NCT01337167|2746585|P2|Infant Series|Physician Decision|1
862288|NCT01337167|2746586|P1|Infant Series|Physician Decision|3
862289|NCT01337167|2746585|P2|Infant Series|Non-compliance with study drug|1
862290|NCT01337167|2746586|P1|Infant Series|Non-compliance with study drug|2
862291|NCT01337167|2746585|P2|Infant Series|Lost to Follow-up|7
862292|NCT01337167|2746586|P1|Infant Series|Lost to Follow-up|13
862293|NCT01337167|2746585|P2|Infant Series|Death|1
862294|NCT01337167|2746586|P1|Infant Series|Death|1
862295|NCT01337167|2746585|P2|Infant Series|Adverse Event|1
862296|NCT01337167|2746586|P1|Infant Series|Adverse Event|1
862297|NCT01337297|2746654|P2|Overall Study|Lost to Follow-up|3
862298|NCT01337297|2746655|P1|Overall Study|Lost to Follow-up|1
862299|NCT01337297|2746654|P2|Overall Study|They entered to single anodal tDCS|3
862300|NCT01337297|2746655|P1|Overall Study|They entered to single anodal tDCS|4
862301|NCT01337635|2746703|P2|Overall Study|Lost to Follow-up|1
862302|NCT01337635|2746704|P1|Overall Study|Lost to Follow-up|0
862303|NCT01337674|2746712|P4|Treatment Period 2|Withdrawal by Subject|0
862304|NCT01337674|2746713|P3|Treatment Period 2|Withdrawal by Subject|1
862305|NCT01337674|2746714|P2|Treatment Period 2|Withdrawal by Subject|0
862306|NCT01337674|2746715|P1|Treatment Period 2|Withdrawal by Subject|0
862307|NCT01337674|2746712|P4|Treatment Period 1|Discontinued due to blood draws|1
862308|NCT01337674|2746713|P3|Treatment Period 1|Discontinued due to blood draws|0
862309|NCT01337674|2746714|P2|Treatment Period 1|Discontinued due to blood draws|0
862310|NCT01337674|2746715|P1|Treatment Period 1|Discontinued due to blood draws|0
862311|NCT01337674|2746712|P4|Treatment Period 1|Adverse Event|0
862312|NCT01337674|2746713|P3|Treatment Period 1|Adverse Event|0
862313|NCT01337674|2746714|P2|Treatment Period 1|Adverse Event|1
862314|NCT01337674|2746715|P1|Treatment Period 1|Adverse Event|0
862315|NCT01337960|2746745|P3|Overall Study|Withdrawal by Subject|0
862316|NCT01337960|2746746|P2|Overall Study|Withdrawal by Subject|0
862317|NCT01337960|2746747|P1|Overall Study|Withdrawal by Subject|1
862318|NCT01337960|2746745|P3|Overall Study|Lost to Follow-up|0
862319|NCT01337960|2746746|P2|Overall Study|Lost to Follow-up|0
862320|NCT01337960|2746747|P1|Overall Study|Lost to Follow-up|1
862321|NCT01338012|2746767|P1|Overall Study|Study terminated|4
862322|NCT01338012|2746767|P1|Overall Study|Death|4
862323|NCT01338025|2746773|P2|Overall Study|Found ineligible after starting|0
862324|NCT01338025|2746774|P1|Overall Study|Found ineligible after starting|1
862325|NCT01338025|2746773|P2|Overall Study|Withdrawal by Subject|2
862326|NCT01338025|2746774|P1|Overall Study|Withdrawal by Subject|0
862327|NCT01338025|2746773|P2|Overall Study|Unexpected closure of study|9
862328|NCT01338025|2746774|P1|Overall Study|Unexpected closure of study|10
862329|NCT01338493|2746786|P1|12 Months Follow up|Lost to Follow-up|9
862330|NCT01338493|2746786|P1|6 Months Follow up|Missed visit|8
862331|NCT01338493|2746786|P1|6 Months Follow up|Lost to Follow-up|11
862332|NCT01338493|2746786|P1|Discharge|Missed visit|1
862333|NCT01338493|2746786|P1|Discharge|Death|1
862334|NCT01338493|2746786|P1|Enrolled|Patient not implanted|4
862335|NCT01338493|2746786|P1|Enrolled|Withdrawal by Subject|1
862336|NCT01332149|2746815|P2|Overall Study|Randomized but not treated|2
862337|NCT01332149|2746816|P1|Overall Study|Randomized but not treated|1
862338|NCT01332149|2746815|P2|Overall Study|Did not meet entrance criteria|4
862339|NCT01332149|2746816|P1|Overall Study|Did not meet entrance criteria|3
862340|NCT01332149|2746815|P2|Overall Study|Insufficient clinical response|7
862341|NCT01332149|2746816|P1|Overall Study|Insufficient clinical response|4
862342|NCT01332149|2746815|P2|Overall Study|Lost to Follow-up|1
862343|NCT01332149|2746816|P1|Overall Study|Lost to Follow-up|1
862344|NCT01332149|2746815|P2|Overall Study|Withdrawal by Subject|5
862345|NCT01332149|2746816|P1|Overall Study|Withdrawal by Subject|4
862346|NCT01332149|2746815|P2|Overall Study|Protocol Violation|3
862347|NCT01332149|2746816|P1|Overall Study|Protocol Violation|1
862348|NCT01332149|2746815|P2|Overall Study|Other unspecified|7
862349|NCT01332149|2746816|P1|Overall Study|Other unspecified|5
862350|NCT01332149|2746815|P2|Overall Study|Adverse Event|9
862351|NCT01332149|2746816|P1|Overall Study|Adverse Event|11
862352|NCT01332227|2747033|P2|Overall Study|Patient began prohibited medication|1
862353|NCT01332227|2747034|P1|Overall Study|Patient began prohibited medication|0
862354|NCT01332227|2747033|P2|Overall Study|Patient moved from area|0
862355|NCT01332227|2747034|P1|Overall Study|Patient moved from area|1
862356|NCT01332227|2747033|P2|Overall Study|Poor compliance/noncompliance|1
862357|NCT01332227|2747034|P1|Overall Study|Poor compliance/noncompliance|1
862358|NCT01332227|2747033|P2|Overall Study|Lack of Efficacy|1
862359|NCT01332227|2747034|P1|Overall Study|Lack of Efficacy|3
862360|NCT01332227|2747033|P2|Overall Study|Lost to Follow-up|0
862361|NCT01332227|2747034|P1|Overall Study|Lost to Follow-up|2
862362|NCT01332227|2747033|P2|Overall Study|Withdrawal by Subject|1
862363|NCT01332227|2747034|P1|Overall Study|Withdrawal by Subject|5
862364|NCT01332227|2747033|P2|Overall Study|Adverse Event|1
862365|NCT01332227|2747034|P1|Overall Study|Adverse Event|4
862366|NCT01332292|2747081|P2|Treatment Period 2 (14 Days)|Physician Decision|1
862367|NCT01332292|2747082|P1|Treatment Period 2 (14 Days)|Physician Decision|1
862368|NCT01332292|2747081|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
862369|NCT01332292|2747082|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
862370|NCT01332292|2747081|P2|Treatment Period 1 (14 Days)|Adverse Event|0
862371|NCT01332292|2747082|P1|Treatment Period 1 (14 Days)|Adverse Event|1
862372|NCT01332305|2747147|P5|Overall Study|Physician Decision|0
862373|NCT01332305|2747148|P4|Overall Study|Physician Decision|1
862374|NCT01332305|2747149|P3|Overall Study|Physician Decision|0
862375|NCT01332305|2747150|P2|Overall Study|Physician Decision|0
862376|NCT01332305|2747151|P1|Overall Study|Physician Decision|0
862377|NCT01332305|2747147|P5|Overall Study|Treatment Failure|0
862378|NCT01332305|2747148|P4|Overall Study|Treatment Failure|0
862379|NCT01332305|2747149|P3|Overall Study|Treatment Failure|0
862380|NCT01332305|2747150|P2|Overall Study|Treatment Failure|1
862381|NCT01332305|2747151|P1|Overall Study|Treatment Failure|1
862382|NCT01332305|2747147|P5|Overall Study|Withdrawal by Sponsor|1
862383|NCT01332305|2747148|P4|Overall Study|Withdrawal by Sponsor|1
862384|NCT01332305|2747149|P3|Overall Study|Withdrawal by Sponsor|0
862385|NCT01332305|2747150|P2|Overall Study|Withdrawal by Sponsor|0
862386|NCT01332305|2747151|P1|Overall Study|Withdrawal by Sponsor|1
862387|NCT01332305|2747147|P5|Overall Study|Protocol Violation|3
862388|NCT01332305|2747148|P4|Overall Study|Protocol Violation|0
862389|NCT01332305|2747149|P3|Overall Study|Protocol Violation|1
862390|NCT01332305|2747150|P2|Overall Study|Protocol Violation|2
862391|NCT01332305|2747151|P1|Overall Study|Protocol Violation|1
862392|NCT01332305|2747147|P5|Overall Study|Lost to Follow-up|3
862393|NCT01332305|2747148|P4|Overall Study|Lost to Follow-up|2
862394|NCT01332305|2747149|P3|Overall Study|Lost to Follow-up|3
862395|NCT01332305|2747150|P2|Overall Study|Lost to Follow-up|2
862396|NCT01332305|2747151|P1|Overall Study|Lost to Follow-up|0
862397|NCT01332305|2747147|P5|Overall Study|Withdrawal by Subject|0
862398|NCT01332305|2747148|P4|Overall Study|Withdrawal by Subject|1
862399|NCT01332305|2747149|P3|Overall Study|Withdrawal by Subject|4
862400|NCT01332305|2747150|P2|Overall Study|Withdrawal by Subject|5
862401|NCT01332305|2747151|P1|Overall Study|Withdrawal by Subject|6
862402|NCT01332305|2747147|P5|Overall Study|Adverse Event|5
862403|NCT01332305|2747148|P4|Overall Study|Adverse Event|3
862404|NCT01332305|2747149|P3|Overall Study|Adverse Event|6
862405|NCT01332305|2747150|P2|Overall Study|Adverse Event|4
862406|NCT01332305|2747151|P1|Overall Study|Adverse Event|1
862407|NCT01332318|2747177|P4|Overall Study|Protocol Violation|1
862408|NCT01332318|2747178|P3|Overall Study|Protocol Violation|1
862409|NCT01332318|2747179|P2|Overall Study|Protocol Violation|0
862410|NCT01332318|2747180|P1|Overall Study|Protocol Violation|1
862411|NCT01332318|2747177|P4|Overall Study|Withdrawal by Subject|1
862412|NCT01332318|2747178|P3|Overall Study|Withdrawal by Subject|0
862413|NCT01332318|2747179|P2|Overall Study|Withdrawal by Subject|1
862414|NCT01332318|2747180|P1|Overall Study|Withdrawal by Subject|1
862415|NCT01332318|2747177|P4|Overall Study|Adverse Event|0
862416|NCT01332318|2747178|P3|Overall Study|Adverse Event|0
862417|NCT01332318|2747179|P2|Overall Study|Adverse Event|3
862418|NCT01332318|2747180|P1|Overall Study|Adverse Event|0
862419|NCT01332968|2747404|P8|Follow-Up Period|Lost to Follow-up|2
862420|NCT01332968|2747405|P7|Follow-Up Period|Lost to Follow-up|1
862421|NCT01332968|2747406|P6|Follow-Up Period|Lost to Follow-up|0
862422|NCT01332968|2747407|P5|Follow-Up Period|Lost to Follow-up|0
862423|NCT01332968|2747408|P4|Follow-Up Period|Lost to Follow-up|0
862424|NCT01332968|2747409|P3|Follow-Up Period|Lost to Follow-up|0
862425|NCT01332968|2747410|P2|Follow-Up Period|Lost to Follow-up|0
862426|NCT01332968|2747411|P1|Follow-Up Period|Lost to Follow-up|0
862427|NCT01332968|2747404|P8|Follow-Up Period|Withdrawal by Subject|2
862428|NCT01332968|2747405|P7|Follow-Up Period|Withdrawal by Subject|1
862429|NCT01332968|2747406|P6|Follow-Up Period|Withdrawal by Subject|0
862430|NCT01332968|2747407|P5|Follow-Up Period|Withdrawal by Subject|0
862431|NCT01332968|2747408|P4|Follow-Up Period|Withdrawal by Subject|0
862432|NCT01332968|2747409|P3|Follow-Up Period|Withdrawal by Subject|0
862433|NCT01332968|2747410|P2|Follow-Up Period|Withdrawal by Subject|0
862434|NCT01332968|2747411|P1|Follow-Up Period|Withdrawal by Subject|0
862435|NCT01332968|2747404|P8|Follow-Up Period|Follow-up ongoing|505
862436|NCT01332968|2747405|P7|Follow-Up Period|Follow-up ongoing|502
862437|NCT01332968|2747406|P6|Follow-Up Period|Follow-up ongoing|0
862438|NCT01332968|2747407|P5|Follow-Up Period|Follow-up ongoing|0
862439|NCT01332968|2747408|P4|Follow-Up Period|Follow-up ongoing|0
862440|NCT01332968|2747409|P3|Follow-Up Period|Follow-up ongoing|0
862441|NCT01332968|2747410|P2|Follow-Up Period|Follow-up ongoing|0
862442|NCT01332968|2747411|P1|Follow-Up Period|Follow-up ongoing|0
862443|NCT01332968|2747404|P8|Follow-Up Period|Death|22
862444|NCT01332968|2747405|P7|Follow-Up Period|Death|38
862445|NCT01332968|2747406|P6|Follow-Up Period|Death|0
862446|NCT01332968|2747407|P5|Follow-Up Period|Death|0
862447|NCT01332968|2747408|P4|Follow-Up Period|Death|0
862448|NCT01332968|2747409|P3|Follow-Up Period|Death|0
862449|NCT01332968|2747410|P2|Follow-Up Period|Death|0
862450|NCT01332968|2747411|P1|Follow-Up Period|Death|0
862451|NCT01332968|2747404|P8|Maintenance/Observation Period|Treatment ongoing|0
862452|NCT01332968|2747405|P7|Maintenance/Observation Period|Treatment ongoing|0
862453|NCT01332968|2747406|P6|Maintenance/Observation Period|Treatment ongoing|8
862454|NCT01332968|2747407|P5|Maintenance/Observation Period|Treatment ongoing|10
862455|NCT01332968|2747408|P4|Maintenance/Observation Period|Treatment ongoing|62
862456|NCT01332968|2747409|P3|Maintenance/Observation Period|Treatment ongoing|54
862457|NCT01332968|2747410|P2|Maintenance/Observation Period|Treatment ongoing|0
862458|NCT01332968|2747411|P1|Maintenance/Observation Period|Treatment ongoing|0
862459|NCT01332968|2747404|P8|Maintenance/Observation Period|Adverse Event|0
862460|NCT01332968|2747405|P7|Maintenance/Observation Period|Adverse Event|0
862461|NCT01332968|2747406|P6|Maintenance/Observation Period|Adverse Event|0
862462|NCT01332968|2747407|P5|Maintenance/Observation Period|Adverse Event|0
862463|NCT01332968|2747408|P4|Maintenance/Observation Period|Adverse Event|65
862464|NCT01332968|2747409|P3|Maintenance/Observation Period|Adverse Event|50
862465|NCT01332968|2747410|P2|Maintenance/Observation Period|Adverse Event|0
862466|NCT01332968|2747411|P1|Maintenance/Observation Period|Adverse Event|0
862467|NCT01332968|2747404|P8|Maintenance/Observation Period|Death|0
862468|NCT01332968|2747405|P7|Maintenance/Observation Period|Death|0
862469|NCT01332968|2747406|P6|Maintenance/Observation Period|Death|0
862470|NCT01332968|2747407|P5|Maintenance/Observation Period|Death|0
862471|NCT01332968|2747408|P4|Maintenance/Observation Period|Death|6
862472|NCT01332968|2747409|P3|Maintenance/Observation Period|Death|5
862473|NCT01332968|2747410|P2|Maintenance/Observation Period|Death|0
862474|NCT01332968|2747411|P1|Maintenance/Observation Period|Death|0
862475|NCT01332968|2747404|P8|Maintenance/Observation Period|Lost to Follow-up|0
862476|NCT01332968|2747405|P7|Maintenance/Observation Period|Lost to Follow-up|0
862477|NCT01332968|2747406|P6|Maintenance/Observation Period|Lost to Follow-up|0
862478|NCT01332968|2747407|P5|Maintenance/Observation Period|Lost to Follow-up|0
862479|NCT01332968|2747408|P4|Maintenance/Observation Period|Lost to Follow-up|2
862480|NCT01332968|2747409|P3|Maintenance/Observation Period|Lost to Follow-up|1
862481|NCT01332968|2747410|P2|Maintenance/Observation Period|Lost to Follow-up|0
862482|NCT01332968|2747411|P1|Maintenance/Observation Period|Lost to Follow-up|0
862483|NCT01332968|2747404|P8|Maintenance/Observation Period|Non-compliance|0
862484|NCT01332968|2747405|P7|Maintenance/Observation Period|Non-compliance|0
862485|NCT01332968|2747406|P6|Maintenance/Observation Period|Non-compliance|1
862486|NCT01332968|2747407|P5|Maintenance/Observation Period|Non-compliance|0
862487|NCT01332968|2747408|P4|Maintenance/Observation Period|Non-compliance|3
862488|NCT01332968|2747409|P3|Maintenance/Observation Period|Non-compliance|2
862489|NCT01332968|2747410|P2|Maintenance/Observation Period|Non-compliance|0
862490|NCT01332968|2747411|P1|Maintenance/Observation Period|Non-compliance|0
862491|NCT01332968|2747404|P8|Maintenance/Observation Period|Other|0
862492|NCT01332968|2747405|P7|Maintenance/Observation Period|Other|0
862493|NCT01332968|2747406|P6|Maintenance/Observation Period|Other|0
862494|NCT01332968|2747407|P5|Maintenance/Observation Period|Other|0
862495|NCT01332968|2747408|P4|Maintenance/Observation Period|Other|5
862496|NCT01332968|2747409|P3|Maintenance/Observation Period|Other|4
862497|NCT01332968|2747410|P2|Maintenance/Observation Period|Other|0
862498|NCT01332968|2747411|P1|Maintenance/Observation Period|Other|0
862499|NCT01332968|2747404|P8|Maintenance/Observation Period|Physician Decision|0
862500|NCT01332968|2747405|P7|Maintenance/Observation Period|Physician Decision|0
862501|NCT01332968|2747406|P6|Maintenance/Observation Period|Physician Decision|0
862502|NCT01332968|2747407|P5|Maintenance/Observation Period|Physician Decision|0
862503|NCT01332968|2747408|P4|Maintenance/Observation Period|Physician Decision|19
862504|NCT01332968|2747409|P3|Maintenance/Observation Period|Physician Decision|14
862505|NCT01332968|2747410|P2|Maintenance/Observation Period|Physician Decision|0
862506|NCT01332968|2747411|P1|Maintenance/Observation Period|Physician Decision|0
862507|NCT01332968|2747404|P8|Maintenance/Observation Period|Progressive disease|0
862508|NCT01332968|2747405|P7|Maintenance/Observation Period|Progressive disease|0
862509|NCT01332968|2747406|P6|Maintenance/Observation Period|Progressive disease|0
862510|NCT01332968|2747407|P5|Maintenance/Observation Period|Progressive disease|0
862511|NCT01332968|2747408|P4|Maintenance/Observation Period|Progressive disease|39
862512|NCT01332968|2747409|P3|Maintenance/Observation Period|Progressive disease|72
862513|NCT01332968|2747410|P2|Maintenance/Observation Period|Progressive disease|0
862514|NCT01332968|2747411|P1|Maintenance/Observation Period|Progressive disease|0
862515|NCT01332968|2747404|P8|Maintenance/Observation Period|Protocol Violation|0
862516|NCT01332968|2747405|P7|Maintenance/Observation Period|Protocol Violation|0
862517|NCT01332968|2747406|P6|Maintenance/Observation Period|Protocol Violation|0
862518|NCT01332968|2747407|P5|Maintenance/Observation Period|Protocol Violation|0
862519|NCT01332968|2747408|P4|Maintenance/Observation Period|Protocol Violation|1
862520|NCT01332968|2747409|P3|Maintenance/Observation Period|Protocol Violation|1
862521|NCT01332968|2747410|P2|Maintenance/Observation Period|Protocol Violation|0
862522|NCT01332968|2747411|P1|Maintenance/Observation Period|Protocol Violation|0
862523|NCT01332968|2747404|P8|Maintenance/Observation Period|Withdrawal by Subject|0
862524|NCT01332968|2747405|P7|Maintenance/Observation Period|Withdrawal by Subject|0
862525|NCT01332968|2747406|P6|Maintenance/Observation Period|Withdrawal by Subject|0
862526|NCT01332968|2747407|P5|Maintenance/Observation Period|Withdrawal by Subject|0
862527|NCT01332968|2747408|P4|Maintenance/Observation Period|Withdrawal by Subject|5
862528|NCT01332968|2747409|P3|Maintenance/Observation Period|Withdrawal by Subject|10
862529|NCT01332968|2747410|P2|Maintenance/Observation Period|Withdrawal by Subject|0
862530|NCT01332968|2747411|P1|Maintenance/Observation Period|Withdrawal by Subject|0
862531|NCT01332968|2747404|P8|Induction Period|Randomized, but not treated|0
862532|NCT01332968|2747405|P7|Induction Period|Randomized, but not treated|0
862533|NCT01332968|2747406|P6|Induction Period|Randomized, but not treated|0
862534|NCT01332968|2747407|P5|Induction Period|Randomized, but not treated|0
862535|NCT01332968|2747408|P4|Induction Period|Randomized, but not treated|0
862536|NCT01332968|2747409|P3|Induction Period|Randomized, but not treated|0
862537|NCT01332968|2747410|P2|Induction Period|Randomized, but not treated|7
862538|NCT01332968|2747411|P1|Induction Period|Randomized, but not treated|4
862539|NCT01332968|2747404|P8|Induction Period|Adverse Event|0
862540|NCT01332968|2747405|P7|Induction Period|Adverse Event|0
862541|NCT01332968|2747406|P6|Induction Period|Adverse Event|0
862542|NCT01332968|2747407|P5|Induction Period|Adverse Event|0
862543|NCT01332968|2747408|P4|Induction Period|Adverse Event|0
862544|NCT01332968|2747409|P3|Induction Period|Adverse Event|0
862545|NCT01332968|2747410|P2|Induction Period|Adverse Event|26
862546|NCT01332968|2747411|P1|Induction Period|Adverse Event|23
862547|NCT01332968|2747404|P8|Induction Period|Death|0
862548|NCT01332968|2747405|P7|Induction Period|Death|0
862549|NCT01332968|2747406|P6|Induction Period|Death|0
862550|NCT01332968|2747407|P5|Induction Period|Death|0
862551|NCT01332968|2747408|P4|Induction Period|Death|0
862552|NCT01332968|2747409|P3|Induction Period|Death|0
862553|NCT01332968|2747410|P2|Induction Period|Death|4
862554|NCT01332968|2747411|P1|Induction Period|Death|1
862555|NCT01332968|2747404|P8|Induction Period|Non-compliance|0
862556|NCT01332968|2747405|P7|Induction Period|Non-compliance|0
862557|NCT01332968|2747406|P6|Induction Period|Non-compliance|0
862558|NCT01332968|2747407|P5|Induction Period|Non-compliance|0
862559|NCT01332968|2747408|P4|Induction Period|Non-compliance|0
862560|NCT01332968|2747409|P3|Induction Period|Non-compliance|0
862561|NCT01332968|2747410|P2|Induction Period|Non-compliance|0
862562|NCT01332968|2747411|P1|Induction Period|Non-compliance|1
862563|NCT01332968|2747404|P8|Induction Period|Other|0
862564|NCT01332968|2747405|P7|Induction Period|Other|0
862565|NCT01332968|2747406|P6|Induction Period|Other|0
862566|NCT01332968|2747407|P5|Induction Period|Other|0
862567|NCT01332968|2747408|P4|Induction Period|Other|0
862568|NCT01332968|2747409|P3|Induction Period|Other|0
862569|NCT01332968|2747410|P2|Induction Period|Other|2
862570|NCT01332968|2747411|P1|Induction Period|Other|2
862571|NCT01332968|2747404|P8|Induction Period|Physician Decision|0
862572|NCT01332968|2747405|P7|Induction Period|Physician Decision|0
862573|NCT01332968|2747406|P6|Induction Period|Physician Decision|0
862574|NCT01332968|2747407|P5|Induction Period|Physician Decision|0
862575|NCT01332968|2747408|P4|Induction Period|Physician Decision|0
862576|NCT01332968|2747409|P3|Induction Period|Physician Decision|0
862577|NCT01332968|2747410|P2|Induction Period|Physician Decision|1
862578|NCT01332968|2747411|P1|Induction Period|Physician Decision|6
862579|NCT01332968|2747404|P8|Induction Period|Progressive disease|0
862580|NCT01332968|2747405|P7|Induction Period|Progressive disease|0
862581|NCT01332968|2747406|P6|Induction Period|Progressive disease|0
862582|NCT01332968|2747407|P5|Induction Period|Progressive disease|0
862583|NCT01332968|2747408|P4|Induction Period|Progressive disease|0
862584|NCT01332968|2747409|P3|Induction Period|Progressive disease|0
862585|NCT01332968|2747410|P2|Induction Period|Progressive disease|7
862586|NCT01332968|2747411|P1|Induction Period|Progressive disease|15
862587|NCT01332968|2747404|P8|Induction Period|Protocol Violation|0
862588|NCT01332968|2747405|P7|Induction Period|Protocol Violation|0
862589|NCT01332968|2747406|P6|Induction Period|Protocol Violation|0
862590|NCT01332968|2747407|P5|Induction Period|Protocol Violation|0
862591|NCT01332968|2747408|P4|Induction Period|Protocol Violation|0
862592|NCT01332968|2747409|P3|Induction Period|Protocol Violation|0
862593|NCT01332968|2747410|P2|Induction Period|Protocol Violation|4
862594|NCT01332968|2747411|P1|Induction Period|Protocol Violation|3
862595|NCT01332968|2747404|P8|Induction Period|Withdrawal by Subject|0
862596|NCT01332968|2747405|P7|Induction Period|Withdrawal by Subject|0
862597|NCT01332968|2747406|P6|Induction Period|Withdrawal by Subject|0
862598|NCT01332968|2747407|P5|Induction Period|Withdrawal by Subject|0
862599|NCT01332968|2747408|P4|Induction Period|Withdrawal by Subject|0
862600|NCT01332968|2747409|P3|Induction Period|Withdrawal by Subject|0
862601|NCT01332968|2747410|P2|Induction Period|Withdrawal by Subject|5
862602|NCT01332968|2747411|P1|Induction Period|Withdrawal by Subject|3
862603|NCT01332994|2747486|P1|Overall Study|Not Specified|8
862604|NCT01332994|2747486|P1|Overall Study|Administrative Problem|2
862605|NCT01332994|2747486|P1|Overall Study|Withdrawal by Subject|15
862606|NCT01332994|2747486|P1|Overall Study|Protocol Violation|6
862607|NCT01332994|2747486|P1|Overall Study|Lost to Follow-up|4
862608|NCT01332994|2747486|P1|Overall Study|Lack of Efficacy|1
862609|NCT01332994|2747486|P1|Overall Study|Death|1
862610|NCT01332994|2747486|P1|Overall Study|Adverse Event|34
862611|NCT01338610|2747545|P3|Overall Study|Adverse Event|0
862612|NCT01338610|2747546|P2|Overall Study|Adverse Event|0
862613|NCT01338610|2747547|P1|Overall Study|Adverse Event|3
862614|NCT01338610|2747545|P3|Overall Study|Protocol Violation|1
862615|NCT01338610|2747546|P2|Overall Study|Protocol Violation|0
862616|NCT01338610|2747547|P1|Overall Study|Protocol Violation|1
862617|NCT01338610|2747545|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
862618|NCT01338610|2747546|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
862619|NCT01338610|2747547|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
862620|NCT01338636|2747554|P1|Overall Study|Withdrawn due to lack of improvement|8
862621|NCT01338792|2747574|P1|Overall Study|Withdrawal by Subject|1
862622|NCT01338792|2747574|P1|Overall Study|Death|1
862623|NCT01338792|2747574|P1|Overall Study|Adverse Event|2
862624|NCT01338818|2747580|P1|Overall Study|Protocol Deviation|4
862625|NCT01338818|2747580|P1|Overall Study|Administrative problems|3
862626|NCT01338818|2747580|P1|Overall Study|Lost to Follow-up|4
862627|NCT01338818|2747580|P1|Overall Study|Withdrawal by Subject|11
862628|NCT01338818|2747580|P1|Overall Study|no longer require study drug|1
862629|NCT01338818|2747580|P1|Overall Study|Lack of Efficacy|5
862630|NCT01338818|2747580|P1|Overall Study|Adverse Event|8
862631|NCT01338870|2747597|P6|Overall Study|Adverse Event|1
862632|NCT01338870|2747598|P5|Overall Study|Adverse Event|4
862633|NCT01338870|2747599|P4|Overall Study|Adverse Event|5
862634|NCT01338870|2747600|P3|Overall Study|Adverse Event|1
862635|NCT01338870|2747601|P2|Overall Study|Adverse Event|4
862636|NCT01338870|2747602|P1|Overall Study|Adverse Event|4
862637|NCT01338870|2747597|P6|Overall Study|Protocol Violation|1
862638|NCT01338870|2747598|P5|Overall Study|Protocol Violation|1
862639|NCT01338870|2747599|P4|Overall Study|Protocol Violation|2
862640|NCT01338870|2747600|P3|Overall Study|Protocol Violation|2
862641|NCT01338870|2747601|P2|Overall Study|Protocol Violation|2
862642|NCT01338870|2747602|P1|Overall Study|Protocol Violation|0
862643|NCT01338870|2747597|P6|Overall Study|Unspecified|2
862644|NCT01338870|2747598|P5|Overall Study|Unspecified|0
862645|NCT01338870|2747599|P4|Overall Study|Unspecified|2
862646|NCT01338870|2747600|P3|Overall Study|Unspecified|3
862647|NCT01338870|2747601|P2|Overall Study|Unspecified|3
862648|NCT01338870|2747602|P1|Overall Study|Unspecified|3
862649|NCT01338870|2747597|P6|Overall Study|Withdrawal by Subject|2
862650|NCT01338870|2747598|P5|Overall Study|Withdrawal by Subject|0
862651|NCT01338870|2747599|P4|Overall Study|Withdrawal by Subject|0
862652|NCT01338870|2747600|P3|Overall Study|Withdrawal by Subject|4
862653|NCT01338870|2747601|P2|Overall Study|Withdrawal by Subject|3
862654|NCT01338870|2747602|P1|Overall Study|Withdrawal by Subject|2
862655|NCT01338870|2747597|P6|Overall Study|Lost to Follow-up|0
862656|NCT01338870|2747598|P5|Overall Study|Lost to Follow-up|1
862657|NCT01338870|2747599|P4|Overall Study|Lost to Follow-up|0
862658|NCT01338870|2747600|P3|Overall Study|Lost to Follow-up|1
862659|NCT01338870|2747601|P2|Overall Study|Lost to Follow-up|0
862660|NCT01338870|2747602|P1|Overall Study|Lost to Follow-up|0
862661|NCT01339390|2747689|P2|Overall Study|Lost to Follow-up|127
862662|NCT01339390|2747690|P1|Overall Study|Lost to Follow-up|125
862663|NCT01339390|2747689|P2|Overall Study|Death|29
862664|NCT01339390|2747690|P1|Overall Study|Death|32
862665|NCT01339429|2747729|P1|Overall Study|Physician Decision|3
862666|NCT01339429|2747729|P1|Overall Study|Withdrawal by Subject|1
862667|NCT01339832|2747734|P1|Overall Study|Death|11
862668|NCT01339832|2747734|P1|Overall Study|Lost to Follow-up|3
862669|NCT01339897|2747749|P4|Overall Study|Adverse Event|1
862670|NCT01339897|2747750|P3|Overall Study|Adverse Event|0
862671|NCT01339897|2747751|P2|Overall Study|Adverse Event|0
862672|NCT01339897|2747752|P1|Overall Study|Adverse Event|1
862673|NCT01339923|2747785|P7|Overall Study|Withdrawal by Subject|2
862674|NCT01339923|2747786|P6|Overall Study|Withdrawal by Subject|3
862675|NCT01339923|2747787|P5|Overall Study|Withdrawal by Subject|4
862676|NCT01339923|2747788|P4|Overall Study|Withdrawal by Subject|1
862677|NCT01339923|2747789|P3|Overall Study|Withdrawal by Subject|6
862678|NCT01339923|2747790|P2|Overall Study|Withdrawal by Subject|11
862679|NCT01339923|2747791|P1|Overall Study|Withdrawal by Subject|7
862680|NCT01339923|2747785|P7|Overall Study|Unable to Classify|5
862681|NCT01339923|2747786|P6|Overall Study|Unable to Classify|1
862682|NCT01339923|2747787|P5|Overall Study|Unable to Classify|0
862683|NCT01339923|2747788|P4|Overall Study|Unable to Classify|0
862684|NCT01339923|2747789|P3|Overall Study|Unable to Classify|1
862685|NCT01339923|2747790|P2|Overall Study|Unable to Classify|0
862686|NCT01339923|2747791|P1|Overall Study|Unable to Classify|1
862687|NCT01339923|2747785|P7|Overall Study|Protocol Violation|1
862688|NCT01339923|2747786|P6|Overall Study|Protocol Violation|3
862689|NCT01339923|2747787|P5|Overall Study|Protocol Violation|0
862690|NCT01339923|2747788|P4|Overall Study|Protocol Violation|0
862691|NCT01339923|2747789|P3|Overall Study|Protocol Violation|0
862692|NCT01339923|2747790|P2|Overall Study|Protocol Violation|0
862693|NCT01339923|2747791|P1|Overall Study|Protocol Violation|0
862694|NCT01339923|2747785|P7|Overall Study|Lost to Follow-up|5
862695|NCT01339923|2747786|P6|Overall Study|Lost to Follow-up|1
862696|NCT01339923|2747787|P5|Overall Study|Lost to Follow-up|1
862697|NCT01339923|2747788|P4|Overall Study|Lost to Follow-up|3
862698|NCT01339923|2747789|P3|Overall Study|Lost to Follow-up|0
862699|NCT01339923|2747790|P2|Overall Study|Lost to Follow-up|4
862700|NCT01339923|2747791|P1|Overall Study|Lost to Follow-up|4
862701|NCT01339923|2747785|P7|Overall Study|Inappropriate Enrollment|0
862702|NCT01339923|2747786|P6|Overall Study|Inappropriate Enrollment|1
862703|NCT01339923|2747787|P5|Overall Study|Inappropriate Enrollment|0
862704|NCT01339923|2747788|P4|Overall Study|Inappropriate Enrollment|0
862705|NCT01339923|2747789|P3|Overall Study|Inappropriate Enrollment|0
862706|NCT01339923|2747790|P2|Overall Study|Inappropriate Enrollment|0
862707|NCT01339923|2747791|P1|Overall Study|Inappropriate Enrollment|1
862708|NCT01339923|2747785|P7|Overall Study|Adverse Event|1
862709|NCT01339923|2747786|P6|Overall Study|Adverse Event|0
862710|NCT01339923|2747787|P5|Overall Study|Adverse Event|0
862711|NCT01339923|2747788|P4|Overall Study|Adverse Event|0
862712|NCT01339923|2747789|P3|Overall Study|Adverse Event|1
862713|NCT01339923|2747790|P2|Overall Study|Adverse Event|1
862714|NCT01339923|2747791|P1|Overall Study|Adverse Event|1
862715|NCT01340014|2747868|P2|Period 2, Second 7 Days|Adverse Event|1
862716|NCT01340014|2747869|P1|Period 2, Second 7 Days|Adverse Event|0
862717|NCT01340014|2747868|P2|Period 1, First 7 Days|Personal Reasons|0
862718|NCT01340014|2747869|P1|Period 1, First 7 Days|Personal Reasons|1
862719|NCT01340014|2747868|P2|Period 1, First 7 Days|Adverse Event|0
862720|NCT01340014|2747869|P1|Period 1, First 7 Days|Adverse Event|1
862721|NCT01340027|2747889|P12|Overall Study|Miscellaneous|0
862722|NCT01340027|2747890|P11|Overall Study|Miscellaneous|1
862723|NCT01340027|2747891|P10|Overall Study|Miscellaneous|0
862724|NCT01340027|2747892|P9|Overall Study|Miscellaneous|0
862725|NCT01340027|2747893|P8|Overall Study|Miscellaneous|0
862726|NCT01340027|2747894|P7|Overall Study|Miscellaneous|0
862727|NCT01340027|2747895|P6|Overall Study|Miscellaneous|0
862728|NCT01340027|2747896|P5|Overall Study|Miscellaneous|0
862729|NCT01340027|2747897|P4|Overall Study|Miscellaneous|1
862730|NCT01340027|2747898|P3|Overall Study|Miscellaneous|0
862731|NCT01340027|2747899|P2|Overall Study|Miscellaneous|0
862732|NCT01340027|2747900|P1|Overall Study|Miscellaneous|0
862733|NCT01340027|2747889|P12|Overall Study|Withdrawal by Subject|1
862734|NCT01340027|2747890|P11|Overall Study|Withdrawal by Subject|0
862735|NCT01340027|2747891|P10|Overall Study|Withdrawal by Subject|2
862736|NCT01340027|2747892|P9|Overall Study|Withdrawal by Subject|1
862737|NCT01340027|2747893|P8|Overall Study|Withdrawal by Subject|4
862738|NCT01340027|2747894|P7|Overall Study|Withdrawal by Subject|3
862739|NCT01340027|2747895|P6|Overall Study|Withdrawal by Subject|2
862740|NCT01340027|2747896|P5|Overall Study|Withdrawal by Subject|3
862741|NCT01340027|2747897|P4|Overall Study|Withdrawal by Subject|3
862742|NCT01340027|2747898|P3|Overall Study|Withdrawal by Subject|1
862743|NCT01340027|2747899|P2|Overall Study|Withdrawal by Subject|3
862744|NCT01340027|2747900|P1|Overall Study|Withdrawal by Subject|4
862745|NCT01340027|2747889|P12|Overall Study|Protocol Violation|0
862746|NCT01340027|2747890|P11|Overall Study|Protocol Violation|0
862747|NCT01340027|2747891|P10|Overall Study|Protocol Violation|2
862748|NCT01340027|2747892|P9|Overall Study|Protocol Violation|2
862749|NCT01340027|2747893|P8|Overall Study|Protocol Violation|1
862750|NCT01340027|2747894|P7|Overall Study|Protocol Violation|0
862751|NCT01340027|2747895|P6|Overall Study|Protocol Violation|0
862752|NCT01340027|2747896|P5|Overall Study|Protocol Violation|6
862753|NCT01340027|2747897|P4|Overall Study|Protocol Violation|0
862754|NCT01340027|2747898|P3|Overall Study|Protocol Violation|0
862755|NCT01340027|2747899|P2|Overall Study|Protocol Violation|2
862756|NCT01340027|2747900|P1|Overall Study|Protocol Violation|1
862757|NCT01340027|2747889|P12|Overall Study|Lost to Follow-up|0
862758|NCT01340027|2747890|P11|Overall Study|Lost to Follow-up|0
862759|NCT01340027|2747891|P10|Overall Study|Lost to Follow-up|1
862760|NCT01340027|2747892|P9|Overall Study|Lost to Follow-up|0
862761|NCT01340027|2747893|P8|Overall Study|Lost to Follow-up|0
862762|NCT01340027|2747894|P7|Overall Study|Lost to Follow-up|1
862763|NCT01340027|2747895|P6|Overall Study|Lost to Follow-up|0
862764|NCT01340027|2747896|P5|Overall Study|Lost to Follow-up|0
862765|NCT01340027|2747897|P4|Overall Study|Lost to Follow-up|0
862766|NCT01340027|2747898|P3|Overall Study|Lost to Follow-up|0
862767|NCT01340027|2747899|P2|Overall Study|Lost to Follow-up|1
862768|NCT01340027|2747900|P1|Overall Study|Lost to Follow-up|0
862769|NCT01340027|2747889|P12|Overall Study|Lack of Efficacy|0
862770|NCT01340027|2747890|P11|Overall Study|Lack of Efficacy|0
862771|NCT01340027|2747891|P10|Overall Study|Lack of Efficacy|0
862772|NCT01340027|2747892|P9|Overall Study|Lack of Efficacy|1
862773|NCT01340027|2747893|P8|Overall Study|Lack of Efficacy|1
862774|NCT01340027|2747894|P7|Overall Study|Lack of Efficacy|1
862775|NCT01340027|2747895|P6|Overall Study|Lack of Efficacy|0
862776|NCT01340027|2747896|P5|Overall Study|Lack of Efficacy|0
862777|NCT01340027|2747897|P4|Overall Study|Lack of Efficacy|0
862778|NCT01340027|2747898|P3|Overall Study|Lack of Efficacy|0
862779|NCT01340027|2747899|P2|Overall Study|Lack of Efficacy|0
862780|NCT01340027|2747900|P1|Overall Study|Lack of Efficacy|0
862781|NCT01340027|2747889|P12|Overall Study|Adverse Event|3
862782|NCT01340027|2747890|P11|Overall Study|Adverse Event|1
862783|NCT01340027|2747891|P10|Overall Study|Adverse Event|1
862784|NCT01340027|2747892|P9|Overall Study|Adverse Event|4
862785|NCT01340027|2747893|P8|Overall Study|Adverse Event|1
862786|NCT01340027|2747894|P7|Overall Study|Adverse Event|2
862787|NCT01340027|2747895|P6|Overall Study|Adverse Event|2
862788|NCT01340027|2747896|P5|Overall Study|Adverse Event|1
862789|NCT01340027|2747897|P4|Overall Study|Adverse Event|0
862790|NCT01340027|2747898|P3|Overall Study|Adverse Event|2
862791|NCT01340027|2747899|P2|Overall Study|Adverse Event|1
862792|NCT01340027|2747900|P1|Overall Study|Adverse Event|0
862793|NCT01340027|2747889|P12|Overall Study|Randomized but Never Received Study Drug|0
862794|NCT01340027|2747890|P11|Overall Study|Randomized but Never Received Study Drug|0
862795|NCT01340027|2747891|P10|Overall Study|Randomized but Never Received Study Drug|0
862796|NCT01340027|2747892|P9|Overall Study|Randomized but Never Received Study Drug|0
862797|NCT01340027|2747893|P8|Overall Study|Randomized but Never Received Study Drug|0
862798|NCT01340027|2747894|P7|Overall Study|Randomized but Never Received Study Drug|0
862799|NCT01340027|2747895|P6|Overall Study|Randomized but Never Received Study Drug|0
862800|NCT01340027|2747896|P5|Overall Study|Randomized but Never Received Study Drug|0
862801|NCT01340027|2747897|P4|Overall Study|Randomized but Never Received Study Drug|0
862802|NCT01340027|2747898|P3|Overall Study|Randomized but Never Received Study Drug|1
862803|NCT01340027|2747899|P2|Overall Study|Randomized but Never Received Study Drug|0
862804|NCT01340027|2747900|P1|Overall Study|Randomized but Never Received Study Drug|0
862805|NCT01340066|2748276|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
862806|NCT01340066|2748277|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
862807|NCT01340066|2748278|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
862808|NCT01340066|2748276|P3|5 Week Double Blind Randomization Period|Physician Decision|0
862809|NCT01340066|2748277|P2|5 Week Double Blind Randomization Period|Physician Decision|1
862810|NCT01340066|2748278|P1|5 Week Double Blind Randomization Period|Physician Decision|0
862811|NCT01340066|2748276|P3|5 Week Double Blind Randomization Period|Adverse Event|2
862812|NCT01340066|2748277|P2|5 Week Double Blind Randomization Period|Adverse Event|2
862813|NCT01340066|2748278|P1|5 Week Double Blind Randomization Period|Adverse Event|0
862814|NCT01340066|2748276|P3|Placebo Run in Period|Screen Failures|0
862815|NCT01340066|2748277|P2|Placebo Run in Period|Screen Failures|0
862816|NCT01340066|2748278|P1|Placebo Run in Period|Screen Failures|27
862817|NCT01340196|2748294|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
862818|NCT01340209|2748326|P3|Overall Study|Other reason not defined above|4
862819|NCT01340209|2748327|P2|Overall Study|Other reason not defined above|5
862820|NCT01340209|2748328|P1|Overall Study|Other reason not defined above|3
862821|NCT01340209|2748326|P3|Overall Study|Withdrawal by Subject|1
862822|NCT01340209|2748327|P2|Overall Study|Withdrawal by Subject|0
862823|NCT01340209|2748328|P1|Overall Study|Withdrawal by Subject|0
862824|NCT01340209|2748326|P3|Overall Study|Protocol Violation|1
862825|NCT01340209|2748327|P2|Overall Study|Protocol Violation|2
862826|NCT01340209|2748328|P1|Overall Study|Protocol Violation|1
862827|NCT01340209|2748326|P3|Overall Study|Adverse Event|2
862828|NCT01340209|2748327|P2|Overall Study|Adverse Event|1
862829|NCT01340209|2748328|P1|Overall Study|Adverse Event|1
862850|NCT01340625|2748491|P2|Washout Period of 28 Days|Withdrawal by Subject|0
862851|NCT01340625|2748492|P1|Washout Period of 28 Days|Withdrawal by Subject|1
862852|NCT01340625|2748491|P2|First Intervention|Adverse Event|0
862853|NCT01340625|2748492|P1|First Intervention|Adverse Event|1
862854|NCT01340651|2748508|P1|Overall Study|Commercial Supply per Sponsor|12
862855|NCT01340651|2748508|P1|Overall Study|Consent Withdrawn|2
862856|NCT01340651|2748508|P1|Overall Study|Adverse Event|3
862857|NCT01340664|2748525|P3|Overall Study|Not specified|2
862858|NCT01340664|2748526|P2|Overall Study|Not specified|2
862859|NCT01340664|2748527|P1|Overall Study|Not specified|1
862860|NCT01340664|2748525|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
862861|NCT01340664|2748526|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
862862|NCT01340664|2748527|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
862863|NCT01340664|2748525|P3|Overall Study|Glycemic withdrawal criteria|0
862864|NCT01340664|2748526|P2|Overall Study|Glycemic withdrawal criteria|0
862865|NCT01340664|2748527|P1|Overall Study|Glycemic withdrawal criteria|2
862866|NCT01340664|2748525|P3|Overall Study|Withdrawal by Subject|0
862867|NCT01340664|2748526|P2|Overall Study|Withdrawal by Subject|4
862868|NCT01340664|2748527|P1|Overall Study|Withdrawal by Subject|2
862869|NCT01340664|2748525|P3|Overall Study|Lost to Follow-up|2
862870|NCT01340664|2748526|P2|Overall Study|Lost to Follow-up|0
862871|NCT01340664|2748527|P1|Overall Study|Lost to Follow-up|2
862872|NCT01340664|2748525|P3|Overall Study|Adverse Event|7
862873|NCT01340664|2748526|P2|Overall Study|Adverse Event|1
862874|NCT01340664|2748527|P1|Overall Study|Adverse Event|0
862875|NCT01340768|2748546|P2|Overall Study|Other|0
862876|NCT01340768|2748547|P1|Overall Study|Other|2
862877|NCT01340768|2748546|P2|Overall Study|Withdrawal by Subject|1
862878|NCT01340768|2748547|P1|Overall Study|Withdrawal by Subject|5
862879|NCT01340768|2748546|P2|Overall Study|Lost to Follow-up|4
862880|NCT01340768|2748547|P1|Overall Study|Lost to Follow-up|10
862881|NCT01340794|2748557|P2|Overall Study|Withdrawal by Subject|1
862882|NCT01340794|2748558|P1|Overall Study|Withdrawal by Subject|0
862883|NCT01340937|2748576|P4|Period 3: Toddler Vaccinations|Technical problem|0
862884|NCT01340937|2748577|P3|Period 3: Toddler Vaccinations|Technical problem|1
862885|NCT01340937|2748578|P2|Period 3: Toddler Vaccinations|Technical problem|1
862886|NCT01340937|2748579|P1|Period 3: Toddler Vaccinations|Technical problem|1
862887|NCT01340937|2748576|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
862888|NCT01340937|2748577|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
862889|NCT01340937|2748578|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
862890|NCT01340937|2748579|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
862891|NCT01340937|2748576|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
862892|NCT01340937|2748577|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
862893|NCT01340937|2748578|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
862894|NCT01340937|2748579|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
862895|NCT01340937|2748576|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
862896|NCT01340937|2748577|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
862897|NCT01340937|2748578|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
862898|NCT01340937|2748579|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
862899|NCT01340937|2748576|P4|Period 2: Interim Period|Technical problems|3
862900|NCT01340937|2748577|P3|Period 2: Interim Period|Technical problems|6
862901|NCT01340937|2748578|P2|Period 2: Interim Period|Technical problems|4
862902|NCT01340937|2748579|P1|Period 2: Interim Period|Technical problems|4
862903|NCT01340937|2748576|P4|Period 2: Interim Period|Protocol Violation|3
862904|NCT01340937|2748577|P3|Period 2: Interim Period|Protocol Violation|6
862905|NCT01340937|2748578|P2|Period 2: Interim Period|Protocol Violation|3
862906|NCT01340937|2748579|P1|Period 2: Interim Period|Protocol Violation|5
862907|NCT01340937|2748576|P4|Period 2: Interim Period|Physician Decision|0
862908|NCT01340937|2748577|P3|Period 2: Interim Period|Physician Decision|1
862909|NCT01340937|2748578|P2|Period 2: Interim Period|Physician Decision|1
862910|NCT01340937|2748579|P1|Period 2: Interim Period|Physician Decision|0
862911|NCT01340937|2748576|P4|Period 2: Interim Period|Lost to Follow-up|23
862912|NCT01340937|2748577|P3|Period 2: Interim Period|Lost to Follow-up|53
862913|NCT01340937|2748578|P2|Period 2: Interim Period|Lost to Follow-up|48
862914|NCT01340937|2748579|P1|Period 2: Interim Period|Lost to Follow-up|29
862915|NCT01340937|2748576|P4|Period 2: Interim Period|Adverse Event|0
862916|NCT01340937|2748577|P3|Period 2: Interim Period|Adverse Event|1
862917|NCT01340937|2748578|P2|Period 2: Interim Period|Adverse Event|0
862918|NCT01340937|2748579|P1|Period 2: Interim Period|Adverse Event|1
862919|NCT01340937|2748576|P4|Period 2: Interim Period|Withdrawal by Subject|12
862920|NCT01340937|2748577|P3|Period 2: Interim Period|Withdrawal by Subject|17
862921|NCT01340937|2748578|P2|Period 2: Interim Period|Withdrawal by Subject|23
862922|NCT01340937|2748579|P1|Period 2: Interim Period|Withdrawal by Subject|28
862923|NCT01340937|2748576|P4|Period 1: Infant Series|Randomized but not vaccinated|1
862924|NCT01340937|2748577|P3|Period 1: Infant Series|Randomized but not vaccinated|2
862925|NCT01340937|2748578|P2|Period 1: Infant Series|Randomized but not vaccinated|5
862926|NCT01340937|2748579|P1|Period 1: Infant Series|Randomized but not vaccinated|0
862927|NCT01340937|2748576|P4|Period 1: Infant Series|Withdrawal by Subject|15
862928|NCT01340937|2748577|P3|Period 1: Infant Series|Withdrawal by Subject|30
862929|NCT01340937|2748578|P2|Period 1: Infant Series|Withdrawal by Subject|32
862930|NCT01340937|2748579|P1|Period 1: Infant Series|Withdrawal by Subject|33
862931|NCT01340937|2748576|P4|Period 1: Infant Series|Protocol Violation|3
862932|NCT01340937|2748577|P3|Period 1: Infant Series|Protocol Violation|4
862933|NCT01340937|2748578|P2|Period 1: Infant Series|Protocol Violation|4
862934|NCT01340937|2748579|P1|Period 1: Infant Series|Protocol Violation|1
862935|NCT01340937|2748576|P4|Period 1: Infant Series|Physician Decision|0
862936|NCT01340937|2748577|P3|Period 1: Infant Series|Physician Decision|1
862937|NCT01340937|2748578|P2|Period 1: Infant Series|Physician Decision|3
862938|NCT01340937|2748579|P1|Period 1: Infant Series|Physician Decision|2
862939|NCT01340937|2748576|P4|Period 1: Infant Series|Lost to Follow-up|13
862940|NCT01340937|2748577|P3|Period 1: Infant Series|Lost to Follow-up|12
862941|NCT01340937|2748578|P2|Period 1: Infant Series|Lost to Follow-up|14
862942|NCT01340937|2748579|P1|Period 1: Infant Series|Lost to Follow-up|20
862943|NCT01340937|2748576|P4|Period 1: Infant Series|Death|0
862944|NCT01340937|2748577|P3|Period 1: Infant Series|Death|2
862945|NCT01340937|2748578|P2|Period 1: Infant Series|Death|0
862946|NCT01340937|2748579|P1|Period 1: Infant Series|Death|2
862947|NCT01340937|2748576|P4|Period 1: Infant Series|Adverse Event|0
862948|NCT01340937|2748577|P3|Period 1: Infant Series|Adverse Event|4
862949|NCT01340937|2748578|P2|Period 1: Infant Series|Adverse Event|1
862950|NCT01340937|2748579|P1|Period 1: Infant Series|Adverse Event|0
862951|NCT01340937|2748576|P4|Period 1: Infant Series|Other protocol criterion not met|0
862952|NCT01340937|2748577|P3|Period 1: Infant Series|Other protocol criterion not met|1
862953|NCT01340937|2748578|P2|Period 1: Infant Series|Other protocol criterion not met|1
862954|NCT01340937|2748579|P1|Period 1: Infant Series|Other protocol criterion not met|0
862955|NCT01341782|2748787|P2|Overall Study|Other|0
862956|NCT01341782|2748788|P1|Overall Study|Other|5
862957|NCT01341782|2748787|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
862958|NCT01341782|2748788|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
862959|NCT01341782|2748787|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
862960|NCT01341782|2748788|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
862961|NCT01341782|2748787|P2|Overall Study|Missed 3 consecutive doses|4
862962|NCT01341782|2748788|P1|Overall Study|Missed 3 consecutive doses|0
862963|NCT01341782|2748787|P2|Overall Study|Withdrawal by Subject|5
862964|NCT01341782|2748788|P1|Overall Study|Withdrawal by Subject|6
862965|NCT01341782|2748787|P2|Overall Study|Adverse Event|1
862966|NCT01341782|2748788|P1|Overall Study|Adverse Event|1
862967|NCT01342094|2748820|P2|Overall Study|Withdrawal by Subject|2
862968|NCT01342094|2748821|P1|Overall Study|Withdrawal by Subject|0
862969|NCT01342094|2748820|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
862970|NCT01342094|2748821|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
862971|NCT01342094|2748820|P2|Overall Study|Adverse Event|0
862972|NCT01342094|2748821|P1|Overall Study|Adverse Event|5
862973|NCT01342341|2748842|P2|Overall Study|Lost to Follow-up|4
862974|NCT01342341|2748843|P1|Overall Study|Lost to Follow-up|4
862975|NCT01342445|2748851|P2|Overall Study|Experienced side effects|2
862976|NCT01342445|2748852|P1|Overall Study|Experienced side effects|0
862977|NCT01342484|2748909|P3|Overall Study|Withdrawal by Subject|0
862978|NCT01342484|2748910|P2|Overall Study|Withdrawal by Subject|0
862979|NCT01342484|2748911|P1|Overall Study|Withdrawal by Subject|1
862980|NCT01342484|2748909|P3|Overall Study|Protocol Violation|1
862981|NCT01342484|2748910|P2|Overall Study|Protocol Violation|0
862982|NCT01342484|2748911|P1|Overall Study|Protocol Violation|0
862983|NCT01342484|2748909|P3|Overall Study|Other Reasons|0
862984|NCT01342484|2748910|P2|Overall Study|Other Reasons|0
862985|NCT01342484|2748911|P1|Overall Study|Other Reasons|1
862986|NCT01342510|2748929|P4|Overall Study|Protocol Violation|11
862987|NCT01342510|2748930|P3|Overall Study|Protocol Violation|13
862988|NCT01342510|2748931|P2|Overall Study|Protocol Violation|6
862989|NCT01342510|2748932|P1|Overall Study|Protocol Violation|12
862990|NCT01342640|2749027|P1|Overall Study|Unspecified|1
862991|NCT01342640|2749027|P1|Overall Study|Lost to Follow-up|21
862992|NCT01342640|2749027|P1|Overall Study|Protocol Violation|16
862993|NCT01342640|2749027|P1|Overall Study|Adverse Event|3
862994|NCT01342887|2749060|P1|Overall Study|Death|2
862995|NCT01342913|2749069|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
862996|NCT01342913|2749070|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
862997|NCT01342913|2749071|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
862998|NCT01342913|2749069|P3|Double-Blind Treatment Period|Physician Decision|0
862999|NCT01342913|2749070|P2|Double-Blind Treatment Period|Physician Decision|2
863000|NCT01342913|2749071|P1|Double-Blind Treatment Period|Physician Decision|0
863001|NCT01342913|2749069|P3|Double-Blind Treatment Period|Lost to Follow-up|3
863002|NCT01342913|2749070|P2|Double-Blind Treatment Period|Lost to Follow-up|1
863003|NCT01342913|2749071|P1|Double-Blind Treatment Period|Lost to Follow-up|0
863004|NCT01342913|2749069|P3|Double-Blind Treatment Period|Protocol Violation|9
863005|NCT01342913|2749070|P2|Double-Blind Treatment Period|Protocol Violation|6
863006|NCT01342913|2749071|P1|Double-Blind Treatment Period|Protocol Violation|0
863007|NCT01342913|2749069|P3|Double-Blind Treatment Period|Lack of Efficacy|3
863008|NCT01342913|2749070|P2|Double-Blind Treatment Period|Lack of Efficacy|2
863009|NCT01342913|2749071|P1|Double-Blind Treatment Period|Lack of Efficacy|0
863010|NCT01342913|2749069|P3|Double-Blind Treatment Period|Adverse Event|6
863011|NCT01342913|2749070|P2|Double-Blind Treatment Period|Adverse Event|3
863012|NCT01342913|2749071|P1|Double-Blind Treatment Period|Adverse Event|0
863013|NCT01342913|2749069|P3|2-week Run-in Period|Continuation Criteria Not Met|0
863014|NCT01342913|2749070|P2|2-week Run-in Period|Continuation Criteria Not Met|0
863015|NCT01342913|2749071|P1|2-week Run-in Period|Continuation Criteria Not Met|88
863016|NCT01342913|2749069|P3|2-week Run-in Period|Protocol Violation|0
863017|NCT01342913|2749070|P2|2-week Run-in Period|Protocol Violation|0
863018|NCT01342913|2749071|P1|2-week Run-in Period|Protocol Violation|5
863019|NCT01342913|2749069|P3|2-week Run-in Period|Adverse Event|0
863020|NCT01342913|2749070|P2|2-week Run-in Period|Adverse Event|0
863021|NCT01342913|2749071|P1|2-week Run-in Period|Adverse Event|2
863022|NCT01342913|2749069|P3|2-week Run-in Period|Withdrawal by Subject|0
863023|NCT01342913|2749070|P2|2-week Run-in Period|Withdrawal by Subject|0
863024|NCT01342913|2749071|P1|2-week Run-in Period|Withdrawal by Subject|7
863025|NCT01342913|2749069|P3|2-week Run-in Period|Physician Decision|0
863026|NCT01342913|2749070|P2|2-week Run-in Period|Physician Decision|0
863027|NCT01342913|2749071|P1|2-week Run-in Period|Physician Decision|6
863028|NCT01342913|2749069|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
863029|NCT01342913|2749070|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
863030|NCT01342913|2749071|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
863031|NCT01342926|2749085|P4|Overall Study|Withdrawal by Subject|5
863032|NCT01342926|2749086|P3|Overall Study|Withdrawal by Subject|3
863033|NCT01342926|2749087|P2|Overall Study|Withdrawal by Subject|4
863034|NCT01342926|2749088|P1|Overall Study|Withdrawal by Subject|2
863035|NCT01342926|2749085|P4|Overall Study|Investigator Discretion|0
863036|NCT01342926|2749086|P3|Overall Study|Investigator Discretion|0
863037|NCT01342926|2749087|P2|Overall Study|Investigator Discretion|2
863038|NCT01342926|2749088|P1|Overall Study|Investigator Discretion|2
863039|NCT01342926|2749085|P4|Overall Study|Lost to Follow-up|0
863040|NCT01342926|2749086|P3|Overall Study|Lost to Follow-up|1
863041|NCT01342926|2749087|P2|Overall Study|Lost to Follow-up|1
863042|NCT01342926|2749088|P1|Overall Study|Lost to Follow-up|0
863043|NCT01342926|2749085|P4|Overall Study|Adverse Event|7
863044|NCT01342926|2749086|P3|Overall Study|Adverse Event|10
863045|NCT01342926|2749087|P2|Overall Study|Adverse Event|8
863046|NCT01342926|2749088|P1|Overall Study|Adverse Event|5
863047|NCT01342965|2749168|P2|Overall Study|Withdrawal by Subject|9
863048|NCT01342965|2749169|P1|Overall Study|Withdrawal by Subject|2
863049|NCT01342965|2749168|P2|Overall Study|Other Reasons- Unspecified|38
863050|NCT01342965|2749169|P1|Overall Study|Other Reasons- Unspecified|44
863051|NCT01342965|2749168|P2|Overall Study|Lost to Follow-up|3
863052|NCT01342965|2749169|P1|Overall Study|Lost to Follow-up|5
863053|NCT01342965|2749168|P2|Overall Study|Death|57
863054|NCT01342965|2749169|P1|Overall Study|Death|58
863055|NCT01343056|2749215|P4|Overall Study|Lost to Follow-up|9
863056|NCT01343056|2749216|P3|Overall Study|Lost to Follow-up|3
863057|NCT01343056|2749217|P2|Overall Study|Lost to Follow-up|5
863058|NCT01343056|2749218|P1|Overall Study|Lost to Follow-up|7
863059|NCT01343082|2749256|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
863060|NCT01343082|2749257|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
863061|NCT01343082|2749258|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
863062|NCT01343082|2749256|P3|Treatment Period , Switched to DE-111|Physician Decision|2
863063|NCT01343082|2749257|P2|Treatment Period , Switched to DE-111|Physician Decision|2
863064|NCT01343082|2749258|P1|Treatment Period , Switched to DE-111|Physician Decision|0
863065|NCT01343082|2749256|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
863066|NCT01343082|2749257|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
863067|NCT01343082|2749258|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
863068|NCT01343082|2749256|P3|Treatment Period , Switched to DE-111|Adverse Event|3
863069|NCT01343082|2749257|P2|Treatment Period , Switched to DE-111|Adverse Event|4
863070|NCT01343082|2749258|P1|Treatment Period , Switched to DE-111|Adverse Event|1
863071|NCT01343082|2749256|P3|The run-in Period|Not meeting criteria|5
863072|NCT01343082|2749257|P2|The run-in Period|Not meeting criteria|4
863073|NCT01343082|2749258|P1|The run-in Period|Not meeting criteria|3
863074|NCT01343277|2749281|P2|Overall Study|Subsequent anticancer therapy|0
863075|NCT01343277|2749282|P1|Overall Study|Subsequent anticancer therapy|1
863076|NCT01343277|2749281|P2|Overall Study|Treatment ongoing|2
863077|NCT01343277|2749282|P1|Overall Study|Treatment ongoing|8
863078|NCT01343277|2749281|P2|Overall Study|Randomized not treated|21
863079|NCT01343277|2749282|P1|Overall Study|Randomized not treated|6
863080|NCT01343277|2749281|P2|Overall Study|Disease progression|138
863081|NCT01343277|2749282|P1|Overall Study|Disease progression|270
863082|NCT01343277|2749281|P2|Overall Study|Adverse Event|13
863083|NCT01343277|2749282|P1|Overall Study|Adverse Event|67
863084|NCT01343277|2749281|P2|Overall Study|Death|1
863085|NCT01343277|2749282|P1|Overall Study|Death|10
863086|NCT01343277|2749281|P2|Overall Study|Physician Decision|2
863087|NCT01343277|2749282|P1|Overall Study|Physician Decision|1
863088|NCT01343277|2749281|P2|Overall Study|Withdrawal by Subject|13
863089|NCT01343277|2749282|P1|Overall Study|Withdrawal by Subject|18
863090|NCT01343277|2749281|P2|Overall Study|Unspecified|3
863091|NCT01343277|2749282|P1|Overall Study|Unspecified|3
863096|NCT01343823|2749357|P4|Overall Study|Withdrawal by Subject|0
863097|NCT01343823|2749358|P3|Overall Study|Withdrawal by Subject|0
863098|NCT01343823|2749359|P2|Overall Study|Withdrawal by Subject|0
863099|NCT01343823|2749360|P1|Overall Study|Withdrawal by Subject|1
863100|NCT01343823|2749357|P4|Overall Study|Study Terminated|1
863101|NCT01343823|2749358|P3|Overall Study|Study Terminated|0
863102|NCT01343823|2749359|P2|Overall Study|Study Terminated|0
863103|NCT01343823|2749360|P1|Overall Study|Study Terminated|1
863104|NCT01343888|2749377|P3|Overall Study|other than stated above|1
863105|NCT01343888|2749378|P2|Overall Study|other than stated above|0
863106|NCT01343888|2749379|P1|Overall Study|other than stated above|0
863107|NCT01343888|2749377|P3|Overall Study|Withdrawal by Subject|2
863108|NCT01343888|2749378|P2|Overall Study|Withdrawal by Subject|4
863109|NCT01343888|2749379|P1|Overall Study|Withdrawal by Subject|4
863110|NCT01343888|2749377|P3|Overall Study|Protocol Violation|0
863111|NCT01343888|2749378|P2|Overall Study|Protocol Violation|2
863112|NCT01343888|2749379|P1|Overall Study|Protocol Violation|0
863113|NCT01343888|2749377|P3|Overall Study|Lost to Follow-up|1
863114|NCT01343888|2749378|P2|Overall Study|Lost to Follow-up|2
863115|NCT01343888|2749379|P1|Overall Study|Lost to Follow-up|0
863116|NCT01343888|2749377|P3|Overall Study|Lack of Efficacy|13
863117|NCT01343888|2749378|P2|Overall Study|Lack of Efficacy|9
863118|NCT01343888|2749379|P1|Overall Study|Lack of Efficacy|9
863119|NCT01343888|2749377|P3|Overall Study|Adverse Event|5
863120|NCT01343888|2749378|P2|Overall Study|Adverse Event|22
863121|NCT01343888|2749379|P1|Overall Study|Adverse Event|12
863122|NCT01343901|2749417|P1|Overall Study|Participant decision|1
863123|NCT01343901|2749417|P1|Overall Study|Management by another medical team|11
863124|NCT01343901|2749417|P1|Overall Study|Lost to Follow-up|12
863125|NCT01343901|2749417|P1|Overall Study|Physician Decision|4
863126|NCT01343901|2749417|P1|Overall Study|Death|85
863127|NCT01344057|2749438|P1|Overall Study|Premature Withdrawal|1
863128|NCT01344161|2749447|P2|Overall Study|Protocol Violation|1
863129|NCT01344161|2749448|P1|Overall Study|Protocol Violation|1
863130|NCT01344161|2749447|P2|Overall Study|Pregnancy|1
863131|NCT01344161|2749448|P1|Overall Study|Pregnancy|0
863132|NCT01344161|2749447|P2|Overall Study|Lost to Follow-up|1
863133|NCT01344161|2749448|P1|Overall Study|Lost to Follow-up|4
863134|NCT01344369|2749462|P2|Second Intervention|Emesis within 2 x Tmax|1
863135|NCT01344369|2749463|P1|Second Intervention|Emesis within 2 x Tmax|0
863136|NCT01344369|2749462|P2|Washout of 28 Days|Physician Decision|1
863137|NCT01344369|2749463|P1|Washout of 28 Days|Physician Decision|0
863138|NCT01344369|2749462|P2|Washout of 28 Days|Withdrawal by Subject|0
863139|NCT01344369|2749463|P1|Washout of 28 Days|Withdrawal by Subject|1
863140|NCT01344447|2749479|P1|Overall Study|Error of power injector|1
863141|NCT01344447|2749479|P1|Overall Study|Bolus tracking failed|1
863142|NCT01344447|2749479|P1|Overall Study|MRA unsuccessful|1
863143|NCT01344447|2749479|P1|Overall Study|Physician Decision|1
863144|NCT01344447|2749479|P1|Overall Study|The contrast was not seen|1
863145|NCT01344447|2749479|P1|Overall Study|Withdrawal by Subject|1
863146|NCT01344447|2749479|P1|Overall Study|Protocol Violation|1
863147|NCT01344447|2749479|P1|Overall Study|Adverse Event|1
863148|NCT01344460|2749521|P1|Overall Study|Lost to Follow-up|2
863149|NCT01344460|2749521|P1|Overall Study|Withdrawal by Subject|1
863150|NCT01344538|2749568|P2|Overall Study|Lost to Follow-up|0
863151|NCT01344538|2749569|P1|Overall Study|Lost to Follow-up|1
863152|NCT01344538|2749568|P2|Overall Study|Adverse Event|1
863153|NCT01344538|2749569|P1|Overall Study|Adverse Event|1
863154|NCT01339000|2749577|P2|Overall Study|study closed due to lack of drug supply|0
863155|NCT01339000|2749578|P1|Overall Study|study closed due to lack of drug supply|1
863164|NCT01344629|2749645|P2|Crossover Period 2|Withdrawal by Subject|1
863165|NCT01344629|2749646|P1|Crossover Period 2|Withdrawal by Subject|0
863166|NCT01344759|2749666|P2|Overall Study|Patients failed to reach sedation level|2
863167|NCT01344759|2749667|P1|Overall Study|Patients failed to reach sedation level|0
863172|NCT01344876|2749703|P5|Overall Study|Definite progression of primary disease|0
863173|NCT01344876|2749704|P4|Overall Study|Definite progression of primary disease|3
863174|NCT01344876|2749705|P3|Overall Study|Definite progression of primary disease|0
863175|NCT01344876|2749706|P2|Overall Study|Definite progression of primary disease|0
863176|NCT01344876|2749707|P1|Overall Study|Definite progression of primary disease|1
863177|NCT01344876|2749703|P5|Overall Study|Withdrawal by Subject|0
863178|NCT01344876|2749704|P4|Overall Study|Withdrawal by Subject|0
863179|NCT01344876|2749705|P3|Overall Study|Withdrawal by Subject|1
863180|NCT01344876|2749706|P2|Overall Study|Withdrawal by Subject|0
863181|NCT01344876|2749707|P1|Overall Study|Withdrawal by Subject|0
863182|NCT01344876|2749703|P5|Overall Study|Adverse Event|1
863183|NCT01344876|2749704|P4|Overall Study|Adverse Event|0
863184|NCT01344876|2749705|P3|Overall Study|Adverse Event|0
863185|NCT01344876|2749706|P2|Overall Study|Adverse Event|0
863186|NCT01344876|2749707|P1|Overall Study|Adverse Event|0
863187|NCT01345240|2749726|P5|Overall Study|Serious Adverse Event|1
863188|NCT01345240|2749727|P4|Overall Study|Serious Adverse Event|2
863189|NCT01345240|2749728|P3|Overall Study|Serious Adverse Event|2
863190|NCT01345240|2749729|P2|Overall Study|Serious Adverse Event|2
863191|NCT01345240|2749730|P1|Overall Study|Serious Adverse Event|1
863192|NCT01345240|2749726|P5|Overall Study|Lost to Follow-up|6
863193|NCT01345240|2749727|P4|Overall Study|Lost to Follow-up|8
863194|NCT01345240|2749728|P3|Overall Study|Lost to Follow-up|8
863195|NCT01345240|2749729|P2|Overall Study|Lost to Follow-up|12
863196|NCT01345240|2749730|P1|Overall Study|Lost to Follow-up|1
863211|NCT01345292|2749843|P3|Overall Study|Withdrawal by Subject|1
863212|NCT01345292|2749844|P2|Overall Study|Withdrawal by Subject|0
863213|NCT01345292|2749845|P1|Overall Study|Withdrawal by Subject|2
863214|NCT01345318|2749874|P1|Overall Study|Unspecified|3
863215|NCT01345318|2749874|P1|Overall Study|Withdrawal by Subject|41
863216|NCT01345318|2749874|P1|Overall Study|Protocol Violation|1
863217|NCT01345318|2749874|P1|Overall Study|Lost to Follow-up|2
863218|NCT01345318|2749874|P1|Overall Study|Lack of Efficacy|17
863219|NCT01345318|2749874|P1|Overall Study|Adverse Event|16
863220|NCT01345591|2749879|P1|Overall Study|Lost to Follow-up|1
863221|NCT01345630|2749890|P2|Overall Study|Insufficient clinical response|11
863222|NCT01345630|2749891|P1|Overall Study|Insufficient clinical response|48
863223|NCT01345630|2749890|P2|Overall Study|No longer willing to participate|12
863224|NCT01345630|2749891|P1|Overall Study|No longer willing to participate|9
863225|NCT01345630|2749890|P2|Overall Study|Withdrawn due to pregnancy|2
863226|NCT01345630|2749891|P1|Overall Study|Withdrawn due to pregnancy|1
863227|NCT01345630|2749890|P2|Overall Study|Other reasons|8
863228|NCT01345630|2749891|P1|Overall Study|Other reasons|6
863229|NCT01345630|2749890|P2|Overall Study|Study terminated by sponsor|285
863230|NCT01345630|2749891|P1|Overall Study|Study terminated by sponsor|254
863231|NCT01345630|2749890|P2|Overall Study|Medication error without associated AE|1
863232|NCT01345630|2749891|P1|Overall Study|Medication error without associated AE|0
863233|NCT01345630|2749890|P2|Overall Study|Protocol Violation|1
863234|NCT01345630|2749891|P1|Overall Study|Protocol Violation|4
863235|NCT01345630|2749890|P2|Overall Study|Lost to Follow-up|16
863236|NCT01345630|2749891|P1|Overall Study|Lost to Follow-up|17
863237|NCT01345630|2749890|P2|Overall Study|Adverse Event|23
863238|NCT01345630|2749891|P1|Overall Study|Adverse Event|22
863239|NCT01345682|2749949|P2|Overall Study|Reason other than those specified above|2
863240|NCT01345682|2749950|P1|Overall Study|Reason other than those specified above|3
863241|NCT01345682|2749949|P2|Overall Study|Not treated|1
863242|NCT01345682|2749950|P1|Overall Study|Not treated|2
863243|NCT01345682|2749949|P2|Overall Study|Refused to continue trial medication|9
863244|NCT01345682|2749950|P1|Overall Study|Refused to continue trial medication|16
863245|NCT01345682|2749949|P2|Overall Study|Lost to Follow-up|1
863246|NCT01345682|2749950|P1|Overall Study|Lost to Follow-up|0
863247|NCT01345682|2749949|P2|Overall Study|Non-compliance with protocol|1
863248|NCT01345682|2749950|P1|Overall Study|Non-compliance with protocol|0
863249|NCT01345682|2749949|P2|Overall Study|Adverse Event|41
863250|NCT01345682|2749950|P1|Overall Study|Adverse Event|49
863251|NCT01345682|2749949|P2|Overall Study|Worsening of underlying cancer disease|13
863252|NCT01345682|2749950|P1|Overall Study|Worsening of underlying cancer disease|21
863253|NCT01345682|2749949|P2|Overall Study|Progressive disease per RECIST|89
863254|NCT01345682|2749950|P1|Overall Study|Progressive disease per RECIST|215
863255|NCT01345786|2750018|P4|Overall Study|Lost to Follow-up|2
863256|NCT01345786|2750019|P3|Overall Study|Lost to Follow-up|0
863257|NCT01345786|2750020|P2|Overall Study|Lost to Follow-up|0
863258|NCT01345786|2750021|P1|Overall Study|Lost to Follow-up|0
863259|NCT01345786|2750018|P4|Overall Study|Administrative|0
863260|NCT01345786|2750019|P3|Overall Study|Administrative|0
863261|NCT01345786|2750020|P2|Overall Study|Administrative|5
863262|NCT01345786|2750021|P1|Overall Study|Administrative|3
863263|NCT01345786|2750018|P4|Overall Study|Noncompliance with protocol|0
863264|NCT01345786|2750019|P3|Overall Study|Noncompliance with protocol|1
863265|NCT01345786|2750020|P2|Overall Study|Noncompliance with protocol|0
863266|NCT01345786|2750021|P1|Overall Study|Noncompliance with protocol|1
863267|NCT01345786|2750018|P4|Overall Study|Subject withdrew consent|0
863268|NCT01345786|2750019|P3|Overall Study|Subject withdrew consent|1
863269|NCT01345786|2750020|P2|Overall Study|Subject withdrew consent|2
863270|NCT01345786|2750021|P1|Overall Study|Subject withdrew consent|2
863271|NCT01345786|2750018|P4|Overall Study|Adverse Event|1
863272|NCT01345786|2750019|P3|Overall Study|Adverse Event|3
863273|NCT01345786|2750020|P2|Overall Study|Adverse Event|1
863274|NCT01345786|2750021|P1|Overall Study|Adverse Event|0
863275|NCT01345929|2750069|P2|Overall Study|Patient withdrawal|1
863276|NCT01345929|2750070|P1|Overall Study|Patient withdrawal|0
863277|NCT01345929|2750069|P2|Overall Study|40,000 CFU/ML|0
863278|NCT01345929|2750070|P1|Overall Study|40,000 CFU/ML|1
863279|NCT01345929|2750069|P2|Overall Study|Didn't meet eligibility criteria|0
863280|NCT01345929|2750070|P1|Overall Study|Didn't meet eligibility criteria|2
863281|NCT01345929|2750069|P2|Overall Study|Adverse Event|1
863282|NCT01345929|2750070|P1|Overall Study|Adverse Event|0
863283|NCT01345929|2750069|P2|Overall Study|Lost to Follow-up|9
863284|NCT01345929|2750070|P1|Overall Study|Lost to Follow-up|9
863285|NCT01345929|2750069|P2|Overall Study|Withdrawal by Subject|8
863286|NCT01345929|2750070|P1|Overall Study|Withdrawal by Subject|9
863287|NCT01346059|2750080|P2|Overall Study|Withdrawal by Subject|0
863288|NCT01346059|2750081|P1|Overall Study|Withdrawal by Subject|1
863289|NCT01346176|2750110|P3|Completed Satisfaction Survey|Lost to Follow-up|4
863290|NCT01346176|2750111|P2|Completed Satisfaction Survey|Lost to Follow-up|4
863291|NCT01346176|2750112|P1|Completed Satisfaction Survey|Lost to Follow-up|3
863292|NCT01346176|2750110|P3|Completed Satisfaction Survey|Death|2
863293|NCT01346176|2750111|P2|Completed Satisfaction Survey|Death|0
863294|NCT01346176|2750112|P1|Completed Satisfaction Survey|Death|3
863295|NCT01346176|2750110|P3|Completed Advance Directive|Other reason did not complete AD|7
863296|NCT01346176|2750111|P2|Completed Advance Directive|Other reason did not complete AD|12
863297|NCT01346176|2750112|P1|Completed Advance Directive|Other reason did not complete AD|7
863298|NCT01346176|2750110|P3|Completed Advance Directive|Became Ineligible|1
863299|NCT01346176|2750111|P2|Completed Advance Directive|Became Ineligible|0
863300|NCT01346176|2750112|P1|Completed Advance Directive|Became Ineligible|3
863301|NCT01346176|2750110|P3|Completed Advance Directive|Death|2
863302|NCT01346176|2750111|P2|Completed Advance Directive|Death|2
863303|NCT01346176|2750112|P1|Completed Advance Directive|Death|3
863304|NCT01346176|2750110|P3|Recruited|Protocol Violation|0
863305|NCT01346176|2750111|P2|Recruited|Protocol Violation|0
863306|NCT01346176|2750112|P1|Recruited|Protocol Violation|1
863307|NCT01346293|2750125|P2|Overall Study|Other|0
863308|NCT01346293|2750126|P1|Overall Study|Other|1
863309|NCT01346293|2750125|P2|Overall Study|Withdrawal by Subject|4
863310|NCT01346293|2750126|P1|Overall Study|Withdrawal by Subject|15
863311|NCT01346293|2750125|P2|Overall Study|Lost to Follow-up|8
863312|NCT01346293|2750126|P1|Overall Study|Lost to Follow-up|21
863313|NCT01346293|2750125|P2|Overall Study|Protocol Violation|9
863314|NCT01346293|2750126|P1|Overall Study|Protocol Violation|30
863315|NCT01346475|2750165|P2|First Intervention|Lost to Follow-up|3
863316|NCT01346475|2750166|P1|First Intervention|Lost to Follow-up|4
863317|NCT01346501|2750198|P2|Overall Study|Not Specified|12
863318|NCT01346501|2750199|P1|Overall Study|Not Specified|8
863319|NCT01346501|2750198|P2|Overall Study|Initiated Other Biological Agents|1
863320|NCT01346501|2750199|P1|Overall Study|Initiated Other Biological Agents|3
863321|NCT01346514|2750214|P2|Overall Study|Death|4
863322|NCT01346514|2750215|P1|Overall Study|Death|3
863323|NCT01346514|2750214|P2|Overall Study|Withdrawal by Subject|3
863324|NCT01346514|2750215|P1|Overall Study|Withdrawal by Subject|7
863325|NCT01346514|2750214|P2|Overall Study|Lost to Follow-up|30
863326|NCT01346514|2750215|P1|Overall Study|Lost to Follow-up|19
863327|NCT01346592|2750236|P3|Overall Study|Unable to Classify|6
863328|NCT01346592|2750237|P2|Overall Study|Unable to Classify|3
863329|NCT01346592|2750238|P1|Overall Study|Unable to Classify|7
863330|NCT01346592|2750236|P3|Overall Study|Administrative reason|0
863331|NCT01346592|2750237|P2|Overall Study|Administrative reason|0
863332|NCT01346592|2750238|P1|Overall Study|Administrative reason|1
863333|NCT01346592|2750236|P3|Overall Study|Inappropriate enrollment|1
863334|NCT01346592|2750237|P2|Overall Study|Inappropriate enrollment|1
863335|NCT01346592|2750238|P1|Overall Study|Inappropriate enrollment|3
863336|NCT01346592|2750236|P3|Overall Study|Withdrawal by Subject|38
863337|NCT01346592|2750237|P2|Overall Study|Withdrawal by Subject|51
863338|NCT01346592|2750238|P1|Overall Study|Withdrawal by Subject|77
863339|NCT01346592|2750236|P3|Overall Study|Adverse Event|0
863340|NCT01346592|2750237|P2|Overall Study|Adverse Event|1
863341|NCT01346592|2750238|P1|Overall Study|Adverse Event|0
863342|NCT01346592|2750236|P3|Overall Study|Death|4
863343|NCT01346592|2750237|P2|Overall Study|Death|3
863344|NCT01346592|2750238|P1|Overall Study|Death|1
863345|NCT01346592|2750236|P3|Overall Study|Protocol Violation|0
863346|NCT01346592|2750237|P2|Overall Study|Protocol Violation|1
863347|NCT01346592|2750238|P1|Overall Study|Protocol Violation|2
863348|NCT01346592|2750236|P3|Overall Study|Lost to Follow-up|29
863349|NCT01346592|2750237|P2|Overall Study|Lost to Follow-up|29
863350|NCT01346592|2750238|P1|Overall Study|Lost to Follow-up|62
863351|NCT01346774|2750330|P2|Overall Study|Adverse Event|2
863352|NCT01346774|2750331|P1|Overall Study|Adverse Event|1
863353|NCT01346774|2750330|P2|Overall Study|Protocol Violation|3
863354|NCT01346774|2750331|P1|Overall Study|Protocol Violation|2
863355|NCT01346774|2750330|P2|Overall Study|Withdrawal by Subject|4
863356|NCT01346774|2750331|P1|Overall Study|Withdrawal by Subject|1
863357|NCT01346774|2750330|P2|Overall Study|Lost to Follow-up|4
863358|NCT01346774|2750331|P1|Overall Study|Lost to Follow-up|3
863359|NCT01346774|2750330|P2|Overall Study|Did not take a single dose|4
863360|NCT01346774|2750331|P1|Overall Study|Did not take a single dose|6
863361|NCT01347073|2750402|P1|Overall Study|Liver Transplant|1
863362|NCT01347073|2750402|P1|Overall Study|Adverse Event|1
863363|NCT01347086|2750424|P10|Overall Study|failed screening visit|1
863364|NCT01347086|2750425|P9|Overall Study|failed screening visit|0
863365|NCT01347086|2750426|P8|Overall Study|failed screening visit|1
863366|NCT01347086|2750427|P7|Overall Study|failed screening visit|1
863367|NCT01347086|2750428|P6|Overall Study|failed screening visit|0
863368|NCT01347086|2750429|P5|Overall Study|failed screening visit|0
863369|NCT01347086|2750430|P4|Overall Study|failed screening visit|0
863370|NCT01347086|2750431|P3|Overall Study|failed screening visit|1
863371|NCT01347086|2750432|P2|Overall Study|failed screening visit|0
863372|NCT01347086|2750433|P1|Overall Study|failed screening visit|0
863373|NCT01347112|2750534|P2|Overall Study|Lost to Follow-up|5
863374|NCT01347112|2750535|P1|Overall Study|Lost to Follow-up|3
863375|NCT01347112|2750534|P2|Overall Study|Withdrawal by Subject|7
863376|NCT01347112|2750535|P1|Overall Study|Withdrawal by Subject|1
863377|NCT01347554|2750570|P2|Overall Study|Lack of Efficacy|11
863378|NCT01347554|2750571|P1|Overall Study|Lack of Efficacy|7
863379|NCT01347580|2750585|P2|Overall Study|Had other reason|6
863380|NCT01347580|2750586|P1|Overall Study|Had other reason|9
863381|NCT01347580|2750585|P2|Overall Study|Lost to Follow-up|1
863382|NCT01347580|2750586|P1|Overall Study|Lost to Follow-up|3
863383|NCT01347580|2750585|P2|Overall Study|Protocol Violation|7
863384|NCT01347580|2750586|P1|Overall Study|Protocol Violation|10
863385|NCT01347580|2750585|P2|Overall Study|Death|19
863386|NCT01347580|2750586|P1|Overall Study|Death|30
863387|NCT01347580|2750585|P2|Overall Study|Withdrawal by Subject|23
863388|NCT01347580|2750586|P1|Overall Study|Withdrawal by Subject|13
863389|NCT01341990|2750620|P2|Overall Study|Withdrawal by Subject|0
863390|NCT01341990|2750621|P1|Overall Study|Withdrawal by Subject|2
863391|NCT01341990|2750620|P2|Overall Study|Torn Study Lens|0
863392|NCT01341990|2750621|P1|Overall Study|Torn Study Lens|1
863393|NCT01341990|2750620|P2|Overall Study|Adverse Event|1
863394|NCT01341990|2750621|P1|Overall Study|Adverse Event|0
863395|NCT01342081|2750632|P3|Overall Study|Withdrawal by Subject|0
863396|NCT01342081|2750633|P2|Overall Study|Withdrawal by Subject|1
863397|NCT01342081|2750634|P1|Overall Study|Withdrawal by Subject|1
863398|NCT01342081|2750632|P3|Overall Study|Physician Decision|0
863399|NCT01342081|2750633|P2|Overall Study|Physician Decision|1
863400|NCT01342081|2750634|P1|Overall Study|Physician Decision|0
863401|NCT01342081|2750632|P3|Overall Study|Adverse Event|0
863402|NCT01342081|2750633|P2|Overall Study|Adverse Event|0
863403|NCT01342081|2750634|P1|Overall Study|Adverse Event|1
863404|NCT01342081|2750632|P3|Overall Study|Did not receive allocated intervention|1
863405|NCT01342081|2750633|P2|Overall Study|Did not receive allocated intervention|0
863406|NCT01342081|2750634|P1|Overall Study|Did not receive allocated intervention|0
863407|NCT01347710|2750642|P1|Overall Study|Other|3
863408|NCT01347710|2750642|P1|Overall Study|Physician Decision|2
863409|NCT01347710|2750642|P1|Overall Study|Lost to Follow-up|1
863410|NCT01347710|2750642|P1|Overall Study|issue with vitals prior to dosing|1
863411|NCT01347710|2750642|P1|Overall Study|Angio or SPECT not completed|18
863412|NCT01347710|2750642|P1|Overall Study|Adverse Event|4
863413|NCT01347710|2750642|P1|Overall Study|Withdrawal by Subject|2
863414|NCT01345058|2750669|P2|Overall Study|Participant No-Show at Multiple Visits|0
863415|NCT01345058|2750670|P1|Overall Study|Participant No-Show at Multiple Visits|1
863416|NCT01345058|2750669|P2|Overall Study|Participant Stopped Taking Study Drug|0
863417|NCT01345058|2750670|P1|Overall Study|Participant Stopped Taking Study Drug|1
863418|NCT01345058|2750669|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
863419|NCT01345058|2750670|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
863420|NCT01345058|2750669|P2|Overall Study|Participant Reported Increase in Events|0
863421|NCT01345058|2750670|P1|Overall Study|Participant Reported Increase in Events|1
863422|NCT01345058|2750669|P2|Overall Study|Withdrawal by Subject|0
863423|NCT01345058|2750670|P1|Overall Study|Withdrawal by Subject|1
863424|NCT01345123|2750687|P3|Overall Study|participants no longer with health plan|88
863425|NCT01345123|2750688|P2|Overall Study|participants no longer with health plan|85
863426|NCT01345123|2750689|P1|Overall Study|participants no longer with health plan|79
863427|NCT01345162|2750711|P2|Overall Study|Protocol Violation|4
863428|NCT01345162|2750712|P1|Overall Study|Protocol Violation|2
863446|NCT02524158|2750826|P2|6-month Assessment|Lost to Follow-up|20
863447|NCT02524158|2750827|P1|6-month Assessment|Lost to Follow-up|21
863448|NCT02524158|2750826|P2|6-month Assessment|Withdrawal by Subject|1
863449|NCT02524158|2750827|P1|6-month Assessment|Withdrawal by Subject|1
863450|NCT02524158|2750826|P2|12-weeks Assessment|Lost to Follow-up|12
863451|NCT02524158|2750827|P1|12-weeks Assessment|Lost to Follow-up|18
863452|NCT02524158|2750826|P2|12-weeks Assessment|Withdrawal by Subject|1
863453|NCT02524158|2750827|P1|12-weeks Assessment|Withdrawal by Subject|1
863463|NCT02374593|2750867|P2|Overall Study|non-compliant|0
863464|NCT02374593|2750868|P1|Overall Study|non-compliant|2
863465|NCT02369341|2750880|P2|Overall Study|Migrated/moved from study area|0
863466|NCT02369341|2750881|P1|Overall Study|Migrated/moved from study area|1
863523|NCT02256436|2750971|P2|Overall Study|Ongoing in Study|67
863524|NCT02256436|2750972|P1|Overall Study|Ongoing in Study|108
863525|NCT02256436|2750971|P2|Overall Study|Withdrawal by Subject|30
863526|NCT02256436|2750972|P1|Overall Study|Withdrawal by Subject|7
863527|NCT02256436|2750971|P2|Overall Study|Protocol Violation|0
863528|NCT02256436|2750972|P1|Overall Study|Protocol Violation|1
863529|NCT02256436|2750971|P2|Overall Study|Physician Decision|3
863530|NCT02256436|2750972|P1|Overall Study|Physician Decision|1
863531|NCT02256436|2750971|P2|Overall Study|Lost to Follow-up|1
863532|NCT02256436|2750972|P1|Overall Study|Lost to Follow-up|1
863533|NCT02256436|2750971|P2|Overall Study|Death|158
863534|NCT02256436|2750972|P1|Overall Study|Death|137
863535|NCT02256436|2750971|P2|Overall Study|Adverse Event|13
863536|NCT02256436|2750972|P1|Overall Study|Adverse Event|15
863599|NCT01908829|2751134|P3|Overall Study|Withdrawal by Subject|22
863600|NCT01908829|2751135|P2|Overall Study|Withdrawal by Subject|29
863601|NCT01908829|2751136|P1|Overall Study|Withdrawal by Subject|26
863602|NCT01908829|2751134|P3|Overall Study|Lack of Efficacy|2
863603|NCT01908829|2751135|P2|Overall Study|Lack of Efficacy|3
863604|NCT01908829|2751136|P1|Overall Study|Lack of Efficacy|1
863605|NCT01908829|2751134|P3|Overall Study|Protocol Violation|0
863606|NCT01908829|2751135|P2|Overall Study|Protocol Violation|2
863607|NCT01908829|2751136|P1|Overall Study|Protocol Violation|2
863608|NCT01908829|2751134|P3|Overall Study|Miscellaneous|0
863609|NCT01908829|2751135|P2|Overall Study|Miscellaneous|2
863610|NCT01908829|2751136|P1|Overall Study|Miscellaneous|0
863611|NCT01908829|2751134|P3|Overall Study|Discontinued (no EoT page)|0
863612|NCT01908829|2751135|P2|Overall Study|Discontinued (no EoT page)|0
863613|NCT01908829|2751136|P1|Overall Study|Discontinued (no EoT page)|2
863614|NCT01908829|2751134|P3|Overall Study|Randomized no double-blind drug received|1
863615|NCT01908829|2751135|P2|Overall Study|Randomized no double-blind drug received|0
863616|NCT01908829|2751136|P1|Overall Study|Randomized no double-blind drug received|1
863617|NCT01908829|2751134|P3|Overall Study|Lost to Follow-up|1
863618|NCT01908829|2751135|P2|Overall Study|Lost to Follow-up|2
863619|NCT01908829|2751136|P1|Overall Study|Lost to Follow-up|4
863620|NCT01908829|2751134|P3|Overall Study|Adverse Event|13
863621|NCT01908829|2751135|P2|Overall Study|Adverse Event|11
863622|NCT01908829|2751136|P1|Overall Study|Adverse Event|13
863623|NCT01884597|2751252|P3|Overall Study|Death|0
863624|NCT01884597|2751253|P2|Overall Study|Death|1
863625|NCT01884597|2751254|P1|Overall Study|Death|0
863626|NCT01884597|2751252|P3|Overall Study|Lack of Efficacy|0
863627|NCT01884597|2751253|P2|Overall Study|Lack of Efficacy|0
863628|NCT01884597|2751254|P1|Overall Study|Lack of Efficacy|1
863629|NCT01884597|2751252|P3|Overall Study|Adverse Event|1
863630|NCT01884597|2751253|P2|Overall Study|Adverse Event|0
863631|NCT01884597|2751254|P1|Overall Study|Adverse Event|0
863632|NCT01740297|2751343|P3|Overall Study|Sponsor Decision|0
863633|NCT01740297|2751344|P2|Overall Study|Sponsor Decision|1
863634|NCT01740297|2751345|P1|Overall Study|Sponsor Decision|0
863635|NCT01740297|2751343|P3|Overall Study|Death|19
863636|NCT01740297|2751344|P2|Overall Study|Death|23
863637|NCT01740297|2751345|P1|Overall Study|Death|8
863638|NCT01740297|2751343|P3|Overall Study|Withdrawal by Subject|11
863639|NCT01740297|2751344|P2|Overall Study|Withdrawal by Subject|9
863640|NCT01740297|2751345|P1|Overall Study|Withdrawal by Subject|1
863641|NCT01740297|2751343|P3|Overall Study|Continuing Study|68
863642|NCT01740297|2751344|P2|Overall Study|Continuing Study|67
863643|NCT01740297|2751345|P1|Overall Study|Continuing Study|10
863650|NCT01682044|2751492|P1|Overall Study|Progression|3
863651|NCT01682044|2751492|P1|Overall Study|Death|1
863668|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
863669|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
863670|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
863671|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
863672|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
863673|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
863674|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
863675|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
863676|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
863677|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
863678|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
863679|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
863680|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
863681|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
863682|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
863683|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
863769|NCT01383928|2751835|P1|Phase 2|Unsatisfactory therapeutic response|0
863684|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
863685|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
863686|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
863687|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
863688|NCT01646177|2751541|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
863689|NCT01646177|2751542|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
863690|NCT01646177|2751543|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
863691|NCT01646177|2751544|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
863719|NCT01465997|2751757|P2|Overall Study|subject left participation SP0993|1
863720|NCT01465997|2751758|P1|Overall Study|subject left participation SP0993|0
863721|NCT01465997|2751757|P2|Overall Study|decision by site staff|1
863722|NCT01465997|2751758|P1|Overall Study|decision by site staff|0
863723|NCT01465997|2751757|P2|Overall Study|withdrew before follow-up|13
863724|NCT01465997|2751758|P1|Overall Study|withdrew before follow-up|0
863725|NCT01465997|2751757|P2|Overall Study|local lab unblinded site|0
863726|NCT01465997|2751758|P1|Overall Study|local lab unblinded site|1
863727|NCT01465997|2751757|P2|Overall Study|subject withdrew consent|0
863728|NCT01465997|2751758|P1|Overall Study|subject withdrew consent|1
863729|NCT01465997|2751757|P2|Overall Study|sponsor's decision|1
863730|NCT01465997|2751758|P1|Overall Study|sponsor's decision|1
863731|NCT01465997|2751757|P2|Overall Study|Death|1
863732|NCT01465997|2751758|P1|Overall Study|Death|0
863733|NCT01465997|2751757|P2|Overall Study|investigator's decision|1
863734|NCT01465997|2751758|P1|Overall Study|investigator's decision|1
863735|NCT01465997|2751757|P2|Overall Study|Withdrawal by Subject|35
863736|NCT01465997|2751758|P1|Overall Study|Withdrawal by Subject|32
863737|NCT01465997|2751757|P2|Overall Study|Lost to Follow-up|9
863738|NCT01465997|2751758|P1|Overall Study|Lost to Follow-up|6
863739|NCT01465997|2751757|P2|Overall Study|Protocol Violation|4
863740|NCT01465997|2751758|P1|Overall Study|Protocol Violation|1
863741|NCT01465997|2751757|P2|Overall Study|Lack of Efficacy|1
863742|NCT01465997|2751758|P1|Overall Study|Lack of Efficacy|13
863743|NCT01465997|2751757|P2|Overall Study|Adverse Event|22
863744|NCT01465997|2751758|P1|Overall Study|Adverse Event|12
863749|NCT01439165|2751779|P2|Overall Study|Withdrawal by Subject|1
863750|NCT01439165|2751780|P1|Overall Study|Withdrawal by Subject|7
863751|NCT01439165|2751779|P2|Overall Study|Lost to Follow-up|1
863752|NCT01439165|2751780|P1|Overall Study|Lost to Follow-up|11
863753|NCT01439165|2751779|P2|Overall Study|Protocol Violation|0
863754|NCT01439165|2751780|P1|Overall Study|Protocol Violation|3
863755|NCT01390948|2751795|P3|Overall Study|Withdrew consent from survival follow-up|0
863756|NCT01390948|2751796|P2|Overall Study|Withdrew consent from survival follow-up|5
863757|NCT01390948|2751797|P1|Overall Study|Withdrew consent from survival follow-up|3
863758|NCT01390948|2751795|P3|Overall Study|Ongoing|0
863759|NCT01390948|2751796|P2|Overall Study|Ongoing|6
863760|NCT01390948|2751797|P1|Overall Study|Ongoing|6
863761|NCT01390948|2751795|P3|Overall Study|Death|2
863762|NCT01390948|2751796|P2|Overall Study|Death|34
863763|NCT01390948|2751797|P1|Overall Study|Death|30
863764|NCT01390948|2751795|P3|Overall Study|Alive in follow-up|1
863765|NCT01390948|2751796|P2|Overall Study|Alive in follow-up|17
863766|NCT01390948|2751797|P1|Overall Study|Alive in follow-up|20
863767|NCT01383928|2751833|P3|Phase 2|Unsatisfactory therapeutic response|1
863768|NCT01383928|2751834|P2|Phase 2|Unsatisfactory therapeutic response|0
863770|NCT01383928|2751833|P3|Phase 2|Withdrawal by Subject|4
863771|NCT01383928|2751834|P2|Phase 2|Withdrawal by Subject|0
863772|NCT01383928|2751835|P1|Phase 2|Withdrawal by Subject|0
863773|NCT01383928|2751833|P3|Phase 2|Progressive Disease|5
863774|NCT01383928|2751834|P2|Phase 2|Progressive Disease|0
863775|NCT01383928|2751835|P1|Phase 2|Progressive Disease|0
863776|NCT01383928|2751833|P3|Phase 2|Other|4
863777|NCT01383928|2751834|P2|Phase 2|Other|0
863778|NCT01383928|2751835|P1|Phase 2|Other|0
863779|NCT01383928|2751833|P3|Phase 2|Adverse Event|8
863780|NCT01383928|2751834|P2|Phase 2|Adverse Event|0
863781|NCT01383928|2751835|P1|Phase 2|Adverse Event|0
863782|NCT01383928|2751833|P3|Phase 2|Autologous Stem Cell Transplantation|18
863783|NCT01383928|2751834|P2|Phase 2|Autologous Stem Cell Transplantation|0
863784|NCT01383928|2751835|P1|Phase 2|Autologous Stem Cell Transplantation|0
863785|NCT01383928|2751833|P3|Phase 1|Progressive Disease|0
863786|NCT01383928|2751834|P2|Phase 1|Progressive Disease|1
863787|NCT01383928|2751835|P1|Phase 1|Progressive Disease|1
863788|NCT01383928|2751833|P3|Phase 1|Other|0
863789|NCT01383928|2751834|P2|Phase 1|Other|3
863790|NCT01383928|2751835|P1|Phase 1|Other|1
863791|NCT01383928|2751833|P3|Phase 1|Adverse Event|0
863792|NCT01383928|2751834|P2|Phase 1|Adverse Event|2
863793|NCT01383928|2751835|P1|Phase 1|Adverse Event|1
863794|NCT01383928|2751833|P3|Phase 1|Autologous Stem Cell Transplantation|0
863795|NCT01383928|2751834|P2|Phase 1|Autologous Stem Cell Transplantation|1
863796|NCT01383928|2751835|P1|Phase 1|Autologous Stem Cell Transplantation|2
863965|NCT01252095|2752145|P2|Overall Study|Disease progression|0
863966|NCT01252095|2752146|P1|Overall Study|Disease progression|1
863967|NCT01225887|2752165|P1|Overall Study|Ineligible:inadequate pathology|2
863968|NCT01225887|2752165|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
863969|NCT01225887|2752165|P1|Overall Study|Ineligible:required test not done|2
864051|NCT00953225|2752271|P2|Overall Study|Withdrawal by Subject|0
864052|NCT00953225|2752272|P1|Overall Study|Withdrawal by Subject|2
864054|NCT00903409|2752289|P2|Overall Study|Lost to Follow-up|6
864055|NCT00903409|2752290|P1|Overall Study|Lost to Follow-up|2
864056|NCT00903409|2752289|P2|Overall Study|Not specified|3
864057|NCT00903409|2752290|P1|Overall Study|Not specified|2
864058|NCT00903409|2752289|P2|Overall Study|Withdrawal by Subject|8
864059|NCT00903409|2752290|P1|Overall Study|Withdrawal by Subject|8
864060|NCT00903409|2752289|P2|Overall Study|Laboratory Abnormality|0
864061|NCT00903409|2752290|P1|Overall Study|Laboratory Abnormality|2
864062|NCT00903409|2752289|P2|Overall Study|Non-compliance with Protocol|1
864063|NCT00903409|2752290|P1|Overall Study|Non-compliance with Protocol|1
864064|NCT00903409|2752289|P2|Overall Study|Adverse Event|9
864065|NCT00903409|2752290|P1|Overall Study|Adverse Event|11
864066|NCT00892775|2752306|P2|Overall Study|Lost to Follow-up|0
864067|NCT00892775|2752307|P1|Overall Study|Lost to Follow-up|1
864068|NCT00892775|2752306|P2|Overall Study|Withdrawal by Subject|1
864069|NCT00892775|2752307|P1|Overall Study|Withdrawal by Subject|0
864070|NCT00892775|2752306|P2|Overall Study|Migrated/ moved from study area|0
864071|NCT00892775|2752307|P1|Overall Study|Migrated/ moved from study area|1
864072|NCT00892775|2752306|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
864073|NCT00892775|2752307|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
864074|NCT00892775|2752306|P2|Overall Study|Subject difficulties with blood drawing|0
864075|NCT00892775|2752307|P1|Overall Study|Subject difficulties with blood drawing|1
864076|NCT00892775|2752306|P2|Overall Study|Protocol Violation|0
864077|NCT00892775|2752307|P1|Overall Study|Protocol Violation|1
864078|NCT00878709|2752333|P2|Overall Study|Other Reasons|84
864079|NCT00878709|2752334|P1|Overall Study|Other Reasons|93
864080|NCT00878709|2752333|P2|Overall Study|Lost to Follow-up|33
864081|NCT00878709|2752334|P1|Overall Study|Lost to Follow-up|35
864082|NCT00878709|2752333|P2|Overall Study|Withdrawal by Subject|120
864083|NCT00878709|2752334|P1|Overall Study|Withdrawal by Subject|197
864092|NCT00842153|2752376|P2|Overall Study|Lost to Follow-up|2
864093|NCT00842153|2752377|P1|Overall Study|Lost to Follow-up|1
864094|NCT00842153|2752376|P2|Overall Study|Adverse Event|1
864095|NCT00842153|2752377|P1|Overall Study|Adverse Event|0
864096|NCT00720096|2752437|P2|Overall Study|Withdrawal by Subject|2
864097|NCT00720096|2752438|P1|Overall Study|Withdrawal by Subject|0
864098|NCT00718328|2752450|P2|Overall Study|Lost to Follow-up|0
864099|NCT00718328|2752451|P1|Overall Study|Lost to Follow-up|1
864100|NCT00703092|2752457|P1|Overall Study|Withdrawal by Subject|2
864104|NCT00676052|2752485|P6|Overall Study|Withdrawal by Subject|0
864105|NCT00676052|2752486|P5|Overall Study|Withdrawal by Subject|0
864106|NCT00676052|2752487|P4|Overall Study|Withdrawal by Subject|0
864107|NCT00676052|2752488|P3|Overall Study|Withdrawal by Subject|1
864108|NCT00676052|2752489|P2|Overall Study|Withdrawal by Subject|0
864109|NCT00676052|2752490|P1|Overall Study|Withdrawal by Subject|1
864110|NCT00676052|2752485|P6|Overall Study|Physician Decision|1
864111|NCT00676052|2752486|P5|Overall Study|Physician Decision|0
864112|NCT00676052|2752487|P4|Overall Study|Physician Decision|0
864113|NCT00676052|2752488|P3|Overall Study|Physician Decision|1
864114|NCT00676052|2752489|P2|Overall Study|Physician Decision|1
864115|NCT00676052|2752490|P1|Overall Study|Physician Decision|1
864116|NCT00676052|2752485|P6|Overall Study|Lost to Follow-up|0
864117|NCT00676052|2752486|P5|Overall Study|Lost to Follow-up|1
864118|NCT00676052|2752487|P4|Overall Study|Lost to Follow-up|0
864119|NCT00676052|2752488|P3|Overall Study|Lost to Follow-up|0
864120|NCT00676052|2752489|P2|Overall Study|Lost to Follow-up|0
864121|NCT00676052|2752490|P1|Overall Study|Lost to Follow-up|0
864122|NCT00676052|2752485|P6|Overall Study|Protocol Violation|2
864123|NCT00676052|2752486|P5|Overall Study|Protocol Violation|1
864124|NCT00676052|2752487|P4|Overall Study|Protocol Violation|2
864125|NCT00676052|2752488|P3|Overall Study|Protocol Violation|2
864126|NCT00676052|2752489|P2|Overall Study|Protocol Violation|3
864127|NCT00676052|2752490|P1|Overall Study|Protocol Violation|5
864128|NCT00676052|2752485|P6|Overall Study|Lack of Efficacy|1
864129|NCT00676052|2752486|P5|Overall Study|Lack of Efficacy|2
864130|NCT00676052|2752487|P4|Overall Study|Lack of Efficacy|1
864131|NCT00676052|2752488|P3|Overall Study|Lack of Efficacy|1
864132|NCT00676052|2752489|P2|Overall Study|Lack of Efficacy|2
864133|NCT00676052|2752490|P1|Overall Study|Lack of Efficacy|2
864134|NCT00676052|2752485|P6|Overall Study|Adverse Event|2
864135|NCT00676052|2752486|P5|Overall Study|Adverse Event|2
864136|NCT00676052|2752487|P4|Overall Study|Adverse Event|2
864137|NCT00676052|2752488|P3|Overall Study|Adverse Event|1
864138|NCT00676052|2752489|P2|Overall Study|Adverse Event|1
864139|NCT00676052|2752490|P1|Overall Study|Adverse Event|0
864209|NCT02786927|2752866|P1|Overall Study|Protocol Violation|4
864210|NCT02786927|2752866|P1|Overall Study|Adverse Event|1
864211|NCT02681510|2752895|P1|Overall Study|Lost to Follow-up|9
864212|NCT02681510|2752895|P1|Overall Study|Withdrawal by Subject|1
864213|NCT02586506|2752908|P1|Overall Study|Other Reason|2
864214|NCT02586506|2752908|P1|Overall Study|Lost to Follow-up|1
864215|NCT02586506|2752908|P1|Overall Study|Protocol Violation|6
864226|NCT02401256|2752941|P1|Overall Study|Withdrawal by Subject|12
864227|NCT02401256|2752941|P1|Overall Study|Adverse Event|5
864228|NCT02387996|2752947|P1|Overall Study|Poor/Non-Compliance|1
864229|NCT02387996|2752947|P1|Overall Study|Lost to Follow-up|1
864230|NCT02387996|2752947|P1|Overall Study|Subject Withdrew Consent|1
864231|NCT02387996|2752947|P1|Overall Study|Subject Request to Discontinue Treatment|9
864232|NCT02387996|2752947|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
864233|NCT02387996|2752947|P1|Overall Study|Study Drug Toxicity|14
864234|NCT02387996|2752947|P1|Overall Study|Disease Progression|144
864247|NCT02275052|2753022|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
864248|NCT02275052|2753023|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
864249|NCT02275052|2753024|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
864250|NCT02275052|2753025|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
864251|NCT02275052|2753022|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
864252|NCT02275052|2753023|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
864253|NCT02275052|2753024|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
864254|NCT02275052|2753025|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
864255|NCT02275052|2753022|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
864256|NCT02275052|2753023|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
864257|NCT02275052|2753024|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864258|NCT02275052|2753025|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864259|NCT02275052|2753022|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
864260|NCT02275052|2753023|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
864261|NCT02275052|2753024|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
864262|NCT02275052|2753025|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
864263|NCT02275052|2753022|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
864264|NCT02275052|2753023|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
864265|NCT02275052|2753024|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
864266|NCT02275052|2753025|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
864267|NCT02275052|2753022|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
864268|NCT02275052|2753023|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
864269|NCT02275052|2753024|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
864270|NCT02275052|2753025|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
864271|NCT02275052|2753022|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
864272|NCT02275052|2753023|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
864273|NCT02275052|2753024|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
864274|NCT02275052|2753025|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
864275|NCT02275052|2753022|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
864276|NCT02275052|2753023|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
864277|NCT02275052|2753024|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
864278|NCT02275052|2753025|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
864279|NCT02275052|2753022|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
864280|NCT02275052|2753023|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
864281|NCT02275052|2753024|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
864282|NCT02275052|2753025|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
864283|NCT02275052|2753022|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
864284|NCT02275052|2753023|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
864285|NCT02275052|2753024|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
864286|NCT02275052|2753025|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
864287|NCT02275052|2753022|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864288|NCT02275052|2753023|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864289|NCT02275052|2753024|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
864290|NCT02275052|2753025|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864291|NCT02236611|2753039|P2|Overall Study|Withdrew consent|4
864292|NCT02236611|2753040|P1|Overall Study|Withdrew consent|9
864293|NCT02236611|2753039|P2|Overall Study|Protocol deviation|5
864294|NCT02236611|2753040|P1|Overall Study|Protocol deviation|3
864295|NCT02236611|2753039|P2|Overall Study|Lost to Follow-up|2
864296|NCT02236611|2753040|P1|Overall Study|Lost to Follow-up|0
864297|NCT02236611|2753039|P2|Overall Study|Lack of Efficacy|7
864298|NCT02236611|2753040|P1|Overall Study|Lack of Efficacy|4
864299|NCT02236611|2753039|P2|Overall Study|Adverse Event|16
864300|NCT02236611|2753040|P1|Overall Study|Adverse Event|10
864323|NCT02164539|2753199|P7|Treatment Phase C (1 Week)|Physician Decision|1
864324|NCT02164539|2753200|P6|Treatment Phase C (1 Week)|Physician Decision|0
864325|NCT02164539|2753201|P5|Treatment Phase C (1 Week)|Physician Decision|0
864326|NCT02164539|2753202|P4|Treatment Phase C (1 Week)|Physician Decision|0
864327|NCT02164539|2753203|P3|Treatment Phase C (1 Week)|Physician Decision|0
864328|NCT02164539|2753204|P2|Treatment Phase C (1 Week)|Physician Decision|0
864329|NCT02164539|2753205|P1|Treatment Phase C (1 Week)|Physician Decision|0
864330|NCT02164539|2753199|P7|Treatment Phase C (1 Week)|Adverse Event|1
864331|NCT02164539|2753200|P6|Treatment Phase C (1 Week)|Adverse Event|0
864332|NCT02164539|2753201|P5|Treatment Phase C (1 Week)|Adverse Event|0
864333|NCT02164539|2753202|P4|Treatment Phase C (1 Week)|Adverse Event|0
864334|NCT02164539|2753203|P3|Treatment Phase C (1 Week)|Adverse Event|0
864335|NCT02164539|2753204|P2|Treatment Phase C (1 Week)|Adverse Event|0
864336|NCT02164539|2753205|P1|Treatment Phase C (1 Week)|Adverse Event|0
864337|NCT02164539|2753199|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864338|NCT02164539|2753200|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864339|NCT02164539|2753201|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864340|NCT02164539|2753202|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864341|NCT02164539|2753203|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864342|NCT02164539|2753204|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
864343|NCT02164539|2753205|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
864344|NCT02164539|2753199|P7|Treatment Phase B (1 Week)|Physician Decision|1
864345|NCT02164539|2753200|P6|Treatment Phase B (1 Week)|Physician Decision|0
864346|NCT02164539|2753201|P5|Treatment Phase B (1 Week)|Physician Decision|1
864347|NCT02164539|2753202|P4|Treatment Phase B (1 Week)|Physician Decision|0
864348|NCT02164539|2753203|P3|Treatment Phase B (1 Week)|Physician Decision|0
864349|NCT02164539|2753204|P2|Treatment Phase B (1 Week)|Physician Decision|0
864350|NCT02164539|2753205|P1|Treatment Phase B (1 Week)|Physician Decision|0
864351|NCT02164539|2753199|P7|Treatment Phase B (1 Week)|Adverse Event|0
864352|NCT02164539|2753200|P6|Treatment Phase B (1 Week)|Adverse Event|0
864353|NCT02164539|2753201|P5|Treatment Phase B (1 Week)|Adverse Event|2
864354|NCT02164539|2753202|P4|Treatment Phase B (1 Week)|Adverse Event|0
864355|NCT02164539|2753203|P3|Treatment Phase B (1 Week)|Adverse Event|0
864356|NCT02164539|2753204|P2|Treatment Phase B (1 Week)|Adverse Event|0
864357|NCT02164539|2753205|P1|Treatment Phase B (1 Week)|Adverse Event|0
864358|NCT02164539|2753199|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
864359|NCT02164539|2753200|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
864360|NCT02164539|2753201|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
864361|NCT02164539|2753202|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
864362|NCT02164539|2753203|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
864363|NCT02164539|2753204|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
864364|NCT02164539|2753205|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
864369|NCT02091869|2753286|P2|Overall Study|Withdrawal by Subject|3
864370|NCT02091869|2753287|P1|Overall Study|Withdrawal by Subject|0
864379|NCT01980888|2753380|P2|Overall Study|Non-Compliance with Study Drug|2
864380|NCT01980888|2753381|P1|Overall Study|Non-Compliance with Study Drug|3
864381|NCT01980888|2753380|P2|Overall Study|Investigator's Discretion|3
864382|NCT01980888|2753381|P1|Overall Study|Investigator's Discretion|8
864383|NCT01980888|2753380|P2|Overall Study|Withdrew Consent|6
864384|NCT01980888|2753381|P1|Overall Study|Withdrew Consent|17
864385|NCT01980888|2753380|P2|Overall Study|Study Terminated by Sponsor|122
864386|NCT01980888|2753381|P1|Overall Study|Study Terminated by Sponsor|116
864513|NCT01649856|2753802|P2|Overall Study|Not Specified|5
864514|NCT01649856|2753803|P1|Overall Study|Not Specified|20
864515|NCT01649856|2753802|P2|Overall Study|Lack of Compliance|1
864516|NCT01649856|2753803|P1|Overall Study|Lack of Compliance|6
864517|NCT01649856|2753802|P2|Overall Study|Lost to Follow-up|16
864518|NCT01649856|2753803|P1|Overall Study|Lost to Follow-up|20
864519|NCT01649856|2753802|P2|Overall Study|Stable or Progressed Disease|3
864520|NCT01649856|2753803|P1|Overall Study|Stable or Progressed Disease|5
864521|NCT01649856|2753802|P2|Overall Study|Death|34
864522|NCT01649856|2753803|P1|Overall Study|Death|69
864523|NCT01649856|2753802|P2|Overall Study|Treatment Failure|1
864524|NCT01649856|2753803|P1|Overall Study|Treatment Failure|1
864525|NCT01649856|2753802|P2|Overall Study|Protocol Violation|4
864526|NCT01649856|2753803|P1|Overall Study|Protocol Violation|4
864527|NCT01649856|2753802|P2|Overall Study|Withdrawal by Subject|14
864528|NCT01649856|2753803|P1|Overall Study|Withdrawal by Subject|14
864581|NCT01597791|2754045|P2|Overall Study|Protocol Violation|1
864582|NCT01597791|2754046|P1|Overall Study|Protocol Violation|0
864583|NCT01597791|2754045|P2|Overall Study|Subject withdrawal|1
864584|NCT01597791|2754046|P1|Overall Study|Subject withdrawal|0
864585|NCT01597791|2754045|P2|Overall Study|Cesarean Section|7
864586|NCT01597791|2754046|P1|Overall Study|Cesarean Section|6
864587|NCT01597791|2754045|P2|Overall Study|Physician Decision|1
864588|NCT01597791|2754046|P1|Overall Study|Physician Decision|2
864595|NCT01550757|2754097|P4|Overall Study|Withdrawal by Subject|1
864596|NCT01550757|2754098|P3|Overall Study|Withdrawal by Subject|3
864597|NCT01550757|2754099|P2|Overall Study|Withdrawal by Subject|0
864598|NCT01550757|2754100|P1|Overall Study|Withdrawal by Subject|2
864599|NCT01550757|2754097|P4|Overall Study|Lost to Follow-up|53
864600|NCT01550757|2754098|P3|Overall Study|Lost to Follow-up|42
864601|NCT01550757|2754099|P2|Overall Study|Lost to Follow-up|14
864602|NCT01550757|2754100|P1|Overall Study|Lost to Follow-up|21
864603|NCT01514760|2754184|P1|Overall Study|Lost to Follow-up|2
864680|NCT01376323|2754439|P5|Overall Study|Withdrawal by Subject|0
864681|NCT01376323|2754440|P4|Overall Study|Withdrawal by Subject|0
864682|NCT01376323|2754441|P3|Overall Study|Withdrawal by Subject|1
864683|NCT01376323|2754442|P2|Overall Study|Withdrawal by Subject|1
864684|NCT01376323|2754443|P1|Overall Study|Withdrawal by Subject|0
864685|NCT01376323|2754439|P5|Overall Study|Physician Decision|1
864686|NCT01376323|2754440|P4|Overall Study|Physician Decision|1
864687|NCT01376323|2754441|P3|Overall Study|Physician Decision|2
864688|NCT01376323|2754442|P2|Overall Study|Physician Decision|0
864689|NCT01376323|2754443|P1|Overall Study|Physician Decision|1
864690|NCT01376323|2754439|P5|Overall Study|Lost to Follow-up|0
864691|NCT01376323|2754440|P4|Overall Study|Lost to Follow-up|2
864692|NCT01376323|2754441|P3|Overall Study|Lost to Follow-up|0
864693|NCT01376323|2754442|P2|Overall Study|Lost to Follow-up|0
864694|NCT01376323|2754443|P1|Overall Study|Lost to Follow-up|0
864695|NCT01376323|2754439|P5|Overall Study|Adverse Event|0
864696|NCT01376323|2754440|P4|Overall Study|Adverse Event|2
864697|NCT01376323|2754441|P3|Overall Study|Adverse Event|0
864698|NCT01376323|2754442|P2|Overall Study|Adverse Event|0
864699|NCT01376323|2754443|P1|Overall Study|Adverse Event|1
864790|NCT01342211|2754684|P5|Overall Study|Randomized, but not Treated|1
864791|NCT01342211|2754685|P4|Overall Study|Randomized, but not Treated|0
864792|NCT01342211|2754686|P3|Overall Study|Randomized, but not Treated|0
864793|NCT01342211|2754687|P2|Overall Study|Randomized, but not Treated|2
864794|NCT01342211|2754688|P1|Overall Study|Randomized, but not Treated|0
864795|NCT01342211|2754684|P5|Overall Study|Withdrawal by Subject|0
864796|NCT01342211|2754685|P4|Overall Study|Withdrawal by Subject|1
864797|NCT01342211|2754686|P3|Overall Study|Withdrawal by Subject|0
864798|NCT01342211|2754687|P2|Overall Study|Withdrawal by Subject|0
864799|NCT01342211|2754688|P1|Overall Study|Withdrawal by Subject|0
864800|NCT01342211|2754684|P5|Overall Study|Adverse Event|1
864801|NCT01342211|2754685|P4|Overall Study|Adverse Event|0
864802|NCT01342211|2754686|P3|Overall Study|Adverse Event|0
864803|NCT01342211|2754687|P2|Overall Study|Adverse Event|0
864804|NCT01342211|2754688|P1|Overall Study|Adverse Event|0
864805|NCT01342211|2754684|P5|Overall Study|Lost to Follow-up|0
864806|NCT01342211|2754685|P4|Overall Study|Lost to Follow-up|1
864807|NCT01342211|2754686|P3|Overall Study|Lost to Follow-up|0
864808|NCT01342211|2754687|P2|Overall Study|Lost to Follow-up|0
864809|NCT01342211|2754688|P1|Overall Study|Lost to Follow-up|0
864836|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
864837|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
864838|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864839|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864840|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864841|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
864842|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
864843|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
864844|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
864845|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
864846|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
864847|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
864848|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
864849|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
864850|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
864851|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
864852|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
864853|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
864854|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
864855|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
864856|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
864857|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
864858|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
864859|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
864860|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
864861|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
864862|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
864863|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
864864|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
864865|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
864866|NCT01328444|2754802|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
864867|NCT01328444|2754803|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
864868|NCT01328444|2754804|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
864869|NCT01328444|2754805|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
864870|NCT01328444|2754806|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
864871|NCT01328444|2754807|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
864872|NCT01328444|2754802|P6|Washout Period (14 Days)|Withdrawal by Subject|1
864873|NCT01328444|2754803|P5|Washout Period (14 Days)|Withdrawal by Subject|0
864874|NCT01328444|2754804|P4|Washout Period (14 Days)|Withdrawal by Subject|0
864875|NCT01328444|2754805|P3|Washout Period (14 Days)|Withdrawal by Subject|0
864876|NCT01328444|2754806|P2|Washout Period (14 Days)|Withdrawal by Subject|0
864877|NCT01328444|2754807|P1|Washout Period (14 Days)|Withdrawal by Subject|0
864878|NCT01328444|2754802|P6|Washout Period (14 Days)|Lack of Efficacy|1
864879|NCT01328444|2754803|P5|Washout Period (14 Days)|Lack of Efficacy|0
864880|NCT01328444|2754804|P4|Washout Period (14 Days)|Lack of Efficacy|0
864881|NCT01328444|2754805|P3|Washout Period (14 Days)|Lack of Efficacy|0
864882|NCT01328444|2754806|P2|Washout Period (14 Days)|Lack of Efficacy|0
864883|NCT01328444|2754807|P1|Washout Period (14 Days)|Lack of Efficacy|0
864884|NCT01328444|2754802|P6|Washout Period (14 Days)|Adverse Event|2
864885|NCT01328444|2754803|P5|Washout Period (14 Days)|Adverse Event|1
864886|NCT01328444|2754804|P4|Washout Period (14 Days)|Adverse Event|1
864887|NCT01328444|2754805|P3|Washout Period (14 Days)|Adverse Event|0
864888|NCT01328444|2754806|P2|Washout Period (14 Days)|Adverse Event|1
864889|NCT01328444|2754807|P1|Washout Period (14 Days)|Adverse Event|1
864890|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
864891|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
864892|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
864893|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
864894|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
864895|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
864896|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
864897|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864898|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
864899|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864900|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
864901|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
864902|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
864903|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
864904|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
864905|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
864906|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
864907|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
864908|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
864909|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
864910|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
864911|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
864912|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
864913|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
864914|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
864915|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
864916|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
864917|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
864918|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
864919|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
864920|NCT01328444|2754802|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
864921|NCT01328444|2754803|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
864922|NCT01328444|2754804|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
864923|NCT01328444|2754805|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
864924|NCT01328444|2754806|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
864925|NCT01328444|2754807|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
864926|NCT01313637|2754855|P4|Overall Study|Withdrawal by Subject|15
864927|NCT01313637|2754856|P3|Overall Study|Withdrawal by Subject|18
864928|NCT01313637|2754857|P2|Overall Study|Withdrawal by Subject|13
864929|NCT01313637|2754858|P1|Overall Study|Withdrawal by Subject|11
864930|NCT01313637|2754855|P4|Overall Study|Lost to Follow-up|3
864931|NCT01313637|2754856|P3|Overall Study|Lost to Follow-up|1
864932|NCT01313637|2754857|P2|Overall Study|Lost to Follow-up|2
864933|NCT01313637|2754858|P1|Overall Study|Lost to Follow-up|0
864934|NCT01313637|2754855|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
864935|NCT01313637|2754856|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
864936|NCT01313637|2754857|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
864937|NCT01313637|2754858|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
864938|NCT01313637|2754855|P4|Overall Study|Protocol Violation|5
864939|NCT01313637|2754856|P3|Overall Study|Protocol Violation|11
864940|NCT01313637|2754857|P2|Overall Study|Protocol Violation|3
864941|NCT01313637|2754858|P1|Overall Study|Protocol Violation|4
864942|NCT01313637|2754855|P4|Overall Study|Lack of Efficacy|24
864943|NCT01313637|2754856|P3|Overall Study|Lack of Efficacy|37
864944|NCT01313637|2754857|P2|Overall Study|Lack of Efficacy|38
864945|NCT01313637|2754858|P1|Overall Study|Lack of Efficacy|44
864946|NCT01313637|2754855|P4|Overall Study|Adverse Event|18
864947|NCT01313637|2754856|P3|Overall Study|Adverse Event|25
864948|NCT01313637|2754857|P2|Overall Study|Adverse Event|24
864949|NCT01313637|2754858|P1|Overall Study|Adverse Event|17
896444|NCT02694744|2846139|P2|Overall Study|Taking potassium supplement: exclusion 6|1
896445|NCT02694744|2846140|P1|Overall Study|Taking potassium supplement: exclusion 6|0
896446|NCT02694744|2846139|P2|Overall Study|Lost to Follow-up|0
896447|NCT02694744|2846140|P1|Overall Study|Lost to Follow-up|1
896448|NCT02694744|2846139|P2|Overall Study|Physician Decision|2
896449|NCT02694744|2846140|P1|Overall Study|Physician Decision|1
896450|NCT02694744|2846139|P2|Overall Study|Withdrawal by Subject|1
896451|NCT02694744|2846140|P1|Overall Study|Withdrawal by Subject|2
896452|NCT02694744|2846139|P2|Overall Study|Adverse Event|1
896453|NCT02694744|2846140|P1|Overall Study|Adverse Event|2
896454|NCT02564055|2846181|P6|Overall Study|Withdrawal by Subject|10
896455|NCT02564055|2846182|P5|Overall Study|Withdrawal by Subject|10
896456|NCT02564055|2846183|P4|Overall Study|Withdrawal by Subject|3
896457|NCT02564055|2846184|P3|Overall Study|Withdrawal by Subject|3
896458|NCT02564055|2846185|P2|Overall Study|Withdrawal by Subject|4
896459|NCT02564055|2846186|P1|Overall Study|Withdrawal by Subject|4
896460|NCT02564055|2846181|P6|Overall Study|Physician Decision|0
896461|NCT02564055|2846182|P5|Overall Study|Physician Decision|0
896462|NCT02564055|2846183|P4|Overall Study|Physician Decision|0
896463|NCT02564055|2846184|P3|Overall Study|Physician Decision|1
896464|NCT02564055|2846185|P2|Overall Study|Physician Decision|0
896465|NCT02564055|2846186|P1|Overall Study|Physician Decision|0
896466|NCT02564055|2846181|P6|Overall Study|Lost to Follow-up|0
896467|NCT02564055|2846182|P5|Overall Study|Lost to Follow-up|1
896468|NCT02564055|2846183|P4|Overall Study|Lost to Follow-up|2
896469|NCT02564055|2846184|P3|Overall Study|Lost to Follow-up|4
896470|NCT02564055|2846185|P2|Overall Study|Lost to Follow-up|1
896471|NCT02564055|2846186|P1|Overall Study|Lost to Follow-up|0
896472|NCT02564055|2846181|P6|Overall Study|Reached stopping criteria|1
896473|NCT02564055|2846182|P5|Overall Study|Reached stopping criteria|0
896474|NCT02564055|2846183|P4|Overall Study|Reached stopping criteria|0
896475|NCT02564055|2846184|P3|Overall Study|Reached stopping criteria|0
896476|NCT02564055|2846185|P2|Overall Study|Reached stopping criteria|0
896477|NCT02564055|2846186|P1|Overall Study|Reached stopping criteria|0
896478|NCT02564055|2846181|P6|Overall Study|Protocol Violation|0
896479|NCT02564055|2846182|P5|Overall Study|Protocol Violation|0
896480|NCT02564055|2846183|P4|Overall Study|Protocol Violation|0
896481|NCT02564055|2846184|P3|Overall Study|Protocol Violation|0
896482|NCT02564055|2846185|P2|Overall Study|Protocol Violation|0
896483|NCT02564055|2846186|P1|Overall Study|Protocol Violation|1
865263|NCT01086384|2755856|P3|Treatment Period|Received Treatment in Error|0
865264|NCT01086384|2755857|P2|Treatment Period|Received Treatment in Error|1
865265|NCT01086384|2755858|P1|Treatment Period|Received Treatment in Error|0
865266|NCT01086384|2755856|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
865267|NCT01086384|2755857|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
865268|NCT01086384|2755858|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
865269|NCT01086384|2755856|P3|Treatment Period|Study Closed/Terminated|8
865270|NCT01086384|2755857|P2|Treatment Period|Study Closed/Terminated|7
865271|NCT01086384|2755858|P1|Treatment Period|Study Closed/Terminated|0
865272|NCT01086384|2755856|P3|Treatment Period|Physician Decision|6
865273|NCT01086384|2755857|P2|Treatment Period|Physician Decision|9
865274|NCT01086384|2755858|P1|Treatment Period|Physician Decision|0
865275|NCT01086384|2755856|P3|Treatment Period|Lost to Follow-up|9
865276|NCT01086384|2755857|P2|Treatment Period|Lost to Follow-up|11
865277|NCT01086384|2755858|P1|Treatment Period|Lost to Follow-up|0
865278|NCT01086384|2755856|P3|Treatment Period|Adverse Event|15
865279|NCT01086384|2755857|P2|Treatment Period|Adverse Event|19
865280|NCT01086384|2755858|P1|Treatment Period|Adverse Event|0
865281|NCT01086384|2755856|P3|Treatment Period|Lack of Efficacy|13
865282|NCT01086384|2755857|P2|Treatment Period|Lack of Efficacy|22
865283|NCT01086384|2755858|P1|Treatment Period|Lack of Efficacy|0
865284|NCT01086384|2755856|P3|Treatment Period|Protocol Violation|17
865285|NCT01086384|2755857|P2|Treatment Period|Protocol Violation|26
865286|NCT01086384|2755858|P1|Treatment Period|Protocol Violation|0
865287|NCT01086384|2755856|P3|Treatment Period|Withdrawal by Subject|55
865288|NCT01086384|2755857|P2|Treatment Period|Withdrawal by Subject|53
865289|NCT01086384|2755858|P1|Treatment Period|Withdrawal by Subject|0
865290|NCT01086384|2755856|P3|2-week Run-in Period|Randomized in Error|0
865291|NCT01086384|2755857|P2|2-week Run-in Period|Randomized in Error|0
865292|NCT01086384|2755858|P1|2-week Run-in Period|Randomized in Error|1
865293|NCT01086384|2755856|P3|2-week Run-in Period|Continuation Criteria Not Met|0
865294|NCT01086384|2755857|P2|2-week Run-in Period|Continuation Criteria Not Met|0
865295|NCT01086384|2755858|P1|2-week Run-in Period|Continuation Criteria Not Met|92
865296|NCT01086384|2755856|P3|2-week Run-in Period|Study Closed/Terminated|0
865297|NCT01086384|2755857|P2|2-week Run-in Period|Study Closed/Terminated|0
865298|NCT01086384|2755858|P1|2-week Run-in Period|Study Closed/Terminated|42
865299|NCT01086384|2755856|P3|2-week Run-in Period|Withdrawal by Subject|0
865300|NCT01086384|2755857|P2|2-week Run-in Period|Withdrawal by Subject|0
865301|NCT01086384|2755858|P1|2-week Run-in Period|Withdrawal by Subject|19
865302|NCT01086384|2755856|P3|2-week Run-in Period|Physician Decision|0
865303|NCT01086384|2755857|P2|2-week Run-in Period|Physician Decision|0
865304|NCT01086384|2755858|P1|2-week Run-in Period|Physician Decision|6
865305|NCT01086384|2755856|P3|2-week Run-in Period|Lost to Follow-up|0
865306|NCT01086384|2755857|P2|2-week Run-in Period|Lost to Follow-up|0
865307|NCT01086384|2755858|P1|2-week Run-in Period|Lost to Follow-up|1
865308|NCT01086384|2755856|P3|2-week Run-in Period|Protocol Violation|0
865309|NCT01086384|2755857|P2|2-week Run-in Period|Protocol Violation|0
865310|NCT01086384|2755858|P1|2-week Run-in Period|Protocol Violation|1
865311|NCT01086384|2755856|P3|2-week Run-in Period|Adverse Event|0
865312|NCT01086384|2755857|P2|2-week Run-in Period|Adverse Event|0
865313|NCT01086384|2755858|P1|2-week Run-in Period|Adverse Event|1
865314|NCT01061671|2755977|P2|Overall Study|Death|30
865315|NCT01061671|2755978|P1|Overall Study|Death|28
865316|NCT01061671|2755977|P2|Overall Study|Lost to Follow-up|5
865317|NCT01061671|2755978|P1|Overall Study|Lost to Follow-up|3
865318|NCT01061671|2755977|P2|Overall Study|Withdrawal by Subject|20
865319|NCT01061671|2755978|P1|Overall Study|Withdrawal by Subject|16
896484|NCT02564055|2846181|P6|Overall Study|Adverse Event|1
896485|NCT02564055|2846182|P5|Overall Study|Adverse Event|4
896486|NCT02564055|2846183|P4|Overall Study|Adverse Event|1
896487|NCT02564055|2846184|P3|Overall Study|Adverse Event|4
896488|NCT02564055|2846185|P2|Overall Study|Adverse Event|0
896489|NCT02564055|2846186|P1|Overall Study|Adverse Event|1
896545|NCT02059174|2846828|P2|Period 3|Physician Decision|0
896546|NCT02059174|2846829|P1|Period 3|Physician Decision|1
896547|NCT02059174|2846828|P2|Period 2|Protocol Violation|0
896548|NCT02059174|2846829|P1|Period 2|Protocol Violation|1
896549|NCT02059174|2846828|P2|Period 2|Withdrawal by Subject|2
896550|NCT02059174|2846829|P1|Period 2|Withdrawal by Subject|0
896551|NCT02059174|2846828|P2|Period 1|Withdrawal by Subject|2
896552|NCT02059174|2846829|P1|Period 1|Withdrawal by Subject|0
896571|NCT01931462|2846912|P1|Overall Study|Withdrawal by Subject|1
896578|NCT01877421|2846964|P18|Phase 2|Protocol Violation|0
896579|NCT01877421|2846965|P17|Phase 2|Protocol Violation|0
896580|NCT01877421|2846966|P16|Phase 2|Protocol Violation|0
896581|NCT01877421|2846967|P15|Phase 2|Protocol Violation|0
896582|NCT01877421|2846968|P14|Phase 2|Protocol Violation|0
896583|NCT01877421|2846969|P13|Phase 2|Protocol Violation|0
896584|NCT01877421|2846970|P12|Phase 2|Protocol Violation|0
896585|NCT01877421|2846971|P11|Phase 2|Protocol Violation|1
896586|NCT01877421|2846972|P10|Phase 2|Protocol Violation|0
896587|NCT01877421|2846973|P9|Phase 2|Protocol Violation|0
896588|NCT01877421|2846974|P8|Phase 2|Protocol Violation|0
896589|NCT01877421|2846975|P7|Phase 2|Protocol Violation|0
896590|NCT01877421|2846976|P6|Phase 2|Protocol Violation|0
896591|NCT01877421|2846977|P5|Phase 2|Protocol Violation|0
896592|NCT01877421|2846978|P4|Phase 2|Protocol Violation|0
896593|NCT01877421|2846979|P3|Phase 2|Protocol Violation|0
896594|NCT01877421|2846980|P2|Phase 2|Protocol Violation|0
896595|NCT01877421|2846981|P1|Phase 2|Protocol Violation|0
896596|NCT01877421|2846964|P18|Phase 2|Withdrawal by Subject|0
896597|NCT01877421|2846965|P17|Phase 2|Withdrawal by Subject|0
896598|NCT01877421|2846966|P16|Phase 2|Withdrawal by Subject|1
896599|NCT01877421|2846967|P15|Phase 2|Withdrawal by Subject|0
896600|NCT01877421|2846968|P14|Phase 2|Withdrawal by Subject|0
896601|NCT01877421|2846969|P13|Phase 2|Withdrawal by Subject|1
896602|NCT01877421|2846970|P12|Phase 2|Withdrawal by Subject|0
896603|NCT01877421|2846971|P11|Phase 2|Withdrawal by Subject|1
896604|NCT01877421|2846972|P10|Phase 2|Withdrawal by Subject|0
896605|NCT01877421|2846973|P9|Phase 2|Withdrawal by Subject|1
896606|NCT01877421|2846974|P8|Phase 2|Withdrawal by Subject|0
896607|NCT01877421|2846975|P7|Phase 2|Withdrawal by Subject|0
896608|NCT01877421|2846976|P6|Phase 2|Withdrawal by Subject|0
896609|NCT01877421|2846977|P5|Phase 2|Withdrawal by Subject|0
896610|NCT01877421|2846978|P4|Phase 2|Withdrawal by Subject|0
896611|NCT01877421|2846979|P3|Phase 2|Withdrawal by Subject|0
896612|NCT01877421|2846980|P2|Phase 2|Withdrawal by Subject|0
896613|NCT01877421|2846981|P1|Phase 2|Withdrawal by Subject|0
896614|NCT01877421|2846964|P18|Phase 2|Lost to Follow-up|0
896615|NCT01877421|2846965|P17|Phase 2|Lost to Follow-up|0
896616|NCT01877421|2846966|P16|Phase 2|Lost to Follow-up|0
896617|NCT01877421|2846967|P15|Phase 2|Lost to Follow-up|0
896618|NCT01877421|2846968|P14|Phase 2|Lost to Follow-up|0
896619|NCT01877421|2846969|P13|Phase 2|Lost to Follow-up|0
896620|NCT01877421|2846970|P12|Phase 2|Lost to Follow-up|0
896621|NCT01877421|2846971|P11|Phase 2|Lost to Follow-up|0
896622|NCT01877421|2846972|P10|Phase 2|Lost to Follow-up|0
896623|NCT01877421|2846973|P9|Phase 2|Lost to Follow-up|0
896624|NCT01877421|2846974|P8|Phase 2|Lost to Follow-up|0
896625|NCT01877421|2846975|P7|Phase 2|Lost to Follow-up|1
896626|NCT01877421|2846976|P6|Phase 2|Lost to Follow-up|0
896627|NCT01877421|2846977|P5|Phase 2|Lost to Follow-up|0
896628|NCT01877421|2846978|P4|Phase 2|Lost to Follow-up|0
896629|NCT01877421|2846979|P3|Phase 2|Lost to Follow-up|0
896630|NCT01877421|2846980|P2|Phase 2|Lost to Follow-up|0
896631|NCT01877421|2846981|P1|Phase 2|Lost to Follow-up|0
896632|NCT01876706|2847089|P1|Overall Study|Lost to Follow-up|2
896633|NCT01876706|2847089|P1|Overall Study|BPH Intervention|2
896634|NCT01870076|2847110|P4|Overall Study|Withdrawal by Subject|0
896635|NCT01870076|2847111|P3|Overall Study|Withdrawal by Subject|1
896636|NCT01870076|2847112|P2|Overall Study|Withdrawal by Subject|0
896637|NCT01870076|2847113|P1|Overall Study|Withdrawal by Subject|1
896663|NCT01814748|2847223|P2|Overall Study|Withdrawal by Subject|4
896664|NCT01814748|2847224|P1|Overall Study|Withdrawal by Subject|6
896665|NCT01814748|2847223|P2|Overall Study|Study site terminated by sponsor|1
896666|NCT01814748|2847224|P1|Overall Study|Study site terminated by sponsor|1
896667|NCT01814748|2847223|P2|Overall Study|Lost to Follow-up|2
896668|NCT01814748|2847224|P1|Overall Study|Lost to Follow-up|1
865508|NCT00936910|2756314|P1|Overall Study|Lack of Efficacy|3
896679|NCT01762943|2847283|P2|Overall Study|Withdrawal by Subject|1
896680|NCT01762943|2847284|P1|Overall Study|Withdrawal by Subject|2
896681|NCT01762943|2847283|P2|Overall Study|Protocol Violation|0
896682|NCT01762943|2847284|P1|Overall Study|Protocol Violation|1
896683|NCT01762943|2847283|P2|Overall Study|Physician Decision|1
896684|NCT01762943|2847284|P1|Overall Study|Physician Decision|1
896685|NCT01718353|2847314|P2|Overall Study|Randomized but not treated|0
896686|NCT01718353|2847315|P1|Overall Study|Randomized but not treated|2
896687|NCT01718353|2847314|P2|Overall Study|Principal Investigator's Decision|4
896688|NCT01718353|2847315|P1|Overall Study|Principal Investigator's Decision|10
896689|NCT01718353|2847314|P2|Overall Study|Lost to Follow-up|1
896690|NCT01718353|2847315|P1|Overall Study|Lost to Follow-up|0
865552|NCT00858702|2756446|P2|Overall Study|Withdrawal by Subject|0
865553|NCT00858702|2756447|P1|Overall Study|Withdrawal by Subject|1
865554|NCT00858702|2756446|P2|Overall Study|Other|1
865555|NCT00858702|2756447|P1|Overall Study|Other|2
865556|NCT00858702|2756446|P2|Overall Study|Protocol Violation|1
865557|NCT00858702|2756447|P1|Overall Study|Protocol Violation|1
865558|NCT00858702|2756446|P2|Overall Study|Lack of Efficacy|0
865559|NCT00858702|2756447|P1|Overall Study|Lack of Efficacy|1
896867|NCT01692730|2847515|P2|Overall Study|Lost to Follow-up|227
896868|NCT01692730|2847516|P1|Overall Study|Lost to Follow-up|225
896869|NCT01660412|2847524|P2|Overall Study|Protocol Violation|3
896870|NCT01660412|2847525|P1|Overall Study|Protocol Violation|0
896913|NCT01524978|2847731|P11|Overall Study|Death|17
896914|NCT01524978|2847732|P10|Overall Study|Death|6
896915|NCT01524978|2847733|P9|Overall Study|Death|5
896916|NCT01524978|2847734|P8|Overall Study|Death|9
896917|NCT01524978|2847735|P7|Overall Study|Death|1
896918|NCT01524978|2847736|P6|Overall Study|Death|4
896919|NCT01524978|2847737|P5|Overall Study|Death|4
896920|NCT01524978|2847738|P4|Overall Study|Death|24
896921|NCT01524978|2847739|P3|Overall Study|Death|5
896922|NCT01524978|2847740|P2|Overall Study|Death|2
896923|NCT01524978|2847741|P1|Overall Study|Death|34
896924|NCT01524978|2847731|P11|Overall Study|Lost to Follow-up|1
896925|NCT01524978|2847732|P10|Overall Study|Lost to Follow-up|1
896926|NCT01524978|2847733|P9|Overall Study|Lost to Follow-up|1
896927|NCT01524978|2847734|P8|Overall Study|Lost to Follow-up|0
896928|NCT01524978|2847735|P7|Overall Study|Lost to Follow-up|2
896929|NCT01524978|2847736|P6|Overall Study|Lost to Follow-up|1
896930|NCT01524978|2847737|P5|Overall Study|Lost to Follow-up|1
896931|NCT01524978|2847738|P4|Overall Study|Lost to Follow-up|0
896932|NCT01524978|2847739|P3|Overall Study|Lost to Follow-up|3
896933|NCT01524978|2847740|P2|Overall Study|Lost to Follow-up|0
896934|NCT01524978|2847741|P1|Overall Study|Lost to Follow-up|0
896935|NCT01524978|2847731|P11|Overall Study|Withdrawal by Subject|5
896936|NCT01524978|2847732|P10|Overall Study|Withdrawal by Subject|0
896937|NCT01524978|2847733|P9|Overall Study|Withdrawal by Subject|4
896938|NCT01524978|2847734|P8|Overall Study|Withdrawal by Subject|2
896939|NCT01524978|2847735|P7|Overall Study|Withdrawal by Subject|6
896940|NCT01524978|2847736|P6|Overall Study|Withdrawal by Subject|1
896941|NCT01524978|2847737|P5|Overall Study|Withdrawal by Subject|3
896942|NCT01524978|2847738|P4|Overall Study|Withdrawal by Subject|1
896943|NCT01524978|2847739|P3|Overall Study|Withdrawal by Subject|1
896944|NCT01524978|2847740|P2|Overall Study|Withdrawal by Subject|0
896945|NCT01524978|2847741|P1|Overall Study|Withdrawal by Subject|12
896946|NCT01524978|2847731|P11|Overall Study|Other|5
896947|NCT01524978|2847732|P10|Overall Study|Other|2
896948|NCT01524978|2847733|P9|Overall Study|Other|2
896949|NCT01524978|2847734|P8|Overall Study|Other|1
896950|NCT01524978|2847735|P7|Overall Study|Other|17
896951|NCT01524978|2847736|P6|Overall Study|Other|3
896952|NCT01524978|2847737|P5|Overall Study|Other|1
896953|NCT01524978|2847738|P4|Overall Study|Other|2
896954|NCT01524978|2847739|P3|Overall Study|Other|1
896955|NCT01524978|2847740|P2|Overall Study|Other|2
896956|NCT01524978|2847741|P1|Overall Study|Other|16
896979|NCT01408914|2847999|P3|Overall Study|Change in local TB/HIV norms|1
896980|NCT01408914|2848000|P2|Overall Study|Change in local TB/HIV norms|1
896981|NCT01408914|2848001|P1|Overall Study|Change in local TB/HIV norms|0
896982|NCT01408914|2847999|P3|Overall Study|Late exclusion|3
896983|NCT01408914|2848000|P2|Overall Study|Late exclusion|3
896984|NCT01408914|2848001|P1|Overall Study|Late exclusion|0
896985|NCT01408914|2847999|P3|Overall Study|Moved out of study jurisdiction|0
896986|NCT01408914|2848000|P2|Overall Study|Moved out of study jurisdiction|1
896987|NCT01408914|2848001|P1|Overall Study|Moved out of study jurisdiction|1
896988|NCT01408914|2847999|P3|Overall Study|Withdrawal by Subject|1
896989|NCT01408914|2848000|P2|Overall Study|Withdrawal by Subject|0
896990|NCT01408914|2848001|P1|Overall Study|Withdrawal by Subject|1
896991|NCT01408914|2847999|P3|Overall Study|Physician Decision|0
896992|NCT01408914|2848000|P2|Overall Study|Physician Decision|1
896993|NCT01408914|2848001|P1|Overall Study|Physician Decision|1
896994|NCT01408914|2847999|P3|Overall Study|Lost to Follow-up|2
896995|NCT01408914|2848000|P2|Overall Study|Lost to Follow-up|1
896996|NCT01408914|2848001|P1|Overall Study|Lost to Follow-up|4
896997|NCT01408914|2847999|P3|Overall Study|Could not complete tx in protocol period|6
896998|NCT01408914|2848000|P2|Overall Study|Could not complete tx in protocol period|5
896999|NCT01408914|2848001|P1|Overall Study|Could not complete tx in protocol period|5
897000|NCT01391546|2848034|P2|Overall Study|History of Herpes Zoster (HZ)|0
897001|NCT01391546|2848035|P1|Overall Study|History of Herpes Zoster (HZ)|1
897002|NCT01380834|2848055|P2|Overall Study|Physician Decision|0
897003|NCT01380834|2848056|P1|Overall Study|Physician Decision|1
897067|NCT01294150|2848181|P2|Overall Study|Physician Decision|2
897068|NCT01294150|2848182|P1|Overall Study|Physician Decision|2
897069|NCT01231620|2848194|P3|Overall Study|Lost to Follow-up|9
897070|NCT01231620|2848195|P2|Overall Study|Lost to Follow-up|4
897071|NCT01231620|2848196|P1|Overall Study|Lost to Follow-up|3
897072|NCT01231620|2848194|P3|Overall Study|Withdrawal by Subject|8
897073|NCT01231620|2848195|P2|Overall Study|Withdrawal by Subject|6
897074|NCT01231620|2848196|P1|Overall Study|Withdrawal by Subject|6
897075|NCT01231620|2848194|P3|Overall Study|Adverse Event|1
897076|NCT01231620|2848195|P2|Overall Study|Adverse Event|2
897077|NCT01231620|2848196|P1|Overall Study|Adverse Event|2
897078|NCT01231620|2848194|P3|Overall Study|Death|11
897079|NCT01231620|2848195|P2|Overall Study|Death|14
897080|NCT01231620|2848196|P1|Overall Study|Death|12
897081|NCT01231620|2848194|P3|Overall Study|Physician Decision|10
897082|NCT01231620|2848195|P2|Overall Study|Physician Decision|5
897083|NCT01231620|2848196|P1|Overall Study|Physician Decision|3
897087|NCT01187446|2848332|P2|Overall Study|Patient started non-protocol therapy|1
897088|NCT01187446|2848333|P1|Overall Study|Patient started non-protocol therapy|0
897099|NCT01165229|2848376|P2|Overall Study|Screening criteria unmet|0
897100|NCT01165229|2848377|P1|Overall Study|Screening criteria unmet|1
897101|NCT01165229|2848376|P2|Overall Study|Lack of time|0
897102|NCT01165229|2848377|P1|Overall Study|Lack of time|1
897103|NCT01165229|2848376|P2|Overall Study|Missed visit|0
897104|NCT01165229|2848377|P1|Overall Study|Missed visit|1
897105|NCT01165229|2848376|P2|Overall Study|Sponsor study termination|0
897106|NCT01165229|2848377|P1|Overall Study|Sponsor study termination|1
897107|NCT01165229|2848376|P2|Overall Study|Investigator decision|2
897108|NCT01165229|2848377|P1|Overall Study|Investigator decision|0
897109|NCT01165229|2848376|P2|Overall Study|Personal reason|4
897110|NCT01165229|2848377|P1|Overall Study|Personal reason|10
897111|NCT01165229|2848376|P2|Overall Study|Site closure|20
897112|NCT01165229|2848377|P1|Overall Study|Site closure|18
897113|NCT01165229|2848376|P2|Overall Study|Health issues|56
897114|NCT01165229|2848377|P1|Overall Study|Health issues|61
897115|NCT01165229|2848376|P2|Overall Study|Patient not eligible|1
897116|NCT01165229|2848377|P1|Overall Study|Patient not eligible|0
897117|NCT01165229|2848376|P2|Overall Study|Page entered in error|1
897118|NCT01165229|2848377|P1|Overall Study|Page entered in error|0
897119|NCT01165229|2848376|P2|Overall Study|No reason from the subject|1
897120|NCT01165229|2848377|P1|Overall Study|No reason from the subject|0
897121|NCT01165229|2848376|P2|Overall Study|Suspected HZ Episode|2
897122|NCT01165229|2848377|P1|Overall Study|Suspected HZ Episode|0
897123|NCT01165229|2848376|P2|Overall Study|Lost to Follow-up|138
897124|NCT01165229|2848377|P1|Overall Study|Lost to Follow-up|124
897125|NCT01165229|2848376|P2|Overall Study|Migrated/moved from study area|46
897126|NCT01165229|2848377|P1|Overall Study|Migrated/moved from study area|51
897127|NCT01165229|2848376|P2|Overall Study|Withdrawal by Subject|403
897128|NCT01165229|2848377|P1|Overall Study|Withdrawal by Subject|396
897129|NCT01165229|2848376|P2|Overall Study|Protocol Violation|12
897130|NCT01165229|2848377|P1|Overall Study|Protocol Violation|10
897131|NCT01165229|2848376|P2|Overall Study|Non-Serious Adverse Event|15
897132|NCT01165229|2848377|P1|Overall Study|Non-Serious Adverse Event|47
897133|NCT01165229|2848376|P2|Overall Study|Serious Adverse Event|487
897134|NCT01165229|2848377|P1|Overall Study|Serious Adverse Event|459
897135|NCT01165229|2848376|P2|Overall Study|Unknown completion status|1
897136|NCT01165229|2848377|P1|Overall Study|Unknown completion status|0
897137|NCT01118117|2848505|P2|Overall Study|Missed 12 Month Visit|0
897138|NCT01118117|2848506|P1|Overall Study|Missed 12 Month Visit|7
897139|NCT01118117|2848505|P2|Overall Study|Lost to Follow-up|0
897140|NCT01118117|2848506|P1|Overall Study|Lost to Follow-up|6
897141|NCT01118117|2848505|P2|Overall Study|Death|0
897142|NCT01118117|2848506|P1|Overall Study|Death|8
866127|NCT00657709|2757496|P5|Overall Study|Protocol Violation|2
866128|NCT00657709|2757497|P4|Overall Study|Protocol Violation|1
866129|NCT00657709|2757498|P3|Overall Study|Protocol Violation|0
866130|NCT00657709|2757499|P2|Overall Study|Protocol Violation|2
866131|NCT00657709|2757500|P1|Overall Study|Protocol Violation|0
866132|NCT00657709|2757496|P5|Overall Study|Lost to Follow-up|21
866133|NCT00657709|2757497|P4|Overall Study|Lost to Follow-up|1
866134|NCT00657709|2757498|P3|Overall Study|Lost to Follow-up|7
866135|NCT00657709|2757499|P2|Overall Study|Lost to Follow-up|9
866136|NCT00657709|2757500|P1|Overall Study|Lost to Follow-up|9
866137|NCT00657709|2757496|P5|Overall Study|Withdrawal by Subject|9
866138|NCT00657709|2757497|P4|Overall Study|Withdrawal by Subject|5
866139|NCT00657709|2757498|P3|Overall Study|Withdrawal by Subject|15
866140|NCT00657709|2757499|P2|Overall Study|Withdrawal by Subject|15
866141|NCT00657709|2757500|P1|Overall Study|Withdrawal by Subject|7
866142|NCT00657709|2757496|P5|Overall Study|AE or Death|1
866143|NCT00657709|2757497|P4|Overall Study|AE or Death|7
866144|NCT00657709|2757498|P3|Overall Study|AE or Death|6
866145|NCT00657709|2757499|P2|Overall Study|AE or Death|7
866146|NCT00657709|2757500|P1|Overall Study|AE or Death|7
897253|NCT00902278|2848908|P5|Overall Study|Lost to Follow-up|1
897254|NCT00902278|2848909|P4|Overall Study|Lost to Follow-up|0
897255|NCT00902278|2848910|P3|Overall Study|Lost to Follow-up|3
897256|NCT00902278|2848911|P2|Overall Study|Lost to Follow-up|2
897257|NCT00902278|2848912|P1|Overall Study|Lost to Follow-up|3
897258|NCT00902278|2848908|P5|Overall Study|Physician Decision|1
897259|NCT00902278|2848909|P4|Overall Study|Physician Decision|0
897260|NCT00902278|2848910|P3|Overall Study|Physician Decision|2
897261|NCT00902278|2848911|P2|Overall Study|Physician Decision|0
897262|NCT00902278|2848912|P1|Overall Study|Physician Decision|1
897277|NCT00748969|2849075|P2|Overall Study|Withdrawal by Subject|1
897278|NCT00748969|2849076|P1|Overall Study|Withdrawal by Subject|0
897279|NCT00748969|2849075|P2|Overall Study|Withdrawal by Subject|0
897280|NCT00748969|2849076|P1|Overall Study|Withdrawal by Subject|1
866191|NCT00605839|2757674|P3|Overall Study|Protocol Violation|0
866192|NCT00605839|2757675|P2|Overall Study|Protocol Violation|0
866193|NCT00605839|2757676|P1|Overall Study|Protocol Violation|1
897326|NCT00723255|2849155|P1|Overall Study|Ineligible: Wrong Primary|2
897327|NCT00723255|2849155|P1|Overall Study|Ineligible: Second primary|1
897328|NCT00723255|2849155|P1|Overall Study|Ineligible: Inadequate pathology|1
897331|NCT00661089|2849276|P2|Overall Study|death at 8 weeks due to new stroke|1
897332|NCT00661089|2849277|P1|Overall Study|death at 8 weeks due to new stroke|0
897333|NCT00661089|2849276|P2|Overall Study|1 subject withdrawal|1
897334|NCT00661089|2849277|P1|Overall Study|1 subject withdrawal|0
897335|NCT00657553|2849287|P2|Overall Study|low accrual, no analysis run|5
897336|NCT00657553|2849288|P1|Overall Study|low accrual, no analysis run|5
897337|NCT00612456|2849302|P3|Overall Study|Withdrawal by Subject|0
897338|NCT00612456|2849303|P2|Overall Study|Withdrawal by Subject|1
897339|NCT00612456|2849304|P1|Overall Study|Withdrawal by Subject|0
897340|NCT00612456|2849302|P3|Overall Study|Lack of Efficacy|0
897341|NCT00612456|2849303|P2|Overall Study|Lack of Efficacy|1
897342|NCT00612456|2849304|P1|Overall Study|Lack of Efficacy|1
897343|NCT00612456|2849302|P3|Overall Study|Adverse Event|0
897344|NCT00612456|2849303|P2|Overall Study|Adverse Event|0
897345|NCT00612456|2849304|P1|Overall Study|Adverse Event|1
897346|NCT00574080|2849354|P2|Overall Study|Death|10
897347|NCT00574080|2849355|P1|Overall Study|Death|10
897363|NCT00541931|2849400|P2|Overall Study|Transportation Issue|1
897364|NCT00541931|2849401|P1|Overall Study|Transportation Issue|0
897365|NCT00541931|2849400|P2|Overall Study|Withdrawal by Subject|0
897366|NCT00541931|2849401|P1|Overall Study|Withdrawal by Subject|1
897367|NCT00541931|2849400|P2|Overall Study|Lost to Follow-up|3
897368|NCT00541931|2849401|P1|Overall Study|Lost to Follow-up|3
897369|NCT00541931|2849400|P2|Overall Study|Adverse Event|0
897370|NCT00541931|2849401|P1|Overall Study|Adverse Event|1
897371|NCT00535626|2849409|P1|Overall Study|Unable to return|2
897372|NCT00535626|2849409|P1|Overall Study|Subject terminated|31
897373|NCT00535626|2849409|P1|Overall Study|Removal/revision of study component|8
897374|NCT00535626|2849409|P1|Overall Study|Withdrawal by Subject|20
897375|NCT00535626|2849409|P1|Overall Study|Lost to Follow-up|29
897376|NCT00535626|2849409|P1|Overall Study|Death|15
897377|NCT00524589|2849419|P1|Overall Study|Disease Progression|16
897378|NCT00524589|2849419|P1|Overall Study|Withdrawal by Subject|2
897449|NCT00356863|2849614|P2|Overall Study|Lost to Follow-up|43
897450|NCT00356863|2849615|P1|Overall Study|Lost to Follow-up|76
897451|NCT00356863|2849614|P2|Overall Study|Death|32
897452|NCT00356863|2849615|P1|Overall Study|Death|16
897453|NCT00356603|2849643|P2|Overall Study|Other|3
897454|NCT00356603|2849644|P1|Overall Study|Other|6
897455|NCT00350545|2849658|P1|Overall Study|Withdrawal by Subject|2
897456|NCT00320424|2849666|P1|Overall Study|Other|3
897457|NCT00320424|2849666|P1|Overall Study|Adverse Event|3
897458|NCT00291018|2849683|P3|Overall Study|Lost to Follow-up|18
897459|NCT00291018|2849684|P2|Overall Study|Lost to Follow-up|4
897460|NCT00291018|2849685|P1|Overall Study|Lost to Follow-up|3
897461|NCT00291018|2849683|P3|Overall Study|Failures|5
897462|NCT00291018|2849684|P2|Overall Study|Failures|12
897463|NCT00291018|2849685|P1|Overall Study|Failures|5
897464|NCT00291018|2849683|P3|Overall Study|Withdrawal by Subject|1
897465|NCT00291018|2849684|P2|Overall Study|Withdrawal by Subject|8
897466|NCT00291018|2849685|P1|Overall Study|Withdrawal by Subject|2
897467|NCT00291018|2849683|P3|Overall Study|Death|4
897468|NCT00291018|2849684|P2|Overall Study|Death|3
897469|NCT00291018|2849685|P1|Overall Study|Death|3
897470|NCT00291018|2849683|P3|Overall Study|Not Consented or Declined PAS|15
897471|NCT00291018|2849684|P2|Overall Study|Not Consented or Declined PAS|15
897472|NCT00291018|2849685|P1|Overall Study|Not Consented or Declined PAS|12
897528|NCT00243386|2849799|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
897529|NCT00243386|2849800|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
897530|NCT00243386|2849801|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
897531|NCT00243386|2849799|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
897532|NCT00243386|2849800|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
897533|NCT00243386|2849801|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
897534|NCT00243386|2849799|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
897535|NCT00243386|2849800|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
897536|NCT00243386|2849801|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
897537|NCT00243386|2849799|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
897538|NCT00243386|2849800|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
897539|NCT00243386|2849801|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
897540|NCT00243386|2849799|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
897541|NCT00243386|2849800|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
897542|NCT00243386|2849801|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
897543|NCT00243386|2849799|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
897544|NCT00243386|2849800|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
897545|NCT00243386|2849801|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
897546|NCT00243386|2849799|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
897547|NCT00243386|2849800|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
897548|NCT00243386|2849801|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
897549|NCT00243386|2849799|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
897550|NCT00243386|2849800|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
897551|NCT00243386|2849801|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
897581|NCT00083915|2849981|P2|Overall Study|Insurance issues|1
897582|NCT00083915|2849982|P1|Overall Study|Insurance issues|1
897583|NCT00083915|2849981|P2|Overall Study|No response|1
897584|NCT00083915|2849982|P1|Overall Study|No response|3
897585|NCT00083915|2849981|P2|Overall Study|Failure to collect|0
897586|NCT00083915|2849982|P1|Overall Study|Failure to collect|3
897587|NCT00083915|2849981|P2|Overall Study|disease progression|23
897588|NCT00083915|2849982|P1|Overall Study|disease progression|18
897589|NCT00083915|2849981|P2|Overall Study|Withdrawal by Subject|3
897590|NCT00083915|2849982|P1|Overall Study|Withdrawal by Subject|8
897591|NCT00083915|2849981|P2|Overall Study|Physician Decision|6
897592|NCT00083915|2849982|P1|Overall Study|Physician Decision|11
897593|NCT00083915|2849981|P2|Overall Study|Death|3
897594|NCT00083915|2849982|P1|Overall Study|Death|6
897627|NCT00068406|2850021|P1|Overall Study|Ineligible-Inadequate Pathology|2
897628|NCT00068406|2850021|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
897629|NCT00003389|2850028|P2|Overall Study|Ineligible|27
897630|NCT00003389|2850029|P1|Overall Study|Ineligible|33
897631|NCT00003389|2850028|P2|Overall Study|Off-treatment reason missing|21
897632|NCT00003389|2850029|P1|Overall Study|Off-treatment reason missing|31
897633|NCT00003389|2850028|P2|Overall Study|Complicating disease|0
897634|NCT00003389|2850029|P1|Overall Study|Complicating disease|1
897635|NCT00003389|2850028|P2|Overall Study|Alternative therapy|1
897636|NCT00003389|2850029|P1|Overall Study|Alternative therapy|2
897637|NCT00003389|2850028|P2|Overall Study|Withdrawal by Subject|5
897638|NCT00003389|2850029|P1|Overall Study|Withdrawal by Subject|12
897639|NCT00003389|2850028|P2|Overall Study|Death|3
897640|NCT00003389|2850029|P1|Overall Study|Death|0
897641|NCT00003389|2850028|P2|Overall Study|Adverse Event|2
897642|NCT00003389|2850029|P1|Overall Study|Adverse Event|13
897643|NCT00003389|2850028|P2|Overall Study|Disease progression|1
897644|NCT00003389|2850029|P1|Overall Study|Disease progression|6
897678|NCT02446990|2850261|P2|Overall Study|Withdrawal by Subject|199
897679|NCT02446990|2850262|P1|Overall Study|Withdrawal by Subject|231
897680|NCT02446990|2850261|P2|Overall Study|Physician Decision|0
897681|NCT02446990|2850262|P1|Overall Study|Physician Decision|1
897682|NCT02446990|2850261|P2|Overall Study|Lost to Follow-up|1
897683|NCT02446990|2850262|P1|Overall Study|Lost to Follow-up|3
897684|NCT02446990|2850261|P2|Overall Study|Death|458
897685|NCT02446990|2850262|P1|Overall Study|Death|485
897686|NCT02441218|2850296|P2|Overall Study|Lost to Follow-up|1
897687|NCT02441218|2850297|P1|Overall Study|Lost to Follow-up|2
897688|NCT02441218|2850296|P2|Overall Study|Withdrawal by Subject|58
897689|NCT02441218|2850297|P1|Overall Study|Withdrawal by Subject|73
897690|NCT02441218|2850296|P2|Overall Study|Death|553
897691|NCT02441218|2850297|P1|Overall Study|Death|503
897716|NCT02277743|2850429|P3|Overall Study|Other than specified above|16
897717|NCT02277743|2850430|P2|Overall Study|Other than specified above|5
897718|NCT02277743|2850431|P1|Overall Study|Other than specified above|18
897719|NCT02277743|2850429|P3|Overall Study|Lack of Efficacy|3
897720|NCT02277743|2850430|P2|Overall Study|Lack of Efficacy|4
897721|NCT02277743|2850431|P1|Overall Study|Lack of Efficacy|11
897722|NCT02277743|2850429|P3|Overall Study|Adverse Event|6
897723|NCT02277743|2850430|P2|Overall Study|Adverse Event|6
897724|NCT02277743|2850431|P1|Overall Study|Adverse Event|10
897725|NCT02277743|2850429|P3|Overall Study|Protocol Violation|1
897726|NCT02277743|2850430|P2|Overall Study|Protocol Violation|1
897727|NCT02277743|2850431|P1|Overall Study|Protocol Violation|1
897732|NCT02159365|2850537|P1|Overall Study|Other|1
897733|NCT02159365|2850537|P1|Overall Study|Subject Withdrew Consent|1
897734|NCT02159365|2850537|P1|Overall Study|Subject Request to Discontinue Treatment|1
897735|NCT02159365|2850537|P1|Overall Study|Study Drug Toxicity|1
897736|NCT02159365|2850537|P1|Overall Study|Lost to Follow-up|1
897737|NCT02159365|2850537|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
897738|NCT02159365|2850537|P1|Overall Study|Disease Progression|11
897755|NCT02033369|2850652|P2|Overall Study|Protocol Violation|0
897756|NCT02033369|2850653|P1|Overall Study|Protocol Violation|2
897757|NCT02033369|2850652|P2|Overall Study|Lost to Follow-up|0
897758|NCT02033369|2850653|P1|Overall Study|Lost to Follow-up|1
897759|NCT02033369|2850652|P2|Overall Study|Withdrawal by Subject|1
897760|NCT02033369|2850653|P1|Overall Study|Withdrawal by Subject|1
897761|NCT02033369|2850652|P2|Overall Study|Not a good demographic match|2
897762|NCT02033369|2850653|P1|Overall Study|Not a good demographic match|0
897763|NCT02033369|2850652|P2|Overall Study|Physician Decision|2
897764|NCT02033369|2850653|P1|Overall Study|Physician Decision|1
897789|NCT01916824|2850736|P2|Overall Study|Withdrawal by Subject|3
897790|NCT01916824|2850737|P1|Overall Study|Withdrawal by Subject|2
897791|NCT01916824|2850736|P2|Overall Study|Physician Decision|0
897792|NCT01916824|2850737|P1|Overall Study|Physician Decision|2
897793|NCT01916824|2850736|P2|Overall Study|Lost to Follow-up|6
897794|NCT01916824|2850737|P1|Overall Study|Lost to Follow-up|3
897891|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
897892|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897893|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897894|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897895|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897896|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897897|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
897898|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
897899|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
897900|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
897901|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
897902|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
897903|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
897904|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
897905|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Participant Moved|2
897906|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Participant Moved|0
897907|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Participant Moved|0
897908|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Participant Moved|0
897909|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Participant Moved|0
897910|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Participant Moved|0
897911|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Participant Moved|0
897912|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Technical Problems|1
897913|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Technical Problems|0
897914|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Technical Problems|0
897915|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Technical Problems|0
897916|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Technical Problems|0
897917|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Technical Problems|0
897918|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Technical Problems|0
897919|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
897920|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897921|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897922|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897923|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897924|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897925|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
897926|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
897927|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
897928|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
897929|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
897930|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
897931|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
897932|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
897933|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
897934|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
897935|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
897936|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
897937|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
897938|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
897939|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
897940|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897941|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
897942|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897943|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897944|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897945|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897946|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
897947|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
897948|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
897949|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
897950|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
897951|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
897952|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
897953|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
897954|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
897955|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
897956|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
897957|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
897958|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
897959|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
897960|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
897961|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Physician Decision|11
897962|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Physician Decision|7
897963|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Physician Decision|0
897964|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Physician Decision|0
897965|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Physician Decision|0
897966|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Physician Decision|0
897967|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Physician Decision|0
897968|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
897969|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
897970|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
897971|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
897972|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
897973|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
897974|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
897975|NCT01697579|2851045|P7|Optional Extension-Cycles 2-6|Death|2
897976|NCT01697579|2851046|P6|Optional Extension-Cycles 2-6|Death|0
897977|NCT01697579|2851047|P5|Optional Extension-Cycles 2-6|Death|0
897978|NCT01697579|2851048|P4|Optional Extension-Cycles 2-6|Death|0
897979|NCT01697579|2851049|P3|Optional Extension-Cycles 2-6|Death|0
897980|NCT01697579|2851050|P2|Optional Extension-Cycles 2-6|Death|0
897981|NCT01697579|2851051|P1|Optional Extension-Cycles 2-6|Death|0
897982|NCT01697579|2851045|P7|Base Study-Cycle 1|Technical Problems|0
897983|NCT01697579|2851046|P6|Base Study-Cycle 1|Technical Problems|0
897984|NCT01697579|2851047|P5|Base Study-Cycle 1|Technical Problems|0
897985|NCT01697579|2851048|P4|Base Study-Cycle 1|Technical Problems|1
897986|NCT01697579|2851049|P3|Base Study-Cycle 1|Technical Problems|1
897987|NCT01697579|2851050|P2|Base Study-Cycle 1|Technical Problems|0
897988|NCT01697579|2851051|P1|Base Study-Cycle 1|Technical Problems|0
897989|NCT01697579|2851045|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897990|NCT01697579|2851046|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897991|NCT01697579|2851047|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897992|NCT01697579|2851048|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897993|NCT01697579|2851049|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897994|NCT01697579|2851050|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
897995|NCT01697579|2851051|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
897996|NCT01697579|2851045|P7|Base Study-Cycle 1|Protocol Violation|0
897997|NCT01697579|2851046|P6|Base Study-Cycle 1|Protocol Violation|0
897998|NCT01697579|2851047|P5|Base Study-Cycle 1|Protocol Violation|3
897999|NCT01697579|2851048|P4|Base Study-Cycle 1|Protocol Violation|0
898000|NCT01697579|2851049|P3|Base Study-Cycle 1|Protocol Violation|0
898001|NCT01697579|2851050|P2|Base Study-Cycle 1|Protocol Violation|0
898002|NCT01697579|2851051|P1|Base Study-Cycle 1|Protocol Violation|0
898003|NCT01697579|2851045|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898004|NCT01697579|2851046|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898005|NCT01697579|2851047|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898006|NCT01697579|2851048|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898007|NCT01697579|2851049|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898008|NCT01697579|2851050|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
898009|NCT01697579|2851051|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
898010|NCT01697579|2851045|P7|Base Study-Cycle 1|Adverse Event|0
898011|NCT01697579|2851046|P6|Base Study-Cycle 1|Adverse Event|0
898012|NCT01697579|2851047|P5|Base Study-Cycle 1|Adverse Event|0
898013|NCT01697579|2851048|P4|Base Study-Cycle 1|Adverse Event|0
898014|NCT01697579|2851049|P3|Base Study-Cycle 1|Adverse Event|0
898015|NCT01697579|2851050|P2|Base Study-Cycle 1|Adverse Event|0
898016|NCT01697579|2851051|P1|Base Study-Cycle 1|Adverse Event|1
898035|NCT01542632|2851337|P6|Overall Study|Sponsor/Investigator Decision|0
898036|NCT01542632|2851338|P5|Overall Study|Sponsor/Investigator Decision|1
898037|NCT01542632|2851339|P4|Overall Study|Sponsor/Investigator Decision|0
898038|NCT01542632|2851340|P3|Overall Study|Sponsor/Investigator Decision|0
898039|NCT01542632|2851341|P2|Overall Study|Sponsor/Investigator Decision|0
898040|NCT01542632|2851342|P1|Overall Study|Sponsor/Investigator Decision|0
898041|NCT01542632|2851337|P6|Overall Study|Lost to Follow-up|0
898042|NCT01542632|2851338|P5|Overall Study|Lost to Follow-up|0
898043|NCT01542632|2851339|P4|Overall Study|Lost to Follow-up|0
898044|NCT01542632|2851340|P3|Overall Study|Lost to Follow-up|0
898045|NCT01542632|2851341|P2|Overall Study|Lost to Follow-up|1
898046|NCT01542632|2851342|P1|Overall Study|Lost to Follow-up|0
898047|NCT01542632|2851337|P6|Overall Study|Adverse Event|0
898048|NCT01542632|2851338|P5|Overall Study|Adverse Event|0
898049|NCT01542632|2851339|P4|Overall Study|Adverse Event|0
898050|NCT01542632|2851340|P3|Overall Study|Adverse Event|1
898051|NCT01542632|2851341|P2|Overall Study|Adverse Event|0
898052|NCT01542632|2851342|P1|Overall Study|Adverse Event|0
898053|NCT01542632|2851337|P6|Overall Study|Withdrawal of Consent|0
898054|NCT01542632|2851338|P5|Overall Study|Withdrawal of Consent|3
898055|NCT01542632|2851339|P4|Overall Study|Withdrawal of Consent|2
898056|NCT01542632|2851340|P3|Overall Study|Withdrawal of Consent|0
898057|NCT01542632|2851341|P2|Overall Study|Withdrawal of Consent|0
898058|NCT01542632|2851342|P1|Overall Study|Withdrawal of Consent|0
898077|NCT01410227|2851502|P4|Overall Study|Met Excl. Criteria After Starting Study|0
898078|NCT01410227|2851503|P3|Overall Study|Met Excl. Criteria After Starting Study|1
898079|NCT01410227|2851504|P2|Overall Study|Met Excl. Criteria After Starting Study|0
898080|NCT01410227|2851505|P1|Overall Study|Met Excl. Criteria After Starting Study|0
898081|NCT01410227|2851502|P4|Overall Study|Pregnancy|1
898082|NCT01410227|2851503|P3|Overall Study|Pregnancy|0
898083|NCT01410227|2851504|P2|Overall Study|Pregnancy|0
898084|NCT01410227|2851505|P1|Overall Study|Pregnancy|0
898085|NCT01410227|2851502|P4|Overall Study|Withdrawal by Subject|0
898086|NCT01410227|2851503|P3|Overall Study|Withdrawal by Subject|1
898087|NCT01410227|2851504|P2|Overall Study|Withdrawal by Subject|0
898088|NCT01410227|2851505|P1|Overall Study|Withdrawal by Subject|3
898089|NCT01410227|2851502|P4|Overall Study|Adverse Event|0
898090|NCT01410227|2851503|P3|Overall Study|Adverse Event|0
898091|NCT01410227|2851504|P2|Overall Study|Adverse Event|0
898092|NCT01410227|2851505|P1|Overall Study|Adverse Event|1
898095|NCT01335698|2851618|P5|Treatment Stage 2|Continuing treatment|6
898096|NCT01335698|2851619|P4|Treatment Stage 2|Continuing treatment|19
898097|NCT01335698|2851620|P3|Treatment Stage 2|Continuing treatment|13
898098|NCT01335698|2851621|P2|Treatment Stage 2|Continuing treatment|3
898099|NCT01335698|2851622|P1|Treatment Stage 2|Continuing treatment|11
898100|NCT01335698|2851618|P5|Treatment Stage 2|Poor compliance/noncompliance|0
898101|NCT01335698|2851619|P4|Treatment Stage 2|Poor compliance/noncompliance|3
898102|NCT01335698|2851620|P3|Treatment Stage 2|Poor compliance/noncompliance|0
898103|NCT01335698|2851621|P2|Treatment Stage 2|Poor compliance/noncompliance|0
898104|NCT01335698|2851622|P1|Treatment Stage 2|Poor compliance/noncompliance|1
898105|NCT01335698|2851618|P5|Treatment Stage 2|Withdrawal by Subject|0
898106|NCT01335698|2851619|P4|Treatment Stage 2|Withdrawal by Subject|0
898107|NCT01335698|2851620|P3|Treatment Stage 2|Withdrawal by Subject|0
898108|NCT01335698|2851621|P2|Treatment Stage 2|Withdrawal by Subject|0
898109|NCT01335698|2851622|P1|Treatment Stage 2|Withdrawal by Subject|1
898110|NCT01335698|2851618|P5|Treatment Stage 2|Adverse Event|0
898111|NCT01335698|2851619|P4|Treatment Stage 2|Adverse Event|1
898112|NCT01335698|2851620|P3|Treatment Stage 2|Adverse Event|0
898113|NCT01335698|2851621|P2|Treatment Stage 2|Adverse Event|0
898114|NCT01335698|2851622|P1|Treatment Stage 2|Adverse Event|0
898115|NCT01335698|2851618|P5|Treatment Stage 2|Lack of Efficacy|0
898116|NCT01335698|2851619|P4|Treatment Stage 2|Lack of Efficacy|1
898117|NCT01335698|2851620|P3|Treatment Stage 2|Lack of Efficacy|3
898118|NCT01335698|2851621|P2|Treatment Stage 2|Lack of Efficacy|1
898119|NCT01335698|2851622|P1|Treatment Stage 2|Lack of Efficacy|2
898120|NCT01335698|2851618|P5|Treatment Stage 1|Not specified|0
898121|NCT01335698|2851619|P4|Treatment Stage 1|Not specified|1
898122|NCT01335698|2851620|P3|Treatment Stage 1|Not specified|0
898123|NCT01335698|2851621|P2|Treatment Stage 1|Not specified|0
898124|NCT01335698|2851622|P1|Treatment Stage 1|Not specified|1
898125|NCT01335698|2851618|P5|Treatment Stage 1|No longer meets study criteria|0
898126|NCT01335698|2851619|P4|Treatment Stage 1|No longer meets study criteria|1
898127|NCT01335698|2851620|P3|Treatment Stage 1|No longer meets study criteria|0
898128|NCT01335698|2851621|P2|Treatment Stage 1|No longer meets study criteria|1
898129|NCT01335698|2851622|P1|Treatment Stage 1|No longer meets study criteria|1
898130|NCT01335698|2851618|P5|Treatment Stage 1|Poor compliance/noncompliance|0
898131|NCT01335698|2851619|P4|Treatment Stage 1|Poor compliance/noncompliance|2
898132|NCT01335698|2851620|P3|Treatment Stage 1|Poor compliance/noncompliance|0
898133|NCT01335698|2851621|P2|Treatment Stage 1|Poor compliance/noncompliance|1
898134|NCT01335698|2851622|P1|Treatment Stage 1|Poor compliance/noncompliance|0
898135|NCT01335698|2851618|P5|Treatment Stage 1|Lost to Follow-up|0
898136|NCT01335698|2851619|P4|Treatment Stage 1|Lost to Follow-up|0
898137|NCT01335698|2851620|P3|Treatment Stage 1|Lost to Follow-up|0
898138|NCT01335698|2851621|P2|Treatment Stage 1|Lost to Follow-up|1
898139|NCT01335698|2851622|P1|Treatment Stage 1|Lost to Follow-up|1
898140|NCT01335698|2851618|P5|Treatment Stage 1|Withdrawal by Subject|0
898141|NCT01335698|2851619|P4|Treatment Stage 1|Withdrawal by Subject|1
898142|NCT01335698|2851620|P3|Treatment Stage 1|Withdrawal by Subject|0
898143|NCT01335698|2851621|P2|Treatment Stage 1|Withdrawal by Subject|2
898144|NCT01335698|2851622|P1|Treatment Stage 1|Withdrawal by Subject|1
898145|NCT01335698|2851618|P5|Treatment Stage 1|Adverse Event|1
898146|NCT01335698|2851619|P4|Treatment Stage 1|Adverse Event|1
898147|NCT01335698|2851620|P3|Treatment Stage 1|Adverse Event|2
898148|NCT01335698|2851621|P2|Treatment Stage 1|Adverse Event|2
898149|NCT01335698|2851622|P1|Treatment Stage 1|Adverse Event|1
898150|NCT01335698|2851618|P5|Treatment Stage 1|Lack of Efficacy|1
898151|NCT01335698|2851619|P4|Treatment Stage 1|Lack of Efficacy|3
898152|NCT01335698|2851620|P3|Treatment Stage 1|Lack of Efficacy|3
898153|NCT01335698|2851621|P2|Treatment Stage 1|Lack of Efficacy|1
898154|NCT01335698|2851622|P1|Treatment Stage 1|Lack of Efficacy|3
898155|NCT01334710|2851669|P1|Overall Study|Trial was terminated|3
898186|NCT01113580|2852033|P2|Overall Study|Protocol Violation|0
898187|NCT01113580|2852034|P1|Overall Study|Protocol Violation|1
898188|NCT01080391|2852050|P2|Overall Study|Withdrawal by Subject|10
898189|NCT01080391|2852051|P1|Overall Study|Withdrawal by Subject|19
898190|NCT01080391|2852050|P2|Overall Study|Lost to Follow-up|3
898191|NCT01080391|2852051|P1|Overall Study|Lost to Follow-up|4
898195|NCT00994643|2852105|P1|Overall Study|Withdrawal by Subject|1
898196|NCT00993616|2852109|P1|Overall Study|Never treated|1
898197|NCT00993616|2852109|P1|Overall Study|No tumor at entry|1
898198|NCT00958243|2852158|P6|Overall Study|Lost to Follow-up|5
898199|NCT00958243|2852159|P5|Overall Study|Lost to Follow-up|8
898200|NCT00958243|2852160|P4|Overall Study|Lost to Follow-up|2
898201|NCT00958243|2852161|P3|Overall Study|Lost to Follow-up|11
898202|NCT00958243|2852162|P2|Overall Study|Lost to Follow-up|5
898203|NCT00958243|2852163|P1|Overall Study|Lost to Follow-up|2
898204|NCT00958243|2852158|P6|Overall Study|Withdrawal by Subject|5
898205|NCT00958243|2852159|P5|Overall Study|Withdrawal by Subject|1
898206|NCT00958243|2852160|P4|Overall Study|Withdrawal by Subject|1
898207|NCT00958243|2852161|P3|Overall Study|Withdrawal by Subject|3
898208|NCT00958243|2852162|P2|Overall Study|Withdrawal by Subject|1
898209|NCT00958243|2852163|P1|Overall Study|Withdrawal by Subject|0
898210|NCT00958126|2852227|P8|Overall Study|Other Reason|0
898211|NCT00958126|2852228|P7|Overall Study|Other Reason|0
898212|NCT00958126|2852229|P6|Overall Study|Other Reason|1
898213|NCT00958126|2852230|P5|Overall Study|Other Reason|0
898214|NCT00958126|2852231|P4|Overall Study|Other Reason|1
898215|NCT00958126|2852232|P3|Overall Study|Other Reason|0
898216|NCT00958126|2852233|P2|Overall Study|Other Reason|0
898217|NCT00958126|2852234|P1|Overall Study|Other Reason|0
898218|NCT00958126|2852227|P8|Overall Study|Sponsor/Investigator decision|0
898219|NCT00958126|2852228|P7|Overall Study|Sponsor/Investigator decision|0
898220|NCT00958126|2852229|P6|Overall Study|Sponsor/Investigator decision|0
898221|NCT00958126|2852230|P5|Overall Study|Sponsor/Investigator decision|0
898222|NCT00958126|2852231|P4|Overall Study|Sponsor/Investigator decision|1
898223|NCT00958126|2852232|P3|Overall Study|Sponsor/Investigator decision|0
898224|NCT00958126|2852233|P2|Overall Study|Sponsor/Investigator decision|0
898225|NCT00958126|2852234|P1|Overall Study|Sponsor/Investigator decision|0
898226|NCT00958126|2852227|P8|Overall Study|Lost to Follow-up|0
898227|NCT00958126|2852228|P7|Overall Study|Lost to Follow-up|0
898228|NCT00958126|2852229|P6|Overall Study|Lost to Follow-up|0
898229|NCT00958126|2852230|P5|Overall Study|Lost to Follow-up|0
898230|NCT00958126|2852231|P4|Overall Study|Lost to Follow-up|8
898231|NCT00958126|2852232|P3|Overall Study|Lost to Follow-up|9
898232|NCT00958126|2852233|P2|Overall Study|Lost to Follow-up|5
898233|NCT00958126|2852234|P1|Overall Study|Lost to Follow-up|1
898234|NCT00958126|2852227|P8|Overall Study|Moved away from study area|0
898235|NCT00958126|2852228|P7|Overall Study|Moved away from study area|0
898236|NCT00958126|2852229|P6|Overall Study|Moved away from study area|0
898237|NCT00958126|2852230|P5|Overall Study|Moved away from study area|0
898238|NCT00958126|2852231|P4|Overall Study|Moved away from study area|1
898239|NCT00958126|2852232|P3|Overall Study|Moved away from study area|1
898240|NCT00958126|2852233|P2|Overall Study|Moved away from study area|0
898241|NCT00958126|2852234|P1|Overall Study|Moved away from study area|0
898242|NCT00958126|2852227|P8|Overall Study|Withdrawal by Subject|0
898243|NCT00958126|2852228|P7|Overall Study|Withdrawal by Subject|0
898244|NCT00958126|2852229|P6|Overall Study|Withdrawal by Subject|0
898245|NCT00958126|2852230|P5|Overall Study|Withdrawal by Subject|0
898246|NCT00958126|2852231|P4|Overall Study|Withdrawal by Subject|0
898247|NCT00958126|2852232|P3|Overall Study|Withdrawal by Subject|0
898248|NCT00958126|2852233|P2|Overall Study|Withdrawal by Subject|2
898249|NCT00958126|2852234|P1|Overall Study|Withdrawal by Subject|0
898250|NCT00958126|2852227|P8|Overall Study|Serious Adverse Event|0
898251|NCT00958126|2852228|P7|Overall Study|Serious Adverse Event|1
898252|NCT00958126|2852229|P6|Overall Study|Serious Adverse Event|0
898253|NCT00958126|2852230|P5|Overall Study|Serious Adverse Event|0
898254|NCT00958126|2852231|P4|Overall Study|Serious Adverse Event|0
898255|NCT00958126|2852232|P3|Overall Study|Serious Adverse Event|0
898256|NCT00958126|2852233|P2|Overall Study|Serious Adverse Event|2
898257|NCT00958126|2852234|P1|Overall Study|Serious Adverse Event|0
898296|NCT00859573|2852453|P2|Overall Study|Physician Decision|1
898297|NCT00859573|2852454|P1|Overall Study|Physician Decision|1
898298|NCT00859573|2852453|P2|Overall Study|Withdrawal by Subject|1
898299|NCT00859573|2852454|P1|Overall Study|Withdrawal by Subject|4
898394|NCT00791648|2852796|P2|Overall Study|Withdrawal by Subject|1
898395|NCT00791648|2852797|P1|Overall Study|Withdrawal by Subject|0
898396|NCT00791648|2852796|P2|Overall Study|Physician Decision|1
898397|NCT00791648|2852797|P1|Overall Study|Physician Decision|0
898398|NCT00730639|2852853|P5|Overall Study|Treatment on-going|4
898399|NCT00730639|2852854|P4|Overall Study|Treatment on-going|4
898400|NCT00730639|2852855|P3|Overall Study|Treatment on-going|5
898401|NCT00730639|2852856|P2|Overall Study|Treatment on-going|5
898402|NCT00730639|2852857|P1|Overall Study|Treatment on-going|2
898403|NCT00730639|2852853|P5|Overall Study|Withdrawal by Subject|4
898404|NCT00730639|2852854|P4|Overall Study|Withdrawal by Subject|3
898405|NCT00730639|2852855|P3|Overall Study|Withdrawal by Subject|6
898406|NCT00730639|2852856|P2|Overall Study|Withdrawal by Subject|0
898407|NCT00730639|2852857|P1|Overall Study|Withdrawal by Subject|0
898408|NCT00730639|2852853|P5|Overall Study|Protocol Violation|0
898409|NCT00730639|2852854|P4|Overall Study|Protocol Violation|0
898410|NCT00730639|2852855|P3|Overall Study|Protocol Violation|1
898411|NCT00730639|2852856|P2|Overall Study|Protocol Violation|0
898412|NCT00730639|2852857|P1|Overall Study|Protocol Violation|0
898413|NCT00730639|2852853|P5|Overall Study|non-specified|3
898414|NCT00730639|2852854|P4|Overall Study|non-specified|2
898415|NCT00730639|2852855|P3|Overall Study|non-specified|4
898416|NCT00730639|2852856|P2|Overall Study|non-specified|0
898417|NCT00730639|2852857|P1|Overall Study|non-specified|0
898418|NCT00730639|2852853|P5|Overall Study|Disease Progression|88
898419|NCT00730639|2852854|P4|Overall Study|Disease Progression|32
898420|NCT00730639|2852855|P3|Overall Study|Disease Progression|48
898421|NCT00730639|2852856|P2|Overall Study|Disease Progression|13
898422|NCT00730639|2852857|P1|Overall Study|Disease Progression|12
898423|NCT00730639|2852853|P5|Overall Study|Death|2
898424|NCT00730639|2852854|P4|Overall Study|Death|0
898425|NCT00730639|2852855|P3|Overall Study|Death|0
898426|NCT00730639|2852856|P2|Overall Study|Death|0
898427|NCT00730639|2852857|P1|Overall Study|Death|0
898428|NCT00730639|2852853|P5|Overall Study|Completed Maximum Cycles|6
898429|NCT00730639|2852854|P4|Overall Study|Completed Maximum Cycles|3
898430|NCT00730639|2852855|P3|Overall Study|Completed Maximum Cycles|11
898431|NCT00730639|2852856|P2|Overall Study|Completed Maximum Cycles|0
898432|NCT00730639|2852857|P1|Overall Study|Completed Maximum Cycles|0
898433|NCT00730639|2852853|P5|Overall Study|Complete Response|1
898434|NCT00730639|2852854|P4|Overall Study|Complete Response|2
898435|NCT00730639|2852855|P3|Overall Study|Complete Response|2
898436|NCT00730639|2852856|P2|Overall Study|Complete Response|0
898437|NCT00730639|2852857|P1|Overall Study|Complete Response|0
898438|NCT00730639|2852853|P5|Overall Study|Adverse Event|23
898439|NCT00730639|2852854|P4|Overall Study|Adverse Event|8
898440|NCT00730639|2852855|P3|Overall Study|Adverse Event|9
898441|NCT00730639|2852856|P2|Overall Study|Adverse Event|0
898442|NCT00730639|2852857|P1|Overall Study|Adverse Event|3
898453|NCT00562484|2853162|P2|Overall Study|Reason not provided or not specified|12
898454|NCT00562484|2853163|P1|Overall Study|Reason not provided or not specified|25
898455|NCT00562484|2853162|P2|Overall Study|Lost to Follow-up|71
898456|NCT00562484|2853163|P1|Overall Study|Lost to Follow-up|132
898457|NCT00562484|2853162|P2|Overall Study|Moved away from the study area|9
898458|NCT00562484|2853163|P1|Overall Study|Moved away from the study area|20
898459|NCT00562484|2853162|P2|Overall Study|Withdrawal by Subject|9
898460|NCT00562484|2853163|P1|Overall Study|Withdrawal by Subject|12
898461|NCT00562484|2853162|P2|Overall Study|Protocol Violation|2
898462|NCT00562484|2853163|P1|Overall Study|Protocol Violation|11
898463|NCT00562484|2853162|P2|Overall Study|Adverse Event|1
898464|NCT00562484|2853163|P1|Overall Study|Adverse Event|6
898465|NCT00551759|2853193|P1|Overall Study|Ineligible|1
898466|NCT00551759|2853193|P1|Overall Study|Death|5
898467|NCT00551759|2853193|P1|Overall Study|Adverse Event|7
898478|NCT00520299|2853304|P3|Overall Study|Progressive disease|4
898479|NCT00520299|2853305|P2|Overall Study|Progressive disease|3
898480|NCT00520299|2853306|P1|Overall Study|Progressive disease|0
898481|NCT00520299|2853304|P3|Overall Study|Withdrawal by Subject|2
898482|NCT00520299|2853305|P2|Overall Study|Withdrawal by Subject|0
898483|NCT00520299|2853306|P1|Overall Study|Withdrawal by Subject|0
898488|NCT00462826|2853382|P1|Overall Study|Never treated|1
898489|NCT00462826|2853382|P1|Overall Study|Ineligible - wrong primary|2
898490|NCT00462826|2853382|P1|Overall Study|Ineligible - wrong cell type|1
898491|NCT00462826|2853382|P1|Overall Study|Ineligible - second primary|1
898492|NCT00429169|2853397|P2|Overall Study|Ineligibility discovered after entry|1
898493|NCT00429169|2853398|P1|Overall Study|Ineligibility discovered after entry|2
898494|NCT00429169|2853397|P2|Overall Study|Lost to Follow-up|1
898495|NCT00429169|2853398|P1|Overall Study|Lost to Follow-up|0
898508|NCT00415610|2853425|P3|Overall Study|Death|5
898509|NCT00415610|2853426|P2|Overall Study|Death|2
898510|NCT00415610|2853427|P1|Overall Study|Death|3
898513|NCT00407758|2853453|P1|Overall Study|ineligible –improper prior treatment|1
898514|NCT00361218|2853485|P1|Overall Study|terminated / withdrawn due to toxicity /|5
898515|NCT00361218|2853485|P1|Overall Study|Personal Reasons|7
898516|NCT00361218|2853485|P1|Overall Study|Lost to Follow-up|11
898517|NCT00361270|2853493|P4|Overall Study|Adverse Event|0
898518|NCT00361270|2853494|P3|Overall Study|Adverse Event|1
898519|NCT00361270|2853495|P2|Overall Study|Adverse Event|1
898520|NCT00361270|2853496|P1|Overall Study|Adverse Event|0
898521|NCT00361270|2853493|P4|Overall Study|Problems with Transportation|0
898522|NCT00361270|2853494|P3|Overall Study|Problems with Transportation|0
898523|NCT00361270|2853495|P2|Overall Study|Problems with Transportation|0
898524|NCT00361270|2853496|P1|Overall Study|Problems with Transportation|4
898525|NCT00361270|2853493|P4|Overall Study|Afraid of Hypnosis|0
898526|NCT00361270|2853494|P3|Overall Study|Afraid of Hypnosis|0
898527|NCT00361270|2853495|P2|Overall Study|Afraid of Hypnosis|2
898528|NCT00361270|2853496|P1|Overall Study|Afraid of Hypnosis|1
898529|NCT00361270|2853493|P4|Overall Study|Withdrawal by Subject|7
898530|NCT00361270|2853494|P3|Overall Study|Withdrawal by Subject|3
898531|NCT00361270|2853495|P2|Overall Study|Withdrawal by Subject|6
898532|NCT00361270|2853496|P1|Overall Study|Withdrawal by Subject|6
898533|NCT00361270|2853493|P4|Overall Study|Protocol Violation|4
898534|NCT00361270|2853494|P3|Overall Study|Protocol Violation|5
898535|NCT00361270|2853495|P2|Overall Study|Protocol Violation|4
898536|NCT00361270|2853496|P1|Overall Study|Protocol Violation|9
898537|NCT00361270|2853493|P4|Overall Study|Physician Decision|0
898538|NCT00361270|2853494|P3|Overall Study|Physician Decision|1
898539|NCT00361270|2853495|P2|Overall Study|Physician Decision|0
898540|NCT00361270|2853496|P1|Overall Study|Physician Decision|0
898541|NCT00361270|2853493|P4|Overall Study|Lost to Follow-up|0
898542|NCT00361270|2853494|P3|Overall Study|Lost to Follow-up|0
898543|NCT00361270|2853495|P2|Overall Study|Lost to Follow-up|1
898544|NCT00361270|2853496|P1|Overall Study|Lost to Follow-up|4
898545|NCT00361270|2853493|P4|Overall Study|Death|2
898546|NCT00361270|2853494|P3|Overall Study|Death|0
898547|NCT00361270|2853495|P2|Overall Study|Death|0
898548|NCT00361270|2853496|P1|Overall Study|Death|0
898564|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
898565|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
898566|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
898567|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
898568|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
898569|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
898570|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
898571|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
898572|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
898573|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
898574|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
898575|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
898576|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
898577|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
898578|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
867508|NCT00066573|2760971|P2|Overall Study|Did not received protocol treatment|28
867509|NCT00066573|2760972|P1|Overall Study|Did not received protocol treatment|28
898579|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
898580|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
898581|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
898582|NCT00274924|2853649|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
898583|NCT00274924|2853650|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
898584|NCT00274924|2853651|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
898585|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
898586|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
898587|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
898588|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
898589|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
898590|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
898591|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
898592|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
898593|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
898594|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
898595|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
898596|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
898597|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
898598|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
898599|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
898600|NCT00274924|2853649|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
898601|NCT00274924|2853650|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
898602|NCT00274924|2853651|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
898616|NCT00214019|2853706|P1|Overall Study|Screen Failed prior to randomization|17
898617|NCT00214019|2853706|P1|Overall Study|Withdrawal by Subject|2
898618|NCT00214019|2853706|P1|Overall Study|Lost to Follow-up|11
898625|NCT00143507|2853753|P2|Overall Study|Withdrawn by sponsor's decision|3
898626|NCT00143507|2853754|P1|Overall Study|Withdrawn by sponsor's decision|0
898627|NCT00143507|2853753|P2|Overall Study|Lost to Follow-up|0
898628|NCT00143507|2853754|P1|Overall Study|Lost to Follow-up|1
898629|NCT00143507|2853753|P2|Overall Study|Withdrawal by Subject|102
898630|NCT00143507|2853754|P1|Overall Study|Withdrawal by Subject|114
898631|NCT00143507|2853753|P2|Overall Study|Death|547
898632|NCT00143507|2853754|P1|Overall Study|Death|572
898643|NCT00110149|2853807|P1|Overall Study|Physician Decision|3
898644|NCT00095979|2853812|P1|Overall Study|Ineligible: Second primary cancer site|2
898683|NCT02758171|2853898|P2|Wash-out|Other reason|0
898684|NCT02758171|2853899|P1|Wash-out|Other reason|1
898685|NCT02758171|2853898|P2|Wash-out|Withdrawal by Subject|0
898686|NCT02758171|2853899|P1|Wash-out|Withdrawal by Subject|1
898722|NCT02289833|2854112|P2|Overall Study|Death|8
898723|NCT02289833|2854113|P1|Overall Study|Death|15
898724|NCT02289833|2854112|P2|Overall Study|Lost to Follow-up|0
898725|NCT02289833|2854113|P1|Overall Study|Lost to Follow-up|2
898726|NCT02289833|2854112|P2|Overall Study|Disease Progression|3
898727|NCT02289833|2854113|P1|Overall Study|Disease Progression|0
898728|NCT02289833|2854112|P2|Overall Study|Clinical Progression|1
898729|NCT02289833|2854113|P1|Overall Study|Clinical Progression|0
898730|NCT02289833|2854112|P2|Overall Study|Continued Participation in Study|8
898731|NCT02289833|2854113|P1|Overall Study|Continued Participation in Study|12
898732|NCT02266875|2854146|P2|Overall Study|Lost to Follow-up|0
898733|NCT02266875|2854147|P1|Overall Study|Lost to Follow-up|2
898734|NCT02266875|2854146|P2|Overall Study|Withdrawal by Subject|0
898735|NCT02266875|2854147|P1|Overall Study|Withdrawal by Subject|9
898746|NCT02092220|2854207|P2|Period 2|Nausea, Anxiety, Inconvenience|1
898747|NCT02092220|2854208|P1|Period 2|Nausea, Anxiety, Inconvenience|0
898748|NCT02092220|2854207|P2|Period 2|Severe Hypoglycaemia|0
898749|NCT02092220|2854208|P1|Period 2|Severe Hypoglycaemia|1
898750|NCT02092220|2854207|P2|Period 1|Unrelated Illness|2
898751|NCT02092220|2854208|P1|Period 1|Unrelated Illness|0
898770|NCT01961297|2854289|P2|Overall Study|unconfirmed diagnosis of SD|1
898771|NCT01961297|2854290|P1|Overall Study|unconfirmed diagnosis of SD|2
898776|NCT01866319|2854340|P3|Overall Study|Remain on study|176
898777|NCT01866319|2854341|P2|Overall Study|Remain on study|190
898778|NCT01866319|2854342|P1|Overall Study|Remain on study|131
898779|NCT01866319|2854340|P3|Overall Study|Withdrawal by Subject|6
898780|NCT01866319|2854341|P2|Overall Study|Withdrawal by Subject|9
898781|NCT01866319|2854342|P1|Overall Study|Withdrawal by Subject|31
898782|NCT01866319|2854340|P3|Overall Study|Physician Decision|0
898783|NCT01866319|2854341|P2|Overall Study|Physician Decision|0
898784|NCT01866319|2854342|P1|Overall Study|Physician Decision|1
898785|NCT01866319|2854340|P3|Overall Study|Lost to Follow-up|6
898786|NCT01866319|2854341|P2|Overall Study|Lost to Follow-up|0
898787|NCT01866319|2854342|P1|Overall Study|Lost to Follow-up|3
898788|NCT01866319|2854340|P3|Overall Study|Death|77
898789|NCT01866319|2854341|P2|Overall Study|Death|74
898790|NCT01866319|2854342|P1|Overall Study|Death|97
898791|NCT01866319|2854340|P3|Overall Study|Clinical progression|0
898792|NCT01866319|2854341|P2|Overall Study|Clinical progression|0
898793|NCT01866319|2854342|P1|Overall Study|Clinical progression|1
898794|NCT01866319|2854340|P3|Overall Study|Adverse Event|12
898795|NCT01866319|2854341|P2|Overall Study|Adverse Event|6
898796|NCT01866319|2854342|P1|Overall Study|Adverse Event|13
898797|NCT01864200|2854358|P2|Overall Study|Protocol Violation|0
898798|NCT01864200|2854359|P1|Overall Study|Protocol Violation|1
898799|NCT01864200|2854358|P2|Overall Study|Lost to Follow-up|3
898800|NCT01864200|2854359|P1|Overall Study|Lost to Follow-up|1
898801|NCT01793935|2854427|P2|Overall Study|Lost to Follow-up|1
898802|NCT01793935|2854428|P1|Overall Study|Lost to Follow-up|0
898803|NCT01793935|2854427|P2|Overall Study|Patient did not take study medication|1
898804|NCT01793935|2854428|P1|Overall Study|Patient did not take study medication|1
898805|NCT01793935|2854427|P2|Overall Study|Adverse Event|0
898806|NCT01793935|2854428|P1|Overall Study|Adverse Event|2
898807|NCT01793935|2854427|P2|Overall Study|Protocol Violation|1
898808|NCT01793935|2854428|P1|Overall Study|Protocol Violation|2
898809|NCT01793935|2854427|P2|Overall Study|Pregnancy|0
898810|NCT01793935|2854428|P1|Overall Study|Pregnancy|1
898822|NCT01704287|2854565|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
898823|NCT01704287|2854566|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
898824|NCT01704287|2854567|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
898825|NCT01704287|2854568|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
898826|NCT01704287|2854569|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
898827|NCT01704287|2854565|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
898828|NCT01704287|2854566|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
898829|NCT01704287|2854567|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
898830|NCT01704287|2854568|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
898831|NCT01704287|2854569|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
898832|NCT01704287|2854565|P5|Switch to Pembrolizumab Treatment Period|Death|28
898833|NCT01704287|2854566|P4|Switch to Pembrolizumab Treatment Period|Death|29
898834|NCT01704287|2854567|P3|Switch to Pembrolizumab Treatment Period|Death|0
898835|NCT01704287|2854568|P2|Switch to Pembrolizumab Treatment Period|Death|0
898836|NCT01704287|2854569|P1|Switch to Pembrolizumab Treatment Period|Death|0
898837|NCT01704287|2854565|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
898838|NCT01704287|2854566|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
898839|NCT01704287|2854567|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
898840|NCT01704287|2854568|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
898841|NCT01704287|2854569|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
898842|NCT01704287|2854565|P5|Initial Treatment Period|Switched to Pembrolizumab|0
898843|NCT01704287|2854566|P4|Initial Treatment Period|Switched to Pembrolizumab|0
898844|NCT01704287|2854567|P3|Initial Treatment Period|Switched to Pembrolizumab|98
898845|NCT01704287|2854568|P2|Initial Treatment Period|Switched to Pembrolizumab|0
898846|NCT01704287|2854569|P1|Initial Treatment Period|Switched to Pembrolizumab|0
898847|NCT01704287|2854565|P5|Initial Treatment Period|Lost to Follow-up|0
898848|NCT01704287|2854566|P4|Initial Treatment Period|Lost to Follow-up|0
898849|NCT01704287|2854567|P3|Initial Treatment Period|Lost to Follow-up|3
898850|NCT01704287|2854568|P2|Initial Treatment Period|Lost to Follow-up|1
898851|NCT01704287|2854569|P1|Initial Treatment Period|Lost to Follow-up|3
898852|NCT01704287|2854565|P5|Initial Treatment Period|Ongoing in Study|0
898853|NCT01704287|2854566|P4|Initial Treatment Period|Ongoing in Study|0
898854|NCT01704287|2854567|P3|Initial Treatment Period|Ongoing in Study|44
898855|NCT01704287|2854568|P2|Initial Treatment Period|Ongoing in Study|62
898856|NCT01704287|2854569|P1|Initial Treatment Period|Ongoing in Study|52
898857|NCT01704287|2854565|P5|Initial Treatment Period|Other|0
898858|NCT01704287|2854566|P4|Initial Treatment Period|Other|0
898859|NCT01704287|2854567|P3|Initial Treatment Period|Other|0
898860|NCT01704287|2854568|P2|Initial Treatment Period|Other|0
898861|NCT01704287|2854569|P1|Initial Treatment Period|Other|1
898862|NCT01704287|2854565|P5|Initial Treatment Period|Withdrawal by Subject|0
898863|NCT01704287|2854566|P4|Initial Treatment Period|Withdrawal by Subject|0
898864|NCT01704287|2854567|P3|Initial Treatment Period|Withdrawal by Subject|4
898865|NCT01704287|2854568|P2|Initial Treatment Period|Withdrawal by Subject|1
898866|NCT01704287|2854569|P1|Initial Treatment Period|Withdrawal by Subject|1
898867|NCT01704287|2854565|P5|Initial Treatment Period|Death|0
898868|NCT01704287|2854566|P4|Initial Treatment Period|Death|0
898869|NCT01704287|2854567|P3|Initial Treatment Period|Death|30
898870|NCT01704287|2854568|P2|Initial Treatment Period|Death|117
898871|NCT01704287|2854569|P1|Initial Treatment Period|Death|123
898872|NCT01639001|2854635|P2|Overall Study|Death|35
898873|NCT01639001|2854636|P1|Overall Study|Death|35
898874|NCT01639001|2854635|P2|Overall Study|Lost to Follow-up|0
898875|NCT01639001|2854636|P1|Overall Study|Lost to Follow-up|1
898876|NCT01639001|2854635|P2|Overall Study|Refused further follow-up|6
898877|NCT01639001|2854636|P1|Overall Study|Refused further follow-up|3
898878|NCT01639001|2854635|P2|Overall Study|Ongoing at date of cutoff|60
898879|NCT01639001|2854636|P1|Overall Study|Ongoing at date of cutoff|65
898880|NCT01639001|2854635|P2|Overall Study|Randomized but not treated|2
898881|NCT01639001|2854636|P1|Overall Study|Randomized but not treated|0
898882|NCT01626352|2854680|P1|Overall Study|Never Treated|1
898883|NCT01626352|2854680|P1|Overall Study|Non-Compliance|1
898884|NCT01626352|2854680|P1|Overall Study|Withdrawal by Subject|1
898885|NCT01626352|2854680|P1|Overall Study|Death|2
898886|NCT01626352|2854680|P1|Overall Study|Intercurrent Illness|2
898887|NCT01626352|2854680|P1|Overall Study|Disease Progression|3
898888|NCT01547286|2854733|P1|Overall Study|Physician Decision|1
898889|NCT01547286|2854733|P1|Overall Study|Did not meet all eligibility criteria|1
898908|NCT01376700|2854857|P1|Overall Study|Low or high titer inhibitor|8
898909|NCT01376700|2854857|P1|Overall Study|Sponsor terminated study early|8
898911|NCT01220609|2854953|P1|Overall Study|Ineligible-Never treated|1
898912|NCT01220609|2854953|P1|Overall Study|Ineligible- Wrong cell type|1
898913|NCT01220609|2854953|P1|Overall Study|Ineligible-Wrong primary cancer site|1
898914|NCT01180049|2854967|P2|Overall Study|Ongoing on treatment|10
898915|NCT01180049|2854968|P1|Overall Study|Ongoing on treatment|18
898916|NCT01180049|2854967|P2|Overall Study|Death|28
898917|NCT01180049|2854968|P1|Overall Study|Death|23
898918|NCT01180049|2854967|P2|Overall Study|Lost to Follow-up|1
898919|NCT01180049|2854968|P1|Overall Study|Lost to Follow-up|0
898920|NCT01180049|2854967|P2|Overall Study|Participant Refused Follow Up|3
898921|NCT01180049|2854968|P1|Overall Study|Participant Refused Follow Up|5
898922|NCT01180049|2854967|P2|Overall Study|Enrolled to Another Clinical Trial|1
898923|NCT01180049|2854968|P1|Overall Study|Enrolled to Another Clinical Trial|1
898940|NCT01023958|2855187|P1|Overall Study|Refused to continue medication|1
898941|NCT01023958|2855187|P1|Overall Study|Other adverse event|1
898942|NCT01023958|2855187|P1|Overall Study|Progressive disease|48
898943|NCT00952822|2855245|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
898944|NCT00952822|2855246|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
898945|NCT00952822|2855247|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
898946|NCT00952822|2855248|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
898947|NCT00952822|2855245|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
898948|NCT00952822|2855246|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
898949|NCT00952822|2855247|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
898950|NCT00952822|2855248|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
898951|NCT00939627|2855280|P3|Overall Study|No off-tx reason given|0
898952|NCT00939627|2855281|P2|Overall Study|No off-tx reason given|2
898953|NCT00939627|2855282|P1|Overall Study|No off-tx reason given|0
898954|NCT00939627|2855280|P3|Overall Study|Not compliant|0
898955|NCT00939627|2855281|P2|Overall Study|Not compliant|0
898956|NCT00939627|2855282|P1|Overall Study|Not compliant|2
898957|NCT00939627|2855280|P3|Overall Study|Other complicating disease|0
898958|NCT00939627|2855281|P2|Overall Study|Other complicating disease|1
898959|NCT00939627|2855282|P1|Overall Study|Other complicating disease|1
898960|NCT00939627|2855280|P3|Overall Study|Withdrawal by Subject|0
898961|NCT00939627|2855281|P2|Overall Study|Withdrawal by Subject|4
898962|NCT00939627|2855282|P1|Overall Study|Withdrawal by Subject|2
898963|NCT00939627|2855280|P3|Overall Study|Death|0
898964|NCT00939627|2855281|P2|Overall Study|Death|2
898965|NCT00939627|2855282|P1|Overall Study|Death|0
898966|NCT00939627|2855280|P3|Overall Study|Adverse Event|0
898967|NCT00939627|2855281|P2|Overall Study|Adverse Event|7
898968|NCT00939627|2855282|P1|Overall Study|Adverse Event|6
898969|NCT00939627|2855280|P3|Overall Study|Disease Progression|0
898970|NCT00939627|2855281|P2|Overall Study|Disease Progression|12
898971|NCT00939627|2855282|P1|Overall Study|Disease Progression|16
898972|NCT00912509|2855343|P2|Overall Study|Lack of Efficacy|3
898973|NCT00912509|2855344|P1|Overall Study|Lack of Efficacy|4
898974|NCT00912509|2855343|P2|Overall Study|Lost to Follow-up|0
898975|NCT00912509|2855344|P1|Overall Study|Lost to Follow-up|1
898976|NCT00851721|2855387|P2|Overall Study|Adverse Event|1
898977|NCT00851721|2855388|P1|Overall Study|Adverse Event|0
898978|NCT00851721|2855387|P2|Overall Study|Death|0
898979|NCT00851721|2855388|P1|Overall Study|Death|1
898980|NCT00851721|2855387|P2|Overall Study|planned surgery|0
898981|NCT00851721|2855388|P1|Overall Study|planned surgery|1
899076|NCT00665444|2855952|P1|Overall Study|Study Terminated by Study Sponsor|1
899077|NCT00665444|2855952|P1|Overall Study|Physician Decision|1
899091|NCT00478933|2856086|P1|Overall Study|Inadequate data available|53
899092|NCT00478933|2856086|P1|Overall Study|Informed consent not verified|3
899093|NCT00478933|2856086|P1|Overall Study|Protocol Violation|22
899094|NCT00408902|2856132|P1|Overall Study|Adverse Event|3
899095|NCT00408902|2856132|P1|Overall Study|Lack of Efficacy|7
899108|NCT00289536|2856250|P3|Period 3|Lost to Follow-up|1
899109|NCT00289536|2856251|P2|Period 3|Lost to Follow-up|0
899110|NCT00289536|2856252|P1|Period 3|Lost to Follow-up|0
899111|NCT00274287|2856291|P1|Overall Study|subject non-compliance|1
899112|NCT00274287|2856291|P1|Overall Study|Withdrawal by Subject|1
899113|NCT00272038|2856295|P1|Overall Study|withdrew before they received 2 cycles|7
899114|NCT00262223|2856303|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
899115|NCT00262223|2856304|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
899116|NCT00262223|2856303|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
899117|NCT00262223|2856304|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
899118|NCT00262223|2856303|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
899119|NCT00262223|2856304|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
899120|NCT00262223|2856303|P2|Treatment Phase|Adverse Event|2
899121|NCT00262223|2856304|P1|Treatment Phase|Adverse Event|1
899122|NCT00262223|2856303|P2|Treatment Phase|Withdrawal by Subject|6
899123|NCT00262223|2856304|P1|Treatment Phase|Withdrawal by Subject|3
899124|NCT00157157|2856352|P1|Overall Study|Inclusion not met- baseline FVIII value|1
899125|NCT00157157|2856352|P1|Overall Study|Met exclusion criteria|1
899126|NCT00157157|2856352|P1|Overall Study|Enrolled in another study|1
899127|NCT00157157|2856352|P1|Overall Study|Lost to Follow-up|1
899128|NCT00157157|2856352|P1|Overall Study|Physician Decision|1
899129|NCT00157157|2856352|P1|Overall Study|Withdrawal by Subject|6
899130|NCT02871375|2856381|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
899131|NCT02871375|2856382|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
899132|NCT02766400|2856393|P2|Overall Study|Withdrawal by Subject|0
899133|NCT02766400|2856394|P1|Overall Study|Withdrawal by Subject|1
899134|NCT02766400|2856393|P2|Overall Study|Death|2
899135|NCT02766400|2856394|P1|Overall Study|Death|1
899136|NCT02622321|2856404|P4|Overall Study|Withdrawal by Subject|0
899137|NCT02622321|2856405|P3|Overall Study|Withdrawal by Subject|0
899138|NCT02622321|2856406|P2|Overall Study|Withdrawal by Subject|0
899139|NCT02622321|2856407|P1|Overall Study|Withdrawal by Subject|1
899140|NCT02622321|2856404|P4|Overall Study|Ongoing treatment with emicizumab|7
899141|NCT02622321|2856405|P3|Overall Study|Ongoing treatment with emicizumab|49
899142|NCT02622321|2856406|P2|Overall Study|Ongoing treatment with emicizumab|13
899143|NCT02622321|2856407|P1|Overall Study|Ongoing treatment with emicizumab|31
899144|NCT02622321|2856404|P4|Overall Study|Ongoing in safety follow-up|0
899145|NCT02622321|2856405|P3|Overall Study|Ongoing in safety follow-up|0
899146|NCT02622321|2856406|P2|Overall Study|Ongoing in safety follow-up|0
899147|NCT02622321|2856407|P1|Overall Study|Ongoing in safety follow-up|3
899148|NCT02622321|2856404|P4|Overall Study|Ongoing treatment with no emicizumab|0
899149|NCT02622321|2856405|P3|Overall Study|Ongoing treatment with no emicizumab|0
899150|NCT02622321|2856406|P2|Overall Study|Ongoing treatment with no emicizumab|5
899151|NCT02622321|2856407|P1|Overall Study|Ongoing treatment with no emicizumab|0
899152|NCT02482805|2856462|P3|Overall Study|Lost to Follow-up|0
899153|NCT02482805|2856463|P2|Overall Study|Lost to Follow-up|4
899154|NCT02482805|2856464|P1|Overall Study|Lost to Follow-up|4
899155|NCT02365519|2856480|P3|Randomized and Treated|Withdrawal by Subject|1
899156|NCT02365519|2856481|P2|Randomized and Treated|Withdrawal by Subject|1
899157|NCT02365519|2856482|P1|Randomized and Treated|Withdrawal by Subject|0
899158|NCT02365519|2856480|P3|Randomized and Treated|Adverse Event|0
899159|NCT02365519|2856481|P2|Randomized and Treated|Adverse Event|1
899160|NCT02365519|2856482|P1|Randomized and Treated|Adverse Event|0
899161|NCT02356562|2856505|P2|Overall Study|site closure|0
899162|NCT02356562|2856506|P1|Overall Study|site closure|1
899163|NCT02356562|2856505|P2|Overall Study|Re-entered treatment in a previous study|0
899164|NCT02356562|2856506|P1|Overall Study|Re-entered treatment in a previous study|1
899165|NCT02356562|2856505|P2|Overall Study|Withdrawal by Subject|1
899166|NCT02356562|2856506|P1|Overall Study|Withdrawal by Subject|0
899167|NCT02301169|2856518|P2|Overall Study|Adverse Event|0
899168|NCT02301169|2856519|P1|Overall Study|Adverse Event|1
899169|NCT02131064|2856535|P2|Overall Study|Other|0
899170|NCT02131064|2856536|P1|Overall Study|Other|1
899171|NCT02131064|2856535|P2|Overall Study|Ongoing|207
899172|NCT02131064|2856536|P1|Overall Study|Ongoing|214
899173|NCT02131064|2856535|P2|Overall Study|Withdrawal by Subject|14
899174|NCT02131064|2856536|P1|Overall Study|Withdrawal by Subject|6
899175|NCT02131064|2856535|P2|Overall Study|Lost to Follow-up|1
899176|NCT02131064|2856536|P1|Overall Study|Lost to Follow-up|0
899177|NCT02131064|2856535|P2|Overall Study|Death|1
899178|NCT02131064|2856536|P1|Overall Study|Death|0
899193|NCT01969565|2856592|P1|Overall Study|Withdrawal by Subject|1
899194|NCT01961323|2856598|P1|Overall Study|screen failure|34
899195|NCT01961323|2856598|P1|Overall Study|Lost to Follow-up|8
899196|NCT01961323|2856598|P1|Overall Study|Withdrawal by Subject|7
899197|NCT01942590|2856606|P2|Overall Study|Adverse Event|0
899198|NCT01942590|2856607|P1|Overall Study|Adverse Event|1
899199|NCT01942590|2856606|P2|Overall Study|Withdrawal by Subject|1
899200|NCT01942590|2856607|P1|Overall Study|Withdrawal by Subject|0
899201|NCT01751412|2856650|P1|Overall Study|Disease Progression Before Treatment|1
899202|NCT01736475|2856675|P2|Overall Study|Other - Surgical procedure|0
899203|NCT01736475|2856676|P1|Overall Study|Other - Surgical procedure|1
899204|NCT01736475|2856675|P2|Overall Study|Other - Screen failure|0
899205|NCT01736475|2856676|P1|Overall Study|Other - Screen failure|1
899206|NCT01736475|2856675|P2|Overall Study|Protocol Violation|0
899207|NCT01736475|2856676|P1|Overall Study|Protocol Violation|4
899208|NCT01736475|2856675|P2|Overall Study|Withdrawal by Subject|0
899209|NCT01736475|2856676|P1|Overall Study|Withdrawal by Subject|2
899210|NCT01736475|2856675|P2|Overall Study|Adverse Event|0
899211|NCT01736475|2856676|P1|Overall Study|Adverse Event|4
899212|NCT01524887|2856816|P3|Overall Study|Use of prohibited medication|0
899213|NCT01524887|2856817|P2|Overall Study|Use of prohibited medication|0
899214|NCT01524887|2856818|P1|Overall Study|Use of prohibited medication|1
899215|NCT01524887|2856816|P3|Overall Study|Withdrawal by Caregiver|2
899216|NCT01524887|2856817|P2|Overall Study|Withdrawal by Caregiver|0
899217|NCT01524887|2856818|P1|Overall Study|Withdrawal by Caregiver|0
899218|NCT01524887|2856816|P3|Overall Study|Study termination|79
899219|NCT01524887|2856817|P2|Overall Study|Study termination|87
899220|NCT01524887|2856818|P1|Overall Study|Study termination|73
899221|NCT01524887|2856816|P3|Overall Study|Protocol Violation|1
899222|NCT01524887|2856817|P2|Overall Study|Protocol Violation|0
899223|NCT01524887|2856818|P1|Overall Study|Protocol Violation|0
899224|NCT01524887|2856816|P3|Overall Study|Adverse Event|1
899225|NCT01524887|2856817|P2|Overall Study|Adverse Event|1
899226|NCT01524887|2856818|P1|Overall Study|Adverse Event|5
899227|NCT01524887|2856816|P3|Overall Study|Withdrawal by Subject|3
899228|NCT01524887|2856817|P2|Overall Study|Withdrawal by Subject|2
899229|NCT01524887|2856818|P1|Overall Study|Withdrawal by Subject|6
899230|NCT01313884|2856963|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
899231|NCT01174446|2856968|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
899232|NCT01174446|2856969|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
899233|NCT01174446|2856970|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
899234|NCT01174446|2856971|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
899235|NCT01174446|2856968|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
899236|NCT01174446|2856969|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
899237|NCT01174446|2856970|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
899238|NCT01174446|2856971|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
899239|NCT01174446|2856968|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
899240|NCT01174446|2856969|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
899241|NCT01174446|2856970|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
899242|NCT01174446|2856971|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
899243|NCT01174446|2856968|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
899244|NCT01174446|2856969|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
899245|NCT01174446|2856970|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
899246|NCT01174446|2856971|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
899247|NCT00818662|2857223|P4|Overall Study|Admitted to long term nursing care|0
899248|NCT00818662|2857224|P3|Overall Study|Admitted to long term nursing care|0
899249|NCT00818662|2857225|P2|Overall Study|Admitted to long term nursing care|1
899250|NCT00818662|2857226|P1|Overall Study|Admitted to long term nursing care|0
899251|NCT00818662|2857223|P4|Overall Study|Study partner decision|1
899252|NCT00818662|2857224|P3|Overall Study|Study partner decision|0
899253|NCT00818662|2857225|P2|Overall Study|Study partner decision|0
899254|NCT00818662|2857226|P1|Overall Study|Study partner decision|0
899255|NCT00818662|2857223|P4|Overall Study|Change in living situation|1
899256|NCT00818662|2857224|P3|Overall Study|Change in living situation|0
899257|NCT00818662|2857225|P2|Overall Study|Change in living situation|0
899258|NCT00818662|2857226|P1|Overall Study|Change in living situation|0
899259|NCT00818662|2857223|P4|Overall Study|Declined move to another study site|0
899260|NCT00818662|2857224|P3|Overall Study|Declined move to another study site|0
899261|NCT00818662|2857225|P2|Overall Study|Declined move to another study site|0
899262|NCT00818662|2857226|P1|Overall Study|Declined move to another study site|1
899263|NCT00818662|2857223|P4|Overall Study|Moving out of state|1
899264|NCT00818662|2857224|P3|Overall Study|Moving out of state|0
899265|NCT00818662|2857225|P2|Overall Study|Moving out of state|0
899266|NCT00818662|2857226|P1|Overall Study|Moving out of state|0
899267|NCT00818662|2857223|P4|Overall Study|Caregiver to pursue other treatment|0
899268|NCT00818662|2857224|P3|Overall Study|Caregiver to pursue other treatment|0
899269|NCT00818662|2857225|P2|Overall Study|Caregiver to pursue other treatment|1
899270|NCT00818662|2857226|P1|Overall Study|Caregiver to pursue other treatment|0
899271|NCT00818662|2857223|P4|Overall Study|Participant's health declined|1
899272|NCT00818662|2857224|P3|Overall Study|Participant's health declined|0
899273|NCT00818662|2857225|P2|Overall Study|Participant's health declined|0
899274|NCT00818662|2857226|P1|Overall Study|Participant's health declined|0
899275|NCT00818662|2857223|P4|Overall Study|Study Partner Unwilling or Unable|1
899276|NCT00818662|2857224|P3|Overall Study|Study Partner Unwilling or Unable|1
899277|NCT00818662|2857225|P2|Overall Study|Study Partner Unwilling or Unable|2
899278|NCT00818662|2857226|P1|Overall Study|Study Partner Unwilling or Unable|3
899279|NCT00818662|2857223|P4|Overall Study|Safety Risk|1
899280|NCT00818662|2857224|P3|Overall Study|Safety Risk|0
899281|NCT00818662|2857225|P2|Overall Study|Safety Risk|1
899282|NCT00818662|2857226|P1|Overall Study|Safety Risk|1
899283|NCT00818662|2857223|P4|Overall Study|Requires a Prohibited Medication|0
899284|NCT00818662|2857224|P3|Overall Study|Requires a Prohibited Medication|0
899285|NCT00818662|2857225|P2|Overall Study|Requires a Prohibited Medication|0
899286|NCT00818662|2857226|P1|Overall Study|Requires a Prohibited Medication|1
899287|NCT00818662|2857223|P4|Overall Study|Protocol Violation|0
899288|NCT00818662|2857224|P3|Overall Study|Protocol Violation|0
899289|NCT00818662|2857225|P2|Overall Study|Protocol Violation|1
899290|NCT00818662|2857226|P1|Overall Study|Protocol Violation|1
899291|NCT00818662|2857223|P4|Overall Study|Unwilling or Unable to Participate|4
899292|NCT00818662|2857224|P3|Overall Study|Unwilling or Unable to Participate|2
899293|NCT00818662|2857225|P2|Overall Study|Unwilling or Unable to Participate|6
899294|NCT00818662|2857226|P1|Overall Study|Unwilling or Unable to Participate|4
899295|NCT00818662|2857223|P4|Overall Study|Lost to Follow-up|1
899296|NCT00818662|2857224|P3|Overall Study|Lost to Follow-up|0
899297|NCT00818662|2857225|P2|Overall Study|Lost to Follow-up|0
899298|NCT00818662|2857226|P1|Overall Study|Lost to Follow-up|0
899299|NCT00818662|2857223|P4|Overall Study|Physician Decision|0
899300|NCT00818662|2857224|P3|Overall Study|Physician Decision|0
899301|NCT00818662|2857225|P2|Overall Study|Physician Decision|0
899302|NCT00818662|2857226|P1|Overall Study|Physician Decision|1
899303|NCT00818662|2857223|P4|Overall Study|Death|0
899304|NCT00818662|2857224|P3|Overall Study|Death|0
899305|NCT00818662|2857225|P2|Overall Study|Death|3
899306|NCT00818662|2857226|P1|Overall Study|Death|1
899307|NCT00818662|2857223|P4|Overall Study|Withdrawal by Subject|2
899308|NCT00818662|2857224|P3|Overall Study|Withdrawal by Subject|2
899309|NCT00818662|2857225|P2|Overall Study|Withdrawal by Subject|4
899310|NCT00818662|2857226|P1|Overall Study|Withdrawal by Subject|5
899311|NCT00818662|2857223|P4|Overall Study|Adverse Event|3
899312|NCT00818662|2857224|P3|Overall Study|Adverse Event|4
899313|NCT00818662|2857225|P2|Overall Study|Adverse Event|14
899314|NCT00818662|2857226|P1|Overall Study|Adverse Event|5
899315|NCT00814320|2857314|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
899316|NCT00814320|2857315|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
899317|NCT00814320|2857314|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
899318|NCT00814320|2857315|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
899319|NCT00814320|2857314|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
899320|NCT00814320|2857315|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
899321|NCT00814320|2857314|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
899322|NCT00814320|2857315|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
899323|NCT00814320|2857314|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
899324|NCT00814320|2857315|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
899325|NCT00814320|2857314|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
899326|NCT00814320|2857315|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
899327|NCT00814320|2857314|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
899328|NCT00814320|2857315|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
899329|NCT00814320|2857314|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
899330|NCT00814320|2857315|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
899331|NCT00814320|2857314|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
899332|NCT00814320|2857315|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
899333|NCT00814320|2857314|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
899334|NCT00814320|2857315|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
899335|NCT00666263|2857457|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
899336|NCT00666263|2857458|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
899337|NCT00666263|2857457|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
899338|NCT00666263|2857458|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
899339|NCT00666263|2857457|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
899340|NCT00666263|2857458|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
899341|NCT00596934|2857600|P1|Overall Study|Withdrawal by Subject|1
899342|NCT00596934|2857600|P1|Overall Study|Protocol Violation|1
899343|NCT00546871|2857611|P2|Study Extension Period|Withdrawal by Subject|1
899344|NCT00546871|2857612|P1|Study Extension Period|Withdrawal by Subject|0
899345|NCT00546871|2857611|P2|Study Extension Period|Protocol Violation|0
899346|NCT00546871|2857612|P1|Study Extension Period|Protocol Violation|1
899347|NCT00546871|2857611|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
899348|NCT00546871|2857612|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
899349|NCT00546871|2857611|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
899350|NCT00546871|2857612|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
899351|NCT00546871|2857611|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
899352|NCT00546871|2857612|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
899353|NCT00499122|2857719|P1|Overall Study|Withdrawal by Subject|2
899354|NCT00313144|2857740|P1|Overall Study|Due to termination of the study|66
899355|NCT00313144|2857740|P1|Overall Study|Change to different product|1
899356|NCT00313144|2857740|P1|Overall Study|Insurance (homecare provider) change|1
899357|NCT00313144|2857740|P1|Overall Study|Liver transplant|1
899358|NCT00313144|2857740|P1|Overall Study|Adverse event - transient|5
899359|NCT00313144|2857740|P1|Overall Study|Physician Decision|4
899360|NCT00313144|2857740|P1|Overall Study|Terminated by sponsor/ homecare provider|4
899361|NCT00313144|2857740|P1|Overall Study|Withdrawal by Subject|4
899362|NCT00313144|2857740|P1|Overall Study|Lost to Follow-up|5
899363|NCT00313144|2857740|P1|Overall Study|Death|7
899364|NCT00313144|2857740|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
899365|NCT00307294|2857824|P1|Overall Study|Withdrawal by Subject|1
868733|NCT03073798|2764663|P1|Overall Study|Withdrawal by Subject|1
868734|NCT03073798|2764663|P1|Overall Study|Adverse Event|1
868749|NCT02294461|2764871|P2|Overall Study|Miscellaneous|34
868750|NCT02294461|2764872|P1|Overall Study|Miscellaneous|13
868751|NCT02294461|2764871|P2|Overall Study|Adverse Event|10
868752|NCT02294461|2764872|P1|Overall Study|Adverse Event|12
868753|NCT02294461|2764871|P2|Overall Study|Disease Progression|39
868754|NCT02294461|2764872|P1|Overall Study|Disease Progression|23
868755|NCT02294461|2764871|P2|Overall Study|Withdrawal by Subject|49
868756|NCT02294461|2764872|P1|Overall Study|Withdrawal by Subject|14
868757|NCT02294461|2764871|P2|Overall Study|Protocol Violation|2
868758|NCT02294461|2764872|P1|Overall Study|Protocol Violation|0
868759|NCT02294461|2764871|P2|Overall Study|Death|3
868760|NCT02294461|2764872|P1|Overall Study|Death|3
868761|NCT02218697|2764926|P2|Overall Study|Withdrawal by Subject|3
868762|NCT02218697|2764927|P1|Overall Study|Withdrawal by Subject|2
868763|NCT02218697|2764926|P2|Overall Study|Unwilling to be vaccinated in left arm|1
868764|NCT02218697|2764927|P1|Overall Study|Unwilling to be vaccinated in left arm|0
868765|NCT02218697|2764926|P2|Overall Study|Adverse Event|2
868766|NCT02218697|2764927|P1|Overall Study|Adverse Event|0
868814|NCT02164929|2765148|P4|Overall Study|Failed regional block|0
868815|NCT02164929|2765149|P3|Overall Study|Failed regional block|1
868816|NCT02164929|2765150|P2|Overall Study|Failed regional block|0
868817|NCT02164929|2765151|P1|Overall Study|Failed regional block|0
868818|NCT02164929|2765148|P4|Overall Study|Converted to open procedure|2
868819|NCT02164929|2765149|P3|Overall Study|Converted to open procedure|0
868820|NCT02164929|2765150|P2|Overall Study|Converted to open procedure|0
868821|NCT02164929|2765151|P1|Overall Study|Converted to open procedure|1
868822|NCT02164318|2765197|P4|Overall Study|Withdrawal by Subject|1
868823|NCT02164318|2765198|P3|Overall Study|Withdrawal by Subject|0
868824|NCT02164318|2765199|P2|Overall Study|Withdrawal by Subject|1
868825|NCT02164318|2765200|P1|Overall Study|Withdrawal by Subject|0
868853|NCT02046148|2765342|P2|Overall Study|Withdrawal by Subject|2
868854|NCT02046148|2765343|P1|Overall Study|Withdrawal by Subject|0
868855|NCT02046148|2765342|P2|Overall Study|Lost to Follow-up|1
868856|NCT02046148|2765343|P1|Overall Study|Lost to Follow-up|1
868865|NCT01994629|2765450|P2|Overall Study|Lost to Follow-up|3
868866|NCT01994629|2765451|P1|Overall Study|Lost to Follow-up|0
868867|NCT01994629|2765450|P2|Overall Study|Withdrawal by Subject|0
868868|NCT01994629|2765451|P1|Overall Study|Withdrawal by Subject|1
868869|NCT01954251|2765477|P2|Overall Study|Withdrawal by Subject|6
868870|NCT01954251|2765478|P1|Overall Study|Withdrawal by Subject|2
868871|NCT01954251|2765477|P2|Overall Study|Lost to Follow-up|6
868872|NCT01954251|2765478|P1|Overall Study|Lost to Follow-up|6
868873|NCT01954251|2765477|P2|Overall Study|Adverse Event|7
868874|NCT01954251|2765478|P1|Overall Study|Adverse Event|5
868875|NCT01903720|2765512|P1|Overall Study|Treatment with alternative drug|1
868876|NCT01903720|2765512|P1|Overall Study|Lost to Follow-up|2
868877|NCT01903720|2765512|P1|Overall Study|Rescinding of informed consent|2
868878|NCT01903720|2765512|P1|Overall Study|Adverse Event|1
868879|NCT01903720|2765512|P1|Overall Study|Inclusion / exclusion criteria not met|6
868880|NCT01867307|2765529|P2|Overall Study|Other Adverse Event|3
868881|NCT01867307|2765530|P1|Overall Study|Other Adverse Event|1
868882|NCT01867307|2765529|P2|Overall Study|Protocol Violation|0
868883|NCT01867307|2765530|P1|Overall Study|Protocol Violation|2
868884|NCT01867047|2765538|P2|Overall Study|surgery not indicated in protocol|2
868885|NCT01867047|2765539|P1|Overall Study|surgery not indicated in protocol|1
868886|NCT01867047|2765538|P2|Overall Study|Physician Decision|0
868887|NCT01867047|2765539|P1|Overall Study|Physician Decision|2
868888|NCT01867047|2765538|P2|Overall Study|Withdrawal by Subject|0
868889|NCT01867047|2765539|P1|Overall Study|Withdrawal by Subject|2
868890|NCT01867047|2765538|P2|Overall Study|Lost to Follow-up|3
868891|NCT01867047|2765539|P1|Overall Study|Lost to Follow-up|3
868896|NCT01804842|2765586|P3|Overall Study|Personal Reason|1
868897|NCT01804842|2765587|P2|Overall Study|Personal Reason|0
868898|NCT01804842|2765588|P1|Overall Study|Personal Reason|0
868899|NCT01804842|2765586|P3|Overall Study|Non-Compliance|0
868900|NCT01804842|2765587|P2|Overall Study|Non-Compliance|1
868901|NCT01804842|2765588|P1|Overall Study|Non-Compliance|1
868902|NCT01804842|2765586|P3|Overall Study|Lost to Follow-up|0
868903|NCT01804842|2765587|P2|Overall Study|Lost to Follow-up|0
868904|NCT01804842|2765588|P1|Overall Study|Lost to Follow-up|1
868905|NCT01804842|2765586|P3|Overall Study|Adverse Event|0
868906|NCT01804842|2765587|P2|Overall Study|Adverse Event|1
868907|NCT01804842|2765588|P1|Overall Study|Adverse Event|1
868908|NCT01797094|2765607|P2|Overall Study|Other Miscellaneous Reasons|0
868909|NCT01797094|2765608|P1|Overall Study|Other Miscellaneous Reasons|1
868910|NCT01797094|2765607|P2|Overall Study|Protocol Violation|1
868911|NCT01797094|2765608|P1|Overall Study|Protocol Violation|0
868912|NCT01797094|2765607|P2|Overall Study|Personal Reasons|0
868913|NCT01797094|2765608|P1|Overall Study|Personal Reasons|4
868914|NCT01797094|2765607|P2|Overall Study|Adverse Event|1
868915|NCT01797094|2765608|P1|Overall Study|Adverse Event|1
868916|NCT01797081|2765630|P4|Overall Study|Protocol Violation|1
868917|NCT01797081|2765631|P3|Overall Study|Protocol Violation|0
868918|NCT01797081|2765632|P2|Overall Study|Protocol Violation|0
868919|NCT01797081|2765633|P1|Overall Study|Protocol Violation|0
868920|NCT01797081|2765630|P4|Overall Study|Personal Reasons|8
868921|NCT01797081|2765631|P3|Overall Study|Personal Reasons|4
868922|NCT01797081|2765632|P2|Overall Study|Personal Reasons|4
868923|NCT01797081|2765633|P1|Overall Study|Personal Reasons|12
868924|NCT01797081|2765630|P4|Overall Study|Pregnancy|0
868925|NCT01797081|2765631|P3|Overall Study|Pregnancy|0
868926|NCT01797081|2765632|P2|Overall Study|Pregnancy|0
868927|NCT01797081|2765633|P1|Overall Study|Pregnancy|1
868928|NCT01797081|2765630|P4|Overall Study|Adverse Event|0
868929|NCT01797081|2765631|P3|Overall Study|Adverse Event|1
868930|NCT01797081|2765632|P2|Overall Study|Adverse Event|0
868931|NCT01797081|2765633|P1|Overall Study|Adverse Event|1
868932|NCT01721746|2765652|P3|Treatment Period|Other|1
868933|NCT01721746|2765653|P2|Treatment Period|Other|1
868934|NCT01721746|2765654|P1|Treatment Period|Other|2
868935|NCT01721746|2765652|P3|Treatment Period|Subject No Longer Met Study Criteria|0
868936|NCT01721746|2765653|P2|Treatment Period|Subject No Longer Met Study Criteria|0
868937|NCT01721746|2765654|P1|Treatment Period|Subject No Longer Met Study Criteria|4
868938|NCT01721746|2765652|P3|Treatment Period|Poor/Non-compliance|0
868939|NCT01721746|2765653|P2|Treatment Period|Poor/Non-compliance|0
868940|NCT01721746|2765654|P1|Treatment Period|Poor/Non-compliance|1
868941|NCT01721746|2765652|P3|Treatment Period|Maximum Clinical Benefit|3
868942|NCT01721746|2765653|P2|Treatment Period|Maximum Clinical Benefit|0
868943|NCT01721746|2765654|P1|Treatment Period|Maximum Clinical Benefit|1
868944|NCT01721746|2765652|P3|Treatment Period|Subject Withdrew Consent|2
868945|NCT01721746|2765653|P2|Treatment Period|Subject Withdrew Consent|0
868946|NCT01721746|2765654|P1|Treatment Period|Subject Withdrew Consent|3
868947|NCT01721746|2765652|P3|Treatment Period|Subject Request to Discontinue Treatment|6
868948|NCT01721746|2765653|P2|Treatment Period|Subject Request to Discontinue Treatment|1
868949|NCT01721746|2765654|P1|Treatment Period|Subject Request to Discontinue Treatment|19
868950|NCT01721746|2765652|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
868951|NCT01721746|2765653|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
868952|NCT01721746|2765654|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
868953|NCT01721746|2765652|P3|Treatment Period|Study Drug Toxicity|9
868954|NCT01721746|2765653|P2|Treatment Period|Study Drug Toxicity|2
868955|NCT01721746|2765654|P1|Treatment Period|Study Drug Toxicity|15
868956|NCT01721746|2765652|P3|Treatment Period|Disease Progression|34
868957|NCT01721746|2765653|P2|Treatment Period|Disease Progression|40
868958|NCT01721746|2765654|P1|Treatment Period|Disease Progression|182
868959|NCT01721759|2765670|P1|Overall Study|Withdrawal by Subject|1
868960|NCT01721759|2765670|P1|Overall Study|Adverse event unrelated to study drug|9
868961|NCT01721759|2765670|P1|Overall Study|Study drug toxicity|14
868962|NCT01721759|2765670|P1|Overall Study|Disease progression|78
868963|NCT01710046|2765700|P2|Overall Study|Lost to Follow-up|0
868964|NCT01710046|2765701|P1|Overall Study|Lost to Follow-up|1
868968|NCT01662440|2765763|P4|Overall Study|Withdrawal by Subject|2
868969|NCT01662440|2765764|P3|Overall Study|Withdrawal by Subject|2
868970|NCT01662440|2765765|P2|Overall Study|Withdrawal by Subject|2
868971|NCT01662440|2765766|P1|Overall Study|Withdrawal by Subject|5
868972|NCT01662440|2765763|P4|Overall Study|Protocol Violation|0
868973|NCT01662440|2765764|P3|Overall Study|Protocol Violation|0
868974|NCT01662440|2765765|P2|Overall Study|Protocol Violation|0
868975|NCT01662440|2765766|P1|Overall Study|Protocol Violation|1
868976|NCT01662440|2765763|P4|Overall Study|Subject moved to another country.|0
868977|NCT01662440|2765764|P3|Overall Study|Subject moved to another country.|0
868978|NCT01662440|2765765|P2|Overall Study|Subject moved to another country.|1
868979|NCT01662440|2765766|P1|Overall Study|Subject moved to another country.|0
868980|NCT01662440|2765763|P4|Overall Study|Lost to Follow-up|1
868981|NCT01662440|2765764|P3|Overall Study|Lost to Follow-up|4
868982|NCT01662440|2765765|P2|Overall Study|Lost to Follow-up|2
868983|NCT01662440|2765766|P1|Overall Study|Lost to Follow-up|2
868984|NCT01662440|2765763|P4|Overall Study|Death|0
868985|NCT01662440|2765764|P3|Overall Study|Death|0
868986|NCT01662440|2765765|P2|Overall Study|Death|1
868987|NCT01662440|2765766|P1|Overall Study|Death|0
868988|NCT01662440|2765763|P4|Overall Study|Adverse Event|1
868989|NCT01662440|2765764|P3|Overall Study|Adverse Event|0
868990|NCT01662440|2765765|P2|Overall Study|Adverse Event|0
868991|NCT01662440|2765766|P1|Overall Study|Adverse Event|1
868994|NCT01621802|2765839|P6|Overall Study|Lost to Follow-up|11
868995|NCT01621802|2765840|P5|Overall Study|Lost to Follow-up|31
868996|NCT01621802|2765841|P4|Overall Study|Lost to Follow-up|7
868997|NCT01621802|2765842|P3|Overall Study|Lost to Follow-up|24
868998|NCT01621802|2765843|P2|Overall Study|Lost to Follow-up|16
868999|NCT01621802|2765844|P1|Overall Study|Lost to Follow-up|36
869000|NCT01621802|2765839|P6|Overall Study|Others|0
869001|NCT01621802|2765840|P5|Overall Study|Others|1
869002|NCT01621802|2765841|P4|Overall Study|Others|2
869003|NCT01621802|2765842|P3|Overall Study|Others|3
869004|NCT01621802|2765843|P2|Overall Study|Others|3
869005|NCT01621802|2765844|P1|Overall Study|Others|3
869006|NCT01621802|2765839|P6|Overall Study|Migrated/moved from study area|0
869007|NCT01621802|2765840|P5|Overall Study|Migrated/moved from study area|1
869008|NCT01621802|2765841|P4|Overall Study|Migrated/moved from study area|0
869009|NCT01621802|2765842|P3|Overall Study|Migrated/moved from study area|2
869010|NCT01621802|2765843|P2|Overall Study|Migrated/moved from study area|0
869011|NCT01621802|2765844|P1|Overall Study|Migrated/moved from study area|0
869012|NCT01621802|2765839|P6|Overall Study|Withdrawal by Subject|0
869013|NCT01621802|2765840|P5|Overall Study|Withdrawal by Subject|2
869014|NCT01621802|2765841|P4|Overall Study|Withdrawal by Subject|2
869015|NCT01621802|2765842|P3|Overall Study|Withdrawal by Subject|4
869016|NCT01621802|2765843|P2|Overall Study|Withdrawal by Subject|4
869017|NCT01621802|2765844|P1|Overall Study|Withdrawal by Subject|8
869018|NCT01621802|2765839|P6|Overall Study|Protocol Violation|1
869019|NCT01621802|2765840|P5|Overall Study|Protocol Violation|0
869020|NCT01621802|2765841|P4|Overall Study|Protocol Violation|0
869021|NCT01621802|2765842|P3|Overall Study|Protocol Violation|0
869022|NCT01621802|2765843|P2|Overall Study|Protocol Violation|0
869023|NCT01621802|2765844|P1|Overall Study|Protocol Violation|0
869028|NCT01600716|2765998|P2|Overall Study|Adverse Event|1
869029|NCT01600716|2765999|P1|Overall Study|Adverse Event|1
869030|NCT01600716|2765998|P2|Overall Study|Lack of Efficacy|1
869031|NCT01600716|2765999|P1|Overall Study|Lack of Efficacy|2
869032|NCT01600716|2765998|P2|Overall Study|Pregnancy|0
869033|NCT01600716|2765999|P1|Overall Study|Pregnancy|1
869034|NCT01600716|2765998|P2|Overall Study|Lost to Follow-up|2
869035|NCT01600716|2765999|P1|Overall Study|Lost to Follow-up|0
869036|NCT01600716|2765998|P2|Overall Study|Personal Reasons|2
869037|NCT01600716|2765999|P1|Overall Study|Personal Reasons|0
869038|NCT01600716|2765998|P2|Overall Study|Other Reasons|1
869039|NCT01600716|2765999|P1|Overall Study|Other Reasons|3
869040|NCT01570192|2766023|P2|Overall Study|Physician Decision|1
869041|NCT01570192|2766024|P1|Overall Study|Physician Decision|0
869042|NCT01570192|2766023|P2|Overall Study|changed to palliative care|0
869043|NCT01570192|2766024|P1|Overall Study|changed to palliative care|1
869044|NCT01570192|2766023|P2|Overall Study|no qualifying organism|12
869045|NCT01570192|2766024|P1|Overall Study|no qualifying organism|6
869060|NCT01466387|2766161|P6|Overall Study|Protocol Violation|0
869061|NCT01466387|2766162|P5|Overall Study|Protocol Violation|0
869062|NCT01466387|2766163|P4|Overall Study|Protocol Violation|1
869063|NCT01466387|2766164|P3|Overall Study|Protocol Violation|0
869064|NCT01466387|2766165|P2|Overall Study|Protocol Violation|0
869065|NCT01466387|2766166|P1|Overall Study|Protocol Violation|1
869066|NCT01466387|2766161|P6|Overall Study|Lost to Follow-up|1
869067|NCT01466387|2766162|P5|Overall Study|Lost to Follow-up|0
869068|NCT01466387|2766163|P4|Overall Study|Lost to Follow-up|0
869069|NCT01466387|2766164|P3|Overall Study|Lost to Follow-up|0
869070|NCT01466387|2766165|P2|Overall Study|Lost to Follow-up|0
869071|NCT01466387|2766166|P1|Overall Study|Lost to Follow-up|0
869072|NCT01466387|2766161|P6|Overall Study|Adverse Event|0
869073|NCT01466387|2766162|P5|Overall Study|Adverse Event|0
869074|NCT01466387|2766163|P4|Overall Study|Adverse Event|1
869075|NCT01466387|2766164|P3|Overall Study|Adverse Event|1
869076|NCT01466387|2766165|P2|Overall Study|Adverse Event|0
869077|NCT01466387|2766166|P1|Overall Study|Adverse Event|0
869078|NCT01453348|2766207|P3|Overall Study|Protocol Violation|0
869079|NCT01453348|2766208|P2|Overall Study|Protocol Violation|0
869080|NCT01453348|2766209|P1|Overall Study|Protocol Violation|1
869081|NCT01453348|2766207|P3|Overall Study|Withdrawal by Subject|0
869082|NCT01453348|2766208|P2|Overall Study|Withdrawal by Subject|1
869083|NCT01453348|2766209|P1|Overall Study|Withdrawal by Subject|0
869084|NCT01453348|2766207|P3|Overall Study|Death|1
869085|NCT01453348|2766208|P2|Overall Study|Death|0
869086|NCT01453348|2766209|P1|Overall Study|Death|0
869087|NCT01439360|2766227|P2|Overall Study|Withdrawal by Subject|129
869088|NCT01439360|2766228|P1|Overall Study|Withdrawal by Subject|140
869089|NCT01439360|2766227|P2|Overall Study|Protocol Violation|0
869090|NCT01439360|2766228|P1|Overall Study|Protocol Violation|1
869091|NCT01439360|2766227|P2|Overall Study|Others|5
869092|NCT01439360|2766228|P1|Overall Study|Others|10
869093|NCT01439360|2766227|P2|Overall Study|Lost to Follow-up|58
869094|NCT01439360|2766228|P1|Overall Study|Lost to Follow-up|43
869095|NCT01439360|2766227|P2|Overall Study|Adverse Event|16
869096|NCT01439360|2766228|P1|Overall Study|Adverse Event|4
869097|NCT01423253|2766276|P1|Overall Study|Withdrawal by Subject|2
869098|NCT01423253|2766276|P1|Overall Study|Protocol Violation|2
869099|NCT01423253|2766276|P1|Overall Study|Lost to Follow-up|1
869100|NCT01423253|2766276|P1|Overall Study|Lack of Efficacy|2
869101|NCT01423253|2766276|P1|Overall Study|Adverse Event|2
869102|NCT01422408|2766287|P1|Overall Study|Withdrawal by Subject|3
869103|NCT01422408|2766287|P1|Overall Study|Adverse Event|1
869104|NCT01411852|2766318|P2|Hospital Intervention Phase|Vascular access failed|0
869105|NCT01411852|2766319|P1|Hospital Intervention Phase|Vascular access failed|1
869106|NCT01411852|2766318|P2|Hospital Intervention Phase|Withdrawal by Subject|0
869107|NCT01411852|2766319|P1|Hospital Intervention Phase|Withdrawal by Subject|1
869108|NCT01411852|2766318|P2|Hospital Intervention Phase|Spinal cord injury|0
869109|NCT01411852|2766319|P1|Hospital Intervention Phase|Spinal cord injury|2
869110|NCT01411852|2766318|P2|Hospital Intervention Phase|Other ineligible|2
869111|NCT01411852|2766319|P1|Hospital Intervention Phase|Other ineligible|2
869112|NCT01411852|2766318|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
869113|NCT01411852|2766319|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
869114|NCT01411852|2766318|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
869115|NCT01411852|2766319|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
869116|NCT01411852|2766318|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
869117|NCT01411852|2766319|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
869118|NCT01411852|2766318|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
869203|NCT01350934|2766517|P1|Base Study|Non-Compliance With Study Drug|2
869119|NCT01411852|2766319|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
869120|NCT01411852|2766318|P2|Hospital Intervention Phase|CPR administered|1
869121|NCT01411852|2766319|P1|Hospital Intervention Phase|CPR administered|3
869122|NCT01411852|2766318|P2|Hospital Intervention Phase|Miscommunication error|2
869123|NCT01411852|2766319|P1|Hospital Intervention Phase|Miscommunication error|1
869124|NCT01411852|2766318|P2|Hospital Intervention Phase|No qualifying SBP|1
869125|NCT01411852|2766319|P1|Hospital Intervention Phase|No qualifying SBP|5
869126|NCT01411852|2766318|P2|Hospital Intervention Phase|Severe head injury|4
869127|NCT01411852|2766319|P1|Hospital Intervention Phase|Severe head injury|5
869128|NCT01411852|2766318|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
869129|NCT01411852|2766319|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
869130|NCT01411852|2766318|P2|Prehospital Intervention Phase|Found to be under age|1
869131|NCT01411852|2766319|P1|Prehospital Intervention Phase|Found to be under age|0
869132|NCT01411852|2766318|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
869133|NCT01411852|2766319|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
869134|NCT01411852|2766318|P2|Prehospital Intervention Phase|No qualifying SBP|4
869135|NCT01411852|2766319|P1|Prehospital Intervention Phase|No qualifying SBP|5
869136|NCT01375374|2766398|P1|Overall Study|Adverse Event|1
869137|NCT01369342|2766408|P3|Overall Study|Not Treated|0
869138|NCT01369342|2766409|P2|Overall Study|Not Treated|0
869139|NCT01369342|2766410|P1|Overall Study|Not Treated|1
869140|NCT01369342|2766408|P3|Overall Study|Lost to Follow-up|1
869141|NCT01369342|2766409|P2|Overall Study|Lost to Follow-up|2
869142|NCT01369342|2766410|P1|Overall Study|Lost to Follow-up|5
869143|NCT01369342|2766408|P3|Overall Study|Withdrawal by Subject|2
869144|NCT01369342|2766409|P2|Overall Study|Withdrawal by Subject|7
869145|NCT01369342|2766410|P1|Overall Study|Withdrawal by Subject|7
869146|NCT01369329|2766433|P3|Overall Study|Other|2
869147|NCT01369329|2766434|P2|Overall Study|Other|3
869148|NCT01369329|2766435|P1|Overall Study|Other|2
869149|NCT01369329|2766433|P3|Overall Study|Lost to Follow-up|2
869150|NCT01369329|2766434|P2|Overall Study|Lost to Follow-up|2
869151|NCT01369329|2766435|P1|Overall Study|Lost to Follow-up|2
869152|NCT01369329|2766433|P3|Overall Study|Withdrawal by Subject|10
869153|NCT01369329|2766434|P2|Overall Study|Withdrawal by Subject|6
869154|NCT01369329|2766435|P1|Overall Study|Withdrawal by Subject|8
869171|NCT01354431|2766492|P3|Participants Treated|Withdrawal by Subject|1
869172|NCT01354431|2766493|P2|Participants Treated|Withdrawal by Subject|2
869173|NCT01354431|2766494|P1|Participants Treated|Withdrawal by Subject|1
869174|NCT01354431|2766492|P3|Participants Treated|Adverse Event|4
869175|NCT01354431|2766493|P2|Participants Treated|Adverse Event|2
869176|NCT01354431|2766494|P1|Participants Treated|Adverse Event|1
869177|NCT01354431|2766492|P3|Participants Treated|Death|0
869178|NCT01354431|2766493|P2|Participants Treated|Death|1
869179|NCT01354431|2766494|P1|Participants Treated|Death|0
869180|NCT01354431|2766492|P3|Participants Treated|Study Drug Toxicity|4
869181|NCT01354431|2766493|P2|Participants Treated|Study Drug Toxicity|7
869182|NCT01354431|2766494|P1|Participants Treated|Study Drug Toxicity|2
869183|NCT01354431|2766492|P3|Participants Treated|Disease Progression|41
869184|NCT01354431|2766493|P2|Participants Treated|Disease Progression|40
869185|NCT01354431|2766494|P1|Participants Treated|Disease Progression|49
869186|NCT01354431|2766492|P3|Participants Treated|Continuing Treatment|4
869187|NCT01354431|2766493|P2|Participants Treated|Continuing Treatment|2
869188|NCT01354431|2766494|P1|Participants Treated|Continuing Treatment|6
869189|NCT01354431|2766492|P3|Randomized to Enter Treatment Period|No longer met criteria|0
869190|NCT01354431|2766493|P2|Randomized to Enter Treatment Period|No longer met criteria|0
869191|NCT01354431|2766494|P1|Randomized to Enter Treatment Period|No longer met criteria|1
869192|NCT01350934|2766516|P2|Extension Study|Withdrawal by Subject|1
869193|NCT01350934|2766517|P1|Extension Study|Withdrawal by Subject|0
869194|NCT01350934|2766516|P2|Extension Study|Lack of Efficacy|1
869195|NCT01350934|2766517|P1|Extension Study|Lack of Efficacy|0
869196|NCT01350934|2766516|P2|Extension Study|Protocol Violation|1
869197|NCT01350934|2766517|P1|Extension Study|Protocol Violation|1
869198|NCT01350934|2766516|P2|Extension Study|Lost to Follow-up|0
869199|NCT01350934|2766517|P1|Extension Study|Lost to Follow-up|2
869200|NCT01350934|2766516|P2|Extension Study|Adverse Event|1
869201|NCT01350934|2766517|P1|Extension Study|Adverse Event|2
869202|NCT01350934|2766516|P2|Base Study|Non-Compliance With Study Drug|0
869204|NCT01350934|2766516|P2|Base Study|Withdrawal by Subject|2
869205|NCT01350934|2766517|P1|Base Study|Withdrawal by Subject|1
869206|NCT01350934|2766516|P2|Base Study|Protocol Violation|1
869207|NCT01350934|2766517|P1|Base Study|Protocol Violation|1
869208|NCT01350934|2766516|P2|Base Study|Lost to Follow-up|0
869209|NCT01350934|2766517|P1|Base Study|Lost to Follow-up|1
869210|NCT01350934|2766516|P2|Base Study|Adverse Event|0
869211|NCT01350934|2766517|P1|Base Study|Adverse Event|6
869212|NCT01340300|2766539|P4|Overall Study|Unrelated sickness, moving|1
869213|NCT01340300|2766540|P3|Overall Study|Unrelated sickness, moving|0
869214|NCT01340300|2766541|P2|Overall Study|Unrelated sickness, moving|2
869215|NCT01340300|2766542|P1|Overall Study|Unrelated sickness, moving|1
869216|NCT01340300|2766539|P4|Overall Study|Physician Decision|0
869217|NCT01340300|2766540|P3|Overall Study|Physician Decision|1
869218|NCT01340300|2766541|P2|Overall Study|Physician Decision|1
869219|NCT01340300|2766542|P1|Overall Study|Physician Decision|2
869220|NCT01340300|2766539|P4|Overall Study|Adverse Event|0
869221|NCT01340300|2766540|P3|Overall Study|Adverse Event|2
869222|NCT01340300|2766541|P2|Overall Study|Adverse Event|0
869223|NCT01340300|2766542|P1|Overall Study|Adverse Event|0
869224|NCT01340300|2766539|P4|Overall Study|Withdrawal by Subject|3
869225|NCT01340300|2766540|P3|Overall Study|Withdrawal by Subject|6
869226|NCT01340300|2766541|P2|Overall Study|Withdrawal by Subject|8
869227|NCT01340300|2766542|P1|Overall Study|Withdrawal by Subject|5
869228|NCT01340300|2766539|P4|Overall Study|Lost to Follow-up|17
869229|NCT01340300|2766540|P3|Overall Study|Lost to Follow-up|12
869230|NCT01340300|2766541|P2|Overall Study|Lost to Follow-up|3
869231|NCT01340300|2766542|P1|Overall Study|Lost to Follow-up|7
869232|NCT01331161|2766574|P2|Overall Study|Pregnancy|1
869233|NCT01331161|2766575|P1|Overall Study|Pregnancy|0
869234|NCT01331161|2766574|P2|Overall Study|Lost to Follow-up|1
869235|NCT01331161|2766575|P1|Overall Study|Lost to Follow-up|0
869236|NCT01331161|2766574|P2|Overall Study|Physician Decision|0
869237|NCT01331161|2766575|P1|Overall Study|Physician Decision|1
869238|NCT01309737|2766586|P5|Week 16 to 52|Other|0
869239|NCT01309737|2766587|P4|Week 16 to 52|Other|2
869240|NCT01309737|2766588|P3|Week 16 to 52|Other|0
869241|NCT01309737|2766589|P2|Week 16 to 52|Other|12
869242|NCT01309737|2766590|P1|Week 16 to 52|Other|10
869243|NCT01309737|2766586|P5|Week 16 to 52|Withdrawal by Subject|2
869244|NCT01309737|2766587|P4|Week 16 to 52|Withdrawal by Subject|0
869245|NCT01309737|2766588|P3|Week 16 to 52|Withdrawal by Subject|0
869246|NCT01309737|2766589|P2|Week 16 to 52|Withdrawal by Subject|6
869247|NCT01309737|2766590|P1|Week 16 to 52|Withdrawal by Subject|5
869248|NCT01309737|2766586|P5|Week 16 to 52|Lost to Follow-up|4
869249|NCT01309737|2766587|P4|Week 16 to 52|Lost to Follow-up|1
869250|NCT01309737|2766588|P3|Week 16 to 52|Lost to Follow-up|0
869251|NCT01309737|2766589|P2|Week 16 to 52|Lost to Follow-up|2
869252|NCT01309737|2766590|P1|Week 16 to 52|Lost to Follow-up|4
869253|NCT01309737|2766586|P5|Week 16 to 52|Lack of Efficacy|21
869254|NCT01309737|2766587|P4|Week 16 to 52|Lack of Efficacy|25
869255|NCT01309737|2766588|P3|Week 16 to 52|Lack of Efficacy|0
869256|NCT01309737|2766589|P2|Week 16 to 52|Lack of Efficacy|76
869257|NCT01309737|2766590|P1|Week 16 to 52|Lack of Efficacy|107
869258|NCT01309737|2766586|P5|Week 16 to 52|Adverse Event|5
869259|NCT01309737|2766587|P4|Week 16 to 52|Adverse Event|6
869260|NCT01309737|2766588|P3|Week 16 to 52|Adverse Event|0
869261|NCT01309737|2766589|P2|Week 16 to 52|Adverse Event|7
869262|NCT01309737|2766590|P1|Week 16 to 52|Adverse Event|7
869263|NCT01309737|2766586|P5|Week 16 to 52|Death|1
869264|NCT01309737|2766587|P4|Week 16 to 52|Death|0
869265|NCT01309737|2766588|P3|Week 16 to 52|Death|0
869266|NCT01309737|2766589|P2|Week 16 to 52|Death|0
869267|NCT01309737|2766590|P1|Week 16 to 52|Death|0
869268|NCT01309737|2766586|P5|Week 0 to 16|Randomized, but not treated|0
869269|NCT01309737|2766587|P4|Week 0 to 16|Randomized, but not treated|0
869270|NCT01309737|2766588|P3|Week 0 to 16|Randomized, but not treated|0
869271|NCT01309737|2766589|P2|Week 0 to 16|Randomized, but not treated|0
869272|NCT01309737|2766590|P1|Week 0 to 16|Randomized, but not treated|1
869273|NCT01309737|2766586|P5|Week 0 to 16|Other|0
869274|NCT01309737|2766587|P4|Week 0 to 16|Other|0
869275|NCT01309737|2766588|P3|Week 0 to 16|Other|4
869276|NCT01309737|2766589|P2|Week 0 to 16|Other|14
869277|NCT01309737|2766590|P1|Week 0 to 16|Other|10
869278|NCT01309737|2766586|P5|Week 0 to 16|Withdrawal by Subject|0
869279|NCT01309737|2766587|P4|Week 0 to 16|Withdrawal by Subject|0
869280|NCT01309737|2766588|P3|Week 0 to 16|Withdrawal by Subject|7
869281|NCT01309737|2766589|P2|Week 0 to 16|Withdrawal by Subject|6
869282|NCT01309737|2766590|P1|Week 0 to 16|Withdrawal by Subject|7
869283|NCT01309737|2766586|P5|Week 0 to 16|Lost to Follow-up|0
869284|NCT01309737|2766587|P4|Week 0 to 16|Lost to Follow-up|0
869285|NCT01309737|2766588|P3|Week 0 to 16|Lost to Follow-up|3
869286|NCT01309737|2766589|P2|Week 0 to 16|Lost to Follow-up|8
869287|NCT01309737|2766590|P1|Week 0 to 16|Lost to Follow-up|7
869288|NCT01309737|2766586|P5|Week 0 to 16|Lack of Efficacy|0
869289|NCT01309737|2766587|P4|Week 0 to 16|Lack of Efficacy|0
869290|NCT01309737|2766588|P3|Week 0 to 16|Lack of Efficacy|24
869291|NCT01309737|2766589|P2|Week 0 to 16|Lack of Efficacy|2
869292|NCT01309737|2766590|P1|Week 0 to 16|Lack of Efficacy|15
869293|NCT01309737|2766586|P5|Week 0 to 16|Adverse Event|0
869294|NCT01309737|2766587|P4|Week 0 to 16|Adverse Event|0
869295|NCT01309737|2766588|P3|Week 0 to 16|Adverse Event|5
869296|NCT01309737|2766589|P2|Week 0 to 16|Adverse Event|10
869297|NCT01309737|2766590|P1|Week 0 to 16|Adverse Event|11
869298|NCT01309737|2766586|P5|Week 0 to 16|Death|0
869299|NCT01309737|2766587|P4|Week 0 to 16|Death|0
869300|NCT01309737|2766588|P3|Week 0 to 16|Death|1
869301|NCT01309737|2766589|P2|Week 0 to 16|Death|0
869302|NCT01309737|2766590|P1|Week 0 to 16|Death|1
869303|NCT01276509|2766789|P4|Overall Study|Other|0
869304|NCT01276509|2766790|P3|Overall Study|Other|0
869305|NCT01276509|2766791|P2|Overall Study|Other|1
869306|NCT01276509|2766792|P1|Overall Study|Other|0
869307|NCT01276509|2766789|P4|Overall Study|Withdrawal by Subject|0
869308|NCT01276509|2766790|P3|Overall Study|Withdrawal by Subject|0
869309|NCT01276509|2766791|P2|Overall Study|Withdrawal by Subject|2
869310|NCT01276509|2766792|P1|Overall Study|Withdrawal by Subject|1
869311|NCT01276509|2766789|P4|Overall Study|Pregnancy|0
869312|NCT01276509|2766790|P3|Overall Study|Pregnancy|0
869313|NCT01276509|2766791|P2|Overall Study|Pregnancy|0
869314|NCT01276509|2766792|P1|Overall Study|Pregnancy|1
869315|NCT01276509|2766789|P4|Overall Study|Lack of Efficacy|2
869316|NCT01276509|2766790|P3|Overall Study|Lack of Efficacy|1
869317|NCT01276509|2766791|P2|Overall Study|Lack of Efficacy|1
869318|NCT01276509|2766792|P1|Overall Study|Lack of Efficacy|2
869319|NCT01276509|2766789|P4|Overall Study|Adverse Event|3
869320|NCT01276509|2766790|P3|Overall Study|Adverse Event|4
869321|NCT01276509|2766791|P2|Overall Study|Adverse Event|8
869322|NCT01276509|2766792|P1|Overall Study|Adverse Event|9
869323|NCT01276639|2766846|P5|Week 16 to 52|Other|3
869324|NCT01276639|2766847|P4|Week 16 to 52|Other|1
869325|NCT01276639|2766848|P3|Week 16 to 52|Other|0
869326|NCT01276639|2766849|P2|Week 16 to 52|Other|12
869327|NCT01276639|2766850|P1|Week 16 to 52|Other|10
869328|NCT01276639|2766846|P5|Week 16 to 52|Withdrawal by Subject|1
869329|NCT01276639|2766847|P4|Week 16 to 52|Withdrawal by Subject|0
869330|NCT01276639|2766848|P3|Week 16 to 52|Withdrawal by Subject|0
869331|NCT01276639|2766849|P2|Week 16 to 52|Withdrawal by Subject|4
869332|NCT01276639|2766850|P1|Week 16 to 52|Withdrawal by Subject|4
869333|NCT01276639|2766846|P5|Week 16 to 52|Lost to Follow-up|1
869334|NCT01276639|2766847|P4|Week 16 to 52|Lost to Follow-up|0
869335|NCT01276639|2766848|P3|Week 16 to 52|Lost to Follow-up|0
869336|NCT01276639|2766849|P2|Week 16 to 52|Lost to Follow-up|1
869337|NCT01276639|2766850|P1|Week 16 to 52|Lost to Follow-up|3
869338|NCT01276639|2766846|P5|Week 16 to 52|Lack of Efficacy|13
869339|NCT01276639|2766847|P4|Week 16 to 52|Lack of Efficacy|14
869340|NCT01276639|2766848|P3|Week 16 to 52|Lack of Efficacy|0
869341|NCT01276639|2766849|P2|Week 16 to 52|Lack of Efficacy|71
869342|NCT01276639|2766850|P1|Week 16 to 52|Lack of Efficacy|99
869343|NCT01276639|2766846|P5|Week 16 to 52|Adverse Event|3
869344|NCT01276639|2766847|P4|Week 16 to 52|Adverse Event|1
869345|NCT01276639|2766848|P3|Week 16 to 52|Adverse Event|0
869346|NCT01276639|2766849|P2|Week 16 to 52|Adverse Event|13
869347|NCT01276639|2766850|P1|Week 16 to 52|Adverse Event|10
869348|NCT01276639|2766846|P5|Week 16 to 52|Death|0
869349|NCT01276639|2766847|P4|Week 16 to 52|Death|0
869350|NCT01276639|2766848|P3|Week 16 to 52|Death|0
869351|NCT01276639|2766849|P2|Week 16 to 52|Death|0
869352|NCT01276639|2766850|P1|Week 16 to 52|Death|1
869353|NCT01276639|2766846|P5|Week 0 to 16|Randomized, But Not Treated|0
869354|NCT01276639|2766847|P4|Week 0 to 16|Randomized, But Not Treated|0
869355|NCT01276639|2766848|P3|Week 0 to 16|Randomized, But Not Treated|0
869356|NCT01276639|2766849|P2|Week 0 to 16|Randomized, But Not Treated|1
869357|NCT01276639|2766850|P1|Week 0 to 16|Randomized, But Not Treated|0
869358|NCT01276639|2766846|P5|Week 0 to 16|Other|0
869359|NCT01276639|2766847|P4|Week 0 to 16|Other|0
869360|NCT01276639|2766848|P3|Week 0 to 16|Other|2
869361|NCT01276639|2766849|P2|Week 0 to 16|Other|7
869362|NCT01276639|2766850|P1|Week 0 to 16|Other|7
869363|NCT01276639|2766846|P5|Week 0 to 16|Withdrawal by Subject|0
869364|NCT01276639|2766847|P4|Week 0 to 16|Withdrawal by Subject|0
869365|NCT01276639|2766848|P3|Week 0 to 16|Withdrawal by Subject|4
869366|NCT01276639|2766849|P2|Week 0 to 16|Withdrawal by Subject|5
869367|NCT01276639|2766850|P1|Week 0 to 16|Withdrawal by Subject|8
869368|NCT01276639|2766846|P5|Week 0 to 16|Lost to Follow-up|0
869369|NCT01276639|2766847|P4|Week 0 to 16|Lost to Follow-up|0
869370|NCT01276639|2766848|P3|Week 0 to 16|Lost to Follow-up|3
869371|NCT01276639|2766849|P2|Week 0 to 16|Lost to Follow-up|5
869372|NCT01276639|2766850|P1|Week 0 to 16|Lost to Follow-up|3
869373|NCT01276639|2766846|P5|Week 0 to 16|Lack of Efficacy|0
869374|NCT01276639|2766847|P4|Week 0 to 16|Lack of Efficacy|0
869375|NCT01276639|2766848|P3|Week 0 to 16|Lack of Efficacy|25
869376|NCT01276639|2766849|P2|Week 0 to 16|Lack of Efficacy|15
869377|NCT01276639|2766850|P1|Week 0 to 16|Lack of Efficacy|20
869378|NCT01276639|2766846|P5|Week 0 to 16|Adverse Event|0
869379|NCT01276639|2766847|P4|Week 0 to 16|Adverse Event|0
869380|NCT01276639|2766848|P3|Week 0 to 16|Adverse Event|11
869381|NCT01276639|2766849|P2|Week 0 to 16|Adverse Event|8
869382|NCT01276639|2766850|P1|Week 0 to 16|Adverse Event|11
869383|NCT01276639|2766846|P5|Week 0 to 16|Death|0
869384|NCT01276639|2766847|P4|Week 0 to 16|Death|0
869385|NCT01276639|2766848|P3|Week 0 to 16|Death|0
869386|NCT01276639|2766849|P2|Week 0 to 16|Death|0
869387|NCT01276639|2766850|P1|Week 0 to 16|Death|1
869400|NCT01257542|2767192|P2|Overall Study|Withdrawal by Subject|2
869401|NCT01257542|2767193|P1|Overall Study|Withdrawal by Subject|0
869402|NCT01257542|2767192|P2|Overall Study|Protocol Violation|5
869403|NCT01257542|2767193|P1|Overall Study|Protocol Violation|3
869404|NCT01232868|2767213|P2|Overall Study|Lost to Follow-up|4
869405|NCT01232868|2767214|P1|Overall Study|Lost to Follow-up|2
869410|NCT01214850|2767242|P3|Overall Study|Unable to classify|1
869411|NCT01214850|2767243|P2|Overall Study|Unable to classify|1
869412|NCT01214850|2767244|P1|Overall Study|Unable to classify|2
869413|NCT01214850|2767242|P3|Overall Study|Administrative reason|0
869414|NCT01214850|2767243|P2|Overall Study|Administrative reason|0
869415|NCT01214850|2767244|P1|Overall Study|Administrative reason|1
869416|NCT01214850|2767242|P3|Overall Study|Inappropriate enrollment|0
869417|NCT01214850|2767243|P2|Overall Study|Inappropriate enrollment|1
869418|NCT01214850|2767244|P1|Overall Study|Inappropriate enrollment|2
869419|NCT01214850|2767242|P3|Overall Study|Adverse event or death|3
869420|NCT01214850|2767243|P2|Overall Study|Adverse event or death|8
869421|NCT01214850|2767244|P1|Overall Study|Adverse event or death|11
869422|NCT01214850|2767242|P3|Overall Study|Protocol Violation|6
869423|NCT01214850|2767243|P2|Overall Study|Protocol Violation|5
869424|NCT01214850|2767244|P1|Overall Study|Protocol Violation|5
869425|NCT01214850|2767242|P3|Overall Study|Lost to Follow-up|123
869426|NCT01214850|2767243|P2|Overall Study|Lost to Follow-up|98
869427|NCT01214850|2767244|P1|Overall Study|Lost to Follow-up|124
869428|NCT01214850|2767242|P3|Overall Study|Withdrawal by Subject|28
869429|NCT01214850|2767243|P2|Overall Study|Withdrawal by Subject|31
869430|NCT01214850|2767244|P1|Overall Study|Withdrawal by Subject|38
869431|NCT01214837|2767328|P3|Overall Study|Unable to Classify|0
869432|NCT01214837|2767329|P2|Overall Study|Unable to Classify|3
869433|NCT01214837|2767330|P1|Overall Study|Unable to Classify|1
869434|NCT01214837|2767328|P3|Overall Study|Protocol Violation|5
869435|NCT01214837|2767329|P2|Overall Study|Protocol Violation|1
869436|NCT01214837|2767330|P1|Overall Study|Protocol Violation|3
869437|NCT01214837|2767328|P3|Overall Study|Administrative Reason|4
869438|NCT01214837|2767329|P2|Overall Study|Administrative Reason|6
869439|NCT01214837|2767330|P1|Overall Study|Administrative Reason|2
869440|NCT01214837|2767328|P3|Overall Study|Inappropriate Enrolment|2
869441|NCT01214837|2767329|P2|Overall Study|Inappropriate Enrolment|1
869442|NCT01214837|2767330|P1|Overall Study|Inappropriate Enrolment|0
869443|NCT01214837|2767328|P3|Overall Study|Lost to Follow-up|21
869444|NCT01214837|2767329|P2|Overall Study|Lost to Follow-up|15
869445|NCT01214837|2767330|P1|Overall Study|Lost to Follow-up|20
869446|NCT01214837|2767328|P3|Overall Study|Withdrawal by Subject|28
869447|NCT01214837|2767329|P2|Overall Study|Withdrawal by Subject|36
869448|NCT01214837|2767330|P1|Overall Study|Withdrawal by Subject|27
869449|NCT01214837|2767328|P3|Overall Study|Adverse Event|1
869450|NCT01214837|2767329|P2|Overall Study|Adverse Event|2
869451|NCT01214837|2767330|P1|Overall Study|Adverse Event|1
869452|NCT01214837|2767328|P3|Overall Study|Death|1
869453|NCT01214837|2767329|P2|Overall Study|Death|0
869454|NCT01214837|2767330|P1|Overall Study|Death|0
869455|NCT01179191|2767376|P1|Maintenance Phase (8 Weeks)|Other|66
869456|NCT01179191|2767376|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
869457|NCT01179191|2767376|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
869458|NCT01179191|2767376|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
869459|NCT01179191|2767376|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
869460|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Other|62
869461|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
869462|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
869463|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
869464|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
869465|NCT01179191|2767376|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
869481|NCT01152996|2767463|P1|Overall Study|Elevated liver enzymes|1
869482|NCT01152996|2767463|P1|Overall Study|Protocol Violation|22
869483|NCT01152996|2767463|P1|Overall Study|Other|36
869484|NCT01152996|2767463|P1|Overall Study|Noncompliance|41
869485|NCT01152996|2767463|P1|Overall Study|Lack of Efficacy|68
869486|NCT01152996|2767463|P1|Overall Study|Lost to Follow-up|112
869487|NCT01152996|2767463|P1|Overall Study|Adverse Event|115
869488|NCT01152996|2767463|P1|Overall Study|Withdrawal by Subject|142
869489|NCT01144416|2767478|P2|Intervention Period|Other|5
869490|NCT01144416|2767479|P1|Intervention Period|Other|7
869491|NCT01144416|2767478|P2|Intervention Period|No/too few/bad quality embryos|3
869492|NCT01144416|2767479|P1|Intervention Period|No/too few/bad quality embryos|3
869493|NCT01144416|2767478|P2|Intervention Period|No or abnormal fertilization|10
869494|NCT01144416|2767479|P1|Intervention Period|No or abnormal fertilization|25
869495|NCT01144416|2767478|P2|Intervention Period|No/too few/bad oocytes|5
869496|NCT01144416|2767479|P1|Intervention Period|No/too few/bad oocytes|7
869497|NCT01144416|2767478|P2|Intervention Period|Too high ovarian response|2
869498|NCT01144416|2767479|P1|Intervention Period|Too high ovarian response|4
869499|NCT01144416|2767478|P2|Intervention Period|Risk of OHSS|1
869500|NCT01144416|2767479|P1|Intervention Period|Risk of OHSS|0
869501|NCT01144416|2767478|P2|Intervention Period|Insufficient ovarian response|17
869502|NCT01144416|2767479|P1|Intervention Period|Insufficient ovarian response|11
869503|NCT01144416|2767478|P2|Intervention Period|Adverse Event|6
869504|NCT01144416|2767479|P1|Intervention Period|Adverse Event|5
869547|NCT01131182|2767516|P2|Overall Study|Other Reason|0
869548|NCT01131182|2767517|P1|Overall Study|Other Reason|1
869549|NCT01131182|2767516|P2|Overall Study|Lost to Follow-up|15
869550|NCT01131182|2767517|P1|Overall Study|Lost to Follow-up|14
869551|NCT01131182|2767516|P2|Overall Study|Withdrawal by Subject|1
869552|NCT01131182|2767517|P1|Overall Study|Withdrawal by Subject|1
869553|NCT01126424|2767531|P6|Overall Study|Withdrawal by Subject|0
869554|NCT01126424|2767532|P5|Overall Study|Withdrawal by Subject|1
869555|NCT01126424|2767533|P4|Overall Study|Withdrawal by Subject|3
869556|NCT01126424|2767534|P3|Overall Study|Withdrawal by Subject|1
869557|NCT01126424|2767535|P2|Overall Study|Withdrawal by Subject|0
869558|NCT01126424|2767536|P1|Overall Study|Withdrawal by Subject|0
869559|NCT01126424|2767531|P6|Overall Study|Adverse Event|0
869560|NCT01126424|2767532|P5|Overall Study|Adverse Event|1
869561|NCT01126424|2767533|P4|Overall Study|Adverse Event|0
869562|NCT01126424|2767534|P3|Overall Study|Adverse Event|0
869563|NCT01126424|2767535|P2|Overall Study|Adverse Event|0
869564|NCT01126424|2767536|P1|Overall Study|Adverse Event|0
869565|NCT01116427|2767572|P2|Extension Phase|Not using appropriate birth control|0
869566|NCT01116427|2767573|P1|Extension Phase|Not using appropriate birth control|1
869567|NCT01116427|2767572|P2|Extension Phase|Withdrawal by Subject|1
869568|NCT01116427|2767573|P1|Extension Phase|Withdrawal by Subject|5
869569|NCT01116427|2767572|P2|Extension Phase|Lost to Follow-up|0
869570|NCT01116427|2767573|P1|Extension Phase|Lost to Follow-up|2
869571|NCT01116427|2767572|P2|Extension Phase|Adverse Event|1
869572|NCT01116427|2767573|P1|Extension Phase|Adverse Event|1
869573|NCT01116427|2767572|P2|Core Phase|Worsening Multiple Sclerosis|0
869574|NCT01116427|2767573|P1|Core Phase|Worsening Multiple Sclerosis|1
869575|NCT01116427|2767572|P2|Core Phase|Withdrawal by Subject|0
869576|NCT01116427|2767573|P1|Core Phase|Withdrawal by Subject|3
869577|NCT01116427|2767572|P2|Core Phase|Lost to Follow-up|0
869578|NCT01116427|2767573|P1|Core Phase|Lost to Follow-up|1
869579|NCT01116427|2767572|P2|Core Phase|Adverse Event|1
869580|NCT01116427|2767573|P1|Core Phase|Adverse Event|0
869581|NCT01112059|2767611|P2|Overall Study|Withdrawal by Subject|0
869582|NCT01112059|2767612|P1|Overall Study|Withdrawal by Subject|1
869583|NCT01106534|2767624|P1|Overall Study|Physician Decision|1
869584|NCT01106534|2767624|P1|Overall Study|Death|16
869585|NCT01106534|2767624|P1|Overall Study|Lost to Follow-up|2
869586|NCT01106534|2767624|P1|Overall Study|Withdrawal by Subject|18
869587|NCT01093534|2767648|P3|Overall Study|Other|4
869588|NCT01093534|2767649|P2|Overall Study|Other|3
869589|NCT01093534|2767650|P1|Overall Study|Other|1
869590|NCT01093534|2767648|P3|Overall Study|Withdrawal by Subject|2
869591|NCT01093534|2767649|P2|Overall Study|Withdrawal by Subject|7
869592|NCT01093534|2767650|P1|Overall Study|Withdrawal by Subject|5
869593|NCT01093534|2767648|P3|Overall Study|Lack of Efficacy|1
869594|NCT01093534|2767649|P2|Overall Study|Lack of Efficacy|1
869595|NCT01093534|2767650|P1|Overall Study|Lack of Efficacy|2
869596|NCT01093534|2767648|P3|Overall Study|Adverse Event|2
869597|NCT01093534|2767649|P2|Overall Study|Adverse Event|5
869598|NCT01093534|2767650|P1|Overall Study|Adverse Event|2
869599|NCT01090427|2767758|P7|After Controlled Period|Adverse Event|0
869600|NCT01090427|2767759|P6|After Controlled Period|Adverse Event|1
869601|NCT01090427|2767760|P5|After Controlled Period|Adverse Event|0
869602|NCT01090427|2767761|P4|After Controlled Period|Adverse Event|2
869603|NCT01090427|2767762|P3|After Controlled Period|Adverse Event|0
869604|NCT01090427|2767763|P2|After Controlled Period|Adverse Event|0
869605|NCT01090427|2767764|P1|After Controlled Period|Adverse Event|0
869606|NCT01090427|2767758|P7|After Controlled Period|Lack of Efficacy|2
869607|NCT01090427|2767759|P6|After Controlled Period|Lack of Efficacy|3
869608|NCT01090427|2767760|P5|After Controlled Period|Lack of Efficacy|0
869609|NCT01090427|2767761|P4|After Controlled Period|Lack of Efficacy|0
869610|NCT01090427|2767762|P3|After Controlled Period|Lack of Efficacy|0
869611|NCT01090427|2767763|P2|After Controlled Period|Lack of Efficacy|0
869612|NCT01090427|2767764|P1|After Controlled Period|Lack of Efficacy|0
869613|NCT01090427|2767758|P7|After Controlled Period|Death|0
869614|NCT01090427|2767759|P6|After Controlled Period|Death|1
869615|NCT01090427|2767760|P5|After Controlled Period|Death|0
869616|NCT01090427|2767761|P4|After Controlled Period|Death|0
869617|NCT01090427|2767762|P3|After Controlled Period|Death|0
869618|NCT01090427|2767763|P2|After Controlled Period|Death|0
869619|NCT01090427|2767764|P1|After Controlled Period|Death|0
869622|NCT01025336|2767920|P5|Overall Study|Protocol Violation|0
869623|NCT01025336|2767921|P4|Overall Study|Protocol Violation|2
869624|NCT01025336|2767922|P3|Overall Study|Protocol Violation|0
869625|NCT01025336|2767923|P2|Overall Study|Protocol Violation|0
869626|NCT01025336|2767924|P1|Overall Study|Protocol Violation|0
869627|NCT01005966|2767976|P5|Treatment Period 4 (14 Days)|Other Reason|1
869628|NCT01005966|2767977|P4|Treatment Period 4 (14 Days)|Other Reason|0
869629|NCT01005966|2767978|P3|Treatment Period 4 (14 Days)|Other Reason|0
869630|NCT01005966|2767979|P2|Treatment Period 4 (14 Days)|Other Reason|0
869631|NCT01005966|2767980|P1|Treatment Period 4 (14 Days)|Other Reason|0
869632|NCT01005966|2767976|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
869633|NCT01005966|2767977|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
869634|NCT01005966|2767978|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
869635|NCT01005966|2767979|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
869636|NCT01005966|2767980|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
869637|NCT01005966|2767976|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
869638|NCT01005966|2767977|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
869639|NCT01005966|2767978|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
869640|NCT01005966|2767979|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
869641|NCT01005966|2767980|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
869642|NCT01005966|2767976|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
869643|NCT01005966|2767977|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
869644|NCT01005966|2767978|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
869645|NCT01005966|2767979|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
869646|NCT01005966|2767980|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
869647|NCT01005966|2767976|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
869648|NCT01005966|2767977|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
869649|NCT01005966|2767978|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
869650|NCT01005966|2767979|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
869651|NCT01005966|2767980|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
869652|NCT01005966|2767976|P5|Treatment Period 2 (14 Days)|Adverse Event|0
869653|NCT01005966|2767977|P4|Treatment Period 2 (14 Days)|Adverse Event|0
869654|NCT01005966|2767978|P3|Treatment Period 2 (14 Days)|Adverse Event|1
869655|NCT01005966|2767979|P2|Treatment Period 2 (14 Days)|Adverse Event|1
869656|NCT01005966|2767980|P1|Treatment Period 2 (14 Days)|Adverse Event|0
869657|NCT01005966|2767976|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
869658|NCT01005966|2767977|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
869659|NCT01005966|2767978|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
869660|NCT01005966|2767979|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
869661|NCT01005966|2767980|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
869662|NCT01005966|2767976|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
869663|NCT01005966|2767977|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
869664|NCT01005966|2767978|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
869665|NCT01005966|2767979|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
869666|NCT01005966|2767980|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
869667|NCT01005966|2767976|P5|Treatment Period 1 (14 Days)|Adverse Event|0
869668|NCT01005966|2767977|P4|Treatment Period 1 (14 Days)|Adverse Event|0
869669|NCT01005966|2767978|P3|Treatment Period 1 (14 Days)|Adverse Event|0
869670|NCT01005966|2767979|P2|Treatment Period 1 (14 Days)|Adverse Event|0
869671|NCT01005966|2767980|P1|Treatment Period 1 (14 Days)|Adverse Event|1
869672|NCT00996307|2768015|P4|Overall Study|Unable to classify|1
869673|NCT00996307|2768016|P3|Overall Study|Unable to classify|2
869674|NCT00996307|2768017|P2|Overall Study|Unable to classify|0
869675|NCT00996307|2768018|P1|Overall Study|Unable to classify|4
869676|NCT00996307|2768015|P4|Overall Study|Administrative reason|0
869677|NCT00996307|2768016|P3|Overall Study|Administrative reason|0
869678|NCT00996307|2768017|P2|Overall Study|Administrative reason|1
869679|NCT00996307|2768018|P1|Overall Study|Administrative reason|0
869680|NCT00996307|2768015|P4|Overall Study|Lost to Follow-up|15
869681|NCT00996307|2768016|P3|Overall Study|Lost to Follow-up|7
869682|NCT00996307|2768017|P2|Overall Study|Lost to Follow-up|13
869683|NCT00996307|2768018|P1|Overall Study|Lost to Follow-up|13
869684|NCT00996307|2768015|P4|Overall Study|Withdrawal by Subject|5
869685|NCT00996307|2768016|P3|Overall Study|Withdrawal by Subject|5
869686|NCT00996307|2768017|P2|Overall Study|Withdrawal by Subject|2
869687|NCT00996307|2768018|P1|Overall Study|Withdrawal by Subject|3
869688|NCT00996307|2768015|P4|Overall Study|Adverse Event|0
869689|NCT00996307|2768016|P3|Overall Study|Adverse Event|0
869690|NCT00996307|2768017|P2|Overall Study|Adverse Event|1
869691|NCT00996307|2768018|P1|Overall Study|Adverse Event|0
869692|NCT00996281|2768078|P2|Overall Study|Other|7
869693|NCT00996281|2768079|P1|Overall Study|Other|5
869694|NCT00996281|2768078|P2|Overall Study|Lack of Efficacy|2
869695|NCT00996281|2768079|P1|Overall Study|Lack of Efficacy|0
869696|NCT00996281|2768078|P2|Overall Study|Withdrawal by Subject|20
869697|NCT00996281|2768079|P1|Overall Study|Withdrawal by Subject|31
869698|NCT00996281|2768078|P2|Overall Study|Lost to Follow-up|16
869699|NCT00996281|2768079|P1|Overall Study|Lost to Follow-up|14
869700|NCT00996281|2768078|P2|Overall Study|Major Protocol Deviation|7
869701|NCT00996281|2768079|P1|Overall Study|Major Protocol Deviation|6
869702|NCT00996281|2768078|P2|Overall Study|Adverse Event|37
869703|NCT00996281|2768079|P1|Overall Study|Adverse Event|75
869752|NCT00973479|2768189|P2|Overall Study|Not Specified|7
869753|NCT00973479|2768190|P1|Overall Study|Not Specified|1
869754|NCT00973479|2768189|P2|Overall Study|Protocol Violation|2
869755|NCT00973479|2768190|P1|Overall Study|Protocol Violation|2
869756|NCT00973479|2768189|P2|Overall Study|Adverse Event|32
869757|NCT00973479|2768190|P1|Overall Study|Adverse Event|12
869758|NCT00973479|2768189|P2|Overall Study|Lack of Efficacy|7
869759|NCT00973479|2768190|P1|Overall Study|Lack of Efficacy|5
869760|NCT00973479|2768189|P2|Overall Study|Withdrawal by Subject|16
869761|NCT00973479|2768190|P1|Overall Study|Withdrawal by Subject|15
869762|NCT00973479|2768189|P2|Overall Study|Death|2
869763|NCT00973479|2768190|P1|Overall Study|Death|2
869764|NCT00973479|2768189|P2|Overall Study|Lost to Follow-up|3
869765|NCT00973479|2768190|P1|Overall Study|Lost to Follow-up|0
869780|NCT00965458|2768221|P2|Overall Study|Withdrawal by Subject|1
869781|NCT00965458|2768222|P1|Overall Study|Withdrawal by Subject|0
869782|NCT00965458|2768221|P2|Overall Study|Lost to Follow-up|3
869783|NCT00965458|2768222|P1|Overall Study|Lost to Follow-up|1
869784|NCT00965458|2768221|P2|Overall Study|Adverse Event|0
869785|NCT00965458|2768222|P1|Overall Study|Adverse Event|1
869786|NCT00952341|2768240|P2|Cycle 2|Progressive Disease|1
869787|NCT00952341|2768241|P1|Cycle 2|Progressive Disease|0
869788|NCT00952341|2768240|P2|Cycle 2|Physician Decision|1
869789|NCT00952341|2768241|P1|Cycle 2|Physician Decision|1
869790|NCT00952341|2768240|P2|Cycle 2|Lost to Follow-up|9
869791|NCT00952341|2768241|P1|Cycle 2|Lost to Follow-up|6
869792|NCT00952341|2768240|P2|Cycle 2|Protocol Violation|0
869793|NCT00952341|2768241|P1|Cycle 2|Protocol Violation|1
869794|NCT00952341|2768240|P2|Cycle 2|Withdrawal by Subject|1
869795|NCT00952341|2768241|P1|Cycle 2|Withdrawal by Subject|1
869796|NCT00952341|2768240|P2|Cycle 1|Physician Decision|1
869797|NCT00952341|2768241|P1|Cycle 1|Physician Decision|0
869798|NCT00952341|2768240|P2|Cycle 1|Lost to Follow-up|2
869799|NCT00952341|2768241|P1|Cycle 1|Lost to Follow-up|11
869800|NCT00952341|2768240|P2|Cycle 1|Protocol Violation|1
869801|NCT00952341|2768241|P1|Cycle 1|Protocol Violation|2
869802|NCT00952341|2768240|P2|Cycle 1|Withdrawal by Subject|8
869803|NCT00952341|2768241|P1|Cycle 1|Withdrawal by Subject|3
869804|NCT00952341|2768240|P2|Cycle 1|Adverse Event|1
869805|NCT00952341|2768241|P1|Cycle 1|Adverse Event|4
869806|NCT00941330|2768263|P2|Overall Study|Physician Decision|2
869807|NCT00941330|2768264|P1|Overall Study|Physician Decision|0
869808|NCT00941330|2768263|P2|Overall Study|Other|0
869809|NCT00941330|2768264|P1|Overall Study|Other|1
869815|NCT00909870|2768281|P2|Overall Study|Other|5
869816|NCT00909870|2768282|P1|Overall Study|Other|1
869817|NCT00909870|2768281|P2|Overall Study|Physician Decision|2
869818|NCT00909870|2768282|P1|Overall Study|Physician Decision|0
869819|NCT00909870|2768281|P2|Overall Study|Lost to Follow-up|3
869820|NCT00909870|2768282|P1|Overall Study|Lost to Follow-up|3
869821|NCT00909870|2768281|P2|Overall Study|Withdrawal by Subject|8
869822|NCT00909870|2768282|P1|Overall Study|Withdrawal by Subject|5
869823|NCT00909870|2768281|P2|Overall Study|Protocol Violation|2
869824|NCT00909870|2768282|P1|Overall Study|Protocol Violation|1
869825|NCT00909870|2768281|P2|Overall Study|Adverse Event|7
869826|NCT00909870|2768282|P1|Overall Study|Adverse Event|13
869827|NCT00891839|2768310|P1|Overall Study|Disease progression|3
869828|NCT00891839|2768310|P1|Overall Study|Withdrawal by Subject|2
869829|NCT00891839|2768310|P1|Overall Study|Adverse Event|2
869830|NCT00882557|2768332|P2|Overall Study|Randomized Not Treated|1
869831|NCT00882557|2768333|P1|Overall Study|Randomized Not Treated|0
869832|NCT00882557|2768332|P2|Overall Study|Trouble with Vein Access|0
869833|NCT00882557|2768333|P1|Overall Study|Trouble with Vein Access|1
869834|NCT00882557|2768332|P2|Overall Study|Withdrawal by Subject|0
869835|NCT00882557|2768333|P1|Overall Study|Withdrawal by Subject|1
869836|NCT00880698|2768355|P4|Overall Study|Lost to Follow-up|1
869837|NCT00880698|2768356|P3|Overall Study|Lost to Follow-up|0
869838|NCT00880698|2768357|P2|Overall Study|Lost to Follow-up|3
869839|NCT00880698|2768358|P1|Overall Study|Lost to Follow-up|1
869840|NCT00880698|2768355|P4|Overall Study|Death|2
869841|NCT00880698|2768356|P3|Overall Study|Death|1
869842|NCT00880698|2768357|P2|Overall Study|Death|0
869843|NCT00880698|2768358|P1|Overall Study|Death|0
869865|NCT00874120|2768447|P2|Second Intervention|Protocol Violation|0
869866|NCT00874120|2768448|P1|Second Intervention|Protocol Violation|1
869867|NCT00874120|2768447|P2|Second Intervention|Withdrawal by Subject|0
869868|NCT00874120|2768448|P1|Second Intervention|Withdrawal by Subject|1
869869|NCT00874120|2768447|P2|First Intervention|positive drug test|0
869870|NCT00874120|2768448|P1|First Intervention|positive drug test|1
869871|NCT00874120|2768447|P2|First Intervention|Protocol Violation|0
869872|NCT00874120|2768448|P1|First Intervention|Protocol Violation|3
869873|NCT00874120|2768447|P2|First Intervention|Lost to Follow-up|1
869874|NCT00874120|2768448|P1|First Intervention|Lost to Follow-up|0
869875|NCT00874120|2768447|P2|First Intervention|Withdrawal by Subject|0
869876|NCT00874120|2768448|P1|First Intervention|Withdrawal by Subject|2
869877|NCT00874120|2768447|P2|First Intervention|Adverse Event|1
869878|NCT00874120|2768448|P1|First Intervention|Adverse Event|0
869879|NCT00856284|2768476|P3|Overall Study|Randomized in error|1
869880|NCT00856284|2768477|P2|Overall Study|Randomized in error|0
869881|NCT00856284|2768478|P1|Overall Study|Randomized in error|0
869882|NCT00856284|2768476|P3|Overall Study|Other|14
869883|NCT00856284|2768477|P2|Overall Study|Other|17
869884|NCT00856284|2768478|P1|Overall Study|Other|15
869885|NCT00856284|2768476|P3|Overall Study|Investigator discretion|10
869886|NCT00856284|2768477|P2|Overall Study|Investigator discretion|8
869887|NCT00856284|2768478|P1|Overall Study|Investigator discretion|9
869888|NCT00856284|2768476|P3|Overall Study|Pregnancy|0
869889|NCT00856284|2768477|P2|Overall Study|Pregnancy|2
869890|NCT00856284|2768478|P1|Overall Study|Pregnancy|1
869891|NCT00856284|2768476|P3|Overall Study|Voluntary withdrawal|62
869892|NCT00856284|2768477|P2|Overall Study|Voluntary withdrawal|52
869893|NCT00856284|2768478|P1|Overall Study|Voluntary withdrawal|48
869894|NCT00856284|2768476|P3|Overall Study|Lost to Follow-up|28
869895|NCT00856284|2768477|P2|Overall Study|Lost to Follow-up|22
869896|NCT00856284|2768478|P1|Overall Study|Lost to Follow-up|20
869897|NCT00856284|2768476|P3|Overall Study|Major protocol deviation|15
869898|NCT00856284|2768477|P2|Overall Study|Major protocol deviation|16
869899|NCT00856284|2768478|P1|Overall Study|Major protocol deviation|24
869900|NCT00856284|2768476|P3|Overall Study|Adverse Event|82
869901|NCT00856284|2768477|P2|Overall Study|Adverse Event|74
869902|NCT00856284|2768478|P1|Overall Study|Adverse Event|60
869903|NCT00856284|2768476|P3|Overall Study|Hyperglycemic rescue|235
869904|NCT00856284|2768477|P2|Overall Study|Hyperglycemic rescue|201
869905|NCT00856284|2768478|P1|Overall Study|Hyperglycemic rescue|231
869906|NCT00847912|2768506|P2|Overall Study|Withdrawal by Subject|6
869907|NCT00847912|2768507|P1|Overall Study|Withdrawal by Subject|3
869908|NCT00847912|2768506|P2|Overall Study|Protocol Violation|7
869909|NCT00847912|2768507|P1|Overall Study|Protocol Violation|6
869922|NCT00819390|2768540|P4|Overall Study|Adverse Event|0
869923|NCT00819390|2768541|P3|Overall Study|Adverse Event|1
869924|NCT00819390|2768542|P2|Overall Study|Adverse Event|0
869925|NCT00819390|2768543|P1|Overall Study|Adverse Event|0
869926|NCT00819390|2768540|P4|Overall Study|Withdrawal by Subject|0
869927|NCT00819390|2768541|P3|Overall Study|Withdrawal by Subject|0
869928|NCT00819390|2768542|P2|Overall Study|Withdrawal by Subject|0
869929|NCT00819390|2768543|P1|Overall Study|Withdrawal by Subject|2
869930|NCT00819390|2768540|P4|Overall Study|Lost to Follow-up|0
869931|NCT00819390|2768541|P3|Overall Study|Lost to Follow-up|0
869932|NCT00819390|2768542|P2|Overall Study|Lost to Follow-up|1
869933|NCT00819390|2768543|P1|Overall Study|Lost to Follow-up|1
869934|NCT00811928|2768655|P2|Overall Study|Poor Compliance|5
869935|NCT00811928|2768656|P1|Overall Study|Poor Compliance|2
869936|NCT00811928|2768655|P2|Overall Study|Investigator Decision|1
869937|NCT00811928|2768656|P1|Overall Study|Investigator Decision|2
869938|NCT00811928|2768655|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
869939|NCT00811928|2768656|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
869940|NCT00811928|2768655|P2|Overall Study|Did Not Take Study Drug|0
869941|NCT00811928|2768656|P1|Overall Study|Did Not Take Study Drug|3
869942|NCT00811928|2768655|P2|Overall Study|Withdrawal by Subject|12
869943|NCT00811928|2768656|P1|Overall Study|Withdrawal by Subject|18
869944|NCT00811928|2768655|P2|Overall Study|AEs and SAEs Including Death|11
869945|NCT00811928|2768656|P1|Overall Study|AEs and SAEs Including Death|7
869946|NCT00806351|2768687|P2|Overall Study|Death|4
869947|NCT00806351|2768688|P1|Overall Study|Death|5
869948|NCT00804843|2768721|P2|Overall Study|Withdrawal by Subject|2
869949|NCT00804843|2768722|P1|Overall Study|Withdrawal by Subject|1
869950|NCT00804843|2768721|P2|Overall Study|Adverse Event|5
869951|NCT00804843|2768722|P1|Overall Study|Adverse Event|8
869952|NCT00804843|2768721|P2|Overall Study|Protocol Violation|0
869953|NCT00804843|2768722|P1|Overall Study|Protocol Violation|1
869954|NCT00799617|2768743|P2|Anemia Trial|Withdrawal by Subject|3
869955|NCT00799617|2768744|P1|Anemia Trial|Withdrawal by Subject|3
869956|NCT00799617|2768743|P2|Cognitive Function Trial|Lost to Follow-up|1
869957|NCT00799617|2768744|P1|Cognitive Function Trial|Lost to Follow-up|0
869958|NCT00799617|2768743|P2|Bone Trial|Month 12 scan not available|16
869959|NCT00799617|2768744|P1|Bone Trial|Month 12 scan not available|6
869960|NCT00799617|2768743|P2|Cardiovascular Trial|Baseline scan not analyzable|2
869961|NCT00799617|2768744|P1|Cardiovascular Trial|Baseline scan not analyzable|0
869962|NCT00799617|2768743|P2|Cardiovascular Trial|Month 12 scan not available|15
869963|NCT00799617|2768744|P1|Cardiovascular Trial|Month 12 scan not available|15
869964|NCT00799617|2768743|P2|Vitality Trial|Lost to Follow-up|22
869965|NCT00799617|2768744|P1|Vitality Trial|Lost to Follow-up|7
869966|NCT00799617|2768743|P2|Physical Function Trial|Lost to Follow-up|11
869967|NCT00799617|2768744|P1|Physical Function Trial|Lost to Follow-up|6
869968|NCT00799617|2768743|P2|Sexual Funtion Trial|No Baseline Data|7
869969|NCT00799617|2768744|P1|Sexual Funtion Trial|No Baseline Data|4
869970|NCT00799617|2768743|P2|Sexual Funtion Trial|Lost to Follow-up|14
869971|NCT00799617|2768744|P1|Sexual Funtion Trial|Lost to Follow-up|12
869972|NCT00799617|2768743|P2|Main Testosterone Trial|Lost to Follow-up|20
869973|NCT00799617|2768744|P1|Main Testosterone Trial|Lost to Follow-up|18
869974|NCT00799617|2768743|P2|Main Testosterone Trial|Randomized in error|1
869975|NCT00799617|2768744|P1|Main Testosterone Trial|Randomized in error|1
869976|NCT00793780|2768824|P2|Overall Study|Withdrawal by Subject|1
869977|NCT00793780|2768825|P1|Overall Study|Withdrawal by Subject|2
869978|NCT00783263|2768845|P4|Overall Study|Withdrawal by Subject|2
869979|NCT00783263|2768846|P3|Overall Study|Withdrawal by Subject|1
869980|NCT00783263|2768847|P2|Overall Study|Withdrawal by Subject|1
869981|NCT00783263|2768848|P1|Overall Study|Withdrawal by Subject|0
869982|NCT00783263|2768845|P4|Overall Study|Lost to Follow-up|0
869983|NCT00783263|2768846|P3|Overall Study|Lost to Follow-up|0
869984|NCT00783263|2768847|P2|Overall Study|Lost to Follow-up|1
869985|NCT00783263|2768848|P1|Overall Study|Lost to Follow-up|1
869986|NCT00783263|2768845|P4|Overall Study|Adverse Event|1
869987|NCT00783263|2768846|P3|Overall Study|Adverse Event|2
869988|NCT00783263|2768847|P2|Overall Study|Adverse Event|0
869989|NCT00783263|2768848|P1|Overall Study|Adverse Event|3
869990|NCT00771667|2768878|P10|Maintenance Phase|Other|3
869991|NCT00771667|2768879|P9|Maintenance Phase|Other|3
869992|NCT00771667|2768880|P8|Maintenance Phase|Other|2
869993|NCT00771667|2768881|P7|Maintenance Phase|Other|2
869994|NCT00771667|2768882|P6|Maintenance Phase|Other|1
869995|NCT00771667|2768883|P5|Maintenance Phase|Other|0
869996|NCT00771667|2768884|P4|Maintenance Phase|Other|0
869997|NCT00771667|2768885|P3|Maintenance Phase|Other|0
869998|NCT00771667|2768886|P2|Maintenance Phase|Other|0
869999|NCT00771667|2768887|P1|Maintenance Phase|Other|0
870000|NCT00771667|2768878|P10|Maintenance Phase|Lack of Efficacy|7
870001|NCT00771667|2768879|P9|Maintenance Phase|Lack of Efficacy|11
870002|NCT00771667|2768880|P8|Maintenance Phase|Lack of Efficacy|2
870003|NCT00771667|2768881|P7|Maintenance Phase|Lack of Efficacy|3
870004|NCT00771667|2768882|P6|Maintenance Phase|Lack of Efficacy|3
870005|NCT00771667|2768883|P5|Maintenance Phase|Lack of Efficacy|1
870006|NCT00771667|2768884|P4|Maintenance Phase|Lack of Efficacy|0
870007|NCT00771667|2768885|P3|Maintenance Phase|Lack of Efficacy|0
870008|NCT00771667|2768886|P2|Maintenance Phase|Lack of Efficacy|0
870009|NCT00771667|2768887|P1|Maintenance Phase|Lack of Efficacy|0
870010|NCT00771667|2768878|P10|Maintenance Phase|Adverse Event|7
870011|NCT00771667|2768879|P9|Maintenance Phase|Adverse Event|8
870012|NCT00771667|2768880|P8|Maintenance Phase|Adverse Event|1
870013|NCT00771667|2768881|P7|Maintenance Phase|Adverse Event|5
870014|NCT00771667|2768882|P6|Maintenance Phase|Adverse Event|3
870015|NCT00771667|2768883|P5|Maintenance Phase|Adverse Event|1
870016|NCT00771667|2768884|P4|Maintenance Phase|Adverse Event|0
870017|NCT00771667|2768885|P3|Maintenance Phase|Adverse Event|0
870018|NCT00771667|2768886|P2|Maintenance Phase|Adverse Event|0
870019|NCT00771667|2768887|P1|Maintenance Phase|Adverse Event|0
870020|NCT00771667|2768878|P10|Induction Phase|Other|0
870021|NCT00771667|2768879|P9|Induction Phase|Other|0
870022|NCT00771667|2768880|P8|Induction Phase|Other|0
870023|NCT00771667|2768881|P7|Induction Phase|Other|0
870024|NCT00771667|2768882|P6|Induction Phase|Other|0
870025|NCT00771667|2768883|P5|Induction Phase|Other|0
870026|NCT00771667|2768884|P4|Induction Phase|Other|4
870027|NCT00771667|2768885|P3|Induction Phase|Other|3
870028|NCT00771667|2768886|P2|Induction Phase|Other|6
870029|NCT00771667|2768887|P1|Induction Phase|Other|4
870030|NCT00771667|2768878|P10|Induction Phase|Lost to Follow-up|0
870031|NCT00771667|2768879|P9|Induction Phase|Lost to Follow-up|0
870032|NCT00771667|2768880|P8|Induction Phase|Lost to Follow-up|0
870033|NCT00771667|2768881|P7|Induction Phase|Lost to Follow-up|0
870034|NCT00771667|2768882|P6|Induction Phase|Lost to Follow-up|0
870035|NCT00771667|2768883|P5|Induction Phase|Lost to Follow-up|0
870036|NCT00771667|2768884|P4|Induction Phase|Lost to Follow-up|0
870037|NCT00771667|2768885|P3|Induction Phase|Lost to Follow-up|1
870038|NCT00771667|2768886|P2|Induction Phase|Lost to Follow-up|0
870039|NCT00771667|2768887|P1|Induction Phase|Lost to Follow-up|1
870040|NCT00771667|2768878|P10|Induction Phase|Lack of Efficacy|0
870041|NCT00771667|2768879|P9|Induction Phase|Lack of Efficacy|0
870042|NCT00771667|2768880|P8|Induction Phase|Lack of Efficacy|0
870043|NCT00771667|2768881|P7|Induction Phase|Lack of Efficacy|0
870044|NCT00771667|2768882|P6|Induction Phase|Lack of Efficacy|0
870045|NCT00771667|2768883|P5|Induction Phase|Lack of Efficacy|0
870046|NCT00771667|2768884|P4|Induction Phase|Lack of Efficacy|3
870047|NCT00771667|2768885|P3|Induction Phase|Lack of Efficacy|4
870048|NCT00771667|2768886|P2|Induction Phase|Lack of Efficacy|2
870049|NCT00771667|2768887|P1|Induction Phase|Lack of Efficacy|9
870050|NCT00771667|2768878|P10|Induction Phase|Adverse Event|0
870051|NCT00771667|2768879|P9|Induction Phase|Adverse Event|0
870052|NCT00771667|2768880|P8|Induction Phase|Adverse Event|0
870053|NCT00771667|2768881|P7|Induction Phase|Adverse Event|0
870054|NCT00771667|2768882|P6|Induction Phase|Adverse Event|0
870055|NCT00771667|2768883|P5|Induction Phase|Adverse Event|0
870056|NCT00771667|2768884|P4|Induction Phase|Adverse Event|1
870057|NCT00771667|2768885|P3|Induction Phase|Adverse Event|4
870058|NCT00771667|2768886|P2|Induction Phase|Adverse Event|2
870059|NCT00771667|2768887|P1|Induction Phase|Adverse Event|5
870060|NCT00770341|2768926|P3|Overall Study|Not treated|0
870061|NCT00770341|2768927|P2|Overall Study|Not treated|0
870062|NCT00770341|2768928|P1|Overall Study|Not treated|1
870063|NCT00770341|2768926|P3|Overall Study|Not specified|0
870064|NCT00770341|2768927|P2|Overall Study|Not specified|0
870065|NCT00770341|2768928|P1|Overall Study|Not specified|1
870066|NCT00770341|2768926|P3|Overall Study|Lack of Efficacy|1
870067|NCT00770341|2768927|P2|Overall Study|Lack of Efficacy|0
870068|NCT00770341|2768928|P1|Overall Study|Lack of Efficacy|3
870069|NCT00770341|2768926|P3|Overall Study|Laboratory adverse event|0
870070|NCT00770341|2768927|P2|Overall Study|Laboratory adverse event|3
870071|NCT00770341|2768928|P1|Overall Study|Laboratory adverse event|3
870072|NCT00770341|2768926|P3|Overall Study|Clinical Adverse Event|2
870073|NCT00770341|2768927|P2|Overall Study|Clinical Adverse Event|1
870074|NCT00770341|2768928|P1|Overall Study|Clinical Adverse Event|3
870075|NCT00770341|2768926|P3|Overall Study|Withdrawal by Subject|0
870076|NCT00770341|2768927|P2|Overall Study|Withdrawal by Subject|1
870077|NCT00770341|2768928|P1|Overall Study|Withdrawal by Subject|0
870078|NCT00770341|2768926|P3|Overall Study|Did not meet eligibility criteria|0
870079|NCT00770341|2768927|P2|Overall Study|Did not meet eligibility criteria|0
870080|NCT00770341|2768928|P1|Overall Study|Did not meet eligibility criteria|1
870081|NCT00761280|2768954|P2|First Dose to End of Study|Lost to Follow-up|1
870082|NCT00761280|2768955|P1|First Dose to End of Study|Lost to Follow-up|0
870083|NCT00761280|2768954|P2|First Dose to End of Study|Death|0
870084|NCT00761280|2768955|P1|First Dose to End of Study|Death|1
870085|NCT00761280|2768954|P2|First Dose to End of Study|Sponsor decision|2
870086|NCT00761280|2768955|P1|First Dose to End of Study|Sponsor decision|1
870087|NCT00761280|2768954|P2|First Dose to End of Study|Progressive disease|3
870088|NCT00761280|2768955|P1|First Dose to End of Study|Progressive disease|5
870089|NCT00761280|2768954|P2|First Dose to End of Study|End of trial|5
870090|NCT00761280|2768955|P1|First Dose to End of Study|End of trial|5
870091|NCT00761280|2768954|P2|Randomization to First Dose|Other|0
870092|NCT00761280|2768955|P1|Randomization to First Dose|Other|1
870093|NCT00761280|2768954|P2|Randomization to First Dose|Sponsor decision|0
870094|NCT00761280|2768955|P1|Randomization to First Dose|Sponsor decision|1
870095|NCT00761280|2768954|P2|Randomization to First Dose|Withdrawal by Subject|2
870096|NCT00761280|2768955|P1|Randomization to First Dose|Withdrawal by Subject|0
870097|NCT00759109|2768985|P2|Overall Study|Lost during study|0
870098|NCT00759109|2768986|P1|Overall Study|Lost during study|1
870099|NCT00759109|2768985|P2|Overall Study|Participant had a liver transplant|1
870100|NCT00759109|2768986|P1|Overall Study|Participant had a liver transplant|0
870101|NCT00759109|2768985|P2|Overall Study|Participant moved to a different city|1
870102|NCT00759109|2768986|P1|Overall Study|Participant moved to a different city|0
870103|NCT00759109|2768985|P2|Overall Study|HCV RNA negative|0
870104|NCT00759109|2768986|P1|Overall Study|HCV RNA negative|1
870105|NCT00759109|2768985|P2|Overall Study|Started new therapy|6
870106|NCT00759109|2768986|P1|Overall Study|Started new therapy|2
870107|NCT00759109|2768985|P2|Overall Study|Lost to Follow-up|6
870108|NCT00759109|2768986|P1|Overall Study|Lost to Follow-up|4
870109|NCT00759109|2768985|P2|Overall Study|Death|3
870110|NCT00759109|2768986|P1|Overall Study|Death|4
870111|NCT00759109|2768985|P2|Overall Study|Withdrawal by Subject|5
870112|NCT00759109|2768986|P1|Overall Study|Withdrawal by Subject|9
870113|NCT00759109|2768985|P2|Overall Study|Inability to comply|1
870114|NCT00759109|2768986|P1|Overall Study|Inability to comply|1
870115|NCT00759109|2768985|P2|Overall Study|Adverse Event|12
870116|NCT00759109|2768986|P1|Overall Study|Adverse Event|17
870117|NCT00756938|2769005|P4|Optional Extension|Adverse Event|1
870118|NCT00756938|2769006|P3|Optional Extension|Adverse Event|0
870119|NCT00756938|2769007|P2|Optional Extension|Adverse Event|0
870120|NCT00756938|2769008|P1|Optional Extension|Adverse Event|0
870121|NCT00756938|2769005|P4|Optional Extension|Withdrawal by Subject|10
870122|NCT00756938|2769006|P3|Optional Extension|Withdrawal by Subject|0
870123|NCT00756938|2769007|P2|Optional Extension|Withdrawal by Subject|0
870124|NCT00756938|2769008|P1|Optional Extension|Withdrawal by Subject|0
870125|NCT00756938|2769005|P4|Optional Extension|Protocol Violation|1
870126|NCT00756938|2769006|P3|Optional Extension|Protocol Violation|0
870127|NCT00756938|2769007|P2|Optional Extension|Protocol Violation|0
870128|NCT00756938|2769008|P1|Optional Extension|Protocol Violation|0
870129|NCT00756938|2769005|P4|Optional Extension|Lost to Follow-up|1
870130|NCT00756938|2769006|P3|Optional Extension|Lost to Follow-up|0
870131|NCT00756938|2769007|P2|Optional Extension|Lost to Follow-up|0
870132|NCT00756938|2769008|P1|Optional Extension|Lost to Follow-up|0
870133|NCT00756938|2769005|P4|Optional Extension|Physician Decision|3
870134|NCT00756938|2769006|P3|Optional Extension|Physician Decision|0
870135|NCT00756938|2769007|P2|Optional Extension|Physician Decision|0
870136|NCT00756938|2769008|P1|Optional Extension|Physician Decision|0
870137|NCT00756938|2769005|P4|Optional Extension|Protocol-specific criteria met|9
870138|NCT00756938|2769006|P3|Optional Extension|Protocol-specific criteria met|0
870139|NCT00756938|2769007|P2|Optional Extension|Protocol-specific criteria met|0
870140|NCT00756938|2769008|P1|Optional Extension|Protocol-specific criteria met|0
870141|NCT00756938|2769005|P4|Optional Extension|End of Study|11
870142|NCT00756938|2769006|P3|Optional Extension|End of Study|0
870143|NCT00756938|2769007|P2|Optional Extension|End of Study|0
870144|NCT00756938|2769008|P1|Optional Extension|End of Study|0
870145|NCT00756938|2769005|P4|Optional Extension|Lack of Efficacy|1
870146|NCT00756938|2769006|P3|Optional Extension|Lack of Efficacy|0
870147|NCT00756938|2769007|P2|Optional Extension|Lack of Efficacy|0
870148|NCT00756938|2769008|P1|Optional Extension|Lack of Efficacy|0
870149|NCT00756938|2769005|P4|12-week Base Study|Lost to Follow-up|0
870150|NCT00756938|2769006|P3|12-week Base Study|Lost to Follow-up|0
870151|NCT00756938|2769007|P2|12-week Base Study|Lost to Follow-up|0
870152|NCT00756938|2769008|P1|12-week Base Study|Lost to Follow-up|1
870153|NCT00756938|2769005|P4|12-week Base Study|Protocol Violation|0
870154|NCT00756938|2769006|P3|12-week Base Study|Protocol Violation|1
870155|NCT00756938|2769007|P2|12-week Base Study|Protocol Violation|0
870156|NCT00756938|2769008|P1|12-week Base Study|Protocol Violation|0
870157|NCT00756938|2769005|P4|12-week Base Study|Protocol-specific Criteria Met|0
870158|NCT00756938|2769006|P3|12-week Base Study|Protocol-specific Criteria Met|1
870159|NCT00756938|2769007|P2|12-week Base Study|Protocol-specific Criteria Met|0
870160|NCT00756938|2769008|P1|12-week Base Study|Protocol-specific Criteria Met|1
870161|NCT00755716|2769037|P3|Overall Study|work schedule issues|1
870162|NCT00755716|2769038|P2|Overall Study|work schedule issues|1
870163|NCT00755716|2769039|P1|Overall Study|work schedule issues|0
870164|NCT00755716|2769037|P3|Overall Study|Lost to Follow-up|1
870165|NCT00755716|2769038|P2|Overall Study|Lost to Follow-up|3
870166|NCT00755716|2769039|P1|Overall Study|Lost to Follow-up|5
870167|NCT00755716|2769037|P3|Overall Study|Lack of Efficacy|0
870168|NCT00755716|2769038|P2|Overall Study|Lack of Efficacy|0
870169|NCT00755716|2769039|P1|Overall Study|Lack of Efficacy|2
870170|NCT00755716|2769037|P3|Overall Study|Adverse Event|1
870171|NCT00755716|2769038|P2|Overall Study|Adverse Event|4
870172|NCT00755716|2769039|P1|Overall Study|Adverse Event|1
870173|NCT00752089|2769050|P1|Overall Study|Cannot continue the study|1
870174|NCT00752089|2769050|P1|Overall Study|Not capable of wearing partial denture|1
870175|NCT00752089|2769050|P1|Overall Study|Could not attend visit 9|1
870176|NCT00752089|2769050|P1|Overall Study|Protocol Deviation|2
870177|NCT00752089|2769050|P1|Overall Study|Adverse Event|1
870178|NCT00745823|2769066|P2|Overall Study|Study Terminated by Sponsor|349
870179|NCT00745823|2769067|P1|Overall Study|Study Terminated by Sponsor|326
870180|NCT00745823|2769066|P2|Overall Study|Withdrawal by Subject|8
870181|NCT00745823|2769067|P1|Overall Study|Withdrawal by Subject|14
870182|NCT00745823|2769066|P2|Overall Study|Pregnancy|4
870183|NCT00745823|2769067|P1|Overall Study|Pregnancy|0
870184|NCT00745823|2769066|P2|Overall Study|Physician Decision|5
870185|NCT00745823|2769067|P1|Overall Study|Physician Decision|10
870186|NCT00745823|2769066|P2|Overall Study|Lost to Follow-up|11
870187|NCT00745823|2769067|P1|Overall Study|Lost to Follow-up|10
870188|NCT00745823|2769066|P2|Overall Study|Lack of Efficacy|6
870189|NCT00745823|2769067|P1|Overall Study|Lack of Efficacy|20
870190|NCT00745823|2769066|P2|Overall Study|Adverse Event|3
870191|NCT00745823|2769067|P1|Overall Study|Adverse Event|5
870192|NCT00737672|2769110|P2|Overall Study|Physician Decision|2
870193|NCT00737672|2769111|P1|Overall Study|Physician Decision|0
870194|NCT00737672|2769110|P2|Overall Study|Miscellaneous|1
870195|NCT00737672|2769111|P1|Overall Study|Miscellaneous|7
870196|NCT00737672|2769110|P2|Overall Study|Lost to Follow-up|0
870197|NCT00737672|2769111|P1|Overall Study|Lost to Follow-up|1
870198|NCT00737672|2769110|P2|Overall Study|Withdrawal by Subject|2
870199|NCT00737672|2769111|P1|Overall Study|Withdrawal by Subject|1
870200|NCT00737672|2769110|P2|Overall Study|Death|22
870201|NCT00737672|2769111|P1|Overall Study|Death|23
870202|NCT00737672|2769110|P2|Overall Study|Graft Abandonment|56
870203|NCT00737672|2769111|P1|Overall Study|Graft Abandonment|48
870204|NCT00734539|2769149|P2|Main Study|Enrolled in error; ineligible|0
870205|NCT00734539|2769150|P1|Main Study|Enrolled in error; ineligible|1
870206|NCT00734539|2769149|P2|Main Study|Withdrawal by Subject|3
870207|NCT00734539|2769150|P1|Main Study|Withdrawal by Subject|1
870208|NCT00734539|2769149|P2|Main Study|Physician Decision|0
870209|NCT00734539|2769150|P1|Main Study|Physician Decision|2
870210|NCT00734539|2769149|P2|Main Study|Death|32
870211|NCT00734539|2769150|P1|Main Study|Death|33
870226|NCT00708123|2769201|P5|Period 4|Protocol Violation|0
870227|NCT00708123|2769202|P4|Period 4|Protocol Violation|0
870228|NCT00708123|2769203|P3|Period 4|Protocol Violation|0
870229|NCT00708123|2769204|P2|Period 4|Protocol Violation|1
870230|NCT00708123|2769205|P1|Period 4|Protocol Violation|0
870231|NCT00708123|2769201|P5|Period 3|Lost to Follow-up|0
870232|NCT00708123|2769202|P4|Period 3|Lost to Follow-up|1
870233|NCT00708123|2769203|P3|Period 3|Lost to Follow-up|1
870234|NCT00708123|2769204|P2|Period 3|Lost to Follow-up|0
870235|NCT00708123|2769205|P1|Period 3|Lost to Follow-up|0
870236|NCT00708123|2769201|P5|Period 2|Other Reason|0
870237|NCT00708123|2769202|P4|Period 2|Other Reason|0
870238|NCT00708123|2769203|P3|Period 2|Other Reason|0
870239|NCT00708123|2769204|P2|Period 2|Other Reason|0
870240|NCT00708123|2769205|P1|Period 2|Other Reason|1
870241|NCT00708123|2769201|P5|Period 2|Protocol Violation|0
870242|NCT00708123|2769202|P4|Period 2|Protocol Violation|1
870243|NCT00708123|2769203|P3|Period 2|Protocol Violation|0
870244|NCT00708123|2769204|P2|Period 2|Protocol Violation|0
870245|NCT00708123|2769205|P1|Period 2|Protocol Violation|0
870246|NCT00708123|2769201|P5|Period 1|Adverse Event|0
870247|NCT00708123|2769202|P4|Period 1|Adverse Event|0
870248|NCT00708123|2769203|P3|Period 1|Adverse Event|1
870249|NCT00708123|2769204|P2|Period 1|Adverse Event|0
870250|NCT00708123|2769205|P1|Period 1|Adverse Event|0
870251|NCT00708123|2769201|P5|Period 1|Protocol Violation|0
870252|NCT00708123|2769202|P4|Period 1|Protocol Violation|1
870253|NCT00708123|2769203|P3|Period 1|Protocol Violation|0
870254|NCT00708123|2769204|P2|Period 1|Protocol Violation|1
870255|NCT00708123|2769205|P1|Period 1|Protocol Violation|0
870256|NCT00708097|2769225|P5|Period 2|Protocol Violation|0
870257|NCT00708097|2769226|P4|Period 2|Protocol Violation|1
870258|NCT00708097|2769227|P3|Period 2|Protocol Violation|1
870259|NCT00708097|2769228|P2|Period 2|Protocol Violation|1
870260|NCT00708097|2769229|P1|Period 2|Protocol Violation|0
870261|NCT00708097|2769225|P5|Period 1|Other Reason|1
870262|NCT00708097|2769226|P4|Period 1|Other Reason|0
870263|NCT00708097|2769227|P3|Period 1|Other Reason|0
870264|NCT00708097|2769228|P2|Period 1|Other Reason|0
870265|NCT00708097|2769229|P1|Period 1|Other Reason|0
870266|NCT00708097|2769225|P5|Period 1|Protocol Violation|0
870267|NCT00708097|2769226|P4|Period 1|Protocol Violation|2
870268|NCT00708097|2769227|P3|Period 1|Protocol Violation|0
870269|NCT00708097|2769228|P2|Period 1|Protocol Violation|1
870270|NCT00708097|2769229|P1|Period 1|Protocol Violation|0
870271|NCT00708305|2769259|P4|Period 3|Other Reason|0
870272|NCT00708305|2769260|P3|Period 3|Other Reason|0
870273|NCT00708305|2769261|P2|Period 3|Other Reason|0
870274|NCT00708305|2769262|P1|Period 3|Other Reason|1
870275|NCT00708305|2769259|P4|Period 3|Protocol Violation|0
870276|NCT00708305|2769260|P3|Period 3|Protocol Violation|0
870277|NCT00708305|2769261|P2|Period 3|Protocol Violation|2
870278|NCT00708305|2769262|P1|Period 3|Protocol Violation|0
870279|NCT00708305|2769259|P4|Period 2|Other Reason|1
870280|NCT00708305|2769260|P3|Period 2|Other Reason|0
870281|NCT00708305|2769261|P2|Period 2|Other Reason|0
870282|NCT00708305|2769262|P1|Period 2|Other Reason|1
870283|NCT00708305|2769259|P4|Period 2|Protocol Violation|0
870284|NCT00708305|2769260|P3|Period 2|Protocol Violation|0
870285|NCT00708305|2769261|P2|Period 2|Protocol Violation|1
870286|NCT00708305|2769262|P1|Period 2|Protocol Violation|0
870287|NCT00708305|2769259|P4|Period 2|Lost to Follow-up|0
870288|NCT00708305|2769260|P3|Period 2|Lost to Follow-up|0
870289|NCT00708305|2769261|P2|Period 2|Lost to Follow-up|1
870290|NCT00708305|2769262|P1|Period 2|Lost to Follow-up|0
870291|NCT00708305|2769259|P4|Period 1|Other Reason|2
870292|NCT00708305|2769260|P3|Period 1|Other Reason|0
870293|NCT00708305|2769261|P2|Period 1|Other Reason|0
870294|NCT00708305|2769262|P1|Period 1|Other Reason|0
870295|NCT00708305|2769259|P4|Period 1|Protocol Violation|0
870296|NCT00708305|2769260|P3|Period 1|Protocol Violation|1
870297|NCT00708305|2769261|P2|Period 1|Protocol Violation|0
870298|NCT00708305|2769262|P1|Period 1|Protocol Violation|1
870299|NCT00705783|2769345|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
870300|NCT00705783|2769346|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
870301|NCT00705783|2769347|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
870302|NCT00705783|2769345|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
870303|NCT00705783|2769346|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
870304|NCT00705783|2769347|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
870305|NCT00705783|2769345|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
870306|NCT00705783|2769346|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
870307|NCT00705783|2769347|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
870308|NCT00705783|2769345|P3|Depot Maintenance Phase|Protocol Deviation|0
870309|NCT00705783|2769346|P2|Depot Maintenance Phase|Protocol Deviation|2
870310|NCT00705783|2769347|P1|Depot Maintenance Phase|Protocol Deviation|0
870311|NCT00705783|2769345|P3|Depot Maintenance Phase|Withdrew Consent|4
870312|NCT00705783|2769346|P2|Depot Maintenance Phase|Withdrew Consent|14
870313|NCT00705783|2769347|P1|Depot Maintenance Phase|Withdrew Consent|0
870314|NCT00705783|2769345|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
870315|NCT00705783|2769346|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
870316|NCT00705783|2769347|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
870317|NCT00705783|2769345|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
870318|NCT00705783|2769346|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
870319|NCT00705783|2769347|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
870320|NCT00705783|2769345|P3|Depot Maintenance Phase|Lost to Follow-up|3
870321|NCT00705783|2769346|P2|Depot Maintenance Phase|Lost to Follow-up|5
870322|NCT00705783|2769347|P1|Depot Maintenance Phase|Lost to Follow-up|0
870323|NCT00705783|2769345|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
870324|NCT00705783|2769346|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
870325|NCT00705783|2769347|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
870326|NCT00705783|2769345|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
870327|NCT00705783|2769346|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
870328|NCT00705783|2769347|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
870329|NCT00705783|2769345|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
870330|NCT00705783|2769346|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
870331|NCT00705783|2769347|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
870332|NCT00705783|2769345|P3|Depot Stabilization Phase|Adverse Event|0
870333|NCT00705783|2769346|P2|Depot Stabilization Phase|Adverse Event|0
870334|NCT00705783|2769347|P1|Depot Stabilization Phase|Adverse Event|17
870335|NCT00705783|2769345|P3|Depot Stabilization Phase|Withdrew Consent|0
870336|NCT00705783|2769346|P2|Depot Stabilization Phase|Withdrew Consent|0
870337|NCT00705783|2769347|P1|Depot Stabilization Phase|Withdrew Consent|29
870338|NCT00705783|2769345|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
870339|NCT00705783|2769346|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
870340|NCT00705783|2769347|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
870341|NCT00705783|2769345|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
870342|NCT00705783|2769346|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
870343|NCT00705783|2769347|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
870344|NCT00705783|2769345|P3|Depot Stabilization Phase|Lost to Follow-up|0
870345|NCT00705783|2769346|P2|Depot Stabilization Phase|Lost to Follow-up|0
870346|NCT00705783|2769347|P1|Depot Stabilization Phase|Lost to Follow-up|11
870347|NCT00705783|2769345|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
870348|NCT00705783|2769346|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
870349|NCT00705783|2769347|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
870350|NCT00705783|2769345|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
870351|NCT00705783|2769346|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
870352|NCT00705783|2769347|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
870353|NCT00705783|2769345|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
870354|NCT00705783|2769346|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
870355|NCT00705783|2769347|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
870356|NCT00705783|2769345|P3|Oral Stabilization Phase|Adverse Event|0
870357|NCT00705783|2769346|P2|Oral Stabilization Phase|Adverse Event|0
870358|NCT00705783|2769347|P1|Oral Stabilization Phase|Adverse Event|14
870359|NCT00705783|2769345|P3|Oral Stabilization Phase|Withdrew Consent|0
870360|NCT00705783|2769346|P2|Oral Stabilization Phase|Withdrew Consent|0
870361|NCT00705783|2769347|P1|Oral Stabilization Phase|Withdrew Consent|29
870362|NCT00705783|2769345|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
870363|NCT00705783|2769346|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
870364|NCT00705783|2769347|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
870365|NCT00705783|2769345|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
870366|NCT00705783|2769346|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
870367|NCT00705783|2769347|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
870368|NCT00705783|2769345|P3|Oral Stabilization Phase|Lost to Follow-up|0
870369|NCT00705783|2769346|P2|Oral Stabilization Phase|Lost to Follow-up|0
870370|NCT00705783|2769347|P1|Oral Stabilization Phase|Lost to Follow-up|7
870371|NCT00705783|2769345|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
870372|NCT00705783|2769346|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
870373|NCT00705783|2769347|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
870374|NCT00705783|2769345|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
870375|NCT00705783|2769346|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
870376|NCT00705783|2769347|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
870377|NCT00705783|2769345|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
870378|NCT00705783|2769346|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
870379|NCT00705783|2769347|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
870380|NCT00705783|2769345|P3|Conversion Phase|Adverse Event|0
870381|NCT00705783|2769346|P2|Conversion Phase|Adverse Event|0
870382|NCT00705783|2769347|P1|Conversion Phase|Adverse Event|11
870383|NCT00705783|2769345|P3|Conversion Phase|Protocol Deviation|0
870384|NCT00705783|2769346|P2|Conversion Phase|Protocol Deviation|0
870385|NCT00705783|2769347|P1|Conversion Phase|Protocol Deviation|2
870386|NCT00705783|2769345|P3|Conversion Phase|Withdrew Consent|0
870387|NCT00705783|2769346|P2|Conversion Phase|Withdrew Consent|0
870388|NCT00705783|2769347|P1|Conversion Phase|Withdrew Consent|24
870389|NCT00705783|2769345|P3|Conversion Phase|Withdrawn by Investigator|0
870390|NCT00705783|2769346|P2|Conversion Phase|Withdrawn by Investigator|0
870391|NCT00705783|2769347|P1|Conversion Phase|Withdrawn by Investigator|4
870392|NCT00705783|2769345|P3|Conversion Phase|Met Withdrawal Criteria|0
870393|NCT00705783|2769346|P2|Conversion Phase|Met Withdrawal Criteria|0
870394|NCT00705783|2769347|P1|Conversion Phase|Met Withdrawal Criteria|4
870395|NCT00705783|2769345|P3|Conversion Phase|Lost to Follow-up|0
870396|NCT00705783|2769346|P2|Conversion Phase|Lost to Follow-up|0
870397|NCT00705783|2769347|P1|Conversion Phase|Lost to Follow-up|13
870398|NCT00705783|2769345|P3|Conversion Phase|Sponsor Discontinued Study|0
870399|NCT00705783|2769346|P2|Conversion Phase|Sponsor Discontinued Study|0
870400|NCT00705783|2769347|P1|Conversion Phase|Sponsor Discontinued Study|54
870401|NCT00700635|2769377|P3|Overall Study|Withdrawal by Subject|1
870402|NCT00700635|2769378|P2|Overall Study|Withdrawal by Subject|3
870403|NCT00700635|2769379|P1|Overall Study|Withdrawal by Subject|7
870404|NCT00700635|2769377|P3|Overall Study|Protocol Violation|0
870405|NCT00700635|2769378|P2|Overall Study|Protocol Violation|2
870406|NCT00700635|2769379|P1|Overall Study|Protocol Violation|2
870407|NCT00700635|2769377|P3|Overall Study|Lost to Follow-up|0
870408|NCT00700635|2769378|P2|Overall Study|Lost to Follow-up|3
870409|NCT00700635|2769379|P1|Overall Study|Lost to Follow-up|1
870410|NCT00700635|2769377|P3|Overall Study|Adverse Event|0
870411|NCT00700635|2769378|P2|Overall Study|Adverse Event|0
870412|NCT00700635|2769379|P1|Overall Study|Adverse Event|1
870413|NCT00686725|2769401|P2|Overall Study|Not Specified|3
870414|NCT00686725|2769402|P1|Overall Study|Not Specified|1
870415|NCT00686725|2769401|P2|Overall Study|Protocol Violation|3
870416|NCT00686725|2769402|P1|Overall Study|Protocol Violation|1
870417|NCT00686725|2769401|P2|Overall Study|Withdrawal by Subject|4
870418|NCT00686725|2769402|P1|Overall Study|Withdrawal by Subject|13
870419|NCT00686725|2769401|P2|Overall Study|Death|3
870420|NCT00686725|2769402|P1|Overall Study|Death|6
870421|NCT00686725|2769401|P2|Overall Study|Lost to Follow-up|5
870422|NCT00686725|2769402|P1|Overall Study|Lost to Follow-up|7
870423|NCT00686725|2769401|P2|Overall Study|Progressive Disease|23
870424|NCT00686725|2769402|P1|Overall Study|Progressive Disease|17
870425|NCT00686725|2769401|P2|Overall Study|Adverse Event|1
870426|NCT00686725|2769402|P1|Overall Study|Adverse Event|1
870427|NCT00674362|2769448|P2|Open Label|Other: Subject moved to extension study|0
870428|NCT00674362|2769449|P1|Open Label|Other: Subject moved to extension study|1
870429|NCT00674362|2769448|P2|Open Label|Adverse Event|0
870430|NCT00674362|2769449|P1|Open Label|Adverse Event|1
870431|NCT00674362|2769448|P2|Double Blind|Other: Surgery|1
870432|NCT00674362|2769449|P1|Double Blind|Other: Surgery|0
870433|NCT00674362|2769448|P2|Double Blind|Other: Loss of Patient Compliance|1
870434|NCT00674362|2769449|P1|Double Blind|Other: Loss of Patient Compliance|0
870435|NCT00674362|2769448|P2|Double Blind|Withdrawal by Subject|3
870436|NCT00674362|2769449|P1|Double Blind|Withdrawal by Subject|4
870437|NCT00674362|2769448|P2|Double Blind|Loss of efficacy|1
870438|NCT00674362|2769449|P1|Double Blind|Loss of efficacy|0
870439|NCT00674362|2769448|P2|Double Blind|Lack of Efficacy|6
870440|NCT00674362|2769449|P1|Double Blind|Lack of Efficacy|2
870441|NCT00674362|2769448|P2|Double Blind|Adverse Event|6
870442|NCT00674362|2769449|P1|Double Blind|Adverse Event|6
870471|NCT00645944|2769565|P2|Received Medication|Protocol Violation|1
870472|NCT00645944|2769566|P1|Received Medication|Protocol Violation|2
870473|NCT00645944|2769565|P2|Received Medication|Lost to Follow-up|0
870474|NCT00645944|2769566|P1|Received Medication|Lost to Follow-up|1
870475|NCT00645944|2769565|P2|Received Medication|Withdrawal by Subject|1
870476|NCT00645944|2769566|P1|Received Medication|Withdrawal by Subject|1
870477|NCT00645944|2769565|P2|Received Medication|Adverse Event|1
870478|NCT00645944|2769566|P1|Received Medication|Adverse Event|2
870479|NCT00645944|2769565|P2|Randomized|Withdrawal by Subject|2
870480|NCT00645944|2769566|P1|Randomized|Withdrawal by Subject|1
870485|NCT00643565|2769595|P2|Overall Study|Lost to Follow-up|0
870486|NCT00643565|2769596|P1|Overall Study|Lost to Follow-up|2
870487|NCT00643565|2769595|P2|Overall Study|Withdrawal by Subject|1
870488|NCT00643565|2769596|P1|Overall Study|Withdrawal by Subject|2
870489|NCT00643565|2769595|P2|Overall Study|Ongoing in Follow-up|39
870490|NCT00643565|2769596|P1|Overall Study|Ongoing in Follow-up|39
870491|NCT00643565|2769595|P2|Overall Study|Death|34
870492|NCT00643565|2769596|P1|Overall Study|Death|37
870493|NCT00623766|2769620|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
870494|NCT00623766|2769621|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
870495|NCT00623766|2769620|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
870496|NCT00623766|2769621|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
870497|NCT00623766|2769620|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
870498|NCT00623766|2769621|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
870499|NCT00623766|2769620|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
870500|NCT00623766|2769621|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
870501|NCT00623766|2769620|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
870502|NCT00623766|2769621|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
870503|NCT00611130|2769674|P2|Overall Study|Death|0
870504|NCT00611130|2769675|P1|Overall Study|Death|1
870505|NCT00611130|2769674|P2|Overall Study|Adverse Event|0
870506|NCT00611130|2769675|P1|Overall Study|Adverse Event|1
870507|NCT00611130|2769674|P2|Overall Study|Administrative|1
870508|NCT00611130|2769675|P1|Overall Study|Administrative|1
870509|NCT00611130|2769674|P2|Overall Study|Incarceration|2
870510|NCT00611130|2769675|P1|Overall Study|Incarceration|3
870511|NCT00611130|2769674|P2|Overall Study|Other|4
870512|NCT00611130|2769675|P1|Overall Study|Other|5
870513|NCT00611130|2769674|P2|Overall Study|Withdrawal by Subject|5
870514|NCT00611130|2769675|P1|Overall Study|Withdrawal by Subject|6
870515|NCT00611130|2769674|P2|Overall Study|Protocol noncompliance|6
870516|NCT00611130|2769675|P1|Overall Study|Protocol noncompliance|7
870517|NCT00611130|2769674|P2|Overall Study|Lost to Follow-up|29
870518|NCT00611130|2769675|P1|Overall Study|Lost to Follow-up|25
870519|NCT00604175|2769700|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
870520|NCT00604175|2769701|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
870521|NCT00604175|2769702|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
870522|NCT00604175|2769700|P3|Week 29 Through Week 72|Site closure|0
870523|NCT00604175|2769701|P2|Week 29 Through Week 72|Site closure|1
870524|NCT00604175|2769702|P1|Week 29 Through Week 72|Site closure|0
870525|NCT00604175|2769700|P3|Week 29 Through Week 72|Lost to Follow-up|2
870526|NCT00604175|2769701|P2|Week 29 Through Week 72|Lost to Follow-up|6
870527|NCT00604175|2769702|P1|Week 29 Through Week 72|Lost to Follow-up|12
870528|NCT00604175|2769700|P3|Week 29 Through Week 72|Death|1
870529|NCT00604175|2769701|P2|Week 29 Through Week 72|Death|0
870530|NCT00604175|2769702|P1|Week 29 Through Week 72|Death|0
870531|NCT00604175|2769700|P3|Entry Through Week 28|Did not start intervention|1
870532|NCT00604175|2769701|P2|Entry Through Week 28|Did not start intervention|0
870533|NCT00604175|2769702|P1|Entry Through Week 28|Did not start intervention|2
870534|NCT00604175|2769700|P3|Entry Through Week 28|Ineligible|0
870535|NCT00604175|2769701|P2|Entry Through Week 28|Ineligible|0
870536|NCT00604175|2769702|P1|Entry Through Week 28|Ineligible|1
870537|NCT00604175|2769700|P3|Entry Through Week 28|Lost to Follow-up|0
870538|NCT00604175|2769701|P2|Entry Through Week 28|Lost to Follow-up|3
870539|NCT00604175|2769702|P1|Entry Through Week 28|Lost to Follow-up|4
870540|NCT00604175|2769700|P3|Entry Through Week 28|Withdrawal by Subject|0
870541|NCT00604175|2769701|P2|Entry Through Week 28|Withdrawal by Subject|0
870542|NCT00604175|2769702|P1|Entry Through Week 28|Withdrawal by Subject|1
870543|NCT00604175|2769700|P3|Entry Through Week 28|Death|0
870544|NCT00604175|2769701|P2|Entry Through Week 28|Death|0
870545|NCT00604175|2769702|P1|Entry Through Week 28|Death|2
870546|NCT00582790|2769791|P1|Overall Study|Rapid progression of disease|1
870547|NCT00582010|2769800|P2|Overall Study|Death|1
870548|NCT00582010|2769801|P1|Overall Study|Death|0
870549|NCT00580606|2769825|P2|Open Label (OL)|Needed Prohibited Medication|1
870550|NCT00580606|2769826|P1|Open Label (OL)|Needed Prohibited Medication|0
870551|NCT00580606|2769825|P2|Open Label (OL)|Physician Decision|1
870552|NCT00580606|2769826|P1|Open Label (OL)|Physician Decision|1
870553|NCT00580606|2769825|P2|Open Label (OL)|Non-compliance|0
870554|NCT00580606|2769826|P1|Open Label (OL)|Non-compliance|2
870555|NCT00580606|2769825|P2|Open Label (OL)|Pregnancy|1
870556|NCT00580606|2769826|P1|Open Label (OL)|Pregnancy|0
870557|NCT00580606|2769825|P2|Open Label (OL)|Lost to Follow-up|1
870558|NCT00580606|2769826|P1|Open Label (OL)|Lost to Follow-up|0
870559|NCT00580606|2769825|P2|Open Label (OL)|Dosing Symptoms|1
870560|NCT00580606|2769826|P1|Open Label (OL)|Dosing Symptoms|0
870561|NCT00580606|2769825|P2|Open Label (OL)|Withdrawal by Subject|6
870562|NCT00580606|2769826|P1|Open Label (OL)|Withdrawal by Subject|4
870563|NCT00580606|2769825|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
870564|NCT00580606|2769826|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
870565|NCT00578448|2769844|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
870566|NCT00578448|2769844|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
870567|NCT00578448|2769844|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
870568|NCT00578448|2769844|P1|Day 1 up to 3 Years of Planned Study|Death|1
870575|NCT00555321|2769893|P5|Long-term Extension Phase|Other Reason|0
870576|NCT00555321|2769894|P4|Long-term Extension Phase|Other Reason|0
870577|NCT00555321|2769895|P3|Long-term Extension Phase|Other Reason|2
870578|NCT00555321|2769896|P2|Long-term Extension Phase|Other Reason|0
870579|NCT00555321|2769897|P1|Long-term Extension Phase|Other Reason|1
870580|NCT00555321|2769893|P5|Long-term Extension Phase|Participant did not meet study criteria|1
870581|NCT00555321|2769894|P4|Long-term Extension Phase|Participant did not meet study criteria|0
870582|NCT00555321|2769895|P3|Long-term Extension Phase|Participant did not meet study criteria|0
870583|NCT00555321|2769896|P2|Long-term Extension Phase|Participant did not meet study criteria|0
870584|NCT00555321|2769897|P1|Long-term Extension Phase|Participant did not meet study criteria|0
870585|NCT00555321|2769893|P5|Long-term Extension Phase|Death|0
870586|NCT00555321|2769894|P4|Long-term Extension Phase|Death|3
870587|NCT00555321|2769895|P3|Long-term Extension Phase|Death|0
870588|NCT00555321|2769896|P2|Long-term Extension Phase|Death|0
870589|NCT00555321|2769897|P1|Long-term Extension Phase|Death|2
870590|NCT00555321|2769893|P5|Long-term Extension Phase|Administrative reason by sponsor|23
870591|NCT00555321|2769894|P4|Long-term Extension Phase|Administrative reason by sponsor|31
870592|NCT00555321|2769895|P3|Long-term Extension Phase|Administrative reason by sponsor|18
870593|NCT00555321|2769896|P2|Long-term Extension Phase|Administrative reason by sponsor|21
870594|NCT00555321|2769897|P1|Long-term Extension Phase|Administrative reason by sponsor|23
870595|NCT00555321|2769893|P5|Long-term Extension Phase|Withdrawal by Subject|2
870596|NCT00555321|2769894|P4|Long-term Extension Phase|Withdrawal by Subject|3
870597|NCT00555321|2769895|P3|Long-term Extension Phase|Withdrawal by Subject|2
870598|NCT00555321|2769896|P2|Long-term Extension Phase|Withdrawal by Subject|1
870599|NCT00555321|2769897|P1|Long-term Extension Phase|Withdrawal by Subject|2
870600|NCT00555321|2769893|P5|Long-term Extension Phase|Adverse Event|0
870601|NCT00555321|2769894|P4|Long-term Extension Phase|Adverse Event|1
870602|NCT00555321|2769895|P3|Long-term Extension Phase|Adverse Event|2
870603|NCT00555321|2769896|P2|Long-term Extension Phase|Adverse Event|5
870604|NCT00555321|2769897|P1|Long-term Extension Phase|Adverse Event|2
870605|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Never treated|4
870606|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Never treated|0
870607|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Never treated|1
870608|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Never treated|3
870609|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Never treated|2
870610|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Other Reason|0
870611|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Other Reason|0
870612|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Other Reason|2
870613|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Other Reason|3
870614|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Other Reason|1
870615|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
870616|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
870617|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
870618|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
870619|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
870620|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Death|0
870621|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Death|0
870622|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Death|4
870623|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Death|1
870624|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Death|2
870625|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
870626|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
870627|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
870628|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
870629|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
870630|NCT00555321|2769893|P5|Treatment Phase up to 12-months|Adverse Event|18
870631|NCT00555321|2769894|P4|Treatment Phase up to 12-months|Adverse Event|7
870632|NCT00555321|2769895|P3|Treatment Phase up to 12-months|Adverse Event|11
870633|NCT00555321|2769896|P2|Treatment Phase up to 12-months|Adverse Event|7
870634|NCT00555321|2769897|P1|Treatment Phase up to 12-months|Adverse Event|6
870635|NCT00552032|2770201|P2|Overall Study|Lost to Follow-up|5
870636|NCT00552032|2770202|P1|Overall Study|Lost to Follow-up|8
870637|NCT00552032|2770201|P2|Overall Study|Protocol Violation|12
870638|NCT00552032|2770202|P1|Overall Study|Protocol Violation|7
870639|NCT00552032|2770201|P2|Overall Study|Withdrawal by Subject|2
870640|NCT00552032|2770202|P1|Overall Study|Withdrawal by Subject|2
870641|NCT00550459|2770259|P2|Overall Study|Withdrawal by Subject|1
870642|NCT00550459|2770260|P1|Overall Study|Withdrawal by Subject|1
870643|NCT00550459|2770259|P2|Overall Study|Adverse Event|2
870644|NCT00550459|2770260|P1|Overall Study|Adverse Event|0
870645|NCT00545584|2770325|P3|Overall Study|Two or more reasons for discontinuation|8
870646|NCT00545584|2770326|P2|Overall Study|Two or more reasons for discontinuation|19
870647|NCT00545584|2770327|P1|Overall Study|Two or more reasons for discontinuation|17
870648|NCT00545584|2770325|P3|Overall Study|Only one reason for discontinuation|48
870649|NCT00545584|2770326|P2|Overall Study|Only one reason for discontinuation|61
870650|NCT00545584|2770327|P1|Overall Study|Only one reason for discontinuation|62
870651|NCT00537316|2770344|P7|Part 2|Administrative|1
870652|NCT00537316|2770345|P6|Part 2|Administrative|4
870653|NCT00537316|2770346|P5|Part 2|Administrative|1
870654|NCT00537316|2770347|P4|Part 2|Administrative|3
870655|NCT00537316|2770348|P3|Part 2|Administrative|24
870656|NCT00537316|2770349|P2|Part 2|Administrative|8
870657|NCT00537316|2770350|P1|Part 2|Administrative|16
870658|NCT00537316|2770344|P7|Part 2|Withdrawal by Subject|0
870659|NCT00537316|2770345|P6|Part 2|Withdrawal by Subject|0
870660|NCT00537316|2770346|P5|Part 2|Withdrawal by Subject|0
870661|NCT00537316|2770347|P4|Part 2|Withdrawal by Subject|0
870662|NCT00537316|2770348|P3|Part 2|Withdrawal by Subject|4
870663|NCT00537316|2770349|P2|Part 2|Withdrawal by Subject|1
870664|NCT00537316|2770350|P1|Part 2|Withdrawal by Subject|5
870665|NCT00537316|2770344|P7|Part 2|Lost to Follow-up|0
870666|NCT00537316|2770345|P6|Part 2|Lost to Follow-up|0
870667|NCT00537316|2770346|P5|Part 2|Lost to Follow-up|0
870668|NCT00537316|2770347|P4|Part 2|Lost to Follow-up|0
870669|NCT00537316|2770348|P3|Part 2|Lost to Follow-up|2
870670|NCT00537316|2770349|P2|Part 2|Lost to Follow-up|0
870671|NCT00537316|2770350|P1|Part 2|Lost to Follow-up|1
870672|NCT00537316|2770344|P7|Part 2|Adverse Event|0
870673|NCT00537316|2770345|P6|Part 2|Adverse Event|0
870674|NCT00537316|2770346|P5|Part 2|Adverse Event|0
870675|NCT00537316|2770347|P4|Part 2|Adverse Event|0
870676|NCT00537316|2770348|P3|Part 2|Adverse Event|2
870677|NCT00537316|2770349|P2|Part 2|Adverse Event|0
870678|NCT00537316|2770350|P1|Part 2|Adverse Event|4
870679|NCT00537316|2770344|P7|Part 2|Never entered follow-up|1
870680|NCT00537316|2770345|P6|Part 2|Never entered follow-up|0
870681|NCT00537316|2770346|P5|Part 2|Never entered follow-up|0
870682|NCT00537316|2770347|P4|Part 2|Never entered follow-up|0
870683|NCT00537316|2770348|P3|Part 2|Never entered follow-up|0
870684|NCT00537316|2770349|P2|Part 2|Never entered follow-up|0
870685|NCT00537316|2770350|P1|Part 2|Never entered follow-up|0
870686|NCT00537316|2770344|P7|Part 1|Administrative|0
870687|NCT00537316|2770345|P6|Part 1|Administrative|0
870688|NCT00537316|2770346|P5|Part 1|Administrative|0
870689|NCT00537316|2770347|P4|Part 1|Administrative|0
870690|NCT00537316|2770348|P3|Part 1|Administrative|2
870691|NCT00537316|2770349|P2|Part 1|Administrative|0
870692|NCT00537316|2770350|P1|Part 1|Administrative|0
870693|NCT00537316|2770344|P7|Part 1|Did not meet protocol eligibility|0
870694|NCT00537316|2770345|P6|Part 1|Did not meet protocol eligibility|0
870695|NCT00537316|2770346|P5|Part 1|Did not meet protocol eligibility|0
870696|NCT00537316|2770347|P4|Part 1|Did not meet protocol eligibility|0
870697|NCT00537316|2770348|P3|Part 1|Did not meet protocol eligibility|2
870698|NCT00537316|2770349|P2|Part 1|Did not meet protocol eligibility|3
870699|NCT00537316|2770350|P1|Part 1|Did not meet protocol eligibility|1
870700|NCT00537316|2770344|P7|Part 1|Protocol Violation|0
870701|NCT00537316|2770345|P6|Part 1|Protocol Violation|0
870702|NCT00537316|2770346|P5|Part 1|Protocol Violation|0
870703|NCT00537316|2770347|P4|Part 1|Protocol Violation|0
870704|NCT00537316|2770348|P3|Part 1|Protocol Violation|1
870705|NCT00537316|2770349|P2|Part 1|Protocol Violation|5
870706|NCT00537316|2770350|P1|Part 1|Protocol Violation|1
870707|NCT00537316|2770344|P7|Part 1|Withdrawal by Subject|0
870708|NCT00537316|2770345|P6|Part 1|Withdrawal by Subject|0
870709|NCT00537316|2770346|P5|Part 1|Withdrawal by Subject|0
870710|NCT00537316|2770347|P4|Part 1|Withdrawal by Subject|0
870711|NCT00537316|2770348|P3|Part 1|Withdrawal by Subject|4
870712|NCT00537316|2770349|P2|Part 1|Withdrawal by Subject|8
870713|NCT00537316|2770350|P1|Part 1|Withdrawal by Subject|3
870714|NCT00537316|2770344|P7|Part 1|Lost to Follow-up|0
870715|NCT00537316|2770345|P6|Part 1|Lost to Follow-up|0
870716|NCT00537316|2770346|P5|Part 1|Lost to Follow-up|0
870717|NCT00537316|2770347|P4|Part 1|Lost to Follow-up|0
870718|NCT00537316|2770348|P3|Part 1|Lost to Follow-up|0
870719|NCT00537316|2770349|P2|Part 1|Lost to Follow-up|0
870720|NCT00537316|2770350|P1|Part 1|Lost to Follow-up|1
870721|NCT00537316|2770344|P7|Part 1|Protocol defined clinical event|0
870722|NCT00537316|2770345|P6|Part 1|Protocol defined clinical event|0
870723|NCT00537316|2770346|P5|Part 1|Protocol defined clinical event|0
870724|NCT00537316|2770347|P4|Part 1|Protocol defined clinical event|0
870725|NCT00537316|2770348|P3|Part 1|Protocol defined clinical event|0
870726|NCT00537316|2770349|P2|Part 1|Protocol defined clinical event|0
870727|NCT00537316|2770350|P1|Part 1|Protocol defined clinical event|1
870728|NCT00537316|2770344|P7|Part 1|Adverse Event|0
870729|NCT00537316|2770345|P6|Part 1|Adverse Event|0
870730|NCT00537316|2770346|P5|Part 1|Adverse Event|0
870731|NCT00537316|2770347|P4|Part 1|Adverse Event|0
870732|NCT00537316|2770348|P3|Part 1|Adverse Event|8
870733|NCT00537316|2770349|P2|Part 1|Adverse Event|11
870734|NCT00537316|2770350|P1|Part 1|Adverse Event|7
870735|NCT00527735|2770378|P3|Overall Study|Completed treatment during maintenance|1
870736|NCT00527735|2770379|P2|Overall Study|Completed treatment during maintenance|2
870737|NCT00527735|2770380|P1|Overall Study|Completed treatment during maintenance|2
870738|NCT00527735|2770378|P3|Overall Study|Poor compliance or noncompliance|1
870739|NCT00527735|2770379|P2|Overall Study|Poor compliance or noncompliance|1
870740|NCT00527735|2770380|P1|Overall Study|Poor compliance or noncompliance|0
870741|NCT00527735|2770378|P3|Overall Study|Lost to Follow-up|3
870742|NCT00527735|2770379|P2|Overall Study|Lost to Follow-up|0
870743|NCT00527735|2770380|P1|Overall Study|Lost to Follow-up|0
870744|NCT00527735|2770378|P3|Overall Study|No longer met study criteria|1
870745|NCT00527735|2770379|P2|Overall Study|No longer met study criteria|2
870746|NCT00527735|2770380|P1|Overall Study|No longer met study criteria|2
870747|NCT00527735|2770378|P3|Overall Study|Withdrawal by Subject|3
870748|NCT00527735|2770379|P2|Overall Study|Withdrawal by Subject|4
870749|NCT00527735|2770380|P1|Overall Study|Withdrawal by Subject|5
870750|NCT00527735|2770378|P3|Overall Study|Not identified|5
870751|NCT00527735|2770379|P2|Overall Study|Not identified|5
870752|NCT00527735|2770380|P1|Overall Study|Not identified|5
870753|NCT00527735|2770378|P3|Overall Study|Adverse Event|7
870754|NCT00527735|2770379|P2|Overall Study|Adverse Event|6
870755|NCT00527735|2770380|P1|Overall Study|Adverse Event|10
870756|NCT00527735|2770378|P3|Overall Study|Completed treatment in treatment phase|18
870757|NCT00527735|2770379|P2|Overall Study|Completed treatment in treatment phase|13
870758|NCT00527735|2770380|P1|Overall Study|Completed treatment in treatment phase|14
870759|NCT00527735|2770378|P3|Overall Study|Death|15
870760|NCT00527735|2770379|P2|Overall Study|Death|13
870761|NCT00527735|2770380|P1|Overall Study|Death|23
870762|NCT00527735|2770378|P3|Overall Study|Disease progression|53
870763|NCT00527735|2770379|P2|Overall Study|Disease progression|61
870764|NCT00527735|2770380|P1|Overall Study|Disease progression|47
870765|NCT00527488|2770456|P4|Overall Study|Withdrawn prior to dosing|0
870766|NCT00527488|2770457|P3|Overall Study|Withdrawn prior to dosing|1
870767|NCT00527488|2770458|P2|Overall Study|Withdrawn prior to dosing|1
870768|NCT00527488|2770459|P1|Overall Study|Withdrawn prior to dosing|0
870772|NCT00500682|2770548|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
870773|NCT00500682|2770549|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
870774|NCT00500682|2770548|P2|Overall Study|Withdrawal by Subject|74
870775|NCT00500682|2770549|P1|Overall Study|Withdrawal by Subject|80
870776|NCT00500682|2770548|P2|Overall Study|Protocol Violation|3
870777|NCT00500682|2770549|P1|Overall Study|Protocol Violation|1
870778|NCT00500682|2770548|P2|Overall Study|Pregnancy|0
870779|NCT00500682|2770549|P1|Overall Study|Pregnancy|2
870780|NCT00500682|2770548|P2|Overall Study|Physician Decision|10
870781|NCT00500682|2770549|P1|Overall Study|Physician Decision|6
870782|NCT00500682|2770548|P2|Overall Study|Lost to Follow-up|11
870783|NCT00500682|2770549|P1|Overall Study|Lost to Follow-up|11
870784|NCT00500682|2770548|P2|Overall Study|Death|16
870785|NCT00500682|2770549|P1|Overall Study|Death|25
870786|NCT00500682|2770548|P2|Overall Study|Adverse Event|29
870787|NCT00500682|2770549|P1|Overall Study|Adverse Event|37
870788|NCT00501046|2770557|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
870789|NCT00501046|2770558|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
870790|NCT00501046|2770557|P2|Overall Study|Withdrawal by Subject|83
870791|NCT00501046|2770558|P1|Overall Study|Withdrawal by Subject|84
870792|NCT00501046|2770557|P2|Overall Study|Protocol Violation|1
870793|NCT00501046|2770558|P1|Overall Study|Protocol Violation|2
870794|NCT00501046|2770557|P2|Overall Study|Pregnancy|3
870795|NCT00501046|2770558|P1|Overall Study|Pregnancy|0
870796|NCT00501046|2770557|P2|Overall Study|Physician Decision|2
870797|NCT00501046|2770558|P1|Overall Study|Physician Decision|7
870798|NCT00501046|2770557|P2|Overall Study|Lost to Follow-up|13
870799|NCT00501046|2770558|P1|Overall Study|Lost to Follow-up|14
870800|NCT00501046|2770557|P2|Overall Study|Death|30
870801|NCT00501046|2770558|P1|Overall Study|Death|23
870802|NCT00501046|2770557|P2|Overall Study|Adverse Event|25
870803|NCT00501046|2770558|P1|Overall Study|Adverse Event|21
870804|NCT00496769|2770575|P2|Overall Study|>=1 reason assigned per patient|649
870805|NCT00496769|2770576|P1|Overall Study|>=1 reason assigned per patient|558
870806|NCT00488774|2770602|P4|Overall Study|Lost to Follow-up|1
870807|NCT00488774|2770603|P3|Overall Study|Lost to Follow-up|1
870808|NCT00488774|2770604|P2|Overall Study|Lost to Follow-up|0
870809|NCT00488774|2770605|P1|Overall Study|Lost to Follow-up|0
870810|NCT00488774|2770602|P4|Overall Study|Other|2
870811|NCT00488774|2770603|P3|Overall Study|Other|2
870812|NCT00488774|2770604|P2|Overall Study|Other|3
870813|NCT00488774|2770605|P1|Overall Study|Other|6
870814|NCT00488774|2770602|P4|Overall Study|Withdrawal of consent|0
870815|NCT00488774|2770603|P3|Overall Study|Withdrawal of consent|2
870816|NCT00488774|2770604|P2|Overall Study|Withdrawal of consent|2
870817|NCT00488774|2770605|P1|Overall Study|Withdrawal of consent|2
870818|NCT00488683|2770622|P3|Overall Study|Unable to Classify|0
870819|NCT00488683|2770623|P2|Overall Study|Unable to Classify|0
870820|NCT00488683|2770624|P1|Overall Study|Unable to Classify|1
870821|NCT00488683|2770622|P3|Overall Study|Protocol Violation|0
870822|NCT00488683|2770623|P2|Overall Study|Protocol Violation|1
870823|NCT00488683|2770624|P1|Overall Study|Protocol Violation|5
870824|NCT00488683|2770622|P3|Overall Study|Lost to Follow-up|0
870825|NCT00488683|2770623|P2|Overall Study|Lost to Follow-up|3
870826|NCT00488683|2770624|P1|Overall Study|Lost to Follow-up|5
870827|NCT00488683|2770622|P3|Overall Study|Withdrawal by Subject|2
870828|NCT00488683|2770623|P2|Overall Study|Withdrawal by Subject|2
870829|NCT00488683|2770624|P1|Overall Study|Withdrawal by Subject|1
870830|NCT00487539|2770687|P4|Overall Study|Other|2
870831|NCT00487539|2770688|P3|Overall Study|Other|2
870832|NCT00487539|2770689|P2|Overall Study|Other|1
870833|NCT00487539|2770690|P1|Overall Study|Other|3
870834|NCT00487539|2770687|P4|Overall Study|Unsatisfactory therapeutic effect|1
870835|NCT00487539|2770688|P3|Overall Study|Unsatisfactory therapeutic effect|0
870836|NCT00487539|2770689|P2|Overall Study|Unsatisfactory therapeutic effect|0
870837|NCT00487539|2770690|P1|Overall Study|Unsatisfactory therapeutic effect|1
870838|NCT00487539|2770687|P4|Overall Study|Adverse Event|1
870839|NCT00487539|2770688|P3|Overall Study|Adverse Event|1
870840|NCT00487539|2770689|P2|Overall Study|Adverse Event|2
870841|NCT00487539|2770690|P1|Overall Study|Adverse Event|3
870842|NCT00474526|2770738|P17|Overall Study|Withdrawal by Subject|1
870843|NCT00474526|2770739|P16|Overall Study|Withdrawal by Subject|1
870844|NCT00474526|2770740|P15|Overall Study|Withdrawal by Subject|22
870845|NCT00474526|2770741|P14|Overall Study|Withdrawal by Subject|37
870846|NCT00474526|2770742|P13|Overall Study|Withdrawal by Subject|4
870847|NCT00474526|2770743|P12|Overall Study|Withdrawal by Subject|4
870848|NCT00474526|2770744|P11|Overall Study|Withdrawal by Subject|5
870849|NCT00474526|2770745|P10|Overall Study|Withdrawal by Subject|13
870850|NCT00474526|2770746|P9|Overall Study|Withdrawal by Subject|4
870851|NCT00474526|2770747|P8|Overall Study|Withdrawal by Subject|4
870852|NCT00474526|2770748|P7|Overall Study|Withdrawal by Subject|12
870853|NCT00474526|2770749|P6|Overall Study|Withdrawal by Subject|6
870854|NCT00474526|2770750|P5|Overall Study|Withdrawal by Subject|38
870855|NCT00474526|2770751|P4|Overall Study|Withdrawal by Subject|52
870856|NCT00474526|2770752|P3|Overall Study|Withdrawal by Subject|21
870857|NCT00474526|2770753|P2|Overall Study|Withdrawal by Subject|24
870858|NCT00474526|2770754|P1|Overall Study|Withdrawal by Subject|9
870859|NCT00474526|2770738|P17|Overall Study|UNABLE TO CLASSIFY|1
870860|NCT00474526|2770739|P16|Overall Study|UNABLE TO CLASSIFY|6
870861|NCT00474526|2770740|P15|Overall Study|UNABLE TO CLASSIFY|12
870862|NCT00474526|2770741|P14|Overall Study|UNABLE TO CLASSIFY|20
870863|NCT00474526|2770742|P13|Overall Study|UNABLE TO CLASSIFY|0
870864|NCT00474526|2770743|P12|Overall Study|UNABLE TO CLASSIFY|0
870865|NCT00474526|2770744|P11|Overall Study|UNABLE TO CLASSIFY|0
870866|NCT00474526|2770745|P10|Overall Study|UNABLE TO CLASSIFY|3
870867|NCT00474526|2770746|P9|Overall Study|UNABLE TO CLASSIFY|0
870868|NCT00474526|2770747|P8|Overall Study|UNABLE TO CLASSIFY|1
870869|NCT00474526|2770748|P7|Overall Study|UNABLE TO CLASSIFY|0
870870|NCT00474526|2770749|P6|Overall Study|UNABLE TO CLASSIFY|2
870871|NCT00474526|2770750|P5|Overall Study|UNABLE TO CLASSIFY|3
870872|NCT00474526|2770751|P4|Overall Study|UNABLE TO CLASSIFY|1
870873|NCT00474526|2770752|P3|Overall Study|UNABLE TO CLASSIFY|0
870874|NCT00474526|2770753|P2|Overall Study|UNABLE TO CLASSIFY|0
870875|NCT00474526|2770754|P1|Overall Study|UNABLE TO CLASSIFY|1
870876|NCT00474526|2770738|P17|Overall Study|Protocol Violation|2
870877|NCT00474526|2770739|P16|Overall Study|Protocol Violation|6
870878|NCT00474526|2770740|P15|Overall Study|Protocol Violation|9
870879|NCT00474526|2770741|P14|Overall Study|Protocol Violation|19
870880|NCT00474526|2770742|P13|Overall Study|Protocol Violation|4
870881|NCT00474526|2770743|P12|Overall Study|Protocol Violation|2
870882|NCT00474526|2770744|P11|Overall Study|Protocol Violation|2
870883|NCT00474526|2770745|P10|Overall Study|Protocol Violation|4
870884|NCT00474526|2770746|P9|Overall Study|Protocol Violation|0
870885|NCT00474526|2770747|P8|Overall Study|Protocol Violation|0
870886|NCT00474526|2770748|P7|Overall Study|Protocol Violation|3
870887|NCT00474526|2770749|P6|Overall Study|Protocol Violation|1
870888|NCT00474526|2770750|P5|Overall Study|Protocol Violation|3
870889|NCT00474526|2770751|P4|Overall Study|Protocol Violation|12
870890|NCT00474526|2770752|P3|Overall Study|Protocol Violation|4
870891|NCT00474526|2770753|P2|Overall Study|Protocol Violation|6
870892|NCT00474526|2770754|P1|Overall Study|Protocol Violation|2
870893|NCT00474526|2770738|P17|Overall Study|Lost to Follow-up|5
870894|NCT00474526|2770739|P16|Overall Study|Lost to Follow-up|4
870895|NCT00474526|2770740|P15|Overall Study|Lost to Follow-up|29
870896|NCT00474526|2770741|P14|Overall Study|Lost to Follow-up|74
870897|NCT00474526|2770742|P13|Overall Study|Lost to Follow-up|6
870898|NCT00474526|2770743|P12|Overall Study|Lost to Follow-up|4
870899|NCT00474526|2770744|P11|Overall Study|Lost to Follow-up|2
870900|NCT00474526|2770745|P10|Overall Study|Lost to Follow-up|6
870901|NCT00474526|2770746|P9|Overall Study|Lost to Follow-up|0
870902|NCT00474526|2770747|P8|Overall Study|Lost to Follow-up|1
870903|NCT00474526|2770748|P7|Overall Study|Lost to Follow-up|8
870904|NCT00474526|2770749|P6|Overall Study|Lost to Follow-up|5
870905|NCT00474526|2770750|P5|Overall Study|Lost to Follow-up|11
870906|NCT00474526|2770751|P4|Overall Study|Lost to Follow-up|29
870907|NCT00474526|2770752|P3|Overall Study|Lost to Follow-up|13
870908|NCT00474526|2770753|P2|Overall Study|Lost to Follow-up|6
870909|NCT00474526|2770754|P1|Overall Study|Lost to Follow-up|8
870910|NCT00474526|2770738|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
870911|NCT00474526|2770739|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
870912|NCT00474526|2770740|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
870913|NCT00474526|2770741|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
870914|NCT00474526|2770742|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
870915|NCT00474526|2770743|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
870916|NCT00474526|2770744|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
870917|NCT00474526|2770745|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
870918|NCT00474526|2770746|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
870919|NCT00474526|2770747|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
870920|NCT00474526|2770748|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
870921|NCT00474526|2770749|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
870922|NCT00474526|2770750|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
870923|NCT00474526|2770751|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
870924|NCT00474526|2770752|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
870925|NCT00474526|2770753|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
870926|NCT00474526|2770754|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
870927|NCT00474526|2770738|P17|Overall Study|Death|0
870928|NCT00474526|2770739|P16|Overall Study|Death|0
870929|NCT00474526|2770740|P15|Overall Study|Death|0
870930|NCT00474526|2770741|P14|Overall Study|Death|3
870931|NCT00474526|2770742|P13|Overall Study|Death|0
870932|NCT00474526|2770743|P12|Overall Study|Death|0
870933|NCT00474526|2770744|P11|Overall Study|Death|0
870934|NCT00474526|2770745|P10|Overall Study|Death|0
870935|NCT00474526|2770746|P9|Overall Study|Death|0
870936|NCT00474526|2770747|P8|Overall Study|Death|0
870937|NCT00474526|2770748|P7|Overall Study|Death|0
870938|NCT00474526|2770749|P6|Overall Study|Death|0
870939|NCT00474526|2770750|P5|Overall Study|Death|0
870940|NCT00474526|2770751|P4|Overall Study|Death|0
870941|NCT00474526|2770752|P3|Overall Study|Death|0
870942|NCT00474526|2770753|P2|Overall Study|Death|0
870943|NCT00474526|2770754|P1|Overall Study|Death|0
870944|NCT00474526|2770738|P17|Overall Study|Adverse Event|0
870945|NCT00474526|2770739|P16|Overall Study|Adverse Event|1
870946|NCT00474526|2770740|P15|Overall Study|Adverse Event|1
870947|NCT00474526|2770741|P14|Overall Study|Adverse Event|0
870948|NCT00474526|2770742|P13|Overall Study|Adverse Event|0
870949|NCT00474526|2770743|P12|Overall Study|Adverse Event|0
870950|NCT00474526|2770744|P11|Overall Study|Adverse Event|0
870951|NCT00474526|2770745|P10|Overall Study|Adverse Event|0
870952|NCT00474526|2770746|P9|Overall Study|Adverse Event|0
870953|NCT00474526|2770747|P8|Overall Study|Adverse Event|0
870954|NCT00474526|2770748|P7|Overall Study|Adverse Event|1
870955|NCT00474526|2770749|P6|Overall Study|Adverse Event|1
870956|NCT00474526|2770750|P5|Overall Study|Adverse Event|2
870957|NCT00474526|2770751|P4|Overall Study|Adverse Event|4
870958|NCT00474526|2770752|P3|Overall Study|Adverse Event|2
870959|NCT00474526|2770753|P2|Overall Study|Adverse Event|0
870960|NCT00474526|2770754|P1|Overall Study|Adverse Event|2
870961|NCT00474526|2770738|P17|Overall Study|ADMINISTRATIVE REASON|0
870962|NCT00474526|2770739|P16|Overall Study|ADMINISTRATIVE REASON|0
870963|NCT00474526|2770740|P15|Overall Study|ADMINISTRATIVE REASON|2
870964|NCT00474526|2770741|P14|Overall Study|ADMINISTRATIVE REASON|1
870965|NCT00474526|2770742|P13|Overall Study|ADMINISTRATIVE REASON|1
870966|NCT00474526|2770743|P12|Overall Study|ADMINISTRATIVE REASON|1
870967|NCT00474526|2770744|P11|Overall Study|ADMINISTRATIVE REASON|1
870968|NCT00474526|2770745|P10|Overall Study|ADMINISTRATIVE REASON|1
870969|NCT00474526|2770746|P9|Overall Study|ADMINISTRATIVE REASON|2
870970|NCT00474526|2770747|P8|Overall Study|ADMINISTRATIVE REASON|0
870971|NCT00474526|2770748|P7|Overall Study|ADMINISTRATIVE REASON|1
870972|NCT00474526|2770749|P6|Overall Study|ADMINISTRATIVE REASON|1
870973|NCT00474526|2770750|P5|Overall Study|ADMINISTRATIVE REASON|9
870974|NCT00474526|2770751|P4|Overall Study|ADMINISTRATIVE REASON|20
870975|NCT00474526|2770752|P3|Overall Study|ADMINISTRATIVE REASON|9
870976|NCT00474526|2770753|P2|Overall Study|ADMINISTRATIVE REASON|9
870977|NCT00474526|2770754|P1|Overall Study|ADMINISTRATIVE REASON|11
870978|NCT00465647|2770975|P4|Overall Study|"The other reasons included loss of IV"|2
870979|NCT00465647|2770976|P3|Overall Study|"The other reasons included loss of IV"|3
870980|NCT00465647|2770977|P2|Overall Study|"The other reasons included loss of IV"|4
870981|NCT00465647|2770978|P1|Overall Study|"The other reasons included loss of IV"|8
870982|NCT00465647|2770975|P4|Overall Study|Withdrawal by Subject|7
870983|NCT00465647|2770976|P3|Overall Study|Withdrawal by Subject|2
870984|NCT00465647|2770977|P2|Overall Study|Withdrawal by Subject|2
870985|NCT00465647|2770978|P1|Overall Study|Withdrawal by Subject|1
870986|NCT00465647|2770975|P4|Overall Study|Adverse Event|2
870987|NCT00465647|2770976|P3|Overall Study|Adverse Event|3
870988|NCT00465647|2770977|P2|Overall Study|Adverse Event|0
870989|NCT00465647|2770978|P1|Overall Study|Adverse Event|2
870990|NCT00465647|2770975|P4|Overall Study|Administrative|2
870991|NCT00465647|2770976|P3|Overall Study|Administrative|3
870992|NCT00465647|2770977|P2|Overall Study|Administrative|2
870993|NCT00465647|2770978|P1|Overall Study|Administrative|2
870994|NCT00462943|2771004|P3|Overall Study|Withdrawal by Subject|0
870995|NCT00462943|2771005|P2|Overall Study|Withdrawal by Subject|1
870996|NCT00462943|2771006|P1|Overall Study|Withdrawal by Subject|0
870997|NCT00462943|2771004|P3|Overall Study|Physician Decision|0
870998|NCT00462943|2771005|P2|Overall Study|Physician Decision|0
870999|NCT00462943|2771006|P1|Overall Study|Physician Decision|1
871000|NCT00462943|2771004|P3|Overall Study|Transplant - not specified|1
871001|NCT00462943|2771005|P2|Overall Study|Transplant - not specified|0
871002|NCT00462943|2771006|P1|Overall Study|Transplant - not specified|1
871003|NCT00462943|2771004|P3|Overall Study|Required Lymphocyte Infusion|0
871004|NCT00462943|2771005|P2|Overall Study|Required Lymphocyte Infusion|0
871005|NCT00462943|2771006|P1|Overall Study|Required Lymphocyte Infusion|1
871006|NCT00462943|2771004|P3|Overall Study|Bone Marrow Transplant|0
871007|NCT00462943|2771005|P2|Overall Study|Bone Marrow Transplant|0
871008|NCT00462943|2771006|P1|Overall Study|Bone Marrow Transplant|1
871009|NCT00462943|2771004|P3|Overall Study|Stem Cell Transplant|0
871010|NCT00462943|2771005|P2|Overall Study|Stem Cell Transplant|1
871011|NCT00462943|2771006|P1|Overall Study|Stem Cell Transplant|1
871012|NCT00462943|2771004|P3|Overall Study|Death|7
871013|NCT00462943|2771005|P2|Overall Study|Death|2
871014|NCT00462943|2771006|P1|Overall Study|Death|5
871015|NCT00462943|2771004|P3|Overall Study|Disease Progression|9
871016|NCT00462943|2771005|P2|Overall Study|Disease Progression|15
871017|NCT00462943|2771006|P1|Overall Study|Disease Progression|15
871018|NCT00462943|2771004|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
871019|NCT00462943|2771005|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
871020|NCT00462943|2771006|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
871021|NCT00462943|2771004|P3|Overall Study|Protocol Violation|0
871022|NCT00462943|2771005|P2|Overall Study|Protocol Violation|0
871023|NCT00462943|2771006|P1|Overall Study|Protocol Violation|1
871024|NCT00462943|2771004|P3|Overall Study|Adverse Event|1
871025|NCT00462943|2771005|P2|Overall Study|Adverse Event|4
871026|NCT00462943|2771006|P1|Overall Study|Adverse Event|6
871027|NCT00462943|2771004|P3|Overall Study|Failure to achieve a response|1
871028|NCT00462943|2771005|P2|Overall Study|Failure to achieve a response|5
871029|NCT00462943|2771006|P1|Overall Study|Failure to achieve a response|5
871030|NCT00455013|2771101|P3|Long Term Extension (LTE)|non-specified|1
871031|NCT00455013|2771102|P2|Long Term Extension (LTE)|non-specified|0
871032|NCT00455013|2771103|P1|Long Term Extension (LTE)|non-specified|0
871033|NCT00455013|2771101|P3|Long Term Extension (LTE)|Poor non-compliance|0
871034|NCT00455013|2771102|P2|Long Term Extension (LTE)|Poor non-compliance|1
871035|NCT00455013|2771103|P1|Long Term Extension (LTE)|Poor non-compliance|0
871036|NCT00455013|2771101|P3|Long Term Extension (LTE)|Subject Request or refused|3
871037|NCT00455013|2771102|P2|Long Term Extension (LTE)|Subject Request or refused|0
871038|NCT00455013|2771103|P1|Long Term Extension (LTE)|Subject Request or refused|0
871039|NCT00455013|2771101|P3|Long Term Extension (LTE)|No longer met criteria|1
871040|NCT00455013|2771102|P2|Long Term Extension (LTE)|No longer met criteria|0
871041|NCT00455013|2771103|P1|Long Term Extension (LTE)|No longer met criteria|0
871042|NCT00455013|2771101|P3|Long Term Extension (LTE)|Death|0
871043|NCT00455013|2771102|P2|Long Term Extension (LTE)|Death|1
871044|NCT00455013|2771103|P1|Long Term Extension (LTE)|Death|1
871045|NCT00455013|2771101|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
871046|NCT00455013|2771102|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
871047|NCT00455013|2771103|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
871048|NCT00455013|2771101|P3|Long Term Extension (LTE)|Adverse Event|1
871049|NCT00455013|2771102|P2|Long Term Extension (LTE)|Adverse Event|1
871050|NCT00455013|2771103|P1|Long Term Extension (LTE)|Adverse Event|0
871051|NCT00455013|2771101|P3|Short Term Period|Other|1
871052|NCT00455013|2771102|P2|Short Term Period|Other|0
871053|NCT00455013|2771103|P1|Short Term Period|Other|0
871054|NCT00455013|2771101|P3|Short Term Period|Lack of Efficacy|0
871055|NCT00455013|2771102|P2|Short Term Period|Lack of Efficacy|0
871056|NCT00455013|2771103|P1|Short Term Period|Lack of Efficacy|4
871057|NCT00455013|2771101|P3|Short Term Period|Withdrawal by Subject|1
871058|NCT00455013|2771102|P2|Short Term Period|Withdrawal by Subject|0
871059|NCT00455013|2771103|P1|Short Term Period|Withdrawal by Subject|0
871060|NCT00455013|2771101|P3|Short Term Period|Adverse Event|0
871061|NCT00455013|2771102|P2|Short Term Period|Adverse Event|5
871062|NCT00455013|2771103|P1|Short Term Period|Adverse Event|2
871063|NCT00453180|2771170|P2|Overall Study|Adverse Event|2
871064|NCT00453180|2771171|P1|Overall Study|Adverse Event|1
871065|NCT00453180|2771170|P2|Overall Study|Lost to Follow-up|1
871066|NCT00453180|2771171|P1|Overall Study|Lost to Follow-up|2
871067|NCT00445003|2771230|P3|Overall Study|Dropped|2
871068|NCT00445003|2771231|P2|Overall Study|Dropped|3
871069|NCT00445003|2771232|P1|Overall Study|Dropped|1
871070|NCT00445003|2771230|P3|Overall Study|Missed Visit|1
871071|NCT00445003|2771231|P2|Overall Study|Missed Visit|5
871072|NCT00445003|2771232|P1|Overall Study|Missed Visit|3
871073|NCT00445003|2771230|P3|Overall Study|Death|1
871074|NCT00445003|2771231|P2|Overall Study|Death|2
871075|NCT00445003|2771232|P1|Overall Study|Death|1
871084|NCT00430950|2771318|P2|Overall Study|concomitant medication,etc.|7
871085|NCT00430950|2771319|P1|Overall Study|concomitant medication,etc.|5
871086|NCT00430950|2771318|P2|Overall Study|Withdrawal by Subject|0
871087|NCT00430950|2771319|P1|Overall Study|Withdrawal by Subject|1
871088|NCT00430950|2771318|P2|Overall Study|Adverse Event|6
871089|NCT00430950|2771319|P1|Overall Study|Adverse Event|7
871090|NCT00404547|2771376|P2|Overall Study|Reason not stated|6
871091|NCT00404547|2771377|P1|Overall Study|Reason not stated|3
871092|NCT00404547|2771376|P2|Overall Study|Other|0
871093|NCT00404547|2771377|P1|Overall Study|Other|4
871094|NCT00404547|2771376|P2|Overall Study|Lack of compliance|1
871095|NCT00404547|2771377|P1|Overall Study|Lack of compliance|5
871096|NCT00404547|2771376|P2|Overall Study|Lost to Follow-up|9
871097|NCT00404547|2771377|P1|Overall Study|Lost to Follow-up|20
871098|NCT00404547|2771376|P2|Overall Study|Protocol Violation|1
871099|NCT00404547|2771377|P1|Overall Study|Protocol Violation|0
871100|NCT00404547|2771376|P2|Overall Study|Withdrawal by Subject|2
871101|NCT00404547|2771377|P1|Overall Study|Withdrawal by Subject|19
871102|NCT00404547|2771376|P2|Overall Study|Adverse Event|6
871103|NCT00404547|2771377|P1|Overall Study|Adverse Event|39
871104|NCT00402168|2771387|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
871105|NCT00402168|2771388|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
871106|NCT00402168|2771387|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
871107|NCT00402168|2771388|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
871108|NCT00402168|2771387|P2|Long Term (LT)|non-specified|2
871109|NCT00402168|2771388|P1|Long Term (LT)|non-specified|1
871110|NCT00402168|2771387|P2|Long Term (LT)|Lack of Efficacy|2
871111|NCT00402168|2771388|P1|Long Term (LT)|Lack of Efficacy|0
871112|NCT00402168|2771387|P2|Long Term (LT)|Death|0
871113|NCT00402168|2771388|P1|Long Term (LT)|Death|4
871114|NCT00402168|2771387|P2|Long Term (LT)|Lost to Follow-up|0
871115|NCT00402168|2771388|P1|Long Term (LT)|Lost to Follow-up|1
871116|NCT00402168|2771387|P2|Long Term (LT)|Pregnancy|1
871117|NCT00402168|2771388|P1|Long Term (LT)|Pregnancy|0
871118|NCT00402168|2771387|P2|Long Term (LT)|Withdrawal by Subject|7
871119|NCT00402168|2771388|P1|Long Term (LT)|Withdrawal by Subject|4
871120|NCT00402168|2771387|P2|Long Term (LT)|Adverse Event|5
871121|NCT00402168|2771388|P1|Long Term (LT)|Adverse Event|1
871122|NCT00402168|2771387|P2|Treatment (up to 12 Months)|non-specified|1
871123|NCT00402168|2771388|P1|Treatment (up to 12 Months)|non-specified|0
871124|NCT00402168|2771387|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
871125|NCT00402168|2771388|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
871126|NCT00402168|2771387|P2|Treatment (up to 12 Months)|Death|1
871127|NCT00402168|2771388|P1|Treatment (up to 12 Months)|Death|0
871128|NCT00402168|2771387|P2|Randomized|Withdrawal by Subject|1
871129|NCT00402168|2771388|P1|Randomized|Withdrawal by Subject|0
871130|NCT00402168|2771387|P2|Randomized|Lost to Follow-up|0
871131|NCT00402168|2771388|P1|Randomized|Lost to Follow-up|1
871132|NCT00375752|2771630|P2|Overall Study|Administrative Problems|1
871133|NCT00375752|2771631|P1|Overall Study|Administrative Problems|0
871134|NCT00375752|2771630|P2|Overall Study|Protocol Violation|2
871135|NCT00375752|2771631|P1|Overall Study|Protocol Violation|0
871136|NCT00375752|2771630|P2|Overall Study|Abnormal Laboratory Value(s)|1
871137|NCT00375752|2771631|P1|Overall Study|Abnormal Laboratory Value(s)|1
871138|NCT00375752|2771630|P2|Overall Study|Withdrawal by Subject|1
871139|NCT00375752|2771631|P1|Overall Study|Withdrawal by Subject|6
871140|NCT00375752|2771630|P2|Overall Study|Adverse Event|6
871141|NCT00375752|2771631|P1|Overall Study|Adverse Event|1
871142|NCT00375752|2771630|P2|Overall Study|Lack of Efficacy|4
871143|NCT00375752|2771631|P1|Overall Study|Lack of Efficacy|4
871144|NCT00375219|2771648|P3|Overall Study|Withdrawal by Subject|0
871145|NCT00375219|2771649|P2|Overall Study|Withdrawal by Subject|0
871146|NCT00375219|2771650|P1|Overall Study|Withdrawal by Subject|1
871147|NCT00375219|2771648|P3|Overall Study|Cord blood transplantation|0
871148|NCT00375219|2771649|P2|Overall Study|Cord blood transplantation|0
871149|NCT00375219|2771650|P1|Overall Study|Cord blood transplantation|1
871150|NCT00375219|2771648|P3|Overall Study|Allograft|0
871151|NCT00375219|2771649|P2|Overall Study|Allograft|0
871152|NCT00375219|2771650|P1|Overall Study|Allograft|2
871153|NCT00375219|2771648|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
871154|NCT00375219|2771649|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
871155|NCT00375219|2771650|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
871156|NCT00375219|2771648|P3|Overall Study|Hematologic resistance|0
871157|NCT00375219|2771649|P2|Overall Study|Hematologic resistance|0
871158|NCT00375219|2771650|P1|Overall Study|Hematologic resistance|1
871159|NCT00375219|2771648|P3|Overall Study|Death|7
871160|NCT00375219|2771649|P2|Overall Study|Death|3
871161|NCT00375219|2771650|P1|Overall Study|Death|4
871162|NCT00375219|2771648|P3|Overall Study|Disease progression|12
871163|NCT00375219|2771649|P2|Overall Study|Disease progression|9
871164|NCT00375219|2771650|P1|Overall Study|Disease progression|18
871165|NCT00375219|2771648|P3|Overall Study|Lost to Follow-up|0
871166|NCT00375219|2771649|P2|Overall Study|Lost to Follow-up|1
871167|NCT00375219|2771650|P1|Overall Study|Lost to Follow-up|1
871168|NCT00375219|2771648|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
871169|NCT00375219|2771649|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
871170|NCT00375219|2771650|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
871171|NCT00375219|2771648|P3|Overall Study|Protocol Violation|1
871172|NCT00375219|2771649|P2|Overall Study|Protocol Violation|0
871173|NCT00375219|2771650|P1|Overall Study|Protocol Violation|1
871174|NCT00375219|2771648|P3|Overall Study|Adverse Event|1
871175|NCT00375219|2771649|P2|Overall Study|Adverse Event|2
871176|NCT00375219|2771650|P1|Overall Study|Adverse Event|8
871177|NCT00375219|2771648|P3|Overall Study|Failure to achieve a response|0
871178|NCT00375219|2771649|P2|Overall Study|Failure to achieve a response|2
871179|NCT00375219|2771650|P1|Overall Study|Failure to achieve a response|16
871180|NCT00374907|2771718|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
871181|NCT00374907|2771719|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
871182|NCT00374907|2771718|P2|116-Week Short-term + Long-term Period|Adverse Event|2
871183|NCT00374907|2771719|P1|116-Week Short-term + Long-term Period|Adverse Event|0
871184|NCT00374907|2771718|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
871185|NCT00374907|2771719|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
871186|NCT00374907|2771718|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
871187|NCT00374907|2771719|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
871188|NCT00374907|2771718|P2|12-Week Short-term Period|Subject Withdrew Consent|1
871189|NCT00374907|2771719|P1|12-Week Short-term Period|Subject Withdrew Consent|3
871190|NCT00355121|2771734|P3|Overall Study|Serious adverse events|0
871191|NCT00355121|2771735|P2|Overall Study|Serious adverse events|2
871192|NCT00355121|2771736|P1|Overall Study|Serious adverse events|0
871193|NCT00355121|2771734|P3|Overall Study|Withdrawal by Subject|2
871194|NCT00355121|2771735|P2|Overall Study|Withdrawal by Subject|10
871195|NCT00355121|2771736|P1|Overall Study|Withdrawal by Subject|9
871196|NCT00355121|2771734|P3|Overall Study|Lost to Follow-up|1
871197|NCT00355121|2771735|P2|Overall Study|Lost to Follow-up|7
871198|NCT00355121|2771736|P1|Overall Study|Lost to Follow-up|4
871199|NCT00355121|2771734|P3|Overall Study|Protocol Violation|1
871200|NCT00355121|2771735|P2|Overall Study|Protocol Violation|9
871201|NCT00355121|2771736|P1|Overall Study|Protocol Violation|7
871202|NCT00355121|2771734|P3|Overall Study|Adverse Event|0
871203|NCT00355121|2771735|P2|Overall Study|Adverse Event|1
871204|NCT00355121|2771736|P1|Overall Study|Adverse Event|0
871205|NCT00355121|2771734|P3|Overall Study|Did not receive study vaccine|1
871206|NCT00355121|2771735|P2|Overall Study|Did not receive study vaccine|0
871207|NCT00355121|2771736|P1|Overall Study|Did not receive study vaccine|1
871208|NCT00354172|2771765|P1|Overall Study|Did not receive transplant|1
871215|NCT00324155|2771819|P2|Follow-up Phase|On-going participants still on drug|6
871216|NCT00324155|2771820|P1|Follow-up Phase|On-going participants still on drug|11
871217|NCT00324155|2771819|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
871218|NCT00324155|2771820|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
871219|NCT00324155|2771819|P2|Received Treatment in Maintenance Phase|Adverse Event|3
871220|NCT00324155|2771820|P1|Received Treatment in Maintenance Phase|Adverse Event|0
871221|NCT00324155|2771819|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
871222|NCT00324155|2771820|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
871223|NCT00324155|2771819|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
871224|NCT00324155|2771820|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
871225|NCT00324155|2771819|P2|Received Treatment in Maintenance Phase|Disease Progression|41
871226|NCT00324155|2771820|P1|Received Treatment in Maintenance Phase|Disease Progression|26
871227|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Physician Decision|0
871228|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Physician Decision|2
871229|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
871230|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
871231|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Adverse Event|7
871232|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Adverse Event|6
871233|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
871234|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
871235|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Death|15
871236|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Death|8
871237|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
871238|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
871239|NCT00324155|2771819|P2|Received Treatment in Induction Phase|Disease Progression|152
871240|NCT00324155|2771820|P1|Received Treatment in Induction Phase|Disease Progression|88
871241|NCT00324155|2771819|P2|Enrolled and Randomized|Lost to Follow-up|1
871242|NCT00324155|2771820|P1|Enrolled and Randomized|Lost to Follow-up|0
871243|NCT00324155|2771819|P2|Enrolled and Randomized|No longer met study criteria|0
871244|NCT00324155|2771820|P1|Enrolled and Randomized|No longer met study criteria|3
871249|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
871250|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
871251|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
871252|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
871253|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
871254|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
871255|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
871256|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
871257|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
871258|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
871259|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
871260|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
871261|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
871262|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
871263|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
871264|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Death|4
871265|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Death|4
871266|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Death|9
871267|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
871268|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
871269|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
871270|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
871271|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
871272|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
871273|NCT00256750|2771978|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
871274|NCT00256750|2771979|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
871275|NCT00256750|2771980|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
871276|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Not specified|1
871277|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Not specified|1
871278|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Not specified|0
871279|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
871280|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
871281|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
871282|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
871283|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
871284|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
871285|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
871286|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
871287|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
871288|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Death|1
871289|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Death|2
871290|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Death|0
871291|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
871292|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
871293|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
871294|NCT00256750|2771978|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
871295|NCT00256750|2771979|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
871296|NCT00256750|2771980|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
871297|NCT00256750|2771978|P3|Post-Transplant Treated (24 Months)|Not Specified|1
871298|NCT00256750|2771979|P2|Post-Transplant Treated (24 Months)|Not Specified|0
871299|NCT00256750|2771980|P1|Post-Transplant Treated (24 Months)|Not Specified|2
871300|NCT00256750|2771978|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
871301|NCT00256750|2771979|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
871302|NCT00256750|2771980|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
871303|NCT00256750|2771978|P3|Post-Transplant Treated (24 Months)|Death|0
871304|NCT00256750|2771979|P2|Post-Transplant Treated (24 Months)|Death|0
871305|NCT00256750|2771980|P1|Post-Transplant Treated (24 Months)|Death|3
871306|NCT00256750|2771978|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
871307|NCT00256750|2771979|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
871308|NCT00256750|2771980|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
871309|NCT00256750|2771978|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
871310|NCT00256750|2771979|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
871311|NCT00256750|2771980|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
871312|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
871313|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
871314|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
871315|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
871316|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
871317|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
871318|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Not Specified|2
871319|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Not Specified|4
871320|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Not Specified|5
871321|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
871322|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
871323|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
871324|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
871325|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
871326|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
871327|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Death|4
871328|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Death|2
871329|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Death|3
871330|NCT00256750|2771978|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
871331|NCT00256750|2771979|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
871332|NCT00256750|2771980|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
871333|NCT00256750|2771978|P3|Transplanted Pre-Treatment|Death|0
871334|NCT00256750|2771979|P2|Transplanted Pre-Treatment|Death|0
871335|NCT00256750|2771980|P1|Transplanted Pre-Treatment|Death|1
871336|NCT00256750|2771978|P3|Transplanted Pre-Treatment|Not Specified|0
871337|NCT00256750|2771979|P2|Transplanted Pre-Treatment|Not Specified|0
871338|NCT00256750|2771980|P1|Transplanted Pre-Treatment|Not Specified|2
871339|NCT00256750|2771978|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
871340|NCT00256750|2771979|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
871341|NCT00256750|2771980|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
871342|NCT00245037|2772187|P1|Overall Study|Death|17
871343|NCT00241839|2772199|P2|Overall Study|Adverse Event|1
871344|NCT00241839|2772200|P1|Overall Study|Adverse Event|1
871345|NCT00241839|2772199|P2|Overall Study|Withdrawal by Subject|17
871346|NCT00241839|2772200|P1|Overall Study|Withdrawal by Subject|18
871347|NCT00238433|2772212|P1|Overall Study|Death|1
871348|NCT00238433|2772212|P1|Overall Study|Lost to Follow-up|1
871349|NCT00238433|2772212|P1|Overall Study|Screen failure|1
871350|NCT00219349|2772217|P1|Escitalopram Phase|Physician Decision|7
871351|NCT00219349|2772217|P1|Escitalopram Phase|Withdrawal by Subject|4
871352|NCT00219349|2772217|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
871353|NCT00219349|2772217|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
871354|NCT00219349|2772217|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
871409|NCT00187889|2772344|P2|Overall Study|Withdrawal by Subject|4
871410|NCT00187889|2772345|P1|Overall Study|Withdrawal by Subject|6
871411|NCT00162123|2772440|P8|Overall Study|Follow-up only (not treated or assessed)|57
871412|NCT00162123|2772441|P7|Overall Study|Follow-up only (not treated or assessed)|0
871413|NCT00162123|2772442|P6|Overall Study|Follow-up only (not treated or assessed)|0
871414|NCT00162123|2772443|P5|Overall Study|Follow-up only (not treated or assessed)|0
871415|NCT00162123|2772444|P4|Overall Study|Follow-up only (not treated or assessed)|0
871416|NCT00162123|2772445|P3|Overall Study|Follow-up only (not treated or assessed)|0
871417|NCT00162123|2772446|P2|Overall Study|Follow-up only (not treated or assessed)|0
871418|NCT00162123|2772447|P1|Overall Study|Follow-up only (not treated or assessed)|0
871419|NCT00162123|2772440|P8|Overall Study|Tumor assessment only (not treated)|1
871420|NCT00162123|2772441|P7|Overall Study|Tumor assessment only (not treated)|0
871421|NCT00162123|2772442|P6|Overall Study|Tumor assessment only (not treated)|0
871422|NCT00162123|2772443|P5|Overall Study|Tumor assessment only (not treated)|0
871423|NCT00162123|2772444|P4|Overall Study|Tumor assessment only (not treated)|0
871424|NCT00162123|2772445|P3|Overall Study|Tumor assessment only (not treated)|0
871425|NCT00162123|2772446|P2|Overall Study|Tumor assessment only (not treated)|0
871426|NCT00162123|2772447|P1|Overall Study|Tumor assessment only (not treated)|0
871427|NCT00162123|2772440|P8|Overall Study|Physician Decision|0
871428|NCT00162123|2772441|P7|Overall Study|Physician Decision|1
871429|NCT00162123|2772442|P6|Overall Study|Physician Decision|1
871430|NCT00162123|2772443|P5|Overall Study|Physician Decision|0
871431|NCT00162123|2772444|P4|Overall Study|Physician Decision|0
871432|NCT00162123|2772445|P3|Overall Study|Physician Decision|0
871433|NCT00162123|2772446|P2|Overall Study|Physician Decision|2
871434|NCT00162123|2772447|P1|Overall Study|Physician Decision|1
871435|NCT00162123|2772440|P8|Overall Study|Not specified (after start of treatment)|0
871436|NCT00162123|2772441|P7|Overall Study|Not specified (after start of treatment)|0
871437|NCT00162123|2772442|P6|Overall Study|Not specified (after start of treatment)|0
871438|NCT00162123|2772443|P5|Overall Study|Not specified (after start of treatment)|3
871439|NCT00162123|2772444|P4|Overall Study|Not specified (after start of treatment)|0
871440|NCT00162123|2772445|P3|Overall Study|Not specified (after start of treatment)|0
871441|NCT00162123|2772446|P2|Overall Study|Not specified (after start of treatment)|0
871442|NCT00162123|2772447|P1|Overall Study|Not specified (after start of treatment)|0
871443|NCT00162123|2772440|P8|Overall Study|Not specified (before treatment)|0
871444|NCT00162123|2772441|P7|Overall Study|Not specified (before treatment)|0
871445|NCT00162123|2772442|P6|Overall Study|Not specified (before treatment)|1
871446|NCT00162123|2772443|P5|Overall Study|Not specified (before treatment)|12
871447|NCT00162123|2772444|P4|Overall Study|Not specified (before treatment)|0
871448|NCT00162123|2772445|P3|Overall Study|Not specified (before treatment)|0
871449|NCT00162123|2772446|P2|Overall Study|Not specified (before treatment)|0
871450|NCT00162123|2772447|P1|Overall Study|Not specified (before treatment)|2
871451|NCT00162123|2772440|P8|Overall Study|Adverse Event|0
871452|NCT00162123|2772441|P7|Overall Study|Adverse Event|0
871453|NCT00162123|2772442|P6|Overall Study|Adverse Event|0
871454|NCT00162123|2772443|P5|Overall Study|Adverse Event|1
871455|NCT00162123|2772444|P4|Overall Study|Adverse Event|2
871456|NCT00162123|2772445|P3|Overall Study|Adverse Event|0
871457|NCT00162123|2772446|P2|Overall Study|Adverse Event|2
871458|NCT00162123|2772447|P1|Overall Study|Adverse Event|1
871459|NCT00162123|2772440|P8|Overall Study|Deterioration without progression|0
871460|NCT00162123|2772441|P7|Overall Study|Deterioration without progression|0
871461|NCT00162123|2772442|P6|Overall Study|Deterioration without progression|0
871462|NCT00162123|2772443|P5|Overall Study|Deterioration without progression|1
871463|NCT00162123|2772444|P4|Overall Study|Deterioration without progression|0
871464|NCT00162123|2772445|P3|Overall Study|Deterioration without progression|3
871465|NCT00162123|2772446|P2|Overall Study|Deterioration without progression|2
871466|NCT00162123|2772447|P1|Overall Study|Deterioration without progression|2
871467|NCT00162123|2772440|P8|Overall Study|Withdrawal by Subject|0
871468|NCT00162123|2772441|P7|Overall Study|Withdrawal by Subject|1
871469|NCT00162123|2772442|P6|Overall Study|Withdrawal by Subject|2
871470|NCT00162123|2772443|P5|Overall Study|Withdrawal by Subject|1
871471|NCT00162123|2772444|P4|Overall Study|Withdrawal by Subject|1
871472|NCT00162123|2772445|P3|Overall Study|Withdrawal by Subject|2
871473|NCT00162123|2772446|P2|Overall Study|Withdrawal by Subject|0
871474|NCT00162123|2772447|P1|Overall Study|Withdrawal by Subject|2
871475|NCT00162123|2772440|P8|Overall Study|Death|0
871476|NCT00162123|2772441|P7|Overall Study|Death|0
871477|NCT00162123|2772442|P6|Overall Study|Death|1
871478|NCT00162123|2772443|P5|Overall Study|Death|1
871479|NCT00162123|2772444|P4|Overall Study|Death|1
871480|NCT00162123|2772445|P3|Overall Study|Death|1
871481|NCT00162123|2772446|P2|Overall Study|Death|3
871482|NCT00162123|2772447|P1|Overall Study|Death|3
871483|NCT00162123|2772440|P8|Overall Study|Study drug toxicity|0
871484|NCT00162123|2772441|P7|Overall Study|Study drug toxicity|1
871485|NCT00162123|2772442|P6|Overall Study|Study drug toxicity|1
871486|NCT00162123|2772443|P5|Overall Study|Study drug toxicity|4
871487|NCT00162123|2772444|P4|Overall Study|Study drug toxicity|0
871488|NCT00162123|2772445|P3|Overall Study|Study drug toxicity|5
871489|NCT00162123|2772446|P2|Overall Study|Study drug toxicity|1
871490|NCT00162123|2772447|P1|Overall Study|Study drug toxicity|6
871491|NCT00162123|2772440|P8|Overall Study|Disease progression|0
871492|NCT00162123|2772441|P7|Overall Study|Disease progression|1
871493|NCT00162123|2772442|P6|Overall Study|Disease progression|3
871494|NCT00162123|2772443|P5|Overall Study|Disease progression|8
871495|NCT00162123|2772444|P4|Overall Study|Disease progression|4
871496|NCT00162123|2772445|P3|Overall Study|Disease progression|10
871497|NCT00162123|2772446|P2|Overall Study|Disease progression|19
871498|NCT00162123|2772447|P1|Overall Study|Disease progression|27
871499|NCT00157014|2772480|P4|Overall Study|Withdrawal by Subject|0
871500|NCT00157014|2772481|P3|Overall Study|Withdrawal by Subject|0
871501|NCT00157014|2772482|P2|Overall Study|Withdrawal by Subject|0
871502|NCT00157014|2772483|P1|Overall Study|Withdrawal by Subject|1
871503|NCT00157014|2772480|P4|Overall Study|Patient would not receive transplant|0
871504|NCT00157014|2772481|P3|Overall Study|Patient would not receive transplant|0
871505|NCT00157014|2772482|P2|Overall Study|Patient would not receive transplant|1
871506|NCT00157014|2772483|P1|Overall Study|Patient would not receive transplant|0
871507|NCT00157014|2772480|P4|Overall Study|Patient unable to return in nursing home|0
871508|NCT00157014|2772481|P3|Overall Study|Patient unable to return in nursing home|0
871509|NCT00157014|2772482|P2|Overall Study|Patient unable to return in nursing home|0
871510|NCT00157014|2772483|P1|Overall Study|Patient unable to return in nursing home|1
871511|NCT00157014|2772480|P4|Overall Study|Patient withdrawn by investigator|0
871512|NCT00157014|2772481|P3|Overall Study|Patient withdrawn by investigator|0
871513|NCT00157014|2772482|P2|Overall Study|Patient withdrawn by investigator|0
871514|NCT00157014|2772483|P1|Overall Study|Patient withdrawn by investigator|1
871515|NCT00157014|2772480|P4|Overall Study|Medications withdrawn on family request|0
871516|NCT00157014|2772481|P3|Overall Study|Medications withdrawn on family request|0
871517|NCT00157014|2772482|P2|Overall Study|Medications withdrawn on family request|1
871518|NCT00157014|2772483|P1|Overall Study|Medications withdrawn on family request|0
871519|NCT00157014|2772480|P4|Overall Study|Physician Decision|0
871520|NCT00157014|2772481|P3|Overall Study|Physician Decision|0
871521|NCT00157014|2772482|P2|Overall Study|Physician Decision|1
871522|NCT00157014|2772483|P1|Overall Study|Physician Decision|0
871523|NCT00157014|2772480|P4|Overall Study|Death|1
871524|NCT00157014|2772481|P3|Overall Study|Death|1
871525|NCT00157014|2772482|P2|Overall Study|Death|2
871526|NCT00157014|2772483|P1|Overall Study|Death|4
871527|NCT00153816|2772567|P6|Overall Study|Follow-up exam done, histology missing|2
871528|NCT00153816|2772568|P5|Overall Study|Follow-up exam done, histology missing|1
871529|NCT00153816|2772569|P4|Overall Study|Follow-up exam done, histology missing|3
871530|NCT00153816|2772570|P3|Overall Study|Follow-up exam done, histology missing|3
871531|NCT00153816|2772571|P2|Overall Study|Follow-up exam done, histology missing|3
871532|NCT00153816|2772572|P1|Overall Study|Follow-up exam done, histology missing|2
871533|NCT00153816|2772567|P6|Overall Study|Follow-up exam not done|9
871534|NCT00153816|2772568|P5|Overall Study|Follow-up exam not done|8
871535|NCT00153816|2772569|P4|Overall Study|Follow-up exam not done|10
871536|NCT00153816|2772570|P3|Overall Study|Follow-up exam not done|11
871537|NCT00153816|2772571|P2|Overall Study|Follow-up exam not done|7
871538|NCT00153816|2772572|P1|Overall Study|Follow-up exam not done|8
871539|NCT00153816|2772567|P6|Overall Study|Withdrawal by Subject|5
871540|NCT00153816|2772568|P5|Overall Study|Withdrawal by Subject|1
871541|NCT00153816|2772569|P4|Overall Study|Withdrawal by Subject|4
871542|NCT00153816|2772570|P3|Overall Study|Withdrawal by Subject|9
871543|NCT00153816|2772571|P2|Overall Study|Withdrawal by Subject|9
871544|NCT00153816|2772572|P1|Overall Study|Withdrawal by Subject|9
871545|NCT00153816|2772567|P6|Overall Study|Lost to Follow-up|9
871546|NCT00153816|2772568|P5|Overall Study|Lost to Follow-up|7
871547|NCT00153816|2772569|P4|Overall Study|Lost to Follow-up|8
871548|NCT00153816|2772570|P3|Overall Study|Lost to Follow-up|5
871549|NCT00153816|2772571|P2|Overall Study|Lost to Follow-up|8
871550|NCT00153816|2772572|P1|Overall Study|Lost to Follow-up|7
871551|NCT00153816|2772567|P6|Overall Study|Death|2
871552|NCT00153816|2772568|P5|Overall Study|Death|0
871553|NCT00153816|2772569|P4|Overall Study|Death|6
871554|NCT00153816|2772570|P3|Overall Study|Death|4
871555|NCT00153816|2772571|P2|Overall Study|Death|5
871556|NCT00153816|2772572|P1|Overall Study|Death|6
871557|NCT00138424|2772596|P4|Overall Study|Physician Decision|0
871558|NCT00138424|2772597|P3|Overall Study|Physician Decision|0
871559|NCT00138424|2772598|P2|Overall Study|Physician Decision|1
871560|NCT00138424|2772599|P1|Overall Study|Physician Decision|0
871561|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Other Reason|1
871562|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Other Reason|0
871563|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Other Reason|2
871564|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Other Reason|3
871565|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Other Reason|5
871566|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Missing|0
871567|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Missing|0
871568|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Missing|1
871569|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Missing|0
871570|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Missing|0
871571|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Death|0
871572|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Death|1
871573|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Death|0
871574|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Death|0
871575|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Death|0
871576|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
871577|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
871578|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
871579|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
871580|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
871581|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Pregnancy|0
871582|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Pregnancy|1
871583|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Pregnancy|0
871584|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Pregnancy|1
871585|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Pregnancy|0
871586|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
871587|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
871588|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
871589|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
871590|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
871591|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
871592|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
871593|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
871594|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
871595|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
871596|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
871597|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
871598|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
871599|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
871600|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
871601|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Adverse Event|5
871602|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Adverse Event|5
871603|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Adverse Event|10
871604|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Adverse Event|10
871605|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Adverse Event|9
871606|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
871607|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
871608|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
871609|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
871610|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
871611|NCT00121641|2772669|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
871612|NCT00121641|2772670|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
871613|NCT00121641|2772671|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
871614|NCT00121641|2772672|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
871615|NCT00121641|2772673|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
871616|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Other Reason|0
871617|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Other Reason|0
871618|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Other Reason|0
871619|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Other Reason|0
871620|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Other Reason|1
871621|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
871622|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
871623|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
871624|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
871625|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
871626|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
871627|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
871628|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
871629|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
871630|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
871631|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
871632|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
871633|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
871634|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
871635|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
871636|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Adverse Event|2
871637|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Adverse Event|0
871638|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Adverse Event|4
871639|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Adverse Event|3
871640|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Adverse Event|3
871641|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
871642|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
871643|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
871644|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
871645|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
871646|NCT00121641|2772669|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
871647|NCT00121641|2772670|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
871648|NCT00121641|2772671|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
871649|NCT00121641|2772672|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
871650|NCT00121641|2772673|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
871651|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Death|2
871652|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Death|0
871653|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Death|0
871654|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Death|1
871655|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
871656|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
871657|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
871658|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
871659|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
871660|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
871661|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
871662|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
871663|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
871664|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
871665|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
871666|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
871667|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
871668|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
871669|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
871670|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
871671|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
871672|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
871673|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
871674|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
871675|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
871676|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
871677|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
871678|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
871679|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
871680|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
871681|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
871682|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
871683|NCT00121667|2772788|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
871684|NCT00121667|2772789|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
871685|NCT00121667|2772790|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
871686|NCT00121667|2772791|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
871687|NCT00121667|2772788|P4|Short Term (ST) Period|Pregnancy|1
871688|NCT00121667|2772789|P3|Short Term (ST) Period|Pregnancy|0
871689|NCT00121667|2772790|P2|Short Term (ST) Period|Pregnancy|0
871690|NCT00121667|2772791|P1|Short Term (ST) Period|Pregnancy|0
871691|NCT00121667|2772788|P4|Short Term (ST) Period|Death|1
871692|NCT00121667|2772789|P3|Short Term (ST) Period|Death|0
871693|NCT00121667|2772790|P2|Short Term (ST) Period|Death|0
871694|NCT00121667|2772791|P1|Short Term (ST) Period|Death|0
871695|NCT00121667|2772788|P4|Short Term (ST) Period|Other Reason|0
871696|NCT00121667|2772789|P3|Short Term (ST) Period|Other Reason|0
871697|NCT00121667|2772790|P2|Short Term (ST) Period|Other Reason|0
871698|NCT00121667|2772791|P1|Short Term (ST) Period|Other Reason|3
871699|NCT00121667|2772788|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
871700|NCT00121667|2772789|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
871701|NCT00121667|2772790|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
871702|NCT00121667|2772791|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
871703|NCT00121667|2772788|P4|Short Term (ST) Period|Poor / Non-compliance|2
871704|NCT00121667|2772789|P3|Short Term (ST) Period|Poor / Non-compliance|1
871705|NCT00121667|2772790|P2|Short Term (ST) Period|Poor / Non-compliance|1
871706|NCT00121667|2772791|P1|Short Term (ST) Period|Poor / Non-compliance|0
871707|NCT00121667|2772788|P4|Short Term (ST) Period|Lost to Follow-up|3
871708|NCT00121667|2772789|P3|Short Term (ST) Period|Lost to Follow-up|4
871709|NCT00121667|2772790|P2|Short Term (ST) Period|Lost to Follow-up|4
871710|NCT00121667|2772791|P1|Short Term (ST) Period|Lost to Follow-up|3
871711|NCT00121667|2772788|P4|Short Term (ST) Period|Adverse Event|3
871712|NCT00121667|2772789|P3|Short Term (ST) Period|Adverse Event|5
871713|NCT00121667|2772790|P2|Short Term (ST) Period|Adverse Event|6
871714|NCT00121667|2772791|P1|Short Term (ST) Period|Adverse Event|5
871715|NCT00121667|2772788|P4|Short Term (ST) Period|Subject Withdrew Consent|11
871716|NCT00121667|2772789|P3|Short Term (ST) Period|Subject Withdrew Consent|4
871717|NCT00121667|2772790|P2|Short Term (ST) Period|Subject Withdrew Consent|13
871718|NCT00121667|2772791|P1|Short Term (ST) Period|Subject Withdrew Consent|8
871719|NCT00121667|2772788|P4|Short Term (ST) Period|Lack of Efficacy|44
871720|NCT00121667|2772789|P3|Short Term (ST) Period|Lack of Efficacy|27
871721|NCT00121667|2772790|P2|Short Term (ST) Period|Lack of Efficacy|22
871722|NCT00121667|2772791|P1|Short Term (ST) Period|Lack of Efficacy|25
871723|NCT00117598|2772888|P5|After Treament Cross Over|Other|2
871724|NCT00117598|2772889|P4|After Treament Cross Over|Other|1
871725|NCT00117598|2772890|P3|After Treament Cross Over|Other|0
871726|NCT00117598|2772891|P2|After Treament Cross Over|Other|0
871727|NCT00117598|2772892|P1|After Treament Cross Over|Other|0
871728|NCT00117598|2772888|P5|After Treament Cross Over|Withdrawal by Subject|0
871729|NCT00117598|2772889|P4|After Treament Cross Over|Withdrawal by Subject|1
871730|NCT00117598|2772890|P3|After Treament Cross Over|Withdrawal by Subject|0
871731|NCT00117598|2772891|P2|After Treament Cross Over|Withdrawal by Subject|0
871732|NCT00117598|2772892|P1|After Treament Cross Over|Withdrawal by Subject|0
871733|NCT00117598|2772888|P5|After Treament Cross Over|Death|2
871734|NCT00117598|2772889|P4|After Treament Cross Over|Death|1
871735|NCT00117598|2772890|P3|After Treament Cross Over|Death|0
871736|NCT00117598|2772891|P2|After Treament Cross Over|Death|0
871737|NCT00117598|2772892|P1|After Treament Cross Over|Death|0
871738|NCT00117598|2772888|P5|Prior to Treatment Cross Over|Other|0
871739|NCT00117598|2772889|P4|Prior to Treatment Cross Over|Other|0
871740|NCT00117598|2772890|P3|Prior to Treatment Cross Over|Other|9
871741|NCT00117598|2772891|P2|Prior to Treatment Cross Over|Other|9
871742|NCT00117598|2772892|P1|Prior to Treatment Cross Over|Other|15
871743|NCT00117598|2772888|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
871744|NCT00117598|2772889|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
871745|NCT00117598|2772890|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
871746|NCT00117598|2772891|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
871747|NCT00117598|2772892|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
871748|NCT00117598|2772888|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
871749|NCT00117598|2772889|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
871750|NCT00117598|2772890|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
871751|NCT00117598|2772891|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
871752|NCT00117598|2772892|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
871753|NCT00117598|2772888|P5|Prior to Treatment Cross Over|Death|0
871754|NCT00117598|2772889|P4|Prior to Treatment Cross Over|Death|0
871755|NCT00117598|2772890|P3|Prior to Treatment Cross Over|Death|37
871756|NCT00117598|2772891|P2|Prior to Treatment Cross Over|Death|41
871757|NCT00117598|2772892|P1|Prior to Treatment Cross Over|Death|40
871758|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Not Specified|2
871759|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Not Specified|0
871760|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Not Specified|2
871761|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
871762|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
871763|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
871764|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
871765|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
871766|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
871767|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
871768|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
871769|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
871770|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Adverse Event|7
871771|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Adverse Event|14
871772|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Adverse Event|15
871773|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
871774|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
871775|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
871776|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
871777|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
871778|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
871779|NCT00114777|2772923|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
871780|NCT00114777|2772924|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
871781|NCT00114777|2772925|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
871782|NCT00114777|2772923|P3|Long-Term Extension to Month 84|Death|7
871783|NCT00114777|2772924|P2|Long-Term Extension to Month 84|Death|13
871784|NCT00114777|2772925|P1|Long-Term Extension to Month 84|Death|8
871785|NCT00114777|2772923|P3|Randomization to Month 36|Not Specified|12
871786|NCT00114777|2772924|P2|Randomization to Month 36|Not Specified|3
871787|NCT00114777|2772925|P1|Randomization to Month 36|Not Specified|9
871788|NCT00114777|2772923|P3|Randomization to Month 36|Withdrawal by Subject|5
871789|NCT00114777|2772924|P2|Randomization to Month 36|Withdrawal by Subject|4
871790|NCT00114777|2772925|P1|Randomization to Month 36|Withdrawal by Subject|3
871791|NCT00114777|2772923|P3|Randomization to Month 36|Adverse Event|44
871792|NCT00114777|2772924|P2|Randomization to Month 36|Adverse Event|35
871793|NCT00114777|2772925|P1|Randomization to Month 36|Adverse Event|34
871794|NCT00114777|2772923|P3|Randomization to Month 36|Poor or Non-Compliance|1
871795|NCT00114777|2772924|P2|Randomization to Month 36|Poor or Non-Compliance|0
871796|NCT00114777|2772925|P1|Randomization to Month 36|Poor or Non-Compliance|0
871797|NCT00114777|2772923|P3|Randomization to Month 36|Lack of Efficacy|17
871798|NCT00114777|2772924|P2|Randomization to Month 36|Lack of Efficacy|15
871799|NCT00114777|2772925|P1|Randomization to Month 36|Lack of Efficacy|19
871800|NCT00114777|2772923|P3|Randomization to Month 36|No Longer Met Study Criteria|2
871801|NCT00114777|2772924|P2|Randomization to Month 36|No Longer Met Study Criteria|0
871802|NCT00114777|2772925|P1|Randomization to Month 36|No Longer Met Study Criteria|0
871803|NCT00114777|2772923|P3|Randomization to Month 36|Death|3
871804|NCT00114777|2772924|P2|Randomization to Month 36|Death|4
871805|NCT00114777|2772925|P1|Randomization to Month 36|Death|10
871806|NCT00051363|2773025|P2|Overall Study|Excluded Pre-Randomization|5
871807|NCT00051363|2773026|P1|Overall Study|Excluded Pre-Randomization|2
871808|NCT00051363|2773025|P2|Overall Study|Death|2
871809|NCT00051363|2773026|P1|Overall Study|Death|2
871810|NCT00051363|2773025|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
871811|NCT00051363|2773026|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
871812|NCT00051363|2773025|P2|Overall Study|Dropped Post-Rand for Any Reason|126
871813|NCT00051363|2773026|P1|Overall Study|Dropped Post-Rand for Any Reason|102
871814|NCT00044213|2773064|P4|Overall Study|Lost to Follow-up|4
871815|NCT00044213|2773065|P3|Overall Study|Lost to Follow-up|5
871816|NCT00044213|2773066|P2|Overall Study|Lost to Follow-up|5
871817|NCT00044213|2773067|P1|Overall Study|Lost to Follow-up|8
871818|NCT00044213|2773064|P4|Overall Study|Death|49
871819|NCT00044213|2773065|P3|Overall Study|Death|42
871820|NCT00044213|2773066|P2|Overall Study|Death|42
871821|NCT00044213|2773067|P1|Overall Study|Death|42
871822|NCT00044213|2773064|P4|Overall Study|Withdrawal by Subject|83
871823|NCT00044213|2773065|P3|Overall Study|Withdrawal by Subject|91
871824|NCT00044213|2773066|P2|Overall Study|Withdrawal by Subject|65
871825|NCT00044213|2773067|P1|Overall Study|Withdrawal by Subject|50
871826|NCT00031486|2773083|P2|Overall Study|Other|1
871827|NCT00031486|2773084|P1|Overall Study|Other|1
871828|NCT00031486|2773083|P2|Overall Study|Did not meet eligibility requirement|1
871829|NCT00031486|2773084|P1|Overall Study|Did not meet eligibility requirement|2
871830|NCT00031486|2773083|P2|Overall Study|Non-compliant|4
871831|NCT00031486|2773084|P1|Overall Study|Non-compliant|0
871832|NCT00031486|2773083|P2|Overall Study|Death|3
871833|NCT00031486|2773084|P1|Overall Study|Death|0
871834|NCT00031486|2773083|P2|Overall Study|Withdrawal by Subject|2
871835|NCT00031486|2773084|P1|Overall Study|Withdrawal by Subject|3
871836|NCT00031486|2773083|P2|Overall Study|Lost to Follow-up|1
871837|NCT00031486|2773084|P1|Overall Study|Lost to Follow-up|0
871838|NCT00031486|2773083|P2|Overall Study|Adverse Event|0
871839|NCT00031486|2773084|P1|Overall Study|Adverse Event|1
871840|NCT02751320|2773165|P1|Overall Study|Withdrawal by Subject|1
871841|NCT02751320|2773165|P1|Overall Study|Adverse Event|2
871842|NCT02730351|2773201|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
871843|NCT02730351|2773202|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
871844|NCT02730351|2773201|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
871845|NCT02730351|2773202|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
871846|NCT02730351|2773201|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
871847|NCT02730351|2773202|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
871848|NCT02730351|2773201|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
871849|NCT02730351|2773202|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
871850|NCT02730351|2773201|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
871851|NCT02730351|2773202|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
871852|NCT02724111|2773216|P2|Overall Study|Protocol Violation|5
871853|NCT02724111|2773217|P1|Overall Study|Protocol Violation|2
871854|NCT02191137|2773303|P1|Follow-up|Adverse Event|1
871855|NCT02191137|2773303|P1|Follow-up|Ongoing/unknown|2
871856|NCT02191137|2773303|P1|Follow-up|Lost to Follow-up|2
871857|NCT02191137|2773303|P1|Treatment|Other|1
871858|NCT02191137|2773303|P1|Treatment|Adverse Event|2
871859|NCT02191137|2773303|P1|Treatment|Withdrawal by Subject|3
871860|NCT02191137|2773303|P1|Treatment|Death|4
871861|NCT02187861|2773335|P4|Overall Study|Alive in Study Follow-Up|31
871862|NCT02187861|2773336|P3|Overall Study|Alive in Study Follow-Up|26
871863|NCT02187861|2773337|P2|Overall Study|Alive in Study Follow-Up|10
871864|NCT02187861|2773338|P1|Overall Study|Alive in Study Follow-Up|4
871865|NCT02187861|2773335|P4|Overall Study|Other|1
871866|NCT02187861|2773336|P3|Overall Study|Other|6
871867|NCT02187861|2773337|P2|Overall Study|Other|2
871868|NCT02187861|2773338|P1|Overall Study|Other|0
871869|NCT02187861|2773335|P4|Overall Study|Withdrawal by Subject|3
871870|NCT02187861|2773336|P3|Overall Study|Withdrawal by Subject|2
871871|NCT02187861|2773337|P2|Overall Study|Withdrawal by Subject|0
871872|NCT02187861|2773338|P1|Overall Study|Withdrawal by Subject|0
871873|NCT02187861|2773335|P4|Overall Study|Progressive Disease|11
871874|NCT02187861|2773336|P3|Overall Study|Progressive Disease|13
871875|NCT02187861|2773337|P2|Overall Study|Progressive Disease|35
871876|NCT02187861|2773338|P1|Overall Study|Progressive Disease|3
871877|NCT02187861|2773335|P4|Overall Study|Physician Decision|3
871878|NCT02187861|2773336|P3|Overall Study|Physician Decision|0
871879|NCT02187861|2773337|P2|Overall Study|Physician Decision|1
871880|NCT02187861|2773338|P1|Overall Study|Physician Decision|0
871881|NCT02187861|2773335|P4|Overall Study|Lack of Efficacy|0
871882|NCT02187861|2773336|P3|Overall Study|Lack of Efficacy|0
871883|NCT02187861|2773337|P2|Overall Study|Lack of Efficacy|1
871884|NCT02187861|2773338|P1|Overall Study|Lack of Efficacy|0
871885|NCT02187861|2773335|P4|Overall Study|Death|2
871886|NCT02187861|2773336|P3|Overall Study|Death|1
871887|NCT02187861|2773337|P2|Overall Study|Death|3
871888|NCT02187861|2773338|P1|Overall Study|Death|0
871889|NCT02187861|2773335|P4|Overall Study|Adverse Event|0
871890|NCT02187861|2773336|P3|Overall Study|Adverse Event|3
871891|NCT02187861|2773337|P2|Overall Study|Adverse Event|1
871892|NCT02187861|2773338|P1|Overall Study|Adverse Event|2
871893|NCT02128997|2773436|P2|Overall Study|Lost to Follow-up|11
871894|NCT02128997|2773437|P1|Overall Study|Lost to Follow-up|6
871895|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
871896|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
871897|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
871898|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Protocol Violation|11
871899|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Pregnancy|1
871900|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Physician Decision|10
871901|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
871902|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
871903|NCT02092285|2773449|P1|Maintenance Phase & Follow-up|Adverse Event|22
871904|NCT02092285|2773449|P1|Induction Phase|Lack of Efficacy|14
871905|NCT02092285|2773449|P1|Induction Phase|Withdrawal by Subject|2
871906|NCT02092285|2773449|P1|Induction Phase|Relapse/Recurrence|7
871907|NCT02092285|2773449|P1|Induction Phase|Pregnancy|1
871908|NCT02092285|2773449|P1|Induction Phase|Physician Decision|4
871909|NCT02092285|2773449|P1|Induction Phase|Adverse Event|7
871910|NCT02077140|2773458|P5|Overall Study|Withdrawal by Subject|2
871911|NCT02077140|2773459|P4|Overall Study|Withdrawal by Subject|2
871912|NCT02077140|2773460|P3|Overall Study|Withdrawal by Subject|0
871913|NCT02077140|2773461|P2|Overall Study|Withdrawal by Subject|1
871914|NCT02077140|2773462|P1|Overall Study|Withdrawal by Subject|0
871915|NCT02077140|2773458|P5|Overall Study|Lost to Follow-up|3
871916|NCT02077140|2773459|P4|Overall Study|Lost to Follow-up|2
871917|NCT02077140|2773460|P3|Overall Study|Lost to Follow-up|2
871918|NCT02077140|2773461|P2|Overall Study|Lost to Follow-up|1
871919|NCT02077140|2773462|P1|Overall Study|Lost to Follow-up|4
871920|NCT02035696|2773560|P4|Overall Study|Withdrawal by Subject|1
871921|NCT02035696|2773561|P3|Overall Study|Withdrawal by Subject|2
871922|NCT02035696|2773562|P2|Overall Study|Withdrawal by Subject|0
871923|NCT02035696|2773563|P1|Overall Study|Withdrawal by Subject|3
871924|NCT02035696|2773560|P4|Overall Study|Lost to Follow-up|2
871925|NCT02035696|2773561|P3|Overall Study|Lost to Follow-up|1
871926|NCT02035696|2773562|P2|Overall Study|Lost to Follow-up|3
871927|NCT02035696|2773563|P1|Overall Study|Lost to Follow-up|0
871928|NCT01683019|2773633|P3|Overall Study|Withdrawal by Subject|4
871929|NCT01683019|2773634|P2|Overall Study|Withdrawal by Subject|1
871930|NCT01683019|2773635|P1|Overall Study|Withdrawal by Subject|2
871931|NCT01639040|2773645|P2|Overall Study|Adverse Event|0
871932|NCT01639040|2773646|P1|Overall Study|Adverse Event|1
871933|NCT01610492|2773666|P1|Overall Study|Other:Treatment stopped due to remission|1
871934|NCT01610492|2773666|P1|Overall Study|Other: Reached stopping criteria|1
871935|NCT01610492|2773666|P1|Overall Study|Lack of Efficacy|3
871936|NCT01610492|2773666|P1|Overall Study|Adverse Event|1
871937|NCT01539759|2773718|P2|Overall Study|Lost to Follow-up|8
871938|NCT01539759|2773719|P1|Overall Study|Lost to Follow-up|6
871939|NCT01506479|2773732|P3|Overall Study|Adverse Event|0
871940|NCT01506479|2773733|P2|Overall Study|Adverse Event|1
871941|NCT01506479|2773734|P1|Overall Study|Adverse Event|0
871942|NCT01506479|2773732|P3|Overall Study|Missing assessment|0
871943|NCT01506479|2773733|P2|Overall Study|Missing assessment|0
871944|NCT01506479|2773734|P1|Overall Study|Missing assessment|1
871945|NCT01506479|2773732|P3|Overall Study|Withdrawal by Subject|1
871946|NCT01506479|2773733|P2|Overall Study|Withdrawal by Subject|2
871947|NCT01506479|2773734|P1|Overall Study|Withdrawal by Subject|1
871948|NCT01506479|2773732|P3|Overall Study|Lost to Follow-up|2
871949|NCT01506479|2773733|P2|Overall Study|Lost to Follow-up|2
871950|NCT01506479|2773734|P1|Overall Study|Lost to Follow-up|1
871963|NCT01154101|2773905|P5|Overall Study|Withdrawal by Subject|1
871964|NCT01154101|2773906|P4|Overall Study|Withdrawal by Subject|0
871965|NCT01154101|2773907|P3|Overall Study|Withdrawal by Subject|2
871966|NCT01154101|2773908|P2|Overall Study|Withdrawal by Subject|1
871967|NCT01154101|2773909|P1|Overall Study|Withdrawal by Subject|0
871968|NCT01154101|2773905|P5|Overall Study|Lost to Follow-up|0
871969|NCT01154101|2773906|P4|Overall Study|Lost to Follow-up|1
871970|NCT01154101|2773907|P3|Overall Study|Lost to Follow-up|0
871971|NCT01154101|2773908|P2|Overall Study|Lost to Follow-up|1
871972|NCT01154101|2773909|P1|Overall Study|Lost to Follow-up|0
871973|NCT01154101|2773905|P5|Overall Study|Adverse Event|0
871974|NCT01154101|2773906|P4|Overall Study|Adverse Event|1
871975|NCT01154101|2773907|P3|Overall Study|Adverse Event|1
871976|NCT01154101|2773908|P2|Overall Study|Adverse Event|2
871977|NCT01154101|2773909|P1|Overall Study|Adverse Event|0
871978|NCT01130493|2773961|P3|Part 2: OLE|Withdrawal by Subject|4
871979|NCT01130493|2773962|P2|Part 2: OLE|Withdrawal by Subject|1
871980|NCT01130493|2773963|P1|Part 2: OLE|Withdrawal by Subject|0
871981|NCT01130493|2773961|P3|Part 2: OLE|Adverse Event|1
871982|NCT01130493|2773962|P2|Part 2: OLE|Adverse Event|2
871983|NCT01130493|2773963|P1|Part 2: OLE|Adverse Event|0
871984|NCT01130493|2773961|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
871985|NCT01130493|2773962|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
871986|NCT01130493|2773963|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
871987|NCT01130493|2773961|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
871988|NCT01130493|2773962|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
871989|NCT01130493|2773963|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
871990|NCT01130493|2773961|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
871991|NCT01130493|2773962|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
871992|NCT01130493|2773963|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
871993|NCT01130493|2773961|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
871994|NCT01130493|2773962|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
871995|NCT01130493|2773963|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
871996|NCT01130493|2773961|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
871997|NCT01130493|2773962|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
871998|NCT01130493|2773963|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
871999|NCT01130493|2773961|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
872000|NCT01130493|2773962|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
872001|NCT01130493|2773963|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
872002|NCT01130493|2773961|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
872003|NCT01130493|2773962|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
872004|NCT01130493|2773963|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
872005|NCT01130493|2773961|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
872006|NCT01130493|2773962|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
872007|NCT01130493|2773963|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
872008|NCT01130493|2773961|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
872009|NCT01130493|2773962|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
872010|NCT01130493|2773963|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
872011|NCT01130493|2773961|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
872012|NCT01130493|2773962|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
872013|NCT01130493|2773963|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
872014|NCT01130493|2773961|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
872015|NCT01130493|2773962|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
872016|NCT01130493|2773963|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
872017|NCT01130493|2773961|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
872018|NCT01130493|2773962|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
872019|NCT01130493|2773963|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
872020|NCT01057862|2773993|P2|Overall Study|Withdrawal by Subject|2
872021|NCT01057862|2773994|P1|Overall Study|Withdrawal by Subject|1
872022|NCT00972478|2774049|P2|Overall Study|Not start protocol treatment|2
872023|NCT00972478|2774050|P1|Overall Study|Not start protocol treatment|1
872024|NCT00972478|2774049|P2|Overall Study|Ineligible|7
872025|NCT00972478|2774050|P1|Overall Study|Ineligible|1
872026|NCT00972478|2774049|P2|Overall Study|Not protocol specified|1
872027|NCT00972478|2774050|P1|Overall Study|Not protocol specified|1
872028|NCT00972478|2774049|P2|Overall Study|Death|2
872029|NCT00972478|2774050|P1|Overall Study|Death|0
872030|NCT00972478|2774049|P2|Overall Study|Progression/Relapse|2
872031|NCT00972478|2774050|P1|Overall Study|Progression/Relapse|0
872032|NCT00972478|2774049|P2|Overall Study|Withdrawal by Subject|8
872033|NCT00972478|2774050|P1|Overall Study|Withdrawal by Subject|1
872034|NCT00972478|2774049|P2|Overall Study|Adverse Event|16
872035|NCT00972478|2774050|P1|Overall Study|Adverse Event|3
872041|NCT00880048|2774080|P3|Overall Study|Study closed/terminated|6
872042|NCT00880048|2774081|P2|Overall Study|Study closed/terminated|7
872043|NCT00880048|2774082|P1|Overall Study|Study closed/terminated|9
872044|NCT00880048|2774080|P3|Overall Study|Withdrawal by Subject|5
872045|NCT00880048|2774081|P2|Overall Study|Withdrawal by Subject|8
872046|NCT00880048|2774082|P1|Overall Study|Withdrawal by Subject|5
872047|NCT00880048|2774080|P3|Overall Study|Physician Decision|7
872048|NCT00880048|2774081|P2|Overall Study|Physician Decision|1
872049|NCT00880048|2774082|P1|Overall Study|Physician Decision|1
872050|NCT00880048|2774080|P3|Overall Study|Lost to Follow-up|5
872051|NCT00880048|2774081|P2|Overall Study|Lost to Follow-up|6
872052|NCT00880048|2774082|P1|Overall Study|Lost to Follow-up|6
872053|NCT00880048|2774080|P3|Overall Study|Protocol Violation|5
872054|NCT00880048|2774081|P2|Overall Study|Protocol Violation|6
872055|NCT00880048|2774082|P1|Overall Study|Protocol Violation|4
872056|NCT00880048|2774080|P3|Overall Study|Lack of Efficacy|2
872057|NCT00880048|2774081|P2|Overall Study|Lack of Efficacy|2
872058|NCT00880048|2774082|P1|Overall Study|Lack of Efficacy|1
872059|NCT00880048|2774080|P3|Overall Study|Adverse Event|5
872060|NCT00880048|2774081|P2|Overall Study|Adverse Event|3
872061|NCT00880048|2774082|P1|Overall Study|Adverse Event|2
872062|NCT00659230|2774162|P2|Overall Study|Did not return post-randomization|3
872063|NCT00659230|2774163|P1|Overall Study|Did not return post-randomization|2
872064|NCT00659230|2774162|P2|Overall Study|Lost source documentation|4
872065|NCT00659230|2774163|P1|Overall Study|Lost source documentation|5
872066|NCT00659230|2774162|P2|Overall Study|Lost to Follow-up|5
872067|NCT00659230|2774163|P1|Overall Study|Lost to Follow-up|2
872090|NCT00644995|2774194|P2|Overall Study|Refused|0
872091|NCT00644995|2774195|P1|Overall Study|Refused|1
872092|NCT00644995|2774194|P2|Overall Study|Lost to Follow-up|4
872093|NCT00644995|2774195|P1|Overall Study|Lost to Follow-up|1
872094|NCT00325819|2774232|P2|Overall Study|Lost to Follow-up|3
872095|NCT00325819|2774233|P1|Overall Study|Lost to Follow-up|3
872096|NCT00325819|2774232|P2|Overall Study|Did not take a dose of study product|9
872097|NCT00325819|2774233|P1|Overall Study|Did not take a dose of study product|4
872098|NCT00325819|2774232|P2|Overall Study|Study product lost in mail|1
872099|NCT00325819|2774233|P1|Overall Study|Study product lost in mail|2
872100|NCT00287365|2774253|P1|Overall Study|sample not acquired|13
900362|NCT02570126|2861927|P2|Overall Study|Withdrawal by Subject|7
900363|NCT02570126|2861928|P1|Overall Study|Withdrawal by Subject|3
900364|NCT02570126|2861927|P2|Overall Study|Protocol Violation|1
900365|NCT02570126|2861928|P1|Overall Study|Protocol Violation|0
900366|NCT02570126|2861927|P2|Overall Study|Violation Of Procedures GSK|1
900367|NCT02570126|2861928|P1|Overall Study|Violation Of Procedures GSK|0
900368|NCT02570126|2861927|P2|Overall Study|Unable To Arrange Visit 3|0
900369|NCT02570126|2861928|P1|Overall Study|Unable To Arrange Visit 3|1
900370|NCT02570126|2861927|P2|Overall Study|Lost to Follow-up|0
900371|NCT02570126|2861928|P1|Overall Study|Lost to Follow-up|2
900389|NCT02411578|2862025|P2|Crossover Trial Phase|Pregnancy|1
900390|NCT02411578|2862026|P1|Crossover Trial Phase|Pregnancy|0
900424|NCT02242643|2862189|P2|Overall Study|Withdrawal by subject at Visit 2|1
900425|NCT02242643|2862190|P1|Overall Study|Withdrawal by subject at Visit 2|0
900426|NCT02242643|2862189|P2|Overall Study|Language barrier|0
900427|NCT02242643|2862190|P1|Overall Study|Language barrier|1
900428|NCT02242643|2862189|P2|Overall Study|Protocol requirements not followed|0
900429|NCT02242643|2862190|P1|Overall Study|Protocol requirements not followed|1
900430|NCT02242643|2862189|P2|Overall Study|Consent withdrawal by parent|0
900431|NCT02242643|2862190|P1|Overall Study|Consent withdrawal by parent|1
900432|NCT02242643|2862189|P2|Overall Study|Non-compliance|0
900433|NCT02242643|2862190|P1|Overall Study|Non-compliance|1
900434|NCT02242643|2862189|P2|Overall Study|Child placed in foster care by family|1
900435|NCT02242643|2862190|P1|Overall Study|Child placed in foster care by family|0
900436|NCT02242643|2862189|P2|Overall Study|Lost to Follow-up|61
900437|NCT02242643|2862190|P1|Overall Study|Lost to Follow-up|54
900438|NCT02242643|2862189|P2|Overall Study|Migrated/moved from study area|3
900439|NCT02242643|2862190|P1|Overall Study|Migrated/moved from study area|1
900440|NCT02242643|2862189|P2|Overall Study|Withdrawal by Subject|10
900441|NCT02242643|2862190|P1|Overall Study|Withdrawal by Subject|15
900442|NCT02242643|2862189|P2|Overall Study|Protocol Violation|2
900443|NCT02242643|2862190|P1|Overall Study|Protocol Violation|1
900500|NCT01827839|2862373|P1|Overall Study|Consent Withdrawal|2
900501|NCT01827839|2862373|P1|Overall Study|Adverse Event|1
900573|NCT01448707|2862778|P2|Overall Study|Other|4
900574|NCT01448707|2862779|P1|Overall Study|Other|7
900575|NCT01448707|2862778|P2|Overall Study|Withdrawal by Subject|7
900576|NCT01448707|2862779|P1|Overall Study|Withdrawal by Subject|6
900577|NCT01448707|2862778|P2|Overall Study|Lost to Follow-up|6
900578|NCT01448707|2862779|P1|Overall Study|Lost to Follow-up|2
900579|NCT01448707|2862778|P2|Overall Study|Adverse Event|1
900580|NCT01448707|2862779|P1|Overall Study|Adverse Event|3
900596|NCT01366534|2862937|P3|Overall Study|Declined challenged|0
900597|NCT01366534|2862938|P2|Overall Study|Declined challenged|1
900598|NCT01366534|2862939|P1|Overall Study|Declined challenged|0
900599|NCT01366534|2862937|P3|Overall Study|Migrated|0
900600|NCT01366534|2862938|P2|Overall Study|Migrated|1
900601|NCT01366534|2862939|P1|Overall Study|Migrated|1
900602|NCT01366534|2862937|P3|Overall Study|Lost to Follow-up|0
900603|NCT01366534|2862938|P2|Overall Study|Lost to Follow-up|0
900604|NCT01366534|2862939|P1|Overall Study|Lost to Follow-up|1
900662|NCT01295320|2863050|P1|Overall Study|Unable to travel|1
900663|NCT01295320|2863050|P1|Overall Study|Subject was bedridden|1
900664|NCT01295320|2863050|P1|Overall Study|Withdrawal by Subject|2
900665|NCT01295320|2863050|P1|Overall Study|Lost to Follow-up|4
900666|NCT01295320|2863050|P1|Overall Study|Adverse Event|2
900669|NCT01165203|2863150|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
900670|NCT01165203|2863151|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
900671|NCT01165203|2863150|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
900672|NCT01165203|2863151|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
900673|NCT01165203|2863150|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
900674|NCT01165203|2863151|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
900675|NCT01165203|2863150|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
900676|NCT01165203|2863151|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
900677|NCT01165203|2863150|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
900678|NCT01165203|2863151|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
900679|NCT01165203|2863150|P2|Active Phase|Lost to Follow-up|0
900680|NCT01165203|2863151|P1|Active Phase|Lost to Follow-up|2
900681|NCT01165203|2863150|P2|Active Phase|Migrated/moved from study area|1
900682|NCT01165203|2863151|P1|Active Phase|Migrated/moved from study area|0
900683|NCT01165203|2863150|P2|Active Phase|Withdrawal by Subject|1
900684|NCT01165203|2863151|P1|Active Phase|Withdrawal by Subject|2
900685|NCT01165203|2863150|P2|Active Phase|Serious Adverse Event|0
900686|NCT01165203|2863151|P1|Active Phase|Serious Adverse Event|1
900910|NCT00940108|2863567|P4|Overall Study|Diagnosed with H1N1|1
900911|NCT00940108|2863568|P3|Overall Study|Diagnosed with H1N1|0
900912|NCT00940108|2863569|P2|Overall Study|Diagnosed with H1N1|0
900913|NCT00940108|2863570|P1|Overall Study|Diagnosed with H1N1|0
900914|NCT00940108|2863567|P4|Overall Study|Viral illness after Dose 1|0
900915|NCT00940108|2863568|P3|Overall Study|Viral illness after Dose 1|0
900916|NCT00940108|2863569|P2|Overall Study|Viral illness after Dose 1|1
900917|NCT00940108|2863570|P1|Overall Study|Viral illness after Dose 1|0
900918|NCT00940108|2863567|P4|Overall Study|Refused - pyrexia after Dose 1|0
900919|NCT00940108|2863568|P3|Overall Study|Refused - pyrexia after Dose 1|0
900920|NCT00940108|2863569|P2|Overall Study|Refused - pyrexia after Dose 1|1
900921|NCT00940108|2863570|P1|Overall Study|Refused - pyrexia after Dose 1|0
900922|NCT00940108|2863567|P4|Overall Study|Declined further vaccination|0
900923|NCT00940108|2863568|P3|Overall Study|Declined further vaccination|3
900924|NCT00940108|2863569|P2|Overall Study|Declined further vaccination|1
900925|NCT00940108|2863570|P1|Overall Study|Declined further vaccination|0
900926|NCT00940108|2863567|P4|Overall Study|Dose 2 contraindicated|1
900927|NCT00940108|2863568|P3|Overall Study|Dose 2 contraindicated|0
900928|NCT00940108|2863569|P2|Overall Study|Dose 2 contraindicated|1
900929|NCT00940108|2863570|P1|Overall Study|Dose 2 contraindicated|1
900930|NCT00940108|2863567|P4|Overall Study|Withdrew Consent|1
900931|NCT00940108|2863568|P3|Overall Study|Withdrew Consent|0
900932|NCT00940108|2863569|P2|Overall Study|Withdrew Consent|1
900933|NCT00940108|2863570|P1|Overall Study|Withdrew Consent|2
900934|NCT00940108|2863567|P4|Overall Study|Adverse Event|2
900935|NCT00940108|2863568|P3|Overall Study|Adverse Event|0
900936|NCT00940108|2863569|P2|Overall Study|Adverse Event|4
900937|NCT00940108|2863570|P1|Overall Study|Adverse Event|2
900938|NCT00938639|2863622|P2|Overall Study|Participant noncompliance|0
900939|NCT00938639|2863623|P1|Overall Study|Participant noncompliance|1
900940|NCT00938639|2863622|P2|Overall Study|Family issues|1
900941|NCT00938639|2863623|P1|Overall Study|Family issues|1
900942|NCT00938639|2863622|P2|Overall Study|Lost to Follow-up|2
900943|NCT00938639|2863623|P1|Overall Study|Lost to Follow-up|1
900944|NCT00938639|2863622|P2|Overall Study|Moved away from study area|1
900945|NCT00938639|2863623|P1|Overall Study|Moved away from study area|0
900956|NCT00888381|2863737|P2|Overall Study|Lost to Follow-up|1
900957|NCT00888381|2863738|P1|Overall Study|Lost to Follow-up|0
900972|NCT00829010|2863806|P5|Overall Study|Migrated/Moved from study area|0
900973|NCT00829010|2863807|P4|Overall Study|Migrated/Moved from study area|5
900974|NCT00829010|2863808|P3|Overall Study|Migrated/Moved from study area|0
900975|NCT00829010|2863809|P2|Overall Study|Migrated/Moved from study area|4
900976|NCT00829010|2863810|P1|Overall Study|Migrated/Moved from study area|3
900977|NCT00829010|2863806|P5|Overall Study|Fatality|0
900978|NCT00829010|2863807|P4|Overall Study|Fatality|3
900979|NCT00829010|2863808|P3|Overall Study|Fatality|0
873078|NCT02675634|2778098|P6|Test Period 2|Adverse Event|1
873079|NCT02675634|2778099|P5|Test Period 2|Adverse Event|0
873080|NCT02675634|2778100|P4|Test Period 2|Adverse Event|0
873081|NCT02675634|2778101|P3|Test Period 2|Adverse Event|0
873082|NCT02675634|2778102|P2|Test Period 2|Adverse Event|0
873083|NCT02675634|2778103|P1|Test Period 2|Adverse Event|0
873084|NCT02675634|2778098|P6|Test Period 2|Lack of Efficacy|0
873085|NCT02675634|2778099|P5|Test Period 2|Lack of Efficacy|0
873086|NCT02675634|2778100|P4|Test Period 2|Lack of Efficacy|0
873087|NCT02675634|2778101|P3|Test Period 2|Lack of Efficacy|0
873088|NCT02675634|2778102|P2|Test Period 2|Lack of Efficacy|0
873089|NCT02675634|2778103|P1|Test Period 2|Lack of Efficacy|1
873090|NCT02675634|2778098|P6|Test Period 1|Device deficiency that did not lead to A|0
873091|NCT02675634|2778099|P5|Test Period 1|Device deficiency that did not lead to A|0
873092|NCT02675634|2778100|P4|Test Period 1|Device deficiency that did not lead to A|0
873093|NCT02675634|2778101|P3|Test Period 1|Device deficiency that did not lead to A|1
873094|NCT02675634|2778102|P2|Test Period 1|Device deficiency that did not lead to A|0
873095|NCT02675634|2778103|P1|Test Period 1|Device deficiency that did not lead to A|0
873096|NCT02675634|2778098|P6|Test Period 1|Adverse Event|0
873097|NCT02675634|2778099|P5|Test Period 1|Adverse Event|0
873098|NCT02675634|2778100|P4|Test Period 1|Adverse Event|1
873099|NCT02675634|2778101|P3|Test Period 1|Adverse Event|0
873100|NCT02675634|2778102|P2|Test Period 1|Adverse Event|1
873101|NCT02675634|2778103|P1|Test Period 1|Adverse Event|0
873102|NCT02651194|2778111|P1|Overall Study|Not Specified|2
873103|NCT02651194|2778111|P1|Overall Study|Lost to Follow-up|3
900980|NCT00829010|2863809|P2|Overall Study|Fatality|4
900981|NCT00829010|2863810|P1|Overall Study|Fatality|5
900982|NCT00829010|2863806|P5|Overall Study|Lost to Follow-up|0
873112|NCT02442284|2778215|P1|Overall Study|Not Specified|1
873113|NCT02442284|2778215|P1|Overall Study|Lost to Follow-up|3
873114|NCT02442284|2778215|P1|Overall Study|Withdrew Consent|2
873115|NCT02442284|2778215|P1|Overall Study|Adverse Event|1
873118|NCT02277769|2778256|P3|Overall Study|Other than specified above|5
873119|NCT02277769|2778257|P2|Overall Study|Other than specified above|8
873120|NCT02277769|2778258|P1|Overall Study|Other than specified above|12
873121|NCT02277769|2778256|P3|Overall Study|Adverse Event|4
873122|NCT02277769|2778257|P2|Overall Study|Adverse Event|2
873123|NCT02277769|2778258|P1|Overall Study|Adverse Event|14
873124|NCT02277769|2778256|P3|Overall Study|Lack of Efficacy|4
873125|NCT02277769|2778257|P2|Overall Study|Lack of Efficacy|0
873126|NCT02277769|2778258|P1|Overall Study|Lack of Efficacy|17
873127|NCT02277769|2778256|P3|Overall Study|Protocol Violation|5
873128|NCT02277769|2778257|P2|Overall Study|Protocol Violation|3
873129|NCT02277769|2778258|P1|Overall Study|Protocol Violation|3
900983|NCT00829010|2863807|P4|Overall Study|Lost to Follow-up|0
900984|NCT00829010|2863808|P3|Overall Study|Lost to Follow-up|2
900985|NCT00829010|2863809|P2|Overall Study|Lost to Follow-up|0
900986|NCT00829010|2863810|P1|Overall Study|Lost to Follow-up|1
900987|NCT00829010|2863806|P5|Overall Study|Withdrawal by Subject|2
900988|NCT00829010|2863807|P4|Overall Study|Withdrawal by Subject|0
900989|NCT00829010|2863808|P3|Overall Study|Withdrawal by Subject|1
900990|NCT00829010|2863809|P2|Overall Study|Withdrawal by Subject|1
900991|NCT00829010|2863810|P1|Overall Study|Withdrawal by Subject|0
900992|NCT00829010|2863806|P5|Overall Study|Adverse Event|0
900993|NCT00829010|2863807|P4|Overall Study|Adverse Event|0
900994|NCT00829010|2863808|P3|Overall Study|Adverse Event|0
900995|NCT00829010|2863809|P2|Overall Study|Adverse Event|0
900996|NCT00829010|2863810|P1|Overall Study|Adverse Event|1
900997|NCT00825162|2863975|P3|Overall Study|Unable to attend the study visit|0
900998|NCT00825162|2863976|P2|Overall Study|Unable to attend the study visit|2
900999|NCT00825162|2863977|P1|Overall Study|Unable to attend the study visit|5
901000|NCT00825162|2863975|P3|Overall Study|Move away from the study area|0
901001|NCT00825162|2863976|P2|Overall Study|Move away from the study area|0
901002|NCT00825162|2863977|P1|Overall Study|Move away from the study area|1
901003|NCT00825162|2863975|P3|Overall Study|Physician Decision|0
901004|NCT00825162|2863976|P2|Overall Study|Physician Decision|0
901005|NCT00825162|2863977|P1|Overall Study|Physician Decision|2
901006|NCT00825162|2863975|P3|Overall Study|Lost to Follow-up|3
901007|NCT00825162|2863976|P2|Overall Study|Lost to Follow-up|6
901008|NCT00825162|2863977|P1|Overall Study|Lost to Follow-up|9
901009|NCT00825162|2863975|P3|Overall Study|Withdrawal by Subject|3
901010|NCT00825162|2863976|P2|Overall Study|Withdrawal by Subject|13
901011|NCT00825162|2863977|P1|Overall Study|Withdrawal by Subject|11
873169|NCT02197247|2778497|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
873170|NCT02197247|2778497|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
873171|NCT02197247|2778497|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
873172|NCT02197247|2778497|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
873173|NCT02197247|2778497|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
873174|NCT02197247|2778497|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
873175|NCT02197247|2778497|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
873176|NCT02197247|2778497|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
901032|NCT00735475|2864109|P2|Overall Study|Withdrawal by Subject|5
901033|NCT00735475|2864110|P1|Overall Study|Withdrawal by Subject|4
901034|NCT00735475|2864109|P2|Overall Study|Physician Decision|1
901035|NCT00735475|2864110|P1|Overall Study|Physician Decision|0
901036|NCT00735475|2864109|P2|Overall Study|Lost to Follow-up|3
901037|NCT00735475|2864110|P1|Overall Study|Lost to Follow-up|3
873193|NCT02105688|2778561|P2|Overall Study|Withdrawal by Subject|2
873194|NCT02105688|2778562|P1|Overall Study|Withdrawal by Subject|4
873195|NCT02105688|2778561|P2|Overall Study|Protocol Violation|1
873196|NCT02105688|2778562|P1|Overall Study|Protocol Violation|0
873197|NCT02105688|2778561|P2|Overall Study|Physician Decision|1
873198|NCT02105688|2778562|P1|Overall Study|Physician Decision|0
873199|NCT02105688|2778561|P2|Overall Study|Lost to Follow-up|4
873200|NCT02105688|2778562|P1|Overall Study|Lost to Follow-up|9
901038|NCT00735475|2864109|P2|Overall Study|Death|1
901039|NCT00735475|2864110|P1|Overall Study|Death|1
901040|NCT00735475|2864109|P2|Overall Study|Adverse Event|1
901041|NCT00735475|2864110|P1|Overall Study|Adverse Event|0
873201|NCT02105688|2778561|P2|Overall Study|Adverse Event|1
873202|NCT02105688|2778562|P1|Overall Study|Adverse Event|1
873203|NCT02105688|2778561|P2|Overall Study|Ongoing|90
873204|NCT02105688|2778562|P1|Overall Study|Ongoing|12
873224|NCT02004236|2778715|P3|Overall Study|Lack of Efficacy|16
873225|NCT02004236|2778716|P2|Overall Study|Lack of Efficacy|0
873226|NCT02004236|2778717|P1|Overall Study|Lack of Efficacy|0
873227|NCT01995071|2778773|P12|Overall Study|Incarcerated|0
873228|NCT01995071|2778774|P11|Overall Study|Incarcerated|0
873229|NCT01995071|2778775|P10|Overall Study|Incarcerated|0
873230|NCT01995071|2778776|P9|Overall Study|Incarcerated|0
873231|NCT01995071|2778777|P8|Overall Study|Incarcerated|1
873232|NCT01995071|2778778|P7|Overall Study|Incarcerated|0
873233|NCT01995071|2778779|P6|Overall Study|Incarcerated|0
873234|NCT01995071|2778780|P5|Overall Study|Incarcerated|0
873235|NCT01995071|2778781|P4|Overall Study|Incarcerated|0
873236|NCT01995071|2778782|P3|Overall Study|Incarcerated|0
873237|NCT01995071|2778783|P2|Overall Study|Incarcerated|0
873238|NCT01995071|2778784|P1|Overall Study|Incarcerated|0
873239|NCT01995071|2778773|P12|Overall Study|Lost to Follow-up|0
873240|NCT01995071|2778774|P11|Overall Study|Lost to Follow-up|0
873241|NCT01995071|2778775|P10|Overall Study|Lost to Follow-up|0
873242|NCT01995071|2778776|P9|Overall Study|Lost to Follow-up|1
873243|NCT01995071|2778777|P8|Overall Study|Lost to Follow-up|1
873244|NCT01995071|2778778|P7|Overall Study|Lost to Follow-up|0
873245|NCT01995071|2778779|P6|Overall Study|Lost to Follow-up|0
873246|NCT01995071|2778780|P5|Overall Study|Lost to Follow-up|0
873247|NCT01995071|2778781|P4|Overall Study|Lost to Follow-up|0
873248|NCT01995071|2778782|P3|Overall Study|Lost to Follow-up|0
873249|NCT01995071|2778783|P2|Overall Study|Lost to Follow-up|0
873250|NCT01995071|2778784|P1|Overall Study|Lost to Follow-up|1
873251|NCT01995071|2778773|P12|Overall Study|Moved|0
873252|NCT01995071|2778774|P11|Overall Study|Moved|1
873253|NCT01995071|2778775|P10|Overall Study|Moved|0
873254|NCT01995071|2778776|P9|Overall Study|Moved|0
873255|NCT01995071|2778777|P8|Overall Study|Moved|0
873256|NCT01995071|2778778|P7|Overall Study|Moved|0
873257|NCT01995071|2778779|P6|Overall Study|Moved|0
873258|NCT01995071|2778780|P5|Overall Study|Moved|1
873259|NCT01995071|2778781|P4|Overall Study|Moved|0
873260|NCT01995071|2778782|P3|Overall Study|Moved|1
873261|NCT01995071|2778783|P2|Overall Study|Moved|0
873262|NCT01995071|2778784|P1|Overall Study|Moved|0
873263|NCT01995071|2778773|P12|Overall Study|Adverse Event|0
873264|NCT01995071|2778774|P11|Overall Study|Adverse Event|0
873265|NCT01995071|2778775|P10|Overall Study|Adverse Event|0
873266|NCT01995071|2778776|P9|Overall Study|Adverse Event|0
873267|NCT01995071|2778777|P8|Overall Study|Adverse Event|0
873268|NCT01995071|2778778|P7|Overall Study|Adverse Event|1
873269|NCT01995071|2778779|P6|Overall Study|Adverse Event|0
873270|NCT01995071|2778780|P5|Overall Study|Adverse Event|0
873271|NCT01995071|2778781|P4|Overall Study|Adverse Event|0
873272|NCT01995071|2778782|P3|Overall Study|Adverse Event|0
873273|NCT01995071|2778783|P2|Overall Study|Adverse Event|0
873274|NCT01995071|2778784|P1|Overall Study|Adverse Event|0
873301|NCT01856686|2778978|P2|Overall Study|Lost to Follow-up|11
873302|NCT01856686|2778979|P1|Overall Study|Lost to Follow-up|5
873315|NCT01847885|2779042|P3|Randomization|Screen Failure|0
873316|NCT01847885|2779043|P2|Randomization|Screen Failure|3
873317|NCT01847885|2779044|P1|Randomization|Screen Failure|0
873318|NCT01847885|2779042|P3|Randomization|Withdrawal by Subject|2
873319|NCT01847885|2779043|P2|Randomization|Withdrawal by Subject|0
873320|NCT01847885|2779044|P1|Randomization|Withdrawal by Subject|0
873321|NCT01847885|2779042|P3|Randomization|Protocol Violation|0
873322|NCT01847885|2779043|P2|Randomization|Protocol Violation|1
873323|NCT01847885|2779044|P1|Randomization|Protocol Violation|0
873324|NCT01847885|2779042|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
873325|NCT01847885|2779043|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
873326|NCT01847885|2779044|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
873327|NCT01847885|2779042|P3|Initial Enrollment (Consented)|Screen failure|0
873328|NCT01847885|2779043|P2|Initial Enrollment (Consented)|Screen failure|0
873329|NCT01847885|2779044|P1|Initial Enrollment (Consented)|Screen failure|39
873330|NCT01847885|2779042|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
873331|NCT01847885|2779043|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
873332|NCT01847885|2779044|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
873333|NCT01847885|2779042|P3|Initial Enrollment (Consented)|Protocol Violation|0
873334|NCT01847885|2779043|P2|Initial Enrollment (Consented)|Protocol Violation|0
873335|NCT01847885|2779044|P1|Initial Enrollment (Consented)|Protocol Violation|1
873387|NCT01561976|2779348|P6|Washout Period 2 (7 Days)|Non-compliance|0
873388|NCT01561976|2779349|P5|Washout Period 2 (7 Days)|Non-compliance|0
873389|NCT01561976|2779350|P4|Washout Period 2 (7 Days)|Non-compliance|0
873390|NCT01561976|2779351|P3|Washout Period 2 (7 Days)|Non-compliance|1
873391|NCT01561976|2779352|P2|Washout Period 2 (7 Days)|Non-compliance|0
873392|NCT01561976|2779353|P1|Washout Period 2 (7 Days)|Non-compliance|1
873393|NCT01561976|2779348|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
873394|NCT01561976|2779349|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
873395|NCT01561976|2779350|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
873396|NCT01561976|2779351|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
873397|NCT01561976|2779352|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
873398|NCT01561976|2779353|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
873399|NCT01561976|2779348|P6|Washout Period 1 (7 Days)|Adverse Event|0
873400|NCT01561976|2779349|P5|Washout Period 1 (7 Days)|Adverse Event|0
873401|NCT01561976|2779350|P4|Washout Period 1 (7 Days)|Adverse Event|1
873402|NCT01561976|2779351|P3|Washout Period 1 (7 Days)|Adverse Event|0
873403|NCT01561976|2779352|P2|Washout Period 1 (7 Days)|Adverse Event|0
873404|NCT01561976|2779353|P1|Washout Period 1 (7 Days)|Adverse Event|0
873405|NCT01561976|2779348|P6|Period 1|Adverse Event|0
873406|NCT01561976|2779349|P5|Period 1|Adverse Event|0
873407|NCT01561976|2779350|P4|Period 1|Adverse Event|0
873408|NCT01561976|2779351|P3|Period 1|Adverse Event|1
873409|NCT01561976|2779352|P2|Period 1|Adverse Event|0
873410|NCT01561976|2779353|P1|Period 1|Adverse Event|0
873411|NCT01470599|2779413|P2|Overall Study|Adverse event not related to study drug|5
873412|NCT01470599|2779414|P1|Overall Study|Adverse event not related to study drug|1
873413|NCT01470599|2779413|P2|Overall Study|Insufficient clinical response|27
873414|NCT01470599|2779414|P1|Overall Study|Insufficient clinical response|6
873415|NCT01470599|2779413|P2|Overall Study|Adverse event related to study drug|5
873416|NCT01470599|2779414|P1|Overall Study|Adverse event related to study drug|2
873417|NCT01470599|2779413|P2|Overall Study|Protocol Violation|1
873418|NCT01470599|2779414|P1|Overall Study|Protocol Violation|3
873419|NCT01470599|2779413|P2|Overall Study|Other|0
873420|NCT01470599|2779414|P1|Overall Study|Other|1
873421|NCT01470599|2779413|P2|Overall Study|Withdrawal by Subject|4
873422|NCT01470599|2779414|P1|Overall Study|Withdrawal by Subject|3
873423|NCT01470599|2779413|P2|Overall Study|Lost to Follow-up|1
873424|NCT01470599|2779414|P1|Overall Study|Lost to Follow-up|2
873425|NCT01470599|2779413|P2|Overall Study|Did not meet entrance criteria|0
873426|NCT01470599|2779414|P1|Overall Study|Did not meet entrance criteria|1
873441|NCT01311024|2779624|P2|Overall Study|Protocol Violation|22
873442|NCT01311024|2779625|P1|Overall Study|Protocol Violation|35
873447|NCT01278394|2779704|P1|Overall Study|Lost to Follow-up|1
901173|NCT00314327|2864464|P1|Overall Study|Withdrawal by Subject|1
901236|NCT02690727|2864687|P2|Overall Study|Adverse Event|2
901237|NCT02690727|2864688|P1|Overall Study|Adverse Event|2
901250|NCT02532179|2864811|P1|Overall Study|Subject received depot steroid injection|1
901251|NCT02532179|2864811|P1|Overall Study|Pregnancy|1
901252|NCT02532179|2864811|P1|Overall Study|Lost to Follow-up|1
901253|NCT02474589|2864822|P2|Overall Study|Inability to complete study procedures|1
901254|NCT02474589|2864823|P1|Overall Study|Inability to complete study procedures|5
901255|NCT02474589|2864822|P2|Overall Study|Withdrawal by Subject|0
901256|NCT02474589|2864823|P1|Overall Study|Withdrawal by Subject|4
901257|NCT02474589|2864822|P2|Overall Study|Protocol Violation|1
901258|NCT02474589|2864823|P1|Overall Study|Protocol Violation|4
901259|NCT02474589|2864822|P2|Overall Study|Lost to Follow-up|1
901260|NCT02474589|2864823|P1|Overall Study|Lost to Follow-up|6
901261|NCT02474589|2864822|P2|Overall Study|Adverse Event|2
901262|NCT02474589|2864823|P1|Overall Study|Adverse Event|6
901263|NCT02473471|2864829|P1|Overall Study|Lost to Follow-up|1
873570|NCT01128621|2780060|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
873571|NCT01128621|2780061|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
901264|NCT02473471|2864829|P1|Overall Study|poor oral hygiene|2
873574|NCT01029691|2780216|P3|Continued APAP to Delivery|Death|1
873575|NCT01029691|2780217|P2|Continued APAP to Delivery|Death|0
873576|NCT01029691|2780218|P1|Continued APAP to Delivery|Death|0
873595|NCT00984165|2780424|P4|Overall Study|removed with a pair recipient|1
873596|NCT00984165|2780425|P3|Overall Study|removed with a pair recipient|0
873597|NCT00984165|2780426|P2|Overall Study|removed with a pair recipient|0
873598|NCT00984165|2780427|P1|Overall Study|removed with a pair recipient|0
873599|NCT00984165|2780424|P4|Overall Study|P+/donor pair removed from protocol|1
873600|NCT00984165|2780425|P3|Overall Study|P+/donor pair removed from protocol|0
873601|NCT00984165|2780426|P2|Overall Study|P+/donor pair removed from protocol|0
873602|NCT00984165|2780427|P1|Overall Study|P+/donor pair removed from protocol|0
873603|NCT00984165|2780424|P4|Overall Study|New protocol|1
873604|NCT00984165|2780425|P3|Overall Study|New protocol|0
873605|NCT00984165|2780426|P2|Overall Study|New protocol|0
873606|NCT00984165|2780427|P1|Overall Study|New protocol|0
873607|NCT00984165|2780424|P4|Overall Study|Death of recipient|1
873608|NCT00984165|2780425|P3|Overall Study|Death of recipient|0
873609|NCT00984165|2780426|P2|Overall Study|Death of recipient|0
873610|NCT00984165|2780427|P1|Overall Study|Death of recipient|0
873611|NCT00984165|2780424|P4|Overall Study|Disease progression on study|0
873612|NCT00984165|2780425|P3|Overall Study|Disease progression on study|0
873613|NCT00984165|2780426|P2|Overall Study|Disease progression on study|1
873614|NCT00984165|2780427|P1|Overall Study|Disease progression on study|5
873615|NCT00984165|2780424|P4|Overall Study|Death on study|0
873616|NCT00984165|2780425|P3|Overall Study|Death on study|0
873617|NCT00984165|2780426|P2|Overall Study|Death on study|0
873618|NCT00984165|2780427|P1|Overall Study|Death on study|2
873627|NCT00943722|2780456|P5|Overall Study|Withdrawal by Subject|8
873628|NCT00943722|2780457|P4|Overall Study|Withdrawal by Subject|13
873629|NCT00943722|2780458|P3|Overall Study|Withdrawal by Subject|2
873630|NCT00943722|2780459|P2|Overall Study|Withdrawal by Subject|13
873631|NCT00943722|2780460|P1|Overall Study|Withdrawal by Subject|12
873632|NCT00943722|2780456|P5|Overall Study|Protocol Violation|2
873633|NCT00943722|2780457|P4|Overall Study|Protocol Violation|0
873634|NCT00943722|2780458|P3|Overall Study|Protocol Violation|0
873635|NCT00943722|2780459|P2|Overall Study|Protocol Violation|1
873636|NCT00943722|2780460|P1|Overall Study|Protocol Violation|0
873637|NCT00943722|2780456|P5|Overall Study|Pregnancy|0
873638|NCT00943722|2780457|P4|Overall Study|Pregnancy|0
873639|NCT00943722|2780458|P3|Overall Study|Pregnancy|1
873640|NCT00943722|2780459|P2|Overall Study|Pregnancy|0
873641|NCT00943722|2780460|P1|Overall Study|Pregnancy|0
873642|NCT00943722|2780456|P5|Overall Study|Physician Decision|1
873643|NCT00943722|2780457|P4|Overall Study|Physician Decision|0
873644|NCT00943722|2780458|P3|Overall Study|Physician Decision|0
873645|NCT00943722|2780459|P2|Overall Study|Physician Decision|0
873646|NCT00943722|2780460|P1|Overall Study|Physician Decision|1
873647|NCT00943722|2780456|P5|Overall Study|Lost to Follow-up|11
873648|NCT00943722|2780457|P4|Overall Study|Lost to Follow-up|8
873649|NCT00943722|2780458|P3|Overall Study|Lost to Follow-up|10
873650|NCT00943722|2780459|P2|Overall Study|Lost to Follow-up|8
873651|NCT00943722|2780460|P1|Overall Study|Lost to Follow-up|12
873652|NCT00943722|2780456|P5|Overall Study|Adverse Event|0
873653|NCT00943722|2780457|P4|Overall Study|Adverse Event|1
873654|NCT00943722|2780458|P3|Overall Study|Adverse Event|0
873655|NCT00943722|2780459|P2|Overall Study|Adverse Event|0
873656|NCT00943722|2780460|P1|Overall Study|Adverse Event|0
901286|NCT02260791|2864966|P2|Overall Study|Protocol deviation|3
901287|NCT02260791|2864967|P1|Overall Study|Protocol deviation|2
901288|NCT02260791|2864966|P2|Overall Study|Screen failure|1
901289|NCT02260791|2864967|P1|Overall Study|Screen failure|0
901290|NCT02260791|2864966|P2|Overall Study|Withdrawal by Subject|16
901291|NCT02260791|2864967|P1|Overall Study|Withdrawal by Subject|11
901292|NCT02260791|2864966|P2|Overall Study|Death|0
901293|NCT02260791|2864967|P1|Overall Study|Death|1
901294|NCT02260791|2864966|P2|Overall Study|Adverse Event|9
901295|NCT02260791|2864967|P1|Overall Study|Adverse Event|13
901296|NCT02260791|2864966|P2|Overall Study|Lack of Efficacy|1
901297|NCT02260791|2864967|P1|Overall Study|Lack of Efficacy|2
901298|NCT02260791|2864966|P2|Overall Study|Lost to Follow-up|4
901299|NCT02260791|2864967|P1|Overall Study|Lost to Follow-up|4
873699|NCT00725764|2780791|P1|Overall Study|Decline in performance status|1
873700|NCT00725764|2780791|P1|Overall Study|Participant non compliant with protocol|1
873701|NCT00725764|2780791|P1|Overall Study|Death|1
873702|NCT00725764|2780791|P1|Overall Study|Lost to Follow-up|1
873703|NCT00725764|2780791|P1|Overall Study|Progressive Disease|7
873704|NCT00725764|2780791|P1|Overall Study|Physician Decision|1
873705|NCT00725764|2780791|P1|Overall Study|Withdrawal by Subject|2
873706|NCT00715520|2780820|P3|Overall Study|Withdrawal by Subject|1
873707|NCT00715520|2780821|P2|Overall Study|Withdrawal by Subject|0
873708|NCT00715520|2780822|P1|Overall Study|Withdrawal by Subject|2
873709|NCT00715520|2780820|P3|Overall Study|Screen failure|1
873710|NCT00715520|2780821|P2|Overall Study|Screen failure|1
873711|NCT00715520|2780822|P1|Overall Study|Screen failure|8
873712|NCT00692770|2780848|P2|Overall Study|Randomized but not treated|4
873713|NCT00692770|2780849|P1|Overall Study|Randomized but not treated|3
873714|NCT00692770|2780848|P2|Overall Study|Study terminated by sponsor|2
873715|NCT00692770|2780849|P1|Overall Study|Study terminated by sponsor|2
873716|NCT00692770|2780848|P2|Overall Study|Clinical endpoint reached|43
873717|NCT00692770|2780849|P1|Overall Study|Clinical endpoint reached|16
873718|NCT00692770|2780848|P2|Overall Study|Radiological and clinical progression|8
873719|NCT00692770|2780849|P1|Overall Study|Radiological and clinical progression|8
873720|NCT00692770|2780848|P2|Overall Study|Completed all planned assessments|101
873721|NCT00692770|2780849|P1|Overall Study|Completed all planned assessments|79
873722|NCT00692770|2780848|P2|Overall Study|Protocol driven decision point|7
873723|NCT00692770|2780849|P1|Overall Study|Protocol driven decision point|3
873724|NCT00692770|2780848|P2|Overall Study|Disease progression, recurrence/relapse|279
873725|NCT00692770|2780849|P1|Overall Study|Disease progression, recurrence/relapse|170
873726|NCT00692770|2780848|P2|Overall Study|Physician decision not protocol driven|14
873727|NCT00692770|2780849|P1|Overall Study|Physician decision not protocol driven|10
873728|NCT00692770|2780848|P2|Overall Study|Progression by clinical judgment|3
873729|NCT00692770|2780849|P1|Overall Study|Progression by clinical judgment|2
873730|NCT00692770|2780848|P2|Overall Study|Non-compliant with study medication|5
873731|NCT00692770|2780849|P1|Overall Study|Non-compliant with study medication|11
873732|NCT00692770|2780848|P2|Overall Study|Lost to Follow-up|3
873733|NCT00692770|2780849|P1|Overall Study|Lost to Follow-up|7
873734|NCT00692770|2780848|P2|Overall Study|Death|5
873735|NCT00692770|2780849|P1|Overall Study|Death|10
873736|NCT00692770|2780848|P2|Overall Study|Adverse Event|41
873737|NCT00692770|2780849|P1|Overall Study|Adverse Event|136
873738|NCT00692770|2780848|P2|Overall Study|Withdrawal by Subject|36
873739|NCT00692770|2780849|P1|Overall Study|Withdrawal by Subject|97
873740|NCT00692770|2780848|P2|Overall Study|Protocol Violation|7
873741|NCT00692770|2780849|P1|Overall Study|Protocol Violation|2
873837|NCT00545844|2780966|P1|Overall Study|Withdrawal by Subject|2
873838|NCT00545844|2780966|P1|Overall Study|Protocol Violation|1
873839|NCT00545844|2780966|P1|Overall Study|Lost to Follow-up|9
873844|NCT00494442|2781069|P2|Overall Study|Intercurrent illness|1
873845|NCT00494442|2781070|P1|Overall Study|Intercurrent illness|0
873846|NCT00494442|2781069|P2|Overall Study|Non-compliance|1
873847|NCT00494442|2781070|P1|Overall Study|Non-compliance|0
873848|NCT00494442|2781069|P2|Overall Study|Physician Decision|1
873849|NCT00494442|2781070|P1|Overall Study|Physician Decision|0
873850|NCT00494442|2781069|P2|Overall Study|Adverse Event|2
873851|NCT00494442|2781070|P1|Overall Study|Adverse Event|0
873852|NCT00494442|2781069|P2|Overall Study|Lack of Efficacy|10
873853|NCT00494442|2781070|P1|Overall Study|Lack of Efficacy|16
873854|NCT00494442|2781069|P2|Overall Study|Death|1
873855|NCT00494442|2781070|P1|Overall Study|Death|1
873856|NCT00218296|2781086|P2|Overall Study|Randomized but did not enter treatment|67
873857|NCT00218296|2781087|P1|Overall Study|Randomized but did not enter treatment|66
873858|NCT00218296|2781086|P2|Overall Study|Withdrawal by Subject|47
873859|NCT00218296|2781087|P1|Overall Study|Withdrawal by Subject|36
873860|NCT00218296|2781086|P2|Overall Study|Lost to Follow-up|7
873861|NCT00218296|2781087|P1|Overall Study|Lost to Follow-up|9
873862|NCT00189540|2781109|P2|Overall Study|Death|1
873863|NCT00189540|2781110|P1|Overall Study|Death|4
873864|NCT00189540|2781109|P2|Overall Study|Withdrawal by Subject|0
873865|NCT00189540|2781110|P1|Overall Study|Withdrawal by Subject|3
873866|NCT00151411|2781137|P2|Overall Study|Pregnancy|4
873867|NCT00151411|2781138|P1|Overall Study|Pregnancy|0
873868|NCT00151411|2781137|P2|Overall Study|Adverse Event|0
873869|NCT00151411|2781138|P1|Overall Study|Adverse Event|6
873870|NCT00151411|2781137|P2|Overall Study|Withdrawal by Subject|20
873871|NCT00151411|2781138|P1|Overall Study|Withdrawal by Subject|12
873872|NCT00151411|2781137|P2|Overall Study|Lost to Follow-up|19
873873|NCT00151411|2781138|P1|Overall Study|Lost to Follow-up|15
873874|NCT00130728|2781150|P2|Overall Study|Withdrawal by Subject|2
873875|NCT00130728|2781151|P1|Overall Study|Withdrawal by Subject|0
873876|NCT00130728|2781150|P2|Overall Study|Lost to Follow-up|0
901427|NCT01385748|2865521|P3|Overall Study|Adverse Event|1
901428|NCT01385748|2865522|P2|Overall Study|Adverse Event|2
873877|NCT00130728|2781151|P1|Overall Study|Lost to Follow-up|4
873878|NCT00130728|2781150|P2|Overall Study|Death|211
873879|NCT00130728|2781151|P1|Overall Study|Death|207
873880|NCT00113919|2781163|P1|Overall Study|Death|6
873881|NCT00113919|2781163|P1|Overall Study|Physician Decision|8
873882|NCT00105560|2781167|P1|Overall Study|Lost to Follow-up|1
901429|NCT01385748|2865523|P1|Overall Study|Adverse Event|4
901430|NCT01385748|2865521|P3|Overall Study|Not specified|1
901431|NCT01385748|2865522|P2|Overall Study|Not specified|7
901432|NCT01385748|2865523|P1|Overall Study|Not specified|1
901433|NCT01385748|2865521|P3|Overall Study|Noncompliance|6
901434|NCT01385748|2865522|P2|Overall Study|Noncompliance|1
901435|NCT01385748|2865523|P1|Overall Study|Noncompliance|3
901436|NCT01385748|2865521|P3|Overall Study|Withdrawal by Subject|5
901437|NCT01385748|2865522|P2|Overall Study|Withdrawal by Subject|4
901438|NCT01385748|2865523|P1|Overall Study|Withdrawal by Subject|7
873917|NCT00001596|2781318|P2|Overall Study|Adverse Event|0
873918|NCT00001596|2781319|P1|Overall Study|Adverse Event|1
873919|NCT00001596|2781318|P2|Overall Study|Study Termination|9
873920|NCT00001596|2781319|P1|Overall Study|Study Termination|12
873921|NCT00001596|2781318|P2|Overall Study|Withdrawal by Subject|1
873922|NCT00001596|2781319|P1|Overall Study|Withdrawal by Subject|3
873923|NCT00001596|2781318|P2|Overall Study|Death|0
873924|NCT00001596|2781319|P1|Overall Study|Death|1
873925|NCT02847260|2781339|P1|Overall Study|Physician Decision|1
873926|NCT02847260|2781339|P1|Overall Study|Clinical Deterioration|1
873927|NCT02847260|2781339|P1|Overall Study|Withdrawal by Subject|2
873928|NCT02847260|2781339|P1|Overall Study|Adverse Event|3
873939|NCT02359890|2781485|P1|Overall Study|Never treated with study catheter|6
873940|NCT02359890|2781485|P1|Overall Study|Not meeting eligibility|4
873997|NCT02260986|2781659|P3|Overall Study|Pregnancy|0
873998|NCT02260986|2781660|P2|Overall Study|Pregnancy|0
873999|NCT02260986|2781661|P1|Overall Study|Pregnancy|2
874000|NCT02260986|2781659|P3|Overall Study|Lost to Follow-up|3
874001|NCT02260986|2781660|P2|Overall Study|Lost to Follow-up|0
874002|NCT02260986|2781661|P1|Overall Study|Lost to Follow-up|4
874003|NCT02260986|2781659|P3|Overall Study|Lack of investigation product supply|1
874004|NCT02260986|2781660|P2|Overall Study|Lack of investigation product supply|0
874005|NCT02260986|2781661|P1|Overall Study|Lack of investigation product supply|2
874006|NCT02260986|2781659|P3|Overall Study|Incorrect randomization|0
874007|NCT02260986|2781660|P2|Overall Study|Incorrect randomization|1
874008|NCT02260986|2781661|P1|Overall Study|Incorrect randomization|0
874009|NCT02260986|2781659|P3|Overall Study|Withdrawal by Subject|9
874010|NCT02260986|2781660|P2|Overall Study|Withdrawal by Subject|4
874011|NCT02260986|2781661|P1|Overall Study|Withdrawal by Subject|17
874012|NCT02260986|2781659|P3|Overall Study|Car accident|1
874013|NCT02260986|2781660|P2|Overall Study|Car accident|0
874014|NCT02260986|2781661|P1|Overall Study|Car accident|0
874015|NCT02260986|2781659|P3|Overall Study|Protocol Violation|16
874016|NCT02260986|2781660|P2|Overall Study|Protocol Violation|5
874017|NCT02260986|2781661|P1|Overall Study|Protocol Violation|14
874018|NCT02260986|2781659|P3|Overall Study|Lack of Efficacy|0
874019|NCT02260986|2781660|P2|Overall Study|Lack of Efficacy|3
874020|NCT02260986|2781661|P1|Overall Study|Lack of Efficacy|27
874021|NCT02260986|2781659|P3|Overall Study|Adverse Event|11
874022|NCT02260986|2781660|P2|Overall Study|Adverse Event|0
874023|NCT02260986|2781661|P1|Overall Study|Adverse Event|24
874082|NCT02119650|2781935|P2|Overall Study|Multiple reasons for termination|1
874083|NCT02119650|2781936|P1|Overall Study|Multiple reasons for termination|2
874084|NCT02119650|2781935|P2|Overall Study|Physician Decision|2
874085|NCT02119650|2781936|P1|Overall Study|Physician Decision|0
874086|NCT02119650|2781935|P2|Overall Study|Study terminated by the sponsor|0
874087|NCT02119650|2781936|P1|Overall Study|Study terminated by the sponsor|1
874088|NCT02119650|2781935|P2|Overall Study|Noncompliance with study treatment|1
874089|NCT02119650|2781936|P1|Overall Study|Noncompliance with study treatment|1
874090|NCT02119650|2781935|P2|Overall Study|Death|1
874091|NCT02119650|2781936|P1|Overall Study|Death|5
874092|NCT02119650|2781935|P2|Overall Study|Disease progression|14
874093|NCT02119650|2781936|P1|Overall Study|Disease progression|11
874094|NCT02119650|2781935|P2|Overall Study|Subject decision|3
874095|NCT02119650|2781936|P1|Overall Study|Subject decision|2
874096|NCT02119650|2781935|P2|Overall Study|Adverse Event|4
874097|NCT02119650|2781936|P1|Overall Study|Adverse Event|3
874101|NCT02075255|2782009|P3|Overall Study|Death|0
874102|NCT02075255|2782010|P2|Overall Study|Death|2
874103|NCT02075255|2782011|P1|Overall Study|Death|0
874104|NCT02075255|2782009|P3|Overall Study|Adverse Event|1
874105|NCT02075255|2782010|P2|Overall Study|Adverse Event|0
874106|NCT02075255|2782011|P1|Overall Study|Adverse Event|0
874107|NCT02075255|2782009|P3|Overall Study|Lost to Follow-up|1
874108|NCT02075255|2782010|P2|Overall Study|Lost to Follow-up|0
874109|NCT02075255|2782011|P1|Overall Study|Lost to Follow-up|0
874110|NCT02075255|2782009|P3|Overall Study|Withdrawal by Subject|0
874111|NCT02075255|2782010|P2|Overall Study|Withdrawal by Subject|1
874112|NCT02075255|2782011|P1|Overall Study|Withdrawal by Subject|4
874113|NCT02075255|2782009|P3|Overall Study|Study specific withdrawal criteria|1
874114|NCT02075255|2782010|P2|Overall Study|Study specific withdrawal criteria|1
874115|NCT02075255|2782011|P1|Overall Study|Study specific withdrawal criteria|0
874116|NCT02015481|2782129|P1|Overall Study|Death|1
901729|NCT00929669|2866106|P1|Overall Study|elevated glucose levels|1
874307|NCT01305941|2783059|P1|Overall Study|Death|1
874308|NCT01305941|2783059|P1|Overall Study|Withdrawal by Subject|1
874309|NCT01305941|2783059|P1|Overall Study|Clinical decline|2
874310|NCT01305941|2783059|P1|Overall Study|Adverse Event|6
901756|NCT00796822|2866226|P2|Overall Study|Adverse Event|0
901757|NCT00796822|2866227|P1|Overall Study|Adverse Event|1
901758|NCT00796822|2866226|P2|Overall Study|Lost to Follow-up|0
901759|NCT00796822|2866227|P1|Overall Study|Lost to Follow-up|2
901764|NCT00736645|2866279|P4|Overall Study|Adverse Event|0
901765|NCT00736645|2866280|P3|Overall Study|Adverse Event|0
901766|NCT00736645|2866281|P2|Overall Study|Adverse Event|2
901767|NCT00736645|2866282|P1|Overall Study|Adverse Event|0
901774|NCT00526890|2866351|P1|Overall Study|Adverse Event|2
901776|NCT00470366|2866375|P1|Overall Study|Poor compliance|1
901777|NCT00470366|2866375|P1|Overall Study|Adverse Event|3
901778|NCT00381797|2866423|P5|Overall Study|Ineligible|0
901779|NCT00381797|2866424|P4|Overall Study|Ineligible|1
901780|NCT00381797|2866425|P3|Overall Study|Ineligible|0
901781|NCT00381797|2866426|P2|Overall Study|Ineligible|0
901782|NCT00381797|2866427|P1|Overall Study|Ineligible|0
901783|NCT00381797|2866423|P5|Overall Study|Withdrawal by Subject|2
901784|NCT00381797|2866424|P4|Overall Study|Withdrawal by Subject|0
901785|NCT00381797|2866425|P3|Overall Study|Withdrawal by Subject|0
901786|NCT00381797|2866426|P2|Overall Study|Withdrawal by Subject|1
901787|NCT00381797|2866427|P1|Overall Study|Withdrawal by Subject|1
901790|NCT00348309|2866503|P3|Overall Study|HCV career|1
901791|NCT00348309|2866504|P2|Overall Study|HCV career|0
901792|NCT00348309|2866505|P1|Overall Study|HCV career|0
901793|NCT00348309|2866503|P3|Overall Study|Cardiologist recommendations|1
901794|NCT00348309|2866504|P2|Overall Study|Cardiologist recommendations|0
901795|NCT00348309|2866505|P1|Overall Study|Cardiologist recommendations|0
901796|NCT00348309|2866503|P3|Overall Study|ECG abnormal|2
901797|NCT00348309|2866504|P2|Overall Study|ECG abnormal|0
901798|NCT00348309|2866505|P1|Overall Study|ECG abnormal|0
901799|NCT00348309|2866503|P3|Overall Study|Adverse event not attended|1
901800|NCT00348309|2866504|P2|Overall Study|Adverse event not attended|0
901801|NCT00348309|2866505|P1|Overall Study|Adverse event not attended|0
901802|NCT00348309|2866503|P3|Overall Study|Site closure|1
901803|NCT00348309|2866504|P2|Overall Study|Site closure|0
901804|NCT00348309|2866505|P1|Overall Study|Site closure|0
901805|NCT00348309|2866503|P3|Overall Study|Increased dose of Aricept|1
901806|NCT00348309|2866504|P2|Overall Study|Increased dose of Aricept|0
901807|NCT00348309|2866505|P1|Overall Study|Increased dose of Aricept|0
901808|NCT00348309|2866503|P3|Overall Study|Medical Monitor decision|1
901809|NCT00348309|2866504|P2|Overall Study|Medical Monitor decision|0
901810|NCT00348309|2866505|P1|Overall Study|Medical Monitor decision|0
901811|NCT00348309|2866503|P3|Overall Study|Forgot often medication|0
901812|NCT00348309|2866504|P2|Overall Study|Forgot often medication|1
901813|NCT00348309|2866505|P1|Overall Study|Forgot often medication|0
901814|NCT00348309|2866503|P3|Overall Study|Sponsor refuseal|1
901815|NCT00348309|2866504|P2|Overall Study|Sponsor refuseal|1
901816|NCT00348309|2866505|P1|Overall Study|Sponsor refuseal|0
901817|NCT00348309|2866503|P3|Overall Study|Participant was hospitalized|0
901818|NCT00348309|2866504|P2|Overall Study|Participant was hospitalized|1
901819|NCT00348309|2866505|P1|Overall Study|Participant was hospitalized|0
901820|NCT00348309|2866503|P3|Overall Study|A foul of exclusion criteria|0
901821|NCT00348309|2866504|P2|Overall Study|A foul of exclusion criteria|1
901822|NCT00348309|2866505|P1|Overall Study|A foul of exclusion criteria|0
901823|NCT00348309|2866503|P3|Overall Study|Ineffectiveness of treatment|0
901824|NCT00348309|2866504|P2|Overall Study|Ineffectiveness of treatment|1
901825|NCT00348309|2866505|P1|Overall Study|Ineffectiveness of treatment|0
901826|NCT00348309|2866503|P3|Overall Study|Decision of sponsor|0
901827|NCT00348309|2866504|P2|Overall Study|Decision of sponsor|0
901828|NCT00348309|2866505|P1|Overall Study|Decision of sponsor|1
901829|NCT00348309|2866503|P3|Overall Study|Participant died|1
901830|NCT00348309|2866504|P2|Overall Study|Participant died|1
901831|NCT00348309|2866505|P1|Overall Study|Participant died|2
901832|NCT00348309|2866503|P3|Overall Study|Did not appear in time for Visit 3|0
901833|NCT00348309|2866504|P2|Overall Study|Did not appear in time for Visit 3|0
901834|NCT00348309|2866505|P1|Overall Study|Did not appear in time for Visit 3|1
901835|NCT00348309|2866503|P3|Overall Study|Worsening of alzheimer|1
901836|NCT00348309|2866504|P2|Overall Study|Worsening of alzheimer|0
901837|NCT00348309|2866505|P1|Overall Study|Worsening of alzheimer|1
901838|NCT00348309|2866503|P3|Overall Study|Cognitive and behaviour worsening|0
901839|NCT00348309|2866504|P2|Overall Study|Cognitive and behaviour worsening|0
901840|NCT00348309|2866505|P1|Overall Study|Cognitive and behaviour worsening|2
901841|NCT00348309|2866503|P3|Overall Study|Worsened neurodegenerative disease|0
901842|NCT00348309|2866504|P2|Overall Study|Worsened neurodegenerative disease|0
901843|NCT00348309|2866505|P1|Overall Study|Worsened neurodegenerative disease|1
901844|NCT00348309|2866503|P3|Overall Study|No disponibility of medication|0
901845|NCT00348309|2866504|P2|Overall Study|No disponibility of medication|0
901846|NCT00348309|2866505|P1|Overall Study|No disponibility of medication|1
901847|NCT00348309|2866503|P3|Overall Study|Principal investigator's decision|0
901848|NCT00348309|2866504|P2|Overall Study|Principal investigator's decision|0
901849|NCT00348309|2866505|P1|Overall Study|Principal investigator's decision|1
901850|NCT00348309|2866503|P3|Overall Study|PI closing medical practice|0
901851|NCT00348309|2866504|P2|Overall Study|PI closing medical practice|0
901852|NCT00348309|2866505|P1|Overall Study|PI closing medical practice|1
901853|NCT00348309|2866503|P3|Overall Study|Unable to complete ET visit|0
901854|NCT00348309|2866504|P2|Overall Study|Unable to complete ET visit|0
901855|NCT00348309|2866505|P1|Overall Study|Unable to complete ET visit|1
901856|NCT00348309|2866503|P3|Overall Study|Caregiver withdrawal|7
901857|NCT00348309|2866504|P2|Overall Study|Caregiver withdrawal|0
901858|NCT00348309|2866505|P1|Overall Study|Caregiver withdrawal|3
901859|NCT00348309|2866503|P3|Overall Study|Use of prohibited medication|2
901860|NCT00348309|2866504|P2|Overall Study|Use of prohibited medication|2
901861|NCT00348309|2866505|P1|Overall Study|Use of prohibited medication|5
901862|NCT00348309|2866503|P3|Overall Study|Caregiver sick|0
901863|NCT00348309|2866504|P2|Overall Study|Caregiver sick|0
901864|NCT00348309|2866505|P1|Overall Study|Caregiver sick|1
901865|NCT00348309|2866503|P3|Overall Study|Wrong bottle allocated|0
901866|NCT00348309|2866504|P2|Overall Study|Wrong bottle allocated|0
901867|NCT00348309|2866505|P1|Overall Study|Wrong bottle allocated|1
901868|NCT00348309|2866503|P3|Overall Study|Lack of insight, dementia|0
901869|NCT00348309|2866504|P2|Overall Study|Lack of insight, dementia|0
901870|NCT00348309|2866505|P1|Overall Study|Lack of insight, dementia|1
901871|NCT00348309|2866503|P3|Overall Study|Death of caregiver|1
901872|NCT00348309|2866504|P2|Overall Study|Death of caregiver|0
901873|NCT00348309|2866505|P1|Overall Study|Death of caregiver|1
901874|NCT00348309|2866503|P3|Overall Study|Non-compliance|8
901875|NCT00348309|2866504|P2|Overall Study|Non-compliance|6
901876|NCT00348309|2866505|P1|Overall Study|Non-compliance|8
901877|NCT00348309|2866503|P3|Overall Study|Withdrawal by Subject|40
901878|NCT00348309|2866504|P2|Overall Study|Withdrawal by Subject|37
901879|NCT00348309|2866505|P1|Overall Study|Withdrawal by Subject|33
901880|NCT00348309|2866503|P3|Overall Study|Protocol Violation|7
901881|NCT00348309|2866504|P2|Overall Study|Protocol Violation|12
901882|NCT00348309|2866505|P1|Overall Study|Protocol Violation|7
901883|NCT00348309|2866503|P3|Overall Study|Lost to Follow-up|4
901884|NCT00348309|2866504|P2|Overall Study|Lost to Follow-up|7
901885|NCT00348309|2866505|P1|Overall Study|Lost to Follow-up|6
901886|NCT00348309|2866503|P3|Overall Study|Adverse Event|63
901887|NCT00348309|2866504|P2|Overall Study|Adverse Event|28
901888|NCT00348309|2866505|P1|Overall Study|Adverse Event|56
901899|NCT00262847|2866643|P3|Overall Study|Did not receive study treatment|4
901900|NCT00262847|2866644|P2|Overall Study|Did not receive study treatment|1
901901|NCT00262847|2866645|P1|Overall Study|Did not receive study treatment|4
901902|NCT00262847|2866643|P3|Overall Study|Other Reasons|27
901903|NCT00262847|2866644|P2|Overall Study|Other Reasons|88
901904|NCT00262847|2866645|P1|Overall Study|Other Reasons|79
901905|NCT00262847|2866643|P3|Overall Study|Concomitant disease|4
901906|NCT00262847|2866644|P2|Overall Study|Concomitant disease|2
901907|NCT00262847|2866645|P1|Overall Study|Concomitant disease|3
901908|NCT00262847|2866643|P3|Overall Study|Death|11
901909|NCT00262847|2866644|P2|Overall Study|Death|8
901910|NCT00262847|2866645|P1|Overall Study|Death|8
901911|NCT00262847|2866643|P3|Overall Study|Adverse Event|108
901912|NCT00262847|2866644|P2|Overall Study|Adverse Event|88
901913|NCT00262847|2866645|P1|Overall Study|Adverse Event|74
901914|NCT00262847|2866643|P3|Overall Study|Patient Refusal|47
901915|NCT00262847|2866644|P2|Overall Study|Patient Refusal|52
901916|NCT00262847|2866645|P1|Overall Study|Patient Refusal|41
901917|NCT00262847|2866643|P3|Overall Study|Disease Progression|195
901918|NCT00262847|2866644|P2|Overall Study|Disease Progression|274
901919|NCT00262847|2866645|P1|Overall Study|Disease Progression|309
901920|NCT00186628|2866690|P1|Overall Study|Withdrawal by subject (before treatment)|1
901921|NCT00186628|2866690|P1|Overall Study|Death|2
901922|NCT00075816|2866737|P2|Overall Study|Did not undergo transplantation|11
901923|NCT00075816|2866738|P1|Overall Study|Did not undergo transplantation|14
874516|NCT01147172|2783870|P1|Overall Study|Lost to Follow-up|2
874517|NCT01147172|2783870|P1|Overall Study|Withdrawal by Subject|2
874518|NCT01098071|2783899|P1|Overall Study|Lost to Follow-up|13
874519|NCT01098071|2783899|P1|Overall Study|Surgery (adenoidectomy)|2
901956|NCT00053365|2866809|P1|Overall Study|Never treated|4
901957|NCT00053365|2866809|P1|Overall Study|Platinum-sensitive interval >12 months|1
901958|NCT00053365|2866809|P1|Overall Study|Incorrect cell type|1
874548|NCT00989781|2784121|P2|Ovarian Response to hCG|Lost to Follow-up|2
874549|NCT00989781|2784122|P1|Ovarian Response to hCG|Lost to Follow-up|3
901991|NCT02377427|2867060|P2|Overall Study|Withdrawal by Subject|0
901992|NCT02377427|2867061|P1|Overall Study|Withdrawal by Subject|2
901993|NCT02377427|2867060|P2|Overall Study|Other: AE of Asthma Exacerbation|0
901994|NCT02377427|2867061|P1|Overall Study|Other: AE of Asthma Exacerbation|1
901995|NCT02377427|2867060|P2|Overall Study|Physician Decision|0
901996|NCT02377427|2867061|P1|Overall Study|Physician Decision|1
901997|NCT02347189|2867092|P1|Overall Study|No primary outcome data available|2
901998|NCT02347189|2867092|P1|Overall Study|No implant attempted of study device|9
902010|NCT02195986|2867135|P3|Overall Study|Non-compliance|0
902011|NCT02195986|2867136|P2|Overall Study|Non-compliance|1
902012|NCT02195986|2867137|P1|Overall Study|Non-compliance|0
902013|NCT02195986|2867135|P3|Overall Study|Protocol Violation|1
902014|NCT02195986|2867136|P2|Overall Study|Protocol Violation|1
902015|NCT02195986|2867137|P1|Overall Study|Protocol Violation|0
902016|NCT02195986|2867135|P3|Overall Study|Family Emergency|1
902017|NCT02195986|2867136|P2|Overall Study|Family Emergency|0
902018|NCT02195986|2867137|P1|Overall Study|Family Emergency|0
902019|NCT02195986|2867135|P3|Overall Study|Withdrawal by Subject|0
902020|NCT02195986|2867136|P2|Overall Study|Withdrawal by Subject|3
902021|NCT02195986|2867137|P1|Overall Study|Withdrawal by Subject|0
902022|NCT02195986|2867135|P3|Overall Study|Adverse Event|0
902023|NCT02195986|2867136|P2|Overall Study|Adverse Event|0
902024|NCT02195986|2867137|P1|Overall Study|Adverse Event|3
874620|NCT00568178|2784553|P6|Open Label Extension|Withdrawal by Subject|4
874621|NCT00568178|2784554|P5|Open Label Extension|Withdrawal by Subject|4
874622|NCT00568178|2784555|P4|Open Label Extension|Withdrawal by Subject|0
874623|NCT00568178|2784556|P3|Open Label Extension|Withdrawal by Subject|0
874624|NCT00568178|2784557|P2|Open Label Extension|Withdrawal by Subject|0
874625|NCT00568178|2784558|P1|Open Label Extension|Withdrawal by Subject|0
874626|NCT00568178|2784553|P6|Open Label Extension|Termination of Trial|47
874627|NCT00568178|2784554|P5|Open Label Extension|Termination of Trial|45
874628|NCT00568178|2784555|P4|Open Label Extension|Termination of Trial|0
874629|NCT00568178|2784556|P3|Open Label Extension|Termination of Trial|0
874630|NCT00568178|2784557|P2|Open Label Extension|Termination of Trial|0
874631|NCT00568178|2784558|P1|Open Label Extension|Termination of Trial|0
874632|NCT00568178|2784553|P6|Open Label Extension|Progressive Disease|1
874633|NCT00568178|2784554|P5|Open Label Extension|Progressive Disease|3
874634|NCT00568178|2784555|P4|Open Label Extension|Progressive Disease|0
874635|NCT00568178|2784556|P3|Open Label Extension|Progressive Disease|0
874636|NCT00568178|2784557|P2|Open Label Extension|Progressive Disease|0
874637|NCT00568178|2784558|P1|Open Label Extension|Progressive Disease|0
874638|NCT00568178|2784553|P6|Open Label Extension|Pregnancy|1
874639|NCT00568178|2784554|P5|Open Label Extension|Pregnancy|0
874640|NCT00568178|2784555|P4|Open Label Extension|Pregnancy|0
874641|NCT00568178|2784556|P3|Open Label Extension|Pregnancy|0
874642|NCT00568178|2784557|P2|Open Label Extension|Pregnancy|0
874643|NCT00568178|2784558|P1|Open Label Extension|Pregnancy|0
874644|NCT00568178|2784553|P6|Open Label Extension|Physician Decision|8
874645|NCT00568178|2784554|P5|Open Label Extension|Physician Decision|9
874646|NCT00568178|2784555|P4|Open Label Extension|Physician Decision|0
874647|NCT00568178|2784556|P3|Open Label Extension|Physician Decision|0
874648|NCT00568178|2784557|P2|Open Label Extension|Physician Decision|0
874649|NCT00568178|2784558|P1|Open Label Extension|Physician Decision|0
874650|NCT00568178|2784553|P6|Open Label Extension|Lost to Follow-up|11
874651|NCT00568178|2784554|P5|Open Label Extension|Lost to Follow-up|6
874652|NCT00568178|2784555|P4|Open Label Extension|Lost to Follow-up|0
874653|NCT00568178|2784556|P3|Open Label Extension|Lost to Follow-up|0
874654|NCT00568178|2784557|P2|Open Label Extension|Lost to Follow-up|0
874655|NCT00568178|2784558|P1|Open Label Extension|Lost to Follow-up|0
874656|NCT00568178|2784553|P6|Open Label Extension|Protocol Violation|0
874657|NCT00568178|2784554|P5|Open Label Extension|Protocol Violation|1
874658|NCT00568178|2784555|P4|Open Label Extension|Protocol Violation|0
874659|NCT00568178|2784556|P3|Open Label Extension|Protocol Violation|0
874660|NCT00568178|2784557|P2|Open Label Extension|Protocol Violation|0
874661|NCT00568178|2784558|P1|Open Label Extension|Protocol Violation|0
874662|NCT00568178|2784553|P6|Open Label Extension|Adverse Event|8
874663|NCT00568178|2784554|P5|Open Label Extension|Adverse Event|11
874664|NCT00568178|2784555|P4|Open Label Extension|Adverse Event|0
874665|NCT00568178|2784556|P3|Open Label Extension|Adverse Event|0
874666|NCT00568178|2784557|P2|Open Label Extension|Adverse Event|0
874667|NCT00568178|2784558|P1|Open Label Extension|Adverse Event|0
874668|NCT00568178|2784553|P6|Double Blind Base Study|Progressive Disease|0
874669|NCT00568178|2784554|P5|Double Blind Base Study|Progressive Disease|0
874670|NCT00568178|2784555|P4|Double Blind Base Study|Progressive Disease|1
874671|NCT00568178|2784556|P3|Double Blind Base Study|Progressive Disease|0
874672|NCT00568178|2784557|P2|Double Blind Base Study|Progressive Disease|0
874673|NCT00568178|2784558|P1|Double Blind Base Study|Progressive Disease|0
874674|NCT00568178|2784553|P6|Double Blind Base Study|Withdrawal by Subject|0
874675|NCT00568178|2784554|P5|Double Blind Base Study|Withdrawal by Subject|0
874676|NCT00568178|2784555|P4|Double Blind Base Study|Withdrawal by Subject|0
874677|NCT00568178|2784556|P3|Double Blind Base Study|Withdrawal by Subject|0
874678|NCT00568178|2784557|P2|Double Blind Base Study|Withdrawal by Subject|1
874679|NCT00568178|2784558|P1|Double Blind Base Study|Withdrawal by Subject|1
874680|NCT00568178|2784553|P6|Double Blind Base Study|Protocol Violation|0
874681|NCT00568178|2784554|P5|Double Blind Base Study|Protocol Violation|0
874682|NCT00568178|2784555|P4|Double Blind Base Study|Protocol Violation|0
874683|NCT00568178|2784556|P3|Double Blind Base Study|Protocol Violation|0
874684|NCT00568178|2784557|P2|Double Blind Base Study|Protocol Violation|2
874685|NCT00568178|2784558|P1|Double Blind Base Study|Protocol Violation|3
874686|NCT00568178|2784553|P6|Double Blind Base Study|Physician Decision|0
874687|NCT00568178|2784554|P5|Double Blind Base Study|Physician Decision|0
874688|NCT00568178|2784555|P4|Double Blind Base Study|Physician Decision|1
874689|NCT00568178|2784556|P3|Double Blind Base Study|Physician Decision|0
874690|NCT00568178|2784557|P2|Double Blind Base Study|Physician Decision|1
874691|NCT00568178|2784558|P1|Double Blind Base Study|Physician Decision|1
874692|NCT00568178|2784553|P6|Double Blind Base Study|Lost to Follow-up|0
874693|NCT00568178|2784554|P5|Double Blind Base Study|Lost to Follow-up|0
874694|NCT00568178|2784555|P4|Double Blind Base Study|Lost to Follow-up|1
874695|NCT00568178|2784556|P3|Double Blind Base Study|Lost to Follow-up|0
874696|NCT00568178|2784557|P2|Double Blind Base Study|Lost to Follow-up|0
874697|NCT00568178|2784558|P1|Double Blind Base Study|Lost to Follow-up|1
874698|NCT00568178|2784553|P6|Double Blind Base Study|Adverse Event|0
874699|NCT00568178|2784554|P5|Double Blind Base Study|Adverse Event|0
874700|NCT00568178|2784555|P4|Double Blind Base Study|Adverse Event|2
874701|NCT00568178|2784556|P3|Double Blind Base Study|Adverse Event|1
874702|NCT00568178|2784557|P2|Double Blind Base Study|Adverse Event|2
874703|NCT00568178|2784558|P1|Double Blind Base Study|Adverse Event|0
874704|NCT00560755|2784574|P1|Overall Study|Physician Decision|2
874705|NCT00560755|2784574|P1|Overall Study|Adverse Event|8
874706|NCT00560755|2784574|P1|Overall Study|Lost to Follow-up|9
874707|NCT00560755|2784574|P1|Overall Study|Withdrawal by Subject|26
874708|NCT00560755|2784574|P1|Overall Study|Protocol Violation|15
874709|NCT00499746|2784593|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
874710|NCT00499746|2784593|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
874711|NCT00499746|2784593|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
874712|NCT00499746|2784593|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
902138|NCT01867580|2867395|P2|Overall Study|Wound recurrence|1
902139|NCT01867580|2867396|P1|Overall Study|Wound recurrence|0
902140|NCT01867580|2867395|P2|Overall Study|Continuation of therapy|1
902141|NCT01867580|2867396|P1|Overall Study|Continuation of therapy|0
902142|NCT01867580|2867395|P2|Overall Study|Osteomyelitis|1
874802|NCT02609659|2784903|P1|Overall Study|Not Specified|1
874803|NCT02609659|2784903|P1|Overall Study|Lost to Follow-up|6
874804|NCT02609659|2784903|P1|Overall Study|Adverse Event|1
902143|NCT01867580|2867396|P1|Overall Study|Osteomyelitis|0
902144|NCT01867580|2867395|P2|Overall Study|Interruption to therapy|0
902145|NCT01867580|2867396|P1|Overall Study|Interruption to therapy|3
902146|NCT01867580|2867395|P2|Overall Study|Missed follow-up assessment|1
902147|NCT01867580|2867396|P1|Overall Study|Missed follow-up assessment|2
902148|NCT01867580|2867395|P2|Overall Study|Sponsor terminated study|0
902149|NCT01867580|2867396|P1|Overall Study|Sponsor terminated study|1
902150|NCT01867580|2867395|P2|Overall Study|Lost to Follow-up|5
902151|NCT01867580|2867396|P1|Overall Study|Lost to Follow-up|3
902152|NCT01867580|2867395|P2|Overall Study|Physician Decision|12
874815|NCT02475395|2784979|P2|Overall Study|Protocol Violation|3
874816|NCT02475395|2784980|P1|Overall Study|Protocol Violation|30
902153|NCT01867580|2867396|P1|Overall Study|Physician Decision|17
902154|NCT01867580|2867395|P2|Overall Study|Withdrawal by Subject|3
902155|NCT01867580|2867396|P1|Overall Study|Withdrawal by Subject|2
902217|NCT01572844|2867709|P2|Overall Study|Physician Decision|1
902218|NCT01572844|2867710|P1|Overall Study|Physician Decision|1
902219|NCT01538199|2867760|P4|Overall Study|Lack of Efficacy|0
902220|NCT01538199|2867761|P3|Overall Study|Lack of Efficacy|0
902221|NCT01538199|2867762|P2|Overall Study|Lack of Efficacy|1
902222|NCT01538199|2867763|P1|Overall Study|Lack of Efficacy|0
902223|NCT01538199|2867760|P4|Overall Study|participant did not have time|2
902224|NCT01538199|2867761|P3|Overall Study|participant did not have time|0
902225|NCT01538199|2867762|P2|Overall Study|participant did not have time|0
902226|NCT01538199|2867763|P1|Overall Study|participant did not have time|1
902227|NCT01538199|2867760|P4|Overall Study|Lost to Follow-up|0
902228|NCT01538199|2867761|P3|Overall Study|Lost to Follow-up|1
902229|NCT01538199|2867762|P2|Overall Study|Lost to Follow-up|2
902230|NCT01538199|2867763|P1|Overall Study|Lost to Follow-up|1
902233|NCT01381562|2867833|P3|Overall Study|Adverse Event|0
902234|NCT01381562|2867834|P2|Overall Study|Adverse Event|1
902235|NCT01381562|2867835|P1|Overall Study|Adverse Event|0
902292|NCT01299909|2867983|P3|Overall Study|Lost to Follow-up|17
902293|NCT01299909|2867984|P2|Overall Study|Lost to Follow-up|18
902294|NCT01299909|2867985|P1|Overall Study|Lost to Follow-up|22
874951|NCT02102464|2785569|P3|Randomized Study|Withdrawal by Subject|0
874952|NCT02102464|2785570|P2|Randomized Study|Withdrawal by Subject|1
874953|NCT02102464|2785571|P1|Randomized Study|Withdrawal by Subject|0
902303|NCT01210222|2868110|P1|Overall Study|Never treated|1
902304|NCT01210222|2868110|P1|Overall Study|Ineligible|2
902314|NCT01145495|2868221|P1|Overall Study|Disease progression after respone|1
902315|NCT01145495|2868221|P1|Overall Study|Withdrawal by Subject|5
902316|NCT01145495|2868221|P1|Overall Study|Adverse Event|6
875015|NCT01916967|2785858|P3|Overall Study|Protocol Violation|0
875016|NCT01916967|2785859|P2|Overall Study|Protocol Violation|1
875017|NCT01916967|2785860|P1|Overall Study|Protocol Violation|0
875018|NCT01916967|2785858|P3|Overall Study|Physician Decision|1
875019|NCT01916967|2785859|P2|Overall Study|Physician Decision|0
875020|NCT01916967|2785860|P1|Overall Study|Physician Decision|0
875021|NCT01916967|2785858|P3|Overall Study|Lack of Efficacy|6
875022|NCT01916967|2785859|P2|Overall Study|Lack of Efficacy|0
875023|NCT01916967|2785860|P1|Overall Study|Lack of Efficacy|0
875024|NCT01916967|2785858|P3|Overall Study|Adverse Event|2
875025|NCT01916967|2785859|P2|Overall Study|Adverse Event|0
875026|NCT01916967|2785860|P1|Overall Study|Adverse Event|0
875027|NCT01916980|2785903|P2|Overall Study|Withdrawal by Subject|0
875028|NCT01916980|2785904|P1|Overall Study|Withdrawal by Subject|1
875029|NCT01916980|2785903|P2|Overall Study|Lack of Efficacy|2
875030|NCT01916980|2785904|P1|Overall Study|Lack of Efficacy|2
875031|NCT01916980|2785903|P2|Overall Study|Adverse Event|2
875032|NCT01916980|2785904|P1|Overall Study|Adverse Event|4
875039|NCT01854710|2785929|P6|Overall Study|CRI procedural error|2
875040|NCT01854710|2785930|P5|Overall Study|CRI procedural error|2
875041|NCT01854710|2785931|P4|Overall Study|CRI procedural error|2
875042|NCT01854710|2785932|P3|Overall Study|CRI procedural error|2
875043|NCT01854710|2785933|P2|Overall Study|CRI procedural error|2
875044|NCT01854710|2785934|P1|Overall Study|CRI procedural error|2
875045|NCT01854710|2785929|P6|Overall Study|Withdrawal by Subject|0
875046|NCT01854710|2785930|P5|Overall Study|Withdrawal by Subject|0
875047|NCT01854710|2785931|P4|Overall Study|Withdrawal by Subject|0
875048|NCT01854710|2785932|P3|Overall Study|Withdrawal by Subject|0
875049|NCT01854710|2785933|P2|Overall Study|Withdrawal by Subject|1
875050|NCT01854710|2785934|P1|Overall Study|Withdrawal by Subject|2
875140|NCT01611792|2786332|P2|Followup: at 6 Months|Lost to Follow-up|13
875141|NCT01611792|2786333|P1|Followup: at 6 Months|Lost to Follow-up|6
875142|NCT01611792|2786332|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
875143|NCT01611792|2786333|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
875190|NCT01369641|2786667|P1|Overall Study|Withdrawal by Subject|1
875191|NCT01323387|2786703|P1|Overall Study|Randomized but Never Treated|16
875192|NCT01323387|2786703|P1|Overall Study|Protocol Violation|12
875193|NCT01323387|2786703|P1|Overall Study|Revision|14
875194|NCT01323387|2786703|P1|Overall Study|Radiographic Data Unavailable|1
875195|NCT01323387|2786703|P1|Overall Study|Withdrawal by Subject|41
875256|NCT01256671|2786965|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
875257|NCT01256671|2786965|P1|Overall Study|Lack of Efficacy|4
875258|NCT01256671|2786965|P1|Overall Study|Physician Decision|3
875259|NCT01256671|2786965|P1|Overall Study|Withdrawal by Subject|31
875260|NCT01256671|2786965|P1|Overall Study|Lost to Follow-up|16
875261|NCT01256671|2786965|P1|Overall Study|Adverse Event|29
875262|NCT01239394|2786976|P1|Overall Study|Adverse Event|1
875269|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Other|0
875270|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Other|0
875271|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Other|0
875272|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Other|1
875273|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Other|1
875274|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Other|0
875275|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Other|0
875276|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875277|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875278|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875279|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
875280|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875281|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875282|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
875283|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875284|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875285|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875286|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875287|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
875288|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875289|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
875290|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
875291|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
875292|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
875293|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
875294|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
875295|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
875296|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
875297|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
875298|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
875299|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
875300|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
875301|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
875302|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
875303|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
875304|NCT01212770|2787139|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
875305|NCT01212770|2787140|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
875306|NCT01212770|2787141|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
875307|NCT01212770|2787142|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
875308|NCT01212770|2787143|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
875309|NCT01212770|2787144|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
875310|NCT01212770|2787145|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
875311|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
875312|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
875313|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
875314|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
875315|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Other|2
875316|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Other|1
875317|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Other|3
875318|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875319|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875320|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875321|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875322|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
875323|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875324|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
875325|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
875326|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
875327|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
875328|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
875329|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
875330|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
875331|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
875332|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
875333|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
875334|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
875335|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
875336|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
875337|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
875338|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
875339|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
875340|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
875341|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
875342|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
875343|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
875344|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
875345|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
875346|NCT01212770|2787139|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
875347|NCT01212770|2787140|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
875348|NCT01212770|2787141|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
875349|NCT01212770|2787142|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
875350|NCT01212770|2787143|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
875351|NCT01212770|2787144|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
875352|NCT01212770|2787145|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
875353|NCT01196416|2787332|P1|Overall Study|Withdrawal by Subject|2
875354|NCT01192295|2787341|P2|Overall Study|Administrative|6
875355|NCT01192295|2787342|P1|Overall Study|Administrative|4
875356|NCT01192295|2787341|P2|Overall Study|Lack of Efficacy|5
875357|NCT01192295|2787342|P1|Overall Study|Lack of Efficacy|0
875358|NCT01192295|2787341|P2|Overall Study|Lost to Follow-up|1
875359|NCT01192295|2787342|P1|Overall Study|Lost to Follow-up|0
875360|NCT01192295|2787341|P2|Overall Study|Withdrawal by Subject|4
875361|NCT01192295|2787342|P1|Overall Study|Withdrawal by Subject|3
875362|NCT01192295|2787341|P2|Overall Study|Adverse Event|7
875363|NCT01192295|2787342|P1|Overall Study|Adverse Event|3
902535|NCT01001988|2868486|P1|Overall Study|Lost to Follow-up|15
902536|NCT01001988|2868486|P1|Overall Study|Withdrawal by Subject|18
902537|NCT01001988|2868486|P1|Overall Study|Protocol Violation|84
902555|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
902556|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
902557|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
902558|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
875402|NCT01009515|2787558|P1|Overall Study|Withdrawal by Subject|3
875403|NCT00996840|2787575|P5|Overall Study|Withdrawal by Subject|0
875404|NCT00996840|2787576|P4|Overall Study|Withdrawal by Subject|0
875405|NCT00996840|2787577|P3|Overall Study|Withdrawal by Subject|0
875406|NCT00996840|2787578|P2|Overall Study|Withdrawal by Subject|1
875407|NCT00996840|2787579|P1|Overall Study|Withdrawal by Subject|1
875408|NCT00996840|2787575|P5|Overall Study|Physician Decision|2
875409|NCT00996840|2787576|P4|Overall Study|Physician Decision|1
875410|NCT00996840|2787577|P3|Overall Study|Physician Decision|1
875411|NCT00996840|2787578|P2|Overall Study|Physician Decision|0
875412|NCT00996840|2787579|P1|Overall Study|Physician Decision|0
875413|NCT00996840|2787575|P5|Overall Study|Adverse Event|0
875414|NCT00996840|2787576|P4|Overall Study|Adverse Event|0
875415|NCT00996840|2787577|P3|Overall Study|Adverse Event|0
875416|NCT00996840|2787578|P2|Overall Study|Adverse Event|1
875417|NCT00996840|2787579|P1|Overall Study|Adverse Event|0
902559|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
902560|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
902561|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
902562|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
902563|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
902564|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
902565|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Death|1
902566|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Death|0
902567|NCT00843518|2868580|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
902568|NCT00843518|2868581|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
902569|NCT00810810|2868613|P4|Overall Study|Physician Decision|5
902570|NCT00810810|2868614|P3|Overall Study|Physician Decision|1
902571|NCT00810810|2868615|P2|Overall Study|Physician Decision|3
902572|NCT00810810|2868616|P1|Overall Study|Physician Decision|0
902573|NCT00810810|2868613|P4|Overall Study|Withdrawal by Subject|8
902574|NCT00810810|2868614|P3|Overall Study|Withdrawal by Subject|10
902575|NCT00810810|2868615|P2|Overall Study|Withdrawal by Subject|8
902576|NCT00810810|2868616|P1|Overall Study|Withdrawal by Subject|0
902640|NCT00334893|2868997|P2|Overall Study|Not Treated|0
902641|NCT00334893|2868998|P1|Overall Study|Not Treated|1
902642|NCT00329797|2869037|P2|Overall Study|Withdrawal by Subject|6
902643|NCT00329797|2869038|P1|Overall Study|Withdrawal by Subject|6
902644|NCT00329797|2869037|P2|Overall Study|Protocol Violation|0
902645|NCT00329797|2869038|P1|Overall Study|Protocol Violation|1
902646|NCT00323063|2869052|P2|Overall Study|brain mets discovered prior to treatment|0
902647|NCT00323063|2869053|P1|Overall Study|brain mets discovered prior to treatment|1
902648|NCT00323063|2869052|P2|Overall Study|Adverse Event|0
902649|NCT00323063|2869053|P1|Overall Study|Adverse Event|1
875576|NCT00069238|2788504|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
875577|NCT00069238|2788505|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
875578|NCT00069238|2788506|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
875579|NCT00069238|2788504|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
875580|NCT00069238|2788505|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
875581|NCT00069238|2788506|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
875582|NCT00069238|2788504|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
875583|NCT00069238|2788505|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
875584|NCT00069238|2788506|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
875585|NCT00064753|2788514|P2|Overall Study|Lost to Follow-up|235
875586|NCT00064753|2788515|P1|Overall Study|Lost to Follow-up|225
875587|NCT00064753|2788514|P2|Overall Study|Withdrawal by Subject|171
875588|NCT00064753|2788515|P1|Overall Study|Withdrawal by Subject|198
875589|NCT00064753|2788514|P2|Overall Study|Death|242
875590|NCT00064753|2788515|P1|Overall Study|Death|251
902693|NCT02698423|2869249|P2|Overall Study|Lost to Follow-up|24
902694|NCT02698423|2869250|P1|Overall Study|Lost to Follow-up|19
902695|NCT02661594|2869260|P4|Overall Study|Protocol Violation|0
902696|NCT02661594|2869261|P3|Overall Study|Protocol Violation|1
902697|NCT02661594|2869262|P2|Overall Study|Protocol Violation|0
902698|NCT02661594|2869263|P1|Overall Study|Protocol Violation|1
902699|NCT02599129|2869275|P2|Overall Study|Withdrawal by Subject|1
902700|NCT02599129|2869276|P1|Overall Study|Withdrawal by Subject|2
902701|NCT02599129|2869275|P2|Overall Study|Lost to Follow-up|0
902702|NCT02599129|2869276|P1|Overall Study|Lost to Follow-up|1
902703|NCT02599129|2869275|P2|Overall Study|Lack of Efficacy|2
902704|NCT02599129|2869276|P1|Overall Study|Lack of Efficacy|2
902705|NCT02577107|2869292|P2|Overall Study|Protocol deviation|1
902706|NCT02577107|2869293|P1|Overall Study|Protocol deviation|0
902707|NCT02534493|2869305|P1|Overall Study|Withdrawal by Subject|1
902708|NCT02534493|2869305|P1|Overall Study|Lost to Follow-up|1
902709|NCT02497755|2869316|P2|Overall Study|Protocol Violation|0
902710|NCT02497755|2869317|P1|Overall Study|Protocol Violation|1
902711|NCT02466659|2869332|P2|Overall Study|Lost to Follow-up|2
902712|NCT02466659|2869333|P1|Overall Study|Lost to Follow-up|5
902713|NCT02429791|2869343|P2|Overall Study|Withdrawal by Subject|7
902714|NCT02429791|2869344|P1|Overall Study|Withdrawal by Subject|3
902715|NCT02429791|2869343|P2|Overall Study|Protocol Violation|4
902716|NCT02429791|2869344|P1|Overall Study|Protocol Violation|1
902717|NCT02429791|2869343|P2|Overall Study|Lost to Follow-up|2
902718|NCT02429791|2869344|P1|Overall Study|Lost to Follow-up|1
902719|NCT02429791|2869343|P2|Overall Study|Lack of Efficacy|1
902720|NCT02429791|2869344|P1|Overall Study|Lack of Efficacy|2
902721|NCT02429791|2869343|P2|Overall Study|Physician Decision|2
902722|NCT02429791|2869344|P1|Overall Study|Physician Decision|0
875621|NCT00045708|2788561|P3|Phase 1|early progressive disease|0
875622|NCT00045708|2788562|P2|Phase 1|early progressive disease|1
875623|NCT00045708|2788563|P1|Phase 1|early progressive disease|0
902723|NCT02429791|2869343|P2|Overall Study|Adverse Event|2
902724|NCT02429791|2869344|P1|Overall Study|Adverse Event|6
902725|NCT02339506|2869425|P2|Washout (Period 2)|Withdrawal by Subject|0
902726|NCT02339506|2869426|P1|Washout (Period 2)|Withdrawal by Subject|2
902727|NCT02339506|2869425|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
902728|NCT02339506|2869426|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
902729|NCT02290691|2869434|P2|Overall Study|Lost to Follow-up|7
902730|NCT02290691|2869435|P1|Overall Study|Lost to Follow-up|7
902731|NCT02290691|2869434|P2|Overall Study|Withdrawal by Subject|1
902732|NCT02290691|2869435|P1|Overall Study|Withdrawal by Subject|1
902733|NCT02290691|2869434|P2|Overall Study|Noncompliance|1
902734|NCT02290691|2869435|P1|Overall Study|Noncompliance|0
902735|NCT02276040|2869449|P1|Overall Study|Physician Decision|15
875637|NCT02447848|2788679|P1|Overall Study|Withdrawal by Subject|4
875638|NCT02447848|2788679|P1|Overall Study|Lack of Efficacy|4
875639|NCT02447848|2788679|P1|Overall Study|Patient discharged|3
902736|NCT02102490|2869461|P1|Overall Study|Lost to Follow-up|1
902737|NCT02102490|2869461|P1|Overall Study|Death|5
902738|NCT02102490|2869461|P1|Overall Study|Adverse Event|3
902739|NCT02095106|2869475|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
902740|NCT02095106|2869476|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
902741|NCT02071082|2869494|P2|Overall Study|Lost to Follow-up|1
902742|NCT02071082|2869495|P1|Overall Study|Lost to Follow-up|1
902743|NCT02071082|2869494|P2|Overall Study|Withdrew Consent|4
902744|NCT02071082|2869495|P1|Overall Study|Withdrew Consent|0
902745|NCT02071082|2869494|P2|Overall Study|Adverse Event|1
902746|NCT02071082|2869495|P1|Overall Study|Adverse Event|0
902747|NCT02071082|2869494|P2|Overall Study|Enrolled and Never Treated|1
902748|NCT02071082|2869495|P1|Overall Study|Enrolled and Never Treated|1
902749|NCT02039674|2869531|P8|Overall Study|Ongoing in Study|4
902750|NCT02039674|2869532|P7|Overall Study|Ongoing in Study|67
902751|NCT02039674|2869533|P6|Overall Study|Ongoing in Study|1
902752|NCT02039674|2869534|P5|Overall Study|Ongoing in Study|6
902753|NCT02039674|2869535|P4|Overall Study|Ongoing in Study|2
875671|NCT02287025|2788762|P2|Overall Study|Screening failed|1
875672|NCT02287025|2788763|P1|Overall Study|Screening failed|1
875673|NCT02287025|2788762|P2|Overall Study|Withdrawal by Subject|2
875674|NCT02287025|2788763|P1|Overall Study|Withdrawal by Subject|2
875675|NCT02287025|2788762|P2|Overall Study|Adverse Event|4
875676|NCT02287025|2788763|P1|Overall Study|Adverse Event|2
875677|NCT02287025|2788762|P2|Overall Study|Progression of disease|2
875678|NCT02287025|2788763|P1|Overall Study|Progression of disease|3
875679|NCT02287025|2788762|P2|Overall Study|Not treated|0
875680|NCT02287025|2788763|P1|Overall Study|Not treated|2
902754|NCT02039674|2869536|P3|Overall Study|Ongoing in Study|5
875682|NCT02281773|2788838|P5|Overall Study|Other Reason|1
875683|NCT02281773|2788839|P4|Overall Study|Other Reason|3
875684|NCT02281773|2788840|P3|Overall Study|Other Reason|2
875685|NCT02281773|2788841|P2|Overall Study|Other Reason|4
875686|NCT02281773|2788842|P1|Overall Study|Other Reason|0
875687|NCT02281773|2788838|P5|Overall Study|Withdrawal by Subject|8
875688|NCT02281773|2788839|P4|Overall Study|Withdrawal by Subject|6
875689|NCT02281773|2788840|P3|Overall Study|Withdrawal by Subject|6
875690|NCT02281773|2788841|P2|Overall Study|Withdrawal by Subject|8
875691|NCT02281773|2788842|P1|Overall Study|Withdrawal by Subject|2
875692|NCT02281773|2788838|P5|Overall Study|Lost to Follow-up|10
875693|NCT02281773|2788839|P4|Overall Study|Lost to Follow-up|2
875694|NCT02281773|2788840|P3|Overall Study|Lost to Follow-up|6
875695|NCT02281773|2788841|P2|Overall Study|Lost to Follow-up|2
875696|NCT02281773|2788842|P1|Overall Study|Lost to Follow-up|2
875697|NCT02281773|2788838|P5|Overall Study|Protocol Violation|2
875698|NCT02281773|2788839|P4|Overall Study|Protocol Violation|2
875699|NCT02281773|2788840|P3|Overall Study|Protocol Violation|0
875700|NCT02281773|2788841|P2|Overall Study|Protocol Violation|0
875701|NCT02281773|2788842|P1|Overall Study|Protocol Violation|1
875702|NCT02281773|2788838|P5|Overall Study|Adverse Event|9
875703|NCT02281773|2788839|P4|Overall Study|Adverse Event|8
875704|NCT02281773|2788840|P3|Overall Study|Adverse Event|4
875705|NCT02281773|2788841|P2|Overall Study|Adverse Event|1
875706|NCT02281773|2788842|P1|Overall Study|Adverse Event|6
902755|NCT02039674|2869537|P2|Overall Study|Ongoing in Study|5
902756|NCT02039674|2869538|P1|Overall Study|Ongoing in Study|7
902757|NCT02039674|2869531|P8|Overall Study|Withdrawal by Subject|2
902758|NCT02039674|2869532|P7|Overall Study|Withdrawal by Subject|8
902759|NCT02039674|2869533|P6|Overall Study|Withdrawal by Subject|1
902760|NCT02039674|2869534|P5|Overall Study|Withdrawal by Subject|2
902761|NCT02039674|2869535|P4|Overall Study|Withdrawal by Subject|0
902762|NCT02039674|2869536|P3|Overall Study|Withdrawal by Subject|1
902763|NCT02039674|2869537|P2|Overall Study|Withdrawal by Subject|1
902764|NCT02039674|2869538|P1|Overall Study|Withdrawal by Subject|2
902765|NCT02039674|2869531|P8|Overall Study|Progressive Disease|23
902766|NCT02039674|2869532|P7|Overall Study|Progressive Disease|35
902767|NCT02039674|2869533|P6|Overall Study|Progressive Disease|0
902768|NCT02039674|2869534|P5|Overall Study|Progressive Disease|2
902769|NCT02039674|2869535|P4|Overall Study|Progressive Disease|4
902770|NCT02039674|2869536|P3|Overall Study|Progressive Disease|15
902771|NCT02039674|2869537|P2|Overall Study|Progressive Disease|13
875725|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
875726|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
875727|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
875728|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Other|3
875729|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Other|2
875730|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Other|0
875731|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
875732|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
875733|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
875734|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
875735|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
875736|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
875737|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
875738|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
875739|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
875740|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
875741|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
875742|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
875743|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
875744|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
875745|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
875746|NCT02207231|2789024|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
875747|NCT02207231|2789025|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
875748|NCT02207231|2789026|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
875749|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
875750|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
875751|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
875752|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
875753|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
875754|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
875755|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
875756|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
875757|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
875758|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
875759|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
875760|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
875761|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
875762|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
875763|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
875764|NCT02207231|2789024|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
875765|NCT02207231|2789025|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
875766|NCT02207231|2789026|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
902772|NCT02039674|2869538|P1|Overall Study|Progressive Disease|13
902773|NCT02039674|2869531|P8|Overall Study|Physician Decision|0
902774|NCT02039674|2869532|P7|Overall Study|Physician Decision|1
902775|NCT02039674|2869533|P6|Overall Study|Physician Decision|0
902776|NCT02039674|2869534|P5|Overall Study|Physician Decision|0
902777|NCT02039674|2869535|P4|Overall Study|Physician Decision|0
902778|NCT02039674|2869536|P3|Overall Study|Physician Decision|0
902779|NCT02039674|2869537|P2|Overall Study|Physician Decision|0
902780|NCT02039674|2869538|P1|Overall Study|Physician Decision|0
902781|NCT02039674|2869531|P8|Overall Study|Lost to Follow-up|0
902782|NCT02039674|2869532|P7|Overall Study|Lost to Follow-up|1
902783|NCT02039674|2869533|P6|Overall Study|Lost to Follow-up|0
902784|NCT02039674|2869534|P5|Overall Study|Lost to Follow-up|0
902785|NCT02039674|2869535|P4|Overall Study|Lost to Follow-up|0
902786|NCT02039674|2869536|P3|Overall Study|Lost to Follow-up|0
902787|NCT02039674|2869537|P2|Overall Study|Lost to Follow-up|0
902788|NCT02039674|2869538|P1|Overall Study|Lost to Follow-up|0
902789|NCT02039674|2869531|P8|Overall Study|Excluded Medication|5
902790|NCT02039674|2869532|P7|Overall Study|Excluded Medication|6
902791|NCT02039674|2869533|P6|Overall Study|Excluded Medication|4
902792|NCT02039674|2869534|P5|Overall Study|Excluded Medication|2
902793|NCT02039674|2869535|P4|Overall Study|Excluded Medication|0
902794|NCT02039674|2869536|P3|Overall Study|Excluded Medication|2
902795|NCT02039674|2869537|P2|Overall Study|Excluded Medication|1
902796|NCT02039674|2869538|P1|Overall Study|Excluded Medication|2
902797|NCT02039674|2869531|P8|Overall Study|Death|8
902798|NCT02039674|2869532|P7|Overall Study|Death|1
902799|NCT02039674|2869533|P6|Overall Study|Death|1
902800|NCT02039674|2869534|P5|Overall Study|Death|0
902801|NCT02039674|2869535|P4|Overall Study|Death|0
902802|NCT02039674|2869536|P3|Overall Study|Death|0
875798|NCT01966003|2789421|P2|Overall Study|Other|1
875799|NCT01966003|2789422|P1|Overall Study|Other|1
875800|NCT01966003|2789421|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
875801|NCT01966003|2789422|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
875802|NCT01966003|2789421|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
875803|NCT01966003|2789422|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
875804|NCT01966003|2789421|P2|Overall Study|Withdrawal by Subject|19
875805|NCT01966003|2789422|P1|Overall Study|Withdrawal by Subject|29
875806|NCT01966003|2789421|P2|Overall Study|Physician Decision|13
875807|NCT01966003|2789422|P1|Overall Study|Physician Decision|12
875808|NCT01966003|2789421|P2|Overall Study|Lost to Follow-up|3
875809|NCT01966003|2789422|P1|Overall Study|Lost to Follow-up|4
875810|NCT01966003|2789421|P2|Overall Study|Protocol Violation|4
875811|NCT01966003|2789422|P1|Overall Study|Protocol Violation|6
875812|NCT01966003|2789421|P2|Overall Study|Death|36
875813|NCT01966003|2789422|P1|Overall Study|Death|43
875814|NCT01946529|2789441|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
875815|NCT01946529|2789442|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
875816|NCT01946529|2789443|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
875817|NCT01946529|2789441|P3|End of Window Therapy (2 Courses)|Physician Decision|0
875818|NCT01946529|2789442|P2|End of Window Therapy (2 Courses)|Physician Decision|1
875819|NCT01946529|2789443|P1|End of Window Therapy (2 Courses)|Physician Decision|0
902803|NCT02039674|2869537|P2|Overall Study|Death|3
902804|NCT02039674|2869538|P1|Overall Study|Death|0
902805|NCT02039674|2869531|P8|Overall Study|Adverse Event|3
902806|NCT02039674|2869532|P7|Overall Study|Adverse Event|4
902807|NCT02039674|2869533|P6|Overall Study|Adverse Event|0
902808|NCT02039674|2869534|P5|Overall Study|Adverse Event|0
902809|NCT02039674|2869535|P4|Overall Study|Adverse Event|0
902810|NCT02039674|2869536|P3|Overall Study|Adverse Event|1
902811|NCT02039674|2869537|P2|Overall Study|Adverse Event|2
902812|NCT02039674|2869538|P1|Overall Study|Adverse Event|0
902813|NCT02030119|2869573|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
902814|NCT02030119|2869574|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
902815|NCT02030119|2869575|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
902816|NCT02030119|2869576|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
902817|NCT02030119|2869573|P4|Overall Study|Withdrawal by Subject|3
902818|NCT02030119|2869574|P3|Overall Study|Withdrawal by Subject|5
902819|NCT02030119|2869575|P2|Overall Study|Withdrawal by Subject|1
902820|NCT02030119|2869576|P1|Overall Study|Withdrawal by Subject|3
902821|NCT02029989|2869592|P2|Overall Study|Protocol Violation|0
902822|NCT02029989|2869593|P1|Overall Study|Protocol Violation|1
902823|NCT02029989|2869592|P2|Overall Study|Death|1
902824|NCT02029989|2869593|P1|Overall Study|Death|0
902825|NCT02029989|2869592|P2|Overall Study|Lost to Follow-up|7
902826|NCT02029989|2869593|P1|Overall Study|Lost to Follow-up|9
902827|NCT02029989|2869592|P2|Overall Study|Physician Decision|0
902828|NCT02029989|2869593|P1|Overall Study|Physician Decision|2
902829|NCT02029989|2869592|P2|Overall Study|Change of location|3
902830|NCT02029989|2869593|P1|Overall Study|Change of location|2
902831|NCT02029989|2869592|P2|Overall Study|Withdrawal: Fear of needles|0
902832|NCT02029989|2869593|P1|Overall Study|Withdrawal: Fear of needles|1
902833|NCT02029989|2869592|P2|Overall Study|Withdrawal by Subject|0
902834|NCT02029989|2869593|P1|Overall Study|Withdrawal by Subject|1
902835|NCT02002533|2869606|P2|Overall Study|Lost to Follow-up|1
902836|NCT02002533|2869607|P1|Overall Study|Lost to Follow-up|0
902837|NCT02002533|2869606|P2|Overall Study|Adverse Event|3
902838|NCT02002533|2869607|P1|Overall Study|Adverse Event|0
902839|NCT02002533|2869606|P2|Overall Study|Protocol Violation|1
902840|NCT02002533|2869607|P1|Overall Study|Protocol Violation|0
902841|NCT02002533|2869606|P2|Overall Study|Withdrawal by Subject|13
902842|NCT02002533|2869607|P1|Overall Study|Withdrawal by Subject|6
902843|NCT01896557|2869648|P2|Clopidogrel + GI Protector|Reading error|3
902844|NCT01896557|2869649|P1|Clopidogrel + GI Protector|Reading error|1
902845|NCT01896557|2869648|P2|Clopidogrel + GI Protector|low adherence|1
902846|NCT01896557|2869649|P1|Clopidogrel + GI Protector|low adherence|1
902847|NCT01896557|2869648|P2|Clopidogrel Alone|Adverse Event|0
902848|NCT01896557|2869649|P1|Clopidogrel Alone|Adverse Event|1
902849|NCT01806298|2869702|P1|Overall Study|Other|5
902850|NCT01806298|2869702|P1|Overall Study|Withdrawal by Subject|1
875863|NCT01732458|2789634|P4|Overall Study|Screen Failure|0
875864|NCT01732458|2789635|P3|Overall Study|Screen Failure|0
875865|NCT01732458|2789636|P2|Overall Study|Screen Failure|1
875866|NCT01732458|2789637|P1|Overall Study|Screen Failure|0
875867|NCT01732458|2789634|P4|Overall Study|Protocol Violation|2
875868|NCT01732458|2789635|P3|Overall Study|Protocol Violation|0
875869|NCT01732458|2789636|P2|Overall Study|Protocol Violation|0
875870|NCT01732458|2789637|P1|Overall Study|Protocol Violation|2
875871|NCT01732458|2789634|P4|Overall Study|Physician Decision|0
875872|NCT01732458|2789635|P3|Overall Study|Physician Decision|2
875873|NCT01732458|2789636|P2|Overall Study|Physician Decision|2
875874|NCT01732458|2789637|P1|Overall Study|Physician Decision|1
875875|NCT01732458|2789634|P4|Overall Study|Non-Compliance With Study Drug|0
875876|NCT01732458|2789635|P3|Overall Study|Non-Compliance With Study Drug|1
875877|NCT01732458|2789636|P2|Overall Study|Non-Compliance With Study Drug|0
875878|NCT01732458|2789637|P1|Overall Study|Non-Compliance With Study Drug|0
875879|NCT01732458|2789634|P4|Overall Study|Lost to Follow-up|0
875880|NCT01732458|2789635|P3|Overall Study|Lost to Follow-up|0
875881|NCT01732458|2789636|P2|Overall Study|Lost to Follow-up|2
875882|NCT01732458|2789637|P1|Overall Study|Lost to Follow-up|0
902851|NCT01806298|2869702|P1|Overall Study|Protocol Non-compliance|1
902852|NCT01806298|2869702|P1|Overall Study|Adverse Event|3
902853|NCT01775787|2869744|P2|Second 7-10 Days|concerns with using IV|1
902854|NCT01775787|2869745|P1|Second 7-10 Days|concerns with using IV|0
902855|NCT01775787|2869744|P2|Second 7-10 Days|time commitment|1
902856|NCT01775787|2869745|P1|Second 7-10 Days|time commitment|0
902857|NCT01775787|2869744|P2|First 7-10 Days|concerns with using IV|2
902858|NCT01775787|2869745|P1|First 7-10 Days|concerns with using IV|1
902859|NCT01775787|2869744|P2|First 7-10 Days|time commitment|2
902860|NCT01775787|2869745|P1|First 7-10 Days|time commitment|0
902861|NCT01775787|2869744|P2|First 7-10 Days|family emergency|1
902862|NCT01775787|2869745|P1|First 7-10 Days|family emergency|0
902863|NCT01775787|2869744|P2|First 7-10 Days|Adverse Event|1
902864|NCT01775787|2869745|P1|First 7-10 Days|Adverse Event|0
902865|NCT01770145|2869753|P1|Treatment|Withdrawal by Subject|1
902866|NCT01770145|2869753|P1|Treatment|Adverse Event|3
902867|NCT01770145|2869753|P1|Baseline|Unable to define optimal dose|4
902868|NCT01770145|2869753|P1|Baseline|Lost to Follow-up|1
902869|NCT01770145|2869753|P1|Baseline|Withdrawal by Subject|1
902870|NCT01770145|2869753|P1|Baseline|Adverse Event|20
902871|NCT01757821|2869758|P1|Overall Study|Adverse Event|1
902872|NCT01686828|2869823|P4|Overall Study|Weight Loss|0
902873|NCT01686828|2869824|P3|Overall Study|Weight Loss|1
902874|NCT01686828|2869825|P2|Overall Study|Weight Loss|0
902875|NCT01686828|2869826|P1|Overall Study|Weight Loss|0
902876|NCT01686828|2869823|P4|Overall Study|New Job|0
875909|NCT01503164|2789829|P2|Overall Study|Withdrawal by Subject|1
875910|NCT01503164|2789830|P1|Overall Study|Withdrawal by Subject|2
902877|NCT01686828|2869824|P3|Overall Study|New Job|0
902878|NCT01686828|2869825|P2|Overall Study|New Job|1
902879|NCT01686828|2869826|P1|Overall Study|New Job|0
902880|NCT01686828|2869823|P4|Overall Study|Physician Decision|0
902881|NCT01686828|2869824|P3|Overall Study|Physician Decision|0
902882|NCT01686828|2869825|P2|Overall Study|Physician Decision|0
902883|NCT01686828|2869826|P1|Overall Study|Physician Decision|1
902884|NCT01685372|2869846|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
902885|NCT01685372|2869847|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
902886|NCT01658813|2869867|P1|Overall Study|Disease progression|3
902887|NCT01639755|2869911|P1|Overall Study|Patient had device explantation|4
902888|NCT01639755|2869911|P1|Overall Study|Study Ongoing|15
902889|NCT01639742|2869919|P1|Overall Study|Lost to Follow-up|1
902890|NCT01639742|2869919|P1|Overall Study|Study Ongoing|17
902891|NCT01625091|2869946|P2|Post-intervention|Study termination|1
902892|NCT01625091|2869947|P1|Post-intervention|Study termination|2
902893|NCT01625091|2869946|P2|Post-intervention|Lost to Follow-up|0
902894|NCT01625091|2869947|P1|Post-intervention|Lost to Follow-up|2
902895|NCT01625091|2869946|P2|Post-intervention|Death|1
902896|NCT01625091|2869947|P1|Post-intervention|Death|0
902897|NCT01625091|2869946|P2|Intervention|Study termination|3
902898|NCT01625091|2869947|P1|Intervention|Study termination|2
902899|NCT01625091|2869946|P2|Intervention|Lost to Follow-up|4
875933|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
875934|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
875935|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
875936|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
875937|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
875938|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
875939|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
875940|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
875941|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
875942|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
875943|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
875944|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
875945|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
875946|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
875947|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
875948|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
875949|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
875950|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
875951|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
875952|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
875953|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
875954|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
875955|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
875956|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
875957|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
875958|NCT01285310|2790018|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
875959|NCT01285310|2790019|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
875960|NCT01285310|2790020|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
875961|NCT01285310|2790021|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
875962|NCT01285310|2790022|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
875963|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
875964|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
875965|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
875966|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
875967|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
875968|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
875969|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
875970|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
875971|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
875972|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
875973|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
875974|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
875975|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
875976|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
875977|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
875978|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
875979|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
875980|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
875981|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
875982|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
875983|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
875984|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
875985|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
875986|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
875987|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
875988|NCT01285310|2790018|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
875989|NCT01285310|2790019|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
875990|NCT01285310|2790020|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
875991|NCT01285310|2790021|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
875992|NCT01285310|2790022|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
902900|NCT01625091|2869947|P1|Intervention|Lost to Follow-up|4
902901|NCT01625091|2869946|P2|Intervention|Adverse Event|2
902902|NCT01625091|2869947|P1|Intervention|Adverse Event|0
902903|NCT01625091|2869946|P2|Intervention|Withdrawal by Subject|1
902904|NCT01625091|2869947|P1|Intervention|Withdrawal by Subject|4
902905|NCT01625091|2869946|P2|Intervention|Death|1
902906|NCT01625091|2869947|P1|Intervention|Death|1
902907|NCT01586156|2869962|P3|Overall Study|Pregnancy|0
902908|NCT01586156|2869963|P2|Overall Study|Pregnancy|1
902909|NCT01586156|2869964|P1|Overall Study|Pregnancy|0
902910|NCT01461707|2870048|P2|Overall Study|Withdrawal by Subject|0
902911|NCT01461707|2870049|P1|Overall Study|Withdrawal by Subject|1
902912|NCT01364870|2870060|P3|Overall Study|Protocol Violation|0
902913|NCT01364870|2870061|P2|Overall Study|Protocol Violation|0
902914|NCT01364870|2870062|P1|Overall Study|Protocol Violation|1
902915|NCT01364870|2870060|P3|Overall Study|Adverse Event|4
902916|NCT01364870|2870061|P2|Overall Study|Adverse Event|6
902917|NCT01364870|2870062|P1|Overall Study|Adverse Event|8
902918|NCT01364870|2870060|P3|Overall Study|Withdrawal by Subject|10
902919|NCT01364870|2870061|P2|Overall Study|Withdrawal by Subject|24
902920|NCT01364870|2870062|P1|Overall Study|Withdrawal by Subject|13
902921|NCT01318915|2870102|P1|Overall Study|Ongoing in study|7
902922|NCT01318915|2870102|P1|Overall Study|Lost to Follow-up|1
902923|NCT01313676|2870110|P4|Overall Study|Missing|0
902924|NCT01313676|2870111|P3|Overall Study|Missing|1
902925|NCT01313676|2870112|P2|Overall Study|Missing|1
902926|NCT01313676|2870113|P1|Overall Study|Missing|1
902927|NCT01313676|2870110|P4|Overall Study|Investigator Site Closed|10
902928|NCT01313676|2870111|P3|Overall Study|Investigator Site Closed|15
876022|NCT01079806|2790546|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
876023|NCT01079806|2790547|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
876024|NCT01079806|2790546|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
876025|NCT01079806|2790547|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
876026|NCT01079806|2790546|P2|Day 1 to Week 96|Pregnancy|1
876027|NCT01079806|2790547|P1|Day 1 to Week 96|Pregnancy|0
876028|NCT01079806|2790546|P2|Day 1 to Week 96|Withdrawal by Subject|1
876029|NCT01079806|2790547|P1|Day 1 to Week 96|Withdrawal by Subject|3
876030|NCT01079806|2790546|P2|Day 1 to Week 96|Adverse Event|2
876031|NCT01079806|2790547|P1|Day 1 to Week 96|Adverse Event|0
876032|NCT01062425|2790569|P2|Overall Study|Protocol Violation|6
876033|NCT01062425|2790570|P1|Overall Study|Protocol Violation|3
902929|NCT01313676|2870112|P2|Overall Study|Investigator Site Closed|11
902930|NCT01313676|2870113|P1|Overall Study|Investigator Site Closed|12
902931|NCT01313676|2870110|P4|Overall Study|Sponsor Terminated Study Treatment|1
876037|NCT00923351|2790621|P3|Overall Study|no apheresis/adequate tumor sample|12
876038|NCT00923351|2790622|P2|Overall Study|no apheresis/adequate tumor sample|0
876039|NCT00923351|2790623|P1|Overall Study|no apheresis/adequate tumor sample|0
902932|NCT01313676|2870111|P3|Overall Study|Sponsor Terminated Study Treatment|0
902933|NCT01313676|2870112|P2|Overall Study|Sponsor Terminated Study Treatment|1
902934|NCT01313676|2870113|P1|Overall Study|Sponsor Terminated Study Treatment|1
902935|NCT01313676|2870110|P4|Overall Study|Decision by Participant or Proxy|492
902936|NCT01313676|2870111|P3|Overall Study|Decision by Participant or Proxy|515
902937|NCT01313676|2870112|P2|Overall Study|Decision by Participant or Proxy|527
902938|NCT01313676|2870113|P1|Overall Study|Decision by Participant or Proxy|643
902939|NCT01313676|2870110|P4|Overall Study|Physician Decision|48
902940|NCT01313676|2870111|P3|Overall Study|Physician Decision|62
902941|NCT01313676|2870112|P2|Overall Study|Physician Decision|64
902942|NCT01313676|2870113|P1|Overall Study|Physician Decision|53
902943|NCT01313676|2870110|P4|Overall Study|Lost to Follow-up|0
902944|NCT01313676|2870111|P3|Overall Study|Lost to Follow-up|1
902945|NCT01313676|2870112|P2|Overall Study|Lost to Follow-up|0
902946|NCT01313676|2870113|P1|Overall Study|Lost to Follow-up|0
902947|NCT01313676|2870110|P4|Overall Study|Study Closed/terminated|9
902948|NCT01313676|2870111|P3|Overall Study|Study Closed/terminated|9
902949|NCT01313676|2870112|P2|Overall Study|Study Closed/terminated|6
902950|NCT01313676|2870113|P1|Overall Study|Study Closed/terminated|7
902951|NCT01313676|2870110|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
902952|NCT01313676|2870111|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
902953|NCT01313676|2870112|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
902954|NCT01313676|2870113|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
902955|NCT01313676|2870110|P4|Overall Study|Protocol Violation|44
902956|NCT01313676|2870111|P3|Overall Study|Protocol Violation|46
902957|NCT01313676|2870112|P2|Overall Study|Protocol Violation|44
902958|NCT01313676|2870113|P1|Overall Study|Protocol Violation|37
902959|NCT01313676|2870110|P4|Overall Study|Lack of Efficacy|46
902960|NCT01313676|2870111|P3|Overall Study|Lack of Efficacy|65
902961|NCT01313676|2870112|P2|Overall Study|Lack of Efficacy|90
902962|NCT01313676|2870113|P1|Overall Study|Lack of Efficacy|98
902963|NCT01313676|2870110|P4|Overall Study|Adverse Event|333
902964|NCT01313676|2870111|P3|Overall Study|Adverse Event|372
902965|NCT01313676|2870112|P2|Overall Study|Adverse Event|365
902966|NCT01313676|2870113|P1|Overall Study|Adverse Event|395
902967|NCT01300650|2870131|P1|Overall Study|Adverse Event|1
902968|NCT01233609|2870171|P2|Overall Study|Withdrawal by Subject|0
902969|NCT01233609|2870172|P1|Overall Study|Withdrawal by Subject|3
902970|NCT01233609|2870171|P2|Overall Study|Adverse Event|1
876079|NCT00689936|2790742|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
876080|NCT00689936|2790743|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
876081|NCT00689936|2790744|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
876082|NCT00689936|2790742|P3|Active Treatment Phase|Miscellaneous|47
876083|NCT00689936|2790743|P2|Active Treatment Phase|Miscellaneous|34
876084|NCT00689936|2790744|P1|Active Treatment Phase|Miscellaneous|52
876085|NCT00689936|2790742|P3|Active Treatment Phase|Study Close Out|21
876086|NCT00689936|2790743|P2|Active Treatment Phase|Study Close Out|26
876087|NCT00689936|2790744|P1|Active Treatment Phase|Study Close Out|64
876088|NCT00689936|2790742|P3|Active Treatment Phase|Protocol Violation|4
876089|NCT00689936|2790743|P2|Active Treatment Phase|Protocol Violation|2
876090|NCT00689936|2790744|P1|Active Treatment Phase|Protocol Violation|2
876091|NCT00689936|2790742|P3|Active Treatment Phase|Lost to Follow-up|2
876092|NCT00689936|2790743|P2|Active Treatment Phase|Lost to Follow-up|2
876093|NCT00689936|2790744|P1|Active Treatment Phase|Lost to Follow-up|0
876094|NCT00689936|2790742|P3|Active Treatment Phase|Death|37
876095|NCT00689936|2790743|P2|Active Treatment Phase|Death|28
876096|NCT00689936|2790744|P1|Active Treatment Phase|Death|60
876097|NCT00689936|2790742|P3|Active Treatment Phase|Withdrawal by Subject|21
876098|NCT00689936|2790743|P2|Active Treatment Phase|Withdrawal by Subject|16
876099|NCT00689936|2790744|P1|Active Treatment Phase|Withdrawal by Subject|16
876100|NCT00689936|2790742|P3|Active Treatment Phase|Disease Progression|339
876101|NCT00689936|2790743|P2|Active Treatment Phase|Disease Progression|362
876102|NCT00689936|2790744|P1|Active Treatment Phase|Disease Progression|273
876103|NCT00689936|2790742|P3|Active Treatment Phase|Adverse Event|76
876104|NCT00689936|2790743|P2|Active Treatment Phase|Adverse Event|71
876105|NCT00689936|2790744|P1|Active Treatment Phase|Adverse Event|68
902971|NCT01233609|2870172|P1|Overall Study|Adverse Event|2
902972|NCT01233609|2870171|P2|Overall Study|Lost to Follow-up|1
902973|NCT01233609|2870172|P1|Overall Study|Lost to Follow-up|3
902974|NCT01233609|2870171|P2|Overall Study|Death|0
902975|NCT01233609|2870172|P1|Overall Study|Death|1
902976|NCT01206439|2870207|P1|Overall Study|subject did not meet inclusion criteria|1
902977|NCT01200810|2870213|P2|Overall Study|Sponsor stopped making study drug|3
902978|NCT01200810|2870214|P1|Overall Study|Sponsor stopped making study drug|3
902979|NCT01200810|2870213|P2|Overall Study|Withdrawal by Subject|2
902980|NCT01200810|2870214|P1|Overall Study|Withdrawal by Subject|1
902981|NCT01200810|2870213|P2|Overall Study|Physician Decision|0
902982|NCT01200810|2870214|P1|Overall Study|Physician Decision|1
902983|NCT01147653|2870245|P2|Year 2|Withdrawal by Subject|3
902984|NCT01147653|2870246|P1|Year 2|Withdrawal by Subject|2
902985|NCT01118052|2870305|P1|Overall Study|Never treated|2
902986|NCT01082614|2870320|P2|Overall Study|Physician Decision|0
902987|NCT01082614|2870321|P1|Overall Study|Physician Decision|2
902988|NCT01082614|2870320|P2|Overall Study|Equipment Malfunction|1
876124|NCT00424047|2791110|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
876125|NCT00424047|2791111|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
876126|NCT00424047|2791110|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
876127|NCT00424047|2791111|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
876128|NCT00424047|2791110|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
876129|NCT00424047|2791111|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
876130|NCT00424047|2791110|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
876131|NCT00424047|2791111|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
876132|NCT00424047|2791110|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
876133|NCT00424047|2791111|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
876134|NCT00424047|2791110|P2|On Study at Time of Unblinding|Other|4
876135|NCT00424047|2791111|P1|On Study at Time of Unblinding|Other|5
876136|NCT00424047|2791110|P2|On Study at Time of Unblinding|Death|11
876137|NCT00424047|2791111|P1|On Study at Time of Unblinding|Death|11
876138|NCT00424047|2791110|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
876139|NCT00424047|2791111|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
876140|NCT00424047|2791110|P2|On Study at Time of Unblinding|Lack of Efficacy|3
876141|NCT00424047|2791111|P1|On Study at Time of Unblinding|Lack of Efficacy|1
876142|NCT00424047|2791110|P2|On Study at Time of Unblinding|Progression of disease|128
876143|NCT00424047|2791111|P1|On Study at Time of Unblinding|Progression of disease|92
876144|NCT00424047|2791110|P2|On Study at Time of Unblinding|Adverse Event|12
876145|NCT00424047|2791111|P1|On Study at Time of Unblinding|Adverse Event|22
876146|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
876147|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
876148|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
876149|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
876150|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
876151|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
876152|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
876153|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
876154|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
876155|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
876156|NCT00424047|2791110|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
876157|NCT00424047|2791111|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
902989|NCT01082614|2870321|P1|Overall Study|Equipment Malfunction|0
902990|NCT01082614|2870320|P2|Overall Study|Adverse Event|4
876160|NCT00374140|2791179|P1|Overall Study|Protocol Violation|1
876161|NCT00374140|2791179|P1|Overall Study|Lost to Follow-up|1
902991|NCT01082614|2870321|P1|Overall Study|Adverse Event|1
902992|NCT01075412|2870333|P2|Overall Study|Withdrawal by Subject|1
902993|NCT01075412|2870334|P1|Overall Study|Withdrawal by Subject|0
876165|NCT00056160|2791266|P2|Final Follow-up|Adverse Event|0
876166|NCT00056160|2791267|P1|Final Follow-up|Adverse Event|1
876167|NCT00056160|2791266|P2|Final Follow-up|Transferred into RevAssist Program|0
876168|NCT00056160|2791267|P1|Final Follow-up|Transferred into RevAssist Program|2
876169|NCT00056160|2791266|P2|Final Follow-up|Transferred into expanded access study.|0
876170|NCT00056160|2791267|P1|Final Follow-up|Transferred into expanded access study.|3
876171|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
876172|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
876173|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
876174|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
876175|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
876176|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
876177|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
876178|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
876179|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
876180|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
876181|NCT00056160|2791266|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
876182|NCT00056160|2791267|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
876183|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
876184|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
876185|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Death|1
876186|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Death|2
876187|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
876188|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
876189|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
876190|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
876191|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
876192|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
876193|NCT00056160|2791266|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
876194|NCT00056160|2791267|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
902994|NCT01074658|2870344|P1|Overall Study|No implant attempted|19
902995|NCT01072175|2870362|P13|Part D (HPMC Capsules)|Ongoing|34
876197|NCT02730819|2791289|P1|Overall Study|Lost to Follow-up|9
876198|NCT02480621|2791303|P2|Follow Up|Lost to Follow-up|2
876199|NCT02480621|2791304|P1|Follow Up|Lost to Follow-up|4
876200|NCT02480621|2791303|P2|Randomization|Surgeon did not give intervention|1
876201|NCT02480621|2791304|P1|Randomization|Surgeon did not give intervention|0
876202|NCT02480621|2791303|P2|Randomization|Withdrawal by Subject|0
876203|NCT02480621|2791304|P1|Randomization|Withdrawal by Subject|1
876204|NCT02478632|2791312|P2|Overall Study|Other (Withdrawal from parent study)|5
876205|NCT02478632|2791313|P1|Overall Study|Other (Withdrawal from parent study)|4
876210|NCT02317016|2791350|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
876211|NCT02317016|2791350|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
876212|NCT02317016|2791350|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
876213|NCT02317016|2791350|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
876214|NCT02317016|2791350|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
876215|NCT02317016|2791350|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
876216|NCT02317016|2791350|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
876231|NCT02135848|2791417|P2|Overall Study|Withdrawal by Subject|1
876232|NCT02135848|2791418|P1|Overall Study|Withdrawal by Subject|1
876233|NCT02135848|2791417|P2|Overall Study|Adverse Event|0
876234|NCT02135848|2791418|P1|Overall Study|Adverse Event|2
902996|NCT01072175|2870363|P12|Part D (HPMC Capsules)|Ongoing|34
902997|NCT01072175|2870364|P11|Part D (HPMC Capsules)|Ongoing|12
902998|NCT01072175|2870365|P10|Part D (HPMC Capsules)|Ongoing|10
876241|NCT01939223|2791633|P2|Overall Study|Withdrawal by Subject|0
876242|NCT01939223|2791634|P1|Overall Study|Withdrawal by Subject|6
876243|NCT01939223|2791633|P2|Overall Study|Study stopped by Sponsor|7
876244|NCT01939223|2791634|P1|Overall Study|Study stopped by Sponsor|5
876245|NCT01939223|2791633|P2|Overall Study|Disease recurrence (radiological)|3
876246|NCT01939223|2791634|P1|Overall Study|Disease recurrence (radiological)|1
876247|NCT01939223|2791633|P2|Overall Study|AE not assoc. with disease recurrence|1
876248|NCT01939223|2791634|P1|Overall Study|AE not assoc. with disease recurrence|1
876249|NCT01938573|2791642|P2|Overall Study|Operation at other hospital|0
876250|NCT01938573|2791643|P1|Overall Study|Operation at other hospital|1
876251|NCT01938573|2791642|P2|Overall Study|Lack of Efficacy|0
876252|NCT01938573|2791643|P1|Overall Study|Lack of Efficacy|1
902999|NCT01072175|2870366|P9|Part D (HPMC Capsules)|Ongoing|0
903000|NCT01072175|2870367|P8|Part D (HPMC Capsules)|Ongoing|0
903001|NCT01072175|2870368|P7|Part D (HPMC Capsules)|Ongoing|0
903002|NCT01072175|2870369|P6|Part D (HPMC Capsules)|Ongoing|0
876263|NCT01748890|2791677|P1|Overall Study|Insufficient recruitment for analysis|4
876264|NCT01748292|2791683|P2|Overall Study|Withdrawal by Subject|2
876265|NCT01748292|2791684|P1|Overall Study|Withdrawal by Subject|0
876266|NCT01748292|2791683|P2|Overall Study|Death|3
876267|NCT01748292|2791684|P1|Overall Study|Death|0
876268|NCT01748292|2791683|P2|Overall Study|Lost to Follow-up|3
876269|NCT01748292|2791684|P1|Overall Study|Lost to Follow-up|0
876270|NCT01748292|2791683|P2|Overall Study|Adverse Event|4
876271|NCT01748292|2791684|P1|Overall Study|Adverse Event|2
876272|NCT01736397|2791702|P2|Overall Study|Not stated|4
876273|NCT01736397|2791703|P1|Overall Study|Not stated|1
876274|NCT01736397|2791702|P2|Overall Study|Adverse Event|3
876275|NCT01736397|2791703|P1|Overall Study|Adverse Event|6
876276|NCT01736397|2791702|P2|Overall Study|Lost to Follow-up|1
876277|NCT01736397|2791703|P1|Overall Study|Lost to Follow-up|0
876278|NCT01736397|2791702|P2|Overall Study|Withdrawal by Subject|5
876279|NCT01736397|2791703|P1|Overall Study|Withdrawal by Subject|6
876280|NCT01736397|2791702|P2|Overall Study|Lack of Efficacy|11
876281|NCT01736397|2791703|P1|Overall Study|Lack of Efficacy|1
876282|NCT01617460|2791724|P1|Overall Study|Withdrawal by Subject|9
876283|NCT01617460|2791724|P1|Overall Study|Protocol Violation|5
876284|NCT01617460|2791724|P1|Overall Study|Physician Decision|16
876285|NCT01617460|2791724|P1|Overall Study|Adverse Event|10
876286|NCT01514357|2791750|P2|Overall Study|Withdrawal by Subject|0
876287|NCT01514357|2791751|P1|Overall Study|Withdrawal by Subject|2
876288|NCT01514357|2791750|P2|Overall Study|Screen failure|0
876289|NCT01514357|2791751|P1|Overall Study|Screen failure|2
876302|NCT01114724|2791814|P1|Overall Study|Withdrawal by Subject|1
876303|NCT01114724|2791814|P1|Overall Study|Lost to Follow-up|1
876304|NCT01114724|2791814|P1|Overall Study|Death|8
876305|NCT01094743|2791832|P1|Period 1|Unsatisfactory comfort at lens fitting|2
876306|NCT01035606|2791852|P3|Overall Study|change in health, job demands,family|4
876307|NCT01035606|2791853|P2|Overall Study|change in health, job demands,family|3
876308|NCT01035606|2791854|P1|Overall Study|change in health, job demands,family|3
876309|NCT00899847|2791883|P1|Overall Study|Lack of suitable allogeneic donor|2
903003|NCT01072175|2870370|P5|Part D (HPMC Capsules)|Ongoing|0
903004|NCT01072175|2870371|P4|Part D (HPMC Capsules)|Ongoing|0
903005|NCT01072175|2870372|P3|Part D (HPMC Capsules)|Ongoing|0
903006|NCT01072175|2870373|P2|Part D (HPMC Capsules)|Ongoing|0
903007|NCT01072175|2870374|P1|Part D (HPMC Capsules)|Ongoing|0
903008|NCT01072175|2870362|P13|Part D (HPMC Capsules)|Death|5
903009|NCT01072175|2870363|P12|Part D (HPMC Capsules)|Death|6
903010|NCT01072175|2870364|P11|Part D (HPMC Capsules)|Death|4
876326|NCT00790569|2791938|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
876327|NCT00790569|2791939|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
876328|NCT00790569|2791940|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
876329|NCT00790569|2791938|P3|End of Treatment (6 Month Interview)|Incarcerated|3
876330|NCT00790569|2791939|P2|End of Treatment (6 Month Interview)|Incarcerated|0
876331|NCT00790569|2791940|P1|End of Treatment (6 Month Interview)|Incarcerated|0
876332|NCT00790569|2791938|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
876333|NCT00790569|2791939|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
876334|NCT00790569|2791940|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
876335|NCT00790569|2791938|P3|End of Treatment (6 Month Interview)|Hospitalized|0
876336|NCT00790569|2791939|P2|End of Treatment (6 Month Interview)|Hospitalized|0
876337|NCT00790569|2791940|P1|End of Treatment (6 Month Interview)|Hospitalized|2
876338|NCT00790569|2791938|P3|End of Treatment (6 Month Interview)|Death|1
876339|NCT00790569|2791939|P2|End of Treatment (6 Month Interview)|Death|2
876340|NCT00790569|2791940|P1|End of Treatment (6 Month Interview)|Death|0
876341|NCT00790569|2791938|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
876342|NCT00790569|2791939|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
876343|NCT00790569|2791940|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
876344|NCT00601900|2791994|P2|Overall Study|Withdrawal by Subject|3
876345|NCT00601900|2791995|P1|Overall Study|Withdrawal by Subject|0
876346|NCT00573833|2792009|P1|Overall Study|Not Treated|2
876347|NCT00432159|2792027|P5|Overall Study|Missing NDI and/or neuro. assessment|7
876348|NCT00432159|2792028|P4|Overall Study|Missing NDI and/or neuro. assessment|3
876349|NCT00432159|2792029|P3|Overall Study|Missing NDI and/or neuro. assessment|1
876350|NCT00432159|2792030|P2|Overall Study|Missing NDI and/or neuro. assessment|24
876351|NCT00432159|2792031|P1|Overall Study|Missing NDI and/or neuro. assessment|13
876352|NCT00432159|2792027|P5|Overall Study|Failure|3
876353|NCT00432159|2792028|P4|Overall Study|Failure|2
876354|NCT00432159|2792029|P3|Overall Study|Failure|3
876355|NCT00432159|2792030|P2|Overall Study|Failure|5
876356|NCT00432159|2792031|P1|Overall Study|Failure|9
876357|NCT00432159|2792027|P5|Overall Study|Death|0
876358|NCT00432159|2792028|P4|Overall Study|Death|0
876359|NCT00432159|2792029|P3|Overall Study|Death|0
876360|NCT00432159|2792030|P2|Overall Study|Death|1
876361|NCT00432159|2792031|P1|Overall Study|Death|0
876362|NCT00414726|2792137|P2|Overall Study|Withdrawal by Subject|1
876363|NCT00414726|2792138|P1|Overall Study|Withdrawal by Subject|0
876364|NCT00272844|2792175|P1|Overall Study|Withdrawal by Subject|5
876365|NCT00006184|2792192|P2|Overall Study|Death|0
876366|NCT00006184|2792193|P1|Overall Study|Death|1
903011|NCT01072175|2870365|P10|Part D (HPMC Capsules)|Death|2
903012|NCT01072175|2870366|P9|Part D (HPMC Capsules)|Death|0
903013|NCT01072175|2870367|P8|Part D (HPMC Capsules)|Death|0
903014|NCT01072175|2870368|P7|Part D (HPMC Capsules)|Death|0
903015|NCT01072175|2870369|P6|Part D (HPMC Capsules)|Death|0
903016|NCT01072175|2870370|P5|Part D (HPMC Capsules)|Death|0
903017|NCT01072175|2870371|P4|Part D (HPMC Capsules)|Death|0
903018|NCT01072175|2870372|P3|Part D (HPMC Capsules)|Death|0
903019|NCT01072175|2870373|P2|Part D (HPMC Capsules)|Death|0
903020|NCT01072175|2870374|P1|Part D (HPMC Capsules)|Death|0
903021|NCT01072175|2870362|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
903022|NCT01072175|2870363|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
903023|NCT01072175|2870364|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
903024|NCT01072175|2870365|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
903025|NCT01072175|2870366|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
903026|NCT01072175|2870367|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
903027|NCT01072175|2870368|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
903028|NCT01072175|2870369|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
903029|NCT01072175|2870370|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
903030|NCT01072175|2870371|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
903031|NCT01072175|2870372|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
903032|NCT01072175|2870373|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
903033|NCT01072175|2870374|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
903034|NCT01072175|2870362|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
903035|NCT01072175|2870363|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
903036|NCT01072175|2870364|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
903037|NCT01072175|2870365|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
903038|NCT01072175|2870366|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
903039|NCT01072175|2870367|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
903040|NCT01072175|2870368|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
903041|NCT01072175|2870369|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
903042|NCT01072175|2870370|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
903043|NCT01072175|2870371|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
903044|NCT01072175|2870372|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
903045|NCT01072175|2870373|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
903046|NCT01072175|2870374|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
903047|NCT01072175|2870362|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903048|NCT01072175|2870363|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903049|NCT01072175|2870364|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903050|NCT01072175|2870365|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903051|NCT01072175|2870366|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
903052|NCT01072175|2870367|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903053|NCT01072175|2870368|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903054|NCT01072175|2870369|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903055|NCT01072175|2870370|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903056|NCT01072175|2870371|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903057|NCT01072175|2870372|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903058|NCT01072175|2870373|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903059|NCT01072175|2870374|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
903060|NCT01072175|2870362|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
903061|NCT01072175|2870363|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
903062|NCT01072175|2870364|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
903063|NCT01072175|2870365|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
903064|NCT01072175|2870366|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
903065|NCT01072175|2870367|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
903066|NCT01072175|2870368|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
903067|NCT01072175|2870369|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
903068|NCT01072175|2870370|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
903069|NCT01072175|2870371|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
903070|NCT01072175|2870372|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
903071|NCT01072175|2870373|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
903072|NCT01072175|2870374|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
903073|NCT01072175|2870362|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
903074|NCT01072175|2870363|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
903075|NCT01072175|2870364|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
903076|NCT01072175|2870365|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
903077|NCT01072175|2870366|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
903078|NCT01072175|2870367|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
903079|NCT01072175|2870368|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
903080|NCT01072175|2870369|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
903081|NCT01072175|2870370|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
903082|NCT01072175|2870371|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
903083|NCT01072175|2870372|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
903084|NCT01072175|2870373|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
903085|NCT01072175|2870374|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
903086|NCT01072175|2870362|P13|Part C (Phase II: Randomized Phase)|Death|0
903087|NCT01072175|2870363|P12|Part C (Phase II: Randomized Phase)|Death|0
903088|NCT01072175|2870364|P11|Part C (Phase II: Randomized Phase)|Death|0
903089|NCT01072175|2870365|P10|Part C (Phase II: Randomized Phase)|Death|0
903090|NCT01072175|2870366|P9|Part C (Phase II: Randomized Phase)|Death|0
903091|NCT01072175|2870367|P8|Part C (Phase II: Randomized Phase)|Death|14
903092|NCT01072175|2870368|P7|Part C (Phase II: Randomized Phase)|Death|18
903093|NCT01072175|2870369|P6|Part C (Phase II: Randomized Phase)|Death|19
903094|NCT01072175|2870370|P5|Part C (Phase II: Randomized Phase)|Death|0
903095|NCT01072175|2870371|P4|Part C (Phase II: Randomized Phase)|Death|0
903096|NCT01072175|2870372|P3|Part C (Phase II: Randomized Phase)|Death|0
903097|NCT01072175|2870373|P2|Part C (Phase II: Randomized Phase)|Death|0
903098|NCT01072175|2870374|P1|Part C (Phase II: Randomized Phase)|Death|0
903099|NCT01072175|2870362|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903100|NCT01072175|2870363|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903101|NCT01072175|2870364|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903102|NCT01072175|2870365|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903103|NCT01072175|2870366|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903104|NCT01072175|2870367|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903105|NCT01072175|2870368|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
903106|NCT01072175|2870369|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903107|NCT01072175|2870370|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903108|NCT01072175|2870371|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903109|NCT01072175|2870372|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903110|NCT01072175|2870373|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903111|NCT01072175|2870374|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
903112|NCT01072175|2870362|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
903113|NCT01072175|2870363|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
903114|NCT01072175|2870364|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
903115|NCT01072175|2870365|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
903116|NCT01072175|2870366|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
903117|NCT01072175|2870367|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
903118|NCT01072175|2870368|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
903119|NCT01072175|2870369|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
903120|NCT01072175|2870370|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
903121|NCT01072175|2870371|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
903122|NCT01072175|2870372|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
903123|NCT01072175|2870373|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
903124|NCT01072175|2870374|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
903125|NCT01072175|2870362|P13|Part B (Dose Escalation and Expansion)|Death|0
903126|NCT01072175|2870363|P12|Part B (Dose Escalation and Expansion)|Death|0
903127|NCT01072175|2870364|P11|Part B (Dose Escalation and Expansion)|Death|0
903128|NCT01072175|2870365|P10|Part B (Dose Escalation and Expansion)|Death|0
903129|NCT01072175|2870366|P9|Part B (Dose Escalation and Expansion)|Death|0
903130|NCT01072175|2870367|P8|Part B (Dose Escalation and Expansion)|Death|0
903131|NCT01072175|2870368|P7|Part B (Dose Escalation and Expansion)|Death|0
903132|NCT01072175|2870369|P6|Part B (Dose Escalation and Expansion)|Death|0
903133|NCT01072175|2870370|P5|Part B (Dose Escalation and Expansion)|Death|36
903134|NCT01072175|2870371|P4|Part B (Dose Escalation and Expansion)|Death|12
903135|NCT01072175|2870372|P3|Part B (Dose Escalation and Expansion)|Death|10
903136|NCT01072175|2870373|P2|Part B (Dose Escalation and Expansion)|Death|3
903137|NCT01072175|2870374|P1|Part B (Dose Escalation and Expansion)|Death|0
903138|NCT01072175|2870362|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903139|NCT01072175|2870363|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903140|NCT01072175|2870364|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903141|NCT01072175|2870365|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903142|NCT01072175|2870366|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903143|NCT01072175|2870367|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903144|NCT01072175|2870368|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903145|NCT01072175|2870369|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903146|NCT01072175|2870370|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
903147|NCT01072175|2870371|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
903148|NCT01072175|2870372|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903149|NCT01072175|2870373|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903150|NCT01072175|2870374|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
903151|NCT01072175|2870362|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
903152|NCT01072175|2870363|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
903153|NCT01072175|2870364|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
903154|NCT01072175|2870365|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
903155|NCT01072175|2870366|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
903156|NCT01072175|2870367|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
903157|NCT01072175|2870368|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
903158|NCT01072175|2870369|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
903159|NCT01072175|2870370|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
903160|NCT01072175|2870371|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
903161|NCT01072175|2870372|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
903162|NCT01072175|2870373|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
903163|NCT01072175|2870374|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
903164|NCT01072175|2870362|P13|Part A (Drug-Drug Interaction)|Death|0
903165|NCT01072175|2870363|P12|Part A (Drug-Drug Interaction)|Death|0
903166|NCT01072175|2870364|P11|Part A (Drug-Drug Interaction)|Death|0
903167|NCT01072175|2870365|P10|Part A (Drug-Drug Interaction)|Death|0
903168|NCT01072175|2870366|P9|Part A (Drug-Drug Interaction)|Death|0
903169|NCT01072175|2870367|P8|Part A (Drug-Drug Interaction)|Death|0
903170|NCT01072175|2870368|P7|Part A (Drug-Drug Interaction)|Death|0
903171|NCT01072175|2870369|P6|Part A (Drug-Drug Interaction)|Death|0
903172|NCT01072175|2870370|P5|Part A (Drug-Drug Interaction)|Death|0
903173|NCT01072175|2870371|P4|Part A (Drug-Drug Interaction)|Death|0
903174|NCT01072175|2870372|P3|Part A (Drug-Drug Interaction)|Death|0
903175|NCT01072175|2870373|P2|Part A (Drug-Drug Interaction)|Death|0
903176|NCT01072175|2870374|P1|Part A (Drug-Drug Interaction)|Death|1
903177|NCT01072175|2870362|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903178|NCT01072175|2870363|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903179|NCT01072175|2870364|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903180|NCT01072175|2870365|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903181|NCT01072175|2870366|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903182|NCT01072175|2870367|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903183|NCT01072175|2870368|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903184|NCT01072175|2870369|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903185|NCT01072175|2870370|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903186|NCT01072175|2870371|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903187|NCT01072175|2870372|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903188|NCT01072175|2870373|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
903189|NCT01072175|2870374|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
903190|NCT01072175|2870362|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
903191|NCT01072175|2870363|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
903192|NCT01072175|2870364|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
903193|NCT01072175|2870365|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
903194|NCT01072175|2870366|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
903195|NCT01072175|2870367|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
903196|NCT01072175|2870368|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
903197|NCT01072175|2870369|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
903198|NCT01072175|2870370|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
903199|NCT01072175|2870371|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
903200|NCT01072175|2870372|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
903201|NCT01072175|2870373|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
903202|NCT01072175|2870374|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
903203|NCT00993031|2870568|P2|Overall Study|Lost to Follow-up|13
903204|NCT00993031|2870569|P1|Overall Study|Lost to Follow-up|19
903205|NCT00993031|2870568|P2|Overall Study|Withdrawal by Subject|3
903206|NCT00993031|2870569|P1|Overall Study|Withdrawal by Subject|3
903207|NCT00993031|2870568|P2|Overall Study|Physician Decision|2
903208|NCT00993031|2870569|P1|Overall Study|Physician Decision|0
903209|NCT00993031|2870568|P2|Overall Study|Death|1
903210|NCT00993031|2870569|P1|Overall Study|Death|0
903216|NCT00923364|2870605|P2|Overall Study|Did not go to transplant|0
903217|NCT00923364|2870606|P1|Overall Study|Did not go to transplant|1
903218|NCT00923364|2870605|P2|Overall Study|Death|0
903219|NCT00923364|2870606|P1|Overall Study|Death|3
903220|NCT00770328|2870672|P2|Overall Study|Lost to Follow-up|2
903221|NCT00770328|2870673|P1|Overall Study|Lost to Follow-up|2
903222|NCT00770328|2870672|P2|Overall Study|Adverse Event|2
903223|NCT00770328|2870673|P1|Overall Study|Adverse Event|11
903224|NCT00743106|2870687|P2|Overall Study|Met intraoperative exclusion criterion|5
903225|NCT00743106|2870688|P1|Overall Study|Met intraoperative exclusion criterion|8
903226|NCT00664209|2870703|P1|Study Treatment Period|Withdrawal by Subject|2
903227|NCT00664209|2870703|P1|Study Treatment Period|Physician Decision|4
903228|NCT00664209|2870703|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
903229|NCT00656019|2870715|P4|Overall Study|Lost to Follow-up|0
903230|NCT00656019|2870716|P3|Overall Study|Lost to Follow-up|0
903231|NCT00656019|2870717|P2|Overall Study|Lost to Follow-up|1
903232|NCT00656019|2870718|P1|Overall Study|Lost to Follow-up|2
903233|NCT00656019|2870715|P4|Overall Study|Withdrawal by Subject|0
903234|NCT00656019|2870716|P3|Overall Study|Withdrawal by Subject|0
903235|NCT00656019|2870717|P2|Overall Study|Withdrawal by Subject|0
903236|NCT00656019|2870718|P1|Overall Study|Withdrawal by Subject|2
903237|NCT00656019|2870715|P4|Overall Study|Not Eligible|0
903238|NCT00656019|2870716|P3|Overall Study|Not Eligible|0
903239|NCT00656019|2870717|P2|Overall Study|Not Eligible|0
876613|NCT02696317|2794076|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
876614|NCT02696317|2794077|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
876615|NCT02696317|2794076|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
876616|NCT02696317|2794077|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
876617|NCT02640482|2794104|P2|Overall Study|Lost to Follow-up|0
876618|NCT02640482|2794105|P1|Overall Study|Lost to Follow-up|3
903240|NCT00656019|2870718|P1|Overall Study|Not Eligible|10
903241|NCT00637156|2870730|P2|Overall Study|Lost to Follow-up|16
903242|NCT00637156|2870731|P1|Overall Study|Lost to Follow-up|10
903243|NCT00637156|2870730|P2|Overall Study|Death|1
903244|NCT00637156|2870731|P1|Overall Study|Death|0
903245|NCT00637156|2870730|P2|Overall Study|Withdrawal by Subject|7
903246|NCT00637156|2870731|P1|Overall Study|Withdrawal by Subject|0
903247|NCT00556374|2870800|P2|Overall Study|Lost to Follow-up|5
903248|NCT00556374|2870801|P1|Overall Study|Lost to Follow-up|7
903249|NCT00556374|2870800|P2|Overall Study|Death|43
903250|NCT00556374|2870801|P1|Overall Study|Death|50
903251|NCT00556374|2870800|P2|Overall Study|Withdrawal by Subject|172
876631|NCT02540356|2794338|P2|Overall Study|Terminated due to disease progression|0
876632|NCT02540356|2794339|P1|Overall Study|Terminated due to disease progression|1
876633|NCT02514473|2794372|P2|Overall Study|Other|1
876634|NCT02514473|2794373|P1|Overall Study|Other|1
876635|NCT02514473|2794372|P2|Overall Study|Lost to Follow-up|1
876636|NCT02514473|2794373|P1|Overall Study|Lost to Follow-up|0
876637|NCT02514473|2794372|P2|Overall Study|Withdrawal by Subject|1
876638|NCT02514473|2794373|P1|Overall Study|Withdrawal by Subject|2
876639|NCT02514473|2794372|P2|Overall Study|Adverse Event|2
876640|NCT02514473|2794373|P1|Overall Study|Adverse Event|0
903252|NCT00556374|2870801|P1|Overall Study|Withdrawal by Subject|190
903253|NCT00533273|2870836|P2|Open-label|Withdrawal by Subject|0
903254|NCT00533273|2870837|P1|Open-label|Withdrawal by Subject|6
903255|NCT00533273|2870836|P2|Double-blind|Withdrew consent|2
903256|NCT00533273|2870837|P1|Double-blind|Withdrew consent|0
903257|NCT00530218|2870868|P1|Overall Study|Death|12
903258|NCT00530218|2870868|P1|Overall Study|CMV Not Detected|13
903259|NCT00528840|2870875|P1|Overall Study|Not Specified|2
903260|NCT00528840|2870875|P1|Overall Study|Administrative Reasons|1
903261|NCT00528840|2870875|P1|Overall Study|Death|2
903262|NCT00528840|2870875|P1|Overall Study|Withdrawal by Subject|17
903263|NCT00528840|2870875|P1|Overall Study|Adverse Event|1
903264|NCT00528840|2870875|P1|Overall Study|Lost to Follow-up|10
903265|NCT00528606|2870889|P2|Overall Study|Not specified|0
903266|NCT00528606|2870890|P1|Overall Study|Not specified|2
903267|NCT00528606|2870889|P2|Overall Study|Adverse Event|0
903268|NCT00528606|2870890|P1|Overall Study|Adverse Event|3
903269|NCT00528606|2870889|P2|Overall Study|Lost to Follow-up|1
903270|NCT00528606|2870890|P1|Overall Study|Lost to Follow-up|4
903271|NCT00528606|2870889|P2|Overall Study|Withdrew consent|3
903272|NCT00528606|2870890|P1|Overall Study|Withdrew consent|4
903273|NCT00528424|2870912|P1|Overall Study|Not specified|12
903274|NCT00528424|2870912|P1|Overall Study|Administrative reason|2
903275|NCT00528424|2870912|P1|Overall Study|Withdrew consent|2
903276|NCT00528424|2870912|P1|Overall Study|Lost to Follow-up|13
903277|NCT00498355|2870924|P1|Overall Study|Lost to Follow-up|1
903278|NCT00434304|2870941|P1|Overall Study|Withdrawal by Subject|4
903279|NCT00434304|2870941|P1|Overall Study|Lack of Efficacy|2
903280|NCT00434304|2870941|P1|Overall Study|Adverse Event|14
903281|NCT00376688|2870988|P1|Overall Study|Death|1
903282|NCT00376688|2870988|P1|Overall Study|Adverse Event|3
903283|NCT00290693|2871021|P1|Overall Study|Withdrawal by Subject|2
903284|NCT00185731|2871057|P1|Overall Study|Not Eligible|1
903285|NCT00185731|2871057|P1|Overall Study|Withdrawal by Subject|1
903286|NCT00094887|2871065|P2|Overall Study|Physician Decision|2
903287|NCT00094887|2871066|P1|Overall Study|Physician Decision|2
903288|NCT00094887|2871065|P2|Overall Study|Family emergency, Subject noncompliance|4
903289|NCT00094887|2871066|P1|Overall Study|Family emergency, Subject noncompliance|3
903322|NCT00023712|2871138|P2|Overall Study|Never treated|1
903323|NCT00023712|2871139|P1|Overall Study|Never treated|1
903324|NCT00023712|2871138|P2|Overall Study|Not platinum sensitive|0
903325|NCT00023712|2871139|P1|Overall Study|Not platinum sensitive|1
876713|NCT02410200|2794640|P1|Overall Study|Adverse Event|2
876728|NCT02283268|2794723|P1|Overall Study|Withdrawal by Subject|1
876764|NCT02210091|2794841|P2|Overall Study|Withdrawal by Sponsor|1
876765|NCT02210091|2794842|P1|Overall Study|Withdrawal by Sponsor|0
876766|NCT02210091|2794841|P2|Overall Study|Physician Decision|1
876767|NCT02210091|2794842|P1|Overall Study|Physician Decision|0
876799|NCT01989156|2794972|P3|End of Study (Population at Day 90)|Employment Conflict|0
876800|NCT01989156|2794973|P2|End of Study (Population at Day 90)|Employment Conflict|1
876801|NCT01989156|2794974|P1|End of Study (Population at Day 90)|Employment Conflict|0
876802|NCT01989156|2794972|P3|End of Study (Population at Day 90)|Moved out of state|0
876803|NCT01989156|2794973|P2|End of Study (Population at Day 90)|Moved out of state|0
876804|NCT01989156|2794974|P1|End of Study (Population at Day 90)|Moved out of state|1
876805|NCT01989156|2794972|P3|End of Study (Population at Day 90)|Physician Decision|1
876806|NCT01989156|2794973|P2|End of Study (Population at Day 90)|Physician Decision|0
876807|NCT01989156|2794974|P1|End of Study (Population at Day 90)|Physician Decision|1
876808|NCT01989156|2794972|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
876809|NCT01989156|2794973|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
876810|NCT01989156|2794974|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
876811|NCT01989156|2794972|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
876812|NCT01989156|2794973|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
876813|NCT01989156|2794974|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
876814|NCT01989156|2794972|P3|Confinement Period (Population at Day 5)|Adverse Event|1
876815|NCT01989156|2794973|P2|Confinement Period (Population at Day 5)|Adverse Event|0
876816|NCT01989156|2794974|P1|Confinement Period (Population at Day 5)|Adverse Event|0
876817|NCT01989156|2794972|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
876818|NCT01989156|2794973|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
876819|NCT01989156|2794974|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
876820|NCT01989156|2794972|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
876821|NCT01989156|2794973|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
876822|NCT01989156|2794974|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
876823|NCT01987908|2794994|P3|Post-Treatment Observation Period|Other: Bad Veins|0
876824|NCT01987908|2794995|P2|Post-Treatment Observation Period|Other: Bad Veins|1
876825|NCT01987908|2794996|P1|Post-Treatment Observation Period|Other: Bad Veins|0
876826|NCT01987908|2794994|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
876827|NCT01987908|2794995|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
876828|NCT01987908|2794996|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
876829|NCT01987908|2794994|P3|Treatment Period|Adverse Event|1
876830|NCT01987908|2794995|P2|Treatment Period|Adverse Event|1
876831|NCT01987908|2794996|P1|Treatment Period|Adverse Event|0
876832|NCT01987908|2794994|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
876833|NCT01987908|2794995|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
876834|NCT01987908|2794996|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
876835|NCT01987908|2794994|P3|Placebo Lead-in Period|Withdrawal by Subject|0
876836|NCT01987908|2794995|P2|Placebo Lead-in Period|Withdrawal by Subject|0
876837|NCT01987908|2794996|P1|Placebo Lead-in Period|Withdrawal by Subject|1
876838|NCT01987908|2794994|P3|Placebo Lead-in Period|Physician Decision|0
876839|NCT01987908|2794995|P2|Placebo Lead-in Period|Physician Decision|0
876840|NCT01987908|2794996|P1|Placebo Lead-in Period|Physician Decision|2
876841|NCT01987908|2794994|P3|Placebo Lead-in Period|Adverse Event|0
876842|NCT01987908|2794995|P2|Placebo Lead-in Period|Adverse Event|0
876843|NCT01987908|2794996|P1|Placebo Lead-in Period|Adverse Event|2
876907|NCT01757405|2795272|P2|Overall Study|Withdrawal by Subject|1
876908|NCT01757405|2795273|P1|Overall Study|Withdrawal by Subject|0
876909|NCT01757405|2795272|P2|Overall Study|Lost to Follow-up|1
876910|NCT01757405|2795273|P1|Overall Study|Lost to Follow-up|1
876915|NCT01736579|2795359|P2|Overall Study|Termination of Study by Sponsor|2
876916|NCT01736579|2795360|P1|Overall Study|Termination of Study by Sponsor|2
876932|NCT01614093|2795634|P1|Overall Study|Withdrawal by Subject|1
876959|NCT01508910|2795732|P4|Treatment|Sponsor Decision|1
876960|NCT01508910|2795733|P3|Treatment|Sponsor Decision|0
876961|NCT01508910|2795734|P2|Treatment|Sponsor Decision|0
876962|NCT01508910|2795735|P1|Treatment|Sponsor Decision|0
876963|NCT01508910|2795732|P4|Treatment|Withdrawal by Subject|1
876964|NCT01508910|2795733|P3|Treatment|Withdrawal by Subject|6
876965|NCT01508910|2795734|P2|Treatment|Withdrawal by Subject|1
876966|NCT01508910|2795735|P1|Treatment|Withdrawal by Subject|0
876967|NCT01508910|2795732|P4|Treatment|Lost to Follow-up|1
876968|NCT01508910|2795733|P3|Treatment|Lost to Follow-up|2
876969|NCT01508910|2795734|P2|Treatment|Lost to Follow-up|0
876970|NCT01508910|2795735|P1|Treatment|Lost to Follow-up|0
876971|NCT01508910|2795732|P4|Treatment|Death|0
876972|NCT01508910|2795733|P3|Treatment|Death|2
876973|NCT01508910|2795734|P2|Treatment|Death|3
876974|NCT01508910|2795735|P1|Treatment|Death|2
876975|NCT01507896|2795757|P1|Overall Study|The surgery was denied by the sponsor.|1
876976|NCT01507896|2795757|P1|Overall Study|Withdrawal by Subject|1
876977|NCT01488994|2795841|P2|Overall Study|Withdrawal by Subject|1
876978|NCT01488994|2795842|P1|Overall Study|Withdrawal by Subject|0
876979|NCT01485796|2795929|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
876980|NCT01485796|2795929|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
876981|NCT01485796|2795929|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
876982|NCT01485796|2795929|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
876983|NCT01485796|2795929|P1|Period 2: Epoch 2|Switch to safety follow-up|26
876984|NCT01485796|2795929|P1|Period 2: Epoch 2|Adverse Event|3
876985|NCT01485796|2795929|P1|Period 2: Epoch 2|Withdrawal by Subject|6
876986|NCT01485796|2795929|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
877070|NCT01308567|2796077|P3|Overall Study|Lost to Follow-up|4
877071|NCT01308567|2796078|P2|Overall Study|Lost to Follow-up|4
877072|NCT01308567|2796079|P1|Overall Study|Lost to Follow-up|2
877119|NCT01218438|2796330|P1|Epoch 4|Withdrawal by Subject|2
877120|NCT01218438|2796330|P1|Epoch 4|Physician Decision|1
877121|NCT01218438|2796330|P1|Epoch 3|Adverse Event|1
877122|NCT01218438|2796330|P1|Epoch 3|Withdrawal by Subject|3
877123|NCT01218438|2796330|P1|Epoch 1|Adverse Event|1
877124|NCT01218438|2796330|P1|Epoch 1|Physician Decision|2
877128|NCT01178294|2796491|P1|Overall Study|Completion status could not be verified|1
877129|NCT01178294|2796491|P1|Overall Study|Subject status is terminal|1
877130|NCT01178294|2796491|P1|Overall Study|Development of inhibitors to OBI-1|1
877131|NCT01178294|2796491|P1|Overall Study|Death|1
877132|NCT01178294|2796491|P1|Overall Study|Lack of Efficacy|1
877133|NCT01178294|2796491|P1|Overall Study|Lost to Follow-up|2
877134|NCT01178294|2796491|P1|Overall Study|Adverse Event|4
877135|NCT01175213|2796516|P2|Safety Follow-up|Adverse Event|0
877136|NCT01175213|2796517|P1|Safety Follow-up|Adverse Event|1
877137|NCT01175213|2796516|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
877138|NCT01175213|2796517|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
877139|NCT01175213|2796516|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
877140|NCT01175213|2796517|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
877141|NCT01175213|2796516|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
877142|NCT01175213|2796517|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
877143|NCT01175213|2796516|P2|IGSC, 10%/rHuPH20|Death|0
877144|NCT01175213|2796517|P1|IGSC, 10%/rHuPH20|Death|1
877145|NCT01175213|2796516|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
877146|NCT01175213|2796517|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
877147|NCT01162499|2796562|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
877148|NCT01162499|2796563|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
877149|NCT01154816|2796595|P12|Overall Study|Adverse Event|0
877150|NCT01154816|2796596|P11|Overall Study|Adverse Event|0
877151|NCT01154816|2796597|P10|Overall Study|Adverse Event|0
877152|NCT01154816|2796598|P9|Overall Study|Adverse Event|0
877153|NCT01154816|2796599|P8|Overall Study|Adverse Event|1
877154|NCT01154816|2796600|P7|Overall Study|Adverse Event|1
877155|NCT01154816|2796601|P6|Overall Study|Adverse Event|0
877156|NCT01154816|2796602|P5|Overall Study|Adverse Event|0
877157|NCT01154816|2796603|P4|Overall Study|Adverse Event|0
877158|NCT01154816|2796604|P3|Overall Study|Adverse Event|0
877159|NCT01154816|2796605|P2|Overall Study|Adverse Event|2
877160|NCT01154816|2796606|P1|Overall Study|Adverse Event|5
877161|NCT01154816|2796595|P12|Overall Study|Physician Decision|1
877162|NCT01154816|2796596|P11|Overall Study|Physician Decision|1
877163|NCT01154816|2796597|P10|Overall Study|Physician Decision|1
877164|NCT01154816|2796598|P9|Overall Study|Physician Decision|0
877165|NCT01154816|2796599|P8|Overall Study|Physician Decision|0
877166|NCT01154816|2796600|P7|Overall Study|Physician Decision|0
877167|NCT01154816|2796601|P6|Overall Study|Physician Decision|0
877168|NCT01154816|2796602|P5|Overall Study|Physician Decision|2
877169|NCT01154816|2796603|P4|Overall Study|Physician Decision|0
877170|NCT01154816|2796604|P3|Overall Study|Physician Decision|1
877171|NCT01154816|2796605|P2|Overall Study|Physician Decision|0
877172|NCT01154816|2796606|P1|Overall Study|Physician Decision|1
877173|NCT01154816|2796595|P12|Overall Study|Progressive Disease|3
877174|NCT01154816|2796596|P11|Overall Study|Progressive Disease|10
877175|NCT01154816|2796597|P10|Overall Study|Progressive Disease|6
877176|NCT01154816|2796598|P9|Overall Study|Progressive Disease|8
877177|NCT01154816|2796599|P8|Overall Study|Progressive Disease|6
877178|NCT01154816|2796600|P7|Overall Study|Progressive Disease|5
877179|NCT01154816|2796601|P6|Overall Study|Progressive Disease|8
877180|NCT01154816|2796602|P5|Overall Study|Progressive Disease|8
877181|NCT01154816|2796603|P4|Overall Study|Progressive Disease|9
877182|NCT01154816|2796604|P3|Overall Study|Progressive Disease|9
877183|NCT01154816|2796605|P2|Overall Study|Progressive Disease|8
877184|NCT01154816|2796606|P1|Overall Study|Progressive Disease|13
877185|NCT01154816|2796595|P12|Overall Study|Withdrawal by Subject|0
877186|NCT01154816|2796596|P11|Overall Study|Withdrawal by Subject|0
877187|NCT01154816|2796597|P10|Overall Study|Withdrawal by Subject|3
877188|NCT01154816|2796598|P9|Overall Study|Withdrawal by Subject|1
877189|NCT01154816|2796599|P8|Overall Study|Withdrawal by Subject|0
877190|NCT01154816|2796600|P7|Overall Study|Withdrawal by Subject|0
877191|NCT01154816|2796601|P6|Overall Study|Withdrawal by Subject|0
877192|NCT01154816|2796602|P5|Overall Study|Withdrawal by Subject|0
877193|NCT01154816|2796603|P4|Overall Study|Withdrawal by Subject|1
877194|NCT01154816|2796604|P3|Overall Study|Withdrawal by Subject|0
877195|NCT01154816|2796605|P2|Overall Study|Withdrawal by Subject|0
877196|NCT01154816|2796606|P1|Overall Study|Withdrawal by Subject|1
877202|NCT00939393|2796785|P2|Overall Study|Lost to Follow-up|0
877203|NCT00939393|2796786|P1|Overall Study|Lost to Follow-up|3
877204|NCT00939393|2796785|P2|Overall Study|Withdrawal by Subject|0
877205|NCT00939393|2796786|P1|Overall Study|Withdrawal by Subject|1
877222|NCT00835731|2796946|P2|Overall Study|Physician Decision|1
877223|NCT00835731|2796947|P1|Overall Study|Physician Decision|1
877224|NCT00835731|2796946|P2|Overall Study|Withdrawal by Subject|0
877225|NCT00835731|2796947|P1|Overall Study|Withdrawal by Subject|1
877303|NCT00496964|2797214|P2|Overall Study|Withdrawal by Subject|1
877304|NCT00496964|2797215|P1|Overall Study|Withdrawal by Subject|0
877307|NCT00464568|2797241|P1|Overall Study|Adverse Event|2
877320|NCT00357656|2797407|P2|Overall Study|Other, No surgery performed|3
877321|NCT00357656|2797408|P1|Overall Study|Other, No surgery performed|0
877522|NCT02542072|2797707|P2|Second Intervention (1 Month)|Lens discomfort|0
877523|NCT02542072|2797708|P1|Second Intervention (1 Month)|Lens discomfort|1
877524|NCT02542072|2797707|P2|Second Intervention (1 Month)|Lost to Follow-up|0
877525|NCT02542072|2797708|P1|Second Intervention (1 Month)|Lost to Follow-up|1
877526|NCT02542072|2797707|P2|First Intervention (1 Month)|Protocol Violation|0
877527|NCT02542072|2797708|P1|First Intervention (1 Month)|Protocol Violation|1
877528|NCT02542072|2797707|P2|First Intervention (1 Month)|Lens discomfort|2
877529|NCT02542072|2797708|P1|First Intervention (1 Month)|Lens discomfort|1
877530|NCT02542072|2797707|P2|First Intervention (1 Month)|Lost to Follow-up|0
877531|NCT02542072|2797708|P1|First Intervention (1 Month)|Lost to Follow-up|2
877532|NCT02542072|2797707|P2|First Intervention (1 Month)|Adverse Event|1
877533|NCT02542072|2797708|P1|First Intervention (1 Month)|Adverse Event|1
877588|NCT02454608|2797923|P2|Overall Study|Lack of Efficacy|2
877589|NCT02454608|2797924|P1|Overall Study|Lack of Efficacy|0
877611|NCT02302716|2798058|P2|Overall Study|Protocol Violation|1
877612|NCT02302716|2798059|P1|Overall Study|Protocol Violation|0
877613|NCT02302716|2798058|P2|Overall Study|Withdrawal by Subject|7
877614|NCT02302716|2798059|P1|Overall Study|Withdrawal by Subject|13
877615|NCT02302716|2798058|P2|Overall Study|Physician Decision|4
877616|NCT02302716|2798059|P1|Overall Study|Physician Decision|3
877617|NCT02302716|2798058|P2|Overall Study|Lost to Follow-up|4
877618|NCT02302716|2798059|P1|Overall Study|Lost to Follow-up|2
877619|NCT02302716|2798058|P2|Overall Study|Lack of Efficacy|1
877620|NCT02302716|2798059|P1|Overall Study|Lack of Efficacy|0
877621|NCT02302716|2798058|P2|Overall Study|Death|1
877622|NCT02302716|2798059|P1|Overall Study|Death|0
877623|NCT02302716|2798058|P2|Overall Study|Adverse Event|1
877624|NCT02302716|2798059|P1|Overall Study|Adverse Event|1
877625|NCT02255097|2798085|P1|Overall Study|Treatment Ongoing|36
877626|NCT02255097|2798085|P1|Overall Study|Allocated but not treated|1
877627|NCT02255097|2798085|P1|Overall Study|Withdrawal by Subject|2
877628|NCT02255097|2798085|P1|Overall Study|Progressive Disease|80
877629|NCT02255097|2798085|P1|Overall Study|Physician Decision|1
877630|NCT02255097|2798085|P1|Overall Study|Lost to Follow-up|1
877631|NCT02255097|2798085|P1|Overall Study|Death|2
877632|NCT02255097|2798085|P1|Overall Study|Excluded Medication|1
877633|NCT02255097|2798085|P1|Overall Study|Complete Response|1
877634|NCT02255097|2798085|P1|Overall Study|Clinical Progression|23
877635|NCT02255097|2798085|P1|Overall Study|Adverse Event|24
877636|NCT02229396|2798113|P3|Overall Study|Other Eligibility criteria|0
877637|NCT02229396|2798114|P2|Overall Study|Other Eligibility criteria|2
877638|NCT02229396|2798115|P1|Overall Study|Other Eligibility criteria|0
877639|NCT02229396|2798113|P3|Overall Study|Withdrawal by Subject|16
877640|NCT02229396|2798114|P2|Overall Study|Withdrawal by Subject|9
877641|NCT02229396|2798115|P1|Overall Study|Withdrawal by Subject|15
877642|NCT02229396|2798113|P3|Overall Study|Withdrew; no record on termination page|4
877643|NCT02229396|2798114|P2|Overall Study|Withdrew; no record on termination page|5
877644|NCT02229396|2798115|P1|Overall Study|Withdrew; no record on termination page|2
877645|NCT02229396|2798113|P3|Overall Study|Patient was incorrectly randomized|1
877646|NCT02229396|2798114|P2|Overall Study|Patient was incorrectly randomized|0
877647|NCT02229396|2798115|P1|Overall Study|Patient was incorrectly randomized|0
877648|NCT02229396|2798113|P3|Overall Study|Protocol deviation; compliance|0
877649|NCT02229396|2798114|P2|Overall Study|Protocol deviation; compliance|0
877650|NCT02229396|2798115|P1|Overall Study|Protocol deviation; compliance|1
877651|NCT02229396|2798113|P3|Overall Study|Lost to Follow-up|11
877652|NCT02229396|2798114|P2|Overall Study|Lost to Follow-up|5
877653|NCT02229396|2798115|P1|Overall Study|Lost to Follow-up|4
877654|NCT02229396|2798113|P3|Overall Study|Death|1
877655|NCT02229396|2798114|P2|Overall Study|Death|3
877656|NCT02229396|2798115|P1|Overall Study|Death|1
877657|NCT02229396|2798113|P3|Overall Study|Adverse Event|5
877658|NCT02229396|2798114|P2|Overall Study|Adverse Event|5
877659|NCT02229396|2798115|P1|Overall Study|Adverse Event|2
877674|NCT02147184|2798195|P2|Overall Study|Other|0
877675|NCT02147184|2798196|P1|Overall Study|Other|1
877676|NCT02147184|2798195|P2|Overall Study|Physician Decision|2
877677|NCT02147184|2798196|P1|Overall Study|Physician Decision|0
877678|NCT02147184|2798195|P2|Overall Study|Moved out of state|3
877679|NCT02147184|2798196|P1|Overall Study|Moved out of state|3
877680|NCT02147184|2798195|P2|Overall Study|Pregnancy|0
877681|NCT02147184|2798196|P1|Overall Study|Pregnancy|6
877682|NCT02147184|2798195|P2|Overall Study|Study Burden|7
877683|NCT02147184|2798196|P1|Overall Study|Study Burden|11
877684|NCT02147184|2798195|P2|Overall Study|Lost to Follow-up|15
877685|NCT02147184|2798196|P1|Overall Study|Lost to Follow-up|28
877686|NCT02133508|2798214|P1|Overall Study|Lost to Follow-up|2
877687|NCT02133508|2798214|P1|Overall Study|Death|12
877688|NCT02133508|2798214|P1|Overall Study|Decision of Investigator or Sponsor|1
877801|NCT01788358|2798432|P1|Overall Study|Adverse Event|51
877802|NCT01788358|2798432|P1|Overall Study|Lack of Efficacy|1
877803|NCT01788358|2798432|P1|Overall Study|Withdrawal by Subject|26
877804|NCT01788358|2798432|P1|Overall Study|Protocol Violation|3
877805|NCT01788358|2798432|P1|Overall Study|Lost to Follow-up|5
877806|NCT01788358|2798432|P1|Overall Study|Logistical difficulties|1
877807|NCT01788358|2798432|P1|Overall Study|Other|11
877845|NCT01515189|2798659|P2|First Re-Induction Phase|Other|0
877846|NCT01515189|2798660|P1|First Re-Induction Phase|Other|1
877847|NCT01515189|2798659|P2|First Re-Induction Phase|No longer meets study criteria|0
877848|NCT01515189|2798660|P1|First Re-Induction Phase|No longer meets study criteria|1
877849|NCT01515189|2798659|P2|First Re-Induction Phase|Withdrawal by Subject|1
877850|NCT01515189|2798660|P1|First Re-Induction Phase|Withdrawal by Subject|1
877851|NCT01515189|2798659|P2|First Re-Induction Phase|Study drug toxicity|0
877852|NCT01515189|2798660|P1|First Re-Induction Phase|Study drug toxicity|5
877853|NCT01515189|2798659|P2|First Re-Induction Phase|Disease progression|14
877854|NCT01515189|2798660|P1|First Re-Induction Phase|Disease progression|6
877855|NCT01515189|2798659|P2|Induction|Other|4
877856|NCT01515189|2798660|P1|Induction|Other|0
877857|NCT01515189|2798659|P2|Induction|Lost to Follow-up|0
877858|NCT01515189|2798660|P1|Induction|Lost to Follow-up|1
877859|NCT01515189|2798659|P2|Induction|No longer meets study criteria|2
877860|NCT01515189|2798660|P1|Induction|No longer meets study criteria|0
877861|NCT01515189|2798659|P2|Induction|Withdrawal by Subject|9
877862|NCT01515189|2798660|P1|Induction|Withdrawal by Subject|3
877863|NCT01515189|2798659|P2|Induction|Adverse Event|9
877864|NCT01515189|2798660|P1|Induction|Adverse Event|14
877865|NCT01515189|2798659|P2|Induction|Death|17
877866|NCT01515189|2798660|P1|Induction|Death|24
877867|NCT01515189|2798659|P2|Induction|Study drug toxicity|36
877868|NCT01515189|2798660|P1|Induction|Study drug toxicity|86
877869|NCT01515189|2798659|P2|Induction|Disease Progression|155
877870|NCT01515189|2798660|P1|Induction|Disease Progression|109
877871|NCT01452529|2798756|P3|Double-blind (DB) Period|Administrative|7
877872|NCT01452529|2798757|P2|Double-blind (DB) Period|Administrative|11
877873|NCT01452529|2798758|P1|Double-blind (DB) Period|Administrative|0
877874|NCT01452529|2798756|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
877875|NCT01452529|2798757|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
877876|NCT01452529|2798758|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
877877|NCT01452529|2798756|P3|Double-blind (DB) Period|Lack of Efficacy|44
877878|NCT01452529|2798757|P2|Double-blind (DB) Period|Lack of Efficacy|16
877879|NCT01452529|2798758|P1|Double-blind (DB) Period|Lack of Efficacy|0
877880|NCT01452529|2798756|P3|Double-blind (DB) Period|Lost to Follow-up|3
877881|NCT01452529|2798757|P2|Double-blind (DB) Period|Lost to Follow-up|5
877882|NCT01452529|2798758|P1|Double-blind (DB) Period|Lost to Follow-up|0
877883|NCT01452529|2798756|P3|Double-blind (DB) Period|Withdrawal by Subject|14
877884|NCT01452529|2798757|P2|Double-blind (DB) Period|Withdrawal by Subject|15
877885|NCT01452529|2798758|P1|Double-blind (DB) Period|Withdrawal by Subject|0
877886|NCT01452529|2798756|P3|Double-blind (DB) Period|Adverse Event|11
877887|NCT01452529|2798757|P2|Double-blind (DB) Period|Adverse Event|18
877888|NCT01452529|2798758|P1|Double-blind (DB) Period|Adverse Event|0
877889|NCT01452529|2798756|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
877890|NCT01452529|2798757|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
877891|NCT01452529|2798758|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
877892|NCT01452529|2798756|P3|Run-in Period|Administrative|0
877893|NCT01452529|2798757|P2|Run-in Period|Administrative|0
877894|NCT01452529|2798758|P1|Run-in Period|Administrative|21
877895|NCT01452529|2798756|P3|Run-in Period|Confirmed or suspected diversion|0
877896|NCT01452529|2798757|P2|Run-in Period|Confirmed or suspected diversion|0
877897|NCT01452529|2798758|P1|Run-in Period|Confirmed or suspected diversion|23
877898|NCT01452529|2798756|P3|Run-in Period|Lack of Efficacy|0
877899|NCT01452529|2798757|P2|Run-in Period|Lack of Efficacy|0
877900|NCT01452529|2798758|P1|Run-in Period|Lack of Efficacy|46
877901|NCT01452529|2798756|P3|Run-in Period|Lost to Follow-up|0
877902|NCT01452529|2798757|P2|Run-in Period|Lost to Follow-up|0
877903|NCT01452529|2798758|P1|Run-in Period|Lost to Follow-up|19
877904|NCT01452529|2798756|P3|Run-in Period|Withdrawal by Subject|0
877905|NCT01452529|2798757|P2|Run-in Period|Withdrawal by Subject|0
877906|NCT01452529|2798758|P1|Run-in Period|Withdrawal by Subject|49
877907|NCT01452529|2798756|P3|Run-in Period|Adverse Event|0
877908|NCT01452529|2798757|P2|Run-in Period|Adverse Event|0
877909|NCT01452529|2798758|P1|Run-in Period|Adverse Event|96
877926|NCT01400139|2798804|P1|HYD Extension Period|Administrative|10
877927|NCT01400139|2798804|P1|HYD Extension Period|Withdrawal by Subject|5
877928|NCT01400139|2798804|P1|HYD Extension Period|Adverse Event|8
877929|NCT01400139|2798804|P1|HYD Core Study|Did not qualify for Maintenance Period|14
877930|NCT01400139|2798804|P1|HYD Core Study|Administrative|56
877931|NCT01400139|2798804|P1|HYD Core Study|Confirmed or suspected diversion|20
877932|NCT01400139|2798804|P1|HYD Core Study|Lost to Follow-up|39
877933|NCT01400139|2798804|P1|HYD Core Study|Withdrawal by Subject|114
877934|NCT01400139|2798804|P1|HYD Core Study|Lack of Efficacy|59
877935|NCT01400139|2798804|P1|HYD Core Study|Adverse Event|210
878061|NCT00924729|2799284|P2|Overall Study|Protocol Violation|0
878062|NCT00924729|2799285|P1|Overall Study|Protocol Violation|1
878063|NCT00924729|2799284|P2|Overall Study|insufficient volume for analysis|0
878064|NCT00924729|2799285|P1|Overall Study|insufficient volume for analysis|1
878075|NCT00853112|2799317|P7|Overall Study|Randomized but not treated|1
878076|NCT00853112|2799318|P6|Overall Study|Randomized but not treated|0
878077|NCT00853112|2799319|P5|Overall Study|Randomized but not treated|0
878078|NCT00853112|2799320|P4|Overall Study|Randomized but not treated|2
878079|NCT00853112|2799321|P3|Overall Study|Randomized but not treated|0
878080|NCT00853112|2799322|P2|Overall Study|Randomized but not treated|1
878081|NCT00853112|2799323|P1|Overall Study|Randomized but not treated|0
878187|NCT00596011|2799676|P2|Overall Study|Adverse Event|7
878188|NCT00596011|2799677|P1|Overall Study|Adverse Event|11
878189|NCT00596011|2799676|P2|Overall Study|Withdrawal by Subject|3
878190|NCT00596011|2799677|P1|Overall Study|Withdrawal by Subject|2
878197|NCT00575042|2799796|P1|Overall Study|Lost to Follow-up|1
878198|NCT00575042|2799796|P1|Overall Study|Adverse Event|2
878240|NCT00116428|2799936|P2|Overall Study|Did not meet inclusion criteria|0
878241|NCT00116428|2799937|P1|Overall Study|Did not meet inclusion criteria|1
878242|NCT00116428|2799936|P2|Overall Study|Withdrawal by Subject|5
878243|NCT00116428|2799937|P1|Overall Study|Withdrawal by Subject|2
878392|NCT00003659|2800058|P1|Overall Study|Withdrawal by Subject|3
878393|NCT03044431|2800080|P1|Overall Study|Lost to Follow-up|59
878394|NCT02750943|2800096|P2|Overall Study|Withdrawal by Subject|7
878395|NCT02750943|2800097|P1|Overall Study|Withdrawal by Subject|5
878396|NCT02750943|2800096|P2|Overall Study|Lost to Follow-up|2
878397|NCT02750943|2800097|P1|Overall Study|Lost to Follow-up|1
878402|NCT02642432|2800149|P1|Overall Study|Not Specified|3
878403|NCT02642432|2800149|P1|Overall Study|Lost to Follow-up|2
878404|NCT02642432|2800149|P1|Overall Study|Withdrew Consent|1
878405|NCT02642432|2800149|P1|Overall Study|Adverse Event|2
878416|NCT02513160|2800214|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
878417|NCT02513160|2800215|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
878418|NCT02513160|2800216|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
878419|NCT02513160|2800217|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
878420|NCT02513160|2800214|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
878421|NCT02513160|2800215|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
878422|NCT02513160|2800216|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
878423|NCT02513160|2800217|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
878424|NCT02513160|2800214|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
878425|NCT02513160|2800215|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
878426|NCT02513160|2800216|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
878427|NCT02513160|2800217|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
878428|NCT02513160|2800214|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
878429|NCT02513160|2800215|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
878430|NCT02513160|2800216|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
878431|NCT02513160|2800217|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
878432|NCT02513160|2800214|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
878433|NCT02513160|2800215|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
878434|NCT02513160|2800216|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
878435|NCT02513160|2800217|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
878436|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
878437|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
878438|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
878439|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
878440|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
878441|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
878442|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
878443|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
878444|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
878445|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
878446|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
878447|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
878448|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
878449|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
878450|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
878451|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
878452|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
878453|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
878454|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
878455|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
878456|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
878457|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
878458|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
878459|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
878460|NCT02513160|2800214|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
878461|NCT02513160|2800215|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
878462|NCT02513160|2800216|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
878463|NCT02513160|2800217|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
878464|NCT02487771|2800254|P2|Overall Study|Withdrawal by Subject|5
878465|NCT02487771|2800255|P1|Overall Study|Withdrawal by Subject|3
878466|NCT02487771|2800254|P2|Overall Study|Moved out of area|6
878467|NCT02487771|2800255|P1|Overall Study|Moved out of area|5
878468|NCT02487771|2800254|P2|Overall Study|Lost to Follow-up|3
878469|NCT02487771|2800255|P1|Overall Study|Lost to Follow-up|2
904506|NCT02665455|2875235|P1|Overall Study|Protocol Violation|1
904507|NCT02665455|2875235|P1|Overall Study|Adverse Event|1
904508|NCT02665455|2875235|P1|Overall Study|Lost to Follow-up|1
904509|NCT02665455|2875235|P1|Overall Study|Withdrawal by Subject|6
904510|NCT02606279|2875241|P2|Overall Study|Lost to Follow-up|1
904511|NCT02606279|2875242|P1|Overall Study|Lost to Follow-up|0
904518|NCT02487199|2875284|P2|Overall Study|Withdrew Consent|1
904519|NCT02487199|2875285|P1|Overall Study|Withdrew Consent|0
878484|NCT02395653|2800388|P1|Overall Study|Lost to Follow-up|1
878485|NCT02395653|2800388|P1|Overall Study|Withdrawal by Subject|1
878486|NCT02395653|2800388|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
878487|NCT02395653|2800388|P1|Overall Study|Investigator Decision at Screening|1
878488|NCT02395653|2800388|P1|Overall Study|SSEC Application But With 0 Dose|1
878489|NCT02395653|2800388|P1|Overall Study|Consent Withdrawn at Screening|1
878490|NCT02395653|2800388|P1|Overall Study|Exclusion Criteria Met at Screening|4
904520|NCT02476994|2875299|P2|Overall Study|Based on feedback from FDA|0
904521|NCT02476994|2875300|P1|Overall Study|Based on feedback from FDA|1
904522|NCT02452892|2875330|P4|Follow-up|Subject left town on Day 42|0
904523|NCT02452892|2875331|P3|Follow-up|Subject left town on Day 42|0
904524|NCT02452892|2875332|P2|Follow-up|Subject left town on Day 42|0
904525|NCT02452892|2875333|P1|Follow-up|Subject left town on Day 42|1
904526|NCT02452892|2875330|P4|Follow-up|Withdrawal by Subject|1
904527|NCT02452892|2875331|P3|Follow-up|Withdrawal by Subject|0
904528|NCT02452892|2875332|P2|Follow-up|Withdrawal by Subject|0
904529|NCT02452892|2875333|P1|Follow-up|Withdrawal by Subject|0
904530|NCT02452892|2875330|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
904531|NCT02452892|2875331|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
904532|NCT02452892|2875332|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
904533|NCT02452892|2875333|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
904534|NCT02452892|2875330|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
904535|NCT02452892|2875331|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
904536|NCT02452892|2875332|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
904537|NCT02452892|2875333|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
904538|NCT02452892|2875330|P4|Week 1 Initial Randommization|Lost to Follow-up|0
904539|NCT02452892|2875331|P3|Week 1 Initial Randommization|Lost to Follow-up|1
904540|NCT02452892|2875332|P2|Week 1 Initial Randommization|Lost to Follow-up|0
904541|NCT02452892|2875333|P1|Week 1 Initial Randommization|Lost to Follow-up|0
904542|NCT02452892|2875330|P4|Week 1 Initial Randommization|Adverse Event|0
904543|NCT02452892|2875331|P3|Week 1 Initial Randommization|Adverse Event|0
904544|NCT02452892|2875332|P2|Week 1 Initial Randommization|Adverse Event|0
904545|NCT02452892|2875333|P1|Week 1 Initial Randommization|Adverse Event|1
878533|NCT02149264|2800589|P1|Overall Study|Protocol Violation|1
878534|NCT02149264|2800589|P1|Overall Study|Physician Decision|3
878535|NCT02149264|2800589|P1|Overall Study|Adverse Event|7
878536|NCT02149264|2800589|P1|Overall Study|Withdrawal by Subject|9
904552|NCT02390219|2875414|P1|Overall Study|Other|2
904553|NCT02390219|2875414|P1|Overall Study|Lost to Follow-up|2
878540|NCT02035553|2800670|P2|Overall Study|Other Reason|4
878541|NCT02035553|2800671|P1|Overall Study|Other Reason|0
878542|NCT02035553|2800670|P2|Overall Study|Lost to Follow-up|1
878543|NCT02035553|2800671|P1|Overall Study|Lost to Follow-up|0
878544|NCT02035553|2800670|P2|Overall Study|Non-compliance with Study Drug|1
878545|NCT02035553|2800671|P1|Overall Study|Non-compliance with Study Drug|0
878546|NCT02035553|2800670|P2|Overall Study|Withdrawal by Subject|7
878547|NCT02035553|2800671|P1|Overall Study|Withdrawal by Subject|4
878548|NCT02035553|2800670|P2|Overall Study|Lack of Efficacy|1
878549|NCT02035553|2800671|P1|Overall Study|Lack of Efficacy|1
878550|NCT02035553|2800670|P2|Overall Study|Physician Decision|2
878551|NCT02035553|2800671|P1|Overall Study|Physician Decision|3
878552|NCT02035553|2800670|P2|Overall Study|Adverse Event|6
878553|NCT02035553|2800671|P1|Overall Study|Adverse Event|10
878554|NCT02035553|2800670|P2|Overall Study|Death (See All-Cause Mortality Table)|1
878555|NCT02035553|2800671|P1|Overall Study|Death (See All-Cause Mortality Table)|0
878556|NCT02019472|2800680|P3|Overall Study|Other|6
878557|NCT02019472|2800681|P2|Overall Study|Other|8
878558|NCT02019472|2800682|P1|Overall Study|Other|3
878559|NCT02019472|2800680|P3|Overall Study|Withdrawal by Subject|11
878560|NCT02019472|2800681|P2|Overall Study|Withdrawal by Subject|10
878561|NCT02019472|2800682|P1|Overall Study|Withdrawal by Subject|11
878562|NCT02019472|2800680|P3|Overall Study|Pregnancy|2
878563|NCT02019472|2800681|P2|Overall Study|Pregnancy|2
878564|NCT02019472|2800682|P1|Overall Study|Pregnancy|1
878565|NCT02019472|2800680|P3|Overall Study|Physician Decision|0
878566|NCT02019472|2800681|P2|Overall Study|Physician Decision|2
878567|NCT02019472|2800682|P1|Overall Study|Physician Decision|1
878568|NCT02019472|2800680|P3|Overall Study|Lost to Follow-up|1
878569|NCT02019472|2800681|P2|Overall Study|Lost to Follow-up|2
878570|NCT02019472|2800682|P1|Overall Study|Lost to Follow-up|0
878571|NCT02019472|2800680|P3|Overall Study|Lack of Efficacy|4
878572|NCT02019472|2800681|P2|Overall Study|Lack of Efficacy|4
878573|NCT02019472|2800682|P1|Overall Study|Lack of Efficacy|7
878574|NCT02019472|2800680|P3|Overall Study|Death|1
878575|NCT02019472|2800681|P2|Overall Study|Death|1
878576|NCT02019472|2800682|P1|Overall Study|Death|0
878577|NCT02019472|2800680|P3|Overall Study|Adverse Event|17
878578|NCT02019472|2800681|P2|Overall Study|Adverse Event|23
878579|NCT02019472|2800682|P1|Overall Study|Adverse Event|14
878580|NCT01972568|2800715|P3|Overall Study|Adverse Event|5
878581|NCT01972568|2800716|P2|Overall Study|Adverse Event|6
878582|NCT01972568|2800717|P1|Overall Study|Adverse Event|5
878583|NCT01972568|2800715|P3|Overall Study|Lost to Follow-up|0
878584|NCT01972568|2800716|P2|Overall Study|Lost to Follow-up|0
878585|NCT01972568|2800717|P1|Overall Study|Lost to Follow-up|1
878586|NCT01972568|2800715|P3|Overall Study|Withdrawal by Subject|7
878587|NCT01972568|2800716|P2|Overall Study|Withdrawal by Subject|3
878588|NCT01972568|2800717|P1|Overall Study|Withdrawal by Subject|6
878589|NCT01972568|2800715|P3|Overall Study|Protocol Violation|2
878590|NCT01972568|2800716|P2|Overall Study|Protocol Violation|2
878591|NCT01972568|2800717|P1|Overall Study|Protocol Violation|1
878592|NCT01972568|2800715|P3|Overall Study|Lack of Efficacy|2
878593|NCT01972568|2800716|P2|Overall Study|Lack of Efficacy|1
878594|NCT01972568|2800717|P1|Overall Study|Lack of Efficacy|0
878595|NCT01972568|2800715|P3|Overall Study|Other events|0
878596|NCT01972568|2800716|P2|Overall Study|Other events|0
878597|NCT01972568|2800717|P1|Overall Study|Other events|3
878598|NCT01944098|2800754|P2|Overall Study|Physician Decision|0
878599|NCT01944098|2800755|P1|Overall Study|Physician Decision|1
904554|NCT02390219|2875414|P1|Overall Study|Withdrawal by Subject|1
904555|NCT02390219|2875414|P1|Overall Study|Adverse Event|6
904556|NCT02390219|2875414|P1|Overall Study|Physician Decision|1
904557|NCT02390219|2875414|P1|Overall Study|Death|1
904560|NCT02285777|2875511|P2|Overall Study|Lost to Follow-up|2
904561|NCT02285777|2875512|P1|Overall Study|Lost to Follow-up|4
904562|NCT02285777|2875511|P2|Overall Study|Withdrawal by Subject|1
904563|NCT02285777|2875512|P1|Overall Study|Withdrawal by Subject|1
904564|NCT02265796|2875562|P2|Overall Study|Withdrawal by Subject|1
904565|NCT02265796|2875563|P1|Overall Study|Withdrawal by Subject|1
904566|NCT02265796|2875562|P2|Overall Study|started on excluded medication|0
904567|NCT02265796|2875563|P1|Overall Study|started on excluded medication|1
904568|NCT02265796|2875562|P2|Overall Study|Death|0
904569|NCT02265796|2875563|P1|Overall Study|Death|1
878618|NCT01871805|2800834|P6|Phase II|Lost to Follow-up|2
878619|NCT01871805|2800835|P5|Phase II|Lost to Follow-up|0
878620|NCT01871805|2800836|P4|Phase II|Lost to Follow-up|0
878621|NCT01871805|2800837|P3|Phase II|Lost to Follow-up|0
878622|NCT01871805|2800838|P2|Phase II|Lost to Follow-up|0
878623|NCT01871805|2800839|P1|Phase II|Lost to Follow-up|0
878624|NCT01871805|2800834|P6|Phase II|Alive in Survival Follow-up|17
878625|NCT01871805|2800835|P5|Phase II|Alive in Survival Follow-up|0
878626|NCT01871805|2800836|P4|Phase II|Alive in Survival Follow-up|0
878627|NCT01871805|2800837|P3|Phase II|Alive in Survival Follow-up|0
878628|NCT01871805|2800838|P2|Phase II|Alive in Survival Follow-up|0
878629|NCT01871805|2800839|P1|Phase II|Alive in Survival Follow-up|0
878630|NCT01871805|2800834|P6|Phase II|Alive on Treatment|56
878631|NCT01871805|2800835|P5|Phase II|Alive on Treatment|0
878632|NCT01871805|2800836|P4|Phase II|Alive on Treatment|0
878633|NCT01871805|2800837|P3|Phase II|Alive on Treatment|0
878634|NCT01871805|2800838|P2|Phase II|Alive on Treatment|0
878635|NCT01871805|2800839|P1|Phase II|Alive on Treatment|0
878636|NCT01871805|2800834|P6|Phase II|Death|12
878637|NCT01871805|2800835|P5|Phase II|Death|0
878638|NCT01871805|2800836|P4|Phase II|Death|0
878639|NCT01871805|2800837|P3|Phase II|Death|0
878640|NCT01871805|2800838|P2|Phase II|Death|0
878641|NCT01871805|2800839|P1|Phase II|Death|0
878642|NCT01871805|2800834|P6|Phase I|Lost to Follow-up|0
878643|NCT01871805|2800835|P5|Phase I|Lost to Follow-up|0
878644|NCT01871805|2800836|P4|Phase I|Lost to Follow-up|0
878645|NCT01871805|2800837|P3|Phase I|Lost to Follow-up|0
878646|NCT01871805|2800838|P2|Phase I|Lost to Follow-up|1
878647|NCT01871805|2800839|P1|Phase I|Lost to Follow-up|0
878648|NCT01871805|2800834|P6|Phase I|Alive in Survival Follow-up|0
878649|NCT01871805|2800835|P5|Phase I|Alive in Survival Follow-up|4
878650|NCT01871805|2800836|P4|Phase I|Alive in Survival Follow-up|1
878651|NCT01871805|2800837|P3|Phase I|Alive in Survival Follow-up|3
878652|NCT01871805|2800838|P2|Phase I|Alive in Survival Follow-up|0
878653|NCT01871805|2800839|P1|Phase I|Alive in Survival Follow-up|1
878654|NCT01871805|2800834|P6|Phase I|Alive on Treatment|0
878655|NCT01871805|2800835|P5|Phase I|Alive on Treatment|3
878656|NCT01871805|2800836|P4|Phase I|Alive on Treatment|4
878657|NCT01871805|2800837|P3|Phase I|Alive on Treatment|5
904570|NCT02251990|2875575|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
878658|NCT01871805|2800838|P2|Phase I|Alive on Treatment|3
878659|NCT01871805|2800839|P1|Phase I|Alive on Treatment|0
878660|NCT01871805|2800834|P6|Phase I|Death|0
878661|NCT01871805|2800835|P5|Phase I|Death|6
878662|NCT01871805|2800836|P4|Phase I|Death|2
878663|NCT01871805|2800837|P3|Phase I|Death|5
878664|NCT01871805|2800838|P2|Phase I|Death|3
878665|NCT01871805|2800839|P1|Phase I|Death|6
904571|NCT02251990|2875576|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
904572|NCT02251990|2875575|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
904573|NCT02251990|2875576|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
904574|NCT02251990|2875575|P2|Period 1 (Double-blind [DB])|Not Treated|0
904575|NCT02251990|2875576|P1|Period 1 (Double-blind [DB])|Not Treated|1
904576|NCT02251990|2875575|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
904577|NCT02251990|2875576|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
904578|NCT02251990|2875575|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
904579|NCT02251990|2875576|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
904580|NCT02251990|2875575|P2|Period 1 (Double-blind [DB])|Adverse Event|1
904581|NCT02251990|2875576|P1|Period 1 (Double-blind [DB])|Adverse Event|1
904582|NCT02166476|2875625|P2|Overall Study|Unable to Come for Visit|3
904583|NCT02166476|2875626|P1|Overall Study|Unable to Come for Visit|0
904584|NCT02166476|2875625|P2|Overall Study|Physician Decision|0
904585|NCT02166476|2875626|P1|Overall Study|Physician Decision|1
904586|NCT02166476|2875625|P2|Overall Study|Lost to Follow-up|10
904587|NCT02166476|2875626|P1|Overall Study|Lost to Follow-up|5
904588|NCT02166476|2875625|P2|Overall Study|Adverse Event|3
904589|NCT02166476|2875626|P1|Overall Study|Adverse Event|3
904590|NCT02166476|2875625|P2|Overall Study|Withdrawal by Subject|7
904591|NCT02166476|2875626|P1|Overall Study|Withdrawal by Subject|5
904592|NCT02151981|2875661|P2|Overall Study|Eligibility criteria not fulfilled|1
904593|NCT02151981|2875662|P1|Overall Study|Eligibility criteria not fulfilled|0
904594|NCT02151981|2875661|P2|Overall Study|Ongoing Study at Data Cut-off|95
904595|NCT02151981|2875662|P1|Overall Study|Ongoing Study at Data Cut-off|224
904596|NCT02151981|2875661|P2|Overall Study|Withdrawal by Subject|18
904597|NCT02151981|2875662|P1|Overall Study|Withdrawal by Subject|19
904598|NCT02151981|2875661|P2|Overall Study|Lost to Follow-up|0
904599|NCT02151981|2875662|P1|Overall Study|Lost to Follow-up|1
904600|NCT02151981|2875661|P2|Overall Study|Death|26
904601|NCT02151981|2875662|P1|Overall Study|Death|35
904602|NCT02140164|2875678|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
904603|NCT02138825|2875695|P2|Safety Follow-up|withdrawn due to lung transplant|1
904604|NCT02138825|2875696|P1|Safety Follow-up|withdrawn due to lung transplant|0
904605|NCT02138825|2875695|P2|Safety Follow-up|treatment unblinded|1
904606|NCT02138825|2875696|P1|Safety Follow-up|treatment unblinded|0
904607|NCT02138825|2875695|P2|Safety Follow-up|too unwell to attend the visit|1
904608|NCT02138825|2875696|P1|Safety Follow-up|too unwell to attend the visit|0
904609|NCT02138825|2875695|P2|Safety Follow-up|progressive disease|2
904610|NCT02138825|2875696|P1|Safety Follow-up|progressive disease|0
904611|NCT02138825|2875695|P2|Safety Follow-up|logistical difficulties|1
904612|NCT02138825|2875696|P1|Safety Follow-up|logistical difficulties|0
904613|NCT02138825|2875695|P2|Safety Follow-up|withdrawal by PI|0
904614|NCT02138825|2875696|P1|Safety Follow-up|withdrawal by PI|1
878712|NCT01744483|2800937|P3|Overall Study|Routed to OSH|1
878713|NCT01744483|2800938|P2|Overall Study|Routed to OSH|0
878714|NCT01744483|2800939|P1|Overall Study|Routed to OSH|2
878715|NCT01744483|2800937|P3|Overall Study|No ICU Admit|2
878716|NCT01744483|2800938|P2|Overall Study|No ICU Admit|1
878717|NCT01744483|2800939|P1|Overall Study|No ICU Admit|5
878718|NCT01744483|2800937|P3|Overall Study|Withdrawal by Subject|2
878719|NCT01744483|2800938|P2|Overall Study|Withdrawal by Subject|6
878720|NCT01744483|2800939|P1|Overall Study|Withdrawal by Subject|4
878721|NCT01744483|2800937|P3|Overall Study|Protocol Violation|1
878722|NCT01744483|2800938|P2|Overall Study|Protocol Violation|2
878723|NCT01744483|2800939|P1|Overall Study|Protocol Violation|1
878724|NCT01744483|2800937|P3|Overall Study|Lost to Follow-up|11
878725|NCT01744483|2800938|P2|Overall Study|Lost to Follow-up|9
878726|NCT01744483|2800939|P1|Overall Study|Lost to Follow-up|8
878727|NCT01744483|2800937|P3|Overall Study|Death|11
878728|NCT01744483|2800938|P2|Overall Study|Death|4
878729|NCT01744483|2800939|P1|Overall Study|Death|9
878730|NCT01741259|2800949|P2|Overall Study|Withdrawal by Subject|2
878731|NCT01741259|2800950|P1|Overall Study|Withdrawal by Subject|0
878732|NCT01741259|2800949|P2|Overall Study|Protocol Violation|4
878733|NCT01741259|2800950|P1|Overall Study|Protocol Violation|6
878734|NCT01709409|2801006|P2|Overall Study|Protocol Violation|0
878735|NCT01709409|2801007|P1|Overall Study|Protocol Violation|1
904615|NCT02138825|2875695|P2|Safety Follow-up|clinic worsening|0
904616|NCT02138825|2875696|P1|Safety Follow-up|clinic worsening|1
904617|NCT02138825|2875695|P2|Safety Follow-up|Withdrawal by Subject|3
904618|NCT02138825|2875696|P1|Safety Follow-up|Withdrawal by Subject|5
904619|NCT02138825|2875695|P2|Safety Follow-up|Death|5
904620|NCT02138825|2875696|P1|Safety Follow-up|Death|11
904621|NCT02138825|2875695|P2|Safety Follow-up|Adverse Event|3
904622|NCT02138825|2875696|P1|Safety Follow-up|Adverse Event|4
904623|NCT02138825|2875695|P2|Long-term Extension|Study termination by sponsor|38
904624|NCT02138825|2875696|P1|Long-term Extension|Study termination by sponsor|32
904625|NCT02138825|2875695|P2|Main Study Treatment|Medical decision|0
904626|NCT02138825|2875696|P1|Main Study Treatment|Medical decision|1
904627|NCT02138825|2875695|P2|Main Study Treatment|Withdrawal by Subject|1
904628|NCT02138825|2875696|P1|Main Study Treatment|Withdrawal by Subject|3
904629|NCT02138825|2875695|P2|Main Study Treatment|Study terminated by sponsor|9
904630|NCT02138825|2875696|P1|Main Study Treatment|Study terminated by sponsor|10
904631|NCT02138825|2875695|P2|Main Study Treatment|Sponsor decision|18
904632|NCT02138825|2875696|P1|Main Study Treatment|Sponsor decision|12
904633|NCT02138825|2875695|P2|Main Study Treatment|Protocol Violation|2
904634|NCT02138825|2875696|P1|Main Study Treatment|Protocol Violation|2
904635|NCT02138825|2875695|P2|Main Study Treatment|Death|2
904636|NCT02138825|2875696|P1|Main Study Treatment|Death|1
904637|NCT02138825|2875695|P2|Main Study Treatment|Adverse Event|3
904638|NCT02138825|2875696|P1|Main Study Treatment|Adverse Event|11
904639|NCT02093520|2875719|P2|Overall Study|Not treated|22
904640|NCT02093520|2875720|P1|Overall Study|Not treated|6
904641|NCT02057068|2875739|P2|Overall Study|Lost to Follow-up|2
904642|NCT02057068|2875740|P1|Overall Study|Lost to Follow-up|2
904643|NCT02057068|2875739|P2|Overall Study|Carepartner (CP) Health|2
878768|NCT01665599|2801109|P1|Overall Study|Could Not Continue Due to Time Constrain|1
878769|NCT01665599|2801109|P1|Overall Study|Participant Left for More Than 3 Months|1
878770|NCT01665599|2801109|P1|Overall Study|Lost to Follow-up|2
878771|NCT01665599|2801109|P1|Overall Study|Death|1
878772|NCT01665599|2801109|P1|Overall Study|Investigator/Sponsor decision|1
878773|NCT01665599|2801109|P1|Overall Study|Consent Withdrawn|1
878774|NCT01665599|2801109|P1|Overall Study|Adverse Event|1
878775|NCT01624233|2801165|P1|Period 3 - Maintenance|Withdrawal by Subject|2
878776|NCT01624233|2801165|P1|Period 3 - Maintenance|Physician Decision|2
878777|NCT01624233|2801165|P1|Period 3 - Maintenance|Lack of Efficacy|1
878778|NCT01624233|2801165|P1|Period 3 - Maintenance|Adverse Event|2
878779|NCT01624233|2801165|P1|Period 2 - Induction|Adverse Event|1
904644|NCT02057068|2875740|P1|Overall Study|Carepartner (CP) Health|4
904645|NCT02057068|2875739|P2|Overall Study|Caregiver (CG) Health|2
904646|NCT02057068|2875740|P1|Overall Study|Caregiver (CG) Health|0
904647|NCT02057068|2875739|P2|Overall Study|Withdrawal by Subject|2
904648|NCT02057068|2875740|P1|Overall Study|Withdrawal by Subject|2
904649|NCT02042924|2875750|P1|Overall Study|Early Death|1
904650|NCT02037568|2875758|P2|Overall Study|Patient did not receive transplant|1
904651|NCT02037568|2875759|P1|Overall Study|Patient did not receive transplant|0
904652|NCT02037568|2875758|P2|Overall Study|Screen Failure|1
904653|NCT02037568|2875759|P1|Overall Study|Screen Failure|3
904654|NCT02037568|2875758|P2|Overall Study|Lost to Follow-up|13
904655|NCT02037568|2875759|P1|Overall Study|Lost to Follow-up|16
904656|NCT02037568|2875758|P2|Overall Study|Withdrawal by Subject|24
904657|NCT02037568|2875759|P1|Overall Study|Withdrawal by Subject|17
904658|NCT02013167|2875815|P2|Overall Study|Death|160
904659|NCT02013167|2875816|P1|Overall Study|Death|85
904660|NCT02013167|2875815|P2|Overall Study|Lost to Follow-up|1
904661|NCT02013167|2875816|P1|Overall Study|Lost to Follow-up|0
904662|NCT02013167|2875815|P2|Overall Study|Sponsor Decision|3
904663|NCT02013167|2875816|P1|Overall Study|Sponsor Decision|1
878800|NCT01449929|2801348|P2|Overall Study|Ongoing|213
878801|NCT01449929|2801349|P1|Overall Study|Ongoing|224
878802|NCT01449929|2801348|P2|Overall Study|Physician Decision|3
878803|NCT01449929|2801349|P1|Overall Study|Physician Decision|2
878804|NCT01449929|2801348|P2|Overall Study|Withdrawal by Subject|1
878805|NCT01449929|2801349|P1|Overall Study|Withdrawal by Subject|1
878806|NCT01449929|2801348|P2|Overall Study|Lost to Follow-up|10
878807|NCT01449929|2801349|P1|Overall Study|Lost to Follow-up|6
878808|NCT01449929|2801348|P2|Overall Study|Protocol-defined Stopping Criteria|1
878809|NCT01449929|2801349|P1|Overall Study|Protocol-defined Stopping Criteria|1
878810|NCT01449929|2801348|P2|Overall Study|Protocol Violation|3
878811|NCT01449929|2801349|P1|Overall Study|Protocol Violation|3
878812|NCT01449929|2801348|P2|Overall Study|Lack of Efficacy|2
878813|NCT01449929|2801349|P1|Overall Study|Lack of Efficacy|2
878814|NCT01449929|2801348|P2|Overall Study|Adverse Event|9
878815|NCT01449929|2801349|P1|Overall Study|Adverse Event|3
904664|NCT02013167|2875815|P2|Overall Study|Withdrawal by Subject|14
904665|NCT02013167|2875816|P1|Overall Study|Withdrawal by Subject|15
904666|NCT01936974|2875871|P2|Overall Study|Physician Decision|5
904667|NCT01936974|2875872|P1|Overall Study|Physician Decision|2
904670|NCT01933919|2875907|P2|Open-label Long-term Phase|Other|2
904671|NCT01933919|2875908|P1|Open-label Long-term Phase|Other|1
904672|NCT01933919|2875907|P2|Open-label Long-term Phase|Lost to Follow-up|0
904673|NCT01933919|2875908|P1|Open-label Long-term Phase|Lost to Follow-up|1
904674|NCT01933919|2875907|P2|Open-label Long-term Phase|Withdrawal by Subject|4
904675|NCT01933919|2875908|P1|Open-label Long-term Phase|Withdrawal by Subject|3
904676|NCT01933919|2875907|P2|Open-label Long-term Phase|Adverse Event|0
904677|NCT01933919|2875908|P1|Open-label Long-term Phase|Adverse Event|2
904678|NCT01933919|2875907|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
904679|NCT01933919|2875908|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
904680|NCT01933919|2875907|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
904681|NCT01933919|2875908|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
904682|NCT01933919|2875907|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
904683|NCT01933919|2875908|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
904694|NCT01910402|2876002|P2|Continuation Phase|Withdrawal by Subject|0
904695|NCT01910402|2876003|P1|Continuation Phase|Withdrawal by Subject|2
904696|NCT01910402|2876002|P2|Continuation Phase|Protocol Violation|0
904697|NCT01910402|2876003|P1|Continuation Phase|Protocol Violation|3
904698|NCT01910402|2876002|P2|Continuation Phase|Adverse Event|0
904699|NCT01910402|2876003|P1|Continuation Phase|Adverse Event|1
904700|NCT01910402|2876002|P2|Continuation Phase|Ongoing|0
904701|NCT01910402|2876003|P1|Continuation Phase|Ongoing|84
904702|NCT01910402|2876002|P2|Randomized Phase|Withdrawal by Subject|7
904703|NCT01910402|2876003|P1|Randomized Phase|Withdrawal by Subject|5
904704|NCT01910402|2876002|P2|Randomized Phase|Protocol Violation|13
904705|NCT01910402|2876003|P1|Randomized Phase|Protocol Violation|10
904706|NCT01910402|2876002|P2|Randomized Phase|Lost to Follow-up|13
904707|NCT01910402|2876003|P1|Randomized Phase|Lost to Follow-up|11
904708|NCT01910402|2876002|P2|Randomized Phase|Lack of Efficacy|4
904709|NCT01910402|2876003|P1|Randomized Phase|Lack of Efficacy|5
904710|NCT01910402|2876002|P2|Randomized Phase|Physician Decision|0
904711|NCT01910402|2876003|P1|Randomized Phase|Physician Decision|1
904712|NCT01910402|2876002|P2|Randomized Phase|Adverse Event|18
904713|NCT01910402|2876003|P1|Randomized Phase|Adverse Event|10
904714|NCT01908803|2876073|P2|Overall Study|Adverse Event (pre-treatment)|0
904715|NCT01908803|2876074|P1|Overall Study|Adverse Event (pre-treatment)|1
904716|NCT01908803|2876073|P2|Overall Study|Randomization Error|0
904717|NCT01908803|2876074|P1|Overall Study|Randomization Error|1
904718|NCT01908803|2876073|P2|Overall Study|Withdrawal by Subject|0
904719|NCT01908803|2876074|P1|Overall Study|Withdrawal by Subject|1
904720|NCT01908803|2876073|P2|Overall Study|Physician Decision|1
904721|NCT01908803|2876074|P1|Overall Study|Physician Decision|0
904722|NCT01908803|2876073|P2|Overall Study|Adverse Event|0
904723|NCT01908803|2876074|P1|Overall Study|Adverse Event|1
878888|NCT01311687|2801562|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
878889|NCT01311687|2801563|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
878890|NCT01311687|2801562|P2|Treatment Phase|On treatment at data cut-off|11
878891|NCT01311687|2801563|P1|Treatment Phase|On treatment at data cut-off|60
878892|NCT01307891|2801615|P2|Overall Study|Progressive Disease|1
878893|NCT01307891|2801616|P1|Overall Study|Progressive Disease|3
904731|NCT01860040|2876100|P2|Overall Study|Withdrawal by Subject|0
904732|NCT01860040|2876101|P1|Overall Study|Withdrawal by Subject|1
904733|NCT01819129|2876119|P2|Overall Study|Withdrawal Criteria|15
904734|NCT01819129|2876120|P1|Overall Study|Withdrawal Criteria|20
904735|NCT01819129|2876119|P2|Overall Study|Death|1
904736|NCT01819129|2876120|P1|Overall Study|Death|1
904737|NCT01819129|2876119|P2|Overall Study|Adverse Event|4
904738|NCT01819129|2876120|P1|Overall Study|Adverse Event|1
904739|NCT01819129|2876119|P2|Overall Study|Lack of Efficacy|1
904740|NCT01819129|2876120|P1|Overall Study|Lack of Efficacy|0
904741|NCT01819129|2876119|P2|Overall Study|Lost to Follow-up|2
878906|NCT01247324|2801650|P2|Overall Study|Lost to Follow-up|1
878907|NCT01247324|2801651|P1|Overall Study|Lost to Follow-up|1
878908|NCT01247324|2801650|P2|Overall Study|Adverse Event|13
878909|NCT01247324|2801651|P1|Overall Study|Adverse Event|25
878910|NCT01247324|2801650|P2|Overall Study|Consent withdrawn by participant|8
878911|NCT01247324|2801651|P1|Overall Study|Consent withdrawn by participant|13
878912|NCT01247324|2801650|P2|Overall Study|Reason not specified|8
878913|NCT01247324|2801651|P1|Overall Study|Reason not specified|11
878914|NCT01247324|2801650|P2|Overall Study|Protocol Violation|2
878915|NCT01247324|2801651|P1|Overall Study|Protocol Violation|1
878916|NCT01247324|2801650|P2|Overall Study|Pregnancy|3
878917|NCT01247324|2801651|P1|Overall Study|Pregnancy|2
878918|NCT01247324|2801650|P2|Overall Study|Non-compliance|0
878919|NCT01247324|2801651|P1|Overall Study|Non-compliance|2
878920|NCT01247324|2801650|P2|Overall Study|Lack of Efficacy|8
878921|NCT01247324|2801651|P1|Overall Study|Lack of Efficacy|12
878922|NCT01247324|2801650|P2|Overall Study|Non-compliance with study drug|0
878923|NCT01247324|2801651|P1|Overall Study|Non-compliance with study drug|3
878924|NCT01247324|2801650|P2|Overall Study|Physician Decision|1
878925|NCT01247324|2801651|P1|Overall Study|Physician Decision|0
878926|NCT01247324|2801650|P2|Overall Study|Death|0
878927|NCT01247324|2801651|P1|Overall Study|Death|1
878928|NCT01245062|2801684|P3|Cross-over Phase|Ongoing|34
878929|NCT01245062|2801685|P2|Cross-over Phase|Ongoing|0
878930|NCT01245062|2801686|P1|Cross-over Phase|Ongoing|0
878931|NCT01245062|2801684|P3|Cross-over Phase|Withdrew Consent|3
878932|NCT01245062|2801685|P2|Cross-over Phase|Withdrew Consent|0
878933|NCT01245062|2801686|P1|Cross-over Phase|Withdrew Consent|0
878934|NCT01245062|2801684|P3|Cross-over Phase|Death|14
878935|NCT01245062|2801685|P2|Cross-over Phase|Death|0
878936|NCT01245062|2801686|P1|Cross-over Phase|Death|0
878937|NCT01245062|2801684|P3|Randomization Phase|Ongoing|0
878938|NCT01245062|2801685|P2|Randomization Phase|Ongoing|65
878939|NCT01245062|2801686|P1|Randomization Phase|Ongoing|169
878940|NCT01245062|2801684|P3|Randomization Phase|Withdrew Consent|0
878941|NCT01245062|2801685|P2|Randomization Phase|Withdrew Consent|10
878942|NCT01245062|2801686|P1|Randomization Phase|Withdrew Consent|6
878943|NCT01245062|2801684|P3|Randomization Phase|Physician Decision|0
878944|NCT01245062|2801685|P2|Randomization Phase|Physician Decision|3
878945|NCT01245062|2801686|P1|Randomization Phase|Physician Decision|2
878946|NCT01245062|2801684|P3|Randomization Phase|Lost to Follow-up|0
878947|NCT01245062|2801685|P2|Randomization Phase|Lost to Follow-up|1
878948|NCT01245062|2801686|P1|Randomization Phase|Lost to Follow-up|2
878949|NCT01245062|2801684|P3|Randomization Phase|Death|0
878950|NCT01245062|2801685|P2|Randomization Phase|Death|29
878951|NCT01245062|2801686|P1|Randomization Phase|Death|35
878952|NCT01243177|2801720|P2|Overall Study|Other Reason|12
878953|NCT01243177|2801721|P1|Overall Study|Other Reason|11
878954|NCT01243177|2801720|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
878955|NCT01243177|2801721|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
878956|NCT01243177|2801720|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
878957|NCT01243177|2801721|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
878958|NCT01243177|2801720|P2|Overall Study|AE, non-serious non-fatal|58
878959|NCT01243177|2801721|P1|Overall Study|AE, non-serious non-fatal|40
878960|NCT01243177|2801720|P2|Overall Study|SAE, non-fatal|9
878961|NCT01243177|2801721|P1|Overall Study|SAE, non-fatal|7
878962|NCT01243177|2801720|P2|Overall Study|AE, serious fatal|1
878963|NCT01243177|2801721|P1|Overall Study|AE, serious fatal|0
878964|NCT01243177|2801720|P2|Overall Study|Withdrawal by Subject|38
878965|NCT01243177|2801721|P1|Overall Study|Withdrawal by Subject|46
878966|NCT01243177|2801720|P2|Overall Study|Lost to Follow-up|18
878967|NCT01243177|2801721|P1|Overall Study|Lost to Follow-up|15
878968|NCT01243177|2801720|P2|Overall Study|Protocol Violation|10
878969|NCT01243177|2801721|P1|Overall Study|Protocol Violation|11
878970|NCT01243177|2801720|P2|Overall Study|Lack of Efficacy|31
878971|NCT01243177|2801721|P1|Overall Study|Lack of Efficacy|47
904742|NCT01819129|2876120|P1|Overall Study|Lost to Follow-up|5
904743|NCT01819129|2876119|P2|Overall Study|Withdrawal by Subject|15
878977|NCT01071512|2801896|P1|Overall Study|positive anti-JC virus antibody test|2
878978|NCT01071512|2801896|P1|Overall Study|Development of antibodies to drug|2
878979|NCT01071512|2801896|P1|Overall Study|Adverse Event|1
904744|NCT01819129|2876120|P1|Overall Study|Withdrawal by Subject|15
904745|NCT01819129|2876119|P2|Overall Study|Other, Subject moved out of the country|1
904746|NCT01819129|2876120|P1|Overall Study|Other, Subject moved out of the country|0
878983|NCT01004003|2801921|P9|Overall Study|Other|0
878984|NCT01004003|2801922|P8|Overall Study|Other|0
878985|NCT01004003|2801923|P7|Overall Study|Other|0
878986|NCT01004003|2801924|P6|Overall Study|Other|1
878987|NCT01004003|2801925|P5|Overall Study|Other|0
878988|NCT01004003|2801926|P4|Overall Study|Other|0
878989|NCT01004003|2801927|P3|Overall Study|Other|0
878990|NCT01004003|2801928|P2|Overall Study|Other|0
878991|NCT01004003|2801929|P1|Overall Study|Other|0
878992|NCT01004003|2801921|P9|Overall Study|Refused to continue taking trial med.|2
878993|NCT01004003|2801922|P8|Overall Study|Refused to continue taking trial med.|0
878994|NCT01004003|2801923|P7|Overall Study|Refused to continue taking trial med.|0
878995|NCT01004003|2801924|P6|Overall Study|Refused to continue taking trial med.|0
878996|NCT01004003|2801925|P5|Overall Study|Refused to continue taking trial med.|0
878997|NCT01004003|2801926|P4|Overall Study|Refused to continue taking trial med.|0
878998|NCT01004003|2801927|P3|Overall Study|Refused to continue taking trial med.|0
878999|NCT01004003|2801928|P2|Overall Study|Refused to continue taking trial med.|0
879000|NCT01004003|2801929|P1|Overall Study|Refused to continue taking trial med.|0
879001|NCT01004003|2801921|P9|Overall Study|Adverse Event|6
879002|NCT01004003|2801922|P8|Overall Study|Adverse Event|21
879003|NCT01004003|2801923|P7|Overall Study|Adverse Event|7
879004|NCT01004003|2801924|P6|Overall Study|Adverse Event|2
879005|NCT01004003|2801925|P5|Overall Study|Adverse Event|2
879006|NCT01004003|2801926|P4|Overall Study|Adverse Event|3
879007|NCT01004003|2801927|P3|Overall Study|Adverse Event|3
879008|NCT01004003|2801928|P2|Overall Study|Adverse Event|2
879009|NCT01004003|2801929|P1|Overall Study|Adverse Event|4
879010|NCT01004003|2801921|P9|Overall Study|Progressive disease|22
879011|NCT01004003|2801922|P8|Overall Study|Progressive disease|39
879012|NCT01004003|2801923|P7|Overall Study|Progressive disease|1
879013|NCT01004003|2801924|P6|Overall Study|Progressive disease|1
879014|NCT01004003|2801925|P5|Overall Study|Progressive disease|2
879015|NCT01004003|2801926|P4|Overall Study|Progressive disease|0
879016|NCT01004003|2801927|P3|Overall Study|Progressive disease|1
879017|NCT01004003|2801928|P2|Overall Study|Progressive disease|1
879018|NCT01004003|2801929|P1|Overall Study|Progressive disease|2
904747|NCT01819129|2876119|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
904748|NCT01819129|2876120|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
904749|NCT01819129|2876119|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
904750|NCT01819129|2876120|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
904766|NCT01773070|2876224|P1|Overall Study|Death (unrelated to study procedures)|3
904767|NCT01773070|2876224|P1|Overall Study|Other|15
904768|NCT01773070|2876224|P1|Overall Study|Lost to Follow-up|39
904769|NCT01773070|2876224|P1|Overall Study|Withdrawal by Subject|24
904770|NCT01740401|2876251|P1|Overall Study|Did not reach primary endpoint|2
904771|NCT01740401|2876251|P1|Overall Study|Adverse Event|2
879053|NCT00857220|2802174|P1|Overall Study|Miscellaneous|8
879054|NCT00857220|2802174|P1|Overall Study|Site Closed|5
879055|NCT00857220|2802174|P1|Overall Study|Clinical Hold|6
879056|NCT00857220|2802174|P1|Overall Study|Withdrawal by Subject|67
879057|NCT00857220|2802174|P1|Overall Study|Protocol Violation|16
879058|NCT00857220|2802174|P1|Overall Study|Physician Decision|4
879059|NCT00857220|2802174|P1|Overall Study|Lost to Follow-up|30
879060|NCT00857220|2802174|P1|Overall Study|Lack of Efficacy|11
879061|NCT00857220|2802174|P1|Overall Study|Death|1
879062|NCT00857220|2802174|P1|Overall Study|Adverse Event|35
879063|NCT00742859|2802242|P4|Overall Study|Site error|1
879064|NCT00742859|2802243|P3|Overall Study|Site error|1
879065|NCT00742859|2802244|P2|Overall Study|Site error|0
879066|NCT00742859|2802245|P1|Overall Study|Site error|0
879067|NCT00742859|2802242|P4|Overall Study|Sponsor request patient out of town|1
879068|NCT00742859|2802243|P3|Overall Study|Sponsor request patient out of town|1
879069|NCT00742859|2802244|P2|Overall Study|Sponsor request patient out of town|0
879070|NCT00742859|2802245|P1|Overall Study|Sponsor request patient out of town|0
879071|NCT00742859|2802242|P4|Overall Study|Sponsor req visit schedule noncompliance|1
879072|NCT00742859|2802243|P3|Overall Study|Sponsor req visit schedule noncompliance|0
879073|NCT00742859|2802244|P2|Overall Study|Sponsor req visit schedule noncompliance|0
879074|NCT00742859|2802245|P1|Overall Study|Sponsor req visit schedule noncompliance|0
879075|NCT00742859|2802242|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
879076|NCT00742859|2802243|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
879077|NCT00742859|2802244|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
879078|NCT00742859|2802245|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
879079|NCT00742859|2802242|P4|Overall Study|Endpoint|2
879080|NCT00742859|2802243|P3|Overall Study|Endpoint|1
879081|NCT00742859|2802244|P2|Overall Study|Endpoint|1
879082|NCT00742859|2802245|P1|Overall Study|Endpoint|0
879083|NCT00742859|2802242|P4|Overall Study|Withdrawal by Subject|1
879084|NCT00742859|2802243|P3|Overall Study|Withdrawal by Subject|4
879085|NCT00742859|2802244|P2|Overall Study|Withdrawal by Subject|2
879086|NCT00742859|2802245|P1|Overall Study|Withdrawal by Subject|4
879087|NCT00742859|2802242|P4|Overall Study|Physician Decision|0
879088|NCT00742859|2802243|P3|Overall Study|Physician Decision|0
879089|NCT00742859|2802244|P2|Overall Study|Physician Decision|2
879090|NCT00742859|2802245|P1|Overall Study|Physician Decision|1
879091|NCT00742859|2802242|P4|Overall Study|Death|1
879092|NCT00742859|2802243|P3|Overall Study|Death|0
879093|NCT00742859|2802244|P2|Overall Study|Death|0
879094|NCT00742859|2802245|P1|Overall Study|Death|1
879095|NCT00742859|2802242|P4|Overall Study|Adverse Event|1
879096|NCT00742859|2802243|P3|Overall Study|Adverse Event|3
879097|NCT00742859|2802244|P2|Overall Study|Adverse Event|6
879098|NCT00742859|2802245|P1|Overall Study|Adverse Event|5
879099|NCT00740870|2802259|P1|Overall Study|Further testing contraindicated implant|17
879100|NCT00740870|2802259|P1|Overall Study|Not Catheterized|4
879101|NCT00731731|2802274|P3|Overall Study|Cancel prior to treatment|2
879102|NCT00731731|2802275|P2|Overall Study|Cancel prior to treatment|0
879103|NCT00731731|2802276|P1|Overall Study|Cancel prior to treatment|0
879104|NCT00731731|2802274|P3|Overall Study|Protocol Violation|1
879105|NCT00731731|2802275|P2|Overall Study|Protocol Violation|0
879106|NCT00731731|2802276|P1|Overall Study|Protocol Violation|0
879107|NCT00725322|2802293|P2|Washout (28 Days)|Protocol Violation|1
879108|NCT00725322|2802294|P1|Washout (28 Days)|Protocol Violation|0
879109|NCT00725322|2802293|P2|Washout (28 Days)|Withdrawal by Subject|0
879110|NCT00725322|2802294|P1|Washout (28 Days)|Withdrawal by Subject|2
879111|NCT00699816|2802304|P2|Overall Study|Protocol Violation|3
879112|NCT00699816|2802305|P1|Overall Study|Protocol Violation|1
904772|NCT01740401|2876251|P1|Overall Study|Progression of disease|6
879124|NCT00676715|2802403|P4|Overall Study|Participants Ongoing|24
879125|NCT00676715|2802404|P3|Overall Study|Participants Ongoing|17
879126|NCT00676715|2802405|P2|Overall Study|Participants Ongoing|29
879127|NCT00676715|2802406|P1|Overall Study|Participants Ongoing|29
879128|NCT00676715|2802403|P4|Overall Study|Adverse Event|0
879129|NCT00676715|2802404|P3|Overall Study|Adverse Event|2
879130|NCT00676715|2802405|P2|Overall Study|Adverse Event|1
879131|NCT00676715|2802406|P1|Overall Study|Adverse Event|0
879132|NCT00676715|2802403|P4|Overall Study|Death|0
879133|NCT00676715|2802404|P3|Overall Study|Death|1
879134|NCT00676715|2802405|P2|Overall Study|Death|1
879135|NCT00676715|2802406|P1|Overall Study|Death|1
879136|NCT00676715|2802403|P4|Overall Study|Lost to Follow-up|3
879137|NCT00676715|2802404|P3|Overall Study|Lost to Follow-up|7
879138|NCT00676715|2802405|P2|Overall Study|Lost to Follow-up|1
879139|NCT00676715|2802406|P1|Overall Study|Lost to Follow-up|1
879140|NCT00676715|2802403|P4|Overall Study|Other|3
879141|NCT00676715|2802404|P3|Overall Study|Other|4
879142|NCT00676715|2802405|P2|Overall Study|Other|6
879143|NCT00676715|2802406|P1|Overall Study|Other|2
879144|NCT00676715|2802403|P4|Overall Study|Withdrawal by Subject|10
879145|NCT00676715|2802404|P3|Overall Study|Withdrawal by Subject|10
879146|NCT00676715|2802405|P2|Overall Study|Withdrawal by Subject|9
879147|NCT00676715|2802406|P1|Overall Study|Withdrawal by Subject|7
879148|NCT00658814|2802442|P2|Maintenance Therapy|Not eligible|0
879149|NCT00658814|2802443|P1|Maintenance Therapy|Not eligible|1
879150|NCT00658814|2802442|P2|Maintenance Therapy|Not protocol specified|0
879151|NCT00658814|2802443|P1|Maintenance Therapy|Not protocol specified|1
879152|NCT00658814|2802442|P2|Maintenance Therapy|Adverse Event|1
879153|NCT00658814|2802443|P1|Maintenance Therapy|Adverse Event|1
879154|NCT00658814|2802442|P2|Consolidation Therapy|Not eligible|2
879155|NCT00658814|2802443|P1|Consolidation Therapy|Not eligible|2
879156|NCT00658814|2802442|P2|Consolidation Therapy|Not protocol specified|1
879157|NCT00658814|2802443|P1|Consolidation Therapy|Not protocol specified|0
879158|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Not eligible|2
879159|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Not eligible|1
879160|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Not protocol specified|4
879161|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Not protocol specified|2
879162|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Death|4
879163|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Death|1
879164|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Progression/Relapse|1
879165|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Progression/Relapse|0
879166|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
879167|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
879168|NCT00658814|2802442|P2|Remission Induction Chemotherapy|Adverse Event|3
879169|NCT00658814|2802443|P1|Remission Induction Chemotherapy|Adverse Event|1
879170|NCT00616759|2802459|P2|Overall Study|Withdrawal by Subject|2
879171|NCT00616759|2802460|P1|Overall Study|Withdrawal by Subject|1
879172|NCT00616759|2802459|P2|Overall Study|Physician Decision|0
879173|NCT00616759|2802460|P1|Overall Study|Physician Decision|2
879174|NCT00586339|2802469|P3|Overall Study|Withdrawal by Subject|1
879175|NCT00586339|2802470|P2|Overall Study|Withdrawal by Subject|3
879176|NCT00586339|2802471|P1|Overall Study|Withdrawal by Subject|1
879177|NCT00586339|2802469|P3|Overall Study|Lost to Follow-up|5
879178|NCT00586339|2802470|P2|Overall Study|Lost to Follow-up|4
879179|NCT00586339|2802471|P1|Overall Study|Lost to Follow-up|6
879201|NCT00331409|2802649|P1|Overall Study|Lack of Efficacy|4
879223|NCT00249444|2802713|P2|Overall Study|life event|1
879224|NCT00249444|2802714|P1|Overall Study|life event|0
879225|NCT00249444|2802713|P2|Overall Study|Adverse Event|1
879226|NCT00249444|2802714|P1|Overall Study|Adverse Event|1
879227|NCT00249444|2802713|P2|Overall Study|non-compliant|11
879228|NCT00249444|2802714|P1|Overall Study|non-compliant|9
879229|NCT00249444|2802713|P2|Overall Study|Lost to Follow-up|2
879230|NCT00249444|2802714|P1|Overall Study|Lost to Follow-up|2
879231|NCT00233324|2802726|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
879232|NCT00233324|2802727|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
879233|NCT00233324|2802728|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
879234|NCT00233324|2802729|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
879235|NCT00233324|2802726|P4|Follow up at 18-22 Months Corrected Age|Death|4
879236|NCT00233324|2802727|P3|Follow up at 18-22 Months Corrected Age|Death|5
879237|NCT00233324|2802728|P2|Follow up at 18-22 Months Corrected Age|Death|7
879238|NCT00233324|2802729|P1|Follow up at 18-22 Months Corrected Age|Death|5
879239|NCT00233324|2802726|P4|Main Study|Death|47
879240|NCT00233324|2802727|P3|Main Study|Death|62
879241|NCT00233324|2802728|P2|Main Study|Death|60
879242|NCT00233324|2802729|P1|Main Study|Death|68
879401|NCT02647944|2802878|P2|Overall Study|Adverse Event|0
879402|NCT02647944|2802879|P1|Overall Study|Adverse Event|2
879403|NCT02647944|2802878|P2|Overall Study|Withdrawal by Subject|3
879404|NCT02647944|2802879|P1|Overall Study|Withdrawal by Subject|0
879405|NCT02609672|2802905|P2|Overall Study|Lost to Follow-up|1
879406|NCT02609672|2802906|P1|Overall Study|Lost to Follow-up|3
879407|NCT02517515|2802942|P2|Overall Study|Not Specified|0
879408|NCT02517515|2802943|P1|Overall Study|Not Specified|1
879409|NCT02517515|2802942|P2|Overall Study|Lost to Follow-up|0
879410|NCT02517515|2802943|P1|Overall Study|Lost to Follow-up|1
879411|NCT02517515|2802942|P2|Overall Study|Withdrew Consent|1
879412|NCT02517515|2802943|P1|Overall Study|Withdrew Consent|0
879413|NCT02517515|2802942|P2|Overall Study|Adverse Event|1
879414|NCT02517515|2802943|P1|Overall Study|Adverse Event|0
879415|NCT02474082|2802960|P2|Overall Study|Protocol deviation|1
879416|NCT02474082|2802961|P1|Overall Study|Protocol deviation|0
879417|NCT02474082|2802960|P2|Overall Study|Non-compliance with study treatment|2
879418|NCT02474082|2802961|P1|Overall Study|Non-compliance with study treatment|0
879419|NCT02474082|2802960|P2|Overall Study|Participant/guardian decision|2
879420|NCT02474082|2802961|P1|Overall Study|Participant/guardian decision|1
879421|NCT02474082|2802960|P2|Overall Study|Dose tapering not achieved|4
879422|NCT02474082|2802961|P1|Overall Study|Dose tapering not achieved|0
879423|NCT02474082|2802960|P2|Overall Study|Lost to Follow-up|2
879424|NCT02474082|2802961|P1|Overall Study|Lost to Follow-up|2
879425|NCT02474082|2802960|P2|Overall Study|Withdrawal of informed consent|11
879426|NCT02474082|2802961|P1|Overall Study|Withdrawal of informed consent|1
879427|NCT02474082|2802960|P2|Overall Study|Adverse Event|32
879428|NCT02474082|2802961|P1|Overall Study|Adverse Event|2
879429|NCT02285998|2803075|P2|Overall Study|Other Reasons|10
879430|NCT02285998|2803076|P1|Overall Study|Other Reasons|7
879431|NCT02285998|2803075|P2|Overall Study|Withdrawal by Subject|61
879432|NCT02285998|2803076|P1|Overall Study|Withdrawal by Subject|53
879433|NCT02285998|2803075|P2|Overall Study|Lost to Follow-up|172
879434|NCT02285998|2803076|P1|Overall Study|Lost to Follow-up|176
879435|NCT02285998|2803075|P2|Overall Study|Physician Decision|2
879436|NCT02285998|2803076|P1|Overall Study|Physician Decision|1
879437|NCT02285998|2803075|P2|Overall Study|Adverse Event|8
879438|NCT02285998|2803076|P1|Overall Study|Adverse Event|9
879439|NCT02224846|2803102|P2|Period 2 (Month 12 to Month 24)|On Study Treatment|357
879440|NCT02224846|2803103|P1|Period 2 (Month 12 to Month 24)|On Study Treatment|173
879441|NCT02224846|2803102|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
879442|NCT02224846|2803103|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
879443|NCT02224846|2803102|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
879444|NCT02224846|2803103|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
879445|NCT02224846|2803102|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
879446|NCT02224846|2803103|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
879447|NCT02224846|2803102|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
879448|NCT02224846|2803103|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
879449|NCT02224846|2803102|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
879450|NCT02224846|2803103|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
879451|NCT02224846|2803102|P2|Period 1 (Month 3)|Sponsor Decision|1
879452|NCT02224846|2803103|P1|Period 1 (Month 3)|Sponsor Decision|2
879453|NCT02224846|2803102|P2|Period 1 (Month 3)|Withdrawal by Subject|18
879454|NCT02224846|2803103|P1|Period 1 (Month 3)|Withdrawal by Subject|8
879455|NCT02224846|2803102|P2|Period 1 (Month 3)|Protocol Violation|8
879456|NCT02224846|2803103|P1|Period 1 (Month 3)|Protocol Violation|4
879457|NCT02224846|2803102|P2|Period 1 (Month 3)|Lost to Follow-up|8
879458|NCT02224846|2803103|P1|Period 1 (Month 3)|Lost to Follow-up|3
879459|NCT02224846|2803102|P2|Period 1 (Month 3)|Adverse Event|1
879460|NCT02224846|2803103|P1|Period 1 (Month 3)|Adverse Event|2
879461|NCT02108951|2803156|P1|Overall Study|Study Terminated by Sponsor|14
879462|NCT02108951|2803156|P1|Overall Study|Patient's/guardian's decision|1
879463|NCT02108951|2803156|P1|Overall Study|Lost to Follow-up|1
879464|NCT01943435|2803204|P3|6 Month Follow up|Lost to Follow-up|15
879465|NCT01943435|2803205|P2|6 Month Follow up|Lost to Follow-up|7
879466|NCT01943435|2803206|P1|6 Month Follow up|Lost to Follow-up|12
879467|NCT01943435|2803204|P3|2 Month Follow up|Lost to Follow-up|0
879468|NCT01943435|2803205|P2|2 Month Follow up|Lost to Follow-up|3
879469|NCT01943435|2803206|P1|2 Month Follow up|Lost to Follow-up|2
879470|NCT01943435|2803204|P3|Intervention Period|Withdrawal by Subject|4
879471|NCT01943435|2803205|P2|Intervention Period|Withdrawal by Subject|3
879472|NCT01943435|2803206|P1|Intervention Period|Withdrawal by Subject|3
879473|NCT01905683|2803231|P1|Overall Study|Lost to Follow-up|4
879474|NCT01905683|2803231|P1|Overall Study|Adverse Event|4
879475|NCT01905683|2803231|P1|Overall Study|Withdrawal by Subject|20
879476|NCT01905683|2803231|P1|Overall Study|Lack of Efficacy|8
879477|NCT01905683|2803231|P1|Overall Study|Physician Decision|1
879478|NCT01905683|2803231|P1|Overall Study|Re-injection criteria not met; others|13
879479|NCT01905683|2803231|P1|Overall Study|Protocol Violation|1
879480|NCT01867710|2803248|P4|Overall Study|Other|0
879481|NCT01867710|2803249|P3|Overall Study|Other|0
879482|NCT01867710|2803250|P2|Overall Study|Other|1
879483|NCT01867710|2803251|P1|Overall Study|Other|0
879484|NCT01867710|2803248|P4|Overall Study|Eligible Criteria Not Met|0
879485|NCT01867710|2803249|P3|Overall Study|Eligible Criteria Not Met|1
879486|NCT01867710|2803250|P2|Overall Study|Eligible Criteria Not Met|0
879487|NCT01867710|2803251|P1|Overall Study|Eligible Criteria Not Met|0
879488|NCT01867710|2803248|P4|Overall Study|Withdrawal by Subject|0
879489|NCT01867710|2803249|P3|Overall Study|Withdrawal by Subject|0
879490|NCT01867710|2803250|P2|Overall Study|Withdrawal by Subject|1
879491|NCT01867710|2803251|P1|Overall Study|Withdrawal by Subject|0
879492|NCT01867710|2803248|P4|Overall Study|Protocol Violation|1
879493|NCT01867710|2803249|P3|Overall Study|Protocol Violation|0
879494|NCT01867710|2803250|P2|Overall Study|Protocol Violation|0
879495|NCT01867710|2803251|P1|Overall Study|Protocol Violation|1
879496|NCT01867710|2803248|P4|Overall Study|Physician Decision|0
879497|NCT01867710|2803249|P3|Overall Study|Physician Decision|1
879498|NCT01867710|2803250|P2|Overall Study|Physician Decision|0
879499|NCT01867710|2803251|P1|Overall Study|Physician Decision|0
879500|NCT01867710|2803248|P4|Overall Study|Death|0
879501|NCT01867710|2803249|P3|Overall Study|Death|1
879502|NCT01867710|2803250|P2|Overall Study|Death|1
879503|NCT01867710|2803251|P1|Overall Study|Death|0
879504|NCT01867710|2803248|P4|Overall Study|Other Adverse Events|3
879505|NCT01867710|2803249|P3|Overall Study|Other Adverse Events|1
879506|NCT01867710|2803250|P2|Overall Study|Other Adverse Events|0
879507|NCT01867710|2803251|P1|Overall Study|Other Adverse Events|1
879508|NCT01867710|2803248|P4|Overall Study|Palliative Radiation Required|1
879509|NCT01867710|2803249|P3|Overall Study|Palliative Radiation Required|1
879510|NCT01867710|2803250|P2|Overall Study|Palliative Radiation Required|0
879511|NCT01867710|2803251|P1|Overall Study|Palliative Radiation Required|0
879512|NCT01867710|2803248|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
879513|NCT01867710|2803249|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
879514|NCT01867710|2803250|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
879515|NCT01867710|2803251|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
879516|NCT01867710|2803248|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
879517|NCT01867710|2803249|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
879518|NCT01867710|2803250|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
879519|NCT01867710|2803251|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
879520|NCT01867710|2803248|P4|Overall Study|Disease Progression|2
879521|NCT01867710|2803249|P3|Overall Study|Disease Progression|4
879522|NCT01867710|2803250|P2|Overall Study|Disease Progression|2
879523|NCT01867710|2803251|P1|Overall Study|Disease Progression|5
879524|NCT01695239|2803269|P4|Overall Study|Protocol Violation|0
879525|NCT01695239|2803270|P3|Overall Study|Protocol Violation|0
879526|NCT01695239|2803271|P2|Overall Study|Protocol Violation|0
879527|NCT01695239|2803272|P1|Overall Study|Protocol Violation|1
879528|NCT01695239|2803269|P4|Overall Study|Lost to Follow-up|0
879529|NCT01695239|2803270|P3|Overall Study|Lost to Follow-up|0
879530|NCT01695239|2803271|P2|Overall Study|Lost to Follow-up|0
879531|NCT01695239|2803272|P1|Overall Study|Lost to Follow-up|1
879532|NCT01695239|2803269|P4|Overall Study|Sponsor Decision|0
879533|NCT01695239|2803270|P3|Overall Study|Sponsor Decision|1
879534|NCT01695239|2803271|P2|Overall Study|Sponsor Decision|0
879535|NCT01695239|2803272|P1|Overall Study|Sponsor Decision|3
879536|NCT01695239|2803269|P4|Overall Study|Withdrawal by Subject|0
879537|NCT01695239|2803270|P3|Overall Study|Withdrawal by Subject|1
879538|NCT01695239|2803271|P2|Overall Study|Withdrawal by Subject|1
879539|NCT01695239|2803272|P1|Overall Study|Withdrawal by Subject|3
879540|NCT01695239|2803269|P4|Overall Study|Lack of Efficacy|0
879541|NCT01695239|2803270|P3|Overall Study|Lack of Efficacy|2
879542|NCT01695239|2803271|P2|Overall Study|Lack of Efficacy|0
879543|NCT01695239|2803272|P1|Overall Study|Lack of Efficacy|4
879544|NCT01695239|2803269|P4|Overall Study|Adverse Event|3
879545|NCT01695239|2803270|P3|Overall Study|Adverse Event|2
879546|NCT01695239|2803271|P2|Overall Study|Adverse Event|2
879547|NCT01695239|2803272|P1|Overall Study|Adverse Event|2
879548|NCT01695239|2803269|P4|Overall Study|Entry Criteria Not Met|3
879549|NCT01695239|2803270|P3|Overall Study|Entry Criteria Not Met|3
879550|NCT01695239|2803271|P2|Overall Study|Entry Criteria Not Met|1
879551|NCT01695239|2803272|P1|Overall Study|Entry Criteria Not Met|1
879552|NCT01695239|2803269|P4|Overall Study|On Study Treatment|0
879553|NCT01695239|2803270|P3|Overall Study|On Study Treatment|1
879554|NCT01695239|2803271|P2|Overall Study|On Study Treatment|0
879555|NCT01695239|2803272|P1|Overall Study|On Study Treatment|0
879556|NCT01618162|2803382|P2|Overall Study|Unclassified|13
879557|NCT01618162|2803383|P1|Overall Study|Unclassified|14
879558|NCT01618162|2803382|P2|Overall Study|Withdrawal Criteria|10
879559|NCT01618162|2803383|P1|Overall Study|Withdrawal Criteria|2
879560|NCT01618162|2803382|P2|Overall Study|Adverse Event|2
879561|NCT01618162|2803383|P1|Overall Study|Adverse Event|9
879562|NCT01618162|2803382|P2|Overall Study|Protocol Violation|10
879563|NCT01618162|2803383|P1|Overall Study|Protocol Violation|13
879564|NCT01544179|2803414|P2|Overall Study|Eligibility criteria not fulfilled|0
879565|NCT01544179|2803415|P1|Overall Study|Eligibility criteria not fulfilled|1
879566|NCT01544179|2803414|P2|Overall Study|Withdrawal by Subject|7
879567|NCT01544179|2803415|P1|Overall Study|Withdrawal by Subject|12
879568|NCT01544179|2803414|P2|Overall Study|Adverse Event|1
879569|NCT01544179|2803415|P1|Overall Study|Adverse Event|0
879570|NCT01544179|2803414|P2|Overall Study|Lost to Follow-up|1
879571|NCT01544179|2803415|P1|Overall Study|Lost to Follow-up|0
879572|NCT01544179|2803414|P2|Overall Study|Death|37
879573|NCT01544179|2803415|P1|Overall Study|Death|50
879574|NCT01512693|2803445|P2|Overall Study|Withdrawal by Subject|1
879575|NCT01512693|2803446|P1|Overall Study|Withdrawal by Subject|0
879588|NCT01387282|2803545|P2|Overall Study|Lost to Follow-up|1
879589|NCT01387282|2803546|P1|Overall Study|Lost to Follow-up|4
879590|NCT01387282|2803545|P2|Overall Study|Study drug-related AE|2
879591|NCT01387282|2803546|P1|Overall Study|Study drug-related AE|2
879592|NCT01387282|2803545|P2|Overall Study|Withdrawal by patient|23
879593|NCT01387282|2803546|P1|Overall Study|Withdrawal by patient|33
879594|NCT01387282|2803545|P2|Overall Study|Unrelated AE|4
879595|NCT01387282|2803546|P1|Overall Study|Unrelated AE|6
879596|NCT01387282|2803545|P2|Overall Study|Other|1
879597|NCT01387282|2803546|P1|Overall Study|Other|5
879598|NCT01387282|2803545|P2|Overall Study|Death|16
879599|NCT01387282|2803546|P1|Overall Study|Death|47
879600|NCT01387269|2803562|P2|Overall Study|Lost to Follow-up|0
879601|NCT01387269|2803563|P1|Overall Study|Lost to Follow-up|1
879602|NCT01387269|2803562|P2|Overall Study|Study drug-related AE|0
879603|NCT01387269|2803563|P1|Overall Study|Study drug-related AE|1
879604|NCT01387269|2803562|P2|Overall Study|Withdrawal by patient|10
879605|NCT01387269|2803563|P1|Overall Study|Withdrawal by patient|32
879606|NCT01387269|2803562|P2|Overall Study|Unrelated AE|3
879607|NCT01387269|2803563|P1|Overall Study|Unrelated AE|12
879608|NCT01387269|2803562|P2|Overall Study|Other|7
879609|NCT01387269|2803563|P1|Overall Study|Other|8
879610|NCT01387269|2803562|P2|Overall Study|Death|20
879611|NCT01387269|2803563|P1|Overall Study|Death|38
879612|NCT01352221|2803579|P4|Open-label Phase|Worsening of IBD|0
879613|NCT01352221|2803580|P3|Open-label Phase|Worsening of IBD|1
879614|NCT01352221|2803581|P2|Open-label Phase|Worsening of IBD|0
879615|NCT01352221|2803582|P1|Open-label Phase|Worsening of IBD|0
879616|NCT01352221|2803579|P4|Open-label Phase|Withdrawal by Subject|6
879617|NCT01352221|2803580|P3|Open-label Phase|Withdrawal by Subject|1
879618|NCT01352221|2803581|P2|Open-label Phase|Withdrawal by Subject|0
879619|NCT01352221|2803582|P1|Open-label Phase|Withdrawal by Subject|0
879620|NCT01352221|2803579|P4|Open-label Phase|Adverse Event|4
879621|NCT01352221|2803580|P3|Open-label Phase|Adverse Event|8
879622|NCT01352221|2803581|P2|Open-label Phase|Adverse Event|0
879623|NCT01352221|2803582|P1|Open-label Phase|Adverse Event|0
879624|NCT01352221|2803579|P4|Open-label Phase|Pregnancy|0
879625|NCT01352221|2803580|P3|Open-label Phase|Pregnancy|1
879626|NCT01352221|2803581|P2|Open-label Phase|Pregnancy|0
879627|NCT01352221|2803582|P1|Open-label Phase|Pregnancy|0
879628|NCT01352221|2803579|P4|Open-label Phase|Physician Decision|1
879629|NCT01352221|2803580|P3|Open-label Phase|Physician Decision|2
879630|NCT01352221|2803581|P2|Open-label Phase|Physician Decision|0
879631|NCT01352221|2803582|P1|Open-label Phase|Physician Decision|0
879632|NCT01352221|2803579|P4|Double-blind Phase|Protocol Violation|0
879633|NCT01352221|2803580|P3|Double-blind Phase|Protocol Violation|0
879634|NCT01352221|2803581|P2|Double-blind Phase|Protocol Violation|1
879635|NCT01352221|2803582|P1|Double-blind Phase|Protocol Violation|0
879636|NCT01352221|2803579|P4|Double-blind Phase|Lost to Follow-up|0
879637|NCT01352221|2803580|P3|Double-blind Phase|Lost to Follow-up|0
879638|NCT01352221|2803581|P2|Double-blind Phase|Lost to Follow-up|1
879639|NCT01352221|2803582|P1|Double-blind Phase|Lost to Follow-up|0
879640|NCT01352221|2803579|P4|Double-blind Phase|Withdrawal by Subject|0
879641|NCT01352221|2803580|P3|Double-blind Phase|Withdrawal by Subject|0
879642|NCT01352221|2803581|P2|Double-blind Phase|Withdrawal by Subject|5
879643|NCT01352221|2803582|P1|Double-blind Phase|Withdrawal by Subject|3
879644|NCT01352221|2803579|P4|Double-blind Phase|Adverse Event|0
879645|NCT01352221|2803580|P3|Double-blind Phase|Adverse Event|0
879646|NCT01352221|2803581|P2|Double-blind Phase|Adverse Event|4
879647|NCT01352221|2803582|P1|Double-blind Phase|Adverse Event|6
879648|NCT01286012|2803654|P2|Overall Study|peritoneal dialysis, randomized in error|3
879649|NCT01286012|2803655|P1|Overall Study|peritoneal dialysis, randomized in error|1
879650|NCT01286012|2803654|P2|Overall Study|Physician Decision|0
879651|NCT01286012|2803655|P1|Overall Study|Physician Decision|2
879652|NCT01286012|2803654|P2|Overall Study|Withdrawal by Subject|4
879653|NCT01286012|2803655|P1|Overall Study|Withdrawal by Subject|4
879654|NCT01286012|2803654|P2|Overall Study|Protocol Violation|1
879655|NCT01286012|2803655|P1|Overall Study|Protocol Violation|1
879656|NCT01286012|2803654|P2|Overall Study|Death|3
879657|NCT01286012|2803655|P1|Overall Study|Death|2
879658|NCT01286012|2803654|P2|Overall Study|Adverse Event|3
879659|NCT01286012|2803655|P1|Overall Study|Adverse Event|3
879660|NCT01141712|2803663|P1|Overall Study|Disease progression|3
879661|NCT01120782|2803682|P1|Overall Study|Test article shipping error|11
879662|NCT01042535|2803699|P1|Overall Study|complications from other disease|2
879663|NCT01042535|2803699|P1|Overall Study|disease progression during treatment|3
879664|NCT01042535|2803699|P1|Overall Study|disease progression prior to treatment|3
879665|NCT01002742|2803709|P2|Overall Study|Determined to be ineligible|1
879666|NCT01002742|2803710|P1|Overall Study|Determined to be ineligible|0
879667|NCT00912223|2803744|P1|Overall Study|Transformed disease|1
879668|NCT00912223|2803744|P1|Overall Study|Not transplanted|1
879669|NCT00912223|2803744|P1|Overall Study|Withdrawal by Subject|1
879688|NCT00864227|2803863|P1|Overall Study|Disease Relapse/Progression|3
879689|NCT00864227|2803863|P1|Overall Study|Withdrawal by Subject|1
879690|NCT00694551|2803897|P3|Overall Study|Disease Progression|1
879691|NCT00694551|2803898|P2|Overall Study|Disease Progression|0
879692|NCT00694551|2803899|P1|Overall Study|Disease Progression|1
879693|NCT00678301|2803915|P2|Overall Study|Lost to Follow-up|1
879694|NCT00678301|2803916|P1|Overall Study|Lost to Follow-up|3
879695|NCT00678301|2803915|P2|Overall Study|Withdrawal by Subject|0
879696|NCT00678301|2803916|P1|Overall Study|Withdrawal by Subject|4
879697|NCT00678301|2803915|P2|Overall Study|Adverse Event|0
879698|NCT00678301|2803916|P1|Overall Study|Adverse Event|1
879699|NCT00678301|2803915|P2|Overall Study|Non-compliance with study procedures|1
879700|NCT00678301|2803916|P1|Overall Study|Non-compliance with study procedures|0
879701|NCT00581308|2803972|P1|Month 12|Other|3
879702|NCT00581308|2803972|P1|Month 12|Device Removed|1
879703|NCT00581308|2803972|P1|Month 12|Withdrawal by Subject|2
879704|NCT00581308|2803972|P1|Month 12|Lost to Follow-up|14
879705|NCT00581308|2803972|P1|Month 12|Death|1
879706|NCT00581308|2803972|P1|Month 6|Withdrawal by Subject|4
879707|NCT00581308|2803972|P1|Month 6|Lost to Follow-up|1
879708|NCT00581308|2803972|P1|Month 1|Device Removed|2
879709|NCT00581308|2803972|P1|Month 1|Withdrawal by Subject|3
879710|NCT00581308|2803972|P1|Month 1|Lost to Follow-up|4
879711|NCT00581308|2803972|P1|Pre Discharge|Device Removed|1
879712|NCT00581308|2803972|P1|Pre Discharge|Lost to Follow-up|2
879713|NCT00554515|2803980|P1|Overall Study|Misc|15
879714|NCT00554515|2803980|P1|Overall Study|Other|1
879715|NCT00554515|2803980|P1|Overall Study|Achieved Stable Disease|7
879716|NCT00554515|2803980|P1|Overall Study|Death|2
879717|NCT00554515|2803980|P1|Overall Study|Adverse Event|9
879718|NCT00554515|2803980|P1|Overall Study|Withdrawal by Subject|11
879719|NCT00554515|2803980|P1|Overall Study|Physician Decision|18
879720|NCT00554515|2803980|P1|Overall Study|Disease progression|52
879721|NCT00554515|2803980|P1|Overall Study|Withdrawal by Subject|3
879722|NCT00326417|2804023|P4|Overall Study|Death|0
879723|NCT00326417|2804024|P3|Overall Study|Death|0
879724|NCT00326417|2804025|P2|Overall Study|Death|0
879725|NCT00326417|2804026|P1|Overall Study|Death|7
879726|NCT00326417|2804023|P4|Overall Study|Arm Closed|3
879727|NCT00326417|2804024|P3|Overall Study|Arm Closed|0
879728|NCT00326417|2804025|P2|Overall Study|Arm Closed|0
879729|NCT00326417|2804026|P1|Overall Study|Arm Closed|7
879730|NCT00326417|2804023|P4|Overall Study|Withdrawal by Subject|0
879731|NCT00326417|2804024|P3|Overall Study|Withdrawal by Subject|1
879732|NCT00326417|2804025|P2|Overall Study|Withdrawal by Subject|0
879733|NCT00326417|2804026|P1|Overall Study|Withdrawal by Subject|0
904829|NCT01687712|2876361|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
904830|NCT01687712|2876362|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
904831|NCT01687712|2876361|P2|Cycle 3|Ectopic Pregnancy|0
904832|NCT01687712|2876362|P1|Cycle 3|Ectopic Pregnancy|1
904833|NCT01687712|2876361|P2|Cycle 3|Early Pregnancy Loss|2
904834|NCT01687712|2876362|P1|Cycle 3|Early Pregnancy Loss|1
904835|NCT01687712|2876361|P2|Cycle 3|Not Biochemically Pregnant|22
904836|NCT01687712|2876362|P1|Cycle 3|Not Biochemically Pregnant|21
904837|NCT01687712|2876361|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
904838|NCT01687712|2876362|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
904839|NCT01687712|2876361|P2|Cycle 2|Still Birth|0
904840|NCT01687712|2876362|P1|Cycle 2|Still Birth|1
904841|NCT01687712|2876361|P2|Cycle 2|Ectopic Pregnancy|1
904842|NCT01687712|2876362|P1|Cycle 2|Ectopic Pregnancy|0
904843|NCT01687712|2876361|P2|Cycle 2|Early Pregnancy Loss|16
904844|NCT01687712|2876362|P1|Cycle 2|Early Pregnancy Loss|18
904845|NCT01687712|2876361|P2|Cycle 2|Not Biochemically Pregnant|77
904846|NCT01687712|2876362|P1|Cycle 2|Not Biochemically Pregnant|74
904847|NCT01687712|2876361|P2|Cycle 1|Lost to Follow-up|1
904848|NCT01687712|2876362|P1|Cycle 1|Lost to Follow-up|1
904849|NCT01687712|2876361|P2|Cycle 1|Intrauterine Fetal Death|1
904850|NCT01687712|2876362|P1|Cycle 1|Intrauterine Fetal Death|0
904851|NCT01687712|2876361|P2|Cycle 1|Abortion|0
904852|NCT01687712|2876362|P1|Cycle 1|Abortion|3
904853|NCT01687712|2876361|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
904854|NCT01687712|2876362|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
904855|NCT01687712|2876361|P2|Cycle 1|Heterotropic Pregnancy|0
904856|NCT01687712|2876362|P1|Cycle 1|Heterotropic Pregnancy|1
904857|NCT01687712|2876361|P2|Cycle 1|Ectopic Pregnancy|5
904858|NCT01687712|2876362|P1|Cycle 1|Ectopic Pregnancy|5
904859|NCT01687712|2876361|P2|Cycle 1|Early Pregnancy Loss|60
904860|NCT01687712|2876362|P1|Cycle 1|Early Pregnancy Loss|43
904861|NCT01687712|2876361|P2|Cycle 1|Not Biochemically Pregnant|348
904862|NCT01687712|2876362|P1|Cycle 1|Not Biochemically Pregnant|386
904863|NCT01670292|2876410|P1|Overall Study|Lost to Follow-up|14
904864|NCT01644500|2876451|P3|Overall Study|Physician Decision|1
904865|NCT01644500|2876452|P2|Overall Study|Physician Decision|1
904866|NCT01644500|2876453|P1|Overall Study|Physician Decision|1
904867|NCT01644500|2876451|P3|Overall Study|Withdrawal by Subject|12
904868|NCT01644500|2876452|P2|Overall Study|Withdrawal by Subject|12
904869|NCT01644500|2876453|P1|Overall Study|Withdrawal by Subject|11
904870|NCT01644500|2876451|P3|Overall Study|Protocol Violation|0
904871|NCT01644500|2876452|P2|Overall Study|Protocol Violation|1
904872|NCT01644500|2876453|P1|Overall Study|Protocol Violation|1
904873|NCT01644500|2876451|P3|Overall Study|Lost to Follow-up|0
904874|NCT01644500|2876452|P2|Overall Study|Lost to Follow-up|8
904875|NCT01644500|2876453|P1|Overall Study|Lost to Follow-up|3
904876|NCT01644500|2876451|P3|Overall Study|Death|0
904877|NCT01644500|2876452|P2|Overall Study|Death|1
904878|NCT01644500|2876453|P1|Overall Study|Death|0
904879|NCT01644500|2876451|P3|Overall Study|Adverse Event|2
904880|NCT01644500|2876452|P2|Overall Study|Adverse Event|1
904881|NCT01644500|2876453|P1|Overall Study|Adverse Event|6
904882|NCT01592240|2876542|P7|Overall Study|Did Not Meet Entrance Criteria|0
904883|NCT01592240|2876543|P6|Overall Study|Did Not Meet Entrance Criteria|0
904884|NCT01592240|2876544|P5|Overall Study|Did Not Meet Entrance Criteria|0
904885|NCT01592240|2876545|P4|Overall Study|Did Not Meet Entrance Criteria|0
904886|NCT01592240|2876546|P3|Overall Study|Did Not Meet Entrance Criteria|1
904887|NCT01592240|2876547|P2|Overall Study|Did Not Meet Entrance Criteria|0
904888|NCT01592240|2876548|P1|Overall Study|Did Not Meet Entrance Criteria|1
904889|NCT01592240|2876542|P7|Overall Study|Other|1
904890|NCT01592240|2876543|P6|Overall Study|Other|0
904891|NCT01592240|2876544|P5|Overall Study|Other|0
904892|NCT01592240|2876545|P4|Overall Study|Other|1
904893|NCT01592240|2876546|P3|Overall Study|Other|1
904894|NCT01592240|2876547|P2|Overall Study|Other|3
904895|NCT01592240|2876548|P1|Overall Study|Other|0
904896|NCT01592240|2876542|P7|Overall Study|Withdrawal by Subject|2
904897|NCT01592240|2876543|P6|Overall Study|Withdrawal by Subject|0
904898|NCT01592240|2876544|P5|Overall Study|Withdrawal by Subject|3
904899|NCT01592240|2876545|P4|Overall Study|Withdrawal by Subject|1
904900|NCT01592240|2876546|P3|Overall Study|Withdrawal by Subject|4
904901|NCT01592240|2876547|P2|Overall Study|Withdrawal by Subject|4
904902|NCT01592240|2876548|P1|Overall Study|Withdrawal by Subject|0
904903|NCT01592240|2876542|P7|Overall Study|Protocol Violation|0
904904|NCT01592240|2876543|P6|Overall Study|Protocol Violation|1
904905|NCT01592240|2876544|P5|Overall Study|Protocol Violation|0
904906|NCT01592240|2876545|P4|Overall Study|Protocol Violation|0
904907|NCT01592240|2876546|P3|Overall Study|Protocol Violation|0
904908|NCT01592240|2876547|P2|Overall Study|Protocol Violation|0
904909|NCT01592240|2876548|P1|Overall Study|Protocol Violation|0
904910|NCT01592240|2876542|P7|Overall Study|Lost to Follow-up|0
904911|NCT01592240|2876543|P6|Overall Study|Lost to Follow-up|2
904912|NCT01592240|2876544|P5|Overall Study|Lost to Follow-up|3
904913|NCT01592240|2876545|P4|Overall Study|Lost to Follow-up|0
904914|NCT01592240|2876546|P3|Overall Study|Lost to Follow-up|1
904915|NCT01592240|2876547|P2|Overall Study|Lost to Follow-up|3
904916|NCT01592240|2876548|P1|Overall Study|Lost to Follow-up|1
904917|NCT01592240|2876542|P7|Overall Study|Death|0
904918|NCT01592240|2876543|P6|Overall Study|Death|0
904919|NCT01592240|2876544|P5|Overall Study|Death|0
904920|NCT01592240|2876545|P4|Overall Study|Death|0
904921|NCT01592240|2876546|P3|Overall Study|Death|0
904922|NCT01592240|2876547|P2|Overall Study|Death|1
904923|NCT01592240|2876548|P1|Overall Study|Death|0
904924|NCT01592240|2876542|P7|Overall Study|Adverse Event|0
904925|NCT01592240|2876543|P6|Overall Study|Adverse Event|0
904926|NCT01592240|2876544|P5|Overall Study|Adverse Event|1
904927|NCT01592240|2876545|P4|Overall Study|Adverse Event|1
904928|NCT01592240|2876546|P3|Overall Study|Adverse Event|0
904929|NCT01592240|2876547|P2|Overall Study|Adverse Event|0
904930|NCT01592240|2876548|P1|Overall Study|Adverse Event|1
904931|NCT01581619|2876737|P1|Overall Study|Lost to Follow-up|1
904932|NCT01581619|2876737|P1|Overall Study|Withdrawal by Subject|1
904933|NCT01552694|2876747|P2|Overall Study|Protocol Violation|1
904934|NCT01552694|2876748|P1|Overall Study|Protocol Violation|0
904935|NCT01552694|2876747|P2|Overall Study|Lost to Follow-up|1
904936|NCT01552694|2876748|P1|Overall Study|Lost to Follow-up|0
904937|NCT01435265|2876786|P2|Overall Study|Lost to Follow-up|1
904938|NCT01435265|2876787|P1|Overall Study|Lost to Follow-up|0
904951|NCT01416389|2876856|P2|Overall Study|Started New Therapy|0
904952|NCT01416389|2876857|P1|Overall Study|Started New Therapy|2
904953|NCT01416389|2876856|P2|Overall Study|Lost to Follow-up|0
904954|NCT01416389|2876857|P1|Overall Study|Lost to Follow-up|1
904959|NCT01346189|2876937|P4|Overall Study|Travel|3
904960|NCT01346189|2876938|P3|Overall Study|Travel|0
904961|NCT01346189|2876939|P2|Overall Study|Travel|0
904962|NCT01346189|2876940|P1|Overall Study|Travel|0
904963|NCT01346189|2876937|P4|Overall Study|Non-health system primary care physician|0
904964|NCT01346189|2876938|P3|Overall Study|Non-health system primary care physician|0
904965|NCT01346189|2876939|P2|Overall Study|Non-health system primary care physician|5
904966|NCT01346189|2876940|P1|Overall Study|Non-health system primary care physician|0
904967|NCT01346189|2876937|P4|Overall Study|Death|0
904968|NCT01346189|2876938|P3|Overall Study|Death|0
904969|NCT01346189|2876939|P2|Overall Study|Death|3
904970|NCT01346189|2876940|P1|Overall Study|Death|0
904971|NCT01346189|2876937|P4|Overall Study|Other|3
904972|NCT01346189|2876938|P3|Overall Study|Other|7
904973|NCT01346189|2876939|P2|Overall Study|Other|4
904974|NCT01346189|2876940|P1|Overall Study|Other|2
904975|NCT01346189|2876937|P4|Overall Study|Moved|0
904976|NCT01346189|2876938|P3|Overall Study|Moved|4
904977|NCT01346189|2876939|P2|Overall Study|Moved|0
904978|NCT01346189|2876940|P1|Overall Study|Moved|3
904979|NCT01346189|2876937|P4|Overall Study|Physician Decision|0
904980|NCT01346189|2876938|P3|Overall Study|Physician Decision|0
904981|NCT01346189|2876939|P2|Overall Study|Physician Decision|0
904982|NCT01346189|2876940|P1|Overall Study|Physician Decision|4
904983|NCT01346189|2876937|P4|Overall Study|Withdrawal by Subject|5
904984|NCT01346189|2876938|P3|Overall Study|Withdrawal by Subject|3
904985|NCT01346189|2876939|P2|Overall Study|Withdrawal by Subject|5
904986|NCT01346189|2876940|P1|Overall Study|Withdrawal by Subject|7
905015|NCT01343368|2876992|P2|Overall Study|Lost to Follow-up|0
905016|NCT01343368|2876993|P1|Overall Study|Lost to Follow-up|1
905017|NCT01343368|2876992|P2|Overall Study|Death|0
905018|NCT01343368|2876993|P1|Overall Study|Death|1
905034|NCT01327547|2877093|P2|Overall Study|By investigator in subject’s interest|1
905035|NCT01327547|2877094|P1|Overall Study|By investigator in subject’s interest|0
905036|NCT01327547|2877093|P2|Overall Study|Non-compliance with study procedures|0
905037|NCT01327547|2877094|P1|Overall Study|Non-compliance with study procedures|1
905038|NCT01327547|2877093|P2|Overall Study|Required prohibited medication|0
905039|NCT01327547|2877094|P1|Overall Study|Required prohibited medication|2
905040|NCT01327547|2877093|P2|Overall Study|Non-compliance due to alcohol intake|1
905041|NCT01327547|2877094|P1|Overall Study|Non-compliance due to alcohol intake|0
905042|NCT01327547|2877093|P2|Overall Study|Protocol Violation|0
905043|NCT01327547|2877094|P1|Overall Study|Protocol Violation|1
905044|NCT01327547|2877093|P2|Overall Study|Does Not Meet Entrance Criteria|2
905045|NCT01327547|2877094|P1|Overall Study|Does Not Meet Entrance Criteria|2
905046|NCT01327547|2877093|P2|Overall Study|Withdrawal by Subject|7
905047|NCT01327547|2877094|P1|Overall Study|Withdrawal by Subject|3
905048|NCT01327547|2877093|P2|Overall Study|Non-Compliance With Study Treatment|2
905049|NCT01327547|2877094|P1|Overall Study|Non-Compliance With Study Treatment|0
905050|NCT01327547|2877093|P2|Overall Study|Lost to Follow-up|6
905051|NCT01327547|2877094|P1|Overall Study|Lost to Follow-up|6
905052|NCT01327547|2877093|P2|Overall Study|Death|2
905053|NCT01327547|2877094|P1|Overall Study|Death|1
905054|NCT01327547|2877093|P2|Overall Study|Adverse Event|1
905055|NCT01327547|2877094|P1|Overall Study|Adverse Event|4
905062|NCT01310699|2877253|P2|Overall Study|Patients did not complete tandem.|6
905063|NCT01310699|2877254|P1|Overall Study|Patients did not complete tandem.|4
905080|NCT01243762|2877328|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
905081|NCT01243762|2877329|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
905082|NCT01243762|2877330|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
905083|NCT01243762|2877331|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
905084|NCT01243762|2877332|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
905085|NCT01243762|2877333|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
905086|NCT01243762|2877334|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
905087|NCT01243762|2877328|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
905088|NCT01243762|2877329|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
905089|NCT01243762|2877330|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
905090|NCT01243762|2877331|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
905091|NCT01243762|2877332|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
905092|NCT01243762|2877333|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
905093|NCT01243762|2877334|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
905094|NCT01243762|2877328|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
905095|NCT01243762|2877329|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
905096|NCT01243762|2877330|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
905097|NCT01243762|2877331|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
905098|NCT01243762|2877332|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
905099|NCT01243762|2877333|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
905100|NCT01243762|2877334|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
905101|NCT01243762|2877328|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
905102|NCT01243762|2877329|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
905103|NCT01243762|2877330|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
905104|NCT01243762|2877331|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
905105|NCT01243762|2877332|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
905106|NCT01243762|2877333|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
905107|NCT01243762|2877334|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
905108|NCT01243762|2877328|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905109|NCT01243762|2877329|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905110|NCT01243762|2877330|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905111|NCT01243762|2877331|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905112|NCT01243762|2877332|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905113|NCT01243762|2877333|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
905114|NCT01243762|2877334|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
905115|NCT01243762|2877328|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
905116|NCT01243762|2877329|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
905117|NCT01243762|2877330|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
905118|NCT01243762|2877331|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
905119|NCT01243762|2877332|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
905120|NCT01243762|2877333|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
905121|NCT01243762|2877334|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
905122|NCT01243762|2877328|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
905123|NCT01243762|2877329|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
905124|NCT01243762|2877330|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
905125|NCT01243762|2877331|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
905126|NCT01243762|2877332|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
905127|NCT01243762|2877333|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
905128|NCT01243762|2877334|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
905129|NCT01243762|2877328|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
905130|NCT01243762|2877329|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
905131|NCT01243762|2877330|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
905132|NCT01243762|2877331|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
905133|NCT01243762|2877332|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
905134|NCT01243762|2877333|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
905135|NCT01243762|2877334|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
905146|NCT01221753|2877469|P1|Overall Study|Adverse Event|1
905147|NCT01209078|2877476|P2|Overall Study|Withdrawal by Subject|1
905148|NCT01209078|2877477|P1|Overall Study|Withdrawal by Subject|2
905149|NCT01209078|2877476|P2|Overall Study|Physician Decision|2
905150|NCT01209078|2877477|P1|Overall Study|Physician Decision|5
905151|NCT01209078|2877476|P2|Overall Study|Lost to Follow-up|0
905152|NCT01209078|2877477|P1|Overall Study|Lost to Follow-up|4
905153|NCT01209078|2877476|P2|Overall Study|Adverse Event|0
905154|NCT01209078|2877477|P1|Overall Study|Adverse Event|5
905155|NCT01166438|2877575|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
905156|NCT01166438|2877576|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
905157|NCT01166438|2877575|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
905158|NCT01166438|2877576|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
905159|NCT01166438|2877575|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
905160|NCT01166438|2877576|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
905161|NCT01166438|2877575|P2|Double-blind Phase: 1st 6 Months|Not treated|1
905162|NCT01166438|2877576|P1|Double-blind Phase: 1st 6 Months|Not treated|1
905163|NCT01166438|2877575|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
905164|NCT01166438|2877576|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
905165|NCT01166438|2877575|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
905166|NCT01166438|2877576|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
905167|NCT01144377|2877595|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
905168|NCT01144377|2877596|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
905169|NCT01144377|2877597|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
905170|NCT01144377|2877598|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
905171|NCT01144377|2877599|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
905172|NCT01144377|2877595|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
905173|NCT01144377|2877596|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
905174|NCT01144377|2877597|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
905175|NCT01144377|2877598|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
905176|NCT01144377|2877599|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
905177|NCT01144377|2877595|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
905178|NCT01144377|2877596|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
905179|NCT01144377|2877597|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
905180|NCT01144377|2877598|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
905181|NCT01144377|2877599|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
905182|NCT01144377|2877595|P5|52 Week Treatment Period|Sponsor Decision|1
905183|NCT01144377|2877596|P4|52 Week Treatment Period|Sponsor Decision|0
905184|NCT01144377|2877597|P3|52 Week Treatment Period|Sponsor Decision|0
905185|NCT01144377|2877598|P2|52 Week Treatment Period|Sponsor Decision|0
905186|NCT01144377|2877599|P1|52 Week Treatment Period|Sponsor Decision|0
905187|NCT01144377|2877595|P5|52 Week Treatment Period|Withdrawal by Subject|0
905188|NCT01144377|2877596|P4|52 Week Treatment Period|Withdrawal by Subject|1
905189|NCT01144377|2877597|P3|52 Week Treatment Period|Withdrawal by Subject|1
905190|NCT01144377|2877598|P2|52 Week Treatment Period|Withdrawal by Subject|1
905191|NCT01144377|2877599|P1|52 Week Treatment Period|Withdrawal by Subject|4
905192|NCT01144377|2877595|P5|52 Week Treatment Period|Lost to Follow-up|0
905193|NCT01144377|2877596|P4|52 Week Treatment Period|Lost to Follow-up|0
905194|NCT01144377|2877597|P3|52 Week Treatment Period|Lost to Follow-up|0
905195|NCT01144377|2877598|P2|52 Week Treatment Period|Lost to Follow-up|0
905196|NCT01144377|2877599|P1|52 Week Treatment Period|Lost to Follow-up|1
905197|NCT01144377|2877595|P5|52 Week Treatment Period|Protocol Violation|1
905198|NCT01144377|2877596|P4|52 Week Treatment Period|Protocol Violation|0
905199|NCT01144377|2877597|P3|52 Week Treatment Period|Protocol Violation|0
905200|NCT01144377|2877598|P2|52 Week Treatment Period|Protocol Violation|0
905201|NCT01144377|2877599|P1|52 Week Treatment Period|Protocol Violation|0
905202|NCT01144377|2877595|P5|52 Week Treatment Period|Entry Criteria Not Met|0
905203|NCT01144377|2877596|P4|52 Week Treatment Period|Entry Criteria Not Met|1
905204|NCT01144377|2877597|P3|52 Week Treatment Period|Entry Criteria Not Met|1
905205|NCT01144377|2877598|P2|52 Week Treatment Period|Entry Criteria Not Met|0
905206|NCT01144377|2877599|P1|52 Week Treatment Period|Entry Criteria Not Met|0
905207|NCT01144377|2877595|P5|52 Week Treatment Period|Adverse Event|1
905208|NCT01144377|2877596|P4|52 Week Treatment Period|Adverse Event|2
905209|NCT01144377|2877597|P3|52 Week Treatment Period|Adverse Event|3
905210|NCT01144377|2877598|P2|52 Week Treatment Period|Adverse Event|0
905211|NCT01144377|2877599|P1|52 Week Treatment Period|Adverse Event|0
905212|NCT01132612|2877649|P3|Overall Study|Lack of Efficacy|73
905213|NCT01132612|2877650|P2|Overall Study|Lack of Efficacy|22
905214|NCT01132612|2877651|P1|Overall Study|Lack of Efficacy|23
905215|NCT01132612|2877649|P3|Overall Study|Administrative problems|52
905216|NCT01132612|2877650|P2|Overall Study|Administrative problems|1
905217|NCT01132612|2877651|P1|Overall Study|Administrative problems|5
905218|NCT01132612|2877649|P3|Overall Study|Withdrawal by Subject|19
905219|NCT01132612|2877650|P2|Overall Study|Withdrawal by Subject|8
905220|NCT01132612|2877651|P1|Overall Study|Withdrawal by Subject|5
905221|NCT01132612|2877649|P3|Overall Study|Adverse Event|15
905222|NCT01132612|2877650|P2|Overall Study|Adverse Event|2
905223|NCT01132612|2877651|P1|Overall Study|Adverse Event|5
905224|NCT01132612|2877649|P3|Overall Study|Lost to Follow-up|7
905225|NCT01132612|2877650|P2|Overall Study|Lost to Follow-up|2
905226|NCT01132612|2877651|P1|Overall Study|Lost to Follow-up|2
905227|NCT01132612|2877649|P3|Overall Study|Protocol deviation|3
905228|NCT01132612|2877650|P2|Overall Study|Protocol deviation|0
905229|NCT01132612|2877651|P1|Overall Study|Protocol deviation|0
905230|NCT01132612|2877649|P3|Overall Study|Death|1
905231|NCT01132612|2877650|P2|Overall Study|Death|0
905232|NCT01132612|2877651|P1|Overall Study|Death|0
905233|NCT01120600|2877667|P2|Overall Study|Withdrawal by Subject|11
905234|NCT01120600|2877668|P1|Overall Study|Withdrawal by Subject|10
905235|NCT01120600|2877667|P2|Overall Study|Protocol Violation|4
905236|NCT01120600|2877668|P1|Overall Study|Protocol Violation|0
905237|NCT01120600|2877667|P2|Overall Study|Physician Decision|3
905238|NCT01120600|2877668|P1|Overall Study|Physician Decision|1
905239|NCT01120600|2877667|P2|Overall Study|Lost to Follow-up|3
905240|NCT01120600|2877668|P1|Overall Study|Lost to Follow-up|1
905241|NCT01120600|2877667|P2|Overall Study|Excessive Bone Loss|4
905242|NCT01120600|2877668|P1|Overall Study|Excessive Bone Loss|0
905243|NCT01120600|2877667|P2|Overall Study|Adverse Event|7
905244|NCT01120600|2877668|P1|Overall Study|Adverse Event|7
905245|NCT01065454|2877718|P4|Follow up|study ongoing|41
905246|NCT01065454|2877719|P3|Follow up|study ongoing|15
905247|NCT01065454|2877720|P2|Follow up|study ongoing|22
905248|NCT01065454|2877721|P1|Follow up|study ongoing|37
905249|NCT01065454|2877718|P4|Follow up|Withdrawal by Subject|0
905250|NCT01065454|2877719|P3|Follow up|Withdrawal by Subject|1
905251|NCT01065454|2877720|P2|Follow up|Withdrawal by Subject|1
905252|NCT01065454|2877721|P1|Follow up|Withdrawal by Subject|1
905253|NCT01065454|2877718|P4|Follow up|Progressive disease|1
905254|NCT01065454|2877719|P3|Follow up|Progressive disease|0
905255|NCT01065454|2877720|P2|Follow up|Progressive disease|0
905256|NCT01065454|2877721|P1|Follow up|Progressive disease|0
905257|NCT01065454|2877718|P4|Follow up|Lost to Follow-up|1
905258|NCT01065454|2877719|P3|Follow up|Lost to Follow-up|0
905259|NCT01065454|2877720|P2|Follow up|Lost to Follow-up|0
905260|NCT01065454|2877721|P1|Follow up|Lost to Follow-up|0
905261|NCT01065454|2877718|P4|Follow up|Death|0
905262|NCT01065454|2877719|P3|Follow up|Death|1
905263|NCT01065454|2877720|P2|Follow up|Death|1
905264|NCT01065454|2877721|P1|Follow up|Death|0
905265|NCT01065454|2877718|P4|Follow up|Adverse Event|1
905266|NCT01065454|2877719|P3|Follow up|Adverse Event|0
905267|NCT01065454|2877720|P2|Follow up|Adverse Event|0
905268|NCT01065454|2877721|P1|Follow up|Adverse Event|1
905269|NCT01065454|2877718|P4|Treatment|Withdrawal by Subject|3
905270|NCT01065454|2877719|P3|Treatment|Withdrawal by Subject|2
905271|NCT01065454|2877720|P2|Treatment|Withdrawal by Subject|1
905272|NCT01065454|2877721|P1|Treatment|Withdrawal by Subject|3
905273|NCT01065454|2877718|P4|Treatment|Protocol Violation|0
905274|NCT01065454|2877719|P3|Treatment|Protocol Violation|1
905275|NCT01065454|2877720|P2|Treatment|Protocol Violation|0
905276|NCT01065454|2877721|P1|Treatment|Protocol Violation|1
905277|NCT01065454|2877718|P4|Treatment|Protocol Decision|2
905278|NCT01065454|2877719|P3|Treatment|Protocol Decision|3
905279|NCT01065454|2877720|P2|Treatment|Protocol Decision|0
905280|NCT01065454|2877721|P1|Treatment|Protocol Decision|0
905281|NCT01065454|2877718|P4|Treatment|Non-compliance|1
905282|NCT01065454|2877719|P3|Treatment|Non-compliance|0
905283|NCT01065454|2877720|P2|Treatment|Non-compliance|0
905284|NCT01065454|2877721|P1|Treatment|Non-compliance|1
905285|NCT01065454|2877718|P4|Treatment|Death|0
905286|NCT01065454|2877719|P3|Treatment|Death|0
905287|NCT01065454|2877720|P2|Treatment|Death|0
905288|NCT01065454|2877721|P1|Treatment|Death|1
905289|NCT01065454|2877718|P4|Treatment|Adverse Event|6
905290|NCT01065454|2877719|P3|Treatment|Adverse Event|3
905291|NCT01065454|2877720|P2|Treatment|Adverse Event|4
905292|NCT01065454|2877721|P1|Treatment|Adverse Event|7
905293|NCT01059643|2877831|P1|Overall Study|Physician Decision|1
905294|NCT01059643|2877831|P1|Overall Study|Withdrawal by Subject|2
905295|NCT01059643|2877831|P1|Overall Study|Adverse Event|3
905296|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Other|3
905297|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Other|0
905298|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
905299|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
905300|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Death|2
905301|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Death|0
905302|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
905303|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
905304|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
905305|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
905306|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
905307|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
905308|NCT01059630|2877846|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
905309|NCT01059630|2877847|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
905310|NCT01059630|2877846|P2|Induction Period (6 Months)|Randomized but not Treated|0
905311|NCT01059630|2877847|P1|Induction Period (6 Months)|Randomized but not Treated|4
905312|NCT01059630|2877846|P2|Induction Period (6 Months)|Other|0
905313|NCT01059630|2877847|P1|Induction Period (6 Months)|Other|1
905314|NCT01059630|2877846|P2|Induction Period (6 Months)|Physician Decision|4
905315|NCT01059630|2877847|P1|Induction Period (6 Months)|Physician Decision|2
905316|NCT01059630|2877846|P2|Induction Period (6 Months)|Death|2
905317|NCT01059630|2877847|P1|Induction Period (6 Months)|Death|2
905318|NCT01059630|2877846|P2|Induction Period (6 Months)|Withdrawal by Subject|2
905319|NCT01059630|2877847|P1|Induction Period (6 Months)|Withdrawal by Subject|7
905320|NCT01059630|2877846|P2|Induction Period (6 Months)|Progressive Disease|9
905321|NCT01059630|2877847|P1|Induction Period (6 Months)|Progressive Disease|14
905322|NCT01059630|2877846|P2|Induction Period (6 Months)|Adverse Event|15
905323|NCT01059630|2877847|P1|Induction Period (6 Months)|Adverse Event|30
905324|NCT01059630|2877846|P2|Induction Period (6 Months)|Induction ongoing|6
905325|NCT01059630|2877847|P1|Induction Period (6 Months)|Induction ongoing|13
905326|NCT01051557|2877910|P7|Overall Study|Adverse Event|4
905327|NCT01051557|2877911|P6|Overall Study|Adverse Event|3
905328|NCT01051557|2877912|P5|Overall Study|Adverse Event|1
905329|NCT01051557|2877913|P4|Overall Study|Adverse Event|1
905330|NCT01051557|2877914|P3|Overall Study|Adverse Event|0
905331|NCT01051557|2877915|P2|Overall Study|Adverse Event|0
905332|NCT01051557|2877916|P1|Overall Study|Adverse Event|0
905333|NCT01051557|2877910|P7|Overall Study|Withdrawal by Subject|1
905334|NCT01051557|2877911|P6|Overall Study|Withdrawal by Subject|0
905335|NCT01051557|2877912|P5|Overall Study|Withdrawal by Subject|2
905336|NCT01051557|2877913|P4|Overall Study|Withdrawal by Subject|0
905337|NCT01051557|2877914|P3|Overall Study|Withdrawal by Subject|1
905338|NCT01051557|2877915|P2|Overall Study|Withdrawal by Subject|0
905339|NCT01051557|2877916|P1|Overall Study|Withdrawal by Subject|0
905340|NCT01051557|2877910|P7|Overall Study|disease progression|1
905341|NCT01051557|2877911|P6|Overall Study|disease progression|3
905342|NCT01051557|2877912|P5|Overall Study|disease progression|4
905343|NCT01051557|2877913|P4|Overall Study|disease progression|2
905344|NCT01051557|2877914|P3|Overall Study|disease progression|5
905345|NCT01051557|2877915|P2|Overall Study|disease progression|3
905346|NCT01051557|2877916|P1|Overall Study|disease progression|3
905347|NCT01051557|2877910|P7|Overall Study|Physician Decision|0
905348|NCT01051557|2877911|P6|Overall Study|Physician Decision|0
905349|NCT01051557|2877912|P5|Overall Study|Physician Decision|0
905350|NCT01051557|2877913|P4|Overall Study|Physician Decision|0
905351|NCT01051557|2877914|P3|Overall Study|Physician Decision|0
905352|NCT01051557|2877915|P2|Overall Study|Physician Decision|0
905353|NCT01051557|2877916|P1|Overall Study|Physician Decision|1
905354|NCT01025284|2877954|P3|Overall Study|Withdrawal by Subject|0
905355|NCT01025284|2877955|P2|Overall Study|Withdrawal by Subject|1
905356|NCT01025284|2877956|P1|Overall Study|Withdrawal by Subject|0
905357|NCT01025284|2877954|P3|Overall Study|Investigator Decision|0
905358|NCT01025284|2877955|P2|Overall Study|Investigator Decision|1
905359|NCT01025284|2877956|P1|Overall Study|Investigator Decision|0
905374|NCT01014533|2878001|P2|Overall Study|unable to come to appointment|3
905375|NCT01014533|2878002|P1|Overall Study|unable to come to appointment|0
905376|NCT01014533|2878001|P2|Overall Study|Withdrawal by Subject|0
905377|NCT01014533|2878002|P1|Overall Study|Withdrawal by Subject|2
905378|NCT01014533|2878001|P2|Overall Study|Protocol Violation|2
905379|NCT01014533|2878002|P1|Overall Study|Protocol Violation|3
905380|NCT01010204|2878019|P2|Overall Study|psychiatric hospitalization|1
905381|NCT01010204|2878020|P1|Overall Study|psychiatric hospitalization|2
905382|NCT01010204|2878019|P2|Overall Study|Withdrawal by Subject|3
905383|NCT01010204|2878020|P1|Overall Study|Withdrawal by Subject|2
905384|NCT01010204|2878019|P2|Overall Study|Adverse Event|3
905385|NCT01010204|2878020|P1|Overall Study|Adverse Event|1
905386|NCT01010204|2878019|P2|Overall Study|Lost to Follow-up|2
905387|NCT01010204|2878020|P1|Overall Study|Lost to Follow-up|2
905388|NCT00984282|2878032|P2|Long Term Follow-up|Ongoing with treatment|26
905389|NCT00984282|2878033|P1|Long Term Follow-up|Ongoing with treatment|33
905390|NCT00984282|2878032|P2|Long Term Follow-up|Lost to Follow-up|4
905391|NCT00984282|2878033|P1|Long Term Follow-up|Lost to Follow-up|8
905392|NCT00984282|2878032|P2|Long Term Follow-up|Death|72
905393|NCT00984282|2878033|P1|Long Term Follow-up|Death|55
905394|NCT00984282|2878032|P2|Long Term Follow-up|Withdrawal by Subject|15
905395|NCT00984282|2878033|P1|Long Term Follow-up|Withdrawal by Subject|18
905396|NCT00984282|2878032|P2|Open-label Treatment|Target lesion removed|1
905397|NCT00984282|2878033|P1|Open-label Treatment|Target lesion removed|0
905398|NCT00984282|2878032|P2|Open-label Treatment|Non-compliant with study medication|0
905399|NCT00984282|2878033|P1|Open-label Treatment|Non-compliant with study medication|1
905400|NCT00984282|2878032|P2|Open-label Treatment|Ongoing with treatment|18
905401|NCT00984282|2878033|P1|Open-label Treatment|Ongoing with treatment|19
905402|NCT00984282|2878032|P2|Open-label Treatment|Lost to Follow-up|0
905403|NCT00984282|2878033|P1|Open-label Treatment|Lost to Follow-up|1
905404|NCT00984282|2878032|P2|Open-label Treatment|Progression, recurrence or relapse|77
905405|NCT00984282|2878033|P1|Open-label Treatment|Progression, recurrence or relapse|37
905406|NCT00984282|2878032|P2|Open-label Treatment|Death|15
905407|NCT00984282|2878033|P1|Open-label Treatment|Death|5
905408|NCT00984282|2878032|P2|Open-label Treatment|Withdrawal by Subject|21
905409|NCT00984282|2878033|P1|Open-label Treatment|Withdrawal by Subject|6
905410|NCT00984282|2878032|P2|Open-label Treatment|Adverse Event|29
905411|NCT00984282|2878033|P1|Open-label Treatment|Adverse Event|17
905412|NCT00984282|2878032|P2|Double Blind Treatment|Switched to follow-up|4
905413|NCT00984282|2878033|P1|Double Blind Treatment|Switched to follow-up|12
905414|NCT00984282|2878032|P2|Double Blind Treatment|Not treated|1
905415|NCT00984282|2878033|P1|Double Blind Treatment|Not treated|0
905416|NCT00984282|2878032|P2|Double Blind Treatment|Death|4
905417|NCT00984282|2878033|P1|Double Blind Treatment|Death|8
905418|NCT00984282|2878032|P2|Double Blind Treatment|Lost to Follow-up|0
905419|NCT00984282|2878033|P1|Double Blind Treatment|Lost to Follow-up|3
905420|NCT00984282|2878032|P2|Double Blind Treatment|Withdrawal by Subject|18
905421|NCT00984282|2878033|P1|Double Blind Treatment|Withdrawal by Subject|14
905422|NCT00984282|2878032|P2|Double Blind Treatment|Progression by clinical judgment|0
905423|NCT00984282|2878033|P1|Double Blind Treatment|Progression by clinical judgment|1
905424|NCT00984282|2878032|P2|Double Blind Treatment|Noncompliance with study medication|0
905425|NCT00984282|2878033|P1|Double Blind Treatment|Noncompliance with study medication|3
905426|NCT00984282|2878032|P2|Double Blind Treatment|Physician Decision|2
905427|NCT00984282|2878033|P1|Double Blind Treatment|Physician Decision|1
905428|NCT00984282|2878032|P2|Double Blind Treatment|Progression, recurrence or relapse|3
905429|NCT00984282|2878033|P1|Double Blind Treatment|Progression, recurrence or relapse|24
905430|NCT00984282|2878032|P2|Double Blind Treatment|Adverse Event|6
905431|NCT00984282|2878033|P1|Double Blind Treatment|Adverse Event|38
905432|NCT00965718|2878054|P1|Overall Study|Withdrawal by Subject|4
905433|NCT00940888|2878064|P1|Overall Study|Lost to Follow-up|6
905434|NCT00940888|2878064|P1|Overall Study|Withdrawn - Non-Death|364
905435|NCT00940888|2878064|P1|Overall Study|Death|461
905436|NCT00940888|2878064|P1|Overall Study|Unsuccessful Implant|4
905437|NCT00931632|2878071|P2|Overall Study|Adverse Event|15
905438|NCT00931632|2878072|P1|Overall Study|Adverse Event|19
905439|NCT00931632|2878071|P2|Overall Study|Withdrawal by Subject|3
905440|NCT00931632|2878072|P1|Overall Study|Withdrawal by Subject|2
905441|NCT00920426|2878095|P4|ITZ111451|Adverse Event|0
905442|NCT00920426|2878096|P3|ITZ111451|Adverse Event|0
905443|NCT00920426|2878097|P2|ITZ111451|Adverse Event|0
905444|NCT00920426|2878098|P1|ITZ111451|Adverse Event|1
905463|NCT00901901|2878262|P2|Follow-up Period|Lost to Follow-up|8
905464|NCT00901901|2878263|P1|Follow-up Period|Lost to Follow-up|12
905465|NCT00901901|2878262|P2|Follow-up Period|Withdrawal by Subject|9
905466|NCT00901901|2878263|P1|Follow-up Period|Withdrawal by Subject|6
905467|NCT00901901|2878262|P2|Follow-up Period|Protocol driven decision point|35
905468|NCT00901901|2878263|P1|Follow-up Period|Protocol driven decision point|47
905469|NCT00901901|2878262|P2|Follow-up Period|Death|207
905470|NCT00901901|2878263|P1|Follow-up Period|Death|181
905471|NCT00901901|2878262|P2|Treatment Period|Never treated|3
905472|NCT00901901|2878263|P1|Treatment Period|Never treated|0
905473|NCT00901901|2878262|P2|Treatment Period|Missing|1
905474|NCT00901901|2878263|P1|Treatment Period|Missing|1
905475|NCT00901901|2878262|P2|Treatment Period|Protocol Violation|9
905476|NCT00901901|2878263|P1|Treatment Period|Protocol Violation|4
905477|NCT00901901|2878262|P2|Treatment Period|Noncompliance with study medication|1
905478|NCT00901901|2878263|P1|Treatment Period|Noncompliance with study medication|4
905479|NCT00901901|2878262|P2|Treatment Period|Lost to Follow-up|5
905480|NCT00901901|2878263|P1|Treatment Period|Lost to Follow-up|3
905481|NCT00901901|2878262|P2|Treatment Period|Physician Decision|2
905482|NCT00901901|2878263|P1|Treatment Period|Physician Decision|2
905483|NCT00901901|2878262|P2|Treatment Period|Withdrawal by Subject|24
905484|NCT00901901|2878263|P1|Treatment Period|Withdrawal by Subject|26
905485|NCT00901901|2878262|P2|Treatment Period|Adverse Event|123
905486|NCT00901901|2878263|P1|Treatment Period|Adverse Event|117
905487|NCT00888173|2878283|P1|Overall Study|Ineligible: required test not done|1
905488|NCT00888173|2878283|P1|Overall Study|Wrong Primary|1
905489|NCT00869323|2878322|P1|Maintenance Therapy|concurrent illness|1
905490|NCT00867087|2878330|P1|Overall Study|Death|37
905491|NCT00867087|2878330|P1|Overall Study|Withdrawal by Subject|4
905492|NCT00867087|2878330|P1|Overall Study|Other|1
905493|NCT00863057|2878348|P4|Period 2 (Weeks 6-10)|Physician Decision|1
905494|NCT00863057|2878349|P3|Period 2 (Weeks 6-10)|Physician Decision|0
905495|NCT00863057|2878350|P2|Period 2 (Weeks 6-10)|Physician Decision|0
905496|NCT00863057|2878351|P1|Period 2 (Weeks 6-10)|Physician Decision|0
905497|NCT00863057|2878348|P4|Period 2 (Weeks 6-10)|Adverse Event|0
905498|NCT00863057|2878349|P3|Period 2 (Weeks 6-10)|Adverse Event|1
905499|NCT00863057|2878350|P2|Period 2 (Weeks 6-10)|Adverse Event|1
905500|NCT00863057|2878351|P1|Period 2 (Weeks 6-10)|Adverse Event|0
905501|NCT00863057|2878348|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
905502|NCT00863057|2878349|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
905503|NCT00863057|2878350|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
905504|NCT00863057|2878351|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
905505|NCT00863057|2878348|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
905506|NCT00863057|2878349|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
905507|NCT00863057|2878350|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
905508|NCT00863057|2878351|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
905509|NCT00851591|2878401|P2|Overall Study|Withdrawal by Subject|0
905510|NCT00851591|2878402|P1|Overall Study|Withdrawal by Subject|2
905511|NCT00825175|2878423|P2|Overall Study|Withdrawal by Subject|5
905512|NCT00825175|2878424|P1|Overall Study|Withdrawal by Subject|0
905513|NCT00820898|2878439|P1|Overall Study|Inelgible - wrong primary site|1
905514|NCT00818779|2878451|P2|Overall Study|Adverse Event|1
905515|NCT00818779|2878452|P1|Overall Study|Adverse Event|4
905516|NCT00818779|2878451|P2|Overall Study|Lost to Follow-up|0
905517|NCT00818779|2878452|P1|Overall Study|Lost to Follow-up|1
905518|NCT00818779|2878451|P2|Overall Study|Protocol Violation|0
905519|NCT00818779|2878452|P1|Overall Study|Protocol Violation|1
905527|NCT00783705|2878506|P2|Overall Study|Lost to Follow-up|3
905528|NCT00783705|2878507|P1|Overall Study|Lost to Follow-up|1
905529|NCT00783705|2878506|P2|Overall Study|Withdrawal by Subject|2
905530|NCT00783705|2878507|P1|Overall Study|Withdrawal by Subject|3
905531|NCT00783705|2878506|P2|Overall Study|Adverse Event|0
905532|NCT00783705|2878507|P1|Overall Study|Adverse Event|2
905533|NCT00737529|2878643|P1|Overall Study|Other|2
905534|NCT00737529|2878643|P1|Overall Study|Protocol Violation|1
905535|NCT00737529|2878643|P1|Overall Study|Death|3
905536|NCT00737529|2878643|P1|Overall Study|Withdrawal by Subject|3
905537|NCT00737529|2878643|P1|Overall Study|Adverse Event|23
905538|NCT00737529|2878643|P1|Overall Study|Disease Progression|80
905544|NCT00733304|2878681|P3|Overall Study|Withdrawal by Subject|0
905545|NCT00733304|2878682|P2|Overall Study|Withdrawal by Subject|1
905546|NCT00733304|2878683|P1|Overall Study|Withdrawal by Subject|1
905547|NCT00733304|2878681|P3|Overall Study|Physician Decision|3
905548|NCT00733304|2878682|P2|Overall Study|Physician Decision|1
905549|NCT00733304|2878683|P1|Overall Study|Physician Decision|3
905550|NCT00733304|2878681|P3|Overall Study|Lost to Follow-up|0
905551|NCT00733304|2878682|P2|Overall Study|Lost to Follow-up|1
905552|NCT00733304|2878683|P1|Overall Study|Lost to Follow-up|0
905553|NCT00733304|2878681|P3|Overall Study|Lack of Efficacy|2
905554|NCT00733304|2878682|P2|Overall Study|Lack of Efficacy|0
905555|NCT00733304|2878683|P1|Overall Study|Lack of Efficacy|0
905556|NCT00733304|2878681|P3|Overall Study|Adverse Event|0
905557|NCT00733304|2878682|P2|Overall Study|Adverse Event|0
905558|NCT00733304|2878683|P1|Overall Study|Adverse Event|3
905559|NCT00718718|2878770|P10|Week 12 to End of Study|Other|0
905560|NCT00718718|2878771|P9|Week 12 to End of Study|Other|0
905561|NCT00718718|2878772|P8|Week 12 to End of Study|Other|0
905562|NCT00718718|2878773|P7|Week 12 to End of Study|Other|1
905563|NCT00718718|2878774|P6|Week 12 to End of Study|Other|0
905564|NCT00718718|2878775|P5|Week 12 to End of Study|Other|0
905565|NCT00718718|2878776|P4|Week 12 to End of Study|Other|1
905566|NCT00718718|2878777|P3|Week 12 to End of Study|Other|0
905567|NCT00718718|2878778|P2|Week 12 to End of Study|Other|1
905568|NCT00718718|2878779|P1|Week 12 to End of Study|Other|0
905569|NCT00718718|2878770|P10|Week 12 to End of Study|Lost to Follow-up|0
905570|NCT00718718|2878771|P9|Week 12 to End of Study|Lost to Follow-up|1
905571|NCT00718718|2878772|P8|Week 12 to End of Study|Lost to Follow-up|0
905572|NCT00718718|2878773|P7|Week 12 to End of Study|Lost to Follow-up|0
905573|NCT00718718|2878774|P6|Week 12 to End of Study|Lost to Follow-up|0
905574|NCT00718718|2878775|P5|Week 12 to End of Study|Lost to Follow-up|0
905575|NCT00718718|2878776|P4|Week 12 to End of Study|Lost to Follow-up|0
905576|NCT00718718|2878777|P3|Week 12 to End of Study|Lost to Follow-up|0
905577|NCT00718718|2878778|P2|Week 12 to End of Study|Lost to Follow-up|0
905578|NCT00718718|2878779|P1|Week 12 to End of Study|Lost to Follow-up|0
905579|NCT00718718|2878770|P10|Week 12 to End of Study|Withdrawal by Subject|0
905580|NCT00718718|2878771|P9|Week 12 to End of Study|Withdrawal by Subject|0
905581|NCT00718718|2878772|P8|Week 12 to End of Study|Withdrawal by Subject|0
905582|NCT00718718|2878773|P7|Week 12 to End of Study|Withdrawal by Subject|1
905583|NCT00718718|2878774|P6|Week 12 to End of Study|Withdrawal by Subject|2
905584|NCT00718718|2878775|P5|Week 12 to End of Study|Withdrawal by Subject|0
905585|NCT00718718|2878776|P4|Week 12 to End of Study|Withdrawal by Subject|0
905586|NCT00718718|2878777|P3|Week 12 to End of Study|Withdrawal by Subject|0
905587|NCT00718718|2878778|P2|Week 12 to End of Study|Withdrawal by Subject|0
905588|NCT00718718|2878779|P1|Week 12 to End of Study|Withdrawal by Subject|0
905589|NCT00718718|2878770|P10|Week 12 to End of Study|Death|0
905590|NCT00718718|2878771|P9|Week 12 to End of Study|Death|0
905591|NCT00718718|2878772|P8|Week 12 to End of Study|Death|0
905592|NCT00718718|2878773|P7|Week 12 to End of Study|Death|0
905593|NCT00718718|2878774|P6|Week 12 to End of Study|Death|1
905594|NCT00718718|2878775|P5|Week 12 to End of Study|Death|0
905595|NCT00718718|2878776|P4|Week 12 to End of Study|Death|0
905596|NCT00718718|2878777|P3|Week 12 to End of Study|Death|0
905597|NCT00718718|2878778|P2|Week 12 to End of Study|Death|0
905598|NCT00718718|2878779|P1|Week 12 to End of Study|Death|0
905599|NCT00718718|2878770|P10|Week 12 to End of Study|Adverse Event|0
905600|NCT00718718|2878771|P9|Week 12 to End of Study|Adverse Event|0
905601|NCT00718718|2878772|P8|Week 12 to End of Study|Adverse Event|1
905602|NCT00718718|2878773|P7|Week 12 to End of Study|Adverse Event|0
905603|NCT00718718|2878774|P6|Week 12 to End of Study|Adverse Event|0
905604|NCT00718718|2878775|P5|Week 12 to End of Study|Adverse Event|0
905605|NCT00718718|2878776|P4|Week 12 to End of Study|Adverse Event|0
905606|NCT00718718|2878777|P3|Week 12 to End of Study|Adverse Event|0
905607|NCT00718718|2878778|P2|Week 12 to End of Study|Adverse Event|0
905608|NCT00718718|2878779|P1|Week 12 to End of Study|Adverse Event|0
905609|NCT00718718|2878770|P10|Prior to Week 12|Other|0
905610|NCT00718718|2878771|P9|Prior to Week 12|Other|0
905611|NCT00718718|2878772|P8|Prior to Week 12|Other|0
905612|NCT00718718|2878773|P7|Prior to Week 12|Other|0
905613|NCT00718718|2878774|P6|Prior to Week 12|Other|0
905614|NCT00718718|2878775|P5|Prior to Week 12|Other|0
905615|NCT00718718|2878776|P4|Prior to Week 12|Other|0
905616|NCT00718718|2878777|P3|Prior to Week 12|Other|1
880517|NCT02480153|2806269|P2|Overall Study|Randomized but not treated|1
880518|NCT02480153|2806270|P1|Overall Study|Randomized but not treated|0
880519|NCT02480153|2806269|P2|Overall Study|Withdrew treatment; continued in study|14
880520|NCT02480153|2806270|P1|Overall Study|Withdrew treatment; continued in study|6
880521|NCT02480153|2806269|P2|Overall Study|Discontinued from treatment and study|12
880522|NCT02480153|2806270|P1|Overall Study|Discontinued from treatment and study|5
905617|NCT00718718|2878778|P2|Prior to Week 12|Other|0
905618|NCT00718718|2878779|P1|Prior to Week 12|Other|1
905619|NCT00718718|2878770|P10|Prior to Week 12|Withdrawal by Subject|0
905620|NCT00718718|2878771|P9|Prior to Week 12|Withdrawal by Subject|1
905621|NCT00718718|2878772|P8|Prior to Week 12|Withdrawal by Subject|1
905622|NCT00718718|2878773|P7|Prior to Week 12|Withdrawal by Subject|1
905623|NCT00718718|2878774|P6|Prior to Week 12|Withdrawal by Subject|0
905624|NCT00718718|2878775|P5|Prior to Week 12|Withdrawal by Subject|3
880531|NCT02301975|2806345|P3|Overall Study|Withdrawal by Subject|11
880532|NCT02301975|2806346|P2|Overall Study|Withdrawal by Subject|12
880533|NCT02301975|2806347|P1|Overall Study|Withdrawal by Subject|15
880534|NCT02301975|2806345|P3|Overall Study|Physician Decision|3
880535|NCT02301975|2806346|P2|Overall Study|Physician Decision|2
880536|NCT02301975|2806347|P1|Overall Study|Physician Decision|4
880537|NCT02301975|2806345|P3|Overall Study|Lost to Follow-up|2
880538|NCT02301975|2806346|P2|Overall Study|Lost to Follow-up|2
880539|NCT02301975|2806347|P1|Overall Study|Lost to Follow-up|0
880540|NCT02301975|2806345|P3|Overall Study|Protocol Violation|3
880541|NCT02301975|2806346|P2|Overall Study|Protocol Violation|5
880542|NCT02301975|2806347|P1|Overall Study|Protocol Violation|3
880543|NCT02301975|2806345|P3|Overall Study|Lack of Efficacy|1
880544|NCT02301975|2806346|P2|Overall Study|Lack of Efficacy|1
880545|NCT02301975|2806347|P1|Overall Study|Lack of Efficacy|1
880546|NCT02301975|2806345|P3|Overall Study|Adverse Event|2
880547|NCT02301975|2806346|P2|Overall Study|Adverse Event|3
880548|NCT02301975|2806347|P1|Overall Study|Adverse Event|8
880549|NCT02229383|2806375|P2|Overall Study|Randomized in error|0
880550|NCT02229383|2806376|P1|Overall Study|Randomized in error|1
880551|NCT02229383|2806375|P2|Overall Study|Investigator decision|4
880552|NCT02229383|2806376|P1|Overall Study|Investigator decision|1
880553|NCT02229383|2806375|P2|Overall Study|Death|1
880554|NCT02229383|2806376|P1|Overall Study|Death|0
880555|NCT02229383|2806375|P2|Overall Study|Fire at the study center|4
880556|NCT02229383|2806376|P1|Overall Study|Fire at the study center|2
880557|NCT02229383|2806375|P2|Overall Study|Withdrawal by Subject|9
880558|NCT02229383|2806376|P1|Overall Study|Withdrawal by Subject|5
880559|NCT02229383|2806375|P2|Overall Study|Lost to Follow-up|2
880560|NCT02229383|2806376|P1|Overall Study|Lost to Follow-up|4
880561|NCT02229383|2806375|P2|Overall Study|Adverse Event|4
880562|NCT02229383|2806376|P1|Overall Study|Adverse Event|9
905625|NCT00718718|2878776|P4|Prior to Week 12|Withdrawal by Subject|0
905626|NCT00718718|2878777|P3|Prior to Week 12|Withdrawal by Subject|0
905627|NCT00718718|2878778|P2|Prior to Week 12|Withdrawal by Subject|0
905628|NCT00718718|2878779|P1|Prior to Week 12|Withdrawal by Subject|0
905629|NCT00718718|2878770|P10|Prior to Week 12|Adverse Event|0
905630|NCT00718718|2878771|P9|Prior to Week 12|Adverse Event|1
905631|NCT00718718|2878772|P8|Prior to Week 12|Adverse Event|1
905632|NCT00718718|2878773|P7|Prior to Week 12|Adverse Event|0
905633|NCT00718718|2878774|P6|Prior to Week 12|Adverse Event|0
905634|NCT00718718|2878775|P5|Prior to Week 12|Adverse Event|0
905635|NCT00718718|2878776|P4|Prior to Week 12|Adverse Event|0
905636|NCT00718718|2878777|P3|Prior to Week 12|Adverse Event|0
905637|NCT00718718|2878778|P2|Prior to Week 12|Adverse Event|0
905638|NCT00718718|2878779|P1|Prior to Week 12|Adverse Event|0
905663|NCT00710034|2878881|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
905664|NCT00710034|2878882|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
905665|NCT00710034|2878881|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
905666|NCT00710034|2878882|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
905667|NCT00710034|2878881|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
905668|NCT00710034|2878882|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
905669|NCT00710034|2878881|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
905670|NCT00710034|2878882|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
905671|NCT00710034|2878881|P2|Completed 12 Weeks of Treatment|Adverse Event|1
905672|NCT00710034|2878882|P1|Completed 12 Weeks of Treatment|Adverse Event|0
905673|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Physician Decision|0
905674|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Physician Decision|1
905675|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
905676|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
905677|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
905678|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
905679|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
905680|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
905681|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
905682|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
905683|NCT00710034|2878881|P2|Completed 6 Weeks of Treatment|Adverse Event|12
905684|NCT00710034|2878882|P1|Completed 6 Weeks of Treatment|Adverse Event|5
905685|NCT00693693|2878920|P3|Overall Study|Lost to Follow-up|2
905686|NCT00693693|2878921|P2|Overall Study|Lost to Follow-up|1
905687|NCT00693693|2878922|P1|Overall Study|Lost to Follow-up|1
905692|NCT00681109|2878983|P3|Overall Study|Lost to Follow-up|0
905693|NCT00681109|2878984|P2|Overall Study|Lost to Follow-up|6
905694|NCT00681109|2878985|P1|Overall Study|Lost to Follow-up|2
905695|NCT00674661|2879004|P2|Overall Study|Withdrawal by Subject|5
905696|NCT00674661|2879005|P1|Overall Study|Withdrawal by Subject|0
905697|NCT00674661|2879004|P2|Overall Study|Lost to Follow-up|3
905698|NCT00674661|2879005|P1|Overall Study|Lost to Follow-up|6
905699|NCT00674661|2879004|P2|Overall Study|not specified|7
905700|NCT00674661|2879005|P1|Overall Study|not specified|5
905701|NCT00661505|2879011|P1|Overall Study|Not Specified|2
905702|NCT00661505|2879011|P1|Overall Study|Lost to Follow-up|3
905703|NCT00661505|2879011|P1|Overall Study|Withdrawal by Subject|8
905704|NCT00661505|2879011|P1|Overall Study|Protocol Violation|14
905705|NCT00661505|2879011|P1|Overall Study|Adverse Event|3
905710|NCT00655824|2879050|P1|Overall Study|Deterioration of Trial Disease|2
905711|NCT00655824|2879050|P1|Overall Study|Withdrawal by Subject|4
905712|NCT00655824|2879050|P1|Overall Study|Protocol Violation|1
905713|NCT00655824|2879050|P1|Overall Study|Early Termination of Study by Sponsor|74
905714|NCT00655824|2879050|P1|Overall Study|Adverse Event|3
905718|NCT00654355|2879091|P2|Overall Study|Lost to Follow-up|2
905719|NCT00654355|2879092|P1|Overall Study|Lost to Follow-up|2
880669|NCT01732822|2806642|P2|Overall Study|Withdrawal by Subject|113
880670|NCT01732822|2806643|P1|Overall Study|Withdrawal by Subject|123
905720|NCT00647699|2879104|P2|Overall Study|Withdrawal by Subject|8
905721|NCT00647699|2879105|P1|Overall Study|Withdrawal by Subject|3
905722|NCT00647699|2879104|P2|Overall Study|Lost to Follow-up|4
905723|NCT00647699|2879105|P1|Overall Study|Lost to Follow-up|5
905724|NCT00608530|2879137|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
905725|NCT00608530|2879138|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
905726|NCT00608530|2879139|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
905727|NCT00608530|2879140|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
905728|NCT00608530|2879137|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
905729|NCT00608530|2879138|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
905730|NCT00608530|2879139|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
905731|NCT00608530|2879140|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
905732|NCT00608530|2879137|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
905733|NCT00608530|2879138|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
905734|NCT00608530|2879139|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
905735|NCT00608530|2879140|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
905736|NCT00608530|2879137|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
905737|NCT00608530|2879138|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
905738|NCT00608530|2879139|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
905739|NCT00608530|2879140|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
905740|NCT00608530|2879137|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
905741|NCT00608530|2879138|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
905742|NCT00608530|2879139|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
905743|NCT00608530|2879140|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
905744|NCT00608530|2879137|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
905745|NCT00608530|2879138|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
905746|NCT00608530|2879139|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
905747|NCT00608530|2879140|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
905748|NCT00559988|2879208|P2|Overall Study|ICD device explanted|17
905749|NCT00559988|2879209|P1|Overall Study|ICD device explanted|10
905750|NCT00559988|2879208|P2|Overall Study|Lost to Follow-up|56
905751|NCT00559988|2879209|P1|Overall Study|Lost to Follow-up|42
905752|NCT00559988|2879208|P2|Overall Study|Withdrawal by Subject|139
905753|NCT00559988|2879209|P1|Overall Study|Withdrawal by Subject|152
905754|NCT00559988|2879208|P2|Overall Study|Death|140
905755|NCT00559988|2879209|P1|Overall Study|Death|147
905771|NCT00500331|2879315|P7|Overall Study|Protocol violated|0
905772|NCT00500331|2879316|P6|Overall Study|Protocol violated|0
905773|NCT00500331|2879317|P5|Overall Study|Protocol violated|0
905774|NCT00500331|2879318|P4|Overall Study|Protocol violated|1
905775|NCT00500331|2879319|P3|Overall Study|Protocol violated|0
880727|NCT01641471|2806855|P2|Overall Study|Protocol Violation|4
880728|NCT01641471|2806856|P1|Overall Study|Protocol Violation|2
880729|NCT01641471|2806855|P2|Overall Study|Lost to Follow-up|4
880730|NCT01641471|2806856|P1|Overall Study|Lost to Follow-up|2
880731|NCT01641471|2806855|P2|Overall Study|Withdrawal by Subject|19
880732|NCT01641471|2806856|P1|Overall Study|Withdrawal by Subject|19
880733|NCT01625182|2806864|P2|Overall Study|Lack of Efficacy|8
880734|NCT01625182|2806865|P1|Overall Study|Lack of Efficacy|12
880735|NCT01625182|2806864|P2|Overall Study|Withdrawal by Subject|1
880736|NCT01625182|2806865|P1|Overall Study|Withdrawal by Subject|5
880737|NCT01625182|2806864|P2|Overall Study|Adverse Event|0
880738|NCT01625182|2806865|P1|Overall Study|Adverse Event|2
880739|NCT01625182|2806864|P2|Overall Study|Protocol deviation|2
880740|NCT01625182|2806865|P1|Overall Study|Protocol deviation|0
880741|NCT01625182|2806864|P2|Overall Study|Administrative problems|0
880742|NCT01625182|2806865|P1|Overall Study|Administrative problems|1
880743|NCT01607346|2806899|P1|Overall Study|Adverse Event|3
905776|NCT00500331|2879320|P2|Overall Study|Protocol violated|0
905777|NCT00500331|2879321|P1|Overall Study|Protocol violated|0
905778|NCT00500331|2879315|P7|Overall Study|State ban of biological samples export|0
905779|NCT00500331|2879316|P6|Overall Study|State ban of biological samples export|0
905780|NCT00500331|2879317|P5|Overall Study|State ban of biological samples export|0
905781|NCT00500331|2879318|P4|Overall Study|State ban of biological samples export|1
905782|NCT00500331|2879319|P3|Overall Study|State ban of biological samples export|0
905783|NCT00500331|2879320|P2|Overall Study|State ban of biological samples export|0
905784|NCT00500331|2879321|P1|Overall Study|State ban of biological samples export|0
905785|NCT00500331|2879315|P7|Overall Study|Diabetologist nurse in the study|0
905786|NCT00500331|2879316|P6|Overall Study|Diabetologist nurse in the study|0
905787|NCT00500331|2879317|P5|Overall Study|Diabetologist nurse in the study|0
905788|NCT00500331|2879318|P4|Overall Study|Diabetologist nurse in the study|0
905789|NCT00500331|2879319|P3|Overall Study|Diabetologist nurse in the study|1
905790|NCT00500331|2879320|P2|Overall Study|Diabetologist nurse in the study|0
905791|NCT00500331|2879321|P1|Overall Study|Diabetologist nurse in the study|0
905792|NCT00500331|2879315|P7|Overall Study|Participant was randomized by mistake|0
905793|NCT00500331|2879316|P6|Overall Study|Participant was randomized by mistake|0
905794|NCT00500331|2879317|P5|Overall Study|Participant was randomized by mistake|0
905795|NCT00500331|2879318|P4|Overall Study|Participant was randomized by mistake|0
905796|NCT00500331|2879319|P3|Overall Study|Participant was randomized by mistake|0
905797|NCT00500331|2879320|P2|Overall Study|Participant was randomized by mistake|0
905798|NCT00500331|2879321|P1|Overall Study|Participant was randomized by mistake|1
905799|NCT00500331|2879315|P7|Overall Study|Sponsor decided to withdraw participant|0
905800|NCT00500331|2879316|P6|Overall Study|Sponsor decided to withdraw participant|0
905801|NCT00500331|2879317|P5|Overall Study|Sponsor decided to withdraw participant|0
905802|NCT00500331|2879318|P4|Overall Study|Sponsor decided to withdraw participant|0
905803|NCT00500331|2879319|P3|Overall Study|Sponsor decided to withdraw participant|0
905804|NCT00500331|2879320|P2|Overall Study|Sponsor decided to withdraw participant|0
905805|NCT00500331|2879321|P1|Overall Study|Sponsor decided to withdraw participant|1
905806|NCT00500331|2879315|P7|Overall Study|Exclusion citeria not met on Visit 4|0
905807|NCT00500331|2879316|P6|Overall Study|Exclusion citeria not met on Visit 4|0
905808|NCT00500331|2879317|P5|Overall Study|Exclusion citeria not met on Visit 4|0
905809|NCT00500331|2879318|P4|Overall Study|Exclusion citeria not met on Visit 4|0
905810|NCT00500331|2879319|P3|Overall Study|Exclusion citeria not met on Visit 4|0
905811|NCT00500331|2879320|P2|Overall Study|Exclusion citeria not met on Visit 4|0
905812|NCT00500331|2879321|P1|Overall Study|Exclusion citeria not met on Visit 4|1
905813|NCT00500331|2879315|P7|Overall Study|Didn't return for continuation of study|0
905814|NCT00500331|2879316|P6|Overall Study|Didn't return for continuation of study|0
905815|NCT00500331|2879317|P5|Overall Study|Didn't return for continuation of study|0
905816|NCT00500331|2879318|P4|Overall Study|Didn't return for continuation of study|0
905817|NCT00500331|2879319|P3|Overall Study|Didn't return for continuation of study|0
880787|NCT01344824|2807078|P1|Overall Study|Progression|15
880788|NCT01344824|2807078|P1|Overall Study|Other complicating disease|1
880789|NCT01344824|2807078|P1|Overall Study|Withdrawal by Subject|6
880790|NCT01344824|2807078|P1|Overall Study|Adverse Event|15
905818|NCT00500331|2879320|P2|Overall Study|Didn't return for continuation of study|0
905819|NCT00500331|2879321|P1|Overall Study|Didn't return for continuation of study|1
905820|NCT00500331|2879315|P7|Overall Study|Increased serum creatinine from Baseline|0
905821|NCT00500331|2879316|P6|Overall Study|Increased serum creatinine from Baseline|1
905822|NCT00500331|2879317|P5|Overall Study|Increased serum creatinine from Baseline|0
905823|NCT00500331|2879318|P4|Overall Study|Increased serum creatinine from Baseline|0
905824|NCT00500331|2879319|P3|Overall Study|Increased serum creatinine from Baseline|0
905825|NCT00500331|2879320|P2|Overall Study|Increased serum creatinine from Baseline|0
905826|NCT00500331|2879321|P1|Overall Study|Increased serum creatinine from Baseline|0
905827|NCT00500331|2879315|P7|Overall Study|Liver function test abnormality|0
905828|NCT00500331|2879316|P6|Overall Study|Liver function test abnormality|0
905829|NCT00500331|2879317|P5|Overall Study|Liver function test abnormality|0
905830|NCT00500331|2879318|P4|Overall Study|Liver function test abnormality|0
905831|NCT00500331|2879319|P3|Overall Study|Liver function test abnormality|1
905832|NCT00500331|2879320|P2|Overall Study|Liver function test abnormality|0
905833|NCT00500331|2879321|P1|Overall Study|Liver function test abnormality|0
905834|NCT00500331|2879315|P7|Overall Study|Lack of Efficacy|0
905835|NCT00500331|2879316|P6|Overall Study|Lack of Efficacy|0
905836|NCT00500331|2879317|P5|Overall Study|Lack of Efficacy|0
905837|NCT00500331|2879318|P4|Overall Study|Lack of Efficacy|0
905838|NCT00500331|2879319|P3|Overall Study|Lack of Efficacy|0
905839|NCT00500331|2879320|P2|Overall Study|Lack of Efficacy|1
905840|NCT00500331|2879321|P1|Overall Study|Lack of Efficacy|3
905841|NCT00500331|2879315|P7|Overall Study|Withdrawal by Subject|1
905842|NCT00500331|2879316|P6|Overall Study|Withdrawal by Subject|1
905843|NCT00500331|2879317|P5|Overall Study|Withdrawal by Subject|0
905844|NCT00500331|2879318|P4|Overall Study|Withdrawal by Subject|5
905845|NCT00500331|2879319|P3|Overall Study|Withdrawal by Subject|1
905846|NCT00500331|2879320|P2|Overall Study|Withdrawal by Subject|0
905847|NCT00500331|2879321|P1|Overall Study|Withdrawal by Subject|4
905848|NCT00500331|2879315|P7|Overall Study|Protocol Violation|1
905849|NCT00500331|2879316|P6|Overall Study|Protocol Violation|1
905850|NCT00500331|2879317|P5|Overall Study|Protocol Violation|1
905851|NCT00500331|2879318|P4|Overall Study|Protocol Violation|0
905852|NCT00500331|2879319|P3|Overall Study|Protocol Violation|1
905853|NCT00500331|2879320|P2|Overall Study|Protocol Violation|1
905854|NCT00500331|2879321|P1|Overall Study|Protocol Violation|3
905855|NCT00500331|2879315|P7|Overall Study|Lost to Follow-up|0
905856|NCT00500331|2879316|P6|Overall Study|Lost to Follow-up|0
905857|NCT00500331|2879317|P5|Overall Study|Lost to Follow-up|1
905858|NCT00500331|2879318|P4|Overall Study|Lost to Follow-up|2
905859|NCT00500331|2879319|P3|Overall Study|Lost to Follow-up|1
905860|NCT00500331|2879320|P2|Overall Study|Lost to Follow-up|1
905861|NCT00500331|2879321|P1|Overall Study|Lost to Follow-up|1
905862|NCT00500331|2879315|P7|Overall Study|Adverse Event|0
905863|NCT00500331|2879316|P6|Overall Study|Adverse Event|2
905864|NCT00500331|2879317|P5|Overall Study|Adverse Event|2
905865|NCT00500331|2879318|P4|Overall Study|Adverse Event|1
905866|NCT00500331|2879319|P3|Overall Study|Adverse Event|0
905867|NCT00500331|2879320|P2|Overall Study|Adverse Event|2
905868|NCT00500331|2879321|P1|Overall Study|Adverse Event|0
905869|NCT00471497|2879463|P3|Overall Study|Sub optimal response or treat. failure|0
905870|NCT00471497|2879464|P2|Overall Study|Sub optimal response or treat. failure|3
905871|NCT00471497|2879465|P1|Overall Study|Sub optimal response or treat. failure|8
905872|NCT00471497|2879463|P3|Overall Study|Protocol Violation|5
905873|NCT00471497|2879464|P2|Overall Study|Protocol Violation|3
905874|NCT00471497|2879465|P1|Overall Study|Protocol Violation|3
905875|NCT00471497|2879463|P3|Overall Study|Disease Progression|2
905876|NCT00471497|2879464|P2|Overall Study|Disease Progression|2
905877|NCT00471497|2879465|P1|Overall Study|Disease Progression|8
905878|NCT00471497|2879463|P3|Overall Study|Death|0
905879|NCT00471497|2879464|P2|Overall Study|Death|2
905880|NCT00471497|2879465|P1|Overall Study|Death|0
905881|NCT00471497|2879463|P3|Overall Study|Lost to Follow-up|1
905882|NCT00471497|2879464|P2|Overall Study|Lost to Follow-up|2
905883|NCT00471497|2879465|P1|Overall Study|Lost to Follow-up|1
905884|NCT00471497|2879463|P3|Overall Study|Withdrawal by Subject|5
905885|NCT00471497|2879464|P2|Overall Study|Withdrawal by Subject|5
905886|NCT00471497|2879465|P1|Overall Study|Withdrawal by Subject|3
905887|NCT00471497|2879463|P3|Overall Study|Condition no longer requires study drug|0
905888|NCT00471497|2879464|P2|Overall Study|Condition no longer requires study drug|1
905889|NCT00471497|2879465|P1|Overall Study|Condition no longer requires study drug|0
905890|NCT00471497|2879463|P3|Overall Study|Abnormal Test Procedure|1
905891|NCT00471497|2879464|P2|Overall Study|Abnormal Test Procedure|0
905892|NCT00471497|2879465|P1|Overall Study|Abnormal Test Procedure|1
905893|NCT00471497|2879463|P3|Overall Study|Abnormal Laboratory Value|4
905894|NCT00471497|2879464|P2|Overall Study|Abnormal Laboratory Value|6
905895|NCT00471497|2879465|P1|Overall Study|Abnormal Laboratory Value|3
905896|NCT00471497|2879463|P3|Overall Study|Adverse Event|22
905897|NCT00471497|2879464|P2|Overall Study|Adverse Event|11
905898|NCT00471497|2879465|P1|Overall Study|Adverse Event|19
905899|NCT00463840|2879473|P1|Overall Study|Adverse Event|3
905900|NCT00463840|2879473|P1|Overall Study|Withdrawal by Subject|2
905901|NCT00463840|2879473|P1|Overall Study|Disease progression|7
905902|NCT00455312|2879480|P2|Overall Study|Death|1
905903|NCT00455312|2879481|P1|Overall Study|Death|0
905904|NCT00433966|2879522|P4|Stent Intervention/Randomization|Lost to Follow-up|47
905905|NCT00433966|2879523|P3|Stent Intervention/Randomization|Lost to Follow-up|113
905906|NCT00433966|2879524|P2|Stent Intervention/Randomization|Lost to Follow-up|0
905907|NCT00433966|2879525|P1|Stent Intervention/Randomization|Lost to Follow-up|0
905908|NCT00433966|2879522|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
905909|NCT00433966|2879523|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
905910|NCT00433966|2879524|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
905911|NCT00433966|2879525|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
905912|NCT00433966|2879522|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
905913|NCT00433966|2879523|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
905914|NCT00433966|2879524|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
905915|NCT00433966|2879525|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
905916|NCT00433966|2879522|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
905917|NCT00433966|2879523|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
905918|NCT00433966|2879524|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
905919|NCT00433966|2879525|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
905920|NCT00433966|2879522|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
905921|NCT00433966|2879523|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
905922|NCT00433966|2879524|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
905923|NCT00433966|2879525|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
905924|NCT00429793|2879545|P1|Overall Study|Non-measurable|1
905925|NCT00429793|2879545|P1|Overall Study|Never treated|1
905926|NCT00429793|2879545|P1|Overall Study|Required test not done|1
905927|NCT00429793|2879545|P1|Overall Study|Improper pre-protocol treatment|3
905938|NCT00352027|2879616|P1|Overall Study|Progressive disease|3
905939|NCT00346775|2879885|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
905940|NCT00346775|2879886|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
905941|NCT00346775|2879885|P2|Period 1: Intervention Period 1|Protocol Violation|2
905942|NCT00346775|2879886|P1|Period 1: Intervention Period 1|Protocol Violation|3
905943|NCT00346775|2879885|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
905944|NCT00346775|2879886|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
905945|NCT00305864|2879900|P4|Overall Study|Ineligible / No protocol treatment|13
905946|NCT00305864|2879901|P3|Overall Study|Ineligible / No protocol treatment|1
905947|NCT00305864|2879902|P2|Overall Study|Ineligible / No protocol treatment|1
905948|NCT00305864|2879903|P1|Overall Study|Ineligible / No protocol treatment|0
905949|NCT00301964|2879914|P1|Overall Study|Inadequate pathology|1
905950|NCT00301964|2879914|P1|Overall Study|Wrong primary|1
905951|NCT00301964|2879914|P1|Overall Study|Second primary|2
905952|NCT00283712|2879931|P2|Overall Study|Death|1
905953|NCT00283712|2879932|P1|Overall Study|Death|0
905954|NCT00238420|2879972|P2|Overall Study|Protocol Violation|1
905955|NCT00238420|2879973|P1|Overall Study|Protocol Violation|1
905956|NCT00194675|2879985|P2|Overall Study|Death|0
905957|NCT00194675|2879986|P1|Overall Study|Death|1
905958|NCT00194675|2879985|P2|Overall Study|Protocol Violation|0
905959|NCT00194675|2879986|P1|Overall Study|Protocol Violation|1
905960|NCT00194675|2879985|P2|Overall Study|"withdrew due to edgy feeling"|0
905961|NCT00194675|2879986|P1|Overall Study|"withdrew due to edgy feeling"|1
905962|NCT00194675|2879985|P2|Overall Study|lack of interest|1
905963|NCT00194675|2879986|P1|Overall Study|lack of interest|1
905964|NCT00194675|2879985|P2|Overall Study|Lost to Follow-up|1
905965|NCT00194675|2879986|P1|Overall Study|Lost to Follow-up|1
905966|NCT00118157|2880127|P1|Overall Study|Withdrawal by Subject|2
905967|NCT00118157|2880127|P1|Overall Study|Death|8
905968|NCT00118157|2880127|P1|Overall Study|Adverse Event|2
881021|NCT01036321|2807376|P2|Overall Study|Adverse Event|1
881022|NCT01036321|2807377|P1|Overall Study|Adverse Event|2
881023|NCT01036321|2807376|P2|Overall Study|Withdrawal by Subject|2
881024|NCT01036321|2807377|P1|Overall Study|Withdrawal by Subject|3
881025|NCT01036321|2807376|P2|Overall Study|Ineligible after randomization|1
881026|NCT01036321|2807377|P1|Overall Study|Ineligible after randomization|0
881033|NCT01000506|2807418|P4|Overall Study|Withdrawal by Subject|7
881034|NCT01000506|2807419|P3|Overall Study|Withdrawal by Subject|2
881035|NCT01000506|2807420|P2|Overall Study|Withdrawal by Subject|8
881036|NCT01000506|2807421|P1|Overall Study|Withdrawal by Subject|11
881037|NCT01000506|2807418|P4|Overall Study|Physician Decision|3
881038|NCT01000506|2807419|P3|Overall Study|Physician Decision|3
881039|NCT01000506|2807420|P2|Overall Study|Physician Decision|3
881040|NCT01000506|2807421|P1|Overall Study|Physician Decision|1
881041|NCT01000506|2807418|P4|Overall Study|Lost to Follow-up|0
881042|NCT01000506|2807419|P3|Overall Study|Lost to Follow-up|4
881043|NCT01000506|2807420|P2|Overall Study|Lost to Follow-up|1
881044|NCT01000506|2807421|P1|Overall Study|Lost to Follow-up|1
881045|NCT01000506|2807418|P4|Overall Study|Protocol Violation|0
881046|NCT01000506|2807419|P3|Overall Study|Protocol Violation|0
881047|NCT01000506|2807420|P2|Overall Study|Protocol Violation|1
881048|NCT01000506|2807421|P1|Overall Study|Protocol Violation|1
881049|NCT01000506|2807418|P4|Overall Study|Lack of Efficacy|4
881050|NCT01000506|2807419|P3|Overall Study|Lack of Efficacy|4
881051|NCT01000506|2807420|P2|Overall Study|Lack of Efficacy|6
881052|NCT01000506|2807421|P1|Overall Study|Lack of Efficacy|8
881053|NCT01000506|2807418|P4|Overall Study|Adverse Event|9
881054|NCT01000506|2807419|P3|Overall Study|Adverse Event|8
881055|NCT01000506|2807420|P2|Overall Study|Adverse Event|5
881056|NCT01000506|2807421|P1|Overall Study|Adverse Event|6
906085|NCT00096447|2880164|P1|Overall Study|Never treated|1
906086|NCT00075400|2880191|P1|Overall Study|Never treated|2
881140|NCT00721409|2807653|P3|Overall Study|Death|0
881141|NCT00721409|2807654|P2|Overall Study|Death|1
881142|NCT00721409|2807655|P1|Overall Study|Death|0
881143|NCT00721409|2807653|P3|Overall Study|Adverse Event|2
881144|NCT00721409|2807654|P2|Overall Study|Adverse Event|11
881145|NCT00721409|2807655|P1|Overall Study|Adverse Event|0
881146|NCT00721409|2807653|P3|Overall Study|Reason not specified|5
906087|NCT00075400|2880191|P1|Overall Study|Ineligible: wrong primary|1
906096|NCT00031551|2880260|P2|Overall Study|Withdrew due to chemotherapy effects|0
881147|NCT00721409|2807654|P2|Overall Study|Reason not specified|1
881148|NCT00721409|2807655|P1|Overall Study|Reason not specified|0
881149|NCT00721409|2807653|P3|Overall Study|Withdrawal by Subject|6
881150|NCT00721409|2807654|P2|Overall Study|Withdrawal by Subject|5
881151|NCT00721409|2807655|P1|Overall Study|Withdrawal by Subject|1
881152|NCT00721409|2807653|P3|Overall Study|Objective progression or relapse|57
881153|NCT00721409|2807654|P2|Overall Study|Objective progression or relapse|42
881154|NCT00721409|2807655|P1|Overall Study|Objective progression or relapse|7
881155|NCT00721409|2807653|P3|Overall Study|Global deterioration of health status|3
881156|NCT00721409|2807654|P2|Overall Study|Global deterioration of health status|5
881157|NCT00721409|2807655|P1|Overall Study|Global deterioration of health status|2
881158|NCT00721409|2807653|P3|Overall Study|Ongoing at date of cutoff|8
881159|NCT00721409|2807654|P2|Overall Study|Ongoing at date of cutoff|19
881160|NCT00721409|2807655|P1|Overall Study|Ongoing at date of cutoff|2
881161|NCT00542425|2807837|P5|Extended 24 Weeks of Treatment|Other|1
881162|NCT00542425|2807838|P4|Extended 24 Weeks of Treatment|Other|0
881163|NCT00542425|2807839|P3|Extended 24 Weeks of Treatment|Other|0
881164|NCT00542425|2807840|P2|Extended 24 Weeks of Treatment|Other|1
881165|NCT00542425|2807841|P1|Extended 24 Weeks of Treatment|Other|1
881166|NCT00542425|2807837|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
881167|NCT00542425|2807838|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
881168|NCT00542425|2807839|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
881169|NCT00542425|2807840|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
881170|NCT00542425|2807841|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
881171|NCT00542425|2807837|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
881172|NCT00542425|2807838|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
881173|NCT00542425|2807839|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
881174|NCT00542425|2807840|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
881175|NCT00542425|2807841|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
881176|NCT00542425|2807837|P5|Extended 24 Weeks of Treatment|Adverse Event|0
881177|NCT00542425|2807838|P4|Extended 24 Weeks of Treatment|Adverse Event|1
881178|NCT00542425|2807839|P3|Extended 24 Weeks of Treatment|Adverse Event|1
881179|NCT00542425|2807840|P2|Extended 24 Weeks of Treatment|Adverse Event|0
881180|NCT00542425|2807841|P1|Extended 24 Weeks of Treatment|Adverse Event|0
881181|NCT00542425|2807837|P5|Initial 24 Weeks|Other|0
881182|NCT00542425|2807838|P4|Initial 24 Weeks|Other|0
881183|NCT00542425|2807839|P3|Initial 24 Weeks|Other|1
881184|NCT00542425|2807840|P2|Initial 24 Weeks|Other|2
881185|NCT00542425|2807841|P1|Initial 24 Weeks|Other|0
881186|NCT00542425|2807837|P5|Initial 24 Weeks|Refusal of treatment|1
881187|NCT00542425|2807838|P4|Initial 24 Weeks|Refusal of treatment|4
881188|NCT00542425|2807839|P3|Initial 24 Weeks|Refusal of treatment|1
881189|NCT00542425|2807840|P2|Initial 24 Weeks|Refusal of treatment|2
881190|NCT00542425|2807841|P1|Initial 24 Weeks|Refusal of treatment|2
881191|NCT00542425|2807837|P5|Initial 24 Weeks|Protocol Violation|0
881192|NCT00542425|2807838|P4|Initial 24 Weeks|Protocol Violation|1
881193|NCT00542425|2807839|P3|Initial 24 Weeks|Protocol Violation|0
881194|NCT00542425|2807840|P2|Initial 24 Weeks|Protocol Violation|0
881195|NCT00542425|2807841|P1|Initial 24 Weeks|Protocol Violation|0
881196|NCT00542425|2807837|P5|Initial 24 Weeks|Non-compliance|1
881197|NCT00542425|2807838|P4|Initial 24 Weeks|Non-compliance|1
881198|NCT00542425|2807839|P3|Initial 24 Weeks|Non-compliance|0
881199|NCT00542425|2807840|P2|Initial 24 Weeks|Non-compliance|0
881200|NCT00542425|2807841|P1|Initial 24 Weeks|Non-compliance|0
881201|NCT00542425|2807837|P5|Initial 24 Weeks|Lost to Follow-up|0
881202|NCT00542425|2807838|P4|Initial 24 Weeks|Lost to Follow-up|0
881203|NCT00542425|2807839|P3|Initial 24 Weeks|Lost to Follow-up|1
881204|NCT00542425|2807840|P2|Initial 24 Weeks|Lost to Follow-up|2
881205|NCT00542425|2807841|P1|Initial 24 Weeks|Lost to Follow-up|2
881206|NCT00542425|2807837|P5|Initial 24 Weeks|Inability to complete procedures|2
881207|NCT00542425|2807838|P4|Initial 24 Weeks|Inability to complete procedures|1
881208|NCT00542425|2807839|P3|Initial 24 Weeks|Inability to complete procedures|2
881209|NCT00542425|2807840|P2|Initial 24 Weeks|Inability to complete procedures|3
881210|NCT00542425|2807841|P1|Initial 24 Weeks|Inability to complete procedures|0
881211|NCT00542425|2807837|P5|Initial 24 Weeks|Adverse Event|2
881212|NCT00542425|2807838|P4|Initial 24 Weeks|Adverse Event|3
881213|NCT00542425|2807839|P3|Initial 24 Weeks|Adverse Event|1
881214|NCT00542425|2807840|P2|Initial 24 Weeks|Adverse Event|1
881215|NCT00542425|2807841|P1|Initial 24 Weeks|Adverse Event|0
881216|NCT00542425|2807837|P5|Initial 24 Weeks|Administrative reasons|0
881217|NCT00542425|2807838|P4|Initial 24 Weeks|Administrative reasons|1
881218|NCT00542425|2807839|P3|Initial 24 Weeks|Administrative reasons|1
881219|NCT00542425|2807840|P2|Initial 24 Weeks|Administrative reasons|0
881220|NCT00542425|2807841|P1|Initial 24 Weeks|Administrative reasons|0
881221|NCT00495469|2807896|P7|Overall Study|ST depression at randomisation in ECG|0
881222|NCT00495469|2807897|P6|Overall Study|ST depression at randomisation in ECG|0
881223|NCT00495469|2807898|P5|Overall Study|ST depression at randomisation in ECG|0
881224|NCT00495469|2807899|P4|Overall Study|ST depression at randomisation in ECG|0
881225|NCT00495469|2807900|P3|Overall Study|ST depression at randomisation in ECG|0
881226|NCT00495469|2807901|P2|Overall Study|ST depression at randomisation in ECG|1
881227|NCT00495469|2807902|P1|Overall Study|ST depression at randomisation in ECG|0
881228|NCT00495469|2807896|P7|Overall Study|Liver function test abnormality|0
881229|NCT00495469|2807897|P6|Overall Study|Liver function test abnormality|0
881230|NCT00495469|2807898|P5|Overall Study|Liver function test abnormality|0
881231|NCT00495469|2807899|P4|Overall Study|Liver function test abnormality|0
881232|NCT00495469|2807900|P3|Overall Study|Liver function test abnormality|0
881233|NCT00495469|2807901|P2|Overall Study|Liver function test abnormality|1
881234|NCT00495469|2807902|P1|Overall Study|Liver function test abnormality|0
881235|NCT00495469|2807896|P7|Overall Study|Lack of Efficacy|1
881236|NCT00495469|2807897|P6|Overall Study|Lack of Efficacy|0
881237|NCT00495469|2807898|P5|Overall Study|Lack of Efficacy|0
881238|NCT00495469|2807899|P4|Overall Study|Lack of Efficacy|0
881239|NCT00495469|2807900|P3|Overall Study|Lack of Efficacy|0
881240|NCT00495469|2807901|P2|Overall Study|Lack of Efficacy|0
881241|NCT00495469|2807902|P1|Overall Study|Lack of Efficacy|0
881242|NCT00495469|2807896|P7|Overall Study|Withdrawal by Subject|3
881243|NCT00495469|2807897|P6|Overall Study|Withdrawal by Subject|2
881244|NCT00495469|2807898|P5|Overall Study|Withdrawal by Subject|3
881245|NCT00495469|2807899|P4|Overall Study|Withdrawal by Subject|3
881246|NCT00495469|2807900|P3|Overall Study|Withdrawal by Subject|1
881247|NCT00495469|2807901|P2|Overall Study|Withdrawal by Subject|3
881248|NCT00495469|2807902|P1|Overall Study|Withdrawal by Subject|5
881249|NCT00495469|2807896|P7|Overall Study|Protocol Violation|0
881250|NCT00495469|2807897|P6|Overall Study|Protocol Violation|2
881251|NCT00495469|2807898|P5|Overall Study|Protocol Violation|1
881252|NCT00495469|2807899|P4|Overall Study|Protocol Violation|0
881253|NCT00495469|2807900|P3|Overall Study|Protocol Violation|0
881254|NCT00495469|2807901|P2|Overall Study|Protocol Violation|0
881255|NCT00495469|2807902|P1|Overall Study|Protocol Violation|0
881256|NCT00495469|2807896|P7|Overall Study|Lost to Follow-up|0
881257|NCT00495469|2807897|P6|Overall Study|Lost to Follow-up|0
881258|NCT00495469|2807898|P5|Overall Study|Lost to Follow-up|0
881259|NCT00495469|2807899|P4|Overall Study|Lost to Follow-up|1
881260|NCT00495469|2807900|P3|Overall Study|Lost to Follow-up|3
881261|NCT00495469|2807901|P2|Overall Study|Lost to Follow-up|1
881262|NCT00495469|2807902|P1|Overall Study|Lost to Follow-up|1
881263|NCT00495469|2807896|P7|Overall Study|Adverse Event|1
881264|NCT00495469|2807897|P6|Overall Study|Adverse Event|1
881265|NCT00495469|2807898|P5|Overall Study|Adverse Event|1
881266|NCT00495469|2807899|P4|Overall Study|Adverse Event|0
881267|NCT00495469|2807900|P3|Overall Study|Adverse Event|3
881268|NCT00495469|2807901|P2|Overall Study|Adverse Event|1
881269|NCT00495469|2807902|P1|Overall Study|Adverse Event|0
906097|NCT00031551|2880261|P1|Overall Study|Withdrew due to chemotherapy effects|2
906098|NCT03254602|2880271|P1|Overall Study|Lost to Follow-up|4
906104|NCT02763189|2880368|P2|Overall Study|Device failure|2
906105|NCT02763189|2880369|P1|Overall Study|Device failure|0
906106|NCT02758613|2880381|P4|Treatment|Withdrawal by Subject|0
906107|NCT02758613|2880382|P3|Treatment|Withdrawal by Subject|1
906108|NCT02758613|2880383|P2|Treatment|Withdrawal by Subject|0
906109|NCT02758613|2880384|P1|Treatment|Withdrawal by Subject|1
906110|NCT02758613|2880381|P4|Treatment|Physician and Sponsor Decision|0
906111|NCT02758613|2880382|P3|Treatment|Physician and Sponsor Decision|0
906112|NCT02758613|2880383|P2|Treatment|Physician and Sponsor Decision|0
906113|NCT02758613|2880384|P1|Treatment|Physician and Sponsor Decision|1
906117|NCT02581410|2880414|P2|Overall Study|Migrated/moved from study area|1
906118|NCT02581410|2880415|P1|Overall Study|Migrated/moved from study area|0
906119|NCT02581410|2880414|P2|Overall Study|Withdrawal by Subject|1
906120|NCT02581410|2880415|P1|Overall Study|Withdrawal by Subject|0
906121|NCT02581410|2880414|P2|Overall Study|Adverse Event|1
906122|NCT02581410|2880415|P1|Overall Study|Adverse Event|2
881359|NCT02526290|2808344|P1|Overall Study|Physician Decision|1
881360|NCT02526290|2808344|P1|Overall Study|Withdrawal by Subject|4
881361|NCT02526290|2808344|P1|Overall Study|Adverse Event|3
881362|NCT02493855|2808367|P3|Overall Study|Withdrawal by Subject|0
881363|NCT02493855|2808368|P2|Overall Study|Withdrawal by Subject|0
881364|NCT02493855|2808369|P1|Overall Study|Withdrawal by Subject|1
881365|NCT02493855|2808367|P3|Overall Study|Adverse Event|0
881366|NCT02493855|2808368|P2|Overall Study|Adverse Event|1
881367|NCT02493855|2808369|P1|Overall Study|Adverse Event|0
881368|NCT02493855|2808367|P3|Overall Study|Non-compliance|0
881369|NCT02493855|2808368|P2|Overall Study|Non-compliance|0
881370|NCT02493855|2808369|P1|Overall Study|Non-compliance|1
881389|NCT02164916|2808470|P2|Overall Study|Not eligible|5
881390|NCT02164916|2808471|P1|Overall Study|Not eligible|2
881391|NCT02164916|2808470|P2|Overall Study|Reason under review|6
881392|NCT02164916|2808471|P1|Overall Study|Reason under review|1
881393|NCT02164916|2808470|P2|Overall Study|Not protocol specified|1
881394|NCT02164916|2808471|P1|Overall Study|Not protocol specified|5
881395|NCT02164916|2808470|P2|Overall Study|Progression|26
881396|NCT02164916|2808471|P1|Overall Study|Progression|37
881397|NCT02164916|2808470|P2|Overall Study|Refusal unrelated to adverse event|7
881398|NCT02164916|2808471|P1|Overall Study|Refusal unrelated to adverse event|3
881399|NCT02164916|2808470|P2|Overall Study|Death|1
881400|NCT02164916|2808471|P1|Overall Study|Death|1
881401|NCT02164916|2808470|P2|Overall Study|Adverse Event|8
881402|NCT02164916|2808471|P1|Overall Study|Adverse Event|3
906179|NCT02332239|2880680|P2|Overall Study|Lost to Follow-up|6
906180|NCT02332239|2880681|P1|Overall Study|Lost to Follow-up|4
881450|NCT01999322|2808557|P2|Overall Study|Adverse Event|0
881451|NCT01999322|2808558|P1|Overall Study|Adverse Event|1
881452|NCT01994395|2808591|P2|Overall Study|Withdrawal by Subject|2
881453|NCT01994395|2808592|P1|Overall Study|Withdrawal by Subject|1
881482|NCT01737268|2808677|P1|Overall Study|In consideration of the patient’s safety|1
881483|NCT01737268|2808677|P1|Overall Study|Worsening of Target Disease|2
881484|NCT01737268|2808677|P1|Overall Study|Adverse Event|6
881493|NCT01684215|2808725|P4|Overall Study|Ongoing at date of cut-off|38
881494|NCT01684215|2808726|P3|Overall Study|Ongoing at date of cut-off|4
881495|NCT01684215|2808727|P2|Overall Study|Ongoing at date of cut-off|0
881496|NCT01684215|2808728|P1|Overall Study|Ongoing at date of cut-off|0
881497|NCT01684215|2808725|P4|Overall Study|Death|1
881498|NCT01684215|2808726|P3|Overall Study|Death|0
881499|NCT01684215|2808727|P2|Overall Study|Death|0
881500|NCT01684215|2808728|P1|Overall Study|Death|0
881501|NCT01684215|2808725|P4|Overall Study|Other|0
881502|NCT01684215|2808726|P3|Overall Study|Other|1
881503|NCT01684215|2808727|P2|Overall Study|Other|0
881504|NCT01684215|2808728|P1|Overall Study|Other|0
881505|NCT01684215|2808725|P4|Overall Study|Objective progression or relapse|0
881506|NCT01684215|2808726|P3|Overall Study|Objective progression or relapse|0
881507|NCT01684215|2808727|P2|Overall Study|Objective progression or relapse|6
881508|NCT01684215|2808728|P1|Overall Study|Objective progression or relapse|5
881509|NCT01684215|2808725|P4|Overall Study|Adverse Event|4
881510|NCT01684215|2808726|P3|Overall Study|Adverse Event|1
881511|NCT01684215|2808727|P2|Overall Study|Adverse Event|0
881512|NCT01684215|2808728|P1|Overall Study|Adverse Event|1
881513|NCT01668784|2808804|P2|Treated (Overall)|Not Specified|4
881514|NCT01668784|2808805|P1|Treated (Overall)|Not Specified|0
881515|NCT01668784|2808804|P2|Treated (Overall)|Maximal Clinical Benefit|3
881516|NCT01668784|2808805|P1|Treated (Overall)|Maximal Clinical Benefit|2
881517|NCT01668784|2808804|P2|Treated (Overall)|Withdrawal by Subject|3
881518|NCT01668784|2808805|P1|Treated (Overall)|Withdrawal by Subject|2
881519|NCT01668784|2808804|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
881520|NCT01668784|2808805|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
881521|NCT01668784|2808804|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
881522|NCT01668784|2808805|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
881523|NCT01668784|2808804|P2|Treated (Overall)|Death|1
881524|NCT01668784|2808805|P1|Treated (Overall)|Death|1
881525|NCT01668784|2808804|P2|Treated (Overall)|Study Drug Toxicity|53
881526|NCT01668784|2808805|P1|Treated (Overall)|Study Drug Toxicity|35
881527|NCT01668784|2808804|P2|Treated (Overall)|Disease Progression|273
881528|NCT01668784|2808805|P1|Treated (Overall)|Disease Progression|285
881529|NCT01668784|2808804|P2|Randomized (Pre-treatment)|Not Specified|1
881530|NCT01668784|2808805|P1|Randomized (Pre-treatment)|Not Specified|0
881531|NCT01668784|2808804|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
881532|NCT01668784|2808805|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
881533|NCT01668784|2808804|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
881534|NCT01668784|2808805|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
881535|NCT01668784|2808804|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
881536|NCT01668784|2808805|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
881537|NCT01668784|2808804|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
881538|NCT01668784|2808805|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
881539|NCT01668784|2808804|P2|Randomized (Pre-treatment)|Disease Progression|1
881540|NCT01668784|2808805|P1|Randomized (Pre-treatment)|Disease Progression|0
881563|NCT01496846|2808882|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
881564|NCT01496846|2808883|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
881565|NCT01496846|2808884|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
881566|NCT01496846|2808885|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
881567|NCT01496846|2808886|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
881568|NCT01496846|2808887|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
881584|NCT01284504|2808971|P2|Overall Study|Withdrawal by Subject|0
881585|NCT01284504|2808972|P1|Overall Study|Withdrawal by Subject|1
906288|NCT01936363|2880847|P2|Overall Study|Ongoing|5
906289|NCT01936363|2880848|P1|Overall Study|Ongoing|7
906290|NCT01920594|2880874|P2|Overall Study|Investigator discretion|1
906291|NCT01920594|2880875|P1|Overall Study|Investigator discretion|0
906292|NCT01920594|2880874|P2|Overall Study|Recovery|0
906293|NCT01920594|2880875|P1|Overall Study|Recovery|2
906294|NCT01920594|2880874|P2|Overall Study|Lost to Follow-up|0
906295|NCT01920594|2880875|P1|Overall Study|Lost to Follow-up|1
906296|NCT01920594|2880874|P2|Overall Study|Adverse Event|2
906297|NCT01920594|2880875|P1|Overall Study|Adverse Event|4
906298|NCT01911546|2880923|P1|Overall Study|Everolimus was discontinued|5
906299|NCT01911546|2880923|P1|Overall Study|Lost to Follow-up|1
906300|NCT01874054|2880930|P1|Follow-up Period|Continuing in Follow-up|48
906301|NCT01874054|2880930|P1|Follow-up Period|Withdrawal by Subject|1
906302|NCT01874054|2880930|P1|Treatment Period|Non-AE related|2
906303|NCT01874054|2880930|P1|Treatment Period|Withdrawal by Subject|6
906304|NCT01874054|2880930|P1|Treatment Period|Physician Decision|3
906305|NCT01874054|2880930|P1|Treatment Period|Adverse Event|20
906306|NCT01874054|2880930|P1|Treatment Period|Progressive Disease|7
906307|NCT01790594|2880985|P3|Overall Study|Terminated prior to week 76|0
906308|NCT01790594|2880986|P2|Overall Study|Terminated prior to week 76|2
906309|NCT01790594|2880987|P1|Overall Study|Terminated prior to week 76|0
906310|NCT01790594|2880985|P3|Overall Study|Transplant was not done|3
906311|NCT01790594|2880986|P2|Overall Study|Transplant was not done|0
906312|NCT01790594|2880987|P1|Overall Study|Transplant was not done|0
906313|NCT01790594|2880985|P3|Overall Study|Withdrawal by Subject|0
906314|NCT01790594|2880986|P2|Overall Study|Withdrawal by Subject|0
906315|NCT01790594|2880987|P1|Overall Study|Withdrawal by Subject|2
906316|NCT01790594|2880985|P3|Overall Study|Physician Decision|0
906317|NCT01790594|2880986|P2|Overall Study|Physician Decision|1
906318|NCT01790594|2880987|P1|Overall Study|Physician Decision|2
906319|NCT01790594|2880985|P3|Overall Study|Death|0
906320|NCT01790594|2880986|P2|Overall Study|Death|0
906321|NCT01790594|2880987|P1|Overall Study|Death|1
906322|NCT01721057|2881071|P7|Rescue Period|Lack of Efficacy|0
906323|NCT01721057|2881072|P6|Rescue Period|Lack of Efficacy|0
906324|NCT01721057|2881073|P5|Rescue Period|Lack of Efficacy|0
906325|NCT01721057|2881074|P4|Rescue Period|Lack of Efficacy|2
906326|NCT01721057|2881075|P3|Rescue Period|Lack of Efficacy|0
906327|NCT01721057|2881076|P2|Rescue Period|Lack of Efficacy|0
906328|NCT01721057|2881077|P1|Rescue Period|Lack of Efficacy|0
906329|NCT01721057|2881071|P7|Rescue Period|Adverse Event|0
906330|NCT01721057|2881072|P6|Rescue Period|Adverse Event|0
906331|NCT01721057|2881073|P5|Rescue Period|Adverse Event|0
906332|NCT01721057|2881074|P4|Rescue Period|Adverse Event|1
906333|NCT01721057|2881075|P3|Rescue Period|Adverse Event|0
906334|NCT01721057|2881076|P2|Rescue Period|Adverse Event|0
906335|NCT01721057|2881077|P1|Rescue Period|Adverse Event|0
906336|NCT01721057|2881071|P7|Treatment Period|Death|0
906337|NCT01721057|2881072|P6|Treatment Period|Death|0
906338|NCT01721057|2881073|P5|Treatment Period|Death|0
906339|NCT01721057|2881074|P4|Treatment Period|Death|0
906340|NCT01721057|2881075|P3|Treatment Period|Death|0
906341|NCT01721057|2881076|P2|Treatment Period|Death|0
906342|NCT01721057|2881077|P1|Treatment Period|Death|2
906343|NCT01721057|2881071|P7|Treatment Period|Physician Decision|0
906344|NCT01721057|2881072|P6|Treatment Period|Physician Decision|0
906345|NCT01721057|2881073|P5|Treatment Period|Physician Decision|0
906346|NCT01721057|2881074|P4|Treatment Period|Physician Decision|0
906347|NCT01721057|2881075|P3|Treatment Period|Physician Decision|3
906348|NCT01721057|2881076|P2|Treatment Period|Physician Decision|1
906349|NCT01721057|2881077|P1|Treatment Period|Physician Decision|0
906350|NCT01721057|2881071|P7|Treatment Period|Lost to Follow-up|0
906351|NCT01721057|2881072|P6|Treatment Period|Lost to Follow-up|0
906352|NCT01721057|2881073|P5|Treatment Period|Lost to Follow-up|0
906353|NCT01721057|2881074|P4|Treatment Period|Lost to Follow-up|0
906354|NCT01721057|2881075|P3|Treatment Period|Lost to Follow-up|0
906355|NCT01721057|2881076|P2|Treatment Period|Lost to Follow-up|0
906356|NCT01721057|2881077|P1|Treatment Period|Lost to Follow-up|1
906357|NCT01721057|2881071|P7|Treatment Period|Lack of Efficacy|0
906358|NCT01721057|2881072|P6|Treatment Period|Lack of Efficacy|0
906359|NCT01721057|2881073|P5|Treatment Period|Lack of Efficacy|0
906360|NCT01721057|2881074|P4|Treatment Period|Lack of Efficacy|0
906361|NCT01721057|2881075|P3|Treatment Period|Lack of Efficacy|0
906362|NCT01721057|2881076|P2|Treatment Period|Lack of Efficacy|3
906363|NCT01721057|2881077|P1|Treatment Period|Lack of Efficacy|7
906364|NCT01721057|2881071|P7|Treatment Period|Adverse Event|0
906365|NCT01721057|2881072|P6|Treatment Period|Adverse Event|0
906366|NCT01721057|2881073|P5|Treatment Period|Adverse Event|0
906367|NCT01721057|2881074|P4|Treatment Period|Adverse Event|0
906368|NCT01721057|2881075|P3|Treatment Period|Adverse Event|12
906369|NCT01721057|2881076|P2|Treatment Period|Adverse Event|10
906370|NCT01721057|2881077|P1|Treatment Period|Adverse Event|7
906371|NCT01721057|2881071|P7|Treatment Period|Withdrawal by Subject|0
906372|NCT01721057|2881072|P6|Treatment Period|Withdrawal by Subject|0
906373|NCT01721057|2881073|P5|Treatment Period|Withdrawal by Subject|0
906374|NCT01721057|2881074|P4|Treatment Period|Withdrawal by Subject|0
906375|NCT01721057|2881075|P3|Treatment Period|Withdrawal by Subject|8
906376|NCT01721057|2881076|P2|Treatment Period|Withdrawal by Subject|5
906377|NCT01721057|2881077|P1|Treatment Period|Withdrawal by Subject|11
906402|NCT01420926|2881323|P2|Overall Study|Continues on active treatment|3
906403|NCT01420926|2881324|P1|Overall Study|Continues on active treatment|1
906404|NCT01420926|2881323|P2|Overall Study|Physician Decision|5
906405|NCT01420926|2881324|P1|Overall Study|Physician Decision|7
906406|NCT01420926|2881323|P2|Overall Study|Non-protocol treatment|20
906407|NCT01420926|2881324|P1|Overall Study|Non-protocol treatment|17
906408|NCT01420926|2881323|P2|Overall Study|Withdrawal by Subject|16
906409|NCT01420926|2881324|P1|Overall Study|Withdrawal by Subject|11
906410|NCT01420926|2881323|P2|Overall Study|Death|17
906411|NCT01420926|2881324|P1|Overall Study|Death|18
906412|NCT01420926|2881323|P2|Overall Study|Adverse Event|4
906413|NCT01420926|2881324|P1|Overall Study|Adverse Event|6
906426|NCT01390389|2881360|P2|Overall Study|Screen Fail|1
906427|NCT01390389|2881361|P1|Overall Study|Screen Fail|2
906428|NCT01390389|2881360|P2|Overall Study|Withdrawal by Subject|0
906429|NCT01390389|2881361|P1|Overall Study|Withdrawal by Subject|2
906430|NCT01345669|2881392|P2|Overall Study|Other Reasons|60
906431|NCT01345669|2881393|P1|Overall Study|Other Reasons|111
906432|NCT01345669|2881392|P2|Overall Study|Withdrawal by Subject|13
906433|NCT01345669|2881393|P1|Overall Study|Withdrawal by Subject|52
906434|NCT01345669|2881392|P2|Overall Study|Lost to Follow-up|1
906435|NCT01345669|2881393|P1|Overall Study|Lost to Follow-up|1
906436|NCT01345669|2881392|P2|Overall Study|Protocol Violation|1
906437|NCT01345669|2881393|P1|Overall Study|Protocol Violation|3
906438|NCT01345669|2881392|P2|Overall Study|Adverse Event|9
906439|NCT01345669|2881393|P1|Overall Study|Adverse Event|63
906440|NCT01345669|2881392|P2|Overall Study|Second primary tumour|3
906441|NCT01345669|2881393|P1|Overall Study|Second primary tumour|4
906442|NCT01345669|2881392|P2|Overall Study|Primary tumour recurrence|32
906443|NCT01345669|2881393|P1|Overall Study|Primary tumour recurrence|53
906444|NCT01345253|2881411|P2|Overall Study|Withdrawal by Subject|19
906445|NCT01345253|2881412|P1|Overall Study|Withdrawal by Subject|9
906446|NCT01345253|2881411|P2|Overall Study|Physician Decision|12
906447|NCT01345253|2881412|P1|Overall Study|Physician Decision|4
906448|NCT01345253|2881411|P2|Overall Study|Lost to Follow-up|8
906449|NCT01345253|2881412|P1|Overall Study|Lost to Follow-up|3
906450|NCT01345253|2881411|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
906451|NCT01345253|2881412|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
906452|NCT01345253|2881411|P2|Overall Study|Protocol Violation|5
906453|NCT01345253|2881412|P1|Overall Study|Protocol Violation|1
906454|NCT01345253|2881411|P2|Overall Study|Lack of Efficacy|7
906455|NCT01345253|2881412|P1|Overall Study|Lack of Efficacy|11
906456|NCT01345253|2881411|P2|Overall Study|Adverse Event|27
906457|NCT01345253|2881412|P1|Overall Study|Adverse Event|22
906458|NCT01336634|2881429|P3|Overall Study|Ongoing|24
906459|NCT01336634|2881430|P2|Overall Study|Ongoing|22
906460|NCT01336634|2881431|P1|Overall Study|Ongoing|15
906461|NCT01336634|2881429|P3|Overall Study|Physician Decision|0
906462|NCT01336634|2881430|P2|Overall Study|Physician Decision|1
906463|NCT01336634|2881431|P1|Overall Study|Physician Decision|1
906464|NCT01336634|2881429|P3|Overall Study|Withdrawal by Subject|1
906465|NCT01336634|2881430|P2|Overall Study|Withdrawal by Subject|0
906466|NCT01336634|2881431|P1|Overall Study|Withdrawal by Subject|6
906467|NCT01336634|2881429|P3|Overall Study|Lost to Follow-up|1
906468|NCT01336634|2881430|P2|Overall Study|Lost to Follow-up|1
906469|NCT01336634|2881431|P1|Overall Study|Lost to Follow-up|2
906470|NCT01336634|2881429|P3|Overall Study|Death|10
906471|NCT01336634|2881430|P2|Overall Study|Death|33
906472|NCT01336634|2881431|P1|Overall Study|Death|60
906473|NCT01324622|2881474|P2|Overall Study|Lack of Efficacy|0
906474|NCT01324622|2881475|P1|Overall Study|Lack of Efficacy|1
906475|NCT01324622|2881474|P2|Overall Study|Death|0
906476|NCT01324622|2881475|P1|Overall Study|Death|1
906477|NCT01324622|2881474|P2|Overall Study|Lost to Follow-up|7
881766|NCT00868608|2809209|P3|Overall Study|Other - Unspecified|0
881767|NCT00868608|2809210|P2|Overall Study|Other - Unspecified|0
881768|NCT00868608|2809211|P1|Overall Study|Other - Unspecified|1
881769|NCT00868608|2809209|P3|Overall Study|Death|4
881770|NCT00868608|2809210|P2|Overall Study|Death|2
881771|NCT00868608|2809211|P1|Overall Study|Death|16
881772|NCT00868608|2809209|P3|Overall Study|Lost to Follow-up|1
881773|NCT00868608|2809210|P2|Overall Study|Lost to Follow-up|0
881774|NCT00868608|2809211|P1|Overall Study|Lost to Follow-up|3
881775|NCT00868608|2809209|P3|Overall Study|Withdrawal by Subject|0
881776|NCT00868608|2809210|P2|Overall Study|Withdrawal by Subject|1
881777|NCT00868608|2809211|P1|Overall Study|Withdrawal by Subject|3
906478|NCT01324622|2881475|P1|Overall Study|Lost to Follow-up|7
906479|NCT01298323|2881520|P2|Overall Study|Eligibility criteria not fulfilled|1
906480|NCT01298323|2881521|P1|Overall Study|Eligibility criteria not fulfilled|0
906481|NCT01298323|2881520|P2|Overall Study|Ongoing|55
906482|NCT01298323|2881521|P1|Overall Study|Ongoing|55
906483|NCT01298323|2881520|P2|Overall Study|Other|9
906484|NCT01298323|2881521|P1|Overall Study|Other|10
906485|NCT01298323|2881520|P2|Overall Study|Protocol Violation|0
906486|NCT01298323|2881521|P1|Overall Study|Protocol Violation|1
906487|NCT01298323|2881520|P2|Overall Study|Withdrawal by Subject|3
906488|NCT01298323|2881521|P1|Overall Study|Withdrawal by Subject|6
906489|NCT01298323|2881520|P2|Overall Study|Lost to Follow-up|0
906490|NCT01298323|2881521|P1|Overall Study|Lost to Follow-up|1
906491|NCT01298323|2881520|P2|Overall Study|Death|16
906492|NCT01298323|2881521|P1|Overall Study|Death|11
906493|NCT01298323|2881520|P2|Overall Study|Adverse Event|4
906494|NCT01298323|2881521|P1|Overall Study|Adverse Event|2
906509|NCT01235689|2881593|P2|Overall Study|Miscellaneous|5
906510|NCT01235689|2881594|P1|Overall Study|Miscellaneous|1
906511|NCT01235689|2881593|P2|Overall Study|Lost to Follow-up|2
906512|NCT01235689|2881594|P1|Overall Study|Lost to Follow-up|1
906513|NCT01235689|2881593|P2|Overall Study|Withdrawal by Subject|4
906514|NCT01235689|2881594|P1|Overall Study|Withdrawal by Subject|3
906515|NCT01235689|2881593|P2|Overall Study|Lack of Efficacy|5
906516|NCT01235689|2881594|P1|Overall Study|Lack of Efficacy|12
906517|NCT01235689|2881593|P2|Overall Study|Adverse Event|16
906518|NCT01235689|2881594|P1|Overall Study|Adverse Event|12
906527|NCT01015118|2881773|P2|Overall Study|Other than stated above|23
906528|NCT01015118|2881774|P1|Overall Study|Other than stated above|42
906529|NCT01015118|2881773|P2|Overall Study|Not treated|5
906530|NCT01015118|2881774|P1|Overall Study|Not treated|9
906531|NCT01015118|2881773|P2|Overall Study|Progressive disease|229
906532|NCT01015118|2881774|P1|Overall Study|Progressive disease|364
906533|NCT01015118|2881773|P2|Overall Study|Worsening or AE of underlying disease|4
906534|NCT01015118|2881774|P1|Overall Study|Worsening or AE of underlying disease|5
906535|NCT01015118|2881773|P2|Overall Study|Other Adverse Event (AE)|33
906536|NCT01015118|2881774|P1|Overall Study|Other Adverse Event (AE)|141
906537|NCT01015118|2881773|P2|Overall Study|Withdrawal by Subject|27
906538|NCT01015118|2881774|P1|Overall Study|Withdrawal by Subject|103
906539|NCT01015118|2881773|P2|Overall Study|Protocol Violation|6
906540|NCT01015118|2881774|P1|Overall Study|Protocol Violation|5
906541|NCT00910962|2881799|P3|Overall Study|Reached defined stopping criteria|17
906542|NCT00910962|2881800|P2|Overall Study|Reached defined stopping criteria|14
906543|NCT00910962|2881801|P1|Overall Study|Reached defined stopping criteria|12
906544|NCT00910962|2881799|P3|Overall Study|Withdrawal by Subject|32
906545|NCT00910962|2881800|P2|Overall Study|Withdrawal by Subject|32
906546|NCT00910962|2881801|P1|Overall Study|Withdrawal by Subject|25
906547|NCT00910962|2881799|P3|Overall Study|Physician Decision|6
906548|NCT00910962|2881800|P2|Overall Study|Physician Decision|6
906549|NCT00910962|2881801|P1|Overall Study|Physician Decision|0
906550|NCT00910962|2881799|P3|Overall Study|Lost to Follow-up|1
906551|NCT00910962|2881800|P2|Overall Study|Lost to Follow-up|3
906552|NCT00910962|2881801|P1|Overall Study|Lost to Follow-up|0
906553|NCT00910962|2881799|P3|Overall Study|Protocol Violation|3
906554|NCT00910962|2881800|P2|Overall Study|Protocol Violation|3
906555|NCT00910962|2881801|P1|Overall Study|Protocol Violation|1
906556|NCT00910962|2881799|P3|Overall Study|Adverse Event|17
906557|NCT00910962|2881800|P2|Overall Study|Adverse Event|20
906558|NCT00910962|2881801|P1|Overall Study|Adverse Event|5
881857|NCT00331344|2809553|P9|Phase II|Death|4
881858|NCT00331344|2809554|P8|Phase II|Death|0
881859|NCT00331344|2809555|P7|Phase II|Death|0
881860|NCT00331344|2809556|P6|Phase II|Death|0
881861|NCT00331344|2809557|P5|Phase II|Death|0
881862|NCT00331344|2809558|P4|Phase II|Death|0
881863|NCT00331344|2809559|P3|Phase II|Death|0
881864|NCT00331344|2809560|P2|Phase II|Death|0
881865|NCT00331344|2809561|P1|Phase II|Death|0
881866|NCT00331344|2809553|P9|Phase I|Adverse Event|0
881867|NCT00331344|2809554|P8|Phase I|Adverse Event|1
881868|NCT00331344|2809555|P7|Phase I|Adverse Event|0
881869|NCT00331344|2809556|P6|Phase I|Adverse Event|2
881870|NCT00331344|2809557|P5|Phase I|Adverse Event|2
881871|NCT00331344|2809558|P4|Phase I|Adverse Event|1
881872|NCT00331344|2809559|P3|Phase I|Adverse Event|0
881873|NCT00331344|2809560|P2|Phase I|Adverse Event|0
881874|NCT00331344|2809561|P1|Phase I|Adverse Event|0
881883|NCT00005044|2809608|P2|Overall Study|No protocol treatment|1
881884|NCT00005044|2809609|P1|Overall Study|No protocol treatment|0
881885|NCT00005044|2809608|P2|Overall Study|Withdrawal by Subject|5
881886|NCT00005044|2809609|P1|Overall Study|Withdrawal by Subject|1
881887|NCT00005044|2809608|P2|Overall Study|Protocol Violation|46
881888|NCT00005044|2809609|P1|Overall Study|Protocol Violation|37
881889|NCT02706327|2809641|P3|Overall Study|Lost to Follow-up|2
881890|NCT02706327|2809642|P2|Overall Study|Lost to Follow-up|1
881891|NCT02706327|2809643|P1|Overall Study|Lost to Follow-up|1
881892|NCT02433483|2809707|P1|Overall Study|Other antineoplastic therapy/HSCT|1
881893|NCT02433483|2809707|P1|Overall Study|Unacceptable toxicity|1
881910|NCT02116309|2809756|P2|Overall Study|Lost to Follow-up|1
881911|NCT02116309|2809757|P1|Overall Study|Lost to Follow-up|0
881912|NCT02099110|2809770|P5|Overall Study|Physician Decision|1
881913|NCT02099110|2809771|P4|Overall Study|Physician Decision|2
881914|NCT02099110|2809772|P3|Overall Study|Physician Decision|1
881915|NCT02099110|2809773|P2|Overall Study|Physician Decision|0
881916|NCT02099110|2809774|P1|Overall Study|Physician Decision|3
881917|NCT02099110|2809770|P5|Overall Study|Non-compliance with study drug|1
881918|NCT02099110|2809771|P4|Overall Study|Non-compliance with study drug|0
881919|NCT02099110|2809772|P3|Overall Study|Non-compliance with study drug|0
881920|NCT02099110|2809773|P2|Overall Study|Non-compliance with study drug|0
881921|NCT02099110|2809774|P1|Overall Study|Non-compliance with study drug|2
881922|NCT02099110|2809770|P5|Overall Study|Screen failure|1
881923|NCT02099110|2809771|P4|Overall Study|Screen failure|0
881924|NCT02099110|2809772|P3|Overall Study|Screen failure|0
881925|NCT02099110|2809773|P2|Overall Study|Screen failure|0
881926|NCT02099110|2809774|P1|Overall Study|Screen failure|0
881927|NCT02099110|2809770|P5|Overall Study|Death|0
881928|NCT02099110|2809771|P4|Overall Study|Death|0
881929|NCT02099110|2809772|P3|Overall Study|Death|0
881930|NCT02099110|2809773|P2|Overall Study|Death|1
881931|NCT02099110|2809774|P1|Overall Study|Death|0
881932|NCT02099110|2809770|P5|Overall Study|Lost to Follow-up|6
881933|NCT02099110|2809771|P4|Overall Study|Lost to Follow-up|5
881934|NCT02099110|2809772|P3|Overall Study|Lost to Follow-up|11
881935|NCT02099110|2809773|P2|Overall Study|Lost to Follow-up|12
881936|NCT02099110|2809774|P1|Overall Study|Lost to Follow-up|6
881937|NCT02099110|2809770|P5|Overall Study|Adverse Event|2
881938|NCT02099110|2809771|P4|Overall Study|Adverse Event|3
881939|NCT02099110|2809772|P3|Overall Study|Adverse Event|2
881940|NCT02099110|2809773|P2|Overall Study|Adverse Event|5
881941|NCT02099110|2809774|P1|Overall Study|Adverse Event|3
881942|NCT02099110|2809770|P5|Overall Study|Withdrawal by Subject|13
881943|NCT02099110|2809771|P4|Overall Study|Withdrawal by Subject|9
881944|NCT02099110|2809772|P3|Overall Study|Withdrawal by Subject|13
881945|NCT02099110|2809773|P2|Overall Study|Withdrawal by Subject|11
881946|NCT02099110|2809774|P1|Overall Study|Withdrawal by Subject|7
881947|NCT02099110|2809770|P5|Overall Study|Participant moved|2
881948|NCT02099110|2809771|P4|Overall Study|Participant moved|0
881949|NCT02099110|2809772|P3|Overall Study|Participant moved|1
881950|NCT02099110|2809773|P2|Overall Study|Participant moved|1
881951|NCT02099110|2809774|P1|Overall Study|Participant moved|1
881952|NCT02099110|2809770|P5|Overall Study|Protocol Violation|1
881953|NCT02099110|2809771|P4|Overall Study|Protocol Violation|3
881954|NCT02099110|2809772|P3|Overall Study|Protocol Violation|0
881955|NCT02099110|2809773|P2|Overall Study|Protocol Violation|1
881956|NCT02099110|2809774|P1|Overall Study|Protocol Violation|2
881957|NCT01945021|2809821|P1|Overall Study|Non-RECIST disease progression|1
881958|NCT01945021|2809821|P1|Overall Study|Withdrawal of consent|3
881959|NCT01945021|2809821|P1|Overall Study|Withdrawal by Subject|2
881960|NCT01945021|2809821|P1|Overall Study|Global deterioration of health-related s|1
881961|NCT01945021|2809821|P1|Overall Study|Disease progression by RECIST v1.1|30
881962|NCT01945021|2809821|P1|Overall Study|Pregnancy|1
881963|NCT01945021|2809821|P1|Overall Study|Death|1
881964|NCT01945021|2809821|P1|Overall Study|Adverse Event|8
881965|NCT01740427|2809837|P2|Overall Study|Study terminated by Sponsor|0
881966|NCT01740427|2809838|P1|Overall Study|Study terminated by Sponsor|1
881967|NCT01740427|2809837|P2|Overall Study|Lost to Follow-up|0
881968|NCT01740427|2809838|P1|Overall Study|Lost to Follow-up|1
881969|NCT01740427|2809837|P2|Overall Study|Protocol Violation|3
881970|NCT01740427|2809838|P1|Overall Study|Protocol Violation|5
881971|NCT01740427|2809837|P2|Overall Study|Death|2
881972|NCT01740427|2809838|P1|Overall Study|Death|6
881973|NCT01740427|2809837|P2|Overall Study|Unspecified reasons|4
881974|NCT01740427|2809838|P1|Overall Study|Unspecified reasons|6
881975|NCT01740427|2809837|P2|Overall Study|Subject refused continued treatment|9
881976|NCT01740427|2809838|P1|Overall Study|Subject refused continued treatment|12
881977|NCT01740427|2809837|P2|Overall Study|Global deterioration of health status|9
881978|NCT01740427|2809838|P1|Overall Study|Global deterioration of health status|16
881979|NCT01740427|2809837|P2|Overall Study|Adverse Event|9
881980|NCT01740427|2809838|P1|Overall Study|Adverse Event|20
881981|NCT01740427|2809837|P2|Overall Study|Objective progression or relapse|125
881982|NCT01740427|2809838|P1|Overall Study|Objective progression or relapse|172
881983|NCT01740427|2809837|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
881984|NCT01740427|2809838|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
881985|NCT01688921|2809867|P2|Overall Study|informed consent|0
881986|NCT01688921|2809868|P1|Overall Study|informed consent|3
881987|NCT01688921|2809867|P2|Overall Study|Protocol Violation|1
881988|NCT01688921|2809868|P1|Overall Study|Protocol Violation|0
881989|NCT01688921|2809867|P2|Overall Study|Physician Decision|1
881990|NCT01688921|2809868|P1|Overall Study|Physician Decision|6
881991|NCT01688921|2809867|P2|Overall Study|Lost to Follow-up|13
881992|NCT01688921|2809868|P1|Overall Study|Lost to Follow-up|7
881993|NCT01572389|2809893|P2|Overall Study|Only A1C or Assessment was Collected|2
881994|NCT01572389|2809894|P1|Overall Study|Only A1C or Assessment was Collected|6
881995|NCT01572389|2809893|P2|Overall Study|Lost to Follow-up|14
881996|NCT01572389|2809894|P1|Overall Study|Lost to Follow-up|25
881997|NCT01572389|2809893|P2|Overall Study|Withdrawal by Subject|2
881998|NCT01572389|2809894|P1|Overall Study|Withdrawal by Subject|14
881999|NCT01572389|2809893|P2|Overall Study|Death|3
882000|NCT01572389|2809894|P1|Overall Study|Death|1
882001|NCT01557166|2809904|P2|Overall Study|Unclassified|5
882002|NCT01557166|2809905|P1|Overall Study|Unclassified|2
882003|NCT01557166|2809904|P2|Overall Study|Psychiatric disorder|0
882004|NCT01557166|2809905|P1|Overall Study|Psychiatric disorder|1
882005|NCT01557166|2809904|P2|Overall Study|Target dose not tolerated|0
882006|NCT01557166|2809905|P1|Overall Study|Target dose not tolerated|1
882007|NCT01557166|2809904|P2|Overall Study|Withdrawn consent|20
882008|NCT01557166|2809905|P1|Overall Study|Withdrawn consent|12
882009|NCT01557166|2809904|P2|Overall Study|Protocol Violation|5
882010|NCT01557166|2809905|P1|Overall Study|Protocol Violation|8
882011|NCT01557166|2809904|P2|Overall Study|Lack of Efficacy|1
882012|NCT01557166|2809905|P1|Overall Study|Lack of Efficacy|2
882013|NCT01557166|2809904|P2|Overall Study|Adverse Event|6
882014|NCT01557166|2809905|P1|Overall Study|Adverse Event|20
882015|NCT01454076|2809922|P5|Overall Study|Adverse Event|2
882016|NCT01454076|2809923|P4|Overall Study|Adverse Event|0
882017|NCT01454076|2809924|P3|Overall Study|Adverse Event|7
882018|NCT01454076|2809925|P2|Overall Study|Adverse Event|2
882019|NCT01454076|2809926|P1|Overall Study|Adverse Event|8
882020|NCT01454076|2809922|P5|Overall Study|Withdrawal by Subject|2
882021|NCT01454076|2809923|P4|Overall Study|Withdrawal by Subject|1
882022|NCT01454076|2809924|P3|Overall Study|Withdrawal by Subject|2
882023|NCT01454076|2809925|P2|Overall Study|Withdrawal by Subject|4
882024|NCT01454076|2809926|P1|Overall Study|Withdrawal by Subject|3
882025|NCT01454076|2809922|P5|Overall Study|Other|2
882026|NCT01454076|2809923|P4|Overall Study|Other|1
882027|NCT01454076|2809924|P3|Overall Study|Other|0
882028|NCT01454076|2809925|P2|Overall Study|Other|0
882029|NCT01454076|2809926|P1|Overall Study|Other|2
882030|NCT01272232|2809980|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
882031|NCT01272232|2809981|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
882032|NCT01272232|2809982|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
882033|NCT01272232|2809980|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
882034|NCT01272232|2809981|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
882035|NCT01272232|2809982|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
882036|NCT01272232|2809980|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
882037|NCT01272232|2809981|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
882038|NCT01272232|2809982|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
882039|NCT01272232|2809980|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
882040|NCT01272232|2809981|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
882041|NCT01272232|2809982|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
882042|NCT01272232|2809980|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
882043|NCT01272232|2809981|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
882044|NCT01272232|2809982|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
882045|NCT01272232|2809980|P3|Weeks 0-56|Unclassified|12
882046|NCT01272232|2809981|P2|Weeks 0-56|Unclassified|7
882047|NCT01272232|2809982|P1|Weeks 0-56|Unclassified|16
882048|NCT01272232|2809980|P3|Weeks 0-56|Withdrawal criteria|37
882049|NCT01272232|2809981|P2|Weeks 0-56|Withdrawal criteria|14
882050|NCT01272232|2809982|P1|Weeks 0-56|Withdrawal criteria|32
882051|NCT01272232|2809980|P3|Weeks 0-56|Protocol Violation|13
882052|NCT01272232|2809981|P2|Weeks 0-56|Protocol Violation|8
882053|NCT01272232|2809982|P1|Weeks 0-56|Protocol Violation|12
882054|NCT01272232|2809980|P3|Weeks 0-56|Lack of Efficacy|3
882055|NCT01272232|2809981|P2|Weeks 0-56|Lack of Efficacy|0
882056|NCT01272232|2809982|P1|Weeks 0-56|Lack of Efficacy|0
882057|NCT01272232|2809980|P3|Weeks 0-56|Adverse Event|7
882058|NCT01272232|2809981|P2|Weeks 0-56|Adverse Event|18
882059|NCT01272232|2809982|P1|Weeks 0-56|Adverse Event|39
882060|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Unclassified|51
882061|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Unclassified|61
882062|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Unclassified|0
882063|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Unclassified|0
882064|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Unclassified|0
882065|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Unclassified|0
882066|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Missing reason|0
882067|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Missing reason|1
882068|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Missing reason|0
882069|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Missing reason|0
882070|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Missing reason|0
882071|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Missing reason|0
882072|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
882073|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
882074|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
882075|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
882076|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
882077|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
882078|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
882079|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
882080|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
882081|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
882082|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
882083|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
882084|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
882085|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
882086|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
882087|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
882088|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
882089|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
882090|NCT01272219|2810027|P6|Main + Extension Period: Week 0-172|Adverse Event|43
882091|NCT01272219|2810028|P5|Main + Extension Period: Week 0-172|Adverse Event|191
882092|NCT01272219|2810029|P4|Main + Extension Period: Week 0-172|Adverse Event|0
882093|NCT01272219|2810030|P3|Main + Extension Period: Week 0-172|Adverse Event|0
882094|NCT01272219|2810031|P2|Main + Extension Period: Week 0-172|Adverse Event|0
882095|NCT01272219|2810032|P1|Main + Extension Period: Week 0-172|Adverse Event|0
882096|NCT01272219|2810027|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
882097|NCT01272219|2810028|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
882098|NCT01272219|2810029|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
882099|NCT01272219|2810030|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
882100|NCT01272219|2810031|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
882101|NCT01272219|2810032|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
882102|NCT01272219|2810027|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
882103|NCT01272219|2810028|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
882104|NCT01272219|2810029|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
882105|NCT01272219|2810030|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
882106|NCT01272219|2810031|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
882107|NCT01272219|2810032|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
882108|NCT01272219|2810027|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
882109|NCT01272219|2810028|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
882110|NCT01272219|2810029|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
882111|NCT01272219|2810030|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
882112|NCT01272219|2810031|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
882113|NCT01272219|2810032|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
882114|NCT01272219|2810027|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
882115|NCT01272219|2810028|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
882116|NCT01272219|2810029|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
882117|NCT01272219|2810030|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
882118|NCT01272219|2810031|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
882119|NCT01272219|2810032|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
882120|NCT01272219|2810027|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
882121|NCT01272219|2810028|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
882122|NCT01272219|2810029|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
882123|NCT01272219|2810030|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
882124|NCT01272219|2810031|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
882125|NCT01272219|2810032|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
882126|NCT01272219|2810027|P6|Main Period: Week 0 to Week 56|Unclassified|34
882127|NCT01272219|2810028|P5|Main Period: Week 0 to Week 56|Unclassified|42
882128|NCT01272219|2810029|P4|Main Period: Week 0 to Week 56|Unclassified|29
882129|NCT01272219|2810030|P3|Main Period: Week 0 to Week 56|Unclassified|0
882130|NCT01272219|2810031|P2|Main Period: Week 0 to Week 56|Unclassified|0
882131|NCT01272219|2810032|P1|Main Period: Week 0 to Week 56|Unclassified|36
882132|NCT01272219|2810027|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
882133|NCT01272219|2810028|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
882134|NCT01272219|2810029|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
882135|NCT01272219|2810030|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
882136|NCT01272219|2810031|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
882137|NCT01272219|2810032|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
882219|NCT00845182|2810207|P2|Overall Study|Lost to Follow-up|3
882138|NCT01272219|2810027|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
882139|NCT01272219|2810028|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
882140|NCT01272219|2810029|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
882141|NCT01272219|2810030|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
882142|NCT01272219|2810031|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
882143|NCT01272219|2810032|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
882144|NCT01272219|2810027|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
882145|NCT01272219|2810028|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
882146|NCT01272219|2810029|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
882147|NCT01272219|2810030|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
882148|NCT01272219|2810031|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
882149|NCT01272219|2810032|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
882150|NCT01272219|2810027|P6|Main Period: Week 0 to Week 56|Adverse Event|29
882151|NCT01272219|2810028|P5|Main Period: Week 0 to Week 56|Adverse Event|152
882152|NCT01272219|2810029|P4|Main Period: Week 0 to Week 56|Adverse Event|16
882153|NCT01272219|2810030|P3|Main Period: Week 0 to Week 56|Adverse Event|0
882154|NCT01272219|2810031|P2|Main Period: Week 0 to Week 56|Adverse Event|0
882155|NCT01272219|2810032|P1|Main Period: Week 0 to Week 56|Adverse Event|86
882156|NCT01200355|2810066|P2|Overall Study|Death|2
882157|NCT01200355|2810067|P1|Overall Study|Death|7
882164|NCT00981149|2810127|P2|Overall Study|Withdrawal by Subject|1
882165|NCT00981149|2810128|P1|Overall Study|Withdrawal by Subject|1
882166|NCT00981149|2810127|P2|Overall Study|Lost to Follow-up|2
882167|NCT00981149|2810128|P1|Overall Study|Lost to Follow-up|1
882168|NCT00950300|2810136|P2|SFU Period|Participant Refusal/Withdrawal|6
882169|NCT00950300|2810137|P1|SFU Period|Participant Refusal/Withdrawal|2
882170|NCT00950300|2810136|P2|SFU Period|Lost to Follow-up|9
882171|NCT00950300|2810137|P1|SFU Period|Lost to Follow-up|11
882172|NCT00950300|2810136|P2|SFU Period|Death|21
882173|NCT00950300|2810137|P1|SFU Period|Death|28
882174|NCT00950300|2810136|P2|SFU Period|Ongoing in SFU|18
882175|NCT00950300|2810137|P1|SFU Period|Ongoing in SFU|12
882176|NCT00950300|2810136|P2|TFFU Period|Not Specified|1
882177|NCT00950300|2810137|P1|TFFU Period|Not Specified|1
882178|NCT00950300|2810136|P2|TFFU Period|Recurrence of Disease|55
882179|NCT00950300|2810137|P1|TFFU Period|Recurrence of Disease|48
882180|NCT00950300|2810136|P2|TFFU Period|Lost to Follow-up|4
882181|NCT00950300|2810137|P1|TFFU Period|Lost to Follow-up|6
882182|NCT00950300|2810136|P2|TFFU Period|Participant Refusal/Withdrawal|8
882183|NCT00950300|2810137|P1|TFFU Period|Participant Refusal/Withdrawal|5
882184|NCT00950300|2810136|P2|TFFU Period|Death|0
882185|NCT00950300|2810137|P1|TFFU Period|Death|1
882186|NCT00950300|2810136|P2|TFFU Period|Adverse Event or Intercurrent Illness|1
882187|NCT00950300|2810137|P1|TFFU Period|Adverse Event or Intercurrent Illness|1
882188|NCT00950300|2810136|P2|TFFU Period|Ongoing in TFFU|183
882189|NCT00950300|2810137|P1|TFFU Period|Ongoing in TFFU|192
882190|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
882191|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
882192|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
882193|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
882194|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
882195|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
882196|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
882197|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
882198|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
882199|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
882200|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
882201|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
882202|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
882203|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
882204|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
882205|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
882206|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
882207|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
882208|NCT00950300|2810136|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
882209|NCT00950300|2810137|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
882210|NCT00860743|2810196|P2|Overall Study|Withdrawal by Subject|0
882211|NCT00860743|2810197|P1|Overall Study|Withdrawal by Subject|3
882212|NCT00845182|2810206|P3|Overall Study|Physician Decision|1
882213|NCT00845182|2810207|P2|Overall Study|Physician Decision|0
882214|NCT00845182|2810208|P1|Overall Study|Physician Decision|0
882215|NCT00845182|2810206|P3|Overall Study|Adverse Event|1
882216|NCT00845182|2810207|P2|Overall Study|Adverse Event|1
882217|NCT00845182|2810208|P1|Overall Study|Adverse Event|0
882218|NCT00845182|2810206|P3|Overall Study|Lost to Follow-up|4
882220|NCT00845182|2810208|P1|Overall Study|Lost to Follow-up|3
882221|NCT00781937|2810221|P2|Follow up Period (Week 56-68)|Unclassified|4
882222|NCT00781937|2810222|P1|Follow up Period (Week 56-68)|Unclassified|5
882223|NCT00781937|2810221|P2|Follow up Period (Week 56-68)|Protocol Violation|1
882224|NCT00781937|2810222|P1|Follow up Period (Week 56-68)|Protocol Violation|1
882225|NCT00781937|2810221|P2|Main Trial Period Through Week 56|Unclassified|15
882226|NCT00781937|2810222|P1|Main Trial Period Through Week 56|Unclassified|10
882227|NCT00781937|2810221|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
882228|NCT00781937|2810222|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
882229|NCT00781937|2810221|P2|Main Trial Period Through Week 56|Protocol Violation|5
882230|NCT00781937|2810222|P1|Main Trial Period Through Week 56|Protocol Violation|8
882231|NCT00781937|2810221|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
882232|NCT00781937|2810222|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
882233|NCT00781937|2810221|P2|Main Trial Period Through Week 56|Adverse Event|18
882234|NCT00781937|2810222|P1|Main Trial Period Through Week 56|Adverse Event|18
882235|NCT00422058|2810295|P6|Open-Label Extension, Week 20-104|Other|18
882236|NCT00422058|2810296|P5|Open-Label Extension, Week 20-104|Other|16
882237|NCT00422058|2810297|P4|Open-Label Extension, Week 20-104|Other|13
882238|NCT00422058|2810298|P3|Open-Label Extension, Week 20-104|Other|6
882239|NCT00422058|2810299|P2|Open-Label Extension, Week 20-104|Other|14
882240|NCT00422058|2810300|P1|Open-Label Extension, Week 20-104|Other|13
882241|NCT00422058|2810295|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
882242|NCT00422058|2810296|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
882243|NCT00422058|2810297|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
882244|NCT00422058|2810298|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
882245|NCT00422058|2810299|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
882246|NCT00422058|2810300|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
882247|NCT00422058|2810295|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
882248|NCT00422058|2810296|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
882249|NCT00422058|2810297|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
882250|NCT00422058|2810298|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
882251|NCT00422058|2810299|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
882252|NCT00422058|2810300|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
882253|NCT00422058|2810295|P6|Open-Label Extension, Week 20-104|Adverse Event|0
882254|NCT00422058|2810296|P5|Open-Label Extension, Week 20-104|Adverse Event|4
882255|NCT00422058|2810297|P4|Open-Label Extension, Week 20-104|Adverse Event|4
882256|NCT00422058|2810298|P3|Open-Label Extension, Week 20-104|Adverse Event|7
882257|NCT00422058|2810299|P2|Open-Label Extension, Week 20-104|Adverse Event|4
882258|NCT00422058|2810300|P1|Open-Label Extension, Week 20-104|Adverse Event|3
882259|NCT00422058|2810295|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
882260|NCT00422058|2810296|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
882261|NCT00422058|2810297|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
882262|NCT00422058|2810298|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
882263|NCT00422058|2810299|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
882264|NCT00422058|2810300|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
882265|NCT00422058|2810295|P6|Double-Blind, Week 0-20|Other|10
882266|NCT00422058|2810296|P5|Double-Blind, Week 0-20|Other|4
882267|NCT00422058|2810297|P4|Double-Blind, Week 0-20|Other|8
882268|NCT00422058|2810298|P3|Double-Blind, Week 0-20|Other|8
882269|NCT00422058|2810299|P2|Double-Blind, Week 0-20|Other|3
882270|NCT00422058|2810300|P1|Double-Blind, Week 0-20|Other|11
882271|NCT00422058|2810295|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
882272|NCT00422058|2810296|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
882273|NCT00422058|2810297|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
882274|NCT00422058|2810298|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
882275|NCT00422058|2810299|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
882276|NCT00422058|2810300|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
882277|NCT00422058|2810295|P6|Double-Blind, Week 0-20|Protocol Violation|2
882278|NCT00422058|2810296|P5|Double-Blind, Week 0-20|Protocol Violation|2
882279|NCT00422058|2810297|P4|Double-Blind, Week 0-20|Protocol Violation|3
882280|NCT00422058|2810298|P3|Double-Blind, Week 0-20|Protocol Violation|2
882281|NCT00422058|2810299|P2|Double-Blind, Week 0-20|Protocol Violation|2
882282|NCT00422058|2810300|P1|Double-Blind, Week 0-20|Protocol Violation|3
882283|NCT00422058|2810295|P6|Double-Blind, Week 0-20|Adverse Event|3
882284|NCT00422058|2810296|P5|Double-Blind, Week 0-20|Adverse Event|5
882285|NCT00422058|2810297|P4|Double-Blind, Week 0-20|Adverse Event|9
882286|NCT00422058|2810298|P3|Double-Blind, Week 0-20|Adverse Event|5
882287|NCT00422058|2810299|P2|Double-Blind, Week 0-20|Adverse Event|4
882288|NCT00422058|2810300|P1|Double-Blind, Week 0-20|Adverse Event|3
882289|NCT00266864|2810441|P2|Overall Study|Withdrawal by Subject|1
882290|NCT00266864|2810442|P1|Overall Study|Withdrawal by Subject|1
882291|NCT00266864|2810441|P2|Overall Study|Lost to Follow-up|1
882292|NCT00266864|2810442|P1|Overall Study|Lost to Follow-up|4
882293|NCT00223795|2810449|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
882294|NCT00223795|2810450|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
882295|NCT00223795|2810449|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
882296|NCT00223795|2810450|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
906601|NCT00737464|2881988|P1|Overall Study|Other reasons|4
906602|NCT00737464|2881988|P1|Overall Study|Refused Treatment / Withdrew Consent|6
906603|NCT00737464|2881988|P1|Overall Study|Other - Failure to Return|1
906604|NCT00737464|2881988|P1|Overall Study|Death|6
906605|NCT00737464|2881988|P1|Overall Study|Adverse Event|1
906616|NCT00710684|2882211|P3|Overall Study|Did not continue after week 24|16
906617|NCT00710684|2882212|P2|Overall Study|Did not continue after week 24|21
906618|NCT00710684|2882213|P1|Overall Study|Did not continue after week 24|25
906619|NCT00710684|2882211|P3|Overall Study|Missing|0
906620|NCT00710684|2882212|P2|Overall Study|Missing|0
906621|NCT00710684|2882213|P1|Overall Study|Missing|1
906622|NCT00710684|2882211|P3|Overall Study|Withdrawal by Subject|11
906623|NCT00710684|2882212|P2|Overall Study|Withdrawal by Subject|18
906624|NCT00710684|2882213|P1|Overall Study|Withdrawal by Subject|24
906625|NCT00710684|2882211|P3|Overall Study|Physician Decision|4
906626|NCT00710684|2882212|P2|Overall Study|Physician Decision|2
906627|NCT00710684|2882213|P1|Overall Study|Physician Decision|0
906628|NCT00710684|2882211|P3|Overall Study|Lost to Follow-up|7
906629|NCT00710684|2882212|P2|Overall Study|Lost to Follow-up|6
906630|NCT00710684|2882213|P1|Overall Study|Lost to Follow-up|4
906631|NCT00710684|2882211|P3|Overall Study|Protocol Violation|5
906632|NCT00710684|2882212|P2|Overall Study|Protocol Violation|5
906633|NCT00710684|2882213|P1|Overall Study|Protocol Violation|5
906634|NCT00710684|2882211|P3|Overall Study|Lack of Efficacy|5
906635|NCT00710684|2882212|P2|Overall Study|Lack of Efficacy|3
906636|NCT00710684|2882213|P1|Overall Study|Lack of Efficacy|4
906637|NCT00710684|2882211|P3|Overall Study|Adverse Event|16
906638|NCT00710684|2882212|P2|Overall Study|Adverse Event|19
906639|NCT00710684|2882213|P1|Overall Study|Adverse Event|11
906640|NCT00688155|2882293|P4|Overall Study|Withdrawal by Subject|1
906641|NCT00688155|2882294|P3|Overall Study|Withdrawal by Subject|1
906642|NCT00688155|2882295|P2|Overall Study|Withdrawal by Subject|2
906643|NCT00688155|2882296|P1|Overall Study|Withdrawal by Subject|2
906654|NCT00661427|2882336|P2|Overall Study|Patient not treated|2
906655|NCT00661427|2882337|P1|Overall Study|Patient not treated|0
906656|NCT00661427|2882336|P2|Overall Study|Adverse Event|5
906657|NCT00661427|2882337|P1|Overall Study|Adverse Event|5
906658|NCT00655564|2882343|P1|Overall Study|Desired Alternate Therapy|1
906659|NCT00655564|2882343|P1|Overall Study|Lost to Follow-up|1
906660|NCT00655564|2882343|P1|Overall Study|Adverse Event|1
906667|NCT00537095|2882372|P2|Overall Study|Incorrect enrolment|1
906668|NCT00537095|2882373|P1|Overall Study|Incorrect enrolment|0
906669|NCT00537095|2882372|P2|Overall Study|subjective disease progression|1
906670|NCT00537095|2882373|P1|Overall Study|subjective disease progression|0
906671|NCT00537095|2882372|P2|Overall Study|Withdrawal by Subject|2
906672|NCT00537095|2882373|P1|Overall Study|Withdrawal by Subject|2
906673|NCT00537095|2882372|P2|Overall Study|Death|1
906674|NCT00537095|2882373|P1|Overall Study|Death|3
906675|NCT00537095|2882372|P2|Overall Study|disease progression|48
906676|NCT00537095|2882373|P1|Overall Study|disease progression|21
906677|NCT00537095|2882372|P2|Overall Study|Adverse Event|4
906678|NCT00537095|2882373|P1|Overall Study|Adverse Event|24
906679|NCT00537095|2882372|P2|Overall Study|surgery|0
906680|NCT00537095|2882373|P1|Overall Study|surgery|1
906681|NCT00528645|2882385|P1|Overall Study|Adverse Event|3
906690|NCT00410761|2882422|P2|Overall Study|Never received randomised treatment|1
906691|NCT00410761|2882423|P1|Overall Study|Never received randomised treatment|0
906692|NCT00410761|2882422|P2|Overall Study|Other|9
906693|NCT00410761|2882423|P1|Overall Study|Other|12
906694|NCT00410761|2882422|P2|Overall Study|Withdrawal by Subject|4
906695|NCT00410761|2882423|P1|Overall Study|Withdrawal by Subject|8
906696|NCT00410761|2882422|P2|Overall Study|objective disease progression|55
906697|NCT00410761|2882423|P1|Overall Study|objective disease progression|71
906698|NCT00410761|2882422|P2|Overall Study|Adverse Event|3
906699|NCT00410761|2882423|P1|Overall Study|Adverse Event|29
906771|NCT00098475|2882637|P4|Step 2|Never started treatment|0
906772|NCT00098475|2882638|P3|Step 2|Never started treatment|0
906773|NCT00098475|2882639|P2|Step 2|Never started treatment|1
906774|NCT00098475|2882640|P1|Step 2|Never started treatment|1
906775|NCT00098475|2882637|P4|Step 2|Alternative therapy|0
906776|NCT00098475|2882638|P3|Step 2|Alternative therapy|0
906777|NCT00098475|2882639|P2|Step 2|Alternative therapy|2
906778|NCT00098475|2882640|P1|Step 2|Alternative therapy|1
906779|NCT00098475|2882637|P4|Step 2|Physician Decision|0
906780|NCT00098475|2882638|P3|Step 2|Physician Decision|0
906781|NCT00098475|2882639|P2|Step 2|Physician Decision|1
906782|NCT00098475|2882640|P1|Step 2|Physician Decision|0
906783|NCT00098475|2882637|P4|Step 2|Withdrawal by Subject|0
906784|NCT00098475|2882638|P3|Step 2|Withdrawal by Subject|0
906785|NCT00098475|2882639|P2|Step 2|Withdrawal by Subject|2
906786|NCT00098475|2882640|P1|Step 2|Withdrawal by Subject|0
906787|NCT00098475|2882637|P4|Step 2|Adverse Event|0
906788|NCT00098475|2882638|P3|Step 2|Adverse Event|0
906789|NCT00098475|2882639|P2|Step 2|Adverse Event|0
906790|NCT00098475|2882640|P1|Step 2|Adverse Event|2
906791|NCT00098475|2882637|P4|Step 2|Disease progression|0
906792|NCT00098475|2882638|P3|Step 2|Disease progression|0
906793|NCT00098475|2882639|P2|Step 2|Disease progression|4
906794|NCT00098475|2882640|P1|Step 2|Disease progression|1
906795|NCT00098475|2882637|P4|Step 1|Not documented|0
906796|NCT00098475|2882638|P3|Step 1|Not documented|0
906797|NCT00098475|2882639|P2|Step 1|Not documented|1
906798|NCT00098475|2882640|P1|Step 1|Not documented|0
906799|NCT00098475|2882637|P4|Step 1|Patient fell with fracture|0
906800|NCT00098475|2882638|P3|Step 1|Patient fell with fracture|0
906801|NCT00098475|2882639|P2|Step 1|Patient fell with fracture|0
906802|NCT00098475|2882640|P1|Step 1|Patient fell with fracture|1
906803|NCT00098475|2882637|P4|Step 1|Misinterpretation of lab data|0
906804|NCT00098475|2882638|P3|Step 1|Misinterpretation of lab data|0
906805|NCT00098475|2882639|P2|Step 1|Misinterpretation of lab data|1
906806|NCT00098475|2882640|P1|Step 1|Misinterpretation of lab data|0
906807|NCT00098475|2882637|P4|Step 1|Criteria to continue treatment not met|0
906808|NCT00098475|2882638|P3|Step 1|Criteria to continue treatment not met|0
906809|NCT00098475|2882639|P2|Step 1|Criteria to continue treatment not met|1
906810|NCT00098475|2882640|P1|Step 1|Criteria to continue treatment not met|0
906811|NCT00098475|2882637|P4|Step 1|Referred to other physicians|0
906812|NCT00098475|2882638|P3|Step 1|Referred to other physicians|0
906813|NCT00098475|2882639|P2|Step 1|Referred to other physicians|1
906814|NCT00098475|2882640|P1|Step 1|Referred to other physicians|0
906815|NCT00098475|2882637|P4|Step 1|Rising paraprotein|0
906816|NCT00098475|2882638|P3|Step 1|Rising paraprotein|0
906817|NCT00098475|2882639|P2|Step 1|Rising paraprotein|1
906818|NCT00098475|2882640|P1|Step 1|Rising paraprotein|0
906819|NCT00098475|2882637|P4|Step 1|Insurance issue|0
906820|NCT00098475|2882638|P3|Step 1|Insurance issue|0
906821|NCT00098475|2882639|P2|Step 1|Insurance issue|1
906822|NCT00098475|2882640|P1|Step 1|Insurance issue|0
906823|NCT00098475|2882637|P4|Step 1|Declining performance status|0
906824|NCT00098475|2882638|P3|Step 1|Declining performance status|0
906825|NCT00098475|2882639|P2|Step 1|Declining performance status|1
906826|NCT00098475|2882640|P1|Step 1|Declining performance status|0
906827|NCT00098475|2882637|P4|Step 1|Off treatment for > specified timeframe|0
906828|NCT00098475|2882638|P3|Step 1|Off treatment for > specified timeframe|0
906829|NCT00098475|2882639|P2|Step 1|Off treatment for > specified timeframe|1
906830|NCT00098475|2882640|P1|Step 1|Off treatment for > specified timeframe|1
906831|NCT00098475|2882637|P4|Step 1|Incorrect disease assessment|0
906832|NCT00098475|2882638|P3|Step 1|Incorrect disease assessment|0
906833|NCT00098475|2882639|P2|Step 1|Incorrect disease assessment|0
906834|NCT00098475|2882640|P1|Step 1|Incorrect disease assessment|2
906835|NCT00098475|2882637|P4|Step 1|Both patient and physician's decision|0
906836|NCT00098475|2882638|P3|Step 1|Both patient and physician's decision|0
906837|NCT00098475|2882639|P2|Step 1|Both patient and physician's decision|1
906838|NCT00098475|2882640|P1|Step 1|Both patient and physician's decision|2
906839|NCT00098475|2882637|P4|Step 1|Cannot comply due to other tx|0
906840|NCT00098475|2882638|P3|Step 1|Cannot comply due to other tx|0
906841|NCT00098475|2882639|P2|Step 1|Cannot comply due to other tx|1
906842|NCT00098475|2882640|P1|Step 1|Cannot comply due to other tx|0
906843|NCT00098475|2882637|P4|Step 1|Complications|0
906844|NCT00098475|2882638|P3|Step 1|Complications|0
906845|NCT00098475|2882639|P2|Step 1|Complications|0
906846|NCT00098475|2882640|P1|Step 1|Complications|1
906847|NCT00098475|2882637|P4|Step 1|Knee surgery|0
906848|NCT00098475|2882638|P3|Step 1|Knee surgery|0
906849|NCT00098475|2882639|P2|Step 1|Knee surgery|0
906850|NCT00098475|2882640|P1|Step 1|Knee surgery|1
906851|NCT00098475|2882637|P4|Step 1|Still on treatment as of this analysis|0
906852|NCT00098475|2882638|P3|Step 1|Still on treatment as of this analysis|0
906853|NCT00098475|2882639|P2|Step 1|Still on treatment as of this analysis|27
906854|NCT00098475|2882640|P1|Step 1|Still on treatment as of this analysis|14
906855|NCT00098475|2882637|P4|Step 1|Never started treatment|0
906856|NCT00098475|2882638|P3|Step 1|Never started treatment|0
906857|NCT00098475|2882639|P2|Step 1|Never started treatment|2
906858|NCT00098475|2882640|P1|Step 1|Never started treatment|0
906859|NCT00098475|2882637|P4|Step 1|Other disease|0
906860|NCT00098475|2882638|P3|Step 1|Other disease|1
906861|NCT00098475|2882639|P2|Step 1|Other disease|1
906862|NCT00098475|2882640|P1|Step 1|Other disease|2
906863|NCT00098475|2882637|P4|Step 1|Alternative therapy|0
906864|NCT00098475|2882638|P3|Step 1|Alternative therapy|1
906865|NCT00098475|2882639|P2|Step 1|Alternative therapy|43
906866|NCT00098475|2882640|P1|Step 1|Alternative therapy|31
906867|NCT00098475|2882637|P4|Step 1|Physician Decision|0
906868|NCT00098475|2882638|P3|Step 1|Physician Decision|0
906869|NCT00098475|2882639|P2|Step 1|Physician Decision|2
906870|NCT00098475|2882640|P1|Step 1|Physician Decision|5
906871|NCT00098475|2882637|P4|Step 1|Withdrawal by Subject|0
906872|NCT00098475|2882638|P3|Step 1|Withdrawal by Subject|0
906873|NCT00098475|2882639|P2|Step 1|Withdrawal by Subject|11
906874|NCT00098475|2882640|P1|Step 1|Withdrawal by Subject|14
906875|NCT00098475|2882637|P4|Step 1|Death|1
906876|NCT00098475|2882638|P3|Step 1|Death|0
906877|NCT00098475|2882639|P2|Step 1|Death|5
906878|NCT00098475|2882640|P1|Step 1|Death|8
906879|NCT00098475|2882637|P4|Step 1|Adverse Event|1
906880|NCT00098475|2882638|P3|Step 1|Adverse Event|0
906881|NCT00098475|2882639|P2|Step 1|Adverse Event|37
906882|NCT00098475|2882640|P1|Step 1|Adverse Event|56
906883|NCT00098475|2882637|P4|Step 1|Progressive disease|1
906884|NCT00098475|2882638|P3|Step 1|Progressive disease|2
906885|NCT00098475|2882639|P2|Step 1|Progressive disease|35
906886|NCT00098475|2882640|P1|Step 1|Progressive disease|33
906897|NCT00025233|2882685|P1|Overall Study|Never treated|1
906898|NCT00025233|2882685|P1|Overall Study|Ineligible: improper prior treatment|1
906899|NCT00025233|2882685|P1|Overall Study|Ineligible: wrong primary|1
906900|NCT00025233|2882685|P1|Overall Study|Ineligible: wrong cell type|1
906901|NCT00025506|2882711|P1|Overall Study|Never Treated|2
906902|NCT00025506|2882711|P1|Overall Study|Ineligible: inadequate pathology|2
906903|NCT00025506|2882711|P1|Overall Study|Ineligible: wrong cell type|5
906904|NCT00025506|2882711|P1|Overall Study|Ineligible: clerical error|1
906905|NCT02988622|2882725|P1|Overall Study|Lost to Follow-up|17
906906|NCT02966015|2882749|P2|Inclusion Visit|did not answer questionnaire|3
906907|NCT02966015|2882750|P1|Inclusion Visit|did not answer questionnaire|8
906908|NCT02956460|2882758|P2|Lens 1|Lost to Follow-up|0
906909|NCT02956460|2882759|P1|Lens 1|Lost to Follow-up|1
906912|NCT02642679|2882837|P1|Overall Study|Physician Decision|1
906913|NCT02642679|2882837|P1|Overall Study|Physician Decision|1
906914|NCT02642679|2882837|P1|Overall Study|Withdrawal by Subject|1
906919|NCT02449915|2882932|P2|Overall Study|Abnormal preop lab|1
906920|NCT02449915|2882933|P1|Overall Study|Abnormal preop lab|0
906921|NCT02449915|2882932|P2|Overall Study|Intraoperative surgical findings|1
906922|NCT02449915|2882933|P1|Overall Study|Intraoperative surgical findings|1
906923|NCT02449915|2882932|P2|Overall Study|Withdrawal by Subject|2
906924|NCT02449915|2882933|P1|Overall Study|Withdrawal by Subject|0
906925|NCT02449915|2882932|P2|Overall Study|Exclusion criteria - drug use|0
906926|NCT02449915|2882933|P1|Overall Study|Exclusion criteria - drug use|1
906933|NCT02415127|2882958|P2|Overall Study|Adverse Event|0
906934|NCT02415127|2882959|P1|Overall Study|Adverse Event|1
906935|NCT02378935|2882980|P7|Overall Study|Death|0
906936|NCT02378935|2882981|P6|Overall Study|Death|0
906937|NCT02378935|2882982|P5|Overall Study|Death|0
906938|NCT02378935|2882983|P4|Overall Study|Death|0
906939|NCT02378935|2882984|P3|Overall Study|Death|1
906940|NCT02378935|2882985|P2|Overall Study|Death|0
906941|NCT02378935|2882986|P1|Overall Study|Death|0
906942|NCT02378935|2882980|P7|Overall Study|Lack of Efficacy|0
906943|NCT02378935|2882981|P6|Overall Study|Lack of Efficacy|0
906944|NCT02378935|2882982|P5|Overall Study|Lack of Efficacy|0
906945|NCT02378935|2882983|P4|Overall Study|Lack of Efficacy|6
906946|NCT02378935|2882984|P3|Overall Study|Lack of Efficacy|2
906947|NCT02378935|2882985|P2|Overall Study|Lack of Efficacy|0
906948|NCT02378935|2882986|P1|Overall Study|Lack of Efficacy|10
906949|NCT02345252|2883039|P2|Overall Study|Still in Study up to the Data Cut Date|300
906950|NCT02345252|2883040|P1|Overall Study|Still in Study up to the Data Cut Date|304
906951|NCT02345252|2883039|P2|Overall Study|Randomized but Never Treated|2
906952|NCT02345252|2883040|P1|Overall Study|Randomized but Never Treated|0
906953|NCT02345252|2883039|P2|Overall Study|Lost to Follow-up|3
906954|NCT02345252|2883040|P1|Overall Study|Lost to Follow-up|2
906955|NCT02345252|2883039|P2|Overall Study|Withdrew Consent|9
906956|NCT02345252|2883040|P1|Overall Study|Withdrew Consent|7
906957|NCT02345252|2883039|P2|Overall Study|Protocol Violation|0
906958|NCT02345252|2883040|P1|Overall Study|Protocol Violation|1
906959|NCT02345252|2883039|P2|Overall Study|Investigator's Discretion|1
906960|NCT02345252|2883040|P1|Overall Study|Investigator's Discretion|0
906961|NCT02345252|2883039|P2|Overall Study|Death|1
906962|NCT02345252|2883040|P1|Overall Study|Death|1
906963|NCT02345252|2883039|P2|Overall Study|Adverse Event|0
906964|NCT02345252|2883040|P1|Overall Study|Adverse Event|1
906985|NCT02332590|2883075|P2|Overall Study|Other than specified above|5
906986|NCT02332590|2883076|P1|Overall Study|Other than specified above|6
906987|NCT02332590|2883075|P2|Overall Study|Randomized but not treated|0
906988|NCT02332590|2883076|P1|Overall Study|Randomized but not treated|1
906989|NCT02332590|2883075|P2|Overall Study|Poor compliance to protocol|1
906990|NCT02332590|2883076|P1|Overall Study|Poor compliance to protocol|3
906991|NCT02332590|2883075|P2|Overall Study|Lack of Efficacy|2
906992|NCT02332590|2883076|P1|Overall Study|Lack of Efficacy|4
906993|NCT02332590|2883075|P2|Overall Study|Adverse Event|11
906994|NCT02332590|2883076|P1|Overall Study|Adverse Event|15
906995|NCT02297815|2883140|P2|Overall Study|Lost to Follow-up|140
906996|NCT02297815|2883141|P1|Overall Study|Lost to Follow-up|236
907007|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Other Reason|1
907008|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Other Reason|1
907009|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Other Reason|1
907010|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Other Reason|0
907011|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Other Reason|0
907012|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
907013|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
907014|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
907015|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
907016|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
907017|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
907018|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
907019|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
907020|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
907021|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
907022|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Physician Decision|0
907023|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Physician Decision|1
907024|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Physician Decision|0
907025|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Physician Decision|0
907026|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Physician Decision|0
907027|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
907028|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
907029|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
907030|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
907031|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
907032|NCT02137226|2883207|P5|Period 2 (Re - Randomization)|Adverse Event|4
907033|NCT02137226|2883208|P4|Period 2 (Re - Randomization)|Adverse Event|1
907034|NCT02137226|2883209|P3|Period 2 (Re - Randomization)|Adverse Event|3
907035|NCT02137226|2883210|P2|Period 2 (Re - Randomization)|Adverse Event|0
907036|NCT02137226|2883211|P1|Period 2 (Re - Randomization)|Adverse Event|0
907037|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Other Reason|0
907038|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Other Reason|0
907039|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Other Reason|0
907040|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Other Reason|3
907041|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Other Reason|1
907042|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
907043|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
907044|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
907045|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
907046|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
907047|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
907048|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
907049|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
907050|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
907051|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
907052|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Physician Decision|0
907053|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Physician Decision|0
907054|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Physician Decision|0
907055|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Physician Decision|3
907056|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Physician Decision|1
907057|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
907058|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
907059|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
907060|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
907061|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
907062|NCT02137226|2883207|P5|Period 1 (Initial Randomization)|Adverse Event|0
907063|NCT02137226|2883208|P4|Period 1 (Initial Randomization)|Adverse Event|0
907064|NCT02137226|2883209|P3|Period 1 (Initial Randomization)|Adverse Event|0
907065|NCT02137226|2883210|P2|Period 1 (Initial Randomization)|Adverse Event|3
907066|NCT02137226|2883211|P1|Period 1 (Initial Randomization)|Adverse Event|3
907067|NCT02131662|2883228|P5|Overall Study|Not treated|3
907068|NCT02131662|2883229|P4|Overall Study|Not treated|2
907069|NCT02131662|2883230|P3|Overall Study|Not treated|2
907070|NCT02131662|2883231|P2|Overall Study|Not treated|0
907071|NCT02131662|2883232|P1|Overall Study|Not treated|2
907072|NCT02131662|2883228|P5|Overall Study|Lost to Follow-up|0
907073|NCT02131662|2883229|P4|Overall Study|Lost to Follow-up|9
907074|NCT02131662|2883230|P3|Overall Study|Lost to Follow-up|0
907075|NCT02131662|2883231|P2|Overall Study|Lost to Follow-up|3
907076|NCT02131662|2883232|P1|Overall Study|Lost to Follow-up|1
907077|NCT02131662|2883228|P5|Overall Study|Withdrawal by Subject|6
907078|NCT02131662|2883229|P4|Overall Study|Withdrawal by Subject|5
907079|NCT02131662|2883230|P3|Overall Study|Withdrawal by Subject|1
907080|NCT02131662|2883231|P2|Overall Study|Withdrawal by Subject|5
907081|NCT02131662|2883232|P1|Overall Study|Withdrawal by Subject|1
907082|NCT02131662|2883228|P5|Overall Study|Lack of Efficacy|1
907083|NCT02131662|2883229|P4|Overall Study|Lack of Efficacy|0
907084|NCT02131662|2883230|P3|Overall Study|Lack of Efficacy|0
907085|NCT02131662|2883231|P2|Overall Study|Lack of Efficacy|0
907086|NCT02131662|2883232|P1|Overall Study|Lack of Efficacy|1
907087|NCT02131662|2883228|P5|Overall Study|Wish for pregnancy|1
907088|NCT02131662|2883229|P4|Overall Study|Wish for pregnancy|0
907089|NCT02131662|2883230|P3|Overall Study|Wish for pregnancy|0
907090|NCT02131662|2883231|P2|Overall Study|Wish for pregnancy|0
907091|NCT02131662|2883232|P1|Overall Study|Wish for pregnancy|0
907092|NCT02131662|2883228|P5|Overall Study|Pregnancy|0
907093|NCT02131662|2883229|P4|Overall Study|Pregnancy|1
907094|NCT02131662|2883230|P3|Overall Study|Pregnancy|0
907095|NCT02131662|2883231|P2|Overall Study|Pregnancy|1
907096|NCT02131662|2883232|P1|Overall Study|Pregnancy|0
907097|NCT02131662|2883228|P5|Overall Study|Adverse Event|3
907098|NCT02131662|2883229|P4|Overall Study|Adverse Event|1
907099|NCT02131662|2883230|P3|Overall Study|Adverse Event|1
907100|NCT02131662|2883231|P2|Overall Study|Adverse Event|1
907101|NCT02131662|2883232|P1|Overall Study|Adverse Event|0
907102|NCT02131662|2883228|P5|Overall Study|Other|4
907103|NCT02131662|2883229|P4|Overall Study|Other|3
907104|NCT02131662|2883230|P3|Overall Study|Other|3
907105|NCT02131662|2883231|P2|Overall Study|Other|4
907106|NCT02131662|2883232|P1|Overall Study|Other|2
907107|NCT02131662|2883228|P5|Overall Study|Protocol Violation|0
907108|NCT02131662|2883229|P4|Overall Study|Protocol Violation|0
907109|NCT02131662|2883230|P3|Overall Study|Protocol Violation|0
907110|NCT02131662|2883231|P2|Overall Study|Protocol Violation|0
907111|NCT02131662|2883232|P1|Overall Study|Protocol Violation|1
907236|NCT01630811|2883943|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
907237|NCT01630811|2883944|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
907241|NCT01617629|2883967|P1|Overall Study|Participant Withdrew Consent|2
907242|NCT01617629|2883967|P1|Overall Study|Reason Not Specified|1
907243|NCT01617629|2883967|P1|Overall Study|Investigator's Clinical Judgement|1
907244|NCT01617629|2883967|P1|Overall Study|Death|2
907275|NCT01567462|2884024|P2|Overall Study|Withdrawal by Subject|7
907276|NCT01567462|2884025|P1|Overall Study|Withdrawal by Subject|4
907281|NCT01564277|2884080|P2|Overall Study|Physician Decision|0
907282|NCT01564277|2884081|P1|Overall Study|Physician Decision|1
907283|NCT01564277|2884080|P2|Overall Study|Protocol Violation|1
907284|NCT01564277|2884081|P1|Overall Study|Protocol Violation|0
907285|NCT01524783|2884149|P2|Randomized and Treated|Death|1
907286|NCT01524783|2884150|P1|Randomized and Treated|Death|4
907287|NCT01524783|2884149|P2|Randomized and Treated|Protocol Violation|1
907288|NCT01524783|2884150|P1|Randomized and Treated|Protocol Violation|1
907289|NCT01524783|2884149|P2|Randomized and Treated|Withdrawal by Subject|5
907290|NCT01524783|2884150|P1|Randomized and Treated|Withdrawal by Subject|15
907291|NCT01524783|2884149|P2|Randomized and Treated|Disease Progression|70
907292|NCT01524783|2884150|P1|Randomized and Treated|Disease Progression|76
907293|NCT01524783|2884149|P2|Randomized and Treated|Adverse Event|7
907294|NCT01524783|2884150|P1|Randomized and Treated|Adverse Event|59
907295|NCT01524783|2884149|P2|Randomized But Not Treated|Randomized, did not receive drug|0
907296|NCT01524783|2884150|P1|Randomized But Not Treated|Randomized, did not receive drug|2
907303|NCT01392573|2884363|P2|Overall Study|Unclassified|6
907304|NCT01392573|2884364|P1|Overall Study|Unclassified|9
907305|NCT01392573|2884363|P2|Overall Study|Site closure|7
907306|NCT01392573|2884364|P1|Overall Study|Site closure|8
907307|NCT01392573|2884363|P2|Overall Study|Withdrawal Criteria|15
907308|NCT01392573|2884364|P1|Overall Study|Withdrawal Criteria|13
907309|NCT01392573|2884363|P2|Overall Study|Protocol Violation|2
907310|NCT01392573|2884364|P1|Overall Study|Protocol Violation|0
907311|NCT01392573|2884363|P2|Overall Study|Lack of Efficacy|2
907312|NCT01392573|2884364|P1|Overall Study|Lack of Efficacy|1
907313|NCT01392573|2884363|P2|Overall Study|Adverse Event|3
907314|NCT01392573|2884364|P1|Overall Study|Adverse Event|1
907351|NCT01279681|2884475|P2|Overall Study|Other Reason|2
907352|NCT01279681|2884476|P1|Overall Study|Other Reason|0
907353|NCT01279681|2884475|P2|Overall Study|Physician Decision|0
907354|NCT01279681|2884476|P1|Overall Study|Physician Decision|1
907355|NCT01279681|2884475|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
907356|NCT01279681|2884476|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
907357|NCT01279681|2884475|P2|Overall Study|Death|1
907358|NCT01279681|2884476|P1|Overall Study|Death|0
907359|NCT01279681|2884475|P2|Overall Study|Adverse Event|3
907360|NCT01279681|2884476|P1|Overall Study|Adverse Event|2
907361|NCT01279681|2884475|P2|Overall Study|Withdrawal by Subject|4
907362|NCT01279681|2884476|P1|Overall Study|Withdrawal by Subject|3
907363|NCT01279681|2884475|P2|Overall Study|Disease Progression|6
907364|NCT01279681|2884476|P1|Overall Study|Disease Progression|9
907383|NCT01228734|2884605|P2|Overall Study|Randomized, but not treated|4
907384|NCT01228734|2884606|P1|Overall Study|Randomized, but not treated|0
907385|NCT01228734|2884605|P2|Overall Study|Ongoing at clinical cut-off date|4
907386|NCT01228734|2884606|P1|Overall Study|Ongoing at clinical cut-off date|16
907387|NCT01167907|2884662|P2|Overall Study|saphenous catheter dislodged before comp|1
907388|NCT01167907|2884663|P1|Overall Study|saphenous catheter dislodged before comp|1
907389|NCT01167907|2884662|P2|Overall Study|Protocol Violation|0
907390|NCT01167907|2884663|P1|Overall Study|Protocol Violation|1
907502|NCT00810043|2885199|P3|Overall Study|No longer met enrollment criteria|3
907503|NCT00810043|2885200|P2|Overall Study|No longer met enrollment criteria|0
907504|NCT00810043|2885201|P1|Overall Study|No longer met enrollment criteria|0
907505|NCT00810043|2885199|P3|Overall Study|Non-medical problem|1
907506|NCT00810043|2885200|P2|Overall Study|Non-medical problem|0
907507|NCT00810043|2885201|P1|Overall Study|Non-medical problem|0
907508|NCT00810043|2885199|P3|Overall Study|Unrelated medical problem|0
907509|NCT00810043|2885200|P2|Overall Study|Unrelated medical problem|1
907510|NCT00810043|2885201|P1|Overall Study|Unrelated medical problem|0
907511|NCT00810043|2885199|P3|Overall Study|Death|0
907512|NCT00810043|2885200|P2|Overall Study|Death|0
907513|NCT00810043|2885201|P1|Overall Study|Death|2
907514|NCT00810043|2885199|P3|Overall Study|Physician Decision|2
907515|NCT00810043|2885200|P2|Overall Study|Physician Decision|0
907516|NCT00810043|2885201|P1|Overall Study|Physician Decision|0
907517|NCT00810043|2885199|P3|Overall Study|Lost to Follow-up|0
907518|NCT00810043|2885200|P2|Overall Study|Lost to Follow-up|0
907519|NCT00810043|2885201|P1|Overall Study|Lost to Follow-up|1
907520|NCT00810043|2885199|P3|Overall Study|Withdrawal by Subject|2
907521|NCT00810043|2885200|P2|Overall Study|Withdrawal by Subject|0
907522|NCT00810043|2885201|P1|Overall Study|Withdrawal by Subject|1
907541|NCT00742183|2885339|P2|Overall Study|Lack of Efficacy|3
907542|NCT00742183|2885340|P1|Overall Study|Lack of Efficacy|0
907543|NCT00742183|2885339|P2|Overall Study|Withdrawal by Subject|0
907544|NCT00742183|2885340|P1|Overall Study|Withdrawal by Subject|1
907545|NCT00742183|2885339|P2|Overall Study|Required skin-graft|1
907546|NCT00742183|2885340|P1|Overall Study|Required skin-graft|1
907547|NCT00742183|2885339|P2|Overall Study|Lost to Follow-up|4
907548|NCT00742183|2885340|P1|Overall Study|Lost to Follow-up|4
907549|NCT00742183|2885339|P2|Overall Study|Physician Decision|2
907550|NCT00742183|2885340|P1|Overall Study|Physician Decision|0
907551|NCT00742183|2885339|P2|Overall Study|Death|0
907552|NCT00742183|2885340|P1|Overall Study|Death|1
907553|NCT00742183|2885339|P2|Overall Study|Adverse Event|2
907554|NCT00742183|2885340|P1|Overall Study|Adverse Event|2
907555|NCT00729378|2885348|P2|36-months|Lost to Follow-up|6
907556|NCT00729378|2885349|P1|36-months|Lost to Follow-up|15
907557|NCT00729378|2885348|P2|24-months|Lost to Follow-up|51
907558|NCT00729378|2885349|P1|24-months|Lost to Follow-up|72
907559|NCT00729378|2885348|P2|12-months|Lost to Follow-up|65
907560|NCT00729378|2885349|P1|12-months|Lost to Follow-up|100
907561|NCT00729378|2885348|P2|Baseline|Withdrawal by Subject|59
907562|NCT00729378|2885349|P1|Baseline|Withdrawal by Subject|66
907563|NCT00729378|2885348|P2|Baseline|Did not complete study measurements|33
907564|NCT00729378|2885349|P1|Baseline|Did not complete study measurements|72
907664|NCT00683696|2885828|P2|Overall Study|Death|30
907665|NCT00683696|2885829|P1|Overall Study|Death|46
907666|NCT00683696|2885828|P2|Overall Study|Vital status follow-up only|3
907667|NCT00683696|2885829|P1|Overall Study|Vital status follow-up only|3
907668|NCT00683696|2885828|P2|Overall Study|Lost to Follow-up|6
907669|NCT00683696|2885829|P1|Overall Study|Lost to Follow-up|5
907670|NCT00683696|2885828|P2|Overall Study|Withdrawn prior to study closure|28
907671|NCT00683696|2885829|P1|Overall Study|Withdrawn prior to study closure|13
907672|NCT00683696|2885828|P2|Overall Study|Withdrawn due to study closure|338
907673|NCT00683696|2885829|P1|Overall Study|Withdrawn due to study closure|337
907701|NCT00630344|2885992|P1|Overall Study|Other|1
907702|NCT00630344|2885992|P1|Overall Study|Intercurrent Illness|1
907703|NCT00630344|2885992|P1|Overall Study|Withdrawal by Subject|1
907704|NCT00630344|2885992|P1|Overall Study|Physician Decision|9
907705|NCT00630344|2885992|P1|Overall Study|Progressive Disease|19
907706|NCT00630344|2885992|P1|Overall Study|Adverse Event|5
907709|NCT00443781|2886110|P1|Overall Study|PD/FAD not done|1
907710|NCT00443781|2886110|P1|Overall Study|Insurance not covered|2
907711|NCT00443781|2886110|P1|Overall Study|Investigator terminated participation|1
907712|NCT00443781|2886110|P1|Overall Study|Unable to comply with study follow up|2
907713|NCT00443781|2886110|P1|Overall Study|Withdrawal by Subject|6
907714|NCT00443781|2886110|P1|Overall Study|Protocol Violation|1
907715|NCT00443781|2886110|P1|Overall Study|Physician Decision|2
907716|NCT00443781|2886110|P1|Overall Study|Lost to Follow-up|10
907745|NCT00348816|2886242|P1|Overall Study|Noncompliance with radiation treatment|1
907746|NCT00345397|2886249|P1|Overall Study|Death|1
907785|NCT00226941|2886445|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
907786|NCT00226941|2886446|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
907787|NCT00226941|2886447|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
907788|NCT00226941|2886448|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
907789|NCT00226941|2886445|P4|Overall Study|Withdrawal by subject - toxicity|1
907790|NCT00226941|2886446|P3|Overall Study|Withdrawal by subject - toxicity|0
907791|NCT00226941|2886447|P2|Overall Study|Withdrawal by subject - toxicity|0
907792|NCT00226941|2886448|P1|Overall Study|Withdrawal by subject - toxicity|0
907793|NCT00211237|2886484|P3|12 Months|unrelated medical problem|1
907794|NCT00211237|2886485|P2|12 Months|unrelated medical problem|0
907795|NCT00211237|2886486|P1|12 Months|unrelated medical problem|0
907796|NCT00211237|2886484|P3|12 Months|Withdrew|1
907797|NCT00211237|2886485|P2|12 Months|Withdrew|0
907798|NCT00211237|2886486|P1|12 Months|Withdrew|0
907799|NCT00211237|2886484|P3|12 Months|Lost to Follow-up|1
907800|NCT00211237|2886485|P2|12 Months|Lost to Follow-up|0
907801|NCT00211237|2886486|P1|12 Months|Lost to Follow-up|1
907802|NCT00211237|2886484|P3|12 Months|Death|3
907803|NCT00211237|2886485|P2|12 Months|Death|2
907804|NCT00211237|2886486|P1|12 Months|Death|8
907805|NCT00211237|2886484|P3|6 Months|Could not comply with protocol|0
907806|NCT00211237|2886485|P2|6 Months|Could not comply with protocol|2
907807|NCT00211237|2886486|P1|6 Months|Could not comply with protocol|0
907808|NCT00211237|2886484|P3|6 Months|Lost to Follow-up|0
907809|NCT00211237|2886485|P2|6 Months|Lost to Follow-up|0
907810|NCT00211237|2886486|P1|6 Months|Lost to Follow-up|2
907811|NCT00211237|2886484|P3|6 Months|Death|3
907812|NCT00211237|2886485|P2|6 Months|Death|0
907813|NCT00211237|2886486|P1|6 Months|Death|6
907814|NCT00211237|2886484|P3|3 Months|Non-medical problem|1
907815|NCT00211237|2886485|P2|3 Months|Non-medical problem|0
907816|NCT00211237|2886486|P1|3 Months|Non-medical problem|0
907817|NCT00211237|2886484|P3|3 Months|Withdrew|0
907818|NCT00211237|2886485|P2|3 Months|Withdrew|1
907819|NCT00211237|2886486|P1|3 Months|Withdrew|0
907820|NCT00211237|2886484|P3|3 Months|Could not comply with protocol|0
907821|NCT00211237|2886485|P2|3 Months|Could not comply with protocol|0
907822|NCT00211237|2886486|P1|3 Months|Could not comply with protocol|1
907823|NCT00211237|2886484|P3|3 Months|Death|0
907824|NCT00211237|2886485|P2|3 Months|Death|3
907825|NCT00211237|2886486|P1|3 Months|Death|7
907826|NCT00211237|2886484|P3|1 Month|Non-medical problem|0
907827|NCT00211237|2886485|P2|1 Month|Non-medical problem|2
907828|NCT00211237|2886486|P1|1 Month|Non-medical problem|0
907829|NCT00211237|2886484|P3|1 Month|Additional surgery needed|0
907830|NCT00211237|2886485|P2|1 Month|Additional surgery needed|0
907831|NCT00211237|2886486|P1|1 Month|Additional surgery needed|1
907832|NCT00211237|2886484|P3|1 Month|Withdrew|0
907833|NCT00211237|2886485|P2|1 Month|Withdrew|4
907834|NCT00211237|2886486|P1|1 Month|Withdrew|0
907835|NCT00211237|2886484|P3|1 Month|Lost to Follow-up|0
907836|NCT00211237|2886485|P2|1 Month|Lost to Follow-up|2
907837|NCT00211237|2886486|P1|1 Month|Lost to Follow-up|0
907838|NCT00211237|2886484|P3|1 Month|Death|0
907839|NCT00211237|2886485|P2|1 Month|Death|1
907840|NCT00211237|2886486|P1|1 Month|Death|2
907841|NCT00211237|2886484|P3|Baseline|Refused random assignment|0
907842|NCT00211237|2886485|P2|Baseline|Refused random assignment|0
907843|NCT00211237|2886486|P1|Baseline|Refused random assignment|1
907844|NCT00211237|2886484|P3|Baseline|Withdrew|0
907845|NCT00211237|2886485|P2|Baseline|Withdrew|3
907846|NCT00211237|2886486|P1|Baseline|Withdrew|1
907847|NCT00189423|2886584|P2|Overall Study|Lost to Follow-up|10
907848|NCT00189423|2886585|P1|Overall Study|Lost to Follow-up|10
907849|NCT00189423|2886584|P2|Overall Study|Withdrawal by Subject|9
907850|NCT00189423|2886585|P1|Overall Study|Withdrawal by Subject|9
907851|NCT00189423|2886584|P2|Overall Study|Death|747
907852|NCT00189423|2886585|P1|Overall Study|Death|746
907863|NCT00114140|2886650|P1|Overall Study|Protocol Violation|7
907902|NCT00053352|2886709|P2|Overall Study|Disease at new site|0
907903|NCT00053352|2886710|P1|Overall Study|Disease at new site|1
907904|NCT00053352|2886709|P2|Overall Study|Ineligible|8
907905|NCT00053352|2886710|P1|Overall Study|Ineligible|8
907906|NCT00053352|2886709|P2|Overall Study|Withdrawal by Subject|0
907907|NCT00053352|2886710|P1|Overall Study|Withdrawal by Subject|1
907908|NCT00053352|2886709|P2|Overall Study|Physician Decision|1
907909|NCT00053352|2886710|P1|Overall Study|Physician Decision|11
907910|NCT00053352|2886709|P2|Overall Study|Lost to Follow-up|1
907911|NCT00053352|2886710|P1|Overall Study|Lost to Follow-up|0
910987|NCT02961244|2899315|P2|Overall Study|İnadequate data|2
910988|NCT02961244|2899316|P1|Overall Study|İnadequate data|0
910989|NCT02961244|2899315|P2|Overall Study|Lost to Follow-up|2
910990|NCT02961244|2899316|P1|Overall Study|Lost to Follow-up|0
910991|NCT02961244|2899315|P2|Overall Study|Surgery plan change after study approval|2
910992|NCT02961244|2899316|P1|Overall Study|Surgery plan change after study approval|0
910993|NCT02961244|2899315|P2|Overall Study|Withdrawal by Subject|2
910994|NCT02961244|2899316|P1|Overall Study|Withdrawal by Subject|1
910995|NCT02961244|2899315|P2|Overall Study|Protocol Violation|1
910996|NCT02961244|2899316|P1|Overall Study|Protocol Violation|0
910999|NCT02657031|2899409|P2|Overall Study|Adverse Event|2
911000|NCT02657031|2899410|P1|Overall Study|Adverse Event|1
911018|NCT02506101|2899948|P2|Overall Study|lack of enrollment and staff avilability|0
911019|NCT02506101|2899949|P1|Overall Study|lack of enrollment and staff avilability|1
911020|NCT02506101|2899948|P2|Overall Study|Transportation issues|0
911021|NCT02506101|2899949|P1|Overall Study|Transportation issues|1
911062|NCT02460991|2900089|P2|Overall Study|Withdrawal by Subject|2
911063|NCT02460991|2900090|P1|Overall Study|Withdrawal by Subject|0
911102|NCT02420262|2900198|P2|Overall Study|Unclassified|1
911103|NCT02420262|2900199|P1|Overall Study|Unclassified|0
911104|NCT02420262|2900198|P2|Overall Study|Withdrawal by Subject|4
911105|NCT02420262|2900199|P1|Overall Study|Withdrawal by Subject|1
911106|NCT02420262|2900198|P2|Overall Study|Adverse Event|0
911107|NCT02420262|2900199|P1|Overall Study|Adverse Event|1
911112|NCT02363439|2900257|P1|Overall Study|Lack of Efficacy|4
911143|NCT02345226|2900344|P2|Overall Study|Still in Study up to the Data Cut Date|409
911144|NCT02345226|2900345|P1|Overall Study|Still in Study up to the Data Cut Date|405
911145|NCT02345226|2900344|P2|Overall Study|Randomized but Never Treated|4
911146|NCT02345226|2900345|P1|Overall Study|Randomized but Never Treated|2
911147|NCT02345226|2900344|P2|Overall Study|Lost to Follow-up|6
911148|NCT02345226|2900345|P1|Overall Study|Lost to Follow-up|7
911149|NCT02345226|2900344|P2|Overall Study|Withdrew Consent|16
911150|NCT02345226|2900345|P1|Overall Study|Withdrew Consent|18
911151|NCT02345226|2900344|P2|Overall Study|Non-Compliance with Study Drug|0
911152|NCT02345226|2900345|P1|Overall Study|Non-Compliance with Study Drug|1
911153|NCT02345226|2900344|P2|Overall Study|Investigator's Discretion|1
911154|NCT02345226|2900345|P1|Overall Study|Investigator's Discretion|3
911155|NCT02345226|2900344|P2|Overall Study|Lack of Efficacy|0
911156|NCT02345226|2900345|P1|Overall Study|Lack of Efficacy|1
911157|NCT02345226|2900344|P2|Overall Study|Pregnancy|1
911158|NCT02345226|2900345|P1|Overall Study|Pregnancy|0
911159|NCT02345226|2900344|P2|Overall Study|Death|0
911160|NCT02345226|2900345|P1|Overall Study|Death|1
911161|NCT02345226|2900344|P2|Overall Study|Adverse Event|4
911162|NCT02345226|2900345|P1|Overall Study|Adverse Event|2
911163|NCT02252146|2900374|P1|Overall Study|Inability to travel to study site|1
911164|NCT02252146|2900374|P1|Overall Study|Entered hospice care|1
911165|NCT02252146|2900374|P1|Overall Study|Lack of Efficacy|4
911166|NCT02239094|2900378|P1|Overall Study|Remitted before started|1
911167|NCT02239094|2900378|P1|Overall Study|Withdrawal by Subject|1
911174|NCT02221674|2900414|P3|Overall Study|Lost to Follow-up|0
911175|NCT02221674|2900415|P2|Overall Study|Lost to Follow-up|0
911176|NCT02221674|2900416|P1|Overall Study|Lost to Follow-up|1
911177|NCT02210000|2900432|P2|Overall Study|Physician Decision|1
911178|NCT02210000|2900433|P1|Overall Study|Physician Decision|0
911179|NCT02210000|2900432|P2|Overall Study|Lost to Follow-up|2
911180|NCT02210000|2900433|P1|Overall Study|Lost to Follow-up|0
911181|NCT02210000|2900432|P2|Overall Study|Adverse Event|5
911182|NCT02210000|2900433|P1|Overall Study|Adverse Event|1
911183|NCT02210000|2900432|P2|Overall Study|Withdrawal by Subject|1
911184|NCT02210000|2900433|P1|Overall Study|Withdrawal by Subject|7
911185|NCT02210000|2900432|P2|Overall Study|Study Terminated|12
911186|NCT02210000|2900433|P1|Overall Study|Study Terminated|11
911191|NCT02158936|2900520|P2|Overall Study|Lost to Follow-up|1
911192|NCT02158936|2900521|P1|Overall Study|Lost to Follow-up|0
911193|NCT02158936|2900520|P2|Overall Study|Physician Decision|13
911194|NCT02158936|2900521|P1|Overall Study|Physician Decision|15
911195|NCT02158936|2900520|P2|Overall Study|Withdrawal by Subject|16
911196|NCT02158936|2900521|P1|Overall Study|Withdrawal by Subject|15
911197|NCT02158936|2900520|P2|Overall Study|Adverse Event|24
911198|NCT02158936|2900521|P1|Overall Study|Adverse Event|39
911199|NCT02158936|2900520|P2|Overall Study|Azacitidine tx discontinued|46
911200|NCT02158936|2900521|P1|Overall Study|Azacitidine tx discontinued|53
911201|NCT02158936|2900520|P2|Overall Study|Study closed/ terminated|77
911202|NCT02158936|2900521|P1|Overall Study|Study closed/ terminated|57
911270|NCT02116582|2900758|P1|Overall Study|Other: Miscellaneous|9
911271|NCT02116582|2900758|P1|Overall Study|Withdrawal by Subject|8
911272|NCT02116582|2900758|P1|Overall Study|Protocol Violation|3
911273|NCT02116582|2900758|P1|Overall Study|Progressive Disease|140
911274|NCT02116582|2900758|P1|Overall Study|Death|7
911275|NCT02116582|2900758|P1|Overall Study|Adverse Event|17
911276|NCT02116582|2900758|P1|Overall Study|Enrolled but Never Received Study Drug|1
911332|NCT02053610|2901001|P2|Overall Study|Failure to Return|3
911333|NCT02053610|2901002|P1|Overall Study|Failure to Return|4
911334|NCT02053610|2901001|P2|Overall Study|Did not Receive Treatment|2
911335|NCT02053610|2901002|P1|Overall Study|Did not Receive Treatment|0
911336|NCT02053610|2901001|P2|Overall Study|Refused treatment/Did not cooperate|0
911337|NCT02053610|2901002|P1|Overall Study|Refused treatment/Did not cooperate|3
911338|NCT02053610|2901001|P2|Overall Study|Disease Progression|94
911339|NCT02053610|2901002|P1|Overall Study|Disease Progression|148
911340|NCT02053610|2901001|P2|Overall Study|Administrative/Other|27
911341|NCT02053610|2901002|P1|Overall Study|Administrative/Other|34
911342|NCT02053610|2901001|P2|Overall Study|Death|25
911343|NCT02053610|2901002|P1|Overall Study|Death|31
911344|NCT02053610|2901001|P2|Overall Study|Withdrew Consent|14
911345|NCT02053610|2901002|P1|Overall Study|Withdrew Consent|12
911346|NCT02053610|2901001|P2|Overall Study|Adverse Event/Intercurrent Illness|9
911347|NCT02053610|2901002|P1|Overall Study|Adverse Event/Intercurrent Illness|3
911348|NCT02040779|2901035|P3|Overall Study|Lack of Efficacy|0
911349|NCT02040779|2901036|P2|Overall Study|Lack of Efficacy|2
911350|NCT02040779|2901037|P1|Overall Study|Lack of Efficacy|4
911351|NCT02040779|2901035|P3|Overall Study|Lost to Follow-up|1
911352|NCT02040779|2901036|P2|Overall Study|Lost to Follow-up|2
911353|NCT02040779|2901037|P1|Overall Study|Lost to Follow-up|1
911354|NCT02040779|2901035|P3|Overall Study|Protocol Violation|0
911355|NCT02040779|2901036|P2|Overall Study|Protocol Violation|1
911356|NCT02040779|2901037|P1|Overall Study|Protocol Violation|2
911357|NCT02040779|2901035|P3|Overall Study|Non-compliance|0
911358|NCT02040779|2901036|P2|Overall Study|Non-compliance|1
911359|NCT02040779|2901037|P1|Overall Study|Non-compliance|0
911360|NCT02040779|2901035|P3|Overall Study|Withdrawal by Subject|3
911361|NCT02040779|2901036|P2|Overall Study|Withdrawal by Subject|1
911362|NCT02040779|2901037|P1|Overall Study|Withdrawal by Subject|4
911363|NCT02040779|2901035|P3|Overall Study|Adverse Event|0
911364|NCT02040779|2901036|P2|Overall Study|Adverse Event|0
911365|NCT02040779|2901037|P1|Overall Study|Adverse Event|1
911366|NCT02023151|2901115|P1|Overall Study|Lost to Follow-up|4
911385|NCT01998399|2901150|P2|Overall Study|Withdrawal by Subject|1
911386|NCT01998399|2901151|P1|Overall Study|Withdrawal by Subject|0
911387|NCT01998399|2901150|P2|Overall Study|Study stopped before dosing completed|3
911388|NCT01998399|2901151|P1|Overall Study|Study stopped before dosing completed|3
911389|NCT01998399|2901150|P2|Overall Study|Death|2
911390|NCT01998399|2901151|P1|Overall Study|Death|4
911391|NCT01998399|2901150|P2|Overall Study|Lost to Follow-up|3
911392|NCT01998399|2901151|P1|Overall Study|Lost to Follow-up|1
911403|NCT01957137|2901353|P1|Randomized Portion|Withdrawal by Subject|1
911404|NCT01957137|2901353|P1|Randomized Portion|Adverse Event|1
911407|NCT01934192|2901415|P4|Overall Study|Physician Decision|0
911408|NCT01934192|2901416|P3|Overall Study|Physician Decision|0
911409|NCT01934192|2901417|P2|Overall Study|Physician Decision|2
911410|NCT01934192|2901418|P1|Overall Study|Physician Decision|3
911411|NCT01934192|2901415|P4|Overall Study|Other: reached stopping criteria|0
911412|NCT01934192|2901416|P3|Overall Study|Other: reached stopping criteria|1
911413|NCT01934192|2901417|P2|Overall Study|Other: reached stopping criteria|5
911414|NCT01934192|2901418|P1|Overall Study|Other: reached stopping criteria|6
911415|NCT01934192|2901415|P4|Overall Study|Protocol Violation|1
911416|NCT01934192|2901416|P3|Overall Study|Protocol Violation|0
911417|NCT01934192|2901417|P2|Overall Study|Protocol Violation|0
911418|NCT01934192|2901418|P1|Overall Study|Protocol Violation|0
911433|NCT01922037|2901586|P2|Overall Study|Other unspecified|66
911434|NCT01922037|2901587|P1|Overall Study|Other unspecified|2
911435|NCT01922037|2901586|P2|Overall Study|Investigator/Sponsor decision|4
911436|NCT01922037|2901587|P1|Overall Study|Investigator/Sponsor decision|1
911437|NCT01922037|2901586|P2|Overall Study|Participant non-compliance|46
911438|NCT01922037|2901587|P1|Overall Study|Participant non-compliance|4
911439|NCT01922037|2901586|P2|Overall Study|Pregnancy|2
911440|NCT01922037|2901587|P1|Overall Study|Pregnancy|0
911441|NCT01922037|2901586|P2|Overall Study|Death|5
911442|NCT01922037|2901587|P1|Overall Study|Death|0
911443|NCT01922037|2901586|P2|Overall Study|Adverse Event|7
911444|NCT01922037|2901587|P1|Overall Study|Adverse Event|1
911445|NCT01922037|2901586|P2|Overall Study|Withdrawal by Subject|44
911446|NCT01922037|2901587|P1|Overall Study|Withdrawal by Subject|2
911455|NCT01876784|2901807|P2|Overall Study|Ongoing|40
911456|NCT01876784|2901808|P1|Overall Study|Ongoing|41
911457|NCT01876784|2901807|P2|Overall Study|Other than specified above|6
911458|NCT01876784|2901808|P1|Overall Study|Other than specified above|5
911459|NCT01876784|2901807|P2|Overall Study|Randomized but not treated|1
911460|NCT01876784|2901808|P1|Overall Study|Randomized but not treated|2
911461|NCT01876784|2901807|P2|Overall Study|Death|0
911462|NCT01876784|2901808|P1|Overall Study|Death|1
911463|NCT01876784|2901807|P2|Overall Study|Lost to Follow-up|1
911464|NCT01876784|2901808|P1|Overall Study|Lost to Follow-up|0
911465|NCT01876784|2901807|P2|Overall Study|Disease progression|67
911466|NCT01876784|2901808|P1|Overall Study|Disease progression|37
911467|NCT01876784|2901807|P2|Overall Study|Protocol Violation|0
911468|NCT01876784|2901808|P1|Overall Study|Protocol Violation|1
911469|NCT01876784|2901807|P2|Overall Study|Adverse Event|2
911470|NCT01876784|2901808|P1|Overall Study|Adverse Event|15
911471|NCT01876784|2901807|P2|Overall Study|Withdrawal by Subject|2
911472|NCT01876784|2901808|P1|Overall Study|Withdrawal by Subject|17
911483|NCT01833169|2901892|P1|Overall Study|Physician Decision|2
911484|NCT01833169|2901892|P1|Overall Study|Death|3
911485|NCT01833169|2901892|P1|Overall Study|Withdrawal by Subject|9
911486|NCT01833169|2901892|P1|Overall Study|Adverse Event|33
911487|NCT01833169|2901892|P1|Overall Study|Disease Progression|99
911488|NCT01813474|2901919|P3|Overall Study|Death|1
911489|NCT01813474|2901920|P2|Overall Study|Death|0
911490|NCT01813474|2901921|P1|Overall Study|Death|0
911491|NCT01813474|2901919|P3|Overall Study|Lack of Efficacy|9
911492|NCT01813474|2901920|P2|Overall Study|Lack of Efficacy|6
911493|NCT01813474|2901921|P1|Overall Study|Lack of Efficacy|2
911494|NCT01813474|2901919|P3|Overall Study|Adverse Event|0
911495|NCT01813474|2901920|P2|Overall Study|Adverse Event|1
911496|NCT01813474|2901921|P1|Overall Study|Adverse Event|1
911497|NCT01813474|2901919|P3|Overall Study|Withdrawal by Subject|1
911498|NCT01813474|2901920|P2|Overall Study|Withdrawal by Subject|0
911499|NCT01813474|2901921|P1|Overall Study|Withdrawal by Subject|0
911504|NCT01777334|2902000|P2|Overall Study|Withdrawal by Subject|11
911505|NCT01777334|2902001|P1|Overall Study|Withdrawal by Subject|14
911506|NCT01777334|2902000|P2|Overall Study|Lost to Follow-up|2
911507|NCT01777334|2902001|P1|Overall Study|Lost to Follow-up|3
911508|NCT01777334|2902000|P2|Overall Study|Protocol Violation|7
911509|NCT01777334|2902001|P1|Overall Study|Protocol Violation|3
911510|NCT01777334|2902000|P2|Overall Study|Lack of Efficacy|29
911511|NCT01777334|2902001|P1|Overall Study|Lack of Efficacy|15
911512|NCT01777334|2902000|P2|Overall Study|Adverse Event|14
911513|NCT01777334|2902001|P1|Overall Study|Adverse Event|18
911514|NCT01769456|2902014|P1|Overall Study|Parental request to youth to withdraw|1
911515|NCT01769456|2902014|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
911516|NCT01769456|2902014|P1|Overall Study|Moved out of the area|3
911517|NCT01769456|2902014|P1|Overall Study|Did not receive PCC intervention|6
911518|NCT01769456|2902014|P1|Overall Study|Withdrawal by Subject|3
911519|NCT01769456|2902014|P1|Overall Study|Lost to Follow-up|19
911520|NCT01765179|2902041|P1|Overall Study|Ca elevated 10.6|1
911521|NCT01765179|2902041|P1|Overall Study|work conflict|1
911522|NCT01765179|2902041|P1|Overall Study|lack of venous access|1
911523|NCT01765179|2902041|P1|Overall Study|Out of country unable to finish study|1
911524|NCT01765179|2902041|P1|Overall Study|prohibited med|1
911525|NCT01765179|2902041|P1|Overall Study|Hematocrit >54%|3
911526|NCT01765179|2902041|P1|Overall Study|Withdrawal by Subject|8
911527|NCT01765179|2902041|P1|Overall Study|Protocol Violation|1
911528|NCT01765179|2902041|P1|Overall Study|Non-compliance with study drug|2
911529|NCT01765179|2902041|P1|Overall Study|Lost to Follow-up|5
911530|NCT01765179|2902041|P1|Overall Study|Adverse Event|3
911543|NCT01713998|2902275|P3|Overall Study|Withdrawal by Subject|0
911544|NCT01713998|2902276|P2|Overall Study|Withdrawal by Subject|0
911545|NCT01713998|2902277|P1|Overall Study|Withdrawal by Subject|1
911546|NCT01713998|2902275|P3|Overall Study|Lost to Follow-up|2
911547|NCT01713998|2902276|P2|Overall Study|Lost to Follow-up|0
911548|NCT01713998|2902277|P1|Overall Study|Lost to Follow-up|2
911549|NCT01713933|2902295|P1|Overall Study|Excluded from analysis as a BMI outlier|1
911550|NCT01713933|2902295|P1|Overall Study|Withdrawal by Subject|3
911551|NCT01713933|2902295|P1|Overall Study|Lost to Follow-up|2
911552|NCT01713686|2902307|P1|Overall Study|Withdrawal by Subject|6
911553|NCT01713686|2902307|P1|Overall Study|Lost to Follow-up|9
911554|NCT01705587|2902329|P2|Overall Study|Withdrawal by Subject|1
911555|NCT01705587|2902330|P1|Overall Study|Withdrawal by Subject|0
911556|NCT01703208|2902348|P2|Overall Study|Protocol Deviation|0
911557|NCT01703208|2902349|P1|Overall Study|Protocol Deviation|2
911558|NCT01703208|2902348|P2|Overall Study|Technical Problems|1
911559|NCT01703208|2902349|P1|Overall Study|Technical Problems|0
911560|NCT01703208|2902348|P2|Overall Study|Adverse Event|19
911561|NCT01703208|2902349|P1|Overall Study|Adverse Event|14
911562|NCT01703208|2902348|P2|Overall Study|Withdrawal by Subject|209
911563|NCT01703208|2902349|P1|Overall Study|Withdrawal by Subject|205
911564|NCT01703208|2902348|P2|Overall Study|Study Terminated by Sponsor|1716
911565|NCT01703208|2902349|P1|Overall Study|Study Terminated by Sponsor|1710
911566|NCT01703208|2902348|P2|Overall Study|Protocol Violation|1
911567|NCT01703208|2902349|P1|Overall Study|Protocol Violation|1
911568|NCT01703208|2902348|P2|Overall Study|Progressive disease|2
911569|NCT01703208|2902349|P1|Overall Study|Progressive disease|2
911570|NCT01703208|2902348|P2|Overall Study|Physician Decision|13
911571|NCT01703208|2902349|P1|Overall Study|Physician Decision|11
911572|NCT01703208|2902348|P2|Overall Study|Site Discontinued Study Participation|27
911573|NCT01703208|2902349|P1|Overall Study|Site Discontinued Study Participation|23
911574|NCT01703208|2902348|P2|Overall Study|Excluded Medication|2
911575|NCT01703208|2902349|P1|Overall Study|Excluded Medication|1
911576|NCT01703208|2902348|P2|Overall Study|Non-Compliance with Study Drug|0
911577|NCT01703208|2902349|P1|Overall Study|Non-Compliance with Study Drug|1
911578|NCT01703208|2902348|P2|Overall Study|Lost to Follow-up|62
911579|NCT01703208|2902349|P1|Overall Study|Lost to Follow-up|68
911580|NCT01703208|2902348|P2|Overall Study|Lack of Efficacy|2
911581|NCT01703208|2902349|P1|Overall Study|Lack of Efficacy|1
911582|NCT01703208|2902348|P2|Overall Study|Death|48
911583|NCT01703208|2902349|P1|Overall Study|Death|61
911590|NCT01685840|2902439|P2|Overall Study|Had VAD, Dialysis or Transplant|17
911591|NCT01685840|2902440|P1|Overall Study|Had VAD, Dialysis or Transplant|11
911592|NCT01685840|2902439|P2|Overall Study|Futility|200
911593|NCT01685840|2902440|P1|Overall Study|Futility|197
911594|NCT01685840|2902439|P2|Overall Study|Withdrawal by Subject|17
911595|NCT01685840|2902440|P1|Overall Study|Withdrawal by Subject|14
911596|NCT01685840|2902439|P2|Overall Study|Physician Decision|7
911597|NCT01685840|2902440|P1|Overall Study|Physician Decision|3
911598|NCT01685840|2902439|P2|Overall Study|Lost to Follow-up|25
911599|NCT01685840|2902440|P1|Overall Study|Lost to Follow-up|27
911600|NCT01685840|2902439|P2|Overall Study|Death|66
911601|NCT01685840|2902440|P1|Overall Study|Death|77
911616|NCT01655069|2902546|P4|Overall Study|Withdrawal by Subject|0
911617|NCT01655069|2902547|P3|Overall Study|Withdrawal by Subject|0
911618|NCT01655069|2902548|P2|Overall Study|Withdrawal by Subject|3
911619|NCT01655069|2902549|P1|Overall Study|Withdrawal by Subject|2
911620|NCT01655069|2902546|P4|Overall Study|No Treatment Needed|0
911621|NCT01655069|2902547|P3|Overall Study|No Treatment Needed|0
911622|NCT01655069|2902548|P2|Overall Study|No Treatment Needed|1
911623|NCT01655069|2902549|P1|Overall Study|No Treatment Needed|0
911624|NCT01655069|2902546|P4|Overall Study|Lack of Efficacy|0
911625|NCT01655069|2902547|P3|Overall Study|Lack of Efficacy|0
911626|NCT01655069|2902548|P2|Overall Study|Lack of Efficacy|1
911627|NCT01655069|2902549|P1|Overall Study|Lack of Efficacy|0
911628|NCT01655069|2902546|P4|Overall Study|Adverse Event|3
911629|NCT01655069|2902547|P3|Overall Study|Adverse Event|2
911630|NCT01655069|2902548|P2|Overall Study|Adverse Event|7
911631|NCT01655069|2902549|P1|Overall Study|Adverse Event|6
911632|NCT01655069|2902546|P4|Overall Study|Physician Decision|1
911633|NCT01655069|2902547|P3|Overall Study|Physician Decision|0
911634|NCT01655069|2902548|P2|Overall Study|Physician Decision|0
911635|NCT01655069|2902549|P1|Overall Study|Physician Decision|0
911722|NCT01622348|2902694|P3|Overall Study|Withdrawal by Subject|1
911723|NCT01622348|2902695|P2|Overall Study|Withdrawal by Subject|0
911724|NCT01622348|2902696|P1|Overall Study|Withdrawal by Subject|1
911725|NCT01615029|2902709|P5|Overall Study|Ongoing|23
911726|NCT01615029|2902710|P4|Overall Study|Ongoing|2
911727|NCT01615029|2902711|P3|Overall Study|Ongoing|3
911728|NCT01615029|2902712|P2|Overall Study|Ongoing|2
911729|NCT01615029|2902713|P1|Overall Study|Ongoing|1
911730|NCT01615029|2902709|P5|Overall Study|Physician Decision|1
911731|NCT01615029|2902710|P4|Overall Study|Physician Decision|0
911732|NCT01615029|2902711|P3|Overall Study|Physician Decision|0
911733|NCT01615029|2902712|P2|Overall Study|Physician Decision|0
911734|NCT01615029|2902713|P1|Overall Study|Physician Decision|0
911735|NCT01615029|2902709|P5|Overall Study|Progressive disease|5
911736|NCT01615029|2902710|P4|Overall Study|Progressive disease|1
911737|NCT01615029|2902711|P3|Overall Study|Progressive disease|1
911738|NCT01615029|2902712|P2|Overall Study|Progressive disease|1
911739|NCT01615029|2902713|P1|Overall Study|Progressive disease|2
911740|NCT01615029|2902709|P5|Overall Study|Lost to Follow-up|1
911741|NCT01615029|2902710|P4|Overall Study|Lost to Follow-up|0
911742|NCT01615029|2902711|P3|Overall Study|Lost to Follow-up|0
911743|NCT01615029|2902712|P2|Overall Study|Lost to Follow-up|0
911744|NCT01615029|2902713|P1|Overall Study|Lost to Follow-up|0
911745|NCT01615029|2902709|P5|Overall Study|Death|1
911746|NCT01615029|2902710|P4|Overall Study|Death|0
911747|NCT01615029|2902711|P3|Overall Study|Death|0
911748|NCT01615029|2902712|P2|Overall Study|Death|0
911749|NCT01615029|2902713|P1|Overall Study|Death|0
911750|NCT01615029|2902709|P5|Overall Study|Adverse Event|1
911751|NCT01615029|2902710|P4|Overall Study|Adverse Event|0
911752|NCT01615029|2902711|P3|Overall Study|Adverse Event|0
911753|NCT01615029|2902712|P2|Overall Study|Adverse Event|0
911754|NCT01615029|2902713|P1|Overall Study|Adverse Event|0
911755|NCT01565941|2902762|P2|Overall Study|Randomized; did not receive intevention|2
911756|NCT01565941|2902763|P1|Overall Study|Randomized; did not receive intevention|8
911757|NCT01565941|2902762|P2|Overall Study|Withdrawn by parent/guardian|2
911758|NCT01565941|2902763|P1|Overall Study|Withdrawn by parent/guardian|3
911759|NCT01519206|2902844|P1|Overall Study|Missed Visit|2
911760|NCT01519206|2902844|P1|Overall Study|Lost to Follow-up|3
911772|NCT01440816|2902891|P2|Overall Study|To Be Seen By Local Oncologist|2
911773|NCT01440816|2902892|P1|Overall Study|To Be Seen By Local Oncologist|1
911774|NCT01440816|2902891|P2|Overall Study|Disease Progression|9
911775|NCT01440816|2902892|P1|Overall Study|Disease Progression|0
911776|NCT01439373|2902908|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
911777|NCT01439373|2902909|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
911778|NCT01439373|2902908|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
911779|NCT01439373|2902909|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
911780|NCT01428219|2902950|P1|Overall Study|25 patients enrolled, 3 were not treated|3
911806|NCT01389596|2903184|P3|Overall Study|Other Unspecified|0
911807|NCT01389596|2903185|P2|Overall Study|Other Unspecified|1
911808|NCT01389596|2903186|P1|Overall Study|Other Unspecified|2
911809|NCT01389596|2903184|P3|Overall Study|Death|0
911810|NCT01389596|2903185|P2|Overall Study|Death|1
911811|NCT01389596|2903186|P1|Overall Study|Death|0
911812|NCT01389596|2903184|P3|Overall Study|Adverse Event|0
911813|NCT01389596|2903185|P2|Overall Study|Adverse Event|4
911814|NCT01389596|2903186|P1|Overall Study|Adverse Event|1
911815|NCT01389596|2903184|P3|Overall Study|Insufficient Clinical Response|5
911816|NCT01389596|2903185|P2|Overall Study|Insufficient Clinical Response|4
911817|NCT01389596|2903186|P1|Overall Study|Insufficient Clinical Response|3
911818|NCT01389596|2903184|P3|Overall Study|Withdrawal by Subject|2
911819|NCT01389596|2903185|P2|Overall Study|Withdrawal by Subject|2
911820|NCT01389596|2903186|P1|Overall Study|Withdrawal by Subject|1
911821|NCT01389596|2903184|P3|Overall Study|Protocol Violation|3
911822|NCT01389596|2903185|P2|Overall Study|Protocol Violation|4
911823|NCT01389596|2903186|P1|Overall Study|Protocol Violation|3
911828|NCT01350102|2903340|P4|Overall Study|Adverse Event|0
911829|NCT01350102|2903341|P3|Overall Study|Adverse Event|1
911830|NCT01350102|2903342|P2|Overall Study|Adverse Event|0
911831|NCT01350102|2903343|P1|Overall Study|Adverse Event|0
911840|NCT01338415|2903395|P2|Overall Study|Other (administrative reason)|0
911841|NCT01338415|2903396|P1|Overall Study|Other (administrative reason)|1
911842|NCT01338415|2903395|P2|Overall Study|Other (PAH not the main etiology of PH)|2
911843|NCT01338415|2903396|P1|Overall Study|Other (PAH not the main etiology of PH)|0
911844|NCT01338415|2903395|P2|Overall Study|Withdrawal by Subject|1
911845|NCT01338415|2903396|P1|Overall Study|Withdrawal by Subject|1
911846|NCT01338415|2903395|P2|Overall Study|Adverse Event|6
911847|NCT01338415|2903396|P1|Overall Study|Adverse Event|8
911848|NCT01314118|2903491|P1|Overall Study|Ongoing|62
911849|NCT01314118|2903491|P1|Overall Study|Other|2
911850|NCT01314118|2903491|P1|Overall Study|Withdrawal by Subject|11
911851|NCT01314118|2903491|P1|Overall Study|Protocol Violation|5
911852|NCT01314118|2903491|P1|Overall Study|Death|4
911853|NCT01314118|2903491|P1|Overall Study|Physician Decision|11
911854|NCT01314118|2903491|P1|Overall Study|Progressive disease|27
911855|NCT01314118|2903491|P1|Overall Study|Adverse Event|9
911856|NCT01287741|2903500|P2|Overall Study|Reason not specified|9
911857|NCT01287741|2903501|P1|Overall Study|Reason not specified|14
911858|NCT01287741|2903500|P2|Overall Study|Progressive disease|148
911859|NCT01287741|2903501|P1|Overall Study|Progressive disease|173
911860|NCT01287741|2903500|P2|Overall Study|Continued in the study|455
911861|NCT01287741|2903501|P1|Overall Study|Continued in the study|446
911862|NCT01287741|2903500|P2|Overall Study|Adverse Event|4
911863|NCT01287741|2903501|P1|Overall Study|Adverse Event|3
911864|NCT01287741|2903500|P2|Overall Study|Death|38
911865|NCT01287741|2903501|P1|Overall Study|Death|31
911866|NCT01287741|2903500|P2|Overall Study|Lost to Follow-up|8
911867|NCT01287741|2903501|P1|Overall Study|Lost to Follow-up|5
911868|NCT01287741|2903500|P2|Overall Study|Non-compliance|3
911869|NCT01287741|2903501|P1|Overall Study|Non-compliance|2
911870|NCT01287741|2903500|P2|Overall Study|Physician Decision|19
911871|NCT01287741|2903501|P1|Overall Study|Physician Decision|12
911872|NCT01287741|2903500|P2|Overall Study|Protocol Violation|0
911873|NCT01287741|2903501|P1|Overall Study|Protocol Violation|1
911874|NCT01287741|2903500|P2|Overall Study|Withdrawal by Subject|22
911875|NCT01287741|2903501|P1|Overall Study|Withdrawal by Subject|25
911910|NCT01271712|2903550|P2|Survival Follow-up|Ongoing survival follow-up|6
911911|NCT01271712|2903551|P1|Survival Follow-up|Ongoing survival follow-up|15
911912|NCT01271712|2903550|P2|Safety Follow-up|Progressive disease|0
911913|NCT01271712|2903551|P1|Safety Follow-up|Progressive disease|1
911914|NCT01271712|2903550|P2|Safety Follow-up|No follow-up|1
911915|NCT01271712|2903551|P1|Safety Follow-up|No follow-up|1
911916|NCT01271712|2903550|P2|Safety Follow-up|Ongoing safety follow-up|4
911917|NCT01271712|2903551|P1|Safety Follow-up|Ongoing safety follow-up|3
911918|NCT01271712|2903550|P2|Safety Follow-up|Protocol Violation|1
911919|NCT01271712|2903551|P1|Safety Follow-up|Protocol Violation|1
911920|NCT01271712|2903550|P2|Safety Follow-up|Withdrawal by Subject|2
911921|NCT01271712|2903551|P1|Safety Follow-up|Withdrawal by Subject|4
911922|NCT01271712|2903550|P2|Safety Follow-up|Death|7
911923|NCT01271712|2903551|P1|Safety Follow-up|Death|11
911924|NCT01271712|2903550|P2|Open Label Treatment|Switching to other therapy|1
911925|NCT01271712|2903551|P1|Open Label Treatment|Switching to other therapy|2
911926|NCT01271712|2903550|P2|Open Label Treatment|Protocol Violation|1
911927|NCT01271712|2903551|P1|Open Label Treatment|Protocol Violation|0
911928|NCT01271712|2903550|P2|Open Label Treatment|Non-compliance with study drug|0
911929|NCT01271712|2903551|P1|Open Label Treatment|Non-compliance with study drug|1
911930|NCT01271712|2903550|P2|Open Label Treatment|Ongoing with open-label treatment|1
911931|NCT01271712|2903551|P1|Open Label Treatment|Ongoing with open-label treatment|6
911932|NCT01271712|2903550|P2|Open Label Treatment|Progressive disease|31
911933|NCT01271712|2903551|P1|Open Label Treatment|Progressive disease|56
911934|NCT01271712|2903550|P2|Open Label Treatment|Adverse Event|8
911935|NCT01271712|2903551|P1|Open Label Treatment|Adverse Event|12
911936|NCT01271712|2903550|P2|Open Label Treatment|Physician Decision|0
911937|NCT01271712|2903551|P1|Open Label Treatment|Physician Decision|2
911938|NCT01271712|2903550|P2|Open Label Treatment|Withdrawal by Subject|11
911939|NCT01271712|2903551|P1|Open Label Treatment|Withdrawal by Subject|6
911940|NCT01271712|2903550|P2|Open Label Treatment|Death|5
911941|NCT01271712|2903551|P1|Open Label Treatment|Death|6
911942|NCT01271712|2903550|P2|Double Blind Treatment|receive no study drug|0
911943|NCT01271712|2903551|P1|Double Blind Treatment|receive no study drug|1
911944|NCT01271712|2903550|P2|Double Blind Treatment|Non compliance with study drug|0
911945|NCT01271712|2903551|P1|Double Blind Treatment|Non compliance with study drug|2
911946|NCT01271712|2903550|P2|Double Blind Treatment|Withdrawal by Subject|1
911947|NCT01271712|2903551|P1|Double Blind Treatment|Withdrawal by Subject|4
911948|NCT01271712|2903550|P2|Double Blind Treatment|Progressive disease|3
911949|NCT01271712|2903551|P1|Double Blind Treatment|Progressive disease|23
911950|NCT01271712|2903550|P2|Double Blind Treatment|Adverse Event|4
911951|NCT01271712|2903551|P1|Double Blind Treatment|Adverse Event|9
911952|NCT01271712|2903550|P2|Double Blind Treatment|Lack of Efficacy|0
911953|NCT01271712|2903551|P1|Double Blind Treatment|Lack of Efficacy|1
911954|NCT01271712|2903550|P2|Double Blind Treatment|Death|0
911955|NCT01271712|2903551|P1|Double Blind Treatment|Death|2
911956|NCT01249404|2903587|P3|Overall Study|Non compliance to visit schedule|0
911957|NCT01249404|2903588|P2|Overall Study|Non compliance to visit schedule|1
911958|NCT01249404|2903589|P1|Overall Study|Non compliance to visit schedule|0
911959|NCT01249404|2903587|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
911960|NCT01249404|2903588|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
911961|NCT01249404|2903589|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
911962|NCT01249404|2903587|P3|Overall Study|Withdrawal by Subject|0
911963|NCT01249404|2903588|P2|Overall Study|Withdrawal by Subject|2
911964|NCT01249404|2903589|P1|Overall Study|Withdrawal by Subject|2
911965|NCT01249404|2903587|P3|Overall Study|Adverse Event|2
911966|NCT01249404|2903588|P2|Overall Study|Adverse Event|2
911967|NCT01249404|2903589|P1|Overall Study|Adverse Event|2
911968|NCT01249404|2903587|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
911969|NCT01249404|2903588|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
911970|NCT01249404|2903589|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
911971|NCT01249404|2903587|P3|Overall Study|Study treatment not received|2
911972|NCT01249404|2903588|P2|Overall Study|Study treatment not received|1
911973|NCT01249404|2903589|P1|Overall Study|Study treatment not received|0
911974|NCT01234337|2903683|P2|Overall Study|Withdrawal by Subject|7
911975|NCT01234337|2903684|P1|Overall Study|Withdrawal by Subject|11
911976|NCT01234337|2903683|P2|Overall Study|Protocol Violation|3
911977|NCT01234337|2903684|P1|Overall Study|Protocol Violation|2
911978|NCT01234337|2903683|P2|Overall Study|Lost to Follow-up|1
911979|NCT01234337|2903684|P1|Overall Study|Lost to Follow-up|0
911980|NCT01234337|2903683|P2|Overall Study|Randomized but not Treated|4
911981|NCT01234337|2903684|P1|Overall Study|Randomized but not Treated|6
911982|NCT01234337|2903683|P2|Overall Study|Non-compliant with study medication|2
911983|NCT01234337|2903684|P1|Overall Study|Non-compliant with study medication|3
911984|NCT01234337|2903683|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
911985|NCT01234337|2903684|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
911986|NCT01234337|2903683|P2|Overall Study|Ongoing|24
911987|NCT01234337|2903684|P1|Overall Study|Ongoing|16
911988|NCT01234337|2903683|P2|Overall Study|Adverse Event|20
911989|NCT01234337|2903684|P1|Overall Study|Adverse Event|55
912032|NCT01191840|2903796|P2|Overall Study|Withdrawal by Subject|0
912033|NCT01191840|2903797|P1|Overall Study|Withdrawal by Subject|2
912034|NCT01191840|2903796|P2|Overall Study|lab error speciation - non Staph infecti|1
912035|NCT01191840|2903797|P1|Overall Study|lab error speciation - non Staph infecti|0
912036|NCT01191840|2903796|P2|Overall Study|IRB approval lapse|2
912037|NCT01191840|2903797|P1|Overall Study|IRB approval lapse|0
912038|NCT01191840|2903796|P2|Overall Study|ineligible at enrollment|0
912039|NCT01191840|2903797|P1|Overall Study|ineligible at enrollment|1
912040|NCT01191840|2903796|P2|Overall Study|Non Staph Infection|3
912041|NCT01191840|2903797|P1|Overall Study|Non Staph Infection|4
912042|NCT01191840|2903796|P2|Overall Study|Lost to Follow-up|6
912043|NCT01191840|2903797|P1|Overall Study|Lost to Follow-up|4
912044|NCT01191840|2903796|P2|Overall Study|Subject discontinued treatment|2
912045|NCT01191840|2903797|P1|Overall Study|Subject discontinued treatment|1
912046|NCT01191840|2903796|P2|Overall Study|withdrew consent|1
912047|NCT01191840|2903797|P1|Overall Study|withdrew consent|2
912051|NCT01185821|2903837|P5|Overall Study|Administrative problems|2
912052|NCT01185821|2903838|P4|Overall Study|Administrative problems|1
912053|NCT01185821|2903839|P3|Overall Study|Administrative problems|1
912054|NCT01185821|2903840|P2|Overall Study|Administrative problems|0
912055|NCT01185821|2903841|P1|Overall Study|Administrative problems|0
912056|NCT01185821|2903837|P5|Overall Study|Lost to Follow-up|2
912057|NCT01185821|2903838|P4|Overall Study|Lost to Follow-up|1
912058|NCT01185821|2903839|P3|Overall Study|Lost to Follow-up|2
912059|NCT01185821|2903840|P2|Overall Study|Lost to Follow-up|1
912060|NCT01185821|2903841|P1|Overall Study|Lost to Follow-up|1
912061|NCT01185821|2903837|P5|Overall Study|Withdrawal by Subject|3
912062|NCT01185821|2903838|P4|Overall Study|Withdrawal by Subject|1
912063|NCT01185821|2903839|P3|Overall Study|Withdrawal by Subject|2
912064|NCT01185821|2903840|P2|Overall Study|Withdrawal by Subject|2
912065|NCT01185821|2903841|P1|Overall Study|Withdrawal by Subject|3
912066|NCT01185821|2903837|P5|Overall Study|Lack of Efficacy|9
912067|NCT01185821|2903838|P4|Overall Study|Lack of Efficacy|0
912068|NCT01185821|2903839|P3|Overall Study|Lack of Efficacy|3
912069|NCT01185821|2903840|P2|Overall Study|Lack of Efficacy|0
912070|NCT01185821|2903841|P1|Overall Study|Lack of Efficacy|0
912071|NCT01185821|2903837|P5|Overall Study|Adverse Event|5
912072|NCT01185821|2903838|P4|Overall Study|Adverse Event|2
912073|NCT01185821|2903839|P3|Overall Study|Adverse Event|1
912074|NCT01185821|2903840|P2|Overall Study|Adverse Event|3
912075|NCT01185821|2903841|P1|Overall Study|Adverse Event|2
912076|NCT01185821|2903837|P5|Overall Study|Condition no longer required study drug|1
912077|NCT01185821|2903838|P4|Overall Study|Condition no longer required study drug|0
912078|NCT01185821|2903839|P3|Overall Study|Condition no longer required study drug|0
912079|NCT01185821|2903840|P2|Overall Study|Condition no longer required study drug|0
912080|NCT01185821|2903841|P1|Overall Study|Condition no longer required study drug|0
912081|NCT01185821|2903837|P5|Overall Study|Death|0
912082|NCT01185821|2903838|P4|Overall Study|Death|0
912083|NCT01185821|2903839|P3|Overall Study|Death|0
912084|NCT01185821|2903840|P2|Overall Study|Death|1
912085|NCT01185821|2903841|P1|Overall Study|Death|0
912086|NCT01185821|2903837|P5|Overall Study|Abnormal test procedure result|1
912087|NCT01185821|2903838|P4|Overall Study|Abnormal test procedure result|0
912088|NCT01185821|2903839|P3|Overall Study|Abnormal test procedure result|0
912089|NCT01185821|2903840|P2|Overall Study|Abnormal test procedure result|0
912090|NCT01185821|2903841|P1|Overall Study|Abnormal test procedure result|0
912091|NCT01185821|2903837|P5|Overall Study|Protocol Violation|1
912092|NCT01185821|2903838|P4|Overall Study|Protocol Violation|1
912093|NCT01185821|2903839|P3|Overall Study|Protocol Violation|0
912094|NCT01185821|2903840|P2|Overall Study|Protocol Violation|0
912095|NCT01185821|2903841|P1|Overall Study|Protocol Violation|0
912096|NCT01185821|2903837|P5|Overall Study|Abnormal laboratory value(s)|0
912097|NCT01185821|2903838|P4|Overall Study|Abnormal laboratory value(s)|0
912098|NCT01185821|2903839|P3|Overall Study|Abnormal laboratory value(s)|1
912099|NCT01185821|2903840|P2|Overall Study|Abnormal laboratory value(s)|2
912100|NCT01185821|2903841|P1|Overall Study|Abnormal laboratory value(s)|1
912101|NCT01131520|2903924|P2|Overall Study|Subject changed history after enrollment|1
912102|NCT01131520|2903925|P1|Overall Study|Subject changed history after enrollment|0
912103|NCT01131520|2903924|P2|Overall Study|Counselor not available|3
912104|NCT01131520|2903925|P1|Overall Study|Counselor not available|0
912105|NCT01131520|2903924|P2|Overall Study|Computer problem|0
912106|NCT01131520|2903925|P1|Overall Study|Computer problem|1
912107|NCT01123382|2903949|P2|Overall Study|Lost to Follow-up|2
912108|NCT01123382|2903950|P1|Overall Study|Lost to Follow-up|1
912109|NCT01123382|2903949|P2|Overall Study|Withdrawal by Subject|4
912110|NCT01123382|2903950|P1|Overall Study|Withdrawal by Subject|1
912164|NCT01088243|2904209|P2|Overall Study|Adverse Event|0
912165|NCT01088243|2904210|P1|Overall Study|Adverse Event|1
912172|NCT01065844|2904234|P1|Overall Study|Adverse Event|5
912177|NCT01011335|2904278|P13|Overall Study|Adverse Event|1
912178|NCT01011335|2904279|P12|Overall Study|Adverse Event|0
912179|NCT01011335|2904280|P11|Overall Study|Adverse Event|4
912180|NCT01011335|2904281|P10|Overall Study|Adverse Event|0
912181|NCT01011335|2904282|P9|Overall Study|Adverse Event|0
912182|NCT01011335|2904283|P8|Overall Study|Adverse Event|0
912183|NCT01011335|2904284|P7|Overall Study|Adverse Event|0
912184|NCT01011335|2904285|P6|Overall Study|Adverse Event|0
912185|NCT01011335|2904286|P5|Overall Study|Adverse Event|0
912186|NCT01011335|2904287|P4|Overall Study|Adverse Event|0
912187|NCT01011335|2904288|P3|Overall Study|Adverse Event|0
912188|NCT01011335|2904289|P2|Overall Study|Adverse Event|0
912189|NCT01011335|2904290|P1|Overall Study|Adverse Event|0
912190|NCT01011335|2904278|P13|Overall Study|Moved/deployed or no booster|0
912191|NCT01011335|2904279|P12|Overall Study|Moved/deployed or no booster|0
912192|NCT01011335|2904280|P11|Overall Study|Moved/deployed or no booster|2
912193|NCT01011335|2904281|P10|Overall Study|Moved/deployed or no booster|0
912194|NCT01011335|2904282|P9|Overall Study|Moved/deployed or no booster|1
912195|NCT01011335|2904283|P8|Overall Study|Moved/deployed or no booster|0
912196|NCT01011335|2904284|P7|Overall Study|Moved/deployed or no booster|1
912197|NCT01011335|2904285|P6|Overall Study|Moved/deployed or no booster|0
912198|NCT01011335|2904286|P5|Overall Study|Moved/deployed or no booster|0
912199|NCT01011335|2904287|P4|Overall Study|Moved/deployed or no booster|1
912200|NCT01011335|2904288|P3|Overall Study|Moved/deployed or no booster|0
912201|NCT01011335|2904289|P2|Overall Study|Moved/deployed or no booster|0
912202|NCT01011335|2904290|P1|Overall Study|Moved/deployed or no booster|1
912203|NCT01011335|2904278|P13|Overall Study|Protocol Violation|0
912204|NCT01011335|2904279|P12|Overall Study|Protocol Violation|0
912205|NCT01011335|2904280|P11|Overall Study|Protocol Violation|0
912206|NCT01011335|2904281|P10|Overall Study|Protocol Violation|0
912207|NCT01011335|2904282|P9|Overall Study|Protocol Violation|0
912208|NCT01011335|2904283|P8|Overall Study|Protocol Violation|0
912209|NCT01011335|2904284|P7|Overall Study|Protocol Violation|0
912210|NCT01011335|2904285|P6|Overall Study|Protocol Violation|0
912211|NCT01011335|2904286|P5|Overall Study|Protocol Violation|0
912212|NCT01011335|2904287|P4|Overall Study|Protocol Violation|0
912213|NCT01011335|2904288|P3|Overall Study|Protocol Violation|0
912214|NCT01011335|2904289|P2|Overall Study|Protocol Violation|1
912215|NCT01011335|2904290|P1|Overall Study|Protocol Violation|0
912216|NCT01011335|2904278|P13|Overall Study|Lost to Follow-up|2
912217|NCT01011335|2904279|P12|Overall Study|Lost to Follow-up|1
912218|NCT01011335|2904280|P11|Overall Study|Lost to Follow-up|0
912219|NCT01011335|2904281|P10|Overall Study|Lost to Follow-up|0
912220|NCT01011335|2904282|P9|Overall Study|Lost to Follow-up|1
912221|NCT01011335|2904283|P8|Overall Study|Lost to Follow-up|2
912222|NCT01011335|2904284|P7|Overall Study|Lost to Follow-up|2
912223|NCT01011335|2904285|P6|Overall Study|Lost to Follow-up|1
912224|NCT01011335|2904286|P5|Overall Study|Lost to Follow-up|1
912225|NCT01011335|2904287|P4|Overall Study|Lost to Follow-up|1
912226|NCT01011335|2904288|P3|Overall Study|Lost to Follow-up|1
912227|NCT01011335|2904289|P2|Overall Study|Lost to Follow-up|0
912228|NCT01011335|2904290|P1|Overall Study|Lost to Follow-up|0
912229|NCT01010061|2904329|P2|Overall Study|Failure to Return|2
912230|NCT01010061|2904330|P1|Overall Study|Failure to Return|3
912231|NCT01010061|2904329|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
912232|NCT01010061|2904330|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
912233|NCT01010061|2904329|P2|Overall Study|Administrative/Other|14
912234|NCT01010061|2904330|P1|Overall Study|Administrative/Other|19
912235|NCT01010061|2904329|P2|Overall Study|Death|7
912236|NCT01010061|2904330|P1|Overall Study|Death|23
912237|NCT01010061|2904329|P2|Overall Study|Withdrew Consent|4
912238|NCT01010061|2904330|P1|Overall Study|Withdrew Consent|9
912239|NCT01010061|2904329|P2|Overall Study|Progression of Disease|63
912240|NCT01010061|2904330|P1|Overall Study|Progression of Disease|71
912241|NCT01010061|2904329|P2|Overall Study|Adverse Events or Intercurrent Illness|4
912242|NCT01010061|2904330|P1|Overall Study|Adverse Events or Intercurrent Illness|7
912243|NCT00985088|2904410|P8|Overall Study|Lost to Follow-up|2
912244|NCT00985088|2904411|P7|Overall Study|Lost to Follow-up|3
912245|NCT00985088|2904412|P6|Overall Study|Lost to Follow-up|5
912246|NCT00985088|2904413|P5|Overall Study|Lost to Follow-up|6
912247|NCT00985088|2904414|P4|Overall Study|Lost to Follow-up|6
912248|NCT00985088|2904415|P3|Overall Study|Lost to Follow-up|2
912249|NCT00985088|2904416|P2|Overall Study|Lost to Follow-up|1
912250|NCT00985088|2904417|P1|Overall Study|Lost to Follow-up|6
912251|NCT00985088|2904410|P8|Overall Study|Migrated/moved from study area|1
912252|NCT00985088|2904411|P7|Overall Study|Migrated/moved from study area|0
912253|NCT00985088|2904412|P6|Overall Study|Migrated/moved from study area|0
912254|NCT00985088|2904413|P5|Overall Study|Migrated/moved from study area|0
912255|NCT00985088|2904414|P4|Overall Study|Migrated/moved from study area|0
912256|NCT00985088|2904415|P3|Overall Study|Migrated/moved from study area|1
912257|NCT00985088|2904416|P2|Overall Study|Migrated/moved from study area|0
912258|NCT00985088|2904417|P1|Overall Study|Migrated/moved from study area|0
912259|NCT00985088|2904410|P8|Overall Study|Withdrawal by Subject|2
912260|NCT00985088|2904411|P7|Overall Study|Withdrawal by Subject|1
912261|NCT00985088|2904412|P6|Overall Study|Withdrawal by Subject|2
912262|NCT00985088|2904413|P5|Overall Study|Withdrawal by Subject|3
912263|NCT00985088|2904414|P4|Overall Study|Withdrawal by Subject|1
912264|NCT00985088|2904415|P3|Overall Study|Withdrawal by Subject|0
912265|NCT00985088|2904416|P2|Overall Study|Withdrawal by Subject|0
912266|NCT00985088|2904417|P1|Overall Study|Withdrawal by Subject|4
912267|NCT00985088|2904410|P8|Overall Study|Adverse Event|0
912268|NCT00985088|2904411|P7|Overall Study|Adverse Event|0
912269|NCT00985088|2904412|P6|Overall Study|Adverse Event|0
912270|NCT00985088|2904413|P5|Overall Study|Adverse Event|0
912271|NCT00985088|2904414|P4|Overall Study|Adverse Event|0
912272|NCT00985088|2904415|P3|Overall Study|Adverse Event|1
912273|NCT00985088|2904416|P2|Overall Study|Adverse Event|0
912274|NCT00985088|2904417|P1|Overall Study|Adverse Event|0
912275|NCT00985088|2904410|P8|Overall Study|Serious Adverse Event|1
912276|NCT00985088|2904411|P7|Overall Study|Serious Adverse Event|0
912277|NCT00985088|2904412|P6|Overall Study|Serious Adverse Event|0
912278|NCT00985088|2904413|P5|Overall Study|Serious Adverse Event|0
912279|NCT00985088|2904414|P4|Overall Study|Serious Adverse Event|0
912280|NCT00985088|2904415|P3|Overall Study|Serious Adverse Event|0
912281|NCT00985088|2904416|P2|Overall Study|Serious Adverse Event|1
912282|NCT00985088|2904417|P1|Overall Study|Serious Adverse Event|1
912283|NCT00979602|2904675|P2|Overall Study|Others|3
912284|NCT00979602|2904676|P1|Overall Study|Others|3
912285|NCT00979602|2904675|P2|Overall Study|Migrated/moved from study area|6
912286|NCT00979602|2904676|P1|Overall Study|Migrated/moved from study area|3
912287|NCT00979602|2904675|P2|Overall Study|Lost to Follow-up|96
912288|NCT00979602|2904676|P1|Overall Study|Lost to Follow-up|100
912289|NCT00979602|2904675|P2|Overall Study|Withdrawal by Subject|25
912290|NCT00979602|2904676|P1|Overall Study|Withdrawal by Subject|31
912291|NCT00979602|2904675|P2|Overall Study|Protocol Violation|0
912292|NCT00979602|2904676|P1|Overall Study|Protocol Violation|3
912293|NCT00979602|2904675|P2|Overall Study|Serious Adverse Event|3
912294|NCT00979602|2904676|P1|Overall Study|Serious Adverse Event|5
912295|NCT00976820|2904848|P4|Overall Study|Withdrawal by Subject|4
912296|NCT00976820|2904849|P3|Overall Study|Withdrawal by Subject|1
912297|NCT00976820|2904850|P2|Overall Study|Withdrawal by Subject|4
912298|NCT00976820|2904851|P1|Overall Study|Withdrawal by Subject|2
912299|NCT00976820|2904848|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
912300|NCT00976820|2904849|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
912301|NCT00976820|2904850|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
912302|NCT00976820|2904851|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
912303|NCT00976820|2904848|P4|Overall Study|Lost to Follow-up|3
912304|NCT00976820|2904849|P3|Overall Study|Lost to Follow-up|2
912305|NCT00976820|2904850|P2|Overall Study|Lost to Follow-up|16
912306|NCT00976820|2904851|P1|Overall Study|Lost to Follow-up|5
912307|NCT00965263|2905189|P2|Overall Study|Protocol Violation|2
912308|NCT00965263|2905190|P1|Overall Study|Protocol Violation|0
912309|NCT00965263|2905189|P2|Overall Study|Family emergency|1
912310|NCT00965263|2905190|P1|Overall Study|Family emergency|0
912311|NCT00965263|2905189|P2|Overall Study|Physician Decision|0
912312|NCT00965263|2905190|P1|Overall Study|Physician Decision|2
912313|NCT00965185|2905222|P2|Overall Study|Withdrawal by Subject|1
912314|NCT00965185|2905223|P1|Overall Study|Withdrawal by Subject|0
912315|NCT00965185|2905222|P2|Overall Study|Lost to Follow-up|0
912316|NCT00965185|2905223|P1|Overall Study|Lost to Follow-up|2
912317|NCT00957723|2905256|P1|Overall Study|2yr ROM Data Not Evaluable|25
912318|NCT00957723|2905256|P1|Overall Study|Intercurrent Illness|2
912319|NCT00957723|2905256|P1|Overall Study|Investigative Site Terminated|55
912320|NCT00957723|2905256|P1|Overall Study|Did not undergo surgery|3
912321|NCT00957723|2905256|P1|Overall Study|Withdrawal by Subject|23
912322|NCT00957723|2905256|P1|Overall Study|Lost to Follow-up|7
912323|NCT00957723|2905256|P1|Overall Study|Revision/ Removal of Study Implant|3
912324|NCT00957723|2905256|P1|Overall Study|Death|3
912325|NCT00957008|2905271|P4|Overall Study|Relocated; Family conflict|3
912326|NCT00957008|2905272|P3|Overall Study|Relocated; Family conflict|1
912327|NCT00957008|2905273|P2|Overall Study|Relocated; Family conflict|1
912328|NCT00957008|2905274|P1|Overall Study|Relocated; Family conflict|4
912329|NCT00957008|2905271|P4|Overall Study|Physician Decision|1
912330|NCT00957008|2905272|P3|Overall Study|Physician Decision|1
912331|NCT00957008|2905273|P2|Overall Study|Physician Decision|0
912332|NCT00957008|2905274|P1|Overall Study|Physician Decision|1
912333|NCT00957008|2905271|P4|Overall Study|Lost to Follow-up|4
912334|NCT00957008|2905272|P3|Overall Study|Lost to Follow-up|3
912335|NCT00957008|2905273|P2|Overall Study|Lost to Follow-up|1
912336|NCT00957008|2905274|P1|Overall Study|Lost to Follow-up|3
912337|NCT00957008|2905271|P4|Overall Study|Withdrawal by Subject|16
912338|NCT00957008|2905272|P3|Overall Study|Withdrawal by Subject|12
912339|NCT00957008|2905273|P2|Overall Study|Withdrawal by Subject|10
912340|NCT00957008|2905274|P1|Overall Study|Withdrawal by Subject|13
912341|NCT00937937|2905288|P1|Overall Study|Not specified|2
912342|NCT00937937|2905288|P1|Overall Study|Death|1
912343|NCT00937937|2905288|P1|Overall Study|Progression/relapse|61
912344|NCT00937937|2905288|P1|Overall Study|Withdrawal by Subject|2
912345|NCT00937937|2905288|P1|Overall Study|Adverse Event|6
912346|NCT00920218|2905299|P4|Overall Study|Not specified|0
912347|NCT00920218|2905300|P3|Overall Study|Not specified|1
912348|NCT00920218|2905301|P2|Overall Study|Not specified|0
912349|NCT00920218|2905302|P1|Overall Study|Not specified|0
912350|NCT00920218|2905299|P4|Overall Study|Transplant failed/malignancy recurrence|3
912351|NCT00920218|2905300|P3|Overall Study|Transplant failed/malignancy recurrence|2
912352|NCT00920218|2905301|P2|Overall Study|Transplant failed/malignancy recurrence|1
912353|NCT00920218|2905302|P1|Overall Study|Transplant failed/malignancy recurrence|0
912354|NCT00920218|2905299|P4|Overall Study|Lost to Follow-up|3
912355|NCT00920218|2905300|P3|Overall Study|Lost to Follow-up|0
912356|NCT00920218|2905301|P2|Overall Study|Lost to Follow-up|1
912357|NCT00920218|2905302|P1|Overall Study|Lost to Follow-up|0
912358|NCT00920218|2905299|P4|Overall Study|Migrated/moved from study area|0
912359|NCT00920218|2905300|P3|Overall Study|Migrated/moved from study area|1
912360|NCT00920218|2905301|P2|Overall Study|Migrated/moved from study area|0
912361|NCT00920218|2905302|P1|Overall Study|Migrated/moved from study area|0
912362|NCT00920218|2905299|P4|Overall Study|Withdrawal by Subject|0
912363|NCT00920218|2905300|P3|Overall Study|Withdrawal by Subject|2
912364|NCT00920218|2905301|P2|Overall Study|Withdrawal by Subject|3
912365|NCT00920218|2905302|P1|Overall Study|Withdrawal by Subject|0
912366|NCT00920218|2905299|P4|Overall Study|Serious Adverse Event|1
912367|NCT00920218|2905300|P3|Overall Study|Serious Adverse Event|2
912368|NCT00920218|2905301|P2|Overall Study|Serious Adverse Event|0
912369|NCT00920218|2905302|P1|Overall Study|Serious Adverse Event|2
912370|NCT00912964|2905403|P3|Overall Study|Randomized but never received study drug|0
912371|NCT00912964|2905404|P2|Overall Study|Randomized but never received study drug|1
912372|NCT00912964|2905405|P1|Overall Study|Randomized but never received study drug|0
912373|NCT00912964|2905403|P3|Overall Study|Violation of exclusion criterion|2
912374|NCT00912964|2905404|P2|Overall Study|Violation of exclusion criterion|0
912375|NCT00912964|2905405|P1|Overall Study|Violation of exclusion criterion|0
912376|NCT00912964|2905403|P3|Overall Study|Non-compliance with study procedures|0
912377|NCT00912964|2905404|P2|Overall Study|Non-compliance with study procedures|0
912378|NCT00912964|2905405|P1|Overall Study|Non-compliance with study procedures|2
912379|NCT00912964|2905403|P3|Overall Study|Medical History|0
912380|NCT00912964|2905404|P2|Overall Study|Medical History|0
912381|NCT00912964|2905405|P1|Overall Study|Medical History|1
912382|NCT00912964|2905403|P3|Overall Study|Taking exclusionary medications|8
912383|NCT00912964|2905404|P2|Overall Study|Taking exclusionary medications|4
912384|NCT00912964|2905405|P1|Overall Study|Taking exclusionary medications|7
912385|NCT00912964|2905403|P3|Overall Study|Protocol Violation|8
912386|NCT00912964|2905404|P2|Overall Study|Protocol Violation|3
912387|NCT00912964|2905405|P1|Overall Study|Protocol Violation|5
912388|NCT00912964|2905403|P3|Overall Study|Lost to Follow-up|3
912389|NCT00912964|2905404|P2|Overall Study|Lost to Follow-up|3
912390|NCT00912964|2905405|P1|Overall Study|Lost to Follow-up|4
912391|NCT00912964|2905403|P3|Overall Study|Withdrawal by Subject|18
912392|NCT00912964|2905404|P2|Overall Study|Withdrawal by Subject|12
912393|NCT00912964|2905405|P1|Overall Study|Withdrawal by Subject|20
912394|NCT00912964|2905403|P3|Overall Study|Lack of Efficacy|3
912395|NCT00912964|2905404|P2|Overall Study|Lack of Efficacy|4
912396|NCT00912964|2905405|P1|Overall Study|Lack of Efficacy|11
912397|NCT00912964|2905403|P3|Overall Study|Adverse Event|12
912398|NCT00912964|2905404|P2|Overall Study|Adverse Event|18
912399|NCT00912964|2905405|P1|Overall Study|Adverse Event|15
912400|NCT00912964|2905403|P3|Overall Study|Eligibility criterion not met|0
912401|NCT00912964|2905404|P2|Overall Study|Eligibility criterion not met|1
912402|NCT00912964|2905405|P1|Overall Study|Eligibility criterion not met|1
912403|NCT00884741|2905530|P4|Randomization|Protocol Violation|8
912404|NCT00884741|2905531|P3|Randomization|Protocol Violation|8
912405|NCT00884741|2905532|P2|Randomization|Protocol Violation|0
912406|NCT00884741|2905533|P1|Randomization|Protocol Violation|0
912407|NCT00884741|2905530|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
912408|NCT00884741|2905531|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
912409|NCT00884741|2905532|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
912410|NCT00884741|2905533|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
912411|NCT00884741|2905530|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
912412|NCT00884741|2905531|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
912413|NCT00884741|2905532|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
912414|NCT00884741|2905533|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
912415|NCT00884741|2905530|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
912416|NCT00884741|2905531|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
912417|NCT00884741|2905532|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
912418|NCT00884741|2905533|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
912419|NCT00884741|2905530|P4|Step 2 Registration: Tissue Analysis|Death|0
912420|NCT00884741|2905531|P3|Step 2 Registration: Tissue Analysis|Death|0
912421|NCT00884741|2905532|P2|Step 2 Registration: Tissue Analysis|Death|1
912422|NCT00884741|2905533|P1|Step 2 Registration: Tissue Analysis|Death|0
912423|NCT00884741|2905530|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
912424|NCT00884741|2905531|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
912425|NCT00884741|2905532|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
912426|NCT00884741|2905533|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
912427|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
912428|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
912429|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
912430|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
912431|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Disease progression|0
912432|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Disease progression|0
912433|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Disease progression|0
912434|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Disease progression|12
912435|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
912436|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
912437|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
912438|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
912439|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
912440|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
912441|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
912442|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
912443|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Death|0
912444|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Death|0
912445|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Death|0
912446|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Death|3
912532|NCT00792948|2905865|P1|Overall Study|Withdrawal by Subject|3
912447|NCT00884741|2905530|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
912448|NCT00884741|2905531|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
912449|NCT00884741|2905532|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
912450|NCT00884741|2905533|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
912451|NCT00843193|2905578|P2|Overall Study|Withdrawal by Subject|3
912452|NCT00843193|2905579|P1|Overall Study|Withdrawal by Subject|3
912453|NCT00843193|2905578|P2|Overall Study|Physician Decision|1
912454|NCT00843193|2905579|P1|Overall Study|Physician Decision|0
912455|NCT00843193|2905578|P2|Overall Study|Lost to Follow-up|0
912456|NCT00843193|2905579|P1|Overall Study|Lost to Follow-up|1
912457|NCT00843193|2905578|P2|Overall Study|Protocol Violation|2
912458|NCT00843193|2905579|P1|Overall Study|Protocol Violation|1
912459|NCT00843193|2905578|P2|Overall Study|Lack of Efficacy|1
912460|NCT00843193|2905579|P1|Overall Study|Lack of Efficacy|1
912461|NCT00843193|2905578|P2|Overall Study|Adverse Event|4
912462|NCT00843193|2905579|P1|Overall Study|Adverse Event|2
912463|NCT00837434|2905645|P2|Overall Study|Unable to obtain study drug|0
912464|NCT00837434|2905646|P1|Overall Study|Unable to obtain study drug|1
912465|NCT00837434|2905645|P2|Overall Study|Baseline assessments not done in time|0
912466|NCT00837434|2905646|P1|Overall Study|Baseline assessments not done in time|1
912467|NCT00837434|2905645|P2|Overall Study|Noncompliant|0
912468|NCT00837434|2905646|P1|Overall Study|Noncompliant|2
912469|NCT00837434|2905645|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
912470|NCT00837434|2905646|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
912471|NCT00837434|2905645|P2|Overall Study|Lost to Follow-up|1
912472|NCT00837434|2905646|P1|Overall Study|Lost to Follow-up|1
912473|NCT00837434|2905645|P2|Overall Study|Physician Decision|0
912474|NCT00837434|2905646|P1|Overall Study|Physician Decision|3
912475|NCT00831389|2905674|P2|Overall Study|Withdrawal by Subject|1
912476|NCT00831389|2905675|P1|Overall Study|Withdrawal by Subject|0
912493|NCT00802464|2905751|P4|Month 8 - Month 14|Lost to Follow-up|0
912494|NCT00802464|2905752|P3|Month 8 - Month 14|Lost to Follow-up|1
912495|NCT00802464|2905753|P2|Month 8 - Month 14|Lost to Follow-up|0
912496|NCT00802464|2905754|P1|Month 8 - Month 14|Lost to Follow-up|0
912497|NCT00802464|2905751|P4|Month 8 - Month 14|Withdrawal by Subject|0
912498|NCT00802464|2905752|P3|Month 8 - Month 14|Withdrawal by Subject|0
912499|NCT00802464|2905753|P2|Month 8 - Month 14|Withdrawal by Subject|1
912500|NCT00802464|2905754|P1|Month 8 - Month 14|Withdrawal by Subject|1
912501|NCT00802464|2905751|P4|Month 8 - Month 14|Adverse Event|0
912502|NCT00802464|2905752|P3|Month 8 - Month 14|Adverse Event|0
912503|NCT00802464|2905753|P2|Month 8 - Month 14|Adverse Event|1
912504|NCT00802464|2905754|P1|Month 8 - Month 14|Adverse Event|0
912505|NCT00802464|2905751|P4|Month 0 - Month 8|Not specified|0
912506|NCT00802464|2905752|P3|Month 0 - Month 8|Not specified|1
912507|NCT00802464|2905753|P2|Month 0 - Month 8|Not specified|0
912508|NCT00802464|2905754|P1|Month 0 - Month 8|Not specified|0
912509|NCT00802464|2905751|P4|Month 0 - Month 8|Lost to Follow-up|2
912510|NCT00802464|2905752|P3|Month 0 - Month 8|Lost to Follow-up|2
912511|NCT00802464|2905753|P2|Month 0 - Month 8|Lost to Follow-up|1
912512|NCT00802464|2905754|P1|Month 0 - Month 8|Lost to Follow-up|0
912513|NCT00802464|2905751|P4|Month 0 - Month 8|Withdrawal by Subject|5
912514|NCT00802464|2905752|P3|Month 0 - Month 8|Withdrawal by Subject|2
912515|NCT00802464|2905753|P2|Month 0 - Month 8|Withdrawal by Subject|1
912516|NCT00802464|2905754|P1|Month 0 - Month 8|Withdrawal by Subject|0
912517|NCT00802464|2905751|P4|Month 0 - Month 8|Protocol Violation|0
912518|NCT00802464|2905752|P3|Month 0 - Month 8|Protocol Violation|1
912519|NCT00802464|2905753|P2|Month 0 - Month 8|Protocol Violation|0
912520|NCT00802464|2905754|P1|Month 0 - Month 8|Protocol Violation|0
912521|NCT00802464|2905751|P4|Month 0 - Month 8|Adverse Event|2
912522|NCT00802464|2905752|P3|Month 0 - Month 8|Adverse Event|1
912523|NCT00802464|2905753|P2|Month 0 - Month 8|Adverse Event|1
912524|NCT00802464|2905754|P1|Month 0 - Month 8|Adverse Event|0
912525|NCT00802438|2905840|P1|Overall Study|Physician Decision|1
912526|NCT00802438|2905840|P1|Overall Study|Withdrawal by Subject|7
912527|NCT00802438|2905840|P1|Overall Study|Screen Failure|20
912528|NCT00792948|2905865|P1|Overall Study|Protocol Violation|1
912529|NCT00792948|2905865|P1|Overall Study|Physician Decision|11
912530|NCT00792948|2905865|P1|Overall Study|Insurance denial - not treated|1
912531|NCT00792948|2905865|P1|Overall Study|Ineligible|2
912533|NCT00792948|2905865|P1|Overall Study|Death|4
912534|NCT00792948|2905865|P1|Overall Study|Adverse Event|6
912538|NCT00788697|2905932|P1|Overall Study|Indeterminate diagnosis from truth stand|17
912539|NCT00788697|2905932|P1|Overall Study|Technically inadequate truth standard|1
912540|NCT00788697|2905932|P1|Overall Study|no truth standard procedure available|5
912541|NCT00788697|2905932|P1|Overall Study|Training Patients|74
912542|NCT00788697|2905932|P1|Overall Study|No study drug administered|12
912543|NCT00782795|2905981|P2|Overall Study|Withdrawal by Subject|2
912544|NCT00782795|2905982|P1|Overall Study|Withdrawal by Subject|1
912545|NCT00772668|2906014|P1|Overall Study|Physician Decision|3
912546|NCT00764517|2906023|P2|Overall Study|Physician Decision|0
912547|NCT00764517|2906024|P1|Overall Study|Physician Decision|3
912548|NCT00764517|2906023|P2|Overall Study|Death|11
912549|NCT00764517|2906024|P1|Overall Study|Death|3
912550|NCT00764517|2906023|P2|Overall Study|Adverse Event|3
912551|NCT00764517|2906024|P1|Overall Study|Adverse Event|9
912552|NCT00743119|2906042|P1|Overall Study|Withdrawal by Subject|1
912553|NCT00743119|2906042|P1|Overall Study|unreliable|3
912554|NCT00726323|2906069|P2|Overall Study|Metastatic lesions inferred cyst|1
912555|NCT00726323|2906070|P1|Overall Study|Metastatic lesions inferred cyst|0
912556|NCT00726323|2906069|P2|Overall Study|Participant wished to discontinue|1
912557|NCT00726323|2906070|P1|Overall Study|Participant wished to discontinue|0
912558|NCT00726323|2906069|P2|Overall Study|Death|0
912559|NCT00726323|2906070|P1|Overall Study|Death|1
912560|NCT00726323|2906069|P2|Overall Study|Adverse Event|9
912561|NCT00726323|2906070|P1|Overall Study|Adverse Event|9
912562|NCT00726323|2906069|P2|Overall Study|Clinical progression|3
912563|NCT00726323|2906070|P1|Overall Study|Clinical progression|0
912564|NCT00726323|2906069|P2|Overall Study|Progressive disease|16
912565|NCT00726323|2906070|P1|Overall Study|Progressive disease|23
912566|NCT00726323|2906069|P2|Overall Study|Physician Decision|0
912567|NCT00726323|2906070|P1|Overall Study|Physician Decision|1
912568|NCT00726323|2906069|P2|Overall Study|Withdrawal by Subject|1
912569|NCT00726323|2906070|P1|Overall Study|Withdrawal by Subject|3
912570|NCT00716976|2906126|P2|Overall Study|Ineligibles|2
912571|NCT00716976|2906127|P1|Overall Study|Ineligibles|4
912572|NCT00716976|2906126|P2|Overall Study|Radiation during protocol|0
912573|NCT00716976|2906127|P1|Overall Study|Radiation during protocol|1
912574|NCT00716976|2906126|P2|Overall Study|Premature discontinuation cisplatin|4
912575|NCT00716976|2906127|P1|Overall Study|Premature discontinuation cisplatin|5
912576|NCT00716976|2906126|P2|Overall Study|Withdrawal by Subject|1
912577|NCT00716976|2906127|P1|Overall Study|Withdrawal by Subject|5
912578|NCT00716976|2906126|P2|Overall Study|Physician Decision|2
912579|NCT00716976|2906127|P1|Overall Study|Physician Decision|2
912580|NCT00716976|2906126|P2|Overall Study|Death|0
912581|NCT00716976|2906127|P1|Overall Study|Death|1
912582|NCT00716976|2906126|P2|Overall Study|Adverse Event|0
912583|NCT00716976|2906127|P1|Overall Study|Adverse Event|2
912584|NCT00688688|2906150|P3|Overall Study|Violation of exclusion criterion|0
912585|NCT00688688|2906151|P2|Overall Study|Violation of exclusion criterion|1
912586|NCT00688688|2906152|P1|Overall Study|Violation of exclusion criterion|0
912587|NCT00688688|2906150|P3|Overall Study|Site closure|0
912588|NCT00688688|2906151|P2|Overall Study|Site closure|1
912589|NCT00688688|2906152|P1|Overall Study|Site closure|0
912590|NCT00688688|2906150|P3|Overall Study|Taking exclusionary medications|0
912591|NCT00688688|2906151|P2|Overall Study|Taking exclusionary medications|0
912592|NCT00688688|2906152|P1|Overall Study|Taking exclusionary medications|1
912593|NCT00688688|2906150|P3|Overall Study|Non-compliance with study procedures|4
912594|NCT00688688|2906151|P2|Overall Study|Non-compliance with study procedures|3
912595|NCT00688688|2906152|P1|Overall Study|Non-compliance with study procedures|5
912596|NCT00688688|2906150|P3|Overall Study|Randomized but never received study drug|0
912597|NCT00688688|2906151|P2|Overall Study|Randomized but never received study drug|0
912598|NCT00688688|2906152|P1|Overall Study|Randomized but never received study drug|1
912599|NCT00688688|2906150|P3|Overall Study|Protocol Violation|11
912600|NCT00688688|2906151|P2|Overall Study|Protocol Violation|9
912601|NCT00688688|2906152|P1|Overall Study|Protocol Violation|6
912602|NCT00688688|2906150|P3|Overall Study|Lost to Follow-up|7
912603|NCT00688688|2906151|P2|Overall Study|Lost to Follow-up|7
912604|NCT00688688|2906152|P1|Overall Study|Lost to Follow-up|14
912605|NCT00688688|2906150|P3|Overall Study|Withdrawal by Subject|65
912606|NCT00688688|2906151|P2|Overall Study|Withdrawal by Subject|75
912607|NCT00688688|2906152|P1|Overall Study|Withdrawal by Subject|66
912608|NCT00688688|2906150|P3|Overall Study|Lack of Efficacy|45
912609|NCT00688688|2906151|P2|Overall Study|Lack of Efficacy|25
912610|NCT00688688|2906152|P1|Overall Study|Lack of Efficacy|34
912611|NCT00688688|2906150|P3|Overall Study|Adverse Event|50
912612|NCT00688688|2906151|P2|Overall Study|Adverse Event|51
912613|NCT00688688|2906152|P1|Overall Study|Adverse Event|52
912614|NCT00688688|2906150|P3|Overall Study|Eligibility criterion not met|10
912615|NCT00688688|2906151|P2|Overall Study|Eligibility criterion not met|7
912616|NCT00688688|2906152|P1|Overall Study|Eligibility criterion not met|7
912617|NCT00689104|2906245|P4|Overall Study|Non-compliance with study procedures|0
912618|NCT00689104|2906246|P3|Overall Study|Non-compliance with study procedures|1
912619|NCT00689104|2906247|P2|Overall Study|Non-compliance with study procedures|0
912620|NCT00689104|2906248|P1|Overall Study|Non-compliance with study procedures|0
912621|NCT00689104|2906245|P4|Overall Study|Physician Decision|0
912622|NCT00689104|2906246|P3|Overall Study|Physician Decision|0
912623|NCT00689104|2906247|P2|Overall Study|Physician Decision|0
912624|NCT00689104|2906248|P1|Overall Study|Physician Decision|1
912625|NCT00689104|2906245|P4|Overall Study|Randomized but never received study drug|0
912626|NCT00689104|2906246|P3|Overall Study|Randomized but never received study drug|1
912627|NCT00689104|2906247|P2|Overall Study|Randomized but never received study drug|1
912628|NCT00689104|2906248|P1|Overall Study|Randomized but never received study drug|2
912629|NCT00689104|2906245|P4|Overall Study|Protocol Violation|3
912630|NCT00689104|2906246|P3|Overall Study|Protocol Violation|5
912631|NCT00689104|2906247|P2|Overall Study|Protocol Violation|3
912632|NCT00689104|2906248|P1|Overall Study|Protocol Violation|2
912633|NCT00689104|2906245|P4|Overall Study|Lost to Follow-up|5
912634|NCT00689104|2906246|P3|Overall Study|Lost to Follow-up|2
912635|NCT00689104|2906247|P2|Overall Study|Lost to Follow-up|3
912636|NCT00689104|2906248|P1|Overall Study|Lost to Follow-up|4
912637|NCT00689104|2906245|P4|Overall Study|Withdrawal by Subject|11
912638|NCT00689104|2906246|P3|Overall Study|Withdrawal by Subject|18
912639|NCT00689104|2906247|P2|Overall Study|Withdrawal by Subject|11
912640|NCT00689104|2906248|P1|Overall Study|Withdrawal by Subject|12
912641|NCT00689104|2906245|P4|Overall Study|Lack of Efficacy|3
912642|NCT00689104|2906246|P3|Overall Study|Lack of Efficacy|2
912643|NCT00689104|2906247|P2|Overall Study|Lack of Efficacy|6
912644|NCT00689104|2906248|P1|Overall Study|Lack of Efficacy|5
912645|NCT00689104|2906245|P4|Overall Study|Adverse Event|24
912646|NCT00689104|2906246|P3|Overall Study|Adverse Event|16
912647|NCT00689104|2906247|P2|Overall Study|Adverse Event|25
912648|NCT00689104|2906248|P1|Overall Study|Adverse Event|13
912649|NCT00689104|2906245|P4|Overall Study|Eligibility criterion not met|4
912650|NCT00689104|2906246|P3|Overall Study|Eligibility criterion not met|0
912651|NCT00689104|2906247|P2|Overall Study|Eligibility criterion not met|8
912652|NCT00689104|2906248|P1|Overall Study|Eligibility criterion not met|5
912689|NCT00662909|2906445|P3|Overall Study|Eligibility criterion not met|1
912690|NCT00662909|2906446|P2|Overall Study|Eligibility criterion not met|1
912691|NCT00662909|2906447|P1|Overall Study|Eligibility criterion not met|0
912692|NCT00662909|2906445|P3|Overall Study|Physician Decision|2
912693|NCT00662909|2906446|P2|Overall Study|Physician Decision|1
912694|NCT00662909|2906447|P1|Overall Study|Physician Decision|1
912695|NCT00662909|2906445|P3|Overall Study|Non-compliance with study procedures|2
912696|NCT00662909|2906446|P2|Overall Study|Non-compliance with study procedures|3
912697|NCT00662909|2906447|P1|Overall Study|Non-compliance with study procedures|3
912698|NCT00662909|2906445|P3|Overall Study|Randomized- never received study drug|0
912699|NCT00662909|2906446|P2|Overall Study|Randomized- never received study drug|0
912700|NCT00662909|2906447|P1|Overall Study|Randomized- never received study drug|1
912701|NCT00662909|2906445|P3|Overall Study|Protocol Violation|5
912702|NCT00662909|2906446|P2|Overall Study|Protocol Violation|4
912703|NCT00662909|2906447|P1|Overall Study|Protocol Violation|7
912704|NCT00662909|2906445|P3|Overall Study|Lost to Follow-up|3
912705|NCT00662909|2906446|P2|Overall Study|Lost to Follow-up|9
912706|NCT00662909|2906447|P1|Overall Study|Lost to Follow-up|2
912707|NCT00662909|2906445|P3|Overall Study|Withdrawal by Subject|16
912708|NCT00662909|2906446|P2|Overall Study|Withdrawal by Subject|22
912709|NCT00662909|2906447|P1|Overall Study|Withdrawal by Subject|29
912710|NCT00662909|2906445|P3|Overall Study|Lack of Efficacy|5
912711|NCT00662909|2906446|P2|Overall Study|Lack of Efficacy|1
912712|NCT00662909|2906447|P1|Overall Study|Lack of Efficacy|9
912713|NCT00662909|2906445|P3|Overall Study|Adverse Event|19
912714|NCT00662909|2906446|P2|Overall Study|Adverse Event|18
912715|NCT00662909|2906447|P1|Overall Study|Adverse Event|17
912730|NCT00547378|2906797|P3|All Implanted Cohort|Other reasons|1
912731|NCT00547378|2906798|P2|All Implanted Cohort|Other reasons|0
912732|NCT00547378|2906799|P1|All Implanted Cohort|Other reasons|1
912733|NCT00547378|2906797|P3|All Implanted Cohort|Site closure|1
912734|NCT00547378|2906798|P2|All Implanted Cohort|Site closure|0
912735|NCT00547378|2906799|P1|All Implanted Cohort|Site closure|2
912736|NCT00547378|2906797|P3|All Implanted Cohort|Physician Decision|6
912737|NCT00547378|2906798|P2|All Implanted Cohort|Physician Decision|2
912738|NCT00547378|2906799|P1|All Implanted Cohort|Physician Decision|0
912739|NCT00547378|2906797|P3|All Implanted Cohort|Death|4
912740|NCT00547378|2906798|P2|All Implanted Cohort|Death|1
912741|NCT00547378|2906799|P1|All Implanted Cohort|Death|3
912742|NCT00547378|2906797|P3|All Implanted Cohort|Lost to Follow-up|14
912743|NCT00547378|2906798|P2|All Implanted Cohort|Lost to Follow-up|1
912744|NCT00547378|2906799|P1|All Implanted Cohort|Lost to Follow-up|0
912745|NCT00547378|2906797|P3|All Implanted Cohort|Adverse Event|17
912746|NCT00547378|2906798|P2|All Implanted Cohort|Adverse Event|10
912747|NCT00547378|2906799|P1|All Implanted Cohort|Adverse Event|4
912748|NCT00547378|2906797|P3|All Implanted Cohort|Withdrawal by Subject|27
912749|NCT00547378|2906798|P2|All Implanted Cohort|Withdrawal by Subject|4
912750|NCT00547378|2906799|P1|All Implanted Cohort|Withdrawal by Subject|5
912751|NCT00547378|2906797|P3|Randomized Cohort|Other reasons|0
912752|NCT00547378|2906798|P2|Randomized Cohort|Other reasons|0
912753|NCT00547378|2906799|P1|Randomized Cohort|Other reasons|2
912754|NCT00547378|2906797|P3|Randomized Cohort|Adverse Event|0
912755|NCT00547378|2906798|P2|Randomized Cohort|Adverse Event|0
912756|NCT00547378|2906799|P1|Randomized Cohort|Adverse Event|1
912757|NCT00547378|2906797|P3|Randomized Cohort|Lost to Follow-up|0
912758|NCT00547378|2906798|P2|Randomized Cohort|Lost to Follow-up|0
912759|NCT00547378|2906799|P1|Randomized Cohort|Lost to Follow-up|1
912760|NCT00547378|2906797|P3|Randomized Cohort|Death|0
912761|NCT00547378|2906798|P2|Randomized Cohort|Death|1
912762|NCT00547378|2906799|P1|Randomized Cohort|Death|0
912763|NCT00547378|2906797|P3|Randomized Cohort|Withdrawal by Subject|0
912764|NCT00547378|2906798|P2|Randomized Cohort|Withdrawal by Subject|5
912765|NCT00547378|2906799|P1|Randomized Cohort|Withdrawal by Subject|7
912767|NCT00467051|2906855|P1|Overall Study|Adverse Event|2
912768|NCT00450411|2906889|P1|Overall Study|No protocol treatment|2
912769|NCT00450411|2906889|P1|Overall Study|Protocol Violation|6
912794|NCT00420407|2906926|P2|Overall Study|Withdrawal by Subject|2
912795|NCT00420407|2906927|P1|Overall Study|Withdrawal by Subject|0
912796|NCT00420407|2906926|P2|Overall Study|subject identified as Jehovah's witness|0
912797|NCT00420407|2906927|P1|Overall Study|subject identified as Jehovah's witness|1
912798|NCT00420407|2906926|P2|Overall Study|subject identified as detainee|0
912799|NCT00420407|2906927|P1|Overall Study|subject identified as detainee|1
912800|NCT00420407|2906926|P2|Overall Study|Physician Decision|1
912801|NCT00420407|2906927|P1|Overall Study|Physician Decision|2
912802|NCT00420407|2906926|P2|Overall Study|Lost to Follow-up|3
912803|NCT00420407|2906927|P1|Overall Study|Lost to Follow-up|0
912804|NCT00417989|2906935|P2|Overall Study|Physician Decision|2
912805|NCT00417989|2906936|P1|Overall Study|Physician Decision|5
912806|NCT00417989|2906935|P2|Overall Study|Death|1
912807|NCT00417989|2906936|P1|Overall Study|Death|0
912808|NCT00417989|2906935|P2|Overall Study|Protocol Violation|0
912809|NCT00417989|2906936|P1|Overall Study|Protocol Violation|1
912810|NCT00417989|2906935|P2|Overall Study|Lost to Follow-up|6
912811|NCT00417989|2906936|P1|Overall Study|Lost to Follow-up|1
912812|NCT00417989|2906935|P2|Overall Study|Withdrawal by Subject|13
912813|NCT00417989|2906936|P1|Overall Study|Withdrawal by Subject|13
912814|NCT00416598|2906956|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
912815|NCT00416598|2906956|P1|Decitabine Maintenance|Alternative treatment|2
912816|NCT00416598|2906956|P1|Decitabine Maintenance|Progression/relapse|38
912817|NCT00416598|2906956|P1|Decitabine Maintenance|Withdrawal by Subject|18
912818|NCT00416598|2906956|P1|Decitabine Maintenance|Adverse Event|5
912819|NCT00416598|2906956|P1|Induction & Intensification|Failed induction|87
912820|NCT00416598|2906956|P1|Induction & Intensification|Relapse/progression|29
912821|NCT00416598|2906956|P1|Induction & Intensification|Physician discretion/other medical issue|45
912822|NCT00416598|2906956|P1|Induction & Intensification|Alternative Treatment|135
912823|NCT00416598|2906956|P1|Induction & Intensification|Withdrawal by Subject|46
912824|NCT00416598|2906956|P1|Induction & Intensification|Death|32
912825|NCT00416598|2906956|P1|Induction & Intensification|Adverse Event|38
912826|NCT00408694|2906970|P1|Overall Study|No protocol treatment|1
912827|NCT00408694|2906970|P1|Overall Study|Ineligible|1
912892|NCT00389597|2907108|P4|Overall Study|Lost to Follow-up|6
912893|NCT00389597|2907109|P3|Overall Study|Lost to Follow-up|4
912894|NCT00389597|2907110|P2|Overall Study|Lost to Follow-up|6
912895|NCT00389597|2907111|P1|Overall Study|Lost to Follow-up|8
912896|NCT00328783|2907147|P1|Overall Study|Withdrawal by Subject|1
912897|NCT00328783|2907147|P1|Overall Study|No heart in RT field|4
912898|NCT00328783|2907147|P1|Overall Study|Could not tolerate ABC|21
912899|NCT00321685|2907155|P1|Overall Study|Ineligible|2
912900|NCT00321685|2907155|P1|Overall Study|Not start protocol therapy|2
912901|NCT00321685|2907155|P1|Overall Study|Other|5
912902|NCT00321685|2907155|P1|Overall Study|Complicating disese|1
912903|NCT00321685|2907155|P1|Overall Study|Alternative therapy|1
912904|NCT00321685|2907155|P1|Overall Study|Withdrawal by Subject|8
912905|NCT00321685|2907155|P1|Overall Study|Death|2
912906|NCT00321685|2907155|P1|Overall Study|Adverse Event|18
912910|NCT00285584|2907201|P2|Month 6|Lost to Follow-up|1
912911|NCT00285584|2907202|P1|Month 6|Lost to Follow-up|0
912912|NCT00285584|2907201|P2|Month 3|Withdrawal by Subject|0
912913|NCT00285584|2907202|P1|Month 3|Withdrawal by Subject|1
912914|NCT00285584|2907201|P2|Month 3|Lost to Follow-up|3
912915|NCT00285584|2907202|P1|Month 3|Lost to Follow-up|3
912916|NCT00278915|2907214|P1|Overall Study|Lack of Efficacy|1
912917|NCT00244751|2907265|P3|Overall Study|Participant randomized by mistake|1
912918|NCT00244751|2907266|P2|Overall Study|Participant randomized by mistake|0
912919|NCT00244751|2907267|P1|Overall Study|Participant randomized by mistake|0
912920|NCT00244751|2907265|P3|Overall Study|Safety reasons|0
912921|NCT00244751|2907266|P2|Overall Study|Safety reasons|1
912922|NCT00244751|2907267|P1|Overall Study|Safety reasons|0
912923|NCT00244751|2907265|P3|Overall Study|Lack of compliance with protocol|0
912924|NCT00244751|2907266|P2|Overall Study|Lack of compliance with protocol|1
912925|NCT00244751|2907267|P1|Overall Study|Lack of compliance with protocol|0
912926|NCT00244751|2907265|P3|Overall Study|Elevated liver enzymes|0
912927|NCT00244751|2907266|P2|Overall Study|Elevated liver enzymes|0
912928|NCT00244751|2907267|P1|Overall Study|Elevated liver enzymes|1
912929|NCT00244751|2907265|P3|Overall Study|Withdrawal by Subject|3
912930|NCT00244751|2907266|P2|Overall Study|Withdrawal by Subject|5
912931|NCT00244751|2907267|P1|Overall Study|Withdrawal by Subject|7
912932|NCT00244751|2907265|P3|Overall Study|Protocol Violation|1
912933|NCT00244751|2907266|P2|Overall Study|Protocol Violation|0
912934|NCT00244751|2907267|P1|Overall Study|Protocol Violation|1
912935|NCT00244751|2907265|P3|Overall Study|Lost to Follow-up|0
912936|NCT00244751|2907266|P2|Overall Study|Lost to Follow-up|1
912937|NCT00244751|2907267|P1|Overall Study|Lost to Follow-up|0
912938|NCT00244751|2907265|P3|Overall Study|Adverse Event|5
912939|NCT00244751|2907266|P2|Overall Study|Adverse Event|7
912940|NCT00244751|2907267|P1|Overall Study|Adverse Event|7
912941|NCT00231894|2907366|P2|Overall Study|Withdrawal by Subject|1
912942|NCT00231894|2907367|P1|Overall Study|Withdrawal by Subject|1
912944|NCT00126581|2907459|P2|Overall Study|Other illness/MD discretion|4
912945|NCT00126581|2907460|P1|Overall Study|Other illness/MD discretion|3
912946|NCT00126581|2907459|P2|Overall Study|Alternative therapy|3
912947|NCT00126581|2907460|P1|Overall Study|Alternative therapy|3
912948|NCT00126581|2907459|P2|Overall Study|Withdrawal by Subject|4
912949|NCT00126581|2907460|P1|Overall Study|Withdrawal by Subject|1
912950|NCT00126581|2907459|P2|Overall Study|Death|2
912951|NCT00126581|2907460|P1|Overall Study|Death|3
912952|NCT00126581|2907459|P2|Overall Study|Adverse Event|7
912953|NCT00126581|2907460|P1|Overall Study|Adverse Event|3
912954|NCT00098839|2907497|P2|Overall Study|Ineligible|0
912955|NCT00098839|2907498|P1|Overall Study|Ineligible|2
912956|NCT00098839|2907497|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
912957|NCT00098839|2907498|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
912958|NCT00098839|2907497|P2|Overall Study|Relapse|3
912959|NCT00098839|2907498|P1|Overall Study|Relapse|6
912960|NCT00098839|2907497|P2|Overall Study|Refusal of further protocol therapy|1
912961|NCT00098839|2907498|P1|Overall Study|Refusal of further protocol therapy|3
912962|NCT00098839|2907497|P2|Overall Study|Withdrawal by Subject|0
912963|NCT00098839|2907498|P1|Overall Study|Withdrawal by Subject|1
912964|NCT00098839|2907497|P2|Overall Study|Physician Decision|14
912965|NCT00098839|2907498|P1|Overall Study|Physician Decision|4
912966|NCT00098839|2907497|P2|Overall Study|Death|2
912967|NCT00098839|2907498|P1|Overall Study|Death|1
912968|NCT00098839|2907497|P2|Overall Study|Adverse Event|2
912969|NCT00098839|2907498|P1|Overall Study|Adverse Event|5
912975|NCT00093795|2907517|P3|Overall Study|No follow up data|17
912976|NCT00093795|2907518|P2|Overall Study|No follow up data|16
912977|NCT00093795|2907519|P1|Overall Study|No follow up data|20
912978|NCT00082888|2907539|P1|Overall Study|Still receiving treatment|4
912979|NCT00082888|2907539|P1|Overall Study|Other Medical Problems|2
912980|NCT00082888|2907539|P1|Overall Study|Alternate Treatment|1
912981|NCT00082888|2907539|P1|Overall Study|Withdrawal by Subject|9
912982|NCT00082888|2907539|P1|Overall Study|Adverse Event|4
912983|NCT00082888|2907539|P1|Overall Study|Death|2
912984|NCT00070499|2907547|P4|Overall Study|Not eligible|2
912985|NCT00070499|2907548|P3|Overall Study|Not eligible|3
912986|NCT00070499|2907549|P2|Overall Study|Not eligible|5
912987|NCT00070499|2907550|P1|Overall Study|Not eligible|2
912988|NCT00070499|2907547|P4|Overall Study|Did not start treatment|2
912989|NCT00070499|2907548|P3|Overall Study|Did not start treatment|0
912990|NCT00070499|2907549|P2|Overall Study|Did not start treatment|0
912991|NCT00070499|2907550|P1|Overall Study|Did not start treatment|1
912992|NCT00070499|2907547|P4|Overall Study|Still on protocol treatment|57
912993|NCT00070499|2907548|P3|Overall Study|Still on protocol treatment|79
912994|NCT00070499|2907549|P2|Overall Study|Still on protocol treatment|4
912995|NCT00070499|2907550|P1|Overall Study|Still on protocol treatment|10
912996|NCT00070499|2907547|P4|Overall Study|Other - not protocol specified|20
912997|NCT00070499|2907548|P3|Overall Study|Other - not protocol specified|12
912998|NCT00070499|2907549|P2|Overall Study|Other - not protocol specified|3
912999|NCT00070499|2907550|P1|Overall Study|Other - not protocol specified|7
913000|NCT00070499|2907547|P4|Overall Study|Death|2
913001|NCT00070499|2907548|P3|Overall Study|Death|1
913002|NCT00070499|2907549|P2|Overall Study|Death|1
913003|NCT00070499|2907550|P1|Overall Study|Death|1
913004|NCT00070499|2907547|P4|Overall Study|Progression/relapse|4
913005|NCT00070499|2907548|P3|Overall Study|Progression/relapse|1
913006|NCT00070499|2907549|P2|Overall Study|Progression/relapse|2
913007|NCT00070499|2907550|P1|Overall Study|Progression/relapse|4
913008|NCT00070499|2907547|P4|Overall Study|Refusal unrelated to adverse effects|8
913009|NCT00070499|2907548|P3|Overall Study|Refusal unrelated to adverse effects|5
913010|NCT00070499|2907549|P2|Overall Study|Refusal unrelated to adverse effects|5
913011|NCT00070499|2907550|P1|Overall Study|Refusal unrelated to adverse effects|7
913012|NCT00070499|2907547|P4|Overall Study|Adverse Event|15
913013|NCT00070499|2907548|P3|Overall Study|Adverse Event|19
913014|NCT00070499|2907549|P2|Overall Study|Adverse Event|6
913015|NCT00070499|2907550|P1|Overall Study|Adverse Event|6
913028|NCT00022659|2907616|P1|Overall Study|Never treated|1
913029|NCT00022659|2907616|P1|Overall Study|Ineligible: wrong primary|1
913037|NCT03255655|2907688|P2|Overall Study|Lost to Follow-up|4
913038|NCT03255655|2907689|P1|Overall Study|Lost to Follow-up|7
913039|NCT03191552|2907700|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
913040|NCT03191552|2907701|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
913041|NCT03191552|2907702|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
913042|NCT03191552|2907700|P3|Overall Study|Lost to Follow-up|0
913043|NCT03191552|2907701|P2|Overall Study|Lost to Follow-up|0
913044|NCT03191552|2907702|P1|Overall Study|Lost to Follow-up|1
913045|NCT03128307|2907753|P1|Overall Study|Withdrawal by Subject|5
913046|NCT03128307|2907753|P1|Overall Study|Lost to Follow-up|29
913047|NCT03035916|2907761|P3|Overall Study|Puncture failed|0
913048|NCT03035916|2907762|P2|Overall Study|Puncture failed|2
913049|NCT03035916|2907763|P1|Overall Study|Puncture failed|0
913050|NCT02987205|2907835|P1|Overall Study|Withdrawal by Subject|3
913051|NCT02987205|2907835|P1|Overall Study|Adverse Event|1
913052|NCT02923245|2907860|P2|Overall Study|ultrasound order was cancelled|1
913053|NCT02923245|2907861|P1|Overall Study|ultrasound order was cancelled|2
913054|NCT02632110|2907903|P10|Overall Study|Withdrawal by Subject|1
913055|NCT02632110|2907904|P9|Overall Study|Withdrawal by Subject|1
913056|NCT02632110|2907905|P8|Overall Study|Withdrawal by Subject|3
913057|NCT02632110|2907906|P7|Overall Study|Withdrawal by Subject|3
913058|NCT02632110|2907907|P6|Overall Study|Withdrawal by Subject|1
913059|NCT02632110|2907908|P5|Overall Study|Withdrawal by Subject|1
913060|NCT02632110|2907909|P4|Overall Study|Withdrawal by Subject|0
913061|NCT02632110|2907910|P3|Overall Study|Withdrawal by Subject|0
913062|NCT02632110|2907911|P2|Overall Study|Withdrawal by Subject|1
913063|NCT02632110|2907912|P1|Overall Study|Withdrawal by Subject|1
913064|NCT02607735|2908398|P2|Overall Study|Withdrew Consent|0
913065|NCT02607735|2908399|P1|Overall Study|Withdrew Consent|2
913066|NCT02607735|2908398|P2|Overall Study|Lost to Follow-up|0
913067|NCT02607735|2908399|P1|Overall Study|Lost to Follow-up|4
913068|NCT02607735|2908398|P2|Overall Study|Randomized/ Enrolled but Never Treated|0
913069|NCT02607735|2908399|P1|Overall Study|Randomized/ Enrolled but Never Treated|1
913070|NCT02582632|2908413|P1|Overall Study|Not Specified|1
913071|NCT02487030|2908433|P7|Overall Study|Death|0
913072|NCT02487030|2908434|P6|Overall Study|Death|0
913073|NCT02487030|2908435|P5|Overall Study|Death|1
913074|NCT02487030|2908436|P4|Overall Study|Death|0
913075|NCT02487030|2908437|P3|Overall Study|Death|0
913076|NCT02487030|2908438|P2|Overall Study|Death|0
913077|NCT02487030|2908439|P1|Overall Study|Death|0
913078|NCT02487030|2908433|P7|Overall Study|Adverse Event|0
913079|NCT02487030|2908434|P6|Overall Study|Adverse Event|0
913080|NCT02487030|2908435|P5|Overall Study|Adverse Event|0
913081|NCT02487030|2908436|P4|Overall Study|Adverse Event|1
913082|NCT02487030|2908437|P3|Overall Study|Adverse Event|0
913083|NCT02487030|2908438|P2|Overall Study|Adverse Event|0
913084|NCT02487030|2908439|P1|Overall Study|Adverse Event|0
913085|NCT02487030|2908433|P7|Overall Study|Lost to Follow-up|0
913086|NCT02487030|2908434|P6|Overall Study|Lost to Follow-up|1
913087|NCT02487030|2908435|P5|Overall Study|Lost to Follow-up|0
913088|NCT02487030|2908436|P4|Overall Study|Lost to Follow-up|1
913089|NCT02487030|2908437|P3|Overall Study|Lost to Follow-up|1
913090|NCT02487030|2908438|P2|Overall Study|Lost to Follow-up|0
913091|NCT02487030|2908439|P1|Overall Study|Lost to Follow-up|0
913092|NCT02487030|2908433|P7|Overall Study|Lack of Efficacy|0
913093|NCT02487030|2908434|P6|Overall Study|Lack of Efficacy|0
913094|NCT02487030|2908435|P5|Overall Study|Lack of Efficacy|1
913095|NCT02487030|2908436|P4|Overall Study|Lack of Efficacy|0
913096|NCT02487030|2908437|P3|Overall Study|Lack of Efficacy|1
913097|NCT02487030|2908438|P2|Overall Study|Lack of Efficacy|4
913098|NCT02487030|2908439|P1|Overall Study|Lack of Efficacy|2
913099|NCT02482298|2908473|P3|Overall Study|Lost to Follow-up|0
913100|NCT02482298|2908474|P2|Overall Study|Lost to Follow-up|1
913101|NCT02482298|2908475|P1|Overall Study|Lost to Follow-up|0
913102|NCT02482298|2908473|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
913103|NCT02482298|2908474|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
913104|NCT02482298|2908475|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
913105|NCT02482298|2908473|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
913106|NCT02482298|2908474|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
913107|NCT02482298|2908475|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
913108|NCT02482298|2908473|P3|Overall Study|Withdrawal by Subject|2
913109|NCT02482298|2908474|P2|Overall Study|Withdrawal by Subject|1
913110|NCT02482298|2908475|P1|Overall Study|Withdrawal by Subject|2
913111|NCT02446743|2908497|P2|Overall Study|Other|3
913112|NCT02446743|2908498|P1|Overall Study|Other|2
913113|NCT02446743|2908497|P2|Overall Study|Adverse Event|1
913114|NCT02446743|2908498|P1|Overall Study|Adverse Event|1
913115|NCT02446743|2908497|P2|Overall Study|Lost to Follow-up|0
913116|NCT02446743|2908498|P1|Overall Study|Lost to Follow-up|1
913117|NCT02446743|2908497|P2|Overall Study|Withdrawal by Subject|1
913118|NCT02446743|2908498|P1|Overall Study|Withdrawal by Subject|1
913119|NCT02425826|2908549|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
913120|NCT02425826|2908550|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
913121|NCT02425826|2908551|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
913122|NCT02425826|2908549|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
913123|NCT02425826|2908550|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
913124|NCT02425826|2908551|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
913125|NCT02425826|2908549|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
913126|NCT02425826|2908550|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
913127|NCT02425826|2908551|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
913128|NCT02425826|2908549|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
913129|NCT02425826|2908550|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
913130|NCT02425826|2908551|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
913131|NCT02425826|2908549|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
913132|NCT02425826|2908550|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
913133|NCT02425826|2908551|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
913134|NCT02425826|2908549|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
913135|NCT02425826|2908550|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
913136|NCT02425826|2908551|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
913137|NCT02425826|2908549|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
913138|NCT02425826|2908550|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
913139|NCT02425826|2908551|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
913140|NCT02425826|2908549|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
913141|NCT02425826|2908550|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
913142|NCT02425826|2908551|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
913143|NCT02425826|2908549|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
913144|NCT02425826|2908550|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
913145|NCT02425826|2908551|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
913146|NCT02425826|2908549|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
913147|NCT02425826|2908550|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
913148|NCT02425826|2908551|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
913149|NCT02408068|2908616|P6|Treatment 3 (1.5 Days)|Adverse Event|0
913150|NCT02408068|2908617|P5|Treatment 3 (1.5 Days)|Adverse Event|0
913151|NCT02408068|2908618|P4|Treatment 3 (1.5 Days)|Adverse Event|0
913152|NCT02408068|2908619|P3|Treatment 3 (1.5 Days)|Adverse Event|1
913153|NCT02408068|2908620|P2|Treatment 3 (1.5 Days)|Adverse Event|0
913154|NCT02408068|2908621|P1|Treatment 3 (1.5 Days)|Adverse Event|0
913155|NCT02404103|2908646|P2|Overall Study|Lost to Follow-up|3
913156|NCT02404103|2908647|P1|Overall Study|Lost to Follow-up|3
913157|NCT02404103|2908646|P2|Overall Study|Adverse Event|0
913158|NCT02404103|2908647|P1|Overall Study|Adverse Event|1
913159|NCT02353871|2908683|P2|Overall Study|Lost to Follow-up|0
913160|NCT02353871|2908684|P1|Overall Study|Lost to Follow-up|2
913161|NCT02353871|2908683|P2|Overall Study|Consent withdrawn|8
913162|NCT02353871|2908684|P1|Overall Study|Consent withdrawn|1
913163|NCT02353871|2908683|P2|Overall Study|Protocol deviation|1
913164|NCT02353871|2908684|P1|Overall Study|Protocol deviation|0
913165|NCT02349295|2908707|P5|IR (Week 16-24)|Lack of Efficacy|1
913166|NCT02349295|2908708|P4|IR (Week 16-24)|Lack of Efficacy|0
913167|NCT02349295|2908709|P3|IR (Week 16-24)|Lack of Efficacy|0
913168|NCT02349295|2908710|P2|IR (Week 16-24)|Lack of Efficacy|0
913169|NCT02349295|2908711|P1|IR (Week 16-24)|Lack of Efficacy|0
913170|NCT02349295|2908707|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
913171|NCT02349295|2908708|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
913172|NCT02349295|2908709|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
913173|NCT02349295|2908710|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
913174|NCT02349295|2908711|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
913175|NCT02349295|2908707|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
913176|NCT02349295|2908708|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
913177|NCT02349295|2908709|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
913178|NCT02349295|2908710|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
913179|NCT02349295|2908711|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
913180|NCT02349295|2908707|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
913181|NCT02349295|2908708|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
913182|NCT02349295|2908709|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
913183|NCT02349295|2908710|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
913184|NCT02349295|2908711|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
913185|NCT02349295|2908707|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
913186|NCT02349295|2908708|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
913187|NCT02349295|2908709|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
913188|NCT02349295|2908710|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
913189|NCT02349295|2908711|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
913190|NCT02349295|2908707|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
913191|NCT02349295|2908708|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
913192|NCT02349295|2908709|P3|Double Blind Treatment (Week 0-24)|Adverse Event|7
913193|NCT02349295|2908710|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
913194|NCT02349295|2908711|P1|Double Blind Treatment (Week 0-24)|Adverse Event|5
913195|NCT02343003|2908787|P2|Overall Study|terminated by sponsor|0
913196|NCT02343003|2908788|P1|Overall Study|terminated by sponsor|2
913197|NCT02343003|2908787|P2|Overall Study|exclusion criteria met|1
913198|NCT02343003|2908788|P1|Overall Study|exclusion criteria met|1
913199|NCT02343003|2908787|P2|Overall Study|Death|1
913200|NCT02343003|2908788|P1|Overall Study|Death|0
913201|NCT02343003|2908787|P2|Overall Study|Protocol Violation|0
913202|NCT02343003|2908788|P1|Overall Study|Protocol Violation|1
913203|NCT02343003|2908787|P2|Overall Study|Lost to Follow-up|1
913204|NCT02343003|2908788|P1|Overall Study|Lost to Follow-up|5
913205|NCT02343003|2908787|P2|Overall Study|Withdrawal by Subject|4
913206|NCT02343003|2908788|P1|Overall Study|Withdrawal by Subject|9
913207|NCT02287883|2908874|P2|Overall Study|Non-response to survey|237
913208|NCT02287883|2908875|P1|Overall Study|Non-response to survey|229
913209|NCT02287883|2908874|P2|Overall Study|No longer eligible|182
913210|NCT02287883|2908875|P1|Overall Study|No longer eligible|222
913211|NCT02287883|2908874|P2|Overall Study|Death|7
913212|NCT02287883|2908875|P1|Overall Study|Death|8
913213|NCT02230332|2908908|P2|Overall Study|Protocol Violation|0
913214|NCT02230332|2908909|P1|Overall Study|Protocol Violation|1
913215|NCT02230332|2908908|P2|Overall Study|Lost to Follow-up|0
913216|NCT02230332|2908909|P1|Overall Study|Lost to Follow-up|1
913217|NCT02230332|2908908|P2|Overall Study|Adverse Event|1
913218|NCT02230332|2908909|P1|Overall Study|Adverse Event|2
913219|NCT02163187|2908961|P2|Overall Study|Progressive disease|0
913220|NCT02163187|2908962|P1|Overall Study|Progressive disease|1
913221|NCT02163187|2908961|P2|Overall Study|Device removed|0
913222|NCT02163187|2908962|P1|Overall Study|Device removed|1
913223|NCT02142738|2908988|P2|Overall Study|Ongoing in Study|82
913224|NCT02142738|2908989|P1|Overall Study|Ongoing in Study|107
913225|NCT02142738|2908988|P2|Overall Study|Withdrawal by Subject|5
913226|NCT02142738|2908989|P1|Overall Study|Withdrawal by Subject|5
913227|NCT02142738|2908988|P2|Overall Study|Progressive Disease|1
913228|NCT02142738|2908989|P1|Overall Study|Progressive Disease|0
913229|NCT02142738|2908988|P2|Overall Study|Death|55
913230|NCT02142738|2908989|P1|Overall Study|Death|33
913231|NCT02142738|2908988|P2|Overall Study|Adverse Event|8
913232|NCT02142738|2908989|P1|Overall Study|Adverse Event|9
913233|NCT02137772|2909001|P2|Overall Study|Not treated|2
913234|NCT02137772|2909002|P1|Overall Study|Not treated|3
913235|NCT02137772|2909001|P2|Overall Study|Non-compliance with study drug|0
913236|NCT02137772|2909002|P1|Overall Study|Non-compliance with study drug|1
913237|NCT02137772|2909001|P2|Overall Study|Withdrawal by Subject|17
913238|NCT02137772|2909002|P1|Overall Study|Withdrawal by Subject|28
913239|NCT02137772|2909001|P2|Overall Study|Physician Decision|5
913240|NCT02137772|2909002|P1|Overall Study|Physician Decision|15
913241|NCT02137772|2909001|P2|Overall Study|Lost to Follow-up|4
913242|NCT02137772|2909002|P1|Overall Study|Lost to Follow-up|8
913243|NCT02137772|2909001|P2|Overall Study|Death|44
913244|NCT02137772|2909002|P1|Overall Study|Death|71
913245|NCT02137772|2909001|P2|Overall Study|Adverse Event|3
913246|NCT02137772|2909002|P1|Overall Study|Adverse Event|6
913247|NCT02136134|2909028|P2|Overall Study|Subjects randomized but not treated|8
913248|NCT02136134|2909029|P1|Overall Study|Subjects randomized but not treated|10
913249|NCT02136134|2909028|P2|Overall Study|Ongoing|207
913250|NCT02136134|2909029|P1|Overall Study|Ongoing|185
913251|NCT02136134|2909028|P2|Overall Study|Other|3
913252|NCT02136134|2909029|P1|Overall Study|Other|3
913253|NCT02136134|2909028|P2|Overall Study|Withdrawal by Subject|4
913254|NCT02136134|2909029|P1|Overall Study|Withdrawal by Subject|14
913255|NCT02136134|2909028|P2|Overall Study|Death|29
913256|NCT02136134|2909029|P1|Overall Study|Death|35
913257|NCT02135029|2909048|P3|Overall Study|Death|0
913258|NCT02135029|2909049|P2|Overall Study|Death|1
913259|NCT02135029|2909050|P1|Overall Study|Death|0
913260|NCT02135029|2909048|P3|Overall Study|Other|0
913261|NCT02135029|2909049|P2|Overall Study|Other|1
913262|NCT02135029|2909050|P1|Overall Study|Other|0
913263|NCT02135029|2909048|P3|Overall Study|Withdrawal by Subject|1
913264|NCT02135029|2909049|P2|Overall Study|Withdrawal by Subject|0
913265|NCT02135029|2909050|P1|Overall Study|Withdrawal by Subject|2
913266|NCT02135029|2909048|P3|Overall Study|Lost to Follow-up|0
913267|NCT02135029|2909049|P2|Overall Study|Lost to Follow-up|1
913268|NCT02135029|2909050|P1|Overall Study|Lost to Follow-up|0
913269|NCT02135029|2909048|P3|Overall Study|Adverse Event|2
913270|NCT02135029|2909049|P2|Overall Study|Adverse Event|2
913271|NCT02135029|2909050|P1|Overall Study|Adverse Event|2
913272|NCT02131233|2909132|P2|Overall Study|Withdrawal by Subject|11
913273|NCT02131233|2909133|P1|Overall Study|Withdrawal by Subject|18
913274|NCT02131233|2909132|P2|Overall Study|Pregnancy|0
913275|NCT02131233|2909133|P1|Overall Study|Pregnancy|4
913276|NCT02131233|2909132|P2|Overall Study|Physician Decision|0
913277|NCT02131233|2909133|P1|Overall Study|Physician Decision|7
913278|NCT02131233|2909132|P2|Overall Study|Non-Compliance With Study Drug|5
913279|NCT02131233|2909133|P1|Overall Study|Non-Compliance With Study Drug|8
913280|NCT02131233|2909132|P2|Overall Study|Lost to Follow-up|13
913281|NCT02131233|2909133|P1|Overall Study|Lost to Follow-up|14
913282|NCT02131233|2909132|P2|Overall Study|Lack of Efficacy|3
913283|NCT02131233|2909133|P1|Overall Study|Lack of Efficacy|6
913284|NCT02131233|2909132|P2|Overall Study|Death|1
913285|NCT02131233|2909133|P1|Overall Study|Death|0
913286|NCT02131233|2909132|P2|Overall Study|Adverse Event|6
913287|NCT02131233|2909133|P1|Overall Study|Adverse Event|7
913288|NCT02131233|2909132|P2|Overall Study|Not Treated|3
913289|NCT02131233|2909133|P1|Overall Study|Not Treated|2
913290|NCT02114203|2909168|P3|Overall Study|Withdrawal by Subject|0
913291|NCT02114203|2909169|P2|Overall Study|Withdrawal by Subject|1
913292|NCT02114203|2909170|P1|Overall Study|Withdrawal by Subject|0
913293|NCT02114203|2909168|P3|Overall Study|Adverse Event|0
913294|NCT02114203|2909169|P2|Overall Study|Adverse Event|1
913295|NCT02114203|2909170|P1|Overall Study|Adverse Event|0
913296|NCT02109484|2909210|P8|Overall Study|Moved away from study area|1
913297|NCT02109484|2909211|P7|Overall Study|Moved away from study area|1
913298|NCT02109484|2909212|P6|Overall Study|Moved away from study area|0
913299|NCT02109484|2909213|P5|Overall Study|Moved away from study area|0
913300|NCT02109484|2909214|P4|Overall Study|Moved away from study area|0
913301|NCT02109484|2909215|P3|Overall Study|Moved away from study area|0
913302|NCT02109484|2909216|P2|Overall Study|Moved away from study area|0
913303|NCT02109484|2909217|P1|Overall Study|Moved away from study area|0
913304|NCT02109484|2909210|P8|Overall Study|Death|2
913305|NCT02109484|2909211|P7|Overall Study|Death|0
913306|NCT02109484|2909212|P6|Overall Study|Death|0
913307|NCT02109484|2909213|P5|Overall Study|Death|0
913308|NCT02109484|2909214|P4|Overall Study|Death|0
913309|NCT02109484|2909215|P3|Overall Study|Death|0
913310|NCT02109484|2909216|P2|Overall Study|Death|0
913311|NCT02109484|2909217|P1|Overall Study|Death|0
913312|NCT02109484|2909210|P8|Overall Study|Physician Decision|0
913313|NCT02109484|2909211|P7|Overall Study|Physician Decision|0
913314|NCT02109484|2909212|P6|Overall Study|Physician Decision|0
913315|NCT02109484|2909213|P5|Overall Study|Physician Decision|2
913316|NCT02109484|2909214|P4|Overall Study|Physician Decision|0
913317|NCT02109484|2909215|P3|Overall Study|Physician Decision|0
913318|NCT02109484|2909216|P2|Overall Study|Physician Decision|0
913319|NCT02109484|2909217|P1|Overall Study|Physician Decision|0
913320|NCT02109484|2909210|P8|Overall Study|Withdrawal by Subject|0
913321|NCT02109484|2909211|P7|Overall Study|Withdrawal by Subject|1
913322|NCT02109484|2909212|P6|Overall Study|Withdrawal by Subject|1
913323|NCT02109484|2909213|P5|Overall Study|Withdrawal by Subject|1
913324|NCT02109484|2909214|P4|Overall Study|Withdrawal by Subject|0
913325|NCT02109484|2909215|P3|Overall Study|Withdrawal by Subject|0
913326|NCT02109484|2909216|P2|Overall Study|Withdrawal by Subject|0
913327|NCT02109484|2909217|P1|Overall Study|Withdrawal by Subject|0
913328|NCT02109484|2909210|P8|Overall Study|Lost to Follow-up|0
913329|NCT02109484|2909211|P7|Overall Study|Lost to Follow-up|1
913330|NCT02109484|2909212|P6|Overall Study|Lost to Follow-up|0
913331|NCT02109484|2909213|P5|Overall Study|Lost to Follow-up|1
913332|NCT02109484|2909214|P4|Overall Study|Lost to Follow-up|1
913333|NCT02109484|2909215|P3|Overall Study|Lost to Follow-up|0
913334|NCT02109484|2909216|P2|Overall Study|Lost to Follow-up|0
913335|NCT02109484|2909217|P1|Overall Study|Lost to Follow-up|0
913336|NCT02093351|2909292|P3|Overall Study|Death|0
913337|NCT02093351|2909293|P2|Overall Study|Death|1
913338|NCT02093351|2909294|P1|Overall Study|Death|0
913339|NCT02093351|2909292|P3|Overall Study|Condition under investigation worsened|2
913340|NCT02093351|2909293|P2|Overall Study|Condition under investigation worsened|0
913341|NCT02093351|2909294|P1|Overall Study|Condition under investigation worsened|2
913342|NCT02093351|2909292|P3|Overall Study|Adverse Event|1
913343|NCT02093351|2909293|P2|Overall Study|Adverse Event|1
913344|NCT02093351|2909294|P1|Overall Study|Adverse Event|0
913345|NCT02076178|2909325|P2|Injection Phase|Lost to Follow-up|1
913346|NCT02076178|2909326|P1|Injection Phase|Lost to Follow-up|0
913347|NCT02076178|2909325|P2|Injection Phase|Physician Decision|3
913348|NCT02076178|2909326|P1|Injection Phase|Physician Decision|0
913349|NCT02076178|2909325|P2|Injection Phase|Withdrawal by Subject|3
913350|NCT02076178|2909326|P1|Injection Phase|Withdrawal by Subject|0
913351|NCT02076178|2909325|P2|Injection Phase|Protocol defined stopping criteria|0
913352|NCT02076178|2909326|P1|Injection Phase|Protocol defined stopping criteria|1
913353|NCT02076178|2909325|P2|Oral Phase|Physician Decision|1
913354|NCT02076178|2909326|P1|Oral Phase|Physician Decision|0
913355|NCT02076178|2909325|P2|Oral Phase|Withdrawal by Subject|4
913356|NCT02076178|2909326|P1|Oral Phase|Withdrawal by Subject|0
913357|NCT02076178|2909325|P2|Oral Phase|Adverse Event|7
913358|NCT02076178|2909326|P1|Oral Phase|Adverse Event|0
913359|NCT01998880|2909433|P2|Overall Study|Violation of Selection Criteria at Entry|1
913360|NCT01998880|2909434|P1|Overall Study|Violation of Selection Criteria at Entry|1
913361|NCT01998880|2909433|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
913362|NCT01998880|2909434|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
913363|NCT01998880|2909433|P2|Overall Study|Other Protocol Violation|1
913364|NCT01998880|2909434|P1|Overall Study|Other Protocol Violation|0
913365|NCT01998880|2909433|P2|Overall Study|Administrative/Other|1
913366|NCT01998880|2909434|P1|Overall Study|Administrative/Other|3
913367|NCT01998880|2909433|P2|Overall Study|Insufficient Therapeutic Response|5
913368|NCT01998880|2909434|P1|Overall Study|Insufficient Therapeutic Response|1
913369|NCT01998880|2909433|P2|Overall Study|Death|6
913370|NCT01998880|2909434|P1|Overall Study|Death|3
913371|NCT01998880|2909433|P2|Overall Study|Withdrew Consent|2
913372|NCT01998880|2909434|P1|Overall Study|Withdrew Consent|2
913373|NCT01998880|2909433|P2|Overall Study|Progression of Disease|8
913374|NCT01998880|2909434|P1|Overall Study|Progression of Disease|2
913375|NCT01998880|2909433|P2|Overall Study|Adverse Events or Intercurrent Illness|16
913376|NCT01998880|2909434|P1|Overall Study|Adverse Events or Intercurrent Illness|16
913377|NCT01976806|2909452|P2|Overall Study|Withdrawal by Subject|1
913378|NCT01976806|2909453|P1|Overall Study|Withdrawal by Subject|1
913379|NCT01976806|2909452|P2|Overall Study|Adverse Event|1
913380|NCT01976806|2909453|P1|Overall Study|Adverse Event|1
913381|NCT01976806|2909452|P2|Overall Study|Lost to Follow-up|4
913382|NCT01976806|2909453|P1|Overall Study|Lost to Follow-up|1
913383|NCT01969058|2909483|P2|Overall Study|Adverse Event|0
913384|NCT01969058|2909484|P1|Overall Study|Adverse Event|1
913385|NCT01969058|2909483|P2|Overall Study|Withdrawal by Subject|0
913386|NCT01969058|2909484|P1|Overall Study|Withdrawal by Subject|2
913387|NCT01943539|2909529|P2|Overall Study|Non-compliance with at-home intervention|0
913388|NCT01943539|2909530|P1|Overall Study|Non-compliance with at-home intervention|4
913389|NCT01927419|2909541|P2|Overall Study|Not reported|0
913390|NCT01927419|2909542|P1|Overall Study|Not reported|1
913391|NCT01927419|2909541|P2|Overall Study|Not specified|1
913392|NCT01927419|2909542|P1|Overall Study|Not specified|2
913393|NCT01927419|2909541|P2|Overall Study|Withdrawal by Subject|1
913394|NCT01927419|2909542|P1|Overall Study|Withdrawal by Subject|3
913395|NCT01927419|2909541|P2|Overall Study|Adverse event unrelated to study drug|1
913396|NCT01927419|2909542|P1|Overall Study|Adverse event unrelated to study drug|6
913397|NCT01927419|2909541|P2|Overall Study|Death|1
913398|NCT01927419|2909542|P1|Overall Study|Death|0
913399|NCT01927419|2909541|P2|Overall Study|Study drug toxicity|7
913400|NCT01927419|2909542|P1|Overall Study|Study drug toxicity|43
913401|NCT01927419|2909541|P2|Overall Study|Disease progression|17
913402|NCT01927419|2909542|P1|Overall Study|Disease progression|15
913403|NCT01911819|2909574|P3|Overall Study|Withdrawal by Subject|0
913404|NCT01911819|2909575|P2|Overall Study|Withdrawal by Subject|1
913405|NCT01911819|2909576|P1|Overall Study|Withdrawal by Subject|1
913406|NCT01911819|2909574|P3|Overall Study|Adverse Event|0
913407|NCT01911819|2909575|P2|Overall Study|Adverse Event|1
913408|NCT01911819|2909576|P1|Overall Study|Adverse Event|0
913409|NCT01900444|2909596|P1|Overall Study|Lost to Follow-up|1
913410|NCT01900444|2909596|P1|Overall Study|Protocol Violation|2
913411|NCT01873950|2909636|P5|Period 5|Withdrawal by Subject|0
913412|NCT01873950|2909637|P4|Period 5|Withdrawal by Subject|1
913413|NCT01873950|2909638|P3|Period 5|Withdrawal by Subject|0
913414|NCT01873950|2909639|P2|Period 5|Withdrawal by Subject|0
913415|NCT01873950|2909640|P1|Period 5|Withdrawal by Subject|0
913416|NCT01872910|2909681|P6|Overall Study|Lost to Follow-up|0
913417|NCT01872910|2909682|P5|Overall Study|Lost to Follow-up|0
913418|NCT01872910|2909683|P4|Overall Study|Lost to Follow-up|0
913419|NCT01872910|2909684|P3|Overall Study|Lost to Follow-up|2
913420|NCT01872910|2909685|P2|Overall Study|Lost to Follow-up|0
913421|NCT01872910|2909686|P1|Overall Study|Lost to Follow-up|2
913422|NCT01843374|2909728|P2|Overall Study|Withdrawal by Subject|19
913423|NCT01843374|2909729|P1|Overall Study|Withdrawal by Subject|14
913424|NCT01843374|2909728|P2|Overall Study|Death|302
913425|NCT01843374|2909729|P1|Overall Study|Death|150
913426|NCT01816048|2909753|P1|Overall Study|Disease Progression|3
913427|NCT01816048|2909753|P1|Overall Study|Withdrawal by Subject|1
913428|NCT01816048|2909753|P1|Overall Study|Death|1
913429|NCT01816048|2909753|P1|Overall Study|Adverse Event|1
913430|NCT01806896|2909775|P2|Overall Study|Other|0
913431|NCT01806896|2909776|P1|Overall Study|Other|1
913432|NCT01806896|2909775|P2|Overall Study|Adverse Event|0
913433|NCT01806896|2909776|P1|Overall Study|Adverse Event|2
913434|NCT01725126|2909835|P6|Overall Study|Withdrawal by Subject|0
913435|NCT01725126|2909836|P5|Overall Study|Withdrawal by Subject|0
913436|NCT01725126|2909837|P4|Overall Study|Withdrawal by Subject|1
913437|NCT01725126|2909838|P3|Overall Study|Withdrawal by Subject|0
913438|NCT01725126|2909839|P2|Overall Study|Withdrawal by Subject|0
913439|NCT01725126|2909840|P1|Overall Study|Withdrawal by Subject|0
913440|NCT01725126|2909835|P6|Overall Study|Protocol Violation|0
913441|NCT01725126|2909836|P5|Overall Study|Protocol Violation|0
913442|NCT01725126|2909837|P4|Overall Study|Protocol Violation|0
913443|NCT01725126|2909838|P3|Overall Study|Protocol Violation|0
913444|NCT01725126|2909839|P2|Overall Study|Protocol Violation|1
913445|NCT01725126|2909840|P1|Overall Study|Protocol Violation|0
913446|NCT01719224|2910036|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
913447|NCT01719224|2910037|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
913448|NCT01696942|2910077|P2|Overall Study|screen failure|1
913449|NCT01696942|2910078|P1|Overall Study|screen failure|0
913450|NCT01696942|2910077|P2|Overall Study|Protocol Violation|2
913451|NCT01696942|2910078|P1|Overall Study|Protocol Violation|1
913452|NCT01696942|2910077|P2|Overall Study|Withdrawal by Subject|0
913453|NCT01696942|2910078|P1|Overall Study|Withdrawal by Subject|1
913454|NCT01664923|2910088|P2|Overall Study|Miscellaneous|1
913455|NCT01664923|2910089|P1|Overall Study|Miscellaneous|5
913456|NCT01664923|2910088|P2|Overall Study|Adverse Event|12
913457|NCT01664923|2910089|P1|Overall Study|Adverse Event|16
913458|NCT01664923|2910088|P2|Overall Study|Disease Progression|139
913459|NCT01664923|2910089|P1|Overall Study|Disease Progression|58
913460|NCT01664923|2910088|P2|Overall Study|Withdrawal by Subject|5
913461|NCT01664923|2910089|P1|Overall Study|Withdrawal by Subject|11
913462|NCT01664923|2910088|P2|Overall Study|Protocol Violation|0
913463|NCT01664923|2910089|P1|Overall Study|Protocol Violation|2
913464|NCT01664923|2910088|P2|Overall Study|Lost to Follow-up|1
913465|NCT01664923|2910089|P1|Overall Study|Lost to Follow-up|0
913466|NCT01664923|2910088|P2|Overall Study|Death|0
913467|NCT01664923|2910089|P1|Overall Study|Death|1
913468|NCT01657253|2910109|P2|Overall Study|Adverse Event|1
913469|NCT01657253|2910110|P1|Overall Study|Adverse Event|0
913470|NCT01657253|2910109|P2|Overall Study|Withdrawal by Subject|12
913471|NCT01657253|2910110|P1|Overall Study|Withdrawal by Subject|11
913472|NCT01657253|2910109|P2|Overall Study|Lost to Follow-up|5
913473|NCT01657253|2910110|P1|Overall Study|Lost to Follow-up|6
913474|NCT01647282|2910148|P2|Overall Study|Physician Decision|5
913475|NCT01647282|2910149|P1|Overall Study|Physician Decision|7
913476|NCT01632345|2910162|P7|Treatment: Part II|Withdrawal by Subject|2
913477|NCT01632345|2910163|P6|Treatment: Part II|Withdrawal by Subject|2
913478|NCT01632345|2910164|P5|Treatment: Part II|Withdrawal by Subject|0
913479|NCT01632345|2910165|P4|Treatment: Part II|Withdrawal by Subject|0
913480|NCT01632345|2910166|P3|Treatment: Part II|Withdrawal by Subject|0
913481|NCT01632345|2910167|P2|Treatment: Part II|Withdrawal by Subject|0
913482|NCT01632345|2910168|P1|Treatment: Part II|Withdrawal by Subject|0
913483|NCT01632345|2910162|P7|Treatment: Part II|Non-Compliance with Study Drug|0
913484|NCT01632345|2910163|P6|Treatment: Part II|Non-Compliance with Study Drug|3
913485|NCT01632345|2910164|P5|Treatment: Part II|Non-Compliance with Study Drug|0
913486|NCT01632345|2910165|P4|Treatment: Part II|Non-Compliance with Study Drug|0
913487|NCT01632345|2910166|P3|Treatment: Part II|Non-Compliance with Study Drug|0
913488|NCT01632345|2910167|P2|Treatment: Part II|Non-Compliance with Study Drug|0
913489|NCT01632345|2910168|P1|Treatment: Part II|Non-Compliance with Study Drug|0
913490|NCT01632345|2910162|P7|Treatment: Part II|Lost to Follow-up|1
913491|NCT01632345|2910163|P6|Treatment: Part II|Lost to Follow-up|3
913492|NCT01632345|2910164|P5|Treatment: Part II|Lost to Follow-up|0
913493|NCT01632345|2910165|P4|Treatment: Part II|Lost to Follow-up|0
913494|NCT01632345|2910166|P3|Treatment: Part II|Lost to Follow-up|0
913495|NCT01632345|2910167|P2|Treatment: Part II|Lost to Follow-up|0
913496|NCT01632345|2910168|P1|Treatment: Part II|Lost to Follow-up|0
913497|NCT01632345|2910162|P7|Treatment: Part II|Adverse Event|8
913498|NCT01632345|2910163|P6|Treatment: Part II|Adverse Event|3
913499|NCT01632345|2910164|P5|Treatment: Part II|Adverse Event|0
913500|NCT01632345|2910165|P4|Treatment: Part II|Adverse Event|0
913501|NCT01632345|2910166|P3|Treatment: Part II|Adverse Event|0
913502|NCT01632345|2910167|P2|Treatment: Part II|Adverse Event|0
913503|NCT01632345|2910168|P1|Treatment: Part II|Adverse Event|0
913504|NCT01632345|2910162|P7|Treatment: Part I|Withdrawal by Subject|0
913505|NCT01632345|2910163|P6|Treatment: Part I|Withdrawal by Subject|0
913506|NCT01632345|2910164|P5|Treatment: Part I|Withdrawal by Subject|4
913507|NCT01632345|2910165|P4|Treatment: Part I|Withdrawal by Subject|1
913508|NCT01632345|2910166|P3|Treatment: Part I|Withdrawal by Subject|4
913509|NCT01632345|2910167|P2|Treatment: Part I|Withdrawal by Subject|4
913510|NCT01632345|2910168|P1|Treatment: Part I|Withdrawal by Subject|3
913511|NCT01632345|2910162|P7|Treatment: Part I|Protocol Deviation|0
913512|NCT01632345|2910163|P6|Treatment: Part I|Protocol Deviation|0
913513|NCT01632345|2910164|P5|Treatment: Part I|Protocol Deviation|0
913514|NCT01632345|2910165|P4|Treatment: Part I|Protocol Deviation|1
913515|NCT01632345|2910166|P3|Treatment: Part I|Protocol Deviation|1
913516|NCT01632345|2910167|P2|Treatment: Part I|Protocol Deviation|0
913517|NCT01632345|2910168|P1|Treatment: Part I|Protocol Deviation|0
913518|NCT01632345|2910162|P7|Treatment: Part I|Pregnancy|0
913519|NCT01632345|2910163|P6|Treatment: Part I|Pregnancy|0
913520|NCT01632345|2910164|P5|Treatment: Part I|Pregnancy|0
913521|NCT01632345|2910165|P4|Treatment: Part I|Pregnancy|0
913522|NCT01632345|2910166|P3|Treatment: Part I|Pregnancy|0
913523|NCT01632345|2910167|P2|Treatment: Part I|Pregnancy|1
913524|NCT01632345|2910168|P1|Treatment: Part I|Pregnancy|0
913525|NCT01632345|2910162|P7|Treatment: Part I|Physician Decision|0
913526|NCT01632345|2910163|P6|Treatment: Part I|Physician Decision|0
913527|NCT01632345|2910164|P5|Treatment: Part I|Physician Decision|1
913528|NCT01632345|2910165|P4|Treatment: Part I|Physician Decision|0
913529|NCT01632345|2910166|P3|Treatment: Part I|Physician Decision|0
913530|NCT01632345|2910167|P2|Treatment: Part I|Physician Decision|1
913531|NCT01632345|2910168|P1|Treatment: Part I|Physician Decision|2
913532|NCT01632345|2910162|P7|Treatment: Part I|Non-Compliance with Study Drug|0
913533|NCT01632345|2910163|P6|Treatment: Part I|Non-Compliance with Study Drug|0
913534|NCT01632345|2910164|P5|Treatment: Part I|Non-Compliance with Study Drug|0
913535|NCT01632345|2910165|P4|Treatment: Part I|Non-Compliance with Study Drug|1
913536|NCT01632345|2910166|P3|Treatment: Part I|Non-Compliance with Study Drug|2
913537|NCT01632345|2910167|P2|Treatment: Part I|Non-Compliance with Study Drug|2
913538|NCT01632345|2910168|P1|Treatment: Part I|Non-Compliance with Study Drug|3
913539|NCT01632345|2910162|P7|Treatment: Part I|Lost to Follow-up|0
913540|NCT01632345|2910163|P6|Treatment: Part I|Lost to Follow-up|0
913541|NCT01632345|2910164|P5|Treatment: Part I|Lost to Follow-up|4
913542|NCT01632345|2910165|P4|Treatment: Part I|Lost to Follow-up|3
913543|NCT01632345|2910166|P3|Treatment: Part I|Lost to Follow-up|1
913544|NCT01632345|2910167|P2|Treatment: Part I|Lost to Follow-up|2
913545|NCT01632345|2910168|P1|Treatment: Part I|Lost to Follow-up|3
913546|NCT01632345|2910162|P7|Treatment: Part I|Lack of Efficacy|0
913547|NCT01632345|2910163|P6|Treatment: Part I|Lack of Efficacy|0
913548|NCT01632345|2910164|P5|Treatment: Part I|Lack of Efficacy|1
913549|NCT01632345|2910165|P4|Treatment: Part I|Lack of Efficacy|1
913550|NCT01632345|2910166|P3|Treatment: Part I|Lack of Efficacy|0
913551|NCT01632345|2910167|P2|Treatment: Part I|Lack of Efficacy|1
913552|NCT01632345|2910168|P1|Treatment: Part I|Lack of Efficacy|0
913553|NCT01632345|2910162|P7|Treatment: Part I|Adverse Event|0
913554|NCT01632345|2910163|P6|Treatment: Part I|Adverse Event|0
913555|NCT01632345|2910164|P5|Treatment: Part I|Adverse Event|3
913556|NCT01632345|2910165|P4|Treatment: Part I|Adverse Event|1
913557|NCT01632345|2910166|P3|Treatment: Part I|Adverse Event|2
913558|NCT01632345|2910167|P2|Treatment: Part I|Adverse Event|4
913559|NCT01632345|2910168|P1|Treatment: Part I|Adverse Event|1
913560|NCT01487265|2910354|P1|Overall Study|Still on Treatment|1
913561|NCT01487265|2910354|P1|Overall Study|Death|2
913562|NCT01487265|2910354|P1|Overall Study|Disease Progression|21
913563|NCT01487265|2910354|P1|Overall Study|Withdrawal by Subject|5
913564|NCT01487265|2910354|P1|Overall Study|Adverse Event|8
913565|NCT01469221|2910364|P3|Double Blind Phase|Sponsor Terminate Study|0
913566|NCT01469221|2910365|P2|Double Blind Phase|Sponsor Terminate Study|16
913567|NCT01469221|2910366|P1|Double Blind Phase|Sponsor Terminate Study|12
913568|NCT01469221|2910364|P3|Double Blind Phase|Physician Decision|0
913569|NCT01469221|2910365|P2|Double Blind Phase|Physician Decision|1
913570|NCT01469221|2910366|P1|Double Blind Phase|Physician Decision|1
913571|NCT01469221|2910364|P3|Double Blind Phase|Protocol Violation|0
913572|NCT01469221|2910365|P2|Double Blind Phase|Protocol Violation|0
913573|NCT01469221|2910366|P1|Double Blind Phase|Protocol Violation|1
913574|NCT01444027|2910378|P3|Overall Study|Lost to Follow-up|14
913575|NCT01444027|2910379|P2|Overall Study|Lost to Follow-up|20
913576|NCT01444027|2910380|P1|Overall Study|Lost to Follow-up|26
913577|NCT01444027|2910378|P3|Overall Study|Withdrawal by Subject|24
913578|NCT01444027|2910379|P2|Overall Study|Withdrawal by Subject|10
913579|NCT01444027|2910380|P1|Overall Study|Withdrawal by Subject|4
913580|NCT01428128|2910400|P1|Overall Study|Adverse Event|1
913581|NCT01428128|2910400|P1|Overall Study|Received Neulasta in one cycle|2
913582|NCT01428128|2910400|P1|Overall Study|Screen failure by p53|10
913583|NCT01428128|2910400|P1|Overall Study|Withdrawal by Subject|4
913584|NCT01422538|2910408|P3|Overall Study|Missed visit|1
913585|NCT01422538|2910409|P2|Overall Study|Missed visit|1
913586|NCT01422538|2910410|P1|Overall Study|Missed visit|0
913587|NCT01422538|2910408|P3|Overall Study|Lost to Follow-up|1
913588|NCT01422538|2910409|P2|Overall Study|Lost to Follow-up|1
913589|NCT01422538|2910410|P1|Overall Study|Lost to Follow-up|0
913590|NCT01414855|2910432|P1|Overall Study|Withdrawal by Subject|7
913591|NCT01414855|2910432|P1|Overall Study|Lost to Follow-up|5
913592|NCT01414855|2910432|P1|Overall Study|Death|17
913593|NCT01397422|2910452|P4|Overall Study|Increased bradykinesia related to PD|0
913594|NCT01397422|2910453|P3|Overall Study|Increased bradykinesia related to PD|0
913595|NCT01397422|2910454|P2|Overall Study|Increased bradykinesia related to PD|0
913596|NCT01397422|2910455|P1|Overall Study|Increased bradykinesia related to PD|1
913597|NCT01397422|2910452|P4|Overall Study|Withdrawal by Subject|0
913598|NCT01397422|2910453|P3|Overall Study|Withdrawal by Subject|0
913599|NCT01397422|2910454|P2|Overall Study|Withdrawal by Subject|0
913600|NCT01397422|2910455|P1|Overall Study|Withdrawal by Subject|1
913601|NCT01397422|2910452|P4|Overall Study|Adverse Event|8
913602|NCT01397422|2910453|P3|Overall Study|Adverse Event|3
913603|NCT01397422|2910454|P2|Overall Study|Adverse Event|3
913604|NCT01397422|2910455|P1|Overall Study|Adverse Event|0
913605|NCT01368965|2910485|P1|Overall Study|Lost to Follow-up|12
913606|NCT01368900|2910494|P1|Overall Study|Lost to Follow-up|7
913607|NCT01368835|2910569|P1|Overall Study|Lost to Follow-up|11
913608|NCT01368835|2910569|P1|Overall Study|Inclusion criteria/photography quality|22
913609|NCT01339052|2910578|P2|Overall Study|Physician Decision|0
913610|NCT01339052|2910579|P1|Overall Study|Physician Decision|1
913611|NCT01339052|2910578|P2|Overall Study|Withdrawal by Subject|3
913612|NCT01339052|2910579|P1|Overall Study|Withdrawal by Subject|0
913613|NCT01339052|2910578|P2|Overall Study|Adverse Event|1
913614|NCT01339052|2910579|P1|Overall Study|Adverse Event|1
913615|NCT01339052|2910578|P2|Overall Study|Disease progression|46
913616|NCT01339052|2910579|P1|Overall Study|Disease progression|13
913617|NCT01285609|2910612|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
913618|NCT01285609|2910613|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
913619|NCT01285609|2910612|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
913620|NCT01285609|2910613|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
913621|NCT01285609|2910612|P2|Treated With Blinded Therapy|Not Reported|4
913622|NCT01285609|2910613|P1|Treated With Blinded Therapy|Not Reported|4
913623|NCT01285609|2910612|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
913624|NCT01285609|2910613|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
913625|NCT01285609|2910612|P2|Treated With Blinded Therapy|Death|3
913626|NCT01285609|2910613|P1|Treated With Blinded Therapy|Death|11
913627|NCT01285609|2910612|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
913628|NCT01285609|2910613|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
913629|NCT01285609|2910612|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
913630|NCT01285609|2910613|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
913631|NCT01285609|2910612|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
913632|NCT01285609|2910613|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
913633|NCT01285609|2910612|P2|Treated With Blinded Therapy|Progressive Disease|305
913634|NCT01285609|2910613|P1|Treated With Blinded Therapy|Progressive Disease|220
913635|NCT01285609|2910612|P2|Randomized|Randomized but not Treated|4
913636|NCT01285609|2910613|P1|Randomized|Randomized but not Treated|4
913637|NCT01285609|2910612|P2|Randomized|Undisclosed Reasons|0
913638|NCT01285609|2910613|P1|Randomized|Undisclosed Reasons|1
913639|NCT01285609|2910612|P2|Randomized|Subject No Longer Met Study Criteria|1
913640|NCT01285609|2910613|P1|Randomized|Subject No Longer Met Study Criteria|1
913641|NCT01285609|2910612|P2|Randomized|Withdrawal by Subject|11
913642|NCT01285609|2910613|P1|Randomized|Withdrawal by Subject|8
913643|NCT01285609|2910612|P2|Randomized|Death|7
913644|NCT01285609|2910613|P1|Randomized|Death|5
913645|NCT01285609|2910612|P2|Randomized|Study Drug Toxicity|14
913646|NCT01285609|2910613|P1|Randomized|Study Drug Toxicity|13
913647|NCT01285609|2910612|P2|Randomized|Adverse Event Unrelated to Study Drug|18
913648|NCT01285609|2910613|P1|Randomized|Adverse Event Unrelated to Study Drug|18
913649|NCT01285609|2910612|P2|Randomized|Progressive Disease|61
913650|NCT01285609|2910613|P1|Randomized|Progressive Disease|41
913651|NCT01231516|2910640|P2|Open-label Phase|Ongoing at the time of analysis|23
913652|NCT01231516|2910641|P1|Open-label Phase|Ongoing at the time of analysis|282
913653|NCT01231516|2910640|P2|Open-label Phase|Withdrawal by Subject|0
913654|NCT01231516|2910641|P1|Open-label Phase|Withdrawal by Subject|1
913655|NCT01231516|2910640|P2|Open-label Phase|Lost to Follow-up|0
913656|NCT01231516|2910641|P1|Open-label Phase|Lost to Follow-up|3
913657|NCT01231516|2910640|P2|Open-label Phase|Protocol Violation|0
913658|NCT01231516|2910641|P1|Open-label Phase|Protocol Violation|2
913659|NCT01231516|2910640|P2|Open-label Phase|Lack of Efficacy|3
913660|NCT01231516|2910641|P1|Open-label Phase|Lack of Efficacy|7
913661|NCT01231516|2910640|P2|48 Week Double-blind Phase|Site Closed|1
913662|NCT01231516|2910641|P1|48 Week Double-blind Phase|Site Closed|3
913663|NCT01231516|2910640|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
913664|NCT01231516|2910641|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
913665|NCT01231516|2910640|P2|48 Week Double-blind Phase|Physician Decision|1
913666|NCT01231516|2910641|P1|48 Week Double-blind Phase|Physician Decision|1
913667|NCT01231516|2910640|P2|48 Week Double-blind Phase|Lost to Follow-up|10
913668|NCT01231516|2910641|P1|48 Week Double-blind Phase|Lost to Follow-up|5
913669|NCT01231516|2910640|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
913670|NCT01231516|2910641|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
913671|NCT01231516|2910640|P2|48 Week Double-blind Phase|Protocol Violation|6
913672|NCT01231516|2910641|P1|48 Week Double-blind Phase|Protocol Violation|9
913673|NCT01231516|2910640|P2|48 Week Double-blind Phase|Lack of Efficacy|42
913674|NCT01231516|2910641|P1|48 Week Double-blind Phase|Lack of Efficacy|20
913675|NCT01231516|2910640|P2|48 Week Double-blind Phase|Adverse Event|11
913676|NCT01231516|2910641|P1|48 Week Double-blind Phase|Adverse Event|4
913677|NCT01198132|2910670|P2|Overall Study|Protocol Violation|0
913678|NCT01198132|2910671|P1|Overall Study|Protocol Violation|1
913679|NCT01198132|2910670|P2|Overall Study|Adverse Event|1
913680|NCT01198132|2910671|P1|Overall Study|Adverse Event|0
913681|NCT01198132|2910670|P2|Overall Study|Abnormal/clinically significant biologic|1
913682|NCT01198132|2910671|P1|Overall Study|Abnormal/clinically significant biologic|1
913683|NCT01198132|2910670|P2|Overall Study|Sign/symptoms of underlying disease|1
913684|NCT01198132|2910671|P1|Overall Study|Sign/symptoms of underlying disease|2
913685|NCT01198132|2910670|P2|Overall Study|Lack of Efficacy|3
913686|NCT01198132|2910671|P1|Overall Study|Lack of Efficacy|2
913687|NCT01198132|2910670|P2|Overall Study|Other Unspecified|6
913688|NCT01198132|2910671|P1|Overall Study|Other Unspecified|3
913689|NCT01198132|2910670|P2|Overall Study|Physician Decision|4
913690|NCT01198132|2910671|P1|Overall Study|Physician Decision|5
913691|NCT01198132|2910670|P2|Overall Study|Withdrawal by Subject|5
913692|NCT01198132|2910671|P1|Overall Study|Withdrawal by Subject|4
913693|NCT01186692|2910708|P1|Overall Study|Adverse Event|2
913694|NCT01186692|2910708|P1|Overall Study|Futher testing contraindicated implant|19
913695|NCT01186692|2910708|P1|Overall Study|Not Catheterized|11
913696|NCT01167179|2910727|P2|Overall Study|diverse|5
913697|NCT01167179|2910728|P1|Overall Study|diverse|6
913698|NCT01167179|2910727|P2|Overall Study|Withdrawal by Subject|2
913699|NCT01167179|2910728|P1|Overall Study|Withdrawal by Subject|1
913700|NCT01167179|2910727|P2|Overall Study|Death|10
913701|NCT01167179|2910728|P1|Overall Study|Death|4
913702|NCT01167179|2910727|P2|Overall Study|disease recurrence|4
913703|NCT01167179|2910728|P1|Overall Study|disease recurrence|4
913704|NCT01113801|2910784|P4|Overall Study|Clinical Endpoint (ESRD)|5
913705|NCT01113801|2910785|P3|Overall Study|Clinical Endpoint (ESRD)|2
913706|NCT01113801|2910786|P2|Overall Study|Clinical Endpoint (ESRD)|4
913707|NCT01113801|2910787|P1|Overall Study|Clinical Endpoint (ESRD)|7
913708|NCT01113801|2910784|P4|Overall Study|Sponsor Decision|15
913709|NCT01113801|2910785|P3|Overall Study|Sponsor Decision|20
913710|NCT01113801|2910786|P2|Overall Study|Sponsor Decision|21
913711|NCT01113801|2910787|P1|Overall Study|Sponsor Decision|15
913712|NCT01113801|2910784|P4|Overall Study|Physician Decision|3
913713|NCT01113801|2910785|P3|Overall Study|Physician Decision|3
913714|NCT01113801|2910786|P2|Overall Study|Physician Decision|2
913715|NCT01113801|2910787|P1|Overall Study|Physician Decision|2
913716|NCT01113801|2910784|P4|Overall Study|Withdrawal by Subject|8
913717|NCT01113801|2910785|P3|Overall Study|Withdrawal by Subject|7
913718|NCT01113801|2910786|P2|Overall Study|Withdrawal by Subject|7
913719|NCT01113801|2910787|P1|Overall Study|Withdrawal by Subject|9
913720|NCT01113801|2910784|P4|Overall Study|Protocol Violation|0
913721|NCT01113801|2910785|P3|Overall Study|Protocol Violation|0
913722|NCT01113801|2910786|P2|Overall Study|Protocol Violation|1
913723|NCT01113801|2910787|P1|Overall Study|Protocol Violation|0
913724|NCT01113801|2910784|P4|Overall Study|Death|4
913725|NCT01113801|2910785|P3|Overall Study|Death|3
913726|NCT01113801|2910786|P2|Overall Study|Death|5
913727|NCT01113801|2910787|P1|Overall Study|Death|4
913728|NCT01113801|2910784|P4|Overall Study|Adverse Event|6
913729|NCT01113801|2910785|P3|Overall Study|Adverse Event|2
913730|NCT01113801|2910786|P2|Overall Study|Adverse Event|0
913731|NCT01113801|2910787|P1|Overall Study|Adverse Event|4
913732|NCT01096667|2910837|P5|Overall Study|Not treated|0
913733|NCT01096667|2910838|P4|Overall Study|Not treated|0
913734|NCT01096667|2910839|P3|Overall Study|Not treated|0
913735|NCT01096667|2910840|P2|Overall Study|Not treated|0
913736|NCT01096667|2910841|P1|Overall Study|Not treated|1
913737|NCT01096667|2910837|P5|Overall Study|Protocol Violation|0
913738|NCT01096667|2910838|P4|Overall Study|Protocol Violation|1
913739|NCT01096667|2910839|P3|Overall Study|Protocol Violation|0
913740|NCT01096667|2910840|P2|Overall Study|Protocol Violation|0
913741|NCT01096667|2910841|P1|Overall Study|Protocol Violation|0
913742|NCT01096667|2910837|P5|Overall Study|Reason not available|0
913743|NCT01096667|2910838|P4|Overall Study|Reason not available|1
913744|NCT01096667|2910839|P3|Overall Study|Reason not available|1
913745|NCT01096667|2910840|P2|Overall Study|Reason not available|1
913746|NCT01096667|2910841|P1|Overall Study|Reason not available|0
913747|NCT01096667|2910837|P5|Overall Study|Withdrawal by Subject|0
913748|NCT01096667|2910838|P4|Overall Study|Withdrawal by Subject|1
913749|NCT01096667|2910839|P3|Overall Study|Withdrawal by Subject|0
913750|NCT01096667|2910840|P2|Overall Study|Withdrawal by Subject|0
913751|NCT01096667|2910841|P1|Overall Study|Withdrawal by Subject|1
913752|NCT01096667|2910837|P5|Overall Study|Lost to Follow-up|0
913753|NCT01096667|2910838|P4|Overall Study|Lost to Follow-up|0
913754|NCT01096667|2910839|P3|Overall Study|Lost to Follow-up|1
913755|NCT01096667|2910840|P2|Overall Study|Lost to Follow-up|1
913756|NCT01096667|2910841|P1|Overall Study|Lost to Follow-up|1
913757|NCT01076400|2910979|P3|Overall Study|Progressive Disease|0
913758|NCT01076400|2910980|P2|Overall Study|Progressive Disease|0
913759|NCT01076400|2910981|P1|Overall Study|Progressive Disease|5
913760|NCT01076400|2910979|P3|Overall Study|Adverse Event|0
913761|NCT01076400|2910980|P2|Overall Study|Adverse Event|0
913762|NCT01076400|2910981|P1|Overall Study|Adverse Event|2
913763|NCT01027416|2910989|P2|Overall Study|Physician Decision|4
913764|NCT01027416|2910990|P1|Overall Study|Physician Decision|1
913765|NCT01027416|2910989|P2|Overall Study|Withdrawal by Subject|1
913766|NCT01027416|2910990|P1|Overall Study|Withdrawal by Subject|0
913767|NCT00805194|2911044|P2|Overall Study|Reasons other than stated above|16
913768|NCT00805194|2911045|P1|Overall Study|Reasons other than stated above|20
913769|NCT00805194|2911044|P2|Overall Study|Not treated|4
913770|NCT00805194|2911045|P1|Overall Study|Not treated|3
913771|NCT00805194|2911044|P2|Overall Study|Withdrawal by Subject|42
913772|NCT00805194|2911045|P1|Overall Study|Withdrawal by Subject|60
913773|NCT00805194|2911044|P2|Overall Study|Lost to Follow-up|5
913774|NCT00805194|2911045|P1|Overall Study|Lost to Follow-up|5
913775|NCT00805194|2911044|P2|Overall Study|Protocol Violation|9
913776|NCT00805194|2911045|P1|Overall Study|Protocol Violation|9
913777|NCT00805194|2911044|P2|Overall Study|Other AE|73
913778|NCT00805194|2911045|P1|Overall Study|Other AE|84
913779|NCT00805194|2911044|P2|Overall Study|Worsening or AE of underlying disease|70
913780|NCT00805194|2911045|P1|Overall Study|Worsening or AE of underlying disease|64
913781|NCT00805194|2911044|P2|Overall Study|Progressive disease (modified RECIST)|435
913782|NCT00805194|2911045|P1|Overall Study|Progressive disease (modified RECIST)|404
913783|NCT00792909|2911080|P3|Overall Study|Withdrawal by Subject|0
913784|NCT00792909|2911081|P2|Overall Study|Withdrawal by Subject|1
913785|NCT00792909|2911082|P1|Overall Study|Withdrawal by Subject|0
913786|NCT00740220|2911135|P1|Overall Study|screen failures (non-COPD patients)|9
913787|NCT00688259|2911188|P2|Overall Study|Hospitalized at Follow-up|1
913788|NCT00688259|2911189|P1|Overall Study|Hospitalized at Follow-up|0
913789|NCT00688259|2911188|P2|Overall Study|Declined Interview|3
913790|NCT00688259|2911189|P1|Overall Study|Declined Interview|2
913791|NCT00688259|2911188|P2|Overall Study|Withdrawal by Subject|0
913792|NCT00688259|2911189|P1|Overall Study|Withdrawal by Subject|2
913793|NCT00688259|2911188|P2|Overall Study|Physician Decision|0
913794|NCT00688259|2911189|P1|Overall Study|Physician Decision|1
913795|NCT00688259|2911188|P2|Overall Study|Lost to Follow-up|4
913796|NCT00688259|2911189|P1|Overall Study|Lost to Follow-up|2
913797|NCT00683644|2911207|P2|Overall Study|Low copper, other health problems,|6
913798|NCT00683644|2911208|P1|Overall Study|Low copper, other health problems,|7
913799|NCT00683644|2911207|P2|Overall Study|Adverse Event|2
913800|NCT00683644|2911208|P1|Overall Study|Adverse Event|1
913801|NCT00683644|2911207|P2|Overall Study|Lost to Follow-up|4
913802|NCT00683644|2911208|P1|Overall Study|Lost to Follow-up|1
913803|NCT00683644|2911207|P2|Overall Study|Withdrawal by Subject|2
913804|NCT00683644|2911208|P1|Overall Study|Withdrawal by Subject|4
913805|NCT00675506|2911233|P2|Overall Study|Schedule conflict|1
913806|NCT00675506|2911234|P1|Overall Study|Schedule conflict|0
913807|NCT00675506|2911233|P2|Overall Study|Declined participation|0
913808|NCT00675506|2911234|P1|Overall Study|Declined participation|1
913809|NCT00675506|2911233|P2|Overall Study|Disclosed history of cancer|0
913810|NCT00675506|2911234|P1|Overall Study|Disclosed history of cancer|1
913811|NCT00675506|2911233|P2|Overall Study|Hypersensitivity Reaction|0
913812|NCT00675506|2911234|P1|Overall Study|Hypersensitivity Reaction|1
913813|NCT00675506|2911233|P2|Overall Study|Elevated IGF-1|0
913814|NCT00675506|2911234|P1|Overall Study|Elevated IGF-1|2
913815|NCT00675506|2911233|P2|Overall Study|Elevated IGF-1 prior to treatment|0
913816|NCT00675506|2911234|P1|Overall Study|Elevated IGF-1 prior to treatment|1
913817|NCT00675506|2911233|P2|Overall Study|Elevated fasting glucose|1
913818|NCT00675506|2911234|P1|Overall Study|Elevated fasting glucose|2
913819|NCT00675506|2911233|P2|Overall Study|Lost interest|5
913820|NCT00675506|2911234|P1|Overall Study|Lost interest|3
913821|NCT00675506|2911233|P2|Overall Study|Lost to Follow-up|5
913822|NCT00675506|2911234|P1|Overall Study|Lost to Follow-up|1
913823|NCT00597766|2911318|P3|Follow-up 2, Week 8|Lost to Follow-up|1
913824|NCT00597766|2911319|P2|Follow-up 2, Week 8|Lost to Follow-up|0
913825|NCT00597766|2911320|P1|Follow-up 2, Week 8|Lost to Follow-up|0
913826|NCT00597766|2911318|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
913827|NCT00597766|2911319|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
913828|NCT00597766|2911320|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
913829|NCT00585546|2911349|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
913830|NCT00585546|2911349|P1|Clenbuterol Treatment - up to 12 Months|Death|1
913831|NCT00572533|2911365|P2|Overall Study|Transfer out of Facility|1
913832|NCT00572533|2911366|P1|Overall Study|Transfer out of Facility|0
913833|NCT00572533|2911365|P2|Overall Study|Social Issues|0
913834|NCT00572533|2911366|P1|Overall Study|Social Issues|1
913835|NCT00572533|2911365|P2|Overall Study|Received Kidney Transplant|1
913836|NCT00572533|2911366|P1|Overall Study|Received Kidney Transplant|2
913837|NCT00572533|2911365|P2|Overall Study|Death|1
913838|NCT00572533|2911366|P1|Overall Study|Death|4
913839|NCT00541099|2911386|P1|Overall Study|Ineligible|3
913840|NCT00474266|2911403|P4|Overall Study|Withdrawal by Subject|7
913841|NCT00474266|2911404|P3|Overall Study|Withdrawal by Subject|4
913842|NCT00474266|2911405|P2|Overall Study|Withdrawal by Subject|20
913843|NCT00474266|2911406|P1|Overall Study|Withdrawal by Subject|7
913844|NCT00441142|2911537|P4|Overall Study|Death|1
913845|NCT00441142|2911538|P3|Overall Study|Death|0
913846|NCT00441142|2911539|P2|Overall Study|Death|0
913847|NCT00441142|2911540|P1|Overall Study|Death|0
913848|NCT00441142|2911537|P4|Overall Study|Physician Decision|1
913849|NCT00441142|2911538|P3|Overall Study|Physician Decision|0
913850|NCT00441142|2911539|P2|Overall Study|Physician Decision|1
913851|NCT00441142|2911540|P1|Overall Study|Physician Decision|0
913852|NCT00441142|2911537|P4|Overall Study|Patient still receiving active study tx|2
913853|NCT00441142|2911538|P3|Overall Study|Patient still receiving active study tx|0
913854|NCT00441142|2911539|P2|Overall Study|Patient still receiving active study tx|0
913855|NCT00441142|2911540|P1|Overall Study|Patient still receiving active study tx|1
913856|NCT00441142|2911537|P4|Overall Study|Withdrawal by Subject|10
913857|NCT00441142|2911538|P3|Overall Study|Withdrawal by Subject|2
913858|NCT00441142|2911539|P2|Overall Study|Withdrawal by Subject|0
913859|NCT00441142|2911540|P1|Overall Study|Withdrawal by Subject|0
913860|NCT00441142|2911537|P4|Overall Study|Lack of Efficacy|32
913861|NCT00441142|2911538|P3|Overall Study|Lack of Efficacy|17
913862|NCT00441142|2911539|P2|Overall Study|Lack of Efficacy|3
913863|NCT00441142|2911540|P1|Overall Study|Lack of Efficacy|3
913864|NCT00441142|2911537|P4|Overall Study|Adverse Event|22
913865|NCT00441142|2911538|P3|Overall Study|Adverse Event|3
913866|NCT00441142|2911539|P2|Overall Study|Adverse Event|3
913867|NCT00441142|2911540|P1|Overall Study|Adverse Event|2
913868|NCT00404768|2911576|P4|Part C|Researcher suspended study medication|1
913869|NCT00404768|2911577|P3|Part C|Researcher suspended study medication|0
913870|NCT00404768|2911578|P2|Part C|Researcher suspended study medication|0
913871|NCT00404768|2911579|P1|Part C|Researcher suspended study medication|0
913872|NCT00404768|2911576|P4|Part C|Investigator discretion|1
913873|NCT00404768|2911577|P3|Part C|Investigator discretion|0
913874|NCT00404768|2911578|P2|Part C|Investigator discretion|0
913875|NCT00404768|2911579|P1|Part C|Investigator discretion|0
913876|NCT00404768|2911576|P4|Part C|Treatment failure|1
913877|NCT00404768|2911577|P3|Part C|Treatment failure|0
913878|NCT00404768|2911578|P2|Part C|Treatment failure|0
913879|NCT00404768|2911579|P1|Part C|Treatment failure|0
913880|NCT00404768|2911576|P4|Part C|Lack of Efficacy|2
913881|NCT00404768|2911577|P3|Part C|Lack of Efficacy|0
913882|NCT00404768|2911578|P2|Part C|Lack of Efficacy|0
913883|NCT00404768|2911579|P1|Part C|Lack of Efficacy|0
913884|NCT00404768|2911576|P4|Part C|Active labor|1
913885|NCT00404768|2911577|P3|Part C|Active labor|0
913886|NCT00404768|2911578|P2|Part C|Active labor|0
913887|NCT00404768|2911579|P1|Part C|Active labor|0
913888|NCT00404768|2911576|P4|Part C|Unsatisfactory uterine response to IP|1
913889|NCT00404768|2911577|P3|Part C|Unsatisfactory uterine response to IP|0
913890|NCT00404768|2911578|P2|Part C|Unsatisfactory uterine response to IP|0
913891|NCT00404768|2911579|P1|Part C|Unsatisfactory uterine response to IP|0
913892|NCT00404768|2911576|P4|Part C|Participant delivered baby|1
913893|NCT00404768|2911577|P3|Part C|Participant delivered baby|0
913894|NCT00404768|2911578|P2|Part C|Participant delivered baby|0
913895|NCT00404768|2911579|P1|Part C|Participant delivered baby|0
913896|NCT00404768|2911576|P4|Part C|Physician withdrew the study medication|0
913897|NCT00404768|2911577|P3|Part C|Physician withdrew the study medication|1
913898|NCT00404768|2911578|P2|Part C|Physician withdrew the study medication|0
913899|NCT00404768|2911579|P1|Part C|Physician withdrew the study medication|0
913900|NCT00404768|2911576|P4|Part C|Participant did not respond to therapy|1
913901|NCT00404768|2911577|P3|Part C|Participant did not respond to therapy|1
913902|NCT00404768|2911578|P2|Part C|Participant did not respond to therapy|0
913903|NCT00404768|2911579|P1|Part C|Participant did not respond to therapy|0
913904|NCT00404768|2911576|P4|Part C|Early withdrawal from study medication|0
913905|NCT00404768|2911577|P3|Part C|Early withdrawal from study medication|1
913906|NCT00404768|2911578|P2|Part C|Early withdrawal from study medication|0
913907|NCT00404768|2911579|P1|Part C|Early withdrawal from study medication|0
913908|NCT00404768|2911576|P4|Part C|Withdrawal by Subject|1
913909|NCT00404768|2911577|P3|Part C|Withdrawal by Subject|2
913910|NCT00404768|2911578|P2|Part C|Withdrawal by Subject|0
913911|NCT00404768|2911579|P1|Part C|Withdrawal by Subject|0
913912|NCT00404768|2911576|P4|Part C|Lost to Follow-up|1
913913|NCT00404768|2911577|P3|Part C|Lost to Follow-up|3
913914|NCT00404768|2911578|P2|Part C|Lost to Follow-up|0
913915|NCT00404768|2911579|P1|Part C|Lost to Follow-up|0
913916|NCT00404768|2911576|P4|Part C|Adverse Event|3
913917|NCT00404768|2911577|P3|Part C|Adverse Event|0
913918|NCT00404768|2911578|P2|Part C|Adverse Event|0
913919|NCT00404768|2911579|P1|Part C|Adverse Event|0
913920|NCT00404768|2911576|P4|Part A and B|Withdrawn as delivery imminemnt|0
913921|NCT00404768|2911577|P3|Part A and B|Withdrawn as delivery imminemnt|0
913922|NCT00404768|2911578|P2|Part A and B|Withdrawn as delivery imminemnt|1
913923|NCT00404768|2911579|P1|Part A and B|Withdrawn as delivery imminemnt|0
913924|NCT00404768|2911576|P4|Part A and B|Withdrawn due to labor progression|0
913925|NCT00404768|2911577|P3|Part A and B|Withdrawn due to labor progression|0
913926|NCT00404768|2911578|P2|Part A and B|Withdrawn due to labor progression|0
913927|NCT00404768|2911579|P1|Part A and B|Withdrawn due to labor progression|1
913928|NCT00390546|2911642|P2|Overall Study|Physician Decision|5
913929|NCT00390546|2911643|P1|Overall Study|Physician Decision|5
913930|NCT00390546|2911642|P2|Overall Study|Renal impairment|0
913931|NCT00390546|2911643|P1|Overall Study|Renal impairment|1
913932|NCT00375609|2911656|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
913933|NCT00375609|2911657|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
913934|NCT00375609|2911658|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
913935|NCT00375609|2911656|P3|Overall Study|Withdrawal by Subject|0
913936|NCT00375609|2911657|P2|Overall Study|Withdrawal by Subject|4
913937|NCT00375609|2911658|P1|Overall Study|Withdrawal by Subject|1
913938|NCT00375609|2911656|P3|Overall Study|Physician Decision|1
913939|NCT00375609|2911657|P2|Overall Study|Physician Decision|0
913940|NCT00375609|2911658|P1|Overall Study|Physician Decision|0
913941|NCT00375609|2911656|P3|Overall Study|Lost to Follow-up|0
913942|NCT00375609|2911657|P2|Overall Study|Lost to Follow-up|0
913943|NCT00375609|2911658|P1|Overall Study|Lost to Follow-up|1
913944|NCT00375609|2911656|P3|Overall Study|Adverse Event|0
913945|NCT00375609|2911657|P2|Overall Study|Adverse Event|3
913946|NCT00375609|2911658|P1|Overall Study|Adverse Event|0
913947|NCT00375609|2911656|P3|Overall Study|Did not receive treatment|0
913948|NCT00375609|2911657|P2|Overall Study|Did not receive treatment|0
913949|NCT00375609|2911658|P1|Overall Study|Did not receive treatment|1
913950|NCT00304356|2911672|P1|Nitazoxanide|Physician Decision|1
913951|NCT00304356|2911672|P1|Nitazoxanide|Physician Decision|1
913952|NCT00304356|2911672|P1|Nitazoxanide|Physician Decision|1
913953|NCT00304356|2911672|P1|Nitazoxanide|number is 0|1
913954|NCT00304356|2911672|P1|Nitazoxanide|Physician Decision|1
913955|NCT00304356|2911672|P1|Nitazoxanide|Physician Decision|5
913956|NCT00301808|2911676|P1|Overall Study|Lack of Efficacy|4
913957|NCT00301808|2911676|P1|Overall Study|Death|3
913958|NCT00301808|2911676|P1|Overall Study|Adverse Event|5
913959|NCT00246740|2911729|P2|Initial Enrollment|Other|2
913960|NCT00246740|2911730|P1|Initial Enrollment|Other|1
913961|NCT00246740|2911729|P2|Initial Enrollment|Surgery schedule change|4
913962|NCT00246740|2911730|P1|Initial Enrollment|Surgery schedule change|4
913963|NCT00246740|2911729|P2|Initial Enrollment|Additional surgery scheduled|2
913964|NCT00246740|2911730|P1|Initial Enrollment|Additional surgery scheduled|0
913965|NCT00246740|2911729|P2|Initial Enrollment|Death|0
913966|NCT00246740|2911730|P1|Initial Enrollment|Death|1
913967|NCT00126568|2911791|P1|Overall Study|Death|2
913968|NCT00098020|2911798|P1|Overall Study|Low epidermal growth factor receptor|1
913969|NCT00098020|2911798|P1|Overall Study|Low urine PCR|1
913970|NCT00098020|2911798|P1|Overall Study|elevated liver enzymes|1
913971|NCT00098020|2911798|P1|Overall Study|Lost to Follow-up|1
913972|NCT00098020|2911798|P1|Overall Study|Adverse Event|2
913973|NCT00065065|2911805|P2|Overall Study|Other|2
913974|NCT00065065|2911806|P1|Overall Study|Other|2
913975|NCT00065065|2911805|P2|Overall Study|Lack of Efficacy|11
913976|NCT00065065|2911806|P1|Overall Study|Lack of Efficacy|4
913977|NCT00065065|2911805|P2|Overall Study|Withdrawal by Subject|5
913978|NCT00065065|2911806|P1|Overall Study|Withdrawal by Subject|1
913979|NCT00065065|2911805|P2|Overall Study|Adverse Event|2
913980|NCT00065065|2911806|P1|Overall Study|Adverse Event|3
913981|NCT00003830|2911818|P2|Overall Study|Sentinel node positive patients|793
913982|NCT00003830|2911819|P1|Overall Study|Sentinel node positive patients|829
913983|NCT00003830|2911818|P2|Overall Study|No follow up data|0
913984|NCT00003830|2911819|P1|Overall Study|No follow up data|3
913985|NCT00003474|2911843|P1|Overall Study|Not Evaluable|14
913986|NCT00003456|2911848|P1|Overall Study|Not evaluable|8
913987|NCT00003471|2911853|P1|Overall Study|Not evaluable|4
913988|NCT00009945|2911860|P2|Overall Study|no follow up data|5
913989|NCT00009945|2911861|P1|Overall Study|no follow up data|7
913990|NCT00003535|2911875|P1|Overall Study|Not evaluable|5
913991|NCT00003472|2911880|P1|Overall Study|Not evaluable|3
